data_2m6k_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2m6k _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -99.7 135.54 40.96 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.1 0.476 . . . . 0.0 110.406 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.48 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -92.51 178.71 1.56 Allowed Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.403 -179.686 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.48 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 27.0 Cg_exo -61.66 147.44 95.34 Favored 'Trans proline' 0 C--N 1.303 -1.833 0 C-N-CA 122.909 2.406 . . . . 0.0 112.214 179.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 35.2 ptt180 -136.32 142.61 43.88 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.571 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -79.94 116.77 20.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.509 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.4 tp -111.45 130.53 64.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.487 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.1 t -71.24 142.5 50.56 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.607 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.519 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.4 t0 -139.45 -179.96 6.2 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.504 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.519 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 78.1 p -73.88 -37.23 64.79 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.683 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -46.69 -94.72 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.304 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.421 ' O ' ' OG1' ' A' ' 36' ' ' THR . . . -166.53 -26.75 0.02 OUTLIER Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.421 ' OG1' ' O ' ' A' ' 35' ' ' GLY . 62.4 m -168.63 105.64 0.44 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.707 0.289 . . . . 0.0 110.531 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 70.0 t60 -129.01 146.63 50.93 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.224 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.482 ' CG2' ' N ' ' A' ' 39' ' ' LEU . 98.8 m -129.96 165.57 21.83 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.377 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.482 ' N ' ' CG2' ' A' ' 38' ' ' THR . 77.9 mt -120.2 127.28 52.3 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.654 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -65.42 -44.91 85.91 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.592 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 37.5 p -165.78 154.95 11.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.55 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.469 ' N ' ' CD ' ' A' ' 42' ' ' GLN . 14.7 mp0 -44.51 101.02 0.24 Allowed Pre-proline 0 C--O 1.235 0.302 0 O-C-N 123.564 0.54 . . . . 0.0 110.467 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -57.61 130.07 36.94 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.449 2.099 . . . . 0.0 112.111 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -82.95 -24.76 32.86 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.573 179.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.537 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.9 mtm-85 -121.23 134.33 55.19 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.995 0.426 . . . . 0.0 110.287 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.3 mt -130.22 133.26 64.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.515 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 46.2 t -124.73 131.04 73.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-O 121.002 0.429 . . . . 0.0 110.163 178.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.503 ' O ' ' O ' ' A' ' 66' ' ' ALA . 4.2 m -154.67 166.42 33.45 Favored 'General case' 0 C--O 1.224 -0.241 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.461 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 72.6 p -124.41 9.11 8.45 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.483 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.1 t -85.65 125.68 33.34 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.942 0.401 . . . . 0.0 110.577 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 90.1 t -65.66 -44.52 93.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.546 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.0 m -62.51 -44.45 96.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.686 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 54.7 tp -62.35 -41.52 98.66 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.65 -179.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 70.5 m -57.88 -44.61 86.8 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.219 -179.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.39 -62.05 5.45 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.5 t -47.55 -35.94 9.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.79 0.328 . . . . 0.0 110.144 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.7 mt -61.87 -44.64 96.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.909 0.385 . . . . 0.0 110.976 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.0 mp -65.17 -41.32 94.74 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.292 178.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.78 -41.19 97.99 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.631 -179.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 7.9 tp -88.06 16.62 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.673 -179.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 56.33 84.09 0.09 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.795 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.21 57.11 0.06 OUTLIER Pre-proline 0 C--N 1.327 -0.371 0 CA-C-O 121.018 0.437 . . . . 0.0 109.907 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -50.17 153.72 6.45 Favored 'Trans proline' 0 C--N 1.298 -2.096 0 C-N-CA 122.972 2.448 . . . . 0.0 112.492 -178.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.425 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -109.15 146.12 15.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.238 -179.728 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 97.0 mt -63.78 -45.08 98.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.116 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.503 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -130.32 134.21 47.02 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.775 0.321 . . . . 0.0 110.266 -179.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.494 ' O ' ' N ' ' A' ' 98' ' ' LEU . 72.9 m -134.47 158.71 43.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.805 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.71 139.35 16.37 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.716 -0.954 . . . . 0.0 110.716 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.46 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.78 -162.67 0.08 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.798 0.333 . . . . 0.0 110.384 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.467 ' O ' ' C ' ' A' ' 71' ' ' THR . 5.9 t -133.97 135.36 43.43 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.096 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.467 ' C ' ' O ' ' A' ' 70' ' ' THR . 0.8 OUTLIER 29.47 68.71 0.64 Allowed Pre-proline 0 N--CA 1.468 0.475 0 CA-C-O 121.216 0.532 . . . . 0.0 110.84 -179.48 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -60.86 144.79 99.63 Favored 'Trans proline' 0 C--N 1.302 -1.911 0 C-N-CA 122.776 2.317 . . . . 0.0 112.064 -178.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.528 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 46.3 p-10 -159.79 -31.83 0.06 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.667 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.528 ' N ' ' OD1' ' A' ' 73' ' ' ASN . 99.0 m-20 -64.29 -39.36 93.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.421 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.6 ttt180 -60.39 -48.46 81.64 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.436 -179.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.425 ' O ' ' O ' ' A' ' 77' ' ' ALA . 93.7 t -60.05 -24.52 30.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.172 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.425 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -45.82 172.95 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.53 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.57 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.5 p30 -61.94 177.64 0.43 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.433 -179.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.599 ' C ' ' H ' ' A' ' 81' ' ' GLY . 35.5 p30 -45.9 85.44 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.807 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.57 ' N ' ' O ' ' A' ' 78' ' ' ASP . 42.2 tp60 -67.14 13.65 0.06 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.261 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.599 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 117.94 -22.31 9.9 Favored Glycine 0 N--CA 1.463 0.471 0 N-CA-C 110.874 -0.891 . . . . 0.0 110.874 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -107.94 116.17 31.47 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.873 0.368 . . . . 0.0 110.348 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 75.9 mt -98.68 0.67 45.13 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.474 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -92.19 6.8 45.28 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.344 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.435 ' O ' ' CG2' ' A' ' 89' ' ' VAL . 88.2 mt-30 -99.91 -28.18 13.23 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.564 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 68.6 t-105 -63.44 -40.91 98.42 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.705 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.545 ' O ' ' N ' ' A' ' 91' ' ' LYS . 64.5 m -77.49 -53.68 7.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.873 -179.177 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -48.4 -51.01 28.58 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.801 -178.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.435 ' CG2' ' O ' ' A' ' 85' ' ' GLN . 16.0 m -68.92 -40.68 81.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.891 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.411 ' H ' HG23 ' A' ' 89' ' ' VAL . . . -72.27 -22.72 61.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.695 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.545 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.0 tttm -61.57 -45.92 92.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.449 -179.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.436 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.7 mm-40 -90.16 -94.58 0.12 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.198 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.609 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.9 mtt180 -143.38 59.3 1.4 Allowed 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.434 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.6 pttp 33.92 26.24 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 O-C-N 123.588 0.555 . . . . 0.0 110.487 -179.198 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.609 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.5 tt -48.29 123.07 5.94 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.648 -177.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -83.11 -170.48 3.06 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.399 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.619 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 82.8 mtp180 -73.42 137.78 44.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.229 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.494 ' N ' ' O ' ' A' ' 67' ' ' SER . 88.9 mt -86.13 -166.37 1.52 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.807 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.53 ' CD2' ' O ' ' A' ' 99' ' ' TYR . 46.9 p90 -167.77 119.83 0.88 Allowed 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.106 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.487 ' C ' ' O ' ' A' ' 99' ' ' TYR . 43.2 mm -29.63 121.33 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 O-C-N 123.482 0.489 . . . . 0.0 110.891 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 113.28 28.59 3.26 Favored Glycine 0 N--CA 1.464 0.504 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.578 ' N ' ' CD ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -143.86 45.45 0.56 Allowed Pre-proline 0 C--N 1.324 -0.504 0 CA-C-O 121.321 0.582 . . . . 0.0 110.502 179.795 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 30.6 Cg_endo -61.95 143.94 95.91 Favored 'Trans proline' 0 C--N 1.298 -2.123 0 C-N-CA 122.614 2.209 . . . . 0.0 112.014 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.693 ' HG ' ' H ' ' A' ' 107' ' ' ALA . 21.9 t -173.18 120.84 0.36 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.534 179.311 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.3 -40.74 64.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.215 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.16 -40.29 90.42 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.69 -179.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.693 ' H ' ' HG ' ' A' ' 104' ' ' SER . . . -64.1 -39.98 95.22 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.659 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 69.4 t -67.71 -43.8 86.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.634 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.37 -39.19 92.36 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.521 -179.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.436 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.6 -23.23 62.79 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.596 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.519 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.3 mm-40 -90.95 4.31 52.3 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.716 -179.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.537 ' O ' ' NE ' ' A' ' 45' ' ' ARG . 10.3 tpt 23.97 63.82 0.4 Allowed Pre-proline 0 N--CA 1.471 0.602 0 O-C-N 123.622 0.576 . . . . 0.0 110.986 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -78.63 168.22 21.49 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 123.019 2.48 . . . . 0.0 112.075 -178.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.511 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 98.8 m-20 -112.56 -43.78 3.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.292 179.379 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.0 tp -121.03 120.09 34.36 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.262 178.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 96.8 mt -117.14 131.14 70.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.719 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 30.1 mt -106.07 132.32 52.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.218 -179.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 98.3 mt -118.08 136.71 54.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.495 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 86.6 p -71.98 152.3 42.59 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.565 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -59.97 -50.05 75.26 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.535 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -149.19 153.52 37.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.513 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 169.76 -170.73 42.95 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -63.07 -35.05 91.56 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.444 ' O ' ' OD1' ' A' ' 124' ' ' ASP . 43.9 p-10 -87.8 120.34 29.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.892 0.377 . . . . 0.0 110.635 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 41.0 t -63.34 143.68 57.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.469 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.516 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.6 -42.74 9.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.647 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.5 tp -62.79 -42.42 99.7 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.761 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.01 -10.63 55.14 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.413 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 83.4 mt -115.59 -24.39 8.32 Favored 'General case' 0 C--O 1.224 -0.238 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.533 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . 0.516 ' N ' ' O ' ' A' ' 126' ' ' ALA . 75.1 t80 -51.39 -49.93 60.59 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.96 -0.296 . . . . 0.0 110.531 -178.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.502 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 37.6 p-10 -65.95 -42.13 90.36 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.933 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.502 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 88.2 mt-30 -67.66 -36.76 81.33 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.73 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 94.3 mt -80.22 -41.85 24.37 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.025 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.4 t -57.16 -44.88 83.88 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.204 -179.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.3 m -62.2 -45.48 93.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.616 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 92.2 mt -62.54 -43.81 98.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.336 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -170.05 163.47 6.4 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.563 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -43.1 111.86 0.25 Allowed 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.576 2.184 . . . . 0.0 112.068 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 17.2 m -85.64 127.72 34.56 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.328 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 34.0 tp -119.45 137.23 53.91 Favored 'General case' 0 C--N 1.334 -0.078 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.404 179.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.431 ' O ' ' OD2' ' A' ' 32' ' ' ASP . 80.7 mt -103.4 119.75 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.844 -178.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 97.2 mt -135.75 133.09 51.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.607 179.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.509 HD22 ' CG ' ' A' ' 241' ' ' ASP . 60.9 t30 -65.2 150.93 47.35 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.41 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.512 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 88.2 t80 -85.91 122.38 29.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.725 -179.2 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.512 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 99.1 m-20 55.38 69.34 0.74 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.497 179.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 43.4 p-10 -126.64 0.54 6.81 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.537 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -150.34 114.79 5.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.833 0.349 . . . . 0.0 110.547 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' SER . . . . . 0.521 ' HG ' ' H ' ' A' ' 150' ' ' GLN . 84.8 p -62.69 168.23 3.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.594 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.408 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.6 p-90 -51.44 -15.86 0.48 Allowed 'General case' 0 C--O 1.22 -0.461 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.299 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . 0.521 ' H ' ' HG ' ' A' ' 148' ' ' SER . 68.3 tp60 -70.49 -75.44 0.12 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.998 0.427 . . . . 0.0 110.613 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.445 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.2 t -62.53 -38.82 91.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.298 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 52.8 tp -60.13 -45.6 92.45 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.511 -178.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.408 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 45.8 tp -62.74 -41.59 99.26 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.604 178.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.445 ' OG1' ' O ' ' A' ' 151' ' ' SER . 59.1 p -63.67 -35.03 79.2 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.275 -179.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . 0.459 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.8 mm-40 -63.67 -42.14 98.1 Favored 'General case' 0 C--O 1.226 -0.161 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.36 179.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 91.3 mt -65.3 -39.09 92.05 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.483 178.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.564 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -60.99 -32.29 79.63 Favored Glycine 0 C--N 1.33 0.237 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 -179.339 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.459 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.3 mt-10 -36.63 -25.38 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.823 0.344 . . . . 0.0 110.937 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.564 ' N ' ' O ' ' A' ' 157' ' ' GLY . 95.3 mt -58.81 148.83 6.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.455 178.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 70.8 p -69.15 137.6 53.48 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.841 -179.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 70.69 21.92 77.95 Favored Glycine 0 CA--C 1.521 0.41 0 N-CA-C 111.085 -0.806 . . . . 0.0 111.085 179.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 59.7 m80 -124.18 -14.18 7.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.562 0.22 . . . . 0.0 110.506 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -66.14 -59.96 3.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.542 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -51.39 -49.42 61.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.086 -179.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -60.58 -40.97 93.66 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.883 0.373 . . . . 0.0 110.495 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.62 -47.42 85.52 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.548 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.77 -40.06 75.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.311 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -61.64 -50.46 72.44 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.697 179.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 60.1 ttt85 -65.28 -43.79 90.07 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.46 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 95.3 mt -64.4 -43.53 97.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.484 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.33 -51.06 70.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.379 -179.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.76 -43.6 95.92 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.875 0.369 . . . . 0.0 110.521 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . 0.502 ' CD1' ' OH ' ' A' ' 301' ' ' TYR . 56.7 t80 -62.54 -44.39 96.47 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.435 179.393 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -63.66 -39.68 94.96 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.378 -179.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -63.08 -42.52 99.65 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.753 179.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -60.64 -44.94 95.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.209 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 85.4 mt -64.31 -41.1 97.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.943 178.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.13 -61.99 1.92 Allowed 'General case' 0 C--O 1.238 0.472 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.499 -179.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.71 -46.83 86.45 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.472 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.12 -41.59 65.18 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.329 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -63.75 -33.99 76.89 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.33 179.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 69.3 tt0 -90.75 8.56 34.01 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.39 0.614 . . . . 0.0 110.283 -178.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -104.3 -32.23 9.18 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.944 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.8 pt -128.09 147.81 32.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.865 0.364 . . . . 0.0 110.58 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -139.71 131.13 26.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.538 178.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . 0.549 ' CD2' ' N ' ' A' ' 186' ' ' LEU . 3.6 mm? -85.35 133.46 42.41 Favored Pre-proline 0 N--CA 1.447 -0.606 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.107 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -44.1 157.83 0.14 Allowed 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.581 2.188 . . . . 0.0 112.188 179.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . 0.489 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.7 Cg_endo -63.35 115.0 2.74 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.815 2.344 . . . . 0.0 111.561 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . 0.489 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.7 mt-30 156.05 148.14 0.0 OUTLIER Pre-proline 0 C--N 1.34 0.178 0 O-C-N 124.353 1.033 . . . . 0.0 110.94 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -73.75 144.48 35.23 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 C-N-CA 122.601 2.201 . . . . 0.0 111.765 177.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.482 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.1 p -124.81 159.04 31.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.206 0.527 . . . . 0.0 110.168 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' THR . . . . . 0.482 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 37.2 p -143.26 165.29 27.88 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 121.428 0.633 . . . . 0.0 110.852 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -135.32 128.91 32.63 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 121.276 0.56 . . . . 0.0 110.422 178.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 47.6 pt -146.64 149.09 16.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.849 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 73.6 t -117.78 123.1 71.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.08 0.467 . . . . 0.0 110.036 178.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 58.1 t80 -134.3 106.45 7.12 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.348 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 95.3 m -130.31 130.49 44.56 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.786 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.408 ' O ' ' N ' ' A' ' 201' ' ' HIS . . . -82.99 -36.58 24.93 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.26 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.41 -67.26 0.25 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.351 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.12 -9.45 58.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.446 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . 0.408 ' N ' ' O ' ' A' ' 198' ' ' ALA . 60.7 t-80 60.51 58.26 2.55 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.749 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 34.9 p -167.28 153.91 8.3 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.601 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.56 144.27 24.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.897 0.379 . . . . 0.0 110.417 179.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -135.32 138.49 43.48 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.41 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 18.2 mt -106.25 125.23 50.75 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.062 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' TRP . . . . . 0.556 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 74.8 m95 -82.31 167.74 18.27 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.563 -179.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -157.62 171.7 7.1 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.611 -178.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -53.92 -37.09 85.46 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 C-N-CA 122.743 2.296 . . . . 0.0 111.992 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -70.77 -34.9 72.3 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.734 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 21.4 m -61.5 150.94 34.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.51 -179.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.76 -36.92 82.43 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.42 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' GLN . . . . . 0.556 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 55.0 tt0 -64.63 -40.29 95.22 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.59 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.88 -43.27 91.87 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -63.07 -43.97 97.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.85 0.357 . . . . 0.0 110.239 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 65.2 ttp -59.42 -47.79 84.11 Favored 'General case' 0 N--CA 1.461 0.103 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.207 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 86.4 mt -60.53 -40.72 92.54 Favored 'General case' 0 CA--C 1.517 -0.303 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' GLU . . . . . 0.448 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.1 tp10 -57.96 -38.04 75.26 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.201 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -65.51 -37.96 88.29 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.725 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 96.0 mt -64.28 -42.76 96.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.655 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.72 44.9 0.08 OUTLIER Glycine 0 N--CA 1.463 0.444 0 N-CA-C 111.079 -0.808 . . . . 0.0 111.079 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' PHE . . . . . 0.448 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 26.9 m-85 -127.89 155.75 43.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.761 0.315 . . . . 0.0 110.498 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' THR . . . . . 0.45 ' O ' ' O ' ' A' ' 191' ' ' VAL . 7.4 p -107.42 122.52 46.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.21 0.529 . . . . 0.0 110.229 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . 0.44 ' CD2' ' N ' ' A' ' 223' ' ' LEU . 4.3 mm? -101.34 133.16 46.37 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.002 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.74 159.4 14.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.433 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.31 115.0 29.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.404 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.451 ' CD1' ' N ' ' A' ' 226' ' ' LEU . 8.9 mp -52.91 156.72 3.23 Favored Pre-proline 0 N--CA 1.446 -0.649 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.794 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -60.47 145.49 98.62 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.719 2.279 . . . . 0.0 112.013 179.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.2 -3.36 59.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.529 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -89.93 -41.26 5.66 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . 0.506 ' O ' ' N ' ' A' ' 233' ' ' SER . 68.3 mt -79.23 -17.15 55.33 Favored 'General case' 0 C--O 1.219 -0.532 0 CA-C-O 120.923 0.392 . . . . 0.0 110.31 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 54.4 t-20 -40.33 -49.73 2.77 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.862 0.363 . . . . 0.0 110.709 -179.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -87.7 15.43 6.91 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.115 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' SER . . . . . 0.506 ' N ' ' O ' ' A' ' 230' ' ' LEU . 77.9 p -60.33 -35.24 75.17 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.601 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . 0.521 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.6 tt0 -119.64 -69.18 0.86 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.73 0.3 . . . . 0.0 110.679 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.3 m -69.58 102.59 1.88 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.538 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -94.28 57.4 2.32 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.357 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -144.73 -122.41 1.56 Allowed Glycine 0 N--CA 1.462 0.426 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -135.42 111.71 9.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.898 0.38 . . . . 0.0 110.379 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . 0.525 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.4 mtt180 -148.28 58.14 1.08 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.578 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -69.38 -32.7 71.9 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.618 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' ASP . . . . . 0.509 ' CG ' HD22 ' A' ' 143' ' ' ASN . 65.2 t0 -56.7 -47.3 80.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.312 -179.001 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' ILE . . . . . 0.434 ' O ' ' O ' ' A' ' 239' ' ' ARG . 18.0 tt -139.39 155.92 26.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.358 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 96.3 mt -106.08 106.49 20.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.406 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . 0.525 ' OE1' ' NH1' ' A' ' 239' ' ' ARG . 88.2 mt-30 -110.57 109.96 20.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.291 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 9.5 mp -121.59 -168.09 1.63 Allowed 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.723 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . 0.521 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.7 -16.46 0.05 OUTLIER Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . 0.691 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -61.14 156.31 33.85 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -63.33 21.81 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.772 0.32 . . . . 0.0 110.629 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . 0.691 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.9 m-20 -97.41 -6.3 34.33 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.407 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 92.0 mt -79.36 -21.98 45.05 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.945 179.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.7 -51.21 70.91 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.647 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.39 -5.74 58.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.372 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -80.87 -74.49 1.13 Allowed Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 80.9 mt -69.99 126.14 28.81 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.455 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -59.64 -39.19 83.56 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.281 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 82.63 51.94 4.11 Favored Glycine 0 CA--C 1.521 0.426 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -95.89 -15.07 22.66 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 121.199 -0.201 . . . . 0.0 110.634 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 258' ' ' SER . . . . . 0.42 ' O ' ' O ' ' A' ' 192' ' ' THR . 3.5 t 174.85 88.71 0.0 OUTLIER 'General case' 0 C--O 1.224 -0.257 0 CA-C-O 121.089 0.471 . . . . 0.0 110.294 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . 0.589 ' N ' ' CD1' ' A' ' 259' ' ' LEU . 0.9 OUTLIER -94.5 124.27 38.43 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.774 0.321 . . . . 0.0 110.874 -178.666 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 15.7 m-30 -93.52 146.13 24.01 Favored 'General case' 0 CA--C 1.499 -0.999 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.541 179.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 85.3 mt -122.09 149.03 44.14 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.517 -179.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.655 ' CG ' ' N ' ' A' ' 263' ' ' ALA . 2.5 p90 -77.23 -138.84 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.407 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 263' ' ' ALA . . . . . 0.655 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -51.46 77.22 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.249 0 O-C-N 123.381 0.426 . . . . 0.0 110.939 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . 0.622 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.29 104.67 0.19 Allowed Glycine 0 CA--C 1.527 0.797 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 265' ' ' ASP . . . . . 0.589 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.8 m-20 -80.14 -177.8 6.24 Favored 'General case' 0 C--N 1.327 -0.394 0 O-C-N 122.79 -0.241 . . . . 0.0 110.718 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -40.78 -17.83 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.486 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 267' ' ' LYS . . . . . 0.589 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.16 -51.52 44.97 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 121.058 0.456 . . . . 0.0 110.724 179.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -63.9 -46.58 84.2 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.102 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . 0.524 ' O ' ' CD2' ' A' ' 273' ' ' TYR . . . -61.6 -34.81 76.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.668 0.746 . . . . 0.0 110.05 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -62.98 -34.89 78.5 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.002 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.07 -43.44 13.91 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.136 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 272' ' ' ILE . . . . . 0.617 ' C ' ' H ' ' A' ' 274' ' ' ALA . 5.0 tt -51.61 -33.59 15.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.471 -178.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 273' ' ' TYR . . . . . 0.524 ' CD2' ' O ' ' A' ' 269' ' ' ALA . 17.1 m-85 -54.62 -1.61 0.03 OUTLIER 'General case' 0 CA--C 1.512 -0.504 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.741 -179.422 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 274' ' ' ALA . . . . . 0.617 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.42 -39.99 70.73 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.917 179.186 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . 0.574 ' O ' ' N ' ' A' ' 279' ' ' ALA . 2.8 p30 -38.55 97.64 0.14 Allowed Pre-proline 0 CA--C 1.528 0.131 0 O-C-N 123.585 0.553 . . . . 0.0 110.355 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -53.75 -43.27 59.37 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 122.565 2.177 . . . . 0.0 112.509 -178.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 89.0 mt -64.42 -43.0 95.73 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.953 -179.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 91.8 mt -95.82 -1.33 49.82 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.756 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 279' ' ' ALA . . . . . 0.574 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.63 -35.18 78.75 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.352 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.13 20.35 0.11 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.892 -178.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . 0.519 ' H ' ' C ' ' A' ' 279' ' ' ALA . 13.9 mt -74.8 120.05 79.7 Favored Pre-proline 0 N--CA 1.442 -0.862 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.821 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -51.33 -39.09 63.47 Favored 'Trans proline' 0 C--N 1.313 -1.321 0 C-N-CA 122.425 2.083 . . . . 0.0 111.817 179.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.71 -50.6 63.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.947 0.403 . . . . 0.0 110.05 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 76.6 t -61.51 -43.8 97.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.199 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -57.64 -41.48 81.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.212 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -90.84 0.62 57.42 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.32 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt 59.0 43.18 18.08 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.811 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -94.52 41.6 1.09 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.377 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 54.0 t -119.16 135.6 59.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-O 120.949 0.404 . . . . 0.0 110.012 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -132.81 162.87 30.38 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.619 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.68 155.14 32.95 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.462 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 79.8 mt -94.07 -1.63 54.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.299 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 120.75 165.49 12.76 Favored Glycine 0 N--CA 1.464 0.512 0 N-CA-C 110.584 -1.006 . . . . 0.0 110.584 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 6.7 m -86.98 -62.3 1.53 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.83 0.347 . . . . 0.0 110.879 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 295' ' ' GLU . . . . . 0.481 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.9 mm-40 -69.36 -3.94 16.2 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.642 -179.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 24.5 p -77.01 32.24 0.14 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.65 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 297' ' ' PHE . . . . . 0.481 ' H ' ' C ' ' A' ' 295' ' ' GLU . 68.5 t80 -60.31 -46.13 90.95 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.704 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . 0.619 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.1 mtt85 -80.76 135.09 35.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.477 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 17.7 tp -114.09 117.07 30.23 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 120.861 0.362 . . . . 0.0 110.394 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . 0.6 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.1 p-10 -165.2 -176.63 4.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.755 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 301' ' ' TYR . . . . . 0.502 ' OH ' ' CD1' ' A' ' 173' ' ' PHE . 82.8 t80 -46.51 -43.57 16.96 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.424 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -67.06 -40.24 87.03 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.001 0.429 . . . . 0.0 110.757 179.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 303' ' ' SER . . . . . 0.6 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 60.2 p -56.22 -36.11 68.09 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.131 -179.086 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . 0.496 ' N ' ' HG ' ' A' ' 303' ' ' SER . . . -57.31 -51.34 69.77 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.215 179.332 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 91.7 mtp -56.01 -44.18 78.43 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -65.79 -42.59 90.53 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.165 0.507 . . . . 0.0 110.437 179.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 55.7 t -64.06 -42.92 97.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.255 179.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 43.6 tp -59.77 -41.94 92.19 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.129 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -62.44 -39.0 91.93 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.299 179.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 310' ' ' ARG . . . . . 0.441 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.5 ttt85 -63.7 -43.79 95.56 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.374 179.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 89.4 mt -63.47 -41.94 98.6 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.572 179.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.3 ttmt -63.2 -33.29 75.16 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.35 179.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.42 -23.58 22.11 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.466 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . 0.441 ' N ' ' O ' ' A' ' 310' ' ' ARG . 6.7 tt -62.31 -43.15 99.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.491 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 . . . . . 0 C--O 1.221 -0.444 0 CA-C-O 118.09 -0.957 . . . . 0.0 110.3 -179.816 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -99.64 136.03 40.18 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.134 0.492 . . . . 0.0 110.475 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.482 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -92.44 178.68 1.58 Allowed Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.47 -179.692 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.482 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.7 Cg_exo -61.71 147.19 95.87 Favored 'Trans proline' 0 C--N 1.303 -1.843 0 C-N-CA 122.814 2.343 . . . . 0.0 112.211 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 35.5 ptt180 -136.53 142.45 43.45 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.565 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -79.63 116.88 20.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.508 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.4 tp -111.13 130.39 64.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.557 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 13.9 t -71.3 142.18 50.47 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.674 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.52 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.4 t0 -139.24 -179.97 6.18 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.478 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.52 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 78.1 p -74.0 -37.05 64.54 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.671 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.8 ttt85 -46.86 -94.78 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.31 -179.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.489 ' C ' ' HG1' ' A' ' 36' ' ' THR . . . -166.07 -27.06 0.02 OUTLIER Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.489 ' HG1' ' C ' ' A' ' 35' ' ' GLY . 62.5 m -168.71 105.76 0.44 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.757 0.313 . . . . 0.0 110.598 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 65.5 t60 -128.86 146.55 50.91 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 120.956 0.408 . . . . 0.0 110.222 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.485 ' CG2' ' N ' ' A' ' 39' ' ' LEU . 95.4 m -129.84 165.53 21.8 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.3 -179.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.485 ' N ' ' CG2' ' A' ' 38' ' ' THR . 78.5 mt -120.21 127.28 52.29 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.691 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -65.41 -44.86 86.1 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.606 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 38.3 p -165.64 154.97 12.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.458 179.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.467 ' N ' ' CD ' ' A' ' 42' ' ' GLN . 14.5 mp0 -44.82 101.19 0.25 Allowed Pre-proline 0 C--O 1.235 0.333 0 O-C-N 123.57 0.544 . . . . 0.0 110.505 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -57.62 130.25 37.83 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.339 2.026 . . . . 0.0 112.16 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -82.69 -25.03 33.37 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.643 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.538 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.8 mtm-85 -120.89 134.53 55.29 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.143 0.497 . . . . 0.0 110.237 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.1 mt -129.75 133.23 65.2 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.327 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.639 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 46.2 t -125.1 130.92 73.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 CA-C-O 120.942 0.401 . . . . 0.0 110.151 178.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.518 ' HG ' ' CD1' ' A' ' 117' ' ' LEU . 4.2 m -154.99 166.6 33.06 Favored 'General case' 0 C--O 1.225 -0.22 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.459 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 73.2 p -124.55 8.92 8.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.417 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.35 125.84 33.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.872 0.368 . . . . 0.0 110.584 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 84.9 t -65.83 -44.58 92.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.611 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 18.5 m -62.59 -44.41 96.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.678 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 52.2 tp -62.39 -41.53 98.72 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.661 -179.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 71.9 m -58.04 -44.61 87.48 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.183 -179.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.31 -62.09 5.44 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 179.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.5 t -47.89 -35.64 10.81 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.5 mt -61.82 -44.55 96.63 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.069 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.1 mp -65.27 -41.17 94.47 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.297 178.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.85 -41.45 97.8 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.611 -179.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.0 tp -87.75 16.8 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.724 -179.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 56.32 84.39 0.09 Allowed 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.814 -179.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.28 58.44 0.08 OUTLIER Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 120.992 0.425 . . . . 0.0 109.931 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -50.91 152.72 9.61 Favored 'Trans proline' 0 C--N 1.296 -2.205 0 C-N-CA 123.061 2.507 . . . . 0.0 112.307 -178.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.429 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -108.85 145.9 15.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.279 -179.789 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.78 -45.13 98.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.191 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.504 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -130.16 134.17 47.12 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.717 0.294 . . . . 0.0 110.389 -179.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.494 ' O ' ' N ' ' A' ' 98' ' ' LEU . 73.5 m -134.3 158.51 43.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.85 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.58 139.21 16.36 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.465 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.69 -162.83 0.09 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.86 0.362 . . . . 0.0 110.382 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.466 ' O ' ' C ' ' A' ' 71' ' ' THR . 5.8 t -134.09 135.57 43.33 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.027 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.466 ' C ' ' O ' ' A' ' 70' ' ' THR . 0.9 OUTLIER 29.78 68.23 0.68 Allowed Pre-proline 0 N--CA 1.469 0.507 0 CA-C-O 121.181 0.515 . . . . 0.0 110.813 -179.569 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -60.8 145.23 99.3 Favored 'Trans proline' 0 C--N 1.301 -1.944 0 C-N-CA 122.737 2.291 . . . . 0.0 111.978 -178.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.539 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 44.9 p-10 -160.06 -32.62 0.06 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.674 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.539 ' N ' ' OD1' ' A' ' 73' ' ' ASN . 98.9 m-20 -63.75 -39.72 94.97 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.364 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -59.97 -48.33 82.16 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.476 -179.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.425 ' O ' ' O ' ' A' ' 77' ' ' ALA . 92.4 t -60.0 -24.75 30.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.125 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.425 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -45.64 173.0 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.53 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.565 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.3 p30 -62.06 177.69 0.44 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.424 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.597 ' C ' ' H ' ' A' ' 81' ' ' GLY . 35.1 p30 -45.81 85.64 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.985 0.421 . . . . 0.0 110.903 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.565 ' N ' ' O ' ' A' ' 78' ' ' ASP . 42.5 tp60 -67.21 13.45 0.06 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.25 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.597 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 117.92 -22.34 9.9 Favored Glycine 0 N--CA 1.463 0.439 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -107.75 116.22 31.55 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.945 0.402 . . . . 0.0 110.483 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 76.5 mt -98.71 0.63 44.96 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.478 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -92.23 6.84 45.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.917 0.389 . . . . 0.0 110.325 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.43 ' O ' ' CG2' ' A' ' 89' ' ' VAL . 88.5 mt-30 -99.88 -27.8 13.43 Favored 'General case' 0 C--O 1.222 -0.379 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.665 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 69.0 t-105 -63.42 -40.96 98.58 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.767 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.545 ' O ' ' N ' ' A' ' 91' ' ' LYS . 67.2 m -77.42 -53.34 7.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.888 -179.286 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -48.59 -51.14 29.35 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.946 -179.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.43 ' CG2' ' O ' ' A' ' 85' ' ' GLN . 15.9 m -68.78 -40.6 81.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.039 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.411 ' H ' HG23 ' A' ' 89' ' ' VAL . . . -72.35 -22.92 61.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.753 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.545 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.0 tttm -61.41 -45.92 92.31 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.391 -179.432 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.438 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.6 mm-40 -90.37 -94.56 0.12 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.128 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.608 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.9 mtt180 -143.49 59.63 1.39 Allowed 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.437 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.7 pttp 34.06 26.32 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.282 0.563 . . . . 0.0 110.517 -179.368 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.608 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.5 tt -48.32 123.15 6.09 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.856 -177.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -83.31 -170.44 3.05 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.314 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.617 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 82.7 mtp180 -73.45 137.89 44.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.952 0.406 . . . . 0.0 110.231 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.494 ' N ' ' O ' ' A' ' 67' ' ' SER . 88.3 mt -86.41 -165.96 1.41 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.83 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.532 ' CD2' ' O ' ' A' ' 99' ' ' TYR . 47.1 p90 -168.51 120.0 0.79 Allowed 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.094 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.488 ' C ' ' O ' ' A' ' 99' ' ' TYR . 42.9 mm -29.67 121.4 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 O-C-N 123.392 0.433 . . . . 0.0 110.898 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 113.7 28.12 3.31 Favored Glycine 0 N--CA 1.463 0.473 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 -179.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.579 ' N ' ' CD ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -143.86 45.5 0.57 Allowed Pre-proline 0 C--N 1.324 -0.54 0 CA-C-O 121.298 0.57 . . . . 0.0 110.463 179.794 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 30.4 Cg_endo -62.14 144.03 95.32 Favored 'Trans proline' 0 C--N 1.297 -2.145 0 C-N-CA 122.572 2.181 . . . . 0.0 111.972 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.704 ' HG ' ' H ' ' A' ' 107' ' ' ALA . 25.3 t -173.17 120.76 0.36 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.573 179.426 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.15 -40.96 64.44 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.188 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -65.97 -40.0 90.85 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.759 -179.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.704 ' H ' ' HG ' ' A' ' 104' ' ' SER . . . -64.05 -39.62 94.49 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.667 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 71.2 t -67.58 -43.73 86.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.638 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.44 -39.3 92.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.527 -179.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.438 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.78 -23.67 63.47 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.561 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.526 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.4 mm-40 -90.89 4.38 52.02 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.769 -179.543 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.538 ' O ' ' NE ' ' A' ' 45' ' ' ARG . 10.5 tpt 22.61 64.37 0.34 Allowed Pre-proline 0 N--CA 1.471 0.598 0 O-C-N 123.5 0.5 . . . . 0.0 111.124 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -79.33 169.4 18.87 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 123.083 2.522 . . . . 0.0 111.938 -178.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.524 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 98.7 m-20 -112.33 -44.72 3.35 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.174 179.507 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 39.1 tp -119.9 121.04 38.15 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.147 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 96.8 mt -118.18 131.32 71.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.769 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.518 ' CD1' ' HG ' ' A' ' 48' ' ' SER . 31.5 mt -106.06 132.11 52.53 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.205 -179.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 98.6 mt -117.76 136.08 56.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.55 -179.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 86.4 p -71.48 151.41 43.97 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.608 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.32 -49.95 75.57 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.582 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -149.29 153.6 37.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.505 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 168.48 -169.69 41.75 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.88 -35.6 92.23 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.449 ' O ' ' OD1' ' A' ' 124' ' ' ASP . 44.3 p-10 -88.46 119.88 29.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.903 0.383 . . . . 0.0 110.598 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 40.6 t -63.0 144.03 57.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.405 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.511 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.55 -43.07 8.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.779 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.8 tp -62.64 -42.42 99.59 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.821 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.85 -10.44 53.06 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.405 -179.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 82.1 mt -115.99 -24.3 8.16 Favored 'General case' 0 C--O 1.225 -0.222 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.56 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . 0.511 ' N ' ' O ' ' A' ' 126' ' ' ALA . 71.3 t80 -51.37 -49.51 61.34 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.914 -0.314 . . . . 0.0 110.558 -178.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.2 p-10 -66.09 -41.79 90.17 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.846 -0.342 . . . . 0.0 111.054 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.504 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 87.9 mt-30 -67.91 -36.49 80.28 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.751 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 96.5 mt -80.35 -42.09 23.55 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.003 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.3 t -57.39 -45.25 84.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.293 -179.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.6 m -62.46 -45.66 92.03 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.656 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 92.2 mt -62.4 -43.78 98.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.312 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -170.2 163.54 6.2 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.581 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -42.14 110.67 0.16 Allowed 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.561 2.174 . . . . 0.0 112.118 179.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.8 m -87.34 127.76 35.19 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.237 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 34.3 tp -119.63 139.21 52.57 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.451 179.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.431 ' O ' ' OD2' ' A' ' 32' ' ' ASP . 81.7 mt -105.11 119.93 54.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-O 120.953 0.406 . . . . 0.0 110.852 -179.206 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 97.1 mt -135.67 132.7 51.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.639 179.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.512 HD22 ' CG ' ' A' ' 241' ' ' ASP . 59.1 t30 -64.59 147.99 51.75 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.465 179.361 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.511 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 87.3 t80 -82.48 122.67 28.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.814 -179.311 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.511 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 99.0 m-20 55.05 69.31 0.75 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.561 179.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 34.2 p-10 -125.62 0.49 7.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.576 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -150.92 115.96 5.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.867 0.365 . . . . 0.0 110.642 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' SER . . . . . 0.521 ' HG ' ' H ' ' A' ' 150' ' ' GLN . 85.0 p -63.76 169.11 4.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.613 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.407 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.7 p-90 -51.83 -16.13 0.64 Allowed 'General case' 0 C--O 1.22 -0.457 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.258 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . 0.521 ' H ' ' HG ' ' A' ' 148' ' ' SER . 68.2 tp60 -70.19 -75.98 0.11 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.021 0.438 . . . . 0.0 110.614 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.443 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.1 t -62.58 -38.45 90.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.265 179.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 51.0 tp -60.16 -45.5 92.87 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.573 -178.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.407 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 45.4 tp -62.85 -41.63 99.43 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.612 178.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.443 ' OG1' ' O ' ' A' ' 151' ' ' SER . 59.6 p -63.67 -35.01 79.15 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.251 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . 0.467 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.5 mm-40 -63.54 -41.99 98.43 Favored 'General case' 0 C--O 1.225 -0.203 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.344 179.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 91.5 mt -65.44 -39.09 91.65 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.413 178.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.562 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.09 -32.15 79.33 Favored Glycine 0 N--CA 1.46 0.264 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 -179.247 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.467 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.3 mt-10 -36.81 -25.26 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.752 0.31 . . . . 0.0 110.881 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.562 ' N ' ' O ' ' A' ' 157' ' ' GLY . 95.5 mt -59.17 148.61 6.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.346 179.084 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 74.7 p -69.13 137.72 53.63 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.879 -179.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 70.69 21.88 77.95 Favored Glycine 0 CA--C 1.519 0.335 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 179.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 59.8 m80 -124.35 -13.78 7.08 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 110.448 -0.204 . . . . 0.0 110.448 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -66.24 -59.9 3.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.506 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -51.79 -49.07 63.41 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.119 -179.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -60.41 -41.03 93.08 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.862 0.363 . . . . 0.0 110.448 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.58 -47.19 86.61 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.551 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -57.0 -39.96 75.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.25 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -61.69 -50.49 72.25 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.694 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -65.29 -43.89 89.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.458 179.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 95.3 mt -64.32 -43.55 97.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.412 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.28 -51.05 70.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.432 -179.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -63.79 -43.43 96.32 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.846 0.355 . . . . 0.0 110.539 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . 0.504 ' CD1' ' OH ' ' A' ' 301' ' ' TYR . 56.6 t80 -62.66 -44.44 96.26 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.084 0.468 . . . . 0.0 110.423 179.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -63.62 -39.87 95.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.475 -179.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -62.97 -42.6 99.88 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.725 179.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -60.74 -44.55 96.52 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.24 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 85.1 mt -64.55 -41.07 96.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.875 178.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.24 -61.95 1.95 Allowed 'General case' 0 C--O 1.239 0.515 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.426 -179.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.72 -47.12 85.68 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.358 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -52.83 -41.55 64.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.314 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -63.79 -33.71 76.28 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.36 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 69.6 tt0 -90.92 8.52 34.66 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.539 0.685 . . . . 0.0 110.302 -178.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -104.24 -32.22 9.22 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.088 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.4 pt -128.04 147.77 32.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.886 0.374 . . . . 0.0 110.635 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -139.93 131.31 26.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.478 179.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . 0.545 ' CD2' ' N ' ' A' ' 186' ' ' LEU . 3.6 mm? -85.36 133.32 42.67 Favored Pre-proline 0 N--CA 1.448 -0.559 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.088 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -44.02 157.9 0.14 Allowed 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.645 2.23 . . . . 0.0 112.194 179.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . 0.49 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.5 Cg_endo -63.12 114.78 2.61 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.716 2.277 . . . . 0.0 111.632 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . 0.49 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.7 mt-30 156.03 148.11 0.0 OUTLIER Pre-proline 0 C--N 1.34 0.194 0 O-C-N 124.401 1.063 . . . . 0.0 110.894 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -73.58 144.56 36.02 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 122.597 2.198 . . . . 0.0 111.905 177.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.481 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.1 p -124.78 158.93 31.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.229 0.538 . . . . 0.0 110.109 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' THR . . . . . 0.481 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 38.1 p -143.16 165.18 28.13 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 121.396 0.617 . . . . 0.0 110.973 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -135.15 128.93 33.03 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 121.377 0.608 . . . . 0.0 110.358 178.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 47.2 pt -146.57 148.97 16.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.972 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 72.3 t -117.73 123.15 71.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.183 0.516 . . . . 0.0 109.932 178.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -134.35 106.91 7.33 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.289 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 94.2 m -130.85 130.44 43.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.872 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.417 ' O ' ' N ' ' A' ' 201' ' ' HIS . . . -82.73 -37.03 25.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.258 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.5 -67.08 0.26 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.297 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -71.91 -9.77 58.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.379 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . 0.417 ' N ' ' O ' ' A' ' 198' ' ' ALA . 60.3 t-80 60.38 57.97 2.7 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.591 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 47.6 p -166.66 153.38 8.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.57 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.29 144.13 24.47 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.946 0.403 . . . . 0.0 110.426 179.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -135.4 138.67 43.51 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.525 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 19.0 mt -106.21 125.26 50.77 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' TRP . . . . . 0.557 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 75.0 m95 -82.12 167.51 18.68 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.593 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -157.18 171.56 7.28 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.595 -178.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.8 -37.26 84.63 Favored 'Trans proline' 0 C--N 1.302 -1.915 0 C-N-CA 122.598 2.199 . . . . 0.0 112.183 179.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -70.89 -34.73 71.87 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.713 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 21.4 m -61.23 151.08 32.63 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.529 -179.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.65 -37.01 82.47 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.392 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' GLN . . . . . 0.557 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 55.0 tt0 -64.8 -40.31 95.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.477 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.78 -43.39 91.82 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -62.74 -44.15 96.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.809 0.338 . . . . 0.0 110.262 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 65.3 ttp -59.46 -47.82 84.03 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.221 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 87.0 mt -60.4 -41.07 93.1 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' GLU . . . . . 0.448 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.3 tp10 -58.18 -38.07 75.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.074 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -65.32 -38.24 89.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.743 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 95.7 mt -64.1 -42.79 96.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.684 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.49 45.45 0.08 OUTLIER Glycine 0 N--CA 1.462 0.416 0 N-CA-C 111.111 -0.795 . . . . 0.0 111.111 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' PHE . . . . . 0.448 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 27.4 m-85 -128.29 155.6 44.34 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.83 0.347 . . . . 0.0 110.482 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' THR . . . . . 0.45 ' O ' ' O ' ' A' ' 191' ' ' VAL . 7.5 p -107.11 122.35 46.32 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-O 121.225 0.536 . . . . 0.0 110.215 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . 0.44 ' CD2' ' N ' ' A' ' 223' ' ' LEU . 4.3 mm? -101.47 133.06 46.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.016 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.76 159.67 14.8 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.471 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.33 115.15 29.76 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.377 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.445 ' CD1' ' N ' ' A' ' 226' ' ' LEU . 9.0 mp -53.08 156.83 3.35 Favored Pre-proline 0 N--CA 1.447 -0.62 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.811 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -60.3 145.36 98.75 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 C-N-CA 122.735 2.29 . . . . 0.0 112.091 179.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.24 -3.22 59.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.521 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.07 -40.94 5.7 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . 0.503 ' O ' ' N ' ' A' ' 233' ' ' SER . 68.7 mt -79.36 -17.25 54.84 Favored 'General case' 0 C--O 1.219 -0.542 0 CA-C-O 121.04 0.447 . . . . 0.0 110.297 -179.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 54.6 t-20 -40.48 -49.51 2.89 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.842 0.354 . . . . 0.0 110.717 -179.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -87.69 15.46 6.86 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.241 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' SER . . . . . 0.503 ' N ' ' O ' ' A' ' 230' ' ' LEU . 77.9 p -60.62 -35.2 75.56 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.608 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . 0.522 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.6 tt0 -119.54 -69.34 0.85 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.717 179.32 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.0 m -69.72 102.1 1.83 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.955 0.407 . . . . 0.0 110.592 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -93.78 57.56 2.52 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.34 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -144.63 -122.5 1.58 Allowed Glycine 0 N--CA 1.462 0.397 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -135.44 111.78 9.79 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.0 0.428 . . . . 0.0 110.374 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . 0.524 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.5 mtt180 -148.27 58.26 1.08 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.596 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -69.47 -32.35 71.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.571 179.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' ASP . . . . . 0.512 ' CG ' HD22 ' A' ' 143' ' ' ASN . 64.8 t0 -56.85 -47.3 80.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.266 -179.042 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' ILE . . . . . 0.435 ' O ' ' O ' ' A' ' 239' ' ' ARG . 17.8 tt -139.65 156.17 25.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.851 0.358 . . . . 0.0 110.371 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 96.2 mt -106.07 106.61 20.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.947 0.403 . . . . 0.0 110.382 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . 0.524 ' OE1' ' NH1' ' A' ' 239' ' ' ARG . 88.3 mt-30 -110.55 110.06 20.63 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.329 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 9.6 mp -121.77 -168.14 1.65 Allowed 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.634 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . 0.522 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.83 -16.57 0.05 OUTLIER Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . 0.69 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -61.09 156.41 33.49 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -63.49 21.63 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.783 0.325 . . . . 0.0 110.563 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . 0.69 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.8 m-20 -96.93 -6.4 35.72 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.756 0.313 . . . . 0.0 110.492 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 91.8 mt -79.5 -21.72 44.92 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.931 179.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.79 -51.36 70.32 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.648 -179.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.33 -5.45 58.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.463 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -80.91 -74.25 1.14 Allowed Glycine 0 CA--C 1.522 0.528 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 80.8 mt -70.17 126.09 28.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.888 0.375 . . . . 0.0 110.344 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -59.69 -39.22 83.82 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.336 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 83.28 51.84 4.0 Favored Glycine 0 CA--C 1.521 0.446 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -95.58 -15.52 22.74 Favored 'General case' 0 C--N 1.331 -0.223 0 O-C-N 122.823 -0.222 . . . . 0.0 110.578 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 258' ' ' SER . . . . . 0.433 ' HG ' ' CG2' ' A' ' 191' ' ' VAL . 3.4 t 174.77 89.14 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.161 0.505 . . . . 0.0 110.268 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . 0.59 ' N ' ' CD1' ' A' ' 259' ' ' LEU . 0.9 OUTLIER -94.76 124.2 38.65 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.857 0.361 . . . . 0.0 110.985 -178.729 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 15.7 m-30 -93.61 146.41 23.83 Favored 'General case' 0 CA--C 1.497 -1.064 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.543 179.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 85.0 mt -122.21 148.87 44.43 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.554 -179.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.654 ' CG ' ' N ' ' A' ' 263' ' ' ALA . 2.5 p90 -77.17 -139.07 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.436 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 263' ' ' ALA . . . . . 0.654 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -51.15 77.22 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.353 0 O-C-N 123.435 0.459 . . . . 0.0 111.108 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . 0.624 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.43 104.64 0.19 Allowed Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 265' ' ' ASP . . . . . 0.588 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.6 m-20 -80.14 -177.77 6.23 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 122.703 -0.293 . . . . 0.0 110.718 -179.549 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -40.8 -17.78 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.496 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 267' ' ' LYS . . . . . 0.588 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.01 -51.3 48.69 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.758 179.111 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -64.11 -46.5 83.92 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.98 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . 0.524 ' O ' ' CD2' ' A' ' 273' ' ' TYR . . . -61.76 -34.83 76.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.697 0.761 . . . . 0.0 109.883 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -62.93 -35.0 78.65 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.185 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.09 -43.12 14.18 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.184 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 272' ' ' ILE . . . . . 0.619 ' C ' ' H ' ' A' ' 274' ' ' ALA . 5.0 tt -51.64 -33.77 15.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.552 -178.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 273' ' ' TYR . . . . . 0.524 ' CD2' ' O ' ' A' ' 269' ' ' ALA . 16.8 m-85 -54.58 -1.67 0.03 OUTLIER 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.767 -179.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 274' ' ' ALA . . . . . 0.619 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.5 -39.94 70.49 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.942 179.194 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . 0.574 ' O ' ' N ' ' A' ' 279' ' ' ALA . 3.1 p30 -38.52 97.52 0.14 Allowed Pre-proline 0 C--N 1.339 0.135 0 O-C-N 123.532 0.52 . . . . 0.0 110.429 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -53.72 -43.17 60.23 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 C-N-CA 122.577 2.184 . . . . 0.0 112.511 -178.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 88.9 mt -64.36 -43.01 95.88 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.008 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 91.7 mt -95.95 -1.06 49.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.75 -179.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 279' ' ' ALA . . . . . 0.574 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.65 -34.93 78.08 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.501 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.32 20.36 0.11 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.841 -179.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . 0.515 ' H ' ' C ' ' A' ' 279' ' ' ALA . 13.7 mt -74.68 119.82 78.54 Favored Pre-proline 0 N--CA 1.442 -0.837 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.776 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -51.15 -39.37 61.31 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 C-N-CA 122.507 2.138 . . . . 0.0 111.922 179.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.74 -50.54 63.25 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.898 0.38 . . . . 0.0 110.033 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 76.8 t -61.42 -43.88 97.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.169 179.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -57.56 -41.21 80.6 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.207 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -91.17 0.47 57.52 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.258 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt 59.26 43.91 16.25 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.84 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -95.01 41.2 1.09 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.32 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 53.9 t -119.13 135.58 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-O 121.018 0.437 . . . . 0.0 110.061 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -132.8 162.76 30.65 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.527 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.37 155.08 32.59 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.515 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 80.8 mt -94.09 -1.75 53.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.246 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 120.89 165.38 12.69 Favored Glycine 0 N--CA 1.464 0.504 0 N-CA-C 110.489 -1.045 . . . . 0.0 110.489 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 7.3 m -87.08 -62.47 1.5 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.829 0.347 . . . . 0.0 110.971 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 295' ' ' GLU . . . . . 0.486 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.5 mm-40 -68.71 -4.35 15.46 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.687 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 24.9 p -76.78 32.16 0.13 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.674 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 297' ' ' PHE . . . . . 0.486 ' H ' ' C ' ' A' ' 295' ' ' GLU . 68.3 t80 -60.48 -46.21 90.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.664 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . 0.617 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.1 mtt85 -80.68 134.89 35.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.453 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 18.6 tp -113.7 116.7 29.85 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-O 120.942 0.401 . . . . 0.0 110.385 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . 0.599 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.2 p-10 -165.0 -176.87 4.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.723 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 301' ' ' TYR . . . . . 0.504 ' OH ' ' CD1' ' A' ' 173' ' ' PHE . 81.6 t80 -46.66 -43.22 17.45 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.373 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -67.15 -40.21 86.67 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 121.028 0.442 . . . . 0.0 110.752 179.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 303' ' ' SER . . . . . 0.599 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 59.6 p -56.34 -36.27 68.58 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.079 -179.023 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -57.33 -51.47 69.25 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 179.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 91.9 mtp -55.71 -44.28 77.27 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -65.8 -42.75 90.32 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.227 0.537 . . . . 0.0 110.454 179.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 54.9 t -64.04 -42.82 96.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.262 179.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 44.2 tp -59.77 -41.92 92.16 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.041 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -62.79 -38.77 91.95 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.116 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 310' ' ' ARG . . . . . 0.449 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.6 ttt85 -63.56 -43.83 95.91 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.32 179.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 87.7 mt -63.37 -42.09 98.83 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.46 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.4 ttmt -63.03 -33.24 75.0 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.39 179.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.84 -23.47 21.67 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.395 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . 0.449 ' N ' ' O ' ' A' ' 310' ' ' ARG . 6.7 tt -62.31 -43.27 99.22 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.488 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 . . . . . 0 C--O 1.22 -0.486 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.317 -179.708 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -99.5 136.48 39.37 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.174 0.512 . . . . 0.0 110.424 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.485 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -91.58 178.7 1.65 Allowed Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.469 -179.707 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.485 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.3 Cg_exo -61.76 147.51 95.14 Favored 'Trans proline' 0 C--N 1.301 -1.948 0 C-N-CA 122.955 2.437 . . . . 0.0 112.207 179.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 35.3 ptt180 -135.02 142.35 46.38 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.591 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -79.01 116.85 19.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.496 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.5 tp -109.93 130.61 62.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.494 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.8 t -70.54 141.59 51.86 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.685 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.421 ' OD2' ' O ' ' A' ' 141' ' ' ILE . 24.8 t70 -139.83 177.1 8.19 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.452 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.454 ' OG ' ' O ' ' A' ' 141' ' ' ILE . 78.4 p -73.11 -36.57 66.77 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.707 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -47.62 -95.05 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.275 -179.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.414 ' O ' ' OG1' ' A' ' 36' ' ' THR . . . -166.15 -25.54 0.02 OUTLIER Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.414 ' OG1' ' O ' ' A' ' 35' ' ' GLY . 62.7 m -168.5 106.42 0.47 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.691 0.281 . . . . 0.0 110.633 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 34.0 t60 -129.79 144.2 51.18 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-O 121.016 0.436 . . . . 0.0 110.099 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.477 ' CG2' ' N ' ' A' ' 39' ' ' LEU . 95.9 m -128.47 166.46 18.72 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.338 -179.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.477 ' N ' ' CG2' ' A' ' 38' ' ' THR . 81.4 mt -121.08 127.73 51.93 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.66 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -63.93 -44.64 92.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.689 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 38.3 p -165.45 155.36 12.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.45 179.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.455 ' N ' ' CD ' ' A' ' 42' ' ' GLN . 14.3 mp0 -42.33 100.07 0.22 Allowed Pre-proline 0 C--O 1.236 0.379 0 O-C-N 123.47 0.481 . . . . 0.0 110.564 179.239 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -56.87 129.3 33.82 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 122.362 2.041 . . . . 0.0 112.191 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -83.89 -24.16 30.92 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.649 179.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.539 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.6 mtm-85 -121.26 134.53 55.18 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.149 0.499 . . . . 0.0 110.193 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.2 mt -130.68 133.34 63.52 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.313 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.598 -179.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 47.0 t -124.91 130.87 73.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 CA-C-O 120.992 0.425 . . . . 0.0 110.039 179.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.5 ' O ' ' O ' ' A' ' 66' ' ' ALA . 4.6 m -154.32 166.38 33.37 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.513 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 67.4 p -124.45 8.96 8.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.389 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.94 125.44 33.36 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.599 -179.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 84.5 t -65.51 -44.44 94.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.557 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.3 m -62.68 -44.25 96.72 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.598 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 52.1 tp -62.46 -41.48 98.78 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.573 -179.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 73.3 m -57.83 -44.59 86.53 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.249 -179.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.26 -62.1 5.44 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.896 -0.881 . . . . 0.0 110.896 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.6 t -48.16 -35.67 12.09 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.6 mt -61.76 -44.42 96.92 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.161 179.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.1 mp -65.47 -41.06 93.75 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.412 177.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.78 -41.45 97.94 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.706 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.1 tp -87.8 16.77 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.82 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 56.34 84.49 0.08 Allowed 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.828 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.22 58.52 0.08 OUTLIER Pre-proline 0 C--N 1.328 -0.368 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -51.24 152.94 10.4 Favored 'Trans proline' 0 C--N 1.294 -2.335 0 C-N-CA 123.148 2.566 . . . . 0.0 112.206 -178.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.428 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -108.76 145.73 15.3 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.265 -179.685 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.68 -45.31 97.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.212 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.5 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -130.18 134.33 47.22 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.803 0.335 . . . . 0.0 110.352 -179.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.488 ' O ' ' N ' ' A' ' 98' ' ' LEU . 75.7 m -134.55 158.73 43.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.913 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.6 139.19 16.32 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.454 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.62 -162.82 0.09 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.893 0.378 . . . . 0.0 110.401 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.468 ' O ' ' C ' ' A' ' 71' ' ' THR . 5.8 t -134.03 135.18 43.19 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.065 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.468 ' C ' ' O ' ' A' ' 70' ' ' THR . 0.8 OUTLIER 29.76 68.43 0.67 Allowed Pre-proline 0 N--CA 1.469 0.477 0 CA-C-O 121.138 0.494 . . . . 0.0 110.853 -179.522 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_exo -61.08 145.2 99.22 Favored 'Trans proline' 0 C--N 1.3 -1.985 0 C-N-CA 122.746 2.297 . . . . 0.0 111.842 -178.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.527 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 44.8 p-10 -159.86 -31.88 0.06 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.725 179.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.527 ' N ' ' OD1' ' A' ' 73' ' ' ASN . 98.7 m-20 -64.45 -39.47 93.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.37 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.2 ttt180 -60.09 -48.56 81.22 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.354 -179.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.424 ' O ' ' O ' ' A' ' 77' ' ' ALA . 95.3 t -60.05 -25.0 31.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.16 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.424 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -45.59 172.89 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.614 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.568 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.3 p30 -61.91 177.68 0.42 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.484 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.596 ' C ' ' H ' ' A' ' 81' ' ' GLY . 36.2 p30 -45.64 85.55 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.95 0.405 . . . . 0.0 110.939 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.568 ' N ' ' O ' ' A' ' 78' ' ' ASP . 42.8 tp60 -67.35 13.56 0.07 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.235 0.541 . . . . 0.0 110.201 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.596 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 117.93 -22.55 9.79 Favored Glycine 0 N--CA 1.463 0.448 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -107.87 116.4 31.89 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.963 0.411 . . . . 0.0 110.415 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 76.1 mt -98.8 0.56 44.6 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.542 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -91.92 6.76 45.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.326 -179.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.435 ' O ' ' CG2' ' A' ' 89' ' ' VAL . 88.3 mt-30 -100.17 -26.96 13.76 Favored 'General case' 0 C--O 1.221 -0.441 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.733 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.1 t-105 -64.01 -40.75 97.03 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.952 -179.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.545 ' O ' ' N ' ' A' ' 91' ' ' LYS . 67.9 m -77.64 -53.33 7.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.053 -179.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -48.55 -51.05 29.57 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.919 -179.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.435 ' CG2' ' O ' ' A' ' 85' ' ' GLN . 15.7 m -68.83 -40.94 81.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.091 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.416 ' H ' HG23 ' A' ' 89' ' ' VAL . . . -71.87 -23.03 61.44 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.641 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.545 ' N ' ' O ' ' A' ' 87' ' ' SER . 65.9 tttm -61.52 -45.93 92.09 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.347 -179.31 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.441 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.6 mm-40 -90.27 -94.65 0.12 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.155 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.609 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.9 mtt180 -143.45 59.59 1.39 Allowed 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.437 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.7 pttp 34.24 26.08 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.247 0.546 . . . . 0.0 110.454 -179.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.609 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.4 tt -48.35 123.34 6.38 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.897 -177.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -83.46 -170.6 3.13 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.275 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.615 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 83.0 mtp180 -73.56 137.62 44.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.984 0.421 . . . . 0.0 110.248 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.488 ' N ' ' O ' ' A' ' 67' ' ' SER . 90.1 mt -86.13 -166.18 1.47 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.899 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.532 ' CD2' ' O ' ' A' ' 99' ' ' TYR . 47.9 p90 -168.05 120.08 0.85 Allowed 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.084 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.488 ' C ' ' O ' ' A' ' 99' ' ' TYR . 43.2 mm -29.75 121.26 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 O-C-N 123.332 0.395 . . . . 0.0 110.922 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 113.87 28.17 3.25 Favored Glycine 0 N--CA 1.462 0.387 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 -179.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.578 ' N ' ' CD ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -143.99 45.81 0.59 Allowed Pre-proline 0 C--N 1.322 -0.594 0 CA-C-O 121.203 0.525 . . . . 0.0 110.436 179.791 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 29.6 Cg_endo -62.06 143.83 95.39 Favored 'Trans proline' 0 C--N 1.295 -2.277 0 C-N-CA 122.667 2.245 . . . . 0.0 111.815 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.708 ' HG ' ' H ' ' A' ' 107' ' ' ALA . 27.2 t -173.13 120.73 0.36 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.47 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.25 -40.69 64.43 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.192 179.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.16 -39.85 90.09 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.7 -179.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.708 ' H ' ' HG ' ' A' ' 104' ' ' SER . . . -64.1 -39.78 94.8 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.673 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 69.7 t -67.7 -43.75 86.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.596 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.5 -39.31 93.09 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.552 -179.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.441 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.68 -23.5 63.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.542 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.527 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.4 mm-40 -91.26 4.77 51.48 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.7 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.539 ' O ' ' NE ' ' A' ' 45' ' ' ARG . 10.7 tpt 22.51 64.52 0.34 Allowed Pre-proline 0 N--CA 1.47 0.57 0 O-C-N 123.342 0.401 . . . . 0.0 111.204 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -79.37 169.1 19.22 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 123.085 2.524 . . . . 0.0 111.679 -177.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.515 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 98.6 m-20 -112.57 -43.67 3.45 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.116 179.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.4 tp -120.64 121.39 38.22 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 120.884 0.373 . . . . 0.0 110.091 179.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 96.9 mt -118.84 130.85 73.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-O 120.888 0.375 . . . . 0.0 110.858 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 32.1 mt -105.69 132.55 51.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.344 -179.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 98.1 mt -117.89 135.97 56.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.565 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 86.9 p -71.79 152.9 42.33 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.577 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -59.96 -50.03 75.35 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.617 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -149.37 153.72 37.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.535 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 169.71 -170.55 42.81 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -63.02 -35.13 91.68 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.449 ' O ' ' OD1' ' A' ' 124' ' ' ASP . 44.1 p-10 -88.04 119.69 28.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.922 0.391 . . . . 0.0 110.578 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 40.4 t -63.39 144.42 56.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.429 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.52 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.51 -42.76 9.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.742 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 56.0 tp -62.76 -42.34 99.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.677 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.25 -11.04 58.7 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.375 -179.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 83.8 mt -115.07 -24.58 8.49 Favored 'General case' 0 C--O 1.225 -0.234 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.57 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . 0.52 ' N ' ' O ' ' A' ' 126' ' ' ALA . 77.3 t80 -51.35 -49.84 60.65 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.936 -0.306 . . . . 0.0 110.612 -178.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.7 p-10 -65.77 -41.71 91.73 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.267 179.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.501 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 88.2 mt-30 -68.06 -36.97 80.73 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.826 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 94.1 mt -79.9 -42.19 24.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.915 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.3 t -57.05 -45.03 83.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.216 -179.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.7 m -62.23 -45.66 92.32 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.615 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 92.9 mt -62.48 -43.94 98.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.361 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.91 163.98 6.4 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.593 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -43.17 111.94 0.26 Allowed 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.544 2.163 . . . . 0.0 112.3 179.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 17.1 m -86.07 127.59 34.71 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.487 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 34.9 tp -119.78 138.0 53.62 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.256 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.454 ' O ' ' OG ' ' A' ' 33' ' ' SER . 79.2 mt -104.88 121.0 56.26 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.184 0 CA-C-O 121.068 0.461 . . . . 0.0 110.879 -179.14 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 93.2 mt -136.86 132.73 47.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.553 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.508 HD22 ' CG ' ' A' ' 241' ' ' ASP . 60.9 t30 -64.19 151.16 44.17 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.534 179.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.516 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 89.0 t80 -86.03 122.52 30.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.786 -179.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.516 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 99.1 m-20 55.3 69.16 0.76 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.547 179.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 36.2 p-10 -125.26 0.61 7.76 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.589 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -151.15 116.15 5.26 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.823 0.344 . . . . 0.0 110.581 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' SER . . . . . 0.51 ' HG ' ' H ' ' A' ' 150' ' ' GLN . 85.3 p -63.24 168.08 4.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.564 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.403 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.7 p-90 -51.13 -15.65 0.37 Allowed 'General case' 0 C--O 1.221 -0.405 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.313 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . 0.51 ' H ' ' HG ' ' A' ' 148' ' ' SER . 68.1 tp60 -71.09 -74.89 0.14 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.009 0.433 . . . . 0.0 110.581 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.444 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.2 t -62.68 -38.87 92.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.238 179.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 52.3 tp -60.23 -45.57 92.78 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.451 -178.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.403 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 45.5 tp -62.61 -41.69 99.15 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.597 178.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.444 ' OG1' ' O ' ' A' ' 151' ' ' SER . 56.1 p -63.85 -34.8 78.75 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.202 -179.37 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . 0.481 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.4 mm-40 -63.69 -42.05 98.06 Favored 'General case' 0 C--O 1.224 -0.262 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.371 179.308 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 91.3 mt -65.44 -38.87 91.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.182 0.515 . . . . 0.0 110.376 178.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.557 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.34 -31.78 78.48 Favored Glycine 0 C--N 1.331 0.279 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 -179.246 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.481 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.3 mt-10 -37.18 -24.99 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.848 0.356 . . . . 0.0 110.948 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.557 ' N ' ' O ' ' A' ' 157' ' ' GLY . 93.8 mt -59.71 149.25 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.385 179.127 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 76.0 p -69.13 137.54 53.48 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.904 -179.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 70.41 22.28 77.65 Favored Glycine 0 CA--C 1.518 0.235 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 179.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 61.7 m80 -124.34 -14.14 7.01 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.621 0.248 . . . . 0.0 110.454 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -66.76 -59.55 3.47 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.56 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -51.73 -49.37 62.68 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.136 -179.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -60.3 -41.21 92.93 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.884 0.373 . . . . 0.0 110.501 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.38 -47.58 85.17 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.472 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.64 -40.06 74.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.306 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -61.7 -50.27 73.13 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.699 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -65.26 -43.67 90.57 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.576 179.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 94.7 mt -64.48 -43.46 96.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.346 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.51 -51.26 70.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.299 -179.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.56 -43.73 96.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.922 0.392 . . . . 0.0 110.655 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . 0.521 ' CD1' ' OH ' ' A' ' 301' ' ' TYR . 55.9 t80 -62.78 -44.29 96.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.363 179.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -63.57 -39.62 94.88 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.446 -179.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -63.15 -42.69 99.48 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.583 179.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -60.62 -44.81 95.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.241 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 85.2 mt -64.65 -41.03 96.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.871 178.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.02 -61.98 1.92 Allowed 'General case' 0 C--O 1.239 0.506 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.428 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.96 -46.8 87.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.333 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -52.97 -41.63 64.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.414 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -63.98 -33.71 76.34 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.32 179.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 69.7 tt0 -90.95 8.75 33.59 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.631 0.729 . . . . 0.0 110.258 -178.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -104.56 -31.97 9.18 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 122.041 -0.412 . . . . 0.0 111.099 179.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.6 pt -128.07 147.87 32.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.625 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -140.0 131.36 26.79 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.463 178.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . 0.55 ' CD2' ' N ' ' A' ' 186' ' ' LEU . 3.6 mm? -85.32 133.1 43.18 Favored Pre-proline 0 N--CA 1.447 -0.584 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.146 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -43.93 157.83 0.14 Allowed 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 122.597 2.198 . . . . 0.0 112.35 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . 0.49 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.6 Cg_endo -63.2 115.11 2.78 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.809 2.339 . . . . 0.0 111.615 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . 0.49 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.7 mt-30 155.91 147.99 0.0 OUTLIER Pre-proline 0 C--O 1.232 0.177 0 O-C-N 124.393 1.058 . . . . 0.0 110.871 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -73.54 144.01 35.29 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 122.612 2.208 . . . . 0.0 112.158 177.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.485 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.1 p -124.82 159.17 31.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.409 0.623 . . . . 0.0 110.147 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' THR . . . . . 0.485 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 35.4 p -143.2 165.47 27.35 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.048 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -135.4 128.89 32.42 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-O 121.364 0.602 . . . . 0.0 110.33 179.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 47.3 pt -146.42 148.83 16.62 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.374 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.113 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 70.2 t -117.55 123.18 71.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.226 0.536 . . . . 0.0 109.973 178.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -134.31 107.07 7.43 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.054 0.454 . . . . 0.0 110.259 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 94.9 m -130.93 130.37 43.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.843 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.413 ' O ' ' N ' ' A' ' 201' ' ' HIS . . . -82.79 -36.84 25.28 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.295 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.22 -67.18 0.25 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.29 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.11 -10.15 59.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.425 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . 0.413 ' N ' ' O ' ' A' ' 198' ' ' ALA . 60.2 t-80 61.01 58.15 2.35 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.64 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 41.9 p -166.86 153.65 8.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.609 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.53 144.23 24.34 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.948 0.404 . . . . 0.0 110.441 179.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -135.42 138.41 43.21 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.554 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 19.4 mt -106.09 125.33 50.86 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.923 0.392 . . . . 0.0 109.974 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' TRP . . . . . 0.556 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 75.2 m95 -82.19 167.39 18.74 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.569 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -157.14 171.67 7.15 Favored Pre-proline 0 C--O 1.225 -0.234 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.622 -178.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -53.79 -36.97 84.25 Favored 'Trans proline' 0 C--N 1.301 -1.935 0 C-N-CA 122.63 2.22 . . . . 0.0 112.306 179.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -71.09 -34.71 71.39 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.679 -179.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 21.7 m -61.3 150.72 34.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.569 -179.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.49 -36.97 81.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.418 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' GLN . . . . . 0.556 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 55.3 tt0 -64.72 -40.21 94.96 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.557 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.98 -43.49 91.12 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -62.91 -44.04 97.16 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.848 0.356 . . . . 0.0 110.249 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 65.4 ttp -59.41 -48.11 82.9 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.069 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 87.1 mt -60.19 -41.16 92.35 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' GLU . . . . . 0.45 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.1 tp10 -57.9 -37.97 74.99 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.148 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -65.49 -38.04 88.58 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.71 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 95.4 mt -64.09 -42.78 96.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.639 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.59 45.16 0.08 OUTLIER Glycine 0 N--CA 1.462 0.393 0 N-CA-C 111.054 -0.819 . . . . 0.0 111.054 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' PHE . . . . . 0.45 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 26.9 m-85 -128.07 155.23 44.7 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.926 0.393 . . . . 0.0 110.509 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' THR . . . . . 0.448 ' O ' ' O ' ' A' ' 191' ' ' VAL . 6.9 p -106.94 122.23 46.02 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-O 121.299 0.571 . . . . 0.0 110.125 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . 0.442 ' CD2' ' N ' ' A' ' 223' ' ' LEU . 4.3 mm? -101.32 132.9 46.63 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.144 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.51 159.46 14.92 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.485 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.19 115.23 29.92 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.416 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.442 ' CD1' ' N ' ' A' ' 226' ' ' LEU . 9.1 mp -53.25 156.79 3.66 Favored Pre-proline 0 N--CA 1.447 -0.623 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.796 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -60.2 145.26 98.92 Favored 'Trans proline' 0 C--N 1.302 -1.873 0 C-N-CA 122.735 2.29 . . . . 0.0 112.145 179.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.42 -3.01 59.01 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.544 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.19 -40.91 5.67 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . 0.51 ' O ' ' N ' ' A' ' 233' ' ' SER . 84.8 mt -79.23 -16.85 55.87 Favored 'General case' 0 C--O 1.218 -0.562 0 CA-C-O 121.131 0.491 . . . . 0.0 110.323 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 54.3 t-20 -40.38 -49.33 2.8 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.839 0.352 . . . . 0.0 110.733 -179.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -87.99 15.44 7.27 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.251 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' SER . . . . . 0.51 ' N ' ' O ' ' A' ' 230' ' ' LEU . 77.8 p -60.59 -35.29 75.74 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.655 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . 0.524 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.6 tt0 -119.03 -69.33 0.86 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.753 0.311 . . . . 0.0 110.751 179.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.2 m -70.0 102.62 2.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.633 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -94.08 57.76 2.44 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.361 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -144.72 -122.59 1.58 Allowed Glycine 0 N--CA 1.461 0.363 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -134.84 111.59 10.01 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.059 0.456 . . . . 0.0 110.35 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . 0.517 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.4 mtt180 -148.05 57.94 1.09 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.664 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -69.75 -31.98 70.26 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.521 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' ASP . . . . . 0.508 ' CG ' HD22 ' A' ' 143' ' ' ASN . 64.9 t0 -56.92 -47.11 81.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.255 -179.004 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' ILE . . . . . 0.437 ' O ' ' O ' ' A' ' 239' ' ' ARG . 17.8 tt -139.95 156.63 25.41 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.263 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.391 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 96.1 mt -106.02 106.37 20.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-O 120.971 0.415 . . . . 0.0 110.468 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . 0.517 ' OE1' ' NH1' ' A' ' 239' ' ' ARG . 88.2 mt-30 -110.57 110.17 20.77 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.362 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 9.6 mp -121.77 -168.24 1.67 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.666 179.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . 0.524 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.7 -16.93 0.05 OUTLIER Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . 0.688 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -60.47 156.7 30.4 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 110.829 -0.908 . . . . 0.0 110.829 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -63.57 21.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.825 0.345 . . . . 0.0 110.583 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . 0.688 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.8 m-20 -96.85 -6.04 36.84 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.436 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 91.5 mt -79.89 -21.65 43.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.902 179.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.65 -51.35 70.28 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.661 -179.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.7 -5.1 58.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.458 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.27 -74.06 1.16 Allowed Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 80.1 mt -70.02 125.95 28.24 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.883 0.373 . . . . 0.0 110.334 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -59.53 -39.48 84.07 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.254 -179.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 83.27 51.77 4.02 Favored Glycine 0 CA--C 1.52 0.368 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -95.3 -15.76 22.9 Favored 'General case' 0 C--N 1.33 -0.243 0 O-C-N 122.77 -0.253 . . . . 0.0 110.661 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 258' ' ' SER . . . . . 0.419 ' O ' ' O ' ' A' ' 192' ' ' THR . 3.4 t 174.87 89.31 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.227 0.537 . . . . 0.0 110.244 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . 0.589 ' N ' ' CD1' ' A' ' 259' ' ' LEU . 0.9 OUTLIER -94.8 124.31 38.77 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.052 0.453 . . . . 0.0 111.052 -178.78 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 15.8 m-30 -93.58 146.4 23.84 Favored 'General case' 0 CA--C 1.495 -1.142 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.494 179.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 85.9 mt -122.18 149.24 43.91 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.564 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.652 ' CG ' ' N ' ' A' ' 263' ' ' ALA . 2.6 p90 -77.23 -138.82 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.534 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 263' ' ' ALA . . . . . 0.652 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -51.39 77.03 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.407 0 O-C-N 123.415 0.447 . . . . 0.0 111.171 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . 0.625 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.16 104.74 0.19 Allowed Glycine 0 CA--C 1.528 0.87 0 N-CA-C 110.421 -1.072 . . . . 0.0 110.421 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 265' ' ' ASP . . . . . 0.589 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.4 m-20 -80.21 -177.9 6.32 Favored 'General case' 0 C--N 1.327 -0.394 0 O-C-N 122.671 -0.311 . . . . 0.0 110.847 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -40.7 -17.76 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.549 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 267' ' ' LYS . . . . . 0.589 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.21 -51.44 45.48 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.614 179.22 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -63.9 -46.39 85.05 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.997 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . 0.523 ' O ' ' CD2' ' A' ' 273' ' ' TYR . . . -61.88 -34.92 76.9 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.657 0.741 . . . . 0.0 109.824 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -62.82 -34.66 77.77 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.292 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.43 -43.11 13.9 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.049 -179.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 272' ' ' ILE . . . . . 0.621 ' C ' ' H ' ' A' ' 274' ' ' ALA . 4.9 tt -51.53 -33.71 14.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.678 -178.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 273' ' ' TYR . . . . . 0.523 ' CD2' ' O ' ' A' ' 269' ' ' ALA . 17.2 m-85 -54.71 -1.55 0.03 OUTLIER 'General case' 0 CA--C 1.513 -0.452 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.616 -179.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 274' ' ' ALA . . . . . 0.621 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.61 -39.78 70.24 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.802 179.408 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . 0.573 ' O ' ' N ' ' A' ' 279' ' ' ALA . 2.6 p30 -38.98 97.9 0.15 Allowed Pre-proline 0 N--CA 1.462 0.151 0 O-C-N 123.49 0.494 . . . . 0.0 110.33 -179.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -54.18 -42.92 63.12 Favored 'Trans proline' 0 C--N 1.303 -1.845 0 C-N-CA 122.58 2.187 . . . . 0.0 112.491 -178.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 88.5 mt -64.41 -43.02 95.69 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.015 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 91.5 mt -95.66 -1.45 50.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.863 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 279' ' ' ALA . . . . . 0.573 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.58 -34.87 77.84 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.486 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.32 20.14 0.12 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.9 -179.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . 0.514 ' H ' ' C ' ' A' ' 279' ' ' ALA . 13.8 mt -74.65 119.53 77.1 Favored Pre-proline 0 N--CA 1.442 -0.838 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.849 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -50.57 -39.71 55.47 Favored 'Trans proline' 0 C--N 1.312 -1.36 0 C-N-CA 122.535 2.156 . . . . 0.0 112.063 178.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.73 -50.69 62.92 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.874 0.369 . . . . 0.0 110.021 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 76.9 t -61.4 -43.77 97.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.162 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -57.81 -41.2 81.71 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.089 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -91.0 0.63 57.5 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.245 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt 59.16 43.63 16.94 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.966 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -95.1 41.22 1.1 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.314 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 53.9 t -118.9 135.68 58.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-O 121.119 0.485 . . . . 0.0 109.967 -179.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -132.81 162.73 30.75 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.534 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.54 155.12 32.79 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.523 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 81.0 mt -94.09 -1.73 53.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.256 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.14 165.59 12.71 Favored Glycine 0 N--CA 1.465 0.613 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 6.8 m -87.33 -62.34 1.52 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.879 0.371 . . . . 0.0 110.947 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 295' ' ' GLU . . . . . 0.482 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.6 mm-40 -69.02 -4.07 15.48 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.755 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 24.5 p -76.92 32.32 0.14 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.68 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 297' ' ' PHE . . . . . 0.482 ' H ' ' C ' ' A' ' 295' ' ' GLU . 70.8 t80 -60.43 -45.97 91.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.624 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . 0.615 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.1 mtt85 -81.27 134.85 35.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.543 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 17.7 tp -113.68 117.22 30.95 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-O 120.918 0.39 . . . . 0.0 110.391 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . 0.602 ' H ' ' CB ' ' A' ' 303' ' ' SER . 49.9 p-10 -165.3 -176.47 4.06 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.758 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 301' ' ' TYR . . . . . 0.521 ' OH ' ' CD1' ' A' ' 173' ' ' PHE . 80.2 t80 -46.81 -43.49 18.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.391 -179.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -66.92 -40.35 87.61 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 121.037 0.446 . . . . 0.0 110.723 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 303' ' ' SER . . . . . 0.602 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 60.1 p -55.99 -36.37 67.81 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.062 -179.054 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -57.11 -51.8 67.85 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 179.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 92.2 mtp -55.48 -44.45 76.52 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -65.86 -42.66 90.15 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.309 0.576 . . . . 0.0 110.398 179.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 55.6 t -63.96 -42.92 97.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.253 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 44.0 tp -59.73 -41.93 92.02 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.029 -179.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -62.87 -38.69 91.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.069 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 310' ' ' ARG . . . . . 0.446 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.7 ttt85 -63.42 -43.84 96.34 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.295 179.512 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 90.2 mt -63.1 -42.1 99.52 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.489 179.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -63.01 -33.36 75.25 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.304 179.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.48 -23.54 22.06 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.285 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . 0.446 ' N ' ' O ' ' A' ' 310' ' ' ARG . 6.7 tt -62.31 -43.19 99.4 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 121.012 0.434 . . . . 0.0 110.526 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 . . . . . 0 C--O 1.22 -0.461 0 CA-C-O 118.041 -0.98 . . . . 0.0 110.263 -179.8 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -99.73 135.85 40.54 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.167 0.508 . . . . 0.0 110.403 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.492 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -92.33 178.62 1.61 Allowed Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.533 -179.797 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.492 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.0 Cg_exo -61.68 147.29 95.68 Favored 'Trans proline' 0 C--N 1.298 -2.104 0 C-N-CA 122.893 2.396 . . . . 0.0 112.164 179.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 35.3 ptt180 -136.91 142.59 42.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.636 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -79.52 117.06 20.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.459 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.5 tp -111.5 130.74 64.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.468 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.6 t -71.55 142.41 50.07 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.677 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.523 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.6 t0 -139.54 -179.81 6.12 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.502 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.523 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 77.9 p -73.83 -37.34 64.87 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.655 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.8 ttt85 -46.97 -94.77 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.335 -179.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.478 ' C ' ' HG1' ' A' ' 36' ' ' THR . . . -165.9 -27.02 0.02 OUTLIER Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.478 ' HG1' ' C ' ' A' ' 35' ' ' GLY . 63.4 m -168.67 105.98 0.44 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.834 0.35 . . . . 0.0 110.643 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.4 t60 -129.11 146.15 51.12 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 121.11 0.481 . . . . 0.0 110.112 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.489 ' CG2' ' N ' ' A' ' 39' ' ' LEU . 93.3 m -129.36 165.59 21.21 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.4 -179.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.489 ' N ' ' CG2' ' A' ' 38' ' ' THR . 79.6 mt -120.26 127.23 52.21 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.537 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -65.39 -44.78 86.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.698 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 39.0 p -165.83 155.28 12.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.374 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.463 ' N ' ' CD ' ' A' ' 42' ' ' GLN . 14.5 mp0 -45.2 101.26 0.25 Allowed Pre-proline 0 C--O 1.235 0.325 0 O-C-N 123.6 0.562 . . . . 0.0 110.558 179.227 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -57.77 130.34 38.04 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 C-N-CA 122.326 2.018 . . . . 0.0 112.315 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -82.76 -24.9 33.28 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.601 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.531 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.7 mtm-85 -120.86 134.98 55.29 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.225 0.536 . . . . 0.0 110.135 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.1 mt -130.26 133.48 63.98 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.345 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.818 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 45.7 t -125.24 130.87 72.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 CA-C-O 120.967 0.413 . . . . 0.0 109.924 179.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.504 ' O ' ' O ' ' A' ' 66' ' ' ALA . 4.7 m -154.87 166.48 33.38 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.527 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 72.8 p -124.49 8.88 8.38 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.313 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.68 125.69 33.37 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.857 0.36 . . . . 0.0 110.635 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 85.5 t -65.71 -44.44 93.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.553 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.8 m -62.7 -44.34 96.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.63 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 53.8 tp -62.46 -41.41 98.73 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.613 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 74.3 m -57.89 -44.6 86.84 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.269 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.27 -62.12 5.42 Favored Glycine 0 N--CA 1.468 0.788 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.6 t -48.24 -35.6 12.31 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 20.1 mt -61.85 -44.02 97.67 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 120.594 -0.442 . . . . 0.0 111.383 179.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.3 mp -65.43 -41.34 93.63 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.404 177.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.82 -41.27 97.9 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.914 -179.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 7.9 tp -87.66 16.55 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.918 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 56.44 84.42 0.09 Allowed 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.841 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.25 58.91 0.08 OUTLIER Pre-proline 0 C--N 1.327 -0.389 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -51.6 152.78 11.97 Favored 'Trans proline' 0 C--N 1.292 -2.437 0 C-N-CA 123.074 2.516 . . . . 0.0 112.053 -178.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.431 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -108.78 145.86 15.15 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.152 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.262 -179.646 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.61 -45.3 97.93 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.471 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.504 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -129.83 134.29 47.45 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.47 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.494 ' O ' ' N ' ' A' ' 98' ' ' LEU . 72.1 m -134.38 158.54 43.58 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.895 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.42 139.01 16.31 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.456 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.61 -162.98 0.09 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.953 0.406 . . . . 0.0 110.437 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.473 ' O ' ' C ' ' A' ' 71' ' ' THR . 5.7 t -133.91 135.83 43.88 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.015 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.473 ' C ' ' O ' ' A' ' 70' ' ' THR . 1.0 OUTLIER 29.68 68.23 0.68 Allowed Pre-proline 0 N--CA 1.468 0.438 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.78 -179.68 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_exo -61.32 145.11 98.7 Favored 'Trans proline' 0 C--N 1.299 -2.072 0 C-N-CA 122.644 2.23 . . . . 0.0 111.762 -177.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.527 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 45.5 p-10 -160.15 -32.02 0.06 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.746 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.527 ' N ' ' OD1' ' A' ' 73' ' ' ASN . 99.1 m-20 -64.29 -39.31 93.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.326 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -60.5 -47.88 84.21 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.509 -179.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.423 ' O ' ' O ' ' A' ' 77' ' ' ALA . 94.3 t -60.48 -24.46 31.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.423 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -45.73 173.03 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.602 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.567 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.6 p30 -61.92 177.59 0.43 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.58 -179.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.597 ' C ' ' H ' ' A' ' 81' ' ' GLY . 36.2 p30 -45.73 85.57 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.031 0.443 . . . . 0.0 111.069 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.567 ' N ' ' O ' ' A' ' 78' ' ' ASP . 42.4 tp60 -67.4 13.36 0.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.297 0.57 . . . . 0.0 110.172 -179.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.597 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 118.06 -22.53 9.71 Favored Glycine 0 C--N 1.333 0.372 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -107.82 116.04 31.24 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.056 0.455 . . . . 0.0 110.461 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 77.7 mt -98.47 0.67 45.62 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.991 0.424 . . . . 0.0 110.553 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -92.08 6.84 44.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.058 0.456 . . . . 0.0 110.387 -179.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.433 ' O ' ' CG2' ' A' ' 89' ' ' VAL . 88.4 mt-30 -100.02 -26.99 13.79 Favored 'General case' 0 C--O 1.22 -0.467 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.821 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.4 t-105 -63.8 -40.66 97.18 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.09 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.546 ' O ' ' N ' ' A' ' 91' ' ' LYS . 69.4 m -77.55 -53.27 7.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.134 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -48.9 -50.8 33.35 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.138 -179.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.433 ' CG2' ' O ' ' A' ' 85' ' ' GLN . 15.3 m -68.75 -40.62 81.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.232 179.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.412 ' H ' HG23 ' A' ' 89' ' ' VAL . . . -72.26 -23.07 61.15 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.678 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.546 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.0 tttm -61.32 -45.93 92.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.369 -179.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.439 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.8 mm-40 -90.5 -94.52 0.12 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.066 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.617 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.9 mtt180 -143.56 60.0 1.39 Allowed 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.442 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.7 pttp 34.22 25.86 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.105 0.478 . . . . 0.0 110.339 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.617 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.4 tt -48.25 123.01 5.83 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.064 -177.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -83.08 -170.62 3.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.059 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.62 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 83.0 mtp180 -73.32 137.85 45.04 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.128 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.494 ' N ' ' O ' ' A' ' 67' ' ' SER . 90.5 mt -86.65 -165.79 1.37 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.886 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.532 ' CD2' ' O ' ' A' ' 99' ' ' TYR . 47.5 p90 -168.84 119.98 0.75 Allowed 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.154 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.492 ' C ' ' O ' ' A' ' 99' ' ' TYR . 43.9 mm -29.22 121.06 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 O-C-N 123.308 0.38 . . . . 0.0 111.125 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 114.15 27.76 3.31 Favored Glycine 0 N--CA 1.461 0.341 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 -179.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.582 ' N ' ' CD ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -143.93 45.82 0.6 Allowed Pre-proline 0 C--N 1.321 -0.649 0 CA-C-O 121.079 0.466 . . . . 0.0 110.391 179.716 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.582 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 29.6 Cg_endo -62.42 144.16 94.51 Favored 'Trans proline' 0 C--N 1.294 -2.342 0 C-N-CA 122.687 2.258 . . . . 0.0 111.727 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.708 ' HG ' ' H ' ' A' ' 107' ' ' ALA . 24.8 t -173.36 121.04 0.35 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.377 179.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.29 -40.92 64.16 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.989 0.423 . . . . 0.0 111.125 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -65.91 -39.85 90.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.865 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.708 ' H ' ' HG ' ' A' ' 104' ' ' SER . . . -63.94 -39.64 94.63 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.754 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 70.0 t -67.52 -43.71 87.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.681 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.49 -39.28 92.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.474 -179.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.439 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.94 -23.83 63.87 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.476 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.537 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.3 mm-40 -91.18 5.04 50.65 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.667 -179.544 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.537 ' C ' ' O ' ' A' ' 111' ' ' GLN . 10.2 tpt 21.54 64.95 0.3 Allowed Pre-proline 0 N--CA 1.469 0.516 0 CA-C-O 120.961 0.41 . . . . 0.0 111.337 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -80.01 169.9 17.22 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 123.094 2.53 . . . . 0.0 111.517 -177.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.519 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 99.2 m-20 -112.34 -45.1 3.3 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.973 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 39.4 tp -119.51 121.23 38.94 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 96.7 mt -118.45 131.41 71.3 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.432 0 CA-C-O 120.953 0.406 . . . . 0.0 111.013 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 32.4 mt -106.04 132.24 52.35 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 121.086 0.47 . . . . 0.0 110.156 -179.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 98.6 mt -117.75 135.75 57.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.628 -179.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 85.3 p -71.17 151.32 44.51 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.62 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.42 -49.98 75.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.642 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.0 t -149.19 153.71 38.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.539 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 168.19 -169.68 41.6 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.93 -35.7 92.42 Favored Glycine 0 CA--C 1.522 0.513 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.445 ' O ' ' OD1' ' A' ' 124' ' ' ASP . 44.2 p-10 -88.2 120.18 29.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.867 0.365 . . . . 0.0 110.696 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 41.3 t -63.6 143.78 57.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.363 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.515 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.67 -42.82 8.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.863 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.4 tp -62.78 -42.45 99.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.674 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.76 -10.43 52.58 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.382 -179.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 83.4 mt -116.23 -24.0 8.17 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.65 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . 0.515 ' N ' ' O ' ' A' ' 126' ' ' ALA . 72.6 t80 -51.79 -49.08 63.42 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.639 -178.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 39.0 p-10 -65.96 -41.56 91.07 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.324 179.203 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.525 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 87.9 mt-30 -68.14 -36.68 80.08 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.874 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 96.3 mt -79.89 -42.67 23.69 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.017 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.402 ' N ' ' OG1' ' A' ' 139' ' ' THR . 11.3 t -57.37 -45.07 84.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.343 -179.018 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 20.0 m -62.36 -45.88 91.17 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.566 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 93.0 mt -62.28 -43.71 98.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.349 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -170.1 163.32 6.38 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.559 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -41.69 110.37 0.14 Allowed 'Trans proline' 0 C--N 1.311 -1.428 0 C-N-CA 122.486 2.124 . . . . 0.0 112.344 179.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' THR . . . . . 0.402 ' OG1' ' N ' ' A' ' 134' ' ' SER . 3.0 m -87.37 127.46 35.2 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.542 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 34.3 tp -119.29 139.24 52.24 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.259 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.428 ' O ' ' OD2' ' A' ' 32' ' ' ASP . 81.3 mt -105.32 120.1 55.49 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.352 0 CA-C-O 121.132 0.491 . . . . 0.0 111.196 -179.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 97.4 mt -135.69 132.75 51.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.585 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.518 HD22 ' CG ' ' A' ' 241' ' ' ASP . 59.3 t30 -64.62 148.22 51.35 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.933 0.397 . . . . 0.0 110.38 179.264 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.515 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 87.6 t80 -82.74 122.72 28.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.973 -179.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.515 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 99.0 m-20 55.11 69.12 0.77 Allowed 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.784 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 34.5 p-10 -125.7 0.31 7.45 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.856 0.36 . . . . 0.0 110.636 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -150.42 115.51 5.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.691 -179.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' SER . . . . . 0.516 ' HG ' ' H ' ' A' ' 150' ' ' GLN . 85.0 p -63.49 168.94 4.16 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.538 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.414 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.5 p-90 -51.84 -16.08 0.63 Allowed 'General case' 0 C--O 1.219 -0.505 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.326 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . 0.516 ' H ' ' HG ' ' A' ' 148' ' ' SER . 67.9 tp60 -70.11 -76.05 0.11 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.891 0.377 . . . . 0.0 110.542 -179.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.447 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.1 t -62.48 -38.66 90.7 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.253 179.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 52.1 tp -60.16 -45.61 92.48 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.354 -178.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.414 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 45.8 tp -62.6 -41.76 99.16 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.55 178.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.447 ' OG1' ' O ' ' A' ' 151' ' ' SER . 58.7 p -63.86 -34.94 79.06 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.098 -179.229 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . 0.467 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 88.0 mm-40 -63.66 -42.03 98.13 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.23 179.291 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 91.6 mt -65.34 -38.82 91.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.192 0.52 . . . . 0.0 110.243 179.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.566 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.34 -32.3 80.38 Favored Glycine 0 C--N 1.332 0.316 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 -179.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.467 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.4 mt-10 -36.79 -25.19 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.901 0.381 . . . . 0.0 110.862 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.566 ' N ' ' O ' ' A' ' 157' ' ' GLY . 94.9 mt -59.22 148.43 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.292 179.031 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 74.6 p -69.09 137.63 53.66 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.994 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 70.48 22.14 77.72 Favored Glycine 0 N--CA 1.458 0.136 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 179.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 59.9 m80 -124.48 -13.96 6.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.597 0.237 . . . . 0.0 110.426 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -66.81 -59.49 3.5 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.593 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -51.92 -48.89 63.99 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.153 -179.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -60.55 -41.09 93.83 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.806 0.336 . . . . 0.0 110.405 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.68 -47.43 85.34 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.534 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.63 -40.27 75.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.225 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -61.58 -50.44 72.59 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.672 179.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -65.25 -43.66 90.66 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.586 179.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 94.4 mt -64.63 -43.33 96.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.441 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.4 -51.12 70.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.313 -179.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.63 -43.41 96.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.851 0.357 . . . . 0.0 110.635 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . 0.504 ' CD1' ' OH ' ' A' ' 301' ' ' TYR . 57.7 t80 -62.94 -44.25 96.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.402 179.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -63.69 -39.65 94.86 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.477 -179.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -63.18 -42.82 99.42 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.564 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -60.63 -44.45 96.33 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.175 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 84.8 mt -64.44 -41.12 96.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.78 178.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.34 -62.14 1.83 Allowed 'General case' 0 C--O 1.24 0.553 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.281 -179.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.23 -47.23 84.16 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.432 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -52.73 -41.72 64.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.353 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -63.74 -33.59 75.99 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.055 0.455 . . . . 0.0 110.284 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 69.8 tt0 -91.08 8.52 35.08 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.666 0.746 . . . . 0.0 110.318 -178.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -104.33 -32.45 9.06 Favored 'General case' 0 CA--C 1.516 -0.361 0 O-C-N 122.001 -0.437 . . . . 0.0 111.222 179.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.7 pt -127.9 147.57 32.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.801 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -139.78 131.26 26.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.966 0.412 . . . . 0.0 110.395 179.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . 0.552 ' CD2' ' N ' ' A' ' 186' ' ' LEU . 3.5 mm? -85.34 133.59 42.16 Favored Pre-proline 0 N--CA 1.449 -0.516 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.193 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -43.65 157.76 0.12 Allowed 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.617 2.212 . . . . 0.0 112.372 179.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . 0.497 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.7 Cg_endo -63.04 114.69 2.55 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 122.817 2.344 . . . . 0.0 111.664 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . 0.497 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.7 mt-30 155.65 148.17 0.0 OUTLIER Pre-proline 0 N--CA 1.456 -0.159 0 O-C-N 124.244 0.965 . . . . 0.0 110.885 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -73.26 144.26 36.77 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.583 2.189 . . . . 0.0 112.289 177.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.487 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.1 p -124.61 158.87 31.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.461 0.648 . . . . 0.0 110.197 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' THR . . . . . 0.487 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 36.6 p -143.18 165.39 27.57 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.112 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -135.44 128.88 32.32 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-O 121.339 0.59 . . . . 0.0 110.209 179.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 47.7 pt -146.73 149.38 15.92 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.404 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.21 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 69.4 t -117.87 123.41 71.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.402 0.62 . . . . 0.0 109.792 179.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -134.34 106.75 7.25 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 121.104 0.478 . . . . 0.0 110.208 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 94.7 m -130.7 130.44 43.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.943 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.42 ' O ' ' N ' ' A' ' 201' ' ' HIS . . . -82.8 -37.18 24.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.25 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.21 -66.92 0.27 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.288 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.47 -9.54 58.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.273 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . 0.42 ' N ' ' O ' ' A' ' 198' ' ' ALA . 60.1 t-80 60.32 58.27 2.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.81 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 39.5 p -167.02 153.79 8.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.568 179.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.36 144.19 24.45 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.054 0.454 . . . . 0.0 110.454 179.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -135.29 138.09 43.13 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.605 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 19.4 mt -106.04 125.44 51.0 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.055 0.455 . . . . 0.0 109.796 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' TRP . . . . . 0.555 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 74.5 m95 -82.15 167.14 19.03 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.587 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -157.45 171.32 7.59 Favored Pre-proline 0 C--O 1.224 -0.268 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.624 -178.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -53.18 -37.12 79.69 Favored 'Trans proline' 0 C--N 1.301 -1.965 0 C-N-CA 122.583 2.189 . . . . 0.0 112.448 178.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -70.84 -35.23 72.34 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.71 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 21.0 m -60.95 151.0 31.53 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.572 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.8 -36.96 82.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.485 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' GLN . . . . . 0.555 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 55.1 tt0 -64.69 -40.27 95.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.519 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.63 -43.58 91.71 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.631 -0.988 . . . . 0.0 110.631 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -62.88 -44.0 97.27 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.789 0.328 . . . . 0.0 110.219 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 65.1 ttp -59.32 -47.91 83.63 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.071 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 87.0 mt -60.73 -41.16 94.76 Favored 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' GLU . . . . . 0.449 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.6 tp10 -58.03 -37.89 75.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.35 -0.386 . . . . 0.0 109.994 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -65.38 -38.31 89.63 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.671 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 95.2 mt -63.91 -42.9 97.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.111 0.482 . . . . 0.0 110.613 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.56 44.93 0.08 OUTLIER Glycine 0 C--N 1.332 0.359 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' PHE . . . . . 0.449 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 26.6 m-85 -127.89 155.49 44.09 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 121.054 0.454 . . . . 0.0 110.439 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' THR . . . . . 0.451 ' O ' ' O ' ' A' ' 191' ' ' VAL . 7.0 p -106.96 122.34 46.24 Favored 'General case' 0 C--O 1.223 -0.294 0 CA-C-O 121.331 0.586 . . . . 0.0 110.067 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . 0.441 ' CD2' ' N ' ' A' ' 223' ' ' LEU . 4.3 mm? -101.4 133.01 46.68 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.229 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.8 159.8 14.72 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.456 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.52 115.35 30.1 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.935 0.398 . . . . 0.0 110.339 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.452 ' CD1' ' N ' ' A' ' 226' ' ' LEU . 8.9 mp -53.08 156.54 3.57 Favored Pre-proline 0 N--CA 1.448 -0.559 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.817 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -59.91 145.17 98.97 Favored 'Trans proline' 0 C--N 1.299 -2.03 0 C-N-CA 122.753 2.302 . . . . 0.0 112.312 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.09 -3.35 59.07 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.516 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.2 -40.96 5.66 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . 0.506 ' O ' ' N ' ' A' ' 233' ' ' SER . 67.7 mt -79.08 -17.8 54.52 Favored 'General case' 0 C--O 1.218 -0.587 0 CA-C-O 121.212 0.529 . . . . 0.0 110.296 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 54.5 t-20 -40.74 -49.17 3.09 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.845 -179.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -87.16 15.05 6.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.459 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' SER . . . . . 0.506 ' N ' ' O ' ' A' ' 230' ' ' LEU . 77.9 p -60.56 -34.99 74.98 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.683 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . 0.525 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.5 tt0 -119.73 -69.3 0.85 Allowed 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.835 179.171 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.3 m -69.3 102.19 1.68 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.022 0.439 . . . . 0.0 110.687 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -94.08 57.51 2.4 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.086 0.47 . . . . 0.0 110.365 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -144.61 -122.43 1.58 Allowed Glycine 0 C--N 1.332 0.343 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -135.64 111.78 9.67 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.161 0.505 . . . . 0.0 110.347 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . 0.524 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.5 mtt180 -148.08 58.26 1.09 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.707 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -69.36 -32.48 71.57 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.457 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' ASP . . . . . 0.518 ' CG ' HD22 ' A' ' 143' ' ' ASN . 64.7 t0 -57.04 -47.24 81.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.211 -178.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' ILE . . . . . 0.435 ' O ' ' O ' ' A' ' 239' ' ' ARG . 18.1 tt -139.62 155.87 25.69 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.275 0 CA-C-O 120.913 0.387 . . . . 0.0 110.44 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 96.3 mt -106.17 106.87 21.39 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 CA-C-O 121.099 0.476 . . . . 0.0 110.479 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . 0.524 ' OE1' ' NH1' ' A' ' 239' ' ' ARG . 88.3 mt-30 -110.71 110.04 20.54 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.261 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 9.5 mp -121.51 -168.2 1.65 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.766 179.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . 0.525 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 174.14 -16.54 0.05 OUTLIER Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . 0.692 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -61.24 156.23 34.37 Favored Glycine 0 CA--C 1.521 0.449 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -63.4 21.94 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.995 0.426 . . . . 0.0 110.647 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . 0.692 ' H ' ' C ' ' A' ' 247' ' ' GLY . 99.0 m-20 -97.2 -6.27 35.13 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.438 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 91.0 mt -79.65 -22.0 44.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.775 179.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.68 -51.43 69.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.712 -179.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.21 -5.53 58.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.47 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.08 -74.24 1.15 Allowed Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.776 -0.929 . . . . 0.0 110.776 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 83.0 mt -70.25 126.43 29.64 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.218 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -59.67 -39.44 84.47 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.081 -179.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 83.16 51.62 4.1 Favored Glycine 0 CA--C 1.519 0.29 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -95.9 -14.96 22.73 Favored 'General case' 0 C--N 1.331 -0.204 0 O-C-N 122.65 -0.323 . . . . 0.0 110.598 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 258' ' ' SER . . . . . 0.422 ' O ' ' O ' ' A' ' 192' ' ' THR . 3.4 t 174.73 88.85 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.24 0.543 . . . . 0.0 110.072 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . 0.588 ' N ' ' CD1' ' A' ' 259' ' ' LEU . 1.0 OUTLIER -94.61 124.28 38.55 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.254 0.549 . . . . 0.0 111.267 -179.143 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 15.7 m-30 -93.37 146.39 23.77 Favored 'General case' 0 CA--C 1.495 -1.171 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.474 179.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 86.1 mt -122.33 149.25 44.02 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.545 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.655 ' CG ' ' N ' ' A' ' 263' ' ' ALA . 2.5 p90 -77.26 -138.77 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.578 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 263' ' ' ALA . . . . . 0.655 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -51.46 76.97 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 121.091 0.472 . . . . 0.0 111.299 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . 0.626 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.15 104.67 0.19 Allowed Glycine 0 CA--C 1.528 0.895 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 -179.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 265' ' ' ASP . . . . . 0.592 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.5 m-20 -80.31 -177.98 6.4 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 122.719 -0.283 . . . . 0.0 110.972 -179.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -40.3 -17.87 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.566 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 267' ' ' LYS . . . . . 0.592 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -67.94 -51.74 44.1 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.759 179.1 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -63.65 -46.47 85.48 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.216 179.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . 0.524 ' O ' ' CD2' ' A' ' 273' ' ' TYR . . . -61.93 -34.99 77.08 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 121.539 0.685 . . . . 0.0 109.658 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -63.2 -34.46 77.69 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.158 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.49 -42.96 13.98 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.081 -179.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 272' ' ' ILE . . . . . 0.62 ' C ' ' H ' ' A' ' 274' ' ' ALA . 4.9 tt -51.44 -33.78 14.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.728 -178.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 273' ' ' TYR . . . . . 0.524 ' CD2' ' O ' ' A' ' 269' ' ' ALA . 17.2 m-85 -54.64 -1.85 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.573 -179.327 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 274' ' ' ALA . . . . . 0.62 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.45 -39.9 70.7 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.952 179.381 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . 0.577 ' O ' ' N ' ' A' ' 279' ' ' ALA . 3.1 p30 -38.8 97.81 0.15 Allowed Pre-proline 0 N--CA 1.462 0.164 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.366 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -54.57 -42.62 66.47 Favored 'Trans proline' 0 C--N 1.303 -1.864 0 C-N-CA 122.428 2.086 . . . . 0.0 112.535 -178.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 89.5 mt -64.4 -42.87 95.87 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.058 0.456 . . . . 0.0 111.218 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 90.9 mt -95.7 -1.58 49.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.967 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 279' ' ' ALA . . . . . 0.577 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.3 -34.8 77.29 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.744 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.18 20.03 0.11 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.012 -179.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . 0.513 ' H ' ' C ' ' A' ' 279' ' ' ALA . 13.8 mt -74.93 119.51 77.2 Favored Pre-proline 0 N--CA 1.445 -0.69 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.801 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -49.96 -39.96 49.56 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.593 2.195 . . . . 0.0 112.279 178.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.72 -50.52 63.24 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.038 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 75.9 t -61.42 -43.96 97.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -57.71 -41.18 81.23 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.039 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -91.17 0.24 57.57 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.133 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt 59.36 43.53 16.48 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.04 0.447 . . . . 0.0 110.906 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -94.75 41.37 1.09 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.31 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 54.3 t -119.31 135.55 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-O 121.129 0.49 . . . . 0.0 109.995 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -132.64 162.98 29.97 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.209 0.528 . . . . 0.0 110.613 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.63 155.4 32.39 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-O 121.073 0.463 . . . . 0.0 110.632 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 82.8 mt -94.35 -1.52 53.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.256 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 120.83 165.32 12.69 Favored Glycine 0 C--N 1.335 0.497 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 7.3 m -86.98 -62.38 1.52 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.864 0.364 . . . . 0.0 111.154 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 295' ' ' GLU . . . . . 0.48 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.7 mm-40 -68.79 -3.97 14.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.738 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 25.0 p -77.08 32.04 0.14 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.651 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 297' ' ' PHE . . . . . 0.48 ' H ' ' C ' ' A' ' 295' ' ' GLU . 68.7 t80 -60.4 -46.18 90.93 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.629 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . 0.62 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.1 mtt85 -80.61 134.81 35.95 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.577 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 18.2 tp -113.87 117.01 30.23 Favored 'General case' 0 C--O 1.23 0.075 0 CA-C-O 121.02 0.438 . . . . 0.0 110.203 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . 0.6 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.5 p-10 -165.03 -176.71 4.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.651 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 301' ' ' TYR . . . . . 0.504 ' OH ' ' CD1' ' A' ' 173' ' ' PHE . 81.0 t80 -46.95 -42.99 18.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.356 -179.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -67.19 -40.14 86.48 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 121.065 0.46 . . . . 0.0 110.746 178.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 303' ' ' SER . . . . . 0.6 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 59.9 p -56.3 -36.35 68.55 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.975 -179.038 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . 0.567 ' N ' ' HG ' ' A' ' 303' ' ' SER . . . -57.04 -52.15 66.43 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 91.7 mtp -55.78 -43.66 77.01 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -66.22 -42.59 88.48 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.241 0.543 . . . . 0.0 110.239 179.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 55.5 t -64.04 -42.95 97.29 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.188 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 42.6 tp -60.05 -42.05 93.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.82 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -62.42 -39.34 92.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.028 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 310' ' ' ARG . . . . . 0.446 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.5 ttt85 -63.49 -44.0 95.64 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.153 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 89.8 mt -63.18 -42.11 99.31 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.103 0.478 . . . . 0.0 110.36 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt -63.16 -33.35 75.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.12 179.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.56 -23.72 21.92 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.329 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . 0.446 ' N ' ' O ' ' A' ' 310' ' ' ARG . 6.7 tt -62.35 -43.17 99.46 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 121.075 0.464 . . . . 0.0 110.521 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 . . . . . 0 C--O 1.22 -0.463 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.346 -179.886 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -99.55 135.98 40.17 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.119 0.485 . . . . 0.0 110.475 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.49 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -92.16 178.55 1.66 Allowed Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.589 -179.893 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.49 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.7 Cg_exo -61.44 147.15 96.2 Favored 'Trans proline' 0 C--N 1.299 -2.046 0 C-N-CA 122.848 2.365 . . . . 0.0 112.208 179.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 35.7 ptt180 -136.12 142.36 44.24 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.585 179.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -79.54 116.6 19.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.521 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.5 tp -111.1 130.66 64.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.564 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 13.7 t -70.79 142.25 51.34 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.987 0.422 . . . . 0.0 110.676 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.511 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.3 t0 -139.8 179.39 6.62 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.458 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.511 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 77.9 p -73.83 -37.05 64.97 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.562 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.8 ttt85 -46.51 -94.62 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.248 -179.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.494 ' C ' ' HG1' ' A' ' 36' ' ' THR . . . -167.06 -26.38 0.02 OUTLIER Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.494 ' HG1' ' C ' ' A' ' 35' ' ' GLY . 55.6 m -169.35 104.94 0.37 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.807 0.337 . . . . 0.0 110.664 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 75.4 t60 -128.47 148.79 50.75 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.055 0.455 . . . . 0.0 110.231 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.487 ' CG2' ' N ' ' A' ' 39' ' ' LEU . 98.6 m -131.02 166.05 21.87 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.498 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.487 ' N ' ' CG2' ' A' ' 38' ' ' THR . 81.2 mt -120.78 127.19 51.73 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.408 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -65.08 -44.62 88.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.794 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 40.9 p -165.71 155.1 12.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.354 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.46 ' N ' ' CD ' ' A' ' 42' ' ' GLN . 14.5 mp0 -44.27 100.91 0.24 Allowed Pre-proline 0 C--O 1.235 0.326 0 O-C-N 123.526 0.516 . . . . 0.0 110.594 179.202 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.54 129.6 34.66 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 C-N-CA 122.344 2.029 . . . . 0.0 112.231 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -83.63 -24.69 31.32 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.609 179.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.539 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.4 mtm-85 -122.25 134.43 54.69 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.257 0.551 . . . . 0.0 110.177 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.0 mt -130.46 133.78 63.24 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.774 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 45.3 t -124.43 130.4 73.58 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 CA-C-O 120.911 0.386 . . . . 0.0 109.986 179.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.504 ' O ' ' O ' ' A' ' 66' ' ' ALA . 2.1 m -154.88 167.27 30.84 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.645 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 65.1 p -124.53 9.16 8.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.419 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.52 125.51 33.13 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.644 -179.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 92.7 t -65.77 -44.51 93.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.555 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.4 m -62.51 -44.18 97.0 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.654 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 53.1 tp -62.33 -41.43 98.56 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.464 -179.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 74.3 m -57.86 -44.58 86.66 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.126 -179.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.19 -62.41 5.19 Favored Glycine 0 N--CA 1.467 0.733 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.7 t -47.94 -35.74 11.23 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 20.1 mt -61.88 -44.13 97.44 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.348 179.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.1 mp -65.62 -41.35 92.79 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.333 177.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.67 -41.1 98.22 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.846 -179.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 7.8 tp -88.35 16.66 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.914 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 56.27 84.79 0.08 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.821 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 178.83 58.34 0.07 OUTLIER Pre-proline 0 C--N 1.328 -0.358 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -51.6 153.51 10.7 Favored 'Trans proline' 0 C--N 1.293 -2.385 0 C-N-CA 123.051 2.501 . . . . 0.0 111.943 -178.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.435 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.2 OUTLIER -108.86 145.33 15.85 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.148 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.341 -179.677 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.36 -45.49 97.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.363 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.504 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -129.43 134.08 47.65 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 120.816 0.341 . . . . 0.0 110.489 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.503 ' O ' ' N ' ' A' ' 98' ' ' LEU . 73.8 m -134.54 158.75 43.17 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.871 -179.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -87.04 139.25 16.06 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 110.621 -0.991 . . . . 0.0 110.621 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.467 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.7 -162.77 0.08 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.938 0.399 . . . . 0.0 110.431 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.478 ' O ' ' C ' ' A' ' 71' ' ' THR . 14.2 t -133.47 134.75 43.91 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.293 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.478 ' C ' ' O ' ' A' ' 70' ' ' THR . 0.6 OUTLIER 29.73 68.74 0.66 Allowed Pre-proline 0 N--CA 1.467 0.397 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.817 -179.865 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_exo -61.85 145.18 97.21 Favored 'Trans proline' 0 C--N 1.299 -2.027 0 C-N-CA 122.706 2.27 . . . . 0.0 111.723 -177.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.528 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 45.7 p-10 -159.4 -31.81 0.06 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.66 179.645 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.528 ' N ' ' OD1' ' A' ' 73' ' ' ASN . 99.1 m-20 -64.35 -39.42 93.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.366 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.4 ttt180 -60.33 -48.16 82.95 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.505 -179.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.424 ' O ' ' O ' ' A' ' 77' ' ' ALA . 93.0 t -60.48 -25.1 33.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.054 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.424 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -45.51 173.04 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.592 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.569 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.4 p30 -62.01 177.59 0.44 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.577 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.594 ' C ' ' H ' ' A' ' 81' ' ' GLY . 35.5 p30 -45.34 85.67 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.036 0.446 . . . . 0.0 111.102 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.569 ' N ' ' O ' ' A' ' 78' ' ' ASP . 42.8 tp60 -67.64 13.29 0.08 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.268 0.556 . . . . 0.0 110.197 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.594 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 118.65 -22.08 9.49 Favored Glycine 0 N--CA 1.462 0.374 0 N-CA-C 110.981 -0.848 . . . . 0.0 110.981 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -108.33 116.42 31.94 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.963 0.411 . . . . 0.0 110.445 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 76.6 mt -98.74 -0.19 43.22 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.578 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -92.15 7.35 42.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.971 0.415 . . . . 0.0 110.299 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.439 ' O ' ' CG2' ' A' ' 89' ' ' VAL . 87.9 mt-30 -100.25 -28.15 13.14 Favored 'General case' 0 C--O 1.22 -0.455 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.795 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 68.9 t-105 -63.03 -40.47 97.82 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.833 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.551 ' O ' ' N ' ' A' ' 91' ' ' LYS . 67.5 m -77.82 -53.74 7.14 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.881 -179.342 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -48.53 -50.68 30.94 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.076 -179.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.439 ' CG2' ' O ' ' A' ' 85' ' ' GLN . 15.5 m -68.81 -40.55 81.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.161 179.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.415 ' H ' HG23 ' A' ' 89' ' ' VAL . . . -72.43 -22.66 61.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.572 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.551 ' N ' ' O ' ' A' ' 87' ' ' SER . 65.9 tttm -61.97 -45.67 92.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.357 -179.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.437 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.8 mm-40 -90.41 -94.64 0.12 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.164 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.621 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.8 mtt180 -143.12 58.73 1.41 Allowed 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.446 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.6 pttp 33.97 26.02 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.149 0.5 . . . . 0.0 110.267 -179.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.621 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.4 tt -48.22 123.48 6.47 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.002 -177.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -83.82 -169.98 2.85 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.146 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.609 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 81.2 mtp180 -74.25 137.07 42.74 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.232 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.503 ' N ' ' O ' ' A' ' 67' ' ' SER . 91.0 mt -85.71 -165.77 1.33 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.901 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.538 ' CD2' ' O ' ' A' ' 99' ' ' TYR . 47.9 p90 -168.57 119.56 0.77 Allowed 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.13 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.502 ' C ' ' O ' ' A' ' 99' ' ' TYR . 43.0 mm -28.69 120.78 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.068 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 114.2 27.61 3.35 Favored Glycine 0 CA--C 1.519 0.315 0 N-CA-C 111.259 -0.736 . . . . 0.0 111.259 -179.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.574 ' N ' ' CD ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -144.52 46.39 0.62 Allowed Pre-proline 0 C--N 1.321 -0.654 0 CA-C-O 121.084 0.468 . . . . 0.0 110.511 179.773 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.574 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 28.8 Cg_endo -62.15 144.34 95.66 Favored 'Trans proline' 0 C--N 1.295 -2.273 0 C-N-CA 122.687 2.258 . . . . 0.0 111.732 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.705 ' HG ' ' H ' ' A' ' 107' ' ' ALA . 24.3 t -173.2 120.52 0.35 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.349 179.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.95 -40.3 63.16 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.011 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.27 -39.91 89.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.892 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.705 ' H ' ' HG ' ' A' ' 104' ' ' SER . . . -64.33 -39.97 94.96 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.769 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 69.6 t -67.83 -43.65 86.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.73 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.04 -38.88 92.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.476 -179.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.437 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.55 -23.2 62.67 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.538 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.535 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.3 mm-40 -91.0 5.88 47.05 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.746 -179.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.539 ' O ' ' NE ' ' A' ' 45' ' ' ARG . 10.6 tpt 22.89 64.64 0.36 Allowed Pre-proline 0 N--CA 1.467 0.416 0 CA-C-O 120.905 0.383 . . . . 0.0 111.215 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -79.04 167.41 21.95 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 123.087 2.524 . . . . 0.0 111.466 -177.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.526 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 99.2 m-20 -110.02 -41.99 4.32 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.038 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.2 tp -121.38 120.26 34.51 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.925 0.393 . . . . 0.0 109.983 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 82.1 mt -112.94 128.92 69.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 CA-C-O 120.833 0.349 . . . . 0.0 110.935 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 29.3 mt -109.08 132.11 54.42 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.281 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 99.0 mt -119.75 138.57 49.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.654 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 85.7 p -72.54 153.8 41.13 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.633 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.28 -50.09 75.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.621 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -149.32 153.8 38.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.561 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 170.68 -170.86 43.43 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -63.11 -34.12 89.11 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.449 ' O ' ' OD1' ' A' ' 124' ' ' ASP . 44.3 p-10 -87.13 120.22 28.18 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.827 0.346 . . . . 0.0 110.612 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 37.7 t -63.18 143.94 57.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.342 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.52 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.09 -43.3 8.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.868 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.9 tp -63.03 -42.36 99.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.747 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.6 -12.1 59.64 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.372 -179.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 84.7 mt -114.88 -23.94 8.89 Favored 'General case' 0 C--O 1.225 -0.196 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.557 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . 0.52 ' N ' ' O ' ' A' ' 126' ' ' ALA . 79.5 t80 -51.07 -49.55 60.41 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.654 -178.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.502 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 37.6 p-10 -66.16 -42.81 88.5 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.762 -0.375 . . . . 0.0 111.255 179.421 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.502 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 88.4 mt-30 -66.94 -37.68 84.74 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.783 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 96.3 mt -80.21 -41.62 24.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.908 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.3 t -56.94 -44.68 82.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.229 -179.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 20.4 m -62.01 -45.1 95.08 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.378 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 94.3 mt -62.06 -43.65 97.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.305 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.44 168.47 4.82 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.649 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -49.91 112.74 0.77 Allowed 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.354 2.036 . . . . 0.0 112.454 179.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 23.6 m -84.07 127.33 33.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.629 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 34.4 tp -117.71 135.89 53.73 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.15 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.438 ' O ' ' OD2' ' A' ' 32' ' ' ASP . 82.1 mt -100.09 119.03 47.61 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.286 0 CA-C-O 121.093 0.473 . . . . 0.0 111.057 -179.301 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 98.0 mt -134.84 132.23 53.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.586 179.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.516 HD22 ' CG ' ' A' ' 241' ' ' ASP . 61.2 t30 -66.69 151.46 47.35 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.473 179.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.521 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 88.1 t80 -86.24 122.47 30.28 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.858 -179.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.521 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 98.9 m-20 55.22 69.17 0.76 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.673 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 35.0 p-10 -125.8 0.36 7.38 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.573 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -150.62 115.07 5.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.687 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' SER . . . . . 0.514 ' HG ' ' H ' ' A' ' 150' ' ' GLN . 84.0 p -63.34 168.41 4.47 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.597 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.411 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.8 p-90 -51.78 -16.05 0.61 Allowed 'General case' 0 C--O 1.22 -0.453 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.386 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . 0.514 ' H ' ' HG ' ' A' ' 148' ' ' SER . 68.1 tp60 -70.22 -76.01 0.11 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.896 0.379 . . . . 0.0 110.585 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.441 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.1 t -62.57 -38.81 91.53 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.224 179.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 54.1 tp -59.82 -45.9 90.93 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.398 -178.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.411 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 46.1 tp -62.63 -41.6 99.1 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.585 178.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.441 ' OG1' ' O ' ' A' ' 151' ' ' SER . 61.5 p -64.11 -34.96 79.25 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.189 -179.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . 0.435 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.9 mm-40 -64.11 -42.49 96.87 Favored 'General case' 0 C--O 1.225 -0.229 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.412 179.308 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 90.6 mt -65.57 -38.57 89.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.147 0.499 . . . . 0.0 110.313 179.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.57 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.52 -32.28 80.66 Favored Glycine 0 C--N 1.331 0.286 0 N-CA-C 110.604 -0.998 . . . . 0.0 110.604 -179.154 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.435 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.2 mt-10 -35.56 -27.07 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.841 0.353 . . . . 0.0 110.827 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.57 ' N ' ' O ' ' A' ' 157' ' ' GLY . 95.6 mt -55.95 149.16 3.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.354 178.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 69.1 p -69.53 137.25 52.32 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.903 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 71.21 21.32 78.47 Favored Glycine 0 N--CA 1.459 0.195 0 N-CA-C 111.198 -0.761 . . . . 0.0 111.198 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 57.2 m80 -122.96 -14.67 7.56 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.6 0.238 . . . . 0.0 110.507 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -65.94 -59.97 3.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.596 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -52.05 -49.42 63.5 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.166 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -60.51 -41.07 93.61 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.838 0.351 . . . . 0.0 110.483 179.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.61 -47.26 86.26 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.505 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.82 -40.15 75.48 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.271 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -61.77 -50.01 74.08 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.616 179.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -65.34 -43.65 90.21 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.556 179.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 93.8 mt -64.88 -43.23 96.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.377 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.45 -51.35 69.8 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.297 -179.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.08 -43.82 97.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.939 0.4 . . . . 0.0 110.723 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . 0.459 ' CD1' ' OH ' ' A' ' 301' ' ' TYR . 57.7 t80 -63.09 -44.16 96.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.34 179.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -63.61 -39.64 94.89 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.498 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -63.16 -42.73 99.48 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.522 179.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -60.53 -44.68 95.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.22 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 84.6 mt -64.66 -40.94 96.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.651 178.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.14 -62.44 1.63 Allowed 'General case' 0 C--O 1.238 0.483 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.33 -179.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.34 -47.04 85.02 Favored 'General case' 0 C--O 1.226 -0.184 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.58 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -52.88 -41.89 64.77 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.368 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -63.97 -33.41 75.67 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.285 179.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 70.0 tt0 -90.76 8.78 32.92 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.609 0.719 . . . . 0.0 110.317 -178.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -105.05 -31.94 8.95 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.155 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 45.3 pt -128.08 147.93 32.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.708 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -140.19 131.34 26.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.463 179.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . 0.552 ' CD2' ' N ' ' A' ' 186' ' ' LEU . 3.6 mm? -85.63 132.63 43.89 Favored Pre-proline 0 N--CA 1.451 -0.41 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.13 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -43.45 157.59 0.11 Allowed 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.701 2.267 . . . . 0.0 112.416 179.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . 0.501 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.6 Cg_endo -62.84 115.1 2.72 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 C-N-CA 122.781 2.321 . . . . 0.0 111.727 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . 0.501 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.7 mt-30 155.72 147.44 0.0 OUTLIER Pre-proline 0 C--O 1.232 0.134 0 O-C-N 124.071 0.857 . . . . 0.0 110.953 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -73.34 143.71 35.54 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.553 2.169 . . . . 0.0 112.381 177.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.493 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.1 p -124.63 159.24 31.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.443 0.64 . . . . 0.0 110.217 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' THR . . . . . 0.493 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 36.0 p -143.45 165.49 27.4 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.082 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -135.4 128.75 32.18 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 121.292 0.568 . . . . 0.0 110.181 179.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 47.3 pt -146.46 148.87 16.55 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.381 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.276 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 69.8 t -117.67 123.28 71.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.334 0.588 . . . . 0.0 109.844 178.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -134.37 107.38 7.58 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.258 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 94.0 m -130.86 130.39 43.51 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.846 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.407 ' O ' ' N ' ' A' ' 201' ' ' HIS . . . -82.74 -37.16 25.06 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.22 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.32 -67.1 0.26 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.383 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.2 -10.07 59.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.387 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . 0.407 ' N ' ' O ' ' A' ' 198' ' ' ALA . 60.2 t-80 61.01 58.25 2.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.721 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 41.4 p -167.03 153.7 8.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.595 179.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.6 144.32 24.35 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.467 179.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -135.46 138.28 43.02 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.647 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 19.6 mt -106.2 125.59 51.18 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.046 0.45 . . . . 0.0 109.876 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' TRP . . . . . 0.555 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 75.8 m95 -82.3 167.24 18.79 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.619 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -157.05 170.94 8.12 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-O 120.981 0.42 . . . . 0.0 110.587 -178.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -53.09 -37.17 79.0 Favored 'Trans proline' 0 C--N 1.301 -1.928 0 C-N-CA 122.659 2.24 . . . . 0.0 112.532 178.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -70.86 -34.78 71.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.64 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 22.4 m -61.24 150.87 33.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.641 -179.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.68 -36.87 82.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.471 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' GLN . . . . . 0.555 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 55.0 tt0 -64.91 -40.1 94.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.515 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.62 -43.66 91.59 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.649 -0.98 . . . . 0.0 110.649 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -62.83 -43.81 97.82 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.874 0.369 . . . . 0.0 110.306 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 65.2 ttp -59.31 -48.23 82.4 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.108 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 88.6 mt -60.27 -41.16 92.72 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' GLU . . . . . 0.453 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.1 tp10 -57.93 -37.78 74.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.14 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -65.33 -38.1 89.1 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.687 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 94.2 mt -64.14 -42.89 96.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.176 0.512 . . . . 0.0 110.653 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.61 44.82 0.08 OUTLIER Glycine 0 N--CA 1.462 0.4 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' PHE . . . . . 0.453 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 27.3 m-85 -127.77 155.31 44.23 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 121.065 0.46 . . . . 0.0 110.463 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' THR . . . . . 0.452 ' O ' ' O ' ' A' ' 191' ' ' VAL . 6.6 p -106.95 122.08 45.73 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.287 0.565 . . . . 0.0 109.992 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . 0.444 ' CD2' ' N ' ' A' ' 223' ' ' LEU . 4.3 mm? -100.99 133.19 45.85 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.139 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.95 159.05 15.13 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.426 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.09 115.43 30.25 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.924 0.392 . . . . 0.0 110.312 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.449 ' CD1' ' N ' ' A' ' 226' ' ' LEU . 8.9 mp -53.62 156.53 4.51 Favored Pre-proline 0 N--CA 1.45 -0.435 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.783 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.82 145.31 98.57 Favored 'Trans proline' 0 C--N 1.3 -1.999 0 C-N-CA 122.764 2.31 . . . . 0.0 112.34 179.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.53 -2.95 58.96 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.473 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.26 -40.8 5.68 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 111.034 -0.827 . . . . 0.0 111.034 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . 0.526 ' O ' ' N ' ' A' ' 233' ' ' SER . 85.7 mt -79.09 -16.85 56.16 Favored 'General case' 0 C--O 1.219 -0.54 0 CA-C-O 121.099 0.476 . . . . 0.0 110.347 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 54.3 t-20 -40.24 -49.15 2.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.857 -179.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -88.08 15.34 7.53 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.386 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' SER . . . . . 0.526 ' N ' ' O ' ' A' ' 230' ' ' LEU . 78.1 p -60.59 -35.5 76.24 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.714 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . 0.523 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.6 tt0 -118.38 -69.41 0.85 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.809 179.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.0 m -70.06 103.5 2.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.678 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -94.57 57.5 2.23 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.279 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -144.84 -122.48 1.56 Allowed Glycine 0 N--CA 1.461 0.304 0 N-CA-C 110.946 -0.861 . . . . 0.0 110.946 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -134.54 111.94 10.48 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.146 0.498 . . . . 0.0 110.339 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . 0.515 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.3 mtt180 -148.33 57.54 1.07 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.69 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -69.77 -31.91 70.11 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.528 179.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' ASP . . . . . 0.516 ' CG ' HD22 ' A' ' 143' ' ' ASN . 65.0 t0 -56.72 -47.09 80.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.304 -179.029 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 242' ' ' ILE . . . . . 0.439 ' O ' ' O ' ' A' ' 239' ' ' ARG . 17.6 tt -140.12 157.06 25.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.867 0.365 . . . . 0.0 110.468 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 96.2 mt -106.07 106.27 20.25 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.168 0 CA-C-O 121.085 0.469 . . . . 0.0 110.461 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . 0.515 ' OE1' ' NH1' ' A' ' 239' ' ' ARG . 88.0 mt-30 -110.55 110.2 20.83 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.309 179.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 9.6 mp -121.86 -168.12 1.65 Allowed 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.643 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . 0.523 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.3 -16.87 0.05 OUTLIER Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . 0.688 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -60.46 157.04 29.74 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -63.74 21.38 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.942 0.401 . . . . 0.0 110.601 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . 0.688 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.8 m-20 -97.08 -6.0 36.15 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.43 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 92.2 mt -80.09 -21.45 43.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.824 179.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.56 -51.31 70.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.634 -179.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.7 -5.25 58.24 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.488 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.16 -74.29 1.15 Allowed Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.829 -0.909 . . . . 0.0 110.829 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 81.3 mt -70.15 126.08 28.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.931 0.396 . . . . 0.0 110.328 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -59.6 -39.26 83.59 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.289 -179.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 82.91 51.68 4.14 Favored Glycine 0 CA--C 1.52 0.382 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -95.77 -15.19 22.74 Favored 'General case' 0 C--N 1.332 -0.187 0 O-C-N 122.69 -0.3 . . . . 0.0 110.616 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 258' ' ' SER . . . . . 0.421 ' O ' ' O ' ' A' ' 192' ' ' THR . 3.3 t 174.69 88.85 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.24 0.543 . . . . 0.0 110.114 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . 0.59 ' N ' ' CD1' ' A' ' 259' ' ' LEU . 0.9 OUTLIER -94.41 124.13 38.25 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.201 0.524 . . . . 0.0 111.266 -179.132 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 15.7 m-30 -93.25 146.28 23.82 Favored 'General case' 0 CA--C 1.498 -1.022 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.379 179.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 86.0 mt -122.27 149.68 43.37 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.622 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.656 ' CG ' ' N ' ' A' ' 263' ' ' ALA . 2.7 p90 -77.17 -138.19 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.587 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 263' ' ' ALA . . . . . 0.656 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -52.34 77.18 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 121.024 0.44 . . . . 0.0 111.165 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . 0.616 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -178.99 104.39 0.19 Allowed Glycine 0 CA--C 1.529 0.951 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 265' ' ' ASP . . . . . 0.592 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.4 m-20 -80.14 -178.15 6.41 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.637 0.256 . . . . 0.0 110.938 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -40.31 -17.66 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.651 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 267' ' ' LYS . . . . . 0.592 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.32 -51.65 42.28 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.647 179.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -63.65 -46.65 84.68 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.007 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . 0.525 ' O ' ' CD2' ' A' ' 273' ' ' TYR . . . -61.79 -35.02 76.94 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.392 0.615 . . . . 0.0 109.701 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -63.15 -34.12 76.93 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.158 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.72 -43.31 13.49 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.969 -179.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 272' ' ' ILE . . . . . 0.618 ' C ' ' H ' ' A' ' 274' ' ' ALA . 4.9 tt -51.42 -33.51 14.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.798 -178.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 273' ' ' TYR . . . . . 0.525 ' CD2' ' O ' ' A' ' 269' ' ' ALA . 17.3 m-85 -54.71 -1.77 0.03 OUTLIER 'General case' 0 CA--C 1.515 -0.385 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.62 -179.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 274' ' ' ALA . . . . . 0.618 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.55 -39.7 70.51 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.912 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . 0.578 ' O ' ' N ' ' A' ' 279' ' ' ALA . 2.9 p30 -39.16 98.26 0.16 Allowed Pre-proline 0 C--O 1.226 -0.137 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.368 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.66 -42.72 65.78 Favored 'Trans proline' 0 C--N 1.303 -1.864 0 C-N-CA 122.413 2.076 . . . . 0.0 112.482 -178.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 88.9 mt -64.43 -42.89 95.78 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.116 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 91.1 mt -95.65 -1.6 49.81 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.984 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 279' ' ' ALA . . . . . 0.578 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.26 -34.71 77.06 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.711 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.8 m80 -74.38 20.1 0.12 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.969 -179.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . 0.513 ' H ' ' C ' ' A' ' 279' ' ' ALA . 13.7 mt -74.93 119.35 76.42 Favored Pre-proline 0 N--CA 1.445 -0.692 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.873 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -49.53 -40.37 45.54 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.658 2.239 . . . . 0.0 112.417 178.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.44 -50.61 62.26 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.116 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 75.4 t -61.29 -43.91 97.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.132 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -57.86 -41.15 81.83 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.129 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -90.97 0.12 57.61 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.102 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt 59.47 42.98 16.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.048 0.452 . . . . 0.0 110.829 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -94.42 41.33 1.09 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.31 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 53.8 t -118.85 135.82 58.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-O 121.141 0.496 . . . . 0.0 110.023 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -133.01 162.71 30.98 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 121.165 0.507 . . . . 0.0 110.633 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.98 155.38 32.93 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.108 0.48 . . . . 0.0 110.589 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 81.8 mt -94.13 -1.51 54.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.173 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.31 165.53 12.66 Favored Glycine 0 N--CA 1.464 0.514 0 N-CA-C 110.494 -1.043 . . . . 0.0 110.494 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 6.9 m -87.21 -62.43 1.5 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.921 0.391 . . . . 0.0 111.015 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 295' ' ' GLU . . . . . 0.466 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.5 mm-40 -69.57 -3.74 16.12 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.653 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 27.2 p -77.17 33.18 0.15 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.574 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 297' ' ' PHE . . . . . 0.466 ' H ' ' C ' ' A' ' 295' ' ' GLU . 83.8 t80 -60.28 -45.96 91.5 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.589 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . 0.609 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.2 mtt85 -81.57 134.36 35.49 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.574 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 16.3 tp -114.34 119.36 36.7 Favored 'General case' 0 C--O 1.23 0.07 0 CA-C-O 120.982 0.42 . . . . 0.0 110.29 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . 0.604 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.1 p-10 -167.07 -174.43 2.65 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.608 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 301' ' ' TYR . . . . . 0.459 ' OH ' ' CD1' ' A' ' 173' ' ' PHE . 83.9 t80 -48.23 -45.14 33.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.203 -179.476 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -65.13 -41.35 94.91 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 121.054 0.454 . . . . 0.0 110.714 178.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 303' ' ' SER . . . . . 0.604 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 53.5 p -55.61 -36.26 66.73 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.059 -179.197 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . 0.525 ' N ' ' HG ' ' A' ' 303' ' ' SER . . . -56.57 -52.18 65.79 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.388 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 91.8 mtp -55.72 -44.06 77.11 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -66.25 -42.6 88.32 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.211 0.529 . . . . 0.0 110.227 179.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 55.6 t -64.03 -42.77 96.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.202 179.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 43.4 tp -59.73 -42.2 92.61 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.77 -179.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -62.75 -38.83 92.11 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.048 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 310' ' ' ARG . . . . . 0.44 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.5 ttt85 -63.46 -44.1 95.45 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.211 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 88.0 mt -63.14 -41.98 99.39 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.416 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -62.96 -33.04 74.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.152 179.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -90.09 -23.36 21.42 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.375 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . 0.44 ' N ' ' O ' ' A' ' 310' ' ' ARG . 6.8 tt -62.31 -43.21 99.35 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 121.11 0.481 . . . . 0.0 110.573 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 . . . . . 0 C--O 1.22 -0.477 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.326 -179.803 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.477 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -99.5 136.06 39.99 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.115 0.483 . . . . 0.0 110.474 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.494 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -92.2 178.59 1.64 Allowed Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.545 -179.813 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.494 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.5 Cg_exo -61.54 147.18 96.05 Favored 'Trans proline' 0 C--N 1.299 -2.068 0 C-N-CA 122.854 2.369 . . . . 0.0 112.193 179.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 35.5 ptt180 -135.89 142.51 44.71 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.634 179.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -79.86 116.55 20.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.482 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.4 tp -111.03 130.47 64.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.458 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 12.5 t -70.79 141.56 51.4 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.62 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.511 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.5 t0 -139.13 179.51 6.47 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.495 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.511 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 78.0 p -73.74 -37.32 65.12 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.6 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -46.3 -94.56 0.0 OUTLIER 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.357 -179.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.429 ' O ' ' OG1' ' A' ' 36' ' ' THR . . . -167.16 -26.56 0.02 OUTLIER Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.429 ' OG1' ' O ' ' A' ' 35' ' ' GLY . 58.4 m -169.03 104.75 0.4 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.879 0.371 . . . . 0.0 110.668 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 74.2 t60 -128.57 148.44 50.77 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 121.119 0.485 . . . . 0.0 110.206 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.485 ' CG2' ' N ' ' A' ' 39' ' ' LEU . 98.4 m -130.83 166.14 21.49 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.458 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.485 ' N ' ' CG2' ' A' ' 38' ' ' THR . 81.6 mt -120.88 127.37 51.81 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.444 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -65.18 -44.61 87.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.716 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 38.9 p -165.67 154.98 12.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.377 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.462 ' N ' ' CD ' ' A' ' 42' ' ' GLN . 14.8 mp0 -44.3 101.0 0.24 Allowed Pre-proline 0 C--N 1.329 -0.306 0 O-C-N 123.419 0.449 . . . . 0.0 110.645 179.272 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -57.44 129.47 34.12 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 C-N-CA 122.347 2.031 . . . . 0.0 112.24 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -83.6 -24.67 31.4 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.621 179.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.539 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.5 mtm-85 -122.01 134.69 54.8 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.201 0.524 . . . . 0.0 110.256 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.2 mt -130.88 133.63 62.82 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.846 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 44.9 t -124.42 130.34 73.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-O 120.932 0.396 . . . . 0.0 109.939 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.497 ' O ' ' O ' ' A' ' 66' ' ' ALA . 2.3 m -154.8 166.89 32.05 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.504 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 69.8 p -124.55 8.83 8.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.404 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.26 125.67 33.08 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.874 0.369 . . . . 0.0 110.63 -179.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 96.3 t -65.92 -44.51 92.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.505 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.7 m -62.69 -44.51 96.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.594 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 50.5 tp -62.32 -41.5 98.59 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.551 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.422 ' CG2' ' HG ' ' A' ' 67' ' ' SER . 75.4 m -57.87 -44.44 86.63 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.206 -179.133 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.14 -62.43 5.18 Favored Glycine 0 N--CA 1.467 0.717 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.7 t -48.2 -35.6 12.11 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 110.159 -0.311 . . . . 0.0 110.159 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 20.1 mt -61.87 -44.39 96.91 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.649 -0.421 . . . . 0.0 111.396 179.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.3 mp -65.5 -41.42 93.23 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.364 177.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.32 -41.27 98.91 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.832 -179.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.3 tp -88.29 17.59 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.888 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 56.14 85.2 0.08 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.797 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.42 59.99 0.09 OUTLIER Pre-proline 0 C--N 1.327 -0.373 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -51.88 151.12 16.28 Favored 'Trans proline' 0 C--N 1.293 -2.363 0 C-N-CA 123.032 2.488 . . . . 0.0 112.047 -178.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.432 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -108.21 145.31 15.45 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.157 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.259 -179.659 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.51 -45.46 97.72 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.272 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.401 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.497 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -130.03 134.55 47.48 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 120.84 0.352 . . . . 0.0 110.491 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.476 ' O ' ' N ' ' A' ' 98' ' ' LEU . 74.8 m -134.56 158.82 43.0 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.831 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.29 138.58 16.02 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.449 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.55 -162.91 0.09 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.921 0.391 . . . . 0.0 110.474 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.48 ' O ' ' C ' ' A' ' 71' ' ' THR . 6.1 t -133.93 135.28 43.47 Favored 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.48 ' C ' ' O ' ' A' ' 70' ' ' THR . 0.9 OUTLIER 29.65 68.74 0.65 Allowed Pre-proline 0 N--CA 1.467 0.403 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.743 -179.685 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -61.72 145.2 97.55 Favored 'Trans proline' 0 C--N 1.299 -2.062 0 C-N-CA 122.708 2.272 . . . . 0.0 111.735 -177.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.535 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 45.0 p-10 -159.65 -31.94 0.06 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.637 179.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.535 ' N ' ' OD1' ' A' ' 73' ' ' ASN . 99.1 m-20 -63.83 -39.92 95.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.337 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -60.08 -47.97 83.68 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.638 -179.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.426 ' O ' ' O ' ' A' ' 77' ' ' ALA . 93.6 t -60.49 -24.87 32.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.426 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -45.81 173.34 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.615 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.569 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.3 p30 -62.15 177.56 0.46 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.421 -179.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.596 ' C ' ' H ' ' A' ' 81' ' ' GLY . 36.4 p30 -45.4 85.68 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.075 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.569 ' N ' ' O ' ' A' ' 78' ' ' ASP . 43.1 tp60 -67.48 13.18 0.07 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.221 0.534 . . . . 0.0 110.142 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.596 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 118.54 -22.35 9.45 Favored Glycine 0 N--CA 1.461 0.305 0 N-CA-C 110.934 -0.866 . . . . 0.0 110.934 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -107.75 116.45 31.97 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.987 0.422 . . . . 0.0 110.453 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 75.0 mt -98.58 0.07 44.18 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.984 0.421 . . . . 0.0 110.559 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -92.63 7.38 43.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.015 0.436 . . . . 0.0 110.357 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.439 ' O ' ' CG2' ' A' ' 89' ' ' VAL . 88.5 mt-30 -100.12 -27.91 13.3 Favored 'General case' 0 C--O 1.222 -0.382 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.81 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 69.1 t-105 -63.49 -40.46 97.14 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.906 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.554 ' O ' ' N ' ' A' ' 91' ' ' LYS . 68.7 m -77.78 -53.79 7.1 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.952 -179.361 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -48.3 -50.57 29.55 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.111 -179.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.439 ' CG2' ' O ' ' A' ' 85' ' ' GLN . 15.7 m -69.03 -40.47 80.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.144 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.409 ' H ' HG23 ' A' ' 89' ' ' VAL . . . -72.63 -22.66 60.91 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.652 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.554 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.0 tttm -62.12 -45.62 92.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.384 -179.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.44 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.6 mm-40 -90.32 -94.8 0.12 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.974 0.416 . . . . 0.0 110.084 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.626 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.9 mtt180 -143.12 59.32 1.41 Allowed 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 109.595 -0.521 . . . . 0.0 109.595 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.449 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.7 pttp 33.8 25.89 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 120.968 0.413 . . . . 0.0 110.234 -179.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.626 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.4 tt -48.31 123.5 6.58 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.934 -177.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -83.62 -170.3 2.99 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.112 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.61 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 82.3 mtp180 -73.82 137.26 43.72 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.233 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.476 ' N ' ' O ' ' A' ' 67' ' ' SER . 90.4 mt -86.32 -165.81 1.37 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.784 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.537 ' CD2' ' O ' ' A' ' 99' ' ' TYR . 48.3 p90 -169.01 120.09 0.74 Allowed 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.114 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.502 ' C ' ' O ' ' A' ' 99' ' ' TYR . 43.9 mm -28.98 121.02 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 O-C-N 123.261 0.351 . . . . 0.0 111.103 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 114.52 26.9 3.51 Favored Glycine 0 C--N 1.332 0.338 0 N-CA-C 111.281 -0.728 . . . . 0.0 111.281 -179.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.575 ' N ' ' CD ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -144.18 46.38 0.63 Allowed Pre-proline 0 C--N 1.322 -0.622 0 CA-C-O 121.023 0.44 . . . . 0.0 110.472 179.833 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 29.1 Cg_endo -62.13 143.92 95.23 Favored 'Trans proline' 0 C--N 1.294 -2.3 0 C-N-CA 122.677 2.251 . . . . 0.0 111.771 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.712 ' HG ' ' H ' ' A' ' 107' ' ' ALA . 26.5 t -173.14 120.35 0.35 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.426 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.39 -40.58 64.21 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.042 0.449 . . . . 0.0 111.145 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -66.19 -39.82 89.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.892 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.712 ' H ' ' HG ' ' A' ' 104' ' ' SER . . . -64.13 -39.88 94.99 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.77 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 71.7 t -67.77 -43.71 86.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.733 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.96 -38.97 93.23 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.555 -179.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.44 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.66 -23.3 62.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.473 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.537 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.4 mm-40 -90.8 5.58 47.77 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.654 -179.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.539 ' O ' ' NE ' ' A' ' 45' ' ' ARG . 10.3 tpt 22.88 64.5 0.36 Allowed Pre-proline 0 N--CA 1.468 0.437 0 CA-C-O 120.913 0.387 . . . . 0.0 111.22 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -78.92 167.5 22.04 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 123.079 2.519 . . . . 0.0 111.657 -177.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.522 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 99.3 m-20 -110.15 -42.05 4.28 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.077 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.8 tp -121.32 120.44 35.1 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 83.8 mt -113.42 129.09 69.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-O 120.848 0.356 . . . . 0.0 110.96 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 29.5 mt -108.86 132.17 54.29 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.044 0.449 . . . . 0.0 110.268 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 98.8 mt -119.66 138.42 50.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.709 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 85.6 p -72.63 153.77 41.07 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.612 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.12 -50.12 74.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.627 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.0 t -149.44 153.92 38.05 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.566 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 170.47 -170.98 43.43 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.89 -34.13 88.99 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.829 -0.908 . . . . 0.0 110.829 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.453 ' O ' ' OD1' ' A' ' 124' ' ' ASP . 44.5 p-10 -87.36 120.01 28.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.882 0.373 . . . . 0.0 110.652 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 37.7 t -63.05 144.01 57.27 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.399 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.521 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.19 -43.26 8.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.836 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.3 tp -62.98 -42.45 99.84 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.739 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.49 -12.0 59.26 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.508 -179.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 85.1 mt -114.93 -23.93 8.87 Favored 'General case' 0 C--O 1.226 -0.159 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.586 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . 0.521 ' N ' ' O ' ' A' ' 126' ' ' ALA . 80.0 t80 -50.94 -49.49 59.76 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.643 -178.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.502 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.5 p-10 -66.09 -42.5 89.24 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.876 -0.33 . . . . 0.0 111.237 179.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.502 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 88.2 mt-30 -67.17 -37.85 84.44 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.874 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 96.1 mt -79.98 -41.83 25.14 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.915 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.3 t -56.86 -44.78 82.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.277 -179.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 20.0 m -61.86 -45.25 94.6 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.507 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 94.1 mt -62.03 -43.68 97.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.262 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.31 168.17 5.08 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.571 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -49.61 113.0 0.79 Allowed 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.288 1.992 . . . . 0.0 112.35 179.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 23.5 m -84.27 127.41 33.94 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.622 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 34.4 tp -117.77 135.34 54.11 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.072 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.435 ' O ' ' OD2' ' A' ' 32' ' ' ASP . 82.3 mt -99.9 118.91 47.24 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.315 0 CA-C-O 121.181 0.515 . . . . 0.0 111.137 -179.299 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 98.1 mt -134.85 131.94 53.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.554 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.511 HD22 ' CG ' ' A' ' 241' ' ' ASP . 60.7 t30 -66.37 151.19 47.63 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.908 0.385 . . . . 0.0 110.479 179.298 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.52 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 88.2 t80 -85.96 122.25 29.73 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.883 -179.567 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.52 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 99.0 m-20 55.41 69.15 0.76 Allowed 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.672 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 35.0 p-10 -125.68 0.2 7.45 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.845 0.355 . . . . 0.0 110.604 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -150.63 115.48 5.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.706 -179.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' SER . . . . . 0.517 ' HG ' ' H ' ' A' ' 150' ' ' GLN . 83.8 p -63.73 168.77 4.59 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.551 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.416 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.5 p-90 -52.3 -16.01 0.75 Allowed 'General case' 0 C--O 1.222 -0.389 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.417 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . 0.517 ' H ' ' HG ' ' A' ' 148' ' ' SER . 68.2 tp60 -69.97 -76.88 0.09 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.508 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.442 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.0 t -62.49 -38.45 89.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.216 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 54.1 tp -59.78 -45.86 90.98 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.356 -178.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.416 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 46.7 tp -62.66 -41.77 99.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.527 178.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.442 ' OG1' ' O ' ' A' ' 151' ' ' SER . 62.7 p -64.0 -34.75 78.7 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.196 -179.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . 0.422 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 88.0 mm-40 -64.05 -42.71 96.94 Favored 'General case' 0 C--O 1.225 -0.196 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.356 179.305 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 91.7 mt -65.52 -38.7 90.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.101 0.477 . . . . 0.0 110.277 179.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.575 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.37 -32.12 79.8 Favored Glycine 0 C--N 1.331 0.295 0 N-CA-C 110.68 -0.968 . . . . 0.0 110.68 -179.207 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 157' ' ' GLY . 97.3 mt-10 -35.64 -26.73 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.839 0.352 . . . . 0.0 110.858 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.575 ' N ' ' O ' ' A' ' 157' ' ' GLY . 95.3 mt -56.16 149.37 3.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.411 178.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 74.8 p -69.68 137.25 51.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.978 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 71.39 21.0 78.64 Favored Glycine 0 CA--C 1.517 0.165 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 179.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 56.3 m80 -122.56 -14.5 7.77 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.602 0.239 . . . . 0.0 110.454 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -65.66 -59.98 3.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.593 -179.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -52.18 -49.34 64.01 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.177 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -60.24 -41.28 92.84 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.805 0.336 . . . . 0.0 110.437 179.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.34 -47.17 87.13 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.59 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -57.04 -40.1 76.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.279 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -61.72 -50.43 72.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.61 179.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -65.25 -43.78 90.23 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.534 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 94.4 mt -64.83 -43.26 96.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.414 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.38 -51.31 69.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.355 -179.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.23 -43.64 97.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.614 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . 0.463 ' CD1' ' OH ' ' A' ' 301' ' ' TYR . 56.9 t80 -62.92 -44.45 96.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.097 0.475 . . . . 0.0 110.396 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -63.53 -39.64 94.95 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.679 -179.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -63.16 -42.85 99.48 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.531 179.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -60.78 -44.39 96.86 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.261 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 84.1 mt -64.78 -40.98 96.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.687 178.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.21 -62.39 1.66 Allowed 'General case' 0 C--O 1.238 0.495 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.355 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.37 -47.02 85.16 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.54 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.01 -41.68 64.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.375 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -63.9 -33.69 76.26 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.281 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 70.0 tt0 -90.64 8.73 32.83 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.616 0.722 . . . . 0.0 110.381 -178.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -104.84 -32.05 9.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.145 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.8 pt -128.08 147.88 32.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.791 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -140.15 131.34 26.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.426 179.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . 0.553 ' CD2' ' N ' ' A' ' 186' ' ' LEU . 3.5 mm? -85.55 133.06 42.81 Favored Pre-proline 0 N--CA 1.451 -0.41 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.042 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -43.82 157.81 0.13 Allowed 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.649 2.232 . . . . 0.0 112.364 179.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . 0.505 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.5 Cg_endo -62.87 114.91 2.62 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 C-N-CA 122.892 2.395 . . . . 0.0 111.657 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . 0.505 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.7 mt-30 155.6 147.65 0.0 OUTLIER Pre-proline 0 N--CA 1.456 -0.138 0 O-C-N 124.028 0.83 . . . . 0.0 110.824 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.35 143.92 35.86 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.614 2.209 . . . . 0.0 112.243 177.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.489 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.1 p -124.58 158.84 31.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.441 0.639 . . . . 0.0 110.162 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' THR . . . . . 0.489 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 37.6 p -143.19 165.24 27.97 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.102 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -135.28 128.75 32.41 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 121.285 0.564 . . . . 0.0 110.224 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 47.4 pt -146.66 149.02 16.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.146 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 69.5 t -117.77 123.41 71.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 CA-C-O 121.32 0.581 . . . . 0.0 109.903 178.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -134.27 107.25 7.55 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.161 0.505 . . . . 0.0 110.205 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 93.3 m -130.97 130.33 43.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.815 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.412 ' O ' ' N ' ' A' ' 201' ' ' HIS . . . -82.92 -37.27 24.42 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.249 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.23 -66.94 0.27 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.362 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.3 -10.17 59.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.346 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . 0.412 ' N ' ' O ' ' A' ' 198' ' ' ALA . 59.9 t-80 61.08 58.1 2.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.745 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 36.3 p -166.69 153.26 8.75 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.602 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.24 144.02 24.43 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.096 0.474 . . . . 0.0 110.416 179.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -135.4 138.32 43.17 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.609 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 19.9 mt -106.24 125.56 51.15 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.065 0.46 . . . . 0.0 109.925 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' TRP . . . . . 0.556 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 75.2 m95 -82.08 167.0 19.24 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.573 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -157.19 171.11 7.88 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.645 -178.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -53.19 -37.29 79.93 Favored 'Trans proline' 0 C--N 1.302 -1.913 0 C-N-CA 122.588 2.192 . . . . 0.0 112.472 178.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -70.57 -35.07 72.87 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.711 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 21.0 m -61.08 150.84 32.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.642 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.7 -36.78 81.9 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.465 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' GLN . . . . . 0.556 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 54.6 tt0 -64.97 -40.02 94.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.475 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.64 -43.4 92.1 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.712 -0.955 . . . . 0.0 110.712 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -63.24 -43.94 96.62 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.788 0.328 . . . . 0.0 110.229 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 65.1 ttp -59.21 -48.1 82.86 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.148 -179.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 87.8 mt -60.42 -41.02 93.06 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' GLU . . . . . 0.457 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.8 tp10 -58.0 -37.67 74.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.05 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -65.53 -38.07 88.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.659 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 94.4 mt -64.09 -42.8 96.79 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.662 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.52 44.91 0.08 OUTLIER Glycine 0 CA--C 1.52 0.391 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' PHE . . . . . 0.457 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 26.9 m-85 -127.92 155.42 44.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.073 0.463 . . . . 0.0 110.463 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' THR . . . . . 0.45 ' O ' ' O ' ' A' ' 191' ' ' VAL . 7.2 p -107.27 122.49 46.66 Favored 'General case' 0 C--O 1.224 -0.248 0 CA-C-O 121.371 0.605 . . . . 0.0 110.088 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . 0.443 ' CD2' ' N ' ' A' ' 223' ' ' LEU . 4.3 mm? -101.43 133.02 46.7 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.162 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.77 159.78 14.73 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.459 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.47 115.33 30.07 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.391 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.453 ' CD1' ' N ' ' A' ' 226' ' ' LEU . 8.9 mp -53.16 156.54 3.71 Favored Pre-proline 0 N--CA 1.451 -0.415 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.764 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.01 145.34 98.6 Favored 'Trans proline' 0 C--N 1.299 -2.03 0 C-N-CA 122.744 2.296 . . . . 0.0 112.298 179.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.28 -3.38 59.04 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.535 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -89.96 -41.22 5.66 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . 0.518 ' O ' ' N ' ' A' ' 233' ' ' SER . 69.8 mt -78.86 -17.59 55.37 Favored 'General case' 0 C--O 1.219 -0.522 0 CA-C-O 121.13 0.491 . . . . 0.0 110.379 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 54.4 t-20 -40.41 -49.2 2.83 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.807 -179.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -87.59 15.15 7.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.352 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' SER . . . . . 0.518 ' N ' ' O ' ' A' ' 230' ' ' LEU . 77.9 p -60.59 -35.3 75.76 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.703 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . 0.524 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.6 tt0 -119.0 -69.33 0.86 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.868 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.3 m -69.76 102.82 2.0 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.675 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -94.37 57.56 2.31 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.34 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -144.78 -122.42 1.56 Allowed Glycine 0 N--CA 1.461 0.309 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -135.12 111.69 9.93 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 121.183 0.516 . . . . 0.0 110.341 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . 0.525 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.6 mtt180 -148.22 57.85 1.08 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.655 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -69.47 -32.39 71.26 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.512 179.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 241' ' ' ASP . . . . . 0.511 ' CG ' HD22 ' A' ' 143' ' ' ASN . 64.8 t0 -56.84 -47.1 81.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.27 -179.027 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 242' ' ' ILE . . . . . 0.44 ' O ' ' O ' ' A' ' 239' ' ' ARG . 18.1 tt -139.88 156.4 25.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.933 0.397 . . . . 0.0 110.445 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 96.2 mt -106.3 106.65 20.99 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.206 0 CA-C-O 121.1 0.476 . . . . 0.0 110.567 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . 0.525 ' OE1' ' NH1' ' A' ' 239' ' ' ARG . 88.2 mt-30 -110.49 110.0 20.57 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.232 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 9.4 mp -121.69 -168.19 1.65 Allowed 'General case' 0 C--O 1.223 -0.297 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.752 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . 0.524 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.51 -16.37 0.05 OUTLIER Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.974 -0.851 . . . . 0.0 110.974 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . 0.693 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -61.04 156.61 32.96 Favored Glycine 0 CA--C 1.521 0.464 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -63.45 21.53 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.98 0.419 . . . . 0.0 110.649 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . 0.693 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.9 m-20 -97.2 -6.22 35.23 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.493 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 92.6 mt -79.48 -21.99 44.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.786 179.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.54 -51.36 70.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.734 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.24 -5.66 58.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.459 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.15 -74.48 1.14 Allowed Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.844 -0.902 . . . . 0.0 110.844 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 82.2 mt -70.02 126.07 28.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.017 0.437 . . . . 0.0 110.315 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -59.5 -39.37 83.57 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.11 -179.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 82.75 51.71 4.17 Favored Glycine 0 CA--C 1.52 0.37 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -96.14 -14.81 22.53 Favored 'General case' 0 C--N 1.333 -0.138 0 O-C-N 122.683 -0.304 . . . . 0.0 110.615 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 258' ' ' SER . . . . . 0.422 ' O ' ' O ' ' A' ' 192' ' ' THR . 3.4 t 174.77 88.59 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.194 0.521 . . . . 0.0 110.092 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . 0.592 ' N ' ' CD1' ' A' ' 259' ' ' LEU . 1.0 OUTLIER -94.43 124.44 38.46 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.228 0.537 . . . . 0.0 111.179 -179.129 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 15.8 m-30 -93.28 146.41 23.73 Favored 'General case' 0 CA--C 1.499 -1.012 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.396 179.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 85.2 mt -122.5 149.39 43.96 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.58 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.656 ' CG ' ' N ' ' A' ' 263' ' ' ALA . 2.6 p90 -77.19 -138.36 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.612 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 263' ' ' ALA . . . . . 0.656 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -52.07 76.95 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 121.049 0.452 . . . . 0.0 111.188 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . 0.624 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -178.76 104.51 0.19 Allowed Glycine 0 CA--C 1.528 0.85 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 265' ' ' ASP . . . . . 0.596 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.5 m-20 -80.38 -178.04 6.46 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.585 0.231 . . . . 0.0 110.928 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -40.25 -17.91 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.579 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 267' ' ' LYS . . . . . 0.596 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.13 -51.66 43.65 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.722 179.195 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -63.6 -46.68 84.69 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.254 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . 0.524 ' O ' ' CD2' ' A' ' 273' ' ' TYR . . . -61.67 -35.13 77.08 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 121.404 0.621 . . . . 0.0 109.822 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -63.07 -34.37 77.44 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.176 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.49 -43.27 13.71 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.126 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 272' ' ' ILE . . . . . 0.619 ' C ' ' H ' ' A' ' 274' ' ' ALA . 4.9 tt -51.39 -33.69 14.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.767 -178.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 273' ' ' TYR . . . . . 0.524 ' CD2' ' O ' ' A' ' 269' ' ' ALA . 17.2 m-85 -54.43 -1.78 0.03 OUTLIER 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.703 -179.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 274' ' ' ALA . . . . . 0.619 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.5 -39.7 70.65 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.93 179.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . 0.579 ' O ' ' N ' ' A' ' 279' ' ' ALA . 3.1 p30 -38.98 98.02 0.15 Allowed Pre-proline 0 C--O 1.226 -0.149 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.449 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -54.64 -42.61 66.73 Favored 'Trans proline' 0 C--N 1.303 -1.835 0 C-N-CA 122.376 2.051 . . . . 0.0 112.513 -178.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 89.2 mt -64.57 -42.86 95.38 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.038 0.447 . . . . 0.0 111.15 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 91.2 mt -95.66 -1.63 49.74 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.939 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 279' ' ' ALA . . . . . 0.579 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.3 -34.68 77.06 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.748 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.21 20.04 0.12 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.014 -179.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . 0.514 ' H ' ' C ' ' A' ' 279' ' ' ALA . 13.8 mt -75.18 119.46 77.04 Favored Pre-proline 0 N--CA 1.447 -0.605 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.729 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -49.9 -39.88 49.01 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.644 2.23 . . . . 0.0 112.281 178.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.64 -50.59 62.87 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.066 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 78.6 t -61.32 -44.0 97.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -57.85 -41.16 81.8 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.15 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -91.06 0.05 57.62 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.104 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt 59.56 43.61 15.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.945 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -95.08 41.42 1.09 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.34 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 54.1 t -119.13 135.68 58.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-O 121.052 0.453 . . . . 0.0 110.067 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -132.58 162.35 31.52 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.22 0.533 . . . . 0.0 110.608 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.6 154.96 33.16 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-O 121.038 0.447 . . . . 0.0 110.663 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 81.5 mt -93.68 -1.56 55.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.253 -179.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.01 166.22 12.93 Favored Glycine 0 CA--C 1.521 0.439 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 7.2 m -87.77 -62.46 1.49 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.855 0.36 . . . . 0.0 110.939 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 295' ' ' GLU . . . . . 0.47 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.4 mm-40 -69.35 -3.87 15.93 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.667 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 27.0 p -77.21 32.7 0.15 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.604 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 297' ' ' PHE . . . . . 0.47 ' H ' ' C ' ' A' ' 295' ' ' GLU . 70.1 t80 -60.15 -46.21 90.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.603 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . 0.61 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.2 mtt85 -81.0 133.66 35.53 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.535 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 16.4 tp -114.23 119.39 36.85 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.319 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . 0.607 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.1 p-10 -167.52 -173.85 2.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.612 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 301' ' ' TYR . . . . . 0.463 ' OH ' ' CD1' ' A' ' 173' ' ' PHE . 83.9 t80 -48.58 -45.41 37.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.236 -179.37 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -64.97 -41.52 95.38 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.09 0.471 . . . . 0.0 110.697 178.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 303' ' ' SER . . . . . 0.607 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 52.6 p -55.39 -36.14 66.09 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.016 -179.223 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -56.7 -51.84 67.26 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 91.5 mtp -56.15 -43.99 78.83 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -66.23 -42.75 88.22 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.152 0.501 . . . . 0.0 110.238 179.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 55.1 t -64.04 -42.74 96.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.26 179.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 43.0 tp -59.67 -42.33 92.62 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.741 -179.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -62.55 -38.8 91.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.139 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 310' ' ' ARG . . . . . 0.442 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.5 ttt85 -63.51 -44.1 95.26 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.165 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 87.8 mt -63.2 -42.02 99.25 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.353 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -62.89 -33.24 74.88 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.13 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.93 -23.36 21.6 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.365 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . 0.442 ' N ' ' O ' ' A' ' 310' ' ' ARG . 6.7 tt -62.41 -43.11 99.59 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 121.069 0.461 . . . . 0.0 110.597 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 . . . . . 0 C--O 1.22 -0.46 0 CA-C-O 117.947 -1.025 . . . . 0.0 110.381 -179.909 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -99.39 135.15 41.23 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.169 0.509 . . . . 0.0 110.469 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.491 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -92.19 178.68 1.6 Allowed Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.545 -179.802 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.491 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.8 Cg_exo -61.66 147.2 95.89 Favored 'Trans proline' 0 C--N 1.298 -2.097 0 C-N-CA 122.89 2.393 . . . . 0.0 112.117 179.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 35.1 ptt180 -135.91 142.11 44.62 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.732 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -79.66 116.94 20.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.462 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.4 tp -111.93 130.55 65.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.399 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 12.6 t -71.01 142.27 50.94 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.008 0.432 . . . . 0.0 110.621 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.515 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.4 t0 -139.08 179.75 6.32 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.505 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.515 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 78.3 p -73.6 -37.37 65.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.777 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.8 ttt85 -46.94 -94.76 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.233 -179.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.421 ' O ' ' OG1' ' A' ' 36' ' ' THR . . . -166.08 -26.73 0.02 OUTLIER Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.421 ' OG1' ' O ' ' A' ' 35' ' ' GLY . 62.5 m -168.58 106.02 0.45 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.806 0.336 . . . . 0.0 110.65 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 71.5 t60 -129.23 146.64 51.1 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 121.075 0.464 . . . . 0.0 110.151 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.487 ' CG2' ' N ' ' A' ' 39' ' ' LEU . 97.5 m -129.86 165.68 21.51 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.41 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.487 ' N ' ' CG2' ' A' ' 38' ' ' THR . 79.5 mt -120.42 127.21 52.05 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.485 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -65.44 -44.8 86.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.728 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 37.8 p -165.65 155.27 12.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.445 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.466 ' N ' ' CD ' ' A' ' 42' ' ' GLN . 14.6 mp0 -44.43 100.71 0.23 Allowed Pre-proline 0 C--O 1.236 0.374 0 O-C-N 123.527 0.517 . . . . 0.0 110.634 179.193 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -57.51 129.78 35.6 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 C-N-CA 122.322 2.014 . . . . 0.0 112.337 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -83.09 -24.62 32.6 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.567 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.531 ' NE ' ' O ' ' A' ' 112' ' ' MET . 90.1 mtm-85 -121.04 134.2 55.27 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.214 0.531 . . . . 0.0 110.15 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.1 mt -130.72 133.67 63.01 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.846 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 46.4 t -124.77 131.34 72.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.535 ' HG ' ' CD1' ' A' ' 117' ' ' LEU . 4.4 m -154.38 166.14 34.16 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.584 179.451 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 63.3 p -124.66 8.32 8.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.395 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.6 126.15 33.68 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.801 0.334 . . . . 0.0 110.687 -179.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 88.7 t -65.65 -44.61 93.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.521 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.3 m -62.55 -44.33 96.6 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.709 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 54.0 tp -62.29 -41.59 98.63 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.558 -179.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 69.5 m -58.18 -44.48 88.04 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.124 -179.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.31 -62.19 5.35 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.7 t -48.08 -35.77 11.91 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 20.3 mt -61.78 -44.26 97.23 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 120.598 -0.441 . . . . 0.0 111.321 179.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.4 mp -65.26 -41.68 94.03 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.518 177.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.45 -41.26 98.64 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.921 -179.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.0 tp -87.8 16.75 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.864 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 56.31 84.14 0.09 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.804 -179.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.61 58.21 0.08 OUTLIER Pre-proline 0 C--N 1.327 -0.381 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -50.93 152.9 9.43 Favored 'Trans proline' 0 C--N 1.294 -2.333 0 C-N-CA 123.033 2.488 . . . . 0.0 112.228 -178.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.43 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -108.78 146.39 14.5 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.178 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.31 -179.69 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 97.0 mt -63.65 -45.08 98.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.478 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.498 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -130.45 134.49 47.14 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 120.868 0.366 . . . . 0.0 110.49 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.489 ' O ' ' N ' ' A' ' 98' ' ' LEU . 66.9 m -134.42 158.55 43.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.922 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.81 139.43 16.35 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.463 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.85 -162.69 0.08 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.003 0.43 . . . . 0.0 110.384 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.474 ' O ' ' C ' ' A' ' 71' ' ' THR . 14.6 t -133.57 135.37 44.27 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.314 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.474 ' C ' ' O ' ' A' ' 70' ' ' THR . 0.7 OUTLIER 29.76 68.88 0.65 Allowed Pre-proline 0 N--CA 1.469 0.475 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.857 -179.866 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -61.59 145.34 97.79 Favored 'Trans proline' 0 C--N 1.299 -2.054 0 C-N-CA 122.672 2.248 . . . . 0.0 111.873 -177.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.528 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 46.0 p-10 -160.05 -31.79 0.06 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.799 179.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.528 ' N ' ' OD1' ' A' ' 73' ' ' ASN . 98.9 m-20 -64.41 -39.33 93.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.348 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -60.7 -47.97 83.88 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.481 -179.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.425 ' O ' ' O ' ' A' ' 77' ' ' ALA . 92.8 t -60.35 -24.86 32.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.425 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -45.52 172.85 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.695 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.566 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.7 p30 -61.72 177.48 0.41 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.448 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.6 ' C ' ' H ' ' A' ' 81' ' ' GLY . 36.3 p30 -46.07 85.65 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.016 0.436 . . . . 0.0 110.971 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.566 ' N ' ' O ' ' A' ' 78' ' ' ASP . 42.7 tp60 -67.19 13.55 0.06 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.176 0.512 . . . . 0.0 110.065 -179.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.6 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 117.82 -22.13 10.08 Favored Glycine 0 N--CA 1.461 0.334 0 N-CA-C 110.911 -0.876 . . . . 0.0 110.911 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -107.44 116.3 31.7 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.01 0.433 . . . . 0.0 110.454 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 75.7 mt -98.49 0.46 45.17 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 120.992 0.425 . . . . 0.0 110.582 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -92.14 6.52 46.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.027 0.441 . . . . 0.0 110.276 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.442 ' O ' ' CG2' ' A' ' 89' ' ' VAL . 88.0 mt-30 -100.12 -26.63 13.88 Favored 'General case' 0 C--O 1.219 -0.511 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.796 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 75.9 t-105 -64.64 -40.76 96.01 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.109 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.549 ' O ' ' N ' ' A' ' 91' ' ' LYS . 68.1 m -77.85 -53.53 7.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.316 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -48.49 -50.52 31.33 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.089 -179.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.442 ' CG2' ' O ' ' A' ' 85' ' ' GLN . 14.3 m -68.92 -40.82 81.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.209 179.387 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.408 ' H ' HG23 ' A' ' 89' ' ' VAL . . . -71.89 -23.04 61.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.725 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.549 ' N ' ' O ' ' A' ' 87' ' ' SER . 65.9 tttm -61.62 -45.67 93.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.442 -179.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.44 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.3 mm-40 -90.6 -94.56 0.12 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.012 0.434 . . . . 0.0 110.05 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.615 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.9 mtt180 -143.48 59.44 1.39 Allowed 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.441 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.6 pttp 34.45 25.77 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.084 0.468 . . . . 0.0 110.336 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.615 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.5 tt -48.24 123.34 6.28 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.078 -177.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -83.53 -170.84 3.26 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.054 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.609 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 82.2 mtp180 -73.17 137.6 45.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.12 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.489 ' N ' ' O ' ' A' ' 67' ' ' SER . 90.3 mt -86.11 -166.29 1.5 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.868 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.536 ' CD2' ' O ' ' A' ' 99' ' ' TYR . 47.5 p90 -167.96 119.95 0.86 Allowed 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.065 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.494 ' C ' ' O ' ' A' ' 99' ' ' TYR . 42.8 mm -29.56 121.05 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.055 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 113.96 27.91 3.32 Favored Glycine 0 C--N 1.331 0.291 0 N-CA-C 111.326 -0.71 . . . . 0.0 111.326 -179.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.581 ' N ' ' CD ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -143.85 45.83 0.6 Allowed Pre-proline 0 C--N 1.321 -0.632 0 CA-C-O 121.087 0.47 . . . . 0.0 110.427 179.817 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.581 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 29.8 Cg_endo -62.02 143.84 95.52 Favored 'Trans proline' 0 C--N 1.294 -2.306 0 C-N-CA 122.593 2.195 . . . . 0.0 111.881 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.699 ' HG ' ' H ' ' A' ' 107' ' ' ALA . 24.3 t -173.26 120.6 0.34 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.283 179.53 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.02 -40.98 64.71 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.104 0.478 . . . . 0.0 111.281 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -65.93 -40.11 91.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.864 -179.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.699 ' H ' ' HG ' ' A' ' 104' ' ' SER . . . -63.98 -39.81 94.98 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.719 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 69.4 t -67.48 -43.87 87.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.762 179.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.43 -39.05 92.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.461 -179.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.44 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.58 -23.58 63.05 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.513 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.533 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.3 mm-40 -91.17 5.05 50.6 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.746 -179.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.533 ' C ' ' O ' ' A' ' 111' ' ' GLN . 10.5 tpt 22.98 64.14 0.36 Allowed Pre-proline 0 N--CA 1.469 0.511 0 CA-C-O 120.883 0.373 . . . . 0.0 111.2 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -78.93 168.37 20.87 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 123.017 2.478 . . . . 0.0 111.758 -177.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.527 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 99.0 m-20 -112.38 -44.21 3.41 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.003 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 39.8 tp -120.67 119.48 32.94 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 96.1 mt -116.43 131.19 69.73 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.408 0 CA-C-O 120.887 0.375 . . . . 0.0 111.007 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.535 ' CD1' ' HG ' ' A' ' 48' ' ' SER . 28.5 mt -105.99 132.67 51.8 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.192 -179.299 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 98.1 mt -118.08 136.01 56.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.695 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 86.4 p -72.09 153.45 41.69 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.603 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.14 -50.04 75.25 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.651 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -149.46 154.03 38.19 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.593 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 169.73 -170.31 42.66 Favored Glycine 0 CA--C 1.525 0.719 0 N-CA-C 110.969 -0.852 . . . . 0.0 110.969 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -63.16 -34.94 91.32 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 110.864 -0.894 . . . . 0.0 110.864 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.444 ' O ' ' OD1' ' A' ' 124' ' ' ASP . 43.9 p-10 -87.89 120.11 28.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.855 0.36 . . . . 0.0 110.607 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 39.6 t -63.51 144.26 57.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.386 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.517 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.2 -43.13 8.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.013 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.4 tp -62.79 -42.43 99.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.752 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.8 -11.11 57.83 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.52 -179.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 85.1 mt -115.54 -23.99 8.53 Favored 'General case' 0 C--O 1.225 -0.23 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.668 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . 0.517 ' N ' ' O ' ' A' ' 126' ' ' ALA . 77.7 t80 -51.87 -49.62 62.6 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.666 -178.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.503 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.5 p-10 -65.83 -42.02 91.05 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.282 179.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.503 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 87.9 mt-30 -67.45 -37.04 82.37 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.949 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 94.1 mt -79.69 -42.31 24.98 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.958 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.3 t -57.12 -44.81 83.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.25 -178.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.9 m -62.33 -45.58 92.56 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.463 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 93.1 mt -62.5 -43.89 98.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.307 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.8 163.68 6.61 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.588 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -43.71 111.91 0.28 Allowed 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.374 2.05 . . . . 0.0 112.3 179.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 18.2 m -85.37 127.34 34.33 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.541 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 34.2 tp -118.73 135.18 54.63 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 120.976 0.417 . . . . 0.0 110.077 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.425 ' O ' ' OD2' ' A' ' 32' ' ' ASP . 80.1 mt -102.01 120.04 51.13 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.345 0 CA-C-O 121.172 0.511 . . . . 0.0 111.332 -179.381 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 97.4 mt -135.79 132.94 51.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.702 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.52 HD22 ' CG ' ' A' ' 241' ' ' ASP . 54.8 t30 -65.81 152.03 45.31 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.99 0.424 . . . . 0.0 110.356 179.21 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.523 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 87.9 t80 -85.81 122.48 29.94 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.999 -179.5 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.523 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 99.2 m-20 55.06 69.41 0.74 Allowed 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.713 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 49.4 p-10 -123.56 0.06 8.73 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 120.853 0.359 . . . . 0.0 110.625 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -151.61 117.17 5.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.735 -179.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' SER . . . . . 0.513 ' HG ' ' H ' ' A' ' 150' ' ' GLN . 84.6 p -63.27 167.49 5.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.557 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.411 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.7 p-90 -50.62 -15.85 0.31 Allowed 'General case' 0 C--O 1.22 -0.497 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.429 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . 0.513 ' H ' ' HG ' ' A' ' 148' ' ' SER . 68.2 tp60 -71.23 -74.81 0.14 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.941 0.401 . . . . 0.0 110.443 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.448 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.2 t -62.62 -39.11 92.77 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.138 179.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 54.3 tp -60.35 -45.41 93.57 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.361 -178.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.411 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 45.9 tp -62.63 -41.62 99.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.52 178.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.448 ' OG1' ' O ' ' A' ' 151' ' ' SER . 54.6 p -64.03 -34.68 78.55 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.136 -179.292 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . 0.445 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 88.0 mm-40 -63.93 -42.47 97.35 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.258 179.235 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 91.1 mt -65.3 -38.97 91.84 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.242 0.544 . . . . 0.0 110.249 179.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.571 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.17 -32.26 79.91 Favored Glycine 0 C--N 1.332 0.331 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 -179.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.445 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.2 mt-10 -36.16 -25.91 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.812 0.339 . . . . 0.0 110.877 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.571 ' N ' ' O ' ' A' ' 157' ' ' GLY . 95.1 mt -58.26 149.6 5.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.326 178.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 77.7 p -69.39 137.27 52.66 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.038 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 70.88 21.46 78.14 Favored Glycine 0 N--CA 1.459 0.201 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 179.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 59.4 m80 -123.09 -15.11 7.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.585 0.231 . . . . 0.0 110.452 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -66.28 -59.54 3.63 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.698 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -52.2 -48.83 64.84 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 120.709 -0.397 . . . . 0.0 110.101 -179.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -60.78 -40.99 94.63 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.839 0.352 . . . . 0.0 110.44 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.47 -47.41 85.79 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.522 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.89 -40.22 75.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.199 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -61.68 -50.22 73.35 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.62 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -65.16 -43.81 90.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.533 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 94.7 mt -64.63 -43.4 96.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.406 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.31 -51.23 70.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.446 -179.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.6 -43.53 96.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.867 0.365 . . . . 0.0 110.592 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . 0.492 ' CD1' ' OH ' ' A' ' 301' ' ' TYR . 57.0 t80 -62.78 -44.42 96.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.144 0.497 . . . . 0.0 110.405 179.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -63.71 -39.68 94.92 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.394 -179.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -62.9 -42.82 99.91 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.573 179.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -60.82 -44.48 96.85 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.064 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 84.7 mt -64.42 -41.18 96.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.983 0.42 . . . . 0.0 110.778 178.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.08 -62.06 1.87 Allowed 'General case' 0 C--O 1.239 0.516 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.34 -179.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.76 -46.83 86.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.42 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.24 -41.59 65.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.275 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -63.8 -33.81 76.5 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.962 0.411 . . . . 0.0 110.23 179.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 70.0 tt0 -90.63 8.79 32.46 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.622 0.725 . . . . 0.0 110.341 -178.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -104.73 -32.09 9.03 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.233 179.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.8 pt -127.95 147.74 32.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.816 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -139.98 131.38 26.87 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.31 179.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . 0.549 ' CD2' ' N ' ' A' ' 186' ' ' LEU . 3.5 mm? -85.42 133.29 42.61 Favored Pre-proline 0 N--CA 1.45 -0.444 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.15 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -43.92 158.0 0.13 Allowed 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.706 2.271 . . . . 0.0 112.258 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . 0.496 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.9 Cg_endo -63.1 114.72 2.58 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.748 2.299 . . . . 0.0 111.677 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . 0.496 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.7 mt-30 155.87 148.1 0.0 OUTLIER Pre-proline 0 N--CA 1.454 -0.264 0 O-C-N 124.088 0.868 . . . . 0.0 110.834 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.63 144.37 35.49 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.593 2.195 . . . . 0.0 112.095 177.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.488 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.1 p -124.9 158.76 32.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.439 0.638 . . . . 0.0 110.159 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' THR . . . . . 0.488 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 37.0 p -143.07 165.34 27.65 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.193 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -135.32 128.74 32.3 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 121.43 0.634 . . . . 0.0 110.099 179.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 47.2 pt -146.52 149.05 16.34 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.44 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.236 179.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 72.1 t -117.95 123.51 71.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.421 0.629 . . . . 0.0 109.691 179.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -134.58 107.27 7.41 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.206 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 94.1 m -130.96 130.66 43.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.868 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.407 ' O ' ' N ' ' A' ' 201' ' ' HIS . . . -82.8 -37.08 24.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.15 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.41 -67.08 0.26 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.276 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.34 -9.88 59.06 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.248 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . 0.407 ' N ' ' O ' ' A' ' 198' ' ' ALA . 60.5 t-80 60.63 58.35 2.47 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.807 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 38.8 p -167.05 153.84 8.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.553 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.4 144.18 24.41 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.031 0.443 . . . . 0.0 110.37 179.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -135.33 138.18 43.16 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.663 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 20.0 mt -106.25 125.55 51.14 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' TRP . . . . . 0.557 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 75.7 m95 -82.0 166.95 19.37 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.666 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -156.98 171.23 7.72 Favored Pre-proline 0 C--O 1.224 -0.25 0 CA-C-O 120.999 0.428 . . . . 0.0 110.562 -178.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.62 -37.03 83.08 Favored 'Trans proline' 0 C--N 1.301 -1.949 0 C-N-CA 122.612 2.208 . . . . 0.0 112.236 179.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -70.64 -35.01 72.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.729 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 22.7 m -61.24 150.57 34.22 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.698 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.41 -37.11 82.28 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.442 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' GLN . . . . . 0.557 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 55.0 tt0 -64.74 -40.07 94.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.538 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.8 -43.46 91.6 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -63.31 -43.5 97.66 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.813 0.339 . . . . 0.0 110.225 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 65.4 ttp -59.49 -48.03 83.21 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.34 -0.391 . . . . 0.0 109.986 -179.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 87.0 mt -60.71 -40.82 93.68 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' GLU . . . . . 0.45 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.4 tp10 -58.2 -37.66 75.22 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -65.33 -38.21 89.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.715 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 94.2 mt -64.06 -42.76 96.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.154 0.502 . . . . 0.0 110.716 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.69 44.77 0.08 OUTLIER Glycine 0 C--N 1.333 0.379 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' PHE . . . . . 0.45 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 27.4 m-85 -127.96 155.48 44.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.02 0.438 . . . . 0.0 110.446 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' THR . . . . . 0.452 ' O ' ' O ' ' A' ' 191' ' ' VAL . 6.8 p -107.23 122.48 46.62 Favored 'General case' 0 C--O 1.223 -0.291 0 CA-C-O 121.368 0.604 . . . . 0.0 110.06 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . 0.44 ' CD2' ' N ' ' A' ' 223' ' ' LEU . 4.3 mm? -101.33 132.73 46.74 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.196 179.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.46 159.54 14.88 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.536 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.43 115.51 30.38 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.992 0.425 . . . . 0.0 110.318 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.452 ' CD1' ' N ' ' A' ' 226' ' ' LEU . 8.8 mp -53.31 156.55 3.97 Favored Pre-proline 0 N--CA 1.449 -0.515 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.764 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -60.09 145.17 99.04 Favored 'Trans proline' 0 C--N 1.3 -1.987 0 C-N-CA 122.677 2.251 . . . . 0.0 112.163 179.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.13 -3.22 59.05 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.545 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.14 -40.99 5.67 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . 0.517 ' O ' ' N ' ' A' ' 233' ' ' SER . 86.0 mt -79.14 -17.04 55.75 Favored 'General case' 0 C--O 1.218 -0.581 0 CA-C-O 121.11 0.481 . . . . 0.0 110.25 -179.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 54.3 t-20 -40.58 -48.96 2.95 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.876 -179.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -87.75 15.25 7.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.493 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' SER . . . . . 0.517 ' N ' ' O ' ' A' ' 230' ' ' LEU . 77.9 p -60.63 -35.28 75.8 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.673 -179.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . 0.526 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.6 tt0 -118.87 -69.28 0.86 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.922 179.132 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.3 m -69.62 103.13 2.02 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.067 0.46 . . . . 0.0 110.701 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -94.55 57.33 2.22 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.305 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -144.65 -122.48 1.58 Allowed Glycine 0 C--N 1.332 0.334 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -135.07 112.09 10.27 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.256 0.551 . . . . 0.0 110.316 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . 0.521 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.4 mtt180 -148.31 58.05 1.08 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.661 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -69.59 -32.16 70.75 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.562 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 241' ' ' ASP . . . . . 0.52 ' CG ' HD22 ' A' ' 143' ' ' ASN . 64.7 t0 -57.05 -46.86 82.12 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.322 -178.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 242' ' ' ILE . . . . . 0.435 ' O ' ' O ' ' A' ' 239' ' ' ARG . 17.8 tt -140.25 156.77 24.66 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.306 0 CA-C-O 120.905 0.383 . . . . 0.0 110.419 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 96.2 mt -106.39 106.87 21.4 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 CA-C-O 121.19 0.519 . . . . 0.0 110.433 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . 0.521 ' OE1' ' NH1' ' A' ' 239' ' ' ARG . 88.2 mt-30 -110.78 110.35 20.95 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.283 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 9.5 mp -121.75 -168.22 1.66 Allowed 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.622 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . 0.526 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.53 -16.65 0.05 OUTLIER Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . 0.688 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -60.72 156.9 31.07 Favored Glycine 0 CA--C 1.521 0.425 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -63.83 21.9 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.901 0.381 . . . . 0.0 110.534 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . 0.688 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.8 m-20 -97.56 -6.08 34.28 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.761 0.315 . . . . 0.0 110.516 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 93.0 mt -79.65 -21.76 44.41 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.868 179.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.6 -51.25 70.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.724 -179.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.46 -5.45 58.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.402 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.17 -74.21 1.15 Allowed Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.744 -0.942 . . . . 0.0 110.744 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 83.3 mt -70.33 126.39 29.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.927 0.394 . . . . 0.0 110.17 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -59.96 -39.04 84.27 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.159 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 82.85 51.67 4.16 Favored Glycine 0 CA--C 1.519 0.335 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -95.59 -15.2 22.96 Favored 'General case' 0 N--CA 1.463 0.189 0 O-C-N 122.666 -0.314 . . . . 0.0 110.623 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 258' ' ' SER . . . . . 0.422 ' O ' ' O ' ' A' ' 192' ' ' THR . 3.4 t 174.72 89.02 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.195 0.521 . . . . 0.0 110.036 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . 0.588 ' N ' ' CD1' ' A' ' 259' ' ' LEU . 0.9 OUTLIER -94.6 124.43 38.63 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.21 0.528 . . . . 0.0 111.291 -179.143 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 15.8 m-30 -93.42 146.3 23.85 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.311 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 86.6 mt -122.29 149.55 43.58 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.532 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.65 ' CG ' ' N ' ' A' ' 263' ' ' ALA . 2.6 p90 -77.28 -138.57 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.657 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 263' ' ' ALA . . . . . 0.65 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -51.87 77.14 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 121.041 0.448 . . . . 0.0 111.27 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . 0.62 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.05 104.58 0.19 Allowed Glycine 0 CA--C 1.527 0.843 0 N-CA-C 110.414 -1.074 . . . . 0.0 110.414 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 265' ' ' ASP . . . . . 0.589 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.8 m-20 -80.32 -177.88 6.35 Favored 'General case' 0 CA--C 1.515 -0.393 0 O-C-N 122.681 -0.306 . . . . 0.0 110.944 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -40.65 -17.82 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.524 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 267' ' ' LYS . . . . . 0.589 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.02 -51.56 45.61 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.743 179.102 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -63.87 -46.48 84.76 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.095 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . 0.525 ' O ' ' CD2' ' A' ' 273' ' ' TYR . . . -61.8 -35.13 77.29 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 121.526 0.679 . . . . 0.0 109.716 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -62.84 -34.54 77.54 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.025 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.66 -43.07 13.74 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.217 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 272' ' ' ILE . . . . . 0.619 ' C ' ' H ' ' A' ' 274' ' ' ALA . 4.9 tt -51.27 -33.71 14.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.776 -178.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 273' ' ' TYR . . . . . 0.525 ' CD2' ' O ' ' A' ' 269' ' ' ALA . 17.2 m-85 -54.5 -1.76 0.03 OUTLIER 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.686 -179.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 274' ' ' ALA . . . . . 0.619 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.51 -39.86 70.53 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.906 179.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . 0.576 ' O ' ' N ' ' A' ' 279' ' ' ALA . 3.0 p30 -38.91 97.74 0.15 Allowed Pre-proline 0 C--O 1.226 -0.174 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.448 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -54.21 -42.8 64.19 Favored 'Trans proline' 0 C--N 1.303 -1.856 0 C-N-CA 122.329 2.02 . . . . 0.0 112.668 -178.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 88.4 mt -64.32 -42.86 96.09 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.089 0.471 . . . . 0.0 111.297 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 91.8 mt -95.56 -1.7 49.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.862 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 279' ' ' ALA . . . . . 0.576 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.36 -34.87 77.52 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.6 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.1 20.0 0.11 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.076 -179.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . 0.514 ' H ' ' C ' ' A' ' 279' ' ' ALA . 13.8 mt -74.97 119.75 78.35 Favored Pre-proline 0 N--CA 1.445 -0.719 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.725 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -50.6 -39.57 55.85 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.539 2.159 . . . . 0.0 112.035 179.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.83 -50.37 63.86 Favored 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 73.0 t -61.54 -43.81 97.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -57.97 -41.2 82.43 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.098 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -90.93 0.31 57.54 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.083 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt 59.24 43.06 17.47 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.027 0.441 . . . . 0.0 110.976 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -94.62 41.65 1.09 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.282 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 53.9 t -119.21 135.48 59.47 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-O 121.096 0.474 . . . . 0.0 109.958 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -132.69 162.6 30.96 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.678 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.74 155.27 32.8 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 121.079 0.466 . . . . 0.0 110.667 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 82.8 mt -94.22 -1.47 54.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.176 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.49 165.81 12.72 Favored Glycine 0 C--N 1.335 0.528 0 N-CA-C 110.489 -1.044 . . . . 0.0 110.489 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 6.7 m -87.75 -62.33 1.52 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.871 0.367 . . . . 0.0 111.044 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 295' ' ' GLU . . . . . 0.477 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.5 mm-40 -69.35 -4.02 16.53 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.69 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 25.5 p -76.71 32.76 0.13 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.623 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 297' ' ' PHE . . . . . 0.477 ' H ' ' C ' ' A' ' 295' ' ' GLU . 85.5 t80 -60.18 -46.07 90.98 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.624 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . 0.609 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.2 mtt85 -81.33 134.76 35.63 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.617 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 16.7 tp -114.66 118.71 34.42 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-O 120.985 0.421 . . . . 0.0 110.206 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . 0.604 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.5 p-10 -166.15 -175.44 3.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.651 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 301' ' ' TYR . . . . . 0.492 ' OH ' ' CD1' ' A' ' 173' ' ' PHE . 81.1 t80 -47.76 -44.22 28.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.209 -179.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -66.09 -40.74 91.04 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.107 0.48 . . . . 0.0 110.804 178.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 303' ' ' SER . . . . . 0.604 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 56.0 p -56.04 -35.73 67.22 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.951 -179.005 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -57.28 -51.45 69.33 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 91.1 mtp -56.46 -43.78 79.9 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -179.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -66.32 -42.52 88.11 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.21 0.528 . . . . 0.0 110.253 179.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 55.7 t -64.08 -42.99 97.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.135 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 42.7 tp -59.63 -42.24 92.27 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.101 -0.499 . . . . 0.0 109.73 -179.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -62.7 -38.71 91.48 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 310' ' ' ARG . . . . . 0.446 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.5 ttt85 -63.49 -43.81 96.17 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.218 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 88.8 mt -63.2 -42.06 99.27 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.273 179.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -62.89 -33.33 75.07 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.083 179.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.86 -23.45 21.65 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.383 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . 0.446 ' N ' ' O ' ' A' ' 310' ' ' ARG . 6.7 tt -62.44 -43.16 99.47 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 121.079 0.466 . . . . 0.0 110.563 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 . . . . . 0 C--O 1.22 -0.484 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.319 -179.907 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -99.55 136.67 39.14 Favored 'General case' 0 CA--C 1.521 -0.164 0 CA-C-O 121.091 0.472 . . . . 0.0 110.442 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.492 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -91.86 178.61 1.66 Allowed Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.57 -179.827 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.492 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.2 Cg_exo -61.61 146.94 96.46 Favored 'Trans proline' 0 C--N 1.3 -2.025 0 C-N-CA 122.833 2.355 . . . . 0.0 112.144 179.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 35.3 ptt180 -136.03 142.16 44.41 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.638 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -79.34 116.69 19.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.44 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.5 tp -110.98 130.53 64.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.536 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.0 t -71.0 141.76 50.97 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.638 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.514 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.5 t0 -139.33 179.51 6.49 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.532 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.514 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 77.9 p -73.8 -36.98 65.07 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.569 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.7 ttt85 -46.48 -94.43 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.296 -179.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.418 ' O ' ' OG1' ' A' ' 36' ' ' THR . . . -167.55 -26.49 0.02 OUTLIER Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.418 ' OG1' ' O ' ' A' ' 35' ' ' GLY . 60.8 m -168.97 104.8 0.4 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.777 0.322 . . . . 0.0 110.657 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 74.6 t60 -128.65 149.0 50.84 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.087 0.47 . . . . 0.0 110.214 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.484 ' CG2' ' N ' ' A' ' 39' ' ' LEU . 98.2 m -131.36 166.07 22.06 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.453 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.484 ' N ' ' CG2' ' A' ' 38' ' ' THR . 81.9 mt -120.93 127.28 51.69 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.464 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -64.91 -44.55 89.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.718 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 40.0 p -165.71 155.08 12.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.373 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.448 ' N ' ' CD ' ' A' ' 42' ' ' GLN . 14.7 mp0 -44.3 100.9 0.24 Allowed Pre-proline 0 C--N 1.329 -0.286 0 O-C-N 123.503 0.502 . . . . 0.0 110.598 179.221 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.53 129.99 36.67 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 C-N-CA 122.305 2.003 . . . . 0.0 112.245 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -83.73 -24.78 31.05 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.558 179.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.538 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.6 mtm-85 -122.33 134.84 54.64 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.27 0.557 . . . . 0.0 110.234 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.2 mt -130.73 133.78 62.83 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.329 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.871 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 45.0 t -124.11 130.55 73.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 CA-C-O 120.945 0.402 . . . . 0.0 109.968 179.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.501 ' O ' ' O ' ' A' ' 66' ' ' ALA . 2.1 m -154.57 167.17 30.99 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.542 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 64.4 p -124.75 9.26 8.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.385 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.98 125.43 33.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.858 0.361 . . . . 0.0 110.685 -179.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 93.3 t -65.63 -44.53 93.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.463 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.1 m -62.38 -44.3 96.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.618 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 49.6 tp -62.34 -41.3 98.46 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.528 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 74.3 m -57.65 -44.43 85.65 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.286 -179.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.3 -62.33 5.23 Favored Glycine 0 N--CA 1.467 0.761 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.7 t -48.22 -35.59 12.21 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.9 mt -61.78 -44.43 96.9 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.648 -0.421 . . . . 0.0 111.305 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.3 mp -65.54 -41.26 93.26 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.333 177.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.59 -40.75 97.75 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.858 -179.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.1 tp -89.03 16.98 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.857 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 56.17 85.33 0.07 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.797 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 178.72 59.47 0.08 OUTLIER Pre-proline 0 C--N 1.327 -0.386 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -52.18 152.55 14.61 Favored 'Trans proline' 0 C--N 1.292 -2.401 0 C-N-CA 123.048 2.499 . . . . 0.0 112.063 -178.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.435 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -108.65 145.27 15.79 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.171 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.271 -179.661 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.8 mt -63.57 -45.42 97.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.388 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.501 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -129.49 134.1 47.61 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.517 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.504 ' O ' ' N ' ' A' ' 98' ' ' LEU . 75.4 m -134.6 158.6 43.6 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.891 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.7 139.0 16.1 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.694 -0.962 . . . . 0.0 110.694 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.464 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.79 -162.81 0.08 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.936 0.398 . . . . 0.0 110.461 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.481 ' O ' ' C ' ' A' ' 71' ' ' THR . 14.5 t -133.65 134.74 43.53 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.289 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.481 ' C ' ' O ' ' A' ' 70' ' ' THR . 0.1 OUTLIER 29.65 68.73 0.65 Allowed Pre-proline 0 N--CA 1.467 0.403 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.735 -179.865 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_exo -61.74 145.67 97.18 Favored 'Trans proline' 0 C--N 1.3 -2.022 0 C-N-CA 122.669 2.246 . . . . 0.0 111.708 -177.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.525 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 45.3 p-10 -159.39 -32.1 0.06 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.718 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.525 ' N ' ' OD1' ' A' ' 73' ' ' ASN . 99.1 m-20 -64.11 -39.42 94.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.387 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -60.36 -48.32 82.25 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.555 -179.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.424 ' O ' ' O ' ' A' ' 77' ' ' ALA . 93.9 t -60.16 -25.1 32.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.053 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.424 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -45.68 173.1 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.635 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.571 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.5 p30 -62.41 178.03 0.45 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.505 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.592 ' C ' ' H ' ' A' ' 81' ' ' GLY . 36.2 p30 -45.0 85.63 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.096 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.571 ' N ' ' O ' ' A' ' 78' ' ' ASP . 42.1 tp60 -67.65 13.21 0.08 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.207 0.527 . . . . 0.0 110.162 -179.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.592 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 118.63 -22.5 9.33 Favored Glycine 0 N--CA 1.461 0.33 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -108.12 116.25 31.62 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.013 0.435 . . . . 0.0 110.381 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 76.1 mt -98.27 -0.0 44.83 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.578 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -92.34 7.4 43.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.015 0.436 . . . . 0.0 110.39 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.433 ' O ' ' CG2' ' A' ' 89' ' ' VAL . 88.2 mt-30 -100.24 -27.7 13.37 Favored 'General case' 0 C--O 1.222 -0.387 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.754 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 69.0 t-105 -62.94 -40.55 98.0 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.942 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.551 ' O ' ' N ' ' A' ' 91' ' ' LYS . 64.2 m -77.93 -53.59 7.28 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.958 -179.311 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -48.49 -50.77 30.26 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.052 -179.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.433 ' CG2' ' O ' ' A' ' 85' ' ' GLN . 15.8 m -68.8 -40.57 81.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.161 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.415 ' H ' HG23 ' A' ' 89' ' ' VAL . . . -72.39 -23.01 61.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.629 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.551 ' N ' ' O ' ' A' ' 87' ' ' SER . 65.9 tttm -61.84 -45.58 93.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.433 -179.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.442 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.8 mm-40 -90.31 -95.3 0.11 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.092 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.629 ' O ' ' N ' ' A' ' 95' ' ' LEU . 96.0 mtt180 -142.79 58.84 1.43 Allowed 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.448 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.7 pttp 33.87 25.7 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.07 0.462 . . . . 0.0 110.25 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.629 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.3 tt -48.26 123.46 6.48 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.983 -177.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -83.52 -169.61 2.64 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.183 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.603 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 81.3 mtp180 -74.69 136.95 41.84 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.256 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.504 ' N ' ' O ' ' A' ' 67' ' ' SER . 91.2 mt -85.63 -165.83 1.34 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.83 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.538 ' CD2' ' O ' ' A' ' 99' ' ' TYR . 48.2 p90 -168.64 119.65 0.77 Allowed 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.152 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.503 ' C ' ' O ' ' A' ' 99' ' ' TYR . 41.7 mm -28.67 120.7 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 O-C-N 123.272 0.358 . . . . 0.0 111.104 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 114.31 27.26 3.44 Favored Glycine 0 C--N 1.331 0.296 0 N-CA-C 111.27 -0.732 . . . . 0.0 111.27 -179.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.572 ' N ' ' CD ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -144.36 46.72 0.65 Allowed Pre-proline 0 C--N 1.322 -0.593 0 CA-C-O 121.145 0.498 . . . . 0.0 110.484 179.783 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.572 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 28.9 Cg_endo -62.02 144.0 95.72 Favored 'Trans proline' 0 C--N 1.295 -2.263 0 C-N-CA 122.643 2.229 . . . . 0.0 111.761 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 27.6 t -173.18 120.37 0.35 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.359 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.83 -40.21 63.49 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.119 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.36 -39.89 89.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.853 -179.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.13 -40.09 95.44 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.73 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 72.3 t -67.77 -43.72 86.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.672 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.81 -39.04 93.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.455 -179.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.442 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.5 -23.39 62.74 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.516 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.537 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.3 mm-40 -90.69 5.55 47.66 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.682 -179.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.538 ' O ' ' NE ' ' A' ' 45' ' ' ARG . 10.2 tpt 22.85 64.46 0.35 Allowed Pre-proline 0 N--CA 1.467 0.385 0 CA-C-O 120.949 0.404 . . . . 0.0 111.209 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -78.75 167.51 22.28 Favored 'Trans proline' 0 C--N 1.307 -1.658 0 C-N-CA 123.077 2.518 . . . . 0.0 111.594 -177.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.52 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 99.1 m-20 -109.71 -42.1 4.37 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.991 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.6 tp -121.5 120.35 34.64 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.904 0.383 . . . . 0.0 109.97 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 84.8 mt -112.78 128.84 69.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 CA-C-O 120.862 0.363 . . . . 0.0 110.998 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 29.6 mt -109.18 132.13 54.41 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.262 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 99.1 mt -119.57 138.69 49.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.687 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 85.6 p -72.3 153.75 41.34 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.571 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.16 -50.25 74.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.705 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -149.51 154.0 38.08 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.602 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 170.5 -170.84 43.34 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.93 -34.3 89.51 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.445 ' O ' ' OD1' ' A' ' 124' ' ' ASP . 44.0 p-10 -86.7 120.43 28.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.856 0.36 . . . . 0.0 110.647 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 39.0 t -63.21 143.75 57.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.392 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.1 -43.24 8.97 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.82 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.5 tp -62.98 -42.36 99.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.716 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.67 -12.07 59.68 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.449 -179.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 85.1 mt -114.76 -24.07 8.88 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.578 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . 0.519 ' N ' ' O ' ' A' ' 126' ' ' ALA . 78.9 t80 -51.01 -49.73 59.88 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.819 -0.352 . . . . 0.0 110.693 -178.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.5 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.1 p-10 -66.06 -42.67 89.18 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.321 179.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.5 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 88.3 mt-30 -67.01 -37.71 84.66 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.818 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 96.2 mt -80.24 -41.68 24.63 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.887 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.3 t -56.77 -44.69 82.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.248 -179.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 18.7 m -61.72 -45.44 93.96 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.613 179.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 94.6 mt -61.91 -43.73 97.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.319 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.27 168.29 5.05 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.644 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -49.59 113.19 0.86 Allowed 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.296 1.997 . . . . 0.0 112.393 179.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 24.0 m -84.59 127.36 34.02 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.617 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 34.7 tp -117.79 135.96 53.71 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 120.998 0.428 . . . . 0.0 110.109 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.441 ' O ' ' OD2' ' A' ' 32' ' ' ASP . 82.7 mt -99.62 118.92 46.95 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 CA-C-O 121.208 0.527 . . . . 0.0 111.089 -179.298 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 97.9 mt -135.15 132.33 52.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.574 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.513 HD22 ' CG ' ' A' ' 241' ' ' ASP . 56.4 t30 -68.04 153.72 43.15 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.987 0.423 . . . . 0.0 110.405 179.296 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.525 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 88.7 t80 -87.46 122.28 30.99 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.85 -179.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.525 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 99.0 m-20 55.11 69.38 0.74 Allowed 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.759 179.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 49.8 p-10 -123.6 -0.72 8.6 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.852 0.358 . . . . 0.0 110.629 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -151.01 116.29 5.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.715 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' SER . . . . . 0.526 ' HG ' ' H ' ' A' ' 150' ' ' GLN . 82.8 p -62.45 167.5 4.24 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.513 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.411 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.2 p-90 -51.05 -15.76 0.36 Allowed 'General case' 0 C--O 1.221 -0.414 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.371 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . 0.526 ' H ' ' HG ' ' A' ' 148' ' ' SER . 67.9 tp60 -70.92 -74.69 0.14 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.912 0.386 . . . . 0.0 110.516 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.434 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.2 t -62.81 -39.19 93.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.181 179.553 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 55.0 tp -60.05 -45.75 91.82 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.393 -178.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.411 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 46.9 tp -62.7 -41.64 99.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.619 178.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.434 ' OG1' ' O ' ' A' ' 151' ' ' SER . 56.5 p -64.25 -34.94 79.26 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.226 -179.372 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . 0.442 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.8 mm-40 -64.11 -42.57 96.83 Favored 'General case' 0 C--O 1.226 -0.161 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.389 179.332 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 90.2 mt -65.46 -38.66 90.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.152 0.501 . . . . 0.0 110.317 179.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.573 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.49 -32.41 81.08 Favored Glycine 0 C--N 1.331 0.287 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 -179.227 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.442 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.2 mt-10 -35.3 -27.23 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.819 0.343 . . . . 0.0 110.815 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.573 ' N ' ' O ' ' A' ' 157' ' ' GLY . 94.7 mt -55.83 149.42 3.1 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.371 178.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 72.7 p -69.82 137.58 51.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.992 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 71.1 20.96 78.33 Favored Glycine 0 N--CA 1.459 0.183 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 58.2 m80 -122.64 -14.49 7.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.641 0.258 . . . . 0.0 110.487 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -66.03 -59.93 3.32 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.584 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -51.98 -49.32 63.5 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.156 -179.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -60.59 -41.29 94.43 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.841 0.353 . . . . 0.0 110.435 179.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.32 -47.32 86.49 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.473 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.74 -40.27 75.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.241 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -61.53 -50.45 72.62 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.652 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -65.24 -43.7 90.56 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.584 179.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 94.2 mt -64.84 -43.3 96.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.4 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.4 -51.27 70.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.369 -179.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -63.41 -43.7 96.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.843 0.354 . . . . 0.0 110.656 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . 0.498 ' CD1' ' OH ' ' A' ' 301' ' ' TYR . 57.0 t80 -62.82 -44.42 96.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.378 179.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 -63.16 -39.67 95.34 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.78 -179.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -63.32 -42.66 99.01 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.518 179.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -60.76 -44.59 96.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.221 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 84.1 mt -64.69 -40.99 96.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.723 178.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.32 -62.46 1.62 Allowed 'General case' 0 C--O 1.238 0.457 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.295 -179.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.35 -47.34 84.09 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.473 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -52.75 -42.02 64.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.329 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -63.78 -33.66 76.17 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.034 0.445 . . . . 0.0 110.291 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 69.6 tt0 -90.81 9.06 31.7 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.552 0.691 . . . . 0.0 110.328 -178.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -105.11 -32.18 8.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.171 179.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 45.1 pt -128.15 147.76 32.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.816 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -140.25 131.36 26.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.388 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . 0.553 ' CD2' ' N ' ' A' ' 186' ' ' LEU . 3.5 mm? -85.26 133.87 41.78 Favored Pre-proline 0 N--CA 1.45 -0.435 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.092 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -43.7 157.67 0.13 Allowed 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.635 2.223 . . . . 0.0 112.387 179.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . 0.508 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 28.3 Cg_endo -63.22 114.9 2.68 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.819 2.346 . . . . 0.0 111.692 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . 0.508 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.7 mt-30 155.43 147.9 0.0 OUTLIER Pre-proline 0 N--CA 1.456 -0.136 0 O-C-N 124.051 0.844 . . . . 0.0 110.93 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.22 143.81 36.19 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.578 2.185 . . . . 0.0 112.316 177.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.494 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.1 p -124.87 159.3 31.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.418 0.628 . . . . 0.0 110.214 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' THR . . . . . 0.494 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 37.7 p -143.52 165.59 27.15 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.095 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -135.13 128.77 32.76 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-O 121.285 0.564 . . . . 0.0 110.229 179.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 47.9 pt -146.47 148.77 16.65 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.383 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.159 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 69.3 t -117.52 123.31 71.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-O 121.376 0.608 . . . . 0.0 109.817 178.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -134.46 107.69 7.71 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 121.156 0.503 . . . . 0.0 110.285 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 94.8 m -131.22 130.55 43.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.834 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.402 ' O ' ' N ' ' A' ' 201' ' ' HIS . . . -82.86 -36.83 25.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.242 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.49 -67.15 0.26 Allowed 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.273 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.34 -10.1 59.35 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.299 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . 0.402 ' N ' ' O ' ' A' ' 198' ' ' ALA . 60.1 t-80 60.77 58.3 2.42 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.71 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 41.6 p -166.77 153.52 8.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.565 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.65 144.49 24.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.977 0.418 . . . . 0.0 110.47 179.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -135.48 138.24 42.95 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.611 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 20.1 mt -106.26 125.81 51.45 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.006 0.432 . . . . 0.0 109.953 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' TRP . . . . . 0.563 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 76.4 m95 -82.52 167.26 18.55 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.536 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -157.25 170.71 8.5 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.617 -178.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -53.22 -37.04 79.94 Favored 'Trans proline' 0 C--N 1.302 -1.911 0 C-N-CA 122.652 2.235 . . . . 0.0 112.446 179.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -70.6 -34.94 72.69 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.657 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 22.9 m -61.56 150.45 35.97 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.633 -179.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.38 -36.87 81.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.436 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' GLN . . . . . 0.563 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 54.6 tt0 -64.73 -40.09 94.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.477 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.62 -43.54 91.83 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.669 -0.972 . . . . 0.0 110.669 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -63.34 -43.46 97.65 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.851 0.358 . . . . 0.0 110.233 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 65.4 ttp -59.1 -48.42 81.67 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.161 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 89.0 mt -60.29 -40.96 92.31 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' GLU . . . . . 0.453 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 40.5 tp10 -57.93 -37.67 74.51 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.057 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -65.48 -37.76 87.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.699 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 95.0 mt -64.37 -42.82 95.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.144 0.497 . . . . 0.0 110.629 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.5 44.62 0.08 OUTLIER Glycine 0 CA--C 1.52 0.387 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' PHE . . . . . 0.453 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 26.4 m-85 -127.58 154.5 45.12 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 121.05 0.452 . . . . 0.0 110.535 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' THR . . . . . 0.457 ' O ' ' O ' ' A' ' 191' ' ' VAL . 4.5 p -106.05 121.65 44.55 Favored 'General case' 0 C--O 1.224 -0.261 0 CA-C-O 121.262 0.554 . . . . 0.0 110.049 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . 0.447 ' CD2' ' N ' ' A' ' 223' ' ' LEU . 4.3 mm? -100.38 133.66 44.47 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.128 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -97.36 157.94 15.72 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.475 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -104.2 115.33 30.22 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.927 0.394 . . . . 0.0 110.416 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.441 ' CD1' ' N ' ' A' ' 226' ' ' LEU . 9.1 mp -53.89 156.55 4.96 Favored Pre-proline 0 N--CA 1.45 -0.462 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.817 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -59.73 145.11 99.04 Favored 'Trans proline' 0 C--N 1.299 -2.052 0 C-N-CA 122.736 2.291 . . . . 0.0 112.348 179.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.75 -2.52 58.67 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.509 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.58 -40.42 5.67 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . 0.532 ' O ' ' N ' ' A' ' 233' ' ' SER . 85.9 mt -79.32 -16.73 55.89 Favored 'General case' 0 C--O 1.22 -0.499 0 CA-C-O 121.085 0.469 . . . . 0.0 110.279 -179.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 54.8 t-20 -40.09 -48.92 2.55 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.79 -179.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -88.38 15.37 7.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.316 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' SER . . . . . 0.532 ' N ' ' O ' ' A' ' 230' ' ' LEU . 77.8 p -60.75 -35.46 76.44 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.676 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . 0.522 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.6 tt0 -118.28 -69.53 0.84 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.858 179.378 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.0 m -70.39 103.27 2.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.678 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -94.27 57.85 2.39 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.007 0.432 . . . . 0.0 110.319 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -145.2 -122.34 1.52 Allowed Glycine 0 C--N 1.332 0.339 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -134.1 112.42 11.14 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 121.141 0.496 . . . . 0.0 110.389 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . 0.461 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.2 mtt180 -148.54 56.79 1.04 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.737 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -69.49 -31.84 70.35 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.504 179.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 241' ' ' ASP . . . . . 0.513 ' CG ' HD22 ' A' ' 143' ' ' ASN . 64.8 t0 -56.58 -47.01 80.46 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.357 -179.042 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 242' ' ' ILE . . . . . 0.441 ' O ' ' O ' ' A' ' 239' ' ' ARG . 17.1 tt -140.4 157.46 24.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.88 0.371 . . . . 0.0 110.547 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 96.0 mt -105.88 106.05 19.84 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 CA-C-O 121.094 0.474 . . . . 0.0 110.505 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . 0.461 ' OE1' ' NH1' ' A' ' 239' ' ' ARG . 88.3 mt-30 -110.99 110.64 21.28 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.351 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 9.8 mp -121.98 -167.79 1.6 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.645 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . 0.522 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 172.79 -16.71 0.05 OUTLIER Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . 0.685 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -60.6 157.62 29.34 Favored Glycine 0 CA--C 1.522 0.49 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -64.05 21.01 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.966 0.412 . . . . 0.0 110.616 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . 0.685 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.9 m-20 -96.75 -5.7 38.0 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.523 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 91.3 mt -80.67 -20.97 41.82 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.763 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.56 -51.44 69.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.615 -179.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -89.14 -4.87 58.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.529 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.33 -74.13 1.16 Allowed Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.896 -0.881 . . . . 0.0 110.896 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 81.5 mt -70.12 125.7 27.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.978 0.418 . . . . 0.0 110.282 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -59.9 -39.26 84.79 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.334 -179.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 83.33 51.57 4.08 Favored Glycine 0 CA--C 1.52 0.393 0 N-CA-C 110.824 -0.91 . . . . 0.0 110.824 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -94.87 -16.7 22.69 Favored 'General case' 0 C--N 1.332 -0.17 0 O-C-N 122.739 -0.271 . . . . 0.0 110.606 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 258' ' ' SER . . . . . 0.417 ' O ' ' O ' ' A' ' 192' ' ' THR . 3.4 t 175.47 89.49 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.159 0.504 . . . . 0.0 110.1 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . 0.594 ' N ' ' CD1' ' A' ' 259' ' ' LEU . 0.9 OUTLIER -94.79 124.49 38.86 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.22 0.534 . . . . 0.0 111.229 -179.03 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 15.9 m-30 -93.98 146.8 23.67 Favored 'General case' 0 CA--C 1.5 -0.956 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.351 179.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 86.7 mt -122.42 150.18 42.82 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.542 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.655 ' CG ' ' N ' ' A' ' 263' ' ' ALA . 2.6 p90 -77.7 -138.27 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.587 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 263' ' ' ALA . . . . . 0.655 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -51.96 77.34 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.156 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . 0.62 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.24 104.35 0.18 Allowed Glycine 0 CA--C 1.528 0.845 0 N-CA-C 110.474 -1.051 . . . . 0.0 110.474 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 265' ' ' ASP . . . . . 0.593 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.6 m-20 -79.98 -177.91 6.23 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 122.75 -0.265 . . . . 0.0 110.945 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -40.47 -17.83 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.567 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 267' ' ' LYS . . . . . 0.593 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.27 -51.7 42.17 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.681 179.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -63.56 -46.7 84.71 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.312 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . 0.523 ' O ' ' CD2' ' A' ' 273' ' ' TYR . . . -61.68 -35.03 76.83 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 121.444 0.64 . . . . 0.0 109.808 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -63.14 -34.19 77.07 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.145 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.62 -43.33 13.55 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.081 -179.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 272' ' ' ILE . . . . . 0.619 ' C ' ' H ' ' A' ' 274' ' ' ALA . 4.9 tt -51.39 -33.78 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.875 -178.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 273' ' ' TYR . . . . . 0.523 ' CD2' ' O ' ' A' ' 269' ' ' ALA . 17.2 m-85 -54.4 -1.73 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.649 -179.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 274' ' ' ALA . . . . . 0.619 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.49 -39.73 70.66 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.848 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . 0.58 ' O ' ' N ' ' A' ' 279' ' ' ALA . 2.8 p30 -39.22 98.29 0.16 Allowed Pre-proline 0 N--CA 1.463 0.178 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.401 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_exo -54.68 -42.69 66.12 Favored 'Trans proline' 0 C--N 1.303 -1.833 0 C-N-CA 122.356 2.037 . . . . 0.0 112.502 -178.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 89.2 mt -64.51 -42.84 95.55 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.093 0.473 . . . . 0.0 111.213 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 91.3 mt -95.59 -1.81 49.63 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.924 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 279' ' ' ALA . . . . . 0.58 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.16 -34.78 77.05 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.701 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.3 20.0 0.12 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.963 -179.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . 0.512 ' H ' ' C ' ' A' ' 279' ' ' ALA . 13.7 mt -74.73 119.24 75.74 Favored Pre-proline 0 N--CA 1.447 -0.607 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.774 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -49.65 -40.34 46.66 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.656 2.237 . . . . 0.0 112.3 178.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.57 -50.66 62.52 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.023 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 78.0 t -61.43 -43.87 97.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.803 0.335 . . . . 0.0 110.118 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -57.64 -41.27 81.08 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.188 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -90.89 0.47 57.48 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.108 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt 59.25 42.04 19.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.784 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -93.79 41.1 1.08 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.398 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 53.7 t -118.31 136.22 56.19 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.126 0 CA-C-O 121.113 0.483 . . . . 0.0 110.009 -179.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -133.31 163.12 30.04 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.184 0.516 . . . . 0.0 110.626 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -120.48 154.88 34.64 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-O 121.048 0.451 . . . . 0.0 110.652 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 82.3 mt -93.41 -1.63 55.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.212 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.59 165.94 12.74 Favored Glycine 0 N--CA 1.463 0.445 0 N-CA-C 110.529 -1.028 . . . . 0.0 110.529 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 6.8 m -87.6 -62.19 1.55 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.857 0.361 . . . . 0.0 110.967 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 295' ' ' GLU . . . . . 0.469 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.4 mm-40 -69.8 -3.85 17.4 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.667 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 25.2 p -77.03 33.38 0.15 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.593 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 297' ' ' PHE . . . . . 0.469 ' H ' ' C ' ' A' ' 295' ' ' GLU . 84.8 t80 -60.11 -45.99 91.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.591 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . 0.603 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.3 mtt85 -81.61 134.84 35.54 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.59 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 16.0 tp -114.39 119.16 35.99 Favored 'General case' 0 C--O 1.231 0.08 0 CA-C-O 120.974 0.416 . . . . 0.0 110.204 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . 0.604 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.2 p-10 -166.73 -174.71 2.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.637 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 301' ' ' TYR . . . . . 0.498 ' OH ' ' CD1' ' A' ' 173' ' ' PHE . 83.5 t80 -47.96 -45.07 30.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.221 -179.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -65.3 -41.2 94.33 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.017 0.437 . . . . 0.0 110.734 178.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 303' ' ' SER . . . . . 0.604 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 53.6 p -55.73 -36.62 67.44 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.059 -179.237 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . 0.491 ' N ' ' HG ' ' A' ' 303' ' ' SER . . . -56.33 -52.74 63.43 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 92.4 mtp -55.21 -43.72 74.72 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -66.25 -42.31 88.76 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.137 0.494 . . . . 0.0 110.264 179.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 55.1 t -64.09 -43.02 97.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.27 179.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 42.3 tp -59.98 -42.26 93.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.846 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -62.33 -38.88 91.17 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.146 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 310' ' ' ARG . . . . . 0.404 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.5 ttt85 -63.87 -44.21 93.74 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.251 179.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 87.9 mt -63.41 -42.42 98.75 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.465 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt -62.88 -33.51 75.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.191 179.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -87.24 -26.25 23.59 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.318 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . 0.457 ' CD2' ' C ' ' A' ' 314' ' ' LEU . 8.4 tt -62.57 -44.4 96.43 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.327 -179.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 . . . . . 0 C--O 1.22 -0.499 0 CA-C-O 118.005 -0.998 . . . . 0.0 110.475 179.975 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -99.67 136.05 40.17 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.002 0.43 . . . . 0.0 110.515 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.497 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -92.29 178.72 1.57 Allowed Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.523 -179.874 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.497 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.8 Cg_exo -61.58 147.3 95.73 Favored 'Trans proline' 0 C--N 1.3 -2.01 0 C-N-CA 122.819 2.346 . . . . 0.0 112.132 179.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 35.5 ptt180 -136.1 142.47 44.3 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.697 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -79.75 116.43 19.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.489 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.4 tp -110.71 130.38 64.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.503 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.3 t -70.74 141.4 51.49 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.571 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.511 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.4 t0 -139.05 179.55 6.43 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.52 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.511 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 77.9 p -74.05 -36.99 64.42 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.557 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.8 ttt85 -46.38 -94.57 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.337 -179.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.439 ' C ' ' HG1' ' A' ' 36' ' ' THR . . . -167.17 -26.74 0.02 OUTLIER Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.439 ' HG1' ' C ' ' A' ' 35' ' ' GLY . 70.7 m -169.01 104.57 0.4 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.9 0.381 . . . . 0.0 110.613 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 74.3 t60 -128.46 148.33 50.72 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.081 0.467 . . . . 0.0 110.187 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.483 ' CG2' ' N ' ' A' ' 39' ' ' LEU . 98.0 m -130.79 166.06 21.62 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.54 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.483 ' N ' ' CG2' ' A' ' 38' ' ' THR . 81.2 mt -120.8 127.63 52.13 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.56 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -65.08 -44.59 88.43 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.67 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.4 ' O ' ' HD3' ' A' ' 43' ' ' PRO . 39.8 p -165.65 154.89 12.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.416 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.462 ' N ' ' CD ' ' A' ' 42' ' ' GLN . 14.8 mp0 -44.32 101.07 0.24 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.607 179.381 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.4 ' HD3' ' O ' ' A' ' 41' ' ' SER . 31.7 Cg_exo -57.23 129.51 34.58 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.391 2.061 . . . . 0.0 112.265 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -83.5 -24.78 31.57 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.527 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.538 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.6 mtm-85 -122.31 134.82 54.65 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 121.179 0.514 . . . . 0.0 110.297 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.2 mt -130.8 133.96 62.5 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.272 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.821 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 45.6 t -124.43 130.55 73.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 179.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.502 ' O ' ' O ' ' A' ' 66' ' ' ALA . 2.2 m -154.81 166.63 32.88 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.576 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 73.1 p -124.41 8.69 8.42 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.372 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.0 125.86 33.06 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.843 0.354 . . . . 0.0 110.653 -179.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 90.8 t -66.02 -44.44 92.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.521 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.7 m -62.69 -44.39 96.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.601 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 50.3 tp -62.38 -41.48 98.67 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.529 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 70.6 m -57.88 -44.51 86.72 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.239 -179.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.17 -62.31 5.28 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 179.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.7 t -48.19 -35.65 12.19 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 20.1 mt -61.81 -44.6 96.55 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.226 179.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.3 mp -65.16 -41.66 94.5 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.391 177.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.42 -41.38 98.71 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.856 -179.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.1 tp -88.1 17.29 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.838 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 56.28 85.01 0.08 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.733 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.36 58.62 0.08 OUTLIER Pre-proline 0 C--N 1.328 -0.355 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -50.92 151.93 10.76 Favored 'Trans proline' 0 C--N 1.294 -2.319 0 C-N-CA 122.902 2.402 . . . . 0.0 112.275 -178.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.433 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -108.71 145.75 15.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.326 -179.691 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.76 -45.17 97.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.361 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.502 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -129.92 134.48 47.51 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 120.8 0.334 . . . . 0.0 110.541 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.48 ' O ' ' N ' ' A' ' 98' ' ' LEU . 73.3 m -134.73 158.87 43.02 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.907 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.45 138.65 15.98 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.445 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.6 -162.85 0.09 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.002 0.429 . . . . 0.0 110.453 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.487 ' O ' ' C ' ' A' ' 71' ' ' THR . 5.8 t -133.97 135.9 43.8 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.156 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.487 ' C ' ' O ' ' A' ' 70' ' ' THR . 1.1 t 29.46 67.99 0.67 Allowed Pre-proline 0 N--CA 1.466 0.332 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.728 -179.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_exo -60.97 145.74 98.69 Favored 'Trans proline' 0 C--N 1.3 -2.009 0 C-N-CA 122.619 2.213 . . . . 0.0 111.99 -178.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.537 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 42.4 p-10 -161.06 -31.86 0.05 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.75 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.537 ' N ' ' OD1' ' A' ' 73' ' ' ASN . 99.1 m-20 -64.16 -39.41 93.94 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.343 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -60.28 -47.98 83.69 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.578 -179.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.427 ' O ' ' O ' ' A' ' 77' ' ' ALA . 98.7 t -60.27 -24.62 31.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.427 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -45.5 172.88 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.631 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.575 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.9 p30 -61.99 177.61 0.44 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.586 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.598 ' C ' ' H ' ' A' ' 81' ' ' GLY . 36.5 p30 -45.96 85.41 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.072 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.575 ' N ' ' O ' ' A' ' 78' ' ' ASP . 42.4 tp60 -67.43 13.66 0.07 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.203 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.598 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 118.16 -21.96 9.9 Favored Glycine 0 CA--C 1.519 0.3 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -107.86 116.51 32.09 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.008 0.432 . . . . 0.0 110.527 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 74.6 mt -98.54 0.03 44.19 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.982 0.42 . . . . 0.0 110.51 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -92.49 7.04 44.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.031 0.443 . . . . 0.0 110.387 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.445 ' O ' ' CG2' ' A' ' 89' ' ' VAL . 88.2 mt-30 -100.24 -27.16 13.64 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.841 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.6 t-105 -64.73 -40.46 95.35 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.035 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.557 ' O ' ' N ' ' A' ' 91' ' ' LYS . 65.8 m -77.89 -54.5 6.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.169 -179.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -47.42 -50.43 22.67 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.087 -179.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.445 ' CG2' ' O ' ' A' ' 85' ' ' GLN . 14.4 m -69.36 -40.54 80.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.137 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.402 ' H ' HG23 ' A' ' 89' ' ' VAL . . . -72.45 -22.76 61.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.658 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.557 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.0 tttm -62.14 -45.57 92.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.445 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.439 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.8 mm-40 -90.37 -94.8 0.12 Allowed 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.078 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.636 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.8 mtt180 -143.01 58.75 1.42 Allowed 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.455 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.6 pttp 33.68 25.8 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 120.947 0.403 . . . . 0.0 110.255 -179.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.636 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.3 tt -47.78 123.68 6.3 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.954 -178.02 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -83.56 -170.39 3.04 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.127 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.613 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 82.2 mtp180 -73.95 137.26 43.46 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.061 0.458 . . . . 0.0 110.246 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.48 ' N ' ' O ' ' A' ' 67' ' ' SER . 90.3 mt -86.12 -165.85 1.37 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.816 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.537 ' CD2' ' O ' ' A' ' 99' ' ' TYR . 48.5 p90 -168.86 119.92 0.75 Allowed 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.137 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.509 ' C ' ' O ' ' A' ' 99' ' ' TYR . 43.7 mm -29.0 121.08 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.067 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 114.15 27.13 3.53 Favored Glycine 0 C--N 1.332 0.318 0 N-CA-C 111.261 -0.735 . . . . 0.0 111.261 -179.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.575 ' N ' ' CD ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -144.2 46.5 0.64 Allowed Pre-proline 0 C--N 1.324 -0.518 0 CA-C-O 120.931 0.396 . . . . 0.0 110.416 179.872 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 29.1 Cg_endo -62.1 143.77 95.14 Favored 'Trans proline' 0 C--N 1.296 -2.233 0 C-N-CA 122.677 2.251 . . . . 0.0 111.845 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.71 ' HG ' ' H ' ' A' ' 107' ' ' ALA . 27.4 t -173.05 120.2 0.35 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.376 179.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.52 -40.49 64.0 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.038 0.447 . . . . 0.0 111.086 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.23 -39.87 89.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.841 -179.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.71 ' H ' ' HG ' ' A' ' 104' ' ' SER . . . -64.23 -40.04 95.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.745 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 71.2 t -67.69 -43.89 86.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.793 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.71 -39.01 92.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.522 -179.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.439 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.5 -23.35 62.72 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.486 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.544 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.2 mm-40 -90.66 5.46 47.96 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.659 -179.49 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.544 ' C ' ' O ' ' A' ' 111' ' ' GLN . 10.5 tpt 23.49 64.23 0.38 Allowed Pre-proline 0 N--CA 1.466 0.367 0 CA-C-O 120.87 0.367 . . . . 0.0 111.02 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -78.54 167.1 23.19 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 C-N-CA 123.051 2.501 . . . . 0.0 111.866 -178.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.523 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 99.2 m-20 -109.83 -42.07 4.34 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.112 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 39.8 tp -121.64 120.28 34.3 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 83.7 mt -112.91 128.85 69.42 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.353 0 CA-C-O 120.934 0.397 . . . . 0.0 110.951 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 29.4 mt -108.87 132.26 54.21 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.063 0.459 . . . . 0.0 110.183 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 98.7 mt -119.67 139.01 48.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.711 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 85.6 p -72.4 153.77 41.26 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.642 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.18 -50.16 74.76 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.631 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -149.45 154.06 38.25 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.555 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 170.64 -171.02 43.53 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -63.17 -34.04 88.89 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.447 ' O ' ' OD1' ' A' ' 124' ' ' ASP . 44.0 p-10 -86.97 119.99 27.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.867 0.365 . . . . 0.0 110.684 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 39.8 t -62.99 143.61 57.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.425 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.04 -43.11 9.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.862 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.7 tp -63.01 -42.47 99.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.75 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.43 -12.08 59.39 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.499 -179.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 84.2 mt -114.94 -23.84 8.91 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.636 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . 0.519 ' N ' ' O ' ' A' ' 126' ' ' ALA . 78.4 t80 -51.0 -49.74 59.81 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.567 -178.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.503 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.1 p-10 -65.84 -42.4 90.56 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.841 -0.344 . . . . 0.0 111.208 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.503 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 88.3 mt-30 -67.45 -37.77 83.46 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.849 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 95.9 mt -80.06 -41.8 24.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.862 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.2 t -57.03 -44.43 82.88 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.166 -178.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 20.2 m -61.91 -45.09 95.24 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.463 179.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 93.8 mt -62.24 -43.59 98.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.196 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.52 167.9 5.08 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.57 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -49.4 113.14 0.83 Allowed 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.298 1.998 . . . . 0.0 112.299 179.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 24.0 m -84.65 127.24 33.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.602 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 34.7 tp -117.75 136.24 53.51 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.05 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.44 ' O ' ' OD2' ' A' ' 32' ' ' ASP . 82.6 mt -100.1 118.89 47.42 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 CA-C-O 121.149 0.5 . . . . 0.0 111.161 -179.326 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 97.8 mt -135.05 132.13 53.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.595 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.516 HD22 ' CG ' ' A' ' 241' ' ' ASP . 55.9 t30 -67.35 153.59 43.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.945 0.403 . . . . 0.0 110.483 179.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.522 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 89.1 t80 -87.58 122.26 31.05 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.865 -179.523 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.522 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 99.0 m-20 55.17 69.45 0.73 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.759 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 49.3 p-10 -123.56 -0.48 8.65 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.923 0.392 . . . . 0.0 110.664 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -151.45 117.5 5.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.69 -179.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' SER . . . . . 0.522 ' HG ' ' H ' ' A' ' 150' ' ' GLN . 83.7 p -63.4 167.78 5.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.524 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.413 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.1 p-90 -51.15 -15.64 0.37 Allowed 'General case' 0 C--O 1.223 -0.326 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.504 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . 0.522 ' H ' ' HG ' ' A' ' 148' ' ' SER . 68.1 tp60 -71.28 -74.91 0.14 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.444 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.447 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.0 t -62.93 -38.84 92.61 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.263 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 54.6 tp -60.14 -45.71 92.11 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.413 -178.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.413 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 47.3 tp -62.62 -41.6 99.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.445 179.002 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.447 ' OG1' ' O ' ' A' ' 151' ' ' SER . 57.1 p -64.23 -34.68 78.65 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.193 -179.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . 0.43 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.7 mm-40 -63.99 -42.78 97.1 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.442 179.263 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 91.5 mt -65.38 -38.92 91.45 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.087 0.47 . . . . 0.0 110.245 179.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.579 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.2 -31.91 78.67 Favored Glycine 0 CA--C 1.519 0.288 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 -179.257 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' A' ' 157' ' ' GLY . 97.3 mt-10 -35.61 -26.73 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.815 0.34 . . . . 0.0 110.803 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.579 ' N ' ' O ' ' A' ' 157' ' ' GLY . 95.7 mt -56.62 149.87 3.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.305 179.072 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 72.4 p -69.98 137.1 51.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.983 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 72.02 19.56 78.45 Favored Glycine 0 CA--C 1.517 0.159 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 58.2 m80 -121.04 -15.05 8.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.683 0.277 . . . . 0.0 110.585 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -65.33 -60.09 3.35 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.684 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -52.01 -49.25 63.73 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 120.819 -0.352 . . . . 0.0 110.166 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -60.29 -41.26 92.99 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.956 -0.298 . . . . 0.0 110.349 179.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.44 -47.24 86.61 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.55 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.86 -40.23 75.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.286 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -61.81 -50.26 73.04 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.601 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 60.1 ttt85 -65.32 -43.76 89.97 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.554 179.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 94.9 mt -64.77 -43.31 96.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.457 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.31 -51.35 69.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.472 -179.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.43 -43.76 96.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.584 179.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . 0.477 ' CD1' ' OH ' ' A' ' 301' ' ' TYR . 56.1 t80 -62.9 -44.35 96.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.423 179.44 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -63.61 -39.96 95.71 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.54 -179.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -62.89 -42.85 99.92 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.67 179.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -60.71 -44.62 96.37 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.201 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 83.6 mt -64.51 -40.96 96.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.01 0.433 . . . . 0.0 110.695 178.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.13 -62.41 1.65 Allowed 'General case' 0 C--O 1.237 0.425 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.411 -179.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.48 -47.01 85.46 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.519 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.2 -41.65 65.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.32 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -63.92 -33.82 76.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.002 0.429 . . . . 0.0 110.397 179.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . 0.4 ' O ' ' HG2' ' A' ' 182' ' ' GLU . 69.5 tt0 -90.62 9.16 30.79 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.448 0.642 . . . . 0.0 110.439 -178.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -105.06 -32.03 8.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.165 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.5 pt -128.17 147.57 32.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.753 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -139.69 131.11 26.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.446 179.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . 0.553 ' CD2' ' N ' ' A' ' 186' ' ' LEU . 3.6 mm? -85.3 133.23 42.96 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.977 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -43.8 157.77 0.13 Allowed 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.75 2.3 . . . . 0.0 112.223 179.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . 0.515 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 28.0 Cg_endo -63.05 114.82 2.61 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 C-N-CA 122.821 2.347 . . . . 0.0 111.716 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . 0.515 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.7 mt-30 155.72 147.71 0.0 OUTLIER Pre-proline 0 N--CA 1.456 -0.144 0 O-C-N 123.76 0.662 . . . . 0.0 110.759 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -73.56 143.53 34.46 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.582 2.188 . . . . 0.0 112.082 177.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.493 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.1 p -124.43 158.88 31.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.362 0.601 . . . . 0.0 110.174 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' THR . . . . . 0.493 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 34.8 p -143.39 165.22 28.12 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.086 -179.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -135.15 128.56 32.32 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.241 0.543 . . . . 0.0 110.201 179.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 47.4 pt -146.48 148.85 16.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.113 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 69.1 t -117.76 123.26 71.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.278 0.561 . . . . 0.0 109.794 179.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -134.07 106.96 7.48 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.295 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 94.5 m -130.57 130.3 43.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.827 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.409 ' O ' ' N ' ' A' ' 201' ' ' HIS . . . -83.01 -36.73 24.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.198 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.54 -67.01 0.27 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.338 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.49 -9.43 58.54 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.268 179.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . 0.409 ' N ' ' O ' ' A' ' 198' ' ' ALA . 59.8 t-80 60.36 58.47 2.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.708 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 48.8 p -166.99 153.51 8.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.547 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.49 144.3 24.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.974 0.416 . . . . 0.0 110.51 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -135.47 138.46 43.19 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.599 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 20.0 mt -106.59 125.68 51.31 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.067 0.46 . . . . 0.0 109.834 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' TRP . . . . . 0.557 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 75.5 m95 -82.23 167.21 18.88 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.621 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -157.03 171.53 7.33 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.632 -179.118 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -53.85 -36.9 84.56 Favored 'Trans proline' 0 C--N 1.302 -1.917 0 C-N-CA 122.691 2.261 . . . . 0.0 112.247 179.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -70.64 -34.99 72.68 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.734 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 21.5 m -61.36 150.75 34.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.606 -179.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.67 -36.96 82.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.452 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' GLN . . . . . 0.557 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 54.8 tt0 -64.63 -40.22 95.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.48 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.68 -43.46 91.88 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.694 -0.963 . . . . 0.0 110.694 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -63.41 -43.53 97.26 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.816 0.341 . . . . 0.0 110.347 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 65.2 ttp -59.43 -48.06 83.1 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.232 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 87.7 mt -60.64 -40.91 93.71 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' GLU . . . . . 0.457 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.5 tp10 -57.79 -37.92 74.59 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -65.32 -37.98 88.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.797 0.332 . . . . 0.0 110.666 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 94.5 mt -64.26 -42.86 96.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.62 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.7 44.88 0.08 OUTLIER Glycine 0 C--N 1.333 0.369 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' PHE . . . . . 0.457 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 27.4 m-85 -128.02 155.11 44.83 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.038 0.447 . . . . 0.0 110.524 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' THR . . . . . 0.453 ' O ' ' O ' ' A' ' 191' ' ' VAL . 7.2 p -106.94 122.17 45.89 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.248 0.547 . . . . 0.0 110.103 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . 0.444 ' CD2' ' N ' ' A' ' 223' ' ' LEU . 4.3 mm? -100.98 133.26 45.74 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.109 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -97.14 159.23 15.03 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.469 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.19 115.35 30.11 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.87 0.367 . . . . 0.0 110.36 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.454 ' CD1' ' N ' ' A' ' 226' ' ' LEU . 8.9 mp -53.22 156.46 3.88 Favored Pre-proline 0 N--CA 1.452 -0.345 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.744 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -60.16 145.27 98.87 Favored 'Trans proline' 0 C--N 1.3 -1.986 0 C-N-CA 122.703 2.269 . . . . 0.0 112.162 179.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.16 -3.25 59.05 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.528 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.14 -40.98 5.67 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 111.024 -0.831 . . . . 0.0 111.024 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . 0.533 ' O ' ' N ' ' A' ' 233' ' ' SER . 85.1 mt -79.25 -17.13 55.34 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-O 121.113 0.482 . . . . 0.0 110.362 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . 0.401 ' C ' ' O ' ' A' ' 230' ' ' LEU . 55.5 t-20 -40.17 -49.12 2.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.821 -179.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -88.08 15.35 7.52 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.373 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' SER . . . . . 0.533 ' N ' ' O ' ' A' ' 230' ' ' LEU . 78.0 p -60.37 -35.6 76.09 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.651 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . 0.526 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.7 tt0 -118.51 -69.32 0.86 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.995 179.424 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.4 m -69.85 103.4 2.19 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.693 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -94.69 57.63 2.21 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.297 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -144.84 -122.59 1.57 Allowed Glycine 0 CA--C 1.52 0.353 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -134.81 111.66 10.09 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.114 0.483 . . . . 0.0 110.389 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . 0.517 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.5 mtt180 -148.04 57.72 1.09 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.762 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -69.55 -32.14 70.76 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.501 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 241' ' ' ASP . . . . . 0.516 ' CG ' HD22 ' A' ' 143' ' ' ASN . 64.8 t0 -56.85 -47.05 81.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.378 -179.077 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 242' ' ' ILE . . . . . 0.436 ' O ' ' O ' ' A' ' 239' ' ' ARG . 17.8 tt -139.97 156.63 25.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.892 0.377 . . . . 0.0 110.479 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 96.3 mt -106.03 106.26 20.24 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.202 0 CA-C-O 121.096 0.474 . . . . 0.0 110.502 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . 0.517 ' OE1' ' NH1' ' A' ' 239' ' ' ARG . 88.3 mt-30 -110.2 110.09 20.81 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.398 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 9.5 mp -121.79 -168.38 1.69 Allowed 'General case' 0 C--O 1.225 -0.199 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.651 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . 0.526 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.65 -16.76 0.05 OUTLIER Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . 0.693 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -60.55 156.64 30.8 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -63.68 21.4 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.0 0.428 . . . . 0.0 110.643 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . 0.693 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.6 m-20 -97.02 -6.03 36.3 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.556 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 93.3 mt -79.68 -21.69 44.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.658 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.5 -51.34 70.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.705 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.31 -5.65 58.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.502 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.2 -74.53 1.14 Allowed Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 82.2 mt -69.83 125.92 28.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.954 0.407 . . . . 0.0 110.366 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -59.26 -39.42 82.82 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.19 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 82.39 51.88 4.2 Favored Glycine 0 CA--C 1.521 0.407 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -96.67 -14.2 22.27 Favored 'General case' 0 C--N 1.331 -0.236 0 O-C-N 122.755 -0.262 . . . . 0.0 110.597 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 258' ' ' SER . . . . . 0.425 ' O ' ' O ' ' A' ' 192' ' ' THR . 3.5 t 174.67 88.18 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.084 0.469 . . . . 0.0 110.167 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . 0.593 ' N ' ' CD1' ' A' ' 259' ' ' LEU . 1.0 OUTLIER -94.26 123.85 37.92 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.245 0.545 . . . . 0.0 111.102 -179.101 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 15.8 m-30 -92.77 146.32 23.74 Favored 'General case' 0 CA--C 1.503 -0.854 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.503 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 86.0 mt -122.3 149.59 43.51 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.519 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.658 ' CG ' ' N ' ' A' ' 263' ' ' ALA . 2.6 p90 -77.46 -138.52 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.579 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 263' ' ' ALA . . . . . 0.658 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -51.9 77.29 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.114 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . 0.629 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.1 104.46 0.19 Allowed Glycine 0 CA--C 1.527 0.794 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 265' ' ' ASP . . . . . 0.599 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.8 m-20 -80.43 -177.85 6.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.649 0.261 . . . . 0.0 110.9 -179.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -40.3 -17.81 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.551 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 267' ' ' LYS . . . . . 0.599 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.36 -51.65 41.97 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.612 179.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -63.59 -46.77 84.3 Favored 'General case' 0 N--CA 1.461 0.095 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.237 179.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . 0.527 ' O ' ' CD2' ' A' ' 273' ' ' TYR . . . -61.62 -35.09 76.9 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 121.263 0.554 . . . . 0.0 109.827 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -63.12 -34.37 77.46 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.167 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.49 -43.39 13.61 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.14 -179.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 272' ' ' ILE . . . . . 0.618 ' C ' ' H ' ' A' ' 274' ' ' ALA . 5.0 tt -51.33 -33.75 14.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.824 -178.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 273' ' ' TYR . . . . . 0.527 ' CD2' ' O ' ' A' ' 269' ' ' ALA . 17.3 m-85 -54.45 -1.75 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.613 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 274' ' ' ALA . . . . . 0.618 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.54 -39.6 70.58 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.931 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . 0.58 ' O ' ' N ' ' A' ' 279' ' ' ALA . 3.2 p30 -39.21 98.0 0.15 Allowed Pre-proline 0 C--O 1.227 -0.126 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.505 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -54.27 -42.92 63.27 Favored 'Trans proline' 0 C--N 1.303 -1.824 0 C-N-CA 122.404 2.069 . . . . 0.0 112.598 -178.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 88.7 mt -64.41 -42.78 95.89 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.133 0.492 . . . . 0.0 111.2 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 91.1 mt -95.64 -1.72 49.62 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.882 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 279' ' ' ALA . . . . . 0.58 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.23 -34.83 77.24 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.703 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -74.27 20.15 0.12 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.981 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . 0.512 ' H ' ' C ' ' A' ' 279' ' ' ALA . 13.8 mt -75.2 119.93 79.26 Favored Pre-proline 0 N--CA 1.449 -0.499 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.595 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -50.49 -39.68 54.73 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.725 2.284 . . . . 0.0 112.019 178.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.69 -50.43 63.32 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.082 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 73.7 t -61.44 -43.91 97.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -57.81 -41.29 81.88 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.212 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -90.92 0.05 57.61 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.201 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt 59.47 43.29 16.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.863 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -94.68 41.42 1.09 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.372 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 53.8 t -118.99 135.83 58.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.089 0.471 . . . . 0.0 110.175 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -133.04 162.89 30.51 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 121.102 0.477 . . . . 0.0 110.637 -179.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -120.08 155.22 33.41 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.022 0.439 . . . . 0.0 110.689 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 81.6 mt -93.87 -1.48 54.75 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.313 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.04 165.74 12.77 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.609 -0.996 . . . . 0.0 110.609 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 7.1 m -87.3 -62.27 1.54 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.875 0.369 . . . . 0.0 111.007 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 295' ' ' GLU . . . . . 0.475 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.4 mm-40 -69.49 -4.0 16.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.672 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 26.2 p -77.03 32.62 0.14 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.619 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 297' ' ' PHE . . . . . 0.475 ' H ' ' C ' ' A' ' 295' ' ' GLU . 69.4 t80 -60.15 -46.19 90.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.512 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . 0.613 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.1 mtt85 -81.26 133.65 35.47 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 120.988 0.423 . . . . 0.0 110.507 -179.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 16.3 tp -114.16 119.67 37.89 Favored 'General case' 0 C--O 1.231 0.083 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.26 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . 0.606 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.5 p-10 -167.53 -174.14 2.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.611 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 301' ' ' TYR . . . . . 0.477 ' OH ' ' CD1' ' A' ' 173' ' ' PHE . 81.5 t80 -48.2 -45.6 34.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.2 -179.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -64.96 -41.64 95.29 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.106 0.479 . . . . 0.0 110.718 179.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 303' ' ' SER . . . . . 0.606 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 53.0 p -55.13 -36.27 65.58 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.052 -179.299 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -56.74 -51.65 68.04 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 91.5 mtp -56.22 -43.98 79.12 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -66.21 -42.71 88.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.02 0.438 . . . . 0.0 110.256 178.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 55.5 t -64.05 -42.81 96.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.254 179.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 42.2 tp -59.56 -42.22 91.92 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.81 -179.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -62.76 -38.78 91.95 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.118 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 310' ' ' ARG . . . . . 0.431 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.6 ttt85 -63.34 -44.1 95.82 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.229 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 88.1 mt -63.3 -42.03 99.01 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.318 179.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -62.78 -33.09 74.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.166 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -90.08 -23.42 21.42 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.456 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . 0.431 ' N ' ' O ' ' A' ' 310' ' ' ARG . 6.8 tt -62.29 -43.16 99.47 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 121.144 0.497 . . . . 0.0 110.677 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 . . . . . 0 C--O 1.219 -0.517 0 CA-C-O 118.026 -0.987 . . . . 0.0 110.409 -179.978 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -99.54 136.56 39.3 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.178 0.513 . . . . 0.0 110.471 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.492 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -91.9 178.61 1.66 Allowed Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.566 -179.821 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.492 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.1 Cg_exo -61.72 146.99 96.31 Favored 'Trans proline' 0 C--N 1.299 -2.071 0 C-N-CA 122.86 2.374 . . . . 0.0 112.163 179.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 35.6 ptt180 -136.21 142.34 44.07 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.653 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -79.48 116.88 19.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.475 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.5 tp -111.25 130.78 64.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.564 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.8 t -71.07 142.37 50.84 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.023 0.439 . . . . 0.0 110.615 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.514 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.4 t0 -139.95 179.53 6.55 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.561 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.514 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 77.9 p -73.67 -37.12 65.36 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.604 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.8 ttt85 -46.45 -94.41 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.29 -179.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.49 ' C ' ' HG1' ' A' ' 36' ' ' THR . . . -167.54 -26.29 0.02 OUTLIER Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.49 ' HG1' ' C ' ' A' ' 35' ' ' GLY . 54.8 m -169.31 104.91 0.37 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.84 0.353 . . . . 0.0 110.622 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 75.3 t60 -128.56 149.32 50.67 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.158 0.504 . . . . 0.0 110.142 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.484 ' CG2' ' N ' ' A' ' 39' ' ' LEU . 98.4 m -131.44 166.02 22.23 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.456 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.484 ' N ' ' CG2' ' A' ' 38' ' ' THR . 81.6 mt -120.85 127.12 51.61 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.432 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -65.02 -44.59 88.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.748 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 39.7 p -165.51 154.94 12.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.429 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.452 ' N ' ' CD ' ' A' ' 42' ' ' GLN . 14.6 mp0 -44.3 100.91 0.24 Allowed Pre-proline 0 C--O 1.235 0.33 0 O-C-N 123.551 0.532 . . . . 0.0 110.635 179.144 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.4 129.92 36.48 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 C-N-CA 122.335 2.023 . . . . 0.0 112.307 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -83.79 -24.92 30.84 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.605 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.54 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.6 mtm-85 -122.19 134.62 54.71 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.279 0.562 . . . . 0.0 110.203 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.3 mt -130.21 133.49 64.05 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.801 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 44.0 t -124.41 130.47 73.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 179.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.495 ' O ' ' O ' ' A' ' 66' ' ' ALA . 2.2 m -154.86 166.89 32.07 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.554 179.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 72.2 p -124.13 8.59 8.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.395 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.45 126.04 33.49 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.862 0.363 . . . . 0.0 110.622 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 90.9 t -66.18 -44.51 91.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.553 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.5 m -62.43 -44.55 96.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.684 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 46.1 tp -62.45 -41.44 98.74 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.543 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 71.8 m -58.1 -44.65 87.79 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.164 -179.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -63.93 -62.53 5.15 Favored Glycine 0 N--CA 1.468 0.795 0 N-CA-C 110.844 -0.903 . . . . 0.0 110.844 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.7 t -48.09 -35.51 11.49 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 20.0 mt -61.89 -44.1 97.5 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.615 -0.434 . . . . 0.0 111.397 179.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.3 mp -65.57 -41.45 92.91 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.415 177.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.41 -41.48 98.72 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.856 -179.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.1 tp -87.44 17.22 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.915 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 56.33 84.37 0.09 Allowed 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.76 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.96 59.74 0.1 OUTLIER Pre-proline 0 C--N 1.328 -0.369 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -51.85 151.56 15.3 Favored 'Trans proline' 0 C--N 1.292 -2.4 0 C-N-CA 123.079 2.519 . . . . 0.0 112.041 -178.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.434 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -108.46 145.04 15.94 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.191 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.29 -179.65 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.8 mt -63.72 -45.47 97.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.46 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.495 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -129.42 134.1 47.67 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.537 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.503 ' O ' ' N ' ' A' ' 98' ' ' LEU . 74.6 m -134.94 158.84 43.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.859 -179.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.61 139.07 16.22 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.608 -0.997 . . . . 0.0 110.608 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.438 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.71 -162.97 0.09 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.962 0.41 . . . . 0.0 110.486 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.477 ' O ' ' C ' ' A' ' 71' ' ' THR . 5.7 t -134.0 134.88 43.0 Favored 'General case' 0 CA--C 1.519 -0.25 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.477 ' C ' ' O ' ' A' ' 70' ' ' THR . 1.0 OUTLIER 29.69 68.29 0.67 Allowed Pre-proline 0 N--CA 1.467 0.415 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.816 -179.646 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_exo -61.63 144.94 97.91 Favored 'Trans proline' 0 C--N 1.299 -2.074 0 C-N-CA 122.617 2.211 . . . . 0.0 111.732 -177.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.51 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 45.8 p-10 -158.72 -31.76 0.07 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.668 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.51 ' N ' ' OD1' ' A' ' 73' ' ' ASN . 99.1 m-20 -64.21 -39.45 94.0 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.41 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -60.49 -47.95 83.88 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.44 -178.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.42 ' O ' ' O ' ' A' ' 77' ' ' ALA . 93.4 t -60.56 -24.79 32.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.42 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -45.88 173.35 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.665 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.574 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.3 p30 -61.93 177.36 0.45 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.622 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.603 ' C ' ' H ' ' A' ' 81' ' ' GLY . 36.0 p30 -45.3 85.28 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.011 0.434 . . . . 0.0 111.13 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.574 ' N ' ' O ' ' A' ' 78' ' ' ASP . 42.7 tp60 -67.33 13.39 0.07 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.212 0.529 . . . . 0.0 110.092 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.603 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 118.49 -22.44 9.45 Favored Glycine 0 N--CA 1.461 0.362 0 N-CA-C 110.921 -0.871 . . . . 0.0 110.921 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -107.85 116.45 31.97 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.992 0.425 . . . . 0.0 110.456 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 74.6 mt -98.12 -0.1 45.01 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.972 0.415 . . . . 0.0 110.55 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -92.7 7.14 44.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.029 0.442 . . . . 0.0 110.377 -179.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.445 ' O ' ' CG2' ' A' ' 89' ' ' VAL . 88.3 mt-30 -100.32 -27.68 13.35 Favored 'General case' 0 C--O 1.219 -0.545 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.813 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.3 t-105 -64.5 -40.53 95.83 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.089 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.549 ' O ' ' N ' ' A' ' 91' ' ' LYS . 63.1 m -77.78 -55.22 5.51 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.181 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -46.86 -50.08 19.16 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.243 -179.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.445 ' CG2' ' O ' ' A' ' 85' ' ' GLN . 14.2 m -69.5 -40.96 80.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.303 179.46 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.407 ' H ' HG23 ' A' ' 89' ' ' VAL . . . -72.01 -22.63 61.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.688 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.549 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.1 tttm -62.47 -45.75 91.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.316 -179.402 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.438 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.6 mm-40 -90.01 -94.02 0.12 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.998 0.428 . . . . 0.0 110.115 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.612 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.9 mtt180 -143.61 58.52 1.38 Allowed 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.445 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.7 pttp 34.01 26.5 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.064 0.459 . . . . 0.0 110.229 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.612 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.6 tt -48.89 123.01 6.36 Favored 'General case' 0 N--CA 1.444 -0.725 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.005 -177.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -83.42 -169.6 2.63 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.212 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.616 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 81.9 mtp180 -74.61 136.88 42.0 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.272 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.503 ' N ' ' O ' ' A' ' 67' ' ' SER . 91.5 mt -85.34 -165.77 1.31 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.877 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.54 ' CD2' ' O ' ' A' ' 99' ' ' TYR . 47.1 p90 -169.05 119.33 0.71 Allowed 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.044 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.502 ' C ' ' O ' ' A' ' 99' ' ' TYR . 42.9 mm -28.31 120.44 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 O-C-N 123.316 0.385 . . . . 0.0 111.192 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 114.67 27.02 3.42 Favored Glycine 0 N--CA 1.461 0.308 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 -179.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.574 ' N ' ' CD ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -144.44 46.51 0.63 Allowed Pre-proline 0 C--N 1.322 -0.612 0 CA-C-O 121.126 0.489 . . . . 0.0 110.442 179.798 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.574 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 28.5 Cg_endo -62.09 144.19 95.69 Favored 'Trans proline' 0 C--N 1.293 -2.346 0 C-N-CA 122.68 2.253 . . . . 0.0 111.686 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.701 ' HG ' ' H ' ' A' ' 107' ' ' ALA . 26.5 t -173.12 120.18 0.35 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.325 179.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.78 -40.27 63.56 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.038 0.447 . . . . 0.0 111.131 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.25 -39.81 89.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.877 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.701 ' H ' ' HG ' ' A' ' 104' ' ' SER . . . -64.3 -39.77 94.59 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.772 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 70.5 t -67.6 -43.81 86.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.686 179.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.94 -38.93 93.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.506 -179.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.438 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.71 -23.45 63.16 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.5 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.53 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.4 mm-40 -90.55 5.31 48.34 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.748 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.54 ' O ' ' NE ' ' A' ' 45' ' ' ARG . 10.6 tpt 23.01 64.41 0.36 Allowed Pre-proline 0 N--CA 1.468 0.45 0 CA-C-O 120.935 0.397 . . . . 0.0 111.312 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -78.65 167.42 22.55 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 123.095 2.53 . . . . 0.0 111.6 -177.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.52 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 99.0 m-20 -109.78 -41.95 4.39 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.046 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.6 tp -121.23 120.7 35.95 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 84.3 mt -113.2 128.75 69.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 CA-C-O 120.89 0.376 . . . . 0.0 110.968 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 31.1 mt -109.6 132.09 54.46 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.207 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 98.9 mt -119.67 138.68 49.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.634 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 85.2 p -72.16 153.9 41.37 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.583 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.08 -50.37 73.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.646 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.0 t -149.61 154.16 38.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.563 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 170.85 -170.85 43.5 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -63.08 -33.99 88.75 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.44 ' O ' ' OD1' ' A' ' 124' ' ' ASP . 43.9 p-10 -86.87 120.42 28.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.815 0.341 . . . . 0.0 110.713 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 38.5 t -62.97 143.5 57.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.072 0.463 . . . . 0.0 110.33 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.513 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -92.82 -43.26 9.09 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.91 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.2 tp -63.04 -42.56 99.77 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.729 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.32 -11.9 58.77 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.47 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 84.8 mt -115.09 -23.87 8.82 Favored 'General case' 0 C--O 1.225 -0.228 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.631 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . 0.513 ' N ' ' O ' ' A' ' 126' ' ' ALA . 79.7 t80 -51.46 -49.45 61.74 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.578 -178.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.8 p-10 -66.01 -42.41 89.75 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.773 -0.371 . . . . 0.0 111.364 179.227 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.504 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 88.3 mt-30 -67.16 -37.64 84.1 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.862 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 96.4 mt -80.36 -41.64 24.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.885 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.3 t -57.09 -44.48 83.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.294 -179.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.7 m -62.09 -45.2 94.54 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.505 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 94.1 mt -62.23 -43.61 98.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.216 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -168.98 168.73 5.01 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.608 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -50.4 112.89 0.83 Allowed 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.24 1.96 . . . . 0.0 112.431 179.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 24.0 m -84.52 127.44 34.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.679 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 34.8 tp -117.88 137.15 52.99 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.009 0.433 . . . . 0.0 110.09 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.439 ' O ' ' OD2' ' A' ' 32' ' ' ASP . 81.9 mt -100.79 118.94 48.24 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.303 0 CA-C-O 121.203 0.525 . . . . 0.0 111.161 -179.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 97.9 mt -134.97 132.34 53.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.531 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.426 HD22 ' CG ' ' A' ' 241' ' ' ASP . 56.1 t30 -67.8 154.12 42.23 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.979 0.418 . . . . 0.0 110.472 179.26 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.528 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 89.8 t80 -87.81 122.53 31.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.866 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.528 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 99.1 m-20 55.14 69.38 0.74 Allowed 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.655 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 49.6 p-10 -123.6 -0.53 8.62 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.865 0.364 . . . . 0.0 110.646 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -151.14 116.19 5.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.736 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' SER . . . . . 0.502 ' HG ' ' H ' ' A' ' 150' ' ' GLN . 82.7 p -62.64 167.5 4.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.582 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.407 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.6 p-90 -51.62 -16.12 0.58 Allowed 'General case' 0 C--O 1.221 -0.44 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.33 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . 0.502 ' H ' ' HG ' ' A' ' 148' ' ' SER . 68.1 tp60 -70.36 -75.4 0.12 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.94 0.4 . . . . 0.0 110.505 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.436 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.1 t -62.71 -39.11 93.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.211 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 56.0 tp -59.76 -45.69 91.47 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.417 -178.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.407 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 46.6 tp -62.7 -41.69 99.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.588 178.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.436 ' OG1' ' O ' ' A' ' 151' ' ' SER . 59.3 p -64.43 -35.02 79.57 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.145 -179.281 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . 0.439 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.5 mm-40 -63.97 -42.79 97.14 Favored 'General case' 0 C--O 1.225 -0.196 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.391 179.351 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 91.8 mt -65.39 -38.74 90.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.17 0.509 . . . . 0.0 110.27 179.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.568 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.48 -32.17 80.19 Favored Glycine 0 C--N 1.331 0.295 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 -179.144 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.439 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.3 mt-10 -35.65 -27.0 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.826 0.346 . . . . 0.0 110.833 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.568 ' N ' ' O ' ' A' ' 157' ' ' GLY . 95.0 mt -55.65 150.26 2.61 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.333 178.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 77.5 p -69.67 137.24 51.99 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.049 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 70.36 22.24 77.57 Favored Glycine 0 N--CA 1.458 0.149 0 N-CA-C 111.266 -0.733 . . . . 0.0 111.266 179.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 57.8 m80 -123.15 -13.86 7.64 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.599 0.237 . . . . 0.0 110.481 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -66.68 -59.47 3.56 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.657 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -52.32 -49.42 64.29 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.196 -179.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -60.38 -41.29 93.47 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.819 0.342 . . . . 0.0 110.445 179.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.41 -47.23 86.75 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.509 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.79 -40.23 75.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.271 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -61.78 -50.09 73.76 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.626 179.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -65.27 -43.54 90.94 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.59 179.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 94.1 mt -64.79 -43.29 96.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.406 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.55 -51.33 69.91 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.339 -179.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -63.37 -44.01 95.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.869 0.366 . . . . 0.0 110.708 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . 0.485 ' CD1' ' OH ' ' A' ' 301' ' ' TYR . 54.8 t80 -63.08 -44.33 96.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.146 0.498 . . . . 0.0 110.394 179.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -63.71 -39.7 94.95 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.634 -179.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -63.12 -42.82 99.59 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.528 179.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -60.72 -44.54 96.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.209 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 85.0 mt -64.73 -41.08 96.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.764 178.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.34 -62.18 1.8 Allowed 'General case' 0 C--O 1.239 0.527 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.363 -179.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.41 -47.1 85.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.459 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -52.85 -41.73 64.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.381 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -63.87 -33.74 76.38 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.325 179.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 69.6 tt0 -90.76 9.0 31.79 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.6 0.714 . . . . 0.0 110.312 -178.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -104.94 -32.01 8.97 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.221 179.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.4 pt -128.0 147.61 32.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.79 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -140.06 131.34 26.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.986 0.422 . . . . 0.0 110.36 179.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . 0.553 ' CD2' ' N ' ' A' ' 186' ' ' LEU . 3.5 mm? -85.66 133.38 41.94 Favored Pre-proline 0 N--CA 1.451 -0.403 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.177 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -43.79 157.96 0.12 Allowed 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.657 2.238 . . . . 0.0 112.374 179.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . 0.498 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.5 Cg_endo -62.89 114.72 2.54 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.829 2.353 . . . . 0.0 111.658 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . 0.498 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.7 mt-30 155.52 148.07 0.0 OUTLIER Pre-proline 0 N--CA 1.456 -0.145 0 O-C-N 124.208 0.942 . . . . 0.0 110.874 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -73.28 144.44 36.98 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.633 2.222 . . . . 0.0 112.282 177.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.488 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.1 p -124.74 158.95 31.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.449 0.643 . . . . 0.0 110.143 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' THR . . . . . 0.488 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 37.6 p -143.3 165.29 27.89 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.133 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -135.18 128.79 32.68 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-O 121.314 0.578 . . . . 0.0 110.173 179.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 47.3 pt -146.34 148.62 16.88 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.375 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.249 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 69.2 t -117.41 123.26 71.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 CA-C-O 121.36 0.6 . . . . 0.0 109.791 178.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -134.55 107.33 7.47 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 121.144 0.497 . . . . 0.0 110.254 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 94.8 m -130.92 130.67 43.77 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.855 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -82.65 -36.9 25.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.208 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.53 -67.2 0.25 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.318 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.58 -9.99 59.25 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.266 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 59.9 t-80 60.53 58.68 2.42 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.722 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 39.1 p -166.88 153.75 8.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.53 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.2 144.25 24.61 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.022 0.439 . . . . 0.0 110.457 179.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -135.05 137.13 42.62 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.548 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 19.4 mt -105.5 125.42 50.97 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.061 0.457 . . . . 0.0 109.867 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' TRP . . . . . 0.555 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 76.6 m95 -81.81 166.52 19.93 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.572 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -156.67 171.58 7.23 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.561 -178.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -54.01 -36.91 85.82 Favored 'Trans proline' 0 C--N 1.301 -1.965 0 C-N-CA 122.664 2.243 . . . . 0.0 112.397 178.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -70.66 -34.86 72.49 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.653 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 22.3 m -61.43 149.7 37.73 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.626 -179.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.58 -36.51 80.86 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.431 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' GLN . . . . . 0.555 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 55.3 tt0 -64.93 -40.5 95.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.53 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.27 -43.66 92.42 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -63.29 -43.06 98.95 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 64.9 ttp -59.25 -48.24 82.37 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 87.5 mt -60.53 -40.97 93.43 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' GLU . . . . . 0.448 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 40.7 tp10 -57.9 -38.11 75.23 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -65.19 -38.12 89.48 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.632 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 94.2 mt -64.16 -43.11 96.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.186 0.517 . . . . 0.0 110.529 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 138.27 45.38 0.08 OUTLIER Glycine 0 C--N 1.334 0.453 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' PHE . . . . . 0.448 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 27.2 m-85 -128.98 156.56 43.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.084 0.469 . . . . 0.0 110.463 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' THR . . . . . 0.451 ' O ' ' O ' ' A' ' 191' ' ' VAL . 7.7 p -108.66 123.22 48.64 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.311 0.577 . . . . 0.0 110.002 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . 0.439 ' CD2' ' N ' ' A' ' 223' ' ' LEU . 4.3 mm? -101.55 133.11 46.73 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.128 179.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -97.07 159.42 14.92 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.487 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -104.64 115.1 29.74 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.949 0.404 . . . . 0.0 110.375 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.448 ' CD1' ' N ' ' A' ' 226' ' ' LEU . 8.9 mp -53.48 156.62 4.19 Favored Pre-proline 0 N--CA 1.449 -0.495 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.827 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -59.75 145.04 99.23 Favored 'Trans proline' 0 C--N 1.299 -2.03 0 C-N-CA 122.726 2.284 . . . . 0.0 112.363 179.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.51 -2.72 58.81 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.51 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.37 -40.66 5.68 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . 0.533 ' O ' ' N ' ' A' ' 233' ' ' SER . 69.4 mt -79.12 -17.2 55.5 Favored 'General case' 0 C--O 1.219 -0.505 0 CA-C-O 121.1 0.476 . . . . 0.0 110.261 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 54.5 t-20 -40.3 -48.77 2.69 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.751 0.31 . . . . 0.0 110.78 -179.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -88.36 15.45 7.75 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.433 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' SER . . . . . 0.533 ' N ' ' O ' ' A' ' 230' ' ' LEU . 77.7 p -60.78 -35.36 76.25 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.724 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . 0.521 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.6 tt0 -118.54 -69.62 0.84 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.864 179.312 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 3.9 m -70.54 103.06 2.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.702 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -94.67 58.29 2.3 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.052 0.453 . . . . 0.0 110.333 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -145.31 -122.63 1.53 Allowed Glycine 0 C--N 1.332 0.342 0 N-CA-C 110.964 -0.855 . . . . 0.0 110.964 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -133.78 111.98 10.97 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.101 0.477 . . . . 0.0 110.398 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . 0.505 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.1 mtt180 -148.42 56.93 1.05 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.742 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -69.37 -31.78 70.41 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.47 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 241' ' ' ASP . . . . . 0.455 ' OD2' ' O ' ' A' ' 144' ' ' TYR . 64.9 t0 -56.67 -47.01 80.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.291 -178.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 242' ' ' ILE . . . . . 0.44 ' O ' ' O ' ' A' ' 239' ' ' ARG . 17.3 tt -140.46 157.48 24.43 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 CA-C-O 120.91 0.386 . . . . 0.0 110.485 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 95.8 mt -105.93 106.3 20.32 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.219 0 CA-C-O 121.165 0.507 . . . . 0.0 110.425 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . 0.505 ' OE1' ' NH1' ' A' ' 239' ' ' ARG . 88.3 mt-30 -110.86 110.4 20.99 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.366 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 9.8 mp -121.78 -167.86 1.6 Allowed 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.627 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . 0.521 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 172.39 -16.04 0.05 OUTLIER Glycine 0 CA--C 1.524 0.596 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . 0.686 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -60.96 157.56 31.07 Favored Glycine 0 CA--C 1.521 0.463 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -63.86 20.87 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.941 0.401 . . . . 0.0 110.581 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . 0.686 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.9 m-20 -96.86 -5.84 37.3 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.528 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 92.5 mt -80.19 -21.45 42.96 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.839 179.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.63 -51.43 69.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.663 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.96 -5.21 58.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.465 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.03 -74.23 1.15 Allowed Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 82.0 mt -70.31 126.15 28.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.014 0.435 . . . . 0.0 110.172 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -59.97 -39.3 85.19 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.274 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 83.11 51.67 4.09 Favored Glycine 0 CA--C 1.519 0.3 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -95.15 -16.05 22.87 Favored 'General case' 0 C--N 1.331 -0.212 0 O-C-N 122.694 -0.297 . . . . 0.0 110.585 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 258' ' ' SER . . . . . 0.44 ' HG ' ' CG2' ' A' ' 191' ' ' VAL . 3.4 t 175.19 89.42 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.182 0.515 . . . . 0.0 110.053 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . 0.59 ' N ' ' CD1' ' A' ' 259' ' ' LEU . 1.0 OUTLIER -94.77 124.56 38.88 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.273 0.559 . . . . 0.0 111.253 -179.094 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 15.8 m-30 -93.95 146.65 23.77 Favored 'General case' 0 CA--C 1.497 -1.086 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.4 179.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 86.4 mt -122.32 149.54 43.6 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.573 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.654 ' CG ' ' N ' ' A' ' 263' ' ' ALA . 2.6 p90 -77.69 -138.91 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.506 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 263' ' ' ALA . . . . . 0.654 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -51.08 77.59 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 121.109 0.48 . . . . 0.0 111.303 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . 0.624 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.93 104.57 0.18 Allowed Glycine 0 CA--C 1.527 0.816 0 N-CA-C 110.466 -1.054 . . . . 0.0 110.466 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 265' ' ' ASP . . . . . 0.589 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.6 m-20 -80.06 -177.94 6.28 Favored 'General case' 0 C--N 1.327 -0.407 0 O-C-N 122.706 -0.291 . . . . 0.0 111.001 -179.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -40.44 -17.81 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.587 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 267' ' ' LYS . . . . . 0.589 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.0 -51.76 43.49 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.013 0.435 . . . . 0.0 110.684 179.125 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -63.68 -46.49 85.29 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.266 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . 0.521 ' O ' ' CD2' ' A' ' 273' ' ' TYR . . . -61.76 -34.81 76.53 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 121.543 0.687 . . . . 0.0 109.746 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -63.42 -34.23 77.3 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.076 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.51 -43.11 13.83 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.112 -179.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 272' ' ' ILE . . . . . 0.62 ' C ' ' H ' ' A' ' 274' ' ' ALA . 4.9 tt -51.44 -33.97 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.799 -178.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 273' ' ' TYR . . . . . 0.521 ' CD2' ' O ' ' A' ' 269' ' ' ALA . 16.9 m-85 -54.43 -2.03 0.03 OUTLIER 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.615 -179.289 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 274' ' ' ALA . . . . . 0.62 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.2 -39.63 71.66 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.868 179.434 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . 0.579 ' O ' ' N ' ' A' ' 279' ' ' ALA . 3.9 p30 -38.78 97.71 0.14 Allowed Pre-proline 0 N--CA 1.462 0.157 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.385 -179.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.7 -42.57 67.27 Favored 'Trans proline' 0 C--N 1.303 -1.865 0 C-N-CA 122.367 2.045 . . . . 0.0 112.506 -178.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 88.9 mt -64.43 -42.83 95.78 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.092 0.472 . . . . 0.0 111.225 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 91.9 mt -95.97 -1.08 49.8 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.954 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 279' ' ' ALA . . . . . 0.579 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.38 -34.83 77.47 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.683 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.22 20.16 0.11 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.982 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . 0.516 ' H ' ' C ' ' A' ' 279' ' ' ALA . 13.6 mt -74.67 119.39 76.43 Favored Pre-proline 0 N--CA 1.444 -0.731 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.834 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -49.87 -40.1 48.74 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.623 2.215 . . . . 0.0 112.327 178.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.86 -50.59 63.48 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.034 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 73.5 t -61.45 -43.85 97.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.096 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -57.64 -41.15 80.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.098 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -91.01 0.05 57.63 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.118 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt 59.94 43.67 14.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.048 0.452 . . . . 0.0 110.772 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -95.01 41.06 1.1 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.382 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 53.8 t -119.33 135.74 58.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-O 121.133 0.492 . . . . 0.0 110.033 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -133.47 163.62 28.98 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 121.236 0.541 . . . . 0.0 110.569 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.8 155.58 32.28 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 121.097 0.475 . . . . 0.0 110.645 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 82.1 mt -94.44 -1.56 53.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.232 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.03 165.38 12.66 Favored Glycine 0 N--CA 1.463 0.489 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 6.7 m -86.64 -61.59 1.7 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.849 0.356 . . . . 0.0 111.092 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 295' ' ' GLU . . . . . 0.488 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.6 mm-40 -69.53 -4.82 20.57 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.729 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 26.8 p -76.55 32.61 0.13 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.632 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 297' ' ' PHE . . . . . 0.488 ' H ' ' C ' ' A' ' 295' ' ' GLU . 67.1 t80 -60.4 -46.18 90.92 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.672 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . 0.616 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.2 mtt85 -80.32 136.93 36.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.657 -179.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -114.61 116.71 29.18 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.994 0.426 . . . . 0.0 110.533 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . 0.627 ' H ' ' HG ' ' A' ' 303' ' ' SER . 48.7 p-10 -167.21 -174.59 2.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.616 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 301' ' ' TYR . . . . . 0.485 ' OH ' ' CD1' ' A' ' 173' ' ' PHE . 80.4 t80 -48.13 -44.44 32.09 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.227 -179.465 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -65.51 -41.53 93.07 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.034 0.445 . . . . 0.0 110.662 178.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 303' ' ' SER . . . . . 0.627 ' HG ' ' H ' ' A' ' 300' ' ' ASP . 53.8 p -55.29 -36.29 65.99 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.952 -179.087 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -57.07 -52.09 66.66 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 91.7 mtp -55.96 -44.32 78.35 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -66.05 -42.87 88.96 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.172 0.51 . . . . 0.0 110.199 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 55.7 t -63.91 -43.03 97.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.245 179.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 42.4 tp -60.04 -41.98 93.47 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.803 -179.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -62.18 -39.16 91.76 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.211 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 310' ' ' ARG . . . . . 0.45 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.7 ttt85 -63.68 -43.91 95.26 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.227 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 89.4 mt -63.1 -42.08 99.5 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.364 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -63.06 -33.77 76.14 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.076 179.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.38 -23.56 22.16 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.346 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . 0.45 ' N ' ' O ' ' A' ' 310' ' ' ARG . 6.8 tt -62.35 -43.06 99.71 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 121.128 0.489 . . . . 0.0 110.56 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 . . . . . 0 C--O 1.22 -0.47 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.327 -179.831 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -99.67 136.29 39.82 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.04 0.448 . . . . 0.0 110.44 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.492 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -91.54 178.41 1.78 Allowed Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.584 -179.87 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.492 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.1 Cg_exo -61.72 147.66 94.82 Favored 'Trans proline' 0 C--N 1.3 -2.001 0 C-N-CA 122.882 2.388 . . . . 0.0 112.182 179.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 35.1 ptt180 -135.35 142.36 45.75 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.567 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -78.91 116.9 19.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.515 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.6 tp -110.35 131.0 62.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.478 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.9 t -70.81 142.41 51.3 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.62 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.424 ' OD1' ' O ' ' A' ' 141' ' ' ILE . 24.7 t70 -140.56 177.58 7.92 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.508 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.448 ' OG ' ' O ' ' A' ' 141' ' ' ILE . 77.9 p -73.81 -36.38 64.98 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.556 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 60.1 ttt85 -47.69 -95.22 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.409 -179.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.426 ' O ' ' OG1' ' A' ' 36' ' ' THR . . . -165.42 -25.51 0.02 OUTLIER Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' A' ' 35' ' ' GLY . 61.2 m -169.05 106.82 0.42 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.844 0.354 . . . . 0.0 110.63 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 33.2 t60 -129.61 144.57 51.33 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.022 0.439 . . . . 0.0 110.199 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.482 ' CG2' ' N ' ' A' ' 39' ' ' LEU . 96.9 m -128.63 166.5 18.77 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.455 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.482 ' N ' ' CG2' ' A' ' 38' ' ' THR . 80.7 mt -121.15 127.52 51.63 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.506 179.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -63.8 -44.4 93.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.709 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 39.6 p -165.84 154.95 11.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.439 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.454 ' N ' ' CD ' ' A' ' 42' ' ' GLN . 14.3 mp0 -43.07 100.64 0.23 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.574 179.433 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -56.94 128.99 32.16 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 122.492 2.128 . . . . 0.0 112.201 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -83.33 -24.35 32.15 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.587 179.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.538 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.5 mtm-85 -121.16 134.48 55.22 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.113 0.482 . . . . 0.0 110.276 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.2 mt -130.09 133.57 64.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.74 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 47.9 t -125.26 130.94 72.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.203 179.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.506 ' O ' ' O ' ' A' ' 66' ' ' ALA . 4.1 m -154.57 166.34 33.63 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.607 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 72.2 p -124.6 8.83 8.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.429 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.72 125.73 33.43 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.587 -179.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 87.8 t -65.68 -44.63 93.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.493 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 18.1 m -62.79 -44.16 96.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.616 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 53.0 tp -62.37 -41.63 98.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.53 -179.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 76.3 m -57.67 -44.74 85.96 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.329 -179.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.4 -62.4 5.14 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.5 t -47.52 -35.96 9.65 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.681 0.277 . . . . 0.0 110.279 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.7 mt -61.77 -44.34 97.08 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.087 179.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.4 HD12 ' N ' ' A' ' 58' ' ' LEU . 8.9 mp -65.39 -41.23 93.9 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.137 178.262 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.86 -41.25 97.81 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.78 -179.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 7.9 tp -88.1 16.77 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.843 -179.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 56.4 84.43 0.09 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.727 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 178.89 57.7 0.07 OUTLIER Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.269 -0.423 . . . . 0.0 109.951 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -51.09 153.83 8.51 Favored 'Trans proline' 0 C--N 1.296 -2.216 0 C-N-CA 123.035 2.49 . . . . 0.0 111.999 -177.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.428 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -109.33 146.15 15.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.366 -179.631 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.67 -45.44 97.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.15 -179.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.506 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -129.83 134.69 47.7 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.883 0.373 . . . . 0.0 110.522 -179.6 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.489 ' O ' ' N ' ' A' ' 98' ' ' LEU . 72.3 m -134.87 158.96 42.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.765 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.92 139.35 16.21 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.451 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.8 -162.67 0.08 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.876 0.369 . . . . 0.0 110.49 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.488 ' O ' ' C ' ' A' ' 71' ' ' THR . 5.8 t -133.76 135.82 44.16 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.256 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.488 ' C ' ' O ' ' A' ' 70' ' ' THR . 1.0 OUTLIER 29.51 68.73 0.64 Allowed Pre-proline 0 N--CA 1.464 0.26 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.74 -179.487 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -61.43 144.79 98.37 Favored 'Trans proline' 0 C--N 1.301 -1.93 0 C-N-CA 122.697 2.265 . . . . 0.0 111.815 -178.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.528 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 45.3 p-10 -160.08 -32.3 0.06 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.592 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.528 ' N ' ' OD1' ' A' ' 73' ' ' ASN . 99.0 m-20 -64.04 -39.51 94.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.358 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 73.2 ttt180 -60.18 -48.41 81.83 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.548 -179.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.426 ' O ' ' O ' ' A' ' 77' ' ' ALA . 94.9 t -59.82 -25.05 31.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.096 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.426 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -45.35 172.67 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.636 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.573 ' O ' ' N ' ' A' ' 80' ' ' GLN . 54.1 p30 -61.94 177.64 0.43 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.483 -179.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.598 ' C ' ' H ' ' A' ' 81' ' ' GLY . 34.4 p30 -46.28 85.58 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.957 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.573 ' N ' ' O ' ' A' ' 78' ' ' ASP . 42.9 tp60 -67.17 13.69 0.06 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.298 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.598 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 118.09 -21.98 9.94 Favored Glycine 0 CA--C 1.519 0.316 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -107.94 116.67 32.38 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.946 0.403 . . . . 0.0 110.469 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 75.4 mt -99.23 0.38 43.08 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.582 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -91.88 6.81 44.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.374 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.441 ' O ' ' CG2' ' A' ' 89' ' ' VAL . 88.0 mt-30 -100.03 -28.04 13.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.704 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 68.4 t-105 -63.43 -40.5 97.34 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.821 -179.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.552 ' O ' ' N ' ' A' ' 91' ' ' LYS . 67.9 m -77.75 -53.81 7.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.837 -179.276 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -48.25 -50.95 27.73 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.936 -179.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.441 ' CG2' ' O ' ' A' ' 85' ' ' GLN . 15.8 m -68.96 -40.44 81.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.992 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.413 ' H ' HG23 ' A' ' 89' ' ' VAL . . . -72.47 -22.6 61.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.624 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.552 ' N ' ' O ' ' A' ' 87' ' ' SER . 65.9 tttm -61.5 -45.95 92.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.429 -179.525 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.435 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.8 mm-40 -90.38 -94.48 0.12 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.251 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.624 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.9 mtt180 -143.34 59.58 1.4 Allowed 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.456 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.6 pttp 33.76 26.35 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.021 0.439 . . . . 0.0 110.388 -179.028 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.624 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.4 tt -48.09 123.07 5.78 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.912 -178.14 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -83.21 -170.68 3.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.224 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.624 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 82.9 mtp180 -73.01 137.67 45.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.329 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.489 ' N ' ' O ' ' A' ' 67' ' ' SER . 88.9 mt -86.41 -165.87 1.39 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.782 -179.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.533 ' CD2' ' O ' ' A' ' 99' ' ' TYR . 47.7 p90 -168.29 119.7 0.81 Allowed 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.23 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.507 ' C ' ' O ' ' A' ' 99' ' ' TYR . 42.8 mm -29.29 121.43 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.935 -179.781 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 113.6 28.05 3.36 Favored Glycine 0 CA--C 1.521 0.417 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 -179.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.581 ' N ' ' CD ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -143.96 46.11 0.62 Allowed Pre-proline 0 C--N 1.324 -0.521 0 CA-C-O 121.044 0.45 . . . . 0.0 110.479 179.874 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.581 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 29.8 Cg_endo -62.47 143.83 93.82 Favored 'Trans proline' 0 C--N 1.298 -2.13 0 C-N-CA 122.728 2.286 . . . . 0.0 111.834 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 26.2 t -173.14 120.68 0.36 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.435 179.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.4 -41.07 63.78 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.866 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -65.73 -39.95 91.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.744 -179.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.77 -39.56 94.55 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.681 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 71.3 t -67.78 -43.58 86.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.659 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.57 -39.28 93.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.491 -179.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.435 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.68 -23.9 63.49 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.508 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.562 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.3 mm-40 -91.32 5.11 50.54 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.658 -179.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.562 ' C ' ' O ' ' A' ' 111' ' ' GLN . 9.5 tpt 21.01 65.51 0.28 Allowed Pre-proline 0 N--CA 1.465 0.299 0 CA-C-O 121.042 0.449 . . . . 0.0 111.116 -179.575 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -79.92 170.03 17.18 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 123.018 2.479 . . . . 0.0 111.617 -178.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.52 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 98.9 m-20 -112.52 -44.25 3.38 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.182 179.464 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 39.4 tp -120.18 121.35 38.56 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.142 179.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 96.6 mt -118.61 131.29 71.83 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.851 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 32.2 mt -105.95 132.01 52.56 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.222 -179.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 98.3 mt -117.26 136.08 55.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.641 -179.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 85.0 p -71.68 151.85 43.31 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.559 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.26 -50.01 75.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.633 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -149.35 153.77 37.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.542 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 168.57 -169.32 41.58 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -63.13 -35.41 92.05 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.447 ' O ' ' OD1' ' A' ' 124' ' ' ASP . 44.2 p-10 -88.81 120.12 29.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.859 0.362 . . . . 0.0 110.643 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 40.6 t -63.35 144.62 56.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.467 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.518 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.92 -42.76 8.9 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.745 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.4 tp -62.79 -42.36 99.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.669 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.99 -10.59 54.74 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.483 -179.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 84.0 mt -115.73 -24.57 8.17 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.591 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . 0.518 ' N ' ' O ' ' A' ' 126' ' ' ALA . 74.3 t80 -50.77 -49.93 57.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.65 -179.109 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.3 p-10 -65.89 -41.91 90.92 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.827 0.346 . . . . 0.0 111.132 179.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.526 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 87.8 mt-30 -68.08 -36.72 80.29 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.804 -179.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 96.5 mt -80.09 -42.78 22.95 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.864 -179.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.402 ' N ' ' OG1' ' A' ' 139' ' ' THR . 11.5 t -56.76 -45.47 82.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.452 -179.337 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 20.0 m -62.38 -45.93 90.91 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.568 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 93.2 mt -62.19 -43.84 98.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.463 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -170.04 163.04 6.53 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.598 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -41.54 110.6 0.14 Allowed 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.629 2.219 . . . . 0.0 112.224 179.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' THR . . . . . 0.402 ' OG1' ' N ' ' A' ' 134' ' ' SER . 3.0 m -87.79 127.11 35.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.62 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 35.1 tp -119.24 139.42 51.91 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.36 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.448 ' O ' ' OG ' ' A' ' 33' ' ' SER . 79.7 mt -105.41 120.27 55.87 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.197 0 CA-C-O 121.1 0.476 . . . . 0.0 110.942 -179.161 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 94.7 mt -136.43 132.6 49.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.562 179.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.514 HD22 ' CG ' ' A' ' 241' ' ' ASP . 54.3 t30 -64.55 148.99 49.62 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.91 0.386 . . . . 0.0 110.475 179.299 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.453 ' O ' ' OD2' ' A' ' 241' ' ' ASP . 87.1 t80 -82.72 122.85 28.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.84 -179.333 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.442 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 91.6 m-20 55.01 69.67 0.71 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.753 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 49.3 p-10 -124.4 0.25 8.27 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.579 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -151.53 117.31 5.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.723 -179.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' SER . . . . . 0.519 ' HG ' ' H ' ' A' ' 150' ' ' GLN . 85.0 p -63.89 168.68 4.87 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.504 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.415 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.6 p-90 -51.21 -15.89 0.42 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.424 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . 0.519 ' H ' ' HG ' ' A' ' 148' ' ' SER . 68.4 tp60 -70.9 -75.46 0.12 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.526 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.453 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.3 t -62.66 -38.58 90.88 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.318 179.473 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 51.1 tp -59.98 -45.88 91.28 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.421 -178.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.415 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 45.2 tp -62.64 -41.61 99.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.581 178.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.453 ' OG1' ' O ' ' A' ' 151' ' ' SER . 59.3 p -63.9 -34.87 78.94 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.298 -179.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . 0.494 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.4 mm-40 -63.56 -42.01 98.38 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.359 179.265 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 91.8 mt -65.6 -38.57 89.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.11 0.481 . . . . 0.0 110.341 178.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.568 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.58 -31.97 79.66 Favored Glycine 0 CA--C 1.52 0.399 0 N-CA-C 110.818 -0.913 . . . . 0.0 110.818 -179.393 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.494 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.3 mt-10 -36.99 -25.32 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.853 0.359 . . . . 0.0 110.772 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.568 ' N ' ' O ' ' A' ' 157' ' ' GLY . 92.9 mt -59.67 149.37 6.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.423 179.268 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 77.6 p -69.18 137.52 53.34 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.854 -179.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 70.54 22.26 77.81 Favored Glycine 0 CA--C 1.519 0.285 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 179.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 62.4 m80 -124.38 -14.12 6.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.715 0.293 . . . . 0.0 110.442 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -66.83 -59.87 3.16 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.579 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -51.3 -49.7 60.76 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.243 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -60.1 -41.13 91.86 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.474 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.5 -47.6 84.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.58 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.55 -40.07 74.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.331 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -61.67 -50.58 71.93 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.603 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -65.32 -43.66 90.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.572 179.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 94.3 mt -64.71 -43.15 96.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.432 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.27 -51.49 69.15 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.382 -179.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.51 -43.64 96.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.601 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . 0.52 ' CD1' ' OH ' ' A' ' 301' ' ' TYR . 55.9 t80 -62.94 -44.01 97.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.484 179.467 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -63.65 -39.72 95.05 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.403 -179.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -63.07 -42.83 99.74 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.537 179.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -60.46 -44.79 95.51 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.322 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 84.6 mt -64.65 -40.97 96.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.652 178.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.0 -62.5 1.59 Allowed 'General case' 0 C--O 1.237 0.438 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.357 -179.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.02 -47.27 83.55 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.51 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -52.65 -41.63 63.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.423 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -64.1 -33.2 75.23 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.361 179.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 69.5 tt0 -91.21 8.43 35.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.357 0.599 . . . . 0.0 110.423 -178.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -104.42 -32.26 9.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.037 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.4 pt -128.02 147.56 32.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.755 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -139.65 131.05 26.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.428 179.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . 0.551 ' CD2' ' N ' ' A' ' 186' ' ' LEU . 3.6 mm? -85.4 133.0 43.21 Favored Pre-proline 0 N--CA 1.452 -0.337 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.933 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -43.61 157.68 0.12 Allowed 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.689 2.259 . . . . 0.0 112.302 179.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . 0.522 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.7 Cg_endo -62.81 114.93 2.63 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 122.805 2.337 . . . . 0.0 111.862 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . 0.522 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.7 mt-30 155.52 147.75 0.0 OUTLIER Pre-proline 0 N--CA 1.456 -0.145 0 O-C-N 123.83 0.706 . . . . 0.0 110.823 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -73.4 143.83 35.52 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.643 2.228 . . . . 0.0 112.266 177.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.493 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.1 p -124.5 159.05 31.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.245 0.545 . . . . 0.0 110.305 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' THR . . . . . 0.493 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 37.9 p -143.47 165.03 28.68 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.922 -179.477 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -135.36 128.73 32.2 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 121.159 0.504 . . . . 0.0 110.33 179.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 47.5 pt -146.73 148.95 16.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.993 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 76.2 t -117.35 123.02 71.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.173 0.511 . . . . 0.0 110.079 178.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -134.22 106.46 7.16 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.371 179.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 95.9 m -130.48 130.71 44.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.763 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.411 ' O ' ' N ' ' A' ' 201' ' ' HIS . . . -82.95 -36.79 24.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.285 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.31 -67.07 0.26 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.348 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.31 -9.66 58.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.357 179.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . 0.411 ' N ' ' O ' ' A' ' 198' ' ' ALA . 60.2 t-80 60.72 58.19 2.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.694 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 41.1 p -167.43 153.61 7.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.569 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.27 144.18 24.51 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.953 0.406 . . . . 0.0 110.509 179.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -135.29 138.25 43.29 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.632 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 18.4 mt -105.98 125.12 50.62 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.0 0.428 . . . . 0.0 110.033 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 206' ' ' TRP . . . . . 0.558 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 74.1 m95 -81.84 167.2 19.26 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.596 -179.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -157.18 171.15 7.83 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.64 -179.056 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -53.1 -37.2 79.13 Favored 'Trans proline' 0 C--N 1.302 -1.907 0 C-N-CA 122.73 2.286 . . . . 0.0 112.377 179.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -70.96 -34.98 71.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.657 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 22.1 m -61.03 150.74 32.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.595 -179.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.46 -36.89 81.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.509 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 212' ' ' GLN . . . . . 0.558 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 54.8 tt0 -64.72 -40.29 95.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.625 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.78 -43.35 91.91 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -62.8 -44.37 96.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.807 0.337 . . . . 0.0 110.319 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 65.1 ttp -59.08 -48.27 82.2 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.233 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 87.6 mt -60.01 -41.36 91.96 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 179.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 217' ' ' GLU . . . . . 0.45 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 40.4 tp10 -57.84 -38.13 75.1 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.205 179.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -65.45 -38.23 89.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.633 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 95.1 mt -64.15 -42.95 96.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.578 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.74 45.39 0.08 OUTLIER Glycine 0 CA--C 1.521 0.456 0 N-CA-C 110.991 -0.843 . . . . 0.0 110.991 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 221' ' ' PHE . . . . . 0.45 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 25.8 m-85 -128.21 155.63 44.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.972 0.415 . . . . 0.0 110.536 -179.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 222' ' ' THR . . . . . 0.454 ' O ' ' O ' ' A' ' 191' ' ' VAL . 7.8 p -107.07 122.4 46.4 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.16 0.505 . . . . 0.0 110.231 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . 0.441 ' CD2' ' N ' ' A' ' 223' ' ' LEU . 4.3 mm? -101.78 132.94 47.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.924 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.76 160.36 14.42 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.527 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.72 115.08 29.63 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.35 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.45 ' CD1' ' N ' ' A' ' 226' ' ' LEU . 9.0 mp -53.1 156.42 3.7 Favored Pre-proline 0 N--CA 1.452 -0.345 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.726 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -59.62 145.2 98.75 Favored 'Trans proline' 0 C--N 1.302 -1.917 0 C-N-CA 122.771 2.314 . . . . 0.0 112.33 179.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.3 -3.15 59.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.498 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.19 -41.08 5.63 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . 0.519 ' O ' ' N ' ' A' ' 233' ' ' SER . 67.7 mt -79.05 -17.75 54.69 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-O 121.051 0.453 . . . . 0.0 110.427 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . 0.4 ' C ' ' O ' ' A' ' 230' ' ' LEU . 55.4 t-20 -40.05 -49.7 2.55 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.78 -179.496 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -87.67 15.19 7.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.096 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 233' ' ' SER . . . . . 0.519 ' N ' ' O ' ' A' ' 230' ' ' LEU . 78.0 p -60.24 -35.17 74.86 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.744 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . 0.522 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.6 tt0 -119.64 -69.4 0.85 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.765 179.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.0 m -69.7 101.88 1.77 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.614 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -93.67 57.73 2.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.413 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -144.56 -122.56 1.59 Allowed Glycine 0 CA--C 1.521 0.451 0 N-CA-C 110.906 -0.877 . . . . 0.0 110.906 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -135.4 111.21 9.38 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.017 0.436 . . . . 0.0 110.406 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . 0.527 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.6 mtt180 -147.79 58.27 1.11 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.678 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -69.6 -32.2 70.8 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.515 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 241' ' ' ASP . . . . . 0.514 ' CG ' HD22 ' A' ' 143' ' ' ASN . 64.7 t0 -56.9 -47.33 80.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.362 -179.208 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 242' ' ' ILE . . . . . 0.433 ' O ' ' O ' ' A' ' 239' ' ' ARG . 17.8 tt -139.61 155.98 25.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.503 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 96.2 mt -106.01 106.47 20.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-O 120.973 0.416 . . . . 0.0 110.496 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . 0.527 ' OE1' ' NH1' ' A' ' 239' ' ' ARG . 88.6 mt-30 -110.34 109.87 20.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.423 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 9.4 mp -121.63 -168.16 1.64 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.65 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . 0.522 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.85 -16.32 0.05 OUTLIER Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . 0.7 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -61.31 156.26 34.59 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -63.35 21.87 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.92 0.39 . . . . 0.0 110.622 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . 0.7 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.8 m-20 -97.32 -6.29 34.64 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.539 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 91.6 mt -79.58 -22.09 44.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.757 179.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.62 -51.65 69.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.645 -179.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.0 -5.6 58.42 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.52 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -80.98 -74.46 1.14 Allowed Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 81.2 mt -69.8 125.8 27.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.846 0.355 . . . . 0.0 110.38 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -59.24 -39.55 83.14 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.251 -179.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 83.32 51.73 4.03 Favored Glycine 0 CA--C 1.521 0.467 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -95.45 -15.57 22.87 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.715 0.293 . . . . 0.0 110.622 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 258' ' ' SER . . . . . 0.42 ' O ' ' O ' ' A' ' 192' ' ' THR . 3.5 t 174.59 89.0 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.07 0.462 . . . . 0.0 110.244 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . 0.595 ' N ' ' CD1' ' A' ' 259' ' ' LEU . 1.0 OUTLIER -94.21 124.04 37.98 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.127 0.489 . . . . 0.0 111.038 -178.92 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 16.0 m-30 -93.31 146.6 23.6 Favored 'General case' 0 CA--C 1.506 -0.722 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.481 179.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 85.4 mt -122.24 149.63 43.41 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.565 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.665 ' CG ' ' N ' ' A' ' 263' ' ' ALA . 2.6 p90 -77.56 -139.01 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.521 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 263' ' ' ALA . . . . . 0.665 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -51.29 77.44 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.997 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . 0.635 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.31 104.77 0.19 Allowed Glycine 0 CA--C 1.528 0.876 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 265' ' ' ASP . . . . . 0.6 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.7 m-20 -80.4 -177.77 6.33 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.701 0.286 . . . . 0.0 110.8 -179.363 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -40.25 -17.84 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.566 179.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 267' ' ' LYS . . . . . 0.6 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.45 -51.7 40.7 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.635 179.449 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -63.52 -46.59 85.36 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.279 179.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . 0.525 ' O ' ' CD2' ' A' ' 273' ' ' TYR . . . -61.78 -34.99 76.86 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.302 0.572 . . . . 0.0 109.95 179.602 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -63.31 -34.05 76.86 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.116 179.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.69 -43.41 13.42 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.928 -179.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 272' ' ' ILE . . . . . 0.62 ' C ' ' H ' ' A' ' 274' ' ' ALA . 4.9 tt -51.42 -33.58 14.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.667 -178.569 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 273' ' ' TYR . . . . . 0.525 ' CD2' ' O ' ' A' ' 269' ' ' ALA . 17.3 m-85 -54.65 -1.61 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.582 -179.558 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 274' ' ' ALA . . . . . 0.62 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.74 -39.7 69.87 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.811 179.512 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . 0.582 ' O ' ' N ' ' A' ' 279' ' ' ALA . 3.1 p30 -39.18 98.34 0.16 Allowed Pre-proline 0 N--CA 1.461 0.108 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.457 -179.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -54.59 -42.83 64.61 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 C-N-CA 122.519 2.146 . . . . 0.0 112.438 -178.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 89.1 mt -64.57 -42.88 95.37 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.024 -179.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 90.9 mt -95.77 -1.47 49.68 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.809 -179.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 279' ' ' ALA . . . . . 0.582 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.24 -34.89 77.37 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.703 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.46 20.35 0.12 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.876 -179.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . 0.514 ' H ' ' C ' ' A' ' 279' ' ' ALA . 13.9 mt -75.04 119.38 76.62 Favored Pre-proline 0 N--CA 1.45 -0.462 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.719 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -49.75 -40.36 47.53 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.719 2.279 . . . . 0.0 112.224 178.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.32 -50.83 61.5 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.263 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 78.6 t -61.28 -43.91 97.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.255 179.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -57.65 -41.21 80.98 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.261 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -91.0 0.13 57.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.313 179.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt 59.73 43.64 15.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.754 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -94.95 41.05 1.09 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.375 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 53.7 t -119.03 135.77 58.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 121.012 0.434 . . . . 0.0 110.203 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -133.07 163.35 29.45 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.638 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.8 155.34 32.74 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.657 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 79.5 mt -94.19 -1.66 53.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.312 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.37 165.79 12.73 Favored Glycine 0 CA--C 1.521 0.462 0 N-CA-C 110.658 -0.977 . . . . 0.0 110.658 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 7.1 m -87.76 -62.39 1.51 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.865 0.365 . . . . 0.0 110.91 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 295' ' ' GLU . . . . . 0.488 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.5 mm-40 -68.86 -4.24 15.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.657 -179.653 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 24.9 p -76.64 32.12 0.13 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.608 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 297' ' ' PHE . . . . . 0.488 ' H ' ' C ' ' A' ' 295' ' ' GLU . 70.4 t80 -60.42 -46.3 90.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.567 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . 0.624 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.2 mtt85 -80.74 134.42 35.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.594 -179.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 18.3 tp -113.13 116.43 29.84 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.325 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . 0.606 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.1 p-10 -164.7 -177.29 4.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.638 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 301' ' ' TYR . . . . . 0.52 ' OH ' ' CD1' ' A' ' 173' ' ' PHE . 81.1 t80 -46.16 -43.15 14.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.406 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -67.62 -40.13 84.68 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.991 0.424 . . . . 0.0 110.692 179.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 303' ' ' SER . . . . . 0.606 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 59.6 p -55.74 -36.73 67.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.26 -179.239 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -56.95 -52.27 65.9 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 179.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 92.7 mtp -54.92 -44.24 74.04 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -66.0 -42.86 89.18 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.066 0.46 . . . . 0.0 110.351 178.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 55.6 t -64.24 -42.81 96.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.286 179.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 42.9 tp -59.63 -41.94 91.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.052 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -62.57 -38.9 91.89 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.295 179.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 310' ' ' ARG . . . . . 0.448 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.7 ttt85 -63.64 -44.05 95.0 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.291 179.482 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 89.6 mt -63.14 -42.03 99.39 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.415 179.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.4 ttmt -63.09 -33.09 74.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.262 179.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -90.02 -23.31 21.52 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.402 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . 0.448 ' N ' ' O ' ' A' ' 310' ' ' ARG . 6.8 tt -62.24 -43.17 99.45 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.013 0.435 . . . . 0.0 110.603 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 . . . . . 0 C--O 1.22 -0.481 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.394 -179.924 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -99.09 135.75 40.04 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.5 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.491 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -92.11 178.45 1.7 Allowed Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.571 -179.882 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.491 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.7 Cg_exo -61.78 147.38 95.39 Favored 'Trans proline' 0 C--N 1.301 -1.929 0 C-N-CA 122.847 2.365 . . . . 0.0 112.161 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 35.2 ptt180 -135.53 141.94 45.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.628 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -79.64 116.31 19.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.498 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.401 ' O ' ' CG2' ' A' ' 30' ' ' ILE . 9.4 tp -110.69 130.1 64.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.553 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 8.8 t -70.35 141.37 52.26 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.646 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.509 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.3 t0 -139.0 179.42 6.51 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.516 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.509 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 77.9 p -74.26 -36.87 63.87 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.582 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 61.0 ttt85 -46.18 -94.65 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.454 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.498 ' C ' ' HG1' ' A' ' 36' ' ' THR . . . -167.3 -26.4 0.02 OUTLIER Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.966 -0.854 . . . . 0.0 110.966 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.498 ' HG1' ' C ' ' A' ' 35' ' ' GLY . 63.2 m -169.21 104.4 0.38 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.789 0.328 . . . . 0.0 110.639 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 74.5 t60 -128.38 148.85 50.72 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.012 0.434 . . . . 0.0 110.291 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.485 ' CG2' ' N ' ' A' ' 39' ' ' LEU . 98.1 m -131.1 166.25 21.49 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.474 -179.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.485 ' N ' ' CG2' ' A' ' 38' ' ' THR . 80.8 mt -121.06 127.45 51.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.53 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -64.94 -44.65 88.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.667 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 42.2 p -166.07 154.96 11.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.507 179.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.457 ' N ' ' CD ' ' A' ' 42' ' ' GLN . 15.2 mp0 -43.71 100.94 0.24 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.558 179.582 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.44 128.99 31.63 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 C-N-CA 122.546 2.164 . . . . 0.0 112.191 -179.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -83.73 -24.56 31.13 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.611 179.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.533 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.6 mtm-85 -122.2 134.43 54.71 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 121.15 0.5 . . . . 0.0 110.335 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.415 HD13 HG21 ' A' ' 46' ' ' ILE . 96.1 mt -130.9 134.08 62.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.639 -179.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 46.0 t -124.61 130.36 73.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.169 179.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.5 ' O ' ' O ' ' A' ' 66' ' ' ALA . 2.0 m -154.6 167.19 30.96 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.55 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 62.6 p -125.04 9.04 8.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.468 179.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.47 125.38 32.99 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.591 -179.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 96.0 t -65.59 -44.6 93.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.548 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.1 m -62.45 -44.35 96.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.664 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 47.8 tp -62.4 -41.37 98.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.573 -179.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 75.8 m -57.57 -44.74 85.54 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.329 -179.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -63.92 -63.03 4.7 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.5 t -47.24 -35.94 8.31 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.768 0.318 . . . . 0.0 110.411 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.5 mt -61.8 -44.63 96.49 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.041 179.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.7 mp -65.9 -41.08 91.94 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.042 178.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.55 -41.3 98.45 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.688 -179.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.1 tp -88.43 17.09 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.801 -179.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 56.28 84.51 0.08 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.731 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.52 59.01 0.09 OUTLIER Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.333 -0.394 . . . . 0.0 109.974 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -52.22 152.75 14.32 Favored 'Trans proline' 0 C--N 1.298 -2.126 0 C-N-CA 122.99 2.46 . . . . 0.0 112.011 -177.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.433 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.2 OUTLIER -108.94 145.63 15.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.379 -179.628 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.57 -45.5 97.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.038 -179.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.5 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -129.77 134.11 47.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.5 -179.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.499 ' O ' ' N ' ' A' ' 98' ' ' LEU . 74.6 m -134.61 158.76 43.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.782 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.79 139.1 16.11 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.459 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.73 -162.79 0.08 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.826 0.346 . . . . 0.0 110.506 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.49 ' O ' ' C ' ' A' ' 71' ' ' THR . 14.7 t -133.54 134.42 43.38 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.435 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.49 ' C ' ' O ' ' A' ' 70' ' ' THR . 0.6 OUTLIER 29.68 69.51 0.62 Allowed Pre-proline 0 N--CA 1.464 0.247 0 CA-C-O 120.94 0.4 . . . . 0.0 110.685 -179.711 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -61.99 146.08 96.45 Favored 'Trans proline' 0 C--N 1.301 -1.94 0 C-N-CA 122.767 2.311 . . . . 0.0 111.817 -178.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.534 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 45.0 p-10 -160.14 -31.67 0.06 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.658 179.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.534 ' N ' ' OD1' ' A' ' 73' ' ' ASN . 99.2 m-20 -64.71 -39.27 93.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.392 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -60.25 -48.83 80.08 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.494 -179.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.423 ' O ' ' O ' ' A' ' 77' ' ' ALA . 94.6 t -59.55 -25.14 30.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.185 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.423 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -45.67 172.87 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.59 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.579 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.7 p30 -62.07 177.93 0.42 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.51 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.597 ' C ' ' H ' ' A' ' 81' ' ' GLY . 35.4 p30 -45.48 85.42 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.887 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.579 ' N ' ' O ' ' A' ' 78' ' ' ASP . 41.8 tp60 -67.32 13.26 0.07 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.351 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.597 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 118.61 -22.35 9.4 Favored Glycine 0 CA--C 1.52 0.389 0 N-CA-C 110.914 -0.875 . . . . 0.0 110.914 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -107.89 116.22 31.55 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.862 0.363 . . . . 0.0 110.487 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 73.5 mt -98.42 -0.15 44.15 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.577 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -92.31 7.44 42.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.441 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.441 ' O ' ' CG2' ' A' ' 89' ' ' VAL . 88.1 mt-30 -100.31 -28.44 12.97 Favored 'General case' 0 C--O 1.224 -0.266 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.613 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 68.8 t-105 -63.31 -40.2 96.67 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.736 -179.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.557 ' O ' ' N ' ' A' ' 91' ' ' LYS . 62.3 m -78.1 -54.01 6.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.791 -179.203 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -48.02 -50.76 26.66 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.861 -179.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.441 ' CG2' ' O ' ' A' ' 85' ' ' GLN . 16.0 m -69.15 -40.33 80.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.914 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.412 ' H ' HG23 ' A' ' 89' ' ' VAL . . . -72.86 -22.37 60.79 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.612 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.557 ' N ' ' O ' ' A' ' 87' ' ' SER . 65.9 tttm -62.28 -45.41 93.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.372 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.44 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.9 mm-40 -90.38 -94.78 0.12 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.265 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.632 ' O ' ' N ' ' A' ' 95' ' ' LEU . 96.0 mtt180 -143.04 58.6 1.41 Allowed 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.093 179.704 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.457 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.7 pttp 33.68 26.09 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 121.062 0.458 . . . . 0.0 110.487 -178.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.632 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.3 tt -47.95 123.04 5.62 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.834 -178.13 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -83.2 -170.45 3.05 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.366 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.606 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 81.5 mtp180 -73.91 137.07 43.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.342 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.499 ' N ' ' O ' ' A' ' 67' ' ' SER . 90.6 mt -86.02 -165.63 1.3 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.784 -179.601 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.539 ' CD2' ' O ' ' A' ' 99' ' ' TYR . 48.6 p90 -169.02 119.81 0.73 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.27 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.515 ' C ' ' O ' ' A' ' 99' ' ' TYR . 42.5 mm -28.77 121.24 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.896 -179.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 114.2 27.24 3.48 Favored Glycine 0 CA--C 1.521 0.462 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 -179.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.577 ' N ' ' CD ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -144.39 46.39 0.62 Allowed Pre-proline 0 C--N 1.324 -0.508 0 CA-C-O 121.097 0.475 . . . . 0.0 110.482 179.966 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 28.8 Cg_endo -62.14 143.89 95.16 Favored 'Trans proline' 0 C--N 1.298 -2.096 0 C-N-CA 122.728 2.285 . . . . 0.0 111.894 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.701 ' HG ' ' H ' ' A' ' 107' ' ' ALA . 25.5 t -173.27 120.34 0.34 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.443 179.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -74.13 -40.16 62.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.903 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.42 -39.89 89.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.685 -179.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.701 ' H ' ' HG ' ' A' ' 104' ' ' SER . . . -64.22 -39.96 95.05 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.645 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 70.2 t -67.85 -43.57 86.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.674 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.99 -38.94 93.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.479 -179.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.44 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.46 -23.14 62.47 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.541 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.552 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.3 mm-40 -90.99 5.68 47.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.628 -179.487 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.552 ' C ' ' O ' ' A' ' 111' ' ' GLN . 10.0 tpt 22.77 65.1 0.35 Allowed Pre-proline 0 N--CA 1.465 0.296 0 CA-C-O 120.985 0.422 . . . . 0.0 110.978 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -79.33 167.69 21.04 Favored 'Trans proline' 0 C--N 1.307 -1.605 0 C-N-CA 123.008 2.472 . . . . 0.0 111.694 -178.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.525 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 99.0 m-20 -110.01 -41.89 4.35 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.286 179.414 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.0 tp -121.54 120.05 33.73 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.306 179.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 82.7 mt -112.66 128.81 69.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.829 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 26.9 mt -108.42 132.41 53.8 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.442 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 98.9 mt -120.1 138.52 50.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.587 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 85.6 p -72.42 154.14 41.04 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.608 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.2 -50.36 73.98 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.627 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.0 t -149.75 154.21 38.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.53 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 170.47 -170.71 43.24 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.91 -33.95 88.52 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.454 ' O ' ' OD1' ' A' ' 124' ' ' ASP . 44.6 p-10 -87.43 120.08 28.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.835 0.35 . . . . 0.0 110.655 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 38.3 t -62.95 143.93 57.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.475 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.521 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.14 -43.27 8.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.785 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 56.4 tp -62.99 -42.21 99.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.681 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.81 -11.82 59.34 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.489 -179.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 83.6 mt -114.73 -24.61 8.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.528 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . 0.521 ' N ' ' O ' ' A' ' 126' ' ' ALA . 78.2 t80 -50.03 -50.17 48.49 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.613 -179.039 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.502 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 37.7 p-10 -66.07 -42.9 88.79 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.928 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.502 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 88.4 mt-30 -67.08 -37.49 84.08 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.733 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 95.9 mt -80.63 -41.42 23.89 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.768 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.4 t -56.35 -44.96 80.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.366 -179.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.7 m -61.87 -45.19 94.84 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.539 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 94.6 mt -61.92 -43.71 97.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.392 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.79 167.98 4.82 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.674 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -49.14 112.68 0.7 Allowed 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.52 2.146 . . . . 0.0 112.349 179.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 24.1 m -83.7 127.29 33.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.612 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 34.2 tp -118.01 135.49 54.13 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.318 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.438 ' O ' ' OD2' ' A' ' 32' ' ' ASP . 82.5 mt -99.85 119.06 47.38 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 CA-C-O 121.016 0.436 . . . . 0.0 110.795 -178.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 97.8 mt -135.1 132.68 53.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.54 179.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.504 HD22 ' CG ' ' A' ' 241' ' ' ASP . 61.1 t30 -67.26 153.44 43.67 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.475 179.478 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.512 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 88.8 t80 -87.67 121.83 30.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.697 -179.46 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.512 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 99.1 m-20 55.27 69.55 0.72 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.588 179.545 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.413 ' N ' ' OD1' ' A' ' 146' ' ' ASP . 34.5 p-10 -125.02 -0.06 7.88 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.595 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -151.08 115.72 5.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.623 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' SER . . . . . 0.522 ' HG ' ' H ' ' A' ' 150' ' ' GLN . 83.2 p -62.91 167.99 4.29 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.574 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.416 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.4 p-90 -51.65 -15.93 0.55 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.406 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . 0.522 ' H ' ' HG ' ' A' ' 148' ' ' SER . 68.0 tp60 -70.47 -75.59 0.12 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.884 0.373 . . . . 0.0 110.615 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.442 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.1 t -62.87 -38.55 91.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.399 179.389 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 53.7 tp -59.73 -46.05 90.31 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.537 -178.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.416 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 47.9 tp -62.69 -41.47 99.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.656 179.017 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.442 ' OG1' ' O ' ' A' ' 151' ' ' SER . 60.8 p -64.13 -35.18 79.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.328 -179.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . 0.442 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.7 mm-40 -63.98 -42.72 97.13 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.54 179.285 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 92.2 mt -65.66 -38.49 89.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.468 178.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.579 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.59 -31.99 79.76 Favored Glycine 0 CA--C 1.52 0.371 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 -179.369 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.442 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.1 mt-10 -35.14 -27.65 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.875 0.369 . . . . 0.0 110.806 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.579 ' N ' ' O ' ' A' ' 157' ' ' GLY . 93.9 mt -55.28 150.43 2.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.46 179.13 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 70.5 p -70.39 137.15 50.23 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.781 -179.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 72.01 19.33 78.31 Favored Glycine 0 CA--C 1.519 0.337 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 179.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 57.3 m80 -120.56 -15.0 8.57 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.71 0.29 . . . . 0.0 110.494 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -65.24 -60.58 2.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.572 -179.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -51.15 -50.28 59.24 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.259 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -60.11 -41.36 92.43 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.54 179.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.29 -47.59 85.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.485 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.41 -40.41 74.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.401 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -61.68 -50.39 72.67 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.605 179.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -65.17 -43.72 90.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.577 179.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 94.6 mt -64.89 -43.18 96.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.497 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.14 -51.63 68.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.367 -179.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.08 -43.84 97.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.644 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . 0.474 ' CD1' ' OH ' ' A' ' 301' ' ' TYR . 56.2 t80 -63.27 -43.87 96.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.452 179.492 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -63.67 -39.88 95.44 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.501 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -63.25 -42.77 99.23 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.545 179.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -60.32 -44.77 95.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.422 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 83.5 mt -64.93 -40.78 95.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.711 178.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -51.86 -62.67 1.49 Allowed 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.391 -179.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.37 -47.35 84.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.461 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -52.65 -41.98 64.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.474 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -63.91 -33.48 75.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.352 179.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . 0.4 ' O ' ' HG2' ' A' ' 182' ' ' GLU . 69.2 tt0 -90.7 8.92 32.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.319 0.581 . . . . 0.0 110.393 -178.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -105.29 -31.92 8.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.85 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.5 pt -128.16 147.47 32.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.649 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -139.91 131.15 26.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.489 179.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . 0.551 ' CD2' ' N ' ' A' ' 186' ' ' LEU . 3.6 mm? -85.68 132.67 43.68 Favored Pre-proline 0 N--CA 1.453 -0.325 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.922 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -43.6 157.57 0.12 Allowed 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.729 2.286 . . . . 0.0 112.389 179.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . 0.52 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.9 Cg_endo -62.9 114.99 2.66 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 C-N-CA 122.83 2.353 . . . . 0.0 111.908 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . 0.52 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.7 mt-30 156.0 147.28 0.0 OUTLIER Pre-proline 0 C--O 1.231 0.099 0 O-C-N 123.794 0.684 . . . . 0.0 110.692 -179.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.37 143.37 34.87 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.657 2.238 . . . . 0.0 112.272 177.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.498 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.1 p -124.52 159.34 30.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.164 0.507 . . . . 0.0 110.372 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' THR . . . . . 0.498 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 36.2 p -143.65 165.16 28.41 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.85 -179.35 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -135.28 128.72 32.36 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 121.167 0.508 . . . . 0.0 110.407 179.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 47.7 pt -146.45 148.43 17.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.961 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 71.7 t -117.19 122.84 70.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.082 0.468 . . . . 0.0 110.218 178.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -134.08 107.31 7.67 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.377 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 95.1 m -131.01 130.44 43.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.742 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.405 ' O ' ' N ' ' A' ' 201' ' ' HIS . . . -82.78 -36.91 25.23 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.399 179.638 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.07 -67.36 0.24 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.433 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.25 -9.91 59.08 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.47 179.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . 0.405 ' N ' ' O ' ' A' ' 198' ' ' ALA . 60.0 t-80 60.95 58.53 2.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.681 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 37.1 p -167.29 153.5 7.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.609 179.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.47 144.43 24.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.942 0.401 . . . . 0.0 110.47 179.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -135.33 138.08 43.05 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.608 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 19.0 mt -105.85 125.3 50.83 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.933 0.397 . . . . 0.0 110.194 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 206' ' ' TRP . . . . . 0.558 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 75.9 m95 -82.3 167.3 18.72 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.515 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -156.94 170.94 8.11 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.588 -179.024 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -53.23 -36.92 79.64 Favored 'Trans proline' 0 C--N 1.302 -1.892 0 C-N-CA 122.77 2.313 . . . . 0.0 112.378 178.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -71.13 -34.51 71.1 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.56 -179.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 22.3 m -61.64 150.61 35.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.624 -179.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.39 -36.94 81.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.456 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 212' ' ' GLN . . . . . 0.558 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 54.5 tt0 -64.74 -40.05 94.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.567 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.94 -43.37 91.51 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.734 -0.947 . . . . 0.0 110.734 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -63.04 -43.93 97.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.839 0.352 . . . . 0.0 110.385 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 65.1 ttp -59.02 -48.63 80.91 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.297 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 89.9 mt -59.65 -41.32 90.27 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 121.01 0.434 . . . . 0.0 110.01 179.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 217' ' ' GLU . . . . . 0.456 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 40.3 tp10 -57.37 -38.14 73.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.317 179.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -65.52 -37.78 87.75 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.605 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 95.5 mt -64.31 -42.76 96.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.725 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.58 44.53 0.08 OUTLIER Glycine 0 CA--C 1.521 0.466 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 221' ' ' PHE . . . . . 0.456 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 25.8 m-85 -127.49 155.33 43.92 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.944 0.402 . . . . 0.0 110.524 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 222' ' ' THR . . . . . 0.457 ' O ' ' O ' ' A' ' 191' ' ' VAL . 6.3 p -106.97 121.98 45.54 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.152 0.501 . . . . 0.0 110.242 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . 0.446 ' CD2' ' N ' ' A' ' 223' ' ' LEU . 4.3 mm? -100.9 133.32 45.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.989 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.98 158.92 15.19 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.506 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.05 115.29 30.03 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.516 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.449 ' CD1' ' N ' ' A' ' 226' ' ' LEU . 9.0 mp -53.56 156.29 4.63 Favored Pre-proline 0 N--CA 1.452 -0.35 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.71 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -59.69 145.31 98.49 Favored 'Trans proline' 0 C--N 1.302 -1.871 0 C-N-CA 122.795 2.33 . . . . 0.0 112.295 179.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.42 -2.91 58.95 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.556 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.31 -40.93 5.63 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . 0.537 ' O ' ' N ' ' A' ' 233' ' ' SER . 84.3 mt -79.2 -16.88 55.87 Favored 'General case' 0 C--O 1.224 -0.267 0 CA-C-O 120.983 0.421 . . . . 0.0 110.449 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . 0.404 ' C ' ' O ' ' A' ' 230' ' ' LEU . 55.1 t-20 -39.5 -49.63 2.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.679 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -88.58 15.58 7.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.009 -179.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 233' ' ' SER . . . . . 0.537 ' N ' ' O ' ' A' ' 230' ' ' LEU . 77.8 p -60.46 -35.47 75.95 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.653 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . 0.526 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.6 tt0 -118.46 -69.49 0.85 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.706 179.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.2 m -69.91 103.71 2.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.592 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -94.73 57.41 2.17 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.439 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -144.85 -122.57 1.57 Allowed Glycine 0 CA--C 1.521 0.441 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -134.46 111.89 10.49 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.002 0.43 . . . . 0.0 110.384 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . 0.515 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.4 mtt180 -148.33 57.75 1.07 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.678 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -69.97 -31.69 69.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.494 179.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 241' ' ' ASP . . . . . 0.504 ' CG ' HD22 ' A' ' 143' ' ' ASN . 65.6 t0 -56.54 -47.13 80.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.365 -179.205 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 242' ' ' ILE . . . . . 0.437 ' O ' ' O ' ' A' ' 239' ' ' ARG . 17.3 tt -140.49 157.49 24.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.493 179.73 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 96.0 mt -105.92 105.88 19.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.575 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . 0.515 ' OE1' ' NH1' ' A' ' 239' ' ' ARG . 88.0 mt-30 -110.06 109.98 20.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.416 179.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 9.4 mp -121.95 -168.13 1.66 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.66 179.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . 0.526 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.27 -16.79 0.05 OUTLIER Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . 0.693 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -60.43 157.01 29.67 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -63.79 21.51 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.86 0.362 . . . . 0.0 110.553 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . 0.693 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.7 m-20 -97.29 -6.1 35.18 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.497 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 92.6 mt -79.81 -21.52 44.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.784 179.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.61 -51.53 69.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.563 -179.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.31 -5.34 58.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.532 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.22 -74.34 1.15 Allowed Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.934 -0.866 . . . . 0.0 110.934 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 80.1 mt -69.95 125.75 27.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.809 0.338 . . . . 0.0 110.445 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -59.09 -39.52 82.44 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.281 -179.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 82.52 51.97 4.13 Favored Glycine 0 CA--C 1.521 0.442 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -96.21 -14.81 22.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.717 0.294 . . . . 0.0 110.665 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 258' ' ' SER . . . . . 0.423 ' O ' ' O ' ' A' ' 192' ' ' THR . 3.5 t 174.71 88.27 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.047 0.451 . . . . 0.0 110.321 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . 0.595 ' N ' ' CD1' ' A' ' 259' ' ' LEU . 1.0 OUTLIER -93.97 123.7 37.51 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.014 0.435 . . . . 0.0 110.992 -178.819 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 15.8 m-30 -92.74 146.35 23.72 Favored 'General case' 0 CA--C 1.508 -0.672 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.532 179.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 86.0 mt -122.36 149.56 43.61 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.6 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.661 ' CG ' ' N ' ' A' ' 263' ' ' ALA . 2.7 p90 -77.23 -138.34 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.632 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 263' ' ' ALA . . . . . 0.661 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -52.27 77.29 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.003 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . 0.625 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -178.93 104.54 0.19 Allowed Glycine 0 CA--C 1.527 0.829 0 N-CA-C 110.644 -0.982 . . . . 0.0 110.644 179.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 265' ' ' ASP . . . . . 0.6 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.9 m-20 -79.98 -178.04 6.29 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.648 0.261 . . . . 0.0 110.781 -179.407 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -40.48 -17.52 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.521 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 267' ' ' LYS . . . . . 0.6 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.47 -51.66 41.01 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.682 179.284 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -63.64 -46.81 83.99 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.198 179.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . 0.526 ' O ' ' CD2' ' A' ' 273' ' ' TYR . . . -61.57 -34.87 76.34 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.291 0.567 . . . . 0.0 110.058 179.611 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -63.17 -34.11 76.92 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.273 179.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.69 -43.68 13.2 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.793 -179.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 272' ' ' ILE . . . . . 0.617 ' C ' ' H ' ' A' ' 274' ' ' ALA . 4.9 tt -51.37 -33.44 14.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.579 -178.441 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 273' ' ' TYR . . . . . 0.526 ' CD2' ' O ' ' A' ' 269' ' ' ALA . 17.5 m-85 -54.76 -1.41 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.567 -179.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 274' ' ' ALA . . . . . 0.617 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.71 -39.74 69.95 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.755 179.448 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . 0.582 ' O ' ' N ' ' A' ' 279' ' ' ALA . 2.9 p30 -39.35 98.42 0.17 Allowed Pre-proline 0 C--N 1.335 -0.055 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.458 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -54.56 -43.01 62.94 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 C-N-CA 122.621 2.214 . . . . 0.0 112.344 -178.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 88.5 mt -64.48 -42.98 95.55 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.871 -179.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 91.0 mt -95.67 -1.68 49.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.839 -179.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 279' ' ' ALA . . . . . 0.582 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.36 -34.65 77.09 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.626 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.8 m80 -74.78 20.41 0.13 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.785 -178.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . 0.51 ' H ' ' C ' ' A' ' 279' ' ' ALA . 14.0 mt -75.25 119.45 77.02 Favored Pre-proline 0 N--CA 1.449 -0.492 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.783 179.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -49.47 -40.18 45.04 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.681 2.254 . . . . 0.0 112.33 178.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -51.97 -51.06 59.75 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.283 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 78.1 t -61.2 -43.87 97.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.248 179.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -57.99 -41.43 82.99 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.268 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -90.59 0.05 57.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.322 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt 59.52 42.87 16.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.742 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -94.38 41.58 1.09 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.463 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 53.8 t -118.97 135.84 58.1 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-O 120.974 0.416 . . . . 0.0 110.205 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -132.99 162.65 31.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.564 -179.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.64 155.31 32.56 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.613 -179.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 79.6 mt -93.95 -1.71 54.26 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.373 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.33 165.81 12.75 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 -179.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 7.1 m -87.51 -62.61 1.46 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.841 0.353 . . . . 0.0 110.75 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 295' ' ' GLU . . . . . 0.468 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.6 mm-40 -69.46 -3.89 16.37 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.597 -179.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 27.6 p -77.06 33.4 0.15 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.664 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 297' ' ' PHE . . . . . 0.468 ' H ' ' C ' ' A' ' 295' ' ' GLU . 84.8 t80 -60.33 -46.03 91.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.522 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . 0.606 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.3 mtt85 -81.48 133.85 35.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.552 -179.712 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 15.8 tp -114.13 119.38 36.91 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.392 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . 0.606 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.0 p-10 -167.48 -174.19 2.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.629 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 301' ' ' TYR . . . . . 0.474 ' OH ' ' CD1' ' A' ' 173' ' ' PHE . 85.1 t80 -47.62 -46.04 28.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.357 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -64.92 -41.58 95.42 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 120.959 0.409 . . . . 0.0 110.6 179.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 303' ' ' SER . . . . . 0.606 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 52.3 p -55.11 -36.47 65.75 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.206 -179.342 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -56.43 -52.4 64.8 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.079 179.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 93.2 mtp -54.64 -44.81 73.54 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -65.93 -42.88 89.52 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.082 0.468 . . . . 0.0 110.39 178.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 55.4 t -64.2 -42.61 96.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.378 179.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 43.1 tp -59.49 -41.96 91.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.186 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -62.97 -38.7 92.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.188 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 310' ' ' ARG . . . . . 0.44 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.6 ttt85 -63.38 -44.15 95.57 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.306 179.517 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 88.8 mt -63.07 -42.0 99.55 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.498 179.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.3 ttmt -63.0 -32.63 74.03 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.374 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -90.42 -23.25 21.09 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.442 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . 0.44 ' N ' ' O ' ' A' ' 310' ' ' ARG . 6.8 tt -62.25 -43.16 99.45 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.528 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 . . . . . 0 C--O 1.22 -0.48 0 CA-C-O 118.005 -0.998 . . . . 0.0 110.426 -179.897 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -99.54 137.11 38.49 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.009 0.433 . . . . 0.0 110.502 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.496 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -92.01 178.5 1.69 Allowed Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.578 -179.881 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.496 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.3 Cg_exo -61.73 147.54 95.08 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 C-N-CA 122.827 2.351 . . . . 0.0 112.201 179.648 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 35.0 ptt180 -134.35 141.76 47.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.696 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -79.2 116.58 19.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.504 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.5 tp -110.57 130.79 63.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.444 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 13.0 t -71.08 142.14 50.84 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.02 0.438 . . . . 0.0 110.582 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.43 ' CG ' ' H ' ' A' ' 33' ' ' SER . 25.3 t70 -139.57 177.73 7.72 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.535 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.452 ' OG ' ' O ' ' A' ' 141' ' ' ILE . 78.0 p -73.93 -36.23 64.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.717 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -48.1 -95.25 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.275 -179.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.42 ' O ' ' OG1' ' A' ' 36' ' ' THR . . . -164.6 -26.26 0.02 OUTLIER Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.42 ' OG1' ' O ' ' A' ' 35' ' ' GLY . 64.6 m -168.76 106.93 0.45 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.878 0.37 . . . . 0.0 110.699 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 36.4 t60 -129.54 144.98 51.5 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.113 0.482 . . . . 0.0 110.185 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.487 ' CG2' ' N ' ' A' ' 39' ' ' LEU . 98.9 m -129.31 166.27 19.81 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.519 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.487 ' N ' ' CG2' ' A' ' 38' ' ' THR . 80.8 mt -120.72 127.93 52.46 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.503 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -64.62 -44.56 90.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.719 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 39.1 p -165.33 154.47 12.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.398 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.46 ' N ' ' CD ' ' A' ' 42' ' ' GLN . 13.8 mp0 -42.55 100.18 0.22 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.602 179.357 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -56.73 129.23 33.5 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 122.382 2.054 . . . . 0.0 112.224 -179.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -84.25 -23.72 30.28 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.486 179.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.541 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.4 mtm-85 -121.18 134.24 55.21 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 121.138 0.494 . . . . 0.0 110.251 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.0 mt -130.5 133.2 64.03 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.254 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.857 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 48.5 t -124.8 130.83 73.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 179.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.506 ' O ' ' O ' ' A' ' 66' ' ' ALA . 4.9 m -154.7 166.28 33.92 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.54 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 71.9 p -124.53 8.47 8.34 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.455 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.38 126.07 33.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.611 -179.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 92.2 t -66.06 -44.58 91.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.6 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.1 m -62.65 -44.19 96.9 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.699 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 52.6 tp -62.39 -41.66 98.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.58 -179.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 77.4 m -57.34 -44.39 84.24 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.399 -179.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.79 -61.73 5.62 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 179.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.6 t -48.62 -35.53 13.86 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.8 mt -61.82 -44.41 96.91 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.18 179.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.3 mp -65.22 -41.36 94.53 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.247 177.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.79 -40.98 97.97 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.954 -179.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.2 tp -88.54 16.93 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.816 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 56.36 84.3 0.09 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.763 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.25 57.63 0.07 OUTLIER Pre-proline 0 C--N 1.328 -0.368 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -50.58 153.35 7.89 Favored 'Trans proline' 0 C--N 1.295 -2.272 0 C-N-CA 122.866 2.377 . . . . 0.0 112.314 -178.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.435 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -109.17 145.8 15.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.329 -179.661 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 97.1 mt -63.7 -45.34 97.64 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.409 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.506 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -129.5 134.58 47.86 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.857 0.361 . . . . 0.0 110.564 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.476 ' O ' ' N ' ' A' ' 98' ' ' LEU . 73.1 m -134.93 159.2 42.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.829 -179.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -87.67 139.36 15.84 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.438 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -175.65 -163.66 0.12 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.957 0.408 . . . . 0.0 110.504 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.424 ' O ' ' C ' ' A' ' 71' ' ' THR . 15.3 t -133.02 131.82 41.12 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.415 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.424 ' C ' ' O ' ' A' ' 70' ' ' THR . 11.9 p 36.88 71.53 0.94 Allowed Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.523 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_exo -60.92 144.17 99.51 Favored 'Trans proline' 0 C--N 1.302 -1.918 0 C-N-CA 122.491 2.127 . . . . 0.0 112.116 -178.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.533 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 44.6 p-10 -165.0 -34.67 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.678 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.533 ' N ' ' OD1' ' A' ' 73' ' ' ASN . 99.1 m-20 -63.94 -39.39 94.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.452 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -60.86 -47.73 85.02 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.655 -179.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.432 ' O ' ' O ' ' A' ' 77' ' ' ALA . 94.9 t -59.95 -24.48 29.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.432 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -44.77 171.64 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.63 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.575 ' O ' ' N ' ' A' ' 80' ' ' GLN . 54.0 p30 -62.19 178.41 0.39 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.638 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.594 ' C ' ' H ' ' A' ' 81' ' ' GLY . 36.2 p30 -46.96 85.4 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.952 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.575 ' N ' ' O ' ' A' ' 78' ' ' ASP . 43.2 tp60 -67.57 14.1 0.06 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.159 0.504 . . . . 0.0 110.187 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.594 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 117.87 -21.62 10.28 Favored Glycine 0 C--N 1.332 0.313 0 N-CA-C 110.841 -0.903 . . . . 0.0 110.841 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -107.91 116.63 32.31 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.971 0.415 . . . . 0.0 110.487 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 74.1 mt -98.98 0.72 44.52 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.447 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -92.03 6.46 46.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.962 0.411 . . . . 0.0 110.396 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.449 ' O ' ' CG2' ' A' ' 89' ' ' VAL . 88.3 mt-30 -99.9 -27.46 13.59 Favored 'General case' 0 C--O 1.223 -0.341 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.811 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.0 t-105 -64.1 -40.51 96.38 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.052 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.554 ' O ' ' N ' ' A' ' 91' ' ' LYS . 70.7 m -77.86 -53.71 7.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.163 -179.495 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -48.51 -50.68 30.84 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.016 -179.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.449 ' CG2' ' O ' ' A' ' 85' ' ' GLN . 14.8 m -68.88 -40.75 81.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 120.937 0.399 . . . . 0.0 111.081 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.411 ' H ' HG23 ' A' ' 89' ' ' VAL . . . -72.29 -22.43 61.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.649 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.554 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.0 tttm -61.6 -45.85 92.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.516 -179.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.437 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.6 mm-40 -90.7 -94.23 0.12 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.198 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.625 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.9 mtt180 -143.77 60.11 1.38 Allowed 'General case' 0 C--O 1.235 0.308 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.457 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.6 pttp 33.6 26.44 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 120.933 0.396 . . . . 0.0 110.25 -179.287 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.625 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.4 tt -47.97 123.28 5.97 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.958 -178.094 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -83.64 -170.6 3.14 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.084 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.628 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 82.0 mtp180 -73.34 137.6 44.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.213 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.476 ' N ' ' O ' ' A' ' 67' ' ' SER . 89.7 mt -86.99 -165.38 1.27 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.727 -179.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.532 ' CD2' ' O ' ' A' ' 99' ' ' TYR . 48.5 p90 -168.82 120.22 0.76 Allowed 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.189 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.504 ' C ' ' O ' ' A' ' 99' ' ' TYR . 43.3 mm -29.42 121.6 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.029 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 114.07 27.87 3.3 Favored Glycine 0 CA--C 1.518 0.253 0 N-CA-C 111.224 -0.751 . . . . 0.0 111.224 -179.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.579 ' N ' ' CD ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -144.14 46.08 0.61 Allowed Pre-proline 0 C--N 1.323 -0.55 0 O-C-N 122.502 -0.411 . . . . 0.0 110.464 179.84 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 30.1 Cg_endo -62.14 143.83 95.08 Favored 'Trans proline' 0 C--N 1.296 -2.226 0 C-N-CA 122.686 2.257 . . . . 0.0 111.908 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.707 ' HG ' ' H ' ' A' ' 107' ' ' ALA . 26.5 t -173.42 120.82 0.34 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.398 179.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.37 -41.03 63.9 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.1 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -65.84 -39.83 91.18 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.846 -179.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.707 ' H ' ' HG ' ' A' ' 104' ' ' SER . . . -63.84 -39.76 94.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.713 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 69.4 t -67.55 -43.84 86.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.705 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.42 -39.29 92.81 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.524 -179.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.437 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.61 -23.87 63.34 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.495 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.555 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.2 mm-40 -91.38 5.15 50.45 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.674 -179.553 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.555 ' C ' ' O ' ' A' ' 111' ' ' GLN . 10.4 tpt 21.65 64.85 0.31 Allowed Pre-proline 0 N--CA 1.466 0.349 0 CA-C-O 120.882 0.372 . . . . 0.0 111.137 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -79.12 169.69 18.79 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 122.993 2.462 . . . . 0.0 111.902 -178.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.525 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 99.0 m-20 -112.84 -43.52 3.42 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.102 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 39.7 tp -120.83 119.9 34.03 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 95.7 mt -117.16 130.85 71.39 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 CA-C-O 120.944 0.402 . . . . 0.0 110.892 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 33.1 mt -105.67 132.73 51.45 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.263 -179.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 98.1 mt -118.15 135.73 57.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.733 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 87.0 p -71.65 153.27 42.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.567 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.31 -50.03 75.24 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.679 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.0 t -149.55 154.01 38.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.505 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 169.36 -170.11 42.39 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -63.02 -35.13 91.67 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.443 ' O ' ' OD1' ' A' ' 124' ' ' ASP . 43.9 p-10 -88.3 119.42 28.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.783 0.325 . . . . 0.0 110.65 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 41.2 t -63.3 144.53 56.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.987 0.422 . . . . 0.0 110.507 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.521 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.65 -42.66 9.06 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.857 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.7 tp -62.79 -42.34 99.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.697 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.01 -10.99 57.99 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.499 -179.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 84.4 mt -115.44 -24.18 8.49 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.683 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . 0.521 ' N ' ' O ' ' A' ' 126' ' ' ALA . 77.1 t80 -51.54 -49.54 61.78 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.566 -178.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.6 p-10 -65.89 -41.81 91.05 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.255 179.451 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.524 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 88.0 mt-30 -67.84 -37.07 81.41 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.87 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 94.5 mt -79.95 -42.35 24.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.944 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.2 t -57.1 -44.91 83.66 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.294 -179.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.4 m -62.18 -45.74 92.05 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.631 179.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 92.7 mt -62.61 -43.98 98.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.377 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.67 164.26 6.58 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.524 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -43.48 111.88 0.27 Allowed 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.49 2.127 . . . . 0.0 112.195 179.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 16.8 m -86.16 127.7 34.76 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.633 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 35.3 tp -120.32 137.69 54.12 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.089 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.452 ' O ' ' OG ' ' A' ' 33' ' ' SER . 80.5 mt -105.32 121.17 57.1 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.336 0 CA-C-O 121.204 0.526 . . . . 0.0 111.196 -179.489 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 97.9 mt -136.02 132.61 50.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.593 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.544 ' OD1' ' N ' ' A' ' 144' ' ' TYR . 60.7 t-20 -64.52 147.36 52.96 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.893 0.378 . . . . 0.0 110.307 179.425 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.544 ' N ' ' OD1' ' A' ' 143' ' ' ASN . 87.1 t80 -82.35 122.1 27.55 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.996 -179.615 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.515 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 98.9 m-20 55.27 69.21 0.76 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.847 179.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 33.7 p-10 -125.15 0.57 7.84 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.891 0.377 . . . . 0.0 110.667 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -151.29 117.48 5.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.773 -179.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' SER . . . . . 0.512 ' HG ' ' H ' ' A' ' 150' ' ' GLN . 87.4 p -64.6 168.89 5.44 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.489 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.412 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.4 p-90 -51.2 -15.37 0.35 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.498 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . 0.512 ' H ' ' HG ' ' A' ' 148' ' ' SER . 67.8 tp60 -71.71 -75.15 0.14 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.398 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.455 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.0 t -62.72 -38.85 92.09 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.244 179.461 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 52.9 tp -60.12 -45.59 92.49 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.307 -178.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.412 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 46.2 tp -62.64 -41.78 99.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.914 0.388 . . . . 0.0 110.508 178.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.455 ' OG1' ' O ' ' A' ' 151' ' ' SER . 57.4 p -64.04 -34.65 78.49 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.201 -179.443 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . 0.468 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.5 mm-40 -63.87 -42.39 97.54 Favored 'General case' 0 C--O 1.227 -0.131 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.22 179.345 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 91.7 mt -65.43 -38.76 90.85 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.066 0.46 . . . . 0.0 110.151 179.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.572 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.47 -31.49 77.69 Favored Glycine 0 CA--C 1.52 0.388 0 N-CA-C 110.771 -0.931 . . . . 0.0 110.771 -179.297 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.468 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.4 mt-10 -37.32 -24.57 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.894 0.378 . . . . 0.0 110.837 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.572 ' N ' ' O ' ' A' ' 157' ' ' GLY . 96.0 mt -59.82 148.53 7.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.312 179.321 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 74.8 p -69.05 137.28 53.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.951 -179.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 71.73 20.93 78.92 Favored Glycine 0 CA--C 1.517 0.159 0 N-CA-C 111.206 -0.757 . . . . 0.0 111.206 179.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 58.9 m80 -123.59 -14.33 7.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.717 0.294 . . . . 0.0 110.581 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -65.29 -60.2 3.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.71 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -52.21 -49.14 64.51 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.145 -179.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -59.88 -41.21 91.06 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.739 0.304 . . . . 0.0 110.28 179.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.55 -46.7 88.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.561 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -57.62 -39.75 77.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.178 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -61.79 -50.11 73.67 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.609 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -65.38 -43.81 89.53 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.531 179.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 94.3 mt -64.55 -43.38 96.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.369 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.56 -51.21 70.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.461 -179.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.43 -43.96 95.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.485 179.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . 0.494 ' CD1' ' OH ' ' A' ' 301' ' ' TYR . 56.3 t80 -62.69 -44.33 96.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.062 0.458 . . . . 0.0 110.37 179.375 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -63.26 -39.6 95.05 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.528 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -63.17 -43.02 99.44 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.615 179.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -60.64 -44.79 95.96 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.195 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 84.3 mt -64.56 -40.96 96.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.995 0.426 . . . . 0.0 110.691 178.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -51.56 -62.9 1.33 Allowed 'General case' 0 C--O 1.238 0.458 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.37 -179.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.34 -47.0 85.17 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.59 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.0 -41.68 64.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.233 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -64.04 -33.31 75.46 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.05 0.452 . . . . 0.0 110.347 179.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 70.1 tt0 -91.21 8.4 35.97 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.436 0.636 . . . . 0.0 110.426 -178.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -103.99 -32.33 9.28 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.205 179.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.6 pt -128.04 147.65 32.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.814 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -140.1 131.36 26.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.442 179.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . 0.55 ' CD2' ' N ' ' A' ' 186' ' ' LEU . 3.6 mm? -85.4 132.64 44.32 Favored Pre-proline 0 N--CA 1.453 -0.321 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.904 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -43.87 157.87 0.13 Allowed 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.686 2.257 . . . . 0.0 112.27 179.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . 0.52 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 26.6 Cg_endo -62.42 115.3 2.8 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 C-N-CA 122.818 2.345 . . . . 0.0 111.759 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . 0.52 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 0.4 OUTLIER 155.4 147.57 0.0 OUTLIER Pre-proline 0 N--CA 1.456 -0.156 0 O-C-N 123.777 0.673 . . . . 0.0 110.758 -179.88 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -73.78 143.59 33.72 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.653 2.235 . . . . 0.0 112.017 177.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.489 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.1 p -124.91 158.7 32.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.347 0.594 . . . . 0.0 110.137 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' THR . . . . . 0.489 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 40.1 p -143.1 164.87 28.97 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.07 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -135.29 128.52 31.96 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.227 0.537 . . . . 0.0 110.223 179.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 47.9 pt -147.44 150.3 14.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.04 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . 0.404 ' CG1' ' CD1' ' A' ' 262' ' ' PHE . 74.6 t -118.31 123.43 71.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-O 121.298 0.57 . . . . 0.0 109.793 179.128 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -134.68 106.91 7.18 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.254 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 95.9 m -131.32 131.35 43.7 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.838 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.406 ' O ' ' N ' ' A' ' 201' ' ' HIS . . . -83.03 -37.14 24.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.308 179.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.39 -66.92 0.27 Allowed 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.402 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.25 -10.22 59.5 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.379 179.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . 0.406 ' N ' ' O ' ' A' ' 198' ' ' ALA . 59.6 t-80 60.89 57.69 2.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.673 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 36.2 p -166.64 152.84 8.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.623 179.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -150.47 143.37 24.7 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.003 0.43 . . . . 0.0 110.452 179.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -134.87 137.68 43.45 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.598 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 16.6 mt -106.42 125.7 51.33 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.122 0.487 . . . . 0.0 109.841 -179.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 206' ' ' TRP . . . . . 0.556 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 74.1 m95 -82.08 167.35 18.89 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.58 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -157.26 171.06 7.94 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.64 -179.181 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -53.08 -37.19 79.0 Favored 'Trans proline' 0 C--N 1.302 -1.873 0 C-N-CA 122.649 2.233 . . . . 0.0 112.163 179.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -70.89 -35.41 72.31 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.774 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 20.0 m -60.49 150.97 29.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.603 -179.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.65 -37.28 83.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.535 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 212' ' ' GLN . . . . . 0.556 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 55.0 tt0 -64.68 -40.28 95.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.52 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.66 -43.44 91.99 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 110.744 -0.943 . . . . 0.0 110.744 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -63.16 -44.39 95.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.807 0.337 . . . . 0.0 110.307 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 65.3 ttp -59.27 -48.01 83.23 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.145 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 86.0 mt -60.49 -40.83 92.74 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 217' ' ' GLU . . . . . 0.451 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.4 tp10 -58.38 -37.76 75.91 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -65.31 -38.24 89.59 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.8 0.333 . . . . 0.0 110.652 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 94.0 mt -64.25 -42.92 96.29 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.509 -179.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.79 44.83 0.08 OUTLIER Glycine 0 C--N 1.333 0.405 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 221' ' ' PHE . . . . . 0.451 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 26.3 m-85 -127.66 154.78 44.88 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.053 0.454 . . . . 0.0 110.497 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 222' ' ' THR . . . . . 0.453 ' O ' ' O ' ' A' ' 191' ' ' VAL . 7.6 p -106.33 122.16 45.68 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.209 0.528 . . . . 0.0 110.147 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . 0.44 ' CD2' ' N ' ' A' ' 223' ' ' LEU . 4.3 mm? -101.6 133.07 46.85 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.023 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.44 159.41 14.96 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.49 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.14 114.99 29.52 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.962 0.411 . . . . 0.0 110.31 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.451 ' CD1' ' N ' ' A' ' 226' ' ' LEU . 9.0 mp -53.03 156.54 3.5 Favored Pre-proline 0 N--CA 1.453 -0.319 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.69 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -60.02 145.32 98.67 Favored 'Trans proline' 0 C--N 1.301 -1.944 0 C-N-CA 122.673 2.249 . . . . 0.0 112.167 179.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -86.89 -3.36 59.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.578 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.69 -40.65 5.58 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . 0.503 ' O ' ' N ' ' A' ' 233' ' ' SER . 65.5 mt -79.53 -18.43 51.87 Favored 'General case' 0 C--O 1.222 -0.389 0 CA-C-O 121.125 0.488 . . . . 0.0 110.365 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -40.76 -49.18 3.1 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.773 -179.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -87.04 15.09 6.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.269 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 233' ' ' SER . . . . . 0.503 ' N ' ' O ' ' A' ' 230' ' ' LEU . 77.6 p -59.74 -34.58 73.14 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.59 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . 0.529 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.5 tt0 -121.73 -68.99 0.86 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.813 179.386 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.3 m -66.31 102.91 0.91 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.559 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -93.83 54.25 1.94 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.415 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -142.84 -122.16 1.7 Allowed Glycine 0 CA--C 1.521 0.434 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -139.01 113.75 9.17 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.018 0.437 . . . . 0.0 110.328 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . 0.529 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.8 mtt180 -147.73 60.31 1.14 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.716 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -68.94 -34.12 74.83 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.518 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 241' ' ' ASP . . . . . 0.454 ' OD2' ' ND2' ' A' ' 143' ' ' ASN . 48.2 t0 -56.79 -47.58 79.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.378 -179.151 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 242' ' ' ILE . . . . . 0.433 ' O ' ' O ' ' A' ' 239' ' ' ARG . 18.9 tt -138.45 153.79 26.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.909 0.385 . . . . 0.0 110.459 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 96.4 mt -106.38 107.55 22.98 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.224 0 CA-C-O 121.095 0.474 . . . . 0.0 110.445 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . 0.529 ' OE1' ' NH1' ' A' ' 239' ' ' ARG . 88.3 mt-30 -111.85 111.03 21.69 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.46 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 9.8 mp -121.21 -168.34 1.66 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.571 179.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . 0.529 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 176.67 -17.42 0.04 OUTLIER Glycine 0 CA--C 1.524 0.602 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . 0.71 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -62.29 154.55 41.09 Favored Glycine 0 CA--C 1.521 0.442 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -62.62 22.3 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.924 0.392 . . . . 0.0 110.644 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . 0.71 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.9 m-20 -96.64 -6.33 36.89 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.49 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 99.0 mt -80.34 -22.55 41.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.705 179.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.65 -51.17 71.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.84 -179.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.24 -4.94 58.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.429 179.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.41 -73.89 1.17 Allowed Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 82.8 mt -70.16 126.64 30.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.018 0.437 . . . . 0.0 110.253 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -59.51 -39.06 82.62 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.392 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 83.3 51.72 4.03 Favored Glycine 0 CA--C 1.521 0.46 0 N-CA-C 110.752 -0.939 . . . . 0.0 110.752 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -95.6 -15.15 22.97 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.687 0.28 . . . . 0.0 110.633 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 258' ' ' SER . . . . . 0.429 ' O ' ' O ' ' A' ' 192' ' ' THR . 3.3 t 174.26 88.91 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.065 0.459 . . . . 0.0 110.086 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . 0.593 ' N ' ' CD1' ' A' ' 259' ' ' LEU . 1.0 OUTLIER -94.3 124.3 38.24 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.276 0.56 . . . . 0.0 111.187 -179.156 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 15.9 m-30 -93.0 146.52 23.56 Favored 'General case' 0 CA--C 1.505 -0.781 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.465 179.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 85.1 mt -122.08 149.85 42.97 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.534 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.659 ' CG ' ' N ' ' A' ' 263' ' ' ALA . 2.6 p90 -77.7 -139.35 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.436 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 263' ' ' ALA . . . . . 0.659 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -51.34 77.66 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.123 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . 0.632 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.36 104.82 0.19 Allowed Glycine 0 CA--C 1.527 0.83 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 265' ' ' ASP . . . . . 0.598 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.6 m-20 -80.38 -177.67 6.28 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.769 0.318 . . . . 0.0 110.861 -179.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -40.45 -17.83 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.539 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 267' ' ' LYS . . . . . 0.598 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.47 -51.63 41.37 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.007 0.432 . . . . 0.0 110.7 179.448 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -63.67 -46.48 85.39 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.259 179.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . 0.524 ' O ' ' CD2' ' A' ' 273' ' ' TYR . . . -61.77 -35.16 77.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.202 0.525 . . . . 0.0 109.732 179.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -63.02 -34.56 77.83 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.113 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.47 -43.27 13.73 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.192 -179.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 272' ' ' ILE . . . . . 0.619 ' C ' ' H ' ' A' ' 274' ' ' ALA . 4.8 tt -51.21 -33.47 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.83 -178.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 273' ' ' TYR . . . . . 0.524 ' CD2' ' O ' ' A' ' 269' ' ' ALA . 17.1 m-85 -54.7 -1.53 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.603 -179.583 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 274' ' ' ALA . . . . . 0.619 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.79 -39.65 69.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.917 179.543 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . 0.58 ' O ' ' N ' ' A' ' 279' ' ' ALA . 3.5 p30 -39.21 97.91 0.15 Allowed Pre-proline 0 N--CA 1.462 0.128 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.55 -179.694 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -54.25 -42.9 63.42 Favored 'Trans proline' 0 C--N 1.304 -1.812 0 C-N-CA 122.32 2.013 . . . . 0.0 112.682 -178.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 89.0 mt -64.43 -42.83 95.79 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.208 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 90.6 mt -95.79 -1.35 49.86 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.883 -179.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 279' ' ' ALA . . . . . 0.58 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.28 -34.73 77.13 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.71 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.14 19.91 0.12 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.99 -179.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . 0.514 ' H ' ' C ' ' A' ' 279' ' ' ALA . 13.7 mt -75.07 119.85 78.88 Favored Pre-proline 0 N--CA 1.451 -0.424 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.58 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -50.64 -39.71 56.13 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.612 2.208 . . . . 0.0 112.035 178.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.76 -50.44 63.49 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.103 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 73.6 t -61.47 -43.85 97.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 179.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -57.95 -41.26 82.48 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.159 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -90.84 0.05 57.58 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.154 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt 59.56 43.23 16.22 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.86 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -94.83 41.49 1.09 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.346 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 54.2 t -118.85 135.72 58.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 121.062 0.458 . . . . 0.0 110.172 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -132.74 162.45 31.4 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.111 0.481 . . . . 0.0 110.606 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.43 154.51 33.59 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.021 0.439 . . . . 0.0 110.681 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 80.9 mt -93.66 -1.69 54.94 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.24 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.83 165.72 12.64 Favored Glycine 0 CA--C 1.522 0.475 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 6.8 m -87.61 -61.9 1.62 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.902 0.382 . . . . 0.0 111.065 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 295' ' ' GLU . . . . . 0.487 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.5 mm-40 -69.22 -4.35 17.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.677 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 26.1 p -76.29 32.43 0.12 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.666 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 297' ' ' PHE . . . . . 0.487 ' H ' ' C ' ' A' ' 295' ' ' GLU . 85.0 t80 -60.56 -46.18 91.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.579 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . 0.628 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.1 mtt85 -81.78 133.65 35.36 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 121.049 0.452 . . . . 0.0 110.54 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 16.8 tp -113.16 118.64 35.27 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-O 120.994 0.426 . . . . 0.0 110.161 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . 0.606 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.4 p-10 -165.81 -176.01 3.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.592 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 301' ' ' TYR . . . . . 0.494 ' OH ' ' CD1' ' A' ' 173' ' ' PHE . 83.5 t80 -47.3 -44.06 23.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.275 -179.645 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -66.45 -40.64 89.54 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.035 0.445 . . . . 0.0 110.827 179.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 303' ' ' SER . . . . . 0.606 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 57.6 p -55.58 -36.21 66.63 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.111 -179.19 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -56.98 -51.67 68.28 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 91.0 mtp -56.26 -43.83 79.14 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -66.3 -42.45 88.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.037 0.446 . . . . 0.0 110.18 178.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 56.1 t -64.1 -42.93 97.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.209 179.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 42.3 tp -59.74 -42.12 92.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.863 -179.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -62.68 -38.82 91.87 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.08 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 310' ' ' ARG . . . . . 0.441 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.7 ttt85 -63.63 -43.73 95.99 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.308 179.554 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 89.3 mt -63.09 -42.22 99.57 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.25 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt -62.85 -33.36 75.1 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.075 179.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.44 -23.68 22.06 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.401 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . 0.441 ' N ' ' O ' ' A' ' 310' ' ' ARG . 6.7 tt -62.26 -43.28 99.2 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 121.068 0.461 . . . . 0.0 110.578 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 . . . . . 0 C--O 1.22 -0.479 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.404 -179.894 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -99.64 135.89 40.39 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.056 0.455 . . . . 0.0 110.476 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.497 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -91.94 178.51 1.7 Allowed Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.586 -179.846 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.497 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.4 Cg_exo -61.6 147.32 95.66 Favored 'Trans proline' 0 C--N 1.299 -2.076 0 C-N-CA 122.802 2.335 . . . . 0.0 112.147 179.568 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 35.7 ptt180 -136.03 142.3 44.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.645 179.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -79.6 116.79 20.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.501 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.5 tp -111.35 130.75 64.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.465 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 13.8 t -70.93 142.36 51.09 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.606 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.515 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.4 t0 -139.85 179.53 6.54 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.526 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.515 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 78.0 p -73.71 -37.12 65.25 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.64 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.7 ttt85 -46.49 -94.56 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.293 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.423 ' O ' ' OG1' ' A' ' 36' ' ' THR . . . -167.22 -26.32 0.02 OUTLIER Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.931 -0.867 . . . . 0.0 110.931 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.423 ' OG1' ' O ' ' A' ' 35' ' ' GLY . 60.9 m -169.25 105.02 0.38 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.891 0.377 . . . . 0.0 110.665 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 74.7 t60 -128.5 149.44 50.59 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.116 0.484 . . . . 0.0 110.227 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.484 ' CG2' ' N ' ' A' ' 39' ' ' LEU . 98.5 m -131.75 165.88 22.77 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.583 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.484 ' N ' ' CG2' ' A' ' 38' ' ' THR . 81.6 mt -120.8 127.31 51.82 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.497 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -64.95 -44.43 89.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.721 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.4 ' O ' ' HD3' ' A' ' 43' ' ' PRO . 39.7 p -165.81 155.08 11.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.492 179.581 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.456 ' N ' ' CD ' ' A' ' 42' ' ' GLN . 14.9 mp0 -44.22 100.96 0.24 Allowed Pre-proline 0 C--N 1.329 -0.287 0 O-C-N 123.364 0.415 . . . . 0.0 110.621 179.362 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.4 ' HD3' ' O ' ' A' ' 41' ' ' SER . 31.6 Cg_exo -57.26 129.37 33.79 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 122.337 2.024 . . . . 0.0 112.271 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -83.98 -24.81 30.45 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.501 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.538 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.3 mtm-85 -121.86 134.37 54.88 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.199 0.523 . . . . 0.0 110.321 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.2 mt -130.6 133.46 63.49 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.3 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.952 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 44.9 t -124.18 130.33 73.77 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.502 ' O ' ' O ' ' A' ' 66' ' ' ALA . 2.1 m -155.48 167.65 29.69 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.523 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 66.8 p -124.45 10.31 8.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.454 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -86.02 124.78 32.85 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.723 -179.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 98.9 t -65.57 -44.55 93.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.398 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.4 m -62.49 -44.18 97.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.627 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 52.3 tp -62.02 -41.54 98.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.514 -179.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 71.2 m -57.67 -44.44 85.72 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.192 -179.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.24 -62.09 5.46 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 179.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.7 t -48.61 -35.51 13.78 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 20.0 mt -61.82 -44.48 96.75 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.675 -0.41 . . . . 0.0 111.284 179.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.3 mp -64.96 -41.61 95.33 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.42 177.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.84 -40.48 96.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.003 -179.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 7.9 tp -89.07 16.49 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.836 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 56.48 85.08 0.08 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.733 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 178.49 58.21 0.07 OUTLIER Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.901 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -50.97 153.1 9.23 Favored 'Trans proline' 0 C--N 1.294 -2.323 0 C-N-CA 122.935 2.423 . . . . 0.0 112.329 -178.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.432 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -108.3 145.37 15.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.318 -179.736 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.69 -45.18 98.09 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.303 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.403 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.502 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -129.83 134.03 47.3 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.504 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.502 ' O ' ' N ' ' A' ' 98' ' ' LEU . 75.4 m -134.48 158.5 43.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.824 -179.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.59 139.03 16.2 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.46 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.79 -162.86 0.08 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.014 0.435 . . . . 0.0 110.465 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.488 ' O ' ' C ' ' A' ' 71' ' ' THR . 14.9 t -133.61 134.5 43.31 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.357 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.488 ' C ' ' O ' ' A' ' 70' ' ' THR . 0.7 OUTLIER 29.62 68.71 0.65 Allowed Pre-proline 0 N--CA 1.464 0.266 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.787 -179.879 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -61.3 145.42 98.41 Favored 'Trans proline' 0 C--N 1.299 -2.077 0 C-N-CA 122.654 2.236 . . . . 0.0 111.969 -178.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.53 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 45.3 p-10 -158.9 -32.29 0.07 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.701 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.53 ' N ' ' OD1' ' A' ' 73' ' ' ASN . 99.1 m-20 -64.03 -39.71 94.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.459 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -60.39 -48.1 83.2 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.704 -179.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.424 ' O ' ' O ' ' A' ' 77' ' ' ALA . 92.7 t -60.48 -25.03 33.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.424 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -45.66 173.04 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.601 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.575 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.6 p30 -62.05 177.86 0.42 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.533 -179.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.596 ' C ' ' H ' ' A' ' 81' ' ' GLY . 36.5 p30 -45.01 85.73 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.994 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.575 ' N ' ' O ' ' A' ' 78' ' ' ASP . 42.7 tp60 -67.36 13.21 0.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.119 0.485 . . . . 0.0 110.116 -179.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.596 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 118.23 -22.29 9.7 Favored Glycine 0 C--N 1.332 0.317 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -108.18 116.18 31.49 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.956 0.407 . . . . 0.0 110.471 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 77.8 mt -98.56 0.58 45.23 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.941 0.401 . . . . 0.0 110.484 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -92.33 7.03 44.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.024 0.44 . . . . 0.0 110.435 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.433 ' O ' ' CG2' ' A' ' 89' ' ' VAL . 88.0 mt-30 -100.2 -27.87 13.3 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.787 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 68.5 t-105 -62.71 -40.91 98.64 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.935 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.552 ' O ' ' N ' ' A' ' 91' ' ' LYS . 68.8 m -77.55 -53.2 7.89 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.164 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -48.79 -50.9 32.03 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.015 -179.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.433 ' CG2' ' O ' ' A' ' 85' ' ' GLN . 15.7 m -68.75 -40.74 81.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 120.88 0.371 . . . . 0.0 111.074 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.417 ' H ' HG23 ' A' ' 89' ' ' VAL . . . -71.99 -23.11 61.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.75 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.552 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.0 tttm -61.6 -45.63 93.29 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.504 -179.537 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.445 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.8 mm-40 -90.46 -95.17 0.12 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.101 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.63 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.8 mtt180 -142.81 59.46 1.43 Allowed 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.458 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.7 pttp 33.55 26.27 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 120.906 0.384 . . . . 0.0 110.132 -179.303 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.63 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.5 tt -48.5 123.23 6.35 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.006 -177.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -83.95 -169.2 2.46 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.06 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.602 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 81.3 mtp180 -74.85 136.86 41.53 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.266 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.502 ' N ' ' O ' ' A' ' 67' ' ' SER . 91.5 mt -85.77 -165.93 1.38 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.718 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.537 ' CD2' ' O ' ' A' ' 99' ' ' TYR . 48.3 p90 -168.2 119.85 0.83 Allowed 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.198 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.511 ' C ' ' O ' ' A' ' 99' ' ' TYR . 42.4 mm -28.99 120.74 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.074 -179.723 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 114.62 27.6 3.25 Favored Glycine 0 CA--C 1.52 0.353 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 -179.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.575 ' N ' ' CD ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -144.78 46.5 0.61 Allowed Pre-proline 0 C--N 1.323 -0.578 0 O-C-N 122.549 -0.383 . . . . 0.0 110.431 179.896 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 29.0 Cg_endo -61.9 144.21 96.36 Favored 'Trans proline' 0 C--N 1.295 -2.258 0 C-N-CA 122.678 2.252 . . . . 0.0 111.93 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.703 ' HG ' ' H ' ' A' ' 107' ' ' ALA . 26.1 t -173.38 120.25 0.33 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.397 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.71 -40.34 63.67 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.034 0.445 . . . . 0.0 111.098 179.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -66.29 -40.16 89.87 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.9 -179.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.703 ' H ' ' HG ' ' A' ' 104' ' ' SER . . . -63.97 -40.07 95.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.697 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 70.7 t -67.45 -43.84 87.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.8 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.86 -38.84 92.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.53 -179.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.445 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.62 -23.34 62.92 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.414 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.547 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.5 mm-40 -90.63 5.14 49.19 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.755 -179.575 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.547 ' C ' ' O ' ' A' ' 111' ' ' GLN . 10.6 tpt 23.49 64.05 0.38 Allowed Pre-proline 0 N--CA 1.466 0.347 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.074 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -78.41 167.78 22.42 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 C-N-CA 122.949 2.433 . . . . 0.0 112.009 -178.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.523 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 99.0 m-20 -110.06 -42.53 4.17 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.133 179.475 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.6 tp -120.64 120.4 35.65 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 84.4 mt -113.36 129.18 69.59 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.401 0 CA-C-O 120.983 0.42 . . . . 0.0 110.942 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.44 ' CD1' ' HG ' ' A' ' 48' ' ' SER . 29.9 mt -109.02 132.46 54.08 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.057 0.456 . . . . 0.0 110.214 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 98.9 mt -119.91 138.2 51.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.666 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 87.4 p -71.92 153.17 42.01 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.57 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.27 -50.19 74.63 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.681 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -149.42 153.91 38.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.615 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 170.25 -170.9 43.27 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.87 -34.28 89.37 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.447 ' O ' ' OD1' ' A' ' 124' ' ' ASP . 44.1 p-10 -87.06 120.06 27.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.805 0.336 . . . . 0.0 110.66 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 40.6 t -63.26 143.6 57.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.451 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.521 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.08 -42.76 9.23 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.866 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.5 tp -62.73 -42.35 99.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.647 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.99 -11.94 59.81 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.485 -179.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 84.8 mt -114.48 -24.1 8.99 Favored 'General case' 0 C--O 1.226 -0.16 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.689 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . 0.521 ' N ' ' O ' ' A' ' 126' ' ' ALA . 77.9 t80 -51.28 -49.44 61.23 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.611 -0.436 . . . . 0.0 110.576 -178.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.498 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.3 p-10 -66.07 -42.27 89.65 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.885 0.374 . . . . 0.0 111.29 179.474 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.498 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 88.2 mt-30 -67.29 -37.92 84.18 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.797 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 96.1 mt -80.33 -41.41 24.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.991 -179.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.1 t -57.26 -44.34 83.82 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.202 -178.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.8 m -62.11 -45.1 94.99 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.766 0.317 . . . . 0.0 110.49 179.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 93.5 mt -62.26 -43.64 98.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.23 -179.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.46 168.35 4.88 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.588 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -49.67 112.93 0.78 Allowed 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.314 2.01 . . . . 0.0 112.277 179.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 23.0 m -84.18 127.55 34.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.636 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 34.5 tp -118.05 135.93 53.87 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.938 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.438 ' O ' ' OD2' ' A' ' 32' ' ' ASP . 81.3 mt -100.38 119.01 47.9 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 CA-C-O 121.192 0.52 . . . . 0.0 111.295 -179.44 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 98.1 mt -134.98 131.83 53.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.619 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.517 HD22 ' CG ' ' A' ' 241' ' ' ASP . 58.9 t30 -66.77 147.48 53.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.866 0.365 . . . . 0.0 110.406 179.289 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.463 ' O ' ' OD2' ' A' ' 241' ' ' ASP . 44.8 t80 -81.69 123.17 28.5 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.932 -179.546 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 54.64 69.57 0.71 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.802 179.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 34.2 p-10 -126.16 0.7 7.15 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.93 0.395 . . . . 0.0 110.74 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -150.65 114.92 5.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.743 -179.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' SER . . . . . 0.527 ' HG ' ' H ' ' A' ' 150' ' ' GLN . 83.6 p -64.14 169.23 4.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.523 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.417 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.4 p-90 -52.1 -16.51 0.79 Allowed 'General case' 0 C--O 1.223 -0.321 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.474 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . 0.527 ' H ' ' HG ' ' A' ' 148' ' ' SER . 68.1 tp60 -69.56 -76.96 0.09 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.495 -179.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.449 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.1 t -62.53 -38.24 89.21 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.287 179.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 53.1 tp -60.05 -45.74 91.84 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.351 -178.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.417 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 46.8 tp -62.76 -41.71 99.34 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.417 179.049 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.449 ' OG1' ' O ' ' A' ' 151' ' ' SER . 63.0 p -63.89 -34.91 79.01 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.222 -179.454 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . 0.445 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 88.0 mm-40 -64.0 -42.52 97.16 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.256 179.308 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 90.7 mt -65.37 -38.85 91.28 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.094 0.473 . . . . 0.0 110.212 179.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.578 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.25 -32.4 80.55 Favored Glycine 0 CA--C 1.519 0.343 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 -179.368 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.445 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.2 mt-10 -35.88 -26.45 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.869 0.366 . . . . 0.0 110.827 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.578 ' N ' ' O ' ' A' ' 157' ' ' GLY . 95.3 mt -57.2 148.75 4.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.287 179.224 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 73.4 p -69.1 137.41 53.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.036 -179.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 70.85 22.18 78.22 Favored Glycine 0 N--CA 1.458 0.162 0 N-CA-C 111.286 -0.726 . . . . 0.0 111.286 179.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 59.0 m80 -124.16 -14.41 7.04 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.719 0.295 . . . . 0.0 110.519 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -66.16 -59.75 3.47 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.718 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -52.16 -49.04 64.57 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.159 -179.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -60.98 -41.09 95.78 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.95 -0.3 . . . . 0.0 110.387 179.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.57 -47.09 87.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.57 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -57.0 -40.22 76.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.188 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -61.49 -49.94 74.73 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.558 179.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -65.35 -43.67 90.13 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.467 179.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 94.7 mt -64.56 -43.41 96.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.468 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.38 -51.02 71.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.451 -179.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.51 -43.68 96.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.493 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . 0.48 ' CD1' ' OH ' ' A' ' 301' ' ' TYR . 57.6 t80 -62.86 -44.52 95.91 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.072 0.463 . . . . 0.0 110.433 179.391 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -63.27 -40.0 96.16 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.579 -179.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -63.02 -42.73 99.88 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.646 179.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -60.65 -44.88 95.9 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.152 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 84.6 mt -64.43 -41.14 96.75 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.992 0.425 . . . . 0.0 110.67 178.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -51.92 -62.15 1.81 Allowed 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.395 -179.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.76 -46.61 87.07 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.568 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.3 -41.86 66.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.28 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -63.66 -33.7 76.22 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.984 0.421 . . . . 0.0 110.4 179.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 69.8 tt0 -90.53 8.76 32.36 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.489 0.662 . . . . 0.0 110.484 -178.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -104.87 -32.29 8.87 Favored 'General case' 0 CA--C 1.515 -0.372 0 O-C-N 122.113 -0.367 . . . . 0.0 111.233 179.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.7 pt -128.01 147.61 32.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.826 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -139.97 131.02 26.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.331 179.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . 0.559 ' CD2' ' N ' ' A' ' 186' ' ' LEU . 3.5 mm? -85.44 133.73 41.69 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.01 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -44.04 157.89 0.14 Allowed 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 122.703 2.269 . . . . 0.0 112.199 179.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . 0.521 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 28.1 Cg_endo -63.13 114.8 2.62 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 C-N-CA 122.765 2.31 . . . . 0.0 111.729 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . 0.521 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.8 mt-30 155.4 147.99 0.0 OUTLIER Pre-proline 0 N--CA 1.455 -0.203 0 O-C-N 123.68 0.612 . . . . 0.0 110.802 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -73.53 144.29 35.77 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.621 2.214 . . . . 0.0 112.005 177.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.494 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.1 p -124.92 158.83 32.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.298 0.57 . . . . 0.0 110.14 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' THR . . . . . 0.494 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 37.4 p -143.3 165.39 27.61 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.121 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -135.28 128.64 32.2 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.222 0.534 . . . . 0.0 110.189 179.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 47.7 pt -146.39 148.79 16.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.186 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 72.1 t -117.77 123.25 71.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.272 0.558 . . . . 0.0 109.684 179.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -134.4 107.37 7.56 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.282 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 94.7 m -130.82 130.46 43.68 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.834 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.413 ' O ' ' N ' ' A' ' 201' ' ' HIS . . . -82.73 -37.36 24.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.265 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.41 -66.98 0.27 Allowed 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.414 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.1 -10.05 59.24 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.266 179.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . 0.413 ' N ' ' O ' ' A' ' 198' ' ' ALA . 60.0 t-80 60.81 58.13 2.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.703 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 41.0 p -166.84 153.49 8.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.52 179.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.32 144.05 24.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.496 179.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -135.34 138.4 43.34 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.641 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 20.4 mt -106.53 125.64 51.25 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.116 0.484 . . . . 0.0 109.779 -179.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 206' ' ' TRP . . . . . 0.556 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 74.8 m95 -82.12 166.99 19.21 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.655 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -156.92 171.26 7.67 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 120.98 0.419 . . . . 0.0 110.521 -179.144 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.54 -37.35 82.65 Favored 'Trans proline' 0 C--N 1.303 -1.832 0 C-N-CA 122.619 2.213 . . . . 0.0 112.186 179.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -70.4 -35.01 73.2 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.875 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 22.8 m -61.01 150.74 32.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.616 -179.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.45 -37.04 82.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.551 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 212' ' ' GLN . . . . . 0.556 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 55.0 tt0 -64.69 -40.24 95.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.543 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.5 -43.46 92.32 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.719 -0.952 . . . . 0.0 110.719 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -63.34 -43.54 97.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.71 0.291 . . . . 0.0 110.247 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 65.1 ttp -59.5 -48.01 83.31 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.207 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 88.0 mt -60.66 -40.74 93.19 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 217' ' ' GLU . . . . . 0.459 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.7 tp10 -58.06 -37.87 75.25 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -65.22 -38.01 89.06 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.81 0.338 . . . . 0.0 110.654 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 94.3 mt -64.3 -42.62 96.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.614 -179.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.27 44.6 0.09 OUTLIER Glycine 0 C--N 1.333 0.408 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 221' ' ' PHE . . . . . 0.459 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 26.1 m-85 -127.66 155.44 43.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.058 0.456 . . . . 0.0 110.527 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 222' ' ' THR . . . . . 0.453 ' O ' ' O ' ' A' ' 191' ' ' VAL . 7.0 p -107.16 122.23 46.09 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.224 0.535 . . . . 0.0 110.196 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . 0.445 ' CD2' ' N ' ' A' ' 223' ' ' LEU . 4.3 mm? -101.03 133.28 45.76 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.134 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -97.1 159.21 15.04 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.473 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.16 115.35 30.13 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-O 120.924 0.392 . . . . 0.0 110.37 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.454 ' CD1' ' N ' ' A' ' 226' ' ' LEU . 8.9 mp -53.37 156.67 3.96 Favored Pre-proline 0 N--CA 1.453 -0.313 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.659 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -60.19 145.3 98.81 Favored 'Trans proline' 0 C--N 1.301 -1.931 0 C-N-CA 122.629 2.219 . . . . 0.0 112.15 179.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.41 -3.02 59.01 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.5 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.22 -40.92 5.66 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.024 -0.831 . . . . 0.0 111.024 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . 0.539 ' O ' ' N ' ' A' ' 233' ' ' SER . 86.3 mt -79.17 -16.82 56.04 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-O 121.019 0.438 . . . . 0.0 110.29 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . 0.402 ' C ' ' O ' ' A' ' 230' ' ' LEU . 54.5 t-20 -40.41 -48.89 2.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.764 -179.399 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -88.2 15.43 7.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.314 179.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 233' ' ' SER . . . . . 0.539 ' N ' ' O ' ' A' ' 230' ' ' LEU . 78.1 p -60.6 -35.51 76.3 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.648 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . 0.528 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.6 tt0 -118.35 -69.26 0.86 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.974 179.428 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.0 m -70.47 103.02 2.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.739 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -94.27 58.08 2.42 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.37 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -145.04 -122.53 1.55 Allowed Glycine 0 CA--C 1.519 0.324 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -134.47 111.79 10.4 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 121.175 0.512 . . . . 0.0 110.408 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . 0.515 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.2 mtt180 -148.25 57.56 1.07 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.762 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -69.83 -31.89 70.01 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.489 179.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 241' ' ' ASP . . . . . 0.517 ' CG ' HD22 ' A' ' 143' ' ' ASN . 64.8 t0 -56.92 -47.03 81.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.344 -179.097 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 242' ' ' ILE . . . . . 0.434 ' O ' ' O ' ' A' ' 239' ' ' ARG . 17.6 tt -140.2 157.03 25.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.912 0.387 . . . . 0.0 110.494 179.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 96.1 mt -106.25 106.33 20.39 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.163 0 CA-C-O 121.169 0.509 . . . . 0.0 110.466 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . 0.515 ' OE1' ' NH1' ' A' ' 239' ' ' ARG . 88.2 mt-30 -110.45 110.31 21.02 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.302 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 9.5 mp -121.87 -168.33 1.69 Allowed 'General case' 0 C--O 1.225 -0.205 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.63 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . 0.528 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.49 -16.9 0.05 OUTLIER Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.919 -0.873 . . . . 0.0 110.919 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . 0.692 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -60.45 156.98 29.78 Favored Glycine 0 CA--C 1.522 0.488 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -63.8 21.42 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.977 0.418 . . . . 0.0 110.604 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . 0.692 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.8 m-20 -97.04 -6.05 36.16 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.576 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 92.4 mt -79.9 -21.57 43.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.648 179.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.57 -51.23 70.76 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.71 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.65 -5.41 58.16 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.467 179.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.14 -74.37 1.15 Allowed Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 82.6 mt -70.08 126.01 28.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.072 0.463 . . . . 0.0 110.254 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -59.47 -39.27 83.14 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.311 -179.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 82.83 51.79 4.12 Favored Glycine 0 CA--C 1.521 0.41 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -95.78 -15.1 22.79 Favored 'General case' 0 C--N 1.332 -0.18 0 O-C-N 122.728 -0.278 . . . . 0.0 110.594 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 258' ' ' SER . . . . . 0.428 ' O ' ' O ' ' A' ' 192' ' ' THR . 3.3 t 174.56 88.93 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.078 0.466 . . . . 0.0 110.108 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . 0.596 ' N ' ' CD1' ' A' ' 259' ' ' LEU . 0.9 OUTLIER -94.43 124.06 38.23 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.254 0.549 . . . . 0.0 111.115 -179.081 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 15.9 m-30 -93.06 146.48 23.61 Favored 'General case' 0 CA--C 1.504 -0.818 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.345 179.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 85.7 mt -122.42 149.63 43.57 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.607 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.66 ' CG ' ' N ' ' A' ' 263' ' ' ALA . 2.6 p90 -77.21 -138.04 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.638 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 263' ' ' ALA . . . . . 0.66 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -52.61 77.52 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.032 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . 0.621 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -178.99 104.32 0.18 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 265' ' ' ASP . . . . . 0.601 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.7 m-20 -80.35 -177.81 6.34 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.684 0.278 . . . . 0.0 110.954 -179.634 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -40.36 -17.69 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.561 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 267' ' ' LYS . . . . . 0.601 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.38 -51.52 43.26 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.71 179.409 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -63.75 -46.65 84.34 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.191 179.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . 0.524 ' O ' ' CD2' ' A' ' 273' ' ' TYR . . . -61.68 -35.12 77.08 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.173 0.511 . . . . 0.0 109.738 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -63.17 -34.38 77.51 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.033 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.51 -43.12 13.83 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.185 -179.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 272' ' ' ILE . . . . . 0.619 ' C ' ' H ' ' A' ' 274' ' ' ALA . 4.9 tt -51.47 -33.73 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.855 -178.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 273' ' ' TYR . . . . . 0.524 ' CD2' ' O ' ' A' ' 269' ' ' ALA . 17.3 m-85 -54.33 -1.89 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.646 -179.546 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 274' ' ' ALA . . . . . 0.619 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.61 -39.61 70.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.919 179.52 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . 0.582 ' O ' ' N ' ' A' ' 279' ' ' ALA . 3.3 p30 -39.28 98.03 0.16 Allowed Pre-proline 0 CA--C 1.528 0.108 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.52 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -54.29 -42.95 63.02 Favored 'Trans proline' 0 C--N 1.303 -1.821 0 C-N-CA 122.341 2.027 . . . . 0.0 112.638 -178.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 88.8 mt -64.45 -42.82 95.76 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.252 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 91.0 mt -95.67 -1.58 49.79 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.848 -179.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 279' ' ' ALA . . . . . 0.582 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.28 -34.82 77.3 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.685 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.21 20.07 0.12 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.052 -179.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . 0.515 ' H ' ' C ' ' A' ' 279' ' ' ALA . 13.8 mt -75.19 120.04 79.8 Favored Pre-proline 0 N--CA 1.451 -0.417 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.523 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -50.91 -39.34 58.96 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.586 2.191 . . . . 0.0 111.859 179.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.92 -50.42 64.0 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.111 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 75.7 t -61.48 -43.91 97.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -57.79 -41.19 81.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.218 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -91.13 0.04 57.61 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.091 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt 59.44 43.71 15.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.039 0.447 . . . . 0.0 110.878 179.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -94.88 41.33 1.09 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.379 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 54.1 t -119.2 135.76 58.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 121.101 0.477 . . . . 0.0 110.136 -179.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -132.93 162.75 30.8 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.709 -179.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.77 155.3 32.78 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-O 121.013 0.435 . . . . 0.0 110.728 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 81.6 mt -94.07 -1.36 54.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.232 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.53 165.69 12.67 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.548 -1.021 . . . . 0.0 110.548 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 6.9 m -87.56 -62.4 1.5 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.921 0.391 . . . . 0.0 111.001 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 295' ' ' GLU . . . . . 0.466 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.4 mm-40 -69.6 -3.79 16.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.675 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 25.4 p -76.89 33.17 0.14 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.645 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 297' ' ' PHE . . . . . 0.466 ' H ' ' C ' ' A' ' 295' ' ' GLU . 84.8 t80 -60.17 -45.85 91.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.555 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . 0.602 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.2 mtt85 -81.72 134.41 35.45 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.989 0.423 . . . . 0.0 110.576 -179.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 16.2 tp -114.18 118.88 35.22 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-O 121.004 0.431 . . . . 0.0 110.066 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . 0.608 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.4 p-10 -166.39 -175.23 3.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.562 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 301' ' ' TYR . . . . . 0.48 ' OH ' ' CD1' ' A' ' 173' ' ' PHE . 86.5 t80 -47.69 -44.64 27.66 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.246 -179.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -65.63 -40.9 93.07 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.034 0.445 . . . . 0.0 110.683 178.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 303' ' ' SER . . . . . 0.608 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 54.5 p -56.16 -36.12 67.96 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.024 -179.171 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -56.85 -52.34 65.47 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 90.9 mtp -56.15 -43.28 78.15 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -66.37 -42.53 87.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.024 0.44 . . . . 0.0 110.155 178.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 55.7 t -64.13 -42.97 97.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.105 179.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 42.5 tp -59.77 -42.26 92.9 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.779 -179.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -62.33 -39.27 92.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.123 179.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 310' ' ' ARG . . . . . 0.436 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.4 ttt85 -63.51 -44.06 95.38 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.18 179.479 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 88.4 mt -63.37 -42.14 98.84 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.233 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -62.99 -33.26 75.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.016 179.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.52 -23.85 21.93 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.416 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . 0.436 ' N ' ' O ' ' A' ' 310' ' ' ARG . 6.7 tt -62.31 -43.29 99.16 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 121.074 0.464 . . . . 0.0 110.552 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 . . . . . 0 C--O 1.219 -0.507 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.45 -179.952 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.327 -0.619 . . . . 0.0 109.327 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -99.59 136.4 39.58 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.045 0.45 . . . . 0.0 110.47 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.496 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -92.07 178.56 1.66 Allowed Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.563 -179.891 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.496 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.6 Cg_exo -61.73 147.16 95.93 Favored 'Trans proline' 0 C--N 1.301 -1.965 0 C-N-CA 122.79 2.327 . . . . 0.0 112.106 179.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 35.6 ptt180 -136.29 142.44 43.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.645 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -79.5 116.76 19.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.456 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.5 tp -111.14 130.44 64.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.456 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 12.9 t -70.89 141.7 51.19 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.55 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.515 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.4 t0 -139.19 179.62 6.41 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.497 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.515 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 78.1 p -74.01 -36.93 64.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.604 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.8 ttt85 -46.64 -94.59 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.293 -179.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.495 ' C ' ' HG1' ' A' ' 36' ' ' THR . . . -166.96 -26.62 0.02 OUTLIER Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.495 ' HG1' ' C ' ' A' ' 35' ' ' GLY . 59.3 m -169.05 105.0 0.4 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.817 0.341 . . . . 0.0 110.672 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 75.5 t60 -128.53 149.09 50.75 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.019 0.437 . . . . 0.0 110.289 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.483 ' CG2' ' N ' ' A' ' 39' ' ' LEU . 98.6 m -131.42 165.91 22.46 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.532 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.483 ' N ' ' CG2' ' A' ' 38' ' ' THR . 81.4 mt -120.75 127.35 51.91 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.501 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -65.09 -44.43 88.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.682 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.407 ' O ' ' HD3' ' A' ' 43' ' ' PRO . 40.6 p -165.97 154.91 11.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.444 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.458 ' N ' ' CD ' ' A' ' 42' ' ' GLN . 14.5 mp0 -44.73 101.3 0.25 Allowed Pre-proline 0 C--N 1.329 -0.308 0 O-C-N 123.392 0.433 . . . . 0.0 110.652 179.426 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.407 ' HD3' ' O ' ' A' ' 41' ' ' SER . 31.7 Cg_exo -57.25 129.66 35.32 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 C-N-CA 122.373 2.049 . . . . 0.0 112.288 -179.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -83.61 -24.73 31.32 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.473 179.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.542 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.2 mtm-85 -122.39 134.83 54.61 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-O 121.176 0.512 . . . . 0.0 110.256 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.1 mt -130.75 133.84 62.74 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.925 -179.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 44.2 t -124.31 130.61 73.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 179.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.509 ' O ' ' O ' ' A' ' 66' ' ' ALA . 2.2 m -155.32 167.8 29.16 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.559 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 67.3 p -124.85 9.96 8.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.425 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.78 125.15 33.03 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.689 -179.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 93.1 t -65.76 -44.41 93.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.48 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.8 m -62.69 -44.04 97.26 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.602 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 52.5 tp -62.15 -41.5 98.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.544 -179.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 75.5 m -57.61 -44.53 85.54 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.32 -179.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.13 -62.31 5.29 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 179.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.6 t -48.24 -35.74 12.58 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 20.0 mt -61.86 -44.37 96.95 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.179 179.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.402 HD12 ' N ' ' A' ' 58' ' ' LEU . 9.2 mp -64.97 -41.66 95.26 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.373 178.035 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.91 -40.71 97.12 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.012 -179.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 7.9 tp -88.73 16.44 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.856 -179.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 56.46 84.58 0.09 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.671 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 178.58 57.1 0.06 OUTLIER Pre-proline 0 C--N 1.328 -0.329 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -50.55 154.25 6.66 Favored 'Trans proline' 0 C--N 1.295 -2.252 0 C-N-CA 122.912 2.408 . . . . 0.0 112.297 -178.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.436 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -108.96 145.64 15.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.375 -179.712 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.66 -45.25 97.98 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.263 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.335 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.509 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -129.49 133.98 47.55 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.522 -179.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.51 ' O ' ' N ' ' A' ' 98' ' ' LEU . 74.8 m -134.59 158.64 43.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.769 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.77 139.27 16.26 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.704 -0.959 . . . . 0.0 110.704 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.461 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.92 -162.69 0.08 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.918 0.389 . . . . 0.0 110.474 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.489 ' O ' ' C ' ' A' ' 71' ' ' THR . 15.2 t -133.52 134.33 43.3 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.397 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.489 ' C ' ' O ' ' A' ' 70' ' ' THR . 0.6 OUTLIER 29.73 68.89 0.65 Allowed Pre-proline 0 N--CA 1.464 0.272 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.754 -179.939 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -61.27 146.67 97.11 Favored 'Trans proline' 0 C--N 1.299 -2.067 0 C-N-CA 122.655 2.237 . . . . 0.0 111.986 -178.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.535 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 45.3 p-10 -160.59 -32.35 0.05 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.673 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.535 ' N ' ' OD1' ' A' ' 73' ' ' ASN . 99.1 m-20 -64.15 -39.43 94.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.451 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -60.51 -48.24 82.65 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.561 -179.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.418 ' O ' ' O ' ' A' ' 77' ' ' ALA . 91.6 t -60.38 -24.77 32.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.418 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -46.02 173.29 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.563 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.57 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.6 p30 -62.25 177.96 0.44 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.582 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.59 ' C ' ' H ' ' A' ' 81' ' ' GLY . 35.8 p30 -45.01 86.12 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.985 0.422 . . . . 0.0 110.946 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.57 ' N ' ' O ' ' A' ' 78' ' ' ASP . 43.1 tp60 -67.57 13.21 0.08 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.127 0.489 . . . . 0.0 110.13 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.59 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 118.51 -22.09 9.58 Favored Glycine 0 CA--C 1.519 0.306 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -108.31 116.49 32.06 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.959 0.409 . . . . 0.0 110.54 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 74.6 mt -98.57 0.17 44.41 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.485 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -92.25 7.18 43.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.013 0.435 . . . . 0.0 110.443 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.428 ' O ' ' CG2' ' A' ' 89' ' ' VAL . 87.8 mt-30 -100.13 -27.99 13.26 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.777 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 68.2 t-105 -62.51 -40.67 97.47 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.866 -179.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.55 ' O ' ' N ' ' A' ' 91' ' ' LYS . 66.1 m -77.64 -53.45 7.56 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.088 -179.389 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -48.73 -50.91 31.53 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.018 -179.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.428 ' CG2' ' O ' ' A' ' 85' ' ' GLN . 15.4 m -68.62 -40.71 82.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 120.934 0.397 . . . . 0.0 111.032 179.717 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.418 ' H ' HG23 ' A' ' 89' ' ' VAL . . . -72.05 -23.04 61.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.702 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.55 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.0 tttm -61.74 -45.68 92.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.482 -179.464 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.439 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.6 mm-40 -90.23 -95.47 0.11 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.16 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.64 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.9 mtt180 -142.59 58.87 1.44 Allowed 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.459 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.7 pttp 33.54 25.77 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 120.92 0.391 . . . . 0.0 110.19 -179.161 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.64 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.3 tt -47.86 123.75 6.49 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.924 -178.061 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -83.91 -169.41 2.57 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.115 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.595 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 81.0 mtp180 -74.6 136.7 42.03 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.291 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.51 ' N ' ' O ' ' A' ' 67' ' ' SER . 90.6 mt -85.52 -165.57 1.26 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.856 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.536 ' CD2' ' O ' ' A' ' 99' ' ' TYR . 48.0 p90 -168.38 119.49 0.79 Allowed 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.254 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.511 ' C ' ' O ' ' A' ' 99' ' ' TYR . 43.3 mm -28.86 121.02 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.058 -179.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 113.76 27.89 3.37 Favored Glycine 0 CA--C 1.52 0.35 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 -179.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.575 ' N ' ' CD ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -144.48 46.65 0.64 Allowed Pre-proline 0 C--N 1.324 -0.524 0 CA-C-O 120.985 0.422 . . . . 0.0 110.425 179.856 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 29.2 Cg_endo -61.97 143.78 95.67 Favored 'Trans proline' 0 C--N 1.297 -2.161 0 C-N-CA 122.656 2.237 . . . . 0.0 111.942 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.701 ' HG ' ' H ' ' A' ' 107' ' ' ALA . 25.3 t -173.01 120.08 0.35 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.367 179.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.25 -40.41 64.66 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.075 0.464 . . . . 0.0 111.122 179.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.39 -39.88 89.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.926 -179.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.701 ' H ' ' HG ' ' A' ' 104' ' ' SER . . . -64.38 -40.16 95.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.729 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 71.7 t -67.79 -43.82 86.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.78 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.82 -38.97 92.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.578 -179.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.439 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.44 -23.4 62.66 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.493 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.545 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.3 mm-40 -90.29 5.23 48.1 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.652 -179.471 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.545 ' C ' ' O ' ' A' ' 111' ' ' GLN . 10.8 tpt 23.89 63.98 0.39 Allowed Pre-proline 0 N--CA 1.466 0.33 0 CA-C-O 120.939 0.399 . . . . 0.0 111.048 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -78.22 166.63 24.3 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 123.035 2.49 . . . . 0.0 112.062 -178.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.524 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 99.2 m-20 -109.77 -41.71 4.45 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.185 179.43 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.2 tp -121.63 120.12 33.82 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 83.2 mt -112.77 128.86 69.25 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.33 0 CA-C-O 120.941 0.401 . . . . 0.0 110.849 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 30.1 mt -109.34 132.25 54.3 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.281 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 98.9 mt -119.6 139.06 48.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.668 -179.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 85.1 p -72.68 153.89 40.98 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.527 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.01 -50.19 74.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.714 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.0 t -149.59 154.24 38.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.518 179.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 170.6 -171.06 43.53 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.99 -33.97 88.68 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.446 ' O ' ' OD1' ' A' ' 124' ' ' ASP . 44.0 p-10 -86.93 120.02 27.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.719 0.295 . . . . 0.0 110.685 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 39.5 t -63.05 143.9 57.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.005 0.431 . . . . 0.0 110.453 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.527 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -92.9 -42.92 9.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.871 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.5 tp -62.98 -42.44 99.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.667 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.51 -12.5 60.48 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.524 -179.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 85.2 mt -114.52 -24.02 9.02 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.696 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . 0.527 ' N ' ' O ' ' A' ' 126' ' ' ALA . 80.0 t80 -50.77 -49.68 57.59 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.634 -178.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.502 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 37.8 p-10 -66.14 -42.69 88.76 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.848 0.356 . . . . 0.0 111.22 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.502 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 88.3 mt-30 -66.98 -37.89 85.06 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.823 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 96.0 mt -80.21 -41.43 25.2 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.92 -179.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.2 t -57.14 -44.58 83.51 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.245 -179.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.0 m -61.65 -45.41 94.17 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.75 0.31 . . . . 0.0 110.562 179.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 94.1 mt -62.18 -43.56 98.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.291 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.34 168.46 4.9 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.556 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -50.35 113.68 1.13 Allowed 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.256 1.971 . . . . 0.0 112.221 179.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 24.1 m -84.61 127.45 34.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.494 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 34.4 tp -117.93 135.88 53.84 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.107 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.442 ' O ' ' OD2' ' A' ' 32' ' ' ASP . 82.2 mt -99.61 118.71 46.62 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.31 0 CA-C-O 121.221 0.534 . . . . 0.0 111.179 -179.293 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 98.0 mt -134.99 132.18 53.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.617 179.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.511 HD22 ' CG ' ' A' ' 241' ' ' ASP . 61.3 t30 -66.9 151.5 47.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.911 0.386 . . . . 0.0 110.436 179.414 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.519 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 88.0 t80 -86.54 122.63 30.75 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.847 -179.532 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.519 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 99.1 m-20 55.23 69.17 0.76 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.769 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 35.7 p-10 -125.81 0.4 7.38 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.637 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -150.71 115.47 5.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.706 -179.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' SER . . . . . 0.524 ' HG ' ' H ' ' A' ' 150' ' ' GLN . 83.5 p -63.3 168.18 4.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.534 -179.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.417 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.4 p-90 -51.61 -15.72 0.5 Allowed 'General case' 0 C--O 1.223 -0.315 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.494 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . 0.524 ' H ' ' HG ' ' A' ' 148' ' ' SER . 68.2 tp60 -70.8 -75.54 0.12 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.51 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.455 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.0 t -62.76 -38.71 91.63 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.28 179.474 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 53.9 tp -60.02 -45.66 92.04 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.389 -178.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.417 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 46.6 tp -62.73 -41.63 99.27 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.473 178.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.455 ' OG1' ' O ' ' A' ' 151' ' ' SER . 59.7 p -63.89 -34.76 78.67 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.226 -179.521 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . 0.441 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 88.0 mm-40 -64.07 -42.42 96.99 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.309 179.257 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 90.8 mt -65.39 -38.79 91.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.033 0.444 . . . . 0.0 110.178 179.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.581 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.2 -32.33 80.21 Favored Glycine 0 CA--C 1.52 0.348 0 N-CA-C 110.719 -0.952 . . . . 0.0 110.719 -179.302 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.441 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.2 mt-10 -35.93 -25.98 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.858 0.361 . . . . 0.0 110.806 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.581 ' N ' ' O ' ' A' ' 157' ' ' GLY . 95.6 mt -57.99 148.99 5.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.299 179.236 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 74.7 p -69.24 137.44 53.14 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.979 -179.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 70.77 22.16 78.11 Favored Glycine 0 N--CA 1.458 0.165 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 179.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 58.1 m80 -124.32 -14.46 6.95 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.695 0.283 . . . . 0.0 110.538 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -66.05 -59.92 3.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.649 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -52.0 -48.83 64.26 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.134 -179.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -60.52 -41.22 93.96 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.728 0.299 . . . . 0.0 110.321 179.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.61 -47.18 86.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.517 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.87 -40.1 75.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.246 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -61.7 -50.33 72.88 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.579 179.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 60.1 ttt85 -65.44 -43.73 89.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.54 179.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 94.9 mt -64.72 -43.37 96.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.486 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.38 -51.23 70.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.498 -179.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -63.57 -43.64 96.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.533 179.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . 0.499 ' CD1' ' OH ' ' A' ' 301' ' ' TYR . 56.6 t80 -62.9 -44.29 96.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.087 0.47 . . . . 0.0 110.442 179.417 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -63.65 -39.86 95.4 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.478 -179.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -62.89 -42.87 99.93 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.659 179.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -60.59 -44.7 95.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.207 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 84.2 mt -64.47 -41.05 96.73 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.994 0.425 . . . . 0.0 110.668 178.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.12 -62.18 1.8 Allowed 'General case' 0 C--O 1.237 0.431 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.382 -179.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.52 -46.78 86.05 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.578 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.24 -41.67 65.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.302 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -63.91 -33.67 76.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.393 179.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . 0.4 ' O ' ' HG2' ' A' ' 182' ' ' GLU . 69.5 tt0 -90.54 8.94 31.51 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.437 0.637 . . . . 0.0 110.491 -178.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -105.04 -32.07 8.89 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.174 179.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.8 pt -128.07 147.55 32.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.842 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -139.68 131.05 26.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.395 179.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . 0.555 ' CD2' ' N ' ' A' ' 186' ' ' LEU . 3.6 mm? -85.47 133.46 42.17 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.9 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -44.12 157.8 0.15 Allowed 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.738 2.292 . . . . 0.0 112.235 179.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . 0.518 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.5 Cg_endo -62.89 114.69 2.53 Favored 'Trans proline' 0 C--N 1.303 -1.82 0 C-N-CA 122.813 2.342 . . . . 0.0 111.748 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . 0.518 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.7 mt-30 155.69 147.88 0.0 OUTLIER Pre-proline 0 C--N 1.332 -0.169 0 O-C-N 123.713 0.633 . . . . 0.0 110.838 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -73.85 144.01 34.13 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.673 2.249 . . . . 0.0 112.012 177.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.496 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.0 p -124.78 158.95 31.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.296 0.569 . . . . 0.0 110.125 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' THR . . . . . 0.496 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 37.5 p -143.46 165.39 27.68 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.048 -179.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -135.2 128.58 32.27 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.173 0.511 . . . . 0.0 110.264 179.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 47.9 pt -146.52 148.86 16.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.084 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 68.8 t -117.73 123.06 71.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.312 0.577 . . . . 0.0 109.813 179.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -134.14 106.62 7.28 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.391 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 94.3 m -130.1 130.41 44.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.764 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -82.88 -36.81 25.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.259 179.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.56 -67.14 0.26 Allowed 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.361 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.28 -9.96 59.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.377 179.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 60.2 t-80 60.94 58.47 2.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.901 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 35.5 p -167.23 153.48 8.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.549 179.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.31 144.16 24.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.943 0.402 . . . . 0.0 110.485 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -135.34 138.16 43.12 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.669 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 19.5 mt -106.32 125.46 51.02 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.061 0.458 . . . . 0.0 109.842 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 206' ' ' TRP . . . . . 0.558 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 74.7 m95 -82.07 167.13 19.12 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.676 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -156.9 171.14 7.83 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.595 -179.165 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.43 -37.15 81.67 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 C-N-CA 122.598 2.198 . . . . 0.0 112.219 179.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -70.56 -34.95 72.8 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.836 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 21.0 m -61.28 150.91 33.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.615 -179.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.61 -37.04 82.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.49 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 212' ' ' GLN . . . . . 0.558 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 54.7 tt0 -64.66 -40.33 95.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.579 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.52 -43.46 92.27 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -63.29 -43.73 97.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.81 0.338 . . . . 0.0 110.288 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 65.1 ttp -59.4 -48.12 82.84 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.26 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 88.4 mt -60.49 -40.94 93.13 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 217' ' ' GLU . . . . . 0.454 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.0 tp10 -57.97 -37.74 74.75 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -65.31 -38.08 89.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.787 0.327 . . . . 0.0 110.652 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 94.7 mt -64.27 -42.71 96.32 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.58 -179.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.52 44.73 0.08 OUTLIER Glycine 0 CA--C 1.52 0.392 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 221' ' ' PHE . . . . . 0.454 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 26.5 m-85 -127.78 155.47 44.01 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.075 0.464 . . . . 0.0 110.522 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 222' ' ' THR . . . . . 0.451 ' O ' ' O ' ' A' ' 191' ' ' VAL . 6.7 p -107.1 122.25 46.11 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.266 0.555 . . . . 0.0 110.122 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . 0.444 ' CD2' ' N ' ' A' ' 223' ' ' LEU . 4.3 mm? -101.17 133.15 46.15 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.056 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -97.01 159.34 14.96 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.467 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.32 115.42 30.24 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.954 0.407 . . . . 0.0 110.344 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.458 ' CD1' ' N ' ' A' ' 226' ' ' LEU . 8.8 mp -53.42 156.51 4.18 Favored Pre-proline 0 N--CA 1.452 -0.328 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.696 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -60.02 145.2 98.94 Favored 'Trans proline' 0 C--N 1.301 -1.929 0 C-N-CA 122.682 2.254 . . . . 0.0 112.163 179.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.25 -2.98 59.01 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.605 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.39 -40.83 5.63 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . 0.539 ' O ' ' N ' ' A' ' 233' ' ' SER . 86.2 mt -79.07 -16.98 56.01 Favored 'General case' 0 C--O 1.222 -0.373 0 CA-C-O 121.069 0.461 . . . . 0.0 110.334 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . 0.404 ' C ' ' O ' ' A' ' 230' ' ' LEU . 53.9 t-20 -40.21 -49.12 2.66 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.732 -179.469 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -88.17 15.35 7.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.255 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 233' ' ' SER . . . . . 0.539 ' N ' ' O ' ' A' ' 230' ' ' LEU . 78.0 p -60.49 -35.68 76.51 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.712 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . 0.524 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.5 tt0 -118.35 -69.34 0.86 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.894 179.457 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.2 m -69.98 103.68 2.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.093 0.473 . . . . 0.0 110.691 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -94.88 57.54 2.13 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.366 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -144.92 -122.61 1.57 Allowed Glycine 0 CA--C 1.52 0.346 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -134.4 111.93 10.56 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 121.132 0.491 . . . . 0.0 110.368 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . 0.512 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.5 mtt180 -148.32 57.52 1.07 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.792 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -69.91 -31.87 69.88 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.539 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 241' ' ' ASP . . . . . 0.511 ' CG ' HD22 ' A' ' 143' ' ' ASN . 64.7 t0 -56.92 -46.93 81.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.33 -179.135 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 242' ' ' ILE . . . . . 0.436 ' O ' ' O ' ' A' ' 239' ' ' ARG . 17.4 tt -140.16 156.92 25.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.9 0.381 . . . . 0.0 110.533 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 96.1 mt -106.0 106.19 20.11 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.214 0 CA-C-O 121.163 0.506 . . . . 0.0 110.529 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . 0.512 ' OE1' ' NH1' ' A' ' 239' ' ' ARG . 88.3 mt-30 -110.37 110.26 20.98 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.42 179.674 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 9.5 mp -121.97 -168.25 1.68 Allowed 'General case' 0 C--O 1.226 -0.177 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.605 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . 0.524 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.37 -16.7 0.05 OUTLIER Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . 0.693 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -60.49 157.05 29.84 Favored Glycine 0 CA--C 1.522 0.477 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -63.8 21.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.879 0.371 . . . . 0.0 110.548 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . 0.693 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.9 m-20 -96.95 -5.97 36.69 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.499 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 92.8 mt -79.88 -21.68 43.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.671 179.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.51 -51.17 71.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.784 -179.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.56 -5.52 58.14 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.473 179.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.36 -74.4 1.15 Allowed Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 81.4 mt -69.98 125.77 27.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.011 0.434 . . . . 0.0 110.332 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -59.26 -39.5 83.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.212 -179.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 82.65 51.93 4.11 Favored Glycine 0 CA--C 1.52 0.404 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -96.48 -14.49 22.31 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.712 0.292 . . . . 0.0 110.581 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 258' ' ' SER . . . . . 0.441 ' HG ' ' CG2' ' A' ' 191' ' ' VAL . 3.5 t 174.58 88.36 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.037 0.446 . . . . 0.0 110.165 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . 0.595 ' N ' ' CD1' ' A' ' 259' ' ' LEU . 0.9 OUTLIER -94.2 123.98 37.93 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.183 0.516 . . . . 0.0 111.088 -179.1 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 15.9 m-30 -92.97 146.24 23.77 Favored 'General case' 0 CA--C 1.505 -0.786 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.428 179.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 86.7 mt -122.21 149.96 42.93 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.628 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.66 ' CG ' ' N ' ' A' ' 263' ' ' ALA . 2.6 p90 -77.53 -138.23 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.619 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 263' ' ' ALA . . . . . 0.66 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -52.43 77.44 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.01 0.433 . . . . 0.0 111.074 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . 0.624 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -178.93 104.42 0.19 Allowed Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.666 -0.974 . . . . 0.0 110.666 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 265' ' ' ASP . . . . . 0.601 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.9 m-20 -80.45 -177.8 6.37 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 120.643 0.259 . . . . 0.0 110.862 -179.424 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -40.41 -17.62 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.548 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 267' ' ' LYS . . . . . 0.601 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.48 -51.66 40.98 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 120.998 0.428 . . . . 0.0 110.687 179.386 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -63.64 -46.72 84.4 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.212 179.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . 0.525 ' O ' ' CD2' ' A' ' 273' ' ' TYR . . . -61.64 -35.08 76.89 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.218 0.532 . . . . 0.0 109.84 179.65 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -63.11 -34.09 76.85 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.045 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.73 -43.37 13.43 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.175 -179.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 272' ' ' ILE . . . . . 0.617 ' C ' ' H ' ' A' ' 274' ' ' ALA . 4.9 tt -51.43 -33.53 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.815 -178.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 273' ' ' TYR . . . . . 0.525 ' CD2' ' O ' ' A' ' 269' ' ' ALA . 17.2 m-85 -54.49 -1.74 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.681 -179.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 274' ' ' ALA . . . . . 0.617 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.55 -39.61 70.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.842 179.525 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . 0.583 ' O ' ' N ' ' A' ' 279' ' ' ALA . 3.1 p30 -39.32 98.06 0.16 Allowed Pre-proline 0 C--O 1.226 -0.144 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.495 -179.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -54.29 -42.92 63.26 Favored 'Trans proline' 0 C--N 1.303 -1.856 0 C-N-CA 122.385 2.056 . . . . 0.0 112.533 -178.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 88.8 mt -64.46 -42.84 95.71 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.103 0.478 . . . . 0.0 111.138 -179.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 90.6 mt -95.67 -1.68 49.62 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.887 -179.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 279' ' ' ALA . . . . . 0.583 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.38 -34.81 77.44 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.668 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.29 20.26 0.11 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.968 -179.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . 0.514 ' H ' ' C ' ' A' ' 279' ' ' ALA . 13.8 mt -75.47 119.89 79.11 Favored Pre-proline 0 N--CA 1.451 -0.423 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.56 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -50.49 -39.41 54.9 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 122.66 2.24 . . . . 0.0 111.951 178.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.75 -50.55 63.25 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.149 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 78.8 t -61.4 -44.02 97.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 179.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -57.74 -41.15 81.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.252 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -90.98 -0.03 57.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.2 179.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt 59.47 43.58 16.05 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.872 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -94.81 41.41 1.09 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.387 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 53.8 t -119.08 135.8 58.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.047 0.451 . . . . 0.0 110.173 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -133.01 162.56 31.37 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.645 -179.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.7 155.11 33.06 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.943 0.401 . . . . 0.0 110.754 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 81.4 mt -93.91 -1.43 54.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.302 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.38 165.93 12.77 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 6.5 m -87.61 -62.39 1.51 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.888 0.375 . . . . 0.0 110.945 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 295' ' ' GLU . . . . . 0.468 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.5 mm-40 -69.54 -3.83 16.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.645 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 27.2 p -76.94 33.27 0.14 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.663 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 297' ' ' PHE . . . . . 0.468 ' H ' ' C ' ' A' ' 295' ' ' GLU . 85.1 t80 -60.21 -46.01 91.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.618 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . 0.595 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.2 mtt85 -81.71 134.6 35.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.584 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 16.3 tp -114.27 119.07 35.73 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-O 121.006 0.431 . . . . 0.0 110.19 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . 0.607 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.9 p-10 -166.52 -175.09 3.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.577 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 301' ' ' TYR . . . . . 0.499 ' OH ' ' CD1' ' A' ' 173' ' ' PHE . 81.5 t80 -47.78 -44.72 28.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.292 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -65.59 -41.16 93.14 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.021 0.438 . . . . 0.0 110.701 178.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 303' ' ' SER . . . . . 0.607 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 54.0 p -55.58 -36.16 66.56 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.042 -179.219 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -57.07 -51.65 68.43 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 90.9 mtp -56.23 -43.87 79.03 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -66.29 -42.68 88.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.029 0.442 . . . . 0.0 110.284 178.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 55.8 t -64.08 -42.75 96.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.208 179.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 42.6 tp -59.57 -42.2 91.91 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.816 -179.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -62.72 -38.83 92.04 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.148 179.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 310' ' ' ARG . . . . . 0.439 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.6 ttt85 -63.33 -44.09 95.89 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.216 179.594 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 88.3 mt -63.24 -42.06 99.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.255 179.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -62.85 -33.03 74.4 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.124 179.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -90.17 -23.32 21.35 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.352 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . 0.439 ' N ' ' O ' ' A' ' 310' ' ' ARG . 6.8 tt -62.33 -43.23 99.3 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 121.041 0.448 . . . . 0.0 110.531 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 . . . . . 0 C--O 1.22 -0.453 0 CA-C-O 117.97 -1.014 . . . . 0.0 110.436 -179.949 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -99.8 135.81 40.66 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.114 0.483 . . . . 0.0 110.503 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.497 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -91.63 178.7 1.64 Allowed Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.53 -179.857 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.497 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.4 Cg_exo -61.62 147.67 94.82 Favored 'Trans proline' 0 C--N 1.3 -2.023 0 C-N-CA 122.901 2.401 . . . . 0.0 112.113 179.53 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 35.1 ptt180 -135.02 142.16 46.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.64 179.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -78.93 116.95 19.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.51 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.6 tp -110.53 131.27 62.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.445 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.9 t -70.84 142.93 51.24 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.655 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 141' ' ' ILE . 24.6 t70 -141.05 177.36 8.11 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.468 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.454 ' OG ' ' O ' ' A' ' 141' ' ' ILE . 78.3 p -73.15 -36.75 66.7 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.696 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -47.68 -95.01 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.303 -179.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.425 ' C ' ' HG1' ' A' ' 36' ' ' THR . . . -165.95 -25.28 0.02 OUTLIER Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.425 ' HG1' ' C ' ' A' ' 35' ' ' GLY . 58.2 m -168.93 106.74 0.43 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.862 0.363 . . . . 0.0 110.632 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 36.4 t60 -129.79 144.49 51.33 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 121.066 0.46 . . . . 0.0 110.114 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.485 ' CG2' ' N ' ' A' ' 39' ' ' LEU . 97.2 m -128.59 166.63 18.49 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.49 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.485 ' N ' ' CG2' ' A' ' 38' ' ' THR . 82.2 mt -121.15 127.8 51.9 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.43 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -64.17 -44.48 91.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.716 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 37.9 p -165.55 155.03 12.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.387 179.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.458 ' N ' ' CD ' ' A' ' 42' ' ' GLN . 14.4 mp0 -42.71 100.28 0.22 Allowed Pre-proline 0 C--N 1.33 -0.261 0 O-C-N 123.352 0.408 . . . . 0.0 110.594 179.261 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -56.88 129.07 32.59 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 122.313 2.008 . . . . 0.0 112.239 -179.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -83.82 -24.13 31.1 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.552 179.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.541 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.5 mtm-85 -121.18 134.11 55.2 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.202 0.525 . . . . 0.0 110.192 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.0 mt -130.43 133.51 63.68 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.272 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.798 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 47.5 t -125.0 130.89 73.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 179.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.502 ' O ' ' O ' ' A' ' 66' ' ' ALA . 5.0 m -154.05 166.48 32.89 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.586 179.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 70.0 p -124.83 8.37 8.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.435 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.81 125.87 33.59 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.643 -179.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 86.5 t -65.7 -44.61 93.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.543 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.7 m -62.62 -44.15 97.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.561 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 53.5 tp -62.38 -41.58 98.74 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.534 -179.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 72.5 m -57.83 -44.42 86.45 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.267 -179.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.4 -62.17 5.34 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 179.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.6 t -48.18 -35.62 12.08 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.8 mt -61.86 -44.34 97.01 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.229 179.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.2 mp -65.43 -41.49 93.48 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.246 178.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.58 -41.13 98.4 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.906 -179.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.0 tp -88.21 16.73 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.857 -179.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 56.51 84.34 0.09 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.753 -179.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.24 57.98 0.07 OUTLIER Pre-proline 0 C--N 1.328 -0.359 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -179.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -51.13 153.39 9.31 Favored 'Trans proline' 0 C--N 1.293 -2.351 0 C-N-CA 123.029 2.486 . . . . 0.0 112.11 -178.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.429 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -109.06 146.01 15.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.332 -179.681 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 97.0 mt -63.62 -45.48 97.43 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.338 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.502 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -129.8 134.58 47.66 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.519 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.482 ' O ' ' N ' ' A' ' 98' ' ' LEU . 73.3 m -134.57 158.82 43.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.838 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.99 139.36 16.17 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.467 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.93 -162.66 0.08 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.967 0.413 . . . . 0.0 110.423 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.482 ' O ' ' C ' ' A' ' 71' ' ' THR . 13.8 t -133.45 135.49 44.58 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.389 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.482 ' C ' ' O ' ' A' ' 70' ' ' THR . 0.7 OUTLIER 29.72 68.94 0.64 Allowed Pre-proline 0 N--CA 1.466 0.354 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.729 -179.883 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_exo -61.52 145.39 97.9 Favored 'Trans proline' 0 C--N 1.3 -2.026 0 C-N-CA 122.714 2.276 . . . . 0.0 111.837 -178.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.527 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 46.4 p-10 -160.49 -31.96 0.06 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.742 179.69 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.527 ' N ' ' OD1' ' A' ' 73' ' ' ASN . 99.1 m-20 -64.51 -39.21 93.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.317 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 -60.63 -48.09 83.32 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.52 -179.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.426 ' O ' ' O ' ' A' ' 77' ' ' ALA . 94.0 t -60.19 -24.9 31.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.373 -0.376 . . . . 0.0 109.999 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.426 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -45.45 172.69 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.648 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.568 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.7 p30 -61.67 177.57 0.4 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.513 -179.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.6 ' C ' ' H ' ' A' ' 81' ' ' GLY . 36.0 p30 -46.27 85.65 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.005 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.568 ' N ' ' O ' ' A' ' 78' ' ' ASP . 42.8 tp60 -67.08 13.54 0.06 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.194 0.521 . . . . 0.0 110.169 -179.822 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.6 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 117.87 -21.93 10.13 Favored Glycine 0 N--CA 1.461 0.309 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -107.83 116.29 31.69 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.985 0.422 . . . . 0.0 110.466 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 75.7 mt -98.84 0.79 44.99 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.502 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -91.94 6.5 46.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.019 0.438 . . . . 0.0 110.397 -179.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.445 ' O ' ' CG2' ' A' ' 89' ' ' VAL . 88.2 mt-30 -100.16 -27.0 13.75 Favored 'General case' 0 C--O 1.222 -0.385 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.78 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.4 t-105 -64.31 -40.64 96.34 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.021 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.551 ' O ' ' N ' ' A' ' 91' ' ' LYS . 68.5 m -77.75 -53.75 7.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.164 -179.567 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -48.33 -50.55 29.91 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.08 -179.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.445 ' CG2' ' O ' ' A' ' 85' ' ' GLN . 14.8 m -69.08 -40.88 81.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 120.9 0.381 . . . . 0.0 111.113 179.602 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.414 ' H ' HG23 ' A' ' 89' ' ' VAL . . . -71.94 -22.82 61.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.655 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.551 ' N ' ' O ' ' A' ' 87' ' ' SER . 65.8 tttm -61.64 -46.13 91.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.428 -179.512 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.441 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.8 mm-40 -90.15 -94.44 0.12 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.152 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.62 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.9 mtt180 -143.49 59.79 1.39 Allowed 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.451 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.6 pttp 33.87 26.28 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.017 0.437 . . . . 0.0 110.286 -179.405 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.62 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.5 tt -48.27 123.14 6.03 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.011 -177.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -83.41 -170.6 3.13 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.148 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.62 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 82.5 mtp180 -73.12 137.85 45.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.308 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.482 ' N ' ' O ' ' A' ' 67' ' ' SER . 88.7 mt -86.58 -166.14 1.47 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.793 -179.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.532 ' CD2' ' O ' ' A' ' 99' ' ' TYR . 47.8 p90 -167.89 119.9 0.86 Allowed 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.198 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.5 ' C ' ' O ' ' A' ' 99' ' ' TYR . 43.4 mm -29.44 121.18 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.005 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 113.64 28.25 3.28 Favored Glycine 0 CA--C 1.519 0.342 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 -179.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.58 ' N ' ' CD ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -144.0 46.15 0.62 Allowed Pre-proline 0 C--N 1.323 -0.582 0 CA-C-O 121.013 0.435 . . . . 0.0 110.428 179.764 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 29.5 Cg_endo -62.29 143.87 94.55 Favored 'Trans proline' 0 C--N 1.295 -2.246 0 C-N-CA 122.684 2.256 . . . . 0.0 111.844 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.686 ' HG ' ' H ' ' A' ' 107' ' ' ALA . 26.8 t -173.13 120.69 0.36 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.319 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.37 -40.94 63.97 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.075 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -65.92 -39.86 90.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.814 -179.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.686 ' H ' ' HG ' ' A' ' 104' ' ' SER . . . -64.01 -39.64 94.56 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.771 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 69.0 t -67.72 -43.74 86.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.724 179.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.43 -39.29 92.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.446 -179.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.441 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.66 -23.71 63.29 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.496 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.549 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.3 mm-40 -91.39 5.13 50.53 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.722 -179.563 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.549 ' C ' ' O ' ' A' ' 111' ' ' GLN . 10.4 tpt 21.96 64.84 0.32 Allowed Pre-proline 0 N--CA 1.467 0.408 0 CA-C-O 120.934 0.397 . . . . 0.0 111.157 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -79.45 169.59 18.43 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 123.023 2.482 . . . . 0.0 111.698 -177.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.491 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 98.9 m-20 -113.12 -44.07 3.31 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.022 179.6 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.3 tp -120.09 120.69 36.98 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 96.4 mt -118.24 130.87 72.46 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.342 0 CA-C-O 120.904 0.383 . . . . 0.0 110.962 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 32.3 mt -105.77 132.71 51.56 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.04 0.448 . . . . 0.0 110.287 -179.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 97.9 mt -117.9 135.74 57.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.673 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 85.5 p -71.7 153.42 42.05 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.593 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.11 -50.2 74.62 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.635 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -149.34 153.8 38.0 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.52 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 169.88 -170.51 42.85 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -63.08 -35.14 91.68 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.453 ' O ' ' OD1' ' A' ' 124' ' ' ASP . 44.4 p-10 -87.75 119.52 28.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.834 0.349 . . . . 0.0 110.701 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 41.1 t -63.47 144.51 56.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.406 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.61 -42.33 9.25 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.775 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.4 tp -62.86 -42.22 99.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.649 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.41 -11.11 59.18 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.441 -179.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 84.5 mt -114.92 -24.55 8.58 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.647 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . 0.519 ' N ' ' O ' ' A' ' 126' ' ' ALA . 80.8 t80 -51.37 -49.91 60.58 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.649 -178.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.502 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.8 p-10 -65.72 -41.91 91.7 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.879 0.371 . . . . 0.0 111.317 179.429 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.502 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 87.8 mt-30 -67.88 -37.16 81.43 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.847 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 93.7 mt -79.7 -42.37 24.81 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.987 -179.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.3 t -56.94 -44.96 83.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.298 -179.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.8 m -62.32 -45.58 92.6 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.58 179.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 92.9 mt -62.49 -44.03 98.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.391 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.86 164.2 6.39 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.598 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -43.32 111.66 0.24 Allowed 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.507 2.138 . . . . 0.0 112.243 179.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 17.1 m -86.12 127.34 34.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.675 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 34.9 tp -119.48 137.48 53.76 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.107 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.454 ' O ' ' OG ' ' A' ' 33' ' ' SER . 78.2 mt -104.82 120.74 55.79 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 CA-C-O 121.154 0.502 . . . . 0.0 111.213 -179.352 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 94.3 mt -136.44 132.55 49.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.576 179.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.517 HD22 ' CG ' ' A' ' 241' ' ' ASP . 56.1 t30 -64.47 151.65 43.77 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.941 0.4 . . . . 0.0 110.43 179.262 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.522 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 88.1 t80 -85.57 122.71 30.08 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.966 -179.492 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.522 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 99.0 m-20 54.95 69.44 0.73 Allowed 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.741 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 49.3 p-10 -123.87 0.07 8.56 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.844 0.354 . . . . 0.0 110.638 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -151.46 117.03 5.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.766 -179.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' SER . . . . . 0.519 ' HG ' ' H ' ' A' ' 150' ' ' GLN . 85.1 p -62.91 167.6 4.59 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.558 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.409 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.5 p-90 -50.56 -15.69 0.29 Allowed 'General case' 0 C--O 1.223 -0.322 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.469 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . 0.519 ' H ' ' HG ' ' A' ' 148' ' ' SER . 68.0 tp60 -71.3 -74.57 0.15 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.496 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.448 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.2 t -62.75 -39.07 92.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.18 179.572 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 52.1 tp -60.08 -45.7 92.05 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.403 -178.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.409 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 46.8 tp -62.67 -41.64 99.19 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.529 178.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.448 ' OG1' ' O ' ' A' ' 151' ' ' SER . 53.4 p -64.02 -34.71 78.63 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.192 -179.425 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . 0.48 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.8 mm-40 -63.82 -42.08 97.73 Favored 'General case' 0 C--O 1.226 -0.178 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.273 179.26 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 90.8 mt -65.44 -38.82 91.0 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.096 0.474 . . . . 0.0 110.203 179.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.567 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.46 -31.94 79.31 Favored Glycine 0 CA--C 1.52 0.353 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 -179.267 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.48 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.3 mt-10 -37.04 -25.17 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.818 0.342 . . . . 0.0 110.799 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.567 ' N ' ' O ' ' A' ' 157' ' ' GLY . 93.4 mt -59.79 149.63 6.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.323 179.285 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 76.5 p -68.99 137.26 53.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.935 -179.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 70.36 22.47 77.63 Favored Glycine 0 N--CA 1.459 0.184 0 N-CA-C 111.211 -0.756 . . . . 0.0 111.211 179.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 62.0 m80 -124.29 -14.63 6.92 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.681 0.276 . . . . 0.0 110.48 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -67.02 -59.41 3.5 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.628 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -51.78 -49.26 63.04 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.119 -179.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -60.7 -41.09 94.5 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.894 -0.322 . . . . 0.0 110.45 179.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.48 -47.69 84.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.567 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.53 -40.25 74.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.244 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -61.56 -50.1 74.01 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.631 179.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -65.3 -43.57 90.68 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.523 179.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 94.4 mt -64.61 -43.38 96.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.366 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.35 -51.41 69.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.378 -179.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -63.51 -43.69 96.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.614 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . 0.519 ' CD1' ' OH ' ' A' ' 301' ' ' TYR . 56.3 t80 -62.88 -44.32 96.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.077 0.465 . . . . 0.0 110.407 179.475 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -63.32 -39.61 95.04 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.659 -179.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -63.15 -42.78 99.5 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.55 179.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -60.76 -44.74 96.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.238 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 85.1 mt -64.66 -41.05 96.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.73 178.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.12 -62.21 1.78 Allowed 'General case' 0 C--O 1.238 0.479 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.37 -179.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.61 -46.66 86.54 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.58 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.27 -41.49 65.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.34 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -64.05 -33.78 76.54 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.011 0.434 . . . . 0.0 110.235 179.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 69.7 tt0 -90.76 8.86 32.51 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.538 0.685 . . . . 0.0 110.371 -178.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -104.73 -32.13 9.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.18 179.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.7 pt -127.96 147.69 32.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.807 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -139.98 131.23 26.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.428 179.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . 0.554 ' CD2' ' N ' ' A' ' 186' ' ' LEU . 3.5 mm? -85.38 133.15 42.95 Favored Pre-proline 0 N--CA 1.452 -0.358 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.077 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -43.78 157.86 0.13 Allowed 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.714 2.276 . . . . 0.0 112.316 179.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . 0.51 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.6 Cg_endo -62.91 114.84 2.6 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 C-N-CA 122.804 2.336 . . . . 0.0 111.746 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . 0.51 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.7 mt-30 155.63 147.69 0.0 OUTLIER Pre-proline 0 N--CA 1.457 -0.113 0 O-C-N 123.916 0.76 . . . . 0.0 110.825 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -73.48 144.18 35.81 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.672 2.248 . . . . 0.0 112.213 177.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.492 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.1 p -124.96 158.97 32.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.319 0.581 . . . . 0.0 110.212 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' THR . . . . . 0.492 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 35.8 p -143.28 165.11 28.38 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.034 -179.704 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -135.38 128.72 32.15 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 121.244 0.545 . . . . 0.0 110.281 179.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 47.5 pt -146.46 148.87 16.55 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.348 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.13 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 69.0 t -117.59 123.23 71.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.32 0.581 . . . . 0.0 109.836 178.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -134.4 107.01 7.35 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.336 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 95.3 m -130.7 130.59 44.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.813 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.405 ' O ' ' N ' ' A' ' 201' ' ' HIS . . . -82.82 -37.04 25.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.21 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.33 -67.21 0.25 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.328 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.16 -9.84 58.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.299 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . 0.405 ' N ' ' O ' ' A' ' 198' ' ' ALA . 59.8 t-80 60.64 58.34 2.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.85 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 31.8 p -167.21 153.76 8.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.555 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.3 144.04 24.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.049 0.452 . . . . 0.0 110.398 179.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -135.18 138.01 43.23 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.714 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 19.7 mt -105.96 125.32 50.85 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.083 0.468 . . . . 0.0 109.843 -179.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 206' ' ' TRP . . . . . 0.554 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 74.6 m95 -81.98 166.98 19.35 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.543 -179.693 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -157.21 171.24 7.7 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.581 -179.083 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.31 -36.92 80.28 Favored 'Trans proline' 0 C--N 1.302 -1.874 0 C-N-CA 122.612 2.208 . . . . 0.0 112.32 179.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -70.86 -35.02 72.21 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.713 -179.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 21.5 m -61.16 150.64 33.62 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.602 -179.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.68 -37.0 82.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.445 -179.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 212' ' ' GLN . . . . . 0.554 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 54.9 tt0 -64.7 -40.26 95.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.498 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.71 -43.44 91.87 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -63.11 -43.96 96.97 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.803 0.335 . . . . 0.0 110.283 179.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 65.1 ttp -59.26 -48.12 82.81 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.123 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 87.3 mt -60.52 -41.04 93.61 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 217' ' ' GLU . . . . . 0.451 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.0 tp10 -57.94 -37.89 74.93 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.059 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -65.34 -38.18 89.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.655 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 94.2 mt -64.08 -42.93 96.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.074 0.464 . . . . 0.0 110.596 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.89 44.74 0.08 OUTLIER Glycine 0 C--N 1.332 0.339 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 221' ' ' PHE . . . . . 0.451 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 26.3 m-85 -127.74 155.64 43.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.987 0.422 . . . . 0.0 110.498 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 222' ' ' THR . . . . . 0.449 ' O ' ' O ' ' A' ' 191' ' ' VAL . 7.4 p -107.36 122.49 46.7 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.285 0.564 . . . . 0.0 110.132 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . 0.44 ' CD2' ' N ' ' A' ' 223' ' ' LEU . 4.3 mm? -101.64 132.7 47.18 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.101 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.4 159.95 14.67 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.476 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.55 115.36 30.11 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.348 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.451 ' CD1' ' N ' ' A' ' 226' ' ' LEU . 8.9 mp -53.37 156.7 3.94 Favored Pre-proline 0 N--CA 1.452 -0.36 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.725 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -59.91 145.1 99.13 Favored 'Trans proline' 0 C--N 1.301 -1.959 0 C-N-CA 122.688 2.259 . . . . 0.0 112.226 179.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.3 -3.14 59.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.584 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.14 -41.0 5.66 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 111.034 -0.827 . . . . 0.0 111.034 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . 0.524 ' O ' ' N ' ' A' ' 233' ' ' SER . 85.3 mt -79.12 -16.98 55.91 Favored 'General case' 0 C--O 1.22 -0.45 0 CA-C-O 121.062 0.458 . . . . 0.0 110.326 -179.694 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 54.5 t-20 -40.43 -49.06 2.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.77 -179.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -87.97 15.16 7.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.323 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 233' ' ' SER . . . . . 0.524 ' N ' ' O ' ' A' ' 230' ' ' LEU . 77.9 p -60.43 -35.41 75.75 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.711 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . 0.526 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.6 tt0 -118.8 -69.36 0.85 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.901 179.329 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.2 m -69.95 102.88 2.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.707 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -94.31 57.72 2.35 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.339 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -144.71 -122.65 1.59 Allowed Glycine 0 CA--C 1.519 0.332 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -134.79 111.62 10.06 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.125 0.488 . . . . 0.0 110.371 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . 0.521 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.4 mtt180 -148.03 57.94 1.09 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.672 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -69.68 -31.88 70.18 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.538 179.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 241' ' ' ASP . . . . . 0.517 ' CG ' HD22 ' A' ' 143' ' ' ASN . 64.7 t0 -56.98 -47.09 81.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.328 -179.096 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 242' ' ' ILE . . . . . 0.435 ' O ' ' O ' ' A' ' 239' ' ' ARG . 17.6 tt -140.19 156.92 24.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.904 0.383 . . . . 0.0 110.475 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 96.2 mt -106.17 106.58 20.85 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.199 0 CA-C-O 121.097 0.475 . . . . 0.0 110.531 179.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . 0.521 ' OE1' ' NH1' ' A' ' 239' ' ' ARG . 88.2 mt-30 -110.51 110.17 20.79 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.363 179.687 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 9.5 mp -121.68 -168.33 1.68 Allowed 'General case' 0 C--O 1.224 -0.264 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.639 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . 0.526 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.61 -16.64 0.05 OUTLIER Glycine 0 CA--C 1.523 0.564 0 N-CA-C 110.999 -0.841 . . . . 0.0 110.999 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . 0.693 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -60.81 156.81 31.64 Favored Glycine 0 CA--C 1.522 0.476 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -63.73 21.79 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.012 0.434 . . . . 0.0 110.643 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . 0.693 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.7 m-20 -97.44 -5.97 34.94 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.515 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 92.2 mt -79.78 -21.71 44.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.769 179.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.51 -51.37 70.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.715 -179.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.37 -5.48 58.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.494 179.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.08 -74.39 1.14 Allowed Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 81.5 mt -70.0 125.98 28.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.908 0.385 . . . . 0.0 110.297 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -59.91 -39.07 84.16 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.208 -179.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 83.29 51.69 4.05 Favored Glycine 0 CA--C 1.521 0.423 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -95.2 -15.67 23.09 Favored 'General case' 0 C--N 1.331 -0.214 0 O-C-N 122.746 -0.267 . . . . 0.0 110.591 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 258' ' ' SER . . . . . 0.426 ' O ' ' O ' ' A' ' 192' ' ' THR . 3.3 t 174.54 89.3 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.099 0.476 . . . . 0.0 110.1 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . 0.591 ' N ' ' CD1' ' A' ' 259' ' ' LEU . 1.0 OUTLIER -94.4 124.24 38.3 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.206 0.527 . . . . 0.0 111.259 -179.072 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 15.9 m-30 -93.34 146.41 23.75 Favored 'General case' 0 CA--C 1.501 -0.917 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.395 179.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 85.9 mt -122.25 149.7 43.32 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.551 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.655 ' CG ' ' N ' ' A' ' 263' ' ' ALA . 2.6 p90 -77.37 -138.69 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.666 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 263' ' ' ALA . . . . . 0.655 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -51.78 77.35 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 121.035 0.445 . . . . 0.0 111.174 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . 0.626 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.15 104.75 0.19 Allowed Glycine 0 CA--C 1.527 0.824 0 N-CA-C 110.554 -1.019 . . . . 0.0 110.554 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 265' ' ' ASP . . . . . 0.601 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.7 m-20 -80.34 -177.94 6.39 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.64 0.257 . . . . 0.0 110.928 -179.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -40.26 -17.73 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.576 179.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 267' ' ' LYS . . . . . 0.601 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.31 -51.74 41.34 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.71 179.287 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -63.55 -46.64 85.04 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.236 179.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . 0.525 ' O ' ' CD2' ' A' ' 273' ' ' TYR . . . -61.66 -35.04 76.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.349 0.595 . . . . 0.0 109.843 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -63.09 -34.06 76.79 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.204 179.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.87 -43.28 13.39 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.108 -179.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 272' ' ' ILE . . . . . 0.618 ' C ' ' H ' ' A' ' 274' ' ' ALA . 4.8 tt -51.31 -33.48 14.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.737 -178.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 273' ' ' TYR . . . . . 0.525 ' CD2' ' O ' ' A' ' 269' ' ' ALA . 17.1 m-85 -54.81 -1.72 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.665 -179.44 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 274' ' ' ALA . . . . . 0.618 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.65 -39.81 70.11 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.952 179.428 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . 0.58 ' O ' ' N ' ' A' ' 279' ' ' ALA . 3.2 p30 -39.02 98.05 0.16 Allowed Pre-proline 0 C--O 1.227 -0.124 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.474 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -54.48 -42.81 64.63 Favored 'Trans proline' 0 C--N 1.303 -1.862 0 C-N-CA 122.42 2.08 . . . . 0.0 112.543 -178.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 89.3 mt -64.4 -42.91 95.83 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.126 0.488 . . . . 0.0 111.158 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 91.2 mt -95.57 -1.77 49.78 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.874 -179.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 279' ' ' ALA . . . . . 0.58 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.25 -34.87 77.36 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.755 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.2 20.11 0.11 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.998 -179.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . 0.513 ' H ' ' C ' ' A' ' 279' ' ' ALA . 13.9 mt -75.2 119.69 78.16 Favored Pre-proline 0 N--CA 1.448 -0.545 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.688 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -49.97 -40.01 49.61 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.678 2.252 . . . . 0.0 112.238 178.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.56 -50.56 62.7 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.118 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 71.8 t -61.46 -43.82 97.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 110.04 -0.355 . . . . 0.0 110.04 179.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -57.84 -41.28 81.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.198 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -90.96 0.29 57.56 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.129 179.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt 59.47 43.04 16.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.844 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -94.49 41.51 1.09 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.429 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 53.8 t -119.03 135.62 58.87 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.156 0 CA-C-O 121.072 0.463 . . . . 0.0 110.111 -179.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -132.85 162.75 30.71 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.153 0.502 . . . . 0.0 110.629 -179.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.69 154.98 33.28 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.015 0.436 . . . . 0.0 110.699 -179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 81.6 mt -93.96 -1.52 54.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.247 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.66 165.88 12.71 Favored Glycine 0 CA--C 1.521 0.45 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 6.5 m -87.8 -62.2 1.55 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.864 0.364 . . . . 0.0 111.008 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 295' ' ' GLU . . . . . 0.484 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.6 mm-40 -69.35 -4.08 16.78 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.701 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 27.0 p -76.46 32.8 0.13 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.645 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 297' ' ' PHE . . . . . 0.484 ' H ' ' C ' ' A' ' 295' ' ' GLU . 85.7 t80 -60.39 -46.06 91.32 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.573 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . 0.62 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.2 mtt85 -81.45 135.06 35.62 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.569 -179.637 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 17.0 tp -114.24 117.77 32.07 Favored 'General case' 0 C--O 1.231 0.085 0 CA-C-O 121.005 0.431 . . . . 0.0 110.182 179.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . 0.603 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.4 p-10 -165.42 -176.38 3.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.624 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 301' ' ' TYR . . . . . 0.519 ' OH ' ' CD1' ' A' ' 173' ' ' PHE . 80.2 t80 -47.07 -43.39 20.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.348 -179.65 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -67.01 -40.49 87.3 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.024 0.44 . . . . 0.0 110.747 179.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 303' ' ' SER . . . . . 0.603 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 60.3 p -55.71 -36.5 67.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.074 -179.193 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -57.08 -51.69 68.27 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 179.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 91.2 mtp -55.97 -43.92 78.01 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -66.2 -42.64 88.51 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.141 0.495 . . . . 0.0 110.257 179.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 55.4 t -64.15 -42.82 96.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.26 179.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 43.1 tp -59.74 -42.15 92.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.871 -179.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -62.63 -38.78 91.57 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.237 179.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 310' ' ' ARG . . . . . 0.45 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.6 ttt85 -63.56 -43.86 95.8 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.246 179.538 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 90.3 mt -63.0 -42.12 99.77 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.311 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -62.94 -33.16 74.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.113 179.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.97 -23.31 21.57 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.318 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . 0.45 ' N ' ' O ' ' A' ' 310' ' ' ARG . 6.7 tt -62.27 -43.19 99.4 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 121.055 0.455 . . . . 0.0 110.52 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 . . . . . 0 C--O 1.22 -0.466 0 CA-C-O 118.055 -0.974 . . . . 0.0 110.405 -179.95 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -99.63 136.43 39.58 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.016 0.436 . . . . 0.0 110.538 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.497 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -91.71 178.46 1.74 Allowed Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.58 -179.882 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.497 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.5 Cg_exo -61.69 147.5 95.18 Favored 'Trans proline' 0 C--N 1.3 -2.007 0 C-N-CA 122.778 2.318 . . . . 0.0 112.123 179.639 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 35.4 ptt180 -135.76 142.65 44.98 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.655 179.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -79.11 116.96 19.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.501 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.6 tp -110.32 130.86 62.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.408 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 13.3 t -71.14 141.93 50.74 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.53 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.429 ' CG ' ' H ' ' A' ' 33' ' ' SER . 25.1 t70 -139.87 177.88 7.65 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.517 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.449 ' OG ' ' O ' ' A' ' 141' ' ' ILE . 78.0 p -73.73 -36.59 65.2 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.688 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.8 ttt85 -47.78 -95.25 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.269 -179.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.517 ' C ' ' HG1' ' A' ' 36' ' ' THR . . . -165.22 -26.06 0.02 OUTLIER Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.517 ' HG1' ' C ' ' A' ' 35' ' ' GLY . 67.5 m -168.32 106.79 0.49 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.889 0.376 . . . . 0.0 110.652 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 33.4 t60 -129.71 143.56 50.88 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.027 0.442 . . . . 0.0 110.152 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.481 ' CG2' ' N ' ' A' ' 39' ' ' LEU . 97.5 m -128.18 166.12 19.13 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.636 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.481 ' N ' ' CG2' ' A' ' 38' ' ' THR . 81.1 mt -120.78 127.61 52.12 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.523 179.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -64.42 -44.26 91.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.656 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 41.5 p -165.68 154.84 11.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.424 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.452 ' N ' ' CD ' ' A' ' 42' ' ' GLN . 13.7 mp0 -43.42 100.69 0.23 Allowed Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.636 179.467 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -56.85 129.33 34.01 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 122.399 2.066 . . . . 0.0 112.262 -179.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -83.88 -23.95 31.05 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.45 179.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.544 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.3 mtm-85 -120.9 134.26 55.29 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 121.132 0.492 . . . . 0.0 110.202 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 95.9 mt -130.65 133.48 63.39 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.939 -179.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 49.1 t -125.05 131.06 73.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.825 0.345 . . . . 0.0 110.119 179.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.51 ' O ' ' O ' ' A' ' 66' ' ' ALA . 5.1 m -154.41 166.16 34.13 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.506 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 65.0 p -124.94 8.5 8.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.501 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.71 125.75 33.44 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.686 -179.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 88.6 t -65.75 -44.65 93.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.47 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 20.0 m -62.53 -44.29 96.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.605 -179.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 51.2 tp -62.28 -41.51 98.55 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.572 -179.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 70.6 m -57.67 -44.36 85.7 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.343 -179.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.48 -61.91 5.55 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.929 -0.869 . . . . 0.0 110.929 179.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.7 t -48.51 -35.67 13.64 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 20.0 mt -61.77 -44.72 96.33 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.661 -0.416 . . . . 0.0 111.126 179.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.403 HD12 ' N ' ' A' ' 58' ' ' LEU . 9.2 mp -64.96 -41.8 95.16 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.189 178.024 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.62 -41.27 98.29 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.947 -179.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.0 tp -88.13 16.7 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.771 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 56.61 84.28 0.09 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.653 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.37 57.38 0.07 OUTLIER Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.058 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -50.3 153.19 7.39 Favored 'Trans proline' 0 C--N 1.296 -2.199 0 C-N-CA 122.874 2.383 . . . . 0.0 112.388 -178.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.428 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.4 OUTLIER -109.03 146.38 14.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.367 -179.699 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 97.1 mt -63.79 -45.16 97.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.368 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.51 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -130.31 134.83 47.49 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.575 -179.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.464 ' O ' ' N ' ' A' ' 98' ' ' LEU . 73.8 m -134.52 158.73 43.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.843 -179.675 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.35 138.94 16.3 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.46 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.86 -162.7 0.08 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.996 0.427 . . . . 0.0 110.515 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.492 ' O ' ' C ' ' A' ' 71' ' ' THR . 5.9 t -133.74 135.94 44.27 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.192 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.492 ' C ' ' O ' ' A' ' 70' ' ' THR . 1.0 OUTLIER 29.55 68.57 0.65 Allowed Pre-proline 0 N--CA 1.465 0.3 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.715 -179.7 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -61.25 144.57 98.8 Favored 'Trans proline' 0 C--N 1.301 -1.964 0 C-N-CA 122.668 2.245 . . . . 0.0 112.092 -178.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.519 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 45.7 p-10 -159.87 -31.61 0.06 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.717 179.709 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.519 ' N ' ' OD1' ' A' ' 73' ' ' ASN . 98.7 m-20 -64.52 -38.92 92.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.46 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 73.2 ttt180 -60.87 -47.9 84.25 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.752 -179.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.422 ' O ' ' O ' ' A' ' 77' ' ' ALA . 94.6 t -60.36 -24.6 31.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.324 -0.398 . . . . 0.0 109.927 179.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.422 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -45.53 172.58 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.5 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.576 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.5 p30 -61.78 177.73 0.4 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.706 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.601 ' C ' ' H ' ' A' ' 81' ' ' GLY . 35.8 p30 -46.11 85.58 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.909 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.576 ' N ' ' O ' ' A' ' 78' ' ' ASP . 43.1 tp60 -67.01 13.62 0.06 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.139 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.601 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 117.78 -22.13 10.1 Favored Glycine 0 CA--C 1.52 0.355 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -107.94 116.52 32.11 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.016 0.436 . . . . 0.0 110.486 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 76.7 mt -98.83 0.86 45.16 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.453 -179.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -91.94 6.48 46.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.972 0.415 . . . . 0.0 110.388 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.447 ' O ' ' CG2' ' A' ' 89' ' ' VAL . 88.0 mt-30 -100.04 -27.27 13.65 Favored 'General case' 0 C--O 1.223 -0.29 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.77 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.5 t-105 -63.87 -40.78 97.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.015 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.555 ' O ' ' N ' ' A' ' 91' ' ' LYS . 67.7 m -77.63 -53.62 7.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.328 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -48.41 -50.85 29.36 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.972 -179.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.447 ' CG2' ' O ' ' A' ' 85' ' ' GLN . 15.1 m -68.89 -40.74 81.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 120.9 0.381 . . . . 0.0 110.984 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.411 ' H ' HG23 ' A' ' 89' ' ' VAL . . . -72.24 -22.59 61.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.704 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.555 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.0 tttm -61.47 -46.19 91.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.437 -179.545 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.438 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.6 mm-40 -90.32 -94.2 0.12 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.149 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.632 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.9 mtt180 -143.44 59.82 1.39 Allowed 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.461 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.6 pttp 33.69 26.18 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.259 -179.247 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.632 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.4 tt -47.87 123.23 5.8 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.969 -178.185 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -83.51 -170.29 2.98 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.08 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.617 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 83.0 mtp180 -73.22 137.8 45.21 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.311 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.464 ' N ' ' O ' ' A' ' 67' ' ' SER . 87.9 mt -86.95 -166.03 1.46 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.721 -179.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.53 ' CD2' ' O ' ' A' ' 99' ' ' TYR . 48.0 p90 -168.06 120.31 0.86 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.236 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.509 ' C ' ' O ' ' A' ' 99' ' ' TYR . 43.5 mm -29.87 121.64 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.956 -179.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 113.72 28.12 3.31 Favored Glycine 0 CA--C 1.52 0.384 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 -179.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.584 ' N ' ' CD ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -143.98 45.87 0.6 Allowed Pre-proline 0 C--N 1.324 -0.536 0 CA-C-O 120.922 0.392 . . . . 0.0 110.43 179.867 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.584 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 29.8 Cg_endo -62.0 143.74 95.51 Favored 'Trans proline' 0 C--N 1.298 -2.109 0 C-N-CA 122.678 2.252 . . . . 0.0 112.004 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.71 ' HG ' ' H ' ' A' ' 107' ' ' ALA . 26.8 t -173.47 120.62 0.33 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.459 179.649 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.12 -41.1 64.36 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.089 0.471 . . . . 0.0 111.165 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -65.87 -40.06 91.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.792 -179.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.71 ' H ' ' HG ' ' A' ' 104' ' ' SER . . . -63.83 -39.89 95.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.698 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 69.6 t -67.66 -43.84 86.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.763 179.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.23 -39.46 92.89 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.566 -179.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.438 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.48 -23.5 62.81 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.469 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.561 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.3 mm-40 -91.35 4.99 51.02 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.755 -179.561 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.561 ' C ' ' O ' ' A' ' 111' ' ' GLN . 10.3 tpt 22.33 64.65 0.33 Allowed Pre-proline 0 N--CA 1.465 0.281 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.039 -179.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -79.12 169.57 18.96 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 C-N-CA 122.957 2.438 . . . . 0.0 112.059 -178.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.485 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 99.0 m-20 -113.32 -44.16 3.27 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.172 179.399 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 41.3 tp -120.26 120.44 36.11 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 96.2 mt -117.96 131.24 71.29 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 CA-C-O 120.999 0.428 . . . . 0.0 110.884 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.495 ' CD1' ' HG ' ' A' ' 48' ' ' SER . 31.4 mt -105.92 132.87 51.5 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.148 0.499 . . . . 0.0 110.204 -179.424 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 97.8 mt -118.27 135.93 57.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.701 -179.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 85.9 p -72.09 153.74 41.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.613 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.19 -50.21 74.58 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.689 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -149.35 153.76 37.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.56 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 169.54 -170.0 42.39 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.82 -35.06 91.45 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.446 ' O ' ' OD1' ' A' ' 124' ' ' ASP . 44.1 p-10 -88.91 119.41 29.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.84 0.352 . . . . 0.0 110.7 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 36.4 t -63.29 145.26 55.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.519 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.52 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.39 -43.8 8.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.958 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.4 tp -62.73 -42.34 99.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.73 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.49 -10.97 56.59 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.564 -179.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 83.9 mt -116.26 -23.59 8.33 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.651 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . 0.52 ' N ' ' O ' ' A' ' 126' ' ' ALA . 77.7 t80 -51.47 -49.6 61.46 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.674 -0.411 . . . . 0.0 110.567 -179.008 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.5 p-10 -65.83 -41.94 91.17 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.846 0.355 . . . . 0.0 111.109 179.554 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.507 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 88.1 mt-30 -67.82 -36.96 81.29 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.777 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 93.0 mt -80.27 -41.98 24.0 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.927 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.2 t -57.5 -44.67 85.19 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.223 -179.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.2 m -62.3 -45.66 92.26 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.735 0.302 . . . . 0.0 110.596 179.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 91.8 mt -62.52 -43.86 98.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.406 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -170.1 163.51 6.32 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.506 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -42.78 111.13 0.19 Allowed 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.469 2.112 . . . . 0.0 112.161 179.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 16.6 m -86.05 127.64 34.71 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.57 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 35.5 tp -119.99 138.39 53.51 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.032 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.449 ' O ' ' OG ' ' A' ' 33' ' ' SER . 77.7 mt -105.57 120.66 56.7 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.358 0 CA-C-O 121.109 0.48 . . . . 0.0 111.291 -179.427 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 97.9 mt -135.93 132.69 50.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.627 179.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.498 HD22 ' CG ' ' A' ' 241' ' ' ASP . 61.0 t30 -64.42 150.87 45.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.939 0.399 . . . . 0.0 110.402 179.407 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.518 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 88.7 t80 -85.69 122.09 29.29 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.913 -179.513 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.518 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 98.8 m-20 55.63 69.01 0.78 Allowed 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.812 179.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 35.9 p-10 -125.4 0.01 7.63 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.683 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -150.64 115.61 5.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.76 -179.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' SER . . . . . 0.524 ' HG ' ' H ' ' A' ' 150' ' ' GLN . 84.6 p -62.67 167.8 4.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.505 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.416 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.5 p-90 -51.09 -15.24 0.3 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.498 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . 0.524 ' H ' ' HG ' ' A' ' 148' ' ' SER . 68.1 tp60 -71.34 -75.01 0.14 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.475 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.45 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.2 t -62.78 -38.83 92.18 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.031 0.444 . . . . 0.0 110.305 179.506 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 52.6 tp -60.17 -45.56 92.68 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.42 -178.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.416 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 45.9 tp -62.8 -41.8 99.44 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.856 0.36 . . . . 0.0 110.375 179.068 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.45 ' OG1' ' O ' ' A' ' 151' ' ' SER . 57.8 p -63.95 -34.52 78.16 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.312 -179.597 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . 0.471 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.6 mm-40 -64.1 -42.24 96.98 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.263 179.269 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 91.4 mt -65.45 -38.83 91.01 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.182 179.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.574 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.34 -31.82 78.62 Favored Glycine 0 CA--C 1.52 0.406 0 N-CA-C 110.846 -0.901 . . . . 0.0 110.846 -179.396 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.471 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.2 mt-10 -36.97 -25.1 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.809 0.338 . . . . 0.0 110.706 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.574 ' N ' ' O ' ' A' ' 157' ' ' GLY . 94.4 mt -59.94 149.59 6.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.317 179.473 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 76.8 p -68.91 137.14 53.58 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.059 -179.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 70.63 22.0 77.89 Favored Glycine 0 N--CA 1.459 0.177 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 179.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 60.4 m80 -123.72 -14.83 7.16 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.786 0.327 . . . . 0.0 110.507 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -66.96 -59.31 3.6 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.686 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -51.85 -49.4 62.94 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.188 -179.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -60.64 -41.21 94.48 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.803 0.335 . . . . 0.0 110.316 179.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.46 -47.45 85.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.589 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.59 -40.27 74.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.247 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -61.57 -50.1 73.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.578 179.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -65.47 -43.63 89.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.471 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 94.8 mt -64.46 -43.48 96.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.429 179.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.41 -51.16 70.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.525 -179.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.76 -43.78 95.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.375 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . 0.521 ' CD1' ' OH ' ' A' ' 301' ' ' TYR . 56.3 t80 -62.74 -44.53 95.97 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.069 0.462 . . . . 0.0 110.41 179.426 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -63.12 -39.8 95.76 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.611 -179.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -63.01 -42.8 99.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.617 179.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -60.69 -44.95 95.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.103 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 85.0 mt -64.52 -41.17 96.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.998 0.428 . . . . 0.0 110.642 178.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.02 -62.15 1.82 Allowed 'General case' 0 C--O 1.237 0.408 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.491 -179.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.86 -46.68 87.2 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.546 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.42 -41.66 66.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.176 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -63.91 -33.67 76.22 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.018 0.437 . . . . 0.0 110.387 179.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . 0.402 ' O ' ' HG2' ' A' ' 182' ' ' GLU . 69.6 tt0 -90.56 8.63 33.12 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.435 0.636 . . . . 0.0 110.56 -178.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -104.55 -32.0 9.17 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.183 179.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.9 pt -127.99 147.74 32.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.882 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -139.77 130.97 26.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.396 179.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . 0.556 ' CD2' ' N ' ' A' ' 186' ' ' LEU . 3.6 mm? -85.73 133.06 42.46 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.852 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -44.24 157.99 0.15 Allowed 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.747 2.298 . . . . 0.0 112.119 179.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . 0.524 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 28.1 Cg_endo -63.08 115.21 2.82 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 C-N-CA 122.736 2.291 . . . . 0.0 111.773 179.749 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . 0.524 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.7 mt-30 155.61 147.63 0.0 OUTLIER Pre-proline 0 N--CA 1.454 -0.241 0 O-C-N 123.57 0.544 . . . . 0.0 110.727 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -73.81 143.73 33.85 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.767 2.311 . . . . 0.0 111.88 178.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.497 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.1 p -124.93 158.93 32.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.24 0.543 . . . . 0.0 110.124 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' THR . . . . . 0.497 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 36.9 p -143.41 165.37 27.71 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.092 -179.669 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -135.63 128.55 31.31 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 121.207 0.527 . . . . 0.0 110.224 179.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 47.2 pt -146.44 149.1 16.34 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.096 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 69.0 t -117.94 123.13 71.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.25 0.548 . . . . 0.0 109.767 179.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -134.24 107.41 7.66 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.252 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 94.7 m -131.33 130.51 42.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.823 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.409 ' O ' ' N ' ' A' ' 201' ' ' HIS . . . -82.93 -36.92 24.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.354 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.48 -66.88 0.28 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.331 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.35 -10.27 59.57 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.278 179.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . 0.409 ' N ' ' O ' ' A' ' 198' ' ' ALA . 60.0 t-80 61.42 58.16 2.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.715 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 39.4 p -167.09 153.55 8.29 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.552 179.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -150.97 143.63 24.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.46 179.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -135.04 138.03 43.51 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 120.926 0.393 . . . . 0.0 110.608 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 19.8 mt -106.16 125.39 50.94 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 121.057 0.456 . . . . 0.0 109.892 -179.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 206' ' ' TRP . . . . . 0.554 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 74.6 m95 -81.88 166.78 19.63 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.564 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -156.86 172.06 6.62 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.022 0.439 . . . . 0.0 110.505 -179.196 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.21 -36.85 87.23 Favored 'Trans proline' 0 C--N 1.303 -1.821 0 C-N-CA 122.624 2.216 . . . . 0.0 112.099 179.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -70.71 -34.84 72.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.822 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 21.3 m -61.3 150.68 34.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.642 -179.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.72 -36.92 82.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.472 -179.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 212' ' ' GLN . . . . . 0.554 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 55.0 tt0 -64.58 -40.37 95.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.491 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.71 -43.4 91.96 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -63.35 -43.8 96.66 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.924 -0.31 . . . . 0.0 110.294 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 65.1 ttp -59.53 -47.94 83.59 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.269 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 87.1 mt -60.61 -40.84 93.33 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 217' ' ' GLU . . . . . 0.453 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 40.9 tp10 -57.93 -38.03 75.17 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -65.35 -37.98 88.7 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.77 0.319 . . . . 0.0 110.672 179.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 94.4 mt -64.3 -42.69 96.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.521 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.51 45.07 0.08 OUTLIER Glycine 0 C--N 1.334 0.419 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 221' ' ' PHE . . . . . 0.453 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 26.1 m-85 -128.04 155.78 43.8 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.05 0.452 . . . . 0.0 110.467 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 222' ' ' THR . . . . . 0.453 ' O ' ' O ' ' A' ' 191' ' ' VAL . 7.2 p -107.66 122.57 46.99 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.3 0.572 . . . . 0.0 110.182 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . 0.442 ' CD2' ' N ' ' A' ' 223' ' ' LEU . 4.3 mm? -101.58 132.72 47.09 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.049 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.38 160.14 14.57 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.535 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -105.55 115.13 29.72 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.973 0.416 . . . . 0.0 110.294 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.453 ' CD1' ' N ' ' A' ' 226' ' ' LEU . 9.0 mp -52.95 156.82 3.18 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.673 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -60.41 145.37 98.81 Favored 'Trans proline' 0 C--N 1.301 -1.945 0 C-N-CA 122.657 2.238 . . . . 0.0 112.075 179.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.22 -3.47 59.05 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.51 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -89.97 -41.19 5.66 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . 0.535 ' O ' ' N ' ' A' ' 233' ' ' SER . 68.2 mt -78.78 -17.54 55.59 Favored 'General case' 0 C--O 1.223 -0.319 0 CA-C-O 120.998 0.428 . . . . 0.0 110.377 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . 0.403 ' C ' ' O ' ' A' ' 230' ' ' LEU . 54.7 t-20 -40.19 -49.34 2.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.789 -179.389 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -87.8 15.32 7.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.258 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 233' ' ' SER . . . . . 0.535 ' N ' ' O ' ' A' ' 230' ' ' LEU . 78.2 p -60.36 -35.61 76.09 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.645 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . 0.525 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.6 tt0 -119.02 -69.26 0.86 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.963 179.607 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.2 m -69.89 102.76 2.04 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.733 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -94.45 57.64 2.29 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.055 0.455 . . . . 0.0 110.364 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -144.65 -122.68 1.59 Allowed Glycine 0 CA--C 1.52 0.364 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -134.86 111.4 9.85 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 121.067 0.46 . . . . 0.0 110.433 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . 0.521 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.6 mtt180 -147.95 58.06 1.1 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.762 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -69.77 -32.31 70.74 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.533 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 241' ' ' ASP . . . . . 0.498 ' CG ' HD22 ' A' ' 143' ' ' ASN . 65.0 t0 -56.86 -46.95 81.44 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.395 -179.093 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 242' ' ' ILE . . . . . 0.434 ' O ' ' O ' ' A' ' 239' ' ' ARG . 18.0 tt -139.93 156.74 25.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.926 0.393 . . . . 0.0 110.492 179.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 96.0 mt -106.36 106.7 21.1 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.214 0 CA-C-O 121.208 0.528 . . . . 0.0 110.489 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . 0.521 ' OE1' ' NH1' ' A' ' 239' ' ' ARG . 88.3 mt-30 -110.48 110.14 20.76 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.331 179.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 9.4 mp -121.81 -168.48 1.71 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.577 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . 0.525 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.9 -16.27 0.05 OUTLIER Glycine 0 CA--C 1.524 0.614 0 N-CA-C 111.039 -0.824 . . . . 0.0 111.039 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . 0.701 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -61.17 156.42 33.77 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -63.45 21.81 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.933 0.397 . . . . 0.0 110.617 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . 0.701 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.8 m-20 -97.35 -6.14 34.87 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.523 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 92.1 mt -79.52 -22.15 44.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.677 179.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.55 -51.26 70.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.711 -179.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.23 -5.76 58.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.48 179.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.02 -74.59 1.13 Allowed Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.909 -0.876 . . . . 0.0 110.909 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 83.0 mt -69.82 125.94 28.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.023 0.44 . . . . 0.0 110.234 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -59.32 -39.44 83.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.178 -179.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 83.1 51.82 4.04 Favored Glycine 0 CA--C 1.521 0.433 0 N-CA-C 110.814 -0.914 . . . . 0.0 110.814 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -95.94 -14.89 22.73 Favored 'General case' 0 C--N 1.33 -0.266 0 O-C-N 122.701 -0.293 . . . . 0.0 110.616 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 258' ' ' SER . . . . . 0.422 ' O ' ' O ' ' A' ' 192' ' ' THR . 3.4 t 174.34 88.85 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.047 0.451 . . . . 0.0 110.177 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . 0.595 ' N ' ' CD1' ' A' ' 259' ' ' LEU . 0.9 OUTLIER -94.18 124.02 37.93 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.223 0.535 . . . . 0.0 111.086 -179.104 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 16.0 m-30 -93.12 146.48 23.63 Favored 'General case' 0 CA--C 1.508 -0.664 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.343 179.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 86.0 mt -122.35 149.83 43.24 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.629 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.661 ' CG ' ' N ' ' A' ' 263' ' ' ALA . 2.6 p90 -77.65 -138.49 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.468 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 263' ' ' ALA . . . . . 0.661 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -52.03 77.54 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 121.04 0.448 . . . . 0.0 111.055 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . 0.632 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.03 104.71 0.19 Allowed Glycine 0 CA--C 1.526 0.724 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 265' ' ' ASP . . . . . 0.606 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.7 m-20 -80.57 -177.79 6.41 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 120.676 0.274 . . . . 0.0 110.92 -179.477 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -40.42 -17.69 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.891 0.377 . . . . 0.0 110.521 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 267' ' ' LYS . . . . . 0.606 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.33 -51.62 42.52 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.73 179.397 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -63.7 -46.54 84.99 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.223 179.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . 0.522 ' O ' ' CD2' ' A' ' 273' ' ' TYR . . . -61.71 -35.11 77.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.856 179.52 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -63.07 -34.41 77.52 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.115 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.48 -43.07 13.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.231 -179.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 272' ' ' ILE . . . . . 0.619 ' C ' ' H ' ' A' ' 274' ' ' ALA . 4.9 tt -51.58 -33.72 15.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.827 -178.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 273' ' ' TYR . . . . . 0.522 ' CD2' ' O ' ' A' ' 269' ' ' ALA . 17.1 m-85 -54.44 -1.71 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.738 -179.568 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 274' ' ' ALA . . . . . 0.619 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.8 -39.54 69.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.927 179.503 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . 0.582 ' O ' ' N ' ' A' ' 279' ' ' ALA . 3.2 p30 -39.52 98.02 0.16 Allowed Pre-proline 0 N--CA 1.461 0.103 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.562 -179.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -54.03 -43.02 61.99 Favored 'Trans proline' 0 C--N 1.304 -1.807 0 C-N-CA 122.372 2.048 . . . . 0.0 112.638 -178.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 89.0 mt -64.37 -42.93 95.92 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.14 0.495 . . . . 0.0 111.208 -179.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 90.7 mt -95.6 -1.67 49.87 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.894 -179.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 279' ' ' ALA . . . . . 0.582 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.34 -34.83 77.41 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.696 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.12 20.01 0.11 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.006 -179.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . 0.515 ' H ' ' C ' ' A' ' 279' ' ' ALA . 13.9 mt -75.31 120.15 80.31 Favored Pre-proline 0 N--CA 1.452 -0.365 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.506 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -51.01 -39.35 59.92 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 122.637 2.225 . . . . 0.0 111.848 179.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.92 -50.53 63.8 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.092 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 75.5 t -61.43 -43.92 97.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -57.83 -41.19 81.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.237 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -91.11 0.38 57.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.212 179.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt 59.3 43.7 16.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.079 0.466 . . . . 0.0 110.962 179.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -95.1 41.62 1.09 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.33 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 53.9 t -119.22 135.63 58.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.02 0.438 . . . . 0.0 110.168 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -132.63 162.65 30.78 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 121.123 0.487 . . . . 0.0 110.634 -179.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.71 154.91 33.39 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.014 0.435 . . . . 0.0 110.745 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 80.8 mt -93.68 -1.58 55.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.275 -179.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.11 165.91 12.81 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 6.9 m -87.47 -62.35 1.52 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.839 0.352 . . . . 0.0 111.016 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 295' ' ' GLU . . . . . 0.477 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.5 mm-40 -69.25 -4.01 16.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.68 -179.75 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 25.9 p -76.89 32.51 0.14 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.654 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 297' ' ' PHE . . . . . 0.477 ' H ' ' C ' ' A' ' 295' ' ' GLU . 73.2 t80 -60.39 -46.14 91.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.669 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . 0.617 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.2 mtt85 -81.19 135.0 35.72 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 120.998 0.427 . . . . 0.0 110.634 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 16.8 tp -114.39 118.26 33.33 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.182 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . 0.605 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.0 p-10 -165.83 -176.2 3.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.507 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 301' ' ' TYR . . . . . 0.521 ' OH ' ' CD1' ' A' ' 173' ' ' PHE . 80.8 t80 -47.08 -43.78 20.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.277 -179.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -66.64 -40.57 88.75 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.968 0.413 . . . . 0.0 110.726 179.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 303' ' ' SER . . . . . 0.605 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 59.7 p -55.92 -36.11 67.35 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.083 -179.17 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -57.37 -51.43 69.44 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 90.6 mtp -56.41 -43.67 79.58 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -66.37 -42.63 87.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.934 0.397 . . . . 0.0 110.17 178.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 56.1 t -63.95 -43.03 97.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.22 179.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 42.9 tp -59.67 -42.31 92.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.781 -179.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -62.6 -38.78 91.48 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 179.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 310' ' ' ARG . . . . . 0.432 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.6 ttt85 -63.51 -44.01 95.54 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.286 179.526 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 89.0 mt -63.21 -42.06 99.24 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.291 179.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt -62.87 -33.41 75.23 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.997 179.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.52 -23.36 22.05 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.46 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . 0.432 ' N ' ' O ' ' A' ' 310' ' ' ARG . 6.8 tt -62.36 -43.1 99.62 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.63 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 . . . . . 0 C--O 1.22 -0.482 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.449 179.969 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -99.58 136.75 39.04 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.079 0.466 . . . . 0.0 110.438 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.494 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -91.99 178.49 1.7 Allowed Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.615 -179.881 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.494 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.4 Cg_exo -61.65 146.99 96.38 Favored 'Trans proline' 0 C--N 1.299 -2.044 0 C-N-CA 122.872 2.381 . . . . 0.0 112.133 179.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 35.5 ptt180 -136.23 142.31 44.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.682 179.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -79.52 116.67 19.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.464 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.5 tp -111.16 130.49 64.53 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.483 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 13.1 t -70.93 141.91 51.1 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.547 179.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.516 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.5 t0 -139.42 179.71 6.39 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.57 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.516 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 78.0 p -73.88 -37.21 64.79 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.626 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -46.37 -94.51 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.292 -179.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.492 ' C ' ' HG1' ' A' ' 36' ' ' THR . . . -167.2 -26.61 0.02 OUTLIER Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.934 -0.867 . . . . 0.0 110.934 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.492 ' HG1' ' C ' ' A' ' 35' ' ' GLY . 60.0 m -168.98 104.78 0.4 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.876 0.37 . . . . 0.0 110.673 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 74.6 t60 -128.44 148.81 50.74 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 121.102 0.477 . . . . 0.0 110.247 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.484 ' CG2' ' N ' ' A' ' 39' ' ' LEU . 98.8 m -131.2 165.84 22.45 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.55 -179.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.484 ' N ' ' CG2' ' A' ' 38' ' ' THR . 82.0 mt -120.67 127.28 51.91 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.439 179.744 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -65.23 -44.45 88.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.698 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.404 ' O ' ' HD3' ' A' ' 43' ' ' PRO . 39.5 p -165.66 154.66 11.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.44 179.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.454 ' N ' ' CD ' ' A' ' 42' ' ' GLN . 14.4 mp0 -44.78 101.3 0.25 Allowed Pre-proline 0 C--N 1.329 -0.315 0 O-C-N 123.376 0.422 . . . . 0.0 110.605 179.397 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.404 ' HD3' ' O ' ' A' ' 41' ' ' SER . 31.5 Cg_exo -57.43 129.94 36.53 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 C-N-CA 122.357 2.038 . . . . 0.0 112.292 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -83.88 -24.68 30.72 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.539 179.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.538 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.2 mtm-85 -122.07 134.9 54.77 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 121.203 0.525 . . . . 0.0 110.291 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 95.9 mt -130.64 133.73 63.05 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.883 -179.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 44.7 t -124.44 130.53 73.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 179.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.5 ' O ' ' O ' ' A' ' 66' ' ' ALA . 2.3 m -155.36 167.34 30.69 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.534 179.681 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 68.2 p -124.68 9.45 8.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.458 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.56 125.51 33.15 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.634 -179.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 92.7 t -65.81 -44.52 92.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.469 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 20.0 m -62.77 -44.19 96.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.607 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 50.2 tp -62.24 -41.61 98.58 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.53 -179.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 77.2 m -57.59 -44.65 85.53 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.394 -179.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.03 -62.33 5.3 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.884 -0.886 . . . . 0.0 110.884 179.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.7 t -48.4 -35.42 12.66 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.7 mt -61.88 -44.52 96.65 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.686 -0.405 . . . . 0.0 111.281 179.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.2 mp -65.18 -41.52 94.52 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.33 177.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.5 -41.26 98.53 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.983 -179.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.1 tp -88.18 17.13 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.824 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 56.24 84.63 0.08 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.688 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.37 59.06 0.08 OUTLIER Pre-proline 0 C--N 1.328 -0.346 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -51.52 152.31 12.51 Favored 'Trans proline' 0 C--N 1.294 -2.301 0 C-N-CA 122.956 2.438 . . . . 0.0 112.254 -178.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.434 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.2 OUTLIER -108.55 145.31 15.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.37 -179.728 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.8 mt -63.56 -45.4 97.77 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.414 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.5 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -129.57 134.19 47.6 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.848 0.356 . . . . 0.0 110.495 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.493 ' O ' ' N ' ' A' ' 98' ' ' LEU . 74.8 m -134.48 158.56 43.6 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.849 -179.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.82 139.13 16.12 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.689 -0.964 . . . . 0.0 110.689 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.469 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.84 -162.77 0.08 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.971 0.415 . . . . 0.0 110.479 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.487 ' O ' ' C ' ' A' ' 71' ' ' THR . 14.7 t -133.49 135.02 44.21 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.382 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.487 ' C ' ' O ' ' A' ' 70' ' ' THR . 0.7 OUTLIER 29.73 68.57 0.66 Allowed Pre-proline 0 N--CA 1.464 0.26 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.801 -179.87 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_exo -60.98 145.64 98.84 Favored 'Trans proline' 0 C--N 1.299 -2.035 0 C-N-CA 122.648 2.232 . . . . 0.0 111.981 -178.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.534 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 46.1 p-10 -160.11 -32.63 0.06 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.639 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.534 ' N ' ' OD1' ' A' ' 73' ' ' ASN . 99.2 m-20 -63.71 -39.74 95.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.451 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 73.1 ttt180 -60.13 -48.08 83.24 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.728 -179.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.423 ' O ' ' O ' ' A' ' 77' ' ' ALA . 94.4 t -60.35 -24.73 31.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.088 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.423 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -45.76 172.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.599 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.571 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.9 p30 -62.07 177.74 0.43 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.522 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.595 ' C ' ' H ' ' A' ' 81' ' ' GLY . 35.4 p30 -45.61 85.67 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.033 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.571 ' N ' ' O ' ' A' ' 78' ' ' ASP . 43.4 tp60 -67.63 13.45 0.07 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.149 0.5 . . . . 0.0 110.135 -179.735 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.595 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 118.32 -22.1 9.72 Favored Glycine 0 CA--C 1.519 0.282 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -107.86 116.61 32.26 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.975 0.417 . . . . 0.0 110.474 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 74.4 mt -98.77 -0.14 43.25 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.937 0.399 . . . . 0.0 110.494 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -92.13 7.08 44.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.98 0.419 . . . . 0.0 110.452 -179.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.445 ' O ' ' CG2' ' A' ' 89' ' ' VAL . 88.1 mt-30 -100.42 -27.76 13.28 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.815 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.8 t-105 -63.73 -40.51 96.93 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.093 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.56 ' O ' ' N ' ' A' ' 91' ' ' LYS . 63.7 m -78.15 -54.16 6.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.118 -179.481 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -47.64 -50.51 24.31 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.06 -179.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.445 ' CG2' ' O ' ' A' ' 85' ' ' GLN . 14.9 m -69.29 -40.75 80.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.066 179.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.413 ' H ' HG23 ' A' ' 89' ' ' VAL . . . -72.3 -22.64 61.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.66 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.56 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.0 tttm -62.23 -45.5 93.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.422 -179.494 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.441 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.8 mm-40 -90.51 -94.37 0.12 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.153 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.628 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.9 mtt180 -143.13 58.72 1.41 Allowed 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.457 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.6 pttp 33.44 26.43 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.195 -179.226 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.628 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.4 tt -48.25 123.29 6.23 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.986 -178.092 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -83.68 -169.62 2.65 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.122 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.605 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 81.4 mtp180 -74.42 137.32 42.57 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.303 -179.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.493 ' N ' ' O ' ' A' ' 67' ' ' SER . 90.6 mt -86.21 -165.85 1.38 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.74 -179.659 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.538 ' CD2' ' O ' ' A' ' 99' ' ' TYR . 48.4 p90 -168.74 119.77 0.76 Allowed 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.207 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.511 ' C ' ' O ' ' A' ' 99' ' ' TYR . 43.0 mm -28.67 120.74 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.085 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 114.38 27.48 3.35 Favored Glycine 0 CA--C 1.519 0.34 0 N-CA-C 111.196 -0.762 . . . . 0.0 111.196 -179.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.575 ' N ' ' CD ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -144.47 46.6 0.64 Allowed Pre-proline 0 C--N 1.323 -0.554 0 CA-C-O 120.979 0.419 . . . . 0.0 110.447 179.861 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 29.0 Cg_endo -62.04 144.01 95.64 Favored 'Trans proline' 0 C--N 1.296 -2.224 0 C-N-CA 122.702 2.268 . . . . 0.0 111.865 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.703 ' HG ' ' H ' ' A' ' 107' ' ' ALA . 26.7 t -173.24 120.23 0.34 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.423 179.718 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.83 -40.4 63.35 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.054 0.454 . . . . 0.0 111.085 179.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.23 -40.06 90.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.888 -179.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.703 ' H ' ' HG ' ' A' ' 104' ' ' SER . . . -64.14 -39.97 95.15 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.677 -179.763 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 70.4 t -67.71 -43.72 86.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.731 179.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.74 -38.96 92.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.53 -179.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.441 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.65 -23.35 62.97 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.49 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.547 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.5 mm-40 -90.5 5.14 48.91 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.714 -179.555 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.547 ' C ' ' O ' ' A' ' 111' ' ' GLN . 10.6 tpt 23.27 64.33 0.37 Allowed Pre-proline 0 N--CA 1.464 0.261 0 CA-C-O 120.935 0.398 . . . . 0.0 111.077 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -78.61 167.5 22.52 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 123.062 2.508 . . . . 0.0 111.861 -178.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.521 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 99.0 m-20 -109.97 -42.27 4.26 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.182 179.474 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.6 tp -121.04 120.66 36.01 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 179.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 83.8 mt -113.44 129.0 70.0 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.39 0 CA-C-O 120.98 0.419 . . . . 0.0 110.903 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 30.2 mt -109.18 132.27 54.28 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 121.084 0.469 . . . . 0.0 110.235 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 99.0 mt -119.84 138.75 49.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.719 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 84.9 p -72.51 153.61 41.25 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.598 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.18 -50.12 74.94 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.678 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -149.44 154.01 38.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.55 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 170.58 -170.99 43.49 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -63.09 -34.16 89.21 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.866 -0.893 . . . . 0.0 110.866 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.45 ' O ' ' OD1' ' A' ' 124' ' ' ASP . 44.3 p-10 -86.82 120.45 28.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.837 0.351 . . . . 0.0 110.705 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 38.9 t -63.23 143.48 57.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.029 0.443 . . . . 0.0 110.495 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.52 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -92.97 -43.18 9.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.972 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.9 tp -62.85 -42.45 99.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.703 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.66 -11.83 59.13 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.53 -179.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 84.8 mt -114.97 -23.86 8.88 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.659 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . 0.52 ' N ' ' O ' ' A' ' 126' ' ' ALA . 80.6 t80 -51.13 -49.55 60.6 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.537 -178.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.499 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.0 p-10 -66.13 -42.41 89.18 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.823 0.344 . . . . 0.0 111.239 179.486 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.499 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 88.2 mt-30 -67.16 -37.81 84.41 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.813 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 96.0 mt -80.36 -41.38 24.81 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.965 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.2 t -57.23 -44.57 83.91 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.218 -179.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.7 m -61.97 -45.23 94.56 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.511 179.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 94.0 mt -62.09 -43.64 97.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.279 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.44 168.22 4.96 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.56 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -49.57 112.82 0.76 Allowed 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.323 2.015 . . . . 0.0 112.282 179.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 23.5 m -84.49 127.53 34.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.617 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 34.7 tp -118.22 137.0 53.31 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.079 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.44 ' O ' ' OD2' ' A' ' 32' ' ' ASP . 81.3 mt -101.26 118.94 48.76 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.353 0 CA-C-O 121.226 0.536 . . . . 0.0 111.222 -179.419 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 98.1 mt -134.78 132.04 53.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.588 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.515 HD22 ' CG ' ' A' ' 241' ' ' ASP . 61.0 t30 -66.28 151.82 46.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.895 0.378 . . . . 0.0 110.413 179.419 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.521 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 88.1 t80 -86.69 122.54 30.73 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.808 -179.581 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.521 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 99.0 m-20 55.31 69.13 0.77 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.788 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 35.9 p-10 -125.9 0.17 7.3 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.652 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -150.54 115.12 5.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.715 -179.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' SER . . . . . 0.519 ' HG ' ' H ' ' A' ' 150' ' ' GLN . 83.9 p -63.29 168.2 4.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.602 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.417 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.7 p-90 -51.88 -15.79 0.59 Allowed 'General case' 0 C--O 1.223 -0.334 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.467 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . 0.519 ' H ' ' HG ' ' A' ' 148' ' ' SER . 68.1 tp60 -70.52 -76.04 0.11 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.474 -179.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.446 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.1 t -62.7 -38.61 91.08 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.255 179.543 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 54.3 tp -59.93 -45.84 91.3 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.412 -178.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.417 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 46.7 tp -62.67 -41.64 99.19 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.497 179.011 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.446 ' OG1' ' O ' ' A' ' 151' ' ' SER . 60.1 p -64.1 -34.79 78.85 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.273 -179.482 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . 0.415 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.9 mm-40 -64.19 -42.77 96.53 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.311 179.35 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 91.8 mt -65.37 -38.73 90.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.148 0.499 . . . . 0.0 110.268 179.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.579 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.23 -32.47 80.75 Favored Glycine 0 CA--C 1.519 0.317 0 N-CA-C 110.712 -0.955 . . . . 0.0 110.712 -179.306 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 157' ' ' GLY . 97.2 mt-10 -35.45 -26.93 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.828 0.347 . . . . 0.0 110.837 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.579 ' N ' ' O ' ' A' ' 157' ' ' GLY . 95.3 mt -56.46 149.81 3.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.295 179.197 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 77.1 p -69.61 137.21 52.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.997 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 71.1 21.17 78.37 Favored Glycine 0 N--CA 1.459 0.19 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 179.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 58.1 m80 -122.47 -14.94 7.72 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.702 0.286 . . . . 0.0 110.529 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -65.96 -59.74 3.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.748 -179.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -52.26 -49.3 64.34 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.209 -179.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -60.54 -41.22 94.05 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.957 -0.297 . . . . 0.0 110.379 179.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.49 -47.12 87.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.541 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.97 -40.14 75.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.244 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -61.82 -50.27 72.96 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.576 179.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -65.17 -43.86 90.36 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.531 179.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 94.6 mt -64.78 -43.29 96.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.402 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.28 -51.23 70.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.475 -179.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.43 -43.86 96.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.543 179.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . 0.459 ' CD1' ' OH ' ' A' ' 301' ' ' TYR . 57.0 t80 -62.75 -44.4 96.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.06 0.457 . . . . 0.0 110.443 179.451 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -63.32 -39.8 95.56 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.617 -179.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -63.01 -42.76 99.9 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.599 179.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -60.72 -44.6 96.42 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.184 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 84.1 mt -64.54 -40.96 96.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.014 0.435 . . . . 0.0 110.707 178.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.18 -62.46 1.62 Allowed 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.368 -179.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.52 -46.86 85.89 Favored 'General case' 0 C--O 1.227 -0.128 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.628 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.13 -41.85 65.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.276 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -63.74 -33.79 76.43 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.982 0.42 . . . . 0.0 110.411 179.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . 0.4 ' O ' ' HG2' ' A' ' 182' ' ' GLU . 69.6 tt0 -90.51 8.83 31.92 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.46 0.648 . . . . 0.0 110.508 -178.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -104.99 -32.07 8.92 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.174 179.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.9 pt -127.98 147.63 32.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.822 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -139.93 131.09 26.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.357 179.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . 0.553 ' CD2' ' N ' ' A' ' 186' ' ' LEU . 3.6 mm? -85.35 133.34 42.64 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.979 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -43.93 157.82 0.14 Allowed 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.69 2.26 . . . . 0.0 112.191 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . 0.521 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.9 Cg_endo -63.1 115.11 2.77 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 C-N-CA 122.795 2.33 . . . . 0.0 111.696 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . 0.521 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.8 mt-30 155.16 147.86 0.0 OUTLIER Pre-proline 0 C--N 1.332 -0.162 0 O-C-N 123.791 0.682 . . . . 0.0 110.832 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -73.49 144.11 35.65 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.667 2.245 . . . . 0.0 112.159 177.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.494 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.1 p -125.04 158.98 32.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.291 0.567 . . . . 0.0 110.185 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' THR . . . . . 0.494 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 37.5 p -143.3 165.39 27.6 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.106 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -135.4 128.69 32.05 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.234 0.54 . . . . 0.0 110.231 179.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 47.6 pt -146.3 148.71 16.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.165 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 70.4 t -117.51 123.01 71.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.282 0.563 . . . . 0.0 109.71 179.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -134.47 107.51 7.6 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.331 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 94.3 m -131.01 130.71 43.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.845 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -82.82 -37.02 25.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.231 179.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.55 -67.17 0.26 Allowed 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.359 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.33 -9.76 58.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.342 179.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 60.1 t-80 60.43 58.3 2.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.774 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 39.4 p -166.8 153.2 8.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.586 179.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.28 144.09 24.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.005 0.431 . . . . 0.0 110.421 179.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -135.3 137.87 42.9 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.619 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 19.6 mt -105.98 125.42 50.97 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.061 0.458 . . . . 0.0 109.81 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 206' ' ' TRP . . . . . 0.555 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 75.6 m95 -82.09 167.15 19.07 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.685 -179.752 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -156.99 171.38 7.53 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.624 -179.189 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -53.57 -37.22 82.85 Favored 'Trans proline' 0 C--N 1.302 -1.902 0 C-N-CA 122.661 2.24 . . . . 0.0 112.27 179.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -70.52 -34.88 72.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.813 -179.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 22.8 m -61.19 150.72 33.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.637 -179.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.52 -36.95 81.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.485 -179.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 212' ' ' GLN . . . . . 0.555 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 54.8 tt0 -64.78 -40.11 94.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.506 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.8 -43.41 91.74 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -63.33 -43.74 96.92 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.791 0.329 . . . . 0.0 110.29 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 65.1 ttp -59.39 -48.18 82.63 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.238 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 88.2 mt -60.37 -40.9 92.49 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 179.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 217' ' ' GLU . . . . . 0.456 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 40.9 tp10 -57.96 -38.03 75.25 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -65.17 -37.92 88.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.67 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 94.5 mt -64.4 -42.72 95.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.141 0.496 . . . . 0.0 110.583 -179.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.56 44.63 0.08 OUTLIER Glycine 0 C--N 1.334 0.417 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 221' ' ' PHE . . . . . 0.456 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 25.9 m-85 -127.68 155.19 44.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.04 0.447 . . . . 0.0 110.471 -179.76 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 222' ' ' THR . . . . . 0.451 ' O ' ' O ' ' A' ' 191' ' ' VAL . 6.1 p -107.05 122.35 46.29 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.272 0.558 . . . . 0.0 110.116 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . 0.444 ' CD2' ' N ' ' A' ' 223' ' ' LEU . 4.3 mm? -101.25 133.04 46.42 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.068 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -97.17 159.53 14.86 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.488 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.21 115.32 30.06 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.399 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.45 ' CD1' ' N ' ' A' ' 226' ' ' LEU . 9.0 mp -53.62 156.84 4.21 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.689 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -59.86 145.21 98.84 Favored 'Trans proline' 0 C--N 1.302 -1.916 0 C-N-CA 122.65 2.233 . . . . 0.0 112.19 179.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.64 -2.73 58.81 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.559 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.46 -40.68 5.65 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . 0.535 ' O ' ' N ' ' A' ' 233' ' ' SER . 86.1 mt -79.13 -16.74 56.22 Favored 'General case' 0 C--O 1.222 -0.379 0 CA-C-O 121.02 0.438 . . . . 0.0 110.383 -179.774 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . 0.402 ' C ' ' O ' ' A' ' 230' ' ' LEU . 54.4 t-20 -40.29 -49.07 2.73 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.777 -179.421 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -88.24 15.44 7.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.368 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 233' ' ' SER . . . . . 0.535 ' N ' ' O ' ' A' ' 230' ' ' LEU . 77.8 p -60.52 -35.52 76.18 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.622 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . 0.523 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.6 tt0 -118.27 -69.37 0.85 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.958 179.508 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 3.9 m -70.39 103.03 2.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.679 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -93.99 57.92 2.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.398 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -145.12 -122.28 1.52 Allowed Glycine 0 CA--C 1.519 0.343 0 N-CA-C 110.989 -0.845 . . . . 0.0 110.989 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -134.56 111.68 10.26 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 121.114 0.483 . . . . 0.0 110.433 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . 0.51 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.3 mtt180 -148.12 57.24 1.08 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.696 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -69.74 -31.99 70.27 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.511 179.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 241' ' ' ASP . . . . . 0.515 ' CG ' HD22 ' A' ' 143' ' ' ASN . 65.1 t0 -56.83 -46.93 81.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.379 -179.07 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 242' ' ' ILE . . . . . 0.437 ' O ' ' O ' ' A' ' 239' ' ' ARG . 17.5 tt -140.02 156.76 25.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.888 0.375 . . . . 0.0 110.537 179.719 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 96.0 mt -105.8 105.9 19.56 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.218 0 CA-C-O 121.122 0.487 . . . . 0.0 110.511 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . 0.51 ' OE1' ' NH1' ' A' ' 239' ' ' ARG . 88.3 mt-30 -110.23 110.03 20.72 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.344 179.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 9.6 mp -121.86 -168.23 1.67 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.663 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . 0.523 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.28 -16.8 0.05 OUTLIER Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . 0.691 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -60.44 157.17 29.42 Favored Glycine 0 CA--C 1.522 0.49 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 -179.81 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -63.86 21.68 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.99 0.424 . . . . 0.0 110.619 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . 0.691 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.7 m-20 -97.43 -5.82 35.32 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.517 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 91.9 mt -80.28 -21.48 42.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.672 179.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.66 -51.36 70.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.702 -179.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.43 -5.19 58.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.453 179.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.15 -74.2 1.15 Allowed Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 80.4 mt -70.09 125.73 27.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.979 0.418 . . . . 0.0 110.274 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -59.7 -39.15 83.65 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.492 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 84.1 51.74 3.86 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 110.712 -0.955 . . . . 0.0 110.712 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -94.87 -16.2 23.09 Favored 'General case' 0 C--N 1.332 -0.191 0 O-C-N 122.651 -0.323 . . . . 0.0 110.654 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 258' ' ' SER . . . . . 0.433 ' HG ' ' CG2' ' A' ' 191' ' ' VAL . 3.3 t 174.06 89.53 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.074 0.464 . . . . 0.0 110.18 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . 0.596 ' N ' ' CD1' ' A' ' 259' ' ' LEU . 1.0 OUTLIER -94.47 124.35 38.44 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.275 0.559 . . . . 0.0 111.079 -179.084 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 16.0 m-30 -93.49 146.64 23.62 Favored 'General case' 0 CA--C 1.504 -0.793 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.441 179.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 85.9 mt -122.46 149.91 43.22 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.567 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.657 ' CG ' ' N ' ' A' ' 263' ' ' ALA . 2.6 p90 -77.61 -138.4 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.541 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 263' ' ' ALA . . . . . 0.657 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -52.24 77.51 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.048 0.452 . . . . 0.0 111.078 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . 0.625 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.17 104.35 0.18 Allowed Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 265' ' ' ASP . . . . . 0.601 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.8 m-20 -80.28 -177.89 6.34 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 120.685 0.279 . . . . 0.0 110.908 -179.478 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -40.44 -17.52 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.567 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 267' ' ' LYS . . . . . 0.601 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.62 -51.45 42.1 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.617 179.502 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -63.79 -46.64 84.28 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.171 179.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . 0.525 ' O ' ' CD2' ' A' ' 273' ' ' TYR . . . -61.58 -34.99 76.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.247 0.546 . . . . 0.0 109.866 179.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -63.13 -34.42 77.58 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.17 179.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.43 -43.31 13.73 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.218 -179.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 272' ' ' ILE . . . . . 0.619 ' C ' ' H ' ' A' ' 274' ' ' ALA . 4.9 tt -51.42 -33.72 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.863 -178.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 273' ' ' TYR . . . . . 0.525 ' CD2' ' O ' ' A' ' 269' ' ' ALA . 17.4 m-85 -54.31 -1.88 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.649 -179.587 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 274' ' ' ALA . . . . . 0.619 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.64 -39.66 70.22 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.95 179.561 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . 0.586 ' O ' ' N ' ' A' ' 279' ' ' ALA . 4.2 p30 -39.12 97.86 0.15 Allowed Pre-proline 0 N--CA 1.462 0.174 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.458 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -54.55 -42.97 63.27 Favored 'Trans proline' 0 C--N 1.303 -1.831 0 C-N-CA 122.372 2.048 . . . . 0.0 112.552 -178.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 88.9 mt -64.45 -42.97 95.66 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.128 0.49 . . . . 0.0 111.211 -179.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 90.8 mt -95.71 -1.38 50.09 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.923 -179.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 279' ' ' ALA . . . . . 0.586 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.19 -34.74 77.02 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.714 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.21 19.8 0.12 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.018 -179.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . 0.512 ' H ' ' C ' ' A' ' 279' ' ' ALA . 13.9 mt -75.08 120.14 80.27 Favored Pre-proline 0 N--CA 1.451 -0.423 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.575 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -49.97 -39.81 49.75 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.625 2.216 . . . . 0.0 112.154 178.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.52 -50.56 62.57 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.084 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 79.9 t -61.79 -43.8 97.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 179.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -57.88 -41.77 83.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.317 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -90.43 0.33 57.34 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.119 179.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt 59.04 41.19 21.17 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.773 179.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -92.89 42.18 1.09 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.355 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 53.7 t -119.1 135.67 58.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.014 0.435 . . . . 0.0 110.246 -179.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -133.05 162.74 30.9 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.656 -179.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.77 154.96 33.42 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.965 0.412 . . . . 0.0 110.747 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 81.8 mt -93.75 -1.46 55.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.231 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.59 165.52 12.62 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 110.58 -1.008 . . . . 0.0 110.58 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 7.1 m -87.38 -62.27 1.54 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.89 0.376 . . . . 0.0 111.004 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 295' ' ' GLU . . . . . 0.473 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.5 mm-40 -69.62 -3.97 17.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.636 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 26.2 p -76.81 33.14 0.14 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.648 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 297' ' ' PHE . . . . . 0.473 ' H ' ' C ' ' A' ' 295' ' ' GLU . 85.0 t80 -60.21 -46.03 91.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.477 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . 0.605 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.2 mtt85 -81.73 133.76 35.38 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.568 -179.726 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 16.1 tp -114.07 119.75 38.2 Favored 'General case' 0 C--O 1.231 0.083 0 CA-C-O 120.992 0.425 . . . . 0.0 110.205 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . 0.608 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.2 p-10 -167.43 -174.15 2.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.551 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 301' ' ' TYR . . . . . 0.459 ' OH ' ' CD1' ' A' ' 173' ' ' PHE . 84.0 t80 -48.23 -45.81 34.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.215 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -64.7 -41.48 95.99 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.033 0.444 . . . . 0.0 110.689 178.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 303' ' ' SER . . . . . 0.608 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 53.1 p -55.53 -36.09 66.37 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.954 -179.073 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . 0.594 ' N ' ' HG ' ' A' ' 303' ' ' SER . . . -56.71 -51.76 67.57 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.442 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 91.0 mtp -56.13 -43.89 78.62 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -66.3 -42.81 87.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.008 0.432 . . . . 0.0 110.246 178.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 55.5 t -64.02 -42.77 96.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.211 179.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 42.3 tp -59.65 -42.29 92.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.791 -179.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -62.54 -38.76 91.28 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.149 179.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 310' ' ' ARG . . . . . 0.442 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.6 ttt85 -63.54 -43.95 95.61 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.229 179.606 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 88.3 mt -63.15 -42.15 99.39 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.303 179.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -62.84 -33.22 74.79 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.04 179.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.94 -23.51 21.55 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.377 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . 0.442 ' N ' ' O ' ' A' ' 310' ' ' ARG . 6.8 tt -62.31 -43.19 99.39 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 121.092 0.473 . . . . 0.0 110.623 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 . . . . . 0 C--O 1.22 -0.475 0 CA-C-O 118.005 -0.997 . . . . 0.0 110.42 -179.957 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -99.41 135.58 40.61 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.087 0.47 . . . . 0.0 110.502 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.495 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.2 OUTLIER -92.14 178.42 1.71 Allowed Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.549 -179.842 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.495 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.3 Cg_exo -61.74 147.47 95.24 Favored 'Trans proline' 0 C--N 1.3 -2.024 0 C-N-CA 122.776 2.317 . . . . 0.0 112.168 179.603 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 35.2 ptt180 -136.12 142.33 44.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.735 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -79.83 116.79 20.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.406 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.5 tp -111.54 130.71 64.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.411 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.1 t -71.19 142.62 50.64 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.623 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.518 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.7 t0 -139.84 179.86 6.35 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.564 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.518 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 77.9 p -73.86 -37.26 64.82 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.707 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.7 ttt85 -46.83 -94.62 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.309 -179.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.425 ' O ' ' OG1' ' A' ' 36' ' ' THR . . . -166.3 -26.8 0.02 OUTLIER Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.425 ' OG1' ' O ' ' A' ' 35' ' ' GLY . 56.9 m -168.87 105.69 0.42 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.892 0.377 . . . . 0.0 110.621 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 69.6 t60 -128.77 147.03 50.75 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.053 0.454 . . . . 0.0 110.262 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.487 ' CG2' ' N ' ' A' ' 39' ' ' LEU . 99.9 m -130.05 165.73 21.6 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.582 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.487 ' N ' ' CG2' ' A' ' 38' ' ' THR . 80.8 mt -120.35 127.33 52.23 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.481 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -65.43 -44.62 86.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.693 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.406 ' O ' ' HD3' ' A' ' 43' ' ' PRO . 41.2 p -165.89 155.23 11.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.46 179.61 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.461 ' N ' ' CD ' ' A' ' 42' ' ' GLN . 15.1 mp0 -45.25 101.63 0.27 Allowed Pre-proline 0 C--N 1.329 -0.295 0 O-C-N 123.388 0.43 . . . . 0.0 110.659 179.327 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.406 ' HD3' ' O ' ' A' ' 41' ' ' SER . 31.2 Cg_exo -57.96 129.58 33.96 Favored 'Trans proline' 0 C--N 1.303 -1.82 0 C-N-CA 122.269 1.979 . . . . 0.0 112.231 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -82.33 -25.2 34.11 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.478 179.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.534 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.7 mtm-85 -120.87 134.39 55.29 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-O 121.194 0.521 . . . . 0.0 110.252 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.1 mt -129.69 133.06 65.59 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.313 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.034 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 46.0 t -124.71 130.9 73.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 179.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.501 ' O ' ' O ' ' A' ' 66' ' ' ALA . 4.4 m -154.99 166.5 33.4 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.541 179.578 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 66.0 p -124.27 8.99 8.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.805 0.336 . . . . 0.0 110.439 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.72 125.82 33.5 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.668 -179.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 85.7 t -65.81 -44.55 92.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.547 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 18.9 m -62.63 -44.35 96.51 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.615 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 53.5 tp -62.26 -41.54 98.54 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.503 -179.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 73.3 m -57.85 -44.54 86.6 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.257 -179.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.39 -62.01 5.48 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 179.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.7 t -48.74 -35.25 13.74 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.9 mt -61.8 -44.38 96.98 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.586 -0.445 . . . . 0.0 111.325 179.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.4 mp -64.74 -41.95 95.55 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.384 177.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.67 -41.03 98.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.033 -179.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.0 tp -88.11 16.77 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.798 -179.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 56.38 84.56 0.08 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.696 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.14 58.21 0.07 OUTLIER Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.287 -0.415 . . . . 0.0 109.904 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -50.58 152.76 8.67 Favored 'Trans proline' 0 C--N 1.293 -2.365 0 C-N-CA 122.84 2.36 . . . . 0.0 112.404 -178.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.432 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -108.78 145.83 15.18 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.219 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.239 -179.716 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 97.0 mt -63.75 -45.06 98.32 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.366 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.559 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.501 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -130.02 134.49 47.44 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 120.836 0.351 . . . . 0.0 110.588 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.497 ' O ' ' N ' ' A' ' 98' ' ' LEU . 73.6 m -134.74 158.71 43.44 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.893 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -87.2 139.54 16.2 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.46 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.72 -162.75 0.08 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.003 0.43 . . . . 0.0 110.453 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.486 ' O ' ' C ' ' A' ' 71' ' ' THR . 14.0 t -133.47 135.15 44.33 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.324 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.486 ' C ' ' O ' ' A' ' 70' ' ' THR . 0.1 OUTLIER 29.77 68.51 0.67 Allowed Pre-proline 0 N--CA 1.466 0.353 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.765 -179.883 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_exo -60.96 145.21 99.4 Favored 'Trans proline' 0 C--N 1.299 -2.047 0 C-N-CA 122.613 2.208 . . . . 0.0 112.017 -178.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.524 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 45.5 p-10 -159.83 -32.6 0.06 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.65 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.524 ' N ' ' OD1' ' A' ' 73' ' ' ASN . 99.0 m-20 -64.0 -39.56 94.39 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.485 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.6 ttt180 -60.65 -47.87 84.29 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.721 -179.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.421 ' O ' ' O ' ' A' ' 77' ' ' ALA . 89.2 t -60.58 -24.59 32.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.421 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -45.85 172.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.581 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.569 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.6 p30 -61.85 177.58 0.42 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.551 -179.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.597 ' C ' ' H ' ' A' ' 81' ' ' GLY . 35.5 p30 -45.61 85.84 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.049 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.569 ' N ' ' O ' ' A' ' 78' ' ' ASP . 43.3 tp60 -67.34 13.32 0.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.232 0.539 . . . . 0.0 110.101 -179.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.597 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 118.04 -22.12 9.91 Favored Glycine 0 C--N 1.332 0.321 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -107.79 116.25 31.62 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.014 0.435 . . . . 0.0 110.419 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 77.6 mt -98.87 0.57 44.47 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.498 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -92.04 6.72 45.36 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.033 0.444 . . . . 0.0 110.327 -179.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.434 ' O ' ' CG2' ' A' ' 89' ' ' VAL . 88.3 mt-30 -100.05 -27.73 13.41 Favored 'General case' 0 C--O 1.223 -0.329 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.869 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 68.7 t-105 -63.08 -40.81 98.77 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.902 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.554 ' O ' ' N ' ' A' ' 91' ' ' LYS . 68.0 m -77.44 -53.44 7.63 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.272 -179.486 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -48.57 -50.73 31.04 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.039 -179.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.434 ' CG2' ' O ' ' A' ' 85' ' ' GLN . 15.5 m -68.87 -40.8 81.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 120.97 0.414 . . . . 0.0 111.175 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.414 ' H ' HG23 ' A' ' 89' ' ' VAL . . . -72.06 -23.05 61.3 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.763 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.554 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.0 tttm -61.51 -45.89 92.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.42 -179.439 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.444 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.8 mm-40 -90.38 -94.59 0.12 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.048 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.622 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.8 mtt180 -143.35 59.97 1.4 Allowed 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.456 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.6 pttp 33.73 26.46 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 120.861 0.362 . . . . 0.0 110.12 -179.525 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.622 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.5 tt -48.49 123.19 6.29 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.081 -178.026 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -83.69 -170.18 2.94 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.007 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.62 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 82.2 mtp180 -73.29 137.77 45.06 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.197 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.497 ' N ' ' O ' ' A' ' 67' ' ' SER . 89.3 mt -86.26 -166.15 1.46 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.777 -179.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.532 ' CD2' ' O ' ' A' ' 99' ' ' TYR . 47.5 p90 -168.01 119.65 0.84 Allowed 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.234 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.505 ' C ' ' O ' ' A' ' 99' ' ' TYR . 42.8 mm -29.4 120.98 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.058 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 113.92 28.03 3.28 Favored Glycine 0 C--N 1.332 0.323 0 N-CA-C 111.176 -0.77 . . . . 0.0 111.176 -179.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.582 ' N ' ' CD ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -143.93 45.94 0.61 Allowed Pre-proline 0 C--N 1.323 -0.566 0 O-C-N 122.481 -0.423 . . . . 0.0 110.434 179.816 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.582 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 30.2 Cg_endo -61.95 143.8 95.77 Favored 'Trans proline' 0 C--N 1.296 -2.229 0 C-N-CA 122.669 2.246 . . . . 0.0 111.971 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.705 ' HG ' ' H ' ' A' ' 107' ' ' ALA . 26.7 t -173.17 120.43 0.35 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.463 179.637 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.1 -41.0 64.53 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.069 0.462 . . . . 0.0 111.157 179.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -65.8 -39.92 91.38 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.85 -179.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.705 ' H ' ' HG ' ' A' ' 104' ' ' SER . . . -63.94 -39.67 94.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.751 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 70.6 t -67.4 -43.88 87.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.769 179.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.52 -39.11 92.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.574 -179.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.444 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.63 -23.85 63.35 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.448 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.554 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.3 mm-40 -91.23 4.71 51.59 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.695 -179.592 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.554 ' C ' ' O ' ' A' ' 111' ' ' GLN . 10.4 tpt 22.11 64.29 0.32 Allowed Pre-proline 0 N--CA 1.466 0.345 0 CA-C-O 120.937 0.398 . . . . 0.0 111.154 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -78.85 169.8 18.98 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 123.072 2.515 . . . . 0.0 112.085 -178.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.518 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 98.8 m-20 -112.3 -44.82 3.34 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.222 -0.444 . . . . 0.0 109.974 179.63 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.2 tp -119.96 120.88 37.67 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 96.6 mt -117.82 131.36 70.79 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.417 0 CA-C-O 120.957 0.408 . . . . 0.0 110.985 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 33.4 mt -106.17 132.2 52.51 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.117 0.484 . . . . 0.0 110.051 -179.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 98.4 mt -117.49 135.93 56.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.791 -179.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 85.4 p -71.37 151.79 43.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.521 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.28 -49.94 75.61 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.712 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -149.33 153.7 37.85 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.544 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 168.7 -169.35 41.66 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -63.08 -35.41 92.05 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.452 ' O ' ' OD1' ' A' ' 124' ' ' ASP . 44.4 p-10 -88.62 120.02 29.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.839 0.352 . . . . 0.0 110.694 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 40.7 t -63.47 144.35 57.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.012 0.434 . . . . 0.0 110.526 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.521 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.32 -42.82 9.1 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.012 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.6 tp -62.65 -42.34 99.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.657 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.05 -10.83 56.88 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.508 -179.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 85.5 mt -115.82 -23.96 8.4 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.62 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . 0.521 ' N ' ' O ' ' A' ' 126' ' ' ALA . 73.2 t80 -51.83 -48.9 63.72 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.569 -0.452 . . . . 0.0 110.537 -178.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.53 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 39.4 p-10 -66.17 -41.67 89.98 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.885 0.374 . . . . 0.0 111.34 179.26 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.53 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 87.9 mt-30 -67.83 -37.33 81.77 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.874 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 97.1 mt -79.65 -42.57 24.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.134 -179.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.2 t -57.78 -44.9 86.54 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.256 -178.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 18.8 m -62.19 -46.09 90.46 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.865 0.364 . . . . 0.0 110.76 179.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 92.3 mt -62.47 -43.63 98.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.374 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -170.02 163.14 6.52 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.459 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -42.02 110.81 0.16 Allowed 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.531 2.154 . . . . 0.0 112.088 179.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.9 m -87.48 127.59 35.23 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.559 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 34.9 tp -119.61 139.42 52.21 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.077 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.429 ' O ' ' OD2' ' A' ' 32' ' ' ASP . 81.0 mt -105.48 120.0 55.54 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.385 0 CA-C-O 121.14 0.495 . . . . 0.0 111.341 -179.665 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 98.2 mt -135.42 132.51 52.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.683 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.515 HD22 ' CG ' ' A' ' 241' ' ' ASP . 59.1 t30 -64.71 147.8 52.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.885 0.374 . . . . 0.0 110.368 179.275 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.454 ' O ' ' OD2' ' A' ' 241' ' ' ASP . 86.5 t80 -82.41 122.69 28.33 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.046 -179.593 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.433 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 91.4 m-20 55.32 69.02 0.78 Allowed 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.951 179.695 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 34.8 p-10 -125.78 0.37 7.39 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.943 0.401 . . . . 0.0 110.68 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -150.55 115.7 5.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.747 -179.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' SER . . . . . 0.513 ' HG ' ' H ' ' A' ' 150' ' ' GLN . 85.9 p -63.93 169.07 4.52 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.566 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.419 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.6 p-90 -51.87 -15.95 0.62 Allowed 'General case' 0 C--O 1.223 -0.341 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.49 -179.763 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . 0.513 ' H ' ' HG ' ' A' ' 148' ' ' SER . 68.1 tp60 -70.41 -76.09 0.11 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.469 -179.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.456 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.1 t -62.47 -38.61 90.51 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.011 0.434 . . . . 0.0 110.241 179.553 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 51.1 tp -60.21 -45.48 93.02 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.334 -178.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.419 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 45.8 tp -62.69 -41.86 99.33 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.859 0.361 . . . . 0.0 110.398 178.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.456 ' OG1' ' O ' ' A' ' 151' ' ' SER . 57.6 p -63.89 -34.74 78.63 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.18 -179.371 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . 0.463 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 88.1 mm-40 -63.85 -42.28 97.61 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.153 179.274 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 90.5 mt -65.28 -39.07 92.09 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.125 0.488 . . . . 0.0 110.096 179.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.577 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.03 -32.39 80.1 Favored Glycine 0 CA--C 1.519 0.321 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 -179.292 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.463 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.3 mt-10 -36.65 -25.09 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.82 0.343 . . . . 0.0 110.807 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.577 ' N ' ' O ' ' A' ' 157' ' ' GLY . 95.8 mt -59.56 148.53 7.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.193 179.284 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 71.3 p -68.91 137.68 54.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.12 -179.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 70.56 21.91 77.77 Favored Glycine 0 N--CA 1.458 0.146 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 179.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 60.3 m80 -124.28 -14.34 7.0 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.73 0.3 . . . . 0.0 110.569 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -66.17 -59.49 3.71 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.792 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -52.22 -48.32 65.18 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 120.679 -0.409 . . . . 0.0 110.093 -179.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -60.88 -40.96 95.0 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.697 0.284 . . . . 0.0 110.313 179.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.61 -47.17 86.64 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.6 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -57.2 -39.83 76.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.179 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -61.85 -50.3 72.79 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.569 179.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 60.1 ttt85 -65.5 -43.78 89.09 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.458 179.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 94.8 mt -64.47 -43.52 96.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.386 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.32 -50.89 71.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.474 -179.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.97 -43.56 95.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.454 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . 0.515 ' CD1' ' OH ' ' A' ' 301' ' ' TYR . 56.7 t80 -62.67 -44.59 95.87 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.07 0.462 . . . . 0.0 110.386 179.407 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -63.38 -39.96 95.94 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.561 -179.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -62.9 -42.8 99.91 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.623 179.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -60.78 -44.69 96.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.044 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 84.7 mt -64.34 -41.26 96.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.058 0.456 . . . . 0.0 110.733 178.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.13 -62.19 1.79 Allowed 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.43 -179.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.35 -46.86 85.46 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.52 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.02 -41.6 64.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.159 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -63.8 -33.48 75.77 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.015 0.436 . . . . 0.0 110.371 179.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 69.7 tt0 -91.1 8.22 36.62 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.476 0.655 . . . . 0.0 110.529 -178.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -103.88 -32.62 9.2 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.348 179.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 45.1 pt -128.0 147.75 32.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.893 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -139.74 131.2 26.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.382 179.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . 0.553 ' CD2' ' N ' ' A' ' 186' ' ' LEU . 3.6 mm? -85.5 133.97 41.09 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.953 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -44.23 157.99 0.15 Allowed 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 122.734 2.289 . . . . 0.0 112.097 179.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . 0.519 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.5 Cg_endo -62.93 115.05 2.7 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 C-N-CA 122.775 2.317 . . . . 0.0 111.662 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . 0.519 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.8 mt-30 155.23 148.33 0.0 OUTLIER Pre-proline 0 C--N 1.332 -0.176 0 O-C-N 123.833 0.708 . . . . 0.0 110.869 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -73.75 144.29 34.93 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.688 2.259 . . . . 0.0 111.881 178.042 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.491 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.1 p -124.92 158.65 32.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.365 0.602 . . . . 0.0 110.12 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 192' ' ' THR . . . . . 0.491 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 35.9 p -143.22 165.31 27.81 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.245 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -135.31 128.63 32.11 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 121.229 0.537 . . . . 0.0 110.233 179.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 48.3 pt -146.7 149.38 15.93 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.362 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.161 179.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 69.0 t -117.95 123.4 71.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.317 0.58 . . . . 0.0 109.621 179.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -134.38 106.71 7.21 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.253 179.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 95.0 m -130.34 130.47 44.48 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.897 179.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.41 ' O ' ' N ' ' A' ' 201' ' ' HIS . . . -83.11 -36.83 24.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.142 179.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.63 -66.72 0.29 Allowed 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.311 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.52 -9.75 58.95 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.231 179.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . 0.41 ' N ' ' O ' ' A' ' 198' ' ' ALA . 60.6 t-80 60.85 58.28 2.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.887 -179.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 36.0 p -167.11 153.64 8.33 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.554 179.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.64 144.18 24.22 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.02 0.438 . . . . 0.0 110.355 179.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -135.53 138.66 43.28 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.67 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 20.3 mt -106.64 125.53 51.12 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 -179.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 206' ' ' TRP . . . . . 0.557 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 73.9 m95 -82.0 167.32 18.99 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.643 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -157.17 171.59 7.25 Favored Pre-proline 0 C--O 1.224 -0.238 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.585 -179.218 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -53.58 -37.29 82.96 Favored 'Trans proline' 0 C--N 1.303 -1.84 0 C-N-CA 122.602 2.201 . . . . 0.0 112.114 179.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -70.45 -35.37 73.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.858 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 21.6 m -60.67 150.94 30.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.591 -179.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.61 -37.22 83.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.524 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 212' ' ' GLN . . . . . 0.557 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 54.9 tt0 -64.5 -40.4 95.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.515 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.59 -43.39 92.26 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -63.26 -43.96 96.48 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 65.6 ttp -59.62 -47.71 84.51 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.196 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 86.0 mt -60.78 -40.81 93.96 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 217' ' ' GLU . . . . . 0.452 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.4 tp10 -58.61 -37.82 76.67 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -65.18 -38.5 90.72 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.721 0.296 . . . . 0.0 110.525 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 94.8 mt -64.09 -42.83 96.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.105 0.479 . . . . 0.0 110.504 -179.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.48 45.13 0.08 OUTLIER Glycine 0 C--N 1.334 0.467 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 221' ' ' PHE . . . . . 0.452 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 26.9 m-85 -128.01 155.59 44.07 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.107 0.48 . . . . 0.0 110.47 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 222' ' ' THR . . . . . 0.455 ' O ' ' O ' ' A' ' 191' ' ' VAL . 7.6 p -106.8 122.29 46.1 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.263 0.554 . . . . 0.0 110.136 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . 0.444 ' CD2' ' N ' ' A' ' 223' ' ' LEU . 4.3 mm? -101.33 133.09 46.47 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.159 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.93 159.68 14.78 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.535 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -105.41 115.26 29.95 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.302 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.45 ' CD1' ' N ' ' A' ' 226' ' ' LEU . 9.0 mp -53.0 156.8 3.24 Favored Pre-proline 0 N--CA 1.452 -0.355 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.746 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -60.39 145.22 99.08 Favored 'Trans proline' 0 C--N 1.3 -1.974 0 C-N-CA 122.628 2.219 . . . . 0.0 112.121 179.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -86.98 -3.43 59.09 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.54 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.12 -41.1 5.64 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . 0.523 ' O ' ' N ' ' A' ' 233' ' ' SER . 69.5 mt -79.15 -17.71 54.48 Favored 'General case' 0 C--O 1.221 -0.42 0 CA-C-O 121.082 0.468 . . . . 0.0 110.319 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 54.8 t-20 -40.72 -48.9 3.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.844 -179.163 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -87.49 15.09 7.03 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.772 0.32 . . . . 0.0 111.428 179.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 233' ' ' SER . . . . . 0.523 ' N ' ' O ' ' A' ' 230' ' ' LEU . 77.9 p -60.45 -35.11 75.06 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.676 -179.7 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . 0.523 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.5 tt0 -119.33 -69.33 0.85 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.977 179.368 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.0 m -70.18 101.4 1.86 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.633 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -93.15 58.24 2.86 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.376 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -144.81 -122.42 1.56 Allowed Glycine 0 CA--C 1.52 0.353 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -135.62 111.36 9.35 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.25 0.548 . . . . 0.0 110.34 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . 0.529 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.5 mtt180 -147.9 57.95 1.1 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.756 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -69.1 -32.85 72.55 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.519 179.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 241' ' ' ASP . . . . . 0.515 ' CG ' HD22 ' A' ' 143' ' ' ASN . 65.1 t0 -57.02 -47.14 81.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.305 -178.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 242' ' ' ILE . . . . . 0.433 ' O ' ' O ' ' A' ' 239' ' ' ARG . 18.5 tt -139.4 155.4 25.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.901 0.382 . . . . 0.0 110.504 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 96.2 mt -106.16 106.86 21.37 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.235 0 CA-C-O 121.232 0.539 . . . . 0.0 110.59 179.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . 0.529 ' OE1' ' NH1' ' A' ' 239' ' ' ARG . 88.3 mt-30 -110.46 109.91 20.46 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.292 179.757 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 9.4 mp -121.51 -168.28 1.66 Allowed 'General case' 0 C--O 1.225 -0.229 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.672 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . 0.523 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.9 -16.21 0.05 OUTLIER Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . 0.699 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -61.49 156.18 35.45 Favored Glycine 0 CA--C 1.521 0.457 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -63.28 21.79 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.991 0.424 . . . . 0.0 110.672 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . 0.699 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.8 m-20 -97.15 -6.19 35.45 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.478 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 91.7 mt -79.76 -21.97 43.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.631 179.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.61 -51.21 70.89 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.824 -179.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.38 -5.5 58.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.443 179.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.38 -74.39 1.15 Allowed Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 83.4 mt -69.96 125.92 28.18 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.067 0.461 . . . . 0.0 110.235 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -59.49 -39.44 83.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.139 -179.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 83.1 51.76 4.06 Favored Glycine 0 CA--C 1.52 0.401 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -95.92 -14.88 22.76 Favored 'General case' 0 C--N 1.331 -0.198 0 O-C-N 122.721 -0.282 . . . . 0.0 110.571 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 258' ' ' SER . . . . . 0.449 ' HG ' ' CG2' ' A' ' 191' ' ' VAL . 3.5 t 174.52 88.99 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.11 0.481 . . . . 0.0 110.049 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . 0.595 ' N ' ' CD1' ' A' ' 259' ' ' LEU . 0.9 OUTLIER -94.47 124.3 38.42 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.367 0.603 . . . . 0.0 111.174 -179.204 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 16.0 m-30 -93.36 146.43 23.74 Favored 'General case' 0 CA--C 1.503 -0.843 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.328 179.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 86.5 mt -122.0 149.86 42.89 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.597 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.658 ' CG ' ' N ' ' A' ' 263' ' ' ALA . 2.5 p90 -77.83 -139.0 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.431 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 263' ' ' ALA . . . . . 0.658 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -51.59 77.71 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 121.047 0.451 . . . . 0.0 111.15 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . 0.628 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.44 104.69 0.19 Allowed Glycine 0 CA--C 1.527 0.795 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 265' ' ' ASP . . . . . 0.601 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.9 m-20 -80.55 -177.56 6.3 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 120.632 0.253 . . . . 0.0 110.971 -179.611 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -40.45 -17.81 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.854 0.359 . . . . 0.0 110.513 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 267' ' ' LYS . . . . . 0.601 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.26 -51.7 42.24 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.684 179.438 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -63.74 -46.69 84.19 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.973 179.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . 0.525 ' O ' ' CD2' ' A' ' 273' ' ' TYR . . . -61.44 -35.28 77.14 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 121.238 0.542 . . . . 0.0 109.753 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -63.06 -34.61 77.96 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.022 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.31 -43.2 13.92 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.393 -179.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 272' ' ' ILE . . . . . 0.618 ' C ' ' H ' ' A' ' 274' ' ' ALA . 4.9 tt -51.36 -33.78 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.864 -178.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 273' ' ' TYR . . . . . 0.525 ' CD2' ' O ' ' A' ' 269' ' ' ALA . 17.1 m-85 -54.31 -2.06 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.674 -179.533 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 274' ' ' ALA . . . . . 0.618 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.54 -39.71 70.51 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.996 179.533 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . 0.582 ' O ' ' N ' ' A' ' 279' ' ' ALA . 4.0 p30 -38.6 97.31 0.13 Allowed Pre-proline 0 C--O 1.225 -0.185 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.556 -179.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 276' ' ' PRO . . . . . 0.401 ' N ' ' O ' ' A' ' 274' ' ' ALA . 47.5 Cg_exo -54.1 -42.82 63.84 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 C-N-CA 122.234 1.956 . . . . 0.0 112.696 -178.728 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 89.7 mt -64.38 -42.73 96.0 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.188 0.518 . . . . 0.0 111.266 -179.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 91.4 mt -95.97 -1.16 49.65 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.922 -179.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 279' ' ' ALA . . . . . 0.582 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.39 -34.94 77.71 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.662 -179.684 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -73.87 20.01 0.11 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.035 -179.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . 0.518 ' H ' ' C ' ' A' ' 279' ' ' ALA . 13.7 mt -75.15 120.12 80.18 Favored Pre-proline 0 N--CA 1.45 -0.439 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.423 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -51.21 -39.26 62.09 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.568 2.178 . . . . 0.0 111.809 179.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -53.19 -50.34 64.85 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 78.1 t -61.47 -43.91 97.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 179.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -57.66 -41.04 80.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.186 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -91.27 0.19 57.57 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.065 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt 59.54 44.06 15.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.07 0.462 . . . . 0.0 110.935 179.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -95.25 41.46 1.1 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.347 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 54.6 t -119.39 135.6 59.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 121.089 0.471 . . . . 0.0 110.161 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -132.92 163.14 29.82 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.071 0.462 . . . . 0.0 110.695 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.59 155.02 33.04 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-O 121.068 0.461 . . . . 0.0 110.782 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 82.1 mt -94.23 -1.36 54.18 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.211 -179.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.72 165.53 12.6 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 6.8 m -87.57 -62.07 1.58 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.905 0.383 . . . . 0.0 111.146 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 295' ' ' GLU . . . . . 0.483 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.6 mm-40 -69.16 -3.97 15.65 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.721 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 25.5 p -76.56 32.39 0.13 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.648 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 297' ' ' PHE . . . . . 0.483 ' H ' ' C ' ' A' ' 295' ' ' GLU . 85.9 t80 -60.47 -45.88 92.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.603 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . 0.62 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.1 mtt85 -81.2 135.02 35.72 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.02 0.438 . . . . 0.0 110.546 -179.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 18.4 tp -113.91 117.18 30.66 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-O 121.054 0.454 . . . . 0.0 110.098 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . 0.603 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.6 p-10 -165.21 -176.66 4.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.533 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 301' ' ' TYR . . . . . 0.515 ' OH ' ' CD1' ' A' ' 173' ' ' PHE . 81.2 t80 -47.05 -43.15 19.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.169 -179.603 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -67.11 -40.13 86.83 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.046 0.451 . . . . 0.0 110.91 179.043 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 303' ' ' SER . . . . . 0.603 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 59.9 p -56.27 -36.27 68.38 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.021 -179.093 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . 0.514 ' N ' ' HG ' ' A' ' 303' ' ' SER . . . -57.32 -51.54 68.95 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.51 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 90.2 mtp -56.67 -43.11 80.1 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -179.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -66.48 -42.72 87.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.003 0.43 . . . . 0.0 110.09 178.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 55.5 t -63.94 -43.19 97.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.126 179.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 43.4 tp -59.9 -42.14 93.18 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.683 -179.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -62.24 -39.27 92.27 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 310' ' ' ARG . . . . . 0.451 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.5 ttt85 -63.75 -44.01 94.75 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.203 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 89.5 mt -63.35 -42.21 98.89 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.194 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt -62.95 -33.57 75.66 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.081 0.467 . . . . 0.0 109.977 179.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.53 -23.75 21.95 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.325 -179.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . 0.451 ' N ' ' O ' ' A' ' 310' ' ' ARG . 6.7 tt -62.33 -43.12 99.56 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 121.111 0.482 . . . . 0.0 110.562 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 . . . . . 0 C--O 1.22 -0.469 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.428 -179.968 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -99.37 135.89 40.12 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.016 0.436 . . . . 0.0 110.504 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.497 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -92.01 178.39 1.74 Allowed Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.548 -179.928 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.497 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.8 Cg_exo -61.61 147.28 95.76 Favored 'Trans proline' 0 C--N 1.3 -2.018 0 C-N-CA 122.79 2.327 . . . . 0.0 112.104 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 35.6 ptt180 -135.79 142.16 44.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.72 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -79.71 116.51 19.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.471 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.4 tp -110.94 130.68 63.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.498 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.6 t -70.71 141.99 51.53 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.563 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.51 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.4 t0 -139.68 179.39 6.61 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.568 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.51 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 78.0 p -73.92 -36.99 64.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.61 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.8 ttt85 -46.54 -94.67 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.331 -179.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.452 ' C ' ' HG1' ' A' ' 36' ' ' THR . . . -167.16 -26.42 0.02 OUTLIER Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.452 ' HG1' ' C ' ' A' ' 35' ' ' GLY . 59.9 m -169.11 104.73 0.39 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.879 0.371 . . . . 0.0 110.65 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 75.6 t60 -128.39 148.89 50.72 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.033 0.444 . . . . 0.0 110.262 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.484 ' CG2' ' N ' ' A' ' 39' ' ' LEU . 98.2 m -131.23 166.04 22.04 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.62 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.484 ' N ' ' CG2' ' A' ' 38' ' ' THR . 81.5 mt -120.83 127.61 52.08 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.43 179.737 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -65.2 -44.55 87.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.694 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.406 ' O ' ' HD3' ' A' ' 43' ' ' PRO . 39.9 p -165.83 154.88 11.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.448 179.667 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.46 ' N ' ' CD ' ' A' ' 42' ' ' GLN . 14.8 mp0 -44.34 101.13 0.24 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.626 179.449 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.406 ' HD3' ' O ' ' A' ' 41' ' ' SER . 31.5 Cg_exo -57.39 129.59 34.79 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 C-N-CA 122.365 2.044 . . . . 0.0 112.283 -179.722 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -84.1 -24.57 30.27 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.502 179.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.539 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.5 mtm-85 -122.29 134.17 54.67 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-O 121.147 0.498 . . . . 0.0 110.34 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.1 mt -130.43 133.76 63.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.949 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 45.4 t -124.25 130.49 73.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 179.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.502 ' O ' ' O ' ' A' ' 66' ' ' ALA . 2.0 m -155.38 167.75 29.36 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.556 179.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 59.5 p -124.9 9.44 8.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.487 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.56 125.42 33.08 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.672 -179.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 95.1 t -65.92 -44.43 92.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.417 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.4 m -62.49 -44.26 96.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.651 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 51.3 tp -62.33 -41.41 98.54 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.5 -179.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 75.5 m -57.7 -44.48 85.88 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.258 -179.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.29 -62.18 5.36 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 179.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.7 t -48.38 -35.51 12.75 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.8 mt -61.87 -44.64 96.4 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.707 -0.397 . . . . 0.0 111.17 179.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.2 mp -65.01 -41.7 95.09 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.303 178.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.63 -40.97 98.24 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.989 -179.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.0 tp -88.65 16.79 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.762 -179.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 56.41 84.82 0.08 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.674 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 178.67 57.86 0.06 OUTLIER Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.016 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -50.77 153.34 8.39 Favored 'Trans proline' 0 C--N 1.296 -2.202 0 C-N-CA 122.892 2.394 . . . . 0.0 112.38 -178.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.437 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.2 OUTLIER -108.93 145.44 15.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.359 -179.714 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.8 mt -63.62 -45.24 98.09 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.317 -179.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.502 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -129.49 134.08 47.61 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 120.848 0.356 . . . . 0.0 110.539 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.501 ' O ' ' N ' ' A' ' 98' ' ' LEU . 75.2 m -134.73 158.84 43.09 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.798 -179.637 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.99 139.15 16.01 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.461 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.81 -162.69 0.08 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.914 0.388 . . . . 0.0 110.503 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.491 ' O ' ' C ' ' A' ' 71' ' ' THR . 14.5 t -133.49 134.43 43.46 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.404 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.491 ' C ' ' O ' ' A' ' 70' ' ' THR . 0.6 OUTLIER 29.69 68.82 0.65 Allowed Pre-proline 0 N--CA 1.464 0.226 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.754 -179.866 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -61.25 145.17 98.83 Favored 'Trans proline' 0 C--N 1.299 -2.031 0 C-N-CA 122.627 2.218 . . . . 0.0 112.062 -178.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.533 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 45.1 p-10 -159.14 -32.04 0.06 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.677 179.643 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.533 ' N ' ' OD1' ' A' ' 73' ' ' ASN . 99.1 m-20 -64.1 -39.7 94.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.489 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -60.23 -48.33 82.19 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.706 -179.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.424 ' O ' ' O ' ' A' ' 77' ' ' ALA . 92.6 t -60.25 -24.9 32.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 179.771 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.424 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -45.71 172.98 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.555 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.575 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.2 p30 -62.18 177.89 0.43 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.564 -179.728 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.593 ' C ' ' H ' ' A' ' 81' ' ' GLY . 36.1 p30 -45.13 85.79 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.965 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.575 ' N ' ' O ' ' A' ' 78' ' ' ASP . 42.5 tp60 -67.69 13.17 0.08 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.109 -179.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.593 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 118.73 -22.34 9.32 Favored Glycine 0 CA--C 1.519 0.324 0 N-CA-C 110.969 -0.852 . . . . 0.0 110.969 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -108.13 116.46 32.01 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.014 0.435 . . . . 0.0 110.44 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 75.8 mt -98.71 0.4 44.49 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.491 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -92.53 7.24 44.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.971 0.415 . . . . 0.0 110.413 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.441 ' O ' ' CG2' ' A' ' 89' ' ' VAL . 87.8 mt-30 -100.12 -28.19 13.16 Favored 'General case' 0 C--O 1.225 -0.234 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.823 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 68.9 t-105 -62.77 -40.71 98.12 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.858 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.554 ' O ' ' N ' ' A' ' 91' ' ' LYS . 65.4 m -77.73 -53.56 7.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.148 -179.364 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -48.51 -50.76 30.48 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.965 -179.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.441 ' CG2' ' O ' ' A' ' 85' ' ' GLN . 15.7 m -68.87 -40.62 81.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 120.867 0.365 . . . . 0.0 111.005 179.76 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.415 ' H ' HG23 ' A' ' 89' ' ' VAL . . . -72.32 -22.63 61.15 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.695 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.554 ' N ' ' O ' ' A' ' 87' ' ' SER . 65.9 tttm -62.01 -45.51 93.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.512 -179.498 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.442 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.6 mm-40 -90.53 -94.85 0.12 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.134 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.636 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.9 mtt180 -142.92 58.97 1.42 Allowed 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.461 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.6 pttp 33.43 26.13 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 120.879 0.371 . . . . 0.0 110.221 -179.145 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.636 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.4 tt -48.08 123.52 6.38 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.925 -178.102 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -83.88 -169.41 2.56 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.092 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.603 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 81.3 mtp180 -74.58 136.84 42.05 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.298 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.501 ' N ' ' O ' ' A' ' 67' ' ' SER . 91.3 mt -85.79 -165.82 1.35 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.762 -179.68 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.537 ' CD2' ' O ' ' A' ' 99' ' ' TYR . 48.3 p90 -168.33 119.77 0.81 Allowed 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.178 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.515 ' C ' ' O ' ' A' ' 99' ' ' TYR . 43.0 mm -28.88 120.96 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.977 -179.693 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 114.25 27.57 3.35 Favored Glycine 0 CA--C 1.52 0.344 0 N-CA-C 111.154 -0.779 . . . . 0.0 111.154 -179.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.575 ' N ' ' CD ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -144.63 46.62 0.63 Allowed Pre-proline 0 C--N 1.324 -0.537 0 CA-C-O 120.995 0.426 . . . . 0.0 110.479 179.885 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 29.5 Cg_endo -61.91 143.97 96.1 Favored 'Trans proline' 0 C--N 1.297 -2.153 0 C-N-CA 122.644 2.229 . . . . 0.0 111.993 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 27.8 t -173.16 120.0 0.34 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.462 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.61 -40.46 63.8 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.035 0.445 . . . . 0.0 111.049 179.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.25 -39.87 89.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.88 -179.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.22 -39.97 95.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.75 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 71.3 t -67.57 -43.87 86.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.798 179.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.84 -38.89 92.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.578 -179.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.442 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.49 -23.31 62.66 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.49 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.551 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.4 mm-40 -90.64 5.3 48.56 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.687 -179.502 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.551 ' C ' ' O ' ' A' ' 111' ' ' GLN . 10.6 tpt 23.55 64.13 0.38 Allowed Pre-proline 0 N--CA 1.465 0.296 0 CA-C-O 120.896 0.379 . . . . 0.0 110.946 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -78.14 167.24 23.64 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 123.03 2.487 . . . . 0.0 112.132 -178.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.524 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 98.9 m-20 -109.96 -42.11 4.31 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.19 179.428 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.3 tp -121.24 120.21 34.5 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.019 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 82.5 mt -112.79 128.88 69.26 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.336 0 CA-C-O 120.918 0.389 . . . . 0.0 110.812 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 29.2 mt -109.13 132.32 54.23 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 121.088 0.471 . . . . 0.0 110.211 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 99.1 mt -119.94 138.57 50.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.645 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 85.9 p -72.44 154.07 41.07 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.608 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.18 -50.21 74.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.636 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.0 t -149.73 154.3 38.29 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.579 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 170.66 -170.79 43.37 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.99 -34.03 88.83 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.452 ' O ' ' OD1' ' A' ' 124' ' ' ASP . 44.5 p-10 -87.29 120.42 28.55 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.796 0.332 . . . . 0.0 110.684 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 38.8 t -63.2 143.83 57.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.504 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.52 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.0 -43.23 9.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.928 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.6 tp -62.86 -42.35 99.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.706 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.58 -12.07 59.54 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.485 -179.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 85.3 mt -114.77 -23.84 8.99 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.649 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . 0.52 ' N ' ' O ' ' A' ' 126' ' ' ALA . 79.9 t80 -50.9 -49.66 58.96 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.592 -178.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.0 p-10 -66.12 -42.6 88.97 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.861 0.363 . . . . 0.0 111.158 179.576 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.501 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 88.4 mt-30 -66.98 -37.94 85.15 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.781 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 96.0 mt -80.32 -41.38 24.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.892 -179.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.2 t -57.21 -44.52 83.76 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.212 -179.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.5 m -61.87 -45.22 94.7 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.751 0.31 . . . . 0.0 110.517 179.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 93.3 mt -62.18 -43.6 98.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.27 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.51 168.69 4.66 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.554 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -50.38 113.04 0.87 Allowed 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.282 1.988 . . . . 0.0 112.206 179.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 23.4 m -83.97 127.39 33.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.609 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 34.8 tp -117.87 135.91 53.79 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.034 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.44 ' O ' ' OD2' ' A' ' 32' ' ' ASP . 81.7 mt -100.18 118.85 47.44 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.331 0 CA-C-O 121.174 0.512 . . . . 0.0 111.194 -179.36 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 98.1 mt -134.74 132.28 54.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.621 179.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.517 HD22 ' CG ' ' A' ' 241' ' ' ASP . 60.9 t30 -66.97 151.42 47.66 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.905 0.383 . . . . 0.0 110.433 179.457 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.522 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 88.0 t80 -86.11 122.38 30.04 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.811 -179.52 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.522 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 98.9 m-20 55.17 69.34 0.74 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.754 179.657 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 35.8 p-10 -125.8 0.16 7.37 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.651 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -150.56 115.13 5.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.7 -179.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' SER . . . . . 0.517 ' HG ' ' H ' ' A' ' 150' ' ' GLN . 84.5 p -63.3 168.33 4.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.542 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.422 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.6 p-90 -51.83 -15.88 0.59 Allowed 'General case' 0 C--O 1.223 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.524 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . 0.517 ' H ' ' HG ' ' A' ' 148' ' ' SER . 68.1 tp60 -70.39 -76.02 0.11 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.511 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.448 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.1 t -62.7 -38.63 91.16 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.295 179.51 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 54.0 tp -60.02 -45.66 92.07 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.379 -178.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.422 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 46.9 tp -62.76 -41.75 99.36 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.832 0.348 . . . . 0.0 110.365 179.066 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.448 ' OG1' ' O ' ' A' ' 151' ' ' SER . 60.2 p -64.14 -34.86 79.03 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.264 -179.498 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . 0.435 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.9 mm-40 -64.24 -42.59 96.45 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.322 179.286 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 91.6 mt -65.55 -38.82 90.68 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.037 0.446 . . . . 0.0 110.252 179.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.583 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.29 -32.31 80.3 Favored Glycine 0 CA--C 1.521 0.418 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 -179.387 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.442 ' C ' ' O ' ' A' ' 157' ' ' GLY . 97.1 mt-10 -35.17 -27.29 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.821 0.344 . . . . 0.0 110.764 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.583 ' N ' ' O ' ' A' ' 157' ' ' GLY . 95.5 mt -56.03 149.76 3.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.33 179.187 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 71.5 p -69.87 137.3 51.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.002 -179.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 71.57 20.34 78.4 Favored Glycine 0 N--CA 1.458 0.143 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 179.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 58.0 m80 -121.78 -14.91 8.02 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.706 0.289 . . . . 0.0 110.571 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -65.85 -59.83 3.48 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.764 -179.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -52.05 -49.35 63.64 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.16 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -60.76 -41.14 94.85 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.718 0.294 . . . . 0.0 110.356 179.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.45 -47.2 86.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.613 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -57.0 -40.16 76.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.241 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -61.65 -50.34 72.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.571 179.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -65.34 -43.75 89.91 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.535 179.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 95.2 mt -64.6 -43.47 96.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.509 179.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.21 -51.17 70.43 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.535 -179.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.44 -43.93 96.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.46 179.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . 0.458 ' CD1' ' OH ' ' A' ' 301' ' ' TYR . 56.7 t80 -62.72 -44.45 96.18 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.04 0.448 . . . . 0.0 110.405 179.44 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -63.35 -39.88 95.75 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.616 -179.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -63.07 -42.78 99.74 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.617 179.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -60.67 -44.77 96.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.181 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 83.7 mt -64.36 -41.23 96.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.031 0.443 . . . . 0.0 110.698 178.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.08 -62.32 1.71 Allowed 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.482 -179.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.52 -46.9 85.81 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.552 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.12 -41.76 65.34 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.223 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -63.94 -33.52 75.91 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.976 0.417 . . . . 0.0 110.352 179.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . 0.404 ' HG2' ' O ' ' A' ' 182' ' ' GLU . 69.6 tt0 -90.72 8.68 33.27 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.37 0.605 . . . . 0.0 110.52 -179.003 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -104.84 -32.12 8.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.195 179.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 45.4 pt -128.11 147.67 32.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.814 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -139.86 131.03 26.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.422 179.362 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . 0.556 ' CD2' ' N ' ' A' ' 186' ' ' LEU . 3.6 mm? -85.59 133.14 42.56 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.901 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -43.89 157.72 0.14 Allowed 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.738 2.292 . . . . 0.0 112.138 179.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . 0.525 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.8 Cg_endo -63.01 115.21 2.81 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 C-N-CA 122.804 2.336 . . . . 0.0 111.724 179.811 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . 0.525 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.7 mt-30 155.53 147.63 0.0 OUTLIER Pre-proline 0 C--N 1.332 -0.195 0 O-C-N 123.596 0.56 . . . . 0.0 110.762 -179.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -73.77 143.85 34.17 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.651 2.234 . . . . 0.0 111.963 178.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.499 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.1 p -125.03 159.09 32.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.27 0.557 . . . . 0.0 110.164 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 192' ' ' THR . . . . . 0.499 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 35.9 p -143.54 165.48 27.45 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.034 -179.636 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -135.38 128.58 31.89 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.159 0.504 . . . . 0.0 110.213 179.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 47.4 pt -146.49 148.81 16.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.048 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 68.9 t -117.67 123.09 71.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-O 121.238 0.542 . . . . 0.0 109.765 179.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -134.3 107.29 7.56 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.332 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 95.2 m -130.96 130.6 43.63 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.756 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.412 ' O ' ' N ' ' A' ' 201' ' ' HIS . . . -82.84 -36.9 25.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.256 179.646 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.34 -67.18 0.25 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.374 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.33 -9.43 58.49 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.348 179.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . 0.412 ' N ' ' O ' ' A' ' 198' ' ' ALA . 60.2 t-80 60.27 58.42 2.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.748 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 46.4 p -167.21 153.65 8.19 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.535 179.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.6 144.23 24.29 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.992 0.425 . . . . 0.0 110.446 179.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -135.39 138.4 43.27 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.646 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 20.0 mt -106.42 125.48 51.05 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 121.11 0.481 . . . . 0.0 109.867 -179.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 206' ' ' TRP . . . . . 0.557 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 75.7 m95 -82.01 167.03 19.28 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.659 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -156.77 171.33 7.56 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.586 -179.156 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.87 -37.03 85.02 Favored 'Trans proline' 0 C--N 1.302 -1.879 0 C-N-CA 122.624 2.216 . . . . 0.0 112.133 179.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -70.47 -34.87 72.89 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.8 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 22.0 m -61.26 150.83 33.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.64 -179.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.59 -36.95 82.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.448 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 212' ' ' GLN . . . . . 0.557 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 54.8 tt0 -64.69 -40.29 95.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.506 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.61 -43.45 92.07 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -63.26 -43.52 97.76 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.741 0.305 . . . . 0.0 110.281 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 65.2 ttp -59.61 -48.11 82.95 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.252 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 87.9 mt -60.49 -41.04 93.45 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 179.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 217' ' ' GLU . . . . . 0.455 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.3 tp10 -57.88 -37.85 74.69 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -65.36 -37.98 88.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.8 0.333 . . . . 0.0 110.679 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 94.4 mt -64.43 -42.64 95.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.606 -179.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.49 44.6 0.08 OUTLIER Glycine 0 C--N 1.333 0.408 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 221' ' ' PHE . . . . . 0.455 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 26.5 m-85 -127.74 155.28 44.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.04 0.447 . . . . 0.0 110.507 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 222' ' ' THR . . . . . 0.456 ' O ' ' O ' ' A' ' 191' ' ' VAL . 6.5 p -106.99 122.11 45.8 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.201 0.524 . . . . 0.0 110.154 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . 0.446 ' CD2' ' N ' ' A' ' 223' ' ' LEU . 4.3 mm? -101.07 133.12 46.06 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.063 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.96 159.31 14.98 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.463 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.43 115.42 30.23 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.942 0.401 . . . . 0.0 110.351 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.456 ' CD1' ' N ' ' A' ' 226' ' ' LEU . 8.9 mp -53.47 156.77 4.04 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.686 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -60.29 145.41 98.65 Favored 'Trans proline' 0 C--N 1.301 -1.956 0 C-N-CA 122.721 2.281 . . . . 0.0 112.058 179.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.36 -2.92 58.96 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.546 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.31 -40.8 5.66 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . 0.54 ' O ' ' N ' ' A' ' 233' ' ' SER . 86.2 mt -79.27 -16.75 55.96 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-O 121.006 0.431 . . . . 0.0 110.386 -179.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . 0.403 ' C ' ' O ' ' A' ' 230' ' ' LEU . 54.5 t-20 -40.21 -49.15 2.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.694 -179.577 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -88.18 15.43 7.54 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.777 0.322 . . . . 0.0 111.27 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 233' ' ' SER . . . . . 0.54 ' N ' ' O ' ' A' ' 230' ' ' LEU . 78.1 p -60.43 -35.65 76.33 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.693 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . 0.526 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.6 tt0 -118.35 -69.39 0.85 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.943 179.554 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.1 m -70.04 103.37 2.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.734 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -94.59 57.69 2.25 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.359 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -144.88 -122.61 1.57 Allowed Glycine 0 CA--C 1.52 0.402 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -134.4 111.7 10.37 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 121.081 0.467 . . . . 0.0 110.433 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . 0.517 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.3 mtt180 -148.1 57.52 1.08 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.778 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -69.92 -31.75 69.69 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.505 179.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 241' ' ' ASP . . . . . 0.517 ' CG ' HD22 ' A' ' 143' ' ' ASN . 64.9 t0 -56.85 -46.98 81.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.343 -179.163 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 242' ' ' ILE . . . . . 0.435 ' O ' ' O ' ' A' ' 239' ' ' ARG . 17.5 tt -140.27 157.11 24.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.898 0.38 . . . . 0.0 110.527 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 96.1 mt -106.12 106.17 20.08 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.196 0 CA-C-O 121.16 0.505 . . . . 0.0 110.504 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . 0.517 ' OE1' ' NH1' ' A' ' 239' ' ' ARG . 88.3 mt-30 -110.5 110.39 21.11 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.405 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 9.5 mp -121.95 -168.3 1.68 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.607 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . 0.526 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.53 -16.88 0.05 OUTLIER Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . 0.694 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -60.47 157.01 29.84 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -63.77 21.27 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.915 0.388 . . . . 0.0 110.585 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . 0.694 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.7 m-20 -96.87 -5.82 37.29 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.569 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 92.7 mt -80.23 -21.45 42.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.6 179.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.47 -51.24 70.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.8 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.72 -5.28 58.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.449 179.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.09 -74.39 1.14 Allowed Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.926 -0.87 . . . . 0.0 110.926 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 81.8 mt -70.13 125.95 28.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.054 0.454 . . . . 0.0 110.227 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -59.45 -39.17 82.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.321 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 82.82 51.94 4.06 Favored Glycine 0 CA--C 1.521 0.463 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -95.8 -15.16 22.71 Favored 'General case' 0 C--N 1.331 -0.203 0 O-C-N 122.723 -0.281 . . . . 0.0 110.553 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 258' ' ' SER . . . . . 0.423 ' O ' ' O ' ' A' ' 192' ' ' THR . 3.4 t 174.5 88.9 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.104 0.478 . . . . 0.0 110.159 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . 0.596 ' N ' ' CD1' ' A' ' 259' ' ' LEU . 0.9 OUTLIER -94.27 123.88 37.94 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.244 0.545 . . . . 0.0 111.098 -179.058 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 16.0 m-30 -92.85 146.4 23.66 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.316 179.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 86.3 mt -122.31 149.73 43.34 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.562 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.66 ' CG ' ' N ' ' A' ' 263' ' ' ALA . 2.7 p90 -77.43 -138.29 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.601 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 263' ' ' ALA . . . . . 0.66 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -52.31 77.55 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 121.044 0.449 . . . . 0.0 111.034 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . 0.627 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.08 104.33 0.18 Allowed Glycine 0 CA--C 1.527 0.786 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 265' ' ' ASP . . . . . 0.603 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.9 m-20 -80.35 -177.68 6.27 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 120.724 0.297 . . . . 0.0 110.912 -179.488 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -40.44 -17.61 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.536 179.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 267' ' ' LYS . . . . . 0.603 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.48 -51.73 40.16 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.019 0.438 . . . . 0.0 110.693 179.457 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -63.58 -46.63 84.97 Favored 'General case' 0 CA--C 1.527 0.09 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.323 179.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . 0.524 ' O ' ' CD2' ' A' ' 273' ' ' TYR . . . -61.59 -35.18 77.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.865 179.531 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -62.97 -34.4 77.43 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.163 179.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.49 -43.37 13.63 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.225 -179.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 272' ' ' ILE . . . . . 0.618 ' C ' ' H ' ' A' ' 274' ' ' ALA . 4.9 tt -51.33 -33.63 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.876 -178.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 273' ' ' TYR . . . . . 0.524 ' CD2' ' O ' ' A' ' 269' ' ' ALA . 17.3 m-85 -54.45 -1.8 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.649 -179.603 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 274' ' ' ALA . . . . . 0.618 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.65 -39.51 70.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.881 179.577 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . 0.583 ' O ' ' N ' ' A' ' 279' ' ' ALA . 2.8 p30 -39.61 98.35 0.17 Allowed Pre-proline 0 C--N 1.333 -0.122 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.514 -179.66 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -54.24 -43.02 62.38 Favored 'Trans proline' 0 C--N 1.303 -1.856 0 C-N-CA 122.391 2.061 . . . . 0.0 112.574 -178.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 89.5 mt -64.46 -42.82 95.7 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.201 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 91.1 mt -95.67 -1.63 49.72 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.812 -179.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 279' ' ' ALA . . . . . 0.583 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.33 -34.91 77.55 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.672 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.26 20.1 0.12 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.994 -179.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . 0.513 ' H ' ' C ' ' A' ' 279' ' ' ALA . 13.8 mt -75.21 120.01 79.66 Favored Pre-proline 0 N--CA 1.451 -0.375 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.484 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -50.83 -39.44 58.16 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.599 2.199 . . . . 0.0 111.946 179.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.8 -50.51 63.49 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.154 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 79.4 t -61.42 -43.96 97.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 179.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -57.7 -41.22 81.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.248 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -90.98 0.15 57.6 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.167 179.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt 59.53 43.41 16.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.035 0.445 . . . . 0.0 110.873 179.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -94.78 41.3 1.09 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.411 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 53.7 t -118.93 135.92 57.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.012 0.434 . . . . 0.0 110.257 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -133.08 162.85 30.64 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.053 0.454 . . . . 0.0 110.701 -179.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.96 155.22 33.22 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.012 0.434 . . . . 0.0 110.731 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 81.4 mt -93.9 -1.38 54.82 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.227 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.43 165.72 12.7 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 110.598 -1.001 . . . . 0.0 110.598 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 7.0 m -87.47 -62.3 1.53 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.899 0.381 . . . . 0.0 111.034 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 295' ' ' GLU . . . . . 0.469 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.5 mm-40 -69.68 -3.85 17.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.61 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 27.0 p -76.91 33.22 0.14 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.66 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 297' ' ' PHE . . . . . 0.469 ' H ' ' C ' ' A' ' 295' ' ' GLU . 84.9 t80 -60.16 -45.86 91.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.58 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . 0.603 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.2 mtt85 -81.87 134.22 35.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.531 -179.684 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 16.2 tp -114.46 119.52 37.15 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-O 120.996 0.427 . . . . 0.0 110.178 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . 0.63 ' H ' ' HG ' ' A' ' 303' ' ' SER . 50.3 p-10 -167.26 -174.44 2.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.553 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 301' ' ' TYR . . . . . 0.458 ' OH ' ' CD1' ' A' ' 173' ' ' PHE . 84.5 t80 -47.92 -45.68 31.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.254 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -64.93 -41.42 95.55 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.022 0.439 . . . . 0.0 110.717 179.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 303' ' ' SER . . . . . 0.63 ' HG ' ' H ' ' A' ' 300' ' ' ASP . 52.8 p -55.52 -36.24 66.51 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.086 -179.251 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -56.79 -51.85 67.32 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 90.9 mtp -56.14 -43.71 78.5 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -66.32 -42.64 87.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.978 0.418 . . . . 0.0 110.278 178.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 55.7 t -64.08 -42.84 96.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.207 179.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 42.3 tp -59.55 -42.27 92.01 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.863 -179.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -62.63 -38.8 91.67 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.163 179.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 310' ' ' ARG . . . . . 0.443 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.6 ttt85 -63.58 -44.07 95.13 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.251 179.549 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 88.4 mt -63.26 -42.01 99.11 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.228 179.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -62.84 -33.03 74.4 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.097 179.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -90.33 -23.31 21.17 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.417 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . 0.443 ' N ' ' O ' ' A' ' 310' ' ' ARG . 6.8 tt -62.3 -43.22 99.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.098 0.475 . . . . 0.0 110.594 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 . . . . . 0 C--O 1.219 -0.511 0 CA-C-O 118.079 -0.962 . . . . 0.0 110.414 -179.988 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -99.64 135.69 40.68 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.064 0.459 . . . . 0.0 110.456 -179.993 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.497 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -92.09 178.61 1.64 Allowed Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.61 -179.813 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.497 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 27.0 Cg_exo -61.63 147.17 96.01 Favored 'Trans proline' 0 C--N 1.3 -1.995 0 C-N-CA 122.749 2.299 . . . . 0.0 112.112 179.694 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 35.1 ptt180 -136.12 142.29 44.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.673 179.701 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -79.79 116.83 20.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.489 179.865 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.404 ' O ' ' CG2' ' A' ' 30' ' ' ILE . 9.5 tp -111.48 129.98 65.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.444 -179.988 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.2 t -70.9 142.11 51.16 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.58 179.881 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.522 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.5 t0 -138.93 179.98 6.18 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.575 -179.985 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.522 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 77.7 p -74.31 -37.23 63.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.616 179.952 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -46.69 -94.58 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.35 -179.515 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.503 ' C ' ' HG1' ' A' ' 36' ' ' THR . . . -165.8 -27.13 0.02 OUTLIER Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 179.953 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.503 ' HG1' ' C ' ' A' ' 35' ' ' GLY . 63.2 m -168.79 106.09 0.44 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.924 0.392 . . . . 0.0 110.696 -179.929 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 67.4 t60 -128.92 146.72 50.87 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.044 0.449 . . . . 0.0 110.232 -179.949 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.488 ' CG2' ' N ' ' A' ' 39' ' ' LEU . 96.5 m -130.08 165.59 21.92 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.57 -179.848 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.488 ' N ' ' CG2' ' A' ' 38' ' ' THR . 80.5 mt -120.29 127.16 52.11 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.461 179.752 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -65.46 -44.61 86.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.588 -179.996 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.413 ' O ' ' HD3' ' A' ' 43' ' ' PRO . 38.6 p -165.59 154.58 11.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.388 179.735 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.461 ' N ' ' CD ' ' A' ' 42' ' ' GLN . 14.7 mp0 -44.98 101.32 0.25 Allowed Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.631 179.436 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.413 ' HD3' ' O ' ' A' ' 41' ' ' SER . 31.5 Cg_exo -57.53 129.54 34.33 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 C-N-CA 122.367 2.045 . . . . 0.0 112.247 -179.731 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -82.42 -25.13 33.95 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.491 179.631 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.537 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.7 mtm-85 -120.96 134.56 55.3 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-O 121.191 0.519 . . . . 0.0 110.28 -179.953 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.0 mt -130.28 133.59 63.79 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.923 -179.771 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 46.5 t -124.61 131.34 72.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.808 0.337 . . . . 0.0 110.126 179.373 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.504 ' O ' ' O ' ' A' ' 66' ' ' ALA . 4.7 m -154.2 165.94 34.69 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.563 179.782 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 71.5 p -124.76 8.29 8.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.463 179.942 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.66 125.8 33.44 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.672 -179.459 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 89.9 t -65.47 -44.61 94.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.44 -179.943 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.6 m -62.52 -44.31 96.67 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.627 -179.917 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 53.1 tp -62.15 -41.58 98.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.512 -179.519 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 72.8 m -57.74 -44.49 86.08 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.292 -179.253 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.39 -62.0 5.5 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 110.906 -0.878 . . . . 0.0 110.906 179.632 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.7 t -48.35 -35.76 13.11 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 -179.904 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 20.2 mt -61.66 -44.61 96.63 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.648 -0.421 . . . . 0.0 111.186 179.424 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.3 mp -64.89 -41.89 95.25 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.342 177.901 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.53 -41.19 98.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.02 -179.279 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.0 tp -88.04 16.62 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.763 -179.711 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 56.45 84.11 0.09 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.736 -179.874 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.9 58.24 0.09 OUTLIER Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.019 -179.745 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -50.77 152.45 9.6 Favored 'Trans proline' 0 C--N 1.296 -2.229 0 C-N-CA 122.751 2.301 . . . . 0.0 112.473 -178.405 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.431 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -109.15 146.25 14.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.372 -179.658 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 97.0 mt -63.86 -44.91 98.24 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.357 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.459 -179.914 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.504 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -129.81 134.22 47.42 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 120.84 0.352 . . . . 0.0 110.632 -179.896 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.509 ' O ' ' N ' ' A' ' 98' ' ' LEU . 58.8 m -134.32 158.39 43.92 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.875 -179.62 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -85.46 138.16 16.11 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.749 -0.941 . . . . 0.0 110.749 179.811 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.449 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.25 -163.81 0.11 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.958 0.408 . . . . 0.0 110.515 -179.906 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.486 ' O ' ' C ' ' A' ' 71' ' ' THR . 6.2 t -134.22 140.61 46.6 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.216 179.936 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.486 ' C ' ' O ' ' A' ' 70' ' ' THR . 0.7 OUTLIER 29.67 70.73 0.56 Allowed Pre-proline 0 N--CA 1.466 0.329 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.657 -179.935 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_exo -60.45 144.44 99.52 Favored 'Trans proline' 0 C--N 1.299 -2.036 0 C-N-CA 122.587 2.191 . . . . 0.0 112.079 -178.323 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.54 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 44.5 p-10 -164.87 -35.56 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.662 179.895 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.54 ' N ' ' OD1' ' A' ' 73' ' ' ASN . 99.0 m-20 -63.88 -39.36 94.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.433 -179.98 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 73.4 ttt180 -60.88 -47.76 84.93 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.67 -179.389 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.433 ' O ' ' O ' ' A' ' 77' ' ' ALA . 95.6 t -60.24 -23.9 29.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.113 179.716 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.433 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -45.14 172.36 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.633 179.853 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.572 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.9 p30 -62.33 178.05 0.44 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.617 -179.7 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.599 ' C ' ' H ' ' A' ' 81' ' ' GLY . 36.6 p30 -46.04 85.64 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.05 179.912 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.572 ' N ' ' O ' ' A' ' 78' ' ' ASP . 42.6 tp60 -67.4 14.04 0.06 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.121 0.486 . . . . 0.0 110.094 -179.718 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.599 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 117.48 -21.62 10.58 Favored Glycine 0 CA--C 1.519 0.339 0 N-CA-C 110.909 -0.876 . . . . 0.0 110.909 179.922 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -107.85 116.71 32.45 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.968 0.413 . . . . 0.0 110.434 179.917 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 74.2 mt -98.62 0.69 45.3 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.551 -179.764 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -92.64 6.38 47.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.99 0.424 . . . . 0.0 110.459 -179.786 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.447 ' O ' ' CG2' ' A' ' 89' ' ' VAL . 88.2 mt-30 -99.83 -27.46 13.61 Favored 'General case' 0 C--O 1.224 -0.289 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.861 179.953 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.4 t-105 -63.84 -40.84 97.54 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.145 -179.795 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.552 ' O ' ' N ' ' A' ' 91' ' ' LYS . 67.3 m -77.76 -53.76 7.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.304 -179.548 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -48.19 -50.81 27.83 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.003 -179.273 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.447 ' CG2' ' O ' ' A' ' 85' ' ' GLN . 14.7 m -68.89 -40.7 81.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 120.919 0.39 . . . . 0.0 111.059 179.757 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.41 ' H ' HG23 ' A' ' 89' ' ' VAL . . . -72.14 -22.81 61.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.721 -179.885 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.552 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.0 tttm -61.6 -46.03 91.55 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.489 -179.539 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.442 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.3 mm-40 -90.11 -94.86 0.11 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.096 -179.964 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.627 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.7 mtt180 -143.19 59.58 1.41 Allowed 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 179.812 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.46 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.6 pttp 33.6 26.45 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.221 -179.214 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.627 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.4 tt -48.12 123.14 5.9 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.904 -178.152 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -83.24 -169.54 2.59 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.057 -179.835 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.612 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 81.2 mtp180 -73.9 138.26 44.19 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.174 -179.677 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.509 ' N ' ' O ' ' A' ' 67' ' ' SER . 87.9 mt -86.61 -166.58 1.6 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.707 -179.524 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.528 ' CD2' ' O ' ' A' ' 99' ' ' TYR . 46.7 p90 -167.32 119.69 0.92 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.324 179.946 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.507 ' C ' ' O ' ' A' ' 99' ' ' TYR . 44.4 mm -29.56 121.08 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.995 -179.744 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 113.2 28.78 3.21 Favored Glycine 0 CA--C 1.52 0.359 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 -179.477 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.587 ' N ' ' CD ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -143.86 45.68 0.59 Allowed Pre-proline 0 C--N 1.323 -0.555 0 CA-C-O 120.948 0.404 . . . . 0.0 110.448 179.839 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.587 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 29.9 Cg_endo -61.97 143.68 95.56 Favored 'Trans proline' 0 C--N 1.297 -2.148 0 C-N-CA 122.683 2.255 . . . . 0.0 111.989 -179.925 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.688 ' HG ' ' H ' ' A' ' 107' ' ' ALA . 21.1 t -173.27 120.77 0.35 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.491 179.717 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.58 -41.09 63.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.067 0.461 . . . . 0.0 111.121 179.725 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -65.85 -40.4 91.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.904 -179.372 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.688 ' H ' ' HG ' ' A' ' 104' ' ' SER . . . -64.07 -39.95 95.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.762 -179.909 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 69.6 t -67.54 -43.77 86.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.795 179.652 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.43 -39.18 92.48 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.589 -179.284 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.442 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.39 -23.59 62.72 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.455 179.858 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.551 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.3 mm-40 -90.79 4.81 50.66 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.717 -179.509 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.551 ' C ' ' O ' ' A' ' 111' ' ' GLN . 10.5 tpt 23.67 63.86 0.39 Allowed Pre-proline 0 N--CA 1.465 0.297 0 CA-C-O 120.898 0.38 . . . . 0.0 111.059 -179.993 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -78.7 168.55 20.93 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 C-N-CA 122.938 2.425 . . . . 0.0 112.213 -178.463 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.498 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 99.0 m-20 -113.04 -44.42 3.28 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.978 179.517 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.2 tp -120.23 119.62 33.74 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.577 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 95.4 mt -116.78 131.04 70.59 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.351 0 CA-C-O 120.953 0.406 . . . . 0.0 110.918 -179.856 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 30.9 mt -105.69 132.75 51.45 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.115 0.483 . . . . 0.0 110.279 -179.466 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 98.2 mt -118.33 136.24 56.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.724 -179.729 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 85.7 p -72.18 153.08 41.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.672 179.975 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -59.96 -50.0 75.49 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.612 -179.817 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -149.45 153.91 38.02 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.571 179.799 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 170.05 -170.56 42.96 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 179.919 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -63.04 -34.77 90.88 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 179.98 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.447 ' O ' ' OD1' ' A' ' 124' ' ' ASP . 43.9 p-10 -88.04 120.4 29.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.764 0.316 . . . . 0.0 110.683 179.934 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 40.8 t -63.45 144.12 57.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.466 -179.928 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.521 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.37 -42.82 9.08 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.031 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.6 tp -62.82 -42.36 99.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.669 -179.832 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.05 -10.93 57.64 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.543 -179.461 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 85.2 mt -115.54 -24.14 8.46 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.695 -179.918 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . 0.521 ' N ' ' O ' ' A' ' 126' ' ' ALA . 78.7 t80 -51.84 -49.88 61.97 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.554 -178.902 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.502 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.1 p-10 -65.91 -42.11 90.57 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.909 0.385 . . . . 0.0 111.232 179.569 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.502 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 88.0 mt-30 -67.32 -36.74 82.07 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.78 179.929 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 93.7 mt -80.38 -41.74 24.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.975 -179.541 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.2 t -57.44 -44.71 84.95 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.223 -179.109 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 18.9 m -62.23 -45.59 92.66 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.799 0.333 . . . . 0.0 110.66 179.264 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 92.1 mt -62.36 -43.85 98.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.325 -179.792 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -170.37 163.79 5.94 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.541 179.832 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -43.36 111.24 0.22 Allowed 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.501 2.134 . . . . 0.0 112.115 179.553 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 17.4 m -85.44 127.55 34.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.594 179.933 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 34.3 tp -119.11 136.93 53.92 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.957 -179.718 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.432 ' O ' ' OD1' ' A' ' 32' ' ' ASP . 79.8 mt -103.9 119.83 53.17 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.41 0 CA-C-O 121.183 0.516 . . . . 0.0 111.308 -179.382 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 98.1 mt -135.42 132.52 52.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.651 179.657 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.513 HD22 ' CG ' ' A' ' 241' ' ' ASP . 53.7 t30 -65.56 149.41 50.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.899 0.38 . . . . 0.0 110.388 179.258 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.524 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 88.1 t80 -83.07 122.5 28.42 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.002 -179.496 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.524 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 98.9 m-20 55.09 69.58 0.72 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.871 179.608 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 49.2 p-10 -123.69 -0.01 8.65 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 120.974 0.416 . . . . 0.0 110.696 179.8 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -151.59 117.25 5.41 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.767 -179.512 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 148' ' ' SER . . . . . 0.52 ' HG ' ' H ' ' A' ' 150' ' ' GLN . 84.7 p -63.07 167.53 4.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.5 -179.811 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.419 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.6 p-90 -50.74 -15.47 0.29 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.518 -179.823 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . 0.52 ' H ' ' HG ' ' A' ' 148' ' ' SER . 68.1 tp60 -71.72 -74.45 0.16 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.458 -179.843 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.451 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.2 t -62.61 -39.22 93.08 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.008 0.432 . . . . 0.0 110.274 179.408 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 53.3 tp -60.23 -45.43 93.25 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.364 -178.516 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.419 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 45.7 tp -62.74 -41.73 99.32 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.398 179.025 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.451 ' OG1' ' O ' ' A' ' 151' ' ' SER . 51.8 p -64.05 -34.64 78.47 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.284 -179.469 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . 0.456 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 88.2 mm-40 -63.98 -42.44 97.21 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.157 179.223 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 92.9 mt -65.35 -38.95 91.63 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.068 0.461 . . . . 0.0 110.223 179.137 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.582 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.15 -32.16 79.48 Favored Glycine 0 CA--C 1.52 0.362 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 -179.367 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.456 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.2 mt-10 -36.22 -25.68 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.814 0.34 . . . . 0.0 110.741 179.95 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.582 ' N ' ' O ' ' A' ' 157' ' ' GLY . 94.9 mt -58.95 149.68 5.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.276 179.303 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 75.2 p -69.3 137.08 52.7 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.076 -179.541 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 70.98 21.67 78.31 Favored Glycine 0 C--N 1.329 0.156 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 179.518 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 59.5 m80 -123.3 -14.95 7.34 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.732 0.301 . . . . 0.0 110.573 179.912 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -66.51 -59.63 3.46 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.779 -179.744 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -51.9 -48.9 63.93 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.173 -179.645 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -60.76 -41.03 94.64 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.981 -0.288 . . . . 0.0 110.316 179.534 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.58 -47.29 86.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.575 179.81 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.8 -40.25 75.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.178 -179.828 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -61.67 -50.24 73.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.627 179.56 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -65.43 -43.76 89.45 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.506 179.532 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 95.4 mt -64.6 -43.44 96.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.51 179.694 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.33 -51.03 71.02 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.542 -179.12 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.91 -43.62 95.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.44 179.685 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . 0.496 ' CD1' ' OH ' ' A' ' 301' ' ' TYR . 56.3 t80 -62.63 -44.63 95.8 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.058 0.456 . . . . 0.0 110.404 179.41 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -63.21 -39.88 95.87 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.59 -179.363 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -62.92 -42.86 99.93 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.637 179.218 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -60.61 -44.83 95.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.073 179.987 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 85.6 mt -64.37 -41.21 96.83 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.044 0.449 . . . . 0.0 110.672 178.901 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.06 -62.16 1.81 Allowed 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.527 -179.342 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.79 -46.54 87.32 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.571 179.803 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.36 -41.58 65.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.179 -179.994 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -63.76 -33.78 76.42 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.932 0.396 . . . . 0.0 110.336 179.305 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . 0.407 ' HG2' ' O ' ' A' ' 182' ' ' GLU . 69.8 tt0 -90.5 8.81 31.99 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.312 0.577 . . . . 0.0 110.509 -179.031 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -104.82 -32.26 8.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.887 0.375 . . . . 0.0 111.274 179.56 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.3 pt -128.01 147.41 32.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.836 -179.861 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -139.88 131.14 26.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.336 179.346 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . 0.556 ' CD2' ' N ' ' A' ' 186' ' ' LEU . 3.5 mm? -85.61 133.7 41.4 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.879 179.938 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -43.95 157.96 0.13 Allowed 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.669 2.246 . . . . 0.0 112.171 179.401 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . 0.523 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.6 Cg_endo -62.95 114.78 2.58 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 C-N-CA 122.82 2.347 . . . . 0.0 111.7 179.773 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . 0.523 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.8 mt-30 155.56 147.89 0.0 OUTLIER Pre-proline 0 N--CA 1.455 -0.195 0 O-C-N 123.555 0.535 . . . . 0.0 110.721 -179.858 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -73.72 144.09 34.73 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.644 2.229 . . . . 0.0 111.911 178.043 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.496 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.1 p -124.93 158.91 32.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.336 0.589 . . . . 0.0 110.086 179.983 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 192' ' ' THR . . . . . 0.496 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 37.1 p -143.47 165.35 27.78 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.135 -179.653 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -135.26 128.49 31.97 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.144 0.497 . . . . 0.0 110.181 179.618 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 47.3 pt -146.48 148.92 16.49 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.056 179.814 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 70.4 t -117.74 123.22 71.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.278 0.561 . . . . 0.0 109.681 179.183 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -134.26 107.35 7.61 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.251 179.66 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 95.8 m -130.93 130.53 43.59 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.85 179.707 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -82.92 -36.92 24.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.245 179.691 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.5 -67.07 0.26 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.343 -179.939 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.52 -10.1 59.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.249 179.606 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 60.0 t-80 61.03 58.42 2.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.816 -179.959 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 37.3 p -166.88 153.33 8.46 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.5 179.573 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.08 143.77 24.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.985 0.421 . . . . 0.0 110.431 179.455 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -135.21 138.06 43.25 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.667 179.993 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 20.0 mt -106.13 125.37 50.91 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.059 0.457 . . . . 0.0 109.848 -179.633 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 206' ' ' TRP . . . . . 0.558 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 74.9 m95 -82.01 167.04 19.27 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.603 -179.787 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -156.75 171.67 7.11 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.598 -179.214 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -54.09 -36.87 86.35 Favored 'Trans proline' 0 C--N 1.303 -1.865 0 C-N-CA 122.663 2.242 . . . . 0.0 111.952 179.379 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -70.61 -34.96 72.68 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.795 -179.811 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 21.2 m -61.28 150.57 34.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.635 -179.321 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.5 -37.07 82.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.52 -179.821 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 212' ' ' GLN . . . . . 0.558 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 54.9 tt0 -64.53 -40.36 95.47 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.497 179.957 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.74 -43.39 91.91 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 179.791 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -63.4 -43.53 97.27 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.715 0.293 . . . . 0.0 110.23 179.842 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 65.1 ttp -59.51 -48.07 83.06 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.227 -179.853 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 87.5 mt -60.64 -40.8 93.3 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.636 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 217' ' ' GLU . . . . . 0.453 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.1 tp10 -58.02 -37.87 75.15 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.852 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -65.29 -38.12 89.26 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.803 0.335 . . . . 0.0 110.686 179.663 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 94.0 mt -64.41 -42.6 95.98 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.587 -179.595 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.62 45.0 0.08 OUTLIER Glycine 0 C--N 1.334 0.429 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 -179.962 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 221' ' ' PHE . . . . . 0.453 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 26.5 m-85 -128.23 155.91 43.8 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.038 0.447 . . . . 0.0 110.492 -179.792 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 222' ' ' THR . . . . . 0.457 ' O ' ' O ' ' A' ' 191' ' ' VAL . 8.2 p -107.62 122.44 46.71 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.191 0.519 . . . . 0.0 110.182 -179.934 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . 0.446 ' CD2' ' N ' ' A' ' 223' ' ' LEU . 4.3 mm? -101.12 133.29 45.86 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.053 -179.995 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -97.0 159.05 15.13 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.494 179.906 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.0 115.16 29.8 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.335 179.899 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.45 ' CD1' ' N ' ' A' ' 226' ' ' LEU . 9.0 mp -53.33 156.66 3.89 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.698 179.921 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -60.27 145.31 98.83 Favored 'Trans proline' 0 C--N 1.301 -1.93 0 C-N-CA 122.598 2.199 . . . . 0.0 112.12 179.296 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.21 -3.05 59.03 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.493 -179.884 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.28 -40.83 5.67 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 -179.828 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . 0.532 ' O ' ' N ' ' A' ' 233' ' ' SER . 85.6 mt -79.44 -16.96 55.26 Favored 'General case' 0 C--O 1.222 -0.344 0 CA-C-O 121.002 0.429 . . . . 0.0 110.295 -179.694 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . 0.401 ' C ' ' O ' ' A' ' 230' ' ' LEU . 55.0 t-20 -40.3 -49.08 2.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.783 -179.541 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -88.08 15.44 7.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.818 0.342 . . . . 0.0 111.325 179.802 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 233' ' ' SER . . . . . 0.532 ' N ' ' O ' ' A' ' 230' ' ' LEU . 78.1 p -60.5 -35.56 76.24 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.594 -179.799 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . 0.525 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.7 tt0 -118.4 -69.36 0.85 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.942 179.575 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.4 m -70.0 103.05 2.15 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.65 -179.776 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -94.13 57.64 2.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.456 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -145.04 -122.1 1.51 Allowed Glycine 0 CA--C 1.521 0.433 0 N-CA-C 110.966 -0.854 . . . . 0.0 110.966 -179.993 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -135.32 112.19 10.18 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 121.172 0.51 . . . . 0.0 110.383 179.939 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . 0.518 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.4 mtt180 -148.28 57.81 1.07 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.709 -179.941 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -69.57 -32.09 70.65 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.482 179.617 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 241' ' ' ASP . . . . . 0.513 ' CG ' HD22 ' A' ' 143' ' ' ASN . 64.8 t0 -56.7 -47.12 80.62 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.436 -179.113 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 242' ' ' ILE . . . . . 0.432 ' O ' ' O ' ' A' ' 239' ' ' ARG . 17.8 tt -140.2 156.92 24.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.925 0.393 . . . . 0.0 110.52 179.758 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 96.2 mt -106.14 106.29 20.3 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.227 0 CA-C-O 121.204 0.526 . . . . 0.0 110.507 179.759 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . 0.518 ' OE1' ' NH1' ' A' ' 239' ' ' ARG . 88.3 mt-30 -110.29 110.04 20.71 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.336 179.702 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 9.4 mp -121.78 -168.18 1.66 Allowed 'General case' 0 C--O 1.225 -0.199 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.711 179.78 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . 0.525 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.32 -16.53 0.05 OUTLIER Glycine 0 CA--C 1.523 0.546 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 179.833 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . 0.695 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -60.62 157.01 30.48 Favored Glycine 0 CA--C 1.521 0.443 0 N-CA-C 110.904 -0.878 . . . . 0.0 110.904 -179.892 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -63.81 21.67 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.947 0.404 . . . . 0.0 110.559 179.899 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . 0.695 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.8 m-20 -97.38 -5.85 35.41 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.572 179.965 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 92.8 mt -80.13 -21.71 42.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.617 179.51 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.55 -51.28 70.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.801 -179.529 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.58 -5.29 58.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.419 179.686 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.15 -74.26 1.15 Allowed Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 -179.897 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 80.9 mt -70.14 126.05 28.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.069 0.462 . . . . 0.0 110.269 -179.87 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -59.59 -39.17 83.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.337 -179.659 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 83.0 51.87 4.04 Favored Glycine 0 CA--C 1.521 0.421 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 179.827 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -95.82 -15.13 22.71 Favored 'General case' 0 C--N 1.332 -0.17 0 O-C-N 122.632 -0.334 . . . . 0.0 110.594 -179.861 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 258' ' ' SER . . . . . 0.423 ' O ' ' O ' ' A' ' 192' ' ' THR . 3.5 t 174.63 88.8 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.063 0.459 . . . . 0.0 110.157 179.989 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . 0.596 ' N ' ' CD1' ' A' ' 259' ' ' LEU . 0.9 OUTLIER -94.26 123.96 37.98 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.309 0.576 . . . . 0.0 111.183 -179.141 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 15.9 m-30 -92.93 146.4 23.65 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.34 179.283 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 86.0 mt -122.37 149.69 43.45 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.491 -179.822 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.659 ' CG ' ' N ' ' A' ' 263' ' ' ALA . 2.6 p90 -77.56 -138.39 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.563 -179.841 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 263' ' ' ALA . . . . . 0.659 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -51.99 77.48 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.006 179.986 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . 0.632 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.1 104.48 0.19 Allowed Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 -179.929 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 265' ' ' ASP . . . . . 0.601 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.8 m-20 -80.47 -177.69 6.33 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 120.741 0.305 . . . . 0.0 110.858 -179.562 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -40.51 -17.64 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.57 179.846 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 267' ' ' LYS . . . . . 0.601 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.54 -51.55 41.67 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.715 179.448 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -63.73 -46.75 83.95 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.15 179.483 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . 0.526 ' O ' ' CD2' ' A' ' 273' ' ' TYR . . . -61.56 -35.17 77.02 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.774 179.545 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -62.87 -34.45 77.4 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.166 179.649 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.46 -43.23 13.77 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.3 -179.569 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 272' ' ' ILE . . . . . 0.615 ' C ' ' H ' ' A' ' 274' ' ' ALA . 5.0 tt -51.41 -33.55 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.904 -178.884 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 273' ' ' TYR . . . . . 0.526 ' CD2' ' O ' ' A' ' 269' ' ' ALA . 17.1 m-85 -54.59 -1.75 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.69 -179.653 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 274' ' ' ALA . . . . . 0.615 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.64 -39.56 70.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.857 179.581 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . 0.583 ' O ' ' N ' ' A' ' 279' ' ' ALA . 3.0 p30 -39.51 98.23 0.16 Allowed Pre-proline 0 N--CA 1.463 0.175 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.538 -179.634 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -54.08 -43.04 61.95 Favored 'Trans proline' 0 C--N 1.303 -1.824 0 C-N-CA 122.388 2.058 . . . . 0.0 112.691 -178.821 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 89.5 mt -64.48 -42.76 95.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.14 0.495 . . . . 0.0 111.181 -179.691 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 91.4 mt -95.82 -1.52 49.43 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.884 -179.456 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 279' ' ' ALA . . . . . 0.583 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.38 -34.93 77.68 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.644 -179.812 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -74.09 20.05 0.11 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.048 -179.354 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . 0.513 ' H ' ' C ' ' A' ' 279' ' ' ALA . 13.7 mt -75.06 120.23 80.68 Favored Pre-proline 0 N--CA 1.452 -0.349 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.424 179.981 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -51.12 -39.5 60.85 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.624 2.216 . . . . 0.0 111.8 179.099 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.82 -50.26 64.02 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.096 179.879 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 74.0 t -61.51 -43.93 97.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.562 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -57.86 -41.19 81.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.305 -179.942 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -90.87 -0.0 57.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.061 179.695 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt 59.47 43.1 16.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.967 0.413 . . . . 0.0 110.829 179.714 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -94.59 41.42 1.09 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.383 179.797 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 54.5 t -118.92 135.84 58.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.074 0.464 . . . . 0.0 110.179 -179.677 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -133.0 162.6 31.25 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.726 -179.663 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.58 155.4 32.3 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-O 120.956 0.408 . . . . 0.0 110.776 -179.87 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 81.5 mt -94.22 -1.47 54.02 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.281 -179.723 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.24 165.93 12.8 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.611 -0.996 . . . . 0.0 110.611 -179.838 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 7.2 m -87.64 -62.46 1.49 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.934 0.397 . . . . 0.0 111.08 -179.901 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 295' ' ' GLU . . . . . 0.474 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.6 mm-40 -69.46 -3.82 16.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.674 -179.845 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 22.7 p -76.91 32.47 0.14 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.601 -179.892 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 297' ' ' PHE . . . . . 0.474 ' H ' ' C ' ' A' ' 295' ' ' GLU . 77.1 t80 -60.24 -46.08 91.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.592 -179.962 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . 0.612 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.1 mtt85 -80.92 134.85 35.8 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.016 0.436 . . . . 0.0 110.583 -179.742 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 17.0 tp -114.48 118.2 33.11 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.203 179.882 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . 0.604 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.0 p-10 -165.78 -176.08 3.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.585 179.94 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 301' ' ' TYR . . . . . 0.496 ' OH ' ' CD1' ' A' ' 173' ' ' PHE . 82.5 t80 -47.16 -43.77 21.38 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.286 -179.719 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -66.69 -40.51 88.55 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.03 0.443 . . . . 0.0 110.823 179.136 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 303' ' ' SER . . . . . 0.604 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 59.6 p -55.87 -36.18 67.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.087 -179.21 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -57.37 -51.48 69.23 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.52 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 91.0 mtp -56.23 -43.63 78.8 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.953 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -66.34 -42.68 87.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.986 0.422 . . . . 0.0 110.226 178.79 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 55.8 t -64.03 -42.95 97.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.154 179.373 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 42.7 tp -59.63 -42.28 92.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.87 -179.513 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -62.71 -38.86 92.11 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 179.465 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 310' ' ' ARG . . . . . 0.444 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.6 ttt85 -63.5 -44.12 95.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.229 179.525 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 88.7 mt -63.19 -41.97 99.26 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.23 179.655 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt -62.84 -33.34 75.05 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.99 179.461 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.86 -23.59 21.62 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.461 -179.775 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . 0.444 ' N ' ' O ' ' A' ' 310' ' ' ARG . 6.7 tt -62.26 -43.14 99.51 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.607 -179.925 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 . . . . . 0 C--O 1.221 -0.431 0 CA-C-O 117.979 -1.01 . . . . 0.0 110.503 179.947 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -100.11 136.85 39.38 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.008 0.432 . . . . 0.0 110.5 -179.929 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.498 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -91.78 178.46 1.73 Allowed Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.54 -179.911 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.498 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.7 Cg_exo -61.61 147.48 95.28 Favored 'Trans proline' 0 C--N 1.3 -2.023 0 C-N-CA 122.772 2.315 . . . . 0.0 112.179 179.627 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 35.6 ptt180 -136.05 142.61 44.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.699 179.766 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -78.96 117.13 19.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.574 179.918 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.6 tp -110.51 130.94 62.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.395 -179.956 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.5 t -70.43 142.07 52.03 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.62 179.812 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.433 ' CG ' ' H ' ' A' ' 33' ' ' SER . 25.8 t70 -139.9 177.42 7.98 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.452 -179.902 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.452 ' OG ' ' O ' ' A' ' 141' ' ' ILE . 78.0 p -73.79 -36.26 65.01 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.693 179.925 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -47.71 -94.86 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.317 -179.525 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.429 ' O ' ' OG1' ' A' ' 36' ' ' THR . . . -165.59 -25.96 0.02 OUTLIER Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.889 -0.885 . . . . 0.0 110.889 179.913 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.429 ' OG1' ' O ' ' A' ' 35' ' ' GLY . 53.2 m -169.25 106.72 0.41 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.864 0.364 . . . . 0.0 110.665 -179.899 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 49.3 t60 -129.48 146.65 51.29 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.095 0.474 . . . . 0.0 110.1 179.997 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.481 ' CG2' ' N ' ' A' ' 39' ' ' LEU . 96.8 m -129.89 166.07 20.74 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.653 -179.814 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.481 ' N ' ' CG2' ' A' ' 38' ' ' THR . 82.5 mt -121.01 127.84 52.14 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.432 179.76 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -64.12 -44.58 91.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.639 -179.905 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 42.9 p -165.96 155.25 11.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.365 179.688 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.443 ' N ' ' CD ' ' A' ' 42' ' ' GLN . 14.1 mp0 -43.34 100.7 0.23 Allowed Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.605 179.415 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -56.8 129.29 33.78 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 122.318 2.012 . . . . 0.0 112.282 -179.612 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -83.72 -24.59 31.14 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.46 179.575 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.538 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.3 mtm-85 -122.31 134.94 54.65 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.169 0.509 . . . . 0.0 110.293 -179.974 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.1 mt -130.24 133.47 64.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.92 -179.681 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 45.4 t -124.34 130.83 73.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-O 120.848 0.356 . . . . 0.0 110.062 179.384 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.5 ' O ' ' O ' ' A' ' 66' ' ' ALA . 2.2 m -154.44 166.55 32.9 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.532 179.795 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 72.5 p -124.13 8.42 8.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.521 179.917 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.3 t -86.13 125.75 33.72 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.677 -179.551 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 87.2 t -65.64 -44.48 93.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.453 -179.984 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.4 m -62.29 -44.31 96.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.667 -179.917 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 46.1 tp -62.39 -41.3 98.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.537 -179.431 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 71.4 m -57.79 -44.64 86.4 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.353 -179.262 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.21 -62.21 5.36 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 179.535 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.7 t -48.39 -35.52 12.84 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 -179.917 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.9 mt -61.71 -44.42 96.96 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.698 -0.401 . . . . 0.0 111.207 179.407 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.2 mp -64.9 -41.8 95.3 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.352 177.956 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.62 -41.05 98.33 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.098 -179.251 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.0 tp -88.25 16.94 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.775 -179.644 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 56.36 84.2 0.09 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.676 -179.899 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.44 57.63 0.07 OUTLIER Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.277 -0.42 . . . . 0.0 109.994 -179.826 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -50.53 153.19 7.99 Favored 'Trans proline' 0 C--N 1.295 -2.237 0 C-N-CA 122.9 2.4 . . . . 0.0 112.426 -178.305 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.439 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -109.16 144.94 16.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.424 -179.709 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.8 mt -63.72 -45.36 97.53 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.35 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.444 -179.775 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.5 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -128.76 133.77 48.2 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.865 0.364 . . . . 0.0 110.518 -179.867 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.516 ' O ' ' N ' ' A' ' 98' ' ' LEU . 75.1 m -135.0 158.87 43.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.819 -179.648 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -87.23 139.45 16.12 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 179.828 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.452 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.88 -162.58 0.08 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.986 0.422 . . . . 0.0 110.429 -179.944 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.492 ' O ' ' C ' ' A' ' 71' ' ' THR . 14.0 t -133.48 133.99 42.95 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.318 179.966 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.492 ' C ' ' O ' ' A' ' 70' ' ' THR . 0.6 OUTLIER 29.69 68.81 0.65 Allowed Pre-proline 0 N--CA 1.464 0.229 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.768 -179.93 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -61.09 145.36 99.01 Favored 'Trans proline' 0 C--N 1.3 -1.992 0 C-N-CA 122.648 2.232 . . . . 0.0 112.101 -178.437 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.533 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 46.1 p-10 -158.74 -32.05 0.07 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.703 179.726 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.533 ' N ' ' OD1' ' A' ' 73' ' ' ASN . 99.1 m-20 -64.14 -39.92 95.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.579 179.825 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -60.49 -48.26 82.55 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.704 -179.207 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.415 ' O ' ' O ' ' A' ' 77' ' ' ALA . 90.4 t -60.23 -24.94 32.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.804 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.415 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -46.03 172.97 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.541 179.862 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.581 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.5 p30 -62.01 177.7 0.43 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.611 -179.691 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.596 ' C ' ' H ' ' A' ' 81' ' ' GLY . 35.6 p30 -44.76 85.72 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.0 179.924 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.581 ' N ' ' O ' ' A' ' 78' ' ' ASP . 42.7 tp60 -67.43 13.03 0.08 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.06 -179.758 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.596 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 118.62 -21.85 9.6 Favored Glycine 0 CA--C 1.519 0.328 0 N-CA-C 110.974 -0.85 . . . . 0.0 110.974 179.94 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -107.92 116.29 31.68 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.953 0.406 . . . . 0.0 110.494 179.856 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 73.2 mt -98.62 -0.01 43.91 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.436 -179.71 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -92.6 7.39 43.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.947 0.403 . . . . 0.0 110.387 -179.785 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.439 ' O ' ' CG2' ' A' ' 89' ' ' VAL . 87.8 mt-30 -100.07 -28.33 13.1 Favored 'General case' 0 C--O 1.224 -0.25 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.842 -179.996 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 68.9 t-105 -62.5 -40.89 98.16 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.867 -179.632 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.555 ' O ' ' N ' ' A' ' 91' ' ' LYS . 63.4 m -77.59 -53.55 7.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.195 -179.425 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -48.53 -50.73 30.76 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.013 -179.277 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.439 ' CG2' ' O ' ' A' ' 85' ' ' GLN . 15.4 m -68.91 -40.59 81.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 120.896 0.379 . . . . 0.0 111.048 179.723 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.415 ' H ' HG23 ' A' ' 89' ' ' VAL . . . -72.29 -22.84 61.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.8 -179.927 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.555 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.0 tttm -61.86 -45.53 93.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.429 -179.541 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.442 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.4 mm-40 -90.49 -94.92 0.12 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.13 -179.846 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.626 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.9 mtt180 -143.09 59.1 1.41 Allowed 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.828 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.462 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.7 pttp 33.37 26.77 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.242 -179.171 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.626 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.4 tt -48.71 123.58 7.08 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.951 -178.131 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -84.33 -169.1 2.44 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.08 -179.937 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.609 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 81.0 mtp180 -74.86 136.64 41.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.279 -179.798 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.516 ' N ' ' O ' ' A' ' 67' ' ' SER . 90.9 mt -85.39 -165.71 1.3 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.633 -179.642 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.54 ' CD2' ' O ' ' A' ' 99' ' ' TYR . 47.7 p90 -168.32 119.49 0.8 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.209 179.982 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.516 ' C ' ' O ' ' A' ' 99' ' ' TYR . 42.8 mm -28.77 120.8 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.0 -179.63 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 114.51 27.63 3.26 Favored Glycine 0 CA--C 1.519 0.315 0 N-CA-C 111.15 -0.78 . . . . 0.0 111.15 -179.494 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.574 ' N ' ' CD ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -144.84 46.51 0.61 Allowed Pre-proline 0 C--N 1.323 -0.546 0 CA-C-O 120.891 0.377 . . . . 0.0 110.488 179.909 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.574 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 29.4 Cg_endo -61.88 144.31 96.56 Favored 'Trans proline' 0 C--N 1.296 -2.197 0 C-N-CA 122.652 2.235 . . . . 0.0 111.968 -179.942 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.714 ' HG ' ' H ' ' A' ' 107' ' ' ALA . 27.0 t -173.24 119.97 0.33 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.446 179.728 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.4 -40.33 64.38 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.021 0.439 . . . . 0.0 111.088 179.647 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -66.32 -39.69 89.44 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.819 -179.403 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.714 ' H ' ' HG ' ' A' ' 104' ' ' SER . . . -63.95 -40.04 95.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.704 -179.816 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 71.7 t -67.38 -43.93 87.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.712 179.681 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.87 -38.91 92.75 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.524 -179.349 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.442 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.4 -23.68 62.82 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.465 179.89 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.561 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.5 mm-40 -91.24 5.17 50.2 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.723 -179.552 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.561 ' C ' ' O ' ' A' ' 111' ' ' GLN . 10.3 tpt 22.24 64.72 0.33 Allowed Pre-proline 0 N--CA 1.465 0.277 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.043 179.985 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -78.57 169.05 20.41 Favored 'Trans proline' 0 C--N 1.304 -1.811 0 C-N-CA 122.99 2.46 . . . . 0.0 112.082 -178.461 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.423 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 98.8 m-20 -110.73 -42.76 3.96 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 121.013 0.435 . . . . 0.0 110.231 179.47 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.0 tp -119.95 120.78 37.37 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.974 179.571 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 83.7 mt -114.02 129.23 70.31 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.37 0 CA-C-O 120.936 0.398 . . . . 0.0 110.92 -179.858 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 30.8 mt -109.24 132.03 54.51 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.048 0.451 . . . . 0.0 110.198 -179.705 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 98.8 mt -119.61 138.05 51.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.706 -179.781 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 85.1 p -71.88 153.97 41.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.554 179.978 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.28 -50.35 74.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.671 -179.793 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -149.58 154.06 38.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.601 179.809 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 170.66 -170.78 43.37 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.911 -0.875 . . . . 0.0 110.911 179.824 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.96 -34.09 88.97 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 179.936 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.45 ' O ' ' OD1' ' A' ' 124' ' ' ASP . 44.4 p-10 -86.96 120.33 28.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.843 0.354 . . . . 0.0 110.673 179.953 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 39.1 t -63.26 143.63 57.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.045 0.45 . . . . 0.0 110.447 -179.932 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.0 -43.26 9.0 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.945 -179.97 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.6 tp -62.81 -42.48 99.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.705 -179.831 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.58 -11.71 58.72 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.515 -179.444 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 84.8 mt -115.0 -24.05 8.78 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.724 -179.866 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . 0.519 ' N ' ' O ' ' A' ' 126' ' ' ALA . 80.8 t80 -51.22 -49.57 60.8 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.579 -178.901 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.7 p-10 -66.17 -42.33 89.06 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.8 0.333 . . . . 0.0 111.18 179.538 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.504 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 88.2 mt-30 -67.42 -37.67 83.42 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.761 179.975 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 95.6 mt -80.22 -41.89 24.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.932 -179.599 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.2 t -57.17 -44.28 83.36 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.24 -179.07 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.1 m -62.06 -45.44 93.55 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.775 0.321 . . . . 0.0 110.572 179.357 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 92.9 mt -62.28 -43.64 98.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.229 -179.774 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.25 167.85 5.31 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.566 179.897 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -49.04 112.56 0.67 Allowed 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.357 2.038 . . . . 0.0 112.116 179.377 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 21.6 m -84.5 127.37 34.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.641 -179.951 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 36.2 tp -118.62 137.95 52.92 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.066 -179.867 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.452 ' O ' ' OG ' ' A' ' 33' ' ' SER . 77.1 mt -102.82 120.05 52.07 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 CA-C-O 121.224 0.535 . . . . 0.0 111.118 -179.415 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 98.5 mt -135.68 131.83 50.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.585 179.662 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.427 ' OD1' ' OD2' ' A' ' 241' ' ' ASP . 56.4 t30 -66.42 153.82 41.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.938 0.399 . . . . 0.0 110.467 179.373 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.527 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 90.5 t80 -87.73 122.43 31.38 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.831 -179.639 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.527 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 99.1 m-20 55.3 69.33 0.75 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.778 179.633 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 49.4 p-10 -123.73 -0.4 8.57 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.664 179.925 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -151.26 116.5 5.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.778 -179.541 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 148' ' ' SER . . . . . 0.494 ' HG ' ' H ' ' A' ' 150' ' ' GLN . 83.4 p -62.15 166.5 4.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.479 -179.752 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.41 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.4 p-90 -50.68 -15.48 0.28 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.545 -179.812 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . 0.494 ' H ' ' HG ' ' A' ' 148' ' ' SER . 68.3 tp60 -71.52 -74.26 0.16 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.466 -179.787 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.439 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.1 t -62.86 -39.29 93.95 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.272 179.467 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 54.8 tp -59.96 -45.76 91.61 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.399 -178.581 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.41 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 46.5 tp -62.65 -41.75 99.22 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.784 0.326 . . . . 0.0 110.404 179.054 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.439 ' OG1' ' O ' ' A' ' 151' ' ' SER . 56.6 p -64.57 -34.73 78.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.358 -179.551 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . 0.45 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 86.9 mm-40 -64.05 -42.84 96.9 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.313 179.284 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 91.5 mt -65.54 -38.83 90.75 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.057 0.456 . . . . 0.0 110.187 179.147 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.58 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.21 -32.11 79.44 Favored Glycine 0 CA--C 1.52 0.344 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 -179.36 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.45 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.2 mt-10 -35.58 -26.91 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.823 0.344 . . . . 0.0 110.812 179.955 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.58 ' N ' ' O ' ' A' ' 157' ' ' GLY . 94.8 mt -56.52 150.84 2.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.264 179.312 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 72.0 p -69.66 137.3 52.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.01 -179.541 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 70.15 22.37 77.34 Favored Glycine 0 N--CA 1.459 0.2 0 N-CA-C 111.214 -0.754 . . . . 0.0 111.214 179.462 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 59.5 m80 -123.12 -13.65 7.71 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.716 0.293 . . . . 0.0 110.566 179.906 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -67.21 -59.32 3.53 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.755 -179.687 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -52.14 -49.42 63.74 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.239 -179.595 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -60.36 -41.3 93.42 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.792 0.33 . . . . 0.0 110.336 179.525 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.52 -47.05 87.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.595 179.831 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.96 -40.14 75.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.204 -179.894 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -61.64 -50.24 73.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.589 179.553 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -65.47 -43.59 89.82 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.501 179.541 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 95.0 mt -64.64 -43.47 96.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.457 179.776 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.44 -51.27 70.1 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.641 -179.232 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.72 -44.16 94.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.545 179.697 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . 0.5 ' CD1' ' OH ' ' A' ' 301' ' ' TYR . 55.0 t80 -62.86 -44.43 96.13 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.069 0.461 . . . . 0.0 110.443 179.438 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -63.33 -40.06 96.28 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.598 -179.331 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -62.92 -42.71 99.88 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.63 179.191 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -60.62 -44.8 95.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.103 -179.97 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 85.7 mt -64.44 -41.16 96.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.01 0.434 . . . . 0.0 110.714 178.951 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.18 -62.3 1.72 Allowed 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.497 -179.351 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.45 -46.81 85.81 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.566 179.887 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.21 -41.64 65.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.238 179.987 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -63.97 -33.77 76.48 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.998 0.428 . . . . 0.0 110.353 179.315 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . 0.403 ' HG2' ' O ' ' A' ' 182' ' ' GLU . 69.6 tt0 -90.49 8.8 32.05 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.347 0.594 . . . . 0.0 110.533 -178.998 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -104.74 -32.14 9.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.181 179.607 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.2 pt -128.13 147.79 32.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.846 -179.818 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -140.11 131.12 26.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.356 179.427 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . 0.558 ' CD2' ' N ' ' A' ' 186' ' ' LEU . 3.5 mm? -85.88 133.68 40.89 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.908 179.924 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -44.33 157.97 0.15 Allowed 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.727 2.284 . . . . 0.0 112.088 179.356 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . 0.526 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.7 Cg_endo -62.92 115.13 2.75 Favored 'Trans proline' 0 C--N 1.303 -1.82 0 C-N-CA 122.801 2.334 . . . . 0.0 111.774 179.768 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . 0.526 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.7 mt-30 155.44 148.09 0.0 OUTLIER Pre-proline 0 N--CA 1.455 -0.208 0 O-C-N 123.635 0.584 . . . . 0.0 110.758 -179.867 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -73.83 144.17 34.4 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.676 2.25 . . . . 0.0 111.914 178.044 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.496 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.1 p -125.13 158.99 32.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.307 0.575 . . . . 0.0 110.121 -179.98 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 192' ' ' THR . . . . . 0.496 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 36.9 p -143.44 165.36 27.75 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.139 -179.678 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -135.41 128.74 32.13 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.135 0.493 . . . . 0.0 110.194 179.543 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 47.9 pt -146.28 148.58 16.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.077 179.825 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 70.2 t -117.33 122.96 71.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.277 0.56 . . . . 0.0 109.681 179.161 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -134.37 107.49 7.64 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.32 179.707 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 95.1 m -131.17 130.54 43.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.855 179.833 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -82.53 -36.84 25.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.33 179.75 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.58 -67.36 0.24 Allowed 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.425 179.981 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.49 -9.86 59.08 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.265 179.55 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 60.5 t-80 60.42 58.78 2.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.784 -179.812 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 42.9 p -167.06 153.62 8.38 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.538 179.53 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.28 144.17 24.5 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.957 0.408 . . . . 0.0 110.453 179.432 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -135.06 137.28 42.75 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.569 -179.988 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 19.6 mt -105.44 125.16 50.67 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 121.066 0.46 . . . . 0.0 109.869 -179.676 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 206' ' ' TRP . . . . . 0.557 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 75.9 m95 -81.57 166.42 20.25 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.634 -179.794 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -156.57 171.52 7.29 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.536 -179.184 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_exo -54.23 -36.78 87.21 Favored 'Trans proline' 0 C--N 1.302 -1.874 0 C-N-CA 122.679 2.253 . . . . 0.0 112.079 179.173 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -70.33 -34.97 73.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.811 -179.806 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 22.3 m -61.6 149.83 38.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.587 -179.392 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.55 -36.83 81.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.494 -179.732 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 212' ' ' GLN . . . . . 0.557 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 55.1 tt0 -64.65 -40.61 95.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.56 179.873 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.08 -43.56 93.09 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 110.591 -1.003 . . . . 0.0 110.591 179.712 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -63.5 -42.76 98.52 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 179.72 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 64.6 ttp -59.47 -48.04 83.17 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.202 -179.898 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 87.6 mt -60.74 -40.67 93.25 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.556 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 217' ' ' GLU . . . . . 0.455 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 40.7 tp10 -58.03 -38.09 75.58 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.841 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -65.12 -38.18 89.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.771 0.319 . . . . 0.0 110.621 179.641 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 94.5 mt -64.41 -42.78 95.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.517 -179.537 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 138.01 45.22 0.08 OUTLIER Glycine 0 C--N 1.335 0.479 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 179.982 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 221' ' ' PHE . . . . . 0.455 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 26.7 m-85 -128.8 156.45 43.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.057 0.456 . . . . 0.0 110.523 -179.739 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 222' ' ' THR . . . . . 0.456 ' O ' ' O ' ' A' ' 191' ' ' VAL . 7.8 p -108.33 122.82 47.76 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 121.204 0.526 . . . . 0.0 110.185 -179.94 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . 0.441 ' CD2' ' N ' ' A' ' 223' ' ' LEU . 4.3 mm? -101.38 132.92 46.7 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.055 179.933 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.9 159.57 14.84 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.54 179.85 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -104.97 115.26 29.97 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.933 0.396 . . . . 0.0 110.395 179.824 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.453 ' CD1' ' N ' ' A' ' 226' ' ' LEU . 8.9 mp -53.72 156.96 4.25 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.669 179.914 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -60.18 145.24 98.93 Favored 'Trans proline' 0 C--N 1.302 -1.914 0 C-N-CA 122.637 2.224 . . . . 0.0 112.108 179.374 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.6 -2.47 58.64 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.56 -179.959 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.62 -40.42 5.66 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 -179.903 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . 0.548 ' O ' ' N ' ' A' ' 233' ' ' SER . 85.9 mt -79.59 -16.51 55.74 Favored 'General case' 0 C--O 1.223 -0.311 0 CA-C-O 120.971 0.415 . . . . 0.0 110.314 -179.735 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . 0.404 ' C ' ' O ' ' A' ' 230' ' ' LEU . 55.4 t-20 -40.27 -48.8 2.67 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.687 -179.566 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -88.59 15.7 7.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.804 0.335 . . . . 0.0 111.258 179.807 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 233' ' ' SER . . . . . 0.548 ' N ' ' O ' ' A' ' 230' ' ' LEU . 78.1 p -60.63 -35.79 77.04 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.738 -179.839 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . 0.525 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.6 tt0 -118.06 -69.6 0.84 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.021 179.535 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 3.8 m -70.46 103.41 2.45 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.673 -179.796 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -94.64 57.94 2.27 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.363 179.93 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -145.15 -122.63 1.55 Allowed Glycine 0 CA--C 1.52 0.365 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 -179.958 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -133.7 112.03 11.07 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 121.118 0.485 . . . . 0.0 110.409 179.945 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . 0.488 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 94.7 mtt180 -148.25 56.61 1.06 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.753 -179.979 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -69.4 -31.36 69.68 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.511 179.593 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 241' ' ' ASP . . . . . 0.456 ' OD2' ' O ' ' A' ' 144' ' ' TYR . 64.8 t0 -56.69 -46.93 80.88 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.403 -179.069 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 242' ' ' ILE . . . . . 0.436 ' O ' ' O ' ' A' ' 239' ' ' ARG . 16.9 tt -140.85 158.18 23.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.934 0.397 . . . . 0.0 110.519 179.738 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 96.0 mt -105.97 105.97 19.71 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.2 0 CA-C-O 121.155 0.503 . . . . 0.0 110.407 179.821 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . 0.488 ' OE1' ' NH1' ' A' ' 239' ' ' ARG . 88.2 mt-30 -110.76 110.69 21.43 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.369 179.74 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 9.7 mp -122.03 -167.92 1.63 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.558 179.748 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . 0.525 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 172.54 -16.48 0.05 OUTLIER Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 179.879 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . 0.689 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -60.56 157.71 29.01 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 -179.855 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -64.22 21.09 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.971 0.415 . . . . 0.0 110.609 179.962 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . 0.689 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.8 m-20 -96.94 -5.54 37.69 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.564 179.955 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 92.2 mt -80.84 -20.99 41.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.611 179.535 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.52 -51.35 70.27 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.79 -179.671 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -89.29 -4.93 57.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.453 179.658 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.09 -74.16 1.15 Allowed Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 -179.923 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 81.7 mt -70.13 125.71 27.56 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.015 0.436 . . . . 0.0 110.237 -179.795 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -59.57 -39.49 84.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.369 -179.709 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 83.51 51.71 4.0 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 179.767 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -94.81 -16.57 22.86 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.724 0.297 . . . . 0.0 110.597 -179.899 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 258' ' ' SER . . . . . 0.425 ' O ' ' O ' ' A' ' 192' ' ' THR . 3.4 t 175.19 89.63 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.057 0.456 . . . . 0.0 110.124 179.996 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . 0.596 ' N ' ' CD1' ' A' ' 259' ' ' LEU . 0.9 OUTLIER -94.5 124.26 38.42 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.323 0.582 . . . . 0.0 111.139 -179.042 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 16.1 m-30 -93.53 146.93 23.43 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.362 179.22 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 86.2 mt -122.44 149.77 43.38 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.599 -179.893 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.659 ' CG ' ' N ' ' A' ' 263' ' ' ALA . 2.6 p90 -77.72 -138.78 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.542 -179.849 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 263' ' ' ALA . . . . . 0.659 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -51.39 78.09 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.056 179.988 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . 0.629 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.95 104.63 0.19 Allowed Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.679 -0.969 . . . . 0.0 110.679 -179.987 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 265' ' ' ASP . . . . . 0.604 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.7 m-20 -80.29 -177.62 6.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.671 0.272 . . . . 0.0 110.883 -179.49 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -40.54 -17.48 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.858 0.361 . . . . 0.0 110.504 179.766 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 267' ' ' LYS . . . . . 0.604 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.53 -51.66 40.58 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.672 179.476 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -63.75 -46.59 84.64 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.212 179.343 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . 0.519 ' O ' ' CD2' ' A' ' 273' ' ' TYR . . . -61.49 -35.41 77.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.78 179.599 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -62.56 -34.71 77.5 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.228 179.694 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.26 -43.09 14.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.319 -179.592 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 272' ' ' ILE . . . . . 0.618 ' C ' ' H ' ' A' ' 274' ' ' ALA . 5.0 tt -51.47 -33.89 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.824 -178.823 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 273' ' ' TYR . . . . . 0.519 ' CD2' ' O ' ' A' ' 269' ' ' ALA . 16.8 m-85 -54.31 -2.11 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.645 -179.599 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 274' ' ' ALA . . . . . 0.618 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.39 -39.58 71.08 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.969 179.5 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . 0.585 ' O ' ' N ' ' A' ' 279' ' ' ALA . 3.6 p30 -39.23 97.96 0.15 Allowed Pre-proline 0 C--O 1.227 -0.113 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.568 -179.691 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -54.15 -43.1 61.49 Favored 'Trans proline' 0 C--N 1.303 -1.824 0 C-N-CA 122.375 2.05 . . . . 0.0 112.611 -178.765 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 89.2 mt -64.42 -42.79 95.86 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.114 -179.64 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 91.2 mt -95.96 -1.18 49.62 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.849 -179.421 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 279' ' ' ALA . . . . . 0.585 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.5 -34.93 77.84 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.612 -179.749 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.26 20.18 0.11 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.004 -179.247 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . 0.513 ' H ' ' C ' ' A' ' 279' ' ' ALA . 13.7 mt -75.03 120.11 80.08 Favored Pre-proline 0 N--CA 1.451 -0.376 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.45 179.94 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -50.96 -39.45 59.36 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.659 2.24 . . . . 0.0 111.831 179.07 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -53.0 -50.38 64.32 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.126 179.849 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 74.6 t -61.6 -43.97 97.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 179.488 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -57.55 -41.17 80.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.234 -179.958 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -90.97 0.23 57.58 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.141 179.687 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt 59.62 43.16 16.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.066 0.46 . . . . 0.0 110.891 179.662 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -94.61 41.31 1.09 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.399 179.884 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 54.1 t -119.21 135.76 58.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 121.009 0.433 . . . . 0.0 110.179 -179.741 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -133.63 163.67 28.9 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 121.026 0.441 . . . . 0.0 110.73 -179.66 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.76 155.77 31.87 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.97 0.414 . . . . 0.0 110.759 -179.797 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 82.2 mt -94.65 -1.45 53.14 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.274 -179.75 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.34 165.22 12.56 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 -179.786 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 6.6 m -86.7 -61.55 1.71 Allowed 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 120.87 0.367 . . . . 0.0 111.102 -179.84 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 295' ' ' GLU . . . . . 0.484 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.6 mm-40 -69.66 -4.56 20.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.66 -179.792 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 26.1 p -76.48 33.03 0.13 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.68 -179.891 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 297' ' ' PHE . . . . . 0.484 ' H ' ' C ' ' A' ' 295' ' ' GLU . 83.3 t80 -60.52 -45.99 91.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.646 -179.956 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . 0.609 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.2 mtt85 -81.08 136.66 35.97 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.627 -179.598 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -114.25 116.87 29.7 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.494 179.667 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . 0.628 ' H ' ' HG ' ' A' ' 303' ' ' SER . 49.1 p-10 -166.84 -174.97 2.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.52 -179.799 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 301' ' ' TYR . . . . . 0.5 ' OH ' ' CD1' ' A' ' 173' ' ' PHE . 78.6 t80 -47.73 -44.46 27.96 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.241 -179.684 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -65.84 -41.27 91.94 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.029 0.442 . . . . 0.0 110.782 179.017 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 303' ' ' SER . . . . . 0.628 ' HG ' ' H ' ' A' ' 300' ' ' ASP . 54.3 p -55.36 -36.15 66.01 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.1 -179.265 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -57.58 -51.4 69.63 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.436 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 90.6 mtp -56.56 -44.02 80.53 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -179.936 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -66.29 -42.88 87.73 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.903 0.382 . . . . 0.0 110.184 178.86 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 55.9 t -63.88 -43.09 97.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.218 179.409 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 42.5 tp -59.87 -42.07 92.92 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.812 -179.618 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -62.31 -39.05 91.75 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.152 179.665 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 310' ' ' ARG . . . . . 0.45 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.8 ttt85 -63.71 -43.89 95.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.266 179.46 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 90.1 mt -63.26 -42.05 99.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.184 179.632 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt -62.85 -33.62 75.63 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.116 179.409 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.73 -23.37 21.82 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.448 -179.888 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . 0.45 ' N ' ' O ' ' A' ' 310' ' ' ARG . 6.9 tt -62.31 -43.06 99.69 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.61 -179.936 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 . . . . . 0 C--O 1.22 -0.484 0 CA-C-O 117.964 -1.017 . . . . 0.0 110.466 179.975 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -99.26 135.82 40.11 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.06 0.457 . . . . 0.0 110.493 -179.995 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.496 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -91.75 178.43 1.75 Allowed Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.637 -179.961 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.496 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.5 Cg_exo -61.57 146.87 96.56 Favored 'Trans proline' 0 C--N 1.3 -2.022 0 C-N-CA 122.808 2.339 . . . . 0.0 112.162 179.635 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.406 ' CZ ' HE21 ' A' ' 42' ' ' GLN . 35.4 ptt180 -136.3 141.82 43.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.647 179.71 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -79.3 116.96 19.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.476 179.923 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.4 ' O ' ' CG2' ' A' ' 30' ' ' ILE . 9.4 tp -111.61 130.24 65.52 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.486 -179.985 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.2 t -71.09 142.45 50.82 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.61 179.842 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.524 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.4 t0 -139.32 179.93 6.25 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.57 -179.937 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.524 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 78.4 p -74.01 -37.12 64.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.785 179.716 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -46.78 -94.66 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.378 -179.459 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.422 ' O ' ' OG1' ' A' ' 36' ' ' THR . . . -166.17 -26.88 0.02 OUTLIER Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 179.893 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.422 ' OG1' ' O ' ' A' ' 35' ' ' GLY . 65.0 m -168.66 105.91 0.44 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.861 0.362 . . . . 0.0 110.618 -179.921 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 69.5 t60 -128.75 147.22 50.76 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.988 0.423 . . . . 0.0 110.324 179.925 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.485 ' CG2' ' N ' ' A' ' 39' ' ' LEU . 99.9 m -130.45 165.53 22.43 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.569 -179.835 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.485 ' N ' ' CG2' ' A' ' 38' ' ' THR . 80.6 mt -120.64 126.98 51.62 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.485 179.731 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -65.44 -44.35 87.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.686 -179.971 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.418 ' O ' ' HD3' ' A' ' 43' ' ' PRO . 41.0 p -165.96 154.82 11.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.405 179.669 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.467 ' N ' ' CD ' ' A' ' 42' ' ' GLN . 14.0 mp0 -45.43 101.55 0.26 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.643 179.471 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.418 ' HD3' ' O ' ' A' ' 41' ' ' SER . 31.4 Cg_exo -57.6 129.64 34.76 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 122.402 2.068 . . . . 0.0 112.235 -179.643 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -82.51 -25.14 33.73 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.5 179.531 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.537 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.7 mtm-85 -120.89 134.03 55.29 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 121.185 0.517 . . . . 0.0 110.27 179.96 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.1 mt -129.82 133.21 65.13 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.273 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.966 -179.721 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 44.3 t -124.84 131.08 73.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.839 0.352 . . . . 0.0 110.101 179.313 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.551 ' HG ' ' CD1' ' A' ' 117' ' ' LEU . 4.9 m -154.74 166.35 33.71 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.515 179.845 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 65.3 p -124.37 8.53 8.44 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.434 179.923 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.709 ' HG ' ' H ' ' A' ' 53' ' ' LEU . 1.2 t -85.58 125.21 32.93 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.616 -179.458 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 94.5 t -65.5 -44.41 94.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.545 -179.938 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.6 m -62.61 -44.31 96.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.639 -179.851 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.709 ' H ' ' HG ' ' A' ' 50' ' ' SER . 48.4 tp -62.5 -41.48 98.85 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.57 -179.476 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 74.6 m -57.63 -44.78 85.81 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.466 -179.438 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.36 -62.09 5.43 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 179.571 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.6 t -48.23 -35.71 12.48 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 179.951 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.7 mt -61.7 -44.46 96.89 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.11 179.331 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.1 mp -65.07 -41.72 94.81 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.201 178.049 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.6 -41.36 98.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.933 -179.243 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.0 tp -87.7 16.81 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.755 -179.63 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 56.45 83.84 0.09 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.73 -179.862 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.89 58.04 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.005 -179.752 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -50.59 152.71 8.78 Favored 'Trans proline' 0 C--N 1.296 -2.207 0 C-N-CA 122.859 2.373 . . . . 0.0 112.38 -178.204 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.431 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -108.96 145.9 15.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.348 -179.727 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 97.0 mt -63.8 -45.18 97.89 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.357 -179.844 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.496 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -129.87 134.48 47.54 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.602 -179.745 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.499 ' O ' ' N ' ' A' ' 98' ' ' LEU . 72.7 m -134.75 158.77 43.29 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.833 -179.637 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.73 139.36 16.36 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.668 -0.973 . . . . 0.0 110.668 179.798 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.455 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.79 -162.92 0.08 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.903 0.382 . . . . 0.0 110.515 179.966 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.495 ' O ' ' C ' ' A' ' 71' ' ' THR . 5.7 t -133.93 135.38 43.52 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.245 -179.973 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.495 ' C ' ' O ' ' A' ' 70' ' ' THR . 1.1 t 29.55 68.19 0.67 Allowed Pre-proline 0 N--CA 1.466 0.328 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.64 -179.626 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -60.98 145.18 99.46 Favored 'Trans proline' 0 C--N 1.3 -1.978 0 C-N-CA 122.619 2.213 . . . . 0.0 112.068 -178.392 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.532 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 45.1 p-10 -159.37 -32.29 0.06 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.662 179.698 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.532 ' N ' ' OD1' ' A' ' 73' ' ' ASN . 99.1 m-20 -64.07 -39.4 94.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.505 179.988 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -60.51 -48.32 82.29 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.642 -179.278 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.423 ' O ' ' O ' ' A' ' 77' ' ' ALA . 94.4 t -60.1 -24.85 31.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 179.704 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.423 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -45.77 172.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.583 179.865 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.571 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.8 p30 -61.98 177.76 0.42 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.614 -179.774 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.597 ' C ' ' H ' ' A' ' 81' ' ' GLY . 36.0 p30 -45.69 85.86 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.962 179.963 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.571 ' N ' ' O ' ' A' ' 78' ' ' ASP . 42.8 tp60 -67.33 13.62 0.06 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.146 -179.837 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.597 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 117.94 -22.04 10.03 Favored Glycine 0 CA--C 1.519 0.338 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.93 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -108.19 116.68 32.41 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.951 0.405 . . . . 0.0 110.56 179.843 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 75.4 mt -98.98 0.88 44.85 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.513 -179.767 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -92.07 6.74 45.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.985 0.421 . . . . 0.0 110.484 -179.797 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.44 ' O ' ' CG2' ' A' ' 89' ' ' VAL . 88.2 mt-30 -100.06 -26.28 14.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.781 179.968 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.5 t-105 -64.28 -40.99 97.1 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.02 -179.688 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.551 ' O ' ' N ' ' A' ' 91' ' ' LYS . 68.5 m -77.6 -53.55 7.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.155 -179.516 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -47.9 -51.27 23.89 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.001 -179.347 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.44 ' CG2' ' O ' ' A' ' 85' ' ' GLN . 15.1 m -69.01 -41.08 81.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 120.905 0.383 . . . . 0.0 111.069 179.88 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.416 ' H ' HG23 ' A' ' 89' ' ' VAL . . . -71.47 -23.57 61.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.768 -179.815 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.551 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.0 tttm -61.07 -46.06 92.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.501 -179.439 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.443 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.6 mm-40 -90.13 -94.87 0.11 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.213 179.971 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.626 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.8 mtt180 -143.19 60.13 1.41 Allowed 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 179.758 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.463 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.6 pttp 33.31 26.88 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.203 -179.082 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.626 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.4 tt -48.61 123.1 6.26 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.931 -178.193 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -83.5 -169.9 2.78 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.145 179.934 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.614 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 81.7 mtp180 -73.71 137.51 44.09 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.328 -179.865 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.499 ' N ' ' O ' ' A' ' 67' ' ' SER . 89.0 mt -85.9 -166.11 1.44 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.709 -179.621 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.532 ' CD2' ' O ' ' A' ' 99' ' ' TYR . 46.7 p90 -168.01 119.48 0.84 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.311 179.962 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.513 ' C ' ' O ' ' A' ' 99' ' ' TYR . 43.1 mm -29.14 121.04 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.922 -179.701 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 113.95 28.11 3.25 Favored Glycine 0 CA--C 1.521 0.431 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 -179.597 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.583 ' N ' ' CD ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -144.0 46.0 0.61 Allowed Pre-proline 0 C--N 1.323 -0.55 0 CA-C-O 120.953 0.406 . . . . 0.0 110.503 179.891 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.583 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 30.2 Cg_endo -62.28 143.83 94.54 Favored 'Trans proline' 0 C--N 1.297 -2.138 0 C-N-CA 122.686 2.257 . . . . 0.0 111.957 -179.966 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.697 ' HG ' ' H ' ' A' ' 107' ' ' ALA . 23.2 t -173.33 120.73 0.34 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.417 179.754 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.58 -40.98 63.48 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.043 179.743 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -65.9 -40.31 91.39 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.864 -179.374 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.697 ' H ' ' HG ' ' A' ' 104' ' ' SER . . . -63.96 -39.86 95.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.687 -179.832 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 70.9 t -67.54 -43.76 86.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.721 179.683 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.43 -39.1 92.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.568 -179.287 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.443 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.51 -23.55 62.9 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.532 179.834 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.549 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.4 mm-40 -90.94 4.75 51.11 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.741 -179.564 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.549 ' C ' ' O ' ' A' ' 111' ' ' GLN . 9.9 tpt 23.17 64.32 0.37 Allowed Pre-proline 0 N--CA 1.464 0.271 0 CA-C-O 120.914 0.388 . . . . 0.0 111.001 -179.806 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -78.9 168.92 20.18 Favored 'Trans proline' 0 C--N 1.304 -1.801 0 C-N-CA 122.984 2.456 . . . . 0.0 112.081 -178.415 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.483 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 98.9 m-20 -113.24 -44.01 3.3 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.103 179.452 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.2 tp -120.47 119.81 34.07 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.324 -0.398 . . . . 0.0 109.935 179.48 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 96.3 mt -117.09 131.1 70.79 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.319 0 CA-C-O 120.9 0.381 . . . . 0.0 110.892 -179.788 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.551 ' CD1' ' HG ' ' A' ' 48' ' ' SER . 29.7 mt -106.0 132.46 52.06 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 121.027 0.441 . . . . 0.0 110.321 -179.489 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 98.1 mt -118.17 136.6 54.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.73 -179.709 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 86.5 p -71.6 152.76 42.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.548 -179.95 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.27 -50.21 74.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.659 -179.857 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -149.24 153.59 37.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.552 179.762 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 169.3 -170.17 42.41 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 179.885 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -63.04 -35.46 92.12 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 179.992 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.447 ' O ' ' OD1' ' A' ' 124' ' ' ASP . 44.1 p-10 -87.18 119.92 27.91 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.808 0.337 . . . . 0.0 110.639 179.885 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 39.2 t -63.56 144.06 57.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.467 -179.928 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.52 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.38 -43.28 8.85 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.872 -179.935 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.8 tp -62.77 -42.35 99.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.654 -179.816 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.73 -10.91 56.64 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.512 -179.395 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 84.1 mt -116.03 -23.9 8.31 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.7 -179.902 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . 0.52 ' N ' ' O ' ' A' ' 126' ' ' ALA . 77.8 t80 -51.53 -49.87 61.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.521 -179.001 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.5 p-10 -65.79 -42.26 90.96 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.852 0.358 . . . . 0.0 111.15 179.628 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.504 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 87.9 mt-30 -67.52 -36.69 81.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.792 -179.97 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 94.1 mt -80.58 -42.05 22.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.871 -179.507 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.2 t -57.23 -44.76 84.07 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.259 -179.21 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.2 m -62.3 -45.8 91.63 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.806 0.336 . . . . 0.0 110.642 179.33 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 92.9 mt -62.31 -43.9 98.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.401 -179.855 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.95 162.93 6.66 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.529 179.844 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -42.71 110.99 0.18 Allowed 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.536 2.157 . . . . 0.0 112.196 179.448 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 16.8 m -85.57 127.76 34.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.555 179.971 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 34.3 tp -119.48 137.94 53.46 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.088 -179.897 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.429 ' O ' ' OD2' ' A' ' 32' ' ' ASP . 80.2 mt -104.22 120.01 53.88 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 CA-C-O 121.122 0.487 . . . . 0.0 111.217 -179.348 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 97.7 mt -135.92 132.58 50.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.595 179.549 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.517 HD22 ' CG ' ' A' ' 241' ' ' ASP . 52.4 t30 -65.75 148.44 51.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.902 0.382 . . . . 0.0 110.422 179.268 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.459 ' O ' ' OD2' ' A' ' 241' ' ' ASP . 42.6 t80 -81.86 123.18 28.6 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.955 -179.456 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 54.79 69.69 0.7 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.881 179.643 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 49.2 p-10 -124.45 0.24 8.24 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.679 179.849 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -151.42 116.4 5.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.695 -179.442 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 148' ' ' SER . . . . . 0.503 ' HG ' ' H ' ' A' ' 150' ' ' GLN . 84.0 p -63.86 168.55 4.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.557 -179.941 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.416 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.6 p-90 -51.8 -16.33 0.67 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.553 -179.846 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . 0.503 ' H ' ' HG ' ' A' ' 148' ' ' SER . 68.2 tp60 -70.1 -76.68 0.1 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.491 -179.744 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.447 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.1 t -62.41 -38.49 89.85 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.321 179.6 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 53.4 tp -59.82 -45.75 91.38 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.377 -178.601 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.416 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 46.3 tp -62.83 -41.72 99.44 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.472 179.012 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.447 ' OG1' ' O ' ' A' ' 151' ' ' SER . 62.2 p -64.01 -34.97 79.2 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.266 -179.592 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . 0.448 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.7 mm-40 -64.02 -42.28 97.18 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.239 179.32 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 92.1 mt -65.51 -38.85 90.9 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.041 0.448 . . . . 0.0 110.232 179.093 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.581 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.22 -32.13 79.52 Favored Glycine 0 CA--C 1.52 0.389 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 -179.374 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.448 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.3 mt-10 -36.02 -26.19 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.804 0.335 . . . . 0.0 110.728 179.953 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.581 ' N ' ' O ' ' A' ' 157' ' ' GLY . 94.4 mt -58.11 150.16 4.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.3 179.375 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 77.1 p -69.21 137.29 53.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.01 -179.508 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 69.96 22.94 77.26 Favored Glycine 0 CA--C 1.517 0.183 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 179.452 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 59.8 m80 -124.11 -13.97 7.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.745 0.307 . . . . 0.0 110.563 179.92 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -67.19 -59.42 3.45 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.702 -179.732 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -51.76 -49.37 62.76 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.215 -179.667 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -60.45 -41.32 93.84 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.735 0.302 . . . . 0.0 110.346 179.509 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.42 -47.34 86.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.609 179.801 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.73 -40.16 75.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.252 -179.915 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -61.49 -50.26 73.45 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.575 179.573 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -65.52 -43.58 89.58 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.492 179.596 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 94.8 mt -64.66 -43.37 96.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.427 179.768 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.29 -51.36 69.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.566 -179.243 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.71 -43.78 95.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.53 179.727 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . 0.52 ' CD1' ' OH ' ' A' ' 301' ' ' TYR . 55.1 t80 -62.87 -44.47 96.03 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.041 0.448 . . . . 0.0 110.454 179.45 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -63.48 -40.0 95.95 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.592 -179.36 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -62.9 -42.83 99.92 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.628 179.333 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -60.76 -44.7 96.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.186 179.93 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 84.9 mt -64.53 -41.2 96.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.02 0.438 . . . . 0.0 110.749 178.887 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.05 -62.09 1.85 Allowed 'General case' 0 C--O 1.236 0.376 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.478 -179.382 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.58 -46.66 86.48 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.609 179.784 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.28 -41.5 65.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.236 -179.984 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -64.01 -33.75 76.45 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.96 0.41 . . . . 0.0 110.424 179.278 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . 0.402 ' O ' ' HG2' ' A' ' 182' ' ' GLU . 69.3 tt0 -90.68 8.86 32.29 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.338 0.589 . . . . 0.0 110.483 -179.019 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -104.78 -32.19 8.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.895 0.379 . . . . 0.0 111.196 179.615 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.6 pt -128.21 147.83 32.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.845 -179.847 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -140.11 131.16 26.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.393 179.364 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . 0.558 ' CD2' ' N ' ' A' ' 186' ' ' LEU . 3.5 mm? -85.45 133.92 41.3 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.882 -179.996 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -43.87 157.93 0.13 Allowed 'Trans proline' 0 C--N 1.307 -1.629 0 C-N-CA 122.743 2.295 . . . . 0.0 112.125 179.316 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . 0.53 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.6 Cg_endo -62.96 114.51 2.47 Favored 'Trans proline' 0 C--N 1.304 -1.807 0 C-N-CA 122.796 2.331 . . . . 0.0 111.717 179.839 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . 0.53 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.7 mt-30 155.13 148.26 0.0 OUTLIER Pre-proline 0 C--N 1.331 -0.207 0 O-C-N 123.643 0.589 . . . . 0.0 110.74 -179.743 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -73.47 144.55 36.45 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.695 2.263 . . . . 0.0 111.928 177.97 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.495 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.1 p -124.84 158.89 32.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.241 0.543 . . . . 0.0 110.194 179.962 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 192' ' ' THR . . . . . 0.495 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 37.6 p -143.46 165.22 28.14 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.086 -179.585 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -135.33 128.65 32.12 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.106 0.479 . . . . 0.0 110.285 179.534 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 47.5 pt -146.5 148.87 16.53 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.297 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.052 179.933 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 74.1 t -117.6 123.06 71.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.247 0.546 . . . . 0.0 109.809 179.073 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -134.3 106.97 7.38 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.27 179.738 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 93.7 m -130.77 130.63 43.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.84 179.782 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.406 ' O ' ' N ' ' A' ' 201' ' ' HIS . . . -82.67 -37.17 25.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.313 179.675 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.37 -67.35 0.24 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.417 -179.98 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.01 -10.0 59.16 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.338 179.508 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . 0.406 ' N ' ' O ' ' A' ' 198' ' ' ALA . 59.9 t-80 60.67 58.32 2.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.719 -179.81 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 41.6 p -166.99 153.29 8.22 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.537 179.643 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.31 144.07 24.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.473 179.395 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -135.34 138.28 43.23 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.642 -179.969 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 19.6 mt -106.12 125.23 50.74 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 121.027 0.442 . . . . 0.0 109.923 -179.737 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 206' ' ' TRP . . . . . 0.574 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 75.0 m95 -81.81 166.87 19.62 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.667 -179.72 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -156.61 171.89 6.81 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.607 -179.15 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -53.98 -37.3 86.06 Favored 'Trans proline' 0 C--N 1.303 -1.856 0 C-N-CA 122.654 2.236 . . . . 0.0 112.172 179.225 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -70.45 -34.81 72.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.76 -179.746 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 22.0 m -61.44 150.51 35.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.596 -179.373 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.17 -36.51 80.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.438 -179.768 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 212' ' ' GLN . . . . . 0.574 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 53.7 tt0 -64.5 -40.6 95.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.482 -179.987 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.67 -43.65 91.47 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 179.821 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -63.14 -44.26 96.05 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.719 0.295 . . . . 0.0 110.283 179.76 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 65.5 ttp -59.56 -48.21 82.53 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.221 -179.886 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 85.8 mt -60.25 -40.92 91.99 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.405 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 217' ' ' GLU . . . . . 0.456 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.0 tp10 -58.06 -38.08 75.64 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.739 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -65.3 -38.17 89.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.784 0.326 . . . . 0.0 110.568 179.677 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 94.7 mt -64.4 -42.79 95.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.441 -179.595 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.54 45.84 0.08 OUTLIER Glycine 0 C--N 1.334 0.47 0 N-CA-C 111.036 -0.825 . . . . 0.0 111.036 179.958 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 221' ' ' PHE . . . . . 0.456 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 26.9 m-85 -129.0 156.02 44.46 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.027 0.441 . . . . 0.0 110.487 -179.802 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 222' ' ' THR . . . . . 0.449 ' O ' ' O ' ' A' ' 191' ' ' VAL . 8.0 p -108.01 122.83 47.66 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.203 0.525 . . . . 0.0 110.208 -179.938 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . 0.446 ' CD2' ' N ' ' A' ' 223' ' ' LEU . 4.3 mm? -101.6 133.41 46.33 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.068 -179.94 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -97.22 159.73 14.74 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.458 179.834 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.01 115.1 29.7 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.927 0.394 . . . . 0.0 110.41 179.84 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.447 ' CD1' ' N ' ' A' ' 226' ' ' LEU . 9.1 mp -53.34 156.75 3.83 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.648 179.93 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -60.09 145.2 98.99 Favored 'Trans proline' 0 C--N 1.302 -1.903 0 C-N-CA 122.667 2.245 . . . . 0.0 112.139 179.283 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.48 -2.78 58.86 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.559 179.981 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.49 -40.64 5.65 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 111.004 -0.838 . . . . 0.0 111.004 -179.835 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . 0.544 ' O ' ' N ' ' A' ' 233' ' ' SER . 84.9 mt -79.53 -16.9 55.16 Favored 'General case' 0 C--O 1.223 -0.337 0 CA-C-O 120.997 0.427 . . . . 0.0 110.368 -179.772 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . 0.405 ' C ' ' O ' ' A' ' 230' ' ' LEU . 54.7 t-20 -40.11 -49.12 2.58 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.678 -179.603 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -88.27 15.58 7.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.783 0.325 . . . . 0.0 111.217 179.963 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 233' ' ' SER . . . . . 0.544 ' N ' ' O ' ' A' ' 230' ' ' LEU . 78.1 p -60.62 -35.81 77.07 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.664 -179.858 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . 0.524 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.6 tt0 -118.21 -69.54 0.84 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.942 179.556 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.1 m -70.37 102.97 2.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.651 -179.765 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -94.31 58.04 2.4 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.442 179.949 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -145.04 -122.52 1.55 Allowed Glycine 0 CA--C 1.52 0.379 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 -179.992 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -134.34 111.77 10.46 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 121.053 0.454 . . . . 0.0 110.452 -179.981 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . 0.515 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.0 mtt180 -148.19 57.5 1.08 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.744 -179.97 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -69.75 -31.59 69.64 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.513 179.574 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 241' ' ' ASP . . . . . 0.517 ' CG ' HD22 ' A' ' 143' ' ' ASN . 65.1 t0 -56.9 -46.95 81.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.339 -179.186 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 242' ' ' ILE . . . . . 0.437 ' O ' ' O ' ' A' ' 239' ' ' ARG . 17.6 tt -140.54 157.41 24.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.865 0.364 . . . . 0.0 110.558 179.713 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 96.0 mt -106.34 106.33 20.4 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.173 0 CA-C-O 121.096 0.474 . . . . 0.0 110.448 179.89 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . 0.515 ' OE1' ' NH1' ' A' ' 239' ' ' ARG . 88.3 mt-30 -110.68 110.62 21.37 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.358 179.733 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 9.6 mp -122.02 -168.03 1.64 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.583 179.784 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . 0.524 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.14 -16.77 0.05 OUTLIER Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 179.895 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . 0.692 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -60.42 157.25 29.21 Favored Glycine 0 CA--C 1.522 0.516 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 -179.823 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -63.94 21.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.921 0.391 . . . . 0.0 110.571 179.942 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . 0.692 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.7 m-20 -96.8 -5.82 37.54 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.576 179.99 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 92.0 mt -80.24 -21.36 42.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.615 179.522 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.53 -51.41 69.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.773 -179.557 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.99 -5.29 58.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.459 179.662 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -80.87 -74.44 1.13 Allowed Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 -179.946 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 80.9 mt -69.87 125.69 27.5 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.058 0.456 . . . . 0.0 110.303 -179.859 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -59.33 -39.67 83.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.297 -179.641 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 83.5 51.76 3.98 Favored Glycine 0 CA--C 1.522 0.473 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 179.9 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -95.1 -16.11 22.88 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.712 0.292 . . . . 0.0 110.588 -179.848 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 258' ' ' SER . . . . . 0.436 ' HG ' ' CG2' ' A' ' 191' ' ' VAL . 3.4 t 174.92 89.51 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.08 0.466 . . . . 0.0 110.161 179.973 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . 0.597 ' N ' ' CD1' ' A' ' 259' ' ' LEU . 0.9 OUTLIER -94.46 124.18 38.33 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.258 0.551 . . . . 0.0 111.058 -178.999 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 16.0 m-30 -93.62 146.91 23.47 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.391 179.218 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 85.5 mt -122.39 149.75 43.38 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.583 -179.933 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.665 ' CG ' ' N ' ' A' ' 263' ' ' ALA . 2.6 p90 -77.99 -139.14 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.46 -179.759 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 263' ' ' ALA . . . . . 0.665 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -50.8 77.86 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.987 -179.947 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . 0.641 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.97 104.66 0.19 Allowed Glycine 0 CA--C 1.526 0.768 0 N-CA-C 110.721 -0.951 . . . . 0.0 110.721 -179.964 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 265' ' ' ASP . . . . . 0.601 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.7 m-20 -80.39 -177.56 6.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.722 0.296 . . . . 0.0 110.84 -179.424 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -40.49 -17.73 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.511 179.823 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 267' ' ' LYS . . . . . 0.601 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.42 -51.51 43.09 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.679 179.582 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -63.77 -46.59 84.58 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.23 179.357 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . 0.524 ' O ' ' CD2' ' A' ' 273' ' ' TYR . . . -61.48 -35.15 76.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.927 179.511 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -63.07 -34.57 77.87 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.155 179.717 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.25 -43.21 13.96 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.192 -179.51 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 272' ' ' ILE . . . . . 0.619 ' C ' ' H ' ' A' ' 274' ' ' ALA . 5.0 tt -51.49 -33.92 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.839 -178.783 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 273' ' ' TYR . . . . . 0.524 ' CD2' ' O ' ' A' ' 269' ' ' ALA . 17.0 m-85 -54.3 -1.91 0.03 OUTLIER 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.71 -179.598 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 274' ' ' ALA . . . . . 0.619 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.63 -39.45 70.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.885 179.574 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . 0.585 ' O ' ' N ' ' A' ' 279' ' ' ALA . 3.8 p30 -39.33 98.04 0.16 Allowed Pre-proline 0 C--O 1.226 -0.153 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.53 -179.636 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -54.19 -43.04 62.07 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 C-N-CA 122.383 2.055 . . . . 0.0 112.595 -178.753 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 89.1 mt -64.49 -42.9 95.58 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.086 -179.621 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 91.1 mt -95.87 -1.11 50.07 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.889 -179.434 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 279' ' ' ALA . . . . . 0.585 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.4 -34.92 77.68 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.666 -179.791 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.3 20.16 0.12 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.979 -179.207 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . 0.514 ' H ' ' C ' ' A' ' 279' ' ' ALA . 13.6 mt -74.91 119.83 78.73 Favored Pre-proline 0 N--CA 1.452 -0.347 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.504 179.9 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -50.57 -39.74 55.43 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.598 2.199 . . . . 0.0 111.949 178.989 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.9 -50.45 63.9 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.122 179.876 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 73.4 t -61.55 -43.91 97.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 179.477 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -57.8 -41.17 81.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.274 -179.906 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -90.73 -0.1 57.59 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.184 179.622 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt 59.92 43.3 15.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.029 0.442 . . . . 0.0 110.821 179.658 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -94.93 41.3 1.09 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.382 179.809 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 54.2 t -119.23 135.82 58.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.022 0.439 . . . . 0.0 110.231 -179.737 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -133.63 163.85 28.5 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.044 0.45 . . . . 0.0 110.658 -179.577 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.81 155.88 31.72 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.94 0.4 . . . . 0.0 110.78 -179.803 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 81.4 mt -94.7 -1.59 52.77 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.25 -179.735 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 120.86 165.21 12.65 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.651 -0.98 . . . . 0.0 110.651 -179.763 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 7.0 m -86.59 -61.73 1.67 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.806 0.336 . . . . 0.0 111.092 -179.828 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 295' ' ' GLU . . . . . 0.492 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.6 mm-40 -69.04 -4.84 18.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.682 -179.686 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 26.3 p -76.48 32.22 0.13 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.641 -179.871 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 297' ' ' PHE . . . . . 0.492 ' H ' ' C ' ' A' ' 295' ' ' GLU . 59.4 t80 -60.59 -46.43 90.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.713 179.944 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . 0.614 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.2 mtt85 -80.23 137.37 36.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.582 -179.65 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 5.7 tp -114.38 115.8 27.91 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.453 179.868 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . 0.604 ' H ' ' CB ' ' A' ' 303' ' ' SER . 48.7 p-10 -165.72 -176.69 3.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.533 -179.977 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 301' ' ' TYR . . . . . 0.52 ' OH ' ' CD1' ' A' ' 173' ' ' PHE . 79.0 t80 -46.59 -42.76 16.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.293 -179.791 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -67.4 -40.58 85.64 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.026 0.441 . . . . 0.0 110.756 179.196 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 303' ' ' SER . . . . . 0.604 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 60.2 p -55.62 -36.38 66.92 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.074 -179.276 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -57.68 -51.61 68.83 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 179.342 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 91.2 mtp -56.06 -44.14 78.59 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 179.838 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -66.11 -43.13 88.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.917 0.389 . . . . 0.0 110.166 178.837 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 55.9 t -63.97 -42.88 97.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.288 179.358 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 44.6 tp -59.89 -42.05 92.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.934 -179.64 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -62.33 -39.31 92.66 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.155 179.59 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 310' ' ' ARG . . . . . 0.468 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.7 ttt85 -63.6 -43.95 95.42 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.29 179.412 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 89.5 mt -63.18 -42.2 99.34 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.31 179.603 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -63.21 -33.57 75.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.079 179.456 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.85 -23.44 21.66 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.488 -179.875 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . 0.468 ' N ' ' O ' ' A' ' 310' ' ' ARG . 6.8 tt -62.3 -43.16 99.47 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.58 -179.95 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 . . . . . 0 C--O 1.22 -0.478 0 CA-C-O 118.043 -0.979 . . . . 0.0 110.482 179.981 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -99.63 135.18 41.43 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.063 0.459 . . . . 0.0 110.452 -179.885 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.497 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -92.15 178.55 1.66 Allowed Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.509 -179.829 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.497 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 27.3 Cg_exo -61.46 147.11 96.3 Favored 'Trans proline' 0 C--N 1.3 -2.008 0 C-N-CA 122.709 2.273 . . . . 0.0 112.173 179.617 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 35.0 ptt180 -135.98 142.35 44.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.714 179.779 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -79.9 116.86 20.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.401 179.922 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.403 ' O ' ' CG2' ' A' ' 30' ' ' ILE . 9.4 tp -111.64 130.12 65.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.408 179.996 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.1 t -70.85 141.95 51.25 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.621 179.763 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.517 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.0 t0 -138.85 -179.97 6.14 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.512 -179.936 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.517 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 78.1 p -73.84 -37.38 64.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.761 179.834 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.8 ttt85 -46.89 -94.72 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.366 -179.338 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.48 ' C ' ' HG1' ' A' ' 36' ' ' THR . . . -166.04 -26.99 0.02 OUTLIER Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.886 -0.885 . . . . 0.0 110.886 179.996 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.48 ' HG1' ' C ' ' A' ' 35' ' ' GLY . 75.2 m -168.29 105.87 0.47 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.924 0.392 . . . . 0.0 110.678 -179.894 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 68.8 t60 -129.07 146.51 51.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.071 0.463 . . . . 0.0 110.317 179.997 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.483 ' CG2' ' N ' ' A' ' 39' ' ' LEU . 99.8 m -129.99 165.59 21.84 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.57 -179.797 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.483 ' N ' ' CG2' ' A' ' 38' ' ' THR . 81.0 mt -120.38 127.25 52.13 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.483 179.727 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -65.44 -44.6 86.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.689 -179.954 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.415 ' O ' ' HD3' ' A' ' 43' ' ' PRO . 40.7 p -165.73 154.97 12.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.404 179.599 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.469 ' N ' ' CD ' ' A' ' 42' ' ' GLN . 14.5 mp0 -45.31 101.58 0.26 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.608 179.427 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.415 ' HD3' ' O ' ' A' ' 41' ' ' SER . 31.4 Cg_exo -57.7 130.32 38.05 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 C-N-CA 122.334 2.023 . . . . 0.0 112.196 -179.772 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -83.01 -24.62 32.77 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.531 179.593 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.535 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.7 mtm-85 -121.22 134.67 55.2 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-O 121.156 0.503 . . . . 0.0 110.246 -179.926 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.0 mt -130.49 133.35 63.82 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.297 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.99 -179.797 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 46.5 t -124.76 131.05 73.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 179.471 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.504 ' O ' ' O ' ' A' ' 66' ' ' ALA . 4.6 m -154.49 166.2 34.04 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.048 0.452 . . . . 0.0 110.505 179.679 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 60.9 p -124.51 8.73 8.36 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.519 179.936 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.8 125.96 33.65 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.617 -179.508 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 84.7 t -65.68 -44.54 93.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.51 -179.99 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.0 m -62.71 -44.26 96.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.66 -179.818 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 52.1 tp -62.27 -41.65 98.66 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.6 -179.415 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 71.9 m -57.92 -44.51 86.92 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.286 -179.326 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.41 -61.97 5.52 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 179.578 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.7 t -48.56 -35.6 13.73 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 -179.812 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 20.0 mt -61.68 -44.58 96.68 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.708 -0.397 . . . . 0.0 111.199 179.19 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.412 ' N ' HD12 ' A' ' 58' ' ' LEU . 9.5 mp -64.58 -42.09 95.86 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.334 177.911 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.63 -41.23 98.28 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.044 -179.222 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 7.9 tp -87.81 16.58 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.726 -179.618 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 56.52 83.61 0.1 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.726 -179.838 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.75 56.72 0.07 OUTLIER Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.01 -179.865 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -49.43 153.46 4.96 Favored 'Trans proline' 0 C--N 1.296 -2.228 0 C-N-CA 122.818 2.345 . . . . 0.0 112.565 -178.52 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.432 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.4 OUTLIER -109.13 146.32 14.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.4 -179.764 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 97.0 mt -63.99 -44.78 97.94 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.335 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.436 -179.986 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.504 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -130.16 134.72 47.51 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 120.851 0.358 . . . . 0.0 110.591 -179.762 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.493 ' O ' ' N ' ' A' ' 98' ' ' LEU . 72.6 m -134.79 158.86 43.1 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.912 -179.719 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.9 139.49 16.33 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 179.877 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.461 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.87 -162.46 0.08 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.98 0.419 . . . . 0.0 110.498 -179.996 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.488 ' O ' ' C ' ' A' ' 71' ' ' THR . 5.9 t -133.86 135.99 44.07 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.179 -179.997 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.488 ' C ' ' O ' ' A' ' 70' ' ' THR . 1.0 OUTLIER 29.65 68.12 0.68 Allowed Pre-proline 0 N--CA 1.466 0.335 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.719 -179.665 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -60.69 144.92 99.61 Favored 'Trans proline' 0 C--N 1.299 -2.045 0 C-N-CA 122.573 2.182 . . . . 0.0 112.242 -178.506 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.525 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 45.2 p-10 -160.37 -32.12 0.06 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.646 179.735 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.525 ' N ' ' OD1' ' A' ' 73' ' ' ASN . 99.1 m-20 -64.07 -39.37 93.92 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.451 -179.987 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -60.7 -47.75 84.88 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.718 -179.165 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.424 ' O ' ' O ' ' A' ' 77' ' ' ALA . 96.1 t -60.3 -24.5 31.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 179.687 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.424 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -45.71 172.81 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.594 179.835 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.568 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.6 p30 -62.01 177.77 0.42 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.605 -179.654 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.596 ' C ' ' H ' ' A' ' 81' ' ' GLY . 35.8 p30 -46.36 85.98 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.012 0.434 . . . . 0.0 110.921 179.956 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.568 ' N ' ' O ' ' A' ' 78' ' ' ASP . 43.0 tp60 -67.49 13.73 0.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.022 -179.78 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.596 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 117.91 -22.24 9.95 Favored Glycine 0 CA--C 1.518 0.269 0 N-CA-C 110.991 -0.844 . . . . 0.0 110.991 179.987 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -107.95 116.7 32.42 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.007 0.432 . . . . 0.0 110.488 179.858 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 76.5 mt -98.88 0.9 45.11 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.482 -179.783 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -91.93 6.57 45.73 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.996 0.427 . . . . 0.0 110.475 -179.749 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.443 ' O ' ' CG2' ' A' ' 89' ' ' VAL . 88.2 mt-30 -100.02 -26.52 13.95 Favored 'General case' 0 C--O 1.224 -0.259 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.843 179.883 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.0 t-105 -64.6 -40.86 96.26 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.121 -179.769 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.551 ' O ' ' N ' ' A' ' 91' ' ' LYS . 70.3 m -77.59 -53.55 7.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.355 -179.67 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -48.22 -50.75 28.22 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.076 -179.24 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.443 ' CG2' ' O ' ' A' ' 85' ' ' GLN . 14.3 m -69.08 -41.03 81.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 120.932 0.396 . . . . 0.0 111.174 179.645 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.41 ' H ' HG23 ' A' ' 89' ' ' VAL . . . -71.72 -22.95 61.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.814 -179.971 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.551 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.0 tttm -61.51 -45.97 91.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.476 -179.493 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.437 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.8 mm-40 -90.43 -94.33 0.12 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.111 -179.867 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.632 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.9 mtt180 -143.37 59.66 1.4 Allowed 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 179.767 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.459 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.6 pttp 33.74 26.08 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 120.833 0.349 . . . . 0.0 110.171 -179.354 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.632 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.3 tt -47.96 123.39 6.11 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.977 -178.076 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -83.45 -170.54 3.1 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.055 -179.841 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.616 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 82.6 mtp180 -72.93 137.74 45.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.182 -179.807 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.493 ' N ' ' O ' ' A' ' 67' ' ' SER . 88.4 mt -86.32 -166.28 1.5 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.702 -179.626 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.531 ' CD2' ' O ' ' A' ' 99' ' ' TYR . 47.1 p90 -167.75 119.8 0.88 Allowed 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.223 179.938 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.508 ' C ' ' O ' ' A' ' 99' ' ' TYR . 43.0 mm -29.6 121.19 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.997 -179.645 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 113.66 28.17 3.3 Favored Glycine 0 CA--C 1.519 0.304 0 N-CA-C 111.179 -0.768 . . . . 0.0 111.179 -179.404 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.584 ' N ' ' CD ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -143.88 45.81 0.6 Allowed Pre-proline 0 C--N 1.324 -0.53 0 CA-C-O 120.947 0.403 . . . . 0.0 110.475 179.827 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.584 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 30.8 Cg_endo -62.06 143.7 95.23 Favored 'Trans proline' 0 C--N 1.296 -2.187 0 C-N-CA 122.639 2.226 . . . . 0.0 112.057 179.926 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.678 ' HG ' ' H ' ' A' ' 107' ' ' ALA . 22.6 t -173.27 120.77 0.35 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.41 179.649 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.28 -41.09 64.03 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.105 0.479 . . . . 0.0 111.262 179.525 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -65.92 -40.27 91.29 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.908 -179.401 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.678 ' H ' ' HG ' ' A' ' 104' ' ' SER . . . -63.89 -39.89 95.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.7 -179.915 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 69.0 t -67.43 -43.91 87.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.774 179.558 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.18 -39.18 91.83 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.554 -179.236 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.437 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.64 -23.62 63.18 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.425 179.835 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.552 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.5 mm-40 -90.83 4.68 51.09 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.703 -179.547 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.552 ' C ' ' O ' ' A' ' 111' ' ' GLN . 10.3 tpt 23.43 63.85 0.38 Allowed Pre-proline 0 N--CA 1.467 0.378 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.982 179.906 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -78.48 168.58 21.18 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 C-N-CA 122.94 2.427 . . . . 0.0 112.28 -178.54 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.523 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 98.9 m-20 -112.7 -44.24 3.35 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.999 0.428 . . . . 0.0 109.97 179.495 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.0 tp -120.58 120.05 34.69 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.665 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 96.4 mt -117.09 131.26 70.33 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 CA-C-O 120.877 0.37 . . . . 0.0 111.017 -179.942 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 30.0 mt -106.27 132.6 52.13 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.133 0.492 . . . . 0.0 110.234 -179.369 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 98.1 mt -117.99 136.58 54.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.718 -179.705 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 86.0 p -72.17 152.93 41.94 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.644 179.979 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.36 -49.98 75.41 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.631 -179.858 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -148.99 153.43 37.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.495 179.811 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 169.53 -170.38 42.63 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 179.837 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.95 -35.31 91.89 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 179.915 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.451 ' O ' ' OD1' ' A' ' 124' ' ' ASP . 44.5 p-10 -87.71 120.0 28.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.822 0.344 . . . . 0.0 110.681 179.922 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 39.8 t -63.62 144.22 57.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.437 -179.947 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.518 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.31 -43.34 8.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.931 180.0 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.6 tp -62.71 -42.35 99.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.684 -179.899 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.72 -11.38 58.22 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.478 -179.361 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 84.9 mt -115.64 -23.6 8.65 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.653 -179.781 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . 0.518 ' N ' ' O ' ' A' ' 126' ' ' ALA . 78.0 t80 -51.91 -49.71 62.54 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 120.534 -0.466 . . . . 0.0 110.548 -178.958 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.6 p-10 -65.91 -42.35 90.27 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.867 0.365 . . . . 0.0 111.268 179.512 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.504 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 87.9 mt-30 -67.0 -37.14 83.66 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.811 179.836 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 93.5 mt -79.98 -41.96 24.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.004 -179.612 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.0 t -57.48 -44.59 85.03 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.172 -178.959 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.8 m -62.25 -45.59 92.63 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.797 0.332 . . . . 0.0 110.54 179.382 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 92.3 mt -62.45 -43.79 98.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.277 -179.829 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -170.14 163.98 6.14 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.525 179.833 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -43.81 111.89 0.28 Allowed 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.414 2.076 . . . . 0.0 112.1 179.523 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 17.8 m -85.97 127.54 34.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.49 179.973 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 34.2 tp -118.94 135.9 54.35 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.896 -179.576 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.435 ' O ' ' OD1' ' A' ' 32' ' ' ASP . 80.2 mt -102.63 119.89 51.63 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.417 0 CA-C-O 121.176 0.512 . . . . 0.0 111.466 -179.524 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 98.0 mt -135.8 132.66 51.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.615 179.791 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.517 HD22 ' CG ' ' A' ' 241' ' ' ASP . 54.5 t30 -65.62 151.7 45.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.966 0.412 . . . . 0.0 110.33 179.195 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.52 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 87.3 t80 -85.62 122.42 29.7 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.978 -179.553 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.52 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 98.9 m-20 55.13 69.33 0.74 Allowed 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.966 179.755 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 49.2 p-10 -123.44 -0.35 8.74 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 120.989 0.423 . . . . 0.0 110.711 179.866 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -151.32 117.24 5.51 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.818 -179.52 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 148' ' ' SER . . . . . 0.523 ' HG ' ' H ' ' A' ' 150' ' ' GLN . 84.8 p -63.26 167.9 4.8 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.519 -179.77 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.419 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.4 p-90 -50.78 -15.7 0.32 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.566 -179.823 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . 0.523 ' H ' ' HG ' ' A' ' 148' ' ' SER . 68.0 tp60 -71.24 -74.78 0.14 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.427 -179.726 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.449 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.1 t -62.66 -39.06 92.73 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.235 179.476 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 53.5 tp -60.25 -45.51 93.03 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.345 -178.476 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.419 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 45.7 tp -62.67 -41.92 99.35 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.83 0.348 . . . . 0.0 110.365 179.013 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.449 ' OG1' ' O ' ' A' ' 151' ' ' SER . 55.3 p -63.92 -34.65 78.45 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.282 -179.461 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . 0.451 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.5 mm-40 -63.93 -42.37 97.37 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.175 179.269 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 92.1 mt -65.32 -39.02 91.92 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.072 0.463 . . . . 0.0 110.122 179.163 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.582 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.05 -32.29 79.77 Favored Glycine 0 CA--C 1.519 0.337 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 -179.308 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.451 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.3 mt-10 -36.48 -25.21 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.88 0.371 . . . . 0.0 110.808 179.913 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.582 ' N ' ' O ' ' A' ' 157' ' ' GLY . 95.7 mt -59.45 148.93 6.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.215 179.319 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 75.3 p -68.94 137.51 53.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.07 -179.554 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 70.6 22.13 77.88 Favored Glycine 0 N--CA 1.459 0.187 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 179.48 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 60.0 m80 -124.24 -14.62 6.95 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.673 0.273 . . . . 0.0 110.542 179.88 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -66.58 -59.44 3.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.696 -179.657 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -52.17 -48.68 64.82 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.141 -179.509 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -60.97 -40.95 95.35 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.742 0.306 . . . . 0.0 110.317 179.454 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.59 -47.31 86.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.57 179.822 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.95 -40.05 75.71 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.197 -179.787 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -61.76 -50.26 73.1 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.511 179.597 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -65.38 -43.68 89.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.493 179.595 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 95.4 mt -64.49 -43.48 96.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.395 179.71 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.23 -51.03 70.98 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.568 -179.129 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.81 -43.54 95.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.431 179.744 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . 0.492 ' CD1' ' OH ' ' A' ' 301' ' ' TYR . 57.1 t80 -62.55 -44.75 95.56 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.117 0.484 . . . . 0.0 110.503 179.272 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -63.22 -39.82 95.71 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.616 -179.365 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -62.9 -42.74 99.88 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.644 179.175 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -60.97 -44.64 97.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.015 -179.944 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 85.1 mt -64.24 -41.25 97.07 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.033 0.445 . . . . 0.0 110.715 178.887 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.41 -62.1 1.85 Allowed 'General case' 0 C--O 1.237 0.432 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.51 -179.317 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.67 -46.71 86.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.545 179.882 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.45 -41.46 66.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.203 -179.979 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -63.77 -33.73 76.31 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.965 0.412 . . . . 0.0 110.347 179.244 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . 0.402 ' O ' ' HG2' ' A' ' 182' ' ' GLU . 69.8 tt0 -90.57 8.56 33.47 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.483 0.659 . . . . 0.0 110.527 -178.997 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -104.51 -32.22 9.08 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.267 179.58 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.6 pt -128.01 147.78 32.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.863 -179.902 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -140.05 131.16 26.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.352 179.409 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . 0.552 ' CD2' ' N ' ' A' ' 186' ' ' LEU . 3.6 mm? -85.68 133.29 42.1 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.905 179.936 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -44.1 157.89 0.14 Allowed 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.685 2.257 . . . . 0.0 112.123 179.468 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . 0.523 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.5 Cg_endo -62.87 115.05 2.69 Favored 'Trans proline' 0 C--N 1.303 -1.828 0 C-N-CA 122.812 2.341 . . . . 0.0 111.701 179.887 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . 0.523 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.7 mt-30 155.59 148.16 0.0 OUTLIER Pre-proline 0 N--CA 1.454 -0.257 0 O-C-N 123.626 0.579 . . . . 0.0 110.726 -179.957 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -73.95 144.13 33.9 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 C-N-CA 122.657 2.238 . . . . 0.0 111.779 178.083 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.493 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.1 p -125.06 158.76 32.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.276 0.56 . . . . 0.0 110.138 -179.95 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 192' ' ' THR . . . . . 0.493 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 35.6 p -143.29 165.46 27.41 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.199 -179.798 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -135.45 128.54 31.67 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.231 0.538 . . . . 0.0 110.206 179.597 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 47.1 pt -146.59 149.36 16.02 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.358 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.138 179.71 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 69.2 t -118.14 123.31 71.45 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-O 121.385 0.612 . . . . 0.0 109.538 179.276 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -134.39 107.08 7.4 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.181 179.759 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 95.2 m -130.89 130.77 43.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.95 179.685 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.413 ' O ' ' N ' ' A' ' 201' ' ' HIS . . . -83.04 -37.03 24.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.227 179.793 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.39 -67.06 0.26 Allowed 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.346 -179.967 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.24 -9.96 59.15 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.272 179.536 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . 0.413 ' N ' ' O ' ' A' ' 198' ' ' ALA . 60.1 t-80 60.8 58.08 2.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.585 -179.841 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 54.4 p -166.89 153.33 8.44 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.472 179.568 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.02 143.86 24.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.454 179.509 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -135.16 138.05 43.32 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.635 179.972 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 20.0 mt -106.23 125.51 51.08 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 121.114 0.483 . . . . 0.0 109.731 -179.67 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 206' ' ' TRP . . . . . 0.56 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 74.4 m95 -81.91 166.88 19.51 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.595 -179.799 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -157.01 172.01 6.7 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.561 -179.173 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.18 -36.94 87.28 Favored 'Trans proline' 0 C--N 1.302 -1.894 0 C-N-CA 122.623 2.215 . . . . 0.0 112.022 179.477 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -70.52 -35.11 72.99 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.888 -179.917 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 21.9 m -61.18 150.63 33.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.662 -179.368 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.62 -36.84 81.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.482 -179.714 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 212' ' ' GLN . . . . . 0.56 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 54.8 tt0 -64.57 -40.44 95.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.524 179.931 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.79 -43.33 91.95 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.679 -0.969 . . . . 0.0 110.679 179.829 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -63.44 -43.7 96.67 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 179.933 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 65.6 ttp -59.64 -47.83 84.05 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.161 -179.764 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 86.7 mt -60.83 -40.68 93.68 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 179.731 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 217' ' ' GLU . . . . . 0.453 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.2 tp10 -58.27 -38.03 76.14 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.784 -0.451 . . . . 0.0 109.784 179.926 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -65.13 -38.23 89.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.836 0.351 . . . . 0.0 110.664 179.605 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 93.6 mt -64.33 -42.65 96.19 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.497 -179.587 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.6 45.22 0.08 OUTLIER Glycine 0 C--N 1.333 0.393 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 179.975 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 221' ' ' PHE . . . . . 0.453 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 26.5 m-85 -128.38 155.83 44.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.025 0.44 . . . . 0.0 110.527 -179.802 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 222' ' ' THR . . . . . 0.453 ' O ' ' O ' ' A' ' 191' ' ' VAL . 8.2 p -107.56 122.61 47.02 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.262 0.553 . . . . 0.0 110.197 -179.913 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . 0.443 ' CD2' ' N ' ' A' ' 223' ' ' LEU . 4.3 mm? -101.52 132.92 46.89 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.082 179.884 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.65 159.84 14.71 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.508 179.883 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.46 115.27 29.97 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.955 0.407 . . . . 0.0 110.306 179.869 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.453 ' CD1' ' N ' ' A' ' 226' ' ' LEU . 9.0 mp -53.1 156.85 3.35 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.672 179.907 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -60.59 145.53 98.65 Favored 'Trans proline' 0 C--N 1.301 -1.96 0 C-N-CA 122.564 2.176 . . . . 0.0 112.076 179.396 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.21 -3.41 59.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.551 -179.966 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.06 -41.09 5.67 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 -179.909 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . 0.53 ' O ' ' N ' ' A' ' 233' ' ' SER . 68.3 mt -78.97 -17.57 55.21 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-O 121.097 0.475 . . . . 0.0 110.372 -179.838 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . 0.401 ' C ' ' O ' ' A' ' 230' ' ' LEU . 55.0 t-20 -40.43 -49.13 2.84 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.827 -179.352 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -87.68 15.28 7.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.779 0.323 . . . . 0.0 111.34 179.748 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 233' ' ' SER . . . . . 0.53 ' N ' ' O ' ' A' ' 230' ' ' LEU . 78.1 p -60.47 -35.32 75.59 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.591 -179.749 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . 0.525 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.7 tt0 -119.35 -69.44 0.85 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.966 179.457 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.2 m -69.25 103.08 1.85 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.686 -179.788 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -94.77 57.19 2.12 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.381 179.951 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -144.58 -122.72 1.61 Allowed Glycine 0 C--N 1.332 0.322 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 -179.989 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -135.03 111.9 10.14 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 121.202 0.525 . . . . 0.0 110.401 179.958 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . 0.525 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.6 mtt180 -148.15 57.74 1.08 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.796 -179.856 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -69.43 -32.16 70.96 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.518 179.681 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 241' ' ' ASP . . . . . 0.517 ' CG ' HD22 ' A' ' 143' ' ' ASN . 65.0 t0 -57.03 -47.04 81.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.372 -179.101 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 242' ' ' ILE . . . . . 0.437 ' O ' ' O ' ' A' ' 239' ' ' ARG . 17.9 tt -139.92 156.59 25.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.944 0.402 . . . . 0.0 110.477 179.771 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 96.1 mt -106.3 106.81 21.29 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.219 0 CA-C-O 121.208 0.527 . . . . 0.0 110.498 179.776 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . 0.525 ' OE1' ' NH1' ' A' ' 239' ' ' ARG . 88.2 mt-30 -110.67 110.15 20.7 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.264 179.717 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 9.4 mp -121.71 -168.14 1.65 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.667 179.725 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . 0.525 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.4 -15.82 0.05 OUTLIER Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.991 -0.844 . . . . 0.0 110.991 179.851 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . 0.698 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -61.47 156.5 34.83 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 110.926 -0.869 . . . . 0.0 110.926 -179.893 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -63.59 21.83 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.975 0.416 . . . . 0.0 110.59 179.948 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . 0.698 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.9 m-20 -97.48 -6.13 34.46 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.572 179.9 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 93.5 mt -79.43 -22.11 44.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.639 179.522 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.66 -51.21 70.89 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.806 -179.445 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.09 -5.82 58.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.375 179.639 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.12 -74.47 1.14 Allowed Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 -179.956 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 83.0 mt -70.15 125.81 27.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.019 0.438 . . . . 0.0 110.168 -179.759 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -59.57 -39.2 83.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.28 -179.691 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 83.27 51.71 4.04 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 110.716 -0.954 . . . . 0.0 110.716 179.755 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -95.62 -15.33 22.83 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.709 0.29 . . . . 0.0 110.641 -179.853 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 258' ' ' SER . . . . . 0.422 ' O ' ' O ' ' A' ' 192' ' ' THR . 3.4 t 174.58 89.07 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.058 0.456 . . . . 0.0 110.083 179.935 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . 0.596 ' N ' ' CD1' ' A' ' 259' ' ' LEU . 0.9 OUTLIER -94.39 124.2 38.27 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.291 0.567 . . . . 0.0 111.165 -179.211 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 15.9 m-30 -93.1 146.68 23.47 Favored 'General case' 0 CA--C 1.506 -0.747 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.324 179.281 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 86.1 mt -122.53 149.7 43.56 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.53 -179.883 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.662 ' CG ' ' N ' ' A' ' 263' ' ' ALA . 2.5 p90 -77.78 -138.56 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.472 -179.724 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 263' ' ' ALA . . . . . 0.662 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -51.72 77.4 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.985 -179.988 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . 0.635 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.17 104.42 0.19 Allowed Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 -179.852 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 265' ' ' ASP . . . . . 0.602 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.6 m-20 -80.41 -177.69 6.3 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.662 0.268 . . . . 0.0 110.932 -179.583 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -40.65 -17.6 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.454 179.939 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 267' ' ' LYS . . . . . 0.602 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.42 -51.59 42.25 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.992 0.425 . . . . 0.0 110.768 179.382 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -63.78 -46.61 84.46 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.126 179.397 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . 0.522 ' O ' ' CD2' ' A' ' 273' ' ' TYR . . . -61.72 -35.1 77.07 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 121.129 0.49 . . . . 0.0 109.71 179.693 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -62.87 -34.91 78.38 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.213 179.672 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.27 -43.02 14.11 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.402 -179.59 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 272' ' ' ILE . . . . . 0.622 ' C ' ' H ' ' A' ' 274' ' ' ALA . 5.0 tt -51.29 -33.82 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.828 -179.006 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 273' ' ' TYR . . . . . 0.522 ' CD2' ' O ' ' A' ' 269' ' ' ALA . 17.3 m-85 -54.15 -1.66 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.695 -179.625 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 274' ' ' ALA . . . . . 0.622 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.81 -39.88 69.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.882 179.626 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . 0.58 ' O ' ' N ' ' A' ' 279' ' ' ALA . 2.9 p30 -39.29 97.93 0.15 Allowed Pre-proline 0 N--CA 1.463 0.196 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.536 -179.76 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -53.87 -43.03 61.65 Favored 'Trans proline' 0 C--N 1.303 -1.828 0 C-N-CA 122.281 1.987 . . . . 0.0 112.78 -178.884 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 89.6 mt -64.28 -42.8 96.24 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 121.2 0.524 . . . . 0.0 111.346 -179.866 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 90.9 mt -95.68 -1.72 49.51 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.826 -179.499 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 279' ' ' ALA . . . . . 0.58 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.37 -34.97 77.73 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.619 -179.727 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -74.06 19.97 0.11 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.047 -179.342 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . 0.513 ' H ' ' C ' ' A' ' 279' ' ' ALA . 13.8 mt -75.19 120.54 82.15 Favored Pre-proline 0 N--CA 1.451 -0.395 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.345 -179.96 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -51.54 -39.15 65.56 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.586 2.191 . . . . 0.0 111.699 179.241 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -53.08 -50.28 64.71 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 179.914 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 74.9 t -61.56 -43.96 97.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.544 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -57.74 -41.22 81.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.281 -179.918 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -91.04 0.35 57.56 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.139 179.676 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt 59.32 43.14 17.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.943 179.731 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -94.64 41.54 1.09 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.298 179.901 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 53.7 t -119.15 135.64 58.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.001 0.429 . . . . 0.0 110.169 -179.7 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -132.73 162.85 30.37 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.072 0.463 . . . . 0.0 110.753 -179.728 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.69 155.26 32.75 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.991 0.424 . . . . 0.0 110.783 -179.938 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 82.2 mt -94.1 -1.4 54.38 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.242 -179.689 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 120.87 165.28 12.66 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.549 -1.02 . . . . 0.0 110.549 -179.886 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 7.0 m -86.89 -62.29 1.54 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.853 0.359 . . . . 0.0 111.118 -179.89 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 295' ' ' GLU . . . . . 0.48 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.5 mm-40 -69.15 -4.09 16.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.667 -179.768 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 25.3 p -76.71 32.07 0.13 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.673 -179.94 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 297' ' ' PHE . . . . . 0.48 ' H ' ' C ' ' A' ' 295' ' ' GLU . 69.0 t80 -60.42 -45.91 91.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.64 -179.99 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . 0.616 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.2 mtt85 -81.02 134.89 35.76 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 121.011 0.434 . . . . 0.0 110.597 -179.677 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 17.6 tp -114.15 117.53 31.45 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.081 179.944 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . 0.603 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.4 p-10 -165.14 -176.81 4.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.543 179.911 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 301' ' ' TYR . . . . . 0.492 ' OH ' ' CD1' ' A' ' 173' ' ' PHE . 84.1 t80 -46.91 -43.22 18.72 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.186 -179.655 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -67.12 -40.25 86.8 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.99 0.424 . . . . 0.0 110.853 179.053 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 303' ' ' SER . . . . . 0.603 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 59.9 p -56.12 -36.11 67.85 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.064 -179.121 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . 0.508 ' N ' ' HG ' ' A' ' 303' ' ' SER . . . -57.58 -51.34 69.89 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 179.463 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 90.3 mtp -56.73 -43.39 80.6 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 108.993 -0.744 . . . . 0.0 108.993 -179.866 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -66.53 -42.54 87.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.905 0.383 . . . . 0.0 110.108 178.884 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 56.0 t -63.94 -43.09 97.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.112 179.344 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 42.7 tp -59.63 -42.19 92.17 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.782 -179.451 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -62.64 -38.91 92.1 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 179.522 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 310' ' ' ARG . . . . . 0.442 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.6 ttt85 -63.62 -43.95 95.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.17 179.553 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 88.4 mt -63.3 -42.08 99.01 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.156 179.693 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -62.85 -33.45 75.27 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.978 179.558 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.96 -23.27 21.59 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.47 -179.809 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . 0.442 ' N ' ' O ' ' A' ' 310' ' ' ARG . 6.8 tt -62.42 -43.05 99.75 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.076 0.465 . . . . 0.0 110.624 -179.884 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 . . . . . 0 C--O 1.22 -0.485 0 CA-C-O 117.937 -1.03 . . . . 0.0 110.479 179.964 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -99.4 136.01 39.98 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.032 0.444 . . . . 0.0 110.547 -179.962 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.498 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -92.26 178.42 1.7 Allowed Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.5 -179.924 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.498 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 27.0 Cg_exo -61.54 147.45 95.4 Favored 'Trans proline' 0 C--N 1.301 -1.958 0 C-N-CA 122.726 2.284 . . . . 0.0 112.173 179.737 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 35.4 ptt180 -135.7 142.18 45.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.608 179.782 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -79.73 116.34 19.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.446 179.896 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.4 ' O ' ' CG2' ' A' ' 30' ' ' ILE . 9.5 tp -110.71 130.25 64.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.438 -179.96 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 12.7 t -70.77 141.43 51.44 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.518 179.925 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.513 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.2 t0 -139.01 179.38 6.53 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.55 -179.928 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.513 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 78.1 p -74.04 -36.88 64.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.684 179.784 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.8 ttt85 -46.53 -94.55 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.344 -179.504 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.433 ' O ' ' OG1' ' A' ' 36' ' ' THR . . . -166.92 -26.78 0.02 OUTLIER Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 179.928 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.433 ' OG1' ' O ' ' A' ' 35' ' ' GLY . 55.1 m -169.21 104.7 0.38 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.979 0.419 . . . . 0.0 110.665 -179.873 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 74.5 t60 -128.39 148.24 50.69 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.042 0.449 . . . . 0.0 110.338 179.795 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.484 ' CG2' ' N ' ' A' ' 39' ' ' LEU . 98.0 m -130.62 166.02 21.56 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.674 -179.889 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.484 ' N ' ' CG2' ' A' ' 38' ' ' THR . 82.4 mt -120.68 127.61 52.21 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.455 179.74 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -65.18 -44.55 88.12 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.653 -179.861 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.407 ' O ' ' HD3' ' A' ' 43' ' ' PRO . 38.8 p -165.63 154.86 12.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.42 179.582 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.463 ' N ' ' CD ' ' A' ' 42' ' ' GLN . 14.8 mp0 -44.33 101.13 0.24 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.676 179.528 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.407 ' HD3' ' O ' ' A' ' 41' ' ' SER . 31.6 Cg_exo -57.29 129.06 32.16 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.421 2.081 . . . . 0.0 112.183 -179.588 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -83.72 -24.76 31.07 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.478 179.619 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.538 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.8 mtm-85 -121.87 134.61 54.87 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-O 121.194 0.521 . . . . 0.0 110.303 -179.99 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 95.9 mt -130.9 133.68 62.73 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.261 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.017 -179.812 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 45.3 t -124.2 130.49 73.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 179.372 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.497 ' O ' ' O ' ' A' ' 66' ' ' ALA . 2.3 m -155.28 166.83 32.34 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.564 179.849 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 66.6 p -124.44 9.16 8.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.5 179.874 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.16 125.43 32.81 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.635 -179.436 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 94.0 t -65.88 -44.61 92.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.51 179.967 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.7 m -62.63 -44.31 96.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.615 -179.805 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 51.0 tp -62.26 -41.57 98.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.541 -179.487 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 74.2 m -57.59 -44.4 85.36 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.404 -179.36 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.2 -62.22 5.35 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 179.539 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.7 t -48.59 -35.47 13.6 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 -179.939 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.8 mt -61.72 -44.96 95.9 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.153 179.379 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.3 mp -64.85 -41.88 95.35 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.081 0.467 . . . . 0.0 111.368 177.918 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.28 -41.12 98.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.96 -179.139 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.2 tp -88.58 17.05 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.71 -179.647 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 56.57 84.85 0.08 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.645 -179.991 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.65 58.86 0.09 OUTLIER Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.072 -179.819 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -50.66 151.41 10.7 Favored 'Trans proline' 0 C--N 1.297 -2.17 0 C-N-CA 122.767 2.312 . . . . 0.0 112.562 -178.366 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.432 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -108.33 145.49 15.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.325 -179.736 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 97.0 mt -63.84 -44.95 98.28 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.439 -179.785 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.497 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -130.13 134.29 47.22 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.545 -179.791 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.491 ' O ' ' N ' ' A' ' 98' ' ' LEU . 75.3 m -134.59 158.67 43.4 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.878 -179.643 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.31 138.71 16.12 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 179.799 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.447 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.62 -162.97 0.09 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.997 0.427 . . . . 0.0 110.426 -179.924 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.494 ' O ' ' C ' ' A' ' 71' ' ' THR . 5.9 t -133.78 135.53 43.93 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.209 -179.985 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.494 ' C ' ' O ' ' A' ' 70' ' ' THR . 1.0 OUTLIER 29.5 68.12 0.67 Allowed Pre-proline 0 N--CA 1.464 0.245 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.685 -179.634 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -60.54 145.14 99.31 Favored 'Trans proline' 0 C--N 1.3 -1.98 0 C-N-CA 122.57 2.18 . . . . 0.0 112.236 -178.618 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.529 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 44.9 p-10 -160.23 -32.18 0.06 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.574 179.757 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.529 ' N ' ' OD1' ' A' ' 73' ' ' ASN . 99.1 m-20 -63.96 -39.4 94.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.385 179.999 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -60.47 -48.21 82.78 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.684 -179.351 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.421 ' O ' ' O ' ' A' ' 77' ' ' ALA . 96.6 t -60.09 -24.4 30.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.133 179.584 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.421 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -45.98 173.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.518 179.922 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.575 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.5 p30 -62.28 177.98 0.44 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.649 -179.766 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.59 ' C ' ' H ' ' A' ' 81' ' ' GLY . 35.4 p30 -45.51 85.75 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.93 179.893 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.575 ' N ' ' O ' ' A' ' 78' ' ' ASP . 42.8 tp60 -68.03 13.48 0.08 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.058 0.456 . . . . 0.0 110.111 -179.835 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.59 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 118.41 -22.29 9.57 Favored Glycine 0 CA--C 1.52 0.352 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 179.996 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -108.02 116.5 32.06 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.954 0.407 . . . . 0.0 110.474 179.785 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 76.6 mt -98.86 0.45 44.24 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.442 -179.724 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -92.52 7.23 44.07 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.996 0.427 . . . . 0.0 110.392 -179.689 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.442 ' O ' ' CG2' ' A' ' 89' ' ' VAL . 88.3 mt-30 -100.1 -27.65 13.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.822 -179.966 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 69.5 t-105 -63.25 -40.91 98.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.916 -179.615 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.56 ' O ' ' N ' ' A' ' 91' ' ' LYS . 66.5 m -77.58 -53.41 7.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.263 -179.405 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -48.46 -50.82 29.81 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.906 -179.302 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.442 ' CG2' ' O ' ' A' ' 85' ' ' GLN . 15.6 m -68.95 -40.84 81.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 120.959 0.409 . . . . 0.0 110.993 179.829 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.413 ' H ' HG23 ' A' ' 89' ' ' VAL . . . -72.18 -22.95 61.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.806 -179.864 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.56 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.0 tttm -61.77 -45.53 93.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.537 -179.558 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.444 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.6 mm-40 -90.47 -94.99 0.12 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.162 -179.957 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.642 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.9 mtt180 -142.78 59.28 1.43 Allowed 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 179.71 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.463 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.7 pttp 33.53 25.79 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 120.86 0.362 . . . . 0.0 110.235 -179.142 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.642 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.3 tt -47.68 123.5 5.98 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.907 -178.166 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -83.81 -169.91 2.81 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.098 179.952 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.612 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 82.4 mtp180 -74.04 137.04 43.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.251 -179.754 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.491 ' N ' ' O ' ' A' ' 67' ' ' SER . 90.0 mt -86.27 -165.7 1.33 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.658 -179.539 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.535 ' CD2' ' O ' ' A' ' 99' ' ' TYR . 47.9 p90 -168.89 120.05 0.75 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.182 179.981 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.519 ' C ' ' O ' ' A' ' 99' ' ' TYR . 43.6 mm -29.14 121.24 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.994 -179.585 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 114.45 27.17 3.43 Favored Glycine 0 CA--C 1.521 0.441 0 N-CA-C 111.126 -0.789 . . . . 0.0 111.126 -179.578 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.58 ' N ' ' CD ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -144.35 46.26 0.61 Allowed Pre-proline 0 C--N 1.325 -0.498 0 CA-C-O 120.866 0.365 . . . . 0.0 110.412 179.986 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 29.9 Cg_endo -61.94 143.76 95.77 Favored 'Trans proline' 0 C--N 1.297 -2.168 0 C-N-CA 122.702 2.268 . . . . 0.0 112.021 179.993 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.696 ' HG ' ' H ' ' A' ' 107' ' ' ALA . 26.2 t -173.32 120.06 0.33 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.474 179.82 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.26 -40.49 64.57 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.045 0.45 . . . . 0.0 111.184 179.644 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.25 -40.05 89.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.923 -179.447 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.696 ' H ' ' HG ' ' A' ' 104' ' ' SER . . . -64.07 -40.06 95.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.736 -179.844 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 71.8 t -67.56 -43.95 86.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.863 179.664 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.83 -38.79 92.18 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.631 -179.323 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.444 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.44 -23.34 62.6 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.418 179.799 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.553 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.3 mm-40 -90.53 5.02 49.49 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.699 -179.454 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.553 ' C ' ' O ' ' A' ' 111' ' ' GLN . 10.2 tpt 24.16 63.59 0.41 Allowed Pre-proline 0 N--CA 1.465 0.278 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.874 -179.981 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -77.53 167.1 24.83 Favored 'Trans proline' 0 C--N 1.303 -1.82 0 C-N-CA 122.987 2.458 . . . . 0.0 112.415 -178.779 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.526 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 99.1 m-20 -110.39 -41.97 4.24 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 121.02 0.438 . . . . 0.0 110.131 179.442 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.7 tp -121.65 120.14 33.87 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.344 -0.389 . . . . 0.0 109.957 179.549 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 83.4 mt -112.99 129.14 69.18 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.341 0 CA-C-O 120.943 0.401 . . . . 0.0 110.891 -179.882 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 29.7 mt -109.13 132.39 54.16 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 121.108 0.48 . . . . 0.0 110.165 -179.682 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 98.8 mt -119.87 139.07 48.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.697 -179.789 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 85.0 p -72.65 153.75 41.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.579 179.951 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.08 -50.06 75.19 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.616 -179.823 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.0 t -149.64 154.19 38.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.573 179.795 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 170.56 -170.96 43.46 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.954 -0.858 . . . . 0.0 110.954 179.917 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -63.1 -34.14 89.16 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 179.932 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.452 ' O ' ' OD1' ' A' ' 124' ' ' ASP . 44.6 p-10 -86.93 120.23 27.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.805 0.336 . . . . 0.0 110.742 179.97 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 40.6 t -63.1 143.58 57.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.431 -179.894 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.524 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.15 -43.27 8.94 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.888 -179.913 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 56.0 tp -62.74 -42.54 99.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.751 -179.858 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.42 -11.97 59.11 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.551 -179.436 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 84.1 mt -115.26 -23.6 8.86 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.663 -179.85 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . 0.524 ' N ' ' O ' ' A' ' 126' ' ' ALA . 79.0 t80 -51.01 -49.76 59.84 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.52 -179.012 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.506 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.3 p-10 -65.99 -42.64 89.51 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.8 0.333 . . . . 0.0 111.11 179.604 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.506 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 88.2 mt-30 -67.02 -37.92 84.99 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.744 179.926 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 95.2 mt -80.22 -41.56 24.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.983 -179.535 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.3 t -57.16 -44.29 83.33 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.196 -179.219 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.3 m -61.86 -45.33 94.23 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.778 0.323 . . . . 0.0 110.476 179.472 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 92.7 mt -62.23 -43.41 97.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.161 -179.742 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.53 168.23 4.89 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.533 179.866 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -50.1 113.01 0.84 Allowed 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.29 1.993 . . . . 0.0 112.106 179.437 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 23.8 m -84.24 127.51 34.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.527 -179.927 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 34.6 tp -117.8 135.94 53.73 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.029 -179.702 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.443 ' O ' ' OD2' ' A' ' 32' ' ' ASP . 81.8 mt -100.17 118.82 47.4 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.36 0 CA-C-O 121.204 0.526 . . . . 0.0 111.231 -179.384 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 97.8 mt -134.73 132.27 54.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.656 179.629 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.516 HD22 ' CG ' ' A' ' 241' ' ' ASP . 61.0 t30 -66.9 151.19 48.04 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.9 0.381 . . . . 0.0 110.402 179.368 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.521 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 87.9 t80 -85.95 122.45 30.02 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.814 -179.577 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.521 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 98.8 m-20 55.16 69.3 0.75 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.87 179.725 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 35.2 p-10 -125.84 0.08 7.34 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.722 179.907 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -150.53 115.36 5.27 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.679 -179.463 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 148' ' ' SER . . . . . 0.515 ' HG ' ' H ' ' A' ' 150' ' ' GLN . 84.0 p -63.61 168.54 4.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.526 -179.744 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.423 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.4 p-90 -52.01 -15.72 0.61 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.555 -179.861 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . 0.515 ' H ' ' HG ' ' A' ' 148' ' ' SER . 67.9 tp60 -70.5 -76.32 0.1 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.446 -179.737 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.45 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.1 t -62.64 -38.46 90.36 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.379 179.488 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 53.6 tp -60.07 -45.57 92.46 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.419 -178.668 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.423 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 47.3 tp -62.82 -41.79 99.45 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.845 0.355 . . . . 0.0 110.3 179.101 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.45 ' OG1' ' O ' ' A' ' 151' ' ' SER . 63.3 p -64.07 -34.61 78.42 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.335 -179.615 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . 0.423 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.3 mm-40 -64.14 -42.85 96.63 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.264 179.247 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 92.4 mt -65.4 -39.0 91.65 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.989 0.423 . . . . 0.0 110.21 179.159 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.587 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.01 -32.13 79.12 Favored Glycine 0 CA--C 1.521 0.426 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 -179.358 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.442 ' C ' ' O ' ' A' ' 157' ' ' GLY . 97.3 mt-10 -35.45 -26.84 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.799 0.333 . . . . 0.0 110.731 179.968 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.587 ' N ' ' O ' ' A' ' 157' ' ' GLY . 95.8 mt -56.87 149.64 3.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.211 179.376 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 72.4 p -69.55 137.12 52.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.031 -179.587 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 71.77 20.26 78.57 Favored Glycine 0 N--CA 1.459 0.197 0 N-CA-C 111.239 -0.744 . . . . 0.0 111.239 179.487 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 57.6 m80 -121.97 -15.09 7.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.731 0.3 . . . . 0.0 110.622 179.928 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -65.74 -59.88 3.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.807 -179.741 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -52.03 -49.13 64.01 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.225 -179.717 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -60.71 -41.22 94.79 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.701 0.286 . . . . 0.0 110.308 179.411 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.39 -47.25 86.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.7 179.779 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.9 -40.24 75.93 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.261 -179.92 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -61.74 -50.15 73.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.561 179.57 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 60.1 ttt85 -65.31 -43.88 89.66 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.462 179.535 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 96.0 mt -64.44 -43.63 96.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.449 179.671 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.18 -50.97 71.19 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.608 -179.148 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -63.76 -43.83 95.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.378 179.803 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . 0.459 ' CD1' ' OH ' ' A' ' 301' ' ' TYR . 56.7 t80 -62.71 -44.53 95.99 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.071 0.462 . . . . 0.0 110.447 179.388 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -63.25 -40.13 96.57 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.435 -179.294 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -62.92 -42.75 99.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.648 179.292 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -60.6 -44.88 95.78 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.116 179.961 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 85.5 mt -64.37 -41.09 96.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.001 0.429 . . . . 0.0 110.692 178.867 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.02 -62.17 1.8 Allowed 'General case' 0 C--O 1.237 0.416 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.491 -179.349 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.94 -46.66 87.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.523 179.902 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.38 -41.69 66.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.15 179.999 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -63.79 -33.67 76.18 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.944 0.402 . . . . 0.0 110.354 179.272 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . 0.405 ' HG2' ' O ' ' A' ' 182' ' ' GLU . 69.6 tt0 -90.48 8.71 32.44 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.25 0.547 . . . . 0.0 110.565 -179.099 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -104.81 -32.26 8.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.232 179.676 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 45.4 pt -128.07 147.49 32.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.826 -179.879 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -139.73 131.02 26.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.335 179.436 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . 0.558 ' CD2' ' N ' ' A' ' 186' ' ' LEU . 3.5 mm? -85.5 133.66 41.71 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.776 179.994 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -44.16 157.74 0.15 Allowed 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.793 2.329 . . . . 0.0 112.053 179.47 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . 0.532 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.7 Cg_endo -62.92 114.88 2.62 Favored 'Trans proline' 0 C--N 1.303 -1.867 0 C-N-CA 122.727 2.284 . . . . 0.0 111.833 179.908 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . 0.532 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.7 mt-30 155.54 148.23 0.0 OUTLIER Pre-proline 0 N--CA 1.454 -0.238 0 O-C-N 123.438 0.461 . . . . 0.0 110.686 -179.761 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -74.13 144.18 33.3 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.736 2.291 . . . . 0.0 111.687 178.165 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.497 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.1 p -124.99 158.82 32.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.195 0.521 . . . . 0.0 110.146 -179.954 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 192' ' ' THR . . . . . 0.497 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 35.8 p -143.39 165.2 28.18 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.08 -179.526 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -135.45 128.48 31.55 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.145 0.498 . . . . 0.0 110.188 179.677 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 47.6 pt -146.52 149.09 16.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.068 179.88 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 69.0 t -117.86 123.03 71.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.236 0.541 . . . . 0.0 109.733 179.08 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -134.15 106.86 7.39 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.288 179.79 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 95.1 m -130.62 130.52 44.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.77 179.751 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -83.18 -36.58 24.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.215 179.804 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.61 -66.99 0.27 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.398 179.878 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.68 -9.36 58.53 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.313 179.487 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 60.5 t-80 60.5 58.56 2.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.856 -179.952 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 37.1 p -167.29 153.64 8.08 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.526 179.512 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.52 144.09 24.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.967 0.413 . . . . 0.0 110.431 179.376 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -135.12 138.2 43.53 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.925 0.393 . . . . 0.0 110.671 -179.994 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 19.4 mt -106.39 125.52 51.1 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 121.117 0.484 . . . . 0.0 109.794 -179.738 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 206' ' ' TRP . . . . . 0.562 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 74.8 m95 -81.85 166.94 19.52 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.641 -179.808 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -156.84 171.4 7.48 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.942 0.401 . . . . 0.0 110.569 -179.288 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -53.83 -37.2 84.8 Favored 'Trans proline' 0 C--N 1.303 -1.838 0 C-N-CA 122.603 2.202 . . . . 0.0 111.97 179.352 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -70.21 -35.19 73.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.923 -179.875 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 21.7 m -61.05 150.79 32.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.601 -179.305 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.59 -37.02 82.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.527 -179.755 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 212' ' ' GLN . . . . . 0.562 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 54.7 tt0 -64.59 -40.32 95.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.566 179.99 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.51 -43.29 92.67 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 179.833 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -63.56 -43.45 96.99 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.76 0.314 . . . . 0.0 110.335 179.897 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 65.4 ttp -59.65 -47.92 83.7 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.37 -179.928 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 88.2 mt -60.56 -40.71 92.64 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.497 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 217' ' ' GLU . . . . . 0.459 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.8 tp10 -58.23 -37.95 75.88 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.806 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -65.2 -38.19 89.71 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.849 0.356 . . . . 0.0 110.651 179.679 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 94.6 mt -64.3 -42.77 96.2 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.618 -179.674 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.71 44.87 0.08 OUTLIER Glycine 0 CA--C 1.52 0.387 0 N-CA-C 110.974 -0.85 . . . . 0.0 110.974 -179.996 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 221' ' ' PHE . . . . . 0.459 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 26.8 m-85 -128.04 155.71 43.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.087 0.47 . . . . 0.0 110.452 -179.843 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 222' ' ' THR . . . . . 0.456 ' O ' ' O ' ' A' ' 191' ' ' VAL . 7.1 p -107.44 122.46 46.67 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 121.138 0.494 . . . . 0.0 110.205 -179.933 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . 0.443 ' CD2' ' N ' ' A' ' 223' ' ' LEU . 4.3 mm? -101.39 132.94 46.7 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.048 -179.991 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.68 159.65 14.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.519 179.876 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.34 115.02 29.55 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.335 179.867 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.453 ' CD1' ' N ' ' A' ' 226' ' ' LEU . 8.9 mp -53.0 156.71 3.31 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.665 179.953 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -60.65 145.61 98.56 Favored 'Trans proline' 0 C--N 1.302 -1.917 0 C-N-CA 122.599 2.199 . . . . 0.0 111.989 179.455 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.34 -3.43 59.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.502 -179.987 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -89.97 -41.21 5.66 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 111.011 -0.836 . . . . 0.0 111.011 -179.855 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . 0.54 ' O ' ' N ' ' A' ' 233' ' ' SER . 70.0 mt -78.91 -17.57 55.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.951 0.405 . . . . 0.0 110.329 -179.845 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . 0.403 ' C ' ' O ' ' A' ' 230' ' ' LEU . 55.2 t-20 -39.97 -49.31 2.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.742 -179.505 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -88.05 15.41 7.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.797 0.332 . . . . 0.0 111.21 -179.996 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 233' ' ' SER . . . . . 0.54 ' N ' ' O ' ' A' ' 230' ' ' LEU . 78.1 p -60.45 -35.68 76.44 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.53 -179.862 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . 0.527 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.6 tt0 -118.66 -69.32 0.86 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.961 179.591 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.2 m -69.81 103.22 2.12 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.744 -179.785 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -94.66 57.53 2.2 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.392 179.953 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -144.72 -122.66 1.59 Allowed Glycine 0 CA--C 1.521 0.418 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 -179.972 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -134.73 111.5 10.0 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.075 0.464 . . . . 0.0 110.494 179.975 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . 0.521 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.6 mtt180 -148.03 57.49 1.09 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.682 -179.9 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -69.48 -32.21 70.97 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.522 179.654 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 241' ' ' ASP . . . . . 0.516 ' CG ' HD22 ' A' ' 143' ' ' ASN . 64.6 t0 -56.89 -47.04 81.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.369 -179.18 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 242' ' ' ILE . . . . . 0.441 ' O ' ' O ' ' A' ' 239' ' ' ARG . 18.0 tt -139.83 156.56 25.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.824 0.345 . . . . 0.0 110.584 179.807 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 96.1 mt -106.27 106.45 20.62 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.212 0 CA-C-O 121.09 0.472 . . . . 0.0 110.569 179.858 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . 0.521 ' OE1' ' NH1' ' A' ' 239' ' ' ARG . 88.2 mt-30 -110.36 110.06 20.71 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.279 179.804 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 9.3 mp -121.89 -168.43 1.7 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.65 179.923 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . 0.527 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.68 -16.37 0.05 OUTLIER Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 179.865 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . 0.702 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -60.91 156.48 32.61 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 -179.892 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -63.31 21.28 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.967 0.413 . . . . 0.0 110.569 179.952 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . 0.702 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.8 m-20 -96.99 -6.2 36.01 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.551 -179.996 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 93.8 mt -79.5 -22.22 44.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.636 179.545 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.51 -51.31 70.42 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.756 -179.49 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.1 -5.85 58.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.402 179.704 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -80.93 -74.63 1.13 Allowed Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 -179.902 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 83.6 mt -70.08 126.03 28.49 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.03 0.443 . . . . 0.0 110.246 -179.885 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -59.19 -39.39 82.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.238 -179.691 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 82.89 51.84 4.08 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 179.929 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -96.46 -14.22 22.54 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.734 0.302 . . . . 0.0 110.658 -179.822 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 258' ' ' SER . . . . . 0.428 ' O ' ' O ' ' A' ' 192' ' ' THR . 3.5 t 174.16 88.47 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.075 0.464 . . . . 0.0 110.168 179.934 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . 0.596 ' N ' ' CD1' ' A' ' 259' ' ' LEU . 1.0 OUTLIER -94.11 123.93 37.8 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.204 0.526 . . . . 0.0 111.073 -179.206 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 16.0 m-30 -92.76 146.42 23.66 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.356 179.175 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 87.0 mt -122.35 149.57 43.59 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.512 -179.917 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.663 ' CG ' ' N ' ' A' ' 263' ' ' ALA . 2.5 p90 -77.64 -138.43 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.484 -179.808 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 263' ' ' ALA . . . . . 0.663 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -51.97 77.51 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.965 -179.945 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . 0.636 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.07 104.36 0.18 Allowed Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.674 -0.971 . . . . 0.0 110.674 -179.937 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 265' ' ' ASP . . . . . 0.608 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.9 m-20 -80.48 -177.74 6.35 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.743 0.306 . . . . 0.0 110.878 -179.477 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -40.43 -17.66 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.503 179.769 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 267' ' ' LYS . . . . . 0.608 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.49 -51.6 41.5 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.965 0.412 . . . . 0.0 110.742 179.434 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -63.81 -46.63 84.25 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.196 179.373 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . 0.527 ' O ' ' CD2' ' A' ' 273' ' ' TYR . . . -61.58 -35.18 77.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.152 -0.477 . . . . 0.0 109.808 179.527 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -62.91 -34.64 77.87 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.164 179.624 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.32 -43.35 13.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.243 -179.535 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 272' ' ' ILE . . . . . 0.616 ' C ' ' H ' ' A' ' 274' ' ' ALA . 4.9 tt -51.53 -33.65 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.72 -178.712 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 273' ' ' TYR . . . . . 0.527 ' CD2' ' O ' ' A' ' 269' ' ' ALA . 17.4 m-85 -54.23 -1.85 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.702 -179.705 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 274' ' ' ALA . . . . . 0.616 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.81 -39.49 69.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.848 179.651 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . 0.585 ' O ' ' N ' ' A' ' 279' ' ' ALA . 3.2 p30 -39.45 98.0 0.15 Allowed Pre-proline 0 C--N 1.332 -0.163 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.592 -179.668 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -53.82 -43.17 60.38 Favored 'Trans proline' 0 C--N 1.303 -1.847 0 C-N-CA 122.361 2.04 . . . . 0.0 112.751 -178.881 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 89.0 mt -64.47 -42.87 95.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.178 -179.667 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 90.7 mt -95.68 -1.51 49.94 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.839 -179.413 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 279' ' ' ALA . . . . . 0.585 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.55 -34.84 77.75 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.562 -179.713 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.08 20.03 0.11 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.045 -179.238 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . 0.513 ' H ' ' C ' ' A' ' 279' ' ' ALA . 13.9 mt -75.54 120.83 83.44 Favored Pre-proline 0 N--CA 1.452 -0.329 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.389 179.977 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_exo -51.54 -38.97 65.68 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.597 2.198 . . . . 0.0 111.617 179.339 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.78 -50.39 63.64 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.165 179.79 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 75.5 t -61.53 -43.95 97.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 179.424 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -57.7 -41.51 81.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.295 -179.992 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -90.94 0.21 57.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.186 179.641 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt 59.09 43.03 18.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.029 0.442 . . . . 0.0 110.969 179.755 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -94.42 41.74 1.09 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.342 179.856 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 54.0 t -119.03 135.8 58.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.989 0.423 . . . . 0.0 110.299 -179.812 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -132.85 162.7 30.87 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.997 0.427 . . . . 0.0 110.669 -179.635 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.81 155.36 32.72 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.974 0.416 . . . . 0.0 110.72 -179.785 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 81.4 mt -94.05 -1.5 54.34 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.225 -179.745 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 120.89 165.72 12.8 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 -179.795 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 6.9 m -87.28 -62.39 1.51 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.847 0.356 . . . . 0.0 111.04 -179.847 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 295' ' ' GLU . . . . . 0.473 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.8 mm-40 -69.53 -3.94 16.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.625 -179.762 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 27.3 p -77.03 32.63 0.14 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.612 -179.906 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 297' ' ' PHE . . . . . 0.473 ' H ' ' C ' ' A' ' 295' ' ' GLU . 70.1 t80 -60.11 -45.97 91.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.549 -179.993 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . 0.612 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.2 mtt85 -81.32 134.13 35.53 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 121.017 0.437 . . . . 0.0 110.51 -179.761 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 16.0 tp -114.67 119.52 36.98 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.213 -179.951 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . 0.607 ' H ' ' CB ' ' A' ' 303' ' ' SER . 49.4 p-10 -167.36 -174.41 2.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.523 -179.936 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 301' ' ' TYR . . . . . 0.459 ' OH ' ' CD1' ' A' ' 173' ' ' PHE . 84.1 t80 -48.06 -45.49 32.42 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.183 -179.603 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -65.05 -41.45 95.14 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.062 0.458 . . . . 0.0 110.771 179.019 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 303' ' ' SER . . . . . 0.607 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 53.0 p -55.55 -35.94 66.26 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.147 -179.37 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -57.16 -51.6 68.66 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.478 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 90.8 mtp -56.39 -43.57 79.39 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.792 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -66.52 -42.57 87.1 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.84 0.352 . . . . 0.0 110.131 178.78 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 56.1 t -64.03 -42.92 97.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.229 179.394 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 42.5 tp -59.63 -42.0 91.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.827 -179.626 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -62.86 -39.0 93.06 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 179.58 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 310' ' ' ARG . . . . . 0.437 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.4 ttt85 -63.59 -44.06 95.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.322 179.514 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 87.8 mt -63.3 -42.07 99.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.215 179.58 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -62.89 -33.18 74.76 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.037 179.521 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.95 -23.46 21.55 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.559 -179.866 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . 0.437 ' N ' ' O ' ' A' ' 310' ' ' ARG . 6.8 tt -62.34 -43.18 99.43 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.626 179.977 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 . . . . . 0 C--O 1.22 -0.471 0 CA-C-O 117.979 -1.01 . . . . 0.0 110.506 179.992 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -99.6 136.5 39.43 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.041 0.448 . . . . 0.0 110.422 -179.906 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.497 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -92.05 178.44 1.72 Allowed Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.63 -179.916 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.497 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.7 Cg_exo -61.62 147.02 96.37 Favored 'Trans proline' 0 C--N 1.3 -2.018 0 C-N-CA 122.801 2.334 . . . . 0.0 112.124 179.784 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 35.3 ptt180 -136.06 142.25 44.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.71 179.771 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -79.56 116.62 19.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.475 179.905 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.5 tp -110.88 130.36 64.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.512 -179.993 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.3 t -70.83 141.5 51.31 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.528 179.818 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.515 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.4 t0 -139.03 179.46 6.48 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.563 -179.944 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.515 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 78.1 p -74.04 -36.93 64.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.733 179.834 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.7 ttt85 -46.44 -94.57 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.351 -179.573 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.496 ' C ' ' HG1' ' A' ' 36' ' ' THR . . . -166.97 -26.68 0.02 OUTLIER Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.899 -0.881 . . . . 0.0 110.899 179.945 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.496 ' HG1' ' C ' ' A' ' 35' ' ' GLY . 62.0 m -169.19 104.84 0.38 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.849 0.357 . . . . 0.0 110.694 -179.938 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 74.6 t60 -128.36 149.03 50.7 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.005 0.431 . . . . 0.0 110.3 179.941 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.484 ' CG2' ' N ' ' A' ' 39' ' ' LEU . 98.9 m -131.4 165.9 22.47 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.543 -179.857 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.484 ' N ' ' CG2' ' A' ' 38' ' ' THR . 81.7 mt -120.64 127.39 52.03 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.481 179.728 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -65.17 -44.51 88.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.706 179.975 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.406 ' O ' ' HD3' ' A' ' 43' ' ' PRO . 40.3 p -165.68 154.62 11.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.433 179.728 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.458 ' N ' ' CD ' ' A' ' 42' ' ' GLN . 14.4 mp0 -44.55 101.34 0.25 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.642 179.437 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.406 ' HD3' ' O ' ' A' ' 41' ' ' SER . 31.7 Cg_exo -57.25 129.36 33.76 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 C-N-CA 122.345 2.03 . . . . 0.0 112.264 -179.713 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -83.45 -24.92 31.61 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.533 179.536 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.537 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.5 mtm-85 -122.04 134.8 54.79 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-O 121.09 0.471 . . . . 0.0 110.364 -179.946 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.2 mt -130.61 133.57 63.32 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.288 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.959 -179.677 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 45.1 t -124.32 130.48 73.63 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-O 120.863 0.363 . . . . 0.0 110.115 179.238 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.496 ' O ' ' O ' ' A' ' 66' ' ' ALA . 2.4 m -154.85 166.59 33.03 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.527 179.842 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 71.4 p -124.47 8.61 8.38 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.489 179.85 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.22 125.85 33.2 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.611 -179.586 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 86.2 t -65.86 -44.54 92.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.568 -179.962 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.9 m -62.65 -44.36 96.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.62 -179.81 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 46.5 tp -62.26 -41.66 98.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.526 -179.439 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 76.2 m -57.58 -44.7 85.55 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.443 -179.426 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.0 -62.47 5.18 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 179.626 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.7 t -48.23 -35.62 12.29 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 -179.947 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.8 mt -61.74 -44.67 96.46 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.735 -0.386 . . . . 0.0 111.209 179.467 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.2 mp -65.1 -41.67 94.72 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.27 177.949 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.19 -41.42 99.18 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.966 -179.254 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.3 tp -88.15 17.41 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.783 -179.637 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 56.46 84.72 0.08 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.674 -179.951 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.8 59.21 0.09 OUTLIER Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.038 -179.79 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -51.09 151.28 12.31 Favored 'Trans proline' 0 C--N 1.296 -2.197 0 C-N-CA 122.779 2.319 . . . . 0.0 112.39 -178.228 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.435 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -108.59 145.21 15.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.332 -179.632 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.8 mt -63.77 -45.17 97.96 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.274 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.37 -179.766 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.496 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -129.76 134.38 47.56 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 120.877 0.37 . . . . 0.0 110.587 -179.811 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.492 ' O ' ' N ' ' A' ' 98' ' ' LEU . 73.2 m -134.76 158.76 43.33 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.804 -179.609 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.42 138.76 16.1 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 179.794 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.441 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.79 -162.79 0.08 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.916 0.388 . . . . 0.0 110.516 -179.908 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.495 ' O ' ' C ' ' A' ' 71' ' ' THR . 6.0 t -133.88 135.46 43.68 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.27 179.996 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.495 ' C ' ' O ' ' A' ' 70' ' ' THR . 1.0 OUTLIER 29.34 68.57 0.64 Allowed Pre-proline 0 N--CA 1.465 0.303 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.637 -179.624 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -61.21 145.67 98.34 Favored 'Trans proline' 0 C--N 1.301 -1.946 0 C-N-CA 122.654 2.236 . . . . 0.0 112.018 -178.344 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.533 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 45.0 p-10 -160.46 -31.26 0.06 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.695 179.75 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.533 ' N ' ' OD1' ' A' ' 73' ' ' ASN . 98.8 m-20 -64.69 -38.97 92.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.47 179.959 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.6 ttt180 -60.99 -48.08 83.48 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.621 -179.347 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.424 ' O ' ' O ' ' A' ' 77' ' ' ALA . 96.7 t -60.22 -24.84 31.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.023 179.631 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.424 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -45.68 172.96 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.497 179.731 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.584 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.4 p30 -62.47 177.83 0.47 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.604 -179.709 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.596 ' C ' ' H ' ' A' ' 81' ' ' GLY . 36.5 p30 -45.05 85.34 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.988 -180.0 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.584 ' N ' ' O ' ' A' ' 78' ' ' ASP . 42.0 tp60 -67.49 13.4 0.07 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.185 -179.892 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.596 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 118.4 -22.45 9.51 Favored Glycine 0 CA--C 1.519 0.319 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 179.951 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -108.03 116.22 31.56 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.986 0.422 . . . . 0.0 110.504 179.848 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 74.7 mt -98.09 0.17 45.61 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.511 -179.725 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -92.48 7.29 43.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.43 -179.815 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.447 ' O ' ' CG2' ' A' ' 89' ' ' VAL . 88.5 mt-30 -100.2 -26.58 13.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.78 179.981 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.4 t-105 -64.54 -40.76 96.18 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.018 -179.647 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.556 ' O ' ' N ' ' A' ' 91' ' ' LYS . 65.3 m -77.89 -53.84 7.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.131 -179.487 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -47.67 -50.97 23.29 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.982 -179.354 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.447 ' CG2' ' O ' ' A' ' 85' ' ' GLN . 14.9 m -69.1 -41.14 81.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.101 179.818 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.415 ' H ' HG23 ' A' ' 89' ' ' VAL . . . -71.7 -23.18 61.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.725 -179.876 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.556 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.0 tttm -61.73 -45.78 92.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.469 -179.53 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.443 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.7 mm-40 -90.13 -95.2 0.11 Allowed 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.175 -179.913 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.638 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.9 mtt180 -142.75 59.29 1.43 Allowed 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.755 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.461 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.7 pttp 33.37 26.1 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.169 -179.061 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.638 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.3 tt -48.04 123.41 6.2 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.916 -178.142 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -83.65 -169.64 2.66 Favored 'General case' 0 N--CA 1.455 -0.175 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.198 179.963 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.61 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 82.1 mtp180 -74.4 136.91 42.42 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.282 -179.82 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.492 ' N ' ' O ' ' A' ' 67' ' ' SER . 90.5 mt -85.91 -165.64 1.3 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.743 -179.63 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.537 ' CD2' ' O ' ' A' ' 99' ' ' TYR . 47.7 p90 -169.05 119.76 0.72 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.268 179.99 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.518 ' C ' ' O ' ' A' ' 99' ' ' TYR . 43.3 mm -28.76 120.91 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.017 -179.693 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 114.53 27.09 3.44 Favored Glycine 0 CA--C 1.521 0.415 0 N-CA-C 111.149 -0.78 . . . . 0.0 111.149 -179.544 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.578 ' N ' ' CD ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -144.27 46.33 0.62 Allowed Pre-proline 0 C--N 1.323 -0.57 0 CA-C-O 120.927 0.394 . . . . 0.0 110.499 179.901 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 29.3 Cg_endo -61.92 143.82 95.9 Favored 'Trans proline' 0 C--N 1.297 -2.171 0 C-N-CA 122.7 2.267 . . . . 0.0 111.975 -179.899 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.704 ' HG ' ' H ' ' A' ' 107' ' ' ALA . 26.2 t -173.3 120.13 0.33 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.445 179.78 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.75 -40.35 63.56 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.065 0.46 . . . . 0.0 111.041 179.744 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.25 -39.98 89.88 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.798 -179.371 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.704 ' H ' ' HG ' ' A' ' 104' ' ' SER . . . -64.06 -39.99 95.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.744 -179.824 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 70.3 t -67.65 -43.77 86.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.753 179.708 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.74 -38.99 92.68 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.561 -179.246 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.443 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.66 -23.4 63.04 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.479 179.863 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.551 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.3 mm-40 -90.18 5.15 48.21 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.713 -179.554 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.551 ' C ' ' O ' ' A' ' 111' ' ' GLN . 10.5 tpt 23.44 64.17 0.38 Allowed Pre-proline 0 N--CA 1.465 0.293 0 CA-C-O 120.859 0.361 . . . . 0.0 110.982 -179.769 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -78.22 167.27 23.45 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 C-N-CA 122.971 2.447 . . . . 0.0 112.082 -178.448 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.523 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 98.8 m-20 -110.04 -42.14 4.28 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.145 179.426 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 41.2 tp -121.19 120.65 35.84 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 179.506 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 83.5 mt -113.29 128.92 69.86 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.343 0 CA-C-O 120.978 0.418 . . . . 0.0 110.88 -179.897 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 30.2 mt -109.42 132.27 54.29 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 121.061 0.458 . . . . 0.0 110.218 -179.73 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 98.9 mt -119.8 138.96 48.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.693 -179.718 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 85.8 p -72.75 153.96 40.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.594 -179.949 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.11 -50.21 74.6 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.686 -179.855 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -149.52 153.97 38.02 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.567 179.869 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 170.66 -170.97 43.51 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 179.876 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.88 -34.13 88.97 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 179.912 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.449 ' O ' ' OD1' ' A' ' 124' ' ' ASP . 44.3 p-10 -87.03 120.67 28.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.821 0.343 . . . . 0.0 110.651 179.983 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 36.1 t -63.26 143.79 57.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.472 -179.935 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.52 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.12 -43.81 8.68 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.944 -179.898 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 56.0 tp -62.93 -42.44 99.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.748 -179.888 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.28 -11.92 58.77 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.522 -179.421 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 84.2 mt -115.37 -23.56 8.82 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.637 -179.811 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . 0.52 ' N ' ' O ' ' A' ' 126' ' ' ALA . 79.4 t80 -51.09 -49.46 60.66 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.542 -178.883 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.499 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 37.7 p-10 -66.33 -42.61 87.94 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.832 0.349 . . . . 0.0 111.138 179.618 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.499 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 88.2 mt-30 -66.92 -37.53 84.51 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.74 -179.995 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 96.3 mt -80.63 -41.28 24.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.868 -179.585 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.2 t -57.13 -44.54 83.42 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.269 -179.139 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.3 m -61.93 -45.32 94.22 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.802 0.334 . . . . 0.0 110.566 179.411 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 94.0 mt -62.02 -43.63 97.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.277 -179.836 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.45 168.25 4.94 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.499 179.895 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -49.95 112.82 0.79 Allowed 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.297 1.998 . . . . 0.0 112.224 179.339 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 24.0 m -84.36 127.52 34.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.644 -179.968 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 34.7 tp -118.03 136.68 53.39 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.09 -179.781 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.441 ' O ' ' OD2' ' A' ' 32' ' ' ASP . 81.6 mt -100.57 118.83 47.84 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 CA-C-O 121.182 0.515 . . . . 0.0 111.128 -179.319 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 97.8 mt -134.71 132.14 54.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.669 179.591 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.521 HD22 ' CG ' ' A' ' 241' ' ' ASP . 56.0 t30 -67.56 153.71 43.09 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.893 0.378 . . . . 0.0 110.469 179.38 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.525 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 89.2 t80 -87.51 122.15 30.86 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.861 -179.55 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.525 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 99.0 m-20 55.33 69.5 0.73 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.762 179.651 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 49.5 p-10 -123.84 -0.69 8.48 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.631 179.88 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -151.07 116.14 5.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.712 -179.534 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 148' ' ' SER . . . . . 0.516 ' HG ' ' H ' ' A' ' 150' ' ' GLN . 83.2 p -62.85 167.88 4.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.474 -179.788 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.417 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.3 p-90 -51.38 -15.81 0.46 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.517 -179.86 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . 0.516 ' H ' ' HG ' ' A' ' 148' ' ' SER . 68.0 tp60 -70.71 -75.32 0.12 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.493 -179.771 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.44 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.1 t -62.75 -38.88 92.32 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.366 179.491 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 55.7 tp -59.91 -45.8 91.39 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.422 -178.649 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.417 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 46.8 tp -62.71 -41.63 99.25 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.425 179.057 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.44 ' OG1' ' O ' ' A' ' 151' ' ' SER . 60.0 p -64.46 -35.01 79.53 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.31 -179.55 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . 0.432 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.5 mm-40 -64.28 -42.88 96.22 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.383 179.374 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 91.5 mt -65.39 -38.91 91.4 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.072 0.463 . . . . 0.0 110.272 179.166 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.582 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.31 -32.08 79.5 Favored Glycine 0 CA--C 1.52 0.347 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 -179.382 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.44 ' C ' ' O ' ' A' ' 157' ' ' GLY . 97.1 mt-10 -35.25 -27.31 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.816 0.341 . . . . 0.0 110.821 179.894 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.582 ' N ' ' O ' ' A' ' 157' ' ' GLY . 95.1 mt -55.57 150.07 2.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.319 179.263 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 73.9 p -70.13 137.34 50.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.057 -179.59 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 72.26 18.44 78.1 Favored Glycine 0 N--CA 1.458 0.163 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 179.507 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 57.3 m80 -119.8 -15.52 8.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.747 0.308 . . . . 0.0 110.606 179.866 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -63.92 -60.78 2.83 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.655 -179.631 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -51.91 -49.42 63.09 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.201 -179.666 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -60.27 -41.24 92.9 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.752 0.31 . . . . 0.0 110.348 179.539 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.49 -47.2 86.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.576 179.851 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.94 -40.17 75.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.259 -179.894 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -61.88 -50.2 73.16 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.578 179.595 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -65.39 -43.73 89.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.492 179.532 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 95.0 mt -64.73 -43.38 96.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.488 179.739 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.36 -51.12 70.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.533 -179.215 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.46 -43.95 95.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.464 179.732 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . 0.48 ' CD1' ' OH ' ' A' ' 301' ' ' TYR . 56.2 t80 -62.83 -44.45 96.1 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.085 0.469 . . . . 0.0 110.44 179.451 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -63.51 -39.98 95.85 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.566 -179.337 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -62.94 -42.77 99.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.64 179.259 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -60.73 -45.07 95.68 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.172 179.945 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 84.4 mt -64.61 -41.06 96.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.036 0.446 . . . . 0.0 110.693 178.918 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -51.93 -62.61 1.52 Allowed 'General case' 0 C--O 1.237 0.441 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.473 -179.343 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.89 -46.58 87.51 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.664 179.767 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.31 -41.77 65.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.281 179.939 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -63.85 -33.84 76.59 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.969 0.414 . . . . 0.0 110.371 179.256 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . 0.406 ' HG2' ' O ' ' A' ' 182' ' ' GLU . 69.5 tt0 -90.47 9.06 30.75 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.37 0.605 . . . . 0.0 110.516 -178.998 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -105.06 -31.99 8.92 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.202 179.555 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.4 pt -128.11 147.52 32.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.828 -179.873 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -140.06 131.14 26.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.423 179.358 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . 0.554 ' CD2' ' N ' ' A' ' 186' ' ' LEU . 3.6 mm? -85.63 133.08 42.61 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.844 -179.947 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -44.0 157.78 0.14 Allowed 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.714 2.276 . . . . 0.0 112.153 179.341 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . 0.524 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.6 Cg_endo -62.78 115.23 2.8 Favored 'Trans proline' 0 C--N 1.304 -1.81 0 C-N-CA 122.775 2.317 . . . . 0.0 111.808 179.772 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . 0.524 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.8 mt-30 155.61 147.52 0.0 OUTLIER Pre-proline 0 C--N 1.332 -0.169 0 O-C-N 123.618 0.574 . . . . 0.0 110.782 -179.791 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -73.76 143.43 33.56 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.659 2.239 . . . . 0.0 111.956 177.983 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.497 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.0 p -124.81 159.02 31.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.276 0.56 . . . . 0.0 110.189 179.959 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 192' ' ' THR . . . . . 0.497 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 35.7 p -143.48 165.47 27.47 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.094 -179.638 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -135.34 128.43 31.69 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 121.128 0.49 . . . . 0.0 110.24 179.576 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 47.8 pt -146.35 148.79 16.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.046 179.986 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 70.3 t -117.6 122.89 70.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.222 0.534 . . . . 0.0 109.734 179.122 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -134.06 107.37 7.72 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.261 179.77 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 94.6 m -131.11 130.45 43.15 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.797 179.784 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.418 ' O ' ' N ' ' A' ' 201' ' ' HIS . . . -82.74 -37.24 24.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.275 179.692 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.32 -67.02 0.26 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.366 -179.973 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.31 -9.76 58.91 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.316 179.425 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . 0.418 ' N ' ' O ' ' A' ' 198' ' ' ALA . 59.7 t-80 60.54 58.27 2.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.628 -179.902 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 45.7 p -166.92 153.26 8.34 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.527 179.611 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.36 144.16 24.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.976 0.417 . . . . 0.0 110.442 179.488 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -135.34 138.1 43.05 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.63 -179.941 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 20.2 mt -106.28 125.56 51.15 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 121.116 0.484 . . . . 0.0 109.934 -179.701 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 206' ' ' TRP . . . . . 0.558 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 75.4 m95 -82.25 167.18 18.9 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.649 -179.727 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -156.88 171.56 7.27 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 120.943 0.402 . . . . 0.0 110.563 -179.194 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_exo -53.94 -36.89 85.2 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 C-N-CA 122.659 2.24 . . . . 0.0 112.16 179.256 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -70.55 -34.93 72.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.761 -179.772 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 21.9 m -61.56 150.54 35.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.543 -179.27 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.42 -36.97 81.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.457 -179.732 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 212' ' ' GLN . . . . . 0.558 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 54.4 tt0 -64.5 -40.28 95.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.472 179.967 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.87 -43.27 91.91 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 179.812 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -63.55 -43.46 97.03 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.752 0.31 . . . . 0.0 110.29 179.807 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 65.3 ttp -59.49 -48.25 82.36 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.234 -179.809 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 88.4 mt -60.37 -40.8 92.12 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.536 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 217' ' ' GLU . . . . . 0.457 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.4 tp10 -57.99 -37.93 75.17 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 179.751 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -65.22 -37.94 88.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.847 0.356 . . . . 0.0 110.676 179.68 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 94.1 mt -64.47 -42.73 95.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.582 -179.645 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.59 44.59 0.08 OUTLIER Glycine 0 C--N 1.334 0.426 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 -179.921 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 221' ' ' PHE . . . . . 0.457 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 26.3 m-85 -127.73 155.22 44.34 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.033 0.445 . . . . 0.0 110.49 -179.82 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 222' ' ' THR . . . . . 0.457 ' O ' ' O ' ' A' ' 191' ' ' VAL . 6.6 p -106.94 122.06 45.68 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.189 0.519 . . . . 0.0 110.198 -179.961 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . 0.448 ' CD2' ' N ' ' A' ' 223' ' ' LEU . 4.3 mm? -100.81 133.46 45.24 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.101 -179.97 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -97.24 158.76 15.29 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.44 179.916 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -104.84 115.21 29.92 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.384 179.898 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.45 ' CD1' ' N ' ' A' ' 226' ' ' LEU . 9.1 mp -53.32 156.57 3.95 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.705 179.86 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -60.26 145.38 98.7 Favored 'Trans proline' 0 C--N 1.301 -1.943 0 C-N-CA 122.711 2.274 . . . . 0.0 112.119 179.218 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.46 -2.89 58.93 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.557 -179.992 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.32 -40.83 5.65 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 111.029 -0.828 . . . . 0.0 111.029 -179.887 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . 0.543 ' O ' ' N ' ' A' ' 233' ' ' SER . 86.0 mt -79.28 -16.89 55.7 Favored 'General case' 0 C--O 1.224 -0.257 0 CA-C-O 121.018 0.437 . . . . 0.0 110.356 -179.755 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . 0.405 ' C ' ' O ' ' A' ' 230' ' ' LEU . 54.6 t-20 -40.05 -49.23 2.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.691 -179.592 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -88.28 15.43 7.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.813 0.339 . . . . 0.0 111.277 179.935 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 233' ' ' SER . . . . . 0.543 ' N ' ' O ' ' A' ' 230' ' ' LEU . 78.1 p -60.48 -35.63 76.36 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.648 -179.77 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . 0.525 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.6 tt0 -118.25 -69.43 0.85 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.954 179.588 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 3.9 m -70.16 103.45 2.33 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.691 -179.744 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -94.59 57.74 2.26 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.345 180.0 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -144.99 -122.57 1.56 Allowed Glycine 0 CA--C 1.519 0.343 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 -179.977 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -134.41 111.85 10.48 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.094 0.473 . . . . 0.0 110.413 179.964 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . 0.513 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.4 mtt180 -148.11 57.39 1.08 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.762 -179.972 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -69.71 -31.89 70.15 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.511 179.664 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 241' ' ' ASP . . . . . 0.521 ' CG ' HD22 ' A' ' 143' ' ' ASN . 65.1 t0 -56.71 -46.99 80.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.404 -179.167 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 242' ' ' ILE . . . . . 0.436 ' O ' ' O ' ' A' ' 239' ' ' ARG . 17.4 tt -140.33 157.27 24.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.886 0.374 . . . . 0.0 110.524 179.748 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 96.0 mt -106.01 106.08 19.9 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.191 0 CA-C-O 121.125 0.488 . . . . 0.0 110.465 179.886 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . 0.513 ' OE1' ' NH1' ' A' ' 239' ' ' ARG . 88.2 mt-30 -110.36 110.17 20.86 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.392 179.755 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 9.5 mp -121.9 -168.19 1.66 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.641 179.774 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . 0.525 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.25 -16.66 0.05 OUTLIER Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.956 -0.857 . . . . 0.0 110.956 179.894 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . 0.695 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -60.46 157.03 29.73 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 -179.83 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -63.82 21.43 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.971 0.415 . . . . 0.0 110.58 179.945 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . 0.695 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.7 m-20 -97.18 -5.93 35.94 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.544 179.983 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 92.6 mt -80.2 -21.58 42.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.604 179.589 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.54 -51.24 70.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.728 -179.579 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.76 -5.33 58.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.481 179.659 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.16 -74.45 1.14 Allowed Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.911 -0.875 . . . . 0.0 110.911 -179.96 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 81.7 mt -69.89 125.93 28.2 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.977 0.418 . . . . 0.0 110.329 -179.859 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -59.22 -39.49 82.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.295 -179.711 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 82.64 51.93 4.11 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 179.95 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -96.22 -14.89 22.36 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.644 0.259 . . . . 0.0 110.541 -179.864 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 258' ' ' SER . . . . . 0.423 ' O ' ' O ' ' A' ' 192' ' ' THR . 3.5 t 174.78 88.55 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.029 0.442 . . . . 0.0 110.194 179.978 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . 0.595 ' N ' ' CD1' ' A' ' 259' ' ' LEU . 0.9 OUTLIER -94.18 124.08 37.97 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.241 0.544 . . . . 0.0 111.066 -179.058 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 15.9 m-30 -93.03 146.45 23.62 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.342 179.17 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 86.1 mt -122.41 149.82 43.29 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.529 -179.905 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.66 ' CG ' ' N ' ' A' ' 263' ' ' ALA . 2.6 p90 -77.63 -138.36 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.562 -179.838 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 263' ' ' ALA . . . . . 0.66 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -52.1 77.45 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.993 -179.989 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . 0.633 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -178.98 104.42 0.19 Allowed Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 -179.976 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 265' ' ' ASP . . . . . 0.602 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.8 m-20 -80.47 -177.74 6.35 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 120.725 0.298 . . . . 0.0 110.896 -179.527 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -40.39 -17.71 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.853 0.358 . . . . 0.0 110.552 179.786 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 267' ' ' LYS . . . . . 0.602 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.71 -51.42 41.75 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.688 179.516 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -63.74 -46.83 83.59 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.175 179.314 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . 0.524 ' O ' ' CD2' ' A' ' 273' ' ' TYR . . . -61.47 -35.05 76.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.111 0.481 . . . . 0.0 109.884 179.533 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -63.22 -34.42 77.62 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.119 179.712 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.36 -43.37 13.73 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.171 -179.572 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 272' ' ' ILE . . . . . 0.619 ' C ' ' H ' ' A' ' 274' ' ' ALA . 5.0 tt -51.37 -33.83 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.893 -178.824 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 273' ' ' TYR . . . . . 0.524 ' CD2' ' O ' ' A' ' 269' ' ' ALA . 17.2 m-85 -54.24 -1.82 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.647 -179.638 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 274' ' ' ALA . . . . . 0.619 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.58 -39.43 70.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.87 179.603 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . 0.583 ' O ' ' N ' ' A' ' 279' ' ' ALA . 3.0 p30 -39.65 98.33 0.17 Allowed Pre-proline 0 N--CA 1.462 0.143 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.506 -179.638 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -54.16 -43.11 61.39 Favored 'Trans proline' 0 C--N 1.304 -1.812 0 C-N-CA 122.389 2.06 . . . . 0.0 112.619 -178.793 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 89.3 mt -64.45 -42.86 95.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.109 -179.613 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 91.0 mt -95.7 -1.64 49.57 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.872 -179.373 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 279' ' ' ALA . . . . . 0.583 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.35 -34.75 77.27 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.678 -179.85 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.4 20.1 0.12 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.966 -179.212 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . 0.511 ' H ' ' C ' ' A' ' 279' ' ' ALA . 13.9 mt -75.19 120.04 79.8 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.505 179.916 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -50.69 -39.48 56.73 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.577 2.185 . . . . 0.0 111.951 179.035 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.8 -50.56 63.38 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.132 179.885 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 74.5 t -61.45 -43.79 97.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.482 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -57.98 -41.22 82.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.28 -179.972 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -90.9 0.14 57.58 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.145 179.575 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt 59.55 43.04 16.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.82 179.568 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -94.66 41.49 1.09 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.38 179.852 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 53.6 t -118.79 136.02 57.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.999 0.428 . . . . 0.0 110.193 -179.759 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -133.17 162.73 30.98 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.665 -179.639 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.9 155.22 33.13 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.968 0.413 . . . . 0.0 110.735 -179.86 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 81.0 mt -93.89 -1.49 54.69 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.235 -179.803 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.06 165.66 12.74 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.689 -0.965 . . . . 0.0 110.689 -179.735 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 6.8 m -87.15 -62.3 1.53 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.892 0.377 . . . . 0.0 111.009 -179.888 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 295' ' ' GLU . . . . . 0.47 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.6 mm-40 -69.57 -3.88 16.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.628 -179.833 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 28.1 p -77.09 32.91 0.14 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.618 -179.96 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 297' ' ' PHE . . . . . 0.47 ' H ' ' C ' ' A' ' 295' ' ' GLU . 70.2 t80 -60.19 -46.06 91.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.546 -179.971 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . 0.61 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.3 mtt85 -81.49 134.01 35.47 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.45 -179.652 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 16.1 tp -114.31 119.75 38.06 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.253 179.924 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . 0.609 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.4 p-10 -167.8 -173.9 2.27 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.524 179.95 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 301' ' ' TYR . . . . . 0.48 ' OH ' ' CD1' ' A' ' 173' ' ' PHE . 84.0 t80 -48.25 -46.0 35.11 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.227 -179.644 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -64.65 -41.61 96.0 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.998 0.428 . . . . 0.0 110.702 179.015 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 303' ' ' SER . . . . . 0.609 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 52.0 p -55.44 -36.11 66.17 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.099 -179.269 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -56.92 -51.76 67.87 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.482 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 91.5 mtp -56.06 -43.87 78.32 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.8 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -66.38 -42.74 87.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.953 0.406 . . . . 0.0 110.207 178.798 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 55.2 t -64.04 -42.89 97.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.261 179.39 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 42.8 tp -59.62 -42.04 91.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.893 -179.616 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -62.87 -38.76 92.12 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.064 179.475 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 310' ' ' ARG . . . . . 0.435 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.6 ttt85 -63.5 -44.03 95.52 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.238 179.569 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 88.5 mt -63.23 -41.93 99.17 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.226 179.548 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -62.9 -33.23 74.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.083 179.492 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.85 -23.51 21.65 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.423 -179.862 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . 0.435 ' N ' ' O ' ' A' ' 310' ' ' ARG . 6.7 tt -62.33 -43.22 99.33 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 121.06 0.457 . . . . 0.0 110.57 -179.92 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 . . . . . 0 C--O 1.22 -0.498 0 CA-C-O 118.003 -0.999 . . . . 0.0 110.482 179.966 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -99.51 135.79 40.4 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.464 -179.926 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.498 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -92.11 178.48 1.69 Allowed Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.532 -179.863 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.498 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.7 Cg_exo -61.54 147.16 96.1 Favored 'Trans proline' 0 C--N 1.301 -1.961 0 C-N-CA 122.696 2.264 . . . . 0.0 112.161 179.576 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 35.4 ptt180 -136.33 142.39 43.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.624 179.692 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -79.7 116.78 20.08 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.453 179.872 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.404 ' O ' ' CG2' ' A' ' 30' ' ' ILE . 9.4 tp -111.54 130.11 65.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.46 179.969 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.4 t -71.14 141.7 50.75 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.599 179.81 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.522 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.1 t0 -138.71 -179.73 5.99 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.524 179.997 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.522 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 78.3 p -73.72 -37.51 65.1 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.856 179.84 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -46.64 -94.74 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.313 -179.411 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.413 ' O ' ' OG1' ' A' ' 36' ' ' THR . . . -166.24 -26.76 0.02 OUTLIER Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 179.919 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.413 ' OG1' ' O ' ' A' ' 35' ' ' GLY . 63.7 m -168.42 105.72 0.46 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.857 0.361 . . . . 0.0 110.603 -179.968 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 68.2 t60 -128.87 146.43 50.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.038 0.447 . . . . 0.0 110.324 179.97 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.485 ' CG2' ' N ' ' A' ' 39' ' ' LEU . 100.0 m -129.82 165.6 21.63 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.608 -179.928 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.485 ' N ' ' CG2' ' A' ' 38' ' ' THR . 80.5 mt -120.3 127.37 52.3 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.466 179.683 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -65.56 -44.53 86.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.605 -179.978 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.419 ' O ' ' HD3' ' A' ' 43' ' ' PRO . 40.8 p -165.91 154.88 11.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.456 179.743 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.46 ' N ' ' CD ' ' A' ' 42' ' ' GLN . 14.5 mp0 -45.4 101.64 0.27 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.658 179.443 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.419 ' HD3' ' O ' ' A' ' 41' ' ' SER . 31.5 Cg_exo -57.66 129.83 35.65 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 C-N-CA 122.294 1.996 . . . . 0.0 112.263 -179.759 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -82.84 -24.92 33.06 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.472 179.593 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.537 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.7 mtm-85 -120.73 134.34 55.29 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 121.125 0.488 . . . . 0.0 110.264 -179.931 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.42 HD13 HG21 ' A' ' 46' ' ' ILE . 96.1 mt -130.23 133.29 64.33 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.091 -179.85 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 47.3 t -124.79 130.96 73.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 179.404 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.502 ' O ' ' O ' ' A' ' 66' ' ' ALA . 4.4 m -155.19 166.48 33.45 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.578 179.666 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 62.4 p -124.53 8.94 8.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.411 -179.981 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.1 t -85.38 125.53 33.05 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.655 -179.467 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 90.8 t -65.72 -44.64 93.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.542 179.961 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.7 m -62.62 -44.39 96.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.655 -179.862 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 53.5 tp -62.18 -41.66 98.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.659 -179.459 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 74.7 m -57.63 -44.54 85.65 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.384 -179.426 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.36 -61.98 5.52 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.941 -0.863 . . . . 0.0 110.941 179.561 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.7 t -48.48 -35.7 13.56 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 -179.979 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.9 mt -61.76 -44.56 96.65 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.644 -0.422 . . . . 0.0 111.136 179.344 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.407 HD12 ' N ' ' A' ' 58' ' ' LEU . 9.4 mp -64.72 -42.07 95.5 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.329 177.961 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.54 -41.16 98.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.086 -179.197 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.1 tp -88.04 16.76 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.735 -179.668 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 56.62 83.78 0.1 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.631 179.972 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.71 57.02 0.07 OUTLIER Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.049 -179.815 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -49.54 153.15 5.51 Favored 'Trans proline' 0 C--N 1.296 -2.21 0 C-N-CA 122.811 2.341 . . . . 0.0 112.638 -178.559 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.432 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -109.03 146.26 14.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.371 -179.734 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 97.0 mt -63.9 -44.86 98.13 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.298 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.488 -179.885 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.502 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -130.27 134.61 47.35 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.512 -179.774 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.485 ' O ' ' N ' ' A' ' 98' ' ' LEU . 72.2 m -134.52 158.6 43.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.859 -179.663 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.55 139.24 16.39 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 110.671 -0.972 . . . . 0.0 110.671 179.848 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.457 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.88 -162.67 0.08 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.95 0.405 . . . . 0.0 110.535 -179.992 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.491 ' O ' ' C ' ' A' ' 71' ' ' THR . 5.8 t -133.71 135.81 44.26 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.177 -179.973 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.491 ' C ' ' O ' ' A' ' 70' ' ' THR . 0.9 OUTLIER 29.6 68.33 0.67 Allowed Pre-proline 0 N--CA 1.465 0.291 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.713 -179.689 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -60.64 145.23 99.21 Favored 'Trans proline' 0 C--N 1.3 -2.009 0 C-N-CA 122.576 2.184 . . . . 0.0 112.167 -178.566 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.523 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 46.2 p-10 -160.65 -31.97 0.05 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.674 179.74 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.523 ' N ' ' OD1' ' A' ' 73' ' ' ASN . 98.8 m-20 -64.31 -38.96 92.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.367 179.973 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -61.15 -47.88 84.15 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.636 -179.236 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.423 ' O ' ' O ' ' A' ' 77' ' ' ALA . 94.4 t -60.21 -24.56 30.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.659 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.423 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -45.64 172.6 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.535 179.881 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.575 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.8 p30 -61.68 177.6 0.4 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.653 -179.707 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.601 ' C ' ' H ' ' A' ' 81' ' ' GLY . 36.1 p30 -45.87 85.54 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.97 179.872 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.575 ' N ' ' O ' ' A' ' 78' ' ' ASP . 43.0 tp60 -67.19 13.59 0.06 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.072 0.463 . . . . 0.0 110.12 -179.774 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.601 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 117.72 -22.0 10.2 Favored Glycine 0 C--N 1.331 0.285 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 179.981 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -107.93 116.35 31.8 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.022 0.439 . . . . 0.0 110.518 179.849 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 75.8 mt -98.8 0.57 44.63 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.516 -179.698 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -91.88 6.61 45.49 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.988 0.423 . . . . 0.0 110.47 -179.707 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.442 ' O ' ' CG2' ' A' ' 89' ' ' VAL . 88.1 mt-30 -99.89 -28.08 13.28 Favored 'General case' 0 C--O 1.224 -0.266 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.784 179.973 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 68.9 t-105 -63.03 -41.07 99.43 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.913 -179.722 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.556 ' O ' ' N ' ' A' ' 91' ' ' LYS . 67.4 m -77.34 -53.53 7.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.313 -179.441 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -48.4 -50.85 29.22 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.979 -179.337 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.442 ' CG2' ' O ' ' A' ' 85' ' ' GLN . 15.6 m -68.9 -40.83 81.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 120.914 0.388 . . . . 0.0 111.075 179.748 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.413 ' H ' HG23 ' A' ' 89' ' ' VAL . . . -72.1 -22.96 61.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.775 -179.912 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.556 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.0 tttm -61.35 -45.69 93.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.45 -179.502 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.437 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.7 mm-40 -90.73 -94.34 0.12 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.091 -179.977 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.633 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.9 mtt180 -143.36 59.95 1.4 Allowed 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.81 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.461 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.7 pttp 33.54 26.27 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 120.791 0.329 . . . . 0.0 110.115 -179.291 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.633 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.5 tt -47.97 122.84 5.45 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.995 -178.243 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -83.25 -169.9 2.77 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.016 -179.882 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.614 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 83.0 mtp180 -73.51 137.88 44.7 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.29 -179.813 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.485 ' N ' ' O ' ' A' ' 67' ' ' SER . 89.0 mt -86.81 -166.2 1.5 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.701 -179.519 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.533 ' CD2' ' O ' ' A' ' 99' ' ' TYR . 47.4 p90 -167.97 120.05 0.86 Allowed 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.296 179.939 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.511 ' C ' ' O ' ' A' ' 99' ' ' TYR . 42.9 mm -29.59 121.25 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.939 -179.639 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 113.96 28.13 3.24 Favored Glycine 0 CA--C 1.519 0.341 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 -179.542 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.585 ' N ' ' CD ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -144.02 45.81 0.59 Allowed Pre-proline 0 C--N 1.324 -0.53 0 CA-C-O 120.932 0.396 . . . . 0.0 110.508 179.883 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 30.5 Cg_endo -62.0 143.72 95.5 Favored 'Trans proline' 0 C--N 1.297 -2.152 0 C-N-CA 122.667 2.245 . . . . 0.0 112.033 179.921 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.695 ' HG ' ' H ' ' A' ' 107' ' ' ALA . 23.1 t -173.43 120.52 0.33 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.404 179.715 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.22 -41.09 64.15 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.057 0.456 . . . . 0.0 111.231 179.652 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -65.93 -40.26 91.26 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.942 -179.412 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.695 ' H ' ' HG ' ' A' ' 104' ' ' SER . . . -63.87 -39.87 95.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.699 -179.852 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 69.5 t -67.39 -43.91 87.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.863 179.627 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.33 -39.0 91.63 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.602 -179.265 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.437 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.58 -23.49 62.96 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.013 0.435 . . . . 0.0 110.505 179.817 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.555 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.4 mm-40 -91.07 4.73 51.37 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.72 -179.5 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.555 ' C ' ' O ' ' A' ' 111' ' ' GLN . 10.6 tpt 23.56 63.85 0.38 Allowed Pre-proline 0 N--CA 1.465 0.32 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.916 179.971 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -78.3 168.79 21.12 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 C-N-CA 122.918 2.412 . . . . 0.0 112.344 -178.645 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.525 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 98.9 m-20 -113.15 -44.16 3.29 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.939 179.639 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 39.9 tp -120.71 119.77 33.76 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.619 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 95.7 mt -116.99 131.14 70.56 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.3 0 CA-C-O 120.909 0.385 . . . . 0.0 110.949 -179.91 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.5 ' CD1' ' HG ' ' A' ' 48' ' ' SER . 30.7 mt -106.06 132.77 51.74 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 121.104 0.478 . . . . 0.0 110.236 -179.387 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 98.0 mt -118.31 136.37 55.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.699 -179.633 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 85.9 p -71.98 153.22 41.93 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.666 179.978 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.19 -50.1 75.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.625 -179.84 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -149.37 153.82 37.99 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.535 179.823 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 169.67 -170.42 42.71 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 179.837 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -63.01 -35.05 91.57 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 110.824 -0.91 . . . . 0.0 110.824 179.986 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.442 ' O ' ' OD1' ' A' ' 124' ' ' ASP . 43.8 p-10 -87.86 119.9 28.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.797 0.332 . . . . 0.0 110.694 179.933 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 40.5 t -63.39 144.17 57.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.472 -179.969 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.522 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.59 -43.03 8.88 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.837 -179.874 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.3 tp -62.66 -42.42 99.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.663 -179.931 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.78 -11.04 57.64 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.518 -179.403 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 84.9 mt -115.96 -23.72 8.43 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.749 -179.868 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . 0.522 ' N ' ' O ' ' A' ' 126' ' ' ALA . 79.0 t80 -51.77 -49.71 62.12 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 120.501 -0.48 . . . . 0.0 110.587 -179.024 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.5 p-10 -65.81 -42.16 90.99 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.946 0.403 . . . . 0.0 111.172 179.564 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.507 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 88.1 mt-30 -67.35 -36.85 82.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.801 -179.983 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 92.8 mt -80.34 -41.85 24.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.012 -179.541 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.1 t -57.55 -44.58 85.3 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.134 -179.095 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.5 m -62.3 -45.65 92.28 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.801 0.334 . . . . 0.0 110.586 179.351 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 92.4 mt -62.49 -43.78 98.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.285 -179.772 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -170.19 163.86 6.13 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.451 179.869 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -43.58 111.32 0.23 Allowed 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.437 2.091 . . . . 0.0 112.076 179.539 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 17.3 m -85.78 127.79 34.64 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.57 179.951 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 34.4 tp -119.65 137.67 53.74 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.244 -0.435 . . . . 0.0 109.964 -179.702 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.433 ' O ' ' OD1' ' A' ' 32' ' ' ASP . 79.6 mt -104.58 119.92 54.21 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.432 0 CA-C-O 121.154 0.502 . . . . 0.0 111.416 -179.556 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 98.4 mt -135.3 133.03 52.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.665 179.676 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.512 HD22 ' CG ' ' A' ' 241' ' ' ASP . 60.6 t30 -64.98 150.31 48.24 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.861 0.362 . . . . 0.0 110.386 179.288 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.517 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 87.9 t80 -85.27 122.45 29.47 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.936 -179.531 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.517 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 99.0 m-20 55.48 68.86 0.8 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.954 179.76 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 36.0 p-10 -125.44 0.27 7.62 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.011 0.434 . . . . 0.0 110.816 179.851 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -150.69 115.57 5.27 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.748 -179.501 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 148' ' ' SER . . . . . 0.52 ' HG ' ' H ' ' A' ' 150' ' ' GLN . 85.0 p -63.28 168.26 4.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.49 -179.742 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.422 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.5 p-90 -51.48 -15.67 0.46 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.484 -179.836 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . 0.52 ' H ' ' HG ' ' A' ' 148' ' ' SER . 68.3 tp60 -70.84 -75.65 0.12 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.414 -179.703 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.455 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.1 t -62.59 -38.76 91.4 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.992 0.425 . . . . 0.0 110.297 179.529 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 53.6 tp -60.25 -45.53 92.96 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.324 -178.493 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.422 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 45.9 tp -62.76 -41.82 99.4 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.844 0.354 . . . . 0.0 110.311 179.03 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.455 ' OG1' ' O ' ' A' ' 151' ' ' SER . 58.8 p -64.01 -34.67 78.54 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.264 -179.507 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . 0.444 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.5 mm-40 -64.03 -42.38 97.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.171 179.256 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 91.8 mt -65.24 -39.05 92.18 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.092 0.472 . . . . 0.0 110.172 179.071 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.582 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.04 -32.25 79.6 Favored Glycine 0 CA--C 1.52 0.352 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 -179.391 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.444 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.3 mt-10 -36.42 -25.38 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.888 0.375 . . . . 0.0 110.811 179.949 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.582 ' N ' ' O ' ' A' ' 157' ' ' GLY . 95.7 mt -59.16 149.29 6.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.171 179.382 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 77.5 p -69.14 137.47 53.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.074 -179.561 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 70.66 21.9 77.91 Favored Glycine 0 N--CA 1.458 0.157 0 N-CA-C 111.274 -0.731 . . . . 0.0 111.274 179.522 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 59.3 m80 -124.02 -14.63 7.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.757 0.313 . . . . 0.0 110.56 179.979 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -66.25 -59.76 3.43 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.774 -179.753 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -52.03 -48.96 64.27 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.278 -179.695 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -60.62 -41.11 94.18 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.76 0.314 . . . . 0.0 110.334 179.463 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.68 -47.11 86.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.633 179.817 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -57.1 -39.99 76.13 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.16 -179.85 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -61.8 -50.15 73.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.525 179.619 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -65.38 -43.77 89.67 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.417 179.554 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 95.1 mt -64.37 -43.53 97.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.421 179.718 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.29 -50.87 71.55 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.639 -179.169 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.79 -43.7 95.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.32 179.727 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . 0.486 ' CD1' ' OH ' ' A' ' 301' ' ' TYR . 56.6 t80 -62.58 -44.62 95.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.026 0.441 . . . . 0.0 110.425 179.373 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -63.4 -39.93 95.82 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.475 -179.204 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -62.85 -42.81 99.89 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.664 179.248 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -60.8 -44.68 96.53 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.069 -179.992 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 84.9 mt -64.29 -41.22 96.99 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.043 0.449 . . . . 0.0 110.681 178.862 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.15 -62.25 1.76 Allowed 'General case' 0 C--O 1.237 0.44 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.487 -179.382 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.64 -46.71 86.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.51 179.86 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.43 -41.67 66.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.135 -179.931 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -63.71 -33.88 76.64 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.07 0.462 . . . . 0.0 110.407 179.336 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . 0.403 ' HG2' ' O ' ' A' ' 182' ' ' GLU . 69.6 tt0 -90.31 8.42 33.47 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-O 121.387 0.613 . . . . 0.0 110.619 -179.078 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -104.31 -32.32 9.13 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-O 120.932 0.396 . . . . 0.0 111.359 179.546 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 43.9 pt -127.88 147.53 32.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.915 -179.902 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -139.83 131.03 26.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.296 179.478 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . 0.554 ' CD2' ' N ' ' A' ' 186' ' ' LEU . 3.6 mm? -85.63 133.46 41.86 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.841 179.922 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -44.28 158.06 0.15 Allowed 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.738 2.292 . . . . 0.0 112.061 179.48 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . 0.527 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.7 Cg_endo -62.9 114.97 2.65 Favored 'Trans proline' 0 C--N 1.303 -1.828 0 C-N-CA 122.747 2.298 . . . . 0.0 111.776 179.801 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . 0.527 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.8 mt-30 155.39 148.14 0.0 OUTLIER Pre-proline 0 N--CA 1.454 -0.247 0 O-C-N 123.552 0.533 . . . . 0.0 110.772 -179.799 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -74.11 144.5 33.8 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.685 2.257 . . . . 0.0 111.777 178.185 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.498 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.1 p -125.31 158.86 33.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.271 0.557 . . . . 0.0 110.067 -179.89 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 192' ' ' THR . . . . . 0.498 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 35.4 p -143.53 165.58 27.19 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.094 -179.653 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -135.66 128.62 31.39 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.212 0.53 . . . . 0.0 110.244 179.625 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 47.1 pt -146.38 148.96 16.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.137 179.732 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 70.4 t -117.87 123.14 71.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 121.263 0.554 . . . . 0.0 109.594 179.254 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 58.8 t80 -134.37 107.32 7.55 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.32 179.688 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 94.8 m -131.02 130.72 43.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.896 179.784 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.411 ' O ' ' N ' ' A' ' 201' ' ' HIS . . . -83.04 -37.09 24.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.252 179.741 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.44 -67.15 0.25 Allowed 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.332 179.996 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.1 -9.73 58.81 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.306 179.523 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . 0.411 ' N ' ' O ' ' A' ' 198' ' ' ALA . 60.1 t-80 60.52 58.36 2.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.825 -179.835 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 42.0 p -167.2 153.53 8.12 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.444 179.558 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.27 143.81 24.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.962 0.41 . . . . 0.0 110.372 179.449 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -135.18 138.34 43.56 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.691 179.939 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 20.3 mt -106.34 125.43 50.99 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 121.119 0.485 . . . . 0.0 109.745 -179.682 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 206' ' ' TRP . . . . . 0.557 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 74.3 m95 -81.96 166.83 19.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.666 -179.796 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -156.78 171.87 6.86 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 120.971 0.415 . . . . 0.0 110.562 -179.213 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -54.02 -37.2 86.28 Favored 'Trans proline' 0 C--N 1.303 -1.839 0 C-N-CA 122.637 2.224 . . . . 0.0 111.954 179.465 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -70.46 -34.96 73.01 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.953 -179.916 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 22.2 m -61.02 150.88 32.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.569 -179.351 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.66 -36.86 82.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.462 -179.709 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 212' ' ' GLN . . . . . 0.557 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 55.2 tt0 -64.77 -40.37 95.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.529 179.957 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.72 -43.32 92.13 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 179.759 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -63.4 -43.9 96.2 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.95 -0.3 . . . . 0.0 110.219 179.879 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 65.0 ttp -59.73 -47.88 83.91 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.199 -179.753 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 86.7 mt -60.65 -40.62 92.69 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 179.531 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 217' ' ' GLU . . . . . 0.456 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.5 tp10 -58.36 -37.88 76.11 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.77 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -65.21 -38.3 90.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.811 0.339 . . . . 0.0 110.648 179.696 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 94.2 mt -64.25 -42.56 96.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.554 -179.557 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.36 45.1 0.08 OUTLIER Glycine 0 C--N 1.334 0.417 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 -179.943 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 221' ' ' PHE . . . . . 0.456 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 26.6 m-85 -127.99 155.41 44.32 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.012 0.434 . . . . 0.0 110.527 -179.812 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 222' ' ' THR . . . . . 0.454 ' O ' ' O ' ' A' ' 191' ' ' VAL . 6.8 p -107.06 122.31 46.22 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.093 0.473 . . . . 0.0 110.2 -179.899 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . 0.444 ' CD2' ' N ' ' A' ' 223' ' ' LEU . 4.3 mm? -101.33 132.81 46.7 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.107 179.967 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.64 159.79 14.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.52 179.86 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.57 115.21 29.86 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.328 179.902 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.45 ' CD1' ' N ' ' A' ' 226' ' ' LEU . 9.1 mp -53.22 156.86 3.54 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.584 179.926 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -60.31 145.38 98.71 Favored 'Trans proline' 0 C--N 1.301 -1.931 0 C-N-CA 122.627 2.218 . . . . 0.0 112.012 179.379 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.3 -3.26 59.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.559 -179.98 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.15 -40.99 5.66 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 -179.859 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . 0.532 ' O ' ' N ' ' A' ' 233' ' ' SER . 85.5 mt -79.18 -17.15 55.47 Favored 'General case' 0 C--O 1.223 -0.316 0 CA-C-O 120.934 0.397 . . . . 0.0 110.301 -179.721 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . 0.401 ' C ' ' O ' ' A' ' 230' ' ' LEU . 54.7 t-20 -40.38 -49.21 2.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.756 -179.527 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -87.88 15.33 7.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.275 179.814 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 233' ' ' SER . . . . . 0.532 ' N ' ' O ' ' A' ' 230' ' ' LEU . 78.0 p -60.35 -35.48 75.77 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.523 -179.732 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . 0.527 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.7 tt0 -118.98 -69.12 0.87 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.917 0.389 . . . . 0.0 111.019 179.491 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.2 m -69.68 102.77 1.96 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.769 -179.882 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -94.27 57.45 2.33 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.341 -179.975 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -144.54 -122.63 1.6 Allowed Glycine 0 CA--C 1.52 0.359 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 179.994 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -135.13 111.53 9.79 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.082 0.468 . . . . 0.0 110.444 179.972 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . 0.519 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.7 mtt180 -148.05 57.88 1.09 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.723 -179.885 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -69.54 -32.27 70.98 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.522 179.65 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 241' ' ' ASP . . . . . 0.512 ' CG ' HD22 ' A' ' 143' ' ' ASN . 65.1 t0 -57.0 -46.97 81.9 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.41 -179.124 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 242' ' ' ILE . . . . . 0.437 ' O ' ' O ' ' A' ' 239' ' ' ARG . 17.7 tt -139.78 156.27 25.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.873 0.368 . . . . 0.0 110.541 179.777 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 96.2 mt -106.06 106.41 20.53 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.216 0 CA-C-O 121.233 0.54 . . . . 0.0 110.458 179.87 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . 0.519 ' OE1' ' NH1' ' A' ' 239' ' ' ARG . 88.2 mt-30 -110.19 109.85 20.48 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.329 179.75 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 9.4 mp -121.75 -168.47 1.7 Allowed 'General case' 0 C--O 1.224 -0.238 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.647 179.774 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . 0.527 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.81 -16.5 0.05 OUTLIER Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 179.892 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . 0.702 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -60.75 156.3 32.24 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 -179.858 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -63.48 21.76 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.001 0.429 . . . . 0.0 110.617 179.973 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . 0.702 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.7 m-20 -97.51 -5.85 34.99 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.554 179.961 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 93.6 mt -79.69 -22.16 43.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.647 179.486 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.64 -51.27 70.65 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.856 -179.543 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -87.96 -5.51 58.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.42 179.653 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.09 -74.33 1.15 Allowed Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 -179.959 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 81.4 mt -70.05 125.89 28.08 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.134 0.493 . . . . 0.0 110.104 -179.759 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -59.69 -39.29 84.08 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.266 -179.656 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 84.37 51.63 3.84 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 179.943 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -95.11 -15.62 23.24 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.698 0.285 . . . . 0.0 110.664 -179.917 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 258' ' ' SER . . . . . 0.422 ' O ' ' O ' ' A' ' 192' ' ' THR . 3.3 t 173.76 89.4 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.033 0.444 . . . . 0.0 110.085 179.979 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . 0.597 ' N ' ' CD1' ' A' ' 259' ' ' LEU . 1.0 OUTLIER -94.38 124.06 38.17 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-O 121.314 0.578 . . . . 0.0 111.144 -179.224 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 15.9 m-30 -93.04 146.72 23.42 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.378 179.269 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 86.3 mt -122.48 149.91 43.23 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.525 -179.921 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.661 ' CG ' ' N ' ' A' ' 263' ' ' ALA . 2.6 p90 -78.13 -138.64 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.422 -179.696 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 263' ' ' ALA . . . . . 0.661 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -51.69 77.62 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.995 -179.921 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . 0.636 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.35 104.46 0.19 Allowed Glycine 0 N--CA 1.468 0.781 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 -179.798 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 265' ' ' ASP . . . . . 0.605 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.6 m-20 -80.48 -177.56 6.27 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.718 0.294 . . . . 0.0 110.966 -179.594 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -40.68 -17.54 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.428 179.859 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 267' ' ' LYS . . . . . 0.605 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.59 -51.4 42.94 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 121.013 0.435 . . . . 0.0 110.782 179.487 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -63.8 -46.72 83.9 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.143 179.399 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . 0.527 ' O ' ' CD2' ' A' ' 273' ' ' TYR . . . -61.7 -35.08 77.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.767 179.646 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -62.93 -34.74 78.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.105 179.729 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.38 -43.1 13.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.409 -179.584 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 272' ' ' ILE . . . . . 0.619 ' C ' ' H ' ' A' ' 274' ' ' ALA . 4.9 tt -51.37 -33.65 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.838 -178.95 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 273' ' ' TYR . . . . . 0.527 ' CD2' ' O ' ' A' ' 269' ' ' ALA . 17.5 m-85 -54.33 -1.67 0.03 OUTLIER 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.742 -179.563 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 274' ' ' ALA . . . . . 0.619 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.94 -39.87 69.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.883 179.648 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . 0.586 ' O ' ' N ' ' A' ' 279' ' ' ALA . 4.3 p30 -38.94 97.53 0.14 Allowed Pre-proline 0 C--O 1.226 -0.168 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.582 -179.68 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 276' ' ' PRO . . . . . 0.402 ' N ' ' O ' ' A' ' 274' ' ' ALA . 45.7 Cg_exo -53.95 -43.15 60.68 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 C-N-CA 122.338 2.025 . . . . 0.0 112.756 -178.884 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 89.8 mt -64.39 -42.82 95.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.136 0.493 . . . . 0.0 111.235 -179.766 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 91.2 mt -95.99 -1.14 49.61 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.849 -179.439 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 279' ' ' ALA . . . . . 0.586 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.39 -34.91 77.65 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.647 -179.762 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -73.76 19.72 0.11 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.126 -179.38 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . 0.517 ' H ' ' C ' ' A' ' 279' ' ' ALA . 13.7 mt -75.2 120.84 83.52 Favored Pre-proline 0 N--CA 1.451 -0.391 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.351 179.99 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_exo -51.58 -39.11 66.05 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.633 2.222 . . . . 0.0 111.603 179.343 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.83 -50.38 63.81 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 179.818 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 79.5 t -61.84 -44.02 98.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 110.083 -0.339 . . . . 0.0 110.083 179.477 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -57.65 -41.6 81.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.301 -179.846 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -90.71 0.7 57.33 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.084 179.675 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt 58.59 41.57 22.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.115 0.483 . . . . 0.0 111.029 179.788 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -93.15 42.22 1.09 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.377 179.804 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 53.8 t -119.37 135.54 59.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 120.943 0.401 . . . . 0.0 110.223 -179.699 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -132.78 162.81 30.52 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.045 0.45 . . . . 0.0 110.703 -179.623 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.65 155.38 32.45 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.032 0.444 . . . . 0.0 110.743 -179.882 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 81.4 mt -94.37 -1.23 54.11 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.211 -179.699 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.1 165.01 12.54 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.634 -0.986 . . . . 0.0 110.634 -179.814 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 7.0 m -86.79 -62.04 1.6 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.804 0.335 . . . . 0.0 111.184 -179.95 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 295' ' ' GLU . . . . . 0.479 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.6 mm-40 -69.41 -4.07 16.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.697 -179.842 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 25.4 p -76.84 32.38 0.14 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.663 -179.887 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 297' ' ' PHE . . . . . 0.479 ' H ' ' C ' ' A' ' 295' ' ' GLU . 70.5 t80 -60.33 -46.06 91.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.607 -179.908 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . 0.614 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.4 mtt85 -81.08 134.93 35.75 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.581 -179.699 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 17.1 tp -114.24 118.07 32.92 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.152 179.898 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . 0.606 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.2 p-10 -165.69 -176.16 3.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.541 179.978 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 301' ' ' TYR . . . . . 0.486 ' OH ' ' CD1' ' A' ' 173' ' ' PHE . 84.5 t80 -47.17 -43.86 21.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.275 -179.675 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -66.6 -40.63 88.95 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.08 0.466 . . . . 0.0 110.833 179.116 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 303' ' ' SER . . . . . 0.606 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 60.8 p -55.71 -36.11 66.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.159 -179.263 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -57.49 -51.31 69.98 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.459 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 90.6 mtp -56.71 -43.52 80.64 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -179.993 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -66.49 -42.56 87.21 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.928 0.394 . . . . 0.0 110.16 178.796 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 55.6 t -64.02 -43.12 97.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.08 179.352 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 43.3 tp -59.66 -42.09 92.05 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.721 -179.409 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -62.72 -38.83 92.03 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 179.565 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 310' ' ' ARG . . . . . 0.446 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.6 ttt85 -63.66 -43.88 95.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.288 179.506 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 89.4 mt -63.21 -42.1 99.23 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.185 179.602 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -62.87 -33.59 75.6 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.993 179.445 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.65 -23.46 21.89 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.507 -179.836 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . 0.446 ' N ' ' O ' ' A' ' 310' ' ' ARG . 6.7 tt -62.32 -43.12 99.56 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 121.087 0.47 . . . . 0.0 110.629 -179.889 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 . . . . . 0 C--O 1.22 -0.457 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.462 179.897 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -99.6 136.04 40.12 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.47 -179.961 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.498 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -92.41 178.45 1.68 Allowed Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.539 -179.88 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.498 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.0 Cg_exo -61.76 147.39 95.39 Favored 'Trans proline' 0 C--N 1.3 -1.996 0 C-N-CA 122.752 2.302 . . . . 0.0 112.162 179.811 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 35.4 ptt180 -136.85 142.47 42.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.679 179.679 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -79.59 116.97 20.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.464 179.962 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.402 ' O ' ' CG2' ' A' ' 30' ' ' ILE . 9.5 tp -111.48 130.25 65.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.46 -179.956 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 13.5 t -71.4 142.13 50.32 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.527 179.811 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.53 ' CG ' ' H ' ' A' ' 33' ' ' SER . 42.8 t0 -139.09 -179.56 5.92 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.629 -179.937 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.53 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 78.0 p -74.15 -37.13 64.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.755 179.863 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.7 ttt85 -47.07 -94.9 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.382 -179.521 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.415 ' O ' ' OG1' ' A' ' 36' ' ' THR . . . -165.65 -27.15 0.02 OUTLIER Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 179.92 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.415 ' OG1' ' O ' ' A' ' 35' ' ' GLY . 67.6 m -168.43 105.9 0.46 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.859 0.361 . . . . 0.0 110.635 -179.909 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.4 t60 -128.9 145.98 51.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.015 0.436 . . . . 0.0 110.267 179.896 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.484 ' CG2' ' N ' ' A' ' 39' ' ' LEU . 99.8 m -129.26 165.42 21.43 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.639 -179.915 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.484 ' N ' ' CG2' ' A' ' 38' ' ' THR . 79.6 mt -120.27 127.39 52.34 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.513 179.785 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -65.51 -44.57 86.6 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.619 -179.951 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.421 ' O ' ' HD3' ' A' ' 43' ' ' PRO . 41.6 p -166.0 154.93 11.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.443 179.719 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.467 ' N ' ' CD ' ' A' ' 42' ' ' GLN . 14.0 mp0 -45.43 101.71 0.27 Allowed Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.673 179.503 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.421 ' HD3' ' O ' ' A' ' 41' ' ' SER . 31.5 Cg_exo -57.71 130.12 37.03 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 C-N-CA 122.351 2.034 . . . . 0.0 112.233 -179.687 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -83.05 -24.68 32.67 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.448 179.631 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.536 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.9 mtm-85 -120.46 134.48 55.26 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-O 121.174 0.511 . . . . 0.0 110.28 -179.987 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 95.9 mt -129.97 133.46 64.48 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.271 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.979 -179.76 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 47.8 t -125.25 131.02 72.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.802 0.334 . . . . 0.0 110.11 179.329 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.505 ' O ' ' O ' ' A' ' 66' ' ' ALA . 4.2 m -154.72 166.31 33.84 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.606 179.81 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 65.8 p -124.85 8.23 8.12 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.483 179.931 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.1 t -85.2 125.8 33.15 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.68 -179.43 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 91.9 t -65.7 -44.52 93.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.51 -179.994 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.8 m -62.74 -44.32 96.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.664 -179.849 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 54.4 tp -62.19 -41.56 98.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.57 -179.536 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 72.1 m -57.72 -44.53 86.04 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.349 -179.397 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.31 -62.09 5.43 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.911 -0.876 . . . . 0.0 110.911 179.554 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.6 t -48.24 -35.76 12.63 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 -179.962 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 20.0 mt -61.77 -44.76 96.25 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.724 -0.391 . . . . 0.0 111.145 179.347 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.2 mp -64.88 -42.0 95.18 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.081 0.467 . . . . 0.0 111.287 178.035 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.59 -41.22 98.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.998 -179.288 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 7.9 tp -87.89 16.53 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.694 -179.662 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 56.58 84.3 0.09 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.575 -179.973 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.59 57.74 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.147 -179.808 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -50.13 152.55 7.73 Favored 'Trans proline' 0 C--N 1.297 -2.169 0 C-N-CA 122.834 2.356 . . . . 0.0 112.475 -178.297 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.428 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -108.93 146.34 14.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.417 -179.747 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 97.1 mt -63.85 -45.03 98.2 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.351 -179.762 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.505 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -130.26 134.48 47.26 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.677 -179.857 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.478 ' O ' ' N ' ' A' ' 98' ' ' LEU . 69.0 m -134.19 158.38 43.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.839 -179.62 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.5 139.18 16.38 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 179.804 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.469 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.91 -162.6 0.08 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.934 0.397 . . . . 0.0 110.495 -179.968 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.493 ' O ' ' C ' ' A' ' 71' ' ' THR . 14.6 t -133.55 135.88 44.61 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.394 -179.992 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.493 ' C ' ' O ' ' A' ' 70' ' ' THR . 0.0 OUTLIER 29.74 68.68 0.66 Allowed Pre-proline 0 N--CA 1.464 0.243 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.646 -179.843 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -60.9 145.23 99.35 Favored 'Trans proline' 0 C--N 1.3 -1.98 0 C-N-CA 122.643 2.229 . . . . 0.0 112.227 -178.73 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.527 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 45.6 p-10 -160.7 -32.59 0.05 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.686 179.659 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.527 ' N ' ' OD1' ' A' ' 73' ' ' ASN . 99.0 m-20 -63.88 -39.36 94.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.488 -179.972 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 73.2 ttt180 -60.56 -48.19 82.87 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.68 -179.405 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.418 ' O ' ' O ' ' A' ' 77' ' ' ALA . 93.6 t -59.91 -24.52 29.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 110.1 -0.334 . . . . 0.0 110.1 179.607 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.418 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -46.1 173.13 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.599 179.924 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.569 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.6 p30 -61.87 177.6 0.42 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.581 -179.738 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.603 ' C ' ' H ' ' A' ' 81' ' ' GLY . 35.9 p30 -46.02 85.95 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.887 -179.942 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.569 ' N ' ' O ' ' A' ' 78' ' ' ASP . 42.6 tp60 -66.92 13.48 0.06 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.143 -179.893 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.603 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 117.76 -22.04 10.16 Favored Glycine 0 CA--C 1.519 0.293 0 N-CA-C 110.994 -0.843 . . . . 0.0 110.994 179.957 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -107.62 116.47 32.0 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.99 0.424 . . . . 0.0 110.497 179.883 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 75.2 mt -98.73 0.67 45.0 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.46 -179.738 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -91.93 6.7 45.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.957 0.408 . . . . 0.0 110.41 -179.833 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.446 ' O ' ' CG2' ' A' ' 89' ' ' VAL . 88.4 mt-30 -99.67 -27.63 13.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.858 179.957 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 68.7 t-105 -63.34 -41.18 98.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.03 -179.619 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.556 ' O ' ' N ' ' A' ' 91' ' ' LYS . 65.8 m -77.42 -53.33 7.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.238 -179.317 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -48.57 -51.09 29.47 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.966 -179.28 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.446 ' CG2' ' O ' ' A' ' 85' ' ' GLN . 15.4 m -68.78 -40.74 81.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 120.903 0.383 . . . . 0.0 110.962 179.9 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.413 ' H ' HG23 ' A' ' 89' ' ' VAL . . . -71.9 -23.11 61.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.786 179.953 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.556 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.0 tttm -60.99 -45.82 93.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.498 -179.602 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.438 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.3 mm-40 -90.82 -94.68 0.12 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.08 179.981 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.634 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.9 mtt180 -143.23 60.03 1.4 Allowed 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.794 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.462 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.6 pttp 33.57 26.23 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.222 -179.048 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.634 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.4 tt -47.62 123.31 5.69 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.92 -178.253 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -83.44 -169.92 2.79 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.061 -179.997 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.613 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 82.3 mtp180 -73.61 138.03 44.6 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.166 -179.837 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.478 ' N ' ' O ' ' A' ' 67' ' ' SER . 89.8 mt -87.27 -165.93 1.43 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.717 -179.647 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.534 ' CD2' ' O ' ' A' ' 99' ' ' TYR . 48.2 p90 -168.46 120.2 0.81 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.32 179.933 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.513 ' C ' ' O ' ' A' ' 99' ' ' TYR . 43.6 mm -29.6 121.5 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.863 -179.63 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 114.22 27.94 3.24 Favored Glycine 0 CA--C 1.521 0.426 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 -179.557 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.582 ' N ' ' CD ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -144.17 46.04 0.6 Allowed Pre-proline 0 C--N 1.324 -0.541 0 CA-C-O 120.907 0.384 . . . . 0.0 110.465 179.903 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.582 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 31.0 Cg_endo -62.28 143.85 94.56 Favored 'Trans proline' 0 C--N 1.298 -2.126 0 C-N-CA 122.735 2.29 . . . . 0.0 111.996 179.932 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.705 ' HG ' ' H ' ' A' ' 107' ' ' ALA . 24.8 t -173.67 120.91 0.32 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.46 179.67 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.42 -41.11 63.68 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.012 0.434 . . . . 0.0 111.154 179.709 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -65.82 -40.16 91.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.856 -179.432 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.705 ' H ' ' HG ' ' A' ' 104' ' ' SER . . . -63.63 -39.77 95.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.708 -179.907 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 72.0 t -67.44 -43.82 87.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.683 179.584 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.18 -39.24 92.04 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.512 -179.233 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.438 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.75 -23.82 63.54 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.431 179.831 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.568 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.3 mm-40 -91.18 4.47 52.15 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.684 -179.574 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.568 ' C ' ' O ' ' A' ' 111' ' ' GLN . 10.4 tpt 22.11 64.56 0.32 Allowed Pre-proline 0 N--CA 1.464 0.266 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.992 -179.911 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -78.66 170.04 18.82 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 C-N-CA 122.972 2.448 . . . . 0.0 112.21 -178.66 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.522 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 99.1 m-20 -113.07 -44.78 3.23 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 121.065 0.46 . . . . 0.0 110.088 179.544 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 39.8 tp -119.91 119.57 33.87 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.514 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 94.7 mt -116.94 131.15 70.49 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 CA-C-O 120.954 0.407 . . . . 0.0 110.887 -179.807 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 31.6 mt -105.63 131.98 52.33 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 121.11 0.481 . . . . 0.0 110.125 -179.528 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 98.3 mt -117.55 135.94 56.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.79 -179.726 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 85.0 p -71.57 151.54 43.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.568 -179.944 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.13 -49.85 76.0 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.678 -179.763 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.0 t -149.4 153.93 38.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.587 179.76 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 168.19 -169.56 41.53 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.875 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.87 -35.73 92.41 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -179.971 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.446 ' O ' ' OD1' ' A' ' 124' ' ' ASP . 44.1 p-10 -87.96 120.04 28.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.782 0.325 . . . . 0.0 110.632 179.871 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 40.5 t -63.44 144.2 57.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.554 -179.956 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.518 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -94.02 -43.08 8.69 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.792 -179.814 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 56.1 tp -62.73 -42.37 99.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.562 -179.841 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.0 -10.52 54.21 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.531 -179.474 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 83.6 mt -116.02 -24.08 8.24 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.678 -179.89 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . 0.518 ' N ' ' O ' ' A' ' 126' ' ' ALA . 74.5 t80 -51.52 -49.55 61.71 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.456 -178.951 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.4 p-10 -65.87 -41.91 91.04 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.893 0.378 . . . . 0.0 111.163 179.607 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.526 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 87.7 mt-30 -67.85 -36.74 80.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.746 -179.905 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 95.9 mt -80.19 -42.45 23.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.955 -179.439 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.3 t -57.49 -44.94 85.35 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.355 -179.117 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.4 m -62.29 -45.95 90.94 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.639 179.409 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 92.2 mt -62.29 -43.79 98.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.325 -179.823 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -170.18 163.75 6.17 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.471 179.842 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -42.38 110.3 0.15 Allowed 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.571 2.181 . . . . 0.0 112.035 179.454 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.8 m -87.27 127.61 35.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.463 -179.927 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 34.1 tp -119.78 138.72 53.17 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.163 -179.818 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.436 ' O ' ' OD1' ' A' ' 32' ' ' ASP . 81.6 mt -105.29 120.04 55.35 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.348 0 CA-C-O 121.125 0.488 . . . . 0.0 111.233 -179.439 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 97.7 mt -135.42 132.73 52.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.721 179.577 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.495 HD22 ' CG ' ' A' ' 241' ' ' ASP . 59.7 t30 -64.49 148.3 50.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.875 0.369 . . . . 0.0 110.37 179.364 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.515 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 86.9 t80 -82.75 122.4 28.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.96 -179.471 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.515 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 99.0 m-20 55.08 69.41 0.73 Allowed 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.827 179.648 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 35.2 p-10 -125.71 0.69 7.46 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 120.906 0.384 . . . . 0.0 110.704 179.787 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -150.9 115.92 5.29 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.668 -179.511 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 148' ' ' SER . . . . . 0.5 ' HG ' ' H ' ' A' ' 150' ' ' GLN . 86.2 p -63.74 168.72 4.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.499 -179.805 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.423 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.3 p-90 -51.6 -15.96 0.54 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.62 -179.868 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . 0.5 ' H ' ' HG ' ' A' ' 148' ' ' SER . 67.9 tp60 -70.36 -76.05 0.11 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.521 -179.748 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.458 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.0 t -62.68 -38.5 90.61 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.339 179.481 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 52.3 tp -60.1 -45.51 92.69 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.401 -178.611 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.423 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 46.5 tp -62.83 -41.84 99.49 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.861 0.362 . . . . 0.0 110.411 178.995 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.458 ' OG1' ' O ' ' A' ' 151' ' ' SER . 59.2 p -63.72 -34.76 78.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.258 -179.566 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . 0.471 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.9 mm-40 -63.98 -42.18 97.3 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.239 179.177 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 91.6 mt -65.42 -38.89 91.27 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.092 179.118 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.582 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.25 -32.42 80.62 Favored Glycine 0 CA--C 1.52 0.375 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 -179.366 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.471 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.1 mt-10 -36.34 -25.55 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.874 0.369 . . . . 0.0 110.791 -179.98 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.582 ' N ' ' O ' ' A' ' 157' ' ' GLY . 94.8 mt -59.35 149.5 6.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.231 179.473 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 74.8 p -69.09 137.07 53.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.049 -179.558 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 71.1 21.62 78.41 Favored Glycine 0 N--CA 1.459 0.194 0 N-CA-C 111.269 -0.732 . . . . 0.0 111.269 179.509 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 60.3 m80 -123.43 -15.45 7.13 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.746 0.307 . . . . 0.0 110.568 179.989 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -66.02 -59.87 3.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.715 -179.756 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -51.62 -49.09 62.9 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.238 -179.755 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -60.83 -41.07 95.04 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.723 0.297 . . . . 0.0 110.312 179.522 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.48 -47.51 85.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.613 179.745 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.64 -40.32 75.23 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.268 -179.921 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -61.66 -50.24 73.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.65 179.525 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -65.38 -43.76 89.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.476 179.495 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 95.1 mt -64.53 -43.41 96.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.52 179.728 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.23 -51.05 70.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.599 -179.308 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.79 -43.67 95.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.421 179.724 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . 0.501 ' CD1' ' OH ' ' A' ' 301' ' ' TYR . 57.3 t80 -62.69 -44.56 95.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.456 179.364 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -63.26 -40.04 96.28 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.527 -179.361 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -63.01 -42.77 99.92 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.624 179.277 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -60.64 -44.78 95.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.119 179.968 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 84.4 mt -64.29 -41.09 97.05 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.02 0.438 . . . . 0.0 110.674 178.956 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.18 -62.12 1.84 Allowed 'General case' 0 C--O 1.237 0.418 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.501 -179.387 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.78 -46.78 86.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.545 179.903 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.3 -41.72 65.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.149 179.974 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -63.72 -33.6 76.02 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.011 0.434 . . . . 0.0 110.415 179.227 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . 0.407 ' HG2' ' O ' ' A' ' 182' ' ' GLU . 69.8 tt0 -90.7 8.61 33.62 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.27 0.557 . . . . 0.0 110.528 -179.01 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -104.58 -32.25 9.03 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.188 179.595 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 45.1 pt -128.04 147.72 32.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.816 -179.803 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -139.76 130.88 26.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.375 179.418 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . 0.555 ' CD2' ' N ' ' A' ' 186' ' ' LEU . 3.6 mm? -85.46 133.24 42.64 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.808 -179.947 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -44.01 157.81 0.14 Allowed 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.704 2.269 . . . . 0.0 112.088 179.46 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . 0.528 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.7 Cg_endo -63.01 114.74 2.57 Favored 'Trans proline' 0 C--N 1.303 -1.858 0 C-N-CA 122.751 2.3 . . . . 0.0 111.752 179.909 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . 0.528 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.8 mt-30 155.6 147.83 0.0 OUTLIER Pre-proline 0 C--N 1.331 -0.215 0 O-C-N 123.433 0.458 . . . . 0.0 110.725 -179.757 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -73.9 144.06 33.98 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.711 2.274 . . . . 0.0 111.771 178.189 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.497 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.1 p -124.92 159.03 32.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.261 0.553 . . . . 0.0 110.082 -179.975 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 192' ' ' THR . . . . . 0.497 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 37.7 p -143.55 165.31 27.94 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.069 -179.506 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -135.55 128.54 31.48 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.122 0.487 . . . . 0.0 110.258 179.704 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 47.5 pt -146.4 148.86 16.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.1 179.928 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 68.9 t -117.89 123.12 71.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.315 0.578 . . . . 0.0 109.7 179.098 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -134.26 107.36 7.62 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.309 179.745 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 94.2 m -131.13 130.53 43.21 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.802 179.871 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.417 ' O ' ' N ' ' A' ' 201' ' ' HIS . . . -82.9 -37.2 24.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.276 179.745 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.25 -67.12 0.25 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.364 179.978 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.15 -9.84 58.98 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.344 179.48 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . 0.417 ' N ' ' O ' ' A' ' 198' ' ' ALA . 60.0 t-80 60.85 58.16 2.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.601 -179.972 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 44.8 p -167.07 153.21 8.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.516 179.666 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.24 143.93 24.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.933 0.397 . . . . 0.0 110.426 179.532 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -135.31 138.51 43.5 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.644 -179.949 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 19.9 mt -106.45 125.42 50.98 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 121.112 0.482 . . . . 0.0 109.862 -179.721 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 206' ' ' TRP . . . . . 0.555 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 74.2 m95 -81.96 166.94 19.42 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.597 -179.713 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -157.05 171.41 7.49 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.56 -179.164 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -53.65 -37.13 83.38 Favored 'Trans proline' 0 C--N 1.303 -1.838 0 C-N-CA 122.664 2.242 . . . . 0.0 111.97 179.333 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -70.58 -35.08 72.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.844 -179.864 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 21.7 m -60.98 151.02 31.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.562 -179.31 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.81 -37.03 82.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.523 -179.767 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 212' ' ' GLN . . . . . 0.555 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 55.0 tt0 -64.64 -40.37 95.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.532 179.916 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.51 -43.34 92.55 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 179.846 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -63.31 -43.68 97.12 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.675 0.274 . . . . 0.0 110.283 179.851 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 65.3 ttp -59.65 -47.98 83.47 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.206 -179.773 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 88.1 mt -60.59 -40.8 93.07 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.531 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 217' ' ' GLU . . . . . 0.459 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.8 tp10 -58.25 -38.01 76.08 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.75 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -65.13 -38.23 89.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.808 0.337 . . . . 0.0 110.671 179.677 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 94.4 mt -64.33 -42.67 96.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.572 -179.616 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.5 44.93 0.08 OUTLIER Glycine 0 CA--C 1.521 0.429 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 -179.958 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 221' ' ' PHE . . . . . 0.459 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 26.4 m-85 -127.91 155.32 44.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.045 0.45 . . . . 0.0 110.507 -179.896 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 222' ' ' THR . . . . . 0.457 ' O ' ' O ' ' A' ' 191' ' ' VAL . 7.2 p -106.8 122.17 45.84 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.214 0.531 . . . . 0.0 110.202 -179.985 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . 0.444 ' CD2' ' N ' ' A' ' 223' ' ' LEU . 4.3 mm? -101.21 132.99 46.44 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.074 179.982 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.85 159.74 14.75 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.005 0.431 . . . . 0.0 110.504 179.86 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.75 115.25 29.92 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.382 179.93 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.462 ' CD1' ' N ' ' A' ' 226' ' ' LEU . 8.8 mp -52.94 156.62 3.33 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.662 179.952 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -60.47 145.45 98.71 Favored 'Trans proline' 0 C--N 1.302 -1.889 0 C-N-CA 122.68 2.253 . . . . 0.0 111.982 179.367 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.02 -3.42 59.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.57 179.994 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.04 -41.11 5.66 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 -179.884 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . 0.537 ' O ' ' N ' ' A' ' 233' ' ' SER . 85.6 mt -79.3 -17.2 55.09 Favored 'General case' 0 C--O 1.224 -0.273 0 CA-C-O 121.037 0.446 . . . . 0.0 110.314 -179.696 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . 0.403 ' C ' ' O ' ' A' ' 230' ' ' LEU . 54.8 t-20 -40.23 -49.31 2.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.73 -179.642 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -87.86 15.35 7.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.828 0.347 . . . . 0.0 111.18 179.945 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 233' ' ' SER . . . . . 0.537 ' N ' ' O ' ' A' ' 230' ' ' LEU . 78.0 p -60.29 -35.54 75.79 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.594 -179.824 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . 0.526 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.5 tt0 -119.11 -69.29 0.86 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.898 179.643 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.2 m -69.28 103.23 1.9 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.612 -179.727 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -94.79 57.18 2.12 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.42 179.912 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -144.57 -122.84 1.62 Allowed Glycine 0 CA--C 1.522 0.48 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 -179.928 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -134.94 111.64 10.0 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.061 0.458 . . . . 0.0 110.423 -179.997 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . 0.523 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.6 mtt180 -148.04 58.16 1.1 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.731 -179.961 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -69.75 -32.03 70.32 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.568 179.571 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 241' ' ' ASP . . . . . 0.495 ' CG ' HD22 ' A' ' 143' ' ' ASN . 65.4 t0 -57.08 -46.93 82.14 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.373 -179.143 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 242' ' ' ILE . . . . . 0.435 ' O ' ' O ' ' A' ' 239' ' ' ARG . 18.1 tt -140.01 156.82 25.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.91 0.386 . . . . 0.0 110.492 179.712 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 96.2 mt -106.54 106.7 21.11 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.173 0 CA-C-O 121.177 0.513 . . . . 0.0 110.523 179.85 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . 0.523 ' OE1' ' NH1' ' A' ' 239' ' ' ARG . 88.2 mt-30 -110.47 110.12 20.75 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.311 179.817 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 9.3 mp -121.86 -168.44 1.7 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.601 179.911 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . 0.526 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.67 -16.47 0.05 OUTLIER Glycine 0 CA--C 1.524 0.628 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 179.876 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . 0.702 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -60.59 156.35 31.49 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 -179.885 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -63.42 21.38 0.01 OUTLIER 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.886 0.374 . . . . 0.0 110.626 179.883 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . 0.702 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.6 m-20 -97.29 -5.78 35.89 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.537 179.942 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 94.8 mt -79.66 -22.11 43.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.543 179.546 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.55 -51.32 70.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.796 -179.591 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.11 -5.68 58.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.476 179.679 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -80.96 -74.69 1.13 Allowed Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 -179.925 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 81.3 mt -69.89 125.97 28.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.069 0.461 . . . . 0.0 110.249 -179.82 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -59.19 -39.52 82.83 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.248 -179.662 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 83.21 51.82 4.02 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 179.903 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -96.04 -14.95 22.56 Favored 'General case' 0 C--N 1.333 -0.152 0 O-C-N 122.729 -0.277 . . . . 0.0 110.564 -179.843 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 258' ' ' SER . . . . . 0.425 ' O ' ' O ' ' A' ' 192' ' ' THR . 3.4 t 174.43 88.62 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.048 0.451 . . . . 0.0 110.169 -179.972 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . 0.597 ' N ' ' CD1' ' A' ' 259' ' ' LEU . 1.0 OUTLIER -94.05 123.93 37.74 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.227 0.537 . . . . 0.0 111.11 -179.159 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 16.0 m-30 -92.93 146.7 23.43 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.337 179.221 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 85.7 mt -122.53 149.9 43.29 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.521 -179.868 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.662 ' CG ' ' N ' ' A' ' 263' ' ' ALA . 2.6 p90 -77.57 -138.47 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.552 -179.865 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 263' ' ' ALA . . . . . 0.662 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -52.16 77.73 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.922 179.957 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . 0.632 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.16 104.46 0.19 Allowed Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 -179.936 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 265' ' ' ASP . . . . . 0.609 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.8 m-20 -80.49 -177.64 6.31 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.749 0.309 . . . . 0.0 110.841 -179.468 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -40.48 -17.54 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.506 179.8 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 267' ' ' LYS . . . . . 0.609 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.63 -51.59 40.52 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.687 179.516 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -63.71 -46.67 84.38 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.187 179.382 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . 0.523 ' O ' ' CD2' ' A' ' 273' ' ' TYR . . . -61.64 -35.04 76.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.845 179.52 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -63.05 -34.53 77.78 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.111 179.744 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.37 -43.21 13.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.261 -179.577 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 272' ' ' ILE . . . . . 0.618 ' C ' ' H ' ' A' ' 274' ' ' ALA . 4.9 tt -51.39 -33.81 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.811 -178.802 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 273' ' ' TYR . . . . . 0.523 ' CD2' ' O ' ' A' ' 269' ' ' ALA . 17.2 m-85 -54.27 -1.76 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.655 -179.628 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 274' ' ' ALA . . . . . 0.618 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.87 -39.41 69.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.844 179.686 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . 0.582 ' O ' ' N ' ' A' ' 279' ' ' ALA . 2.9 p30 -39.63 98.28 0.16 Allowed Pre-proline 0 C--N 1.333 -0.141 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.513 -179.671 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -54.02 -43.17 60.61 Favored 'Trans proline' 0 C--N 1.302 -1.874 0 C-N-CA 122.411 2.074 . . . . 0.0 112.613 -178.855 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 88.9 mt -64.47 -42.83 95.69 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.137 0.494 . . . . 0.0 111.218 -179.625 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 89.7 mt -95.67 -1.54 49.9 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.875 -179.47 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 279' ' ' ALA . . . . . 0.582 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.42 -34.65 77.17 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.646 -179.807 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.45 20.04 0.12 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.024 -179.226 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . 0.508 ' H ' ' C ' ' A' ' 279' ' ' ALA . 13.9 mt -75.32 120.52 82.06 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.394 179.968 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -51.36 -39.23 63.56 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 122.625 2.217 . . . . 0.0 111.676 179.312 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.9 -50.42 63.93 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.09 179.878 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 75.2 t -61.48 -43.93 97.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 179.502 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -57.67 -41.27 81.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.317 -179.981 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -91.14 0.45 57.53 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.123 179.599 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt 59.06 43.25 17.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.042 0.448 . . . . 0.0 110.928 179.67 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -94.59 41.43 1.09 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.399 179.793 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 53.4 t -118.85 135.86 57.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.031 0.443 . . . . 0.0 110.166 -179.707 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -133.01 162.8 30.73 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.706 -179.637 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.94 155.19 33.24 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.988 0.423 . . . . 0.0 110.701 -179.743 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 80.4 mt -93.95 -1.36 54.76 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.364 -179.794 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.26 165.89 12.78 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 110.65 -0.98 . . . . 0.0 110.65 -179.747 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 6.9 m -87.75 -62.26 1.54 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.889 0.376 . . . . 0.0 111.124 -179.922 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 295' ' ' GLU . . . . . 0.475 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.7 mm-40 -69.48 -3.78 16.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.569 -179.729 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 27.6 p -76.74 32.8 0.14 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.698 -179.963 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 297' ' ' PHE . . . . . 0.475 ' H ' ' C ' ' A' ' 295' ' ' GLU . 85.5 t80 -60.21 -45.92 91.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.677 179.995 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . 0.613 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.1 mtt85 -81.54 134.23 35.48 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.592 -179.68 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 16.6 tp -114.04 118.35 33.84 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.115 179.969 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . 0.609 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.7 p-10 -165.8 -175.96 3.66 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.526 -179.934 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 301' ' ' TYR . . . . . 0.501 ' OH ' ' CD1' ' A' ' 173' ' ' PHE . 83.0 t80 -47.34 -44.04 23.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.194 -179.639 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -66.33 -40.76 90.1 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.013 0.435 . . . . 0.0 110.776 179.05 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 303' ' ' SER . . . . . 0.609 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 57.6 p -55.72 -36.17 66.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.168 -179.334 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -57.35 -51.68 68.43 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.439 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 91.1 mtp -56.15 -43.59 78.42 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.778 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -66.54 -42.49 87.11 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.912 0.387 . . . . 0.0 110.167 178.821 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 55.9 t -64.13 -42.86 96.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.179 179.305 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 43.5 tp -59.68 -42.14 92.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.88 -179.588 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -62.54 -39.15 92.67 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.112 179.494 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 310' ' ' ARG . . . . . 0.438 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.5 ttt85 -63.45 -43.99 95.77 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.293 179.445 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 88.9 mt -63.34 -42.13 98.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.226 179.566 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.4 ttmt -62.84 -33.26 74.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.068 0.461 . . . . 0.0 110.108 179.485 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.84 -23.46 21.67 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.579 -179.942 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . 0.438 ' N ' ' O ' ' A' ' 310' ' ' ARG . 6.7 tt -62.39 -43.17 99.47 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.547 -179.894 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 . . . . . 0 C--O 1.219 -0.502 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.498 179.989 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -99.67 135.97 40.29 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.047 0.451 . . . . 0.0 110.485 -179.962 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.497 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.2 OUTLIER -91.64 178.43 1.76 Allowed Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.601 -179.87 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.497 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.6 Cg_exo -61.73 147.73 94.65 Favored 'Trans proline' 0 C--N 1.3 -1.987 0 C-N-CA 122.755 2.303 . . . . 0.0 112.118 179.708 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 35.4 ptt180 -135.48 142.34 45.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.618 179.797 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -78.95 116.84 19.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.576 179.953 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.6 tp -110.17 130.86 62.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.436 -179.998 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 13.2 t -70.69 142.3 51.53 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.614 179.839 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 141' ' ' ILE . 25.2 t70 -140.25 177.56 7.9 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.481 -179.939 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.455 ' OG ' ' O ' ' A' ' 141' ' ' ILE . 77.9 p -74.13 -36.33 64.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.529 -179.945 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -47.69 -94.96 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.347 -179.606 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.421 ' O ' ' OG1' ' A' ' 36' ' ' THR . . . -165.46 -25.83 0.02 OUTLIER Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 179.892 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.421 ' OG1' ' O ' ' A' ' 35' ' ' GLY . 59.0 m -168.84 106.96 0.44 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.846 0.355 . . . . 0.0 110.689 -179.96 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 35.5 t60 -129.57 144.77 51.42 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.012 0.434 . . . . 0.0 110.224 179.885 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.482 ' CG2' ' N ' ' A' ' 39' ' ' LEU . 97.4 m -128.95 166.24 19.53 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.582 -179.76 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.482 ' N ' ' CG2' ' A' ' 38' ' ' THR . 81.9 mt -121.04 127.48 51.76 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.486 179.738 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -64.05 -44.55 92.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.618 -179.829 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 40.7 p -165.68 154.75 11.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.463 179.719 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.456 ' N ' ' CD ' ' A' ' 42' ' ' GLN . 14.4 mp0 -43.36 100.86 0.23 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.595 179.61 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -57.03 128.95 31.95 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.384 2.056 . . . . 0.0 112.29 -179.637 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -83.34 -24.54 32.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.551 179.6 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.541 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.7 mtm-85 -121.03 134.43 55.29 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 121.095 0.474 . . . . 0.0 110.294 -179.985 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.0 mt -130.23 133.35 64.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.943 -179.746 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 45.9 t -124.9 131.13 73.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.817 0.341 . . . . 0.0 110.156 179.334 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.496 ' O ' ' O ' ' A' ' 66' ' ' ALA . 4.8 m -154.55 166.32 33.7 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.543 179.881 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 72.0 p -124.56 8.55 8.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.519 179.856 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.699 ' HG ' ' H ' ' A' ' 53' ' ' LEU . 1.3 t -85.73 125.33 33.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.579 -179.485 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 96.4 t -65.66 -44.46 93.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.544 179.961 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.7 m -62.48 -44.36 96.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.57 -179.841 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.699 ' H ' ' HG ' ' A' ' 50' ' ' SER . 46.3 tp -62.41 -41.3 98.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.516 -179.441 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 73.7 m -57.59 -44.57 85.48 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.451 -179.326 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.43 -62.3 5.22 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 179.602 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.6 t -48.14 -35.78 12.19 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 179.807 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.5 mt -61.66 -44.79 96.29 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.038 179.474 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.1 mp -64.96 -41.81 95.15 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.164 178.114 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.48 -41.49 98.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.921 -179.164 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.1 tp -87.9 16.94 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.711 -179.574 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 56.58 84.01 0.09 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.646 179.999 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.74 58.2 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.106 -179.803 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -50.84 152.6 9.6 Favored 'Trans proline' 0 C--N 1.298 -2.121 0 C-N-CA 122.832 2.355 . . . . 0.0 112.485 -178.264 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.431 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -108.99 145.74 15.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.348 -179.63 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.86 -45.17 97.78 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.3 -179.671 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.496 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -129.85 134.53 47.59 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.598 -179.713 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.5 ' O ' ' N ' ' A' ' 98' ' ' LEU . 75.3 m -134.83 158.79 43.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.788 -179.605 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -87.07 139.45 16.19 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.752 -0.939 . . . . 0.0 110.752 179.753 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.465 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.98 -162.49 0.08 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.931 0.396 . . . . 0.0 110.481 -179.921 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.496 ' O ' ' C ' ' A' ' 71' ' ' THR . 14.6 t -133.67 135.35 44.03 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.353 179.942 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.496 ' C ' ' O ' ' A' ' 70' ' ' THR . 0.1 OUTLIER 29.58 68.54 0.65 Allowed Pre-proline 0 N--CA 1.463 0.222 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.705 -179.824 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -60.98 145.11 99.55 Favored 'Trans proline' 0 C--N 1.301 -1.963 0 C-N-CA 122.626 2.218 . . . . 0.0 112.155 -178.525 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.528 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 45.2 p-10 -159.54 -32.3 0.06 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.645 179.723 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.528 ' N ' ' OD1' ' A' ' 73' ' ' ASN . 99.1 m-20 -64.12 -39.45 94.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.464 -179.992 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -60.49 -48.49 81.54 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.646 -179.284 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.424 ' O ' ' O ' ' A' ' 77' ' ' ALA . 92.8 t -59.68 -24.92 30.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.091 179.697 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.424 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -45.54 172.32 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.567 179.869 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.574 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.6 p30 -61.74 177.77 0.39 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.546 -179.732 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.597 ' C ' ' H ' ' A' ' 81' ' ' GLY . 35.6 p30 -45.92 85.8 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.847 179.98 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.574 ' N ' ' O ' ' A' ' 78' ' ' ASP . 42.8 tp60 -67.31 13.62 0.06 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.192 -179.983 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.597 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 117.93 -22.14 9.99 Favored Glycine 0 CA--C 1.52 0.364 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 179.969 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -107.62 116.39 31.87 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.932 0.396 . . . . 0.0 110.513 179.911 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 74.4 mt -98.84 0.86 45.13 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.473 -179.713 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -92.18 6.62 45.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.42 -179.811 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.451 ' O ' ' CG2' ' A' ' 89' ' ' VAL . 88.1 mt-30 -100.0 -27.41 13.59 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.85 179.971 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.6 t-105 -63.89 -40.74 97.23 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.981 -179.628 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.556 ' O ' ' N ' ' A' ' 91' ' ' LYS . 68.1 m -77.75 -53.84 7.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.225 -179.496 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -48.02 -50.77 26.64 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.908 -179.249 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.451 ' CG2' ' O ' ' A' ' 85' ' ' GLN . 15.4 m -69.07 -40.97 81.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 120.909 0.385 . . . . 0.0 110.922 179.955 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.414 ' H ' HG23 ' A' ' 89' ' ' VAL . . . -71.93 -22.89 61.41 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.71 -179.873 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.556 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.0 tttm -61.54 -45.91 92.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.482 -179.535 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.439 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.4 mm-40 -90.25 -94.57 0.12 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.151 -179.997 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.624 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.8 mtt180 -143.54 59.96 1.39 Allowed 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.734 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.466 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.7 pttp 33.32 27.1 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.338 -179.029 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.624 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.5 tt -48.55 123.12 6.24 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.915 -178.328 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -83.6 -170.38 3.03 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.227 179.863 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.613 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 81.6 mtp180 -73.31 137.84 45.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.297 -179.847 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.5 ' N ' ' O ' ' A' ' 67' ' ' SER . 88.6 mt -86.09 -166.66 1.6 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.725 -179.584 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.528 ' CD2' ' O ' ' A' ' 99' ' ' TYR . 47.4 p90 -166.77 119.9 1.01 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.302 179.984 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.512 ' C ' ' O ' ' A' ' 99' ' ' TYR . 43.7 mm -29.75 121.15 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.865 -179.6 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 113.43 28.93 3.1 Favored Glycine 0 CA--C 1.522 0.492 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 -179.66 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.582 ' N ' ' CD ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -144.25 46.12 0.61 Allowed Pre-proline 0 C--N 1.325 -0.493 0 CA-C-O 120.922 0.391 . . . . 0.0 110.456 179.934 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.582 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 30.2 Cg_endo -62.01 143.72 95.45 Favored 'Trans proline' 0 C--N 1.299 -2.079 0 C-N-CA 122.733 2.289 . . . . 0.0 112.018 -179.985 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.693 ' HG ' ' H ' ' A' ' 107' ' ' ALA . 26.1 t -173.36 120.7 0.34 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.454 179.712 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.76 -41.0 63.06 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.056 179.767 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -65.86 -40.26 91.5 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.831 -179.383 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.693 ' H ' ' HG ' ' A' ' 104' ' ' SER . . . -63.97 -40.01 95.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.688 -179.777 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 70.7 t -67.39 -43.85 87.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.735 179.676 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.53 -39.22 92.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.577 -179.329 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.439 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.29 -23.49 62.46 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.521 179.81 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.557 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.4 mm-40 -91.25 5.08 50.55 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.698 -179.552 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.557 ' C ' ' O ' ' A' ' 111' ' ' GLN . 10.2 tpt 22.81 64.59 0.35 Allowed Pre-proline 0 N--CA 1.465 0.288 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.879 -179.85 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -78.98 169.27 19.59 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 C-N-CA 122.975 2.45 . . . . 0.0 112.223 -178.684 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.464 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 98.8 m-20 -113.44 -44.08 3.26 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.148 179.43 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.7 tp -120.24 120.92 37.52 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.001 179.432 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 96.7 mt -118.49 131.07 72.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.795 -179.705 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 32.4 mt -106.1 132.76 51.79 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.127 0.489 . . . . 0.0 110.298 -179.502 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 98.0 mt -118.17 136.57 54.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.687 -179.753 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 87.0 p -72.07 153.47 41.7 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.566 -179.938 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.34 -50.27 74.27 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.689 -179.888 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.0 t -149.31 153.74 37.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.51 179.785 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 169.58 -169.99 42.4 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 179.89 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -63.08 -35.14 91.69 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 179.922 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.453 ' O ' ' OD1' ' A' ' 124' ' ' ASP . 44.6 p-10 -88.05 119.86 28.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.843 0.354 . . . . 0.0 110.679 179.897 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 37.0 t -63.4 144.53 56.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.445 -179.914 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.523 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.23 -43.43 8.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.936 -179.997 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.7 tp -62.86 -42.3 99.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.655 -179.864 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.48 -11.08 57.03 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.52 -179.519 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 84.4 mt -116.08 -24.07 8.21 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.642 -179.775 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . 0.523 ' N ' ' O ' ' A' ' 126' ' ' ALA . 79.3 t80 -51.12 -50.18 59.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.587 -179.154 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.5 p-10 -65.82 -42.16 90.95 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.906 0.384 . . . . 0.0 111.133 179.716 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.504 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 87.7 mt-30 -67.55 -36.85 81.76 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.698 -179.882 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 93.7 mt -80.61 -42.0 22.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.952 -179.543 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.3 t -57.03 -44.87 83.32 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.283 -179.279 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.5 m -62.32 -45.78 91.66 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.812 0.339 . . . . 0.0 110.615 179.42 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 92.8 mt -62.34 -43.81 98.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.35 -179.765 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -170.07 162.85 6.52 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.573 179.811 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -42.71 110.88 0.18 Allowed 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.562 2.175 . . . . 0.0 112.1 179.554 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 16.7 m -85.77 127.79 34.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.632 179.968 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 35.6 tp -119.77 139.06 52.9 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.127 179.974 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.455 ' O ' ' OG ' ' A' ' 33' ' ' SER . 78.6 mt -105.65 120.78 57.0 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 CA-C-O 121.088 0.47 . . . . 0.0 111.071 -179.275 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 96.4 mt -136.33 133.05 49.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.597 179.522 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.473 HD22 ' CG ' ' A' ' 241' ' ' ASP . 61.4 t30 -64.26 151.19 44.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.939 0.399 . . . . 0.0 110.4 179.468 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.517 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 89.3 t80 -86.38 122.94 31.05 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.805 -179.484 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.517 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 99.1 m-20 55.12 69.5 0.73 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.841 179.648 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 42.8 p-10 -127.54 1.06 6.22 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.917 0.389 . . . . 0.0 110.617 -179.956 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -150.45 114.76 5.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.718 -179.643 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 148' ' ' SER . . . . . 0.517 ' HG ' ' H ' ' A' ' 150' ' ' GLN . 83.4 p -63.44 168.44 4.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.517 -179.803 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.414 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.6 p-90 -52.13 -15.66 0.63 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.599 -179.858 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . 0.517 ' H ' ' HG ' ' A' ' 148' ' ' SER . 68.1 tp60 -70.62 -76.17 0.11 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.507 -179.801 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.451 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.0 t -62.79 -38.55 91.07 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.309 179.584 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 53.2 tp -59.82 -45.79 91.26 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.459 -178.636 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.414 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 46.7 tp -62.77 -41.72 99.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.431 179.051 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.451 ' OG1' ' O ' ' A' ' 151' ' ' SER . 60.4 p -63.96 -34.87 78.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.311 -179.633 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . 0.461 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.6 mm-40 -63.89 -42.34 97.48 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.277 179.266 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 92.4 mt -65.45 -38.81 90.94 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.949 0.404 . . . . 0.0 110.215 179.027 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.579 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.32 -31.89 78.85 Favored Glycine 0 CA--C 1.521 0.442 0 N-CA-C 110.829 -0.908 . . . . 0.0 110.829 -179.428 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.461 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.3 mt-10 -36.62 -25.53 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.87 0.367 . . . . 0.0 110.814 179.976 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.579 ' N ' ' O ' ' A' ' 157' ' ' GLY . 93.9 mt -59.02 150.63 5.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.288 179.464 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 73.5 p -69.26 137.2 52.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.922 -179.435 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 69.88 22.98 77.17 Favored Glycine 0 CA--C 1.517 0.197 0 N-CA-C 111.226 -0.75 . . . . 0.0 111.226 179.408 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 61.4 m80 -124.0 -13.92 7.22 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.717 0.294 . . . . 0.0 110.576 179.91 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -67.13 -59.53 3.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.764 -179.71 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -51.49 -49.59 61.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.261 -179.718 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -60.08 -41.31 92.15 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.732 0.301 . . . . 0.0 110.374 179.484 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.44 -47.61 84.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.596 179.85 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.57 -40.25 74.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.297 -179.901 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -61.46 -50.32 73.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.621 179.613 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -65.65 -43.61 88.87 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.477 179.6 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 94.6 mt -64.46 -43.51 96.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.46 179.747 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.38 -51.31 69.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.616 -179.269 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.8 -44.18 94.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.49 179.686 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . 0.526 ' CD1' ' OH ' ' A' ' 301' ' ' TYR . 55.1 t80 -62.76 -44.38 96.34 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.494 179.458 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -63.3 -40.0 96.13 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.621 -179.434 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -62.89 -42.74 99.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.677 179.231 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -60.78 -44.89 96.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.148 179.936 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 85.6 mt -64.6 -41.08 96.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.053 0.454 . . . . 0.0 110.771 178.887 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.04 -61.95 1.94 Allowed 'General case' 0 C--O 1.236 0.38 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.558 -179.415 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.83 -46.75 86.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.484 179.825 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.24 -41.41 65.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.268 -179.968 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -64.18 -33.78 76.57 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.958 0.409 . . . . 0.0 110.391 179.282 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . 0.407 ' HG2' ' O ' ' A' ' 182' ' ' GLU . 69.4 tt0 -90.74 9.04 31.58 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.255 0.55 . . . . 0.0 110.575 -179.018 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -104.94 -32.19 8.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.045 179.746 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.4 pt -128.22 147.86 32.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.799 -179.773 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -140.05 131.1 26.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.398 179.385 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . 0.559 ' CD2' ' N ' ' A' ' 186' ' ' LEU . 3.6 mm? -85.54 133.9 41.16 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.789 179.99 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -44.15 157.99 0.14 Allowed 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.773 2.315 . . . . 0.0 112.055 179.363 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . 0.535 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.9 Cg_endo -63.02 114.84 2.61 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 C-N-CA 122.774 2.316 . . . . 0.0 111.786 179.783 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . 0.535 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.7 mt-30 155.36 148.15 0.0 OUTLIER Pre-proline 0 N--CA 1.455 -0.186 0 O-C-N 123.461 0.476 . . . . 0.0 110.67 -179.809 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -73.61 144.22 35.34 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.738 2.292 . . . . 0.0 111.861 178.001 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.498 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.1 p -124.99 158.95 32.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.232 0.539 . . . . 0.0 110.165 -179.979 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 192' ' ' THR . . . . . 0.498 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 38.5 p -143.51 165.13 28.43 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.01 -179.427 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -135.45 128.53 31.65 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.109 0.48 . . . . 0.0 110.231 179.543 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 47.7 pt -146.27 148.39 17.15 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.04 -179.945 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 72.2 t -117.28 123.09 71.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.21 0.529 . . . . 0.0 109.909 178.962 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -134.13 107.4 7.7 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.296 179.674 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 94.5 m -130.95 130.42 43.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.853 179.797 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -82.76 -36.95 25.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.324 179.668 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.55 -67.39 0.24 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.422 179.942 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -71.93 -9.97 59.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.314 179.515 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 59.7 t-80 60.85 58.34 2.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.738 -179.877 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 39.7 p -167.18 153.39 8.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.594 179.596 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.24 144.08 24.47 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.987 0.422 . . . . 0.0 110.496 179.433 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -135.41 138.43 43.25 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.583 -179.914 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 20.1 mt -106.16 125.33 50.86 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 121.074 0.464 . . . . 0.0 109.926 -179.758 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 206' ' ' TRP . . . . . 0.569 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 74.7 m95 -81.82 166.82 19.65 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.623 -179.81 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -156.47 172.35 6.2 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.615 -179.244 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -54.42 -37.29 89.39 Favored 'Trans proline' 0 C--N 1.303 -1.825 0 C-N-CA 122.716 2.277 . . . . 0.0 112.015 179.297 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -70.45 -34.68 72.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.765 -179.75 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 21.6 m -61.5 150.57 35.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.586 -179.357 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.41 -36.47 80.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.471 -179.75 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 212' ' ' GLN . . . . . 0.569 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 54.2 tt0 -64.46 -40.81 96.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.543 179.908 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.61 -43.47 92.04 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 179.837 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -63.23 -44.14 96.09 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.761 0.315 . . . . 0.0 110.295 179.658 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 65.1 ttp -59.61 -48.0 83.39 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.314 -179.879 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 86.3 mt -60.55 -40.82 93.01 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.353 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 217' ' ' GLU . . . . . 0.456 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 40.7 tp10 -57.86 -38.2 75.29 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 179.513 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -65.26 -38.17 89.48 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.8 0.333 . . . . 0.0 110.624 179.678 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 94.6 mt -64.35 -42.82 96.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.491 -179.689 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.63 45.96 0.08 OUTLIER Glycine 0 CA--C 1.521 0.435 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 179.993 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 221' ' ' PHE . . . . . 0.456 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 26.8 m-85 -129.07 156.13 44.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.993 0.425 . . . . 0.0 110.487 -179.829 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 222' ' ' THR . . . . . 0.452 ' O ' ' O ' ' A' ' 191' ' ' VAL . 7.7 p -108.1 122.7 47.43 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.112 0.482 . . . . 0.0 110.239 -179.997 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . 0.446 ' CD2' ' N ' ' A' ' 223' ' ' LEU . 4.3 mm? -101.43 133.17 46.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.089 -179.889 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.99 159.81 14.7 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.52 179.776 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -105.03 115.08 29.68 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.934 0.397 . . . . 0.0 110.398 179.853 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.448 ' CD1' ' N ' ' A' ' 226' ' ' LEU . 9.1 mp -53.37 156.86 3.79 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.574 179.954 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -60.27 145.22 99.03 Favored 'Trans proline' 0 C--N 1.302 -1.887 0 C-N-CA 122.615 2.21 . . . . 0.0 112.076 179.303 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.56 -2.78 58.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.543 -179.969 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.41 -40.67 5.67 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -179.842 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . 0.552 ' O ' ' N ' ' A' ' 233' ' ' SER . 85.3 mt -79.29 -16.77 55.86 Favored 'General case' 0 C--O 1.224 -0.242 0 CA-C-O 120.929 0.395 . . . . 0.0 110.41 -179.821 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . 0.407 ' C ' ' O ' ' A' ' 230' ' ' LEU . 54.8 t-20 -39.82 -49.21 2.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.708 -179.706 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -88.55 15.71 7.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.103 -179.926 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 233' ' ' SER . . . . . 0.552 ' N ' ' O ' ' A' ' 230' ' ' LEU . 78.2 p -60.64 -35.96 77.47 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.64 -179.891 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . 0.527 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.7 tt0 -118.01 -69.55 0.84 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.911 179.677 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.0 m -70.56 103.36 2.48 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.658 -179.791 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -94.54 58.09 2.32 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.387 179.885 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -145.11 -122.71 1.56 Allowed Glycine 0 CA--C 1.522 0.47 0 N-CA-C 110.931 -0.868 . . . . 0.0 110.931 -179.927 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -133.71 111.7 10.79 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.052 0.454 . . . . 0.0 110.487 179.964 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . 0.496 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.0 mtt180 -148.18 56.88 1.07 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.741 -179.926 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 94.2 m-70 -69.66 -31.46 69.54 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.569 179.578 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 241' ' ' ASP . . . . . 0.473 ' CG ' HD22 ' A' ' 143' ' ' ASN . 65.2 t0 -56.87 -46.84 81.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.33 -179.147 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 242' ' ' ILE . . . . . 0.439 ' O ' ' O ' ' A' ' 239' ' ' ARG . 17.2 tt -140.71 157.86 23.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.913 0.387 . . . . 0.0 110.529 179.726 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 96.0 mt -106.28 106.13 20.02 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.198 0 CA-C-O 121.147 0.498 . . . . 0.0 110.489 179.886 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . 0.496 ' OE1' ' NH1' ' A' ' 239' ' ' ARG . 88.3 mt-30 -110.68 110.62 21.36 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.375 179.765 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 9.5 mp -122.19 -168.05 1.65 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.619 179.826 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . 0.527 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 172.98 -16.63 0.05 OUTLIER Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 179.901 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . 0.691 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -60.42 157.46 28.85 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 -179.819 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -64.21 21.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.955 0.407 . . . . 0.0 110.584 179.964 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . 0.691 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.8 m-20 -97.01 -5.84 36.74 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.548 179.932 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 92.5 mt -80.15 -21.18 43.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.643 179.464 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.52 -51.39 70.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.764 -179.555 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.83 -5.34 58.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.423 179.67 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.06 -74.43 1.14 Allowed Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 -179.863 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 80.1 mt -69.84 125.51 26.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.044 0.449 . . . . 0.0 110.253 -179.882 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -59.41 -39.53 83.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.29 -179.679 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 83.35 51.77 4.01 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 110.806 -0.917 . . . . 0.0 110.806 179.897 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -95.17 -16.08 22.83 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.79 0.329 . . . . 0.0 110.623 -179.883 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 258' ' ' SER . . . . . 0.442 ' HG ' ' CG2' ' A' ' 191' ' ' VAL . 3.4 t 174.92 89.29 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.014 0.435 . . . . 0.0 110.222 179.995 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . 0.599 ' N ' ' CD1' ' A' ' 259' ' ' LEU . 0.9 OUTLIER -94.17 124.2 38.04 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.22 0.533 . . . . 0.0 111.052 -179.024 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 16.1 m-30 -93.55 146.98 23.4 Favored 'General case' 0 CA--C 1.51 -0.577 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.406 179.053 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 85.3 mt -122.46 150.02 43.08 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.537 -179.895 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.662 ' CG ' ' N ' ' A' ' 263' ' ' ALA . 2.7 p90 -77.85 -138.86 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.533 -179.795 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 263' ' ' ALA . . . . . 0.662 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -51.44 78.17 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.942 -179.885 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . 0.631 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.88 104.57 0.19 Allowed Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 179.942 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 265' ' ' ASP . . . . . 0.601 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.8 m-20 -80.29 -177.23 6.03 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 120.692 0.282 . . . . 0.0 110.858 -179.432 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -40.7 -17.69 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.49 179.825 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 267' ' ' LYS . . . . . 0.601 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.5 -51.57 41.84 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.78 179.521 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -63.89 -46.62 84.09 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.282 179.312 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . 0.526 ' O ' ' CD2' ' A' ' 273' ' ' TYR . . . -61.56 -35.1 76.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.976 179.424 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -62.89 -34.5 77.54 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.177 179.561 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.46 -43.36 13.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.223 -179.536 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 272' ' ' ILE . . . . . 0.618 ' C ' ' H ' ' A' ' 274' ' ' ALA . 5.0 tt -51.56 -33.65 15.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.704 -178.643 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 273' ' ' TYR . . . . . 0.526 ' CD2' ' O ' ' A' ' 269' ' ' ALA . 16.9 m-85 -54.25 -1.82 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.71 -179.755 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 274' ' ' ALA . . . . . 0.618 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.75 -39.59 69.92 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.906 179.571 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . 0.586 ' O ' ' N ' ' A' ' 279' ' ' ALA . 3.7 p30 -39.17 97.94 0.15 Allowed Pre-proline 0 C--N 1.333 -0.15 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.576 -179.679 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo -53.97 -43.18 60.46 Favored 'Trans proline' 0 C--N 1.304 -1.814 0 C-N-CA 122.463 2.109 . . . . 0.0 112.614 -178.803 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 89.2 mt -64.5 -42.82 95.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.072 -179.563 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 91.0 mt -95.98 -1.11 49.69 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.814 -179.399 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 279' ' ' ALA . . . . . 0.586 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.49 -34.93 77.82 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.568 -179.721 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.33 20.28 0.12 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.965 -179.204 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . 0.513 ' H ' ' C ' ' A' ' 279' ' ' ALA . 13.7 mt -75.16 120.03 79.72 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.43 179.859 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -50.9 -39.61 58.66 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.617 2.211 . . . . 0.0 111.781 179.172 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.75 -50.63 63.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.171 179.731 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 74.7 t -61.48 -43.99 97.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 179.487 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -57.68 -41.28 81.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.283 -179.983 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -90.68 0.21 57.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.221 179.593 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt 59.73 42.93 16.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.872 179.658 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -94.7 41.34 1.09 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.356 179.793 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 54.0 t -119.02 135.92 57.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.964 0.412 . . . . 0.0 110.237 -179.832 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -133.68 163.61 29.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.69 -179.57 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.86 155.52 32.48 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.944 0.402 . . . . 0.0 110.721 -179.735 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 80.7 mt -94.32 -1.66 53.5 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.311 -179.765 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.46 165.3 12.57 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 -179.653 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 6.8 m -86.8 -61.66 1.68 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.871 0.367 . . . . 0.0 111.066 -179.814 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 295' ' ' GLU . . . . . 0.492 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.5 mm-40 -69.55 -4.75 20.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.657 -179.704 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 25.6 p -76.14 32.82 0.12 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.617 -179.88 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 297' ' ' PHE . . . . . 0.492 ' H ' ' C ' ' A' ' 295' ' ' GLU . 82.5 t80 -60.62 -46.12 91.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.662 -179.967 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . 0.613 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.2 mtt85 -80.76 137.11 36.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.679 -179.535 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 4.2 tp -114.16 116.17 28.66 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.407 179.775 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . 0.62 ' H ' ' HG ' ' A' ' 303' ' ' SER . 48.3 p-10 -166.05 -176.17 3.65 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.497 -179.921 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 301' ' ' TYR . . . . . 0.526 ' OH ' ' CD1' ' A' ' 173' ' ' PHE . 77.9 t80 -46.79 -43.44 18.33 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.226 -179.946 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -66.85 -40.81 88.04 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.991 0.424 . . . . 0.0 110.741 179.289 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 303' ' ' SER . . . . . 0.62 ' HG ' ' H ' ' A' ' 300' ' ' ASP . 60.7 p -55.74 -36.22 67.03 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.068 -179.178 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -57.74 -51.61 68.83 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.085 179.385 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 91.1 mtp -55.96 -44.23 78.28 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.688 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -65.91 -43.27 88.66 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.869 0.366 . . . . 0.0 110.195 178.741 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 56.0 t -63.89 -43.03 97.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.249 179.463 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 43.8 tp -59.74 -42.12 92.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.938 -179.747 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -62.41 -39.24 92.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.07 179.767 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 310' ' ' ARG . . . . . 0.455 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.7 ttt85 -63.67 -43.84 95.52 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.32 179.487 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 89.5 mt -63.31 -42.04 98.99 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.325 179.563 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -62.97 -33.68 75.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.138 179.341 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.68 -23.47 21.85 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.388 -179.777 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . 0.455 ' N ' ' O ' ' A' ' 310' ' ' ARG . 6.8 tt -62.28 -43.11 99.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.574 -179.971 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 . . . . . 0 C--O 1.22 -0.478 0 CA-C-O 118.028 -0.987 . . . . 0.0 110.483 179.939 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -99.35 135.88 40.11 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.563 179.993 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.499 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -92.28 178.52 1.66 Allowed Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.572 -179.884 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.499 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 27.0 Cg_exo -61.63 147.34 95.59 Favored 'Trans proline' 0 C--N 1.301 -1.97 0 C-N-CA 122.777 2.318 . . . . 0.0 112.09 179.709 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 35.2 ptt180 -135.65 142.38 45.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.691 179.742 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -79.88 116.29 19.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.524 179.923 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.4 tp -110.77 130.45 64.13 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.427 179.979 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.2 t -70.85 141.97 51.24 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.571 179.811 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.516 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.3 t0 -139.7 179.48 6.55 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.516 -179.913 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.516 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 78.5 p -73.67 -37.0 65.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.842 179.706 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.8 ttt85 -46.56 -94.66 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.354 -179.534 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.426 ' O ' ' OG1' ' A' ' 36' ' ' THR . . . -167.29 -26.55 0.02 OUTLIER Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 179.89 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' A' ' 35' ' ' GLY . 64.8 m -168.76 104.37 0.42 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.908 0.385 . . . . 0.0 110.65 -179.826 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 73.9 t60 -128.41 147.93 50.68 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.031 0.443 . . . . 0.0 110.293 179.95 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.483 ' CG2' ' N ' ' A' ' 39' ' ' LEU . 98.5 m -130.48 165.93 21.61 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.66 -179.894 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.483 ' N ' ' CG2' ' A' ' 38' ' ' THR . 83.1 mt -120.51 127.75 52.48 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.513 179.729 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -65.33 -44.63 87.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.626 -179.901 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.408 ' O ' ' HD3' ' A' ' 43' ' ' PRO . 42.2 p -165.77 154.77 11.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.466 179.652 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.468 ' N ' ' CD ' ' A' ' 42' ' ' GLN . 14.7 mp0 -44.32 101.31 0.25 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.644 179.495 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.408 ' HD3' ' O ' ' A' ' 41' ' ' SER . 31.6 Cg_exo -57.36 129.22 32.89 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 122.378 2.052 . . . . 0.0 112.178 -179.716 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -83.61 -24.68 31.36 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.495 179.654 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.54 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.1 mtm-85 -122.02 134.98 54.8 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-O 121.133 0.492 . . . . 0.0 110.345 -179.922 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 95.9 mt -131.19 133.82 62.02 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.272 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.96 -179.711 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 45.7 t -124.38 130.38 73.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.325 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.499 ' O ' ' O ' ' A' ' 66' ' ' ALA . 2.3 m -154.94 166.64 32.93 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.548 179.865 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 67.7 p -124.59 9.31 8.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.515 179.904 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.45 125.53 33.09 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.665 -179.512 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 98.4 t -65.86 -44.46 92.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.479 -179.982 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.5 m -62.68 -44.35 96.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.642 -179.839 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 51.1 tp -62.16 -41.6 98.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.555 -179.455 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 76.3 m -57.6 -44.34 85.37 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.308 -179.322 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.22 -62.18 5.38 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 179.547 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.7 t -48.44 -35.65 13.32 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 -179.99 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.8 mt -61.77 -44.91 95.96 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.636 -0.426 . . . . 0.0 111.174 179.448 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.3 mp -64.68 -41.82 95.79 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.091 0.472 . . . . 0.0 111.382 177.86 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.6 -40.95 98.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.652 -0.703 . . . . 0.0 111.014 -179.206 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.1 tp -88.6 17.18 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.724 -179.602 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 56.32 84.95 0.08 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.694 -179.977 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.24 58.99 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.081 -179.8 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -50.75 151.6 10.72 Favored 'Trans proline' 0 C--N 1.297 -2.155 0 C-N-CA 122.799 2.333 . . . . 0.0 112.579 -178.359 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.434 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -108.46 145.64 15.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.391 -179.764 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.8 mt -63.89 -44.91 98.16 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.298 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.416 -179.721 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.499 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -130.18 134.41 47.27 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.574 -179.806 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.479 ' O ' ' N ' ' A' ' 98' ' ' LEU . 72.9 m -134.67 158.82 43.09 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.83 -179.589 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.32 138.5 15.94 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 110.726 -0.949 . . . . 0.0 110.726 179.816 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.449 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.46 -163.0 0.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.96 0.41 . . . . 0.0 110.508 -179.988 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.494 ' O ' ' C ' ' A' ' 71' ' ' THR . 5.9 t -133.75 135.39 43.91 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.242 -179.977 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.494 ' C ' ' O ' ' A' ' 70' ' ' THR . 0.9 OUTLIER 29.61 68.35 0.67 Allowed Pre-proline 0 N--CA 1.464 0.236 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.745 -179.663 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -60.98 144.59 99.61 Favored 'Trans proline' 0 C--N 1.301 -1.958 0 C-N-CA 122.548 2.165 . . . . 0.0 112.252 -178.573 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.528 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 45.4 p-10 -159.68 -31.7 0.06 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.634 179.624 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.528 ' N ' ' OD1' ' A' ' 73' ' ' ASN . 99.1 m-20 -64.15 -39.44 94.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.415 179.998 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -60.43 -48.2 82.8 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.644 -179.242 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.425 ' O ' ' O ' ' A' ' 77' ' ' ALA . 97.0 t -60.15 -24.7 31.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.154 179.596 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.425 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -45.72 173.15 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.588 179.853 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.574 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.3 p30 -62.06 177.56 0.45 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.583 -179.689 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.595 ' C ' ' H ' ' A' ' 81' ' ' GLY . 36.2 p30 -45.46 85.86 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.942 179.99 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.574 ' N ' ' O ' ' A' ' 78' ' ' ASP . 43.0 tp60 -67.65 13.23 0.08 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.08 -179.838 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.595 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 118.52 -21.89 9.66 Favored Glycine 0 CA--C 1.519 0.321 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.985 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -108.4 116.46 32.02 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.941 0.4 . . . . 0.0 110.522 179.894 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 75.6 mt -98.79 0.49 44.5 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.451 -179.726 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -92.65 7.18 44.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.988 0.423 . . . . 0.0 110.46 -179.778 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.443 ' O ' ' CG2' ' A' ' 89' ' ' VAL . 88.5 mt-30 -100.03 -27.91 13.33 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.855 -179.971 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 69.3 t-105 -63.19 -40.71 98.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.877 -179.544 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.56 ' O ' ' N ' ' A' ' 91' ' ' LYS . 65.7 m -77.65 -53.68 7.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.203 -179.394 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -48.19 -50.86 27.59 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.939 -179.363 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.443 ' CG2' ' O ' ' A' ' 85' ' ' GLN . 15.7 m -68.89 -40.75 81.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 120.936 0.398 . . . . 0.0 111.034 179.836 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.41 ' H ' HG23 ' A' ' 89' ' ' VAL . . . -72.46 -22.65 61.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.83 -179.869 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.56 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.1 tttm -61.91 -45.41 93.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.477 -179.578 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.441 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.7 mm-40 -90.69 -94.88 0.12 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.118 -179.869 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.644 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.8 mtt180 -142.9 59.31 1.42 Allowed 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.716 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.466 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.8 pttp 33.33 25.97 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.162 -179.098 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.644 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.3 tt -47.78 123.54 6.13 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.918 -178.287 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -83.8 -169.89 2.8 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.075 -179.913 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.612 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 82.4 mtp180 -74.1 137.17 43.12 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.197 -179.805 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.479 ' N ' ' O ' ' A' ' 67' ' ' SER . 90.4 mt -86.46 -165.74 1.35 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.704 -179.618 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.536 ' CD2' ' O ' ' A' ' 99' ' ' TYR . 48.6 p90 -168.87 120.14 0.75 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.297 179.972 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.518 ' C ' ' O ' ' A' ' 99' ' ' TYR . 43.3 mm -29.18 121.27 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.995 -179.563 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 114.38 27.06 3.49 Favored Glycine 0 CA--C 1.52 0.344 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 -179.575 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.578 ' N ' ' CD ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -144.27 46.2 0.61 Allowed Pre-proline 0 C--N 1.324 -0.508 0 CA-C-O 120.913 0.387 . . . . 0.0 110.511 179.946 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 29.8 Cg_endo -61.8 143.63 96.2 Favored 'Trans proline' 0 C--N 1.297 -2.146 0 C-N-CA 122.695 2.263 . . . . 0.0 111.989 -179.937 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.706 ' HG ' ' H ' ' A' ' 107' ' ' ALA . 26.2 t -173.19 119.97 0.34 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.489 179.698 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.19 -40.56 64.68 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.068 0.461 . . . . 0.0 111.1 179.76 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.19 -40.02 90.12 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.819 -179.368 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.706 ' H ' ' HG ' ' A' ' 104' ' ' SER . . . -64.02 -39.95 95.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.713 -179.768 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 72.0 t -67.74 -43.97 86.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.839 179.709 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.77 -38.98 92.73 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.552 -179.31 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.441 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.47 -23.3 62.61 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.434 179.867 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.554 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.5 mm-40 -90.51 5.12 49.06 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.651 -179.518 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.554 ' C ' ' O ' ' A' ' 111' ' ' GLN . 10.4 tpt 24.03 63.73 0.4 Allowed Pre-proline 0 N--CA 1.464 0.266 0 CA-C-O 120.861 0.362 . . . . 0.0 110.866 -179.967 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -77.92 167.36 23.8 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 C-N-CA 122.998 2.465 . . . . 0.0 112.392 -178.739 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.525 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 99.4 m-20 -110.49 -42.38 4.11 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.982 0.42 . . . . 0.0 110.042 179.55 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 39.8 tp -120.98 120.14 34.59 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.036 179.54 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 84.7 mt -113.21 129.19 69.38 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 CA-C-O 120.978 0.418 . . . . 0.0 110.848 -179.832 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 29.2 mt -108.95 132.26 54.25 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.235 -179.71 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 98.8 mt -119.59 138.77 49.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.712 -179.766 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 85.8 p -72.65 153.45 41.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.565 -179.998 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.21 -49.98 75.46 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.682 -179.769 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -149.55 154.07 38.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.6 179.811 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 170.36 -170.86 43.29 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 179.838 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.99 -34.17 89.24 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 179.949 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.453 ' O ' ' OD1' ' A' ' 124' ' ' ASP . 44.2 p-10 -87.33 120.27 28.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.833 0.349 . . . . 0.0 110.626 -179.942 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 40.0 t -63.22 143.74 57.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.538 -179.976 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.521 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.23 -43.18 8.95 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.819 -179.778 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.2 tp -62.7 -42.55 99.7 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.718 -179.912 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.26 -12.23 59.56 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.574 -179.459 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 84.1 mt -114.91 -23.51 9.08 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.721 -179.797 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . 0.521 ' N ' ' O ' ' A' ' 126' ' ' ALA . 78.0 t80 -51.12 -49.67 60.31 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 120.586 -0.446 . . . . 0.0 110.476 -178.929 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.503 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.1 p-10 -65.81 -42.52 90.55 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.905 0.383 . . . . 0.0 111.138 179.599 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.503 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 88.2 mt-30 -67.13 -37.84 84.53 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.832 179.97 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 95.9 mt -80.39 -41.32 24.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.881 -179.505 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.2 t -57.26 -44.53 83.98 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.243 -179.236 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 18.8 m -61.77 -45.36 94.22 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.8 0.333 . . . . 0.0 110.597 179.326 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 93.0 mt -62.11 -43.55 97.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.226 -179.784 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.63 168.31 4.77 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.559 179.867 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -49.94 113.25 0.92 Allowed 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.286 1.991 . . . . 0.0 112.092 179.507 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 23.8 m -84.15 127.22 33.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.594 -179.954 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 34.4 tp -117.66 135.23 54.14 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.988 -179.77 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.439 ' O ' ' OD2' ' A' ' 32' ' ' ASP . 81.5 mt -99.54 118.95 46.91 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 CA-C-O 121.175 0.512 . . . . 0.0 111.276 -179.336 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 98.1 mt -135.02 132.05 53.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.64 179.627 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.507 HD22 ' CG ' ' A' ' 241' ' ' ASP . 60.2 t30 -66.63 150.26 49.3 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.842 0.353 . . . . 0.0 110.428 179.4 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.517 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 87.7 t80 -85.01 122.39 29.16 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.859 -179.499 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.517 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 98.7 m-20 55.25 69.21 0.76 Allowed 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.856 179.748 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 34.9 p-10 -125.82 0.56 7.38 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.926 0.393 . . . . 0.0 110.753 179.857 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -150.85 115.73 5.26 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.699 -179.522 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 148' ' ' SER . . . . . 0.521 ' HG ' ' H ' ' A' ' 150' ' ' GLN . 83.9 p -64.39 169.15 4.95 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.528 -179.842 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.423 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.4 p-90 -52.21 -16.12 0.75 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.559 -179.863 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . 0.521 ' H ' ' HG ' ' A' ' 148' ' ' SER . 68.2 tp60 -70.07 -77.01 0.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.425 -179.712 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.453 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.1 t -62.57 -38.26 89.39 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.369 179.568 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 53.2 tp -60.06 -45.53 92.55 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.373 -178.566 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.423 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 46.8 tp -62.85 -41.74 99.48 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.821 0.343 . . . . 0.0 110.321 179.086 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.453 ' OG1' ' O ' ' A' ' 151' ' ' SER . 63.5 p -64.07 -34.75 78.74 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.285 -179.611 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . 0.432 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.8 mm-40 -63.97 -42.77 97.14 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.316 179.235 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 92.7 mt -65.39 -39.02 91.72 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.016 0.436 . . . . 0.0 110.255 179.099 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.587 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -60.93 -32.08 78.58 Favored Glycine 0 CA--C 1.52 0.404 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 -179.468 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.439 ' C ' ' O ' ' A' ' 157' ' ' GLY . 97.2 mt-10 -35.71 -26.42 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.815 0.341 . . . . 0.0 110.744 179.93 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.587 ' N ' ' O ' ' A' ' 157' ' ' GLY . 95.7 mt -57.02 149.32 4.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.251 179.313 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 72.6 p -69.61 137.27 52.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.979 -179.535 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 71.77 20.45 78.68 Favored Glycine 0 N--CA 1.458 0.156 0 N-CA-C 111.243 -0.743 . . . . 0.0 111.243 179.457 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 56.8 m80 -122.3 -14.66 7.85 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.785 0.326 . . . . 0.0 110.64 179.816 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -65.22 -60.31 3.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.723 -179.684 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -51.85 -49.14 63.47 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.246 -179.771 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -60.66 -41.08 94.29 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.704 0.288 . . . . 0.0 110.284 179.542 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.55 -47.02 87.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.637 179.828 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -57.24 -40.03 76.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.251 -179.983 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -61.85 -50.31 72.77 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.562 179.621 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -65.36 -43.84 89.57 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.511 179.551 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 95.1 mt -64.65 -43.47 96.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.473 179.736 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.23 -50.92 71.35 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.627 -179.261 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.47 -43.72 96.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.363 179.747 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . 0.454 ' CD1' ' OH ' ' A' ' 301' ' ' TYR . 56.1 t80 -62.7 -44.64 95.71 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.123 0.487 . . . . 0.0 110.443 179.4 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -63.33 -40.08 96.31 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.522 -179.312 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -62.95 -42.73 99.9 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.704 179.259 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -60.77 -44.85 96.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.071 179.946 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 84.8 mt -64.3 -41.13 97.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.033 0.444 . . . . 0.0 110.661 178.917 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -51.88 -62.51 1.58 Allowed 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.478 -179.335 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.52 -46.86 85.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.58 179.819 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.26 -41.71 65.77 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.245 -179.993 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -63.8 -33.59 76.01 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.946 0.403 . . . . 0.0 110.364 179.27 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . 0.405 ' HG2' ' O ' ' A' ' 182' ' ' GLU . 69.6 tt0 -90.51 8.49 33.7 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.317 0.58 . . . . 0.0 110.586 -179.091 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -104.5 -32.33 9.04 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.257 179.597 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.3 pt -128.01 147.6 32.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.843 -179.878 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -139.76 130.99 26.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.347 179.506 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . 0.558 ' CD2' ' N ' ' A' ' 186' ' ' LEU . 3.6 mm? -85.49 133.37 42.32 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.793 179.992 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -44.05 157.9 0.14 Allowed 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.735 2.29 . . . . 0.0 112.042 179.527 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . 0.535 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.7 Cg_endo -62.96 114.87 2.62 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 122.748 2.299 . . . . 0.0 111.76 179.817 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . 0.535 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.8 mt-30 155.28 148.17 0.0 OUTLIER Pre-proline 0 C--N 1.331 -0.199 0 O-C-N 123.383 0.427 . . . . 0.0 110.665 -179.784 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -73.94 144.5 34.49 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 122.725 2.283 . . . . 0.0 111.734 178.126 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.497 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.1 p -125.29 158.94 33.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.198 0.523 . . . . 0.0 110.12 -179.974 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 192' ' ' THR . . . . . 0.497 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 35.4 p -143.61 165.58 27.22 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.129 -179.609 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -135.76 128.66 31.28 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.151 0.501 . . . . 0.0 110.273 179.69 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 47.3 pt -146.3 148.76 16.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.021 179.899 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 70.3 t -117.49 122.88 70.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.245 0.545 . . . . 0.0 109.692 179.112 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -134.21 107.32 7.62 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.292 179.699 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 95.2 m -131.08 130.56 43.35 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.818 179.833 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.405 ' O ' ' N ' ' A' ' 201' ' ' HIS . . . -83.09 -36.87 24.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.228 179.71 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.6 -66.95 0.27 Allowed 'General case' 0 C--O 1.231 0.129 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.402 179.997 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.42 -9.76 58.93 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.246 179.494 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . 0.405 ' N ' ' O ' ' A' ' 198' ' ' ALA . 60.0 t-80 60.7 58.46 2.41 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.799 -179.844 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 40.6 p -167.16 153.25 7.96 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.505 179.55 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.26 143.92 24.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.997 0.427 . . . . 0.0 110.452 179.458 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -135.38 138.83 43.69 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.655 179.952 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 20.3 mt -106.69 125.54 51.13 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 121.134 0.492 . . . . 0.0 109.795 -179.687 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 206' ' ' TRP . . . . . 0.556 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 74.9 m95 -81.93 166.95 19.43 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.575 -179.72 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -156.94 171.62 7.2 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 120.997 0.427 . . . . 0.0 110.525 -179.223 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.06 -36.99 86.54 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 C-N-CA 122.639 2.226 . . . . 0.0 111.959 179.473 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -70.43 -35.16 73.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.906 -179.893 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 21.4 m -60.94 150.92 31.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.614 -179.296 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.58 -37.12 82.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.529 -179.751 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 212' ' ' GLN . . . . . 0.556 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 55.0 tt0 -64.56 -40.36 95.42 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.519 179.977 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.52 -43.32 92.58 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 179.804 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -63.45 -43.93 95.97 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.707 0.289 . . . . 0.0 110.276 179.883 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 65.4 ttp -59.49 -48.1 82.95 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.322 -179.805 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 87.7 mt -60.38 -40.6 91.42 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 179.416 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 217' ' ' GLU . . . . . 0.462 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.9 tp10 -58.34 -37.98 76.25 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.739 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -65.14 -38.28 90.11 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.813 0.34 . . . . 0.0 110.709 179.702 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 93.9 mt -64.36 -42.65 96.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.584 -179.62 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.56 45.1 0.08 OUTLIER Glycine 0 C--N 1.333 0.379 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 -179.937 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 221' ' ' PHE . . . . . 0.462 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 27.0 m-85 -128.08 155.18 44.79 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.052 0.454 . . . . 0.0 110.487 -179.807 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 222' ' ' THR . . . . . 0.46 ' O ' ' O ' ' A' ' 191' ' ' VAL . 6.4 p -106.92 122.28 46.11 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.179 0.514 . . . . 0.0 110.261 -179.987 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . 0.445 ' CD2' ' N ' ' A' ' 223' ' ' LEU . 4.3 mm? -101.22 133.0 46.45 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.077 -179.957 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.85 159.55 14.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.509 179.886 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.38 114.99 29.5 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.333 179.88 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.449 ' CD1' ' N ' ' A' ' 226' ' ' LEU . 9.1 mp -53.13 156.94 3.33 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.626 179.935 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -60.46 145.36 98.87 Favored 'Trans proline' 0 C--N 1.302 -1.903 0 C-N-CA 122.601 2.201 . . . . 0.0 112.004 179.485 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.3 -3.27 59.03 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.556 -179.989 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.01 -41.16 5.66 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 -179.885 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . 0.536 ' O ' ' N ' ' A' ' 233' ' ' SER . 85.5 mt -79.08 -17.19 55.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.983 0.42 . . . . 0.0 110.364 -179.738 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 231' ' ' ASN . . . . . 0.404 ' C ' ' O ' ' A' ' 230' ' ' LEU . 54.8 t-20 -40.11 -49.41 2.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.757 -179.694 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -87.82 15.32 7.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.768 0.318 . . . . 0.0 111.186 -179.967 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 233' ' ' SER . . . . . 0.536 ' N ' ' O ' ' A' ' 230' ' ' LEU . 78.1 p -60.4 -35.74 76.45 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.535 -179.811 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 234' ' ' GLN . . . . . 0.525 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.6 tt0 -118.74 -69.19 0.86 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.917 179.642 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.3 m -69.73 103.11 2.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.633 -179.785 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -94.29 57.5 2.33 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.391 179.909 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -144.82 -122.42 1.56 Allowed Glycine 0 CA--C 1.521 0.43 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 -179.987 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -135.17 111.8 9.98 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 121.115 0.483 . . . . 0.0 110.468 179.983 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 239' ' ' ARG . . . . . 0.523 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.5 mtt180 -148.15 57.74 1.08 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.738 -179.894 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -69.64 -32.21 70.75 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.548 179.625 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 241' ' ' ASP . . . . . 0.507 ' CG ' HD22 ' A' ' 143' ' ' ASN . 65.1 t0 -56.94 -46.94 81.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.396 -179.159 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 242' ' ' ILE . . . . . 0.437 ' O ' ' O ' ' A' ' 239' ' ' ARG . 17.8 tt -139.84 156.43 25.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.893 0.378 . . . . 0.0 110.518 179.746 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 96.2 mt -106.24 106.34 20.4 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.188 0 CA-C-O 121.108 0.48 . . . . 0.0 110.511 179.863 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . 0.523 ' OE1' ' NH1' ' A' ' 239' ' ' ARG . 88.2 mt-30 -110.25 110.06 20.74 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.261 179.76 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 9.4 mp -121.96 -168.45 1.71 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.663 179.839 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . 0.525 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.54 -16.66 0.05 OUTLIER Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.911 -0.875 . . . . 0.0 110.911 179.945 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . 0.698 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -60.62 156.83 30.79 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -179.888 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -63.72 21.73 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.936 0.398 . . . . 0.0 110.655 179.924 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . 0.698 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.8 m-20 -97.34 -5.94 35.39 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.572 179.943 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 93.5 mt -79.85 -21.82 43.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.619 179.575 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.54 -51.27 70.59 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.864 -179.57 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.4 -5.54 58.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.394 179.642 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -80.93 -74.53 1.13 Allowed Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 -179.911 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 81.5 mt -69.79 125.4 26.62 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.025 0.44 . . . . 0.0 110.178 -179.816 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -59.49 -39.48 83.91 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.389 -179.739 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 84.45 51.71 3.8 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -179.938 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -94.62 -16.51 23.12 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.738 0.304 . . . . 0.0 110.597 -179.862 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 258' ' ' SER . . . . . 0.455 ' HG ' ' CG2' ' A' ' 191' ' ' VAL . 3.3 t 174.17 89.83 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.045 0.45 . . . . 0.0 110.119 -179.971 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . 0.598 ' N ' ' CD1' ' A' ' 259' ' ' LEU . 1.0 OUTLIER -94.46 124.03 38.24 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.224 0.535 . . . . 0.0 111.088 -179.099 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 16.0 m-30 -93.18 146.85 23.37 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.332 179.166 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 86.7 mt -122.57 149.87 43.36 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.512 -179.9 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.661 ' CG ' ' N ' ' A' ' 263' ' ' ALA . 2.6 p90 -77.94 -138.48 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.526 -179.813 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 263' ' ' ALA . . . . . 0.661 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -51.89 77.49 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.92 -179.942 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . 0.637 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.13 104.42 0.19 Allowed Glycine 0 N--CA 1.467 0.721 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 -179.986 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 265' ' ' ASP . . . . . 0.604 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.6 m-20 -80.43 -177.54 6.24 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.713 0.292 . . . . 0.0 110.91 -179.497 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -40.64 -17.56 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.852 0.358 . . . . 0.0 110.493 179.866 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 267' ' ' LYS . . . . . 0.604 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.64 -51.51 41.39 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.637 179.576 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -63.88 -46.71 83.69 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.076 179.525 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . 0.526 ' O ' ' CD2' ' A' ' 273' ' ' TYR . . . -61.54 -35.12 76.85 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.839 179.552 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -62.98 -34.59 77.86 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.126 179.653 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.36 -43.3 13.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.336 -179.588 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 272' ' ' ILE . . . . . 0.616 ' C ' ' H ' ' A' ' 274' ' ' ALA . 4.9 tt -51.42 -33.63 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.826 -178.872 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 273' ' ' TYR . . . . . 0.526 ' CD2' ' O ' ' A' ' 269' ' ' ALA . 17.4 m-85 -54.37 -1.7 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.677 -179.7 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 274' ' ' ALA . . . . . 0.616 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -72.13 -39.71 68.62 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.906 179.63 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . 0.588 ' O ' ' N ' ' A' ' 279' ' ' ALA . 3.9 p30 -39.36 97.78 0.15 Allowed Pre-proline 0 N--CA 1.462 0.156 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.54 -179.653 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 276' ' ' PRO . . . . . 0.402 ' N ' ' O ' ' A' ' 274' ' ' ALA . 45.5 Cg_exo -53.97 -43.31 59.36 Favored 'Trans proline' 0 C--N 1.303 -1.848 0 C-N-CA 122.363 2.042 . . . . 0.0 112.737 -178.857 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 89.4 mt -64.37 -42.83 95.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.206 -179.674 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 90.8 mt -95.94 -1.31 49.43 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.842 -179.361 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 279' ' ' ALA . . . . . 0.588 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.42 -34.89 77.66 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.604 -179.69 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -73.99 19.55 0.12 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.078 -179.224 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . 0.494 ' H ' ' C ' ' A' ' 279' ' ' ALA . 14.0 mt -74.95 121.0 84.31 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.355 179.873 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_exo -51.24 -39.44 62.12 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 122.573 2.182 . . . . 0.0 111.657 179.289 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.57 -50.65 62.53 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 179.748 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 81.8 t -61.84 -43.91 98.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 179.507 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -57.57 -41.86 81.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.418 -179.871 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -90.47 1.06 57.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.215 179.572 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt 58.39 40.42 24.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.036 0.446 . . . . 0.0 110.903 179.681 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -92.36 42.41 1.1 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.37 179.781 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 54.4 t -119.16 135.79 58.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.023 0.44 . . . . 0.0 110.182 -179.724 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -132.93 162.97 30.23 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.031 0.443 . . . . 0.0 110.697 -179.663 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.92 155.02 33.57 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.968 0.413 . . . . 0.0 110.774 -179.85 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 80.9 mt -93.69 -1.39 55.26 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.278 -179.782 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.17 165.38 12.64 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 -179.725 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 6.8 m -87.13 -62.32 1.53 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.866 0.365 . . . . 0.0 111.008 -179.802 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 295' ' ' GLU . . . . . 0.476 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.6 mm-40 -69.53 -4.2 17.97 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.544 -179.738 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 29.1 p -76.66 32.51 0.13 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.662 -179.877 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 297' ' ' PHE . . . . . 0.476 ' H ' ' C ' ' A' ' 295' ' ' GLU . 70.4 t80 -60.18 -46.05 91.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.565 -179.905 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 298' ' ' ARG . . . . . 0.612 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.1 mtt85 -81.09 133.45 35.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.073 0.463 . . . . 0.0 110.433 -179.712 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 16.3 tp -114.19 119.4 36.95 Favored 'General case' 0 CA--C 1.527 0.089 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.205 -179.97 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . 0.611 ' H ' ' CB ' ' A' ' 303' ' ' SER . 49.9 p-10 -167.29 -174.21 2.51 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.508 -179.968 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 301' ' ' TYR . . . . . 0.454 ' OH ' ' CD1' ' A' ' 173' ' ' PHE . 85.7 t80 -48.34 -45.46 35.33 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.127 -179.591 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -65.0 -41.62 95.23 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.004 0.43 . . . . 0.0 110.724 178.969 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 303' ' ' SER . . . . . 0.611 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 52.7 p -55.15 -36.04 65.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.182 -179.5 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -57.13 -51.49 69.08 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 110.016 -0.365 . . . . 0.0 110.016 179.459 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 90.8 mtp -56.37 -43.82 79.56 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.689 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -66.57 -42.65 86.7 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.867 0.365 . . . . 0.0 110.18 178.778 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 56.0 t -64.06 -42.89 97.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.192 179.401 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 43.4 tp -59.55 -42.17 91.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.827 -179.593 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -62.73 -39.0 92.71 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 179.61 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 310' ' ' ARG . . . . . 0.44 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.6 ttt85 -63.54 -44.01 95.45 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.3 179.515 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 87.9 mt -63.36 -42.0 98.87 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.188 179.56 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -62.81 -33.18 74.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.106 179.454 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -90.19 -23.13 21.38 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.564 -179.908 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . 0.44 ' N ' ' O ' ' A' ' 310' ' ' ARG . 6.7 tt -62.43 -43.23 99.31 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.063 0.459 . . . . 0.0 110.589 -179.902 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 . . . . . 0 C--O 1.22 -0.462 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.508 179.989 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -99.7 135.54 40.96 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.1 0.476 . . . . 0.0 110.406 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.48 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -92.51 178.71 1.56 Allowed Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.403 -179.686 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.48 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 27.0 Cg_exo -61.66 147.44 95.34 Favored 'Trans proline' 0 C--N 1.303 -1.833 0 C-N-CA 122.909 2.406 . . . . 0.0 112.214 179.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 35.2 ptt180 -136.32 142.61 43.88 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.571 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -79.94 116.77 20.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.509 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.4 tp -111.45 130.53 64.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.487 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.1 t -71.24 142.5 50.56 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.607 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.519 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.4 t0 -139.45 -179.96 6.2 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.504 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.519 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 78.1 p -73.88 -37.23 64.79 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.683 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -46.69 -94.72 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.304 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.421 ' O ' ' OG1' ' A' ' 36' ' ' THR . . . -166.53 -26.75 0.02 OUTLIER Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.421 ' OG1' ' O ' ' A' ' 35' ' ' GLY . 62.4 m -168.63 105.64 0.44 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.707 0.289 . . . . 0.0 110.531 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 70.0 t60 -129.01 146.63 50.93 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.224 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.482 ' CG2' ' N ' ' A' ' 39' ' ' LEU . 98.8 m -129.96 165.57 21.83 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.377 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.482 ' N ' ' CG2' ' A' ' 38' ' ' THR . 77.9 mt -120.2 127.28 52.3 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.654 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -65.42 -44.91 85.91 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.592 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 37.5 p -165.78 154.95 11.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.55 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.469 ' N ' ' CD ' ' A' ' 42' ' ' GLN . 14.7 mp0 -44.51 101.02 0.24 Allowed Pre-proline 0 C--O 1.235 0.302 0 O-C-N 123.564 0.54 . . . . 0.0 110.467 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -57.61 130.07 36.94 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.449 2.099 . . . . 0.0 112.111 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -82.95 -24.76 32.86 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.573 179.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.537 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.9 mtm-85 -121.23 134.33 55.19 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.995 0.426 . . . . 0.0 110.287 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.3 mt -130.22 133.26 64.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.515 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 46.2 t -124.73 131.04 73.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-O 121.002 0.429 . . . . 0.0 110.163 178.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.503 ' O ' ' O ' ' A' ' 66' ' ' ALA . 4.2 m -154.67 166.42 33.45 Favored 'General case' 0 C--O 1.224 -0.241 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.461 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 72.6 p -124.41 9.11 8.45 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.483 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.1 t -85.65 125.68 33.34 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.942 0.401 . . . . 0.0 110.577 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 90.1 t -65.66 -44.52 93.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.546 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.0 m -62.51 -44.45 96.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.686 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 54.7 tp -62.35 -41.52 98.66 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.65 -179.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 70.5 m -57.88 -44.61 86.8 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.219 -179.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.39 -62.05 5.45 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.5 t -47.55 -35.94 9.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.79 0.328 . . . . 0.0 110.144 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.7 mt -61.87 -44.64 96.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.909 0.385 . . . . 0.0 110.976 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.0 mp -65.17 -41.32 94.74 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.292 178.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.78 -41.19 97.99 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.631 -179.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 7.9 tp -88.06 16.62 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.673 -179.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 56.33 84.09 0.09 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.795 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.21 57.11 0.06 OUTLIER Pre-proline 0 C--N 1.327 -0.371 0 CA-C-O 121.018 0.437 . . . . 0.0 109.907 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -50.17 153.72 6.45 Favored 'Trans proline' 0 C--N 1.298 -2.096 0 C-N-CA 122.972 2.448 . . . . 0.0 112.492 -178.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.425 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -109.15 146.12 15.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.238 -179.728 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 97.0 mt -63.78 -45.08 98.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.116 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.503 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -130.32 134.21 47.02 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.775 0.321 . . . . 0.0 110.266 -179.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.494 ' O ' ' N ' ' A' ' 98' ' ' LEU . 72.9 m -134.47 158.71 43.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.805 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.71 139.35 16.37 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.716 -0.954 . . . . 0.0 110.716 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.46 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.78 -162.67 0.08 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.798 0.333 . . . . 0.0 110.384 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.467 ' O ' ' C ' ' A' ' 71' ' ' THR . 5.9 t -133.97 135.36 43.43 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.096 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.467 ' C ' ' O ' ' A' ' 70' ' ' THR . 0.8 OUTLIER 29.47 68.71 0.64 Allowed Pre-proline 0 N--CA 1.468 0.475 0 CA-C-O 121.216 0.532 . . . . 0.0 110.84 -179.48 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -60.86 144.79 99.63 Favored 'Trans proline' 0 C--N 1.302 -1.911 0 C-N-CA 122.776 2.317 . . . . 0.0 112.064 -178.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.528 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 46.3 p-10 -159.79 -31.83 0.06 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.667 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.528 ' N ' ' OD1' ' A' ' 73' ' ' ASN . 99.0 m-20 -64.29 -39.36 93.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.421 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.6 ttt180 -60.39 -48.46 81.64 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.436 -179.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.425 ' O ' ' O ' ' A' ' 77' ' ' ALA . 93.7 t -60.05 -24.52 30.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.172 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.425 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -45.82 172.95 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.53 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.57 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.5 p30 -61.94 177.64 0.43 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.433 -179.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.599 ' C ' ' H ' ' A' ' 81' ' ' GLY . 35.5 p30 -45.9 85.44 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.807 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.57 ' N ' ' O ' ' A' ' 78' ' ' ASP . 42.2 tp60 -67.14 13.65 0.06 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.261 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.599 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 117.94 -22.31 9.9 Favored Glycine 0 N--CA 1.463 0.471 0 N-CA-C 110.874 -0.891 . . . . 0.0 110.874 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -107.94 116.17 31.47 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.873 0.368 . . . . 0.0 110.348 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 75.9 mt -98.68 0.67 45.13 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.474 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -92.19 6.8 45.28 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.344 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.435 ' O ' ' CG2' ' A' ' 89' ' ' VAL . 88.2 mt-30 -99.91 -28.18 13.23 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.564 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 68.6 t-105 -63.44 -40.91 98.42 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.705 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.545 ' O ' ' N ' ' A' ' 91' ' ' LYS . 64.5 m -77.49 -53.68 7.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.873 -179.177 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -48.4 -51.01 28.58 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.801 -178.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.435 ' CG2' ' O ' ' A' ' 85' ' ' GLN . 16.0 m -68.92 -40.68 81.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.891 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.411 ' H ' HG23 ' A' ' 89' ' ' VAL . . . -72.27 -22.72 61.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.695 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.545 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.0 tttm -61.57 -45.92 92.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.449 -179.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.436 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.7 mm-40 -90.16 -94.58 0.12 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.198 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.609 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.9 mtt180 -143.38 59.3 1.4 Allowed 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.434 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.6 pttp 33.92 26.24 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 O-C-N 123.588 0.555 . . . . 0.0 110.487 -179.198 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.609 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.5 tt -48.29 123.07 5.94 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.648 -177.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -83.11 -170.48 3.06 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.399 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.619 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 82.8 mtp180 -73.42 137.78 44.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.229 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.494 ' N ' ' O ' ' A' ' 67' ' ' SER . 88.9 mt -86.13 -166.37 1.52 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.807 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.53 ' CD2' ' O ' ' A' ' 99' ' ' TYR . 46.9 p90 -167.77 119.83 0.88 Allowed 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.106 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.487 ' C ' ' O ' ' A' ' 99' ' ' TYR . 43.2 mm -29.63 121.33 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 O-C-N 123.482 0.489 . . . . 0.0 110.891 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 113.28 28.59 3.26 Favored Glycine 0 N--CA 1.464 0.504 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.578 ' N ' ' CD ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -143.86 45.45 0.56 Allowed Pre-proline 0 C--N 1.324 -0.504 0 CA-C-O 121.321 0.582 . . . . 0.0 110.502 179.795 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 30.6 Cg_endo -61.95 143.94 95.91 Favored 'Trans proline' 0 C--N 1.298 -2.123 0 C-N-CA 122.614 2.209 . . . . 0.0 112.014 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.693 ' HG ' ' H ' ' A' ' 107' ' ' ALA . 21.9 t -173.18 120.84 0.36 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.534 179.311 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.3 -40.74 64.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.215 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.16 -40.29 90.42 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.69 -179.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.693 ' H ' ' HG ' ' A' ' 104' ' ' SER . . . -64.1 -39.98 95.22 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.659 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 69.4 t -67.71 -43.8 86.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.634 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.37 -39.19 92.36 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.521 -179.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.436 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.6 -23.23 62.79 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.596 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.519 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.3 mm-40 -90.95 4.31 52.3 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.716 -179.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.537 ' O ' ' NE ' ' A' ' 45' ' ' ARG . 10.3 tpt 23.97 63.82 0.4 Allowed Pre-proline 0 N--CA 1.471 0.602 0 O-C-N 123.622 0.576 . . . . 0.0 110.986 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -78.63 168.22 21.49 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 123.019 2.48 . . . . 0.0 112.075 -178.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.511 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 98.8 m-20 -112.56 -43.78 3.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.292 179.379 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.0 tp -121.03 120.09 34.36 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.262 178.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 96.8 mt -117.14 131.14 70.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.719 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 30.1 mt -106.07 132.32 52.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.218 -179.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 98.3 mt -118.08 136.71 54.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.495 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 86.6 p -71.98 152.3 42.59 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.565 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -59.97 -50.05 75.26 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.535 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -149.19 153.52 37.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.513 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 169.76 -170.73 42.95 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -63.07 -35.05 91.56 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.444 ' O ' ' OD1' ' A' ' 124' ' ' ASP . 43.9 p-10 -87.8 120.34 29.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.892 0.377 . . . . 0.0 110.635 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 41.0 t -63.34 143.68 57.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.469 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.516 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.6 -42.74 9.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.647 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.5 tp -62.79 -42.42 99.7 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.761 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.01 -10.63 55.14 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.413 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 83.4 mt -115.59 -24.39 8.32 Favored 'General case' 0 C--O 1.224 -0.238 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.533 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . 0.516 ' N ' ' O ' ' A' ' 126' ' ' ALA . 75.1 t80 -51.39 -49.93 60.59 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.96 -0.296 . . . . 0.0 110.531 -178.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.502 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 37.6 p-10 -65.95 -42.13 90.36 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.933 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.502 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 88.2 mt-30 -67.66 -36.76 81.33 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.73 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 94.3 mt -80.22 -41.85 24.37 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.025 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.4 t -57.16 -44.88 83.88 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.204 -179.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.3 m -62.2 -45.48 93.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.616 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 92.2 mt -62.54 -43.81 98.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.336 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -170.05 163.47 6.4 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.563 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -43.1 111.86 0.25 Allowed 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.576 2.184 . . . . 0.0 112.068 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 17.2 m -85.64 127.72 34.56 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.328 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 34.0 tp -119.45 137.23 53.91 Favored 'General case' 0 C--N 1.334 -0.078 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.404 179.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.431 ' O ' ' OD2' ' A' ' 32' ' ' ASP . 80.7 mt -103.4 119.75 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.844 -178.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 97.2 mt -135.75 133.09 51.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.607 179.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.509 HD22 ' CG ' ' A' ' 241' ' ' ASP . 60.9 t30 -65.2 150.93 47.35 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.41 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.512 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 88.2 t80 -85.91 122.38 29.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.725 -179.2 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.512 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 99.1 m-20 55.38 69.34 0.74 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.497 179.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 43.4 p-10 -126.64 0.54 6.81 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.537 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -150.34 114.79 5.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.833 0.349 . . . . 0.0 110.547 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' SER . . . . . 0.521 ' HG ' ' H ' ' A' ' 150' ' ' GLN . 84.8 p -62.69 168.23 3.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.594 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.408 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.6 p-90 -51.44 -15.86 0.48 Allowed 'General case' 0 C--O 1.22 -0.461 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.299 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . 0.521 ' H ' ' HG ' ' A' ' 148' ' ' SER . 68.3 tp60 -70.49 -75.44 0.12 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.998 0.427 . . . . 0.0 110.613 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.445 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.2 t -62.53 -38.82 91.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.298 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 52.8 tp -60.13 -45.6 92.45 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.511 -178.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.408 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 45.8 tp -62.74 -41.59 99.26 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.604 178.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.445 ' OG1' ' O ' ' A' ' 151' ' ' SER . 59.1 p -63.67 -35.03 79.2 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.275 -179.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.459 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.8 mm-40 -63.67 -42.14 98.1 Favored 'General case' 0 C--O 1.226 -0.161 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.36 179.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 91.3 mt -65.3 -39.09 92.05 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.483 178.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.564 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -60.99 -32.29 79.63 Favored Glycine 0 C--N 1.33 0.237 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 -179.339 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.459 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.3 mt-10 -36.63 -25.38 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.823 0.344 . . . . 0.0 110.937 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.564 ' N ' ' O ' ' A' ' 157' ' ' GLY . 95.3 mt -58.81 148.83 6.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.455 178.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 70.8 p -69.15 137.6 53.48 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.841 -179.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 70.69 21.92 77.95 Favored Glycine 0 CA--C 1.521 0.41 0 N-CA-C 111.085 -0.806 . . . . 0.0 111.085 179.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 59.7 m80 -124.18 -14.18 7.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.562 0.22 . . . . 0.0 110.506 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -66.14 -59.96 3.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.542 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -51.39 -49.42 61.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.086 -179.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -60.58 -40.97 93.66 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.883 0.373 . . . . 0.0 110.495 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.62 -47.42 85.52 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.548 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.77 -40.06 75.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.311 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -61.64 -50.46 72.44 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.697 179.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 60.1 ttt85 -65.28 -43.79 90.07 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.46 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 95.3 mt -64.4 -43.53 97.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.484 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.33 -51.06 70.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.379 -179.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.76 -43.6 95.92 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.875 0.369 . . . . 0.0 110.521 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . 0.502 ' CD1' ' OH ' ' A' ' 301' ' ' TYR . 56.7 t80 -62.54 -44.39 96.47 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.435 179.393 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -63.66 -39.68 94.96 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.378 -179.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -63.08 -42.52 99.65 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.753 179.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -60.64 -44.94 95.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.209 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 85.4 mt -64.31 -41.1 97.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.943 178.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.13 -61.99 1.92 Allowed 'General case' 0 C--O 1.238 0.472 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.499 -179.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.71 -46.83 86.45 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.472 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.12 -41.59 65.18 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.329 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -63.75 -33.99 76.89 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.33 179.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 69.3 tt0 -90.75 8.56 34.01 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.39 0.614 . . . . 0.0 110.283 -178.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -104.3 -32.23 9.18 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.944 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.8 pt -128.09 147.81 32.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.865 0.364 . . . . 0.0 110.58 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -139.71 131.13 26.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.538 178.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.549 ' CD2' ' N ' ' A' ' 186' ' ' LEU . 3.6 mm? -85.35 133.46 42.41 Favored Pre-proline 0 N--CA 1.447 -0.606 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.107 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -44.1 157.83 0.14 Allowed 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.581 2.188 . . . . 0.0 112.188 179.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . 0.489 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.7 Cg_endo -63.35 115.0 2.74 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.815 2.344 . . . . 0.0 111.561 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . 0.489 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.7 mt-30 156.05 148.14 0.0 OUTLIER Pre-proline 0 C--N 1.34 0.178 0 O-C-N 124.353 1.033 . . . . 0.0 110.94 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -73.75 144.48 35.23 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 C-N-CA 122.601 2.201 . . . . 0.0 111.765 177.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.482 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.1 p -124.81 159.04 31.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.206 0.527 . . . . 0.0 110.168 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' THR . . . . . 0.482 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 37.2 p -143.26 165.29 27.88 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 121.428 0.633 . . . . 0.0 110.852 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -135.32 128.91 32.63 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 121.276 0.56 . . . . 0.0 110.422 178.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 47.6 pt -146.64 149.09 16.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.849 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 73.6 t -117.78 123.1 71.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.08 0.467 . . . . 0.0 110.036 178.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 58.1 t80 -134.3 106.45 7.12 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.348 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 95.3 m -130.31 130.49 44.56 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.786 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.408 ' O ' ' N ' ' A' ' 201' ' ' HIS . . . -82.99 -36.58 24.93 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.26 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.41 -67.26 0.25 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.351 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.12 -9.45 58.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.446 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . 0.408 ' N ' ' O ' ' A' ' 198' ' ' ALA . 60.7 t-80 60.51 58.26 2.55 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.749 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 34.9 p -167.28 153.91 8.3 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.601 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.56 144.27 24.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.897 0.379 . . . . 0.0 110.417 179.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -135.32 138.49 43.48 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.41 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 18.2 mt -106.25 125.23 50.75 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.062 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' TRP . . . . . 0.556 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 74.8 m95 -82.31 167.74 18.27 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.563 -179.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -157.62 171.7 7.1 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.611 -178.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -53.92 -37.09 85.46 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 C-N-CA 122.743 2.296 . . . . 0.0 111.992 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -70.77 -34.9 72.3 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.734 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 21.4 m -61.5 150.94 34.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.51 -179.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.76 -36.92 82.43 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.42 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . 0.556 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 55.0 tt0 -64.63 -40.29 95.22 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.59 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.88 -43.27 91.87 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -63.07 -43.97 97.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.85 0.357 . . . . 0.0 110.239 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 65.2 ttp -59.42 -47.79 84.11 Favored 'General case' 0 N--CA 1.461 0.103 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.207 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 86.4 mt -60.53 -40.72 92.54 Favored 'General case' 0 CA--C 1.517 -0.303 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . 0.448 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.1 tp10 -57.96 -38.04 75.26 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.201 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -65.51 -37.96 88.29 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.725 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 96.0 mt -64.28 -42.76 96.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.655 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.72 44.9 0.08 OUTLIER Glycine 0 N--CA 1.463 0.444 0 N-CA-C 111.079 -0.808 . . . . 0.0 111.079 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . 0.448 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 26.9 m-85 -127.89 155.75 43.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.761 0.315 . . . . 0.0 110.498 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' THR . . . . . 0.45 ' O ' ' O ' ' A' ' 191' ' ' VAL . 7.4 p -107.42 122.52 46.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.21 0.529 . . . . 0.0 110.229 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . 0.44 ' CD2' ' N ' ' A' ' 223' ' ' LEU . 4.3 mm? -101.34 133.16 46.37 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.002 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.74 159.4 14.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.433 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.31 115.0 29.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.404 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.451 ' CD1' ' N ' ' A' ' 226' ' ' LEU . 8.9 mp -52.91 156.72 3.23 Favored Pre-proline 0 N--CA 1.446 -0.649 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.794 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -60.47 145.49 98.62 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.719 2.279 . . . . 0.0 112.013 179.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.2 -3.36 59.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.529 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -89.93 -41.26 5.66 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.506 ' O ' ' N ' ' A' ' 233' ' ' SER . 68.3 mt -79.23 -17.15 55.33 Favored 'General case' 0 C--O 1.219 -0.532 0 CA-C-O 120.923 0.392 . . . . 0.0 110.31 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 54.4 t-20 -40.33 -49.73 2.77 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.862 0.363 . . . . 0.0 110.709 -179.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -87.7 15.43 6.91 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.115 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' SER . . . . . 0.506 ' N ' ' O ' ' A' ' 230' ' ' LEU . 77.9 p -60.33 -35.24 75.17 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.601 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . 0.521 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.6 tt0 -119.64 -69.18 0.86 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.73 0.3 . . . . 0.0 110.679 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.3 m -69.58 102.59 1.88 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.538 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -94.28 57.4 2.32 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.357 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -144.73 -122.41 1.56 Allowed Glycine 0 N--CA 1.462 0.426 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -135.42 111.71 9.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.898 0.38 . . . . 0.0 110.379 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . 0.525 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.4 mtt180 -148.28 58.14 1.08 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.578 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -69.38 -32.7 71.9 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.618 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . 0.509 ' CG ' HD22 ' A' ' 143' ' ' ASN . 65.2 t0 -56.7 -47.3 80.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.312 -179.001 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' ILE . . . . . 0.434 ' O ' ' O ' ' A' ' 239' ' ' ARG . 18.0 tt -139.39 155.92 26.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.358 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 96.3 mt -106.08 106.49 20.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.406 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . 0.525 ' OE1' ' NH1' ' A' ' 239' ' ' ARG . 88.2 mt-30 -110.57 109.96 20.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.291 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 9.5 mp -121.59 -168.09 1.63 Allowed 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.723 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . 0.521 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.7 -16.46 0.05 OUTLIER Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . 0.691 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -61.14 156.31 33.85 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -63.33 21.81 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.772 0.32 . . . . 0.0 110.629 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . 0.691 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.9 m-20 -97.41 -6.3 34.33 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.407 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 92.0 mt -79.36 -21.98 45.05 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.945 179.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.7 -51.21 70.91 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.647 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.39 -5.74 58.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.372 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -80.87 -74.49 1.13 Allowed Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 80.9 mt -69.99 126.14 28.81 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.455 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -59.64 -39.19 83.56 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.281 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 82.63 51.94 4.11 Favored Glycine 0 CA--C 1.521 0.426 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -95.89 -15.07 22.66 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 121.199 -0.201 . . . . 0.0 110.634 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' SER . . . . . 0.42 ' O ' ' O ' ' A' ' 192' ' ' THR . 3.5 t 174.85 88.71 0.0 OUTLIER 'General case' 0 C--O 1.224 -0.257 0 CA-C-O 121.089 0.471 . . . . 0.0 110.294 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . 0.589 ' N ' ' CD1' ' A' ' 259' ' ' LEU . 0.9 OUTLIER -94.5 124.27 38.43 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.774 0.321 . . . . 0.0 110.874 -178.666 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 15.7 m-30 -93.52 146.13 24.01 Favored 'General case' 0 CA--C 1.499 -0.999 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.541 179.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 85.3 mt -122.09 149.03 44.14 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.517 -179.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.655 ' CG ' ' N ' ' A' ' 263' ' ' ALA . 2.5 p90 -77.23 -138.84 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.407 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . 0.655 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -51.46 77.22 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.249 0 O-C-N 123.381 0.426 . . . . 0.0 110.939 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . 0.622 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.29 104.67 0.19 Allowed Glycine 0 CA--C 1.527 0.797 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' ASP . . . . . 0.589 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.8 m-20 -80.14 -177.8 6.24 Favored 'General case' 0 C--N 1.327 -0.394 0 O-C-N 122.79 -0.241 . . . . 0.0 110.718 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -40.78 -17.83 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.486 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . 0.589 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.16 -51.52 44.97 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 121.058 0.456 . . . . 0.0 110.724 179.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -63.9 -46.58 84.2 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.102 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . 0.524 ' O ' ' CD2' ' A' ' 273' ' ' TYR . . . -61.6 -34.81 76.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.668 0.746 . . . . 0.0 110.05 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -62.98 -34.89 78.5 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.002 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.07 -43.44 13.91 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.136 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 272' ' ' ILE . . . . . 0.617 ' C ' ' H ' ' A' ' 274' ' ' ALA . 5.0 tt -51.61 -33.59 15.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.471 -178.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 273' ' ' TYR . . . . . 0.524 ' CD2' ' O ' ' A' ' 269' ' ' ALA . 17.1 m-85 -54.62 -1.61 0.03 OUTLIER 'General case' 0 CA--C 1.512 -0.504 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.741 -179.422 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 274' ' ' ALA . . . . . 0.617 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.42 -39.99 70.73 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.917 179.186 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . 0.574 ' O ' ' N ' ' A' ' 279' ' ' ALA . 2.8 p30 -38.55 97.64 0.14 Allowed Pre-proline 0 CA--C 1.528 0.131 0 O-C-N 123.585 0.553 . . . . 0.0 110.355 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -53.75 -43.27 59.37 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 122.565 2.177 . . . . 0.0 112.509 -178.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 89.0 mt -64.42 -43.0 95.73 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.953 -179.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 91.8 mt -95.82 -1.33 49.82 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.756 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 279' ' ' ALA . . . . . 0.574 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.63 -35.18 78.75 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.352 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.13 20.35 0.11 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.892 -178.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . 0.519 ' H ' ' C ' ' A' ' 279' ' ' ALA . 13.9 mt -74.8 120.05 79.7 Favored Pre-proline 0 N--CA 1.442 -0.862 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.821 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -51.33 -39.09 63.47 Favored 'Trans proline' 0 C--N 1.313 -1.321 0 C-N-CA 122.425 2.083 . . . . 0.0 111.817 179.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.71 -50.6 63.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.947 0.403 . . . . 0.0 110.05 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 76.6 t -61.51 -43.8 97.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.199 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -57.64 -41.48 81.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.212 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -90.84 0.62 57.42 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.32 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt 59.0 43.18 18.08 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.811 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -94.52 41.6 1.09 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.377 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 54.0 t -119.16 135.6 59.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-O 120.949 0.404 . . . . 0.0 110.012 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -132.81 162.87 30.38 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.619 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.68 155.14 32.95 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.462 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 79.8 mt -94.07 -1.63 54.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.299 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 120.75 165.49 12.76 Favored Glycine 0 N--CA 1.464 0.512 0 N-CA-C 110.584 -1.006 . . . . 0.0 110.584 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 6.7 m -86.98 -62.3 1.53 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.83 0.347 . . . . 0.0 110.879 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 295' ' ' GLU . . . . . 0.481 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.9 mm-40 -69.36 -3.94 16.2 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.642 -179.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 24.5 p -77.01 32.24 0.14 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.65 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 297' ' ' PHE . . . . . 0.481 ' H ' ' C ' ' A' ' 295' ' ' GLU . 68.5 t80 -60.31 -46.13 90.95 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.704 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . 0.619 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.1 mtt85 -80.76 135.09 35.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.477 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 17.7 tp -114.09 117.07 30.23 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 120.861 0.362 . . . . 0.0 110.394 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . 0.6 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.1 p-10 -165.2 -176.63 4.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.755 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 301' ' ' TYR . . . . . 0.502 ' OH ' ' CD1' ' A' ' 173' ' ' PHE . 82.8 t80 -46.51 -43.57 16.96 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.424 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -67.06 -40.24 87.03 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.001 0.429 . . . . 0.0 110.757 179.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 303' ' ' SER . . . . . 0.6 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 60.2 p -56.22 -36.11 68.09 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.131 -179.086 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . 0.496 ' N ' ' HG ' ' A' ' 303' ' ' SER . . . -57.31 -51.34 69.77 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.215 179.332 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 91.7 mtp -56.01 -44.18 78.43 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -65.79 -42.59 90.53 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.165 0.507 . . . . 0.0 110.437 179.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 55.7 t -64.06 -42.92 97.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.255 179.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 43.6 tp -59.77 -41.94 92.19 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.129 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -62.44 -39.0 91.93 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.299 179.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 310' ' ' ARG . . . . . 0.441 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.5 ttt85 -63.7 -43.79 95.56 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.374 179.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 89.4 mt -63.47 -41.94 98.6 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.572 179.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.3 ttmt -63.2 -33.29 75.16 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.35 179.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.42 -23.58 22.11 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.466 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . 0.441 ' N ' ' O ' ' A' ' 310' ' ' ARG . 6.7 tt -62.31 -43.15 99.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.491 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 . . . . . 0 C--O 1.221 -0.444 0 CA-C-O 118.09 -0.957 . . . . 0.0 110.3 -179.816 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -99.64 136.03 40.18 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.134 0.492 . . . . 0.0 110.475 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.482 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -92.44 178.68 1.58 Allowed Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.47 -179.692 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.482 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.7 Cg_exo -61.71 147.19 95.87 Favored 'Trans proline' 0 C--N 1.303 -1.843 0 C-N-CA 122.814 2.343 . . . . 0.0 112.211 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 35.5 ptt180 -136.53 142.45 43.45 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.565 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -79.63 116.88 20.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.508 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.4 tp -111.13 130.39 64.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.557 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 13.9 t -71.3 142.18 50.47 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.674 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.52 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.4 t0 -139.24 -179.97 6.18 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.478 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.52 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 78.1 p -74.0 -37.05 64.54 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.671 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.8 ttt85 -46.86 -94.78 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.31 -179.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.489 ' C ' ' HG1' ' A' ' 36' ' ' THR . . . -166.07 -27.06 0.02 OUTLIER Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.489 ' HG1' ' C ' ' A' ' 35' ' ' GLY . 62.5 m -168.71 105.76 0.44 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.757 0.313 . . . . 0.0 110.598 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 65.5 t60 -128.86 146.55 50.91 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 120.956 0.408 . . . . 0.0 110.222 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.485 ' CG2' ' N ' ' A' ' 39' ' ' LEU . 95.4 m -129.84 165.53 21.8 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.3 -179.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.485 ' N ' ' CG2' ' A' ' 38' ' ' THR . 78.5 mt -120.21 127.28 52.29 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.691 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -65.41 -44.86 86.1 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.606 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 38.3 p -165.64 154.97 12.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.458 179.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.467 ' N ' ' CD ' ' A' ' 42' ' ' GLN . 14.5 mp0 -44.82 101.19 0.25 Allowed Pre-proline 0 C--O 1.235 0.333 0 O-C-N 123.57 0.544 . . . . 0.0 110.505 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -57.62 130.25 37.83 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.339 2.026 . . . . 0.0 112.16 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -82.69 -25.03 33.37 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.643 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.538 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.8 mtm-85 -120.89 134.53 55.29 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.143 0.497 . . . . 0.0 110.237 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.1 mt -129.75 133.23 65.2 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.327 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.639 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 46.2 t -125.1 130.92 73.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 CA-C-O 120.942 0.401 . . . . 0.0 110.151 178.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.518 ' HG ' ' CD1' ' A' ' 117' ' ' LEU . 4.2 m -154.99 166.6 33.06 Favored 'General case' 0 C--O 1.225 -0.22 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.459 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 73.2 p -124.55 8.92 8.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.417 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.35 125.84 33.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.872 0.368 . . . . 0.0 110.584 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 84.9 t -65.83 -44.58 92.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.611 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 18.5 m -62.59 -44.41 96.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.678 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 52.2 tp -62.39 -41.53 98.72 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.661 -179.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 71.9 m -58.04 -44.61 87.48 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.183 -179.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.31 -62.09 5.44 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 179.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.5 t -47.89 -35.64 10.81 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.5 mt -61.82 -44.55 96.63 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.069 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.1 mp -65.27 -41.17 94.47 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.297 178.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.85 -41.45 97.8 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.611 -179.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.0 tp -87.75 16.8 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.724 -179.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 56.32 84.39 0.09 Allowed 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.814 -179.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.28 58.44 0.08 OUTLIER Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 120.992 0.425 . . . . 0.0 109.931 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -50.91 152.72 9.61 Favored 'Trans proline' 0 C--N 1.296 -2.205 0 C-N-CA 123.061 2.507 . . . . 0.0 112.307 -178.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.429 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -108.85 145.9 15.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.279 -179.789 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.78 -45.13 98.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.191 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.504 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -130.16 134.17 47.12 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.717 0.294 . . . . 0.0 110.389 -179.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.494 ' O ' ' N ' ' A' ' 98' ' ' LEU . 73.5 m -134.3 158.51 43.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.85 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.58 139.21 16.36 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.465 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.69 -162.83 0.09 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.86 0.362 . . . . 0.0 110.382 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.466 ' O ' ' C ' ' A' ' 71' ' ' THR . 5.8 t -134.09 135.57 43.33 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.027 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.466 ' C ' ' O ' ' A' ' 70' ' ' THR . 0.9 OUTLIER 29.78 68.23 0.68 Allowed Pre-proline 0 N--CA 1.469 0.507 0 CA-C-O 121.181 0.515 . . . . 0.0 110.813 -179.569 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -60.8 145.23 99.3 Favored 'Trans proline' 0 C--N 1.301 -1.944 0 C-N-CA 122.737 2.291 . . . . 0.0 111.978 -178.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.539 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 44.9 p-10 -160.06 -32.62 0.06 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.674 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.539 ' N ' ' OD1' ' A' ' 73' ' ' ASN . 98.9 m-20 -63.75 -39.72 94.97 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.364 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -59.97 -48.33 82.16 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.476 -179.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.425 ' O ' ' O ' ' A' ' 77' ' ' ALA . 92.4 t -60.0 -24.75 30.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.125 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.425 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -45.64 173.0 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.53 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.565 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.3 p30 -62.06 177.69 0.44 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.424 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.597 ' C ' ' H ' ' A' ' 81' ' ' GLY . 35.1 p30 -45.81 85.64 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.985 0.421 . . . . 0.0 110.903 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.565 ' N ' ' O ' ' A' ' 78' ' ' ASP . 42.5 tp60 -67.21 13.45 0.06 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.25 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.597 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 117.92 -22.34 9.9 Favored Glycine 0 N--CA 1.463 0.439 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -107.75 116.22 31.55 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.945 0.402 . . . . 0.0 110.483 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 76.5 mt -98.71 0.63 44.96 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.478 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -92.23 6.84 45.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.917 0.389 . . . . 0.0 110.325 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.43 ' O ' ' CG2' ' A' ' 89' ' ' VAL . 88.5 mt-30 -99.88 -27.8 13.43 Favored 'General case' 0 C--O 1.222 -0.379 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.665 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 69.0 t-105 -63.42 -40.96 98.58 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.767 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.545 ' O ' ' N ' ' A' ' 91' ' ' LYS . 67.2 m -77.42 -53.34 7.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.888 -179.286 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -48.59 -51.14 29.35 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.946 -179.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.43 ' CG2' ' O ' ' A' ' 85' ' ' GLN . 15.9 m -68.78 -40.6 81.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.039 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.411 ' H ' HG23 ' A' ' 89' ' ' VAL . . . -72.35 -22.92 61.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.753 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.545 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.0 tttm -61.41 -45.92 92.31 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.391 -179.432 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.438 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.6 mm-40 -90.37 -94.56 0.12 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.128 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.608 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.9 mtt180 -143.49 59.63 1.39 Allowed 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.437 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.7 pttp 34.06 26.32 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.282 0.563 . . . . 0.0 110.517 -179.368 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.608 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.5 tt -48.32 123.15 6.09 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.856 -177.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -83.31 -170.44 3.05 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.314 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.617 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 82.7 mtp180 -73.45 137.89 44.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.952 0.406 . . . . 0.0 110.231 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.494 ' N ' ' O ' ' A' ' 67' ' ' SER . 88.3 mt -86.41 -165.96 1.41 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.83 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.532 ' CD2' ' O ' ' A' ' 99' ' ' TYR . 47.1 p90 -168.51 120.0 0.79 Allowed 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.094 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.488 ' C ' ' O ' ' A' ' 99' ' ' TYR . 42.9 mm -29.67 121.4 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 O-C-N 123.392 0.433 . . . . 0.0 110.898 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 113.7 28.12 3.31 Favored Glycine 0 N--CA 1.463 0.473 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 -179.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.579 ' N ' ' CD ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -143.86 45.5 0.57 Allowed Pre-proline 0 C--N 1.324 -0.54 0 CA-C-O 121.298 0.57 . . . . 0.0 110.463 179.794 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 30.4 Cg_endo -62.14 144.03 95.32 Favored 'Trans proline' 0 C--N 1.297 -2.145 0 C-N-CA 122.572 2.181 . . . . 0.0 111.972 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.704 ' HG ' ' H ' ' A' ' 107' ' ' ALA . 25.3 t -173.17 120.76 0.36 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.573 179.426 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.15 -40.96 64.44 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.188 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -65.97 -40.0 90.85 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.759 -179.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.704 ' H ' ' HG ' ' A' ' 104' ' ' SER . . . -64.05 -39.62 94.49 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.667 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 71.2 t -67.58 -43.73 86.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.638 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.44 -39.3 92.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.527 -179.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.438 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.78 -23.67 63.47 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.561 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.526 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.4 mm-40 -90.89 4.38 52.02 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.769 -179.543 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.538 ' O ' ' NE ' ' A' ' 45' ' ' ARG . 10.5 tpt 22.61 64.37 0.34 Allowed Pre-proline 0 N--CA 1.471 0.598 0 O-C-N 123.5 0.5 . . . . 0.0 111.124 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -79.33 169.4 18.87 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 123.083 2.522 . . . . 0.0 111.938 -178.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.524 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 98.7 m-20 -112.33 -44.72 3.35 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.174 179.507 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 39.1 tp -119.9 121.04 38.15 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.147 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 96.8 mt -118.18 131.32 71.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.769 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.518 ' CD1' ' HG ' ' A' ' 48' ' ' SER . 31.5 mt -106.06 132.11 52.53 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.205 -179.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 98.6 mt -117.76 136.08 56.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.55 -179.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 86.4 p -71.48 151.41 43.97 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.608 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.32 -49.95 75.57 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.582 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -149.29 153.6 37.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.505 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 168.48 -169.69 41.75 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.88 -35.6 92.23 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.449 ' O ' ' OD1' ' A' ' 124' ' ' ASP . 44.3 p-10 -88.46 119.88 29.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.903 0.383 . . . . 0.0 110.598 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 40.6 t -63.0 144.03 57.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.405 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.511 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.55 -43.07 8.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.779 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.8 tp -62.64 -42.42 99.59 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.821 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.85 -10.44 53.06 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.405 -179.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 82.1 mt -115.99 -24.3 8.16 Favored 'General case' 0 C--O 1.225 -0.222 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.56 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . 0.511 ' N ' ' O ' ' A' ' 126' ' ' ALA . 71.3 t80 -51.37 -49.51 61.34 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.914 -0.314 . . . . 0.0 110.558 -178.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.2 p-10 -66.09 -41.79 90.17 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.846 -0.342 . . . . 0.0 111.054 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.504 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 87.9 mt-30 -67.91 -36.49 80.28 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.751 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 96.5 mt -80.35 -42.09 23.55 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.003 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.3 t -57.39 -45.25 84.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.293 -179.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.6 m -62.46 -45.66 92.03 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.656 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 92.2 mt -62.4 -43.78 98.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.312 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -170.2 163.54 6.2 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.581 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -42.14 110.67 0.16 Allowed 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.561 2.174 . . . . 0.0 112.118 179.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.8 m -87.34 127.76 35.19 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.237 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 34.3 tp -119.63 139.21 52.57 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.451 179.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.431 ' O ' ' OD2' ' A' ' 32' ' ' ASP . 81.7 mt -105.11 119.93 54.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-O 120.953 0.406 . . . . 0.0 110.852 -179.206 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 97.1 mt -135.67 132.7 51.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.639 179.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.512 HD22 ' CG ' ' A' ' 241' ' ' ASP . 59.1 t30 -64.59 147.99 51.75 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.465 179.361 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.511 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 87.3 t80 -82.48 122.67 28.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.814 -179.311 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.511 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 99.0 m-20 55.05 69.31 0.75 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.561 179.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 34.2 p-10 -125.62 0.49 7.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.576 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -150.92 115.96 5.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.867 0.365 . . . . 0.0 110.642 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' SER . . . . . 0.521 ' HG ' ' H ' ' A' ' 150' ' ' GLN . 85.0 p -63.76 169.11 4.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.613 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.407 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.7 p-90 -51.83 -16.13 0.64 Allowed 'General case' 0 C--O 1.22 -0.457 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.258 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . 0.521 ' H ' ' HG ' ' A' ' 148' ' ' SER . 68.2 tp60 -70.19 -75.98 0.11 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.021 0.438 . . . . 0.0 110.614 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.443 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.1 t -62.58 -38.45 90.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.265 179.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 51.0 tp -60.16 -45.5 92.87 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.573 -178.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.407 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 45.4 tp -62.85 -41.63 99.43 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.612 178.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.443 ' OG1' ' O ' ' A' ' 151' ' ' SER . 59.6 p -63.67 -35.01 79.15 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.251 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.467 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.5 mm-40 -63.54 -41.99 98.43 Favored 'General case' 0 C--O 1.225 -0.203 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.344 179.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 91.5 mt -65.44 -39.09 91.65 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.413 178.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.562 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.09 -32.15 79.33 Favored Glycine 0 N--CA 1.46 0.264 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 -179.247 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.467 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.3 mt-10 -36.81 -25.26 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.752 0.31 . . . . 0.0 110.881 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.562 ' N ' ' O ' ' A' ' 157' ' ' GLY . 95.5 mt -59.17 148.61 6.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.346 179.084 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 74.7 p -69.13 137.72 53.63 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.879 -179.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 70.69 21.88 77.95 Favored Glycine 0 CA--C 1.519 0.335 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 179.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 59.8 m80 -124.35 -13.78 7.08 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 110.448 -0.204 . . . . 0.0 110.448 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -66.24 -59.9 3.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.506 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -51.79 -49.07 63.41 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.119 -179.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -60.41 -41.03 93.08 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.862 0.363 . . . . 0.0 110.448 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.58 -47.19 86.61 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.551 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -57.0 -39.96 75.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.25 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -61.69 -50.49 72.25 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.694 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -65.29 -43.89 89.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.458 179.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 95.3 mt -64.32 -43.55 97.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.412 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.28 -51.05 70.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.432 -179.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -63.79 -43.43 96.32 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.846 0.355 . . . . 0.0 110.539 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . 0.504 ' CD1' ' OH ' ' A' ' 301' ' ' TYR . 56.6 t80 -62.66 -44.44 96.26 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.084 0.468 . . . . 0.0 110.423 179.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -63.62 -39.87 95.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.475 -179.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -62.97 -42.6 99.88 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.725 179.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -60.74 -44.55 96.52 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.24 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 85.1 mt -64.55 -41.07 96.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.875 178.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.24 -61.95 1.95 Allowed 'General case' 0 C--O 1.239 0.515 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.426 -179.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.72 -47.12 85.68 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.358 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -52.83 -41.55 64.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.314 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -63.79 -33.71 76.28 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.36 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 69.6 tt0 -90.92 8.52 34.66 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.539 0.685 . . . . 0.0 110.302 -178.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -104.24 -32.22 9.22 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.088 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.4 pt -128.04 147.77 32.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.886 0.374 . . . . 0.0 110.635 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -139.93 131.31 26.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.478 179.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.545 ' CD2' ' N ' ' A' ' 186' ' ' LEU . 3.6 mm? -85.36 133.32 42.67 Favored Pre-proline 0 N--CA 1.448 -0.559 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.088 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -44.02 157.9 0.14 Allowed 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.645 2.23 . . . . 0.0 112.194 179.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . 0.49 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.5 Cg_endo -63.12 114.78 2.61 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.716 2.277 . . . . 0.0 111.632 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . 0.49 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.7 mt-30 156.03 148.11 0.0 OUTLIER Pre-proline 0 C--N 1.34 0.194 0 O-C-N 124.401 1.063 . . . . 0.0 110.894 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -73.58 144.56 36.02 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 122.597 2.198 . . . . 0.0 111.905 177.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.481 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.1 p -124.78 158.93 31.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.229 0.538 . . . . 0.0 110.109 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' THR . . . . . 0.481 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 38.1 p -143.16 165.18 28.13 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 121.396 0.617 . . . . 0.0 110.973 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -135.15 128.93 33.03 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 121.377 0.608 . . . . 0.0 110.358 178.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 47.2 pt -146.57 148.97 16.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.972 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 72.3 t -117.73 123.15 71.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.183 0.516 . . . . 0.0 109.932 178.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -134.35 106.91 7.33 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.289 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 94.2 m -130.85 130.44 43.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.872 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.417 ' O ' ' N ' ' A' ' 201' ' ' HIS . . . -82.73 -37.03 25.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.258 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.5 -67.08 0.26 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.297 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -71.91 -9.77 58.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.379 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . 0.417 ' N ' ' O ' ' A' ' 198' ' ' ALA . 60.3 t-80 60.38 57.97 2.7 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.591 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 47.6 p -166.66 153.38 8.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.57 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.29 144.13 24.47 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.946 0.403 . . . . 0.0 110.426 179.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -135.4 138.67 43.51 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.525 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 19.0 mt -106.21 125.26 50.77 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' TRP . . . . . 0.557 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 75.0 m95 -82.12 167.51 18.68 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.593 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -157.18 171.56 7.28 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.595 -178.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.8 -37.26 84.63 Favored 'Trans proline' 0 C--N 1.302 -1.915 0 C-N-CA 122.598 2.199 . . . . 0.0 112.183 179.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -70.89 -34.73 71.87 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.713 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 21.4 m -61.23 151.08 32.63 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.529 -179.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.65 -37.01 82.47 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.392 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . 0.557 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 55.0 tt0 -64.8 -40.31 95.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.477 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.78 -43.39 91.82 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -62.74 -44.15 96.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.809 0.338 . . . . 0.0 110.262 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 65.3 ttp -59.46 -47.82 84.03 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.221 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 87.0 mt -60.4 -41.07 93.1 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . 0.448 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.3 tp10 -58.18 -38.07 75.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.074 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -65.32 -38.24 89.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.743 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 95.7 mt -64.1 -42.79 96.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.684 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.49 45.45 0.08 OUTLIER Glycine 0 N--CA 1.462 0.416 0 N-CA-C 111.111 -0.795 . . . . 0.0 111.111 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . 0.448 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 27.4 m-85 -128.29 155.6 44.34 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.83 0.347 . . . . 0.0 110.482 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' THR . . . . . 0.45 ' O ' ' O ' ' A' ' 191' ' ' VAL . 7.5 p -107.11 122.35 46.32 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-O 121.225 0.536 . . . . 0.0 110.215 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . 0.44 ' CD2' ' N ' ' A' ' 223' ' ' LEU . 4.3 mm? -101.47 133.06 46.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.016 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.76 159.67 14.8 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.471 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.33 115.15 29.76 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.377 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.445 ' CD1' ' N ' ' A' ' 226' ' ' LEU . 9.0 mp -53.08 156.83 3.35 Favored Pre-proline 0 N--CA 1.447 -0.62 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.811 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -60.3 145.36 98.75 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 C-N-CA 122.735 2.29 . . . . 0.0 112.091 179.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.24 -3.22 59.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.521 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.07 -40.94 5.7 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.503 ' O ' ' N ' ' A' ' 233' ' ' SER . 68.7 mt -79.36 -17.25 54.84 Favored 'General case' 0 C--O 1.219 -0.542 0 CA-C-O 121.04 0.447 . . . . 0.0 110.297 -179.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 54.6 t-20 -40.48 -49.51 2.89 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.842 0.354 . . . . 0.0 110.717 -179.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -87.69 15.46 6.86 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.241 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' SER . . . . . 0.503 ' N ' ' O ' ' A' ' 230' ' ' LEU . 77.9 p -60.62 -35.2 75.56 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.608 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . 0.522 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.6 tt0 -119.54 -69.34 0.85 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.717 179.32 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.0 m -69.72 102.1 1.83 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.955 0.407 . . . . 0.0 110.592 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -93.78 57.56 2.52 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.34 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -144.63 -122.5 1.58 Allowed Glycine 0 N--CA 1.462 0.397 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -135.44 111.78 9.79 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.0 0.428 . . . . 0.0 110.374 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . 0.524 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.5 mtt180 -148.27 58.26 1.08 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.596 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -69.47 -32.35 71.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.571 179.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . 0.512 ' CG ' HD22 ' A' ' 143' ' ' ASN . 64.8 t0 -56.85 -47.3 80.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.266 -179.042 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' ILE . . . . . 0.435 ' O ' ' O ' ' A' ' 239' ' ' ARG . 17.8 tt -139.65 156.17 25.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.851 0.358 . . . . 0.0 110.371 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 96.2 mt -106.07 106.61 20.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.947 0.403 . . . . 0.0 110.382 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . 0.524 ' OE1' ' NH1' ' A' ' 239' ' ' ARG . 88.3 mt-30 -110.55 110.06 20.63 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.329 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 9.6 mp -121.77 -168.14 1.65 Allowed 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.634 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . 0.522 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.83 -16.57 0.05 OUTLIER Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . 0.69 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -61.09 156.41 33.49 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -63.49 21.63 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.783 0.325 . . . . 0.0 110.563 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . 0.69 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.8 m-20 -96.93 -6.4 35.72 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.756 0.313 . . . . 0.0 110.492 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 91.8 mt -79.5 -21.72 44.92 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.931 179.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.79 -51.36 70.32 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.648 -179.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.33 -5.45 58.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.463 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -80.91 -74.25 1.14 Allowed Glycine 0 CA--C 1.522 0.528 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 80.8 mt -70.17 126.09 28.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.888 0.375 . . . . 0.0 110.344 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -59.69 -39.22 83.82 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.336 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 83.28 51.84 4.0 Favored Glycine 0 CA--C 1.521 0.446 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -95.58 -15.52 22.74 Favored 'General case' 0 C--N 1.331 -0.223 0 O-C-N 122.823 -0.222 . . . . 0.0 110.578 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 258' ' ' SER . . . . . 0.433 ' HG ' ' CG2' ' A' ' 191' ' ' VAL . 3.4 t 174.77 89.14 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.161 0.505 . . . . 0.0 110.268 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . 0.59 ' N ' ' CD1' ' A' ' 259' ' ' LEU . 0.9 OUTLIER -94.76 124.2 38.65 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.857 0.361 . . . . 0.0 110.985 -178.729 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 15.7 m-30 -93.61 146.41 23.83 Favored 'General case' 0 CA--C 1.497 -1.064 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.543 179.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 85.0 mt -122.21 148.87 44.43 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.554 -179.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.654 ' CG ' ' N ' ' A' ' 263' ' ' ALA . 2.5 p90 -77.17 -139.07 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.436 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . 0.654 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -51.15 77.22 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.353 0 O-C-N 123.435 0.459 . . . . 0.0 111.108 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . 0.624 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.43 104.64 0.19 Allowed Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 265' ' ' ASP . . . . . 0.588 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.6 m-20 -80.14 -177.77 6.23 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 122.703 -0.293 . . . . 0.0 110.718 -179.549 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -40.8 -17.78 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.496 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . 0.588 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.01 -51.3 48.69 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.758 179.111 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -64.11 -46.5 83.92 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.98 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . 0.524 ' O ' ' CD2' ' A' ' 273' ' ' TYR . . . -61.76 -34.83 76.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.697 0.761 . . . . 0.0 109.883 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -62.93 -35.0 78.65 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.185 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.09 -43.12 14.18 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.184 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 272' ' ' ILE . . . . . 0.619 ' C ' ' H ' ' A' ' 274' ' ' ALA . 5.0 tt -51.64 -33.77 15.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.552 -178.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 273' ' ' TYR . . . . . 0.524 ' CD2' ' O ' ' A' ' 269' ' ' ALA . 16.8 m-85 -54.58 -1.67 0.03 OUTLIER 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.767 -179.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 274' ' ' ALA . . . . . 0.619 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.5 -39.94 70.49 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.942 179.194 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . 0.574 ' O ' ' N ' ' A' ' 279' ' ' ALA . 3.1 p30 -38.52 97.52 0.14 Allowed Pre-proline 0 C--N 1.339 0.135 0 O-C-N 123.532 0.52 . . . . 0.0 110.429 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -53.72 -43.17 60.23 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 C-N-CA 122.577 2.184 . . . . 0.0 112.511 -178.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 88.9 mt -64.36 -43.01 95.88 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.008 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 91.7 mt -95.95 -1.06 49.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.75 -179.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 279' ' ' ALA . . . . . 0.574 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.65 -34.93 78.08 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.501 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.32 20.36 0.11 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.841 -179.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . 0.515 ' H ' ' C ' ' A' ' 279' ' ' ALA . 13.7 mt -74.68 119.82 78.54 Favored Pre-proline 0 N--CA 1.442 -0.837 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.776 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -51.15 -39.37 61.31 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 C-N-CA 122.507 2.138 . . . . 0.0 111.922 179.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.74 -50.54 63.25 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.898 0.38 . . . . 0.0 110.033 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 76.8 t -61.42 -43.88 97.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.169 179.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -57.56 -41.21 80.6 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.207 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -91.17 0.47 57.52 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.258 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt 59.26 43.91 16.25 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.84 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -95.01 41.2 1.09 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.32 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 53.9 t -119.13 135.58 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-O 121.018 0.437 . . . . 0.0 110.061 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -132.8 162.76 30.65 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.527 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.37 155.08 32.59 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.515 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 80.8 mt -94.09 -1.75 53.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.246 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 120.89 165.38 12.69 Favored Glycine 0 N--CA 1.464 0.504 0 N-CA-C 110.489 -1.045 . . . . 0.0 110.489 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 7.3 m -87.08 -62.47 1.5 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.829 0.347 . . . . 0.0 110.971 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 295' ' ' GLU . . . . . 0.486 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.5 mm-40 -68.71 -4.35 15.46 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.687 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 24.9 p -76.78 32.16 0.13 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.674 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 297' ' ' PHE . . . . . 0.486 ' H ' ' C ' ' A' ' 295' ' ' GLU . 68.3 t80 -60.48 -46.21 90.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.664 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . 0.617 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.1 mtt85 -80.68 134.89 35.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.453 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 18.6 tp -113.7 116.7 29.85 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-O 120.942 0.401 . . . . 0.0 110.385 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . 0.599 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.2 p-10 -165.0 -176.87 4.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.723 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 301' ' ' TYR . . . . . 0.504 ' OH ' ' CD1' ' A' ' 173' ' ' PHE . 81.6 t80 -46.66 -43.22 17.45 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.373 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -67.15 -40.21 86.67 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 121.028 0.442 . . . . 0.0 110.752 179.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 303' ' ' SER . . . . . 0.599 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 59.6 p -56.34 -36.27 68.58 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.079 -179.023 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -57.33 -51.47 69.25 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 179.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 91.9 mtp -55.71 -44.28 77.27 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -65.8 -42.75 90.32 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.227 0.537 . . . . 0.0 110.454 179.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 54.9 t -64.04 -42.82 96.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.262 179.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 44.2 tp -59.77 -41.92 92.16 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.041 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -62.79 -38.77 91.95 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.116 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 310' ' ' ARG . . . . . 0.449 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.6 ttt85 -63.56 -43.83 95.91 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.32 179.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 87.7 mt -63.37 -42.09 98.83 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.46 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.4 ttmt -63.03 -33.24 75.0 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.39 179.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.84 -23.47 21.67 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.395 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . 0.449 ' N ' ' O ' ' A' ' 310' ' ' ARG . 6.7 tt -62.31 -43.27 99.22 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.488 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 . . . . . 0 C--O 1.22 -0.486 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.317 -179.708 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -99.5 136.48 39.37 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.174 0.512 . . . . 0.0 110.424 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.485 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -91.58 178.7 1.65 Allowed Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.469 -179.707 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.485 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.3 Cg_exo -61.76 147.51 95.14 Favored 'Trans proline' 0 C--N 1.301 -1.948 0 C-N-CA 122.955 2.437 . . . . 0.0 112.207 179.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 35.3 ptt180 -135.02 142.35 46.38 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.591 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -79.01 116.85 19.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.496 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.5 tp -109.93 130.61 62.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.494 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.8 t -70.54 141.59 51.86 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.685 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.421 ' OD2' ' O ' ' A' ' 141' ' ' ILE . 24.8 t70 -139.83 177.1 8.19 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.452 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.454 ' OG ' ' O ' ' A' ' 141' ' ' ILE . 78.4 p -73.11 -36.57 66.77 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.707 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -47.62 -95.05 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.275 -179.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.414 ' O ' ' OG1' ' A' ' 36' ' ' THR . . . -166.15 -25.54 0.02 OUTLIER Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.414 ' OG1' ' O ' ' A' ' 35' ' ' GLY . 62.7 m -168.5 106.42 0.47 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.691 0.281 . . . . 0.0 110.633 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 34.0 t60 -129.79 144.2 51.18 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-O 121.016 0.436 . . . . 0.0 110.099 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.477 ' CG2' ' N ' ' A' ' 39' ' ' LEU . 95.9 m -128.47 166.46 18.72 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.338 -179.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.477 ' N ' ' CG2' ' A' ' 38' ' ' THR . 81.4 mt -121.08 127.73 51.93 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.66 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -63.93 -44.64 92.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.689 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 38.3 p -165.45 155.36 12.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.45 179.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.455 ' N ' ' CD ' ' A' ' 42' ' ' GLN . 14.3 mp0 -42.33 100.07 0.22 Allowed Pre-proline 0 C--O 1.236 0.379 0 O-C-N 123.47 0.481 . . . . 0.0 110.564 179.239 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -56.87 129.3 33.82 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 122.362 2.041 . . . . 0.0 112.191 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -83.89 -24.16 30.92 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.649 179.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.539 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.6 mtm-85 -121.26 134.53 55.18 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.149 0.499 . . . . 0.0 110.193 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.2 mt -130.68 133.34 63.52 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.313 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.598 -179.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 47.0 t -124.91 130.87 73.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 CA-C-O 120.992 0.425 . . . . 0.0 110.039 179.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.5 ' O ' ' O ' ' A' ' 66' ' ' ALA . 4.6 m -154.32 166.38 33.37 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.513 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 67.4 p -124.45 8.96 8.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.389 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.94 125.44 33.36 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.599 -179.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 84.5 t -65.51 -44.44 94.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.557 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.3 m -62.68 -44.25 96.72 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.598 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 52.1 tp -62.46 -41.48 98.78 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.573 -179.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 73.3 m -57.83 -44.59 86.53 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.249 -179.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.26 -62.1 5.44 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.896 -0.881 . . . . 0.0 110.896 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.6 t -48.16 -35.67 12.09 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.6 mt -61.76 -44.42 96.92 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.161 179.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.1 mp -65.47 -41.06 93.75 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.412 177.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.78 -41.45 97.94 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.706 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.1 tp -87.8 16.77 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.82 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 56.34 84.49 0.08 Allowed 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.828 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.22 58.52 0.08 OUTLIER Pre-proline 0 C--N 1.328 -0.368 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -51.24 152.94 10.4 Favored 'Trans proline' 0 C--N 1.294 -2.335 0 C-N-CA 123.148 2.566 . . . . 0.0 112.206 -178.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.428 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -108.76 145.73 15.3 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.265 -179.685 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.68 -45.31 97.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.212 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.5 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -130.18 134.33 47.22 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.803 0.335 . . . . 0.0 110.352 -179.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.488 ' O ' ' N ' ' A' ' 98' ' ' LEU . 75.7 m -134.55 158.73 43.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.913 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.6 139.19 16.32 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.454 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.62 -162.82 0.09 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.893 0.378 . . . . 0.0 110.401 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.468 ' O ' ' C ' ' A' ' 71' ' ' THR . 5.8 t -134.03 135.18 43.19 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.065 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.468 ' C ' ' O ' ' A' ' 70' ' ' THR . 0.8 OUTLIER 29.76 68.43 0.67 Allowed Pre-proline 0 N--CA 1.469 0.477 0 CA-C-O 121.138 0.494 . . . . 0.0 110.853 -179.522 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_exo -61.08 145.2 99.22 Favored 'Trans proline' 0 C--N 1.3 -1.985 0 C-N-CA 122.746 2.297 . . . . 0.0 111.842 -178.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.527 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 44.8 p-10 -159.86 -31.88 0.06 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.725 179.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.527 ' N ' ' OD1' ' A' ' 73' ' ' ASN . 98.7 m-20 -64.45 -39.47 93.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.37 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.2 ttt180 -60.09 -48.56 81.22 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.354 -179.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.424 ' O ' ' O ' ' A' ' 77' ' ' ALA . 95.3 t -60.05 -25.0 31.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.16 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.424 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -45.59 172.89 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.614 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.568 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.3 p30 -61.91 177.68 0.42 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.484 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.596 ' C ' ' H ' ' A' ' 81' ' ' GLY . 36.2 p30 -45.64 85.55 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.95 0.405 . . . . 0.0 110.939 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.568 ' N ' ' O ' ' A' ' 78' ' ' ASP . 42.8 tp60 -67.35 13.56 0.07 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.235 0.541 . . . . 0.0 110.201 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.596 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 117.93 -22.55 9.79 Favored Glycine 0 N--CA 1.463 0.448 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -107.87 116.4 31.89 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.963 0.411 . . . . 0.0 110.415 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 76.1 mt -98.8 0.56 44.6 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.542 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -91.92 6.76 45.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.326 -179.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.435 ' O ' ' CG2' ' A' ' 89' ' ' VAL . 88.3 mt-30 -100.17 -26.96 13.76 Favored 'General case' 0 C--O 1.221 -0.441 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.733 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.1 t-105 -64.01 -40.75 97.03 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.952 -179.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.545 ' O ' ' N ' ' A' ' 91' ' ' LYS . 67.9 m -77.64 -53.33 7.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.053 -179.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -48.55 -51.05 29.57 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.919 -179.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.435 ' CG2' ' O ' ' A' ' 85' ' ' GLN . 15.7 m -68.83 -40.94 81.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.091 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.416 ' H ' HG23 ' A' ' 89' ' ' VAL . . . -71.87 -23.03 61.44 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.641 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.545 ' N ' ' O ' ' A' ' 87' ' ' SER . 65.9 tttm -61.52 -45.93 92.09 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.347 -179.31 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.441 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.6 mm-40 -90.27 -94.65 0.12 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.155 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.609 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.9 mtt180 -143.45 59.59 1.39 Allowed 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.437 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.7 pttp 34.24 26.08 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.247 0.546 . . . . 0.0 110.454 -179.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.609 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.4 tt -48.35 123.34 6.38 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.897 -177.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -83.46 -170.6 3.13 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.275 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.615 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 83.0 mtp180 -73.56 137.62 44.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.984 0.421 . . . . 0.0 110.248 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.488 ' N ' ' O ' ' A' ' 67' ' ' SER . 90.1 mt -86.13 -166.18 1.47 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.899 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.532 ' CD2' ' O ' ' A' ' 99' ' ' TYR . 47.9 p90 -168.05 120.08 0.85 Allowed 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.084 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.488 ' C ' ' O ' ' A' ' 99' ' ' TYR . 43.2 mm -29.75 121.26 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 O-C-N 123.332 0.395 . . . . 0.0 110.922 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 113.87 28.17 3.25 Favored Glycine 0 N--CA 1.462 0.387 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 -179.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.578 ' N ' ' CD ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -143.99 45.81 0.59 Allowed Pre-proline 0 C--N 1.322 -0.594 0 CA-C-O 121.203 0.525 . . . . 0.0 110.436 179.791 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 29.6 Cg_endo -62.06 143.83 95.39 Favored 'Trans proline' 0 C--N 1.295 -2.277 0 C-N-CA 122.667 2.245 . . . . 0.0 111.815 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.708 ' HG ' ' H ' ' A' ' 107' ' ' ALA . 27.2 t -173.13 120.73 0.36 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.47 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.25 -40.69 64.43 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.192 179.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.16 -39.85 90.09 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.7 -179.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.708 ' H ' ' HG ' ' A' ' 104' ' ' SER . . . -64.1 -39.78 94.8 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.673 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 69.7 t -67.7 -43.75 86.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.596 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.5 -39.31 93.09 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.552 -179.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.441 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.68 -23.5 63.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.542 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.527 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.4 mm-40 -91.26 4.77 51.48 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.7 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.539 ' O ' ' NE ' ' A' ' 45' ' ' ARG . 10.7 tpt 22.51 64.52 0.34 Allowed Pre-proline 0 N--CA 1.47 0.57 0 O-C-N 123.342 0.401 . . . . 0.0 111.204 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -79.37 169.1 19.22 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 123.085 2.524 . . . . 0.0 111.679 -177.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.515 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 98.6 m-20 -112.57 -43.67 3.45 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.116 179.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.4 tp -120.64 121.39 38.22 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 120.884 0.373 . . . . 0.0 110.091 179.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 96.9 mt -118.84 130.85 73.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-O 120.888 0.375 . . . . 0.0 110.858 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 32.1 mt -105.69 132.55 51.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.344 -179.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 98.1 mt -117.89 135.97 56.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.565 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 86.9 p -71.79 152.9 42.33 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.577 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -59.96 -50.03 75.35 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.617 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -149.37 153.72 37.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.535 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 169.71 -170.55 42.81 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -63.02 -35.13 91.68 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.449 ' O ' ' OD1' ' A' ' 124' ' ' ASP . 44.1 p-10 -88.04 119.69 28.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.922 0.391 . . . . 0.0 110.578 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 40.4 t -63.39 144.42 56.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.429 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.52 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.51 -42.76 9.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.742 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 56.0 tp -62.76 -42.34 99.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.677 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.25 -11.04 58.7 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.375 -179.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 83.8 mt -115.07 -24.58 8.49 Favored 'General case' 0 C--O 1.225 -0.234 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.57 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . 0.52 ' N ' ' O ' ' A' ' 126' ' ' ALA . 77.3 t80 -51.35 -49.84 60.65 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.936 -0.306 . . . . 0.0 110.612 -178.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.7 p-10 -65.77 -41.71 91.73 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.267 179.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.501 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 88.2 mt-30 -68.06 -36.97 80.73 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.826 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 94.1 mt -79.9 -42.19 24.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.915 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.3 t -57.05 -45.03 83.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.216 -179.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.7 m -62.23 -45.66 92.32 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.615 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 92.9 mt -62.48 -43.94 98.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.361 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.91 163.98 6.4 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.593 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -43.17 111.94 0.26 Allowed 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.544 2.163 . . . . 0.0 112.3 179.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 17.1 m -86.07 127.59 34.71 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.487 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 34.9 tp -119.78 138.0 53.62 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.256 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.454 ' O ' ' OG ' ' A' ' 33' ' ' SER . 79.2 mt -104.88 121.0 56.26 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.184 0 CA-C-O 121.068 0.461 . . . . 0.0 110.879 -179.14 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 93.2 mt -136.86 132.73 47.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.553 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.508 HD22 ' CG ' ' A' ' 241' ' ' ASP . 60.9 t30 -64.19 151.16 44.17 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.534 179.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.516 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 89.0 t80 -86.03 122.52 30.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.786 -179.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.516 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 99.1 m-20 55.3 69.16 0.76 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.547 179.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 36.2 p-10 -125.26 0.61 7.76 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.589 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -151.15 116.15 5.26 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.823 0.344 . . . . 0.0 110.581 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' SER . . . . . 0.51 ' HG ' ' H ' ' A' ' 150' ' ' GLN . 85.3 p -63.24 168.08 4.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.564 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.403 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.7 p-90 -51.13 -15.65 0.37 Allowed 'General case' 0 C--O 1.221 -0.405 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.313 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . 0.51 ' H ' ' HG ' ' A' ' 148' ' ' SER . 68.1 tp60 -71.09 -74.89 0.14 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.009 0.433 . . . . 0.0 110.581 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.444 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.2 t -62.68 -38.87 92.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.238 179.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 52.3 tp -60.23 -45.57 92.78 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.451 -178.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.403 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 45.5 tp -62.61 -41.69 99.15 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.597 178.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.444 ' OG1' ' O ' ' A' ' 151' ' ' SER . 56.1 p -63.85 -34.8 78.75 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.202 -179.37 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.481 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.4 mm-40 -63.69 -42.05 98.06 Favored 'General case' 0 C--O 1.224 -0.262 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.371 179.308 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 91.3 mt -65.44 -38.87 91.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.182 0.515 . . . . 0.0 110.376 178.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.557 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.34 -31.78 78.48 Favored Glycine 0 C--N 1.331 0.279 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 -179.246 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.481 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.3 mt-10 -37.18 -24.99 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.848 0.356 . . . . 0.0 110.948 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.557 ' N ' ' O ' ' A' ' 157' ' ' GLY . 93.8 mt -59.71 149.25 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.385 179.127 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 76.0 p -69.13 137.54 53.48 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.904 -179.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 70.41 22.28 77.65 Favored Glycine 0 CA--C 1.518 0.235 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 179.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 61.7 m80 -124.34 -14.14 7.01 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.621 0.248 . . . . 0.0 110.454 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -66.76 -59.55 3.47 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.56 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -51.73 -49.37 62.68 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.136 -179.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -60.3 -41.21 92.93 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.884 0.373 . . . . 0.0 110.501 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.38 -47.58 85.17 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.472 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.64 -40.06 74.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.306 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -61.7 -50.27 73.13 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.699 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -65.26 -43.67 90.57 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.576 179.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 94.7 mt -64.48 -43.46 96.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.346 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.51 -51.26 70.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.299 -179.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.56 -43.73 96.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.922 0.392 . . . . 0.0 110.655 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . 0.521 ' CD1' ' OH ' ' A' ' 301' ' ' TYR . 55.9 t80 -62.78 -44.29 96.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.363 179.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -63.57 -39.62 94.88 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.446 -179.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -63.15 -42.69 99.48 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.583 179.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -60.62 -44.81 95.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.241 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 85.2 mt -64.65 -41.03 96.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.871 178.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.02 -61.98 1.92 Allowed 'General case' 0 C--O 1.239 0.506 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.428 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.96 -46.8 87.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.333 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -52.97 -41.63 64.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.414 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -63.98 -33.71 76.34 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.32 179.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 69.7 tt0 -90.95 8.75 33.59 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.631 0.729 . . . . 0.0 110.258 -178.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -104.56 -31.97 9.18 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 122.041 -0.412 . . . . 0.0 111.099 179.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.6 pt -128.07 147.87 32.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.625 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -140.0 131.36 26.79 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.463 178.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.55 ' CD2' ' N ' ' A' ' 186' ' ' LEU . 3.6 mm? -85.32 133.1 43.18 Favored Pre-proline 0 N--CA 1.447 -0.584 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.146 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -43.93 157.83 0.14 Allowed 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 122.597 2.198 . . . . 0.0 112.35 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . 0.49 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.6 Cg_endo -63.2 115.11 2.78 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.809 2.339 . . . . 0.0 111.615 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . 0.49 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.7 mt-30 155.91 147.99 0.0 OUTLIER Pre-proline 0 C--O 1.232 0.177 0 O-C-N 124.393 1.058 . . . . 0.0 110.871 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -73.54 144.01 35.29 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 122.612 2.208 . . . . 0.0 112.158 177.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.485 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.1 p -124.82 159.17 31.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.409 0.623 . . . . 0.0 110.147 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' THR . . . . . 0.485 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 35.4 p -143.2 165.47 27.35 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.048 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -135.4 128.89 32.42 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-O 121.364 0.602 . . . . 0.0 110.33 179.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 47.3 pt -146.42 148.83 16.62 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.374 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.113 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 70.2 t -117.55 123.18 71.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.226 0.536 . . . . 0.0 109.973 178.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -134.31 107.07 7.43 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.054 0.454 . . . . 0.0 110.259 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 94.9 m -130.93 130.37 43.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.843 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.413 ' O ' ' N ' ' A' ' 201' ' ' HIS . . . -82.79 -36.84 25.28 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.295 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.22 -67.18 0.25 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.29 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.11 -10.15 59.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.425 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . 0.413 ' N ' ' O ' ' A' ' 198' ' ' ALA . 60.2 t-80 61.01 58.15 2.35 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.64 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 41.9 p -166.86 153.65 8.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.609 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.53 144.23 24.34 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.948 0.404 . . . . 0.0 110.441 179.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -135.42 138.41 43.21 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.554 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 19.4 mt -106.09 125.33 50.86 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.923 0.392 . . . . 0.0 109.974 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' TRP . . . . . 0.556 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 75.2 m95 -82.19 167.39 18.74 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.569 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -157.14 171.67 7.15 Favored Pre-proline 0 C--O 1.225 -0.234 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.622 -178.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -53.79 -36.97 84.25 Favored 'Trans proline' 0 C--N 1.301 -1.935 0 C-N-CA 122.63 2.22 . . . . 0.0 112.306 179.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -71.09 -34.71 71.39 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.679 -179.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 21.7 m -61.3 150.72 34.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.569 -179.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.49 -36.97 81.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.418 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . 0.556 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 55.3 tt0 -64.72 -40.21 94.96 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.557 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.98 -43.49 91.12 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -62.91 -44.04 97.16 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.848 0.356 . . . . 0.0 110.249 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 65.4 ttp -59.41 -48.11 82.9 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.069 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 87.1 mt -60.19 -41.16 92.35 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . 0.45 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.1 tp10 -57.9 -37.97 74.99 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.148 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -65.49 -38.04 88.58 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.71 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 95.4 mt -64.09 -42.78 96.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.639 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.59 45.16 0.08 OUTLIER Glycine 0 N--CA 1.462 0.393 0 N-CA-C 111.054 -0.819 . . . . 0.0 111.054 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . 0.45 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 26.9 m-85 -128.07 155.23 44.7 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.926 0.393 . . . . 0.0 110.509 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' THR . . . . . 0.448 ' O ' ' O ' ' A' ' 191' ' ' VAL . 6.9 p -106.94 122.23 46.02 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-O 121.299 0.571 . . . . 0.0 110.125 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . 0.442 ' CD2' ' N ' ' A' ' 223' ' ' LEU . 4.3 mm? -101.32 132.9 46.63 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.144 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.51 159.46 14.92 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.485 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.19 115.23 29.92 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.416 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.442 ' CD1' ' N ' ' A' ' 226' ' ' LEU . 9.1 mp -53.25 156.79 3.66 Favored Pre-proline 0 N--CA 1.447 -0.623 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.796 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -60.2 145.26 98.92 Favored 'Trans proline' 0 C--N 1.302 -1.873 0 C-N-CA 122.735 2.29 . . . . 0.0 112.145 179.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.42 -3.01 59.01 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.544 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.19 -40.91 5.67 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.51 ' O ' ' N ' ' A' ' 233' ' ' SER . 84.8 mt -79.23 -16.85 55.87 Favored 'General case' 0 C--O 1.218 -0.562 0 CA-C-O 121.131 0.491 . . . . 0.0 110.323 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 54.3 t-20 -40.38 -49.33 2.8 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.839 0.352 . . . . 0.0 110.733 -179.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -87.99 15.44 7.27 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.251 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' SER . . . . . 0.51 ' N ' ' O ' ' A' ' 230' ' ' LEU . 77.8 p -60.59 -35.29 75.74 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.655 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . 0.524 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.6 tt0 -119.03 -69.33 0.86 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.753 0.311 . . . . 0.0 110.751 179.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.2 m -70.0 102.62 2.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.633 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -94.08 57.76 2.44 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.361 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -144.72 -122.59 1.58 Allowed Glycine 0 N--CA 1.461 0.363 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -134.84 111.59 10.01 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.059 0.456 . . . . 0.0 110.35 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . 0.517 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.4 mtt180 -148.05 57.94 1.09 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.664 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -69.75 -31.98 70.26 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.521 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . 0.508 ' CG ' HD22 ' A' ' 143' ' ' ASN . 64.9 t0 -56.92 -47.11 81.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.255 -179.004 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' ILE . . . . . 0.437 ' O ' ' O ' ' A' ' 239' ' ' ARG . 17.8 tt -139.95 156.63 25.41 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.263 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.391 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 96.1 mt -106.02 106.37 20.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-O 120.971 0.415 . . . . 0.0 110.468 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . 0.517 ' OE1' ' NH1' ' A' ' 239' ' ' ARG . 88.2 mt-30 -110.57 110.17 20.77 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.362 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 9.6 mp -121.77 -168.24 1.67 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.666 179.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . 0.524 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.7 -16.93 0.05 OUTLIER Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . 0.688 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -60.47 156.7 30.4 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 110.829 -0.908 . . . . 0.0 110.829 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -63.57 21.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.825 0.345 . . . . 0.0 110.583 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . 0.688 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.8 m-20 -96.85 -6.04 36.84 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.436 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 91.5 mt -79.89 -21.65 43.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.902 179.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.65 -51.35 70.28 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.661 -179.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.7 -5.1 58.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.458 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.27 -74.06 1.16 Allowed Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 80.1 mt -70.02 125.95 28.24 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.883 0.373 . . . . 0.0 110.334 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -59.53 -39.48 84.07 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.254 -179.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 83.27 51.77 4.02 Favored Glycine 0 CA--C 1.52 0.368 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -95.3 -15.76 22.9 Favored 'General case' 0 C--N 1.33 -0.243 0 O-C-N 122.77 -0.253 . . . . 0.0 110.661 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 258' ' ' SER . . . . . 0.419 ' O ' ' O ' ' A' ' 192' ' ' THR . 3.4 t 174.87 89.31 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.227 0.537 . . . . 0.0 110.244 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . 0.589 ' N ' ' CD1' ' A' ' 259' ' ' LEU . 0.9 OUTLIER -94.8 124.31 38.77 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.052 0.453 . . . . 0.0 111.052 -178.78 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 15.8 m-30 -93.58 146.4 23.84 Favored 'General case' 0 CA--C 1.495 -1.142 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.494 179.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 85.9 mt -122.18 149.24 43.91 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.564 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.652 ' CG ' ' N ' ' A' ' 263' ' ' ALA . 2.6 p90 -77.23 -138.82 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.534 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . 0.652 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -51.39 77.03 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.407 0 O-C-N 123.415 0.447 . . . . 0.0 111.171 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . 0.625 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.16 104.74 0.19 Allowed Glycine 0 CA--C 1.528 0.87 0 N-CA-C 110.421 -1.072 . . . . 0.0 110.421 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 265' ' ' ASP . . . . . 0.589 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.4 m-20 -80.21 -177.9 6.32 Favored 'General case' 0 C--N 1.327 -0.394 0 O-C-N 122.671 -0.311 . . . . 0.0 110.847 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -40.7 -17.76 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.549 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . 0.589 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.21 -51.44 45.48 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.614 179.22 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -63.9 -46.39 85.05 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.997 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . 0.523 ' O ' ' CD2' ' A' ' 273' ' ' TYR . . . -61.88 -34.92 76.9 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.657 0.741 . . . . 0.0 109.824 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -62.82 -34.66 77.77 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.292 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.43 -43.11 13.9 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.049 -179.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 272' ' ' ILE . . . . . 0.621 ' C ' ' H ' ' A' ' 274' ' ' ALA . 4.9 tt -51.53 -33.71 14.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.678 -178.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 273' ' ' TYR . . . . . 0.523 ' CD2' ' O ' ' A' ' 269' ' ' ALA . 17.2 m-85 -54.71 -1.55 0.03 OUTLIER 'General case' 0 CA--C 1.513 -0.452 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.616 -179.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 274' ' ' ALA . . . . . 0.621 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.61 -39.78 70.24 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.802 179.408 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . 0.573 ' O ' ' N ' ' A' ' 279' ' ' ALA . 2.6 p30 -38.98 97.9 0.15 Allowed Pre-proline 0 N--CA 1.462 0.151 0 O-C-N 123.49 0.494 . . . . 0.0 110.33 -179.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -54.18 -42.92 63.12 Favored 'Trans proline' 0 C--N 1.303 -1.845 0 C-N-CA 122.58 2.187 . . . . 0.0 112.491 -178.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 88.5 mt -64.41 -43.02 95.69 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.015 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 91.5 mt -95.66 -1.45 50.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.863 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 279' ' ' ALA . . . . . 0.573 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.58 -34.87 77.84 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.486 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.32 20.14 0.12 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.9 -179.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . 0.514 ' H ' ' C ' ' A' ' 279' ' ' ALA . 13.8 mt -74.65 119.53 77.1 Favored Pre-proline 0 N--CA 1.442 -0.838 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.849 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -50.57 -39.71 55.47 Favored 'Trans proline' 0 C--N 1.312 -1.36 0 C-N-CA 122.535 2.156 . . . . 0.0 112.063 178.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.73 -50.69 62.92 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.874 0.369 . . . . 0.0 110.021 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 76.9 t -61.4 -43.77 97.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.162 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -57.81 -41.2 81.71 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.089 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -91.0 0.63 57.5 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.245 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt 59.16 43.63 16.94 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.966 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -95.1 41.22 1.1 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.314 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 53.9 t -118.9 135.68 58.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-O 121.119 0.485 . . . . 0.0 109.967 -179.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -132.81 162.73 30.75 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.534 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.54 155.12 32.79 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.523 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 81.0 mt -94.09 -1.73 53.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.256 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.14 165.59 12.71 Favored Glycine 0 N--CA 1.465 0.613 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 6.8 m -87.33 -62.34 1.52 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.879 0.371 . . . . 0.0 110.947 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 295' ' ' GLU . . . . . 0.482 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.6 mm-40 -69.02 -4.07 15.48 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.755 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 24.5 p -76.92 32.32 0.14 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.68 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 297' ' ' PHE . . . . . 0.482 ' H ' ' C ' ' A' ' 295' ' ' GLU . 70.8 t80 -60.43 -45.97 91.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.624 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . 0.615 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.1 mtt85 -81.27 134.85 35.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.543 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 17.7 tp -113.68 117.22 30.95 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-O 120.918 0.39 . . . . 0.0 110.391 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . 0.602 ' H ' ' CB ' ' A' ' 303' ' ' SER . 49.9 p-10 -165.3 -176.47 4.06 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.758 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 301' ' ' TYR . . . . . 0.521 ' OH ' ' CD1' ' A' ' 173' ' ' PHE . 80.2 t80 -46.81 -43.49 18.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.391 -179.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -66.92 -40.35 87.61 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 121.037 0.446 . . . . 0.0 110.723 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 303' ' ' SER . . . . . 0.602 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 60.1 p -55.99 -36.37 67.81 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.062 -179.054 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -57.11 -51.8 67.85 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 179.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 92.2 mtp -55.48 -44.45 76.52 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -65.86 -42.66 90.15 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.309 0.576 . . . . 0.0 110.398 179.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 55.6 t -63.96 -42.92 97.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.253 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 44.0 tp -59.73 -41.93 92.02 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.029 -179.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -62.87 -38.69 91.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.069 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 310' ' ' ARG . . . . . 0.446 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.7 ttt85 -63.42 -43.84 96.34 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.295 179.512 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 90.2 mt -63.1 -42.1 99.52 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.489 179.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -63.01 -33.36 75.25 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.304 179.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.48 -23.54 22.06 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.285 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . 0.446 ' N ' ' O ' ' A' ' 310' ' ' ARG . 6.7 tt -62.31 -43.19 99.4 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 121.012 0.434 . . . . 0.0 110.526 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 . . . . . 0 C--O 1.22 -0.461 0 CA-C-O 118.041 -0.98 . . . . 0.0 110.263 -179.8 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -99.73 135.85 40.54 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.167 0.508 . . . . 0.0 110.403 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.492 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -92.33 178.62 1.61 Allowed Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.533 -179.797 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.492 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.0 Cg_exo -61.68 147.29 95.68 Favored 'Trans proline' 0 C--N 1.298 -2.104 0 C-N-CA 122.893 2.396 . . . . 0.0 112.164 179.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 35.3 ptt180 -136.91 142.59 42.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.636 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -79.52 117.06 20.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.459 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.5 tp -111.5 130.74 64.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.468 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.6 t -71.55 142.41 50.07 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.677 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.523 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.6 t0 -139.54 -179.81 6.12 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.502 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.523 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 77.9 p -73.83 -37.34 64.87 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.655 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.8 ttt85 -46.97 -94.77 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.335 -179.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.478 ' C ' ' HG1' ' A' ' 36' ' ' THR . . . -165.9 -27.02 0.02 OUTLIER Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.478 ' HG1' ' C ' ' A' ' 35' ' ' GLY . 63.4 m -168.67 105.98 0.44 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.834 0.35 . . . . 0.0 110.643 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.4 t60 -129.11 146.15 51.12 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 121.11 0.481 . . . . 0.0 110.112 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.489 ' CG2' ' N ' ' A' ' 39' ' ' LEU . 93.3 m -129.36 165.59 21.21 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.4 -179.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.489 ' N ' ' CG2' ' A' ' 38' ' ' THR . 79.6 mt -120.26 127.23 52.21 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.537 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -65.39 -44.78 86.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.698 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 39.0 p -165.83 155.28 12.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.374 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.463 ' N ' ' CD ' ' A' ' 42' ' ' GLN . 14.5 mp0 -45.2 101.26 0.25 Allowed Pre-proline 0 C--O 1.235 0.325 0 O-C-N 123.6 0.562 . . . . 0.0 110.558 179.227 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -57.77 130.34 38.04 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 C-N-CA 122.326 2.018 . . . . 0.0 112.315 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -82.76 -24.9 33.28 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.601 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.531 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.7 mtm-85 -120.86 134.98 55.29 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.225 0.536 . . . . 0.0 110.135 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.1 mt -130.26 133.48 63.98 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.345 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.818 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 45.7 t -125.24 130.87 72.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 CA-C-O 120.967 0.413 . . . . 0.0 109.924 179.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.504 ' O ' ' O ' ' A' ' 66' ' ' ALA . 4.7 m -154.87 166.48 33.38 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.527 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 72.8 p -124.49 8.88 8.38 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.313 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.68 125.69 33.37 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.857 0.36 . . . . 0.0 110.635 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 85.5 t -65.71 -44.44 93.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.553 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.8 m -62.7 -44.34 96.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.63 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 53.8 tp -62.46 -41.41 98.73 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.613 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 74.3 m -57.89 -44.6 86.84 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.269 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.27 -62.12 5.42 Favored Glycine 0 N--CA 1.468 0.788 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.6 t -48.24 -35.6 12.31 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 20.1 mt -61.85 -44.02 97.67 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 120.594 -0.442 . . . . 0.0 111.383 179.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.3 mp -65.43 -41.34 93.63 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.404 177.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.82 -41.27 97.9 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.914 -179.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 7.9 tp -87.66 16.55 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.918 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 56.44 84.42 0.09 Allowed 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.841 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.25 58.91 0.08 OUTLIER Pre-proline 0 C--N 1.327 -0.389 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -51.6 152.78 11.97 Favored 'Trans proline' 0 C--N 1.292 -2.437 0 C-N-CA 123.074 2.516 . . . . 0.0 112.053 -178.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.431 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -108.78 145.86 15.15 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.152 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.262 -179.646 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.61 -45.3 97.93 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.471 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.504 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -129.83 134.29 47.45 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.47 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.494 ' O ' ' N ' ' A' ' 98' ' ' LEU . 72.1 m -134.38 158.54 43.58 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.895 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.42 139.01 16.31 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.456 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.61 -162.98 0.09 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.953 0.406 . . . . 0.0 110.437 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.473 ' O ' ' C ' ' A' ' 71' ' ' THR . 5.7 t -133.91 135.83 43.88 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.015 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.473 ' C ' ' O ' ' A' ' 70' ' ' THR . 1.0 OUTLIER 29.68 68.23 0.68 Allowed Pre-proline 0 N--CA 1.468 0.438 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.78 -179.68 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_exo -61.32 145.11 98.7 Favored 'Trans proline' 0 C--N 1.299 -2.072 0 C-N-CA 122.644 2.23 . . . . 0.0 111.762 -177.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.527 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 45.5 p-10 -160.15 -32.02 0.06 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.746 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.527 ' N ' ' OD1' ' A' ' 73' ' ' ASN . 99.1 m-20 -64.29 -39.31 93.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.326 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -60.5 -47.88 84.21 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.509 -179.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.423 ' O ' ' O ' ' A' ' 77' ' ' ALA . 94.3 t -60.48 -24.46 31.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.423 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -45.73 173.03 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.602 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.567 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.6 p30 -61.92 177.59 0.43 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.58 -179.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.597 ' C ' ' H ' ' A' ' 81' ' ' GLY . 36.2 p30 -45.73 85.57 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.031 0.443 . . . . 0.0 111.069 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.567 ' N ' ' O ' ' A' ' 78' ' ' ASP . 42.4 tp60 -67.4 13.36 0.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.297 0.57 . . . . 0.0 110.172 -179.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.597 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 118.06 -22.53 9.71 Favored Glycine 0 C--N 1.333 0.372 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -107.82 116.04 31.24 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.056 0.455 . . . . 0.0 110.461 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 77.7 mt -98.47 0.67 45.62 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.991 0.424 . . . . 0.0 110.553 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -92.08 6.84 44.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.058 0.456 . . . . 0.0 110.387 -179.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.433 ' O ' ' CG2' ' A' ' 89' ' ' VAL . 88.4 mt-30 -100.02 -26.99 13.79 Favored 'General case' 0 C--O 1.22 -0.467 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.821 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.4 t-105 -63.8 -40.66 97.18 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.09 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.546 ' O ' ' N ' ' A' ' 91' ' ' LYS . 69.4 m -77.55 -53.27 7.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.134 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -48.9 -50.8 33.35 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.138 -179.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.433 ' CG2' ' O ' ' A' ' 85' ' ' GLN . 15.3 m -68.75 -40.62 81.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.232 179.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.412 ' H ' HG23 ' A' ' 89' ' ' VAL . . . -72.26 -23.07 61.15 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.678 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.546 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.0 tttm -61.32 -45.93 92.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.369 -179.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.439 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.8 mm-40 -90.5 -94.52 0.12 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.066 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.617 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.9 mtt180 -143.56 60.0 1.39 Allowed 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.442 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.7 pttp 34.22 25.86 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.105 0.478 . . . . 0.0 110.339 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.617 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.4 tt -48.25 123.01 5.83 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.064 -177.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -83.08 -170.62 3.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.059 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.62 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 83.0 mtp180 -73.32 137.85 45.04 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.128 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.494 ' N ' ' O ' ' A' ' 67' ' ' SER . 90.5 mt -86.65 -165.79 1.37 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.886 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.532 ' CD2' ' O ' ' A' ' 99' ' ' TYR . 47.5 p90 -168.84 119.98 0.75 Allowed 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.154 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.492 ' C ' ' O ' ' A' ' 99' ' ' TYR . 43.9 mm -29.22 121.06 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 O-C-N 123.308 0.38 . . . . 0.0 111.125 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 114.15 27.76 3.31 Favored Glycine 0 N--CA 1.461 0.341 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 -179.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.582 ' N ' ' CD ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -143.93 45.82 0.6 Allowed Pre-proline 0 C--N 1.321 -0.649 0 CA-C-O 121.079 0.466 . . . . 0.0 110.391 179.716 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.582 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 29.6 Cg_endo -62.42 144.16 94.51 Favored 'Trans proline' 0 C--N 1.294 -2.342 0 C-N-CA 122.687 2.258 . . . . 0.0 111.727 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.708 ' HG ' ' H ' ' A' ' 107' ' ' ALA . 24.8 t -173.36 121.04 0.35 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.377 179.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.29 -40.92 64.16 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.989 0.423 . . . . 0.0 111.125 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -65.91 -39.85 90.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.865 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.708 ' H ' ' HG ' ' A' ' 104' ' ' SER . . . -63.94 -39.64 94.63 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.754 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 70.0 t -67.52 -43.71 87.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.681 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.49 -39.28 92.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.474 -179.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.439 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.94 -23.83 63.87 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.476 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.537 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.3 mm-40 -91.18 5.04 50.65 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.667 -179.544 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.537 ' C ' ' O ' ' A' ' 111' ' ' GLN . 10.2 tpt 21.54 64.95 0.3 Allowed Pre-proline 0 N--CA 1.469 0.516 0 CA-C-O 120.961 0.41 . . . . 0.0 111.337 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -80.01 169.9 17.22 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 123.094 2.53 . . . . 0.0 111.517 -177.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.519 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 99.2 m-20 -112.34 -45.1 3.3 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.973 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 39.4 tp -119.51 121.23 38.94 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 96.7 mt -118.45 131.41 71.3 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.432 0 CA-C-O 120.953 0.406 . . . . 0.0 111.013 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 32.4 mt -106.04 132.24 52.35 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 121.086 0.47 . . . . 0.0 110.156 -179.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 98.6 mt -117.75 135.75 57.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.628 -179.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 85.3 p -71.17 151.32 44.51 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.62 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.42 -49.98 75.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.642 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.0 t -149.19 153.71 38.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.539 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 168.19 -169.68 41.6 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.93 -35.7 92.42 Favored Glycine 0 CA--C 1.522 0.513 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.445 ' O ' ' OD1' ' A' ' 124' ' ' ASP . 44.2 p-10 -88.2 120.18 29.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.867 0.365 . . . . 0.0 110.696 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 41.3 t -63.6 143.78 57.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.363 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.515 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.67 -42.82 8.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.863 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.4 tp -62.78 -42.45 99.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.674 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.76 -10.43 52.58 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.382 -179.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 83.4 mt -116.23 -24.0 8.17 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.65 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . 0.515 ' N ' ' O ' ' A' ' 126' ' ' ALA . 72.6 t80 -51.79 -49.08 63.42 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.639 -178.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 39.0 p-10 -65.96 -41.56 91.07 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.324 179.203 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.525 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 87.9 mt-30 -68.14 -36.68 80.08 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.874 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 96.3 mt -79.89 -42.67 23.69 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.017 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.402 ' N ' ' OG1' ' A' ' 139' ' ' THR . 11.3 t -57.37 -45.07 84.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.343 -179.018 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 20.0 m -62.36 -45.88 91.17 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.566 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 93.0 mt -62.28 -43.71 98.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.349 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -170.1 163.32 6.38 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.559 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -41.69 110.37 0.14 Allowed 'Trans proline' 0 C--N 1.311 -1.428 0 C-N-CA 122.486 2.124 . . . . 0.0 112.344 179.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' THR . . . . . 0.402 ' OG1' ' N ' ' A' ' 134' ' ' SER . 3.0 m -87.37 127.46 35.2 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.542 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 34.3 tp -119.29 139.24 52.24 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.259 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.428 ' O ' ' OD2' ' A' ' 32' ' ' ASP . 81.3 mt -105.32 120.1 55.49 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.352 0 CA-C-O 121.132 0.491 . . . . 0.0 111.196 -179.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 97.4 mt -135.69 132.75 51.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.585 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.518 HD22 ' CG ' ' A' ' 241' ' ' ASP . 59.3 t30 -64.62 148.22 51.35 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.933 0.397 . . . . 0.0 110.38 179.264 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.515 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 87.6 t80 -82.74 122.72 28.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.973 -179.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.515 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 99.0 m-20 55.11 69.12 0.77 Allowed 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.784 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 34.5 p-10 -125.7 0.31 7.45 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.856 0.36 . . . . 0.0 110.636 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -150.42 115.51 5.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.691 -179.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' SER . . . . . 0.516 ' HG ' ' H ' ' A' ' 150' ' ' GLN . 85.0 p -63.49 168.94 4.16 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.538 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.414 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.5 p-90 -51.84 -16.08 0.63 Allowed 'General case' 0 C--O 1.219 -0.505 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.326 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . 0.516 ' H ' ' HG ' ' A' ' 148' ' ' SER . 67.9 tp60 -70.11 -76.05 0.11 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.891 0.377 . . . . 0.0 110.542 -179.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.447 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.1 t -62.48 -38.66 90.7 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.253 179.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 52.1 tp -60.16 -45.61 92.48 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.354 -178.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.414 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 45.8 tp -62.6 -41.76 99.16 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.55 178.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.447 ' OG1' ' O ' ' A' ' 151' ' ' SER . 58.7 p -63.86 -34.94 79.06 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.098 -179.229 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.467 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 88.0 mm-40 -63.66 -42.03 98.13 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.23 179.291 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 91.6 mt -65.34 -38.82 91.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.192 0.52 . . . . 0.0 110.243 179.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.566 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.34 -32.3 80.38 Favored Glycine 0 C--N 1.332 0.316 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 -179.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.467 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.4 mt-10 -36.79 -25.19 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.901 0.381 . . . . 0.0 110.862 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.566 ' N ' ' O ' ' A' ' 157' ' ' GLY . 94.9 mt -59.22 148.43 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.292 179.031 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 74.6 p -69.09 137.63 53.66 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.994 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 70.48 22.14 77.72 Favored Glycine 0 N--CA 1.458 0.136 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 179.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 59.9 m80 -124.48 -13.96 6.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.597 0.237 . . . . 0.0 110.426 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -66.81 -59.49 3.5 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.593 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -51.92 -48.89 63.99 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.153 -179.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -60.55 -41.09 93.83 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.806 0.336 . . . . 0.0 110.405 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.68 -47.43 85.34 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.534 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.63 -40.27 75.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.225 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -61.58 -50.44 72.59 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.672 179.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -65.25 -43.66 90.66 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.586 179.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 94.4 mt -64.63 -43.33 96.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.441 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.4 -51.12 70.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.313 -179.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.63 -43.41 96.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.851 0.357 . . . . 0.0 110.635 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . 0.504 ' CD1' ' OH ' ' A' ' 301' ' ' TYR . 57.7 t80 -62.94 -44.25 96.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.402 179.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -63.69 -39.65 94.86 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.477 -179.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -63.18 -42.82 99.42 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.564 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -60.63 -44.45 96.33 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.175 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 84.8 mt -64.44 -41.12 96.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.78 178.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.34 -62.14 1.83 Allowed 'General case' 0 C--O 1.24 0.553 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.281 -179.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.23 -47.23 84.16 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.432 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -52.73 -41.72 64.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.353 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -63.74 -33.59 75.99 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.055 0.455 . . . . 0.0 110.284 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 69.8 tt0 -91.08 8.52 35.08 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.666 0.746 . . . . 0.0 110.318 -178.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -104.33 -32.45 9.06 Favored 'General case' 0 CA--C 1.516 -0.361 0 O-C-N 122.001 -0.437 . . . . 0.0 111.222 179.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.7 pt -127.9 147.57 32.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.801 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -139.78 131.26 26.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.966 0.412 . . . . 0.0 110.395 179.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.552 ' CD2' ' N ' ' A' ' 186' ' ' LEU . 3.5 mm? -85.34 133.59 42.16 Favored Pre-proline 0 N--CA 1.449 -0.516 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.193 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -43.65 157.76 0.12 Allowed 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.617 2.212 . . . . 0.0 112.372 179.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . 0.497 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.7 Cg_endo -63.04 114.69 2.55 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 122.817 2.344 . . . . 0.0 111.664 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . 0.497 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.7 mt-30 155.65 148.17 0.0 OUTLIER Pre-proline 0 N--CA 1.456 -0.159 0 O-C-N 124.244 0.965 . . . . 0.0 110.885 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -73.26 144.26 36.77 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.583 2.189 . . . . 0.0 112.289 177.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.487 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.1 p -124.61 158.87 31.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.461 0.648 . . . . 0.0 110.197 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' THR . . . . . 0.487 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 36.6 p -143.18 165.39 27.57 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.112 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -135.44 128.88 32.32 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-O 121.339 0.59 . . . . 0.0 110.209 179.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 47.7 pt -146.73 149.38 15.92 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.404 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.21 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 69.4 t -117.87 123.41 71.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.402 0.62 . . . . 0.0 109.792 179.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -134.34 106.75 7.25 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 121.104 0.478 . . . . 0.0 110.208 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 94.7 m -130.7 130.44 43.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.943 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.42 ' O ' ' N ' ' A' ' 201' ' ' HIS . . . -82.8 -37.18 24.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.25 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.21 -66.92 0.27 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.288 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.47 -9.54 58.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.273 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . 0.42 ' N ' ' O ' ' A' ' 198' ' ' ALA . 60.1 t-80 60.32 58.27 2.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.81 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 39.5 p -167.02 153.79 8.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.568 179.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.36 144.19 24.45 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.054 0.454 . . . . 0.0 110.454 179.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -135.29 138.09 43.13 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.605 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 19.4 mt -106.04 125.44 51.0 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.055 0.455 . . . . 0.0 109.796 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' TRP . . . . . 0.555 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 74.5 m95 -82.15 167.14 19.03 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.587 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -157.45 171.32 7.59 Favored Pre-proline 0 C--O 1.224 -0.268 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.624 -178.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -53.18 -37.12 79.69 Favored 'Trans proline' 0 C--N 1.301 -1.965 0 C-N-CA 122.583 2.189 . . . . 0.0 112.448 178.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -70.84 -35.23 72.34 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.71 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 21.0 m -60.95 151.0 31.53 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.572 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.8 -36.96 82.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.485 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . 0.555 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 55.1 tt0 -64.69 -40.27 95.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.519 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.63 -43.58 91.71 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.631 -0.988 . . . . 0.0 110.631 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -62.88 -44.0 97.27 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.789 0.328 . . . . 0.0 110.219 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 65.1 ttp -59.32 -47.91 83.63 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.071 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 87.0 mt -60.73 -41.16 94.76 Favored 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . 0.449 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.6 tp10 -58.03 -37.89 75.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.35 -0.386 . . . . 0.0 109.994 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -65.38 -38.31 89.63 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.671 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 95.2 mt -63.91 -42.9 97.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.111 0.482 . . . . 0.0 110.613 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.56 44.93 0.08 OUTLIER Glycine 0 C--N 1.332 0.359 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . 0.449 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 26.6 m-85 -127.89 155.49 44.09 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 121.054 0.454 . . . . 0.0 110.439 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' THR . . . . . 0.451 ' O ' ' O ' ' A' ' 191' ' ' VAL . 7.0 p -106.96 122.34 46.24 Favored 'General case' 0 C--O 1.223 -0.294 0 CA-C-O 121.331 0.586 . . . . 0.0 110.067 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . 0.441 ' CD2' ' N ' ' A' ' 223' ' ' LEU . 4.3 mm? -101.4 133.01 46.68 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.229 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.8 159.8 14.72 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.456 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.52 115.35 30.1 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.935 0.398 . . . . 0.0 110.339 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.452 ' CD1' ' N ' ' A' ' 226' ' ' LEU . 8.9 mp -53.08 156.54 3.57 Favored Pre-proline 0 N--CA 1.448 -0.559 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.817 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -59.91 145.17 98.97 Favored 'Trans proline' 0 C--N 1.299 -2.03 0 C-N-CA 122.753 2.302 . . . . 0.0 112.312 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.09 -3.35 59.07 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.516 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.2 -40.96 5.66 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.506 ' O ' ' N ' ' A' ' 233' ' ' SER . 67.7 mt -79.08 -17.8 54.52 Favored 'General case' 0 C--O 1.218 -0.587 0 CA-C-O 121.212 0.529 . . . . 0.0 110.296 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 54.5 t-20 -40.74 -49.17 3.09 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.845 -179.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -87.16 15.05 6.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.459 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' SER . . . . . 0.506 ' N ' ' O ' ' A' ' 230' ' ' LEU . 77.9 p -60.56 -34.99 74.98 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.683 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . 0.525 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.5 tt0 -119.73 -69.3 0.85 Allowed 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.835 179.171 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.3 m -69.3 102.19 1.68 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.022 0.439 . . . . 0.0 110.687 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -94.08 57.51 2.4 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.086 0.47 . . . . 0.0 110.365 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -144.61 -122.43 1.58 Allowed Glycine 0 C--N 1.332 0.343 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -135.64 111.78 9.67 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.161 0.505 . . . . 0.0 110.347 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . 0.524 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.5 mtt180 -148.08 58.26 1.09 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.707 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -69.36 -32.48 71.57 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.457 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . 0.518 ' CG ' HD22 ' A' ' 143' ' ' ASN . 64.7 t0 -57.04 -47.24 81.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.211 -178.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' ILE . . . . . 0.435 ' O ' ' O ' ' A' ' 239' ' ' ARG . 18.1 tt -139.62 155.87 25.69 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.275 0 CA-C-O 120.913 0.387 . . . . 0.0 110.44 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 96.3 mt -106.17 106.87 21.39 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 CA-C-O 121.099 0.476 . . . . 0.0 110.479 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . 0.524 ' OE1' ' NH1' ' A' ' 239' ' ' ARG . 88.3 mt-30 -110.71 110.04 20.54 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.261 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 9.5 mp -121.51 -168.2 1.65 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.766 179.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . 0.525 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 174.14 -16.54 0.05 OUTLIER Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . 0.692 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -61.24 156.23 34.37 Favored Glycine 0 CA--C 1.521 0.449 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -63.4 21.94 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.995 0.426 . . . . 0.0 110.647 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . 0.692 ' H ' ' C ' ' A' ' 247' ' ' GLY . 99.0 m-20 -97.2 -6.27 35.13 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.438 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 91.0 mt -79.65 -22.0 44.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.775 179.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.68 -51.43 69.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.712 -179.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.21 -5.53 58.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.47 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.08 -74.24 1.15 Allowed Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.776 -0.929 . . . . 0.0 110.776 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 83.0 mt -70.25 126.43 29.64 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.218 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -59.67 -39.44 84.47 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.081 -179.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 83.16 51.62 4.1 Favored Glycine 0 CA--C 1.519 0.29 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -95.9 -14.96 22.73 Favored 'General case' 0 C--N 1.331 -0.204 0 O-C-N 122.65 -0.323 . . . . 0.0 110.598 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 258' ' ' SER . . . . . 0.422 ' O ' ' O ' ' A' ' 192' ' ' THR . 3.4 t 174.73 88.85 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.24 0.543 . . . . 0.0 110.072 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . 0.588 ' N ' ' CD1' ' A' ' 259' ' ' LEU . 1.0 OUTLIER -94.61 124.28 38.55 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.254 0.549 . . . . 0.0 111.267 -179.143 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 15.7 m-30 -93.37 146.39 23.77 Favored 'General case' 0 CA--C 1.495 -1.171 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.474 179.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 86.1 mt -122.33 149.25 44.02 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.545 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.655 ' CG ' ' N ' ' A' ' 263' ' ' ALA . 2.5 p90 -77.26 -138.77 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.578 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . 0.655 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -51.46 76.97 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 121.091 0.472 . . . . 0.0 111.299 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . 0.626 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.15 104.67 0.19 Allowed Glycine 0 CA--C 1.528 0.895 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 -179.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 265' ' ' ASP . . . . . 0.592 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.5 m-20 -80.31 -177.98 6.4 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 122.719 -0.283 . . . . 0.0 110.972 -179.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -40.3 -17.87 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.566 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . 0.592 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -67.94 -51.74 44.1 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.759 179.1 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -63.65 -46.47 85.48 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.216 179.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . 0.524 ' O ' ' CD2' ' A' ' 273' ' ' TYR . . . -61.93 -34.99 77.08 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 121.539 0.685 . . . . 0.0 109.658 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -63.2 -34.46 77.69 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.158 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.49 -42.96 13.98 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.081 -179.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 272' ' ' ILE . . . . . 0.62 ' C ' ' H ' ' A' ' 274' ' ' ALA . 4.9 tt -51.44 -33.78 14.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.728 -178.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 273' ' ' TYR . . . . . 0.524 ' CD2' ' O ' ' A' ' 269' ' ' ALA . 17.2 m-85 -54.64 -1.85 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.573 -179.327 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 274' ' ' ALA . . . . . 0.62 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.45 -39.9 70.7 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.952 179.381 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . 0.577 ' O ' ' N ' ' A' ' 279' ' ' ALA . 3.1 p30 -38.8 97.81 0.15 Allowed Pre-proline 0 N--CA 1.462 0.164 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.366 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -54.57 -42.62 66.47 Favored 'Trans proline' 0 C--N 1.303 -1.864 0 C-N-CA 122.428 2.086 . . . . 0.0 112.535 -178.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 89.5 mt -64.4 -42.87 95.87 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.058 0.456 . . . . 0.0 111.218 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 90.9 mt -95.7 -1.58 49.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.967 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 279' ' ' ALA . . . . . 0.577 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.3 -34.8 77.29 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.744 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.18 20.03 0.11 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.012 -179.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . 0.513 ' H ' ' C ' ' A' ' 279' ' ' ALA . 13.8 mt -74.93 119.51 77.2 Favored Pre-proline 0 N--CA 1.445 -0.69 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.801 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -49.96 -39.96 49.56 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.593 2.195 . . . . 0.0 112.279 178.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.72 -50.52 63.24 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.038 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 75.9 t -61.42 -43.96 97.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -57.71 -41.18 81.23 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.039 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -91.17 0.24 57.57 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.133 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt 59.36 43.53 16.48 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.04 0.447 . . . . 0.0 110.906 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -94.75 41.37 1.09 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.31 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 54.3 t -119.31 135.55 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-O 121.129 0.49 . . . . 0.0 109.995 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -132.64 162.98 29.97 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.209 0.528 . . . . 0.0 110.613 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.63 155.4 32.39 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-O 121.073 0.463 . . . . 0.0 110.632 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 82.8 mt -94.35 -1.52 53.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.256 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 120.83 165.32 12.69 Favored Glycine 0 C--N 1.335 0.497 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 7.3 m -86.98 -62.38 1.52 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.864 0.364 . . . . 0.0 111.154 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 295' ' ' GLU . . . . . 0.48 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.7 mm-40 -68.79 -3.97 14.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.738 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 25.0 p -77.08 32.04 0.14 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.651 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 297' ' ' PHE . . . . . 0.48 ' H ' ' C ' ' A' ' 295' ' ' GLU . 68.7 t80 -60.4 -46.18 90.93 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.629 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . 0.62 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.1 mtt85 -80.61 134.81 35.95 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.577 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 18.2 tp -113.87 117.01 30.23 Favored 'General case' 0 C--O 1.23 0.075 0 CA-C-O 121.02 0.438 . . . . 0.0 110.203 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . 0.6 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.5 p-10 -165.03 -176.71 4.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.651 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 301' ' ' TYR . . . . . 0.504 ' OH ' ' CD1' ' A' ' 173' ' ' PHE . 81.0 t80 -46.95 -42.99 18.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.356 -179.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -67.19 -40.14 86.48 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 121.065 0.46 . . . . 0.0 110.746 178.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 303' ' ' SER . . . . . 0.6 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 59.9 p -56.3 -36.35 68.55 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.975 -179.038 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . 0.567 ' N ' ' HG ' ' A' ' 303' ' ' SER . . . -57.04 -52.15 66.43 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 91.7 mtp -55.78 -43.66 77.01 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -66.22 -42.59 88.48 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.241 0.543 . . . . 0.0 110.239 179.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 55.5 t -64.04 -42.95 97.29 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.188 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 42.6 tp -60.05 -42.05 93.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.82 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -62.42 -39.34 92.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.028 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 310' ' ' ARG . . . . . 0.446 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.5 ttt85 -63.49 -44.0 95.64 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.153 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 89.8 mt -63.18 -42.11 99.31 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.103 0.478 . . . . 0.0 110.36 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt -63.16 -33.35 75.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.12 179.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.56 -23.72 21.92 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.329 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . 0.446 ' N ' ' O ' ' A' ' 310' ' ' ARG . 6.7 tt -62.35 -43.17 99.46 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 121.075 0.464 . . . . 0.0 110.521 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 . . . . . 0 C--O 1.22 -0.463 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.346 -179.886 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -99.55 135.98 40.17 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.119 0.485 . . . . 0.0 110.475 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.49 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -92.16 178.55 1.66 Allowed Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.589 -179.893 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.49 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.7 Cg_exo -61.44 147.15 96.2 Favored 'Trans proline' 0 C--N 1.299 -2.046 0 C-N-CA 122.848 2.365 . . . . 0.0 112.208 179.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 35.7 ptt180 -136.12 142.36 44.24 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.585 179.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -79.54 116.6 19.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.521 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.5 tp -111.1 130.66 64.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.564 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 13.7 t -70.79 142.25 51.34 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.987 0.422 . . . . 0.0 110.676 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.511 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.3 t0 -139.8 179.39 6.62 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.458 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.511 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 77.9 p -73.83 -37.05 64.97 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.562 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.8 ttt85 -46.51 -94.62 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.248 -179.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.494 ' C ' ' HG1' ' A' ' 36' ' ' THR . . . -167.06 -26.38 0.02 OUTLIER Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.494 ' HG1' ' C ' ' A' ' 35' ' ' GLY . 55.6 m -169.35 104.94 0.37 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.807 0.337 . . . . 0.0 110.664 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 75.4 t60 -128.47 148.79 50.75 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.055 0.455 . . . . 0.0 110.231 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.487 ' CG2' ' N ' ' A' ' 39' ' ' LEU . 98.6 m -131.02 166.05 21.87 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.498 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.487 ' N ' ' CG2' ' A' ' 38' ' ' THR . 81.2 mt -120.78 127.19 51.73 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.408 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -65.08 -44.62 88.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.794 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 40.9 p -165.71 155.1 12.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.354 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.46 ' N ' ' CD ' ' A' ' 42' ' ' GLN . 14.5 mp0 -44.27 100.91 0.24 Allowed Pre-proline 0 C--O 1.235 0.326 0 O-C-N 123.526 0.516 . . . . 0.0 110.594 179.202 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.54 129.6 34.66 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 C-N-CA 122.344 2.029 . . . . 0.0 112.231 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -83.63 -24.69 31.32 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.609 179.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.539 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.4 mtm-85 -122.25 134.43 54.69 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.257 0.551 . . . . 0.0 110.177 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.0 mt -130.46 133.78 63.24 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.774 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 45.3 t -124.43 130.4 73.58 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 CA-C-O 120.911 0.386 . . . . 0.0 109.986 179.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.504 ' O ' ' O ' ' A' ' 66' ' ' ALA . 2.1 m -154.88 167.27 30.84 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.645 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 65.1 p -124.53 9.16 8.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.419 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.52 125.51 33.13 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.644 -179.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 92.7 t -65.77 -44.51 93.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.555 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.4 m -62.51 -44.18 97.0 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.654 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 53.1 tp -62.33 -41.43 98.56 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.464 -179.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 74.3 m -57.86 -44.58 86.66 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.126 -179.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.19 -62.41 5.19 Favored Glycine 0 N--CA 1.467 0.733 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.7 t -47.94 -35.74 11.23 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 20.1 mt -61.88 -44.13 97.44 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.348 179.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.1 mp -65.62 -41.35 92.79 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.333 177.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.67 -41.1 98.22 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.846 -179.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 7.8 tp -88.35 16.66 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.914 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 56.27 84.79 0.08 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.821 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 178.83 58.34 0.07 OUTLIER Pre-proline 0 C--N 1.328 -0.358 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -51.6 153.51 10.7 Favored 'Trans proline' 0 C--N 1.293 -2.385 0 C-N-CA 123.051 2.501 . . . . 0.0 111.943 -178.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.435 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.2 OUTLIER -108.86 145.33 15.85 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.148 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.341 -179.677 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.36 -45.49 97.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.363 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.504 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -129.43 134.08 47.65 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 120.816 0.341 . . . . 0.0 110.489 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.503 ' O ' ' N ' ' A' ' 98' ' ' LEU . 73.8 m -134.54 158.75 43.17 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.871 -179.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -87.04 139.25 16.06 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 110.621 -0.991 . . . . 0.0 110.621 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.467 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.7 -162.77 0.08 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.938 0.399 . . . . 0.0 110.431 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.478 ' O ' ' C ' ' A' ' 71' ' ' THR . 14.2 t -133.47 134.75 43.91 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.293 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.478 ' C ' ' O ' ' A' ' 70' ' ' THR . 0.6 OUTLIER 29.73 68.74 0.66 Allowed Pre-proline 0 N--CA 1.467 0.397 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.817 -179.865 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_exo -61.85 145.18 97.21 Favored 'Trans proline' 0 C--N 1.299 -2.027 0 C-N-CA 122.706 2.27 . . . . 0.0 111.723 -177.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.528 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 45.7 p-10 -159.4 -31.81 0.06 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.66 179.645 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.528 ' N ' ' OD1' ' A' ' 73' ' ' ASN . 99.1 m-20 -64.35 -39.42 93.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.366 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.4 ttt180 -60.33 -48.16 82.95 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.505 -179.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.424 ' O ' ' O ' ' A' ' 77' ' ' ALA . 93.0 t -60.48 -25.1 33.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.054 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.424 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -45.51 173.04 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.592 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.569 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.4 p30 -62.01 177.59 0.44 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.577 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.594 ' C ' ' H ' ' A' ' 81' ' ' GLY . 35.5 p30 -45.34 85.67 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.036 0.446 . . . . 0.0 111.102 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.569 ' N ' ' O ' ' A' ' 78' ' ' ASP . 42.8 tp60 -67.64 13.29 0.08 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.268 0.556 . . . . 0.0 110.197 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.594 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 118.65 -22.08 9.49 Favored Glycine 0 N--CA 1.462 0.374 0 N-CA-C 110.981 -0.848 . . . . 0.0 110.981 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -108.33 116.42 31.94 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.963 0.411 . . . . 0.0 110.445 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 76.6 mt -98.74 -0.19 43.22 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.578 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -92.15 7.35 42.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.971 0.415 . . . . 0.0 110.299 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.439 ' O ' ' CG2' ' A' ' 89' ' ' VAL . 87.9 mt-30 -100.25 -28.15 13.14 Favored 'General case' 0 C--O 1.22 -0.455 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.795 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 68.9 t-105 -63.03 -40.47 97.82 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.833 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.551 ' O ' ' N ' ' A' ' 91' ' ' LYS . 67.5 m -77.82 -53.74 7.14 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.881 -179.342 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -48.53 -50.68 30.94 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.076 -179.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.439 ' CG2' ' O ' ' A' ' 85' ' ' GLN . 15.5 m -68.81 -40.55 81.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.161 179.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.415 ' H ' HG23 ' A' ' 89' ' ' VAL . . . -72.43 -22.66 61.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.572 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.551 ' N ' ' O ' ' A' ' 87' ' ' SER . 65.9 tttm -61.97 -45.67 92.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.357 -179.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.437 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.8 mm-40 -90.41 -94.64 0.12 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.164 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.621 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.8 mtt180 -143.12 58.73 1.41 Allowed 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.446 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.6 pttp 33.97 26.02 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.149 0.5 . . . . 0.0 110.267 -179.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.621 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.4 tt -48.22 123.48 6.47 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.002 -177.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -83.82 -169.98 2.85 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.146 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.609 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 81.2 mtp180 -74.25 137.07 42.74 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.232 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.503 ' N ' ' O ' ' A' ' 67' ' ' SER . 91.0 mt -85.71 -165.77 1.33 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.901 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.538 ' CD2' ' O ' ' A' ' 99' ' ' TYR . 47.9 p90 -168.57 119.56 0.77 Allowed 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.13 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.502 ' C ' ' O ' ' A' ' 99' ' ' TYR . 43.0 mm -28.69 120.78 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.068 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 114.2 27.61 3.35 Favored Glycine 0 CA--C 1.519 0.315 0 N-CA-C 111.259 -0.736 . . . . 0.0 111.259 -179.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.574 ' N ' ' CD ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -144.52 46.39 0.62 Allowed Pre-proline 0 C--N 1.321 -0.654 0 CA-C-O 121.084 0.468 . . . . 0.0 110.511 179.773 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.574 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 28.8 Cg_endo -62.15 144.34 95.66 Favored 'Trans proline' 0 C--N 1.295 -2.273 0 C-N-CA 122.687 2.258 . . . . 0.0 111.732 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.705 ' HG ' ' H ' ' A' ' 107' ' ' ALA . 24.3 t -173.2 120.52 0.35 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.349 179.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.95 -40.3 63.16 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.011 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.27 -39.91 89.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.892 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.705 ' H ' ' HG ' ' A' ' 104' ' ' SER . . . -64.33 -39.97 94.96 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.769 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 69.6 t -67.83 -43.65 86.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.73 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.04 -38.88 92.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.476 -179.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.437 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.55 -23.2 62.67 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.538 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.535 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.3 mm-40 -91.0 5.88 47.05 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.746 -179.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.539 ' O ' ' NE ' ' A' ' 45' ' ' ARG . 10.6 tpt 22.89 64.64 0.36 Allowed Pre-proline 0 N--CA 1.467 0.416 0 CA-C-O 120.905 0.383 . . . . 0.0 111.215 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -79.04 167.41 21.95 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 123.087 2.524 . . . . 0.0 111.466 -177.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.526 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 99.2 m-20 -110.02 -41.99 4.32 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.038 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.2 tp -121.38 120.26 34.51 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.925 0.393 . . . . 0.0 109.983 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 82.1 mt -112.94 128.92 69.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 CA-C-O 120.833 0.349 . . . . 0.0 110.935 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 29.3 mt -109.08 132.11 54.42 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.281 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 99.0 mt -119.75 138.57 49.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.654 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 85.7 p -72.54 153.8 41.13 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.633 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.28 -50.09 75.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.621 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -149.32 153.8 38.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.561 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 170.68 -170.86 43.43 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -63.11 -34.12 89.11 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.449 ' O ' ' OD1' ' A' ' 124' ' ' ASP . 44.3 p-10 -87.13 120.22 28.18 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.827 0.346 . . . . 0.0 110.612 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 37.7 t -63.18 143.94 57.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.342 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.52 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.09 -43.3 8.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.868 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.9 tp -63.03 -42.36 99.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.747 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.6 -12.1 59.64 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.372 -179.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 84.7 mt -114.88 -23.94 8.89 Favored 'General case' 0 C--O 1.225 -0.196 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.557 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . 0.52 ' N ' ' O ' ' A' ' 126' ' ' ALA . 79.5 t80 -51.07 -49.55 60.41 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.654 -178.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.502 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 37.6 p-10 -66.16 -42.81 88.5 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.762 -0.375 . . . . 0.0 111.255 179.421 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.502 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 88.4 mt-30 -66.94 -37.68 84.74 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.783 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 96.3 mt -80.21 -41.62 24.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.908 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.3 t -56.94 -44.68 82.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.229 -179.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 20.4 m -62.01 -45.1 95.08 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.378 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 94.3 mt -62.06 -43.65 97.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.305 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.44 168.47 4.82 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.649 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -49.91 112.74 0.77 Allowed 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.354 2.036 . . . . 0.0 112.454 179.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 23.6 m -84.07 127.33 33.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.629 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 34.4 tp -117.71 135.89 53.73 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.15 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.438 ' O ' ' OD2' ' A' ' 32' ' ' ASP . 82.1 mt -100.09 119.03 47.61 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.286 0 CA-C-O 121.093 0.473 . . . . 0.0 111.057 -179.301 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 98.0 mt -134.84 132.23 53.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.586 179.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.516 HD22 ' CG ' ' A' ' 241' ' ' ASP . 61.2 t30 -66.69 151.46 47.35 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.473 179.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.521 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 88.1 t80 -86.24 122.47 30.28 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.858 -179.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.521 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 98.9 m-20 55.22 69.17 0.76 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.673 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 35.0 p-10 -125.8 0.36 7.38 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.573 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -150.62 115.07 5.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.687 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' SER . . . . . 0.514 ' HG ' ' H ' ' A' ' 150' ' ' GLN . 84.0 p -63.34 168.41 4.47 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.597 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.411 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.8 p-90 -51.78 -16.05 0.61 Allowed 'General case' 0 C--O 1.22 -0.453 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.386 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . 0.514 ' H ' ' HG ' ' A' ' 148' ' ' SER . 68.1 tp60 -70.22 -76.01 0.11 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.896 0.379 . . . . 0.0 110.585 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.441 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.1 t -62.57 -38.81 91.53 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.224 179.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 54.1 tp -59.82 -45.9 90.93 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.398 -178.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.411 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 46.1 tp -62.63 -41.6 99.1 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.585 178.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.441 ' OG1' ' O ' ' A' ' 151' ' ' SER . 61.5 p -64.11 -34.96 79.25 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.189 -179.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.435 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.9 mm-40 -64.11 -42.49 96.87 Favored 'General case' 0 C--O 1.225 -0.229 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.412 179.308 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 90.6 mt -65.57 -38.57 89.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.147 0.499 . . . . 0.0 110.313 179.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.57 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.52 -32.28 80.66 Favored Glycine 0 C--N 1.331 0.286 0 N-CA-C 110.604 -0.998 . . . . 0.0 110.604 -179.154 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.435 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.2 mt-10 -35.56 -27.07 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.841 0.353 . . . . 0.0 110.827 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.57 ' N ' ' O ' ' A' ' 157' ' ' GLY . 95.6 mt -55.95 149.16 3.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.354 178.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 69.1 p -69.53 137.25 52.32 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.903 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 71.21 21.32 78.47 Favored Glycine 0 N--CA 1.459 0.195 0 N-CA-C 111.198 -0.761 . . . . 0.0 111.198 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 57.2 m80 -122.96 -14.67 7.56 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.6 0.238 . . . . 0.0 110.507 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -65.94 -59.97 3.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.596 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -52.05 -49.42 63.5 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.166 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -60.51 -41.07 93.61 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.838 0.351 . . . . 0.0 110.483 179.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.61 -47.26 86.26 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.505 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.82 -40.15 75.48 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.271 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -61.77 -50.01 74.08 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.616 179.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -65.34 -43.65 90.21 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.556 179.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 93.8 mt -64.88 -43.23 96.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.377 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.45 -51.35 69.8 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.297 -179.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.08 -43.82 97.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.939 0.4 . . . . 0.0 110.723 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . 0.459 ' CD1' ' OH ' ' A' ' 301' ' ' TYR . 57.7 t80 -63.09 -44.16 96.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.34 179.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -63.61 -39.64 94.89 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.498 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -63.16 -42.73 99.48 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.522 179.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -60.53 -44.68 95.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.22 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 84.6 mt -64.66 -40.94 96.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.651 178.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.14 -62.44 1.63 Allowed 'General case' 0 C--O 1.238 0.483 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.33 -179.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.34 -47.04 85.02 Favored 'General case' 0 C--O 1.226 -0.184 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.58 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -52.88 -41.89 64.77 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.368 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -63.97 -33.41 75.67 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.285 179.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 70.0 tt0 -90.76 8.78 32.92 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.609 0.719 . . . . 0.0 110.317 -178.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -105.05 -31.94 8.95 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.155 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 45.3 pt -128.08 147.93 32.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.708 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -140.19 131.34 26.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.463 179.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.552 ' CD2' ' N ' ' A' ' 186' ' ' LEU . 3.6 mm? -85.63 132.63 43.89 Favored Pre-proline 0 N--CA 1.451 -0.41 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.13 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -43.45 157.59 0.11 Allowed 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.701 2.267 . . . . 0.0 112.416 179.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . 0.501 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.6 Cg_endo -62.84 115.1 2.72 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 C-N-CA 122.781 2.321 . . . . 0.0 111.727 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . 0.501 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.7 mt-30 155.72 147.44 0.0 OUTLIER Pre-proline 0 C--O 1.232 0.134 0 O-C-N 124.071 0.857 . . . . 0.0 110.953 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -73.34 143.71 35.54 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.553 2.169 . . . . 0.0 112.381 177.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.493 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.1 p -124.63 159.24 31.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.443 0.64 . . . . 0.0 110.217 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' THR . . . . . 0.493 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 36.0 p -143.45 165.49 27.4 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.082 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -135.4 128.75 32.18 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 121.292 0.568 . . . . 0.0 110.181 179.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 47.3 pt -146.46 148.87 16.55 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.381 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.276 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 69.8 t -117.67 123.28 71.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.334 0.588 . . . . 0.0 109.844 178.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -134.37 107.38 7.58 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.258 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 94.0 m -130.86 130.39 43.51 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.846 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.407 ' O ' ' N ' ' A' ' 201' ' ' HIS . . . -82.74 -37.16 25.06 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.22 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.32 -67.1 0.26 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.383 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.2 -10.07 59.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.387 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . 0.407 ' N ' ' O ' ' A' ' 198' ' ' ALA . 60.2 t-80 61.01 58.25 2.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.721 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 41.4 p -167.03 153.7 8.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.595 179.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.6 144.32 24.35 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.467 179.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -135.46 138.28 43.02 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.647 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 19.6 mt -106.2 125.59 51.18 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.046 0.45 . . . . 0.0 109.876 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' TRP . . . . . 0.555 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 75.8 m95 -82.3 167.24 18.79 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.619 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -157.05 170.94 8.12 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-O 120.981 0.42 . . . . 0.0 110.587 -178.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -53.09 -37.17 79.0 Favored 'Trans proline' 0 C--N 1.301 -1.928 0 C-N-CA 122.659 2.24 . . . . 0.0 112.532 178.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -70.86 -34.78 71.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.64 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 22.4 m -61.24 150.87 33.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.641 -179.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.68 -36.87 82.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.471 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . 0.555 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 55.0 tt0 -64.91 -40.1 94.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.515 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.62 -43.66 91.59 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.649 -0.98 . . . . 0.0 110.649 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -62.83 -43.81 97.82 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.874 0.369 . . . . 0.0 110.306 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 65.2 ttp -59.31 -48.23 82.4 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.108 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 88.6 mt -60.27 -41.16 92.72 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . 0.453 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.1 tp10 -57.93 -37.78 74.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.14 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -65.33 -38.1 89.1 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.687 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 94.2 mt -64.14 -42.89 96.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.176 0.512 . . . . 0.0 110.653 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.61 44.82 0.08 OUTLIER Glycine 0 N--CA 1.462 0.4 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . 0.453 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 27.3 m-85 -127.77 155.31 44.23 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 121.065 0.46 . . . . 0.0 110.463 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' THR . . . . . 0.452 ' O ' ' O ' ' A' ' 191' ' ' VAL . 6.6 p -106.95 122.08 45.73 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.287 0.565 . . . . 0.0 109.992 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . 0.444 ' CD2' ' N ' ' A' ' 223' ' ' LEU . 4.3 mm? -100.99 133.19 45.85 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.139 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.95 159.05 15.13 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.426 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.09 115.43 30.25 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.924 0.392 . . . . 0.0 110.312 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.449 ' CD1' ' N ' ' A' ' 226' ' ' LEU . 8.9 mp -53.62 156.53 4.51 Favored Pre-proline 0 N--CA 1.45 -0.435 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.783 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.82 145.31 98.57 Favored 'Trans proline' 0 C--N 1.3 -1.999 0 C-N-CA 122.764 2.31 . . . . 0.0 112.34 179.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.53 -2.95 58.96 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.473 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.26 -40.8 5.68 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 111.034 -0.827 . . . . 0.0 111.034 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.526 ' O ' ' N ' ' A' ' 233' ' ' SER . 85.7 mt -79.09 -16.85 56.16 Favored 'General case' 0 C--O 1.219 -0.54 0 CA-C-O 121.099 0.476 . . . . 0.0 110.347 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 54.3 t-20 -40.24 -49.15 2.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.857 -179.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -88.08 15.34 7.53 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.386 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' SER . . . . . 0.526 ' N ' ' O ' ' A' ' 230' ' ' LEU . 78.1 p -60.59 -35.5 76.24 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.714 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . 0.523 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.6 tt0 -118.38 -69.41 0.85 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.809 179.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.0 m -70.06 103.5 2.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.678 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -94.57 57.5 2.23 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.279 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -144.84 -122.48 1.56 Allowed Glycine 0 N--CA 1.461 0.304 0 N-CA-C 110.946 -0.861 . . . . 0.0 110.946 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -134.54 111.94 10.48 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.146 0.498 . . . . 0.0 110.339 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . 0.515 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.3 mtt180 -148.33 57.54 1.07 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.69 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -69.77 -31.91 70.11 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.528 179.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . 0.516 ' CG ' HD22 ' A' ' 143' ' ' ASN . 65.0 t0 -56.72 -47.09 80.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.304 -179.029 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' ILE . . . . . 0.439 ' O ' ' O ' ' A' ' 239' ' ' ARG . 17.6 tt -140.12 157.06 25.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.867 0.365 . . . . 0.0 110.468 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 96.2 mt -106.07 106.27 20.25 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.168 0 CA-C-O 121.085 0.469 . . . . 0.0 110.461 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . 0.515 ' OE1' ' NH1' ' A' ' 239' ' ' ARG . 88.0 mt-30 -110.55 110.2 20.83 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.309 179.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 9.6 mp -121.86 -168.12 1.65 Allowed 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.643 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . 0.523 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.3 -16.87 0.05 OUTLIER Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . 0.688 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -60.46 157.04 29.74 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -63.74 21.38 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.942 0.401 . . . . 0.0 110.601 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . 0.688 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.8 m-20 -97.08 -6.0 36.15 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.43 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 92.2 mt -80.09 -21.45 43.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.824 179.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.56 -51.31 70.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.634 -179.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.7 -5.25 58.24 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.488 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.16 -74.29 1.15 Allowed Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.829 -0.909 . . . . 0.0 110.829 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 81.3 mt -70.15 126.08 28.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.931 0.396 . . . . 0.0 110.328 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -59.6 -39.26 83.59 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.289 -179.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 82.91 51.68 4.14 Favored Glycine 0 CA--C 1.52 0.382 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -95.77 -15.19 22.74 Favored 'General case' 0 C--N 1.332 -0.187 0 O-C-N 122.69 -0.3 . . . . 0.0 110.616 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 258' ' ' SER . . . . . 0.421 ' O ' ' O ' ' A' ' 192' ' ' THR . 3.3 t 174.69 88.85 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.24 0.543 . . . . 0.0 110.114 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . 0.59 ' N ' ' CD1' ' A' ' 259' ' ' LEU . 0.9 OUTLIER -94.41 124.13 38.25 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.201 0.524 . . . . 0.0 111.266 -179.132 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 15.7 m-30 -93.25 146.28 23.82 Favored 'General case' 0 CA--C 1.498 -1.022 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.379 179.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 86.0 mt -122.27 149.68 43.37 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.622 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.656 ' CG ' ' N ' ' A' ' 263' ' ' ALA . 2.7 p90 -77.17 -138.19 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.587 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . 0.656 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -52.34 77.18 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 121.024 0.44 . . . . 0.0 111.165 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . 0.616 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -178.99 104.39 0.19 Allowed Glycine 0 CA--C 1.529 0.951 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 265' ' ' ASP . . . . . 0.592 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.4 m-20 -80.14 -178.15 6.41 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.637 0.256 . . . . 0.0 110.938 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -40.31 -17.66 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.651 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . 0.592 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.32 -51.65 42.28 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.647 179.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -63.65 -46.65 84.68 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.007 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . 0.525 ' O ' ' CD2' ' A' ' 273' ' ' TYR . . . -61.79 -35.02 76.94 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.392 0.615 . . . . 0.0 109.701 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -63.15 -34.12 76.93 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.158 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.72 -43.31 13.49 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.969 -179.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 272' ' ' ILE . . . . . 0.618 ' C ' ' H ' ' A' ' 274' ' ' ALA . 4.9 tt -51.42 -33.51 14.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.798 -178.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 273' ' ' TYR . . . . . 0.525 ' CD2' ' O ' ' A' ' 269' ' ' ALA . 17.3 m-85 -54.71 -1.77 0.03 OUTLIER 'General case' 0 CA--C 1.515 -0.385 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.62 -179.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 274' ' ' ALA . . . . . 0.618 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.55 -39.7 70.51 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.912 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . 0.578 ' O ' ' N ' ' A' ' 279' ' ' ALA . 2.9 p30 -39.16 98.26 0.16 Allowed Pre-proline 0 C--O 1.226 -0.137 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.368 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.66 -42.72 65.78 Favored 'Trans proline' 0 C--N 1.303 -1.864 0 C-N-CA 122.413 2.076 . . . . 0.0 112.482 -178.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 88.9 mt -64.43 -42.89 95.78 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.116 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 91.1 mt -95.65 -1.6 49.81 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.984 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 279' ' ' ALA . . . . . 0.578 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.26 -34.71 77.06 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.711 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.8 m80 -74.38 20.1 0.12 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.969 -179.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . 0.513 ' H ' ' C ' ' A' ' 279' ' ' ALA . 13.7 mt -74.93 119.35 76.42 Favored Pre-proline 0 N--CA 1.445 -0.692 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.873 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -49.53 -40.37 45.54 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.658 2.239 . . . . 0.0 112.417 178.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.44 -50.61 62.26 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.116 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 75.4 t -61.29 -43.91 97.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.132 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -57.86 -41.15 81.83 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.129 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -90.97 0.12 57.61 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.102 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt 59.47 42.98 16.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.048 0.452 . . . . 0.0 110.829 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -94.42 41.33 1.09 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.31 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 53.8 t -118.85 135.82 58.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-O 121.141 0.496 . . . . 0.0 110.023 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -133.01 162.71 30.98 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 121.165 0.507 . . . . 0.0 110.633 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.98 155.38 32.93 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.108 0.48 . . . . 0.0 110.589 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 81.8 mt -94.13 -1.51 54.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.173 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.31 165.53 12.66 Favored Glycine 0 N--CA 1.464 0.514 0 N-CA-C 110.494 -1.043 . . . . 0.0 110.494 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 6.9 m -87.21 -62.43 1.5 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.921 0.391 . . . . 0.0 111.015 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 295' ' ' GLU . . . . . 0.466 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.5 mm-40 -69.57 -3.74 16.12 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.653 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 27.2 p -77.17 33.18 0.15 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.574 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 297' ' ' PHE . . . . . 0.466 ' H ' ' C ' ' A' ' 295' ' ' GLU . 83.8 t80 -60.28 -45.96 91.5 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.589 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . 0.609 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.2 mtt85 -81.57 134.36 35.49 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.574 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 16.3 tp -114.34 119.36 36.7 Favored 'General case' 0 C--O 1.23 0.07 0 CA-C-O 120.982 0.42 . . . . 0.0 110.29 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . 0.604 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.1 p-10 -167.07 -174.43 2.65 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.608 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 301' ' ' TYR . . . . . 0.459 ' OH ' ' CD1' ' A' ' 173' ' ' PHE . 83.9 t80 -48.23 -45.14 33.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.203 -179.476 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -65.13 -41.35 94.91 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 121.054 0.454 . . . . 0.0 110.714 178.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 303' ' ' SER . . . . . 0.604 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 53.5 p -55.61 -36.26 66.73 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.059 -179.197 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . 0.525 ' N ' ' HG ' ' A' ' 303' ' ' SER . . . -56.57 -52.18 65.79 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.388 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 91.8 mtp -55.72 -44.06 77.11 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -66.25 -42.6 88.32 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.211 0.529 . . . . 0.0 110.227 179.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 55.6 t -64.03 -42.77 96.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.202 179.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 43.4 tp -59.73 -42.2 92.61 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.77 -179.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -62.75 -38.83 92.11 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.048 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 310' ' ' ARG . . . . . 0.44 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.5 ttt85 -63.46 -44.1 95.45 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.211 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 88.0 mt -63.14 -41.98 99.39 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.416 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -62.96 -33.04 74.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.152 179.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -90.09 -23.36 21.42 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.375 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . 0.44 ' N ' ' O ' ' A' ' 310' ' ' ARG . 6.8 tt -62.31 -43.21 99.35 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 121.11 0.481 . . . . 0.0 110.573 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 . . . . . 0 C--O 1.22 -0.477 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.326 -179.803 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.477 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -99.5 136.06 39.99 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.115 0.483 . . . . 0.0 110.474 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.494 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -92.2 178.59 1.64 Allowed Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.545 -179.813 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.494 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.5 Cg_exo -61.54 147.18 96.05 Favored 'Trans proline' 0 C--N 1.299 -2.068 0 C-N-CA 122.854 2.369 . . . . 0.0 112.193 179.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 35.5 ptt180 -135.89 142.51 44.71 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.634 179.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -79.86 116.55 20.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.482 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.4 tp -111.03 130.47 64.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.458 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 12.5 t -70.79 141.56 51.4 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.62 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.511 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.5 t0 -139.13 179.51 6.47 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.495 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.511 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 78.0 p -73.74 -37.32 65.12 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.6 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -46.3 -94.56 0.0 OUTLIER 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.357 -179.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.429 ' O ' ' OG1' ' A' ' 36' ' ' THR . . . -167.16 -26.56 0.02 OUTLIER Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.429 ' OG1' ' O ' ' A' ' 35' ' ' GLY . 58.4 m -169.03 104.75 0.4 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.879 0.371 . . . . 0.0 110.668 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 74.2 t60 -128.57 148.44 50.77 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 121.119 0.485 . . . . 0.0 110.206 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.485 ' CG2' ' N ' ' A' ' 39' ' ' LEU . 98.4 m -130.83 166.14 21.49 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.458 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.485 ' N ' ' CG2' ' A' ' 38' ' ' THR . 81.6 mt -120.88 127.37 51.81 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.444 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -65.18 -44.61 87.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.716 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 38.9 p -165.67 154.98 12.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.377 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.462 ' N ' ' CD ' ' A' ' 42' ' ' GLN . 14.8 mp0 -44.3 101.0 0.24 Allowed Pre-proline 0 C--N 1.329 -0.306 0 O-C-N 123.419 0.449 . . . . 0.0 110.645 179.272 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -57.44 129.47 34.12 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 C-N-CA 122.347 2.031 . . . . 0.0 112.24 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -83.6 -24.67 31.4 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.621 179.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.539 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.5 mtm-85 -122.01 134.69 54.8 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.201 0.524 . . . . 0.0 110.256 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.2 mt -130.88 133.63 62.82 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.846 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 44.9 t -124.42 130.34 73.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-O 120.932 0.396 . . . . 0.0 109.939 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.497 ' O ' ' O ' ' A' ' 66' ' ' ALA . 2.3 m -154.8 166.89 32.05 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.504 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 69.8 p -124.55 8.83 8.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.404 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.26 125.67 33.08 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.874 0.369 . . . . 0.0 110.63 -179.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 96.3 t -65.92 -44.51 92.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.505 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.7 m -62.69 -44.51 96.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.594 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 50.5 tp -62.32 -41.5 98.59 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.551 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.422 ' CG2' ' HG ' ' A' ' 67' ' ' SER . 75.4 m -57.87 -44.44 86.63 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.206 -179.133 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.14 -62.43 5.18 Favored Glycine 0 N--CA 1.467 0.717 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.7 t -48.2 -35.6 12.11 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 110.159 -0.311 . . . . 0.0 110.159 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 20.1 mt -61.87 -44.39 96.91 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.649 -0.421 . . . . 0.0 111.396 179.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.3 mp -65.5 -41.42 93.23 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.364 177.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.32 -41.27 98.91 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.832 -179.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.3 tp -88.29 17.59 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.888 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 56.14 85.2 0.08 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.797 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.42 59.99 0.09 OUTLIER Pre-proline 0 C--N 1.327 -0.373 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -51.88 151.12 16.28 Favored 'Trans proline' 0 C--N 1.293 -2.363 0 C-N-CA 123.032 2.488 . . . . 0.0 112.047 -178.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.432 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -108.21 145.31 15.45 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.157 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.259 -179.659 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.51 -45.46 97.72 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.272 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.401 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.497 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -130.03 134.55 47.48 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 120.84 0.352 . . . . 0.0 110.491 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.476 ' O ' ' N ' ' A' ' 98' ' ' LEU . 74.8 m -134.56 158.82 43.0 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.831 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.29 138.58 16.02 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.449 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.55 -162.91 0.09 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.921 0.391 . . . . 0.0 110.474 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.48 ' O ' ' C ' ' A' ' 71' ' ' THR . 6.1 t -133.93 135.28 43.47 Favored 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.48 ' C ' ' O ' ' A' ' 70' ' ' THR . 0.9 OUTLIER 29.65 68.74 0.65 Allowed Pre-proline 0 N--CA 1.467 0.403 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.743 -179.685 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -61.72 145.2 97.55 Favored 'Trans proline' 0 C--N 1.299 -2.062 0 C-N-CA 122.708 2.272 . . . . 0.0 111.735 -177.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.535 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 45.0 p-10 -159.65 -31.94 0.06 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.637 179.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.535 ' N ' ' OD1' ' A' ' 73' ' ' ASN . 99.1 m-20 -63.83 -39.92 95.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.337 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -60.08 -47.97 83.68 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.638 -179.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.426 ' O ' ' O ' ' A' ' 77' ' ' ALA . 93.6 t -60.49 -24.87 32.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.426 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -45.81 173.34 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.615 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.569 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.3 p30 -62.15 177.56 0.46 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.421 -179.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.596 ' C ' ' H ' ' A' ' 81' ' ' GLY . 36.4 p30 -45.4 85.68 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.075 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.569 ' N ' ' O ' ' A' ' 78' ' ' ASP . 43.1 tp60 -67.48 13.18 0.07 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.221 0.534 . . . . 0.0 110.142 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.596 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 118.54 -22.35 9.45 Favored Glycine 0 N--CA 1.461 0.305 0 N-CA-C 110.934 -0.866 . . . . 0.0 110.934 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -107.75 116.45 31.97 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.987 0.422 . . . . 0.0 110.453 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 75.0 mt -98.58 0.07 44.18 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.984 0.421 . . . . 0.0 110.559 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -92.63 7.38 43.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.015 0.436 . . . . 0.0 110.357 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.439 ' O ' ' CG2' ' A' ' 89' ' ' VAL . 88.5 mt-30 -100.12 -27.91 13.3 Favored 'General case' 0 C--O 1.222 -0.382 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.81 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 69.1 t-105 -63.49 -40.46 97.14 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.906 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.554 ' O ' ' N ' ' A' ' 91' ' ' LYS . 68.7 m -77.78 -53.79 7.1 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.952 -179.361 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -48.3 -50.57 29.55 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.111 -179.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.439 ' CG2' ' O ' ' A' ' 85' ' ' GLN . 15.7 m -69.03 -40.47 80.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.144 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.409 ' H ' HG23 ' A' ' 89' ' ' VAL . . . -72.63 -22.66 60.91 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.652 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.554 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.0 tttm -62.12 -45.62 92.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.384 -179.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.44 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.6 mm-40 -90.32 -94.8 0.12 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.974 0.416 . . . . 0.0 110.084 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.626 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.9 mtt180 -143.12 59.32 1.41 Allowed 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 109.595 -0.521 . . . . 0.0 109.595 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.449 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.7 pttp 33.8 25.89 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 120.968 0.413 . . . . 0.0 110.234 -179.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.626 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.4 tt -48.31 123.5 6.58 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.934 -177.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -83.62 -170.3 2.99 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.112 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.61 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 82.3 mtp180 -73.82 137.26 43.72 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.233 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.476 ' N ' ' O ' ' A' ' 67' ' ' SER . 90.4 mt -86.32 -165.81 1.37 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.784 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.537 ' CD2' ' O ' ' A' ' 99' ' ' TYR . 48.3 p90 -169.01 120.09 0.74 Allowed 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.114 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.502 ' C ' ' O ' ' A' ' 99' ' ' TYR . 43.9 mm -28.98 121.02 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 O-C-N 123.261 0.351 . . . . 0.0 111.103 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 114.52 26.9 3.51 Favored Glycine 0 C--N 1.332 0.338 0 N-CA-C 111.281 -0.728 . . . . 0.0 111.281 -179.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.575 ' N ' ' CD ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -144.18 46.38 0.63 Allowed Pre-proline 0 C--N 1.322 -0.622 0 CA-C-O 121.023 0.44 . . . . 0.0 110.472 179.833 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 29.1 Cg_endo -62.13 143.92 95.23 Favored 'Trans proline' 0 C--N 1.294 -2.3 0 C-N-CA 122.677 2.251 . . . . 0.0 111.771 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.712 ' HG ' ' H ' ' A' ' 107' ' ' ALA . 26.5 t -173.14 120.35 0.35 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.426 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.39 -40.58 64.21 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.042 0.449 . . . . 0.0 111.145 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -66.19 -39.82 89.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.892 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.712 ' H ' ' HG ' ' A' ' 104' ' ' SER . . . -64.13 -39.88 94.99 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.77 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 71.7 t -67.77 -43.71 86.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.733 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.96 -38.97 93.23 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.555 -179.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.44 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.66 -23.3 62.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.473 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.537 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.4 mm-40 -90.8 5.58 47.77 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.654 -179.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.539 ' O ' ' NE ' ' A' ' 45' ' ' ARG . 10.3 tpt 22.88 64.5 0.36 Allowed Pre-proline 0 N--CA 1.468 0.437 0 CA-C-O 120.913 0.387 . . . . 0.0 111.22 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -78.92 167.5 22.04 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 123.079 2.519 . . . . 0.0 111.657 -177.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.522 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 99.3 m-20 -110.15 -42.05 4.28 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.077 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.8 tp -121.32 120.44 35.1 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 83.8 mt -113.42 129.09 69.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-O 120.848 0.356 . . . . 0.0 110.96 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 29.5 mt -108.86 132.17 54.29 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.044 0.449 . . . . 0.0 110.268 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 98.8 mt -119.66 138.42 50.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.709 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 85.6 p -72.63 153.77 41.07 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.612 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.12 -50.12 74.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.627 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.0 t -149.44 153.92 38.05 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.566 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 170.47 -170.98 43.43 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.89 -34.13 88.99 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.829 -0.908 . . . . 0.0 110.829 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.453 ' O ' ' OD1' ' A' ' 124' ' ' ASP . 44.5 p-10 -87.36 120.01 28.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.882 0.373 . . . . 0.0 110.652 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 37.7 t -63.05 144.01 57.27 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.399 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.521 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.19 -43.26 8.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.836 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.3 tp -62.98 -42.45 99.84 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.739 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.49 -12.0 59.26 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.508 -179.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 85.1 mt -114.93 -23.93 8.87 Favored 'General case' 0 C--O 1.226 -0.159 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.586 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . 0.521 ' N ' ' O ' ' A' ' 126' ' ' ALA . 80.0 t80 -50.94 -49.49 59.76 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.643 -178.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.502 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.5 p-10 -66.09 -42.5 89.24 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.876 -0.33 . . . . 0.0 111.237 179.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.502 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 88.2 mt-30 -67.17 -37.85 84.44 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.874 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 96.1 mt -79.98 -41.83 25.14 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.915 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.3 t -56.86 -44.78 82.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.277 -179.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 20.0 m -61.86 -45.25 94.6 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.507 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 94.1 mt -62.03 -43.68 97.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.262 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.31 168.17 5.08 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.571 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -49.61 113.0 0.79 Allowed 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.288 1.992 . . . . 0.0 112.35 179.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 23.5 m -84.27 127.41 33.94 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.622 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 34.4 tp -117.77 135.34 54.11 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.072 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.435 ' O ' ' OD2' ' A' ' 32' ' ' ASP . 82.3 mt -99.9 118.91 47.24 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.315 0 CA-C-O 121.181 0.515 . . . . 0.0 111.137 -179.299 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 98.1 mt -134.85 131.94 53.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.554 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.511 HD22 ' CG ' ' A' ' 241' ' ' ASP . 60.7 t30 -66.37 151.19 47.63 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.908 0.385 . . . . 0.0 110.479 179.298 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.52 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 88.2 t80 -85.96 122.25 29.73 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.883 -179.567 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.52 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 99.0 m-20 55.41 69.15 0.76 Allowed 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.672 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 35.0 p-10 -125.68 0.2 7.45 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.845 0.355 . . . . 0.0 110.604 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -150.63 115.48 5.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.706 -179.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' SER . . . . . 0.517 ' HG ' ' H ' ' A' ' 150' ' ' GLN . 83.8 p -63.73 168.77 4.59 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.551 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.416 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.5 p-90 -52.3 -16.01 0.75 Allowed 'General case' 0 C--O 1.222 -0.389 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.417 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . 0.517 ' H ' ' HG ' ' A' ' 148' ' ' SER . 68.2 tp60 -69.97 -76.88 0.09 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.508 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.442 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.0 t -62.49 -38.45 89.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.216 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 54.1 tp -59.78 -45.86 90.98 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.356 -178.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.416 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 46.7 tp -62.66 -41.77 99.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.527 178.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.442 ' OG1' ' O ' ' A' ' 151' ' ' SER . 62.7 p -64.0 -34.75 78.7 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.196 -179.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.422 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 88.0 mm-40 -64.05 -42.71 96.94 Favored 'General case' 0 C--O 1.225 -0.196 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.356 179.305 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 91.7 mt -65.52 -38.7 90.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.101 0.477 . . . . 0.0 110.277 179.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.575 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.37 -32.12 79.8 Favored Glycine 0 C--N 1.331 0.295 0 N-CA-C 110.68 -0.968 . . . . 0.0 110.68 -179.207 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 157' ' ' GLY . 97.3 mt-10 -35.64 -26.73 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.839 0.352 . . . . 0.0 110.858 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.575 ' N ' ' O ' ' A' ' 157' ' ' GLY . 95.3 mt -56.16 149.37 3.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.411 178.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 74.8 p -69.68 137.25 51.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.978 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 71.39 21.0 78.64 Favored Glycine 0 CA--C 1.517 0.165 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 179.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 56.3 m80 -122.56 -14.5 7.77 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.602 0.239 . . . . 0.0 110.454 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -65.66 -59.98 3.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.593 -179.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -52.18 -49.34 64.01 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.177 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -60.24 -41.28 92.84 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.805 0.336 . . . . 0.0 110.437 179.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.34 -47.17 87.13 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.59 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -57.04 -40.1 76.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.279 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -61.72 -50.43 72.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.61 179.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -65.25 -43.78 90.23 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.534 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 94.4 mt -64.83 -43.26 96.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.414 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.38 -51.31 69.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.355 -179.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.23 -43.64 97.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.614 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . 0.463 ' CD1' ' OH ' ' A' ' 301' ' ' TYR . 56.9 t80 -62.92 -44.45 96.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.097 0.475 . . . . 0.0 110.396 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -63.53 -39.64 94.95 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.679 -179.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -63.16 -42.85 99.48 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.531 179.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -60.78 -44.39 96.86 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.261 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 84.1 mt -64.78 -40.98 96.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.687 178.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.21 -62.39 1.66 Allowed 'General case' 0 C--O 1.238 0.495 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.355 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.37 -47.02 85.16 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.54 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.01 -41.68 64.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.375 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -63.9 -33.69 76.26 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.281 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 70.0 tt0 -90.64 8.73 32.83 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.616 0.722 . . . . 0.0 110.381 -178.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -104.84 -32.05 9.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.145 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.8 pt -128.08 147.88 32.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.791 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -140.15 131.34 26.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.426 179.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.553 ' CD2' ' N ' ' A' ' 186' ' ' LEU . 3.5 mm? -85.55 133.06 42.81 Favored Pre-proline 0 N--CA 1.451 -0.41 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.042 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -43.82 157.81 0.13 Allowed 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.649 2.232 . . . . 0.0 112.364 179.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . 0.505 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.5 Cg_endo -62.87 114.91 2.62 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 C-N-CA 122.892 2.395 . . . . 0.0 111.657 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . 0.505 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.7 mt-30 155.6 147.65 0.0 OUTLIER Pre-proline 0 N--CA 1.456 -0.138 0 O-C-N 124.028 0.83 . . . . 0.0 110.824 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.35 143.92 35.86 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.614 2.209 . . . . 0.0 112.243 177.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.489 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.1 p -124.58 158.84 31.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.441 0.639 . . . . 0.0 110.162 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' THR . . . . . 0.489 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 37.6 p -143.19 165.24 27.97 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.102 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -135.28 128.75 32.41 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 121.285 0.564 . . . . 0.0 110.224 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 47.4 pt -146.66 149.02 16.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.146 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 69.5 t -117.77 123.41 71.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 CA-C-O 121.32 0.581 . . . . 0.0 109.903 178.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -134.27 107.25 7.55 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.161 0.505 . . . . 0.0 110.205 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 93.3 m -130.97 130.33 43.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.815 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.412 ' O ' ' N ' ' A' ' 201' ' ' HIS . . . -82.92 -37.27 24.42 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.249 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.23 -66.94 0.27 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.362 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.3 -10.17 59.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.346 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . 0.412 ' N ' ' O ' ' A' ' 198' ' ' ALA . 59.9 t-80 61.08 58.1 2.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.745 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 36.3 p -166.69 153.26 8.75 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.602 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.24 144.02 24.43 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.096 0.474 . . . . 0.0 110.416 179.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -135.4 138.32 43.17 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.609 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 19.9 mt -106.24 125.56 51.15 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.065 0.46 . . . . 0.0 109.925 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' TRP . . . . . 0.556 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 75.2 m95 -82.08 167.0 19.24 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.573 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -157.19 171.11 7.88 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.645 -178.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -53.19 -37.29 79.93 Favored 'Trans proline' 0 C--N 1.302 -1.913 0 C-N-CA 122.588 2.192 . . . . 0.0 112.472 178.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -70.57 -35.07 72.87 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.711 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 21.0 m -61.08 150.84 32.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.642 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.7 -36.78 81.9 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.465 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . 0.556 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 54.6 tt0 -64.97 -40.02 94.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.475 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.64 -43.4 92.1 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.712 -0.955 . . . . 0.0 110.712 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -63.24 -43.94 96.62 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.788 0.328 . . . . 0.0 110.229 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 65.1 ttp -59.21 -48.1 82.86 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.148 -179.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 87.8 mt -60.42 -41.02 93.06 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . 0.457 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.8 tp10 -58.0 -37.67 74.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.05 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -65.53 -38.07 88.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.659 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 94.4 mt -64.09 -42.8 96.79 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.662 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.52 44.91 0.08 OUTLIER Glycine 0 CA--C 1.52 0.391 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . 0.457 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 26.9 m-85 -127.92 155.42 44.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.073 0.463 . . . . 0.0 110.463 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' THR . . . . . 0.45 ' O ' ' O ' ' A' ' 191' ' ' VAL . 7.2 p -107.27 122.49 46.66 Favored 'General case' 0 C--O 1.224 -0.248 0 CA-C-O 121.371 0.605 . . . . 0.0 110.088 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . 0.443 ' CD2' ' N ' ' A' ' 223' ' ' LEU . 4.3 mm? -101.43 133.02 46.7 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.162 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.77 159.78 14.73 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.459 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.47 115.33 30.07 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.391 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.453 ' CD1' ' N ' ' A' ' 226' ' ' LEU . 8.9 mp -53.16 156.54 3.71 Favored Pre-proline 0 N--CA 1.451 -0.415 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.764 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.01 145.34 98.6 Favored 'Trans proline' 0 C--N 1.299 -2.03 0 C-N-CA 122.744 2.296 . . . . 0.0 112.298 179.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.28 -3.38 59.04 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.535 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -89.96 -41.22 5.66 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.518 ' O ' ' N ' ' A' ' 233' ' ' SER . 69.8 mt -78.86 -17.59 55.37 Favored 'General case' 0 C--O 1.219 -0.522 0 CA-C-O 121.13 0.491 . . . . 0.0 110.379 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 54.4 t-20 -40.41 -49.2 2.83 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.807 -179.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -87.59 15.15 7.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.352 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' SER . . . . . 0.518 ' N ' ' O ' ' A' ' 230' ' ' LEU . 77.9 p -60.59 -35.3 75.76 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.703 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . 0.524 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.6 tt0 -119.0 -69.33 0.86 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.868 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.3 m -69.76 102.82 2.0 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.675 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -94.37 57.56 2.31 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.34 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -144.78 -122.42 1.56 Allowed Glycine 0 N--CA 1.461 0.309 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -135.12 111.69 9.93 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 121.183 0.516 . . . . 0.0 110.341 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . 0.525 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.6 mtt180 -148.22 57.85 1.08 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.655 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -69.47 -32.39 71.26 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.512 179.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . 0.511 ' CG ' HD22 ' A' ' 143' ' ' ASN . 64.8 t0 -56.84 -47.1 81.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.27 -179.027 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' ILE . . . . . 0.44 ' O ' ' O ' ' A' ' 239' ' ' ARG . 18.1 tt -139.88 156.4 25.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.933 0.397 . . . . 0.0 110.445 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 96.2 mt -106.3 106.65 20.99 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.206 0 CA-C-O 121.1 0.476 . . . . 0.0 110.567 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . 0.525 ' OE1' ' NH1' ' A' ' 239' ' ' ARG . 88.2 mt-30 -110.49 110.0 20.57 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.232 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 9.4 mp -121.69 -168.19 1.65 Allowed 'General case' 0 C--O 1.223 -0.297 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.752 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . 0.524 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.51 -16.37 0.05 OUTLIER Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.974 -0.851 . . . . 0.0 110.974 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . 0.693 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -61.04 156.61 32.96 Favored Glycine 0 CA--C 1.521 0.464 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -63.45 21.53 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.98 0.419 . . . . 0.0 110.649 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . 0.693 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.9 m-20 -97.2 -6.22 35.23 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.493 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 92.6 mt -79.48 -21.99 44.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.786 179.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.54 -51.36 70.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.734 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.24 -5.66 58.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.459 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.15 -74.48 1.14 Allowed Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.844 -0.902 . . . . 0.0 110.844 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 82.2 mt -70.02 126.07 28.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.017 0.437 . . . . 0.0 110.315 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -59.5 -39.37 83.57 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.11 -179.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 82.75 51.71 4.17 Favored Glycine 0 CA--C 1.52 0.37 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -96.14 -14.81 22.53 Favored 'General case' 0 C--N 1.333 -0.138 0 O-C-N 122.683 -0.304 . . . . 0.0 110.615 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 258' ' ' SER . . . . . 0.422 ' O ' ' O ' ' A' ' 192' ' ' THR . 3.4 t 174.77 88.59 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.194 0.521 . . . . 0.0 110.092 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . 0.592 ' N ' ' CD1' ' A' ' 259' ' ' LEU . 1.0 OUTLIER -94.43 124.44 38.46 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.228 0.537 . . . . 0.0 111.179 -179.129 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 15.8 m-30 -93.28 146.41 23.73 Favored 'General case' 0 CA--C 1.499 -1.012 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.396 179.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 85.2 mt -122.5 149.39 43.96 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.58 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.656 ' CG ' ' N ' ' A' ' 263' ' ' ALA . 2.6 p90 -77.19 -138.36 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.612 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . 0.656 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -52.07 76.95 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 121.049 0.452 . . . . 0.0 111.188 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . 0.624 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -178.76 104.51 0.19 Allowed Glycine 0 CA--C 1.528 0.85 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 265' ' ' ASP . . . . . 0.596 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.5 m-20 -80.38 -178.04 6.46 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.585 0.231 . . . . 0.0 110.928 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -40.25 -17.91 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.579 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . 0.596 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.13 -51.66 43.65 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.722 179.195 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -63.6 -46.68 84.69 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.254 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . 0.524 ' O ' ' CD2' ' A' ' 273' ' ' TYR . . . -61.67 -35.13 77.08 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 121.404 0.621 . . . . 0.0 109.822 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -63.07 -34.37 77.44 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.176 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.49 -43.27 13.71 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.126 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 272' ' ' ILE . . . . . 0.619 ' C ' ' H ' ' A' ' 274' ' ' ALA . 4.9 tt -51.39 -33.69 14.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.767 -178.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 273' ' ' TYR . . . . . 0.524 ' CD2' ' O ' ' A' ' 269' ' ' ALA . 17.2 m-85 -54.43 -1.78 0.03 OUTLIER 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.703 -179.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 274' ' ' ALA . . . . . 0.619 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.5 -39.7 70.65 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.93 179.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . 0.579 ' O ' ' N ' ' A' ' 279' ' ' ALA . 3.1 p30 -38.98 98.02 0.15 Allowed Pre-proline 0 C--O 1.226 -0.149 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.449 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -54.64 -42.61 66.73 Favored 'Trans proline' 0 C--N 1.303 -1.835 0 C-N-CA 122.376 2.051 . . . . 0.0 112.513 -178.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 89.2 mt -64.57 -42.86 95.38 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.038 0.447 . . . . 0.0 111.15 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 91.2 mt -95.66 -1.63 49.74 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.939 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 279' ' ' ALA . . . . . 0.579 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.3 -34.68 77.06 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.748 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.21 20.04 0.12 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.014 -179.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . 0.514 ' H ' ' C ' ' A' ' 279' ' ' ALA . 13.8 mt -75.18 119.46 77.04 Favored Pre-proline 0 N--CA 1.447 -0.605 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.729 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -49.9 -39.88 49.01 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.644 2.23 . . . . 0.0 112.281 178.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.64 -50.59 62.87 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.066 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 78.6 t -61.32 -44.0 97.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -57.85 -41.16 81.8 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.15 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -91.06 0.05 57.62 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.104 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt 59.56 43.61 15.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.945 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -95.08 41.42 1.09 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.34 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 54.1 t -119.13 135.68 58.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-O 121.052 0.453 . . . . 0.0 110.067 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -132.58 162.35 31.52 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.22 0.533 . . . . 0.0 110.608 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.6 154.96 33.16 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-O 121.038 0.447 . . . . 0.0 110.663 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 81.5 mt -93.68 -1.56 55.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.253 -179.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.01 166.22 12.93 Favored Glycine 0 CA--C 1.521 0.439 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 7.2 m -87.77 -62.46 1.49 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.855 0.36 . . . . 0.0 110.939 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 295' ' ' GLU . . . . . 0.47 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.4 mm-40 -69.35 -3.87 15.93 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.667 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 27.0 p -77.21 32.7 0.15 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.604 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 297' ' ' PHE . . . . . 0.47 ' H ' ' C ' ' A' ' 295' ' ' GLU . 70.1 t80 -60.15 -46.21 90.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.603 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . 0.61 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.2 mtt85 -81.0 133.66 35.53 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.535 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 16.4 tp -114.23 119.39 36.85 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.319 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . 0.607 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.1 p-10 -167.52 -173.85 2.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.612 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 301' ' ' TYR . . . . . 0.463 ' OH ' ' CD1' ' A' ' 173' ' ' PHE . 83.9 t80 -48.58 -45.41 37.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.236 -179.37 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -64.97 -41.52 95.38 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.09 0.471 . . . . 0.0 110.697 178.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 303' ' ' SER . . . . . 0.607 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 52.6 p -55.39 -36.14 66.09 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.016 -179.223 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -56.7 -51.84 67.26 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 91.5 mtp -56.15 -43.99 78.83 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -66.23 -42.75 88.22 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.152 0.501 . . . . 0.0 110.238 179.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 55.1 t -64.04 -42.74 96.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.26 179.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 43.0 tp -59.67 -42.33 92.62 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.741 -179.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -62.55 -38.8 91.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.139 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 310' ' ' ARG . . . . . 0.442 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.5 ttt85 -63.51 -44.1 95.26 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.165 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 87.8 mt -63.2 -42.02 99.25 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.353 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -62.89 -33.24 74.88 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.13 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.93 -23.36 21.6 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.365 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . 0.442 ' N ' ' O ' ' A' ' 310' ' ' ARG . 6.7 tt -62.41 -43.11 99.59 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 121.069 0.461 . . . . 0.0 110.597 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 . . . . . 0 C--O 1.22 -0.46 0 CA-C-O 117.947 -1.025 . . . . 0.0 110.381 -179.909 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -99.39 135.15 41.23 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.169 0.509 . . . . 0.0 110.469 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.491 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -92.19 178.68 1.6 Allowed Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.545 -179.802 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.491 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.8 Cg_exo -61.66 147.2 95.89 Favored 'Trans proline' 0 C--N 1.298 -2.097 0 C-N-CA 122.89 2.393 . . . . 0.0 112.117 179.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 35.1 ptt180 -135.91 142.11 44.62 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.732 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -79.66 116.94 20.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.462 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.4 tp -111.93 130.55 65.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.399 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 12.6 t -71.01 142.27 50.94 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.008 0.432 . . . . 0.0 110.621 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.515 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.4 t0 -139.08 179.75 6.32 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.505 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.515 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 78.3 p -73.6 -37.37 65.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.777 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.8 ttt85 -46.94 -94.76 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.233 -179.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.421 ' O ' ' OG1' ' A' ' 36' ' ' THR . . . -166.08 -26.73 0.02 OUTLIER Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.421 ' OG1' ' O ' ' A' ' 35' ' ' GLY . 62.5 m -168.58 106.02 0.45 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.806 0.336 . . . . 0.0 110.65 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 71.5 t60 -129.23 146.64 51.1 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 121.075 0.464 . . . . 0.0 110.151 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.487 ' CG2' ' N ' ' A' ' 39' ' ' LEU . 97.5 m -129.86 165.68 21.51 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.41 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.487 ' N ' ' CG2' ' A' ' 38' ' ' THR . 79.5 mt -120.42 127.21 52.05 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.485 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -65.44 -44.8 86.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.728 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 37.8 p -165.65 155.27 12.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.445 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.466 ' N ' ' CD ' ' A' ' 42' ' ' GLN . 14.6 mp0 -44.43 100.71 0.23 Allowed Pre-proline 0 C--O 1.236 0.374 0 O-C-N 123.527 0.517 . . . . 0.0 110.634 179.193 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -57.51 129.78 35.6 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 C-N-CA 122.322 2.014 . . . . 0.0 112.337 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -83.09 -24.62 32.6 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.567 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.531 ' NE ' ' O ' ' A' ' 112' ' ' MET . 90.1 mtm-85 -121.04 134.2 55.27 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.214 0.531 . . . . 0.0 110.15 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.1 mt -130.72 133.67 63.01 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.846 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 46.4 t -124.77 131.34 72.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.535 ' HG ' ' CD1' ' A' ' 117' ' ' LEU . 4.4 m -154.38 166.14 34.16 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.584 179.451 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 63.3 p -124.66 8.32 8.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.395 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.6 126.15 33.68 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.801 0.334 . . . . 0.0 110.687 -179.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 88.7 t -65.65 -44.61 93.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.521 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.3 m -62.55 -44.33 96.6 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.709 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 54.0 tp -62.29 -41.59 98.63 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.558 -179.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 69.5 m -58.18 -44.48 88.04 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.124 -179.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.31 -62.19 5.35 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.7 t -48.08 -35.77 11.91 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 20.3 mt -61.78 -44.26 97.23 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 120.598 -0.441 . . . . 0.0 111.321 179.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.4 mp -65.26 -41.68 94.03 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.518 177.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.45 -41.26 98.64 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.921 -179.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.0 tp -87.8 16.75 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.864 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 56.31 84.14 0.09 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.804 -179.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.61 58.21 0.08 OUTLIER Pre-proline 0 C--N 1.327 -0.381 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -50.93 152.9 9.43 Favored 'Trans proline' 0 C--N 1.294 -2.333 0 C-N-CA 123.033 2.488 . . . . 0.0 112.228 -178.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.43 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -108.78 146.39 14.5 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.178 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.31 -179.69 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 97.0 mt -63.65 -45.08 98.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.478 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.498 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -130.45 134.49 47.14 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 120.868 0.366 . . . . 0.0 110.49 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.489 ' O ' ' N ' ' A' ' 98' ' ' LEU . 66.9 m -134.42 158.55 43.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.922 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.81 139.43 16.35 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.463 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.85 -162.69 0.08 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.003 0.43 . . . . 0.0 110.384 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.474 ' O ' ' C ' ' A' ' 71' ' ' THR . 14.6 t -133.57 135.37 44.27 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.314 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.474 ' C ' ' O ' ' A' ' 70' ' ' THR . 0.7 OUTLIER 29.76 68.88 0.65 Allowed Pre-proline 0 N--CA 1.469 0.475 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.857 -179.866 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -61.59 145.34 97.79 Favored 'Trans proline' 0 C--N 1.299 -2.054 0 C-N-CA 122.672 2.248 . . . . 0.0 111.873 -177.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.528 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 46.0 p-10 -160.05 -31.79 0.06 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.799 179.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.528 ' N ' ' OD1' ' A' ' 73' ' ' ASN . 98.9 m-20 -64.41 -39.33 93.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.348 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -60.7 -47.97 83.88 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.481 -179.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.425 ' O ' ' O ' ' A' ' 77' ' ' ALA . 92.8 t -60.35 -24.86 32.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.425 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -45.52 172.85 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.695 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.566 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.7 p30 -61.72 177.48 0.41 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.448 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.6 ' C ' ' H ' ' A' ' 81' ' ' GLY . 36.3 p30 -46.07 85.65 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.016 0.436 . . . . 0.0 110.971 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.566 ' N ' ' O ' ' A' ' 78' ' ' ASP . 42.7 tp60 -67.19 13.55 0.06 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.176 0.512 . . . . 0.0 110.065 -179.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.6 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 117.82 -22.13 10.08 Favored Glycine 0 N--CA 1.461 0.334 0 N-CA-C 110.911 -0.876 . . . . 0.0 110.911 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -107.44 116.3 31.7 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.01 0.433 . . . . 0.0 110.454 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 75.7 mt -98.49 0.46 45.17 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 120.992 0.425 . . . . 0.0 110.582 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -92.14 6.52 46.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.027 0.441 . . . . 0.0 110.276 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.442 ' O ' ' CG2' ' A' ' 89' ' ' VAL . 88.0 mt-30 -100.12 -26.63 13.88 Favored 'General case' 0 C--O 1.219 -0.511 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.796 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 75.9 t-105 -64.64 -40.76 96.01 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.109 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.549 ' O ' ' N ' ' A' ' 91' ' ' LYS . 68.1 m -77.85 -53.53 7.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.316 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -48.49 -50.52 31.33 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.089 -179.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.442 ' CG2' ' O ' ' A' ' 85' ' ' GLN . 14.3 m -68.92 -40.82 81.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.209 179.387 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.408 ' H ' HG23 ' A' ' 89' ' ' VAL . . . -71.89 -23.04 61.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.725 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.549 ' N ' ' O ' ' A' ' 87' ' ' SER . 65.9 tttm -61.62 -45.67 93.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.442 -179.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.44 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.3 mm-40 -90.6 -94.56 0.12 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.012 0.434 . . . . 0.0 110.05 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.615 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.9 mtt180 -143.48 59.44 1.39 Allowed 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.441 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.6 pttp 34.45 25.77 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.084 0.468 . . . . 0.0 110.336 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.615 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.5 tt -48.24 123.34 6.28 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.078 -177.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -83.53 -170.84 3.26 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.054 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.609 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 82.2 mtp180 -73.17 137.6 45.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.12 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.489 ' N ' ' O ' ' A' ' 67' ' ' SER . 90.3 mt -86.11 -166.29 1.5 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.868 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.536 ' CD2' ' O ' ' A' ' 99' ' ' TYR . 47.5 p90 -167.96 119.95 0.86 Allowed 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.065 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.494 ' C ' ' O ' ' A' ' 99' ' ' TYR . 42.8 mm -29.56 121.05 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.055 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 113.96 27.91 3.32 Favored Glycine 0 C--N 1.331 0.291 0 N-CA-C 111.326 -0.71 . . . . 0.0 111.326 -179.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.581 ' N ' ' CD ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -143.85 45.83 0.6 Allowed Pre-proline 0 C--N 1.321 -0.632 0 CA-C-O 121.087 0.47 . . . . 0.0 110.427 179.817 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.581 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 29.8 Cg_endo -62.02 143.84 95.52 Favored 'Trans proline' 0 C--N 1.294 -2.306 0 C-N-CA 122.593 2.195 . . . . 0.0 111.881 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.699 ' HG ' ' H ' ' A' ' 107' ' ' ALA . 24.3 t -173.26 120.6 0.34 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.283 179.53 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.02 -40.98 64.71 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.104 0.478 . . . . 0.0 111.281 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -65.93 -40.11 91.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.864 -179.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.699 ' H ' ' HG ' ' A' ' 104' ' ' SER . . . -63.98 -39.81 94.98 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.719 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 69.4 t -67.48 -43.87 87.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.762 179.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.43 -39.05 92.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.461 -179.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.44 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.58 -23.58 63.05 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.513 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.533 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.3 mm-40 -91.17 5.05 50.6 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.746 -179.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.533 ' C ' ' O ' ' A' ' 111' ' ' GLN . 10.5 tpt 22.98 64.14 0.36 Allowed Pre-proline 0 N--CA 1.469 0.511 0 CA-C-O 120.883 0.373 . . . . 0.0 111.2 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -78.93 168.37 20.87 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 123.017 2.478 . . . . 0.0 111.758 -177.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.527 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 99.0 m-20 -112.38 -44.21 3.41 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.003 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 39.8 tp -120.67 119.48 32.94 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 96.1 mt -116.43 131.19 69.73 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.408 0 CA-C-O 120.887 0.375 . . . . 0.0 111.007 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.535 ' CD1' ' HG ' ' A' ' 48' ' ' SER . 28.5 mt -105.99 132.67 51.8 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.192 -179.299 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 98.1 mt -118.08 136.01 56.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.695 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 86.4 p -72.09 153.45 41.69 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.603 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.14 -50.04 75.25 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.651 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -149.46 154.03 38.19 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.593 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 169.73 -170.31 42.66 Favored Glycine 0 CA--C 1.525 0.719 0 N-CA-C 110.969 -0.852 . . . . 0.0 110.969 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -63.16 -34.94 91.32 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 110.864 -0.894 . . . . 0.0 110.864 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.444 ' O ' ' OD1' ' A' ' 124' ' ' ASP . 43.9 p-10 -87.89 120.11 28.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.855 0.36 . . . . 0.0 110.607 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 39.6 t -63.51 144.26 57.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.386 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.517 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.2 -43.13 8.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.013 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.4 tp -62.79 -42.43 99.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.752 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.8 -11.11 57.83 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.52 -179.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 85.1 mt -115.54 -23.99 8.53 Favored 'General case' 0 C--O 1.225 -0.23 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.668 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . 0.517 ' N ' ' O ' ' A' ' 126' ' ' ALA . 77.7 t80 -51.87 -49.62 62.6 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.666 -178.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.503 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.5 p-10 -65.83 -42.02 91.05 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.282 179.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.503 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 87.9 mt-30 -67.45 -37.04 82.37 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.949 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 94.1 mt -79.69 -42.31 24.98 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.958 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.3 t -57.12 -44.81 83.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.25 -178.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.9 m -62.33 -45.58 92.56 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.463 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 93.1 mt -62.5 -43.89 98.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.307 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.8 163.68 6.61 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.588 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -43.71 111.91 0.28 Allowed 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.374 2.05 . . . . 0.0 112.3 179.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 18.2 m -85.37 127.34 34.33 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.541 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 34.2 tp -118.73 135.18 54.63 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 120.976 0.417 . . . . 0.0 110.077 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.425 ' O ' ' OD2' ' A' ' 32' ' ' ASP . 80.1 mt -102.01 120.04 51.13 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.345 0 CA-C-O 121.172 0.511 . . . . 0.0 111.332 -179.381 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 97.4 mt -135.79 132.94 51.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.702 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.52 HD22 ' CG ' ' A' ' 241' ' ' ASP . 54.8 t30 -65.81 152.03 45.31 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.99 0.424 . . . . 0.0 110.356 179.21 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.523 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 87.9 t80 -85.81 122.48 29.94 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.999 -179.5 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.523 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 99.2 m-20 55.06 69.41 0.74 Allowed 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.713 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 49.4 p-10 -123.56 0.06 8.73 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 120.853 0.359 . . . . 0.0 110.625 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -151.61 117.17 5.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.735 -179.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' SER . . . . . 0.513 ' HG ' ' H ' ' A' ' 150' ' ' GLN . 84.6 p -63.27 167.49 5.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.557 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.411 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.7 p-90 -50.62 -15.85 0.31 Allowed 'General case' 0 C--O 1.22 -0.497 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.429 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . 0.513 ' H ' ' HG ' ' A' ' 148' ' ' SER . 68.2 tp60 -71.23 -74.81 0.14 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.941 0.401 . . . . 0.0 110.443 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.448 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.2 t -62.62 -39.11 92.77 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.138 179.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 54.3 tp -60.35 -45.41 93.57 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.361 -178.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.411 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 45.9 tp -62.63 -41.62 99.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.52 178.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.448 ' OG1' ' O ' ' A' ' 151' ' ' SER . 54.6 p -64.03 -34.68 78.55 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.136 -179.292 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.445 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 88.0 mm-40 -63.93 -42.47 97.35 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.258 179.235 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 91.1 mt -65.3 -38.97 91.84 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.242 0.544 . . . . 0.0 110.249 179.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.571 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.17 -32.26 79.91 Favored Glycine 0 C--N 1.332 0.331 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 -179.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.445 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.2 mt-10 -36.16 -25.91 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.812 0.339 . . . . 0.0 110.877 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.571 ' N ' ' O ' ' A' ' 157' ' ' GLY . 95.1 mt -58.26 149.6 5.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.326 178.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 77.7 p -69.39 137.27 52.66 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.038 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 70.88 21.46 78.14 Favored Glycine 0 N--CA 1.459 0.201 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 179.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 59.4 m80 -123.09 -15.11 7.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.585 0.231 . . . . 0.0 110.452 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -66.28 -59.54 3.63 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.698 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -52.2 -48.83 64.84 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 120.709 -0.397 . . . . 0.0 110.101 -179.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -60.78 -40.99 94.63 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.839 0.352 . . . . 0.0 110.44 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.47 -47.41 85.79 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.522 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.89 -40.22 75.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.199 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -61.68 -50.22 73.35 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.62 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -65.16 -43.81 90.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.533 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 94.7 mt -64.63 -43.4 96.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.406 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.31 -51.23 70.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.446 -179.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.6 -43.53 96.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.867 0.365 . . . . 0.0 110.592 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . 0.492 ' CD1' ' OH ' ' A' ' 301' ' ' TYR . 57.0 t80 -62.78 -44.42 96.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.144 0.497 . . . . 0.0 110.405 179.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -63.71 -39.68 94.92 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.394 -179.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -62.9 -42.82 99.91 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.573 179.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -60.82 -44.48 96.85 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.064 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 84.7 mt -64.42 -41.18 96.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.983 0.42 . . . . 0.0 110.778 178.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.08 -62.06 1.87 Allowed 'General case' 0 C--O 1.239 0.516 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.34 -179.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.76 -46.83 86.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.42 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.24 -41.59 65.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.275 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -63.8 -33.81 76.5 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.962 0.411 . . . . 0.0 110.23 179.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 70.0 tt0 -90.63 8.79 32.46 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.622 0.725 . . . . 0.0 110.341 -178.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -104.73 -32.09 9.03 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.233 179.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.8 pt -127.95 147.74 32.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.816 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -139.98 131.38 26.87 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.31 179.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.549 ' CD2' ' N ' ' A' ' 186' ' ' LEU . 3.5 mm? -85.42 133.29 42.61 Favored Pre-proline 0 N--CA 1.45 -0.444 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.15 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -43.92 158.0 0.13 Allowed 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.706 2.271 . . . . 0.0 112.258 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . 0.496 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.9 Cg_endo -63.1 114.72 2.58 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.748 2.299 . . . . 0.0 111.677 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . 0.496 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.7 mt-30 155.87 148.1 0.0 OUTLIER Pre-proline 0 N--CA 1.454 -0.264 0 O-C-N 124.088 0.868 . . . . 0.0 110.834 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.63 144.37 35.49 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.593 2.195 . . . . 0.0 112.095 177.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.488 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.1 p -124.9 158.76 32.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.439 0.638 . . . . 0.0 110.159 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' THR . . . . . 0.488 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 37.0 p -143.07 165.34 27.65 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.193 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -135.32 128.74 32.3 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 121.43 0.634 . . . . 0.0 110.099 179.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 47.2 pt -146.52 149.05 16.34 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.44 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.236 179.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 72.1 t -117.95 123.51 71.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.421 0.629 . . . . 0.0 109.691 179.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -134.58 107.27 7.41 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.206 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 94.1 m -130.96 130.66 43.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.868 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.407 ' O ' ' N ' ' A' ' 201' ' ' HIS . . . -82.8 -37.08 24.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.15 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.41 -67.08 0.26 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.276 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.34 -9.88 59.06 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.248 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . 0.407 ' N ' ' O ' ' A' ' 198' ' ' ALA . 60.5 t-80 60.63 58.35 2.47 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.807 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 38.8 p -167.05 153.84 8.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.553 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.4 144.18 24.41 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.031 0.443 . . . . 0.0 110.37 179.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -135.33 138.18 43.16 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.663 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 20.0 mt -106.25 125.55 51.14 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' TRP . . . . . 0.557 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 75.7 m95 -82.0 166.95 19.37 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.666 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -156.98 171.23 7.72 Favored Pre-proline 0 C--O 1.224 -0.25 0 CA-C-O 120.999 0.428 . . . . 0.0 110.562 -178.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.62 -37.03 83.08 Favored 'Trans proline' 0 C--N 1.301 -1.949 0 C-N-CA 122.612 2.208 . . . . 0.0 112.236 179.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -70.64 -35.01 72.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.729 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 22.7 m -61.24 150.57 34.22 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.698 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.41 -37.11 82.28 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.442 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . 0.557 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 55.0 tt0 -64.74 -40.07 94.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.538 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.8 -43.46 91.6 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -63.31 -43.5 97.66 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.813 0.339 . . . . 0.0 110.225 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 65.4 ttp -59.49 -48.03 83.21 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.34 -0.391 . . . . 0.0 109.986 -179.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 87.0 mt -60.71 -40.82 93.68 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . 0.45 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.4 tp10 -58.2 -37.66 75.22 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -65.33 -38.21 89.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.715 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 94.2 mt -64.06 -42.76 96.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.154 0.502 . . . . 0.0 110.716 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.69 44.77 0.08 OUTLIER Glycine 0 C--N 1.333 0.379 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . 0.45 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 27.4 m-85 -127.96 155.48 44.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.02 0.438 . . . . 0.0 110.446 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' THR . . . . . 0.452 ' O ' ' O ' ' A' ' 191' ' ' VAL . 6.8 p -107.23 122.48 46.62 Favored 'General case' 0 C--O 1.223 -0.291 0 CA-C-O 121.368 0.604 . . . . 0.0 110.06 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . 0.44 ' CD2' ' N ' ' A' ' 223' ' ' LEU . 4.3 mm? -101.33 132.73 46.74 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.196 179.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.46 159.54 14.88 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.536 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.43 115.51 30.38 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.992 0.425 . . . . 0.0 110.318 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.452 ' CD1' ' N ' ' A' ' 226' ' ' LEU . 8.8 mp -53.31 156.55 3.97 Favored Pre-proline 0 N--CA 1.449 -0.515 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.764 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -60.09 145.17 99.04 Favored 'Trans proline' 0 C--N 1.3 -1.987 0 C-N-CA 122.677 2.251 . . . . 0.0 112.163 179.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.13 -3.22 59.05 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.545 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.14 -40.99 5.67 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.517 ' O ' ' N ' ' A' ' 233' ' ' SER . 86.0 mt -79.14 -17.04 55.75 Favored 'General case' 0 C--O 1.218 -0.581 0 CA-C-O 121.11 0.481 . . . . 0.0 110.25 -179.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 54.3 t-20 -40.58 -48.96 2.95 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.876 -179.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -87.75 15.25 7.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.493 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' SER . . . . . 0.517 ' N ' ' O ' ' A' ' 230' ' ' LEU . 77.9 p -60.63 -35.28 75.8 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.673 -179.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . 0.526 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.6 tt0 -118.87 -69.28 0.86 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.922 179.132 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.3 m -69.62 103.13 2.02 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.067 0.46 . . . . 0.0 110.701 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -94.55 57.33 2.22 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.305 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -144.65 -122.48 1.58 Allowed Glycine 0 C--N 1.332 0.334 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -135.07 112.09 10.27 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.256 0.551 . . . . 0.0 110.316 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . 0.521 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.4 mtt180 -148.31 58.05 1.08 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.661 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -69.59 -32.16 70.75 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.562 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . 0.52 ' CG ' HD22 ' A' ' 143' ' ' ASN . 64.7 t0 -57.05 -46.86 82.12 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.322 -178.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' ILE . . . . . 0.435 ' O ' ' O ' ' A' ' 239' ' ' ARG . 17.8 tt -140.25 156.77 24.66 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.306 0 CA-C-O 120.905 0.383 . . . . 0.0 110.419 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 96.2 mt -106.39 106.87 21.4 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 CA-C-O 121.19 0.519 . . . . 0.0 110.433 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . 0.521 ' OE1' ' NH1' ' A' ' 239' ' ' ARG . 88.2 mt-30 -110.78 110.35 20.95 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.283 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 9.5 mp -121.75 -168.22 1.66 Allowed 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.622 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . 0.526 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.53 -16.65 0.05 OUTLIER Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . 0.688 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -60.72 156.9 31.07 Favored Glycine 0 CA--C 1.521 0.425 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -63.83 21.9 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.901 0.381 . . . . 0.0 110.534 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . 0.688 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.8 m-20 -97.56 -6.08 34.28 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.761 0.315 . . . . 0.0 110.516 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 93.0 mt -79.65 -21.76 44.41 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.868 179.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.6 -51.25 70.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.724 -179.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.46 -5.45 58.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.402 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.17 -74.21 1.15 Allowed Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.744 -0.942 . . . . 0.0 110.744 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 83.3 mt -70.33 126.39 29.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.927 0.394 . . . . 0.0 110.17 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -59.96 -39.04 84.27 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.159 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 82.85 51.67 4.16 Favored Glycine 0 CA--C 1.519 0.335 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -95.59 -15.2 22.96 Favored 'General case' 0 N--CA 1.463 0.189 0 O-C-N 122.666 -0.314 . . . . 0.0 110.623 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 258' ' ' SER . . . . . 0.422 ' O ' ' O ' ' A' ' 192' ' ' THR . 3.4 t 174.72 89.02 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.195 0.521 . . . . 0.0 110.036 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . 0.588 ' N ' ' CD1' ' A' ' 259' ' ' LEU . 0.9 OUTLIER -94.6 124.43 38.63 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.21 0.528 . . . . 0.0 111.291 -179.143 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 15.8 m-30 -93.42 146.3 23.85 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.311 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 86.6 mt -122.29 149.55 43.58 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.532 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.65 ' CG ' ' N ' ' A' ' 263' ' ' ALA . 2.6 p90 -77.28 -138.57 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.657 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . 0.65 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -51.87 77.14 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 121.041 0.448 . . . . 0.0 111.27 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . 0.62 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.05 104.58 0.19 Allowed Glycine 0 CA--C 1.527 0.843 0 N-CA-C 110.414 -1.074 . . . . 0.0 110.414 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 265' ' ' ASP . . . . . 0.589 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.8 m-20 -80.32 -177.88 6.35 Favored 'General case' 0 CA--C 1.515 -0.393 0 O-C-N 122.681 -0.306 . . . . 0.0 110.944 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -40.65 -17.82 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.524 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . 0.589 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.02 -51.56 45.61 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.743 179.102 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -63.87 -46.48 84.76 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.095 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . 0.525 ' O ' ' CD2' ' A' ' 273' ' ' TYR . . . -61.8 -35.13 77.29 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 121.526 0.679 . . . . 0.0 109.716 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -62.84 -34.54 77.54 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.025 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.66 -43.07 13.74 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.217 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 272' ' ' ILE . . . . . 0.619 ' C ' ' H ' ' A' ' 274' ' ' ALA . 4.9 tt -51.27 -33.71 14.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.776 -178.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 273' ' ' TYR . . . . . 0.525 ' CD2' ' O ' ' A' ' 269' ' ' ALA . 17.2 m-85 -54.5 -1.76 0.03 OUTLIER 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.686 -179.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 274' ' ' ALA . . . . . 0.619 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.51 -39.86 70.53 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.906 179.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . 0.576 ' O ' ' N ' ' A' ' 279' ' ' ALA . 3.0 p30 -38.91 97.74 0.15 Allowed Pre-proline 0 C--O 1.226 -0.174 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.448 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -54.21 -42.8 64.19 Favored 'Trans proline' 0 C--N 1.303 -1.856 0 C-N-CA 122.329 2.02 . . . . 0.0 112.668 -178.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 88.4 mt -64.32 -42.86 96.09 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.089 0.471 . . . . 0.0 111.297 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 91.8 mt -95.56 -1.7 49.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.862 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 279' ' ' ALA . . . . . 0.576 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.36 -34.87 77.52 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.6 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.1 20.0 0.11 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.076 -179.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . 0.514 ' H ' ' C ' ' A' ' 279' ' ' ALA . 13.8 mt -74.97 119.75 78.35 Favored Pre-proline 0 N--CA 1.445 -0.719 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.725 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -50.6 -39.57 55.85 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.539 2.159 . . . . 0.0 112.035 179.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.83 -50.37 63.86 Favored 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 73.0 t -61.54 -43.81 97.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -57.97 -41.2 82.43 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.098 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -90.93 0.31 57.54 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.083 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt 59.24 43.06 17.47 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.027 0.441 . . . . 0.0 110.976 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -94.62 41.65 1.09 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.282 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 53.9 t -119.21 135.48 59.47 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-O 121.096 0.474 . . . . 0.0 109.958 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -132.69 162.6 30.96 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.678 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.74 155.27 32.8 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 121.079 0.466 . . . . 0.0 110.667 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 82.8 mt -94.22 -1.47 54.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.176 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.49 165.81 12.72 Favored Glycine 0 C--N 1.335 0.528 0 N-CA-C 110.489 -1.044 . . . . 0.0 110.489 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 6.7 m -87.75 -62.33 1.52 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.871 0.367 . . . . 0.0 111.044 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 295' ' ' GLU . . . . . 0.477 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.5 mm-40 -69.35 -4.02 16.53 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.69 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 25.5 p -76.71 32.76 0.13 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.623 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 297' ' ' PHE . . . . . 0.477 ' H ' ' C ' ' A' ' 295' ' ' GLU . 85.5 t80 -60.18 -46.07 90.98 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.624 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . 0.609 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.2 mtt85 -81.33 134.76 35.63 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.617 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 16.7 tp -114.66 118.71 34.42 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-O 120.985 0.421 . . . . 0.0 110.206 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . 0.604 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.5 p-10 -166.15 -175.44 3.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.651 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 301' ' ' TYR . . . . . 0.492 ' OH ' ' CD1' ' A' ' 173' ' ' PHE . 81.1 t80 -47.76 -44.22 28.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.209 -179.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -66.09 -40.74 91.04 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.107 0.48 . . . . 0.0 110.804 178.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 303' ' ' SER . . . . . 0.604 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 56.0 p -56.04 -35.73 67.22 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.951 -179.005 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -57.28 -51.45 69.33 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 91.1 mtp -56.46 -43.78 79.9 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -179.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -66.32 -42.52 88.11 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.21 0.528 . . . . 0.0 110.253 179.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 55.7 t -64.08 -42.99 97.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.135 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 42.7 tp -59.63 -42.24 92.27 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.101 -0.499 . . . . 0.0 109.73 -179.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -62.7 -38.71 91.48 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 310' ' ' ARG . . . . . 0.446 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.5 ttt85 -63.49 -43.81 96.17 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.218 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 88.8 mt -63.2 -42.06 99.27 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.273 179.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -62.89 -33.33 75.07 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.083 179.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.86 -23.45 21.65 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.383 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . 0.446 ' N ' ' O ' ' A' ' 310' ' ' ARG . 6.7 tt -62.44 -43.16 99.47 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 121.079 0.466 . . . . 0.0 110.563 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 . . . . . 0 C--O 1.22 -0.484 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.319 -179.907 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -99.55 136.67 39.14 Favored 'General case' 0 CA--C 1.521 -0.164 0 CA-C-O 121.091 0.472 . . . . 0.0 110.442 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.492 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -91.86 178.61 1.66 Allowed Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.57 -179.827 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.492 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.2 Cg_exo -61.61 146.94 96.46 Favored 'Trans proline' 0 C--N 1.3 -2.025 0 C-N-CA 122.833 2.355 . . . . 0.0 112.144 179.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 35.3 ptt180 -136.03 142.16 44.41 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.638 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -79.34 116.69 19.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.44 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.5 tp -110.98 130.53 64.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.536 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.0 t -71.0 141.76 50.97 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.638 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.514 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.5 t0 -139.33 179.51 6.49 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.532 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.514 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 77.9 p -73.8 -36.98 65.07 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.569 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.7 ttt85 -46.48 -94.43 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.296 -179.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.418 ' O ' ' OG1' ' A' ' 36' ' ' THR . . . -167.55 -26.49 0.02 OUTLIER Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.418 ' OG1' ' O ' ' A' ' 35' ' ' GLY . 60.8 m -168.97 104.8 0.4 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.777 0.322 . . . . 0.0 110.657 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 74.6 t60 -128.65 149.0 50.84 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.087 0.47 . . . . 0.0 110.214 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.484 ' CG2' ' N ' ' A' ' 39' ' ' LEU . 98.2 m -131.36 166.07 22.06 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.453 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.484 ' N ' ' CG2' ' A' ' 38' ' ' THR . 81.9 mt -120.93 127.28 51.69 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.464 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -64.91 -44.55 89.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.718 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 40.0 p -165.71 155.08 12.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.373 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.448 ' N ' ' CD ' ' A' ' 42' ' ' GLN . 14.7 mp0 -44.3 100.9 0.24 Allowed Pre-proline 0 C--N 1.329 -0.286 0 O-C-N 123.503 0.502 . . . . 0.0 110.598 179.221 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.53 129.99 36.67 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 C-N-CA 122.305 2.003 . . . . 0.0 112.245 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -83.73 -24.78 31.05 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.558 179.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.538 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.6 mtm-85 -122.33 134.84 54.64 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.27 0.557 . . . . 0.0 110.234 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.2 mt -130.73 133.78 62.83 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.329 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.871 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 45.0 t -124.11 130.55 73.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 CA-C-O 120.945 0.402 . . . . 0.0 109.968 179.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.501 ' O ' ' O ' ' A' ' 66' ' ' ALA . 2.1 m -154.57 167.17 30.99 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.542 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 64.4 p -124.75 9.26 8.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.385 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.98 125.43 33.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.858 0.361 . . . . 0.0 110.685 -179.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 93.3 t -65.63 -44.53 93.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.463 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.1 m -62.38 -44.3 96.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.618 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 49.6 tp -62.34 -41.3 98.46 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.528 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 74.3 m -57.65 -44.43 85.65 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.286 -179.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.3 -62.33 5.23 Favored Glycine 0 N--CA 1.467 0.761 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.7 t -48.22 -35.59 12.21 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.9 mt -61.78 -44.43 96.9 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.648 -0.421 . . . . 0.0 111.305 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.3 mp -65.54 -41.26 93.26 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.333 177.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.59 -40.75 97.75 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.858 -179.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.1 tp -89.03 16.98 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.857 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 56.17 85.33 0.07 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.797 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 178.72 59.47 0.08 OUTLIER Pre-proline 0 C--N 1.327 -0.386 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -52.18 152.55 14.61 Favored 'Trans proline' 0 C--N 1.292 -2.401 0 C-N-CA 123.048 2.499 . . . . 0.0 112.063 -178.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.435 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -108.65 145.27 15.79 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.171 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.271 -179.661 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.8 mt -63.57 -45.42 97.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.388 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.501 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -129.49 134.1 47.61 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.517 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.504 ' O ' ' N ' ' A' ' 98' ' ' LEU . 75.4 m -134.6 158.6 43.6 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.891 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.7 139.0 16.1 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.694 -0.962 . . . . 0.0 110.694 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.464 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.79 -162.81 0.08 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.936 0.398 . . . . 0.0 110.461 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.481 ' O ' ' C ' ' A' ' 71' ' ' THR . 14.5 t -133.65 134.74 43.53 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.289 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.481 ' C ' ' O ' ' A' ' 70' ' ' THR . 0.1 OUTLIER 29.65 68.73 0.65 Allowed Pre-proline 0 N--CA 1.467 0.403 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.735 -179.865 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_exo -61.74 145.67 97.18 Favored 'Trans proline' 0 C--N 1.3 -2.022 0 C-N-CA 122.669 2.246 . . . . 0.0 111.708 -177.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.525 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 45.3 p-10 -159.39 -32.1 0.06 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.718 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.525 ' N ' ' OD1' ' A' ' 73' ' ' ASN . 99.1 m-20 -64.11 -39.42 94.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.387 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -60.36 -48.32 82.25 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.555 -179.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.424 ' O ' ' O ' ' A' ' 77' ' ' ALA . 93.9 t -60.16 -25.1 32.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.053 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.424 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -45.68 173.1 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.635 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.571 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.5 p30 -62.41 178.03 0.45 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.505 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.592 ' C ' ' H ' ' A' ' 81' ' ' GLY . 36.2 p30 -45.0 85.63 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.096 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.571 ' N ' ' O ' ' A' ' 78' ' ' ASP . 42.1 tp60 -67.65 13.21 0.08 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.207 0.527 . . . . 0.0 110.162 -179.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.592 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 118.63 -22.5 9.33 Favored Glycine 0 N--CA 1.461 0.33 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -108.12 116.25 31.62 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.013 0.435 . . . . 0.0 110.381 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 76.1 mt -98.27 -0.0 44.83 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.578 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -92.34 7.4 43.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.015 0.436 . . . . 0.0 110.39 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.433 ' O ' ' CG2' ' A' ' 89' ' ' VAL . 88.2 mt-30 -100.24 -27.7 13.37 Favored 'General case' 0 C--O 1.222 -0.387 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.754 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 69.0 t-105 -62.94 -40.55 98.0 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.942 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.551 ' O ' ' N ' ' A' ' 91' ' ' LYS . 64.2 m -77.93 -53.59 7.28 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.958 -179.311 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -48.49 -50.77 30.26 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.052 -179.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.433 ' CG2' ' O ' ' A' ' 85' ' ' GLN . 15.8 m -68.8 -40.57 81.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.161 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.415 ' H ' HG23 ' A' ' 89' ' ' VAL . . . -72.39 -23.01 61.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.629 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.551 ' N ' ' O ' ' A' ' 87' ' ' SER . 65.9 tttm -61.84 -45.58 93.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.433 -179.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.442 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.8 mm-40 -90.31 -95.3 0.11 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.092 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.629 ' O ' ' N ' ' A' ' 95' ' ' LEU . 96.0 mtt180 -142.79 58.84 1.43 Allowed 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.448 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.7 pttp 33.87 25.7 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.07 0.462 . . . . 0.0 110.25 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.629 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.3 tt -48.26 123.46 6.48 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.983 -177.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -83.52 -169.61 2.64 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.183 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.603 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 81.3 mtp180 -74.69 136.95 41.84 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.256 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.504 ' N ' ' O ' ' A' ' 67' ' ' SER . 91.2 mt -85.63 -165.83 1.34 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.83 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.538 ' CD2' ' O ' ' A' ' 99' ' ' TYR . 48.2 p90 -168.64 119.65 0.77 Allowed 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.152 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.503 ' C ' ' O ' ' A' ' 99' ' ' TYR . 41.7 mm -28.67 120.7 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 O-C-N 123.272 0.358 . . . . 0.0 111.104 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 114.31 27.26 3.44 Favored Glycine 0 C--N 1.331 0.296 0 N-CA-C 111.27 -0.732 . . . . 0.0 111.27 -179.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.572 ' N ' ' CD ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -144.36 46.72 0.65 Allowed Pre-proline 0 C--N 1.322 -0.593 0 CA-C-O 121.145 0.498 . . . . 0.0 110.484 179.783 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.572 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 28.9 Cg_endo -62.02 144.0 95.72 Favored 'Trans proline' 0 C--N 1.295 -2.263 0 C-N-CA 122.643 2.229 . . . . 0.0 111.761 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 27.6 t -173.18 120.37 0.35 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.359 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.83 -40.21 63.49 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.119 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.36 -39.89 89.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.853 -179.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.13 -40.09 95.44 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.73 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 72.3 t -67.77 -43.72 86.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.672 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.81 -39.04 93.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.455 -179.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.442 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.5 -23.39 62.74 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.516 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.537 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.3 mm-40 -90.69 5.55 47.66 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.682 -179.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.538 ' O ' ' NE ' ' A' ' 45' ' ' ARG . 10.2 tpt 22.85 64.46 0.35 Allowed Pre-proline 0 N--CA 1.467 0.385 0 CA-C-O 120.949 0.404 . . . . 0.0 111.209 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -78.75 167.51 22.28 Favored 'Trans proline' 0 C--N 1.307 -1.658 0 C-N-CA 123.077 2.518 . . . . 0.0 111.594 -177.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.52 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 99.1 m-20 -109.71 -42.1 4.37 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.991 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.6 tp -121.5 120.35 34.64 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.904 0.383 . . . . 0.0 109.97 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 84.8 mt -112.78 128.84 69.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 CA-C-O 120.862 0.363 . . . . 0.0 110.998 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 29.6 mt -109.18 132.13 54.41 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.262 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 99.1 mt -119.57 138.69 49.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.687 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 85.6 p -72.3 153.75 41.34 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.571 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.16 -50.25 74.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.705 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -149.51 154.0 38.08 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.602 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 170.5 -170.84 43.34 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.93 -34.3 89.51 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.445 ' O ' ' OD1' ' A' ' 124' ' ' ASP . 44.0 p-10 -86.7 120.43 28.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.856 0.36 . . . . 0.0 110.647 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 39.0 t -63.21 143.75 57.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.392 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.1 -43.24 8.97 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.82 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.5 tp -62.98 -42.36 99.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.716 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.67 -12.07 59.68 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.449 -179.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 85.1 mt -114.76 -24.07 8.88 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.578 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . 0.519 ' N ' ' O ' ' A' ' 126' ' ' ALA . 78.9 t80 -51.01 -49.73 59.88 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.819 -0.352 . . . . 0.0 110.693 -178.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.5 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.1 p-10 -66.06 -42.67 89.18 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.321 179.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.5 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 88.3 mt-30 -67.01 -37.71 84.66 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.818 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 96.2 mt -80.24 -41.68 24.63 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.887 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.3 t -56.77 -44.69 82.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.248 -179.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 18.7 m -61.72 -45.44 93.96 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.613 179.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 94.6 mt -61.91 -43.73 97.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.319 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.27 168.29 5.05 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.644 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -49.59 113.19 0.86 Allowed 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.296 1.997 . . . . 0.0 112.393 179.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 24.0 m -84.59 127.36 34.02 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.617 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 34.7 tp -117.79 135.96 53.71 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 120.998 0.428 . . . . 0.0 110.109 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.441 ' O ' ' OD2' ' A' ' 32' ' ' ASP . 82.7 mt -99.62 118.92 46.95 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 CA-C-O 121.208 0.527 . . . . 0.0 111.089 -179.298 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 97.9 mt -135.15 132.33 52.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.574 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.513 HD22 ' CG ' ' A' ' 241' ' ' ASP . 56.4 t30 -68.04 153.72 43.15 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.987 0.423 . . . . 0.0 110.405 179.296 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.525 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 88.7 t80 -87.46 122.28 30.99 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.85 -179.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.525 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 99.0 m-20 55.11 69.38 0.74 Allowed 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.759 179.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 49.8 p-10 -123.6 -0.72 8.6 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.852 0.358 . . . . 0.0 110.629 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -151.01 116.29 5.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.715 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' SER . . . . . 0.526 ' HG ' ' H ' ' A' ' 150' ' ' GLN . 82.8 p -62.45 167.5 4.24 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.513 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.411 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.2 p-90 -51.05 -15.76 0.36 Allowed 'General case' 0 C--O 1.221 -0.414 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.371 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . 0.526 ' H ' ' HG ' ' A' ' 148' ' ' SER . 67.9 tp60 -70.92 -74.69 0.14 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.912 0.386 . . . . 0.0 110.516 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.434 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.2 t -62.81 -39.19 93.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.181 179.553 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 55.0 tp -60.05 -45.75 91.82 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.393 -178.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.411 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 46.9 tp -62.7 -41.64 99.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.619 178.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.434 ' OG1' ' O ' ' A' ' 151' ' ' SER . 56.5 p -64.25 -34.94 79.26 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.226 -179.372 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.442 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.8 mm-40 -64.11 -42.57 96.83 Favored 'General case' 0 C--O 1.226 -0.161 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.389 179.332 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 90.2 mt -65.46 -38.66 90.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.152 0.501 . . . . 0.0 110.317 179.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.573 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.49 -32.41 81.08 Favored Glycine 0 C--N 1.331 0.287 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 -179.227 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.442 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.2 mt-10 -35.3 -27.23 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.819 0.343 . . . . 0.0 110.815 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.573 ' N ' ' O ' ' A' ' 157' ' ' GLY . 94.7 mt -55.83 149.42 3.1 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.371 178.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 72.7 p -69.82 137.58 51.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.992 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 71.1 20.96 78.33 Favored Glycine 0 N--CA 1.459 0.183 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 58.2 m80 -122.64 -14.49 7.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.641 0.258 . . . . 0.0 110.487 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -66.03 -59.93 3.32 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.584 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -51.98 -49.32 63.5 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.156 -179.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -60.59 -41.29 94.43 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.841 0.353 . . . . 0.0 110.435 179.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.32 -47.32 86.49 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.473 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.74 -40.27 75.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.241 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -61.53 -50.45 72.62 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.652 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -65.24 -43.7 90.56 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.584 179.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 94.2 mt -64.84 -43.3 96.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.4 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.4 -51.27 70.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.369 -179.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -63.41 -43.7 96.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.843 0.354 . . . . 0.0 110.656 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . 0.498 ' CD1' ' OH ' ' A' ' 301' ' ' TYR . 57.0 t80 -62.82 -44.42 96.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.378 179.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 -63.16 -39.67 95.34 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.78 -179.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -63.32 -42.66 99.01 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.518 179.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -60.76 -44.59 96.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.221 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 84.1 mt -64.69 -40.99 96.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.723 178.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.32 -62.46 1.62 Allowed 'General case' 0 C--O 1.238 0.457 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.295 -179.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.35 -47.34 84.09 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.473 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -52.75 -42.02 64.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.329 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -63.78 -33.66 76.17 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.034 0.445 . . . . 0.0 110.291 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 69.6 tt0 -90.81 9.06 31.7 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.552 0.691 . . . . 0.0 110.328 -178.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -105.11 -32.18 8.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.171 179.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 45.1 pt -128.15 147.76 32.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.816 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -140.25 131.36 26.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.388 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.553 ' CD2' ' N ' ' A' ' 186' ' ' LEU . 3.5 mm? -85.26 133.87 41.78 Favored Pre-proline 0 N--CA 1.45 -0.435 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.092 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -43.7 157.67 0.13 Allowed 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.635 2.223 . . . . 0.0 112.387 179.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . 0.508 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 28.3 Cg_endo -63.22 114.9 2.68 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.819 2.346 . . . . 0.0 111.692 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . 0.508 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.7 mt-30 155.43 147.9 0.0 OUTLIER Pre-proline 0 N--CA 1.456 -0.136 0 O-C-N 124.051 0.844 . . . . 0.0 110.93 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.22 143.81 36.19 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.578 2.185 . . . . 0.0 112.316 177.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.494 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.1 p -124.87 159.3 31.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.418 0.628 . . . . 0.0 110.214 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' THR . . . . . 0.494 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 37.7 p -143.52 165.59 27.15 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.095 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -135.13 128.77 32.76 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-O 121.285 0.564 . . . . 0.0 110.229 179.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 47.9 pt -146.47 148.77 16.65 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.383 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.159 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 69.3 t -117.52 123.31 71.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-O 121.376 0.608 . . . . 0.0 109.817 178.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -134.46 107.69 7.71 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 121.156 0.503 . . . . 0.0 110.285 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 94.8 m -131.22 130.55 43.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.834 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.402 ' O ' ' N ' ' A' ' 201' ' ' HIS . . . -82.86 -36.83 25.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.242 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.49 -67.15 0.26 Allowed 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.273 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.34 -10.1 59.35 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.299 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . 0.402 ' N ' ' O ' ' A' ' 198' ' ' ALA . 60.1 t-80 60.77 58.3 2.42 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.71 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 41.6 p -166.77 153.52 8.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.565 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.65 144.49 24.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.977 0.418 . . . . 0.0 110.47 179.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -135.48 138.24 42.95 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.611 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 20.1 mt -106.26 125.81 51.45 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.006 0.432 . . . . 0.0 109.953 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' TRP . . . . . 0.563 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 76.4 m95 -82.52 167.26 18.55 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.536 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -157.25 170.71 8.5 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.617 -178.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -53.22 -37.04 79.94 Favored 'Trans proline' 0 C--N 1.302 -1.911 0 C-N-CA 122.652 2.235 . . . . 0.0 112.446 179.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -70.6 -34.94 72.69 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.657 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 22.9 m -61.56 150.45 35.97 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.633 -179.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.38 -36.87 81.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.436 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . 0.563 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 54.6 tt0 -64.73 -40.09 94.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.477 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.62 -43.54 91.83 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.669 -0.972 . . . . 0.0 110.669 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -63.34 -43.46 97.65 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.851 0.358 . . . . 0.0 110.233 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 65.4 ttp -59.1 -48.42 81.67 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.161 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 89.0 mt -60.29 -40.96 92.31 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . 0.453 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 40.5 tp10 -57.93 -37.67 74.51 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.057 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -65.48 -37.76 87.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.699 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 95.0 mt -64.37 -42.82 95.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.144 0.497 . . . . 0.0 110.629 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.5 44.62 0.08 OUTLIER Glycine 0 CA--C 1.52 0.387 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . 0.453 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 26.4 m-85 -127.58 154.5 45.12 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 121.05 0.452 . . . . 0.0 110.535 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' THR . . . . . 0.457 ' O ' ' O ' ' A' ' 191' ' ' VAL . 4.5 p -106.05 121.65 44.55 Favored 'General case' 0 C--O 1.224 -0.261 0 CA-C-O 121.262 0.554 . . . . 0.0 110.049 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . 0.447 ' CD2' ' N ' ' A' ' 223' ' ' LEU . 4.3 mm? -100.38 133.66 44.47 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.128 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -97.36 157.94 15.72 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.475 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -104.2 115.33 30.22 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.927 0.394 . . . . 0.0 110.416 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.441 ' CD1' ' N ' ' A' ' 226' ' ' LEU . 9.1 mp -53.89 156.55 4.96 Favored Pre-proline 0 N--CA 1.45 -0.462 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.817 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -59.73 145.11 99.04 Favored 'Trans proline' 0 C--N 1.299 -2.052 0 C-N-CA 122.736 2.291 . . . . 0.0 112.348 179.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.75 -2.52 58.67 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.509 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.58 -40.42 5.67 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.532 ' O ' ' N ' ' A' ' 233' ' ' SER . 85.9 mt -79.32 -16.73 55.89 Favored 'General case' 0 C--O 1.22 -0.499 0 CA-C-O 121.085 0.469 . . . . 0.0 110.279 -179.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 54.8 t-20 -40.09 -48.92 2.55 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.79 -179.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -88.38 15.37 7.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.316 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' SER . . . . . 0.532 ' N ' ' O ' ' A' ' 230' ' ' LEU . 77.8 p -60.75 -35.46 76.44 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.676 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . 0.522 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.6 tt0 -118.28 -69.53 0.84 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.858 179.378 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.0 m -70.39 103.27 2.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.678 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -94.27 57.85 2.39 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.007 0.432 . . . . 0.0 110.319 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -145.2 -122.34 1.52 Allowed Glycine 0 C--N 1.332 0.339 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -134.1 112.42 11.14 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 121.141 0.496 . . . . 0.0 110.389 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . 0.461 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.2 mtt180 -148.54 56.79 1.04 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.737 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -69.49 -31.84 70.35 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.504 179.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . 0.513 ' CG ' HD22 ' A' ' 143' ' ' ASN . 64.8 t0 -56.58 -47.01 80.46 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.357 -179.042 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' ILE . . . . . 0.441 ' O ' ' O ' ' A' ' 239' ' ' ARG . 17.1 tt -140.4 157.46 24.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.88 0.371 . . . . 0.0 110.547 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 96.0 mt -105.88 106.05 19.84 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 CA-C-O 121.094 0.474 . . . . 0.0 110.505 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . 0.461 ' OE1' ' NH1' ' A' ' 239' ' ' ARG . 88.3 mt-30 -110.99 110.64 21.28 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.351 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 9.8 mp -121.98 -167.79 1.6 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.645 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . 0.522 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 172.79 -16.71 0.05 OUTLIER Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . 0.685 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -60.6 157.62 29.34 Favored Glycine 0 CA--C 1.522 0.49 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -64.05 21.01 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.966 0.412 . . . . 0.0 110.616 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . 0.685 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.9 m-20 -96.75 -5.7 38.0 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.523 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 91.3 mt -80.67 -20.97 41.82 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.763 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.56 -51.44 69.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.615 -179.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -89.14 -4.87 58.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.529 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.33 -74.13 1.16 Allowed Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.896 -0.881 . . . . 0.0 110.896 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 81.5 mt -70.12 125.7 27.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.978 0.418 . . . . 0.0 110.282 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -59.9 -39.26 84.79 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.334 -179.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 83.33 51.57 4.08 Favored Glycine 0 CA--C 1.52 0.393 0 N-CA-C 110.824 -0.91 . . . . 0.0 110.824 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -94.87 -16.7 22.69 Favored 'General case' 0 C--N 1.332 -0.17 0 O-C-N 122.739 -0.271 . . . . 0.0 110.606 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 258' ' ' SER . . . . . 0.417 ' O ' ' O ' ' A' ' 192' ' ' THR . 3.4 t 175.47 89.49 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.159 0.504 . . . . 0.0 110.1 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . 0.594 ' N ' ' CD1' ' A' ' 259' ' ' LEU . 0.9 OUTLIER -94.79 124.49 38.86 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.22 0.534 . . . . 0.0 111.229 -179.03 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 15.9 m-30 -93.98 146.8 23.67 Favored 'General case' 0 CA--C 1.5 -0.956 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.351 179.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 86.7 mt -122.42 150.18 42.82 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.542 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.655 ' CG ' ' N ' ' A' ' 263' ' ' ALA . 2.6 p90 -77.7 -138.27 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.587 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . 0.655 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -51.96 77.34 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.156 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . 0.62 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.24 104.35 0.18 Allowed Glycine 0 CA--C 1.528 0.845 0 N-CA-C 110.474 -1.051 . . . . 0.0 110.474 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 265' ' ' ASP . . . . . 0.593 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.6 m-20 -79.98 -177.91 6.23 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 122.75 -0.265 . . . . 0.0 110.945 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -40.47 -17.83 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.567 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . 0.593 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.27 -51.7 42.17 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.681 179.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -63.56 -46.7 84.71 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.312 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . 0.523 ' O ' ' CD2' ' A' ' 273' ' ' TYR . . . -61.68 -35.03 76.83 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 121.444 0.64 . . . . 0.0 109.808 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -63.14 -34.19 77.07 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.145 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.62 -43.33 13.55 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.081 -179.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 272' ' ' ILE . . . . . 0.619 ' C ' ' H ' ' A' ' 274' ' ' ALA . 4.9 tt -51.39 -33.78 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.875 -178.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 273' ' ' TYR . . . . . 0.523 ' CD2' ' O ' ' A' ' 269' ' ' ALA . 17.2 m-85 -54.4 -1.73 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.649 -179.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 274' ' ' ALA . . . . . 0.619 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.49 -39.73 70.66 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.848 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . 0.58 ' O ' ' N ' ' A' ' 279' ' ' ALA . 2.8 p30 -39.22 98.29 0.16 Allowed Pre-proline 0 N--CA 1.463 0.178 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.401 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_exo -54.68 -42.69 66.12 Favored 'Trans proline' 0 C--N 1.303 -1.833 0 C-N-CA 122.356 2.037 . . . . 0.0 112.502 -178.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 89.2 mt -64.51 -42.84 95.55 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.093 0.473 . . . . 0.0 111.213 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 91.3 mt -95.59 -1.81 49.63 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.924 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 279' ' ' ALA . . . . . 0.58 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.16 -34.78 77.05 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.701 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.3 20.0 0.12 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.963 -179.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . 0.512 ' H ' ' C ' ' A' ' 279' ' ' ALA . 13.7 mt -74.73 119.24 75.74 Favored Pre-proline 0 N--CA 1.447 -0.607 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.774 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -49.65 -40.34 46.66 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.656 2.237 . . . . 0.0 112.3 178.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.57 -50.66 62.52 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.023 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 78.0 t -61.43 -43.87 97.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.803 0.335 . . . . 0.0 110.118 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -57.64 -41.27 81.08 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.188 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -90.89 0.47 57.48 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.108 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt 59.25 42.04 19.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.784 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -93.79 41.1 1.08 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.398 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 53.7 t -118.31 136.22 56.19 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.126 0 CA-C-O 121.113 0.483 . . . . 0.0 110.009 -179.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -133.31 163.12 30.04 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.184 0.516 . . . . 0.0 110.626 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -120.48 154.88 34.64 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-O 121.048 0.451 . . . . 0.0 110.652 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 82.3 mt -93.41 -1.63 55.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.212 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.59 165.94 12.74 Favored Glycine 0 N--CA 1.463 0.445 0 N-CA-C 110.529 -1.028 . . . . 0.0 110.529 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 6.8 m -87.6 -62.19 1.55 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.857 0.361 . . . . 0.0 110.967 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 295' ' ' GLU . . . . . 0.469 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.4 mm-40 -69.8 -3.85 17.4 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.667 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 25.2 p -77.03 33.38 0.15 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.593 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 297' ' ' PHE . . . . . 0.469 ' H ' ' C ' ' A' ' 295' ' ' GLU . 84.8 t80 -60.11 -45.99 91.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.591 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . 0.603 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.3 mtt85 -81.61 134.84 35.54 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.59 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 16.0 tp -114.39 119.16 35.99 Favored 'General case' 0 C--O 1.231 0.08 0 CA-C-O 120.974 0.416 . . . . 0.0 110.204 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . 0.604 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.2 p-10 -166.73 -174.71 2.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.637 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 301' ' ' TYR . . . . . 0.498 ' OH ' ' CD1' ' A' ' 173' ' ' PHE . 83.5 t80 -47.96 -45.07 30.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.221 -179.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -65.3 -41.2 94.33 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.017 0.437 . . . . 0.0 110.734 178.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 303' ' ' SER . . . . . 0.604 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 53.6 p -55.73 -36.62 67.44 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.059 -179.237 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . 0.491 ' N ' ' HG ' ' A' ' 303' ' ' SER . . . -56.33 -52.74 63.43 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 92.4 mtp -55.21 -43.72 74.72 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -66.25 -42.31 88.76 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.137 0.494 . . . . 0.0 110.264 179.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 55.1 t -64.09 -43.02 97.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.27 179.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 42.3 tp -59.98 -42.26 93.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.846 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -62.33 -38.88 91.17 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.146 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 310' ' ' ARG . . . . . 0.404 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.5 ttt85 -63.87 -44.21 93.74 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.251 179.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 87.9 mt -63.41 -42.42 98.75 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.465 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt -62.88 -33.51 75.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.191 179.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -87.24 -26.25 23.59 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.318 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . 0.457 ' CD2' ' C ' ' A' ' 314' ' ' LEU . 8.4 tt -62.57 -44.4 96.43 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.327 -179.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 . . . . . 0 C--O 1.22 -0.499 0 CA-C-O 118.005 -0.998 . . . . 0.0 110.475 179.975 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -99.67 136.05 40.17 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.002 0.43 . . . . 0.0 110.515 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.497 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -92.29 178.72 1.57 Allowed Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.523 -179.874 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.497 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.8 Cg_exo -61.58 147.3 95.73 Favored 'Trans proline' 0 C--N 1.3 -2.01 0 C-N-CA 122.819 2.346 . . . . 0.0 112.132 179.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 35.5 ptt180 -136.1 142.47 44.3 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.697 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -79.75 116.43 19.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.489 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.4 tp -110.71 130.38 64.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.503 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.3 t -70.74 141.4 51.49 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.571 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.511 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.4 t0 -139.05 179.55 6.43 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.52 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.511 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 77.9 p -74.05 -36.99 64.42 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.557 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.8 ttt85 -46.38 -94.57 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.337 -179.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.439 ' C ' ' HG1' ' A' ' 36' ' ' THR . . . -167.17 -26.74 0.02 OUTLIER Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.439 ' HG1' ' C ' ' A' ' 35' ' ' GLY . 70.7 m -169.01 104.57 0.4 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.9 0.381 . . . . 0.0 110.613 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 74.3 t60 -128.46 148.33 50.72 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.081 0.467 . . . . 0.0 110.187 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.483 ' CG2' ' N ' ' A' ' 39' ' ' LEU . 98.0 m -130.79 166.06 21.62 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.54 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.483 ' N ' ' CG2' ' A' ' 38' ' ' THR . 81.2 mt -120.8 127.63 52.13 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.56 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -65.08 -44.59 88.43 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.67 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.4 ' O ' ' HD3' ' A' ' 43' ' ' PRO . 39.8 p -165.65 154.89 12.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.416 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.462 ' N ' ' CD ' ' A' ' 42' ' ' GLN . 14.8 mp0 -44.32 101.07 0.24 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.607 179.381 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.4 ' HD3' ' O ' ' A' ' 41' ' ' SER . 31.7 Cg_exo -57.23 129.51 34.58 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.391 2.061 . . . . 0.0 112.265 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -83.5 -24.78 31.57 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.527 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.538 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.6 mtm-85 -122.31 134.82 54.65 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 121.179 0.514 . . . . 0.0 110.297 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.2 mt -130.8 133.96 62.5 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.272 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.821 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 45.6 t -124.43 130.55 73.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 179.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.502 ' O ' ' O ' ' A' ' 66' ' ' ALA . 2.2 m -154.81 166.63 32.88 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.576 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 73.1 p -124.41 8.69 8.42 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.372 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.0 125.86 33.06 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.843 0.354 . . . . 0.0 110.653 -179.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 90.8 t -66.02 -44.44 92.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.521 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.7 m -62.69 -44.39 96.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.601 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 50.3 tp -62.38 -41.48 98.67 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.529 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 70.6 m -57.88 -44.51 86.72 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.239 -179.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.17 -62.31 5.28 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 179.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.7 t -48.19 -35.65 12.19 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 20.1 mt -61.81 -44.6 96.55 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.226 179.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.3 mp -65.16 -41.66 94.5 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.391 177.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.42 -41.38 98.71 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.856 -179.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.1 tp -88.1 17.29 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.838 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 56.28 85.01 0.08 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.733 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.36 58.62 0.08 OUTLIER Pre-proline 0 C--N 1.328 -0.355 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -50.92 151.93 10.76 Favored 'Trans proline' 0 C--N 1.294 -2.319 0 C-N-CA 122.902 2.402 . . . . 0.0 112.275 -178.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.433 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -108.71 145.75 15.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.326 -179.691 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.76 -45.17 97.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.361 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.502 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -129.92 134.48 47.51 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 120.8 0.334 . . . . 0.0 110.541 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.48 ' O ' ' N ' ' A' ' 98' ' ' LEU . 73.3 m -134.73 158.87 43.02 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.907 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.45 138.65 15.98 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.445 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.6 -162.85 0.09 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.002 0.429 . . . . 0.0 110.453 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.487 ' O ' ' C ' ' A' ' 71' ' ' THR . 5.8 t -133.97 135.9 43.8 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.156 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.487 ' C ' ' O ' ' A' ' 70' ' ' THR . 1.1 t 29.46 67.99 0.67 Allowed Pre-proline 0 N--CA 1.466 0.332 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.728 -179.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_exo -60.97 145.74 98.69 Favored 'Trans proline' 0 C--N 1.3 -2.009 0 C-N-CA 122.619 2.213 . . . . 0.0 111.99 -178.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.537 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 42.4 p-10 -161.06 -31.86 0.05 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.75 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.537 ' N ' ' OD1' ' A' ' 73' ' ' ASN . 99.1 m-20 -64.16 -39.41 93.94 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.343 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -60.28 -47.98 83.69 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.578 -179.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.427 ' O ' ' O ' ' A' ' 77' ' ' ALA . 98.7 t -60.27 -24.62 31.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.427 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -45.5 172.88 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.631 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.575 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.9 p30 -61.99 177.61 0.44 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.586 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.598 ' C ' ' H ' ' A' ' 81' ' ' GLY . 36.5 p30 -45.96 85.41 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.072 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.575 ' N ' ' O ' ' A' ' 78' ' ' ASP . 42.4 tp60 -67.43 13.66 0.07 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.203 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.598 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 118.16 -21.96 9.9 Favored Glycine 0 CA--C 1.519 0.3 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -107.86 116.51 32.09 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.008 0.432 . . . . 0.0 110.527 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 74.6 mt -98.54 0.03 44.19 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.982 0.42 . . . . 0.0 110.51 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -92.49 7.04 44.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.031 0.443 . . . . 0.0 110.387 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.445 ' O ' ' CG2' ' A' ' 89' ' ' VAL . 88.2 mt-30 -100.24 -27.16 13.64 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.841 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.6 t-105 -64.73 -40.46 95.35 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.035 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.557 ' O ' ' N ' ' A' ' 91' ' ' LYS . 65.8 m -77.89 -54.5 6.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.169 -179.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -47.42 -50.43 22.67 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.087 -179.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.445 ' CG2' ' O ' ' A' ' 85' ' ' GLN . 14.4 m -69.36 -40.54 80.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.137 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.402 ' H ' HG23 ' A' ' 89' ' ' VAL . . . -72.45 -22.76 61.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.658 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.557 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.0 tttm -62.14 -45.57 92.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.445 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.439 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.8 mm-40 -90.37 -94.8 0.12 Allowed 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.078 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.636 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.8 mtt180 -143.01 58.75 1.42 Allowed 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.455 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.6 pttp 33.68 25.8 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 120.947 0.403 . . . . 0.0 110.255 -179.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.636 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.3 tt -47.78 123.68 6.3 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.954 -178.02 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -83.56 -170.39 3.04 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.127 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.613 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 82.2 mtp180 -73.95 137.26 43.46 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.061 0.458 . . . . 0.0 110.246 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.48 ' N ' ' O ' ' A' ' 67' ' ' SER . 90.3 mt -86.12 -165.85 1.37 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.816 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.537 ' CD2' ' O ' ' A' ' 99' ' ' TYR . 48.5 p90 -168.86 119.92 0.75 Allowed 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.137 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.509 ' C ' ' O ' ' A' ' 99' ' ' TYR . 43.7 mm -29.0 121.08 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.067 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 114.15 27.13 3.53 Favored Glycine 0 C--N 1.332 0.318 0 N-CA-C 111.261 -0.735 . . . . 0.0 111.261 -179.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.575 ' N ' ' CD ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -144.2 46.5 0.64 Allowed Pre-proline 0 C--N 1.324 -0.518 0 CA-C-O 120.931 0.396 . . . . 0.0 110.416 179.872 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 29.1 Cg_endo -62.1 143.77 95.14 Favored 'Trans proline' 0 C--N 1.296 -2.233 0 C-N-CA 122.677 2.251 . . . . 0.0 111.845 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.71 ' HG ' ' H ' ' A' ' 107' ' ' ALA . 27.4 t -173.05 120.2 0.35 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.376 179.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.52 -40.49 64.0 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.038 0.447 . . . . 0.0 111.086 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.23 -39.87 89.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.841 -179.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.71 ' H ' ' HG ' ' A' ' 104' ' ' SER . . . -64.23 -40.04 95.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.745 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 71.2 t -67.69 -43.89 86.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.793 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.71 -39.01 92.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.522 -179.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.439 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.5 -23.35 62.72 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.486 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.544 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.2 mm-40 -90.66 5.46 47.96 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.659 -179.49 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.544 ' C ' ' O ' ' A' ' 111' ' ' GLN . 10.5 tpt 23.49 64.23 0.38 Allowed Pre-proline 0 N--CA 1.466 0.367 0 CA-C-O 120.87 0.367 . . . . 0.0 111.02 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -78.54 167.1 23.19 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 C-N-CA 123.051 2.501 . . . . 0.0 111.866 -178.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.523 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 99.2 m-20 -109.83 -42.07 4.34 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.112 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 39.8 tp -121.64 120.28 34.3 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 83.7 mt -112.91 128.85 69.42 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.353 0 CA-C-O 120.934 0.397 . . . . 0.0 110.951 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 29.4 mt -108.87 132.26 54.21 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.063 0.459 . . . . 0.0 110.183 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 98.7 mt -119.67 139.01 48.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.711 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 85.6 p -72.4 153.77 41.26 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.642 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.18 -50.16 74.76 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.631 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -149.45 154.06 38.25 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.555 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 170.64 -171.02 43.53 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -63.17 -34.04 88.89 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.447 ' O ' ' OD1' ' A' ' 124' ' ' ASP . 44.0 p-10 -86.97 119.99 27.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.867 0.365 . . . . 0.0 110.684 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 39.8 t -62.99 143.61 57.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.425 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.04 -43.11 9.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.862 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.7 tp -63.01 -42.47 99.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.75 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.43 -12.08 59.39 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.499 -179.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 84.2 mt -114.94 -23.84 8.91 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.636 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . 0.519 ' N ' ' O ' ' A' ' 126' ' ' ALA . 78.4 t80 -51.0 -49.74 59.81 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.567 -178.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.503 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.1 p-10 -65.84 -42.4 90.56 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.841 -0.344 . . . . 0.0 111.208 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.503 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 88.3 mt-30 -67.45 -37.77 83.46 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.849 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 95.9 mt -80.06 -41.8 24.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.862 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.2 t -57.03 -44.43 82.88 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.166 -178.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 20.2 m -61.91 -45.09 95.24 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.463 179.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 93.8 mt -62.24 -43.59 98.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.196 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.52 167.9 5.08 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.57 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -49.4 113.14 0.83 Allowed 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.298 1.998 . . . . 0.0 112.299 179.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 24.0 m -84.65 127.24 33.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.602 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 34.7 tp -117.75 136.24 53.51 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.05 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.44 ' O ' ' OD2' ' A' ' 32' ' ' ASP . 82.6 mt -100.1 118.89 47.42 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 CA-C-O 121.149 0.5 . . . . 0.0 111.161 -179.326 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 97.8 mt -135.05 132.13 53.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.595 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.516 HD22 ' CG ' ' A' ' 241' ' ' ASP . 55.9 t30 -67.35 153.59 43.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.945 0.403 . . . . 0.0 110.483 179.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.522 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 89.1 t80 -87.58 122.26 31.05 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.865 -179.523 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.522 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 99.0 m-20 55.17 69.45 0.73 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.759 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 49.3 p-10 -123.56 -0.48 8.65 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.923 0.392 . . . . 0.0 110.664 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -151.45 117.5 5.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.69 -179.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' SER . . . . . 0.522 ' HG ' ' H ' ' A' ' 150' ' ' GLN . 83.7 p -63.4 167.78 5.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.524 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.413 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.1 p-90 -51.15 -15.64 0.37 Allowed 'General case' 0 C--O 1.223 -0.326 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.504 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . 0.522 ' H ' ' HG ' ' A' ' 148' ' ' SER . 68.1 tp60 -71.28 -74.91 0.14 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.444 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.447 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.0 t -62.93 -38.84 92.61 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.263 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 54.6 tp -60.14 -45.71 92.11 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.413 -178.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.413 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 47.3 tp -62.62 -41.6 99.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.445 179.002 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.447 ' OG1' ' O ' ' A' ' 151' ' ' SER . 57.1 p -64.23 -34.68 78.65 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.193 -179.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.43 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.7 mm-40 -63.99 -42.78 97.1 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.442 179.263 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 91.5 mt -65.38 -38.92 91.45 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.087 0.47 . . . . 0.0 110.245 179.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.579 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.2 -31.91 78.67 Favored Glycine 0 CA--C 1.519 0.288 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 -179.257 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' A' ' 157' ' ' GLY . 97.3 mt-10 -35.61 -26.73 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.815 0.34 . . . . 0.0 110.803 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.579 ' N ' ' O ' ' A' ' 157' ' ' GLY . 95.7 mt -56.62 149.87 3.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.305 179.072 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 72.4 p -69.98 137.1 51.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.983 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 72.02 19.56 78.45 Favored Glycine 0 CA--C 1.517 0.159 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 58.2 m80 -121.04 -15.05 8.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.683 0.277 . . . . 0.0 110.585 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -65.33 -60.09 3.35 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.684 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -52.01 -49.25 63.73 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 120.819 -0.352 . . . . 0.0 110.166 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -60.29 -41.26 92.99 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.956 -0.298 . . . . 0.0 110.349 179.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.44 -47.24 86.61 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.55 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.86 -40.23 75.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.286 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -61.81 -50.26 73.04 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.601 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 60.1 ttt85 -65.32 -43.76 89.97 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.554 179.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 94.9 mt -64.77 -43.31 96.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.457 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.31 -51.35 69.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.472 -179.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.43 -43.76 96.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.584 179.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . 0.477 ' CD1' ' OH ' ' A' ' 301' ' ' TYR . 56.1 t80 -62.9 -44.35 96.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.423 179.44 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -63.61 -39.96 95.71 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.54 -179.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -62.89 -42.85 99.92 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.67 179.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -60.71 -44.62 96.37 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.201 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 83.6 mt -64.51 -40.96 96.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.01 0.433 . . . . 0.0 110.695 178.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.13 -62.41 1.65 Allowed 'General case' 0 C--O 1.237 0.425 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.411 -179.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.48 -47.01 85.46 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.519 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.2 -41.65 65.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.32 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -63.92 -33.82 76.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.002 0.429 . . . . 0.0 110.397 179.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . 0.4 ' O ' ' HG2' ' A' ' 182' ' ' GLU . 69.5 tt0 -90.62 9.16 30.79 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.448 0.642 . . . . 0.0 110.439 -178.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -105.06 -32.03 8.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.165 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.5 pt -128.17 147.57 32.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.753 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -139.69 131.11 26.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.446 179.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.553 ' CD2' ' N ' ' A' ' 186' ' ' LEU . 3.6 mm? -85.3 133.23 42.96 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.977 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -43.8 157.77 0.13 Allowed 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.75 2.3 . . . . 0.0 112.223 179.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . 0.515 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 28.0 Cg_endo -63.05 114.82 2.61 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 C-N-CA 122.821 2.347 . . . . 0.0 111.716 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . 0.515 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.7 mt-30 155.72 147.71 0.0 OUTLIER Pre-proline 0 N--CA 1.456 -0.144 0 O-C-N 123.76 0.662 . . . . 0.0 110.759 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -73.56 143.53 34.46 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.582 2.188 . . . . 0.0 112.082 177.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.493 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.1 p -124.43 158.88 31.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.362 0.601 . . . . 0.0 110.174 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' THR . . . . . 0.493 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 34.8 p -143.39 165.22 28.12 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.086 -179.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -135.15 128.56 32.32 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.241 0.543 . . . . 0.0 110.201 179.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 47.4 pt -146.48 148.85 16.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.113 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 69.1 t -117.76 123.26 71.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.278 0.561 . . . . 0.0 109.794 179.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -134.07 106.96 7.48 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.295 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 94.5 m -130.57 130.3 43.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.827 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.409 ' O ' ' N ' ' A' ' 201' ' ' HIS . . . -83.01 -36.73 24.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.198 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.54 -67.01 0.27 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.338 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.49 -9.43 58.54 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.268 179.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . 0.409 ' N ' ' O ' ' A' ' 198' ' ' ALA . 59.8 t-80 60.36 58.47 2.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.708 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 48.8 p -166.99 153.51 8.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.547 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.49 144.3 24.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.974 0.416 . . . . 0.0 110.51 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -135.47 138.46 43.19 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.599 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 20.0 mt -106.59 125.68 51.31 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.067 0.46 . . . . 0.0 109.834 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' TRP . . . . . 0.557 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 75.5 m95 -82.23 167.21 18.88 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.621 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -157.03 171.53 7.33 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.632 -179.118 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -53.85 -36.9 84.56 Favored 'Trans proline' 0 C--N 1.302 -1.917 0 C-N-CA 122.691 2.261 . . . . 0.0 112.247 179.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -70.64 -34.99 72.68 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.734 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 21.5 m -61.36 150.75 34.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.606 -179.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.67 -36.96 82.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.452 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . 0.557 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 54.8 tt0 -64.63 -40.22 95.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.48 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.68 -43.46 91.88 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.694 -0.963 . . . . 0.0 110.694 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -63.41 -43.53 97.26 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.816 0.341 . . . . 0.0 110.347 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 65.2 ttp -59.43 -48.06 83.1 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.232 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 87.7 mt -60.64 -40.91 93.71 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . 0.457 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.5 tp10 -57.79 -37.92 74.59 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -65.32 -37.98 88.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.797 0.332 . . . . 0.0 110.666 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 94.5 mt -64.26 -42.86 96.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.62 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.7 44.88 0.08 OUTLIER Glycine 0 C--N 1.333 0.369 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . 0.457 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 27.4 m-85 -128.02 155.11 44.83 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.038 0.447 . . . . 0.0 110.524 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' THR . . . . . 0.453 ' O ' ' O ' ' A' ' 191' ' ' VAL . 7.2 p -106.94 122.17 45.89 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.248 0.547 . . . . 0.0 110.103 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . 0.444 ' CD2' ' N ' ' A' ' 223' ' ' LEU . 4.3 mm? -100.98 133.26 45.74 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.109 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -97.14 159.23 15.03 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.469 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.19 115.35 30.11 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.87 0.367 . . . . 0.0 110.36 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.454 ' CD1' ' N ' ' A' ' 226' ' ' LEU . 8.9 mp -53.22 156.46 3.88 Favored Pre-proline 0 N--CA 1.452 -0.345 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.744 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -60.16 145.27 98.87 Favored 'Trans proline' 0 C--N 1.3 -1.986 0 C-N-CA 122.703 2.269 . . . . 0.0 112.162 179.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.16 -3.25 59.05 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.528 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.14 -40.98 5.67 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 111.024 -0.831 . . . . 0.0 111.024 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.533 ' O ' ' N ' ' A' ' 233' ' ' SER . 85.1 mt -79.25 -17.13 55.34 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-O 121.113 0.482 . . . . 0.0 110.362 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . 0.401 ' C ' ' O ' ' A' ' 230' ' ' LEU . 55.5 t-20 -40.17 -49.12 2.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.821 -179.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -88.08 15.35 7.52 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.373 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' SER . . . . . 0.533 ' N ' ' O ' ' A' ' 230' ' ' LEU . 78.0 p -60.37 -35.6 76.09 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.651 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . 0.526 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.7 tt0 -118.51 -69.32 0.86 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.995 179.424 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.4 m -69.85 103.4 2.19 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.693 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -94.69 57.63 2.21 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.297 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -144.84 -122.59 1.57 Allowed Glycine 0 CA--C 1.52 0.353 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -134.81 111.66 10.09 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.114 0.483 . . . . 0.0 110.389 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . 0.517 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.5 mtt180 -148.04 57.72 1.09 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.762 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -69.55 -32.14 70.76 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.501 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . 0.516 ' CG ' HD22 ' A' ' 143' ' ' ASN . 64.8 t0 -56.85 -47.05 81.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.378 -179.077 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' ILE . . . . . 0.436 ' O ' ' O ' ' A' ' 239' ' ' ARG . 17.8 tt -139.97 156.63 25.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.892 0.377 . . . . 0.0 110.479 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 96.3 mt -106.03 106.26 20.24 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.202 0 CA-C-O 121.096 0.474 . . . . 0.0 110.502 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . 0.517 ' OE1' ' NH1' ' A' ' 239' ' ' ARG . 88.3 mt-30 -110.2 110.09 20.81 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.398 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 9.5 mp -121.79 -168.38 1.69 Allowed 'General case' 0 C--O 1.225 -0.199 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.651 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . 0.526 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.65 -16.76 0.05 OUTLIER Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . 0.693 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -60.55 156.64 30.8 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -63.68 21.4 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.0 0.428 . . . . 0.0 110.643 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . 0.693 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.6 m-20 -97.02 -6.03 36.3 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.556 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 93.3 mt -79.68 -21.69 44.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.658 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.5 -51.34 70.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.705 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.31 -5.65 58.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.502 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.2 -74.53 1.14 Allowed Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 82.2 mt -69.83 125.92 28.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.954 0.407 . . . . 0.0 110.366 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -59.26 -39.42 82.82 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.19 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 82.39 51.88 4.2 Favored Glycine 0 CA--C 1.521 0.407 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -96.67 -14.2 22.27 Favored 'General case' 0 C--N 1.331 -0.236 0 O-C-N 122.755 -0.262 . . . . 0.0 110.597 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 258' ' ' SER . . . . . 0.425 ' O ' ' O ' ' A' ' 192' ' ' THR . 3.5 t 174.67 88.18 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.084 0.469 . . . . 0.0 110.167 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . 0.593 ' N ' ' CD1' ' A' ' 259' ' ' LEU . 1.0 OUTLIER -94.26 123.85 37.92 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.245 0.545 . . . . 0.0 111.102 -179.101 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 15.8 m-30 -92.77 146.32 23.74 Favored 'General case' 0 CA--C 1.503 -0.854 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.503 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 86.0 mt -122.3 149.59 43.51 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.519 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.658 ' CG ' ' N ' ' A' ' 263' ' ' ALA . 2.6 p90 -77.46 -138.52 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.579 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . 0.658 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -51.9 77.29 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.114 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . 0.629 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.1 104.46 0.19 Allowed Glycine 0 CA--C 1.527 0.794 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 265' ' ' ASP . . . . . 0.599 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.8 m-20 -80.43 -177.85 6.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.649 0.261 . . . . 0.0 110.9 -179.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -40.3 -17.81 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.551 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . 0.599 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.36 -51.65 41.97 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.612 179.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -63.59 -46.77 84.3 Favored 'General case' 0 N--CA 1.461 0.095 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.237 179.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . 0.527 ' O ' ' CD2' ' A' ' 273' ' ' TYR . . . -61.62 -35.09 76.9 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 121.263 0.554 . . . . 0.0 109.827 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -63.12 -34.37 77.46 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.167 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.49 -43.39 13.61 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.14 -179.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 272' ' ' ILE . . . . . 0.618 ' C ' ' H ' ' A' ' 274' ' ' ALA . 5.0 tt -51.33 -33.75 14.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.824 -178.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 273' ' ' TYR . . . . . 0.527 ' CD2' ' O ' ' A' ' 269' ' ' ALA . 17.3 m-85 -54.45 -1.75 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.613 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 274' ' ' ALA . . . . . 0.618 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.54 -39.6 70.58 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.931 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . 0.58 ' O ' ' N ' ' A' ' 279' ' ' ALA . 3.2 p30 -39.21 98.0 0.15 Allowed Pre-proline 0 C--O 1.227 -0.126 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.505 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -54.27 -42.92 63.27 Favored 'Trans proline' 0 C--N 1.303 -1.824 0 C-N-CA 122.404 2.069 . . . . 0.0 112.598 -178.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 88.7 mt -64.41 -42.78 95.89 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.133 0.492 . . . . 0.0 111.2 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 91.1 mt -95.64 -1.72 49.62 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.882 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 279' ' ' ALA . . . . . 0.58 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.23 -34.83 77.24 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.703 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -74.27 20.15 0.12 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.981 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . 0.512 ' H ' ' C ' ' A' ' 279' ' ' ALA . 13.8 mt -75.2 119.93 79.26 Favored Pre-proline 0 N--CA 1.449 -0.499 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.595 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -50.49 -39.68 54.73 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.725 2.284 . . . . 0.0 112.019 178.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.69 -50.43 63.32 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.082 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 73.7 t -61.44 -43.91 97.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -57.81 -41.29 81.88 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.212 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -90.92 0.05 57.61 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.201 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt 59.47 43.29 16.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.863 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -94.68 41.42 1.09 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.372 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 53.8 t -118.99 135.83 58.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.089 0.471 . . . . 0.0 110.175 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -133.04 162.89 30.51 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 121.102 0.477 . . . . 0.0 110.637 -179.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -120.08 155.22 33.41 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.022 0.439 . . . . 0.0 110.689 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 81.6 mt -93.87 -1.48 54.75 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.313 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.04 165.74 12.77 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.609 -0.996 . . . . 0.0 110.609 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 7.1 m -87.3 -62.27 1.54 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.875 0.369 . . . . 0.0 111.007 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 295' ' ' GLU . . . . . 0.475 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.4 mm-40 -69.49 -4.0 16.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.672 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 26.2 p -77.03 32.62 0.14 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.619 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 297' ' ' PHE . . . . . 0.475 ' H ' ' C ' ' A' ' 295' ' ' GLU . 69.4 t80 -60.15 -46.19 90.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.512 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . 0.613 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.1 mtt85 -81.26 133.65 35.47 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 120.988 0.423 . . . . 0.0 110.507 -179.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 16.3 tp -114.16 119.67 37.89 Favored 'General case' 0 C--O 1.231 0.083 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.26 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . 0.606 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.5 p-10 -167.53 -174.14 2.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.611 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 301' ' ' TYR . . . . . 0.477 ' OH ' ' CD1' ' A' ' 173' ' ' PHE . 81.5 t80 -48.2 -45.6 34.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.2 -179.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -64.96 -41.64 95.29 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.106 0.479 . . . . 0.0 110.718 179.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 303' ' ' SER . . . . . 0.606 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 53.0 p -55.13 -36.27 65.58 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.052 -179.299 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -56.74 -51.65 68.04 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 91.5 mtp -56.22 -43.98 79.12 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -66.21 -42.71 88.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.02 0.438 . . . . 0.0 110.256 178.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 55.5 t -64.05 -42.81 96.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.254 179.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 42.2 tp -59.56 -42.22 91.92 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.81 -179.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -62.76 -38.78 91.95 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.118 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 310' ' ' ARG . . . . . 0.431 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.6 ttt85 -63.34 -44.1 95.82 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.229 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 88.1 mt -63.3 -42.03 99.01 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.318 179.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -62.78 -33.09 74.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.166 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -90.08 -23.42 21.42 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.456 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . 0.431 ' N ' ' O ' ' A' ' 310' ' ' ARG . 6.8 tt -62.29 -43.16 99.47 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 121.144 0.497 . . . . 0.0 110.677 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 . . . . . 0 C--O 1.219 -0.517 0 CA-C-O 118.026 -0.987 . . . . 0.0 110.409 -179.978 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -99.54 136.56 39.3 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.178 0.513 . . . . 0.0 110.471 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.492 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -91.9 178.61 1.66 Allowed Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.566 -179.821 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.492 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.1 Cg_exo -61.72 146.99 96.31 Favored 'Trans proline' 0 C--N 1.299 -2.071 0 C-N-CA 122.86 2.374 . . . . 0.0 112.163 179.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 35.6 ptt180 -136.21 142.34 44.07 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.653 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -79.48 116.88 19.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.475 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.5 tp -111.25 130.78 64.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.564 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.8 t -71.07 142.37 50.84 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.023 0.439 . . . . 0.0 110.615 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.514 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.4 t0 -139.95 179.53 6.55 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.561 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.514 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 77.9 p -73.67 -37.12 65.36 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.604 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.8 ttt85 -46.45 -94.41 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.29 -179.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.49 ' C ' ' HG1' ' A' ' 36' ' ' THR . . . -167.54 -26.29 0.02 OUTLIER Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.49 ' HG1' ' C ' ' A' ' 35' ' ' GLY . 54.8 m -169.31 104.91 0.37 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.84 0.353 . . . . 0.0 110.622 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 75.3 t60 -128.56 149.32 50.67 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.158 0.504 . . . . 0.0 110.142 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.484 ' CG2' ' N ' ' A' ' 39' ' ' LEU . 98.4 m -131.44 166.02 22.23 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.456 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.484 ' N ' ' CG2' ' A' ' 38' ' ' THR . 81.6 mt -120.85 127.12 51.61 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.432 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -65.02 -44.59 88.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.748 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 39.7 p -165.51 154.94 12.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.429 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.452 ' N ' ' CD ' ' A' ' 42' ' ' GLN . 14.6 mp0 -44.3 100.91 0.24 Allowed Pre-proline 0 C--O 1.235 0.33 0 O-C-N 123.551 0.532 . . . . 0.0 110.635 179.144 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.4 129.92 36.48 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 C-N-CA 122.335 2.023 . . . . 0.0 112.307 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -83.79 -24.92 30.84 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.605 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.54 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.6 mtm-85 -122.19 134.62 54.71 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.279 0.562 . . . . 0.0 110.203 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.3 mt -130.21 133.49 64.05 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.801 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 44.0 t -124.41 130.47 73.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 179.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.495 ' O ' ' O ' ' A' ' 66' ' ' ALA . 2.2 m -154.86 166.89 32.07 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.554 179.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 72.2 p -124.13 8.59 8.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.395 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.45 126.04 33.49 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.862 0.363 . . . . 0.0 110.622 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 90.9 t -66.18 -44.51 91.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.553 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.5 m -62.43 -44.55 96.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.684 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 46.1 tp -62.45 -41.44 98.74 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.543 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 71.8 m -58.1 -44.65 87.79 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.164 -179.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -63.93 -62.53 5.15 Favored Glycine 0 N--CA 1.468 0.795 0 N-CA-C 110.844 -0.903 . . . . 0.0 110.844 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.7 t -48.09 -35.51 11.49 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 20.0 mt -61.89 -44.1 97.5 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.615 -0.434 . . . . 0.0 111.397 179.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.3 mp -65.57 -41.45 92.91 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.415 177.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.41 -41.48 98.72 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.856 -179.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.1 tp -87.44 17.22 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.915 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 56.33 84.37 0.09 Allowed 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.76 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.96 59.74 0.1 OUTLIER Pre-proline 0 C--N 1.328 -0.369 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -51.85 151.56 15.3 Favored 'Trans proline' 0 C--N 1.292 -2.4 0 C-N-CA 123.079 2.519 . . . . 0.0 112.041 -178.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.434 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -108.46 145.04 15.94 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.191 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.29 -179.65 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.8 mt -63.72 -45.47 97.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.46 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.495 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -129.42 134.1 47.67 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.537 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.503 ' O ' ' N ' ' A' ' 98' ' ' LEU . 74.6 m -134.94 158.84 43.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.859 -179.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.61 139.07 16.22 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.608 -0.997 . . . . 0.0 110.608 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.438 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.71 -162.97 0.09 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.962 0.41 . . . . 0.0 110.486 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.477 ' O ' ' C ' ' A' ' 71' ' ' THR . 5.7 t -134.0 134.88 43.0 Favored 'General case' 0 CA--C 1.519 -0.25 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.477 ' C ' ' O ' ' A' ' 70' ' ' THR . 1.0 OUTLIER 29.69 68.29 0.67 Allowed Pre-proline 0 N--CA 1.467 0.415 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.816 -179.646 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_exo -61.63 144.94 97.91 Favored 'Trans proline' 0 C--N 1.299 -2.074 0 C-N-CA 122.617 2.211 . . . . 0.0 111.732 -177.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.51 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 45.8 p-10 -158.72 -31.76 0.07 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.668 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.51 ' N ' ' OD1' ' A' ' 73' ' ' ASN . 99.1 m-20 -64.21 -39.45 94.0 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.41 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -60.49 -47.95 83.88 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.44 -178.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.42 ' O ' ' O ' ' A' ' 77' ' ' ALA . 93.4 t -60.56 -24.79 32.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.42 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -45.88 173.35 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.665 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.574 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.3 p30 -61.93 177.36 0.45 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.622 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.603 ' C ' ' H ' ' A' ' 81' ' ' GLY . 36.0 p30 -45.3 85.28 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.011 0.434 . . . . 0.0 111.13 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.574 ' N ' ' O ' ' A' ' 78' ' ' ASP . 42.7 tp60 -67.33 13.39 0.07 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.212 0.529 . . . . 0.0 110.092 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.603 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 118.49 -22.44 9.45 Favored Glycine 0 N--CA 1.461 0.362 0 N-CA-C 110.921 -0.871 . . . . 0.0 110.921 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -107.85 116.45 31.97 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.992 0.425 . . . . 0.0 110.456 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 74.6 mt -98.12 -0.1 45.01 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.972 0.415 . . . . 0.0 110.55 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -92.7 7.14 44.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.029 0.442 . . . . 0.0 110.377 -179.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.445 ' O ' ' CG2' ' A' ' 89' ' ' VAL . 88.3 mt-30 -100.32 -27.68 13.35 Favored 'General case' 0 C--O 1.219 -0.545 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.813 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.3 t-105 -64.5 -40.53 95.83 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.089 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.549 ' O ' ' N ' ' A' ' 91' ' ' LYS . 63.1 m -77.78 -55.22 5.51 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.181 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -46.86 -50.08 19.16 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.243 -179.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.445 ' CG2' ' O ' ' A' ' 85' ' ' GLN . 14.2 m -69.5 -40.96 80.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.303 179.46 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.407 ' H ' HG23 ' A' ' 89' ' ' VAL . . . -72.01 -22.63 61.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.688 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.549 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.1 tttm -62.47 -45.75 91.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.316 -179.402 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.438 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.6 mm-40 -90.01 -94.02 0.12 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.998 0.428 . . . . 0.0 110.115 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.612 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.9 mtt180 -143.61 58.52 1.38 Allowed 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.445 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.7 pttp 34.01 26.5 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.064 0.459 . . . . 0.0 110.229 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.612 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.6 tt -48.89 123.01 6.36 Favored 'General case' 0 N--CA 1.444 -0.725 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.005 -177.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -83.42 -169.6 2.63 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.212 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.616 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 81.9 mtp180 -74.61 136.88 42.0 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.272 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.503 ' N ' ' O ' ' A' ' 67' ' ' SER . 91.5 mt -85.34 -165.77 1.31 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.877 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.54 ' CD2' ' O ' ' A' ' 99' ' ' TYR . 47.1 p90 -169.05 119.33 0.71 Allowed 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.044 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.502 ' C ' ' O ' ' A' ' 99' ' ' TYR . 42.9 mm -28.31 120.44 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 O-C-N 123.316 0.385 . . . . 0.0 111.192 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 114.67 27.02 3.42 Favored Glycine 0 N--CA 1.461 0.308 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 -179.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.574 ' N ' ' CD ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -144.44 46.51 0.63 Allowed Pre-proline 0 C--N 1.322 -0.612 0 CA-C-O 121.126 0.489 . . . . 0.0 110.442 179.798 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.574 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 28.5 Cg_endo -62.09 144.19 95.69 Favored 'Trans proline' 0 C--N 1.293 -2.346 0 C-N-CA 122.68 2.253 . . . . 0.0 111.686 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.701 ' HG ' ' H ' ' A' ' 107' ' ' ALA . 26.5 t -173.12 120.18 0.35 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.325 179.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.78 -40.27 63.56 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.038 0.447 . . . . 0.0 111.131 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.25 -39.81 89.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.877 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.701 ' H ' ' HG ' ' A' ' 104' ' ' SER . . . -64.3 -39.77 94.59 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.772 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 70.5 t -67.6 -43.81 86.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.686 179.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.94 -38.93 93.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.506 -179.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.438 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.71 -23.45 63.16 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.5 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.53 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.4 mm-40 -90.55 5.31 48.34 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.748 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.54 ' O ' ' NE ' ' A' ' 45' ' ' ARG . 10.6 tpt 23.01 64.41 0.36 Allowed Pre-proline 0 N--CA 1.468 0.45 0 CA-C-O 120.935 0.397 . . . . 0.0 111.312 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -78.65 167.42 22.55 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 123.095 2.53 . . . . 0.0 111.6 -177.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.52 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 99.0 m-20 -109.78 -41.95 4.39 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.046 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.6 tp -121.23 120.7 35.95 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 84.3 mt -113.2 128.75 69.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 CA-C-O 120.89 0.376 . . . . 0.0 110.968 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 31.1 mt -109.6 132.09 54.46 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.207 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 98.9 mt -119.67 138.68 49.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.634 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 85.2 p -72.16 153.9 41.37 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.583 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.08 -50.37 73.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.646 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.0 t -149.61 154.16 38.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.563 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 170.85 -170.85 43.5 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -63.08 -33.99 88.75 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.44 ' O ' ' OD1' ' A' ' 124' ' ' ASP . 43.9 p-10 -86.87 120.42 28.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.815 0.341 . . . . 0.0 110.713 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 38.5 t -62.97 143.5 57.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.072 0.463 . . . . 0.0 110.33 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.513 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -92.82 -43.26 9.09 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.91 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.2 tp -63.04 -42.56 99.77 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.729 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.32 -11.9 58.77 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.47 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 84.8 mt -115.09 -23.87 8.82 Favored 'General case' 0 C--O 1.225 -0.228 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.631 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . 0.513 ' N ' ' O ' ' A' ' 126' ' ' ALA . 79.7 t80 -51.46 -49.45 61.74 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.578 -178.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.8 p-10 -66.01 -42.41 89.75 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.773 -0.371 . . . . 0.0 111.364 179.227 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.504 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 88.3 mt-30 -67.16 -37.64 84.1 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.862 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 96.4 mt -80.36 -41.64 24.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.885 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.3 t -57.09 -44.48 83.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.294 -179.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.7 m -62.09 -45.2 94.54 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.505 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 94.1 mt -62.23 -43.61 98.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.216 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -168.98 168.73 5.01 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.608 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -50.4 112.89 0.83 Allowed 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.24 1.96 . . . . 0.0 112.431 179.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 24.0 m -84.52 127.44 34.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.679 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 34.8 tp -117.88 137.15 52.99 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.009 0.433 . . . . 0.0 110.09 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.439 ' O ' ' OD2' ' A' ' 32' ' ' ASP . 81.9 mt -100.79 118.94 48.24 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.303 0 CA-C-O 121.203 0.525 . . . . 0.0 111.161 -179.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 97.9 mt -134.97 132.34 53.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.531 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.426 HD22 ' CG ' ' A' ' 241' ' ' ASP . 56.1 t30 -67.8 154.12 42.23 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.979 0.418 . . . . 0.0 110.472 179.26 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.528 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 89.8 t80 -87.81 122.53 31.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.866 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.528 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 99.1 m-20 55.14 69.38 0.74 Allowed 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.655 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 49.6 p-10 -123.6 -0.53 8.62 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.865 0.364 . . . . 0.0 110.646 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -151.14 116.19 5.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.736 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' SER . . . . . 0.502 ' HG ' ' H ' ' A' ' 150' ' ' GLN . 82.7 p -62.64 167.5 4.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.582 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.407 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.6 p-90 -51.62 -16.12 0.58 Allowed 'General case' 0 C--O 1.221 -0.44 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.33 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . 0.502 ' H ' ' HG ' ' A' ' 148' ' ' SER . 68.1 tp60 -70.36 -75.4 0.12 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.94 0.4 . . . . 0.0 110.505 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.436 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.1 t -62.71 -39.11 93.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.211 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 56.0 tp -59.76 -45.69 91.47 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.417 -178.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.407 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 46.6 tp -62.7 -41.69 99.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.588 178.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.436 ' OG1' ' O ' ' A' ' 151' ' ' SER . 59.3 p -64.43 -35.02 79.57 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.145 -179.281 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.439 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.5 mm-40 -63.97 -42.79 97.14 Favored 'General case' 0 C--O 1.225 -0.196 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.391 179.351 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 91.8 mt -65.39 -38.74 90.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.17 0.509 . . . . 0.0 110.27 179.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.568 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.48 -32.17 80.19 Favored Glycine 0 C--N 1.331 0.295 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 -179.144 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.439 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.3 mt-10 -35.65 -27.0 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.826 0.346 . . . . 0.0 110.833 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.568 ' N ' ' O ' ' A' ' 157' ' ' GLY . 95.0 mt -55.65 150.26 2.61 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.333 178.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 77.5 p -69.67 137.24 51.99 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.049 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 70.36 22.24 77.57 Favored Glycine 0 N--CA 1.458 0.149 0 N-CA-C 111.266 -0.733 . . . . 0.0 111.266 179.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 57.8 m80 -123.15 -13.86 7.64 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.599 0.237 . . . . 0.0 110.481 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -66.68 -59.47 3.56 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.657 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -52.32 -49.42 64.29 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.196 -179.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -60.38 -41.29 93.47 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.819 0.342 . . . . 0.0 110.445 179.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.41 -47.23 86.75 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.509 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.79 -40.23 75.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.271 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -61.78 -50.09 73.76 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.626 179.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -65.27 -43.54 90.94 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.59 179.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 94.1 mt -64.79 -43.29 96.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.406 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.55 -51.33 69.91 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.339 -179.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -63.37 -44.01 95.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.869 0.366 . . . . 0.0 110.708 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . 0.485 ' CD1' ' OH ' ' A' ' 301' ' ' TYR . 54.8 t80 -63.08 -44.33 96.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.146 0.498 . . . . 0.0 110.394 179.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -63.71 -39.7 94.95 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.634 -179.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -63.12 -42.82 99.59 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.528 179.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -60.72 -44.54 96.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.209 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 85.0 mt -64.73 -41.08 96.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.764 178.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.34 -62.18 1.8 Allowed 'General case' 0 C--O 1.239 0.527 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.363 -179.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.41 -47.1 85.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.459 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -52.85 -41.73 64.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.381 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -63.87 -33.74 76.38 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.325 179.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 69.6 tt0 -90.76 9.0 31.79 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.6 0.714 . . . . 0.0 110.312 -178.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -104.94 -32.01 8.97 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.221 179.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.4 pt -128.0 147.61 32.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.79 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -140.06 131.34 26.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.986 0.422 . . . . 0.0 110.36 179.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.553 ' CD2' ' N ' ' A' ' 186' ' ' LEU . 3.5 mm? -85.66 133.38 41.94 Favored Pre-proline 0 N--CA 1.451 -0.403 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.177 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -43.79 157.96 0.12 Allowed 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.657 2.238 . . . . 0.0 112.374 179.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . 0.498 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.5 Cg_endo -62.89 114.72 2.54 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.829 2.353 . . . . 0.0 111.658 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . 0.498 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.7 mt-30 155.52 148.07 0.0 OUTLIER Pre-proline 0 N--CA 1.456 -0.145 0 O-C-N 124.208 0.942 . . . . 0.0 110.874 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -73.28 144.44 36.98 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.633 2.222 . . . . 0.0 112.282 177.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.488 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.1 p -124.74 158.95 31.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.449 0.643 . . . . 0.0 110.143 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' THR . . . . . 0.488 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 37.6 p -143.3 165.29 27.89 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.133 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -135.18 128.79 32.68 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-O 121.314 0.578 . . . . 0.0 110.173 179.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 47.3 pt -146.34 148.62 16.88 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.375 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.249 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 69.2 t -117.41 123.26 71.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 CA-C-O 121.36 0.6 . . . . 0.0 109.791 178.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -134.55 107.33 7.47 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 121.144 0.497 . . . . 0.0 110.254 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 94.8 m -130.92 130.67 43.77 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.855 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -82.65 -36.9 25.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.208 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.53 -67.2 0.25 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.318 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.58 -9.99 59.25 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.266 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 59.9 t-80 60.53 58.68 2.42 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.722 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 39.1 p -166.88 153.75 8.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.53 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.2 144.25 24.61 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.022 0.439 . . . . 0.0 110.457 179.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -135.05 137.13 42.62 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.548 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 19.4 mt -105.5 125.42 50.97 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.061 0.457 . . . . 0.0 109.867 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' TRP . . . . . 0.555 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 76.6 m95 -81.81 166.52 19.93 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.572 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -156.67 171.58 7.23 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.561 -178.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -54.01 -36.91 85.82 Favored 'Trans proline' 0 C--N 1.301 -1.965 0 C-N-CA 122.664 2.243 . . . . 0.0 112.397 178.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -70.66 -34.86 72.49 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.653 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 22.3 m -61.43 149.7 37.73 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.626 -179.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.58 -36.51 80.86 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.431 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . 0.555 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 55.3 tt0 -64.93 -40.5 95.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.53 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.27 -43.66 92.42 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -63.29 -43.06 98.95 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 64.9 ttp -59.25 -48.24 82.37 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 87.5 mt -60.53 -40.97 93.43 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . 0.448 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 40.7 tp10 -57.9 -38.11 75.23 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -65.19 -38.12 89.48 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.632 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 94.2 mt -64.16 -43.11 96.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.186 0.517 . . . . 0.0 110.529 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 138.27 45.38 0.08 OUTLIER Glycine 0 C--N 1.334 0.453 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . 0.448 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 27.2 m-85 -128.98 156.56 43.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.084 0.469 . . . . 0.0 110.463 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' THR . . . . . 0.451 ' O ' ' O ' ' A' ' 191' ' ' VAL . 7.7 p -108.66 123.22 48.64 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.311 0.577 . . . . 0.0 110.002 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . 0.439 ' CD2' ' N ' ' A' ' 223' ' ' LEU . 4.3 mm? -101.55 133.11 46.73 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.128 179.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -97.07 159.42 14.92 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.487 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -104.64 115.1 29.74 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.949 0.404 . . . . 0.0 110.375 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.448 ' CD1' ' N ' ' A' ' 226' ' ' LEU . 8.9 mp -53.48 156.62 4.19 Favored Pre-proline 0 N--CA 1.449 -0.495 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.827 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -59.75 145.04 99.23 Favored 'Trans proline' 0 C--N 1.299 -2.03 0 C-N-CA 122.726 2.284 . . . . 0.0 112.363 179.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.51 -2.72 58.81 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.51 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.37 -40.66 5.68 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.533 ' O ' ' N ' ' A' ' 233' ' ' SER . 69.4 mt -79.12 -17.2 55.5 Favored 'General case' 0 C--O 1.219 -0.505 0 CA-C-O 121.1 0.476 . . . . 0.0 110.261 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 54.5 t-20 -40.3 -48.77 2.69 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.751 0.31 . . . . 0.0 110.78 -179.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -88.36 15.45 7.75 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.433 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' SER . . . . . 0.533 ' N ' ' O ' ' A' ' 230' ' ' LEU . 77.7 p -60.78 -35.36 76.25 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.724 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . 0.521 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.6 tt0 -118.54 -69.62 0.84 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.864 179.312 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 3.9 m -70.54 103.06 2.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.702 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -94.67 58.29 2.3 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.052 0.453 . . . . 0.0 110.333 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -145.31 -122.63 1.53 Allowed Glycine 0 C--N 1.332 0.342 0 N-CA-C 110.964 -0.855 . . . . 0.0 110.964 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -133.78 111.98 10.97 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.101 0.477 . . . . 0.0 110.398 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . 0.505 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.1 mtt180 -148.42 56.93 1.05 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.742 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -69.37 -31.78 70.41 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.47 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . 0.455 ' OD2' ' O ' ' A' ' 144' ' ' TYR . 64.9 t0 -56.67 -47.01 80.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.291 -178.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' ILE . . . . . 0.44 ' O ' ' O ' ' A' ' 239' ' ' ARG . 17.3 tt -140.46 157.48 24.43 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 CA-C-O 120.91 0.386 . . . . 0.0 110.485 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 95.8 mt -105.93 106.3 20.32 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.219 0 CA-C-O 121.165 0.507 . . . . 0.0 110.425 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . 0.505 ' OE1' ' NH1' ' A' ' 239' ' ' ARG . 88.3 mt-30 -110.86 110.4 20.99 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.366 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 9.8 mp -121.78 -167.86 1.6 Allowed 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.627 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . 0.521 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 172.39 -16.04 0.05 OUTLIER Glycine 0 CA--C 1.524 0.596 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . 0.686 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -60.96 157.56 31.07 Favored Glycine 0 CA--C 1.521 0.463 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -63.86 20.87 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.941 0.401 . . . . 0.0 110.581 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . 0.686 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.9 m-20 -96.86 -5.84 37.3 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.528 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 92.5 mt -80.19 -21.45 42.96 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.839 179.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.63 -51.43 69.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.663 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.96 -5.21 58.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.465 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.03 -74.23 1.15 Allowed Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 82.0 mt -70.31 126.15 28.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.014 0.435 . . . . 0.0 110.172 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -59.97 -39.3 85.19 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.274 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 83.11 51.67 4.09 Favored Glycine 0 CA--C 1.519 0.3 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -95.15 -16.05 22.87 Favored 'General case' 0 C--N 1.331 -0.212 0 O-C-N 122.694 -0.297 . . . . 0.0 110.585 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 258' ' ' SER . . . . . 0.44 ' HG ' ' CG2' ' A' ' 191' ' ' VAL . 3.4 t 175.19 89.42 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.182 0.515 . . . . 0.0 110.053 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . 0.59 ' N ' ' CD1' ' A' ' 259' ' ' LEU . 1.0 OUTLIER -94.77 124.56 38.88 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.273 0.559 . . . . 0.0 111.253 -179.094 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 15.8 m-30 -93.95 146.65 23.77 Favored 'General case' 0 CA--C 1.497 -1.086 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.4 179.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 86.4 mt -122.32 149.54 43.6 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.573 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.654 ' CG ' ' N ' ' A' ' 263' ' ' ALA . 2.6 p90 -77.69 -138.91 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.506 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . 0.654 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -51.08 77.59 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 121.109 0.48 . . . . 0.0 111.303 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . 0.624 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.93 104.57 0.18 Allowed Glycine 0 CA--C 1.527 0.816 0 N-CA-C 110.466 -1.054 . . . . 0.0 110.466 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 265' ' ' ASP . . . . . 0.589 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.6 m-20 -80.06 -177.94 6.28 Favored 'General case' 0 C--N 1.327 -0.407 0 O-C-N 122.706 -0.291 . . . . 0.0 111.001 -179.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -40.44 -17.81 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.587 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . 0.589 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.0 -51.76 43.49 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.013 0.435 . . . . 0.0 110.684 179.125 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -63.68 -46.49 85.29 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.266 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . 0.521 ' O ' ' CD2' ' A' ' 273' ' ' TYR . . . -61.76 -34.81 76.53 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 121.543 0.687 . . . . 0.0 109.746 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -63.42 -34.23 77.3 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.076 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.51 -43.11 13.83 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.112 -179.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 272' ' ' ILE . . . . . 0.62 ' C ' ' H ' ' A' ' 274' ' ' ALA . 4.9 tt -51.44 -33.97 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.799 -178.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 273' ' ' TYR . . . . . 0.521 ' CD2' ' O ' ' A' ' 269' ' ' ALA . 16.9 m-85 -54.43 -2.03 0.03 OUTLIER 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.615 -179.289 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 274' ' ' ALA . . . . . 0.62 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.2 -39.63 71.66 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.868 179.434 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . 0.579 ' O ' ' N ' ' A' ' 279' ' ' ALA . 3.9 p30 -38.78 97.71 0.14 Allowed Pre-proline 0 N--CA 1.462 0.157 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.385 -179.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.7 -42.57 67.27 Favored 'Trans proline' 0 C--N 1.303 -1.865 0 C-N-CA 122.367 2.045 . . . . 0.0 112.506 -178.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 88.9 mt -64.43 -42.83 95.78 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.092 0.472 . . . . 0.0 111.225 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 91.9 mt -95.97 -1.08 49.8 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.954 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 279' ' ' ALA . . . . . 0.579 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.38 -34.83 77.47 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.683 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.22 20.16 0.11 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.982 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . 0.516 ' H ' ' C ' ' A' ' 279' ' ' ALA . 13.6 mt -74.67 119.39 76.43 Favored Pre-proline 0 N--CA 1.444 -0.731 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.834 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -49.87 -40.1 48.74 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.623 2.215 . . . . 0.0 112.327 178.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.86 -50.59 63.48 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.034 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 73.5 t -61.45 -43.85 97.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.096 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -57.64 -41.15 80.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.098 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -91.01 0.05 57.63 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.118 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt 59.94 43.67 14.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.048 0.452 . . . . 0.0 110.772 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -95.01 41.06 1.1 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.382 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 53.8 t -119.33 135.74 58.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-O 121.133 0.492 . . . . 0.0 110.033 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -133.47 163.62 28.98 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 121.236 0.541 . . . . 0.0 110.569 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.8 155.58 32.28 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 121.097 0.475 . . . . 0.0 110.645 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 82.1 mt -94.44 -1.56 53.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.232 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.03 165.38 12.66 Favored Glycine 0 N--CA 1.463 0.489 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 6.7 m -86.64 -61.59 1.7 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.849 0.356 . . . . 0.0 111.092 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 295' ' ' GLU . . . . . 0.488 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.6 mm-40 -69.53 -4.82 20.57 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.729 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 26.8 p -76.55 32.61 0.13 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.632 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 297' ' ' PHE . . . . . 0.488 ' H ' ' C ' ' A' ' 295' ' ' GLU . 67.1 t80 -60.4 -46.18 90.92 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.672 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . 0.616 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.2 mtt85 -80.32 136.93 36.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.657 -179.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -114.61 116.71 29.18 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.994 0.426 . . . . 0.0 110.533 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . 0.627 ' H ' ' HG ' ' A' ' 303' ' ' SER . 48.7 p-10 -167.21 -174.59 2.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.616 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 301' ' ' TYR . . . . . 0.485 ' OH ' ' CD1' ' A' ' 173' ' ' PHE . 80.4 t80 -48.13 -44.44 32.09 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.227 -179.465 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -65.51 -41.53 93.07 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.034 0.445 . . . . 0.0 110.662 178.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 303' ' ' SER . . . . . 0.627 ' HG ' ' H ' ' A' ' 300' ' ' ASP . 53.8 p -55.29 -36.29 65.99 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.952 -179.087 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -57.07 -52.09 66.66 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 91.7 mtp -55.96 -44.32 78.35 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -66.05 -42.87 88.96 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.172 0.51 . . . . 0.0 110.199 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 55.7 t -63.91 -43.03 97.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.245 179.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 42.4 tp -60.04 -41.98 93.47 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.803 -179.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -62.18 -39.16 91.76 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.211 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 310' ' ' ARG . . . . . 0.45 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.7 ttt85 -63.68 -43.91 95.26 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.227 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 89.4 mt -63.1 -42.08 99.5 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.364 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -63.06 -33.77 76.14 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.076 179.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.38 -23.56 22.16 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.346 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . 0.45 ' N ' ' O ' ' A' ' 310' ' ' ARG . 6.8 tt -62.35 -43.06 99.71 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 121.128 0.489 . . . . 0.0 110.56 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 . . . . . 0 C--O 1.22 -0.47 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.327 -179.831 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -99.67 136.29 39.82 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.04 0.448 . . . . 0.0 110.44 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.492 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -91.54 178.41 1.78 Allowed Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.584 -179.87 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.492 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.1 Cg_exo -61.72 147.66 94.82 Favored 'Trans proline' 0 C--N 1.3 -2.001 0 C-N-CA 122.882 2.388 . . . . 0.0 112.182 179.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 35.1 ptt180 -135.35 142.36 45.75 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.567 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -78.91 116.9 19.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.515 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.6 tp -110.35 131.0 62.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.478 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.9 t -70.81 142.41 51.3 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.62 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.424 ' OD1' ' O ' ' A' ' 141' ' ' ILE . 24.7 t70 -140.56 177.58 7.92 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.508 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.448 ' OG ' ' O ' ' A' ' 141' ' ' ILE . 77.9 p -73.81 -36.38 64.98 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.556 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 60.1 ttt85 -47.69 -95.22 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.409 -179.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.426 ' O ' ' OG1' ' A' ' 36' ' ' THR . . . -165.42 -25.51 0.02 OUTLIER Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' A' ' 35' ' ' GLY . 61.2 m -169.05 106.82 0.42 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.844 0.354 . . . . 0.0 110.63 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 33.2 t60 -129.61 144.57 51.33 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.022 0.439 . . . . 0.0 110.199 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.482 ' CG2' ' N ' ' A' ' 39' ' ' LEU . 96.9 m -128.63 166.5 18.77 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.455 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.482 ' N ' ' CG2' ' A' ' 38' ' ' THR . 80.7 mt -121.15 127.52 51.63 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.506 179.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -63.8 -44.4 93.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.709 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 39.6 p -165.84 154.95 11.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.439 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.454 ' N ' ' CD ' ' A' ' 42' ' ' GLN . 14.3 mp0 -43.07 100.64 0.23 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.574 179.433 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -56.94 128.99 32.16 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 122.492 2.128 . . . . 0.0 112.201 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -83.33 -24.35 32.15 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.587 179.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.538 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.5 mtm-85 -121.16 134.48 55.22 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.113 0.482 . . . . 0.0 110.276 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.2 mt -130.09 133.57 64.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.74 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 47.9 t -125.26 130.94 72.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.203 179.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.506 ' O ' ' O ' ' A' ' 66' ' ' ALA . 4.1 m -154.57 166.34 33.63 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.607 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 72.2 p -124.6 8.83 8.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.429 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.72 125.73 33.43 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.587 -179.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 87.8 t -65.68 -44.63 93.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.493 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 18.1 m -62.79 -44.16 96.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.616 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 53.0 tp -62.37 -41.63 98.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.53 -179.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 76.3 m -57.67 -44.74 85.96 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.329 -179.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.4 -62.4 5.14 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.5 t -47.52 -35.96 9.65 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.681 0.277 . . . . 0.0 110.279 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.7 mt -61.77 -44.34 97.08 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.087 179.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.4 HD12 ' N ' ' A' ' 58' ' ' LEU . 8.9 mp -65.39 -41.23 93.9 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.137 178.262 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.86 -41.25 97.81 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.78 -179.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 7.9 tp -88.1 16.77 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.843 -179.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 56.4 84.43 0.09 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.727 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 178.89 57.7 0.07 OUTLIER Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.269 -0.423 . . . . 0.0 109.951 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -51.09 153.83 8.51 Favored 'Trans proline' 0 C--N 1.296 -2.216 0 C-N-CA 123.035 2.49 . . . . 0.0 111.999 -177.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.428 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -109.33 146.15 15.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.366 -179.631 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.67 -45.44 97.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.15 -179.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.506 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -129.83 134.69 47.7 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.883 0.373 . . . . 0.0 110.522 -179.6 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.489 ' O ' ' N ' ' A' ' 98' ' ' LEU . 72.3 m -134.87 158.96 42.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.765 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.92 139.35 16.21 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.451 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.8 -162.67 0.08 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.876 0.369 . . . . 0.0 110.49 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.488 ' O ' ' C ' ' A' ' 71' ' ' THR . 5.8 t -133.76 135.82 44.16 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.256 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.488 ' C ' ' O ' ' A' ' 70' ' ' THR . 1.0 OUTLIER 29.51 68.73 0.64 Allowed Pre-proline 0 N--CA 1.464 0.26 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.74 -179.487 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -61.43 144.79 98.37 Favored 'Trans proline' 0 C--N 1.301 -1.93 0 C-N-CA 122.697 2.265 . . . . 0.0 111.815 -178.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.528 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 45.3 p-10 -160.08 -32.3 0.06 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.592 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.528 ' N ' ' OD1' ' A' ' 73' ' ' ASN . 99.0 m-20 -64.04 -39.51 94.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.358 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 73.2 ttt180 -60.18 -48.41 81.83 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.548 -179.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.426 ' O ' ' O ' ' A' ' 77' ' ' ALA . 94.9 t -59.82 -25.05 31.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.096 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.426 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -45.35 172.67 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.636 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.573 ' O ' ' N ' ' A' ' 80' ' ' GLN . 54.1 p30 -61.94 177.64 0.43 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.483 -179.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.598 ' C ' ' H ' ' A' ' 81' ' ' GLY . 34.4 p30 -46.28 85.58 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.957 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.573 ' N ' ' O ' ' A' ' 78' ' ' ASP . 42.9 tp60 -67.17 13.69 0.06 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.298 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.598 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 118.09 -21.98 9.94 Favored Glycine 0 CA--C 1.519 0.316 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -107.94 116.67 32.38 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.946 0.403 . . . . 0.0 110.469 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 75.4 mt -99.23 0.38 43.08 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.582 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -91.88 6.81 44.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.374 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.441 ' O ' ' CG2' ' A' ' 89' ' ' VAL . 88.0 mt-30 -100.03 -28.04 13.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.704 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 68.4 t-105 -63.43 -40.5 97.34 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.821 -179.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.552 ' O ' ' N ' ' A' ' 91' ' ' LYS . 67.9 m -77.75 -53.81 7.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.837 -179.276 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -48.25 -50.95 27.73 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.936 -179.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.441 ' CG2' ' O ' ' A' ' 85' ' ' GLN . 15.8 m -68.96 -40.44 81.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.992 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.413 ' H ' HG23 ' A' ' 89' ' ' VAL . . . -72.47 -22.6 61.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.624 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.552 ' N ' ' O ' ' A' ' 87' ' ' SER . 65.9 tttm -61.5 -45.95 92.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.429 -179.525 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.435 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.8 mm-40 -90.38 -94.48 0.12 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.251 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.624 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.9 mtt180 -143.34 59.58 1.4 Allowed 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.456 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.6 pttp 33.76 26.35 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.021 0.439 . . . . 0.0 110.388 -179.028 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.624 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.4 tt -48.09 123.07 5.78 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.912 -178.14 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -83.21 -170.68 3.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.224 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.624 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 82.9 mtp180 -73.01 137.67 45.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.329 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.489 ' N ' ' O ' ' A' ' 67' ' ' SER . 88.9 mt -86.41 -165.87 1.39 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.782 -179.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.533 ' CD2' ' O ' ' A' ' 99' ' ' TYR . 47.7 p90 -168.29 119.7 0.81 Allowed 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.23 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.507 ' C ' ' O ' ' A' ' 99' ' ' TYR . 42.8 mm -29.29 121.43 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.935 -179.781 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 113.6 28.05 3.36 Favored Glycine 0 CA--C 1.521 0.417 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 -179.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.581 ' N ' ' CD ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -143.96 46.11 0.62 Allowed Pre-proline 0 C--N 1.324 -0.521 0 CA-C-O 121.044 0.45 . . . . 0.0 110.479 179.874 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.581 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 29.8 Cg_endo -62.47 143.83 93.82 Favored 'Trans proline' 0 C--N 1.298 -2.13 0 C-N-CA 122.728 2.286 . . . . 0.0 111.834 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 26.2 t -173.14 120.68 0.36 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.435 179.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.4 -41.07 63.78 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.866 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -65.73 -39.95 91.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.744 -179.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.77 -39.56 94.55 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.681 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 71.3 t -67.78 -43.58 86.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.659 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.57 -39.28 93.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.491 -179.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.435 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.68 -23.9 63.49 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.508 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.562 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.3 mm-40 -91.32 5.11 50.54 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.658 -179.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.562 ' C ' ' O ' ' A' ' 111' ' ' GLN . 9.5 tpt 21.01 65.51 0.28 Allowed Pre-proline 0 N--CA 1.465 0.299 0 CA-C-O 121.042 0.449 . . . . 0.0 111.116 -179.575 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -79.92 170.03 17.18 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 123.018 2.479 . . . . 0.0 111.617 -178.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.52 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 98.9 m-20 -112.52 -44.25 3.38 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.182 179.464 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 39.4 tp -120.18 121.35 38.56 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.142 179.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 96.6 mt -118.61 131.29 71.83 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.851 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 32.2 mt -105.95 132.01 52.56 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.222 -179.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 98.3 mt -117.26 136.08 55.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.641 -179.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 85.0 p -71.68 151.85 43.31 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.559 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.26 -50.01 75.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.633 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -149.35 153.77 37.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.542 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 168.57 -169.32 41.58 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -63.13 -35.41 92.05 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.447 ' O ' ' OD1' ' A' ' 124' ' ' ASP . 44.2 p-10 -88.81 120.12 29.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.859 0.362 . . . . 0.0 110.643 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 40.6 t -63.35 144.62 56.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.467 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.518 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.92 -42.76 8.9 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.745 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.4 tp -62.79 -42.36 99.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.669 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.99 -10.59 54.74 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.483 -179.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 84.0 mt -115.73 -24.57 8.17 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.591 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . 0.518 ' N ' ' O ' ' A' ' 126' ' ' ALA . 74.3 t80 -50.77 -49.93 57.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.65 -179.109 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.3 p-10 -65.89 -41.91 90.92 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.827 0.346 . . . . 0.0 111.132 179.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.526 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 87.8 mt-30 -68.08 -36.72 80.29 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.804 -179.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 96.5 mt -80.09 -42.78 22.95 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.864 -179.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.402 ' N ' ' OG1' ' A' ' 139' ' ' THR . 11.5 t -56.76 -45.47 82.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.452 -179.337 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 20.0 m -62.38 -45.93 90.91 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.568 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 93.2 mt -62.19 -43.84 98.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.463 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -170.04 163.04 6.53 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.598 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -41.54 110.6 0.14 Allowed 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.629 2.219 . . . . 0.0 112.224 179.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' THR . . . . . 0.402 ' OG1' ' N ' ' A' ' 134' ' ' SER . 3.0 m -87.79 127.11 35.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.62 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 35.1 tp -119.24 139.42 51.91 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.36 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.448 ' O ' ' OG ' ' A' ' 33' ' ' SER . 79.7 mt -105.41 120.27 55.87 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.197 0 CA-C-O 121.1 0.476 . . . . 0.0 110.942 -179.161 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 94.7 mt -136.43 132.6 49.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.562 179.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.514 HD22 ' CG ' ' A' ' 241' ' ' ASP . 54.3 t30 -64.55 148.99 49.62 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.91 0.386 . . . . 0.0 110.475 179.299 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.453 ' O ' ' OD2' ' A' ' 241' ' ' ASP . 87.1 t80 -82.72 122.85 28.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.84 -179.333 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.442 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 91.6 m-20 55.01 69.67 0.71 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.753 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 49.3 p-10 -124.4 0.25 8.27 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.579 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -151.53 117.31 5.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.723 -179.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' SER . . . . . 0.519 ' HG ' ' H ' ' A' ' 150' ' ' GLN . 85.0 p -63.89 168.68 4.87 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.504 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.415 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.6 p-90 -51.21 -15.89 0.42 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.424 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . 0.519 ' H ' ' HG ' ' A' ' 148' ' ' SER . 68.4 tp60 -70.9 -75.46 0.12 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.526 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.453 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.3 t -62.66 -38.58 90.88 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.318 179.473 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 51.1 tp -59.98 -45.88 91.28 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.421 -178.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.415 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 45.2 tp -62.64 -41.61 99.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.581 178.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.453 ' OG1' ' O ' ' A' ' 151' ' ' SER . 59.3 p -63.9 -34.87 78.94 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.298 -179.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.494 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.4 mm-40 -63.56 -42.01 98.38 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.359 179.265 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 91.8 mt -65.6 -38.57 89.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.11 0.481 . . . . 0.0 110.341 178.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.568 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.58 -31.97 79.66 Favored Glycine 0 CA--C 1.52 0.399 0 N-CA-C 110.818 -0.913 . . . . 0.0 110.818 -179.393 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.494 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.3 mt-10 -36.99 -25.32 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.853 0.359 . . . . 0.0 110.772 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.568 ' N ' ' O ' ' A' ' 157' ' ' GLY . 92.9 mt -59.67 149.37 6.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.423 179.268 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 77.6 p -69.18 137.52 53.34 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.854 -179.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 70.54 22.26 77.81 Favored Glycine 0 CA--C 1.519 0.285 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 179.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 62.4 m80 -124.38 -14.12 6.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.715 0.293 . . . . 0.0 110.442 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -66.83 -59.87 3.16 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.579 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -51.3 -49.7 60.76 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.243 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -60.1 -41.13 91.86 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.474 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.5 -47.6 84.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.58 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.55 -40.07 74.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.331 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -61.67 -50.58 71.93 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.603 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -65.32 -43.66 90.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.572 179.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 94.3 mt -64.71 -43.15 96.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.432 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.27 -51.49 69.15 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.382 -179.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.51 -43.64 96.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.601 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . 0.52 ' CD1' ' OH ' ' A' ' 301' ' ' TYR . 55.9 t80 -62.94 -44.01 97.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.484 179.467 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -63.65 -39.72 95.05 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.403 -179.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -63.07 -42.83 99.74 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.537 179.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -60.46 -44.79 95.51 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.322 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 84.6 mt -64.65 -40.97 96.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.652 178.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.0 -62.5 1.59 Allowed 'General case' 0 C--O 1.237 0.438 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.357 -179.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.02 -47.27 83.55 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.51 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -52.65 -41.63 63.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.423 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -64.1 -33.2 75.23 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.361 179.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 69.5 tt0 -91.21 8.43 35.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.357 0.599 . . . . 0.0 110.423 -178.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -104.42 -32.26 9.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.037 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.4 pt -128.02 147.56 32.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.755 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -139.65 131.05 26.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.428 179.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.551 ' CD2' ' N ' ' A' ' 186' ' ' LEU . 3.6 mm? -85.4 133.0 43.21 Favored Pre-proline 0 N--CA 1.452 -0.337 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.933 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -43.61 157.68 0.12 Allowed 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.689 2.259 . . . . 0.0 112.302 179.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . 0.522 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.7 Cg_endo -62.81 114.93 2.63 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 122.805 2.337 . . . . 0.0 111.862 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . 0.522 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.7 mt-30 155.52 147.75 0.0 OUTLIER Pre-proline 0 N--CA 1.456 -0.145 0 O-C-N 123.83 0.706 . . . . 0.0 110.823 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -73.4 143.83 35.52 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.643 2.228 . . . . 0.0 112.266 177.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.493 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.1 p -124.5 159.05 31.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.245 0.545 . . . . 0.0 110.305 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' THR . . . . . 0.493 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 37.9 p -143.47 165.03 28.68 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.922 -179.477 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -135.36 128.73 32.2 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 121.159 0.504 . . . . 0.0 110.33 179.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 47.5 pt -146.73 148.95 16.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.993 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 76.2 t -117.35 123.02 71.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.173 0.511 . . . . 0.0 110.079 178.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -134.22 106.46 7.16 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.371 179.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 95.9 m -130.48 130.71 44.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.763 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.411 ' O ' ' N ' ' A' ' 201' ' ' HIS . . . -82.95 -36.79 24.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.285 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.31 -67.07 0.26 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.348 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.31 -9.66 58.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.357 179.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . 0.411 ' N ' ' O ' ' A' ' 198' ' ' ALA . 60.2 t-80 60.72 58.19 2.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.694 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 41.1 p -167.43 153.61 7.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.569 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.27 144.18 24.51 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.953 0.406 . . . . 0.0 110.509 179.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -135.29 138.25 43.29 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.632 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 18.4 mt -105.98 125.12 50.62 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.0 0.428 . . . . 0.0 110.033 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' TRP . . . . . 0.558 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 74.1 m95 -81.84 167.2 19.26 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.596 -179.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -157.18 171.15 7.83 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.64 -179.056 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -53.1 -37.2 79.13 Favored 'Trans proline' 0 C--N 1.302 -1.907 0 C-N-CA 122.73 2.286 . . . . 0.0 112.377 179.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -70.96 -34.98 71.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.657 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 22.1 m -61.03 150.74 32.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.595 -179.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.46 -36.89 81.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.509 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . 0.558 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 54.8 tt0 -64.72 -40.29 95.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.625 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.78 -43.35 91.91 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -62.8 -44.37 96.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.807 0.337 . . . . 0.0 110.319 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 65.1 ttp -59.08 -48.27 82.2 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.233 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 87.6 mt -60.01 -41.36 91.96 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 179.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . 0.45 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 40.4 tp10 -57.84 -38.13 75.1 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.205 179.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -65.45 -38.23 89.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.633 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 95.1 mt -64.15 -42.95 96.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.578 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.74 45.39 0.08 OUTLIER Glycine 0 CA--C 1.521 0.456 0 N-CA-C 110.991 -0.843 . . . . 0.0 110.991 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . 0.45 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 25.8 m-85 -128.21 155.63 44.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.972 0.415 . . . . 0.0 110.536 -179.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' THR . . . . . 0.454 ' O ' ' O ' ' A' ' 191' ' ' VAL . 7.8 p -107.07 122.4 46.4 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.16 0.505 . . . . 0.0 110.231 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . 0.441 ' CD2' ' N ' ' A' ' 223' ' ' LEU . 4.3 mm? -101.78 132.94 47.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.924 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.76 160.36 14.42 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.527 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.72 115.08 29.63 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.35 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.45 ' CD1' ' N ' ' A' ' 226' ' ' LEU . 9.0 mp -53.1 156.42 3.7 Favored Pre-proline 0 N--CA 1.452 -0.345 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.726 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -59.62 145.2 98.75 Favored 'Trans proline' 0 C--N 1.302 -1.917 0 C-N-CA 122.771 2.314 . . . . 0.0 112.33 179.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.3 -3.15 59.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.498 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.19 -41.08 5.63 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.519 ' O ' ' N ' ' A' ' 233' ' ' SER . 67.7 mt -79.05 -17.75 54.69 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-O 121.051 0.453 . . . . 0.0 110.427 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . 0.4 ' C ' ' O ' ' A' ' 230' ' ' LEU . 55.4 t-20 -40.05 -49.7 2.55 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.78 -179.496 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -87.67 15.19 7.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.096 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' SER . . . . . 0.519 ' N ' ' O ' ' A' ' 230' ' ' LEU . 78.0 p -60.24 -35.17 74.86 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.744 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . 0.522 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.6 tt0 -119.64 -69.4 0.85 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.765 179.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.0 m -69.7 101.88 1.77 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.614 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -93.67 57.73 2.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.413 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -144.56 -122.56 1.59 Allowed Glycine 0 CA--C 1.521 0.451 0 N-CA-C 110.906 -0.877 . . . . 0.0 110.906 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -135.4 111.21 9.38 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.017 0.436 . . . . 0.0 110.406 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . 0.527 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.6 mtt180 -147.79 58.27 1.11 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.678 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -69.6 -32.2 70.8 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.515 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . 0.514 ' CG ' HD22 ' A' ' 143' ' ' ASN . 64.7 t0 -56.9 -47.33 80.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.362 -179.208 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 242' ' ' ILE . . . . . 0.433 ' O ' ' O ' ' A' ' 239' ' ' ARG . 17.8 tt -139.61 155.98 25.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.503 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 96.2 mt -106.01 106.47 20.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-O 120.973 0.416 . . . . 0.0 110.496 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . 0.527 ' OE1' ' NH1' ' A' ' 239' ' ' ARG . 88.6 mt-30 -110.34 109.87 20.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.423 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 9.4 mp -121.63 -168.16 1.64 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.65 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . 0.522 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.85 -16.32 0.05 OUTLIER Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . 0.7 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -61.31 156.26 34.59 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -63.35 21.87 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.92 0.39 . . . . 0.0 110.622 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . 0.7 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.8 m-20 -97.32 -6.29 34.64 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.539 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 91.6 mt -79.58 -22.09 44.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.757 179.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.62 -51.65 69.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.645 -179.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.0 -5.6 58.42 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.52 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -80.98 -74.46 1.14 Allowed Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 81.2 mt -69.8 125.8 27.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.846 0.355 . . . . 0.0 110.38 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -59.24 -39.55 83.14 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.251 -179.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 83.32 51.73 4.03 Favored Glycine 0 CA--C 1.521 0.467 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -95.45 -15.57 22.87 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.715 0.293 . . . . 0.0 110.622 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 258' ' ' SER . . . . . 0.42 ' O ' ' O ' ' A' ' 192' ' ' THR . 3.5 t 174.59 89.0 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.07 0.462 . . . . 0.0 110.244 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . 0.595 ' N ' ' CD1' ' A' ' 259' ' ' LEU . 1.0 OUTLIER -94.21 124.04 37.98 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.127 0.489 . . . . 0.0 111.038 -178.92 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 16.0 m-30 -93.31 146.6 23.6 Favored 'General case' 0 CA--C 1.506 -0.722 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.481 179.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 85.4 mt -122.24 149.63 43.41 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.565 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.665 ' CG ' ' N ' ' A' ' 263' ' ' ALA . 2.6 p90 -77.56 -139.01 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.521 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . 0.665 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -51.29 77.44 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.997 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . 0.635 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.31 104.77 0.19 Allowed Glycine 0 CA--C 1.528 0.876 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 265' ' ' ASP . . . . . 0.6 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.7 m-20 -80.4 -177.77 6.33 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.701 0.286 . . . . 0.0 110.8 -179.363 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -40.25 -17.84 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.566 179.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . 0.6 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.45 -51.7 40.7 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.635 179.449 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -63.52 -46.59 85.36 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.279 179.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . 0.525 ' O ' ' CD2' ' A' ' 273' ' ' TYR . . . -61.78 -34.99 76.86 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.302 0.572 . . . . 0.0 109.95 179.602 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -63.31 -34.05 76.86 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.116 179.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.69 -43.41 13.42 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.928 -179.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 272' ' ' ILE . . . . . 0.62 ' C ' ' H ' ' A' ' 274' ' ' ALA . 4.9 tt -51.42 -33.58 14.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.667 -178.569 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 273' ' ' TYR . . . . . 0.525 ' CD2' ' O ' ' A' ' 269' ' ' ALA . 17.3 m-85 -54.65 -1.61 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.582 -179.558 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 274' ' ' ALA . . . . . 0.62 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.74 -39.7 69.87 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.811 179.512 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . 0.582 ' O ' ' N ' ' A' ' 279' ' ' ALA . 3.1 p30 -39.18 98.34 0.16 Allowed Pre-proline 0 N--CA 1.461 0.108 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.457 -179.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -54.59 -42.83 64.61 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 C-N-CA 122.519 2.146 . . . . 0.0 112.438 -178.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 89.1 mt -64.57 -42.88 95.37 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.024 -179.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 90.9 mt -95.77 -1.47 49.68 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.809 -179.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 279' ' ' ALA . . . . . 0.582 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.24 -34.89 77.37 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.703 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.46 20.35 0.12 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.876 -179.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . 0.514 ' H ' ' C ' ' A' ' 279' ' ' ALA . 13.9 mt -75.04 119.38 76.62 Favored Pre-proline 0 N--CA 1.45 -0.462 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.719 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -49.75 -40.36 47.53 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.719 2.279 . . . . 0.0 112.224 178.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.32 -50.83 61.5 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.263 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 78.6 t -61.28 -43.91 97.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.255 179.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -57.65 -41.21 80.98 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.261 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -91.0 0.13 57.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.313 179.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt 59.73 43.64 15.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.754 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -94.95 41.05 1.09 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.375 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 53.7 t -119.03 135.77 58.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 121.012 0.434 . . . . 0.0 110.203 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -133.07 163.35 29.45 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.638 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.8 155.34 32.74 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.657 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 79.5 mt -94.19 -1.66 53.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.312 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.37 165.79 12.73 Favored Glycine 0 CA--C 1.521 0.462 0 N-CA-C 110.658 -0.977 . . . . 0.0 110.658 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 7.1 m -87.76 -62.39 1.51 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.865 0.365 . . . . 0.0 110.91 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 295' ' ' GLU . . . . . 0.488 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.5 mm-40 -68.86 -4.24 15.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.657 -179.653 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 24.9 p -76.64 32.12 0.13 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.608 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 297' ' ' PHE . . . . . 0.488 ' H ' ' C ' ' A' ' 295' ' ' GLU . 70.4 t80 -60.42 -46.3 90.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.567 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . 0.624 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.2 mtt85 -80.74 134.42 35.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.594 -179.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 18.3 tp -113.13 116.43 29.84 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.325 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . 0.606 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.1 p-10 -164.7 -177.29 4.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.638 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 301' ' ' TYR . . . . . 0.52 ' OH ' ' CD1' ' A' ' 173' ' ' PHE . 81.1 t80 -46.16 -43.15 14.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.406 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -67.62 -40.13 84.68 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.991 0.424 . . . . 0.0 110.692 179.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 303' ' ' SER . . . . . 0.606 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 59.6 p -55.74 -36.73 67.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.26 -179.239 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -56.95 -52.27 65.9 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 179.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 92.7 mtp -54.92 -44.24 74.04 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -66.0 -42.86 89.18 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.066 0.46 . . . . 0.0 110.351 178.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 55.6 t -64.24 -42.81 96.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.286 179.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 42.9 tp -59.63 -41.94 91.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.052 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -62.57 -38.9 91.89 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.295 179.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 310' ' ' ARG . . . . . 0.448 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.7 ttt85 -63.64 -44.05 95.0 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.291 179.482 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 89.6 mt -63.14 -42.03 99.39 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.415 179.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.4 ttmt -63.09 -33.09 74.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.262 179.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -90.02 -23.31 21.52 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.402 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . 0.448 ' N ' ' O ' ' A' ' 310' ' ' ARG . 6.8 tt -62.24 -43.17 99.45 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.013 0.435 . . . . 0.0 110.603 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 . . . . . 0 C--O 1.22 -0.481 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.394 -179.924 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -99.09 135.75 40.04 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.5 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.491 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -92.11 178.45 1.7 Allowed Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.571 -179.882 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.491 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.7 Cg_exo -61.78 147.38 95.39 Favored 'Trans proline' 0 C--N 1.301 -1.929 0 C-N-CA 122.847 2.365 . . . . 0.0 112.161 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 35.2 ptt180 -135.53 141.94 45.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.628 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -79.64 116.31 19.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.498 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.401 ' O ' ' CG2' ' A' ' 30' ' ' ILE . 9.4 tp -110.69 130.1 64.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.553 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 8.8 t -70.35 141.37 52.26 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.646 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.509 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.3 t0 -139.0 179.42 6.51 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.516 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.509 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 77.9 p -74.26 -36.87 63.87 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.582 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 61.0 ttt85 -46.18 -94.65 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.454 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.498 ' C ' ' HG1' ' A' ' 36' ' ' THR . . . -167.3 -26.4 0.02 OUTLIER Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.966 -0.854 . . . . 0.0 110.966 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.498 ' HG1' ' C ' ' A' ' 35' ' ' GLY . 63.2 m -169.21 104.4 0.38 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.789 0.328 . . . . 0.0 110.639 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 74.5 t60 -128.38 148.85 50.72 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.012 0.434 . . . . 0.0 110.291 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.485 ' CG2' ' N ' ' A' ' 39' ' ' LEU . 98.1 m -131.1 166.25 21.49 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.474 -179.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.485 ' N ' ' CG2' ' A' ' 38' ' ' THR . 80.8 mt -121.06 127.45 51.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.53 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -64.94 -44.65 88.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.667 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 42.2 p -166.07 154.96 11.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.507 179.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.457 ' N ' ' CD ' ' A' ' 42' ' ' GLN . 15.2 mp0 -43.71 100.94 0.24 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.558 179.582 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.44 128.99 31.63 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 C-N-CA 122.546 2.164 . . . . 0.0 112.191 -179.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -83.73 -24.56 31.13 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.611 179.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.533 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.6 mtm-85 -122.2 134.43 54.71 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 121.15 0.5 . . . . 0.0 110.335 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.415 HD13 HG21 ' A' ' 46' ' ' ILE . 96.1 mt -130.9 134.08 62.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.639 -179.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 46.0 t -124.61 130.36 73.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.169 179.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.5 ' O ' ' O ' ' A' ' 66' ' ' ALA . 2.0 m -154.6 167.19 30.96 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.55 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 62.6 p -125.04 9.04 8.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.468 179.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.47 125.38 32.99 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.591 -179.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 96.0 t -65.59 -44.6 93.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.548 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.1 m -62.45 -44.35 96.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.664 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 47.8 tp -62.4 -41.37 98.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.573 -179.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 75.8 m -57.57 -44.74 85.54 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.329 -179.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -63.92 -63.03 4.7 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.5 t -47.24 -35.94 8.31 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.768 0.318 . . . . 0.0 110.411 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.5 mt -61.8 -44.63 96.49 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.041 179.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.7 mp -65.9 -41.08 91.94 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.042 178.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.55 -41.3 98.45 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.688 -179.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.1 tp -88.43 17.09 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.801 -179.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 56.28 84.51 0.08 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.731 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.52 59.01 0.09 OUTLIER Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.333 -0.394 . . . . 0.0 109.974 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -52.22 152.75 14.32 Favored 'Trans proline' 0 C--N 1.298 -2.126 0 C-N-CA 122.99 2.46 . . . . 0.0 112.011 -177.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.433 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.2 OUTLIER -108.94 145.63 15.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.379 -179.628 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.57 -45.5 97.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.038 -179.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.5 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -129.77 134.11 47.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.5 -179.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.499 ' O ' ' N ' ' A' ' 98' ' ' LEU . 74.6 m -134.61 158.76 43.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.782 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.79 139.1 16.11 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.459 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.73 -162.79 0.08 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.826 0.346 . . . . 0.0 110.506 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.49 ' O ' ' C ' ' A' ' 71' ' ' THR . 14.7 t -133.54 134.42 43.38 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.435 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.49 ' C ' ' O ' ' A' ' 70' ' ' THR . 0.6 OUTLIER 29.68 69.51 0.62 Allowed Pre-proline 0 N--CA 1.464 0.247 0 CA-C-O 120.94 0.4 . . . . 0.0 110.685 -179.711 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -61.99 146.08 96.45 Favored 'Trans proline' 0 C--N 1.301 -1.94 0 C-N-CA 122.767 2.311 . . . . 0.0 111.817 -178.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.534 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 45.0 p-10 -160.14 -31.67 0.06 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.658 179.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.534 ' N ' ' OD1' ' A' ' 73' ' ' ASN . 99.2 m-20 -64.71 -39.27 93.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.392 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -60.25 -48.83 80.08 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.494 -179.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.423 ' O ' ' O ' ' A' ' 77' ' ' ALA . 94.6 t -59.55 -25.14 30.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.185 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.423 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -45.67 172.87 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.59 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.579 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.7 p30 -62.07 177.93 0.42 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.51 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.597 ' C ' ' H ' ' A' ' 81' ' ' GLY . 35.4 p30 -45.48 85.42 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.887 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.579 ' N ' ' O ' ' A' ' 78' ' ' ASP . 41.8 tp60 -67.32 13.26 0.07 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.351 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.597 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 118.61 -22.35 9.4 Favored Glycine 0 CA--C 1.52 0.389 0 N-CA-C 110.914 -0.875 . . . . 0.0 110.914 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -107.89 116.22 31.55 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.862 0.363 . . . . 0.0 110.487 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 73.5 mt -98.42 -0.15 44.15 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.577 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -92.31 7.44 42.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.441 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.441 ' O ' ' CG2' ' A' ' 89' ' ' VAL . 88.1 mt-30 -100.31 -28.44 12.97 Favored 'General case' 0 C--O 1.224 -0.266 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.613 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 68.8 t-105 -63.31 -40.2 96.67 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.736 -179.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.557 ' O ' ' N ' ' A' ' 91' ' ' LYS . 62.3 m -78.1 -54.01 6.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.791 -179.203 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -48.02 -50.76 26.66 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.861 -179.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.441 ' CG2' ' O ' ' A' ' 85' ' ' GLN . 16.0 m -69.15 -40.33 80.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.914 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.412 ' H ' HG23 ' A' ' 89' ' ' VAL . . . -72.86 -22.37 60.79 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.612 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.557 ' N ' ' O ' ' A' ' 87' ' ' SER . 65.9 tttm -62.28 -45.41 93.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.372 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.44 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.9 mm-40 -90.38 -94.78 0.12 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.265 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.632 ' O ' ' N ' ' A' ' 95' ' ' LEU . 96.0 mtt180 -143.04 58.6 1.41 Allowed 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.093 179.704 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.457 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.7 pttp 33.68 26.09 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 121.062 0.458 . . . . 0.0 110.487 -178.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.632 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.3 tt -47.95 123.04 5.62 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.834 -178.13 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -83.2 -170.45 3.05 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.366 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.606 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 81.5 mtp180 -73.91 137.07 43.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.342 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.499 ' N ' ' O ' ' A' ' 67' ' ' SER . 90.6 mt -86.02 -165.63 1.3 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.784 -179.601 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.539 ' CD2' ' O ' ' A' ' 99' ' ' TYR . 48.6 p90 -169.02 119.81 0.73 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.27 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.515 ' C ' ' O ' ' A' ' 99' ' ' TYR . 42.5 mm -28.77 121.24 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.896 -179.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 114.2 27.24 3.48 Favored Glycine 0 CA--C 1.521 0.462 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 -179.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.577 ' N ' ' CD ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -144.39 46.39 0.62 Allowed Pre-proline 0 C--N 1.324 -0.508 0 CA-C-O 121.097 0.475 . . . . 0.0 110.482 179.966 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 28.8 Cg_endo -62.14 143.89 95.16 Favored 'Trans proline' 0 C--N 1.298 -2.096 0 C-N-CA 122.728 2.285 . . . . 0.0 111.894 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.701 ' HG ' ' H ' ' A' ' 107' ' ' ALA . 25.5 t -173.27 120.34 0.34 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.443 179.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -74.13 -40.16 62.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.903 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.42 -39.89 89.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.685 -179.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.701 ' H ' ' HG ' ' A' ' 104' ' ' SER . . . -64.22 -39.96 95.05 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.645 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 70.2 t -67.85 -43.57 86.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.674 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.99 -38.94 93.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.479 -179.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.44 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.46 -23.14 62.47 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.541 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.552 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.3 mm-40 -90.99 5.68 47.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.628 -179.487 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.552 ' C ' ' O ' ' A' ' 111' ' ' GLN . 10.0 tpt 22.77 65.1 0.35 Allowed Pre-proline 0 N--CA 1.465 0.296 0 CA-C-O 120.985 0.422 . . . . 0.0 110.978 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -79.33 167.69 21.04 Favored 'Trans proline' 0 C--N 1.307 -1.605 0 C-N-CA 123.008 2.472 . . . . 0.0 111.694 -178.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.525 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 99.0 m-20 -110.01 -41.89 4.35 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.286 179.414 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.0 tp -121.54 120.05 33.73 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.306 179.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 82.7 mt -112.66 128.81 69.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.829 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 26.9 mt -108.42 132.41 53.8 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.442 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 98.9 mt -120.1 138.52 50.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.587 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 85.6 p -72.42 154.14 41.04 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.608 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.2 -50.36 73.98 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.627 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.0 t -149.75 154.21 38.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.53 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 170.47 -170.71 43.24 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.91 -33.95 88.52 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.454 ' O ' ' OD1' ' A' ' 124' ' ' ASP . 44.6 p-10 -87.43 120.08 28.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.835 0.35 . . . . 0.0 110.655 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 38.3 t -62.95 143.93 57.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.475 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.521 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.14 -43.27 8.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.785 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 56.4 tp -62.99 -42.21 99.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.681 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.81 -11.82 59.34 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.489 -179.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 83.6 mt -114.73 -24.61 8.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.528 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . 0.521 ' N ' ' O ' ' A' ' 126' ' ' ALA . 78.2 t80 -50.03 -50.17 48.49 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.613 -179.039 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.502 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 37.7 p-10 -66.07 -42.9 88.79 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.928 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.502 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 88.4 mt-30 -67.08 -37.49 84.08 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.733 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 95.9 mt -80.63 -41.42 23.89 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.768 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.4 t -56.35 -44.96 80.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.366 -179.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.7 m -61.87 -45.19 94.84 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.539 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 94.6 mt -61.92 -43.71 97.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.392 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.79 167.98 4.82 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.674 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -49.14 112.68 0.7 Allowed 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.52 2.146 . . . . 0.0 112.349 179.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 24.1 m -83.7 127.29 33.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.612 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 34.2 tp -118.01 135.49 54.13 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.318 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.438 ' O ' ' OD2' ' A' ' 32' ' ' ASP . 82.5 mt -99.85 119.06 47.38 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 CA-C-O 121.016 0.436 . . . . 0.0 110.795 -178.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 97.8 mt -135.1 132.68 53.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.54 179.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.504 HD22 ' CG ' ' A' ' 241' ' ' ASP . 61.1 t30 -67.26 153.44 43.67 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.475 179.478 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.512 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 88.8 t80 -87.67 121.83 30.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.697 -179.46 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.512 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 99.1 m-20 55.27 69.55 0.72 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.588 179.545 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.413 ' N ' ' OD1' ' A' ' 146' ' ' ASP . 34.5 p-10 -125.02 -0.06 7.88 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.595 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -151.08 115.72 5.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.623 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' SER . . . . . 0.522 ' HG ' ' H ' ' A' ' 150' ' ' GLN . 83.2 p -62.91 167.99 4.29 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.574 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.416 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.4 p-90 -51.65 -15.93 0.55 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.406 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . 0.522 ' H ' ' HG ' ' A' ' 148' ' ' SER . 68.0 tp60 -70.47 -75.59 0.12 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.884 0.373 . . . . 0.0 110.615 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.442 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.1 t -62.87 -38.55 91.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.399 179.389 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 53.7 tp -59.73 -46.05 90.31 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.537 -178.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.416 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 47.9 tp -62.69 -41.47 99.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.656 179.017 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.442 ' OG1' ' O ' ' A' ' 151' ' ' SER . 60.8 p -64.13 -35.18 79.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.328 -179.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.442 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.7 mm-40 -63.98 -42.72 97.13 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.54 179.285 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 92.2 mt -65.66 -38.49 89.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.468 178.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.579 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.59 -31.99 79.76 Favored Glycine 0 CA--C 1.52 0.371 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 -179.369 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.442 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.1 mt-10 -35.14 -27.65 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.875 0.369 . . . . 0.0 110.806 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.579 ' N ' ' O ' ' A' ' 157' ' ' GLY . 93.9 mt -55.28 150.43 2.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.46 179.13 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 70.5 p -70.39 137.15 50.23 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.781 -179.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 72.01 19.33 78.31 Favored Glycine 0 CA--C 1.519 0.337 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 179.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 57.3 m80 -120.56 -15.0 8.57 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.71 0.29 . . . . 0.0 110.494 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -65.24 -60.58 2.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.572 -179.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -51.15 -50.28 59.24 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.259 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -60.11 -41.36 92.43 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.54 179.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.29 -47.59 85.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.485 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.41 -40.41 74.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.401 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -61.68 -50.39 72.67 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.605 179.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -65.17 -43.72 90.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.577 179.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 94.6 mt -64.89 -43.18 96.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.497 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.14 -51.63 68.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.367 -179.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.08 -43.84 97.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.644 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . 0.474 ' CD1' ' OH ' ' A' ' 301' ' ' TYR . 56.2 t80 -63.27 -43.87 96.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.452 179.492 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -63.67 -39.88 95.44 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.501 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -63.25 -42.77 99.23 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.545 179.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -60.32 -44.77 95.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.422 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 83.5 mt -64.93 -40.78 95.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.711 178.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -51.86 -62.67 1.49 Allowed 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.391 -179.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.37 -47.35 84.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.461 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -52.65 -41.98 64.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.474 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -63.91 -33.48 75.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.352 179.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . 0.4 ' O ' ' HG2' ' A' ' 182' ' ' GLU . 69.2 tt0 -90.7 8.92 32.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.319 0.581 . . . . 0.0 110.393 -178.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -105.29 -31.92 8.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.85 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.5 pt -128.16 147.47 32.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.649 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -139.91 131.15 26.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.489 179.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.551 ' CD2' ' N ' ' A' ' 186' ' ' LEU . 3.6 mm? -85.68 132.67 43.68 Favored Pre-proline 0 N--CA 1.453 -0.325 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.922 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -43.6 157.57 0.12 Allowed 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.729 2.286 . . . . 0.0 112.389 179.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . 0.52 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.9 Cg_endo -62.9 114.99 2.66 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 C-N-CA 122.83 2.353 . . . . 0.0 111.908 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . 0.52 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.7 mt-30 156.0 147.28 0.0 OUTLIER Pre-proline 0 C--O 1.231 0.099 0 O-C-N 123.794 0.684 . . . . 0.0 110.692 -179.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.37 143.37 34.87 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.657 2.238 . . . . 0.0 112.272 177.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.498 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.1 p -124.52 159.34 30.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.164 0.507 . . . . 0.0 110.372 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' THR . . . . . 0.498 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 36.2 p -143.65 165.16 28.41 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.85 -179.35 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -135.28 128.72 32.36 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 121.167 0.508 . . . . 0.0 110.407 179.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 47.7 pt -146.45 148.43 17.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.961 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 71.7 t -117.19 122.84 70.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.082 0.468 . . . . 0.0 110.218 178.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -134.08 107.31 7.67 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.377 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 95.1 m -131.01 130.44 43.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.742 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.405 ' O ' ' N ' ' A' ' 201' ' ' HIS . . . -82.78 -36.91 25.23 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.399 179.638 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.07 -67.36 0.24 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.433 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.25 -9.91 59.08 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.47 179.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . 0.405 ' N ' ' O ' ' A' ' 198' ' ' ALA . 60.0 t-80 60.95 58.53 2.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.681 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 37.1 p -167.29 153.5 7.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.609 179.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.47 144.43 24.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.942 0.401 . . . . 0.0 110.47 179.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -135.33 138.08 43.05 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.608 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 19.0 mt -105.85 125.3 50.83 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.933 0.397 . . . . 0.0 110.194 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' TRP . . . . . 0.558 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 75.9 m95 -82.3 167.3 18.72 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.515 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -156.94 170.94 8.11 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.588 -179.024 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -53.23 -36.92 79.64 Favored 'Trans proline' 0 C--N 1.302 -1.892 0 C-N-CA 122.77 2.313 . . . . 0.0 112.378 178.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -71.13 -34.51 71.1 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.56 -179.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 22.3 m -61.64 150.61 35.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.624 -179.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.39 -36.94 81.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.456 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . 0.558 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 54.5 tt0 -64.74 -40.05 94.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.567 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.94 -43.37 91.51 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.734 -0.947 . . . . 0.0 110.734 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -63.04 -43.93 97.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.839 0.352 . . . . 0.0 110.385 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 65.1 ttp -59.02 -48.63 80.91 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.297 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 89.9 mt -59.65 -41.32 90.27 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 121.01 0.434 . . . . 0.0 110.01 179.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . 0.456 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 40.3 tp10 -57.37 -38.14 73.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.317 179.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -65.52 -37.78 87.75 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.605 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 95.5 mt -64.31 -42.76 96.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.725 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.58 44.53 0.08 OUTLIER Glycine 0 CA--C 1.521 0.466 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . 0.456 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 25.8 m-85 -127.49 155.33 43.92 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.944 0.402 . . . . 0.0 110.524 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' THR . . . . . 0.457 ' O ' ' O ' ' A' ' 191' ' ' VAL . 6.3 p -106.97 121.98 45.54 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.152 0.501 . . . . 0.0 110.242 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . 0.446 ' CD2' ' N ' ' A' ' 223' ' ' LEU . 4.3 mm? -100.9 133.32 45.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.989 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.98 158.92 15.19 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.506 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.05 115.29 30.03 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.516 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.449 ' CD1' ' N ' ' A' ' 226' ' ' LEU . 9.0 mp -53.56 156.29 4.63 Favored Pre-proline 0 N--CA 1.452 -0.35 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.71 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -59.69 145.31 98.49 Favored 'Trans proline' 0 C--N 1.302 -1.871 0 C-N-CA 122.795 2.33 . . . . 0.0 112.295 179.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.42 -2.91 58.95 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.556 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.31 -40.93 5.63 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.537 ' O ' ' N ' ' A' ' 233' ' ' SER . 84.3 mt -79.2 -16.88 55.87 Favored 'General case' 0 C--O 1.224 -0.267 0 CA-C-O 120.983 0.421 . . . . 0.0 110.449 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . 0.404 ' C ' ' O ' ' A' ' 230' ' ' LEU . 55.1 t-20 -39.5 -49.63 2.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.679 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -88.58 15.58 7.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.009 -179.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 233' ' ' SER . . . . . 0.537 ' N ' ' O ' ' A' ' 230' ' ' LEU . 77.8 p -60.46 -35.47 75.95 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.653 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . 0.526 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.6 tt0 -118.46 -69.49 0.85 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.706 179.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.2 m -69.91 103.71 2.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.592 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -94.73 57.41 2.17 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.439 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -144.85 -122.57 1.57 Allowed Glycine 0 CA--C 1.521 0.441 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -134.46 111.89 10.49 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.002 0.43 . . . . 0.0 110.384 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . 0.515 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.4 mtt180 -148.33 57.75 1.07 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.678 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -69.97 -31.69 69.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.494 179.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . 0.504 ' CG ' HD22 ' A' ' 143' ' ' ASN . 65.6 t0 -56.54 -47.13 80.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.365 -179.205 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 242' ' ' ILE . . . . . 0.437 ' O ' ' O ' ' A' ' 239' ' ' ARG . 17.3 tt -140.49 157.49 24.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.493 179.73 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 96.0 mt -105.92 105.88 19.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.575 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . 0.515 ' OE1' ' NH1' ' A' ' 239' ' ' ARG . 88.0 mt-30 -110.06 109.98 20.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.416 179.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 9.4 mp -121.95 -168.13 1.66 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.66 179.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . 0.526 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.27 -16.79 0.05 OUTLIER Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . 0.693 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -60.43 157.01 29.67 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -63.79 21.51 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.86 0.362 . . . . 0.0 110.553 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . 0.693 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.7 m-20 -97.29 -6.1 35.18 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.497 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 92.6 mt -79.81 -21.52 44.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.784 179.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.61 -51.53 69.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.563 -179.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.31 -5.34 58.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.532 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.22 -74.34 1.15 Allowed Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.934 -0.866 . . . . 0.0 110.934 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 80.1 mt -69.95 125.75 27.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.809 0.338 . . . . 0.0 110.445 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -59.09 -39.52 82.44 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.281 -179.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 82.52 51.97 4.13 Favored Glycine 0 CA--C 1.521 0.442 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -96.21 -14.81 22.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.717 0.294 . . . . 0.0 110.665 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 258' ' ' SER . . . . . 0.423 ' O ' ' O ' ' A' ' 192' ' ' THR . 3.5 t 174.71 88.27 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.047 0.451 . . . . 0.0 110.321 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . 0.595 ' N ' ' CD1' ' A' ' 259' ' ' LEU . 1.0 OUTLIER -93.97 123.7 37.51 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.014 0.435 . . . . 0.0 110.992 -178.819 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 15.8 m-30 -92.74 146.35 23.72 Favored 'General case' 0 CA--C 1.508 -0.672 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.532 179.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 86.0 mt -122.36 149.56 43.61 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.6 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.661 ' CG ' ' N ' ' A' ' 263' ' ' ALA . 2.7 p90 -77.23 -138.34 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.632 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . 0.661 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -52.27 77.29 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.003 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . 0.625 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -178.93 104.54 0.19 Allowed Glycine 0 CA--C 1.527 0.829 0 N-CA-C 110.644 -0.982 . . . . 0.0 110.644 179.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 265' ' ' ASP . . . . . 0.6 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.9 m-20 -79.98 -178.04 6.29 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.648 0.261 . . . . 0.0 110.781 -179.407 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -40.48 -17.52 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.521 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . 0.6 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.47 -51.66 41.01 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.682 179.284 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -63.64 -46.81 83.99 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.198 179.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . 0.526 ' O ' ' CD2' ' A' ' 273' ' ' TYR . . . -61.57 -34.87 76.34 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.291 0.567 . . . . 0.0 110.058 179.611 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -63.17 -34.11 76.92 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.273 179.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.69 -43.68 13.2 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.793 -179.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 272' ' ' ILE . . . . . 0.617 ' C ' ' H ' ' A' ' 274' ' ' ALA . 4.9 tt -51.37 -33.44 14.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.579 -178.441 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 273' ' ' TYR . . . . . 0.526 ' CD2' ' O ' ' A' ' 269' ' ' ALA . 17.5 m-85 -54.76 -1.41 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.567 -179.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 274' ' ' ALA . . . . . 0.617 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.71 -39.74 69.95 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.755 179.448 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . 0.582 ' O ' ' N ' ' A' ' 279' ' ' ALA . 2.9 p30 -39.35 98.42 0.17 Allowed Pre-proline 0 C--N 1.335 -0.055 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.458 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -54.56 -43.01 62.94 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 C-N-CA 122.621 2.214 . . . . 0.0 112.344 -178.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 88.5 mt -64.48 -42.98 95.55 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.871 -179.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 91.0 mt -95.67 -1.68 49.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.839 -179.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 279' ' ' ALA . . . . . 0.582 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.36 -34.65 77.09 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.626 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.8 m80 -74.78 20.41 0.13 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.785 -178.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . 0.51 ' H ' ' C ' ' A' ' 279' ' ' ALA . 14.0 mt -75.25 119.45 77.02 Favored Pre-proline 0 N--CA 1.449 -0.492 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.783 179.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -49.47 -40.18 45.04 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.681 2.254 . . . . 0.0 112.33 178.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -51.97 -51.06 59.75 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.283 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 78.1 t -61.2 -43.87 97.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.248 179.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -57.99 -41.43 82.99 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.268 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -90.59 0.05 57.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.322 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt 59.52 42.87 16.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.742 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -94.38 41.58 1.09 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.463 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 53.8 t -118.97 135.84 58.1 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-O 120.974 0.416 . . . . 0.0 110.205 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -132.99 162.65 31.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.564 -179.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.64 155.31 32.56 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.613 -179.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 79.6 mt -93.95 -1.71 54.26 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.373 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.33 165.81 12.75 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 -179.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 7.1 m -87.51 -62.61 1.46 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.841 0.353 . . . . 0.0 110.75 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 295' ' ' GLU . . . . . 0.468 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.6 mm-40 -69.46 -3.89 16.37 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.597 -179.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 27.6 p -77.06 33.4 0.15 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.664 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 297' ' ' PHE . . . . . 0.468 ' H ' ' C ' ' A' ' 295' ' ' GLU . 84.8 t80 -60.33 -46.03 91.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.522 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . 0.606 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.3 mtt85 -81.48 133.85 35.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.552 -179.712 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 15.8 tp -114.13 119.38 36.91 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.392 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . 0.606 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.0 p-10 -167.48 -174.19 2.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.629 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 301' ' ' TYR . . . . . 0.474 ' OH ' ' CD1' ' A' ' 173' ' ' PHE . 85.1 t80 -47.62 -46.04 28.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.357 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -64.92 -41.58 95.42 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 120.959 0.409 . . . . 0.0 110.6 179.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 303' ' ' SER . . . . . 0.606 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 52.3 p -55.11 -36.47 65.75 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.206 -179.342 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -56.43 -52.4 64.8 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.079 179.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 93.2 mtp -54.64 -44.81 73.54 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -65.93 -42.88 89.52 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.082 0.468 . . . . 0.0 110.39 178.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 55.4 t -64.2 -42.61 96.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.378 179.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 43.1 tp -59.49 -41.96 91.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.186 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -62.97 -38.7 92.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.188 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 310' ' ' ARG . . . . . 0.44 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.6 ttt85 -63.38 -44.15 95.57 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.306 179.517 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 88.8 mt -63.07 -42.0 99.55 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.498 179.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.3 ttmt -63.0 -32.63 74.03 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.374 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -90.42 -23.25 21.09 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.442 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . 0.44 ' N ' ' O ' ' A' ' 310' ' ' ARG . 6.8 tt -62.25 -43.16 99.45 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.528 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 . . . . . 0 C--O 1.22 -0.48 0 CA-C-O 118.005 -0.998 . . . . 0.0 110.426 -179.897 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -99.54 137.11 38.49 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.009 0.433 . . . . 0.0 110.502 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.496 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -92.01 178.5 1.69 Allowed Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.578 -179.881 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.496 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.3 Cg_exo -61.73 147.54 95.08 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 C-N-CA 122.827 2.351 . . . . 0.0 112.201 179.648 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 35.0 ptt180 -134.35 141.76 47.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.696 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -79.2 116.58 19.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.504 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.5 tp -110.57 130.79 63.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.444 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 13.0 t -71.08 142.14 50.84 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.02 0.438 . . . . 0.0 110.582 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.43 ' CG ' ' H ' ' A' ' 33' ' ' SER . 25.3 t70 -139.57 177.73 7.72 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.535 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.452 ' OG ' ' O ' ' A' ' 141' ' ' ILE . 78.0 p -73.93 -36.23 64.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.717 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -48.1 -95.25 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.275 -179.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.42 ' O ' ' OG1' ' A' ' 36' ' ' THR . . . -164.6 -26.26 0.02 OUTLIER Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.42 ' OG1' ' O ' ' A' ' 35' ' ' GLY . 64.6 m -168.76 106.93 0.45 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.878 0.37 . . . . 0.0 110.699 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 36.4 t60 -129.54 144.98 51.5 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.113 0.482 . . . . 0.0 110.185 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.487 ' CG2' ' N ' ' A' ' 39' ' ' LEU . 98.9 m -129.31 166.27 19.81 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.519 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.487 ' N ' ' CG2' ' A' ' 38' ' ' THR . 80.8 mt -120.72 127.93 52.46 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.503 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -64.62 -44.56 90.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.719 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 39.1 p -165.33 154.47 12.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.398 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.46 ' N ' ' CD ' ' A' ' 42' ' ' GLN . 13.8 mp0 -42.55 100.18 0.22 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.602 179.357 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -56.73 129.23 33.5 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 122.382 2.054 . . . . 0.0 112.224 -179.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -84.25 -23.72 30.28 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.486 179.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.541 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.4 mtm-85 -121.18 134.24 55.21 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 121.138 0.494 . . . . 0.0 110.251 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.0 mt -130.5 133.2 64.03 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.254 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.857 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 48.5 t -124.8 130.83 73.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 179.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.506 ' O ' ' O ' ' A' ' 66' ' ' ALA . 4.9 m -154.7 166.28 33.92 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.54 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 71.9 p -124.53 8.47 8.34 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.455 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.38 126.07 33.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.611 -179.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 92.2 t -66.06 -44.58 91.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.6 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.1 m -62.65 -44.19 96.9 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.699 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 52.6 tp -62.39 -41.66 98.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.58 -179.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 77.4 m -57.34 -44.39 84.24 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.399 -179.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.79 -61.73 5.62 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 179.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.6 t -48.62 -35.53 13.86 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.8 mt -61.82 -44.41 96.91 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.18 179.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.3 mp -65.22 -41.36 94.53 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.247 177.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.79 -40.98 97.97 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.954 -179.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.2 tp -88.54 16.93 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.816 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 56.36 84.3 0.09 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.763 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.25 57.63 0.07 OUTLIER Pre-proline 0 C--N 1.328 -0.368 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -50.58 153.35 7.89 Favored 'Trans proline' 0 C--N 1.295 -2.272 0 C-N-CA 122.866 2.377 . . . . 0.0 112.314 -178.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.435 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -109.17 145.8 15.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.329 -179.661 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 97.1 mt -63.7 -45.34 97.64 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.409 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.506 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -129.5 134.58 47.86 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.857 0.361 . . . . 0.0 110.564 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.476 ' O ' ' N ' ' A' ' 98' ' ' LEU . 73.1 m -134.93 159.2 42.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.829 -179.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -87.67 139.36 15.84 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.438 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -175.65 -163.66 0.12 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.957 0.408 . . . . 0.0 110.504 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.424 ' O ' ' C ' ' A' ' 71' ' ' THR . 15.3 t -133.02 131.82 41.12 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.415 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.424 ' C ' ' O ' ' A' ' 70' ' ' THR . 11.9 p 36.88 71.53 0.94 Allowed Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.523 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_exo -60.92 144.17 99.51 Favored 'Trans proline' 0 C--N 1.302 -1.918 0 C-N-CA 122.491 2.127 . . . . 0.0 112.116 -178.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.533 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 44.6 p-10 -165.0 -34.67 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.678 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.533 ' N ' ' OD1' ' A' ' 73' ' ' ASN . 99.1 m-20 -63.94 -39.39 94.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.452 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -60.86 -47.73 85.02 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.655 -179.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.432 ' O ' ' O ' ' A' ' 77' ' ' ALA . 94.9 t -59.95 -24.48 29.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.432 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -44.77 171.64 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.63 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.575 ' O ' ' N ' ' A' ' 80' ' ' GLN . 54.0 p30 -62.19 178.41 0.39 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.638 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.594 ' C ' ' H ' ' A' ' 81' ' ' GLY . 36.2 p30 -46.96 85.4 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.952 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.575 ' N ' ' O ' ' A' ' 78' ' ' ASP . 43.2 tp60 -67.57 14.1 0.06 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.159 0.504 . . . . 0.0 110.187 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.594 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 117.87 -21.62 10.28 Favored Glycine 0 C--N 1.332 0.313 0 N-CA-C 110.841 -0.903 . . . . 0.0 110.841 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -107.91 116.63 32.31 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.971 0.415 . . . . 0.0 110.487 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 74.1 mt -98.98 0.72 44.52 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.447 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -92.03 6.46 46.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.962 0.411 . . . . 0.0 110.396 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.449 ' O ' ' CG2' ' A' ' 89' ' ' VAL . 88.3 mt-30 -99.9 -27.46 13.59 Favored 'General case' 0 C--O 1.223 -0.341 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.811 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.0 t-105 -64.1 -40.51 96.38 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.052 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.554 ' O ' ' N ' ' A' ' 91' ' ' LYS . 70.7 m -77.86 -53.71 7.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.163 -179.495 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -48.51 -50.68 30.84 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.016 -179.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.449 ' CG2' ' O ' ' A' ' 85' ' ' GLN . 14.8 m -68.88 -40.75 81.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 120.937 0.399 . . . . 0.0 111.081 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.411 ' H ' HG23 ' A' ' 89' ' ' VAL . . . -72.29 -22.43 61.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.649 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.554 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.0 tttm -61.6 -45.85 92.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.516 -179.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.437 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.6 mm-40 -90.7 -94.23 0.12 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.198 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.625 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.9 mtt180 -143.77 60.11 1.38 Allowed 'General case' 0 C--O 1.235 0.308 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.457 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.6 pttp 33.6 26.44 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 120.933 0.396 . . . . 0.0 110.25 -179.287 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.625 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.4 tt -47.97 123.28 5.97 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.958 -178.094 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -83.64 -170.6 3.14 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.084 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.628 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 82.0 mtp180 -73.34 137.6 44.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.213 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.476 ' N ' ' O ' ' A' ' 67' ' ' SER . 89.7 mt -86.99 -165.38 1.27 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.727 -179.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.532 ' CD2' ' O ' ' A' ' 99' ' ' TYR . 48.5 p90 -168.82 120.22 0.76 Allowed 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.189 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.504 ' C ' ' O ' ' A' ' 99' ' ' TYR . 43.3 mm -29.42 121.6 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.029 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 114.07 27.87 3.3 Favored Glycine 0 CA--C 1.518 0.253 0 N-CA-C 111.224 -0.751 . . . . 0.0 111.224 -179.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.579 ' N ' ' CD ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -144.14 46.08 0.61 Allowed Pre-proline 0 C--N 1.323 -0.55 0 O-C-N 122.502 -0.411 . . . . 0.0 110.464 179.84 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 30.1 Cg_endo -62.14 143.83 95.08 Favored 'Trans proline' 0 C--N 1.296 -2.226 0 C-N-CA 122.686 2.257 . . . . 0.0 111.908 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.707 ' HG ' ' H ' ' A' ' 107' ' ' ALA . 26.5 t -173.42 120.82 0.34 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.398 179.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.37 -41.03 63.9 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.1 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -65.84 -39.83 91.18 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.846 -179.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.707 ' H ' ' HG ' ' A' ' 104' ' ' SER . . . -63.84 -39.76 94.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.713 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 69.4 t -67.55 -43.84 86.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.705 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.42 -39.29 92.81 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.524 -179.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.437 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.61 -23.87 63.34 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.495 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.555 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.2 mm-40 -91.38 5.15 50.45 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.674 -179.553 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.555 ' C ' ' O ' ' A' ' 111' ' ' GLN . 10.4 tpt 21.65 64.85 0.31 Allowed Pre-proline 0 N--CA 1.466 0.349 0 CA-C-O 120.882 0.372 . . . . 0.0 111.137 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -79.12 169.69 18.79 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 122.993 2.462 . . . . 0.0 111.902 -178.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.525 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 99.0 m-20 -112.84 -43.52 3.42 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.102 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 39.7 tp -120.83 119.9 34.03 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 95.7 mt -117.16 130.85 71.39 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 CA-C-O 120.944 0.402 . . . . 0.0 110.892 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 33.1 mt -105.67 132.73 51.45 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.263 -179.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 98.1 mt -118.15 135.73 57.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.733 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 87.0 p -71.65 153.27 42.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.567 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.31 -50.03 75.24 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.679 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.0 t -149.55 154.01 38.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.505 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 169.36 -170.11 42.39 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -63.02 -35.13 91.67 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.443 ' O ' ' OD1' ' A' ' 124' ' ' ASP . 43.9 p-10 -88.3 119.42 28.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.783 0.325 . . . . 0.0 110.65 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 41.2 t -63.3 144.53 56.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.987 0.422 . . . . 0.0 110.507 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.521 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.65 -42.66 9.06 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.857 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.7 tp -62.79 -42.34 99.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.697 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.01 -10.99 57.99 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.499 -179.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 84.4 mt -115.44 -24.18 8.49 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.683 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . 0.521 ' N ' ' O ' ' A' ' 126' ' ' ALA . 77.1 t80 -51.54 -49.54 61.78 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.566 -178.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.6 p-10 -65.89 -41.81 91.05 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.255 179.451 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.524 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 88.0 mt-30 -67.84 -37.07 81.41 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.87 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 94.5 mt -79.95 -42.35 24.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.944 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.2 t -57.1 -44.91 83.66 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.294 -179.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.4 m -62.18 -45.74 92.05 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.631 179.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 92.7 mt -62.61 -43.98 98.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.377 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.67 164.26 6.58 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.524 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -43.48 111.88 0.27 Allowed 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.49 2.127 . . . . 0.0 112.195 179.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 16.8 m -86.16 127.7 34.76 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.633 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 35.3 tp -120.32 137.69 54.12 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.089 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.452 ' O ' ' OG ' ' A' ' 33' ' ' SER . 80.5 mt -105.32 121.17 57.1 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.336 0 CA-C-O 121.204 0.526 . . . . 0.0 111.196 -179.489 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 97.9 mt -136.02 132.61 50.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.593 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.544 ' OD1' ' N ' ' A' ' 144' ' ' TYR . 60.7 t-20 -64.52 147.36 52.96 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.893 0.378 . . . . 0.0 110.307 179.425 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.544 ' N ' ' OD1' ' A' ' 143' ' ' ASN . 87.1 t80 -82.35 122.1 27.55 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.996 -179.615 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.515 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 98.9 m-20 55.27 69.21 0.76 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.847 179.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 33.7 p-10 -125.15 0.57 7.84 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.891 0.377 . . . . 0.0 110.667 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -151.29 117.48 5.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.773 -179.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' SER . . . . . 0.512 ' HG ' ' H ' ' A' ' 150' ' ' GLN . 87.4 p -64.6 168.89 5.44 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.489 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.412 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.4 p-90 -51.2 -15.37 0.35 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.498 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . 0.512 ' H ' ' HG ' ' A' ' 148' ' ' SER . 67.8 tp60 -71.71 -75.15 0.14 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.398 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.455 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.0 t -62.72 -38.85 92.09 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.244 179.461 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 52.9 tp -60.12 -45.59 92.49 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.307 -178.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.412 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 46.2 tp -62.64 -41.78 99.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.914 0.388 . . . . 0.0 110.508 178.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.455 ' OG1' ' O ' ' A' ' 151' ' ' SER . 57.4 p -64.04 -34.65 78.49 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.201 -179.443 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.468 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.5 mm-40 -63.87 -42.39 97.54 Favored 'General case' 0 C--O 1.227 -0.131 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.22 179.345 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 91.7 mt -65.43 -38.76 90.85 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.066 0.46 . . . . 0.0 110.151 179.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.572 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.47 -31.49 77.69 Favored Glycine 0 CA--C 1.52 0.388 0 N-CA-C 110.771 -0.931 . . . . 0.0 110.771 -179.297 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.468 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.4 mt-10 -37.32 -24.57 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.894 0.378 . . . . 0.0 110.837 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.572 ' N ' ' O ' ' A' ' 157' ' ' GLY . 96.0 mt -59.82 148.53 7.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.312 179.321 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 74.8 p -69.05 137.28 53.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.951 -179.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 71.73 20.93 78.92 Favored Glycine 0 CA--C 1.517 0.159 0 N-CA-C 111.206 -0.757 . . . . 0.0 111.206 179.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 58.9 m80 -123.59 -14.33 7.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.717 0.294 . . . . 0.0 110.581 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -65.29 -60.2 3.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.71 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -52.21 -49.14 64.51 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.145 -179.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -59.88 -41.21 91.06 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.739 0.304 . . . . 0.0 110.28 179.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.55 -46.7 88.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.561 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -57.62 -39.75 77.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.178 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -61.79 -50.11 73.67 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.609 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -65.38 -43.81 89.53 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.531 179.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 94.3 mt -64.55 -43.38 96.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.369 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.56 -51.21 70.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.461 -179.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.43 -43.96 95.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.485 179.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . 0.494 ' CD1' ' OH ' ' A' ' 301' ' ' TYR . 56.3 t80 -62.69 -44.33 96.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.062 0.458 . . . . 0.0 110.37 179.375 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -63.26 -39.6 95.05 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.528 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -63.17 -43.02 99.44 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.615 179.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -60.64 -44.79 95.96 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.195 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 84.3 mt -64.56 -40.96 96.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.995 0.426 . . . . 0.0 110.691 178.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -51.56 -62.9 1.33 Allowed 'General case' 0 C--O 1.238 0.458 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.37 -179.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.34 -47.0 85.17 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.59 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.0 -41.68 64.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.233 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -64.04 -33.31 75.46 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.05 0.452 . . . . 0.0 110.347 179.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 70.1 tt0 -91.21 8.4 35.97 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.436 0.636 . . . . 0.0 110.426 -178.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -103.99 -32.33 9.28 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.205 179.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.6 pt -128.04 147.65 32.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.814 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -140.1 131.36 26.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.442 179.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.55 ' CD2' ' N ' ' A' ' 186' ' ' LEU . 3.6 mm? -85.4 132.64 44.32 Favored Pre-proline 0 N--CA 1.453 -0.321 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.904 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -43.87 157.87 0.13 Allowed 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.686 2.257 . . . . 0.0 112.27 179.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . 0.52 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 26.6 Cg_endo -62.42 115.3 2.8 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 C-N-CA 122.818 2.345 . . . . 0.0 111.759 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . 0.52 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 0.4 OUTLIER 155.4 147.57 0.0 OUTLIER Pre-proline 0 N--CA 1.456 -0.156 0 O-C-N 123.777 0.673 . . . . 0.0 110.758 -179.88 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -73.78 143.59 33.72 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.653 2.235 . . . . 0.0 112.017 177.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.489 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.1 p -124.91 158.7 32.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.347 0.594 . . . . 0.0 110.137 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' THR . . . . . 0.489 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 40.1 p -143.1 164.87 28.97 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.07 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -135.29 128.52 31.96 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.227 0.537 . . . . 0.0 110.223 179.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 47.9 pt -147.44 150.3 14.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.04 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . 0.404 ' CG1' ' CD1' ' A' ' 262' ' ' PHE . 74.6 t -118.31 123.43 71.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-O 121.298 0.57 . . . . 0.0 109.793 179.128 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -134.68 106.91 7.18 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.254 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 95.9 m -131.32 131.35 43.7 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.838 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.406 ' O ' ' N ' ' A' ' 201' ' ' HIS . . . -83.03 -37.14 24.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.308 179.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.39 -66.92 0.27 Allowed 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.402 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.25 -10.22 59.5 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.379 179.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . 0.406 ' N ' ' O ' ' A' ' 198' ' ' ALA . 59.6 t-80 60.89 57.69 2.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.673 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 36.2 p -166.64 152.84 8.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.623 179.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -150.47 143.37 24.7 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.003 0.43 . . . . 0.0 110.452 179.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -134.87 137.68 43.45 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.598 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 16.6 mt -106.42 125.7 51.33 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.122 0.487 . . . . 0.0 109.841 -179.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' TRP . . . . . 0.556 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 74.1 m95 -82.08 167.35 18.89 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.58 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -157.26 171.06 7.94 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.64 -179.181 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -53.08 -37.19 79.0 Favored 'Trans proline' 0 C--N 1.302 -1.873 0 C-N-CA 122.649 2.233 . . . . 0.0 112.163 179.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -70.89 -35.41 72.31 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.774 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 20.0 m -60.49 150.97 29.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.603 -179.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.65 -37.28 83.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.535 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . 0.556 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 55.0 tt0 -64.68 -40.28 95.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.52 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.66 -43.44 91.99 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 110.744 -0.943 . . . . 0.0 110.744 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -63.16 -44.39 95.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.807 0.337 . . . . 0.0 110.307 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 65.3 ttp -59.27 -48.01 83.23 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.145 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 86.0 mt -60.49 -40.83 92.74 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . 0.451 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.4 tp10 -58.38 -37.76 75.91 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -65.31 -38.24 89.59 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.8 0.333 . . . . 0.0 110.652 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 94.0 mt -64.25 -42.92 96.29 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.509 -179.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.79 44.83 0.08 OUTLIER Glycine 0 C--N 1.333 0.405 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . 0.451 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 26.3 m-85 -127.66 154.78 44.88 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.053 0.454 . . . . 0.0 110.497 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' THR . . . . . 0.453 ' O ' ' O ' ' A' ' 191' ' ' VAL . 7.6 p -106.33 122.16 45.68 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.209 0.528 . . . . 0.0 110.147 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . 0.44 ' CD2' ' N ' ' A' ' 223' ' ' LEU . 4.3 mm? -101.6 133.07 46.85 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.023 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.44 159.41 14.96 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.49 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.14 114.99 29.52 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.962 0.411 . . . . 0.0 110.31 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.451 ' CD1' ' N ' ' A' ' 226' ' ' LEU . 9.0 mp -53.03 156.54 3.5 Favored Pre-proline 0 N--CA 1.453 -0.319 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.69 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -60.02 145.32 98.67 Favored 'Trans proline' 0 C--N 1.301 -1.944 0 C-N-CA 122.673 2.249 . . . . 0.0 112.167 179.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -86.89 -3.36 59.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.578 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.69 -40.65 5.58 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.503 ' O ' ' N ' ' A' ' 233' ' ' SER . 65.5 mt -79.53 -18.43 51.87 Favored 'General case' 0 C--O 1.222 -0.389 0 CA-C-O 121.125 0.488 . . . . 0.0 110.365 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -40.76 -49.18 3.1 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.773 -179.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -87.04 15.09 6.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.269 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 233' ' ' SER . . . . . 0.503 ' N ' ' O ' ' A' ' 230' ' ' LEU . 77.6 p -59.74 -34.58 73.14 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.59 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . 0.529 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.5 tt0 -121.73 -68.99 0.86 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.813 179.386 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.3 m -66.31 102.91 0.91 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.559 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -93.83 54.25 1.94 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.415 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -142.84 -122.16 1.7 Allowed Glycine 0 CA--C 1.521 0.434 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -139.01 113.75 9.17 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.018 0.437 . . . . 0.0 110.328 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . 0.529 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.8 mtt180 -147.73 60.31 1.14 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.716 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -68.94 -34.12 74.83 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.518 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . 0.454 ' OD2' ' ND2' ' A' ' 143' ' ' ASN . 48.2 t0 -56.79 -47.58 79.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.378 -179.151 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 242' ' ' ILE . . . . . 0.433 ' O ' ' O ' ' A' ' 239' ' ' ARG . 18.9 tt -138.45 153.79 26.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.909 0.385 . . . . 0.0 110.459 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 96.4 mt -106.38 107.55 22.98 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.224 0 CA-C-O 121.095 0.474 . . . . 0.0 110.445 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . 0.529 ' OE1' ' NH1' ' A' ' 239' ' ' ARG . 88.3 mt-30 -111.85 111.03 21.69 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.46 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 9.8 mp -121.21 -168.34 1.66 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.571 179.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . 0.529 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 176.67 -17.42 0.04 OUTLIER Glycine 0 CA--C 1.524 0.602 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . 0.71 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -62.29 154.55 41.09 Favored Glycine 0 CA--C 1.521 0.442 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -62.62 22.3 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.924 0.392 . . . . 0.0 110.644 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . 0.71 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.9 m-20 -96.64 -6.33 36.89 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.49 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 99.0 mt -80.34 -22.55 41.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.705 179.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.65 -51.17 71.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.84 -179.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.24 -4.94 58.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.429 179.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.41 -73.89 1.17 Allowed Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 82.8 mt -70.16 126.64 30.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.018 0.437 . . . . 0.0 110.253 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -59.51 -39.06 82.62 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.392 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 83.3 51.72 4.03 Favored Glycine 0 CA--C 1.521 0.46 0 N-CA-C 110.752 -0.939 . . . . 0.0 110.752 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -95.6 -15.15 22.97 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.687 0.28 . . . . 0.0 110.633 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 258' ' ' SER . . . . . 0.429 ' O ' ' O ' ' A' ' 192' ' ' THR . 3.3 t 174.26 88.91 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.065 0.459 . . . . 0.0 110.086 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . 0.593 ' N ' ' CD1' ' A' ' 259' ' ' LEU . 1.0 OUTLIER -94.3 124.3 38.24 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.276 0.56 . . . . 0.0 111.187 -179.156 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 15.9 m-30 -93.0 146.52 23.56 Favored 'General case' 0 CA--C 1.505 -0.781 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.465 179.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 85.1 mt -122.08 149.85 42.97 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.534 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.659 ' CG ' ' N ' ' A' ' 263' ' ' ALA . 2.6 p90 -77.7 -139.35 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.436 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . 0.659 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -51.34 77.66 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.123 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . 0.632 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.36 104.82 0.19 Allowed Glycine 0 CA--C 1.527 0.83 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 265' ' ' ASP . . . . . 0.598 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.6 m-20 -80.38 -177.67 6.28 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.769 0.318 . . . . 0.0 110.861 -179.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -40.45 -17.83 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.539 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . 0.598 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.47 -51.63 41.37 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.007 0.432 . . . . 0.0 110.7 179.448 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -63.67 -46.48 85.39 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.259 179.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . 0.524 ' O ' ' CD2' ' A' ' 273' ' ' TYR . . . -61.77 -35.16 77.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.202 0.525 . . . . 0.0 109.732 179.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -63.02 -34.56 77.83 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.113 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.47 -43.27 13.73 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.192 -179.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 272' ' ' ILE . . . . . 0.619 ' C ' ' H ' ' A' ' 274' ' ' ALA . 4.8 tt -51.21 -33.47 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.83 -178.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 273' ' ' TYR . . . . . 0.524 ' CD2' ' O ' ' A' ' 269' ' ' ALA . 17.1 m-85 -54.7 -1.53 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.603 -179.583 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 274' ' ' ALA . . . . . 0.619 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.79 -39.65 69.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.917 179.543 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . 0.58 ' O ' ' N ' ' A' ' 279' ' ' ALA . 3.5 p30 -39.21 97.91 0.15 Allowed Pre-proline 0 N--CA 1.462 0.128 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.55 -179.694 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -54.25 -42.9 63.42 Favored 'Trans proline' 0 C--N 1.304 -1.812 0 C-N-CA 122.32 2.013 . . . . 0.0 112.682 -178.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 89.0 mt -64.43 -42.83 95.79 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.208 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 90.6 mt -95.79 -1.35 49.86 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.883 -179.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 279' ' ' ALA . . . . . 0.58 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.28 -34.73 77.13 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.71 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.14 19.91 0.12 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.99 -179.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . 0.514 ' H ' ' C ' ' A' ' 279' ' ' ALA . 13.7 mt -75.07 119.85 78.88 Favored Pre-proline 0 N--CA 1.451 -0.424 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.58 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -50.64 -39.71 56.13 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.612 2.208 . . . . 0.0 112.035 178.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.76 -50.44 63.49 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.103 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 73.6 t -61.47 -43.85 97.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 179.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -57.95 -41.26 82.48 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.159 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -90.84 0.05 57.58 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.154 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt 59.56 43.23 16.22 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.86 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -94.83 41.49 1.09 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.346 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 54.2 t -118.85 135.72 58.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 121.062 0.458 . . . . 0.0 110.172 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -132.74 162.45 31.4 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.111 0.481 . . . . 0.0 110.606 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.43 154.51 33.59 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.021 0.439 . . . . 0.0 110.681 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 80.9 mt -93.66 -1.69 54.94 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.24 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.83 165.72 12.64 Favored Glycine 0 CA--C 1.522 0.475 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 6.8 m -87.61 -61.9 1.62 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.902 0.382 . . . . 0.0 111.065 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 295' ' ' GLU . . . . . 0.487 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.5 mm-40 -69.22 -4.35 17.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.677 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 26.1 p -76.29 32.43 0.12 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.666 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 297' ' ' PHE . . . . . 0.487 ' H ' ' C ' ' A' ' 295' ' ' GLU . 85.0 t80 -60.56 -46.18 91.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.579 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . 0.628 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.1 mtt85 -81.78 133.65 35.36 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 121.049 0.452 . . . . 0.0 110.54 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 16.8 tp -113.16 118.64 35.27 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-O 120.994 0.426 . . . . 0.0 110.161 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . 0.606 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.4 p-10 -165.81 -176.01 3.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.592 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 301' ' ' TYR . . . . . 0.494 ' OH ' ' CD1' ' A' ' 173' ' ' PHE . 83.5 t80 -47.3 -44.06 23.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.275 -179.645 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -66.45 -40.64 89.54 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.035 0.445 . . . . 0.0 110.827 179.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 303' ' ' SER . . . . . 0.606 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 57.6 p -55.58 -36.21 66.63 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.111 -179.19 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -56.98 -51.67 68.28 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 91.0 mtp -56.26 -43.83 79.14 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -66.3 -42.45 88.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.037 0.446 . . . . 0.0 110.18 178.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 56.1 t -64.1 -42.93 97.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.209 179.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 42.3 tp -59.74 -42.12 92.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.863 -179.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -62.68 -38.82 91.87 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.08 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 310' ' ' ARG . . . . . 0.441 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.7 ttt85 -63.63 -43.73 95.99 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.308 179.554 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 89.3 mt -63.09 -42.22 99.57 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.25 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt -62.85 -33.36 75.1 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.075 179.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.44 -23.68 22.06 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.401 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . 0.441 ' N ' ' O ' ' A' ' 310' ' ' ARG . 6.7 tt -62.26 -43.28 99.2 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 121.068 0.461 . . . . 0.0 110.578 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 . . . . . 0 C--O 1.22 -0.479 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.404 -179.894 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -99.64 135.89 40.39 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.056 0.455 . . . . 0.0 110.476 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.497 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -91.94 178.51 1.7 Allowed Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.586 -179.846 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.497 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.4 Cg_exo -61.6 147.32 95.66 Favored 'Trans proline' 0 C--N 1.299 -2.076 0 C-N-CA 122.802 2.335 . . . . 0.0 112.147 179.568 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 35.7 ptt180 -136.03 142.3 44.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.645 179.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -79.6 116.79 20.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.501 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.5 tp -111.35 130.75 64.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.465 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 13.8 t -70.93 142.36 51.09 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.606 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.515 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.4 t0 -139.85 179.53 6.54 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.526 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.515 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 78.0 p -73.71 -37.12 65.25 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.64 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.7 ttt85 -46.49 -94.56 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.293 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.423 ' O ' ' OG1' ' A' ' 36' ' ' THR . . . -167.22 -26.32 0.02 OUTLIER Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.931 -0.867 . . . . 0.0 110.931 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.423 ' OG1' ' O ' ' A' ' 35' ' ' GLY . 60.9 m -169.25 105.02 0.38 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.891 0.377 . . . . 0.0 110.665 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 74.7 t60 -128.5 149.44 50.59 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.116 0.484 . . . . 0.0 110.227 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.484 ' CG2' ' N ' ' A' ' 39' ' ' LEU . 98.5 m -131.75 165.88 22.77 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.583 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.484 ' N ' ' CG2' ' A' ' 38' ' ' THR . 81.6 mt -120.8 127.31 51.82 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.497 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -64.95 -44.43 89.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.721 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.4 ' O ' ' HD3' ' A' ' 43' ' ' PRO . 39.7 p -165.81 155.08 11.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.492 179.581 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.456 ' N ' ' CD ' ' A' ' 42' ' ' GLN . 14.9 mp0 -44.22 100.96 0.24 Allowed Pre-proline 0 C--N 1.329 -0.287 0 O-C-N 123.364 0.415 . . . . 0.0 110.621 179.362 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.4 ' HD3' ' O ' ' A' ' 41' ' ' SER . 31.6 Cg_exo -57.26 129.37 33.79 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 122.337 2.024 . . . . 0.0 112.271 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -83.98 -24.81 30.45 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.501 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.538 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.3 mtm-85 -121.86 134.37 54.88 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.199 0.523 . . . . 0.0 110.321 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.2 mt -130.6 133.46 63.49 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.3 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.952 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 44.9 t -124.18 130.33 73.77 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.502 ' O ' ' O ' ' A' ' 66' ' ' ALA . 2.1 m -155.48 167.65 29.69 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.523 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 66.8 p -124.45 10.31 8.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.454 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -86.02 124.78 32.85 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.723 -179.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 98.9 t -65.57 -44.55 93.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.398 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.4 m -62.49 -44.18 97.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.627 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 52.3 tp -62.02 -41.54 98.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.514 -179.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 71.2 m -57.67 -44.44 85.72 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.192 -179.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.24 -62.09 5.46 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 179.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.7 t -48.61 -35.51 13.78 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 20.0 mt -61.82 -44.48 96.75 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.675 -0.41 . . . . 0.0 111.284 179.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.3 mp -64.96 -41.61 95.33 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.42 177.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.84 -40.48 96.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.003 -179.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 7.9 tp -89.07 16.49 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.836 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 56.48 85.08 0.08 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.733 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 178.49 58.21 0.07 OUTLIER Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.901 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -50.97 153.1 9.23 Favored 'Trans proline' 0 C--N 1.294 -2.323 0 C-N-CA 122.935 2.423 . . . . 0.0 112.329 -178.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.432 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -108.3 145.37 15.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.318 -179.736 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.69 -45.18 98.09 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.303 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.403 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.502 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -129.83 134.03 47.3 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.504 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.502 ' O ' ' N ' ' A' ' 98' ' ' LEU . 75.4 m -134.48 158.5 43.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.824 -179.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.59 139.03 16.2 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.46 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.79 -162.86 0.08 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.014 0.435 . . . . 0.0 110.465 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.488 ' O ' ' C ' ' A' ' 71' ' ' THR . 14.9 t -133.61 134.5 43.31 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.357 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.488 ' C ' ' O ' ' A' ' 70' ' ' THR . 0.7 OUTLIER 29.62 68.71 0.65 Allowed Pre-proline 0 N--CA 1.464 0.266 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.787 -179.879 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -61.3 145.42 98.41 Favored 'Trans proline' 0 C--N 1.299 -2.077 0 C-N-CA 122.654 2.236 . . . . 0.0 111.969 -178.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.53 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 45.3 p-10 -158.9 -32.29 0.07 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.701 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.53 ' N ' ' OD1' ' A' ' 73' ' ' ASN . 99.1 m-20 -64.03 -39.71 94.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.459 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -60.39 -48.1 83.2 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.704 -179.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.424 ' O ' ' O ' ' A' ' 77' ' ' ALA . 92.7 t -60.48 -25.03 33.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.424 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -45.66 173.04 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.601 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.575 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.6 p30 -62.05 177.86 0.42 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.533 -179.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.596 ' C ' ' H ' ' A' ' 81' ' ' GLY . 36.5 p30 -45.01 85.73 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.994 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.575 ' N ' ' O ' ' A' ' 78' ' ' ASP . 42.7 tp60 -67.36 13.21 0.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.119 0.485 . . . . 0.0 110.116 -179.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.596 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 118.23 -22.29 9.7 Favored Glycine 0 C--N 1.332 0.317 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -108.18 116.18 31.49 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.956 0.407 . . . . 0.0 110.471 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 77.8 mt -98.56 0.58 45.23 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.941 0.401 . . . . 0.0 110.484 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -92.33 7.03 44.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.024 0.44 . . . . 0.0 110.435 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.433 ' O ' ' CG2' ' A' ' 89' ' ' VAL . 88.0 mt-30 -100.2 -27.87 13.3 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.787 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 68.5 t-105 -62.71 -40.91 98.64 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.935 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.552 ' O ' ' N ' ' A' ' 91' ' ' LYS . 68.8 m -77.55 -53.2 7.89 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.164 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -48.79 -50.9 32.03 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.015 -179.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.433 ' CG2' ' O ' ' A' ' 85' ' ' GLN . 15.7 m -68.75 -40.74 81.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 120.88 0.371 . . . . 0.0 111.074 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.417 ' H ' HG23 ' A' ' 89' ' ' VAL . . . -71.99 -23.11 61.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.75 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.552 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.0 tttm -61.6 -45.63 93.29 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.504 -179.537 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.445 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.8 mm-40 -90.46 -95.17 0.12 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.101 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.63 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.8 mtt180 -142.81 59.46 1.43 Allowed 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.458 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.7 pttp 33.55 26.27 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 120.906 0.384 . . . . 0.0 110.132 -179.303 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.63 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.5 tt -48.5 123.23 6.35 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.006 -177.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -83.95 -169.2 2.46 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.06 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.602 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 81.3 mtp180 -74.85 136.86 41.53 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.266 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.502 ' N ' ' O ' ' A' ' 67' ' ' SER . 91.5 mt -85.77 -165.93 1.38 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.718 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.537 ' CD2' ' O ' ' A' ' 99' ' ' TYR . 48.3 p90 -168.2 119.85 0.83 Allowed 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.198 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.511 ' C ' ' O ' ' A' ' 99' ' ' TYR . 42.4 mm -28.99 120.74 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.074 -179.723 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 114.62 27.6 3.25 Favored Glycine 0 CA--C 1.52 0.353 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 -179.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.575 ' N ' ' CD ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -144.78 46.5 0.61 Allowed Pre-proline 0 C--N 1.323 -0.578 0 O-C-N 122.549 -0.383 . . . . 0.0 110.431 179.896 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 29.0 Cg_endo -61.9 144.21 96.36 Favored 'Trans proline' 0 C--N 1.295 -2.258 0 C-N-CA 122.678 2.252 . . . . 0.0 111.93 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.703 ' HG ' ' H ' ' A' ' 107' ' ' ALA . 26.1 t -173.38 120.25 0.33 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.397 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.71 -40.34 63.67 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.034 0.445 . . . . 0.0 111.098 179.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -66.29 -40.16 89.87 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.9 -179.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.703 ' H ' ' HG ' ' A' ' 104' ' ' SER . . . -63.97 -40.07 95.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.697 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 70.7 t -67.45 -43.84 87.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.8 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.86 -38.84 92.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.53 -179.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.445 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.62 -23.34 62.92 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.414 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.547 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.5 mm-40 -90.63 5.14 49.19 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.755 -179.575 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.547 ' C ' ' O ' ' A' ' 111' ' ' GLN . 10.6 tpt 23.49 64.05 0.38 Allowed Pre-proline 0 N--CA 1.466 0.347 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.074 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -78.41 167.78 22.42 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 C-N-CA 122.949 2.433 . . . . 0.0 112.009 -178.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.523 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 99.0 m-20 -110.06 -42.53 4.17 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.133 179.475 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.6 tp -120.64 120.4 35.65 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 84.4 mt -113.36 129.18 69.59 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.401 0 CA-C-O 120.983 0.42 . . . . 0.0 110.942 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.44 ' CD1' ' HG ' ' A' ' 48' ' ' SER . 29.9 mt -109.02 132.46 54.08 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.057 0.456 . . . . 0.0 110.214 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 98.9 mt -119.91 138.2 51.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.666 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 87.4 p -71.92 153.17 42.01 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.57 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.27 -50.19 74.63 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.681 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -149.42 153.91 38.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.615 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 170.25 -170.9 43.27 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.87 -34.28 89.37 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.447 ' O ' ' OD1' ' A' ' 124' ' ' ASP . 44.1 p-10 -87.06 120.06 27.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.805 0.336 . . . . 0.0 110.66 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 40.6 t -63.26 143.6 57.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.451 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.521 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.08 -42.76 9.23 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.866 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.5 tp -62.73 -42.35 99.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.647 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.99 -11.94 59.81 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.485 -179.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 84.8 mt -114.48 -24.1 8.99 Favored 'General case' 0 C--O 1.226 -0.16 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.689 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . 0.521 ' N ' ' O ' ' A' ' 126' ' ' ALA . 77.9 t80 -51.28 -49.44 61.23 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.611 -0.436 . . . . 0.0 110.576 -178.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.498 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.3 p-10 -66.07 -42.27 89.65 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.885 0.374 . . . . 0.0 111.29 179.474 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.498 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 88.2 mt-30 -67.29 -37.92 84.18 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.797 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 96.1 mt -80.33 -41.41 24.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.991 -179.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.1 t -57.26 -44.34 83.82 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.202 -178.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.8 m -62.11 -45.1 94.99 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.766 0.317 . . . . 0.0 110.49 179.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 93.5 mt -62.26 -43.64 98.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.23 -179.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.46 168.35 4.88 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.588 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -49.67 112.93 0.78 Allowed 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.314 2.01 . . . . 0.0 112.277 179.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 23.0 m -84.18 127.55 34.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.636 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 34.5 tp -118.05 135.93 53.87 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.938 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.438 ' O ' ' OD2' ' A' ' 32' ' ' ASP . 81.3 mt -100.38 119.01 47.9 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 CA-C-O 121.192 0.52 . . . . 0.0 111.295 -179.44 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 98.1 mt -134.98 131.83 53.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.619 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.517 HD22 ' CG ' ' A' ' 241' ' ' ASP . 58.9 t30 -66.77 147.48 53.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.866 0.365 . . . . 0.0 110.406 179.289 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.463 ' O ' ' OD2' ' A' ' 241' ' ' ASP . 44.8 t80 -81.69 123.17 28.5 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.932 -179.546 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 54.64 69.57 0.71 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.802 179.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 34.2 p-10 -126.16 0.7 7.15 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.93 0.395 . . . . 0.0 110.74 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -150.65 114.92 5.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.743 -179.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' SER . . . . . 0.527 ' HG ' ' H ' ' A' ' 150' ' ' GLN . 83.6 p -64.14 169.23 4.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.523 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.417 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.4 p-90 -52.1 -16.51 0.79 Allowed 'General case' 0 C--O 1.223 -0.321 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.474 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . 0.527 ' H ' ' HG ' ' A' ' 148' ' ' SER . 68.1 tp60 -69.56 -76.96 0.09 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.495 -179.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.449 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.1 t -62.53 -38.24 89.21 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.287 179.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 53.1 tp -60.05 -45.74 91.84 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.351 -178.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.417 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 46.8 tp -62.76 -41.71 99.34 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.417 179.049 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.449 ' OG1' ' O ' ' A' ' 151' ' ' SER . 63.0 p -63.89 -34.91 79.01 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.222 -179.454 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.445 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 88.0 mm-40 -64.0 -42.52 97.16 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.256 179.308 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 90.7 mt -65.37 -38.85 91.28 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.094 0.473 . . . . 0.0 110.212 179.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.578 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.25 -32.4 80.55 Favored Glycine 0 CA--C 1.519 0.343 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 -179.368 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.445 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.2 mt-10 -35.88 -26.45 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.869 0.366 . . . . 0.0 110.827 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.578 ' N ' ' O ' ' A' ' 157' ' ' GLY . 95.3 mt -57.2 148.75 4.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.287 179.224 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 73.4 p -69.1 137.41 53.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.036 -179.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 70.85 22.18 78.22 Favored Glycine 0 N--CA 1.458 0.162 0 N-CA-C 111.286 -0.726 . . . . 0.0 111.286 179.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 59.0 m80 -124.16 -14.41 7.04 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.719 0.295 . . . . 0.0 110.519 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -66.16 -59.75 3.47 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.718 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -52.16 -49.04 64.57 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.159 -179.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -60.98 -41.09 95.78 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.95 -0.3 . . . . 0.0 110.387 179.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.57 -47.09 87.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.57 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -57.0 -40.22 76.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.188 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -61.49 -49.94 74.73 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.558 179.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -65.35 -43.67 90.13 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.467 179.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 94.7 mt -64.56 -43.41 96.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.468 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.38 -51.02 71.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.451 -179.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.51 -43.68 96.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.493 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . 0.48 ' CD1' ' OH ' ' A' ' 301' ' ' TYR . 57.6 t80 -62.86 -44.52 95.91 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.072 0.463 . . . . 0.0 110.433 179.391 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -63.27 -40.0 96.16 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.579 -179.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -63.02 -42.73 99.88 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.646 179.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -60.65 -44.88 95.9 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.152 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 84.6 mt -64.43 -41.14 96.75 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.992 0.425 . . . . 0.0 110.67 178.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -51.92 -62.15 1.81 Allowed 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.395 -179.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.76 -46.61 87.07 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.568 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.3 -41.86 66.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.28 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -63.66 -33.7 76.22 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.984 0.421 . . . . 0.0 110.4 179.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 69.8 tt0 -90.53 8.76 32.36 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.489 0.662 . . . . 0.0 110.484 -178.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -104.87 -32.29 8.87 Favored 'General case' 0 CA--C 1.515 -0.372 0 O-C-N 122.113 -0.367 . . . . 0.0 111.233 179.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.7 pt -128.01 147.61 32.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.826 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -139.97 131.02 26.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.331 179.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.559 ' CD2' ' N ' ' A' ' 186' ' ' LEU . 3.5 mm? -85.44 133.73 41.69 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.01 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -44.04 157.89 0.14 Allowed 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 122.703 2.269 . . . . 0.0 112.199 179.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . 0.521 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 28.1 Cg_endo -63.13 114.8 2.62 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 C-N-CA 122.765 2.31 . . . . 0.0 111.729 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . 0.521 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.8 mt-30 155.4 147.99 0.0 OUTLIER Pre-proline 0 N--CA 1.455 -0.203 0 O-C-N 123.68 0.612 . . . . 0.0 110.802 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -73.53 144.29 35.77 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.621 2.214 . . . . 0.0 112.005 177.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.494 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.1 p -124.92 158.83 32.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.298 0.57 . . . . 0.0 110.14 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' THR . . . . . 0.494 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 37.4 p -143.3 165.39 27.61 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.121 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -135.28 128.64 32.2 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.222 0.534 . . . . 0.0 110.189 179.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 47.7 pt -146.39 148.79 16.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.186 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 72.1 t -117.77 123.25 71.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.272 0.558 . . . . 0.0 109.684 179.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -134.4 107.37 7.56 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.282 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 94.7 m -130.82 130.46 43.68 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.834 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.413 ' O ' ' N ' ' A' ' 201' ' ' HIS . . . -82.73 -37.36 24.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.265 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.41 -66.98 0.27 Allowed 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.414 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.1 -10.05 59.24 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.266 179.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . 0.413 ' N ' ' O ' ' A' ' 198' ' ' ALA . 60.0 t-80 60.81 58.13 2.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.703 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 41.0 p -166.84 153.49 8.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.52 179.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.32 144.05 24.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.496 179.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -135.34 138.4 43.34 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.641 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 20.4 mt -106.53 125.64 51.25 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.116 0.484 . . . . 0.0 109.779 -179.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' TRP . . . . . 0.556 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 74.8 m95 -82.12 166.99 19.21 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.655 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -156.92 171.26 7.67 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 120.98 0.419 . . . . 0.0 110.521 -179.144 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.54 -37.35 82.65 Favored 'Trans proline' 0 C--N 1.303 -1.832 0 C-N-CA 122.619 2.213 . . . . 0.0 112.186 179.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -70.4 -35.01 73.2 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.875 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 22.8 m -61.01 150.74 32.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.616 -179.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.45 -37.04 82.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.551 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . 0.556 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 55.0 tt0 -64.69 -40.24 95.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.543 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.5 -43.46 92.32 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.719 -0.952 . . . . 0.0 110.719 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -63.34 -43.54 97.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.71 0.291 . . . . 0.0 110.247 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 65.1 ttp -59.5 -48.01 83.31 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.207 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 88.0 mt -60.66 -40.74 93.19 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . 0.459 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.7 tp10 -58.06 -37.87 75.25 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -65.22 -38.01 89.06 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.81 0.338 . . . . 0.0 110.654 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 94.3 mt -64.3 -42.62 96.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.614 -179.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.27 44.6 0.09 OUTLIER Glycine 0 C--N 1.333 0.408 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . 0.459 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 26.1 m-85 -127.66 155.44 43.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.058 0.456 . . . . 0.0 110.527 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' THR . . . . . 0.453 ' O ' ' O ' ' A' ' 191' ' ' VAL . 7.0 p -107.16 122.23 46.09 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.224 0.535 . . . . 0.0 110.196 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . 0.445 ' CD2' ' N ' ' A' ' 223' ' ' LEU . 4.3 mm? -101.03 133.28 45.76 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.134 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -97.1 159.21 15.04 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.473 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.16 115.35 30.13 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-O 120.924 0.392 . . . . 0.0 110.37 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.454 ' CD1' ' N ' ' A' ' 226' ' ' LEU . 8.9 mp -53.37 156.67 3.96 Favored Pre-proline 0 N--CA 1.453 -0.313 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.659 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -60.19 145.3 98.81 Favored 'Trans proline' 0 C--N 1.301 -1.931 0 C-N-CA 122.629 2.219 . . . . 0.0 112.15 179.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.41 -3.02 59.01 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.5 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.22 -40.92 5.66 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.024 -0.831 . . . . 0.0 111.024 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.539 ' O ' ' N ' ' A' ' 233' ' ' SER . 86.3 mt -79.17 -16.82 56.04 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-O 121.019 0.438 . . . . 0.0 110.29 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . 0.402 ' C ' ' O ' ' A' ' 230' ' ' LEU . 54.5 t-20 -40.41 -48.89 2.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.764 -179.399 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -88.2 15.43 7.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.314 179.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 233' ' ' SER . . . . . 0.539 ' N ' ' O ' ' A' ' 230' ' ' LEU . 78.1 p -60.6 -35.51 76.3 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.648 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . 0.528 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.6 tt0 -118.35 -69.26 0.86 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.974 179.428 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.0 m -70.47 103.02 2.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.739 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -94.27 58.08 2.42 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.37 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -145.04 -122.53 1.55 Allowed Glycine 0 CA--C 1.519 0.324 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -134.47 111.79 10.4 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 121.175 0.512 . . . . 0.0 110.408 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . 0.515 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.2 mtt180 -148.25 57.56 1.07 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.762 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -69.83 -31.89 70.01 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.489 179.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . 0.517 ' CG ' HD22 ' A' ' 143' ' ' ASN . 64.8 t0 -56.92 -47.03 81.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.344 -179.097 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 242' ' ' ILE . . . . . 0.434 ' O ' ' O ' ' A' ' 239' ' ' ARG . 17.6 tt -140.2 157.03 25.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.912 0.387 . . . . 0.0 110.494 179.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 96.1 mt -106.25 106.33 20.39 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.163 0 CA-C-O 121.169 0.509 . . . . 0.0 110.466 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . 0.515 ' OE1' ' NH1' ' A' ' 239' ' ' ARG . 88.2 mt-30 -110.45 110.31 21.02 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.302 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 9.5 mp -121.87 -168.33 1.69 Allowed 'General case' 0 C--O 1.225 -0.205 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.63 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . 0.528 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.49 -16.9 0.05 OUTLIER Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.919 -0.873 . . . . 0.0 110.919 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . 0.692 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -60.45 156.98 29.78 Favored Glycine 0 CA--C 1.522 0.488 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -63.8 21.42 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.977 0.418 . . . . 0.0 110.604 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . 0.692 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.8 m-20 -97.04 -6.05 36.16 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.576 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 92.4 mt -79.9 -21.57 43.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.648 179.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.57 -51.23 70.76 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.71 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.65 -5.41 58.16 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.467 179.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.14 -74.37 1.15 Allowed Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 82.6 mt -70.08 126.01 28.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.072 0.463 . . . . 0.0 110.254 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -59.47 -39.27 83.14 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.311 -179.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 82.83 51.79 4.12 Favored Glycine 0 CA--C 1.521 0.41 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -95.78 -15.1 22.79 Favored 'General case' 0 C--N 1.332 -0.18 0 O-C-N 122.728 -0.278 . . . . 0.0 110.594 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 258' ' ' SER . . . . . 0.428 ' O ' ' O ' ' A' ' 192' ' ' THR . 3.3 t 174.56 88.93 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.078 0.466 . . . . 0.0 110.108 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . 0.596 ' N ' ' CD1' ' A' ' 259' ' ' LEU . 0.9 OUTLIER -94.43 124.06 38.23 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.254 0.549 . . . . 0.0 111.115 -179.081 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 15.9 m-30 -93.06 146.48 23.61 Favored 'General case' 0 CA--C 1.504 -0.818 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.345 179.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 85.7 mt -122.42 149.63 43.57 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.607 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.66 ' CG ' ' N ' ' A' ' 263' ' ' ALA . 2.6 p90 -77.21 -138.04 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.638 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . 0.66 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -52.61 77.52 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.032 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . 0.621 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -178.99 104.32 0.18 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 265' ' ' ASP . . . . . 0.601 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.7 m-20 -80.35 -177.81 6.34 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.684 0.278 . . . . 0.0 110.954 -179.634 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -40.36 -17.69 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.561 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . 0.601 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.38 -51.52 43.26 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.71 179.409 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -63.75 -46.65 84.34 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.191 179.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . 0.524 ' O ' ' CD2' ' A' ' 273' ' ' TYR . . . -61.68 -35.12 77.08 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.173 0.511 . . . . 0.0 109.738 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -63.17 -34.38 77.51 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.033 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.51 -43.12 13.83 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.185 -179.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 272' ' ' ILE . . . . . 0.619 ' C ' ' H ' ' A' ' 274' ' ' ALA . 4.9 tt -51.47 -33.73 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.855 -178.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 273' ' ' TYR . . . . . 0.524 ' CD2' ' O ' ' A' ' 269' ' ' ALA . 17.3 m-85 -54.33 -1.89 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.646 -179.546 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 274' ' ' ALA . . . . . 0.619 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.61 -39.61 70.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.919 179.52 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . 0.582 ' O ' ' N ' ' A' ' 279' ' ' ALA . 3.3 p30 -39.28 98.03 0.16 Allowed Pre-proline 0 CA--C 1.528 0.108 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.52 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -54.29 -42.95 63.02 Favored 'Trans proline' 0 C--N 1.303 -1.821 0 C-N-CA 122.341 2.027 . . . . 0.0 112.638 -178.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 88.8 mt -64.45 -42.82 95.76 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.252 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 91.0 mt -95.67 -1.58 49.79 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.848 -179.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 279' ' ' ALA . . . . . 0.582 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.28 -34.82 77.3 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.685 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.21 20.07 0.12 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.052 -179.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . 0.515 ' H ' ' C ' ' A' ' 279' ' ' ALA . 13.8 mt -75.19 120.04 79.8 Favored Pre-proline 0 N--CA 1.451 -0.417 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.523 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -50.91 -39.34 58.96 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.586 2.191 . . . . 0.0 111.859 179.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.92 -50.42 64.0 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.111 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 75.7 t -61.48 -43.91 97.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -57.79 -41.19 81.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.218 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -91.13 0.04 57.61 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.091 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt 59.44 43.71 15.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.039 0.447 . . . . 0.0 110.878 179.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -94.88 41.33 1.09 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.379 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 54.1 t -119.2 135.76 58.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 121.101 0.477 . . . . 0.0 110.136 -179.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -132.93 162.75 30.8 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.709 -179.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.77 155.3 32.78 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-O 121.013 0.435 . . . . 0.0 110.728 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 81.6 mt -94.07 -1.36 54.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.232 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.53 165.69 12.67 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.548 -1.021 . . . . 0.0 110.548 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 6.9 m -87.56 -62.4 1.5 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.921 0.391 . . . . 0.0 111.001 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 295' ' ' GLU . . . . . 0.466 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.4 mm-40 -69.6 -3.79 16.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.675 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 25.4 p -76.89 33.17 0.14 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.645 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 297' ' ' PHE . . . . . 0.466 ' H ' ' C ' ' A' ' 295' ' ' GLU . 84.8 t80 -60.17 -45.85 91.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.555 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . 0.602 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.2 mtt85 -81.72 134.41 35.45 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.989 0.423 . . . . 0.0 110.576 -179.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 16.2 tp -114.18 118.88 35.22 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-O 121.004 0.431 . . . . 0.0 110.066 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . 0.608 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.4 p-10 -166.39 -175.23 3.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.562 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 301' ' ' TYR . . . . . 0.48 ' OH ' ' CD1' ' A' ' 173' ' ' PHE . 86.5 t80 -47.69 -44.64 27.66 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.246 -179.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -65.63 -40.9 93.07 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.034 0.445 . . . . 0.0 110.683 178.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 303' ' ' SER . . . . . 0.608 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 54.5 p -56.16 -36.12 67.96 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.024 -179.171 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -56.85 -52.34 65.47 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 90.9 mtp -56.15 -43.28 78.15 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -66.37 -42.53 87.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.024 0.44 . . . . 0.0 110.155 178.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 55.7 t -64.13 -42.97 97.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.105 179.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 42.5 tp -59.77 -42.26 92.9 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.779 -179.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -62.33 -39.27 92.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.123 179.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 310' ' ' ARG . . . . . 0.436 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.4 ttt85 -63.51 -44.06 95.38 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.18 179.479 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 88.4 mt -63.37 -42.14 98.84 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.233 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -62.99 -33.26 75.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.016 179.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.52 -23.85 21.93 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.416 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . 0.436 ' N ' ' O ' ' A' ' 310' ' ' ARG . 6.7 tt -62.31 -43.29 99.16 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 121.074 0.464 . . . . 0.0 110.552 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 . . . . . 0 C--O 1.219 -0.507 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.45 -179.952 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.327 -0.619 . . . . 0.0 109.327 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -99.59 136.4 39.58 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.045 0.45 . . . . 0.0 110.47 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.496 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -92.07 178.56 1.66 Allowed Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.563 -179.891 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.496 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.6 Cg_exo -61.73 147.16 95.93 Favored 'Trans proline' 0 C--N 1.301 -1.965 0 C-N-CA 122.79 2.327 . . . . 0.0 112.106 179.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 35.6 ptt180 -136.29 142.44 43.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.645 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -79.5 116.76 19.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.456 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.5 tp -111.14 130.44 64.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.456 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 12.9 t -70.89 141.7 51.19 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.55 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.515 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.4 t0 -139.19 179.62 6.41 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.497 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.515 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 78.1 p -74.01 -36.93 64.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.604 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.8 ttt85 -46.64 -94.59 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.293 -179.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.495 ' C ' ' HG1' ' A' ' 36' ' ' THR . . . -166.96 -26.62 0.02 OUTLIER Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.495 ' HG1' ' C ' ' A' ' 35' ' ' GLY . 59.3 m -169.05 105.0 0.4 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.817 0.341 . . . . 0.0 110.672 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 75.5 t60 -128.53 149.09 50.75 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.019 0.437 . . . . 0.0 110.289 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.483 ' CG2' ' N ' ' A' ' 39' ' ' LEU . 98.6 m -131.42 165.91 22.46 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.532 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.483 ' N ' ' CG2' ' A' ' 38' ' ' THR . 81.4 mt -120.75 127.35 51.91 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.501 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -65.09 -44.43 88.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.682 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.407 ' O ' ' HD3' ' A' ' 43' ' ' PRO . 40.6 p -165.97 154.91 11.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.444 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.458 ' N ' ' CD ' ' A' ' 42' ' ' GLN . 14.5 mp0 -44.73 101.3 0.25 Allowed Pre-proline 0 C--N 1.329 -0.308 0 O-C-N 123.392 0.433 . . . . 0.0 110.652 179.426 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.407 ' HD3' ' O ' ' A' ' 41' ' ' SER . 31.7 Cg_exo -57.25 129.66 35.32 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 C-N-CA 122.373 2.049 . . . . 0.0 112.288 -179.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -83.61 -24.73 31.32 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.473 179.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.542 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.2 mtm-85 -122.39 134.83 54.61 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-O 121.176 0.512 . . . . 0.0 110.256 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.1 mt -130.75 133.84 62.74 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.925 -179.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 44.2 t -124.31 130.61 73.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 179.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.509 ' O ' ' O ' ' A' ' 66' ' ' ALA . 2.2 m -155.32 167.8 29.16 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.559 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 67.3 p -124.85 9.96 8.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.425 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.78 125.15 33.03 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.689 -179.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 93.1 t -65.76 -44.41 93.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.48 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.8 m -62.69 -44.04 97.26 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.602 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 52.5 tp -62.15 -41.5 98.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.544 -179.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 75.5 m -57.61 -44.53 85.54 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.32 -179.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.13 -62.31 5.29 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 179.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.6 t -48.24 -35.74 12.58 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 20.0 mt -61.86 -44.37 96.95 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.179 179.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.402 HD12 ' N ' ' A' ' 58' ' ' LEU . 9.2 mp -64.97 -41.66 95.26 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.373 178.035 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.91 -40.71 97.12 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.012 -179.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 7.9 tp -88.73 16.44 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.856 -179.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 56.46 84.58 0.09 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.671 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 178.58 57.1 0.06 OUTLIER Pre-proline 0 C--N 1.328 -0.329 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -50.55 154.25 6.66 Favored 'Trans proline' 0 C--N 1.295 -2.252 0 C-N-CA 122.912 2.408 . . . . 0.0 112.297 -178.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.436 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -108.96 145.64 15.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.375 -179.712 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.66 -45.25 97.98 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.263 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.335 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.509 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -129.49 133.98 47.55 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.522 -179.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.51 ' O ' ' N ' ' A' ' 98' ' ' LEU . 74.8 m -134.59 158.64 43.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.769 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.77 139.27 16.26 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.704 -0.959 . . . . 0.0 110.704 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.461 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.92 -162.69 0.08 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.918 0.389 . . . . 0.0 110.474 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.489 ' O ' ' C ' ' A' ' 71' ' ' THR . 15.2 t -133.52 134.33 43.3 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.397 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.489 ' C ' ' O ' ' A' ' 70' ' ' THR . 0.6 OUTLIER 29.73 68.89 0.65 Allowed Pre-proline 0 N--CA 1.464 0.272 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.754 -179.939 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -61.27 146.67 97.11 Favored 'Trans proline' 0 C--N 1.299 -2.067 0 C-N-CA 122.655 2.237 . . . . 0.0 111.986 -178.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.535 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 45.3 p-10 -160.59 -32.35 0.05 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.673 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.535 ' N ' ' OD1' ' A' ' 73' ' ' ASN . 99.1 m-20 -64.15 -39.43 94.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.451 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -60.51 -48.24 82.65 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.561 -179.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.418 ' O ' ' O ' ' A' ' 77' ' ' ALA . 91.6 t -60.38 -24.77 32.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.418 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -46.02 173.29 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.563 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.57 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.6 p30 -62.25 177.96 0.44 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.582 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.59 ' C ' ' H ' ' A' ' 81' ' ' GLY . 35.8 p30 -45.01 86.12 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.985 0.422 . . . . 0.0 110.946 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.57 ' N ' ' O ' ' A' ' 78' ' ' ASP . 43.1 tp60 -67.57 13.21 0.08 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.127 0.489 . . . . 0.0 110.13 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.59 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 118.51 -22.09 9.58 Favored Glycine 0 CA--C 1.519 0.306 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -108.31 116.49 32.06 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.959 0.409 . . . . 0.0 110.54 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 74.6 mt -98.57 0.17 44.41 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.485 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -92.25 7.18 43.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.013 0.435 . . . . 0.0 110.443 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.428 ' O ' ' CG2' ' A' ' 89' ' ' VAL . 87.8 mt-30 -100.13 -27.99 13.26 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.777 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 68.2 t-105 -62.51 -40.67 97.47 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.866 -179.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.55 ' O ' ' N ' ' A' ' 91' ' ' LYS . 66.1 m -77.64 -53.45 7.56 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.088 -179.389 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -48.73 -50.91 31.53 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.018 -179.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.428 ' CG2' ' O ' ' A' ' 85' ' ' GLN . 15.4 m -68.62 -40.71 82.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 120.934 0.397 . . . . 0.0 111.032 179.717 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.418 ' H ' HG23 ' A' ' 89' ' ' VAL . . . -72.05 -23.04 61.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.702 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.55 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.0 tttm -61.74 -45.68 92.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.482 -179.464 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.439 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.6 mm-40 -90.23 -95.47 0.11 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.16 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.64 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.9 mtt180 -142.59 58.87 1.44 Allowed 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.459 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.7 pttp 33.54 25.77 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 120.92 0.391 . . . . 0.0 110.19 -179.161 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.64 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.3 tt -47.86 123.75 6.49 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.924 -178.061 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -83.91 -169.41 2.57 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.115 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.595 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 81.0 mtp180 -74.6 136.7 42.03 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.291 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.51 ' N ' ' O ' ' A' ' 67' ' ' SER . 90.6 mt -85.52 -165.57 1.26 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.856 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.536 ' CD2' ' O ' ' A' ' 99' ' ' TYR . 48.0 p90 -168.38 119.49 0.79 Allowed 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.254 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.511 ' C ' ' O ' ' A' ' 99' ' ' TYR . 43.3 mm -28.86 121.02 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.058 -179.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 113.76 27.89 3.37 Favored Glycine 0 CA--C 1.52 0.35 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 -179.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.575 ' N ' ' CD ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -144.48 46.65 0.64 Allowed Pre-proline 0 C--N 1.324 -0.524 0 CA-C-O 120.985 0.422 . . . . 0.0 110.425 179.856 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 29.2 Cg_endo -61.97 143.78 95.67 Favored 'Trans proline' 0 C--N 1.297 -2.161 0 C-N-CA 122.656 2.237 . . . . 0.0 111.942 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.701 ' HG ' ' H ' ' A' ' 107' ' ' ALA . 25.3 t -173.01 120.08 0.35 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.367 179.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.25 -40.41 64.66 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.075 0.464 . . . . 0.0 111.122 179.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.39 -39.88 89.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.926 -179.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.701 ' H ' ' HG ' ' A' ' 104' ' ' SER . . . -64.38 -40.16 95.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.729 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 71.7 t -67.79 -43.82 86.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.78 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.82 -38.97 92.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.578 -179.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.439 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.44 -23.4 62.66 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.493 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.545 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.3 mm-40 -90.29 5.23 48.1 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.652 -179.471 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.545 ' C ' ' O ' ' A' ' 111' ' ' GLN . 10.8 tpt 23.89 63.98 0.39 Allowed Pre-proline 0 N--CA 1.466 0.33 0 CA-C-O 120.939 0.399 . . . . 0.0 111.048 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -78.22 166.63 24.3 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 123.035 2.49 . . . . 0.0 112.062 -178.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.524 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 99.2 m-20 -109.77 -41.71 4.45 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.185 179.43 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.2 tp -121.63 120.12 33.82 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 83.2 mt -112.77 128.86 69.25 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.33 0 CA-C-O 120.941 0.401 . . . . 0.0 110.849 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 30.1 mt -109.34 132.25 54.3 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.281 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 98.9 mt -119.6 139.06 48.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.668 -179.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 85.1 p -72.68 153.89 40.98 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.527 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.01 -50.19 74.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.714 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.0 t -149.59 154.24 38.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.518 179.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 170.6 -171.06 43.53 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.99 -33.97 88.68 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.446 ' O ' ' OD1' ' A' ' 124' ' ' ASP . 44.0 p-10 -86.93 120.02 27.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.719 0.295 . . . . 0.0 110.685 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 39.5 t -63.05 143.9 57.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.005 0.431 . . . . 0.0 110.453 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.527 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -92.9 -42.92 9.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.871 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.5 tp -62.98 -42.44 99.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.667 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.51 -12.5 60.48 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.524 -179.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 85.2 mt -114.52 -24.02 9.02 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.696 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . 0.527 ' N ' ' O ' ' A' ' 126' ' ' ALA . 80.0 t80 -50.77 -49.68 57.59 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.634 -178.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.502 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 37.8 p-10 -66.14 -42.69 88.76 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.848 0.356 . . . . 0.0 111.22 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.502 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 88.3 mt-30 -66.98 -37.89 85.06 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.823 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 96.0 mt -80.21 -41.43 25.2 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.92 -179.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.2 t -57.14 -44.58 83.51 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.245 -179.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.0 m -61.65 -45.41 94.17 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.75 0.31 . . . . 0.0 110.562 179.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 94.1 mt -62.18 -43.56 98.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.291 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.34 168.46 4.9 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.556 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -50.35 113.68 1.13 Allowed 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.256 1.971 . . . . 0.0 112.221 179.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 24.1 m -84.61 127.45 34.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.494 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 34.4 tp -117.93 135.88 53.84 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.107 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.442 ' O ' ' OD2' ' A' ' 32' ' ' ASP . 82.2 mt -99.61 118.71 46.62 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.31 0 CA-C-O 121.221 0.534 . . . . 0.0 111.179 -179.293 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 98.0 mt -134.99 132.18 53.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.617 179.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.511 HD22 ' CG ' ' A' ' 241' ' ' ASP . 61.3 t30 -66.9 151.5 47.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.911 0.386 . . . . 0.0 110.436 179.414 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.519 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 88.0 t80 -86.54 122.63 30.75 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.847 -179.532 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.519 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 99.1 m-20 55.23 69.17 0.76 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.769 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 35.7 p-10 -125.81 0.4 7.38 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.637 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -150.71 115.47 5.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.706 -179.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' SER . . . . . 0.524 ' HG ' ' H ' ' A' ' 150' ' ' GLN . 83.5 p -63.3 168.18 4.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.534 -179.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.417 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.4 p-90 -51.61 -15.72 0.5 Allowed 'General case' 0 C--O 1.223 -0.315 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.494 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . 0.524 ' H ' ' HG ' ' A' ' 148' ' ' SER . 68.2 tp60 -70.8 -75.54 0.12 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.51 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.455 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.0 t -62.76 -38.71 91.63 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.28 179.474 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 53.9 tp -60.02 -45.66 92.04 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.389 -178.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.417 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 46.6 tp -62.73 -41.63 99.27 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.473 178.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.455 ' OG1' ' O ' ' A' ' 151' ' ' SER . 59.7 p -63.89 -34.76 78.67 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.226 -179.521 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.441 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 88.0 mm-40 -64.07 -42.42 96.99 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.309 179.257 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 90.8 mt -65.39 -38.79 91.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.033 0.444 . . . . 0.0 110.178 179.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.581 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.2 -32.33 80.21 Favored Glycine 0 CA--C 1.52 0.348 0 N-CA-C 110.719 -0.952 . . . . 0.0 110.719 -179.302 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.441 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.2 mt-10 -35.93 -25.98 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.858 0.361 . . . . 0.0 110.806 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.581 ' N ' ' O ' ' A' ' 157' ' ' GLY . 95.6 mt -57.99 148.99 5.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.299 179.236 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 74.7 p -69.24 137.44 53.14 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.979 -179.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 70.77 22.16 78.11 Favored Glycine 0 N--CA 1.458 0.165 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 179.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 58.1 m80 -124.32 -14.46 6.95 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.695 0.283 . . . . 0.0 110.538 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -66.05 -59.92 3.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.649 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -52.0 -48.83 64.26 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.134 -179.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -60.52 -41.22 93.96 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.728 0.299 . . . . 0.0 110.321 179.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.61 -47.18 86.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.517 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.87 -40.1 75.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.246 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -61.7 -50.33 72.88 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.579 179.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 60.1 ttt85 -65.44 -43.73 89.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.54 179.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 94.9 mt -64.72 -43.37 96.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.486 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.38 -51.23 70.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.498 -179.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -63.57 -43.64 96.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.533 179.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . 0.499 ' CD1' ' OH ' ' A' ' 301' ' ' TYR . 56.6 t80 -62.9 -44.29 96.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.087 0.47 . . . . 0.0 110.442 179.417 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -63.65 -39.86 95.4 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.478 -179.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -62.89 -42.87 99.93 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.659 179.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -60.59 -44.7 95.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.207 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 84.2 mt -64.47 -41.05 96.73 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.994 0.425 . . . . 0.0 110.668 178.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.12 -62.18 1.8 Allowed 'General case' 0 C--O 1.237 0.431 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.382 -179.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.52 -46.78 86.05 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.578 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.24 -41.67 65.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.302 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -63.91 -33.67 76.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.393 179.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . 0.4 ' O ' ' HG2' ' A' ' 182' ' ' GLU . 69.5 tt0 -90.54 8.94 31.51 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.437 0.637 . . . . 0.0 110.491 -178.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -105.04 -32.07 8.89 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.174 179.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.8 pt -128.07 147.55 32.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.842 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -139.68 131.05 26.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.395 179.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.555 ' CD2' ' N ' ' A' ' 186' ' ' LEU . 3.6 mm? -85.47 133.46 42.17 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.9 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -44.12 157.8 0.15 Allowed 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.738 2.292 . . . . 0.0 112.235 179.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . 0.518 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.5 Cg_endo -62.89 114.69 2.53 Favored 'Trans proline' 0 C--N 1.303 -1.82 0 C-N-CA 122.813 2.342 . . . . 0.0 111.748 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . 0.518 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.7 mt-30 155.69 147.88 0.0 OUTLIER Pre-proline 0 C--N 1.332 -0.169 0 O-C-N 123.713 0.633 . . . . 0.0 110.838 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -73.85 144.01 34.13 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.673 2.249 . . . . 0.0 112.012 177.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.496 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.0 p -124.78 158.95 31.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.296 0.569 . . . . 0.0 110.125 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' THR . . . . . 0.496 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 37.5 p -143.46 165.39 27.68 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.048 -179.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -135.2 128.58 32.27 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.173 0.511 . . . . 0.0 110.264 179.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 47.9 pt -146.52 148.86 16.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.084 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 68.8 t -117.73 123.06 71.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.312 0.577 . . . . 0.0 109.813 179.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -134.14 106.62 7.28 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.391 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 94.3 m -130.1 130.41 44.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.764 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -82.88 -36.81 25.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.259 179.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.56 -67.14 0.26 Allowed 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.361 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.28 -9.96 59.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.377 179.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 60.2 t-80 60.94 58.47 2.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.901 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 35.5 p -167.23 153.48 8.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.549 179.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.31 144.16 24.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.943 0.402 . . . . 0.0 110.485 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -135.34 138.16 43.12 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.669 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 19.5 mt -106.32 125.46 51.02 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.061 0.458 . . . . 0.0 109.842 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' TRP . . . . . 0.558 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 74.7 m95 -82.07 167.13 19.12 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.676 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -156.9 171.14 7.83 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.595 -179.165 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.43 -37.15 81.67 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 C-N-CA 122.598 2.198 . . . . 0.0 112.219 179.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -70.56 -34.95 72.8 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.836 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 21.0 m -61.28 150.91 33.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.615 -179.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.61 -37.04 82.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.49 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . 0.558 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 54.7 tt0 -64.66 -40.33 95.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.579 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.52 -43.46 92.27 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -63.29 -43.73 97.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.81 0.338 . . . . 0.0 110.288 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 65.1 ttp -59.4 -48.12 82.84 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.26 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 88.4 mt -60.49 -40.94 93.13 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . 0.454 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.0 tp10 -57.97 -37.74 74.75 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -65.31 -38.08 89.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.787 0.327 . . . . 0.0 110.652 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 94.7 mt -64.27 -42.71 96.32 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.58 -179.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.52 44.73 0.08 OUTLIER Glycine 0 CA--C 1.52 0.392 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . 0.454 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 26.5 m-85 -127.78 155.47 44.01 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.075 0.464 . . . . 0.0 110.522 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' THR . . . . . 0.451 ' O ' ' O ' ' A' ' 191' ' ' VAL . 6.7 p -107.1 122.25 46.11 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.266 0.555 . . . . 0.0 110.122 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . 0.444 ' CD2' ' N ' ' A' ' 223' ' ' LEU . 4.3 mm? -101.17 133.15 46.15 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.056 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -97.01 159.34 14.96 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.467 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.32 115.42 30.24 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.954 0.407 . . . . 0.0 110.344 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.458 ' CD1' ' N ' ' A' ' 226' ' ' LEU . 8.8 mp -53.42 156.51 4.18 Favored Pre-proline 0 N--CA 1.452 -0.328 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.696 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -60.02 145.2 98.94 Favored 'Trans proline' 0 C--N 1.301 -1.929 0 C-N-CA 122.682 2.254 . . . . 0.0 112.163 179.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.25 -2.98 59.01 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.605 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.39 -40.83 5.63 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.539 ' O ' ' N ' ' A' ' 233' ' ' SER . 86.2 mt -79.07 -16.98 56.01 Favored 'General case' 0 C--O 1.222 -0.373 0 CA-C-O 121.069 0.461 . . . . 0.0 110.334 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . 0.404 ' C ' ' O ' ' A' ' 230' ' ' LEU . 53.9 t-20 -40.21 -49.12 2.66 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.732 -179.469 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -88.17 15.35 7.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.255 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 233' ' ' SER . . . . . 0.539 ' N ' ' O ' ' A' ' 230' ' ' LEU . 78.0 p -60.49 -35.68 76.51 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.712 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . 0.524 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.5 tt0 -118.35 -69.34 0.86 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.894 179.457 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.2 m -69.98 103.68 2.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.093 0.473 . . . . 0.0 110.691 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -94.88 57.54 2.13 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.366 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -144.92 -122.61 1.57 Allowed Glycine 0 CA--C 1.52 0.346 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -134.4 111.93 10.56 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 121.132 0.491 . . . . 0.0 110.368 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . 0.512 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.5 mtt180 -148.32 57.52 1.07 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.792 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -69.91 -31.87 69.88 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.539 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . 0.511 ' CG ' HD22 ' A' ' 143' ' ' ASN . 64.7 t0 -56.92 -46.93 81.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.33 -179.135 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 242' ' ' ILE . . . . . 0.436 ' O ' ' O ' ' A' ' 239' ' ' ARG . 17.4 tt -140.16 156.92 25.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.9 0.381 . . . . 0.0 110.533 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 96.1 mt -106.0 106.19 20.11 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.214 0 CA-C-O 121.163 0.506 . . . . 0.0 110.529 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . 0.512 ' OE1' ' NH1' ' A' ' 239' ' ' ARG . 88.3 mt-30 -110.37 110.26 20.98 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.42 179.674 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 9.5 mp -121.97 -168.25 1.68 Allowed 'General case' 0 C--O 1.226 -0.177 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.605 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . 0.524 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.37 -16.7 0.05 OUTLIER Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . 0.693 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -60.49 157.05 29.84 Favored Glycine 0 CA--C 1.522 0.477 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -63.8 21.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.879 0.371 . . . . 0.0 110.548 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . 0.693 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.9 m-20 -96.95 -5.97 36.69 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.499 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 92.8 mt -79.88 -21.68 43.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.671 179.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.51 -51.17 71.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.784 -179.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.56 -5.52 58.14 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.473 179.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.36 -74.4 1.15 Allowed Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 81.4 mt -69.98 125.77 27.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.011 0.434 . . . . 0.0 110.332 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -59.26 -39.5 83.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.212 -179.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 82.65 51.93 4.11 Favored Glycine 0 CA--C 1.52 0.404 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -96.48 -14.49 22.31 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.712 0.292 . . . . 0.0 110.581 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 258' ' ' SER . . . . . 0.441 ' HG ' ' CG2' ' A' ' 191' ' ' VAL . 3.5 t 174.58 88.36 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.037 0.446 . . . . 0.0 110.165 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . 0.595 ' N ' ' CD1' ' A' ' 259' ' ' LEU . 0.9 OUTLIER -94.2 123.98 37.93 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.183 0.516 . . . . 0.0 111.088 -179.1 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 15.9 m-30 -92.97 146.24 23.77 Favored 'General case' 0 CA--C 1.505 -0.786 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.428 179.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 86.7 mt -122.21 149.96 42.93 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.628 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.66 ' CG ' ' N ' ' A' ' 263' ' ' ALA . 2.6 p90 -77.53 -138.23 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.619 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . 0.66 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -52.43 77.44 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.01 0.433 . . . . 0.0 111.074 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . 0.624 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -178.93 104.42 0.19 Allowed Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.666 -0.974 . . . . 0.0 110.666 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 265' ' ' ASP . . . . . 0.601 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.9 m-20 -80.45 -177.8 6.37 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 120.643 0.259 . . . . 0.0 110.862 -179.424 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -40.41 -17.62 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.548 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . 0.601 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.48 -51.66 40.98 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 120.998 0.428 . . . . 0.0 110.687 179.386 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -63.64 -46.72 84.4 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.212 179.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . 0.525 ' O ' ' CD2' ' A' ' 273' ' ' TYR . . . -61.64 -35.08 76.89 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.218 0.532 . . . . 0.0 109.84 179.65 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -63.11 -34.09 76.85 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.045 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.73 -43.37 13.43 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.175 -179.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 272' ' ' ILE . . . . . 0.617 ' C ' ' H ' ' A' ' 274' ' ' ALA . 4.9 tt -51.43 -33.53 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.815 -178.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 273' ' ' TYR . . . . . 0.525 ' CD2' ' O ' ' A' ' 269' ' ' ALA . 17.2 m-85 -54.49 -1.74 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.681 -179.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 274' ' ' ALA . . . . . 0.617 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.55 -39.61 70.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.842 179.525 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . 0.583 ' O ' ' N ' ' A' ' 279' ' ' ALA . 3.1 p30 -39.32 98.06 0.16 Allowed Pre-proline 0 C--O 1.226 -0.144 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.495 -179.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -54.29 -42.92 63.26 Favored 'Trans proline' 0 C--N 1.303 -1.856 0 C-N-CA 122.385 2.056 . . . . 0.0 112.533 -178.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 88.8 mt -64.46 -42.84 95.71 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.103 0.478 . . . . 0.0 111.138 -179.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 90.6 mt -95.67 -1.68 49.62 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.887 -179.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 279' ' ' ALA . . . . . 0.583 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.38 -34.81 77.44 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.668 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.29 20.26 0.11 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.968 -179.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . 0.514 ' H ' ' C ' ' A' ' 279' ' ' ALA . 13.8 mt -75.47 119.89 79.11 Favored Pre-proline 0 N--CA 1.451 -0.423 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.56 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -50.49 -39.41 54.9 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 122.66 2.24 . . . . 0.0 111.951 178.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.75 -50.55 63.25 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.149 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 78.8 t -61.4 -44.02 97.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 179.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -57.74 -41.15 81.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.252 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -90.98 -0.03 57.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.2 179.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt 59.47 43.58 16.05 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.872 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -94.81 41.41 1.09 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.387 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 53.8 t -119.08 135.8 58.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.047 0.451 . . . . 0.0 110.173 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -133.01 162.56 31.37 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.645 -179.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.7 155.11 33.06 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.943 0.401 . . . . 0.0 110.754 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 81.4 mt -93.91 -1.43 54.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.302 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.38 165.93 12.77 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 6.5 m -87.61 -62.39 1.51 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.888 0.375 . . . . 0.0 110.945 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 295' ' ' GLU . . . . . 0.468 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.5 mm-40 -69.54 -3.83 16.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.645 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 27.2 p -76.94 33.27 0.14 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.663 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 297' ' ' PHE . . . . . 0.468 ' H ' ' C ' ' A' ' 295' ' ' GLU . 85.1 t80 -60.21 -46.01 91.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.618 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . 0.595 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.2 mtt85 -81.71 134.6 35.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.584 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 16.3 tp -114.27 119.07 35.73 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-O 121.006 0.431 . . . . 0.0 110.19 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . 0.607 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.9 p-10 -166.52 -175.09 3.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.577 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 301' ' ' TYR . . . . . 0.499 ' OH ' ' CD1' ' A' ' 173' ' ' PHE . 81.5 t80 -47.78 -44.72 28.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.292 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -65.59 -41.16 93.14 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.021 0.438 . . . . 0.0 110.701 178.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 303' ' ' SER . . . . . 0.607 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 54.0 p -55.58 -36.16 66.56 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.042 -179.219 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -57.07 -51.65 68.43 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 90.9 mtp -56.23 -43.87 79.03 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -66.29 -42.68 88.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.029 0.442 . . . . 0.0 110.284 178.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 55.8 t -64.08 -42.75 96.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.208 179.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 42.6 tp -59.57 -42.2 91.91 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.816 -179.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -62.72 -38.83 92.04 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.148 179.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 310' ' ' ARG . . . . . 0.439 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.6 ttt85 -63.33 -44.09 95.89 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.216 179.594 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 88.3 mt -63.24 -42.06 99.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.255 179.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -62.85 -33.03 74.4 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.124 179.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -90.17 -23.32 21.35 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.352 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . 0.439 ' N ' ' O ' ' A' ' 310' ' ' ARG . 6.8 tt -62.33 -43.23 99.3 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 121.041 0.448 . . . . 0.0 110.531 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 . . . . . 0 C--O 1.22 -0.453 0 CA-C-O 117.97 -1.014 . . . . 0.0 110.436 -179.949 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -99.8 135.81 40.66 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.114 0.483 . . . . 0.0 110.503 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.497 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -91.63 178.7 1.64 Allowed Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.53 -179.857 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.497 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.4 Cg_exo -61.62 147.67 94.82 Favored 'Trans proline' 0 C--N 1.3 -2.023 0 C-N-CA 122.901 2.401 . . . . 0.0 112.113 179.53 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 35.1 ptt180 -135.02 142.16 46.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.64 179.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -78.93 116.95 19.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.51 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.6 tp -110.53 131.27 62.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.445 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.9 t -70.84 142.93 51.24 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.655 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 141' ' ' ILE . 24.6 t70 -141.05 177.36 8.11 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.468 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.454 ' OG ' ' O ' ' A' ' 141' ' ' ILE . 78.3 p -73.15 -36.75 66.7 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.696 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -47.68 -95.01 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.303 -179.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.425 ' C ' ' HG1' ' A' ' 36' ' ' THR . . . -165.95 -25.28 0.02 OUTLIER Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.425 ' HG1' ' C ' ' A' ' 35' ' ' GLY . 58.2 m -168.93 106.74 0.43 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.862 0.363 . . . . 0.0 110.632 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 36.4 t60 -129.79 144.49 51.33 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 121.066 0.46 . . . . 0.0 110.114 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.485 ' CG2' ' N ' ' A' ' 39' ' ' LEU . 97.2 m -128.59 166.63 18.49 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.49 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.485 ' N ' ' CG2' ' A' ' 38' ' ' THR . 82.2 mt -121.15 127.8 51.9 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.43 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -64.17 -44.48 91.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.716 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 37.9 p -165.55 155.03 12.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.387 179.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.458 ' N ' ' CD ' ' A' ' 42' ' ' GLN . 14.4 mp0 -42.71 100.28 0.22 Allowed Pre-proline 0 C--N 1.33 -0.261 0 O-C-N 123.352 0.408 . . . . 0.0 110.594 179.261 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -56.88 129.07 32.59 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 122.313 2.008 . . . . 0.0 112.239 -179.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -83.82 -24.13 31.1 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.552 179.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.541 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.5 mtm-85 -121.18 134.11 55.2 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.202 0.525 . . . . 0.0 110.192 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.0 mt -130.43 133.51 63.68 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.272 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.798 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 47.5 t -125.0 130.89 73.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 179.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.502 ' O ' ' O ' ' A' ' 66' ' ' ALA . 5.0 m -154.05 166.48 32.89 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.586 179.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 70.0 p -124.83 8.37 8.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.435 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.81 125.87 33.59 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.643 -179.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 86.5 t -65.7 -44.61 93.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.543 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.7 m -62.62 -44.15 97.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.561 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 53.5 tp -62.38 -41.58 98.74 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.534 -179.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 72.5 m -57.83 -44.42 86.45 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.267 -179.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.4 -62.17 5.34 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 179.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.6 t -48.18 -35.62 12.08 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.8 mt -61.86 -44.34 97.01 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.229 179.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.2 mp -65.43 -41.49 93.48 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.246 178.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.58 -41.13 98.4 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.906 -179.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.0 tp -88.21 16.73 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.857 -179.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 56.51 84.34 0.09 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.753 -179.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.24 57.98 0.07 OUTLIER Pre-proline 0 C--N 1.328 -0.359 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -179.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -51.13 153.39 9.31 Favored 'Trans proline' 0 C--N 1.293 -2.351 0 C-N-CA 123.029 2.486 . . . . 0.0 112.11 -178.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.429 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -109.06 146.01 15.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.332 -179.681 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 97.0 mt -63.62 -45.48 97.43 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.338 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.502 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -129.8 134.58 47.66 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.519 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.482 ' O ' ' N ' ' A' ' 98' ' ' LEU . 73.3 m -134.57 158.82 43.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.838 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.99 139.36 16.17 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.467 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.93 -162.66 0.08 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.967 0.413 . . . . 0.0 110.423 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.482 ' O ' ' C ' ' A' ' 71' ' ' THR . 13.8 t -133.45 135.49 44.58 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.389 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.482 ' C ' ' O ' ' A' ' 70' ' ' THR . 0.7 OUTLIER 29.72 68.94 0.64 Allowed Pre-proline 0 N--CA 1.466 0.354 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.729 -179.883 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_exo -61.52 145.39 97.9 Favored 'Trans proline' 0 C--N 1.3 -2.026 0 C-N-CA 122.714 2.276 . . . . 0.0 111.837 -178.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.527 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 46.4 p-10 -160.49 -31.96 0.06 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.742 179.69 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.527 ' N ' ' OD1' ' A' ' 73' ' ' ASN . 99.1 m-20 -64.51 -39.21 93.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.317 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 -60.63 -48.09 83.32 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.52 -179.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.426 ' O ' ' O ' ' A' ' 77' ' ' ALA . 94.0 t -60.19 -24.9 31.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.373 -0.376 . . . . 0.0 109.999 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.426 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -45.45 172.69 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.648 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.568 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.7 p30 -61.67 177.57 0.4 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.513 -179.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.6 ' C ' ' H ' ' A' ' 81' ' ' GLY . 36.0 p30 -46.27 85.65 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.005 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.568 ' N ' ' O ' ' A' ' 78' ' ' ASP . 42.8 tp60 -67.08 13.54 0.06 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.194 0.521 . . . . 0.0 110.169 -179.822 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.6 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 117.87 -21.93 10.13 Favored Glycine 0 N--CA 1.461 0.309 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -107.83 116.29 31.69 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.985 0.422 . . . . 0.0 110.466 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 75.7 mt -98.84 0.79 44.99 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.502 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -91.94 6.5 46.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.019 0.438 . . . . 0.0 110.397 -179.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.445 ' O ' ' CG2' ' A' ' 89' ' ' VAL . 88.2 mt-30 -100.16 -27.0 13.75 Favored 'General case' 0 C--O 1.222 -0.385 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.78 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.4 t-105 -64.31 -40.64 96.34 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.021 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.551 ' O ' ' N ' ' A' ' 91' ' ' LYS . 68.5 m -77.75 -53.75 7.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.164 -179.567 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -48.33 -50.55 29.91 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.08 -179.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.445 ' CG2' ' O ' ' A' ' 85' ' ' GLN . 14.8 m -69.08 -40.88 81.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 120.9 0.381 . . . . 0.0 111.113 179.602 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.414 ' H ' HG23 ' A' ' 89' ' ' VAL . . . -71.94 -22.82 61.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.655 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.551 ' N ' ' O ' ' A' ' 87' ' ' SER . 65.8 tttm -61.64 -46.13 91.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.428 -179.512 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.441 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.8 mm-40 -90.15 -94.44 0.12 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.152 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.62 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.9 mtt180 -143.49 59.79 1.39 Allowed 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.451 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.6 pttp 33.87 26.28 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.017 0.437 . . . . 0.0 110.286 -179.405 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.62 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.5 tt -48.27 123.14 6.03 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.011 -177.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -83.41 -170.6 3.13 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.148 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.62 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 82.5 mtp180 -73.12 137.85 45.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.308 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.482 ' N ' ' O ' ' A' ' 67' ' ' SER . 88.7 mt -86.58 -166.14 1.47 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.793 -179.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.532 ' CD2' ' O ' ' A' ' 99' ' ' TYR . 47.8 p90 -167.89 119.9 0.86 Allowed 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.198 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.5 ' C ' ' O ' ' A' ' 99' ' ' TYR . 43.4 mm -29.44 121.18 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.005 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 113.64 28.25 3.28 Favored Glycine 0 CA--C 1.519 0.342 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 -179.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.58 ' N ' ' CD ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -144.0 46.15 0.62 Allowed Pre-proline 0 C--N 1.323 -0.582 0 CA-C-O 121.013 0.435 . . . . 0.0 110.428 179.764 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 29.5 Cg_endo -62.29 143.87 94.55 Favored 'Trans proline' 0 C--N 1.295 -2.246 0 C-N-CA 122.684 2.256 . . . . 0.0 111.844 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.686 ' HG ' ' H ' ' A' ' 107' ' ' ALA . 26.8 t -173.13 120.69 0.36 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.319 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.37 -40.94 63.97 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.075 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -65.92 -39.86 90.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.814 -179.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.686 ' H ' ' HG ' ' A' ' 104' ' ' SER . . . -64.01 -39.64 94.56 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.771 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 69.0 t -67.72 -43.74 86.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.724 179.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.43 -39.29 92.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.446 -179.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.441 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.66 -23.71 63.29 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.496 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.549 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.3 mm-40 -91.39 5.13 50.53 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.722 -179.563 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.549 ' C ' ' O ' ' A' ' 111' ' ' GLN . 10.4 tpt 21.96 64.84 0.32 Allowed Pre-proline 0 N--CA 1.467 0.408 0 CA-C-O 120.934 0.397 . . . . 0.0 111.157 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -79.45 169.59 18.43 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 123.023 2.482 . . . . 0.0 111.698 -177.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.491 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 98.9 m-20 -113.12 -44.07 3.31 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.022 179.6 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.3 tp -120.09 120.69 36.98 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 96.4 mt -118.24 130.87 72.46 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.342 0 CA-C-O 120.904 0.383 . . . . 0.0 110.962 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 32.3 mt -105.77 132.71 51.56 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.04 0.448 . . . . 0.0 110.287 -179.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 97.9 mt -117.9 135.74 57.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.673 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 85.5 p -71.7 153.42 42.05 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.593 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.11 -50.2 74.62 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.635 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -149.34 153.8 38.0 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.52 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 169.88 -170.51 42.85 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -63.08 -35.14 91.68 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.453 ' O ' ' OD1' ' A' ' 124' ' ' ASP . 44.4 p-10 -87.75 119.52 28.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.834 0.349 . . . . 0.0 110.701 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 41.1 t -63.47 144.51 56.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.406 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.61 -42.33 9.25 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.775 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.4 tp -62.86 -42.22 99.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.649 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.41 -11.11 59.18 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.441 -179.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 84.5 mt -114.92 -24.55 8.58 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.647 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . 0.519 ' N ' ' O ' ' A' ' 126' ' ' ALA . 80.8 t80 -51.37 -49.91 60.58 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.649 -178.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.502 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.8 p-10 -65.72 -41.91 91.7 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.879 0.371 . . . . 0.0 111.317 179.429 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.502 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 87.8 mt-30 -67.88 -37.16 81.43 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.847 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 93.7 mt -79.7 -42.37 24.81 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.987 -179.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.3 t -56.94 -44.96 83.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.298 -179.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.8 m -62.32 -45.58 92.6 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.58 179.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 92.9 mt -62.49 -44.03 98.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.391 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.86 164.2 6.39 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.598 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -43.32 111.66 0.24 Allowed 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.507 2.138 . . . . 0.0 112.243 179.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 17.1 m -86.12 127.34 34.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.675 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 34.9 tp -119.48 137.48 53.76 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.107 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.454 ' O ' ' OG ' ' A' ' 33' ' ' SER . 78.2 mt -104.82 120.74 55.79 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 CA-C-O 121.154 0.502 . . . . 0.0 111.213 -179.352 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 94.3 mt -136.44 132.55 49.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.576 179.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.517 HD22 ' CG ' ' A' ' 241' ' ' ASP . 56.1 t30 -64.47 151.65 43.77 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.941 0.4 . . . . 0.0 110.43 179.262 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.522 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 88.1 t80 -85.57 122.71 30.08 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.966 -179.492 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.522 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 99.0 m-20 54.95 69.44 0.73 Allowed 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.741 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 49.3 p-10 -123.87 0.07 8.56 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.844 0.354 . . . . 0.0 110.638 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -151.46 117.03 5.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.766 -179.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' SER . . . . . 0.519 ' HG ' ' H ' ' A' ' 150' ' ' GLN . 85.1 p -62.91 167.6 4.59 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.558 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.409 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.5 p-90 -50.56 -15.69 0.29 Allowed 'General case' 0 C--O 1.223 -0.322 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.469 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . 0.519 ' H ' ' HG ' ' A' ' 148' ' ' SER . 68.0 tp60 -71.3 -74.57 0.15 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.496 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.448 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.2 t -62.75 -39.07 92.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.18 179.572 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 52.1 tp -60.08 -45.7 92.05 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.403 -178.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.409 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 46.8 tp -62.67 -41.64 99.19 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.529 178.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.448 ' OG1' ' O ' ' A' ' 151' ' ' SER . 53.4 p -64.02 -34.71 78.63 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.192 -179.425 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.48 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.8 mm-40 -63.82 -42.08 97.73 Favored 'General case' 0 C--O 1.226 -0.178 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.273 179.26 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 90.8 mt -65.44 -38.82 91.0 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.096 0.474 . . . . 0.0 110.203 179.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.567 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.46 -31.94 79.31 Favored Glycine 0 CA--C 1.52 0.353 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 -179.267 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.48 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.3 mt-10 -37.04 -25.17 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.818 0.342 . . . . 0.0 110.799 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.567 ' N ' ' O ' ' A' ' 157' ' ' GLY . 93.4 mt -59.79 149.63 6.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.323 179.285 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 76.5 p -68.99 137.26 53.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.935 -179.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 70.36 22.47 77.63 Favored Glycine 0 N--CA 1.459 0.184 0 N-CA-C 111.211 -0.756 . . . . 0.0 111.211 179.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 62.0 m80 -124.29 -14.63 6.92 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.681 0.276 . . . . 0.0 110.48 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -67.02 -59.41 3.5 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.628 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -51.78 -49.26 63.04 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.119 -179.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -60.7 -41.09 94.5 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.894 -0.322 . . . . 0.0 110.45 179.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.48 -47.69 84.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.567 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.53 -40.25 74.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.244 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -61.56 -50.1 74.01 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.631 179.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -65.3 -43.57 90.68 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.523 179.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 94.4 mt -64.61 -43.38 96.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.366 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.35 -51.41 69.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.378 -179.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -63.51 -43.69 96.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.614 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . 0.519 ' CD1' ' OH ' ' A' ' 301' ' ' TYR . 56.3 t80 -62.88 -44.32 96.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.077 0.465 . . . . 0.0 110.407 179.475 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -63.32 -39.61 95.04 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.659 -179.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -63.15 -42.78 99.5 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.55 179.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -60.76 -44.74 96.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.238 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 85.1 mt -64.66 -41.05 96.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.73 178.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.12 -62.21 1.78 Allowed 'General case' 0 C--O 1.238 0.479 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.37 -179.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.61 -46.66 86.54 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.58 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.27 -41.49 65.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.34 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -64.05 -33.78 76.54 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.011 0.434 . . . . 0.0 110.235 179.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 69.7 tt0 -90.76 8.86 32.51 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.538 0.685 . . . . 0.0 110.371 -178.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -104.73 -32.13 9.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.18 179.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.7 pt -127.96 147.69 32.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.807 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -139.98 131.23 26.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.428 179.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.554 ' CD2' ' N ' ' A' ' 186' ' ' LEU . 3.5 mm? -85.38 133.15 42.95 Favored Pre-proline 0 N--CA 1.452 -0.358 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.077 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -43.78 157.86 0.13 Allowed 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.714 2.276 . . . . 0.0 112.316 179.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . 0.51 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.6 Cg_endo -62.91 114.84 2.6 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 C-N-CA 122.804 2.336 . . . . 0.0 111.746 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . 0.51 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.7 mt-30 155.63 147.69 0.0 OUTLIER Pre-proline 0 N--CA 1.457 -0.113 0 O-C-N 123.916 0.76 . . . . 0.0 110.825 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -73.48 144.18 35.81 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.672 2.248 . . . . 0.0 112.213 177.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.492 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.1 p -124.96 158.97 32.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.319 0.581 . . . . 0.0 110.212 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' THR . . . . . 0.492 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 35.8 p -143.28 165.11 28.38 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.034 -179.704 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -135.38 128.72 32.15 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 121.244 0.545 . . . . 0.0 110.281 179.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 47.5 pt -146.46 148.87 16.55 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.348 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.13 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 69.0 t -117.59 123.23 71.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.32 0.581 . . . . 0.0 109.836 178.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -134.4 107.01 7.35 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.336 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 95.3 m -130.7 130.59 44.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.813 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.405 ' O ' ' N ' ' A' ' 201' ' ' HIS . . . -82.82 -37.04 25.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.21 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.33 -67.21 0.25 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.328 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.16 -9.84 58.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.299 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . 0.405 ' N ' ' O ' ' A' ' 198' ' ' ALA . 59.8 t-80 60.64 58.34 2.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.85 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 31.8 p -167.21 153.76 8.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.555 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.3 144.04 24.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.049 0.452 . . . . 0.0 110.398 179.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -135.18 138.01 43.23 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.714 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 19.7 mt -105.96 125.32 50.85 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.083 0.468 . . . . 0.0 109.843 -179.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' TRP . . . . . 0.554 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 74.6 m95 -81.98 166.98 19.35 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.543 -179.693 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -157.21 171.24 7.7 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.581 -179.083 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.31 -36.92 80.28 Favored 'Trans proline' 0 C--N 1.302 -1.874 0 C-N-CA 122.612 2.208 . . . . 0.0 112.32 179.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -70.86 -35.02 72.21 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.713 -179.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 21.5 m -61.16 150.64 33.62 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.602 -179.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.68 -37.0 82.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.445 -179.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . 0.554 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 54.9 tt0 -64.7 -40.26 95.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.498 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.71 -43.44 91.87 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -63.11 -43.96 96.97 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.803 0.335 . . . . 0.0 110.283 179.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 65.1 ttp -59.26 -48.12 82.81 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.123 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 87.3 mt -60.52 -41.04 93.61 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . 0.451 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.0 tp10 -57.94 -37.89 74.93 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.059 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -65.34 -38.18 89.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.655 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 94.2 mt -64.08 -42.93 96.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.074 0.464 . . . . 0.0 110.596 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.89 44.74 0.08 OUTLIER Glycine 0 C--N 1.332 0.339 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . 0.451 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 26.3 m-85 -127.74 155.64 43.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.987 0.422 . . . . 0.0 110.498 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 222' ' ' THR . . . . . 0.449 ' O ' ' O ' ' A' ' 191' ' ' VAL . 7.4 p -107.36 122.49 46.7 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.285 0.564 . . . . 0.0 110.132 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . 0.44 ' CD2' ' N ' ' A' ' 223' ' ' LEU . 4.3 mm? -101.64 132.7 47.18 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.101 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.4 159.95 14.67 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.476 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.55 115.36 30.11 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.348 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.451 ' CD1' ' N ' ' A' ' 226' ' ' LEU . 8.9 mp -53.37 156.7 3.94 Favored Pre-proline 0 N--CA 1.452 -0.36 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.725 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -59.91 145.1 99.13 Favored 'Trans proline' 0 C--N 1.301 -1.959 0 C-N-CA 122.688 2.259 . . . . 0.0 112.226 179.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.3 -3.14 59.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.584 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.14 -41.0 5.66 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 111.034 -0.827 . . . . 0.0 111.034 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.524 ' O ' ' N ' ' A' ' 233' ' ' SER . 85.3 mt -79.12 -16.98 55.91 Favored 'General case' 0 C--O 1.22 -0.45 0 CA-C-O 121.062 0.458 . . . . 0.0 110.326 -179.694 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 54.5 t-20 -40.43 -49.06 2.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.77 -179.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -87.97 15.16 7.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.323 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 233' ' ' SER . . . . . 0.524 ' N ' ' O ' ' A' ' 230' ' ' LEU . 77.9 p -60.43 -35.41 75.75 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.711 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . 0.526 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.6 tt0 -118.8 -69.36 0.85 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.901 179.329 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.2 m -69.95 102.88 2.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.707 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -94.31 57.72 2.35 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.339 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -144.71 -122.65 1.59 Allowed Glycine 0 CA--C 1.519 0.332 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -134.79 111.62 10.06 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.125 0.488 . . . . 0.0 110.371 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . 0.521 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.4 mtt180 -148.03 57.94 1.09 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.672 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -69.68 -31.88 70.18 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.538 179.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . 0.517 ' CG ' HD22 ' A' ' 143' ' ' ASN . 64.7 t0 -56.98 -47.09 81.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.328 -179.096 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 242' ' ' ILE . . . . . 0.435 ' O ' ' O ' ' A' ' 239' ' ' ARG . 17.6 tt -140.19 156.92 24.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.904 0.383 . . . . 0.0 110.475 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 96.2 mt -106.17 106.58 20.85 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.199 0 CA-C-O 121.097 0.475 . . . . 0.0 110.531 179.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . 0.521 ' OE1' ' NH1' ' A' ' 239' ' ' ARG . 88.2 mt-30 -110.51 110.17 20.79 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.363 179.687 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 9.5 mp -121.68 -168.33 1.68 Allowed 'General case' 0 C--O 1.224 -0.264 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.639 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . 0.526 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.61 -16.64 0.05 OUTLIER Glycine 0 CA--C 1.523 0.564 0 N-CA-C 110.999 -0.841 . . . . 0.0 110.999 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . 0.693 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -60.81 156.81 31.64 Favored Glycine 0 CA--C 1.522 0.476 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -63.73 21.79 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.012 0.434 . . . . 0.0 110.643 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . 0.693 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.7 m-20 -97.44 -5.97 34.94 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.515 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 92.2 mt -79.78 -21.71 44.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.769 179.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.51 -51.37 70.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.715 -179.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.37 -5.48 58.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.494 179.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.08 -74.39 1.14 Allowed Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 81.5 mt -70.0 125.98 28.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.908 0.385 . . . . 0.0 110.297 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -59.91 -39.07 84.16 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.208 -179.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 83.29 51.69 4.05 Favored Glycine 0 CA--C 1.521 0.423 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -95.2 -15.67 23.09 Favored 'General case' 0 C--N 1.331 -0.214 0 O-C-N 122.746 -0.267 . . . . 0.0 110.591 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 258' ' ' SER . . . . . 0.426 ' O ' ' O ' ' A' ' 192' ' ' THR . 3.3 t 174.54 89.3 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.099 0.476 . . . . 0.0 110.1 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . 0.591 ' N ' ' CD1' ' A' ' 259' ' ' LEU . 1.0 OUTLIER -94.4 124.24 38.3 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.206 0.527 . . . . 0.0 111.259 -179.072 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 15.9 m-30 -93.34 146.41 23.75 Favored 'General case' 0 CA--C 1.501 -0.917 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.395 179.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 85.9 mt -122.25 149.7 43.32 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.551 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.655 ' CG ' ' N ' ' A' ' 263' ' ' ALA . 2.6 p90 -77.37 -138.69 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.666 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . 0.655 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -51.78 77.35 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 121.035 0.445 . . . . 0.0 111.174 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . 0.626 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.15 104.75 0.19 Allowed Glycine 0 CA--C 1.527 0.824 0 N-CA-C 110.554 -1.019 . . . . 0.0 110.554 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 265' ' ' ASP . . . . . 0.601 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.7 m-20 -80.34 -177.94 6.39 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.64 0.257 . . . . 0.0 110.928 -179.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -40.26 -17.73 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.576 179.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . 0.601 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.31 -51.74 41.34 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.71 179.287 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -63.55 -46.64 85.04 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.236 179.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . 0.525 ' O ' ' CD2' ' A' ' 273' ' ' TYR . . . -61.66 -35.04 76.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.349 0.595 . . . . 0.0 109.843 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -63.09 -34.06 76.79 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.204 179.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.87 -43.28 13.39 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.108 -179.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 272' ' ' ILE . . . . . 0.618 ' C ' ' H ' ' A' ' 274' ' ' ALA . 4.8 tt -51.31 -33.48 14.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.737 -178.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 273' ' ' TYR . . . . . 0.525 ' CD2' ' O ' ' A' ' 269' ' ' ALA . 17.1 m-85 -54.81 -1.72 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.665 -179.44 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 274' ' ' ALA . . . . . 0.618 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.65 -39.81 70.11 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.952 179.428 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . 0.58 ' O ' ' N ' ' A' ' 279' ' ' ALA . 3.2 p30 -39.02 98.05 0.16 Allowed Pre-proline 0 C--O 1.227 -0.124 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.474 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -54.48 -42.81 64.63 Favored 'Trans proline' 0 C--N 1.303 -1.862 0 C-N-CA 122.42 2.08 . . . . 0.0 112.543 -178.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 89.3 mt -64.4 -42.91 95.83 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.126 0.488 . . . . 0.0 111.158 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 91.2 mt -95.57 -1.77 49.78 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.874 -179.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 279' ' ' ALA . . . . . 0.58 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.25 -34.87 77.36 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.755 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.2 20.11 0.11 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.998 -179.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . 0.513 ' H ' ' C ' ' A' ' 279' ' ' ALA . 13.9 mt -75.2 119.69 78.16 Favored Pre-proline 0 N--CA 1.448 -0.545 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.688 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -49.97 -40.01 49.61 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.678 2.252 . . . . 0.0 112.238 178.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.56 -50.56 62.7 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.118 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 71.8 t -61.46 -43.82 97.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 110.04 -0.355 . . . . 0.0 110.04 179.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -57.84 -41.28 81.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.198 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -90.96 0.29 57.56 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.129 179.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt 59.47 43.04 16.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.844 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -94.49 41.51 1.09 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.429 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 53.8 t -119.03 135.62 58.87 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.156 0 CA-C-O 121.072 0.463 . . . . 0.0 110.111 -179.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -132.85 162.75 30.71 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.153 0.502 . . . . 0.0 110.629 -179.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.69 154.98 33.28 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.015 0.436 . . . . 0.0 110.699 -179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 81.6 mt -93.96 -1.52 54.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.247 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.66 165.88 12.71 Favored Glycine 0 CA--C 1.521 0.45 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 6.5 m -87.8 -62.2 1.55 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.864 0.364 . . . . 0.0 111.008 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 295' ' ' GLU . . . . . 0.484 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.6 mm-40 -69.35 -4.08 16.78 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.701 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 27.0 p -76.46 32.8 0.13 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.645 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 297' ' ' PHE . . . . . 0.484 ' H ' ' C ' ' A' ' 295' ' ' GLU . 85.7 t80 -60.39 -46.06 91.32 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.573 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . 0.62 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.2 mtt85 -81.45 135.06 35.62 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.569 -179.637 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 17.0 tp -114.24 117.77 32.07 Favored 'General case' 0 C--O 1.231 0.085 0 CA-C-O 121.005 0.431 . . . . 0.0 110.182 179.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . 0.603 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.4 p-10 -165.42 -176.38 3.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.624 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 301' ' ' TYR . . . . . 0.519 ' OH ' ' CD1' ' A' ' 173' ' ' PHE . 80.2 t80 -47.07 -43.39 20.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.348 -179.65 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -67.01 -40.49 87.3 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.024 0.44 . . . . 0.0 110.747 179.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 303' ' ' SER . . . . . 0.603 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 60.3 p -55.71 -36.5 67.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.074 -179.193 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -57.08 -51.69 68.27 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 179.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 91.2 mtp -55.97 -43.92 78.01 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -66.2 -42.64 88.51 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.141 0.495 . . . . 0.0 110.257 179.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 55.4 t -64.15 -42.82 96.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.26 179.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 43.1 tp -59.74 -42.15 92.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.871 -179.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -62.63 -38.78 91.57 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.237 179.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 310' ' ' ARG . . . . . 0.45 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.6 ttt85 -63.56 -43.86 95.8 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.246 179.538 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 90.3 mt -63.0 -42.12 99.77 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.311 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -62.94 -33.16 74.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.113 179.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.97 -23.31 21.57 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.318 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . 0.45 ' N ' ' O ' ' A' ' 310' ' ' ARG . 6.7 tt -62.27 -43.19 99.4 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 121.055 0.455 . . . . 0.0 110.52 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 . . . . . 0 C--O 1.22 -0.466 0 CA-C-O 118.055 -0.974 . . . . 0.0 110.405 -179.95 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -99.63 136.43 39.58 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.016 0.436 . . . . 0.0 110.538 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.497 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -91.71 178.46 1.74 Allowed Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.58 -179.882 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.497 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.5 Cg_exo -61.69 147.5 95.18 Favored 'Trans proline' 0 C--N 1.3 -2.007 0 C-N-CA 122.778 2.318 . . . . 0.0 112.123 179.639 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 35.4 ptt180 -135.76 142.65 44.98 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.655 179.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -79.11 116.96 19.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.501 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.6 tp -110.32 130.86 62.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.408 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 13.3 t -71.14 141.93 50.74 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.53 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.429 ' CG ' ' H ' ' A' ' 33' ' ' SER . 25.1 t70 -139.87 177.88 7.65 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.517 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.449 ' OG ' ' O ' ' A' ' 141' ' ' ILE . 78.0 p -73.73 -36.59 65.2 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.688 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.8 ttt85 -47.78 -95.25 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.269 -179.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.517 ' C ' ' HG1' ' A' ' 36' ' ' THR . . . -165.22 -26.06 0.02 OUTLIER Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.517 ' HG1' ' C ' ' A' ' 35' ' ' GLY . 67.5 m -168.32 106.79 0.49 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.889 0.376 . . . . 0.0 110.652 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 33.4 t60 -129.71 143.56 50.88 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.027 0.442 . . . . 0.0 110.152 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.481 ' CG2' ' N ' ' A' ' 39' ' ' LEU . 97.5 m -128.18 166.12 19.13 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.636 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.481 ' N ' ' CG2' ' A' ' 38' ' ' THR . 81.1 mt -120.78 127.61 52.12 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.523 179.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -64.42 -44.26 91.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.656 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 41.5 p -165.68 154.84 11.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.424 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.452 ' N ' ' CD ' ' A' ' 42' ' ' GLN . 13.7 mp0 -43.42 100.69 0.23 Allowed Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.636 179.467 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -56.85 129.33 34.01 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 122.399 2.066 . . . . 0.0 112.262 -179.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -83.88 -23.95 31.05 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.45 179.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.544 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.3 mtm-85 -120.9 134.26 55.29 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 121.132 0.492 . . . . 0.0 110.202 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 95.9 mt -130.65 133.48 63.39 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.939 -179.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 49.1 t -125.05 131.06 73.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.825 0.345 . . . . 0.0 110.119 179.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.51 ' O ' ' O ' ' A' ' 66' ' ' ALA . 5.1 m -154.41 166.16 34.13 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.506 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 65.0 p -124.94 8.5 8.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.501 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.71 125.75 33.44 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.686 -179.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 88.6 t -65.75 -44.65 93.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.47 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 20.0 m -62.53 -44.29 96.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.605 -179.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 51.2 tp -62.28 -41.51 98.55 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.572 -179.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 70.6 m -57.67 -44.36 85.7 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.343 -179.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.48 -61.91 5.55 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.929 -0.869 . . . . 0.0 110.929 179.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.7 t -48.51 -35.67 13.64 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 20.0 mt -61.77 -44.72 96.33 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.661 -0.416 . . . . 0.0 111.126 179.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.403 HD12 ' N ' ' A' ' 58' ' ' LEU . 9.2 mp -64.96 -41.8 95.16 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.189 178.024 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.62 -41.27 98.29 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.947 -179.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.0 tp -88.13 16.7 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.771 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 56.61 84.28 0.09 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.653 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.37 57.38 0.07 OUTLIER Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.058 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -50.3 153.19 7.39 Favored 'Trans proline' 0 C--N 1.296 -2.199 0 C-N-CA 122.874 2.383 . . . . 0.0 112.388 -178.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.428 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.4 OUTLIER -109.03 146.38 14.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.367 -179.699 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 97.1 mt -63.79 -45.16 97.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.368 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.51 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -130.31 134.83 47.49 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.575 -179.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.464 ' O ' ' N ' ' A' ' 98' ' ' LEU . 73.8 m -134.52 158.73 43.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.843 -179.675 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.35 138.94 16.3 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.46 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.86 -162.7 0.08 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.996 0.427 . . . . 0.0 110.515 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.492 ' O ' ' C ' ' A' ' 71' ' ' THR . 5.9 t -133.74 135.94 44.27 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.192 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.492 ' C ' ' O ' ' A' ' 70' ' ' THR . 1.0 OUTLIER 29.55 68.57 0.65 Allowed Pre-proline 0 N--CA 1.465 0.3 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.715 -179.7 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -61.25 144.57 98.8 Favored 'Trans proline' 0 C--N 1.301 -1.964 0 C-N-CA 122.668 2.245 . . . . 0.0 112.092 -178.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.519 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 45.7 p-10 -159.87 -31.61 0.06 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.717 179.709 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.519 ' N ' ' OD1' ' A' ' 73' ' ' ASN . 98.7 m-20 -64.52 -38.92 92.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.46 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 73.2 ttt180 -60.87 -47.9 84.25 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.752 -179.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.422 ' O ' ' O ' ' A' ' 77' ' ' ALA . 94.6 t -60.36 -24.6 31.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.324 -0.398 . . . . 0.0 109.927 179.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.422 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -45.53 172.58 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.5 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.576 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.5 p30 -61.78 177.73 0.4 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.706 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.601 ' C ' ' H ' ' A' ' 81' ' ' GLY . 35.8 p30 -46.11 85.58 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.909 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.576 ' N ' ' O ' ' A' ' 78' ' ' ASP . 43.1 tp60 -67.01 13.62 0.06 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.139 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.601 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 117.78 -22.13 10.1 Favored Glycine 0 CA--C 1.52 0.355 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -107.94 116.52 32.11 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.016 0.436 . . . . 0.0 110.486 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 76.7 mt -98.83 0.86 45.16 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.453 -179.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -91.94 6.48 46.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.972 0.415 . . . . 0.0 110.388 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.447 ' O ' ' CG2' ' A' ' 89' ' ' VAL . 88.0 mt-30 -100.04 -27.27 13.65 Favored 'General case' 0 C--O 1.223 -0.29 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.77 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.5 t-105 -63.87 -40.78 97.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.015 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.555 ' O ' ' N ' ' A' ' 91' ' ' LYS . 67.7 m -77.63 -53.62 7.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.328 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -48.41 -50.85 29.36 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.972 -179.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.447 ' CG2' ' O ' ' A' ' 85' ' ' GLN . 15.1 m -68.89 -40.74 81.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 120.9 0.381 . . . . 0.0 110.984 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.411 ' H ' HG23 ' A' ' 89' ' ' VAL . . . -72.24 -22.59 61.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.704 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.555 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.0 tttm -61.47 -46.19 91.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.437 -179.545 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.438 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.6 mm-40 -90.32 -94.2 0.12 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.149 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.632 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.9 mtt180 -143.44 59.82 1.39 Allowed 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.461 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.6 pttp 33.69 26.18 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.259 -179.247 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.632 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.4 tt -47.87 123.23 5.8 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.969 -178.185 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -83.51 -170.29 2.98 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.08 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.617 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 83.0 mtp180 -73.22 137.8 45.21 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.311 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.464 ' N ' ' O ' ' A' ' 67' ' ' SER . 87.9 mt -86.95 -166.03 1.46 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.721 -179.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.53 ' CD2' ' O ' ' A' ' 99' ' ' TYR . 48.0 p90 -168.06 120.31 0.86 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.236 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.509 ' C ' ' O ' ' A' ' 99' ' ' TYR . 43.5 mm -29.87 121.64 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.956 -179.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 113.72 28.12 3.31 Favored Glycine 0 CA--C 1.52 0.384 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 -179.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.584 ' N ' ' CD ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -143.98 45.87 0.6 Allowed Pre-proline 0 C--N 1.324 -0.536 0 CA-C-O 120.922 0.392 . . . . 0.0 110.43 179.867 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.584 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 29.8 Cg_endo -62.0 143.74 95.51 Favored 'Trans proline' 0 C--N 1.298 -2.109 0 C-N-CA 122.678 2.252 . . . . 0.0 112.004 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.71 ' HG ' ' H ' ' A' ' 107' ' ' ALA . 26.8 t -173.47 120.62 0.33 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.459 179.649 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.12 -41.1 64.36 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.089 0.471 . . . . 0.0 111.165 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -65.87 -40.06 91.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.792 -179.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.71 ' H ' ' HG ' ' A' ' 104' ' ' SER . . . -63.83 -39.89 95.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.698 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 69.6 t -67.66 -43.84 86.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.763 179.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.23 -39.46 92.89 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.566 -179.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.438 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.48 -23.5 62.81 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.469 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.561 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.3 mm-40 -91.35 4.99 51.02 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.755 -179.561 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.561 ' C ' ' O ' ' A' ' 111' ' ' GLN . 10.3 tpt 22.33 64.65 0.33 Allowed Pre-proline 0 N--CA 1.465 0.281 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.039 -179.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -79.12 169.57 18.96 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 C-N-CA 122.957 2.438 . . . . 0.0 112.059 -178.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.485 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 99.0 m-20 -113.32 -44.16 3.27 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.172 179.399 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 41.3 tp -120.26 120.44 36.11 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 96.2 mt -117.96 131.24 71.29 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 CA-C-O 120.999 0.428 . . . . 0.0 110.884 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.495 ' CD1' ' HG ' ' A' ' 48' ' ' SER . 31.4 mt -105.92 132.87 51.5 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.148 0.499 . . . . 0.0 110.204 -179.424 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 97.8 mt -118.27 135.93 57.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.701 -179.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 85.9 p -72.09 153.74 41.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.613 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.19 -50.21 74.58 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.689 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -149.35 153.76 37.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.56 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 169.54 -170.0 42.39 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.82 -35.06 91.45 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.446 ' O ' ' OD1' ' A' ' 124' ' ' ASP . 44.1 p-10 -88.91 119.41 29.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.84 0.352 . . . . 0.0 110.7 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 36.4 t -63.29 145.26 55.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.519 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.52 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.39 -43.8 8.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.958 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.4 tp -62.73 -42.34 99.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.73 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.49 -10.97 56.59 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.564 -179.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 83.9 mt -116.26 -23.59 8.33 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.651 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . 0.52 ' N ' ' O ' ' A' ' 126' ' ' ALA . 77.7 t80 -51.47 -49.6 61.46 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.674 -0.411 . . . . 0.0 110.567 -179.008 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.5 p-10 -65.83 -41.94 91.17 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.846 0.355 . . . . 0.0 111.109 179.554 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.507 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 88.1 mt-30 -67.82 -36.96 81.29 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.777 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 93.0 mt -80.27 -41.98 24.0 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.927 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.2 t -57.5 -44.67 85.19 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.223 -179.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.2 m -62.3 -45.66 92.26 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.735 0.302 . . . . 0.0 110.596 179.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 91.8 mt -62.52 -43.86 98.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.406 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -170.1 163.51 6.32 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.506 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -42.78 111.13 0.19 Allowed 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.469 2.112 . . . . 0.0 112.161 179.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 16.6 m -86.05 127.64 34.71 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.57 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 35.5 tp -119.99 138.39 53.51 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.032 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.449 ' O ' ' OG ' ' A' ' 33' ' ' SER . 77.7 mt -105.57 120.66 56.7 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.358 0 CA-C-O 121.109 0.48 . . . . 0.0 111.291 -179.427 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 97.9 mt -135.93 132.69 50.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.627 179.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.498 HD22 ' CG ' ' A' ' 241' ' ' ASP . 61.0 t30 -64.42 150.87 45.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.939 0.399 . . . . 0.0 110.402 179.407 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.518 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 88.7 t80 -85.69 122.09 29.29 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.913 -179.513 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.518 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 98.8 m-20 55.63 69.01 0.78 Allowed 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.812 179.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 35.9 p-10 -125.4 0.01 7.63 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.683 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -150.64 115.61 5.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.76 -179.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' SER . . . . . 0.524 ' HG ' ' H ' ' A' ' 150' ' ' GLN . 84.6 p -62.67 167.8 4.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.505 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.416 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.5 p-90 -51.09 -15.24 0.3 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.498 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . 0.524 ' H ' ' HG ' ' A' ' 148' ' ' SER . 68.1 tp60 -71.34 -75.01 0.14 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.475 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.45 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.2 t -62.78 -38.83 92.18 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.031 0.444 . . . . 0.0 110.305 179.506 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 52.6 tp -60.17 -45.56 92.68 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.42 -178.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.416 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 45.9 tp -62.8 -41.8 99.44 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.856 0.36 . . . . 0.0 110.375 179.068 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.45 ' OG1' ' O ' ' A' ' 151' ' ' SER . 57.8 p -63.95 -34.52 78.16 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.312 -179.597 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.471 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.6 mm-40 -64.1 -42.24 96.98 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.263 179.269 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 91.4 mt -65.45 -38.83 91.01 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.182 179.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.574 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.34 -31.82 78.62 Favored Glycine 0 CA--C 1.52 0.406 0 N-CA-C 110.846 -0.901 . . . . 0.0 110.846 -179.396 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.471 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.2 mt-10 -36.97 -25.1 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.809 0.338 . . . . 0.0 110.706 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.574 ' N ' ' O ' ' A' ' 157' ' ' GLY . 94.4 mt -59.94 149.59 6.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.317 179.473 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 76.8 p -68.91 137.14 53.58 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.059 -179.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 70.63 22.0 77.89 Favored Glycine 0 N--CA 1.459 0.177 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 179.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 60.4 m80 -123.72 -14.83 7.16 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.786 0.327 . . . . 0.0 110.507 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -66.96 -59.31 3.6 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.686 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -51.85 -49.4 62.94 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.188 -179.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -60.64 -41.21 94.48 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.803 0.335 . . . . 0.0 110.316 179.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.46 -47.45 85.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.589 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.59 -40.27 74.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.247 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -61.57 -50.1 73.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.578 179.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -65.47 -43.63 89.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.471 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 94.8 mt -64.46 -43.48 96.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.429 179.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.41 -51.16 70.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.525 -179.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.76 -43.78 95.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.375 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . 0.521 ' CD1' ' OH ' ' A' ' 301' ' ' TYR . 56.3 t80 -62.74 -44.53 95.97 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.069 0.462 . . . . 0.0 110.41 179.426 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -63.12 -39.8 95.76 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.611 -179.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -63.01 -42.8 99.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.617 179.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -60.69 -44.95 95.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.103 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 85.0 mt -64.52 -41.17 96.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.998 0.428 . . . . 0.0 110.642 178.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.02 -62.15 1.82 Allowed 'General case' 0 C--O 1.237 0.408 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.491 -179.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.86 -46.68 87.2 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.546 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.42 -41.66 66.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.176 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -63.91 -33.67 76.22 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.018 0.437 . . . . 0.0 110.387 179.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . 0.402 ' O ' ' HG2' ' A' ' 182' ' ' GLU . 69.6 tt0 -90.56 8.63 33.12 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.435 0.636 . . . . 0.0 110.56 -178.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -104.55 -32.0 9.17 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.183 179.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.9 pt -127.99 147.74 32.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.882 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -139.77 130.97 26.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.396 179.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.556 ' CD2' ' N ' ' A' ' 186' ' ' LEU . 3.6 mm? -85.73 133.06 42.46 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.852 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -44.24 157.99 0.15 Allowed 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.747 2.298 . . . . 0.0 112.119 179.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . 0.524 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 28.1 Cg_endo -63.08 115.21 2.82 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 C-N-CA 122.736 2.291 . . . . 0.0 111.773 179.749 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . 0.524 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.7 mt-30 155.61 147.63 0.0 OUTLIER Pre-proline 0 N--CA 1.454 -0.241 0 O-C-N 123.57 0.544 . . . . 0.0 110.727 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -73.81 143.73 33.85 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.767 2.311 . . . . 0.0 111.88 178.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.497 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.1 p -124.93 158.93 32.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.24 0.543 . . . . 0.0 110.124 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' THR . . . . . 0.497 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 36.9 p -143.41 165.37 27.71 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.092 -179.669 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -135.63 128.55 31.31 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 121.207 0.527 . . . . 0.0 110.224 179.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 47.2 pt -146.44 149.1 16.34 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.096 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 69.0 t -117.94 123.13 71.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.25 0.548 . . . . 0.0 109.767 179.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -134.24 107.41 7.66 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.252 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 94.7 m -131.33 130.51 42.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.823 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.409 ' O ' ' N ' ' A' ' 201' ' ' HIS . . . -82.93 -36.92 24.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.354 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.48 -66.88 0.28 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.331 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.35 -10.27 59.57 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.278 179.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . 0.409 ' N ' ' O ' ' A' ' 198' ' ' ALA . 60.0 t-80 61.42 58.16 2.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.715 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 39.4 p -167.09 153.55 8.29 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.552 179.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -150.97 143.63 24.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.46 179.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -135.04 138.03 43.51 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 120.926 0.393 . . . . 0.0 110.608 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 19.8 mt -106.16 125.39 50.94 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 121.057 0.456 . . . . 0.0 109.892 -179.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' TRP . . . . . 0.554 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 74.6 m95 -81.88 166.78 19.63 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.564 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -156.86 172.06 6.62 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.022 0.439 . . . . 0.0 110.505 -179.196 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.21 -36.85 87.23 Favored 'Trans proline' 0 C--N 1.303 -1.821 0 C-N-CA 122.624 2.216 . . . . 0.0 112.099 179.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -70.71 -34.84 72.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.822 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 21.3 m -61.3 150.68 34.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.642 -179.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.72 -36.92 82.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.472 -179.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . 0.554 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 55.0 tt0 -64.58 -40.37 95.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.491 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.71 -43.4 91.96 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -63.35 -43.8 96.66 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.924 -0.31 . . . . 0.0 110.294 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 65.1 ttp -59.53 -47.94 83.59 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.269 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 87.1 mt -60.61 -40.84 93.33 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . 0.453 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 40.9 tp10 -57.93 -38.03 75.17 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -65.35 -37.98 88.7 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.77 0.319 . . . . 0.0 110.672 179.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 94.4 mt -64.3 -42.69 96.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.521 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.51 45.07 0.08 OUTLIER Glycine 0 C--N 1.334 0.419 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . 0.453 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 26.1 m-85 -128.04 155.78 43.8 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.05 0.452 . . . . 0.0 110.467 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 222' ' ' THR . . . . . 0.453 ' O ' ' O ' ' A' ' 191' ' ' VAL . 7.2 p -107.66 122.57 46.99 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.3 0.572 . . . . 0.0 110.182 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . 0.442 ' CD2' ' N ' ' A' ' 223' ' ' LEU . 4.3 mm? -101.58 132.72 47.09 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.049 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.38 160.14 14.57 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.535 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -105.55 115.13 29.72 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.973 0.416 . . . . 0.0 110.294 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.453 ' CD1' ' N ' ' A' ' 226' ' ' LEU . 9.0 mp -52.95 156.82 3.18 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.673 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -60.41 145.37 98.81 Favored 'Trans proline' 0 C--N 1.301 -1.945 0 C-N-CA 122.657 2.238 . . . . 0.0 112.075 179.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.22 -3.47 59.05 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.51 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -89.97 -41.19 5.66 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.535 ' O ' ' N ' ' A' ' 233' ' ' SER . 68.2 mt -78.78 -17.54 55.59 Favored 'General case' 0 C--O 1.223 -0.319 0 CA-C-O 120.998 0.428 . . . . 0.0 110.377 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . 0.403 ' C ' ' O ' ' A' ' 230' ' ' LEU . 54.7 t-20 -40.19 -49.34 2.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.789 -179.389 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -87.8 15.32 7.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.258 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 233' ' ' SER . . . . . 0.535 ' N ' ' O ' ' A' ' 230' ' ' LEU . 78.2 p -60.36 -35.61 76.09 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.645 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . 0.525 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.6 tt0 -119.02 -69.26 0.86 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.963 179.607 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.2 m -69.89 102.76 2.04 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.733 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -94.45 57.64 2.29 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.055 0.455 . . . . 0.0 110.364 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -144.65 -122.68 1.59 Allowed Glycine 0 CA--C 1.52 0.364 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -134.86 111.4 9.85 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 121.067 0.46 . . . . 0.0 110.433 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . 0.521 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.6 mtt180 -147.95 58.06 1.1 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.762 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -69.77 -32.31 70.74 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.533 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . 0.498 ' CG ' HD22 ' A' ' 143' ' ' ASN . 65.0 t0 -56.86 -46.95 81.44 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.395 -179.093 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 242' ' ' ILE . . . . . 0.434 ' O ' ' O ' ' A' ' 239' ' ' ARG . 18.0 tt -139.93 156.74 25.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.926 0.393 . . . . 0.0 110.492 179.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 96.0 mt -106.36 106.7 21.1 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.214 0 CA-C-O 121.208 0.528 . . . . 0.0 110.489 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . 0.521 ' OE1' ' NH1' ' A' ' 239' ' ' ARG . 88.3 mt-30 -110.48 110.14 20.76 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.331 179.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 9.4 mp -121.81 -168.48 1.71 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.577 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . 0.525 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.9 -16.27 0.05 OUTLIER Glycine 0 CA--C 1.524 0.614 0 N-CA-C 111.039 -0.824 . . . . 0.0 111.039 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . 0.701 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -61.17 156.42 33.77 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -63.45 21.81 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.933 0.397 . . . . 0.0 110.617 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . 0.701 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.8 m-20 -97.35 -6.14 34.87 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.523 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 92.1 mt -79.52 -22.15 44.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.677 179.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.55 -51.26 70.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.711 -179.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.23 -5.76 58.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.48 179.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.02 -74.59 1.13 Allowed Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.909 -0.876 . . . . 0.0 110.909 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 83.0 mt -69.82 125.94 28.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.023 0.44 . . . . 0.0 110.234 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -59.32 -39.44 83.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.178 -179.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 83.1 51.82 4.04 Favored Glycine 0 CA--C 1.521 0.433 0 N-CA-C 110.814 -0.914 . . . . 0.0 110.814 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -95.94 -14.89 22.73 Favored 'General case' 0 C--N 1.33 -0.266 0 O-C-N 122.701 -0.293 . . . . 0.0 110.616 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 258' ' ' SER . . . . . 0.422 ' O ' ' O ' ' A' ' 192' ' ' THR . 3.4 t 174.34 88.85 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.047 0.451 . . . . 0.0 110.177 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . 0.595 ' N ' ' CD1' ' A' ' 259' ' ' LEU . 0.9 OUTLIER -94.18 124.02 37.93 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.223 0.535 . . . . 0.0 111.086 -179.104 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 16.0 m-30 -93.12 146.48 23.63 Favored 'General case' 0 CA--C 1.508 -0.664 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.343 179.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 86.0 mt -122.35 149.83 43.24 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.629 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.661 ' CG ' ' N ' ' A' ' 263' ' ' ALA . 2.6 p90 -77.65 -138.49 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.468 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . 0.661 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -52.03 77.54 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 121.04 0.448 . . . . 0.0 111.055 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . 0.632 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.03 104.71 0.19 Allowed Glycine 0 CA--C 1.526 0.724 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 265' ' ' ASP . . . . . 0.606 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.7 m-20 -80.57 -177.79 6.41 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 120.676 0.274 . . . . 0.0 110.92 -179.477 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -40.42 -17.69 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.891 0.377 . . . . 0.0 110.521 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . 0.606 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.33 -51.62 42.52 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.73 179.397 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -63.7 -46.54 84.99 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.223 179.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . 0.522 ' O ' ' CD2' ' A' ' 273' ' ' TYR . . . -61.71 -35.11 77.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.856 179.52 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -63.07 -34.41 77.52 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.115 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.48 -43.07 13.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.231 -179.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 272' ' ' ILE . . . . . 0.619 ' C ' ' H ' ' A' ' 274' ' ' ALA . 4.9 tt -51.58 -33.72 15.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.827 -178.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 273' ' ' TYR . . . . . 0.522 ' CD2' ' O ' ' A' ' 269' ' ' ALA . 17.1 m-85 -54.44 -1.71 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.738 -179.568 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 274' ' ' ALA . . . . . 0.619 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.8 -39.54 69.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.927 179.503 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . 0.582 ' O ' ' N ' ' A' ' 279' ' ' ALA . 3.2 p30 -39.52 98.02 0.16 Allowed Pre-proline 0 N--CA 1.461 0.103 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.562 -179.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -54.03 -43.02 61.99 Favored 'Trans proline' 0 C--N 1.304 -1.807 0 C-N-CA 122.372 2.048 . . . . 0.0 112.638 -178.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 89.0 mt -64.37 -42.93 95.92 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.14 0.495 . . . . 0.0 111.208 -179.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 90.7 mt -95.6 -1.67 49.87 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.894 -179.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 279' ' ' ALA . . . . . 0.582 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.34 -34.83 77.41 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.696 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.12 20.01 0.11 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.006 -179.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . 0.515 ' H ' ' C ' ' A' ' 279' ' ' ALA . 13.9 mt -75.31 120.15 80.31 Favored Pre-proline 0 N--CA 1.452 -0.365 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.506 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -51.01 -39.35 59.92 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 122.637 2.225 . . . . 0.0 111.848 179.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.92 -50.53 63.8 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.092 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 75.5 t -61.43 -43.92 97.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -57.83 -41.19 81.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.237 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -91.11 0.38 57.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.212 179.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt 59.3 43.7 16.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.079 0.466 . . . . 0.0 110.962 179.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -95.1 41.62 1.09 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.33 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 53.9 t -119.22 135.63 58.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.02 0.438 . . . . 0.0 110.168 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -132.63 162.65 30.78 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 121.123 0.487 . . . . 0.0 110.634 -179.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.71 154.91 33.39 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.014 0.435 . . . . 0.0 110.745 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 80.8 mt -93.68 -1.58 55.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.275 -179.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.11 165.91 12.81 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 6.9 m -87.47 -62.35 1.52 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.839 0.352 . . . . 0.0 111.016 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 295' ' ' GLU . . . . . 0.477 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.5 mm-40 -69.25 -4.01 16.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.68 -179.75 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 25.9 p -76.89 32.51 0.14 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.654 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 297' ' ' PHE . . . . . 0.477 ' H ' ' C ' ' A' ' 295' ' ' GLU . 73.2 t80 -60.39 -46.14 91.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.669 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . 0.617 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.2 mtt85 -81.19 135.0 35.72 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 120.998 0.427 . . . . 0.0 110.634 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 16.8 tp -114.39 118.26 33.33 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.182 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . 0.605 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.0 p-10 -165.83 -176.2 3.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.507 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 301' ' ' TYR . . . . . 0.521 ' OH ' ' CD1' ' A' ' 173' ' ' PHE . 80.8 t80 -47.08 -43.78 20.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.277 -179.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -66.64 -40.57 88.75 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.968 0.413 . . . . 0.0 110.726 179.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 303' ' ' SER . . . . . 0.605 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 59.7 p -55.92 -36.11 67.35 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.083 -179.17 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -57.37 -51.43 69.44 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 90.6 mtp -56.41 -43.67 79.58 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -66.37 -42.63 87.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.934 0.397 . . . . 0.0 110.17 178.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 56.1 t -63.95 -43.03 97.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.22 179.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 42.9 tp -59.67 -42.31 92.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.781 -179.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -62.6 -38.78 91.48 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 179.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 310' ' ' ARG . . . . . 0.432 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.6 ttt85 -63.51 -44.01 95.54 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.286 179.526 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 89.0 mt -63.21 -42.06 99.24 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.291 179.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt -62.87 -33.41 75.23 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.997 179.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.52 -23.36 22.05 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.46 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . 0.432 ' N ' ' O ' ' A' ' 310' ' ' ARG . 6.8 tt -62.36 -43.1 99.62 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.63 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 . . . . . 0 C--O 1.22 -0.482 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.449 179.969 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -99.58 136.75 39.04 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.079 0.466 . . . . 0.0 110.438 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.494 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -91.99 178.49 1.7 Allowed Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.615 -179.881 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.494 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.4 Cg_exo -61.65 146.99 96.38 Favored 'Trans proline' 0 C--N 1.299 -2.044 0 C-N-CA 122.872 2.381 . . . . 0.0 112.133 179.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 35.5 ptt180 -136.23 142.31 44.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.682 179.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -79.52 116.67 19.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.464 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.5 tp -111.16 130.49 64.53 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.483 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 13.1 t -70.93 141.91 51.1 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.547 179.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.516 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.5 t0 -139.42 179.71 6.39 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.57 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.516 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 78.0 p -73.88 -37.21 64.79 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.626 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -46.37 -94.51 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.292 -179.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.492 ' C ' ' HG1' ' A' ' 36' ' ' THR . . . -167.2 -26.61 0.02 OUTLIER Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.934 -0.867 . . . . 0.0 110.934 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.492 ' HG1' ' C ' ' A' ' 35' ' ' GLY . 60.0 m -168.98 104.78 0.4 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.876 0.37 . . . . 0.0 110.673 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 74.6 t60 -128.44 148.81 50.74 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 121.102 0.477 . . . . 0.0 110.247 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.484 ' CG2' ' N ' ' A' ' 39' ' ' LEU . 98.8 m -131.2 165.84 22.45 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.55 -179.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.484 ' N ' ' CG2' ' A' ' 38' ' ' THR . 82.0 mt -120.67 127.28 51.91 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.439 179.744 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -65.23 -44.45 88.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.698 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.404 ' O ' ' HD3' ' A' ' 43' ' ' PRO . 39.5 p -165.66 154.66 11.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.44 179.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.454 ' N ' ' CD ' ' A' ' 42' ' ' GLN . 14.4 mp0 -44.78 101.3 0.25 Allowed Pre-proline 0 C--N 1.329 -0.315 0 O-C-N 123.376 0.422 . . . . 0.0 110.605 179.397 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.404 ' HD3' ' O ' ' A' ' 41' ' ' SER . 31.5 Cg_exo -57.43 129.94 36.53 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 C-N-CA 122.357 2.038 . . . . 0.0 112.292 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -83.88 -24.68 30.72 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.539 179.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.538 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.2 mtm-85 -122.07 134.9 54.77 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 121.203 0.525 . . . . 0.0 110.291 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 95.9 mt -130.64 133.73 63.05 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.883 -179.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 44.7 t -124.44 130.53 73.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 179.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.5 ' O ' ' O ' ' A' ' 66' ' ' ALA . 2.3 m -155.36 167.34 30.69 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.534 179.681 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 68.2 p -124.68 9.45 8.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.458 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.56 125.51 33.15 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.634 -179.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 92.7 t -65.81 -44.52 92.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.469 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 20.0 m -62.77 -44.19 96.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.607 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 50.2 tp -62.24 -41.61 98.58 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.53 -179.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 77.2 m -57.59 -44.65 85.53 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.394 -179.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.03 -62.33 5.3 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.884 -0.886 . . . . 0.0 110.884 179.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.7 t -48.4 -35.42 12.66 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.7 mt -61.88 -44.52 96.65 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.686 -0.405 . . . . 0.0 111.281 179.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.2 mp -65.18 -41.52 94.52 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.33 177.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.5 -41.26 98.53 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.983 -179.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.1 tp -88.18 17.13 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.824 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 56.24 84.63 0.08 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.688 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.37 59.06 0.08 OUTLIER Pre-proline 0 C--N 1.328 -0.346 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -51.52 152.31 12.51 Favored 'Trans proline' 0 C--N 1.294 -2.301 0 C-N-CA 122.956 2.438 . . . . 0.0 112.254 -178.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.434 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.2 OUTLIER -108.55 145.31 15.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.37 -179.728 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.8 mt -63.56 -45.4 97.77 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.414 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.5 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -129.57 134.19 47.6 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.848 0.356 . . . . 0.0 110.495 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.493 ' O ' ' N ' ' A' ' 98' ' ' LEU . 74.8 m -134.48 158.56 43.6 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.849 -179.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.82 139.13 16.12 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.689 -0.964 . . . . 0.0 110.689 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.469 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.84 -162.77 0.08 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.971 0.415 . . . . 0.0 110.479 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.487 ' O ' ' C ' ' A' ' 71' ' ' THR . 14.7 t -133.49 135.02 44.21 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.382 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.487 ' C ' ' O ' ' A' ' 70' ' ' THR . 0.7 OUTLIER 29.73 68.57 0.66 Allowed Pre-proline 0 N--CA 1.464 0.26 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.801 -179.87 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_exo -60.98 145.64 98.84 Favored 'Trans proline' 0 C--N 1.299 -2.035 0 C-N-CA 122.648 2.232 . . . . 0.0 111.981 -178.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.534 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 46.1 p-10 -160.11 -32.63 0.06 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.639 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.534 ' N ' ' OD1' ' A' ' 73' ' ' ASN . 99.2 m-20 -63.71 -39.74 95.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.451 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 73.1 ttt180 -60.13 -48.08 83.24 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.728 -179.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.423 ' O ' ' O ' ' A' ' 77' ' ' ALA . 94.4 t -60.35 -24.73 31.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.088 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.423 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -45.76 172.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.599 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.571 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.9 p30 -62.07 177.74 0.43 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.522 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.595 ' C ' ' H ' ' A' ' 81' ' ' GLY . 35.4 p30 -45.61 85.67 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.033 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.571 ' N ' ' O ' ' A' ' 78' ' ' ASP . 43.4 tp60 -67.63 13.45 0.07 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.149 0.5 . . . . 0.0 110.135 -179.735 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.595 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 118.32 -22.1 9.72 Favored Glycine 0 CA--C 1.519 0.282 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -107.86 116.61 32.26 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.975 0.417 . . . . 0.0 110.474 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 74.4 mt -98.77 -0.14 43.25 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.937 0.399 . . . . 0.0 110.494 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -92.13 7.08 44.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.98 0.419 . . . . 0.0 110.452 -179.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.445 ' O ' ' CG2' ' A' ' 89' ' ' VAL . 88.1 mt-30 -100.42 -27.76 13.28 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.815 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.8 t-105 -63.73 -40.51 96.93 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.093 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.56 ' O ' ' N ' ' A' ' 91' ' ' LYS . 63.7 m -78.15 -54.16 6.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.118 -179.481 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -47.64 -50.51 24.31 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.06 -179.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.445 ' CG2' ' O ' ' A' ' 85' ' ' GLN . 14.9 m -69.29 -40.75 80.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.066 179.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.413 ' H ' HG23 ' A' ' 89' ' ' VAL . . . -72.3 -22.64 61.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.66 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.56 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.0 tttm -62.23 -45.5 93.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.422 -179.494 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.441 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.8 mm-40 -90.51 -94.37 0.12 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.153 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.628 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.9 mtt180 -143.13 58.72 1.41 Allowed 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.457 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.6 pttp 33.44 26.43 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.195 -179.226 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.628 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.4 tt -48.25 123.29 6.23 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.986 -178.092 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -83.68 -169.62 2.65 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.122 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.605 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 81.4 mtp180 -74.42 137.32 42.57 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.303 -179.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.493 ' N ' ' O ' ' A' ' 67' ' ' SER . 90.6 mt -86.21 -165.85 1.38 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.74 -179.659 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.538 ' CD2' ' O ' ' A' ' 99' ' ' TYR . 48.4 p90 -168.74 119.77 0.76 Allowed 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.207 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.511 ' C ' ' O ' ' A' ' 99' ' ' TYR . 43.0 mm -28.67 120.74 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.085 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 114.38 27.48 3.35 Favored Glycine 0 CA--C 1.519 0.34 0 N-CA-C 111.196 -0.762 . . . . 0.0 111.196 -179.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.575 ' N ' ' CD ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -144.47 46.6 0.64 Allowed Pre-proline 0 C--N 1.323 -0.554 0 CA-C-O 120.979 0.419 . . . . 0.0 110.447 179.861 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 29.0 Cg_endo -62.04 144.01 95.64 Favored 'Trans proline' 0 C--N 1.296 -2.224 0 C-N-CA 122.702 2.268 . . . . 0.0 111.865 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.703 ' HG ' ' H ' ' A' ' 107' ' ' ALA . 26.7 t -173.24 120.23 0.34 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.423 179.718 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.83 -40.4 63.35 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.054 0.454 . . . . 0.0 111.085 179.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.23 -40.06 90.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.888 -179.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.703 ' H ' ' HG ' ' A' ' 104' ' ' SER . . . -64.14 -39.97 95.15 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.677 -179.763 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 70.4 t -67.71 -43.72 86.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.731 179.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.74 -38.96 92.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.53 -179.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.441 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.65 -23.35 62.97 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.49 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.547 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.5 mm-40 -90.5 5.14 48.91 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.714 -179.555 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.547 ' C ' ' O ' ' A' ' 111' ' ' GLN . 10.6 tpt 23.27 64.33 0.37 Allowed Pre-proline 0 N--CA 1.464 0.261 0 CA-C-O 120.935 0.398 . . . . 0.0 111.077 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -78.61 167.5 22.52 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 123.062 2.508 . . . . 0.0 111.861 -178.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.521 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 99.0 m-20 -109.97 -42.27 4.26 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.182 179.474 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.6 tp -121.04 120.66 36.01 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 179.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 83.8 mt -113.44 129.0 70.0 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.39 0 CA-C-O 120.98 0.419 . . . . 0.0 110.903 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 30.2 mt -109.18 132.27 54.28 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 121.084 0.469 . . . . 0.0 110.235 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 99.0 mt -119.84 138.75 49.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.719 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 84.9 p -72.51 153.61 41.25 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.598 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.18 -50.12 74.94 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.678 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -149.44 154.01 38.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.55 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 170.58 -170.99 43.49 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -63.09 -34.16 89.21 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.866 -0.893 . . . . 0.0 110.866 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.45 ' O ' ' OD1' ' A' ' 124' ' ' ASP . 44.3 p-10 -86.82 120.45 28.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.837 0.351 . . . . 0.0 110.705 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 38.9 t -63.23 143.48 57.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.029 0.443 . . . . 0.0 110.495 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.52 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -92.97 -43.18 9.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.972 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.9 tp -62.85 -42.45 99.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.703 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.66 -11.83 59.13 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.53 -179.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 84.8 mt -114.97 -23.86 8.88 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.659 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . 0.52 ' N ' ' O ' ' A' ' 126' ' ' ALA . 80.6 t80 -51.13 -49.55 60.6 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.537 -178.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.499 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.0 p-10 -66.13 -42.41 89.18 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.823 0.344 . . . . 0.0 111.239 179.486 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.499 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 88.2 mt-30 -67.16 -37.81 84.41 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.813 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 96.0 mt -80.36 -41.38 24.81 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.965 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.2 t -57.23 -44.57 83.91 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.218 -179.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.7 m -61.97 -45.23 94.56 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.511 179.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 94.0 mt -62.09 -43.64 97.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.279 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.44 168.22 4.96 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.56 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -49.57 112.82 0.76 Allowed 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.323 2.015 . . . . 0.0 112.282 179.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 23.5 m -84.49 127.53 34.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.617 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 34.7 tp -118.22 137.0 53.31 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.079 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.44 ' O ' ' OD2' ' A' ' 32' ' ' ASP . 81.3 mt -101.26 118.94 48.76 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.353 0 CA-C-O 121.226 0.536 . . . . 0.0 111.222 -179.419 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 98.1 mt -134.78 132.04 53.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.588 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.515 HD22 ' CG ' ' A' ' 241' ' ' ASP . 61.0 t30 -66.28 151.82 46.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.895 0.378 . . . . 0.0 110.413 179.419 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.521 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 88.1 t80 -86.69 122.54 30.73 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.808 -179.581 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.521 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 99.0 m-20 55.31 69.13 0.77 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.788 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 35.9 p-10 -125.9 0.17 7.3 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.652 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -150.54 115.12 5.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.715 -179.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' SER . . . . . 0.519 ' HG ' ' H ' ' A' ' 150' ' ' GLN . 83.9 p -63.29 168.2 4.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.602 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.417 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.7 p-90 -51.88 -15.79 0.59 Allowed 'General case' 0 C--O 1.223 -0.334 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.467 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . 0.519 ' H ' ' HG ' ' A' ' 148' ' ' SER . 68.1 tp60 -70.52 -76.04 0.11 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.474 -179.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.446 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.1 t -62.7 -38.61 91.08 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.255 179.543 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 54.3 tp -59.93 -45.84 91.3 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.412 -178.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.417 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 46.7 tp -62.67 -41.64 99.19 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.497 179.011 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.446 ' OG1' ' O ' ' A' ' 151' ' ' SER . 60.1 p -64.1 -34.79 78.85 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.273 -179.482 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.415 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.9 mm-40 -64.19 -42.77 96.53 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.311 179.35 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 91.8 mt -65.37 -38.73 90.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.148 0.499 . . . . 0.0 110.268 179.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.579 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.23 -32.47 80.75 Favored Glycine 0 CA--C 1.519 0.317 0 N-CA-C 110.712 -0.955 . . . . 0.0 110.712 -179.306 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 157' ' ' GLY . 97.2 mt-10 -35.45 -26.93 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.828 0.347 . . . . 0.0 110.837 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.579 ' N ' ' O ' ' A' ' 157' ' ' GLY . 95.3 mt -56.46 149.81 3.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.295 179.197 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 77.1 p -69.61 137.21 52.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.997 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 71.1 21.17 78.37 Favored Glycine 0 N--CA 1.459 0.19 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 179.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 58.1 m80 -122.47 -14.94 7.72 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.702 0.286 . . . . 0.0 110.529 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -65.96 -59.74 3.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.748 -179.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -52.26 -49.3 64.34 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.209 -179.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -60.54 -41.22 94.05 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.957 -0.297 . . . . 0.0 110.379 179.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.49 -47.12 87.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.541 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.97 -40.14 75.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.244 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -61.82 -50.27 72.96 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.576 179.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -65.17 -43.86 90.36 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.531 179.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 94.6 mt -64.78 -43.29 96.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.402 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.28 -51.23 70.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.475 -179.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.43 -43.86 96.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.543 179.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . 0.459 ' CD1' ' OH ' ' A' ' 301' ' ' TYR . 57.0 t80 -62.75 -44.4 96.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.06 0.457 . . . . 0.0 110.443 179.451 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -63.32 -39.8 95.56 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.617 -179.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -63.01 -42.76 99.9 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.599 179.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -60.72 -44.6 96.42 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.184 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 84.1 mt -64.54 -40.96 96.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.014 0.435 . . . . 0.0 110.707 178.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.18 -62.46 1.62 Allowed 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.368 -179.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.52 -46.86 85.89 Favored 'General case' 0 C--O 1.227 -0.128 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.628 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.13 -41.85 65.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.276 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -63.74 -33.79 76.43 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.982 0.42 . . . . 0.0 110.411 179.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . 0.4 ' O ' ' HG2' ' A' ' 182' ' ' GLU . 69.6 tt0 -90.51 8.83 31.92 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.46 0.648 . . . . 0.0 110.508 -178.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -104.99 -32.07 8.92 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.174 179.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.9 pt -127.98 147.63 32.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.822 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -139.93 131.09 26.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.357 179.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.553 ' CD2' ' N ' ' A' ' 186' ' ' LEU . 3.6 mm? -85.35 133.34 42.64 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.979 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -43.93 157.82 0.14 Allowed 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.69 2.26 . . . . 0.0 112.191 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . 0.521 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.9 Cg_endo -63.1 115.11 2.77 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 C-N-CA 122.795 2.33 . . . . 0.0 111.696 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . 0.521 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.8 mt-30 155.16 147.86 0.0 OUTLIER Pre-proline 0 C--N 1.332 -0.162 0 O-C-N 123.791 0.682 . . . . 0.0 110.832 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -73.49 144.11 35.65 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.667 2.245 . . . . 0.0 112.159 177.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.494 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.1 p -125.04 158.98 32.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.291 0.567 . . . . 0.0 110.185 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' THR . . . . . 0.494 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 37.5 p -143.3 165.39 27.6 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.106 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -135.4 128.69 32.05 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.234 0.54 . . . . 0.0 110.231 179.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 47.6 pt -146.3 148.71 16.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.165 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 70.4 t -117.51 123.01 71.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.282 0.563 . . . . 0.0 109.71 179.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -134.47 107.51 7.6 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.331 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 94.3 m -131.01 130.71 43.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.845 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -82.82 -37.02 25.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.231 179.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.55 -67.17 0.26 Allowed 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.359 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.33 -9.76 58.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.342 179.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 60.1 t-80 60.43 58.3 2.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.774 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 39.4 p -166.8 153.2 8.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.586 179.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.28 144.09 24.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.005 0.431 . . . . 0.0 110.421 179.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -135.3 137.87 42.9 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.619 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 19.6 mt -105.98 125.42 50.97 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.061 0.458 . . . . 0.0 109.81 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' TRP . . . . . 0.555 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 75.6 m95 -82.09 167.15 19.07 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.685 -179.752 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -156.99 171.38 7.53 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.624 -179.189 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -53.57 -37.22 82.85 Favored 'Trans proline' 0 C--N 1.302 -1.902 0 C-N-CA 122.661 2.24 . . . . 0.0 112.27 179.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -70.52 -34.88 72.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.813 -179.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 22.8 m -61.19 150.72 33.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.637 -179.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.52 -36.95 81.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.485 -179.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . 0.555 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 54.8 tt0 -64.78 -40.11 94.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.506 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.8 -43.41 91.74 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -63.33 -43.74 96.92 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.791 0.329 . . . . 0.0 110.29 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 65.1 ttp -59.39 -48.18 82.63 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.238 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 88.2 mt -60.37 -40.9 92.49 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 179.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . 0.456 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 40.9 tp10 -57.96 -38.03 75.25 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -65.17 -37.92 88.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.67 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 94.5 mt -64.4 -42.72 95.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.141 0.496 . . . . 0.0 110.583 -179.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.56 44.63 0.08 OUTLIER Glycine 0 C--N 1.334 0.417 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . 0.456 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 25.9 m-85 -127.68 155.19 44.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.04 0.447 . . . . 0.0 110.471 -179.76 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 222' ' ' THR . . . . . 0.451 ' O ' ' O ' ' A' ' 191' ' ' VAL . 6.1 p -107.05 122.35 46.29 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.272 0.558 . . . . 0.0 110.116 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . 0.444 ' CD2' ' N ' ' A' ' 223' ' ' LEU . 4.3 mm? -101.25 133.04 46.42 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.068 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -97.17 159.53 14.86 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.488 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.21 115.32 30.06 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.399 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.45 ' CD1' ' N ' ' A' ' 226' ' ' LEU . 9.0 mp -53.62 156.84 4.21 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.689 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -59.86 145.21 98.84 Favored 'Trans proline' 0 C--N 1.302 -1.916 0 C-N-CA 122.65 2.233 . . . . 0.0 112.19 179.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.64 -2.73 58.81 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.559 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.46 -40.68 5.65 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.535 ' O ' ' N ' ' A' ' 233' ' ' SER . 86.1 mt -79.13 -16.74 56.22 Favored 'General case' 0 C--O 1.222 -0.379 0 CA-C-O 121.02 0.438 . . . . 0.0 110.383 -179.774 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . 0.402 ' C ' ' O ' ' A' ' 230' ' ' LEU . 54.4 t-20 -40.29 -49.07 2.73 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.777 -179.421 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -88.24 15.44 7.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.368 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 233' ' ' SER . . . . . 0.535 ' N ' ' O ' ' A' ' 230' ' ' LEU . 77.8 p -60.52 -35.52 76.18 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.622 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . 0.523 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.6 tt0 -118.27 -69.37 0.85 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.958 179.508 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 3.9 m -70.39 103.03 2.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.679 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -93.99 57.92 2.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.398 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -145.12 -122.28 1.52 Allowed Glycine 0 CA--C 1.519 0.343 0 N-CA-C 110.989 -0.845 . . . . 0.0 110.989 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -134.56 111.68 10.26 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 121.114 0.483 . . . . 0.0 110.433 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . 0.51 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.3 mtt180 -148.12 57.24 1.08 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.696 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -69.74 -31.99 70.27 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.511 179.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . 0.515 ' CG ' HD22 ' A' ' 143' ' ' ASN . 65.1 t0 -56.83 -46.93 81.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.379 -179.07 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 242' ' ' ILE . . . . . 0.437 ' O ' ' O ' ' A' ' 239' ' ' ARG . 17.5 tt -140.02 156.76 25.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.888 0.375 . . . . 0.0 110.537 179.719 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 96.0 mt -105.8 105.9 19.56 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.218 0 CA-C-O 121.122 0.487 . . . . 0.0 110.511 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . 0.51 ' OE1' ' NH1' ' A' ' 239' ' ' ARG . 88.3 mt-30 -110.23 110.03 20.72 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.344 179.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 9.6 mp -121.86 -168.23 1.67 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.663 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . 0.523 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.28 -16.8 0.05 OUTLIER Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . 0.691 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -60.44 157.17 29.42 Favored Glycine 0 CA--C 1.522 0.49 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 -179.81 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -63.86 21.68 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.99 0.424 . . . . 0.0 110.619 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . 0.691 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.7 m-20 -97.43 -5.82 35.32 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.517 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 91.9 mt -80.28 -21.48 42.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.672 179.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.66 -51.36 70.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.702 -179.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.43 -5.19 58.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.453 179.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.15 -74.2 1.15 Allowed Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 80.4 mt -70.09 125.73 27.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.979 0.418 . . . . 0.0 110.274 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -59.7 -39.15 83.65 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.492 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 84.1 51.74 3.86 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 110.712 -0.955 . . . . 0.0 110.712 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -94.87 -16.2 23.09 Favored 'General case' 0 C--N 1.332 -0.191 0 O-C-N 122.651 -0.323 . . . . 0.0 110.654 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 258' ' ' SER . . . . . 0.433 ' HG ' ' CG2' ' A' ' 191' ' ' VAL . 3.3 t 174.06 89.53 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.074 0.464 . . . . 0.0 110.18 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . 0.596 ' N ' ' CD1' ' A' ' 259' ' ' LEU . 1.0 OUTLIER -94.47 124.35 38.44 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.275 0.559 . . . . 0.0 111.079 -179.084 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 16.0 m-30 -93.49 146.64 23.62 Favored 'General case' 0 CA--C 1.504 -0.793 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.441 179.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 85.9 mt -122.46 149.91 43.22 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.567 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.657 ' CG ' ' N ' ' A' ' 263' ' ' ALA . 2.6 p90 -77.61 -138.4 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.541 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . 0.657 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -52.24 77.51 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.048 0.452 . . . . 0.0 111.078 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . 0.625 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.17 104.35 0.18 Allowed Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 265' ' ' ASP . . . . . 0.601 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.8 m-20 -80.28 -177.89 6.34 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 120.685 0.279 . . . . 0.0 110.908 -179.478 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -40.44 -17.52 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.567 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . 0.601 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.62 -51.45 42.1 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.617 179.502 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -63.79 -46.64 84.28 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.171 179.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . 0.525 ' O ' ' CD2' ' A' ' 273' ' ' TYR . . . -61.58 -34.99 76.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.247 0.546 . . . . 0.0 109.866 179.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -63.13 -34.42 77.58 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.17 179.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.43 -43.31 13.73 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.218 -179.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 272' ' ' ILE . . . . . 0.619 ' C ' ' H ' ' A' ' 274' ' ' ALA . 4.9 tt -51.42 -33.72 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.863 -178.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 273' ' ' TYR . . . . . 0.525 ' CD2' ' O ' ' A' ' 269' ' ' ALA . 17.4 m-85 -54.31 -1.88 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.649 -179.587 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 274' ' ' ALA . . . . . 0.619 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.64 -39.66 70.22 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.95 179.561 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . 0.586 ' O ' ' N ' ' A' ' 279' ' ' ALA . 4.2 p30 -39.12 97.86 0.15 Allowed Pre-proline 0 N--CA 1.462 0.174 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.458 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -54.55 -42.97 63.27 Favored 'Trans proline' 0 C--N 1.303 -1.831 0 C-N-CA 122.372 2.048 . . . . 0.0 112.552 -178.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 88.9 mt -64.45 -42.97 95.66 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.128 0.49 . . . . 0.0 111.211 -179.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 90.8 mt -95.71 -1.38 50.09 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.923 -179.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 279' ' ' ALA . . . . . 0.586 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.19 -34.74 77.02 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.714 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.21 19.8 0.12 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.018 -179.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . 0.512 ' H ' ' C ' ' A' ' 279' ' ' ALA . 13.9 mt -75.08 120.14 80.27 Favored Pre-proline 0 N--CA 1.451 -0.423 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.575 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -49.97 -39.81 49.75 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.625 2.216 . . . . 0.0 112.154 178.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.52 -50.56 62.57 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.084 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 79.9 t -61.79 -43.8 97.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 179.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -57.88 -41.77 83.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.317 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -90.43 0.33 57.34 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.119 179.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt 59.04 41.19 21.17 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.773 179.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -92.89 42.18 1.09 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.355 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 53.7 t -119.1 135.67 58.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.014 0.435 . . . . 0.0 110.246 -179.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -133.05 162.74 30.9 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.656 -179.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.77 154.96 33.42 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.965 0.412 . . . . 0.0 110.747 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 81.8 mt -93.75 -1.46 55.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.231 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.59 165.52 12.62 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 110.58 -1.008 . . . . 0.0 110.58 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 7.1 m -87.38 -62.27 1.54 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.89 0.376 . . . . 0.0 111.004 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 295' ' ' GLU . . . . . 0.473 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.5 mm-40 -69.62 -3.97 17.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.636 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 26.2 p -76.81 33.14 0.14 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.648 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 297' ' ' PHE . . . . . 0.473 ' H ' ' C ' ' A' ' 295' ' ' GLU . 85.0 t80 -60.21 -46.03 91.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.477 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . 0.605 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.2 mtt85 -81.73 133.76 35.38 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.568 -179.726 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 16.1 tp -114.07 119.75 38.2 Favored 'General case' 0 C--O 1.231 0.083 0 CA-C-O 120.992 0.425 . . . . 0.0 110.205 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . 0.608 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.2 p-10 -167.43 -174.15 2.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.551 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 301' ' ' TYR . . . . . 0.459 ' OH ' ' CD1' ' A' ' 173' ' ' PHE . 84.0 t80 -48.23 -45.81 34.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.215 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -64.7 -41.48 95.99 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.033 0.444 . . . . 0.0 110.689 178.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 303' ' ' SER . . . . . 0.608 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 53.1 p -55.53 -36.09 66.37 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.954 -179.073 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . 0.594 ' N ' ' HG ' ' A' ' 303' ' ' SER . . . -56.71 -51.76 67.57 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.442 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 91.0 mtp -56.13 -43.89 78.62 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -66.3 -42.81 87.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.008 0.432 . . . . 0.0 110.246 178.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 55.5 t -64.02 -42.77 96.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.211 179.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 42.3 tp -59.65 -42.29 92.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.791 -179.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -62.54 -38.76 91.28 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.149 179.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 310' ' ' ARG . . . . . 0.442 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.6 ttt85 -63.54 -43.95 95.61 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.229 179.606 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 88.3 mt -63.15 -42.15 99.39 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.303 179.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -62.84 -33.22 74.79 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.04 179.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.94 -23.51 21.55 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.377 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . 0.442 ' N ' ' O ' ' A' ' 310' ' ' ARG . 6.8 tt -62.31 -43.19 99.39 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 121.092 0.473 . . . . 0.0 110.623 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 . . . . . 0 C--O 1.22 -0.475 0 CA-C-O 118.005 -0.997 . . . . 0.0 110.42 -179.957 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -99.41 135.58 40.61 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.087 0.47 . . . . 0.0 110.502 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.495 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.2 OUTLIER -92.14 178.42 1.71 Allowed Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.549 -179.842 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.495 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.3 Cg_exo -61.74 147.47 95.24 Favored 'Trans proline' 0 C--N 1.3 -2.024 0 C-N-CA 122.776 2.317 . . . . 0.0 112.168 179.603 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 35.2 ptt180 -136.12 142.33 44.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.735 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -79.83 116.79 20.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.406 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.5 tp -111.54 130.71 64.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.411 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.1 t -71.19 142.62 50.64 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.623 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.518 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.7 t0 -139.84 179.86 6.35 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.564 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.518 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 77.9 p -73.86 -37.26 64.82 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.707 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.7 ttt85 -46.83 -94.62 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.309 -179.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.425 ' O ' ' OG1' ' A' ' 36' ' ' THR . . . -166.3 -26.8 0.02 OUTLIER Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.425 ' OG1' ' O ' ' A' ' 35' ' ' GLY . 56.9 m -168.87 105.69 0.42 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.892 0.377 . . . . 0.0 110.621 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 69.6 t60 -128.77 147.03 50.75 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.053 0.454 . . . . 0.0 110.262 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.487 ' CG2' ' N ' ' A' ' 39' ' ' LEU . 99.9 m -130.05 165.73 21.6 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.582 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.487 ' N ' ' CG2' ' A' ' 38' ' ' THR . 80.8 mt -120.35 127.33 52.23 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.481 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -65.43 -44.62 86.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.693 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.406 ' O ' ' HD3' ' A' ' 43' ' ' PRO . 41.2 p -165.89 155.23 11.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.46 179.61 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.461 ' N ' ' CD ' ' A' ' 42' ' ' GLN . 15.1 mp0 -45.25 101.63 0.27 Allowed Pre-proline 0 C--N 1.329 -0.295 0 O-C-N 123.388 0.43 . . . . 0.0 110.659 179.327 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.406 ' HD3' ' O ' ' A' ' 41' ' ' SER . 31.2 Cg_exo -57.96 129.58 33.96 Favored 'Trans proline' 0 C--N 1.303 -1.82 0 C-N-CA 122.269 1.979 . . . . 0.0 112.231 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -82.33 -25.2 34.11 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.478 179.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.534 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.7 mtm-85 -120.87 134.39 55.29 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-O 121.194 0.521 . . . . 0.0 110.252 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.1 mt -129.69 133.06 65.59 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.313 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.034 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 46.0 t -124.71 130.9 73.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 179.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.501 ' O ' ' O ' ' A' ' 66' ' ' ALA . 4.4 m -154.99 166.5 33.4 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.541 179.578 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 66.0 p -124.27 8.99 8.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.805 0.336 . . . . 0.0 110.439 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.72 125.82 33.5 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.668 -179.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 85.7 t -65.81 -44.55 92.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.547 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 18.9 m -62.63 -44.35 96.51 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.615 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 53.5 tp -62.26 -41.54 98.54 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.503 -179.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 73.3 m -57.85 -44.54 86.6 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.257 -179.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.39 -62.01 5.48 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 179.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.7 t -48.74 -35.25 13.74 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.9 mt -61.8 -44.38 96.98 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.586 -0.445 . . . . 0.0 111.325 179.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.4 mp -64.74 -41.95 95.55 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.384 177.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.67 -41.03 98.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.033 -179.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.0 tp -88.11 16.77 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.798 -179.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 56.38 84.56 0.08 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.696 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.14 58.21 0.07 OUTLIER Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.287 -0.415 . . . . 0.0 109.904 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -50.58 152.76 8.67 Favored 'Trans proline' 0 C--N 1.293 -2.365 0 C-N-CA 122.84 2.36 . . . . 0.0 112.404 -178.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.432 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -108.78 145.83 15.18 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.219 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.239 -179.716 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 97.0 mt -63.75 -45.06 98.32 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.366 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.559 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.501 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -130.02 134.49 47.44 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 120.836 0.351 . . . . 0.0 110.588 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.497 ' O ' ' N ' ' A' ' 98' ' ' LEU . 73.6 m -134.74 158.71 43.44 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.893 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -87.2 139.54 16.2 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.46 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.72 -162.75 0.08 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.003 0.43 . . . . 0.0 110.453 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.486 ' O ' ' C ' ' A' ' 71' ' ' THR . 14.0 t -133.47 135.15 44.33 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.324 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.486 ' C ' ' O ' ' A' ' 70' ' ' THR . 0.1 OUTLIER 29.77 68.51 0.67 Allowed Pre-proline 0 N--CA 1.466 0.353 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.765 -179.883 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_exo -60.96 145.21 99.4 Favored 'Trans proline' 0 C--N 1.299 -2.047 0 C-N-CA 122.613 2.208 . . . . 0.0 112.017 -178.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.524 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 45.5 p-10 -159.83 -32.6 0.06 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.65 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.524 ' N ' ' OD1' ' A' ' 73' ' ' ASN . 99.0 m-20 -64.0 -39.56 94.39 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.485 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.6 ttt180 -60.65 -47.87 84.29 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.721 -179.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.421 ' O ' ' O ' ' A' ' 77' ' ' ALA . 89.2 t -60.58 -24.59 32.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.421 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -45.85 172.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.581 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.569 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.6 p30 -61.85 177.58 0.42 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.551 -179.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.597 ' C ' ' H ' ' A' ' 81' ' ' GLY . 35.5 p30 -45.61 85.84 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.049 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.569 ' N ' ' O ' ' A' ' 78' ' ' ASP . 43.3 tp60 -67.34 13.32 0.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.232 0.539 . . . . 0.0 110.101 -179.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.597 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 118.04 -22.12 9.91 Favored Glycine 0 C--N 1.332 0.321 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -107.79 116.25 31.62 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.014 0.435 . . . . 0.0 110.419 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 77.6 mt -98.87 0.57 44.47 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.498 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -92.04 6.72 45.36 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.033 0.444 . . . . 0.0 110.327 -179.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.434 ' O ' ' CG2' ' A' ' 89' ' ' VAL . 88.3 mt-30 -100.05 -27.73 13.41 Favored 'General case' 0 C--O 1.223 -0.329 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.869 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 68.7 t-105 -63.08 -40.81 98.77 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.902 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.554 ' O ' ' N ' ' A' ' 91' ' ' LYS . 68.0 m -77.44 -53.44 7.63 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.272 -179.486 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -48.57 -50.73 31.04 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.039 -179.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.434 ' CG2' ' O ' ' A' ' 85' ' ' GLN . 15.5 m -68.87 -40.8 81.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 120.97 0.414 . . . . 0.0 111.175 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.414 ' H ' HG23 ' A' ' 89' ' ' VAL . . . -72.06 -23.05 61.3 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.763 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.554 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.0 tttm -61.51 -45.89 92.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.42 -179.439 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.444 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.8 mm-40 -90.38 -94.59 0.12 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.048 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.622 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.8 mtt180 -143.35 59.97 1.4 Allowed 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.456 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.6 pttp 33.73 26.46 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 120.861 0.362 . . . . 0.0 110.12 -179.525 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.622 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.5 tt -48.49 123.19 6.29 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.081 -178.026 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -83.69 -170.18 2.94 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.007 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.62 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 82.2 mtp180 -73.29 137.77 45.06 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.197 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.497 ' N ' ' O ' ' A' ' 67' ' ' SER . 89.3 mt -86.26 -166.15 1.46 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.777 -179.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.532 ' CD2' ' O ' ' A' ' 99' ' ' TYR . 47.5 p90 -168.01 119.65 0.84 Allowed 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.234 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.505 ' C ' ' O ' ' A' ' 99' ' ' TYR . 42.8 mm -29.4 120.98 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.058 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 113.92 28.03 3.28 Favored Glycine 0 C--N 1.332 0.323 0 N-CA-C 111.176 -0.77 . . . . 0.0 111.176 -179.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.582 ' N ' ' CD ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -143.93 45.94 0.61 Allowed Pre-proline 0 C--N 1.323 -0.566 0 O-C-N 122.481 -0.423 . . . . 0.0 110.434 179.816 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.582 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 30.2 Cg_endo -61.95 143.8 95.77 Favored 'Trans proline' 0 C--N 1.296 -2.229 0 C-N-CA 122.669 2.246 . . . . 0.0 111.971 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.705 ' HG ' ' H ' ' A' ' 107' ' ' ALA . 26.7 t -173.17 120.43 0.35 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.463 179.637 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.1 -41.0 64.53 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.069 0.462 . . . . 0.0 111.157 179.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -65.8 -39.92 91.38 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.85 -179.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.705 ' H ' ' HG ' ' A' ' 104' ' ' SER . . . -63.94 -39.67 94.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.751 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 70.6 t -67.4 -43.88 87.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.769 179.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.52 -39.11 92.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.574 -179.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.444 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.63 -23.85 63.35 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.448 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.554 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.3 mm-40 -91.23 4.71 51.59 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.695 -179.592 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.554 ' C ' ' O ' ' A' ' 111' ' ' GLN . 10.4 tpt 22.11 64.29 0.32 Allowed Pre-proline 0 N--CA 1.466 0.345 0 CA-C-O 120.937 0.398 . . . . 0.0 111.154 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -78.85 169.8 18.98 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 123.072 2.515 . . . . 0.0 112.085 -178.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.518 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 98.8 m-20 -112.3 -44.82 3.34 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.222 -0.444 . . . . 0.0 109.974 179.63 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.2 tp -119.96 120.88 37.67 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 96.6 mt -117.82 131.36 70.79 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.417 0 CA-C-O 120.957 0.408 . . . . 0.0 110.985 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 33.4 mt -106.17 132.2 52.51 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.117 0.484 . . . . 0.0 110.051 -179.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 98.4 mt -117.49 135.93 56.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.791 -179.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 85.4 p -71.37 151.79 43.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.521 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.28 -49.94 75.61 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.712 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -149.33 153.7 37.85 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.544 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 168.7 -169.35 41.66 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -63.08 -35.41 92.05 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.452 ' O ' ' OD1' ' A' ' 124' ' ' ASP . 44.4 p-10 -88.62 120.02 29.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.839 0.352 . . . . 0.0 110.694 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 40.7 t -63.47 144.35 57.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.012 0.434 . . . . 0.0 110.526 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.521 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.32 -42.82 9.1 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.012 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.6 tp -62.65 -42.34 99.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.657 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.05 -10.83 56.88 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.508 -179.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 85.5 mt -115.82 -23.96 8.4 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.62 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . 0.521 ' N ' ' O ' ' A' ' 126' ' ' ALA . 73.2 t80 -51.83 -48.9 63.72 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.569 -0.452 . . . . 0.0 110.537 -178.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.53 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 39.4 p-10 -66.17 -41.67 89.98 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.885 0.374 . . . . 0.0 111.34 179.26 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.53 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 87.9 mt-30 -67.83 -37.33 81.77 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.874 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 97.1 mt -79.65 -42.57 24.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.134 -179.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.2 t -57.78 -44.9 86.54 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.256 -178.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 18.8 m -62.19 -46.09 90.46 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.865 0.364 . . . . 0.0 110.76 179.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 92.3 mt -62.47 -43.63 98.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.374 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -170.02 163.14 6.52 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.459 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -42.02 110.81 0.16 Allowed 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.531 2.154 . . . . 0.0 112.088 179.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.9 m -87.48 127.59 35.23 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.559 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 34.9 tp -119.61 139.42 52.21 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.077 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.429 ' O ' ' OD2' ' A' ' 32' ' ' ASP . 81.0 mt -105.48 120.0 55.54 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.385 0 CA-C-O 121.14 0.495 . . . . 0.0 111.341 -179.665 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 98.2 mt -135.42 132.51 52.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.683 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.515 HD22 ' CG ' ' A' ' 241' ' ' ASP . 59.1 t30 -64.71 147.8 52.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.885 0.374 . . . . 0.0 110.368 179.275 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.454 ' O ' ' OD2' ' A' ' 241' ' ' ASP . 86.5 t80 -82.41 122.69 28.33 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.046 -179.593 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.433 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 91.4 m-20 55.32 69.02 0.78 Allowed 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.951 179.695 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 34.8 p-10 -125.78 0.37 7.39 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.943 0.401 . . . . 0.0 110.68 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -150.55 115.7 5.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.747 -179.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' SER . . . . . 0.513 ' HG ' ' H ' ' A' ' 150' ' ' GLN . 85.9 p -63.93 169.07 4.52 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.566 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.419 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.6 p-90 -51.87 -15.95 0.62 Allowed 'General case' 0 C--O 1.223 -0.341 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.49 -179.763 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . 0.513 ' H ' ' HG ' ' A' ' 148' ' ' SER . 68.1 tp60 -70.41 -76.09 0.11 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.469 -179.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.456 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.1 t -62.47 -38.61 90.51 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.011 0.434 . . . . 0.0 110.241 179.553 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 51.1 tp -60.21 -45.48 93.02 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.334 -178.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.419 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 45.8 tp -62.69 -41.86 99.33 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.859 0.361 . . . . 0.0 110.398 178.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.456 ' OG1' ' O ' ' A' ' 151' ' ' SER . 57.6 p -63.89 -34.74 78.63 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.18 -179.371 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.463 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 88.1 mm-40 -63.85 -42.28 97.61 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.153 179.274 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 90.5 mt -65.28 -39.07 92.09 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.125 0.488 . . . . 0.0 110.096 179.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.577 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.03 -32.39 80.1 Favored Glycine 0 CA--C 1.519 0.321 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 -179.292 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.463 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.3 mt-10 -36.65 -25.09 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.82 0.343 . . . . 0.0 110.807 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.577 ' N ' ' O ' ' A' ' 157' ' ' GLY . 95.8 mt -59.56 148.53 7.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.193 179.284 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 71.3 p -68.91 137.68 54.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.12 -179.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 70.56 21.91 77.77 Favored Glycine 0 N--CA 1.458 0.146 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 179.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 60.3 m80 -124.28 -14.34 7.0 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.73 0.3 . . . . 0.0 110.569 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -66.17 -59.49 3.71 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.792 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -52.22 -48.32 65.18 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 120.679 -0.409 . . . . 0.0 110.093 -179.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -60.88 -40.96 95.0 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.697 0.284 . . . . 0.0 110.313 179.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.61 -47.17 86.64 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.6 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -57.2 -39.83 76.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.179 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -61.85 -50.3 72.79 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.569 179.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 60.1 ttt85 -65.5 -43.78 89.09 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.458 179.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 94.8 mt -64.47 -43.52 96.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.386 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.32 -50.89 71.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.474 -179.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.97 -43.56 95.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.454 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . 0.515 ' CD1' ' OH ' ' A' ' 301' ' ' TYR . 56.7 t80 -62.67 -44.59 95.87 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.07 0.462 . . . . 0.0 110.386 179.407 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -63.38 -39.96 95.94 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.561 -179.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -62.9 -42.8 99.91 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.623 179.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -60.78 -44.69 96.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.044 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 84.7 mt -64.34 -41.26 96.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.058 0.456 . . . . 0.0 110.733 178.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.13 -62.19 1.79 Allowed 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.43 -179.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.35 -46.86 85.46 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.52 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.02 -41.6 64.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.159 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -63.8 -33.48 75.77 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.015 0.436 . . . . 0.0 110.371 179.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 69.7 tt0 -91.1 8.22 36.62 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.476 0.655 . . . . 0.0 110.529 -178.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -103.88 -32.62 9.2 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.348 179.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 45.1 pt -128.0 147.75 32.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.893 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -139.74 131.2 26.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.382 179.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.553 ' CD2' ' N ' ' A' ' 186' ' ' LEU . 3.6 mm? -85.5 133.97 41.09 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.953 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -44.23 157.99 0.15 Allowed 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 122.734 2.289 . . . . 0.0 112.097 179.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . 0.519 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.5 Cg_endo -62.93 115.05 2.7 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 C-N-CA 122.775 2.317 . . . . 0.0 111.662 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . 0.519 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.8 mt-30 155.23 148.33 0.0 OUTLIER Pre-proline 0 C--N 1.332 -0.176 0 O-C-N 123.833 0.708 . . . . 0.0 110.869 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -73.75 144.29 34.93 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.688 2.259 . . . . 0.0 111.881 178.042 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.491 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.1 p -124.92 158.65 32.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.365 0.602 . . . . 0.0 110.12 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' THR . . . . . 0.491 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 35.9 p -143.22 165.31 27.81 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.245 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -135.31 128.63 32.11 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 121.229 0.537 . . . . 0.0 110.233 179.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 48.3 pt -146.7 149.38 15.93 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.362 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.161 179.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 69.0 t -117.95 123.4 71.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.317 0.58 . . . . 0.0 109.621 179.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -134.38 106.71 7.21 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.253 179.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 95.0 m -130.34 130.47 44.48 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.897 179.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.41 ' O ' ' N ' ' A' ' 201' ' ' HIS . . . -83.11 -36.83 24.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.142 179.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.63 -66.72 0.29 Allowed 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.311 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.52 -9.75 58.95 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.231 179.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . 0.41 ' N ' ' O ' ' A' ' 198' ' ' ALA . 60.6 t-80 60.85 58.28 2.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.887 -179.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 36.0 p -167.11 153.64 8.33 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.554 179.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.64 144.18 24.22 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.02 0.438 . . . . 0.0 110.355 179.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -135.53 138.66 43.28 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.67 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 20.3 mt -106.64 125.53 51.12 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 -179.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' TRP . . . . . 0.557 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 73.9 m95 -82.0 167.32 18.99 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.643 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -157.17 171.59 7.25 Favored Pre-proline 0 C--O 1.224 -0.238 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.585 -179.218 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -53.58 -37.29 82.96 Favored 'Trans proline' 0 C--N 1.303 -1.84 0 C-N-CA 122.602 2.201 . . . . 0.0 112.114 179.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -70.45 -35.37 73.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.858 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 21.6 m -60.67 150.94 30.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.591 -179.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.61 -37.22 83.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.524 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . 0.557 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 54.9 tt0 -64.5 -40.4 95.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.515 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.59 -43.39 92.26 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -63.26 -43.96 96.48 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 65.6 ttp -59.62 -47.71 84.51 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.196 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 86.0 mt -60.78 -40.81 93.96 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . 0.452 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.4 tp10 -58.61 -37.82 76.67 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -65.18 -38.5 90.72 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.721 0.296 . . . . 0.0 110.525 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 94.8 mt -64.09 -42.83 96.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.105 0.479 . . . . 0.0 110.504 -179.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.48 45.13 0.08 OUTLIER Glycine 0 C--N 1.334 0.467 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . 0.452 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 26.9 m-85 -128.01 155.59 44.07 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.107 0.48 . . . . 0.0 110.47 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 222' ' ' THR . . . . . 0.455 ' O ' ' O ' ' A' ' 191' ' ' VAL . 7.6 p -106.8 122.29 46.1 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.263 0.554 . . . . 0.0 110.136 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . 0.444 ' CD2' ' N ' ' A' ' 223' ' ' LEU . 4.3 mm? -101.33 133.09 46.47 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.159 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.93 159.68 14.78 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.535 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -105.41 115.26 29.95 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.302 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.45 ' CD1' ' N ' ' A' ' 226' ' ' LEU . 9.0 mp -53.0 156.8 3.24 Favored Pre-proline 0 N--CA 1.452 -0.355 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.746 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -60.39 145.22 99.08 Favored 'Trans proline' 0 C--N 1.3 -1.974 0 C-N-CA 122.628 2.219 . . . . 0.0 112.121 179.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -86.98 -3.43 59.09 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.54 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.12 -41.1 5.64 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.523 ' O ' ' N ' ' A' ' 233' ' ' SER . 69.5 mt -79.15 -17.71 54.48 Favored 'General case' 0 C--O 1.221 -0.42 0 CA-C-O 121.082 0.468 . . . . 0.0 110.319 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 54.8 t-20 -40.72 -48.9 3.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.844 -179.163 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -87.49 15.09 7.03 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.772 0.32 . . . . 0.0 111.428 179.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 233' ' ' SER . . . . . 0.523 ' N ' ' O ' ' A' ' 230' ' ' LEU . 77.9 p -60.45 -35.11 75.06 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.676 -179.7 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . 0.523 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.5 tt0 -119.33 -69.33 0.85 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.977 179.368 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.0 m -70.18 101.4 1.86 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.633 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -93.15 58.24 2.86 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.376 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -144.81 -122.42 1.56 Allowed Glycine 0 CA--C 1.52 0.353 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -135.62 111.36 9.35 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.25 0.548 . . . . 0.0 110.34 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . 0.529 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.5 mtt180 -147.9 57.95 1.1 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.756 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -69.1 -32.85 72.55 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.519 179.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . 0.515 ' CG ' HD22 ' A' ' 143' ' ' ASN . 65.1 t0 -57.02 -47.14 81.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.305 -178.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 242' ' ' ILE . . . . . 0.433 ' O ' ' O ' ' A' ' 239' ' ' ARG . 18.5 tt -139.4 155.4 25.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.901 0.382 . . . . 0.0 110.504 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 96.2 mt -106.16 106.86 21.37 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.235 0 CA-C-O 121.232 0.539 . . . . 0.0 110.59 179.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . 0.529 ' OE1' ' NH1' ' A' ' 239' ' ' ARG . 88.3 mt-30 -110.46 109.91 20.46 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.292 179.757 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 9.4 mp -121.51 -168.28 1.66 Allowed 'General case' 0 C--O 1.225 -0.229 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.672 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . 0.523 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.9 -16.21 0.05 OUTLIER Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . 0.699 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -61.49 156.18 35.45 Favored Glycine 0 CA--C 1.521 0.457 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -63.28 21.79 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.991 0.424 . . . . 0.0 110.672 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . 0.699 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.8 m-20 -97.15 -6.19 35.45 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.478 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 91.7 mt -79.76 -21.97 43.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.631 179.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.61 -51.21 70.89 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.824 -179.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.38 -5.5 58.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.443 179.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.38 -74.39 1.15 Allowed Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 83.4 mt -69.96 125.92 28.18 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.067 0.461 . . . . 0.0 110.235 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -59.49 -39.44 83.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.139 -179.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 83.1 51.76 4.06 Favored Glycine 0 CA--C 1.52 0.401 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -95.92 -14.88 22.76 Favored 'General case' 0 C--N 1.331 -0.198 0 O-C-N 122.721 -0.282 . . . . 0.0 110.571 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 258' ' ' SER . . . . . 0.449 ' HG ' ' CG2' ' A' ' 191' ' ' VAL . 3.5 t 174.52 88.99 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.11 0.481 . . . . 0.0 110.049 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . 0.595 ' N ' ' CD1' ' A' ' 259' ' ' LEU . 0.9 OUTLIER -94.47 124.3 38.42 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.367 0.603 . . . . 0.0 111.174 -179.204 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 16.0 m-30 -93.36 146.43 23.74 Favored 'General case' 0 CA--C 1.503 -0.843 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.328 179.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 86.5 mt -122.0 149.86 42.89 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.597 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.658 ' CG ' ' N ' ' A' ' 263' ' ' ALA . 2.5 p90 -77.83 -139.0 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.431 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . 0.658 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -51.59 77.71 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 121.047 0.451 . . . . 0.0 111.15 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . 0.628 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.44 104.69 0.19 Allowed Glycine 0 CA--C 1.527 0.795 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 265' ' ' ASP . . . . . 0.601 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.9 m-20 -80.55 -177.56 6.3 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 120.632 0.253 . . . . 0.0 110.971 -179.611 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -40.45 -17.81 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.854 0.359 . . . . 0.0 110.513 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . 0.601 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.26 -51.7 42.24 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.684 179.438 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -63.74 -46.69 84.19 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.973 179.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . 0.525 ' O ' ' CD2' ' A' ' 273' ' ' TYR . . . -61.44 -35.28 77.14 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 121.238 0.542 . . . . 0.0 109.753 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -63.06 -34.61 77.96 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.022 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.31 -43.2 13.92 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.393 -179.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 272' ' ' ILE . . . . . 0.618 ' C ' ' H ' ' A' ' 274' ' ' ALA . 4.9 tt -51.36 -33.78 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.864 -178.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 273' ' ' TYR . . . . . 0.525 ' CD2' ' O ' ' A' ' 269' ' ' ALA . 17.1 m-85 -54.31 -2.06 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.674 -179.533 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 274' ' ' ALA . . . . . 0.618 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.54 -39.71 70.51 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.996 179.533 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . 0.582 ' O ' ' N ' ' A' ' 279' ' ' ALA . 4.0 p30 -38.6 97.31 0.13 Allowed Pre-proline 0 C--O 1.225 -0.185 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.556 -179.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 276' ' ' PRO . . . . . 0.401 ' N ' ' O ' ' A' ' 274' ' ' ALA . 47.5 Cg_exo -54.1 -42.82 63.84 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 C-N-CA 122.234 1.956 . . . . 0.0 112.696 -178.728 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 89.7 mt -64.38 -42.73 96.0 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.188 0.518 . . . . 0.0 111.266 -179.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 91.4 mt -95.97 -1.16 49.65 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.922 -179.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 279' ' ' ALA . . . . . 0.582 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.39 -34.94 77.71 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.662 -179.684 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -73.87 20.01 0.11 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.035 -179.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . 0.518 ' H ' ' C ' ' A' ' 279' ' ' ALA . 13.7 mt -75.15 120.12 80.18 Favored Pre-proline 0 N--CA 1.45 -0.439 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.423 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -51.21 -39.26 62.09 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.568 2.178 . . . . 0.0 111.809 179.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -53.19 -50.34 64.85 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 78.1 t -61.47 -43.91 97.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 179.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -57.66 -41.04 80.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.186 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -91.27 0.19 57.57 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.065 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt 59.54 44.06 15.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.07 0.462 . . . . 0.0 110.935 179.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -95.25 41.46 1.1 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.347 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 54.6 t -119.39 135.6 59.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 121.089 0.471 . . . . 0.0 110.161 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -132.92 163.14 29.82 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.071 0.462 . . . . 0.0 110.695 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.59 155.02 33.04 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-O 121.068 0.461 . . . . 0.0 110.782 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 82.1 mt -94.23 -1.36 54.18 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.211 -179.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.72 165.53 12.6 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 6.8 m -87.57 -62.07 1.58 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.905 0.383 . . . . 0.0 111.146 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 295' ' ' GLU . . . . . 0.483 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.6 mm-40 -69.16 -3.97 15.65 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.721 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 25.5 p -76.56 32.39 0.13 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.648 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 297' ' ' PHE . . . . . 0.483 ' H ' ' C ' ' A' ' 295' ' ' GLU . 85.9 t80 -60.47 -45.88 92.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.603 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . 0.62 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.1 mtt85 -81.2 135.02 35.72 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.02 0.438 . . . . 0.0 110.546 -179.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 18.4 tp -113.91 117.18 30.66 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-O 121.054 0.454 . . . . 0.0 110.098 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . 0.603 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.6 p-10 -165.21 -176.66 4.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.533 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 301' ' ' TYR . . . . . 0.515 ' OH ' ' CD1' ' A' ' 173' ' ' PHE . 81.2 t80 -47.05 -43.15 19.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.169 -179.603 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -67.11 -40.13 86.83 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.046 0.451 . . . . 0.0 110.91 179.043 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 303' ' ' SER . . . . . 0.603 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 59.9 p -56.27 -36.27 68.38 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.021 -179.093 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . 0.514 ' N ' ' HG ' ' A' ' 303' ' ' SER . . . -57.32 -51.54 68.95 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.51 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 90.2 mtp -56.67 -43.11 80.1 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -179.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -66.48 -42.72 87.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.003 0.43 . . . . 0.0 110.09 178.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 55.5 t -63.94 -43.19 97.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.126 179.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 43.4 tp -59.9 -42.14 93.18 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.683 -179.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -62.24 -39.27 92.27 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 310' ' ' ARG . . . . . 0.451 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.5 ttt85 -63.75 -44.01 94.75 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.203 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 89.5 mt -63.35 -42.21 98.89 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.194 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt -62.95 -33.57 75.66 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.081 0.467 . . . . 0.0 109.977 179.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.53 -23.75 21.95 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.325 -179.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . 0.451 ' N ' ' O ' ' A' ' 310' ' ' ARG . 6.7 tt -62.33 -43.12 99.56 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 121.111 0.482 . . . . 0.0 110.562 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 . . . . . 0 C--O 1.22 -0.469 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.428 -179.968 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -99.37 135.89 40.12 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.016 0.436 . . . . 0.0 110.504 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.497 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -92.01 178.39 1.74 Allowed Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.548 -179.928 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.497 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.8 Cg_exo -61.61 147.28 95.76 Favored 'Trans proline' 0 C--N 1.3 -2.018 0 C-N-CA 122.79 2.327 . . . . 0.0 112.104 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 35.6 ptt180 -135.79 142.16 44.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.72 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -79.71 116.51 19.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.471 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.4 tp -110.94 130.68 63.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.498 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.6 t -70.71 141.99 51.53 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.563 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.51 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.4 t0 -139.68 179.39 6.61 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.568 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.51 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 78.0 p -73.92 -36.99 64.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.61 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.8 ttt85 -46.54 -94.67 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.331 -179.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.452 ' C ' ' HG1' ' A' ' 36' ' ' THR . . . -167.16 -26.42 0.02 OUTLIER Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.452 ' HG1' ' C ' ' A' ' 35' ' ' GLY . 59.9 m -169.11 104.73 0.39 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.879 0.371 . . . . 0.0 110.65 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 75.6 t60 -128.39 148.89 50.72 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.033 0.444 . . . . 0.0 110.262 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.484 ' CG2' ' N ' ' A' ' 39' ' ' LEU . 98.2 m -131.23 166.04 22.04 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.62 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.484 ' N ' ' CG2' ' A' ' 38' ' ' THR . 81.5 mt -120.83 127.61 52.08 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.43 179.737 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -65.2 -44.55 87.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.694 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.406 ' O ' ' HD3' ' A' ' 43' ' ' PRO . 39.9 p -165.83 154.88 11.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.448 179.667 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.46 ' N ' ' CD ' ' A' ' 42' ' ' GLN . 14.8 mp0 -44.34 101.13 0.24 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.626 179.449 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.406 ' HD3' ' O ' ' A' ' 41' ' ' SER . 31.5 Cg_exo -57.39 129.59 34.79 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 C-N-CA 122.365 2.044 . . . . 0.0 112.283 -179.722 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -84.1 -24.57 30.27 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.502 179.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.539 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.5 mtm-85 -122.29 134.17 54.67 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-O 121.147 0.498 . . . . 0.0 110.34 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.1 mt -130.43 133.76 63.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.949 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 45.4 t -124.25 130.49 73.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 179.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.502 ' O ' ' O ' ' A' ' 66' ' ' ALA . 2.0 m -155.38 167.75 29.36 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.556 179.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 59.5 p -124.9 9.44 8.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.487 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.56 125.42 33.08 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.672 -179.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 95.1 t -65.92 -44.43 92.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.417 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.4 m -62.49 -44.26 96.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.651 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 51.3 tp -62.33 -41.41 98.54 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.5 -179.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 75.5 m -57.7 -44.48 85.88 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.258 -179.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.29 -62.18 5.36 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 179.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.7 t -48.38 -35.51 12.75 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.8 mt -61.87 -44.64 96.4 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.707 -0.397 . . . . 0.0 111.17 179.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.2 mp -65.01 -41.7 95.09 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.303 178.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.63 -40.97 98.24 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.989 -179.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.0 tp -88.65 16.79 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.762 -179.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 56.41 84.82 0.08 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.674 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 178.67 57.86 0.06 OUTLIER Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.016 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -50.77 153.34 8.39 Favored 'Trans proline' 0 C--N 1.296 -2.202 0 C-N-CA 122.892 2.394 . . . . 0.0 112.38 -178.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.437 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.2 OUTLIER -108.93 145.44 15.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.359 -179.714 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.8 mt -63.62 -45.24 98.09 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.317 -179.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.502 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -129.49 134.08 47.61 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 120.848 0.356 . . . . 0.0 110.539 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.501 ' O ' ' N ' ' A' ' 98' ' ' LEU . 75.2 m -134.73 158.84 43.09 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.798 -179.637 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.99 139.15 16.01 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.461 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.81 -162.69 0.08 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.914 0.388 . . . . 0.0 110.503 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.491 ' O ' ' C ' ' A' ' 71' ' ' THR . 14.5 t -133.49 134.43 43.46 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.404 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.491 ' C ' ' O ' ' A' ' 70' ' ' THR . 0.6 OUTLIER 29.69 68.82 0.65 Allowed Pre-proline 0 N--CA 1.464 0.226 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.754 -179.866 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -61.25 145.17 98.83 Favored 'Trans proline' 0 C--N 1.299 -2.031 0 C-N-CA 122.627 2.218 . . . . 0.0 112.062 -178.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.533 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 45.1 p-10 -159.14 -32.04 0.06 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.677 179.643 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.533 ' N ' ' OD1' ' A' ' 73' ' ' ASN . 99.1 m-20 -64.1 -39.7 94.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.489 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -60.23 -48.33 82.19 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.706 -179.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.424 ' O ' ' O ' ' A' ' 77' ' ' ALA . 92.6 t -60.25 -24.9 32.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 179.771 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.424 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -45.71 172.98 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.555 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.575 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.2 p30 -62.18 177.89 0.43 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.564 -179.728 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.593 ' C ' ' H ' ' A' ' 81' ' ' GLY . 36.1 p30 -45.13 85.79 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.965 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.575 ' N ' ' O ' ' A' ' 78' ' ' ASP . 42.5 tp60 -67.69 13.17 0.08 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.109 -179.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.593 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 118.73 -22.34 9.32 Favored Glycine 0 CA--C 1.519 0.324 0 N-CA-C 110.969 -0.852 . . . . 0.0 110.969 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -108.13 116.46 32.01 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.014 0.435 . . . . 0.0 110.44 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 75.8 mt -98.71 0.4 44.49 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.491 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -92.53 7.24 44.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.971 0.415 . . . . 0.0 110.413 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.441 ' O ' ' CG2' ' A' ' 89' ' ' VAL . 87.8 mt-30 -100.12 -28.19 13.16 Favored 'General case' 0 C--O 1.225 -0.234 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.823 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 68.9 t-105 -62.77 -40.71 98.12 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.858 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.554 ' O ' ' N ' ' A' ' 91' ' ' LYS . 65.4 m -77.73 -53.56 7.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.148 -179.364 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -48.51 -50.76 30.48 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.965 -179.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.441 ' CG2' ' O ' ' A' ' 85' ' ' GLN . 15.7 m -68.87 -40.62 81.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 120.867 0.365 . . . . 0.0 111.005 179.76 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.415 ' H ' HG23 ' A' ' 89' ' ' VAL . . . -72.32 -22.63 61.15 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.695 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.554 ' N ' ' O ' ' A' ' 87' ' ' SER . 65.9 tttm -62.01 -45.51 93.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.512 -179.498 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.442 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.6 mm-40 -90.53 -94.85 0.12 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.134 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.636 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.9 mtt180 -142.92 58.97 1.42 Allowed 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.461 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.6 pttp 33.43 26.13 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 120.879 0.371 . . . . 0.0 110.221 -179.145 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.636 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.4 tt -48.08 123.52 6.38 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.925 -178.102 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -83.88 -169.41 2.56 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.092 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.603 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 81.3 mtp180 -74.58 136.84 42.05 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.298 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.501 ' N ' ' O ' ' A' ' 67' ' ' SER . 91.3 mt -85.79 -165.82 1.35 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.762 -179.68 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.537 ' CD2' ' O ' ' A' ' 99' ' ' TYR . 48.3 p90 -168.33 119.77 0.81 Allowed 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.178 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.515 ' C ' ' O ' ' A' ' 99' ' ' TYR . 43.0 mm -28.88 120.96 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.977 -179.693 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 114.25 27.57 3.35 Favored Glycine 0 CA--C 1.52 0.344 0 N-CA-C 111.154 -0.779 . . . . 0.0 111.154 -179.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.575 ' N ' ' CD ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -144.63 46.62 0.63 Allowed Pre-proline 0 C--N 1.324 -0.537 0 CA-C-O 120.995 0.426 . . . . 0.0 110.479 179.885 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 29.5 Cg_endo -61.91 143.97 96.1 Favored 'Trans proline' 0 C--N 1.297 -2.153 0 C-N-CA 122.644 2.229 . . . . 0.0 111.993 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 27.8 t -173.16 120.0 0.34 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.462 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.61 -40.46 63.8 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.035 0.445 . . . . 0.0 111.049 179.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.25 -39.87 89.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.88 -179.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.22 -39.97 95.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.75 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 71.3 t -67.57 -43.87 86.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.798 179.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.84 -38.89 92.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.578 -179.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.442 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.49 -23.31 62.66 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.49 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.551 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.4 mm-40 -90.64 5.3 48.56 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.687 -179.502 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.551 ' C ' ' O ' ' A' ' 111' ' ' GLN . 10.6 tpt 23.55 64.13 0.38 Allowed Pre-proline 0 N--CA 1.465 0.296 0 CA-C-O 120.896 0.379 . . . . 0.0 110.946 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -78.14 167.24 23.64 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 123.03 2.487 . . . . 0.0 112.132 -178.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.524 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 98.9 m-20 -109.96 -42.11 4.31 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.19 179.428 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.3 tp -121.24 120.21 34.5 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.019 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 82.5 mt -112.79 128.88 69.26 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.336 0 CA-C-O 120.918 0.389 . . . . 0.0 110.812 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 29.2 mt -109.13 132.32 54.23 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 121.088 0.471 . . . . 0.0 110.211 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 99.1 mt -119.94 138.57 50.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.645 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 85.9 p -72.44 154.07 41.07 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.608 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.18 -50.21 74.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.636 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.0 t -149.73 154.3 38.29 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.579 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 170.66 -170.79 43.37 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.99 -34.03 88.83 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.452 ' O ' ' OD1' ' A' ' 124' ' ' ASP . 44.5 p-10 -87.29 120.42 28.55 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.796 0.332 . . . . 0.0 110.684 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 38.8 t -63.2 143.83 57.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.504 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.52 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.0 -43.23 9.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.928 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.6 tp -62.86 -42.35 99.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.706 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.58 -12.07 59.54 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.485 -179.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 85.3 mt -114.77 -23.84 8.99 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.649 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . 0.52 ' N ' ' O ' ' A' ' 126' ' ' ALA . 79.9 t80 -50.9 -49.66 58.96 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.592 -178.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.0 p-10 -66.12 -42.6 88.97 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.861 0.363 . . . . 0.0 111.158 179.576 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.501 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 88.4 mt-30 -66.98 -37.94 85.15 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.781 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 96.0 mt -80.32 -41.38 24.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.892 -179.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.2 t -57.21 -44.52 83.76 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.212 -179.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.5 m -61.87 -45.22 94.7 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.751 0.31 . . . . 0.0 110.517 179.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 93.3 mt -62.18 -43.6 98.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.27 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.51 168.69 4.66 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.554 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -50.38 113.04 0.87 Allowed 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.282 1.988 . . . . 0.0 112.206 179.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 23.4 m -83.97 127.39 33.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.609 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 34.8 tp -117.87 135.91 53.79 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.034 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.44 ' O ' ' OD2' ' A' ' 32' ' ' ASP . 81.7 mt -100.18 118.85 47.44 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.331 0 CA-C-O 121.174 0.512 . . . . 0.0 111.194 -179.36 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 98.1 mt -134.74 132.28 54.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.621 179.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.517 HD22 ' CG ' ' A' ' 241' ' ' ASP . 60.9 t30 -66.97 151.42 47.66 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.905 0.383 . . . . 0.0 110.433 179.457 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.522 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 88.0 t80 -86.11 122.38 30.04 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.811 -179.52 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.522 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 98.9 m-20 55.17 69.34 0.74 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.754 179.657 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 35.8 p-10 -125.8 0.16 7.37 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.651 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -150.56 115.13 5.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.7 -179.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' SER . . . . . 0.517 ' HG ' ' H ' ' A' ' 150' ' ' GLN . 84.5 p -63.3 168.33 4.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.542 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.422 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.6 p-90 -51.83 -15.88 0.59 Allowed 'General case' 0 C--O 1.223 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.524 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . 0.517 ' H ' ' HG ' ' A' ' 148' ' ' SER . 68.1 tp60 -70.39 -76.02 0.11 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.511 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.448 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.1 t -62.7 -38.63 91.16 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.295 179.51 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 54.0 tp -60.02 -45.66 92.07 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.379 -178.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.422 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 46.9 tp -62.76 -41.75 99.36 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.832 0.348 . . . . 0.0 110.365 179.066 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.448 ' OG1' ' O ' ' A' ' 151' ' ' SER . 60.2 p -64.14 -34.86 79.03 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.264 -179.498 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.435 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.9 mm-40 -64.24 -42.59 96.45 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.322 179.286 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 91.6 mt -65.55 -38.82 90.68 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.037 0.446 . . . . 0.0 110.252 179.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.583 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.29 -32.31 80.3 Favored Glycine 0 CA--C 1.521 0.418 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 -179.387 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.442 ' C ' ' O ' ' A' ' 157' ' ' GLY . 97.1 mt-10 -35.17 -27.29 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.821 0.344 . . . . 0.0 110.764 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.583 ' N ' ' O ' ' A' ' 157' ' ' GLY . 95.5 mt -56.03 149.76 3.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.33 179.187 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 71.5 p -69.87 137.3 51.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.002 -179.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 71.57 20.34 78.4 Favored Glycine 0 N--CA 1.458 0.143 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 179.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 58.0 m80 -121.78 -14.91 8.02 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.706 0.289 . . . . 0.0 110.571 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -65.85 -59.83 3.48 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.764 -179.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -52.05 -49.35 63.64 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.16 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -60.76 -41.14 94.85 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.718 0.294 . . . . 0.0 110.356 179.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.45 -47.2 86.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.613 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -57.0 -40.16 76.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.241 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -61.65 -50.34 72.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.571 179.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -65.34 -43.75 89.91 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.535 179.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 95.2 mt -64.6 -43.47 96.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.509 179.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.21 -51.17 70.43 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.535 -179.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.44 -43.93 96.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.46 179.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . 0.458 ' CD1' ' OH ' ' A' ' 301' ' ' TYR . 56.7 t80 -62.72 -44.45 96.18 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.04 0.448 . . . . 0.0 110.405 179.44 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -63.35 -39.88 95.75 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.616 -179.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -63.07 -42.78 99.74 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.617 179.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -60.67 -44.77 96.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.181 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 83.7 mt -64.36 -41.23 96.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.031 0.443 . . . . 0.0 110.698 178.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.08 -62.32 1.71 Allowed 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.482 -179.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.52 -46.9 85.81 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.552 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.12 -41.76 65.34 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.223 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -63.94 -33.52 75.91 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.976 0.417 . . . . 0.0 110.352 179.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . 0.404 ' HG2' ' O ' ' A' ' 182' ' ' GLU . 69.6 tt0 -90.72 8.68 33.27 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.37 0.605 . . . . 0.0 110.52 -179.003 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -104.84 -32.12 8.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.195 179.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 45.4 pt -128.11 147.67 32.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.814 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -139.86 131.03 26.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.422 179.362 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.556 ' CD2' ' N ' ' A' ' 186' ' ' LEU . 3.6 mm? -85.59 133.14 42.56 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.901 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -43.89 157.72 0.14 Allowed 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.738 2.292 . . . . 0.0 112.138 179.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . 0.525 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.8 Cg_endo -63.01 115.21 2.81 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 C-N-CA 122.804 2.336 . . . . 0.0 111.724 179.811 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . 0.525 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.7 mt-30 155.53 147.63 0.0 OUTLIER Pre-proline 0 C--N 1.332 -0.195 0 O-C-N 123.596 0.56 . . . . 0.0 110.762 -179.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -73.77 143.85 34.17 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.651 2.234 . . . . 0.0 111.963 178.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.499 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.1 p -125.03 159.09 32.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.27 0.557 . . . . 0.0 110.164 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' THR . . . . . 0.499 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 35.9 p -143.54 165.48 27.45 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.034 -179.636 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -135.38 128.58 31.89 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.159 0.504 . . . . 0.0 110.213 179.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 47.4 pt -146.49 148.81 16.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.048 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 68.9 t -117.67 123.09 71.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-O 121.238 0.542 . . . . 0.0 109.765 179.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -134.3 107.29 7.56 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.332 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 95.2 m -130.96 130.6 43.63 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.756 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.412 ' O ' ' N ' ' A' ' 201' ' ' HIS . . . -82.84 -36.9 25.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.256 179.646 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.34 -67.18 0.25 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.374 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.33 -9.43 58.49 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.348 179.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . 0.412 ' N ' ' O ' ' A' ' 198' ' ' ALA . 60.2 t-80 60.27 58.42 2.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.748 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 46.4 p -167.21 153.65 8.19 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.535 179.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.6 144.23 24.29 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.992 0.425 . . . . 0.0 110.446 179.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -135.39 138.4 43.27 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.646 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 20.0 mt -106.42 125.48 51.05 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 121.11 0.481 . . . . 0.0 109.867 -179.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' TRP . . . . . 0.557 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 75.7 m95 -82.01 167.03 19.28 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.659 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -156.77 171.33 7.56 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.586 -179.156 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.87 -37.03 85.02 Favored 'Trans proline' 0 C--N 1.302 -1.879 0 C-N-CA 122.624 2.216 . . . . 0.0 112.133 179.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -70.47 -34.87 72.89 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.8 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 22.0 m -61.26 150.83 33.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.64 -179.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.59 -36.95 82.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.448 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . 0.557 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 54.8 tt0 -64.69 -40.29 95.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.506 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.61 -43.45 92.07 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -63.26 -43.52 97.76 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.741 0.305 . . . . 0.0 110.281 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 65.2 ttp -59.61 -48.11 82.95 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.252 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 87.9 mt -60.49 -41.04 93.45 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 179.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . 0.455 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.3 tp10 -57.88 -37.85 74.69 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -65.36 -37.98 88.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.8 0.333 . . . . 0.0 110.679 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 94.4 mt -64.43 -42.64 95.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.606 -179.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.49 44.6 0.08 OUTLIER Glycine 0 C--N 1.333 0.408 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . 0.455 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 26.5 m-85 -127.74 155.28 44.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.04 0.447 . . . . 0.0 110.507 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 222' ' ' THR . . . . . 0.456 ' O ' ' O ' ' A' ' 191' ' ' VAL . 6.5 p -106.99 122.11 45.8 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.201 0.524 . . . . 0.0 110.154 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . 0.446 ' CD2' ' N ' ' A' ' 223' ' ' LEU . 4.3 mm? -101.07 133.12 46.06 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.063 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.96 159.31 14.98 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.463 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.43 115.42 30.23 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.942 0.401 . . . . 0.0 110.351 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.456 ' CD1' ' N ' ' A' ' 226' ' ' LEU . 8.9 mp -53.47 156.77 4.04 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.686 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -60.29 145.41 98.65 Favored 'Trans proline' 0 C--N 1.301 -1.956 0 C-N-CA 122.721 2.281 . . . . 0.0 112.058 179.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.36 -2.92 58.96 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.546 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.31 -40.8 5.66 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.54 ' O ' ' N ' ' A' ' 233' ' ' SER . 86.2 mt -79.27 -16.75 55.96 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-O 121.006 0.431 . . . . 0.0 110.386 -179.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . 0.403 ' C ' ' O ' ' A' ' 230' ' ' LEU . 54.5 t-20 -40.21 -49.15 2.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.694 -179.577 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -88.18 15.43 7.54 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.777 0.322 . . . . 0.0 111.27 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 233' ' ' SER . . . . . 0.54 ' N ' ' O ' ' A' ' 230' ' ' LEU . 78.1 p -60.43 -35.65 76.33 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.693 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . 0.526 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.6 tt0 -118.35 -69.39 0.85 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.943 179.554 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.1 m -70.04 103.37 2.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.734 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -94.59 57.69 2.25 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.359 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -144.88 -122.61 1.57 Allowed Glycine 0 CA--C 1.52 0.402 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -134.4 111.7 10.37 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 121.081 0.467 . . . . 0.0 110.433 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . 0.517 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.3 mtt180 -148.1 57.52 1.08 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.778 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -69.92 -31.75 69.69 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.505 179.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . 0.517 ' CG ' HD22 ' A' ' 143' ' ' ASN . 64.9 t0 -56.85 -46.98 81.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.343 -179.163 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 242' ' ' ILE . . . . . 0.435 ' O ' ' O ' ' A' ' 239' ' ' ARG . 17.5 tt -140.27 157.11 24.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.898 0.38 . . . . 0.0 110.527 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 96.1 mt -106.12 106.17 20.08 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.196 0 CA-C-O 121.16 0.505 . . . . 0.0 110.504 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . 0.517 ' OE1' ' NH1' ' A' ' 239' ' ' ARG . 88.3 mt-30 -110.5 110.39 21.11 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.405 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 9.5 mp -121.95 -168.3 1.68 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.607 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . 0.526 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.53 -16.88 0.05 OUTLIER Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . 0.694 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -60.47 157.01 29.84 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -63.77 21.27 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.915 0.388 . . . . 0.0 110.585 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . 0.694 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.7 m-20 -96.87 -5.82 37.29 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.569 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 92.7 mt -80.23 -21.45 42.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.6 179.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.47 -51.24 70.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.8 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.72 -5.28 58.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.449 179.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.09 -74.39 1.14 Allowed Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.926 -0.87 . . . . 0.0 110.926 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 81.8 mt -70.13 125.95 28.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.054 0.454 . . . . 0.0 110.227 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -59.45 -39.17 82.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.321 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 82.82 51.94 4.06 Favored Glycine 0 CA--C 1.521 0.463 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -95.8 -15.16 22.71 Favored 'General case' 0 C--N 1.331 -0.203 0 O-C-N 122.723 -0.281 . . . . 0.0 110.553 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 258' ' ' SER . . . . . 0.423 ' O ' ' O ' ' A' ' 192' ' ' THR . 3.4 t 174.5 88.9 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.104 0.478 . . . . 0.0 110.159 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . 0.596 ' N ' ' CD1' ' A' ' 259' ' ' LEU . 0.9 OUTLIER -94.27 123.88 37.94 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.244 0.545 . . . . 0.0 111.098 -179.058 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 16.0 m-30 -92.85 146.4 23.66 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.316 179.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 86.3 mt -122.31 149.73 43.34 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.562 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.66 ' CG ' ' N ' ' A' ' 263' ' ' ALA . 2.7 p90 -77.43 -138.29 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.601 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . 0.66 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -52.31 77.55 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 121.044 0.449 . . . . 0.0 111.034 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . 0.627 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.08 104.33 0.18 Allowed Glycine 0 CA--C 1.527 0.786 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 265' ' ' ASP . . . . . 0.603 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.9 m-20 -80.35 -177.68 6.27 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 120.724 0.297 . . . . 0.0 110.912 -179.488 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -40.44 -17.61 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.536 179.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . 0.603 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.48 -51.73 40.16 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.019 0.438 . . . . 0.0 110.693 179.457 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -63.58 -46.63 84.97 Favored 'General case' 0 CA--C 1.527 0.09 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.323 179.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . 0.524 ' O ' ' CD2' ' A' ' 273' ' ' TYR . . . -61.59 -35.18 77.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.865 179.531 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -62.97 -34.4 77.43 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.163 179.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.49 -43.37 13.63 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.225 -179.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 272' ' ' ILE . . . . . 0.618 ' C ' ' H ' ' A' ' 274' ' ' ALA . 4.9 tt -51.33 -33.63 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.876 -178.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 273' ' ' TYR . . . . . 0.524 ' CD2' ' O ' ' A' ' 269' ' ' ALA . 17.3 m-85 -54.45 -1.8 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.649 -179.603 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 274' ' ' ALA . . . . . 0.618 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.65 -39.51 70.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.881 179.577 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . 0.583 ' O ' ' N ' ' A' ' 279' ' ' ALA . 2.8 p30 -39.61 98.35 0.17 Allowed Pre-proline 0 C--N 1.333 -0.122 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.514 -179.66 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -54.24 -43.02 62.38 Favored 'Trans proline' 0 C--N 1.303 -1.856 0 C-N-CA 122.391 2.061 . . . . 0.0 112.574 -178.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 89.5 mt -64.46 -42.82 95.7 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.201 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 91.1 mt -95.67 -1.63 49.72 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.812 -179.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 279' ' ' ALA . . . . . 0.583 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.33 -34.91 77.55 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.672 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.26 20.1 0.12 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.994 -179.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . 0.513 ' H ' ' C ' ' A' ' 279' ' ' ALA . 13.8 mt -75.21 120.01 79.66 Favored Pre-proline 0 N--CA 1.451 -0.375 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.484 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -50.83 -39.44 58.16 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.599 2.199 . . . . 0.0 111.946 179.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.8 -50.51 63.49 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.154 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 79.4 t -61.42 -43.96 97.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 179.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -57.7 -41.22 81.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.248 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -90.98 0.15 57.6 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.167 179.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt 59.53 43.41 16.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.035 0.445 . . . . 0.0 110.873 179.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -94.78 41.3 1.09 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.411 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 53.7 t -118.93 135.92 57.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.012 0.434 . . . . 0.0 110.257 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -133.08 162.85 30.64 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.053 0.454 . . . . 0.0 110.701 -179.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.96 155.22 33.22 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.012 0.434 . . . . 0.0 110.731 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 81.4 mt -93.9 -1.38 54.82 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.227 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.43 165.72 12.7 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 110.598 -1.001 . . . . 0.0 110.598 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 7.0 m -87.47 -62.3 1.53 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.899 0.381 . . . . 0.0 111.034 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 295' ' ' GLU . . . . . 0.469 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.5 mm-40 -69.68 -3.85 17.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.61 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 27.0 p -76.91 33.22 0.14 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.66 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 297' ' ' PHE . . . . . 0.469 ' H ' ' C ' ' A' ' 295' ' ' GLU . 84.9 t80 -60.16 -45.86 91.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.58 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . 0.603 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.2 mtt85 -81.87 134.22 35.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.531 -179.684 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 16.2 tp -114.46 119.52 37.15 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-O 120.996 0.427 . . . . 0.0 110.178 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . 0.63 ' H ' ' HG ' ' A' ' 303' ' ' SER . 50.3 p-10 -167.26 -174.44 2.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.553 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 301' ' ' TYR . . . . . 0.458 ' OH ' ' CD1' ' A' ' 173' ' ' PHE . 84.5 t80 -47.92 -45.68 31.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.254 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -64.93 -41.42 95.55 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.022 0.439 . . . . 0.0 110.717 179.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 303' ' ' SER . . . . . 0.63 ' HG ' ' H ' ' A' ' 300' ' ' ASP . 52.8 p -55.52 -36.24 66.51 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.086 -179.251 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -56.79 -51.85 67.32 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 90.9 mtp -56.14 -43.71 78.5 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -66.32 -42.64 87.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.978 0.418 . . . . 0.0 110.278 178.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 55.7 t -64.08 -42.84 96.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.207 179.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 42.3 tp -59.55 -42.27 92.01 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.863 -179.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -62.63 -38.8 91.67 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.163 179.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 310' ' ' ARG . . . . . 0.443 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.6 ttt85 -63.58 -44.07 95.13 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.251 179.549 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 88.4 mt -63.26 -42.01 99.11 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.228 179.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -62.84 -33.03 74.4 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.097 179.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -90.33 -23.31 21.17 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.417 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . 0.443 ' N ' ' O ' ' A' ' 310' ' ' ARG . 6.8 tt -62.3 -43.22 99.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.098 0.475 . . . . 0.0 110.594 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 . . . . . 0 C--O 1.219 -0.511 0 CA-C-O 118.079 -0.962 . . . . 0.0 110.414 -179.988 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -99.64 135.69 40.68 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.064 0.459 . . . . 0.0 110.456 -179.993 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.497 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -92.09 178.61 1.64 Allowed Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.61 -179.813 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.497 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 27.0 Cg_exo -61.63 147.17 96.01 Favored 'Trans proline' 0 C--N 1.3 -1.995 0 C-N-CA 122.749 2.299 . . . . 0.0 112.112 179.694 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 35.1 ptt180 -136.12 142.29 44.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.673 179.701 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -79.79 116.83 20.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.489 179.865 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.404 ' O ' ' CG2' ' A' ' 30' ' ' ILE . 9.5 tp -111.48 129.98 65.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.444 -179.988 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.2 t -70.9 142.11 51.16 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.58 179.881 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.522 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.5 t0 -138.93 179.98 6.18 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.575 -179.985 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.522 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 77.7 p -74.31 -37.23 63.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.616 179.952 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -46.69 -94.58 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.35 -179.515 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.503 ' C ' ' HG1' ' A' ' 36' ' ' THR . . . -165.8 -27.13 0.02 OUTLIER Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 179.953 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.503 ' HG1' ' C ' ' A' ' 35' ' ' GLY . 63.2 m -168.79 106.09 0.44 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.924 0.392 . . . . 0.0 110.696 -179.929 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 67.4 t60 -128.92 146.72 50.87 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.044 0.449 . . . . 0.0 110.232 -179.949 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.488 ' CG2' ' N ' ' A' ' 39' ' ' LEU . 96.5 m -130.08 165.59 21.92 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.57 -179.848 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.488 ' N ' ' CG2' ' A' ' 38' ' ' THR . 80.5 mt -120.29 127.16 52.11 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.461 179.752 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -65.46 -44.61 86.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.588 -179.996 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.413 ' O ' ' HD3' ' A' ' 43' ' ' PRO . 38.6 p -165.59 154.58 11.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.388 179.735 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.461 ' N ' ' CD ' ' A' ' 42' ' ' GLN . 14.7 mp0 -44.98 101.32 0.25 Allowed Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.631 179.436 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.413 ' HD3' ' O ' ' A' ' 41' ' ' SER . 31.5 Cg_exo -57.53 129.54 34.33 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 C-N-CA 122.367 2.045 . . . . 0.0 112.247 -179.731 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -82.42 -25.13 33.95 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.491 179.631 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.537 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.7 mtm-85 -120.96 134.56 55.3 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-O 121.191 0.519 . . . . 0.0 110.28 -179.953 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.0 mt -130.28 133.59 63.79 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.923 -179.771 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 46.5 t -124.61 131.34 72.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.808 0.337 . . . . 0.0 110.126 179.373 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.504 ' O ' ' O ' ' A' ' 66' ' ' ALA . 4.7 m -154.2 165.94 34.69 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.563 179.782 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 71.5 p -124.76 8.29 8.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.463 179.942 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.66 125.8 33.44 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.672 -179.459 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 89.9 t -65.47 -44.61 94.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.44 -179.943 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.6 m -62.52 -44.31 96.67 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.627 -179.917 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 53.1 tp -62.15 -41.58 98.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.512 -179.519 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 72.8 m -57.74 -44.49 86.08 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.292 -179.253 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.39 -62.0 5.5 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 110.906 -0.878 . . . . 0.0 110.906 179.632 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.7 t -48.35 -35.76 13.11 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 -179.904 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 20.2 mt -61.66 -44.61 96.63 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.648 -0.421 . . . . 0.0 111.186 179.424 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.3 mp -64.89 -41.89 95.25 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.342 177.901 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.53 -41.19 98.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.02 -179.279 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.0 tp -88.04 16.62 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.763 -179.711 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 56.45 84.11 0.09 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.736 -179.874 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.9 58.24 0.09 OUTLIER Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.019 -179.745 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -50.77 152.45 9.6 Favored 'Trans proline' 0 C--N 1.296 -2.229 0 C-N-CA 122.751 2.301 . . . . 0.0 112.473 -178.405 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.431 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -109.15 146.25 14.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.372 -179.658 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 97.0 mt -63.86 -44.91 98.24 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.357 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.459 -179.914 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.504 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -129.81 134.22 47.42 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 120.84 0.352 . . . . 0.0 110.632 -179.896 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.509 ' O ' ' N ' ' A' ' 98' ' ' LEU . 58.8 m -134.32 158.39 43.92 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.875 -179.62 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -85.46 138.16 16.11 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.749 -0.941 . . . . 0.0 110.749 179.811 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.449 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.25 -163.81 0.11 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.958 0.408 . . . . 0.0 110.515 -179.906 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.486 ' O ' ' C ' ' A' ' 71' ' ' THR . 6.2 t -134.22 140.61 46.6 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.216 179.936 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.486 ' C ' ' O ' ' A' ' 70' ' ' THR . 0.7 OUTLIER 29.67 70.73 0.56 Allowed Pre-proline 0 N--CA 1.466 0.329 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.657 -179.935 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_exo -60.45 144.44 99.52 Favored 'Trans proline' 0 C--N 1.299 -2.036 0 C-N-CA 122.587 2.191 . . . . 0.0 112.079 -178.323 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.54 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 44.5 p-10 -164.87 -35.56 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.662 179.895 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.54 ' N ' ' OD1' ' A' ' 73' ' ' ASN . 99.0 m-20 -63.88 -39.36 94.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.433 -179.98 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 73.4 ttt180 -60.88 -47.76 84.93 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.67 -179.389 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.433 ' O ' ' O ' ' A' ' 77' ' ' ALA . 95.6 t -60.24 -23.9 29.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.113 179.716 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.433 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -45.14 172.36 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.633 179.853 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.572 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.9 p30 -62.33 178.05 0.44 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.617 -179.7 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.599 ' C ' ' H ' ' A' ' 81' ' ' GLY . 36.6 p30 -46.04 85.64 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.05 179.912 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.572 ' N ' ' O ' ' A' ' 78' ' ' ASP . 42.6 tp60 -67.4 14.04 0.06 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.121 0.486 . . . . 0.0 110.094 -179.718 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.599 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 117.48 -21.62 10.58 Favored Glycine 0 CA--C 1.519 0.339 0 N-CA-C 110.909 -0.876 . . . . 0.0 110.909 179.922 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -107.85 116.71 32.45 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.968 0.413 . . . . 0.0 110.434 179.917 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 74.2 mt -98.62 0.69 45.3 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.551 -179.764 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -92.64 6.38 47.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.99 0.424 . . . . 0.0 110.459 -179.786 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.447 ' O ' ' CG2' ' A' ' 89' ' ' VAL . 88.2 mt-30 -99.83 -27.46 13.61 Favored 'General case' 0 C--O 1.224 -0.289 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.861 179.953 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.4 t-105 -63.84 -40.84 97.54 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.145 -179.795 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.552 ' O ' ' N ' ' A' ' 91' ' ' LYS . 67.3 m -77.76 -53.76 7.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.304 -179.548 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -48.19 -50.81 27.83 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.003 -179.273 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.447 ' CG2' ' O ' ' A' ' 85' ' ' GLN . 14.7 m -68.89 -40.7 81.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 120.919 0.39 . . . . 0.0 111.059 179.757 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.41 ' H ' HG23 ' A' ' 89' ' ' VAL . . . -72.14 -22.81 61.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.721 -179.885 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.552 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.0 tttm -61.6 -46.03 91.55 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.489 -179.539 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.442 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.3 mm-40 -90.11 -94.86 0.11 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.096 -179.964 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.627 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.7 mtt180 -143.19 59.58 1.41 Allowed 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 179.812 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.46 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.6 pttp 33.6 26.45 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.221 -179.214 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.627 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.4 tt -48.12 123.14 5.9 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.904 -178.152 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -83.24 -169.54 2.59 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.057 -179.835 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.612 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 81.2 mtp180 -73.9 138.26 44.19 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.174 -179.677 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.509 ' N ' ' O ' ' A' ' 67' ' ' SER . 87.9 mt -86.61 -166.58 1.6 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.707 -179.524 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.528 ' CD2' ' O ' ' A' ' 99' ' ' TYR . 46.7 p90 -167.32 119.69 0.92 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.324 179.946 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.507 ' C ' ' O ' ' A' ' 99' ' ' TYR . 44.4 mm -29.56 121.08 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.995 -179.744 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 113.2 28.78 3.21 Favored Glycine 0 CA--C 1.52 0.359 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 -179.477 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.587 ' N ' ' CD ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -143.86 45.68 0.59 Allowed Pre-proline 0 C--N 1.323 -0.555 0 CA-C-O 120.948 0.404 . . . . 0.0 110.448 179.839 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.587 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 29.9 Cg_endo -61.97 143.68 95.56 Favored 'Trans proline' 0 C--N 1.297 -2.148 0 C-N-CA 122.683 2.255 . . . . 0.0 111.989 -179.925 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.688 ' HG ' ' H ' ' A' ' 107' ' ' ALA . 21.1 t -173.27 120.77 0.35 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.491 179.717 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.58 -41.09 63.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.067 0.461 . . . . 0.0 111.121 179.725 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -65.85 -40.4 91.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.904 -179.372 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.688 ' H ' ' HG ' ' A' ' 104' ' ' SER . . . -64.07 -39.95 95.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.762 -179.909 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 69.6 t -67.54 -43.77 86.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.795 179.652 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.43 -39.18 92.48 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.589 -179.284 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.442 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.39 -23.59 62.72 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.455 179.858 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.551 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.3 mm-40 -90.79 4.81 50.66 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.717 -179.509 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.551 ' C ' ' O ' ' A' ' 111' ' ' GLN . 10.5 tpt 23.67 63.86 0.39 Allowed Pre-proline 0 N--CA 1.465 0.297 0 CA-C-O 120.898 0.38 . . . . 0.0 111.059 -179.993 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -78.7 168.55 20.93 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 C-N-CA 122.938 2.425 . . . . 0.0 112.213 -178.463 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.498 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 99.0 m-20 -113.04 -44.42 3.28 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.978 179.517 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.2 tp -120.23 119.62 33.74 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.577 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 95.4 mt -116.78 131.04 70.59 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.351 0 CA-C-O 120.953 0.406 . . . . 0.0 110.918 -179.856 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 30.9 mt -105.69 132.75 51.45 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.115 0.483 . . . . 0.0 110.279 -179.466 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 98.2 mt -118.33 136.24 56.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.724 -179.729 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 85.7 p -72.18 153.08 41.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.672 179.975 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -59.96 -50.0 75.49 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.612 -179.817 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -149.45 153.91 38.02 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.571 179.799 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 170.05 -170.56 42.96 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 179.919 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -63.04 -34.77 90.88 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 179.98 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.447 ' O ' ' OD1' ' A' ' 124' ' ' ASP . 43.9 p-10 -88.04 120.4 29.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.764 0.316 . . . . 0.0 110.683 179.934 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 40.8 t -63.45 144.12 57.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.466 -179.928 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.521 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.37 -42.82 9.08 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.031 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.6 tp -62.82 -42.36 99.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.669 -179.832 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.05 -10.93 57.64 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.543 -179.461 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 85.2 mt -115.54 -24.14 8.46 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.695 -179.918 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . 0.521 ' N ' ' O ' ' A' ' 126' ' ' ALA . 78.7 t80 -51.84 -49.88 61.97 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.554 -178.902 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.502 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.1 p-10 -65.91 -42.11 90.57 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.909 0.385 . . . . 0.0 111.232 179.569 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.502 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 88.0 mt-30 -67.32 -36.74 82.07 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.78 179.929 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 93.7 mt -80.38 -41.74 24.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.975 -179.541 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.2 t -57.44 -44.71 84.95 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.223 -179.109 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 18.9 m -62.23 -45.59 92.66 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.799 0.333 . . . . 0.0 110.66 179.264 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 92.1 mt -62.36 -43.85 98.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.325 -179.792 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -170.37 163.79 5.94 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.541 179.832 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -43.36 111.24 0.22 Allowed 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.501 2.134 . . . . 0.0 112.115 179.553 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 17.4 m -85.44 127.55 34.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.594 179.933 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 34.3 tp -119.11 136.93 53.92 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.957 -179.718 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.432 ' O ' ' OD1' ' A' ' 32' ' ' ASP . 79.8 mt -103.9 119.83 53.17 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.41 0 CA-C-O 121.183 0.516 . . . . 0.0 111.308 -179.382 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 98.1 mt -135.42 132.52 52.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.651 179.657 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.513 HD22 ' CG ' ' A' ' 241' ' ' ASP . 53.7 t30 -65.56 149.41 50.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.899 0.38 . . . . 0.0 110.388 179.258 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.524 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 88.1 t80 -83.07 122.5 28.42 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.002 -179.496 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.524 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 98.9 m-20 55.09 69.58 0.72 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.871 179.608 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 49.2 p-10 -123.69 -0.01 8.65 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 120.974 0.416 . . . . 0.0 110.696 179.8 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -151.59 117.25 5.41 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.767 -179.512 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 148' ' ' SER . . . . . 0.52 ' HG ' ' H ' ' A' ' 150' ' ' GLN . 84.7 p -63.07 167.53 4.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.5 -179.811 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.419 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.6 p-90 -50.74 -15.47 0.29 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.518 -179.823 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . 0.52 ' H ' ' HG ' ' A' ' 148' ' ' SER . 68.1 tp60 -71.72 -74.45 0.16 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.458 -179.843 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.451 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.2 t -62.61 -39.22 93.08 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.008 0.432 . . . . 0.0 110.274 179.408 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 53.3 tp -60.23 -45.43 93.25 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.364 -178.516 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.419 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 45.7 tp -62.74 -41.73 99.32 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.398 179.025 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.451 ' OG1' ' O ' ' A' ' 151' ' ' SER . 51.8 p -64.05 -34.64 78.47 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.284 -179.469 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.456 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 88.2 mm-40 -63.98 -42.44 97.21 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.157 179.223 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 92.9 mt -65.35 -38.95 91.63 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.068 0.461 . . . . 0.0 110.223 179.137 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.582 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.15 -32.16 79.48 Favored Glycine 0 CA--C 1.52 0.362 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 -179.367 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.456 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.2 mt-10 -36.22 -25.68 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.814 0.34 . . . . 0.0 110.741 179.95 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.582 ' N ' ' O ' ' A' ' 157' ' ' GLY . 94.9 mt -58.95 149.68 5.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.276 179.303 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 75.2 p -69.3 137.08 52.7 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.076 -179.541 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 70.98 21.67 78.31 Favored Glycine 0 C--N 1.329 0.156 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 179.518 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 59.5 m80 -123.3 -14.95 7.34 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.732 0.301 . . . . 0.0 110.573 179.912 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -66.51 -59.63 3.46 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.779 -179.744 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -51.9 -48.9 63.93 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.173 -179.645 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -60.76 -41.03 94.64 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.981 -0.288 . . . . 0.0 110.316 179.534 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.58 -47.29 86.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.575 179.81 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.8 -40.25 75.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.178 -179.828 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -61.67 -50.24 73.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.627 179.56 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -65.43 -43.76 89.45 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.506 179.532 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 95.4 mt -64.6 -43.44 96.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.51 179.694 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.33 -51.03 71.02 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.542 -179.12 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.91 -43.62 95.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.44 179.685 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . 0.496 ' CD1' ' OH ' ' A' ' 301' ' ' TYR . 56.3 t80 -62.63 -44.63 95.8 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.058 0.456 . . . . 0.0 110.404 179.41 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -63.21 -39.88 95.87 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.59 -179.363 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -62.92 -42.86 99.93 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.637 179.218 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -60.61 -44.83 95.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.073 179.987 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 85.6 mt -64.37 -41.21 96.83 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.044 0.449 . . . . 0.0 110.672 178.901 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.06 -62.16 1.81 Allowed 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.527 -179.342 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.79 -46.54 87.32 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.571 179.803 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.36 -41.58 65.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.179 -179.994 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -63.76 -33.78 76.42 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.932 0.396 . . . . 0.0 110.336 179.305 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . 0.407 ' HG2' ' O ' ' A' ' 182' ' ' GLU . 69.8 tt0 -90.5 8.81 31.99 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.312 0.577 . . . . 0.0 110.509 -179.031 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -104.82 -32.26 8.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.887 0.375 . . . . 0.0 111.274 179.56 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.3 pt -128.01 147.41 32.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.836 -179.861 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -139.88 131.14 26.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.336 179.346 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.556 ' CD2' ' N ' ' A' ' 186' ' ' LEU . 3.5 mm? -85.61 133.7 41.4 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.879 179.938 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -43.95 157.96 0.13 Allowed 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.669 2.246 . . . . 0.0 112.171 179.401 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . 0.523 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.6 Cg_endo -62.95 114.78 2.58 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 C-N-CA 122.82 2.347 . . . . 0.0 111.7 179.773 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . 0.523 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.8 mt-30 155.56 147.89 0.0 OUTLIER Pre-proline 0 N--CA 1.455 -0.195 0 O-C-N 123.555 0.535 . . . . 0.0 110.721 -179.858 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -73.72 144.09 34.73 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.644 2.229 . . . . 0.0 111.911 178.043 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.496 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.1 p -124.93 158.91 32.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.336 0.589 . . . . 0.0 110.086 179.983 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 192' ' ' THR . . . . . 0.496 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 37.1 p -143.47 165.35 27.78 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.135 -179.653 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -135.26 128.49 31.97 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.144 0.497 . . . . 0.0 110.181 179.618 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 47.3 pt -146.48 148.92 16.49 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.056 179.814 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 70.4 t -117.74 123.22 71.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.278 0.561 . . . . 0.0 109.681 179.183 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -134.26 107.35 7.61 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.251 179.66 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 95.8 m -130.93 130.53 43.59 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.85 179.707 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -82.92 -36.92 24.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.245 179.691 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.5 -67.07 0.26 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.343 -179.939 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.52 -10.1 59.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.249 179.606 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 60.0 t-80 61.03 58.42 2.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.816 -179.959 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 37.3 p -166.88 153.33 8.46 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.5 179.573 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.08 143.77 24.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.985 0.421 . . . . 0.0 110.431 179.455 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -135.21 138.06 43.25 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.667 179.993 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 20.0 mt -106.13 125.37 50.91 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.059 0.457 . . . . 0.0 109.848 -179.633 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 206' ' ' TRP . . . . . 0.558 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 74.9 m95 -82.01 167.04 19.27 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.603 -179.787 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -156.75 171.67 7.11 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.598 -179.214 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -54.09 -36.87 86.35 Favored 'Trans proline' 0 C--N 1.303 -1.865 0 C-N-CA 122.663 2.242 . . . . 0.0 111.952 179.379 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -70.61 -34.96 72.68 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.795 -179.811 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 21.2 m -61.28 150.57 34.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.635 -179.321 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.5 -37.07 82.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.52 -179.821 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . 0.558 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 54.9 tt0 -64.53 -40.36 95.47 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.497 179.957 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.74 -43.39 91.91 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 179.791 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -63.4 -43.53 97.27 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.715 0.293 . . . . 0.0 110.23 179.842 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 65.1 ttp -59.51 -48.07 83.06 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.227 -179.853 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 87.5 mt -60.64 -40.8 93.3 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.636 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . 0.453 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.1 tp10 -58.02 -37.87 75.15 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.852 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -65.29 -38.12 89.26 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.803 0.335 . . . . 0.0 110.686 179.663 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 94.0 mt -64.41 -42.6 95.98 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.587 -179.595 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.62 45.0 0.08 OUTLIER Glycine 0 C--N 1.334 0.429 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 -179.962 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . 0.453 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 26.5 m-85 -128.23 155.91 43.8 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.038 0.447 . . . . 0.0 110.492 -179.792 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 222' ' ' THR . . . . . 0.457 ' O ' ' O ' ' A' ' 191' ' ' VAL . 8.2 p -107.62 122.44 46.71 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.191 0.519 . . . . 0.0 110.182 -179.934 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . 0.446 ' CD2' ' N ' ' A' ' 223' ' ' LEU . 4.3 mm? -101.12 133.29 45.86 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.053 -179.995 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -97.0 159.05 15.13 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.494 179.906 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.0 115.16 29.8 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.335 179.899 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.45 ' CD1' ' N ' ' A' ' 226' ' ' LEU . 9.0 mp -53.33 156.66 3.89 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.698 179.921 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -60.27 145.31 98.83 Favored 'Trans proline' 0 C--N 1.301 -1.93 0 C-N-CA 122.598 2.199 . . . . 0.0 112.12 179.296 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.21 -3.05 59.03 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.493 -179.884 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.28 -40.83 5.67 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 -179.828 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.532 ' O ' ' N ' ' A' ' 233' ' ' SER . 85.6 mt -79.44 -16.96 55.26 Favored 'General case' 0 C--O 1.222 -0.344 0 CA-C-O 121.002 0.429 . . . . 0.0 110.295 -179.694 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . 0.401 ' C ' ' O ' ' A' ' 230' ' ' LEU . 55.0 t-20 -40.3 -49.08 2.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.783 -179.541 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -88.08 15.44 7.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.818 0.342 . . . . 0.0 111.325 179.802 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 233' ' ' SER . . . . . 0.532 ' N ' ' O ' ' A' ' 230' ' ' LEU . 78.1 p -60.5 -35.56 76.24 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.594 -179.799 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . 0.525 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.7 tt0 -118.4 -69.36 0.85 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.942 179.575 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.4 m -70.0 103.05 2.15 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.65 -179.776 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -94.13 57.64 2.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.456 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -145.04 -122.1 1.51 Allowed Glycine 0 CA--C 1.521 0.433 0 N-CA-C 110.966 -0.854 . . . . 0.0 110.966 -179.993 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -135.32 112.19 10.18 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 121.172 0.51 . . . . 0.0 110.383 179.939 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . 0.518 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.4 mtt180 -148.28 57.81 1.07 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.709 -179.941 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -69.57 -32.09 70.65 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.482 179.617 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . 0.513 ' CG ' HD22 ' A' ' 143' ' ' ASN . 64.8 t0 -56.7 -47.12 80.62 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.436 -179.113 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 242' ' ' ILE . . . . . 0.432 ' O ' ' O ' ' A' ' 239' ' ' ARG . 17.8 tt -140.2 156.92 24.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.925 0.393 . . . . 0.0 110.52 179.758 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 96.2 mt -106.14 106.29 20.3 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.227 0 CA-C-O 121.204 0.526 . . . . 0.0 110.507 179.759 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . 0.518 ' OE1' ' NH1' ' A' ' 239' ' ' ARG . 88.3 mt-30 -110.29 110.04 20.71 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.336 179.702 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 9.4 mp -121.78 -168.18 1.66 Allowed 'General case' 0 C--O 1.225 -0.199 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.711 179.78 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . 0.525 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.32 -16.53 0.05 OUTLIER Glycine 0 CA--C 1.523 0.546 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 179.833 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . 0.695 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -60.62 157.01 30.48 Favored Glycine 0 CA--C 1.521 0.443 0 N-CA-C 110.904 -0.878 . . . . 0.0 110.904 -179.892 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -63.81 21.67 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.947 0.404 . . . . 0.0 110.559 179.899 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . 0.695 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.8 m-20 -97.38 -5.85 35.41 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.572 179.965 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 92.8 mt -80.13 -21.71 42.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.617 179.51 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.55 -51.28 70.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.801 -179.529 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.58 -5.29 58.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.419 179.686 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.15 -74.26 1.15 Allowed Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 -179.897 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 80.9 mt -70.14 126.05 28.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.069 0.462 . . . . 0.0 110.269 -179.87 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -59.59 -39.17 83.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.337 -179.659 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 83.0 51.87 4.04 Favored Glycine 0 CA--C 1.521 0.421 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 179.827 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -95.82 -15.13 22.71 Favored 'General case' 0 C--N 1.332 -0.17 0 O-C-N 122.632 -0.334 . . . . 0.0 110.594 -179.861 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 258' ' ' SER . . . . . 0.423 ' O ' ' O ' ' A' ' 192' ' ' THR . 3.5 t 174.63 88.8 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.063 0.459 . . . . 0.0 110.157 179.989 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . 0.596 ' N ' ' CD1' ' A' ' 259' ' ' LEU . 0.9 OUTLIER -94.26 123.96 37.98 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.309 0.576 . . . . 0.0 111.183 -179.141 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 15.9 m-30 -92.93 146.4 23.65 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.34 179.283 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 86.0 mt -122.37 149.69 43.45 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.491 -179.822 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.659 ' CG ' ' N ' ' A' ' 263' ' ' ALA . 2.6 p90 -77.56 -138.39 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.563 -179.841 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . 0.659 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -51.99 77.48 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.006 179.986 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . 0.632 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.1 104.48 0.19 Allowed Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 -179.929 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 265' ' ' ASP . . . . . 0.601 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.8 m-20 -80.47 -177.69 6.33 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 120.741 0.305 . . . . 0.0 110.858 -179.562 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -40.51 -17.64 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.57 179.846 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . 0.601 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.54 -51.55 41.67 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.715 179.448 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -63.73 -46.75 83.95 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.15 179.483 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . 0.526 ' O ' ' CD2' ' A' ' 273' ' ' TYR . . . -61.56 -35.17 77.02 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.774 179.545 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -62.87 -34.45 77.4 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.166 179.649 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.46 -43.23 13.77 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.3 -179.569 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 272' ' ' ILE . . . . . 0.615 ' C ' ' H ' ' A' ' 274' ' ' ALA . 5.0 tt -51.41 -33.55 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.904 -178.884 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 273' ' ' TYR . . . . . 0.526 ' CD2' ' O ' ' A' ' 269' ' ' ALA . 17.1 m-85 -54.59 -1.75 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.69 -179.653 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 274' ' ' ALA . . . . . 0.615 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.64 -39.56 70.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.857 179.581 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . 0.583 ' O ' ' N ' ' A' ' 279' ' ' ALA . 3.0 p30 -39.51 98.23 0.16 Allowed Pre-proline 0 N--CA 1.463 0.175 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.538 -179.634 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -54.08 -43.04 61.95 Favored 'Trans proline' 0 C--N 1.303 -1.824 0 C-N-CA 122.388 2.058 . . . . 0.0 112.691 -178.821 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 89.5 mt -64.48 -42.76 95.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.14 0.495 . . . . 0.0 111.181 -179.691 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 91.4 mt -95.82 -1.52 49.43 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.884 -179.456 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 279' ' ' ALA . . . . . 0.583 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.38 -34.93 77.68 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.644 -179.812 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -74.09 20.05 0.11 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.048 -179.354 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . 0.513 ' H ' ' C ' ' A' ' 279' ' ' ALA . 13.7 mt -75.06 120.23 80.68 Favored Pre-proline 0 N--CA 1.452 -0.349 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.424 179.981 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -51.12 -39.5 60.85 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.624 2.216 . . . . 0.0 111.8 179.099 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.82 -50.26 64.02 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.096 179.879 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 74.0 t -61.51 -43.93 97.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.562 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -57.86 -41.19 81.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.305 -179.942 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -90.87 -0.0 57.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.061 179.695 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt 59.47 43.1 16.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.967 0.413 . . . . 0.0 110.829 179.714 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -94.59 41.42 1.09 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.383 179.797 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 54.5 t -118.92 135.84 58.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.074 0.464 . . . . 0.0 110.179 -179.677 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -133.0 162.6 31.25 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.726 -179.663 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.58 155.4 32.3 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-O 120.956 0.408 . . . . 0.0 110.776 -179.87 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 81.5 mt -94.22 -1.47 54.02 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.281 -179.723 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.24 165.93 12.8 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.611 -0.996 . . . . 0.0 110.611 -179.838 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 7.2 m -87.64 -62.46 1.49 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.934 0.397 . . . . 0.0 111.08 -179.901 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 295' ' ' GLU . . . . . 0.474 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.6 mm-40 -69.46 -3.82 16.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.674 -179.845 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 22.7 p -76.91 32.47 0.14 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.601 -179.892 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 297' ' ' PHE . . . . . 0.474 ' H ' ' C ' ' A' ' 295' ' ' GLU . 77.1 t80 -60.24 -46.08 91.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.592 -179.962 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . 0.612 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.1 mtt85 -80.92 134.85 35.8 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.016 0.436 . . . . 0.0 110.583 -179.742 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 17.0 tp -114.48 118.2 33.11 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.203 179.882 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . 0.604 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.0 p-10 -165.78 -176.08 3.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.585 179.94 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 301' ' ' TYR . . . . . 0.496 ' OH ' ' CD1' ' A' ' 173' ' ' PHE . 82.5 t80 -47.16 -43.77 21.38 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.286 -179.719 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -66.69 -40.51 88.55 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.03 0.443 . . . . 0.0 110.823 179.136 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 303' ' ' SER . . . . . 0.604 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 59.6 p -55.87 -36.18 67.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.087 -179.21 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -57.37 -51.48 69.23 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.52 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 91.0 mtp -56.23 -43.63 78.8 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.953 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -66.34 -42.68 87.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.986 0.422 . . . . 0.0 110.226 178.79 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 55.8 t -64.03 -42.95 97.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.154 179.373 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 42.7 tp -59.63 -42.28 92.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.87 -179.513 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -62.71 -38.86 92.11 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 179.465 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 310' ' ' ARG . . . . . 0.444 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.6 ttt85 -63.5 -44.12 95.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.229 179.525 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 88.7 mt -63.19 -41.97 99.26 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.23 179.655 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt -62.84 -33.34 75.05 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.99 179.461 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.86 -23.59 21.62 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.461 -179.775 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . 0.444 ' N ' ' O ' ' A' ' 310' ' ' ARG . 6.7 tt -62.26 -43.14 99.51 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.607 -179.925 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 . . . . . 0 C--O 1.221 -0.431 0 CA-C-O 117.979 -1.01 . . . . 0.0 110.503 179.947 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -100.11 136.85 39.38 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.008 0.432 . . . . 0.0 110.5 -179.929 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.498 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -91.78 178.46 1.73 Allowed Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.54 -179.911 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.498 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.7 Cg_exo -61.61 147.48 95.28 Favored 'Trans proline' 0 C--N 1.3 -2.023 0 C-N-CA 122.772 2.315 . . . . 0.0 112.179 179.627 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 35.6 ptt180 -136.05 142.61 44.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.699 179.766 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -78.96 117.13 19.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.574 179.918 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.6 tp -110.51 130.94 62.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.395 -179.956 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.5 t -70.43 142.07 52.03 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.62 179.812 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.433 ' CG ' ' H ' ' A' ' 33' ' ' SER . 25.8 t70 -139.9 177.42 7.98 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.452 -179.902 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.452 ' OG ' ' O ' ' A' ' 141' ' ' ILE . 78.0 p -73.79 -36.26 65.01 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.693 179.925 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -47.71 -94.86 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.317 -179.525 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.429 ' O ' ' OG1' ' A' ' 36' ' ' THR . . . -165.59 -25.96 0.02 OUTLIER Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.889 -0.885 . . . . 0.0 110.889 179.913 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.429 ' OG1' ' O ' ' A' ' 35' ' ' GLY . 53.2 m -169.25 106.72 0.41 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.864 0.364 . . . . 0.0 110.665 -179.899 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 49.3 t60 -129.48 146.65 51.29 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.095 0.474 . . . . 0.0 110.1 179.997 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.481 ' CG2' ' N ' ' A' ' 39' ' ' LEU . 96.8 m -129.89 166.07 20.74 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.653 -179.814 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.481 ' N ' ' CG2' ' A' ' 38' ' ' THR . 82.5 mt -121.01 127.84 52.14 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.432 179.76 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -64.12 -44.58 91.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.639 -179.905 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 42.9 p -165.96 155.25 11.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.365 179.688 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.443 ' N ' ' CD ' ' A' ' 42' ' ' GLN . 14.1 mp0 -43.34 100.7 0.23 Allowed Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.605 179.415 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -56.8 129.29 33.78 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 122.318 2.012 . . . . 0.0 112.282 -179.612 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -83.72 -24.59 31.14 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.46 179.575 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.538 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.3 mtm-85 -122.31 134.94 54.65 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.169 0.509 . . . . 0.0 110.293 -179.974 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.1 mt -130.24 133.47 64.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.92 -179.681 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 45.4 t -124.34 130.83 73.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-O 120.848 0.356 . . . . 0.0 110.062 179.384 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.5 ' O ' ' O ' ' A' ' 66' ' ' ALA . 2.2 m -154.44 166.55 32.9 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.532 179.795 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 72.5 p -124.13 8.42 8.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.521 179.917 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.3 t -86.13 125.75 33.72 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.677 -179.551 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 87.2 t -65.64 -44.48 93.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.453 -179.984 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.4 m -62.29 -44.31 96.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.667 -179.917 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 46.1 tp -62.39 -41.3 98.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.537 -179.431 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 71.4 m -57.79 -44.64 86.4 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.353 -179.262 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.21 -62.21 5.36 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 179.535 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.7 t -48.39 -35.52 12.84 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 -179.917 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.9 mt -61.71 -44.42 96.96 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.698 -0.401 . . . . 0.0 111.207 179.407 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.2 mp -64.9 -41.8 95.3 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.352 177.956 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.62 -41.05 98.33 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.098 -179.251 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.0 tp -88.25 16.94 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.775 -179.644 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 56.36 84.2 0.09 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.676 -179.899 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.44 57.63 0.07 OUTLIER Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.277 -0.42 . . . . 0.0 109.994 -179.826 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -50.53 153.19 7.99 Favored 'Trans proline' 0 C--N 1.295 -2.237 0 C-N-CA 122.9 2.4 . . . . 0.0 112.426 -178.305 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.439 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -109.16 144.94 16.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.424 -179.709 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.8 mt -63.72 -45.36 97.53 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.35 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.444 -179.775 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.5 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -128.76 133.77 48.2 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.865 0.364 . . . . 0.0 110.518 -179.867 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.516 ' O ' ' N ' ' A' ' 98' ' ' LEU . 75.1 m -135.0 158.87 43.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.819 -179.648 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -87.23 139.45 16.12 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 179.828 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.452 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.88 -162.58 0.08 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.986 0.422 . . . . 0.0 110.429 -179.944 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.492 ' O ' ' C ' ' A' ' 71' ' ' THR . 14.0 t -133.48 133.99 42.95 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.318 179.966 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.492 ' C ' ' O ' ' A' ' 70' ' ' THR . 0.6 OUTLIER 29.69 68.81 0.65 Allowed Pre-proline 0 N--CA 1.464 0.229 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.768 -179.93 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -61.09 145.36 99.01 Favored 'Trans proline' 0 C--N 1.3 -1.992 0 C-N-CA 122.648 2.232 . . . . 0.0 112.101 -178.437 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.533 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 46.1 p-10 -158.74 -32.05 0.07 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.703 179.726 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.533 ' N ' ' OD1' ' A' ' 73' ' ' ASN . 99.1 m-20 -64.14 -39.92 95.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.579 179.825 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -60.49 -48.26 82.55 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.704 -179.207 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.415 ' O ' ' O ' ' A' ' 77' ' ' ALA . 90.4 t -60.23 -24.94 32.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.804 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.415 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -46.03 172.97 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.541 179.862 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.581 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.5 p30 -62.01 177.7 0.43 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.611 -179.691 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.596 ' C ' ' H ' ' A' ' 81' ' ' GLY . 35.6 p30 -44.76 85.72 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.0 179.924 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.581 ' N ' ' O ' ' A' ' 78' ' ' ASP . 42.7 tp60 -67.43 13.03 0.08 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.06 -179.758 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.596 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 118.62 -21.85 9.6 Favored Glycine 0 CA--C 1.519 0.328 0 N-CA-C 110.974 -0.85 . . . . 0.0 110.974 179.94 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -107.92 116.29 31.68 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.953 0.406 . . . . 0.0 110.494 179.856 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 73.2 mt -98.62 -0.01 43.91 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.436 -179.71 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -92.6 7.39 43.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.947 0.403 . . . . 0.0 110.387 -179.785 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.439 ' O ' ' CG2' ' A' ' 89' ' ' VAL . 87.8 mt-30 -100.07 -28.33 13.1 Favored 'General case' 0 C--O 1.224 -0.25 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.842 -179.996 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 68.9 t-105 -62.5 -40.89 98.16 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.867 -179.632 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.555 ' O ' ' N ' ' A' ' 91' ' ' LYS . 63.4 m -77.59 -53.55 7.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.195 -179.425 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -48.53 -50.73 30.76 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.013 -179.277 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.439 ' CG2' ' O ' ' A' ' 85' ' ' GLN . 15.4 m -68.91 -40.59 81.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 120.896 0.379 . . . . 0.0 111.048 179.723 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.415 ' H ' HG23 ' A' ' 89' ' ' VAL . . . -72.29 -22.84 61.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.8 -179.927 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.555 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.0 tttm -61.86 -45.53 93.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.429 -179.541 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.442 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.4 mm-40 -90.49 -94.92 0.12 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.13 -179.846 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.626 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.9 mtt180 -143.09 59.1 1.41 Allowed 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.828 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.462 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.7 pttp 33.37 26.77 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.242 -179.171 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.626 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.4 tt -48.71 123.58 7.08 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.951 -178.131 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -84.33 -169.1 2.44 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.08 -179.937 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.609 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 81.0 mtp180 -74.86 136.64 41.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.279 -179.798 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.516 ' N ' ' O ' ' A' ' 67' ' ' SER . 90.9 mt -85.39 -165.71 1.3 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.633 -179.642 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.54 ' CD2' ' O ' ' A' ' 99' ' ' TYR . 47.7 p90 -168.32 119.49 0.8 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.209 179.982 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.516 ' C ' ' O ' ' A' ' 99' ' ' TYR . 42.8 mm -28.77 120.8 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.0 -179.63 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 114.51 27.63 3.26 Favored Glycine 0 CA--C 1.519 0.315 0 N-CA-C 111.15 -0.78 . . . . 0.0 111.15 -179.494 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.574 ' N ' ' CD ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -144.84 46.51 0.61 Allowed Pre-proline 0 C--N 1.323 -0.546 0 CA-C-O 120.891 0.377 . . . . 0.0 110.488 179.909 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.574 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 29.4 Cg_endo -61.88 144.31 96.56 Favored 'Trans proline' 0 C--N 1.296 -2.197 0 C-N-CA 122.652 2.235 . . . . 0.0 111.968 -179.942 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.714 ' HG ' ' H ' ' A' ' 107' ' ' ALA . 27.0 t -173.24 119.97 0.33 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.446 179.728 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.4 -40.33 64.38 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.021 0.439 . . . . 0.0 111.088 179.647 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -66.32 -39.69 89.44 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.819 -179.403 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.714 ' H ' ' HG ' ' A' ' 104' ' ' SER . . . -63.95 -40.04 95.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.704 -179.816 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 71.7 t -67.38 -43.93 87.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.712 179.681 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.87 -38.91 92.75 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.524 -179.349 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.442 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.4 -23.68 62.82 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.465 179.89 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.561 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.5 mm-40 -91.24 5.17 50.2 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.723 -179.552 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.561 ' C ' ' O ' ' A' ' 111' ' ' GLN . 10.3 tpt 22.24 64.72 0.33 Allowed Pre-proline 0 N--CA 1.465 0.277 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.043 179.985 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -78.57 169.05 20.41 Favored 'Trans proline' 0 C--N 1.304 -1.811 0 C-N-CA 122.99 2.46 . . . . 0.0 112.082 -178.461 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.423 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 98.8 m-20 -110.73 -42.76 3.96 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 121.013 0.435 . . . . 0.0 110.231 179.47 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.0 tp -119.95 120.78 37.37 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.974 179.571 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 83.7 mt -114.02 129.23 70.31 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.37 0 CA-C-O 120.936 0.398 . . . . 0.0 110.92 -179.858 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 30.8 mt -109.24 132.03 54.51 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.048 0.451 . . . . 0.0 110.198 -179.705 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 98.8 mt -119.61 138.05 51.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.706 -179.781 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 85.1 p -71.88 153.97 41.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.554 179.978 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.28 -50.35 74.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.671 -179.793 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -149.58 154.06 38.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.601 179.809 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 170.66 -170.78 43.37 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.911 -0.875 . . . . 0.0 110.911 179.824 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.96 -34.09 88.97 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 179.936 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.45 ' O ' ' OD1' ' A' ' 124' ' ' ASP . 44.4 p-10 -86.96 120.33 28.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.843 0.354 . . . . 0.0 110.673 179.953 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 39.1 t -63.26 143.63 57.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.045 0.45 . . . . 0.0 110.447 -179.932 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.0 -43.26 9.0 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.945 -179.97 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.6 tp -62.81 -42.48 99.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.705 -179.831 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.58 -11.71 58.72 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.515 -179.444 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 84.8 mt -115.0 -24.05 8.78 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.724 -179.866 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . 0.519 ' N ' ' O ' ' A' ' 126' ' ' ALA . 80.8 t80 -51.22 -49.57 60.8 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.579 -178.901 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.7 p-10 -66.17 -42.33 89.06 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.8 0.333 . . . . 0.0 111.18 179.538 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.504 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 88.2 mt-30 -67.42 -37.67 83.42 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.761 179.975 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 95.6 mt -80.22 -41.89 24.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.932 -179.599 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.2 t -57.17 -44.28 83.36 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.24 -179.07 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.1 m -62.06 -45.44 93.55 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.775 0.321 . . . . 0.0 110.572 179.357 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 92.9 mt -62.28 -43.64 98.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.229 -179.774 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.25 167.85 5.31 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.566 179.897 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -49.04 112.56 0.67 Allowed 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.357 2.038 . . . . 0.0 112.116 179.377 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 21.6 m -84.5 127.37 34.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.641 -179.951 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 36.2 tp -118.62 137.95 52.92 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.066 -179.867 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.452 ' O ' ' OG ' ' A' ' 33' ' ' SER . 77.1 mt -102.82 120.05 52.07 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 CA-C-O 121.224 0.535 . . . . 0.0 111.118 -179.415 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 98.5 mt -135.68 131.83 50.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.585 179.662 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.427 ' OD1' ' OD2' ' A' ' 241' ' ' ASP . 56.4 t30 -66.42 153.82 41.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.938 0.399 . . . . 0.0 110.467 179.373 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.527 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 90.5 t80 -87.73 122.43 31.38 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.831 -179.639 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.527 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 99.1 m-20 55.3 69.33 0.75 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.778 179.633 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 49.4 p-10 -123.73 -0.4 8.57 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.664 179.925 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -151.26 116.5 5.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.778 -179.541 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 148' ' ' SER . . . . . 0.494 ' HG ' ' H ' ' A' ' 150' ' ' GLN . 83.4 p -62.15 166.5 4.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.479 -179.752 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.41 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.4 p-90 -50.68 -15.48 0.28 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.545 -179.812 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . 0.494 ' H ' ' HG ' ' A' ' 148' ' ' SER . 68.3 tp60 -71.52 -74.26 0.16 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.466 -179.787 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.439 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.1 t -62.86 -39.29 93.95 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.272 179.467 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 54.8 tp -59.96 -45.76 91.61 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.399 -178.581 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.41 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 46.5 tp -62.65 -41.75 99.22 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.784 0.326 . . . . 0.0 110.404 179.054 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.439 ' OG1' ' O ' ' A' ' 151' ' ' SER . 56.6 p -64.57 -34.73 78.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.358 -179.551 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.45 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 86.9 mm-40 -64.05 -42.84 96.9 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.313 179.284 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 91.5 mt -65.54 -38.83 90.75 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.057 0.456 . . . . 0.0 110.187 179.147 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.58 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.21 -32.11 79.44 Favored Glycine 0 CA--C 1.52 0.344 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 -179.36 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.45 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.2 mt-10 -35.58 -26.91 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.823 0.344 . . . . 0.0 110.812 179.955 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.58 ' N ' ' O ' ' A' ' 157' ' ' GLY . 94.8 mt -56.52 150.84 2.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.264 179.312 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 72.0 p -69.66 137.3 52.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.01 -179.541 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 70.15 22.37 77.34 Favored Glycine 0 N--CA 1.459 0.2 0 N-CA-C 111.214 -0.754 . . . . 0.0 111.214 179.462 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 59.5 m80 -123.12 -13.65 7.71 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.716 0.293 . . . . 0.0 110.566 179.906 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -67.21 -59.32 3.53 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.755 -179.687 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -52.14 -49.42 63.74 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.239 -179.595 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -60.36 -41.3 93.42 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.792 0.33 . . . . 0.0 110.336 179.525 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.52 -47.05 87.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.595 179.831 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.96 -40.14 75.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.204 -179.894 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -61.64 -50.24 73.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.589 179.553 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -65.47 -43.59 89.82 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.501 179.541 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 95.0 mt -64.64 -43.47 96.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.457 179.776 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.44 -51.27 70.1 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.641 -179.232 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.72 -44.16 94.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.545 179.697 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . 0.5 ' CD1' ' OH ' ' A' ' 301' ' ' TYR . 55.0 t80 -62.86 -44.43 96.13 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.069 0.461 . . . . 0.0 110.443 179.438 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -63.33 -40.06 96.28 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.598 -179.331 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -62.92 -42.71 99.88 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.63 179.191 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -60.62 -44.8 95.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.103 -179.97 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 85.7 mt -64.44 -41.16 96.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.01 0.434 . . . . 0.0 110.714 178.951 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.18 -62.3 1.72 Allowed 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.497 -179.351 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.45 -46.81 85.81 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.566 179.887 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.21 -41.64 65.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.238 179.987 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -63.97 -33.77 76.48 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.998 0.428 . . . . 0.0 110.353 179.315 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . 0.403 ' HG2' ' O ' ' A' ' 182' ' ' GLU . 69.6 tt0 -90.49 8.8 32.05 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.347 0.594 . . . . 0.0 110.533 -178.998 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -104.74 -32.14 9.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.181 179.607 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.2 pt -128.13 147.79 32.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.846 -179.818 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -140.11 131.12 26.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.356 179.427 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.558 ' CD2' ' N ' ' A' ' 186' ' ' LEU . 3.5 mm? -85.88 133.68 40.89 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.908 179.924 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -44.33 157.97 0.15 Allowed 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.727 2.284 . . . . 0.0 112.088 179.356 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . 0.526 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.7 Cg_endo -62.92 115.13 2.75 Favored 'Trans proline' 0 C--N 1.303 -1.82 0 C-N-CA 122.801 2.334 . . . . 0.0 111.774 179.768 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . 0.526 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.7 mt-30 155.44 148.09 0.0 OUTLIER Pre-proline 0 N--CA 1.455 -0.208 0 O-C-N 123.635 0.584 . . . . 0.0 110.758 -179.867 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -73.83 144.17 34.4 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.676 2.25 . . . . 0.0 111.914 178.044 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.496 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.1 p -125.13 158.99 32.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.307 0.575 . . . . 0.0 110.121 -179.98 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 192' ' ' THR . . . . . 0.496 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 36.9 p -143.44 165.36 27.75 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.139 -179.678 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -135.41 128.74 32.13 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.135 0.493 . . . . 0.0 110.194 179.543 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 47.9 pt -146.28 148.58 16.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.077 179.825 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 70.2 t -117.33 122.96 71.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.277 0.56 . . . . 0.0 109.681 179.161 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -134.37 107.49 7.64 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.32 179.707 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 95.1 m -131.17 130.54 43.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.855 179.833 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -82.53 -36.84 25.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.33 179.75 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.58 -67.36 0.24 Allowed 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.425 179.981 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.49 -9.86 59.08 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.265 179.55 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 60.5 t-80 60.42 58.78 2.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.784 -179.812 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 42.9 p -167.06 153.62 8.38 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.538 179.53 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.28 144.17 24.5 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.957 0.408 . . . . 0.0 110.453 179.432 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -135.06 137.28 42.75 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.569 -179.988 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 19.6 mt -105.44 125.16 50.67 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 121.066 0.46 . . . . 0.0 109.869 -179.676 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 206' ' ' TRP . . . . . 0.557 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 75.9 m95 -81.57 166.42 20.25 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.634 -179.794 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -156.57 171.52 7.29 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.536 -179.184 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_exo -54.23 -36.78 87.21 Favored 'Trans proline' 0 C--N 1.302 -1.874 0 C-N-CA 122.679 2.253 . . . . 0.0 112.079 179.173 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -70.33 -34.97 73.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.811 -179.806 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 22.3 m -61.6 149.83 38.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.587 -179.392 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.55 -36.83 81.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.494 -179.732 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . 0.557 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 55.1 tt0 -64.65 -40.61 95.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.56 179.873 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.08 -43.56 93.09 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 110.591 -1.003 . . . . 0.0 110.591 179.712 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -63.5 -42.76 98.52 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 179.72 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 64.6 ttp -59.47 -48.04 83.17 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.202 -179.898 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 87.6 mt -60.74 -40.67 93.25 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.556 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . 0.455 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 40.7 tp10 -58.03 -38.09 75.58 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.841 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -65.12 -38.18 89.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.771 0.319 . . . . 0.0 110.621 179.641 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 94.5 mt -64.41 -42.78 95.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.517 -179.537 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 138.01 45.22 0.08 OUTLIER Glycine 0 C--N 1.335 0.479 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 179.982 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . 0.455 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 26.7 m-85 -128.8 156.45 43.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.057 0.456 . . . . 0.0 110.523 -179.739 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 222' ' ' THR . . . . . 0.456 ' O ' ' O ' ' A' ' 191' ' ' VAL . 7.8 p -108.33 122.82 47.76 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 121.204 0.526 . . . . 0.0 110.185 -179.94 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . 0.441 ' CD2' ' N ' ' A' ' 223' ' ' LEU . 4.3 mm? -101.38 132.92 46.7 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.055 179.933 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.9 159.57 14.84 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.54 179.85 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -104.97 115.26 29.97 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.933 0.396 . . . . 0.0 110.395 179.824 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.453 ' CD1' ' N ' ' A' ' 226' ' ' LEU . 8.9 mp -53.72 156.96 4.25 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.669 179.914 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -60.18 145.24 98.93 Favored 'Trans proline' 0 C--N 1.302 -1.914 0 C-N-CA 122.637 2.224 . . . . 0.0 112.108 179.374 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.6 -2.47 58.64 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.56 -179.959 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.62 -40.42 5.66 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 -179.903 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.548 ' O ' ' N ' ' A' ' 233' ' ' SER . 85.9 mt -79.59 -16.51 55.74 Favored 'General case' 0 C--O 1.223 -0.311 0 CA-C-O 120.971 0.415 . . . . 0.0 110.314 -179.735 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . 0.404 ' C ' ' O ' ' A' ' 230' ' ' LEU . 55.4 t-20 -40.27 -48.8 2.67 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.687 -179.566 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -88.59 15.7 7.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.804 0.335 . . . . 0.0 111.258 179.807 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 233' ' ' SER . . . . . 0.548 ' N ' ' O ' ' A' ' 230' ' ' LEU . 78.1 p -60.63 -35.79 77.04 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.738 -179.839 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . 0.525 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.6 tt0 -118.06 -69.6 0.84 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.021 179.535 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 3.8 m -70.46 103.41 2.45 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.673 -179.796 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -94.64 57.94 2.27 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.363 179.93 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -145.15 -122.63 1.55 Allowed Glycine 0 CA--C 1.52 0.365 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 -179.958 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -133.7 112.03 11.07 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 121.118 0.485 . . . . 0.0 110.409 179.945 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . 0.488 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 94.7 mtt180 -148.25 56.61 1.06 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.753 -179.979 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -69.4 -31.36 69.68 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.511 179.593 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . 0.456 ' OD2' ' O ' ' A' ' 144' ' ' TYR . 64.8 t0 -56.69 -46.93 80.88 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.403 -179.069 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 242' ' ' ILE . . . . . 0.436 ' O ' ' O ' ' A' ' 239' ' ' ARG . 16.9 tt -140.85 158.18 23.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.934 0.397 . . . . 0.0 110.519 179.738 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 96.0 mt -105.97 105.97 19.71 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.2 0 CA-C-O 121.155 0.503 . . . . 0.0 110.407 179.821 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . 0.488 ' OE1' ' NH1' ' A' ' 239' ' ' ARG . 88.2 mt-30 -110.76 110.69 21.43 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.369 179.74 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 9.7 mp -122.03 -167.92 1.63 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.558 179.748 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . 0.525 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 172.54 -16.48 0.05 OUTLIER Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 179.879 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . 0.689 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -60.56 157.71 29.01 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 -179.855 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -64.22 21.09 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.971 0.415 . . . . 0.0 110.609 179.962 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . 0.689 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.8 m-20 -96.94 -5.54 37.69 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.564 179.955 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 92.2 mt -80.84 -20.99 41.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.611 179.535 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.52 -51.35 70.27 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.79 -179.671 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -89.29 -4.93 57.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.453 179.658 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.09 -74.16 1.15 Allowed Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 -179.923 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 81.7 mt -70.13 125.71 27.56 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.015 0.436 . . . . 0.0 110.237 -179.795 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -59.57 -39.49 84.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.369 -179.709 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 83.51 51.71 4.0 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 179.767 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -94.81 -16.57 22.86 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.724 0.297 . . . . 0.0 110.597 -179.899 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 258' ' ' SER . . . . . 0.425 ' O ' ' O ' ' A' ' 192' ' ' THR . 3.4 t 175.19 89.63 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.057 0.456 . . . . 0.0 110.124 179.996 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . 0.596 ' N ' ' CD1' ' A' ' 259' ' ' LEU . 0.9 OUTLIER -94.5 124.26 38.42 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.323 0.582 . . . . 0.0 111.139 -179.042 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 16.1 m-30 -93.53 146.93 23.43 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.362 179.22 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 86.2 mt -122.44 149.77 43.38 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.599 -179.893 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.659 ' CG ' ' N ' ' A' ' 263' ' ' ALA . 2.6 p90 -77.72 -138.78 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.542 -179.849 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . 0.659 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -51.39 78.09 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.056 179.988 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . 0.629 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.95 104.63 0.19 Allowed Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.679 -0.969 . . . . 0.0 110.679 -179.987 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 265' ' ' ASP . . . . . 0.604 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.7 m-20 -80.29 -177.62 6.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.671 0.272 . . . . 0.0 110.883 -179.49 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -40.54 -17.48 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.858 0.361 . . . . 0.0 110.504 179.766 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . 0.604 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.53 -51.66 40.58 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.672 179.476 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -63.75 -46.59 84.64 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.212 179.343 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . 0.519 ' O ' ' CD2' ' A' ' 273' ' ' TYR . . . -61.49 -35.41 77.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.78 179.599 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -62.56 -34.71 77.5 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.228 179.694 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.26 -43.09 14.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.319 -179.592 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 272' ' ' ILE . . . . . 0.618 ' C ' ' H ' ' A' ' 274' ' ' ALA . 5.0 tt -51.47 -33.89 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.824 -178.823 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 273' ' ' TYR . . . . . 0.519 ' CD2' ' O ' ' A' ' 269' ' ' ALA . 16.8 m-85 -54.31 -2.11 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.645 -179.599 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 274' ' ' ALA . . . . . 0.618 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.39 -39.58 71.08 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.969 179.5 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . 0.585 ' O ' ' N ' ' A' ' 279' ' ' ALA . 3.6 p30 -39.23 97.96 0.15 Allowed Pre-proline 0 C--O 1.227 -0.113 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.568 -179.691 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -54.15 -43.1 61.49 Favored 'Trans proline' 0 C--N 1.303 -1.824 0 C-N-CA 122.375 2.05 . . . . 0.0 112.611 -178.765 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 89.2 mt -64.42 -42.79 95.86 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.114 -179.64 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 91.2 mt -95.96 -1.18 49.62 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.849 -179.421 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 279' ' ' ALA . . . . . 0.585 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.5 -34.93 77.84 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.612 -179.749 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.26 20.18 0.11 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.004 -179.247 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . 0.513 ' H ' ' C ' ' A' ' 279' ' ' ALA . 13.7 mt -75.03 120.11 80.08 Favored Pre-proline 0 N--CA 1.451 -0.376 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.45 179.94 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -50.96 -39.45 59.36 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.659 2.24 . . . . 0.0 111.831 179.07 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -53.0 -50.38 64.32 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.126 179.849 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 74.6 t -61.6 -43.97 97.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 179.488 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -57.55 -41.17 80.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.234 -179.958 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -90.97 0.23 57.58 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.141 179.687 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt 59.62 43.16 16.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.066 0.46 . . . . 0.0 110.891 179.662 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -94.61 41.31 1.09 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.399 179.884 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 54.1 t -119.21 135.76 58.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 121.009 0.433 . . . . 0.0 110.179 -179.741 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -133.63 163.67 28.9 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 121.026 0.441 . . . . 0.0 110.73 -179.66 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.76 155.77 31.87 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.97 0.414 . . . . 0.0 110.759 -179.797 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 82.2 mt -94.65 -1.45 53.14 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.274 -179.75 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.34 165.22 12.56 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 -179.786 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 6.6 m -86.7 -61.55 1.71 Allowed 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 120.87 0.367 . . . . 0.0 111.102 -179.84 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 295' ' ' GLU . . . . . 0.484 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.6 mm-40 -69.66 -4.56 20.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.66 -179.792 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 26.1 p -76.48 33.03 0.13 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.68 -179.891 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 297' ' ' PHE . . . . . 0.484 ' H ' ' C ' ' A' ' 295' ' ' GLU . 83.3 t80 -60.52 -45.99 91.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.646 -179.956 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . 0.609 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.2 mtt85 -81.08 136.66 35.97 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.627 -179.598 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -114.25 116.87 29.7 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.494 179.667 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . 0.628 ' H ' ' HG ' ' A' ' 303' ' ' SER . 49.1 p-10 -166.84 -174.97 2.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.52 -179.799 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 301' ' ' TYR . . . . . 0.5 ' OH ' ' CD1' ' A' ' 173' ' ' PHE . 78.6 t80 -47.73 -44.46 27.96 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.241 -179.684 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -65.84 -41.27 91.94 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.029 0.442 . . . . 0.0 110.782 179.017 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 303' ' ' SER . . . . . 0.628 ' HG ' ' H ' ' A' ' 300' ' ' ASP . 54.3 p -55.36 -36.15 66.01 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.1 -179.265 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -57.58 -51.4 69.63 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.436 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 90.6 mtp -56.56 -44.02 80.53 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -179.936 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -66.29 -42.88 87.73 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.903 0.382 . . . . 0.0 110.184 178.86 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 55.9 t -63.88 -43.09 97.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.218 179.409 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 42.5 tp -59.87 -42.07 92.92 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.812 -179.618 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -62.31 -39.05 91.75 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.152 179.665 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 310' ' ' ARG . . . . . 0.45 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.8 ttt85 -63.71 -43.89 95.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.266 179.46 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 90.1 mt -63.26 -42.05 99.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.184 179.632 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt -62.85 -33.62 75.63 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.116 179.409 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.73 -23.37 21.82 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.448 -179.888 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . 0.45 ' N ' ' O ' ' A' ' 310' ' ' ARG . 6.9 tt -62.31 -43.06 99.69 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.61 -179.936 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 . . . . . 0 C--O 1.22 -0.484 0 CA-C-O 117.964 -1.017 . . . . 0.0 110.466 179.975 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -99.26 135.82 40.11 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.06 0.457 . . . . 0.0 110.493 -179.995 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.496 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -91.75 178.43 1.75 Allowed Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.637 -179.961 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.496 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.5 Cg_exo -61.57 146.87 96.56 Favored 'Trans proline' 0 C--N 1.3 -2.022 0 C-N-CA 122.808 2.339 . . . . 0.0 112.162 179.635 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.406 ' CZ ' HE21 ' A' ' 42' ' ' GLN . 35.4 ptt180 -136.3 141.82 43.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.647 179.71 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -79.3 116.96 19.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.476 179.923 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.4 ' O ' ' CG2' ' A' ' 30' ' ' ILE . 9.4 tp -111.61 130.24 65.52 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.486 -179.985 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.2 t -71.09 142.45 50.82 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.61 179.842 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.524 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.4 t0 -139.32 179.93 6.25 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.57 -179.937 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.524 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 78.4 p -74.01 -37.12 64.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.785 179.716 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -46.78 -94.66 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.378 -179.459 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.422 ' O ' ' OG1' ' A' ' 36' ' ' THR . . . -166.17 -26.88 0.02 OUTLIER Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 179.893 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.422 ' OG1' ' O ' ' A' ' 35' ' ' GLY . 65.0 m -168.66 105.91 0.44 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.861 0.362 . . . . 0.0 110.618 -179.921 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 69.5 t60 -128.75 147.22 50.76 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.988 0.423 . . . . 0.0 110.324 179.925 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.485 ' CG2' ' N ' ' A' ' 39' ' ' LEU . 99.9 m -130.45 165.53 22.43 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.569 -179.835 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.485 ' N ' ' CG2' ' A' ' 38' ' ' THR . 80.6 mt -120.64 126.98 51.62 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.485 179.731 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -65.44 -44.35 87.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.686 -179.971 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.418 ' O ' ' HD3' ' A' ' 43' ' ' PRO . 41.0 p -165.96 154.82 11.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.405 179.669 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.467 ' N ' ' CD ' ' A' ' 42' ' ' GLN . 14.0 mp0 -45.43 101.55 0.26 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.643 179.471 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.418 ' HD3' ' O ' ' A' ' 41' ' ' SER . 31.4 Cg_exo -57.6 129.64 34.76 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 122.402 2.068 . . . . 0.0 112.235 -179.643 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -82.51 -25.14 33.73 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.5 179.531 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.537 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.7 mtm-85 -120.89 134.03 55.29 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 121.185 0.517 . . . . 0.0 110.27 179.96 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.1 mt -129.82 133.21 65.13 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.273 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.966 -179.721 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 44.3 t -124.84 131.08 73.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.839 0.352 . . . . 0.0 110.101 179.313 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.551 ' HG ' ' CD1' ' A' ' 117' ' ' LEU . 4.9 m -154.74 166.35 33.71 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.515 179.845 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 65.3 p -124.37 8.53 8.44 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.434 179.923 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.709 ' HG ' ' H ' ' A' ' 53' ' ' LEU . 1.2 t -85.58 125.21 32.93 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.616 -179.458 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 94.5 t -65.5 -44.41 94.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.545 -179.938 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.6 m -62.61 -44.31 96.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.639 -179.851 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.709 ' H ' ' HG ' ' A' ' 50' ' ' SER . 48.4 tp -62.5 -41.48 98.85 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.57 -179.476 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 74.6 m -57.63 -44.78 85.81 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.466 -179.438 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.36 -62.09 5.43 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 179.571 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.6 t -48.23 -35.71 12.48 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 179.951 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.7 mt -61.7 -44.46 96.89 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.11 179.331 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.1 mp -65.07 -41.72 94.81 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.201 178.049 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.6 -41.36 98.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.933 -179.243 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.0 tp -87.7 16.81 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.755 -179.63 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 56.45 83.84 0.09 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.73 -179.862 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.89 58.04 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.005 -179.752 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -50.59 152.71 8.78 Favored 'Trans proline' 0 C--N 1.296 -2.207 0 C-N-CA 122.859 2.373 . . . . 0.0 112.38 -178.204 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.431 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -108.96 145.9 15.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.348 -179.727 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 97.0 mt -63.8 -45.18 97.89 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.357 -179.844 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.496 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -129.87 134.48 47.54 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.602 -179.745 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.499 ' O ' ' N ' ' A' ' 98' ' ' LEU . 72.7 m -134.75 158.77 43.29 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.833 -179.637 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.73 139.36 16.36 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.668 -0.973 . . . . 0.0 110.668 179.798 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.455 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.79 -162.92 0.08 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.903 0.382 . . . . 0.0 110.515 179.966 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.495 ' O ' ' C ' ' A' ' 71' ' ' THR . 5.7 t -133.93 135.38 43.52 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.245 -179.973 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.495 ' C ' ' O ' ' A' ' 70' ' ' THR . 1.1 t 29.55 68.19 0.67 Allowed Pre-proline 0 N--CA 1.466 0.328 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.64 -179.626 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -60.98 145.18 99.46 Favored 'Trans proline' 0 C--N 1.3 -1.978 0 C-N-CA 122.619 2.213 . . . . 0.0 112.068 -178.392 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.532 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 45.1 p-10 -159.37 -32.29 0.06 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.662 179.698 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.532 ' N ' ' OD1' ' A' ' 73' ' ' ASN . 99.1 m-20 -64.07 -39.4 94.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.505 179.988 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -60.51 -48.32 82.29 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.642 -179.278 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.423 ' O ' ' O ' ' A' ' 77' ' ' ALA . 94.4 t -60.1 -24.85 31.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 179.704 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.423 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -45.77 172.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.583 179.865 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.571 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.8 p30 -61.98 177.76 0.42 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.614 -179.774 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.597 ' C ' ' H ' ' A' ' 81' ' ' GLY . 36.0 p30 -45.69 85.86 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.962 179.963 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.571 ' N ' ' O ' ' A' ' 78' ' ' ASP . 42.8 tp60 -67.33 13.62 0.06 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.146 -179.837 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.597 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 117.94 -22.04 10.03 Favored Glycine 0 CA--C 1.519 0.338 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.93 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -108.19 116.68 32.41 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.951 0.405 . . . . 0.0 110.56 179.843 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 75.4 mt -98.98 0.88 44.85 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.513 -179.767 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -92.07 6.74 45.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.985 0.421 . . . . 0.0 110.484 -179.797 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.44 ' O ' ' CG2' ' A' ' 89' ' ' VAL . 88.2 mt-30 -100.06 -26.28 14.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.781 179.968 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.5 t-105 -64.28 -40.99 97.1 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.02 -179.688 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.551 ' O ' ' N ' ' A' ' 91' ' ' LYS . 68.5 m -77.6 -53.55 7.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.155 -179.516 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -47.9 -51.27 23.89 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.001 -179.347 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.44 ' CG2' ' O ' ' A' ' 85' ' ' GLN . 15.1 m -69.01 -41.08 81.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 120.905 0.383 . . . . 0.0 111.069 179.88 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.416 ' H ' HG23 ' A' ' 89' ' ' VAL . . . -71.47 -23.57 61.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.768 -179.815 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.551 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.0 tttm -61.07 -46.06 92.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.501 -179.439 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.443 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.6 mm-40 -90.13 -94.87 0.11 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.213 179.971 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.626 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.8 mtt180 -143.19 60.13 1.41 Allowed 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 179.758 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.463 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.6 pttp 33.31 26.88 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.203 -179.082 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.626 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.4 tt -48.61 123.1 6.26 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.931 -178.193 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -83.5 -169.9 2.78 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.145 179.934 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.614 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 81.7 mtp180 -73.71 137.51 44.09 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.328 -179.865 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.499 ' N ' ' O ' ' A' ' 67' ' ' SER . 89.0 mt -85.9 -166.11 1.44 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.709 -179.621 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.532 ' CD2' ' O ' ' A' ' 99' ' ' TYR . 46.7 p90 -168.01 119.48 0.84 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.311 179.962 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.513 ' C ' ' O ' ' A' ' 99' ' ' TYR . 43.1 mm -29.14 121.04 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.922 -179.701 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 113.95 28.11 3.25 Favored Glycine 0 CA--C 1.521 0.431 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 -179.597 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.583 ' N ' ' CD ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -144.0 46.0 0.61 Allowed Pre-proline 0 C--N 1.323 -0.55 0 CA-C-O 120.953 0.406 . . . . 0.0 110.503 179.891 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.583 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 30.2 Cg_endo -62.28 143.83 94.54 Favored 'Trans proline' 0 C--N 1.297 -2.138 0 C-N-CA 122.686 2.257 . . . . 0.0 111.957 -179.966 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.697 ' HG ' ' H ' ' A' ' 107' ' ' ALA . 23.2 t -173.33 120.73 0.34 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.417 179.754 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.58 -40.98 63.48 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.043 179.743 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -65.9 -40.31 91.39 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.864 -179.374 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.697 ' H ' ' HG ' ' A' ' 104' ' ' SER . . . -63.96 -39.86 95.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.687 -179.832 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 70.9 t -67.54 -43.76 86.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.721 179.683 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.43 -39.1 92.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.568 -179.287 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.443 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.51 -23.55 62.9 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.532 179.834 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.549 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.4 mm-40 -90.94 4.75 51.11 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.741 -179.564 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.549 ' C ' ' O ' ' A' ' 111' ' ' GLN . 9.9 tpt 23.17 64.32 0.37 Allowed Pre-proline 0 N--CA 1.464 0.271 0 CA-C-O 120.914 0.388 . . . . 0.0 111.001 -179.806 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -78.9 168.92 20.18 Favored 'Trans proline' 0 C--N 1.304 -1.801 0 C-N-CA 122.984 2.456 . . . . 0.0 112.081 -178.415 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.483 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 98.9 m-20 -113.24 -44.01 3.3 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.103 179.452 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.2 tp -120.47 119.81 34.07 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.324 -0.398 . . . . 0.0 109.935 179.48 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 96.3 mt -117.09 131.1 70.79 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.319 0 CA-C-O 120.9 0.381 . . . . 0.0 110.892 -179.788 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.551 ' CD1' ' HG ' ' A' ' 48' ' ' SER . 29.7 mt -106.0 132.46 52.06 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 121.027 0.441 . . . . 0.0 110.321 -179.489 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 98.1 mt -118.17 136.6 54.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.73 -179.709 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 86.5 p -71.6 152.76 42.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.548 -179.95 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.27 -50.21 74.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.659 -179.857 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -149.24 153.59 37.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.552 179.762 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 169.3 -170.17 42.41 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 179.885 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -63.04 -35.46 92.12 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 179.992 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.447 ' O ' ' OD1' ' A' ' 124' ' ' ASP . 44.1 p-10 -87.18 119.92 27.91 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.808 0.337 . . . . 0.0 110.639 179.885 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 39.2 t -63.56 144.06 57.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.467 -179.928 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.52 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.38 -43.28 8.85 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.872 -179.935 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.8 tp -62.77 -42.35 99.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.654 -179.816 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.73 -10.91 56.64 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.512 -179.395 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 84.1 mt -116.03 -23.9 8.31 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.7 -179.902 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . 0.52 ' N ' ' O ' ' A' ' 126' ' ' ALA . 77.8 t80 -51.53 -49.87 61.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.521 -179.001 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.5 p-10 -65.79 -42.26 90.96 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.852 0.358 . . . . 0.0 111.15 179.628 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.504 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 87.9 mt-30 -67.52 -36.69 81.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.792 -179.97 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 94.1 mt -80.58 -42.05 22.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.871 -179.507 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.2 t -57.23 -44.76 84.07 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.259 -179.21 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.2 m -62.3 -45.8 91.63 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.806 0.336 . . . . 0.0 110.642 179.33 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 92.9 mt -62.31 -43.9 98.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.401 -179.855 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.95 162.93 6.66 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.529 179.844 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -42.71 110.99 0.18 Allowed 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.536 2.157 . . . . 0.0 112.196 179.448 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 16.8 m -85.57 127.76 34.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.555 179.971 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 34.3 tp -119.48 137.94 53.46 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.088 -179.897 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.429 ' O ' ' OD2' ' A' ' 32' ' ' ASP . 80.2 mt -104.22 120.01 53.88 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 CA-C-O 121.122 0.487 . . . . 0.0 111.217 -179.348 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 97.7 mt -135.92 132.58 50.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.595 179.549 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.517 HD22 ' CG ' ' A' ' 241' ' ' ASP . 52.4 t30 -65.75 148.44 51.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.902 0.382 . . . . 0.0 110.422 179.268 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.459 ' O ' ' OD2' ' A' ' 241' ' ' ASP . 42.6 t80 -81.86 123.18 28.6 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.955 -179.456 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 54.79 69.69 0.7 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.881 179.643 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 49.2 p-10 -124.45 0.24 8.24 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.679 179.849 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -151.42 116.4 5.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.695 -179.442 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 148' ' ' SER . . . . . 0.503 ' HG ' ' H ' ' A' ' 150' ' ' GLN . 84.0 p -63.86 168.55 4.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.557 -179.941 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.416 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.6 p-90 -51.8 -16.33 0.67 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.553 -179.846 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . 0.503 ' H ' ' HG ' ' A' ' 148' ' ' SER . 68.2 tp60 -70.1 -76.68 0.1 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.491 -179.744 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.447 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.1 t -62.41 -38.49 89.85 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.321 179.6 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 53.4 tp -59.82 -45.75 91.38 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.377 -178.601 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.416 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 46.3 tp -62.83 -41.72 99.44 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.472 179.012 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.447 ' OG1' ' O ' ' A' ' 151' ' ' SER . 62.2 p -64.01 -34.97 79.2 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.266 -179.592 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.448 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.7 mm-40 -64.02 -42.28 97.18 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.239 179.32 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 92.1 mt -65.51 -38.85 90.9 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.041 0.448 . . . . 0.0 110.232 179.093 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.581 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.22 -32.13 79.52 Favored Glycine 0 CA--C 1.52 0.389 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 -179.374 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.448 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.3 mt-10 -36.02 -26.19 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.804 0.335 . . . . 0.0 110.728 179.953 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.581 ' N ' ' O ' ' A' ' 157' ' ' GLY . 94.4 mt -58.11 150.16 4.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.3 179.375 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 77.1 p -69.21 137.29 53.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.01 -179.508 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 69.96 22.94 77.26 Favored Glycine 0 CA--C 1.517 0.183 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 179.452 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 59.8 m80 -124.11 -13.97 7.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.745 0.307 . . . . 0.0 110.563 179.92 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -67.19 -59.42 3.45 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.702 -179.732 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -51.76 -49.37 62.76 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.215 -179.667 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -60.45 -41.32 93.84 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.735 0.302 . . . . 0.0 110.346 179.509 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.42 -47.34 86.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.609 179.801 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.73 -40.16 75.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.252 -179.915 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -61.49 -50.26 73.45 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.575 179.573 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -65.52 -43.58 89.58 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.492 179.596 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 94.8 mt -64.66 -43.37 96.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.427 179.768 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.29 -51.36 69.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.566 -179.243 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.71 -43.78 95.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.53 179.727 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . 0.52 ' CD1' ' OH ' ' A' ' 301' ' ' TYR . 55.1 t80 -62.87 -44.47 96.03 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.041 0.448 . . . . 0.0 110.454 179.45 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -63.48 -40.0 95.95 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.592 -179.36 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -62.9 -42.83 99.92 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.628 179.333 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -60.76 -44.7 96.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.186 179.93 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 84.9 mt -64.53 -41.2 96.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.02 0.438 . . . . 0.0 110.749 178.887 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.05 -62.09 1.85 Allowed 'General case' 0 C--O 1.236 0.376 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.478 -179.382 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.58 -46.66 86.48 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.609 179.784 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.28 -41.5 65.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.236 -179.984 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -64.01 -33.75 76.45 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.96 0.41 . . . . 0.0 110.424 179.278 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . 0.402 ' O ' ' HG2' ' A' ' 182' ' ' GLU . 69.3 tt0 -90.68 8.86 32.29 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.338 0.589 . . . . 0.0 110.483 -179.019 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -104.78 -32.19 8.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.895 0.379 . . . . 0.0 111.196 179.615 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.6 pt -128.21 147.83 32.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.845 -179.847 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -140.11 131.16 26.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.393 179.364 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.558 ' CD2' ' N ' ' A' ' 186' ' ' LEU . 3.5 mm? -85.45 133.92 41.3 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.882 -179.996 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -43.87 157.93 0.13 Allowed 'Trans proline' 0 C--N 1.307 -1.629 0 C-N-CA 122.743 2.295 . . . . 0.0 112.125 179.316 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . 0.53 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.6 Cg_endo -62.96 114.51 2.47 Favored 'Trans proline' 0 C--N 1.304 -1.807 0 C-N-CA 122.796 2.331 . . . . 0.0 111.717 179.839 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . 0.53 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.7 mt-30 155.13 148.26 0.0 OUTLIER Pre-proline 0 C--N 1.331 -0.207 0 O-C-N 123.643 0.589 . . . . 0.0 110.74 -179.743 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -73.47 144.55 36.45 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.695 2.263 . . . . 0.0 111.928 177.97 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.495 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.1 p -124.84 158.89 32.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.241 0.543 . . . . 0.0 110.194 179.962 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 192' ' ' THR . . . . . 0.495 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 37.6 p -143.46 165.22 28.14 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.086 -179.585 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -135.33 128.65 32.12 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.106 0.479 . . . . 0.0 110.285 179.534 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 47.5 pt -146.5 148.87 16.53 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.297 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.052 179.933 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 74.1 t -117.6 123.06 71.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.247 0.546 . . . . 0.0 109.809 179.073 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -134.3 106.97 7.38 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.27 179.738 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 93.7 m -130.77 130.63 43.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.84 179.782 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.406 ' O ' ' N ' ' A' ' 201' ' ' HIS . . . -82.67 -37.17 25.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.313 179.675 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.37 -67.35 0.24 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.417 -179.98 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.01 -10.0 59.16 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.338 179.508 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . 0.406 ' N ' ' O ' ' A' ' 198' ' ' ALA . 59.9 t-80 60.67 58.32 2.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.719 -179.81 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 41.6 p -166.99 153.29 8.22 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.537 179.643 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.31 144.07 24.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.473 179.395 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -135.34 138.28 43.23 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.642 -179.969 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 19.6 mt -106.12 125.23 50.74 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 121.027 0.442 . . . . 0.0 109.923 -179.737 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 206' ' ' TRP . . . . . 0.574 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 75.0 m95 -81.81 166.87 19.62 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.667 -179.72 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -156.61 171.89 6.81 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.607 -179.15 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -53.98 -37.3 86.06 Favored 'Trans proline' 0 C--N 1.303 -1.856 0 C-N-CA 122.654 2.236 . . . . 0.0 112.172 179.225 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -70.45 -34.81 72.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.76 -179.746 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 22.0 m -61.44 150.51 35.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.596 -179.373 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.17 -36.51 80.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.438 -179.768 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . 0.574 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 53.7 tt0 -64.5 -40.6 95.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.482 -179.987 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.67 -43.65 91.47 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 179.821 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -63.14 -44.26 96.05 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.719 0.295 . . . . 0.0 110.283 179.76 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 65.5 ttp -59.56 -48.21 82.53 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.221 -179.886 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 85.8 mt -60.25 -40.92 91.99 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.405 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . 0.456 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.0 tp10 -58.06 -38.08 75.64 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.739 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -65.3 -38.17 89.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.784 0.326 . . . . 0.0 110.568 179.677 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 94.7 mt -64.4 -42.79 95.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.441 -179.595 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.54 45.84 0.08 OUTLIER Glycine 0 C--N 1.334 0.47 0 N-CA-C 111.036 -0.825 . . . . 0.0 111.036 179.958 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . 0.456 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 26.9 m-85 -129.0 156.02 44.46 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.027 0.441 . . . . 0.0 110.487 -179.802 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 222' ' ' THR . . . . . 0.449 ' O ' ' O ' ' A' ' 191' ' ' VAL . 8.0 p -108.01 122.83 47.66 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.203 0.525 . . . . 0.0 110.208 -179.938 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . 0.446 ' CD2' ' N ' ' A' ' 223' ' ' LEU . 4.3 mm? -101.6 133.41 46.33 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.068 -179.94 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -97.22 159.73 14.74 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.458 179.834 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.01 115.1 29.7 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.927 0.394 . . . . 0.0 110.41 179.84 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.447 ' CD1' ' N ' ' A' ' 226' ' ' LEU . 9.1 mp -53.34 156.75 3.83 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.648 179.93 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -60.09 145.2 98.99 Favored 'Trans proline' 0 C--N 1.302 -1.903 0 C-N-CA 122.667 2.245 . . . . 0.0 112.139 179.283 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.48 -2.78 58.86 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.559 179.981 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.49 -40.64 5.65 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 111.004 -0.838 . . . . 0.0 111.004 -179.835 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.544 ' O ' ' N ' ' A' ' 233' ' ' SER . 84.9 mt -79.53 -16.9 55.16 Favored 'General case' 0 C--O 1.223 -0.337 0 CA-C-O 120.997 0.427 . . . . 0.0 110.368 -179.772 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . 0.405 ' C ' ' O ' ' A' ' 230' ' ' LEU . 54.7 t-20 -40.11 -49.12 2.58 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.678 -179.603 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -88.27 15.58 7.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.783 0.325 . . . . 0.0 111.217 179.963 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 233' ' ' SER . . . . . 0.544 ' N ' ' O ' ' A' ' 230' ' ' LEU . 78.1 p -60.62 -35.81 77.07 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.664 -179.858 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . 0.524 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.6 tt0 -118.21 -69.54 0.84 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.942 179.556 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.1 m -70.37 102.97 2.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.651 -179.765 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -94.31 58.04 2.4 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.442 179.949 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -145.04 -122.52 1.55 Allowed Glycine 0 CA--C 1.52 0.379 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 -179.992 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -134.34 111.77 10.46 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 121.053 0.454 . . . . 0.0 110.452 -179.981 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . 0.515 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.0 mtt180 -148.19 57.5 1.08 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.744 -179.97 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -69.75 -31.59 69.64 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.513 179.574 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . 0.517 ' CG ' HD22 ' A' ' 143' ' ' ASN . 65.1 t0 -56.9 -46.95 81.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.339 -179.186 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 242' ' ' ILE . . . . . 0.437 ' O ' ' O ' ' A' ' 239' ' ' ARG . 17.6 tt -140.54 157.41 24.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.865 0.364 . . . . 0.0 110.558 179.713 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 96.0 mt -106.34 106.33 20.4 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.173 0 CA-C-O 121.096 0.474 . . . . 0.0 110.448 179.89 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . 0.515 ' OE1' ' NH1' ' A' ' 239' ' ' ARG . 88.3 mt-30 -110.68 110.62 21.37 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.358 179.733 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 9.6 mp -122.02 -168.03 1.64 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.583 179.784 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . 0.524 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.14 -16.77 0.05 OUTLIER Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 179.895 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . 0.692 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -60.42 157.25 29.21 Favored Glycine 0 CA--C 1.522 0.516 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 -179.823 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -63.94 21.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.921 0.391 . . . . 0.0 110.571 179.942 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . 0.692 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.7 m-20 -96.8 -5.82 37.54 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.576 179.99 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 92.0 mt -80.24 -21.36 42.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.615 179.522 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.53 -51.41 69.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.773 -179.557 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.99 -5.29 58.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.459 179.662 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -80.87 -74.44 1.13 Allowed Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 -179.946 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 80.9 mt -69.87 125.69 27.5 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.058 0.456 . . . . 0.0 110.303 -179.859 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -59.33 -39.67 83.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.297 -179.641 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 83.5 51.76 3.98 Favored Glycine 0 CA--C 1.522 0.473 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 179.9 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -95.1 -16.11 22.88 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.712 0.292 . . . . 0.0 110.588 -179.848 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 258' ' ' SER . . . . . 0.436 ' HG ' ' CG2' ' A' ' 191' ' ' VAL . 3.4 t 174.92 89.51 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.08 0.466 . . . . 0.0 110.161 179.973 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . 0.597 ' N ' ' CD1' ' A' ' 259' ' ' LEU . 0.9 OUTLIER -94.46 124.18 38.33 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.258 0.551 . . . . 0.0 111.058 -178.999 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 16.0 m-30 -93.62 146.91 23.47 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.391 179.218 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 85.5 mt -122.39 149.75 43.38 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.583 -179.933 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.665 ' CG ' ' N ' ' A' ' 263' ' ' ALA . 2.6 p90 -77.99 -139.14 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.46 -179.759 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . 0.665 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -50.8 77.86 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.987 -179.947 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . 0.641 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.97 104.66 0.19 Allowed Glycine 0 CA--C 1.526 0.768 0 N-CA-C 110.721 -0.951 . . . . 0.0 110.721 -179.964 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 265' ' ' ASP . . . . . 0.601 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.7 m-20 -80.39 -177.56 6.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.722 0.296 . . . . 0.0 110.84 -179.424 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -40.49 -17.73 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.511 179.823 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . 0.601 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.42 -51.51 43.09 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.679 179.582 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -63.77 -46.59 84.58 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.23 179.357 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . 0.524 ' O ' ' CD2' ' A' ' 273' ' ' TYR . . . -61.48 -35.15 76.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.927 179.511 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -63.07 -34.57 77.87 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.155 179.717 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.25 -43.21 13.96 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.192 -179.51 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 272' ' ' ILE . . . . . 0.619 ' C ' ' H ' ' A' ' 274' ' ' ALA . 5.0 tt -51.49 -33.92 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.839 -178.783 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 273' ' ' TYR . . . . . 0.524 ' CD2' ' O ' ' A' ' 269' ' ' ALA . 17.0 m-85 -54.3 -1.91 0.03 OUTLIER 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.71 -179.598 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 274' ' ' ALA . . . . . 0.619 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.63 -39.45 70.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.885 179.574 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . 0.585 ' O ' ' N ' ' A' ' 279' ' ' ALA . 3.8 p30 -39.33 98.04 0.16 Allowed Pre-proline 0 C--O 1.226 -0.153 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.53 -179.636 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -54.19 -43.04 62.07 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 C-N-CA 122.383 2.055 . . . . 0.0 112.595 -178.753 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 89.1 mt -64.49 -42.9 95.58 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.086 -179.621 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 91.1 mt -95.87 -1.11 50.07 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.889 -179.434 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 279' ' ' ALA . . . . . 0.585 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.4 -34.92 77.68 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.666 -179.791 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.3 20.16 0.12 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.979 -179.207 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . 0.514 ' H ' ' C ' ' A' ' 279' ' ' ALA . 13.6 mt -74.91 119.83 78.73 Favored Pre-proline 0 N--CA 1.452 -0.347 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.504 179.9 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -50.57 -39.74 55.43 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.598 2.199 . . . . 0.0 111.949 178.989 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.9 -50.45 63.9 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.122 179.876 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 73.4 t -61.55 -43.91 97.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 179.477 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -57.8 -41.17 81.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.274 -179.906 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -90.73 -0.1 57.59 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.184 179.622 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt 59.92 43.3 15.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.029 0.442 . . . . 0.0 110.821 179.658 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -94.93 41.3 1.09 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.382 179.809 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 54.2 t -119.23 135.82 58.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.022 0.439 . . . . 0.0 110.231 -179.737 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -133.63 163.85 28.5 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.044 0.45 . . . . 0.0 110.658 -179.577 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.81 155.88 31.72 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.94 0.4 . . . . 0.0 110.78 -179.803 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 81.4 mt -94.7 -1.59 52.77 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.25 -179.735 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 120.86 165.21 12.65 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.651 -0.98 . . . . 0.0 110.651 -179.763 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 7.0 m -86.59 -61.73 1.67 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.806 0.336 . . . . 0.0 111.092 -179.828 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 295' ' ' GLU . . . . . 0.492 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.6 mm-40 -69.04 -4.84 18.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.682 -179.686 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 26.3 p -76.48 32.22 0.13 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.641 -179.871 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 297' ' ' PHE . . . . . 0.492 ' H ' ' C ' ' A' ' 295' ' ' GLU . 59.4 t80 -60.59 -46.43 90.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.713 179.944 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . 0.614 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.2 mtt85 -80.23 137.37 36.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.582 -179.65 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 5.7 tp -114.38 115.8 27.91 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.453 179.868 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . 0.604 ' H ' ' CB ' ' A' ' 303' ' ' SER . 48.7 p-10 -165.72 -176.69 3.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.533 -179.977 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 301' ' ' TYR . . . . . 0.52 ' OH ' ' CD1' ' A' ' 173' ' ' PHE . 79.0 t80 -46.59 -42.76 16.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.293 -179.791 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -67.4 -40.58 85.64 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.026 0.441 . . . . 0.0 110.756 179.196 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 303' ' ' SER . . . . . 0.604 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 60.2 p -55.62 -36.38 66.92 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.074 -179.276 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -57.68 -51.61 68.83 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 179.342 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 91.2 mtp -56.06 -44.14 78.59 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 179.838 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -66.11 -43.13 88.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.917 0.389 . . . . 0.0 110.166 178.837 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 55.9 t -63.97 -42.88 97.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.288 179.358 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 44.6 tp -59.89 -42.05 92.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.934 -179.64 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -62.33 -39.31 92.66 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.155 179.59 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 310' ' ' ARG . . . . . 0.468 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.7 ttt85 -63.6 -43.95 95.42 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.29 179.412 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 89.5 mt -63.18 -42.2 99.34 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.31 179.603 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -63.21 -33.57 75.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.079 179.456 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.85 -23.44 21.66 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.488 -179.875 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . 0.468 ' N ' ' O ' ' A' ' 310' ' ' ARG . 6.8 tt -62.3 -43.16 99.47 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.58 -179.95 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 . . . . . 0 C--O 1.22 -0.478 0 CA-C-O 118.043 -0.979 . . . . 0.0 110.482 179.981 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -99.63 135.18 41.43 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.063 0.459 . . . . 0.0 110.452 -179.885 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.497 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -92.15 178.55 1.66 Allowed Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.509 -179.829 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.497 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 27.3 Cg_exo -61.46 147.11 96.3 Favored 'Trans proline' 0 C--N 1.3 -2.008 0 C-N-CA 122.709 2.273 . . . . 0.0 112.173 179.617 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 35.0 ptt180 -135.98 142.35 44.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.714 179.779 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -79.9 116.86 20.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.401 179.922 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.403 ' O ' ' CG2' ' A' ' 30' ' ' ILE . 9.4 tp -111.64 130.12 65.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.408 179.996 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.1 t -70.85 141.95 51.25 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.621 179.763 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.517 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.0 t0 -138.85 -179.97 6.14 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.512 -179.936 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.517 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 78.1 p -73.84 -37.38 64.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.761 179.834 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.8 ttt85 -46.89 -94.72 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.366 -179.338 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.48 ' C ' ' HG1' ' A' ' 36' ' ' THR . . . -166.04 -26.99 0.02 OUTLIER Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.886 -0.885 . . . . 0.0 110.886 179.996 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.48 ' HG1' ' C ' ' A' ' 35' ' ' GLY . 75.2 m -168.29 105.87 0.47 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.924 0.392 . . . . 0.0 110.678 -179.894 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 68.8 t60 -129.07 146.51 51.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.071 0.463 . . . . 0.0 110.317 179.997 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.483 ' CG2' ' N ' ' A' ' 39' ' ' LEU . 99.8 m -129.99 165.59 21.84 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.57 -179.797 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.483 ' N ' ' CG2' ' A' ' 38' ' ' THR . 81.0 mt -120.38 127.25 52.13 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.483 179.727 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -65.44 -44.6 86.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.689 -179.954 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.415 ' O ' ' HD3' ' A' ' 43' ' ' PRO . 40.7 p -165.73 154.97 12.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.404 179.599 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.469 ' N ' ' CD ' ' A' ' 42' ' ' GLN . 14.5 mp0 -45.31 101.58 0.26 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.608 179.427 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.415 ' HD3' ' O ' ' A' ' 41' ' ' SER . 31.4 Cg_exo -57.7 130.32 38.05 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 C-N-CA 122.334 2.023 . . . . 0.0 112.196 -179.772 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -83.01 -24.62 32.77 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.531 179.593 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.535 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.7 mtm-85 -121.22 134.67 55.2 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-O 121.156 0.503 . . . . 0.0 110.246 -179.926 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.0 mt -130.49 133.35 63.82 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.297 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.99 -179.797 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 46.5 t -124.76 131.05 73.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 179.471 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.504 ' O ' ' O ' ' A' ' 66' ' ' ALA . 4.6 m -154.49 166.2 34.04 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.048 0.452 . . . . 0.0 110.505 179.679 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 60.9 p -124.51 8.73 8.36 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.519 179.936 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.8 125.96 33.65 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.617 -179.508 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 84.7 t -65.68 -44.54 93.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.51 -179.99 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.0 m -62.71 -44.26 96.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.66 -179.818 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 52.1 tp -62.27 -41.65 98.66 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.6 -179.415 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 71.9 m -57.92 -44.51 86.92 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.286 -179.326 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.41 -61.97 5.52 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 179.578 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.7 t -48.56 -35.6 13.73 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 -179.812 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 20.0 mt -61.68 -44.58 96.68 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.708 -0.397 . . . . 0.0 111.199 179.19 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.412 ' N ' HD12 ' A' ' 58' ' ' LEU . 9.5 mp -64.58 -42.09 95.86 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.334 177.911 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.63 -41.23 98.28 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.044 -179.222 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 7.9 tp -87.81 16.58 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.726 -179.618 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 56.52 83.61 0.1 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.726 -179.838 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.75 56.72 0.07 OUTLIER Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.01 -179.865 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -49.43 153.46 4.96 Favored 'Trans proline' 0 C--N 1.296 -2.228 0 C-N-CA 122.818 2.345 . . . . 0.0 112.565 -178.52 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.432 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.4 OUTLIER -109.13 146.32 14.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.4 -179.764 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 97.0 mt -63.99 -44.78 97.94 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.335 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.436 -179.986 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.504 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -130.16 134.72 47.51 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 120.851 0.358 . . . . 0.0 110.591 -179.762 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.493 ' O ' ' N ' ' A' ' 98' ' ' LEU . 72.6 m -134.79 158.86 43.1 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.912 -179.719 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.9 139.49 16.33 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 179.877 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.461 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.87 -162.46 0.08 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.98 0.419 . . . . 0.0 110.498 -179.996 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.488 ' O ' ' C ' ' A' ' 71' ' ' THR . 5.9 t -133.86 135.99 44.07 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.179 -179.997 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.488 ' C ' ' O ' ' A' ' 70' ' ' THR . 1.0 OUTLIER 29.65 68.12 0.68 Allowed Pre-proline 0 N--CA 1.466 0.335 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.719 -179.665 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -60.69 144.92 99.61 Favored 'Trans proline' 0 C--N 1.299 -2.045 0 C-N-CA 122.573 2.182 . . . . 0.0 112.242 -178.506 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.525 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 45.2 p-10 -160.37 -32.12 0.06 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.646 179.735 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.525 ' N ' ' OD1' ' A' ' 73' ' ' ASN . 99.1 m-20 -64.07 -39.37 93.92 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.451 -179.987 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -60.7 -47.75 84.88 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.718 -179.165 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.424 ' O ' ' O ' ' A' ' 77' ' ' ALA . 96.1 t -60.3 -24.5 31.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 179.687 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.424 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -45.71 172.81 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.594 179.835 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.568 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.6 p30 -62.01 177.77 0.42 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.605 -179.654 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.596 ' C ' ' H ' ' A' ' 81' ' ' GLY . 35.8 p30 -46.36 85.98 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.012 0.434 . . . . 0.0 110.921 179.956 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.568 ' N ' ' O ' ' A' ' 78' ' ' ASP . 43.0 tp60 -67.49 13.73 0.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.022 -179.78 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.596 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 117.91 -22.24 9.95 Favored Glycine 0 CA--C 1.518 0.269 0 N-CA-C 110.991 -0.844 . . . . 0.0 110.991 179.987 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -107.95 116.7 32.42 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.007 0.432 . . . . 0.0 110.488 179.858 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 76.5 mt -98.88 0.9 45.11 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.482 -179.783 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -91.93 6.57 45.73 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.996 0.427 . . . . 0.0 110.475 -179.749 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.443 ' O ' ' CG2' ' A' ' 89' ' ' VAL . 88.2 mt-30 -100.02 -26.52 13.95 Favored 'General case' 0 C--O 1.224 -0.259 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.843 179.883 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.0 t-105 -64.6 -40.86 96.26 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.121 -179.769 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.551 ' O ' ' N ' ' A' ' 91' ' ' LYS . 70.3 m -77.59 -53.55 7.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.355 -179.67 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -48.22 -50.75 28.22 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.076 -179.24 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.443 ' CG2' ' O ' ' A' ' 85' ' ' GLN . 14.3 m -69.08 -41.03 81.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 120.932 0.396 . . . . 0.0 111.174 179.645 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.41 ' H ' HG23 ' A' ' 89' ' ' VAL . . . -71.72 -22.95 61.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.814 -179.971 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.551 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.0 tttm -61.51 -45.97 91.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.476 -179.493 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.437 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.8 mm-40 -90.43 -94.33 0.12 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.111 -179.867 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.632 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.9 mtt180 -143.37 59.66 1.4 Allowed 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 179.767 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.459 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.6 pttp 33.74 26.08 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 120.833 0.349 . . . . 0.0 110.171 -179.354 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.632 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.3 tt -47.96 123.39 6.11 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.977 -178.076 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -83.45 -170.54 3.1 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.055 -179.841 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.616 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 82.6 mtp180 -72.93 137.74 45.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.182 -179.807 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.493 ' N ' ' O ' ' A' ' 67' ' ' SER . 88.4 mt -86.32 -166.28 1.5 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.702 -179.626 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.531 ' CD2' ' O ' ' A' ' 99' ' ' TYR . 47.1 p90 -167.75 119.8 0.88 Allowed 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.223 179.938 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.508 ' C ' ' O ' ' A' ' 99' ' ' TYR . 43.0 mm -29.6 121.19 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.997 -179.645 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 113.66 28.17 3.3 Favored Glycine 0 CA--C 1.519 0.304 0 N-CA-C 111.179 -0.768 . . . . 0.0 111.179 -179.404 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.584 ' N ' ' CD ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -143.88 45.81 0.6 Allowed Pre-proline 0 C--N 1.324 -0.53 0 CA-C-O 120.947 0.403 . . . . 0.0 110.475 179.827 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.584 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 30.8 Cg_endo -62.06 143.7 95.23 Favored 'Trans proline' 0 C--N 1.296 -2.187 0 C-N-CA 122.639 2.226 . . . . 0.0 112.057 179.926 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.678 ' HG ' ' H ' ' A' ' 107' ' ' ALA . 22.6 t -173.27 120.77 0.35 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.41 179.649 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.28 -41.09 64.03 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.105 0.479 . . . . 0.0 111.262 179.525 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -65.92 -40.27 91.29 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.908 -179.401 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.678 ' H ' ' HG ' ' A' ' 104' ' ' SER . . . -63.89 -39.89 95.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.7 -179.915 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 69.0 t -67.43 -43.91 87.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.774 179.558 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.18 -39.18 91.83 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.554 -179.236 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.437 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.64 -23.62 63.18 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.425 179.835 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.552 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.5 mm-40 -90.83 4.68 51.09 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.703 -179.547 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.552 ' C ' ' O ' ' A' ' 111' ' ' GLN . 10.3 tpt 23.43 63.85 0.38 Allowed Pre-proline 0 N--CA 1.467 0.378 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.982 179.906 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -78.48 168.58 21.18 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 C-N-CA 122.94 2.427 . . . . 0.0 112.28 -178.54 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.523 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 98.9 m-20 -112.7 -44.24 3.35 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.999 0.428 . . . . 0.0 109.97 179.495 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.0 tp -120.58 120.05 34.69 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.665 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 96.4 mt -117.09 131.26 70.33 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 CA-C-O 120.877 0.37 . . . . 0.0 111.017 -179.942 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 30.0 mt -106.27 132.6 52.13 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.133 0.492 . . . . 0.0 110.234 -179.369 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 98.1 mt -117.99 136.58 54.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.718 -179.705 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 86.0 p -72.17 152.93 41.94 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.644 179.979 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.36 -49.98 75.41 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.631 -179.858 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -148.99 153.43 37.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.495 179.811 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 169.53 -170.38 42.63 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 179.837 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.95 -35.31 91.89 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 179.915 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.451 ' O ' ' OD1' ' A' ' 124' ' ' ASP . 44.5 p-10 -87.71 120.0 28.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.822 0.344 . . . . 0.0 110.681 179.922 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 39.8 t -63.62 144.22 57.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.437 -179.947 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.518 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.31 -43.34 8.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.931 180.0 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.6 tp -62.71 -42.35 99.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.684 -179.899 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.72 -11.38 58.22 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.478 -179.361 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 84.9 mt -115.64 -23.6 8.65 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.653 -179.781 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . 0.518 ' N ' ' O ' ' A' ' 126' ' ' ALA . 78.0 t80 -51.91 -49.71 62.54 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 120.534 -0.466 . . . . 0.0 110.548 -178.958 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.6 p-10 -65.91 -42.35 90.27 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.867 0.365 . . . . 0.0 111.268 179.512 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.504 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 87.9 mt-30 -67.0 -37.14 83.66 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.811 179.836 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 93.5 mt -79.98 -41.96 24.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.004 -179.612 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.0 t -57.48 -44.59 85.03 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.172 -178.959 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.8 m -62.25 -45.59 92.63 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.797 0.332 . . . . 0.0 110.54 179.382 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 92.3 mt -62.45 -43.79 98.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.277 -179.829 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -170.14 163.98 6.14 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.525 179.833 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -43.81 111.89 0.28 Allowed 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.414 2.076 . . . . 0.0 112.1 179.523 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 17.8 m -85.97 127.54 34.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.49 179.973 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 34.2 tp -118.94 135.9 54.35 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.896 -179.576 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.435 ' O ' ' OD1' ' A' ' 32' ' ' ASP . 80.2 mt -102.63 119.89 51.63 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.417 0 CA-C-O 121.176 0.512 . . . . 0.0 111.466 -179.524 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 98.0 mt -135.8 132.66 51.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.615 179.791 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.517 HD22 ' CG ' ' A' ' 241' ' ' ASP . 54.5 t30 -65.62 151.7 45.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.966 0.412 . . . . 0.0 110.33 179.195 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.52 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 87.3 t80 -85.62 122.42 29.7 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.978 -179.553 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.52 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 98.9 m-20 55.13 69.33 0.74 Allowed 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.966 179.755 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 49.2 p-10 -123.44 -0.35 8.74 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 120.989 0.423 . . . . 0.0 110.711 179.866 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -151.32 117.24 5.51 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.818 -179.52 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 148' ' ' SER . . . . . 0.523 ' HG ' ' H ' ' A' ' 150' ' ' GLN . 84.8 p -63.26 167.9 4.8 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.519 -179.77 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.419 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.4 p-90 -50.78 -15.7 0.32 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.566 -179.823 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . 0.523 ' H ' ' HG ' ' A' ' 148' ' ' SER . 68.0 tp60 -71.24 -74.78 0.14 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.427 -179.726 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.449 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.1 t -62.66 -39.06 92.73 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.235 179.476 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 53.5 tp -60.25 -45.51 93.03 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.345 -178.476 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.419 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 45.7 tp -62.67 -41.92 99.35 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.83 0.348 . . . . 0.0 110.365 179.013 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.449 ' OG1' ' O ' ' A' ' 151' ' ' SER . 55.3 p -63.92 -34.65 78.45 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.282 -179.461 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.451 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.5 mm-40 -63.93 -42.37 97.37 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.175 179.269 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 92.1 mt -65.32 -39.02 91.92 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.072 0.463 . . . . 0.0 110.122 179.163 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.582 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.05 -32.29 79.77 Favored Glycine 0 CA--C 1.519 0.337 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 -179.308 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.451 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.3 mt-10 -36.48 -25.21 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.88 0.371 . . . . 0.0 110.808 179.913 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.582 ' N ' ' O ' ' A' ' 157' ' ' GLY . 95.7 mt -59.45 148.93 6.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.215 179.319 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 75.3 p -68.94 137.51 53.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.07 -179.554 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 70.6 22.13 77.88 Favored Glycine 0 N--CA 1.459 0.187 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 179.48 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 60.0 m80 -124.24 -14.62 6.95 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.673 0.273 . . . . 0.0 110.542 179.88 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -66.58 -59.44 3.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.696 -179.657 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -52.17 -48.68 64.82 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.141 -179.509 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -60.97 -40.95 95.35 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.742 0.306 . . . . 0.0 110.317 179.454 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.59 -47.31 86.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.57 179.822 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.95 -40.05 75.71 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.197 -179.787 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -61.76 -50.26 73.1 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.511 179.597 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -65.38 -43.68 89.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.493 179.595 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 95.4 mt -64.49 -43.48 96.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.395 179.71 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.23 -51.03 70.98 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.568 -179.129 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.81 -43.54 95.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.431 179.744 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . 0.492 ' CD1' ' OH ' ' A' ' 301' ' ' TYR . 57.1 t80 -62.55 -44.75 95.56 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.117 0.484 . . . . 0.0 110.503 179.272 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -63.22 -39.82 95.71 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.616 -179.365 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -62.9 -42.74 99.88 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.644 179.175 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -60.97 -44.64 97.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.015 -179.944 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 85.1 mt -64.24 -41.25 97.07 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.033 0.445 . . . . 0.0 110.715 178.887 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.41 -62.1 1.85 Allowed 'General case' 0 C--O 1.237 0.432 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.51 -179.317 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.67 -46.71 86.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.545 179.882 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.45 -41.46 66.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.203 -179.979 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -63.77 -33.73 76.31 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.965 0.412 . . . . 0.0 110.347 179.244 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . 0.402 ' O ' ' HG2' ' A' ' 182' ' ' GLU . 69.8 tt0 -90.57 8.56 33.47 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.483 0.659 . . . . 0.0 110.527 -178.997 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -104.51 -32.22 9.08 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.267 179.58 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.6 pt -128.01 147.78 32.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.863 -179.902 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -140.05 131.16 26.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.352 179.409 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.552 ' CD2' ' N ' ' A' ' 186' ' ' LEU . 3.6 mm? -85.68 133.29 42.1 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.905 179.936 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -44.1 157.89 0.14 Allowed 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.685 2.257 . . . . 0.0 112.123 179.468 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . 0.523 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.5 Cg_endo -62.87 115.05 2.69 Favored 'Trans proline' 0 C--N 1.303 -1.828 0 C-N-CA 122.812 2.341 . . . . 0.0 111.701 179.887 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . 0.523 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.7 mt-30 155.59 148.16 0.0 OUTLIER Pre-proline 0 N--CA 1.454 -0.257 0 O-C-N 123.626 0.579 . . . . 0.0 110.726 -179.957 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -73.95 144.13 33.9 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 C-N-CA 122.657 2.238 . . . . 0.0 111.779 178.083 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.493 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.1 p -125.06 158.76 32.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.276 0.56 . . . . 0.0 110.138 -179.95 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 192' ' ' THR . . . . . 0.493 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 35.6 p -143.29 165.46 27.41 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.199 -179.798 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -135.45 128.54 31.67 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.231 0.538 . . . . 0.0 110.206 179.597 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 47.1 pt -146.59 149.36 16.02 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.358 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.138 179.71 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 69.2 t -118.14 123.31 71.45 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-O 121.385 0.612 . . . . 0.0 109.538 179.276 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -134.39 107.08 7.4 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.181 179.759 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 95.2 m -130.89 130.77 43.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.95 179.685 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.413 ' O ' ' N ' ' A' ' 201' ' ' HIS . . . -83.04 -37.03 24.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.227 179.793 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.39 -67.06 0.26 Allowed 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.346 -179.967 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.24 -9.96 59.15 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.272 179.536 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . 0.413 ' N ' ' O ' ' A' ' 198' ' ' ALA . 60.1 t-80 60.8 58.08 2.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.585 -179.841 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 54.4 p -166.89 153.33 8.44 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.472 179.568 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.02 143.86 24.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.454 179.509 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -135.16 138.05 43.32 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.635 179.972 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 20.0 mt -106.23 125.51 51.08 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 121.114 0.483 . . . . 0.0 109.731 -179.67 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 206' ' ' TRP . . . . . 0.56 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 74.4 m95 -81.91 166.88 19.51 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.595 -179.799 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -157.01 172.01 6.7 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.561 -179.173 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.18 -36.94 87.28 Favored 'Trans proline' 0 C--N 1.302 -1.894 0 C-N-CA 122.623 2.215 . . . . 0.0 112.022 179.477 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -70.52 -35.11 72.99 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.888 -179.917 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 21.9 m -61.18 150.63 33.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.662 -179.368 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.62 -36.84 81.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.482 -179.714 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . 0.56 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 54.8 tt0 -64.57 -40.44 95.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.524 179.931 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.79 -43.33 91.95 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.679 -0.969 . . . . 0.0 110.679 179.829 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -63.44 -43.7 96.67 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 179.933 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 65.6 ttp -59.64 -47.83 84.05 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.161 -179.764 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 86.7 mt -60.83 -40.68 93.68 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 179.731 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . 0.453 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.2 tp10 -58.27 -38.03 76.14 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.784 -0.451 . . . . 0.0 109.784 179.926 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -65.13 -38.23 89.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.836 0.351 . . . . 0.0 110.664 179.605 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 93.6 mt -64.33 -42.65 96.19 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.497 -179.587 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.6 45.22 0.08 OUTLIER Glycine 0 C--N 1.333 0.393 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 179.975 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . 0.453 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 26.5 m-85 -128.38 155.83 44.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.025 0.44 . . . . 0.0 110.527 -179.802 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 222' ' ' THR . . . . . 0.453 ' O ' ' O ' ' A' ' 191' ' ' VAL . 8.2 p -107.56 122.61 47.02 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.262 0.553 . . . . 0.0 110.197 -179.913 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . 0.443 ' CD2' ' N ' ' A' ' 223' ' ' LEU . 4.3 mm? -101.52 132.92 46.89 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.082 179.884 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.65 159.84 14.71 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.508 179.883 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.46 115.27 29.97 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.955 0.407 . . . . 0.0 110.306 179.869 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.453 ' CD1' ' N ' ' A' ' 226' ' ' LEU . 9.0 mp -53.1 156.85 3.35 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.672 179.907 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -60.59 145.53 98.65 Favored 'Trans proline' 0 C--N 1.301 -1.96 0 C-N-CA 122.564 2.176 . . . . 0.0 112.076 179.396 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.21 -3.41 59.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.551 -179.966 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.06 -41.09 5.67 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 -179.909 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.53 ' O ' ' N ' ' A' ' 233' ' ' SER . 68.3 mt -78.97 -17.57 55.21 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-O 121.097 0.475 . . . . 0.0 110.372 -179.838 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . 0.401 ' C ' ' O ' ' A' ' 230' ' ' LEU . 55.0 t-20 -40.43 -49.13 2.84 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.827 -179.352 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -87.68 15.28 7.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.779 0.323 . . . . 0.0 111.34 179.748 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 233' ' ' SER . . . . . 0.53 ' N ' ' O ' ' A' ' 230' ' ' LEU . 78.1 p -60.47 -35.32 75.59 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.591 -179.749 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . 0.525 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.7 tt0 -119.35 -69.44 0.85 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.966 179.457 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.2 m -69.25 103.08 1.85 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.686 -179.788 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -94.77 57.19 2.12 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.381 179.951 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -144.58 -122.72 1.61 Allowed Glycine 0 C--N 1.332 0.322 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 -179.989 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -135.03 111.9 10.14 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 121.202 0.525 . . . . 0.0 110.401 179.958 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . 0.525 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.6 mtt180 -148.15 57.74 1.08 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.796 -179.856 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -69.43 -32.16 70.96 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.518 179.681 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . 0.517 ' CG ' HD22 ' A' ' 143' ' ' ASN . 65.0 t0 -57.03 -47.04 81.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.372 -179.101 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 242' ' ' ILE . . . . . 0.437 ' O ' ' O ' ' A' ' 239' ' ' ARG . 17.9 tt -139.92 156.59 25.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.944 0.402 . . . . 0.0 110.477 179.771 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 96.1 mt -106.3 106.81 21.29 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.219 0 CA-C-O 121.208 0.527 . . . . 0.0 110.498 179.776 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . 0.525 ' OE1' ' NH1' ' A' ' 239' ' ' ARG . 88.2 mt-30 -110.67 110.15 20.7 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.264 179.717 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 9.4 mp -121.71 -168.14 1.65 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.667 179.725 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . 0.525 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.4 -15.82 0.05 OUTLIER Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.991 -0.844 . . . . 0.0 110.991 179.851 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . 0.698 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -61.47 156.5 34.83 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 110.926 -0.869 . . . . 0.0 110.926 -179.893 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -63.59 21.83 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.975 0.416 . . . . 0.0 110.59 179.948 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . 0.698 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.9 m-20 -97.48 -6.13 34.46 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.572 179.9 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 93.5 mt -79.43 -22.11 44.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.639 179.522 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.66 -51.21 70.89 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.806 -179.445 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.09 -5.82 58.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.375 179.639 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.12 -74.47 1.14 Allowed Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 -179.956 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 83.0 mt -70.15 125.81 27.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.019 0.438 . . . . 0.0 110.168 -179.759 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -59.57 -39.2 83.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.28 -179.691 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 83.27 51.71 4.04 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 110.716 -0.954 . . . . 0.0 110.716 179.755 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -95.62 -15.33 22.83 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.709 0.29 . . . . 0.0 110.641 -179.853 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 258' ' ' SER . . . . . 0.422 ' O ' ' O ' ' A' ' 192' ' ' THR . 3.4 t 174.58 89.07 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.058 0.456 . . . . 0.0 110.083 179.935 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . 0.596 ' N ' ' CD1' ' A' ' 259' ' ' LEU . 0.9 OUTLIER -94.39 124.2 38.27 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.291 0.567 . . . . 0.0 111.165 -179.211 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 15.9 m-30 -93.1 146.68 23.47 Favored 'General case' 0 CA--C 1.506 -0.747 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.324 179.281 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 86.1 mt -122.53 149.7 43.56 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.53 -179.883 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.662 ' CG ' ' N ' ' A' ' 263' ' ' ALA . 2.5 p90 -77.78 -138.56 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.472 -179.724 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . 0.662 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -51.72 77.4 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.985 -179.988 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . 0.635 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.17 104.42 0.19 Allowed Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 -179.852 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 265' ' ' ASP . . . . . 0.602 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.6 m-20 -80.41 -177.69 6.3 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.662 0.268 . . . . 0.0 110.932 -179.583 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -40.65 -17.6 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.454 179.939 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . 0.602 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.42 -51.59 42.25 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.992 0.425 . . . . 0.0 110.768 179.382 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -63.78 -46.61 84.46 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.126 179.397 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . 0.522 ' O ' ' CD2' ' A' ' 273' ' ' TYR . . . -61.72 -35.1 77.07 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 121.129 0.49 . . . . 0.0 109.71 179.693 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -62.87 -34.91 78.38 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.213 179.672 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.27 -43.02 14.11 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.402 -179.59 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 272' ' ' ILE . . . . . 0.622 ' C ' ' H ' ' A' ' 274' ' ' ALA . 5.0 tt -51.29 -33.82 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.828 -179.006 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 273' ' ' TYR . . . . . 0.522 ' CD2' ' O ' ' A' ' 269' ' ' ALA . 17.3 m-85 -54.15 -1.66 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.695 -179.625 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 274' ' ' ALA . . . . . 0.622 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.81 -39.88 69.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.882 179.626 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . 0.58 ' O ' ' N ' ' A' ' 279' ' ' ALA . 2.9 p30 -39.29 97.93 0.15 Allowed Pre-proline 0 N--CA 1.463 0.196 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.536 -179.76 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -53.87 -43.03 61.65 Favored 'Trans proline' 0 C--N 1.303 -1.828 0 C-N-CA 122.281 1.987 . . . . 0.0 112.78 -178.884 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 89.6 mt -64.28 -42.8 96.24 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 121.2 0.524 . . . . 0.0 111.346 -179.866 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 90.9 mt -95.68 -1.72 49.51 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.826 -179.499 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 279' ' ' ALA . . . . . 0.58 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.37 -34.97 77.73 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.619 -179.727 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -74.06 19.97 0.11 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.047 -179.342 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . 0.513 ' H ' ' C ' ' A' ' 279' ' ' ALA . 13.8 mt -75.19 120.54 82.15 Favored Pre-proline 0 N--CA 1.451 -0.395 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.345 -179.96 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -51.54 -39.15 65.56 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.586 2.191 . . . . 0.0 111.699 179.241 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -53.08 -50.28 64.71 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 179.914 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 74.9 t -61.56 -43.96 97.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.544 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -57.74 -41.22 81.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.281 -179.918 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -91.04 0.35 57.56 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.139 179.676 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt 59.32 43.14 17.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.943 179.731 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -94.64 41.54 1.09 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.298 179.901 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 53.7 t -119.15 135.64 58.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.001 0.429 . . . . 0.0 110.169 -179.7 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -132.73 162.85 30.37 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.072 0.463 . . . . 0.0 110.753 -179.728 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.69 155.26 32.75 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.991 0.424 . . . . 0.0 110.783 -179.938 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 82.2 mt -94.1 -1.4 54.38 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.242 -179.689 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 120.87 165.28 12.66 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.549 -1.02 . . . . 0.0 110.549 -179.886 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 7.0 m -86.89 -62.29 1.54 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.853 0.359 . . . . 0.0 111.118 -179.89 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 295' ' ' GLU . . . . . 0.48 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.5 mm-40 -69.15 -4.09 16.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.667 -179.768 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 25.3 p -76.71 32.07 0.13 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.673 -179.94 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 297' ' ' PHE . . . . . 0.48 ' H ' ' C ' ' A' ' 295' ' ' GLU . 69.0 t80 -60.42 -45.91 91.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.64 -179.99 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . 0.616 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.2 mtt85 -81.02 134.89 35.76 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 121.011 0.434 . . . . 0.0 110.597 -179.677 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 17.6 tp -114.15 117.53 31.45 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.081 179.944 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . 0.603 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.4 p-10 -165.14 -176.81 4.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.543 179.911 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 301' ' ' TYR . . . . . 0.492 ' OH ' ' CD1' ' A' ' 173' ' ' PHE . 84.1 t80 -46.91 -43.22 18.72 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.186 -179.655 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -67.12 -40.25 86.8 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.99 0.424 . . . . 0.0 110.853 179.053 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 303' ' ' SER . . . . . 0.603 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 59.9 p -56.12 -36.11 67.85 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.064 -179.121 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . 0.508 ' N ' ' HG ' ' A' ' 303' ' ' SER . . . -57.58 -51.34 69.89 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 179.463 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 90.3 mtp -56.73 -43.39 80.6 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 108.993 -0.744 . . . . 0.0 108.993 -179.866 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -66.53 -42.54 87.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.905 0.383 . . . . 0.0 110.108 178.884 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 56.0 t -63.94 -43.09 97.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.112 179.344 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 42.7 tp -59.63 -42.19 92.17 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.782 -179.451 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -62.64 -38.91 92.1 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 179.522 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 310' ' ' ARG . . . . . 0.442 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.6 ttt85 -63.62 -43.95 95.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.17 179.553 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 88.4 mt -63.3 -42.08 99.01 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.156 179.693 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -62.85 -33.45 75.27 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.978 179.558 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.96 -23.27 21.59 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.47 -179.809 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . 0.442 ' N ' ' O ' ' A' ' 310' ' ' ARG . 6.8 tt -62.42 -43.05 99.75 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.076 0.465 . . . . 0.0 110.624 -179.884 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 . . . . . 0 C--O 1.22 -0.485 0 CA-C-O 117.937 -1.03 . . . . 0.0 110.479 179.964 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -99.4 136.01 39.98 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.032 0.444 . . . . 0.0 110.547 -179.962 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.498 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -92.26 178.42 1.7 Allowed Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.5 -179.924 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.498 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 27.0 Cg_exo -61.54 147.45 95.4 Favored 'Trans proline' 0 C--N 1.301 -1.958 0 C-N-CA 122.726 2.284 . . . . 0.0 112.173 179.737 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 35.4 ptt180 -135.7 142.18 45.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.608 179.782 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -79.73 116.34 19.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.446 179.896 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.4 ' O ' ' CG2' ' A' ' 30' ' ' ILE . 9.5 tp -110.71 130.25 64.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.438 -179.96 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 12.7 t -70.77 141.43 51.44 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.518 179.925 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.513 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.2 t0 -139.01 179.38 6.53 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.55 -179.928 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.513 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 78.1 p -74.04 -36.88 64.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.684 179.784 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.8 ttt85 -46.53 -94.55 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.344 -179.504 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.433 ' O ' ' OG1' ' A' ' 36' ' ' THR . . . -166.92 -26.78 0.02 OUTLIER Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 179.928 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.433 ' OG1' ' O ' ' A' ' 35' ' ' GLY . 55.1 m -169.21 104.7 0.38 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.979 0.419 . . . . 0.0 110.665 -179.873 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 74.5 t60 -128.39 148.24 50.69 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.042 0.449 . . . . 0.0 110.338 179.795 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.484 ' CG2' ' N ' ' A' ' 39' ' ' LEU . 98.0 m -130.62 166.02 21.56 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.674 -179.889 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.484 ' N ' ' CG2' ' A' ' 38' ' ' THR . 82.4 mt -120.68 127.61 52.21 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.455 179.74 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -65.18 -44.55 88.12 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.653 -179.861 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.407 ' O ' ' HD3' ' A' ' 43' ' ' PRO . 38.8 p -165.63 154.86 12.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.42 179.582 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.463 ' N ' ' CD ' ' A' ' 42' ' ' GLN . 14.8 mp0 -44.33 101.13 0.24 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.676 179.528 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.407 ' HD3' ' O ' ' A' ' 41' ' ' SER . 31.6 Cg_exo -57.29 129.06 32.16 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.421 2.081 . . . . 0.0 112.183 -179.588 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -83.72 -24.76 31.07 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.478 179.619 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.538 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.8 mtm-85 -121.87 134.61 54.87 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-O 121.194 0.521 . . . . 0.0 110.303 -179.99 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 95.9 mt -130.9 133.68 62.73 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.261 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.017 -179.812 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 45.3 t -124.2 130.49 73.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 179.372 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.497 ' O ' ' O ' ' A' ' 66' ' ' ALA . 2.3 m -155.28 166.83 32.34 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.564 179.849 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 66.6 p -124.44 9.16 8.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.5 179.874 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.16 125.43 32.81 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.635 -179.436 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 94.0 t -65.88 -44.61 92.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.51 179.967 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.7 m -62.63 -44.31 96.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.615 -179.805 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 51.0 tp -62.26 -41.57 98.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.541 -179.487 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 74.2 m -57.59 -44.4 85.36 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.404 -179.36 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.2 -62.22 5.35 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 179.539 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.7 t -48.59 -35.47 13.6 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 -179.939 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.8 mt -61.72 -44.96 95.9 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.153 179.379 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.3 mp -64.85 -41.88 95.35 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.081 0.467 . . . . 0.0 111.368 177.918 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.28 -41.12 98.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.96 -179.139 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.2 tp -88.58 17.05 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.71 -179.647 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 56.57 84.85 0.08 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.645 -179.991 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.65 58.86 0.09 OUTLIER Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.072 -179.819 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -50.66 151.41 10.7 Favored 'Trans proline' 0 C--N 1.297 -2.17 0 C-N-CA 122.767 2.312 . . . . 0.0 112.562 -178.366 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.432 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -108.33 145.49 15.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.325 -179.736 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 97.0 mt -63.84 -44.95 98.28 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.439 -179.785 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.497 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -130.13 134.29 47.22 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.545 -179.791 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.491 ' O ' ' N ' ' A' ' 98' ' ' LEU . 75.3 m -134.59 158.67 43.4 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.878 -179.643 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.31 138.71 16.12 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 179.799 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.447 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.62 -162.97 0.09 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.997 0.427 . . . . 0.0 110.426 -179.924 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.494 ' O ' ' C ' ' A' ' 71' ' ' THR . 5.9 t -133.78 135.53 43.93 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.209 -179.985 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.494 ' C ' ' O ' ' A' ' 70' ' ' THR . 1.0 OUTLIER 29.5 68.12 0.67 Allowed Pre-proline 0 N--CA 1.464 0.245 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.685 -179.634 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -60.54 145.14 99.31 Favored 'Trans proline' 0 C--N 1.3 -1.98 0 C-N-CA 122.57 2.18 . . . . 0.0 112.236 -178.618 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.529 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 44.9 p-10 -160.23 -32.18 0.06 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.574 179.757 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.529 ' N ' ' OD1' ' A' ' 73' ' ' ASN . 99.1 m-20 -63.96 -39.4 94.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.385 179.999 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -60.47 -48.21 82.78 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.684 -179.351 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.421 ' O ' ' O ' ' A' ' 77' ' ' ALA . 96.6 t -60.09 -24.4 30.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.133 179.584 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.421 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -45.98 173.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.518 179.922 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.575 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.5 p30 -62.28 177.98 0.44 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.649 -179.766 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.59 ' C ' ' H ' ' A' ' 81' ' ' GLY . 35.4 p30 -45.51 85.75 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.93 179.893 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.575 ' N ' ' O ' ' A' ' 78' ' ' ASP . 42.8 tp60 -68.03 13.48 0.08 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.058 0.456 . . . . 0.0 110.111 -179.835 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.59 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 118.41 -22.29 9.57 Favored Glycine 0 CA--C 1.52 0.352 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 179.996 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -108.02 116.5 32.06 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.954 0.407 . . . . 0.0 110.474 179.785 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 76.6 mt -98.86 0.45 44.24 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.442 -179.724 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -92.52 7.23 44.07 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.996 0.427 . . . . 0.0 110.392 -179.689 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.442 ' O ' ' CG2' ' A' ' 89' ' ' VAL . 88.3 mt-30 -100.1 -27.65 13.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.822 -179.966 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 69.5 t-105 -63.25 -40.91 98.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.916 -179.615 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.56 ' O ' ' N ' ' A' ' 91' ' ' LYS . 66.5 m -77.58 -53.41 7.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.263 -179.405 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -48.46 -50.82 29.81 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.906 -179.302 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.442 ' CG2' ' O ' ' A' ' 85' ' ' GLN . 15.6 m -68.95 -40.84 81.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 120.959 0.409 . . . . 0.0 110.993 179.829 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.413 ' H ' HG23 ' A' ' 89' ' ' VAL . . . -72.18 -22.95 61.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.806 -179.864 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.56 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.0 tttm -61.77 -45.53 93.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.537 -179.558 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.444 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.6 mm-40 -90.47 -94.99 0.12 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.162 -179.957 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.642 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.9 mtt180 -142.78 59.28 1.43 Allowed 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 179.71 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.463 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.7 pttp 33.53 25.79 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 120.86 0.362 . . . . 0.0 110.235 -179.142 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.642 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.3 tt -47.68 123.5 5.98 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.907 -178.166 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -83.81 -169.91 2.81 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.098 179.952 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.612 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 82.4 mtp180 -74.04 137.04 43.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.251 -179.754 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.491 ' N ' ' O ' ' A' ' 67' ' ' SER . 90.0 mt -86.27 -165.7 1.33 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.658 -179.539 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.535 ' CD2' ' O ' ' A' ' 99' ' ' TYR . 47.9 p90 -168.89 120.05 0.75 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.182 179.981 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.519 ' C ' ' O ' ' A' ' 99' ' ' TYR . 43.6 mm -29.14 121.24 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.994 -179.585 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 114.45 27.17 3.43 Favored Glycine 0 CA--C 1.521 0.441 0 N-CA-C 111.126 -0.789 . . . . 0.0 111.126 -179.578 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.58 ' N ' ' CD ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -144.35 46.26 0.61 Allowed Pre-proline 0 C--N 1.325 -0.498 0 CA-C-O 120.866 0.365 . . . . 0.0 110.412 179.986 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 29.9 Cg_endo -61.94 143.76 95.77 Favored 'Trans proline' 0 C--N 1.297 -2.168 0 C-N-CA 122.702 2.268 . . . . 0.0 112.021 179.993 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.696 ' HG ' ' H ' ' A' ' 107' ' ' ALA . 26.2 t -173.32 120.06 0.33 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.474 179.82 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.26 -40.49 64.57 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.045 0.45 . . . . 0.0 111.184 179.644 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.25 -40.05 89.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.923 -179.447 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.696 ' H ' ' HG ' ' A' ' 104' ' ' SER . . . -64.07 -40.06 95.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.736 -179.844 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 71.8 t -67.56 -43.95 86.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.863 179.664 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.83 -38.79 92.18 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.631 -179.323 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.444 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.44 -23.34 62.6 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.418 179.799 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.553 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.3 mm-40 -90.53 5.02 49.49 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.699 -179.454 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.553 ' C ' ' O ' ' A' ' 111' ' ' GLN . 10.2 tpt 24.16 63.59 0.41 Allowed Pre-proline 0 N--CA 1.465 0.278 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.874 -179.981 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -77.53 167.1 24.83 Favored 'Trans proline' 0 C--N 1.303 -1.82 0 C-N-CA 122.987 2.458 . . . . 0.0 112.415 -178.779 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.526 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 99.1 m-20 -110.39 -41.97 4.24 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 121.02 0.438 . . . . 0.0 110.131 179.442 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.7 tp -121.65 120.14 33.87 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.344 -0.389 . . . . 0.0 109.957 179.549 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 83.4 mt -112.99 129.14 69.18 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.341 0 CA-C-O 120.943 0.401 . . . . 0.0 110.891 -179.882 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 29.7 mt -109.13 132.39 54.16 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 121.108 0.48 . . . . 0.0 110.165 -179.682 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 98.8 mt -119.87 139.07 48.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.697 -179.789 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 85.0 p -72.65 153.75 41.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.579 179.951 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.08 -50.06 75.19 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.616 -179.823 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.0 t -149.64 154.19 38.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.573 179.795 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 170.56 -170.96 43.46 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.954 -0.858 . . . . 0.0 110.954 179.917 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -63.1 -34.14 89.16 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 179.932 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.452 ' O ' ' OD1' ' A' ' 124' ' ' ASP . 44.6 p-10 -86.93 120.23 27.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.805 0.336 . . . . 0.0 110.742 179.97 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 40.6 t -63.1 143.58 57.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.431 -179.894 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.524 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.15 -43.27 8.94 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.888 -179.913 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 56.0 tp -62.74 -42.54 99.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.751 -179.858 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.42 -11.97 59.11 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.551 -179.436 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 84.1 mt -115.26 -23.6 8.86 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.663 -179.85 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . 0.524 ' N ' ' O ' ' A' ' 126' ' ' ALA . 79.0 t80 -51.01 -49.76 59.84 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.52 -179.012 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.506 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.3 p-10 -65.99 -42.64 89.51 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.8 0.333 . . . . 0.0 111.11 179.604 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.506 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 88.2 mt-30 -67.02 -37.92 84.99 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.744 179.926 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 95.2 mt -80.22 -41.56 24.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.983 -179.535 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.3 t -57.16 -44.29 83.33 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.196 -179.219 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.3 m -61.86 -45.33 94.23 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.778 0.323 . . . . 0.0 110.476 179.472 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 92.7 mt -62.23 -43.41 97.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.161 -179.742 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.53 168.23 4.89 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.533 179.866 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -50.1 113.01 0.84 Allowed 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.29 1.993 . . . . 0.0 112.106 179.437 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 23.8 m -84.24 127.51 34.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.527 -179.927 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 34.6 tp -117.8 135.94 53.73 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.029 -179.702 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.443 ' O ' ' OD2' ' A' ' 32' ' ' ASP . 81.8 mt -100.17 118.82 47.4 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.36 0 CA-C-O 121.204 0.526 . . . . 0.0 111.231 -179.384 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 97.8 mt -134.73 132.27 54.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.656 179.629 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.516 HD22 ' CG ' ' A' ' 241' ' ' ASP . 61.0 t30 -66.9 151.19 48.04 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.9 0.381 . . . . 0.0 110.402 179.368 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.521 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 87.9 t80 -85.95 122.45 30.02 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.814 -179.577 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.521 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 98.8 m-20 55.16 69.3 0.75 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.87 179.725 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 35.2 p-10 -125.84 0.08 7.34 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.722 179.907 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -150.53 115.36 5.27 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.679 -179.463 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 148' ' ' SER . . . . . 0.515 ' HG ' ' H ' ' A' ' 150' ' ' GLN . 84.0 p -63.61 168.54 4.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.526 -179.744 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.423 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.4 p-90 -52.01 -15.72 0.61 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.555 -179.861 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . 0.515 ' H ' ' HG ' ' A' ' 148' ' ' SER . 67.9 tp60 -70.5 -76.32 0.1 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.446 -179.737 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.45 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.1 t -62.64 -38.46 90.36 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.379 179.488 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 53.6 tp -60.07 -45.57 92.46 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.419 -178.668 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.423 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 47.3 tp -62.82 -41.79 99.45 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.845 0.355 . . . . 0.0 110.3 179.101 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.45 ' OG1' ' O ' ' A' ' 151' ' ' SER . 63.3 p -64.07 -34.61 78.42 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.335 -179.615 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.423 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.3 mm-40 -64.14 -42.85 96.63 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.264 179.247 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 92.4 mt -65.4 -39.0 91.65 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.989 0.423 . . . . 0.0 110.21 179.159 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.587 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.01 -32.13 79.12 Favored Glycine 0 CA--C 1.521 0.426 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 -179.358 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.442 ' C ' ' O ' ' A' ' 157' ' ' GLY . 97.3 mt-10 -35.45 -26.84 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.799 0.333 . . . . 0.0 110.731 179.968 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.587 ' N ' ' O ' ' A' ' 157' ' ' GLY . 95.8 mt -56.87 149.64 3.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.211 179.376 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 72.4 p -69.55 137.12 52.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.031 -179.587 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 71.77 20.26 78.57 Favored Glycine 0 N--CA 1.459 0.197 0 N-CA-C 111.239 -0.744 . . . . 0.0 111.239 179.487 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 57.6 m80 -121.97 -15.09 7.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.731 0.3 . . . . 0.0 110.622 179.928 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -65.74 -59.88 3.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.807 -179.741 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -52.03 -49.13 64.01 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.225 -179.717 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -60.71 -41.22 94.79 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.701 0.286 . . . . 0.0 110.308 179.411 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.39 -47.25 86.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.7 179.779 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.9 -40.24 75.93 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.261 -179.92 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -61.74 -50.15 73.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.561 179.57 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 60.1 ttt85 -65.31 -43.88 89.66 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.462 179.535 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 96.0 mt -64.44 -43.63 96.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.449 179.671 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.18 -50.97 71.19 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.608 -179.148 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -63.76 -43.83 95.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.378 179.803 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . 0.459 ' CD1' ' OH ' ' A' ' 301' ' ' TYR . 56.7 t80 -62.71 -44.53 95.99 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.071 0.462 . . . . 0.0 110.447 179.388 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -63.25 -40.13 96.57 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.435 -179.294 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -62.92 -42.75 99.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.648 179.292 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -60.6 -44.88 95.78 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.116 179.961 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 85.5 mt -64.37 -41.09 96.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.001 0.429 . . . . 0.0 110.692 178.867 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.02 -62.17 1.8 Allowed 'General case' 0 C--O 1.237 0.416 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.491 -179.349 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.94 -46.66 87.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.523 179.902 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.38 -41.69 66.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.15 179.999 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -63.79 -33.67 76.18 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.944 0.402 . . . . 0.0 110.354 179.272 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . 0.405 ' HG2' ' O ' ' A' ' 182' ' ' GLU . 69.6 tt0 -90.48 8.71 32.44 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.25 0.547 . . . . 0.0 110.565 -179.099 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -104.81 -32.26 8.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.232 179.676 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 45.4 pt -128.07 147.49 32.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.826 -179.879 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -139.73 131.02 26.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.335 179.436 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.558 ' CD2' ' N ' ' A' ' 186' ' ' LEU . 3.5 mm? -85.5 133.66 41.71 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.776 179.994 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -44.16 157.74 0.15 Allowed 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.793 2.329 . . . . 0.0 112.053 179.47 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . 0.532 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.7 Cg_endo -62.92 114.88 2.62 Favored 'Trans proline' 0 C--N 1.303 -1.867 0 C-N-CA 122.727 2.284 . . . . 0.0 111.833 179.908 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . 0.532 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.7 mt-30 155.54 148.23 0.0 OUTLIER Pre-proline 0 N--CA 1.454 -0.238 0 O-C-N 123.438 0.461 . . . . 0.0 110.686 -179.761 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -74.13 144.18 33.3 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.736 2.291 . . . . 0.0 111.687 178.165 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.497 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.1 p -124.99 158.82 32.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.195 0.521 . . . . 0.0 110.146 -179.954 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 192' ' ' THR . . . . . 0.497 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 35.8 p -143.39 165.2 28.18 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.08 -179.526 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -135.45 128.48 31.55 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.145 0.498 . . . . 0.0 110.188 179.677 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 47.6 pt -146.52 149.09 16.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.068 179.88 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 69.0 t -117.86 123.03 71.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.236 0.541 . . . . 0.0 109.733 179.08 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -134.15 106.86 7.39 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.288 179.79 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 95.1 m -130.62 130.52 44.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.77 179.751 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -83.18 -36.58 24.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.215 179.804 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.61 -66.99 0.27 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.398 179.878 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.68 -9.36 58.53 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.313 179.487 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 60.5 t-80 60.5 58.56 2.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.856 -179.952 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 37.1 p -167.29 153.64 8.08 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.526 179.512 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.52 144.09 24.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.967 0.413 . . . . 0.0 110.431 179.376 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -135.12 138.2 43.53 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.925 0.393 . . . . 0.0 110.671 -179.994 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 19.4 mt -106.39 125.52 51.1 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 121.117 0.484 . . . . 0.0 109.794 -179.738 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 206' ' ' TRP . . . . . 0.562 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 74.8 m95 -81.85 166.94 19.52 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.641 -179.808 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -156.84 171.4 7.48 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.942 0.401 . . . . 0.0 110.569 -179.288 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -53.83 -37.2 84.8 Favored 'Trans proline' 0 C--N 1.303 -1.838 0 C-N-CA 122.603 2.202 . . . . 0.0 111.97 179.352 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -70.21 -35.19 73.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.923 -179.875 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 21.7 m -61.05 150.79 32.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.601 -179.305 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.59 -37.02 82.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.527 -179.755 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . 0.562 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 54.7 tt0 -64.59 -40.32 95.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.566 179.99 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.51 -43.29 92.67 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 179.833 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -63.56 -43.45 96.99 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.76 0.314 . . . . 0.0 110.335 179.897 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 65.4 ttp -59.65 -47.92 83.7 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.37 -179.928 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 88.2 mt -60.56 -40.71 92.64 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.497 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . 0.459 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.8 tp10 -58.23 -37.95 75.88 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.806 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -65.2 -38.19 89.71 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.849 0.356 . . . . 0.0 110.651 179.679 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 94.6 mt -64.3 -42.77 96.2 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.618 -179.674 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.71 44.87 0.08 OUTLIER Glycine 0 CA--C 1.52 0.387 0 N-CA-C 110.974 -0.85 . . . . 0.0 110.974 -179.996 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . 0.459 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 26.8 m-85 -128.04 155.71 43.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.087 0.47 . . . . 0.0 110.452 -179.843 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 222' ' ' THR . . . . . 0.456 ' O ' ' O ' ' A' ' 191' ' ' VAL . 7.1 p -107.44 122.46 46.67 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 121.138 0.494 . . . . 0.0 110.205 -179.933 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . 0.443 ' CD2' ' N ' ' A' ' 223' ' ' LEU . 4.3 mm? -101.39 132.94 46.7 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.048 -179.991 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.68 159.65 14.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.519 179.876 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.34 115.02 29.55 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.335 179.867 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.453 ' CD1' ' N ' ' A' ' 226' ' ' LEU . 8.9 mp -53.0 156.71 3.31 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.665 179.953 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -60.65 145.61 98.56 Favored 'Trans proline' 0 C--N 1.302 -1.917 0 C-N-CA 122.599 2.199 . . . . 0.0 111.989 179.455 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.34 -3.43 59.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.502 -179.987 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -89.97 -41.21 5.66 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 111.011 -0.836 . . . . 0.0 111.011 -179.855 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.54 ' O ' ' N ' ' A' ' 233' ' ' SER . 70.0 mt -78.91 -17.57 55.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.951 0.405 . . . . 0.0 110.329 -179.845 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . 0.403 ' C ' ' O ' ' A' ' 230' ' ' LEU . 55.2 t-20 -39.97 -49.31 2.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.742 -179.505 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -88.05 15.41 7.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.797 0.332 . . . . 0.0 111.21 -179.996 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 233' ' ' SER . . . . . 0.54 ' N ' ' O ' ' A' ' 230' ' ' LEU . 78.1 p -60.45 -35.68 76.44 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.53 -179.862 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . 0.527 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.6 tt0 -118.66 -69.32 0.86 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.961 179.591 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.2 m -69.81 103.22 2.12 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.744 -179.785 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -94.66 57.53 2.2 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.392 179.953 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -144.72 -122.66 1.59 Allowed Glycine 0 CA--C 1.521 0.418 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 -179.972 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -134.73 111.5 10.0 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.075 0.464 . . . . 0.0 110.494 179.975 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . 0.521 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.6 mtt180 -148.03 57.49 1.09 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.682 -179.9 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -69.48 -32.21 70.97 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.522 179.654 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . 0.516 ' CG ' HD22 ' A' ' 143' ' ' ASN . 64.6 t0 -56.89 -47.04 81.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.369 -179.18 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 242' ' ' ILE . . . . . 0.441 ' O ' ' O ' ' A' ' 239' ' ' ARG . 18.0 tt -139.83 156.56 25.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.824 0.345 . . . . 0.0 110.584 179.807 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 96.1 mt -106.27 106.45 20.62 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.212 0 CA-C-O 121.09 0.472 . . . . 0.0 110.569 179.858 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . 0.521 ' OE1' ' NH1' ' A' ' 239' ' ' ARG . 88.2 mt-30 -110.36 110.06 20.71 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.279 179.804 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 9.3 mp -121.89 -168.43 1.7 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.65 179.923 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . 0.527 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.68 -16.37 0.05 OUTLIER Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 179.865 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . 0.702 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -60.91 156.48 32.61 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 -179.892 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -63.31 21.28 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.967 0.413 . . . . 0.0 110.569 179.952 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . 0.702 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.8 m-20 -96.99 -6.2 36.01 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.551 -179.996 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 93.8 mt -79.5 -22.22 44.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.636 179.545 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.51 -51.31 70.42 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.756 -179.49 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.1 -5.85 58.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.402 179.704 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -80.93 -74.63 1.13 Allowed Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 -179.902 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 83.6 mt -70.08 126.03 28.49 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.03 0.443 . . . . 0.0 110.246 -179.885 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -59.19 -39.39 82.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.238 -179.691 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 82.89 51.84 4.08 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 179.929 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -96.46 -14.22 22.54 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.734 0.302 . . . . 0.0 110.658 -179.822 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 258' ' ' SER . . . . . 0.428 ' O ' ' O ' ' A' ' 192' ' ' THR . 3.5 t 174.16 88.47 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.075 0.464 . . . . 0.0 110.168 179.934 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . 0.596 ' N ' ' CD1' ' A' ' 259' ' ' LEU . 1.0 OUTLIER -94.11 123.93 37.8 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.204 0.526 . . . . 0.0 111.073 -179.206 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 16.0 m-30 -92.76 146.42 23.66 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.356 179.175 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 87.0 mt -122.35 149.57 43.59 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.512 -179.917 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.663 ' CG ' ' N ' ' A' ' 263' ' ' ALA . 2.5 p90 -77.64 -138.43 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.484 -179.808 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . 0.663 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -51.97 77.51 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.965 -179.945 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . 0.636 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.07 104.36 0.18 Allowed Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.674 -0.971 . . . . 0.0 110.674 -179.937 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 265' ' ' ASP . . . . . 0.608 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.9 m-20 -80.48 -177.74 6.35 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.743 0.306 . . . . 0.0 110.878 -179.477 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -40.43 -17.66 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.503 179.769 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . 0.608 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.49 -51.6 41.5 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.965 0.412 . . . . 0.0 110.742 179.434 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -63.81 -46.63 84.25 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.196 179.373 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . 0.527 ' O ' ' CD2' ' A' ' 273' ' ' TYR . . . -61.58 -35.18 77.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.152 -0.477 . . . . 0.0 109.808 179.527 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -62.91 -34.64 77.87 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.164 179.624 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.32 -43.35 13.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.243 -179.535 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 272' ' ' ILE . . . . . 0.616 ' C ' ' H ' ' A' ' 274' ' ' ALA . 4.9 tt -51.53 -33.65 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.72 -178.712 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 273' ' ' TYR . . . . . 0.527 ' CD2' ' O ' ' A' ' 269' ' ' ALA . 17.4 m-85 -54.23 -1.85 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.702 -179.705 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 274' ' ' ALA . . . . . 0.616 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.81 -39.49 69.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.848 179.651 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . 0.585 ' O ' ' N ' ' A' ' 279' ' ' ALA . 3.2 p30 -39.45 98.0 0.15 Allowed Pre-proline 0 C--N 1.332 -0.163 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.592 -179.668 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -53.82 -43.17 60.38 Favored 'Trans proline' 0 C--N 1.303 -1.847 0 C-N-CA 122.361 2.04 . . . . 0.0 112.751 -178.881 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 89.0 mt -64.47 -42.87 95.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.178 -179.667 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 90.7 mt -95.68 -1.51 49.94 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.839 -179.413 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 279' ' ' ALA . . . . . 0.585 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.55 -34.84 77.75 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.562 -179.713 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.08 20.03 0.11 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.045 -179.238 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . 0.513 ' H ' ' C ' ' A' ' 279' ' ' ALA . 13.9 mt -75.54 120.83 83.44 Favored Pre-proline 0 N--CA 1.452 -0.329 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.389 179.977 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_exo -51.54 -38.97 65.68 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.597 2.198 . . . . 0.0 111.617 179.339 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.78 -50.39 63.64 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.165 179.79 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 75.5 t -61.53 -43.95 97.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 179.424 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -57.7 -41.51 81.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.295 -179.992 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -90.94 0.21 57.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.186 179.641 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt 59.09 43.03 18.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.029 0.442 . . . . 0.0 110.969 179.755 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -94.42 41.74 1.09 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.342 179.856 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 54.0 t -119.03 135.8 58.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.989 0.423 . . . . 0.0 110.299 -179.812 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -132.85 162.7 30.87 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.997 0.427 . . . . 0.0 110.669 -179.635 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.81 155.36 32.72 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.974 0.416 . . . . 0.0 110.72 -179.785 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 81.4 mt -94.05 -1.5 54.34 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.225 -179.745 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 120.89 165.72 12.8 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 -179.795 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 6.9 m -87.28 -62.39 1.51 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.847 0.356 . . . . 0.0 111.04 -179.847 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 295' ' ' GLU . . . . . 0.473 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.8 mm-40 -69.53 -3.94 16.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.625 -179.762 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 27.3 p -77.03 32.63 0.14 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.612 -179.906 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 297' ' ' PHE . . . . . 0.473 ' H ' ' C ' ' A' ' 295' ' ' GLU . 70.1 t80 -60.11 -45.97 91.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.549 -179.993 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . 0.612 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.2 mtt85 -81.32 134.13 35.53 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 121.017 0.437 . . . . 0.0 110.51 -179.761 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 16.0 tp -114.67 119.52 36.98 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.213 -179.951 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . 0.607 ' H ' ' CB ' ' A' ' 303' ' ' SER . 49.4 p-10 -167.36 -174.41 2.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.523 -179.936 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 301' ' ' TYR . . . . . 0.459 ' OH ' ' CD1' ' A' ' 173' ' ' PHE . 84.1 t80 -48.06 -45.49 32.42 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.183 -179.603 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -65.05 -41.45 95.14 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.062 0.458 . . . . 0.0 110.771 179.019 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 303' ' ' SER . . . . . 0.607 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 53.0 p -55.55 -35.94 66.26 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.147 -179.37 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -57.16 -51.6 68.66 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.478 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 90.8 mtp -56.39 -43.57 79.39 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.792 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -66.52 -42.57 87.1 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.84 0.352 . . . . 0.0 110.131 178.78 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 56.1 t -64.03 -42.92 97.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.229 179.394 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 42.5 tp -59.63 -42.0 91.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.827 -179.626 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -62.86 -39.0 93.06 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 179.58 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 310' ' ' ARG . . . . . 0.437 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.4 ttt85 -63.59 -44.06 95.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.322 179.514 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 87.8 mt -63.3 -42.07 99.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.215 179.58 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -62.89 -33.18 74.76 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.037 179.521 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.95 -23.46 21.55 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.559 -179.866 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . 0.437 ' N ' ' O ' ' A' ' 310' ' ' ARG . 6.8 tt -62.34 -43.18 99.43 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.626 179.977 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 . . . . . 0 C--O 1.22 -0.471 0 CA-C-O 117.979 -1.01 . . . . 0.0 110.506 179.992 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -99.6 136.5 39.43 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.041 0.448 . . . . 0.0 110.422 -179.906 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.497 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -92.05 178.44 1.72 Allowed Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.63 -179.916 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.497 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.7 Cg_exo -61.62 147.02 96.37 Favored 'Trans proline' 0 C--N 1.3 -2.018 0 C-N-CA 122.801 2.334 . . . . 0.0 112.124 179.784 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 35.3 ptt180 -136.06 142.25 44.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.71 179.771 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -79.56 116.62 19.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.475 179.905 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.5 tp -110.88 130.36 64.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.512 -179.993 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.3 t -70.83 141.5 51.31 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.528 179.818 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.515 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.4 t0 -139.03 179.46 6.48 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.563 -179.944 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.515 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 78.1 p -74.04 -36.93 64.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.733 179.834 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.7 ttt85 -46.44 -94.57 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.351 -179.573 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.496 ' C ' ' HG1' ' A' ' 36' ' ' THR . . . -166.97 -26.68 0.02 OUTLIER Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.899 -0.881 . . . . 0.0 110.899 179.945 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.496 ' HG1' ' C ' ' A' ' 35' ' ' GLY . 62.0 m -169.19 104.84 0.38 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.849 0.357 . . . . 0.0 110.694 -179.938 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 74.6 t60 -128.36 149.03 50.7 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.005 0.431 . . . . 0.0 110.3 179.941 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.484 ' CG2' ' N ' ' A' ' 39' ' ' LEU . 98.9 m -131.4 165.9 22.47 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.543 -179.857 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.484 ' N ' ' CG2' ' A' ' 38' ' ' THR . 81.7 mt -120.64 127.39 52.03 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.481 179.728 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -65.17 -44.51 88.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.706 179.975 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.406 ' O ' ' HD3' ' A' ' 43' ' ' PRO . 40.3 p -165.68 154.62 11.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.433 179.728 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.458 ' N ' ' CD ' ' A' ' 42' ' ' GLN . 14.4 mp0 -44.55 101.34 0.25 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.642 179.437 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.406 ' HD3' ' O ' ' A' ' 41' ' ' SER . 31.7 Cg_exo -57.25 129.36 33.76 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 C-N-CA 122.345 2.03 . . . . 0.0 112.264 -179.713 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -83.45 -24.92 31.61 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.533 179.536 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.537 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.5 mtm-85 -122.04 134.8 54.79 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-O 121.09 0.471 . . . . 0.0 110.364 -179.946 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.2 mt -130.61 133.57 63.32 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.288 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.959 -179.677 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 45.1 t -124.32 130.48 73.63 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-O 120.863 0.363 . . . . 0.0 110.115 179.238 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.496 ' O ' ' O ' ' A' ' 66' ' ' ALA . 2.4 m -154.85 166.59 33.03 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.527 179.842 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 71.4 p -124.47 8.61 8.38 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.489 179.85 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.22 125.85 33.2 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.611 -179.586 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 86.2 t -65.86 -44.54 92.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.568 -179.962 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.9 m -62.65 -44.36 96.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.62 -179.81 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 46.5 tp -62.26 -41.66 98.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.526 -179.439 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 76.2 m -57.58 -44.7 85.55 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.443 -179.426 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.0 -62.47 5.18 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 179.626 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.7 t -48.23 -35.62 12.29 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 -179.947 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.8 mt -61.74 -44.67 96.46 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.735 -0.386 . . . . 0.0 111.209 179.467 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.2 mp -65.1 -41.67 94.72 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.27 177.949 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.19 -41.42 99.18 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.966 -179.254 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.3 tp -88.15 17.41 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.783 -179.637 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 56.46 84.72 0.08 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.674 -179.951 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.8 59.21 0.09 OUTLIER Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.038 -179.79 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -51.09 151.28 12.31 Favored 'Trans proline' 0 C--N 1.296 -2.197 0 C-N-CA 122.779 2.319 . . . . 0.0 112.39 -178.228 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.435 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -108.59 145.21 15.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.332 -179.632 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.8 mt -63.77 -45.17 97.96 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.274 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.37 -179.766 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.496 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -129.76 134.38 47.56 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 120.877 0.37 . . . . 0.0 110.587 -179.811 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.492 ' O ' ' N ' ' A' ' 98' ' ' LEU . 73.2 m -134.76 158.76 43.33 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.804 -179.609 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.42 138.76 16.1 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 179.794 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.441 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.79 -162.79 0.08 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.916 0.388 . . . . 0.0 110.516 -179.908 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.495 ' O ' ' C ' ' A' ' 71' ' ' THR . 6.0 t -133.88 135.46 43.68 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.27 179.996 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.495 ' C ' ' O ' ' A' ' 70' ' ' THR . 1.0 OUTLIER 29.34 68.57 0.64 Allowed Pre-proline 0 N--CA 1.465 0.303 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.637 -179.624 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -61.21 145.67 98.34 Favored 'Trans proline' 0 C--N 1.301 -1.946 0 C-N-CA 122.654 2.236 . . . . 0.0 112.018 -178.344 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.533 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 45.0 p-10 -160.46 -31.26 0.06 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.695 179.75 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.533 ' N ' ' OD1' ' A' ' 73' ' ' ASN . 98.8 m-20 -64.69 -38.97 92.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.47 179.959 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.6 ttt180 -60.99 -48.08 83.48 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.621 -179.347 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.424 ' O ' ' O ' ' A' ' 77' ' ' ALA . 96.7 t -60.22 -24.84 31.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.023 179.631 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.424 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -45.68 172.96 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.497 179.731 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.584 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.4 p30 -62.47 177.83 0.47 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.604 -179.709 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.596 ' C ' ' H ' ' A' ' 81' ' ' GLY . 36.5 p30 -45.05 85.34 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.988 -180.0 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.584 ' N ' ' O ' ' A' ' 78' ' ' ASP . 42.0 tp60 -67.49 13.4 0.07 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.185 -179.892 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.596 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 118.4 -22.45 9.51 Favored Glycine 0 CA--C 1.519 0.319 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 179.951 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -108.03 116.22 31.56 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.986 0.422 . . . . 0.0 110.504 179.848 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 74.7 mt -98.09 0.17 45.61 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.511 -179.725 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -92.48 7.29 43.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.43 -179.815 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.447 ' O ' ' CG2' ' A' ' 89' ' ' VAL . 88.5 mt-30 -100.2 -26.58 13.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.78 179.981 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.4 t-105 -64.54 -40.76 96.18 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.018 -179.647 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.556 ' O ' ' N ' ' A' ' 91' ' ' LYS . 65.3 m -77.89 -53.84 7.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.131 -179.487 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -47.67 -50.97 23.29 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.982 -179.354 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.447 ' CG2' ' O ' ' A' ' 85' ' ' GLN . 14.9 m -69.1 -41.14 81.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.101 179.818 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.415 ' H ' HG23 ' A' ' 89' ' ' VAL . . . -71.7 -23.18 61.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.725 -179.876 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.556 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.0 tttm -61.73 -45.78 92.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.469 -179.53 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.443 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.7 mm-40 -90.13 -95.2 0.11 Allowed 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.175 -179.913 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.638 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.9 mtt180 -142.75 59.29 1.43 Allowed 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.755 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.461 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.7 pttp 33.37 26.1 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.169 -179.061 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.638 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.3 tt -48.04 123.41 6.2 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.916 -178.142 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -83.65 -169.64 2.66 Favored 'General case' 0 N--CA 1.455 -0.175 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.198 179.963 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.61 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 82.1 mtp180 -74.4 136.91 42.42 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.282 -179.82 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.492 ' N ' ' O ' ' A' ' 67' ' ' SER . 90.5 mt -85.91 -165.64 1.3 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.743 -179.63 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.537 ' CD2' ' O ' ' A' ' 99' ' ' TYR . 47.7 p90 -169.05 119.76 0.72 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.268 179.99 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.518 ' C ' ' O ' ' A' ' 99' ' ' TYR . 43.3 mm -28.76 120.91 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.017 -179.693 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 114.53 27.09 3.44 Favored Glycine 0 CA--C 1.521 0.415 0 N-CA-C 111.149 -0.78 . . . . 0.0 111.149 -179.544 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.578 ' N ' ' CD ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -144.27 46.33 0.62 Allowed Pre-proline 0 C--N 1.323 -0.57 0 CA-C-O 120.927 0.394 . . . . 0.0 110.499 179.901 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 29.3 Cg_endo -61.92 143.82 95.9 Favored 'Trans proline' 0 C--N 1.297 -2.171 0 C-N-CA 122.7 2.267 . . . . 0.0 111.975 -179.899 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.704 ' HG ' ' H ' ' A' ' 107' ' ' ALA . 26.2 t -173.3 120.13 0.33 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.445 179.78 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.75 -40.35 63.56 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.065 0.46 . . . . 0.0 111.041 179.744 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.25 -39.98 89.88 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.798 -179.371 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.704 ' H ' ' HG ' ' A' ' 104' ' ' SER . . . -64.06 -39.99 95.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.744 -179.824 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 70.3 t -67.65 -43.77 86.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.753 179.708 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.74 -38.99 92.68 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.561 -179.246 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.443 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.66 -23.4 63.04 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.479 179.863 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.551 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.3 mm-40 -90.18 5.15 48.21 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.713 -179.554 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.551 ' C ' ' O ' ' A' ' 111' ' ' GLN . 10.5 tpt 23.44 64.17 0.38 Allowed Pre-proline 0 N--CA 1.465 0.293 0 CA-C-O 120.859 0.361 . . . . 0.0 110.982 -179.769 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -78.22 167.27 23.45 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 C-N-CA 122.971 2.447 . . . . 0.0 112.082 -178.448 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.523 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 98.8 m-20 -110.04 -42.14 4.28 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.145 179.426 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 41.2 tp -121.19 120.65 35.84 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 179.506 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 83.5 mt -113.29 128.92 69.86 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.343 0 CA-C-O 120.978 0.418 . . . . 0.0 110.88 -179.897 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 30.2 mt -109.42 132.27 54.29 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 121.061 0.458 . . . . 0.0 110.218 -179.73 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 98.9 mt -119.8 138.96 48.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.693 -179.718 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 85.8 p -72.75 153.96 40.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.594 -179.949 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.11 -50.21 74.6 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.686 -179.855 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -149.52 153.97 38.02 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.567 179.869 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 170.66 -170.97 43.51 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 179.876 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.88 -34.13 88.97 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 179.912 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.449 ' O ' ' OD1' ' A' ' 124' ' ' ASP . 44.3 p-10 -87.03 120.67 28.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.821 0.343 . . . . 0.0 110.651 179.983 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 36.1 t -63.26 143.79 57.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.472 -179.935 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.52 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.12 -43.81 8.68 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.944 -179.898 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 56.0 tp -62.93 -42.44 99.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.748 -179.888 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.28 -11.92 58.77 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.522 -179.421 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 84.2 mt -115.37 -23.56 8.82 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.637 -179.811 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . 0.52 ' N ' ' O ' ' A' ' 126' ' ' ALA . 79.4 t80 -51.09 -49.46 60.66 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.542 -178.883 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.499 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 37.7 p-10 -66.33 -42.61 87.94 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.832 0.349 . . . . 0.0 111.138 179.618 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.499 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 88.2 mt-30 -66.92 -37.53 84.51 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.74 -179.995 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 96.3 mt -80.63 -41.28 24.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.868 -179.585 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.2 t -57.13 -44.54 83.42 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.269 -179.139 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.3 m -61.93 -45.32 94.22 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.802 0.334 . . . . 0.0 110.566 179.411 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 94.0 mt -62.02 -43.63 97.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.277 -179.836 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.45 168.25 4.94 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.499 179.895 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -49.95 112.82 0.79 Allowed 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.297 1.998 . . . . 0.0 112.224 179.339 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 24.0 m -84.36 127.52 34.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.644 -179.968 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 34.7 tp -118.03 136.68 53.39 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.09 -179.781 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.441 ' O ' ' OD2' ' A' ' 32' ' ' ASP . 81.6 mt -100.57 118.83 47.84 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 CA-C-O 121.182 0.515 . . . . 0.0 111.128 -179.319 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 97.8 mt -134.71 132.14 54.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.669 179.591 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.521 HD22 ' CG ' ' A' ' 241' ' ' ASP . 56.0 t30 -67.56 153.71 43.09 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.893 0.378 . . . . 0.0 110.469 179.38 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.525 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 89.2 t80 -87.51 122.15 30.86 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.861 -179.55 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.525 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 99.0 m-20 55.33 69.5 0.73 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.762 179.651 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 49.5 p-10 -123.84 -0.69 8.48 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.631 179.88 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -151.07 116.14 5.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.712 -179.534 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 148' ' ' SER . . . . . 0.516 ' HG ' ' H ' ' A' ' 150' ' ' GLN . 83.2 p -62.85 167.88 4.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.474 -179.788 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.417 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.3 p-90 -51.38 -15.81 0.46 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.517 -179.86 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . 0.516 ' H ' ' HG ' ' A' ' 148' ' ' SER . 68.0 tp60 -70.71 -75.32 0.12 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.493 -179.771 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.44 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.1 t -62.75 -38.88 92.32 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.366 179.491 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 55.7 tp -59.91 -45.8 91.39 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.422 -178.649 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.417 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 46.8 tp -62.71 -41.63 99.25 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.425 179.057 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.44 ' OG1' ' O ' ' A' ' 151' ' ' SER . 60.0 p -64.46 -35.01 79.53 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.31 -179.55 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.432 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.5 mm-40 -64.28 -42.88 96.22 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.383 179.374 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 91.5 mt -65.39 -38.91 91.4 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.072 0.463 . . . . 0.0 110.272 179.166 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.582 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.31 -32.08 79.5 Favored Glycine 0 CA--C 1.52 0.347 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 -179.382 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.44 ' C ' ' O ' ' A' ' 157' ' ' GLY . 97.1 mt-10 -35.25 -27.31 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.816 0.341 . . . . 0.0 110.821 179.894 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.582 ' N ' ' O ' ' A' ' 157' ' ' GLY . 95.1 mt -55.57 150.07 2.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.319 179.263 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 73.9 p -70.13 137.34 50.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.057 -179.59 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 72.26 18.44 78.1 Favored Glycine 0 N--CA 1.458 0.163 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 179.507 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 57.3 m80 -119.8 -15.52 8.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.747 0.308 . . . . 0.0 110.606 179.866 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -63.92 -60.78 2.83 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.655 -179.631 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -51.91 -49.42 63.09 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.201 -179.666 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -60.27 -41.24 92.9 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.752 0.31 . . . . 0.0 110.348 179.539 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.49 -47.2 86.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.576 179.851 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.94 -40.17 75.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.259 -179.894 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -61.88 -50.2 73.16 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.578 179.595 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -65.39 -43.73 89.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.492 179.532 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 95.0 mt -64.73 -43.38 96.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.488 179.739 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.36 -51.12 70.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.533 -179.215 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.46 -43.95 95.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.464 179.732 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . 0.48 ' CD1' ' OH ' ' A' ' 301' ' ' TYR . 56.2 t80 -62.83 -44.45 96.1 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.085 0.469 . . . . 0.0 110.44 179.451 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -63.51 -39.98 95.85 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.566 -179.337 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -62.94 -42.77 99.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.64 179.259 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -60.73 -45.07 95.68 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.172 179.945 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 84.4 mt -64.61 -41.06 96.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.036 0.446 . . . . 0.0 110.693 178.918 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -51.93 -62.61 1.52 Allowed 'General case' 0 C--O 1.237 0.441 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.473 -179.343 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.89 -46.58 87.51 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.664 179.767 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.31 -41.77 65.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.281 179.939 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -63.85 -33.84 76.59 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.969 0.414 . . . . 0.0 110.371 179.256 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . 0.406 ' HG2' ' O ' ' A' ' 182' ' ' GLU . 69.5 tt0 -90.47 9.06 30.75 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.37 0.605 . . . . 0.0 110.516 -178.998 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -105.06 -31.99 8.92 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.202 179.555 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.4 pt -128.11 147.52 32.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.828 -179.873 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -140.06 131.14 26.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.423 179.358 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.554 ' CD2' ' N ' ' A' ' 186' ' ' LEU . 3.6 mm? -85.63 133.08 42.61 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.844 -179.947 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -44.0 157.78 0.14 Allowed 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.714 2.276 . . . . 0.0 112.153 179.341 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . 0.524 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.6 Cg_endo -62.78 115.23 2.8 Favored 'Trans proline' 0 C--N 1.304 -1.81 0 C-N-CA 122.775 2.317 . . . . 0.0 111.808 179.772 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . 0.524 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.8 mt-30 155.61 147.52 0.0 OUTLIER Pre-proline 0 C--N 1.332 -0.169 0 O-C-N 123.618 0.574 . . . . 0.0 110.782 -179.791 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -73.76 143.43 33.56 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.659 2.239 . . . . 0.0 111.956 177.983 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.497 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.0 p -124.81 159.02 31.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.276 0.56 . . . . 0.0 110.189 179.959 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 192' ' ' THR . . . . . 0.497 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 35.7 p -143.48 165.47 27.47 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.094 -179.638 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -135.34 128.43 31.69 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 121.128 0.49 . . . . 0.0 110.24 179.576 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 47.8 pt -146.35 148.79 16.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.046 179.986 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 70.3 t -117.6 122.89 70.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.222 0.534 . . . . 0.0 109.734 179.122 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -134.06 107.37 7.72 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.261 179.77 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 94.6 m -131.11 130.45 43.15 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.797 179.784 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.418 ' O ' ' N ' ' A' ' 201' ' ' HIS . . . -82.74 -37.24 24.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.275 179.692 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.32 -67.02 0.26 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.366 -179.973 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.31 -9.76 58.91 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.316 179.425 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . 0.418 ' N ' ' O ' ' A' ' 198' ' ' ALA . 59.7 t-80 60.54 58.27 2.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.628 -179.902 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 45.7 p -166.92 153.26 8.34 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.527 179.611 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.36 144.16 24.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.976 0.417 . . . . 0.0 110.442 179.488 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -135.34 138.1 43.05 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.63 -179.941 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 20.2 mt -106.28 125.56 51.15 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 121.116 0.484 . . . . 0.0 109.934 -179.701 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 206' ' ' TRP . . . . . 0.558 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 75.4 m95 -82.25 167.18 18.9 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.649 -179.727 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -156.88 171.56 7.27 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 120.943 0.402 . . . . 0.0 110.563 -179.194 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_exo -53.94 -36.89 85.2 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 C-N-CA 122.659 2.24 . . . . 0.0 112.16 179.256 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -70.55 -34.93 72.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.761 -179.772 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 21.9 m -61.56 150.54 35.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.543 -179.27 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.42 -36.97 81.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.457 -179.732 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . 0.558 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 54.4 tt0 -64.5 -40.28 95.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.472 179.967 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.87 -43.27 91.91 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 179.812 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -63.55 -43.46 97.03 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.752 0.31 . . . . 0.0 110.29 179.807 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 65.3 ttp -59.49 -48.25 82.36 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.234 -179.809 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 88.4 mt -60.37 -40.8 92.12 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.536 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . 0.457 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.4 tp10 -57.99 -37.93 75.17 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 179.751 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -65.22 -37.94 88.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.847 0.356 . . . . 0.0 110.676 179.68 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 94.1 mt -64.47 -42.73 95.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.582 -179.645 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.59 44.59 0.08 OUTLIER Glycine 0 C--N 1.334 0.426 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 -179.921 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . 0.457 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 26.3 m-85 -127.73 155.22 44.34 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.033 0.445 . . . . 0.0 110.49 -179.82 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 222' ' ' THR . . . . . 0.457 ' O ' ' O ' ' A' ' 191' ' ' VAL . 6.6 p -106.94 122.06 45.68 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.189 0.519 . . . . 0.0 110.198 -179.961 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . 0.448 ' CD2' ' N ' ' A' ' 223' ' ' LEU . 4.3 mm? -100.81 133.46 45.24 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.101 -179.97 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -97.24 158.76 15.29 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.44 179.916 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -104.84 115.21 29.92 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.384 179.898 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.45 ' CD1' ' N ' ' A' ' 226' ' ' LEU . 9.1 mp -53.32 156.57 3.95 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.705 179.86 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -60.26 145.38 98.7 Favored 'Trans proline' 0 C--N 1.301 -1.943 0 C-N-CA 122.711 2.274 . . . . 0.0 112.119 179.218 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.46 -2.89 58.93 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.557 -179.992 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.32 -40.83 5.65 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 111.029 -0.828 . . . . 0.0 111.029 -179.887 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.543 ' O ' ' N ' ' A' ' 233' ' ' SER . 86.0 mt -79.28 -16.89 55.7 Favored 'General case' 0 C--O 1.224 -0.257 0 CA-C-O 121.018 0.437 . . . . 0.0 110.356 -179.755 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . 0.405 ' C ' ' O ' ' A' ' 230' ' ' LEU . 54.6 t-20 -40.05 -49.23 2.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.691 -179.592 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -88.28 15.43 7.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.813 0.339 . . . . 0.0 111.277 179.935 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 233' ' ' SER . . . . . 0.543 ' N ' ' O ' ' A' ' 230' ' ' LEU . 78.1 p -60.48 -35.63 76.36 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.648 -179.77 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . 0.525 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.6 tt0 -118.25 -69.43 0.85 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.954 179.588 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 3.9 m -70.16 103.45 2.33 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.691 -179.744 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -94.59 57.74 2.26 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.345 180.0 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -144.99 -122.57 1.56 Allowed Glycine 0 CA--C 1.519 0.343 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 -179.977 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -134.41 111.85 10.48 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.094 0.473 . . . . 0.0 110.413 179.964 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . 0.513 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.4 mtt180 -148.11 57.39 1.08 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.762 -179.972 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -69.71 -31.89 70.15 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.511 179.664 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . 0.521 ' CG ' HD22 ' A' ' 143' ' ' ASN . 65.1 t0 -56.71 -46.99 80.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.404 -179.167 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 242' ' ' ILE . . . . . 0.436 ' O ' ' O ' ' A' ' 239' ' ' ARG . 17.4 tt -140.33 157.27 24.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.886 0.374 . . . . 0.0 110.524 179.748 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 96.0 mt -106.01 106.08 19.9 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.191 0 CA-C-O 121.125 0.488 . . . . 0.0 110.465 179.886 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . 0.513 ' OE1' ' NH1' ' A' ' 239' ' ' ARG . 88.2 mt-30 -110.36 110.17 20.86 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.392 179.755 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 9.5 mp -121.9 -168.19 1.66 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.641 179.774 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . 0.525 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.25 -16.66 0.05 OUTLIER Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.956 -0.857 . . . . 0.0 110.956 179.894 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . 0.695 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -60.46 157.03 29.73 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 -179.83 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -63.82 21.43 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.971 0.415 . . . . 0.0 110.58 179.945 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . 0.695 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.7 m-20 -97.18 -5.93 35.94 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.544 179.983 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 92.6 mt -80.2 -21.58 42.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.604 179.589 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.54 -51.24 70.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.728 -179.579 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.76 -5.33 58.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.481 179.659 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.16 -74.45 1.14 Allowed Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.911 -0.875 . . . . 0.0 110.911 -179.96 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 81.7 mt -69.89 125.93 28.2 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.977 0.418 . . . . 0.0 110.329 -179.859 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -59.22 -39.49 82.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.295 -179.711 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 82.64 51.93 4.11 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 179.95 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -96.22 -14.89 22.36 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.644 0.259 . . . . 0.0 110.541 -179.864 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 258' ' ' SER . . . . . 0.423 ' O ' ' O ' ' A' ' 192' ' ' THR . 3.5 t 174.78 88.55 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.029 0.442 . . . . 0.0 110.194 179.978 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . 0.595 ' N ' ' CD1' ' A' ' 259' ' ' LEU . 0.9 OUTLIER -94.18 124.08 37.97 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.241 0.544 . . . . 0.0 111.066 -179.058 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 15.9 m-30 -93.03 146.45 23.62 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.342 179.17 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 86.1 mt -122.41 149.82 43.29 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.529 -179.905 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.66 ' CG ' ' N ' ' A' ' 263' ' ' ALA . 2.6 p90 -77.63 -138.36 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.562 -179.838 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . 0.66 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -52.1 77.45 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.993 -179.989 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . 0.633 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -178.98 104.42 0.19 Allowed Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 -179.976 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 265' ' ' ASP . . . . . 0.602 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.8 m-20 -80.47 -177.74 6.35 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 120.725 0.298 . . . . 0.0 110.896 -179.527 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -40.39 -17.71 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.853 0.358 . . . . 0.0 110.552 179.786 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . 0.602 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.71 -51.42 41.75 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.688 179.516 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -63.74 -46.83 83.59 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.175 179.314 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . 0.524 ' O ' ' CD2' ' A' ' 273' ' ' TYR . . . -61.47 -35.05 76.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.111 0.481 . . . . 0.0 109.884 179.533 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -63.22 -34.42 77.62 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.119 179.712 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.36 -43.37 13.73 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.171 -179.572 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 272' ' ' ILE . . . . . 0.619 ' C ' ' H ' ' A' ' 274' ' ' ALA . 5.0 tt -51.37 -33.83 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.893 -178.824 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 273' ' ' TYR . . . . . 0.524 ' CD2' ' O ' ' A' ' 269' ' ' ALA . 17.2 m-85 -54.24 -1.82 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.647 -179.638 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 274' ' ' ALA . . . . . 0.619 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.58 -39.43 70.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.87 179.603 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . 0.583 ' O ' ' N ' ' A' ' 279' ' ' ALA . 3.0 p30 -39.65 98.33 0.17 Allowed Pre-proline 0 N--CA 1.462 0.143 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.506 -179.638 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -54.16 -43.11 61.39 Favored 'Trans proline' 0 C--N 1.304 -1.812 0 C-N-CA 122.389 2.06 . . . . 0.0 112.619 -178.793 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 89.3 mt -64.45 -42.86 95.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.109 -179.613 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 91.0 mt -95.7 -1.64 49.57 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.872 -179.373 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 279' ' ' ALA . . . . . 0.583 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.35 -34.75 77.27 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.678 -179.85 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.4 20.1 0.12 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.966 -179.212 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . 0.511 ' H ' ' C ' ' A' ' 279' ' ' ALA . 13.9 mt -75.19 120.04 79.8 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.505 179.916 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -50.69 -39.48 56.73 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.577 2.185 . . . . 0.0 111.951 179.035 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.8 -50.56 63.38 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.132 179.885 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 74.5 t -61.45 -43.79 97.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.482 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -57.98 -41.22 82.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.28 -179.972 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -90.9 0.14 57.58 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.145 179.575 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt 59.55 43.04 16.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.82 179.568 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -94.66 41.49 1.09 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.38 179.852 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 53.6 t -118.79 136.02 57.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.999 0.428 . . . . 0.0 110.193 -179.759 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -133.17 162.73 30.98 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.665 -179.639 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.9 155.22 33.13 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.968 0.413 . . . . 0.0 110.735 -179.86 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 81.0 mt -93.89 -1.49 54.69 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.235 -179.803 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.06 165.66 12.74 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.689 -0.965 . . . . 0.0 110.689 -179.735 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 6.8 m -87.15 -62.3 1.53 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.892 0.377 . . . . 0.0 111.009 -179.888 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 295' ' ' GLU . . . . . 0.47 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.6 mm-40 -69.57 -3.88 16.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.628 -179.833 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 28.1 p -77.09 32.91 0.14 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.618 -179.96 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 297' ' ' PHE . . . . . 0.47 ' H ' ' C ' ' A' ' 295' ' ' GLU . 70.2 t80 -60.19 -46.06 91.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.546 -179.971 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . 0.61 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.3 mtt85 -81.49 134.01 35.47 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.45 -179.652 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 16.1 tp -114.31 119.75 38.06 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.253 179.924 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . 0.609 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.4 p-10 -167.8 -173.9 2.27 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.524 179.95 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 301' ' ' TYR . . . . . 0.48 ' OH ' ' CD1' ' A' ' 173' ' ' PHE . 84.0 t80 -48.25 -46.0 35.11 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.227 -179.644 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -64.65 -41.61 96.0 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.998 0.428 . . . . 0.0 110.702 179.015 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 303' ' ' SER . . . . . 0.609 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 52.0 p -55.44 -36.11 66.17 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.099 -179.269 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -56.92 -51.76 67.87 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.482 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 91.5 mtp -56.06 -43.87 78.32 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.8 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -66.38 -42.74 87.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.953 0.406 . . . . 0.0 110.207 178.798 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 55.2 t -64.04 -42.89 97.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.261 179.39 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 42.8 tp -59.62 -42.04 91.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.893 -179.616 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -62.87 -38.76 92.12 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.064 179.475 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 310' ' ' ARG . . . . . 0.435 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.6 ttt85 -63.5 -44.03 95.52 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.238 179.569 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 88.5 mt -63.23 -41.93 99.17 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.226 179.548 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -62.9 -33.23 74.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.083 179.492 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.85 -23.51 21.65 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.423 -179.862 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . 0.435 ' N ' ' O ' ' A' ' 310' ' ' ARG . 6.7 tt -62.33 -43.22 99.33 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 121.06 0.457 . . . . 0.0 110.57 -179.92 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 . . . . . 0 C--O 1.22 -0.498 0 CA-C-O 118.003 -0.999 . . . . 0.0 110.482 179.966 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -99.51 135.79 40.4 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.464 -179.926 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.498 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -92.11 178.48 1.69 Allowed Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.532 -179.863 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.498 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.7 Cg_exo -61.54 147.16 96.1 Favored 'Trans proline' 0 C--N 1.301 -1.961 0 C-N-CA 122.696 2.264 . . . . 0.0 112.161 179.576 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 35.4 ptt180 -136.33 142.39 43.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.624 179.692 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -79.7 116.78 20.08 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.453 179.872 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.404 ' O ' ' CG2' ' A' ' 30' ' ' ILE . 9.4 tp -111.54 130.11 65.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.46 179.969 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.4 t -71.14 141.7 50.75 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.599 179.81 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.522 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.1 t0 -138.71 -179.73 5.99 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.524 179.997 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.522 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 78.3 p -73.72 -37.51 65.1 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.856 179.84 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -46.64 -94.74 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.313 -179.411 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.413 ' O ' ' OG1' ' A' ' 36' ' ' THR . . . -166.24 -26.76 0.02 OUTLIER Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 179.919 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.413 ' OG1' ' O ' ' A' ' 35' ' ' GLY . 63.7 m -168.42 105.72 0.46 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.857 0.361 . . . . 0.0 110.603 -179.968 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 68.2 t60 -128.87 146.43 50.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.038 0.447 . . . . 0.0 110.324 179.97 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.485 ' CG2' ' N ' ' A' ' 39' ' ' LEU . 100.0 m -129.82 165.6 21.63 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.608 -179.928 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.485 ' N ' ' CG2' ' A' ' 38' ' ' THR . 80.5 mt -120.3 127.37 52.3 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.466 179.683 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -65.56 -44.53 86.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.605 -179.978 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.419 ' O ' ' HD3' ' A' ' 43' ' ' PRO . 40.8 p -165.91 154.88 11.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.456 179.743 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.46 ' N ' ' CD ' ' A' ' 42' ' ' GLN . 14.5 mp0 -45.4 101.64 0.27 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.658 179.443 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.419 ' HD3' ' O ' ' A' ' 41' ' ' SER . 31.5 Cg_exo -57.66 129.83 35.65 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 C-N-CA 122.294 1.996 . . . . 0.0 112.263 -179.759 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -82.84 -24.92 33.06 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.472 179.593 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.537 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.7 mtm-85 -120.73 134.34 55.29 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 121.125 0.488 . . . . 0.0 110.264 -179.931 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.42 HD13 HG21 ' A' ' 46' ' ' ILE . 96.1 mt -130.23 133.29 64.33 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.091 -179.85 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 47.3 t -124.79 130.96 73.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 179.404 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.502 ' O ' ' O ' ' A' ' 66' ' ' ALA . 4.4 m -155.19 166.48 33.45 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.578 179.666 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 62.4 p -124.53 8.94 8.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.411 -179.981 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.1 t -85.38 125.53 33.05 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.655 -179.467 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 90.8 t -65.72 -44.64 93.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.542 179.961 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.7 m -62.62 -44.39 96.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.655 -179.862 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 53.5 tp -62.18 -41.66 98.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.659 -179.459 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 74.7 m -57.63 -44.54 85.65 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.384 -179.426 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.36 -61.98 5.52 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.941 -0.863 . . . . 0.0 110.941 179.561 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.7 t -48.48 -35.7 13.56 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 -179.979 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.9 mt -61.76 -44.56 96.65 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.644 -0.422 . . . . 0.0 111.136 179.344 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.407 HD12 ' N ' ' A' ' 58' ' ' LEU . 9.4 mp -64.72 -42.07 95.5 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.329 177.961 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.54 -41.16 98.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.086 -179.197 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.1 tp -88.04 16.76 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.735 -179.668 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 56.62 83.78 0.1 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.631 179.972 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.71 57.02 0.07 OUTLIER Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.049 -179.815 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -49.54 153.15 5.51 Favored 'Trans proline' 0 C--N 1.296 -2.21 0 C-N-CA 122.811 2.341 . . . . 0.0 112.638 -178.559 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.432 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -109.03 146.26 14.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.371 -179.734 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 97.0 mt -63.9 -44.86 98.13 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.298 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.488 -179.885 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.502 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -130.27 134.61 47.35 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.512 -179.774 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.485 ' O ' ' N ' ' A' ' 98' ' ' LEU . 72.2 m -134.52 158.6 43.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.859 -179.663 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.55 139.24 16.39 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 110.671 -0.972 . . . . 0.0 110.671 179.848 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.457 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.88 -162.67 0.08 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.95 0.405 . . . . 0.0 110.535 -179.992 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.491 ' O ' ' C ' ' A' ' 71' ' ' THR . 5.8 t -133.71 135.81 44.26 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.177 -179.973 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.491 ' C ' ' O ' ' A' ' 70' ' ' THR . 0.9 OUTLIER 29.6 68.33 0.67 Allowed Pre-proline 0 N--CA 1.465 0.291 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.713 -179.689 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -60.64 145.23 99.21 Favored 'Trans proline' 0 C--N 1.3 -2.009 0 C-N-CA 122.576 2.184 . . . . 0.0 112.167 -178.566 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.523 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 46.2 p-10 -160.65 -31.97 0.05 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.674 179.74 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.523 ' N ' ' OD1' ' A' ' 73' ' ' ASN . 98.8 m-20 -64.31 -38.96 92.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.367 179.973 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -61.15 -47.88 84.15 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.636 -179.236 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.423 ' O ' ' O ' ' A' ' 77' ' ' ALA . 94.4 t -60.21 -24.56 30.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.659 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.423 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -45.64 172.6 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.535 179.881 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.575 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.8 p30 -61.68 177.6 0.4 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.653 -179.707 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.601 ' C ' ' H ' ' A' ' 81' ' ' GLY . 36.1 p30 -45.87 85.54 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.97 179.872 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.575 ' N ' ' O ' ' A' ' 78' ' ' ASP . 43.0 tp60 -67.19 13.59 0.06 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.072 0.463 . . . . 0.0 110.12 -179.774 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.601 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 117.72 -22.0 10.2 Favored Glycine 0 C--N 1.331 0.285 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 179.981 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -107.93 116.35 31.8 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.022 0.439 . . . . 0.0 110.518 179.849 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 75.8 mt -98.8 0.57 44.63 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.516 -179.698 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -91.88 6.61 45.49 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.988 0.423 . . . . 0.0 110.47 -179.707 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.442 ' O ' ' CG2' ' A' ' 89' ' ' VAL . 88.1 mt-30 -99.89 -28.08 13.28 Favored 'General case' 0 C--O 1.224 -0.266 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.784 179.973 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 68.9 t-105 -63.03 -41.07 99.43 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.913 -179.722 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.556 ' O ' ' N ' ' A' ' 91' ' ' LYS . 67.4 m -77.34 -53.53 7.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.313 -179.441 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -48.4 -50.85 29.22 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.979 -179.337 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.442 ' CG2' ' O ' ' A' ' 85' ' ' GLN . 15.6 m -68.9 -40.83 81.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 120.914 0.388 . . . . 0.0 111.075 179.748 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.413 ' H ' HG23 ' A' ' 89' ' ' VAL . . . -72.1 -22.96 61.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.775 -179.912 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.556 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.0 tttm -61.35 -45.69 93.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.45 -179.502 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.437 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.7 mm-40 -90.73 -94.34 0.12 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.091 -179.977 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.633 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.9 mtt180 -143.36 59.95 1.4 Allowed 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.81 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.461 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.7 pttp 33.54 26.27 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 120.791 0.329 . . . . 0.0 110.115 -179.291 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.633 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.5 tt -47.97 122.84 5.45 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.995 -178.243 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -83.25 -169.9 2.77 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.016 -179.882 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.614 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 83.0 mtp180 -73.51 137.88 44.7 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.29 -179.813 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.485 ' N ' ' O ' ' A' ' 67' ' ' SER . 89.0 mt -86.81 -166.2 1.5 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.701 -179.519 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.533 ' CD2' ' O ' ' A' ' 99' ' ' TYR . 47.4 p90 -167.97 120.05 0.86 Allowed 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.296 179.939 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.511 ' C ' ' O ' ' A' ' 99' ' ' TYR . 42.9 mm -29.59 121.25 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.939 -179.639 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 113.96 28.13 3.24 Favored Glycine 0 CA--C 1.519 0.341 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 -179.542 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.585 ' N ' ' CD ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -144.02 45.81 0.59 Allowed Pre-proline 0 C--N 1.324 -0.53 0 CA-C-O 120.932 0.396 . . . . 0.0 110.508 179.883 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 30.5 Cg_endo -62.0 143.72 95.5 Favored 'Trans proline' 0 C--N 1.297 -2.152 0 C-N-CA 122.667 2.245 . . . . 0.0 112.033 179.921 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.695 ' HG ' ' H ' ' A' ' 107' ' ' ALA . 23.1 t -173.43 120.52 0.33 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.404 179.715 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.22 -41.09 64.15 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.057 0.456 . . . . 0.0 111.231 179.652 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -65.93 -40.26 91.26 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.942 -179.412 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.695 ' H ' ' HG ' ' A' ' 104' ' ' SER . . . -63.87 -39.87 95.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.699 -179.852 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 69.5 t -67.39 -43.91 87.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.863 179.627 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.33 -39.0 91.63 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.602 -179.265 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.437 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.58 -23.49 62.96 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.013 0.435 . . . . 0.0 110.505 179.817 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.555 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.4 mm-40 -91.07 4.73 51.37 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.72 -179.5 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.555 ' C ' ' O ' ' A' ' 111' ' ' GLN . 10.6 tpt 23.56 63.85 0.38 Allowed Pre-proline 0 N--CA 1.465 0.32 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.916 179.971 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -78.3 168.79 21.12 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 C-N-CA 122.918 2.412 . . . . 0.0 112.344 -178.645 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.525 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 98.9 m-20 -113.15 -44.16 3.29 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.939 179.639 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 39.9 tp -120.71 119.77 33.76 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.619 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 95.7 mt -116.99 131.14 70.56 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.3 0 CA-C-O 120.909 0.385 . . . . 0.0 110.949 -179.91 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.5 ' CD1' ' HG ' ' A' ' 48' ' ' SER . 30.7 mt -106.06 132.77 51.74 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 121.104 0.478 . . . . 0.0 110.236 -179.387 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 98.0 mt -118.31 136.37 55.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.699 -179.633 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 85.9 p -71.98 153.22 41.93 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.666 179.978 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.19 -50.1 75.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.625 -179.84 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -149.37 153.82 37.99 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.535 179.823 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 169.67 -170.42 42.71 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 179.837 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -63.01 -35.05 91.57 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 110.824 -0.91 . . . . 0.0 110.824 179.986 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.442 ' O ' ' OD1' ' A' ' 124' ' ' ASP . 43.8 p-10 -87.86 119.9 28.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.797 0.332 . . . . 0.0 110.694 179.933 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 40.5 t -63.39 144.17 57.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.472 -179.969 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.522 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.59 -43.03 8.88 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.837 -179.874 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.3 tp -62.66 -42.42 99.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.663 -179.931 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.78 -11.04 57.64 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.518 -179.403 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 84.9 mt -115.96 -23.72 8.43 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.749 -179.868 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . 0.522 ' N ' ' O ' ' A' ' 126' ' ' ALA . 79.0 t80 -51.77 -49.71 62.12 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 120.501 -0.48 . . . . 0.0 110.587 -179.024 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.5 p-10 -65.81 -42.16 90.99 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.946 0.403 . . . . 0.0 111.172 179.564 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.507 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 88.1 mt-30 -67.35 -36.85 82.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.801 -179.983 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 92.8 mt -80.34 -41.85 24.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.012 -179.541 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.1 t -57.55 -44.58 85.3 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.134 -179.095 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.5 m -62.3 -45.65 92.28 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.801 0.334 . . . . 0.0 110.586 179.351 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 92.4 mt -62.49 -43.78 98.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.285 -179.772 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -170.19 163.86 6.13 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.451 179.869 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -43.58 111.32 0.23 Allowed 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.437 2.091 . . . . 0.0 112.076 179.539 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 17.3 m -85.78 127.79 34.64 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.57 179.951 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 34.4 tp -119.65 137.67 53.74 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.244 -0.435 . . . . 0.0 109.964 -179.702 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.433 ' O ' ' OD1' ' A' ' 32' ' ' ASP . 79.6 mt -104.58 119.92 54.21 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.432 0 CA-C-O 121.154 0.502 . . . . 0.0 111.416 -179.556 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 98.4 mt -135.3 133.03 52.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.665 179.676 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.512 HD22 ' CG ' ' A' ' 241' ' ' ASP . 60.6 t30 -64.98 150.31 48.24 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.861 0.362 . . . . 0.0 110.386 179.288 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.517 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 87.9 t80 -85.27 122.45 29.47 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.936 -179.531 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.517 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 99.0 m-20 55.48 68.86 0.8 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.954 179.76 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 36.0 p-10 -125.44 0.27 7.62 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.011 0.434 . . . . 0.0 110.816 179.851 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -150.69 115.57 5.27 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.748 -179.501 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 148' ' ' SER . . . . . 0.52 ' HG ' ' H ' ' A' ' 150' ' ' GLN . 85.0 p -63.28 168.26 4.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.49 -179.742 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.422 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.5 p-90 -51.48 -15.67 0.46 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.484 -179.836 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . 0.52 ' H ' ' HG ' ' A' ' 148' ' ' SER . 68.3 tp60 -70.84 -75.65 0.12 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.414 -179.703 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.455 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.1 t -62.59 -38.76 91.4 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.992 0.425 . . . . 0.0 110.297 179.529 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 53.6 tp -60.25 -45.53 92.96 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.324 -178.493 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.422 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 45.9 tp -62.76 -41.82 99.4 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.844 0.354 . . . . 0.0 110.311 179.03 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.455 ' OG1' ' O ' ' A' ' 151' ' ' SER . 58.8 p -64.01 -34.67 78.54 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.264 -179.507 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.444 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.5 mm-40 -64.03 -42.38 97.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.171 179.256 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 91.8 mt -65.24 -39.05 92.18 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.092 0.472 . . . . 0.0 110.172 179.071 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.582 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.04 -32.25 79.6 Favored Glycine 0 CA--C 1.52 0.352 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 -179.391 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.444 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.3 mt-10 -36.42 -25.38 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.888 0.375 . . . . 0.0 110.811 179.949 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.582 ' N ' ' O ' ' A' ' 157' ' ' GLY . 95.7 mt -59.16 149.29 6.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.171 179.382 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 77.5 p -69.14 137.47 53.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.074 -179.561 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 70.66 21.9 77.91 Favored Glycine 0 N--CA 1.458 0.157 0 N-CA-C 111.274 -0.731 . . . . 0.0 111.274 179.522 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 59.3 m80 -124.02 -14.63 7.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.757 0.313 . . . . 0.0 110.56 179.979 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -66.25 -59.76 3.43 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.774 -179.753 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -52.03 -48.96 64.27 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.278 -179.695 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -60.62 -41.11 94.18 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.76 0.314 . . . . 0.0 110.334 179.463 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.68 -47.11 86.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.633 179.817 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -57.1 -39.99 76.13 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.16 -179.85 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -61.8 -50.15 73.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.525 179.619 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -65.38 -43.77 89.67 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.417 179.554 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 95.1 mt -64.37 -43.53 97.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.421 179.718 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.29 -50.87 71.55 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.639 -179.169 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.79 -43.7 95.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.32 179.727 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . 0.486 ' CD1' ' OH ' ' A' ' 301' ' ' TYR . 56.6 t80 -62.58 -44.62 95.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.026 0.441 . . . . 0.0 110.425 179.373 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -63.4 -39.93 95.82 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.475 -179.204 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -62.85 -42.81 99.89 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.664 179.248 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -60.8 -44.68 96.53 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.069 -179.992 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 84.9 mt -64.29 -41.22 96.99 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.043 0.449 . . . . 0.0 110.681 178.862 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.15 -62.25 1.76 Allowed 'General case' 0 C--O 1.237 0.44 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.487 -179.382 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.64 -46.71 86.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.51 179.86 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.43 -41.67 66.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.135 -179.931 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -63.71 -33.88 76.64 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.07 0.462 . . . . 0.0 110.407 179.336 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . 0.403 ' HG2' ' O ' ' A' ' 182' ' ' GLU . 69.6 tt0 -90.31 8.42 33.47 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-O 121.387 0.613 . . . . 0.0 110.619 -179.078 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -104.31 -32.32 9.13 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-O 120.932 0.396 . . . . 0.0 111.359 179.546 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 43.9 pt -127.88 147.53 32.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.915 -179.902 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -139.83 131.03 26.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.296 179.478 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.554 ' CD2' ' N ' ' A' ' 186' ' ' LEU . 3.6 mm? -85.63 133.46 41.86 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.841 179.922 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -44.28 158.06 0.15 Allowed 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.738 2.292 . . . . 0.0 112.061 179.48 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . 0.527 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.7 Cg_endo -62.9 114.97 2.65 Favored 'Trans proline' 0 C--N 1.303 -1.828 0 C-N-CA 122.747 2.298 . . . . 0.0 111.776 179.801 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . 0.527 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.8 mt-30 155.39 148.14 0.0 OUTLIER Pre-proline 0 N--CA 1.454 -0.247 0 O-C-N 123.552 0.533 . . . . 0.0 110.772 -179.799 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -74.11 144.5 33.8 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.685 2.257 . . . . 0.0 111.777 178.185 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.498 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.1 p -125.31 158.86 33.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.271 0.557 . . . . 0.0 110.067 -179.89 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 192' ' ' THR . . . . . 0.498 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 35.4 p -143.53 165.58 27.19 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.094 -179.653 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -135.66 128.62 31.39 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.212 0.53 . . . . 0.0 110.244 179.625 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 47.1 pt -146.38 148.96 16.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.137 179.732 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 70.4 t -117.87 123.14 71.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 121.263 0.554 . . . . 0.0 109.594 179.254 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 58.8 t80 -134.37 107.32 7.55 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.32 179.688 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 94.8 m -131.02 130.72 43.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.896 179.784 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.411 ' O ' ' N ' ' A' ' 201' ' ' HIS . . . -83.04 -37.09 24.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.252 179.741 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.44 -67.15 0.25 Allowed 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.332 179.996 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.1 -9.73 58.81 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.306 179.523 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . 0.411 ' N ' ' O ' ' A' ' 198' ' ' ALA . 60.1 t-80 60.52 58.36 2.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.825 -179.835 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 42.0 p -167.2 153.53 8.12 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.444 179.558 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.27 143.81 24.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.962 0.41 . . . . 0.0 110.372 179.449 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -135.18 138.34 43.56 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.691 179.939 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 20.3 mt -106.34 125.43 50.99 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 121.119 0.485 . . . . 0.0 109.745 -179.682 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 206' ' ' TRP . . . . . 0.557 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 74.3 m95 -81.96 166.83 19.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.666 -179.796 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -156.78 171.87 6.86 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 120.971 0.415 . . . . 0.0 110.562 -179.213 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -54.02 -37.2 86.28 Favored 'Trans proline' 0 C--N 1.303 -1.839 0 C-N-CA 122.637 2.224 . . . . 0.0 111.954 179.465 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -70.46 -34.96 73.01 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.953 -179.916 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 22.2 m -61.02 150.88 32.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.569 -179.351 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.66 -36.86 82.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.462 -179.709 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . 0.557 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 55.2 tt0 -64.77 -40.37 95.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.529 179.957 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.72 -43.32 92.13 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 179.759 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -63.4 -43.9 96.2 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.95 -0.3 . . . . 0.0 110.219 179.879 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 65.0 ttp -59.73 -47.88 83.91 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.199 -179.753 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 86.7 mt -60.65 -40.62 92.69 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 179.531 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . 0.456 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.5 tp10 -58.36 -37.88 76.11 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.77 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -65.21 -38.3 90.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.811 0.339 . . . . 0.0 110.648 179.696 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 94.2 mt -64.25 -42.56 96.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.554 -179.557 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.36 45.1 0.08 OUTLIER Glycine 0 C--N 1.334 0.417 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 -179.943 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . 0.456 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 26.6 m-85 -127.99 155.41 44.32 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.012 0.434 . . . . 0.0 110.527 -179.812 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 222' ' ' THR . . . . . 0.454 ' O ' ' O ' ' A' ' 191' ' ' VAL . 6.8 p -107.06 122.31 46.22 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.093 0.473 . . . . 0.0 110.2 -179.899 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . 0.444 ' CD2' ' N ' ' A' ' 223' ' ' LEU . 4.3 mm? -101.33 132.81 46.7 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.107 179.967 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.64 159.79 14.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.52 179.86 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.57 115.21 29.86 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.328 179.902 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.45 ' CD1' ' N ' ' A' ' 226' ' ' LEU . 9.1 mp -53.22 156.86 3.54 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.584 179.926 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -60.31 145.38 98.71 Favored 'Trans proline' 0 C--N 1.301 -1.931 0 C-N-CA 122.627 2.218 . . . . 0.0 112.012 179.379 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.3 -3.26 59.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.559 -179.98 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.15 -40.99 5.66 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 -179.859 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.532 ' O ' ' N ' ' A' ' 233' ' ' SER . 85.5 mt -79.18 -17.15 55.47 Favored 'General case' 0 C--O 1.223 -0.316 0 CA-C-O 120.934 0.397 . . . . 0.0 110.301 -179.721 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . 0.401 ' C ' ' O ' ' A' ' 230' ' ' LEU . 54.7 t-20 -40.38 -49.21 2.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.756 -179.527 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -87.88 15.33 7.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.275 179.814 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 233' ' ' SER . . . . . 0.532 ' N ' ' O ' ' A' ' 230' ' ' LEU . 78.0 p -60.35 -35.48 75.77 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.523 -179.732 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . 0.527 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.7 tt0 -118.98 -69.12 0.87 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.917 0.389 . . . . 0.0 111.019 179.491 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.2 m -69.68 102.77 1.96 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.769 -179.882 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -94.27 57.45 2.33 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.341 -179.975 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -144.54 -122.63 1.6 Allowed Glycine 0 CA--C 1.52 0.359 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 179.994 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -135.13 111.53 9.79 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.082 0.468 . . . . 0.0 110.444 179.972 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . 0.519 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.7 mtt180 -148.05 57.88 1.09 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.723 -179.885 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -69.54 -32.27 70.98 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.522 179.65 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . 0.512 ' CG ' HD22 ' A' ' 143' ' ' ASN . 65.1 t0 -57.0 -46.97 81.9 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.41 -179.124 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 242' ' ' ILE . . . . . 0.437 ' O ' ' O ' ' A' ' 239' ' ' ARG . 17.7 tt -139.78 156.27 25.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.873 0.368 . . . . 0.0 110.541 179.777 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 96.2 mt -106.06 106.41 20.53 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.216 0 CA-C-O 121.233 0.54 . . . . 0.0 110.458 179.87 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . 0.519 ' OE1' ' NH1' ' A' ' 239' ' ' ARG . 88.2 mt-30 -110.19 109.85 20.48 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.329 179.75 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 9.4 mp -121.75 -168.47 1.7 Allowed 'General case' 0 C--O 1.224 -0.238 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.647 179.774 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . 0.527 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.81 -16.5 0.05 OUTLIER Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 179.892 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . 0.702 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -60.75 156.3 32.24 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 -179.858 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -63.48 21.76 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.001 0.429 . . . . 0.0 110.617 179.973 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . 0.702 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.7 m-20 -97.51 -5.85 34.99 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.554 179.961 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 93.6 mt -79.69 -22.16 43.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.647 179.486 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.64 -51.27 70.65 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.856 -179.543 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -87.96 -5.51 58.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.42 179.653 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.09 -74.33 1.15 Allowed Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 -179.959 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 81.4 mt -70.05 125.89 28.08 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.134 0.493 . . . . 0.0 110.104 -179.759 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -59.69 -39.29 84.08 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.266 -179.656 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 84.37 51.63 3.84 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 179.943 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -95.11 -15.62 23.24 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.698 0.285 . . . . 0.0 110.664 -179.917 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 258' ' ' SER . . . . . 0.422 ' O ' ' O ' ' A' ' 192' ' ' THR . 3.3 t 173.76 89.4 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.033 0.444 . . . . 0.0 110.085 179.979 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . 0.597 ' N ' ' CD1' ' A' ' 259' ' ' LEU . 1.0 OUTLIER -94.38 124.06 38.17 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-O 121.314 0.578 . . . . 0.0 111.144 -179.224 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 15.9 m-30 -93.04 146.72 23.42 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.378 179.269 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 86.3 mt -122.48 149.91 43.23 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.525 -179.921 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.661 ' CG ' ' N ' ' A' ' 263' ' ' ALA . 2.6 p90 -78.13 -138.64 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.422 -179.696 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . 0.661 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -51.69 77.62 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.995 -179.921 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . 0.636 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.35 104.46 0.19 Allowed Glycine 0 N--CA 1.468 0.781 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 -179.798 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 265' ' ' ASP . . . . . 0.605 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.6 m-20 -80.48 -177.56 6.27 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.718 0.294 . . . . 0.0 110.966 -179.594 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -40.68 -17.54 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.428 179.859 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . 0.605 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.59 -51.4 42.94 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 121.013 0.435 . . . . 0.0 110.782 179.487 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -63.8 -46.72 83.9 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.143 179.399 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . 0.527 ' O ' ' CD2' ' A' ' 273' ' ' TYR . . . -61.7 -35.08 77.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.767 179.646 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -62.93 -34.74 78.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.105 179.729 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.38 -43.1 13.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.409 -179.584 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 272' ' ' ILE . . . . . 0.619 ' C ' ' H ' ' A' ' 274' ' ' ALA . 4.9 tt -51.37 -33.65 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.838 -178.95 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 273' ' ' TYR . . . . . 0.527 ' CD2' ' O ' ' A' ' 269' ' ' ALA . 17.5 m-85 -54.33 -1.67 0.03 OUTLIER 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.742 -179.563 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 274' ' ' ALA . . . . . 0.619 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.94 -39.87 69.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.883 179.648 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . 0.586 ' O ' ' N ' ' A' ' 279' ' ' ALA . 4.3 p30 -38.94 97.53 0.14 Allowed Pre-proline 0 C--O 1.226 -0.168 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.582 -179.68 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 276' ' ' PRO . . . . . 0.402 ' N ' ' O ' ' A' ' 274' ' ' ALA . 45.7 Cg_exo -53.95 -43.15 60.68 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 C-N-CA 122.338 2.025 . . . . 0.0 112.756 -178.884 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 89.8 mt -64.39 -42.82 95.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.136 0.493 . . . . 0.0 111.235 -179.766 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 91.2 mt -95.99 -1.14 49.61 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.849 -179.439 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 279' ' ' ALA . . . . . 0.586 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.39 -34.91 77.65 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.647 -179.762 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -73.76 19.72 0.11 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.126 -179.38 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . 0.517 ' H ' ' C ' ' A' ' 279' ' ' ALA . 13.7 mt -75.2 120.84 83.52 Favored Pre-proline 0 N--CA 1.451 -0.391 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.351 179.99 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_exo -51.58 -39.11 66.05 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.633 2.222 . . . . 0.0 111.603 179.343 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.83 -50.38 63.81 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 179.818 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 79.5 t -61.84 -44.02 98.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 110.083 -0.339 . . . . 0.0 110.083 179.477 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -57.65 -41.6 81.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.301 -179.846 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -90.71 0.7 57.33 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.084 179.675 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt 58.59 41.57 22.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.115 0.483 . . . . 0.0 111.029 179.788 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -93.15 42.22 1.09 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.377 179.804 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 53.8 t -119.37 135.54 59.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 120.943 0.401 . . . . 0.0 110.223 -179.699 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -132.78 162.81 30.52 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.045 0.45 . . . . 0.0 110.703 -179.623 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.65 155.38 32.45 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.032 0.444 . . . . 0.0 110.743 -179.882 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 81.4 mt -94.37 -1.23 54.11 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.211 -179.699 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.1 165.01 12.54 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.634 -0.986 . . . . 0.0 110.634 -179.814 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 7.0 m -86.79 -62.04 1.6 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.804 0.335 . . . . 0.0 111.184 -179.95 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 295' ' ' GLU . . . . . 0.479 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.6 mm-40 -69.41 -4.07 16.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.697 -179.842 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 25.4 p -76.84 32.38 0.14 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.663 -179.887 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 297' ' ' PHE . . . . . 0.479 ' H ' ' C ' ' A' ' 295' ' ' GLU . 70.5 t80 -60.33 -46.06 91.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.607 -179.908 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . 0.614 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.4 mtt85 -81.08 134.93 35.75 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.581 -179.699 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 17.1 tp -114.24 118.07 32.92 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.152 179.898 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . 0.606 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.2 p-10 -165.69 -176.16 3.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.541 179.978 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 301' ' ' TYR . . . . . 0.486 ' OH ' ' CD1' ' A' ' 173' ' ' PHE . 84.5 t80 -47.17 -43.86 21.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.275 -179.675 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -66.6 -40.63 88.95 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.08 0.466 . . . . 0.0 110.833 179.116 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 303' ' ' SER . . . . . 0.606 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 60.8 p -55.71 -36.11 66.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.159 -179.263 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -57.49 -51.31 69.98 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.459 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 90.6 mtp -56.71 -43.52 80.64 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -179.993 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -66.49 -42.56 87.21 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.928 0.394 . . . . 0.0 110.16 178.796 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 55.6 t -64.02 -43.12 97.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.08 179.352 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 43.3 tp -59.66 -42.09 92.05 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.721 -179.409 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -62.72 -38.83 92.03 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 179.565 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 310' ' ' ARG . . . . . 0.446 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.6 ttt85 -63.66 -43.88 95.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.288 179.506 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 89.4 mt -63.21 -42.1 99.23 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.185 179.602 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -62.87 -33.59 75.6 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.993 179.445 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.65 -23.46 21.89 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.507 -179.836 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . 0.446 ' N ' ' O ' ' A' ' 310' ' ' ARG . 6.7 tt -62.32 -43.12 99.56 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 121.087 0.47 . . . . 0.0 110.629 -179.889 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 . . . . . 0 C--O 1.22 -0.457 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.462 179.897 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -99.6 136.04 40.12 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.47 -179.961 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.498 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -92.41 178.45 1.68 Allowed Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.539 -179.88 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.498 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.0 Cg_exo -61.76 147.39 95.39 Favored 'Trans proline' 0 C--N 1.3 -1.996 0 C-N-CA 122.752 2.302 . . . . 0.0 112.162 179.811 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 35.4 ptt180 -136.85 142.47 42.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.679 179.679 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -79.59 116.97 20.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.464 179.962 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.402 ' O ' ' CG2' ' A' ' 30' ' ' ILE . 9.5 tp -111.48 130.25 65.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.46 -179.956 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 13.5 t -71.4 142.13 50.32 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.527 179.811 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.53 ' CG ' ' H ' ' A' ' 33' ' ' SER . 42.8 t0 -139.09 -179.56 5.92 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.629 -179.937 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.53 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 78.0 p -74.15 -37.13 64.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.755 179.863 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.7 ttt85 -47.07 -94.9 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.382 -179.521 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.415 ' O ' ' OG1' ' A' ' 36' ' ' THR . . . -165.65 -27.15 0.02 OUTLIER Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 179.92 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.415 ' OG1' ' O ' ' A' ' 35' ' ' GLY . 67.6 m -168.43 105.9 0.46 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.859 0.361 . . . . 0.0 110.635 -179.909 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 64.4 t60 -128.9 145.98 51.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.015 0.436 . . . . 0.0 110.267 179.896 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.484 ' CG2' ' N ' ' A' ' 39' ' ' LEU . 99.8 m -129.26 165.42 21.43 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.639 -179.915 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.484 ' N ' ' CG2' ' A' ' 38' ' ' THR . 79.6 mt -120.27 127.39 52.34 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.513 179.785 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -65.51 -44.57 86.6 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.619 -179.951 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.421 ' O ' ' HD3' ' A' ' 43' ' ' PRO . 41.6 p -166.0 154.93 11.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.443 179.719 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.467 ' N ' ' CD ' ' A' ' 42' ' ' GLN . 14.0 mp0 -45.43 101.71 0.27 Allowed Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.673 179.503 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.421 ' HD3' ' O ' ' A' ' 41' ' ' SER . 31.5 Cg_exo -57.71 130.12 37.03 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 C-N-CA 122.351 2.034 . . . . 0.0 112.233 -179.687 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -83.05 -24.68 32.67 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.448 179.631 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.536 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.9 mtm-85 -120.46 134.48 55.26 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-O 121.174 0.511 . . . . 0.0 110.28 -179.987 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 95.9 mt -129.97 133.46 64.48 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.271 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.979 -179.76 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 47.8 t -125.25 131.02 72.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.802 0.334 . . . . 0.0 110.11 179.329 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.505 ' O ' ' O ' ' A' ' 66' ' ' ALA . 4.2 m -154.72 166.31 33.84 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.606 179.81 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 65.8 p -124.85 8.23 8.12 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.483 179.931 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.1 t -85.2 125.8 33.15 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.68 -179.43 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 91.9 t -65.7 -44.52 93.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.51 -179.994 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.8 m -62.74 -44.32 96.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.664 -179.849 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 54.4 tp -62.19 -41.56 98.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.57 -179.536 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 72.1 m -57.72 -44.53 86.04 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.349 -179.397 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.31 -62.09 5.43 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.911 -0.876 . . . . 0.0 110.911 179.554 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.6 t -48.24 -35.76 12.63 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 -179.962 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 20.0 mt -61.77 -44.76 96.25 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.724 -0.391 . . . . 0.0 111.145 179.347 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.2 mp -64.88 -42.0 95.18 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.081 0.467 . . . . 0.0 111.287 178.035 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.59 -41.22 98.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.998 -179.288 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 7.9 tp -87.89 16.53 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.694 -179.662 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 56.58 84.3 0.09 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.575 -179.973 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.59 57.74 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.147 -179.808 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -50.13 152.55 7.73 Favored 'Trans proline' 0 C--N 1.297 -2.169 0 C-N-CA 122.834 2.356 . . . . 0.0 112.475 -178.297 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.428 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -108.93 146.34 14.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.417 -179.747 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 97.1 mt -63.85 -45.03 98.2 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.351 -179.762 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.505 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -130.26 134.48 47.26 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.677 -179.857 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.478 ' O ' ' N ' ' A' ' 98' ' ' LEU . 69.0 m -134.19 158.38 43.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.839 -179.62 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.5 139.18 16.38 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 179.804 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.469 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.91 -162.6 0.08 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.934 0.397 . . . . 0.0 110.495 -179.968 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.493 ' O ' ' C ' ' A' ' 71' ' ' THR . 14.6 t -133.55 135.88 44.61 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.394 -179.992 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.493 ' C ' ' O ' ' A' ' 70' ' ' THR . 0.0 OUTLIER 29.74 68.68 0.66 Allowed Pre-proline 0 N--CA 1.464 0.243 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.646 -179.843 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -60.9 145.23 99.35 Favored 'Trans proline' 0 C--N 1.3 -1.98 0 C-N-CA 122.643 2.229 . . . . 0.0 112.227 -178.73 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.527 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 45.6 p-10 -160.7 -32.59 0.05 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.686 179.659 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.527 ' N ' ' OD1' ' A' ' 73' ' ' ASN . 99.0 m-20 -63.88 -39.36 94.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.488 -179.972 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 73.2 ttt180 -60.56 -48.19 82.87 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.68 -179.405 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.418 ' O ' ' O ' ' A' ' 77' ' ' ALA . 93.6 t -59.91 -24.52 29.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 110.1 -0.334 . . . . 0.0 110.1 179.607 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.418 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -46.1 173.13 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.599 179.924 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.569 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.6 p30 -61.87 177.6 0.42 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.581 -179.738 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.603 ' C ' ' H ' ' A' ' 81' ' ' GLY . 35.9 p30 -46.02 85.95 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.887 -179.942 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.569 ' N ' ' O ' ' A' ' 78' ' ' ASP . 42.6 tp60 -66.92 13.48 0.06 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.143 -179.893 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.603 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 117.76 -22.04 10.16 Favored Glycine 0 CA--C 1.519 0.293 0 N-CA-C 110.994 -0.843 . . . . 0.0 110.994 179.957 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -107.62 116.47 32.0 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.99 0.424 . . . . 0.0 110.497 179.883 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 75.2 mt -98.73 0.67 45.0 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.46 -179.738 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -91.93 6.7 45.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.957 0.408 . . . . 0.0 110.41 -179.833 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.446 ' O ' ' CG2' ' A' ' 89' ' ' VAL . 88.4 mt-30 -99.67 -27.63 13.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.858 179.957 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 68.7 t-105 -63.34 -41.18 98.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.03 -179.619 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.556 ' O ' ' N ' ' A' ' 91' ' ' LYS . 65.8 m -77.42 -53.33 7.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.238 -179.317 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -48.57 -51.09 29.47 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.966 -179.28 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.446 ' CG2' ' O ' ' A' ' 85' ' ' GLN . 15.4 m -68.78 -40.74 81.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 120.903 0.383 . . . . 0.0 110.962 179.9 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.413 ' H ' HG23 ' A' ' 89' ' ' VAL . . . -71.9 -23.11 61.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.786 179.953 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.556 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.0 tttm -60.99 -45.82 93.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.498 -179.602 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.438 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.3 mm-40 -90.82 -94.68 0.12 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.08 179.981 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.634 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.9 mtt180 -143.23 60.03 1.4 Allowed 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.794 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.462 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.6 pttp 33.57 26.23 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.222 -179.048 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.634 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.4 tt -47.62 123.31 5.69 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.92 -178.253 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -83.44 -169.92 2.79 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.061 -179.997 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.613 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 82.3 mtp180 -73.61 138.03 44.6 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.166 -179.837 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.478 ' N ' ' O ' ' A' ' 67' ' ' SER . 89.8 mt -87.27 -165.93 1.43 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.717 -179.647 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.534 ' CD2' ' O ' ' A' ' 99' ' ' TYR . 48.2 p90 -168.46 120.2 0.81 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.32 179.933 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.513 ' C ' ' O ' ' A' ' 99' ' ' TYR . 43.6 mm -29.6 121.5 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.863 -179.63 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 114.22 27.94 3.24 Favored Glycine 0 CA--C 1.521 0.426 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 -179.557 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.582 ' N ' ' CD ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -144.17 46.04 0.6 Allowed Pre-proline 0 C--N 1.324 -0.541 0 CA-C-O 120.907 0.384 . . . . 0.0 110.465 179.903 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.582 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 31.0 Cg_endo -62.28 143.85 94.56 Favored 'Trans proline' 0 C--N 1.298 -2.126 0 C-N-CA 122.735 2.29 . . . . 0.0 111.996 179.932 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.705 ' HG ' ' H ' ' A' ' 107' ' ' ALA . 24.8 t -173.67 120.91 0.32 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.46 179.67 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.42 -41.11 63.68 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.012 0.434 . . . . 0.0 111.154 179.709 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -65.82 -40.16 91.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.856 -179.432 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.705 ' H ' ' HG ' ' A' ' 104' ' ' SER . . . -63.63 -39.77 95.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.708 -179.907 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 72.0 t -67.44 -43.82 87.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.683 179.584 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.18 -39.24 92.04 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.512 -179.233 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.438 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.75 -23.82 63.54 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.431 179.831 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.568 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.3 mm-40 -91.18 4.47 52.15 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.684 -179.574 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.568 ' C ' ' O ' ' A' ' 111' ' ' GLN . 10.4 tpt 22.11 64.56 0.32 Allowed Pre-proline 0 N--CA 1.464 0.266 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.992 -179.911 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -78.66 170.04 18.82 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 C-N-CA 122.972 2.448 . . . . 0.0 112.21 -178.66 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.522 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 99.1 m-20 -113.07 -44.78 3.23 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 121.065 0.46 . . . . 0.0 110.088 179.544 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 39.8 tp -119.91 119.57 33.87 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.514 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 94.7 mt -116.94 131.15 70.49 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 CA-C-O 120.954 0.407 . . . . 0.0 110.887 -179.807 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 31.6 mt -105.63 131.98 52.33 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 121.11 0.481 . . . . 0.0 110.125 -179.528 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 98.3 mt -117.55 135.94 56.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.79 -179.726 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 85.0 p -71.57 151.54 43.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.568 -179.944 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.13 -49.85 76.0 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.678 -179.763 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.0 t -149.4 153.93 38.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.587 179.76 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 168.19 -169.56 41.53 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.875 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.87 -35.73 92.41 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -179.971 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.446 ' O ' ' OD1' ' A' ' 124' ' ' ASP . 44.1 p-10 -87.96 120.04 28.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.782 0.325 . . . . 0.0 110.632 179.871 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 40.5 t -63.44 144.2 57.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.554 -179.956 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.518 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -94.02 -43.08 8.69 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.792 -179.814 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 56.1 tp -62.73 -42.37 99.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.562 -179.841 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.0 -10.52 54.21 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.531 -179.474 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 83.6 mt -116.02 -24.08 8.24 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.678 -179.89 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . 0.518 ' N ' ' O ' ' A' ' 126' ' ' ALA . 74.5 t80 -51.52 -49.55 61.71 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.456 -178.951 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.4 p-10 -65.87 -41.91 91.04 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.893 0.378 . . . . 0.0 111.163 179.607 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.526 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 87.7 mt-30 -67.85 -36.74 80.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.746 -179.905 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 95.9 mt -80.19 -42.45 23.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.955 -179.439 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.3 t -57.49 -44.94 85.35 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.355 -179.117 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.4 m -62.29 -45.95 90.94 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.639 179.409 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 92.2 mt -62.29 -43.79 98.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.325 -179.823 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -170.18 163.75 6.17 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.471 179.842 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -42.38 110.3 0.15 Allowed 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.571 2.181 . . . . 0.0 112.035 179.454 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.8 m -87.27 127.61 35.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.463 -179.927 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 34.1 tp -119.78 138.72 53.17 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.163 -179.818 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.436 ' O ' ' OD1' ' A' ' 32' ' ' ASP . 81.6 mt -105.29 120.04 55.35 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.348 0 CA-C-O 121.125 0.488 . . . . 0.0 111.233 -179.439 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 97.7 mt -135.42 132.73 52.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.721 179.577 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.495 HD22 ' CG ' ' A' ' 241' ' ' ASP . 59.7 t30 -64.49 148.3 50.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.875 0.369 . . . . 0.0 110.37 179.364 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.515 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 86.9 t80 -82.75 122.4 28.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.96 -179.471 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.515 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 99.0 m-20 55.08 69.41 0.73 Allowed 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.827 179.648 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 35.2 p-10 -125.71 0.69 7.46 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 120.906 0.384 . . . . 0.0 110.704 179.787 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -150.9 115.92 5.29 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.668 -179.511 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 148' ' ' SER . . . . . 0.5 ' HG ' ' H ' ' A' ' 150' ' ' GLN . 86.2 p -63.74 168.72 4.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.499 -179.805 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.423 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.3 p-90 -51.6 -15.96 0.54 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.62 -179.868 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . 0.5 ' H ' ' HG ' ' A' ' 148' ' ' SER . 67.9 tp60 -70.36 -76.05 0.11 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.521 -179.748 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.458 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.0 t -62.68 -38.5 90.61 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.339 179.481 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 52.3 tp -60.1 -45.51 92.69 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.401 -178.611 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.423 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 46.5 tp -62.83 -41.84 99.49 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.861 0.362 . . . . 0.0 110.411 178.995 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.458 ' OG1' ' O ' ' A' ' 151' ' ' SER . 59.2 p -63.72 -34.76 78.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.258 -179.566 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.471 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.9 mm-40 -63.98 -42.18 97.3 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.239 179.177 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 91.6 mt -65.42 -38.89 91.27 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.092 179.118 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.582 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.25 -32.42 80.62 Favored Glycine 0 CA--C 1.52 0.375 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 -179.366 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.471 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.1 mt-10 -36.34 -25.55 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.874 0.369 . . . . 0.0 110.791 -179.98 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.582 ' N ' ' O ' ' A' ' 157' ' ' GLY . 94.8 mt -59.35 149.5 6.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.231 179.473 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 74.8 p -69.09 137.07 53.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.049 -179.558 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 71.1 21.62 78.41 Favored Glycine 0 N--CA 1.459 0.194 0 N-CA-C 111.269 -0.732 . . . . 0.0 111.269 179.509 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 60.3 m80 -123.43 -15.45 7.13 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.746 0.307 . . . . 0.0 110.568 179.989 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -66.02 -59.87 3.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.715 -179.756 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -51.62 -49.09 62.9 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.238 -179.755 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -60.83 -41.07 95.04 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.723 0.297 . . . . 0.0 110.312 179.522 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.48 -47.51 85.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.613 179.745 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.64 -40.32 75.23 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.268 -179.921 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -61.66 -50.24 73.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.65 179.525 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -65.38 -43.76 89.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.476 179.495 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 95.1 mt -64.53 -43.41 96.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.52 179.728 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.23 -51.05 70.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.599 -179.308 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.79 -43.67 95.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.421 179.724 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . 0.501 ' CD1' ' OH ' ' A' ' 301' ' ' TYR . 57.3 t80 -62.69 -44.56 95.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.456 179.364 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -63.26 -40.04 96.28 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.527 -179.361 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -63.01 -42.77 99.92 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.624 179.277 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -60.64 -44.78 95.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.119 179.968 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 84.4 mt -64.29 -41.09 97.05 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.02 0.438 . . . . 0.0 110.674 178.956 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.18 -62.12 1.84 Allowed 'General case' 0 C--O 1.237 0.418 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.501 -179.387 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.78 -46.78 86.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.545 179.903 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.3 -41.72 65.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.149 179.974 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -63.72 -33.6 76.02 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.011 0.434 . . . . 0.0 110.415 179.227 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . 0.407 ' HG2' ' O ' ' A' ' 182' ' ' GLU . 69.8 tt0 -90.7 8.61 33.62 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.27 0.557 . . . . 0.0 110.528 -179.01 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -104.58 -32.25 9.03 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.188 179.595 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 45.1 pt -128.04 147.72 32.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.816 -179.803 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -139.76 130.88 26.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.375 179.418 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.555 ' CD2' ' N ' ' A' ' 186' ' ' LEU . 3.6 mm? -85.46 133.24 42.64 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.808 -179.947 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -44.01 157.81 0.14 Allowed 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.704 2.269 . . . . 0.0 112.088 179.46 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . 0.528 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.7 Cg_endo -63.01 114.74 2.57 Favored 'Trans proline' 0 C--N 1.303 -1.858 0 C-N-CA 122.751 2.3 . . . . 0.0 111.752 179.909 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . 0.528 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.8 mt-30 155.6 147.83 0.0 OUTLIER Pre-proline 0 C--N 1.331 -0.215 0 O-C-N 123.433 0.458 . . . . 0.0 110.725 -179.757 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -73.9 144.06 33.98 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.711 2.274 . . . . 0.0 111.771 178.189 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.497 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.1 p -124.92 159.03 32.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.261 0.553 . . . . 0.0 110.082 -179.975 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 192' ' ' THR . . . . . 0.497 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 37.7 p -143.55 165.31 27.94 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.069 -179.506 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -135.55 128.54 31.48 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.122 0.487 . . . . 0.0 110.258 179.704 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 47.5 pt -146.4 148.86 16.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.1 179.928 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 68.9 t -117.89 123.12 71.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.315 0.578 . . . . 0.0 109.7 179.098 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -134.26 107.36 7.62 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.309 179.745 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 94.2 m -131.13 130.53 43.21 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.802 179.871 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.417 ' O ' ' N ' ' A' ' 201' ' ' HIS . . . -82.9 -37.2 24.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.276 179.745 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.25 -67.12 0.25 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.364 179.978 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.15 -9.84 58.98 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.344 179.48 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . 0.417 ' N ' ' O ' ' A' ' 198' ' ' ALA . 60.0 t-80 60.85 58.16 2.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.601 -179.972 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 44.8 p -167.07 153.21 8.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.516 179.666 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.24 143.93 24.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.933 0.397 . . . . 0.0 110.426 179.532 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -135.31 138.51 43.5 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.644 -179.949 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 19.9 mt -106.45 125.42 50.98 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 121.112 0.482 . . . . 0.0 109.862 -179.721 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 206' ' ' TRP . . . . . 0.555 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 74.2 m95 -81.96 166.94 19.42 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.597 -179.713 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -157.05 171.41 7.49 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.56 -179.164 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -53.65 -37.13 83.38 Favored 'Trans proline' 0 C--N 1.303 -1.838 0 C-N-CA 122.664 2.242 . . . . 0.0 111.97 179.333 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -70.58 -35.08 72.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.844 -179.864 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 21.7 m -60.98 151.02 31.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.562 -179.31 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.81 -37.03 82.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.523 -179.767 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . 0.555 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 55.0 tt0 -64.64 -40.37 95.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.532 179.916 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.51 -43.34 92.55 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 179.846 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -63.31 -43.68 97.12 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.675 0.274 . . . . 0.0 110.283 179.851 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 65.3 ttp -59.65 -47.98 83.47 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.206 -179.773 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 88.1 mt -60.59 -40.8 93.07 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.531 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . 0.459 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.8 tp10 -58.25 -38.01 76.08 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.75 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -65.13 -38.23 89.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.808 0.337 . . . . 0.0 110.671 179.677 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 94.4 mt -64.33 -42.67 96.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.572 -179.616 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.5 44.93 0.08 OUTLIER Glycine 0 CA--C 1.521 0.429 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 -179.958 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . 0.459 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 26.4 m-85 -127.91 155.32 44.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.045 0.45 . . . . 0.0 110.507 -179.896 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 222' ' ' THR . . . . . 0.457 ' O ' ' O ' ' A' ' 191' ' ' VAL . 7.2 p -106.8 122.17 45.84 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.214 0.531 . . . . 0.0 110.202 -179.985 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . 0.444 ' CD2' ' N ' ' A' ' 223' ' ' LEU . 4.3 mm? -101.21 132.99 46.44 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.074 179.982 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.85 159.74 14.75 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.005 0.431 . . . . 0.0 110.504 179.86 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.75 115.25 29.92 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.382 179.93 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.462 ' CD1' ' N ' ' A' ' 226' ' ' LEU . 8.8 mp -52.94 156.62 3.33 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.662 179.952 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -60.47 145.45 98.71 Favored 'Trans proline' 0 C--N 1.302 -1.889 0 C-N-CA 122.68 2.253 . . . . 0.0 111.982 179.367 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.02 -3.42 59.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.57 179.994 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.04 -41.11 5.66 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 -179.884 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.537 ' O ' ' N ' ' A' ' 233' ' ' SER . 85.6 mt -79.3 -17.2 55.09 Favored 'General case' 0 C--O 1.224 -0.273 0 CA-C-O 121.037 0.446 . . . . 0.0 110.314 -179.696 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . 0.403 ' C ' ' O ' ' A' ' 230' ' ' LEU . 54.8 t-20 -40.23 -49.31 2.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.73 -179.642 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -87.86 15.35 7.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.828 0.347 . . . . 0.0 111.18 179.945 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 233' ' ' SER . . . . . 0.537 ' N ' ' O ' ' A' ' 230' ' ' LEU . 78.0 p -60.29 -35.54 75.79 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.594 -179.824 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . 0.526 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.5 tt0 -119.11 -69.29 0.86 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.898 179.643 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.2 m -69.28 103.23 1.9 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.612 -179.727 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -94.79 57.18 2.12 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.42 179.912 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -144.57 -122.84 1.62 Allowed Glycine 0 CA--C 1.522 0.48 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 -179.928 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -134.94 111.64 10.0 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.061 0.458 . . . . 0.0 110.423 -179.997 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . 0.523 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.6 mtt180 -148.04 58.16 1.1 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.731 -179.961 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -69.75 -32.03 70.32 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.568 179.571 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . 0.495 ' CG ' HD22 ' A' ' 143' ' ' ASN . 65.4 t0 -57.08 -46.93 82.14 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.373 -179.143 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 242' ' ' ILE . . . . . 0.435 ' O ' ' O ' ' A' ' 239' ' ' ARG . 18.1 tt -140.01 156.82 25.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.91 0.386 . . . . 0.0 110.492 179.712 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 96.2 mt -106.54 106.7 21.11 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.173 0 CA-C-O 121.177 0.513 . . . . 0.0 110.523 179.85 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . 0.523 ' OE1' ' NH1' ' A' ' 239' ' ' ARG . 88.2 mt-30 -110.47 110.12 20.75 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.311 179.817 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 9.3 mp -121.86 -168.44 1.7 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.601 179.911 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . 0.526 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.67 -16.47 0.05 OUTLIER Glycine 0 CA--C 1.524 0.628 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 179.876 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . 0.702 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -60.59 156.35 31.49 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 -179.885 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -63.42 21.38 0.01 OUTLIER 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.886 0.374 . . . . 0.0 110.626 179.883 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . 0.702 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.6 m-20 -97.29 -5.78 35.89 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.537 179.942 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 94.8 mt -79.66 -22.11 43.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.543 179.546 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.55 -51.32 70.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.796 -179.591 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.11 -5.68 58.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.476 179.679 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -80.96 -74.69 1.13 Allowed Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 -179.925 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 81.3 mt -69.89 125.97 28.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.069 0.461 . . . . 0.0 110.249 -179.82 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -59.19 -39.52 82.83 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.248 -179.662 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 83.21 51.82 4.02 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 179.903 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -96.04 -14.95 22.56 Favored 'General case' 0 C--N 1.333 -0.152 0 O-C-N 122.729 -0.277 . . . . 0.0 110.564 -179.843 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 258' ' ' SER . . . . . 0.425 ' O ' ' O ' ' A' ' 192' ' ' THR . 3.4 t 174.43 88.62 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.048 0.451 . . . . 0.0 110.169 -179.972 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . 0.597 ' N ' ' CD1' ' A' ' 259' ' ' LEU . 1.0 OUTLIER -94.05 123.93 37.74 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.227 0.537 . . . . 0.0 111.11 -179.159 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 16.0 m-30 -92.93 146.7 23.43 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.337 179.221 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 85.7 mt -122.53 149.9 43.29 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.521 -179.868 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.662 ' CG ' ' N ' ' A' ' 263' ' ' ALA . 2.6 p90 -77.57 -138.47 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.552 -179.865 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . 0.662 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -52.16 77.73 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.922 179.957 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . 0.632 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.16 104.46 0.19 Allowed Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 -179.936 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 265' ' ' ASP . . . . . 0.609 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.8 m-20 -80.49 -177.64 6.31 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.749 0.309 . . . . 0.0 110.841 -179.468 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -40.48 -17.54 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.506 179.8 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . 0.609 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.63 -51.59 40.52 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.687 179.516 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -63.71 -46.67 84.38 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.187 179.382 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . 0.523 ' O ' ' CD2' ' A' ' 273' ' ' TYR . . . -61.64 -35.04 76.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.845 179.52 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -63.05 -34.53 77.78 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.111 179.744 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.37 -43.21 13.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.261 -179.577 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 272' ' ' ILE . . . . . 0.618 ' C ' ' H ' ' A' ' 274' ' ' ALA . 4.9 tt -51.39 -33.81 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.811 -178.802 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 273' ' ' TYR . . . . . 0.523 ' CD2' ' O ' ' A' ' 269' ' ' ALA . 17.2 m-85 -54.27 -1.76 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.655 -179.628 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 274' ' ' ALA . . . . . 0.618 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.87 -39.41 69.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.844 179.686 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . 0.582 ' O ' ' N ' ' A' ' 279' ' ' ALA . 2.9 p30 -39.63 98.28 0.16 Allowed Pre-proline 0 C--N 1.333 -0.141 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.513 -179.671 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -54.02 -43.17 60.61 Favored 'Trans proline' 0 C--N 1.302 -1.874 0 C-N-CA 122.411 2.074 . . . . 0.0 112.613 -178.855 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 88.9 mt -64.47 -42.83 95.69 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.137 0.494 . . . . 0.0 111.218 -179.625 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 89.7 mt -95.67 -1.54 49.9 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.875 -179.47 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 279' ' ' ALA . . . . . 0.582 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.42 -34.65 77.17 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.646 -179.807 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.45 20.04 0.12 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.024 -179.226 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . 0.508 ' H ' ' C ' ' A' ' 279' ' ' ALA . 13.9 mt -75.32 120.52 82.06 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.394 179.968 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -51.36 -39.23 63.56 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 122.625 2.217 . . . . 0.0 111.676 179.312 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.9 -50.42 63.93 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.09 179.878 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 75.2 t -61.48 -43.93 97.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 179.502 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -57.67 -41.27 81.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.317 -179.981 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -91.14 0.45 57.53 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.123 179.599 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt 59.06 43.25 17.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.042 0.448 . . . . 0.0 110.928 179.67 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -94.59 41.43 1.09 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.399 179.793 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 53.4 t -118.85 135.86 57.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.031 0.443 . . . . 0.0 110.166 -179.707 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -133.01 162.8 30.73 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.706 -179.637 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.94 155.19 33.24 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.988 0.423 . . . . 0.0 110.701 -179.743 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 80.4 mt -93.95 -1.36 54.76 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.364 -179.794 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.26 165.89 12.78 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 110.65 -0.98 . . . . 0.0 110.65 -179.747 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 6.9 m -87.75 -62.26 1.54 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.889 0.376 . . . . 0.0 111.124 -179.922 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 295' ' ' GLU . . . . . 0.475 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.7 mm-40 -69.48 -3.78 16.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.569 -179.729 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 27.6 p -76.74 32.8 0.14 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.698 -179.963 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 297' ' ' PHE . . . . . 0.475 ' H ' ' C ' ' A' ' 295' ' ' GLU . 85.5 t80 -60.21 -45.92 91.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.677 179.995 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . 0.613 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.1 mtt85 -81.54 134.23 35.48 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.592 -179.68 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 16.6 tp -114.04 118.35 33.84 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.115 179.969 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . 0.609 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.7 p-10 -165.8 -175.96 3.66 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.526 -179.934 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 301' ' ' TYR . . . . . 0.501 ' OH ' ' CD1' ' A' ' 173' ' ' PHE . 83.0 t80 -47.34 -44.04 23.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.194 -179.639 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -66.33 -40.76 90.1 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.013 0.435 . . . . 0.0 110.776 179.05 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 303' ' ' SER . . . . . 0.609 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 57.6 p -55.72 -36.17 66.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.168 -179.334 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -57.35 -51.68 68.43 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.439 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 91.1 mtp -56.15 -43.59 78.42 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.778 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -66.54 -42.49 87.11 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.912 0.387 . . . . 0.0 110.167 178.821 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 55.9 t -64.13 -42.86 96.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.179 179.305 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 43.5 tp -59.68 -42.14 92.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.88 -179.588 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -62.54 -39.15 92.67 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.112 179.494 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 310' ' ' ARG . . . . . 0.438 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.5 ttt85 -63.45 -43.99 95.77 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.293 179.445 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 88.9 mt -63.34 -42.13 98.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.226 179.566 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.4 ttmt -62.84 -33.26 74.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.068 0.461 . . . . 0.0 110.108 179.485 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.84 -23.46 21.67 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.579 -179.942 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . 0.438 ' N ' ' O ' ' A' ' 310' ' ' ARG . 6.7 tt -62.39 -43.17 99.47 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.547 -179.894 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 . . . . . 0 C--O 1.219 -0.502 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.498 179.989 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -99.67 135.97 40.29 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.047 0.451 . . . . 0.0 110.485 -179.962 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.497 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.2 OUTLIER -91.64 178.43 1.76 Allowed Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.601 -179.87 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.497 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.6 Cg_exo -61.73 147.73 94.65 Favored 'Trans proline' 0 C--N 1.3 -1.987 0 C-N-CA 122.755 2.303 . . . . 0.0 112.118 179.708 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 35.4 ptt180 -135.48 142.34 45.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.618 179.797 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -78.95 116.84 19.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.576 179.953 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.6 tp -110.17 130.86 62.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.436 -179.998 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 13.2 t -70.69 142.3 51.53 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.614 179.839 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 141' ' ' ILE . 25.2 t70 -140.25 177.56 7.9 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.481 -179.939 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.455 ' OG ' ' O ' ' A' ' 141' ' ' ILE . 77.9 p -74.13 -36.33 64.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.529 -179.945 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -47.69 -94.96 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.347 -179.606 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.421 ' O ' ' OG1' ' A' ' 36' ' ' THR . . . -165.46 -25.83 0.02 OUTLIER Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 179.892 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.421 ' OG1' ' O ' ' A' ' 35' ' ' GLY . 59.0 m -168.84 106.96 0.44 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.846 0.355 . . . . 0.0 110.689 -179.96 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 35.5 t60 -129.57 144.77 51.42 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.012 0.434 . . . . 0.0 110.224 179.885 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.482 ' CG2' ' N ' ' A' ' 39' ' ' LEU . 97.4 m -128.95 166.24 19.53 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.582 -179.76 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.482 ' N ' ' CG2' ' A' ' 38' ' ' THR . 81.9 mt -121.04 127.48 51.76 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.486 179.738 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -64.05 -44.55 92.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.618 -179.829 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 40.7 p -165.68 154.75 11.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.463 179.719 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.456 ' N ' ' CD ' ' A' ' 42' ' ' GLN . 14.4 mp0 -43.36 100.86 0.23 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.595 179.61 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -57.03 128.95 31.95 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.384 2.056 . . . . 0.0 112.29 -179.637 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -83.34 -24.54 32.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.551 179.6 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.541 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.7 mtm-85 -121.03 134.43 55.29 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 121.095 0.474 . . . . 0.0 110.294 -179.985 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.0 mt -130.23 133.35 64.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.943 -179.746 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 45.9 t -124.9 131.13 73.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.817 0.341 . . . . 0.0 110.156 179.334 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.496 ' O ' ' O ' ' A' ' 66' ' ' ALA . 4.8 m -154.55 166.32 33.7 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.543 179.881 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 72.0 p -124.56 8.55 8.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.519 179.856 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.699 ' HG ' ' H ' ' A' ' 53' ' ' LEU . 1.3 t -85.73 125.33 33.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.579 -179.485 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 96.4 t -65.66 -44.46 93.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.544 179.961 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.7 m -62.48 -44.36 96.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.57 -179.841 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.699 ' H ' ' HG ' ' A' ' 50' ' ' SER . 46.3 tp -62.41 -41.3 98.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.516 -179.441 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 73.7 m -57.59 -44.57 85.48 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.451 -179.326 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.43 -62.3 5.22 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 179.602 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.6 t -48.14 -35.78 12.19 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 179.807 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.5 mt -61.66 -44.79 96.29 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.038 179.474 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.1 mp -64.96 -41.81 95.15 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.164 178.114 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.48 -41.49 98.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.921 -179.164 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.1 tp -87.9 16.94 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.711 -179.574 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 56.58 84.01 0.09 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.646 179.999 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.74 58.2 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.106 -179.803 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -50.84 152.6 9.6 Favored 'Trans proline' 0 C--N 1.298 -2.121 0 C-N-CA 122.832 2.355 . . . . 0.0 112.485 -178.264 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.431 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -108.99 145.74 15.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.348 -179.63 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.86 -45.17 97.78 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.3 -179.671 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.496 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -129.85 134.53 47.59 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.598 -179.713 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.5 ' O ' ' N ' ' A' ' 98' ' ' LEU . 75.3 m -134.83 158.79 43.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.788 -179.605 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -87.07 139.45 16.19 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.752 -0.939 . . . . 0.0 110.752 179.753 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.465 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.98 -162.49 0.08 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.931 0.396 . . . . 0.0 110.481 -179.921 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.496 ' O ' ' C ' ' A' ' 71' ' ' THR . 14.6 t -133.67 135.35 44.03 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.353 179.942 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.496 ' C ' ' O ' ' A' ' 70' ' ' THR . 0.1 OUTLIER 29.58 68.54 0.65 Allowed Pre-proline 0 N--CA 1.463 0.222 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.705 -179.824 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -60.98 145.11 99.55 Favored 'Trans proline' 0 C--N 1.301 -1.963 0 C-N-CA 122.626 2.218 . . . . 0.0 112.155 -178.525 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.528 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 45.2 p-10 -159.54 -32.3 0.06 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.645 179.723 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.528 ' N ' ' OD1' ' A' ' 73' ' ' ASN . 99.1 m-20 -64.12 -39.45 94.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.464 -179.992 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -60.49 -48.49 81.54 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.646 -179.284 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.424 ' O ' ' O ' ' A' ' 77' ' ' ALA . 92.8 t -59.68 -24.92 30.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.091 179.697 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.424 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -45.54 172.32 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.567 179.869 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.574 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.6 p30 -61.74 177.77 0.39 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.546 -179.732 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.597 ' C ' ' H ' ' A' ' 81' ' ' GLY . 35.6 p30 -45.92 85.8 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.847 179.98 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.574 ' N ' ' O ' ' A' ' 78' ' ' ASP . 42.8 tp60 -67.31 13.62 0.06 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.192 -179.983 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.597 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 117.93 -22.14 9.99 Favored Glycine 0 CA--C 1.52 0.364 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 179.969 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -107.62 116.39 31.87 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.932 0.396 . . . . 0.0 110.513 179.911 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 74.4 mt -98.84 0.86 45.13 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.473 -179.713 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -92.18 6.62 45.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.42 -179.811 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.451 ' O ' ' CG2' ' A' ' 89' ' ' VAL . 88.1 mt-30 -100.0 -27.41 13.59 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.85 179.971 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.6 t-105 -63.89 -40.74 97.23 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.981 -179.628 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.556 ' O ' ' N ' ' A' ' 91' ' ' LYS . 68.1 m -77.75 -53.84 7.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.225 -179.496 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -48.02 -50.77 26.64 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.908 -179.249 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.451 ' CG2' ' O ' ' A' ' 85' ' ' GLN . 15.4 m -69.07 -40.97 81.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 120.909 0.385 . . . . 0.0 110.922 179.955 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.414 ' H ' HG23 ' A' ' 89' ' ' VAL . . . -71.93 -22.89 61.41 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.71 -179.873 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.556 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.0 tttm -61.54 -45.91 92.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.482 -179.535 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.439 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.4 mm-40 -90.25 -94.57 0.12 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.151 -179.997 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.624 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.8 mtt180 -143.54 59.96 1.39 Allowed 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.734 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.466 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.7 pttp 33.32 27.1 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.338 -179.029 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.624 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.5 tt -48.55 123.12 6.24 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.915 -178.328 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -83.6 -170.38 3.03 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.227 179.863 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.613 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 81.6 mtp180 -73.31 137.84 45.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.297 -179.847 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.5 ' N ' ' O ' ' A' ' 67' ' ' SER . 88.6 mt -86.09 -166.66 1.6 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.725 -179.584 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.528 ' CD2' ' O ' ' A' ' 99' ' ' TYR . 47.4 p90 -166.77 119.9 1.01 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.302 179.984 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.512 ' C ' ' O ' ' A' ' 99' ' ' TYR . 43.7 mm -29.75 121.15 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.865 -179.6 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 113.43 28.93 3.1 Favored Glycine 0 CA--C 1.522 0.492 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 -179.66 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.582 ' N ' ' CD ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -144.25 46.12 0.61 Allowed Pre-proline 0 C--N 1.325 -0.493 0 CA-C-O 120.922 0.391 . . . . 0.0 110.456 179.934 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.582 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 30.2 Cg_endo -62.01 143.72 95.45 Favored 'Trans proline' 0 C--N 1.299 -2.079 0 C-N-CA 122.733 2.289 . . . . 0.0 112.018 -179.985 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.693 ' HG ' ' H ' ' A' ' 107' ' ' ALA . 26.1 t -173.36 120.7 0.34 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.454 179.712 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.76 -41.0 63.06 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.056 179.767 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -65.86 -40.26 91.5 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.831 -179.383 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.693 ' H ' ' HG ' ' A' ' 104' ' ' SER . . . -63.97 -40.01 95.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.688 -179.777 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 70.7 t -67.39 -43.85 87.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.735 179.676 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.53 -39.22 92.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.577 -179.329 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.439 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.29 -23.49 62.46 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.521 179.81 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.557 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.4 mm-40 -91.25 5.08 50.55 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.698 -179.552 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.557 ' C ' ' O ' ' A' ' 111' ' ' GLN . 10.2 tpt 22.81 64.59 0.35 Allowed Pre-proline 0 N--CA 1.465 0.288 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.879 -179.85 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -78.98 169.27 19.59 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 C-N-CA 122.975 2.45 . . . . 0.0 112.223 -178.684 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.464 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 98.8 m-20 -113.44 -44.08 3.26 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.148 179.43 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.7 tp -120.24 120.92 37.52 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.001 179.432 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 96.7 mt -118.49 131.07 72.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.795 -179.705 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 32.4 mt -106.1 132.76 51.79 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.127 0.489 . . . . 0.0 110.298 -179.502 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 98.0 mt -118.17 136.57 54.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.687 -179.753 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 87.0 p -72.07 153.47 41.7 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.566 -179.938 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.34 -50.27 74.27 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.689 -179.888 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.0 t -149.31 153.74 37.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.51 179.785 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 169.58 -169.99 42.4 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 179.89 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -63.08 -35.14 91.69 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 179.922 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.453 ' O ' ' OD1' ' A' ' 124' ' ' ASP . 44.6 p-10 -88.05 119.86 28.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.843 0.354 . . . . 0.0 110.679 179.897 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 37.0 t -63.4 144.53 56.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.445 -179.914 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.523 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.23 -43.43 8.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.936 -179.997 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.7 tp -62.86 -42.3 99.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.655 -179.864 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.48 -11.08 57.03 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.52 -179.519 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 84.4 mt -116.08 -24.07 8.21 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.642 -179.775 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . 0.523 ' N ' ' O ' ' A' ' 126' ' ' ALA . 79.3 t80 -51.12 -50.18 59.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.587 -179.154 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.5 p-10 -65.82 -42.16 90.95 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.906 0.384 . . . . 0.0 111.133 179.716 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.504 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 87.7 mt-30 -67.55 -36.85 81.76 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.698 -179.882 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 93.7 mt -80.61 -42.0 22.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.952 -179.543 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.3 t -57.03 -44.87 83.32 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.283 -179.279 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.5 m -62.32 -45.78 91.66 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.812 0.339 . . . . 0.0 110.615 179.42 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 92.8 mt -62.34 -43.81 98.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.35 -179.765 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -170.07 162.85 6.52 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.573 179.811 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -42.71 110.88 0.18 Allowed 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.562 2.175 . . . . 0.0 112.1 179.554 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 16.7 m -85.77 127.79 34.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.632 179.968 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 35.6 tp -119.77 139.06 52.9 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.127 179.974 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.455 ' O ' ' OG ' ' A' ' 33' ' ' SER . 78.6 mt -105.65 120.78 57.0 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 CA-C-O 121.088 0.47 . . . . 0.0 111.071 -179.275 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 96.4 mt -136.33 133.05 49.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.597 179.522 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.473 HD22 ' CG ' ' A' ' 241' ' ' ASP . 61.4 t30 -64.26 151.19 44.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.939 0.399 . . . . 0.0 110.4 179.468 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.517 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 89.3 t80 -86.38 122.94 31.05 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.805 -179.484 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.517 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 99.1 m-20 55.12 69.5 0.73 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.841 179.648 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 42.8 p-10 -127.54 1.06 6.22 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.917 0.389 . . . . 0.0 110.617 -179.956 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -150.45 114.76 5.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.718 -179.643 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 148' ' ' SER . . . . . 0.517 ' HG ' ' H ' ' A' ' 150' ' ' GLN . 83.4 p -63.44 168.44 4.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.517 -179.803 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.414 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.6 p-90 -52.13 -15.66 0.63 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.599 -179.858 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . 0.517 ' H ' ' HG ' ' A' ' 148' ' ' SER . 68.1 tp60 -70.62 -76.17 0.11 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.507 -179.801 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.451 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.0 t -62.79 -38.55 91.07 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.309 179.584 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 53.2 tp -59.82 -45.79 91.26 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.459 -178.636 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.414 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 46.7 tp -62.77 -41.72 99.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.431 179.051 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.451 ' OG1' ' O ' ' A' ' 151' ' ' SER . 60.4 p -63.96 -34.87 78.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.311 -179.633 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.461 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.6 mm-40 -63.89 -42.34 97.48 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.277 179.266 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 92.4 mt -65.45 -38.81 90.94 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.949 0.404 . . . . 0.0 110.215 179.027 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.579 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.32 -31.89 78.85 Favored Glycine 0 CA--C 1.521 0.442 0 N-CA-C 110.829 -0.908 . . . . 0.0 110.829 -179.428 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.461 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.3 mt-10 -36.62 -25.53 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.87 0.367 . . . . 0.0 110.814 179.976 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.579 ' N ' ' O ' ' A' ' 157' ' ' GLY . 93.9 mt -59.02 150.63 5.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.288 179.464 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 73.5 p -69.26 137.2 52.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.922 -179.435 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 69.88 22.98 77.17 Favored Glycine 0 CA--C 1.517 0.197 0 N-CA-C 111.226 -0.75 . . . . 0.0 111.226 179.408 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 61.4 m80 -124.0 -13.92 7.22 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.717 0.294 . . . . 0.0 110.576 179.91 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -67.13 -59.53 3.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.764 -179.71 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -51.49 -49.59 61.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.261 -179.718 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -60.08 -41.31 92.15 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.732 0.301 . . . . 0.0 110.374 179.484 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.44 -47.61 84.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.596 179.85 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.57 -40.25 74.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.297 -179.901 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -61.46 -50.32 73.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.621 179.613 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -65.65 -43.61 88.87 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.477 179.6 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 94.6 mt -64.46 -43.51 96.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.46 179.747 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.38 -51.31 69.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.616 -179.269 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.8 -44.18 94.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.49 179.686 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . 0.526 ' CD1' ' OH ' ' A' ' 301' ' ' TYR . 55.1 t80 -62.76 -44.38 96.34 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.494 179.458 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -63.3 -40.0 96.13 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.621 -179.434 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -62.89 -42.74 99.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.677 179.231 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -60.78 -44.89 96.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.148 179.936 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 85.6 mt -64.6 -41.08 96.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.053 0.454 . . . . 0.0 110.771 178.887 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.04 -61.95 1.94 Allowed 'General case' 0 C--O 1.236 0.38 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.558 -179.415 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.83 -46.75 86.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.484 179.825 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.24 -41.41 65.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.268 -179.968 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -64.18 -33.78 76.57 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.958 0.409 . . . . 0.0 110.391 179.282 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . 0.407 ' HG2' ' O ' ' A' ' 182' ' ' GLU . 69.4 tt0 -90.74 9.04 31.58 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.255 0.55 . . . . 0.0 110.575 -179.018 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -104.94 -32.19 8.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.045 179.746 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.4 pt -128.22 147.86 32.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.799 -179.773 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -140.05 131.1 26.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.398 179.385 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.559 ' CD2' ' N ' ' A' ' 186' ' ' LEU . 3.6 mm? -85.54 133.9 41.16 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.789 179.99 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -44.15 157.99 0.14 Allowed 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.773 2.315 . . . . 0.0 112.055 179.363 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . 0.535 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.9 Cg_endo -63.02 114.84 2.61 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 C-N-CA 122.774 2.316 . . . . 0.0 111.786 179.783 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . 0.535 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.7 mt-30 155.36 148.15 0.0 OUTLIER Pre-proline 0 N--CA 1.455 -0.186 0 O-C-N 123.461 0.476 . . . . 0.0 110.67 -179.809 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -73.61 144.22 35.34 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.738 2.292 . . . . 0.0 111.861 178.001 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.498 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.1 p -124.99 158.95 32.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.232 0.539 . . . . 0.0 110.165 -179.979 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 192' ' ' THR . . . . . 0.498 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 38.5 p -143.51 165.13 28.43 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.01 -179.427 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -135.45 128.53 31.65 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.109 0.48 . . . . 0.0 110.231 179.543 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 47.7 pt -146.27 148.39 17.15 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.04 -179.945 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 72.2 t -117.28 123.09 71.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.21 0.529 . . . . 0.0 109.909 178.962 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -134.13 107.4 7.7 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.296 179.674 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 94.5 m -130.95 130.42 43.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.853 179.797 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -82.76 -36.95 25.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.324 179.668 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.55 -67.39 0.24 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.422 179.942 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -71.93 -9.97 59.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.314 179.515 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 59.7 t-80 60.85 58.34 2.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.738 -179.877 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 39.7 p -167.18 153.39 8.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.594 179.596 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.24 144.08 24.47 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.987 0.422 . . . . 0.0 110.496 179.433 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -135.41 138.43 43.25 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.583 -179.914 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 20.1 mt -106.16 125.33 50.86 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 121.074 0.464 . . . . 0.0 109.926 -179.758 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 206' ' ' TRP . . . . . 0.569 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 74.7 m95 -81.82 166.82 19.65 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.623 -179.81 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -156.47 172.35 6.2 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.615 -179.244 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -54.42 -37.29 89.39 Favored 'Trans proline' 0 C--N 1.303 -1.825 0 C-N-CA 122.716 2.277 . . . . 0.0 112.015 179.297 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -70.45 -34.68 72.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.765 -179.75 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 21.6 m -61.5 150.57 35.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.586 -179.357 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.41 -36.47 80.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.471 -179.75 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . 0.569 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 54.2 tt0 -64.46 -40.81 96.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.543 179.908 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.61 -43.47 92.04 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 179.837 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -63.23 -44.14 96.09 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.761 0.315 . . . . 0.0 110.295 179.658 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 65.1 ttp -59.61 -48.0 83.39 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.314 -179.879 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 86.3 mt -60.55 -40.82 93.01 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.353 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . 0.456 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 40.7 tp10 -57.86 -38.2 75.29 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 179.513 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -65.26 -38.17 89.48 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.8 0.333 . . . . 0.0 110.624 179.678 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 94.6 mt -64.35 -42.82 96.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.491 -179.689 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.63 45.96 0.08 OUTLIER Glycine 0 CA--C 1.521 0.435 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 179.993 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . 0.456 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 26.8 m-85 -129.07 156.13 44.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.993 0.425 . . . . 0.0 110.487 -179.829 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 222' ' ' THR . . . . . 0.452 ' O ' ' O ' ' A' ' 191' ' ' VAL . 7.7 p -108.1 122.7 47.43 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.112 0.482 . . . . 0.0 110.239 -179.997 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . 0.446 ' CD2' ' N ' ' A' ' 223' ' ' LEU . 4.3 mm? -101.43 133.17 46.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.089 -179.889 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.99 159.81 14.7 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.52 179.776 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -105.03 115.08 29.68 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.934 0.397 . . . . 0.0 110.398 179.853 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.448 ' CD1' ' N ' ' A' ' 226' ' ' LEU . 9.1 mp -53.37 156.86 3.79 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.574 179.954 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -60.27 145.22 99.03 Favored 'Trans proline' 0 C--N 1.302 -1.887 0 C-N-CA 122.615 2.21 . . . . 0.0 112.076 179.303 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.56 -2.78 58.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.543 -179.969 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.41 -40.67 5.67 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -179.842 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.552 ' O ' ' N ' ' A' ' 233' ' ' SER . 85.3 mt -79.29 -16.77 55.86 Favored 'General case' 0 C--O 1.224 -0.242 0 CA-C-O 120.929 0.395 . . . . 0.0 110.41 -179.821 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . 0.407 ' C ' ' O ' ' A' ' 230' ' ' LEU . 54.8 t-20 -39.82 -49.21 2.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.708 -179.706 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -88.55 15.71 7.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.103 -179.926 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 233' ' ' SER . . . . . 0.552 ' N ' ' O ' ' A' ' 230' ' ' LEU . 78.2 p -60.64 -35.96 77.47 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.64 -179.891 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . 0.527 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.7 tt0 -118.01 -69.55 0.84 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.911 179.677 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.0 m -70.56 103.36 2.48 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.658 -179.791 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -94.54 58.09 2.32 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.387 179.885 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -145.11 -122.71 1.56 Allowed Glycine 0 CA--C 1.522 0.47 0 N-CA-C 110.931 -0.868 . . . . 0.0 110.931 -179.927 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -133.71 111.7 10.79 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.052 0.454 . . . . 0.0 110.487 179.964 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . 0.496 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.0 mtt180 -148.18 56.88 1.07 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.741 -179.926 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 94.2 m-70 -69.66 -31.46 69.54 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.569 179.578 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . 0.473 ' CG ' HD22 ' A' ' 143' ' ' ASN . 65.2 t0 -56.87 -46.84 81.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.33 -179.147 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 242' ' ' ILE . . . . . 0.439 ' O ' ' O ' ' A' ' 239' ' ' ARG . 17.2 tt -140.71 157.86 23.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.913 0.387 . . . . 0.0 110.529 179.726 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 96.0 mt -106.28 106.13 20.02 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.198 0 CA-C-O 121.147 0.498 . . . . 0.0 110.489 179.886 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . 0.496 ' OE1' ' NH1' ' A' ' 239' ' ' ARG . 88.3 mt-30 -110.68 110.62 21.36 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.375 179.765 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 9.5 mp -122.19 -168.05 1.65 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.619 179.826 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . 0.527 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 172.98 -16.63 0.05 OUTLIER Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 179.901 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . 0.691 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -60.42 157.46 28.85 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 -179.819 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -64.21 21.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.955 0.407 . . . . 0.0 110.584 179.964 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . 0.691 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.8 m-20 -97.01 -5.84 36.74 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.548 179.932 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 92.5 mt -80.15 -21.18 43.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.643 179.464 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.52 -51.39 70.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.764 -179.555 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.83 -5.34 58.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.423 179.67 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.06 -74.43 1.14 Allowed Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 -179.863 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 80.1 mt -69.84 125.51 26.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.044 0.449 . . . . 0.0 110.253 -179.882 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -59.41 -39.53 83.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.29 -179.679 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 83.35 51.77 4.01 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 110.806 -0.917 . . . . 0.0 110.806 179.897 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -95.17 -16.08 22.83 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.79 0.329 . . . . 0.0 110.623 -179.883 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 258' ' ' SER . . . . . 0.442 ' HG ' ' CG2' ' A' ' 191' ' ' VAL . 3.4 t 174.92 89.29 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.014 0.435 . . . . 0.0 110.222 179.995 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . 0.599 ' N ' ' CD1' ' A' ' 259' ' ' LEU . 0.9 OUTLIER -94.17 124.2 38.04 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.22 0.533 . . . . 0.0 111.052 -179.024 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 16.1 m-30 -93.55 146.98 23.4 Favored 'General case' 0 CA--C 1.51 -0.577 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.406 179.053 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 85.3 mt -122.46 150.02 43.08 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.537 -179.895 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.662 ' CG ' ' N ' ' A' ' 263' ' ' ALA . 2.7 p90 -77.85 -138.86 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.533 -179.795 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . 0.662 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -51.44 78.17 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.942 -179.885 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . 0.631 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.88 104.57 0.19 Allowed Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 179.942 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 265' ' ' ASP . . . . . 0.601 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.8 m-20 -80.29 -177.23 6.03 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 120.692 0.282 . . . . 0.0 110.858 -179.432 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -40.7 -17.69 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.49 179.825 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . 0.601 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.5 -51.57 41.84 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.78 179.521 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -63.89 -46.62 84.09 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.282 179.312 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . 0.526 ' O ' ' CD2' ' A' ' 273' ' ' TYR . . . -61.56 -35.1 76.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.976 179.424 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -62.89 -34.5 77.54 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.177 179.561 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.46 -43.36 13.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.223 -179.536 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 272' ' ' ILE . . . . . 0.618 ' C ' ' H ' ' A' ' 274' ' ' ALA . 5.0 tt -51.56 -33.65 15.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.704 -178.643 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 273' ' ' TYR . . . . . 0.526 ' CD2' ' O ' ' A' ' 269' ' ' ALA . 16.9 m-85 -54.25 -1.82 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.71 -179.755 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 274' ' ' ALA . . . . . 0.618 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.75 -39.59 69.92 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.906 179.571 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . 0.586 ' O ' ' N ' ' A' ' 279' ' ' ALA . 3.7 p30 -39.17 97.94 0.15 Allowed Pre-proline 0 C--N 1.333 -0.15 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.576 -179.679 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo -53.97 -43.18 60.46 Favored 'Trans proline' 0 C--N 1.304 -1.814 0 C-N-CA 122.463 2.109 . . . . 0.0 112.614 -178.803 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 89.2 mt -64.5 -42.82 95.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.072 -179.563 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 91.0 mt -95.98 -1.11 49.69 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.814 -179.399 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 279' ' ' ALA . . . . . 0.586 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.49 -34.93 77.82 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.568 -179.721 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.33 20.28 0.12 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.965 -179.204 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . 0.513 ' H ' ' C ' ' A' ' 279' ' ' ALA . 13.7 mt -75.16 120.03 79.72 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.43 179.859 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -50.9 -39.61 58.66 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.617 2.211 . . . . 0.0 111.781 179.172 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.75 -50.63 63.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.171 179.731 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 74.7 t -61.48 -43.99 97.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 179.487 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -57.68 -41.28 81.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.283 -179.983 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -90.68 0.21 57.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.221 179.593 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt 59.73 42.93 16.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.872 179.658 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -94.7 41.34 1.09 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.356 179.793 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 54.0 t -119.02 135.92 57.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.964 0.412 . . . . 0.0 110.237 -179.832 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -133.68 163.61 29.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.69 -179.57 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.86 155.52 32.48 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.944 0.402 . . . . 0.0 110.721 -179.735 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 80.7 mt -94.32 -1.66 53.5 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.311 -179.765 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.46 165.3 12.57 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 -179.653 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 6.8 m -86.8 -61.66 1.68 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.871 0.367 . . . . 0.0 111.066 -179.814 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 295' ' ' GLU . . . . . 0.492 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.5 mm-40 -69.55 -4.75 20.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.657 -179.704 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 25.6 p -76.14 32.82 0.12 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.617 -179.88 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 297' ' ' PHE . . . . . 0.492 ' H ' ' C ' ' A' ' 295' ' ' GLU . 82.5 t80 -60.62 -46.12 91.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.662 -179.967 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . 0.613 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.2 mtt85 -80.76 137.11 36.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.679 -179.535 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 4.2 tp -114.16 116.17 28.66 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.407 179.775 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . 0.62 ' H ' ' HG ' ' A' ' 303' ' ' SER . 48.3 p-10 -166.05 -176.17 3.65 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.497 -179.921 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 301' ' ' TYR . . . . . 0.526 ' OH ' ' CD1' ' A' ' 173' ' ' PHE . 77.9 t80 -46.79 -43.44 18.33 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.226 -179.946 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -66.85 -40.81 88.04 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.991 0.424 . . . . 0.0 110.741 179.289 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 303' ' ' SER . . . . . 0.62 ' HG ' ' H ' ' A' ' 300' ' ' ASP . 60.7 p -55.74 -36.22 67.03 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.068 -179.178 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -57.74 -51.61 68.83 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.085 179.385 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 91.1 mtp -55.96 -44.23 78.28 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.688 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -65.91 -43.27 88.66 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.869 0.366 . . . . 0.0 110.195 178.741 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 56.0 t -63.89 -43.03 97.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.249 179.463 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 43.8 tp -59.74 -42.12 92.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.938 -179.747 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -62.41 -39.24 92.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.07 179.767 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 310' ' ' ARG . . . . . 0.455 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.7 ttt85 -63.67 -43.84 95.52 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.32 179.487 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 89.5 mt -63.31 -42.04 98.99 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.325 179.563 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -62.97 -33.68 75.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.138 179.341 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.68 -23.47 21.85 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.388 -179.777 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . 0.455 ' N ' ' O ' ' A' ' 310' ' ' ARG . 6.8 tt -62.28 -43.11 99.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.574 -179.971 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 . . . . . 0 C--O 1.22 -0.478 0 CA-C-O 118.028 -0.987 . . . . 0.0 110.483 179.939 . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -99.35 135.88 40.11 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.563 179.993 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.499 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -92.28 178.52 1.66 Allowed Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.572 -179.884 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.499 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 27.0 Cg_exo -61.63 147.34 95.59 Favored 'Trans proline' 0 C--N 1.301 -1.97 0 C-N-CA 122.777 2.318 . . . . 0.0 112.09 179.709 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 35.2 ptt180 -135.65 142.38 45.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.691 179.742 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -79.88 116.29 19.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.524 179.923 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.4 tp -110.77 130.45 64.13 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.427 179.979 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.2 t -70.85 141.97 51.24 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.571 179.811 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.516 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.3 t0 -139.7 179.48 6.55 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.516 -179.913 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.516 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 78.5 p -73.67 -37.0 65.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.842 179.706 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.8 ttt85 -46.56 -94.66 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.354 -179.534 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.426 ' O ' ' OG1' ' A' ' 36' ' ' THR . . . -167.29 -26.55 0.02 OUTLIER Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 179.89 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' A' ' 35' ' ' GLY . 64.8 m -168.76 104.37 0.42 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.908 0.385 . . . . 0.0 110.65 -179.826 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 73.9 t60 -128.41 147.93 50.68 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.031 0.443 . . . . 0.0 110.293 179.95 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.483 ' CG2' ' N ' ' A' ' 39' ' ' LEU . 98.5 m -130.48 165.93 21.61 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.66 -179.894 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.483 ' N ' ' CG2' ' A' ' 38' ' ' THR . 83.1 mt -120.51 127.75 52.48 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.513 179.729 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -65.33 -44.63 87.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.626 -179.901 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.408 ' O ' ' HD3' ' A' ' 43' ' ' PRO . 42.2 p -165.77 154.77 11.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.466 179.652 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.468 ' N ' ' CD ' ' A' ' 42' ' ' GLN . 14.7 mp0 -44.32 101.31 0.25 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.644 179.495 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.408 ' HD3' ' O ' ' A' ' 41' ' ' SER . 31.6 Cg_exo -57.36 129.22 32.89 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 122.378 2.052 . . . . 0.0 112.178 -179.716 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -83.61 -24.68 31.36 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.495 179.654 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.54 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.1 mtm-85 -122.02 134.98 54.8 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-O 121.133 0.492 . . . . 0.0 110.345 -179.922 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 95.9 mt -131.19 133.82 62.02 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.272 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.96 -179.711 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 45.7 t -124.38 130.38 73.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.325 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.499 ' O ' ' O ' ' A' ' 66' ' ' ALA . 2.3 m -154.94 166.64 32.93 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.548 179.865 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 67.7 p -124.59 9.31 8.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.515 179.904 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.45 125.53 33.09 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.665 -179.512 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 98.4 t -65.86 -44.46 92.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.479 -179.982 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.5 m -62.68 -44.35 96.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.642 -179.839 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 51.1 tp -62.16 -41.6 98.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.555 -179.455 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 76.3 m -57.6 -44.34 85.37 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.308 -179.322 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.22 -62.18 5.38 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 179.547 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.7 t -48.44 -35.65 13.32 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 -179.99 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.8 mt -61.77 -44.91 95.96 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.636 -0.426 . . . . 0.0 111.174 179.448 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.3 mp -64.68 -41.82 95.79 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.091 0.472 . . . . 0.0 111.382 177.86 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.6 -40.95 98.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.652 -0.703 . . . . 0.0 111.014 -179.206 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.1 tp -88.6 17.18 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.724 -179.602 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 56.32 84.95 0.08 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.694 -179.977 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.24 58.99 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.081 -179.8 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -50.75 151.6 10.72 Favored 'Trans proline' 0 C--N 1.297 -2.155 0 C-N-CA 122.799 2.333 . . . . 0.0 112.579 -178.359 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.434 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -108.46 145.64 15.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.391 -179.764 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.8 mt -63.89 -44.91 98.16 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.298 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.416 -179.721 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.499 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -130.18 134.41 47.27 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.574 -179.806 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.479 ' O ' ' N ' ' A' ' 98' ' ' LEU . 72.9 m -134.67 158.82 43.09 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.83 -179.589 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.32 138.5 15.94 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 110.726 -0.949 . . . . 0.0 110.726 179.816 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.449 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.46 -163.0 0.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.96 0.41 . . . . 0.0 110.508 -179.988 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.494 ' O ' ' C ' ' A' ' 71' ' ' THR . 5.9 t -133.75 135.39 43.91 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.242 -179.977 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.494 ' C ' ' O ' ' A' ' 70' ' ' THR . 0.9 OUTLIER 29.61 68.35 0.67 Allowed Pre-proline 0 N--CA 1.464 0.236 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.745 -179.663 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -60.98 144.59 99.61 Favored 'Trans proline' 0 C--N 1.301 -1.958 0 C-N-CA 122.548 2.165 . . . . 0.0 112.252 -178.573 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.528 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 45.4 p-10 -159.68 -31.7 0.06 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.634 179.624 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.528 ' N ' ' OD1' ' A' ' 73' ' ' ASN . 99.1 m-20 -64.15 -39.44 94.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.415 179.998 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -60.43 -48.2 82.8 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.644 -179.242 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.425 ' O ' ' O ' ' A' ' 77' ' ' ALA . 97.0 t -60.15 -24.7 31.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.154 179.596 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.425 ' O ' ' O ' ' A' ' 76' ' ' VAL . . . -45.72 173.15 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.588 179.853 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.574 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.3 p30 -62.06 177.56 0.45 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.583 -179.689 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.595 ' C ' ' H ' ' A' ' 81' ' ' GLY . 36.2 p30 -45.46 85.86 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.942 179.99 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.574 ' N ' ' O ' ' A' ' 78' ' ' ASP . 43.0 tp60 -67.65 13.23 0.08 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.08 -179.838 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.595 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 118.52 -21.89 9.66 Favored Glycine 0 CA--C 1.519 0.321 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.985 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -108.4 116.46 32.02 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.941 0.4 . . . . 0.0 110.522 179.894 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 75.6 mt -98.79 0.49 44.5 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.451 -179.726 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -92.65 7.18 44.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.988 0.423 . . . . 0.0 110.46 -179.778 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.443 ' O ' ' CG2' ' A' ' 89' ' ' VAL . 88.5 mt-30 -100.03 -27.91 13.33 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.855 -179.971 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 69.3 t-105 -63.19 -40.71 98.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.877 -179.544 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.56 ' O ' ' N ' ' A' ' 91' ' ' LYS . 65.7 m -77.65 -53.68 7.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.203 -179.394 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -48.19 -50.86 27.59 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.939 -179.363 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.443 ' CG2' ' O ' ' A' ' 85' ' ' GLN . 15.7 m -68.89 -40.75 81.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 120.936 0.398 . . . . 0.0 111.034 179.836 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.41 ' H ' HG23 ' A' ' 89' ' ' VAL . . . -72.46 -22.65 61.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.83 -179.869 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.56 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.1 tttm -61.91 -45.41 93.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.477 -179.578 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.441 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.7 mm-40 -90.69 -94.88 0.12 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.118 -179.869 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.644 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.8 mtt180 -142.9 59.31 1.42 Allowed 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.716 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.466 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.8 pttp 33.33 25.97 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.162 -179.098 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.644 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.3 tt -47.78 123.54 6.13 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.918 -178.287 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -83.8 -169.89 2.8 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.075 -179.913 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.612 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 82.4 mtp180 -74.1 137.17 43.12 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.197 -179.805 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.479 ' N ' ' O ' ' A' ' 67' ' ' SER . 90.4 mt -86.46 -165.74 1.35 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.704 -179.618 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.536 ' CD2' ' O ' ' A' ' 99' ' ' TYR . 48.6 p90 -168.87 120.14 0.75 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.297 179.972 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.518 ' C ' ' O ' ' A' ' 99' ' ' TYR . 43.3 mm -29.18 121.27 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.995 -179.563 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 114.38 27.06 3.49 Favored Glycine 0 CA--C 1.52 0.344 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 -179.575 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.578 ' N ' ' CD ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -144.27 46.2 0.61 Allowed Pre-proline 0 C--N 1.324 -0.508 0 CA-C-O 120.913 0.387 . . . . 0.0 110.511 179.946 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 29.8 Cg_endo -61.8 143.63 96.2 Favored 'Trans proline' 0 C--N 1.297 -2.146 0 C-N-CA 122.695 2.263 . . . . 0.0 111.989 -179.937 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.706 ' HG ' ' H ' ' A' ' 107' ' ' ALA . 26.2 t -173.19 119.97 0.34 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.489 179.698 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.19 -40.56 64.68 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.068 0.461 . . . . 0.0 111.1 179.76 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.19 -40.02 90.12 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.819 -179.368 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.706 ' H ' ' HG ' ' A' ' 104' ' ' SER . . . -64.02 -39.95 95.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.713 -179.768 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 72.0 t -67.74 -43.97 86.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.839 179.709 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.77 -38.98 92.73 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.552 -179.31 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.441 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.47 -23.3 62.61 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.434 179.867 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.554 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.5 mm-40 -90.51 5.12 49.06 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.651 -179.518 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.554 ' C ' ' O ' ' A' ' 111' ' ' GLN . 10.4 tpt 24.03 63.73 0.4 Allowed Pre-proline 0 N--CA 1.464 0.266 0 CA-C-O 120.861 0.362 . . . . 0.0 110.866 -179.967 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -77.92 167.36 23.8 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 C-N-CA 122.998 2.465 . . . . 0.0 112.392 -178.739 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.525 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 99.4 m-20 -110.49 -42.38 4.11 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.982 0.42 . . . . 0.0 110.042 179.55 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 39.8 tp -120.98 120.14 34.59 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.036 179.54 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 84.7 mt -113.21 129.19 69.38 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 CA-C-O 120.978 0.418 . . . . 0.0 110.848 -179.832 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 29.2 mt -108.95 132.26 54.25 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.235 -179.71 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 98.8 mt -119.59 138.77 49.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.712 -179.766 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 85.8 p -72.65 153.45 41.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.565 -179.998 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.21 -49.98 75.46 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.682 -179.769 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -149.55 154.07 38.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.6 179.811 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 170.36 -170.86 43.29 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 179.838 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.99 -34.17 89.24 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 179.949 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.453 ' O ' ' OD1' ' A' ' 124' ' ' ASP . 44.2 p-10 -87.33 120.27 28.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.833 0.349 . . . . 0.0 110.626 -179.942 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 40.0 t -63.22 143.74 57.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.538 -179.976 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.521 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.23 -43.18 8.95 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.819 -179.778 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.2 tp -62.7 -42.55 99.7 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.718 -179.912 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.26 -12.23 59.56 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.574 -179.459 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 84.1 mt -114.91 -23.51 9.08 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.721 -179.797 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . 0.521 ' N ' ' O ' ' A' ' 126' ' ' ALA . 78.0 t80 -51.12 -49.67 60.31 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 120.586 -0.446 . . . . 0.0 110.476 -178.929 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.503 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.1 p-10 -65.81 -42.52 90.55 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.905 0.383 . . . . 0.0 111.138 179.599 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.503 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 88.2 mt-30 -67.13 -37.84 84.53 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.832 179.97 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 95.9 mt -80.39 -41.32 24.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.881 -179.505 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.2 t -57.26 -44.53 83.98 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.243 -179.236 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 18.8 m -61.77 -45.36 94.22 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.8 0.333 . . . . 0.0 110.597 179.326 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 93.0 mt -62.11 -43.55 97.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.226 -179.784 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -169.63 168.31 4.77 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.559 179.867 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -49.94 113.25 0.92 Allowed 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.286 1.991 . . . . 0.0 112.092 179.507 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 23.8 m -84.15 127.22 33.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.594 -179.954 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 34.4 tp -117.66 135.23 54.14 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.988 -179.77 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.439 ' O ' ' OD2' ' A' ' 32' ' ' ASP . 81.5 mt -99.54 118.95 46.91 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 CA-C-O 121.175 0.512 . . . . 0.0 111.276 -179.336 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 98.1 mt -135.02 132.05 53.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.64 179.627 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.507 HD22 ' CG ' ' A' ' 241' ' ' ASP . 60.2 t30 -66.63 150.26 49.3 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.842 0.353 . . . . 0.0 110.428 179.4 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.517 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 87.7 t80 -85.01 122.39 29.16 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.859 -179.499 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.517 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 98.7 m-20 55.25 69.21 0.76 Allowed 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.856 179.748 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 34.9 p-10 -125.82 0.56 7.38 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.926 0.393 . . . . 0.0 110.753 179.857 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -150.85 115.73 5.26 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.699 -179.522 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 148' ' ' SER . . . . . 0.521 ' HG ' ' H ' ' A' ' 150' ' ' GLN . 83.9 p -64.39 169.15 4.95 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.528 -179.842 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.423 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.4 p-90 -52.21 -16.12 0.75 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.559 -179.863 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . 0.521 ' H ' ' HG ' ' A' ' 148' ' ' SER . 68.2 tp60 -70.07 -77.01 0.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.425 -179.712 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.453 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.1 t -62.57 -38.26 89.39 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.369 179.568 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 53.2 tp -60.06 -45.53 92.55 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.373 -178.566 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.423 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 46.8 tp -62.85 -41.74 99.48 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.821 0.343 . . . . 0.0 110.321 179.086 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.453 ' OG1' ' O ' ' A' ' 151' ' ' SER . 63.5 p -64.07 -34.75 78.74 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.285 -179.611 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.432 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.8 mm-40 -63.97 -42.77 97.14 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.316 179.235 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 92.7 mt -65.39 -39.02 91.72 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.016 0.436 . . . . 0.0 110.255 179.099 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.587 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -60.93 -32.08 78.58 Favored Glycine 0 CA--C 1.52 0.404 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 -179.468 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.439 ' C ' ' O ' ' A' ' 157' ' ' GLY . 97.2 mt-10 -35.71 -26.42 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.815 0.341 . . . . 0.0 110.744 179.93 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.587 ' N ' ' O ' ' A' ' 157' ' ' GLY . 95.7 mt -57.02 149.32 4.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.251 179.313 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 72.6 p -69.61 137.27 52.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.979 -179.535 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 71.77 20.45 78.68 Favored Glycine 0 N--CA 1.458 0.156 0 N-CA-C 111.243 -0.743 . . . . 0.0 111.243 179.457 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 56.8 m80 -122.3 -14.66 7.85 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.785 0.326 . . . . 0.0 110.64 179.816 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -65.22 -60.31 3.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.723 -179.684 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -51.85 -49.14 63.47 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.246 -179.771 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -60.66 -41.08 94.29 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.704 0.288 . . . . 0.0 110.284 179.542 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.55 -47.02 87.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.637 179.828 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -57.24 -40.03 76.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.251 -179.983 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -61.85 -50.31 72.77 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.562 179.621 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -65.36 -43.84 89.57 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.511 179.551 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 95.1 mt -64.65 -43.47 96.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.473 179.736 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.23 -50.92 71.35 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.627 -179.261 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.47 -43.72 96.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.363 179.747 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . 0.454 ' CD1' ' OH ' ' A' ' 301' ' ' TYR . 56.1 t80 -62.7 -44.64 95.71 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.123 0.487 . . . . 0.0 110.443 179.4 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -63.33 -40.08 96.31 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.522 -179.312 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -62.95 -42.73 99.9 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.704 179.259 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -60.77 -44.85 96.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.071 179.946 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 84.8 mt -64.3 -41.13 97.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.033 0.444 . . . . 0.0 110.661 178.917 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -51.88 -62.51 1.58 Allowed 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.478 -179.335 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.52 -46.86 85.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.58 179.819 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.26 -41.71 65.77 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.245 -179.993 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -63.8 -33.59 76.01 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.946 0.403 . . . . 0.0 110.364 179.27 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . 0.405 ' HG2' ' O ' ' A' ' 182' ' ' GLU . 69.6 tt0 -90.51 8.49 33.7 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.317 0.58 . . . . 0.0 110.586 -179.091 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -104.5 -32.33 9.04 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.257 179.597 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.3 pt -128.01 147.6 32.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.843 -179.878 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -139.76 130.99 26.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.347 179.506 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.558 ' CD2' ' N ' ' A' ' 186' ' ' LEU . 3.6 mm? -85.49 133.37 42.32 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.793 179.992 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -44.05 157.9 0.14 Allowed 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.735 2.29 . . . . 0.0 112.042 179.527 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . 0.535 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.7 Cg_endo -62.96 114.87 2.62 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 122.748 2.299 . . . . 0.0 111.76 179.817 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . 0.535 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.8 mt-30 155.28 148.17 0.0 OUTLIER Pre-proline 0 C--N 1.331 -0.199 0 O-C-N 123.383 0.427 . . . . 0.0 110.665 -179.784 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -73.94 144.5 34.49 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 122.725 2.283 . . . . 0.0 111.734 178.126 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.497 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.1 p -125.29 158.94 33.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.198 0.523 . . . . 0.0 110.12 -179.974 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 192' ' ' THR . . . . . 0.497 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 35.4 p -143.61 165.58 27.22 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.129 -179.609 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -135.76 128.66 31.28 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.151 0.501 . . . . 0.0 110.273 179.69 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 47.3 pt -146.3 148.76 16.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.021 179.899 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 70.3 t -117.49 122.88 70.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.245 0.545 . . . . 0.0 109.692 179.112 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -134.21 107.32 7.62 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.292 179.699 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 95.2 m -131.08 130.56 43.35 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.818 179.833 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.405 ' O ' ' N ' ' A' ' 201' ' ' HIS . . . -83.09 -36.87 24.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.228 179.71 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.6 -66.95 0.27 Allowed 'General case' 0 C--O 1.231 0.129 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.402 179.997 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.42 -9.76 58.93 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.246 179.494 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . 0.405 ' N ' ' O ' ' A' ' 198' ' ' ALA . 60.0 t-80 60.7 58.46 2.41 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.799 -179.844 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 40.6 p -167.16 153.25 7.96 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.505 179.55 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.26 143.92 24.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.997 0.427 . . . . 0.0 110.452 179.458 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -135.38 138.83 43.69 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.655 179.952 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 20.3 mt -106.69 125.54 51.13 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 121.134 0.492 . . . . 0.0 109.795 -179.687 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 206' ' ' TRP . . . . . 0.556 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 74.9 m95 -81.93 166.95 19.43 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.575 -179.72 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -156.94 171.62 7.2 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 120.997 0.427 . . . . 0.0 110.525 -179.223 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.06 -36.99 86.54 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 C-N-CA 122.639 2.226 . . . . 0.0 111.959 179.473 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -70.43 -35.16 73.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.906 -179.893 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 21.4 m -60.94 150.92 31.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.614 -179.296 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.58 -37.12 82.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.529 -179.751 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 212' ' ' GLN . . . . . 0.556 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 55.0 tt0 -64.56 -40.36 95.42 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.519 179.977 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.52 -43.32 92.58 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 179.804 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -63.45 -43.93 95.97 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.707 0.289 . . . . 0.0 110.276 179.883 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 65.4 ttp -59.49 -48.1 82.95 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.322 -179.805 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 87.7 mt -60.38 -40.6 91.42 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 179.416 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 217' ' ' GLU . . . . . 0.462 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.9 tp10 -58.34 -37.98 76.25 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.739 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -65.14 -38.28 90.11 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.813 0.34 . . . . 0.0 110.709 179.702 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 93.9 mt -64.36 -42.65 96.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.584 -179.62 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.56 45.1 0.08 OUTLIER Glycine 0 C--N 1.333 0.379 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 -179.937 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . 0.462 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 27.0 m-85 -128.08 155.18 44.79 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.052 0.454 . . . . 0.0 110.487 -179.807 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 222' ' ' THR . . . . . 0.46 ' O ' ' O ' ' A' ' 191' ' ' VAL . 6.4 p -106.92 122.28 46.11 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.179 0.514 . . . . 0.0 110.261 -179.987 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . 0.445 ' CD2' ' N ' ' A' ' 223' ' ' LEU . 4.3 mm? -101.22 133.0 46.45 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.077 -179.957 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.85 159.55 14.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.509 179.886 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.38 114.99 29.5 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.333 179.88 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.449 ' CD1' ' N ' ' A' ' 226' ' ' LEU . 9.1 mp -53.13 156.94 3.33 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.626 179.935 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -60.46 145.36 98.87 Favored 'Trans proline' 0 C--N 1.302 -1.903 0 C-N-CA 122.601 2.201 . . . . 0.0 112.004 179.485 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.3 -3.27 59.03 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.556 -179.989 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.01 -41.16 5.66 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 -179.885 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.536 ' O ' ' N ' ' A' ' 233' ' ' SER . 85.5 mt -79.08 -17.19 55.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.983 0.42 . . . . 0.0 110.364 -179.738 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . 0.404 ' C ' ' O ' ' A' ' 230' ' ' LEU . 54.8 t-20 -40.11 -49.41 2.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.757 -179.694 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -87.82 15.32 7.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.768 0.318 . . . . 0.0 111.186 -179.967 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 233' ' ' SER . . . . . 0.536 ' N ' ' O ' ' A' ' 230' ' ' LEU . 78.1 p -60.4 -35.74 76.45 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.535 -179.811 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . 0.525 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.6 tt0 -118.74 -69.19 0.86 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.917 179.642 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.3 m -69.73 103.11 2.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.633 -179.785 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -94.29 57.5 2.33 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.391 179.909 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -144.82 -122.42 1.56 Allowed Glycine 0 CA--C 1.521 0.43 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 -179.987 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -135.17 111.8 9.98 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 121.115 0.483 . . . . 0.0 110.468 179.983 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . 0.523 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.5 mtt180 -148.15 57.74 1.08 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.738 -179.894 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -69.64 -32.21 70.75 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.548 179.625 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . 0.507 ' CG ' HD22 ' A' ' 143' ' ' ASN . 65.1 t0 -56.94 -46.94 81.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.396 -179.159 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 242' ' ' ILE . . . . . 0.437 ' O ' ' O ' ' A' ' 239' ' ' ARG . 17.8 tt -139.84 156.43 25.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.893 0.378 . . . . 0.0 110.518 179.746 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 96.2 mt -106.24 106.34 20.4 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.188 0 CA-C-O 121.108 0.48 . . . . 0.0 110.511 179.863 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . 0.523 ' OE1' ' NH1' ' A' ' 239' ' ' ARG . 88.2 mt-30 -110.25 110.06 20.74 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.261 179.76 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 9.4 mp -121.96 -168.45 1.71 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.663 179.839 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . 0.525 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.54 -16.66 0.05 OUTLIER Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.911 -0.875 . . . . 0.0 110.911 179.945 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . 0.698 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -60.62 156.83 30.79 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -179.888 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -63.72 21.73 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.936 0.398 . . . . 0.0 110.655 179.924 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . 0.698 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.8 m-20 -97.34 -5.94 35.39 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.572 179.943 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 93.5 mt -79.85 -21.82 43.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.619 179.575 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.54 -51.27 70.59 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.864 -179.57 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.4 -5.54 58.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.394 179.642 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -80.93 -74.53 1.13 Allowed Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 -179.911 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 81.5 mt -69.79 125.4 26.62 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.025 0.44 . . . . 0.0 110.178 -179.816 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -59.49 -39.48 83.91 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.389 -179.739 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 84.45 51.71 3.8 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -179.938 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -94.62 -16.51 23.12 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.738 0.304 . . . . 0.0 110.597 -179.862 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 258' ' ' SER . . . . . 0.455 ' HG ' ' CG2' ' A' ' 191' ' ' VAL . 3.3 t 174.17 89.83 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.045 0.45 . . . . 0.0 110.119 -179.971 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . 0.598 ' N ' ' CD1' ' A' ' 259' ' ' LEU . 1.0 OUTLIER -94.46 124.03 38.24 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.224 0.535 . . . . 0.0 111.088 -179.099 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 16.0 m-30 -93.18 146.85 23.37 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.332 179.166 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 86.7 mt -122.57 149.87 43.36 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.512 -179.9 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.661 ' CG ' ' N ' ' A' ' 263' ' ' ALA . 2.6 p90 -77.94 -138.48 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.526 -179.813 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . 0.661 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -51.89 77.49 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.92 -179.942 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . 0.637 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.13 104.42 0.19 Allowed Glycine 0 N--CA 1.467 0.721 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 -179.986 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 265' ' ' ASP . . . . . 0.604 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.6 m-20 -80.43 -177.54 6.24 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.713 0.292 . . . . 0.0 110.91 -179.497 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -40.64 -17.56 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.852 0.358 . . . . 0.0 110.493 179.866 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . 0.604 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.64 -51.51 41.39 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.637 179.576 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -63.88 -46.71 83.69 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.076 179.525 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . 0.526 ' O ' ' CD2' ' A' ' 273' ' ' TYR . . . -61.54 -35.12 76.85 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.839 179.552 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -62.98 -34.59 77.86 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.126 179.653 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.36 -43.3 13.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.336 -179.588 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 272' ' ' ILE . . . . . 0.616 ' C ' ' H ' ' A' ' 274' ' ' ALA . 4.9 tt -51.42 -33.63 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.826 -178.872 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 273' ' ' TYR . . . . . 0.526 ' CD2' ' O ' ' A' ' 269' ' ' ALA . 17.4 m-85 -54.37 -1.7 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.677 -179.7 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 274' ' ' ALA . . . . . 0.616 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -72.13 -39.71 68.62 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.906 179.63 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . 0.588 ' O ' ' N ' ' A' ' 279' ' ' ALA . 3.9 p30 -39.36 97.78 0.15 Allowed Pre-proline 0 N--CA 1.462 0.156 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.54 -179.653 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 276' ' ' PRO . . . . . 0.402 ' N ' ' O ' ' A' ' 274' ' ' ALA . 45.5 Cg_exo -53.97 -43.31 59.36 Favored 'Trans proline' 0 C--N 1.303 -1.848 0 C-N-CA 122.363 2.042 . . . . 0.0 112.737 -178.857 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 89.4 mt -64.37 -42.83 95.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.206 -179.674 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 90.8 mt -95.94 -1.31 49.43 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.842 -179.361 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 279' ' ' ALA . . . . . 0.588 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.42 -34.89 77.66 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.604 -179.69 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -73.99 19.55 0.12 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.078 -179.224 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . 0.494 ' H ' ' C ' ' A' ' 279' ' ' ALA . 14.0 mt -74.95 121.0 84.31 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.355 179.873 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_exo -51.24 -39.44 62.12 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 122.573 2.182 . . . . 0.0 111.657 179.289 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.57 -50.65 62.53 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 179.748 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 81.8 t -61.84 -43.91 98.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 179.507 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -57.57 -41.86 81.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.418 -179.871 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -90.47 1.06 57.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.215 179.572 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt 58.39 40.42 24.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.036 0.446 . . . . 0.0 110.903 179.681 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -92.36 42.41 1.1 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.37 179.781 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 54.4 t -119.16 135.79 58.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.023 0.44 . . . . 0.0 110.182 -179.724 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -132.93 162.97 30.23 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.031 0.443 . . . . 0.0 110.697 -179.663 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.92 155.02 33.57 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.968 0.413 . . . . 0.0 110.774 -179.85 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 80.9 mt -93.69 -1.39 55.26 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.278 -179.782 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.17 165.38 12.64 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 -179.725 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 6.8 m -87.13 -62.32 1.53 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.866 0.365 . . . . 0.0 111.008 -179.802 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 295' ' ' GLU . . . . . 0.476 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.6 mm-40 -69.53 -4.2 17.97 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.544 -179.738 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 29.1 p -76.66 32.51 0.13 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.662 -179.877 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 297' ' ' PHE . . . . . 0.476 ' H ' ' C ' ' A' ' 295' ' ' GLU . 70.4 t80 -60.18 -46.05 91.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.565 -179.905 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . 0.612 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.1 mtt85 -81.09 133.45 35.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.073 0.463 . . . . 0.0 110.433 -179.712 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 16.3 tp -114.19 119.4 36.95 Favored 'General case' 0 CA--C 1.527 0.089 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.205 -179.97 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . 0.611 ' H ' ' CB ' ' A' ' 303' ' ' SER . 49.9 p-10 -167.29 -174.21 2.51 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.508 -179.968 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 301' ' ' TYR . . . . . 0.454 ' OH ' ' CD1' ' A' ' 173' ' ' PHE . 85.7 t80 -48.34 -45.46 35.33 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.127 -179.591 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -65.0 -41.62 95.23 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.004 0.43 . . . . 0.0 110.724 178.969 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 303' ' ' SER . . . . . 0.611 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 52.7 p -55.15 -36.04 65.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.182 -179.5 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -57.13 -51.49 69.08 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 110.016 -0.365 . . . . 0.0 110.016 179.459 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 90.8 mtp -56.37 -43.82 79.56 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.689 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -66.57 -42.65 86.7 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.867 0.365 . . . . 0.0 110.18 178.778 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 56.0 t -64.06 -42.89 97.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.192 179.401 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 43.4 tp -59.55 -42.17 91.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.827 -179.593 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -62.73 -39.0 92.71 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 179.61 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 310' ' ' ARG . . . . . 0.44 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.6 ttt85 -63.54 -44.01 95.45 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.3 179.515 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 87.9 mt -63.36 -42.0 98.87 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.188 179.56 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -62.81 -33.18 74.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.106 179.454 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -90.19 -23.13 21.38 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.564 -179.908 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . 0.44 ' N ' ' O ' ' A' ' 310' ' ' ARG . 6.7 tt -62.43 -43.23 99.31 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.063 0.459 . . . . 0.0 110.589 -179.902 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 . . . . . 0 C--O 1.22 -0.462 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.508 179.989 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -99.7 135.54 40.96 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.1 0.476 . . . . 0.0 110.406 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.48 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -92.51 178.71 1.56 Allowed Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.403 -179.686 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.48 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 27.0 Cg_exo -61.66 147.44 95.34 Favored 'Trans proline' 0 C--N 1.303 -1.833 0 C-N-CA 122.909 2.406 . . . . 0.0 112.214 179.537 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.492 ' HE ' HD12 ' A' ' 39' ' ' LEU . 35.2 ptt180 -136.32 142.61 43.88 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.571 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -79.94 116.77 20.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.509 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.443 ' O ' HG23 ' A' ' 30' ' ' ILE . 9.4 tp -111.45 130.53 64.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.487 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.1 t -71.24 142.5 50.56 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.607 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.478 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.4 t0 -139.45 -179.96 6.2 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.504 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.478 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 78.1 p -73.88 -37.23 64.79 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.683 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -46.69 -94.72 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.304 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -166.53 -26.75 0.02 OUTLIER Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 62.4 m -168.63 105.64 0.44 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.707 0.289 . . . . 0.0 110.531 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.656 ' CD2' HD13 ' A' ' 140' ' ' LEU . 70.0 t60 -129.01 146.63 50.93 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.224 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.619 HG22 ' N ' ' A' ' 39' ' ' LEU . 98.8 m -129.96 165.57 21.83 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.377 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.619 ' N ' HG22 ' A' ' 38' ' ' THR . 77.9 mt -120.2 127.28 52.3 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.654 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -65.42 -44.91 85.91 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.592 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 37.5 p -165.78 154.95 11.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.55 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.499 ' CD ' ' H ' ' A' ' 42' ' ' GLN . 14.7 mp0 -44.51 101.02 0.24 Allowed Pre-proline 0 C--O 1.235 0.302 0 O-C-N 123.564 0.54 . . . . 0.0 110.467 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -57.61 130.07 36.94 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.449 2.099 . . . . 0.0 112.111 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -82.95 -24.76 32.86 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.573 179.341 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.537 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.9 mtm-85 -121.23 134.33 55.19 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.995 0.426 . . . . 0.0 110.287 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.3 mt -130.22 133.26 64.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.515 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 46.2 t -124.73 131.04 73.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-O 121.002 0.429 . . . . 0.0 110.163 178.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.611 ' OG ' HD12 ' A' ' 117' ' ' LEU . 4.2 m -154.67 166.42 33.45 Favored 'General case' 0 C--O 1.224 -0.241 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.461 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 72.6 p -124.41 9.11 8.45 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.483 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.1 t -85.65 125.68 33.34 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.942 0.401 . . . . 0.0 110.577 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.462 HG11 ' H ' ' A' ' 299' ' ' LEU . 90.1 t -65.66 -44.52 93.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.546 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.0 m -62.51 -44.45 96.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.686 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 54.7 tp -62.35 -41.52 98.66 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.65 -179.331 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.447 ' O ' HD13 ' A' ' 58' ' ' LEU . 70.5 m -57.88 -44.61 86.8 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.219 -179.211 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.39 -62.05 5.45 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.5 t -47.55 -35.94 9.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.79 0.328 . . . . 0.0 110.144 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.7 mt -61.87 -44.64 96.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.909 0.385 . . . . 0.0 110.976 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.447 HD13 ' O ' ' A' ' 54' ' ' THR . 9.0 mp -65.17 -41.32 94.74 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.292 178.282 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.415 ' HB1' ' NE ' ' A' ' 169' ' ' ARG . . . -63.78 -41.19 97.99 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.631 -179.208 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.415 ' O ' HG23 ' A' ' 60' ' ' ILE . 7.9 tp -88.06 16.62 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.673 -179.383 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 56.33 84.09 0.09 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.795 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.21 57.11 0.06 OUTLIER Pre-proline 0 C--N 1.327 -0.371 0 CA-C-O 121.018 0.437 . . . . 0.0 109.907 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -50.17 153.72 6.45 Favored 'Trans proline' 0 C--N 1.298 -2.096 0 C-N-CA 122.972 2.448 . . . . 0.0 112.492 -178.415 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.425 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -109.15 146.12 15.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.238 -179.728 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 97.0 mt -63.78 -45.08 98.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.116 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.503 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -130.32 134.21 47.02 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.775 0.321 . . . . 0.0 110.266 -179.461 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.494 ' O ' ' N ' ' A' ' 98' ' ' LEU . 72.9 m -134.47 158.71 43.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.805 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.71 139.35 16.37 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.716 -0.954 . . . . 0.0 110.716 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.488 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.78 -162.67 0.08 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.798 0.333 . . . . 0.0 110.384 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.505 HG22 ' CD2' ' A' ' 297' ' ' PHE . 5.9 t -133.97 135.36 43.43 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.096 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.467 ' C ' ' O ' ' A' ' 70' ' ' THR . 0.8 OUTLIER 29.47 68.71 0.64 Allowed Pre-proline 0 N--CA 1.468 0.475 0 CA-C-O 121.216 0.532 . . . . 0.0 110.84 -179.48 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -60.86 144.79 99.63 Favored 'Trans proline' 0 C--N 1.302 -1.911 0 C-N-CA 122.776 2.317 . . . . 0.0 112.064 -178.289 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.528 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 46.3 p-10 -159.79 -31.83 0.06 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.667 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.529 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 99.0 m-20 -64.29 -39.36 93.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.421 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.6 ttt180 -60.39 -48.46 81.64 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.436 -179.184 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.425 ' O ' ' O ' ' A' ' 77' ' ' ALA . 93.7 t -60.05 -24.52 30.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.172 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.529 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -45.82 172.95 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.53 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.57 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.5 p30 -61.94 177.64 0.43 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.433 -179.581 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.566 ' C ' ' H ' ' A' ' 81' ' ' GLY . 35.5 p30 -45.9 85.44 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.807 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.57 ' N ' ' O ' ' A' ' 78' ' ' ASP . 42.2 tp60 -67.14 13.65 0.06 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.261 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.566 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 117.94 -22.31 9.9 Favored Glycine 0 N--CA 1.463 0.471 0 N-CA-C 110.874 -0.891 . . . . 0.0 110.874 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -107.94 116.17 31.47 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.873 0.368 . . . . 0.0 110.348 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 75.9 mt -98.68 0.67 45.13 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.474 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -92.19 6.8 45.28 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.344 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.783 ' O ' HG22 ' A' ' 89' ' ' VAL . 27.2 mt-30 -99.91 -28.18 13.23 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.564 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 68.6 t-105 -63.44 -40.91 98.42 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.705 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.545 ' O ' ' N ' ' A' ' 91' ' ' LYS . 64.5 m -77.49 -53.68 7.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.873 -179.177 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -48.4 -51.01 28.58 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.801 -178.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.783 HG22 ' O ' ' A' ' 85' ' ' GLN . 16.0 m -68.92 -40.68 81.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.891 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.491 ' N ' HG23 ' A' ' 89' ' ' VAL . . . -72.27 -22.72 61.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.695 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.545 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.0 tttm -61.57 -45.92 92.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.449 -179.533 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.436 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.7 mm-40 -90.16 -94.58 0.12 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.198 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.609 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.9 mtt180 -143.38 59.3 1.4 Allowed 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.434 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.6 pttp 33.92 26.24 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 O-C-N 123.588 0.555 . . . . 0.0 110.487 -179.198 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.609 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.5 tt -48.29 123.07 5.94 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.648 -177.845 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.456 ' O ' HD23 ' A' ' 95' ' ' LEU . 98.9 mm-40 -83.11 -170.48 3.06 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.399 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.619 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 82.8 mtp180 -73.42 137.78 44.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.229 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.494 ' N ' ' O ' ' A' ' 67' ' ' SER . 88.9 mt -86.13 -166.37 1.52 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.807 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.53 ' O ' ' CD2' ' A' ' 99' ' ' TYR . 46.9 p90 -167.77 119.83 0.88 Allowed 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.106 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.487 ' C ' ' O ' ' A' ' 99' ' ' TYR . 43.2 mm -29.63 121.33 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 O-C-N 123.482 0.489 . . . . 0.0 110.891 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 113.28 28.59 3.26 Favored Glycine 0 N--CA 1.464 0.504 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.578 ' N ' ' CD ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -143.86 45.45 0.56 Allowed Pre-proline 0 C--N 1.324 -0.504 0 CA-C-O 121.321 0.582 . . . . 0.0 110.502 179.795 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 30.6 Cg_endo -61.95 143.94 95.91 Favored 'Trans proline' 0 C--N 1.298 -2.123 0 C-N-CA 122.614 2.209 . . . . 0.0 112.014 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.471 ' O ' HG23 ' A' ' 108' ' ' VAL . 21.9 t -173.18 120.84 0.36 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.534 179.311 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.3 -40.74 64.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.215 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.16 -40.29 90.42 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.69 -179.327 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.1 -39.98 95.22 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.659 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 104' ' ' SER . 69.4 t -67.71 -43.8 86.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.634 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.37 -39.19 92.36 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.521 -179.119 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.436 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.6 -23.23 62.79 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.596 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.519 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.3 mm-40 -90.95 4.31 52.3 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.716 -179.494 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.537 ' O ' ' NE ' ' A' ' 45' ' ' ARG . 10.3 tpt 23.97 63.82 0.4 Allowed Pre-proline 0 N--CA 1.471 0.602 0 O-C-N 123.622 0.576 . . . . 0.0 110.986 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.46 ' HG2' HD11 ' A' ' 116' ' ' ILE . 71.0 Cg_endo -78.63 168.22 21.49 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 123.019 2.48 . . . . 0.0 112.075 -178.234 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.511 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 98.8 m-20 -112.56 -43.78 3.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.292 179.379 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.0 tp -121.03 120.09 34.36 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.262 178.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.46 HD11 ' HG2' ' A' ' 113' ' ' PRO . 96.8 mt -117.14 131.14 70.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.719 -179.59 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.611 HD12 ' OG ' ' A' ' 48' ' ' SER . 30.1 mt -106.07 132.32 52.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.218 -179.569 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.447 HD12 HG23 ' A' ' 139' ' ' THR . 98.3 mt -118.08 136.71 54.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.495 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 86.6 p -71.98 152.3 42.59 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.565 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -59.97 -50.05 75.26 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.535 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -149.19 153.52 37.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.513 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 169.76 -170.73 42.95 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -63.07 -35.05 91.56 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.444 ' OD1' ' O ' ' A' ' 124' ' ' ASP . 43.9 p-10 -87.8 120.34 29.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.892 0.377 . . . . 0.0 110.635 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.441 ' O ' HD12 ' A' ' 129' ' ' LEU . 41.0 t -63.34 143.68 57.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.469 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.516 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.6 -42.74 9.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.647 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.5 tp -62.79 -42.42 99.7 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.761 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.01 -10.63 55.14 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.413 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.441 HD12 ' O ' ' A' ' 125' ' ' SER . 83.4 mt -115.59 -24.39 8.32 Favored 'General case' 0 C--O 1.224 -0.238 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.533 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' TYR . . . . . 0.516 ' N ' ' O ' ' A' ' 126' ' ' ALA . 75.1 t80 -51.39 -49.93 60.59 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.96 -0.296 . . . . 0.0 110.531 -178.733 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 37.6 p-10 -65.95 -42.13 90.36 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.933 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.52 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 88.2 mt-30 -67.66 -36.76 81.33 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.73 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.454 HD22 HD13 ' A' ' 116' ' ' ILE . 94.3 mt -80.22 -41.85 24.37 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.025 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.4 t -57.16 -44.88 83.88 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.204 -179.159 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.3 m -62.2 -45.48 93.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.616 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 92.2 mt -62.54 -43.81 98.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.336 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.592 ' HB1' ' HD2' ' A' ' 138' ' ' PRO . . . -170.05 163.47 6.4 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.563 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.592 ' HD2' ' HB1' ' A' ' 137' ' ' ALA . 77.0 Cg_exo -43.1 111.86 0.25 Allowed 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.576 2.184 . . . . 0.0 112.068 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.491 HG21 ' CD1' ' A' ' 130' ' ' TYR . 17.2 m -85.64 127.72 34.56 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.328 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.656 HD13 ' CD2' ' A' ' 37' ' ' HIS . 34.0 tp -119.45 137.23 53.91 Favored 'General case' 0 C--N 1.334 -0.078 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.404 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.431 ' O ' ' OD2' ' A' ' 32' ' ' ASP . 80.7 mt -103.4 119.75 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.844 -178.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.496 HD12 HD22 ' A' ' 117' ' ' LEU . 97.2 mt -135.75 133.09 51.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.607 179.085 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.545 HD21 ' CG ' ' A' ' 241' ' ' ASP . 60.9 t30 -65.2 150.93 47.35 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.41 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.512 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 88.2 t80 -85.91 122.38 29.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.725 -179.2 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.512 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 99.1 m-20 55.38 69.34 0.74 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.497 179.407 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 43.4 p-10 -126.64 0.54 6.81 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.537 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -150.34 114.79 5.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.833 0.349 . . . . 0.0 110.547 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 84.8 p -62.69 168.23 3.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.594 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.408 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.6 p-90 -51.44 -15.86 0.48 Allowed 'General case' 0 C--O 1.22 -0.461 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.299 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' GLN . . . . . 0.441 ' O ' HG23 ' A' ' 154' ' ' THR . 68.3 tp60 -70.49 -75.44 0.12 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.998 0.427 . . . . 0.0 110.613 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.445 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.2 t -62.53 -38.82 91.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.298 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 52.8 tp -60.13 -45.6 92.45 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.511 -178.338 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.408 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 45.8 tp -62.74 -41.59 99.26 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.604 178.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.445 ' OG1' ' O ' ' A' ' 151' ' ' SER . 59.1 p -63.67 -35.03 79.2 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.275 -179.434 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' GLN . . . . . 0.459 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.8 mm-40 -63.67 -42.14 98.1 Favored 'General case' 0 C--O 1.226 -0.161 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.36 179.344 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 91.3 mt -65.3 -39.09 92.05 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.483 178.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.564 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -60.99 -32.29 79.63 Favored Glycine 0 C--N 1.33 0.237 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 -179.339 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.459 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.3 mt-10 -36.63 -25.38 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.823 0.344 . . . . 0.0 110.937 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.564 ' N ' ' O ' ' A' ' 157' ' ' GLY . 95.3 mt -58.81 148.83 6.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.455 178.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 70.8 p -69.15 137.6 53.48 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.841 -179.33 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 70.69 21.92 77.95 Favored Glycine 0 CA--C 1.521 0.41 0 N-CA-C 111.085 -0.806 . . . . 0.0 111.085 179.288 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 59.7 m80 -124.18 -14.18 7.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.562 0.22 . . . . 0.0 110.506 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -66.14 -59.96 3.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.542 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -51.39 -49.42 61.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.086 -179.43 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -60.58 -40.97 93.66 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.883 0.373 . . . . 0.0 110.495 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.62 -47.42 85.52 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.548 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.77 -40.06 75.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.311 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -61.64 -50.46 72.44 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.697 179.419 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.415 ' NE ' ' HB1' ' A' ' 59' ' ' ALA . 60.1 ttt85 -65.28 -43.79 90.07 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.46 179.509 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 95.3 mt -64.4 -43.53 97.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.484 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.33 -51.06 70.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.379 -179.053 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.76 -43.6 95.92 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.875 0.369 . . . . 0.0 110.521 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' PHE . . . . . 0.655 ' CE2' HD11 ' A' ' 177' ' ' LEU . 56.7 t80 -62.54 -44.39 96.47 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.435 179.393 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -63.66 -39.68 94.96 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.378 -179.168 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -63.08 -42.52 99.65 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.753 179.29 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -60.64 -44.94 95.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.209 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.655 HD11 ' CE2' ' A' ' 173' ' ' PHE . 85.4 mt -64.31 -41.1 97.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.943 178.801 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.13 -61.99 1.92 Allowed 'General case' 0 C--O 1.238 0.472 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.499 -179.338 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.71 -46.83 86.45 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.472 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.12 -41.59 65.18 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.329 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -63.75 -33.99 76.89 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.33 179.302 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 182' ' ' GLU . . . . . 0.4 ' O ' ' HG2' ' A' ' 182' ' ' GLU . 69.3 tt0 -90.75 8.56 34.01 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.39 0.614 . . . . 0.0 110.283 -178.72 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -104.3 -32.23 9.18 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.944 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.8 pt -128.09 147.81 32.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.865 0.364 . . . . 0.0 110.58 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -139.71 131.13 26.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.538 178.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 186' ' ' LEU . . . . . 0.587 HD22 ' N ' ' A' ' 186' ' ' LEU . 3.6 mm? -85.35 133.46 42.41 Favored Pre-proline 0 N--CA 1.447 -0.606 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.107 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -44.1 157.83 0.14 Allowed 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.581 2.188 . . . . 0.0 112.188 179.55 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 188' ' ' PRO . . . . . 0.489 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.7 Cg_endo -63.35 115.0 2.74 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.815 2.344 . . . . 0.0 111.561 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 189' ' ' GLN . . . . . 0.489 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.7 mt-30 156.05 148.14 0.0 OUTLIER Pre-proline 0 C--N 1.34 0.178 0 O-C-N 124.353 1.033 . . . . 0.0 110.94 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -73.75 144.48 35.23 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 C-N-CA 122.601 2.201 . . . . 0.0 111.765 177.765 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.495 HG23 ' OG ' ' A' ' 258' ' ' SER . 2.1 p -124.81 159.04 31.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.206 0.527 . . . . 0.0 110.168 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 192' ' ' THR . . . . . 0.482 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 37.2 p -143.26 165.29 27.88 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 121.428 0.633 . . . . 0.0 110.852 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 193' ' ' ALA . . . . . 0.447 ' HA ' ' H ' ' A' ' 260' ' ' PHE . . . -135.32 128.91 32.63 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 121.276 0.56 . . . . 0.0 110.422 178.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.509 HD11 HD23 ' A' ' 259' ' ' LEU . 47.6 pt -146.64 149.09 16.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.849 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 195' ' ' VAL . . . . . 0.744 HG13 ' CD1' ' A' ' 262' ' ' PHE . 73.6 t -117.78 123.1 71.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.08 0.467 . . . . 0.0 110.036 178.498 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 58.1 t80 -134.3 106.45 7.12 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.348 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 95.3 m -130.31 130.49 44.56 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.786 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.401 ' O ' ' N ' ' A' ' 201' ' ' HIS . . . -82.99 -36.58 24.93 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.26 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.41 -67.26 0.25 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.351 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.12 -9.45 58.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.446 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 201' ' ' HIS . . . . . 0.402 ' O ' ' ND1' ' A' ' 201' ' ' HIS . 60.7 t-80 60.51 58.26 2.55 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.749 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 34.9 p -167.28 153.91 8.3 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.601 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.56 144.27 24.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.897 0.379 . . . . 0.0 110.417 179.232 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -135.32 138.49 43.48 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.41 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 18.2 mt -106.25 125.23 50.75 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.062 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 206' ' ' TRP . . . . . 0.556 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 74.8 m95 -82.31 167.74 18.27 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.563 -179.628 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 207' ' ' THR . . . . . 0.455 HG22 ' C ' ' A' ' 206' ' ' TRP . 0.1 OUTLIER -157.62 171.7 7.1 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.611 -178.635 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -53.92 -37.09 85.46 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 C-N-CA 122.743 2.296 . . . . 0.0 111.992 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -70.77 -34.9 72.3 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.734 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 21.4 m -61.5 150.94 34.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.51 -179.43 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.76 -36.92 82.43 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.42 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 212' ' ' GLN . . . . . 0.556 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 55.0 tt0 -64.63 -40.29 95.22 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.59 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.88 -43.27 91.87 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -63.07 -43.97 97.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.85 0.357 . . . . 0.0 110.239 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 215' ' ' MET . . . . . 0.55 ' SD ' ' HB2' ' A' ' 304' ' ' ALA . 65.2 ttp -59.42 -47.79 84.11 Favored 'General case' 0 N--CA 1.461 0.103 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.207 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 86.4 mt -60.53 -40.72 92.54 Favored 'General case' 0 CA--C 1.517 -0.303 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 217' ' ' GLU . . . . . 0.448 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.1 tp10 -57.96 -38.04 75.26 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.201 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -65.51 -37.96 88.29 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.725 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 96.0 mt -64.28 -42.76 96.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.655 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.72 44.9 0.08 OUTLIER Glycine 0 N--CA 1.463 0.444 0 N-CA-C 111.079 -0.808 . . . . 0.0 111.079 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 221' ' ' PHE . . . . . 0.448 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 26.9 m-85 -127.89 155.75 43.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.761 0.315 . . . . 0.0 110.498 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.481 ' O ' HG13 ' A' ' 191' ' ' VAL . 7.4 p -107.42 122.52 46.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.21 0.529 . . . . 0.0 110.229 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.472 HD22 ' C ' ' A' ' 222' ' ' THR . 4.3 mm? -101.34 133.16 46.37 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.002 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.74 159.4 14.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.433 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.31 115.0 29.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.404 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.497 HD12 ' N ' ' A' ' 226' ' ' LEU . 8.9 mp -52.91 156.72 3.23 Favored Pre-proline 0 N--CA 1.446 -0.649 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.794 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -60.47 145.49 98.62 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.719 2.279 . . . . 0.0 112.013 179.208 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.2 -3.36 59.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.529 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -89.93 -41.26 5.66 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 230' ' ' LEU . . . . . 0.506 ' O ' ' N ' ' A' ' 233' ' ' SER . 68.3 mt -79.23 -17.15 55.33 Favored 'General case' 0 C--O 1.219 -0.532 0 CA-C-O 120.923 0.392 . . . . 0.0 110.31 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 54.4 t-20 -40.33 -49.73 2.77 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.862 0.363 . . . . 0.0 110.709 -179.495 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -87.7 15.43 6.91 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.115 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 233' ' ' SER . . . . . 0.506 ' N ' ' O ' ' A' ' 230' ' ' LEU . 77.9 p -60.33 -35.24 75.17 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.601 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 234' ' ' GLN . . . . . 0.521 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.6 tt0 -119.64 -69.18 0.86 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.73 0.3 . . . . 0.0 110.679 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.3 m -69.58 102.59 1.88 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.538 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -94.28 57.4 2.32 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.357 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -144.73 -122.41 1.56 Allowed Glycine 0 N--CA 1.462 0.426 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -135.42 111.71 9.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.898 0.38 . . . . 0.0 110.379 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 239' ' ' ARG . . . . . 0.525 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.4 mtt180 -148.28 58.14 1.08 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.578 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -69.38 -32.7 71.9 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.618 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 241' ' ' ASP . . . . . 0.545 ' CG ' HD21 ' A' ' 143' ' ' ASN . 65.2 t0 -56.7 -47.3 80.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.312 -179.001 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 242' ' ' ILE . . . . . 0.434 ' O ' ' O ' ' A' ' 239' ' ' ARG . 18.0 tt -139.39 155.92 26.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.358 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.445 HG22 HD13 ' A' ' 245' ' ' LEU . 96.3 mt -106.08 106.49 20.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.406 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 244' ' ' GLN . . . . . 0.586 ' O ' HD12 ' A' ' 245' ' ' LEU . 88.2 mt-30 -110.57 109.96 20.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.291 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.586 HD12 ' O ' ' A' ' 244' ' ' GLN . 9.5 mp -121.59 -168.09 1.63 Allowed 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.723 179.442 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 246' ' ' GLY . . . . . 0.521 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.7 -16.46 0.05 OUTLIER Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 247' ' ' GLY . . . . . 0.666 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -61.14 156.31 33.85 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -63.33 21.81 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.772 0.32 . . . . 0.0 110.629 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 249' ' ' ASN . . . . . 0.666 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.9 m-20 -97.41 -6.3 34.33 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.407 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 92.0 mt -79.36 -21.98 45.05 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.945 179.193 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.7 -51.21 70.91 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.647 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.39 -5.74 58.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.372 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -80.87 -74.49 1.13 Allowed Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 80.9 mt -69.99 126.14 28.81 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.455 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -59.64 -39.19 83.56 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.281 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 82.63 51.94 4.11 Favored Glycine 0 CA--C 1.521 0.426 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -95.89 -15.07 22.66 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 121.199 -0.201 . . . . 0.0 110.634 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 258' ' ' SER . . . . . 0.495 ' OG ' HG23 ' A' ' 191' ' ' VAL . 3.5 t 174.85 88.71 0.0 OUTLIER 'General case' 0 C--O 1.224 -0.257 0 CA-C-O 121.089 0.471 . . . . 0.0 110.294 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.848 HD12 ' N ' ' A' ' 259' ' ' LEU . 0.9 OUTLIER -94.5 124.27 38.43 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.774 0.321 . . . . 0.0 110.874 -178.666 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 260' ' ' PHE . . . . . 0.447 ' H ' ' HA ' ' A' ' 193' ' ' ALA . 15.7 m-30 -93.52 146.13 24.01 Favored 'General case' 0 CA--C 1.499 -0.999 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.541 179.016 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 85.3 mt -122.09 149.03 44.14 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.517 -179.486 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.744 ' CD1' HG13 ' A' ' 195' ' ' VAL . 2.5 p90 -77.23 -138.84 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.407 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 263' ' ' ALA . . . . . 0.655 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -51.46 77.22 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.249 0 O-C-N 123.381 0.426 . . . . 0.0 110.939 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 264' ' ' GLY . . . . . 0.622 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.29 104.67 0.19 Allowed Glycine 0 CA--C 1.527 0.797 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 265' ' ' ASP . . . . . 0.589 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.8 m-20 -80.14 -177.8 6.24 Favored 'General case' 0 C--N 1.327 -0.394 0 O-C-N 122.79 -0.241 . . . . 0.0 110.718 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -40.78 -17.83 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.486 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 267' ' ' LYS . . . . . 0.589 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.16 -51.52 44.97 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 121.058 0.456 . . . . 0.0 110.724 179.146 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -63.9 -46.58 84.2 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.102 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 269' ' ' ALA . . . . . 0.566 ' HB1' ' OH ' ' A' ' 273' ' ' TYR . . . -61.6 -34.81 76.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.668 0.746 . . . . 0.0 110.05 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -62.98 -34.89 78.5 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.002 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.07 -43.44 13.91 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.136 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 272' ' ' ILE . . . . . 0.589 ' C ' ' H ' ' A' ' 274' ' ' ALA . 5.0 tt -51.61 -33.59 15.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.471 -178.517 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 273' ' ' TYR . . . . . 0.566 ' OH ' ' HB1' ' A' ' 269' ' ' ALA . 17.1 m-85 -54.62 -1.61 0.03 OUTLIER 'General case' 0 CA--C 1.512 -0.504 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.741 -179.422 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 274' ' ' ALA . . . . . 0.589 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.42 -39.99 70.73 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.917 179.186 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 275' ' ' ASN . . . . . 0.574 ' O ' ' N ' ' A' ' 279' ' ' ALA . 2.8 p30 -38.55 97.64 0.14 Allowed Pre-proline 0 CA--C 1.528 0.131 0 O-C-N 123.585 0.553 . . . . 0.0 110.355 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -53.75 -43.27 59.37 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 122.565 2.177 . . . . 0.0 112.509 -178.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 89.0 mt -64.42 -43.0 95.73 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.953 -179.289 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 91.8 mt -95.82 -1.33 49.82 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.756 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 279' ' ' ALA . . . . . 0.574 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.63 -35.18 78.75 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.352 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.13 20.35 0.11 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.892 -178.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 281' ' ' LEU . . . . . 0.488 ' H ' ' C ' ' A' ' 279' ' ' ALA . 13.9 mt -74.8 120.05 79.7 Favored Pre-proline 0 N--CA 1.442 -0.862 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.821 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -51.33 -39.09 63.47 Favored 'Trans proline' 0 C--N 1.313 -1.321 0 C-N-CA 122.425 2.083 . . . . 0.0 111.817 179.358 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.71 -50.6 63.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.947 0.403 . . . . 0.0 110.05 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 76.6 t -61.51 -43.8 97.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.199 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -57.64 -41.48 81.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.212 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -90.84 0.62 57.42 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.32 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt 59.0 43.18 18.08 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.811 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -94.52 41.6 1.09 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.377 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 54.0 t -119.16 135.6 59.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-O 120.949 0.404 . . . . 0.0 110.012 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -132.81 162.87 30.38 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.619 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.68 155.14 32.95 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.462 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 79.8 mt -94.07 -1.63 54.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.299 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 120.75 165.49 12.76 Favored Glycine 0 N--CA 1.464 0.512 0 N-CA-C 110.584 -1.006 . . . . 0.0 110.584 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 6.7 m -86.98 -62.3 1.53 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.83 0.347 . . . . 0.0 110.879 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 295' ' ' GLU . . . . . 0.446 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.9 mm-40 -69.36 -3.94 16.2 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.642 -179.519 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 24.5 p -77.01 32.24 0.14 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.65 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 297' ' ' PHE . . . . . 0.505 ' CD2' HG22 ' A' ' 70' ' ' THR . 68.5 t80 -60.31 -46.13 90.95 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.704 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 298' ' ' ARG . . . . . 0.619 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.1 mtt85 -80.76 135.09 35.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.477 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.462 ' H ' HG11 ' A' ' 51' ' ' VAL . 17.7 tp -114.09 117.07 30.23 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 120.861 0.362 . . . . 0.0 110.394 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 300' ' ' ASP . . . . . 0.618 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.1 p-10 -165.2 -176.63 4.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.755 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 82.8 t80 -46.51 -43.57 16.96 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.424 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -67.06 -40.24 87.03 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.001 0.429 . . . . 0.0 110.757 179.203 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 303' ' ' SER . . . . . 0.618 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 60.2 p -56.22 -36.11 68.09 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.131 -179.086 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 304' ' ' ALA . . . . . 0.55 ' HB2' ' SD ' ' A' ' 215' ' ' MET . . . -57.31 -51.34 69.77 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.215 179.332 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 91.7 mtp -56.01 -44.18 78.43 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -65.79 -42.59 90.53 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.165 0.507 . . . . 0.0 110.437 179.08 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 307' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 303' ' ' SER . 55.7 t -64.06 -42.92 97.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.255 179.358 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 43.6 tp -59.77 -41.94 92.19 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.129 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -62.44 -39.0 91.93 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.299 179.31 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 310' ' ' ARG . . . . . 0.441 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.5 ttt85 -63.7 -43.79 95.56 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.374 179.389 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 89.4 mt -63.47 -41.94 98.6 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.572 179.444 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.3 ttmt -63.2 -33.29 75.16 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.35 179.263 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.42 -23.58 22.11 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.466 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 314' ' ' LEU . . . . . 0.486 HD22 ' CE2' ' A' ' 315' ' ' PHE . 6.7 tt -62.31 -43.15 99.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.491 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 315' ' ' PHE . . . . . 0.486 ' CE2' HD22 ' A' ' 314' ' ' LEU . 89.8 m-85 . . . . . 0 C--O 1.221 -0.444 0 CA-C-O 118.09 -0.957 . . . . 0.0 110.3 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -99.64 136.03 40.18 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.134 0.492 . . . . 0.0 110.475 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.482 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -92.44 178.68 1.58 Allowed Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.47 -179.692 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.482 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.7 Cg_exo -61.71 147.19 95.87 Favored 'Trans proline' 0 C--N 1.303 -1.843 0 C-N-CA 122.814 2.343 . . . . 0.0 112.211 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.487 ' HE ' HD12 ' A' ' 39' ' ' LEU . 35.5 ptt180 -136.53 142.45 43.45 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.565 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -79.63 116.88 20.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.508 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.445 ' O ' HG23 ' A' ' 30' ' ' ILE . 9.4 tp -111.13 130.39 64.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.557 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 13.9 t -71.3 142.18 50.47 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.674 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.478 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.4 t0 -139.24 -179.97 6.18 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.478 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.478 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 78.1 p -74.0 -37.05 64.54 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.671 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.8 ttt85 -46.86 -94.78 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.31 -179.343 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -166.07 -27.06 0.02 OUTLIER Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 62.5 m -168.71 105.76 0.44 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.757 0.313 . . . . 0.0 110.598 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.644 ' CD2' HD13 ' A' ' 140' ' ' LEU . 65.5 t60 -128.86 146.55 50.91 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 120.956 0.408 . . . . 0.0 110.222 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.619 HG22 ' N ' ' A' ' 39' ' ' LEU . 95.4 m -129.84 165.53 21.8 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.3 -179.669 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.619 ' N ' HG22 ' A' ' 38' ' ' THR . 78.5 mt -120.21 127.28 52.29 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.691 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -65.41 -44.86 86.1 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.606 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 38.3 p -165.64 154.97 12.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.458 179.385 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.491 ' CD ' ' H ' ' A' ' 42' ' ' GLN . 14.5 mp0 -44.82 101.19 0.25 Allowed Pre-proline 0 C--O 1.235 0.333 0 O-C-N 123.57 0.544 . . . . 0.0 110.505 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -57.62 130.25 37.83 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.339 2.026 . . . . 0.0 112.16 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -82.69 -25.03 33.37 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.643 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.538 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.8 mtm-85 -120.89 134.53 55.29 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.143 0.497 . . . . 0.0 110.237 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.1 mt -129.75 133.23 65.2 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.327 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.639 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 46.2 t -125.1 130.92 73.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 CA-C-O 120.942 0.401 . . . . 0.0 110.151 178.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.609 ' OG ' HD12 ' A' ' 117' ' ' LEU . 4.2 m -154.99 166.6 33.06 Favored 'General case' 0 C--O 1.225 -0.22 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.459 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 73.2 p -124.55 8.92 8.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.417 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.35 125.84 33.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.872 0.368 . . . . 0.0 110.584 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.467 HG11 ' H ' ' A' ' 299' ' ' LEU . 84.9 t -65.83 -44.58 92.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.611 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 18.5 m -62.59 -44.41 96.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.678 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 52.2 tp -62.39 -41.53 98.72 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.661 -179.344 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.438 ' O ' HD13 ' A' ' 58' ' ' LEU . 71.9 m -58.04 -44.61 87.48 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.183 -179.183 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.31 -62.09 5.44 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 179.679 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.5 t -47.89 -35.64 10.81 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.5 mt -61.82 -44.55 96.63 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.069 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.438 HD13 ' O ' ' A' ' 54' ' ' THR . 9.1 mp -65.27 -41.17 94.47 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.297 178.132 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.412 ' HB1' ' NE ' ' A' ' 169' ' ' ARG . . . -63.85 -41.45 97.8 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.611 -179.193 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.414 ' O ' HG23 ' A' ' 60' ' ' ILE . 8.0 tp -87.75 16.8 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.724 -179.496 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 56.32 84.39 0.09 Allowed 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.814 -179.63 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.28 58.44 0.08 OUTLIER Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 120.992 0.425 . . . . 0.0 109.931 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -50.91 152.72 9.61 Favored 'Trans proline' 0 C--N 1.296 -2.205 0 C-N-CA 123.061 2.507 . . . . 0.0 112.307 -178.347 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.429 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -108.85 145.9 15.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.279 -179.789 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.78 -45.13 98.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.191 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.504 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -130.16 134.17 47.12 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.717 0.294 . . . . 0.0 110.389 -179.585 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.494 ' O ' ' N ' ' A' ' 98' ' ' LEU . 73.5 m -134.3 158.51 43.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.85 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.58 139.21 16.36 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.494 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.69 -162.83 0.09 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.86 0.362 . . . . 0.0 110.382 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.502 HG22 ' CD2' ' A' ' 297' ' ' PHE . 5.8 t -134.09 135.57 43.33 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.027 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.466 ' C ' ' O ' ' A' ' 70' ' ' THR . 0.9 OUTLIER 29.78 68.23 0.68 Allowed Pre-proline 0 N--CA 1.469 0.507 0 CA-C-O 121.181 0.515 . . . . 0.0 110.813 -179.569 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -60.8 145.23 99.3 Favored 'Trans proline' 0 C--N 1.301 -1.944 0 C-N-CA 122.737 2.291 . . . . 0.0 111.978 -178.191 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.539 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 44.9 p-10 -160.06 -32.62 0.06 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.674 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.539 ' N ' ' OD1' ' A' ' 73' ' ' ASN . 98.9 m-20 -63.75 -39.72 94.97 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.364 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -59.97 -48.33 82.16 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.476 -179.128 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.425 ' O ' ' O ' ' A' ' 77' ' ' ALA . 92.4 t -60.0 -24.75 30.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.125 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.526 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -45.64 173.0 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.53 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.565 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.3 p30 -62.06 177.69 0.44 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.424 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.564 ' C ' ' H ' ' A' ' 81' ' ' GLY . 35.1 p30 -45.81 85.64 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.985 0.421 . . . . 0.0 110.903 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.565 ' N ' ' O ' ' A' ' 78' ' ' ASP . 42.5 tp60 -67.21 13.45 0.06 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.25 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.564 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 117.92 -22.34 9.9 Favored Glycine 0 N--CA 1.463 0.439 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -107.75 116.22 31.55 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.945 0.402 . . . . 0.0 110.483 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 76.5 mt -98.71 0.63 44.96 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.478 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -92.23 6.84 45.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.917 0.389 . . . . 0.0 110.325 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.781 ' O ' HG22 ' A' ' 89' ' ' VAL . 27.4 mt-30 -99.88 -27.8 13.43 Favored 'General case' 0 C--O 1.222 -0.379 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.665 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 69.0 t-105 -63.42 -40.96 98.58 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.767 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.545 ' O ' ' N ' ' A' ' 91' ' ' LYS . 67.2 m -77.42 -53.34 7.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.888 -179.286 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -48.59 -51.14 29.35 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.946 -179.021 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.781 HG22 ' O ' ' A' ' 85' ' ' GLN . 15.9 m -68.78 -40.6 81.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.039 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.489 ' N ' HG23 ' A' ' 89' ' ' VAL . . . -72.35 -22.92 61.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.753 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.545 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.0 tttm -61.41 -45.92 92.31 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.391 -179.432 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.438 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.6 mm-40 -90.37 -94.56 0.12 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.128 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.608 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.9 mtt180 -143.49 59.63 1.39 Allowed 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.437 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.7 pttp 34.06 26.32 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.282 0.563 . . . . 0.0 110.517 -179.368 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.608 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.5 tt -48.32 123.15 6.09 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.856 -177.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.45 ' O ' HD23 ' A' ' 95' ' ' LEU . 98.9 mm-40 -83.31 -170.44 3.05 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.314 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.617 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 82.7 mtp180 -73.45 137.89 44.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.952 0.406 . . . . 0.0 110.231 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.494 ' N ' ' O ' ' A' ' 67' ' ' SER . 88.3 mt -86.41 -165.96 1.41 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.83 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.532 ' O ' ' CD2' ' A' ' 99' ' ' TYR . 47.1 p90 -168.51 120.0 0.79 Allowed 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.094 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.488 ' C ' ' O ' ' A' ' 99' ' ' TYR . 42.9 mm -29.67 121.4 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 O-C-N 123.392 0.433 . . . . 0.0 110.898 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 113.7 28.12 3.31 Favored Glycine 0 N--CA 1.463 0.473 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 -179.347 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.579 ' N ' ' CD ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -143.86 45.5 0.57 Allowed Pre-proline 0 C--N 1.324 -0.54 0 CA-C-O 121.298 0.57 . . . . 0.0 110.463 179.794 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 30.4 Cg_endo -62.14 144.03 95.32 Favored 'Trans proline' 0 C--N 1.297 -2.145 0 C-N-CA 122.572 2.181 . . . . 0.0 111.972 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.462 ' O ' HG23 ' A' ' 108' ' ' VAL . 25.3 t -173.17 120.76 0.36 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.573 179.426 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.15 -40.96 64.44 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.188 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -65.97 -40.0 90.85 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.759 -179.374 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.05 -39.62 94.49 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.667 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 104' ' ' SER . 71.2 t -67.58 -43.73 86.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.638 179.593 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.44 -39.3 92.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.527 -179.115 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.438 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.78 -23.67 63.47 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.561 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.526 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.4 mm-40 -90.89 4.38 52.02 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.769 -179.543 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.538 ' O ' ' NE ' ' A' ' 45' ' ' ARG . 10.5 tpt 22.61 64.37 0.34 Allowed Pre-proline 0 N--CA 1.471 0.598 0 O-C-N 123.5 0.5 . . . . 0.0 111.124 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.466 ' HG2' HD11 ' A' ' 116' ' ' ILE . 68.2 Cg_endo -79.33 169.4 18.87 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 123.083 2.522 . . . . 0.0 111.938 -178.093 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.524 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 98.7 m-20 -112.33 -44.72 3.35 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.174 179.507 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 39.1 tp -119.9 121.04 38.15 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.147 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.466 HD11 ' HG2' ' A' ' 113' ' ' PRO . 96.8 mt -118.18 131.32 71.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.769 -179.7 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.609 HD12 ' OG ' ' A' ' 48' ' ' SER . 31.5 mt -106.06 132.11 52.53 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.205 -179.587 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.497 HD12 HG23 ' A' ' 139' ' ' THR . 98.6 mt -117.76 136.08 56.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.55 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 86.4 p -71.48 151.41 43.97 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.608 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.32 -49.95 75.57 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.582 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -149.29 153.6 37.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.505 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 168.48 -169.69 41.75 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.88 -35.6 92.23 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.449 ' OD1' ' O ' ' A' ' 124' ' ' ASP . 44.3 p-10 -88.46 119.88 29.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.903 0.383 . . . . 0.0 110.598 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.446 ' O ' HD12 ' A' ' 129' ' ' LEU . 40.6 t -63.0 144.03 57.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.405 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.511 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.55 -43.07 8.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.779 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.8 tp -62.64 -42.42 99.59 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.821 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.85 -10.44 53.06 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.405 -179.294 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.446 HD12 ' O ' ' A' ' 125' ' ' SER . 82.1 mt -115.99 -24.3 8.16 Favored 'General case' 0 C--O 1.225 -0.222 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.56 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' TYR . . . . . 0.522 ' CD1' HG21 ' A' ' 139' ' ' THR . 71.3 t80 -51.37 -49.51 61.34 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.914 -0.314 . . . . 0.0 110.558 -178.795 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.2 p-10 -66.09 -41.79 90.17 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.846 -0.342 . . . . 0.0 111.054 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.523 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 87.9 mt-30 -67.91 -36.49 80.28 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.751 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.466 HD12 HD11 ' A' ' 118' ' ' ILE . 96.5 mt -80.35 -42.09 23.55 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.003 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.3 t -57.39 -45.25 84.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.293 -179.05 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.6 m -62.46 -45.66 92.03 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.656 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 92.2 mt -62.4 -43.78 98.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.312 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.598 ' HB1' ' HD2' ' A' ' 138' ' ' PRO . . . -170.2 163.54 6.2 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.581 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.598 ' HD2' ' HB1' ' A' ' 137' ' ' ALA . 76.0 Cg_exo -42.14 110.67 0.16 Allowed 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.561 2.174 . . . . 0.0 112.118 179.31 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.522 HG21 ' CD1' ' A' ' 130' ' ' TYR . 2.8 m -87.34 127.76 35.19 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.237 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.644 HD13 ' CD2' ' A' ' 37' ' ' HIS . 34.3 tp -119.63 139.21 52.57 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.451 179.525 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.431 ' O ' ' OD2' ' A' ' 32' ' ' ASP . 81.7 mt -105.11 119.93 54.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-O 120.953 0.406 . . . . 0.0 110.852 -179.206 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.48 HD12 HD22 ' A' ' 117' ' ' LEU . 97.1 mt -135.67 132.7 51.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.639 179.144 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -64.59 147.99 51.75 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.465 179.361 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.511 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 87.3 t80 -82.48 122.67 28.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.814 -179.311 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.511 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 99.0 m-20 55.05 69.31 0.75 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.561 179.445 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 34.2 p-10 -125.62 0.49 7.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.576 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -150.92 115.96 5.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.867 0.365 . . . . 0.0 110.642 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 85.0 p -63.76 169.11 4.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.613 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.407 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.7 p-90 -51.83 -16.13 0.64 Allowed 'General case' 0 C--O 1.22 -0.457 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.258 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' GLN . . . . . 0.435 ' O ' HG23 ' A' ' 154' ' ' THR . 68.2 tp60 -70.19 -75.98 0.11 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.021 0.438 . . . . 0.0 110.614 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 11.1 t -62.58 -38.45 90.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.265 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 51.0 tp -60.16 -45.5 92.87 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.573 -178.353 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.407 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 45.4 tp -62.85 -41.63 99.43 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.612 178.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.435 HG23 ' O ' ' A' ' 150' ' ' GLN . 59.6 p -63.67 -35.01 79.15 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.251 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' GLN . . . . . 0.467 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.5 mm-40 -63.54 -41.99 98.43 Favored 'General case' 0 C--O 1.225 -0.203 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.344 179.272 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 91.5 mt -65.44 -39.09 91.65 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.413 178.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.562 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.09 -32.15 79.33 Favored Glycine 0 N--CA 1.46 0.264 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 -179.247 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.467 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.3 mt-10 -36.81 -25.26 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.752 0.31 . . . . 0.0 110.881 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.562 ' N ' ' O ' ' A' ' 157' ' ' GLY . 95.5 mt -59.17 148.61 6.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.346 179.084 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 74.7 p -69.13 137.72 53.63 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.879 -179.331 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 70.69 21.88 77.95 Favored Glycine 0 CA--C 1.519 0.335 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 179.426 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 59.8 m80 -124.35 -13.78 7.08 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 110.448 -0.204 . . . . 0.0 110.448 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -66.24 -59.9 3.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.506 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -51.79 -49.07 63.41 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.119 -179.377 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -60.41 -41.03 93.08 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.862 0.363 . . . . 0.0 110.448 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.58 -47.19 86.61 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.551 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -57.0 -39.96 75.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.25 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -61.69 -50.49 72.25 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.694 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.412 ' NE ' ' HB1' ' A' ' 59' ' ' ALA . 60.0 ttt85 -65.29 -43.89 89.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.458 179.497 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 95.3 mt -64.32 -43.55 97.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.412 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.28 -51.05 70.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.432 -179.048 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -63.79 -43.43 96.32 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.846 0.355 . . . . 0.0 110.539 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' PHE . . . . . 0.657 ' CE2' HD11 ' A' ' 177' ' ' LEU . 56.6 t80 -62.66 -44.44 96.26 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.084 0.468 . . . . 0.0 110.423 179.379 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -63.62 -39.87 95.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.475 -179.264 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -62.97 -42.6 99.88 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.725 179.214 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -60.74 -44.55 96.52 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.24 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.657 HD11 ' CE2' ' A' ' 173' ' ' PHE . 85.1 mt -64.55 -41.07 96.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.875 178.741 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.24 -61.95 1.95 Allowed 'General case' 0 C--O 1.239 0.515 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.426 -179.238 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.72 -47.12 85.68 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.358 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -52.83 -41.55 64.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.314 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -63.79 -33.71 76.28 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.36 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 182' ' ' GLU . . . . . 0.405 ' O ' ' HG2' ' A' ' 182' ' ' GLU . 69.6 tt0 -90.92 8.52 34.66 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.539 0.685 . . . . 0.0 110.302 -178.777 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -104.24 -32.22 9.22 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.088 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.4 pt -128.04 147.77 32.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.886 0.374 . . . . 0.0 110.635 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -139.93 131.31 26.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.478 179.004 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 186' ' ' LEU . . . . . 0.585 HD22 ' N ' ' A' ' 186' ' ' LEU . 3.6 mm? -85.36 133.32 42.67 Favored Pre-proline 0 N--CA 1.448 -0.559 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.088 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -44.02 157.9 0.14 Allowed 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.645 2.23 . . . . 0.0 112.194 179.462 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 188' ' ' PRO . . . . . 0.49 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.5 Cg_endo -63.12 114.78 2.61 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.716 2.277 . . . . 0.0 111.632 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 189' ' ' GLN . . . . . 0.49 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.7 mt-30 156.03 148.11 0.0 OUTLIER Pre-proline 0 C--N 1.34 0.194 0 O-C-N 124.401 1.063 . . . . 0.0 110.894 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -73.58 144.56 36.02 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 122.597 2.198 . . . . 0.0 111.905 177.703 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.496 HG23 ' OG ' ' A' ' 258' ' ' SER . 2.1 p -124.78 158.93 31.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.229 0.538 . . . . 0.0 110.109 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 192' ' ' THR . . . . . 0.481 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 38.1 p -143.16 165.18 28.13 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 121.396 0.617 . . . . 0.0 110.973 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 193' ' ' ALA . . . . . 0.445 ' HA ' ' H ' ' A' ' 260' ' ' PHE . . . -135.15 128.93 33.03 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 121.377 0.608 . . . . 0.0 110.358 178.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.509 HD11 HD23 ' A' ' 259' ' ' LEU . 47.2 pt -146.57 148.97 16.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.972 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 195' ' ' VAL . . . . . 0.74 HG13 ' CD1' ' A' ' 262' ' ' PHE . 72.3 t -117.73 123.15 71.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.183 0.516 . . . . 0.0 109.932 178.643 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -134.35 106.91 7.33 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.289 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 94.2 m -130.85 130.44 43.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.872 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.41 ' O ' ' N ' ' A' ' 201' ' ' HIS . . . -82.73 -37.03 25.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.258 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.5 -67.08 0.26 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.297 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -71.91 -9.77 58.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.379 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 201' ' ' HIS . . . . . 0.41 ' N ' ' O ' ' A' ' 198' ' ' ALA . 60.3 t-80 60.38 57.97 2.7 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.591 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 47.6 p -166.66 153.38 8.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.57 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.29 144.13 24.47 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.946 0.403 . . . . 0.0 110.426 179.118 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -135.4 138.67 43.51 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.525 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 19.0 mt -106.21 125.26 50.77 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 206' ' ' TRP . . . . . 0.557 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 75.0 m95 -82.12 167.51 18.68 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.593 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 207' ' ' THR . . . . . 0.45 HG22 ' C ' ' A' ' 206' ' ' TRP . 0.1 OUTLIER -157.18 171.56 7.28 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.595 -178.674 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.8 -37.26 84.63 Favored 'Trans proline' 0 C--N 1.302 -1.915 0 C-N-CA 122.598 2.199 . . . . 0.0 112.183 179.152 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -70.89 -34.73 71.87 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.713 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 21.4 m -61.23 151.08 32.63 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.529 -179.411 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.65 -37.01 82.47 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.392 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 212' ' ' GLN . . . . . 0.557 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 55.0 tt0 -64.8 -40.31 95.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.477 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.78 -43.39 91.82 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -62.74 -44.15 96.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.809 0.338 . . . . 0.0 110.262 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 215' ' ' MET . . . . . 0.546 ' SD ' ' HB2' ' A' ' 304' ' ' ALA . 65.3 ttp -59.46 -47.82 84.03 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.221 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 87.0 mt -60.4 -41.07 93.1 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 217' ' ' GLU . . . . . 0.448 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.3 tp10 -58.18 -38.07 75.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.074 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -65.32 -38.24 89.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.743 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 95.7 mt -64.1 -42.79 96.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.684 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.49 45.45 0.08 OUTLIER Glycine 0 N--CA 1.462 0.416 0 N-CA-C 111.111 -0.795 . . . . 0.0 111.111 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 221' ' ' PHE . . . . . 0.448 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 27.4 m-85 -128.29 155.6 44.34 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.83 0.347 . . . . 0.0 110.482 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.476 ' O ' HG13 ' A' ' 191' ' ' VAL . 7.5 p -107.11 122.35 46.32 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-O 121.225 0.536 . . . . 0.0 110.215 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.475 HD22 ' C ' ' A' ' 222' ' ' THR . 4.3 mm? -101.47 133.06 46.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.016 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.76 159.67 14.8 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.471 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.33 115.15 29.76 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.377 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.493 HD12 ' N ' ' A' ' 226' ' ' LEU . 9.0 mp -53.08 156.83 3.35 Favored Pre-proline 0 N--CA 1.447 -0.62 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.811 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -60.3 145.36 98.75 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 C-N-CA 122.735 2.29 . . . . 0.0 112.091 179.204 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.24 -3.22 59.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.521 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.07 -40.94 5.7 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 230' ' ' LEU . . . . . 0.503 ' O ' ' N ' ' A' ' 233' ' ' SER . 68.7 mt -79.36 -17.25 54.84 Favored 'General case' 0 C--O 1.219 -0.542 0 CA-C-O 121.04 0.447 . . . . 0.0 110.297 -179.725 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 54.6 t-20 -40.48 -49.51 2.89 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.842 0.354 . . . . 0.0 110.717 -179.375 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -87.69 15.46 6.86 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.241 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 233' ' ' SER . . . . . 0.503 ' N ' ' O ' ' A' ' 230' ' ' LEU . 77.9 p -60.62 -35.2 75.56 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.608 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 234' ' ' GLN . . . . . 0.522 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.6 tt0 -119.54 -69.34 0.85 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.717 179.32 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.0 m -69.72 102.1 1.83 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.955 0.407 . . . . 0.0 110.592 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -93.78 57.56 2.52 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.34 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -144.63 -122.5 1.58 Allowed Glycine 0 N--CA 1.462 0.397 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -135.44 111.78 9.79 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.0 0.428 . . . . 0.0 110.374 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 239' ' ' ARG . . . . . 0.524 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.5 mtt180 -148.27 58.26 1.08 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.596 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -69.47 -32.35 71.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.571 179.386 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 241' ' ' ASP . . . . . 0.451 ' OD2' ' O ' ' A' ' 144' ' ' TYR . 64.8 t0 -56.85 -47.3 80.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.266 -179.042 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 242' ' ' ILE . . . . . 0.435 ' O ' ' O ' ' A' ' 239' ' ' ARG . 17.8 tt -139.65 156.17 25.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.851 0.358 . . . . 0.0 110.371 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.451 HG22 HD13 ' A' ' 245' ' ' LEU . 96.2 mt -106.07 106.61 20.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.947 0.403 . . . . 0.0 110.382 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 244' ' ' GLN . . . . . 0.589 ' O ' HD12 ' A' ' 245' ' ' LEU . 88.3 mt-30 -110.55 110.06 20.63 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.329 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.589 HD12 ' O ' ' A' ' 244' ' ' GLN . 9.6 mp -121.77 -168.14 1.65 Allowed 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.634 179.54 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 246' ' ' GLY . . . . . 0.522 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.83 -16.57 0.05 OUTLIER Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 247' ' ' GLY . . . . . 0.668 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -61.09 156.41 33.49 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -63.49 21.63 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.783 0.325 . . . . 0.0 110.563 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 249' ' ' ASN . . . . . 0.668 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.8 m-20 -96.93 -6.4 35.72 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.756 0.313 . . . . 0.0 110.492 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 91.8 mt -79.5 -21.72 44.92 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.931 179.18 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.79 -51.36 70.32 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.648 -179.466 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.33 -5.45 58.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.463 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -80.91 -74.25 1.14 Allowed Glycine 0 CA--C 1.522 0.528 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 80.8 mt -70.17 126.09 28.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.888 0.375 . . . . 0.0 110.344 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -59.69 -39.22 83.82 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.336 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 83.28 51.84 4.0 Favored Glycine 0 CA--C 1.521 0.446 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -95.58 -15.52 22.74 Favored 'General case' 0 C--N 1.331 -0.223 0 O-C-N 122.823 -0.222 . . . . 0.0 110.578 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 258' ' ' SER . . . . . 0.496 ' OG ' HG23 ' A' ' 191' ' ' VAL . 3.4 t 174.77 89.14 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.161 0.505 . . . . 0.0 110.268 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.85 HD12 ' N ' ' A' ' 259' ' ' LEU . 0.9 OUTLIER -94.76 124.2 38.65 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.857 0.361 . . . . 0.0 110.985 -178.729 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 260' ' ' PHE . . . . . 0.445 ' H ' ' HA ' ' A' ' 193' ' ' ALA . 15.7 m-30 -93.61 146.41 23.83 Favored 'General case' 0 CA--C 1.497 -1.064 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.543 179.202 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 85.0 mt -122.21 148.87 44.43 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.554 -179.431 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.74 ' CD1' HG13 ' A' ' 195' ' ' VAL . 2.5 p90 -77.17 -139.07 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.436 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 263' ' ' ALA . . . . . 0.654 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -51.15 77.22 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.353 0 O-C-N 123.435 0.459 . . . . 0.0 111.108 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 264' ' ' GLY . . . . . 0.624 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.43 104.64 0.19 Allowed Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 265' ' ' ASP . . . . . 0.588 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.6 m-20 -80.14 -177.77 6.23 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 122.703 -0.293 . . . . 0.0 110.718 -179.549 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -40.8 -17.78 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.496 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 267' ' ' LYS . . . . . 0.588 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.01 -51.3 48.69 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.758 179.111 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -64.11 -46.5 83.92 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.98 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 269' ' ' ALA . . . . . 0.572 ' HB1' ' OH ' ' A' ' 273' ' ' TYR . . . -61.76 -34.83 76.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.697 0.761 . . . . 0.0 109.883 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -62.93 -35.0 78.65 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.185 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.09 -43.12 14.18 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.184 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 272' ' ' ILE . . . . . 0.589 ' C ' ' H ' ' A' ' 274' ' ' ALA . 5.0 tt -51.64 -33.77 15.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.552 -178.654 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 273' ' ' TYR . . . . . 0.572 ' OH ' ' HB1' ' A' ' 269' ' ' ALA . 16.8 m-85 -54.58 -1.67 0.03 OUTLIER 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.767 -179.4 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 274' ' ' ALA . . . . . 0.589 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.5 -39.94 70.49 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.942 179.194 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 275' ' ' ASN . . . . . 0.574 ' O ' ' N ' ' A' ' 279' ' ' ALA . 3.1 p30 -38.52 97.52 0.14 Allowed Pre-proline 0 C--N 1.339 0.135 0 O-C-N 123.532 0.52 . . . . 0.0 110.429 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -53.72 -43.17 60.23 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 C-N-CA 122.577 2.184 . . . . 0.0 112.511 -178.823 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 88.9 mt -64.36 -43.01 95.88 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.008 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 91.7 mt -95.95 -1.06 49.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.75 -179.398 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 279' ' ' ALA . . . . . 0.574 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.65 -34.93 78.08 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.501 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.32 20.36 0.11 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.841 -179.097 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 281' ' ' LEU . . . . . 0.485 ' H ' ' C ' ' A' ' 279' ' ' ALA . 13.7 mt -74.68 119.82 78.54 Favored Pre-proline 0 N--CA 1.442 -0.837 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.776 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -51.15 -39.37 61.31 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 C-N-CA 122.507 2.138 . . . . 0.0 111.922 179.18 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.74 -50.54 63.25 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.898 0.38 . . . . 0.0 110.033 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 76.8 t -61.42 -43.88 97.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.169 179.576 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -57.56 -41.21 80.6 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.207 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -91.17 0.47 57.52 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.258 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt 59.26 43.91 16.25 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.84 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -95.01 41.2 1.09 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.32 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 53.9 t -119.13 135.58 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-O 121.018 0.437 . . . . 0.0 110.061 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -132.8 162.76 30.65 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.527 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.37 155.08 32.59 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.515 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 80.8 mt -94.09 -1.75 53.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.246 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 120.89 165.38 12.69 Favored Glycine 0 N--CA 1.464 0.504 0 N-CA-C 110.489 -1.045 . . . . 0.0 110.489 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 7.3 m -87.08 -62.47 1.5 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.829 0.347 . . . . 0.0 110.971 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 295' ' ' GLU . . . . . 0.45 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.5 mm-40 -68.71 -4.35 15.46 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.687 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 24.9 p -76.78 32.16 0.13 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.674 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 297' ' ' PHE . . . . . 0.502 ' CD2' HG22 ' A' ' 70' ' ' THR . 68.3 t80 -60.48 -46.21 90.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.664 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 298' ' ' ARG . . . . . 0.617 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.1 mtt85 -80.68 134.89 35.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.453 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.467 ' H ' HG11 ' A' ' 51' ' ' VAL . 18.6 tp -113.7 116.7 29.85 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-O 120.942 0.401 . . . . 0.0 110.385 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 300' ' ' ASP . . . . . 0.619 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.2 p-10 -165.0 -176.87 4.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.723 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -46.66 -43.22 17.45 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.373 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -67.15 -40.21 86.67 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 121.028 0.442 . . . . 0.0 110.752 179.101 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 303' ' ' SER . . . . . 0.619 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 59.6 p -56.34 -36.27 68.58 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.079 -179.023 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 304' ' ' ALA . . . . . 0.546 ' HB2' ' SD ' ' A' ' 215' ' ' MET . . . -57.33 -51.47 69.25 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 179.404 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 91.9 mtp -55.71 -44.28 77.27 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -65.8 -42.75 90.32 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.227 0.537 . . . . 0.0 110.454 179.124 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 307' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 303' ' ' SER . 54.9 t -64.04 -42.82 96.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.262 179.356 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 44.2 tp -59.77 -41.92 92.16 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.041 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -62.79 -38.77 91.95 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.116 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 310' ' ' ARG . . . . . 0.449 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.6 ttt85 -63.56 -43.83 95.91 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.32 179.492 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 87.7 mt -63.37 -42.09 98.83 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.46 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.4 ttmt -63.03 -33.24 75.0 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.39 179.255 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.84 -23.47 21.67 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.395 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 314' ' ' LEU . . . . . 0.486 HD22 ' CE2' ' A' ' 315' ' ' PHE . 6.7 tt -62.31 -43.27 99.22 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.488 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 315' ' ' PHE . . . . . 0.486 ' CE2' HD22 ' A' ' 314' ' ' LEU . 90.4 m-85 . . . . . 0 C--O 1.22 -0.486 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.317 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -99.5 136.48 39.37 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.174 0.512 . . . . 0.0 110.424 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.485 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -91.58 178.7 1.65 Allowed Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.469 -179.707 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.485 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.3 Cg_exo -61.76 147.51 95.14 Favored 'Trans proline' 0 C--N 1.301 -1.948 0 C-N-CA 122.955 2.437 . . . . 0.0 112.207 179.452 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.472 ' HE ' HD12 ' A' ' 39' ' ' LEU . 35.3 ptt180 -135.02 142.35 46.38 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.591 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -79.01 116.85 19.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.496 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.425 ' O ' HG23 ' A' ' 30' ' ' ILE . 9.5 tp -109.93 130.61 62.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.494 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.8 t -70.54 141.59 51.86 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.685 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.421 ' OD2' ' O ' ' A' ' 141' ' ' ILE . 24.8 t70 -139.83 177.1 8.19 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.452 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.4 p -73.11 -36.57 66.77 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.707 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -47.62 -95.05 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.275 -179.302 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -166.15 -25.54 0.02 OUTLIER Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 62.7 m -168.5 106.42 0.47 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.691 0.281 . . . . 0.0 110.633 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 51.5 t-80 -129.79 144.2 51.18 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-O 121.016 0.436 . . . . 0.0 110.099 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.626 HG22 ' N ' ' A' ' 39' ' ' LEU . 95.9 m -128.47 166.46 18.72 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.338 -179.559 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.626 ' N ' HG22 ' A' ' 38' ' ' THR . 81.4 mt -121.08 127.73 51.93 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.66 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -63.93 -44.64 92.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.689 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 38.3 p -165.45 155.36 12.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.45 179.285 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.519 ' CD ' ' H ' ' A' ' 42' ' ' GLN . 14.3 mp0 -42.33 100.07 0.22 Allowed Pre-proline 0 C--O 1.236 0.379 0 O-C-N 123.47 0.481 . . . . 0.0 110.564 179.239 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -56.87 129.3 33.82 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 122.362 2.041 . . . . 0.0 112.191 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -83.89 -24.16 30.92 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.649 179.387 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.539 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.6 mtm-85 -121.26 134.53 55.18 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.149 0.499 . . . . 0.0 110.193 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.2 mt -130.68 133.34 63.52 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.313 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.598 -179.593 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 47.0 t -124.91 130.87 73.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 CA-C-O 120.992 0.425 . . . . 0.0 110.039 179.034 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.595 ' OG ' HD12 ' A' ' 117' ' ' LEU . 4.6 m -154.32 166.38 33.37 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.513 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 67.4 p -124.45 8.96 8.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.389 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.94 125.44 33.36 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.599 -179.542 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.454 HG11 ' H ' ' A' ' 299' ' ' LEU . 84.5 t -65.51 -44.44 94.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.557 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.3 m -62.68 -44.25 96.72 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.598 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 52.1 tp -62.46 -41.48 98.78 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.573 -179.341 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.445 ' O ' HD13 ' A' ' 58' ' ' LEU . 73.3 m -57.83 -44.59 86.53 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.249 -179.286 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.26 -62.1 5.44 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.896 -0.881 . . . . 0.0 110.896 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.6 t -48.16 -35.67 12.09 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.6 mt -61.76 -44.42 96.92 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.161 179.302 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.445 HD13 ' O ' ' A' ' 54' ' ' THR . 9.1 mp -65.47 -41.06 93.75 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.412 177.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.404 ' HB1' ' NE ' ' A' ' 169' ' ' ARG . . . -63.78 -41.45 97.94 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.706 -179.289 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.411 ' O ' HG23 ' A' ' 60' ' ' ILE . 8.1 tp -87.8 16.77 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.82 -179.655 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 56.34 84.49 0.08 Allowed 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.828 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.22 58.52 0.08 OUTLIER Pre-proline 0 C--N 1.328 -0.368 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -51.24 152.94 10.4 Favored 'Trans proline' 0 C--N 1.294 -2.335 0 C-N-CA 123.148 2.566 . . . . 0.0 112.206 -178.309 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.428 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -108.76 145.73 15.3 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.265 -179.685 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.68 -45.31 97.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.212 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.5 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -130.18 134.33 47.22 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.803 0.335 . . . . 0.0 110.352 -179.564 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.488 ' O ' ' N ' ' A' ' 98' ' ' LEU . 75.7 m -134.55 158.73 43.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.913 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.6 139.19 16.32 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.484 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.62 -162.82 0.09 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.893 0.378 . . . . 0.0 110.401 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.511 HG22 ' CD2' ' A' ' 297' ' ' PHE . 5.8 t -134.03 135.18 43.19 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.065 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.468 ' C ' ' O ' ' A' ' 70' ' ' THR . 0.8 OUTLIER 29.76 68.43 0.67 Allowed Pre-proline 0 N--CA 1.469 0.477 0 CA-C-O 121.138 0.494 . . . . 0.0 110.853 -179.522 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_exo -61.08 145.2 99.22 Favored 'Trans proline' 0 C--N 1.3 -1.985 0 C-N-CA 122.746 2.297 . . . . 0.0 111.842 -178.105 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.527 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 44.8 p-10 -159.86 -31.88 0.06 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.725 179.672 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.539 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 98.7 m-20 -64.45 -39.47 93.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.37 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.2 ttt180 -60.09 -48.56 81.22 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.354 -179.303 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.424 ' O ' ' O ' ' A' ' 77' ' ' ALA . 95.3 t -60.05 -25.0 31.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.16 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.539 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -45.59 172.89 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.614 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.568 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.3 p30 -61.91 177.68 0.42 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.484 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.563 ' C ' ' H ' ' A' ' 81' ' ' GLY . 36.2 p30 -45.64 85.55 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.95 0.405 . . . . 0.0 110.939 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.568 ' N ' ' O ' ' A' ' 78' ' ' ASP . 42.8 tp60 -67.35 13.56 0.07 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.235 0.541 . . . . 0.0 110.201 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.563 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 117.93 -22.55 9.79 Favored Glycine 0 N--CA 1.463 0.448 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -107.87 116.4 31.89 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.963 0.411 . . . . 0.0 110.415 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 76.1 mt -98.8 0.56 44.6 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.542 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -91.92 6.76 45.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.326 -179.642 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.779 ' O ' HG22 ' A' ' 89' ' ' VAL . 27.3 mt-30 -100.17 -26.96 13.76 Favored 'General case' 0 C--O 1.221 -0.441 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.733 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.1 t-105 -64.01 -40.75 97.03 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.952 -179.663 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.545 ' O ' ' N ' ' A' ' 91' ' ' LYS . 67.9 m -77.64 -53.33 7.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.053 -179.624 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -48.55 -51.05 29.57 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.919 -179.08 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.779 HG22 ' O ' ' A' ' 85' ' ' GLN . 15.7 m -68.83 -40.94 81.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.091 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.5 ' N ' HG23 ' A' ' 89' ' ' VAL . . . -71.87 -23.03 61.44 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.641 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.545 ' N ' ' O ' ' A' ' 87' ' ' SER . 65.9 tttm -61.52 -45.93 92.09 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.347 -179.31 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.441 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.6 mm-40 -90.27 -94.65 0.12 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.155 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.609 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.9 mtt180 -143.45 59.59 1.39 Allowed 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.437 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.7 pttp 34.24 26.08 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.247 0.546 . . . . 0.0 110.454 -179.568 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.609 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.4 tt -48.35 123.34 6.38 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.897 -177.769 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.452 ' O ' HD23 ' A' ' 95' ' ' LEU . 98.9 mm-40 -83.46 -170.6 3.13 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.275 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.615 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 83.0 mtp180 -73.56 137.62 44.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.984 0.421 . . . . 0.0 110.248 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.488 ' N ' ' O ' ' A' ' 67' ' ' SER . 90.1 mt -86.13 -166.18 1.47 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.899 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.532 ' O ' ' CD2' ' A' ' 99' ' ' TYR . 47.9 p90 -168.05 120.08 0.85 Allowed 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.084 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.488 ' C ' ' O ' ' A' ' 99' ' ' TYR . 43.2 mm -29.75 121.26 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 O-C-N 123.332 0.395 . . . . 0.0 110.922 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 113.87 28.17 3.25 Favored Glycine 0 N--CA 1.462 0.387 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 -179.306 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.578 ' N ' ' CD ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -143.99 45.81 0.59 Allowed Pre-proline 0 C--N 1.322 -0.594 0 CA-C-O 121.203 0.525 . . . . 0.0 110.436 179.791 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 29.6 Cg_endo -62.06 143.83 95.39 Favored 'Trans proline' 0 C--N 1.295 -2.277 0 C-N-CA 122.667 2.245 . . . . 0.0 111.815 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.455 ' O ' HG23 ' A' ' 108' ' ' VAL . 27.2 t -173.13 120.73 0.36 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.47 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.25 -40.69 64.43 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.192 179.516 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.16 -39.85 90.09 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.7 -179.396 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.1 -39.78 94.8 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.673 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 104' ' ' SER . 69.7 t -67.7 -43.75 86.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.596 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.5 -39.31 93.09 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.552 -179.095 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.441 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.68 -23.5 63.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.542 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.527 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.4 mm-40 -91.26 4.77 51.48 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.7 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.539 ' O ' ' NE ' ' A' ' 45' ' ' ARG . 10.7 tpt 22.51 64.52 0.34 Allowed Pre-proline 0 N--CA 1.47 0.57 0 O-C-N 123.342 0.401 . . . . 0.0 111.204 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.452 ' HG2' HD11 ' A' ' 116' ' ' ILE . 65.3 Cg_endo -79.37 169.1 19.22 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 123.085 2.524 . . . . 0.0 111.679 -177.824 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.515 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 98.6 m-20 -112.57 -43.67 3.45 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.116 179.567 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.4 tp -120.64 121.39 38.22 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 120.884 0.373 . . . . 0.0 110.091 179.31 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.457 HD13 HD22 ' A' ' 133' ' ' LEU . 96.9 mt -118.84 130.85 73.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-O 120.888 0.375 . . . . 0.0 110.858 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.595 HD12 ' OG ' ' A' ' 48' ' ' SER . 32.1 mt -105.69 132.55 51.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.344 -179.471 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.417 HD12 HG23 ' A' ' 139' ' ' THR . 98.1 mt -117.89 135.97 56.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.565 -179.711 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 86.9 p -71.79 152.9 42.33 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.577 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -59.96 -50.03 75.35 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.617 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -149.37 153.72 37.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.535 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 169.71 -170.55 42.81 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -63.02 -35.13 91.68 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.449 ' OD1' ' O ' ' A' ' 124' ' ' ASP . 44.1 p-10 -88.04 119.69 28.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.922 0.391 . . . . 0.0 110.578 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.444 ' O ' HD12 ' A' ' 129' ' ' LEU . 40.4 t -63.39 144.42 56.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.429 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.52 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.51 -42.76 9.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.742 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 56.0 tp -62.76 -42.34 99.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.677 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.25 -11.04 58.7 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.375 -179.253 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.444 HD12 ' O ' ' A' ' 125' ' ' SER . 83.8 mt -115.07 -24.58 8.49 Favored 'General case' 0 C--O 1.225 -0.234 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.57 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' TYR . . . . . 0.52 ' N ' ' O ' ' A' ' 126' ' ' ALA . 77.3 t80 -51.35 -49.84 60.65 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.936 -0.306 . . . . 0.0 110.612 -178.765 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.7 p-10 -65.77 -41.71 91.73 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.267 179.449 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.521 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 88.2 mt-30 -68.06 -36.97 80.73 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.826 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.457 HD22 HD13 ' A' ' 116' ' ' ILE . 94.1 mt -79.9 -42.19 24.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.915 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.3 t -57.05 -45.03 83.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.216 -179.052 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.7 m -62.23 -45.66 92.32 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.615 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 92.9 mt -62.48 -43.94 98.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.361 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.609 ' HB1' ' HD2' ' A' ' 138' ' ' PRO . . . -169.91 163.98 6.4 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.593 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.609 ' HD2' ' HB1' ' A' ' 137' ' ' ALA . 78.2 Cg_exo -43.17 111.94 0.26 Allowed 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.544 2.163 . . . . 0.0 112.3 179.267 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.485 HG21 ' CD1' ' A' ' 130' ' ' TYR . 17.1 m -86.07 127.59 34.71 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.487 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.439 HD12 ' HA ' ' A' ' 140' ' ' LEU . 34.9 tp -119.78 138.0 53.62 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.256 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.421 ' O ' ' OD2' ' A' ' 32' ' ' ASP . 79.2 mt -104.88 121.0 56.26 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.184 0 CA-C-O 121.068 0.461 . . . . 0.0 110.879 -179.14 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.497 HD12 HD22 ' A' ' 117' ' ' LEU . 93.2 mt -136.86 132.73 47.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.553 179.359 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.542 HD21 ' CG ' ' A' ' 241' ' ' ASP . 60.9 t30 -64.19 151.16 44.17 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.534 179.319 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.516 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 89.0 t80 -86.03 122.52 30.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.786 -179.423 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.516 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 99.1 m-20 55.3 69.16 0.76 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.547 179.576 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 36.2 p-10 -125.26 0.61 7.76 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.589 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -151.15 116.15 5.26 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.823 0.344 . . . . 0.0 110.581 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 85.3 p -63.24 168.08 4.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.564 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.403 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.7 p-90 -51.13 -15.65 0.37 Allowed 'General case' 0 C--O 1.221 -0.405 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.313 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' GLN . . . . . 0.439 ' O ' HG23 ' A' ' 154' ' ' THR . 68.1 tp60 -71.09 -74.89 0.14 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.009 0.433 . . . . 0.0 110.581 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 11.2 t -62.68 -38.87 92.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.238 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 52.3 tp -60.23 -45.57 92.78 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.451 -178.268 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.403 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 45.5 tp -62.61 -41.69 99.15 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.597 178.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.439 HG23 ' O ' ' A' ' 150' ' ' GLN . 56.1 p -63.85 -34.8 78.75 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.202 -179.37 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' GLN . . . . . 0.481 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.4 mm-40 -63.69 -42.05 98.06 Favored 'General case' 0 C--O 1.224 -0.262 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.371 179.308 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 91.3 mt -65.44 -38.87 91.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.182 0.515 . . . . 0.0 110.376 178.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.557 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.34 -31.78 78.48 Favored Glycine 0 C--N 1.331 0.279 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 -179.246 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.481 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.3 mt-10 -37.18 -24.99 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.848 0.356 . . . . 0.0 110.948 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.557 ' N ' ' O ' ' A' ' 157' ' ' GLY . 93.8 mt -59.71 149.25 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.385 179.127 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 76.0 p -69.13 137.54 53.48 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.904 -179.43 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 70.41 22.28 77.65 Favored Glycine 0 CA--C 1.518 0.235 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 179.453 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 61.7 m80 -124.34 -14.14 7.01 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.621 0.248 . . . . 0.0 110.454 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -66.76 -59.55 3.47 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.56 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -51.73 -49.37 62.68 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.136 -179.418 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -60.3 -41.21 92.93 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.884 0.373 . . . . 0.0 110.501 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.38 -47.58 85.17 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.472 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.64 -40.06 74.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.306 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -61.7 -50.27 73.13 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.699 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.404 ' NE ' ' HB1' ' A' ' 59' ' ' ALA . 60.0 ttt85 -65.26 -43.67 90.57 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.576 179.401 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 94.7 mt -64.48 -43.46 96.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.346 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.51 -51.26 70.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.299 -179.04 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.56 -43.73 96.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.922 0.392 . . . . 0.0 110.655 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' PHE . . . . . 0.657 ' CE2' HD11 ' A' ' 177' ' ' LEU . 55.9 t80 -62.78 -44.29 96.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.363 179.465 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -63.57 -39.62 94.88 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.446 -179.218 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -63.15 -42.69 99.48 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.583 179.261 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -60.62 -44.81 95.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.241 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.657 HD11 ' CE2' ' A' ' 173' ' ' PHE . 85.2 mt -64.65 -41.03 96.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.871 178.773 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.02 -61.98 1.92 Allowed 'General case' 0 C--O 1.239 0.506 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.428 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.96 -46.8 87.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.333 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -52.97 -41.63 64.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.414 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -63.98 -33.71 76.34 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.32 179.333 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 182' ' ' GLU . . . . . 0.407 ' O ' ' HG2' ' A' ' 182' ' ' GLU . 69.7 tt0 -90.95 8.75 33.59 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.631 0.729 . . . . 0.0 110.258 -178.683 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -104.56 -31.97 9.18 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 122.041 -0.412 . . . . 0.0 111.099 179.416 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.6 pt -128.07 147.87 32.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.625 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -140.0 131.36 26.79 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.463 178.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 186' ' ' LEU . . . . . 0.591 HD22 ' N ' ' A' ' 186' ' ' LEU . 3.6 mm? -85.32 133.1 43.18 Favored Pre-proline 0 N--CA 1.447 -0.584 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.146 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -43.93 157.83 0.14 Allowed 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 122.597 2.198 . . . . 0.0 112.35 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 188' ' ' PRO . . . . . 0.49 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.6 Cg_endo -63.2 115.11 2.78 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.809 2.339 . . . . 0.0 111.615 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 189' ' ' GLN . . . . . 0.49 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.7 mt-30 155.91 147.99 0.0 OUTLIER Pre-proline 0 C--O 1.232 0.177 0 O-C-N 124.393 1.058 . . . . 0.0 110.871 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -73.54 144.01 35.29 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 122.612 2.208 . . . . 0.0 112.158 177.574 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.496 HG23 ' OG ' ' A' ' 258' ' ' SER . 2.1 p -124.82 159.17 31.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.409 0.623 . . . . 0.0 110.147 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 192' ' ' THR . . . . . 0.485 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 35.4 p -143.2 165.47 27.35 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.048 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 193' ' ' ALA . . . . . 0.448 ' HA ' ' H ' ' A' ' 260' ' ' PHE . . . -135.4 128.89 32.42 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-O 121.364 0.602 . . . . 0.0 110.33 179.02 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.509 HD11 HD23 ' A' ' 259' ' ' LEU . 47.3 pt -146.42 148.83 16.62 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.374 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.113 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 195' ' ' VAL . . . . . 0.74 HG13 ' CD1' ' A' ' 262' ' ' PHE . 70.2 t -117.55 123.18 71.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.226 0.536 . . . . 0.0 109.973 178.706 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -134.31 107.07 7.43 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.054 0.454 . . . . 0.0 110.259 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 94.9 m -130.93 130.37 43.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.843 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.407 ' O ' ' N ' ' A' ' 201' ' ' HIS . . . -82.79 -36.84 25.28 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.295 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.22 -67.18 0.25 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.29 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.11 -10.15 59.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.425 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 201' ' ' HIS . . . . . 0.407 ' N ' ' O ' ' A' ' 198' ' ' ALA . 60.2 t-80 61.01 58.15 2.35 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.64 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 41.9 p -166.86 153.65 8.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.609 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.53 144.23 24.34 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.948 0.404 . . . . 0.0 110.441 179.178 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -135.42 138.41 43.21 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.554 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 19.4 mt -106.09 125.33 50.86 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.923 0.392 . . . . 0.0 109.974 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 206' ' ' TRP . . . . . 0.556 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 75.2 m95 -82.19 167.39 18.74 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.569 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 207' ' ' THR . . . . . 0.449 HG22 ' C ' ' A' ' 206' ' ' TRP . 0.1 OUTLIER -157.14 171.67 7.15 Favored Pre-proline 0 C--O 1.225 -0.234 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.622 -178.764 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -53.79 -36.97 84.25 Favored 'Trans proline' 0 C--N 1.301 -1.935 0 C-N-CA 122.63 2.22 . . . . 0.0 112.306 179.022 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -71.09 -34.71 71.39 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.679 -179.67 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 21.7 m -61.3 150.72 34.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.569 -179.504 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.49 -36.97 81.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.418 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 212' ' ' GLN . . . . . 0.556 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 55.3 tt0 -64.72 -40.21 94.96 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.557 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.98 -43.49 91.12 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -62.91 -44.04 97.16 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.848 0.356 . . . . 0.0 110.249 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 215' ' ' MET . . . . . 0.546 ' SD ' ' HB2' ' A' ' 304' ' ' ALA . 65.4 ttp -59.41 -48.11 82.9 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.069 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 87.1 mt -60.19 -41.16 92.35 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 217' ' ' GLU . . . . . 0.45 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.1 tp10 -57.9 -37.97 74.99 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.148 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -65.49 -38.04 88.58 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.71 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 95.4 mt -64.09 -42.78 96.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.639 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.59 45.16 0.08 OUTLIER Glycine 0 N--CA 1.462 0.393 0 N-CA-C 111.054 -0.819 . . . . 0.0 111.054 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 221' ' ' PHE . . . . . 0.45 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 26.9 m-85 -128.07 155.23 44.7 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.926 0.393 . . . . 0.0 110.509 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.474 ' C ' HD22 ' A' ' 223' ' ' LEU . 6.9 p -106.94 122.23 46.02 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-O 121.299 0.571 . . . . 0.0 110.125 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.474 HD22 ' C ' ' A' ' 222' ' ' THR . 4.3 mm? -101.32 132.9 46.63 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.144 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.51 159.46 14.92 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.485 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.19 115.23 29.92 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.416 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.489 HD12 ' N ' ' A' ' 226' ' ' LEU . 9.1 mp -53.25 156.79 3.66 Favored Pre-proline 0 N--CA 1.447 -0.623 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.796 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -60.2 145.26 98.92 Favored 'Trans proline' 0 C--N 1.302 -1.873 0 C-N-CA 122.735 2.29 . . . . 0.0 112.145 179.09 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.42 -3.01 59.01 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.544 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.19 -40.91 5.67 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 230' ' ' LEU . . . . . 0.51 ' O ' ' N ' ' A' ' 233' ' ' SER . 84.8 mt -79.23 -16.85 55.87 Favored 'General case' 0 C--O 1.218 -0.562 0 CA-C-O 121.131 0.491 . . . . 0.0 110.323 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 54.3 t-20 -40.38 -49.33 2.8 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.839 0.352 . . . . 0.0 110.733 -179.397 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -87.99 15.44 7.27 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.251 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 233' ' ' SER . . . . . 0.51 ' N ' ' O ' ' A' ' 230' ' ' LEU . 77.8 p -60.59 -35.29 75.74 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.655 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 234' ' ' GLN . . . . . 0.524 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.6 tt0 -119.03 -69.33 0.86 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.753 0.311 . . . . 0.0 110.751 179.264 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.2 m -70.0 102.62 2.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.633 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -94.08 57.76 2.44 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.361 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -144.72 -122.59 1.58 Allowed Glycine 0 N--CA 1.461 0.363 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -134.84 111.59 10.01 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.059 0.456 . . . . 0.0 110.35 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 239' ' ' ARG . . . . . 0.517 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.4 mtt180 -148.05 57.94 1.09 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.664 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -69.75 -31.98 70.26 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.521 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 241' ' ' ASP . . . . . 0.542 ' CG ' HD21 ' A' ' 143' ' ' ASN . 64.9 t0 -56.92 -47.11 81.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.255 -179.004 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 242' ' ' ILE . . . . . 0.437 ' O ' ' O ' ' A' ' 239' ' ' ARG . 17.8 tt -139.95 156.63 25.41 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.263 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.391 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.445 HG22 HD13 ' A' ' 245' ' ' LEU . 96.1 mt -106.02 106.37 20.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-O 120.971 0.415 . . . . 0.0 110.468 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 244' ' ' GLN . . . . . 0.59 ' C ' HD12 ' A' ' 245' ' ' LEU . 88.2 mt-30 -110.57 110.17 20.77 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.362 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.59 HD12 ' C ' ' A' ' 244' ' ' GLN . 9.6 mp -121.77 -168.24 1.67 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.666 179.532 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 246' ' ' GLY . . . . . 0.524 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.7 -16.93 0.05 OUTLIER Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 247' ' ' GLY . . . . . 0.67 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -60.47 156.7 30.4 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 110.829 -0.908 . . . . 0.0 110.829 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -63.57 21.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.825 0.345 . . . . 0.0 110.583 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 249' ' ' ASN . . . . . 0.67 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.8 m-20 -96.85 -6.04 36.84 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.436 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 91.5 mt -79.89 -21.65 43.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.902 179.177 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.65 -51.35 70.28 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.661 -179.506 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.7 -5.1 58.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.458 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.27 -74.06 1.16 Allowed Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 80.1 mt -70.02 125.95 28.24 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.883 0.373 . . . . 0.0 110.334 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -59.53 -39.48 84.07 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.254 -179.564 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 83.27 51.77 4.02 Favored Glycine 0 CA--C 1.52 0.368 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -95.3 -15.76 22.9 Favored 'General case' 0 C--N 1.33 -0.243 0 O-C-N 122.77 -0.253 . . . . 0.0 110.661 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 258' ' ' SER . . . . . 0.496 ' OG ' HG23 ' A' ' 191' ' ' VAL . 3.4 t 174.87 89.31 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.227 0.537 . . . . 0.0 110.244 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.849 HD12 ' N ' ' A' ' 259' ' ' LEU . 0.9 OUTLIER -94.8 124.31 38.77 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.052 0.453 . . . . 0.0 111.052 -178.78 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 260' ' ' PHE . . . . . 0.448 ' H ' ' HA ' ' A' ' 193' ' ' ALA . 15.8 m-30 -93.58 146.4 23.84 Favored 'General case' 0 CA--C 1.495 -1.142 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.494 179.273 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 85.9 mt -122.18 149.24 43.91 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.564 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.74 ' CD1' HG13 ' A' ' 195' ' ' VAL . 2.6 p90 -77.23 -138.82 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.534 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 263' ' ' ALA . . . . . 0.652 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -51.39 77.03 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.407 0 O-C-N 123.415 0.447 . . . . 0.0 111.171 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 264' ' ' GLY . . . . . 0.625 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.16 104.74 0.19 Allowed Glycine 0 CA--C 1.528 0.87 0 N-CA-C 110.421 -1.072 . . . . 0.0 110.421 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 265' ' ' ASP . . . . . 0.589 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.4 m-20 -80.21 -177.9 6.32 Favored 'General case' 0 C--N 1.327 -0.394 0 O-C-N 122.671 -0.311 . . . . 0.0 110.847 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -40.7 -17.76 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.549 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 267' ' ' LYS . . . . . 0.589 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.21 -51.44 45.48 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.614 179.22 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -63.9 -46.39 85.05 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.997 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 269' ' ' ALA . . . . . 0.566 ' HB1' ' OH ' ' A' ' 273' ' ' TYR . . . -61.88 -34.92 76.9 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.657 0.741 . . . . 0.0 109.824 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -62.82 -34.66 77.77 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.292 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.43 -43.11 13.9 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.049 -179.316 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 272' ' ' ILE . . . . . 0.595 ' C ' ' H ' ' A' ' 274' ' ' ALA . 4.9 tt -51.53 -33.71 14.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.678 -178.732 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 273' ' ' TYR . . . . . 0.566 ' OH ' ' HB1' ' A' ' 269' ' ' ALA . 17.2 m-85 -54.71 -1.55 0.03 OUTLIER 'General case' 0 CA--C 1.513 -0.452 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.616 -179.271 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 274' ' ' ALA . . . . . 0.595 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.61 -39.78 70.24 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.802 179.408 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 275' ' ' ASN . . . . . 0.573 ' O ' ' N ' ' A' ' 279' ' ' ALA . 2.6 p30 -38.98 97.9 0.15 Allowed Pre-proline 0 N--CA 1.462 0.151 0 O-C-N 123.49 0.494 . . . . 0.0 110.33 -179.592 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -54.18 -42.92 63.12 Favored 'Trans proline' 0 C--N 1.303 -1.845 0 C-N-CA 122.58 2.187 . . . . 0.0 112.491 -178.762 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 88.5 mt -64.41 -43.02 95.69 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.015 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 91.5 mt -95.66 -1.45 50.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.863 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 279' ' ' ALA . . . . . 0.573 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.58 -34.87 77.84 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.486 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.32 20.14 0.12 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.9 -179.156 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 281' ' ' LEU . . . . . 0.483 ' H ' ' C ' ' A' ' 279' ' ' ALA . 13.8 mt -74.65 119.53 77.1 Favored Pre-proline 0 N--CA 1.442 -0.838 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.849 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -50.57 -39.71 55.47 Favored 'Trans proline' 0 C--N 1.312 -1.36 0 C-N-CA 122.535 2.156 . . . . 0.0 112.063 178.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.73 -50.69 62.92 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.874 0.369 . . . . 0.0 110.021 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 76.9 t -61.4 -43.77 97.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.162 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -57.81 -41.2 81.71 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.089 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -91.0 0.63 57.5 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.245 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt 59.16 43.63 16.94 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.966 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -95.1 41.22 1.1 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.314 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 53.9 t -118.9 135.68 58.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-O 121.119 0.485 . . . . 0.0 109.967 -179.668 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -132.81 162.73 30.75 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.534 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.54 155.12 32.79 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.523 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 81.0 mt -94.09 -1.73 53.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.256 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.14 165.59 12.71 Favored Glycine 0 N--CA 1.465 0.613 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 6.8 m -87.33 -62.34 1.52 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.879 0.371 . . . . 0.0 110.947 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 295' ' ' GLU . . . . . 0.446 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.6 mm-40 -69.02 -4.07 15.48 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.755 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 24.5 p -76.92 32.32 0.14 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.68 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 297' ' ' PHE . . . . . 0.511 ' CD2' HG22 ' A' ' 70' ' ' THR . 70.8 t80 -60.43 -45.97 91.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.624 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 298' ' ' ARG . . . . . 0.615 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.1 mtt85 -81.27 134.85 35.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.543 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.454 ' H ' HG11 ' A' ' 51' ' ' VAL . 17.7 tp -113.68 117.22 30.95 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-O 120.918 0.39 . . . . 0.0 110.391 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 300' ' ' ASP . . . . . 0.639 ' H ' ' CB ' ' A' ' 303' ' ' SER . 49.9 p-10 -165.3 -176.47 4.06 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.758 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 80.2 t80 -46.81 -43.49 18.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.391 -179.656 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -66.92 -40.35 87.61 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 121.037 0.446 . . . . 0.0 110.723 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 303' ' ' SER . . . . . 0.639 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 60.1 p -55.99 -36.37 67.81 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.062 -179.054 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 304' ' ' ALA . . . . . 0.546 ' HB2' ' SD ' ' A' ' 215' ' ' MET . . . -57.11 -51.8 67.85 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 179.421 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 92.2 mtp -55.48 -44.45 76.52 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -65.86 -42.66 90.15 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.309 0.576 . . . . 0.0 110.398 179.228 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 307' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 303' ' ' SER . 55.6 t -63.96 -42.92 97.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.253 179.307 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 44.0 tp -59.73 -41.93 92.02 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.029 -179.452 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -62.87 -38.69 91.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.069 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 310' ' ' ARG . . . . . 0.446 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.7 ttt85 -63.42 -43.84 96.34 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.295 179.512 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 90.2 mt -63.1 -42.1 99.52 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.489 179.635 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -63.01 -33.36 75.25 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.304 179.293 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.48 -23.54 22.06 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.285 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 314' ' ' LEU . . . . . 0.481 HD22 ' CE2' ' A' ' 315' ' ' PHE . 6.7 tt -62.31 -43.19 99.4 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 121.012 0.434 . . . . 0.0 110.526 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 315' ' ' PHE . . . . . 0.481 ' CE2' HD22 ' A' ' 314' ' ' LEU . 89.4 m-85 . . . . . 0 C--O 1.22 -0.461 0 CA-C-O 118.041 -0.98 . . . . 0.0 110.263 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -99.73 135.85 40.54 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.167 0.508 . . . . 0.0 110.403 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.492 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -92.33 178.62 1.61 Allowed Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.533 -179.797 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.492 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.0 Cg_exo -61.68 147.29 95.68 Favored 'Trans proline' 0 C--N 1.298 -2.104 0 C-N-CA 122.893 2.396 . . . . 0.0 112.164 179.547 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.498 ' HE ' HD12 ' A' ' 39' ' ' LEU . 35.3 ptt180 -136.91 142.59 42.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.636 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -79.52 117.06 20.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.459 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.443 ' O ' HG23 ' A' ' 30' ' ' ILE . 9.5 tp -111.5 130.74 64.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.468 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.6 t -71.55 142.41 50.07 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.677 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.481 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.6 t0 -139.54 -179.81 6.12 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.502 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.481 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 77.9 p -73.83 -37.34 64.87 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.655 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.8 ttt85 -46.97 -94.77 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.335 -179.198 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -165.9 -27.02 0.02 OUTLIER Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 63.4 m -168.67 105.98 0.44 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.834 0.35 . . . . 0.0 110.643 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.638 ' CD2' HD13 ' A' ' 140' ' ' LEU . 64.4 t60 -129.11 146.15 51.12 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 121.11 0.481 . . . . 0.0 110.112 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.62 HG22 ' N ' ' A' ' 39' ' ' LEU . 93.3 m -129.36 165.59 21.21 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.4 -179.684 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.62 ' N ' HG22 ' A' ' 38' ' ' THR . 79.6 mt -120.26 127.23 52.21 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.537 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -65.39 -44.78 86.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.698 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 39.0 p -165.83 155.28 12.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.374 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.483 ' CD ' ' H ' ' A' ' 42' ' ' GLN . 14.5 mp0 -45.2 101.26 0.25 Allowed Pre-proline 0 C--O 1.235 0.325 0 O-C-N 123.6 0.562 . . . . 0.0 110.558 179.227 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -57.77 130.34 38.04 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 C-N-CA 122.326 2.018 . . . . 0.0 112.315 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -82.76 -24.9 33.28 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.601 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.531 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.7 mtm-85 -120.86 134.98 55.29 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.225 0.536 . . . . 0.0 110.135 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.1 mt -130.26 133.48 63.98 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.345 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.818 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 45.7 t -125.24 130.87 72.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 CA-C-O 120.967 0.413 . . . . 0.0 109.924 179.247 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.61 ' OG ' HD12 ' A' ' 117' ' ' LEU . 4.7 m -154.87 166.48 33.38 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.527 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 72.8 p -124.49 8.88 8.38 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.313 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.68 125.69 33.37 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.857 0.36 . . . . 0.0 110.635 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.465 HG11 ' H ' ' A' ' 299' ' ' LEU . 85.5 t -65.71 -44.44 93.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.553 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.8 m -62.7 -44.34 96.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.63 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 53.8 tp -62.46 -41.41 98.73 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.613 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.447 ' O ' HD13 ' A' ' 58' ' ' LEU . 74.3 m -57.89 -44.6 86.84 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.269 -179.309 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.27 -62.12 5.42 Favored Glycine 0 N--CA 1.468 0.788 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.6 t -48.24 -35.6 12.31 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 20.1 mt -61.85 -44.02 97.67 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 120.594 -0.442 . . . . 0.0 111.383 179.216 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.447 HD13 ' O ' ' A' ' 54' ' ' THR . 9.3 mp -65.43 -41.34 93.63 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.404 177.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.82 -41.27 97.9 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.914 -179.332 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.415 ' O ' HG23 ' A' ' 60' ' ' ILE . 7.9 tp -87.66 16.55 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.918 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 56.44 84.42 0.09 Allowed 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.841 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.25 58.91 0.08 OUTLIER Pre-proline 0 C--N 1.327 -0.389 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -51.6 152.78 11.97 Favored 'Trans proline' 0 C--N 1.292 -2.437 0 C-N-CA 123.074 2.516 . . . . 0.0 112.053 -178.3 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.431 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -108.78 145.86 15.15 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.152 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.262 -179.646 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.61 -45.3 97.93 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.471 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.504 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -129.83 134.29 47.45 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.47 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.494 ' O ' ' N ' ' A' ' 98' ' ' LEU . 72.1 m -134.38 158.54 43.58 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.895 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.42 139.01 16.31 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.486 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.61 -162.98 0.09 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.953 0.406 . . . . 0.0 110.437 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.5 HG22 ' CD2' ' A' ' 297' ' ' PHE . 5.7 t -133.91 135.83 43.88 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.015 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.473 ' C ' ' O ' ' A' ' 70' ' ' THR . 1.0 OUTLIER 29.68 68.23 0.68 Allowed Pre-proline 0 N--CA 1.468 0.438 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.78 -179.68 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_exo -61.32 145.11 98.7 Favored 'Trans proline' 0 C--N 1.299 -2.072 0 C-N-CA 122.644 2.23 . . . . 0.0 111.762 -177.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.527 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 45.5 p-10 -160.15 -32.02 0.06 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.746 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.528 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 99.1 m-20 -64.29 -39.31 93.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.326 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -60.5 -47.88 84.21 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.509 -179.015 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.423 ' O ' ' O ' ' A' ' 77' ' ' ALA . 94.3 t -60.48 -24.46 31.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.528 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -45.73 173.03 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.602 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.567 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.6 p30 -61.92 177.59 0.43 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.58 -179.683 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.562 ' C ' ' H ' ' A' ' 81' ' ' GLY . 36.2 p30 -45.73 85.57 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.031 0.443 . . . . 0.0 111.069 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.567 ' N ' ' O ' ' A' ' 78' ' ' ASP . 42.4 tp60 -67.4 13.36 0.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.297 0.57 . . . . 0.0 110.172 -179.645 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.562 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 118.06 -22.53 9.71 Favored Glycine 0 C--N 1.333 0.372 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -107.82 116.04 31.24 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.056 0.455 . . . . 0.0 110.461 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 77.7 mt -98.47 0.67 45.62 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.991 0.424 . . . . 0.0 110.553 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -92.08 6.84 44.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.058 0.456 . . . . 0.0 110.387 -179.584 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.783 ' O ' HG22 ' A' ' 89' ' ' VAL . 27.3 mt-30 -100.02 -26.99 13.79 Favored 'General case' 0 C--O 1.22 -0.467 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.821 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.4 t-105 -63.8 -40.66 97.18 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.09 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.546 ' O ' ' N ' ' A' ' 91' ' ' LYS . 69.4 m -77.55 -53.27 7.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.134 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -48.9 -50.8 33.35 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.138 -179.053 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.783 HG22 ' O ' ' A' ' 85' ' ' GLN . 15.3 m -68.75 -40.62 81.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.232 179.397 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.494 ' N ' HG23 ' A' ' 89' ' ' VAL . . . -72.26 -23.07 61.15 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.678 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.546 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.0 tttm -61.32 -45.93 92.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.369 -179.374 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.439 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.8 mm-40 -90.5 -94.52 0.12 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.066 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.617 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.9 mtt180 -143.56 60.0 1.39 Allowed 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.442 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.7 pttp 34.22 25.86 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.105 0.478 . . . . 0.0 110.339 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.617 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.4 tt -48.25 123.01 5.83 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.064 -177.744 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.451 ' O ' HD23 ' A' ' 95' ' ' LEU . 98.9 mm-40 -83.08 -170.62 3.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.059 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.62 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 83.0 mtp180 -73.32 137.85 45.04 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.128 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.494 ' N ' ' O ' ' A' ' 67' ' ' SER . 90.5 mt -86.65 -165.79 1.37 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.886 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.532 ' O ' ' CD2' ' A' ' 99' ' ' TYR . 47.5 p90 -168.84 119.98 0.75 Allowed 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.154 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.492 ' C ' ' O ' ' A' ' 99' ' ' TYR . 43.9 mm -29.22 121.06 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 O-C-N 123.308 0.38 . . . . 0.0 111.125 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 114.15 27.76 3.31 Favored Glycine 0 N--CA 1.461 0.341 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 -179.246 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.582 ' N ' ' CD ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -143.93 45.82 0.6 Allowed Pre-proline 0 C--N 1.321 -0.649 0 CA-C-O 121.079 0.466 . . . . 0.0 110.391 179.716 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.582 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 29.6 Cg_endo -62.42 144.16 94.51 Favored 'Trans proline' 0 C--N 1.294 -2.342 0 C-N-CA 122.687 2.258 . . . . 0.0 111.727 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.456 ' O ' HG23 ' A' ' 108' ' ' VAL . 24.8 t -173.36 121.04 0.35 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.377 179.546 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.29 -40.92 64.16 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.989 0.423 . . . . 0.0 111.125 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -65.91 -39.85 90.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.865 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.94 -39.64 94.63 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.754 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 104' ' ' SER . 70.0 t -67.52 -43.71 87.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.681 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.49 -39.28 92.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.474 -179.055 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.439 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.94 -23.83 63.87 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.476 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.537 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.3 mm-40 -91.18 5.04 50.65 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.667 -179.544 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.537 ' C ' ' O ' ' A' ' 111' ' ' GLN . 10.2 tpt 21.54 64.95 0.3 Allowed Pre-proline 0 N--CA 1.469 0.516 0 CA-C-O 120.961 0.41 . . . . 0.0 111.337 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.461 ' HG2' HD11 ' A' ' 116' ' ' ILE . 61.6 Cg_endo -80.01 169.9 17.22 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 123.094 2.53 . . . . 0.0 111.517 -177.605 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.519 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 99.2 m-20 -112.34 -45.1 3.3 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.973 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 39.4 tp -119.51 121.23 38.94 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.461 HD11 ' HG2' ' A' ' 113' ' ' PRO . 96.7 mt -118.45 131.41 71.3 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.432 0 CA-C-O 120.953 0.406 . . . . 0.0 111.013 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.61 HD12 ' OG ' ' A' ' 48' ' ' SER . 32.4 mt -106.04 132.24 52.35 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 121.086 0.47 . . . . 0.0 110.156 -179.469 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.495 HD12 HG23 ' A' ' 139' ' ' THR . 98.6 mt -117.75 135.75 57.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.628 -179.521 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 85.3 p -71.17 151.32 44.51 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.62 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.42 -49.98 75.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.642 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.0 t -149.19 153.71 38.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.539 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 168.19 -169.68 41.6 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.93 -35.7 92.42 Favored Glycine 0 CA--C 1.522 0.513 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.445 ' OD1' ' O ' ' A' ' 124' ' ' ASP . 44.2 p-10 -88.2 120.18 29.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.867 0.365 . . . . 0.0 110.696 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.439 ' O ' HD12 ' A' ' 129' ' ' LEU . 41.3 t -63.6 143.78 57.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.363 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.515 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.67 -42.82 8.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.863 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.4 tp -62.78 -42.45 99.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.674 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.76 -10.43 52.58 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.382 -179.3 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.439 HD12 ' O ' ' A' ' 125' ' ' SER . 83.4 mt -116.23 -24.0 8.17 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.65 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' TYR . . . . . 0.525 ' CD1' HG21 ' A' ' 139' ' ' THR . 72.6 t80 -51.79 -49.08 63.42 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.639 -178.804 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 39.0 p-10 -65.96 -41.56 91.07 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.324 179.203 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.525 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 87.9 mt-30 -68.14 -36.68 80.08 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.874 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.457 HD12 HD11 ' A' ' 118' ' ' ILE . 96.3 mt -79.89 -42.67 23.69 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.017 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.402 ' N ' ' OG1' ' A' ' 139' ' ' THR . 11.3 t -57.37 -45.07 84.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.343 -179.018 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 20.0 m -62.36 -45.88 91.17 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.566 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 93.0 mt -62.28 -43.71 98.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.349 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.598 ' HB1' ' HD2' ' A' ' 138' ' ' PRO . . . -170.1 163.32 6.38 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.559 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.598 ' HD2' ' HB1' ' A' ' 137' ' ' ALA . 78.3 Cg_exo -41.69 110.37 0.14 Allowed 'Trans proline' 0 C--N 1.311 -1.428 0 C-N-CA 122.486 2.124 . . . . 0.0 112.344 179.092 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.525 HG21 ' CD1' ' A' ' 130' ' ' TYR . 3.0 m -87.37 127.46 35.2 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.542 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.638 HD13 ' CD2' ' A' ' 37' ' ' HIS . 34.3 tp -119.29 139.24 52.24 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.259 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.428 ' O ' ' OD2' ' A' ' 32' ' ' ASP . 81.3 mt -105.32 120.1 55.49 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.352 0 CA-C-O 121.132 0.491 . . . . 0.0 111.196 -179.59 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.48 HD12 HD22 ' A' ' 117' ' ' LEU . 97.4 mt -135.69 132.75 51.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.585 179.59 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.55 HD21 ' CG ' ' A' ' 241' ' ' ASP . 59.3 t30 -64.62 148.22 51.35 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.933 0.397 . . . . 0.0 110.38 179.264 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.515 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 87.6 t80 -82.74 122.72 28.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.973 -179.564 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.515 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 99.0 m-20 55.11 69.12 0.77 Allowed 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.784 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 34.5 p-10 -125.7 0.31 7.45 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.856 0.36 . . . . 0.0 110.636 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -150.42 115.51 5.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.691 -179.473 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 85.0 p -63.49 168.94 4.16 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.538 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.414 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.5 p-90 -51.84 -16.08 0.63 Allowed 'General case' 0 C--O 1.219 -0.505 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.326 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' GLN . . . . . 0.436 ' O ' HG23 ' A' ' 154' ' ' THR . 67.9 tp60 -70.11 -76.05 0.11 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.891 0.377 . . . . 0.0 110.542 -179.689 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.433 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.1 t -62.48 -38.66 90.7 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.253 179.509 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 52.1 tp -60.16 -45.61 92.48 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.354 -178.29 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.414 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 45.8 tp -62.6 -41.76 99.16 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.55 178.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.436 HG23 ' O ' ' A' ' 150' ' ' GLN . 58.7 p -63.86 -34.94 79.06 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.098 -179.229 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' GLN . . . . . 0.467 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 88.0 mm-40 -63.66 -42.03 98.13 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.23 179.291 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 91.6 mt -65.34 -38.82 91.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.192 0.52 . . . . 0.0 110.243 179.128 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.566 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.34 -32.3 80.38 Favored Glycine 0 C--N 1.332 0.316 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 -179.197 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.467 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.4 mt-10 -36.79 -25.19 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.901 0.381 . . . . 0.0 110.862 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.566 ' N ' ' O ' ' A' ' 157' ' ' GLY . 94.9 mt -59.22 148.43 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.292 179.031 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 74.6 p -69.09 137.63 53.66 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.994 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 70.48 22.14 77.72 Favored Glycine 0 N--CA 1.458 0.136 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 179.517 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 59.9 m80 -124.48 -13.96 6.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.597 0.237 . . . . 0.0 110.426 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -66.81 -59.49 3.5 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.593 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -51.92 -48.89 63.99 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.153 -179.445 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -60.55 -41.09 93.83 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.806 0.336 . . . . 0.0 110.405 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.68 -47.43 85.34 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.534 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.63 -40.27 75.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.225 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -61.58 -50.44 72.59 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.672 179.511 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -65.25 -43.66 90.66 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.586 179.472 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 94.4 mt -64.63 -43.33 96.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.441 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.4 -51.12 70.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.313 -179.074 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.63 -43.41 96.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.851 0.357 . . . . 0.0 110.635 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' PHE . . . . . 0.662 ' CE2' HD11 ' A' ' 177' ' ' LEU . 57.7 t80 -62.94 -44.25 96.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.402 179.466 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -63.69 -39.65 94.86 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.477 -179.212 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -63.18 -42.82 99.42 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.564 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -60.63 -44.45 96.33 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.175 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.662 HD11 ' CE2' ' A' ' 173' ' ' PHE . 84.8 mt -64.44 -41.12 96.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.78 178.789 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.34 -62.14 1.83 Allowed 'General case' 0 C--O 1.24 0.553 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.281 -179.203 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.23 -47.23 84.16 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.432 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -52.73 -41.72 64.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.353 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -63.74 -33.59 75.99 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.055 0.455 . . . . 0.0 110.284 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 182' ' ' GLU . . . . . 0.41 ' O ' ' HG2' ' A' ' 182' ' ' GLU . 69.8 tt0 -91.08 8.52 35.08 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.666 0.746 . . . . 0.0 110.318 -178.729 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -104.33 -32.45 9.06 Favored 'General case' 0 CA--C 1.516 -0.361 0 O-C-N 122.001 -0.437 . . . . 0.0 111.222 179.395 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.7 pt -127.9 147.57 32.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.801 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -139.78 131.26 26.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.966 0.412 . . . . 0.0 110.395 179.099 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 186' ' ' LEU . . . . . 0.59 HD22 ' N ' ' A' ' 186' ' ' LEU . 3.5 mm? -85.34 133.59 42.16 Favored Pre-proline 0 N--CA 1.449 -0.516 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.193 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -43.65 157.76 0.12 Allowed 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.617 2.212 . . . . 0.0 112.372 179.376 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 188' ' ' PRO . . . . . 0.497 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.7 Cg_endo -63.04 114.69 2.55 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 122.817 2.344 . . . . 0.0 111.664 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 189' ' ' GLN . . . . . 0.497 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.7 mt-30 155.65 148.17 0.0 OUTLIER Pre-proline 0 N--CA 1.456 -0.159 0 O-C-N 124.244 0.965 . . . . 0.0 110.885 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -73.26 144.26 36.77 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.583 2.189 . . . . 0.0 112.289 177.63 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.496 HG23 ' OG ' ' A' ' 258' ' ' SER . 2.1 p -124.61 158.87 31.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.461 0.648 . . . . 0.0 110.197 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 192' ' ' THR . . . . . 0.487 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 36.6 p -143.18 165.39 27.57 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.112 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 193' ' ' ALA . . . . . 0.448 ' HA ' ' H ' ' A' ' 260' ' ' PHE . . . -135.44 128.88 32.32 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-O 121.339 0.59 . . . . 0.0 110.209 179.232 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.509 HD11 HD23 ' A' ' 259' ' ' LEU . 47.7 pt -146.73 149.38 15.92 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.404 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.21 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 195' ' ' VAL . . . . . 0.736 HG13 ' CD1' ' A' ' 262' ' ' PHE . 69.4 t -117.87 123.41 71.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.402 0.62 . . . . 0.0 109.792 179.002 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -134.34 106.75 7.25 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 121.104 0.478 . . . . 0.0 110.208 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 94.7 m -130.7 130.44 43.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.943 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.413 ' O ' ' N ' ' A' ' 201' ' ' HIS . . . -82.8 -37.18 24.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.25 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.21 -66.92 0.27 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.288 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.47 -9.54 58.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.273 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 201' ' ' HIS . . . . . 0.413 ' N ' ' O ' ' A' ' 198' ' ' ALA . 60.1 t-80 60.32 58.27 2.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.81 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 39.5 p -167.02 153.79 8.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.568 179.348 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.36 144.19 24.45 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.054 0.454 . . . . 0.0 110.454 179.148 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -135.29 138.09 43.13 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.605 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 19.4 mt -106.04 125.44 51.0 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.055 0.455 . . . . 0.0 109.796 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 206' ' ' TRP . . . . . 0.555 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 74.5 m95 -82.15 167.14 19.03 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.587 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 207' ' ' THR . . . . . 0.46 HG22 ' C ' ' A' ' 206' ' ' TRP . 0.1 OUTLIER -157.45 171.32 7.59 Favored Pre-proline 0 C--O 1.224 -0.268 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.624 -178.909 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -53.18 -37.12 79.69 Favored 'Trans proline' 0 C--N 1.301 -1.965 0 C-N-CA 122.583 2.189 . . . . 0.0 112.448 178.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -70.84 -35.23 72.34 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.71 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 21.0 m -60.95 151.0 31.53 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.572 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.8 -36.96 82.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.485 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 212' ' ' GLN . . . . . 0.555 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 55.1 tt0 -64.69 -40.27 95.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.519 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.63 -43.58 91.71 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.631 -0.988 . . . . 0.0 110.631 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -62.88 -44.0 97.27 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.789 0.328 . . . . 0.0 110.219 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 215' ' ' MET . . . . . 0.551 ' SD ' ' HB2' ' A' ' 304' ' ' ALA . 65.1 ttp -59.32 -47.91 83.63 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.071 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 87.0 mt -60.73 -41.16 94.76 Favored 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 217' ' ' GLU . . . . . 0.449 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.6 tp10 -58.03 -37.89 75.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.35 -0.386 . . . . 0.0 109.994 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -65.38 -38.31 89.63 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.671 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 95.2 mt -63.91 -42.9 97.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.111 0.482 . . . . 0.0 110.613 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.56 44.93 0.08 OUTLIER Glycine 0 C--N 1.332 0.359 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 221' ' ' PHE . . . . . 0.449 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 26.6 m-85 -127.89 155.49 44.09 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 121.054 0.454 . . . . 0.0 110.439 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.481 ' O ' HG13 ' A' ' 191' ' ' VAL . 7.0 p -106.96 122.34 46.24 Favored 'General case' 0 C--O 1.223 -0.294 0 CA-C-O 121.331 0.586 . . . . 0.0 110.067 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.474 HD22 ' C ' ' A' ' 222' ' ' THR . 4.3 mm? -101.4 133.01 46.68 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.229 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.8 159.8 14.72 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.456 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.52 115.35 30.1 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.935 0.398 . . . . 0.0 110.339 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.498 HD12 ' N ' ' A' ' 226' ' ' LEU . 8.9 mp -53.08 156.54 3.57 Favored Pre-proline 0 N--CA 1.448 -0.559 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.817 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -59.91 145.17 98.97 Favored 'Trans proline' 0 C--N 1.299 -2.03 0 C-N-CA 122.753 2.302 . . . . 0.0 112.312 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.09 -3.35 59.07 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.516 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.2 -40.96 5.66 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 230' ' ' LEU . . . . . 0.506 ' O ' ' N ' ' A' ' 233' ' ' SER . 67.7 mt -79.08 -17.8 54.52 Favored 'General case' 0 C--O 1.218 -0.587 0 CA-C-O 121.212 0.529 . . . . 0.0 110.296 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 54.5 t-20 -40.74 -49.17 3.09 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.845 -179.061 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -87.16 15.05 6.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.459 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 233' ' ' SER . . . . . 0.506 ' N ' ' O ' ' A' ' 230' ' ' LEU . 77.9 p -60.56 -34.99 74.98 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.683 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 234' ' ' GLN . . . . . 0.525 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.5 tt0 -119.73 -69.3 0.85 Allowed 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.835 179.171 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.3 m -69.3 102.19 1.68 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.022 0.439 . . . . 0.0 110.687 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -94.08 57.51 2.4 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.086 0.47 . . . . 0.0 110.365 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -144.61 -122.43 1.58 Allowed Glycine 0 C--N 1.332 0.343 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -135.64 111.78 9.67 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.161 0.505 . . . . 0.0 110.347 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 239' ' ' ARG . . . . . 0.524 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.5 mtt180 -148.08 58.26 1.09 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.707 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -69.36 -32.48 71.57 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.457 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 241' ' ' ASP . . . . . 0.55 ' CG ' HD21 ' A' ' 143' ' ' ASN . 64.7 t0 -57.04 -47.24 81.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.211 -178.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 242' ' ' ILE . . . . . 0.435 ' O ' ' O ' ' A' ' 239' ' ' ARG . 18.1 tt -139.62 155.87 25.69 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.275 0 CA-C-O 120.913 0.387 . . . . 0.0 110.44 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.445 HG22 HD13 ' A' ' 245' ' ' LEU . 96.3 mt -106.17 106.87 21.39 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 CA-C-O 121.099 0.476 . . . . 0.0 110.479 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 244' ' ' GLN . . . . . 0.595 ' O ' HD12 ' A' ' 245' ' ' LEU . 88.3 mt-30 -110.71 110.04 20.54 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.261 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.595 HD12 ' O ' ' A' ' 244' ' ' GLN . 9.5 mp -121.51 -168.2 1.65 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.766 179.497 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 246' ' ' GLY . . . . . 0.525 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 174.14 -16.54 0.05 OUTLIER Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 247' ' ' GLY . . . . . 0.67 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -61.24 156.23 34.37 Favored Glycine 0 CA--C 1.521 0.449 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -63.4 21.94 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.995 0.426 . . . . 0.0 110.647 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 249' ' ' ASN . . . . . 0.67 ' H ' ' C ' ' A' ' 247' ' ' GLY . 99.0 m-20 -97.2 -6.27 35.13 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.438 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 91.0 mt -79.65 -22.0 44.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.775 179.292 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.68 -51.43 69.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.712 -179.482 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.21 -5.53 58.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.47 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.08 -74.24 1.15 Allowed Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.776 -0.929 . . . . 0.0 110.776 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 83.0 mt -70.25 126.43 29.64 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.218 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -59.67 -39.44 84.47 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.081 -179.445 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 83.16 51.62 4.1 Favored Glycine 0 CA--C 1.519 0.29 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -95.9 -14.96 22.73 Favored 'General case' 0 C--N 1.331 -0.204 0 O-C-N 122.65 -0.323 . . . . 0.0 110.598 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 258' ' ' SER . . . . . 0.496 ' OG ' HG23 ' A' ' 191' ' ' VAL . 3.4 t 174.73 88.85 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.24 0.543 . . . . 0.0 110.072 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.853 HD12 ' N ' ' A' ' 259' ' ' LEU . 1.0 OUTLIER -94.61 124.28 38.55 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.254 0.549 . . . . 0.0 111.267 -179.143 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 260' ' ' PHE . . . . . 0.448 ' H ' ' HA ' ' A' ' 193' ' ' ALA . 15.7 m-30 -93.37 146.39 23.77 Favored 'General case' 0 CA--C 1.495 -1.171 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.474 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 86.1 mt -122.33 149.25 44.02 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.545 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.736 ' CD1' HG13 ' A' ' 195' ' ' VAL . 2.5 p90 -77.26 -138.77 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.578 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 263' ' ' ALA . . . . . 0.655 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -51.46 76.97 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 121.091 0.472 . . . . 0.0 111.299 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 264' ' ' GLY . . . . . 0.626 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.15 104.67 0.19 Allowed Glycine 0 CA--C 1.528 0.895 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 -179.716 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 265' ' ' ASP . . . . . 0.592 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.5 m-20 -80.31 -177.98 6.4 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 122.719 -0.283 . . . . 0.0 110.972 -179.746 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -40.3 -17.87 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.566 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 267' ' ' LYS . . . . . 0.592 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -67.94 -51.74 44.1 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.759 179.1 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -63.65 -46.47 85.48 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.216 179.43 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 269' ' ' ALA . . . . . 0.568 ' HB1' ' OH ' ' A' ' 273' ' ' TYR . . . -61.93 -34.99 77.08 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 121.539 0.685 . . . . 0.0 109.658 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -63.2 -34.46 77.69 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.158 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.49 -42.96 13.98 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.081 -179.428 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 272' ' ' ILE . . . . . 0.591 ' C ' ' H ' ' A' ' 274' ' ' ALA . 4.9 tt -51.44 -33.78 14.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.728 -178.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 273' ' ' TYR . . . . . 0.568 ' OH ' ' HB1' ' A' ' 269' ' ' ALA . 17.2 m-85 -54.64 -1.85 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.573 -179.327 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 274' ' ' ALA . . . . . 0.591 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.45 -39.9 70.7 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.952 179.381 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 275' ' ' ASN . . . . . 0.577 ' O ' ' N ' ' A' ' 279' ' ' ALA . 3.1 p30 -38.8 97.81 0.15 Allowed Pre-proline 0 N--CA 1.462 0.164 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.366 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -54.57 -42.62 66.47 Favored 'Trans proline' 0 C--N 1.303 -1.864 0 C-N-CA 122.428 2.086 . . . . 0.0 112.535 -178.634 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 89.5 mt -64.4 -42.87 95.87 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.058 0.456 . . . . 0.0 111.218 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 90.9 mt -95.7 -1.58 49.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.967 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 279' ' ' ALA . . . . . 0.577 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.3 -34.8 77.29 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.744 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.18 20.03 0.11 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.012 -179.315 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 281' ' ' LEU . . . . . 0.481 ' H ' ' C ' ' A' ' 279' ' ' ALA . 13.8 mt -74.93 119.51 77.2 Favored Pre-proline 0 N--CA 1.445 -0.69 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.801 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -49.96 -39.96 49.56 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.593 2.195 . . . . 0.0 112.279 178.706 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.72 -50.52 63.24 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.038 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 75.9 t -61.42 -43.96 97.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -57.71 -41.18 81.23 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.039 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -91.17 0.24 57.57 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.133 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt 59.36 43.53 16.48 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.04 0.447 . . . . 0.0 110.906 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -94.75 41.37 1.09 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.31 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 54.3 t -119.31 135.55 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-O 121.129 0.49 . . . . 0.0 109.995 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -132.64 162.98 29.97 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.209 0.528 . . . . 0.0 110.613 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.63 155.4 32.39 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-O 121.073 0.463 . . . . 0.0 110.632 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 82.8 mt -94.35 -1.52 53.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.256 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 120.83 165.32 12.69 Favored Glycine 0 C--N 1.335 0.497 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 7.3 m -86.98 -62.38 1.52 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.864 0.364 . . . . 0.0 111.154 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 295' ' ' GLU . . . . . 0.445 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.7 mm-40 -68.79 -3.97 14.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.738 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 25.0 p -77.08 32.04 0.14 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.651 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 297' ' ' PHE . . . . . 0.5 ' CD2' HG22 ' A' ' 70' ' ' THR . 68.7 t80 -60.4 -46.18 90.93 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.629 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 298' ' ' ARG . . . . . 0.62 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.1 mtt85 -80.61 134.81 35.95 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.577 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.465 ' H ' HG11 ' A' ' 51' ' ' VAL . 18.2 tp -113.87 117.01 30.23 Favored 'General case' 0 C--O 1.23 0.075 0 CA-C-O 121.02 0.438 . . . . 0.0 110.203 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 300' ' ' ASP . . . . . 0.621 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.5 p-10 -165.03 -176.71 4.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.651 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -46.95 -42.99 18.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.356 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -67.19 -40.14 86.48 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 121.065 0.46 . . . . 0.0 110.746 178.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 303' ' ' SER . . . . . 0.621 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 59.9 p -56.3 -36.35 68.55 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.975 -179.038 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 304' ' ' ALA . . . . . 0.551 ' HB2' ' SD ' ' A' ' 215' ' ' MET . . . -57.04 -52.15 66.43 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.453 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 91.7 mtp -55.78 -43.66 77.01 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -66.22 -42.59 88.48 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.241 0.543 . . . . 0.0 110.239 179.111 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 307' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 303' ' ' SER . 55.5 t -64.04 -42.95 97.29 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.188 179.359 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 42.6 tp -60.05 -42.05 93.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.82 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -62.42 -39.34 92.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.028 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 310' ' ' ARG . . . . . 0.446 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.5 ttt85 -63.49 -44.0 95.64 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.153 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 89.8 mt -63.18 -42.11 99.31 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.103 0.478 . . . . 0.0 110.36 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt -63.16 -33.35 75.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.12 179.446 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.56 -23.72 21.92 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.329 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 314' ' ' LEU . . . . . 0.485 HD22 ' CE2' ' A' ' 315' ' ' PHE . 6.7 tt -62.35 -43.17 99.46 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 121.075 0.464 . . . . 0.0 110.521 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 315' ' ' PHE . . . . . 0.485 ' CE2' HD22 ' A' ' 314' ' ' LEU . 90.0 m-85 . . . . . 0 C--O 1.22 -0.463 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.346 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -99.55 135.98 40.17 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.119 0.485 . . . . 0.0 110.475 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.49 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -92.16 178.55 1.66 Allowed Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.589 -179.893 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.49 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.7 Cg_exo -61.44 147.15 96.2 Favored 'Trans proline' 0 C--N 1.299 -2.046 0 C-N-CA 122.848 2.365 . . . . 0.0 112.208 179.558 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.468 ' HE ' HD12 ' A' ' 39' ' ' LEU . 35.7 ptt180 -136.12 142.36 44.24 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.585 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -79.54 116.6 19.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.521 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.443 ' O ' HG23 ' A' ' 30' ' ' ILE . 9.5 tp -111.1 130.66 64.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.564 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 13.7 t -70.79 142.25 51.34 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.987 0.422 . . . . 0.0 110.676 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.477 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.3 t0 -139.8 179.39 6.62 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.458 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.477 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 77.9 p -73.83 -37.05 64.97 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.562 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.8 ttt85 -46.51 -94.62 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.248 -179.396 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -167.06 -26.38 0.02 OUTLIER Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 55.6 m -169.35 104.94 0.37 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.807 0.337 . . . . 0.0 110.664 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.691 ' CD2' HD13 ' A' ' 140' ' ' LEU . 75.4 t60 -128.47 148.79 50.75 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.055 0.455 . . . . 0.0 110.231 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.625 HG22 ' N ' ' A' ' 39' ' ' LEU . 98.6 m -131.02 166.05 21.87 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.498 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.625 ' N ' HG22 ' A' ' 38' ' ' THR . 81.2 mt -120.78 127.19 51.73 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.408 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -65.08 -44.62 88.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.794 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 40.9 p -165.71 155.1 12.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.354 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.487 ' CD ' ' H ' ' A' ' 42' ' ' GLN . 14.5 mp0 -44.27 100.91 0.24 Allowed Pre-proline 0 C--O 1.235 0.326 0 O-C-N 123.526 0.516 . . . . 0.0 110.594 179.202 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.54 129.6 34.66 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 C-N-CA 122.344 2.029 . . . . 0.0 112.231 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -83.63 -24.69 31.32 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.609 179.455 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.539 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.4 mtm-85 -122.25 134.43 54.69 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.257 0.551 . . . . 0.0 110.177 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.0 mt -130.46 133.78 63.24 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.774 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 45.3 t -124.43 130.4 73.58 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 CA-C-O 120.911 0.386 . . . . 0.0 109.986 179.207 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.63 ' OG ' HD12 ' A' ' 117' ' ' LEU . 2.1 m -154.88 167.27 30.84 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.645 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 65.1 p -124.53 9.16 8.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.419 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.52 125.51 33.13 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.644 -179.492 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.447 HG11 ' H ' ' A' ' 299' ' ' LEU . 92.7 t -65.77 -44.51 93.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.555 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.4 m -62.51 -44.18 97.0 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.654 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 53.1 tp -62.33 -41.43 98.56 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.464 -179.417 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.445 ' O ' HD13 ' A' ' 58' ' ' LEU . 74.3 m -57.86 -44.58 86.66 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.126 -179.111 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.19 -62.41 5.19 Favored Glycine 0 N--CA 1.467 0.733 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.7 t -47.94 -35.74 11.23 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 20.1 mt -61.88 -44.13 97.44 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.348 179.299 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.445 HD13 ' O ' ' A' ' 54' ' ' THR . 9.1 mp -65.62 -41.35 92.79 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.333 177.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.67 -41.1 98.22 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.846 -179.335 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.424 ' O ' HG23 ' A' ' 60' ' ' ILE . 7.8 tp -88.35 16.66 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.914 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 56.27 84.79 0.08 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.821 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 178.83 58.34 0.07 OUTLIER Pre-proline 0 C--N 1.328 -0.358 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -51.6 153.51 10.7 Favored 'Trans proline' 0 C--N 1.293 -2.385 0 C-N-CA 123.051 2.501 . . . . 0.0 111.943 -178.065 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.435 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.2 OUTLIER -108.86 145.33 15.85 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.148 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.341 -179.677 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.36 -45.49 97.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.363 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.504 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -129.43 134.08 47.65 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 120.816 0.341 . . . . 0.0 110.489 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.503 ' O ' ' N ' ' A' ' 98' ' ' LEU . 73.8 m -134.54 158.75 43.17 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.871 -179.741 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -87.04 139.25 16.06 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 110.621 -0.991 . . . . 0.0 110.621 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.494 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.7 -162.77 0.08 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.938 0.399 . . . . 0.0 110.431 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.533 HG22 ' CD2' ' A' ' 297' ' ' PHE . 14.2 t -133.47 134.75 43.91 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.293 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.478 ' C ' ' O ' ' A' ' 70' ' ' THR . 0.6 OUTLIER 29.73 68.74 0.66 Allowed Pre-proline 0 N--CA 1.467 0.397 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.817 -179.865 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_exo -61.85 145.18 97.21 Favored 'Trans proline' 0 C--N 1.299 -2.027 0 C-N-CA 122.706 2.27 . . . . 0.0 111.723 -177.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.528 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 45.7 p-10 -159.4 -31.81 0.06 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.66 179.645 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.541 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 99.1 m-20 -64.35 -39.42 93.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.366 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.4 ttt180 -60.33 -48.16 82.95 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.505 -179.138 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.424 ' O ' ' O ' ' A' ' 77' ' ' ALA . 93.0 t -60.48 -25.1 33.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.054 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.541 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -45.51 173.04 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.592 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.569 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.4 p30 -62.01 177.59 0.44 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.577 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.558 ' C ' ' H ' ' A' ' 81' ' ' GLY . 35.5 p30 -45.34 85.67 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.036 0.446 . . . . 0.0 111.102 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.569 ' N ' ' O ' ' A' ' 78' ' ' ASP . 42.8 tp60 -67.64 13.29 0.08 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.268 0.556 . . . . 0.0 110.197 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.558 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 118.65 -22.08 9.49 Favored Glycine 0 N--CA 1.462 0.374 0 N-CA-C 110.981 -0.848 . . . . 0.0 110.981 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -108.33 116.42 31.94 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.963 0.411 . . . . 0.0 110.445 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 76.6 mt -98.74 -0.19 43.22 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.578 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -92.15 7.35 42.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.971 0.415 . . . . 0.0 110.299 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.795 ' O ' HG22 ' A' ' 89' ' ' VAL . 27.1 mt-30 -100.25 -28.15 13.14 Favored 'General case' 0 C--O 1.22 -0.455 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.795 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 68.9 t-105 -63.03 -40.47 97.82 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.833 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.551 ' O ' ' N ' ' A' ' 91' ' ' LYS . 67.5 m -77.82 -53.74 7.14 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.881 -179.342 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -48.53 -50.68 30.94 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.076 -179.134 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.795 HG22 ' O ' ' A' ' 85' ' ' GLN . 15.5 m -68.81 -40.55 81.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.161 179.495 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.494 ' N ' HG23 ' A' ' 89' ' ' VAL . . . -72.43 -22.66 61.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.572 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.551 ' N ' ' O ' ' A' ' 87' ' ' SER . 65.9 tttm -61.97 -45.67 92.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.357 -179.399 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.437 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.8 mm-40 -90.41 -94.64 0.12 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.164 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.621 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.8 mtt180 -143.12 58.73 1.41 Allowed 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.446 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.6 pttp 33.97 26.02 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.149 0.5 . . . . 0.0 110.267 -179.465 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.621 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.4 tt -48.22 123.48 6.47 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.002 -177.864 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.457 ' O ' HD23 ' A' ' 95' ' ' LEU . 99.0 mm-40 -83.82 -169.98 2.85 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.146 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.609 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 81.2 mtp180 -74.25 137.07 42.74 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.232 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.503 ' N ' ' O ' ' A' ' 67' ' ' SER . 91.0 mt -85.71 -165.77 1.33 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.901 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.538 ' O ' ' CD2' ' A' ' 99' ' ' TYR . 47.9 p90 -168.57 119.56 0.77 Allowed 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.13 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.502 ' C ' ' O ' ' A' ' 99' ' ' TYR . 43.0 mm -28.69 120.78 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.068 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 114.2 27.61 3.35 Favored Glycine 0 CA--C 1.519 0.315 0 N-CA-C 111.259 -0.736 . . . . 0.0 111.259 -179.353 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.574 ' N ' ' CD ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -144.52 46.39 0.62 Allowed Pre-proline 0 C--N 1.321 -0.654 0 CA-C-O 121.084 0.468 . . . . 0.0 110.511 179.773 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.574 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 28.8 Cg_endo -62.15 144.34 95.66 Favored 'Trans proline' 0 C--N 1.295 -2.273 0 C-N-CA 122.687 2.258 . . . . 0.0 111.732 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.452 ' O ' HG23 ' A' ' 108' ' ' VAL . 24.3 t -173.2 120.52 0.35 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.349 179.607 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.95 -40.3 63.16 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.011 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.27 -39.91 89.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.892 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.33 -39.97 94.96 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.769 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 104' ' ' SER . 69.6 t -67.83 -43.65 86.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.73 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.04 -38.88 92.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.476 -179.189 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.437 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.55 -23.2 62.67 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.538 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.535 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.3 mm-40 -91.0 5.88 47.05 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.746 -179.615 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.539 ' O ' ' NE ' ' A' ' 45' ' ' ARG . 10.6 tpt 22.89 64.64 0.36 Allowed Pre-proline 0 N--CA 1.467 0.416 0 CA-C-O 120.905 0.383 . . . . 0.0 111.215 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -79.04 167.41 21.95 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 123.087 2.524 . . . . 0.0 111.466 -177.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.526 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 99.2 m-20 -110.02 -41.99 4.32 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.038 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.2 tp -121.38 120.26 34.51 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.925 0.393 . . . . 0.0 109.983 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 82.1 mt -112.94 128.92 69.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 CA-C-O 120.833 0.349 . . . . 0.0 110.935 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.63 HD12 ' OG ' ' A' ' 48' ' ' SER . 29.3 mt -109.08 132.11 54.42 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.281 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.496 HD12 HG23 ' A' ' 139' ' ' THR . 99.0 mt -119.75 138.57 49.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.654 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 85.7 p -72.54 153.8 41.13 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.633 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.28 -50.09 75.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.621 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -149.32 153.8 38.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.561 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 170.68 -170.86 43.43 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -63.11 -34.12 89.11 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.449 ' OD1' ' O ' ' A' ' 124' ' ' ASP . 44.3 p-10 -87.13 120.22 28.18 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.827 0.346 . . . . 0.0 110.612 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.443 ' O ' HD12 ' A' ' 129' ' ' LEU . 37.7 t -63.18 143.94 57.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.342 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.52 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.09 -43.3 8.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.868 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.9 tp -63.03 -42.36 99.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.747 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.6 -12.1 59.64 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.372 -179.313 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.443 HD12 ' O ' ' A' ' 125' ' ' SER . 84.7 mt -114.88 -23.94 8.89 Favored 'General case' 0 C--O 1.225 -0.196 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.557 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' TYR . . . . . 0.52 ' N ' ' O ' ' A' ' 126' ' ' ALA . 79.5 t80 -51.07 -49.55 60.41 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.654 -178.883 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 37.6 p-10 -66.16 -42.81 88.5 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.762 -0.375 . . . . 0.0 111.255 179.421 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.519 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 88.4 mt-30 -66.94 -37.68 84.74 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.783 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.428 HD12 HD11 ' A' ' 118' ' ' ILE . 96.3 mt -80.21 -41.62 24.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.908 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.3 t -56.94 -44.68 82.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.229 -179.127 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 20.4 m -62.01 -45.1 95.08 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.378 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 94.3 mt -62.06 -43.65 97.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.305 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.666 ' HB1' ' HD2' ' A' ' 138' ' ' PRO . . . -169.44 168.47 4.82 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.649 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.666 ' HD2' ' HB1' ' A' ' 137' ' ' ALA . 52.3 Cg_exo -49.91 112.74 0.77 Allowed 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.354 2.036 . . . . 0.0 112.454 179.03 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.496 HG23 HD12 ' A' ' 118' ' ' ILE . 23.6 m -84.07 127.33 33.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.629 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.691 HD13 ' CD2' ' A' ' 37' ' ' HIS . 34.4 tp -117.71 135.89 53.73 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.15 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.438 ' O ' ' OD2' ' A' ' 32' ' ' ASP . 82.1 mt -100.09 119.03 47.61 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.286 0 CA-C-O 121.093 0.473 . . . . 0.0 111.057 -179.301 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.428 HD12 HD22 ' A' ' 117' ' ' LEU . 98.0 mt -134.84 132.23 53.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.586 179.548 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.466 ' ND2' ' OD2' ' A' ' 241' ' ' ASP . 2.1 t-20 -66.69 151.46 47.35 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.473 179.329 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.521 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 88.1 t80 -86.24 122.47 30.28 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.858 -179.59 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.521 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 98.9 m-20 55.22 69.17 0.76 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.673 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 35.0 p-10 -125.8 0.36 7.38 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.573 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -150.62 115.07 5.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.687 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 84.0 p -63.34 168.41 4.47 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.597 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.411 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.8 p-90 -51.78 -16.05 0.61 Allowed 'General case' 0 C--O 1.22 -0.453 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.386 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' GLN . . . . . 0.446 ' O ' HG23 ' A' ' 154' ' ' THR . 68.1 tp60 -70.22 -76.01 0.11 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.896 0.379 . . . . 0.0 110.585 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.441 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.1 t -62.57 -38.81 91.53 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.224 179.516 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 54.1 tp -59.82 -45.9 90.93 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.398 -178.363 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.411 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 46.1 tp -62.63 -41.6 99.1 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.585 178.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.446 HG23 ' O ' ' A' ' 150' ' ' GLN . 61.5 p -64.11 -34.96 79.25 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.189 -179.366 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' GLN . . . . . 0.435 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.9 mm-40 -64.11 -42.49 96.87 Favored 'General case' 0 C--O 1.225 -0.229 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.412 179.308 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 90.6 mt -65.57 -38.57 89.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.147 0.499 . . . . 0.0 110.313 179.089 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.57 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.52 -32.28 80.66 Favored Glycine 0 C--N 1.331 0.286 0 N-CA-C 110.604 -0.998 . . . . 0.0 110.604 -179.154 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.435 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.2 mt-10 -35.56 -27.07 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.841 0.353 . . . . 0.0 110.827 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.57 ' N ' ' O ' ' A' ' 157' ' ' GLY . 95.6 mt -55.95 149.16 3.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.354 178.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 69.1 p -69.53 137.25 52.32 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.903 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 71.21 21.32 78.47 Favored Glycine 0 N--CA 1.459 0.195 0 N-CA-C 111.198 -0.761 . . . . 0.0 111.198 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 57.2 m80 -122.96 -14.67 7.56 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.6 0.238 . . . . 0.0 110.507 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -65.94 -59.97 3.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.596 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -52.05 -49.42 63.5 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.166 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -60.51 -41.07 93.61 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.838 0.351 . . . . 0.0 110.483 179.446 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.61 -47.26 86.26 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.505 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.82 -40.15 75.48 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.271 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -61.77 -50.01 74.08 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.616 179.486 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -65.34 -43.65 90.21 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.556 179.42 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 93.8 mt -64.88 -43.23 96.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.377 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.45 -51.35 69.8 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.297 -179.124 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.08 -43.82 97.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.939 0.4 . . . . 0.0 110.723 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' PHE . . . . . 0.66 ' CE2' HD11 ' A' ' 177' ' ' LEU . 57.7 t80 -63.09 -44.16 96.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.34 179.485 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -63.61 -39.64 94.89 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.498 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -63.16 -42.73 99.48 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.522 179.134 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -60.53 -44.68 95.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.22 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.66 HD11 ' CE2' ' A' ' 173' ' ' PHE . 84.6 mt -64.66 -40.94 96.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.651 178.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.14 -62.44 1.63 Allowed 'General case' 0 C--O 1.238 0.483 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.33 -179.219 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.34 -47.04 85.02 Favored 'General case' 0 C--O 1.226 -0.184 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.58 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -52.88 -41.89 64.77 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.368 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -63.97 -33.41 75.67 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.285 179.438 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 182' ' ' GLU . . . . . 0.415 ' O ' ' HG2' ' A' ' 182' ' ' GLU . 70.0 tt0 -90.76 8.78 32.92 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.609 0.719 . . . . 0.0 110.317 -178.819 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -105.05 -31.94 8.95 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.155 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 45.3 pt -128.08 147.93 32.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.708 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -140.19 131.34 26.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.463 179.013 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 186' ' ' LEU . . . . . 0.593 HD22 ' N ' ' A' ' 186' ' ' LEU . 3.6 mm? -85.63 132.63 43.89 Favored Pre-proline 0 N--CA 1.451 -0.41 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.13 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -43.45 157.59 0.11 Allowed 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.701 2.267 . . . . 0.0 112.416 179.306 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 188' ' ' PRO . . . . . 0.501 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.6 Cg_endo -62.84 115.1 2.72 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 C-N-CA 122.781 2.321 . . . . 0.0 111.727 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 189' ' ' GLN . . . . . 0.501 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.7 mt-30 155.72 147.44 0.0 OUTLIER Pre-proline 0 C--O 1.232 0.134 0 O-C-N 124.071 0.857 . . . . 0.0 110.953 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -73.34 143.71 35.54 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.553 2.169 . . . . 0.0 112.381 177.627 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.5 HG23 ' OG ' ' A' ' 258' ' ' SER . 2.1 p -124.63 159.24 31.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.443 0.64 . . . . 0.0 110.217 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 192' ' ' THR . . . . . 0.493 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 36.0 p -143.45 165.49 27.4 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.082 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 193' ' ' ALA . . . . . 0.446 ' HA ' ' H ' ' A' ' 260' ' ' PHE . . . -135.4 128.75 32.18 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 121.292 0.568 . . . . 0.0 110.181 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.504 HD11 HD23 ' A' ' 259' ' ' LEU . 47.3 pt -146.46 148.87 16.55 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.381 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.276 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 195' ' ' VAL . . . . . 0.757 HG13 ' CD1' ' A' ' 262' ' ' PHE . 69.8 t -117.67 123.28 71.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.334 0.588 . . . . 0.0 109.844 178.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -134.37 107.38 7.58 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.258 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 94.0 m -130.86 130.39 43.51 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.846 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.401 ' O ' ' N ' ' A' ' 201' ' ' HIS . . . -82.74 -37.16 25.06 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.22 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.32 -67.1 0.26 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.383 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.2 -10.07 59.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.387 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 201' ' ' HIS . . . . . 0.401 ' N ' ' O ' ' A' ' 198' ' ' ALA . 60.2 t-80 61.01 58.25 2.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.721 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 41.4 p -167.03 153.7 8.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.595 179.364 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.6 144.32 24.35 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.467 179.249 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -135.46 138.28 43.02 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.647 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 19.6 mt -106.2 125.59 51.18 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.046 0.45 . . . . 0.0 109.876 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 206' ' ' TRP . . . . . 0.555 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 75.8 m95 -82.3 167.24 18.79 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.619 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 207' ' ' THR . . . . . 0.457 HG22 ' C ' ' A' ' 206' ' ' TRP . 0.1 OUTLIER -157.05 170.94 8.12 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-O 120.981 0.42 . . . . 0.0 110.587 -178.954 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -53.09 -37.17 79.0 Favored 'Trans proline' 0 C--N 1.301 -1.928 0 C-N-CA 122.659 2.24 . . . . 0.0 112.532 178.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -70.86 -34.78 71.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.64 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 22.4 m -61.24 150.87 33.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.641 -179.418 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.68 -36.87 82.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.471 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 212' ' ' GLN . . . . . 0.555 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 55.0 tt0 -64.91 -40.1 94.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.515 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.62 -43.66 91.59 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.649 -0.98 . . . . 0.0 110.649 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -62.83 -43.81 97.82 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.874 0.369 . . . . 0.0 110.306 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 215' ' ' MET . . . . . 0.529 ' SD ' ' HB2' ' A' ' 304' ' ' ALA . 65.2 ttp -59.31 -48.23 82.4 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.108 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 88.6 mt -60.27 -41.16 92.72 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 217' ' ' GLU . . . . . 0.453 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.1 tp10 -57.93 -37.78 74.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.14 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -65.33 -38.1 89.1 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.687 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 94.2 mt -64.14 -42.89 96.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.176 0.512 . . . . 0.0 110.653 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.61 44.82 0.08 OUTLIER Glycine 0 N--CA 1.462 0.4 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 221' ' ' PHE . . . . . 0.453 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 27.3 m-85 -127.77 155.31 44.23 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 121.065 0.46 . . . . 0.0 110.463 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.48 ' O ' HG13 ' A' ' 191' ' ' VAL . 6.6 p -106.95 122.08 45.73 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.287 0.565 . . . . 0.0 109.992 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.468 HD22 ' C ' ' A' ' 222' ' ' THR . 4.3 mm? -100.99 133.19 45.85 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.139 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.95 159.05 15.13 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.426 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.09 115.43 30.25 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.924 0.392 . . . . 0.0 110.312 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.491 HD12 ' N ' ' A' ' 226' ' ' LEU . 8.9 mp -53.62 156.53 4.51 Favored Pre-proline 0 N--CA 1.45 -0.435 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.783 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.82 145.31 98.57 Favored 'Trans proline' 0 C--N 1.3 -1.999 0 C-N-CA 122.764 2.31 . . . . 0.0 112.34 179.019 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.53 -2.95 58.96 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.473 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.26 -40.8 5.68 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 111.034 -0.827 . . . . 0.0 111.034 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 230' ' ' LEU . . . . . 0.526 ' O ' ' N ' ' A' ' 233' ' ' SER . 85.7 mt -79.09 -16.85 56.16 Favored 'General case' 0 C--O 1.219 -0.54 0 CA-C-O 121.099 0.476 . . . . 0.0 110.347 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 54.3 t-20 -40.24 -49.15 2.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.857 -179.409 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -88.08 15.34 7.53 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.386 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 233' ' ' SER . . . . . 0.526 ' N ' ' O ' ' A' ' 230' ' ' LEU . 78.1 p -60.59 -35.5 76.24 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.714 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 234' ' ' GLN . . . . . 0.523 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.6 tt0 -118.38 -69.41 0.85 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.809 179.372 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.0 m -70.06 103.5 2.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.678 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -94.57 57.5 2.23 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.279 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -144.84 -122.48 1.56 Allowed Glycine 0 N--CA 1.461 0.304 0 N-CA-C 110.946 -0.861 . . . . 0.0 110.946 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -134.54 111.94 10.48 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.146 0.498 . . . . 0.0 110.339 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 239' ' ' ARG . . . . . 0.515 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.3 mtt180 -148.33 57.54 1.07 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.69 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -69.77 -31.91 70.11 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.528 179.486 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 241' ' ' ASP . . . . . 0.466 ' OD2' ' ND2' ' A' ' 143' ' ' ASN . 65.0 t0 -56.72 -47.09 80.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.304 -179.029 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 242' ' ' ILE . . . . . 0.439 ' O ' ' O ' ' A' ' 239' ' ' ARG . 17.6 tt -140.12 157.06 25.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.867 0.365 . . . . 0.0 110.468 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.439 HG22 HD13 ' A' ' 245' ' ' LEU . 96.2 mt -106.07 106.27 20.25 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.168 0 CA-C-O 121.085 0.469 . . . . 0.0 110.461 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 244' ' ' GLN . . . . . 0.596 ' O ' HD12 ' A' ' 245' ' ' LEU . 88.0 mt-30 -110.55 110.2 20.83 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.309 179.718 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.596 HD12 ' O ' ' A' ' 244' ' ' GLN . 9.6 mp -121.86 -168.12 1.65 Allowed 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.643 179.572 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 246' ' ' GLY . . . . . 0.523 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.3 -16.87 0.05 OUTLIER Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 247' ' ' GLY . . . . . 0.667 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -60.46 157.04 29.74 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -63.74 21.38 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.942 0.401 . . . . 0.0 110.601 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 249' ' ' ASN . . . . . 0.667 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.8 m-20 -97.08 -6.0 36.15 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.43 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 92.2 mt -80.09 -21.45 43.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.824 179.307 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.56 -51.31 70.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.634 -179.544 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.7 -5.25 58.24 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.488 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.16 -74.29 1.15 Allowed Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.829 -0.909 . . . . 0.0 110.829 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 81.3 mt -70.15 126.08 28.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.931 0.396 . . . . 0.0 110.328 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -59.6 -39.26 83.59 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.289 -179.604 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 82.91 51.68 4.14 Favored Glycine 0 CA--C 1.52 0.382 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -95.77 -15.19 22.74 Favored 'General case' 0 C--N 1.332 -0.187 0 O-C-N 122.69 -0.3 . . . . 0.0 110.616 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 258' ' ' SER . . . . . 0.5 ' OG ' HG23 ' A' ' 191' ' ' VAL . 3.3 t 174.69 88.85 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.24 0.543 . . . . 0.0 110.114 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.855 HD12 ' N ' ' A' ' 259' ' ' LEU . 0.9 OUTLIER -94.41 124.13 38.25 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.201 0.524 . . . . 0.0 111.266 -179.132 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 260' ' ' PHE . . . . . 0.446 ' H ' ' HA ' ' A' ' 193' ' ' ALA . 15.7 m-30 -93.25 146.28 23.82 Favored 'General case' 0 CA--C 1.498 -1.022 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.379 179.39 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 86.0 mt -122.27 149.68 43.37 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.622 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.757 ' CD1' HG13 ' A' ' 195' ' ' VAL . 2.7 p90 -77.17 -138.19 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.587 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 263' ' ' ALA . . . . . 0.656 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -52.34 77.18 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 121.024 0.44 . . . . 0.0 111.165 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 264' ' ' GLY . . . . . 0.616 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -178.99 104.39 0.19 Allowed Glycine 0 CA--C 1.529 0.951 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 265' ' ' ASP . . . . . 0.592 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.4 m-20 -80.14 -178.15 6.41 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.637 0.256 . . . . 0.0 110.938 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -40.31 -17.66 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.651 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 267' ' ' LYS . . . . . 0.592 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.32 -51.65 42.28 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.647 179.216 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -63.65 -46.65 84.68 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.007 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 269' ' ' ALA . . . . . 0.57 ' HB1' ' OH ' ' A' ' 273' ' ' TYR . . . -61.79 -35.02 76.94 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.392 0.615 . . . . 0.0 109.701 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -63.15 -34.12 76.93 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.158 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.72 -43.31 13.49 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.969 -179.444 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 272' ' ' ILE . . . . . 0.591 ' C ' ' H ' ' A' ' 274' ' ' ALA . 4.9 tt -51.42 -33.51 14.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.798 -178.781 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 273' ' ' TYR . . . . . 0.57 ' OH ' ' HB1' ' A' ' 269' ' ' ALA . 17.3 m-85 -54.71 -1.77 0.03 OUTLIER 'General case' 0 CA--C 1.515 -0.385 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.62 -179.4 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 274' ' ' ALA . . . . . 0.591 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.55 -39.7 70.51 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.912 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 275' ' ' ASN . . . . . 0.578 ' O ' ' N ' ' A' ' 279' ' ' ALA . 2.9 p30 -39.16 98.26 0.16 Allowed Pre-proline 0 C--O 1.226 -0.137 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.368 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.66 -42.72 65.78 Favored 'Trans proline' 0 C--N 1.303 -1.864 0 C-N-CA 122.413 2.076 . . . . 0.0 112.482 -178.575 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 88.9 mt -64.43 -42.89 95.78 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.116 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 91.1 mt -95.65 -1.6 49.81 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.984 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 279' ' ' ALA . . . . . 0.578 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.26 -34.71 77.06 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.711 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.8 m80 -74.38 20.1 0.12 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.969 -179.235 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 281' ' ' LEU . . . . . 0.482 HD23 ' HA ' ' A' ' 281' ' ' LEU . 13.7 mt -74.93 119.35 76.42 Favored Pre-proline 0 N--CA 1.445 -0.692 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.873 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -49.53 -40.37 45.54 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.658 2.239 . . . . 0.0 112.417 178.544 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.44 -50.61 62.26 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.116 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 75.4 t -61.29 -43.91 97.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.132 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -57.86 -41.15 81.83 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.129 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -90.97 0.12 57.61 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.102 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt 59.47 42.98 16.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.048 0.452 . . . . 0.0 110.829 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -94.42 41.33 1.09 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.31 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 53.8 t -118.85 135.82 58.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-O 121.141 0.496 . . . . 0.0 110.023 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -133.01 162.71 30.98 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 121.165 0.507 . . . . 0.0 110.633 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.98 155.38 32.93 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.108 0.48 . . . . 0.0 110.589 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 81.8 mt -94.13 -1.51 54.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.173 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.31 165.53 12.66 Favored Glycine 0 N--CA 1.464 0.514 0 N-CA-C 110.494 -1.043 . . . . 0.0 110.494 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 6.9 m -87.21 -62.43 1.5 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.921 0.391 . . . . 0.0 111.015 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 295' ' ' GLU . . . . . 0.433 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.5 mm-40 -69.57 -3.74 16.12 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.653 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 27.2 p -77.17 33.18 0.15 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.574 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 297' ' ' PHE . . . . . 0.533 ' CD2' HG22 ' A' ' 70' ' ' THR . 83.8 t80 -60.28 -45.96 91.5 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.589 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 298' ' ' ARG . . . . . 0.609 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.2 mtt85 -81.57 134.36 35.49 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.574 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.447 ' H ' HG11 ' A' ' 51' ' ' VAL . 16.3 tp -114.34 119.36 36.7 Favored 'General case' 0 C--O 1.23 0.07 0 CA-C-O 120.982 0.42 . . . . 0.0 110.29 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 300' ' ' ASP . . . . . 0.619 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.1 p-10 -167.07 -174.43 2.65 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.608 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -48.23 -45.14 33.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.203 -179.476 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -65.13 -41.35 94.91 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 121.054 0.454 . . . . 0.0 110.714 178.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 303' ' ' SER . . . . . 0.619 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 53.5 p -55.61 -36.26 66.73 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.059 -179.197 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 304' ' ' ALA . . . . . 0.529 ' HB2' ' SD ' ' A' ' 215' ' ' MET . . . -56.57 -52.18 65.79 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.388 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 91.8 mtp -55.72 -44.06 77.11 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -66.25 -42.6 88.32 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.211 0.529 . . . . 0.0 110.227 179.139 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 307' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 303' ' ' SER . 55.6 t -64.03 -42.77 96.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.202 179.4 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 43.4 tp -59.73 -42.2 92.61 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.77 -179.429 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -62.75 -38.83 92.11 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.048 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 310' ' ' ARG . . . . . 0.44 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.5 ttt85 -63.46 -44.1 95.45 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.211 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 88.0 mt -63.14 -41.98 99.39 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.416 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -62.96 -33.04 74.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.152 179.43 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -90.09 -23.36 21.42 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.375 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 314' ' ' LEU . . . . . 0.482 HD22 ' CE2' ' A' ' 315' ' ' PHE . 6.8 tt -62.31 -43.21 99.35 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 121.11 0.481 . . . . 0.0 110.573 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 315' ' ' PHE . . . . . 0.482 ' CE2' HD22 ' A' ' 314' ' ' LEU . 90.5 m-85 . . . . . 0 C--O 1.22 -0.477 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.326 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.477 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -99.5 136.06 39.99 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.115 0.483 . . . . 0.0 110.474 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.494 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -92.2 178.59 1.64 Allowed Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.545 -179.813 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.494 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.5 Cg_exo -61.54 147.18 96.05 Favored 'Trans proline' 0 C--N 1.299 -2.068 0 C-N-CA 122.854 2.369 . . . . 0.0 112.193 179.513 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.455 ' HE ' HD12 ' A' ' 39' ' ' LEU . 35.5 ptt180 -135.89 142.51 44.71 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.634 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -79.86 116.55 20.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.482 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.445 ' O ' HG23 ' A' ' 30' ' ' ILE . 9.4 tp -111.03 130.47 64.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.458 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 12.5 t -70.79 141.56 51.4 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.62 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.476 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.5 t0 -139.13 179.51 6.47 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.495 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.476 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 78.0 p -73.74 -37.32 65.12 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.6 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -46.3 -94.56 0.0 OUTLIER 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.357 -179.336 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -167.16 -26.56 0.02 OUTLIER Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 58.4 m -169.03 104.75 0.4 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.879 0.371 . . . . 0.0 110.668 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.68 ' CD2' HD13 ' A' ' 140' ' ' LEU . 74.2 t60 -128.57 148.44 50.77 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 121.119 0.485 . . . . 0.0 110.206 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.625 HG22 ' N ' ' A' ' 39' ' ' LEU . 98.4 m -130.83 166.14 21.49 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.458 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.625 ' N ' HG22 ' A' ' 38' ' ' THR . 81.6 mt -120.88 127.37 51.81 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.444 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -65.18 -44.61 87.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.716 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 38.9 p -165.67 154.98 12.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.377 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.497 ' CD ' ' H ' ' A' ' 42' ' ' GLN . 14.8 mp0 -44.3 101.0 0.24 Allowed Pre-proline 0 C--N 1.329 -0.306 0 O-C-N 123.419 0.449 . . . . 0.0 110.645 179.272 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -57.44 129.47 34.12 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 C-N-CA 122.347 2.031 . . . . 0.0 112.24 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -83.6 -24.67 31.4 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.621 179.548 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.539 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.5 mtm-85 -122.01 134.69 54.8 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.201 0.524 . . . . 0.0 110.256 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.2 mt -130.88 133.63 62.82 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.846 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 44.9 t -124.42 130.34 73.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-O 120.932 0.396 . . . . 0.0 109.939 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.626 ' OG ' HD12 ' A' ' 117' ' ' LEU . 2.3 m -154.8 166.89 32.05 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.504 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 69.8 p -124.55 8.83 8.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.404 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.26 125.67 33.08 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.874 0.369 . . . . 0.0 110.63 -179.473 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.442 HG11 ' H ' ' A' ' 299' ' ' LEU . 96.3 t -65.92 -44.51 92.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.505 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.7 m -62.69 -44.51 96.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.594 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 50.5 tp -62.32 -41.5 98.59 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.551 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.432 ' O ' HD13 ' A' ' 58' ' ' LEU . 75.4 m -57.87 -44.44 86.63 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.206 -179.133 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.14 -62.43 5.18 Favored Glycine 0 N--CA 1.467 0.717 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.7 t -48.2 -35.6 12.11 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 110.159 -0.311 . . . . 0.0 110.159 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 20.1 mt -61.87 -44.39 96.91 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.649 -0.421 . . . . 0.0 111.396 179.271 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.432 HD13 ' O ' ' A' ' 54' ' ' THR . 9.3 mp -65.5 -41.42 93.23 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.364 177.767 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.32 -41.27 98.91 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.832 -179.208 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.42 ' O ' HG23 ' A' ' 60' ' ' ILE . 8.3 tp -88.29 17.59 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.888 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 56.14 85.2 0.08 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.797 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.42 59.99 0.09 OUTLIER Pre-proline 0 C--N 1.327 -0.373 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -51.88 151.12 16.28 Favored 'Trans proline' 0 C--N 1.293 -2.363 0 C-N-CA 123.032 2.488 . . . . 0.0 112.047 -178.256 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.432 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -108.21 145.31 15.45 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.157 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.259 -179.659 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.51 -45.46 97.72 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.272 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.401 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.497 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -130.03 134.55 47.48 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 120.84 0.352 . . . . 0.0 110.491 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.476 ' O ' ' N ' ' A' ' 98' ' ' LEU . 74.8 m -134.56 158.82 43.0 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.831 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.29 138.58 16.02 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.48 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.55 -162.91 0.09 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.921 0.391 . . . . 0.0 110.474 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.529 HG22 ' CD2' ' A' ' 297' ' ' PHE . 6.1 t -133.93 135.28 43.47 Favored 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.48 ' C ' ' O ' ' A' ' 70' ' ' THR . 0.9 OUTLIER 29.65 68.74 0.65 Allowed Pre-proline 0 N--CA 1.467 0.403 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.743 -179.685 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -61.72 145.2 97.55 Favored 'Trans proline' 0 C--N 1.299 -2.062 0 C-N-CA 122.708 2.272 . . . . 0.0 111.735 -177.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.535 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 45.0 p-10 -159.65 -31.94 0.06 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.637 179.679 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.535 ' N ' ' OD1' ' A' ' 73' ' ' ASN . 99.1 m-20 -63.83 -39.92 95.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.337 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -60.08 -47.97 83.68 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.638 -179.123 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.426 ' O ' ' O ' ' A' ' 77' ' ' ALA . 93.6 t -60.49 -24.87 32.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.535 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -45.81 173.34 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.615 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.569 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.3 p30 -62.15 177.56 0.46 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.421 -179.651 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.561 ' C ' ' H ' ' A' ' 81' ' ' GLY . 36.4 p30 -45.4 85.68 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.075 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.569 ' N ' ' O ' ' A' ' 78' ' ' ASP . 43.1 tp60 -67.48 13.18 0.07 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.221 0.534 . . . . 0.0 110.142 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.561 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 118.54 -22.35 9.45 Favored Glycine 0 N--CA 1.461 0.305 0 N-CA-C 110.934 -0.866 . . . . 0.0 110.934 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -107.75 116.45 31.97 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.987 0.422 . . . . 0.0 110.453 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 75.0 mt -98.58 0.07 44.18 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.984 0.421 . . . . 0.0 110.559 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -92.63 7.38 43.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.015 0.436 . . . . 0.0 110.357 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.787 ' O ' HG22 ' A' ' 89' ' ' VAL . 27.4 mt-30 -100.12 -27.91 13.3 Favored 'General case' 0 C--O 1.222 -0.382 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.81 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 69.1 t-105 -63.49 -40.46 97.14 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.906 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.554 ' O ' ' N ' ' A' ' 91' ' ' LYS . 68.7 m -77.78 -53.79 7.1 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.952 -179.361 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -48.3 -50.57 29.55 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.111 -179.218 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.787 HG22 ' O ' ' A' ' 85' ' ' GLN . 15.7 m -69.03 -40.47 80.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.144 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.493 ' N ' HG23 ' A' ' 89' ' ' VAL . . . -72.63 -22.66 60.91 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.652 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.554 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.0 tttm -62.12 -45.62 92.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.384 -179.458 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.44 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.6 mm-40 -90.32 -94.8 0.12 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.974 0.416 . . . . 0.0 110.084 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.626 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.9 mtt180 -143.12 59.32 1.41 Allowed 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 109.595 -0.521 . . . . 0.0 109.595 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.449 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.7 pttp 33.8 25.89 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 120.968 0.413 . . . . 0.0 110.234 -179.479 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.626 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.4 tt -48.31 123.5 6.58 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.934 -177.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.451 ' O ' HD23 ' A' ' 95' ' ' LEU . 98.9 mm-40 -83.62 -170.3 2.99 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.112 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.61 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 82.3 mtp180 -73.82 137.26 43.72 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.233 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.476 ' N ' ' O ' ' A' ' 67' ' ' SER . 90.4 mt -86.32 -165.81 1.37 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.784 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.537 ' O ' ' CD2' ' A' ' 99' ' ' TYR . 48.3 p90 -169.01 120.09 0.74 Allowed 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.114 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.502 ' C ' ' O ' ' A' ' 99' ' ' TYR . 43.9 mm -28.98 121.02 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 O-C-N 123.261 0.351 . . . . 0.0 111.103 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 114.52 26.9 3.51 Favored Glycine 0 C--N 1.332 0.338 0 N-CA-C 111.281 -0.728 . . . . 0.0 111.281 -179.309 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.575 ' N ' ' CD ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -144.18 46.38 0.63 Allowed Pre-proline 0 C--N 1.322 -0.622 0 CA-C-O 121.023 0.44 . . . . 0.0 110.472 179.833 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 29.1 Cg_endo -62.13 143.92 95.23 Favored 'Trans proline' 0 C--N 1.294 -2.3 0 C-N-CA 122.677 2.251 . . . . 0.0 111.771 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.451 ' O ' HG23 ' A' ' 108' ' ' VAL . 26.5 t -173.14 120.35 0.35 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.426 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.39 -40.58 64.21 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.042 0.449 . . . . 0.0 111.145 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -66.19 -39.82 89.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.892 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.13 -39.88 94.99 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.77 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 104' ' ' SER . 71.7 t -67.77 -43.71 86.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.733 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.96 -38.97 93.23 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.555 -179.168 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.44 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.66 -23.3 62.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.473 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.537 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.4 mm-40 -90.8 5.58 47.77 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.654 -179.536 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.539 ' O ' ' NE ' ' A' ' 45' ' ' ARG . 10.3 tpt 22.88 64.5 0.36 Allowed Pre-proline 0 N--CA 1.468 0.437 0 CA-C-O 120.913 0.387 . . . . 0.0 111.22 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -78.92 167.5 22.04 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 123.079 2.519 . . . . 0.0 111.657 -177.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.522 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 99.3 m-20 -110.15 -42.05 4.28 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.077 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.8 tp -121.32 120.44 35.1 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 83.8 mt -113.42 129.09 69.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-O 120.848 0.356 . . . . 0.0 110.96 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.626 HD12 ' OG ' ' A' ' 48' ' ' SER . 29.5 mt -108.86 132.17 54.29 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.044 0.449 . . . . 0.0 110.268 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.49 HD12 HG23 ' A' ' 139' ' ' THR . 98.8 mt -119.66 138.42 50.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.709 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 85.6 p -72.63 153.77 41.07 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.612 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.12 -50.12 74.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.627 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.0 t -149.44 153.92 38.05 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.566 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 170.47 -170.98 43.43 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.89 -34.13 88.99 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.829 -0.908 . . . . 0.0 110.829 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.453 ' OD1' ' O ' ' A' ' 124' ' ' ASP . 44.5 p-10 -87.36 120.01 28.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.882 0.373 . . . . 0.0 110.652 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.444 ' O ' HD12 ' A' ' 129' ' ' LEU . 37.7 t -63.05 144.01 57.27 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.399 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.521 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.19 -43.26 8.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.836 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.3 tp -62.98 -42.45 99.84 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.739 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.49 -12.0 59.26 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.508 -179.397 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.444 HD12 ' O ' ' A' ' 125' ' ' SER . 85.1 mt -114.93 -23.93 8.87 Favored 'General case' 0 C--O 1.226 -0.159 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.586 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' TYR . . . . . 0.521 ' N ' ' O ' ' A' ' 126' ' ' ALA . 80.0 t80 -50.94 -49.49 59.76 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.643 -178.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.5 p-10 -66.09 -42.5 89.24 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.876 -0.33 . . . . 0.0 111.237 179.333 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.523 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 88.2 mt-30 -67.17 -37.85 84.44 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.874 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.429 HD12 HD11 ' A' ' 118' ' ' ILE . 96.1 mt -79.98 -41.83 25.14 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.915 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.3 t -56.86 -44.78 82.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.277 -179.066 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 20.0 m -61.86 -45.25 94.6 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.507 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 94.1 mt -62.03 -43.68 97.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.262 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.656 ' HB1' ' HD2' ' A' ' 138' ' ' PRO . . . -169.31 168.17 5.08 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.571 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.656 ' HD2' ' HB1' ' A' ' 137' ' ' ALA . 52.5 Cg_exo -49.61 113.0 0.79 Allowed 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.288 1.992 . . . . 0.0 112.35 179.078 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.49 HG23 HD12 ' A' ' 118' ' ' ILE . 23.5 m -84.27 127.41 33.94 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.622 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.68 HD13 ' CD2' ' A' ' 37' ' ' HIS . 34.4 tp -117.77 135.34 54.11 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.072 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.435 ' O ' ' OD2' ' A' ' 32' ' ' ASP . 82.3 mt -99.9 118.91 47.24 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.315 0 CA-C-O 121.181 0.515 . . . . 0.0 111.137 -179.299 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.438 HD12 HD22 ' A' ' 117' ' ' LEU . 98.1 mt -134.85 131.94 53.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.554 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.546 HD21 ' CG ' ' A' ' 241' ' ' ASP . 60.7 t30 -66.37 151.19 47.63 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.908 0.385 . . . . 0.0 110.479 179.298 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.52 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 88.2 t80 -85.96 122.25 29.73 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.883 -179.567 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.52 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 99.0 m-20 55.41 69.15 0.76 Allowed 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.672 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 35.0 p-10 -125.68 0.2 7.45 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.845 0.355 . . . . 0.0 110.604 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -150.63 115.48 5.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.706 -179.481 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 83.8 p -63.73 168.77 4.59 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.551 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.416 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.5 p-90 -52.3 -16.01 0.75 Allowed 'General case' 0 C--O 1.222 -0.389 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.417 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' GLN . . . . . 0.433 ' O ' HG23 ' A' ' 154' ' ' THR . 68.2 tp60 -69.97 -76.88 0.09 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.508 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.441 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.0 t -62.49 -38.45 89.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.216 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 54.1 tp -59.78 -45.86 90.98 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.356 -178.457 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.416 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 46.7 tp -62.66 -41.77 99.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.527 178.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.441 ' OG1' ' O ' ' A' ' 151' ' ' SER . 62.7 p -64.0 -34.75 78.7 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.196 -179.309 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' GLN . . . . . 0.422 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 88.0 mm-40 -64.05 -42.71 96.94 Favored 'General case' 0 C--O 1.225 -0.196 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.356 179.305 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 91.7 mt -65.52 -38.7 90.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.101 0.477 . . . . 0.0 110.277 179.163 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.575 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.37 -32.12 79.8 Favored Glycine 0 C--N 1.331 0.295 0 N-CA-C 110.68 -0.968 . . . . 0.0 110.68 -179.207 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 157' ' ' GLY . 97.3 mt-10 -35.64 -26.73 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.839 0.352 . . . . 0.0 110.858 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.575 ' N ' ' O ' ' A' ' 157' ' ' GLY . 95.3 mt -56.16 149.37 3.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.411 178.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 74.8 p -69.68 137.25 51.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.978 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 71.39 21.0 78.64 Favored Glycine 0 CA--C 1.517 0.165 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 179.477 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 56.3 m80 -122.56 -14.5 7.77 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.602 0.239 . . . . 0.0 110.454 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -65.66 -59.98 3.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.593 -179.558 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -52.18 -49.34 64.01 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.177 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -60.24 -41.28 92.84 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.805 0.336 . . . . 0.0 110.437 179.486 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.34 -47.17 87.13 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.59 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -57.04 -40.1 76.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.279 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -61.72 -50.43 72.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.61 179.488 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -65.25 -43.78 90.23 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.534 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 94.4 mt -64.83 -43.26 96.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.414 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.38 -51.31 69.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.355 -179.113 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.23 -43.64 97.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.614 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' PHE . . . . . 0.663 ' CE2' HD11 ' A' ' 177' ' ' LEU . 56.9 t80 -62.92 -44.45 96.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.097 0.475 . . . . 0.0 110.396 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -63.53 -39.64 94.95 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.679 -179.315 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -63.16 -42.85 99.48 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.531 179.184 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -60.78 -44.39 96.86 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.261 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.663 HD11 ' CE2' ' A' ' 173' ' ' PHE . 84.1 mt -64.78 -40.98 96.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.687 178.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.21 -62.39 1.66 Allowed 'General case' 0 C--O 1.238 0.495 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.355 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.37 -47.02 85.16 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.54 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.01 -41.68 64.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.375 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -63.9 -33.69 76.26 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.281 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 182' ' ' GLU . . . . . 0.417 ' O ' ' HG2' ' A' ' 182' ' ' GLU . 70.0 tt0 -90.64 8.73 32.83 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.616 0.722 . . . . 0.0 110.381 -178.808 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -104.84 -32.05 9.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.145 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.8 pt -128.08 147.88 32.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.791 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -140.15 131.34 26.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.426 179.182 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 186' ' ' LEU . . . . . 0.593 HD22 ' N ' ' A' ' 186' ' ' LEU . 3.5 mm? -85.55 133.06 42.81 Favored Pre-proline 0 N--CA 1.451 -0.41 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.042 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -43.82 157.81 0.13 Allowed 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.649 2.232 . . . . 0.0 112.364 179.338 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 188' ' ' PRO . . . . . 0.505 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.5 Cg_endo -62.87 114.91 2.62 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 C-N-CA 122.892 2.395 . . . . 0.0 111.657 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 189' ' ' GLN . . . . . 0.505 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.7 mt-30 155.6 147.65 0.0 OUTLIER Pre-proline 0 N--CA 1.456 -0.138 0 O-C-N 124.028 0.83 . . . . 0.0 110.824 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.35 143.92 35.86 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.614 2.209 . . . . 0.0 112.243 177.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.501 HG23 ' OG ' ' A' ' 258' ' ' SER . 2.1 p -124.58 158.84 31.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.441 0.639 . . . . 0.0 110.162 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 192' ' ' THR . . . . . 0.489 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 37.6 p -143.19 165.24 27.97 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.102 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 193' ' ' ALA . . . . . 0.447 ' HA ' ' H ' ' A' ' 260' ' ' PHE . . . -135.28 128.75 32.41 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 121.285 0.564 . . . . 0.0 110.224 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.506 HD11 HD23 ' A' ' 259' ' ' LEU . 47.4 pt -146.66 149.02 16.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.146 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 195' ' ' VAL . . . . . 0.746 HG13 ' CD1' ' A' ' 262' ' ' PHE . 69.5 t -117.77 123.41 71.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 CA-C-O 121.32 0.581 . . . . 0.0 109.903 178.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -134.27 107.25 7.55 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.161 0.505 . . . . 0.0 110.205 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 93.3 m -130.97 130.33 43.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.815 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.406 ' O ' ' N ' ' A' ' 201' ' ' HIS . . . -82.92 -37.27 24.42 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.249 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.23 -66.94 0.27 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.362 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.3 -10.17 59.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.346 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 201' ' ' HIS . . . . . 0.406 ' N ' ' O ' ' A' ' 198' ' ' ALA . 59.9 t-80 61.08 58.1 2.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.745 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 36.3 p -166.69 153.26 8.75 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.602 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.24 144.02 24.43 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.096 0.474 . . . . 0.0 110.416 179.209 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -135.4 138.32 43.17 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.609 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 19.9 mt -106.24 125.56 51.15 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.065 0.46 . . . . 0.0 109.925 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 206' ' ' TRP . . . . . 0.556 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 75.2 m95 -82.08 167.0 19.24 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.573 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 207' ' ' THR . . . . . 0.462 HG22 ' C ' ' A' ' 206' ' ' TRP . 0.1 OUTLIER -157.19 171.11 7.88 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.645 -178.961 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -53.19 -37.29 79.93 Favored 'Trans proline' 0 C--N 1.302 -1.913 0 C-N-CA 122.588 2.192 . . . . 0.0 112.472 178.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -70.57 -35.07 72.87 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.711 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 21.0 m -61.08 150.84 32.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.642 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.7 -36.78 81.9 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.465 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 212' ' ' GLN . . . . . 0.556 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 54.6 tt0 -64.97 -40.02 94.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.475 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.64 -43.4 92.1 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.712 -0.955 . . . . 0.0 110.712 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -63.24 -43.94 96.62 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.788 0.328 . . . . 0.0 110.229 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 215' ' ' MET . . . . . 0.521 ' SD ' ' HB2' ' A' ' 304' ' ' ALA . 65.1 ttp -59.21 -48.1 82.86 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.148 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 87.8 mt -60.42 -41.02 93.06 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 217' ' ' GLU . . . . . 0.457 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.8 tp10 -58.0 -37.67 74.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.05 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -65.53 -38.07 88.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.659 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 94.4 mt -64.09 -42.8 96.79 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.662 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.52 44.91 0.08 OUTLIER Glycine 0 CA--C 1.52 0.391 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 221' ' ' PHE . . . . . 0.457 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 26.9 m-85 -127.92 155.42 44.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.073 0.463 . . . . 0.0 110.463 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.48 ' O ' HG13 ' A' ' 191' ' ' VAL . 7.2 p -107.27 122.49 46.66 Favored 'General case' 0 C--O 1.224 -0.248 0 CA-C-O 121.371 0.605 . . . . 0.0 110.088 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.476 HD22 ' C ' ' A' ' 222' ' ' THR . 4.3 mm? -101.43 133.02 46.7 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.162 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.77 159.78 14.73 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.459 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.47 115.33 30.07 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.391 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.497 HD12 ' N ' ' A' ' 226' ' ' LEU . 8.9 mp -53.16 156.54 3.71 Favored Pre-proline 0 N--CA 1.451 -0.415 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.764 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.01 145.34 98.6 Favored 'Trans proline' 0 C--N 1.299 -2.03 0 C-N-CA 122.744 2.296 . . . . 0.0 112.298 179.083 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.28 -3.38 59.04 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.535 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -89.96 -41.22 5.66 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 230' ' ' LEU . . . . . 0.518 ' O ' ' N ' ' A' ' 233' ' ' SER . 69.8 mt -78.86 -17.59 55.37 Favored 'General case' 0 C--O 1.219 -0.522 0 CA-C-O 121.13 0.491 . . . . 0.0 110.379 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 54.4 t-20 -40.41 -49.2 2.83 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.807 -179.218 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -87.59 15.15 7.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.352 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 233' ' ' SER . . . . . 0.518 ' N ' ' O ' ' A' ' 230' ' ' LEU . 77.9 p -60.59 -35.3 75.76 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.703 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 234' ' ' GLN . . . . . 0.524 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.6 tt0 -119.0 -69.33 0.86 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.868 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.3 m -69.76 102.82 2.0 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.675 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -94.37 57.56 2.31 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.34 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -144.78 -122.42 1.56 Allowed Glycine 0 N--CA 1.461 0.309 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -135.12 111.69 9.93 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 121.183 0.516 . . . . 0.0 110.341 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 239' ' ' ARG . . . . . 0.525 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.6 mtt180 -148.22 57.85 1.08 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.655 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -69.47 -32.39 71.26 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.512 179.503 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 241' ' ' ASP . . . . . 0.546 ' CG ' HD21 ' A' ' 143' ' ' ASN . 64.8 t0 -56.84 -47.1 81.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.27 -179.027 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 242' ' ' ILE . . . . . 0.44 ' O ' ' O ' ' A' ' 239' ' ' ARG . 18.1 tt -139.88 156.4 25.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.933 0.397 . . . . 0.0 110.445 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.446 HG22 HD13 ' A' ' 245' ' ' LEU . 96.2 mt -106.3 106.65 20.99 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.206 0 CA-C-O 121.1 0.476 . . . . 0.0 110.567 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 244' ' ' GLN . . . . . 0.6 ' O ' HD12 ' A' ' 245' ' ' LEU . 88.2 mt-30 -110.49 110.0 20.57 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.232 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.6 HD12 ' O ' ' A' ' 244' ' ' GLN . 9.4 mp -121.69 -168.19 1.65 Allowed 'General case' 0 C--O 1.223 -0.297 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.752 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 246' ' ' GLY . . . . . 0.524 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.51 -16.37 0.05 OUTLIER Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.974 -0.851 . . . . 0.0 110.974 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 247' ' ' GLY . . . . . 0.672 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -61.04 156.61 32.96 Favored Glycine 0 CA--C 1.521 0.464 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -63.45 21.53 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.98 0.419 . . . . 0.0 110.649 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 249' ' ' ASN . . . . . 0.672 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.9 m-20 -97.2 -6.22 35.23 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.493 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 92.6 mt -79.48 -21.99 44.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.786 179.296 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.54 -51.36 70.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.734 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.24 -5.66 58.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.459 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.15 -74.48 1.14 Allowed Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.844 -0.902 . . . . 0.0 110.844 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 82.2 mt -70.02 126.07 28.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.017 0.437 . . . . 0.0 110.315 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -59.5 -39.37 83.57 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.11 -179.468 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 82.75 51.71 4.17 Favored Glycine 0 CA--C 1.52 0.37 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -96.14 -14.81 22.53 Favored 'General case' 0 C--N 1.333 -0.138 0 O-C-N 122.683 -0.304 . . . . 0.0 110.615 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 258' ' ' SER . . . . . 0.501 ' OG ' HG23 ' A' ' 191' ' ' VAL . 3.4 t 174.77 88.59 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.194 0.521 . . . . 0.0 110.092 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.857 HD12 ' N ' ' A' ' 259' ' ' LEU . 1.0 OUTLIER -94.43 124.44 38.46 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.228 0.537 . . . . 0.0 111.179 -179.129 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 260' ' ' PHE . . . . . 0.447 ' H ' ' HA ' ' A' ' 193' ' ' ALA . 15.8 m-30 -93.28 146.41 23.73 Favored 'General case' 0 CA--C 1.499 -1.012 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.396 179.394 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 85.2 mt -122.5 149.39 43.96 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.58 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.746 ' CD1' HG13 ' A' ' 195' ' ' VAL . 2.6 p90 -77.19 -138.36 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.612 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 263' ' ' ALA . . . . . 0.656 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -52.07 76.95 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 121.049 0.452 . . . . 0.0 111.188 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 264' ' ' GLY . . . . . 0.624 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -178.76 104.51 0.19 Allowed Glycine 0 CA--C 1.528 0.85 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 265' ' ' ASP . . . . . 0.596 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.5 m-20 -80.38 -178.04 6.46 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.585 0.231 . . . . 0.0 110.928 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -40.25 -17.91 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.579 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 267' ' ' LYS . . . . . 0.596 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.13 -51.66 43.65 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.722 179.195 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -63.6 -46.68 84.69 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.254 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 269' ' ' ALA . . . . . 0.569 ' HB1' ' OH ' ' A' ' 273' ' ' TYR . . . -61.67 -35.13 77.08 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 121.404 0.621 . . . . 0.0 109.822 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -63.07 -34.37 77.44 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.176 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.49 -43.27 13.71 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.126 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 272' ' ' ILE . . . . . 0.591 ' C ' ' H ' ' A' ' 274' ' ' ALA . 4.9 tt -51.39 -33.69 14.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.767 -178.845 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 273' ' ' TYR . . . . . 0.569 ' OH ' ' HB1' ' A' ' 269' ' ' ALA . 17.2 m-85 -54.43 -1.78 0.03 OUTLIER 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.703 -179.504 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 274' ' ' ALA . . . . . 0.591 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.5 -39.7 70.65 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.93 179.473 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 275' ' ' ASN . . . . . 0.579 ' O ' ' N ' ' A' ' 279' ' ' ALA . 3.1 p30 -38.98 98.02 0.15 Allowed Pre-proline 0 C--O 1.226 -0.149 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.449 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -54.64 -42.61 66.73 Favored 'Trans proline' 0 C--N 1.303 -1.835 0 C-N-CA 122.376 2.051 . . . . 0.0 112.513 -178.569 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 89.2 mt -64.57 -42.86 95.38 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.038 0.447 . . . . 0.0 111.15 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 91.2 mt -95.66 -1.63 49.74 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.939 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 279' ' ' ALA . . . . . 0.579 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.3 -34.68 77.06 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.748 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.21 20.04 0.12 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.014 -179.318 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 281' ' ' LEU . . . . . 0.481 ' H ' ' C ' ' A' ' 279' ' ' ALA . 13.8 mt -75.18 119.46 77.04 Favored Pre-proline 0 N--CA 1.447 -0.605 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.729 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -49.9 -39.88 49.01 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.644 2.23 . . . . 0.0 112.281 178.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.64 -50.59 62.87 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.066 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 78.6 t -61.32 -44.0 97.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -57.85 -41.16 81.8 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.15 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -91.06 0.05 57.62 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.104 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt 59.56 43.61 15.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.945 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -95.08 41.42 1.09 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.34 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 54.1 t -119.13 135.68 58.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-O 121.052 0.453 . . . . 0.0 110.067 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -132.58 162.35 31.52 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.22 0.533 . . . . 0.0 110.608 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.6 154.96 33.16 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-O 121.038 0.447 . . . . 0.0 110.663 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 81.5 mt -93.68 -1.56 55.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.253 -179.645 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.01 166.22 12.93 Favored Glycine 0 CA--C 1.521 0.439 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 7.2 m -87.77 -62.46 1.49 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.855 0.36 . . . . 0.0 110.939 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 295' ' ' GLU . . . . . 0.437 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.4 mm-40 -69.35 -3.87 15.93 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.667 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 27.0 p -77.21 32.7 0.15 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.604 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 297' ' ' PHE . . . . . 0.529 ' CD2' HG22 ' A' ' 70' ' ' THR . 70.1 t80 -60.15 -46.21 90.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.603 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 298' ' ' ARG . . . . . 0.61 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.2 mtt85 -81.0 133.66 35.53 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.535 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.442 ' H ' HG11 ' A' ' 51' ' ' VAL . 16.4 tp -114.23 119.39 36.85 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.319 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 300' ' ' ASP . . . . . 0.622 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.1 p-10 -167.52 -173.85 2.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.612 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -48.58 -45.41 37.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.236 -179.37 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -64.97 -41.52 95.38 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.09 0.471 . . . . 0.0 110.697 178.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 303' ' ' SER . . . . . 0.622 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 52.6 p -55.39 -36.14 66.09 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.016 -179.223 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 304' ' ' ALA . . . . . 0.521 ' HB2' ' SD ' ' A' ' 215' ' ' MET . . . -56.7 -51.84 67.26 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.435 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 91.5 mtp -56.15 -43.99 78.83 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -66.23 -42.75 88.22 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.152 0.501 . . . . 0.0 110.238 179.038 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 307' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 303' ' ' SER . 55.1 t -64.04 -42.74 96.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.26 179.3 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 43.0 tp -59.67 -42.33 92.62 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.741 -179.341 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -62.55 -38.8 91.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.139 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 310' ' ' ARG . . . . . 0.442 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.5 ttt85 -63.51 -44.1 95.26 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.165 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 87.8 mt -63.2 -42.02 99.25 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.353 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -62.89 -33.24 74.88 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.13 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.93 -23.36 21.6 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.365 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 314' ' ' LEU . . . . . 0.479 HD22 ' CE2' ' A' ' 315' ' ' PHE . 6.7 tt -62.41 -43.11 99.59 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 121.069 0.461 . . . . 0.0 110.597 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 315' ' ' PHE . . . . . 0.479 ' CE2' HD22 ' A' ' 314' ' ' LEU . 91.2 m-85 . . . . . 0 C--O 1.22 -0.46 0 CA-C-O 117.947 -1.025 . . . . 0.0 110.381 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -99.39 135.15 41.23 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.169 0.509 . . . . 0.0 110.469 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.491 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -92.19 178.68 1.6 Allowed Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.545 -179.802 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.491 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.8 Cg_exo -61.66 147.2 95.89 Favored 'Trans proline' 0 C--N 1.298 -2.097 0 C-N-CA 122.89 2.393 . . . . 0.0 112.117 179.56 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.477 ' HE ' HD12 ' A' ' 39' ' ' LEU . 35.1 ptt180 -135.91 142.11 44.62 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.732 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -79.66 116.94 20.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.462 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.449 ' O ' HG23 ' A' ' 30' ' ' ILE . 9.4 tp -111.93 130.55 65.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.399 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 12.6 t -71.01 142.27 50.94 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.008 0.432 . . . . 0.0 110.621 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.472 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.4 t0 -139.08 179.75 6.32 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.505 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.472 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 78.3 p -73.6 -37.37 65.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.777 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.8 ttt85 -46.94 -94.76 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.233 -179.278 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -166.08 -26.73 0.02 OUTLIER Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 62.5 m -168.58 106.02 0.45 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.806 0.336 . . . . 0.0 110.65 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.658 ' CD2' HD13 ' A' ' 140' ' ' LEU . 71.5 t60 -129.23 146.64 51.1 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 121.075 0.464 . . . . 0.0 110.151 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.62 HG22 ' N ' ' A' ' 39' ' ' LEU . 97.5 m -129.86 165.68 21.51 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.41 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.62 ' N ' HG22 ' A' ' 38' ' ' THR . 79.5 mt -120.42 127.21 52.05 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.485 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -65.44 -44.8 86.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.728 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 37.8 p -165.65 155.27 12.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.445 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.497 ' CD ' ' H ' ' A' ' 42' ' ' GLN . 14.6 mp0 -44.43 100.71 0.23 Allowed Pre-proline 0 C--O 1.236 0.374 0 O-C-N 123.527 0.517 . . . . 0.0 110.634 179.193 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -57.51 129.78 35.6 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 C-N-CA 122.322 2.014 . . . . 0.0 112.337 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -83.09 -24.62 32.6 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.567 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.531 ' NE ' ' O ' ' A' ' 112' ' ' MET . 90.1 mtm-85 -121.04 134.2 55.27 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.214 0.531 . . . . 0.0 110.15 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.1 mt -130.72 133.67 63.01 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.846 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 46.4 t -124.77 131.34 72.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.619 ' OG ' HD12 ' A' ' 117' ' ' LEU . 4.4 m -154.38 166.14 34.16 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.584 179.451 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 63.3 p -124.66 8.32 8.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.395 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.6 126.15 33.68 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.801 0.334 . . . . 0.0 110.687 -179.525 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.461 HG11 ' H ' ' A' ' 299' ' ' LEU . 88.7 t -65.65 -44.61 93.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.521 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.3 m -62.55 -44.33 96.6 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.709 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 54.0 tp -62.29 -41.59 98.63 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.558 -179.464 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.451 ' O ' HD13 ' A' ' 58' ' ' LEU . 69.5 m -58.18 -44.48 88.04 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.124 -179.05 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.31 -62.19 5.35 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.7 t -48.08 -35.77 11.91 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 20.3 mt -61.78 -44.26 97.23 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 120.598 -0.441 . . . . 0.0 111.321 179.188 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.451 HD13 ' O ' ' A' ' 54' ' ' THR . 9.4 mp -65.26 -41.68 94.03 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.518 177.866 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.45 -41.26 98.64 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.921 -179.323 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.415 ' O ' HG23 ' A' ' 60' ' ' ILE . 8.0 tp -87.8 16.75 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.864 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 56.31 84.14 0.09 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.804 -179.641 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.61 58.21 0.08 OUTLIER Pre-proline 0 C--N 1.327 -0.381 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -50.93 152.9 9.43 Favored 'Trans proline' 0 C--N 1.294 -2.333 0 C-N-CA 123.033 2.488 . . . . 0.0 112.228 -178.536 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.43 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -108.78 146.39 14.5 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.178 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.31 -179.69 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 97.0 mt -63.65 -45.08 98.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.478 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.498 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -130.45 134.49 47.14 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 120.868 0.366 . . . . 0.0 110.49 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.489 ' O ' ' N ' ' A' ' 98' ' ' LEU . 66.9 m -134.42 158.55 43.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.922 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.81 139.43 16.35 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.494 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.85 -162.69 0.08 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.003 0.43 . . . . 0.0 110.384 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.522 HG22 ' CD2' ' A' ' 297' ' ' PHE . 14.6 t -133.57 135.37 44.27 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.314 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.474 ' C ' ' O ' ' A' ' 70' ' ' THR . 0.7 OUTLIER 29.76 68.88 0.65 Allowed Pre-proline 0 N--CA 1.469 0.475 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.857 -179.866 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -61.59 145.34 97.79 Favored 'Trans proline' 0 C--N 1.299 -2.054 0 C-N-CA 122.672 2.248 . . . . 0.0 111.873 -177.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.528 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 46.0 p-10 -160.05 -31.79 0.06 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.799 179.486 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.529 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 98.9 m-20 -64.41 -39.33 93.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.348 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -60.7 -47.97 83.88 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.481 -179.024 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.425 ' O ' ' O ' ' A' ' 77' ' ' ALA . 92.8 t -60.35 -24.86 32.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.529 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -45.52 172.85 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.695 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.566 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.7 p30 -61.72 177.48 0.41 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.448 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.565 ' C ' ' H ' ' A' ' 81' ' ' GLY . 36.3 p30 -46.07 85.65 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.016 0.436 . . . . 0.0 110.971 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.566 ' N ' ' O ' ' A' ' 78' ' ' ASP . 42.7 tp60 -67.19 13.55 0.06 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.176 0.512 . . . . 0.0 110.065 -179.637 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.565 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 117.82 -22.13 10.08 Favored Glycine 0 N--CA 1.461 0.334 0 N-CA-C 110.911 -0.876 . . . . 0.0 110.911 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -107.44 116.3 31.7 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.01 0.433 . . . . 0.0 110.454 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 75.7 mt -98.49 0.46 45.17 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 120.992 0.425 . . . . 0.0 110.582 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -92.14 6.52 46.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.027 0.441 . . . . 0.0 110.276 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.772 ' O ' HG22 ' A' ' 89' ' ' VAL . 27.1 mt-30 -100.12 -26.63 13.88 Favored 'General case' 0 C--O 1.219 -0.511 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.796 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 75.9 t-105 -64.64 -40.76 96.01 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.109 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.549 ' O ' ' N ' ' A' ' 91' ' ' LYS . 68.1 m -77.85 -53.53 7.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.316 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -48.49 -50.52 31.33 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.089 -179.126 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.772 HG22 ' O ' ' A' ' 85' ' ' GLN . 14.3 m -68.92 -40.82 81.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.209 179.387 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.499 ' N ' HG23 ' A' ' 89' ' ' VAL . . . -71.89 -23.04 61.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.725 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.549 ' N ' ' O ' ' A' ' 87' ' ' SER . 65.9 tttm -61.62 -45.67 93.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.442 -179.428 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.44 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.3 mm-40 -90.6 -94.56 0.12 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.012 0.434 . . . . 0.0 110.05 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.615 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.9 mtt180 -143.48 59.44 1.39 Allowed 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.441 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.6 pttp 34.45 25.77 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.084 0.468 . . . . 0.0 110.336 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.615 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.5 tt -48.24 123.34 6.28 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.078 -177.8 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.451 ' O ' HD23 ' A' ' 95' ' ' LEU . 99.0 mm-40 -83.53 -170.84 3.26 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.054 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.609 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 82.2 mtp180 -73.17 137.6 45.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.12 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.489 ' N ' ' O ' ' A' ' 67' ' ' SER . 90.3 mt -86.11 -166.29 1.5 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.868 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.536 ' O ' ' CD2' ' A' ' 99' ' ' TYR . 47.5 p90 -167.96 119.95 0.86 Allowed 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.065 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.494 ' C ' ' O ' ' A' ' 99' ' ' TYR . 42.8 mm -29.56 121.05 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.055 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 113.96 27.91 3.32 Favored Glycine 0 C--N 1.331 0.291 0 N-CA-C 111.326 -0.71 . . . . 0.0 111.326 -179.216 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.581 ' N ' ' CD ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -143.85 45.83 0.6 Allowed Pre-proline 0 C--N 1.321 -0.632 0 CA-C-O 121.087 0.47 . . . . 0.0 110.427 179.817 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.581 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 29.8 Cg_endo -62.02 143.84 95.52 Favored 'Trans proline' 0 C--N 1.294 -2.306 0 C-N-CA 122.593 2.195 . . . . 0.0 111.881 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.464 ' O ' HG23 ' A' ' 108' ' ' VAL . 24.3 t -173.26 120.6 0.34 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.283 179.53 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.02 -40.98 64.71 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.104 0.478 . . . . 0.0 111.281 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -65.93 -40.11 91.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.864 -179.475 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.98 -39.81 94.98 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.719 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 104' ' ' SER . 69.4 t -67.48 -43.87 87.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.762 179.585 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.43 -39.05 92.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.461 -179.119 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.44 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.58 -23.58 63.05 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.513 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.533 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.3 mm-40 -91.17 5.05 50.6 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.746 -179.568 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.533 ' C ' ' O ' ' A' ' 111' ' ' GLN . 10.5 tpt 22.98 64.14 0.36 Allowed Pre-proline 0 N--CA 1.469 0.511 0 CA-C-O 120.883 0.373 . . . . 0.0 111.2 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.442 ' HG2' HD11 ' A' ' 116' ' ' ILE . 65.0 Cg_endo -78.93 168.37 20.87 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 123.017 2.478 . . . . 0.0 111.758 -177.839 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.527 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 99.0 m-20 -112.38 -44.21 3.41 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.003 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 39.8 tp -120.67 119.48 32.94 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.456 HD13 HD22 ' A' ' 133' ' ' LEU . 96.1 mt -116.43 131.19 69.73 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.408 0 CA-C-O 120.887 0.375 . . . . 0.0 111.007 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.619 HD12 ' OG ' ' A' ' 48' ' ' SER . 28.5 mt -105.99 132.67 51.8 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.192 -179.299 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.42 HD12 HG23 ' A' ' 139' ' ' THR . 98.1 mt -118.08 136.01 56.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.695 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 86.4 p -72.09 153.45 41.69 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.603 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.14 -50.04 75.25 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.651 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -149.46 154.03 38.19 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.593 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 169.73 -170.31 42.66 Favored Glycine 0 CA--C 1.525 0.719 0 N-CA-C 110.969 -0.852 . . . . 0.0 110.969 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -63.16 -34.94 91.32 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 110.864 -0.894 . . . . 0.0 110.864 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.444 ' OD1' ' O ' ' A' ' 124' ' ' ASP . 43.9 p-10 -87.89 120.11 28.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.855 0.36 . . . . 0.0 110.607 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.446 ' O ' HD12 ' A' ' 129' ' ' LEU . 39.6 t -63.51 144.26 57.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.386 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.517 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.2 -43.13 8.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.013 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.4 tp -62.79 -42.43 99.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.752 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.8 -11.11 57.83 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.52 -179.328 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.446 HD12 ' O ' ' A' ' 125' ' ' SER . 85.1 mt -115.54 -23.99 8.53 Favored 'General case' 0 C--O 1.225 -0.23 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.668 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' TYR . . . . . 0.517 ' N ' ' O ' ' A' ' 126' ' ' ALA . 77.7 t80 -51.87 -49.62 62.6 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.666 -178.802 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.5 p-10 -65.83 -42.02 91.05 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.282 179.177 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.522 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 87.9 mt-30 -67.45 -37.04 82.37 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.949 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.456 HD22 HD13 ' A' ' 116' ' ' ILE . 94.1 mt -79.69 -42.31 24.98 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.958 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.3 t -57.12 -44.81 83.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.25 -178.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.9 m -62.33 -45.58 92.56 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.463 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 93.1 mt -62.5 -43.89 98.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.307 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.595 ' HB1' ' HD2' ' A' ' 138' ' ' PRO . . . -169.8 163.68 6.61 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.588 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.595 ' HD2' ' HB1' ' A' ' 137' ' ' ALA . 75.4 Cg_exo -43.71 111.91 0.28 Allowed 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.374 2.05 . . . . 0.0 112.3 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.458 HG21 ' CD1' ' A' ' 130' ' ' TYR . 18.2 m -85.37 127.34 34.33 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.541 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.658 HD13 ' CD2' ' A' ' 37' ' ' HIS . 34.2 tp -118.73 135.18 54.63 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 120.976 0.417 . . . . 0.0 110.077 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.425 ' O ' ' OD2' ' A' ' 32' ' ' ASP . 80.1 mt -102.01 120.04 51.13 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.345 0 CA-C-O 121.172 0.511 . . . . 0.0 111.332 -179.381 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.497 HD12 HD22 ' A' ' 117' ' ' LEU . 97.4 mt -135.79 132.94 51.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.702 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.519 ' ND2' ' H ' ' A' ' 144' ' ' TYR . 2.2 t-20 -65.81 152.03 45.31 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.99 0.424 . . . . 0.0 110.356 179.21 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.523 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 87.9 t80 -85.81 122.48 29.94 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.999 -179.5 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.523 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 99.2 m-20 55.06 69.41 0.74 Allowed 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.713 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 49.4 p-10 -123.56 0.06 8.73 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 120.853 0.359 . . . . 0.0 110.625 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -151.61 117.17 5.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.735 -179.419 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 84.6 p -63.27 167.49 5.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.557 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.411 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.7 p-90 -50.62 -15.85 0.31 Allowed 'General case' 0 C--O 1.22 -0.497 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.429 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' GLN . . . . . 0.445 ' O ' HG23 ' A' ' 154' ' ' THR . 68.2 tp60 -71.23 -74.81 0.14 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.941 0.401 . . . . 0.0 110.443 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.448 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.2 t -62.62 -39.11 92.77 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.138 179.535 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 54.3 tp -60.35 -45.41 93.57 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.361 -178.32 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.411 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 45.9 tp -62.63 -41.62 99.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.52 178.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.448 ' OG1' ' O ' ' A' ' 151' ' ' SER . 54.6 p -64.03 -34.68 78.55 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.136 -179.292 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' GLN . . . . . 0.445 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 88.0 mm-40 -63.93 -42.47 97.35 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.258 179.235 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 91.1 mt -65.3 -38.97 91.84 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.242 0.544 . . . . 0.0 110.249 179.132 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.571 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.17 -32.26 79.91 Favored Glycine 0 C--N 1.332 0.331 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 -179.177 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.445 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.2 mt-10 -36.16 -25.91 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.812 0.339 . . . . 0.0 110.877 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.571 ' N ' ' O ' ' A' ' 157' ' ' GLY . 95.1 mt -58.26 149.6 5.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.326 178.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 77.7 p -69.39 137.27 52.66 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.038 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 70.88 21.46 78.14 Favored Glycine 0 N--CA 1.459 0.201 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 179.54 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 59.4 m80 -123.09 -15.11 7.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.585 0.231 . . . . 0.0 110.452 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -66.28 -59.54 3.63 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.698 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -52.2 -48.83 64.84 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 120.709 -0.397 . . . . 0.0 110.101 -179.432 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -60.78 -40.99 94.63 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.839 0.352 . . . . 0.0 110.44 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.47 -47.41 85.79 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.522 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.89 -40.22 75.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.199 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -61.68 -50.22 73.35 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.62 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -65.16 -43.81 90.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.533 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 94.7 mt -64.63 -43.4 96.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.406 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.31 -51.23 70.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.446 -179.074 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.6 -43.53 96.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.867 0.365 . . . . 0.0 110.592 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' PHE . . . . . 0.663 ' CE2' HD11 ' A' ' 177' ' ' LEU . 57.0 t80 -62.78 -44.42 96.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.144 0.497 . . . . 0.0 110.405 179.442 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -63.71 -39.68 94.92 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.394 -179.148 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -62.9 -42.82 99.91 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.573 179.152 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -60.82 -44.48 96.85 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.064 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.663 HD11 ' CE2' ' A' ' 173' ' ' PHE . 84.7 mt -64.42 -41.18 96.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.983 0.42 . . . . 0.0 110.778 178.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.08 -62.06 1.87 Allowed 'General case' 0 C--O 1.239 0.516 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.34 -179.286 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.76 -46.83 86.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.42 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.24 -41.59 65.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.275 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -63.8 -33.81 76.5 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.962 0.411 . . . . 0.0 110.23 179.378 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 182' ' ' GLU . . . . . 0.412 ' O ' ' HG2' ' A' ' 182' ' ' GLU . 70.0 tt0 -90.63 8.79 32.46 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.622 0.725 . . . . 0.0 110.341 -178.814 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -104.73 -32.09 9.03 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.233 179.38 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.8 pt -127.95 147.74 32.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.816 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -139.98 131.38 26.87 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.31 179.18 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 186' ' ' LEU . . . . . 0.589 HD22 ' N ' ' A' ' 186' ' ' LEU . 3.5 mm? -85.42 133.29 42.61 Favored Pre-proline 0 N--CA 1.45 -0.444 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.15 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -43.92 158.0 0.13 Allowed 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.706 2.271 . . . . 0.0 112.258 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 188' ' ' PRO . . . . . 0.496 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.9 Cg_endo -63.1 114.72 2.58 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.748 2.299 . . . . 0.0 111.677 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 189' ' ' GLN . . . . . 0.496 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.7 mt-30 155.87 148.1 0.0 OUTLIER Pre-proline 0 N--CA 1.454 -0.264 0 O-C-N 124.088 0.868 . . . . 0.0 110.834 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.63 144.37 35.49 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.593 2.195 . . . . 0.0 112.095 177.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.497 HG23 ' OG ' ' A' ' 258' ' ' SER . 2.1 p -124.9 158.76 32.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.439 0.638 . . . . 0.0 110.159 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 192' ' ' THR . . . . . 0.488 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 37.0 p -143.07 165.34 27.65 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.193 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 193' ' ' ALA . . . . . 0.45 ' HA ' ' H ' ' A' ' 260' ' ' PHE . . . -135.32 128.74 32.3 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 121.43 0.634 . . . . 0.0 110.099 179.341 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.51 HD11 HD23 ' A' ' 259' ' ' LEU . 47.2 pt -146.52 149.05 16.34 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.44 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.236 179.638 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 195' ' ' VAL . . . . . 0.75 HG13 ' CD1' ' A' ' 262' ' ' PHE . 72.1 t -117.95 123.51 71.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.421 0.629 . . . . 0.0 109.691 179.048 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -134.58 107.27 7.41 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.206 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 94.1 m -130.96 130.66 43.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.868 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.401 ' O ' ' N ' ' A' ' 201' ' ' HIS . . . -82.8 -37.08 24.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.15 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.41 -67.08 0.26 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.276 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.34 -9.88 59.06 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.248 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 201' ' ' HIS . . . . . 0.401 ' N ' ' O ' ' A' ' 198' ' ' ALA . 60.5 t-80 60.63 58.35 2.47 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.807 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 38.8 p -167.05 153.84 8.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.553 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.4 144.18 24.41 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.031 0.443 . . . . 0.0 110.37 179.265 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -135.33 138.18 43.16 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.663 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 20.0 mt -106.25 125.55 51.14 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 206' ' ' TRP . . . . . 0.557 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 75.7 m95 -82.0 166.95 19.37 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.666 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 207' ' ' THR . . . . . 0.454 HG22 ' C ' ' A' ' 206' ' ' TRP . 0.1 OUTLIER -156.98 171.23 7.72 Favored Pre-proline 0 C--O 1.224 -0.25 0 CA-C-O 120.999 0.428 . . . . 0.0 110.562 -178.99 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.62 -37.03 83.08 Favored 'Trans proline' 0 C--N 1.301 -1.949 0 C-N-CA 122.612 2.208 . . . . 0.0 112.236 179.149 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -70.64 -35.01 72.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.729 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 22.7 m -61.24 150.57 34.22 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.698 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.41 -37.11 82.28 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.442 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 212' ' ' GLN . . . . . 0.557 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 55.0 tt0 -64.74 -40.07 94.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.538 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.8 -43.46 91.6 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -63.31 -43.5 97.66 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.813 0.339 . . . . 0.0 110.225 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 215' ' ' MET . . . . . 0.532 ' SD ' ' HB2' ' A' ' 304' ' ' ALA . 65.4 ttp -59.49 -48.03 83.21 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.34 -0.391 . . . . 0.0 109.986 -179.667 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 87.0 mt -60.71 -40.82 93.68 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 217' ' ' GLU . . . . . 0.45 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.4 tp10 -58.2 -37.66 75.22 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -65.33 -38.21 89.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.715 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 94.2 mt -64.06 -42.76 96.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.154 0.502 . . . . 0.0 110.716 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.69 44.77 0.08 OUTLIER Glycine 0 C--N 1.333 0.379 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 221' ' ' PHE . . . . . 0.45 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 27.4 m-85 -127.96 155.48 44.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.02 0.438 . . . . 0.0 110.446 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.482 ' O ' HG13 ' A' ' 191' ' ' VAL . 6.8 p -107.23 122.48 46.62 Favored 'General case' 0 C--O 1.223 -0.291 0 CA-C-O 121.368 0.604 . . . . 0.0 110.06 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.472 HD22 ' C ' ' A' ' 222' ' ' THR . 4.3 mm? -101.33 132.73 46.74 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.196 179.671 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.46 159.54 14.88 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.536 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.43 115.51 30.38 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.992 0.425 . . . . 0.0 110.318 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.497 HD12 ' N ' ' A' ' 226' ' ' LEU . 8.8 mp -53.31 156.55 3.97 Favored Pre-proline 0 N--CA 1.449 -0.515 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.764 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -60.09 145.17 99.04 Favored 'Trans proline' 0 C--N 1.3 -1.987 0 C-N-CA 122.677 2.251 . . . . 0.0 112.163 179.171 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.13 -3.22 59.05 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.545 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.14 -40.99 5.67 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 230' ' ' LEU . . . . . 0.517 ' O ' ' N ' ' A' ' 233' ' ' SER . 86.0 mt -79.14 -17.04 55.75 Favored 'General case' 0 C--O 1.218 -0.581 0 CA-C-O 121.11 0.481 . . . . 0.0 110.25 -179.646 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 54.3 t-20 -40.58 -48.96 2.95 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.876 -179.3 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -87.75 15.25 7.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.493 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 233' ' ' SER . . . . . 0.517 ' N ' ' O ' ' A' ' 230' ' ' LEU . 77.9 p -60.63 -35.28 75.8 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.673 -179.646 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 234' ' ' GLN . . . . . 0.526 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.6 tt0 -118.87 -69.28 0.86 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.922 179.132 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.3 m -69.62 103.13 2.02 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.067 0.46 . . . . 0.0 110.701 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -94.55 57.33 2.22 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.305 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -144.65 -122.48 1.58 Allowed Glycine 0 C--N 1.332 0.334 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -135.07 112.09 10.27 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.256 0.551 . . . . 0.0 110.316 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 239' ' ' ARG . . . . . 0.521 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.4 mtt180 -148.31 58.05 1.08 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.661 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -69.59 -32.16 70.75 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.562 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 241' ' ' ASP . . . . . 0.453 ' OD2' ' O ' ' A' ' 144' ' ' TYR . 64.7 t0 -57.05 -46.86 82.12 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.322 -178.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 242' ' ' ILE . . . . . 0.435 ' O ' ' O ' ' A' ' 239' ' ' ARG . 17.8 tt -140.25 156.77 24.66 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.306 0 CA-C-O 120.905 0.383 . . . . 0.0 110.419 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.444 HG22 HD13 ' A' ' 245' ' ' LEU . 96.2 mt -106.39 106.87 21.4 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 CA-C-O 121.19 0.519 . . . . 0.0 110.433 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 244' ' ' GLN . . . . . 0.595 ' O ' HD12 ' A' ' 245' ' ' LEU . 88.2 mt-30 -110.78 110.35 20.95 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.283 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.595 HD12 ' O ' ' A' ' 244' ' ' GLN . 9.5 mp -121.75 -168.22 1.66 Allowed 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.622 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 246' ' ' GLY . . . . . 0.526 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.53 -16.65 0.05 OUTLIER Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 247' ' ' GLY . . . . . 0.667 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -60.72 156.9 31.07 Favored Glycine 0 CA--C 1.521 0.425 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -63.83 21.9 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.901 0.381 . . . . 0.0 110.534 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 249' ' ' ASN . . . . . 0.667 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.8 m-20 -97.56 -6.08 34.28 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.761 0.315 . . . . 0.0 110.516 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 93.0 mt -79.65 -21.76 44.41 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.868 179.285 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.6 -51.25 70.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.724 -179.527 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.46 -5.45 58.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.402 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.17 -74.21 1.15 Allowed Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.744 -0.942 . . . . 0.0 110.744 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 83.3 mt -70.33 126.39 29.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.927 0.394 . . . . 0.0 110.17 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -59.96 -39.04 84.27 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.159 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 82.85 51.67 4.16 Favored Glycine 0 CA--C 1.519 0.335 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -95.59 -15.2 22.96 Favored 'General case' 0 N--CA 1.463 0.189 0 O-C-N 122.666 -0.314 . . . . 0.0 110.623 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 258' ' ' SER . . . . . 0.497 ' OG ' HG23 ' A' ' 191' ' ' VAL . 3.4 t 174.72 89.02 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.195 0.521 . . . . 0.0 110.036 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.852 HD12 ' N ' ' A' ' 259' ' ' LEU . 0.9 OUTLIER -94.6 124.43 38.63 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.21 0.528 . . . . 0.0 111.291 -179.143 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 260' ' ' PHE . . . . . 0.45 ' H ' ' HA ' ' A' ' 193' ' ' ALA . 15.8 m-30 -93.42 146.3 23.85 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.311 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 86.6 mt -122.29 149.55 43.58 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.532 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.75 ' CD1' HG13 ' A' ' 195' ' ' VAL . 2.6 p90 -77.28 -138.57 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.657 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 263' ' ' ALA . . . . . 0.65 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -51.87 77.14 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 121.041 0.448 . . . . 0.0 111.27 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 264' ' ' GLY . . . . . 0.62 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.05 104.58 0.19 Allowed Glycine 0 CA--C 1.527 0.843 0 N-CA-C 110.414 -1.074 . . . . 0.0 110.414 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 265' ' ' ASP . . . . . 0.589 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.8 m-20 -80.32 -177.88 6.35 Favored 'General case' 0 CA--C 1.515 -0.393 0 O-C-N 122.681 -0.306 . . . . 0.0 110.944 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -40.65 -17.82 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.524 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 267' ' ' LYS . . . . . 0.589 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.02 -51.56 45.61 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.743 179.102 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -63.87 -46.48 84.76 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.095 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 269' ' ' ALA . . . . . 0.57 ' HB1' ' OH ' ' A' ' 273' ' ' TYR . . . -61.8 -35.13 77.29 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 121.526 0.679 . . . . 0.0 109.716 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -62.84 -34.54 77.54 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.025 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.66 -43.07 13.74 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.217 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 272' ' ' ILE . . . . . 0.592 ' C ' ' H ' ' A' ' 274' ' ' ALA . 4.9 tt -51.27 -33.71 14.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.776 -178.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 273' ' ' TYR . . . . . 0.57 ' OH ' ' HB1' ' A' ' 269' ' ' ALA . 17.2 m-85 -54.5 -1.76 0.03 OUTLIER 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.686 -179.392 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 274' ' ' ALA . . . . . 0.592 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.51 -39.86 70.53 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.906 179.502 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 275' ' ' ASN . . . . . 0.576 ' O ' ' N ' ' A' ' 279' ' ' ALA . 3.0 p30 -38.91 97.74 0.15 Allowed Pre-proline 0 C--O 1.226 -0.174 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.448 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -54.21 -42.8 64.19 Favored 'Trans proline' 0 C--N 1.303 -1.856 0 C-N-CA 122.329 2.02 . . . . 0.0 112.668 -178.752 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 88.4 mt -64.32 -42.86 96.09 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.089 0.471 . . . . 0.0 111.297 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 91.8 mt -95.56 -1.7 49.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.862 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 279' ' ' ALA . . . . . 0.576 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.36 -34.87 77.52 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.6 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.1 20.0 0.11 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.076 -179.31 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 281' ' ' LEU . . . . . 0.481 ' H ' ' C ' ' A' ' 279' ' ' ALA . 13.8 mt -74.97 119.75 78.35 Favored Pre-proline 0 N--CA 1.445 -0.719 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.725 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -50.6 -39.57 55.85 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.539 2.159 . . . . 0.0 112.035 179.012 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.83 -50.37 63.86 Favored 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 73.0 t -61.54 -43.81 97.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -57.97 -41.2 82.43 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.098 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -90.93 0.31 57.54 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.083 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt 59.24 43.06 17.47 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.027 0.441 . . . . 0.0 110.976 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -94.62 41.65 1.09 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.282 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 53.9 t -119.21 135.48 59.47 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-O 121.096 0.474 . . . . 0.0 109.958 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -132.69 162.6 30.96 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.678 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.74 155.27 32.8 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 121.079 0.466 . . . . 0.0 110.667 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 82.8 mt -94.22 -1.47 54.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.176 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.49 165.81 12.72 Favored Glycine 0 C--N 1.335 0.528 0 N-CA-C 110.489 -1.044 . . . . 0.0 110.489 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 6.7 m -87.75 -62.33 1.52 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.871 0.367 . . . . 0.0 111.044 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 295' ' ' GLU . . . . . 0.442 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.5 mm-40 -69.35 -4.02 16.53 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.69 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 25.5 p -76.71 32.76 0.13 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.623 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 297' ' ' PHE . . . . . 0.522 ' CD2' HG22 ' A' ' 70' ' ' THR . 85.5 t80 -60.18 -46.07 90.98 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.624 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 298' ' ' ARG . . . . . 0.609 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.2 mtt85 -81.33 134.76 35.63 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.617 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.461 ' H ' HG11 ' A' ' 51' ' ' VAL . 16.7 tp -114.66 118.71 34.42 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-O 120.985 0.421 . . . . 0.0 110.206 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 300' ' ' ASP . . . . . 0.628 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.5 p-10 -166.15 -175.44 3.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.651 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 81.1 t80 -47.76 -44.22 28.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.209 -179.549 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -66.09 -40.74 91.04 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.107 0.48 . . . . 0.0 110.804 178.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 303' ' ' SER . . . . . 0.628 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 56.0 p -56.04 -35.73 67.22 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.951 -179.005 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 304' ' ' ALA . . . . . 0.532 ' HB2' ' SD ' ' A' ' 215' ' ' MET . . . -57.28 -51.45 69.33 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.409 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 91.1 mtp -56.46 -43.78 79.9 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -179.568 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -66.32 -42.52 88.11 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.21 0.528 . . . . 0.0 110.253 179.077 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 307' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 303' ' ' SER . 55.7 t -64.08 -42.99 97.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.135 179.364 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 42.7 tp -59.63 -42.24 92.27 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.101 -0.499 . . . . 0.0 109.73 -179.29 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -62.7 -38.71 91.48 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 310' ' ' ARG . . . . . 0.446 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.5 ttt85 -63.49 -43.81 96.17 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.218 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 88.8 mt -63.2 -42.06 99.27 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.273 179.693 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -62.89 -33.33 75.07 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.083 179.493 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.86 -23.45 21.65 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.383 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 314' ' ' LEU . . . . . 0.479 HD22 ' CE2' ' A' ' 315' ' ' PHE . 6.7 tt -62.44 -43.16 99.47 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 121.079 0.466 . . . . 0.0 110.563 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 315' ' ' PHE . . . . . 0.479 ' CE2' HD22 ' A' ' 314' ' ' LEU . 91.1 m-85 . . . . . 0 C--O 1.22 -0.484 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.319 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -99.55 136.67 39.14 Favored 'General case' 0 CA--C 1.521 -0.164 0 CA-C-O 121.091 0.472 . . . . 0.0 110.442 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.492 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -91.86 178.61 1.66 Allowed Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.57 -179.827 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.492 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.2 Cg_exo -61.61 146.94 96.46 Favored 'Trans proline' 0 C--N 1.3 -2.025 0 C-N-CA 122.833 2.355 . . . . 0.0 112.144 179.564 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.456 ' HE ' HD12 ' A' ' 39' ' ' LEU . 35.3 ptt180 -136.03 142.16 44.41 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.638 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -79.34 116.69 19.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.44 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.446 ' O ' HG23 ' A' ' 30' ' ' ILE . 9.5 tp -110.98 130.53 64.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.536 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.0 t -71.0 141.76 50.97 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.638 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.477 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.5 t0 -139.33 179.51 6.49 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.532 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.477 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 77.9 p -73.8 -36.98 65.07 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.569 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.7 ttt85 -46.48 -94.43 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.296 -179.347 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -167.55 -26.49 0.02 OUTLIER Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 60.8 m -168.97 104.8 0.4 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.777 0.322 . . . . 0.0 110.657 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.688 ' CD2' HD13 ' A' ' 140' ' ' LEU . 74.6 t60 -128.65 149.0 50.84 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.087 0.47 . . . . 0.0 110.214 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.624 HG22 ' N ' ' A' ' 39' ' ' LEU . 98.2 m -131.36 166.07 22.06 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.453 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.624 ' N ' HG22 ' A' ' 38' ' ' THR . 81.9 mt -120.93 127.28 51.69 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.464 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -64.91 -44.55 89.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.718 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 40.0 p -165.71 155.08 12.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.373 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.468 ' CD ' ' H ' ' A' ' 42' ' ' GLN . 14.7 mp0 -44.3 100.9 0.24 Allowed Pre-proline 0 C--N 1.329 -0.286 0 O-C-N 123.503 0.502 . . . . 0.0 110.598 179.221 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.53 129.99 36.67 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 C-N-CA 122.305 2.003 . . . . 0.0 112.245 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -83.73 -24.78 31.05 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.558 179.577 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.538 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.6 mtm-85 -122.33 134.84 54.64 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.27 0.557 . . . . 0.0 110.234 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.2 mt -130.73 133.78 62.83 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.329 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.871 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 45.0 t -124.11 130.55 73.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 CA-C-O 120.945 0.402 . . . . 0.0 109.968 179.274 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.624 ' OG ' HD12 ' A' ' 117' ' ' LEU . 2.1 m -154.57 167.17 30.99 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.542 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 64.4 p -124.75 9.26 8.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.385 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.98 125.43 33.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.858 0.361 . . . . 0.0 110.685 -179.495 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.458 HG11 ' H ' ' A' ' 299' ' ' LEU . 93.3 t -65.63 -44.53 93.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.463 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.1 m -62.38 -44.3 96.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.618 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 49.6 tp -62.34 -41.3 98.46 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.528 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.439 ' O ' HD13 ' A' ' 58' ' ' LEU . 74.3 m -57.65 -44.43 85.65 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.286 -179.309 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.3 -62.33 5.23 Favored Glycine 0 N--CA 1.467 0.761 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.7 t -48.22 -35.59 12.21 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.9 mt -61.78 -44.43 96.9 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.648 -0.421 . . . . 0.0 111.305 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.439 HD13 ' O ' ' A' ' 54' ' ' THR . 9.3 mp -65.54 -41.26 93.26 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.333 177.869 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.59 -40.75 97.75 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.858 -179.266 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.42 ' O ' HG23 ' A' ' 60' ' ' ILE . 8.1 tp -89.03 16.98 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.857 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 56.17 85.33 0.07 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.797 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 178.72 59.47 0.08 OUTLIER Pre-proline 0 C--N 1.327 -0.386 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -52.18 152.55 14.61 Favored 'Trans proline' 0 C--N 1.292 -2.401 0 C-N-CA 123.048 2.499 . . . . 0.0 112.063 -178.179 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.435 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -108.65 145.27 15.79 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.171 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.271 -179.661 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.8 mt -63.57 -45.42 97.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.388 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.501 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -129.49 134.1 47.61 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.517 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.504 ' O ' ' N ' ' A' ' 98' ' ' LEU . 75.4 m -134.6 158.6 43.6 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.891 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.7 139.0 16.1 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.694 -0.962 . . . . 0.0 110.694 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.493 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.79 -162.81 0.08 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.936 0.398 . . . . 0.0 110.461 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.537 HG22 ' CD2' ' A' ' 297' ' ' PHE . 14.5 t -133.65 134.74 43.53 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.289 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.481 ' C ' ' O ' ' A' ' 70' ' ' THR . 0.1 OUTLIER 29.65 68.73 0.65 Allowed Pre-proline 0 N--CA 1.467 0.403 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.735 -179.865 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_exo -61.74 145.67 97.18 Favored 'Trans proline' 0 C--N 1.3 -2.022 0 C-N-CA 122.669 2.246 . . . . 0.0 111.708 -177.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.525 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 45.3 p-10 -159.39 -32.1 0.06 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.718 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.541 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 99.1 m-20 -64.11 -39.42 94.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.387 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -60.36 -48.32 82.25 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.555 -179.136 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.424 ' O ' ' O ' ' A' ' 77' ' ' ALA . 93.9 t -60.16 -25.1 32.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.053 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.541 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -45.68 173.1 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.635 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.571 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.5 p30 -62.41 178.03 0.45 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.505 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.556 ' C ' ' H ' ' A' ' 81' ' ' GLY . 36.2 p30 -45.0 85.63 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.096 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.571 ' N ' ' O ' ' A' ' 78' ' ' ASP . 42.1 tp60 -67.65 13.21 0.08 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.207 0.527 . . . . 0.0 110.162 -179.657 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.556 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 118.63 -22.5 9.33 Favored Glycine 0 N--CA 1.461 0.33 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -108.12 116.25 31.62 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.013 0.435 . . . . 0.0 110.381 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 76.1 mt -98.27 -0.0 44.83 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.578 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -92.34 7.4 43.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.015 0.436 . . . . 0.0 110.39 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.794 ' O ' HG22 ' A' ' 89' ' ' VAL . 27.2 mt-30 -100.24 -27.7 13.37 Favored 'General case' 0 C--O 1.222 -0.387 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.754 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 69.0 t-105 -62.94 -40.55 98.0 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.942 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.551 ' O ' ' N ' ' A' ' 91' ' ' LYS . 64.2 m -77.93 -53.59 7.28 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.958 -179.311 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -48.49 -50.77 30.26 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.052 -179.136 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.794 HG22 ' O ' ' A' ' 85' ' ' GLN . 15.8 m -68.8 -40.57 81.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.161 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.496 ' N ' HG23 ' A' ' 89' ' ' VAL . . . -72.39 -23.01 61.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.629 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.551 ' N ' ' O ' ' A' ' 87' ' ' SER . 65.9 tttm -61.84 -45.58 93.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.433 -179.463 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.442 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.8 mm-40 -90.31 -95.3 0.11 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.092 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.629 ' O ' ' N ' ' A' ' 95' ' ' LEU . 96.0 mtt180 -142.79 58.84 1.43 Allowed 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.448 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.7 pttp 33.87 25.7 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.07 0.462 . . . . 0.0 110.25 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.629 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.3 tt -48.26 123.46 6.48 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.983 -177.87 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.457 ' O ' HD23 ' A' ' 95' ' ' LEU . 99.0 mm-40 -83.52 -169.61 2.64 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.183 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.603 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 81.3 mtp180 -74.69 136.95 41.84 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.256 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.504 ' N ' ' O ' ' A' ' 67' ' ' SER . 91.2 mt -85.63 -165.83 1.34 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.83 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.538 ' O ' ' CD2' ' A' ' 99' ' ' TYR . 48.2 p90 -168.64 119.65 0.77 Allowed 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.152 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.503 ' C ' ' O ' ' A' ' 99' ' ' TYR . 41.7 mm -28.67 120.7 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 O-C-N 123.272 0.358 . . . . 0.0 111.104 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 114.31 27.26 3.44 Favored Glycine 0 C--N 1.331 0.296 0 N-CA-C 111.27 -0.732 . . . . 0.0 111.27 -179.34 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.572 ' N ' ' CD ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -144.36 46.72 0.65 Allowed Pre-proline 0 C--N 1.322 -0.593 0 CA-C-O 121.145 0.498 . . . . 0.0 110.484 179.783 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.572 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 28.9 Cg_endo -62.02 144.0 95.72 Favored 'Trans proline' 0 C--N 1.295 -2.263 0 C-N-CA 122.643 2.229 . . . . 0.0 111.761 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.446 ' O ' HG23 ' A' ' 108' ' ' VAL . 27.6 t -173.18 120.37 0.35 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.359 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.83 -40.21 63.49 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.119 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.36 -39.89 89.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.853 -179.442 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.13 -40.09 95.44 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.73 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 104' ' ' SER . 72.3 t -67.77 -43.72 86.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.672 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.81 -39.04 93.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.455 -179.185 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.442 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.5 -23.39 62.74 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.516 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.537 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.3 mm-40 -90.69 5.55 47.66 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.682 -179.503 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.538 ' O ' ' NE ' ' A' ' 45' ' ' ARG . 10.2 tpt 22.85 64.46 0.35 Allowed Pre-proline 0 N--CA 1.467 0.385 0 CA-C-O 120.949 0.404 . . . . 0.0 111.209 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -78.75 167.51 22.28 Favored 'Trans proline' 0 C--N 1.307 -1.658 0 C-N-CA 123.077 2.518 . . . . 0.0 111.594 -177.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.52 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 99.1 m-20 -109.71 -42.1 4.37 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.991 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.6 tp -121.5 120.35 34.64 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.904 0.383 . . . . 0.0 109.97 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 84.8 mt -112.78 128.84 69.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 CA-C-O 120.862 0.363 . . . . 0.0 110.998 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.624 HD12 ' OG ' ' A' ' 48' ' ' SER . 29.6 mt -109.18 132.13 54.41 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.262 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.496 HD12 HG23 ' A' ' 139' ' ' THR . 99.1 mt -119.57 138.69 49.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.687 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 85.6 p -72.3 153.75 41.34 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.571 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.16 -50.25 74.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.705 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -149.51 154.0 38.08 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.602 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 170.5 -170.84 43.34 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.93 -34.3 89.51 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.445 ' OD1' ' O ' ' A' ' 124' ' ' ASP . 44.0 p-10 -86.7 120.43 28.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.856 0.36 . . . . 0.0 110.647 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.44 ' O ' HD12 ' A' ' 129' ' ' LEU . 39.0 t -63.21 143.75 57.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.392 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.1 -43.24 8.97 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.82 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.5 tp -62.98 -42.36 99.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.716 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.67 -12.07 59.68 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.449 -179.34 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.44 HD12 ' O ' ' A' ' 125' ' ' SER . 85.1 mt -114.76 -24.07 8.88 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.578 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' TYR . . . . . 0.519 ' N ' ' O ' ' A' ' 126' ' ' ALA . 78.9 t80 -51.01 -49.73 59.88 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.819 -0.352 . . . . 0.0 110.693 -178.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.1 p-10 -66.06 -42.67 89.18 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.321 179.354 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.52 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 88.3 mt-30 -67.01 -37.71 84.66 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.818 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.434 HD12 HD11 ' A' ' 118' ' ' ILE . 96.2 mt -80.24 -41.68 24.63 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.887 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.3 t -56.77 -44.69 82.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.248 -179.134 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 18.7 m -61.72 -45.44 93.96 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.613 179.336 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 94.6 mt -61.91 -43.73 97.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.319 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.661 ' HB1' ' HD2' ' A' ' 138' ' ' PRO . . . -169.27 168.29 5.05 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.644 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.661 ' HD2' ' HB1' ' A' ' 137' ' ' ALA . 52.8 Cg_exo -49.59 113.19 0.86 Allowed 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.296 1.997 . . . . 0.0 112.393 179.053 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.496 HG23 HD12 ' A' ' 118' ' ' ILE . 24.0 m -84.59 127.36 34.02 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.617 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.688 HD13 ' CD2' ' A' ' 37' ' ' HIS . 34.7 tp -117.79 135.96 53.71 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 120.998 0.428 . . . . 0.0 110.109 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.441 ' O ' ' OD2' ' A' ' 32' ' ' ASP . 82.7 mt -99.62 118.92 46.95 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 CA-C-O 121.208 0.527 . . . . 0.0 111.089 -179.298 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.425 HD12 HD22 ' A' ' 117' ' ' LEU . 97.9 mt -135.15 132.33 52.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.574 179.588 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.551 ' ND2' ' OD2' ' A' ' 241' ' ' ASP . 2.2 t-20 -68.04 153.72 43.15 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.987 0.423 . . . . 0.0 110.405 179.296 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.542 ' H ' ' ND2' ' A' ' 143' ' ' ASN . 88.7 t80 -87.46 122.28 30.99 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.85 -179.571 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.525 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 99.0 m-20 55.11 69.38 0.74 Allowed 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.759 179.659 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 49.8 p-10 -123.6 -0.72 8.6 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.852 0.358 . . . . 0.0 110.629 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -151.01 116.29 5.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.715 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 82.8 p -62.45 167.5 4.24 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.513 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.411 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.2 p-90 -51.05 -15.76 0.36 Allowed 'General case' 0 C--O 1.221 -0.414 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.371 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' GLN . . . . . 0.452 ' O ' HG23 ' A' ' 154' ' ' THR . 67.9 tp60 -70.92 -74.69 0.14 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.912 0.386 . . . . 0.0 110.516 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.434 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.2 t -62.81 -39.19 93.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.181 179.553 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 55.0 tp -60.05 -45.75 91.82 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.393 -178.407 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.411 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 46.9 tp -62.7 -41.64 99.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.619 178.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.452 HG23 ' O ' ' A' ' 150' ' ' GLN . 56.5 p -64.25 -34.94 79.26 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.226 -179.372 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' GLN . . . . . 0.442 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.8 mm-40 -64.11 -42.57 96.83 Favored 'General case' 0 C--O 1.226 -0.161 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.389 179.332 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 90.2 mt -65.46 -38.66 90.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.152 0.501 . . . . 0.0 110.317 179.135 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.573 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.49 -32.41 81.08 Favored Glycine 0 C--N 1.331 0.287 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 -179.227 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.442 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.2 mt-10 -35.3 -27.23 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.819 0.343 . . . . 0.0 110.815 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.573 ' N ' ' O ' ' A' ' 157' ' ' GLY . 94.7 mt -55.83 149.42 3.1 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.371 178.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 72.7 p -69.82 137.58 51.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.992 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 71.1 20.96 78.33 Favored Glycine 0 N--CA 1.459 0.183 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 58.2 m80 -122.64 -14.49 7.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.641 0.258 . . . . 0.0 110.487 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -66.03 -59.93 3.32 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.584 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -51.98 -49.32 63.5 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.156 -179.541 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -60.59 -41.29 94.43 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.841 0.353 . . . . 0.0 110.435 179.432 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.32 -47.32 86.49 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.473 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.74 -40.27 75.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.241 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -61.53 -50.45 72.62 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.652 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -65.24 -43.7 90.56 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.584 179.451 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 94.2 mt -64.84 -43.3 96.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.4 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.4 -51.27 70.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.369 -179.11 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -63.41 -43.7 96.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.843 0.354 . . . . 0.0 110.656 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' PHE . . . . . 0.665 ' CE2' HD11 ' A' ' 177' ' ' LEU . 57.0 t80 -62.82 -44.42 96.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.378 179.44 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 -63.16 -39.67 95.34 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.78 -179.51 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -63.32 -42.66 99.01 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.518 179.216 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -60.76 -44.59 96.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.221 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.665 HD11 ' CE2' ' A' ' 173' ' ' PHE . 84.1 mt -64.69 -40.99 96.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.723 178.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.32 -62.46 1.62 Allowed 'General case' 0 C--O 1.238 0.457 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.295 -179.252 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.35 -47.34 84.09 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.473 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -52.75 -42.02 64.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.329 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -63.78 -33.66 76.17 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.034 0.445 . . . . 0.0 110.291 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 182' ' ' GLU . . . . . 0.415 ' O ' ' HG2' ' A' ' 182' ' ' GLU . 69.6 tt0 -90.81 9.06 31.7 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.552 0.691 . . . . 0.0 110.328 -178.779 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -105.11 -32.18 8.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.171 179.448 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 45.1 pt -128.15 147.76 32.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.816 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -140.25 131.36 26.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.388 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 186' ' ' LEU . . . . . 0.592 HD22 ' N ' ' A' ' 186' ' ' LEU . 3.5 mm? -85.26 133.87 41.78 Favored Pre-proline 0 N--CA 1.45 -0.435 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.092 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -43.7 157.67 0.13 Allowed 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.635 2.223 . . . . 0.0 112.387 179.274 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 188' ' ' PRO . . . . . 0.508 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 28.3 Cg_endo -63.22 114.9 2.68 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.819 2.346 . . . . 0.0 111.692 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 189' ' ' GLN . . . . . 0.508 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.7 mt-30 155.43 147.9 0.0 OUTLIER Pre-proline 0 N--CA 1.456 -0.136 0 O-C-N 124.051 0.844 . . . . 0.0 110.93 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.22 143.81 36.19 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.578 2.185 . . . . 0.0 112.316 177.654 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.494 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.1 p -124.87 159.3 31.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.418 0.628 . . . . 0.0 110.214 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 192' ' ' THR . . . . . 0.494 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 37.7 p -143.52 165.59 27.15 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.095 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 193' ' ' ALA . . . . . 0.439 ' HA ' ' H ' ' A' ' 260' ' ' PHE . . . -135.13 128.77 32.76 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-O 121.285 0.564 . . . . 0.0 110.229 179.319 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.513 HD11 HD23 ' A' ' 259' ' ' LEU . 47.9 pt -146.47 148.77 16.65 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.383 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.159 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 195' ' ' VAL . . . . . 0.753 HG13 ' CD1' ' A' ' 262' ' ' PHE . 69.3 t -117.52 123.31 71.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-O 121.376 0.608 . . . . 0.0 109.817 178.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -134.46 107.69 7.71 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 121.156 0.503 . . . . 0.0 110.285 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 94.8 m -131.22 130.55 43.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.834 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -82.86 -36.83 25.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.242 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.49 -67.15 0.26 Allowed 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.273 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.34 -10.1 59.35 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.299 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 60.1 t-80 60.77 58.3 2.42 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.71 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 41.6 p -166.77 153.52 8.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.565 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.65 144.49 24.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.977 0.418 . . . . 0.0 110.47 179.258 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -135.48 138.24 42.95 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.611 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 20.1 mt -106.26 125.81 51.45 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.006 0.432 . . . . 0.0 109.953 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 206' ' ' TRP . . . . . 0.563 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 76.4 m95 -82.52 167.26 18.55 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.536 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 207' ' ' THR . . . . . 0.462 HG22 ' C ' ' A' ' 206' ' ' TRP . 0.1 OUTLIER -157.25 170.71 8.5 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.617 -178.985 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -53.22 -37.04 79.94 Favored 'Trans proline' 0 C--N 1.302 -1.911 0 C-N-CA 122.652 2.235 . . . . 0.0 112.446 179.037 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -70.6 -34.94 72.69 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.657 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 22.9 m -61.56 150.45 35.97 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.633 -179.501 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.38 -36.87 81.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.436 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 212' ' ' GLN . . . . . 0.563 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 54.6 tt0 -64.73 -40.09 94.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.477 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.62 -43.54 91.83 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.669 -0.972 . . . . 0.0 110.669 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -63.34 -43.46 97.65 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.851 0.358 . . . . 0.0 110.233 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 215' ' ' MET . . . . . 0.535 ' SD ' ' HB2' ' A' ' 304' ' ' ALA . 65.4 ttp -59.1 -48.42 81.67 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.161 -179.731 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 89.0 mt -60.29 -40.96 92.31 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 217' ' ' GLU . . . . . 0.453 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 40.5 tp10 -57.93 -37.67 74.51 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.057 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -65.48 -37.76 87.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.699 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 95.0 mt -64.37 -42.82 95.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.144 0.497 . . . . 0.0 110.629 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.5 44.62 0.08 OUTLIER Glycine 0 CA--C 1.52 0.387 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 221' ' ' PHE . . . . . 0.453 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 26.4 m-85 -127.58 154.5 45.12 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 121.05 0.452 . . . . 0.0 110.535 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.476 ' O ' HG13 ' A' ' 191' ' ' VAL . 4.5 p -106.05 121.65 44.55 Favored 'General case' 0 C--O 1.224 -0.261 0 CA-C-O 121.262 0.554 . . . . 0.0 110.049 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.462 HD22 ' N ' ' A' ' 223' ' ' LEU . 4.3 mm? -100.38 133.66 44.47 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.128 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -97.36 157.94 15.72 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.475 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -104.2 115.33 30.22 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.927 0.394 . . . . 0.0 110.416 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.486 HD12 ' N ' ' A' ' 226' ' ' LEU . 9.1 mp -53.89 156.55 4.96 Favored Pre-proline 0 N--CA 1.45 -0.462 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.817 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -59.73 145.11 99.04 Favored 'Trans proline' 0 C--N 1.299 -2.052 0 C-N-CA 122.736 2.291 . . . . 0.0 112.348 179.008 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.75 -2.52 58.67 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.509 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.58 -40.42 5.67 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 230' ' ' LEU . . . . . 0.532 ' O ' ' N ' ' A' ' 233' ' ' SER . 85.9 mt -79.32 -16.73 55.89 Favored 'General case' 0 C--O 1.22 -0.499 0 CA-C-O 121.085 0.469 . . . . 0.0 110.279 -179.66 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 54.8 t-20 -40.09 -48.92 2.55 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.79 -179.501 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -88.38 15.37 7.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.316 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 233' ' ' SER . . . . . 0.532 ' N ' ' O ' ' A' ' 230' ' ' LEU . 77.8 p -60.75 -35.46 76.44 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.676 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 234' ' ' GLN . . . . . 0.522 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.6 tt0 -118.28 -69.53 0.84 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.858 179.378 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.0 m -70.39 103.27 2.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.678 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -94.27 57.85 2.39 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.007 0.432 . . . . 0.0 110.319 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -145.2 -122.34 1.52 Allowed Glycine 0 C--N 1.332 0.339 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -134.1 112.42 11.14 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 121.141 0.496 . . . . 0.0 110.389 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 239' ' ' ARG . . . . . 0.461 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.2 mtt180 -148.54 56.79 1.04 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.737 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -69.49 -31.84 70.35 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.504 179.492 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 241' ' ' ASP . . . . . 0.551 ' OD2' ' ND2' ' A' ' 143' ' ' ASN . 64.8 t0 -56.58 -47.01 80.46 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.357 -179.042 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 242' ' ' ILE . . . . . 0.441 ' O ' ' O ' ' A' ' 239' ' ' ARG . 17.1 tt -140.4 157.46 24.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.88 0.371 . . . . 0.0 110.547 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.441 HG22 HD13 ' A' ' 245' ' ' LEU . 96.0 mt -105.88 106.05 19.84 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 CA-C-O 121.094 0.474 . . . . 0.0 110.505 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 244' ' ' GLN . . . . . 0.611 ' C ' HD12 ' A' ' 245' ' ' LEU . 88.3 mt-30 -110.99 110.64 21.28 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.351 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.611 HD12 ' C ' ' A' ' 244' ' ' GLN . 9.8 mp -121.98 -167.79 1.6 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.645 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 246' ' ' GLY . . . . . 0.522 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 172.79 -16.71 0.05 OUTLIER Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 247' ' ' GLY . . . . . 0.663 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -60.6 157.62 29.34 Favored Glycine 0 CA--C 1.522 0.49 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -64.05 21.01 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.966 0.412 . . . . 0.0 110.616 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 249' ' ' ASN . . . . . 0.663 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.9 m-20 -96.75 -5.7 38.0 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.523 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 91.3 mt -80.67 -20.97 41.82 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.763 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.56 -51.44 69.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.615 -179.575 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -89.14 -4.87 58.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.529 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.33 -74.13 1.16 Allowed Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.896 -0.881 . . . . 0.0 110.896 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 81.5 mt -70.12 125.7 27.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.978 0.418 . . . . 0.0 110.282 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -59.9 -39.26 84.79 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.334 -179.524 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 83.33 51.57 4.08 Favored Glycine 0 CA--C 1.52 0.393 0 N-CA-C 110.824 -0.91 . . . . 0.0 110.824 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -94.87 -16.7 22.69 Favored 'General case' 0 C--N 1.332 -0.17 0 O-C-N 122.739 -0.271 . . . . 0.0 110.606 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 258' ' ' SER . . . . . 0.49 ' OG ' HG23 ' A' ' 191' ' ' VAL . 3.4 t 175.47 89.49 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.159 0.504 . . . . 0.0 110.1 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.858 HD12 ' N ' ' A' ' 259' ' ' LEU . 0.9 OUTLIER -94.79 124.49 38.86 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.22 0.534 . . . . 0.0 111.229 -179.03 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 260' ' ' PHE . . . . . 0.439 ' H ' ' HA ' ' A' ' 193' ' ' ALA . 15.9 m-30 -93.98 146.8 23.67 Favored 'General case' 0 CA--C 1.5 -0.956 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.351 179.398 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 86.7 mt -122.42 150.18 42.82 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.542 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.753 ' CD1' HG13 ' A' ' 195' ' ' VAL . 2.6 p90 -77.7 -138.27 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.587 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 263' ' ' ALA . . . . . 0.655 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -51.96 77.34 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.156 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 264' ' ' GLY . . . . . 0.62 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.24 104.35 0.18 Allowed Glycine 0 CA--C 1.528 0.845 0 N-CA-C 110.474 -1.051 . . . . 0.0 110.474 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 265' ' ' ASP . . . . . 0.593 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.6 m-20 -79.98 -177.91 6.23 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 122.75 -0.265 . . . . 0.0 110.945 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -40.47 -17.83 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.567 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 267' ' ' LYS . . . . . 0.593 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.27 -51.7 42.17 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.681 179.247 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -63.56 -46.7 84.71 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.312 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 269' ' ' ALA . . . . . 0.574 ' HB1' ' OH ' ' A' ' 273' ' ' TYR . . . -61.68 -35.03 76.83 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 121.444 0.64 . . . . 0.0 109.808 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -63.14 -34.19 77.07 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.145 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.62 -43.33 13.55 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.081 -179.459 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 272' ' ' ILE . . . . . 0.593 ' C ' ' H ' ' A' ' 274' ' ' ALA . 4.9 tt -51.39 -33.78 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.875 -178.848 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 273' ' ' TYR . . . . . 0.574 ' OH ' ' HB1' ' A' ' 269' ' ' ALA . 17.2 m-85 -54.4 -1.73 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.649 -179.41 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 274' ' ' ALA . . . . . 0.593 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.49 -39.73 70.66 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.848 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 275' ' ' ASN . . . . . 0.58 ' O ' ' N ' ' A' ' 279' ' ' ALA . 2.8 p30 -39.22 98.29 0.16 Allowed Pre-proline 0 N--CA 1.463 0.178 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.401 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_exo -54.68 -42.69 66.12 Favored 'Trans proline' 0 C--N 1.303 -1.833 0 C-N-CA 122.356 2.037 . . . . 0.0 112.502 -178.601 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 89.2 mt -64.51 -42.84 95.55 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.093 0.473 . . . . 0.0 111.213 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 91.3 mt -95.59 -1.81 49.63 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.924 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 279' ' ' ALA . . . . . 0.58 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.16 -34.78 77.05 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.701 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.3 20.0 0.12 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.963 -179.312 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 281' ' ' LEU . . . . . 0.484 HD23 ' HA ' ' A' ' 281' ' ' LEU . 13.7 mt -74.73 119.24 75.74 Favored Pre-proline 0 N--CA 1.447 -0.607 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.774 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -49.65 -40.34 46.66 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.656 2.237 . . . . 0.0 112.3 178.691 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.57 -50.66 62.52 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.023 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 78.0 t -61.43 -43.87 97.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.803 0.335 . . . . 0.0 110.118 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -57.64 -41.27 81.08 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.188 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -90.89 0.47 57.48 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.108 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt 59.25 42.04 19.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.784 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -93.79 41.1 1.08 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.398 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 53.7 t -118.31 136.22 56.19 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.126 0 CA-C-O 121.113 0.483 . . . . 0.0 110.009 -179.526 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -133.31 163.12 30.04 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.184 0.516 . . . . 0.0 110.626 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -120.48 154.88 34.64 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-O 121.048 0.451 . . . . 0.0 110.652 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 82.3 mt -93.41 -1.63 55.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.212 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.59 165.94 12.74 Favored Glycine 0 N--CA 1.463 0.445 0 N-CA-C 110.529 -1.028 . . . . 0.0 110.529 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 6.8 m -87.6 -62.19 1.55 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.857 0.361 . . . . 0.0 110.967 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 295' ' ' GLU . . . . . 0.435 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.4 mm-40 -69.8 -3.85 17.4 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.667 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 25.2 p -77.03 33.38 0.15 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.593 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 297' ' ' PHE . . . . . 0.537 ' CD2' HG22 ' A' ' 70' ' ' THR . 84.8 t80 -60.11 -45.99 91.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.591 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 298' ' ' ARG . . . . . 0.603 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.3 mtt85 -81.61 134.84 35.54 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.59 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.458 ' H ' HG11 ' A' ' 51' ' ' VAL . 16.0 tp -114.39 119.16 35.99 Favored 'General case' 0 C--O 1.231 0.08 0 CA-C-O 120.974 0.416 . . . . 0.0 110.204 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 300' ' ' ASP . . . . . 0.62 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.2 p-10 -166.73 -174.71 2.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.637 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 83.5 t80 -47.96 -45.07 30.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.221 -179.479 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -65.3 -41.2 94.33 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.017 0.437 . . . . 0.0 110.734 178.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 303' ' ' SER . . . . . 0.62 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 53.6 p -55.73 -36.62 67.44 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.059 -179.237 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 304' ' ' ALA . . . . . 0.535 ' HB2' ' SD ' ' A' ' 215' ' ' MET . . . -56.33 -52.74 63.43 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 92.4 mtp -55.21 -43.72 74.72 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -66.25 -42.31 88.76 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.137 0.494 . . . . 0.0 110.264 179.04 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 307' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 303' ' ' SER . 55.1 t -64.09 -43.02 97.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.27 179.378 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 42.3 tp -59.98 -42.26 93.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.846 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -62.33 -38.88 91.17 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.146 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 310' ' ' ARG . . . . . 0.404 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.5 ttt85 -63.87 -44.21 93.74 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.251 179.58 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 87.9 mt -63.41 -42.42 98.75 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.465 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt -62.88 -33.51 75.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.191 179.377 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -87.24 -26.25 23.59 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.318 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 314' ' ' LEU . . . . . 0.712 ' C ' HD23 ' A' ' 314' ' ' LEU . 8.4 tt -62.57 -44.4 96.43 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.327 -179.516 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 . . . . . 0 C--O 1.22 -0.499 0 CA-C-O 118.005 -0.998 . . . . 0.0 110.475 179.975 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -99.67 136.05 40.17 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.002 0.43 . . . . 0.0 110.515 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.497 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -92.29 178.72 1.57 Allowed Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.523 -179.874 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.497 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.8 Cg_exo -61.58 147.3 95.73 Favored 'Trans proline' 0 C--N 1.3 -2.01 0 C-N-CA 122.819 2.346 . . . . 0.0 112.132 179.599 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.461 ' HE ' HD12 ' A' ' 39' ' ' LEU . 35.5 ptt180 -136.1 142.47 44.3 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.697 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -79.75 116.43 19.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.489 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.448 ' O ' HG23 ' A' ' 30' ' ' ILE . 9.4 tp -110.71 130.38 64.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.503 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.3 t -70.74 141.4 51.49 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.571 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.477 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.4 t0 -139.05 179.55 6.43 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.52 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.477 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 77.9 p -74.05 -36.99 64.42 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.557 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.8 ttt85 -46.38 -94.57 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.337 -179.451 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.423 ' O ' ' OG1' ' A' ' 36' ' ' THR . . . -167.17 -26.74 0.02 OUTLIER Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.423 ' OG1' ' O ' ' A' ' 35' ' ' GLY . 70.7 m -169.01 104.57 0.4 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.9 0.381 . . . . 0.0 110.613 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.681 ' CD2' HD13 ' A' ' 140' ' ' LEU . 74.3 t60 -128.46 148.33 50.72 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.081 0.467 . . . . 0.0 110.187 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.626 HG22 ' N ' ' A' ' 39' ' ' LEU . 98.0 m -130.79 166.06 21.62 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.54 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.626 ' N ' HG22 ' A' ' 38' ' ' THR . 81.2 mt -120.8 127.63 52.13 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.56 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -65.08 -44.59 88.43 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.67 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 39.8 p -165.65 154.89 12.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.416 179.634 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.499 ' CD ' ' H ' ' A' ' 42' ' ' GLN . 14.8 mp0 -44.32 101.07 0.24 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.607 179.381 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.23 129.51 34.58 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.391 2.061 . . . . 0.0 112.265 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -83.5 -24.78 31.57 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.527 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.538 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.6 mtm-85 -122.31 134.82 54.65 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 121.179 0.514 . . . . 0.0 110.297 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.2 mt -130.8 133.96 62.5 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.272 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.821 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 45.6 t -124.43 130.55 73.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 179.326 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.615 ' OG ' HD12 ' A' ' 117' ' ' LEU . 2.2 m -154.81 166.63 32.88 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.576 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 73.1 p -124.41 8.69 8.42 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.372 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.0 125.86 33.06 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.843 0.354 . . . . 0.0 110.653 -179.526 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.428 HG11 ' H ' ' A' ' 299' ' ' LEU . 90.8 t -66.02 -44.44 92.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.521 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.7 m -62.69 -44.39 96.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.601 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 50.3 tp -62.38 -41.48 98.67 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.529 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.443 ' O ' HD13 ' A' ' 58' ' ' LEU . 70.6 m -57.88 -44.51 86.72 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.239 -179.213 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.17 -62.31 5.28 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 179.627 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.7 t -48.19 -35.65 12.19 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 20.1 mt -61.81 -44.6 96.55 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.226 179.37 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.443 HD13 ' O ' ' A' ' 54' ' ' THR . 9.3 mp -65.16 -41.66 94.5 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.391 177.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.42 -41.38 98.71 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.856 -179.197 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.428 ' O ' HG23 ' A' ' 60' ' ' ILE . 8.1 tp -88.1 17.29 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.838 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 56.28 85.01 0.08 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.733 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.36 58.62 0.08 OUTLIER Pre-proline 0 C--N 1.328 -0.355 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -50.92 151.93 10.76 Favored 'Trans proline' 0 C--N 1.294 -2.319 0 C-N-CA 122.902 2.402 . . . . 0.0 112.275 -178.273 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.433 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -108.71 145.75 15.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.326 -179.691 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.76 -45.17 97.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.361 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.502 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -129.92 134.48 47.51 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 120.8 0.334 . . . . 0.0 110.541 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.48 ' O ' ' N ' ' A' ' 98' ' ' LEU . 73.3 m -134.73 158.87 43.02 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.907 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.45 138.65 15.98 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.474 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.6 -162.85 0.09 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.002 0.429 . . . . 0.0 110.453 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.53 HG22 ' CD2' ' A' ' 297' ' ' PHE . 5.8 t -133.97 135.9 43.8 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.156 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.487 ' C ' ' O ' ' A' ' 70' ' ' THR . 1.1 t 29.46 67.99 0.67 Allowed Pre-proline 0 N--CA 1.466 0.332 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.728 -179.581 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_exo -60.97 145.74 98.69 Favored 'Trans proline' 0 C--N 1.3 -2.009 0 C-N-CA 122.619 2.213 . . . . 0.0 111.99 -178.259 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.537 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 42.4 p-10 -161.06 -31.86 0.05 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.75 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.537 ' N ' ' OD1' ' A' ' 73' ' ' ASN . 99.1 m-20 -64.16 -39.41 93.94 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.343 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -60.28 -47.98 83.69 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.578 -179.214 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.427 ' O ' ' O ' ' A' ' 77' ' ' ALA . 98.7 t -60.27 -24.62 31.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.532 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -45.5 172.88 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.631 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.575 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.9 p30 -61.99 177.61 0.44 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.586 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.563 ' C ' ' H ' ' A' ' 81' ' ' GLY . 36.5 p30 -45.96 85.41 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.072 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.575 ' N ' ' O ' ' A' ' 78' ' ' ASP . 42.4 tp60 -67.43 13.66 0.07 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.203 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.563 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 118.16 -21.96 9.9 Favored Glycine 0 CA--C 1.519 0.3 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -107.86 116.51 32.09 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.008 0.432 . . . . 0.0 110.527 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 74.6 mt -98.54 0.03 44.19 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.982 0.42 . . . . 0.0 110.51 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -92.49 7.04 44.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.031 0.443 . . . . 0.0 110.387 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.773 ' O ' HG22 ' A' ' 89' ' ' VAL . 27.1 mt-30 -100.24 -27.16 13.64 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.841 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.6 t-105 -64.73 -40.46 95.35 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.035 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.557 ' O ' ' N ' ' A' ' 91' ' ' LYS . 65.8 m -77.89 -54.5 6.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.169 -179.559 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -47.42 -50.43 22.67 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.087 -179.223 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.773 HG22 ' O ' ' A' ' 85' ' ' GLN . 14.4 m -69.36 -40.54 80.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.137 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.496 ' N ' HG23 ' A' ' 89' ' ' VAL . . . -72.45 -22.76 61.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.658 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.557 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.0 tttm -62.14 -45.57 92.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.445 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.439 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.8 mm-40 -90.37 -94.8 0.12 Allowed 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.078 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.636 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.8 mtt180 -143.01 58.75 1.42 Allowed 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.455 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.6 pttp 33.68 25.8 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 120.947 0.403 . . . . 0.0 110.255 -179.243 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.636 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.3 tt -47.78 123.68 6.3 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.954 -178.02 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.453 ' O ' HD23 ' A' ' 95' ' ' LEU . 99.0 mm-40 -83.56 -170.39 3.04 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.127 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.613 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 82.2 mtp180 -73.95 137.26 43.46 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.061 0.458 . . . . 0.0 110.246 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.48 ' N ' ' O ' ' A' ' 67' ' ' SER . 90.3 mt -86.12 -165.85 1.37 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.816 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.537 ' O ' ' CD2' ' A' ' 99' ' ' TYR . 48.5 p90 -168.86 119.92 0.75 Allowed 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.137 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.509 ' C ' ' O ' ' A' ' 99' ' ' TYR . 43.7 mm -29.0 121.08 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.067 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 114.15 27.13 3.53 Favored Glycine 0 C--N 1.332 0.318 0 N-CA-C 111.261 -0.735 . . . . 0.0 111.261 -179.402 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.576 ' CD ' ' H ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -144.2 46.5 0.64 Allowed Pre-proline 0 C--N 1.324 -0.518 0 CA-C-O 120.931 0.396 . . . . 0.0 110.416 179.872 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 29.1 Cg_endo -62.1 143.77 95.14 Favored 'Trans proline' 0 C--N 1.296 -2.233 0 C-N-CA 122.677 2.251 . . . . 0.0 111.845 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.455 ' O ' HG23 ' A' ' 108' ' ' VAL . 27.4 t -173.05 120.2 0.35 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.376 179.677 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.52 -40.49 64.0 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.038 0.447 . . . . 0.0 111.086 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.23 -39.87 89.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.841 -179.406 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.23 -40.04 95.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.745 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 104' ' ' SER . 71.2 t -67.69 -43.89 86.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.793 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.71 -39.01 92.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.522 -179.296 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.439 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.5 -23.35 62.72 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.486 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.544 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.2 mm-40 -90.66 5.46 47.96 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.659 -179.49 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.544 ' C ' ' O ' ' A' ' 111' ' ' GLN . 10.5 tpt 23.49 64.23 0.38 Allowed Pre-proline 0 N--CA 1.466 0.367 0 CA-C-O 120.87 0.367 . . . . 0.0 111.02 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -78.54 167.1 23.19 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 C-N-CA 123.051 2.501 . . . . 0.0 111.866 -178.178 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.523 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 99.2 m-20 -109.83 -42.07 4.34 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.112 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 39.8 tp -121.64 120.28 34.3 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 83.7 mt -112.91 128.85 69.42 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.353 0 CA-C-O 120.934 0.397 . . . . 0.0 110.951 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.615 HD12 ' OG ' ' A' ' 48' ' ' SER . 29.4 mt -108.87 132.26 54.21 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.063 0.459 . . . . 0.0 110.183 -179.659 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.496 HD12 HG23 ' A' ' 139' ' ' THR . 98.7 mt -119.67 139.01 48.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.711 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 85.6 p -72.4 153.77 41.26 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.642 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.18 -50.16 74.76 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.631 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -149.45 154.06 38.25 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.555 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 170.64 -171.02 43.53 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -63.17 -34.04 88.89 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.447 ' OD1' ' O ' ' A' ' 124' ' ' ASP . 44.0 p-10 -86.97 119.99 27.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.867 0.365 . . . . 0.0 110.684 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.444 ' O ' HD12 ' A' ' 129' ' ' LEU . 39.8 t -62.99 143.61 57.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.425 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.04 -43.11 9.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.862 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.7 tp -63.01 -42.47 99.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.75 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.43 -12.08 59.39 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.499 -179.35 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.444 HD12 ' O ' ' A' ' 125' ' ' SER . 84.2 mt -114.94 -23.84 8.91 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.636 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' TYR . . . . . 0.519 ' N ' ' O ' ' A' ' 126' ' ' ALA . 78.4 t80 -51.0 -49.74 59.81 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.567 -178.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.1 p-10 -65.84 -42.4 90.56 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.841 -0.344 . . . . 0.0 111.208 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.523 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 88.3 mt-30 -67.45 -37.77 83.46 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.849 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.424 HD12 HD11 ' A' ' 118' ' ' ILE . 95.9 mt -80.06 -41.8 24.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.862 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.2 t -57.03 -44.43 82.88 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.166 -178.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 20.2 m -61.91 -45.09 95.24 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.463 179.488 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 93.8 mt -62.24 -43.59 98.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.196 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.65 ' HB1' ' HD2' ' A' ' 138' ' ' PRO . . . -169.52 167.9 5.08 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.57 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.65 ' HD2' ' HB1' ' A' ' 137' ' ' ALA . 51.9 Cg_exo -49.4 113.14 0.83 Allowed 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.298 1.998 . . . . 0.0 112.299 179.184 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.496 HG23 HD12 ' A' ' 118' ' ' ILE . 24.0 m -84.65 127.24 33.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.602 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.681 HD13 ' CD2' ' A' ' 37' ' ' HIS . 34.7 tp -117.75 136.24 53.51 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.05 -179.696 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.44 ' O ' ' OD2' ' A' ' 32' ' ' ASP . 82.6 mt -100.1 118.89 47.42 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 CA-C-O 121.149 0.5 . . . . 0.0 111.161 -179.326 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.425 HD12 HD22 ' A' ' 117' ' ' LEU . 97.8 mt -135.05 132.13 53.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.595 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.55 ' ND2' ' H ' ' A' ' 144' ' ' TYR . 2.2 t-20 -67.35 153.59 43.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.945 0.403 . . . . 0.0 110.483 179.366 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.55 ' H ' ' ND2' ' A' ' 143' ' ' ASN . 89.1 t80 -87.58 122.26 31.05 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.865 -179.523 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.522 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 99.0 m-20 55.17 69.45 0.73 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.759 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 49.3 p-10 -123.56 -0.48 8.65 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.923 0.392 . . . . 0.0 110.664 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -151.45 117.5 5.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.69 -179.502 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 83.7 p -63.4 167.78 5.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.524 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.413 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.1 p-90 -51.15 -15.64 0.37 Allowed 'General case' 0 C--O 1.223 -0.326 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.504 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' GLN . . . . . 0.445 ' O ' HG23 ' A' ' 154' ' ' THR . 68.1 tp60 -71.28 -74.91 0.14 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.444 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.444 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.0 t -62.93 -38.84 92.61 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.263 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 54.6 tp -60.14 -45.71 92.11 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.413 -178.525 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.413 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 47.3 tp -62.62 -41.6 99.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.445 179.002 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.445 HG23 ' O ' ' A' ' 150' ' ' GLN . 57.1 p -64.23 -34.68 78.65 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.193 -179.455 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' GLN . . . . . 0.43 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.7 mm-40 -63.99 -42.78 97.1 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.442 179.263 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 91.5 mt -65.38 -38.92 91.45 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.087 0.47 . . . . 0.0 110.245 179.103 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.579 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.2 -31.91 78.67 Favored Glycine 0 CA--C 1.519 0.288 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 -179.257 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' A' ' 157' ' ' GLY . 97.3 mt-10 -35.61 -26.73 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.815 0.34 . . . . 0.0 110.803 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.579 ' N ' ' O ' ' A' ' 157' ' ' GLY . 95.7 mt -56.62 149.87 3.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.305 179.072 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 72.4 p -69.98 137.1 51.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.983 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 72.02 19.56 78.45 Favored Glycine 0 CA--C 1.517 0.159 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 58.2 m80 -121.04 -15.05 8.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.683 0.277 . . . . 0.0 110.585 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -65.33 -60.09 3.35 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.684 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -52.01 -49.25 63.73 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 120.819 -0.352 . . . . 0.0 110.166 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -60.29 -41.26 92.99 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.956 -0.298 . . . . 0.0 110.349 179.479 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.44 -47.24 86.61 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.55 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.86 -40.23 75.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.286 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -61.81 -50.26 73.04 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.601 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 60.1 ttt85 -65.32 -43.76 89.97 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.554 179.514 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 94.9 mt -64.77 -43.31 96.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.457 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.31 -51.35 69.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.472 -179.181 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.43 -43.76 96.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.584 179.684 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' PHE . . . . . 0.654 ' CE2' HD11 ' A' ' 177' ' ' LEU . 56.1 t80 -62.9 -44.35 96.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.423 179.44 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -63.61 -39.96 95.71 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.54 -179.312 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -62.89 -42.85 99.92 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.67 179.222 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -60.71 -44.62 96.37 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.201 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.654 HD11 ' CE2' ' A' ' 173' ' ' PHE . 83.6 mt -64.51 -40.96 96.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.01 0.433 . . . . 0.0 110.695 178.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.13 -62.41 1.65 Allowed 'General case' 0 C--O 1.237 0.425 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.411 -179.334 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.48 -47.01 85.46 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.519 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.2 -41.65 65.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.32 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -63.92 -33.82 76.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.002 0.429 . . . . 0.0 110.397 179.282 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 182' ' ' GLU . . . . . 0.421 ' O ' ' HG2' ' A' ' 182' ' ' GLU . 69.5 tt0 -90.62 9.16 30.79 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.448 0.642 . . . . 0.0 110.439 -178.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -105.06 -32.03 8.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.165 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.5 pt -128.17 147.57 32.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.753 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -139.69 131.11 26.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.446 179.239 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 186' ' ' LEU . . . . . 0.592 HD22 ' N ' ' A' ' 186' ' ' LEU . 3.6 mm? -85.3 133.23 42.96 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.977 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -43.8 157.77 0.13 Allowed 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.75 2.3 . . . . 0.0 112.223 179.35 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 188' ' ' PRO . . . . . 0.515 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 28.0 Cg_endo -63.05 114.82 2.61 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 C-N-CA 122.821 2.347 . . . . 0.0 111.716 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 189' ' ' GLN . . . . . 0.515 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.7 mt-30 155.72 147.71 0.0 OUTLIER Pre-proline 0 N--CA 1.456 -0.144 0 O-C-N 123.76 0.662 . . . . 0.0 110.759 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -73.56 143.53 34.46 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.582 2.188 . . . . 0.0 112.082 177.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.5 HG23 ' OG ' ' A' ' 258' ' ' SER . 2.1 p -124.43 158.88 31.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.362 0.601 . . . . 0.0 110.174 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 192' ' ' THR . . . . . 0.493 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 34.8 p -143.39 165.22 28.12 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.086 -179.682 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 193' ' ' ALA . . . . . 0.441 ' HA ' ' H ' ' A' ' 260' ' ' PHE . . . -135.15 128.56 32.32 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.241 0.543 . . . . 0.0 110.201 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.508 HD11 HD23 ' A' ' 259' ' ' LEU . 47.4 pt -146.48 148.85 16.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.113 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 195' ' ' VAL . . . . . 0.748 HG13 ' CD1' ' A' ' 262' ' ' PHE . 69.1 t -117.76 123.26 71.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.278 0.561 . . . . 0.0 109.794 179.049 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -134.07 106.96 7.48 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.295 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 94.5 m -130.57 130.3 43.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.827 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.403 ' O ' ' N ' ' A' ' 201' ' ' HIS . . . -83.01 -36.73 24.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.198 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.54 -67.01 0.27 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.338 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.49 -9.43 58.54 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.268 179.523 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 201' ' ' HIS . . . . . 0.403 ' N ' ' O ' ' A' ' 198' ' ' ALA . 59.8 t-80 60.36 58.47 2.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.708 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 48.8 p -166.99 153.51 8.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.547 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.49 144.3 24.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.974 0.416 . . . . 0.0 110.51 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -135.47 138.46 43.19 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.599 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 20.0 mt -106.59 125.68 51.31 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.067 0.46 . . . . 0.0 109.834 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 206' ' ' TRP . . . . . 0.557 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 75.5 m95 -82.23 167.21 18.88 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.621 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 207' ' ' THR . . . . . 0.464 HG22 ' C ' ' A' ' 206' ' ' TRP . 0.1 OUTLIER -157.03 171.53 7.33 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.632 -179.118 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -53.85 -36.9 84.56 Favored 'Trans proline' 0 C--N 1.302 -1.917 0 C-N-CA 122.691 2.261 . . . . 0.0 112.247 179.188 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -70.64 -34.99 72.68 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.734 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 21.5 m -61.36 150.75 34.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.606 -179.399 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.67 -36.96 82.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.452 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 212' ' ' GLN . . . . . 0.557 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 54.8 tt0 -64.63 -40.22 95.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.48 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.68 -43.46 91.88 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.694 -0.963 . . . . 0.0 110.694 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -63.41 -43.53 97.26 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.816 0.341 . . . . 0.0 110.347 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 215' ' ' MET . . . . . 0.521 ' SD ' ' HB2' ' A' ' 304' ' ' ALA . 65.2 ttp -59.43 -48.06 83.1 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.232 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 87.7 mt -60.64 -40.91 93.71 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 217' ' ' GLU . . . . . 0.457 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.5 tp10 -57.79 -37.92 74.59 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -65.32 -37.98 88.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.797 0.332 . . . . 0.0 110.666 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 94.5 mt -64.26 -42.86 96.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.62 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.7 44.88 0.08 OUTLIER Glycine 0 C--N 1.333 0.369 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 221' ' ' PHE . . . . . 0.457 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 27.4 m-85 -128.02 155.11 44.83 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.038 0.447 . . . . 0.0 110.524 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.483 ' O ' HG13 ' A' ' 191' ' ' VAL . 7.2 p -106.94 122.17 45.89 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.248 0.547 . . . . 0.0 110.103 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.467 HD22 ' C ' ' A' ' 222' ' ' THR . 4.3 mm? -100.98 133.26 45.74 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.109 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -97.14 159.23 15.03 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.469 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.19 115.35 30.11 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.87 0.367 . . . . 0.0 110.36 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.495 HD12 ' N ' ' A' ' 226' ' ' LEU . 8.9 mp -53.22 156.46 3.88 Favored Pre-proline 0 N--CA 1.452 -0.345 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.744 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -60.16 145.27 98.87 Favored 'Trans proline' 0 C--N 1.3 -1.986 0 C-N-CA 122.703 2.269 . . . . 0.0 112.162 179.216 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.16 -3.25 59.05 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.528 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.14 -40.98 5.67 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 111.024 -0.831 . . . . 0.0 111.024 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 230' ' ' LEU . . . . . 0.533 ' O ' ' N ' ' A' ' 233' ' ' SER . 85.1 mt -79.25 -17.13 55.34 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-O 121.113 0.482 . . . . 0.0 110.362 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 231' ' ' ASN . . . . . 0.401 ' C ' ' O ' ' A' ' 230' ' ' LEU . 55.5 t-20 -40.17 -49.12 2.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.821 -179.496 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -88.08 15.35 7.52 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.373 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 233' ' ' SER . . . . . 0.533 ' N ' ' O ' ' A' ' 230' ' ' LEU . 78.0 p -60.37 -35.6 76.09 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.651 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 234' ' ' GLN . . . . . 0.526 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.7 tt0 -118.51 -69.32 0.86 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.995 179.424 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.4 m -69.85 103.4 2.19 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.693 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -94.69 57.63 2.21 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.297 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -144.84 -122.59 1.57 Allowed Glycine 0 CA--C 1.52 0.353 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -134.81 111.66 10.09 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.114 0.483 . . . . 0.0 110.389 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 239' ' ' ARG . . . . . 0.517 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.5 mtt180 -148.04 57.72 1.09 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.762 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -69.55 -32.14 70.76 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.501 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 241' ' ' ASP . . . . . 0.461 ' OD2' ' O ' ' A' ' 144' ' ' TYR . 64.8 t0 -56.85 -47.05 81.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.378 -179.077 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 242' ' ' ILE . . . . . 0.436 ' O ' ' O ' ' A' ' 239' ' ' ARG . 17.8 tt -139.97 156.63 25.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.892 0.377 . . . . 0.0 110.479 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.441 HG22 HD13 ' A' ' 245' ' ' LEU . 96.3 mt -106.03 106.26 20.24 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.202 0 CA-C-O 121.096 0.474 . . . . 0.0 110.502 179.762 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 244' ' ' GLN . . . . . 0.601 ' O ' HD12 ' A' ' 245' ' ' LEU . 88.3 mt-30 -110.2 110.09 20.81 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.398 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.601 HD12 ' O ' ' A' ' 244' ' ' GLN . 9.5 mp -121.79 -168.38 1.69 Allowed 'General case' 0 C--O 1.225 -0.199 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.651 179.721 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 246' ' ' GLY . . . . . 0.526 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.65 -16.76 0.05 OUTLIER Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 247' ' ' GLY . . . . . 0.672 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -60.55 156.64 30.8 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -63.68 21.4 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.0 0.428 . . . . 0.0 110.643 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 249' ' ' ASN . . . . . 0.672 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.6 m-20 -97.02 -6.03 36.3 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.556 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 93.3 mt -79.68 -21.69 44.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.658 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.5 -51.34 70.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.705 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.31 -5.65 58.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.502 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.2 -74.53 1.14 Allowed Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 82.2 mt -69.83 125.92 28.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.954 0.407 . . . . 0.0 110.366 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -59.26 -39.42 82.82 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.19 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 82.39 51.88 4.2 Favored Glycine 0 CA--C 1.521 0.407 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -96.67 -14.2 22.27 Favored 'General case' 0 C--N 1.331 -0.236 0 O-C-N 122.755 -0.262 . . . . 0.0 110.597 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 258' ' ' SER . . . . . 0.5 ' OG ' HG23 ' A' ' 191' ' ' VAL . 3.5 t 174.67 88.18 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.084 0.469 . . . . 0.0 110.167 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.861 HD12 ' N ' ' A' ' 259' ' ' LEU . 1.0 OUTLIER -94.26 123.85 37.92 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.245 0.545 . . . . 0.0 111.102 -179.101 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 260' ' ' PHE . . . . . 0.441 ' H ' ' HA ' ' A' ' 193' ' ' ALA . 15.8 m-30 -92.77 146.32 23.74 Favored 'General case' 0 CA--C 1.503 -0.854 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.503 179.274 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 86.0 mt -122.3 149.59 43.51 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.519 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.748 ' CD1' HG13 ' A' ' 195' ' ' VAL . 2.6 p90 -77.46 -138.52 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.579 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 263' ' ' ALA . . . . . 0.658 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -51.9 77.29 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.114 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 264' ' ' GLY . . . . . 0.629 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.1 104.46 0.19 Allowed Glycine 0 CA--C 1.527 0.794 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 265' ' ' ASP . . . . . 0.599 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.8 m-20 -80.43 -177.85 6.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.649 0.261 . . . . 0.0 110.9 -179.517 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -40.3 -17.81 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.551 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 267' ' ' LYS . . . . . 0.599 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.36 -51.65 41.97 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.612 179.366 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -63.59 -46.77 84.3 Favored 'General case' 0 N--CA 1.461 0.095 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.237 179.387 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 269' ' ' ALA . . . . . 0.573 ' HB1' ' OH ' ' A' ' 273' ' ' TYR . . . -61.62 -35.09 76.9 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 121.263 0.554 . . . . 0.0 109.827 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -63.12 -34.37 77.46 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.167 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.49 -43.39 13.61 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.14 -179.471 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 272' ' ' ILE . . . . . 0.589 ' C ' ' H ' ' A' ' 274' ' ' ALA . 5.0 tt -51.33 -33.75 14.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.824 -178.827 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 273' ' ' TYR . . . . . 0.573 ' OH ' ' HB1' ' A' ' 269' ' ' ALA . 17.3 m-85 -54.45 -1.75 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.613 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 274' ' ' ALA . . . . . 0.589 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.54 -39.6 70.58 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.931 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 275' ' ' ASN . . . . . 0.58 ' O ' ' N ' ' A' ' 279' ' ' ALA . 3.2 p30 -39.21 98.0 0.15 Allowed Pre-proline 0 C--O 1.227 -0.126 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.505 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -54.27 -42.92 63.27 Favored 'Trans proline' 0 C--N 1.303 -1.824 0 C-N-CA 122.404 2.069 . . . . 0.0 112.598 -178.692 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 88.7 mt -64.41 -42.78 95.89 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.133 0.492 . . . . 0.0 111.2 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 91.1 mt -95.64 -1.72 49.62 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.882 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 279' ' ' ALA . . . . . 0.58 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.23 -34.83 77.24 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.703 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -74.27 20.15 0.12 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.981 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 281' ' ' LEU . . . . . 0.487 HD23 ' HA ' ' A' ' 281' ' ' LEU . 13.8 mt -75.2 119.93 79.26 Favored Pre-proline 0 N--CA 1.449 -0.499 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.595 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -50.49 -39.68 54.73 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.725 2.284 . . . . 0.0 112.019 178.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.69 -50.43 63.32 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.082 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 73.7 t -61.44 -43.91 97.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -57.81 -41.29 81.88 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.212 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -90.92 0.05 57.61 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.201 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt 59.47 43.29 16.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.863 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -94.68 41.42 1.09 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.372 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 53.8 t -118.99 135.83 58.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.089 0.471 . . . . 0.0 110.175 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -133.04 162.89 30.51 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 121.102 0.477 . . . . 0.0 110.637 -179.599 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -120.08 155.22 33.41 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.022 0.439 . . . . 0.0 110.689 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 81.6 mt -93.87 -1.48 54.75 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.313 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.04 165.74 12.77 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.609 -0.996 . . . . 0.0 110.609 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 7.1 m -87.3 -62.27 1.54 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.875 0.369 . . . . 0.0 111.007 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 295' ' ' GLU . . . . . 0.441 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.4 mm-40 -69.49 -4.0 16.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.672 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 26.2 p -77.03 32.62 0.14 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.619 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 297' ' ' PHE . . . . . 0.53 ' CD2' HG22 ' A' ' 70' ' ' THR . 69.4 t80 -60.15 -46.19 90.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.512 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 298' ' ' ARG . . . . . 0.613 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.1 mtt85 -81.26 133.65 35.47 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 120.988 0.423 . . . . 0.0 110.507 -179.696 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.428 ' H ' HG11 ' A' ' 51' ' ' VAL . 16.3 tp -114.16 119.67 37.89 Favored 'General case' 0 C--O 1.231 0.083 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.26 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 300' ' ' ASP . . . . . 0.621 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.5 p-10 -167.53 -174.14 2.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.611 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 81.5 t80 -48.2 -45.6 34.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.2 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -64.96 -41.64 95.29 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.106 0.479 . . . . 0.0 110.718 179.022 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 303' ' ' SER . . . . . 0.621 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 53.0 p -55.13 -36.27 65.58 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.052 -179.299 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 304' ' ' ALA . . . . . 0.521 ' HB2' ' SD ' ' A' ' 215' ' ' MET . . . -56.74 -51.65 68.04 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 179.475 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 91.5 mtp -56.22 -43.98 79.12 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -66.21 -42.71 88.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.02 0.438 . . . . 0.0 110.256 178.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 307' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 303' ' ' SER . 55.5 t -64.05 -42.81 96.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.254 179.374 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 42.2 tp -59.56 -42.22 91.92 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.81 -179.446 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -62.76 -38.78 91.95 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.118 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 310' ' ' ARG . . . . . 0.431 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.6 ttt85 -63.34 -44.1 95.82 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.229 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 88.1 mt -63.3 -42.03 99.01 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.318 179.528 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -62.78 -33.09 74.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.166 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -90.08 -23.42 21.42 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.456 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 314' ' ' LEU . . . . . 0.476 HD22 ' CE2' ' A' ' 315' ' ' PHE . 6.8 tt -62.29 -43.16 99.47 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 121.144 0.497 . . . . 0.0 110.677 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 315' ' ' PHE . . . . . 0.476 ' CE2' HD22 ' A' ' 314' ' ' LEU . 91.0 m-85 . . . . . 0 C--O 1.219 -0.517 0 CA-C-O 118.026 -0.987 . . . . 0.0 110.409 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -99.54 136.56 39.3 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.178 0.513 . . . . 0.0 110.471 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.492 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -91.9 178.61 1.66 Allowed Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.566 -179.821 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.492 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.1 Cg_exo -61.72 146.99 96.31 Favored 'Trans proline' 0 C--N 1.299 -2.071 0 C-N-CA 122.86 2.374 . . . . 0.0 112.163 179.531 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.455 ' HE ' HD12 ' A' ' 39' ' ' LEU . 35.6 ptt180 -136.21 142.34 44.07 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.653 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -79.48 116.88 19.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.475 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.441 ' O ' HG23 ' A' ' 30' ' ' ILE . 9.5 tp -111.25 130.78 64.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.564 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.8 t -71.07 142.37 50.84 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.023 0.439 . . . . 0.0 110.615 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.477 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.4 t0 -139.95 179.53 6.55 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.561 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.477 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 77.9 p -73.67 -37.12 65.36 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.604 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.8 ttt85 -46.45 -94.41 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.29 -179.366 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -167.54 -26.29 0.02 OUTLIER Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 54.8 m -169.31 104.91 0.37 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.84 0.353 . . . . 0.0 110.622 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.683 ' CD2' HD13 ' A' ' 140' ' ' LEU . 75.3 t60 -128.56 149.32 50.67 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.158 0.504 . . . . 0.0 110.142 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.622 HG22 ' N ' ' A' ' 39' ' ' LEU . 98.4 m -131.44 166.02 22.23 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.456 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.622 ' N ' HG22 ' A' ' 38' ' ' THR . 81.6 mt -120.85 127.12 51.61 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.432 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -65.02 -44.59 88.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.748 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 39.7 p -165.51 154.94 12.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.429 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.474 ' CD ' ' H ' ' A' ' 42' ' ' GLN . 14.6 mp0 -44.3 100.91 0.24 Allowed Pre-proline 0 C--O 1.235 0.33 0 O-C-N 123.551 0.532 . . . . 0.0 110.635 179.144 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.4 129.92 36.48 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 C-N-CA 122.335 2.023 . . . . 0.0 112.307 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -83.79 -24.92 30.84 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.605 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.54 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.6 mtm-85 -122.19 134.62 54.71 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.279 0.562 . . . . 0.0 110.203 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.3 mt -130.21 133.49 64.05 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.801 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 44.0 t -124.41 130.47 73.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 179.225 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.616 ' OG ' HD12 ' A' ' 117' ' ' LEU . 2.2 m -154.86 166.89 32.07 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.554 179.569 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 72.2 p -124.13 8.59 8.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.395 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.45 126.04 33.49 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.862 0.363 . . . . 0.0 110.622 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.49 HG11 ' H ' ' A' ' 299' ' ' LEU . 90.9 t -66.18 -44.51 91.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.553 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.5 m -62.43 -44.55 96.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.684 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 46.1 tp -62.45 -41.44 98.74 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.543 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.434 ' O ' HD13 ' A' ' 58' ' ' LEU . 71.8 m -58.1 -44.65 87.79 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.164 -179.061 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -63.93 -62.53 5.15 Favored Glycine 0 N--CA 1.468 0.795 0 N-CA-C 110.844 -0.903 . . . . 0.0 110.844 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.7 t -48.09 -35.51 11.49 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 20.0 mt -61.89 -44.1 97.5 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.615 -0.434 . . . . 0.0 111.397 179.214 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.434 HD13 ' O ' ' A' ' 54' ' ' THR . 9.3 mp -65.57 -41.45 92.91 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.415 177.819 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.41 -41.48 98.72 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.856 -179.297 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.421 ' O ' HG23 ' A' ' 60' ' ' ILE . 8.1 tp -87.44 17.22 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.915 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 56.33 84.37 0.09 Allowed 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.76 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.96 59.74 0.1 OUTLIER Pre-proline 0 C--N 1.328 -0.369 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -51.85 151.56 15.3 Favored 'Trans proline' 0 C--N 1.292 -2.4 0 C-N-CA 123.079 2.519 . . . . 0.0 112.041 -178.274 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.434 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -108.46 145.04 15.94 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.191 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.29 -179.65 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.8 mt -63.72 -45.47 97.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.46 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.495 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -129.42 134.1 47.67 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.537 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.503 ' O ' ' N ' ' A' ' 98' ' ' LEU . 74.6 m -134.94 158.84 43.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.859 -179.746 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.61 139.07 16.22 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.608 -0.997 . . . . 0.0 110.608 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.471 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.71 -162.97 0.09 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.962 0.41 . . . . 0.0 110.486 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.52 HG22 ' CD2' ' A' ' 297' ' ' PHE . 5.7 t -134.0 134.88 43.0 Favored 'General case' 0 CA--C 1.519 -0.25 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.477 ' C ' ' O ' ' A' ' 70' ' ' THR . 1.0 OUTLIER 29.69 68.29 0.67 Allowed Pre-proline 0 N--CA 1.467 0.415 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.816 -179.646 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_exo -61.63 144.94 97.91 Favored 'Trans proline' 0 C--N 1.299 -2.074 0 C-N-CA 122.617 2.211 . . . . 0.0 111.732 -177.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.51 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 45.8 p-10 -158.72 -31.76 0.07 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.668 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.54 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 99.1 m-20 -64.21 -39.45 94.0 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.41 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -60.49 -47.95 83.88 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.44 -178.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.42 ' O ' ' O ' ' A' ' 77' ' ' ALA . 93.4 t -60.56 -24.79 32.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.54 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -45.88 173.35 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.665 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.574 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.3 p30 -61.93 177.36 0.45 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.622 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.566 ' C ' ' H ' ' A' ' 81' ' ' GLY . 36.0 p30 -45.3 85.28 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.011 0.434 . . . . 0.0 111.13 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.574 ' N ' ' O ' ' A' ' 78' ' ' ASP . 42.7 tp60 -67.33 13.39 0.07 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.212 0.529 . . . . 0.0 110.092 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.566 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 118.49 -22.44 9.45 Favored Glycine 0 N--CA 1.461 0.362 0 N-CA-C 110.921 -0.871 . . . . 0.0 110.921 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -107.85 116.45 31.97 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.992 0.425 . . . . 0.0 110.456 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 74.6 mt -98.12 -0.1 45.01 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.972 0.415 . . . . 0.0 110.55 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -92.7 7.14 44.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.029 0.442 . . . . 0.0 110.377 -179.613 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.77 ' O ' HG22 ' A' ' 89' ' ' VAL . 27.1 mt-30 -100.32 -27.68 13.35 Favored 'General case' 0 C--O 1.219 -0.545 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.813 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.3 t-105 -64.5 -40.53 95.83 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.089 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.53 ' O ' ' N ' ' A' ' 91' ' ' LYS . 63.1 m -77.78 -55.22 5.51 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.181 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -46.86 -50.08 19.16 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.243 -179.215 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.77 HG22 ' O ' ' A' ' 85' ' ' GLN . 14.2 m -69.5 -40.96 80.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.303 179.46 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.5 ' N ' HG23 ' A' ' 89' ' ' VAL . . . -72.01 -22.63 61.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.688 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.53 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.1 tttm -62.47 -45.75 91.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.316 -179.402 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.438 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.6 mm-40 -90.01 -94.02 0.12 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.998 0.428 . . . . 0.0 110.115 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.612 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.9 mtt180 -143.61 58.52 1.38 Allowed 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.445 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.7 pttp 34.01 26.5 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.064 0.459 . . . . 0.0 110.229 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.612 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.6 tt -48.89 123.01 6.36 Favored 'General case' 0 N--CA 1.444 -0.725 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.005 -177.855 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.46 ' O ' HD23 ' A' ' 95' ' ' LEU . 99.0 mm-40 -83.42 -169.6 2.63 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.212 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.616 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 81.9 mtp180 -74.61 136.88 42.0 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.272 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.503 ' N ' ' O ' ' A' ' 67' ' ' SER . 91.5 mt -85.34 -165.77 1.31 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.877 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.54 ' O ' ' CD2' ' A' ' 99' ' ' TYR . 47.1 p90 -169.05 119.33 0.71 Allowed 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.044 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.502 ' C ' ' O ' ' A' ' 99' ' ' TYR . 42.9 mm -28.31 120.44 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 O-C-N 123.316 0.385 . . . . 0.0 111.192 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 114.67 27.02 3.42 Favored Glycine 0 N--CA 1.461 0.308 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 -179.189 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.574 ' N ' ' CD ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -144.44 46.51 0.63 Allowed Pre-proline 0 C--N 1.322 -0.612 0 CA-C-O 121.126 0.489 . . . . 0.0 110.442 179.798 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.574 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 28.5 Cg_endo -62.09 144.19 95.69 Favored 'Trans proline' 0 C--N 1.293 -2.346 0 C-N-CA 122.68 2.253 . . . . 0.0 111.686 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.453 ' O ' HG23 ' A' ' 108' ' ' VAL . 26.5 t -173.12 120.18 0.35 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.325 179.584 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.78 -40.27 63.56 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.038 0.447 . . . . 0.0 111.131 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.25 -39.81 89.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.877 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.3 -39.77 94.59 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.772 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 104' ' ' SER . 70.5 t -67.6 -43.81 86.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.686 179.6 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.94 -38.93 93.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.506 -179.132 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.438 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.71 -23.45 63.16 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.5 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.53 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.4 mm-40 -90.55 5.31 48.34 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.748 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.54 ' O ' ' NE ' ' A' ' 45' ' ' ARG . 10.6 tpt 23.01 64.41 0.36 Allowed Pre-proline 0 N--CA 1.468 0.45 0 CA-C-O 120.935 0.397 . . . . 0.0 111.312 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -78.65 167.42 22.55 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 123.095 2.53 . . . . 0.0 111.6 -177.689 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.52 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 99.0 m-20 -109.78 -41.95 4.39 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.046 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.6 tp -121.23 120.7 35.95 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 84.3 mt -113.2 128.75 69.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 CA-C-O 120.89 0.376 . . . . 0.0 110.968 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.616 HD12 ' OG ' ' A' ' 48' ' ' SER . 31.1 mt -109.6 132.09 54.46 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.207 -179.694 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.498 HD12 HG23 ' A' ' 139' ' ' THR . 98.9 mt -119.67 138.68 49.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.634 -179.669 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 85.2 p -72.16 153.9 41.37 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.583 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.08 -50.37 73.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.646 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.0 t -149.61 154.16 38.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.563 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 170.85 -170.85 43.5 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -63.08 -33.99 88.75 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.44 ' OD1' ' O ' ' A' ' 124' ' ' ASP . 43.9 p-10 -86.87 120.42 28.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.815 0.341 . . . . 0.0 110.713 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.439 ' O ' HD12 ' A' ' 129' ' ' LEU . 38.5 t -62.97 143.5 57.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.072 0.463 . . . . 0.0 110.33 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.513 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -92.82 -43.26 9.09 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.91 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.2 tp -63.04 -42.56 99.77 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.729 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.32 -11.9 58.77 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.47 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.439 HD12 ' O ' ' A' ' 125' ' ' SER . 84.8 mt -115.09 -23.87 8.82 Favored 'General case' 0 C--O 1.225 -0.228 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.631 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' TYR . . . . . 0.513 ' N ' ' O ' ' A' ' 126' ' ' ALA . 79.7 t80 -51.46 -49.45 61.74 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.578 -178.786 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.8 p-10 -66.01 -42.41 89.75 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.773 -0.371 . . . . 0.0 111.364 179.227 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.524 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 88.3 mt-30 -67.16 -37.64 84.1 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.862 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.43 HD12 HD11 ' A' ' 118' ' ' ILE . 96.4 mt -80.36 -41.64 24.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.885 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.3 t -57.09 -44.48 83.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.294 -179.007 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.7 m -62.09 -45.2 94.54 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.505 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 94.1 mt -62.23 -43.61 98.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.216 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.666 ' HB1' ' HD2' ' A' ' 138' ' ' PRO . . . -168.98 168.73 5.01 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.608 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.666 ' HD2' ' HB1' ' A' ' 137' ' ' ALA . 51.6 Cg_exo -50.4 112.89 0.83 Allowed 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.24 1.96 . . . . 0.0 112.431 179.044 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.498 HG23 HD12 ' A' ' 118' ' ' ILE . 24.0 m -84.52 127.44 34.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.679 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.683 HD13 ' CD2' ' A' ' 37' ' ' HIS . 34.8 tp -117.88 137.15 52.99 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.009 0.433 . . . . 0.0 110.09 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.439 ' O ' ' OD2' ' A' ' 32' ' ' ASP . 81.9 mt -100.79 118.94 48.24 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.303 0 CA-C-O 121.203 0.525 . . . . 0.0 111.161 -179.433 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.425 HD12 HD22 ' A' ' 117' ' ' LEU . 97.9 mt -134.97 132.34 53.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.531 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.452 HD21 ' CG ' ' A' ' 241' ' ' ASP . 56.1 t30 -67.8 154.12 42.23 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.979 0.418 . . . . 0.0 110.472 179.26 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.528 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 89.8 t80 -87.81 122.53 31.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.866 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.528 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 99.1 m-20 55.14 69.38 0.74 Allowed 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.655 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 49.6 p-10 -123.6 -0.53 8.62 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.865 0.364 . . . . 0.0 110.646 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -151.14 116.19 5.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.736 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 82.7 p -62.64 167.5 4.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.582 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.407 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.6 p-90 -51.62 -16.12 0.58 Allowed 'General case' 0 C--O 1.221 -0.44 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.33 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' GLN . . . . . 0.443 ' O ' HG23 ' A' ' 154' ' ' THR . 68.1 tp60 -70.36 -75.4 0.12 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.94 0.4 . . . . 0.0 110.505 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 11.1 t -62.71 -39.11 93.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.211 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 56.0 tp -59.76 -45.69 91.47 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.417 -178.352 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.407 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 46.6 tp -62.7 -41.69 99.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.588 178.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.443 HG23 ' O ' ' A' ' 150' ' ' GLN . 59.3 p -64.43 -35.02 79.57 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.145 -179.281 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' GLN . . . . . 0.439 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.5 mm-40 -63.97 -42.79 97.14 Favored 'General case' 0 C--O 1.225 -0.196 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.391 179.351 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 91.8 mt -65.39 -38.74 90.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.17 0.509 . . . . 0.0 110.27 179.211 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.568 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.48 -32.17 80.19 Favored Glycine 0 C--N 1.331 0.295 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 -179.144 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.439 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.3 mt-10 -35.65 -27.0 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.826 0.346 . . . . 0.0 110.833 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.568 ' N ' ' O ' ' A' ' 157' ' ' GLY . 95.0 mt -55.65 150.26 2.61 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.333 178.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 77.5 p -69.67 137.24 51.99 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.049 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 70.36 22.24 77.57 Favored Glycine 0 N--CA 1.458 0.149 0 N-CA-C 111.266 -0.733 . . . . 0.0 111.266 179.537 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 57.8 m80 -123.15 -13.86 7.64 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.599 0.237 . . . . 0.0 110.481 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -66.68 -59.47 3.56 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.657 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -52.32 -49.42 64.29 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.196 -179.493 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -60.38 -41.29 93.47 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.819 0.342 . . . . 0.0 110.445 179.45 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.41 -47.23 86.75 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.509 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.79 -40.23 75.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.271 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -61.78 -50.09 73.76 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.626 179.476 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -65.27 -43.54 90.94 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.59 179.437 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 94.1 mt -64.79 -43.29 96.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.406 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.55 -51.33 69.91 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.339 -179.015 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -63.37 -44.01 95.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.869 0.366 . . . . 0.0 110.708 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' PHE . . . . . 0.651 ' CE2' HD11 ' A' ' 177' ' ' LEU . 54.8 t80 -63.08 -44.33 96.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.146 0.498 . . . . 0.0 110.394 179.49 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -63.71 -39.7 94.95 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.634 -179.315 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -63.12 -42.82 99.59 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.528 179.18 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -60.72 -44.54 96.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.209 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.651 HD11 ' CE2' ' A' ' 173' ' ' PHE . 85.0 mt -64.73 -41.08 96.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.764 178.892 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.34 -62.18 1.8 Allowed 'General case' 0 C--O 1.239 0.527 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.363 -179.233 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.41 -47.1 85.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.459 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -52.85 -41.73 64.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.381 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -63.87 -33.74 76.38 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.325 179.347 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 182' ' ' GLU . . . . . 0.412 ' O ' ' HG2' ' A' ' 182' ' ' GLU . 69.6 tt0 -90.76 9.0 31.79 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.6 0.714 . . . . 0.0 110.312 -178.76 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -104.94 -32.01 8.97 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.221 179.38 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.4 pt -128.0 147.61 32.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.79 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -140.06 131.34 26.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.986 0.422 . . . . 0.0 110.36 179.133 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 186' ' ' LEU . . . . . 0.596 HD22 ' N ' ' A' ' 186' ' ' LEU . 3.5 mm? -85.66 133.38 41.94 Favored Pre-proline 0 N--CA 1.451 -0.403 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.177 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -43.79 157.96 0.12 Allowed 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.657 2.238 . . . . 0.0 112.374 179.323 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 188' ' ' PRO . . . . . 0.498 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.5 Cg_endo -62.89 114.72 2.54 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.829 2.353 . . . . 0.0 111.658 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 189' ' ' GLN . . . . . 0.498 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.7 mt-30 155.52 148.07 0.0 OUTLIER Pre-proline 0 N--CA 1.456 -0.145 0 O-C-N 124.208 0.942 . . . . 0.0 110.874 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -73.28 144.44 36.98 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.633 2.222 . . . . 0.0 112.282 177.598 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.493 HG23 ' OG ' ' A' ' 258' ' ' SER . 2.1 p -124.74 158.95 31.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.449 0.643 . . . . 0.0 110.143 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 192' ' ' THR . . . . . 0.488 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 37.6 p -143.3 165.29 27.89 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.133 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 193' ' ' ALA . . . . . 0.448 ' HA ' ' H ' ' A' ' 260' ' ' PHE . . . -135.18 128.79 32.68 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-O 121.314 0.578 . . . . 0.0 110.173 179.28 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.514 HD11 HD23 ' A' ' 259' ' ' LEU . 47.3 pt -146.34 148.62 16.88 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.375 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.249 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 195' ' ' VAL . . . . . 0.744 HG13 ' CD1' ' A' ' 262' ' ' PHE . 69.2 t -117.41 123.26 71.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 CA-C-O 121.36 0.6 . . . . 0.0 109.791 178.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -134.55 107.33 7.47 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 121.144 0.497 . . . . 0.0 110.254 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 94.8 m -130.92 130.67 43.77 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.855 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -82.65 -36.9 25.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.208 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.53 -67.2 0.25 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.318 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.58 -9.99 59.25 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.266 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 59.9 t-80 60.53 58.68 2.42 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.722 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 39.1 p -166.88 153.75 8.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.53 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.2 144.25 24.61 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.022 0.439 . . . . 0.0 110.457 179.183 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -135.05 137.13 42.62 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.548 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 19.4 mt -105.5 125.42 50.97 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.061 0.457 . . . . 0.0 109.867 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 206' ' ' TRP . . . . . 0.555 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 76.6 m95 -81.81 166.52 19.93 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.572 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 207' ' ' THR . . . . . 0.447 HG22 ' C ' ' A' ' 206' ' ' TRP . 0.1 OUTLIER -156.67 171.58 7.23 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.561 -178.957 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -54.01 -36.91 85.82 Favored 'Trans proline' 0 C--N 1.301 -1.965 0 C-N-CA 122.664 2.243 . . . . 0.0 112.397 178.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -70.66 -34.86 72.49 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.653 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 22.3 m -61.43 149.7 37.73 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.626 -179.452 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.58 -36.51 80.86 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.431 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 212' ' ' GLN . . . . . 0.555 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 55.3 tt0 -64.93 -40.5 95.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.53 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.27 -43.66 92.42 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -63.29 -43.06 98.95 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 215' ' ' MET . . . . . 0.573 ' SD ' ' HB2' ' A' ' 304' ' ' ALA . 64.9 ttp -59.25 -48.24 82.37 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 87.5 mt -60.53 -40.97 93.43 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 217' ' ' GLU . . . . . 0.448 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 40.7 tp10 -57.9 -38.11 75.23 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -65.19 -38.12 89.48 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.632 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 94.2 mt -64.16 -43.11 96.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.186 0.517 . . . . 0.0 110.529 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 138.27 45.38 0.08 OUTLIER Glycine 0 C--N 1.334 0.453 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 221' ' ' PHE . . . . . 0.448 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 27.2 m-85 -128.98 156.56 43.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.084 0.469 . . . . 0.0 110.463 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.484 ' O ' HG13 ' A' ' 191' ' ' VAL . 7.7 p -108.66 123.22 48.64 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.311 0.577 . . . . 0.0 110.002 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.473 HD22 ' C ' ' A' ' 222' ' ' THR . 4.3 mm? -101.55 133.11 46.73 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.128 179.671 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -97.07 159.42 14.92 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.487 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -104.64 115.1 29.74 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.949 0.404 . . . . 0.0 110.375 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.493 HD12 ' N ' ' A' ' 226' ' ' LEU . 8.9 mp -53.48 156.62 4.19 Favored Pre-proline 0 N--CA 1.449 -0.495 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.827 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -59.75 145.04 99.23 Favored 'Trans proline' 0 C--N 1.299 -2.03 0 C-N-CA 122.726 2.284 . . . . 0.0 112.363 179.095 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.51 -2.72 58.81 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.51 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.37 -40.66 5.68 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 230' ' ' LEU . . . . . 0.533 ' O ' ' N ' ' A' ' 233' ' ' SER . 69.4 mt -79.12 -17.2 55.5 Favored 'General case' 0 C--O 1.219 -0.505 0 CA-C-O 121.1 0.476 . . . . 0.0 110.261 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 54.5 t-20 -40.3 -48.77 2.69 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.751 0.31 . . . . 0.0 110.78 -179.088 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -88.36 15.45 7.75 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.433 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 233' ' ' SER . . . . . 0.533 ' N ' ' O ' ' A' ' 230' ' ' LEU . 77.7 p -60.78 -35.36 76.25 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.724 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 234' ' ' GLN . . . . . 0.521 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.6 tt0 -118.54 -69.62 0.84 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.864 179.312 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 3.9 m -70.54 103.06 2.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.702 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -94.67 58.29 2.3 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.052 0.453 . . . . 0.0 110.333 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -145.31 -122.63 1.53 Allowed Glycine 0 C--N 1.332 0.342 0 N-CA-C 110.964 -0.855 . . . . 0.0 110.964 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -133.78 111.98 10.97 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.101 0.477 . . . . 0.0 110.398 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 239' ' ' ARG . . . . . 0.505 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.1 mtt180 -148.42 56.93 1.05 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.742 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -69.37 -31.78 70.41 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.47 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 241' ' ' ASP . . . . . 0.455 ' OD2' ' O ' ' A' ' 144' ' ' TYR . 64.9 t0 -56.67 -47.01 80.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.291 -178.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 242' ' ' ILE . . . . . 0.44 ' O ' ' O ' ' A' ' 239' ' ' ARG . 17.3 tt -140.46 157.48 24.43 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 CA-C-O 120.91 0.386 . . . . 0.0 110.485 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.463 HG22 HD13 ' A' ' 245' ' ' LEU . 95.8 mt -105.93 106.3 20.32 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.219 0 CA-C-O 121.165 0.507 . . . . 0.0 110.425 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 244' ' ' GLN . . . . . 0.606 ' C ' HD12 ' A' ' 245' ' ' LEU . 88.3 mt-30 -110.86 110.4 20.99 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.366 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.606 HD12 ' C ' ' A' ' 244' ' ' GLN . 9.8 mp -121.78 -167.86 1.6 Allowed 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.627 179.567 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 246' ' ' GLY . . . . . 0.521 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 172.39 -16.04 0.05 OUTLIER Glycine 0 CA--C 1.524 0.596 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 247' ' ' GLY . . . . . 0.665 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -60.96 157.56 31.07 Favored Glycine 0 CA--C 1.521 0.463 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -63.86 20.87 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.941 0.401 . . . . 0.0 110.581 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 249' ' ' ASN . . . . . 0.665 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.9 m-20 -96.86 -5.84 37.3 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.528 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 92.5 mt -80.19 -21.45 42.96 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.839 179.294 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.63 -51.43 69.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.663 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.96 -5.21 58.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.465 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.03 -74.23 1.15 Allowed Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 82.0 mt -70.31 126.15 28.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.014 0.435 . . . . 0.0 110.172 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -59.97 -39.3 85.19 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.274 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 83.11 51.67 4.09 Favored Glycine 0 CA--C 1.519 0.3 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -95.15 -16.05 22.87 Favored 'General case' 0 C--N 1.331 -0.212 0 O-C-N 122.694 -0.297 . . . . 0.0 110.585 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 258' ' ' SER . . . . . 0.493 ' OG ' HG23 ' A' ' 191' ' ' VAL . 3.4 t 175.19 89.42 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.182 0.515 . . . . 0.0 110.053 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.852 HD12 ' N ' ' A' ' 259' ' ' LEU . 1.0 OUTLIER -94.77 124.56 38.88 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.273 0.559 . . . . 0.0 111.253 -179.094 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 260' ' ' PHE . . . . . 0.448 ' H ' ' HA ' ' A' ' 193' ' ' ALA . 15.8 m-30 -93.95 146.65 23.77 Favored 'General case' 0 CA--C 1.497 -1.086 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.4 179.509 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 86.4 mt -122.32 149.54 43.6 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.573 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.744 ' CD1' HG13 ' A' ' 195' ' ' VAL . 2.6 p90 -77.69 -138.91 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.506 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 263' ' ' ALA . . . . . 0.654 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -51.08 77.59 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 121.109 0.48 . . . . 0.0 111.303 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 264' ' ' GLY . . . . . 0.624 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.93 104.57 0.18 Allowed Glycine 0 CA--C 1.527 0.816 0 N-CA-C 110.466 -1.054 . . . . 0.0 110.466 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 265' ' ' ASP . . . . . 0.589 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.6 m-20 -80.06 -177.94 6.28 Favored 'General case' 0 C--N 1.327 -0.407 0 O-C-N 122.706 -0.291 . . . . 0.0 111.001 -179.686 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -40.44 -17.81 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.587 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 267' ' ' LYS . . . . . 0.589 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.0 -51.76 43.49 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.013 0.435 . . . . 0.0 110.684 179.125 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -63.68 -46.49 85.29 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.266 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 269' ' ' ALA . . . . . 0.58 ' HB1' ' OH ' ' A' ' 273' ' ' TYR . . . -61.76 -34.81 76.53 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 121.543 0.687 . . . . 0.0 109.746 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -63.42 -34.23 77.3 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.076 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.51 -43.11 13.83 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.112 -179.396 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 272' ' ' ILE . . . . . 0.593 ' C ' ' H ' ' A' ' 274' ' ' ALA . 4.9 tt -51.44 -33.97 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.799 -178.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 273' ' ' TYR . . . . . 0.58 ' OH ' ' HB1' ' A' ' 269' ' ' ALA . 16.9 m-85 -54.43 -2.03 0.03 OUTLIER 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.615 -179.289 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 274' ' ' ALA . . . . . 0.593 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.2 -39.63 71.66 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.868 179.434 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 275' ' ' ASN . . . . . 0.579 ' O ' ' N ' ' A' ' 279' ' ' ALA . 3.9 p30 -38.78 97.71 0.14 Allowed Pre-proline 0 N--CA 1.462 0.157 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.385 -179.667 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.7 -42.57 67.27 Favored 'Trans proline' 0 C--N 1.303 -1.865 0 C-N-CA 122.367 2.045 . . . . 0.0 112.506 -178.567 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 88.9 mt -64.43 -42.83 95.78 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.092 0.472 . . . . 0.0 111.225 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 91.9 mt -95.97 -1.08 49.8 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.954 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 279' ' ' ALA . . . . . 0.579 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.38 -34.83 77.47 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.683 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.22 20.16 0.11 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.982 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 281' ' ' LEU . . . . . 0.482 ' H ' ' C ' ' A' ' 279' ' ' ALA . 13.6 mt -74.67 119.39 76.43 Favored Pre-proline 0 N--CA 1.444 -0.731 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.834 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -49.87 -40.1 48.74 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.623 2.215 . . . . 0.0 112.327 178.543 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.86 -50.59 63.48 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.034 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 73.5 t -61.45 -43.85 97.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.096 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -57.64 -41.15 80.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.098 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -91.01 0.05 57.63 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.118 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt 59.94 43.67 14.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.048 0.452 . . . . 0.0 110.772 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -95.01 41.06 1.1 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.382 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 53.8 t -119.33 135.74 58.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-O 121.133 0.492 . . . . 0.0 110.033 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -133.47 163.62 28.98 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 121.236 0.541 . . . . 0.0 110.569 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.8 155.58 32.28 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 121.097 0.475 . . . . 0.0 110.645 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 82.1 mt -94.44 -1.56 53.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.232 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.03 165.38 12.66 Favored Glycine 0 N--CA 1.463 0.489 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 6.7 m -86.64 -61.59 1.7 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.849 0.356 . . . . 0.0 111.092 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 295' ' ' GLU . . . . . 0.454 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.6 mm-40 -69.53 -4.82 20.57 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.729 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 26.8 p -76.55 32.61 0.13 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.632 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 297' ' ' PHE . . . . . 0.52 ' CD2' HG22 ' A' ' 70' ' ' THR . 67.1 t80 -60.4 -46.18 90.92 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.672 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 298' ' ' ARG . . . . . 0.616 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.2 mtt85 -80.32 136.93 36.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.657 -179.586 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.49 ' H ' HG11 ' A' ' 51' ' ' VAL . 0.9 OUTLIER -114.61 116.71 29.18 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.994 0.426 . . . . 0.0 110.533 179.65 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 300' ' ' ASP . . . . . 0.624 ' H ' ' CB ' ' A' ' 303' ' ' SER . 48.7 p-10 -167.21 -174.59 2.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.616 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 80.4 t80 -48.13 -44.44 32.09 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.227 -179.465 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -65.51 -41.53 93.07 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.034 0.445 . . . . 0.0 110.662 178.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 303' ' ' SER . . . . . 0.624 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 53.8 p -55.29 -36.29 65.99 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.952 -179.087 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 304' ' ' ALA . . . . . 0.573 ' HB2' ' SD ' ' A' ' 215' ' ' MET . . . -57.07 -52.09 66.66 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.429 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 91.7 mtp -55.96 -44.32 78.35 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -66.05 -42.87 88.96 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.172 0.51 . . . . 0.0 110.199 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 307' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 303' ' ' SER . 55.7 t -63.91 -43.03 97.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.245 179.39 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 42.4 tp -60.04 -41.98 93.47 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.803 -179.418 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -62.18 -39.16 91.76 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.211 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 310' ' ' ARG . . . . . 0.45 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.7 ttt85 -63.68 -43.91 95.26 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.227 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 89.4 mt -63.1 -42.08 99.5 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.364 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -63.06 -33.77 76.14 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.076 179.523 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.38 -23.56 22.16 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.346 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 314' ' ' LEU . . . . . 0.484 HD22 ' CE2' ' A' ' 315' ' ' PHE . 6.8 tt -62.35 -43.06 99.71 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 121.128 0.489 . . . . 0.0 110.56 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 315' ' ' PHE . . . . . 0.484 ' CE2' HD22 ' A' ' 314' ' ' LEU . 89.8 m-85 . . . . . 0 C--O 1.22 -0.47 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.327 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -99.67 136.29 39.82 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.04 0.448 . . . . 0.0 110.44 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.492 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -91.54 178.41 1.78 Allowed Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.584 -179.87 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.492 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.1 Cg_exo -61.72 147.66 94.82 Favored 'Trans proline' 0 C--N 1.3 -2.001 0 C-N-CA 122.882 2.388 . . . . 0.0 112.182 179.603 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.496 ' HE ' HD12 ' A' ' 39' ' ' LEU . 35.1 ptt180 -135.35 142.36 45.75 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.567 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -78.91 116.9 19.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.515 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.424 ' O ' HG23 ' A' ' 30' ' ' ILE . 9.6 tp -110.35 131.0 62.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.478 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.9 t -70.81 142.41 51.3 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.62 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.424 ' OD1' ' O ' ' A' ' 141' ' ' ILE . 24.7 t70 -140.56 177.58 7.92 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.508 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 77.9 p -73.81 -36.38 64.98 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.556 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 60.1 ttt85 -47.69 -95.22 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.409 -179.596 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.419 ' O ' ' OG1' ' A' ' 36' ' ' THR . . . -165.42 -25.51 0.02 OUTLIER Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.419 ' OG1' ' O ' ' A' ' 35' ' ' GLY . 61.2 m -169.05 106.82 0.42 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.844 0.354 . . . . 0.0 110.63 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 52.6 t-80 -129.61 144.57 51.33 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.022 0.439 . . . . 0.0 110.199 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.629 HG22 ' N ' ' A' ' 39' ' ' LEU . 96.9 m -128.63 166.5 18.77 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.455 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.629 ' N ' HG22 ' A' ' 38' ' ' THR . 80.7 mt -121.15 127.52 51.63 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.506 179.713 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -63.8 -44.4 93.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.709 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 39.6 p -165.84 154.95 11.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.439 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.493 ' CD ' ' H ' ' A' ' 42' ' ' GLN . 14.3 mp0 -43.07 100.64 0.23 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.574 179.433 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -56.94 128.99 32.16 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 122.492 2.128 . . . . 0.0 112.201 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -83.33 -24.35 32.15 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.587 179.546 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.538 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.5 mtm-85 -121.16 134.48 55.22 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.113 0.482 . . . . 0.0 110.276 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.2 mt -130.09 133.57 64.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.74 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 47.9 t -125.26 130.94 72.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.203 179.167 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.574 ' OG ' HD12 ' A' ' 117' ' ' LEU . 4.1 m -154.57 166.34 33.63 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.607 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 72.2 p -124.6 8.83 8.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.429 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.72 125.73 33.43 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.587 -179.498 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.454 HG11 ' H ' ' A' ' 299' ' ' LEU . 87.8 t -65.68 -44.63 93.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.493 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 18.1 m -62.79 -44.16 96.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.616 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 53.0 tp -62.37 -41.63 98.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.53 -179.361 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.457 ' O ' HD13 ' A' ' 58' ' ' LEU . 76.3 m -57.67 -44.74 85.96 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.329 -179.332 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.4 -62.4 5.14 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.5 t -47.52 -35.96 9.65 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.681 0.277 . . . . 0.0 110.279 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.7 mt -61.77 -44.34 97.08 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.087 179.469 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.457 HD13 ' O ' ' A' ' 54' ' ' THR . 8.9 mp -65.39 -41.23 93.9 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.137 178.262 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.401 ' HB1' ' NE ' ' A' ' 169' ' ' ARG . . . -63.86 -41.25 97.81 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.78 -179.266 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.43 ' O ' HG23 ' A' ' 60' ' ' ILE . 7.9 tp -88.1 16.77 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.843 -179.619 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 56.4 84.43 0.09 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.727 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 178.89 57.7 0.07 OUTLIER Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.269 -0.423 . . . . 0.0 109.951 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -51.09 153.83 8.51 Favored 'Trans proline' 0 C--N 1.296 -2.216 0 C-N-CA 123.035 2.49 . . . . 0.0 111.999 -177.836 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.428 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -109.33 146.15 15.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.366 -179.631 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.67 -45.44 97.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.15 -179.759 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.506 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -129.83 134.69 47.7 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.883 0.373 . . . . 0.0 110.522 -179.6 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.489 ' O ' ' N ' ' A' ' 98' ' ' LEU . 72.3 m -134.87 158.96 42.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.765 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.92 139.35 16.21 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.481 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.8 -162.67 0.08 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.876 0.369 . . . . 0.0 110.49 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.504 HG22 ' CD2' ' A' ' 297' ' ' PHE . 5.8 t -133.76 135.82 44.16 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.256 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.488 ' C ' ' O ' ' A' ' 70' ' ' THR . 1.0 OUTLIER 29.51 68.73 0.64 Allowed Pre-proline 0 N--CA 1.464 0.26 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.74 -179.487 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -61.43 144.79 98.37 Favored 'Trans proline' 0 C--N 1.301 -1.93 0 C-N-CA 122.697 2.265 . . . . 0.0 111.815 -178.097 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.528 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 45.3 p-10 -160.08 -32.3 0.06 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.592 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.537 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 99.0 m-20 -64.04 -39.51 94.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.358 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 73.2 ttt180 -60.18 -48.41 81.83 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.548 -179.378 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.426 ' O ' ' O ' ' A' ' 77' ' ' ALA . 94.9 t -59.82 -25.05 31.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.096 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.537 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -45.35 172.67 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.636 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.573 ' O ' ' N ' ' A' ' 80' ' ' GLN . 54.1 p30 -61.94 177.64 0.43 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.483 -179.68 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.563 ' C ' ' H ' ' A' ' 81' ' ' GLY . 34.4 p30 -46.28 85.58 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.957 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.573 ' N ' ' O ' ' A' ' 78' ' ' ASP . 42.9 tp60 -67.17 13.69 0.06 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.298 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.563 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 118.09 -21.98 9.94 Favored Glycine 0 CA--C 1.519 0.316 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -107.94 116.67 32.38 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.946 0.403 . . . . 0.0 110.469 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 75.4 mt -99.23 0.38 43.08 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.582 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -91.88 6.81 44.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.374 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.794 ' O ' HG22 ' A' ' 89' ' ' VAL . 27.1 mt-30 -100.03 -28.04 13.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.704 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 68.4 t-105 -63.43 -40.5 97.34 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.821 -179.517 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.552 ' O ' ' N ' ' A' ' 91' ' ' LYS . 67.9 m -77.75 -53.81 7.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.837 -179.276 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -48.25 -50.95 27.73 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.936 -179.111 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.794 HG22 ' O ' ' A' ' 85' ' ' GLN . 15.8 m -68.96 -40.44 81.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.992 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.495 ' N ' HG23 ' A' ' 89' ' ' VAL . . . -72.47 -22.6 61.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.624 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.552 ' N ' ' O ' ' A' ' 87' ' ' SER . 65.9 tttm -61.5 -45.95 92.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.429 -179.525 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.435 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.8 mm-40 -90.38 -94.48 0.12 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.251 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.624 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.9 mtt180 -143.34 59.58 1.4 Allowed 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.456 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.6 pttp 33.76 26.35 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.021 0.439 . . . . 0.0 110.388 -179.028 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.624 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.4 tt -48.09 123.07 5.78 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.912 -178.14 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.45 ' O ' HD23 ' A' ' 95' ' ' LEU . 98.9 mm-40 -83.21 -170.68 3.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.224 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.624 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 82.9 mtp180 -73.01 137.67 45.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.329 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.489 ' N ' ' O ' ' A' ' 67' ' ' SER . 88.9 mt -86.41 -165.87 1.39 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.782 -179.632 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.533 ' O ' ' CD2' ' A' ' 99' ' ' TYR . 47.7 p90 -168.29 119.7 0.81 Allowed 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.23 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.507 ' C ' ' O ' ' A' ' 99' ' ' TYR . 42.8 mm -29.29 121.43 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.935 -179.781 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 113.6 28.05 3.36 Favored Glycine 0 CA--C 1.521 0.417 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 -179.503 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.583 ' CD ' ' H ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -143.96 46.11 0.62 Allowed Pre-proline 0 C--N 1.324 -0.521 0 CA-C-O 121.044 0.45 . . . . 0.0 110.479 179.874 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.581 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 29.8 Cg_endo -62.47 143.83 93.82 Favored 'Trans proline' 0 C--N 1.298 -2.13 0 C-N-CA 122.728 2.286 . . . . 0.0 111.834 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.459 ' O ' HG23 ' A' ' 108' ' ' VAL . 26.2 t -173.14 120.68 0.36 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.435 179.656 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.4 -41.07 63.78 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.866 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -65.73 -39.95 91.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.744 -179.396 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.77 -39.56 94.55 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.681 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 104' ' ' SER . 71.3 t -67.78 -43.58 86.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.659 179.715 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.57 -39.28 93.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.491 -179.279 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.435 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.68 -23.9 63.49 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.508 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.562 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.3 mm-40 -91.32 5.11 50.54 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.658 -179.532 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.562 ' C ' ' O ' ' A' ' 111' ' ' GLN . 9.5 tpt 21.01 65.51 0.28 Allowed Pre-proline 0 N--CA 1.465 0.299 0 CA-C-O 121.042 0.449 . . . . 0.0 111.116 -179.575 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.46 ' HG2' HD11 ' A' ' 116' ' ' ILE . 61.9 Cg_endo -79.92 170.03 17.18 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 123.018 2.479 . . . . 0.0 111.617 -178.083 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.52 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 98.9 m-20 -112.52 -44.25 3.38 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.182 179.464 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 39.4 tp -120.18 121.35 38.56 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.142 179.324 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.46 HD11 ' HG2' ' A' ' 113' ' ' PRO . 96.6 mt -118.61 131.29 71.83 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.851 -179.688 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.574 HD12 ' OG ' ' A' ' 48' ' ' SER . 32.2 mt -105.95 132.01 52.56 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.222 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.479 HD12 HG23 ' A' ' 139' ' ' THR . 98.3 mt -117.26 136.08 55.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.641 -179.647 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 85.0 p -71.68 151.85 43.31 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.559 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.26 -50.01 75.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.633 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -149.35 153.77 37.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.542 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 168.57 -169.32 41.58 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -63.13 -35.41 92.05 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.447 ' OD1' ' O ' ' A' ' 124' ' ' ASP . 44.2 p-10 -88.81 120.12 29.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.859 0.362 . . . . 0.0 110.643 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.448 ' O ' HD12 ' A' ' 129' ' ' LEU . 40.6 t -63.35 144.62 56.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.467 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.518 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.92 -42.76 8.9 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.745 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.4 tp -62.79 -42.36 99.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.669 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.99 -10.59 54.74 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.483 -179.416 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.448 HD12 ' O ' ' A' ' 125' ' ' SER . 84.0 mt -115.73 -24.57 8.17 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.591 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' TYR . . . . . 0.518 ' N ' ' O ' ' A' ' 126' ' ' ALA . 74.3 t80 -50.77 -49.93 57.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.65 -179.109 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.3 p-10 -65.89 -41.91 90.92 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.827 0.346 . . . . 0.0 111.132 179.623 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.526 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 87.8 mt-30 -68.08 -36.72 80.29 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.804 -179.776 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.458 HD12 HD11 ' A' ' 118' ' ' ILE . 96.5 mt -80.09 -42.78 22.95 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.864 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.402 ' N ' ' OG1' ' A' ' 139' ' ' THR . 11.5 t -56.76 -45.47 82.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.452 -179.337 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 20.0 m -62.38 -45.93 90.91 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.568 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 93.2 mt -62.19 -43.84 98.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.463 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.596 ' HB1' ' HD2' ' A' ' 138' ' ' PRO . . . -170.04 163.04 6.53 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.598 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.596 ' HD2' ' HB1' ' A' ' 137' ' ' ALA . 77.5 Cg_exo -41.54 110.6 0.14 Allowed 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.629 2.219 . . . . 0.0 112.224 179.336 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.499 HG21 ' CD1' ' A' ' 130' ' ' TYR . 3.0 m -87.79 127.11 35.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.62 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.436 HD12 ' HA ' ' A' ' 140' ' ' LEU . 35.1 tp -119.24 139.42 51.91 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.36 179.749 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.424 ' O ' ' OD1' ' A' ' 32' ' ' ASP . 79.7 mt -105.41 120.27 55.87 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.197 0 CA-C-O 121.1 0.476 . . . . 0.0 110.942 -179.161 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.459 HD12 HD22 ' A' ' 117' ' ' LEU . 94.7 mt -136.43 132.6 49.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.562 179.358 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.548 HD21 ' CG ' ' A' ' 241' ' ' ASP . 54.3 t30 -64.55 148.99 49.62 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.91 0.386 . . . . 0.0 110.475 179.299 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.453 ' O ' ' OD2' ' A' ' 241' ' ' ASP . 87.1 t80 -82.72 122.85 28.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.84 -179.333 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.442 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 91.6 m-20 55.01 69.67 0.71 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.753 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 49.3 p-10 -124.4 0.25 8.27 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.579 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -151.53 117.31 5.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.723 -179.452 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 85.0 p -63.89 168.68 4.87 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.504 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.415 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.6 p-90 -51.21 -15.89 0.42 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.424 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' GLN . . . . . 0.439 ' O ' HG23 ' A' ' 154' ' ' THR . 68.4 tp60 -70.9 -75.46 0.12 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.526 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.439 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.3 t -62.66 -38.58 90.88 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.318 179.473 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 51.1 tp -59.98 -45.88 91.28 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.421 -178.639 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.415 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 45.2 tp -62.64 -41.61 99.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.581 178.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.439 HG23 ' O ' ' A' ' 150' ' ' GLN . 59.3 p -63.9 -34.87 78.94 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.298 -179.631 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' GLN . . . . . 0.494 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.4 mm-40 -63.56 -42.01 98.38 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.359 179.265 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 91.8 mt -65.6 -38.57 89.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.11 0.481 . . . . 0.0 110.341 178.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.568 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.58 -31.97 79.66 Favored Glycine 0 CA--C 1.52 0.399 0 N-CA-C 110.818 -0.913 . . . . 0.0 110.818 -179.393 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.494 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.3 mt-10 -36.99 -25.32 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.853 0.359 . . . . 0.0 110.772 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.568 ' N ' ' O ' ' A' ' 157' ' ' GLY . 92.9 mt -59.67 149.37 6.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.423 179.268 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 77.6 p -69.18 137.52 53.34 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.854 -179.458 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 70.54 22.26 77.81 Favored Glycine 0 CA--C 1.519 0.285 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 179.408 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 62.4 m80 -124.38 -14.12 6.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.715 0.293 . . . . 0.0 110.442 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -66.83 -59.87 3.16 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.579 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -51.3 -49.7 60.76 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.243 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -60.1 -41.13 91.86 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.474 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.5 -47.6 84.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.58 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.55 -40.07 74.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.331 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -61.67 -50.58 71.93 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.603 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.401 ' NE ' ' HB1' ' A' ' 59' ' ' ALA . 59.9 ttt85 -65.32 -43.66 90.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.572 179.47 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 94.3 mt -64.71 -43.15 96.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.432 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.27 -51.49 69.15 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.382 -179.283 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.51 -43.64 96.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.601 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 173' ' ' PHE . . . . . 0.658 ' CE2' HD11 ' A' ' 177' ' ' LEU . 55.9 t80 -62.94 -44.01 97.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.484 179.467 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -63.65 -39.72 95.05 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.403 -179.273 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -63.07 -42.83 99.74 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.537 179.326 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -60.46 -44.79 95.51 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.322 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.658 HD11 ' CE2' ' A' ' 173' ' ' PHE . 84.6 mt -64.65 -40.97 96.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.652 178.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.0 -62.5 1.59 Allowed 'General case' 0 C--O 1.237 0.438 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.357 -179.428 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.02 -47.27 83.55 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.51 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -52.65 -41.63 63.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.423 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -64.1 -33.2 75.23 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.361 179.292 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 182' ' ' GLU . . . . . 0.418 ' O ' ' HG2' ' A' ' 182' ' ' GLU . 69.5 tt0 -91.21 8.43 35.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.357 0.599 . . . . 0.0 110.423 -178.852 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -104.42 -32.26 9.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.037 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.4 pt -128.02 147.56 32.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.755 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -139.65 131.05 26.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.428 179.242 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 186' ' ' LEU . . . . . 0.592 HD22 ' N ' ' A' ' 186' ' ' LEU . 3.6 mm? -85.4 133.0 43.21 Favored Pre-proline 0 N--CA 1.452 -0.337 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.933 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -43.61 157.68 0.12 Allowed 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.689 2.259 . . . . 0.0 112.302 179.152 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 188' ' ' PRO . . . . . 0.522 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.7 Cg_endo -62.81 114.93 2.63 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 122.805 2.337 . . . . 0.0 111.862 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 189' ' ' GLN . . . . . 0.522 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.7 mt-30 155.52 147.75 0.0 OUTLIER Pre-proline 0 N--CA 1.456 -0.145 0 O-C-N 123.83 0.706 . . . . 0.0 110.823 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -73.4 143.83 35.52 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.643 2.228 . . . . 0.0 112.266 177.637 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.495 HG23 ' OG ' ' A' ' 258' ' ' SER . 2.1 p -124.5 159.05 31.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.245 0.545 . . . . 0.0 110.305 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 192' ' ' THR . . . . . 0.493 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 37.9 p -143.47 165.03 28.68 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.922 -179.477 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 193' ' ' ALA . . . . . 0.444 ' HA ' ' H ' ' A' ' 260' ' ' PHE . . . -135.36 128.73 32.2 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 121.159 0.504 . . . . 0.0 110.33 179.341 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.515 HD11 HD23 ' A' ' 259' ' ' LEU . 47.5 pt -146.73 148.95 16.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.993 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 195' ' ' VAL . . . . . 0.739 HG13 ' CD1' ' A' ' 262' ' ' PHE . 76.2 t -117.35 123.02 71.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.173 0.511 . . . . 0.0 110.079 178.816 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -134.22 106.46 7.16 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.371 179.705 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 95.9 m -130.48 130.71 44.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.763 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.404 ' O ' ' N ' ' A' ' 201' ' ' HIS . . . -82.95 -36.79 24.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.285 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.31 -67.07 0.26 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.348 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.31 -9.66 58.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.357 179.497 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 201' ' ' HIS . . . . . 0.404 ' N ' ' O ' ' A' ' 198' ' ' ALA . 60.2 t-80 60.72 58.19 2.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.694 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 41.1 p -167.43 153.61 7.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.569 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.27 144.18 24.51 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.953 0.406 . . . . 0.0 110.509 179.353 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -135.29 138.25 43.29 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.632 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 18.4 mt -105.98 125.12 50.62 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.0 0.428 . . . . 0.0 110.033 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 206' ' ' TRP . . . . . 0.558 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 74.1 m95 -81.84 167.2 19.26 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.596 -179.663 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 207' ' ' THR . . . . . 0.469 HG22 ' C ' ' A' ' 206' ' ' TRP . 0.1 OUTLIER -157.18 171.15 7.83 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.64 -179.056 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -53.1 -37.2 79.13 Favored 'Trans proline' 0 C--N 1.302 -1.907 0 C-N-CA 122.73 2.286 . . . . 0.0 112.377 179.041 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -70.96 -34.98 71.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.657 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 22.1 m -61.03 150.74 32.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.595 -179.434 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.46 -36.89 81.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.509 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 212' ' ' GLN . . . . . 0.558 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 54.8 tt0 -64.72 -40.29 95.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.625 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.78 -43.35 91.91 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -62.8 -44.37 96.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.807 0.337 . . . . 0.0 110.319 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 215' ' ' MET . . . . . 0.551 ' SD ' ' HB2' ' A' ' 304' ' ' ALA . 65.1 ttp -59.08 -48.27 82.2 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.233 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 87.6 mt -60.01 -41.36 91.96 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 179.497 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 217' ' ' GLU . . . . . 0.45 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 40.4 tp10 -57.84 -38.13 75.1 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.205 179.588 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -65.45 -38.23 89.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.633 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 95.1 mt -64.15 -42.95 96.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.578 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.74 45.39 0.08 OUTLIER Glycine 0 CA--C 1.521 0.456 0 N-CA-C 110.991 -0.843 . . . . 0.0 110.991 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 221' ' ' PHE . . . . . 0.45 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 25.8 m-85 -128.21 155.63 44.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.972 0.415 . . . . 0.0 110.536 -179.833 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.482 ' O ' HG13 ' A' ' 191' ' ' VAL . 7.8 p -107.07 122.4 46.4 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.16 0.505 . . . . 0.0 110.231 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.479 HD22 ' C ' ' A' ' 222' ' ' THR . 4.3 mm? -101.78 132.94 47.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.924 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.76 160.36 14.42 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.527 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.72 115.08 29.63 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.35 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.494 HD12 ' N ' ' A' ' 226' ' ' LEU . 9.0 mp -53.1 156.42 3.7 Favored Pre-proline 0 N--CA 1.452 -0.345 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.726 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -59.62 145.2 98.75 Favored 'Trans proline' 0 C--N 1.302 -1.917 0 C-N-CA 122.771 2.314 . . . . 0.0 112.33 179.09 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.3 -3.15 59.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.498 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.19 -41.08 5.63 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 230' ' ' LEU . . . . . 0.519 ' O ' ' N ' ' A' ' 233' ' ' SER . 67.7 mt -79.05 -17.75 54.69 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-O 121.051 0.453 . . . . 0.0 110.427 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 231' ' ' ASN . . . . . 0.4 ' C ' ' O ' ' A' ' 230' ' ' LEU . 55.4 t-20 -40.05 -49.7 2.55 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.78 -179.496 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -87.67 15.19 7.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.096 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 233' ' ' SER . . . . . 0.519 ' N ' ' O ' ' A' ' 230' ' ' LEU . 78.0 p -60.24 -35.17 74.86 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.744 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 234' ' ' GLN . . . . . 0.522 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.6 tt0 -119.64 -69.4 0.85 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.765 179.591 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.0 m -69.7 101.88 1.77 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.614 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -93.67 57.73 2.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.413 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -144.56 -122.56 1.59 Allowed Glycine 0 CA--C 1.521 0.451 0 N-CA-C 110.906 -0.877 . . . . 0.0 110.906 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -135.4 111.21 9.38 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.017 0.436 . . . . 0.0 110.406 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 239' ' ' ARG . . . . . 0.527 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.6 mtt180 -147.79 58.27 1.11 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.678 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -69.6 -32.2 70.8 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.515 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 241' ' ' ASP . . . . . 0.548 ' CG ' HD21 ' A' ' 143' ' ' ASN . 64.7 t0 -56.9 -47.33 80.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.362 -179.208 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 242' ' ' ILE . . . . . 0.433 ' O ' ' O ' ' A' ' 239' ' ' ARG . 17.8 tt -139.61 155.98 25.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.503 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.442 HG22 HD13 ' A' ' 245' ' ' LEU . 96.2 mt -106.01 106.47 20.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-O 120.973 0.416 . . . . 0.0 110.496 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 244' ' ' GLN . . . . . 0.6 ' O ' HD12 ' A' ' 245' ' ' LEU . 88.6 mt-30 -110.34 109.87 20.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.423 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.6 HD12 ' O ' ' A' ' 244' ' ' GLN . 9.4 mp -121.63 -168.16 1.64 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.65 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 246' ' ' GLY . . . . . 0.522 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.85 -16.32 0.05 OUTLIER Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 247' ' ' GLY . . . . . 0.674 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -61.31 156.26 34.59 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -63.35 21.87 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.92 0.39 . . . . 0.0 110.622 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 249' ' ' ASN . . . . . 0.674 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.8 m-20 -97.32 -6.29 34.64 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.539 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 91.6 mt -79.58 -22.09 44.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.757 179.412 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.62 -51.65 69.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.645 -179.498 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.0 -5.6 58.42 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.52 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -80.98 -74.46 1.14 Allowed Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 81.2 mt -69.8 125.8 27.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.846 0.355 . . . . 0.0 110.38 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -59.24 -39.55 83.14 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.251 -179.632 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 83.32 51.73 4.03 Favored Glycine 0 CA--C 1.521 0.467 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -95.45 -15.57 22.87 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.715 0.293 . . . . 0.0 110.622 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 258' ' ' SER . . . . . 0.495 ' OG ' HG23 ' A' ' 191' ' ' VAL . 3.5 t 174.59 89.0 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.07 0.462 . . . . 0.0 110.244 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.861 HD12 ' N ' ' A' ' 259' ' ' LEU . 1.0 OUTLIER -94.21 124.04 37.98 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.127 0.489 . . . . 0.0 111.038 -178.92 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 260' ' ' PHE . . . . . 0.444 ' H ' ' HA ' ' A' ' 193' ' ' ALA . 16.0 m-30 -93.31 146.6 23.6 Favored 'General case' 0 CA--C 1.506 -0.722 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.481 179.149 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 85.4 mt -122.24 149.63 43.41 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.565 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.739 ' CD1' HG13 ' A' ' 195' ' ' VAL . 2.6 p90 -77.56 -139.01 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.521 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 263' ' ' ALA . . . . . 0.665 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -51.29 77.44 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.997 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 264' ' ' GLY . . . . . 0.635 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.31 104.77 0.19 Allowed Glycine 0 CA--C 1.528 0.876 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 265' ' ' ASP . . . . . 0.6 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.7 m-20 -80.4 -177.77 6.33 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.701 0.286 . . . . 0.0 110.8 -179.363 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -40.25 -17.84 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.566 179.643 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 267' ' ' LYS . . . . . 0.6 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.45 -51.7 40.7 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.635 179.449 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -63.52 -46.59 85.36 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.279 179.333 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 269' ' ' ALA . . . . . 0.568 ' HB1' ' OH ' ' A' ' 273' ' ' TYR . . . -61.78 -34.99 76.86 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.302 0.572 . . . . 0.0 109.95 179.602 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -63.31 -34.05 76.86 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.116 179.783 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.69 -43.41 13.42 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.928 -179.441 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 272' ' ' ILE . . . . . 0.589 ' C ' ' H ' ' A' ' 274' ' ' ALA . 4.9 tt -51.42 -33.58 14.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.667 -178.569 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 273' ' ' TYR . . . . . 0.568 ' OH ' ' HB1' ' A' ' 269' ' ' ALA . 17.3 m-85 -54.65 -1.61 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.582 -179.558 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 274' ' ' ALA . . . . . 0.589 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.74 -39.7 69.87 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.811 179.512 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 275' ' ' ASN . . . . . 0.582 ' O ' ' N ' ' A' ' 279' ' ' ALA . 3.1 p30 -39.18 98.34 0.16 Allowed Pre-proline 0 N--CA 1.461 0.108 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.457 -179.642 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -54.59 -42.83 64.61 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 C-N-CA 122.519 2.146 . . . . 0.0 112.438 -178.669 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 89.1 mt -64.57 -42.88 95.37 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.024 -179.586 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 90.9 mt -95.77 -1.47 49.68 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.809 -179.403 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 279' ' ' ALA . . . . . 0.582 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.24 -34.89 77.37 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.703 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.46 20.35 0.12 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.876 -179.09 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 281' ' ' LEU . . . . . 0.486 HD23 ' HA ' ' A' ' 281' ' ' LEU . 13.9 mt -75.04 119.38 76.62 Favored Pre-proline 0 N--CA 1.45 -0.462 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.719 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -49.75 -40.36 47.53 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.719 2.279 . . . . 0.0 112.224 178.663 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.32 -50.83 61.5 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.263 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 78.6 t -61.28 -43.91 97.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.255 179.439 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -57.65 -41.21 80.98 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.261 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -91.0 0.13 57.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.313 179.617 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt 59.73 43.64 15.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.754 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -94.95 41.05 1.09 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.375 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 53.7 t -119.03 135.77 58.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 121.012 0.434 . . . . 0.0 110.203 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -133.07 163.35 29.45 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.638 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.8 155.34 32.74 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.657 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 79.5 mt -94.19 -1.66 53.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.312 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.37 165.79 12.73 Favored Glycine 0 CA--C 1.521 0.462 0 N-CA-C 110.658 -0.977 . . . . 0.0 110.658 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 7.1 m -87.76 -62.39 1.51 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.865 0.365 . . . . 0.0 110.91 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 295' ' ' GLU . . . . . 0.452 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.5 mm-40 -68.86 -4.24 15.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.657 -179.653 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 24.9 p -76.64 32.12 0.13 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.608 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 297' ' ' PHE . . . . . 0.504 ' CD2' HG22 ' A' ' 70' ' ' THR . 70.4 t80 -60.42 -46.3 90.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.567 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 298' ' ' ARG . . . . . 0.624 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.2 mtt85 -80.74 134.42 35.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.594 -179.589 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.454 ' H ' HG11 ' A' ' 51' ' ' VAL . 18.3 tp -113.13 116.43 29.84 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.325 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 300' ' ' ASP . . . . . 0.628 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.1 p-10 -164.7 -177.29 4.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.638 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 81.1 t80 -46.16 -43.15 14.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.406 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -67.62 -40.13 84.68 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.991 0.424 . . . . 0.0 110.692 179.283 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 303' ' ' SER . . . . . 0.628 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 59.6 p -55.74 -36.73 67.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.26 -179.239 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 304' ' ' ALA . . . . . 0.551 ' HB2' ' SD ' ' A' ' 215' ' ' MET . . . -56.95 -52.27 65.9 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 179.389 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 92.7 mtp -54.92 -44.24 74.04 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -66.0 -42.86 89.18 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.066 0.46 . . . . 0.0 110.351 178.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 307' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 303' ' ' SER . 55.6 t -64.24 -42.81 96.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.286 179.391 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 42.9 tp -59.63 -41.94 91.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.052 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -62.57 -38.9 91.89 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.295 179.325 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 310' ' ' ARG . . . . . 0.448 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.7 ttt85 -63.64 -44.05 95.0 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.291 179.482 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 89.6 mt -63.14 -42.03 99.39 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.415 179.482 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.4 ttmt -63.09 -33.09 74.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.262 179.323 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -90.02 -23.31 21.52 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.402 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 314' ' ' LEU . . . . . 0.481 HD22 ' CE2' ' A' ' 315' ' ' PHE . 6.8 tt -62.24 -43.17 99.45 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.013 0.435 . . . . 0.0 110.603 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 315' ' ' PHE . . . . . 0.481 ' CE2' HD22 ' A' ' 314' ' ' LEU . 91.0 m-85 . . . . . 0 C--O 1.22 -0.481 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.394 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -99.09 135.75 40.04 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.5 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.491 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -92.11 178.45 1.7 Allowed Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.571 -179.882 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.491 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.7 Cg_exo -61.78 147.38 95.39 Favored 'Trans proline' 0 C--N 1.301 -1.929 0 C-N-CA 122.847 2.365 . . . . 0.0 112.161 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.456 HH12 HG23 ' A' ' 159' ' ' ILE . 35.2 ptt180 -135.53 141.94 45.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.628 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -79.64 116.31 19.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.498 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.452 ' O ' HG23 ' A' ' 30' ' ' ILE . 9.4 tp -110.69 130.1 64.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.553 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 8.8 t -70.35 141.37 52.26 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.646 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.477 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.3 t0 -139.0 179.42 6.51 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.516 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.477 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 77.9 p -74.26 -36.87 63.87 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.582 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 61.0 ttt85 -46.18 -94.65 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.454 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -167.3 -26.4 0.02 OUTLIER Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.966 -0.854 . . . . 0.0 110.966 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 63.2 m -169.21 104.4 0.38 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.789 0.328 . . . . 0.0 110.639 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.681 ' CD2' HD13 ' A' ' 140' ' ' LEU . 74.5 t60 -128.38 148.85 50.72 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.012 0.434 . . . . 0.0 110.291 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.629 HG22 ' N ' ' A' ' 39' ' ' LEU . 98.1 m -131.1 166.25 21.49 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.474 -179.692 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.629 ' N ' HG22 ' A' ' 38' ' ' THR . 80.8 mt -121.06 127.45 51.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.53 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -64.94 -44.65 88.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.667 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 42.2 p -166.07 154.96 11.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.507 179.608 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.52 ' CD ' ' H ' ' A' ' 42' ' ' GLN . 15.2 mp0 -43.71 100.94 0.24 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.558 179.582 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.44 128.99 31.63 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 C-N-CA 122.546 2.164 . . . . 0.0 112.191 -179.695 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -83.73 -24.56 31.13 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.611 179.527 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.533 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.6 mtm-85 -122.2 134.43 54.71 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 121.15 0.5 . . . . 0.0 110.335 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.1 mt -130.9 134.08 62.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.639 -179.568 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 46.0 t -124.61 130.36 73.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.169 179.069 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.644 ' OG ' HD12 ' A' ' 117' ' ' LEU . 2.0 m -154.6 167.19 30.96 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.55 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 62.6 p -125.04 9.04 8.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.468 179.68 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.47 125.38 32.99 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.591 -179.445 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.443 HG11 ' H ' ' A' ' 299' ' ' LEU . 96.0 t -65.59 -44.6 93.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.548 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.1 m -62.45 -44.35 96.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.664 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 47.8 tp -62.4 -41.37 98.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.573 -179.402 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.435 ' O ' HD13 ' A' ' 58' ' ' LEU . 75.8 m -57.57 -44.74 85.54 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.329 -179.397 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -63.92 -63.03 4.7 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.5 t -47.24 -35.94 8.31 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.768 0.318 . . . . 0.0 110.411 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.5 mt -61.8 -44.63 96.49 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.041 179.647 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.435 HD13 ' O ' ' A' ' 54' ' ' THR . 8.7 mp -65.9 -41.08 91.94 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.042 178.365 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.55 -41.3 98.45 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.688 -179.268 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.427 ' O ' HG23 ' A' ' 60' ' ' ILE . 8.1 tp -88.43 17.09 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.801 -179.493 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 56.28 84.51 0.08 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.731 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.52 59.01 0.09 OUTLIER Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.333 -0.394 . . . . 0.0 109.974 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -52.22 152.75 14.32 Favored 'Trans proline' 0 C--N 1.298 -2.126 0 C-N-CA 122.99 2.46 . . . . 0.0 112.011 -177.639 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.433 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.2 OUTLIER -108.94 145.63 15.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.379 -179.628 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.57 -45.5 97.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.038 -179.565 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.5 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -129.77 134.11 47.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.5 -179.547 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.499 ' O ' ' N ' ' A' ' 98' ' ' LEU . 74.6 m -134.61 158.76 43.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.782 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.79 139.1 16.11 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.488 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.73 -162.79 0.08 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.826 0.346 . . . . 0.0 110.506 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.541 HG22 ' CD2' ' A' ' 297' ' ' PHE . 14.7 t -133.54 134.42 43.38 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.435 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.49 ' C ' ' O ' ' A' ' 70' ' ' THR . 0.6 OUTLIER 29.68 69.51 0.62 Allowed Pre-proline 0 N--CA 1.464 0.247 0 CA-C-O 120.94 0.4 . . . . 0.0 110.685 -179.711 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -61.99 146.08 96.45 Favored 'Trans proline' 0 C--N 1.301 -1.94 0 C-N-CA 122.767 2.311 . . . . 0.0 111.817 -178.206 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.534 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 45.0 p-10 -160.14 -31.67 0.06 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.658 179.674 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.538 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 99.2 m-20 -64.71 -39.27 93.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.392 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -60.25 -48.83 80.08 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.494 -179.349 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.423 ' O ' ' O ' ' A' ' 77' ' ' ALA . 94.6 t -59.55 -25.14 30.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.185 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.538 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -45.67 172.87 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.59 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.579 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.7 p30 -62.07 177.93 0.42 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.51 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.559 ' C ' ' H ' ' A' ' 81' ' ' GLY . 35.4 p30 -45.48 85.42 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.887 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.579 ' N ' ' O ' ' A' ' 78' ' ' ASP . 41.8 tp60 -67.32 13.26 0.07 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.351 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.559 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 118.61 -22.35 9.4 Favored Glycine 0 CA--C 1.52 0.389 0 N-CA-C 110.914 -0.875 . . . . 0.0 110.914 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -107.89 116.22 31.55 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.862 0.363 . . . . 0.0 110.487 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 73.5 mt -98.42 -0.15 44.15 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.577 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -92.31 7.44 42.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.441 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.797 ' O ' HG22 ' A' ' 89' ' ' VAL . 27.2 mt-30 -100.31 -28.44 12.97 Favored 'General case' 0 C--O 1.224 -0.266 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.613 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 68.8 t-105 -63.31 -40.2 96.67 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.736 -179.388 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.557 ' O ' ' N ' ' A' ' 91' ' ' LYS . 62.3 m -78.1 -54.01 6.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.791 -179.203 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -48.02 -50.76 26.66 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.861 -179.086 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.797 HG22 ' O ' ' A' ' 85' ' ' GLN . 16.0 m -69.15 -40.33 80.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.914 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.494 ' N ' HG23 ' A' ' 89' ' ' VAL . . . -72.86 -22.37 60.79 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.612 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.557 ' N ' ' O ' ' A' ' 87' ' ' SER . 65.9 tttm -62.28 -45.41 93.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.372 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.44 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.9 mm-40 -90.38 -94.78 0.12 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.265 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.632 ' O ' ' N ' ' A' ' 95' ' ' LEU . 96.0 mtt180 -143.04 58.6 1.41 Allowed 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.093 179.704 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.457 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.7 pttp 33.68 26.09 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 121.062 0.458 . . . . 0.0 110.487 -178.906 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.632 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.3 tt -47.95 123.04 5.62 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.834 -178.13 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.455 ' O ' HD23 ' A' ' 95' ' ' LEU . 99.0 mm-40 -83.2 -170.45 3.05 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.366 179.657 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.606 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 81.5 mtp180 -73.91 137.07 43.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.342 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.499 ' N ' ' O ' ' A' ' 67' ' ' SER . 90.6 mt -86.02 -165.63 1.3 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.784 -179.601 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.539 ' O ' ' CD2' ' A' ' 99' ' ' TYR . 48.6 p90 -169.02 119.81 0.73 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.27 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.515 ' C ' ' O ' ' A' ' 99' ' ' TYR . 42.5 mm -28.77 121.24 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.896 -179.62 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 114.2 27.24 3.48 Favored Glycine 0 CA--C 1.521 0.462 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 -179.601 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.579 ' CD ' ' H ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -144.39 46.39 0.62 Allowed Pre-proline 0 C--N 1.324 -0.508 0 CA-C-O 121.097 0.475 . . . . 0.0 110.482 179.966 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 28.8 Cg_endo -62.14 143.89 95.16 Favored 'Trans proline' 0 C--N 1.298 -2.096 0 C-N-CA 122.728 2.285 . . . . 0.0 111.894 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.455 ' O ' HG23 ' A' ' 108' ' ' VAL . 25.5 t -173.27 120.34 0.34 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.443 179.742 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -74.13 -40.16 62.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.903 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.42 -39.89 89.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.685 -179.343 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.22 -39.96 95.05 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.645 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 104' ' ' SER . 70.2 t -67.85 -43.57 86.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.674 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.99 -38.94 93.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.479 -179.332 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.44 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.46 -23.14 62.47 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.541 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.552 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.3 mm-40 -90.99 5.68 47.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.628 -179.487 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.552 ' C ' ' O ' ' A' ' 111' ' ' GLN . 10.0 tpt 22.77 65.1 0.35 Allowed Pre-proline 0 N--CA 1.465 0.296 0 CA-C-O 120.985 0.422 . . . . 0.0 110.978 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -79.33 167.69 21.04 Favored 'Trans proline' 0 C--N 1.307 -1.605 0 C-N-CA 123.008 2.472 . . . . 0.0 111.694 -178.119 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.525 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 99.0 m-20 -110.01 -41.89 4.35 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.286 179.414 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.0 tp -121.54 120.05 33.73 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.306 179.227 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 82.7 mt -112.66 128.81 69.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.829 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.644 HD12 ' OG ' ' A' ' 48' ' ' SER . 26.9 mt -108.42 132.41 53.8 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.442 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.491 HD12 HG23 ' A' ' 139' ' ' THR . 98.9 mt -120.1 138.52 50.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.587 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 85.6 p -72.42 154.14 41.04 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.608 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.2 -50.36 73.98 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.627 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.0 t -149.75 154.21 38.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.53 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 170.47 -170.71 43.24 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.91 -33.95 88.52 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.454 ' OD1' ' O ' ' A' ' 124' ' ' ASP . 44.6 p-10 -87.43 120.08 28.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.835 0.35 . . . . 0.0 110.655 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.44 ' O ' HD12 ' A' ' 129' ' ' LEU . 38.3 t -62.95 143.93 57.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.475 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.521 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.14 -43.27 8.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.785 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 56.4 tp -62.99 -42.21 99.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.681 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.81 -11.82 59.34 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.489 -179.408 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.44 HD12 ' O ' ' A' ' 125' ' ' SER . 83.6 mt -114.73 -24.61 8.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.528 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' TYR . . . . . 0.521 ' N ' ' O ' ' A' ' 126' ' ' ALA . 78.2 t80 -50.03 -50.17 48.49 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.613 -179.039 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 37.7 p-10 -66.07 -42.9 88.79 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.928 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.522 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 88.4 mt-30 -67.08 -37.49 84.08 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.733 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.44 HD12 HD11 ' A' ' 118' ' ' ILE . 95.9 mt -80.63 -41.42 23.89 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.768 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.4 t -56.35 -44.96 80.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.366 -179.377 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.7 m -61.87 -45.19 94.84 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.539 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 94.6 mt -61.92 -43.71 97.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.392 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.66 ' HB1' ' HD2' ' A' ' 138' ' ' PRO . . . -169.79 167.98 4.82 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.674 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.66 ' HD2' ' HB1' ' A' ' 137' ' ' ALA . 51.9 Cg_exo -49.14 112.68 0.7 Allowed 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.52 2.146 . . . . 0.0 112.349 179.244 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.491 HG23 HD12 ' A' ' 118' ' ' ILE . 24.1 m -83.7 127.29 33.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.612 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.681 HD13 ' CD2' ' A' ' 37' ' ' HIS . 34.2 tp -118.01 135.49 54.13 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.318 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.438 ' O ' ' OD2' ' A' ' 32' ' ' ASP . 82.5 mt -99.85 119.06 47.38 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 CA-C-O 121.016 0.436 . . . . 0.0 110.795 -178.865 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.433 HD12 HD22 ' A' ' 117' ' ' LEU . 97.8 mt -135.1 132.68 53.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.54 179.28 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.488 ' ND2' ' H ' ' A' ' 144' ' ' TYR . 2.1 t-20 -67.26 153.44 43.67 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.475 179.478 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.512 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 88.8 t80 -87.67 121.83 30.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.697 -179.46 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.512 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 99.1 m-20 55.27 69.55 0.72 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.588 179.545 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 34.5 p-10 -125.02 -0.06 7.88 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.595 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -151.08 115.72 5.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.623 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 83.2 p -62.91 167.99 4.29 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.574 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.416 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.4 p-90 -51.65 -15.93 0.55 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.406 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' GLN . . . . . 0.441 ' O ' HG23 ' A' ' 154' ' ' THR . 68.0 tp60 -70.47 -75.59 0.12 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.884 0.373 . . . . 0.0 110.615 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.441 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.1 t -62.87 -38.55 91.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.399 179.389 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 53.7 tp -59.73 -46.05 90.31 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.537 -178.707 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.416 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 47.9 tp -62.69 -41.47 99.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.656 179.017 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.441 HG23 ' O ' ' A' ' 150' ' ' GLN . 60.8 p -64.13 -35.18 79.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.328 -179.7 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' GLN . . . . . 0.442 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.7 mm-40 -63.98 -42.72 97.13 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.54 179.285 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 92.2 mt -65.66 -38.49 89.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.468 178.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.579 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.59 -31.99 79.76 Favored Glycine 0 CA--C 1.52 0.371 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 -179.369 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.442 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.1 mt-10 -35.14 -27.65 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.875 0.369 . . . . 0.0 110.806 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.579 ' N ' ' O ' ' A' ' 157' ' ' GLY . 93.9 mt -55.28 150.43 2.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.46 179.13 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 70.5 p -70.39 137.15 50.23 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.781 -179.409 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 72.01 19.33 78.31 Favored Glycine 0 CA--C 1.519 0.337 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 179.314 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 57.3 m80 -120.56 -15.0 8.57 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.71 0.29 . . . . 0.0 110.494 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -65.24 -60.58 2.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.572 -179.695 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -51.15 -50.28 59.24 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.259 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -60.11 -41.36 92.43 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.54 179.543 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.29 -47.59 85.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.485 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.41 -40.41 74.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.401 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -61.68 -50.39 72.67 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.605 179.565 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -65.17 -43.72 90.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.577 179.487 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 94.6 mt -64.89 -43.18 96.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.497 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.14 -51.63 68.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.367 -179.295 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.08 -43.84 97.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.644 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 173' ' ' PHE . . . . . 0.652 ' CE2' HD11 ' A' ' 177' ' ' LEU . 56.2 t80 -63.27 -43.87 96.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.452 179.492 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -63.67 -39.88 95.44 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.501 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -63.25 -42.77 99.23 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.545 179.385 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -60.32 -44.77 95.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.422 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.652 HD11 ' CE2' ' A' ' 173' ' ' PHE . 83.5 mt -64.93 -40.78 95.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.711 178.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -51.86 -62.67 1.49 Allowed 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.391 -179.47 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.37 -47.35 84.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.461 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -52.65 -41.98 64.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.474 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -63.91 -33.48 75.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.352 179.319 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 182' ' ' GLU . . . . . 0.42 ' O ' ' HG2' ' A' ' 182' ' ' GLU . 69.2 tt0 -90.7 8.92 32.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.319 0.581 . . . . 0.0 110.393 -178.926 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -105.29 -31.92 8.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.85 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.5 pt -128.16 147.47 32.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.649 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -139.91 131.15 26.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.489 179.232 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 186' ' ' LEU . . . . . 0.593 HD22 ' N ' ' A' ' 186' ' ' LEU . 3.6 mm? -85.68 132.67 43.68 Favored Pre-proline 0 N--CA 1.453 -0.325 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.922 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -43.6 157.57 0.12 Allowed 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.729 2.286 . . . . 0.0 112.389 179.145 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 188' ' ' PRO . . . . . 0.52 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.9 Cg_endo -62.9 114.99 2.66 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 C-N-CA 122.83 2.353 . . . . 0.0 111.908 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 189' ' ' GLN . . . . . 0.52 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.7 mt-30 156.0 147.28 0.0 OUTLIER Pre-proline 0 C--O 1.231 0.099 0 O-C-N 123.794 0.684 . . . . 0.0 110.692 -179.81 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.37 143.37 34.87 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.657 2.238 . . . . 0.0 112.272 177.659 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.498 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.1 p -124.52 159.34 30.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.164 0.507 . . . . 0.0 110.372 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 192' ' ' THR . . . . . 0.498 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 36.2 p -143.65 165.16 28.41 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.85 -179.35 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 193' ' ' ALA . . . . . 0.441 ' HA ' ' H ' ' A' ' 260' ' ' PHE . . . -135.28 128.72 32.36 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 121.167 0.508 . . . . 0.0 110.407 179.205 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.509 HD11 HD23 ' A' ' 259' ' ' LEU . 47.7 pt -146.45 148.43 17.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.961 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 195' ' ' VAL . . . . . 0.751 HG13 ' CD1' ' A' ' 262' ' ' PHE . 71.7 t -117.19 122.84 70.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.082 0.468 . . . . 0.0 110.218 178.621 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -134.08 107.31 7.67 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.377 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 95.1 m -131.01 130.44 43.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.742 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -82.78 -36.91 25.23 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.399 179.638 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.07 -67.36 0.24 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.433 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.25 -9.91 59.08 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.47 179.518 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 60.0 t-80 60.95 58.53 2.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.681 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 37.1 p -167.29 153.5 7.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.609 179.441 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.47 144.43 24.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.942 0.401 . . . . 0.0 110.47 179.236 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -135.33 138.08 43.05 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.608 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 19.0 mt -105.85 125.3 50.83 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.933 0.397 . . . . 0.0 110.194 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 206' ' ' TRP . . . . . 0.558 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 75.9 m95 -82.3 167.3 18.72 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.515 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 207' ' ' THR . . . . . 0.466 HG22 ' C ' ' A' ' 206' ' ' TRP . 0.1 OUTLIER -156.94 170.94 8.11 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.588 -179.024 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -53.23 -36.92 79.64 Favored 'Trans proline' 0 C--N 1.302 -1.892 0 C-N-CA 122.77 2.313 . . . . 0.0 112.378 178.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -71.13 -34.51 71.1 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.56 -179.51 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 22.3 m -61.64 150.61 35.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.624 -179.439 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.39 -36.94 81.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.456 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 212' ' ' GLN . . . . . 0.558 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 54.5 tt0 -64.74 -40.05 94.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.567 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.94 -43.37 91.51 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.734 -0.947 . . . . 0.0 110.734 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -63.04 -43.93 97.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.839 0.352 . . . . 0.0 110.385 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 215' ' ' MET . . . . . 0.529 ' SD ' ' HB2' ' A' ' 304' ' ' ALA . 65.1 ttp -59.02 -48.63 80.91 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.297 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 89.9 mt -59.65 -41.32 90.27 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 121.01 0.434 . . . . 0.0 110.01 179.33 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 217' ' ' GLU . . . . . 0.456 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 40.3 tp10 -57.37 -38.14 73.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.317 179.527 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -65.52 -37.78 87.75 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.605 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 95.5 mt -64.31 -42.76 96.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.725 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.58 44.53 0.08 OUTLIER Glycine 0 CA--C 1.521 0.466 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 221' ' ' PHE . . . . . 0.456 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 25.8 m-85 -127.49 155.33 43.92 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.944 0.402 . . . . 0.0 110.524 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.487 ' O ' HG13 ' A' ' 191' ' ' VAL . 6.3 p -106.97 121.98 45.54 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.152 0.501 . . . . 0.0 110.242 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.468 HD22 ' C ' ' A' ' 222' ' ' THR . 4.3 mm? -100.9 133.32 45.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.989 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.98 158.92 15.19 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.506 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.05 115.29 30.03 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.516 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.492 HD12 ' N ' ' A' ' 226' ' ' LEU . 9.0 mp -53.56 156.29 4.63 Favored Pre-proline 0 N--CA 1.452 -0.35 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.71 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -59.69 145.31 98.49 Favored 'Trans proline' 0 C--N 1.302 -1.871 0 C-N-CA 122.795 2.33 . . . . 0.0 112.295 179.043 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.42 -2.91 58.95 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.556 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.31 -40.93 5.63 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 230' ' ' LEU . . . . . 0.537 ' O ' ' N ' ' A' ' 233' ' ' SER . 84.3 mt -79.2 -16.88 55.87 Favored 'General case' 0 C--O 1.224 -0.267 0 CA-C-O 120.983 0.421 . . . . 0.0 110.449 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 231' ' ' ASN . . . . . 0.404 ' C ' ' O ' ' A' ' 230' ' ' LEU . 55.1 t-20 -39.5 -49.63 2.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.679 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -88.58 15.58 7.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.009 -179.592 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 233' ' ' SER . . . . . 0.537 ' N ' ' O ' ' A' ' 230' ' ' LEU . 77.8 p -60.46 -35.47 75.95 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.653 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 234' ' ' GLN . . . . . 0.526 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.6 tt0 -118.46 -69.49 0.85 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.706 179.714 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.2 m -69.91 103.71 2.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.592 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -94.73 57.41 2.17 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.439 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -144.85 -122.57 1.57 Allowed Glycine 0 CA--C 1.521 0.441 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -134.46 111.89 10.49 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.002 0.43 . . . . 0.0 110.384 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 239' ' ' ARG . . . . . 0.515 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.4 mtt180 -148.33 57.75 1.07 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.678 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -69.97 -31.69 69.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.494 179.578 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 241' ' ' ASP . . . . . 0.472 ' OD2' ' ND2' ' A' ' 143' ' ' ASN . 65.6 t0 -56.54 -47.13 80.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.365 -179.205 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 242' ' ' ILE . . . . . 0.437 ' O ' ' O ' ' A' ' 239' ' ' ARG . 17.3 tt -140.49 157.49 24.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.493 179.73 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.441 HG22 HD13 ' A' ' 245' ' ' LEU . 96.0 mt -105.92 105.88 19.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.575 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 244' ' ' GLN . . . . . 0.602 ' O ' HD12 ' A' ' 245' ' ' LEU . 88.0 mt-30 -110.06 109.98 20.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.416 179.715 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.602 HD12 ' O ' ' A' ' 244' ' ' GLN . 9.4 mp -121.95 -168.13 1.66 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.66 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 246' ' ' GLY . . . . . 0.526 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.27 -16.79 0.05 OUTLIER Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 247' ' ' GLY . . . . . 0.67 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -60.43 157.01 29.67 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -63.79 21.51 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.86 0.362 . . . . 0.0 110.553 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 249' ' ' ASN . . . . . 0.67 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.7 m-20 -97.29 -6.1 35.18 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.497 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 92.6 mt -79.81 -21.52 44.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.784 179.349 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.61 -51.53 69.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.563 -179.426 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.31 -5.34 58.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.532 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.22 -74.34 1.15 Allowed Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.934 -0.866 . . . . 0.0 110.934 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 80.1 mt -69.95 125.75 27.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.809 0.338 . . . . 0.0 110.445 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -59.09 -39.52 82.44 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.281 -179.626 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 82.52 51.97 4.13 Favored Glycine 0 CA--C 1.521 0.442 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -96.21 -14.81 22.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.717 0.294 . . . . 0.0 110.665 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 258' ' ' SER . . . . . 0.494 ' OG ' HG23 ' A' ' 191' ' ' VAL . 3.5 t 174.71 88.27 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.047 0.451 . . . . 0.0 110.321 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.86 HD12 ' N ' ' A' ' 259' ' ' LEU . 1.0 OUTLIER -93.97 123.7 37.51 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.014 0.435 . . . . 0.0 110.992 -178.819 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 260' ' ' PHE . . . . . 0.441 ' H ' ' HA ' ' A' ' 193' ' ' ALA . 15.8 m-30 -92.74 146.35 23.72 Favored 'General case' 0 CA--C 1.508 -0.672 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.532 179.051 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 86.0 mt -122.36 149.56 43.61 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.6 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.751 ' CD1' HG13 ' A' ' 195' ' ' VAL . 2.7 p90 -77.23 -138.34 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.632 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 263' ' ' ALA . . . . . 0.661 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -52.27 77.29 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.003 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 264' ' ' GLY . . . . . 0.625 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -178.93 104.54 0.19 Allowed Glycine 0 CA--C 1.527 0.829 0 N-CA-C 110.644 -0.982 . . . . 0.0 110.644 179.72 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 265' ' ' ASP . . . . . 0.6 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.9 m-20 -79.98 -178.04 6.29 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.648 0.261 . . . . 0.0 110.781 -179.407 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -40.48 -17.52 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.521 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 267' ' ' LYS . . . . . 0.6 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.47 -51.66 41.01 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.682 179.284 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -63.64 -46.81 83.99 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.198 179.272 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 269' ' ' ALA . . . . . 0.562 ' HB1' ' OH ' ' A' ' 273' ' ' TYR . . . -61.57 -34.87 76.34 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.291 0.567 . . . . 0.0 110.058 179.611 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -63.17 -34.11 76.92 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.273 179.548 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.69 -43.68 13.2 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.793 -179.385 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 272' ' ' ILE . . . . . 0.589 ' C ' ' H ' ' A' ' 274' ' ' ALA . 4.9 tt -51.37 -33.44 14.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.579 -178.441 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 273' ' ' TYR . . . . . 0.562 ' OH ' ' HB1' ' A' ' 269' ' ' ALA . 17.5 m-85 -54.76 -1.41 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.567 -179.547 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 274' ' ' ALA . . . . . 0.589 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.71 -39.74 69.95 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.755 179.448 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 275' ' ' ASN . . . . . 0.582 ' O ' ' N ' ' A' ' 279' ' ' ALA . 2.9 p30 -39.35 98.42 0.17 Allowed Pre-proline 0 C--N 1.335 -0.055 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.458 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -54.56 -43.01 62.94 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 C-N-CA 122.621 2.214 . . . . 0.0 112.344 -178.64 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 88.5 mt -64.48 -42.98 95.55 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.871 -179.39 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 91.0 mt -95.67 -1.68 49.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.839 -179.296 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 279' ' ' ALA . . . . . 0.582 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.36 -34.65 77.09 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.626 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.8 m80 -74.78 20.41 0.13 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.785 -178.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 281' ' ' LEU . . . . . 0.483 HD23 ' HA ' ' A' ' 281' ' ' LEU . 14.0 mt -75.25 119.45 77.02 Favored Pre-proline 0 N--CA 1.449 -0.492 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.783 179.715 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -49.47 -40.18 45.04 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.681 2.254 . . . . 0.0 112.33 178.636 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -51.97 -51.06 59.75 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.283 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 78.1 t -61.2 -43.87 97.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.248 179.497 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -57.99 -41.43 82.99 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.268 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -90.59 0.05 57.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.322 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt 59.52 42.87 16.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.742 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -94.38 41.58 1.09 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.463 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 53.8 t -118.97 135.84 58.1 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-O 120.974 0.416 . . . . 0.0 110.205 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -132.99 162.65 31.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.564 -179.621 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.64 155.31 32.56 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.613 -179.713 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 79.6 mt -93.95 -1.71 54.26 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.373 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.33 165.81 12.75 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 -179.62 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 7.1 m -87.51 -62.61 1.46 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.841 0.353 . . . . 0.0 110.75 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 295' ' ' GLU . . . . . 0.432 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.6 mm-40 -69.46 -3.89 16.37 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.597 -179.627 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 27.6 p -77.06 33.4 0.15 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.664 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 297' ' ' PHE . . . . . 0.541 ' CD2' HG22 ' A' ' 70' ' ' THR . 84.8 t80 -60.33 -46.03 91.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.522 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 298' ' ' ARG . . . . . 0.606 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.3 mtt85 -81.48 133.85 35.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.552 -179.712 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.443 ' H ' HG11 ' A' ' 51' ' ' VAL . 15.8 tp -114.13 119.38 36.91 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.392 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 300' ' ' ASP . . . . . 0.621 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.0 p-10 -167.48 -174.19 2.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.629 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 85.1 t80 -47.62 -46.04 28.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.357 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -64.92 -41.58 95.42 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 120.959 0.409 . . . . 0.0 110.6 179.191 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 303' ' ' SER . . . . . 0.621 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 52.3 p -55.11 -36.47 65.75 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.206 -179.342 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 304' ' ' ALA . . . . . 0.529 ' HB2' ' SD ' ' A' ' 215' ' ' MET . . . -56.43 -52.4 64.8 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.079 179.364 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 93.2 mtp -54.64 -44.81 73.54 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -65.93 -42.88 89.52 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.082 0.468 . . . . 0.0 110.39 178.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 307' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 303' ' ' SER . 55.4 t -64.2 -42.61 96.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.378 179.359 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 43.1 tp -59.49 -41.96 91.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.186 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -62.97 -38.7 92.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.188 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 310' ' ' ARG . . . . . 0.44 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.6 ttt85 -63.38 -44.15 95.57 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.306 179.517 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 88.8 mt -63.07 -42.0 99.55 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.498 179.384 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.3 ttmt -63.0 -32.63 74.03 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.374 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -90.42 -23.25 21.09 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.442 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 314' ' ' LEU . . . . . 0.483 HD22 ' CE2' ' A' ' 315' ' ' PHE . 6.8 tt -62.25 -43.16 99.45 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.528 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 315' ' ' PHE . . . . . 0.483 ' CE2' HD22 ' A' ' 314' ' ' LEU . 90.9 m-85 . . . . . 0 C--O 1.22 -0.48 0 CA-C-O 118.005 -0.998 . . . . 0.0 110.426 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -99.54 137.11 38.49 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.009 0.433 . . . . 0.0 110.502 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.496 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -92.01 178.5 1.69 Allowed Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.578 -179.881 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.496 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.3 Cg_exo -61.73 147.54 95.08 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 C-N-CA 122.827 2.351 . . . . 0.0 112.201 179.648 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.507 ' HE ' HD12 ' A' ' 39' ' ' LEU . 35.0 ptt180 -134.35 141.76 47.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.696 179.741 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -79.2 116.58 19.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.504 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.433 ' O ' HG23 ' A' ' 30' ' ' ILE . 9.5 tp -110.57 130.79 63.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.444 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 13.0 t -71.08 142.14 50.84 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.02 0.438 . . . . 0.0 110.582 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 141' ' ' ILE . 25.3 t70 -139.57 177.73 7.72 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.535 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.0 p -73.93 -36.23 64.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.717 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -48.1 -95.25 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.275 -179.379 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.414 ' O ' ' OG1' ' A' ' 36' ' ' THR . . . -164.6 -26.26 0.02 OUTLIER Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.414 ' OG1' ' O ' ' A' ' 35' ' ' GLY . 64.6 m -168.76 106.93 0.45 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.878 0.37 . . . . 0.0 110.699 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 52.0 t-80 -129.54 144.98 51.5 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.113 0.482 . . . . 0.0 110.185 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.628 HG22 ' N ' ' A' ' 39' ' ' LEU . 98.9 m -129.31 166.27 19.81 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.519 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.628 ' N ' HG22 ' A' ' 38' ' ' THR . 80.8 mt -120.72 127.93 52.46 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.503 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -64.62 -44.56 90.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.719 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 39.1 p -165.33 154.47 12.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.398 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.526 ' CD ' ' H ' ' A' ' 42' ' ' GLN . 13.8 mp0 -42.55 100.18 0.22 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.602 179.357 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -56.73 129.23 33.5 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 122.382 2.054 . . . . 0.0 112.224 -179.545 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -84.25 -23.72 30.28 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.486 179.588 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.541 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.4 mtm-85 -121.18 134.24 55.21 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 121.138 0.494 . . . . 0.0 110.251 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.0 mt -130.5 133.2 64.03 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.254 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.857 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 48.5 t -124.8 130.83 73.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 179.363 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.632 ' OG ' HD12 ' A' ' 117' ' ' LEU . 4.9 m -154.7 166.28 33.92 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.54 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 71.9 p -124.53 8.47 8.34 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.455 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.38 126.07 33.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.611 -179.474 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.403 HG11 ' H ' ' A' ' 299' ' ' LEU . 92.2 t -66.06 -44.58 91.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.6 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.1 m -62.65 -44.19 96.9 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.699 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 52.6 tp -62.39 -41.66 98.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.58 -179.392 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.46 ' O ' HD13 ' A' ' 58' ' ' LEU . 77.4 m -57.34 -44.39 84.24 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.399 -179.377 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.79 -61.73 5.62 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 179.609 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.6 t -48.62 -35.53 13.86 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.8 mt -61.82 -44.41 96.91 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.18 179.385 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.46 HD13 ' O ' ' A' ' 54' ' ' THR . 9.3 mp -65.22 -41.36 94.53 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.247 177.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.405 ' HB1' ' NE ' ' A' ' 169' ' ' ARG . . . -63.79 -40.98 97.97 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.954 -179.243 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.422 ' O ' HG23 ' A' ' 60' ' ' ILE . 8.2 tp -88.54 16.93 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.816 -179.616 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 56.36 84.3 0.09 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.763 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.25 57.63 0.07 OUTLIER Pre-proline 0 C--N 1.328 -0.368 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -50.58 153.35 7.89 Favored 'Trans proline' 0 C--N 1.295 -2.272 0 C-N-CA 122.866 2.377 . . . . 0.0 112.314 -178.326 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.435 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -109.17 145.8 15.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.329 -179.661 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 97.1 mt -63.7 -45.34 97.64 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.409 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.506 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -129.5 134.58 47.86 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.857 0.361 . . . . 0.0 110.564 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.476 ' O ' ' N ' ' A' ' 98' ' ' LEU . 73.1 m -134.93 159.2 42.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.829 -179.674 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -87.67 139.36 15.84 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.469 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -175.65 -163.66 0.12 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.957 0.408 . . . . 0.0 110.504 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.514 HG22 ' CD2' ' A' ' 297' ' ' PHE . 15.3 t -133.02 131.82 41.12 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.415 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.424 ' C ' ' O ' ' A' ' 70' ' ' THR . 11.9 p 36.88 71.53 0.94 Allowed Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.523 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_exo -60.92 144.17 99.51 Favored 'Trans proline' 0 C--N 1.302 -1.918 0 C-N-CA 122.491 2.127 . . . . 0.0 112.116 -178.66 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.533 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 44.6 p-10 -165.0 -34.67 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.678 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.533 ' N ' ' OD1' ' A' ' 73' ' ' ASN . 99.1 m-20 -63.94 -39.39 94.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.452 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -60.86 -47.73 85.02 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.655 -179.281 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.432 ' O ' ' O ' ' A' ' 77' ' ' ALA . 94.9 t -59.95 -24.48 29.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.509 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -44.77 171.64 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.63 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.575 ' O ' ' N ' ' A' ' 80' ' ' GLN . 54.0 p30 -62.19 178.41 0.39 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.638 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.559 ' C ' ' H ' ' A' ' 81' ' ' GLY . 36.2 p30 -46.96 85.4 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.952 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.575 ' N ' ' O ' ' A' ' 78' ' ' ASP . 43.2 tp60 -67.57 14.1 0.06 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.159 0.504 . . . . 0.0 110.187 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.559 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 117.87 -21.62 10.28 Favored Glycine 0 C--N 1.332 0.313 0 N-CA-C 110.841 -0.903 . . . . 0.0 110.841 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -107.91 116.63 32.31 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.971 0.415 . . . . 0.0 110.487 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 74.1 mt -98.98 0.72 44.52 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.447 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -92.03 6.46 46.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.962 0.411 . . . . 0.0 110.396 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.786 ' O ' HG22 ' A' ' 89' ' ' VAL . 27.2 mt-30 -99.9 -27.46 13.59 Favored 'General case' 0 C--O 1.223 -0.341 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.811 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.0 t-105 -64.1 -40.51 96.38 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.052 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.554 ' O ' ' N ' ' A' ' 91' ' ' LYS . 70.7 m -77.86 -53.71 7.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.163 -179.495 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -48.51 -50.68 30.84 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.016 -179.219 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.786 HG22 ' O ' ' A' ' 85' ' ' GLN . 14.8 m -68.88 -40.75 81.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 120.937 0.399 . . . . 0.0 111.081 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.5 ' N ' HG23 ' A' ' 89' ' ' VAL . . . -72.29 -22.43 61.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.649 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.554 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.0 tttm -61.6 -45.85 92.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.516 -179.61 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.437 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.6 mm-40 -90.7 -94.23 0.12 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.198 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.625 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.9 mtt180 -143.77 60.11 1.38 Allowed 'General case' 0 C--O 1.235 0.308 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.457 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.6 pttp 33.6 26.44 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 120.933 0.396 . . . . 0.0 110.25 -179.287 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.625 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.4 tt -47.97 123.28 5.97 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.958 -178.094 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.441 ' O ' HD23 ' A' ' 95' ' ' LEU . 98.7 mm-40 -83.64 -170.6 3.14 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.084 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.628 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 82.0 mtp180 -73.34 137.6 44.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.213 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.476 ' N ' ' O ' ' A' ' 67' ' ' SER . 89.7 mt -86.99 -165.38 1.27 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.727 -179.586 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.532 ' O ' ' CD2' ' A' ' 99' ' ' TYR . 48.5 p90 -168.82 120.22 0.76 Allowed 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.189 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.504 ' C ' ' O ' ' A' ' 99' ' ' TYR . 43.3 mm -29.42 121.6 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.029 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 114.07 27.87 3.3 Favored Glycine 0 CA--C 1.518 0.253 0 N-CA-C 111.224 -0.751 . . . . 0.0 111.224 -179.416 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.584 ' CD ' ' H ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -144.14 46.08 0.61 Allowed Pre-proline 0 C--N 1.323 -0.55 0 O-C-N 122.502 -0.411 . . . . 0.0 110.464 179.84 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 30.1 Cg_endo -62.14 143.83 95.08 Favored 'Trans proline' 0 C--N 1.296 -2.226 0 C-N-CA 122.686 2.257 . . . . 0.0 111.908 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.46 ' O ' HG23 ' A' ' 108' ' ' VAL . 26.5 t -173.42 120.82 0.34 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.398 179.632 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.37 -41.03 63.9 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.1 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -65.84 -39.83 91.18 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.846 -179.451 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.84 -39.76 94.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.713 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 104' ' ' SER . 69.4 t -67.55 -43.84 86.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.705 179.668 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.42 -39.29 92.81 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.524 -179.174 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.437 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.61 -23.87 63.34 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.495 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.555 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.2 mm-40 -91.38 5.15 50.45 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.674 -179.553 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.555 ' C ' ' O ' ' A' ' 111' ' ' GLN . 10.4 tpt 21.65 64.85 0.31 Allowed Pre-proline 0 N--CA 1.466 0.349 0 CA-C-O 120.882 0.372 . . . . 0.0 111.137 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.449 ' HG2' HD11 ' A' ' 116' ' ' ILE . 66.1 Cg_endo -79.12 169.69 18.79 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 122.993 2.462 . . . . 0.0 111.902 -178.137 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.525 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 99.0 m-20 -112.84 -43.52 3.42 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.102 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 39.7 tp -120.83 119.9 34.03 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.566 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.458 HD13 HD22 ' A' ' 133' ' ' LEU . 95.7 mt -117.16 130.85 71.39 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 CA-C-O 120.944 0.402 . . . . 0.0 110.892 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.632 HD12 ' OG ' ' A' ' 48' ' ' SER . 33.1 mt -105.67 132.73 51.45 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.263 -179.449 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.438 HD12 HG23 ' A' ' 139' ' ' THR . 98.1 mt -118.15 135.73 57.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.733 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 87.0 p -71.65 153.27 42.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.567 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.31 -50.03 75.24 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.679 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.0 t -149.55 154.01 38.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.505 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 169.36 -170.11 42.39 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -63.02 -35.13 91.67 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.443 ' OD1' ' O ' ' A' ' 124' ' ' ASP . 43.9 p-10 -88.3 119.42 28.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.783 0.325 . . . . 0.0 110.65 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.448 ' O ' HD12 ' A' ' 129' ' ' LEU . 41.2 t -63.3 144.53 56.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.987 0.422 . . . . 0.0 110.507 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.521 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.65 -42.66 9.06 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.857 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.7 tp -62.79 -42.34 99.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.697 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.01 -10.99 57.99 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.499 -179.449 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.448 HD12 ' O ' ' A' ' 125' ' ' SER . 84.4 mt -115.44 -24.18 8.49 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.683 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' TYR . . . . . 0.521 ' N ' ' O ' ' A' ' 126' ' ' ALA . 77.1 t80 -51.54 -49.54 61.78 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.566 -178.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.6 p-10 -65.89 -41.81 91.05 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.255 179.451 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.524 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 88.0 mt-30 -67.84 -37.07 81.41 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.87 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.458 HD22 HD13 ' A' ' 116' ' ' ILE . 94.5 mt -79.95 -42.35 24.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.944 -179.634 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.2 t -57.1 -44.91 83.66 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.294 -179.202 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.4 m -62.18 -45.74 92.05 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.631 179.364 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 92.7 mt -62.61 -43.98 98.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.377 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.612 ' HB1' ' HD2' ' A' ' 138' ' ' PRO . . . -169.67 164.26 6.58 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.524 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.612 ' HD2' ' HB1' ' A' ' 137' ' ' ALA . 77.3 Cg_exo -43.48 111.88 0.27 Allowed 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.49 2.127 . . . . 0.0 112.195 179.359 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.506 HG21 ' CD1' ' A' ' 130' ' ' TYR . 16.8 m -86.16 127.7 34.76 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.633 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.453 HD12 ' HA ' ' A' ' 140' ' ' LEU . 35.3 tp -120.32 137.69 54.12 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.089 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.425 ' O ' ' OD1' ' A' ' 32' ' ' ASP . 80.5 mt -105.32 121.17 57.1 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.336 0 CA-C-O 121.204 0.526 . . . . 0.0 111.196 -179.489 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.498 HD12 HD22 ' A' ' 117' ' ' LEU . 97.9 mt -136.02 132.61 50.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.593 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.544 ' OD1' ' N ' ' A' ' 144' ' ' TYR . 60.7 t-20 -64.52 147.36 52.96 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.893 0.378 . . . . 0.0 110.307 179.425 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.544 ' N ' ' OD1' ' A' ' 143' ' ' ASN . 87.1 t80 -82.35 122.1 27.55 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.996 -179.615 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.515 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 98.9 m-20 55.27 69.21 0.76 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.847 179.618 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 33.7 p-10 -125.15 0.57 7.84 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.891 0.377 . . . . 0.0 110.667 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -151.29 117.48 5.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.773 -179.463 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 87.4 p -64.6 168.89 5.44 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.489 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.412 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.4 p-90 -51.2 -15.37 0.35 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.498 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' GLN . . . . . 0.447 ' O ' HG23 ' A' ' 154' ' ' THR . 67.8 tp60 -71.71 -75.15 0.14 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.398 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.438 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.0 t -62.72 -38.85 92.09 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.244 179.461 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 52.9 tp -60.12 -45.59 92.49 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.307 -178.514 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.412 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 46.2 tp -62.64 -41.78 99.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.914 0.388 . . . . 0.0 110.508 178.902 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.447 HG23 ' O ' ' A' ' 150' ' ' GLN . 57.4 p -64.04 -34.65 78.49 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.201 -179.443 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' GLN . . . . . 0.468 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.5 mm-40 -63.87 -42.39 97.54 Favored 'General case' 0 C--O 1.227 -0.131 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.22 179.345 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 91.7 mt -65.43 -38.76 90.85 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.066 0.46 . . . . 0.0 110.151 179.086 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.572 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.47 -31.49 77.69 Favored Glycine 0 CA--C 1.52 0.388 0 N-CA-C 110.771 -0.931 . . . . 0.0 110.771 -179.297 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.468 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.4 mt-10 -37.32 -24.57 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.894 0.378 . . . . 0.0 110.837 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.572 ' N ' ' O ' ' A' ' 157' ' ' GLY . 96.0 mt -59.82 148.53 7.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.312 179.321 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 74.8 p -69.05 137.28 53.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.951 -179.548 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 71.73 20.93 78.92 Favored Glycine 0 CA--C 1.517 0.159 0 N-CA-C 111.206 -0.757 . . . . 0.0 111.206 179.539 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 58.9 m80 -123.59 -14.33 7.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.717 0.294 . . . . 0.0 110.581 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -65.29 -60.2 3.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.71 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -52.21 -49.14 64.51 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.145 -179.594 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -59.88 -41.21 91.06 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.739 0.304 . . . . 0.0 110.28 179.564 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.55 -46.7 88.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.561 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -57.62 -39.75 77.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.178 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -61.79 -50.11 73.67 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.609 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.405 ' NE ' ' HB1' ' A' ' 59' ' ' ALA . 59.9 ttt85 -65.38 -43.81 89.53 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.531 179.52 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 94.3 mt -64.55 -43.38 96.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.369 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.56 -51.21 70.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.461 -179.201 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.43 -43.96 95.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.485 179.614 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 173' ' ' PHE . . . . . 0.67 ' CE2' HD11 ' A' ' 177' ' ' LEU . 56.3 t80 -62.69 -44.33 96.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.062 0.458 . . . . 0.0 110.37 179.375 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -63.26 -39.6 95.05 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.528 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -63.17 -43.02 99.44 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.615 179.175 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -60.64 -44.79 95.96 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.195 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.67 HD11 ' CE2' ' A' ' 173' ' ' PHE . 84.3 mt -64.56 -40.96 96.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.995 0.426 . . . . 0.0 110.691 178.805 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -51.56 -62.9 1.33 Allowed 'General case' 0 C--O 1.238 0.458 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.37 -179.276 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.34 -47.0 85.17 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.59 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.0 -41.68 64.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.233 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -64.04 -33.31 75.46 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.05 0.452 . . . . 0.0 110.347 179.308 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 182' ' ' GLU . . . . . 0.421 ' O ' ' HG2' ' A' ' 182' ' ' GLU . 70.1 tt0 -91.21 8.4 35.97 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.436 0.636 . . . . 0.0 110.426 -178.834 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -103.99 -32.33 9.28 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.205 179.556 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.6 pt -128.04 147.65 32.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.814 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -140.1 131.36 26.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.442 179.241 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 186' ' ' LEU . . . . . 0.595 HD22 ' N ' ' A' ' 186' ' ' LEU . 3.6 mm? -85.4 132.64 44.32 Favored Pre-proline 0 N--CA 1.453 -0.321 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.904 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -43.87 157.87 0.13 Allowed 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.686 2.257 . . . . 0.0 112.27 179.327 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 188' ' ' PRO . . . . . 0.52 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 26.6 Cg_endo -62.42 115.3 2.8 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 C-N-CA 122.818 2.345 . . . . 0.0 111.759 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 189' ' ' GLN . . . . . 0.52 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 0.4 OUTLIER 155.4 147.57 0.0 OUTLIER Pre-proline 0 N--CA 1.456 -0.156 0 O-C-N 123.777 0.673 . . . . 0.0 110.758 -179.88 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -73.78 143.59 33.72 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.653 2.235 . . . . 0.0 112.017 177.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.504 HG23 ' OG ' ' A' ' 258' ' ' SER . 2.1 p -124.91 158.7 32.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.347 0.594 . . . . 0.0 110.137 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 192' ' ' THR . . . . . 0.489 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 40.1 p -143.1 164.87 28.97 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.07 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 193' ' ' ALA . . . . . 0.455 ' HA ' ' H ' ' A' ' 260' ' ' PHE . . . -135.29 128.52 31.96 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.227 0.537 . . . . 0.0 110.223 179.567 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.528 HD11 HD23 ' A' ' 259' ' ' LEU . 47.9 pt -147.44 150.3 14.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.04 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 195' ' ' VAL . . . . . 0.729 HG13 ' CD1' ' A' ' 262' ' ' PHE . 74.6 t -118.31 123.43 71.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-O 121.298 0.57 . . . . 0.0 109.793 179.128 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -134.68 106.91 7.18 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.254 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 95.9 m -131.32 131.35 43.7 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.838 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.401 ' O ' ' N ' ' A' ' 201' ' ' HIS . . . -83.03 -37.14 24.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.308 179.727 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.39 -66.92 0.27 Allowed 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.402 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.25 -10.22 59.5 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.379 179.55 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 201' ' ' HIS . . . . . 0.401 ' N ' ' O ' ' A' ' 198' ' ' ALA . 59.6 t-80 60.89 57.69 2.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.673 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 36.2 p -166.64 152.84 8.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.623 179.489 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -150.47 143.37 24.7 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.003 0.43 . . . . 0.0 110.452 179.394 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -134.87 137.68 43.45 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.598 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 16.6 mt -106.42 125.7 51.33 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.122 0.487 . . . . 0.0 109.841 -179.683 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 206' ' ' TRP . . . . . 0.556 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 74.1 m95 -82.08 167.35 18.89 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.58 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 207' ' ' THR . . . . . 0.473 HG22 ' C ' ' A' ' 206' ' ' TRP . 0.1 OUTLIER -157.26 171.06 7.94 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.64 -179.181 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -53.08 -37.19 79.0 Favored 'Trans proline' 0 C--N 1.302 -1.873 0 C-N-CA 122.649 2.233 . . . . 0.0 112.163 179.169 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -70.89 -35.41 72.31 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.774 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 210' ' ' SER . . . . . 0.4 ' HB2' ' H ' ' A' ' 207' ' ' THR . 20.0 m -60.49 150.97 29.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.603 -179.423 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.65 -37.28 83.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.535 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 212' ' ' GLN . . . . . 0.556 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 55.0 tt0 -64.68 -40.28 95.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.52 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.66 -43.44 91.99 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 110.744 -0.943 . . . . 0.0 110.744 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -63.16 -44.39 95.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.807 0.337 . . . . 0.0 110.307 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 215' ' ' MET . . . . . 0.555 ' SD ' ' HB2' ' A' ' 304' ' ' ALA . 65.3 ttp -59.27 -48.01 83.23 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.145 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 86.0 mt -60.49 -40.83 92.74 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 217' ' ' GLU . . . . . 0.451 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.4 tp10 -58.38 -37.76 75.91 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -65.31 -38.24 89.59 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.8 0.333 . . . . 0.0 110.652 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 94.0 mt -64.25 -42.92 96.29 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.509 -179.509 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.79 44.83 0.08 OUTLIER Glycine 0 C--N 1.333 0.405 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 221' ' ' PHE . . . . . 0.451 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 26.3 m-85 -127.66 154.78 44.88 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.053 0.454 . . . . 0.0 110.497 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.479 ' O ' HG13 ' A' ' 191' ' ' VAL . 7.6 p -106.33 122.16 45.68 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.209 0.528 . . . . 0.0 110.147 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.474 HD22 ' C ' ' A' ' 222' ' ' THR . 4.3 mm? -101.6 133.07 46.85 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.023 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.44 159.41 14.96 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.49 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.14 114.99 29.52 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.962 0.411 . . . . 0.0 110.31 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.494 HD12 ' N ' ' A' ' 226' ' ' LEU . 9.0 mp -53.03 156.54 3.5 Favored Pre-proline 0 N--CA 1.453 -0.319 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.69 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -60.02 145.32 98.67 Favored 'Trans proline' 0 C--N 1.301 -1.944 0 C-N-CA 122.673 2.249 . . . . 0.0 112.167 179.201 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -86.89 -3.36 59.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.578 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.69 -40.65 5.58 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 230' ' ' LEU . . . . . 0.503 ' O ' ' N ' ' A' ' 233' ' ' SER . 65.5 mt -79.53 -18.43 51.87 Favored 'General case' 0 C--O 1.222 -0.389 0 CA-C-O 121.125 0.488 . . . . 0.0 110.365 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -40.76 -49.18 3.1 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.773 -179.333 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -87.04 15.09 6.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.269 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 233' ' ' SER . . . . . 0.503 ' N ' ' O ' ' A' ' 230' ' ' LEU . 77.6 p -59.74 -34.58 73.14 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.59 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 234' ' ' GLN . . . . . 0.529 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.5 tt0 -121.73 -68.99 0.86 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.813 179.386 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.3 m -66.31 102.91 0.91 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.559 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -93.83 54.25 1.94 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.415 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -142.84 -122.16 1.7 Allowed Glycine 0 CA--C 1.521 0.434 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -139.01 113.75 9.17 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.018 0.437 . . . . 0.0 110.328 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 239' ' ' ARG . . . . . 0.529 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.8 mtt180 -147.73 60.31 1.14 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.716 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -68.94 -34.12 74.83 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.518 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 241' ' ' ASP . . . . . 0.454 ' OD2' ' ND2' ' A' ' 143' ' ' ASN . 48.2 t0 -56.79 -47.58 79.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.378 -179.151 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 242' ' ' ILE . . . . . 0.433 ' O ' ' O ' ' A' ' 239' ' ' ARG . 18.9 tt -138.45 153.79 26.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.909 0.385 . . . . 0.0 110.459 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.456 HG22 HD13 ' A' ' 245' ' ' LEU . 96.4 mt -106.38 107.55 22.98 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.224 0 CA-C-O 121.095 0.474 . . . . 0.0 110.445 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 244' ' ' GLN . . . . . 0.611 ' C ' HD12 ' A' ' 245' ' ' LEU . 88.3 mt-30 -111.85 111.03 21.69 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.46 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.611 HD12 ' C ' ' A' ' 244' ' ' GLN . 9.8 mp -121.21 -168.34 1.66 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.571 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 246' ' ' GLY . . . . . 0.529 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 176.67 -17.42 0.04 OUTLIER Glycine 0 CA--C 1.524 0.602 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 247' ' ' GLY . . . . . 0.679 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -62.29 154.55 41.09 Favored Glycine 0 CA--C 1.521 0.442 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -62.62 22.3 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.924 0.392 . . . . 0.0 110.644 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 249' ' ' ASN . . . . . 0.679 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.9 m-20 -96.64 -6.33 36.89 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.49 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 99.0 mt -80.34 -22.55 41.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.705 179.32 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.65 -51.17 71.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.84 -179.515 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.24 -4.94 58.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.429 179.661 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.41 -73.89 1.17 Allowed Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 82.8 mt -70.16 126.64 30.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.018 0.437 . . . . 0.0 110.253 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -59.51 -39.06 82.62 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.392 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 83.3 51.72 4.03 Favored Glycine 0 CA--C 1.521 0.46 0 N-CA-C 110.752 -0.939 . . . . 0.0 110.752 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -95.6 -15.15 22.97 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.687 0.28 . . . . 0.0 110.633 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 258' ' ' SER . . . . . 0.504 ' OG ' HG23 ' A' ' 191' ' ' VAL . 3.3 t 174.26 88.91 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.065 0.459 . . . . 0.0 110.086 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.864 HD12 ' N ' ' A' ' 259' ' ' LEU . 1.0 OUTLIER -94.3 124.3 38.24 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.276 0.56 . . . . 0.0 111.187 -179.156 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 260' ' ' PHE . . . . . 0.455 ' H ' ' HA ' ' A' ' 193' ' ' ALA . 15.9 m-30 -93.0 146.52 23.56 Favored 'General case' 0 CA--C 1.505 -0.781 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.465 179.282 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 85.1 mt -122.08 149.85 42.97 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.534 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.729 ' CD1' HG13 ' A' ' 195' ' ' VAL . 2.6 p90 -77.7 -139.35 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.436 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 263' ' ' ALA . . . . . 0.659 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -51.34 77.66 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.123 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 264' ' ' GLY . . . . . 0.632 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.36 104.82 0.19 Allowed Glycine 0 CA--C 1.527 0.83 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 265' ' ' ASP . . . . . 0.598 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.6 m-20 -80.38 -177.67 6.28 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.769 0.318 . . . . 0.0 110.861 -179.563 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -40.45 -17.83 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.539 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 267' ' ' LYS . . . . . 0.598 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.47 -51.63 41.37 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.007 0.432 . . . . 0.0 110.7 179.448 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -63.67 -46.48 85.39 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.259 179.368 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 269' ' ' ALA . . . . . 0.573 ' HB1' ' OH ' ' A' ' 273' ' ' TYR . . . -61.77 -35.16 77.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.202 0.525 . . . . 0.0 109.732 179.589 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -63.02 -34.56 77.83 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.113 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.47 -43.27 13.73 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.192 -179.559 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 272' ' ' ILE . . . . . 0.585 ' C ' ' H ' ' A' ' 274' ' ' ALA . 4.8 tt -51.21 -33.47 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.83 -178.84 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 273' ' ' TYR . . . . . 0.573 ' OH ' ' HB1' ' A' ' 269' ' ' ALA . 17.1 m-85 -54.7 -1.53 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.603 -179.583 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 274' ' ' ALA . . . . . 0.585 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.79 -39.65 69.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.917 179.543 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 275' ' ' ASN . . . . . 0.58 ' O ' ' N ' ' A' ' 279' ' ' ALA . 3.5 p30 -39.21 97.91 0.15 Allowed Pre-proline 0 N--CA 1.462 0.128 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.55 -179.694 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -54.25 -42.9 63.42 Favored 'Trans proline' 0 C--N 1.304 -1.812 0 C-N-CA 122.32 2.013 . . . . 0.0 112.682 -178.724 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 89.0 mt -64.43 -42.83 95.79 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.208 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 90.6 mt -95.79 -1.35 49.86 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.883 -179.479 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 279' ' ' ALA . . . . . 0.58 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.28 -34.73 77.13 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.71 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.14 19.91 0.12 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.99 -179.266 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 281' ' ' LEU . . . . . 0.49 HD23 ' HA ' ' A' ' 281' ' ' LEU . 13.7 mt -75.07 119.85 78.88 Favored Pre-proline 0 N--CA 1.451 -0.424 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.58 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -50.64 -39.71 56.13 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.612 2.208 . . . . 0.0 112.035 178.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.76 -50.44 63.49 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.103 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 73.6 t -61.47 -43.85 97.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 179.463 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -57.95 -41.26 82.48 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.159 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -90.84 0.05 57.58 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.154 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt 59.56 43.23 16.22 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.86 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -94.83 41.49 1.09 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.346 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 54.2 t -118.85 135.72 58.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 121.062 0.458 . . . . 0.0 110.172 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -132.74 162.45 31.4 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.111 0.481 . . . . 0.0 110.606 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.43 154.51 33.59 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.021 0.439 . . . . 0.0 110.681 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 80.9 mt -93.66 -1.69 54.94 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.24 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.83 165.72 12.64 Favored Glycine 0 CA--C 1.522 0.475 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 6.8 m -87.61 -61.9 1.62 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.902 0.382 . . . . 0.0 111.065 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 295' ' ' GLU . . . . . 0.452 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.5 mm-40 -69.22 -4.35 17.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.677 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 26.1 p -76.29 32.43 0.12 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.666 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 297' ' ' PHE . . . . . 0.514 ' CD2' HG22 ' A' ' 70' ' ' THR . 85.0 t80 -60.56 -46.18 91.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.579 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 298' ' ' ARG . . . . . 0.628 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.1 mtt85 -81.78 133.65 35.36 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 121.049 0.452 . . . . 0.0 110.54 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.403 ' H ' HG11 ' A' ' 51' ' ' VAL . 16.8 tp -113.16 118.64 35.27 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-O 120.994 0.426 . . . . 0.0 110.161 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 300' ' ' ASP . . . . . 0.632 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.4 p-10 -165.81 -176.01 3.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.592 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 83.5 t80 -47.3 -44.06 23.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.275 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -66.45 -40.64 89.54 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.035 0.445 . . . . 0.0 110.827 179.06 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 303' ' ' SER . . . . . 0.632 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 57.6 p -55.58 -36.21 66.63 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.111 -179.19 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 304' ' ' ALA . . . . . 0.555 ' HB2' ' SD ' ' A' ' 215' ' ' MET . . . -56.98 -51.67 68.28 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.46 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 91.0 mtp -56.26 -43.83 79.14 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -66.3 -42.45 88.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.037 0.446 . . . . 0.0 110.18 178.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 307' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 303' ' ' SER . 56.1 t -64.1 -42.93 97.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.209 179.376 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 42.3 tp -59.74 -42.12 92.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.863 -179.513 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -62.68 -38.82 91.87 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.08 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 310' ' ' ARG . . . . . 0.441 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.7 ttt85 -63.63 -43.73 95.99 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.308 179.554 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 89.3 mt -63.09 -42.22 99.57 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.25 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt -62.85 -33.36 75.1 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.075 179.438 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.44 -23.68 22.06 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.401 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 314' ' ' LEU . . . . . 0.477 HD22 ' CE2' ' A' ' 315' ' ' PHE . 6.7 tt -62.26 -43.28 99.2 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 121.068 0.461 . . . . 0.0 110.578 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 315' ' ' PHE . . . . . 0.477 ' CE2' HD22 ' A' ' 314' ' ' LEU . 90.1 m-85 . . . . . 0 C--O 1.22 -0.479 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.404 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -99.64 135.89 40.39 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.056 0.455 . . . . 0.0 110.476 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.497 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -91.94 178.51 1.7 Allowed Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.586 -179.846 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.497 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.4 Cg_exo -61.6 147.32 95.66 Favored 'Trans proline' 0 C--N 1.299 -2.076 0 C-N-CA 122.802 2.335 . . . . 0.0 112.147 179.568 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.463 ' HE ' HD12 ' A' ' 39' ' ' LEU . 35.7 ptt180 -136.03 142.3 44.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.645 179.699 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -79.6 116.79 20.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.501 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.443 ' O ' HG23 ' A' ' 30' ' ' ILE . 9.5 tp -111.35 130.75 64.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.465 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 13.8 t -70.93 142.36 51.09 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.606 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.478 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.4 t0 -139.85 179.53 6.54 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.526 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.478 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 78.0 p -73.71 -37.12 65.25 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.64 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.7 ttt85 -46.49 -94.56 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.293 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -167.22 -26.32 0.02 OUTLIER Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.931 -0.867 . . . . 0.0 110.931 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 60.9 m -169.25 105.02 0.38 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.891 0.377 . . . . 0.0 110.665 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.68 ' CD2' HD13 ' A' ' 140' ' ' LEU . 74.7 t60 -128.5 149.44 50.59 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.116 0.484 . . . . 0.0 110.227 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.623 HG22 ' N ' ' A' ' 39' ' ' LEU . 98.5 m -131.75 165.88 22.77 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.583 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.623 ' N ' HG22 ' A' ' 38' ' ' THR . 81.6 mt -120.8 127.31 51.82 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.497 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -64.95 -44.43 89.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.721 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 39.7 p -165.81 155.08 11.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.492 179.581 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.49 ' CD ' ' H ' ' A' ' 42' ' ' GLN . 14.9 mp0 -44.22 100.96 0.24 Allowed Pre-proline 0 C--N 1.329 -0.287 0 O-C-N 123.364 0.415 . . . . 0.0 110.621 179.362 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -57.26 129.37 33.79 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 122.337 2.024 . . . . 0.0 112.271 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -83.98 -24.81 30.45 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.501 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.538 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.3 mtm-85 -121.86 134.37 54.88 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.199 0.523 . . . . 0.0 110.321 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.2 mt -130.6 133.46 63.49 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.3 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.952 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 44.9 t -124.18 130.33 73.77 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.334 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.646 ' OG ' HD12 ' A' ' 117' ' ' LEU . 2.1 m -155.48 167.65 29.69 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.523 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 66.8 p -124.45 10.31 8.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.454 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -86.02 124.78 32.85 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.723 -179.464 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.464 HG11 ' H ' ' A' ' 299' ' ' LEU . 98.9 t -65.57 -44.55 93.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.398 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.4 m -62.49 -44.18 97.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.627 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 52.3 tp -62.02 -41.54 98.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.514 -179.442 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.453 ' O ' HD13 ' A' ' 58' ' ' LEU . 71.2 m -57.67 -44.44 85.72 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.192 -179.27 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.24 -62.09 5.46 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 179.624 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.7 t -48.61 -35.51 13.78 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 57' ' ' LEU . 20.0 mt -61.82 -44.48 96.75 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.675 -0.41 . . . . 0.0 111.284 179.335 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.453 HD13 ' O ' ' A' ' 54' ' ' THR . 9.3 mp -64.96 -41.61 95.33 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.42 177.905 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.84 -40.48 96.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.003 -179.244 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.43 ' O ' HG23 ' A' ' 60' ' ' ILE . 7.9 tp -89.07 16.49 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.836 -179.677 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 56.48 85.08 0.08 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.733 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 178.49 58.21 0.07 OUTLIER Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.901 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -50.97 153.1 9.23 Favored 'Trans proline' 0 C--N 1.294 -2.323 0 C-N-CA 122.935 2.423 . . . . 0.0 112.329 -178.229 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.432 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -108.3 145.37 15.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.318 -179.736 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.69 -45.18 98.09 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.303 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.403 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.502 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -129.83 134.03 47.3 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.504 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.502 ' O ' ' N ' ' A' ' 98' ' ' LEU . 75.4 m -134.48 158.5 43.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.824 -179.674 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.59 139.03 16.2 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.487 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.79 -162.86 0.08 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.014 0.435 . . . . 0.0 110.465 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.538 HG22 ' CD2' ' A' ' 297' ' ' PHE . 14.9 t -133.61 134.5 43.31 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.357 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.488 ' C ' ' O ' ' A' ' 70' ' ' THR . 0.7 OUTLIER 29.62 68.71 0.65 Allowed Pre-proline 0 N--CA 1.464 0.266 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.787 -179.879 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -61.3 145.42 98.41 Favored 'Trans proline' 0 C--N 1.299 -2.077 0 C-N-CA 122.654 2.236 . . . . 0.0 111.969 -178.392 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.53 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 45.3 p-10 -158.9 -32.29 0.07 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.701 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.545 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 99.1 m-20 -64.03 -39.71 94.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.459 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -60.39 -48.1 83.2 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.704 -179.213 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.424 ' O ' ' O ' ' A' ' 77' ' ' ALA . 92.7 t -60.48 -25.03 33.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.545 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -45.66 173.04 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.601 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.575 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.6 p30 -62.05 177.86 0.42 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.533 -179.715 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.559 ' C ' ' H ' ' A' ' 81' ' ' GLY . 36.5 p30 -45.01 85.73 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.994 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.575 ' N ' ' O ' ' A' ' 78' ' ' ASP . 42.7 tp60 -67.36 13.21 0.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.119 0.485 . . . . 0.0 110.116 -179.753 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.559 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 118.23 -22.29 9.7 Favored Glycine 0 C--N 1.332 0.317 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -108.18 116.18 31.49 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.956 0.407 . . . . 0.0 110.471 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 77.8 mt -98.56 0.58 45.23 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.941 0.401 . . . . 0.0 110.484 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -92.33 7.03 44.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.024 0.44 . . . . 0.0 110.435 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.8 ' O ' HG22 ' A' ' 89' ' ' VAL . 27.1 mt-30 -100.2 -27.87 13.3 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.787 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 68.5 t-105 -62.71 -40.91 98.64 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.935 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.552 ' O ' ' N ' ' A' ' 91' ' ' LYS . 68.8 m -77.55 -53.2 7.89 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.164 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -48.79 -50.9 32.03 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.015 -179.212 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.8 HG22 ' O ' ' A' ' 85' ' ' GLN . 15.7 m -68.75 -40.74 81.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 120.88 0.371 . . . . 0.0 111.074 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.497 ' N ' HG23 ' A' ' 89' ' ' VAL . . . -71.99 -23.11 61.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.75 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.552 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.0 tttm -61.6 -45.63 93.29 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.504 -179.537 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.445 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.8 mm-40 -90.46 -95.17 0.12 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.101 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.63 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.8 mtt180 -142.81 59.46 1.43 Allowed 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.458 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.7 pttp 33.55 26.27 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 120.906 0.384 . . . . 0.0 110.132 -179.303 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.63 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.5 tt -48.5 123.23 6.35 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.006 -177.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.456 ' O ' HD23 ' A' ' 95' ' ' LEU . 99.1 mm-40 -83.95 -169.2 2.46 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.06 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.602 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 81.3 mtp180 -74.85 136.86 41.53 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.266 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.502 ' N ' ' O ' ' A' ' 67' ' ' SER . 91.5 mt -85.77 -165.93 1.38 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.718 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.537 ' O ' ' CD2' ' A' ' 99' ' ' TYR . 48.3 p90 -168.2 119.85 0.83 Allowed 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.198 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.511 ' C ' ' O ' ' A' ' 99' ' ' TYR . 42.4 mm -28.99 120.74 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.074 -179.723 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 114.62 27.6 3.25 Favored Glycine 0 CA--C 1.52 0.353 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 -179.405 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.576 ' CD ' ' H ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -144.78 46.5 0.61 Allowed Pre-proline 0 C--N 1.323 -0.578 0 O-C-N 122.549 -0.383 . . . . 0.0 110.431 179.896 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 29.0 Cg_endo -61.9 144.21 96.36 Favored 'Trans proline' 0 C--N 1.295 -2.258 0 C-N-CA 122.678 2.252 . . . . 0.0 111.93 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.457 ' O ' HG23 ' A' ' 108' ' ' VAL . 26.1 t -173.38 120.25 0.33 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.397 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.71 -40.34 63.67 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.034 0.445 . . . . 0.0 111.098 179.594 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -66.29 -40.16 89.87 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.9 -179.419 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.97 -40.07 95.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.697 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 104' ' ' SER . 70.7 t -67.45 -43.84 87.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.8 179.625 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.86 -38.84 92.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.53 -179.297 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.445 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.62 -23.34 62.92 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.414 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.547 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.5 mm-40 -90.63 5.14 49.19 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.755 -179.575 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.547 ' C ' ' O ' ' A' ' 111' ' ' GLN . 10.6 tpt 23.49 64.05 0.38 Allowed Pre-proline 0 N--CA 1.466 0.347 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.074 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -78.41 167.78 22.42 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 C-N-CA 122.949 2.433 . . . . 0.0 112.009 -178.332 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.523 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 99.0 m-20 -110.06 -42.53 4.17 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.133 179.475 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.6 tp -120.64 120.4 35.65 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 84.4 mt -113.36 129.18 69.59 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.401 0 CA-C-O 120.983 0.42 . . . . 0.0 110.942 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.646 HD12 ' OG ' ' A' ' 48' ' ' SER . 29.9 mt -109.02 132.46 54.08 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.057 0.456 . . . . 0.0 110.214 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.505 HD12 HG23 ' A' ' 139' ' ' THR . 98.9 mt -119.91 138.2 51.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.666 -179.711 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 87.4 p -71.92 153.17 42.01 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.57 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.27 -50.19 74.63 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.681 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -149.42 153.91 38.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.615 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 170.25 -170.9 43.27 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.87 -34.28 89.37 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.447 ' OD1' ' O ' ' A' ' 124' ' ' ASP . 44.1 p-10 -87.06 120.06 27.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.805 0.336 . . . . 0.0 110.66 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.447 ' O ' HD12 ' A' ' 129' ' ' LEU . 40.6 t -63.26 143.6 57.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.451 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.521 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.08 -42.76 9.23 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.866 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.5 tp -62.73 -42.35 99.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.647 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.99 -11.94 59.81 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.485 -179.409 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.447 HD12 ' O ' ' A' ' 125' ' ' SER . 84.8 mt -114.48 -24.1 8.99 Favored 'General case' 0 C--O 1.226 -0.16 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.689 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' TYR . . . . . 0.521 ' N ' ' O ' ' A' ' 126' ' ' ALA . 77.9 t80 -51.28 -49.44 61.23 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.611 -0.436 . . . . 0.0 110.576 -178.898 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.3 p-10 -66.07 -42.27 89.65 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.885 0.374 . . . . 0.0 111.29 179.474 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.518 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 88.2 mt-30 -67.29 -37.92 84.18 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.797 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.446 HD12 HD11 ' A' ' 118' ' ' ILE . 96.1 mt -80.33 -41.41 24.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.991 -179.681 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.1 t -57.26 -44.34 83.82 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.202 -178.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.8 m -62.11 -45.1 94.99 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.766 0.317 . . . . 0.0 110.49 179.488 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 93.5 mt -62.26 -43.64 98.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.23 -179.699 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.664 ' HB1' ' HD2' ' A' ' 138' ' ' PRO . . . -169.46 168.35 4.88 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.588 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.664 ' HD2' ' HB1' ' A' ' 137' ' ' ALA . 52.1 Cg_exo -49.67 112.93 0.78 Allowed 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.314 2.01 . . . . 0.0 112.277 179.319 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.505 HG23 HD12 ' A' ' 118' ' ' ILE . 23.0 m -84.18 127.55 34.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.636 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.68 HD13 ' CD2' ' A' ' 37' ' ' HIS . 34.5 tp -118.05 135.93 53.87 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.938 -179.733 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.438 ' O ' ' OD2' ' A' ' 32' ' ' ASP . 81.3 mt -100.38 119.01 47.9 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 CA-C-O 121.192 0.52 . . . . 0.0 111.295 -179.44 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.44 HD12 HD22 ' A' ' 117' ' ' LEU . 98.1 mt -134.98 131.83 53.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.619 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.509 ' ND2' ' OD2' ' A' ' 241' ' ' ASP . 2.1 t-20 -66.77 147.48 53.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.866 0.365 . . . . 0.0 110.406 179.289 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.463 ' O ' ' OD2' ' A' ' 241' ' ' ASP . 44.8 t80 -81.69 123.17 28.5 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.932 -179.546 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 54.64 69.57 0.71 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.802 179.656 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 34.2 p-10 -126.16 0.7 7.15 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.93 0.395 . . . . 0.0 110.74 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -150.65 114.92 5.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.743 -179.566 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 83.6 p -64.14 169.23 4.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.523 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.417 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.4 p-90 -52.1 -16.51 0.79 Allowed 'General case' 0 C--O 1.223 -0.321 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.474 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' GLN . . . . . 0.434 ' O ' HG23 ' A' ' 154' ' ' THR . 68.1 tp60 -69.56 -76.96 0.09 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.495 -179.71 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.449 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.1 t -62.53 -38.24 89.21 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.287 179.63 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 53.1 tp -60.05 -45.74 91.84 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.351 -178.441 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.417 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 46.8 tp -62.76 -41.71 99.34 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.417 179.049 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.449 ' OG1' ' O ' ' A' ' 151' ' ' SER . 63.0 p -63.89 -34.91 79.01 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.222 -179.454 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' GLN . . . . . 0.445 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 88.0 mm-40 -64.0 -42.52 97.16 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.256 179.308 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 90.7 mt -65.37 -38.85 91.28 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.094 0.473 . . . . 0.0 110.212 179.174 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.578 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.25 -32.4 80.55 Favored Glycine 0 CA--C 1.519 0.343 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 -179.368 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.445 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.2 mt-10 -35.88 -26.45 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.869 0.366 . . . . 0.0 110.827 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.578 ' N ' ' O ' ' A' ' 157' ' ' GLY . 95.3 mt -57.2 148.75 4.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.287 179.224 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 73.4 p -69.1 137.41 53.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.036 -179.543 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 70.85 22.18 78.22 Favored Glycine 0 N--CA 1.458 0.162 0 N-CA-C 111.286 -0.726 . . . . 0.0 111.286 179.553 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 59.0 m80 -124.16 -14.41 7.04 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.719 0.295 . . . . 0.0 110.519 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -66.16 -59.75 3.47 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.718 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -52.16 -49.04 64.57 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.159 -179.566 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -60.98 -41.09 95.78 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.95 -0.3 . . . . 0.0 110.387 179.507 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.57 -47.09 87.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.57 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -57.0 -40.22 76.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.188 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -61.49 -49.94 74.73 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.558 179.53 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -65.35 -43.67 90.13 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.467 179.526 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 94.7 mt -64.56 -43.41 96.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.468 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.38 -51.02 71.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.451 -179.099 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.51 -43.68 96.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.493 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' PHE . . . . . 0.665 ' CE2' HD11 ' A' ' 177' ' ' LEU . 57.6 t80 -62.86 -44.52 95.91 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.072 0.463 . . . . 0.0 110.433 179.391 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -63.27 -40.0 96.16 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.579 -179.356 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -63.02 -42.73 99.88 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.646 179.226 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -60.65 -44.88 95.9 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.152 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.665 HD11 ' CE2' ' A' ' 173' ' ' PHE . 84.6 mt -64.43 -41.14 96.75 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.992 0.425 . . . . 0.0 110.67 178.922 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -51.92 -62.15 1.81 Allowed 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.395 -179.252 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.76 -46.61 87.07 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.568 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.3 -41.86 66.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.28 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -63.66 -33.7 76.22 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.984 0.421 . . . . 0.0 110.4 179.256 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 182' ' ' GLU . . . . . 0.421 ' O ' ' HG2' ' A' ' 182' ' ' GLU . 69.8 tt0 -90.53 8.76 32.36 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.489 0.662 . . . . 0.0 110.484 -178.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -104.87 -32.29 8.87 Favored 'General case' 0 CA--C 1.515 -0.372 0 O-C-N 122.113 -0.367 . . . . 0.0 111.233 179.537 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.7 pt -128.01 147.61 32.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.826 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -139.97 131.02 26.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.331 179.348 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 186' ' ' LEU . . . . . 0.597 HD22 ' N ' ' A' ' 186' ' ' LEU . 3.5 mm? -85.44 133.73 41.69 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.01 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -44.04 157.89 0.14 Allowed 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 122.703 2.269 . . . . 0.0 112.199 179.444 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 188' ' ' PRO . . . . . 0.521 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 28.1 Cg_endo -63.13 114.8 2.62 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 C-N-CA 122.765 2.31 . . . . 0.0 111.729 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 189' ' ' GLN . . . . . 0.521 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.8 mt-30 155.4 147.99 0.0 OUTLIER Pre-proline 0 N--CA 1.455 -0.203 0 O-C-N 123.68 0.612 . . . . 0.0 110.802 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -73.53 144.29 35.77 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.621 2.214 . . . . 0.0 112.005 177.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.503 HG23 ' OG ' ' A' ' 258' ' ' SER . 2.1 p -124.92 158.83 32.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.298 0.57 . . . . 0.0 110.14 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 192' ' ' THR . . . . . 0.494 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 37.4 p -143.3 165.39 27.61 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.121 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 193' ' ' ALA . . . . . 0.446 ' HA ' ' H ' ' A' ' 260' ' ' PHE . . . -135.28 128.64 32.2 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.222 0.534 . . . . 0.0 110.189 179.492 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.508 HD11 HD23 ' A' ' 259' ' ' LEU . 47.7 pt -146.39 148.79 16.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.186 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 195' ' ' VAL . . . . . 0.749 HG13 ' CD1' ' A' ' 262' ' ' PHE . 72.1 t -117.77 123.25 71.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.272 0.558 . . . . 0.0 109.684 179.167 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -134.4 107.37 7.56 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.282 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 94.7 m -130.82 130.46 43.68 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.834 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.406 ' O ' ' N ' ' A' ' 201' ' ' HIS . . . -82.73 -37.36 24.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.265 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.41 -66.98 0.27 Allowed 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.414 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.1 -10.05 59.24 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.266 179.517 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 201' ' ' HIS . . . . . 0.406 ' N ' ' O ' ' A' ' 198' ' ' ALA . 60.0 t-80 60.81 58.13 2.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.703 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 41.0 p -166.84 153.49 8.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.52 179.486 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.32 144.05 24.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.496 179.385 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -135.34 138.4 43.34 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.641 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 20.4 mt -106.53 125.64 51.25 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.116 0.484 . . . . 0.0 109.779 -179.706 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 206' ' ' TRP . . . . . 0.556 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 74.8 m95 -82.12 166.99 19.21 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.655 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 207' ' ' THR . . . . . 0.466 HG22 ' C ' ' A' ' 206' ' ' TRP . 0.1 OUTLIER -156.92 171.26 7.67 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 120.98 0.419 . . . . 0.0 110.521 -179.144 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.54 -37.35 82.65 Favored 'Trans proline' 0 C--N 1.303 -1.832 0 C-N-CA 122.619 2.213 . . . . 0.0 112.186 179.225 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -70.4 -35.01 73.2 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.875 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 22.8 m -61.01 150.74 32.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.616 -179.385 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.45 -37.04 82.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.551 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 212' ' ' GLN . . . . . 0.556 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 55.0 tt0 -64.69 -40.24 95.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.543 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.5 -43.46 92.32 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.719 -0.952 . . . . 0.0 110.719 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -63.34 -43.54 97.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.71 0.291 . . . . 0.0 110.247 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 215' ' ' MET . . . . . 0.537 ' SD ' ' HB2' ' A' ' 304' ' ' ALA . 65.1 ttp -59.5 -48.01 83.31 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.207 -179.753 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 88.0 mt -60.66 -40.74 93.19 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 217' ' ' GLU . . . . . 0.459 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.7 tp10 -58.06 -37.87 75.25 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -65.22 -38.01 89.06 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.81 0.338 . . . . 0.0 110.654 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 94.3 mt -64.3 -42.62 96.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.614 -179.715 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.27 44.6 0.09 OUTLIER Glycine 0 C--N 1.333 0.408 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 221' ' ' PHE . . . . . 0.459 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 26.1 m-85 -127.66 155.44 43.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.058 0.456 . . . . 0.0 110.527 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.487 ' O ' HG13 ' A' ' 191' ' ' VAL . 7.0 p -107.16 122.23 46.09 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.224 0.535 . . . . 0.0 110.196 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.472 HD22 ' C ' ' A' ' 222' ' ' THR . 4.3 mm? -101.03 133.28 45.76 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.134 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -97.1 159.21 15.04 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.473 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.16 115.35 30.13 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-O 120.924 0.392 . . . . 0.0 110.37 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.496 HD12 ' N ' ' A' ' 226' ' ' LEU . 8.9 mp -53.37 156.67 3.96 Favored Pre-proline 0 N--CA 1.453 -0.313 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.659 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -60.19 145.3 98.81 Favored 'Trans proline' 0 C--N 1.301 -1.931 0 C-N-CA 122.629 2.219 . . . . 0.0 112.15 179.261 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.41 -3.02 59.01 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.5 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.22 -40.92 5.66 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.024 -0.831 . . . . 0.0 111.024 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 230' ' ' LEU . . . . . 0.539 ' O ' ' N ' ' A' ' 233' ' ' SER . 86.3 mt -79.17 -16.82 56.04 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-O 121.019 0.438 . . . . 0.0 110.29 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 231' ' ' ASN . . . . . 0.402 ' C ' ' O ' ' A' ' 230' ' ' LEU . 54.5 t-20 -40.41 -48.89 2.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.764 -179.399 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -88.2 15.43 7.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.314 179.719 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 233' ' ' SER . . . . . 0.539 ' N ' ' O ' ' A' ' 230' ' ' LEU . 78.1 p -60.6 -35.51 76.3 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.648 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 234' ' ' GLN . . . . . 0.528 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.6 tt0 -118.35 -69.26 0.86 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.974 179.428 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.0 m -70.47 103.02 2.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.739 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -94.27 58.08 2.42 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.37 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -145.04 -122.53 1.55 Allowed Glycine 0 CA--C 1.519 0.324 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -134.47 111.79 10.4 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 121.175 0.512 . . . . 0.0 110.408 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 239' ' ' ARG . . . . . 0.515 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.2 mtt180 -148.25 57.56 1.07 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.762 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -69.83 -31.89 70.01 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.489 179.67 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 241' ' ' ASP . . . . . 0.509 ' OD2' ' ND2' ' A' ' 143' ' ' ASN . 64.8 t0 -56.92 -47.03 81.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.344 -179.097 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 242' ' ' ILE . . . . . 0.434 ' O ' ' O ' ' A' ' 239' ' ' ARG . 17.6 tt -140.2 157.03 25.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.912 0.387 . . . . 0.0 110.494 179.79 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.45 HG22 HD13 ' A' ' 245' ' ' LEU . 96.1 mt -106.25 106.33 20.39 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.163 0 CA-C-O 121.169 0.509 . . . . 0.0 110.466 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 244' ' ' GLN . . . . . 0.599 ' O ' HD12 ' A' ' 245' ' ' LEU . 88.2 mt-30 -110.45 110.31 21.02 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.302 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.599 HD12 ' O ' ' A' ' 244' ' ' GLN . 9.5 mp -121.87 -168.33 1.69 Allowed 'General case' 0 C--O 1.225 -0.205 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.63 179.728 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 246' ' ' GLY . . . . . 0.528 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.49 -16.9 0.05 OUTLIER Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.919 -0.873 . . . . 0.0 110.919 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 247' ' ' GLY . . . . . 0.668 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -60.45 156.98 29.78 Favored Glycine 0 CA--C 1.522 0.488 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -63.8 21.42 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.977 0.418 . . . . 0.0 110.604 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 249' ' ' ASN . . . . . 0.668 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.8 m-20 -97.04 -6.05 36.16 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.576 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 92.4 mt -79.9 -21.57 43.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.648 179.423 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.57 -51.23 70.76 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.71 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.65 -5.41 58.16 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.467 179.661 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.14 -74.37 1.15 Allowed Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 82.6 mt -70.08 126.01 28.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.072 0.463 . . . . 0.0 110.254 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -59.47 -39.27 83.14 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.311 -179.716 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 82.83 51.79 4.12 Favored Glycine 0 CA--C 1.521 0.41 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -95.78 -15.1 22.79 Favored 'General case' 0 C--N 1.332 -0.18 0 O-C-N 122.728 -0.278 . . . . 0.0 110.594 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 258' ' ' SER . . . . . 0.503 ' OG ' HG23 ' A' ' 191' ' ' VAL . 3.3 t 174.56 88.93 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.078 0.466 . . . . 0.0 110.108 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.861 HD12 ' N ' ' A' ' 259' ' ' LEU . 0.9 OUTLIER -94.43 124.06 38.23 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.254 0.549 . . . . 0.0 111.115 -179.081 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 260' ' ' PHE . . . . . 0.446 ' H ' ' HA ' ' A' ' 193' ' ' ALA . 15.9 m-30 -93.06 146.48 23.61 Favored 'General case' 0 CA--C 1.504 -0.818 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.345 179.349 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 85.7 mt -122.42 149.63 43.57 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.607 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.749 ' CD1' HG13 ' A' ' 195' ' ' VAL . 2.6 p90 -77.21 -138.04 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.638 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 263' ' ' ALA . . . . . 0.66 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -52.61 77.52 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.032 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 264' ' ' GLY . . . . . 0.621 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -178.99 104.32 0.18 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 265' ' ' ASP . . . . . 0.601 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.7 m-20 -80.35 -177.81 6.34 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.684 0.278 . . . . 0.0 110.954 -179.634 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -40.36 -17.69 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.561 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 267' ' ' LYS . . . . . 0.601 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.38 -51.52 43.26 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.71 179.409 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -63.75 -46.65 84.34 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.191 179.384 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 269' ' ' ALA . . . . . 0.565 ' HB1' ' OH ' ' A' ' 273' ' ' TYR . . . -61.68 -35.12 77.08 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.173 0.511 . . . . 0.0 109.738 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -63.17 -34.38 77.51 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.033 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.51 -43.12 13.83 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.185 -179.539 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 272' ' ' ILE . . . . . 0.589 ' C ' ' H ' ' A' ' 274' ' ' ALA . 4.9 tt -51.47 -33.73 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.855 -178.837 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 273' ' ' TYR . . . . . 0.565 ' OH ' ' HB1' ' A' ' 269' ' ' ALA . 17.3 m-85 -54.33 -1.89 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.646 -179.546 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 274' ' ' ALA . . . . . 0.589 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.61 -39.61 70.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.919 179.52 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 275' ' ' ASN . . . . . 0.582 ' O ' ' N ' ' A' ' 279' ' ' ALA . 3.3 p30 -39.28 98.03 0.16 Allowed Pre-proline 0 CA--C 1.528 0.108 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.52 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -54.29 -42.95 63.02 Favored 'Trans proline' 0 C--N 1.303 -1.821 0 C-N-CA 122.341 2.027 . . . . 0.0 112.638 -178.758 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 88.8 mt -64.45 -42.82 95.76 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.252 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 91.0 mt -95.67 -1.58 49.79 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.848 -179.506 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 279' ' ' ALA . . . . . 0.582 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.28 -34.82 77.3 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.685 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.21 20.07 0.12 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.052 -179.281 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 281' ' ' LEU . . . . . 0.487 HD23 ' HA ' ' A' ' 281' ' ' LEU . 13.8 mt -75.19 120.04 79.8 Favored Pre-proline 0 N--CA 1.451 -0.417 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.523 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -50.91 -39.34 58.96 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.586 2.191 . . . . 0.0 111.859 179.064 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.92 -50.42 64.0 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.111 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 75.7 t -61.48 -43.91 97.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.482 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -57.79 -41.19 81.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.218 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -91.13 0.04 57.61 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.091 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt 59.44 43.71 15.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.039 0.447 . . . . 0.0 110.878 179.698 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -94.88 41.33 1.09 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.379 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 54.1 t -119.2 135.76 58.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 121.101 0.477 . . . . 0.0 110.136 -179.701 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -132.93 162.75 30.8 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.709 -179.689 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.77 155.3 32.78 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-O 121.013 0.435 . . . . 0.0 110.728 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 81.6 mt -94.07 -1.36 54.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.232 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.53 165.69 12.67 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.548 -1.021 . . . . 0.0 110.548 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 6.9 m -87.56 -62.4 1.5 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.921 0.391 . . . . 0.0 111.001 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 295' ' ' GLU . . . . . 0.431 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.4 mm-40 -69.6 -3.79 16.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.675 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 25.4 p -76.89 33.17 0.14 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.645 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 297' ' ' PHE . . . . . 0.538 ' CD2' HG22 ' A' ' 70' ' ' THR . 84.8 t80 -60.17 -45.85 91.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.555 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 298' ' ' ARG . . . . . 0.602 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.2 mtt85 -81.72 134.41 35.45 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.989 0.423 . . . . 0.0 110.576 -179.716 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.464 ' H ' HG11 ' A' ' 51' ' ' VAL . 16.2 tp -114.18 118.88 35.22 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-O 121.004 0.431 . . . . 0.0 110.066 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 300' ' ' ASP . . . . . 0.631 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.4 p-10 -166.39 -175.23 3.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.562 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -47.69 -44.64 27.66 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.246 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -65.63 -40.9 93.07 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.034 0.445 . . . . 0.0 110.683 178.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 303' ' ' SER . . . . . 0.631 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 54.5 p -56.16 -36.12 67.96 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.024 -179.171 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 304' ' ' ALA . . . . . 0.537 ' HB2' ' SD ' ' A' ' 215' ' ' MET . . . -56.85 -52.34 65.47 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.485 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 90.9 mtp -56.15 -43.28 78.15 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -66.37 -42.53 87.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.024 0.44 . . . . 0.0 110.155 178.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 307' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 303' ' ' SER . 55.7 t -64.13 -42.97 97.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.105 179.399 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 42.5 tp -59.77 -42.26 92.9 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.779 -179.486 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -62.33 -39.27 92.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.123 179.565 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 310' ' ' ARG . . . . . 0.436 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.4 ttt85 -63.51 -44.06 95.38 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.18 179.479 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 88.4 mt -63.37 -42.14 98.84 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.233 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -62.99 -33.26 75.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.016 179.468 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.52 -23.85 21.93 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.416 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 314' ' ' LEU . . . . . 0.483 HD22 ' CE2' ' A' ' 315' ' ' PHE . 6.7 tt -62.31 -43.29 99.16 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 121.074 0.464 . . . . 0.0 110.552 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 315' ' ' PHE . . . . . 0.483 ' CE2' HD22 ' A' ' 314' ' ' LEU . 90.5 m-85 . . . . . 0 C--O 1.219 -0.507 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.45 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.327 -0.619 . . . . 0.0 109.327 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -99.59 136.4 39.58 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.045 0.45 . . . . 0.0 110.47 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.496 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -92.07 178.56 1.66 Allowed Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.563 -179.891 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.496 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.6 Cg_exo -61.73 147.16 95.93 Favored 'Trans proline' 0 C--N 1.301 -1.965 0 C-N-CA 122.79 2.327 . . . . 0.0 112.106 179.722 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.459 ' HE ' HD12 ' A' ' 39' ' ' LEU . 35.6 ptt180 -136.29 142.44 43.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.645 179.694 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -79.5 116.76 19.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.456 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.45 ' O ' HG23 ' A' ' 30' ' ' ILE . 9.5 tp -111.14 130.44 64.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.456 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 12.9 t -70.89 141.7 51.19 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.55 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.48 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.4 t0 -139.19 179.62 6.41 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.497 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.48 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 78.1 p -74.01 -36.93 64.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.604 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.8 ttt85 -46.64 -94.59 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.293 -179.463 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -166.96 -26.62 0.02 OUTLIER Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 59.3 m -169.05 105.0 0.4 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.817 0.341 . . . . 0.0 110.672 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.691 ' CD2' HD13 ' A' ' 140' ' ' LEU . 75.5 t60 -128.53 149.09 50.75 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.019 0.437 . . . . 0.0 110.289 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.623 HG22 ' N ' ' A' ' 39' ' ' LEU . 98.6 m -131.42 165.91 22.46 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.532 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.623 ' N ' HG22 ' A' ' 38' ' ' THR . 81.4 mt -120.75 127.35 51.91 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.501 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -65.09 -44.43 88.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.682 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 40.6 p -165.97 154.91 11.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.444 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.484 ' CD ' ' H ' ' A' ' 42' ' ' GLN . 14.5 mp0 -44.73 101.3 0.25 Allowed Pre-proline 0 C--N 1.329 -0.308 0 O-C-N 123.392 0.433 . . . . 0.0 110.652 179.426 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.25 129.66 35.32 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 C-N-CA 122.373 2.049 . . . . 0.0 112.288 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -83.61 -24.73 31.32 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.473 179.531 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.542 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.2 mtm-85 -122.39 134.83 54.61 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-O 121.176 0.512 . . . . 0.0 110.256 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.1 mt -130.75 133.84 62.74 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.925 -179.697 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 44.2 t -124.31 130.61 73.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 179.327 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.612 ' OG ' HD12 ' A' ' 117' ' ' LEU . 2.2 m -155.32 167.8 29.16 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.559 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 67.3 p -124.85 9.96 8.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.425 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.78 125.15 33.03 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.689 -179.513 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.456 HG11 ' H ' ' A' ' 299' ' ' LEU . 93.1 t -65.76 -44.41 93.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.48 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.8 m -62.69 -44.04 97.26 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.602 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 52.5 tp -62.15 -41.5 98.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.544 -179.397 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.459 ' O ' HD13 ' A' ' 58' ' ' LEU . 75.5 m -57.61 -44.53 85.54 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.32 -179.341 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.13 -62.31 5.29 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 179.578 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.6 t -48.24 -35.74 12.58 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' A' ' 57' ' ' LEU . 20.0 mt -61.86 -44.37 96.95 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.179 179.428 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.459 HD13 ' O ' ' A' ' 54' ' ' THR . 9.2 mp -64.97 -41.66 95.26 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.373 178.035 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.91 -40.71 97.12 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.012 -179.28 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.43 ' O ' HG23 ' A' ' 60' ' ' ILE . 7.9 tp -88.73 16.44 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.856 -179.609 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 56.46 84.58 0.09 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.671 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 178.58 57.1 0.06 OUTLIER Pre-proline 0 C--N 1.328 -0.329 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -50.55 154.25 6.66 Favored 'Trans proline' 0 C--N 1.295 -2.252 0 C-N-CA 122.912 2.408 . . . . 0.0 112.297 -178.18 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.436 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -108.96 145.64 15.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.375 -179.712 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.66 -45.25 97.98 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.263 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.335 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.509 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -129.49 133.98 47.55 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.522 -179.727 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.51 ' O ' ' N ' ' A' ' 98' ' ' LEU . 74.8 m -134.59 158.64 43.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.769 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.77 139.27 16.26 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.704 -0.959 . . . . 0.0 110.704 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.488 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.92 -162.69 0.08 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.918 0.389 . . . . 0.0 110.474 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.532 HG22 ' CD2' ' A' ' 297' ' ' PHE . 15.2 t -133.52 134.33 43.3 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.397 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.489 ' C ' ' O ' ' A' ' 70' ' ' THR . 0.6 OUTLIER 29.73 68.89 0.65 Allowed Pre-proline 0 N--CA 1.464 0.272 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.754 -179.939 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -61.27 146.67 97.11 Favored 'Trans proline' 0 C--N 1.299 -2.067 0 C-N-CA 122.655 2.237 . . . . 0.0 111.986 -178.526 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.535 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 45.3 p-10 -160.59 -32.35 0.05 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.673 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.545 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 99.1 m-20 -64.15 -39.43 94.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.451 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -60.51 -48.24 82.65 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.561 -179.346 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.418 ' O ' ' O ' ' A' ' 77' ' ' ALA . 91.6 t -60.38 -24.77 32.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.545 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -46.02 173.29 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.563 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.57 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.6 p30 -62.25 177.96 0.44 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.582 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.554 ' C ' ' H ' ' A' ' 81' ' ' GLY . 35.8 p30 -45.01 86.12 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.985 0.422 . . . . 0.0 110.946 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.57 ' N ' ' O ' ' A' ' 78' ' ' ASP . 43.1 tp60 -67.57 13.21 0.08 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.127 0.489 . . . . 0.0 110.13 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.554 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 118.51 -22.09 9.58 Favored Glycine 0 CA--C 1.519 0.306 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -108.31 116.49 32.06 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.959 0.409 . . . . 0.0 110.54 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 74.6 mt -98.57 0.17 44.41 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.485 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -92.25 7.18 43.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.013 0.435 . . . . 0.0 110.443 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.795 ' O ' HG22 ' A' ' 89' ' ' VAL . 27.0 mt-30 -100.13 -27.99 13.26 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.777 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 68.2 t-105 -62.51 -40.67 97.47 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.866 -179.638 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.55 ' O ' ' N ' ' A' ' 91' ' ' LYS . 66.1 m -77.64 -53.45 7.56 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.088 -179.389 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -48.73 -50.91 31.53 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.018 -179.193 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.795 HG22 ' O ' ' A' ' 85' ' ' GLN . 15.4 m -68.62 -40.71 82.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 120.934 0.397 . . . . 0.0 111.032 179.717 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.498 ' N ' HG23 ' A' ' 89' ' ' VAL . . . -72.05 -23.04 61.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.702 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.55 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.0 tttm -61.74 -45.68 92.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.482 -179.464 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.439 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.6 mm-40 -90.23 -95.47 0.11 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.16 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.64 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.9 mtt180 -142.59 58.87 1.44 Allowed 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.459 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.7 pttp 33.54 25.77 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 120.92 0.391 . . . . 0.0 110.19 -179.161 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.64 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.3 tt -47.86 123.75 6.49 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.924 -178.061 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.457 ' O ' HD23 ' A' ' 95' ' ' LEU . 99.0 mm-40 -83.91 -169.41 2.57 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.115 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.595 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 81.0 mtp180 -74.6 136.7 42.03 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.291 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.51 ' N ' ' O ' ' A' ' 67' ' ' SER . 90.6 mt -85.52 -165.57 1.26 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.856 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.536 ' O ' ' CD2' ' A' ' 99' ' ' TYR . 48.0 p90 -168.38 119.49 0.79 Allowed 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.254 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.511 ' C ' ' O ' ' A' ' 99' ' ' TYR . 43.3 mm -28.86 121.02 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.058 -179.709 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 113.76 27.89 3.37 Favored Glycine 0 CA--C 1.52 0.35 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 -179.452 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.58 ' CD ' ' H ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -144.48 46.65 0.64 Allowed Pre-proline 0 C--N 1.324 -0.524 0 CA-C-O 120.985 0.422 . . . . 0.0 110.425 179.856 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 29.2 Cg_endo -61.97 143.78 95.67 Favored 'Trans proline' 0 C--N 1.297 -2.161 0 C-N-CA 122.656 2.237 . . . . 0.0 111.942 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.455 ' O ' HG23 ' A' ' 108' ' ' VAL . 25.3 t -173.01 120.08 0.35 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.367 179.71 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.25 -40.41 64.66 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.075 0.464 . . . . 0.0 111.122 179.646 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.39 -39.88 89.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.926 -179.413 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.38 -40.16 95.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.729 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 104' ' ' SER . 71.7 t -67.79 -43.82 86.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.78 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.82 -38.97 92.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.578 -179.313 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.439 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.44 -23.4 62.66 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.493 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.545 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.3 mm-40 -90.29 5.23 48.1 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.652 -179.471 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.545 ' C ' ' O ' ' A' ' 111' ' ' GLN . 10.8 tpt 23.89 63.98 0.39 Allowed Pre-proline 0 N--CA 1.466 0.33 0 CA-C-O 120.939 0.399 . . . . 0.0 111.048 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -78.22 166.63 24.3 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 123.035 2.49 . . . . 0.0 112.062 -178.25 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.524 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 99.2 m-20 -109.77 -41.71 4.45 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.185 179.43 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.2 tp -121.63 120.12 33.82 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.522 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 83.2 mt -112.77 128.86 69.25 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.33 0 CA-C-O 120.941 0.401 . . . . 0.0 110.849 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.612 HD12 ' OG ' ' A' ' 48' ' ' SER . 30.1 mt -109.34 132.25 54.3 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.281 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.501 HD12 HG23 ' A' ' 139' ' ' THR . 98.9 mt -119.6 139.06 48.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.668 -179.697 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 85.1 p -72.68 153.89 40.98 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.527 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.01 -50.19 74.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.714 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.0 t -149.59 154.24 38.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.518 179.81 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 170.6 -171.06 43.53 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.99 -33.97 88.68 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.446 ' OD1' ' O ' ' A' ' 124' ' ' ASP . 44.0 p-10 -86.93 120.02 27.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.719 0.295 . . . . 0.0 110.685 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.436 ' O ' HD12 ' A' ' 129' ' ' LEU . 39.5 t -63.05 143.9 57.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.005 0.431 . . . . 0.0 110.453 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.527 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -92.9 -42.92 9.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.871 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.5 tp -62.98 -42.44 99.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.667 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.51 -12.5 60.48 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.524 -179.426 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.436 HD12 ' O ' ' A' ' 125' ' ' SER . 85.2 mt -114.52 -24.02 9.02 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.696 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' TYR . . . . . 0.527 ' N ' ' O ' ' A' ' 126' ' ' ALA . 80.0 t80 -50.77 -49.68 57.59 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.634 -178.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 37.8 p-10 -66.14 -42.69 88.76 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.848 0.356 . . . . 0.0 111.22 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.522 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 88.3 mt-30 -66.98 -37.89 85.06 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.823 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.435 HD12 HD11 ' A' ' 118' ' ' ILE . 96.0 mt -80.21 -41.43 25.2 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.92 -179.64 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.2 t -57.14 -44.58 83.51 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.245 -179.097 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.0 m -61.65 -45.41 94.17 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.75 0.31 . . . . 0.0 110.562 179.325 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 94.1 mt -62.18 -43.56 98.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.291 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.661 ' HB1' ' HD2' ' A' ' 138' ' ' PRO . . . -169.34 168.46 4.9 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.556 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.661 ' HD2' ' HB1' ' A' ' 137' ' ' ALA . 52.9 Cg_exo -50.35 113.68 1.13 Allowed 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.256 1.971 . . . . 0.0 112.221 179.341 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.501 HG23 HD12 ' A' ' 118' ' ' ILE . 24.1 m -84.61 127.45 34.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.494 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.691 HD13 ' CD2' ' A' ' 37' ' ' HIS . 34.4 tp -117.93 135.88 53.84 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.107 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.442 ' O ' ' OD2' ' A' ' 32' ' ' ASP . 82.2 mt -99.61 118.71 46.62 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.31 0 CA-C-O 121.221 0.534 . . . . 0.0 111.179 -179.293 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.423 HD12 HD22 ' A' ' 117' ' ' LEU . 98.0 mt -134.99 132.18 53.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.617 179.661 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.454 ' ND2' ' OD2' ' A' ' 241' ' ' ASP . 2.1 t-20 -66.9 151.5 47.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.911 0.386 . . . . 0.0 110.436 179.414 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.519 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 88.0 t80 -86.54 122.63 30.75 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.847 -179.532 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.519 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 99.1 m-20 55.23 69.17 0.76 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.769 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 35.7 p-10 -125.81 0.4 7.38 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.637 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -150.71 115.47 5.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.706 -179.512 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 83.5 p -63.3 168.18 4.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.534 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.417 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.4 p-90 -51.61 -15.72 0.5 Allowed 'General case' 0 C--O 1.223 -0.315 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.494 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' GLN . . . . . 0.448 ' O ' HG23 ' A' ' 154' ' ' THR . 68.2 tp60 -70.8 -75.54 0.12 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.51 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.455 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.0 t -62.76 -38.71 91.63 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.28 179.474 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 53.9 tp -60.02 -45.66 92.04 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.389 -178.578 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.417 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 46.6 tp -62.73 -41.63 99.27 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.473 178.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.455 ' OG1' ' O ' ' A' ' 151' ' ' SER . 59.7 p -63.89 -34.76 78.67 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.226 -179.521 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' GLN . . . . . 0.441 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 88.0 mm-40 -64.07 -42.42 96.99 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.309 179.257 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 90.8 mt -65.39 -38.79 91.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.033 0.444 . . . . 0.0 110.178 179.064 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.581 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.2 -32.33 80.21 Favored Glycine 0 CA--C 1.52 0.348 0 N-CA-C 110.719 -0.952 . . . . 0.0 110.719 -179.302 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.441 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.2 mt-10 -35.93 -25.98 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.858 0.361 . . . . 0.0 110.806 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.581 ' N ' ' O ' ' A' ' 157' ' ' GLY . 95.6 mt -57.99 148.99 5.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.299 179.236 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 74.7 p -69.24 137.44 53.14 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.979 -179.529 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 70.77 22.16 78.11 Favored Glycine 0 N--CA 1.458 0.165 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 179.463 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 58.1 m80 -124.32 -14.46 6.95 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.695 0.283 . . . . 0.0 110.538 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -66.05 -59.92 3.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.649 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -52.0 -48.83 64.26 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.134 -179.546 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -60.52 -41.22 93.96 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.728 0.299 . . . . 0.0 110.321 179.518 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.61 -47.18 86.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.517 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.87 -40.1 75.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.246 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -61.7 -50.33 72.88 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.579 179.532 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 60.1 ttt85 -65.44 -43.73 89.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.54 179.486 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 94.9 mt -64.72 -43.37 96.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.486 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.38 -51.23 70.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.498 -179.213 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -63.57 -43.64 96.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.533 179.687 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 173' ' ' PHE . . . . . 0.652 ' CE2' HD11 ' A' ' 177' ' ' LEU . 56.6 t80 -62.9 -44.29 96.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.087 0.47 . . . . 0.0 110.442 179.417 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -63.65 -39.86 95.4 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.478 -179.23 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -62.89 -42.87 99.93 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.659 179.176 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -60.59 -44.7 95.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.207 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.652 HD11 ' CE2' ' A' ' 173' ' ' PHE . 84.2 mt -64.47 -41.05 96.73 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.994 0.425 . . . . 0.0 110.668 178.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.12 -62.18 1.8 Allowed 'General case' 0 C--O 1.237 0.431 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.382 -179.329 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.52 -46.78 86.05 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.578 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.24 -41.67 65.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.302 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -63.91 -33.67 76.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.393 179.324 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 182' ' ' GLU . . . . . 0.421 ' O ' ' HG2' ' A' ' 182' ' ' GLU . 69.5 tt0 -90.54 8.94 31.51 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.437 0.637 . . . . 0.0 110.491 -178.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -105.04 -32.07 8.89 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.174 179.612 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.8 pt -128.07 147.55 32.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.842 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -139.68 131.05 26.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.395 179.337 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 186' ' ' LEU . . . . . 0.593 HD22 ' N ' ' A' ' 186' ' ' LEU . 3.6 mm? -85.47 133.46 42.17 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.9 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -44.12 157.8 0.15 Allowed 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.738 2.292 . . . . 0.0 112.235 179.342 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 188' ' ' PRO . . . . . 0.518 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.5 Cg_endo -62.89 114.69 2.53 Favored 'Trans proline' 0 C--N 1.303 -1.82 0 C-N-CA 122.813 2.342 . . . . 0.0 111.748 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 189' ' ' GLN . . . . . 0.518 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.7 mt-30 155.69 147.88 0.0 OUTLIER Pre-proline 0 C--N 1.332 -0.169 0 O-C-N 123.713 0.633 . . . . 0.0 110.838 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -73.85 144.01 34.13 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.673 2.249 . . . . 0.0 112.012 177.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.496 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.0 p -124.78 158.95 31.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.296 0.569 . . . . 0.0 110.125 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 192' ' ' THR . . . . . 0.496 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 37.5 p -143.46 165.39 27.68 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.048 -179.712 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 193' ' ' ALA . . . . . 0.443 ' HA ' ' H ' ' A' ' 260' ' ' PHE . . . -135.2 128.58 32.27 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.173 0.511 . . . . 0.0 110.264 179.516 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.516 HD11 HD23 ' A' ' 259' ' ' LEU . 47.9 pt -146.52 148.86 16.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.084 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 195' ' ' VAL . . . . . 0.75 HG13 ' CD1' ' A' ' 262' ' ' PHE . 68.8 t -117.73 123.06 71.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.312 0.577 . . . . 0.0 109.813 179.028 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -134.14 106.62 7.28 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.391 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 94.3 m -130.1 130.41 44.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.764 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -82.88 -36.81 25.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.259 179.602 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.56 -67.14 0.26 Allowed 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.361 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.28 -9.96 59.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.377 179.524 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 60.2 t-80 60.94 58.47 2.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.901 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 35.5 p -167.23 153.48 8.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.549 179.481 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.31 144.16 24.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.943 0.402 . . . . 0.0 110.485 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -135.34 138.16 43.12 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.669 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 19.5 mt -106.32 125.46 51.02 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.061 0.458 . . . . 0.0 109.842 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 206' ' ' TRP . . . . . 0.558 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 74.7 m95 -82.07 167.13 19.12 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.676 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 207' ' ' THR . . . . . 0.468 HG22 ' C ' ' A' ' 206' ' ' TRP . 0.1 OUTLIER -156.9 171.14 7.83 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.595 -179.165 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.43 -37.15 81.67 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 C-N-CA 122.598 2.198 . . . . 0.0 112.219 179.126 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -70.56 -34.95 72.8 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.836 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 21.0 m -61.28 150.91 33.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.615 -179.364 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.61 -37.04 82.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.49 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 212' ' ' GLN . . . . . 0.558 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 54.7 tt0 -64.66 -40.33 95.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.579 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.52 -43.46 92.27 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -63.29 -43.73 97.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.81 0.338 . . . . 0.0 110.288 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 215' ' ' MET . . . . . 0.531 ' SD ' ' HB2' ' A' ' 304' ' ' ALA . 65.1 ttp -59.4 -48.12 82.84 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.26 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 88.4 mt -60.49 -40.94 93.13 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.685 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 217' ' ' GLU . . . . . 0.454 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.0 tp10 -57.97 -37.74 74.75 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -65.31 -38.08 89.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.787 0.327 . . . . 0.0 110.652 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 94.7 mt -64.27 -42.71 96.32 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.58 -179.676 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.52 44.73 0.08 OUTLIER Glycine 0 CA--C 1.52 0.392 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 221' ' ' PHE . . . . . 0.454 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 26.5 m-85 -127.78 155.47 44.01 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.075 0.464 . . . . 0.0 110.522 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.486 ' O ' HG13 ' A' ' 191' ' ' VAL . 6.7 p -107.1 122.25 46.11 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.266 0.555 . . . . 0.0 110.122 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.47 HD22 ' C ' ' A' ' 222' ' ' THR . 4.3 mm? -101.17 133.15 46.15 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.056 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -97.01 159.34 14.96 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.467 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.32 115.42 30.24 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.954 0.407 . . . . 0.0 110.344 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.503 HD12 ' N ' ' A' ' 226' ' ' LEU . 8.8 mp -53.42 156.51 4.18 Favored Pre-proline 0 N--CA 1.452 -0.328 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.696 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -60.02 145.2 98.94 Favored 'Trans proline' 0 C--N 1.301 -1.929 0 C-N-CA 122.682 2.254 . . . . 0.0 112.163 179.265 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.25 -2.98 59.01 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.605 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.39 -40.83 5.63 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 230' ' ' LEU . . . . . 0.539 ' O ' ' N ' ' A' ' 233' ' ' SER . 86.2 mt -79.07 -16.98 56.01 Favored 'General case' 0 C--O 1.222 -0.373 0 CA-C-O 121.069 0.461 . . . . 0.0 110.334 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 231' ' ' ASN . . . . . 0.404 ' C ' ' O ' ' A' ' 230' ' ' LEU . 53.9 t-20 -40.21 -49.12 2.66 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.732 -179.469 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -88.17 15.35 7.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.255 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 233' ' ' SER . . . . . 0.539 ' N ' ' O ' ' A' ' 230' ' ' LEU . 78.0 p -60.49 -35.68 76.51 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.712 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 234' ' ' GLN . . . . . 0.524 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.5 tt0 -118.35 -69.34 0.86 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.894 179.457 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.2 m -69.98 103.68 2.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.093 0.473 . . . . 0.0 110.691 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -94.88 57.54 2.13 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.366 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -144.92 -122.61 1.57 Allowed Glycine 0 CA--C 1.52 0.346 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -134.4 111.93 10.56 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 121.132 0.491 . . . . 0.0 110.368 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 239' ' ' ARG . . . . . 0.512 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.5 mtt180 -148.32 57.52 1.07 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.792 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -69.91 -31.87 69.88 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.539 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 241' ' ' ASP . . . . . 0.457 ' OD2' ' O ' ' A' ' 144' ' ' TYR . 64.7 t0 -56.92 -46.93 81.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.33 -179.135 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 242' ' ' ILE . . . . . 0.436 ' O ' ' O ' ' A' ' 239' ' ' ARG . 17.4 tt -140.16 156.92 25.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.9 0.381 . . . . 0.0 110.533 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.439 HG22 HD13 ' A' ' 245' ' ' LEU . 96.1 mt -106.0 106.19 20.11 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.214 0 CA-C-O 121.163 0.506 . . . . 0.0 110.529 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 244' ' ' GLN . . . . . 0.604 ' O ' HD12 ' A' ' 245' ' ' LEU . 88.3 mt-30 -110.37 110.26 20.98 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.42 179.674 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.604 HD12 ' O ' ' A' ' 244' ' ' GLN . 9.5 mp -121.97 -168.25 1.68 Allowed 'General case' 0 C--O 1.226 -0.177 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.605 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 246' ' ' GLY . . . . . 0.524 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.37 -16.7 0.05 OUTLIER Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 247' ' ' GLY . . . . . 0.67 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -60.49 157.05 29.84 Favored Glycine 0 CA--C 1.522 0.477 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -63.8 21.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.879 0.371 . . . . 0.0 110.548 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 249' ' ' ASN . . . . . 0.67 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.9 m-20 -96.95 -5.97 36.69 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.499 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 92.8 mt -79.88 -21.68 43.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.671 179.408 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.51 -51.17 71.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.784 -179.551 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.56 -5.52 58.14 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.473 179.59 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.36 -74.4 1.15 Allowed Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 81.4 mt -69.98 125.77 27.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.011 0.434 . . . . 0.0 110.332 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -59.26 -39.5 83.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.212 -179.614 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 82.65 51.93 4.11 Favored Glycine 0 CA--C 1.52 0.404 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -96.48 -14.49 22.31 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.712 0.292 . . . . 0.0 110.581 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 258' ' ' SER . . . . . 0.494 ' OG ' HG23 ' A' ' 191' ' ' VAL . 3.5 t 174.58 88.36 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.037 0.446 . . . . 0.0 110.165 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.86 HD12 ' N ' ' A' ' 259' ' ' LEU . 0.9 OUTLIER -94.2 123.98 37.93 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.183 0.516 . . . . 0.0 111.088 -179.1 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 260' ' ' PHE . . . . . 0.443 ' H ' ' HA ' ' A' ' 193' ' ' ALA . 15.9 m-30 -92.97 146.24 23.77 Favored 'General case' 0 CA--C 1.505 -0.786 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.428 179.295 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 86.7 mt -122.21 149.96 42.93 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.628 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.75 ' CD1' HG13 ' A' ' 195' ' ' VAL . 2.6 p90 -77.53 -138.23 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.619 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 263' ' ' ALA . . . . . 0.66 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -52.43 77.44 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.01 0.433 . . . . 0.0 111.074 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 264' ' ' GLY . . . . . 0.624 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -178.93 104.42 0.19 Allowed Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.666 -0.974 . . . . 0.0 110.666 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 265' ' ' ASP . . . . . 0.601 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.9 m-20 -80.45 -177.8 6.37 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 120.643 0.259 . . . . 0.0 110.862 -179.424 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -40.41 -17.62 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.548 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 267' ' ' LYS . . . . . 0.601 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.48 -51.66 40.98 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 120.998 0.428 . . . . 0.0 110.687 179.386 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -63.64 -46.72 84.4 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.212 179.394 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 269' ' ' ALA . . . . . 0.573 ' HB1' ' OH ' ' A' ' 273' ' ' TYR . . . -61.64 -35.08 76.89 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.218 0.532 . . . . 0.0 109.84 179.65 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -63.11 -34.09 76.85 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.045 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.73 -43.37 13.43 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.175 -179.557 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 272' ' ' ILE . . . . . 0.587 ' C ' ' H ' ' A' ' 274' ' ' ALA . 4.9 tt -51.43 -33.53 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.815 -178.792 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 273' ' ' TYR . . . . . 0.573 ' OH ' ' HB1' ' A' ' 269' ' ' ALA . 17.2 m-85 -54.49 -1.74 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.681 -179.599 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 274' ' ' ALA . . . . . 0.587 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.55 -39.61 70.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.842 179.525 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 275' ' ' ASN . . . . . 0.583 ' O ' ' N ' ' A' ' 279' ' ' ALA . 3.1 p30 -39.32 98.06 0.16 Allowed Pre-proline 0 C--O 1.226 -0.144 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.495 -179.662 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -54.29 -42.92 63.26 Favored 'Trans proline' 0 C--N 1.303 -1.856 0 C-N-CA 122.385 2.056 . . . . 0.0 112.533 -178.715 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 88.8 mt -64.46 -42.84 95.71 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.103 0.478 . . . . 0.0 111.138 -179.673 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 90.6 mt -95.67 -1.68 49.62 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.887 -179.523 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 279' ' ' ALA . . . . . 0.583 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.38 -34.81 77.44 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.668 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.29 20.26 0.11 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.968 -179.254 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 281' ' ' LEU . . . . . 0.488 HD23 ' HA ' ' A' ' 281' ' ' LEU . 13.8 mt -75.47 119.89 79.11 Favored Pre-proline 0 N--CA 1.451 -0.423 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.56 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -50.49 -39.41 54.9 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 122.66 2.24 . . . . 0.0 111.951 178.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.75 -50.55 63.25 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.149 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 78.8 t -61.4 -44.02 97.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 179.479 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -57.74 -41.15 81.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.252 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -90.98 -0.03 57.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.2 179.608 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt 59.47 43.58 16.05 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.872 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -94.81 41.41 1.09 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.387 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 53.8 t -119.08 135.8 58.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.047 0.451 . . . . 0.0 110.173 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -133.01 162.56 31.37 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.645 -179.624 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.7 155.11 33.06 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.943 0.401 . . . . 0.0 110.754 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 81.4 mt -93.91 -1.43 54.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.302 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.38 165.93 12.77 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 6.5 m -87.61 -62.39 1.51 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.888 0.375 . . . . 0.0 110.945 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 295' ' ' GLU . . . . . 0.434 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.5 mm-40 -69.54 -3.83 16.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.645 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 27.2 p -76.94 33.27 0.14 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.663 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 297' ' ' PHE . . . . . 0.532 ' CD2' HG22 ' A' ' 70' ' ' THR . 85.1 t80 -60.21 -46.01 91.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.618 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 298' ' ' ARG . . . . . 0.595 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.2 mtt85 -81.71 134.6 35.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.584 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.456 ' H ' HG11 ' A' ' 51' ' ' VAL . 16.3 tp -114.27 119.07 35.73 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-O 121.006 0.431 . . . . 0.0 110.19 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 300' ' ' ASP . . . . . 0.626 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.9 p-10 -166.52 -175.09 3.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.577 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 81.5 t80 -47.78 -44.72 28.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.292 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -65.59 -41.16 93.14 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.021 0.438 . . . . 0.0 110.701 178.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 303' ' ' SER . . . . . 0.626 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 54.0 p -55.58 -36.16 66.56 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.042 -179.219 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 304' ' ' ALA . . . . . 0.531 ' HB2' ' SD ' ' A' ' 215' ' ' MET . . . -57.07 -51.65 68.43 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.418 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 90.9 mtp -56.23 -43.87 79.03 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -66.29 -42.68 88.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.029 0.442 . . . . 0.0 110.284 178.795 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 307' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 303' ' ' SER . 55.8 t -64.08 -42.75 96.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.208 179.377 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 42.6 tp -59.57 -42.2 91.91 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.816 -179.519 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -62.72 -38.83 92.04 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.148 179.465 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 310' ' ' ARG . . . . . 0.439 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.6 ttt85 -63.33 -44.09 95.89 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.216 179.594 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 88.3 mt -63.24 -42.06 99.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.255 179.58 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -62.85 -33.03 74.4 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.124 179.456 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -90.17 -23.32 21.35 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.352 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 314' ' ' LEU . . . . . 0.479 HD22 ' CE2' ' A' ' 315' ' ' PHE . 6.8 tt -62.33 -43.23 99.3 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 121.041 0.448 . . . . 0.0 110.531 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 315' ' ' PHE . . . . . 0.479 ' CE2' HD22 ' A' ' 314' ' ' LEU . 91.7 m-85 . . . . . 0 C--O 1.22 -0.453 0 CA-C-O 117.97 -1.014 . . . . 0.0 110.436 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -99.8 135.81 40.66 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.114 0.483 . . . . 0.0 110.503 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.497 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -91.63 178.7 1.64 Allowed Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.53 -179.857 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.497 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.4 Cg_exo -61.62 147.67 94.82 Favored 'Trans proline' 0 C--N 1.3 -2.023 0 C-N-CA 122.901 2.401 . . . . 0.0 112.113 179.53 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.486 ' HE ' HD12 ' A' ' 39' ' ' LEU . 35.1 ptt180 -135.02 142.16 46.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.64 179.664 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -78.93 116.95 19.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.51 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.422 ' O ' HG23 ' A' ' 30' ' ' ILE . 9.6 tp -110.53 131.27 62.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.445 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.9 t -70.84 142.93 51.24 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.655 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 141' ' ' ILE . 24.6 t70 -141.05 177.36 8.11 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.468 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.3 p -73.15 -36.75 66.7 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.696 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -47.68 -95.01 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.303 -179.376 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -165.95 -25.28 0.02 OUTLIER Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 58.2 m -168.93 106.74 0.43 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.862 0.363 . . . . 0.0 110.632 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 50.9 t-80 -129.79 144.49 51.33 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 121.066 0.46 . . . . 0.0 110.114 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.63 HG22 ' N ' ' A' ' 39' ' ' LEU . 97.2 m -128.59 166.63 18.49 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.49 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.63 ' N ' HG22 ' A' ' 38' ' ' THR . 82.2 mt -121.15 127.8 51.9 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.43 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -64.17 -44.48 91.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.716 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 37.9 p -165.55 155.03 12.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.387 179.601 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.53 ' CD ' ' H ' ' A' ' 42' ' ' GLN . 14.4 mp0 -42.71 100.28 0.22 Allowed Pre-proline 0 C--N 1.33 -0.261 0 O-C-N 123.352 0.408 . . . . 0.0 110.594 179.261 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -56.88 129.07 32.59 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 122.313 2.008 . . . . 0.0 112.239 -179.485 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -83.82 -24.13 31.1 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.552 179.577 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.541 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.5 mtm-85 -121.18 134.11 55.2 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.202 0.525 . . . . 0.0 110.192 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.0 mt -130.43 133.51 63.68 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.272 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.798 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 47.5 t -125.0 130.89 73.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 179.32 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.601 ' OG ' HD12 ' A' ' 117' ' ' LEU . 5.0 m -154.05 166.48 32.89 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.586 179.676 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 70.0 p -124.83 8.37 8.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.435 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.81 125.87 33.59 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.643 -179.468 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.46 HG11 ' H ' ' A' ' 299' ' ' LEU . 86.5 t -65.7 -44.61 93.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.543 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.7 m -62.62 -44.15 97.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.561 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 53.5 tp -62.38 -41.58 98.74 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.534 -179.432 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.452 ' O ' HD13 ' A' ' 58' ' ' LEU . 72.5 m -57.83 -44.42 86.45 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.267 -179.198 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.4 -62.17 5.34 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 179.589 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.6 t -48.18 -35.62 12.08 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.8 mt -61.86 -44.34 97.01 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.229 179.34 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.452 HD13 ' O ' ' A' ' 54' ' ' THR . 9.2 mp -65.43 -41.49 93.48 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.246 178.025 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.406 ' HB1' ' NE ' ' A' ' 169' ' ' ARG . . . -63.58 -41.13 98.4 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.906 -179.243 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.422 ' O ' HG23 ' A' ' 60' ' ' ILE . 8.0 tp -88.21 16.73 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.857 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 56.51 84.34 0.09 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.753 -179.735 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.24 57.98 0.07 OUTLIER Pre-proline 0 C--N 1.328 -0.359 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -179.801 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -51.13 153.39 9.31 Favored 'Trans proline' 0 C--N 1.293 -2.351 0 C-N-CA 123.029 2.486 . . . . 0.0 112.11 -178.175 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.429 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -109.06 146.01 15.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.332 -179.681 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 97.0 mt -63.62 -45.48 97.43 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.338 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.502 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -129.8 134.58 47.66 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.519 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.482 ' O ' ' N ' ' A' ' 98' ' ' LEU . 73.3 m -134.57 158.82 43.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.838 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.99 139.36 16.17 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.496 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.93 -162.66 0.08 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.967 0.413 . . . . 0.0 110.423 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.52 HG22 ' CD2' ' A' ' 297' ' ' PHE . 13.8 t -133.45 135.49 44.58 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.389 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.482 ' C ' ' O ' ' A' ' 70' ' ' THR . 0.7 OUTLIER 29.72 68.94 0.64 Allowed Pre-proline 0 N--CA 1.466 0.354 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.729 -179.883 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_exo -61.52 145.39 97.9 Favored 'Trans proline' 0 C--N 1.3 -2.026 0 C-N-CA 122.714 2.276 . . . . 0.0 111.837 -178.059 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.527 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 46.4 p-10 -160.49 -31.96 0.06 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.742 179.69 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.533 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 99.1 m-20 -64.51 -39.21 93.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.317 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 -60.63 -48.09 83.32 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.52 -179.133 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.426 ' O ' ' O ' ' A' ' 77' ' ' ALA . 94.0 t -60.19 -24.9 31.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.373 -0.376 . . . . 0.0 109.999 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.533 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -45.45 172.69 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.648 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.568 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.7 p30 -61.67 177.57 0.4 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.513 -179.663 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.566 ' C ' ' H ' ' A' ' 81' ' ' GLY . 36.0 p30 -46.27 85.65 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.005 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.568 ' N ' ' O ' ' A' ' 78' ' ' ASP . 42.8 tp60 -67.08 13.54 0.06 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.194 0.521 . . . . 0.0 110.169 -179.822 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.566 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 117.87 -21.93 10.13 Favored Glycine 0 N--CA 1.461 0.309 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -107.83 116.29 31.69 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.985 0.422 . . . . 0.0 110.466 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 75.7 mt -98.84 0.79 44.99 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.502 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -91.94 6.5 46.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.019 0.438 . . . . 0.0 110.397 -179.682 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.783 ' O ' HG22 ' A' ' 89' ' ' VAL . 27.1 mt-30 -100.16 -27.0 13.75 Favored 'General case' 0 C--O 1.222 -0.385 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.78 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.4 t-105 -64.31 -40.64 96.34 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.021 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.551 ' O ' ' N ' ' A' ' 91' ' ' LYS . 68.5 m -77.75 -53.75 7.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.164 -179.567 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -48.33 -50.55 29.91 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.08 -179.157 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.783 HG22 ' O ' ' A' ' 85' ' ' GLN . 14.8 m -69.08 -40.88 81.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 120.9 0.381 . . . . 0.0 111.113 179.602 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.503 ' N ' HG23 ' A' ' 89' ' ' VAL . . . -71.94 -22.82 61.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.655 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.551 ' N ' ' O ' ' A' ' 87' ' ' SER . 65.8 tttm -61.64 -46.13 91.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.428 -179.512 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.441 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.8 mm-40 -90.15 -94.44 0.12 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.152 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.62 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.9 mtt180 -143.49 59.79 1.39 Allowed 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.451 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.6 pttp 33.87 26.28 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.017 0.437 . . . . 0.0 110.286 -179.405 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.62 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.5 tt -48.27 123.14 6.03 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.011 -177.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.452 ' O ' HD23 ' A' ' 95' ' ' LEU . 99.0 mm-40 -83.41 -170.6 3.13 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.148 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.62 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 82.5 mtp180 -73.12 137.85 45.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.308 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.482 ' N ' ' O ' ' A' ' 67' ' ' SER . 88.7 mt -86.58 -166.14 1.47 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.793 -179.689 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.532 ' O ' ' CD2' ' A' ' 99' ' ' TYR . 47.8 p90 -167.89 119.9 0.86 Allowed 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.198 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.5 ' C ' ' O ' ' A' ' 99' ' ' TYR . 43.4 mm -29.44 121.18 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.005 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 113.64 28.25 3.28 Favored Glycine 0 CA--C 1.519 0.342 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 -179.447 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.58 ' N ' ' CD ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -144.0 46.15 0.62 Allowed Pre-proline 0 C--N 1.323 -0.582 0 CA-C-O 121.013 0.435 . . . . 0.0 110.428 179.764 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 29.5 Cg_endo -62.29 143.87 94.55 Favored 'Trans proline' 0 C--N 1.295 -2.246 0 C-N-CA 122.684 2.256 . . . . 0.0 111.844 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.46 ' O ' HG23 ' A' ' 108' ' ' VAL . 26.8 t -173.13 120.69 0.36 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.319 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.37 -40.94 63.97 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.075 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -65.92 -39.86 90.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.814 -179.417 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.01 -39.64 94.56 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.771 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 104' ' ' SER . 69.0 t -67.72 -43.74 86.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.724 179.585 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.43 -39.29 92.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.446 -179.161 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.441 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.66 -23.71 63.29 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.496 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.549 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.3 mm-40 -91.39 5.13 50.53 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.722 -179.563 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.549 ' C ' ' O ' ' A' ' 111' ' ' GLN . 10.4 tpt 21.96 64.84 0.32 Allowed Pre-proline 0 N--CA 1.467 0.408 0 CA-C-O 120.934 0.397 . . . . 0.0 111.157 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.448 ' HG2' HD11 ' A' ' 116' ' ' ILE . 61.8 Cg_endo -79.45 169.59 18.43 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 123.023 2.482 . . . . 0.0 111.698 -177.919 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.491 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 98.9 m-20 -113.12 -44.07 3.31 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.022 179.6 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.3 tp -120.09 120.69 36.98 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.562 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.462 HD13 HD22 ' A' ' 133' ' ' LEU . 96.4 mt -118.24 130.87 72.46 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.342 0 CA-C-O 120.904 0.383 . . . . 0.0 110.962 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.601 HD12 ' OG ' ' A' ' 48' ' ' SER . 32.3 mt -105.77 132.71 51.56 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.04 0.448 . . . . 0.0 110.287 -179.413 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 97.9 mt -117.9 135.74 57.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.673 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 85.5 p -71.7 153.42 42.05 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.593 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.11 -50.2 74.62 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.635 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -149.34 153.8 38.0 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.52 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 169.88 -170.51 42.85 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -63.08 -35.14 91.68 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.453 ' OD1' ' O ' ' A' ' 124' ' ' ASP . 44.4 p-10 -87.75 119.52 28.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.834 0.349 . . . . 0.0 110.701 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.446 ' O ' HD12 ' A' ' 129' ' ' LEU . 41.1 t -63.47 144.51 56.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.406 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.61 -42.33 9.25 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.775 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.4 tp -62.86 -42.22 99.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.649 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.41 -11.11 59.18 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.441 -179.389 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.446 HD12 ' O ' ' A' ' 125' ' ' SER . 84.5 mt -114.92 -24.55 8.58 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.647 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' TYR . . . . . 0.519 ' N ' ' O ' ' A' ' 126' ' ' ALA . 80.8 t80 -51.37 -49.91 60.58 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.649 -178.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.8 p-10 -65.72 -41.91 91.7 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.879 0.371 . . . . 0.0 111.317 179.429 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.521 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 87.8 mt-30 -67.88 -37.16 81.43 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.847 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.462 HD22 HD13 ' A' ' 116' ' ' ILE . 93.7 mt -79.7 -42.37 24.81 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.987 -179.682 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.3 t -56.94 -44.96 83.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.298 -179.164 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.8 m -62.32 -45.58 92.6 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.58 179.484 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 92.9 mt -62.49 -44.03 98.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.391 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.613 ' HB1' ' HD2' ' A' ' 138' ' ' PRO . . . -169.86 164.2 6.39 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.598 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.613 ' HD2' ' HB1' ' A' ' 137' ' ' ALA . 74.3 Cg_exo -43.32 111.66 0.24 Allowed 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.507 2.138 . . . . 0.0 112.243 179.249 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.467 HG21 ' CD1' ' A' ' 130' ' ' TYR . 17.1 m -86.12 127.34 34.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.675 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.447 HD12 ' HA ' ' A' ' 140' ' ' LEU . 34.9 tp -119.48 137.48 53.76 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.107 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.423 ' O ' ' OD1' ' A' ' 32' ' ' ASP . 78.2 mt -104.82 120.74 55.79 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 CA-C-O 121.154 0.502 . . . . 0.0 111.213 -179.352 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.506 HD12 HD22 ' A' ' 117' ' ' LEU . 94.3 mt -136.44 132.55 49.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.576 179.543 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.55 HD21 ' CG ' ' A' ' 241' ' ' ASP . 56.1 t30 -64.47 151.65 43.77 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.941 0.4 . . . . 0.0 110.43 179.262 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.522 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 88.1 t80 -85.57 122.71 30.08 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.966 -179.492 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.522 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 99.0 m-20 54.95 69.44 0.73 Allowed 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.741 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 49.3 p-10 -123.87 0.07 8.56 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.844 0.354 . . . . 0.0 110.638 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -151.46 117.03 5.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.766 -179.487 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 85.1 p -62.91 167.6 4.59 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.558 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.409 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.5 p-90 -50.56 -15.69 0.29 Allowed 'General case' 0 C--O 1.223 -0.322 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.469 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' GLN . . . . . 0.445 ' O ' HG23 ' A' ' 154' ' ' THR . 68.0 tp60 -71.3 -74.57 0.15 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.496 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.448 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.2 t -62.75 -39.07 92.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.18 179.572 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 52.1 tp -60.08 -45.7 92.05 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.403 -178.464 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.409 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 46.8 tp -62.67 -41.64 99.19 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.529 178.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.448 ' OG1' ' O ' ' A' ' 151' ' ' SER . 53.4 p -64.02 -34.71 78.63 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.192 -179.425 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 155' ' ' GLN . . . . . 0.48 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.8 mm-40 -63.82 -42.08 97.73 Favored 'General case' 0 C--O 1.226 -0.178 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.273 179.26 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 90.8 mt -65.44 -38.82 91.0 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.096 0.474 . . . . 0.0 110.203 179.176 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.567 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.46 -31.94 79.31 Favored Glycine 0 CA--C 1.52 0.353 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 -179.267 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.48 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.3 mt-10 -37.04 -25.17 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.818 0.342 . . . . 0.0 110.799 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.567 ' N ' ' O ' ' A' ' 157' ' ' GLY . 93.4 mt -59.79 149.63 6.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.323 179.285 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 76.5 p -68.99 137.26 53.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.935 -179.493 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 70.36 22.47 77.63 Favored Glycine 0 N--CA 1.459 0.184 0 N-CA-C 111.211 -0.756 . . . . 0.0 111.211 179.442 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 62.0 m80 -124.29 -14.63 6.92 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.681 0.276 . . . . 0.0 110.48 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -67.02 -59.41 3.5 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.628 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -51.78 -49.26 63.04 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.119 -179.54 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -60.7 -41.09 94.5 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.894 -0.322 . . . . 0.0 110.45 179.479 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.48 -47.69 84.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.567 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.53 -40.25 74.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.244 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -61.56 -50.1 74.01 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.631 179.505 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.406 ' NE ' ' HB1' ' A' ' 59' ' ' ALA . 59.9 ttt85 -65.3 -43.57 90.68 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.523 179.461 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 94.4 mt -64.61 -43.38 96.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.366 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.35 -51.41 69.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.378 -179.116 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -63.51 -43.69 96.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.614 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 173' ' ' PHE . . . . . 0.665 ' CE2' HD11 ' A' ' 177' ' ' LEU . 56.3 t80 -62.88 -44.32 96.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.077 0.465 . . . . 0.0 110.407 179.475 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -63.32 -39.61 95.04 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.659 -179.465 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -63.15 -42.78 99.5 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.55 179.224 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -60.76 -44.74 96.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.238 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.665 HD11 ' CE2' ' A' ' 173' ' ' PHE . 85.1 mt -64.66 -41.05 96.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.73 178.895 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.12 -62.21 1.78 Allowed 'General case' 0 C--O 1.238 0.479 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.37 -179.323 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.61 -46.66 86.54 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.58 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.27 -41.49 65.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.34 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -64.05 -33.78 76.54 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.011 0.434 . . . . 0.0 110.235 179.399 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 182' ' ' GLU . . . . . 0.417 ' O ' ' HG2' ' A' ' 182' ' ' GLU . 69.7 tt0 -90.76 8.86 32.51 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.538 0.685 . . . . 0.0 110.371 -178.78 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -104.73 -32.13 9.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.18 179.492 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.7 pt -127.96 147.69 32.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.807 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -139.98 131.23 26.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.428 179.211 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 186' ' ' LEU . . . . . 0.592 HD22 ' N ' ' A' ' 186' ' ' LEU . 3.5 mm? -85.38 133.15 42.95 Favored Pre-proline 0 N--CA 1.452 -0.358 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.077 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -43.78 157.86 0.13 Allowed 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.714 2.276 . . . . 0.0 112.316 179.267 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 188' ' ' PRO . . . . . 0.51 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.6 Cg_endo -62.91 114.84 2.6 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 C-N-CA 122.804 2.336 . . . . 0.0 111.746 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 189' ' ' GLN . . . . . 0.51 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.7 mt-30 155.63 147.69 0.0 OUTLIER Pre-proline 0 N--CA 1.457 -0.113 0 O-C-N 123.916 0.76 . . . . 0.0 110.825 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -73.48 144.18 35.81 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.672 2.248 . . . . 0.0 112.213 177.725 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.496 HG23 ' OG ' ' A' ' 258' ' ' SER . 2.1 p -124.96 158.97 32.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.319 0.581 . . . . 0.0 110.212 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 192' ' ' THR . . . . . 0.492 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 35.8 p -143.28 165.11 28.38 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.034 -179.704 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 193' ' ' ALA . . . . . 0.448 ' HA ' ' H ' ' A' ' 260' ' ' PHE . . . -135.38 128.72 32.15 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 121.244 0.545 . . . . 0.0 110.281 179.395 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.511 HD11 HD23 ' A' ' 259' ' ' LEU . 47.5 pt -146.46 148.87 16.55 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.348 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.13 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 195' ' ' VAL . . . . . 0.749 HG13 ' CD1' ' A' ' 262' ' ' PHE . 69.0 t -117.59 123.23 71.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.32 0.581 . . . . 0.0 109.836 178.919 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -134.4 107.01 7.35 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.336 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 95.3 m -130.7 130.59 44.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.813 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.4 ' O ' ' N ' ' A' ' 201' ' ' HIS . . . -82.82 -37.04 25.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.21 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.33 -67.21 0.25 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.328 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.16 -9.84 58.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.299 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 201' ' ' HIS . . . . . 0.4 ' N ' ' O ' ' A' ' 198' ' ' ALA . 59.8 t-80 60.64 58.34 2.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.85 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 31.8 p -167.21 153.76 8.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.555 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.3 144.04 24.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.049 0.452 . . . . 0.0 110.398 179.245 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -135.18 138.01 43.23 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.714 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 19.7 mt -105.96 125.32 50.85 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.083 0.468 . . . . 0.0 109.843 -179.683 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 206' ' ' TRP . . . . . 0.554 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 74.6 m95 -81.98 166.98 19.35 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.543 -179.693 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 207' ' ' THR . . . . . 0.465 HG22 ' C ' ' A' ' 206' ' ' TRP . 0.1 OUTLIER -157.21 171.24 7.7 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.581 -179.083 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.31 -36.92 80.28 Favored 'Trans proline' 0 C--N 1.302 -1.874 0 C-N-CA 122.612 2.208 . . . . 0.0 112.32 179.093 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -70.86 -35.02 72.21 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.713 -179.759 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 21.5 m -61.16 150.64 33.62 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.602 -179.431 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.68 -37.0 82.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.445 -179.699 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 212' ' ' GLN . . . . . 0.554 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 54.9 tt0 -64.7 -40.26 95.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.498 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.71 -43.44 91.87 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -63.11 -43.96 96.97 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.803 0.335 . . . . 0.0 110.283 179.792 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 215' ' ' MET . . . . . 0.541 ' SD ' ' HB2' ' A' ' 304' ' ' ALA . 65.1 ttp -59.26 -48.12 82.81 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.123 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 87.3 mt -60.52 -41.04 93.61 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 217' ' ' GLU . . . . . 0.451 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.0 tp10 -57.94 -37.89 74.93 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.059 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -65.34 -38.18 89.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.655 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 94.2 mt -64.08 -42.93 96.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.074 0.464 . . . . 0.0 110.596 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.89 44.74 0.08 OUTLIER Glycine 0 C--N 1.332 0.339 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 221' ' ' PHE . . . . . 0.451 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 26.3 m-85 -127.74 155.64 43.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.987 0.422 . . . . 0.0 110.498 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.483 ' O ' HG13 ' A' ' 191' ' ' VAL . 7.4 p -107.36 122.49 46.7 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.285 0.564 . . . . 0.0 110.132 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.476 HD22 ' C ' ' A' ' 222' ' ' THR . 4.3 mm? -101.64 132.7 47.18 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.101 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.4 159.95 14.67 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.476 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.55 115.36 30.11 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.348 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.494 HD12 ' N ' ' A' ' 226' ' ' LEU . 8.9 mp -53.37 156.7 3.94 Favored Pre-proline 0 N--CA 1.452 -0.36 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.725 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -59.91 145.1 99.13 Favored 'Trans proline' 0 C--N 1.301 -1.959 0 C-N-CA 122.688 2.259 . . . . 0.0 112.226 179.129 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.3 -3.14 59.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.584 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.14 -41.0 5.66 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 111.034 -0.827 . . . . 0.0 111.034 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 230' ' ' LEU . . . . . 0.524 ' O ' ' N ' ' A' ' 233' ' ' SER . 85.3 mt -79.12 -16.98 55.91 Favored 'General case' 0 C--O 1.22 -0.45 0 CA-C-O 121.062 0.458 . . . . 0.0 110.326 -179.694 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 54.5 t-20 -40.43 -49.06 2.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.77 -179.405 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -87.97 15.16 7.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.323 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 233' ' ' SER . . . . . 0.524 ' N ' ' O ' ' A' ' 230' ' ' LEU . 77.9 p -60.43 -35.41 75.75 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.711 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 234' ' ' GLN . . . . . 0.526 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.6 tt0 -118.8 -69.36 0.85 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.901 179.329 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.2 m -69.95 102.88 2.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.707 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -94.31 57.72 2.35 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.339 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -144.71 -122.65 1.59 Allowed Glycine 0 CA--C 1.519 0.332 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -134.79 111.62 10.06 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.125 0.488 . . . . 0.0 110.371 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 239' ' ' ARG . . . . . 0.521 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.4 mtt180 -148.03 57.94 1.09 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.672 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -69.68 -31.88 70.18 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.538 179.502 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 241' ' ' ASP . . . . . 0.55 ' CG ' HD21 ' A' ' 143' ' ' ASN . 64.7 t0 -56.98 -47.09 81.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.328 -179.096 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 242' ' ' ILE . . . . . 0.435 ' O ' ' O ' ' A' ' 239' ' ' ARG . 17.6 tt -140.19 156.92 24.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.904 0.383 . . . . 0.0 110.475 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.442 HG22 HD13 ' A' ' 245' ' ' LEU . 96.2 mt -106.17 106.58 20.85 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.199 0 CA-C-O 121.097 0.475 . . . . 0.0 110.531 179.74 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 244' ' ' GLN . . . . . 0.596 ' O ' HD12 ' A' ' 245' ' ' LEU . 88.2 mt-30 -110.51 110.17 20.79 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.363 179.687 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.596 HD12 ' O ' ' A' ' 244' ' ' GLN . 9.5 mp -121.68 -168.33 1.68 Allowed 'General case' 0 C--O 1.224 -0.264 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.639 179.635 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 246' ' ' GLY . . . . . 0.526 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.61 -16.64 0.05 OUTLIER Glycine 0 CA--C 1.523 0.564 0 N-CA-C 110.999 -0.841 . . . . 0.0 110.999 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 247' ' ' GLY . . . . . 0.67 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -60.81 156.81 31.64 Favored Glycine 0 CA--C 1.522 0.476 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -63.73 21.79 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.012 0.434 . . . . 0.0 110.643 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 249' ' ' ASN . . . . . 0.67 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.7 m-20 -97.44 -5.97 34.94 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.515 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 92.2 mt -79.78 -21.71 44.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.769 179.331 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.51 -51.37 70.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.715 -179.527 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.37 -5.48 58.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.494 179.631 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.08 -74.39 1.14 Allowed Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 81.5 mt -70.0 125.98 28.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.908 0.385 . . . . 0.0 110.297 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -59.91 -39.07 84.16 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.208 -179.502 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 83.29 51.69 4.05 Favored Glycine 0 CA--C 1.521 0.423 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -95.2 -15.67 23.09 Favored 'General case' 0 C--N 1.331 -0.214 0 O-C-N 122.746 -0.267 . . . . 0.0 110.591 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 258' ' ' SER . . . . . 0.496 ' OG ' HG23 ' A' ' 191' ' ' VAL . 3.3 t 174.54 89.3 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.099 0.476 . . . . 0.0 110.1 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.856 HD12 ' N ' ' A' ' 259' ' ' LEU . 1.0 OUTLIER -94.4 124.24 38.3 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.206 0.527 . . . . 0.0 111.259 -179.072 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 260' ' ' PHE . . . . . 0.448 ' H ' ' HA ' ' A' ' 193' ' ' ALA . 15.9 m-30 -93.34 146.41 23.75 Favored 'General case' 0 CA--C 1.501 -0.917 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.395 179.315 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 85.9 mt -122.25 149.7 43.32 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.551 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.749 ' CD1' HG13 ' A' ' 195' ' ' VAL . 2.6 p90 -77.37 -138.69 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.666 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 263' ' ' ALA . . . . . 0.655 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -51.78 77.35 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 121.035 0.445 . . . . 0.0 111.174 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 264' ' ' GLY . . . . . 0.626 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.15 104.75 0.19 Allowed Glycine 0 CA--C 1.527 0.824 0 N-CA-C 110.554 -1.019 . . . . 0.0 110.554 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 265' ' ' ASP . . . . . 0.601 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.7 m-20 -80.34 -177.94 6.39 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.64 0.257 . . . . 0.0 110.928 -179.611 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -40.26 -17.73 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.576 179.691 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 267' ' ' LYS . . . . . 0.601 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.31 -51.74 41.34 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.71 179.287 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -63.55 -46.64 85.04 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.236 179.378 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 269' ' ' ALA . . . . . 0.572 ' HB1' ' OH ' ' A' ' 273' ' ' TYR . . . -61.66 -35.04 76.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.349 0.595 . . . . 0.0 109.843 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -63.09 -34.06 76.79 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.204 179.696 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.87 -43.28 13.39 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.108 -179.473 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 272' ' ' ILE . . . . . 0.586 ' C ' ' H ' ' A' ' 274' ' ' ALA . 4.8 tt -51.31 -33.48 14.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.737 -178.82 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 273' ' ' TYR . . . . . 0.572 ' OH ' ' HB1' ' A' ' 269' ' ' ALA . 17.1 m-85 -54.81 -1.72 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.665 -179.44 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 274' ' ' ALA . . . . . 0.586 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.65 -39.81 70.11 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.952 179.428 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 275' ' ' ASN . . . . . 0.58 ' O ' ' N ' ' A' ' 279' ' ' ALA . 3.2 p30 -39.02 98.05 0.16 Allowed Pre-proline 0 C--O 1.227 -0.124 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.474 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -54.48 -42.81 64.63 Favored 'Trans proline' 0 C--N 1.303 -1.862 0 C-N-CA 122.42 2.08 . . . . 0.0 112.543 -178.623 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 89.3 mt -64.4 -42.91 95.83 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.126 0.488 . . . . 0.0 111.158 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 91.2 mt -95.57 -1.77 49.78 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.874 -179.491 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 279' ' ' ALA . . . . . 0.58 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.25 -34.87 77.36 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.755 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.2 20.11 0.11 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.998 -179.288 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 281' ' ' LEU . . . . . 0.481 ' H ' ' C ' ' A' ' 279' ' ' ALA . 13.9 mt -75.2 119.69 78.16 Favored Pre-proline 0 N--CA 1.448 -0.545 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.688 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -49.97 -40.01 49.61 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.678 2.252 . . . . 0.0 112.238 178.697 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.56 -50.56 62.7 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.118 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 71.8 t -61.46 -43.82 97.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 110.04 -0.355 . . . . 0.0 110.04 179.536 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -57.84 -41.28 81.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.198 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -90.96 0.29 57.56 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.129 179.767 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt 59.47 43.04 16.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.844 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -94.49 41.51 1.09 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.429 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 53.8 t -119.03 135.62 58.87 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.156 0 CA-C-O 121.072 0.463 . . . . 0.0 110.111 -179.665 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -132.85 162.75 30.71 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.153 0.502 . . . . 0.0 110.629 -179.713 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.69 154.98 33.28 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.015 0.436 . . . . 0.0 110.699 -179.825 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 81.6 mt -93.96 -1.52 54.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.247 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.66 165.88 12.71 Favored Glycine 0 CA--C 1.521 0.45 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 6.5 m -87.8 -62.2 1.55 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.864 0.364 . . . . 0.0 111.008 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 295' ' ' GLU . . . . . 0.448 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.6 mm-40 -69.35 -4.08 16.78 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.701 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 27.0 p -76.46 32.8 0.13 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.645 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 297' ' ' PHE . . . . . 0.52 ' CD2' HG22 ' A' ' 70' ' ' THR . 85.7 t80 -60.39 -46.06 91.32 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.573 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 298' ' ' ARG . . . . . 0.62 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.2 mtt85 -81.45 135.06 35.62 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.569 -179.637 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.46 ' H ' HG11 ' A' ' 51' ' ' VAL . 17.0 tp -114.24 117.77 32.07 Favored 'General case' 0 C--O 1.231 0.085 0 CA-C-O 121.005 0.431 . . . . 0.0 110.182 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 300' ' ' ASP . . . . . 0.636 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.4 p-10 -165.42 -176.38 3.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.624 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 80.2 t80 -47.07 -43.39 20.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.348 -179.65 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -67.01 -40.49 87.3 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.024 0.44 . . . . 0.0 110.747 179.083 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 303' ' ' SER . . . . . 0.636 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 60.3 p -55.71 -36.5 67.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.074 -179.193 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 304' ' ' ALA . . . . . 0.541 ' HB2' ' SD ' ' A' ' 215' ' ' MET . . . -57.08 -51.69 68.27 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 179.46 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 91.2 mtp -55.97 -43.92 78.01 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -66.2 -42.64 88.51 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.141 0.495 . . . . 0.0 110.257 179.004 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 307' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 303' ' ' SER . 55.4 t -64.15 -42.82 96.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.26 179.374 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 43.1 tp -59.74 -42.15 92.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.871 -179.499 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -62.63 -38.78 91.57 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.237 179.421 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 310' ' ' ARG . . . . . 0.45 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.6 ttt85 -63.56 -43.86 95.8 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.246 179.538 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 90.3 mt -63.0 -42.12 99.77 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.311 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -62.94 -33.16 74.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.113 179.422 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.97 -23.31 21.57 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.318 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 314' ' ' LEU . . . . . 0.481 HD22 ' CE2' ' A' ' 315' ' ' PHE . 6.7 tt -62.27 -43.19 99.4 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 121.055 0.455 . . . . 0.0 110.52 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 315' ' ' PHE . . . . . 0.481 ' CE2' HD22 ' A' ' 314' ' ' LEU . 91.2 m-85 . . . . . 0 C--O 1.22 -0.466 0 CA-C-O 118.055 -0.974 . . . . 0.0 110.405 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -99.63 136.43 39.58 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.016 0.436 . . . . 0.0 110.538 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.497 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -91.71 178.46 1.74 Allowed Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.58 -179.882 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.497 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.5 Cg_exo -61.69 147.5 95.18 Favored 'Trans proline' 0 C--N 1.3 -2.007 0 C-N-CA 122.778 2.318 . . . . 0.0 112.123 179.639 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.494 ' HE ' HD12 ' A' ' 39' ' ' LEU . 35.4 ptt180 -135.76 142.65 44.98 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.655 179.742 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -79.11 116.96 19.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.501 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.431 ' O ' HG23 ' A' ' 30' ' ' ILE . 9.6 tp -110.32 130.86 62.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.408 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 13.3 t -71.14 141.93 50.74 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.53 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.427 ' OD1' ' O ' ' A' ' 141' ' ' ILE . 25.1 t70 -139.87 177.88 7.65 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.517 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.0 p -73.73 -36.59 65.2 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.688 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.8 ttt85 -47.78 -95.25 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.269 -179.459 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -165.22 -26.06 0.02 OUTLIER Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 67.5 m -168.32 106.79 0.49 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.889 0.376 . . . . 0.0 110.652 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 52.3 t-80 -129.71 143.56 50.88 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.027 0.442 . . . . 0.0 110.152 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.627 HG22 ' N ' ' A' ' 39' ' ' LEU . 97.5 m -128.18 166.12 19.13 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.636 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.627 ' N ' HG22 ' A' ' 38' ' ' THR . 81.1 mt -120.78 127.61 52.12 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.523 179.724 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -64.42 -44.26 91.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.656 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 41.5 p -165.68 154.84 11.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.424 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.478 ' CD ' ' H ' ' A' ' 42' ' ' GLN . 13.7 mp0 -43.42 100.69 0.23 Allowed Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.636 179.467 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -56.85 129.33 34.01 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 122.399 2.066 . . . . 0.0 112.262 -179.66 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -83.88 -23.95 31.05 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.45 179.575 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.544 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.3 mtm-85 -120.9 134.26 55.29 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 121.132 0.492 . . . . 0.0 110.202 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 95.9 mt -130.65 133.48 63.39 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.939 -179.718 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 49.1 t -125.05 131.06 73.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.825 0.345 . . . . 0.0 110.119 179.335 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.617 ' OG ' HD12 ' A' ' 117' ' ' LEU . 5.1 m -154.41 166.16 34.13 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.506 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 65.0 p -124.94 8.5 8.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.501 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.71 125.75 33.44 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.686 -179.468 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.457 HG11 ' H ' ' A' ' 299' ' ' LEU . 88.6 t -65.75 -44.65 93.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.47 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 20.0 m -62.53 -44.29 96.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.605 -179.73 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 51.2 tp -62.28 -41.51 98.55 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.572 -179.454 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.459 ' O ' HD13 ' A' ' 58' ' ' LEU . 70.6 m -57.67 -44.36 85.7 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.343 -179.313 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.48 -61.91 5.55 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.929 -0.869 . . . . 0.0 110.929 179.556 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.7 t -48.51 -35.67 13.64 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 20.0 mt -61.77 -44.72 96.33 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.661 -0.416 . . . . 0.0 111.126 179.377 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.459 HD13 ' O ' ' A' ' 54' ' ' THR . 9.2 mp -64.96 -41.8 95.16 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.189 178.024 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.405 ' HB1' ' NE ' ' A' ' 169' ' ' ARG . . . -63.62 -41.27 98.29 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.947 -179.152 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.429 ' O ' HG23 ' A' ' 60' ' ' ILE . 8.0 tp -88.13 16.7 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.771 -179.619 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 56.61 84.28 0.09 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.653 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.37 57.38 0.07 OUTLIER Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.058 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -50.3 153.19 7.39 Favored 'Trans proline' 0 C--N 1.296 -2.199 0 C-N-CA 122.874 2.383 . . . . 0.0 112.388 -178.303 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.428 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.4 OUTLIER -109.03 146.38 14.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.367 -179.699 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 97.1 mt -63.79 -45.16 97.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.368 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.51 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -130.31 134.83 47.49 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.575 -179.741 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.464 ' O ' ' N ' ' A' ' 98' ' ' LEU . 73.8 m -134.52 158.73 43.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.843 -179.675 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.35 138.94 16.3 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.488 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.86 -162.7 0.08 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.996 0.427 . . . . 0.0 110.515 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.513 HG22 ' CD2' ' A' ' 297' ' ' PHE . 5.9 t -133.74 135.94 44.27 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.192 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.492 ' C ' ' O ' ' A' ' 70' ' ' THR . 1.0 OUTLIER 29.55 68.57 0.65 Allowed Pre-proline 0 N--CA 1.465 0.3 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.715 -179.7 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -61.25 144.57 98.8 Favored 'Trans proline' 0 C--N 1.301 -1.964 0 C-N-CA 122.668 2.245 . . . . 0.0 112.092 -178.435 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.519 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 45.7 p-10 -159.87 -31.61 0.06 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.717 179.709 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.537 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 98.7 m-20 -64.52 -38.92 92.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.46 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 73.2 ttt180 -60.87 -47.9 84.25 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.752 -179.368 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.422 ' O ' ' O ' ' A' ' 77' ' ' ALA . 94.6 t -60.36 -24.6 31.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.324 -0.398 . . . . 0.0 109.927 179.655 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.537 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -45.53 172.58 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.5 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.576 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.5 p30 -61.78 177.73 0.4 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.706 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.565 ' C ' ' H ' ' A' ' 81' ' ' GLY . 35.8 p30 -46.11 85.58 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.909 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.576 ' N ' ' O ' ' A' ' 78' ' ' ASP . 43.1 tp60 -67.01 13.62 0.06 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.139 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.565 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 117.78 -22.13 10.1 Favored Glycine 0 CA--C 1.52 0.355 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -107.94 116.52 32.11 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.016 0.436 . . . . 0.0 110.486 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 76.7 mt -98.83 0.86 45.16 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.453 -179.71 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -91.94 6.48 46.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.972 0.415 . . . . 0.0 110.388 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.79 ' O ' HG22 ' A' ' 89' ' ' VAL . 27.1 mt-30 -100.04 -27.27 13.65 Favored 'General case' 0 C--O 1.223 -0.29 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.77 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.5 t-105 -63.87 -40.78 97.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.015 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.555 ' O ' ' N ' ' A' ' 91' ' ' LYS . 67.7 m -77.63 -53.62 7.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.328 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -48.41 -50.85 29.36 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.972 -179.221 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.79 HG22 ' O ' ' A' ' 85' ' ' GLN . 15.1 m -68.89 -40.74 81.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 120.9 0.381 . . . . 0.0 110.984 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.498 ' N ' HG23 ' A' ' 89' ' ' VAL . . . -72.24 -22.59 61.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.704 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.555 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.0 tttm -61.47 -46.19 91.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.437 -179.545 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.438 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.6 mm-40 -90.32 -94.2 0.12 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.149 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.632 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.9 mtt180 -143.44 59.82 1.39 Allowed 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.782 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.461 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.6 pttp 33.69 26.18 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.259 -179.247 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.632 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.4 tt -47.87 123.23 5.8 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.969 -178.185 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.445 ' O ' HD23 ' A' ' 95' ' ' LEU . 98.8 mm-40 -83.51 -170.29 2.98 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.08 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.617 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 83.0 mtp180 -73.22 137.8 45.21 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.311 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.464 ' N ' ' O ' ' A' ' 67' ' ' SER . 87.9 mt -86.95 -166.03 1.46 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.721 -179.674 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.53 ' O ' ' CD2' ' A' ' 99' ' ' TYR . 48.0 p90 -168.06 120.31 0.86 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.236 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.509 ' C ' ' O ' ' A' ' 99' ' ' TYR . 43.5 mm -29.87 121.64 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.956 -179.674 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 113.72 28.12 3.31 Favored Glycine 0 CA--C 1.52 0.384 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 -179.468 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.589 ' CD ' ' H ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -143.98 45.87 0.6 Allowed Pre-proline 0 C--N 1.324 -0.536 0 CA-C-O 120.922 0.392 . . . . 0.0 110.43 179.867 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.584 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 29.8 Cg_endo -62.0 143.74 95.51 Favored 'Trans proline' 0 C--N 1.298 -2.109 0 C-N-CA 122.678 2.252 . . . . 0.0 112.004 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.462 ' O ' HG23 ' A' ' 108' ' ' VAL . 26.8 t -173.47 120.62 0.33 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.459 179.649 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.12 -41.1 64.36 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.089 0.471 . . . . 0.0 111.165 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -65.87 -40.06 91.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.792 -179.388 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.83 -39.89 95.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.698 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 104' ' ' SER . 69.6 t -67.66 -43.84 86.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.763 179.709 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.23 -39.46 92.89 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.566 -179.276 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.438 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.48 -23.5 62.81 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.469 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.561 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.3 mm-40 -91.35 4.99 51.02 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.755 -179.561 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.561 ' C ' ' O ' ' A' ' 111' ' ' GLN . 10.3 tpt 22.33 64.65 0.33 Allowed Pre-proline 0 N--CA 1.465 0.281 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.039 -179.807 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.453 ' HG2' HD11 ' A' ' 116' ' ' ILE . 67.9 Cg_endo -79.12 169.57 18.96 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 C-N-CA 122.957 2.438 . . . . 0.0 112.059 -178.395 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.485 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 99.0 m-20 -113.32 -44.16 3.27 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.172 179.399 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 41.3 tp -120.26 120.44 36.11 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.506 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.454 HD13 HD22 ' A' ' 133' ' ' LEU . 96.2 mt -117.96 131.24 71.29 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 CA-C-O 120.999 0.428 . . . . 0.0 110.884 -179.853 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.617 HD12 ' OG ' ' A' ' 48' ' ' SER . 31.4 mt -105.92 132.87 51.5 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.148 0.499 . . . . 0.0 110.204 -179.424 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.407 HD12 HG23 ' A' ' 139' ' ' THR . 97.8 mt -118.27 135.93 57.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.701 -179.721 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 85.9 p -72.09 153.74 41.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.613 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.19 -50.21 74.58 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.689 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -149.35 153.76 37.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.56 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 169.54 -170.0 42.39 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.82 -35.06 91.45 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.446 ' OD1' ' O ' ' A' ' 124' ' ' ASP . 44.1 p-10 -88.91 119.41 29.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.84 0.352 . . . . 0.0 110.7 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.449 ' O ' HD12 ' A' ' 129' ' ' LEU . 36.4 t -63.29 145.26 55.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.519 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.52 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.39 -43.8 8.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.958 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.4 tp -62.73 -42.34 99.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.73 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.49 -10.97 56.59 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.564 -179.442 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.449 HD12 ' O ' ' A' ' 125' ' ' SER . 83.9 mt -116.26 -23.59 8.33 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.651 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' TYR . . . . . 0.52 ' N ' ' O ' ' A' ' 126' ' ' ALA . 77.7 t80 -51.47 -49.6 61.46 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.674 -0.411 . . . . 0.0 110.567 -179.008 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.5 p-10 -65.83 -41.94 91.17 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.846 0.355 . . . . 0.0 111.109 179.554 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.526 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 88.1 mt-30 -67.82 -36.96 81.29 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.777 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.454 HD22 HD13 ' A' ' 116' ' ' ILE . 93.0 mt -80.27 -41.98 24.0 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.927 -179.517 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.2 t -57.5 -44.67 85.19 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.223 -179.171 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.2 m -62.3 -45.66 92.26 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.735 0.302 . . . . 0.0 110.596 179.337 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 91.8 mt -62.52 -43.86 98.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.406 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.598 ' HB1' ' HD2' ' A' ' 138' ' ' PRO . . . -170.1 163.51 6.32 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.506 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.598 ' HD2' ' HB1' ' A' ' 137' ' ' ALA . 78.5 Cg_exo -42.78 111.13 0.19 Allowed 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.469 2.112 . . . . 0.0 112.161 179.348 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.481 HG21 ' CD1' ' A' ' 130' ' ' TYR . 16.6 m -86.05 127.64 34.71 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.57 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.449 HD12 ' HA ' ' A' ' 140' ' ' LEU . 35.5 tp -119.99 138.39 53.51 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.032 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.427 ' O ' ' OD1' ' A' ' 32' ' ' ASP . 77.7 mt -105.57 120.66 56.7 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.358 0 CA-C-O 121.109 0.48 . . . . 0.0 111.291 -179.427 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.489 HD12 HD22 ' A' ' 117' ' ' LEU . 97.9 mt -135.93 132.69 50.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.627 179.602 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.533 HD21 ' CG ' ' A' ' 241' ' ' ASP . 61.0 t30 -64.42 150.87 45.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.939 0.399 . . . . 0.0 110.402 179.407 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.518 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 88.7 t80 -85.69 122.09 29.29 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.913 -179.513 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.518 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 98.8 m-20 55.63 69.01 0.78 Allowed 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.812 179.63 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 35.9 p-10 -125.4 0.01 7.63 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.683 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -150.64 115.61 5.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.76 -179.445 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 84.6 p -62.67 167.8 4.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.505 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.416 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.5 p-90 -51.09 -15.24 0.3 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.498 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 150' ' ' GLN . . . . . 0.445 ' O ' HG23 ' A' ' 154' ' ' THR . 68.1 tp60 -71.34 -75.01 0.14 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.475 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.45 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.2 t -62.78 -38.83 92.18 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.031 0.444 . . . . 0.0 110.305 179.506 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 52.6 tp -60.17 -45.56 92.68 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.42 -178.576 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.416 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 45.9 tp -62.8 -41.8 99.44 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.856 0.36 . . . . 0.0 110.375 179.068 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.45 ' OG1' ' O ' ' A' ' 151' ' ' SER . 57.8 p -63.95 -34.52 78.16 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.312 -179.597 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' GLN . . . . . 0.471 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.6 mm-40 -64.1 -42.24 96.98 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.263 179.269 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 91.4 mt -65.45 -38.83 91.01 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.182 179.102 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.574 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.34 -31.82 78.62 Favored Glycine 0 CA--C 1.52 0.406 0 N-CA-C 110.846 -0.901 . . . . 0.0 110.846 -179.396 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.471 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.2 mt-10 -36.97 -25.1 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.809 0.338 . . . . 0.0 110.706 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.574 ' N ' ' O ' ' A' ' 157' ' ' GLY . 94.4 mt -59.94 149.59 6.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.317 179.473 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 76.8 p -68.91 137.14 53.58 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.059 -179.508 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 70.63 22.0 77.89 Favored Glycine 0 N--CA 1.459 0.177 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 179.441 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 60.4 m80 -123.72 -14.83 7.16 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.786 0.327 . . . . 0.0 110.507 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -66.96 -59.31 3.6 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.686 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -51.85 -49.4 62.94 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.188 -179.655 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -60.64 -41.21 94.48 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.803 0.335 . . . . 0.0 110.316 179.522 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.46 -47.45 85.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.589 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.59 -40.27 74.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.247 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -61.57 -50.1 73.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.578 179.556 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.405 ' NE ' ' HB1' ' A' ' 59' ' ' ALA . 59.9 ttt85 -65.47 -43.63 89.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.471 179.523 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 94.8 mt -64.46 -43.48 96.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.429 179.732 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.41 -51.16 70.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.525 -179.227 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.76 -43.78 95.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.375 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 173' ' ' PHE . . . . . 0.658 ' CE2' HD11 ' A' ' 177' ' ' LEU . 56.3 t80 -62.74 -44.53 95.97 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.069 0.462 . . . . 0.0 110.41 179.426 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -63.12 -39.8 95.76 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.611 -179.462 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -63.01 -42.8 99.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.617 179.197 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -60.69 -44.95 95.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.103 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.658 HD11 ' CE2' ' A' ' 173' ' ' PHE . 85.0 mt -64.52 -41.17 96.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.998 0.428 . . . . 0.0 110.642 178.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.02 -62.15 1.82 Allowed 'General case' 0 C--O 1.237 0.408 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.491 -179.32 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.86 -46.68 87.2 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.546 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.42 -41.66 66.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.176 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -63.91 -33.67 76.22 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.018 0.437 . . . . 0.0 110.387 179.266 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 182' ' ' GLU . . . . . 0.423 ' O ' ' HG2' ' A' ' 182' ' ' GLU . 69.6 tt0 -90.56 8.63 33.12 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.435 0.636 . . . . 0.0 110.56 -178.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -104.55 -32.0 9.17 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.183 179.61 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.9 pt -127.99 147.74 32.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.882 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -139.77 130.97 26.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.396 179.393 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 186' ' ' LEU . . . . . 0.595 HD22 ' N ' ' A' ' 186' ' ' LEU . 3.6 mm? -85.73 133.06 42.46 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.852 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -44.24 157.99 0.15 Allowed 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.747 2.298 . . . . 0.0 112.119 179.467 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 188' ' ' PRO . . . . . 0.524 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 28.1 Cg_endo -63.08 115.21 2.82 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 C-N-CA 122.736 2.291 . . . . 0.0 111.773 179.749 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 189' ' ' GLN . . . . . 0.524 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.7 mt-30 155.61 147.63 0.0 OUTLIER Pre-proline 0 N--CA 1.454 -0.241 0 O-C-N 123.57 0.544 . . . . 0.0 110.727 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -73.81 143.73 33.85 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.767 2.311 . . . . 0.0 111.88 178.082 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.497 HG23 ' OG ' ' A' ' 258' ' ' SER . 2.1 p -124.93 158.93 32.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.24 0.543 . . . . 0.0 110.124 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 192' ' ' THR . . . . . 0.497 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 36.9 p -143.41 165.37 27.71 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.092 -179.669 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 193' ' ' ALA . . . . . 0.446 ' HA ' ' H ' ' A' ' 260' ' ' PHE . . . -135.63 128.55 31.31 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 121.207 0.527 . . . . 0.0 110.224 179.533 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.504 HD11 HD23 ' A' ' 259' ' ' LEU . 47.2 pt -146.44 149.1 16.34 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.096 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 195' ' ' VAL . . . . . 0.743 HG13 ' CD1' ' A' ' 262' ' ' PHE . 69.0 t -117.94 123.13 71.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.25 0.548 . . . . 0.0 109.767 179.11 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -134.24 107.41 7.66 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.252 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 94.7 m -131.33 130.51 42.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.823 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.404 ' O ' ' N ' ' A' ' 201' ' ' HIS . . . -82.93 -36.92 24.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.354 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.48 -66.88 0.28 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.331 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.35 -10.27 59.57 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.278 179.49 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 201' ' ' HIS . . . . . 0.404 ' N ' ' O ' ' A' ' 198' ' ' ALA . 60.0 t-80 61.42 58.16 2.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.715 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 39.4 p -167.09 153.55 8.29 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.552 179.469 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -150.97 143.63 24.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.46 179.421 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -135.04 138.03 43.51 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 120.926 0.393 . . . . 0.0 110.608 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 19.8 mt -106.16 125.39 50.94 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 121.057 0.456 . . . . 0.0 109.892 -179.696 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 206' ' ' TRP . . . . . 0.554 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 74.6 m95 -81.88 166.78 19.63 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.564 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 207' ' ' THR . . . . . 0.463 HG22 ' C ' ' A' ' 206' ' ' TRP . 0.1 OUTLIER -156.86 172.06 6.62 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.022 0.439 . . . . 0.0 110.505 -179.196 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.21 -36.85 87.23 Favored 'Trans proline' 0 C--N 1.303 -1.821 0 C-N-CA 122.624 2.216 . . . . 0.0 112.099 179.391 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -70.71 -34.84 72.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.822 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 21.3 m -61.3 150.68 34.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.642 -179.359 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.72 -36.92 82.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.472 -179.726 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 212' ' ' GLN . . . . . 0.554 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 55.0 tt0 -64.58 -40.37 95.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.491 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.71 -43.4 91.96 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -63.35 -43.8 96.66 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.924 -0.31 . . . . 0.0 110.294 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 215' ' ' MET . . . . . 0.538 ' SD ' ' HB2' ' A' ' 304' ' ' ALA . 65.1 ttp -59.53 -47.94 83.59 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.269 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 87.1 mt -60.61 -40.84 93.33 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.556 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 217' ' ' GLU . . . . . 0.453 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 40.9 tp10 -57.93 -38.03 75.17 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -65.35 -37.98 88.7 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.77 0.319 . . . . 0.0 110.672 179.716 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 94.4 mt -64.3 -42.69 96.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.521 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.51 45.07 0.08 OUTLIER Glycine 0 C--N 1.334 0.419 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 221' ' ' PHE . . . . . 0.453 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 26.1 m-85 -128.04 155.78 43.8 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.05 0.452 . . . . 0.0 110.467 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.484 ' O ' HG13 ' A' ' 191' ' ' VAL . 7.2 p -107.66 122.57 46.99 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.3 0.572 . . . . 0.0 110.182 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.476 HD22 ' C ' ' A' ' 222' ' ' THR . 4.3 mm? -101.58 132.72 47.09 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.049 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.38 160.14 14.57 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.535 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -105.55 115.13 29.72 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.973 0.416 . . . . 0.0 110.294 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.498 HD12 ' N ' ' A' ' 226' ' ' LEU . 9.0 mp -52.95 156.82 3.18 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.673 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -60.41 145.37 98.81 Favored 'Trans proline' 0 C--N 1.301 -1.945 0 C-N-CA 122.657 2.238 . . . . 0.0 112.075 179.29 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.22 -3.47 59.05 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.51 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -89.97 -41.19 5.66 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 230' ' ' LEU . . . . . 0.535 ' O ' ' N ' ' A' ' 233' ' ' SER . 68.2 mt -78.78 -17.54 55.59 Favored 'General case' 0 C--O 1.223 -0.319 0 CA-C-O 120.998 0.428 . . . . 0.0 110.377 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 231' ' ' ASN . . . . . 0.403 ' C ' ' O ' ' A' ' 230' ' ' LEU . 54.7 t-20 -40.19 -49.34 2.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.789 -179.389 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -87.8 15.32 7.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.258 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 233' ' ' SER . . . . . 0.535 ' N ' ' O ' ' A' ' 230' ' ' LEU . 78.2 p -60.36 -35.61 76.09 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.645 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 234' ' ' GLN . . . . . 0.525 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.6 tt0 -119.02 -69.26 0.86 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.963 179.607 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.2 m -69.89 102.76 2.04 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.733 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -94.45 57.64 2.29 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.055 0.455 . . . . 0.0 110.364 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -144.65 -122.68 1.59 Allowed Glycine 0 CA--C 1.52 0.364 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -134.86 111.4 9.85 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 121.067 0.46 . . . . 0.0 110.433 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 239' ' ' ARG . . . . . 0.521 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.6 mtt180 -147.95 58.06 1.1 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.762 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -69.77 -32.31 70.74 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.533 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 241' ' ' ASP . . . . . 0.533 ' CG ' HD21 ' A' ' 143' ' ' ASN . 65.0 t0 -56.86 -46.95 81.44 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.395 -179.093 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 242' ' ' ILE . . . . . 0.434 ' O ' ' O ' ' A' ' 239' ' ' ARG . 18.0 tt -139.93 156.74 25.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.926 0.393 . . . . 0.0 110.492 179.691 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.448 HG22 HD13 ' A' ' 245' ' ' LEU . 96.0 mt -106.36 106.7 21.1 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.214 0 CA-C-O 121.208 0.528 . . . . 0.0 110.489 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 244' ' ' GLN . . . . . 0.604 ' O ' HD12 ' A' ' 245' ' ' LEU . 88.3 mt-30 -110.48 110.14 20.76 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.331 179.805 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.604 HD12 ' O ' ' A' ' 244' ' ' GLN . 9.4 mp -121.81 -168.48 1.71 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.577 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 246' ' ' GLY . . . . . 0.525 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.9 -16.27 0.05 OUTLIER Glycine 0 CA--C 1.524 0.614 0 N-CA-C 111.039 -0.824 . . . . 0.0 111.039 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 247' ' ' GLY . . . . . 0.674 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -61.17 156.42 33.77 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -63.45 21.81 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.933 0.397 . . . . 0.0 110.617 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 249' ' ' ASN . . . . . 0.674 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.8 m-20 -97.35 -6.14 34.87 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.523 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 92.1 mt -79.52 -22.15 44.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.677 179.423 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.55 -51.26 70.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.711 -179.456 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.23 -5.76 58.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.48 179.692 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.02 -74.59 1.13 Allowed Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.909 -0.876 . . . . 0.0 110.909 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 83.0 mt -69.82 125.94 28.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.023 0.44 . . . . 0.0 110.234 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -59.32 -39.44 83.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.178 -179.608 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 83.1 51.82 4.04 Favored Glycine 0 CA--C 1.521 0.433 0 N-CA-C 110.814 -0.914 . . . . 0.0 110.814 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -95.94 -14.89 22.73 Favored 'General case' 0 C--N 1.33 -0.266 0 O-C-N 122.701 -0.293 . . . . 0.0 110.616 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 258' ' ' SER . . . . . 0.497 ' OG ' HG23 ' A' ' 191' ' ' VAL . 3.4 t 174.34 88.85 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.047 0.451 . . . . 0.0 110.177 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.862 HD12 ' N ' ' A' ' 259' ' ' LEU . 0.9 OUTLIER -94.18 124.02 37.93 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.223 0.535 . . . . 0.0 111.086 -179.104 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 260' ' ' PHE . . . . . 0.446 ' H ' ' HA ' ' A' ' 193' ' ' ALA . 16.0 m-30 -93.12 146.48 23.63 Favored 'General case' 0 CA--C 1.508 -0.664 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.343 179.251 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 86.0 mt -122.35 149.83 43.24 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.629 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.743 ' CD1' HG13 ' A' ' 195' ' ' VAL . 2.6 p90 -77.65 -138.49 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.468 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 263' ' ' ALA . . . . . 0.661 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -52.03 77.54 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 121.04 0.448 . . . . 0.0 111.055 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 264' ' ' GLY . . . . . 0.632 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.03 104.71 0.19 Allowed Glycine 0 CA--C 1.526 0.724 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 265' ' ' ASP . . . . . 0.606 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.7 m-20 -80.57 -177.79 6.41 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 120.676 0.274 . . . . 0.0 110.92 -179.477 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -40.42 -17.69 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.891 0.377 . . . . 0.0 110.521 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 267' ' ' LYS . . . . . 0.606 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.33 -51.62 42.52 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.73 179.397 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -63.7 -46.54 84.99 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.223 179.368 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 269' ' ' ALA . . . . . 0.575 ' HB1' ' OH ' ' A' ' 273' ' ' TYR . . . -61.71 -35.11 77.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.856 179.52 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -63.07 -34.41 77.52 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.115 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.48 -43.07 13.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.231 -179.522 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 272' ' ' ILE . . . . . 0.587 ' C ' ' H ' ' A' ' 274' ' ' ALA . 4.9 tt -51.58 -33.72 15.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.827 -178.842 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 273' ' ' TYR . . . . . 0.575 ' OH ' ' HB1' ' A' ' 269' ' ' ALA . 17.1 m-85 -54.44 -1.71 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.738 -179.568 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 274' ' ' ALA . . . . . 0.587 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.8 -39.54 69.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.927 179.503 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 275' ' ' ASN . . . . . 0.582 ' O ' ' N ' ' A' ' 279' ' ' ALA . 3.2 p30 -39.52 98.02 0.16 Allowed Pre-proline 0 N--CA 1.461 0.103 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.562 -179.648 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -54.03 -43.02 61.99 Favored 'Trans proline' 0 C--N 1.304 -1.807 0 C-N-CA 122.372 2.048 . . . . 0.0 112.638 -178.788 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 89.0 mt -64.37 -42.93 95.92 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.14 0.495 . . . . 0.0 111.208 -179.708 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 90.7 mt -95.6 -1.67 49.87 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.894 -179.454 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 279' ' ' ALA . . . . . 0.582 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.34 -34.83 77.41 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.696 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.12 20.01 0.11 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.006 -179.293 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 281' ' ' LEU . . . . . 0.49 HD23 ' HA ' ' A' ' 281' ' ' LEU . 13.9 mt -75.31 120.15 80.31 Favored Pre-proline 0 N--CA 1.452 -0.365 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.506 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -51.01 -39.35 59.92 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 122.637 2.225 . . . . 0.0 111.848 179.164 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.92 -50.53 63.8 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.092 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 75.5 t -61.43 -43.92 97.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.587 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -57.83 -41.19 81.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.237 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -91.11 0.38 57.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.212 179.599 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt 59.3 43.7 16.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.079 0.466 . . . . 0.0 110.962 179.606 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -95.1 41.62 1.09 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.33 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 53.9 t -119.22 135.63 58.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.02 0.438 . . . . 0.0 110.168 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -132.63 162.65 30.78 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 121.123 0.487 . . . . 0.0 110.634 -179.642 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.71 154.91 33.39 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.014 0.435 . . . . 0.0 110.745 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 80.8 mt -93.68 -1.58 55.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.275 -179.707 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.11 165.91 12.81 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 6.9 m -87.47 -62.35 1.52 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.839 0.352 . . . . 0.0 111.016 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 295' ' ' GLU . . . . . 0.441 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.5 mm-40 -69.25 -4.01 16.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.68 -179.75 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 25.9 p -76.89 32.51 0.14 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.654 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 297' ' ' PHE . . . . . 0.513 ' CD2' HG22 ' A' ' 70' ' ' THR . 73.2 t80 -60.39 -46.14 91.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.669 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 298' ' ' ARG . . . . . 0.617 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.2 mtt85 -81.19 135.0 35.72 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 120.998 0.427 . . . . 0.0 110.634 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.457 ' H ' HG11 ' A' ' 51' ' ' VAL . 16.8 tp -114.39 118.26 33.33 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.182 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 300' ' ' ASP . . . . . 0.635 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.0 p-10 -165.83 -176.2 3.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.507 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -47.08 -43.78 20.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.277 -179.674 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -66.64 -40.57 88.75 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.968 0.413 . . . . 0.0 110.726 179.12 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 303' ' ' SER . . . . . 0.635 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 59.7 p -55.92 -36.11 67.35 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.083 -179.17 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 304' ' ' ALA . . . . . 0.538 ' HB2' ' SD ' ' A' ' 215' ' ' MET . . . -57.37 -51.43 69.44 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.445 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 90.6 mtp -56.41 -43.67 79.58 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -66.37 -42.63 87.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.934 0.397 . . . . 0.0 110.17 178.837 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 307' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 303' ' ' SER . 56.1 t -63.95 -43.03 97.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.22 179.407 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 42.9 tp -59.67 -42.31 92.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.781 -179.471 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -62.6 -38.78 91.48 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 179.612 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 310' ' ' ARG . . . . . 0.432 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.6 ttt85 -63.51 -44.01 95.54 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.286 179.526 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 89.0 mt -63.21 -42.06 99.24 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.291 179.517 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt -62.87 -33.41 75.23 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.997 179.494 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.52 -23.36 22.05 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.46 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 314' ' ' LEU . . . . . 0.476 HD22 ' CE2' ' A' ' 315' ' ' PHE . 6.8 tt -62.36 -43.1 99.62 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.63 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 315' ' ' PHE . . . . . 0.476 ' CE2' HD22 ' A' ' 314' ' ' LEU . 91.0 m-85 . . . . . 0 C--O 1.22 -0.482 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.449 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -99.58 136.75 39.04 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.079 0.466 . . . . 0.0 110.438 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.494 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -91.99 178.49 1.7 Allowed Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.615 -179.881 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.494 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.4 Cg_exo -61.65 146.99 96.38 Favored 'Trans proline' 0 C--N 1.299 -2.044 0 C-N-CA 122.872 2.381 . . . . 0.0 112.133 179.679 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.46 ' HE ' HD12 ' A' ' 39' ' ' LEU . 35.5 ptt180 -136.23 142.31 44.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.682 179.668 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -79.52 116.67 19.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.464 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.449 ' O ' HG23 ' A' ' 30' ' ' ILE . 9.5 tp -111.16 130.49 64.53 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.483 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 13.1 t -70.93 141.91 51.1 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.547 179.745 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.478 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.5 t0 -139.42 179.71 6.39 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.57 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.478 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 78.0 p -73.88 -37.21 64.79 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.626 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -46.37 -94.51 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.292 -179.446 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -167.2 -26.61 0.02 OUTLIER Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.934 -0.867 . . . . 0.0 110.934 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 60.0 m -168.98 104.78 0.4 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.876 0.37 . . . . 0.0 110.673 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.678 ' CD2' HD13 ' A' ' 140' ' ' LEU . 74.6 t60 -128.44 148.81 50.74 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 121.102 0.477 . . . . 0.0 110.247 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.623 HG22 ' N ' ' A' ' 39' ' ' LEU . 98.8 m -131.2 165.84 22.45 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.55 -179.816 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.623 ' N ' HG22 ' A' ' 38' ' ' THR . 82.0 mt -120.67 127.28 51.91 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.439 179.744 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -65.23 -44.45 88.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.698 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 39.5 p -165.66 154.66 11.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.44 179.678 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.478 ' CD ' ' H ' ' A' ' 42' ' ' GLN . 14.4 mp0 -44.78 101.3 0.25 Allowed Pre-proline 0 C--N 1.329 -0.315 0 O-C-N 123.376 0.422 . . . . 0.0 110.605 179.397 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -57.43 129.94 36.53 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 C-N-CA 122.357 2.038 . . . . 0.0 112.292 -179.672 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -83.88 -24.68 30.72 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.539 179.551 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.538 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.2 mtm-85 -122.07 134.9 54.77 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 121.203 0.525 . . . . 0.0 110.291 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 95.9 mt -130.64 133.73 63.05 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.883 -179.696 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 44.7 t -124.44 130.53 73.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 179.312 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.627 ' OG ' HD12 ' A' ' 117' ' ' LEU . 2.3 m -155.36 167.34 30.69 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.534 179.681 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 68.2 p -124.68 9.45 8.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.458 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.56 125.51 33.15 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.634 -179.5 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.44 HG11 ' H ' ' A' ' 299' ' ' LEU . 92.7 t -65.81 -44.52 92.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.469 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 20.0 m -62.77 -44.19 96.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.607 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 50.2 tp -62.24 -41.61 98.58 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.53 -179.502 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.444 ' O ' HD13 ' A' ' 58' ' ' LEU . 77.2 m -57.59 -44.65 85.53 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.394 -179.41 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.03 -62.33 5.3 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.884 -0.886 . . . . 0.0 110.884 179.612 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.7 t -48.4 -35.42 12.66 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.7 mt -61.88 -44.52 96.65 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.686 -0.405 . . . . 0.0 111.281 179.365 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.444 HD13 ' O ' ' A' ' 54' ' ' THR . 9.2 mp -65.18 -41.52 94.52 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.33 177.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.5 -41.26 98.53 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.983 -179.241 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.426 ' O ' HG23 ' A' ' 60' ' ' ILE . 8.1 tp -88.18 17.13 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.824 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 56.24 84.63 0.08 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.688 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.37 59.06 0.08 OUTLIER Pre-proline 0 C--N 1.328 -0.346 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -51.52 152.31 12.51 Favored 'Trans proline' 0 C--N 1.294 -2.301 0 C-N-CA 122.956 2.438 . . . . 0.0 112.254 -178.233 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.434 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.2 OUTLIER -108.55 145.31 15.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.37 -179.728 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.8 mt -63.56 -45.4 97.77 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.414 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.5 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -129.57 134.19 47.6 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.848 0.356 . . . . 0.0 110.495 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.493 ' O ' ' N ' ' A' ' 98' ' ' LEU . 74.8 m -134.48 158.56 43.6 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.849 -179.617 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.82 139.13 16.12 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.689 -0.964 . . . . 0.0 110.689 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.497 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.84 -162.77 0.08 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.971 0.415 . . . . 0.0 110.479 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.535 HG22 ' CD2' ' A' ' 297' ' ' PHE . 14.7 t -133.49 135.02 44.21 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.382 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.487 ' C ' ' O ' ' A' ' 70' ' ' THR . 0.7 OUTLIER 29.73 68.57 0.66 Allowed Pre-proline 0 N--CA 1.464 0.26 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.801 -179.87 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_exo -60.98 145.64 98.84 Favored 'Trans proline' 0 C--N 1.299 -2.035 0 C-N-CA 122.648 2.232 . . . . 0.0 111.981 -178.355 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.534 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 46.1 p-10 -160.11 -32.63 0.06 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.639 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.537 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 99.2 m-20 -63.71 -39.74 95.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.451 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 73.1 ttt180 -60.13 -48.08 83.24 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.728 -179.206 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.423 ' O ' ' O ' ' A' ' 77' ' ' ALA . 94.4 t -60.35 -24.73 31.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.088 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.537 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -45.76 172.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.599 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.571 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.9 p30 -62.07 177.74 0.43 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.522 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.558 ' C ' ' H ' ' A' ' 81' ' ' GLY . 35.4 p30 -45.61 85.67 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.033 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.571 ' N ' ' O ' ' A' ' 78' ' ' ASP . 43.4 tp60 -67.63 13.45 0.07 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.149 0.5 . . . . 0.0 110.135 -179.735 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.558 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 118.32 -22.1 9.72 Favored Glycine 0 CA--C 1.519 0.282 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -107.86 116.61 32.26 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.975 0.417 . . . . 0.0 110.474 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 74.4 mt -98.77 -0.14 43.25 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.937 0.399 . . . . 0.0 110.494 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -92.13 7.08 44.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.98 0.419 . . . . 0.0 110.452 -179.726 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.788 ' O ' HG22 ' A' ' 89' ' ' VAL . 27.1 mt-30 -100.42 -27.76 13.28 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.815 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.8 t-105 -63.73 -40.51 96.93 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.093 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.56 ' O ' ' N ' ' A' ' 91' ' ' LYS . 63.7 m -78.15 -54.16 6.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.118 -179.481 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -47.64 -50.51 24.31 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.06 -179.332 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.788 HG22 ' O ' ' A' ' 85' ' ' GLN . 14.9 m -69.29 -40.75 80.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.066 179.698 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.499 ' N ' HG23 ' A' ' 89' ' ' VAL . . . -72.3 -22.64 61.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.66 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.56 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.0 tttm -62.23 -45.5 93.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.422 -179.494 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.441 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.8 mm-40 -90.51 -94.37 0.12 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.153 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.628 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.9 mtt180 -143.13 58.72 1.41 Allowed 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.457 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.6 pttp 33.44 26.43 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.195 -179.226 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.628 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.4 tt -48.25 123.29 6.23 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.986 -178.092 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.455 ' O ' HD23 ' A' ' 95' ' ' LEU . 99.0 mm-40 -83.68 -169.62 2.65 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.122 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.605 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 81.4 mtp180 -74.42 137.32 42.57 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.303 -179.805 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.493 ' N ' ' O ' ' A' ' 67' ' ' SER . 90.6 mt -86.21 -165.85 1.38 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.74 -179.659 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.538 ' O ' ' CD2' ' A' ' 99' ' ' TYR . 48.4 p90 -168.74 119.77 0.76 Allowed 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.207 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.511 ' C ' ' O ' ' A' ' 99' ' ' TYR . 43.0 mm -28.67 120.74 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.085 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 114.38 27.48 3.35 Favored Glycine 0 CA--C 1.519 0.34 0 N-CA-C 111.196 -0.762 . . . . 0.0 111.196 -179.46 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.576 ' CD ' ' H ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -144.47 46.6 0.64 Allowed Pre-proline 0 C--N 1.323 -0.554 0 CA-C-O 120.979 0.419 . . . . 0.0 110.447 179.861 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 29.0 Cg_endo -62.04 144.01 95.64 Favored 'Trans proline' 0 C--N 1.296 -2.224 0 C-N-CA 122.702 2.268 . . . . 0.0 111.865 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.459 ' O ' HG23 ' A' ' 108' ' ' VAL . 26.7 t -173.24 120.23 0.34 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.423 179.718 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.83 -40.4 63.35 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.054 0.454 . . . . 0.0 111.085 179.639 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.23 -40.06 90.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.888 -179.455 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.14 -39.97 95.15 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.677 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 104' ' ' SER . 70.4 t -67.71 -43.72 86.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.731 179.705 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.74 -38.96 92.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.53 -179.26 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.441 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.65 -23.35 62.97 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.49 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.547 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.5 mm-40 -90.5 5.14 48.91 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.714 -179.555 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.547 ' C ' ' O ' ' A' ' 111' ' ' GLN . 10.6 tpt 23.27 64.33 0.37 Allowed Pre-proline 0 N--CA 1.464 0.261 0 CA-C-O 120.935 0.398 . . . . 0.0 111.077 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -78.61 167.5 22.52 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 123.062 2.508 . . . . 0.0 111.861 -178.172 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.521 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 99.0 m-20 -109.97 -42.27 4.26 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.182 179.474 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.6 tp -121.04 120.66 36.01 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 179.635 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 83.8 mt -113.44 129.0 70.0 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.39 0 CA-C-O 120.98 0.419 . . . . 0.0 110.903 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.627 HD12 ' OG ' ' A' ' 48' ' ' SER . 30.2 mt -109.18 132.27 54.28 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 121.084 0.469 . . . . 0.0 110.235 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.491 HD12 HG23 ' A' ' 139' ' ' THR . 99.0 mt -119.84 138.75 49.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.719 -179.752 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 84.9 p -72.51 153.61 41.25 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.598 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.18 -50.12 74.94 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.678 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -149.44 154.01 38.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.55 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 170.58 -170.99 43.49 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -63.09 -34.16 89.21 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.866 -0.893 . . . . 0.0 110.866 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.45 ' OD1' ' O ' ' A' ' 124' ' ' ASP . 44.3 p-10 -86.82 120.45 28.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.837 0.351 . . . . 0.0 110.705 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.443 ' O ' HD12 ' A' ' 129' ' ' LEU . 38.9 t -63.23 143.48 57.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.029 0.443 . . . . 0.0 110.495 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.52 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -92.97 -43.18 9.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.972 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.9 tp -62.85 -42.45 99.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.703 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.66 -11.83 59.13 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.53 -179.36 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.443 HD12 ' O ' ' A' ' 125' ' ' SER . 84.8 mt -114.97 -23.86 8.88 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.659 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' TYR . . . . . 0.52 ' N ' ' O ' ' A' ' 126' ' ' ALA . 80.6 t80 -51.13 -49.55 60.6 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.537 -178.868 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.0 p-10 -66.13 -42.41 89.18 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.823 0.344 . . . . 0.0 111.239 179.486 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.519 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 88.2 mt-30 -67.16 -37.81 84.41 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.813 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.431 HD12 HD11 ' A' ' 118' ' ' ILE . 96.0 mt -80.36 -41.38 24.81 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.965 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.2 t -57.23 -44.57 83.91 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.218 -179.109 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.7 m -61.97 -45.23 94.56 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.511 179.456 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 94.0 mt -62.09 -43.64 97.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.279 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.66 ' HB1' ' HD2' ' A' ' 138' ' ' PRO . . . -169.44 168.22 4.96 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.56 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.66 ' HD2' ' HB1' ' A' ' 137' ' ' ALA . 52.3 Cg_exo -49.57 112.82 0.76 Allowed 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.323 2.015 . . . . 0.0 112.282 179.214 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.491 HG23 HD12 ' A' ' 118' ' ' ILE . 23.5 m -84.49 127.53 34.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.617 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.678 HD13 ' CD2' ' A' ' 37' ' ' HIS . 34.7 tp -118.22 137.0 53.31 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.079 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.44 ' O ' ' OD2' ' A' ' 32' ' ' ASP . 81.3 mt -101.26 118.94 48.76 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.353 0 CA-C-O 121.226 0.536 . . . . 0.0 111.222 -179.419 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.431 HD12 HD22 ' A' ' 117' ' ' LEU . 98.1 mt -134.78 132.04 53.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.588 179.676 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.475 ' ND2' ' OD2' ' A' ' 241' ' ' ASP . 2.1 t-20 -66.28 151.82 46.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.895 0.378 . . . . 0.0 110.413 179.419 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.521 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 88.1 t80 -86.69 122.54 30.73 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.808 -179.581 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.521 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 99.0 m-20 55.31 69.13 0.77 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.788 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 35.9 p-10 -125.9 0.17 7.3 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.652 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -150.54 115.12 5.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.715 -179.491 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 83.9 p -63.29 168.2 4.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.602 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.417 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.7 p-90 -51.88 -15.79 0.59 Allowed 'General case' 0 C--O 1.223 -0.334 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.467 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' GLN . . . . . 0.44 ' O ' HG23 ' A' ' 154' ' ' THR . 68.1 tp60 -70.52 -76.04 0.11 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.474 -179.673 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.444 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.1 t -62.7 -38.61 91.08 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.255 179.543 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 54.3 tp -59.93 -45.84 91.3 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.412 -178.572 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.417 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 46.7 tp -62.67 -41.64 99.19 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.497 179.011 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.444 ' OG1' ' O ' ' A' ' 151' ' ' SER . 60.1 p -64.1 -34.79 78.85 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.273 -179.482 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 155' ' ' GLN . . . . . 0.415 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.9 mm-40 -64.19 -42.77 96.53 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.311 179.35 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 91.8 mt -65.37 -38.73 90.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.148 0.499 . . . . 0.0 110.268 179.122 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.579 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.23 -32.47 80.75 Favored Glycine 0 CA--C 1.519 0.317 0 N-CA-C 110.712 -0.955 . . . . 0.0 110.712 -179.306 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 157' ' ' GLY . 97.2 mt-10 -35.45 -26.93 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.828 0.347 . . . . 0.0 110.837 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.579 ' N ' ' O ' ' A' ' 157' ' ' GLY . 95.3 mt -56.46 149.81 3.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.295 179.197 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 77.1 p -69.61 137.21 52.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.997 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 71.1 21.17 78.37 Favored Glycine 0 N--CA 1.459 0.19 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 179.476 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 58.1 m80 -122.47 -14.94 7.72 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.702 0.286 . . . . 0.0 110.529 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -65.96 -59.74 3.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.748 -179.717 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -52.26 -49.3 64.34 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.209 -179.601 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -60.54 -41.22 94.05 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.957 -0.297 . . . . 0.0 110.379 179.468 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.49 -47.12 87.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.541 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.97 -40.14 75.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.244 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -61.82 -50.27 72.96 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.576 179.572 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -65.17 -43.86 90.36 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.531 179.472 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 94.6 mt -64.78 -43.29 96.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.402 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.28 -51.23 70.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.475 -179.172 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.43 -43.86 96.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.543 179.665 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 173' ' ' PHE . . . . . 0.654 ' CE2' HD11 ' A' ' 177' ' ' LEU . 57.0 t80 -62.75 -44.4 96.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.06 0.457 . . . . 0.0 110.443 179.451 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -63.32 -39.8 95.56 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.617 -179.382 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -63.01 -42.76 99.9 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.599 179.223 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -60.72 -44.6 96.42 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.184 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.654 HD11 ' CE2' ' A' ' 173' ' ' PHE . 84.1 mt -64.54 -40.96 96.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.014 0.435 . . . . 0.0 110.707 178.893 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.18 -62.46 1.62 Allowed 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.368 -179.298 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.52 -46.86 85.89 Favored 'General case' 0 C--O 1.227 -0.128 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.628 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.13 -41.85 65.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.276 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -63.74 -33.79 76.43 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.982 0.42 . . . . 0.0 110.411 179.262 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 182' ' ' GLU . . . . . 0.422 ' O ' ' HG2' ' A' ' 182' ' ' GLU . 69.6 tt0 -90.51 8.83 31.92 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.46 0.648 . . . . 0.0 110.508 -178.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -104.99 -32.07 8.92 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.174 179.559 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.9 pt -127.98 147.63 32.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.822 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -139.93 131.09 26.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.357 179.286 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 186' ' ' LEU . . . . . 0.593 HD22 ' N ' ' A' ' 186' ' ' LEU . 3.6 mm? -85.35 133.34 42.64 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.979 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -43.93 157.82 0.14 Allowed 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.69 2.26 . . . . 0.0 112.191 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 188' ' ' PRO . . . . . 0.521 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.9 Cg_endo -63.1 115.11 2.77 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 C-N-CA 122.795 2.33 . . . . 0.0 111.696 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 189' ' ' GLN . . . . . 0.521 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.8 mt-30 155.16 147.86 0.0 OUTLIER Pre-proline 0 C--N 1.332 -0.162 0 O-C-N 123.791 0.682 . . . . 0.0 110.832 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -73.49 144.11 35.65 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.667 2.245 . . . . 0.0 112.159 177.829 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.496 HG23 ' OG ' ' A' ' 258' ' ' SER . 2.1 p -125.04 158.98 32.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.291 0.567 . . . . 0.0 110.185 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 192' ' ' THR . . . . . 0.494 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 37.5 p -143.3 165.39 27.6 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.106 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 193' ' ' ALA . . . . . 0.45 ' HA ' ' H ' ' A' ' 260' ' ' PHE . . . -135.4 128.69 32.05 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.234 0.54 . . . . 0.0 110.231 179.431 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.504 HD11 HD23 ' A' ' 259' ' ' LEU . 47.6 pt -146.3 148.71 16.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.165 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 195' ' ' VAL . . . . . 0.749 HG13 ' CD1' ' A' ' 262' ' ' PHE . 70.4 t -117.51 123.01 71.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.282 0.563 . . . . 0.0 109.71 179.083 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -134.47 107.51 7.6 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.331 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 94.3 m -131.01 130.71 43.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.845 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -82.82 -37.02 25.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.231 179.682 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.55 -67.17 0.26 Allowed 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.359 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.33 -9.76 58.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.342 179.583 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 60.1 t-80 60.43 58.3 2.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.774 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 39.4 p -166.8 153.2 8.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.586 179.445 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.28 144.09 24.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.005 0.431 . . . . 0.0 110.421 179.419 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -135.3 137.87 42.9 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.619 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 19.6 mt -105.98 125.42 50.97 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.061 0.458 . . . . 0.0 109.81 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 206' ' ' TRP . . . . . 0.555 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 75.6 m95 -82.09 167.15 19.07 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.685 -179.752 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 207' ' ' THR . . . . . 0.466 HG22 ' C ' ' A' ' 206' ' ' TRP . 0.1 OUTLIER -156.99 171.38 7.53 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.624 -179.189 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -53.57 -37.22 82.85 Favored 'Trans proline' 0 C--N 1.302 -1.902 0 C-N-CA 122.661 2.24 . . . . 0.0 112.27 179.214 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -70.52 -34.88 72.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.813 -179.738 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 22.8 m -61.19 150.72 33.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.637 -179.396 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.52 -36.95 81.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.485 -179.715 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 212' ' ' GLN . . . . . 0.555 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 54.8 tt0 -64.78 -40.11 94.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.506 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.8 -43.41 91.74 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -63.33 -43.74 96.92 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.791 0.329 . . . . 0.0 110.29 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 215' ' ' MET . . . . . 0.522 ' SD ' ' HB2' ' A' ' 304' ' ' ALA . 65.1 ttp -59.39 -48.18 82.63 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.238 -179.789 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 88.2 mt -60.37 -40.9 92.49 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 179.602 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 217' ' ' GLU . . . . . 0.456 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 40.9 tp10 -57.96 -38.03 75.25 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -65.17 -37.92 88.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.67 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 94.5 mt -64.4 -42.72 95.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.141 0.496 . . . . 0.0 110.583 -179.696 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.56 44.63 0.08 OUTLIER Glycine 0 C--N 1.334 0.417 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 221' ' ' PHE . . . . . 0.456 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 25.9 m-85 -127.68 155.19 44.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.04 0.447 . . . . 0.0 110.471 -179.76 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.481 ' O ' HG13 ' A' ' 191' ' ' VAL . 6.1 p -107.05 122.35 46.29 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.272 0.558 . . . . 0.0 110.116 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.473 HD22 ' C ' ' A' ' 222' ' ' THR . 4.3 mm? -101.25 133.04 46.42 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.068 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -97.17 159.53 14.86 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.488 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.21 115.32 30.06 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.399 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.496 HD12 ' N ' ' A' ' 226' ' ' LEU . 9.0 mp -53.62 156.84 4.21 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.689 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -59.86 145.21 98.84 Favored 'Trans proline' 0 C--N 1.302 -1.916 0 C-N-CA 122.65 2.233 . . . . 0.0 112.19 179.237 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.64 -2.73 58.81 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.559 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.46 -40.68 5.65 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 230' ' ' LEU . . . . . 0.535 ' O ' ' N ' ' A' ' 233' ' ' SER . 86.1 mt -79.13 -16.74 56.22 Favored 'General case' 0 C--O 1.222 -0.379 0 CA-C-O 121.02 0.438 . . . . 0.0 110.383 -179.774 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 231' ' ' ASN . . . . . 0.402 ' C ' ' O ' ' A' ' 230' ' ' LEU . 54.4 t-20 -40.29 -49.07 2.73 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.777 -179.421 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -88.24 15.44 7.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.368 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 233' ' ' SER . . . . . 0.535 ' N ' ' O ' ' A' ' 230' ' ' LEU . 77.8 p -60.52 -35.52 76.18 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.622 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 234' ' ' GLN . . . . . 0.523 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.6 tt0 -118.27 -69.37 0.85 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.958 179.508 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 3.9 m -70.39 103.03 2.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.679 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -93.99 57.92 2.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.398 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -145.12 -122.28 1.52 Allowed Glycine 0 CA--C 1.519 0.343 0 N-CA-C 110.989 -0.845 . . . . 0.0 110.989 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -134.56 111.68 10.26 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 121.114 0.483 . . . . 0.0 110.433 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 239' ' ' ARG . . . . . 0.51 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.3 mtt180 -148.12 57.24 1.08 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.696 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -69.74 -31.99 70.27 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.511 179.608 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 241' ' ' ASP . . . . . 0.475 ' OD2' ' ND2' ' A' ' 143' ' ' ASN . 65.1 t0 -56.83 -46.93 81.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.379 -179.07 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 242' ' ' ILE . . . . . 0.437 ' O ' ' O ' ' A' ' 239' ' ' ARG . 17.5 tt -140.02 156.76 25.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.888 0.375 . . . . 0.0 110.537 179.719 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.438 HG22 HD13 ' A' ' 245' ' ' LEU . 96.0 mt -105.8 105.9 19.56 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.218 0 CA-C-O 121.122 0.487 . . . . 0.0 110.511 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 244' ' ' GLN . . . . . 0.602 ' O ' HD12 ' A' ' 245' ' ' LEU . 88.3 mt-30 -110.23 110.03 20.72 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.344 179.704 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.602 HD12 ' O ' ' A' ' 244' ' ' GLN . 9.6 mp -121.86 -168.23 1.67 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.663 179.692 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 246' ' ' GLY . . . . . 0.523 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.28 -16.8 0.05 OUTLIER Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 247' ' ' GLY . . . . . 0.669 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -60.44 157.17 29.42 Favored Glycine 0 CA--C 1.522 0.49 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 -179.81 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -63.86 21.68 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.99 0.424 . . . . 0.0 110.619 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 249' ' ' ASN . . . . . 0.669 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.7 m-20 -97.43 -5.82 35.32 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.517 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 91.9 mt -80.28 -21.48 42.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.672 179.46 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.66 -51.36 70.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.702 -179.574 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.43 -5.19 58.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.453 179.643 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.15 -74.2 1.15 Allowed Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 80.4 mt -70.09 125.73 27.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.979 0.418 . . . . 0.0 110.274 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -59.7 -39.15 83.65 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.492 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 84.1 51.74 3.86 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 110.712 -0.955 . . . . 0.0 110.712 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -94.87 -16.2 23.09 Favored 'General case' 0 C--N 1.332 -0.191 0 O-C-N 122.651 -0.323 . . . . 0.0 110.654 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 258' ' ' SER . . . . . 0.496 ' OG ' HG23 ' A' ' 191' ' ' VAL . 3.3 t 174.06 89.53 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.074 0.464 . . . . 0.0 110.18 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.863 HD12 ' N ' ' A' ' 259' ' ' LEU . 1.0 OUTLIER -94.47 124.35 38.44 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.275 0.559 . . . . 0.0 111.079 -179.084 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 260' ' ' PHE . . . . . 0.45 ' H ' ' HA ' ' A' ' 193' ' ' ALA . 16.0 m-30 -93.49 146.64 23.62 Favored 'General case' 0 CA--C 1.504 -0.793 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.441 179.262 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 85.9 mt -122.46 149.91 43.22 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.567 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.749 ' CD1' HG13 ' A' ' 195' ' ' VAL . 2.6 p90 -77.61 -138.4 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.541 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 263' ' ' ALA . . . . . 0.657 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -52.24 77.51 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.048 0.452 . . . . 0.0 111.078 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 264' ' ' GLY . . . . . 0.625 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.17 104.35 0.18 Allowed Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 265' ' ' ASP . . . . . 0.601 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.8 m-20 -80.28 -177.89 6.34 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 120.685 0.279 . . . . 0.0 110.908 -179.478 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -40.44 -17.52 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.567 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 267' ' ' LYS . . . . . 0.601 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.62 -51.45 42.1 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.617 179.502 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -63.79 -46.64 84.28 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.171 179.401 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 269' ' ' ALA . . . . . 0.566 ' HB1' ' OH ' ' A' ' 273' ' ' TYR . . . -61.58 -34.99 76.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.247 0.546 . . . . 0.0 109.866 179.653 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -63.13 -34.42 77.58 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.17 179.705 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.43 -43.31 13.73 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.218 -179.517 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 272' ' ' ILE . . . . . 0.588 ' C ' ' H ' ' A' ' 274' ' ' ALA . 4.9 tt -51.42 -33.72 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.863 -178.884 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 273' ' ' TYR . . . . . 0.566 ' OH ' ' HB1' ' A' ' 269' ' ' ALA . 17.4 m-85 -54.31 -1.88 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.649 -179.587 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 274' ' ' ALA . . . . . 0.588 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.64 -39.66 70.22 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.95 179.561 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 275' ' ' ASN . . . . . 0.586 ' O ' ' N ' ' A' ' 279' ' ' ALA . 4.2 p30 -39.12 97.86 0.15 Allowed Pre-proline 0 N--CA 1.462 0.174 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.458 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -54.55 -42.97 63.27 Favored 'Trans proline' 0 C--N 1.303 -1.831 0 C-N-CA 122.372 2.048 . . . . 0.0 112.552 -178.7 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 88.9 mt -64.45 -42.97 95.66 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.128 0.49 . . . . 0.0 111.211 -179.744 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 90.8 mt -95.71 -1.38 50.09 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.923 -179.485 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 279' ' ' ALA . . . . . 0.586 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.19 -34.74 77.02 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.714 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.21 19.8 0.12 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.018 -179.27 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 281' ' ' LEU . . . . . 0.487 HD23 ' HA ' ' A' ' 281' ' ' LEU . 13.9 mt -75.08 120.14 80.27 Favored Pre-proline 0 N--CA 1.451 -0.423 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.575 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -49.97 -39.81 49.75 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.625 2.216 . . . . 0.0 112.154 178.769 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.52 -50.56 62.57 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.084 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 79.9 t -61.79 -43.8 97.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 179.538 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -57.88 -41.77 83.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.317 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -90.43 0.33 57.34 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.119 179.724 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt 59.04 41.19 21.17 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.773 179.661 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -92.89 42.18 1.09 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.355 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 53.7 t -119.1 135.67 58.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.014 0.435 . . . . 0.0 110.246 -179.731 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -133.05 162.74 30.9 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.656 -179.626 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.77 154.96 33.42 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.965 0.412 . . . . 0.0 110.747 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 81.8 mt -93.75 -1.46 55.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.231 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.59 165.52 12.62 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 110.58 -1.008 . . . . 0.0 110.58 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 7.1 m -87.38 -62.27 1.54 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.89 0.376 . . . . 0.0 111.004 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 295' ' ' GLU . . . . . 0.438 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.5 mm-40 -69.62 -3.97 17.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.636 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 26.2 p -76.81 33.14 0.14 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.648 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 297' ' ' PHE . . . . . 0.535 ' CD2' HG22 ' A' ' 70' ' ' THR . 85.0 t80 -60.21 -46.03 91.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.477 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 298' ' ' ARG . . . . . 0.605 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.2 mtt85 -81.73 133.76 35.38 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.568 -179.726 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.44 ' H ' HG11 ' A' ' 51' ' ' VAL . 16.1 tp -114.07 119.75 38.2 Favored 'General case' 0 C--O 1.231 0.083 0 CA-C-O 120.992 0.425 . . . . 0.0 110.205 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 300' ' ' ASP . . . . . 0.622 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.2 p-10 -167.43 -174.15 2.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.551 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 84.0 t80 -48.23 -45.81 34.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.215 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -64.7 -41.48 95.99 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.033 0.444 . . . . 0.0 110.689 178.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 303' ' ' SER . . . . . 0.622 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 53.1 p -55.53 -36.09 66.37 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.954 -179.073 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 304' ' ' ALA . . . . . 0.522 ' HB2' ' SD ' ' A' ' 215' ' ' MET . . . -56.71 -51.76 67.57 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.442 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 91.0 mtp -56.13 -43.89 78.62 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -66.3 -42.81 87.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.008 0.432 . . . . 0.0 110.246 178.833 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 307' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 303' ' ' SER . 55.5 t -64.02 -42.77 96.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.211 179.44 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 42.3 tp -59.65 -42.29 92.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.791 -179.519 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -62.54 -38.76 91.28 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.149 179.446 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 310' ' ' ARG . . . . . 0.442 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.6 ttt85 -63.54 -43.95 95.61 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.229 179.606 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 88.3 mt -63.15 -42.15 99.39 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.303 179.57 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -62.84 -33.22 74.79 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.04 179.474 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.94 -23.51 21.55 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.377 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 314' ' ' LEU . . . . . 0.478 HD22 ' CE2' ' A' ' 315' ' ' PHE . 6.8 tt -62.31 -43.19 99.39 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 121.092 0.473 . . . . 0.0 110.623 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 315' ' ' PHE . . . . . 0.478 ' CE2' HD22 ' A' ' 314' ' ' LEU . 90.8 m-85 . . . . . 0 C--O 1.22 -0.475 0 CA-C-O 118.005 -0.997 . . . . 0.0 110.42 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -99.41 135.58 40.61 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.087 0.47 . . . . 0.0 110.502 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.495 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.2 OUTLIER -92.14 178.42 1.71 Allowed Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.549 -179.842 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.495 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.3 Cg_exo -61.74 147.47 95.24 Favored 'Trans proline' 0 C--N 1.3 -2.024 0 C-N-CA 122.776 2.317 . . . . 0.0 112.168 179.603 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.482 ' HE ' HD12 ' A' ' 39' ' ' LEU . 35.2 ptt180 -136.12 142.33 44.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.735 179.682 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -79.83 116.79 20.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.406 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.447 ' O ' HG23 ' A' ' 30' ' ' ILE . 9.5 tp -111.54 130.71 64.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.411 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.1 t -71.19 142.62 50.64 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.623 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.479 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.7 t0 -139.84 179.86 6.35 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.564 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.479 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 77.9 p -73.86 -37.26 64.82 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.707 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.7 ttt85 -46.83 -94.62 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.309 -179.358 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -166.3 -26.8 0.02 OUTLIER Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 56.9 m -168.87 105.69 0.42 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.892 0.377 . . . . 0.0 110.621 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.653 ' CD2' HD13 ' A' ' 140' ' ' LEU . 69.6 t60 -128.77 147.03 50.75 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.053 0.454 . . . . 0.0 110.262 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.623 HG22 ' N ' ' A' ' 39' ' ' LEU . 99.9 m -130.05 165.73 21.6 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.582 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.623 ' N ' HG22 ' A' ' 38' ' ' THR . 80.8 mt -120.35 127.33 52.23 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.481 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -65.43 -44.62 86.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.693 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 41.2 p -165.89 155.23 11.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.46 179.61 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.489 ' CD ' ' H ' ' A' ' 42' ' ' GLN . 15.1 mp0 -45.25 101.63 0.27 Allowed Pre-proline 0 C--N 1.329 -0.295 0 O-C-N 123.388 0.43 . . . . 0.0 110.659 179.327 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -57.96 129.58 33.96 Favored 'Trans proline' 0 C--N 1.303 -1.82 0 C-N-CA 122.269 1.979 . . . . 0.0 112.231 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -82.33 -25.2 34.11 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.478 179.605 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.534 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.7 mtm-85 -120.87 134.39 55.29 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-O 121.194 0.521 . . . . 0.0 110.252 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.1 mt -129.69 133.06 65.59 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.313 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.034 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 46.0 t -124.71 130.9 73.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 179.403 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.622 ' OG ' HD12 ' A' ' 117' ' ' LEU . 4.4 m -154.99 166.5 33.4 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.541 179.578 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 66.0 p -124.27 8.99 8.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.805 0.336 . . . . 0.0 110.439 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.72 125.82 33.5 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.668 -179.514 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.471 HG11 ' H ' ' A' ' 299' ' ' LEU . 85.7 t -65.81 -44.55 92.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.547 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 18.9 m -62.63 -44.35 96.51 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.615 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 53.5 tp -62.26 -41.54 98.54 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.503 -179.403 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.45 ' O ' HD13 ' A' ' 58' ' ' LEU . 73.3 m -57.85 -44.54 86.6 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.257 -179.271 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.39 -62.01 5.48 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 179.706 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.7 t -48.74 -35.25 13.74 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.9 mt -61.8 -44.38 96.98 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.586 -0.445 . . . . 0.0 111.325 179.13 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.45 HD13 ' O ' ' A' ' 54' ' ' THR . 9.4 mp -64.74 -41.95 95.55 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.384 177.765 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.406 ' HB1' ' NE ' ' A' ' 169' ' ' ARG . . . -63.67 -41.03 98.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.033 -179.196 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.426 ' O ' HG23 ' A' ' 60' ' ' ILE . 8.0 tp -88.11 16.77 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.798 -179.726 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 56.38 84.56 0.08 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.696 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.14 58.21 0.07 OUTLIER Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.287 -0.415 . . . . 0.0 109.904 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -50.58 152.76 8.67 Favored 'Trans proline' 0 C--N 1.293 -2.365 0 C-N-CA 122.84 2.36 . . . . 0.0 112.404 -178.509 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.432 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -108.78 145.83 15.18 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.219 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.239 -179.716 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 97.0 mt -63.75 -45.06 98.32 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.366 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.559 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.501 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -130.02 134.49 47.44 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 120.836 0.351 . . . . 0.0 110.588 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.497 ' O ' ' N ' ' A' ' 98' ' ' LEU . 73.6 m -134.74 158.71 43.44 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.893 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -87.2 139.54 16.2 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.491 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.72 -162.75 0.08 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.003 0.43 . . . . 0.0 110.453 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.513 HG22 ' CD2' ' A' ' 297' ' ' PHE . 14.0 t -133.47 135.15 44.33 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.324 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.486 ' C ' ' O ' ' A' ' 70' ' ' THR . 0.1 OUTLIER 29.77 68.51 0.67 Allowed Pre-proline 0 N--CA 1.466 0.353 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.765 -179.883 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_exo -60.96 145.21 99.4 Favored 'Trans proline' 0 C--N 1.299 -2.047 0 C-N-CA 122.613 2.208 . . . . 0.0 112.017 -178.299 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.524 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 45.5 p-10 -159.83 -32.6 0.06 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.65 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.54 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 99.0 m-20 -64.0 -39.56 94.39 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.485 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.6 ttt180 -60.65 -47.87 84.29 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.721 -179.187 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.421 ' O ' ' O ' ' A' ' 77' ' ' ALA . 89.2 t -60.58 -24.59 32.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.54 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -45.85 172.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.581 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.569 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.6 p30 -61.85 177.58 0.42 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.551 -179.746 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.56 ' C ' ' H ' ' A' ' 81' ' ' GLY . 35.5 p30 -45.61 85.84 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.049 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.569 ' N ' ' O ' ' A' ' 78' ' ' ASP . 43.3 tp60 -67.34 13.32 0.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.232 0.539 . . . . 0.0 110.101 -179.713 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.56 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 118.04 -22.12 9.91 Favored Glycine 0 C--N 1.332 0.321 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -107.79 116.25 31.62 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.014 0.435 . . . . 0.0 110.419 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 77.6 mt -98.87 0.57 44.47 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.498 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -92.04 6.72 45.36 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.033 0.444 . . . . 0.0 110.327 -179.622 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.794 ' O ' HG22 ' A' ' 89' ' ' VAL . 27.2 mt-30 -100.05 -27.73 13.41 Favored 'General case' 0 C--O 1.223 -0.329 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.869 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 68.7 t-105 -63.08 -40.81 98.77 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.902 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.554 ' O ' ' N ' ' A' ' 91' ' ' LYS . 68.0 m -77.44 -53.44 7.63 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.272 -179.486 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -48.57 -50.73 31.04 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.039 -179.279 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.794 HG22 ' O ' ' A' ' 85' ' ' GLN . 15.5 m -68.87 -40.8 81.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 120.97 0.414 . . . . 0.0 111.175 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.498 ' N ' HG23 ' A' ' 89' ' ' VAL . . . -72.06 -23.05 61.3 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.763 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.554 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.0 tttm -61.51 -45.89 92.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.42 -179.439 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.444 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.8 mm-40 -90.38 -94.59 0.12 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.048 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.622 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.8 mtt180 -143.35 59.97 1.4 Allowed 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.456 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.6 pttp 33.73 26.46 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 120.861 0.362 . . . . 0.0 110.12 -179.525 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.622 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.5 tt -48.49 123.19 6.29 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.081 -178.026 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.456 ' O ' HD23 ' A' ' 95' ' ' LEU . 99.0 mm-40 -83.69 -170.18 2.94 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.007 -179.763 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.62 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 82.2 mtp180 -73.29 137.77 45.06 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.197 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.497 ' N ' ' O ' ' A' ' 67' ' ' SER . 89.3 mt -86.26 -166.15 1.46 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.777 -179.764 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.532 ' O ' ' CD2' ' A' ' 99' ' ' TYR . 47.5 p90 -168.01 119.65 0.84 Allowed 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.234 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.505 ' C ' ' O ' ' A' ' 99' ' ' TYR . 42.8 mm -29.4 120.98 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.058 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 113.92 28.03 3.28 Favored Glycine 0 C--N 1.332 0.323 0 N-CA-C 111.176 -0.77 . . . . 0.0 111.176 -179.361 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.582 ' N ' ' CD ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -143.93 45.94 0.61 Allowed Pre-proline 0 C--N 1.323 -0.566 0 O-C-N 122.481 -0.423 . . . . 0.0 110.434 179.816 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.582 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 30.2 Cg_endo -61.95 143.8 95.77 Favored 'Trans proline' 0 C--N 1.296 -2.229 0 C-N-CA 122.669 2.246 . . . . 0.0 111.971 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.46 ' O ' HG23 ' A' ' 108' ' ' VAL . 26.7 t -173.17 120.43 0.35 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.463 179.637 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.1 -41.0 64.53 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.069 0.462 . . . . 0.0 111.157 179.567 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -65.8 -39.92 91.38 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.85 -179.451 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.94 -39.67 94.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.751 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 104' ' ' SER . 70.6 t -67.4 -43.88 87.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.769 179.572 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.52 -39.11 92.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.574 -179.211 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.444 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.63 -23.85 63.35 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.448 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.554 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.3 mm-40 -91.23 4.71 51.59 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.695 -179.592 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.554 ' C ' ' O ' ' A' ' 111' ' ' GLN . 10.4 tpt 22.11 64.29 0.32 Allowed Pre-proline 0 N--CA 1.466 0.345 0 CA-C-O 120.937 0.398 . . . . 0.0 111.154 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.446 ' HG2' HD11 ' A' ' 116' ' ' ILE . 67.7 Cg_endo -78.85 169.8 18.98 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 123.072 2.515 . . . . 0.0 112.085 -178.252 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.518 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 98.8 m-20 -112.3 -44.82 3.34 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.222 -0.444 . . . . 0.0 109.974 179.63 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.2 tp -119.96 120.88 37.67 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.727 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.45 HD13 HD22 ' A' ' 133' ' ' LEU . 96.6 mt -117.82 131.36 70.79 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.417 0 CA-C-O 120.957 0.408 . . . . 0.0 110.985 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.622 HD12 ' OG ' ' A' ' 48' ' ' SER . 33.4 mt -106.17 132.2 52.51 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.117 0.484 . . . . 0.0 110.051 -179.405 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.498 HD12 HG23 ' A' ' 139' ' ' THR . 98.4 mt -117.49 135.93 56.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.791 -179.687 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 85.4 p -71.37 151.79 43.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.521 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.28 -49.94 75.61 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.712 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -149.33 153.7 37.85 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.544 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 168.7 -169.35 41.66 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -63.08 -35.41 92.05 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.452 ' OD1' ' O ' ' A' ' 124' ' ' ASP . 44.4 p-10 -88.62 120.02 29.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.839 0.352 . . . . 0.0 110.694 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.443 ' O ' HD12 ' A' ' 129' ' ' LEU . 40.7 t -63.47 144.35 57.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.012 0.434 . . . . 0.0 110.526 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.521 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.32 -42.82 9.1 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.012 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.6 tp -62.65 -42.34 99.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.657 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.05 -10.83 56.88 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.508 -179.416 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.443 HD12 ' O ' ' A' ' 125' ' ' SER . 85.5 mt -115.82 -23.96 8.4 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.62 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' TYR . . . . . 0.521 ' N ' ' O ' ' A' ' 126' ' ' ALA . 73.2 t80 -51.83 -48.9 63.72 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.569 -0.452 . . . . 0.0 110.537 -178.843 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.53 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 39.4 p-10 -66.17 -41.67 89.98 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.885 0.374 . . . . 0.0 111.34 179.26 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.53 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 87.9 mt-30 -67.83 -37.33 81.77 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.874 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.464 HD12 HD11 ' A' ' 118' ' ' ILE . 97.1 mt -79.65 -42.57 24.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.134 -179.674 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.2 t -57.78 -44.9 86.54 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.256 -178.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 18.8 m -62.19 -46.09 90.46 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.865 0.364 . . . . 0.0 110.76 179.299 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 92.3 mt -62.47 -43.63 98.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.374 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.589 ' HB1' ' HD2' ' A' ' 138' ' ' PRO . . . -170.02 163.14 6.52 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.459 179.833 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.589 ' HD2' ' HB1' ' A' ' 137' ' ' ALA . 77.4 Cg_exo -42.02 110.81 0.16 Allowed 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.531 2.154 . . . . 0.0 112.088 179.413 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.503 HG21 ' CD1' ' A' ' 130' ' ' TYR . 2.9 m -87.48 127.59 35.23 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.559 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.653 HD13 ' CD2' ' A' ' 37' ' ' HIS . 34.9 tp -119.61 139.42 52.21 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.077 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.429 ' O ' ' OD2' ' A' ' 32' ' ' ASP . 81.0 mt -105.48 120.0 55.54 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.385 0 CA-C-O 121.14 0.495 . . . . 0.0 111.341 -179.665 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.494 HD12 HD22 ' A' ' 117' ' ' LEU . 98.2 mt -135.42 132.51 52.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.683 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.546 HD21 ' CG ' ' A' ' 241' ' ' ASP . 59.1 t30 -64.71 147.8 52.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.885 0.374 . . . . 0.0 110.368 179.275 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.454 ' O ' ' OD2' ' A' ' 241' ' ' ASP . 86.5 t80 -82.41 122.69 28.33 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.046 -179.593 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.433 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 91.4 m-20 55.32 69.02 0.78 Allowed 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.951 179.695 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 34.8 p-10 -125.78 0.37 7.39 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.943 0.401 . . . . 0.0 110.68 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -150.55 115.7 5.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.747 -179.507 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 85.9 p -63.93 169.07 4.52 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.566 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.419 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.6 p-90 -51.87 -15.95 0.62 Allowed 'General case' 0 C--O 1.223 -0.341 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.49 -179.763 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' GLN . . . . . 0.43 ' O ' HG23 ' A' ' 154' ' ' THR . 68.1 tp60 -70.41 -76.09 0.11 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.469 -179.755 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.442 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.1 t -62.47 -38.61 90.51 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.011 0.434 . . . . 0.0 110.241 179.553 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 51.1 tp -60.21 -45.48 93.02 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.334 -178.425 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.419 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 45.8 tp -62.69 -41.86 99.33 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.859 0.361 . . . . 0.0 110.398 178.943 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.442 ' OG1' ' O ' ' A' ' 151' ' ' SER . 57.6 p -63.89 -34.74 78.63 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.18 -179.371 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 155' ' ' GLN . . . . . 0.463 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 88.1 mm-40 -63.85 -42.28 97.61 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.153 179.274 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 90.5 mt -65.28 -39.07 92.09 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.125 0.488 . . . . 0.0 110.096 179.2 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.577 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.03 -32.39 80.1 Favored Glycine 0 CA--C 1.519 0.321 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 -179.292 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.463 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.3 mt-10 -36.65 -25.09 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.82 0.343 . . . . 0.0 110.807 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.577 ' N ' ' O ' ' A' ' 157' ' ' GLY . 95.8 mt -59.56 148.53 7.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.193 179.284 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 71.3 p -68.91 137.68 54.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.12 -179.62 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 70.56 21.91 77.77 Favored Glycine 0 N--CA 1.458 0.146 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 179.61 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 60.3 m80 -124.28 -14.34 7.0 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.73 0.3 . . . . 0.0 110.569 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -66.17 -59.49 3.71 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.792 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -52.22 -48.32 65.18 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 120.679 -0.409 . . . . 0.0 110.093 -179.505 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -60.88 -40.96 95.0 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.697 0.284 . . . . 0.0 110.313 179.477 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.61 -47.17 86.64 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.6 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -57.2 -39.83 76.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.179 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -61.85 -50.3 72.79 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.569 179.566 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.406 ' NE ' ' HB1' ' A' ' 59' ' ' ALA . 60.1 ttt85 -65.5 -43.78 89.09 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.458 179.536 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 94.8 mt -64.47 -43.52 96.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.386 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.32 -50.89 71.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.474 -179.123 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.97 -43.56 95.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.454 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 173' ' ' PHE . . . . . 0.658 ' CE2' HD11 ' A' ' 177' ' ' LEU . 56.7 t80 -62.67 -44.59 95.87 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.07 0.462 . . . . 0.0 110.386 179.407 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -63.38 -39.96 95.94 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.561 -179.274 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -62.9 -42.8 99.91 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.623 179.159 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -60.78 -44.69 96.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.044 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.658 HD11 ' CE2' ' A' ' 173' ' ' PHE . 84.7 mt -64.34 -41.26 96.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.058 0.456 . . . . 0.0 110.733 178.897 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.13 -62.19 1.79 Allowed 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.43 -179.297 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.35 -46.86 85.46 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.52 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.02 -41.6 64.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.159 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -63.8 -33.48 75.77 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.015 0.436 . . . . 0.0 110.371 179.312 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 182' ' ' GLU . . . . . 0.419 ' O ' ' HG2' ' A' ' 182' ' ' GLU . 69.7 tt0 -91.1 8.22 36.62 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.476 0.655 . . . . 0.0 110.529 -178.914 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -103.88 -32.62 9.2 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.348 179.427 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 45.1 pt -128.0 147.75 32.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.893 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -139.74 131.2 26.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.382 179.365 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 186' ' ' LEU . . . . . 0.593 HD22 ' N ' ' A' ' 186' ' ' LEU . 3.6 mm? -85.5 133.97 41.09 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.953 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -44.23 157.99 0.15 Allowed 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 122.734 2.289 . . . . 0.0 112.097 179.442 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 188' ' ' PRO . . . . . 0.519 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.5 Cg_endo -62.93 115.05 2.7 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 C-N-CA 122.775 2.317 . . . . 0.0 111.662 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 189' ' ' GLN . . . . . 0.519 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.8 mt-30 155.23 148.33 0.0 OUTLIER Pre-proline 0 C--N 1.332 -0.176 0 O-C-N 123.833 0.708 . . . . 0.0 110.869 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -73.75 144.29 34.93 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.688 2.259 . . . . 0.0 111.881 178.042 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.495 HG23 ' OG ' ' A' ' 258' ' ' SER . 2.1 p -124.92 158.65 32.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.365 0.602 . . . . 0.0 110.12 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 192' ' ' THR . . . . . 0.491 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 35.9 p -143.22 165.31 27.81 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.245 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 193' ' ' ALA . . . . . 0.448 ' HA ' ' H ' ' A' ' 260' ' ' PHE . . . -135.31 128.63 32.11 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 121.229 0.537 . . . . 0.0 110.233 179.589 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.52 HD11 HD23 ' A' ' 259' ' ' LEU . 48.3 pt -146.7 149.38 15.93 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.362 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.161 179.683 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 195' ' ' VAL . . . . . 0.739 HG13 ' CD1' ' A' ' 262' ' ' PHE . 69.0 t -117.95 123.4 71.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.317 0.58 . . . . 0.0 109.621 179.255 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -134.38 106.71 7.21 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.253 179.741 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 95.0 m -130.34 130.47 44.48 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.897 179.611 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.402 ' O ' ' N ' ' A' ' 201' ' ' HIS . . . -83.11 -36.83 24.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.142 179.818 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.63 -66.72 0.29 Allowed 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.311 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.52 -9.75 58.95 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.231 179.599 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 201' ' ' HIS . . . . . 0.402 ' N ' ' O ' ' A' ' 198' ' ' ALA . 60.6 t-80 60.85 58.28 2.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.887 -179.836 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 36.0 p -167.11 153.64 8.33 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.554 179.546 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.64 144.18 24.22 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.02 0.438 . . . . 0.0 110.355 179.374 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -135.53 138.66 43.28 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.67 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 20.3 mt -106.64 125.53 51.12 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 -179.54 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 206' ' ' TRP . . . . . 0.557 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 73.9 m95 -82.0 167.32 18.99 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.643 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 207' ' ' THR . . . . . 0.468 HG22 ' C ' ' A' ' 206' ' ' TRP . 0.1 OUTLIER -157.17 171.59 7.25 Favored Pre-proline 0 C--O 1.224 -0.238 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.585 -179.218 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -53.58 -37.29 82.96 Favored 'Trans proline' 0 C--N 1.303 -1.84 0 C-N-CA 122.602 2.201 . . . . 0.0 112.114 179.328 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -70.45 -35.37 73.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.858 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 21.6 m -60.67 150.94 30.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.591 -179.353 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.61 -37.22 83.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.524 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 212' ' ' GLN . . . . . 0.557 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 54.9 tt0 -64.5 -40.4 95.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.515 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.59 -43.39 92.26 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -63.26 -43.96 96.48 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 215' ' ' MET . . . . . 0.547 ' SD ' ' HB2' ' A' ' 304' ' ' ALA . 65.6 ttp -59.62 -47.71 84.51 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.196 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 216' ' ' LEU . 86.0 mt -60.78 -40.81 93.96 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 217' ' ' GLU . . . . . 0.452 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.4 tp10 -58.61 -37.82 76.67 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -65.18 -38.5 90.72 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.721 0.296 . . . . 0.0 110.525 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 94.8 mt -64.09 -42.83 96.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.105 0.479 . . . . 0.0 110.504 -179.515 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.48 45.13 0.08 OUTLIER Glycine 0 C--N 1.334 0.467 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 221' ' ' PHE . . . . . 0.452 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 26.9 m-85 -128.01 155.59 44.07 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.107 0.48 . . . . 0.0 110.47 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.486 ' O ' HG13 ' A' ' 191' ' ' VAL . 7.6 p -106.8 122.29 46.1 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.263 0.554 . . . . 0.0 110.136 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.475 HD22 ' C ' ' A' ' 222' ' ' THR . 4.3 mm? -101.33 133.09 46.47 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.159 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.93 159.68 14.78 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.535 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -105.41 115.26 29.95 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.302 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.494 HD12 ' N ' ' A' ' 226' ' ' LEU . 9.0 mp -53.0 156.8 3.24 Favored Pre-proline 0 N--CA 1.452 -0.355 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.746 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -60.39 145.22 99.08 Favored 'Trans proline' 0 C--N 1.3 -1.974 0 C-N-CA 122.628 2.219 . . . . 0.0 112.121 179.208 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -86.98 -3.43 59.09 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.54 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.12 -41.1 5.64 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 230' ' ' LEU . . . . . 0.523 ' O ' ' N ' ' A' ' 233' ' ' SER . 69.5 mt -79.15 -17.71 54.48 Favored 'General case' 0 C--O 1.221 -0.42 0 CA-C-O 121.082 0.468 . . . . 0.0 110.319 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 54.8 t-20 -40.72 -48.9 3.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.844 -179.163 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -87.49 15.09 7.03 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.772 0.32 . . . . 0.0 111.428 179.561 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 233' ' ' SER . . . . . 0.523 ' N ' ' O ' ' A' ' 230' ' ' LEU . 77.9 p -60.45 -35.11 75.06 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.676 -179.7 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 234' ' ' GLN . . . . . 0.523 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.5 tt0 -119.33 -69.33 0.85 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.977 179.368 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.0 m -70.18 101.4 1.86 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.633 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -93.15 58.24 2.86 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.376 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -144.81 -122.42 1.56 Allowed Glycine 0 CA--C 1.52 0.353 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -135.62 111.36 9.35 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.25 0.548 . . . . 0.0 110.34 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 239' ' ' ARG . . . . . 0.529 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.5 mtt180 -147.9 57.95 1.1 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.756 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -69.1 -32.85 72.55 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.519 179.573 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 241' ' ' ASP . . . . . 0.546 ' CG ' HD21 ' A' ' 143' ' ' ASN . 65.1 t0 -57.02 -47.14 81.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.305 -178.964 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 242' ' ' ILE . . . . . 0.433 ' O ' ' O ' ' A' ' 239' ' ' ARG . 18.5 tt -139.4 155.4 25.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.901 0.382 . . . . 0.0 110.504 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.444 HG22 HD13 ' A' ' 245' ' ' LEU . 96.2 mt -106.16 106.86 21.37 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.235 0 CA-C-O 121.232 0.539 . . . . 0.0 110.59 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 244' ' ' GLN . . . . . 0.601 ' O ' HD12 ' A' ' 245' ' ' LEU . 88.3 mt-30 -110.46 109.91 20.46 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.292 179.757 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.601 HD12 ' O ' ' A' ' 244' ' ' GLN . 9.4 mp -121.51 -168.28 1.66 Allowed 'General case' 0 C--O 1.225 -0.229 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.672 179.736 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 246' ' ' GLY . . . . . 0.523 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.9 -16.21 0.05 OUTLIER Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 247' ' ' GLY . . . . . 0.673 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -61.49 156.18 35.45 Favored Glycine 0 CA--C 1.521 0.457 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -63.28 21.79 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.991 0.424 . . . . 0.0 110.672 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 249' ' ' ASN . . . . . 0.673 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.8 m-20 -97.15 -6.19 35.45 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.478 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 91.7 mt -79.76 -21.97 43.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.631 179.483 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.61 -51.21 70.89 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.824 -179.566 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.38 -5.5 58.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.443 179.632 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.38 -74.39 1.15 Allowed Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 83.4 mt -69.96 125.92 28.18 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.067 0.461 . . . . 0.0 110.235 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -59.49 -39.44 83.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.139 -179.581 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 83.1 51.76 4.06 Favored Glycine 0 CA--C 1.52 0.401 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -95.92 -14.88 22.76 Favored 'General case' 0 C--N 1.331 -0.198 0 O-C-N 122.721 -0.282 . . . . 0.0 110.571 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 258' ' ' SER . . . . . 0.495 ' OG ' HG23 ' A' ' 191' ' ' VAL . 3.5 t 174.52 88.99 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.11 0.481 . . . . 0.0 110.049 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.86 HD12 ' N ' ' A' ' 259' ' ' LEU . 0.9 OUTLIER -94.47 124.3 38.42 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.367 0.603 . . . . 0.0 111.174 -179.204 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 260' ' ' PHE . . . . . 0.448 ' H ' ' HA ' ' A' ' 193' ' ' ALA . 16.0 m-30 -93.36 146.43 23.74 Favored 'General case' 0 CA--C 1.503 -0.843 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.328 179.43 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 86.5 mt -122.0 149.86 42.89 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.597 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.739 ' CD1' HG13 ' A' ' 195' ' ' VAL . 2.5 p90 -77.83 -139.0 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.431 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 263' ' ' ALA . . . . . 0.658 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -51.59 77.71 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 121.047 0.451 . . . . 0.0 111.15 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 264' ' ' GLY . . . . . 0.628 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.44 104.69 0.19 Allowed Glycine 0 CA--C 1.527 0.795 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 265' ' ' ASP . . . . . 0.601 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.9 m-20 -80.55 -177.56 6.3 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 120.632 0.253 . . . . 0.0 110.971 -179.611 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -40.45 -17.81 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.854 0.359 . . . . 0.0 110.513 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 267' ' ' LYS . . . . . 0.601 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.26 -51.7 42.24 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.684 179.438 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -63.74 -46.69 84.19 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.973 179.587 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 269' ' ' ALA . . . . . 0.58 ' HB1' ' OH ' ' A' ' 273' ' ' TYR . . . -61.44 -35.28 77.14 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 121.238 0.542 . . . . 0.0 109.753 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -63.06 -34.61 77.96 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.022 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.31 -43.2 13.92 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.393 -179.594 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 272' ' ' ILE . . . . . 0.586 ' C ' ' H ' ' A' ' 274' ' ' ALA . 4.9 tt -51.36 -33.78 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.864 -178.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 273' ' ' TYR . . . . . 0.58 ' OH ' ' HB1' ' A' ' 269' ' ' ALA . 17.1 m-85 -54.31 -2.06 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.674 -179.533 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 274' ' ' ALA . . . . . 0.586 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.54 -39.71 70.51 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.996 179.533 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 275' ' ' ASN . . . . . 0.582 ' O ' ' N ' ' A' ' 279' ' ' ALA . 4.0 p30 -38.6 97.31 0.13 Allowed Pre-proline 0 C--O 1.225 -0.185 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.556 -179.764 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 276' ' ' PRO . . . . . 0.401 ' N ' ' O ' ' A' ' 274' ' ' ALA . 47.5 Cg_exo -54.1 -42.82 63.84 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 C-N-CA 122.234 1.956 . . . . 0.0 112.696 -178.728 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 89.7 mt -64.38 -42.73 96.0 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.188 0.518 . . . . 0.0 111.266 -179.837 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 91.4 mt -95.97 -1.16 49.65 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.922 -179.583 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 279' ' ' ALA . . . . . 0.582 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.39 -34.94 77.71 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.662 -179.684 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -73.87 20.01 0.11 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.035 -179.339 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 281' ' ' LEU . . . . . 0.489 HD23 ' HA ' ' A' ' 281' ' ' LEU . 13.7 mt -75.15 120.12 80.18 Favored Pre-proline 0 N--CA 1.45 -0.439 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.423 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -51.21 -39.26 62.09 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.568 2.178 . . . . 0.0 111.809 179.168 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -53.19 -50.34 64.85 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 78.1 t -61.47 -43.91 97.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 179.589 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -57.66 -41.04 80.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.186 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -91.27 0.19 57.57 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.065 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt 59.54 44.06 15.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.07 0.462 . . . . 0.0 110.935 179.782 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -95.25 41.46 1.1 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.347 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 54.6 t -119.39 135.6 59.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 121.089 0.471 . . . . 0.0 110.161 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -132.92 163.14 29.82 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.071 0.462 . . . . 0.0 110.695 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.59 155.02 33.04 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-O 121.068 0.461 . . . . 0.0 110.782 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 82.1 mt -94.23 -1.36 54.18 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.211 -179.665 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.72 165.53 12.6 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 6.8 m -87.57 -62.07 1.58 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.905 0.383 . . . . 0.0 111.146 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 295' ' ' GLU . . . . . 0.447 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.6 mm-40 -69.16 -3.97 15.65 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.721 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 25.5 p -76.56 32.39 0.13 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.648 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 297' ' ' PHE . . . . . 0.513 ' CD2' HG22 ' A' ' 70' ' ' THR . 85.9 t80 -60.47 -45.88 92.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.603 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 298' ' ' ARG . . . . . 0.62 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.1 mtt85 -81.2 135.02 35.72 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.02 0.438 . . . . 0.0 110.546 -179.698 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.471 ' H ' HG11 ' A' ' 51' ' ' VAL . 18.4 tp -113.91 117.18 30.66 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-O 121.054 0.454 . . . . 0.0 110.098 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 300' ' ' ASP . . . . . 0.621 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.6 p-10 -165.21 -176.66 4.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.533 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 81.2 t80 -47.05 -43.15 19.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.169 -179.603 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -67.11 -40.13 86.83 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.046 0.451 . . . . 0.0 110.91 179.043 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 303' ' ' SER . . . . . 0.621 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 59.9 p -56.27 -36.27 68.38 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.021 -179.093 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 304' ' ' ALA . . . . . 0.547 ' HB2' ' SD ' ' A' ' 215' ' ' MET . . . -57.32 -51.54 68.95 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.51 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 90.2 mtp -56.67 -43.11 80.1 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -179.619 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -66.48 -42.72 87.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.003 0.43 . . . . 0.0 110.09 178.9 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 307' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 303' ' ' SER . 55.5 t -63.94 -43.19 97.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.126 179.381 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 43.4 tp -59.9 -42.14 93.18 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.683 -179.433 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -62.24 -39.27 92.27 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 310' ' ' ARG . . . . . 0.451 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.5 ttt85 -63.75 -44.01 94.75 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.203 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 89.5 mt -63.35 -42.21 98.89 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.194 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt -62.95 -33.57 75.66 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.081 0.467 . . . . 0.0 109.977 179.494 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.53 -23.75 21.95 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.325 -179.713 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 314' ' ' LEU . . . . . 0.484 HD22 ' CE2' ' A' ' 315' ' ' PHE . 6.7 tt -62.33 -43.12 99.56 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 121.111 0.482 . . . . 0.0 110.562 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 315' ' ' PHE . . . . . 0.484 ' CE2' HD22 ' A' ' 314' ' ' LEU . 90.3 m-85 . . . . . 0 C--O 1.22 -0.469 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.428 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -99.37 135.89 40.12 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.016 0.436 . . . . 0.0 110.504 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.497 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -92.01 178.39 1.74 Allowed Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.548 -179.928 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.497 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.8 Cg_exo -61.61 147.28 95.76 Favored 'Trans proline' 0 C--N 1.3 -2.018 0 C-N-CA 122.79 2.327 . . . . 0.0 112.104 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.46 ' HE ' HD12 ' A' ' 39' ' ' LEU . 35.6 ptt180 -135.79 142.16 44.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.72 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -79.71 116.51 19.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.471 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.445 ' O ' HG23 ' A' ' 30' ' ' ILE . 9.4 tp -110.94 130.68 63.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.498 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.6 t -70.71 141.99 51.53 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.563 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.475 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.4 t0 -139.68 179.39 6.61 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.568 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.475 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 78.0 p -73.92 -36.99 64.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.61 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.8 ttt85 -46.54 -94.67 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.331 -179.533 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -167.16 -26.42 0.02 OUTLIER Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 59.9 m -169.11 104.73 0.39 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.879 0.371 . . . . 0.0 110.65 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.686 ' CD2' HD13 ' A' ' 140' ' ' LEU . 75.6 t60 -128.39 148.89 50.72 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.033 0.444 . . . . 0.0 110.262 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.626 HG22 ' N ' ' A' ' 39' ' ' LEU . 98.2 m -131.23 166.04 22.04 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.62 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.626 ' N ' HG22 ' A' ' 38' ' ' THR . 81.5 mt -120.83 127.61 52.08 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.43 179.737 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -65.2 -44.55 87.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.694 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 39.9 p -165.83 154.88 11.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.448 179.667 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.495 ' CD ' ' H ' ' A' ' 42' ' ' GLN . 14.8 mp0 -44.34 101.13 0.24 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.626 179.449 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -57.39 129.59 34.79 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 C-N-CA 122.365 2.044 . . . . 0.0 112.283 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -84.1 -24.57 30.27 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.502 179.602 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.539 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.5 mtm-85 -122.29 134.17 54.67 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-O 121.147 0.498 . . . . 0.0 110.34 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.1 mt -130.43 133.76 63.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.949 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 45.4 t -124.25 130.49 73.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 179.323 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.642 ' OG ' HD12 ' A' ' 117' ' ' LEU . 2.0 m -155.38 167.75 29.36 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.556 179.813 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 59.5 p -124.9 9.44 8.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.487 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.56 125.42 33.08 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.672 -179.437 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.45 HG11 ' H ' ' A' ' 299' ' ' LEU . 95.1 t -65.92 -44.43 92.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.417 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.4 m -62.49 -44.26 96.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.651 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 51.3 tp -62.33 -41.41 98.54 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.5 -179.47 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.453 ' O ' HD13 ' A' ' 58' ' ' LEU . 75.5 m -57.7 -44.48 85.88 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.258 -179.209 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.29 -62.18 5.36 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 179.554 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.7 t -48.38 -35.51 12.75 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 57' ' ' LEU . 19.8 mt -61.87 -44.64 96.4 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.707 -0.397 . . . . 0.0 111.17 179.41 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.453 HD13 ' O ' ' A' ' 54' ' ' THR . 9.2 mp -65.01 -41.7 95.09 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.303 178.014 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.63 -40.97 98.24 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.989 -179.275 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.431 ' O ' HG23 ' A' ' 60' ' ' ILE . 8.0 tp -88.65 16.79 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.762 -179.6 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 56.41 84.82 0.08 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.674 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 178.67 57.86 0.06 OUTLIER Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.016 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -50.77 153.34 8.39 Favored 'Trans proline' 0 C--N 1.296 -2.202 0 C-N-CA 122.892 2.394 . . . . 0.0 112.38 -178.276 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.437 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.2 OUTLIER -108.93 145.44 15.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.359 -179.714 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.8 mt -63.62 -45.24 98.09 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.317 -179.736 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.502 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -129.49 134.08 47.61 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 120.848 0.356 . . . . 0.0 110.539 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.501 ' O ' ' N ' ' A' ' 98' ' ' LEU . 75.2 m -134.73 158.84 43.09 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.798 -179.637 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.99 139.15 16.01 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.489 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.81 -162.69 0.08 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.914 0.388 . . . . 0.0 110.503 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.539 HG22 ' CD2' ' A' ' 297' ' ' PHE . 14.5 t -133.49 134.43 43.46 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.404 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.491 ' C ' ' O ' ' A' ' 70' ' ' THR . 0.6 OUTLIER 29.69 68.82 0.65 Allowed Pre-proline 0 N--CA 1.464 0.226 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.754 -179.866 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -61.25 145.17 98.83 Favored 'Trans proline' 0 C--N 1.299 -2.031 0 C-N-CA 122.627 2.218 . . . . 0.0 112.062 -178.425 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.533 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 45.1 p-10 -159.14 -32.04 0.06 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.677 179.643 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.542 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 99.1 m-20 -64.1 -39.7 94.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.489 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -60.23 -48.33 82.19 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.706 -179.228 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.424 ' O ' ' O ' ' A' ' 77' ' ' ALA . 92.6 t -60.25 -24.9 32.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 179.771 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.542 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -45.71 172.98 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.555 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.575 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.2 p30 -62.18 177.89 0.43 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.564 -179.728 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.554 ' C ' ' H ' ' A' ' 81' ' ' GLY . 36.1 p30 -45.13 85.79 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.965 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.575 ' N ' ' O ' ' A' ' 78' ' ' ASP . 42.5 tp60 -67.69 13.17 0.08 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.109 -179.817 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.554 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 118.73 -22.34 9.32 Favored Glycine 0 CA--C 1.519 0.324 0 N-CA-C 110.969 -0.852 . . . . 0.0 110.969 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -108.13 116.46 32.01 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.014 0.435 . . . . 0.0 110.44 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 75.8 mt -98.71 0.4 44.49 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.491 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -92.53 7.24 44.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.971 0.415 . . . . 0.0 110.413 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.802 ' O ' HG22 ' A' ' 89' ' ' VAL . 27.0 mt-30 -100.12 -28.19 13.16 Favored 'General case' 0 C--O 1.225 -0.234 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.823 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 68.9 t-105 -62.77 -40.71 98.12 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.858 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.554 ' O ' ' N ' ' A' ' 91' ' ' LYS . 65.4 m -77.73 -53.56 7.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.148 -179.364 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -48.51 -50.76 30.48 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.965 -179.262 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.802 HG22 ' O ' ' A' ' 85' ' ' GLN . 15.7 m -68.87 -40.62 81.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 120.867 0.365 . . . . 0.0 111.005 179.76 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.497 ' N ' HG23 ' A' ' 89' ' ' VAL . . . -72.32 -22.63 61.15 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.695 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.554 ' N ' ' O ' ' A' ' 87' ' ' SER . 65.9 tttm -62.01 -45.51 93.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.512 -179.498 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.442 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.6 mm-40 -90.53 -94.85 0.12 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.134 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.636 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.9 mtt180 -142.92 58.97 1.42 Allowed 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.461 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.6 pttp 33.43 26.13 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 120.879 0.371 . . . . 0.0 110.221 -179.145 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.636 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.4 tt -48.08 123.52 6.38 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.925 -178.102 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.454 ' O ' HD23 ' A' ' 95' ' ' LEU . 99.0 mm-40 -83.88 -169.41 2.56 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.092 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.603 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 81.3 mtp180 -74.58 136.84 42.05 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.298 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.501 ' N ' ' O ' ' A' ' 67' ' ' SER . 91.3 mt -85.79 -165.82 1.35 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.762 -179.68 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.537 ' O ' ' CD2' ' A' ' 99' ' ' TYR . 48.3 p90 -168.33 119.77 0.81 Allowed 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.178 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.515 ' C ' ' O ' ' A' ' 99' ' ' TYR . 43.0 mm -28.88 120.96 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.977 -179.693 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 114.25 27.57 3.35 Favored Glycine 0 CA--C 1.52 0.344 0 N-CA-C 111.154 -0.779 . . . . 0.0 111.154 -179.543 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.582 ' CD ' ' H ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -144.63 46.62 0.63 Allowed Pre-proline 0 C--N 1.324 -0.537 0 CA-C-O 120.995 0.426 . . . . 0.0 110.479 179.885 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 29.5 Cg_endo -61.91 143.97 96.1 Favored 'Trans proline' 0 C--N 1.297 -2.153 0 C-N-CA 122.644 2.229 . . . . 0.0 111.993 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.455 ' O ' HG23 ' A' ' 108' ' ' VAL . 27.8 t -173.16 120.0 0.34 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.462 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.61 -40.46 63.8 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.035 0.445 . . . . 0.0 111.049 179.745 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.25 -39.87 89.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.88 -179.37 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.22 -39.97 95.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.75 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 104' ' ' SER . 71.3 t -67.57 -43.87 86.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.798 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.84 -38.89 92.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.578 -179.332 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.442 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.49 -23.31 62.66 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.49 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.551 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.4 mm-40 -90.64 5.3 48.56 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.687 -179.502 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.551 ' C ' ' O ' ' A' ' 111' ' ' GLN . 10.6 tpt 23.55 64.13 0.38 Allowed Pre-proline 0 N--CA 1.465 0.296 0 CA-C-O 120.896 0.379 . . . . 0.0 110.946 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -78.14 167.24 23.64 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 123.03 2.487 . . . . 0.0 112.132 -178.452 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.524 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 98.9 m-20 -109.96 -42.11 4.31 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.19 179.428 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.3 tp -121.24 120.21 34.5 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.019 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 82.5 mt -112.79 128.88 69.26 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.336 0 CA-C-O 120.918 0.389 . . . . 0.0 110.812 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.642 HD12 ' OG ' ' A' ' 48' ' ' SER . 29.2 mt -109.13 132.32 54.23 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 121.088 0.471 . . . . 0.0 110.211 -179.727 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.494 HD12 HG23 ' A' ' 139' ' ' THR . 99.1 mt -119.94 138.57 50.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.645 -179.743 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 85.9 p -72.44 154.07 41.07 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.608 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.18 -50.21 74.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.636 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.0 t -149.73 154.3 38.29 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.579 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 170.66 -170.79 43.37 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.99 -34.03 88.83 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.452 ' OD1' ' O ' ' A' ' 124' ' ' ASP . 44.5 p-10 -87.29 120.42 28.55 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.796 0.332 . . . . 0.0 110.684 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.441 ' O ' HD12 ' A' ' 129' ' ' LEU . 38.8 t -63.2 143.83 57.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.504 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.52 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.0 -43.23 9.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.928 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.6 tp -62.86 -42.35 99.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.706 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.58 -12.07 59.54 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.485 -179.49 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.441 HD12 ' O ' ' A' ' 125' ' ' SER . 85.3 mt -114.77 -23.84 8.99 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.649 -179.766 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' TYR . . . . . 0.52 ' N ' ' O ' ' A' ' 126' ' ' ALA . 79.9 t80 -50.9 -49.66 58.96 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.592 -178.953 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.0 p-10 -66.12 -42.6 88.97 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.861 0.363 . . . . 0.0 111.158 179.576 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.521 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 88.4 mt-30 -66.98 -37.94 85.15 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.781 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.433 HD12 HD11 ' A' ' 118' ' ' ILE . 96.0 mt -80.32 -41.38 24.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.892 -179.549 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.2 t -57.21 -44.52 83.76 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.212 -179.098 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.5 m -61.87 -45.22 94.7 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.751 0.31 . . . . 0.0 110.517 179.414 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 93.3 mt -62.18 -43.6 98.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.27 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.67 ' HB1' ' HD2' ' A' ' 138' ' ' PRO . . . -169.51 168.69 4.66 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.554 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.67 ' HD2' ' HB1' ' A' ' 137' ' ' ALA . 52.7 Cg_exo -50.38 113.04 0.87 Allowed 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.282 1.988 . . . . 0.0 112.206 179.414 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.494 HG23 HD12 ' A' ' 118' ' ' ILE . 23.4 m -83.97 127.39 33.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.609 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.686 HD13 ' CD2' ' A' ' 37' ' ' HIS . 34.8 tp -117.87 135.91 53.79 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.034 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.44 ' O ' ' OD2' ' A' ' 32' ' ' ASP . 81.7 mt -100.18 118.85 47.44 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.331 0 CA-C-O 121.174 0.512 . . . . 0.0 111.194 -179.36 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.428 HD12 HD22 ' A' ' 117' ' ' LEU . 98.1 mt -134.74 132.28 54.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.621 179.593 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.479 ' ND2' ' OD2' ' A' ' 241' ' ' ASP . 2.1 t-20 -66.97 151.42 47.66 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.905 0.383 . . . . 0.0 110.433 179.457 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.522 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 88.0 t80 -86.11 122.38 30.04 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.811 -179.52 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.522 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 98.9 m-20 55.17 69.34 0.74 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.754 179.657 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 35.8 p-10 -125.8 0.16 7.37 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.651 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -150.56 115.13 5.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.7 -179.504 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 84.5 p -63.3 168.33 4.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.542 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.422 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.6 p-90 -51.83 -15.88 0.59 Allowed 'General case' 0 C--O 1.223 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.524 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 150' ' ' GLN . . . . . 0.439 ' O ' HG23 ' A' ' 154' ' ' THR . 68.1 tp60 -70.39 -76.02 0.11 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.511 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.448 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.1 t -62.7 -38.63 91.16 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.295 179.51 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 54.0 tp -60.02 -45.66 92.07 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.379 -178.571 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.422 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 46.9 tp -62.76 -41.75 99.36 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.832 0.348 . . . . 0.0 110.365 179.066 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.448 ' OG1' ' O ' ' A' ' 151' ' ' SER . 60.2 p -64.14 -34.86 79.03 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.264 -179.498 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 155' ' ' GLN . . . . . 0.435 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.9 mm-40 -64.24 -42.59 96.45 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.322 179.286 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 91.6 mt -65.55 -38.82 90.68 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.037 0.446 . . . . 0.0 110.252 179.133 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.583 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.29 -32.31 80.3 Favored Glycine 0 CA--C 1.521 0.418 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 -179.387 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.442 ' C ' ' O ' ' A' ' 157' ' ' GLY . 97.1 mt-10 -35.17 -27.29 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.821 0.344 . . . . 0.0 110.764 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.583 ' N ' ' O ' ' A' ' 157' ' ' GLY . 95.5 mt -56.03 149.76 3.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.33 179.187 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 71.5 p -69.87 137.3 51.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.002 -179.557 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 71.57 20.34 78.4 Favored Glycine 0 N--CA 1.458 0.143 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 179.481 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 58.0 m80 -121.78 -14.91 8.02 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.706 0.289 . . . . 0.0 110.571 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -65.85 -59.83 3.48 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.764 -179.696 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -52.05 -49.35 63.64 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.16 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -60.76 -41.14 94.85 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.718 0.294 . . . . 0.0 110.356 179.462 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.45 -47.2 86.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.613 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -57.0 -40.16 76.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.241 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -61.65 -50.34 72.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.571 179.542 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -65.34 -43.75 89.91 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.535 179.55 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 95.2 mt -64.6 -43.47 96.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.509 179.743 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.21 -51.17 70.43 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.535 -179.216 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.44 -43.93 96.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.46 179.711 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 173' ' ' PHE . . . . . 0.654 ' CE2' HD11 ' A' ' 177' ' ' LEU . 56.7 t80 -62.72 -44.45 96.18 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.04 0.448 . . . . 0.0 110.405 179.44 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -63.35 -39.88 95.75 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.616 -179.363 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -63.07 -42.78 99.74 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.617 179.224 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -60.67 -44.77 96.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.181 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.654 HD11 ' CE2' ' A' ' 173' ' ' PHE . 83.7 mt -64.36 -41.23 96.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.031 0.443 . . . . 0.0 110.698 178.885 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.08 -62.32 1.71 Allowed 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.482 -179.4 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.52 -46.9 85.81 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.552 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.12 -41.76 65.34 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.223 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -63.94 -33.52 75.91 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.976 0.417 . . . . 0.0 110.352 179.314 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 182' ' ' GLU . . . . . 0.423 ' O ' ' HG2' ' A' ' 182' ' ' GLU . 69.6 tt0 -90.72 8.68 33.27 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.37 0.605 . . . . 0.0 110.52 -179.003 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -104.84 -32.12 8.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.195 179.603 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 45.4 pt -128.11 147.67 32.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.814 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -139.86 131.03 26.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.422 179.362 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 186' ' ' LEU . . . . . 0.596 HD22 ' N ' ' A' ' 186' ' ' LEU . 3.6 mm? -85.59 133.14 42.56 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.901 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -43.89 157.72 0.14 Allowed 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.738 2.292 . . . . 0.0 112.138 179.38 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 188' ' ' PRO . . . . . 0.525 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.8 Cg_endo -63.01 115.21 2.81 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 C-N-CA 122.804 2.336 . . . . 0.0 111.724 179.811 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 189' ' ' GLN . . . . . 0.525 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.7 mt-30 155.53 147.63 0.0 OUTLIER Pre-proline 0 C--N 1.332 -0.195 0 O-C-N 123.596 0.56 . . . . 0.0 110.762 -179.836 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -73.77 143.85 34.17 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.651 2.234 . . . . 0.0 111.963 178.052 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.499 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.1 p -125.03 159.09 32.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.27 0.557 . . . . 0.0 110.164 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 192' ' ' THR . . . . . 0.499 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 35.9 p -143.54 165.48 27.45 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.034 -179.636 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 193' ' ' ALA . . . . . 0.44 ' HA ' ' H ' ' A' ' 260' ' ' PHE . . . -135.38 128.58 31.89 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.159 0.504 . . . . 0.0 110.213 179.587 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.509 HD11 HD23 ' A' ' 259' ' ' LEU . 47.4 pt -146.49 148.81 16.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.048 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 195' ' ' VAL . . . . . 0.752 HG13 ' CD1' ' A' ' 262' ' ' PHE . 68.9 t -117.67 123.09 71.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-O 121.238 0.542 . . . . 0.0 109.765 179.104 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -134.3 107.29 7.56 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.332 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 95.2 m -130.96 130.6 43.63 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.756 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.406 ' O ' ' N ' ' A' ' 201' ' ' HIS . . . -82.84 -36.9 25.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.256 179.646 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.34 -67.18 0.25 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.374 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.33 -9.43 58.49 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.348 179.489 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 201' ' ' HIS . . . . . 0.406 ' N ' ' O ' ' A' ' 198' ' ' ALA . 60.2 t-80 60.27 58.42 2.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.748 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 46.4 p -167.21 153.65 8.19 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.535 179.535 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.6 144.23 24.29 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.992 0.425 . . . . 0.0 110.446 179.479 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -135.39 138.4 43.27 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.646 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 20.0 mt -106.42 125.48 51.05 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 121.11 0.481 . . . . 0.0 109.867 -179.683 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 206' ' ' TRP . . . . . 0.557 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 75.7 m95 -82.01 167.03 19.28 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.659 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 207' ' ' THR . . . . . 0.466 HG22 ' C ' ' A' ' 206' ' ' TRP . 0.1 OUTLIER -156.77 171.33 7.56 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.586 -179.156 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.87 -37.03 85.02 Favored 'Trans proline' 0 C--N 1.302 -1.879 0 C-N-CA 122.624 2.216 . . . . 0.0 112.133 179.27 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -70.47 -34.87 72.89 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.8 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 22.0 m -61.26 150.83 33.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.64 -179.419 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.59 -36.95 82.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.448 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 212' ' ' GLN . . . . . 0.557 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 54.8 tt0 -64.69 -40.29 95.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.506 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.61 -43.45 92.07 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -63.26 -43.52 97.76 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.741 0.305 . . . . 0.0 110.281 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 215' ' ' MET . . . . . 0.525 ' SD ' ' HB2' ' A' ' 304' ' ' ALA . 65.2 ttp -59.61 -48.11 82.95 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.252 -179.732 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 87.9 mt -60.49 -41.04 93.45 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 179.546 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 217' ' ' GLU . . . . . 0.455 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.3 tp10 -57.88 -37.85 74.69 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.795 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -65.36 -37.98 88.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.8 0.333 . . . . 0.0 110.679 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 94.4 mt -64.43 -42.64 95.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.606 -179.653 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.49 44.6 0.08 OUTLIER Glycine 0 C--N 1.333 0.408 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 221' ' ' PHE . . . . . 0.455 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 26.5 m-85 -127.74 155.28 44.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.04 0.447 . . . . 0.0 110.507 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.487 ' O ' HG13 ' A' ' 191' ' ' VAL . 6.5 p -106.99 122.11 45.8 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.201 0.524 . . . . 0.0 110.154 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.472 HD22 ' C ' ' A' ' 222' ' ' THR . 4.3 mm? -101.07 133.12 46.06 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.063 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.96 159.31 14.98 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.463 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.43 115.42 30.23 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.942 0.401 . . . . 0.0 110.351 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.499 HD12 ' N ' ' A' ' 226' ' ' LEU . 8.9 mp -53.47 156.77 4.04 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.686 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -60.29 145.41 98.65 Favored 'Trans proline' 0 C--N 1.301 -1.956 0 C-N-CA 122.721 2.281 . . . . 0.0 112.058 179.368 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.36 -2.92 58.96 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.546 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.31 -40.8 5.66 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 230' ' ' LEU . . . . . 0.54 ' O ' ' N ' ' A' ' 233' ' ' SER . 86.2 mt -79.27 -16.75 55.96 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-O 121.006 0.431 . . . . 0.0 110.386 -179.798 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 231' ' ' ASN . . . . . 0.403 ' C ' ' O ' ' A' ' 230' ' ' LEU . 54.5 t-20 -40.21 -49.15 2.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.694 -179.577 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -88.18 15.43 7.54 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.777 0.322 . . . . 0.0 111.27 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 233' ' ' SER . . . . . 0.54 ' N ' ' O ' ' A' ' 230' ' ' LEU . 78.1 p -60.43 -35.65 76.33 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.693 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 234' ' ' GLN . . . . . 0.526 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.6 tt0 -118.35 -69.39 0.85 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.943 179.554 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.1 m -70.04 103.37 2.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.734 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -94.59 57.69 2.25 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.359 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -144.88 -122.61 1.57 Allowed Glycine 0 CA--C 1.52 0.402 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -134.4 111.7 10.37 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 121.081 0.467 . . . . 0.0 110.433 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 239' ' ' ARG . . . . . 0.517 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.3 mtt180 -148.1 57.52 1.08 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.778 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -69.92 -31.75 69.69 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.505 179.591 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 241' ' ' ASP . . . . . 0.479 ' OD2' ' ND2' ' A' ' 143' ' ' ASN . 64.9 t0 -56.85 -46.98 81.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.343 -179.163 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 242' ' ' ILE . . . . . 0.435 ' O ' ' O ' ' A' ' 239' ' ' ARG . 17.5 tt -140.27 157.11 24.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.898 0.38 . . . . 0.0 110.527 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.44 HG22 HD13 ' A' ' 245' ' ' LEU . 96.1 mt -106.12 106.17 20.08 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.196 0 CA-C-O 121.16 0.505 . . . . 0.0 110.504 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 244' ' ' GLN . . . . . 0.603 ' O ' HD12 ' A' ' 245' ' ' LEU . 88.3 mt-30 -110.5 110.39 21.11 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.405 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.603 HD12 ' O ' ' A' ' 244' ' ' GLN . 9.5 mp -121.95 -168.3 1.68 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.607 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 246' ' ' GLY . . . . . 0.526 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.53 -16.88 0.05 OUTLIER Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 247' ' ' GLY . . . . . 0.671 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -60.47 157.01 29.84 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -63.77 21.27 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.915 0.388 . . . . 0.0 110.585 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 249' ' ' ASN . . . . . 0.671 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.7 m-20 -96.87 -5.82 37.29 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.569 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 92.7 mt -80.23 -21.45 42.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.6 179.511 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.47 -51.24 70.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.8 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.72 -5.28 58.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.449 179.665 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.09 -74.39 1.14 Allowed Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.926 -0.87 . . . . 0.0 110.926 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 81.8 mt -70.13 125.95 28.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.054 0.454 . . . . 0.0 110.227 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -59.45 -39.17 82.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.321 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 82.82 51.94 4.06 Favored Glycine 0 CA--C 1.521 0.463 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -95.8 -15.16 22.71 Favored 'General case' 0 C--N 1.331 -0.203 0 O-C-N 122.723 -0.281 . . . . 0.0 110.553 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 258' ' ' SER . . . . . 0.496 ' OG ' HG23 ' A' ' 191' ' ' VAL . 3.4 t 174.5 88.9 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.104 0.478 . . . . 0.0 110.159 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.862 HD12 ' N ' ' A' ' 259' ' ' LEU . 0.9 OUTLIER -94.27 123.88 37.94 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.244 0.545 . . . . 0.0 111.098 -179.058 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 260' ' ' PHE . . . . . 0.44 ' H ' ' HA ' ' A' ' 193' ' ' ALA . 16.0 m-30 -92.85 146.4 23.66 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.316 179.244 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 86.3 mt -122.31 149.73 43.34 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.562 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.752 ' CD1' HG13 ' A' ' 195' ' ' VAL . 2.7 p90 -77.43 -138.29 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.601 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 263' ' ' ALA . . . . . 0.66 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -52.31 77.55 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 121.044 0.449 . . . . 0.0 111.034 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 264' ' ' GLY . . . . . 0.627 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.08 104.33 0.18 Allowed Glycine 0 CA--C 1.527 0.786 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 265' ' ' ASP . . . . . 0.603 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.9 m-20 -80.35 -177.68 6.27 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 120.724 0.297 . . . . 0.0 110.912 -179.488 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -40.44 -17.61 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.536 179.734 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 267' ' ' LYS . . . . . 0.603 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.48 -51.73 40.16 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.019 0.438 . . . . 0.0 110.693 179.457 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -63.58 -46.63 84.97 Favored 'General case' 0 CA--C 1.527 0.09 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.323 179.313 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 269' ' ' ALA . . . . . 0.565 ' HB1' ' OH ' ' A' ' 273' ' ' TYR . . . -61.59 -35.18 77.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.865 179.531 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -62.97 -34.4 77.43 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.163 179.615 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.49 -43.37 13.63 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.225 -179.558 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 272' ' ' ILE . . . . . 0.587 ' C ' ' H ' ' A' ' 274' ' ' ALA . 4.9 tt -51.33 -33.63 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.876 -178.827 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 273' ' ' TYR . . . . . 0.565 ' OH ' ' HB1' ' A' ' 269' ' ' ALA . 17.3 m-85 -54.45 -1.8 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.649 -179.603 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 274' ' ' ALA . . . . . 0.587 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.65 -39.51 70.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.881 179.577 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 275' ' ' ASN . . . . . 0.583 ' O ' ' N ' ' A' ' 279' ' ' ALA . 2.8 p30 -39.61 98.35 0.17 Allowed Pre-proline 0 C--N 1.333 -0.122 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.514 -179.66 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -54.24 -43.02 62.38 Favored 'Trans proline' 0 C--N 1.303 -1.856 0 C-N-CA 122.391 2.061 . . . . 0.0 112.574 -178.771 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 89.5 mt -64.46 -42.82 95.7 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.201 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 91.1 mt -95.67 -1.63 49.72 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.812 -179.461 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 279' ' ' ALA . . . . . 0.583 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.33 -34.91 77.55 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.672 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.26 20.1 0.12 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.994 -179.227 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 281' ' ' LEU . . . . . 0.49 HD23 ' HA ' ' A' ' 281' ' ' LEU . 13.8 mt -75.21 120.01 79.66 Favored Pre-proline 0 N--CA 1.451 -0.375 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.484 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -50.83 -39.44 58.16 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.599 2.199 . . . . 0.0 111.946 179.029 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.8 -50.51 63.49 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.154 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 79.4 t -61.42 -43.96 97.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 179.488 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -57.7 -41.22 81.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.248 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -90.98 0.15 57.6 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.167 179.681 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt 59.53 43.41 16.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.035 0.445 . . . . 0.0 110.873 179.683 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -94.78 41.3 1.09 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.411 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 53.7 t -118.93 135.92 57.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.012 0.434 . . . . 0.0 110.257 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -133.08 162.85 30.64 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.053 0.454 . . . . 0.0 110.701 -179.668 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.96 155.22 33.22 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.012 0.434 . . . . 0.0 110.731 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 81.4 mt -93.9 -1.38 54.82 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.227 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.43 165.72 12.7 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 110.598 -1.001 . . . . 0.0 110.598 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 7.0 m -87.47 -62.3 1.53 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.899 0.381 . . . . 0.0 111.034 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 295' ' ' GLU . . . . . 0.437 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.5 mm-40 -69.68 -3.85 17.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.61 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 27.0 p -76.91 33.22 0.14 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.66 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 297' ' ' PHE . . . . . 0.539 ' CD2' HG22 ' A' ' 70' ' ' THR . 84.9 t80 -60.16 -45.86 91.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.58 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 298' ' ' ARG . . . . . 0.603 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.2 mtt85 -81.87 134.22 35.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.531 -179.684 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.45 ' H ' HG11 ' A' ' 51' ' ' VAL . 16.2 tp -114.46 119.52 37.15 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-O 120.996 0.427 . . . . 0.0 110.178 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 300' ' ' ASP . . . . . 0.623 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.3 p-10 -167.26 -174.44 2.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.553 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 84.5 t80 -47.92 -45.68 31.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.254 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -64.93 -41.42 95.55 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.022 0.439 . . . . 0.0 110.717 179.014 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 303' ' ' SER . . . . . 0.623 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 52.8 p -55.52 -36.24 66.51 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.086 -179.251 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 304' ' ' ALA . . . . . 0.525 ' HB2' ' SD ' ' A' ' 215' ' ' MET . . . -56.79 -51.85 67.32 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.442 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 90.9 mtp -56.14 -43.71 78.5 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -66.32 -42.64 87.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.978 0.418 . . . . 0.0 110.278 178.738 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 307' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 303' ' ' SER . 55.7 t -64.08 -42.84 96.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.207 179.38 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 42.3 tp -59.55 -42.27 92.01 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.863 -179.561 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -62.63 -38.8 91.67 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.163 179.415 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 310' ' ' ARG . . . . . 0.443 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.6 ttt85 -63.58 -44.07 95.13 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.251 179.549 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 88.4 mt -63.26 -42.01 99.11 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.228 179.593 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -62.84 -33.03 74.4 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.097 179.44 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -90.33 -23.31 21.17 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.417 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 314' ' ' LEU . . . . . 0.477 HD22 ' CE2' ' A' ' 315' ' ' PHE . 6.8 tt -62.3 -43.22 99.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.098 0.475 . . . . 0.0 110.594 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 315' ' ' PHE . . . . . 0.477 ' CE2' HD22 ' A' ' 314' ' ' LEU . 91.0 m-85 . . . . . 0 C--O 1.219 -0.511 0 CA-C-O 118.079 -0.962 . . . . 0.0 110.414 -179.988 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -99.64 135.69 40.68 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.064 0.459 . . . . 0.0 110.456 -179.993 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.497 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -92.09 178.61 1.64 Allowed Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.61 -179.813 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.497 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 27.0 Cg_exo -61.63 147.17 96.01 Favored 'Trans proline' 0 C--N 1.3 -1.995 0 C-N-CA 122.749 2.299 . . . . 0.0 112.112 179.694 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.484 ' HE ' HD12 ' A' ' 39' ' ' LEU . 35.1 ptt180 -136.12 142.29 44.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.673 179.701 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -79.79 116.83 20.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.489 179.865 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.46 ' O ' HG23 ' A' ' 30' ' ' ILE . 9.5 tp -111.48 129.98 65.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.444 -179.988 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.2 t -70.9 142.11 51.16 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.58 179.881 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.484 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.5 t0 -138.93 179.98 6.18 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.575 -179.985 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.484 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 77.7 p -74.31 -37.23 63.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.616 179.952 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -46.69 -94.58 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.35 -179.515 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -165.8 -27.13 0.02 OUTLIER Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 179.953 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 63.2 m -168.79 106.09 0.44 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.924 0.392 . . . . 0.0 110.696 -179.929 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.643 ' CD2' HD13 ' A' ' 140' ' ' LEU . 67.4 t60 -128.92 146.72 50.87 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.044 0.449 . . . . 0.0 110.232 -179.949 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.623 HG22 ' N ' ' A' ' 39' ' ' LEU . 96.5 m -130.08 165.59 21.92 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.57 -179.848 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.623 ' N ' HG22 ' A' ' 38' ' ' THR . 80.5 mt -120.29 127.16 52.11 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.461 179.752 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -65.46 -44.61 86.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.588 -179.996 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 38.6 p -165.59 154.58 11.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.388 179.735 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.489 ' CD ' ' H ' ' A' ' 42' ' ' GLN . 14.7 mp0 -44.98 101.32 0.25 Allowed Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.631 179.436 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -57.53 129.54 34.33 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 C-N-CA 122.367 2.045 . . . . 0.0 112.247 -179.731 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -82.42 -25.13 33.95 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.491 179.631 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.537 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.7 mtm-85 -120.96 134.56 55.3 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-O 121.191 0.519 . . . . 0.0 110.28 -179.953 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.0 mt -130.28 133.59 63.79 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.923 -179.771 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 46.5 t -124.61 131.34 72.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.808 0.337 . . . . 0.0 110.126 179.373 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.617 ' OG ' HD12 ' A' ' 117' ' ' LEU . 4.7 m -154.2 165.94 34.69 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.563 179.782 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 71.5 p -124.76 8.29 8.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.463 179.942 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.66 125.8 33.44 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.672 -179.459 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.452 HG11 ' H ' ' A' ' 299' ' ' LEU . 89.9 t -65.47 -44.61 94.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.44 -179.943 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.6 m -62.52 -44.31 96.67 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.627 -179.917 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 53.1 tp -62.15 -41.58 98.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.512 -179.519 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.45 ' O ' HD13 ' A' ' 58' ' ' LEU . 72.8 m -57.74 -44.49 86.08 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.292 -179.253 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.39 -62.0 5.5 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 110.906 -0.878 . . . . 0.0 110.906 179.632 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.7 t -48.35 -35.76 13.11 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 -179.904 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 20.2 mt -61.66 -44.61 96.63 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.648 -0.421 . . . . 0.0 111.186 179.424 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.45 HD13 ' O ' ' A' ' 54' ' ' THR . 9.3 mp -64.89 -41.89 95.25 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.342 177.901 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.53 -41.19 98.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.02 -179.279 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.429 ' O ' HG23 ' A' ' 60' ' ' ILE . 8.0 tp -88.04 16.62 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.763 -179.711 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 56.45 84.11 0.09 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.736 -179.874 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.9 58.24 0.09 OUTLIER Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.019 -179.745 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -50.77 152.45 9.6 Favored 'Trans proline' 0 C--N 1.296 -2.229 0 C-N-CA 122.751 2.301 . . . . 0.0 112.473 -178.405 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.431 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -109.15 146.25 14.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.372 -179.658 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 97.0 mt -63.86 -44.91 98.24 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.357 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.459 -179.914 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.504 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -129.81 134.22 47.42 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 120.84 0.352 . . . . 0.0 110.632 -179.896 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.509 ' O ' ' N ' ' A' ' 98' ' ' LEU . 58.8 m -134.32 158.39 43.92 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.875 -179.62 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -85.46 138.16 16.11 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.749 -0.941 . . . . 0.0 110.749 179.811 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.481 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.25 -163.81 0.11 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.958 0.408 . . . . 0.0 110.515 -179.906 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.502 HG22 ' CD2' ' A' ' 297' ' ' PHE . 6.2 t -134.22 140.61 46.6 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.216 179.936 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.486 ' C ' ' O ' ' A' ' 70' ' ' THR . 0.7 OUTLIER 29.67 70.73 0.56 Allowed Pre-proline 0 N--CA 1.466 0.329 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.657 -179.935 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_exo -60.45 144.44 99.52 Favored 'Trans proline' 0 C--N 1.299 -2.036 0 C-N-CA 122.587 2.191 . . . . 0.0 112.079 -178.323 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.54 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 44.5 p-10 -164.87 -35.56 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.662 179.895 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.54 ' N ' ' OD1' ' A' ' 73' ' ' ASN . 99.0 m-20 -63.88 -39.36 94.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.433 -179.98 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 73.4 ttt180 -60.88 -47.76 84.93 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.67 -179.389 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.433 ' O ' ' O ' ' A' ' 77' ' ' ALA . 95.6 t -60.24 -23.9 29.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.113 179.716 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.512 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -45.14 172.36 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.633 179.853 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.572 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.9 p30 -62.33 178.05 0.44 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.617 -179.7 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.562 ' C ' ' H ' ' A' ' 81' ' ' GLY . 36.6 p30 -46.04 85.64 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.05 179.912 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.572 ' N ' ' O ' ' A' ' 78' ' ' ASP . 42.6 tp60 -67.4 14.04 0.06 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.121 0.486 . . . . 0.0 110.094 -179.718 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.562 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 117.48 -21.62 10.58 Favored Glycine 0 CA--C 1.519 0.339 0 N-CA-C 110.909 -0.876 . . . . 0.0 110.909 179.922 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -107.85 116.71 32.45 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.968 0.413 . . . . 0.0 110.434 179.917 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 74.2 mt -98.62 0.69 45.3 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.551 -179.764 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -92.64 6.38 47.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.99 0.424 . . . . 0.0 110.459 -179.786 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.789 ' O ' HG22 ' A' ' 89' ' ' VAL . 27.2 mt-30 -99.83 -27.46 13.61 Favored 'General case' 0 C--O 1.224 -0.289 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.861 179.953 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.4 t-105 -63.84 -40.84 97.54 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.145 -179.795 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.552 ' O ' ' N ' ' A' ' 91' ' ' LYS . 67.3 m -77.76 -53.76 7.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.304 -179.548 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -48.19 -50.81 27.83 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.003 -179.273 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.789 HG22 ' O ' ' A' ' 85' ' ' GLN . 14.7 m -68.89 -40.7 81.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 120.919 0.39 . . . . 0.0 111.059 179.757 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.499 ' N ' HG23 ' A' ' 89' ' ' VAL . . . -72.14 -22.81 61.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.721 -179.885 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.552 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.0 tttm -61.6 -46.03 91.55 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.489 -179.539 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.442 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.3 mm-40 -90.11 -94.86 0.11 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.096 -179.964 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.627 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.7 mtt180 -143.19 59.58 1.41 Allowed 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 179.812 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.46 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.6 pttp 33.6 26.45 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.221 -179.214 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.627 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.4 tt -48.12 123.14 5.9 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.904 -178.152 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.456 ' O ' HD23 ' A' ' 95' ' ' LEU . 98.8 mm-40 -83.24 -169.54 2.59 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.057 -179.835 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.612 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 81.2 mtp180 -73.9 138.26 44.19 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.174 -179.677 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.509 ' N ' ' O ' ' A' ' 67' ' ' SER . 87.9 mt -86.61 -166.58 1.6 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.707 -179.524 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.528 ' O ' ' CD2' ' A' ' 99' ' ' TYR . 46.7 p90 -167.32 119.69 0.92 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.324 179.946 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.507 ' C ' ' O ' ' A' ' 99' ' ' TYR . 44.4 mm -29.56 121.08 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.995 -179.744 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 113.2 28.78 3.21 Favored Glycine 0 CA--C 1.52 0.359 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 -179.477 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.59 ' CD ' ' H ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -143.86 45.68 0.59 Allowed Pre-proline 0 C--N 1.323 -0.555 0 CA-C-O 120.948 0.404 . . . . 0.0 110.448 179.839 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.587 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 29.9 Cg_endo -61.97 143.68 95.56 Favored 'Trans proline' 0 C--N 1.297 -2.148 0 C-N-CA 122.683 2.255 . . . . 0.0 111.989 -179.925 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.484 ' O ' HG23 ' A' ' 108' ' ' VAL . 21.1 t -173.27 120.77 0.35 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.491 179.717 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.58 -41.09 63.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.067 0.461 . . . . 0.0 111.121 179.725 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -65.85 -40.4 91.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.904 -179.372 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.07 -39.95 95.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.762 -179.909 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 104' ' ' SER . 69.6 t -67.54 -43.77 86.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.795 179.652 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.43 -39.18 92.48 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.589 -179.284 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.442 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.39 -23.59 62.72 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.455 179.858 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.551 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.3 mm-40 -90.79 4.81 50.66 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.717 -179.509 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.551 ' C ' ' O ' ' A' ' 111' ' ' GLN . 10.5 tpt 23.67 63.86 0.39 Allowed Pre-proline 0 N--CA 1.465 0.297 0 CA-C-O 120.898 0.38 . . . . 0.0 111.059 -179.993 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.445 ' HG2' HD11 ' A' ' 116' ' ' ILE . 70.6 Cg_endo -78.7 168.55 20.93 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 C-N-CA 122.938 2.425 . . . . 0.0 112.213 -178.463 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.498 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 99.0 m-20 -113.04 -44.42 3.28 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.978 179.517 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.2 tp -120.23 119.62 33.74 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.577 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.456 HD13 HD22 ' A' ' 133' ' ' LEU . 95.4 mt -116.78 131.04 70.59 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.351 0 CA-C-O 120.953 0.406 . . . . 0.0 110.918 -179.856 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.617 HD12 ' OG ' ' A' ' 48' ' ' SER . 30.9 mt -105.69 132.75 51.45 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.115 0.483 . . . . 0.0 110.279 -179.466 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.421 HD12 HG23 ' A' ' 139' ' ' THR . 98.2 mt -118.33 136.24 56.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.724 -179.729 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 85.7 p -72.18 153.08 41.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.672 179.975 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -59.96 -50.0 75.49 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.612 -179.817 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -149.45 153.91 38.02 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.571 179.799 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 170.05 -170.56 42.96 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 179.919 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -63.04 -34.77 90.88 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 179.98 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.447 ' OD1' ' O ' ' A' ' 124' ' ' ASP . 43.9 p-10 -88.04 120.4 29.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.764 0.316 . . . . 0.0 110.683 179.934 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.455 ' O ' HD12 ' A' ' 129' ' ' LEU . 40.8 t -63.45 144.12 57.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.466 -179.928 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.521 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.37 -42.82 9.08 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.031 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.6 tp -62.82 -42.36 99.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.669 -179.832 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.05 -10.93 57.64 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.543 -179.461 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.455 HD12 ' O ' ' A' ' 125' ' ' SER . 85.2 mt -115.54 -24.14 8.46 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.695 -179.918 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 130' ' ' TYR . . . . . 0.521 ' N ' ' O ' ' A' ' 126' ' ' ALA . 78.7 t80 -51.84 -49.88 61.97 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.554 -178.902 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.1 p-10 -65.91 -42.11 90.57 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.909 0.385 . . . . 0.0 111.232 179.569 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.52 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 88.0 mt-30 -67.32 -36.74 82.07 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.78 179.929 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.456 HD22 HD13 ' A' ' 116' ' ' ILE . 93.7 mt -80.38 -41.74 24.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.975 -179.541 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.2 t -57.44 -44.71 84.95 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.223 -179.109 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 18.9 m -62.23 -45.59 92.66 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.799 0.333 . . . . 0.0 110.66 179.264 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 92.1 mt -62.36 -43.85 98.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.325 -179.792 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.605 ' HB1' ' HD2' ' A' ' 138' ' ' PRO . . . -170.37 163.79 5.94 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.541 179.832 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.605 ' HD2' ' HB1' ' A' ' 137' ' ' ALA . 78.3 Cg_exo -43.36 111.24 0.22 Allowed 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.501 2.134 . . . . 0.0 112.115 179.553 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.469 HG21 ' CD1' ' A' ' 130' ' ' TYR . 17.4 m -85.44 127.55 34.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.594 179.933 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.643 HD13 ' CD2' ' A' ' 37' ' ' HIS . 34.3 tp -119.11 136.93 53.92 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.957 -179.718 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.432 ' O ' ' OD1' ' A' ' 32' ' ' ASP . 79.8 mt -103.9 119.83 53.17 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.41 0 CA-C-O 121.183 0.516 . . . . 0.0 111.308 -179.382 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.507 HD12 HD22 ' A' ' 117' ' ' LEU . 98.1 mt -135.42 132.52 52.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.651 179.657 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.481 ' ND2' ' OD2' ' A' ' 241' ' ' ASP . 2.2 t-20 -65.56 149.41 50.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.899 0.38 . . . . 0.0 110.388 179.258 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.524 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 88.1 t80 -83.07 122.5 28.42 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.002 -179.496 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.524 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 98.9 m-20 55.09 69.58 0.72 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.871 179.608 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 49.2 p-10 -123.69 -0.01 8.65 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 120.974 0.416 . . . . 0.0 110.696 179.8 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -151.59 117.25 5.41 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.767 -179.512 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 84.7 p -63.07 167.53 4.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.5 -179.811 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.419 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.6 p-90 -50.74 -15.47 0.29 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.518 -179.823 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 150' ' ' GLN . . . . . 0.442 ' O ' HG23 ' A' ' 154' ' ' THR . 68.1 tp60 -71.72 -74.45 0.16 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.458 -179.843 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.451 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.2 t -62.61 -39.22 93.08 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.008 0.432 . . . . 0.0 110.274 179.408 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 53.3 tp -60.23 -45.43 93.25 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.364 -178.516 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.419 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 45.7 tp -62.74 -41.73 99.32 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.398 179.025 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.451 ' OG1' ' O ' ' A' ' 151' ' ' SER . 51.8 p -64.05 -34.64 78.47 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.284 -179.469 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 155' ' ' GLN . . . . . 0.456 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 88.2 mm-40 -63.98 -42.44 97.21 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.157 179.223 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 92.9 mt -65.35 -38.95 91.63 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.068 0.461 . . . . 0.0 110.223 179.137 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.582 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.15 -32.16 79.48 Favored Glycine 0 CA--C 1.52 0.362 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 -179.367 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.456 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.2 mt-10 -36.22 -25.68 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.814 0.34 . . . . 0.0 110.741 179.95 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.582 ' N ' ' O ' ' A' ' 157' ' ' GLY . 94.9 mt -58.95 149.68 5.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.276 179.303 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 75.2 p -69.3 137.08 52.7 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.076 -179.541 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 70.98 21.67 78.31 Favored Glycine 0 C--N 1.329 0.156 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 179.518 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 59.5 m80 -123.3 -14.95 7.34 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.732 0.301 . . . . 0.0 110.573 179.912 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -66.51 -59.63 3.46 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.779 -179.744 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -51.9 -48.9 63.93 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.173 -179.645 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -60.76 -41.03 94.64 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.981 -0.288 . . . . 0.0 110.316 179.534 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.58 -47.29 86.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.575 179.81 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.8 -40.25 75.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.178 -179.828 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -61.67 -50.24 73.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.627 179.56 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -65.43 -43.76 89.45 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.506 179.532 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 95.4 mt -64.6 -43.44 96.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.51 179.694 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.33 -51.03 71.02 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.542 -179.12 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.91 -43.62 95.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.44 179.685 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 173' ' ' PHE . . . . . 0.659 ' CE2' HD11 ' A' ' 177' ' ' LEU . 56.3 t80 -62.63 -44.63 95.8 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.058 0.456 . . . . 0.0 110.404 179.41 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -63.21 -39.88 95.87 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.59 -179.363 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -62.92 -42.86 99.93 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.637 179.218 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -60.61 -44.83 95.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.073 179.987 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.659 HD11 ' CE2' ' A' ' 173' ' ' PHE . 85.6 mt -64.37 -41.21 96.83 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.044 0.449 . . . . 0.0 110.672 178.901 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.06 -62.16 1.81 Allowed 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.527 -179.342 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.79 -46.54 87.32 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.571 179.803 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.36 -41.58 65.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.179 -179.994 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -63.76 -33.78 76.42 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.932 0.396 . . . . 0.0 110.336 179.305 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 182' ' ' GLU . . . . . 0.427 ' O ' ' HG2' ' A' ' 182' ' ' GLU . 69.8 tt0 -90.5 8.81 31.99 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.312 0.577 . . . . 0.0 110.509 -179.031 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -104.82 -32.26 8.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.887 0.375 . . . . 0.0 111.274 179.56 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.3 pt -128.01 147.41 32.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.836 -179.861 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -139.88 131.14 26.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.336 179.346 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 186' ' ' LEU . . . . . 0.596 HD22 ' N ' ' A' ' 186' ' ' LEU . 3.5 mm? -85.61 133.7 41.4 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.879 179.938 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -43.95 157.96 0.13 Allowed 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.669 2.246 . . . . 0.0 112.171 179.401 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 188' ' ' PRO . . . . . 0.523 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.6 Cg_endo -62.95 114.78 2.58 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 C-N-CA 122.82 2.347 . . . . 0.0 111.7 179.773 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 189' ' ' GLN . . . . . 0.523 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.8 mt-30 155.56 147.89 0.0 OUTLIER Pre-proline 0 N--CA 1.455 -0.195 0 O-C-N 123.555 0.535 . . . . 0.0 110.721 -179.858 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -73.72 144.09 34.73 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.644 2.229 . . . . 0.0 111.911 178.043 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.496 HG23 ' OG ' ' A' ' 258' ' ' SER . 2.1 p -124.93 158.91 32.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.336 0.589 . . . . 0.0 110.086 179.983 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 192' ' ' THR . . . . . 0.496 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 37.1 p -143.47 165.35 27.78 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.135 -179.653 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 193' ' ' ALA . . . . . 0.441 ' HA ' ' H ' ' A' ' 260' ' ' PHE . . . -135.26 128.49 31.97 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.144 0.497 . . . . 0.0 110.181 179.618 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.508 HD11 HD23 ' A' ' 259' ' ' LEU . 47.3 pt -146.48 148.92 16.49 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.056 179.814 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 195' ' ' VAL . . . . . 0.744 HG13 ' CD1' ' A' ' 262' ' ' PHE . 70.4 t -117.74 123.22 71.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.278 0.561 . . . . 0.0 109.681 179.183 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -134.26 107.35 7.61 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.251 179.66 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 95.8 m -130.93 130.53 43.59 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.85 179.707 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -82.92 -36.92 24.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.245 179.691 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.5 -67.07 0.26 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.343 -179.939 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.52 -10.1 59.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.249 179.606 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 60.0 t-80 61.03 58.42 2.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.816 -179.959 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 37.3 p -166.88 153.33 8.46 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.5 179.573 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.08 143.77 24.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.985 0.421 . . . . 0.0 110.431 179.455 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -135.21 138.06 43.25 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.667 179.993 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 20.0 mt -106.13 125.37 50.91 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.059 0.457 . . . . 0.0 109.848 -179.633 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 206' ' ' TRP . . . . . 0.558 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 74.9 m95 -82.01 167.04 19.27 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.603 -179.787 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 207' ' ' THR . . . . . 0.465 HG22 ' C ' ' A' ' 206' ' ' TRP . 0.1 OUTLIER -156.75 171.67 7.11 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.598 -179.214 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -54.09 -36.87 86.35 Favored 'Trans proline' 0 C--N 1.303 -1.865 0 C-N-CA 122.663 2.242 . . . . 0.0 111.952 179.379 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -70.61 -34.96 72.68 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.795 -179.811 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 21.2 m -61.28 150.57 34.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.635 -179.321 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.5 -37.07 82.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.52 -179.821 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 212' ' ' GLN . . . . . 0.558 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 54.9 tt0 -64.53 -40.36 95.47 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.497 179.957 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.74 -43.39 91.91 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 179.791 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -63.4 -43.53 97.27 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.715 0.293 . . . . 0.0 110.23 179.842 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 215' ' ' MET . . . . . 0.542 ' SD ' ' HB2' ' A' ' 304' ' ' ALA . 65.1 ttp -59.51 -48.07 83.06 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.227 -179.853 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 216' ' ' LEU . 87.5 mt -60.64 -40.8 93.3 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.636 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 217' ' ' GLU . . . . . 0.453 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.1 tp10 -58.02 -37.87 75.15 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.852 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -65.29 -38.12 89.26 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.803 0.335 . . . . 0.0 110.686 179.663 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 94.0 mt -64.41 -42.6 95.98 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.587 -179.595 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.62 45.0 0.08 OUTLIER Glycine 0 C--N 1.334 0.429 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 -179.962 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 221' ' ' PHE . . . . . 0.453 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 26.5 m-85 -128.23 155.91 43.8 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.038 0.447 . . . . 0.0 110.492 -179.792 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.491 ' O ' HG13 ' A' ' 191' ' ' VAL . 8.2 p -107.62 122.44 46.71 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.191 0.519 . . . . 0.0 110.182 -179.934 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.472 HD22 ' C ' ' A' ' 222' ' ' THR . 4.3 mm? -101.12 133.29 45.86 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.053 -179.995 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -97.0 159.05 15.13 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.494 179.906 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.0 115.16 29.8 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.335 179.899 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.494 HD12 ' N ' ' A' ' 226' ' ' LEU . 9.0 mp -53.33 156.66 3.89 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.698 179.921 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -60.27 145.31 98.83 Favored 'Trans proline' 0 C--N 1.301 -1.93 0 C-N-CA 122.598 2.199 . . . . 0.0 112.12 179.296 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.21 -3.05 59.03 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.493 -179.884 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.28 -40.83 5.67 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 -179.828 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 230' ' ' LEU . . . . . 0.532 ' O ' ' N ' ' A' ' 233' ' ' SER . 85.6 mt -79.44 -16.96 55.26 Favored 'General case' 0 C--O 1.222 -0.344 0 CA-C-O 121.002 0.429 . . . . 0.0 110.295 -179.694 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 231' ' ' ASN . . . . . 0.401 ' C ' ' O ' ' A' ' 230' ' ' LEU . 55.0 t-20 -40.3 -49.08 2.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.783 -179.541 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -88.08 15.44 7.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.818 0.342 . . . . 0.0 111.325 179.802 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 233' ' ' SER . . . . . 0.532 ' N ' ' O ' ' A' ' 230' ' ' LEU . 78.1 p -60.5 -35.56 76.24 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.594 -179.799 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 234' ' ' GLN . . . . . 0.525 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.7 tt0 -118.4 -69.36 0.85 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.942 179.575 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.4 m -70.0 103.05 2.15 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.65 -179.776 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -94.13 57.64 2.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.456 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -145.04 -122.1 1.51 Allowed Glycine 0 CA--C 1.521 0.433 0 N-CA-C 110.966 -0.854 . . . . 0.0 110.966 -179.993 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -135.32 112.19 10.18 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 121.172 0.51 . . . . 0.0 110.383 179.939 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 239' ' ' ARG . . . . . 0.518 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.4 mtt180 -148.28 57.81 1.07 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.709 -179.941 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -69.57 -32.09 70.65 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.482 179.617 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 241' ' ' ASP . . . . . 0.481 ' OD2' ' ND2' ' A' ' 143' ' ' ASN . 64.8 t0 -56.7 -47.12 80.62 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.436 -179.113 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 242' ' ' ILE . . . . . 0.432 ' O ' ' O ' ' A' ' 239' ' ' ARG . 17.8 tt -140.2 156.92 24.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.925 0.393 . . . . 0.0 110.52 179.758 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.442 HG22 HD13 ' A' ' 245' ' ' LEU . 96.2 mt -106.14 106.29 20.3 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.227 0 CA-C-O 121.204 0.526 . . . . 0.0 110.507 179.759 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 244' ' ' GLN . . . . . 0.603 ' O ' HD12 ' A' ' 245' ' ' LEU . 88.3 mt-30 -110.29 110.04 20.71 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.336 179.702 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.603 HD12 ' O ' ' A' ' 244' ' ' GLN . 9.4 mp -121.78 -168.18 1.66 Allowed 'General case' 0 C--O 1.225 -0.199 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.711 179.78 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 246' ' ' GLY . . . . . 0.525 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.32 -16.53 0.05 OUTLIER Glycine 0 CA--C 1.523 0.546 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 179.833 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 247' ' ' GLY . . . . . 0.669 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -60.62 157.01 30.48 Favored Glycine 0 CA--C 1.521 0.443 0 N-CA-C 110.904 -0.878 . . . . 0.0 110.904 -179.892 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -63.81 21.67 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.947 0.404 . . . . 0.0 110.559 179.899 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 249' ' ' ASN . . . . . 0.669 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.8 m-20 -97.38 -5.85 35.41 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.572 179.965 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 92.8 mt -80.13 -21.71 42.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.617 179.51 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.55 -51.28 70.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.801 -179.529 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.58 -5.29 58.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.419 179.686 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.15 -74.26 1.15 Allowed Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 -179.897 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 80.9 mt -70.14 126.05 28.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.069 0.462 . . . . 0.0 110.269 -179.87 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -59.59 -39.17 83.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.337 -179.659 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 83.0 51.87 4.04 Favored Glycine 0 CA--C 1.521 0.421 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 179.827 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -95.82 -15.13 22.71 Favored 'General case' 0 C--N 1.332 -0.17 0 O-C-N 122.632 -0.334 . . . . 0.0 110.594 -179.861 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 258' ' ' SER . . . . . 0.496 ' OG ' HG23 ' A' ' 191' ' ' VAL . 3.5 t 174.63 88.8 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.063 0.459 . . . . 0.0 110.157 179.989 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.862 HD12 ' N ' ' A' ' 259' ' ' LEU . 0.9 OUTLIER -94.26 123.96 37.98 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.309 0.576 . . . . 0.0 111.183 -179.141 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 260' ' ' PHE . . . . . 0.441 ' H ' ' HA ' ' A' ' 193' ' ' ALA . 15.9 m-30 -92.93 146.4 23.65 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.34 179.283 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 86.0 mt -122.37 149.69 43.45 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.491 -179.822 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.744 ' CD1' HG13 ' A' ' 195' ' ' VAL . 2.6 p90 -77.56 -138.39 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.563 -179.841 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 263' ' ' ALA . . . . . 0.659 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -51.99 77.48 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.006 179.986 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 264' ' ' GLY . . . . . 0.632 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.1 104.48 0.19 Allowed Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 -179.929 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 265' ' ' ASP . . . . . 0.601 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.8 m-20 -80.47 -177.69 6.33 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 120.741 0.305 . . . . 0.0 110.858 -179.562 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -40.51 -17.64 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.57 179.846 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 267' ' ' LYS . . . . . 0.601 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.54 -51.55 41.67 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.715 179.448 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -63.73 -46.75 83.95 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.15 179.483 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 269' ' ' ALA . . . . . 0.572 ' HB1' ' OH ' ' A' ' 273' ' ' TYR . . . -61.56 -35.17 77.02 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.774 179.545 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -62.87 -34.45 77.4 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.166 179.649 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.46 -43.23 13.77 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.3 -179.569 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 272' ' ' ILE . . . . . 0.584 ' C ' ' H ' ' A' ' 274' ' ' ALA . 5.0 tt -51.41 -33.55 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.904 -178.884 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 273' ' ' TYR . . . . . 0.572 ' OH ' ' HB1' ' A' ' 269' ' ' ALA . 17.1 m-85 -54.59 -1.75 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.69 -179.653 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 274' ' ' ALA . . . . . 0.584 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.64 -39.56 70.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.857 179.581 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 275' ' ' ASN . . . . . 0.583 ' O ' ' N ' ' A' ' 279' ' ' ALA . 3.0 p30 -39.51 98.23 0.16 Allowed Pre-proline 0 N--CA 1.463 0.175 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.538 -179.634 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -54.08 -43.04 61.95 Favored 'Trans proline' 0 C--N 1.303 -1.824 0 C-N-CA 122.388 2.058 . . . . 0.0 112.691 -178.821 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 89.5 mt -64.48 -42.76 95.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.14 0.495 . . . . 0.0 111.181 -179.691 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 91.4 mt -95.82 -1.52 49.43 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.884 -179.456 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 279' ' ' ALA . . . . . 0.583 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.38 -34.93 77.68 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.644 -179.812 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -74.09 20.05 0.11 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.048 -179.354 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 281' ' ' LEU . . . . . 0.492 HD23 ' HA ' ' A' ' 281' ' ' LEU . 13.7 mt -75.06 120.23 80.68 Favored Pre-proline 0 N--CA 1.452 -0.349 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.424 179.981 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -51.12 -39.5 60.85 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.624 2.216 . . . . 0.0 111.8 179.099 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.82 -50.26 64.02 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.096 179.879 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 74.0 t -61.51 -43.93 97.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.562 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -57.86 -41.19 81.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.305 -179.942 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -90.87 -0.0 57.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.061 179.695 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt 59.47 43.1 16.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.967 0.413 . . . . 0.0 110.829 179.714 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -94.59 41.42 1.09 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.383 179.797 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 54.5 t -118.92 135.84 58.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.074 0.464 . . . . 0.0 110.179 -179.677 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -133.0 162.6 31.25 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.726 -179.663 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.58 155.4 32.3 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-O 120.956 0.408 . . . . 0.0 110.776 -179.87 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 81.5 mt -94.22 -1.47 54.02 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.281 -179.723 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.24 165.93 12.8 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.611 -0.996 . . . . 0.0 110.611 -179.838 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 7.2 m -87.64 -62.46 1.49 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.934 0.397 . . . . 0.0 111.08 -179.901 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 295' ' ' GLU . . . . . 0.44 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.6 mm-40 -69.46 -3.82 16.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.674 -179.845 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 22.7 p -76.91 32.47 0.14 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.601 -179.892 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 297' ' ' PHE . . . . . 0.502 ' CD2' HG22 ' A' ' 70' ' ' THR . 77.1 t80 -60.24 -46.08 91.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.592 -179.962 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 298' ' ' ARG . . . . . 0.612 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.1 mtt85 -80.92 134.85 35.8 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.016 0.436 . . . . 0.0 110.583 -179.742 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.452 ' H ' HG11 ' A' ' 51' ' ' VAL . 17.0 tp -114.48 118.2 33.11 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.203 179.882 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 300' ' ' ASP . . . . . 0.631 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.0 p-10 -165.78 -176.08 3.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.585 179.94 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 82.5 t80 -47.16 -43.77 21.38 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.286 -179.719 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -66.69 -40.51 88.55 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.03 0.443 . . . . 0.0 110.823 179.136 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 303' ' ' SER . . . . . 0.631 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 59.6 p -55.87 -36.18 67.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.087 -179.21 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 304' ' ' ALA . . . . . 0.542 ' HB2' ' SD ' ' A' ' 215' ' ' MET . . . -57.37 -51.48 69.23 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.52 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 91.0 mtp -56.23 -43.63 78.8 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.953 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -66.34 -42.68 87.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.986 0.422 . . . . 0.0 110.226 178.79 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 307' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 303' ' ' SER . 55.8 t -64.03 -42.95 97.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.154 179.373 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 42.7 tp -59.63 -42.28 92.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.87 -179.513 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -62.71 -38.86 92.11 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 179.465 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 310' ' ' ARG . . . . . 0.444 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.6 ttt85 -63.5 -44.12 95.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.229 179.525 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 88.7 mt -63.19 -41.97 99.26 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.23 179.655 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt -62.84 -33.34 75.05 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.99 179.461 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.86 -23.59 21.62 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.461 -179.775 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 314' ' ' LEU . . . . . 0.48 HD22 ' CE2' ' A' ' 315' ' ' PHE . 6.7 tt -62.26 -43.14 99.51 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.607 -179.925 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 315' ' ' PHE . . . . . 0.48 ' CE2' HD22 ' A' ' 314' ' ' LEU . 90.9 m-85 . . . . . 0 C--O 1.221 -0.431 0 CA-C-O 117.979 -1.01 . . . . 0.0 110.503 179.947 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -100.11 136.85 39.38 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.008 0.432 . . . . 0.0 110.5 -179.929 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.498 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -91.78 178.46 1.73 Allowed Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.54 -179.911 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.498 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.7 Cg_exo -61.61 147.48 95.28 Favored 'Trans proline' 0 C--N 1.3 -2.023 0 C-N-CA 122.772 2.315 . . . . 0.0 112.179 179.627 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.465 ' HE ' HD12 ' A' ' 39' ' ' LEU . 35.6 ptt180 -136.05 142.61 44.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.699 179.766 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -78.96 117.13 19.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.574 179.918 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.433 ' O ' HG23 ' A' ' 30' ' ' ILE . 9.6 tp -110.51 130.94 62.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.395 -179.956 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.5 t -70.43 142.07 52.03 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.62 179.812 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.422 ' OD1' ' O ' ' A' ' 141' ' ' ILE . 25.8 t70 -139.9 177.42 7.98 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.452 -179.902 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.0 p -73.79 -36.26 65.01 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.693 179.925 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -47.71 -94.86 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.317 -179.525 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.422 ' O ' ' OG1' ' A' ' 36' ' ' THR . . . -165.59 -25.96 0.02 OUTLIER Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.889 -0.885 . . . . 0.0 110.889 179.913 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.422 ' OG1' ' O ' ' A' ' 35' ' ' GLY . 53.2 m -169.25 106.72 0.41 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.864 0.364 . . . . 0.0 110.665 -179.899 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.426 ' ND1' HD13 ' A' ' 140' ' ' LEU . 50.8 t-80 -129.48 146.65 51.29 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.095 0.474 . . . . 0.0 110.1 179.997 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.623 HG22 ' N ' ' A' ' 39' ' ' LEU . 96.8 m -129.89 166.07 20.74 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.653 -179.814 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.623 ' N ' HG22 ' A' ' 38' ' ' THR . 82.5 mt -121.01 127.84 52.14 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.432 179.76 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -64.12 -44.58 91.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.639 -179.905 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 42.9 p -165.96 155.25 11.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.365 179.688 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.472 ' CD ' ' H ' ' A' ' 42' ' ' GLN . 14.1 mp0 -43.34 100.7 0.23 Allowed Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.605 179.415 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -56.8 129.29 33.78 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 122.318 2.012 . . . . 0.0 112.282 -179.612 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -83.72 -24.59 31.14 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.46 179.575 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.538 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.3 mtm-85 -122.31 134.94 54.65 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.169 0.509 . . . . 0.0 110.293 -179.974 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.1 mt -130.24 133.47 64.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.92 -179.681 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 45.4 t -124.34 130.83 73.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-O 120.848 0.356 . . . . 0.0 110.062 179.384 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.622 ' OG ' HD12 ' A' ' 117' ' ' LEU . 2.2 m -154.44 166.55 32.9 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.532 179.795 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 72.5 p -124.13 8.42 8.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.521 179.917 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.3 t -86.13 125.75 33.72 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.677 -179.551 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.483 HG11 ' H ' ' A' ' 299' ' ' LEU . 87.2 t -65.64 -44.48 93.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.453 -179.984 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.4 m -62.29 -44.31 96.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.667 -179.917 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 46.1 tp -62.39 -41.3 98.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.537 -179.431 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.447 ' O ' HD13 ' A' ' 58' ' ' LEU . 71.4 m -57.79 -44.64 86.4 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.353 -179.262 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.21 -62.21 5.36 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 179.535 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.7 t -48.39 -35.52 12.84 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 -179.917 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.9 mt -61.71 -44.42 96.96 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.698 -0.401 . . . . 0.0 111.207 179.407 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.447 HD13 ' O ' ' A' ' 54' ' ' THR . 9.2 mp -64.9 -41.8 95.3 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.352 177.956 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.62 -41.05 98.33 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.098 -179.251 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.432 ' O ' HG23 ' A' ' 60' ' ' ILE . 8.0 tp -88.25 16.94 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.775 -179.644 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 56.36 84.2 0.09 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.676 -179.899 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.44 57.63 0.07 OUTLIER Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.277 -0.42 . . . . 0.0 109.994 -179.826 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -50.53 153.19 7.99 Favored 'Trans proline' 0 C--N 1.295 -2.237 0 C-N-CA 122.9 2.4 . . . . 0.0 112.426 -178.305 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.439 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -109.16 144.94 16.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.424 -179.709 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.8 mt -63.72 -45.36 97.53 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.35 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.444 -179.775 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.5 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -128.76 133.77 48.2 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.865 0.364 . . . . 0.0 110.518 -179.867 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.516 ' O ' ' N ' ' A' ' 98' ' ' LEU . 75.1 m -135.0 158.87 43.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.819 -179.648 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -87.23 139.45 16.12 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 179.828 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.481 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.88 -162.58 0.08 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.986 0.422 . . . . 0.0 110.429 -179.944 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.533 HG22 ' CD2' ' A' ' 297' ' ' PHE . 14.0 t -133.48 133.99 42.95 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.318 179.966 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.492 ' C ' ' O ' ' A' ' 70' ' ' THR . 0.6 OUTLIER 29.69 68.81 0.65 Allowed Pre-proline 0 N--CA 1.464 0.229 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.768 -179.93 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -61.09 145.36 99.01 Favored 'Trans proline' 0 C--N 1.3 -1.992 0 C-N-CA 122.648 2.232 . . . . 0.0 112.101 -178.437 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.533 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 46.1 p-10 -158.74 -32.05 0.07 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.703 179.726 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.547 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 99.1 m-20 -64.14 -39.92 95.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.579 179.825 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -60.49 -48.26 82.55 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.704 -179.207 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.415 ' O ' ' O ' ' A' ' 77' ' ' ALA . 90.4 t -60.23 -24.94 32.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.804 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.547 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -46.03 172.97 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.541 179.862 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.581 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.5 p30 -62.01 177.7 0.43 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.611 -179.691 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.558 ' C ' ' H ' ' A' ' 81' ' ' GLY . 35.6 p30 -44.76 85.72 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.0 179.924 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.581 ' N ' ' O ' ' A' ' 78' ' ' ASP . 42.7 tp60 -67.43 13.03 0.08 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.06 -179.758 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.558 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 118.62 -21.85 9.6 Favored Glycine 0 CA--C 1.519 0.328 0 N-CA-C 110.974 -0.85 . . . . 0.0 110.974 179.94 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -107.92 116.29 31.68 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.953 0.406 . . . . 0.0 110.494 179.856 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 73.2 mt -98.62 -0.01 43.91 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.436 -179.71 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -92.6 7.39 43.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.947 0.403 . . . . 0.0 110.387 -179.785 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.802 ' O ' HG22 ' A' ' 89' ' ' VAL . 27.1 mt-30 -100.07 -28.33 13.1 Favored 'General case' 0 C--O 1.224 -0.25 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.842 -179.996 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 68.9 t-105 -62.5 -40.89 98.16 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.867 -179.632 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.555 ' O ' ' N ' ' A' ' 91' ' ' LYS . 63.4 m -77.59 -53.55 7.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.195 -179.425 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -48.53 -50.73 30.76 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.013 -179.277 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.802 HG22 ' O ' ' A' ' 85' ' ' GLN . 15.4 m -68.91 -40.59 81.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 120.896 0.379 . . . . 0.0 111.048 179.723 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.496 ' N ' HG23 ' A' ' 89' ' ' VAL . . . -72.29 -22.84 61.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.8 -179.927 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.555 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.0 tttm -61.86 -45.53 93.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.429 -179.541 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.442 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.4 mm-40 -90.49 -94.92 0.12 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.13 -179.846 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.626 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.9 mtt180 -143.09 59.1 1.41 Allowed 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.828 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.462 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.7 pttp 33.37 26.77 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.242 -179.171 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.626 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.4 tt -48.71 123.58 7.08 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.951 -178.131 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.459 ' O ' HD23 ' A' ' 95' ' ' LEU . 99.1 mm-40 -84.33 -169.1 2.44 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.08 -179.937 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.609 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 81.0 mtp180 -74.86 136.64 41.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.279 -179.798 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.516 ' N ' ' O ' ' A' ' 67' ' ' SER . 90.9 mt -85.39 -165.71 1.3 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.633 -179.642 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.54 ' O ' ' CD2' ' A' ' 99' ' ' TYR . 47.7 p90 -168.32 119.49 0.8 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.209 179.982 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.516 ' C ' ' O ' ' A' ' 99' ' ' TYR . 42.8 mm -28.77 120.8 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.0 -179.63 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 114.51 27.63 3.26 Favored Glycine 0 CA--C 1.519 0.315 0 N-CA-C 111.15 -0.78 . . . . 0.0 111.15 -179.494 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.579 ' CD ' ' H ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -144.84 46.51 0.61 Allowed Pre-proline 0 C--N 1.323 -0.546 0 CA-C-O 120.891 0.377 . . . . 0.0 110.488 179.909 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.574 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 29.4 Cg_endo -61.88 144.31 96.56 Favored 'Trans proline' 0 C--N 1.296 -2.197 0 C-N-CA 122.652 2.235 . . . . 0.0 111.968 -179.942 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.449 ' O ' HG23 ' A' ' 108' ' ' VAL . 27.0 t -173.24 119.97 0.33 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.446 179.728 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.4 -40.33 64.38 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.021 0.439 . . . . 0.0 111.088 179.647 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -66.32 -39.69 89.44 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.819 -179.403 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.95 -40.04 95.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.704 -179.816 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 104' ' ' SER . 71.7 t -67.38 -43.93 87.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.712 179.681 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.87 -38.91 92.75 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.524 -179.349 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.442 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.4 -23.68 62.82 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.465 179.89 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.561 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.5 mm-40 -91.24 5.17 50.2 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.723 -179.552 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.561 ' C ' ' O ' ' A' ' 111' ' ' GLN . 10.3 tpt 22.24 64.72 0.33 Allowed Pre-proline 0 N--CA 1.465 0.277 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.043 179.985 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -78.57 169.05 20.41 Favored 'Trans proline' 0 C--N 1.304 -1.811 0 C-N-CA 122.99 2.46 . . . . 0.0 112.082 -178.461 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.423 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 98.8 m-20 -110.73 -42.76 3.96 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 121.013 0.435 . . . . 0.0 110.231 179.47 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.0 tp -119.95 120.78 37.37 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.974 179.571 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 83.7 mt -114.02 129.23 70.31 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.37 0 CA-C-O 120.936 0.398 . . . . 0.0 110.92 -179.858 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.622 HD12 ' OG ' ' A' ' 48' ' ' SER . 30.8 mt -109.24 132.03 54.51 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.048 0.451 . . . . 0.0 110.198 -179.705 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.496 HD12 HG23 ' A' ' 139' ' ' THR . 98.8 mt -119.61 138.05 51.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.706 -179.781 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 85.1 p -71.88 153.97 41.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.554 179.978 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.28 -50.35 74.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.671 -179.793 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -149.58 154.06 38.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.601 179.809 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 170.66 -170.78 43.37 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.911 -0.875 . . . . 0.0 110.911 179.824 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.96 -34.09 88.97 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 179.936 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.45 ' OD1' ' O ' ' A' ' 124' ' ' ASP . 44.4 p-10 -86.96 120.33 28.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.843 0.354 . . . . 0.0 110.673 179.953 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.45 ' O ' HD12 ' A' ' 129' ' ' LEU . 39.1 t -63.26 143.63 57.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.045 0.45 . . . . 0.0 110.447 -179.932 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.0 -43.26 9.0 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.945 -179.97 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.6 tp -62.81 -42.48 99.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.705 -179.831 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.58 -11.71 58.72 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.515 -179.444 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.45 HD12 ' O ' ' A' ' 125' ' ' SER . 84.8 mt -115.0 -24.05 8.78 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.724 -179.866 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 130' ' ' TYR . . . . . 0.519 ' N ' ' O ' ' A' ' 126' ' ' ALA . 80.8 t80 -51.22 -49.57 60.8 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.579 -178.901 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.7 p-10 -66.17 -42.33 89.06 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.8 0.333 . . . . 0.0 111.18 179.538 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.524 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 88.2 mt-30 -67.42 -37.67 83.42 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.761 179.975 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.416 HD12 HD11 ' A' ' 118' ' ' ILE . 95.6 mt -80.22 -41.89 24.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.932 -179.599 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.2 t -57.17 -44.28 83.36 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.24 -179.07 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.1 m -62.06 -45.44 93.55 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.775 0.321 . . . . 0.0 110.572 179.357 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 92.9 mt -62.28 -43.64 98.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.229 -179.774 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.658 ' HB1' ' HD2' ' A' ' 138' ' ' PRO . . . -169.25 167.85 5.31 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.566 179.897 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.658 ' HD2' ' HB1' ' A' ' 137' ' ' ALA . 50.9 Cg_exo -49.04 112.56 0.67 Allowed 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.357 2.038 . . . . 0.0 112.116 179.377 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.496 HG23 HD12 ' A' ' 118' ' ' ILE . 21.6 m -84.5 127.37 34.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.641 -179.951 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.447 HD12 ' HA ' ' A' ' 140' ' ' LEU . 36.2 tp -118.62 137.95 52.92 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.066 -179.867 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.422 ' O ' ' OD1' ' A' ' 32' ' ' ASP . 77.1 mt -102.82 120.05 52.07 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 CA-C-O 121.224 0.535 . . . . 0.0 111.118 -179.415 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.443 HD12 HD22 ' A' ' 117' ' ' LEU . 98.5 mt -135.68 131.83 50.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.585 179.662 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.434 HD21 ' CG ' ' A' ' 241' ' ' ASP . 56.4 t30 -66.42 153.82 41.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.938 0.399 . . . . 0.0 110.467 179.373 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.527 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 90.5 t80 -87.73 122.43 31.38 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.831 -179.639 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.527 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 99.1 m-20 55.3 69.33 0.75 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.778 179.633 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 49.4 p-10 -123.73 -0.4 8.57 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.664 179.925 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -151.26 116.5 5.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.778 -179.541 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 148' ' ' SER . . . . . 0.418 ' C ' ' N ' ' A' ' 150' ' ' GLN . 83.4 p -62.15 166.5 4.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.479 -179.752 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.41 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.4 p-90 -50.68 -15.48 0.28 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.545 -179.812 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 150' ' ' GLN . . . . . 0.452 ' O ' HG23 ' A' ' 154' ' ' THR . 68.3 tp60 -71.52 -74.26 0.16 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.466 -179.787 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.432 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.1 t -62.86 -39.29 93.95 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.272 179.467 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 54.8 tp -59.96 -45.76 91.61 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.399 -178.581 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.41 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 46.5 tp -62.65 -41.75 99.22 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.784 0.326 . . . . 0.0 110.404 179.054 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.452 HG23 ' O ' ' A' ' 150' ' ' GLN . 56.6 p -64.57 -34.73 78.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.358 -179.551 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 155' ' ' GLN . . . . . 0.45 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 86.9 mm-40 -64.05 -42.84 96.9 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.313 179.284 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 91.5 mt -65.54 -38.83 90.75 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.057 0.456 . . . . 0.0 110.187 179.147 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.58 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.21 -32.11 79.44 Favored Glycine 0 CA--C 1.52 0.344 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 -179.36 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.45 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.2 mt-10 -35.58 -26.91 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.823 0.344 . . . . 0.0 110.812 179.955 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.58 ' N ' ' O ' ' A' ' 157' ' ' GLY . 94.8 mt -56.52 150.84 2.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.264 179.312 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 72.0 p -69.66 137.3 52.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.01 -179.541 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 70.15 22.37 77.34 Favored Glycine 0 N--CA 1.459 0.2 0 N-CA-C 111.214 -0.754 . . . . 0.0 111.214 179.462 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 59.5 m80 -123.12 -13.65 7.71 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.716 0.293 . . . . 0.0 110.566 179.906 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -67.21 -59.32 3.53 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.755 -179.687 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -52.14 -49.42 63.74 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.239 -179.595 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -60.36 -41.3 93.42 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.792 0.33 . . . . 0.0 110.336 179.525 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.52 -47.05 87.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.595 179.831 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.96 -40.14 75.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.204 -179.894 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -61.64 -50.24 73.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.589 179.553 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -65.47 -43.59 89.82 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.501 179.541 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 95.0 mt -64.64 -43.47 96.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.457 179.776 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.44 -51.27 70.1 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.641 -179.232 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.72 -44.16 94.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.545 179.697 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 173' ' ' PHE . . . . . 0.644 ' CE2' HD11 ' A' ' 177' ' ' LEU . 55.0 t80 -62.86 -44.43 96.13 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.069 0.461 . . . . 0.0 110.443 179.438 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -63.33 -40.06 96.28 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.598 -179.331 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -62.92 -42.71 99.88 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.63 179.191 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -60.62 -44.8 95.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.103 -179.97 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.644 HD11 ' CE2' ' A' ' 173' ' ' PHE . 85.7 mt -64.44 -41.16 96.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.01 0.434 . . . . 0.0 110.714 178.951 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.18 -62.3 1.72 Allowed 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.497 -179.351 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.45 -46.81 85.81 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.566 179.887 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.21 -41.64 65.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.238 179.987 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -63.97 -33.77 76.48 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.998 0.428 . . . . 0.0 110.353 179.315 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 182' ' ' GLU . . . . . 0.423 ' O ' ' HG2' ' A' ' 182' ' ' GLU . 69.6 tt0 -90.49 8.8 32.05 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.347 0.594 . . . . 0.0 110.533 -178.998 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -104.74 -32.14 9.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.181 179.607 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.2 pt -128.13 147.79 32.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.846 -179.818 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -140.11 131.12 26.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.356 179.427 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 186' ' ' LEU . . . . . 0.602 HD22 ' N ' ' A' ' 186' ' ' LEU . 3.5 mm? -85.88 133.68 40.89 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.908 179.924 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -44.33 157.97 0.15 Allowed 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.727 2.284 . . . . 0.0 112.088 179.356 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 188' ' ' PRO . . . . . 0.526 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.7 Cg_endo -62.92 115.13 2.75 Favored 'Trans proline' 0 C--N 1.303 -1.82 0 C-N-CA 122.801 2.334 . . . . 0.0 111.774 179.768 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 189' ' ' GLN . . . . . 0.526 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.7 mt-30 155.44 148.09 0.0 OUTLIER Pre-proline 0 N--CA 1.455 -0.208 0 O-C-N 123.635 0.584 . . . . 0.0 110.758 -179.867 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -73.83 144.17 34.4 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.676 2.25 . . . . 0.0 111.914 178.044 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.496 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.1 p -125.13 158.99 32.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.307 0.575 . . . . 0.0 110.121 -179.98 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 192' ' ' THR . . . . . 0.496 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 36.9 p -143.44 165.36 27.75 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.139 -179.678 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 193' ' ' ALA . . . . . 0.444 ' HA ' ' H ' ' A' ' 260' ' ' PHE . . . -135.41 128.74 32.13 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.135 0.493 . . . . 0.0 110.194 179.543 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.504 HD11 HD23 ' A' ' 259' ' ' LEU . 47.9 pt -146.28 148.58 16.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.077 179.825 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 195' ' ' VAL . . . . . 0.754 HG13 ' CD1' ' A' ' 262' ' ' PHE . 70.2 t -117.33 122.96 71.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.277 0.56 . . . . 0.0 109.681 179.161 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -134.37 107.49 7.64 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.32 179.707 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 95.1 m -131.17 130.54 43.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.855 179.833 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -82.53 -36.84 25.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.33 179.75 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.58 -67.36 0.24 Allowed 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.425 179.981 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.49 -9.86 59.08 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.265 179.55 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 60.5 t-80 60.42 58.78 2.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.784 -179.812 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 42.9 p -167.06 153.62 8.38 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.538 179.53 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.28 144.17 24.5 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.957 0.408 . . . . 0.0 110.453 179.432 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -135.06 137.28 42.75 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.569 -179.988 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 19.6 mt -105.44 125.16 50.67 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 121.066 0.46 . . . . 0.0 109.869 -179.676 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 206' ' ' TRP . . . . . 0.557 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 75.9 m95 -81.57 166.42 20.25 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.634 -179.794 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 207' ' ' THR . . . . . 0.463 HG22 ' C ' ' A' ' 206' ' ' TRP . 0.1 OUTLIER -156.57 171.52 7.29 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.536 -179.184 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_exo -54.23 -36.78 87.21 Favored 'Trans proline' 0 C--N 1.302 -1.874 0 C-N-CA 122.679 2.253 . . . . 0.0 112.079 179.173 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -70.33 -34.97 73.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.811 -179.806 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 22.3 m -61.6 149.83 38.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.587 -179.392 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.55 -36.83 81.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.494 -179.732 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 212' ' ' GLN . . . . . 0.557 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 55.1 tt0 -64.65 -40.61 95.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.56 179.873 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.08 -43.56 93.09 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 110.591 -1.003 . . . . 0.0 110.591 179.712 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -63.5 -42.76 98.52 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 179.72 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 215' ' ' MET . . . . . 0.568 ' SD ' ' HB2' ' A' ' 304' ' ' ALA . 64.6 ttp -59.47 -48.04 83.17 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.202 -179.898 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 216' ' ' LEU . 87.6 mt -60.74 -40.67 93.25 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.556 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 217' ' ' GLU . . . . . 0.455 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 40.7 tp10 -58.03 -38.09 75.58 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.841 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -65.12 -38.18 89.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.771 0.319 . . . . 0.0 110.621 179.641 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 94.5 mt -64.41 -42.78 95.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.517 -179.537 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 138.01 45.22 0.08 OUTLIER Glycine 0 C--N 1.335 0.479 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 179.982 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 221' ' ' PHE . . . . . 0.455 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 26.7 m-85 -128.8 156.45 43.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.057 0.456 . . . . 0.0 110.523 -179.739 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.49 ' O ' HG13 ' A' ' 191' ' ' VAL . 7.8 p -108.33 122.82 47.76 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 121.204 0.526 . . . . 0.0 110.185 -179.94 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.474 HD22 ' C ' ' A' ' 222' ' ' THR . 4.3 mm? -101.38 132.92 46.7 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.055 179.933 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.9 159.57 14.84 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.54 179.85 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -104.97 115.26 29.97 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.933 0.396 . . . . 0.0 110.395 179.824 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.495 HD12 ' N ' ' A' ' 226' ' ' LEU . 8.9 mp -53.72 156.96 4.25 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.669 179.914 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -60.18 145.24 98.93 Favored 'Trans proline' 0 C--N 1.302 -1.914 0 C-N-CA 122.637 2.224 . . . . 0.0 112.108 179.374 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.6 -2.47 58.64 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.56 -179.959 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.62 -40.42 5.66 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 -179.903 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 230' ' ' LEU . . . . . 0.548 ' O ' ' N ' ' A' ' 233' ' ' SER . 85.9 mt -79.59 -16.51 55.74 Favored 'General case' 0 C--O 1.223 -0.311 0 CA-C-O 120.971 0.415 . . . . 0.0 110.314 -179.735 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 231' ' ' ASN . . . . . 0.404 ' C ' ' O ' ' A' ' 230' ' ' LEU . 55.4 t-20 -40.27 -48.8 2.67 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.687 -179.566 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -88.59 15.7 7.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.804 0.335 . . . . 0.0 111.258 179.807 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 233' ' ' SER . . . . . 0.548 ' N ' ' O ' ' A' ' 230' ' ' LEU . 78.1 p -60.63 -35.79 77.04 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.738 -179.839 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 234' ' ' GLN . . . . . 0.525 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.6 tt0 -118.06 -69.6 0.84 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.021 179.535 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 3.8 m -70.46 103.41 2.45 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.673 -179.796 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -94.64 57.94 2.27 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.363 179.93 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -145.15 -122.63 1.55 Allowed Glycine 0 CA--C 1.52 0.365 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 -179.958 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -133.7 112.03 11.07 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 121.118 0.485 . . . . 0.0 110.409 179.945 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 239' ' ' ARG . . . . . 0.488 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 94.7 mtt180 -148.25 56.61 1.06 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.753 -179.979 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -69.4 -31.36 69.68 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.511 179.593 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 241' ' ' ASP . . . . . 0.456 ' OD2' ' O ' ' A' ' 144' ' ' TYR . 64.8 t0 -56.69 -46.93 80.88 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.403 -179.069 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 242' ' ' ILE . . . . . 0.436 ' O ' ' O ' ' A' ' 239' ' ' ARG . 16.9 tt -140.85 158.18 23.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.934 0.397 . . . . 0.0 110.519 179.738 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.442 HG22 HD13 ' A' ' 245' ' ' LEU . 96.0 mt -105.97 105.97 19.71 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.2 0 CA-C-O 121.155 0.503 . . . . 0.0 110.407 179.821 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 244' ' ' GLN . . . . . 0.614 ' C ' HD12 ' A' ' 245' ' ' LEU . 88.2 mt-30 -110.76 110.69 21.43 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.369 179.74 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.614 HD12 ' C ' ' A' ' 244' ' ' GLN . 9.7 mp -122.03 -167.92 1.63 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.558 179.748 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 246' ' ' GLY . . . . . 0.525 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 172.54 -16.48 0.05 OUTLIER Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 179.879 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 247' ' ' GLY . . . . . 0.663 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -60.56 157.71 29.01 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 -179.855 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -64.22 21.09 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.971 0.415 . . . . 0.0 110.609 179.962 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 249' ' ' ASN . . . . . 0.663 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.8 m-20 -96.94 -5.54 37.69 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.564 179.955 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 92.2 mt -80.84 -20.99 41.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.611 179.535 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.52 -51.35 70.27 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.79 -179.671 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -89.29 -4.93 57.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.453 179.658 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.09 -74.16 1.15 Allowed Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 -179.923 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 81.7 mt -70.13 125.71 27.56 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.015 0.436 . . . . 0.0 110.237 -179.795 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -59.57 -39.49 84.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.369 -179.709 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 83.51 51.71 4.0 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 179.767 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -94.81 -16.57 22.86 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.724 0.297 . . . . 0.0 110.597 -179.899 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 258' ' ' SER . . . . . 0.495 ' OG ' HG23 ' A' ' 191' ' ' VAL . 3.4 t 175.19 89.63 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.057 0.456 . . . . 0.0 110.124 179.996 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.862 HD12 ' N ' ' A' ' 259' ' ' LEU . 0.9 OUTLIER -94.5 124.26 38.42 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.323 0.582 . . . . 0.0 111.139 -179.042 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 260' ' ' PHE . . . . . 0.444 ' H ' ' HA ' ' A' ' 193' ' ' ALA . 16.1 m-30 -93.53 146.93 23.43 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.362 179.22 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 86.2 mt -122.44 149.77 43.38 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.599 -179.893 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.754 ' CD1' HG13 ' A' ' 195' ' ' VAL . 2.6 p90 -77.72 -138.78 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.542 -179.849 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 263' ' ' ALA . . . . . 0.659 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -51.39 78.09 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.056 179.988 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 264' ' ' GLY . . . . . 0.629 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.95 104.63 0.19 Allowed Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.679 -0.969 . . . . 0.0 110.679 -179.987 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 265' ' ' ASP . . . . . 0.604 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.7 m-20 -80.29 -177.62 6.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.671 0.272 . . . . 0.0 110.883 -179.49 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -40.54 -17.48 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.858 0.361 . . . . 0.0 110.504 179.766 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 267' ' ' LYS . . . . . 0.604 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.53 -51.66 40.58 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.672 179.476 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -63.75 -46.59 84.64 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.212 179.343 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 269' ' ' ALA . . . . . 0.578 ' HB1' ' OH ' ' A' ' 273' ' ' TYR . . . -61.49 -35.41 77.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.78 179.599 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -62.56 -34.71 77.5 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.228 179.694 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.26 -43.09 14.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.319 -179.592 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 272' ' ' ILE . . . . . 0.586 ' C ' ' H ' ' A' ' 274' ' ' ALA . 5.0 tt -51.47 -33.89 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.824 -178.823 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 273' ' ' TYR . . . . . 0.578 ' OH ' ' HB1' ' A' ' 269' ' ' ALA . 16.8 m-85 -54.31 -2.11 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.645 -179.599 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 274' ' ' ALA . . . . . 0.586 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.39 -39.58 71.08 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.969 179.5 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 275' ' ' ASN . . . . . 0.585 ' O ' ' N ' ' A' ' 279' ' ' ALA . 3.6 p30 -39.23 97.96 0.15 Allowed Pre-proline 0 C--O 1.227 -0.113 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.568 -179.691 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -54.15 -43.1 61.49 Favored 'Trans proline' 0 C--N 1.303 -1.824 0 C-N-CA 122.375 2.05 . . . . 0.0 112.611 -178.765 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 89.2 mt -64.42 -42.79 95.86 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.114 -179.64 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 91.2 mt -95.96 -1.18 49.62 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.849 -179.421 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 279' ' ' ALA . . . . . 0.585 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.5 -34.93 77.84 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.612 -179.749 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.26 20.18 0.11 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.004 -179.247 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 281' ' ' LEU . . . . . 0.491 HD23 ' HA ' ' A' ' 281' ' ' LEU . 13.7 mt -75.03 120.11 80.08 Favored Pre-proline 0 N--CA 1.451 -0.376 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.45 179.94 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -50.96 -39.45 59.36 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.659 2.24 . . . . 0.0 111.831 179.07 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -53.0 -50.38 64.32 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.126 179.849 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 74.6 t -61.6 -43.97 97.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 179.488 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -57.55 -41.17 80.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.234 -179.958 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -90.97 0.23 57.58 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.141 179.687 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt 59.62 43.16 16.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.066 0.46 . . . . 0.0 110.891 179.662 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -94.61 41.31 1.09 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.399 179.884 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 54.1 t -119.21 135.76 58.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 121.009 0.433 . . . . 0.0 110.179 -179.741 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -133.63 163.67 28.9 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 121.026 0.441 . . . . 0.0 110.73 -179.66 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.76 155.77 31.87 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.97 0.414 . . . . 0.0 110.759 -179.797 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 82.2 mt -94.65 -1.45 53.14 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.274 -179.75 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.34 165.22 12.56 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 -179.786 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 6.6 m -86.7 -61.55 1.71 Allowed 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 120.87 0.367 . . . . 0.0 111.102 -179.84 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 295' ' ' GLU . . . . . 0.448 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.6 mm-40 -69.66 -4.56 20.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.66 -179.792 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 26.1 p -76.48 33.03 0.13 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.68 -179.891 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 297' ' ' PHE . . . . . 0.533 ' CD2' HG22 ' A' ' 70' ' ' THR . 83.3 t80 -60.52 -45.99 91.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.646 -179.956 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 298' ' ' ARG . . . . . 0.609 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.2 mtt85 -81.08 136.66 35.97 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.627 -179.598 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.483 ' H ' HG11 ' A' ' 51' ' ' VAL . 0.9 OUTLIER -114.25 116.87 29.7 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.494 179.667 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 300' ' ' ASP . . . . . 0.624 ' H ' ' CB ' ' A' ' 303' ' ' SER . 49.1 p-10 -166.84 -174.97 2.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.52 -179.799 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 78.6 t80 -47.73 -44.46 27.96 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.241 -179.684 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -65.84 -41.27 91.94 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.029 0.442 . . . . 0.0 110.782 179.017 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 303' ' ' SER . . . . . 0.624 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 54.3 p -55.36 -36.15 66.01 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.1 -179.265 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 304' ' ' ALA . . . . . 0.568 ' HB2' ' SD ' ' A' ' 215' ' ' MET . . . -57.58 -51.4 69.63 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.436 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 90.6 mtp -56.56 -44.02 80.53 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -179.936 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -66.29 -42.88 87.73 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.903 0.382 . . . . 0.0 110.184 178.86 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 307' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 303' ' ' SER . 55.9 t -63.88 -43.09 97.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.218 179.409 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 42.5 tp -59.87 -42.07 92.92 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.812 -179.618 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -62.31 -39.05 91.75 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.152 179.665 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 310' ' ' ARG . . . . . 0.45 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.8 ttt85 -63.71 -43.89 95.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.266 179.46 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 90.1 mt -63.26 -42.05 99.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.184 179.632 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt -62.85 -33.62 75.63 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.116 179.409 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.73 -23.37 21.82 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.448 -179.888 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 314' ' ' LEU . . . . . 0.488 HD22 ' CE2' ' A' ' 315' ' ' PHE . 6.9 tt -62.31 -43.06 99.69 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.61 -179.936 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 315' ' ' PHE . . . . . 0.488 ' CE2' HD22 ' A' ' 314' ' ' LEU . 90.9 m-85 . . . . . 0 C--O 1.22 -0.484 0 CA-C-O 117.964 -1.017 . . . . 0.0 110.466 179.975 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -99.26 135.82 40.11 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.06 0.457 . . . . 0.0 110.493 -179.995 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.496 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -91.75 178.43 1.75 Allowed Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.637 -179.961 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.496 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.5 Cg_exo -61.57 146.87 96.56 Favored 'Trans proline' 0 C--N 1.3 -2.022 0 C-N-CA 122.808 2.339 . . . . 0.0 112.162 179.635 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.464 ' HE ' HD12 ' A' ' 39' ' ' LEU . 35.4 ptt180 -136.3 141.82 43.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.647 179.71 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -79.3 116.96 19.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.476 179.923 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.454 ' O ' HG23 ' A' ' 30' ' ' ILE . 9.4 tp -111.61 130.24 65.52 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.486 -179.985 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.2 t -71.09 142.45 50.82 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.61 179.842 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.481 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.4 t0 -139.32 179.93 6.25 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.57 -179.937 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.481 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 78.4 p -74.01 -37.12 64.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.785 179.716 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -46.78 -94.66 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.378 -179.459 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -166.17 -26.88 0.02 OUTLIER Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 179.893 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 65.0 m -168.66 105.91 0.44 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.861 0.362 . . . . 0.0 110.618 -179.921 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.651 ' CD2' HD13 ' A' ' 140' ' ' LEU . 69.5 t60 -128.75 147.22 50.76 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.988 0.423 . . . . 0.0 110.324 179.925 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.62 HG22 ' N ' ' A' ' 39' ' ' LEU . 99.9 m -130.45 165.53 22.43 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.569 -179.835 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.62 ' N ' HG22 ' A' ' 38' ' ' THR . 80.6 mt -120.64 126.98 51.62 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.485 179.731 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -65.44 -44.35 87.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.686 -179.971 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 41.0 p -165.96 154.82 11.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.405 179.669 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.486 ' CD ' ' H ' ' A' ' 42' ' ' GLN . 14.0 mp0 -45.43 101.55 0.26 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.643 179.471 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -57.6 129.64 34.76 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 122.402 2.068 . . . . 0.0 112.235 -179.643 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -82.51 -25.14 33.73 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.5 179.531 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.537 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.7 mtm-85 -120.89 134.03 55.29 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 121.185 0.517 . . . . 0.0 110.27 179.96 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.1 mt -129.82 133.21 65.13 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.273 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.966 -179.721 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 44.3 t -124.84 131.08 73.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.839 0.352 . . . . 0.0 110.101 179.313 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.63 ' OG ' HD12 ' A' ' 117' ' ' LEU . 4.9 m -154.74 166.35 33.71 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.515 179.845 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 65.3 p -124.37 8.53 8.44 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.434 179.923 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.58 125.21 32.93 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.616 -179.458 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.503 HG11 ' H ' ' A' ' 299' ' ' LEU . 94.5 t -65.5 -44.41 94.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.545 -179.938 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.6 m -62.61 -44.31 96.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.639 -179.851 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 48.4 tp -62.5 -41.48 98.85 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.57 -179.476 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.455 ' O ' HD13 ' A' ' 58' ' ' LEU . 74.6 m -57.63 -44.78 85.81 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.466 -179.438 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.36 -62.09 5.43 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 179.571 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.6 t -48.23 -35.71 12.48 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 179.951 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.7 mt -61.7 -44.46 96.89 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.11 179.331 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.455 HD13 ' O ' ' A' ' 54' ' ' THR . 9.1 mp -65.07 -41.72 94.81 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.201 178.049 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.4 ' HB1' ' NE ' ' A' ' 169' ' ' ARG . . . -63.6 -41.36 98.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.933 -179.243 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.431 ' O ' HG23 ' A' ' 60' ' ' ILE . 8.0 tp -87.7 16.81 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.755 -179.63 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 56.45 83.84 0.09 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.73 -179.862 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.89 58.04 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.005 -179.752 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -50.59 152.71 8.78 Favored 'Trans proline' 0 C--N 1.296 -2.207 0 C-N-CA 122.859 2.373 . . . . 0.0 112.38 -178.204 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.431 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -108.96 145.9 15.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.348 -179.727 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 97.0 mt -63.8 -45.18 97.89 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.357 -179.844 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.496 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -129.87 134.48 47.54 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.602 -179.745 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.499 ' O ' ' N ' ' A' ' 98' ' ' LEU . 72.7 m -134.75 158.77 43.29 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.833 -179.637 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.73 139.36 16.36 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.668 -0.973 . . . . 0.0 110.668 179.798 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.485 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.79 -162.92 0.08 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.903 0.382 . . . . 0.0 110.515 179.966 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.495 ' O ' ' C ' ' A' ' 71' ' ' THR . 5.7 t -133.93 135.38 43.52 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.245 -179.973 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.495 ' C ' ' O ' ' A' ' 70' ' ' THR . 1.1 t 29.55 68.19 0.67 Allowed Pre-proline 0 N--CA 1.466 0.328 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.64 -179.626 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -60.98 145.18 99.46 Favored 'Trans proline' 0 C--N 1.3 -1.978 0 C-N-CA 122.619 2.213 . . . . 0.0 112.068 -178.392 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.532 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 45.1 p-10 -159.37 -32.29 0.06 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.662 179.698 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.542 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 99.1 m-20 -64.07 -39.4 94.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.505 179.988 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -60.51 -48.32 82.29 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.642 -179.278 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.423 ' O ' ' O ' ' A' ' 77' ' ' ALA . 94.4 t -60.1 -24.85 31.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 179.704 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.542 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -45.77 172.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.583 179.865 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.571 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.8 p30 -61.98 177.76 0.42 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.614 -179.774 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.562 ' C ' ' H ' ' A' ' 81' ' ' GLY . 36.0 p30 -45.69 85.86 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.962 179.963 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.571 ' N ' ' O ' ' A' ' 78' ' ' ASP . 42.8 tp60 -67.33 13.62 0.06 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.146 -179.837 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.562 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 117.94 -22.04 10.03 Favored Glycine 0 CA--C 1.519 0.338 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.93 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -108.19 116.68 32.41 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.951 0.405 . . . . 0.0 110.56 179.843 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 75.4 mt -98.98 0.88 44.85 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.513 -179.767 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -92.07 6.74 45.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.985 0.421 . . . . 0.0 110.484 -179.797 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.785 ' O ' HG22 ' A' ' 89' ' ' VAL . 27.2 mt-30 -100.06 -26.28 14.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.781 179.968 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.5 t-105 -64.28 -40.99 97.1 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.02 -179.688 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.551 ' O ' ' N ' ' A' ' 91' ' ' LYS . 68.5 m -77.6 -53.55 7.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.155 -179.516 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -47.9 -51.27 23.89 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.001 -179.347 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.785 HG22 ' O ' ' A' ' 85' ' ' GLN . 15.1 m -69.01 -41.08 81.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 120.905 0.383 . . . . 0.0 111.069 179.88 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.508 ' N ' HG23 ' A' ' 89' ' ' VAL . . . -71.47 -23.57 61.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.768 -179.815 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.551 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.0 tttm -61.07 -46.06 92.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.501 -179.439 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.443 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.6 mm-40 -90.13 -94.87 0.11 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.213 179.971 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.626 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.8 mtt180 -143.19 60.13 1.41 Allowed 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 179.758 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.463 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.6 pttp 33.31 26.88 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.203 -179.082 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.626 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.4 tt -48.61 123.1 6.26 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.931 -178.193 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.45 ' O ' HD23 ' A' ' 95' ' ' LEU . 98.9 mm-40 -83.5 -169.9 2.78 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.145 179.934 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.614 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 81.7 mtp180 -73.71 137.51 44.09 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.328 -179.865 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.499 ' N ' ' O ' ' A' ' 67' ' ' SER . 89.0 mt -85.9 -166.11 1.44 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.709 -179.621 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.532 ' O ' ' CD2' ' A' ' 99' ' ' TYR . 46.7 p90 -168.01 119.48 0.84 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.311 179.962 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.513 ' C ' ' O ' ' A' ' 99' ' ' TYR . 43.1 mm -29.14 121.04 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.922 -179.701 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 113.95 28.11 3.25 Favored Glycine 0 CA--C 1.521 0.431 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 -179.597 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.588 ' CD ' ' H ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -144.0 46.0 0.61 Allowed Pre-proline 0 C--N 1.323 -0.55 0 CA-C-O 120.953 0.406 . . . . 0.0 110.503 179.891 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.583 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 30.2 Cg_endo -62.28 143.83 94.54 Favored 'Trans proline' 0 C--N 1.297 -2.138 0 C-N-CA 122.686 2.257 . . . . 0.0 111.957 -179.966 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.476 ' O ' HG23 ' A' ' 108' ' ' VAL . 23.2 t -173.33 120.73 0.34 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.417 179.754 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.58 -40.98 63.48 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.043 179.743 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -65.9 -40.31 91.39 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.864 -179.374 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.96 -39.86 95.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.687 -179.832 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 104' ' ' SER . 70.9 t -67.54 -43.76 86.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.721 179.683 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.43 -39.1 92.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.568 -179.287 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.443 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.51 -23.55 62.9 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.532 179.834 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.549 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.4 mm-40 -90.94 4.75 51.11 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.741 -179.564 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.549 ' C ' ' O ' ' A' ' 111' ' ' GLN . 9.9 tpt 23.17 64.32 0.37 Allowed Pre-proline 0 N--CA 1.464 0.271 0 CA-C-O 120.914 0.388 . . . . 0.0 111.001 -179.806 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.444 ' HG2' HD11 ' A' ' 116' ' ' ILE . 68.1 Cg_endo -78.9 168.92 20.18 Favored 'Trans proline' 0 C--N 1.304 -1.801 0 C-N-CA 122.984 2.456 . . . . 0.0 112.081 -178.415 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.483 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 98.9 m-20 -113.24 -44.01 3.3 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.103 179.452 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.2 tp -120.47 119.81 34.07 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.324 -0.398 . . . . 0.0 109.935 179.48 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.455 HD13 HD22 ' A' ' 133' ' ' LEU . 96.3 mt -117.09 131.1 70.79 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.319 0 CA-C-O 120.9 0.381 . . . . 0.0 110.892 -179.788 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.63 HD12 ' OG ' ' A' ' 48' ' ' SER . 29.7 mt -106.0 132.46 52.06 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 121.027 0.441 . . . . 0.0 110.321 -179.489 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.434 HD12 HG23 ' A' ' 139' ' ' THR . 98.1 mt -118.17 136.6 54.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.73 -179.709 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 86.5 p -71.6 152.76 42.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.548 -179.95 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.27 -50.21 74.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.659 -179.857 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -149.24 153.59 37.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.552 179.762 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 169.3 -170.17 42.41 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 179.885 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -63.04 -35.46 92.12 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 179.992 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.447 ' OD1' ' O ' ' A' ' 124' ' ' ASP . 44.1 p-10 -87.18 119.92 27.91 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.808 0.337 . . . . 0.0 110.639 179.885 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.441 ' O ' HD12 ' A' ' 129' ' ' LEU . 39.2 t -63.56 144.06 57.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.467 -179.928 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.52 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.38 -43.28 8.85 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.872 -179.935 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.8 tp -62.77 -42.35 99.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.654 -179.816 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.73 -10.91 56.64 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.512 -179.395 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.441 HD12 ' O ' ' A' ' 125' ' ' SER . 84.1 mt -116.03 -23.9 8.31 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.7 -179.902 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 130' ' ' TYR . . . . . 0.52 ' N ' ' O ' ' A' ' 126' ' ' ALA . 77.8 t80 -51.53 -49.87 61.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.521 -179.001 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.5 p-10 -65.79 -42.26 90.96 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.852 0.358 . . . . 0.0 111.15 179.628 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.523 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 87.9 mt-30 -67.52 -36.69 81.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.792 -179.97 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.455 HD22 HD13 ' A' ' 116' ' ' ILE . 94.1 mt -80.58 -42.05 22.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.871 -179.507 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.2 t -57.23 -44.76 84.07 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.259 -179.21 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.2 m -62.3 -45.8 91.63 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.806 0.336 . . . . 0.0 110.642 179.33 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 92.9 mt -62.31 -43.9 98.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.401 -179.855 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.584 ' HB1' ' HD2' ' A' ' 138' ' ' PRO . . . -169.95 162.93 6.66 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.529 179.844 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.584 ' HD2' ' HB1' ' A' ' 137' ' ' ALA . 78.4 Cg_exo -42.71 110.99 0.18 Allowed 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.536 2.157 . . . . 0.0 112.196 179.448 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.474 HG21 ' CD1' ' A' ' 130' ' ' TYR . 16.8 m -85.57 127.76 34.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.555 179.971 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.651 HD13 ' CD2' ' A' ' 37' ' ' HIS . 34.3 tp -119.48 137.94 53.46 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.088 -179.897 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.429 ' O ' ' OD2' ' A' ' 32' ' ' ASP . 80.2 mt -104.22 120.01 53.88 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 CA-C-O 121.122 0.487 . . . . 0.0 111.217 -179.348 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.494 HD12 HD22 ' A' ' 117' ' ' LEU . 97.7 mt -135.92 132.58 50.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.595 179.549 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.534 ' ND2' ' OD2' ' A' ' 241' ' ' ASP . 2.3 t-20 -65.75 148.44 51.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.902 0.382 . . . . 0.0 110.422 179.268 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.459 ' O ' ' OD2' ' A' ' 241' ' ' ASP . 42.6 t80 -81.86 123.18 28.6 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.955 -179.456 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 54.79 69.69 0.7 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.881 179.643 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 49.2 p-10 -124.45 0.24 8.24 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.679 179.849 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -151.42 116.4 5.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.695 -179.442 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 84.0 p -63.86 168.55 4.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.557 -179.941 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.416 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.6 p-90 -51.8 -16.33 0.67 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.553 -179.846 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 150' ' ' GLN . . . . . 0.431 ' O ' HG23 ' A' ' 154' ' ' THR . 68.2 tp60 -70.1 -76.68 0.1 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.491 -179.744 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.447 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.1 t -62.41 -38.49 89.85 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.321 179.6 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 53.4 tp -59.82 -45.75 91.38 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.377 -178.601 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.416 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 46.3 tp -62.83 -41.72 99.44 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.472 179.012 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.447 ' OG1' ' O ' ' A' ' 151' ' ' SER . 62.2 p -64.01 -34.97 79.2 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.266 -179.592 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 155' ' ' GLN . . . . . 0.448 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.7 mm-40 -64.02 -42.28 97.18 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.239 179.32 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 92.1 mt -65.51 -38.85 90.9 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.041 0.448 . . . . 0.0 110.232 179.093 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.581 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.22 -32.13 79.52 Favored Glycine 0 CA--C 1.52 0.389 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 -179.374 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.448 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.3 mt-10 -36.02 -26.19 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.804 0.335 . . . . 0.0 110.728 179.953 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.581 ' N ' ' O ' ' A' ' 157' ' ' GLY . 94.4 mt -58.11 150.16 4.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.3 179.375 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 77.1 p -69.21 137.29 53.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.01 -179.508 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 69.96 22.94 77.26 Favored Glycine 0 CA--C 1.517 0.183 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 179.452 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 59.8 m80 -124.11 -13.97 7.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.745 0.307 . . . . 0.0 110.563 179.92 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -67.19 -59.42 3.45 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.702 -179.732 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -51.76 -49.37 62.76 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.215 -179.667 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -60.45 -41.32 93.84 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.735 0.302 . . . . 0.0 110.346 179.509 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.42 -47.34 86.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.609 179.801 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.73 -40.16 75.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.252 -179.915 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -61.49 -50.26 73.45 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.575 179.573 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.4 ' NE ' ' HB1' ' A' ' 59' ' ' ALA . 60.0 ttt85 -65.52 -43.58 89.58 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.492 179.596 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 94.8 mt -64.66 -43.37 96.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.427 179.768 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.29 -51.36 69.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.566 -179.243 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.71 -43.78 95.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.53 179.727 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 173' ' ' PHE . . . . . 0.654 ' CE2' HD11 ' A' ' 177' ' ' LEU . 55.1 t80 -62.87 -44.47 96.03 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.041 0.448 . . . . 0.0 110.454 179.45 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -63.48 -40.0 95.95 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.592 -179.36 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -62.9 -42.83 99.92 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.628 179.333 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -60.76 -44.7 96.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.186 179.93 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.654 HD11 ' CE2' ' A' ' 173' ' ' PHE . 84.9 mt -64.53 -41.2 96.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.02 0.438 . . . . 0.0 110.749 178.887 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.05 -62.09 1.85 Allowed 'General case' 0 C--O 1.236 0.376 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.478 -179.382 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.58 -46.66 86.48 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.609 179.784 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.28 -41.5 65.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.236 -179.984 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -64.01 -33.75 76.45 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.96 0.41 . . . . 0.0 110.424 179.278 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 182' ' ' GLU . . . . . 0.422 ' O ' ' HG2' ' A' ' 182' ' ' GLU . 69.3 tt0 -90.68 8.86 32.29 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.338 0.589 . . . . 0.0 110.483 -179.019 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -104.78 -32.19 8.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.895 0.379 . . . . 0.0 111.196 179.615 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.6 pt -128.21 147.83 32.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.845 -179.847 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -140.11 131.16 26.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.393 179.364 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 186' ' ' LEU . . . . . 0.597 HD22 ' N ' ' A' ' 186' ' ' LEU . 3.5 mm? -85.45 133.92 41.3 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.882 -179.996 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -43.87 157.93 0.13 Allowed 'Trans proline' 0 C--N 1.307 -1.629 0 C-N-CA 122.743 2.295 . . . . 0.0 112.125 179.316 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 188' ' ' PRO . . . . . 0.53 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.6 Cg_endo -62.96 114.51 2.47 Favored 'Trans proline' 0 C--N 1.304 -1.807 0 C-N-CA 122.796 2.331 . . . . 0.0 111.717 179.839 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 189' ' ' GLN . . . . . 0.53 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.7 mt-30 155.13 148.26 0.0 OUTLIER Pre-proline 0 C--N 1.331 -0.207 0 O-C-N 123.643 0.589 . . . . 0.0 110.74 -179.743 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -73.47 144.55 36.45 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.695 2.263 . . . . 0.0 111.928 177.97 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.495 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.1 p -124.84 158.89 32.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.241 0.543 . . . . 0.0 110.194 179.962 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 192' ' ' THR . . . . . 0.495 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 37.6 p -143.46 165.22 28.14 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.086 -179.585 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 193' ' ' ALA . . . . . 0.444 ' HA ' ' H ' ' A' ' 260' ' ' PHE . . . -135.33 128.65 32.12 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.106 0.479 . . . . 0.0 110.285 179.534 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.511 HD11 HD23 ' A' ' 259' ' ' LEU . 47.5 pt -146.5 148.87 16.53 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.297 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.052 179.933 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 195' ' ' VAL . . . . . 0.734 HG13 ' CD1' ' A' ' 262' ' ' PHE . 74.1 t -117.6 123.06 71.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.247 0.546 . . . . 0.0 109.809 179.073 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -134.3 106.97 7.38 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.27 179.738 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 93.7 m -130.77 130.63 43.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.84 179.782 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -82.67 -37.17 25.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.313 179.675 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.37 -67.35 0.24 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.417 -179.98 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.01 -10.0 59.16 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.338 179.508 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 59.9 t-80 60.67 58.32 2.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.719 -179.81 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 41.6 p -166.99 153.29 8.22 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.537 179.643 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.31 144.07 24.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.473 179.395 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -135.34 138.28 43.23 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.642 -179.969 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 19.6 mt -106.12 125.23 50.74 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 121.027 0.442 . . . . 0.0 109.923 -179.737 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 206' ' ' TRP . . . . . 0.574 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 75.0 m95 -81.81 166.87 19.62 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.667 -179.72 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 207' ' ' THR . . . . . 0.464 HG22 ' C ' ' A' ' 206' ' ' TRP . 0.1 OUTLIER -156.61 171.89 6.81 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.607 -179.15 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -53.98 -37.3 86.06 Favored 'Trans proline' 0 C--N 1.303 -1.856 0 C-N-CA 122.654 2.236 . . . . 0.0 112.172 179.225 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -70.45 -34.81 72.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.76 -179.746 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 22.0 m -61.44 150.51 35.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.596 -179.373 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.17 -36.51 80.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.438 -179.768 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 212' ' ' GLN . . . . . 0.574 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 53.7 tt0 -64.5 -40.6 95.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.482 -179.987 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.67 -43.65 91.47 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 179.821 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -63.14 -44.26 96.05 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.719 0.295 . . . . 0.0 110.283 179.76 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 215' ' ' MET . . . . . 0.577 ' SD ' ' HB2' ' A' ' 304' ' ' ALA . 65.5 ttp -59.56 -48.21 82.53 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.221 -179.886 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 85.8 mt -60.25 -40.92 91.99 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.405 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 217' ' ' GLU . . . . . 0.456 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.0 tp10 -58.06 -38.08 75.64 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.739 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -65.3 -38.17 89.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.784 0.326 . . . . 0.0 110.568 179.677 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 219' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 219' ' ' LEU . 94.7 mt -64.4 -42.79 95.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.441 -179.595 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.54 45.84 0.08 OUTLIER Glycine 0 C--N 1.334 0.47 0 N-CA-C 111.036 -0.825 . . . . 0.0 111.036 179.958 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 221' ' ' PHE . . . . . 0.456 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 26.9 m-85 -129.0 156.02 44.46 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.027 0.441 . . . . 0.0 110.487 -179.802 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.481 ' O ' HG13 ' A' ' 191' ' ' VAL . 8.0 p -108.01 122.83 47.66 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.203 0.525 . . . . 0.0 110.208 -179.938 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.479 HD22 ' C ' ' A' ' 222' ' ' THR . 4.3 mm? -101.6 133.41 46.33 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.068 -179.94 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -97.22 159.73 14.74 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.458 179.834 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.01 115.1 29.7 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.927 0.394 . . . . 0.0 110.41 179.84 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.494 HD12 ' N ' ' A' ' 226' ' ' LEU . 9.1 mp -53.34 156.75 3.83 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.648 179.93 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -60.09 145.2 98.99 Favored 'Trans proline' 0 C--N 1.302 -1.903 0 C-N-CA 122.667 2.245 . . . . 0.0 112.139 179.283 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.48 -2.78 58.86 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.559 179.981 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.49 -40.64 5.65 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 111.004 -0.838 . . . . 0.0 111.004 -179.835 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 230' ' ' LEU . . . . . 0.544 ' O ' ' N ' ' A' ' 233' ' ' SER . 84.9 mt -79.53 -16.9 55.16 Favored 'General case' 0 C--O 1.223 -0.337 0 CA-C-O 120.997 0.427 . . . . 0.0 110.368 -179.772 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 231' ' ' ASN . . . . . 0.405 ' C ' ' O ' ' A' ' 230' ' ' LEU . 54.7 t-20 -40.11 -49.12 2.58 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.678 -179.603 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -88.27 15.58 7.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.783 0.325 . . . . 0.0 111.217 179.963 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 233' ' ' SER . . . . . 0.544 ' N ' ' O ' ' A' ' 230' ' ' LEU . 78.1 p -60.62 -35.81 77.07 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.664 -179.858 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 234' ' ' GLN . . . . . 0.524 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.6 tt0 -118.21 -69.54 0.84 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.942 179.556 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.1 m -70.37 102.97 2.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.651 -179.765 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -94.31 58.04 2.4 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.442 179.949 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -145.04 -122.52 1.55 Allowed Glycine 0 CA--C 1.52 0.379 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 -179.992 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -134.34 111.77 10.46 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 121.053 0.454 . . . . 0.0 110.452 -179.981 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 239' ' ' ARG . . . . . 0.515 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.0 mtt180 -148.19 57.5 1.08 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.744 -179.97 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -69.75 -31.59 69.64 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.513 179.574 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 241' ' ' ASP . . . . . 0.534 ' OD2' ' ND2' ' A' ' 143' ' ' ASN . 65.1 t0 -56.9 -46.95 81.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.339 -179.186 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 242' ' ' ILE . . . . . 0.437 ' O ' ' O ' ' A' ' 239' ' ' ARG . 17.6 tt -140.54 157.41 24.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.865 0.364 . . . . 0.0 110.558 179.713 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.445 HG22 HD13 ' A' ' 245' ' ' LEU . 96.0 mt -106.34 106.33 20.4 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.173 0 CA-C-O 121.096 0.474 . . . . 0.0 110.448 179.89 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 244' ' ' GLN . . . . . 0.604 ' O ' HD12 ' A' ' 245' ' ' LEU . 88.3 mt-30 -110.68 110.62 21.37 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.358 179.733 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.604 HD12 ' O ' ' A' ' 244' ' ' GLN . 9.6 mp -122.02 -168.03 1.64 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.583 179.784 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 246' ' ' GLY . . . . . 0.524 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.14 -16.77 0.05 OUTLIER Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 179.895 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 247' ' ' GLY . . . . . 0.667 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -60.42 157.25 29.21 Favored Glycine 0 CA--C 1.522 0.516 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 -179.823 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -63.94 21.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.921 0.391 . . . . 0.0 110.571 179.942 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 249' ' ' ASN . . . . . 0.667 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.7 m-20 -96.8 -5.82 37.54 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.576 179.99 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 92.0 mt -80.24 -21.36 42.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.615 179.522 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.53 -51.41 69.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.773 -179.557 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.99 -5.29 58.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.459 179.662 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -80.87 -74.44 1.13 Allowed Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 -179.946 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 80.9 mt -69.87 125.69 27.5 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.058 0.456 . . . . 0.0 110.303 -179.859 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -59.33 -39.67 83.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.297 -179.641 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 83.5 51.76 3.98 Favored Glycine 0 CA--C 1.522 0.473 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 179.9 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -95.1 -16.11 22.88 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.712 0.292 . . . . 0.0 110.588 -179.848 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 258' ' ' SER . . . . . 0.494 ' OG ' HG23 ' A' ' 191' ' ' VAL . 3.4 t 174.92 89.51 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.08 0.466 . . . . 0.0 110.161 179.973 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.863 HD12 ' N ' ' A' ' 259' ' ' LEU . 0.9 OUTLIER -94.46 124.18 38.33 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.258 0.551 . . . . 0.0 111.058 -178.999 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 260' ' ' PHE . . . . . 0.444 ' H ' ' HA ' ' A' ' 193' ' ' ALA . 16.0 m-30 -93.62 146.91 23.47 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.391 179.218 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 85.5 mt -122.39 149.75 43.38 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.583 -179.933 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.734 ' CD1' HG13 ' A' ' 195' ' ' VAL . 2.6 p90 -77.99 -139.14 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.46 -179.759 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 263' ' ' ALA . . . . . 0.665 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -50.8 77.86 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.987 -179.947 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 264' ' ' GLY . . . . . 0.641 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.97 104.66 0.19 Allowed Glycine 0 CA--C 1.526 0.768 0 N-CA-C 110.721 -0.951 . . . . 0.0 110.721 -179.964 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 265' ' ' ASP . . . . . 0.601 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.7 m-20 -80.39 -177.56 6.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.722 0.296 . . . . 0.0 110.84 -179.424 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -40.49 -17.73 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.511 179.823 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 267' ' ' LYS . . . . . 0.601 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.42 -51.51 43.09 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.679 179.582 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -63.77 -46.59 84.58 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.23 179.357 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 269' ' ' ALA . . . . . 0.581 ' HB1' ' OH ' ' A' ' 273' ' ' TYR . . . -61.48 -35.15 76.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.927 179.511 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -63.07 -34.57 77.87 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.155 179.717 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.25 -43.21 13.96 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.192 -179.51 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 272' ' ' ILE . . . . . 0.588 ' C ' ' H ' ' A' ' 274' ' ' ALA . 5.0 tt -51.49 -33.92 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.839 -178.783 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 273' ' ' TYR . . . . . 0.581 ' OH ' ' HB1' ' A' ' 269' ' ' ALA . 17.0 m-85 -54.3 -1.91 0.03 OUTLIER 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.71 -179.598 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 274' ' ' ALA . . . . . 0.588 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.63 -39.45 70.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.885 179.574 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 275' ' ' ASN . . . . . 0.585 ' O ' ' N ' ' A' ' 279' ' ' ALA . 3.8 p30 -39.33 98.04 0.16 Allowed Pre-proline 0 C--O 1.226 -0.153 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.53 -179.636 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -54.19 -43.04 62.07 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 C-N-CA 122.383 2.055 . . . . 0.0 112.595 -178.753 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 89.1 mt -64.49 -42.9 95.58 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.086 -179.621 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 91.1 mt -95.87 -1.11 50.07 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.889 -179.434 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 279' ' ' ALA . . . . . 0.585 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.4 -34.92 77.68 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.666 -179.791 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.3 20.16 0.12 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.979 -179.207 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 281' ' ' LEU . . . . . 0.494 HD23 ' HA ' ' A' ' 281' ' ' LEU . 13.6 mt -74.91 119.83 78.73 Favored Pre-proline 0 N--CA 1.452 -0.347 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.504 179.9 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -50.57 -39.74 55.43 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.598 2.199 . . . . 0.0 111.949 178.989 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.9 -50.45 63.9 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.122 179.876 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 73.4 t -61.55 -43.91 97.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 179.477 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -57.8 -41.17 81.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.274 -179.906 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -90.73 -0.1 57.59 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.184 179.622 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt 59.92 43.3 15.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.029 0.442 . . . . 0.0 110.821 179.658 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -94.93 41.3 1.09 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.382 179.809 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 54.2 t -119.23 135.82 58.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.022 0.439 . . . . 0.0 110.231 -179.737 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -133.63 163.85 28.5 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.044 0.45 . . . . 0.0 110.658 -179.577 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.81 155.88 31.72 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.94 0.4 . . . . 0.0 110.78 -179.803 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 81.4 mt -94.7 -1.59 52.77 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.25 -179.735 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 120.86 165.21 12.65 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.651 -0.98 . . . . 0.0 110.651 -179.763 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 7.0 m -86.59 -61.73 1.67 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.806 0.336 . . . . 0.0 111.092 -179.828 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 295' ' ' GLU . . . . . 0.455 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.6 mm-40 -69.04 -4.84 18.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.682 -179.686 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 26.3 p -76.48 32.22 0.13 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.641 -179.871 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 297' ' ' PHE . . . . . 0.495 ' CD1' HG22 ' A' ' 70' ' ' THR . 59.4 t80 -60.59 -46.43 90.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.713 179.944 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 298' ' ' ARG . . . . . 0.614 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.2 mtt85 -80.23 137.37 36.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.582 -179.65 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.503 ' H ' HG11 ' A' ' 51' ' ' VAL . 5.7 tp -114.38 115.8 27.91 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.453 179.868 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 300' ' ' ASP . . . . . 0.631 ' H ' ' CB ' ' A' ' 303' ' ' SER . 48.7 p-10 -165.72 -176.69 3.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.533 -179.977 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 79.0 t80 -46.59 -42.76 16.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.293 -179.791 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -67.4 -40.58 85.64 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.026 0.441 . . . . 0.0 110.756 179.196 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 303' ' ' SER . . . . . 0.631 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 60.2 p -55.62 -36.38 66.92 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.074 -179.276 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 304' ' ' ALA . . . . . 0.577 ' HB2' ' SD ' ' A' ' 215' ' ' MET . . . -57.68 -51.61 68.83 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 179.342 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 91.2 mtp -56.06 -44.14 78.59 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 179.838 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -66.11 -43.13 88.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.917 0.389 . . . . 0.0 110.166 178.837 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 307' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 303' ' ' SER . 55.9 t -63.97 -42.88 97.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.288 179.358 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 44.6 tp -59.89 -42.05 92.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.934 -179.64 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -62.33 -39.31 92.66 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.155 179.59 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 310' ' ' ARG . . . . . 0.468 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.7 ttt85 -63.6 -43.95 95.42 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.29 179.412 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 89.5 mt -63.18 -42.2 99.34 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.31 179.603 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -63.21 -33.57 75.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.079 179.456 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.85 -23.44 21.66 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.488 -179.875 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 314' ' ' LEU . . . . . 0.483 HD22 ' CE2' ' A' ' 315' ' ' PHE . 6.8 tt -62.3 -43.16 99.47 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.58 -179.95 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 315' ' ' PHE . . . . . 0.483 ' CE2' HD22 ' A' ' 314' ' ' LEU . 90.5 m-85 . . . . . 0 C--O 1.22 -0.478 0 CA-C-O 118.043 -0.979 . . . . 0.0 110.482 179.981 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -99.63 135.18 41.43 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.063 0.459 . . . . 0.0 110.452 -179.885 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.497 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -92.15 178.55 1.66 Allowed Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.509 -179.829 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.497 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 27.3 Cg_exo -61.46 147.11 96.3 Favored 'Trans proline' 0 C--N 1.3 -2.008 0 C-N-CA 122.709 2.273 . . . . 0.0 112.173 179.617 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.482 ' HE ' HD12 ' A' ' 39' ' ' LEU . 35.0 ptt180 -135.98 142.35 44.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.714 179.779 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -79.9 116.86 20.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.401 179.922 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.457 ' O ' HG23 ' A' ' 30' ' ' ILE . 9.4 tp -111.64 130.12 65.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.408 179.996 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.1 t -70.85 141.95 51.25 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.621 179.763 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.476 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.0 t0 -138.85 -179.97 6.14 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.512 -179.936 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.476 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 78.1 p -73.84 -37.38 64.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.761 179.834 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.8 ttt85 -46.89 -94.72 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.366 -179.338 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.414 ' O ' ' OG1' ' A' ' 36' ' ' THR . . . -166.04 -26.99 0.02 OUTLIER Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.886 -0.885 . . . . 0.0 110.886 179.996 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.414 ' OG1' ' O ' ' A' ' 35' ' ' GLY . 75.2 m -168.29 105.87 0.47 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.924 0.392 . . . . 0.0 110.678 -179.894 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.649 ' CD2' HD13 ' A' ' 140' ' ' LEU . 68.8 t60 -129.07 146.51 51.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.071 0.463 . . . . 0.0 110.317 179.997 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.622 HG22 ' N ' ' A' ' 39' ' ' LEU . 99.8 m -129.99 165.59 21.84 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.57 -179.797 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.622 ' N ' HG22 ' A' ' 38' ' ' THR . 81.0 mt -120.38 127.25 52.13 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.483 179.727 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -65.44 -44.6 86.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.689 -179.954 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 40.7 p -165.73 154.97 12.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.404 179.599 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.5 ' CD ' ' H ' ' A' ' 42' ' ' GLN . 14.5 mp0 -45.31 101.58 0.26 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.608 179.427 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -57.7 130.32 38.05 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 C-N-CA 122.334 2.023 . . . . 0.0 112.196 -179.772 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -83.01 -24.62 32.77 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.531 179.593 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.535 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.7 mtm-85 -121.22 134.67 55.2 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-O 121.156 0.503 . . . . 0.0 110.246 -179.926 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.0 mt -130.49 133.35 63.82 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.297 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.99 -179.797 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 46.5 t -124.76 131.05 73.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 179.471 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.621 ' OG ' HD12 ' A' ' 117' ' ' LEU . 4.6 m -154.49 166.2 34.04 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.048 0.452 . . . . 0.0 110.505 179.679 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 60.9 p -124.51 8.73 8.36 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.519 179.936 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.8 125.96 33.65 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.617 -179.508 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.465 HG11 ' H ' ' A' ' 299' ' ' LEU . 84.7 t -65.68 -44.54 93.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.51 -179.99 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.0 m -62.71 -44.26 96.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.66 -179.818 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 52.1 tp -62.27 -41.65 98.66 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.6 -179.415 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.472 ' O ' HD13 ' A' ' 58' ' ' LEU . 71.9 m -57.92 -44.51 86.92 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.286 -179.326 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.41 -61.97 5.52 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 179.578 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.7 t -48.56 -35.6 13.73 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 -179.812 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 20.0 mt -61.68 -44.58 96.68 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.708 -0.397 . . . . 0.0 111.199 179.19 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.472 HD13 ' O ' ' A' ' 54' ' ' THR . 9.5 mp -64.58 -42.09 95.86 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.334 177.911 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.63 -41.23 98.28 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.044 -179.222 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.434 ' O ' HG23 ' A' ' 60' ' ' ILE . 7.9 tp -87.81 16.58 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.726 -179.618 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 56.52 83.61 0.1 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.726 -179.838 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.75 56.72 0.07 OUTLIER Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.01 -179.865 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -49.43 153.46 4.96 Favored 'Trans proline' 0 C--N 1.296 -2.228 0 C-N-CA 122.818 2.345 . . . . 0.0 112.565 -178.52 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.432 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.4 OUTLIER -109.13 146.32 14.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.4 -179.764 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 97.0 mt -63.99 -44.78 97.94 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.335 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.436 -179.986 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.504 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -130.16 134.72 47.51 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 120.851 0.358 . . . . 0.0 110.591 -179.762 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.493 ' O ' ' N ' ' A' ' 98' ' ' LEU . 72.6 m -134.79 158.86 43.1 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.912 -179.719 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.9 139.49 16.33 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 179.877 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.492 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.87 -162.46 0.08 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.98 0.419 . . . . 0.0 110.498 -179.996 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.507 HG22 ' CD2' ' A' ' 297' ' ' PHE . 5.9 t -133.86 135.99 44.07 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.179 -179.997 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.488 ' C ' ' O ' ' A' ' 70' ' ' THR . 1.0 OUTLIER 29.65 68.12 0.68 Allowed Pre-proline 0 N--CA 1.466 0.335 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.719 -179.665 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -60.69 144.92 99.61 Favored 'Trans proline' 0 C--N 1.299 -2.045 0 C-N-CA 122.573 2.182 . . . . 0.0 112.242 -178.506 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.525 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 45.2 p-10 -160.37 -32.12 0.06 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.646 179.735 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.531 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 99.1 m-20 -64.07 -39.37 93.92 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.451 -179.987 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -60.7 -47.75 84.88 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.718 -179.165 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.424 ' O ' ' O ' ' A' ' 77' ' ' ALA . 96.1 t -60.3 -24.5 31.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 179.687 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.531 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -45.71 172.81 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.594 179.835 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.568 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.6 p30 -62.01 177.77 0.42 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.605 -179.654 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.56 ' C ' ' H ' ' A' ' 81' ' ' GLY . 35.8 p30 -46.36 85.98 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.012 0.434 . . . . 0.0 110.921 179.956 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.568 ' N ' ' O ' ' A' ' 78' ' ' ASP . 43.0 tp60 -67.49 13.73 0.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.022 -179.78 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.56 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 117.91 -22.24 9.95 Favored Glycine 0 CA--C 1.518 0.269 0 N-CA-C 110.991 -0.844 . . . . 0.0 110.991 179.987 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -107.95 116.7 32.42 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.007 0.432 . . . . 0.0 110.488 179.858 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 76.5 mt -98.88 0.9 45.11 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.482 -179.783 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -91.93 6.57 45.73 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.996 0.427 . . . . 0.0 110.475 -179.749 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.777 ' O ' HG22 ' A' ' 89' ' ' VAL . 27.2 mt-30 -100.02 -26.52 13.95 Favored 'General case' 0 C--O 1.224 -0.259 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.843 179.883 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.0 t-105 -64.6 -40.86 96.26 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.121 -179.769 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.551 ' O ' ' N ' ' A' ' 91' ' ' LYS . 70.3 m -77.59 -53.55 7.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.355 -179.67 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -48.22 -50.75 28.22 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.076 -179.24 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.777 HG22 ' O ' ' A' ' 85' ' ' GLN . 14.3 m -69.08 -41.03 81.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 120.932 0.396 . . . . 0.0 111.174 179.645 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.505 ' N ' HG23 ' A' ' 89' ' ' VAL . . . -71.72 -22.95 61.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.814 -179.971 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.551 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.0 tttm -61.51 -45.97 91.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.476 -179.493 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.437 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.8 mm-40 -90.43 -94.33 0.12 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.111 -179.867 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.632 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.9 mtt180 -143.37 59.66 1.4 Allowed 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 179.767 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.459 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.6 pttp 33.74 26.08 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 120.833 0.349 . . . . 0.0 110.171 -179.354 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.632 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.3 tt -47.96 123.39 6.11 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.977 -178.076 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.447 ' O ' HD23 ' A' ' 95' ' ' LEU . 99.0 mm-40 -83.45 -170.54 3.1 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.055 -179.841 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.616 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 82.6 mtp180 -72.93 137.74 45.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.182 -179.807 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.493 ' N ' ' O ' ' A' ' 67' ' ' SER . 88.4 mt -86.32 -166.28 1.5 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.702 -179.626 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.531 ' O ' ' CD2' ' A' ' 99' ' ' TYR . 47.1 p90 -167.75 119.8 0.88 Allowed 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.223 179.938 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.508 ' C ' ' O ' ' A' ' 99' ' ' TYR . 43.0 mm -29.6 121.19 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.997 -179.645 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 113.66 28.17 3.3 Favored Glycine 0 CA--C 1.519 0.304 0 N-CA-C 111.179 -0.768 . . . . 0.0 111.179 -179.404 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.585 ' CD ' ' H ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -143.88 45.81 0.6 Allowed Pre-proline 0 C--N 1.324 -0.53 0 CA-C-O 120.947 0.403 . . . . 0.0 110.475 179.827 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.584 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 30.8 Cg_endo -62.06 143.7 95.23 Favored 'Trans proline' 0 C--N 1.296 -2.187 0 C-N-CA 122.639 2.226 . . . . 0.0 112.057 179.926 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.475 ' O ' HG23 ' A' ' 108' ' ' VAL . 22.6 t -173.27 120.77 0.35 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.41 179.649 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.28 -41.09 64.03 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.105 0.479 . . . . 0.0 111.262 179.525 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -65.92 -40.27 91.29 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.908 -179.401 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.89 -39.89 95.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.7 -179.915 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 104' ' ' SER . 69.0 t -67.43 -43.91 87.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.774 179.558 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.18 -39.18 91.83 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.554 -179.236 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.437 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.64 -23.62 63.18 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.425 179.835 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.552 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.5 mm-40 -90.83 4.68 51.09 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.703 -179.547 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.552 ' C ' ' O ' ' A' ' 111' ' ' GLN . 10.3 tpt 23.43 63.85 0.38 Allowed Pre-proline 0 N--CA 1.467 0.378 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.982 179.906 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.443 ' HG2' HD11 ' A' ' 116' ' ' ILE . 71.6 Cg_endo -78.48 168.58 21.18 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 C-N-CA 122.94 2.427 . . . . 0.0 112.28 -178.54 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.523 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 98.9 m-20 -112.7 -44.24 3.35 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.999 0.428 . . . . 0.0 109.97 179.495 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.0 tp -120.58 120.05 34.69 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.665 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.457 HD13 HD22 ' A' ' 133' ' ' LEU . 96.4 mt -117.09 131.26 70.33 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 CA-C-O 120.877 0.37 . . . . 0.0 111.017 -179.942 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.621 HD12 ' OG ' ' A' ' 48' ' ' SER . 30.0 mt -106.27 132.6 52.13 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.133 0.492 . . . . 0.0 110.234 -179.369 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.411 HD12 HG23 ' A' ' 139' ' ' THR . 98.1 mt -117.99 136.58 54.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.718 -179.705 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 86.0 p -72.17 152.93 41.94 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.644 179.979 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.36 -49.98 75.41 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.631 -179.858 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -148.99 153.43 37.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.495 179.811 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 169.53 -170.38 42.63 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 179.837 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.95 -35.31 91.89 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 179.915 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.451 ' OD1' ' O ' ' A' ' 124' ' ' ASP . 44.5 p-10 -87.71 120.0 28.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.822 0.344 . . . . 0.0 110.681 179.922 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.449 ' O ' HD12 ' A' ' 129' ' ' LEU . 39.8 t -63.62 144.22 57.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.437 -179.947 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.518 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.31 -43.34 8.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.931 180.0 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.6 tp -62.71 -42.35 99.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.684 -179.899 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.72 -11.38 58.22 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.478 -179.361 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.449 HD12 ' O ' ' A' ' 125' ' ' SER . 84.9 mt -115.64 -23.6 8.65 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.653 -179.781 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 130' ' ' TYR . . . . . 0.518 ' N ' ' O ' ' A' ' 126' ' ' ALA . 78.0 t80 -51.91 -49.71 62.54 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 120.534 -0.466 . . . . 0.0 110.548 -178.958 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.6 p-10 -65.91 -42.35 90.27 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.867 0.365 . . . . 0.0 111.268 179.512 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.521 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 87.9 mt-30 -67.0 -37.14 83.66 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.811 179.836 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.457 HD22 HD13 ' A' ' 116' ' ' ILE . 93.5 mt -79.98 -41.96 24.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.004 -179.612 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.0 t -57.48 -44.59 85.03 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.172 -178.959 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.8 m -62.25 -45.59 92.63 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.797 0.332 . . . . 0.0 110.54 179.382 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 92.3 mt -62.45 -43.79 98.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.277 -179.829 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.603 ' HB1' ' HD2' ' A' ' 138' ' ' PRO . . . -170.14 163.98 6.14 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.525 179.833 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.603 ' HD2' ' HB1' ' A' ' 137' ' ' ALA . 78.4 Cg_exo -43.81 111.89 0.28 Allowed 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.414 2.076 . . . . 0.0 112.1 179.523 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.471 HG21 ' CD1' ' A' ' 130' ' ' TYR . 17.8 m -85.97 127.54 34.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.49 179.973 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.649 HD13 ' CD2' ' A' ' 37' ' ' HIS . 34.2 tp -118.94 135.9 54.35 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.896 -179.576 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.435 ' O ' ' OD1' ' A' ' 32' ' ' ASP . 80.2 mt -102.63 119.89 51.63 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.417 0 CA-C-O 121.176 0.512 . . . . 0.0 111.466 -179.524 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.511 HD12 HD22 ' A' ' 117' ' ' LEU . 98.0 mt -135.8 132.66 51.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.615 179.791 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.549 HD21 ' CG ' ' A' ' 241' ' ' ASP . 54.5 t30 -65.62 151.7 45.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.966 0.412 . . . . 0.0 110.33 179.195 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.52 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 87.3 t80 -85.62 122.42 29.7 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.978 -179.553 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.52 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 98.9 m-20 55.13 69.33 0.74 Allowed 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.966 179.755 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 49.2 p-10 -123.44 -0.35 8.74 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 120.989 0.423 . . . . 0.0 110.711 179.866 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -151.32 117.24 5.51 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.818 -179.52 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 84.8 p -63.26 167.9 4.8 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.519 -179.77 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.419 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.4 p-90 -50.78 -15.7 0.32 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.566 -179.823 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 150' ' ' GLN . . . . . 0.444 ' O ' HG23 ' A' ' 154' ' ' THR . 68.0 tp60 -71.24 -74.78 0.14 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.427 -179.726 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.449 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.1 t -62.66 -39.06 92.73 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.235 179.476 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 53.5 tp -60.25 -45.51 93.03 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.345 -178.476 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.419 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 45.7 tp -62.67 -41.92 99.35 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.83 0.348 . . . . 0.0 110.365 179.013 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.449 ' OG1' ' O ' ' A' ' 151' ' ' SER . 55.3 p -63.92 -34.65 78.45 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.282 -179.461 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 155' ' ' GLN . . . . . 0.451 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.5 mm-40 -63.93 -42.37 97.37 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.175 179.269 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 92.1 mt -65.32 -39.02 91.92 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.072 0.463 . . . . 0.0 110.122 179.163 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.582 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.05 -32.29 79.77 Favored Glycine 0 CA--C 1.519 0.337 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 -179.308 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.451 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.3 mt-10 -36.48 -25.21 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.88 0.371 . . . . 0.0 110.808 179.913 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.582 ' N ' ' O ' ' A' ' 157' ' ' GLY . 95.7 mt -59.45 148.93 6.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.215 179.319 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 75.3 p -68.94 137.51 53.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.07 -179.554 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 70.6 22.13 77.88 Favored Glycine 0 N--CA 1.459 0.187 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 179.48 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 60.0 m80 -124.24 -14.62 6.95 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.673 0.273 . . . . 0.0 110.542 179.88 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -66.58 -59.44 3.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.696 -179.657 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -52.17 -48.68 64.82 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.141 -179.509 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -60.97 -40.95 95.35 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.742 0.306 . . . . 0.0 110.317 179.454 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.59 -47.31 86.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.57 179.822 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.95 -40.05 75.71 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.197 -179.787 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -61.76 -50.26 73.1 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.511 179.597 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -65.38 -43.68 89.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.493 179.595 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 95.4 mt -64.49 -43.48 96.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.395 179.71 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.23 -51.03 70.98 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.568 -179.129 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.81 -43.54 95.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.431 179.744 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 173' ' ' PHE . . . . . 0.666 ' CE2' HD11 ' A' ' 177' ' ' LEU . 57.1 t80 -62.55 -44.75 95.56 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.117 0.484 . . . . 0.0 110.503 179.272 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -63.22 -39.82 95.71 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.616 -179.365 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -62.9 -42.74 99.88 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.644 179.175 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -60.97 -44.64 97.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.015 -179.944 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.666 HD11 ' CE2' ' A' ' 173' ' ' PHE . 85.1 mt -64.24 -41.25 97.07 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.033 0.445 . . . . 0.0 110.715 178.887 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.41 -62.1 1.85 Allowed 'General case' 0 C--O 1.237 0.432 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.51 -179.317 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.67 -46.71 86.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.545 179.882 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.45 -41.46 66.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.203 -179.979 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -63.77 -33.73 76.31 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.965 0.412 . . . . 0.0 110.347 179.244 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 182' ' ' GLU . . . . . 0.423 ' O ' ' HG2' ' A' ' 182' ' ' GLU . 69.8 tt0 -90.57 8.56 33.47 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.483 0.659 . . . . 0.0 110.527 -178.997 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -104.51 -32.22 9.08 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.267 179.58 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.6 pt -128.01 147.78 32.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.863 -179.902 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -140.05 131.16 26.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.352 179.409 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 186' ' ' LEU . . . . . 0.591 HD22 ' N ' ' A' ' 186' ' ' LEU . 3.6 mm? -85.68 133.29 42.1 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.905 179.936 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -44.1 157.89 0.14 Allowed 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.685 2.257 . . . . 0.0 112.123 179.468 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 188' ' ' PRO . . . . . 0.523 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.5 Cg_endo -62.87 115.05 2.69 Favored 'Trans proline' 0 C--N 1.303 -1.828 0 C-N-CA 122.812 2.341 . . . . 0.0 111.701 179.887 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 189' ' ' GLN . . . . . 0.523 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.7 mt-30 155.59 148.16 0.0 OUTLIER Pre-proline 0 N--CA 1.454 -0.257 0 O-C-N 123.626 0.579 . . . . 0.0 110.726 -179.957 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -73.95 144.13 33.9 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 C-N-CA 122.657 2.238 . . . . 0.0 111.779 178.083 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.503 HG23 ' OG ' ' A' ' 258' ' ' SER . 2.1 p -125.06 158.76 32.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.276 0.56 . . . . 0.0 110.138 -179.95 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 192' ' ' THR . . . . . 0.493 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 35.6 p -143.29 165.46 27.41 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.199 -179.798 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 193' ' ' ALA . . . . . 0.445 ' HA ' ' H ' ' A' ' 260' ' ' PHE . . . -135.45 128.54 31.67 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.231 0.538 . . . . 0.0 110.206 179.597 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.506 HD11 HD23 ' A' ' 259' ' ' LEU . 47.1 pt -146.59 149.36 16.02 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.358 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.138 179.71 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 195' ' ' VAL . . . . . 0.739 HG13 ' CD1' ' A' ' 262' ' ' PHE . 69.2 t -118.14 123.31 71.45 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-O 121.385 0.612 . . . . 0.0 109.538 179.276 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -134.39 107.08 7.4 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.181 179.759 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 95.2 m -130.89 130.77 43.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.95 179.685 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.406 ' O ' ' N ' ' A' ' 201' ' ' HIS . . . -83.04 -37.03 24.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.227 179.793 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.39 -67.06 0.26 Allowed 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.346 -179.967 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.24 -9.96 59.15 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.272 179.536 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 201' ' ' HIS . . . . . 0.406 ' N ' ' O ' ' A' ' 198' ' ' ALA . 60.1 t-80 60.8 58.08 2.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.585 -179.841 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 54.4 p -166.89 153.33 8.44 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.472 179.568 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.02 143.86 24.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.454 179.509 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -135.16 138.05 43.32 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.635 179.972 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 20.0 mt -106.23 125.51 51.08 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 121.114 0.483 . . . . 0.0 109.731 -179.67 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 206' ' ' TRP . . . . . 0.56 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 74.4 m95 -81.91 166.88 19.51 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.595 -179.799 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 207' ' ' THR . . . . . 0.465 HG22 ' C ' ' A' ' 206' ' ' TRP . 0.1 OUTLIER -157.01 172.01 6.7 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.561 -179.173 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.18 -36.94 87.28 Favored 'Trans proline' 0 C--N 1.302 -1.894 0 C-N-CA 122.623 2.215 . . . . 0.0 112.022 179.477 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -70.52 -35.11 72.99 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.888 -179.917 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 21.9 m -61.18 150.63 33.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.662 -179.368 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.62 -36.84 81.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.482 -179.714 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 212' ' ' GLN . . . . . 0.56 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 54.8 tt0 -64.57 -40.44 95.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.524 179.931 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.79 -43.33 91.95 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.679 -0.969 . . . . 0.0 110.679 179.829 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -63.44 -43.7 96.67 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 179.933 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 215' ' ' MET . . . . . 0.55 ' SD ' ' HB2' ' A' ' 304' ' ' ALA . 65.6 ttp -59.64 -47.83 84.05 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.161 -179.764 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 86.7 mt -60.83 -40.68 93.68 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 179.731 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 217' ' ' GLU . . . . . 0.453 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.2 tp10 -58.27 -38.03 76.14 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.784 -0.451 . . . . 0.0 109.784 179.926 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -65.13 -38.23 89.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.836 0.351 . . . . 0.0 110.664 179.605 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 93.6 mt -64.33 -42.65 96.19 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.497 -179.587 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.6 45.22 0.08 OUTLIER Glycine 0 C--N 1.333 0.393 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 179.975 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 221' ' ' PHE . . . . . 0.453 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 26.5 m-85 -128.38 155.83 44.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.025 0.44 . . . . 0.0 110.527 -179.802 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.489 ' O ' HG13 ' A' ' 191' ' ' VAL . 8.2 p -107.56 122.61 47.02 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.262 0.553 . . . . 0.0 110.197 -179.913 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.475 HD22 ' C ' ' A' ' 222' ' ' THR . 4.3 mm? -101.52 132.92 46.89 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.082 179.884 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.65 159.84 14.71 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.508 179.883 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.46 115.27 29.97 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.955 0.407 . . . . 0.0 110.306 179.869 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.499 HD12 ' N ' ' A' ' 226' ' ' LEU . 9.0 mp -53.1 156.85 3.35 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.672 179.907 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -60.59 145.53 98.65 Favored 'Trans proline' 0 C--N 1.301 -1.96 0 C-N-CA 122.564 2.176 . . . . 0.0 112.076 179.396 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.21 -3.41 59.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.551 -179.966 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.06 -41.09 5.67 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 -179.909 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 230' ' ' LEU . . . . . 0.53 ' O ' ' N ' ' A' ' 233' ' ' SER . 68.3 mt -78.97 -17.57 55.21 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-O 121.097 0.475 . . . . 0.0 110.372 -179.838 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 231' ' ' ASN . . . . . 0.401 ' C ' ' O ' ' A' ' 230' ' ' LEU . 55.0 t-20 -40.43 -49.13 2.84 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.827 -179.352 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -87.68 15.28 7.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.779 0.323 . . . . 0.0 111.34 179.748 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 233' ' ' SER . . . . . 0.53 ' N ' ' O ' ' A' ' 230' ' ' LEU . 78.1 p -60.47 -35.32 75.59 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.591 -179.749 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 234' ' ' GLN . . . . . 0.525 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.7 tt0 -119.35 -69.44 0.85 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.966 179.457 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.2 m -69.25 103.08 1.85 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.686 -179.788 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -94.77 57.19 2.12 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.381 179.951 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -144.58 -122.72 1.61 Allowed Glycine 0 C--N 1.332 0.322 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 -179.989 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -135.03 111.9 10.14 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 121.202 0.525 . . . . 0.0 110.401 179.958 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 239' ' ' ARG . . . . . 0.525 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.6 mtt180 -148.15 57.74 1.08 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.796 -179.856 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -69.43 -32.16 70.96 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.518 179.681 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 241' ' ' ASP . . . . . 0.549 ' CG ' HD21 ' A' ' 143' ' ' ASN . 65.0 t0 -57.03 -47.04 81.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.372 -179.101 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 242' ' ' ILE . . . . . 0.437 ' O ' ' O ' ' A' ' 239' ' ' ARG . 17.9 tt -139.92 156.59 25.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.944 0.402 . . . . 0.0 110.477 179.771 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.444 HG22 HD13 ' A' ' 245' ' ' LEU . 96.1 mt -106.3 106.81 21.29 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.219 0 CA-C-O 121.208 0.527 . . . . 0.0 110.498 179.776 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 244' ' ' GLN . . . . . 0.601 ' O ' HD12 ' A' ' 245' ' ' LEU . 88.2 mt-30 -110.67 110.15 20.7 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.264 179.717 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.601 HD12 ' O ' ' A' ' 244' ' ' GLN . 9.4 mp -121.71 -168.14 1.65 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.667 179.725 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 246' ' ' GLY . . . . . 0.525 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.4 -15.82 0.05 OUTLIER Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.991 -0.844 . . . . 0.0 110.991 179.851 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 247' ' ' GLY . . . . . 0.673 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -61.47 156.5 34.83 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 110.926 -0.869 . . . . 0.0 110.926 -179.893 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -63.59 21.83 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.975 0.416 . . . . 0.0 110.59 179.948 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 249' ' ' ASN . . . . . 0.673 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.9 m-20 -97.48 -6.13 34.46 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.572 179.9 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 93.5 mt -79.43 -22.11 44.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.639 179.522 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.66 -51.21 70.89 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.806 -179.445 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.09 -5.82 58.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.375 179.639 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.12 -74.47 1.14 Allowed Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 -179.956 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 83.0 mt -70.15 125.81 27.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.019 0.438 . . . . 0.0 110.168 -179.759 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -59.57 -39.2 83.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.28 -179.691 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 83.27 51.71 4.04 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 110.716 -0.954 . . . . 0.0 110.716 179.755 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -95.62 -15.33 22.83 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.709 0.29 . . . . 0.0 110.641 -179.853 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 258' ' ' SER . . . . . 0.503 ' OG ' HG23 ' A' ' 191' ' ' VAL . 3.4 t 174.58 89.07 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.058 0.456 . . . . 0.0 110.083 179.935 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.862 HD12 ' N ' ' A' ' 259' ' ' LEU . 0.9 OUTLIER -94.39 124.2 38.27 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.291 0.567 . . . . 0.0 111.165 -179.211 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 260' ' ' PHE . . . . . 0.445 ' H ' ' HA ' ' A' ' 193' ' ' ALA . 15.9 m-30 -93.1 146.68 23.47 Favored 'General case' 0 CA--C 1.506 -0.747 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.324 179.281 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 86.1 mt -122.53 149.7 43.56 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.53 -179.883 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.739 ' CD1' HG13 ' A' ' 195' ' ' VAL . 2.5 p90 -77.78 -138.56 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.472 -179.724 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 263' ' ' ALA . . . . . 0.662 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -51.72 77.4 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.985 -179.988 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 264' ' ' GLY . . . . . 0.635 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.17 104.42 0.19 Allowed Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 -179.852 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 265' ' ' ASP . . . . . 0.602 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.6 m-20 -80.41 -177.69 6.3 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.662 0.268 . . . . 0.0 110.932 -179.583 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -40.65 -17.6 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.454 179.939 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 267' ' ' LYS . . . . . 0.602 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.42 -51.59 42.25 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.992 0.425 . . . . 0.0 110.768 179.382 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -63.78 -46.61 84.46 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.126 179.397 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 269' ' ' ALA . . . . . 0.562 ' HB1' ' OH ' ' A' ' 273' ' ' TYR . . . -61.72 -35.1 77.07 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 121.129 0.49 . . . . 0.0 109.71 179.693 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -62.87 -34.91 78.38 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.213 179.672 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.27 -43.02 14.11 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.402 -179.59 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 272' ' ' ILE . . . . . 0.59 ' C ' ' H ' ' A' ' 274' ' ' ALA . 5.0 tt -51.29 -33.82 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.828 -179.006 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 273' ' ' TYR . . . . . 0.562 ' OH ' ' HB1' ' A' ' 269' ' ' ALA . 17.3 m-85 -54.15 -1.66 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.695 -179.625 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 274' ' ' ALA . . . . . 0.59 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.81 -39.88 69.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.882 179.626 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 275' ' ' ASN . . . . . 0.58 ' O ' ' N ' ' A' ' 279' ' ' ALA . 2.9 p30 -39.29 97.93 0.15 Allowed Pre-proline 0 N--CA 1.463 0.196 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.536 -179.76 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -53.87 -43.03 61.65 Favored 'Trans proline' 0 C--N 1.303 -1.828 0 C-N-CA 122.281 1.987 . . . . 0.0 112.78 -178.884 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 89.6 mt -64.28 -42.8 96.24 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 121.2 0.524 . . . . 0.0 111.346 -179.866 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 90.9 mt -95.68 -1.72 49.51 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.826 -179.499 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 279' ' ' ALA . . . . . 0.58 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.37 -34.97 77.73 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.619 -179.727 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -74.06 19.97 0.11 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.047 -179.342 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 281' ' ' LEU . . . . . 0.491 HD23 ' HA ' ' A' ' 281' ' ' LEU . 13.8 mt -75.19 120.54 82.15 Favored Pre-proline 0 N--CA 1.451 -0.395 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.345 -179.96 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -51.54 -39.15 65.56 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.586 2.191 . . . . 0.0 111.699 179.241 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -53.08 -50.28 64.71 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 179.914 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 74.9 t -61.56 -43.96 97.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.544 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -57.74 -41.22 81.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.281 -179.918 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -91.04 0.35 57.56 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.139 179.676 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt 59.32 43.14 17.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.943 179.731 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -94.64 41.54 1.09 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.298 179.901 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 53.7 t -119.15 135.64 58.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.001 0.429 . . . . 0.0 110.169 -179.7 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -132.73 162.85 30.37 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.072 0.463 . . . . 0.0 110.753 -179.728 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.69 155.26 32.75 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.991 0.424 . . . . 0.0 110.783 -179.938 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 82.2 mt -94.1 -1.4 54.38 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.242 -179.689 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 120.87 165.28 12.66 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.549 -1.02 . . . . 0.0 110.549 -179.886 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 7.0 m -86.89 -62.29 1.54 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.853 0.359 . . . . 0.0 111.118 -179.89 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 295' ' ' GLU . . . . . 0.446 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.5 mm-40 -69.15 -4.09 16.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.667 -179.768 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 25.3 p -76.71 32.07 0.13 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.673 -179.94 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 297' ' ' PHE . . . . . 0.507 ' CD2' HG22 ' A' ' 70' ' ' THR . 69.0 t80 -60.42 -45.91 91.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.64 -179.99 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 298' ' ' ARG . . . . . 0.616 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.2 mtt85 -81.02 134.89 35.76 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 121.011 0.434 . . . . 0.0 110.597 -179.677 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.465 ' H ' HG11 ' A' ' 51' ' ' VAL . 17.6 tp -114.15 117.53 31.45 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.081 179.944 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 300' ' ' ASP . . . . . 0.619 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.4 p-10 -165.14 -176.81 4.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.543 179.911 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -46.91 -43.22 18.72 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.186 -179.655 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -67.12 -40.25 86.8 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.99 0.424 . . . . 0.0 110.853 179.053 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 303' ' ' SER . . . . . 0.619 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 59.9 p -56.12 -36.11 67.85 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.064 -179.121 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 304' ' ' ALA . . . . . 0.55 ' HB2' ' SD ' ' A' ' 215' ' ' MET . . . -57.58 -51.34 69.89 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 179.463 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 90.3 mtp -56.73 -43.39 80.6 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 108.993 -0.744 . . . . 0.0 108.993 -179.866 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -66.53 -42.54 87.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.905 0.383 . . . . 0.0 110.108 178.884 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 307' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 303' ' ' SER . 56.0 t -63.94 -43.09 97.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.112 179.344 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 42.7 tp -59.63 -42.19 92.17 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.782 -179.451 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -62.64 -38.91 92.1 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 179.522 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 310' ' ' ARG . . . . . 0.442 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.6 ttt85 -63.62 -43.95 95.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.17 179.553 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 88.4 mt -63.3 -42.08 99.01 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.156 179.693 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -62.85 -33.45 75.27 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.978 179.558 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.96 -23.27 21.59 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.47 -179.809 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 314' ' ' LEU . . . . . 0.481 HD22 ' CE2' ' A' ' 315' ' ' PHE . 6.8 tt -62.42 -43.05 99.75 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.076 0.465 . . . . 0.0 110.624 -179.884 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 315' ' ' PHE . . . . . 0.481 ' CE2' HD22 ' A' ' 314' ' ' LEU . 90.9 m-85 . . . . . 0 C--O 1.22 -0.485 0 CA-C-O 117.937 -1.03 . . . . 0.0 110.479 179.964 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -99.4 136.01 39.98 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.032 0.444 . . . . 0.0 110.547 -179.962 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.498 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -92.26 178.42 1.7 Allowed Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.5 -179.924 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.498 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 27.0 Cg_exo -61.54 147.45 95.4 Favored 'Trans proline' 0 C--N 1.301 -1.958 0 C-N-CA 122.726 2.284 . . . . 0.0 112.173 179.737 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.453 ' HE ' HD12 ' A' ' 39' ' ' LEU . 35.4 ptt180 -135.7 142.18 45.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.608 179.782 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -79.73 116.34 19.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.446 179.896 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.453 ' O ' HG23 ' A' ' 30' ' ' ILE . 9.5 tp -110.71 130.25 64.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.438 -179.96 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 12.7 t -70.77 141.43 51.44 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.518 179.925 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.477 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.2 t0 -139.01 179.38 6.53 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.55 -179.928 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.477 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 78.1 p -74.04 -36.88 64.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.684 179.784 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.8 ttt85 -46.53 -94.55 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.344 -179.504 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -166.92 -26.78 0.02 OUTLIER Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 179.928 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 55.1 m -169.21 104.7 0.38 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.979 0.419 . . . . 0.0 110.665 -179.873 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.683 ' CD2' HD13 ' A' ' 140' ' ' LEU . 74.5 t60 -128.39 148.24 50.69 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.042 0.449 . . . . 0.0 110.338 179.795 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.627 HG22 ' N ' ' A' ' 39' ' ' LEU . 98.0 m -130.62 166.02 21.56 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.674 -179.889 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.627 ' N ' HG22 ' A' ' 38' ' ' THR . 82.4 mt -120.68 127.61 52.21 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.455 179.74 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -65.18 -44.55 88.12 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.653 -179.861 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 38.8 p -165.63 154.86 12.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.42 179.582 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.524 ' CD ' ' H ' ' A' ' 42' ' ' GLN . 14.8 mp0 -44.33 101.13 0.24 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.676 179.528 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -57.29 129.06 32.16 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.421 2.081 . . . . 0.0 112.183 -179.588 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -83.72 -24.76 31.07 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.478 179.619 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.538 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.8 mtm-85 -121.87 134.61 54.87 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-O 121.194 0.521 . . . . 0.0 110.303 -179.99 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 95.9 mt -130.9 133.68 62.73 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.261 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.017 -179.812 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 45.3 t -124.2 130.49 73.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 179.372 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.625 ' OG ' HD12 ' A' ' 117' ' ' LEU . 2.3 m -155.28 166.83 32.34 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.564 179.849 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 66.6 p -124.44 9.16 8.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.5 179.874 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.16 125.43 32.81 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.635 -179.436 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.444 HG11 ' H ' ' A' ' 299' ' ' LEU . 94.0 t -65.88 -44.61 92.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.51 179.967 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.7 m -62.63 -44.31 96.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.615 -179.805 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 51.0 tp -62.26 -41.57 98.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.541 -179.487 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.44 ' O ' HD13 ' A' ' 58' ' ' LEU . 74.2 m -57.59 -44.4 85.36 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.404 -179.36 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.2 -62.22 5.35 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 179.539 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.7 t -48.59 -35.47 13.6 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 -179.939 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.8 mt -61.72 -44.96 95.9 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.153 179.379 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.44 HD13 ' O ' ' A' ' 54' ' ' THR . 9.3 mp -64.85 -41.88 95.35 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.081 0.467 . . . . 0.0 111.368 177.918 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.28 -41.12 98.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.96 -179.139 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.427 ' O ' HG23 ' A' ' 60' ' ' ILE . 8.2 tp -88.58 17.05 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.71 -179.647 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 56.57 84.85 0.08 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.645 -179.991 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.65 58.86 0.09 OUTLIER Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.072 -179.819 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -50.66 151.41 10.7 Favored 'Trans proline' 0 C--N 1.297 -2.17 0 C-N-CA 122.767 2.312 . . . . 0.0 112.562 -178.366 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.432 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -108.33 145.49 15.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.325 -179.736 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 97.0 mt -63.84 -44.95 98.28 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.439 -179.785 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.497 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -130.13 134.29 47.22 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.545 -179.791 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.491 ' O ' ' N ' ' A' ' 98' ' ' LEU . 75.3 m -134.59 158.67 43.4 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.878 -179.643 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.31 138.71 16.12 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 179.799 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.476 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.62 -162.97 0.09 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.997 0.427 . . . . 0.0 110.426 -179.924 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.525 HG22 ' CD2' ' A' ' 297' ' ' PHE . 5.9 t -133.78 135.53 43.93 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.209 -179.985 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.494 ' C ' ' O ' ' A' ' 70' ' ' THR . 1.0 OUTLIER 29.5 68.12 0.67 Allowed Pre-proline 0 N--CA 1.464 0.245 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.685 -179.634 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -60.54 145.14 99.31 Favored 'Trans proline' 0 C--N 1.3 -1.98 0 C-N-CA 122.57 2.18 . . . . 0.0 112.236 -178.618 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.529 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 44.9 p-10 -160.23 -32.18 0.06 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.574 179.757 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.536 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 99.1 m-20 -63.96 -39.4 94.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.385 179.999 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -60.47 -48.21 82.78 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.684 -179.351 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.421 ' O ' ' O ' ' A' ' 77' ' ' ALA . 96.6 t -60.09 -24.4 30.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.133 179.584 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.536 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -45.98 173.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.518 179.922 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.575 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.5 p30 -62.28 177.98 0.44 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.649 -179.766 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.551 ' C ' ' H ' ' A' ' 81' ' ' GLY . 35.4 p30 -45.51 85.75 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.93 179.893 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.575 ' N ' ' O ' ' A' ' 78' ' ' ASP . 42.8 tp60 -68.03 13.48 0.08 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.058 0.456 . . . . 0.0 110.111 -179.835 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.551 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 118.41 -22.29 9.57 Favored Glycine 0 CA--C 1.52 0.352 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 179.996 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -108.02 116.5 32.06 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.954 0.407 . . . . 0.0 110.474 179.785 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 76.6 mt -98.86 0.45 44.24 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.442 -179.724 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -92.52 7.23 44.07 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.996 0.427 . . . . 0.0 110.392 -179.689 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.796 ' O ' HG22 ' A' ' 89' ' ' VAL . 27.2 mt-30 -100.1 -27.65 13.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.822 -179.966 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 69.5 t-105 -63.25 -40.91 98.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.916 -179.615 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.56 ' O ' ' N ' ' A' ' 91' ' ' LYS . 66.5 m -77.58 -53.41 7.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.263 -179.405 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -48.46 -50.82 29.81 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.906 -179.302 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.796 HG22 ' O ' ' A' ' 85' ' ' GLN . 15.6 m -68.95 -40.84 81.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 120.959 0.409 . . . . 0.0 110.993 179.829 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.503 ' N ' HG23 ' A' ' 89' ' ' VAL . . . -72.18 -22.95 61.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.806 -179.864 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.56 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.0 tttm -61.77 -45.53 93.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.537 -179.558 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.444 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.6 mm-40 -90.47 -94.99 0.12 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.162 -179.957 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.642 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.9 mtt180 -142.78 59.28 1.43 Allowed 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 179.71 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.463 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.7 pttp 33.53 25.79 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 120.86 0.362 . . . . 0.0 110.235 -179.142 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.642 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.3 tt -47.68 123.5 5.98 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.907 -178.166 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.45 ' O ' HD23 ' A' ' 95' ' ' LEU . 99.0 mm-40 -83.81 -169.91 2.81 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.098 179.952 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.612 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 82.4 mtp180 -74.04 137.04 43.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.251 -179.754 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.491 ' N ' ' O ' ' A' ' 67' ' ' SER . 90.0 mt -86.27 -165.7 1.33 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.658 -179.539 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.535 ' O ' ' CD2' ' A' ' 99' ' ' TYR . 47.9 p90 -168.89 120.05 0.75 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.182 179.981 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.519 ' C ' ' O ' ' A' ' 99' ' ' TYR . 43.6 mm -29.14 121.24 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.994 -179.585 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 114.45 27.17 3.43 Favored Glycine 0 CA--C 1.521 0.441 0 N-CA-C 111.126 -0.789 . . . . 0.0 111.126 -179.578 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.587 ' CD ' ' H ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -144.35 46.26 0.61 Allowed Pre-proline 0 C--N 1.325 -0.498 0 CA-C-O 120.866 0.365 . . . . 0.0 110.412 179.986 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 29.9 Cg_endo -61.94 143.76 95.77 Favored 'Trans proline' 0 C--N 1.297 -2.168 0 C-N-CA 122.702 2.268 . . . . 0.0 112.021 179.993 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.464 ' O ' HG23 ' A' ' 108' ' ' VAL . 26.2 t -173.32 120.06 0.33 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.474 179.82 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.26 -40.49 64.57 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.045 0.45 . . . . 0.0 111.184 179.644 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.25 -40.05 89.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.923 -179.447 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.07 -40.06 95.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.736 -179.844 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 104' ' ' SER . 71.8 t -67.56 -43.95 86.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.863 179.664 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.83 -38.79 92.18 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.631 -179.323 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.444 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.44 -23.34 62.6 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.418 179.799 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.553 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.3 mm-40 -90.53 5.02 49.49 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.699 -179.454 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.553 ' C ' ' O ' ' A' ' 111' ' ' GLN . 10.2 tpt 24.16 63.59 0.41 Allowed Pre-proline 0 N--CA 1.465 0.278 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.874 -179.981 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -77.53 167.1 24.83 Favored 'Trans proline' 0 C--N 1.303 -1.82 0 C-N-CA 122.987 2.458 . . . . 0.0 112.415 -178.779 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.526 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 99.1 m-20 -110.39 -41.97 4.24 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 121.02 0.438 . . . . 0.0 110.131 179.442 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.7 tp -121.65 120.14 33.87 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.344 -0.389 . . . . 0.0 109.957 179.549 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 83.4 mt -112.99 129.14 69.18 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.341 0 CA-C-O 120.943 0.401 . . . . 0.0 110.891 -179.882 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.625 HD12 ' OG ' ' A' ' 48' ' ' SER . 29.7 mt -109.13 132.39 54.16 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 121.108 0.48 . . . . 0.0 110.165 -179.682 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.492 HD12 HG23 ' A' ' 139' ' ' THR . 98.8 mt -119.87 139.07 48.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.697 -179.789 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 85.0 p -72.65 153.75 41.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.579 179.951 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.08 -50.06 75.19 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.616 -179.823 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.0 t -149.64 154.19 38.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.573 179.795 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 170.56 -170.96 43.46 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.954 -0.858 . . . . 0.0 110.954 179.917 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -63.1 -34.14 89.16 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 179.932 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.452 ' OD1' ' O ' ' A' ' 124' ' ' ASP . 44.6 p-10 -86.93 120.23 27.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.805 0.336 . . . . 0.0 110.742 179.97 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.437 ' O ' HD12 ' A' ' 129' ' ' LEU . 40.6 t -63.1 143.58 57.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.431 -179.894 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.524 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.15 -43.27 8.94 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.888 -179.913 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 56.0 tp -62.74 -42.54 99.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.751 -179.858 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.42 -11.97 59.11 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.551 -179.436 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.437 HD12 ' O ' ' A' ' 125' ' ' SER . 84.1 mt -115.26 -23.6 8.86 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.663 -179.85 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 130' ' ' TYR . . . . . 0.524 ' N ' ' O ' ' A' ' 126' ' ' ALA . 79.0 t80 -51.01 -49.76 59.84 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.52 -179.012 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.3 p-10 -65.99 -42.64 89.51 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.8 0.333 . . . . 0.0 111.11 179.604 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.526 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 88.2 mt-30 -67.02 -37.92 84.99 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.744 179.926 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.414 HD12 HD11 ' A' ' 118' ' ' ILE . 95.2 mt -80.22 -41.56 24.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.983 -179.535 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.3 t -57.16 -44.29 83.33 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.196 -179.219 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.3 m -61.86 -45.33 94.23 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.778 0.323 . . . . 0.0 110.476 179.472 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 92.7 mt -62.23 -43.41 97.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.161 -179.742 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.657 ' HB1' ' HD2' ' A' ' 138' ' ' PRO . . . -169.53 168.23 4.89 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.533 179.866 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.657 ' HD2' ' HB1' ' A' ' 137' ' ' ALA . 51.9 Cg_exo -50.1 113.01 0.84 Allowed 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.29 1.993 . . . . 0.0 112.106 179.437 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.492 HG23 HD12 ' A' ' 118' ' ' ILE . 23.8 m -84.24 127.51 34.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.527 -179.927 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.683 HD13 ' CD2' ' A' ' 37' ' ' HIS . 34.6 tp -117.8 135.94 53.73 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.029 -179.702 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.443 ' O ' ' OD2' ' A' ' 32' ' ' ASP . 81.8 mt -100.17 118.82 47.4 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.36 0 CA-C-O 121.204 0.526 . . . . 0.0 111.231 -179.384 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.428 HD12 HD22 ' A' ' 117' ' ' LEU . 97.8 mt -134.73 132.27 54.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.656 179.629 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.446 ' ND2' ' H ' ' A' ' 144' ' ' TYR . 2.1 t-20 -66.9 151.19 48.04 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.9 0.381 . . . . 0.0 110.402 179.368 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.521 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 87.9 t80 -85.95 122.45 30.02 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.814 -179.577 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.521 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 98.8 m-20 55.16 69.3 0.75 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.87 179.725 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 35.2 p-10 -125.84 0.08 7.34 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.722 179.907 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -150.53 115.36 5.27 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.679 -179.463 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 84.0 p -63.61 168.54 4.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.526 -179.744 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.423 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.4 p-90 -52.01 -15.72 0.61 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.555 -179.861 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 150' ' ' GLN . . . . . 0.444 ' O ' HG23 ' A' ' 154' ' ' THR . 67.9 tp60 -70.5 -76.32 0.1 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.446 -179.737 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.449 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.1 t -62.64 -38.46 90.36 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.379 179.488 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 53.6 tp -60.07 -45.57 92.46 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.419 -178.668 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.423 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 47.3 tp -62.82 -41.79 99.45 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.845 0.355 . . . . 0.0 110.3 179.101 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.449 ' OG1' ' O ' ' A' ' 151' ' ' SER . 63.3 p -64.07 -34.61 78.42 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.335 -179.615 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 155' ' ' GLN . . . . . 0.423 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.3 mm-40 -64.14 -42.85 96.63 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.264 179.247 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 92.4 mt -65.4 -39.0 91.65 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.989 0.423 . . . . 0.0 110.21 179.159 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.587 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.01 -32.13 79.12 Favored Glycine 0 CA--C 1.521 0.426 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 -179.358 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.442 ' C ' ' O ' ' A' ' 157' ' ' GLY . 97.3 mt-10 -35.45 -26.84 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.799 0.333 . . . . 0.0 110.731 179.968 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.587 ' N ' ' O ' ' A' ' 157' ' ' GLY . 95.8 mt -56.87 149.64 3.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.211 179.376 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 72.4 p -69.55 137.12 52.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.031 -179.587 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 71.77 20.26 78.57 Favored Glycine 0 N--CA 1.459 0.197 0 N-CA-C 111.239 -0.744 . . . . 0.0 111.239 179.487 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 57.6 m80 -121.97 -15.09 7.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.731 0.3 . . . . 0.0 110.622 179.928 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -65.74 -59.88 3.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.807 -179.741 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -52.03 -49.13 64.01 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.225 -179.717 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -60.71 -41.22 94.79 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.701 0.286 . . . . 0.0 110.308 179.411 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.39 -47.25 86.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.7 179.779 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.9 -40.24 75.93 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.261 -179.92 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -61.74 -50.15 73.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.561 179.57 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 60.1 ttt85 -65.31 -43.88 89.66 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.462 179.535 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 96.0 mt -64.44 -43.63 96.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.449 179.671 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.18 -50.97 71.19 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.608 -179.148 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -63.76 -43.83 95.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.378 179.803 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 173' ' ' PHE . . . . . 0.657 ' CE2' HD11 ' A' ' 177' ' ' LEU . 56.7 t80 -62.71 -44.53 95.99 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.071 0.462 . . . . 0.0 110.447 179.388 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -63.25 -40.13 96.57 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.435 -179.294 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -62.92 -42.75 99.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.648 179.292 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -60.6 -44.88 95.78 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.116 179.961 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.657 HD11 ' CE2' ' A' ' 173' ' ' PHE . 85.5 mt -64.37 -41.09 96.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.001 0.429 . . . . 0.0 110.692 178.867 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.02 -62.17 1.8 Allowed 'General case' 0 C--O 1.237 0.416 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.491 -179.349 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.94 -46.66 87.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.523 179.902 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.38 -41.69 66.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.15 179.999 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -63.79 -33.67 76.18 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.944 0.402 . . . . 0.0 110.354 179.272 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 182' ' ' GLU . . . . . 0.424 ' O ' ' HG2' ' A' ' 182' ' ' GLU . 69.6 tt0 -90.48 8.71 32.44 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.25 0.547 . . . . 0.0 110.565 -179.099 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -104.81 -32.26 8.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.232 179.676 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 45.4 pt -128.07 147.49 32.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.826 -179.879 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -139.73 131.02 26.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.335 179.436 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 186' ' ' LEU . . . . . 0.596 HD22 ' N ' ' A' ' 186' ' ' LEU . 3.5 mm? -85.5 133.66 41.71 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.776 179.994 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -44.16 157.74 0.15 Allowed 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.793 2.329 . . . . 0.0 112.053 179.47 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 188' ' ' PRO . . . . . 0.532 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.7 Cg_endo -62.92 114.88 2.62 Favored 'Trans proline' 0 C--N 1.303 -1.867 0 C-N-CA 122.727 2.284 . . . . 0.0 111.833 179.908 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 189' ' ' GLN . . . . . 0.532 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.7 mt-30 155.54 148.23 0.0 OUTLIER Pre-proline 0 N--CA 1.454 -0.238 0 O-C-N 123.438 0.461 . . . . 0.0 110.686 -179.761 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -74.13 144.18 33.3 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.736 2.291 . . . . 0.0 111.687 178.165 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.499 HG23 ' OG ' ' A' ' 258' ' ' SER . 2.1 p -124.99 158.82 32.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.195 0.521 . . . . 0.0 110.146 -179.954 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 192' ' ' THR . . . . . 0.497 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 35.8 p -143.39 165.2 28.18 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.08 -179.526 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 193' ' ' ALA . . . . . 0.444 ' HA ' ' H ' ' A' ' 260' ' ' PHE . . . -135.45 128.48 31.55 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.145 0.498 . . . . 0.0 110.188 179.677 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.507 HD11 HD23 ' A' ' 259' ' ' LEU . 47.6 pt -146.52 149.09 16.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.068 179.88 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 195' ' ' VAL . . . . . 0.74 HG13 ' CD1' ' A' ' 262' ' ' PHE . 69.0 t -117.86 123.03 71.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.236 0.541 . . . . 0.0 109.733 179.08 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -134.15 106.86 7.39 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.288 179.79 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 95.1 m -130.62 130.52 44.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.77 179.751 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -83.18 -36.58 24.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.215 179.804 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.61 -66.99 0.27 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.398 179.878 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.68 -9.36 58.53 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.313 179.487 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 60.5 t-80 60.5 58.56 2.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.856 -179.952 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 37.1 p -167.29 153.64 8.08 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.526 179.512 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.52 144.09 24.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.967 0.413 . . . . 0.0 110.431 179.376 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -135.12 138.2 43.53 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.925 0.393 . . . . 0.0 110.671 -179.994 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 19.4 mt -106.39 125.52 51.1 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 121.117 0.484 . . . . 0.0 109.794 -179.738 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 206' ' ' TRP . . . . . 0.562 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 74.8 m95 -81.85 166.94 19.52 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.641 -179.808 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 207' ' ' THR . . . . . 0.473 HG22 ' C ' ' A' ' 206' ' ' TRP . 0.1 OUTLIER -156.84 171.4 7.48 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.942 0.401 . . . . 0.0 110.569 -179.288 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -53.83 -37.2 84.8 Favored 'Trans proline' 0 C--N 1.303 -1.838 0 C-N-CA 122.603 2.202 . . . . 0.0 111.97 179.352 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -70.21 -35.19 73.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.923 -179.875 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 21.7 m -61.05 150.79 32.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.601 -179.305 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.59 -37.02 82.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.527 -179.755 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 212' ' ' GLN . . . . . 0.562 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 54.7 tt0 -64.59 -40.32 95.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.566 179.99 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.51 -43.29 92.67 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 179.833 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -63.56 -43.45 96.99 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.76 0.314 . . . . 0.0 110.335 179.897 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 215' ' ' MET . . . . . 0.526 ' SD ' ' HB2' ' A' ' 304' ' ' ALA . 65.4 ttp -59.65 -47.92 83.7 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.37 -179.928 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' A' ' 216' ' ' LEU . 88.2 mt -60.56 -40.71 92.64 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.497 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 217' ' ' GLU . . . . . 0.459 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.8 tp10 -58.23 -37.95 75.88 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.806 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -65.2 -38.19 89.71 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.849 0.356 . . . . 0.0 110.651 179.679 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 94.6 mt -64.3 -42.77 96.2 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.618 -179.674 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.71 44.87 0.08 OUTLIER Glycine 0 CA--C 1.52 0.387 0 N-CA-C 110.974 -0.85 . . . . 0.0 110.974 -179.996 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 221' ' ' PHE . . . . . 0.459 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 26.8 m-85 -128.04 155.71 43.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.087 0.47 . . . . 0.0 110.452 -179.843 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.49 ' O ' HG13 ' A' ' 191' ' ' VAL . 7.1 p -107.44 122.46 46.67 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 121.138 0.494 . . . . 0.0 110.205 -179.933 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.475 HD22 ' C ' ' A' ' 222' ' ' THR . 4.3 mm? -101.39 132.94 46.7 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.048 -179.991 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.68 159.65 14.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.519 179.876 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.34 115.02 29.55 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.335 179.867 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.496 HD12 ' N ' ' A' ' 226' ' ' LEU . 8.9 mp -53.0 156.71 3.31 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.665 179.953 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -60.65 145.61 98.56 Favored 'Trans proline' 0 C--N 1.302 -1.917 0 C-N-CA 122.599 2.199 . . . . 0.0 111.989 179.455 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.34 -3.43 59.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.502 -179.987 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -89.97 -41.21 5.66 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 111.011 -0.836 . . . . 0.0 111.011 -179.855 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 230' ' ' LEU . . . . . 0.54 ' O ' ' N ' ' A' ' 233' ' ' SER . 70.0 mt -78.91 -17.57 55.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.951 0.405 . . . . 0.0 110.329 -179.845 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 231' ' ' ASN . . . . . 0.403 ' C ' ' O ' ' A' ' 230' ' ' LEU . 55.2 t-20 -39.97 -49.31 2.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.742 -179.505 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -88.05 15.41 7.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.797 0.332 . . . . 0.0 111.21 -179.996 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 233' ' ' SER . . . . . 0.54 ' N ' ' O ' ' A' ' 230' ' ' LEU . 78.1 p -60.45 -35.68 76.44 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.53 -179.862 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 234' ' ' GLN . . . . . 0.527 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.6 tt0 -118.66 -69.32 0.86 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.961 179.591 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.2 m -69.81 103.22 2.12 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.744 -179.785 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -94.66 57.53 2.2 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.392 179.953 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -144.72 -122.66 1.59 Allowed Glycine 0 CA--C 1.521 0.418 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 -179.972 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -134.73 111.5 10.0 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.075 0.464 . . . . 0.0 110.494 179.975 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 239' ' ' ARG . . . . . 0.521 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.6 mtt180 -148.03 57.49 1.09 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.682 -179.9 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -69.48 -32.21 70.97 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.522 179.654 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 241' ' ' ASP . . . . . 0.455 ' OD2' ' O ' ' A' ' 144' ' ' TYR . 64.6 t0 -56.89 -47.04 81.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.369 -179.18 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 242' ' ' ILE . . . . . 0.441 ' O ' ' O ' ' A' ' 239' ' ' ARG . 18.0 tt -139.83 156.56 25.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.824 0.345 . . . . 0.0 110.584 179.807 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.442 HG22 HD13 ' A' ' 245' ' ' LEU . 96.1 mt -106.27 106.45 20.62 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.212 0 CA-C-O 121.09 0.472 . . . . 0.0 110.569 179.858 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 244' ' ' GLN . . . . . 0.606 ' O ' HD12 ' A' ' 245' ' ' LEU . 88.2 mt-30 -110.36 110.06 20.71 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.279 179.804 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.606 HD12 ' O ' ' A' ' 244' ' ' GLN . 9.3 mp -121.89 -168.43 1.7 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.65 179.923 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 246' ' ' GLY . . . . . 0.527 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.68 -16.37 0.05 OUTLIER Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 179.865 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 247' ' ' GLY . . . . . 0.676 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -60.91 156.48 32.61 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 -179.892 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -63.31 21.28 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.967 0.413 . . . . 0.0 110.569 179.952 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 249' ' ' ASN . . . . . 0.676 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.8 m-20 -96.99 -6.2 36.01 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.551 -179.996 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 93.8 mt -79.5 -22.22 44.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.636 179.545 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.51 -51.31 70.42 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.756 -179.49 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.1 -5.85 58.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.402 179.704 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -80.93 -74.63 1.13 Allowed Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 -179.902 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 83.6 mt -70.08 126.03 28.49 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.03 0.443 . . . . 0.0 110.246 -179.885 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -59.19 -39.39 82.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.238 -179.691 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 82.89 51.84 4.08 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 179.929 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -96.46 -14.22 22.54 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.734 0.302 . . . . 0.0 110.658 -179.822 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 258' ' ' SER . . . . . 0.499 ' OG ' HG23 ' A' ' 191' ' ' VAL . 3.5 t 174.16 88.47 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.075 0.464 . . . . 0.0 110.168 179.934 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.863 HD12 ' N ' ' A' ' 259' ' ' LEU . 1.0 OUTLIER -94.11 123.93 37.8 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.204 0.526 . . . . 0.0 111.073 -179.206 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 260' ' ' PHE . . . . . 0.444 ' H ' ' HA ' ' A' ' 193' ' ' ALA . 16.0 m-30 -92.76 146.42 23.66 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.356 179.175 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 87.0 mt -122.35 149.57 43.59 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.512 -179.917 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.74 ' CD1' HG13 ' A' ' 195' ' ' VAL . 2.5 p90 -77.64 -138.43 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.484 -179.808 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 263' ' ' ALA . . . . . 0.663 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -51.97 77.51 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.965 -179.945 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 264' ' ' GLY . . . . . 0.636 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.07 104.36 0.18 Allowed Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.674 -0.971 . . . . 0.0 110.674 -179.937 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 265' ' ' ASP . . . . . 0.608 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.9 m-20 -80.48 -177.74 6.35 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.743 0.306 . . . . 0.0 110.878 -179.477 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -40.43 -17.66 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.503 179.769 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 267' ' ' LYS . . . . . 0.608 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.49 -51.6 41.5 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.965 0.412 . . . . 0.0 110.742 179.434 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -63.81 -46.63 84.25 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.196 179.373 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 269' ' ' ALA . . . . . 0.568 ' HB1' ' OH ' ' A' ' 273' ' ' TYR . . . -61.58 -35.18 77.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.152 -0.477 . . . . 0.0 109.808 179.527 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -62.91 -34.64 77.87 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.164 179.624 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.32 -43.35 13.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.243 -179.535 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 272' ' ' ILE . . . . . 0.584 ' C ' ' H ' ' A' ' 274' ' ' ALA . 4.9 tt -51.53 -33.65 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.72 -178.712 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 273' ' ' TYR . . . . . 0.568 ' OH ' ' HB1' ' A' ' 269' ' ' ALA . 17.4 m-85 -54.23 -1.85 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.702 -179.705 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 274' ' ' ALA . . . . . 0.584 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.81 -39.49 69.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.848 179.651 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 275' ' ' ASN . . . . . 0.585 ' O ' ' N ' ' A' ' 279' ' ' ALA . 3.2 p30 -39.45 98.0 0.15 Allowed Pre-proline 0 C--N 1.332 -0.163 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.592 -179.668 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -53.82 -43.17 60.38 Favored 'Trans proline' 0 C--N 1.303 -1.847 0 C-N-CA 122.361 2.04 . . . . 0.0 112.751 -178.881 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 89.0 mt -64.47 -42.87 95.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.178 -179.667 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 90.7 mt -95.68 -1.51 49.94 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.839 -179.413 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 279' ' ' ALA . . . . . 0.585 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.55 -34.84 77.75 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.562 -179.713 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.08 20.03 0.11 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.045 -179.238 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 281' ' ' LEU . . . . . 0.491 HD23 ' HA ' ' A' ' 281' ' ' LEU . 13.9 mt -75.54 120.83 83.44 Favored Pre-proline 0 N--CA 1.452 -0.329 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.389 179.977 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_exo -51.54 -38.97 65.68 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.597 2.198 . . . . 0.0 111.617 179.339 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.78 -50.39 63.64 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.165 179.79 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 75.5 t -61.53 -43.95 97.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 179.424 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -57.7 -41.51 81.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.295 -179.992 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -90.94 0.21 57.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.186 179.641 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt 59.09 43.03 18.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.029 0.442 . . . . 0.0 110.969 179.755 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -94.42 41.74 1.09 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.342 179.856 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 54.0 t -119.03 135.8 58.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.989 0.423 . . . . 0.0 110.299 -179.812 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -132.85 162.7 30.87 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.997 0.427 . . . . 0.0 110.669 -179.635 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.81 155.36 32.72 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.974 0.416 . . . . 0.0 110.72 -179.785 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 81.4 mt -94.05 -1.5 54.34 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.225 -179.745 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 120.89 165.72 12.8 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 -179.795 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 6.9 m -87.28 -62.39 1.51 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.847 0.356 . . . . 0.0 111.04 -179.847 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 295' ' ' GLU . . . . . 0.438 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.8 mm-40 -69.53 -3.94 16.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.625 -179.762 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 27.3 p -77.03 32.63 0.14 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.612 -179.906 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 297' ' ' PHE . . . . . 0.525 ' CD2' HG22 ' A' ' 70' ' ' THR . 70.1 t80 -60.11 -45.97 91.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.549 -179.993 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 298' ' ' ARG . . . . . 0.612 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.2 mtt85 -81.32 134.13 35.53 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 121.017 0.437 . . . . 0.0 110.51 -179.761 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.444 ' H ' HG11 ' A' ' 51' ' ' VAL . 16.0 tp -114.67 119.52 36.98 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.213 -179.951 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 300' ' ' ASP . . . . . 0.62 ' H ' ' CB ' ' A' ' 303' ' ' SER . 49.4 p-10 -167.36 -174.41 2.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.523 -179.936 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -48.06 -45.49 32.42 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.183 -179.603 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -65.05 -41.45 95.14 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.062 0.458 . . . . 0.0 110.771 179.019 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 303' ' ' SER . . . . . 0.62 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 53.0 p -55.55 -35.94 66.26 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.147 -179.37 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 304' ' ' ALA . . . . . 0.526 ' HB2' ' SD ' ' A' ' 215' ' ' MET . . . -57.16 -51.6 68.66 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.478 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 90.8 mtp -56.39 -43.57 79.39 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.792 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -66.52 -42.57 87.1 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.84 0.352 . . . . 0.0 110.131 178.78 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 307' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 303' ' ' SER . 56.1 t -64.03 -42.92 97.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.229 179.394 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 42.5 tp -59.63 -42.0 91.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.827 -179.626 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -62.86 -39.0 93.06 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 179.58 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 310' ' ' ARG . . . . . 0.437 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.4 ttt85 -63.59 -44.06 95.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.322 179.514 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 87.8 mt -63.3 -42.07 99.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.215 179.58 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -62.89 -33.18 74.76 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.037 179.521 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.95 -23.46 21.55 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.559 -179.866 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 314' ' ' LEU . . . . . 0.483 HD22 ' CE2' ' A' ' 315' ' ' PHE . 6.8 tt -62.34 -43.18 99.43 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.626 179.977 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 315' ' ' PHE . . . . . 0.483 ' CE2' HD22 ' A' ' 314' ' ' LEU . 91.1 m-85 . . . . . 0 C--O 1.22 -0.471 0 CA-C-O 117.979 -1.01 . . . . 0.0 110.506 179.992 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -99.6 136.5 39.43 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.041 0.448 . . . . 0.0 110.422 -179.906 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.497 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -92.05 178.44 1.72 Allowed Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.63 -179.916 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.497 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.7 Cg_exo -61.62 147.02 96.37 Favored 'Trans proline' 0 C--N 1.3 -2.018 0 C-N-CA 122.801 2.334 . . . . 0.0 112.124 179.784 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.456 ' HE ' HD12 ' A' ' 39' ' ' LEU . 35.3 ptt180 -136.06 142.25 44.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.71 179.771 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -79.56 116.62 19.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.475 179.905 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.45 ' O ' HG23 ' A' ' 30' ' ' ILE . 9.5 tp -110.88 130.36 64.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.512 -179.993 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.3 t -70.83 141.5 51.31 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.528 179.818 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.478 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.4 t0 -139.03 179.46 6.48 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.563 -179.944 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.478 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 78.1 p -74.04 -36.93 64.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.733 179.834 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.7 ttt85 -46.44 -94.57 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.351 -179.573 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -166.97 -26.68 0.02 OUTLIER Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.899 -0.881 . . . . 0.0 110.899 179.945 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 62.0 m -169.19 104.84 0.38 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.849 0.357 . . . . 0.0 110.694 -179.938 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.679 ' CD2' HD13 ' A' ' 140' ' ' LEU . 74.6 t60 -128.36 149.03 50.7 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.005 0.431 . . . . 0.0 110.3 179.941 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.625 HG22 ' N ' ' A' ' 39' ' ' LEU . 98.9 m -131.4 165.9 22.47 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.543 -179.857 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.625 ' N ' HG22 ' A' ' 38' ' ' THR . 81.7 mt -120.64 127.39 52.03 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.481 179.728 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -65.17 -44.51 88.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.706 179.975 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 40.3 p -165.68 154.62 11.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.433 179.728 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.485 ' CD ' ' H ' ' A' ' 42' ' ' GLN . 14.4 mp0 -44.55 101.34 0.25 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.642 179.437 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.25 129.36 33.76 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 C-N-CA 122.345 2.03 . . . . 0.0 112.264 -179.713 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -83.45 -24.92 31.61 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.533 179.536 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.537 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.5 mtm-85 -122.04 134.8 54.79 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-O 121.09 0.471 . . . . 0.0 110.364 -179.946 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.2 mt -130.61 133.57 63.32 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.288 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.959 -179.677 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 45.1 t -124.32 130.48 73.63 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-O 120.863 0.363 . . . . 0.0 110.115 179.238 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.619 ' OG ' HD12 ' A' ' 117' ' ' LEU . 2.4 m -154.85 166.59 33.03 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.527 179.842 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 71.4 p -124.47 8.61 8.38 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.489 179.85 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.22 125.85 33.2 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.611 -179.586 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.421 HG11 ' H ' ' A' ' 299' ' ' LEU . 86.2 t -65.86 -44.54 92.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.568 -179.962 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.9 m -62.65 -44.36 96.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.62 -179.81 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 46.5 tp -62.26 -41.66 98.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.526 -179.439 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.44 ' O ' HD13 ' A' ' 58' ' ' LEU . 76.2 m -57.58 -44.7 85.55 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.443 -179.426 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.0 -62.47 5.18 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 179.626 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.7 t -48.23 -35.62 12.29 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 -179.947 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.8 mt -61.74 -44.67 96.46 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.735 -0.386 . . . . 0.0 111.209 179.467 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.44 HD13 ' O ' ' A' ' 54' ' ' THR . 9.2 mp -65.1 -41.67 94.72 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.27 177.949 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.19 -41.42 99.18 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.966 -179.254 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.432 ' O ' HG23 ' A' ' 60' ' ' ILE . 8.3 tp -88.15 17.41 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.783 -179.637 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 56.46 84.72 0.08 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.674 -179.951 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.8 59.21 0.09 OUTLIER Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.038 -179.79 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -51.09 151.28 12.31 Favored 'Trans proline' 0 C--N 1.296 -2.197 0 C-N-CA 122.779 2.319 . . . . 0.0 112.39 -178.228 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.435 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -108.59 145.21 15.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.332 -179.632 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.8 mt -63.77 -45.17 97.96 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.274 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.37 -179.766 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.496 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -129.76 134.38 47.56 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 120.877 0.37 . . . . 0.0 110.587 -179.811 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.492 ' O ' ' N ' ' A' ' 98' ' ' LEU . 73.2 m -134.76 158.76 43.33 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.804 -179.609 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.42 138.76 16.1 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 179.794 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.47 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.79 -162.79 0.08 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.916 0.388 . . . . 0.0 110.516 -179.908 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.532 HG22 ' CD2' ' A' ' 297' ' ' PHE . 6.0 t -133.88 135.46 43.68 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.27 179.996 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.495 ' C ' ' O ' ' A' ' 70' ' ' THR . 1.0 OUTLIER 29.34 68.57 0.64 Allowed Pre-proline 0 N--CA 1.465 0.303 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.637 -179.624 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -61.21 145.67 98.34 Favored 'Trans proline' 0 C--N 1.301 -1.946 0 C-N-CA 122.654 2.236 . . . . 0.0 112.018 -178.344 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.533 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 45.0 p-10 -160.46 -31.26 0.06 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.695 179.75 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.544 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 98.8 m-20 -64.69 -38.97 92.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.47 179.959 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.6 ttt180 -60.99 -48.08 83.48 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.621 -179.347 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.424 ' O ' ' O ' ' A' ' 77' ' ' ALA . 96.7 t -60.22 -24.84 31.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.023 179.631 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.544 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -45.68 172.96 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.497 179.731 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.584 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.4 p30 -62.47 177.83 0.47 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.604 -179.709 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.558 ' C ' ' H ' ' A' ' 81' ' ' GLY . 36.5 p30 -45.05 85.34 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.988 -180.0 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.584 ' N ' ' O ' ' A' ' 78' ' ' ASP . 42.0 tp60 -67.49 13.4 0.07 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.185 -179.892 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.558 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 118.4 -22.45 9.51 Favored Glycine 0 CA--C 1.519 0.319 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 179.951 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -108.03 116.22 31.56 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.986 0.422 . . . . 0.0 110.504 179.848 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 74.7 mt -98.09 0.17 45.61 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.511 -179.725 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -92.48 7.29 43.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.43 -179.815 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.784 ' O ' HG22 ' A' ' 89' ' ' VAL . 27.2 mt-30 -100.2 -26.58 13.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.78 179.981 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.4 t-105 -64.54 -40.76 96.18 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.018 -179.647 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.556 ' O ' ' N ' ' A' ' 91' ' ' LYS . 65.3 m -77.89 -53.84 7.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.131 -179.487 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -47.67 -50.97 23.29 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.982 -179.354 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.784 HG22 ' O ' ' A' ' 85' ' ' GLN . 14.9 m -69.1 -41.14 81.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.101 179.818 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.507 ' N ' HG23 ' A' ' 89' ' ' VAL . . . -71.7 -23.18 61.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.725 -179.876 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.556 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.0 tttm -61.73 -45.78 92.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.469 -179.53 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.443 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.7 mm-40 -90.13 -95.2 0.11 Allowed 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.175 -179.913 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.638 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.9 mtt180 -142.75 59.29 1.43 Allowed 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.755 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.461 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.7 pttp 33.37 26.1 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.169 -179.061 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.638 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.3 tt -48.04 123.41 6.2 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.916 -178.142 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.456 ' O ' HD23 ' A' ' 95' ' ' LEU . 98.9 mm-40 -83.65 -169.64 2.66 Favored 'General case' 0 N--CA 1.455 -0.175 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.198 179.963 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.61 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 82.1 mtp180 -74.4 136.91 42.42 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.282 -179.82 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.492 ' N ' ' O ' ' A' ' 67' ' ' SER . 90.5 mt -85.91 -165.64 1.3 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.743 -179.63 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.537 ' O ' ' CD2' ' A' ' 99' ' ' TYR . 47.7 p90 -169.05 119.76 0.72 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.268 179.99 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.518 ' C ' ' O ' ' A' ' 99' ' ' TYR . 43.3 mm -28.76 120.91 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.017 -179.693 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 114.53 27.09 3.44 Favored Glycine 0 CA--C 1.521 0.415 0 N-CA-C 111.149 -0.78 . . . . 0.0 111.149 -179.544 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.586 ' CD ' ' H ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -144.27 46.33 0.62 Allowed Pre-proline 0 C--N 1.323 -0.57 0 CA-C-O 120.927 0.394 . . . . 0.0 110.499 179.901 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 29.3 Cg_endo -61.92 143.82 95.9 Favored 'Trans proline' 0 C--N 1.297 -2.171 0 C-N-CA 122.7 2.267 . . . . 0.0 111.975 -179.899 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.452 ' O ' HG23 ' A' ' 108' ' ' VAL . 26.2 t -173.3 120.13 0.33 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.445 179.78 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.75 -40.35 63.56 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.065 0.46 . . . . 0.0 111.041 179.744 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.25 -39.98 89.88 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.798 -179.371 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.06 -39.99 95.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.744 -179.824 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 104' ' ' SER . 70.3 t -67.65 -43.77 86.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.753 179.708 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.74 -38.99 92.68 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.561 -179.246 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.443 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.66 -23.4 63.04 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.479 179.863 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.551 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.3 mm-40 -90.18 5.15 48.21 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.713 -179.554 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.551 ' C ' ' O ' ' A' ' 111' ' ' GLN . 10.5 tpt 23.44 64.17 0.38 Allowed Pre-proline 0 N--CA 1.465 0.293 0 CA-C-O 120.859 0.361 . . . . 0.0 110.982 -179.769 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -78.22 167.27 23.45 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 C-N-CA 122.971 2.447 . . . . 0.0 112.082 -178.448 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.523 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 98.8 m-20 -110.04 -42.14 4.28 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.145 179.426 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 41.2 tp -121.19 120.65 35.84 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 179.506 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 83.5 mt -113.29 128.92 69.86 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.343 0 CA-C-O 120.978 0.418 . . . . 0.0 110.88 -179.897 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.619 HD12 ' OG ' ' A' ' 48' ' ' SER . 30.2 mt -109.42 132.27 54.29 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 121.061 0.458 . . . . 0.0 110.218 -179.73 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.49 HD12 HG23 ' A' ' 139' ' ' THR . 98.9 mt -119.8 138.96 48.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.693 -179.718 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 85.8 p -72.75 153.96 40.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.594 -179.949 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.11 -50.21 74.6 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.686 -179.855 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -149.52 153.97 38.02 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.567 179.869 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 170.66 -170.97 43.51 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 179.876 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.88 -34.13 88.97 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 179.912 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.449 ' OD1' ' O ' ' A' ' 124' ' ' ASP . 44.3 p-10 -87.03 120.67 28.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.821 0.343 . . . . 0.0 110.651 179.983 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.446 ' O ' HD12 ' A' ' 129' ' ' LEU . 36.1 t -63.26 143.79 57.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.472 -179.935 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.52 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.12 -43.81 8.68 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.944 -179.898 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 56.0 tp -62.93 -42.44 99.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.748 -179.888 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.28 -11.92 58.77 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.522 -179.421 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.446 HD12 ' O ' ' A' ' 125' ' ' SER . 84.2 mt -115.37 -23.56 8.82 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.637 -179.811 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 130' ' ' TYR . . . . . 0.52 ' N ' ' O ' ' A' ' 126' ' ' ALA . 79.4 t80 -51.09 -49.46 60.66 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.542 -178.883 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 37.7 p-10 -66.33 -42.61 87.94 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.832 0.349 . . . . 0.0 111.138 179.618 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.519 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 88.2 mt-30 -66.92 -37.53 84.51 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.74 -179.995 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.431 HD12 HD11 ' A' ' 118' ' ' ILE . 96.3 mt -80.63 -41.28 24.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.868 -179.585 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.2 t -57.13 -44.54 83.42 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.269 -179.139 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.3 m -61.93 -45.32 94.22 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.802 0.334 . . . . 0.0 110.566 179.411 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 94.0 mt -62.02 -43.63 97.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.277 -179.836 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.662 ' HB1' ' HD2' ' A' ' 138' ' ' PRO . . . -169.45 168.25 4.94 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.499 179.895 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.662 ' HD2' ' HB1' ' A' ' 137' ' ' ALA . 52.4 Cg_exo -49.95 112.82 0.79 Allowed 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.297 1.998 . . . . 0.0 112.224 179.339 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.49 HG23 HD12 ' A' ' 118' ' ' ILE . 24.0 m -84.36 127.52 34.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.644 -179.968 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.679 HD13 ' CD2' ' A' ' 37' ' ' HIS . 34.7 tp -118.03 136.68 53.39 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.09 -179.781 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.441 ' O ' ' OD2' ' A' ' 32' ' ' ASP . 81.6 mt -100.57 118.83 47.84 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 CA-C-O 121.182 0.515 . . . . 0.0 111.128 -179.319 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.42 HD12 HD22 ' A' ' 117' ' ' LEU . 97.8 mt -134.71 132.14 54.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.669 179.591 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.548 ' ND2' ' H ' ' A' ' 144' ' ' TYR . 2.2 t-20 -67.56 153.71 43.09 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.893 0.378 . . . . 0.0 110.469 179.38 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.548 ' H ' ' ND2' ' A' ' 143' ' ' ASN . 89.2 t80 -87.51 122.15 30.86 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.861 -179.55 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.525 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 99.0 m-20 55.33 69.5 0.73 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.762 179.651 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 49.5 p-10 -123.84 -0.69 8.48 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.631 179.88 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -151.07 116.14 5.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.712 -179.534 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 83.2 p -62.85 167.88 4.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.474 -179.788 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.417 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.3 p-90 -51.38 -15.81 0.46 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.517 -179.86 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 150' ' ' GLN . . . . . 0.445 ' O ' HG23 ' A' ' 154' ' ' THR . 68.0 tp60 -70.71 -75.32 0.12 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.493 -179.771 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 11.1 t -62.75 -38.88 92.32 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.366 179.491 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 55.7 tp -59.91 -45.8 91.39 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.422 -178.649 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.417 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 46.8 tp -62.71 -41.63 99.25 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.425 179.057 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.445 HG23 ' O ' ' A' ' 150' ' ' GLN . 60.0 p -64.46 -35.01 79.53 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.31 -179.55 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 155' ' ' GLN . . . . . 0.432 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.5 mm-40 -64.28 -42.88 96.22 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.383 179.374 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 91.5 mt -65.39 -38.91 91.4 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.072 0.463 . . . . 0.0 110.272 179.166 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.582 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.31 -32.08 79.5 Favored Glycine 0 CA--C 1.52 0.347 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 -179.382 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.44 ' C ' ' O ' ' A' ' 157' ' ' GLY . 97.1 mt-10 -35.25 -27.31 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.816 0.341 . . . . 0.0 110.821 179.894 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.582 ' N ' ' O ' ' A' ' 157' ' ' GLY . 95.1 mt -55.57 150.07 2.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.319 179.263 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 73.9 p -70.13 137.34 50.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.057 -179.59 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 72.26 18.44 78.1 Favored Glycine 0 N--CA 1.458 0.163 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 179.507 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 57.3 m80 -119.8 -15.52 8.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.747 0.308 . . . . 0.0 110.606 179.866 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -63.92 -60.78 2.83 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.655 -179.631 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -51.91 -49.42 63.09 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.201 -179.666 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -60.27 -41.24 92.9 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.752 0.31 . . . . 0.0 110.348 179.539 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.49 -47.2 86.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.576 179.851 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.94 -40.17 75.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.259 -179.894 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -61.88 -50.2 73.16 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.578 179.595 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -65.39 -43.73 89.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.492 179.532 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 95.0 mt -64.73 -43.38 96.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.488 179.739 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.36 -51.12 70.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.533 -179.215 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.46 -43.95 95.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.464 179.732 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 173' ' ' PHE . . . . . 0.656 ' CE2' HD11 ' A' ' 177' ' ' LEU . 56.2 t80 -62.83 -44.45 96.1 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.085 0.469 . . . . 0.0 110.44 179.451 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -63.51 -39.98 95.85 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.566 -179.337 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -62.94 -42.77 99.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.64 179.259 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -60.73 -45.07 95.68 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.172 179.945 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.656 HD11 ' CE2' ' A' ' 173' ' ' PHE . 84.4 mt -64.61 -41.06 96.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.036 0.446 . . . . 0.0 110.693 178.918 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -51.93 -62.61 1.52 Allowed 'General case' 0 C--O 1.237 0.441 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.473 -179.343 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.89 -46.58 87.51 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.664 179.767 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.31 -41.77 65.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.281 179.939 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -63.85 -33.84 76.59 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.969 0.414 . . . . 0.0 110.371 179.256 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 182' ' ' GLU . . . . . 0.425 ' O ' ' HG2' ' A' ' 182' ' ' GLU . 69.5 tt0 -90.47 9.06 30.75 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.37 0.605 . . . . 0.0 110.516 -178.998 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -105.06 -31.99 8.92 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.202 179.555 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.4 pt -128.11 147.52 32.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.828 -179.873 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -140.06 131.14 26.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.423 179.358 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 186' ' ' LEU . . . . . 0.597 HD22 ' N ' ' A' ' 186' ' ' LEU . 3.6 mm? -85.63 133.08 42.61 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.844 -179.947 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -44.0 157.78 0.14 Allowed 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.714 2.276 . . . . 0.0 112.153 179.341 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 188' ' ' PRO . . . . . 0.524 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.6 Cg_endo -62.78 115.23 2.8 Favored 'Trans proline' 0 C--N 1.304 -1.81 0 C-N-CA 122.775 2.317 . . . . 0.0 111.808 179.772 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 189' ' ' GLN . . . . . 0.524 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.8 mt-30 155.61 147.52 0.0 OUTLIER Pre-proline 0 C--N 1.332 -0.169 0 O-C-N 123.618 0.574 . . . . 0.0 110.782 -179.791 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -73.76 143.43 33.56 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.659 2.239 . . . . 0.0 111.956 177.983 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.499 HG23 ' OG ' ' A' ' 258' ' ' SER . 2.0 p -124.81 159.02 31.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.276 0.56 . . . . 0.0 110.189 179.959 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 192' ' ' THR . . . . . 0.497 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 35.7 p -143.48 165.47 27.47 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.094 -179.638 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 193' ' ' ALA . . . . . 0.443 ' HA ' ' H ' ' A' ' 260' ' ' PHE . . . -135.34 128.43 31.69 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 121.128 0.49 . . . . 0.0 110.24 179.576 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.509 HD11 HD23 ' A' ' 259' ' ' LEU . 47.8 pt -146.35 148.79 16.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.046 179.986 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 195' ' ' VAL . . . . . 0.746 HG13 ' CD1' ' A' ' 262' ' ' PHE . 70.3 t -117.6 122.89 70.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.222 0.534 . . . . 0.0 109.734 179.122 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -134.06 107.37 7.72 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.261 179.77 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 94.6 m -131.11 130.45 43.15 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.797 179.784 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.412 ' O ' ' N ' ' A' ' 201' ' ' HIS . . . -82.74 -37.24 24.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.275 179.692 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.32 -67.02 0.26 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.366 -179.973 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.31 -9.76 58.91 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.316 179.425 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 201' ' ' HIS . . . . . 0.412 ' N ' ' O ' ' A' ' 198' ' ' ALA . 59.7 t-80 60.54 58.27 2.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.628 -179.902 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 45.7 p -166.92 153.26 8.34 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.527 179.611 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.36 144.16 24.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.976 0.417 . . . . 0.0 110.442 179.488 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -135.34 138.1 43.05 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.63 -179.941 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 20.2 mt -106.28 125.56 51.15 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 121.116 0.484 . . . . 0.0 109.934 -179.701 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 206' ' ' TRP . . . . . 0.558 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 75.4 m95 -82.25 167.18 18.9 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.649 -179.727 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 207' ' ' THR . . . . . 0.467 HG22 ' C ' ' A' ' 206' ' ' TRP . 0.1 OUTLIER -156.88 171.56 7.27 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 120.943 0.402 . . . . 0.0 110.563 -179.194 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_exo -53.94 -36.89 85.2 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 C-N-CA 122.659 2.24 . . . . 0.0 112.16 179.256 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -70.55 -34.93 72.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.761 -179.772 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 21.9 m -61.56 150.54 35.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.543 -179.27 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.42 -36.97 81.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.457 -179.732 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 212' ' ' GLN . . . . . 0.558 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 54.4 tt0 -64.5 -40.28 95.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.472 179.967 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.87 -43.27 91.91 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 179.812 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -63.55 -43.46 97.03 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.752 0.31 . . . . 0.0 110.29 179.807 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 215' ' ' MET . . . . . 0.519 ' SD ' ' HB2' ' A' ' 304' ' ' ALA . 65.3 ttp -59.49 -48.25 82.36 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.234 -179.809 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 216' ' ' LEU . 88.4 mt -60.37 -40.8 92.12 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.536 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 217' ' ' GLU . . . . . 0.457 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.4 tp10 -57.99 -37.93 75.17 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 179.751 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -65.22 -37.94 88.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.847 0.356 . . . . 0.0 110.676 179.68 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 94.1 mt -64.47 -42.73 95.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.582 -179.645 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.59 44.59 0.08 OUTLIER Glycine 0 C--N 1.334 0.426 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 -179.921 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 221' ' ' PHE . . . . . 0.457 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 26.3 m-85 -127.73 155.22 44.34 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.033 0.445 . . . . 0.0 110.49 -179.82 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.484 ' O ' HG13 ' A' ' 191' ' ' VAL . 6.6 p -106.94 122.06 45.68 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.189 0.519 . . . . 0.0 110.198 -179.961 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.467 HD22 ' C ' ' A' ' 222' ' ' THR . 4.3 mm? -100.81 133.46 45.24 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.101 -179.97 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -97.24 158.76 15.29 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.44 179.916 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -104.84 115.21 29.92 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.384 179.898 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.496 HD12 ' N ' ' A' ' 226' ' ' LEU . 9.1 mp -53.32 156.57 3.95 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.705 179.86 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -60.26 145.38 98.7 Favored 'Trans proline' 0 C--N 1.301 -1.943 0 C-N-CA 122.711 2.274 . . . . 0.0 112.119 179.218 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.46 -2.89 58.93 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.557 -179.992 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.32 -40.83 5.65 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 111.029 -0.828 . . . . 0.0 111.029 -179.887 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 230' ' ' LEU . . . . . 0.543 ' O ' ' N ' ' A' ' 233' ' ' SER . 86.0 mt -79.28 -16.89 55.7 Favored 'General case' 0 C--O 1.224 -0.257 0 CA-C-O 121.018 0.437 . . . . 0.0 110.356 -179.755 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 231' ' ' ASN . . . . . 0.405 ' C ' ' O ' ' A' ' 230' ' ' LEU . 54.6 t-20 -40.05 -49.23 2.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.691 -179.592 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -88.28 15.43 7.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.813 0.339 . . . . 0.0 111.277 179.935 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 233' ' ' SER . . . . . 0.543 ' N ' ' O ' ' A' ' 230' ' ' LEU . 78.1 p -60.48 -35.63 76.36 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.648 -179.77 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 234' ' ' GLN . . . . . 0.525 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.6 tt0 -118.25 -69.43 0.85 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.954 179.588 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 3.9 m -70.16 103.45 2.33 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.691 -179.744 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -94.59 57.74 2.26 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.345 180.0 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -144.99 -122.57 1.56 Allowed Glycine 0 CA--C 1.519 0.343 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 -179.977 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -134.41 111.85 10.48 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.094 0.473 . . . . 0.0 110.413 179.964 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 239' ' ' ARG . . . . . 0.513 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.4 mtt180 -148.11 57.39 1.08 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.762 -179.972 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -69.71 -31.89 70.15 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.511 179.664 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 241' ' ' ASP . . . . . 0.543 ' OD2' ' ND2' ' A' ' 143' ' ' ASN . 65.1 t0 -56.71 -46.99 80.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.404 -179.167 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 242' ' ' ILE . . . . . 0.436 ' O ' ' O ' ' A' ' 239' ' ' ARG . 17.4 tt -140.33 157.27 24.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.886 0.374 . . . . 0.0 110.524 179.748 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.444 HG22 HD13 ' A' ' 245' ' ' LEU . 96.0 mt -106.01 106.08 19.9 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.191 0 CA-C-O 121.125 0.488 . . . . 0.0 110.465 179.886 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 244' ' ' GLN . . . . . 0.602 ' O ' HD12 ' A' ' 245' ' ' LEU . 88.2 mt-30 -110.36 110.17 20.86 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.392 179.755 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.602 HD12 ' O ' ' A' ' 244' ' ' GLN . 9.5 mp -121.9 -168.19 1.66 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.641 179.774 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 246' ' ' GLY . . . . . 0.525 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.25 -16.66 0.05 OUTLIER Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.956 -0.857 . . . . 0.0 110.956 179.894 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 247' ' ' GLY . . . . . 0.67 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -60.46 157.03 29.73 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 -179.83 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -63.82 21.43 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.971 0.415 . . . . 0.0 110.58 179.945 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 249' ' ' ASN . . . . . 0.67 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.7 m-20 -97.18 -5.93 35.94 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.544 179.983 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 92.6 mt -80.2 -21.58 42.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.604 179.589 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.54 -51.24 70.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.728 -179.579 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.76 -5.33 58.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.481 179.659 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.16 -74.45 1.14 Allowed Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.911 -0.875 . . . . 0.0 110.911 -179.96 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 81.7 mt -69.89 125.93 28.2 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.977 0.418 . . . . 0.0 110.329 -179.859 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -59.22 -39.49 82.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.295 -179.711 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 82.64 51.93 4.11 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 179.95 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -96.22 -14.89 22.36 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.644 0.259 . . . . 0.0 110.541 -179.864 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 258' ' ' SER . . . . . 0.499 ' OG ' HG23 ' A' ' 191' ' ' VAL . 3.5 t 174.78 88.55 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.029 0.442 . . . . 0.0 110.194 179.978 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.86 HD12 ' N ' ' A' ' 259' ' ' LEU . 0.9 OUTLIER -94.18 124.08 37.97 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.241 0.544 . . . . 0.0 111.066 -179.058 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 260' ' ' PHE . . . . . 0.443 ' H ' ' HA ' ' A' ' 193' ' ' ALA . 15.9 m-30 -93.03 146.45 23.62 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.342 179.17 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 86.1 mt -122.41 149.82 43.29 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.529 -179.905 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.746 ' CD1' HG13 ' A' ' 195' ' ' VAL . 2.6 p90 -77.63 -138.36 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.562 -179.838 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 263' ' ' ALA . . . . . 0.66 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -52.1 77.45 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.993 -179.989 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 264' ' ' GLY . . . . . 0.633 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -178.98 104.42 0.19 Allowed Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 -179.976 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 265' ' ' ASP . . . . . 0.602 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.8 m-20 -80.47 -177.74 6.35 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 120.725 0.298 . . . . 0.0 110.896 -179.527 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -40.39 -17.71 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.853 0.358 . . . . 0.0 110.552 179.786 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 267' ' ' LYS . . . . . 0.602 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.71 -51.42 41.75 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.688 179.516 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -63.74 -46.83 83.59 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.175 179.314 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 269' ' ' ALA . . . . . 0.573 ' HB1' ' OH ' ' A' ' 273' ' ' TYR . . . -61.47 -35.05 76.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.111 0.481 . . . . 0.0 109.884 179.533 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -63.22 -34.42 77.62 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.119 179.712 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.36 -43.37 13.73 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.171 -179.572 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 272' ' ' ILE . . . . . 0.589 ' C ' ' H ' ' A' ' 274' ' ' ALA . 5.0 tt -51.37 -33.83 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.893 -178.824 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 273' ' ' TYR . . . . . 0.573 ' OH ' ' HB1' ' A' ' 269' ' ' ALA . 17.2 m-85 -54.24 -1.82 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.647 -179.638 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 274' ' ' ALA . . . . . 0.589 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.58 -39.43 70.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.87 179.603 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 275' ' ' ASN . . . . . 0.583 ' O ' ' N ' ' A' ' 279' ' ' ALA . 3.0 p30 -39.65 98.33 0.17 Allowed Pre-proline 0 N--CA 1.462 0.143 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.506 -179.638 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -54.16 -43.11 61.39 Favored 'Trans proline' 0 C--N 1.304 -1.812 0 C-N-CA 122.389 2.06 . . . . 0.0 112.619 -178.793 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 89.3 mt -64.45 -42.86 95.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.109 -179.613 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 91.0 mt -95.7 -1.64 49.57 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.872 -179.373 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 279' ' ' ALA . . . . . 0.583 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.35 -34.75 77.27 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.678 -179.85 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.4 20.1 0.12 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.966 -179.212 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 281' ' ' LEU . . . . . 0.489 HD23 ' HA ' ' A' ' 281' ' ' LEU . 13.9 mt -75.19 120.04 79.8 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.505 179.916 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -50.69 -39.48 56.73 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.577 2.185 . . . . 0.0 111.951 179.035 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.8 -50.56 63.38 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.132 179.885 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 74.5 t -61.45 -43.79 97.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.482 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -57.98 -41.22 82.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.28 -179.972 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -90.9 0.14 57.58 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.145 179.575 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt 59.55 43.04 16.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.82 179.568 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -94.66 41.49 1.09 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.38 179.852 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 53.6 t -118.79 136.02 57.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.999 0.428 . . . . 0.0 110.193 -179.759 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -133.17 162.73 30.98 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.665 -179.639 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.9 155.22 33.13 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.968 0.413 . . . . 0.0 110.735 -179.86 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 81.0 mt -93.89 -1.49 54.69 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.235 -179.803 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.06 165.66 12.74 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.689 -0.965 . . . . 0.0 110.689 -179.735 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 6.8 m -87.15 -62.3 1.53 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.892 0.377 . . . . 0.0 111.009 -179.888 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 295' ' ' GLU . . . . . 0.436 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.6 mm-40 -69.57 -3.88 16.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.628 -179.833 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 28.1 p -77.09 32.91 0.14 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.618 -179.96 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 297' ' ' PHE . . . . . 0.532 ' CD2' HG22 ' A' ' 70' ' ' THR . 70.2 t80 -60.19 -46.06 91.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.546 -179.971 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 298' ' ' ARG . . . . . 0.61 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.3 mtt85 -81.49 134.01 35.47 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.45 -179.652 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.421 ' H ' HG11 ' A' ' 51' ' ' VAL . 16.1 tp -114.31 119.75 38.06 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.253 179.924 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 300' ' ' ASP . . . . . 0.625 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.4 p-10 -167.8 -173.9 2.27 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.524 179.95 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 84.0 t80 -48.25 -46.0 35.11 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.227 -179.644 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -64.65 -41.61 96.0 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.998 0.428 . . . . 0.0 110.702 179.015 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 303' ' ' SER . . . . . 0.625 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 52.0 p -55.44 -36.11 66.17 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.099 -179.269 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 304' ' ' ALA . . . . . 0.519 ' HB2' ' SD ' ' A' ' 215' ' ' MET . . . -56.92 -51.76 67.87 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.482 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 91.5 mtp -56.06 -43.87 78.32 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.8 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -66.38 -42.74 87.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.953 0.406 . . . . 0.0 110.207 178.798 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 307' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 303' ' ' SER . 55.2 t -64.04 -42.89 97.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.261 179.39 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 42.8 tp -59.62 -42.04 91.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.893 -179.616 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -62.87 -38.76 92.12 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.064 179.475 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 310' ' ' ARG . . . . . 0.435 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.6 ttt85 -63.5 -44.03 95.52 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.238 179.569 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 88.5 mt -63.23 -41.93 99.17 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.226 179.548 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -62.9 -33.23 74.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.083 179.492 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.85 -23.51 21.65 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.423 -179.862 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 314' ' ' LEU . . . . . 0.479 HD22 ' CE2' ' A' ' 315' ' ' PHE . 6.7 tt -62.33 -43.22 99.33 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 121.06 0.457 . . . . 0.0 110.57 -179.92 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 315' ' ' PHE . . . . . 0.479 ' CE2' HD22 ' A' ' 314' ' ' LEU . 91.0 m-85 . . . . . 0 C--O 1.22 -0.498 0 CA-C-O 118.003 -0.999 . . . . 0.0 110.482 179.966 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -99.51 135.79 40.4 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.464 -179.926 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.498 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -92.11 178.48 1.69 Allowed Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.532 -179.863 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.498 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.7 Cg_exo -61.54 147.16 96.1 Favored 'Trans proline' 0 C--N 1.301 -1.961 0 C-N-CA 122.696 2.264 . . . . 0.0 112.161 179.576 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.487 ' HE ' HD12 ' A' ' 39' ' ' LEU . 35.4 ptt180 -136.33 142.39 43.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.624 179.692 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -79.7 116.78 20.08 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.453 179.872 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.46 ' O ' HG23 ' A' ' 30' ' ' ILE . 9.4 tp -111.54 130.11 65.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.46 179.969 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.4 t -71.14 141.7 50.75 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.599 179.81 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.478 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.1 t0 -138.71 -179.73 5.99 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.524 179.997 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.478 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 78.3 p -73.72 -37.51 65.1 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.856 179.84 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -46.64 -94.74 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.313 -179.411 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -166.24 -26.76 0.02 OUTLIER Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 179.919 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 63.7 m -168.42 105.72 0.46 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.857 0.361 . . . . 0.0 110.603 -179.968 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.646 ' CD2' HD13 ' A' ' 140' ' ' LEU . 68.2 t60 -128.87 146.43 50.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.038 0.447 . . . . 0.0 110.324 179.97 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.62 HG22 ' N ' ' A' ' 39' ' ' LEU . 100.0 m -129.82 165.6 21.63 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.608 -179.928 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.62 ' N ' HG22 ' A' ' 38' ' ' THR . 80.5 mt -120.3 127.37 52.3 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.466 179.683 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -65.56 -44.53 86.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.605 -179.978 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 40.8 p -165.91 154.88 11.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.456 179.743 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.482 ' CD ' ' H ' ' A' ' 42' ' ' GLN . 14.5 mp0 -45.4 101.64 0.27 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.658 179.443 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -57.66 129.83 35.65 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 C-N-CA 122.294 1.996 . . . . 0.0 112.263 -179.759 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -82.84 -24.92 33.06 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.472 179.593 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.537 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.7 mtm-85 -120.73 134.34 55.29 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 121.125 0.488 . . . . 0.0 110.264 -179.931 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.1 mt -130.23 133.29 64.33 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.091 -179.85 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 47.3 t -124.79 130.96 73.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 179.404 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.621 ' OG ' HD12 ' A' ' 117' ' ' LEU . 4.4 m -155.19 166.48 33.45 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.578 179.666 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 62.4 p -124.53 8.94 8.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.411 -179.981 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.1 t -85.38 125.53 33.05 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.655 -179.467 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.457 HG11 ' H ' ' A' ' 299' ' ' LEU . 90.8 t -65.72 -44.64 93.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.542 179.961 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.7 m -62.62 -44.39 96.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.655 -179.862 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 53.5 tp -62.18 -41.66 98.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.659 -179.459 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.465 ' O ' HD13 ' A' ' 58' ' ' LEU . 74.7 m -57.63 -44.54 85.65 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.384 -179.426 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.36 -61.98 5.52 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.941 -0.863 . . . . 0.0 110.941 179.561 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.7 t -48.48 -35.7 13.56 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 -179.979 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.9 mt -61.76 -44.56 96.65 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.644 -0.422 . . . . 0.0 111.136 179.344 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.465 HD13 ' O ' ' A' ' 54' ' ' THR . 9.4 mp -64.72 -42.07 95.5 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.329 177.961 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.405 ' HB1' ' NE ' ' A' ' 169' ' ' ARG . . . -63.54 -41.16 98.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.086 -179.197 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.43 ' O ' HG23 ' A' ' 60' ' ' ILE . 8.1 tp -88.04 16.76 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.735 -179.668 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 56.62 83.78 0.1 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.631 179.972 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.71 57.02 0.07 OUTLIER Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.049 -179.815 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -49.54 153.15 5.51 Favored 'Trans proline' 0 C--N 1.296 -2.21 0 C-N-CA 122.811 2.341 . . . . 0.0 112.638 -178.559 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.432 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -109.03 146.26 14.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.371 -179.734 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 97.0 mt -63.9 -44.86 98.13 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.298 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.488 -179.885 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.502 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -130.27 134.61 47.35 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.512 -179.774 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.485 ' O ' ' N ' ' A' ' 98' ' ' LEU . 72.2 m -134.52 158.6 43.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.859 -179.663 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.55 139.24 16.39 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 110.671 -0.972 . . . . 0.0 110.671 179.848 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.488 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.88 -162.67 0.08 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.95 0.405 . . . . 0.0 110.535 -179.992 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.511 HG22 ' CD2' ' A' ' 297' ' ' PHE . 5.8 t -133.71 135.81 44.26 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.177 -179.973 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.491 ' C ' ' O ' ' A' ' 70' ' ' THR . 0.9 OUTLIER 29.6 68.33 0.67 Allowed Pre-proline 0 N--CA 1.465 0.291 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.713 -179.689 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -60.64 145.23 99.21 Favored 'Trans proline' 0 C--N 1.3 -2.009 0 C-N-CA 122.576 2.184 . . . . 0.0 112.167 -178.566 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.523 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 46.2 p-10 -160.65 -31.97 0.05 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.674 179.74 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.529 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 98.8 m-20 -64.31 -38.96 92.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.367 179.973 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -61.15 -47.88 84.15 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.636 -179.236 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.423 ' O ' ' O ' ' A' ' 77' ' ' ALA . 94.4 t -60.21 -24.56 30.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.659 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.529 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -45.64 172.6 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.535 179.881 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.575 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.8 p30 -61.68 177.6 0.4 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.653 -179.707 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.566 ' C ' ' H ' ' A' ' 81' ' ' GLY . 36.1 p30 -45.87 85.54 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.97 179.872 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.575 ' N ' ' O ' ' A' ' 78' ' ' ASP . 43.0 tp60 -67.19 13.59 0.06 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.072 0.463 . . . . 0.0 110.12 -179.774 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.566 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 117.72 -22.0 10.2 Favored Glycine 0 C--N 1.331 0.285 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 179.981 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -107.93 116.35 31.8 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.022 0.439 . . . . 0.0 110.518 179.849 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 75.8 mt -98.8 0.57 44.63 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.516 -179.698 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -91.88 6.61 45.49 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.988 0.423 . . . . 0.0 110.47 -179.707 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.798 ' O ' HG22 ' A' ' 89' ' ' VAL . 27.2 mt-30 -99.89 -28.08 13.28 Favored 'General case' 0 C--O 1.224 -0.266 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.784 179.973 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 68.9 t-105 -63.03 -41.07 99.43 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.913 -179.722 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.556 ' O ' ' N ' ' A' ' 91' ' ' LYS . 67.4 m -77.34 -53.53 7.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.313 -179.441 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -48.4 -50.85 29.22 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.979 -179.337 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.798 HG22 ' O ' ' A' ' 85' ' ' GLN . 15.6 m -68.9 -40.83 81.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 120.914 0.388 . . . . 0.0 111.075 179.748 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.5 ' N ' HG23 ' A' ' 89' ' ' VAL . . . -72.1 -22.96 61.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.775 -179.912 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.556 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.0 tttm -61.35 -45.69 93.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.45 -179.502 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.437 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.7 mm-40 -90.73 -94.34 0.12 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.091 -179.977 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.633 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.9 mtt180 -143.36 59.95 1.4 Allowed 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.81 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.461 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.7 pttp 33.54 26.27 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 120.791 0.329 . . . . 0.0 110.115 -179.291 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.633 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.5 tt -47.97 122.84 5.45 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.995 -178.243 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.447 ' O ' HD23 ' A' ' 95' ' ' LEU . 98.9 mm-40 -83.25 -169.9 2.77 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.016 -179.882 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.614 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 83.0 mtp180 -73.51 137.88 44.7 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.29 -179.813 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.485 ' N ' ' O ' ' A' ' 67' ' ' SER . 89.0 mt -86.81 -166.2 1.5 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.701 -179.519 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.533 ' O ' ' CD2' ' A' ' 99' ' ' TYR . 47.4 p90 -167.97 120.05 0.86 Allowed 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.296 179.939 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.511 ' C ' ' O ' ' A' ' 99' ' ' TYR . 42.9 mm -29.59 121.25 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.939 -179.639 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 113.96 28.13 3.24 Favored Glycine 0 CA--C 1.519 0.341 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 -179.542 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.587 ' CD ' ' H ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -144.02 45.81 0.59 Allowed Pre-proline 0 C--N 1.324 -0.53 0 CA-C-O 120.932 0.396 . . . . 0.0 110.508 179.883 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 30.5 Cg_endo -62.0 143.72 95.5 Favored 'Trans proline' 0 C--N 1.297 -2.152 0 C-N-CA 122.667 2.245 . . . . 0.0 112.033 179.921 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.476 ' O ' HG23 ' A' ' 108' ' ' VAL . 23.1 t -173.43 120.52 0.33 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.404 179.715 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.22 -41.09 64.15 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.057 0.456 . . . . 0.0 111.231 179.652 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -65.93 -40.26 91.26 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.942 -179.412 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.87 -39.87 95.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.699 -179.852 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 104' ' ' SER . 69.5 t -67.39 -43.91 87.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.863 179.627 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.33 -39.0 91.63 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.602 -179.265 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.437 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.58 -23.49 62.96 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.013 0.435 . . . . 0.0 110.505 179.817 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.555 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.4 mm-40 -91.07 4.73 51.37 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.72 -179.5 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.555 ' C ' ' O ' ' A' ' 111' ' ' GLN . 10.6 tpt 23.56 63.85 0.38 Allowed Pre-proline 0 N--CA 1.465 0.32 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.916 179.971 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.445 ' HG2' HD11 ' A' ' 116' ' ' ILE . 69.8 Cg_endo -78.3 168.79 21.12 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 C-N-CA 122.918 2.412 . . . . 0.0 112.344 -178.645 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.525 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 98.9 m-20 -113.15 -44.16 3.29 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.939 179.639 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 39.9 tp -120.71 119.77 33.76 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.619 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.455 HD13 HD22 ' A' ' 133' ' ' LEU . 95.7 mt -116.99 131.14 70.56 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.3 0 CA-C-O 120.909 0.385 . . . . 0.0 110.949 -179.91 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.621 HD12 ' OG ' ' A' ' 48' ' ' SER . 30.7 mt -106.06 132.77 51.74 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 121.104 0.478 . . . . 0.0 110.236 -179.387 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.419 HD12 HG23 ' A' ' 139' ' ' THR . 98.0 mt -118.31 136.37 55.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.699 -179.633 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 85.9 p -71.98 153.22 41.93 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.666 179.978 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.19 -50.1 75.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.625 -179.84 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -149.37 153.82 37.99 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.535 179.823 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 169.67 -170.42 42.71 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 179.837 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -63.01 -35.05 91.57 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 110.824 -0.91 . . . . 0.0 110.824 179.986 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' A' ' 124' ' ' ASP . 43.8 p-10 -87.86 119.9 28.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.797 0.332 . . . . 0.0 110.694 179.933 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.444 ' O ' HD12 ' A' ' 129' ' ' LEU . 40.5 t -63.39 144.17 57.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.472 -179.969 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.522 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.59 -43.03 8.88 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.837 -179.874 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.3 tp -62.66 -42.42 99.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.663 -179.931 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.78 -11.04 57.64 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.518 -179.403 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.444 HD12 ' O ' ' A' ' 125' ' ' SER . 84.9 mt -115.96 -23.72 8.43 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.749 -179.868 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 130' ' ' TYR . . . . . 0.522 ' N ' ' O ' ' A' ' 126' ' ' ALA . 79.0 t80 -51.77 -49.71 62.12 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 120.501 -0.48 . . . . 0.0 110.587 -179.024 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.5 p-10 -65.81 -42.16 90.99 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.946 0.403 . . . . 0.0 111.172 179.564 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.525 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 88.1 mt-30 -67.35 -36.85 82.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.801 -179.983 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.455 HD22 HD13 ' A' ' 116' ' ' ILE . 92.8 mt -80.34 -41.85 24.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.012 -179.541 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.1 t -57.55 -44.58 85.3 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.134 -179.095 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.5 m -62.3 -45.65 92.28 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.801 0.334 . . . . 0.0 110.586 179.351 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 92.4 mt -62.49 -43.78 98.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.285 -179.772 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.601 ' HB1' ' HD2' ' A' ' 138' ' ' PRO . . . -170.19 163.86 6.13 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.451 179.869 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.601 ' HD2' ' HB1' ' A' ' 137' ' ' ALA . 78.0 Cg_exo -43.58 111.32 0.23 Allowed 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.437 2.091 . . . . 0.0 112.076 179.539 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.475 HG21 ' CD1' ' A' ' 130' ' ' TYR . 17.3 m -85.78 127.79 34.64 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.57 179.951 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.646 HD13 ' CD2' ' A' ' 37' ' ' HIS . 34.4 tp -119.65 137.67 53.74 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.244 -0.435 . . . . 0.0 109.964 -179.702 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.433 ' O ' ' OD1' ' A' ' 32' ' ' ASP . 79.6 mt -104.58 119.92 54.21 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.432 0 CA-C-O 121.154 0.502 . . . . 0.0 111.416 -179.556 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.494 HD12 HD22 ' A' ' 117' ' ' LEU . 98.4 mt -135.3 133.03 52.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.665 179.676 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.546 HD21 ' CG ' ' A' ' 241' ' ' ASP . 60.6 t30 -64.98 150.31 48.24 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.861 0.362 . . . . 0.0 110.386 179.288 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.517 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 87.9 t80 -85.27 122.45 29.47 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.936 -179.531 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.517 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 99.0 m-20 55.48 68.86 0.8 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.954 179.76 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 36.0 p-10 -125.44 0.27 7.62 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.011 0.434 . . . . 0.0 110.816 179.851 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -150.69 115.57 5.27 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.748 -179.501 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 85.0 p -63.28 168.26 4.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.49 -179.742 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.422 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.5 p-90 -51.48 -15.67 0.46 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.484 -179.836 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 150' ' ' GLN . . . . . 0.444 ' O ' HG23 ' A' ' 154' ' ' THR . 68.3 tp60 -70.84 -75.65 0.12 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.414 -179.703 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.455 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.1 t -62.59 -38.76 91.4 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.992 0.425 . . . . 0.0 110.297 179.529 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 53.6 tp -60.25 -45.53 92.96 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.324 -178.493 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.422 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 45.9 tp -62.76 -41.82 99.4 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.844 0.354 . . . . 0.0 110.311 179.03 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.455 ' OG1' ' O ' ' A' ' 151' ' ' SER . 58.8 p -64.01 -34.67 78.54 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.264 -179.507 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 155' ' ' GLN . . . . . 0.444 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.5 mm-40 -64.03 -42.38 97.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.171 179.256 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 91.8 mt -65.24 -39.05 92.18 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.092 0.472 . . . . 0.0 110.172 179.071 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.582 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.04 -32.25 79.6 Favored Glycine 0 CA--C 1.52 0.352 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 -179.391 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.444 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.3 mt-10 -36.42 -25.38 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.888 0.375 . . . . 0.0 110.811 179.949 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.582 ' N ' ' O ' ' A' ' 157' ' ' GLY . 95.7 mt -59.16 149.29 6.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.171 179.382 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 77.5 p -69.14 137.47 53.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.074 -179.561 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 70.66 21.9 77.91 Favored Glycine 0 N--CA 1.458 0.157 0 N-CA-C 111.274 -0.731 . . . . 0.0 111.274 179.522 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 59.3 m80 -124.02 -14.63 7.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.757 0.313 . . . . 0.0 110.56 179.979 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -66.25 -59.76 3.43 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.774 -179.753 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -52.03 -48.96 64.27 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.278 -179.695 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -60.62 -41.11 94.18 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.76 0.314 . . . . 0.0 110.334 179.463 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.68 -47.11 86.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.633 179.817 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -57.1 -39.99 76.13 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.16 -179.85 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -61.8 -50.15 73.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.525 179.619 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.405 ' NE ' ' HB1' ' A' ' 59' ' ' ALA . 59.9 ttt85 -65.38 -43.77 89.67 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.417 179.554 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 95.1 mt -64.37 -43.53 97.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.421 179.718 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.29 -50.87 71.55 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.639 -179.169 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.79 -43.7 95.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.32 179.727 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 173' ' ' PHE . . . . . 0.659 ' CE2' HD11 ' A' ' 177' ' ' LEU . 56.6 t80 -62.58 -44.62 95.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.026 0.441 . . . . 0.0 110.425 179.373 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -63.4 -39.93 95.82 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.475 -179.204 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -62.85 -42.81 99.89 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.664 179.248 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -60.8 -44.68 96.53 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.069 -179.992 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.659 HD11 ' CE2' ' A' ' 173' ' ' PHE . 84.9 mt -64.29 -41.22 96.99 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.043 0.449 . . . . 0.0 110.681 178.862 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.15 -62.25 1.76 Allowed 'General case' 0 C--O 1.237 0.44 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.487 -179.382 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.64 -46.71 86.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.51 179.86 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.43 -41.67 66.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.135 -179.931 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -63.71 -33.88 76.64 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.07 0.462 . . . . 0.0 110.407 179.336 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 182' ' ' GLU . . . . . 0.424 ' O ' ' HG2' ' A' ' 182' ' ' GLU . 69.6 tt0 -90.31 8.42 33.47 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-O 121.387 0.613 . . . . 0.0 110.619 -179.078 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -104.31 -32.32 9.13 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-O 120.932 0.396 . . . . 0.0 111.359 179.546 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 43.9 pt -127.88 147.53 32.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.915 -179.902 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -139.83 131.03 26.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.296 179.478 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 186' ' ' LEU . . . . . 0.595 HD22 ' N ' ' A' ' 186' ' ' LEU . 3.6 mm? -85.63 133.46 41.86 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.841 179.922 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -44.28 158.06 0.15 Allowed 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.738 2.292 . . . . 0.0 112.061 179.48 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 188' ' ' PRO . . . . . 0.527 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.7 Cg_endo -62.9 114.97 2.65 Favored 'Trans proline' 0 C--N 1.303 -1.828 0 C-N-CA 122.747 2.298 . . . . 0.0 111.776 179.801 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 189' ' ' GLN . . . . . 0.527 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.8 mt-30 155.39 148.14 0.0 OUTLIER Pre-proline 0 N--CA 1.454 -0.247 0 O-C-N 123.552 0.533 . . . . 0.0 110.772 -179.799 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -74.11 144.5 33.8 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.685 2.257 . . . . 0.0 111.777 178.185 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.498 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.1 p -125.31 158.86 33.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.271 0.557 . . . . 0.0 110.067 -179.89 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 192' ' ' THR . . . . . 0.498 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 35.4 p -143.53 165.58 27.19 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.094 -179.653 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 193' ' ' ALA . . . . . 0.446 ' HA ' ' H ' ' A' ' 260' ' ' PHE . . . -135.66 128.62 31.39 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.212 0.53 . . . . 0.0 110.244 179.625 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.504 HD11 HD23 ' A' ' 259' ' ' LEU . 47.1 pt -146.38 148.96 16.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.137 179.732 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 195' ' ' VAL . . . . . 0.742 HG13 ' CD1' ' A' ' 262' ' ' PHE . 70.4 t -117.87 123.14 71.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 121.263 0.554 . . . . 0.0 109.594 179.254 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 58.8 t80 -134.37 107.32 7.55 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.32 179.688 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 94.8 m -131.02 130.72 43.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.896 179.784 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.406 ' O ' ' N ' ' A' ' 201' ' ' HIS . . . -83.04 -37.09 24.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.252 179.741 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.44 -67.15 0.25 Allowed 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.332 179.996 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.1 -9.73 58.81 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.306 179.523 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 201' ' ' HIS . . . . . 0.406 ' N ' ' O ' ' A' ' 198' ' ' ALA . 60.1 t-80 60.52 58.36 2.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.825 -179.835 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 42.0 p -167.2 153.53 8.12 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.444 179.558 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.27 143.81 24.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.962 0.41 . . . . 0.0 110.372 179.449 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -135.18 138.34 43.56 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.691 179.939 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 20.3 mt -106.34 125.43 50.99 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 121.119 0.485 . . . . 0.0 109.745 -179.682 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 206' ' ' TRP . . . . . 0.557 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 74.3 m95 -81.96 166.83 19.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.666 -179.796 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 207' ' ' THR . . . . . 0.466 HG22 ' C ' ' A' ' 206' ' ' TRP . 0.1 OUTLIER -156.78 171.87 6.86 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 120.971 0.415 . . . . 0.0 110.562 -179.213 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -54.02 -37.2 86.28 Favored 'Trans proline' 0 C--N 1.303 -1.839 0 C-N-CA 122.637 2.224 . . . . 0.0 111.954 179.465 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -70.46 -34.96 73.01 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.953 -179.916 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 22.2 m -61.02 150.88 32.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.569 -179.351 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.66 -36.86 82.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.462 -179.709 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 212' ' ' GLN . . . . . 0.557 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 55.2 tt0 -64.77 -40.37 95.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.529 179.957 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.72 -43.32 92.13 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 179.759 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -63.4 -43.9 96.2 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.95 -0.3 . . . . 0.0 110.219 179.879 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 215' ' ' MET . . . . . 0.545 ' SD ' ' HB2' ' A' ' 304' ' ' ALA . 65.0 ttp -59.73 -47.88 83.91 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.199 -179.753 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 86.7 mt -60.65 -40.62 92.69 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 179.531 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 217' ' ' GLU . . . . . 0.456 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.5 tp10 -58.36 -37.88 76.11 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.77 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -65.21 -38.3 90.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.811 0.339 . . . . 0.0 110.648 179.696 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 94.2 mt -64.25 -42.56 96.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.554 -179.557 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.36 45.1 0.08 OUTLIER Glycine 0 C--N 1.334 0.417 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 -179.943 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 221' ' ' PHE . . . . . 0.456 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 26.6 m-85 -127.99 155.41 44.32 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.012 0.434 . . . . 0.0 110.527 -179.812 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.487 ' O ' HG13 ' A' ' 191' ' ' VAL . 6.8 p -107.06 122.31 46.22 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.093 0.473 . . . . 0.0 110.2 -179.899 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.475 HD22 ' C ' ' A' ' 222' ' ' THR . 4.3 mm? -101.33 132.81 46.7 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.107 179.967 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.64 159.79 14.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.52 179.86 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.57 115.21 29.86 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.328 179.902 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.494 HD12 ' N ' ' A' ' 226' ' ' LEU . 9.1 mp -53.22 156.86 3.54 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.584 179.926 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -60.31 145.38 98.71 Favored 'Trans proline' 0 C--N 1.301 -1.931 0 C-N-CA 122.627 2.218 . . . . 0.0 112.012 179.379 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.3 -3.26 59.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.559 -179.98 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.15 -40.99 5.66 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 -179.859 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 230' ' ' LEU . . . . . 0.532 ' O ' ' N ' ' A' ' 233' ' ' SER . 85.5 mt -79.18 -17.15 55.47 Favored 'General case' 0 C--O 1.223 -0.316 0 CA-C-O 120.934 0.397 . . . . 0.0 110.301 -179.721 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 231' ' ' ASN . . . . . 0.401 ' C ' ' O ' ' A' ' 230' ' ' LEU . 54.7 t-20 -40.38 -49.21 2.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.756 -179.527 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -87.88 15.33 7.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.275 179.814 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 233' ' ' SER . . . . . 0.532 ' N ' ' O ' ' A' ' 230' ' ' LEU . 78.0 p -60.35 -35.48 75.77 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.523 -179.732 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 234' ' ' GLN . . . . . 0.527 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.7 tt0 -118.98 -69.12 0.87 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.917 0.389 . . . . 0.0 111.019 179.491 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.2 m -69.68 102.77 1.96 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.769 -179.882 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -94.27 57.45 2.33 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.341 -179.975 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -144.54 -122.63 1.6 Allowed Glycine 0 CA--C 1.52 0.359 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 179.994 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -135.13 111.53 9.79 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.082 0.468 . . . . 0.0 110.444 179.972 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 239' ' ' ARG . . . . . 0.519 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.7 mtt180 -148.05 57.88 1.09 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.723 -179.885 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -69.54 -32.27 70.98 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.522 179.65 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 241' ' ' ASP . . . . . 0.546 ' CG ' HD21 ' A' ' 143' ' ' ASN . 65.1 t0 -57.0 -46.97 81.9 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.41 -179.124 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 242' ' ' ILE . . . . . 0.437 ' O ' ' O ' ' A' ' 239' ' ' ARG . 17.7 tt -139.78 156.27 25.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.873 0.368 . . . . 0.0 110.541 179.777 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.441 HG22 HD13 ' A' ' 245' ' ' LEU . 96.2 mt -106.06 106.41 20.53 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.216 0 CA-C-O 121.233 0.54 . . . . 0.0 110.458 179.87 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 244' ' ' GLN . . . . . 0.606 ' O ' HD12 ' A' ' 245' ' ' LEU . 88.2 mt-30 -110.19 109.85 20.48 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.329 179.75 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.606 HD12 ' O ' ' A' ' 244' ' ' GLN . 9.4 mp -121.75 -168.47 1.7 Allowed 'General case' 0 C--O 1.224 -0.238 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.647 179.774 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 246' ' ' GLY . . . . . 0.527 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.81 -16.5 0.05 OUTLIER Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 179.892 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 247' ' ' GLY . . . . . 0.675 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -60.75 156.3 32.24 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 -179.858 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -63.48 21.76 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.001 0.429 . . . . 0.0 110.617 179.973 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 249' ' ' ASN . . . . . 0.675 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.7 m-20 -97.51 -5.85 34.99 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.554 179.961 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 93.6 mt -79.69 -22.16 43.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.647 179.486 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.64 -51.27 70.65 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.856 -179.543 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -87.96 -5.51 58.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.42 179.653 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.09 -74.33 1.15 Allowed Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 -179.959 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 81.4 mt -70.05 125.89 28.08 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.134 0.493 . . . . 0.0 110.104 -179.759 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -59.69 -39.29 84.08 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.266 -179.656 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 84.37 51.63 3.84 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 179.943 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -95.11 -15.62 23.24 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.698 0.285 . . . . 0.0 110.664 -179.917 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 258' ' ' SER . . . . . 0.497 ' OG ' HG23 ' A' ' 191' ' ' VAL . 3.3 t 173.76 89.4 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.033 0.444 . . . . 0.0 110.085 179.979 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.865 HD12 ' N ' ' A' ' 259' ' ' LEU . 1.0 OUTLIER -94.38 124.06 38.17 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-O 121.314 0.578 . . . . 0.0 111.144 -179.224 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 260' ' ' PHE . . . . . 0.446 ' H ' ' HA ' ' A' ' 193' ' ' ALA . 15.9 m-30 -93.04 146.72 23.42 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.378 179.269 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 86.3 mt -122.48 149.91 43.23 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.525 -179.921 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.742 ' CD1' HG13 ' A' ' 195' ' ' VAL . 2.6 p90 -78.13 -138.64 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.422 -179.696 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 263' ' ' ALA . . . . . 0.661 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -51.69 77.62 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.995 -179.921 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 264' ' ' GLY . . . . . 0.636 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.35 104.46 0.19 Allowed Glycine 0 N--CA 1.468 0.781 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 -179.798 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 265' ' ' ASP . . . . . 0.605 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.6 m-20 -80.48 -177.56 6.27 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.718 0.294 . . . . 0.0 110.966 -179.594 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -40.68 -17.54 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.428 179.859 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 267' ' ' LYS . . . . . 0.605 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.59 -51.4 42.94 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 121.013 0.435 . . . . 0.0 110.782 179.487 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -63.8 -46.72 83.9 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.143 179.399 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 269' ' ' ALA . . . . . 0.566 ' HB1' ' OH ' ' A' ' 273' ' ' TYR . . . -61.7 -35.08 77.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.767 179.646 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -62.93 -34.74 78.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.105 179.729 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.38 -43.1 13.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.409 -179.584 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 272' ' ' ILE . . . . . 0.587 ' C ' ' H ' ' A' ' 274' ' ' ALA . 4.9 tt -51.37 -33.65 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.838 -178.95 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 273' ' ' TYR . . . . . 0.566 ' OH ' ' HB1' ' A' ' 269' ' ' ALA . 17.5 m-85 -54.33 -1.67 0.03 OUTLIER 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.742 -179.563 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 274' ' ' ALA . . . . . 0.587 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.94 -39.87 69.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.883 179.648 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 275' ' ' ASN . . . . . 0.586 ' O ' ' N ' ' A' ' 279' ' ' ALA . 4.3 p30 -38.94 97.53 0.14 Allowed Pre-proline 0 C--O 1.226 -0.168 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.582 -179.68 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 276' ' ' PRO . . . . . 0.402 ' N ' ' O ' ' A' ' 274' ' ' ALA . 45.7 Cg_exo -53.95 -43.15 60.68 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 C-N-CA 122.338 2.025 . . . . 0.0 112.756 -178.884 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 89.8 mt -64.39 -42.82 95.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.136 0.493 . . . . 0.0 111.235 -179.766 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 91.2 mt -95.99 -1.14 49.61 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.849 -179.439 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 279' ' ' ALA . . . . . 0.586 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.39 -34.91 77.65 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.647 -179.762 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -73.76 19.72 0.11 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.126 -179.38 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 281' ' ' LEU . . . . . 0.495 HD23 ' HA ' ' A' ' 281' ' ' LEU . 13.7 mt -75.2 120.84 83.52 Favored Pre-proline 0 N--CA 1.451 -0.391 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.351 179.99 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_exo -51.58 -39.11 66.05 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.633 2.222 . . . . 0.0 111.603 179.343 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.83 -50.38 63.81 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 179.818 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 79.5 t -61.84 -44.02 98.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 110.083 -0.339 . . . . 0.0 110.083 179.477 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -57.65 -41.6 81.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.301 -179.846 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -90.71 0.7 57.33 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.084 179.675 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt 58.59 41.57 22.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.115 0.483 . . . . 0.0 111.029 179.788 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -93.15 42.22 1.09 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.377 179.804 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 53.8 t -119.37 135.54 59.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 120.943 0.401 . . . . 0.0 110.223 -179.699 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -132.78 162.81 30.52 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.045 0.45 . . . . 0.0 110.703 -179.623 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.65 155.38 32.45 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.032 0.444 . . . . 0.0 110.743 -179.882 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 81.4 mt -94.37 -1.23 54.11 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.211 -179.699 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.1 165.01 12.54 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.634 -0.986 . . . . 0.0 110.634 -179.814 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 7.0 m -86.79 -62.04 1.6 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.804 0.335 . . . . 0.0 111.184 -179.95 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 295' ' ' GLU . . . . . 0.444 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.6 mm-40 -69.41 -4.07 16.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.697 -179.842 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 25.4 p -76.84 32.38 0.14 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.663 -179.887 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 297' ' ' PHE . . . . . 0.511 ' CD2' HG22 ' A' ' 70' ' ' THR . 70.5 t80 -60.33 -46.06 91.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.607 -179.908 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 298' ' ' ARG . . . . . 0.614 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.4 mtt85 -81.08 134.93 35.75 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.581 -179.699 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.457 ' H ' HG11 ' A' ' 51' ' ' VAL . 17.1 tp -114.24 118.07 32.92 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.152 179.898 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 300' ' ' ASP . . . . . 0.635 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.2 p-10 -165.69 -176.16 3.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.541 179.978 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 84.5 t80 -47.17 -43.86 21.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.275 -179.675 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -66.6 -40.63 88.95 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.08 0.466 . . . . 0.0 110.833 179.116 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 303' ' ' SER . . . . . 0.635 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 60.8 p -55.71 -36.11 66.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.159 -179.263 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 304' ' ' ALA . . . . . 0.545 ' HB2' ' SD ' ' A' ' 215' ' ' MET . . . -57.49 -51.31 69.98 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.459 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 90.6 mtp -56.71 -43.52 80.64 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -179.993 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -66.49 -42.56 87.21 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.928 0.394 . . . . 0.0 110.16 178.796 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 307' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 303' ' ' SER . 55.6 t -64.02 -43.12 97.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.08 179.352 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 43.3 tp -59.66 -42.09 92.05 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.721 -179.409 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -62.72 -38.83 92.03 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 179.565 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 310' ' ' ARG . . . . . 0.446 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.6 ttt85 -63.66 -43.88 95.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.288 179.506 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 89.4 mt -63.21 -42.1 99.23 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.185 179.602 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -62.87 -33.59 75.6 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.993 179.445 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.65 -23.46 21.89 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.507 -179.836 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 314' ' ' LEU . . . . . 0.479 HD22 ' CE2' ' A' ' 315' ' ' PHE . 6.7 tt -62.32 -43.12 99.56 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 121.087 0.47 . . . . 0.0 110.629 -179.889 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 315' ' ' PHE . . . . . 0.479 ' CE2' HD22 ' A' ' 314' ' ' LEU . 90.9 m-85 . . . . . 0 C--O 1.22 -0.457 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.462 179.897 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -99.6 136.04 40.12 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.47 -179.961 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.498 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -92.41 178.45 1.68 Allowed Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.539 -179.88 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.498 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.0 Cg_exo -61.76 147.39 95.39 Favored 'Trans proline' 0 C--N 1.3 -1.996 0 C-N-CA 122.752 2.302 . . . . 0.0 112.162 179.811 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.493 ' HE ' HD12 ' A' ' 39' ' ' LEU . 35.4 ptt180 -136.85 142.47 42.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.679 179.679 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -79.59 116.97 20.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.464 179.962 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.458 ' O ' HG23 ' A' ' 30' ' ' ILE . 9.5 tp -111.48 130.25 65.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.46 -179.956 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 13.5 t -71.4 142.13 50.32 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.527 179.811 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.484 ' CG ' ' H ' ' A' ' 33' ' ' SER . 42.8 t0 -139.09 -179.56 5.92 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.629 -179.937 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.484 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 78.0 p -74.15 -37.13 64.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.755 179.863 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.7 ttt85 -47.07 -94.9 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.382 -179.521 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.415 ' O ' ' OG1' ' A' ' 36' ' ' THR . . . -165.65 -27.15 0.02 OUTLIER Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 179.92 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.415 ' OG1' ' O ' ' A' ' 35' ' ' GLY . 67.6 m -168.43 105.9 0.46 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.859 0.361 . . . . 0.0 110.635 -179.909 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.63 ' CD2' HD13 ' A' ' 140' ' ' LEU . 64.4 t60 -128.9 145.98 51.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.015 0.436 . . . . 0.0 110.267 179.896 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.617 HG22 ' N ' ' A' ' 39' ' ' LEU . 99.8 m -129.26 165.42 21.43 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.639 -179.915 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.617 ' N ' HG22 ' A' ' 38' ' ' THR . 79.6 mt -120.27 127.39 52.34 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.513 179.785 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -65.51 -44.57 86.6 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.619 -179.951 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 41.6 p -166.0 154.93 11.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.443 179.719 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.492 ' CD ' ' H ' ' A' ' 42' ' ' GLN . 14.0 mp0 -45.43 101.71 0.27 Allowed Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.673 179.503 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -57.71 130.12 37.03 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 C-N-CA 122.351 2.034 . . . . 0.0 112.233 -179.687 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -83.05 -24.68 32.67 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.448 179.631 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.536 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.9 mtm-85 -120.46 134.48 55.26 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-O 121.174 0.511 . . . . 0.0 110.28 -179.987 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 95.9 mt -129.97 133.46 64.48 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.271 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.979 -179.76 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 47.8 t -125.25 131.02 72.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.802 0.334 . . . . 0.0 110.11 179.329 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.601 ' OG ' HD12 ' A' ' 117' ' ' LEU . 4.2 m -154.72 166.31 33.84 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.606 179.81 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 65.8 p -124.85 8.23 8.12 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.483 179.931 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.1 t -85.2 125.8 33.15 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.68 -179.43 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.463 HG11 ' H ' ' A' ' 299' ' ' LEU . 91.9 t -65.7 -44.52 93.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.51 -179.994 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.8 m -62.74 -44.32 96.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.664 -179.849 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 54.4 tp -62.19 -41.56 98.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.57 -179.536 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.455 ' O ' HD13 ' A' ' 58' ' ' LEU . 72.1 m -57.72 -44.53 86.04 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.349 -179.397 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.31 -62.09 5.43 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.911 -0.876 . . . . 0.0 110.911 179.554 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.6 t -48.24 -35.76 12.63 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 -179.962 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 20.0 mt -61.77 -44.76 96.25 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.724 -0.391 . . . . 0.0 111.145 179.347 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.455 HD13 ' O ' ' A' ' 54' ' ' THR . 9.2 mp -64.88 -42.0 95.18 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.081 0.467 . . . . 0.0 111.287 178.035 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.407 ' HB1' ' NE ' ' A' ' 169' ' ' ARG . . . -63.59 -41.22 98.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.998 -179.288 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.434 ' O ' HG23 ' A' ' 60' ' ' ILE . 7.9 tp -87.89 16.53 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.694 -179.662 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 56.58 84.3 0.09 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.575 -179.973 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.59 57.74 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.147 -179.808 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -50.13 152.55 7.73 Favored 'Trans proline' 0 C--N 1.297 -2.169 0 C-N-CA 122.834 2.356 . . . . 0.0 112.475 -178.297 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.428 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -108.93 146.34 14.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.417 -179.747 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 97.1 mt -63.85 -45.03 98.2 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.351 -179.762 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.505 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -130.26 134.48 47.26 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.677 -179.857 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.478 ' O ' ' N ' ' A' ' 98' ' ' LEU . 69.0 m -134.19 158.38 43.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.839 -179.62 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.5 139.18 16.38 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 179.804 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.498 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.91 -162.6 0.08 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.934 0.397 . . . . 0.0 110.495 -179.968 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.524 HG22 ' CD2' ' A' ' 297' ' ' PHE . 14.6 t -133.55 135.88 44.61 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.394 -179.992 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.493 ' C ' ' O ' ' A' ' 70' ' ' THR . 0.0 OUTLIER 29.74 68.68 0.66 Allowed Pre-proline 0 N--CA 1.464 0.243 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.646 -179.843 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -60.9 145.23 99.35 Favored 'Trans proline' 0 C--N 1.3 -1.98 0 C-N-CA 122.643 2.229 . . . . 0.0 112.227 -178.73 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.527 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 45.6 p-10 -160.7 -32.59 0.05 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.686 179.659 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.537 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 99.0 m-20 -63.88 -39.36 94.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.488 -179.972 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 73.2 ttt180 -60.56 -48.19 82.87 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.68 -179.405 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.418 ' O ' ' O ' ' A' ' 77' ' ' ALA . 93.6 t -59.91 -24.52 29.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 110.1 -0.334 . . . . 0.0 110.1 179.607 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.537 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -46.1 173.13 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.599 179.924 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.569 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.6 p30 -61.87 177.6 0.42 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.581 -179.738 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.567 ' C ' ' H ' ' A' ' 81' ' ' GLY . 35.9 p30 -46.02 85.95 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.887 -179.942 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.569 ' N ' ' O ' ' A' ' 78' ' ' ASP . 42.6 tp60 -66.92 13.48 0.06 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.143 -179.893 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.567 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 117.76 -22.04 10.16 Favored Glycine 0 CA--C 1.519 0.293 0 N-CA-C 110.994 -0.843 . . . . 0.0 110.994 179.957 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -107.62 116.47 32.0 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.99 0.424 . . . . 0.0 110.497 179.883 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 75.2 mt -98.73 0.67 45.0 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.46 -179.738 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -91.93 6.7 45.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.957 0.408 . . . . 0.0 110.41 -179.833 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.8 ' O ' HG22 ' A' ' 89' ' ' VAL . 27.2 mt-30 -99.67 -27.63 13.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.858 179.957 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 68.7 t-105 -63.34 -41.18 98.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.03 -179.619 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.556 ' O ' ' N ' ' A' ' 91' ' ' LYS . 65.8 m -77.42 -53.33 7.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.238 -179.317 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -48.57 -51.09 29.47 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.966 -179.28 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.8 HG22 ' O ' ' A' ' 85' ' ' GLN . 15.4 m -68.78 -40.74 81.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 120.903 0.383 . . . . 0.0 110.962 179.9 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.5 ' N ' HG23 ' A' ' 89' ' ' VAL . . . -71.9 -23.11 61.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.786 179.953 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.556 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.0 tttm -60.99 -45.82 93.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.498 -179.602 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.438 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.3 mm-40 -90.82 -94.68 0.12 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.08 179.981 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.634 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.9 mtt180 -143.23 60.03 1.4 Allowed 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.794 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.462 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.6 pttp 33.57 26.23 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.222 -179.048 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.634 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.4 tt -47.62 123.31 5.69 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.92 -178.253 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.456 ' O ' HD23 ' A' ' 95' ' ' LEU . 98.8 mm-40 -83.44 -169.92 2.79 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.061 -179.997 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.613 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 82.3 mtp180 -73.61 138.03 44.6 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.166 -179.837 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.478 ' N ' ' O ' ' A' ' 67' ' ' SER . 89.8 mt -87.27 -165.93 1.43 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.717 -179.647 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.534 ' O ' ' CD2' ' A' ' 99' ' ' TYR . 48.2 p90 -168.46 120.2 0.81 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.32 179.933 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.513 ' C ' ' O ' ' A' ' 99' ' ' TYR . 43.6 mm -29.6 121.5 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.863 -179.63 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 114.22 27.94 3.24 Favored Glycine 0 CA--C 1.521 0.426 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 -179.557 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.59 ' CD ' ' H ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -144.17 46.04 0.6 Allowed Pre-proline 0 C--N 1.324 -0.541 0 CA-C-O 120.907 0.384 . . . . 0.0 110.465 179.903 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.582 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 31.0 Cg_endo -62.28 143.85 94.56 Favored 'Trans proline' 0 C--N 1.298 -2.126 0 C-N-CA 122.735 2.29 . . . . 0.0 111.996 179.932 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.464 ' O ' HG23 ' A' ' 108' ' ' VAL . 24.8 t -173.67 120.91 0.32 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.46 179.67 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.42 -41.11 63.68 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.012 0.434 . . . . 0.0 111.154 179.709 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -65.82 -40.16 91.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.856 -179.432 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.63 -39.77 95.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.708 -179.907 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 104' ' ' SER . 72.0 t -67.44 -43.82 87.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.683 179.584 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.18 -39.24 92.04 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.512 -179.233 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.438 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.75 -23.82 63.54 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.431 179.831 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.568 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.3 mm-40 -91.18 4.47 52.15 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.684 -179.574 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.568 ' C ' ' O ' ' A' ' 111' ' ' GLN . 10.4 tpt 22.11 64.56 0.32 Allowed Pre-proline 0 N--CA 1.464 0.266 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.992 -179.911 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.478 ' HG2' HD11 ' A' ' 116' ' ' ILE . 67.8 Cg_endo -78.66 170.04 18.82 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 C-N-CA 122.972 2.448 . . . . 0.0 112.21 -178.66 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.522 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 99.1 m-20 -113.07 -44.78 3.23 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 121.065 0.46 . . . . 0.0 110.088 179.544 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 39.8 tp -119.91 119.57 33.87 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.514 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.478 HD11 ' HG2' ' A' ' 113' ' ' PRO . 94.7 mt -116.94 131.15 70.49 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 CA-C-O 120.954 0.407 . . . . 0.0 110.887 -179.807 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.601 HD12 ' OG ' ' A' ' 48' ' ' SER . 31.6 mt -105.63 131.98 52.33 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 121.11 0.481 . . . . 0.0 110.125 -179.528 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.488 HD12 HG23 ' A' ' 139' ' ' THR . 98.3 mt -117.55 135.94 56.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.79 -179.726 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 85.0 p -71.57 151.54 43.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.568 -179.944 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.13 -49.85 76.0 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.678 -179.763 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.0 t -149.4 153.93 38.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.587 179.76 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 168.19 -169.56 41.53 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.875 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.87 -35.73 92.41 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -179.971 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.446 ' OD1' ' O ' ' A' ' 124' ' ' ASP . 44.1 p-10 -87.96 120.04 28.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.782 0.325 . . . . 0.0 110.632 179.871 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.454 ' O ' HD12 ' A' ' 129' ' ' LEU . 40.5 t -63.44 144.2 57.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.554 -179.956 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.518 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -94.02 -43.08 8.69 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.792 -179.814 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 56.1 tp -62.73 -42.37 99.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.562 -179.841 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.0 -10.52 54.21 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.531 -179.474 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.454 HD12 ' O ' ' A' ' 125' ' ' SER . 83.6 mt -116.02 -24.08 8.24 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.678 -179.89 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 130' ' ' TYR . . . . . 0.518 ' N ' ' O ' ' A' ' 126' ' ' ALA . 74.5 t80 -51.52 -49.55 61.71 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.456 -178.951 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.4 p-10 -65.87 -41.91 91.04 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.893 0.378 . . . . 0.0 111.163 179.607 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.526 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 87.7 mt-30 -67.85 -36.74 80.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.746 -179.905 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.453 HD22 HD13 ' A' ' 116' ' ' ILE . 95.9 mt -80.19 -42.45 23.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.955 -179.439 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.3 t -57.49 -44.94 85.35 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.355 -179.117 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.4 m -62.29 -45.95 90.94 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.639 179.409 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 92.2 mt -62.29 -43.79 98.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.325 -179.823 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.604 ' HB1' ' HD2' ' A' ' 138' ' ' PRO . . . -170.18 163.75 6.17 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.471 179.842 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.604 ' HD2' ' HB1' ' A' ' 137' ' ' ALA . 76.6 Cg_exo -42.38 110.3 0.15 Allowed 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.571 2.181 . . . . 0.0 112.035 179.454 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.515 HG21 ' CD1' ' A' ' 130' ' ' TYR . 2.8 m -87.27 127.61 35.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.463 -179.927 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.63 HD13 ' CD2' ' A' ' 37' ' ' HIS . 34.1 tp -119.78 138.72 53.17 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.163 -179.818 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.436 ' O ' ' OD1' ' A' ' 32' ' ' ASP . 81.6 mt -105.29 120.04 55.35 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.348 0 CA-C-O 121.125 0.488 . . . . 0.0 111.233 -179.439 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.49 HD12 HD22 ' A' ' 117' ' ' LEU . 97.7 mt -135.42 132.73 52.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.721 179.577 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -64.49 148.3 50.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.875 0.369 . . . . 0.0 110.37 179.364 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.515 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 86.9 t80 -82.75 122.4 28.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.96 -179.471 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.515 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 99.0 m-20 55.08 69.41 0.73 Allowed 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.827 179.648 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 35.2 p-10 -125.71 0.69 7.46 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 120.906 0.384 . . . . 0.0 110.704 179.787 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -150.9 115.92 5.29 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.668 -179.511 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 86.2 p -63.74 168.72 4.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.499 -179.805 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.423 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.3 p-90 -51.6 -15.96 0.54 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.62 -179.868 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 150' ' ' GLN . . . . . 0.44 ' O ' HG23 ' A' ' 154' ' ' THR . 67.9 tp60 -70.36 -76.05 0.11 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.521 -179.748 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.458 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.0 t -62.68 -38.5 90.61 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.339 179.481 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 52.3 tp -60.1 -45.51 92.69 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.401 -178.611 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.423 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 46.5 tp -62.83 -41.84 99.49 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.861 0.362 . . . . 0.0 110.411 178.995 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.458 ' OG1' ' O ' ' A' ' 151' ' ' SER . 59.2 p -63.72 -34.76 78.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.258 -179.566 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 155' ' ' GLN . . . . . 0.471 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.9 mm-40 -63.98 -42.18 97.3 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.239 179.177 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 91.6 mt -65.42 -38.89 91.27 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.092 179.118 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.582 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.25 -32.42 80.62 Favored Glycine 0 CA--C 1.52 0.375 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 -179.366 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.471 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.1 mt-10 -36.34 -25.55 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.874 0.369 . . . . 0.0 110.791 -179.98 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.582 ' N ' ' O ' ' A' ' 157' ' ' GLY . 94.8 mt -59.35 149.5 6.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.231 179.473 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 74.8 p -69.09 137.07 53.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.049 -179.558 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 71.1 21.62 78.41 Favored Glycine 0 N--CA 1.459 0.194 0 N-CA-C 111.269 -0.732 . . . . 0.0 111.269 179.509 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 60.3 m80 -123.43 -15.45 7.13 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.746 0.307 . . . . 0.0 110.568 179.989 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -66.02 -59.87 3.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.715 -179.756 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -51.62 -49.09 62.9 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.238 -179.755 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -60.83 -41.07 95.04 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.723 0.297 . . . . 0.0 110.312 179.522 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.48 -47.51 85.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.613 179.745 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.64 -40.32 75.23 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.268 -179.921 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -61.66 -50.24 73.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.65 179.525 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.407 ' NE ' ' HB1' ' A' ' 59' ' ' ALA . 59.9 ttt85 -65.38 -43.76 89.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.476 179.495 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 95.1 mt -64.53 -43.41 96.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.52 179.728 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.23 -51.05 70.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.599 -179.308 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.79 -43.67 95.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.421 179.724 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 173' ' ' PHE . . . . . 0.658 ' CE2' HD11 ' A' ' 177' ' ' LEU . 57.3 t80 -62.69 -44.56 95.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.456 179.364 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -63.26 -40.04 96.28 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.527 -179.361 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -63.01 -42.77 99.92 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.624 179.277 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -60.64 -44.78 95.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.119 179.968 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.658 HD11 ' CE2' ' A' ' 173' ' ' PHE . 84.4 mt -64.29 -41.09 97.05 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.02 0.438 . . . . 0.0 110.674 178.956 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.18 -62.12 1.84 Allowed 'General case' 0 C--O 1.237 0.418 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.501 -179.387 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.78 -46.78 86.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.545 179.903 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.3 -41.72 65.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.149 179.974 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -63.72 -33.6 76.02 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.011 0.434 . . . . 0.0 110.415 179.227 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 182' ' ' GLU . . . . . 0.428 ' O ' ' HG2' ' A' ' 182' ' ' GLU . 69.8 tt0 -90.7 8.61 33.62 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.27 0.557 . . . . 0.0 110.528 -179.01 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -104.58 -32.25 9.03 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.188 179.595 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 45.1 pt -128.04 147.72 32.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.816 -179.803 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -139.76 130.88 26.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.375 179.418 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 186' ' ' LEU . . . . . 0.592 HD22 ' N ' ' A' ' 186' ' ' LEU . 3.6 mm? -85.46 133.24 42.64 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.808 -179.947 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -44.01 157.81 0.14 Allowed 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.704 2.269 . . . . 0.0 112.088 179.46 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 188' ' ' PRO . . . . . 0.528 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.7 Cg_endo -63.01 114.74 2.57 Favored 'Trans proline' 0 C--N 1.303 -1.858 0 C-N-CA 122.751 2.3 . . . . 0.0 111.752 179.909 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 189' ' ' GLN . . . . . 0.528 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.8 mt-30 155.6 147.83 0.0 OUTLIER Pre-proline 0 C--N 1.331 -0.215 0 O-C-N 123.433 0.458 . . . . 0.0 110.725 -179.757 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -73.9 144.06 33.98 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.711 2.274 . . . . 0.0 111.771 178.189 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.498 HG23 ' OG ' ' A' ' 258' ' ' SER . 2.1 p -124.92 159.03 32.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.261 0.553 . . . . 0.0 110.082 -179.975 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 192' ' ' THR . . . . . 0.497 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 37.7 p -143.55 165.31 27.94 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.069 -179.506 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 193' ' ' ALA . . . . . 0.443 ' HA ' ' H ' ' A' ' 260' ' ' PHE . . . -135.55 128.54 31.48 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.122 0.487 . . . . 0.0 110.258 179.704 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.503 HD11 HD23 ' A' ' 259' ' ' LEU . 47.5 pt -146.4 148.86 16.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.1 179.928 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 195' ' ' VAL . . . . . 0.747 HG13 ' CD1' ' A' ' 262' ' ' PHE . 68.9 t -117.89 123.12 71.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.315 0.578 . . . . 0.0 109.7 179.098 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -134.26 107.36 7.62 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.309 179.745 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 94.2 m -131.13 130.53 43.21 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.802 179.871 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.411 ' O ' ' N ' ' A' ' 201' ' ' HIS . . . -82.9 -37.2 24.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.276 179.745 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.25 -67.12 0.25 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.364 179.978 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.15 -9.84 58.98 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.344 179.48 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 201' ' ' HIS . . . . . 0.411 ' N ' ' O ' ' A' ' 198' ' ' ALA . 60.0 t-80 60.85 58.16 2.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.601 -179.972 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 44.8 p -167.07 153.21 8.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.516 179.666 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.24 143.93 24.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.933 0.397 . . . . 0.0 110.426 179.532 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -135.31 138.51 43.5 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.644 -179.949 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 19.9 mt -106.45 125.42 50.98 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 121.112 0.482 . . . . 0.0 109.862 -179.721 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 206' ' ' TRP . . . . . 0.555 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 74.2 m95 -81.96 166.94 19.42 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.597 -179.713 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 207' ' ' THR . . . . . 0.475 HG22 ' C ' ' A' ' 206' ' ' TRP . 0.1 OUTLIER -157.05 171.41 7.49 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.56 -179.164 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -53.65 -37.13 83.38 Favored 'Trans proline' 0 C--N 1.303 -1.838 0 C-N-CA 122.664 2.242 . . . . 0.0 111.97 179.333 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -70.58 -35.08 72.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.844 -179.864 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 21.7 m -60.98 151.02 31.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.562 -179.31 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.81 -37.03 82.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.523 -179.767 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 212' ' ' GLN . . . . . 0.555 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 55.0 tt0 -64.64 -40.37 95.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.532 179.916 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.51 -43.34 92.55 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 179.846 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -63.31 -43.68 97.12 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.675 0.274 . . . . 0.0 110.283 179.851 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 215' ' ' MET . . . . . 0.546 ' SD ' ' HB2' ' A' ' 304' ' ' ALA . 65.3 ttp -59.65 -47.98 83.47 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.206 -179.773 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 216' ' ' LEU . 88.1 mt -60.59 -40.8 93.07 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.531 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 217' ' ' GLU . . . . . 0.459 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.8 tp10 -58.25 -38.01 76.08 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.75 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -65.13 -38.23 89.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.808 0.337 . . . . 0.0 110.671 179.677 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 94.4 mt -64.33 -42.67 96.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.572 -179.616 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.5 44.93 0.08 OUTLIER Glycine 0 CA--C 1.521 0.429 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 -179.958 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 221' ' ' PHE . . . . . 0.459 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 26.4 m-85 -127.91 155.32 44.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.045 0.45 . . . . 0.0 110.507 -179.896 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.489 ' O ' HG13 ' A' ' 191' ' ' VAL . 7.2 p -106.8 122.17 45.84 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.214 0.531 . . . . 0.0 110.202 -179.985 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.473 HD22 ' C ' ' A' ' 222' ' ' THR . 4.3 mm? -101.21 132.99 46.44 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.074 179.982 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.85 159.74 14.75 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.005 0.431 . . . . 0.0 110.504 179.86 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.75 115.25 29.92 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.382 179.93 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.508 HD12 ' N ' ' A' ' 226' ' ' LEU . 8.8 mp -52.94 156.62 3.33 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.662 179.952 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -60.47 145.45 98.71 Favored 'Trans proline' 0 C--N 1.302 -1.889 0 C-N-CA 122.68 2.253 . . . . 0.0 111.982 179.367 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.02 -3.42 59.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.57 179.994 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.04 -41.11 5.66 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 -179.884 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 230' ' ' LEU . . . . . 0.537 ' O ' ' N ' ' A' ' 233' ' ' SER . 85.6 mt -79.3 -17.2 55.09 Favored 'General case' 0 C--O 1.224 -0.273 0 CA-C-O 121.037 0.446 . . . . 0.0 110.314 -179.696 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 231' ' ' ASN . . . . . 0.403 ' C ' ' O ' ' A' ' 230' ' ' LEU . 54.8 t-20 -40.23 -49.31 2.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.73 -179.642 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -87.86 15.35 7.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.828 0.347 . . . . 0.0 111.18 179.945 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 233' ' ' SER . . . . . 0.537 ' N ' ' O ' ' A' ' 230' ' ' LEU . 78.0 p -60.29 -35.54 75.79 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.594 -179.824 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 234' ' ' GLN . . . . . 0.526 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.5 tt0 -119.11 -69.29 0.86 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.898 179.643 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.2 m -69.28 103.23 1.9 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.612 -179.727 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -94.79 57.18 2.12 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.42 179.912 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -144.57 -122.84 1.62 Allowed Glycine 0 CA--C 1.522 0.48 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 -179.928 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -134.94 111.64 10.0 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.061 0.458 . . . . 0.0 110.423 -179.997 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 239' ' ' ARG . . . . . 0.523 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.6 mtt180 -148.04 58.16 1.1 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.731 -179.961 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -69.75 -32.03 70.32 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.568 179.571 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 241' ' ' ASP . . . . . 0.449 ' OD2' ' O ' ' A' ' 144' ' ' TYR . 65.4 t0 -57.08 -46.93 82.14 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.373 -179.143 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 242' ' ' ILE . . . . . 0.435 ' O ' ' O ' ' A' ' 239' ' ' ARG . 18.1 tt -140.01 156.82 25.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.91 0.386 . . . . 0.0 110.492 179.712 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.443 HG22 HD13 ' A' ' 245' ' ' LEU . 96.2 mt -106.54 106.7 21.11 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.173 0 CA-C-O 121.177 0.513 . . . . 0.0 110.523 179.85 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 244' ' ' GLN . . . . . 0.606 ' O ' HD12 ' A' ' 245' ' ' LEU . 88.2 mt-30 -110.47 110.12 20.75 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.311 179.817 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.606 HD12 ' O ' ' A' ' 244' ' ' GLN . 9.3 mp -121.86 -168.44 1.7 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.601 179.911 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 246' ' ' GLY . . . . . 0.526 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.67 -16.47 0.05 OUTLIER Glycine 0 CA--C 1.524 0.628 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 179.876 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 247' ' ' GLY . . . . . 0.677 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -60.59 156.35 31.49 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 -179.885 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -63.42 21.38 0.01 OUTLIER 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.886 0.374 . . . . 0.0 110.626 179.883 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 249' ' ' ASN . . . . . 0.677 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.6 m-20 -97.29 -5.78 35.89 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.537 179.942 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 94.8 mt -79.66 -22.11 43.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.543 179.546 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.55 -51.32 70.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.796 -179.591 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.11 -5.68 58.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.476 179.679 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -80.96 -74.69 1.13 Allowed Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 -179.925 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 81.3 mt -69.89 125.97 28.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.069 0.461 . . . . 0.0 110.249 -179.82 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -59.19 -39.52 82.83 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.248 -179.662 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 83.21 51.82 4.02 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 179.903 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -96.04 -14.95 22.56 Favored 'General case' 0 C--N 1.333 -0.152 0 O-C-N 122.729 -0.277 . . . . 0.0 110.564 -179.843 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 258' ' ' SER . . . . . 0.498 ' OG ' HG23 ' A' ' 191' ' ' VAL . 3.4 t 174.43 88.62 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.048 0.451 . . . . 0.0 110.169 -179.972 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.864 HD12 ' N ' ' A' ' 259' ' ' LEU . 1.0 OUTLIER -94.05 123.93 37.74 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.227 0.537 . . . . 0.0 111.11 -179.159 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 260' ' ' PHE . . . . . 0.443 ' H ' ' HA ' ' A' ' 193' ' ' ALA . 16.0 m-30 -92.93 146.7 23.43 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.337 179.221 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 85.7 mt -122.53 149.9 43.29 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.521 -179.868 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.747 ' CD1' HG13 ' A' ' 195' ' ' VAL . 2.6 p90 -77.57 -138.47 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.552 -179.865 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 263' ' ' ALA . . . . . 0.662 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -52.16 77.73 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.922 179.957 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 264' ' ' GLY . . . . . 0.632 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.16 104.46 0.19 Allowed Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 -179.936 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 265' ' ' ASP . . . . . 0.609 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.8 m-20 -80.49 -177.64 6.31 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.749 0.309 . . . . 0.0 110.841 -179.468 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -40.48 -17.54 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.506 179.8 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 267' ' ' LYS . . . . . 0.609 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.63 -51.59 40.52 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.687 179.516 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -63.71 -46.67 84.38 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.187 179.382 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 269' ' ' ALA . . . . . 0.569 ' HB1' ' OH ' ' A' ' 273' ' ' TYR . . . -61.64 -35.04 76.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.845 179.52 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -63.05 -34.53 77.78 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.111 179.744 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.37 -43.21 13.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.261 -179.577 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 272' ' ' ILE . . . . . 0.586 ' C ' ' H ' ' A' ' 274' ' ' ALA . 4.9 tt -51.39 -33.81 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.811 -178.802 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 273' ' ' TYR . . . . . 0.569 ' OH ' ' HB1' ' A' ' 269' ' ' ALA . 17.2 m-85 -54.27 -1.76 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.655 -179.628 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 274' ' ' ALA . . . . . 0.586 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.87 -39.41 69.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.844 179.686 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 275' ' ' ASN . . . . . 0.582 ' O ' ' N ' ' A' ' 279' ' ' ALA . 2.9 p30 -39.63 98.28 0.16 Allowed Pre-proline 0 C--N 1.333 -0.141 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.513 -179.671 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -54.02 -43.17 60.61 Favored 'Trans proline' 0 C--N 1.302 -1.874 0 C-N-CA 122.411 2.074 . . . . 0.0 112.613 -178.855 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 88.9 mt -64.47 -42.83 95.69 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.137 0.494 . . . . 0.0 111.218 -179.625 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 89.7 mt -95.67 -1.54 49.9 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.875 -179.47 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 279' ' ' ALA . . . . . 0.582 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.42 -34.65 77.17 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.646 -179.807 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.45 20.04 0.12 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.024 -179.226 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 281' ' ' LEU . . . . . 0.492 HD23 ' HA ' ' A' ' 281' ' ' LEU . 13.9 mt -75.32 120.52 82.06 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.394 179.968 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -51.36 -39.23 63.56 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 122.625 2.217 . . . . 0.0 111.676 179.312 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.9 -50.42 63.93 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.09 179.878 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 75.2 t -61.48 -43.93 97.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 179.502 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -57.67 -41.27 81.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.317 -179.981 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -91.14 0.45 57.53 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.123 179.599 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt 59.06 43.25 17.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.042 0.448 . . . . 0.0 110.928 179.67 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -94.59 41.43 1.09 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.399 179.793 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 53.4 t -118.85 135.86 57.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.031 0.443 . . . . 0.0 110.166 -179.707 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -133.01 162.8 30.73 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.706 -179.637 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.94 155.19 33.24 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.988 0.423 . . . . 0.0 110.701 -179.743 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 80.4 mt -93.95 -1.36 54.76 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.364 -179.794 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.26 165.89 12.78 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 110.65 -0.98 . . . . 0.0 110.65 -179.747 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 6.9 m -87.75 -62.26 1.54 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.889 0.376 . . . . 0.0 111.124 -179.922 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 295' ' ' GLU . . . . . 0.441 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.7 mm-40 -69.48 -3.78 16.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.569 -179.729 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 27.6 p -76.74 32.8 0.14 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.698 -179.963 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 297' ' ' PHE . . . . . 0.524 ' CD2' HG22 ' A' ' 70' ' ' THR . 85.5 t80 -60.21 -45.92 91.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.677 179.995 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 298' ' ' ARG . . . . . 0.613 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.1 mtt85 -81.54 134.23 35.48 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.592 -179.68 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.463 ' H ' HG11 ' A' ' 51' ' ' VAL . 16.6 tp -114.04 118.35 33.84 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.115 179.969 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 300' ' ' ASP . . . . . 0.635 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.7 p-10 -165.8 -175.96 3.66 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.526 -179.934 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -47.34 -44.04 23.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.194 -179.639 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -66.33 -40.76 90.1 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.013 0.435 . . . . 0.0 110.776 179.05 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 303' ' ' SER . . . . . 0.635 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 57.6 p -55.72 -36.17 66.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.168 -179.334 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 304' ' ' ALA . . . . . 0.546 ' HB2' ' SD ' ' A' ' 215' ' ' MET . . . -57.35 -51.68 68.43 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.439 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 91.1 mtp -56.15 -43.59 78.42 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.778 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -66.54 -42.49 87.11 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.912 0.387 . . . . 0.0 110.167 178.821 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 307' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 303' ' ' SER . 55.9 t -64.13 -42.86 96.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.179 179.305 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 43.5 tp -59.68 -42.14 92.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.88 -179.588 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -62.54 -39.15 92.67 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.112 179.494 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 310' ' ' ARG . . . . . 0.438 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.5 ttt85 -63.45 -43.99 95.77 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.293 179.445 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 88.9 mt -63.34 -42.13 98.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.226 179.566 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.4 ttmt -62.84 -33.26 74.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.068 0.461 . . . . 0.0 110.108 179.485 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.84 -23.46 21.67 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.579 -179.942 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 314' ' ' LEU . . . . . 0.478 HD22 ' CE2' ' A' ' 315' ' ' PHE . 6.7 tt -62.39 -43.17 99.47 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.547 -179.894 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 315' ' ' PHE . . . . . 0.478 ' CE2' HD22 ' A' ' 314' ' ' LEU . 91.0 m-85 . . . . . 0 C--O 1.219 -0.502 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.498 179.989 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -99.67 135.97 40.29 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.047 0.451 . . . . 0.0 110.485 -179.962 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.497 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.2 OUTLIER -91.64 178.43 1.76 Allowed Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.601 -179.87 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.497 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.6 Cg_exo -61.73 147.73 94.65 Favored 'Trans proline' 0 C--N 1.3 -1.987 0 C-N-CA 122.755 2.303 . . . . 0.0 112.118 179.708 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.473 ' HE ' HD12 ' A' ' 39' ' ' LEU . 35.4 ptt180 -135.48 142.34 45.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.618 179.797 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -78.95 116.84 19.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.576 179.953 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.431 ' O ' HG23 ' A' ' 30' ' ' ILE . 9.6 tp -110.17 130.86 62.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.436 -179.998 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 13.2 t -70.69 142.3 51.53 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.614 179.839 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 141' ' ' ILE . 25.2 t70 -140.25 177.56 7.9 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.481 -179.939 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 77.9 p -74.13 -36.33 64.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.529 -179.945 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -47.69 -94.96 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.347 -179.606 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -165.46 -25.83 0.02 OUTLIER Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 179.892 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 59.0 m -168.84 106.96 0.44 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.846 0.355 . . . . 0.0 110.689 -179.96 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 51.0 t-80 -129.57 144.77 51.42 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.012 0.434 . . . . 0.0 110.224 179.885 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.628 HG22 ' N ' ' A' ' 39' ' ' LEU . 97.4 m -128.95 166.24 19.53 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.582 -179.76 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.628 ' N ' HG22 ' A' ' 38' ' ' THR . 81.9 mt -121.04 127.48 51.76 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.486 179.738 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -64.05 -44.55 92.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.618 -179.829 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 40.7 p -165.68 154.75 11.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.463 179.719 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.52 ' CD ' ' H ' ' A' ' 42' ' ' GLN . 14.4 mp0 -43.36 100.86 0.23 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.595 179.61 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -57.03 128.95 31.95 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.384 2.056 . . . . 0.0 112.29 -179.637 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -83.34 -24.54 32.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.551 179.6 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.541 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.7 mtm-85 -121.03 134.43 55.29 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 121.095 0.474 . . . . 0.0 110.294 -179.985 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.0 mt -130.23 133.35 64.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.943 -179.746 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 45.9 t -124.9 131.13 73.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.817 0.341 . . . . 0.0 110.156 179.334 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.601 ' OG ' HD12 ' A' ' 117' ' ' LEU . 4.8 m -154.55 166.32 33.7 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.543 179.881 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 72.0 p -124.56 8.55 8.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.519 179.856 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.3 t -85.73 125.33 33.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.579 -179.485 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.499 HG11 ' H ' ' A' ' 299' ' ' LEU . 96.4 t -65.66 -44.46 93.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.544 179.961 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.7 m -62.48 -44.36 96.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.57 -179.841 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 46.3 tp -62.41 -41.3 98.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.516 -179.441 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.454 ' O ' HD13 ' A' ' 58' ' ' LEU . 73.7 m -57.59 -44.57 85.48 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.451 -179.326 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.43 -62.3 5.22 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 179.602 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.6 t -48.14 -35.78 12.19 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 179.807 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.5 mt -61.66 -44.79 96.29 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.038 179.474 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.454 HD13 ' O ' ' A' ' 54' ' ' THR . 9.1 mp -64.96 -41.81 95.15 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.164 178.114 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.403 ' HB1' ' NE ' ' A' ' 169' ' ' ARG . . . -63.48 -41.49 98.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.921 -179.164 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.433 ' O ' HG23 ' A' ' 60' ' ' ILE . 8.1 tp -87.9 16.94 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.711 -179.574 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 56.58 84.01 0.09 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.646 179.999 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.74 58.2 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.106 -179.803 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -50.84 152.6 9.6 Favored 'Trans proline' 0 C--N 1.298 -2.121 0 C-N-CA 122.832 2.355 . . . . 0.0 112.485 -178.264 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.431 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -108.99 145.74 15.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.348 -179.63 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.86 -45.17 97.78 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.3 -179.671 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.496 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -129.85 134.53 47.59 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.598 -179.713 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.5 ' O ' ' N ' ' A' ' 98' ' ' LEU . 75.3 m -134.83 158.79 43.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.788 -179.605 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -87.07 139.45 16.19 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.752 -0.939 . . . . 0.0 110.752 179.753 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.493 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.98 -162.49 0.08 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.931 0.396 . . . . 0.0 110.481 -179.921 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.522 HG22 ' CD2' ' A' ' 297' ' ' PHE . 14.6 t -133.67 135.35 44.03 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.353 179.942 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.496 ' C ' ' O ' ' A' ' 70' ' ' THR . 0.1 OUTLIER 29.58 68.54 0.65 Allowed Pre-proline 0 N--CA 1.463 0.222 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.705 -179.824 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -60.98 145.11 99.55 Favored 'Trans proline' 0 C--N 1.301 -1.963 0 C-N-CA 122.626 2.218 . . . . 0.0 112.155 -178.525 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.528 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 45.2 p-10 -159.54 -32.3 0.06 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.645 179.723 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.537 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 99.1 m-20 -64.12 -39.45 94.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.464 -179.992 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -60.49 -48.49 81.54 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.646 -179.284 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.424 ' O ' ' O ' ' A' ' 77' ' ' ALA . 92.8 t -59.68 -24.92 30.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.091 179.697 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.537 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -45.54 172.32 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.567 179.869 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.574 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.6 p30 -61.74 177.77 0.39 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.546 -179.732 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.56 ' C ' ' H ' ' A' ' 81' ' ' GLY . 35.6 p30 -45.92 85.8 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.847 179.98 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.574 ' N ' ' O ' ' A' ' 78' ' ' ASP . 42.8 tp60 -67.31 13.62 0.06 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.192 -179.983 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.56 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 117.93 -22.14 9.99 Favored Glycine 0 CA--C 1.52 0.364 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 179.969 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -107.62 116.39 31.87 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.932 0.396 . . . . 0.0 110.513 179.911 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 74.4 mt -98.84 0.86 45.13 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.473 -179.713 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -92.18 6.62 45.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.42 -179.811 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.795 ' O ' HG22 ' A' ' 89' ' ' VAL . 27.1 mt-30 -100.0 -27.41 13.59 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.85 179.971 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.6 t-105 -63.89 -40.74 97.23 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.981 -179.628 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.556 ' O ' ' N ' ' A' ' 91' ' ' LYS . 68.1 m -77.75 -53.84 7.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.225 -179.496 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -48.02 -50.77 26.64 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.908 -179.249 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.795 HG22 ' O ' ' A' ' 85' ' ' GLN . 15.4 m -69.07 -40.97 81.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 120.909 0.385 . . . . 0.0 110.922 179.955 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.503 ' N ' HG23 ' A' ' 89' ' ' VAL . . . -71.93 -22.89 61.41 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.71 -179.873 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.556 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.0 tttm -61.54 -45.91 92.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.482 -179.535 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.439 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.4 mm-40 -90.25 -94.57 0.12 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.151 -179.997 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.624 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.8 mtt180 -143.54 59.96 1.39 Allowed 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.734 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.466 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.7 pttp 33.32 27.1 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.338 -179.029 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.624 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.5 tt -48.55 123.12 6.24 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.915 -178.328 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.45 ' O ' HD23 ' A' ' 95' ' ' LEU . 99.0 mm-40 -83.6 -170.38 3.03 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.227 179.863 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.613 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 81.6 mtp180 -73.31 137.84 45.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.297 -179.847 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.5 ' N ' ' O ' ' A' ' 67' ' ' SER . 88.6 mt -86.09 -166.66 1.6 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.725 -179.584 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.528 ' O ' ' CD2' ' A' ' 99' ' ' TYR . 47.4 p90 -166.77 119.9 1.01 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.302 179.984 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.512 ' C ' ' O ' ' A' ' 99' ' ' TYR . 43.7 mm -29.75 121.15 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.865 -179.6 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 113.43 28.93 3.1 Favored Glycine 0 CA--C 1.522 0.492 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 -179.66 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.59 ' CD ' ' H ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -144.25 46.12 0.61 Allowed Pre-proline 0 C--N 1.325 -0.493 0 CA-C-O 120.922 0.391 . . . . 0.0 110.456 179.934 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.582 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 30.2 Cg_endo -62.01 143.72 95.45 Favored 'Trans proline' 0 C--N 1.299 -2.079 0 C-N-CA 122.733 2.289 . . . . 0.0 112.018 -179.985 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.471 ' O ' HG23 ' A' ' 108' ' ' VAL . 26.1 t -173.36 120.7 0.34 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.454 179.712 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.76 -41.0 63.06 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.056 179.767 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -65.86 -40.26 91.5 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.831 -179.383 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.97 -40.01 95.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.688 -179.777 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 104' ' ' SER . 70.7 t -67.39 -43.85 87.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.735 179.676 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.53 -39.22 92.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.577 -179.329 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.439 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.29 -23.49 62.46 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.521 179.81 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.557 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.4 mm-40 -91.25 5.08 50.55 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.698 -179.552 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.557 ' C ' ' O ' ' A' ' 111' ' ' GLN . 10.2 tpt 22.81 64.59 0.35 Allowed Pre-proline 0 N--CA 1.465 0.288 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.879 -179.85 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.447 ' HG2' HD11 ' A' ' 116' ' ' ILE . 68.4 Cg_endo -78.98 169.27 19.59 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 C-N-CA 122.975 2.45 . . . . 0.0 112.223 -178.684 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.464 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 98.8 m-20 -113.44 -44.08 3.26 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.148 179.43 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.7 tp -120.24 120.92 37.52 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.001 179.432 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.458 HD13 HD22 ' A' ' 133' ' ' LEU . 96.7 mt -118.49 131.07 72.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.795 -179.705 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.601 HD12 ' OG ' ' A' ' 48' ' ' SER . 32.4 mt -106.1 132.76 51.79 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.127 0.489 . . . . 0.0 110.298 -179.502 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.421 HD12 HG23 ' A' ' 139' ' ' THR . 98.0 mt -118.17 136.57 54.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.687 -179.753 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 87.0 p -72.07 153.47 41.7 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.566 -179.938 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.34 -50.27 74.27 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.689 -179.888 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.0 t -149.31 153.74 37.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.51 179.785 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 169.58 -169.99 42.4 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 179.89 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -63.08 -35.14 91.69 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 179.922 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.453 ' OD1' ' O ' ' A' ' 124' ' ' ASP . 44.6 p-10 -88.05 119.86 28.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.843 0.354 . . . . 0.0 110.679 179.897 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.443 ' O ' HD12 ' A' ' 129' ' ' LEU . 37.0 t -63.4 144.53 56.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.445 -179.914 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.523 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.23 -43.43 8.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.936 -179.997 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.7 tp -62.86 -42.3 99.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.655 -179.864 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.48 -11.08 57.03 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.52 -179.519 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.443 HD12 ' O ' ' A' ' 125' ' ' SER . 84.4 mt -116.08 -24.07 8.21 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.642 -179.775 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 130' ' ' TYR . . . . . 0.523 ' N ' ' O ' ' A' ' 126' ' ' ALA . 79.3 t80 -51.12 -50.18 59.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.587 -179.154 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.5 p-10 -65.82 -42.16 90.95 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.906 0.384 . . . . 0.0 111.133 179.716 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.524 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 87.7 mt-30 -67.55 -36.85 81.76 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.698 -179.882 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.458 HD22 HD13 ' A' ' 116' ' ' ILE . 93.7 mt -80.61 -42.0 22.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.952 -179.543 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.3 t -57.03 -44.87 83.32 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.283 -179.279 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.5 m -62.32 -45.78 91.66 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.812 0.339 . . . . 0.0 110.615 179.42 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 92.8 mt -62.34 -43.81 98.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.35 -179.765 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.581 ' HB1' ' HD2' ' A' ' 138' ' ' PRO . . . -170.07 162.85 6.52 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.573 179.811 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.581 ' HD2' ' HB1' ' A' ' 137' ' ' ALA . 77.5 Cg_exo -42.71 110.88 0.18 Allowed 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.562 2.175 . . . . 0.0 112.1 179.554 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.459 HG21 ' CD1' ' A' ' 130' ' ' TYR . 16.7 m -85.77 127.79 34.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.632 179.968 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.444 HD12 ' HA ' ' A' ' 140' ' ' LEU . 35.6 tp -119.77 139.06 52.9 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.127 179.974 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.425 ' O ' ' OD1' ' A' ' 32' ' ' ASP . 78.6 mt -105.65 120.78 57.0 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 CA-C-O 121.088 0.47 . . . . 0.0 111.071 -179.275 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.476 HD12 HD22 ' A' ' 117' ' ' LEU . 96.4 mt -136.33 133.05 49.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.597 179.522 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.476 ' ND2' ' OD2' ' A' ' 241' ' ' ASP . 2.1 t-20 -64.26 151.19 44.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.939 0.399 . . . . 0.0 110.4 179.468 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.517 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 89.3 t80 -86.38 122.94 31.05 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.805 -179.484 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.517 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 99.1 m-20 55.12 69.5 0.73 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.841 179.648 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 42.8 p-10 -127.54 1.06 6.22 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.917 0.389 . . . . 0.0 110.617 -179.956 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -150.45 114.76 5.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.718 -179.643 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 83.4 p -63.44 168.44 4.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.517 -179.803 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.414 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.6 p-90 -52.13 -15.66 0.63 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.599 -179.858 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 150' ' ' GLN . . . . . 0.436 ' O ' HG23 ' A' ' 154' ' ' THR . 68.1 tp60 -70.62 -76.17 0.11 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.507 -179.801 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.45 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.0 t -62.79 -38.55 91.07 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.309 179.584 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 53.2 tp -59.82 -45.79 91.26 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.459 -178.636 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.414 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 46.7 tp -62.77 -41.72 99.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.431 179.051 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.45 ' OG1' ' O ' ' A' ' 151' ' ' SER . 60.4 p -63.96 -34.87 78.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.311 -179.633 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 155' ' ' GLN . . . . . 0.461 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.6 mm-40 -63.89 -42.34 97.48 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.277 179.266 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 92.4 mt -65.45 -38.81 90.94 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.949 0.404 . . . . 0.0 110.215 179.027 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.579 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.32 -31.89 78.85 Favored Glycine 0 CA--C 1.521 0.442 0 N-CA-C 110.829 -0.908 . . . . 0.0 110.829 -179.428 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.461 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.3 mt-10 -36.62 -25.53 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.87 0.367 . . . . 0.0 110.814 179.976 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.579 ' N ' ' O ' ' A' ' 157' ' ' GLY . 93.9 mt -59.02 150.63 5.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.288 179.464 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 73.5 p -69.26 137.2 52.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.922 -179.435 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 69.88 22.98 77.17 Favored Glycine 0 CA--C 1.517 0.197 0 N-CA-C 111.226 -0.75 . . . . 0.0 111.226 179.408 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 61.4 m80 -124.0 -13.92 7.22 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.717 0.294 . . . . 0.0 110.576 179.91 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -67.13 -59.53 3.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.764 -179.71 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -51.49 -49.59 61.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.261 -179.718 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -60.08 -41.31 92.15 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.732 0.301 . . . . 0.0 110.374 179.484 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.44 -47.61 84.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.596 179.85 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.57 -40.25 74.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.297 -179.901 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -61.46 -50.32 73.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.621 179.613 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.403 ' NE ' ' HB1' ' A' ' 59' ' ' ALA . 59.9 ttt85 -65.65 -43.61 88.87 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.477 179.6 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 94.6 mt -64.46 -43.51 96.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.46 179.747 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.38 -51.31 69.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.616 -179.269 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.8 -44.18 94.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.49 179.686 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 173' ' ' PHE . . . . . 0.659 ' CE2' HD11 ' A' ' 177' ' ' LEU . 55.1 t80 -62.76 -44.38 96.34 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.494 179.458 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -63.3 -40.0 96.13 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.621 -179.434 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -62.89 -42.74 99.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.677 179.231 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -60.78 -44.89 96.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.148 179.936 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.659 HD11 ' CE2' ' A' ' 173' ' ' PHE . 85.6 mt -64.6 -41.08 96.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.053 0.454 . . . . 0.0 110.771 178.887 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.04 -61.95 1.94 Allowed 'General case' 0 C--O 1.236 0.38 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.558 -179.415 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.83 -46.75 86.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.484 179.825 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.24 -41.41 65.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.268 -179.968 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -64.18 -33.78 76.57 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.958 0.409 . . . . 0.0 110.391 179.282 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 182' ' ' GLU . . . . . 0.426 ' O ' ' HG2' ' A' ' 182' ' ' GLU . 69.4 tt0 -90.74 9.04 31.58 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.255 0.55 . . . . 0.0 110.575 -179.018 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -104.94 -32.19 8.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.045 179.746 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.4 pt -128.22 147.86 32.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.799 -179.773 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -140.05 131.1 26.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.398 179.385 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 186' ' ' LEU . . . . . 0.6 HD22 ' N ' ' A' ' 186' ' ' LEU . 3.6 mm? -85.54 133.9 41.16 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.789 179.99 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -44.15 157.99 0.14 Allowed 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.773 2.315 . . . . 0.0 112.055 179.363 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 188' ' ' PRO . . . . . 0.535 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.9 Cg_endo -63.02 114.84 2.61 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 C-N-CA 122.774 2.316 . . . . 0.0 111.786 179.783 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 189' ' ' GLN . . . . . 0.535 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.7 mt-30 155.36 148.15 0.0 OUTLIER Pre-proline 0 N--CA 1.455 -0.186 0 O-C-N 123.461 0.476 . . . . 0.0 110.67 -179.809 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -73.61 144.22 35.34 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.738 2.292 . . . . 0.0 111.861 178.001 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.498 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.1 p -124.99 158.95 32.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.232 0.539 . . . . 0.0 110.165 -179.979 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 192' ' ' THR . . . . . 0.498 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 38.5 p -143.51 165.13 28.43 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.01 -179.427 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 193' ' ' ALA . . . . . 0.444 ' HA ' ' H ' ' A' ' 260' ' ' PHE . . . -135.45 128.53 31.65 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.109 0.48 . . . . 0.0 110.231 179.543 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.505 HD11 HD23 ' A' ' 259' ' ' LEU . 47.7 pt -146.27 148.39 17.15 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.04 -179.945 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 195' ' ' VAL . . . . . 0.746 HG13 ' CD1' ' A' ' 262' ' ' PHE . 72.2 t -117.28 123.09 71.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.21 0.529 . . . . 0.0 109.909 178.962 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -134.13 107.4 7.7 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.296 179.674 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 94.5 m -130.95 130.42 43.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.853 179.797 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -82.76 -36.95 25.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.324 179.668 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.55 -67.39 0.24 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.422 179.942 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -71.93 -9.97 59.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.314 179.515 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 59.7 t-80 60.85 58.34 2.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.738 -179.877 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 39.7 p -167.18 153.39 8.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.594 179.596 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.24 144.08 24.47 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.987 0.422 . . . . 0.0 110.496 179.433 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -135.41 138.43 43.25 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.583 -179.914 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 20.1 mt -106.16 125.33 50.86 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 121.074 0.464 . . . . 0.0 109.926 -179.758 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 206' ' ' TRP . . . . . 0.569 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 74.7 m95 -81.82 166.82 19.65 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.623 -179.81 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 207' ' ' THR . . . . . 0.463 HG22 ' C ' ' A' ' 206' ' ' TRP . 0.1 OUTLIER -156.47 172.35 6.2 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.615 -179.244 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -54.42 -37.29 89.39 Favored 'Trans proline' 0 C--N 1.303 -1.825 0 C-N-CA 122.716 2.277 . . . . 0.0 112.015 179.297 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -70.45 -34.68 72.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.765 -179.75 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 21.6 m -61.5 150.57 35.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.586 -179.357 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.41 -36.47 80.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.471 -179.75 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 212' ' ' GLN . . . . . 0.569 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 54.2 tt0 -64.46 -40.81 96.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.543 179.908 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.61 -43.47 92.04 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 179.837 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -63.23 -44.14 96.09 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.761 0.315 . . . . 0.0 110.295 179.658 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 215' ' ' MET . . . . . 0.579 ' SD ' ' HB2' ' A' ' 304' ' ' ALA . 65.1 ttp -59.61 -48.0 83.39 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.314 -179.879 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 86.3 mt -60.55 -40.82 93.01 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.353 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 217' ' ' GLU . . . . . 0.456 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 40.7 tp10 -57.86 -38.2 75.29 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 179.513 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -65.26 -38.17 89.48 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.8 0.333 . . . . 0.0 110.624 179.678 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 94.6 mt -64.35 -42.82 96.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.491 -179.689 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.63 45.96 0.08 OUTLIER Glycine 0 CA--C 1.521 0.435 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 179.993 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 221' ' ' PHE . . . . . 0.456 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 26.8 m-85 -129.07 156.13 44.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.993 0.425 . . . . 0.0 110.487 -179.829 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.487 ' O ' HG13 ' A' ' 191' ' ' VAL . 7.7 p -108.1 122.7 47.43 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.112 0.482 . . . . 0.0 110.239 -179.997 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.478 HD22 ' C ' ' A' ' 222' ' ' THR . 4.3 mm? -101.43 133.17 46.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.089 -179.889 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.99 159.81 14.7 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.52 179.776 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -105.03 115.08 29.68 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.934 0.397 . . . . 0.0 110.398 179.853 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.494 HD12 ' N ' ' A' ' 226' ' ' LEU . 9.1 mp -53.37 156.86 3.79 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.574 179.954 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -60.27 145.22 99.03 Favored 'Trans proline' 0 C--N 1.302 -1.887 0 C-N-CA 122.615 2.21 . . . . 0.0 112.076 179.303 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.56 -2.78 58.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.543 -179.969 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.41 -40.67 5.67 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -179.842 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 230' ' ' LEU . . . . . 0.552 ' O ' ' N ' ' A' ' 233' ' ' SER . 85.3 mt -79.29 -16.77 55.86 Favored 'General case' 0 C--O 1.224 -0.242 0 CA-C-O 120.929 0.395 . . . . 0.0 110.41 -179.821 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 231' ' ' ASN . . . . . 0.407 ' C ' ' O ' ' A' ' 230' ' ' LEU . 54.8 t-20 -39.82 -49.21 2.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.708 -179.706 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -88.55 15.71 7.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.103 -179.926 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 233' ' ' SER . . . . . 0.552 ' N ' ' O ' ' A' ' 230' ' ' LEU . 78.2 p -60.64 -35.96 77.47 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.64 -179.891 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 234' ' ' GLN . . . . . 0.527 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.7 tt0 -118.01 -69.55 0.84 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.911 179.677 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.0 m -70.56 103.36 2.48 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.658 -179.791 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -94.54 58.09 2.32 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.387 179.885 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -145.11 -122.71 1.56 Allowed Glycine 0 CA--C 1.522 0.47 0 N-CA-C 110.931 -0.868 . . . . 0.0 110.931 -179.927 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -133.71 111.7 10.79 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.052 0.454 . . . . 0.0 110.487 179.964 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 239' ' ' ARG . . . . . 0.496 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.0 mtt180 -148.18 56.88 1.07 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.741 -179.926 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 94.2 m-70 -69.66 -31.46 69.54 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.569 179.578 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 241' ' ' ASP . . . . . 0.476 ' OD2' ' ND2' ' A' ' 143' ' ' ASN . 65.2 t0 -56.87 -46.84 81.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.33 -179.147 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 242' ' ' ILE . . . . . 0.439 ' O ' ' O ' ' A' ' 239' ' ' ARG . 17.2 tt -140.71 157.86 23.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.913 0.387 . . . . 0.0 110.529 179.726 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.445 HG22 HD13 ' A' ' 245' ' ' LEU . 96.0 mt -106.28 106.13 20.02 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.198 0 CA-C-O 121.147 0.498 . . . . 0.0 110.489 179.886 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 244' ' ' GLN . . . . . 0.608 ' C ' HD12 ' A' ' 245' ' ' LEU . 88.3 mt-30 -110.68 110.62 21.36 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.375 179.765 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.608 HD12 ' C ' ' A' ' 244' ' ' GLN . 9.5 mp -122.19 -168.05 1.65 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.619 179.826 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 246' ' ' GLY . . . . . 0.527 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 172.98 -16.63 0.05 OUTLIER Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 179.901 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 247' ' ' GLY . . . . . 0.666 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -60.42 157.46 28.85 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 -179.819 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -64.21 21.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.955 0.407 . . . . 0.0 110.584 179.964 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 249' ' ' ASN . . . . . 0.666 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.8 m-20 -97.01 -5.84 36.74 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.548 179.932 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 92.5 mt -80.15 -21.18 43.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.643 179.464 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.52 -51.39 70.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.764 -179.555 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.83 -5.34 58.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.423 179.67 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.06 -74.43 1.14 Allowed Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 -179.863 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 80.1 mt -69.84 125.51 26.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.044 0.449 . . . . 0.0 110.253 -179.882 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -59.41 -39.53 83.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.29 -179.679 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 83.35 51.77 4.01 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 110.806 -0.917 . . . . 0.0 110.806 179.897 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -95.17 -16.08 22.83 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.79 0.329 . . . . 0.0 110.623 -179.883 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 258' ' ' SER . . . . . 0.492 ' OG ' HG23 ' A' ' 191' ' ' VAL . 3.4 t 174.92 89.29 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.014 0.435 . . . . 0.0 110.222 179.995 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.865 HD12 ' N ' ' A' ' 259' ' ' LEU . 0.9 OUTLIER -94.17 124.2 38.04 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.22 0.533 . . . . 0.0 111.052 -179.024 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 260' ' ' PHE . . . . . 0.444 ' H ' ' HA ' ' A' ' 193' ' ' ALA . 16.1 m-30 -93.55 146.98 23.4 Favored 'General case' 0 CA--C 1.51 -0.577 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.406 179.053 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 85.3 mt -122.46 150.02 43.08 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.537 -179.895 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.746 ' CD1' HG13 ' A' ' 195' ' ' VAL . 2.7 p90 -77.85 -138.86 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.533 -179.795 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 263' ' ' ALA . . . . . 0.662 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -51.44 78.17 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.942 -179.885 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 264' ' ' GLY . . . . . 0.631 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.88 104.57 0.19 Allowed Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 179.942 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 265' ' ' ASP . . . . . 0.601 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.8 m-20 -80.29 -177.23 6.03 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 120.692 0.282 . . . . 0.0 110.858 -179.432 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -40.7 -17.69 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.49 179.825 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 267' ' ' LYS . . . . . 0.601 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.5 -51.57 41.84 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.78 179.521 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -63.89 -46.62 84.09 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.282 179.312 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 269' ' ' ALA . . . . . 0.583 ' HB1' ' OH ' ' A' ' 273' ' ' TYR . . . -61.56 -35.1 76.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.976 179.424 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -62.89 -34.5 77.54 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.177 179.561 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.46 -43.36 13.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.223 -179.536 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 272' ' ' ILE . . . . . 0.588 ' C ' ' H ' ' A' ' 274' ' ' ALA . 5.0 tt -51.56 -33.65 15.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.704 -178.643 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 273' ' ' TYR . . . . . 0.583 ' OH ' ' HB1' ' A' ' 269' ' ' ALA . 16.9 m-85 -54.25 -1.82 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.71 -179.755 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 274' ' ' ALA . . . . . 0.588 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.75 -39.59 69.92 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.906 179.571 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 275' ' ' ASN . . . . . 0.586 ' O ' ' N ' ' A' ' 279' ' ' ALA . 3.7 p30 -39.17 97.94 0.15 Allowed Pre-proline 0 C--N 1.333 -0.15 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.576 -179.679 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo -53.97 -43.18 60.46 Favored 'Trans proline' 0 C--N 1.304 -1.814 0 C-N-CA 122.463 2.109 . . . . 0.0 112.614 -178.803 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 89.2 mt -64.5 -42.82 95.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.072 -179.563 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 91.0 mt -95.98 -1.11 49.69 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.814 -179.399 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 279' ' ' ALA . . . . . 0.586 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.49 -34.93 77.82 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.568 -179.721 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.33 20.28 0.12 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.965 -179.204 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 281' ' ' LEU . . . . . 0.495 HD23 ' HA ' ' A' ' 281' ' ' LEU . 13.7 mt -75.16 120.03 79.72 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.43 179.859 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -50.9 -39.61 58.66 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.617 2.211 . . . . 0.0 111.781 179.172 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.75 -50.63 63.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.171 179.731 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 74.7 t -61.48 -43.99 97.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 179.487 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -57.68 -41.28 81.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.283 -179.983 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -90.68 0.21 57.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.221 179.593 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt 59.73 42.93 16.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.872 179.658 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -94.7 41.34 1.09 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.356 179.793 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 54.0 t -119.02 135.92 57.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.964 0.412 . . . . 0.0 110.237 -179.832 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -133.68 163.61 29.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.69 -179.57 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.86 155.52 32.48 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.944 0.402 . . . . 0.0 110.721 -179.735 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 80.7 mt -94.32 -1.66 53.5 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.311 -179.765 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.46 165.3 12.57 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 -179.653 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 6.8 m -86.8 -61.66 1.68 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.871 0.367 . . . . 0.0 111.066 -179.814 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 295' ' ' GLU . . . . . 0.455 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.5 mm-40 -69.55 -4.75 20.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.657 -179.704 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 25.6 p -76.14 32.82 0.12 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.617 -179.88 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 297' ' ' PHE . . . . . 0.522 ' CD2' HG22 ' A' ' 70' ' ' THR . 82.5 t80 -60.62 -46.12 91.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.662 -179.967 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 298' ' ' ARG . . . . . 0.613 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.2 mtt85 -80.76 137.11 36.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.679 -179.535 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.499 ' H ' HG11 ' A' ' 51' ' ' VAL . 4.2 tp -114.16 116.17 28.66 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.407 179.775 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 300' ' ' ASP . . . . . 0.627 ' H ' ' CB ' ' A' ' 303' ' ' SER . 48.3 p-10 -166.05 -176.17 3.65 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.497 -179.921 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 77.9 t80 -46.79 -43.44 18.33 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.226 -179.946 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -66.85 -40.81 88.04 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.991 0.424 . . . . 0.0 110.741 179.289 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 303' ' ' SER . . . . . 0.627 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 60.7 p -55.74 -36.22 67.03 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.068 -179.178 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 304' ' ' ALA . . . . . 0.579 ' HB2' ' SD ' ' A' ' 215' ' ' MET . . . -57.74 -51.61 68.83 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.085 179.385 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 91.1 mtp -55.96 -44.23 78.28 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.688 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -65.91 -43.27 88.66 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.869 0.366 . . . . 0.0 110.195 178.741 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 307' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 303' ' ' SER . 56.0 t -63.89 -43.03 97.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.249 179.463 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 43.8 tp -59.74 -42.12 92.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.938 -179.747 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -62.41 -39.24 92.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.07 179.767 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 310' ' ' ARG . . . . . 0.455 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.7 ttt85 -63.67 -43.84 95.52 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.32 179.487 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 89.5 mt -63.31 -42.04 98.99 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.325 179.563 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -62.97 -33.68 75.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.138 179.341 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.68 -23.47 21.85 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.388 -179.777 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 314' ' ' LEU . . . . . 0.483 HD22 ' CE2' ' A' ' 315' ' ' PHE . 6.8 tt -62.28 -43.11 99.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.574 -179.971 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 315' ' ' PHE . . . . . 0.483 ' CE2' HD22 ' A' ' 314' ' ' LEU . 90.3 m-85 . . . . . 0 C--O 1.22 -0.478 0 CA-C-O 118.028 -0.987 . . . . 0.0 110.483 179.939 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -99.35 135.88 40.11 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.563 179.993 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.499 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -92.28 178.52 1.66 Allowed Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.572 -179.884 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.499 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 27.0 Cg_exo -61.63 147.34 95.59 Favored 'Trans proline' 0 C--N 1.301 -1.97 0 C-N-CA 122.777 2.318 . . . . 0.0 112.09 179.709 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.456 HH12 HG23 ' A' ' 159' ' ' ILE . 35.2 ptt180 -135.65 142.38 45.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.691 179.742 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -79.88 116.29 19.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.524 179.923 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.45 ' O ' HG23 ' A' ' 30' ' ' ILE . 9.4 tp -110.77 130.45 64.13 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.427 179.979 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.2 t -70.85 141.97 51.24 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.571 179.811 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.476 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.3 t0 -139.7 179.48 6.55 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.516 -179.913 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.476 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 78.5 p -73.67 -37.0 65.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.842 179.706 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.8 ttt85 -46.56 -94.66 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.354 -179.534 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.417 ' O ' ' OG1' ' A' ' 36' ' ' THR . . . -167.29 -26.55 0.02 OUTLIER Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 179.89 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.417 ' OG1' ' O ' ' A' ' 35' ' ' GLY . 64.8 m -168.76 104.37 0.42 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.908 0.385 . . . . 0.0 110.65 -179.826 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.675 ' CD2' HD13 ' A' ' 140' ' ' LEU . 73.9 t60 -128.41 147.93 50.68 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.031 0.443 . . . . 0.0 110.293 179.95 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.623 HG22 ' N ' ' A' ' 39' ' ' LEU . 98.5 m -130.48 165.93 21.61 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.66 -179.894 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.623 ' N ' HG22 ' A' ' 38' ' ' THR . 83.1 mt -120.51 127.75 52.48 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.513 179.729 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -65.33 -44.63 87.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.626 -179.901 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 42.2 p -165.77 154.77 11.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.466 179.652 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.532 ' CD ' ' H ' ' A' ' 42' ' ' GLN . 14.7 mp0 -44.32 101.31 0.25 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.644 179.495 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -57.36 129.22 32.89 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 122.378 2.052 . . . . 0.0 112.178 -179.716 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -83.61 -24.68 31.36 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.495 179.654 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.54 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.1 mtm-85 -122.02 134.98 54.8 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-O 121.133 0.492 . . . . 0.0 110.345 -179.922 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 95.9 mt -131.19 133.82 62.02 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.272 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.96 -179.711 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 45.7 t -124.38 130.38 73.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.325 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.626 ' OG ' HD12 ' A' ' 117' ' ' LEU . 2.3 m -154.94 166.64 32.93 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.548 179.865 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 67.7 p -124.59 9.31 8.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.515 179.904 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.45 125.53 33.09 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.665 -179.512 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.443 HG11 ' H ' ' A' ' 299' ' ' LEU . 98.4 t -65.86 -44.46 92.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.479 -179.982 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.5 m -62.68 -44.35 96.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.642 -179.839 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 51.1 tp -62.16 -41.6 98.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.555 -179.455 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.443 ' O ' HD13 ' A' ' 58' ' ' LEU . 76.3 m -57.6 -44.34 85.37 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.308 -179.322 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.22 -62.18 5.38 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 179.547 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.7 t -48.44 -35.65 13.32 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 -179.99 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.8 mt -61.77 -44.91 95.96 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.636 -0.426 . . . . 0.0 111.174 179.448 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.443 HD13 ' O ' ' A' ' 54' ' ' THR . 9.3 mp -64.68 -41.82 95.79 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.091 0.472 . . . . 0.0 111.382 177.86 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.404 ' HB1' ' NE ' ' A' ' 169' ' ' ARG . . . -63.6 -40.95 98.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.652 -0.703 . . . . 0.0 111.014 -179.206 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.439 ' O ' HG23 ' A' ' 60' ' ' ILE . 8.1 tp -88.6 17.18 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.724 -179.602 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 56.32 84.95 0.08 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.694 -179.977 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.24 58.99 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.081 -179.8 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -50.75 151.6 10.72 Favored 'Trans proline' 0 C--N 1.297 -2.155 0 C-N-CA 122.799 2.333 . . . . 0.0 112.579 -178.359 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.434 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -108.46 145.64 15.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.391 -179.764 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.8 mt -63.89 -44.91 98.16 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.298 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.416 -179.721 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.499 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -130.18 134.41 47.27 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.574 -179.806 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.479 ' O ' ' N ' ' A' ' 98' ' ' LEU . 72.9 m -134.67 158.82 43.09 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.83 -179.589 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.32 138.5 15.94 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 110.726 -0.949 . . . . 0.0 110.726 179.816 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.478 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.46 -163.0 0.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.96 0.41 . . . . 0.0 110.508 -179.988 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.523 HG22 ' CD2' ' A' ' 297' ' ' PHE . 5.9 t -133.75 135.39 43.91 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.242 -179.977 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.494 ' C ' ' O ' ' A' ' 70' ' ' THR . 0.9 OUTLIER 29.61 68.35 0.67 Allowed Pre-proline 0 N--CA 1.464 0.236 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.745 -179.663 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -60.98 144.59 99.61 Favored 'Trans proline' 0 C--N 1.301 -1.958 0 C-N-CA 122.548 2.165 . . . . 0.0 112.252 -178.573 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.528 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 45.4 p-10 -159.68 -31.7 0.06 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.634 179.624 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.539 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 99.1 m-20 -64.15 -39.44 94.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.415 179.998 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -60.43 -48.2 82.8 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.644 -179.242 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.425 ' O ' ' O ' ' A' ' 77' ' ' ALA . 97.0 t -60.15 -24.7 31.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.154 179.596 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.539 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -45.72 173.15 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.588 179.853 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.574 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.3 p30 -62.06 177.56 0.45 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.583 -179.689 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.556 ' C ' ' H ' ' A' ' 81' ' ' GLY . 36.2 p30 -45.46 85.86 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.942 179.99 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.574 ' N ' ' O ' ' A' ' 78' ' ' ASP . 43.0 tp60 -67.65 13.23 0.08 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.08 -179.838 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.556 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 118.52 -21.89 9.66 Favored Glycine 0 CA--C 1.519 0.321 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.985 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -108.4 116.46 32.02 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.941 0.4 . . . . 0.0 110.522 179.894 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 75.6 mt -98.79 0.49 44.5 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.451 -179.726 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -92.65 7.18 44.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.988 0.423 . . . . 0.0 110.46 -179.778 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.798 ' O ' HG22 ' A' ' 89' ' ' VAL . 27.3 mt-30 -100.03 -27.91 13.33 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.855 -179.971 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 69.3 t-105 -63.19 -40.71 98.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.877 -179.544 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.56 ' O ' ' N ' ' A' ' 91' ' ' LYS . 65.7 m -77.65 -53.68 7.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.203 -179.394 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -48.19 -50.86 27.59 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.939 -179.363 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.798 HG22 ' O ' ' A' ' 85' ' ' GLN . 15.7 m -68.89 -40.75 81.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 120.936 0.398 . . . . 0.0 111.034 179.836 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.499 ' N ' HG23 ' A' ' 89' ' ' VAL . . . -72.46 -22.65 61.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.83 -179.869 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.56 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.1 tttm -61.91 -45.41 93.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.477 -179.578 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.441 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.7 mm-40 -90.69 -94.88 0.12 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.118 -179.869 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.644 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.8 mtt180 -142.9 59.31 1.42 Allowed 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.716 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.466 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.8 pttp 33.33 25.97 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.162 -179.098 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.644 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.3 tt -47.78 123.54 6.13 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.918 -178.287 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.451 ' O ' HD23 ' A' ' 95' ' ' LEU . 99.1 mm-40 -83.8 -169.89 2.8 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.075 -179.913 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.612 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 82.4 mtp180 -74.1 137.17 43.12 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.197 -179.805 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.479 ' N ' ' O ' ' A' ' 67' ' ' SER . 90.4 mt -86.46 -165.74 1.35 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.704 -179.618 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.536 ' O ' ' CD2' ' A' ' 99' ' ' TYR . 48.6 p90 -168.87 120.14 0.75 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.297 179.972 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.518 ' C ' ' O ' ' A' ' 99' ' ' TYR . 43.3 mm -29.18 121.27 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.995 -179.563 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 114.38 27.06 3.49 Favored Glycine 0 CA--C 1.52 0.344 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 -179.575 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.587 ' CD ' ' H ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -144.27 46.2 0.61 Allowed Pre-proline 0 C--N 1.324 -0.508 0 CA-C-O 120.913 0.387 . . . . 0.0 110.511 179.946 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 29.8 Cg_endo -61.8 143.63 96.2 Favored 'Trans proline' 0 C--N 1.297 -2.146 0 C-N-CA 122.695 2.263 . . . . 0.0 111.989 -179.937 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.458 ' O ' HG23 ' A' ' 108' ' ' VAL . 26.2 t -173.19 119.97 0.34 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.489 179.698 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.19 -40.56 64.68 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.068 0.461 . . . . 0.0 111.1 179.76 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.19 -40.02 90.12 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.819 -179.368 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.02 -39.95 95.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.713 -179.768 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 104' ' ' SER . 72.0 t -67.74 -43.97 86.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.839 179.709 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.77 -38.98 92.73 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.552 -179.31 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.441 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.47 -23.3 62.61 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.434 179.867 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.554 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.5 mm-40 -90.51 5.12 49.06 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.651 -179.518 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.554 ' C ' ' O ' ' A' ' 111' ' ' GLN . 10.4 tpt 24.03 63.73 0.4 Allowed Pre-proline 0 N--CA 1.464 0.266 0 CA-C-O 120.861 0.362 . . . . 0.0 110.866 -179.967 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -77.92 167.36 23.8 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 C-N-CA 122.998 2.465 . . . . 0.0 112.392 -178.739 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.525 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 99.4 m-20 -110.49 -42.38 4.11 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.982 0.42 . . . . 0.0 110.042 179.55 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 39.8 tp -120.98 120.14 34.59 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.036 179.54 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 84.7 mt -113.21 129.19 69.38 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 CA-C-O 120.978 0.418 . . . . 0.0 110.848 -179.832 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.626 HD12 ' OG ' ' A' ' 48' ' ' SER . 29.2 mt -108.95 132.26 54.25 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.235 -179.71 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.497 HD12 HG23 ' A' ' 139' ' ' THR . 98.8 mt -119.59 138.77 49.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.712 -179.766 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 85.8 p -72.65 153.45 41.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.565 -179.998 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.21 -49.98 75.46 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.682 -179.769 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -149.55 154.07 38.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.6 179.811 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 170.36 -170.86 43.29 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 179.838 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.99 -34.17 89.24 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 179.949 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.453 ' OD1' ' O ' ' A' ' 124' ' ' ASP . 44.2 p-10 -87.33 120.27 28.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.833 0.349 . . . . 0.0 110.626 -179.942 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.435 ' O ' HD12 ' A' ' 129' ' ' LEU . 40.0 t -63.22 143.74 57.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.538 -179.976 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.521 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.23 -43.18 8.95 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.819 -179.778 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.2 tp -62.7 -42.55 99.7 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.718 -179.912 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.26 -12.23 59.56 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.574 -179.459 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.435 HD12 ' O ' ' A' ' 125' ' ' SER . 84.1 mt -114.91 -23.51 9.08 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.721 -179.797 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 130' ' ' TYR . . . . . 0.521 ' N ' ' O ' ' A' ' 126' ' ' ALA . 78.0 t80 -51.12 -49.67 60.31 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 120.586 -0.446 . . . . 0.0 110.476 -178.929 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.1 p-10 -65.81 -42.52 90.55 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.905 0.383 . . . . 0.0 111.138 179.599 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.523 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 88.2 mt-30 -67.13 -37.84 84.53 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.832 179.97 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.431 HD12 HD11 ' A' ' 118' ' ' ILE . 95.9 mt -80.39 -41.32 24.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.881 -179.505 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.2 t -57.26 -44.53 83.98 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.243 -179.236 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 18.8 m -61.77 -45.36 94.22 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.8 0.333 . . . . 0.0 110.597 179.326 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 93.0 mt -62.11 -43.55 97.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.226 -179.784 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.658 ' HB1' ' HD2' ' A' ' 138' ' ' PRO . . . -169.63 168.31 4.77 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.559 179.867 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.658 ' HD2' ' HB1' ' A' ' 137' ' ' ALA . 51.4 Cg_exo -49.94 113.25 0.92 Allowed 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.286 1.991 . . . . 0.0 112.092 179.507 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.497 HG23 HD12 ' A' ' 118' ' ' ILE . 23.8 m -84.15 127.22 33.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.594 -179.954 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.675 HD13 ' CD2' ' A' ' 37' ' ' HIS . 34.4 tp -117.66 135.23 54.14 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.988 -179.77 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.439 ' O ' ' OD2' ' A' ' 32' ' ' ASP . 81.5 mt -99.54 118.95 46.91 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 CA-C-O 121.175 0.512 . . . . 0.0 111.276 -179.336 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.438 HD12 HD22 ' A' ' 117' ' ' LEU . 98.1 mt -135.02 132.05 53.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.64 179.627 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.542 HD21 ' CG ' ' A' ' 241' ' ' ASP . 60.2 t30 -66.63 150.26 49.3 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.842 0.353 . . . . 0.0 110.428 179.4 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.517 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 87.7 t80 -85.01 122.39 29.16 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.859 -179.499 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.517 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 98.7 m-20 55.25 69.21 0.76 Allowed 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.856 179.748 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 34.9 p-10 -125.82 0.56 7.38 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.926 0.393 . . . . 0.0 110.753 179.857 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -150.85 115.73 5.26 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.699 -179.522 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 83.9 p -64.39 169.15 4.95 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.528 -179.842 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.423 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.4 p-90 -52.21 -16.12 0.75 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.559 -179.863 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 150' ' ' GLN . . . . . 0.435 ' O ' HG23 ' A' ' 154' ' ' THR . 68.2 tp60 -70.07 -77.01 0.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.425 -179.712 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.453 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.1 t -62.57 -38.26 89.39 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.369 179.568 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 53.2 tp -60.06 -45.53 92.55 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.373 -178.566 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.423 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 46.8 tp -62.85 -41.74 99.48 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.821 0.343 . . . . 0.0 110.321 179.086 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.453 ' OG1' ' O ' ' A' ' 151' ' ' SER . 63.5 p -64.07 -34.75 78.74 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.285 -179.611 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 155' ' ' GLN . . . . . 0.432 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.8 mm-40 -63.97 -42.77 97.14 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.316 179.235 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 92.7 mt -65.39 -39.02 91.72 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.016 0.436 . . . . 0.0 110.255 179.099 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.587 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -60.93 -32.08 78.58 Favored Glycine 0 CA--C 1.52 0.404 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 -179.468 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.439 ' C ' ' O ' ' A' ' 157' ' ' GLY . 97.2 mt-10 -35.71 -26.42 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.815 0.341 . . . . 0.0 110.744 179.93 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.587 ' N ' ' O ' ' A' ' 157' ' ' GLY . 95.7 mt -57.02 149.32 4.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.251 179.313 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 72.6 p -69.61 137.27 52.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.979 -179.535 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 71.77 20.45 78.68 Favored Glycine 0 N--CA 1.458 0.156 0 N-CA-C 111.243 -0.743 . . . . 0.0 111.243 179.457 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 56.8 m80 -122.3 -14.66 7.85 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.785 0.326 . . . . 0.0 110.64 179.816 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -65.22 -60.31 3.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.723 -179.684 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -51.85 -49.14 63.47 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.246 -179.771 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -60.66 -41.08 94.29 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.704 0.288 . . . . 0.0 110.284 179.542 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.55 -47.02 87.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.637 179.828 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -57.24 -40.03 76.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.251 -179.983 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -61.85 -50.31 72.77 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.562 179.621 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.404 ' NE ' ' HB1' ' A' ' 59' ' ' ALA . 59.9 ttt85 -65.36 -43.84 89.57 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.511 179.551 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 95.1 mt -64.65 -43.47 96.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.473 179.736 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.23 -50.92 71.35 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.627 -179.261 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.47 -43.72 96.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.363 179.747 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 173' ' ' PHE . . . . . 0.659 ' CE2' HD11 ' A' ' 177' ' ' LEU . 56.1 t80 -62.7 -44.64 95.71 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.123 0.487 . . . . 0.0 110.443 179.4 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -63.33 -40.08 96.31 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.522 -179.312 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -62.95 -42.73 99.9 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.704 179.259 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -60.77 -44.85 96.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.071 179.946 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.659 HD11 ' CE2' ' A' ' 173' ' ' PHE . 84.8 mt -64.3 -41.13 97.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.033 0.444 . . . . 0.0 110.661 178.917 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -51.88 -62.51 1.58 Allowed 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.478 -179.335 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.52 -46.86 85.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.58 179.819 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.26 -41.71 65.77 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.245 -179.993 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -63.8 -33.59 76.01 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.946 0.403 . . . . 0.0 110.364 179.27 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 182' ' ' GLU . . . . . 0.425 ' O ' ' HG2' ' A' ' 182' ' ' GLU . 69.6 tt0 -90.51 8.49 33.7 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.317 0.58 . . . . 0.0 110.586 -179.091 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -104.5 -32.33 9.04 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.257 179.597 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.3 pt -128.01 147.6 32.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.843 -179.878 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -139.76 130.99 26.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.347 179.506 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 186' ' ' LEU . . . . . 0.598 HD22 ' N ' ' A' ' 186' ' ' LEU . 3.6 mm? -85.49 133.37 42.32 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.793 179.992 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -44.05 157.9 0.14 Allowed 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.735 2.29 . . . . 0.0 112.042 179.527 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 188' ' ' PRO . . . . . 0.535 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.7 Cg_endo -62.96 114.87 2.62 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 122.748 2.299 . . . . 0.0 111.76 179.817 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 189' ' ' GLN . . . . . 0.535 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.8 mt-30 155.28 148.17 0.0 OUTLIER Pre-proline 0 C--N 1.331 -0.199 0 O-C-N 123.383 0.427 . . . . 0.0 110.665 -179.784 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -73.94 144.5 34.49 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 122.725 2.283 . . . . 0.0 111.734 178.126 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.498 HG23 ' OG ' ' A' ' 258' ' ' SER . 2.1 p -125.29 158.94 33.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.198 0.523 . . . . 0.0 110.12 -179.974 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 192' ' ' THR . . . . . 0.497 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 35.4 p -143.61 165.58 27.22 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.129 -179.609 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 193' ' ' ALA . . . . . 0.444 ' HA ' ' H ' ' A' ' 260' ' ' PHE . . . -135.76 128.66 31.28 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.151 0.501 . . . . 0.0 110.273 179.69 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.498 HD11 HD23 ' A' ' 259' ' ' LEU . 47.3 pt -146.3 148.76 16.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.021 179.899 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 195' ' ' VAL . . . . . 0.743 HG13 ' CD1' ' A' ' 262' ' ' PHE . 70.3 t -117.49 122.88 70.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.245 0.545 . . . . 0.0 109.692 179.112 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -134.21 107.32 7.62 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.292 179.699 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 95.2 m -131.08 130.56 43.35 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.818 179.833 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -83.09 -36.87 24.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.228 179.71 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.6 -66.95 0.27 Allowed 'General case' 0 C--O 1.231 0.129 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.402 179.997 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.42 -9.76 58.93 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.246 179.494 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 60.0 t-80 60.7 58.46 2.41 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.799 -179.844 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 40.6 p -167.16 153.25 7.96 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.505 179.55 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.26 143.92 24.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.997 0.427 . . . . 0.0 110.452 179.458 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -135.38 138.83 43.69 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.655 179.952 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 20.3 mt -106.69 125.54 51.13 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 121.134 0.492 . . . . 0.0 109.795 -179.687 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 206' ' ' TRP . . . . . 0.556 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 74.9 m95 -81.93 166.95 19.43 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.575 -179.72 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 207' ' ' THR . . . . . 0.473 HG22 ' C ' ' A' ' 206' ' ' TRP . 0.1 OUTLIER -156.94 171.62 7.2 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 120.997 0.427 . . . . 0.0 110.525 -179.223 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.06 -36.99 86.54 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 C-N-CA 122.639 2.226 . . . . 0.0 111.959 179.473 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -70.43 -35.16 73.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.906 -179.893 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 21.4 m -60.94 150.92 31.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.614 -179.296 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.58 -37.12 82.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.529 -179.751 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 212' ' ' GLN . . . . . 0.556 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 55.0 tt0 -64.56 -40.36 95.42 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.519 179.977 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.52 -43.32 92.58 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 179.804 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -63.45 -43.93 95.97 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.707 0.289 . . . . 0.0 110.276 179.883 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 215' ' ' MET . . . . . 0.525 ' SD ' ' HB2' ' A' ' 304' ' ' ALA . 65.4 ttp -59.49 -48.1 82.95 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.322 -179.805 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 216' ' ' LEU . 87.7 mt -60.38 -40.6 91.42 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 179.416 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 217' ' ' GLU . . . . . 0.462 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.9 tp10 -58.34 -37.98 76.25 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.739 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -65.14 -38.28 90.11 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.813 0.34 . . . . 0.0 110.709 179.702 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 93.9 mt -64.36 -42.65 96.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.584 -179.62 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.56 45.1 0.08 OUTLIER Glycine 0 C--N 1.333 0.379 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 -179.937 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 221' ' ' PHE . . . . . 0.462 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 27.0 m-85 -128.08 155.18 44.79 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.052 0.454 . . . . 0.0 110.487 -179.807 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.485 ' O ' HG13 ' A' ' 191' ' ' VAL . 6.4 p -106.92 122.28 46.11 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.179 0.514 . . . . 0.0 110.261 -179.987 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.473 HD22 ' C ' ' A' ' 222' ' ' THR . 4.3 mm? -101.22 133.0 46.45 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.077 -179.957 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.85 159.55 14.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.509 179.886 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.38 114.99 29.5 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.333 179.88 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.495 HD12 ' N ' ' A' ' 226' ' ' LEU . 9.1 mp -53.13 156.94 3.33 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.626 179.935 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -60.46 145.36 98.87 Favored 'Trans proline' 0 C--N 1.302 -1.903 0 C-N-CA 122.601 2.201 . . . . 0.0 112.004 179.485 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.3 -3.27 59.03 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.556 -179.989 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.01 -41.16 5.66 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 -179.885 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 230' ' ' LEU . . . . . 0.536 ' O ' ' N ' ' A' ' 233' ' ' SER . 85.5 mt -79.08 -17.19 55.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.983 0.42 . . . . 0.0 110.364 -179.738 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 231' ' ' ASN . . . . . 0.404 ' C ' ' O ' ' A' ' 230' ' ' LEU . 54.8 t-20 -40.11 -49.41 2.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.757 -179.694 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -87.82 15.32 7.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.768 0.318 . . . . 0.0 111.186 -179.967 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 233' ' ' SER . . . . . 0.536 ' N ' ' O ' ' A' ' 230' ' ' LEU . 78.1 p -60.4 -35.74 76.45 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.535 -179.811 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 234' ' ' GLN . . . . . 0.525 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.6 tt0 -118.74 -69.19 0.86 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.917 179.642 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.3 m -69.73 103.11 2.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.633 -179.785 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -94.29 57.5 2.33 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.391 179.909 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -144.82 -122.42 1.56 Allowed Glycine 0 CA--C 1.521 0.43 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 -179.987 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -135.17 111.8 9.98 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 121.115 0.483 . . . . 0.0 110.468 179.983 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 239' ' ' ARG . . . . . 0.523 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.5 mtt180 -148.15 57.74 1.08 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.738 -179.894 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -69.64 -32.21 70.75 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.548 179.625 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 241' ' ' ASP . . . . . 0.542 ' CG ' HD21 ' A' ' 143' ' ' ASN . 65.1 t0 -56.94 -46.94 81.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.396 -179.159 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 242' ' ' ILE . . . . . 0.437 ' O ' ' O ' ' A' ' 239' ' ' ARG . 17.8 tt -139.84 156.43 25.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.893 0.378 . . . . 0.0 110.518 179.746 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.439 HG22 HD13 ' A' ' 245' ' ' LEU . 96.2 mt -106.24 106.34 20.4 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.188 0 CA-C-O 121.108 0.48 . . . . 0.0 110.511 179.863 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 244' ' ' GLN . . . . . 0.609 ' O ' HD12 ' A' ' 245' ' ' LEU . 88.2 mt-30 -110.25 110.06 20.74 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.261 179.76 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.609 HD12 ' O ' ' A' ' 244' ' ' GLN . 9.4 mp -121.96 -168.45 1.71 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.663 179.839 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 246' ' ' GLY . . . . . 0.525 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.54 -16.66 0.05 OUTLIER Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.911 -0.875 . . . . 0.0 110.911 179.945 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 247' ' ' GLY . . . . . 0.672 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -60.62 156.83 30.79 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -179.888 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -63.72 21.73 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.936 0.398 . . . . 0.0 110.655 179.924 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 249' ' ' ASN . . . . . 0.672 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.8 m-20 -97.34 -5.94 35.39 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.572 179.943 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 93.5 mt -79.85 -21.82 43.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.619 179.575 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.54 -51.27 70.59 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.864 -179.57 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.4 -5.54 58.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.394 179.642 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -80.93 -74.53 1.13 Allowed Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 -179.911 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 81.5 mt -69.79 125.4 26.62 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.025 0.44 . . . . 0.0 110.178 -179.816 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -59.49 -39.48 83.91 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.389 -179.739 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 84.45 51.71 3.8 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -179.938 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -94.62 -16.51 23.12 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.738 0.304 . . . . 0.0 110.597 -179.862 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 258' ' ' SER . . . . . 0.498 ' OG ' HG23 ' A' ' 191' ' ' VAL . 3.3 t 174.17 89.83 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.045 0.45 . . . . 0.0 110.119 -179.971 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.866 HD12 ' N ' ' A' ' 259' ' ' LEU . 1.0 OUTLIER -94.46 124.03 38.24 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.224 0.535 . . . . 0.0 111.088 -179.099 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 260' ' ' PHE . . . . . 0.444 ' H ' ' HA ' ' A' ' 193' ' ' ALA . 16.0 m-30 -93.18 146.85 23.37 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.332 179.166 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 86.7 mt -122.57 149.87 43.36 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.512 -179.9 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.743 ' CD1' HG13 ' A' ' 195' ' ' VAL . 2.6 p90 -77.94 -138.48 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.526 -179.813 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 263' ' ' ALA . . . . . 0.661 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -51.89 77.49 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.92 -179.942 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 264' ' ' GLY . . . . . 0.637 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.13 104.42 0.19 Allowed Glycine 0 N--CA 1.467 0.721 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 -179.986 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 265' ' ' ASP . . . . . 0.604 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.6 m-20 -80.43 -177.54 6.24 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.713 0.292 . . . . 0.0 110.91 -179.497 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -40.64 -17.56 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.852 0.358 . . . . 0.0 110.493 179.866 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 267' ' ' LYS . . . . . 0.604 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.64 -51.51 41.39 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.637 179.576 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -63.88 -46.71 83.69 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.076 179.525 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 269' ' ' ALA . . . . . 0.568 ' HB1' ' OH ' ' A' ' 273' ' ' TYR . . . -61.54 -35.12 76.85 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.839 179.552 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -62.98 -34.59 77.86 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.126 179.653 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.36 -43.3 13.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.336 -179.588 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 272' ' ' ILE . . . . . 0.584 ' C ' ' H ' ' A' ' 274' ' ' ALA . 4.9 tt -51.42 -33.63 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.826 -178.872 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 273' ' ' TYR . . . . . 0.568 ' OH ' ' HB1' ' A' ' 269' ' ' ALA . 17.4 m-85 -54.37 -1.7 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.677 -179.7 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 274' ' ' ALA . . . . . 0.584 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -72.13 -39.71 68.62 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.906 179.63 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 275' ' ' ASN . . . . . 0.588 ' O ' ' N ' ' A' ' 279' ' ' ALA . 3.9 p30 -39.36 97.78 0.15 Allowed Pre-proline 0 N--CA 1.462 0.156 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.54 -179.653 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 276' ' ' PRO . . . . . 0.402 ' N ' ' O ' ' A' ' 274' ' ' ALA . 45.5 Cg_exo -53.97 -43.31 59.36 Favored 'Trans proline' 0 C--N 1.303 -1.848 0 C-N-CA 122.363 2.042 . . . . 0.0 112.737 -178.857 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 89.4 mt -64.37 -42.83 95.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.206 -179.674 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 90.8 mt -95.94 -1.31 49.43 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.842 -179.361 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 279' ' ' ALA . . . . . 0.588 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.42 -34.89 77.66 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.604 -179.69 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -73.99 19.55 0.12 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.078 -179.224 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 281' ' ' LEU . . . . . 0.491 HD23 ' HA ' ' A' ' 281' ' ' LEU . 14.0 mt -74.95 121.0 84.31 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.355 179.873 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_exo -51.24 -39.44 62.12 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 122.573 2.182 . . . . 0.0 111.657 179.289 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.57 -50.65 62.53 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 179.748 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 81.8 t -61.84 -43.91 98.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 179.507 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -57.57 -41.86 81.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.418 -179.871 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -90.47 1.06 57.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.215 179.572 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt 58.39 40.42 24.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.036 0.446 . . . . 0.0 110.903 179.681 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -92.36 42.41 1.1 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.37 179.781 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 54.4 t -119.16 135.79 58.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.023 0.44 . . . . 0.0 110.182 -179.724 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -132.93 162.97 30.23 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.031 0.443 . . . . 0.0 110.697 -179.663 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.92 155.02 33.57 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.968 0.413 . . . . 0.0 110.774 -179.85 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 80.9 mt -93.69 -1.39 55.26 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.278 -179.782 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.17 165.38 12.64 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 -179.725 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 6.8 m -87.13 -62.32 1.53 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.866 0.365 . . . . 0.0 111.008 -179.802 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 295' ' ' GLU . . . . . 0.444 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.6 mm-40 -69.53 -4.2 17.97 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.544 -179.738 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 29.1 p -76.66 32.51 0.13 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.662 -179.877 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 297' ' ' PHE . . . . . 0.523 ' CD2' HG22 ' A' ' 70' ' ' THR . 70.4 t80 -60.18 -46.05 91.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.565 -179.905 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 298' ' ' ARG . . . . . 0.612 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.1 mtt85 -81.09 133.45 35.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.073 0.463 . . . . 0.0 110.433 -179.712 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.443 ' H ' HG11 ' A' ' 51' ' ' VAL . 16.3 tp -114.19 119.4 36.95 Favored 'General case' 0 CA--C 1.527 0.089 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.205 -179.97 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 300' ' ' ASP . . . . . 0.626 ' H ' ' CB ' ' A' ' 303' ' ' SER . 49.9 p-10 -167.29 -174.21 2.51 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.508 -179.968 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -48.34 -45.46 35.33 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.127 -179.591 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -65.0 -41.62 95.23 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.004 0.43 . . . . 0.0 110.724 178.969 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 303' ' ' SER . . . . . 0.626 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 52.7 p -55.15 -36.04 65.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.182 -179.5 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 304' ' ' ALA . . . . . 0.525 ' HB2' ' SD ' ' A' ' 215' ' ' MET . . . -57.13 -51.49 69.08 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 110.016 -0.365 . . . . 0.0 110.016 179.459 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 90.8 mtp -56.37 -43.82 79.56 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.689 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -66.57 -42.65 86.7 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.867 0.365 . . . . 0.0 110.18 178.778 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 307' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 303' ' ' SER . 56.0 t -64.06 -42.89 97.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.192 179.401 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 43.4 tp -59.55 -42.17 91.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.827 -179.593 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -62.73 -39.0 92.71 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 179.61 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 310' ' ' ARG . . . . . 0.44 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.6 ttt85 -63.54 -44.01 95.45 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.3 179.515 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 87.9 mt -63.36 -42.0 98.87 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.188 179.56 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -62.81 -33.18 74.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.106 179.454 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -90.19 -23.13 21.38 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.564 -179.908 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 314' ' ' LEU . . . . . 0.478 HD22 ' CE2' ' A' ' 315' ' ' PHE . 6.7 tt -62.43 -43.23 99.31 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.063 0.459 . . . . 0.0 110.589 -179.902 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 315' ' ' PHE . . . . . 0.478 ' CE2' HD22 ' A' ' 314' ' ' LEU . 91.3 m-85 . . . . . 0 C--O 1.22 -0.462 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.508 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -99.7 135.54 40.96 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.1 0.476 . . . . 0.0 110.406 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.48 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -92.51 178.71 1.56 Allowed Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.403 -179.686 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.48 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 27.0 Cg_exo -61.66 147.44 95.34 Favored 'Trans proline' 0 C--N 1.303 -1.833 0 C-N-CA 122.909 2.406 . . . . 0.0 112.214 179.537 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.492 ' HE ' HD12 ' A' ' 39' ' ' LEU . 35.2 ptt180 -136.32 142.61 43.88 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.571 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -79.94 116.77 20.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.509 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.443 ' O ' HG23 ' A' ' 30' ' ' ILE . 9.4 tp -111.45 130.53 64.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.487 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.1 t -71.24 142.5 50.56 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.607 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.478 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.4 t0 -139.45 -179.96 6.2 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.504 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.478 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 78.1 p -73.88 -37.23 64.79 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.683 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -46.69 -94.72 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.304 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -166.53 -26.75 0.02 OUTLIER Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 62.4 m -168.63 105.64 0.44 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.707 0.289 . . . . 0.0 110.531 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.656 ' CD2' HD13 ' A' ' 140' ' ' LEU . 70.0 t60 -129.01 146.63 50.93 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.224 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.619 HG22 ' N ' ' A' ' 39' ' ' LEU . 98.8 m -129.96 165.57 21.83 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.377 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.619 ' N ' HG22 ' A' ' 38' ' ' THR . 77.9 mt -120.2 127.28 52.3 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.654 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -65.42 -44.91 85.91 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.592 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 37.5 p -165.78 154.95 11.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.55 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.499 ' CD ' ' H ' ' A' ' 42' ' ' GLN . 14.7 mp0 -44.51 101.02 0.24 Allowed Pre-proline 0 C--O 1.235 0.302 0 O-C-N 123.564 0.54 . . . . 0.0 110.467 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -57.61 130.07 36.94 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.449 2.099 . . . . 0.0 112.111 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -82.95 -24.76 32.86 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.573 179.341 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.537 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.9 mtm-85 -121.23 134.33 55.19 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.995 0.426 . . . . 0.0 110.287 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.3 mt -130.22 133.26 64.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.515 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 46.2 t -124.73 131.04 73.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-O 121.002 0.429 . . . . 0.0 110.163 178.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.611 ' OG ' HD12 ' A' ' 117' ' ' LEU . 4.2 m -154.67 166.42 33.45 Favored 'General case' 0 C--O 1.224 -0.241 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.461 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 72.6 p -124.41 9.11 8.45 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.483 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.1 t -85.65 125.68 33.34 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.942 0.401 . . . . 0.0 110.577 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.462 HG11 ' H ' ' A' ' 299' ' ' LEU . 90.1 t -65.66 -44.52 93.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.546 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.0 m -62.51 -44.45 96.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.686 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 54.7 tp -62.35 -41.52 98.66 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.65 -179.331 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.447 ' O ' HD13 ' A' ' 58' ' ' LEU . 70.5 m -57.88 -44.61 86.8 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.219 -179.211 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.39 -62.05 5.45 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.5 t -47.55 -35.94 9.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.79 0.328 . . . . 0.0 110.144 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.7 mt -61.87 -44.64 96.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.909 0.385 . . . . 0.0 110.976 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.447 HD13 ' O ' ' A' ' 54' ' ' THR . 9.0 mp -65.17 -41.32 94.74 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.292 178.282 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.415 ' HB1' ' NE ' ' A' ' 169' ' ' ARG . . . -63.78 -41.19 97.99 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.631 -179.208 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.415 ' O ' HG23 ' A' ' 60' ' ' ILE . 7.9 tp -88.06 16.62 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.673 -179.383 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 56.33 84.09 0.09 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.795 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.21 57.11 0.06 OUTLIER Pre-proline 0 C--N 1.327 -0.371 0 CA-C-O 121.018 0.437 . . . . 0.0 109.907 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -50.17 153.72 6.45 Favored 'Trans proline' 0 C--N 1.298 -2.096 0 C-N-CA 122.972 2.448 . . . . 0.0 112.492 -178.415 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.425 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -109.15 146.12 15.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.238 -179.728 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 97.0 mt -63.78 -45.08 98.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.116 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.503 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -130.32 134.21 47.02 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.775 0.321 . . . . 0.0 110.266 -179.461 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.494 ' O ' ' N ' ' A' ' 98' ' ' LEU . 72.9 m -134.47 158.71 43.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.805 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.71 139.35 16.37 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.716 -0.954 . . . . 0.0 110.716 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.488 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.78 -162.67 0.08 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.798 0.333 . . . . 0.0 110.384 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.505 HG22 ' CD2' ' A' ' 297' ' ' PHE . 5.9 t -133.97 135.36 43.43 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.096 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.467 ' C ' ' O ' ' A' ' 70' ' ' THR . 0.8 OUTLIER 29.47 68.71 0.64 Allowed Pre-proline 0 N--CA 1.468 0.475 0 CA-C-O 121.216 0.532 . . . . 0.0 110.84 -179.48 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -60.86 144.79 99.63 Favored 'Trans proline' 0 C--N 1.302 -1.911 0 C-N-CA 122.776 2.317 . . . . 0.0 112.064 -178.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.528 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 46.3 p-10 -159.79 -31.83 0.06 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.667 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.529 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 99.0 m-20 -64.29 -39.36 93.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.421 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.6 ttt180 -60.39 -48.46 81.64 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.436 -179.184 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.425 ' O ' ' O ' ' A' ' 77' ' ' ALA . 93.7 t -60.05 -24.52 30.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.172 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.529 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -45.82 172.95 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.53 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.57 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.5 p30 -61.94 177.64 0.43 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.433 -179.581 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.566 ' C ' ' H ' ' A' ' 81' ' ' GLY . 35.5 p30 -45.9 85.44 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.807 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.57 ' N ' ' O ' ' A' ' 78' ' ' ASP . 42.2 tp60 -67.14 13.65 0.06 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.261 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.566 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 117.94 -22.31 9.9 Favored Glycine 0 N--CA 1.463 0.471 0 N-CA-C 110.874 -0.891 . . . . 0.0 110.874 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -107.94 116.17 31.47 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.873 0.368 . . . . 0.0 110.348 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 75.9 mt -98.68 0.67 45.13 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.474 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -92.19 6.8 45.28 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.344 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.783 ' O ' HG22 ' A' ' 89' ' ' VAL . 27.2 mt-30 -99.91 -28.18 13.23 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.564 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 68.6 t-105 -63.44 -40.91 98.42 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.705 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.545 ' O ' ' N ' ' A' ' 91' ' ' LYS . 64.5 m -77.49 -53.68 7.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.873 -179.177 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -48.4 -51.01 28.58 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.801 -178.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.783 HG22 ' O ' ' A' ' 85' ' ' GLN . 16.0 m -68.92 -40.68 81.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.891 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.491 ' N ' HG23 ' A' ' 89' ' ' VAL . . . -72.27 -22.72 61.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.695 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.545 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.0 tttm -61.57 -45.92 92.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.449 -179.533 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.436 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.7 mm-40 -90.16 -94.58 0.12 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.198 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.609 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.9 mtt180 -143.38 59.3 1.4 Allowed 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.434 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.6 pttp 33.92 26.24 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 O-C-N 123.588 0.555 . . . . 0.0 110.487 -179.198 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.609 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.5 tt -48.29 123.07 5.94 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.648 -177.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.456 ' O ' HD23 ' A' ' 95' ' ' LEU . 98.9 mm-40 -83.11 -170.48 3.06 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.399 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.619 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 82.8 mtp180 -73.42 137.78 44.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.229 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.494 ' N ' ' O ' ' A' ' 67' ' ' SER . 88.9 mt -86.13 -166.37 1.52 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.807 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.53 ' O ' ' CD2' ' A' ' 99' ' ' TYR . 46.9 p90 -167.77 119.83 0.88 Allowed 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.106 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.487 ' C ' ' O ' ' A' ' 99' ' ' TYR . 43.2 mm -29.63 121.33 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 O-C-N 123.482 0.489 . . . . 0.0 110.891 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 113.28 28.59 3.26 Favored Glycine 0 N--CA 1.464 0.504 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.578 ' N ' ' CD ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -143.86 45.45 0.56 Allowed Pre-proline 0 C--N 1.324 -0.504 0 CA-C-O 121.321 0.582 . . . . 0.0 110.502 179.795 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 30.6 Cg_endo -61.95 143.94 95.91 Favored 'Trans proline' 0 C--N 1.298 -2.123 0 C-N-CA 122.614 2.209 . . . . 0.0 112.014 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.471 ' O ' HG23 ' A' ' 108' ' ' VAL . 21.9 t -173.18 120.84 0.36 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.534 179.311 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.3 -40.74 64.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.215 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.16 -40.29 90.42 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.69 -179.327 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.1 -39.98 95.22 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.659 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 104' ' ' SER . 69.4 t -67.71 -43.8 86.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.634 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.37 -39.19 92.36 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.521 -179.119 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.436 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.6 -23.23 62.79 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.596 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.519 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.3 mm-40 -90.95 4.31 52.3 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.716 -179.494 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.537 ' O ' ' NE ' ' A' ' 45' ' ' ARG . 10.3 tpt 23.97 63.82 0.4 Allowed Pre-proline 0 N--CA 1.471 0.602 0 O-C-N 123.622 0.576 . . . . 0.0 110.986 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.46 ' HG2' HD11 ' A' ' 116' ' ' ILE . 71.0 Cg_endo -78.63 168.22 21.49 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 123.019 2.48 . . . . 0.0 112.075 -178.234 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.511 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 98.8 m-20 -112.56 -43.78 3.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.292 179.379 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.0 tp -121.03 120.09 34.36 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.262 178.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.46 HD11 ' HG2' ' A' ' 113' ' ' PRO . 96.8 mt -117.14 131.14 70.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.719 -179.59 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.611 HD12 ' OG ' ' A' ' 48' ' ' SER . 30.1 mt -106.07 132.32 52.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.218 -179.569 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.447 HD12 HG23 ' A' ' 139' ' ' THR . 98.3 mt -118.08 136.71 54.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.495 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 86.6 p -71.98 152.3 42.59 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.565 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -59.97 -50.05 75.26 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.535 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -149.19 153.52 37.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.513 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 169.76 -170.73 42.95 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -63.07 -35.05 91.56 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.444 ' OD1' ' O ' ' A' ' 124' ' ' ASP . 43.9 p-10 -87.8 120.34 29.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.892 0.377 . . . . 0.0 110.635 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.441 ' O ' HD12 ' A' ' 129' ' ' LEU . 41.0 t -63.34 143.68 57.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.469 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.516 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.6 -42.74 9.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.647 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.5 tp -62.79 -42.42 99.7 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.761 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.01 -10.63 55.14 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.413 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.441 HD12 ' O ' ' A' ' 125' ' ' SER . 83.4 mt -115.59 -24.39 8.32 Favored 'General case' 0 C--O 1.224 -0.238 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.533 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' TYR . . . . . 0.516 ' N ' ' O ' ' A' ' 126' ' ' ALA . 75.1 t80 -51.39 -49.93 60.59 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.96 -0.296 . . . . 0.0 110.531 -178.733 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 37.6 p-10 -65.95 -42.13 90.36 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.933 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.52 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 88.2 mt-30 -67.66 -36.76 81.33 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.73 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.454 HD22 HD13 ' A' ' 116' ' ' ILE . 94.3 mt -80.22 -41.85 24.37 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.025 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.4 t -57.16 -44.88 83.88 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.204 -179.159 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.3 m -62.2 -45.48 93.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.616 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 92.2 mt -62.54 -43.81 98.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.336 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.592 ' HB1' ' HD2' ' A' ' 138' ' ' PRO . . . -170.05 163.47 6.4 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.563 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.592 ' HD2' ' HB1' ' A' ' 137' ' ' ALA . 77.0 Cg_exo -43.1 111.86 0.25 Allowed 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.576 2.184 . . . . 0.0 112.068 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.491 HG21 ' CD1' ' A' ' 130' ' ' TYR . 17.2 m -85.64 127.72 34.56 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.328 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.656 HD13 ' CD2' ' A' ' 37' ' ' HIS . 34.0 tp -119.45 137.23 53.91 Favored 'General case' 0 C--N 1.334 -0.078 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.404 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.431 ' O ' ' OD2' ' A' ' 32' ' ' ASP . 80.7 mt -103.4 119.75 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.844 -178.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.496 HD12 HD22 ' A' ' 117' ' ' LEU . 97.2 mt -135.75 133.09 51.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.607 179.085 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.545 HD21 ' CG ' ' A' ' 241' ' ' ASP . 60.9 t30 -65.2 150.93 47.35 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.41 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.512 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 88.2 t80 -85.91 122.38 29.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.725 -179.2 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.512 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 99.1 m-20 55.38 69.34 0.74 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.497 179.407 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 43.4 p-10 -126.64 0.54 6.81 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.537 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -150.34 114.79 5.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.833 0.349 . . . . 0.0 110.547 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 84.8 p -62.69 168.23 3.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.594 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.408 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.6 p-90 -51.44 -15.86 0.48 Allowed 'General case' 0 C--O 1.22 -0.461 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.299 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.441 ' O ' HG23 ' A' ' 154' ' ' THR . 68.3 tp60 -70.49 -75.44 0.12 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.998 0.427 . . . . 0.0 110.613 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.445 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.2 t -62.53 -38.82 91.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.298 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 52.8 tp -60.13 -45.6 92.45 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.511 -178.338 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.408 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 45.8 tp -62.74 -41.59 99.26 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.604 178.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.445 ' OG1' ' O ' ' A' ' 151' ' ' SER . 59.1 p -63.67 -35.03 79.2 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.275 -179.434 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.459 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.8 mm-40 -63.67 -42.14 98.1 Favored 'General case' 0 C--O 1.226 -0.161 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.36 179.344 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 91.3 mt -65.3 -39.09 92.05 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.483 178.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.564 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -60.99 -32.29 79.63 Favored Glycine 0 C--N 1.33 0.237 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 -179.339 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.459 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.3 mt-10 -36.63 -25.38 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.823 0.344 . . . . 0.0 110.937 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.564 ' N ' ' O ' ' A' ' 157' ' ' GLY . 95.3 mt -58.81 148.83 6.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.455 178.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 70.8 p -69.15 137.6 53.48 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.841 -179.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 70.69 21.92 77.95 Favored Glycine 0 CA--C 1.521 0.41 0 N-CA-C 111.085 -0.806 . . . . 0.0 111.085 179.288 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 59.7 m80 -124.18 -14.18 7.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.562 0.22 . . . . 0.0 110.506 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -66.14 -59.96 3.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.542 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -51.39 -49.42 61.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.086 -179.43 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -60.58 -40.97 93.66 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.883 0.373 . . . . 0.0 110.495 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.62 -47.42 85.52 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.548 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.77 -40.06 75.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.311 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -61.64 -50.46 72.44 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.697 179.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.415 ' NE ' ' HB1' ' A' ' 59' ' ' ALA . 60.1 ttt85 -65.28 -43.79 90.07 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.46 179.509 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 95.3 mt -64.4 -43.53 97.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.484 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.33 -51.06 70.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.379 -179.053 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.76 -43.6 95.92 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.875 0.369 . . . . 0.0 110.521 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.655 ' CE2' HD11 ' A' ' 177' ' ' LEU . 56.7 t80 -62.54 -44.39 96.47 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.435 179.393 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -63.66 -39.68 94.96 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.378 -179.168 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -63.08 -42.52 99.65 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.753 179.29 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -60.64 -44.94 95.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.209 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.655 HD11 ' CE2' ' A' ' 173' ' ' PHE . 85.4 mt -64.31 -41.1 97.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.943 178.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.13 -61.99 1.92 Allowed 'General case' 0 C--O 1.238 0.472 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.499 -179.338 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.71 -46.83 86.45 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.472 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.12 -41.59 65.18 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.329 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -63.75 -33.99 76.89 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.33 179.302 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.4 ' O ' ' HG2' ' A' ' 182' ' ' GLU . 69.3 tt0 -90.75 8.56 34.01 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.39 0.614 . . . . 0.0 110.283 -178.72 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -104.3 -32.23 9.18 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.944 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.8 pt -128.09 147.81 32.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.865 0.364 . . . . 0.0 110.58 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -139.71 131.13 26.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.538 178.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.587 HD22 ' N ' ' A' ' 186' ' ' LEU . 3.6 mm? -85.35 133.46 42.41 Favored Pre-proline 0 N--CA 1.447 -0.606 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.107 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -44.1 157.83 0.14 Allowed 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.581 2.188 . . . . 0.0 112.188 179.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 0.489 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.7 Cg_endo -63.35 115.0 2.74 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.815 2.344 . . . . 0.0 111.561 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 189' ' ' GLN . . . . . 0.489 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.7 mt-30 156.05 148.14 0.0 OUTLIER Pre-proline 0 C--N 1.34 0.178 0 O-C-N 124.353 1.033 . . . . 0.0 110.94 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -73.75 144.48 35.23 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 C-N-CA 122.601 2.201 . . . . 0.0 111.765 177.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.495 HG23 ' OG ' ' A' ' 258' ' ' SER . 2.1 p -124.81 159.04 31.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.206 0.527 . . . . 0.0 110.168 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 192' ' ' THR . . . . . 0.482 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 37.2 p -143.26 165.29 27.88 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 121.428 0.633 . . . . 0.0 110.852 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 193' ' ' ALA . . . . . 0.447 ' HA ' ' H ' ' A' ' 260' ' ' PHE . . . -135.32 128.91 32.63 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 121.276 0.56 . . . . 0.0 110.422 178.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.509 HD11 HD23 ' A' ' 259' ' ' LEU . 47.6 pt -146.64 149.09 16.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.849 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 195' ' ' VAL . . . . . 0.744 HG13 ' CD1' ' A' ' 262' ' ' PHE . 73.6 t -117.78 123.1 71.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.08 0.467 . . . . 0.0 110.036 178.498 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 58.1 t80 -134.3 106.45 7.12 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.348 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 95.3 m -130.31 130.49 44.56 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.786 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.401 ' O ' ' N ' ' A' ' 201' ' ' HIS . . . -82.99 -36.58 24.93 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.26 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.41 -67.26 0.25 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.351 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.12 -9.45 58.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.446 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' HIS . . . . . 0.402 ' O ' ' ND1' ' A' ' 201' ' ' HIS . 60.7 t-80 60.51 58.26 2.55 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.749 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 34.9 p -167.28 153.91 8.3 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.601 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.56 144.27 24.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.897 0.379 . . . . 0.0 110.417 179.232 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -135.32 138.49 43.48 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.41 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 18.2 mt -106.25 125.23 50.75 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.062 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' TRP . . . . . 0.556 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 74.8 m95 -82.31 167.74 18.27 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.563 -179.628 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 207' ' ' THR . . . . . 0.455 HG22 ' C ' ' A' ' 206' ' ' TRP . 0.1 OUTLIER -157.62 171.7 7.1 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.611 -178.635 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -53.92 -37.09 85.46 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 C-N-CA 122.743 2.296 . . . . 0.0 111.992 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -70.77 -34.9 72.3 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.734 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 21.4 m -61.5 150.94 34.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.51 -179.43 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.76 -36.92 82.43 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.42 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 212' ' ' GLN . . . . . 0.556 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 55.0 tt0 -64.63 -40.29 95.22 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.59 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.88 -43.27 91.87 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -63.07 -43.97 97.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.85 0.357 . . . . 0.0 110.239 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 215' ' ' MET . . . . . 0.55 ' SD ' ' HB2' ' A' ' 304' ' ' ALA . 65.2 ttp -59.42 -47.79 84.11 Favored 'General case' 0 N--CA 1.461 0.103 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.207 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 86.4 mt -60.53 -40.72 92.54 Favored 'General case' 0 CA--C 1.517 -0.303 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' GLU . . . . . 0.448 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.1 tp10 -57.96 -38.04 75.26 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.201 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -65.51 -37.96 88.29 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.725 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 96.0 mt -64.28 -42.76 96.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.655 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.72 44.9 0.08 OUTLIER Glycine 0 N--CA 1.463 0.444 0 N-CA-C 111.079 -0.808 . . . . 0.0 111.079 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' PHE . . . . . 0.448 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 26.9 m-85 -127.89 155.75 43.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.761 0.315 . . . . 0.0 110.498 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.481 ' O ' HG13 ' A' ' 191' ' ' VAL . 7.4 p -107.42 122.52 46.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.21 0.529 . . . . 0.0 110.229 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.472 HD22 ' C ' ' A' ' 222' ' ' THR . 4.3 mm? -101.34 133.16 46.37 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.002 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.74 159.4 14.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.433 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.31 115.0 29.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.404 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.497 HD12 ' N ' ' A' ' 226' ' ' LEU . 8.9 mp -52.91 156.72 3.23 Favored Pre-proline 0 N--CA 1.446 -0.649 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.794 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -60.47 145.49 98.62 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.719 2.279 . . . . 0.0 112.013 179.208 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.2 -3.36 59.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.529 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -89.93 -41.26 5.66 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.506 ' O ' ' N ' ' A' ' 233' ' ' SER . 68.3 mt -79.23 -17.15 55.33 Favored 'General case' 0 C--O 1.219 -0.532 0 CA-C-O 120.923 0.392 . . . . 0.0 110.31 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 54.4 t-20 -40.33 -49.73 2.77 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.862 0.363 . . . . 0.0 110.709 -179.495 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -87.7 15.43 6.91 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.115 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.506 ' N ' ' O ' ' A' ' 230' ' ' LEU . 77.9 p -60.33 -35.24 75.17 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.601 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 234' ' ' GLN . . . . . 0.521 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.6 tt0 -119.64 -69.18 0.86 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.73 0.3 . . . . 0.0 110.679 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.3 m -69.58 102.59 1.88 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.538 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -94.28 57.4 2.32 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.357 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -144.73 -122.41 1.56 Allowed Glycine 0 N--CA 1.462 0.426 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -135.42 111.71 9.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.898 0.38 . . . . 0.0 110.379 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 239' ' ' ARG . . . . . 0.525 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.4 mtt180 -148.28 58.14 1.08 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.578 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -69.38 -32.7 71.9 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.618 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 241' ' ' ASP . . . . . 0.545 ' CG ' HD21 ' A' ' 143' ' ' ASN . 65.2 t0 -56.7 -47.3 80.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.312 -179.001 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 242' ' ' ILE . . . . . 0.434 ' O ' ' O ' ' A' ' 239' ' ' ARG . 18.0 tt -139.39 155.92 26.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.358 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.445 HG22 HD13 ' A' ' 245' ' ' LEU . 96.3 mt -106.08 106.49 20.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.406 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 244' ' ' GLN . . . . . 0.586 ' O ' HD12 ' A' ' 245' ' ' LEU . 88.2 mt-30 -110.57 109.96 20.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.291 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.586 HD12 ' O ' ' A' ' 244' ' ' GLN . 9.5 mp -121.59 -168.09 1.63 Allowed 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.723 179.442 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 246' ' ' GLY . . . . . 0.521 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.7 -16.46 0.05 OUTLIER Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 247' ' ' GLY . . . . . 0.666 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -61.14 156.31 33.85 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -63.33 21.81 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.772 0.32 . . . . 0.0 110.629 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 249' ' ' ASN . . . . . 0.666 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.9 m-20 -97.41 -6.3 34.33 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.407 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 92.0 mt -79.36 -21.98 45.05 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.945 179.193 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.7 -51.21 70.91 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.647 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.39 -5.74 58.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.372 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -80.87 -74.49 1.13 Allowed Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 80.9 mt -69.99 126.14 28.81 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.455 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -59.64 -39.19 83.56 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.281 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 82.63 51.94 4.11 Favored Glycine 0 CA--C 1.521 0.426 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -95.89 -15.07 22.66 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 121.199 -0.201 . . . . 0.0 110.634 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 258' ' ' SER . . . . . 0.495 ' OG ' HG23 ' A' ' 191' ' ' VAL . 3.5 t 174.85 88.71 0.0 OUTLIER 'General case' 0 C--O 1.224 -0.257 0 CA-C-O 121.089 0.471 . . . . 0.0 110.294 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.848 HD12 ' N ' ' A' ' 259' ' ' LEU . 0.9 OUTLIER -94.5 124.27 38.43 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.774 0.321 . . . . 0.0 110.874 -178.666 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 260' ' ' PHE . . . . . 0.447 ' H ' ' HA ' ' A' ' 193' ' ' ALA . 15.7 m-30 -93.52 146.13 24.01 Favored 'General case' 0 CA--C 1.499 -0.999 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.541 179.016 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 85.3 mt -122.09 149.03 44.14 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.517 -179.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.744 ' CD1' HG13 ' A' ' 195' ' ' VAL . 2.5 p90 -77.23 -138.84 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.407 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 263' ' ' ALA . . . . . 0.655 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -51.46 77.22 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.249 0 O-C-N 123.381 0.426 . . . . 0.0 110.939 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 264' ' ' GLY . . . . . 0.622 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.29 104.67 0.19 Allowed Glycine 0 CA--C 1.527 0.797 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 265' ' ' ASP . . . . . 0.589 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.8 m-20 -80.14 -177.8 6.24 Favored 'General case' 0 C--N 1.327 -0.394 0 O-C-N 122.79 -0.241 . . . . 0.0 110.718 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -40.78 -17.83 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.486 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 267' ' ' LYS . . . . . 0.589 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.16 -51.52 44.97 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 121.058 0.456 . . . . 0.0 110.724 179.146 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -63.9 -46.58 84.2 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.102 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 269' ' ' ALA . . . . . 0.566 ' HB1' ' OH ' ' A' ' 273' ' ' TYR . . . -61.6 -34.81 76.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.668 0.746 . . . . 0.0 110.05 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -62.98 -34.89 78.5 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.002 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.07 -43.44 13.91 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.136 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 272' ' ' ILE . . . . . 0.589 ' C ' ' H ' ' A' ' 274' ' ' ALA . 5.0 tt -51.61 -33.59 15.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.471 -178.517 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 273' ' ' TYR . . . . . 0.566 ' OH ' ' HB1' ' A' ' 269' ' ' ALA . 17.1 m-85 -54.62 -1.61 0.03 OUTLIER 'General case' 0 CA--C 1.512 -0.504 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.741 -179.422 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 274' ' ' ALA . . . . . 0.589 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.42 -39.99 70.73 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.917 179.186 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 275' ' ' ASN . . . . . 0.574 ' O ' ' N ' ' A' ' 279' ' ' ALA . 2.8 p30 -38.55 97.64 0.14 Allowed Pre-proline 0 CA--C 1.528 0.131 0 O-C-N 123.585 0.553 . . . . 0.0 110.355 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -53.75 -43.27 59.37 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 122.565 2.177 . . . . 0.0 112.509 -178.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 89.0 mt -64.42 -43.0 95.73 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.953 -179.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 91.8 mt -95.82 -1.33 49.82 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.756 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 279' ' ' ALA . . . . . 0.574 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.63 -35.18 78.75 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.352 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.13 20.35 0.11 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.892 -178.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 0.488 ' H ' ' C ' ' A' ' 279' ' ' ALA . 13.9 mt -74.8 120.05 79.7 Favored Pre-proline 0 N--CA 1.442 -0.862 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.821 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -51.33 -39.09 63.47 Favored 'Trans proline' 0 C--N 1.313 -1.321 0 C-N-CA 122.425 2.083 . . . . 0.0 111.817 179.358 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.71 -50.6 63.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.947 0.403 . . . . 0.0 110.05 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 76.6 t -61.51 -43.8 97.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.199 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -57.64 -41.48 81.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.212 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -90.84 0.62 57.42 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.32 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt 59.0 43.18 18.08 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.811 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -94.52 41.6 1.09 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.377 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 54.0 t -119.16 135.6 59.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-O 120.949 0.404 . . . . 0.0 110.012 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -132.81 162.87 30.38 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.619 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.68 155.14 32.95 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.462 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 79.8 mt -94.07 -1.63 54.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.299 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 120.75 165.49 12.76 Favored Glycine 0 N--CA 1.464 0.512 0 N-CA-C 110.584 -1.006 . . . . 0.0 110.584 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 6.7 m -86.98 -62.3 1.53 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.83 0.347 . . . . 0.0 110.879 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 295' ' ' GLU . . . . . 0.446 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.9 mm-40 -69.36 -3.94 16.2 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.642 -179.519 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 24.5 p -77.01 32.24 0.14 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.65 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 297' ' ' PHE . . . . . 0.505 ' CD2' HG22 ' A' ' 70' ' ' THR . 68.5 t80 -60.31 -46.13 90.95 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.704 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 298' ' ' ARG . . . . . 0.619 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.1 mtt85 -80.76 135.09 35.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.477 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.462 ' H ' HG11 ' A' ' 51' ' ' VAL . 17.7 tp -114.09 117.07 30.23 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 120.861 0.362 . . . . 0.0 110.394 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 300' ' ' ASP . . . . . 0.618 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.1 p-10 -165.2 -176.63 4.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.755 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 82.8 t80 -46.51 -43.57 16.96 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.424 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -67.06 -40.24 87.03 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.001 0.429 . . . . 0.0 110.757 179.203 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 303' ' ' SER . . . . . 0.618 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 60.2 p -56.22 -36.11 68.09 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.131 -179.086 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 304' ' ' ALA . . . . . 0.55 ' HB2' ' SD ' ' A' ' 215' ' ' MET . . . -57.31 -51.34 69.77 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.215 179.332 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 91.7 mtp -56.01 -44.18 78.43 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -65.79 -42.59 90.53 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.165 0.507 . . . . 0.0 110.437 179.08 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 307' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 303' ' ' SER . 55.7 t -64.06 -42.92 97.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.255 179.358 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 43.6 tp -59.77 -41.94 92.19 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.129 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -62.44 -39.0 91.93 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.299 179.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 310' ' ' ARG . . . . . 0.441 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.5 ttt85 -63.7 -43.79 95.56 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.374 179.389 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 89.4 mt -63.47 -41.94 98.6 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.572 179.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.3 ttmt -63.2 -33.29 75.16 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.35 179.263 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.42 -23.58 22.11 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.466 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.486 HD22 ' CE2' ' A' ' 315' ' ' PHE . 6.7 tt -62.31 -43.15 99.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.491 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 315' ' ' PHE . . . . . 0.486 ' CE2' HD22 ' A' ' 314' ' ' LEU . 89.8 m-85 . . . . . 0 C--O 1.221 -0.444 0 CA-C-O 118.09 -0.957 . . . . 0.0 110.3 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -99.64 136.03 40.18 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.134 0.492 . . . . 0.0 110.475 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.482 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -92.44 178.68 1.58 Allowed Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.47 -179.692 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.482 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.7 Cg_exo -61.71 147.19 95.87 Favored 'Trans proline' 0 C--N 1.303 -1.843 0 C-N-CA 122.814 2.343 . . . . 0.0 112.211 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.487 ' HE ' HD12 ' A' ' 39' ' ' LEU . 35.5 ptt180 -136.53 142.45 43.45 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.565 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -79.63 116.88 20.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.508 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.445 ' O ' HG23 ' A' ' 30' ' ' ILE . 9.4 tp -111.13 130.39 64.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.557 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 13.9 t -71.3 142.18 50.47 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.674 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.478 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.4 t0 -139.24 -179.97 6.18 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.478 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.478 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 78.1 p -74.0 -37.05 64.54 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.671 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.8 ttt85 -46.86 -94.78 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.31 -179.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -166.07 -27.06 0.02 OUTLIER Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 62.5 m -168.71 105.76 0.44 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.757 0.313 . . . . 0.0 110.598 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.644 ' CD2' HD13 ' A' ' 140' ' ' LEU . 65.5 t60 -128.86 146.55 50.91 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 120.956 0.408 . . . . 0.0 110.222 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.619 HG22 ' N ' ' A' ' 39' ' ' LEU . 95.4 m -129.84 165.53 21.8 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.3 -179.669 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.619 ' N ' HG22 ' A' ' 38' ' ' THR . 78.5 mt -120.21 127.28 52.29 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.691 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -65.41 -44.86 86.1 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.606 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 38.3 p -165.64 154.97 12.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.458 179.385 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.491 ' CD ' ' H ' ' A' ' 42' ' ' GLN . 14.5 mp0 -44.82 101.19 0.25 Allowed Pre-proline 0 C--O 1.235 0.333 0 O-C-N 123.57 0.544 . . . . 0.0 110.505 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -57.62 130.25 37.83 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.339 2.026 . . . . 0.0 112.16 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -82.69 -25.03 33.37 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.643 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.538 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.8 mtm-85 -120.89 134.53 55.29 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.143 0.497 . . . . 0.0 110.237 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.1 mt -129.75 133.23 65.2 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.327 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.639 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 46.2 t -125.1 130.92 73.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 CA-C-O 120.942 0.401 . . . . 0.0 110.151 178.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.609 ' OG ' HD12 ' A' ' 117' ' ' LEU . 4.2 m -154.99 166.6 33.06 Favored 'General case' 0 C--O 1.225 -0.22 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.459 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 73.2 p -124.55 8.92 8.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.417 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.35 125.84 33.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.872 0.368 . . . . 0.0 110.584 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.467 HG11 ' H ' ' A' ' 299' ' ' LEU . 84.9 t -65.83 -44.58 92.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.611 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 18.5 m -62.59 -44.41 96.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.678 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 52.2 tp -62.39 -41.53 98.72 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.661 -179.344 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.438 ' O ' HD13 ' A' ' 58' ' ' LEU . 71.9 m -58.04 -44.61 87.48 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.183 -179.183 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.31 -62.09 5.44 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 179.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.5 t -47.89 -35.64 10.81 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.5 mt -61.82 -44.55 96.63 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.069 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.438 HD13 ' O ' ' A' ' 54' ' ' THR . 9.1 mp -65.27 -41.17 94.47 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.297 178.132 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.412 ' HB1' ' NE ' ' A' ' 169' ' ' ARG . . . -63.85 -41.45 97.8 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.611 -179.193 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.414 ' O ' HG23 ' A' ' 60' ' ' ILE . 8.0 tp -87.75 16.8 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.724 -179.496 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 56.32 84.39 0.09 Allowed 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.814 -179.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.28 58.44 0.08 OUTLIER Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 120.992 0.425 . . . . 0.0 109.931 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -50.91 152.72 9.61 Favored 'Trans proline' 0 C--N 1.296 -2.205 0 C-N-CA 123.061 2.507 . . . . 0.0 112.307 -178.347 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.429 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -108.85 145.9 15.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.279 -179.789 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.78 -45.13 98.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.191 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.504 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -130.16 134.17 47.12 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.717 0.294 . . . . 0.0 110.389 -179.585 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.494 ' O ' ' N ' ' A' ' 98' ' ' LEU . 73.5 m -134.3 158.51 43.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.85 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.58 139.21 16.36 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.494 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.69 -162.83 0.09 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.86 0.362 . . . . 0.0 110.382 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.502 HG22 ' CD2' ' A' ' 297' ' ' PHE . 5.8 t -134.09 135.57 43.33 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.027 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.466 ' C ' ' O ' ' A' ' 70' ' ' THR . 0.9 OUTLIER 29.78 68.23 0.68 Allowed Pre-proline 0 N--CA 1.469 0.507 0 CA-C-O 121.181 0.515 . . . . 0.0 110.813 -179.569 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -60.8 145.23 99.3 Favored 'Trans proline' 0 C--N 1.301 -1.944 0 C-N-CA 122.737 2.291 . . . . 0.0 111.978 -178.191 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.539 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 44.9 p-10 -160.06 -32.62 0.06 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.674 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.539 ' N ' ' OD1' ' A' ' 73' ' ' ASN . 98.9 m-20 -63.75 -39.72 94.97 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.364 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -59.97 -48.33 82.16 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.476 -179.128 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.425 ' O ' ' O ' ' A' ' 77' ' ' ALA . 92.4 t -60.0 -24.75 30.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.125 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.526 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -45.64 173.0 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.53 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.565 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.3 p30 -62.06 177.69 0.44 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.424 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.564 ' C ' ' H ' ' A' ' 81' ' ' GLY . 35.1 p30 -45.81 85.64 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.985 0.421 . . . . 0.0 110.903 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.565 ' N ' ' O ' ' A' ' 78' ' ' ASP . 42.5 tp60 -67.21 13.45 0.06 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.25 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.564 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 117.92 -22.34 9.9 Favored Glycine 0 N--CA 1.463 0.439 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -107.75 116.22 31.55 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.945 0.402 . . . . 0.0 110.483 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 76.5 mt -98.71 0.63 44.96 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.478 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -92.23 6.84 45.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.917 0.389 . . . . 0.0 110.325 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.781 ' O ' HG22 ' A' ' 89' ' ' VAL . 27.4 mt-30 -99.88 -27.8 13.43 Favored 'General case' 0 C--O 1.222 -0.379 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.665 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 69.0 t-105 -63.42 -40.96 98.58 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.767 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.545 ' O ' ' N ' ' A' ' 91' ' ' LYS . 67.2 m -77.42 -53.34 7.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.888 -179.286 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -48.59 -51.14 29.35 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.946 -179.021 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.781 HG22 ' O ' ' A' ' 85' ' ' GLN . 15.9 m -68.78 -40.6 81.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.039 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.489 ' N ' HG23 ' A' ' 89' ' ' VAL . . . -72.35 -22.92 61.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.753 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.545 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.0 tttm -61.41 -45.92 92.31 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.391 -179.432 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.438 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.6 mm-40 -90.37 -94.56 0.12 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.128 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.608 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.9 mtt180 -143.49 59.63 1.39 Allowed 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.437 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.7 pttp 34.06 26.32 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.282 0.563 . . . . 0.0 110.517 -179.368 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.608 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.5 tt -48.32 123.15 6.09 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.856 -177.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.45 ' O ' HD23 ' A' ' 95' ' ' LEU . 98.9 mm-40 -83.31 -170.44 3.05 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.314 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.617 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 82.7 mtp180 -73.45 137.89 44.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.952 0.406 . . . . 0.0 110.231 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.494 ' N ' ' O ' ' A' ' 67' ' ' SER . 88.3 mt -86.41 -165.96 1.41 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.83 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.532 ' O ' ' CD2' ' A' ' 99' ' ' TYR . 47.1 p90 -168.51 120.0 0.79 Allowed 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.094 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.488 ' C ' ' O ' ' A' ' 99' ' ' TYR . 42.9 mm -29.67 121.4 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 O-C-N 123.392 0.433 . . . . 0.0 110.898 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 113.7 28.12 3.31 Favored Glycine 0 N--CA 1.463 0.473 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 -179.347 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.579 ' N ' ' CD ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -143.86 45.5 0.57 Allowed Pre-proline 0 C--N 1.324 -0.54 0 CA-C-O 121.298 0.57 . . . . 0.0 110.463 179.794 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 30.4 Cg_endo -62.14 144.03 95.32 Favored 'Trans proline' 0 C--N 1.297 -2.145 0 C-N-CA 122.572 2.181 . . . . 0.0 111.972 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.462 ' O ' HG23 ' A' ' 108' ' ' VAL . 25.3 t -173.17 120.76 0.36 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.573 179.426 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.15 -40.96 64.44 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.188 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -65.97 -40.0 90.85 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.759 -179.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.05 -39.62 94.49 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.667 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 104' ' ' SER . 71.2 t -67.58 -43.73 86.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.638 179.593 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.44 -39.3 92.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.527 -179.115 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.438 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.78 -23.67 63.47 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.561 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.526 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.4 mm-40 -90.89 4.38 52.02 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.769 -179.543 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.538 ' O ' ' NE ' ' A' ' 45' ' ' ARG . 10.5 tpt 22.61 64.37 0.34 Allowed Pre-proline 0 N--CA 1.471 0.598 0 O-C-N 123.5 0.5 . . . . 0.0 111.124 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.466 ' HG2' HD11 ' A' ' 116' ' ' ILE . 68.2 Cg_endo -79.33 169.4 18.87 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 123.083 2.522 . . . . 0.0 111.938 -178.093 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.524 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 98.7 m-20 -112.33 -44.72 3.35 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.174 179.507 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 39.1 tp -119.9 121.04 38.15 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.147 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.466 HD11 ' HG2' ' A' ' 113' ' ' PRO . 96.8 mt -118.18 131.32 71.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.769 -179.7 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.609 HD12 ' OG ' ' A' ' 48' ' ' SER . 31.5 mt -106.06 132.11 52.53 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.205 -179.587 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.497 HD12 HG23 ' A' ' 139' ' ' THR . 98.6 mt -117.76 136.08 56.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.55 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 86.4 p -71.48 151.41 43.97 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.608 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.32 -49.95 75.57 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.582 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -149.29 153.6 37.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.505 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 168.48 -169.69 41.75 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.88 -35.6 92.23 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.449 ' OD1' ' O ' ' A' ' 124' ' ' ASP . 44.3 p-10 -88.46 119.88 29.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.903 0.383 . . . . 0.0 110.598 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.446 ' O ' HD12 ' A' ' 129' ' ' LEU . 40.6 t -63.0 144.03 57.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.405 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.511 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.55 -43.07 8.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.779 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.8 tp -62.64 -42.42 99.59 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.821 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.85 -10.44 53.06 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.405 -179.294 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.446 HD12 ' O ' ' A' ' 125' ' ' SER . 82.1 mt -115.99 -24.3 8.16 Favored 'General case' 0 C--O 1.225 -0.222 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.56 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' TYR . . . . . 0.522 ' CD1' HG21 ' A' ' 139' ' ' THR . 71.3 t80 -51.37 -49.51 61.34 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.914 -0.314 . . . . 0.0 110.558 -178.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.2 p-10 -66.09 -41.79 90.17 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.846 -0.342 . . . . 0.0 111.054 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.523 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 87.9 mt-30 -67.91 -36.49 80.28 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.751 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.466 HD12 HD11 ' A' ' 118' ' ' ILE . 96.5 mt -80.35 -42.09 23.55 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.003 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.3 t -57.39 -45.25 84.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.293 -179.05 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.6 m -62.46 -45.66 92.03 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.656 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 92.2 mt -62.4 -43.78 98.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.312 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.598 ' HB1' ' HD2' ' A' ' 138' ' ' PRO . . . -170.2 163.54 6.2 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.581 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.598 ' HD2' ' HB1' ' A' ' 137' ' ' ALA . 76.0 Cg_exo -42.14 110.67 0.16 Allowed 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.561 2.174 . . . . 0.0 112.118 179.31 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.522 HG21 ' CD1' ' A' ' 130' ' ' TYR . 2.8 m -87.34 127.76 35.19 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.237 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.644 HD13 ' CD2' ' A' ' 37' ' ' HIS . 34.3 tp -119.63 139.21 52.57 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.451 179.525 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.431 ' O ' ' OD2' ' A' ' 32' ' ' ASP . 81.7 mt -105.11 119.93 54.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-O 120.953 0.406 . . . . 0.0 110.852 -179.206 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.48 HD12 HD22 ' A' ' 117' ' ' LEU . 97.1 mt -135.67 132.7 51.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.639 179.144 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -64.59 147.99 51.75 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.465 179.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.511 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 87.3 t80 -82.48 122.67 28.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.814 -179.311 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.511 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 99.0 m-20 55.05 69.31 0.75 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.561 179.445 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 34.2 p-10 -125.62 0.49 7.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.576 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -150.92 115.96 5.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.867 0.365 . . . . 0.0 110.642 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 85.0 p -63.76 169.11 4.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.613 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.407 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.7 p-90 -51.83 -16.13 0.64 Allowed 'General case' 0 C--O 1.22 -0.457 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.258 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.435 ' O ' HG23 ' A' ' 154' ' ' THR . 68.2 tp60 -70.19 -75.98 0.11 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.021 0.438 . . . . 0.0 110.614 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 11.1 t -62.58 -38.45 90.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.265 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 51.0 tp -60.16 -45.5 92.87 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.573 -178.353 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.407 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 45.4 tp -62.85 -41.63 99.43 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.612 178.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.435 HG23 ' O ' ' A' ' 150' ' ' GLN . 59.6 p -63.67 -35.01 79.15 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.251 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.467 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.5 mm-40 -63.54 -41.99 98.43 Favored 'General case' 0 C--O 1.225 -0.203 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.344 179.272 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 91.5 mt -65.44 -39.09 91.65 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.413 178.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.562 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.09 -32.15 79.33 Favored Glycine 0 N--CA 1.46 0.264 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 -179.247 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.467 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.3 mt-10 -36.81 -25.26 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.752 0.31 . . . . 0.0 110.881 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.562 ' N ' ' O ' ' A' ' 157' ' ' GLY . 95.5 mt -59.17 148.61 6.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.346 179.084 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 74.7 p -69.13 137.72 53.63 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.879 -179.331 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 70.69 21.88 77.95 Favored Glycine 0 CA--C 1.519 0.335 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 179.426 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 59.8 m80 -124.35 -13.78 7.08 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 110.448 -0.204 . . . . 0.0 110.448 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -66.24 -59.9 3.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.506 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -51.79 -49.07 63.41 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.119 -179.377 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -60.41 -41.03 93.08 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.862 0.363 . . . . 0.0 110.448 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.58 -47.19 86.61 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.551 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -57.0 -39.96 75.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.25 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -61.69 -50.49 72.25 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.694 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.412 ' NE ' ' HB1' ' A' ' 59' ' ' ALA . 60.0 ttt85 -65.29 -43.89 89.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.458 179.497 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 95.3 mt -64.32 -43.55 97.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.412 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.28 -51.05 70.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.432 -179.048 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -63.79 -43.43 96.32 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.846 0.355 . . . . 0.0 110.539 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.657 ' CE2' HD11 ' A' ' 177' ' ' LEU . 56.6 t80 -62.66 -44.44 96.26 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.084 0.468 . . . . 0.0 110.423 179.379 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -63.62 -39.87 95.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.475 -179.264 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -62.97 -42.6 99.88 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.725 179.214 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -60.74 -44.55 96.52 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.24 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.657 HD11 ' CE2' ' A' ' 173' ' ' PHE . 85.1 mt -64.55 -41.07 96.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.875 178.741 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.24 -61.95 1.95 Allowed 'General case' 0 C--O 1.239 0.515 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.426 -179.238 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.72 -47.12 85.68 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.358 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -52.83 -41.55 64.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.314 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -63.79 -33.71 76.28 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.36 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.405 ' O ' ' HG2' ' A' ' 182' ' ' GLU . 69.6 tt0 -90.92 8.52 34.66 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.539 0.685 . . . . 0.0 110.302 -178.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -104.24 -32.22 9.22 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.088 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.4 pt -128.04 147.77 32.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.886 0.374 . . . . 0.0 110.635 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -139.93 131.31 26.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.478 179.004 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.585 HD22 ' N ' ' A' ' 186' ' ' LEU . 3.6 mm? -85.36 133.32 42.67 Favored Pre-proline 0 N--CA 1.448 -0.559 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.088 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -44.02 157.9 0.14 Allowed 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.645 2.23 . . . . 0.0 112.194 179.462 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 0.49 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.5 Cg_endo -63.12 114.78 2.61 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.716 2.277 . . . . 0.0 111.632 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 189' ' ' GLN . . . . . 0.49 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.7 mt-30 156.03 148.11 0.0 OUTLIER Pre-proline 0 C--N 1.34 0.194 0 O-C-N 124.401 1.063 . . . . 0.0 110.894 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -73.58 144.56 36.02 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 122.597 2.198 . . . . 0.0 111.905 177.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.496 HG23 ' OG ' ' A' ' 258' ' ' SER . 2.1 p -124.78 158.93 31.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.229 0.538 . . . . 0.0 110.109 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 192' ' ' THR . . . . . 0.481 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 38.1 p -143.16 165.18 28.13 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 121.396 0.617 . . . . 0.0 110.973 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 193' ' ' ALA . . . . . 0.445 ' HA ' ' H ' ' A' ' 260' ' ' PHE . . . -135.15 128.93 33.03 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 121.377 0.608 . . . . 0.0 110.358 178.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.509 HD11 HD23 ' A' ' 259' ' ' LEU . 47.2 pt -146.57 148.97 16.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.972 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 195' ' ' VAL . . . . . 0.74 HG13 ' CD1' ' A' ' 262' ' ' PHE . 72.3 t -117.73 123.15 71.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.183 0.516 . . . . 0.0 109.932 178.643 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -134.35 106.91 7.33 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.289 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 94.2 m -130.85 130.44 43.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.872 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.41 ' O ' ' N ' ' A' ' 201' ' ' HIS . . . -82.73 -37.03 25.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.258 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.5 -67.08 0.26 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.297 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -71.91 -9.77 58.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.379 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' HIS . . . . . 0.41 ' N ' ' O ' ' A' ' 198' ' ' ALA . 60.3 t-80 60.38 57.97 2.7 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.591 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 47.6 p -166.66 153.38 8.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.57 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.29 144.13 24.47 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.946 0.403 . . . . 0.0 110.426 179.118 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -135.4 138.67 43.51 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.525 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 19.0 mt -106.21 125.26 50.77 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 206' ' ' TRP . . . . . 0.557 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 75.0 m95 -82.12 167.51 18.68 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.593 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 207' ' ' THR . . . . . 0.45 HG22 ' C ' ' A' ' 206' ' ' TRP . 0.1 OUTLIER -157.18 171.56 7.28 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.595 -178.674 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.8 -37.26 84.63 Favored 'Trans proline' 0 C--N 1.302 -1.915 0 C-N-CA 122.598 2.199 . . . . 0.0 112.183 179.152 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -70.89 -34.73 71.87 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.713 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 21.4 m -61.23 151.08 32.63 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.529 -179.411 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.65 -37.01 82.47 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.392 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 212' ' ' GLN . . . . . 0.557 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 55.0 tt0 -64.8 -40.31 95.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.477 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.78 -43.39 91.82 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -62.74 -44.15 96.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.809 0.338 . . . . 0.0 110.262 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 215' ' ' MET . . . . . 0.546 ' SD ' ' HB2' ' A' ' 304' ' ' ALA . 65.3 ttp -59.46 -47.82 84.03 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.221 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 87.0 mt -60.4 -41.07 93.1 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 217' ' ' GLU . . . . . 0.448 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.3 tp10 -58.18 -38.07 75.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.074 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -65.32 -38.24 89.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.743 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 95.7 mt -64.1 -42.79 96.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.684 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.49 45.45 0.08 OUTLIER Glycine 0 N--CA 1.462 0.416 0 N-CA-C 111.111 -0.795 . . . . 0.0 111.111 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 221' ' ' PHE . . . . . 0.448 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 27.4 m-85 -128.29 155.6 44.34 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.83 0.347 . . . . 0.0 110.482 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.476 ' O ' HG13 ' A' ' 191' ' ' VAL . 7.5 p -107.11 122.35 46.32 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-O 121.225 0.536 . . . . 0.0 110.215 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.475 HD22 ' C ' ' A' ' 222' ' ' THR . 4.3 mm? -101.47 133.06 46.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.016 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.76 159.67 14.8 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.471 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.33 115.15 29.76 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.377 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.493 HD12 ' N ' ' A' ' 226' ' ' LEU . 9.0 mp -53.08 156.83 3.35 Favored Pre-proline 0 N--CA 1.447 -0.62 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.811 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -60.3 145.36 98.75 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 C-N-CA 122.735 2.29 . . . . 0.0 112.091 179.204 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.24 -3.22 59.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.521 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.07 -40.94 5.7 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.503 ' O ' ' N ' ' A' ' 233' ' ' SER . 68.7 mt -79.36 -17.25 54.84 Favored 'General case' 0 C--O 1.219 -0.542 0 CA-C-O 121.04 0.447 . . . . 0.0 110.297 -179.725 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 54.6 t-20 -40.48 -49.51 2.89 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.842 0.354 . . . . 0.0 110.717 -179.375 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -87.69 15.46 6.86 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.241 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.503 ' N ' ' O ' ' A' ' 230' ' ' LEU . 77.9 p -60.62 -35.2 75.56 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.608 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 234' ' ' GLN . . . . . 0.522 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.6 tt0 -119.54 -69.34 0.85 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.717 179.32 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.0 m -69.72 102.1 1.83 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.955 0.407 . . . . 0.0 110.592 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -93.78 57.56 2.52 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.34 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -144.63 -122.5 1.58 Allowed Glycine 0 N--CA 1.462 0.397 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -135.44 111.78 9.79 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.0 0.428 . . . . 0.0 110.374 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 239' ' ' ARG . . . . . 0.524 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.5 mtt180 -148.27 58.26 1.08 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.596 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -69.47 -32.35 71.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.571 179.386 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 241' ' ' ASP . . . . . 0.451 ' OD2' ' O ' ' A' ' 144' ' ' TYR . 64.8 t0 -56.85 -47.3 80.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.266 -179.042 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 242' ' ' ILE . . . . . 0.435 ' O ' ' O ' ' A' ' 239' ' ' ARG . 17.8 tt -139.65 156.17 25.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.851 0.358 . . . . 0.0 110.371 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.451 HG22 HD13 ' A' ' 245' ' ' LEU . 96.2 mt -106.07 106.61 20.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.947 0.403 . . . . 0.0 110.382 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 244' ' ' GLN . . . . . 0.589 ' O ' HD12 ' A' ' 245' ' ' LEU . 88.3 mt-30 -110.55 110.06 20.63 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.329 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.589 HD12 ' O ' ' A' ' 244' ' ' GLN . 9.6 mp -121.77 -168.14 1.65 Allowed 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.634 179.54 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 246' ' ' GLY . . . . . 0.522 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.83 -16.57 0.05 OUTLIER Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 247' ' ' GLY . . . . . 0.668 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -61.09 156.41 33.49 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -63.49 21.63 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.783 0.325 . . . . 0.0 110.563 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 249' ' ' ASN . . . . . 0.668 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.8 m-20 -96.93 -6.4 35.72 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.756 0.313 . . . . 0.0 110.492 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 91.8 mt -79.5 -21.72 44.92 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.931 179.18 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.79 -51.36 70.32 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.648 -179.466 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.33 -5.45 58.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.463 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -80.91 -74.25 1.14 Allowed Glycine 0 CA--C 1.522 0.528 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 80.8 mt -70.17 126.09 28.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.888 0.375 . . . . 0.0 110.344 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -59.69 -39.22 83.82 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.336 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 83.28 51.84 4.0 Favored Glycine 0 CA--C 1.521 0.446 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -95.58 -15.52 22.74 Favored 'General case' 0 C--N 1.331 -0.223 0 O-C-N 122.823 -0.222 . . . . 0.0 110.578 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 258' ' ' SER . . . . . 0.496 ' OG ' HG23 ' A' ' 191' ' ' VAL . 3.4 t 174.77 89.14 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.161 0.505 . . . . 0.0 110.268 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.85 HD12 ' N ' ' A' ' 259' ' ' LEU . 0.9 OUTLIER -94.76 124.2 38.65 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.857 0.361 . . . . 0.0 110.985 -178.729 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 260' ' ' PHE . . . . . 0.445 ' H ' ' HA ' ' A' ' 193' ' ' ALA . 15.7 m-30 -93.61 146.41 23.83 Favored 'General case' 0 CA--C 1.497 -1.064 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.543 179.202 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 85.0 mt -122.21 148.87 44.43 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.554 -179.431 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.74 ' CD1' HG13 ' A' ' 195' ' ' VAL . 2.5 p90 -77.17 -139.07 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.436 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 263' ' ' ALA . . . . . 0.654 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -51.15 77.22 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.353 0 O-C-N 123.435 0.459 . . . . 0.0 111.108 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 264' ' ' GLY . . . . . 0.624 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.43 104.64 0.19 Allowed Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 265' ' ' ASP . . . . . 0.588 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.6 m-20 -80.14 -177.77 6.23 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 122.703 -0.293 . . . . 0.0 110.718 -179.549 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -40.8 -17.78 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.496 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 267' ' ' LYS . . . . . 0.588 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.01 -51.3 48.69 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.758 179.111 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -64.11 -46.5 83.92 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.98 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 269' ' ' ALA . . . . . 0.572 ' HB1' ' OH ' ' A' ' 273' ' ' TYR . . . -61.76 -34.83 76.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.697 0.761 . . . . 0.0 109.883 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -62.93 -35.0 78.65 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.185 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.09 -43.12 14.18 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.184 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 272' ' ' ILE . . . . . 0.589 ' C ' ' H ' ' A' ' 274' ' ' ALA . 5.0 tt -51.64 -33.77 15.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.552 -178.654 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 273' ' ' TYR . . . . . 0.572 ' OH ' ' HB1' ' A' ' 269' ' ' ALA . 16.8 m-85 -54.58 -1.67 0.03 OUTLIER 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.767 -179.4 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 274' ' ' ALA . . . . . 0.589 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.5 -39.94 70.49 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.942 179.194 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 275' ' ' ASN . . . . . 0.574 ' O ' ' N ' ' A' ' 279' ' ' ALA . 3.1 p30 -38.52 97.52 0.14 Allowed Pre-proline 0 C--N 1.339 0.135 0 O-C-N 123.532 0.52 . . . . 0.0 110.429 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -53.72 -43.17 60.23 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 C-N-CA 122.577 2.184 . . . . 0.0 112.511 -178.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 88.9 mt -64.36 -43.01 95.88 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.008 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 91.7 mt -95.95 -1.06 49.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.75 -179.398 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 279' ' ' ALA . . . . . 0.574 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.65 -34.93 78.08 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.501 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.32 20.36 0.11 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.841 -179.097 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 0.485 ' H ' ' C ' ' A' ' 279' ' ' ALA . 13.7 mt -74.68 119.82 78.54 Favored Pre-proline 0 N--CA 1.442 -0.837 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.776 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -51.15 -39.37 61.31 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 C-N-CA 122.507 2.138 . . . . 0.0 111.922 179.18 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.74 -50.54 63.25 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.898 0.38 . . . . 0.0 110.033 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 76.8 t -61.42 -43.88 97.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.169 179.576 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -57.56 -41.21 80.6 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.207 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -91.17 0.47 57.52 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.258 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt 59.26 43.91 16.25 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.84 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -95.01 41.2 1.09 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.32 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 53.9 t -119.13 135.58 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-O 121.018 0.437 . . . . 0.0 110.061 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -132.8 162.76 30.65 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.527 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.37 155.08 32.59 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.515 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 80.8 mt -94.09 -1.75 53.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.246 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 120.89 165.38 12.69 Favored Glycine 0 N--CA 1.464 0.504 0 N-CA-C 110.489 -1.045 . . . . 0.0 110.489 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 7.3 m -87.08 -62.47 1.5 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.829 0.347 . . . . 0.0 110.971 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 295' ' ' GLU . . . . . 0.45 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.5 mm-40 -68.71 -4.35 15.46 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.687 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 24.9 p -76.78 32.16 0.13 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.674 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 297' ' ' PHE . . . . . 0.502 ' CD2' HG22 ' A' ' 70' ' ' THR . 68.3 t80 -60.48 -46.21 90.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.664 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 298' ' ' ARG . . . . . 0.617 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.1 mtt85 -80.68 134.89 35.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.453 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.467 ' H ' HG11 ' A' ' 51' ' ' VAL . 18.6 tp -113.7 116.7 29.85 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-O 120.942 0.401 . . . . 0.0 110.385 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 300' ' ' ASP . . . . . 0.619 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.2 p-10 -165.0 -176.87 4.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.723 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -46.66 -43.22 17.45 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.373 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -67.15 -40.21 86.67 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 121.028 0.442 . . . . 0.0 110.752 179.101 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 303' ' ' SER . . . . . 0.619 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 59.6 p -56.34 -36.27 68.58 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.079 -179.023 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 304' ' ' ALA . . . . . 0.546 ' HB2' ' SD ' ' A' ' 215' ' ' MET . . . -57.33 -51.47 69.25 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 179.404 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 91.9 mtp -55.71 -44.28 77.27 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -65.8 -42.75 90.32 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.227 0.537 . . . . 0.0 110.454 179.124 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 307' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 303' ' ' SER . 54.9 t -64.04 -42.82 96.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.262 179.356 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 44.2 tp -59.77 -41.92 92.16 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.041 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -62.79 -38.77 91.95 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.116 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 310' ' ' ARG . . . . . 0.449 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.6 ttt85 -63.56 -43.83 95.91 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.32 179.492 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 87.7 mt -63.37 -42.09 98.83 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.46 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.4 ttmt -63.03 -33.24 75.0 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.39 179.255 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.84 -23.47 21.67 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.395 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.486 HD22 ' CE2' ' A' ' 315' ' ' PHE . 6.7 tt -62.31 -43.27 99.22 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.488 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 315' ' ' PHE . . . . . 0.486 ' CE2' HD22 ' A' ' 314' ' ' LEU . 90.4 m-85 . . . . . 0 C--O 1.22 -0.486 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.317 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -99.5 136.48 39.37 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.174 0.512 . . . . 0.0 110.424 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.485 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -91.58 178.7 1.65 Allowed Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.469 -179.707 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.485 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.3 Cg_exo -61.76 147.51 95.14 Favored 'Trans proline' 0 C--N 1.301 -1.948 0 C-N-CA 122.955 2.437 . . . . 0.0 112.207 179.452 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.472 ' HE ' HD12 ' A' ' 39' ' ' LEU . 35.3 ptt180 -135.02 142.35 46.38 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.591 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -79.01 116.85 19.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.496 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.425 ' O ' HG23 ' A' ' 30' ' ' ILE . 9.5 tp -109.93 130.61 62.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.494 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.8 t -70.54 141.59 51.86 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.685 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.421 ' OD2' ' O ' ' A' ' 141' ' ' ILE . 24.8 t70 -139.83 177.1 8.19 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.452 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.4 p -73.11 -36.57 66.77 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.707 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -47.62 -95.05 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.275 -179.302 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -166.15 -25.54 0.02 OUTLIER Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 62.7 m -168.5 106.42 0.47 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.691 0.281 . . . . 0.0 110.633 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 51.5 t-80 -129.79 144.2 51.18 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-O 121.016 0.436 . . . . 0.0 110.099 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.626 HG22 ' N ' ' A' ' 39' ' ' LEU . 95.9 m -128.47 166.46 18.72 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.338 -179.559 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.626 ' N ' HG22 ' A' ' 38' ' ' THR . 81.4 mt -121.08 127.73 51.93 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.66 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -63.93 -44.64 92.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.689 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 38.3 p -165.45 155.36 12.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.45 179.285 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.519 ' CD ' ' H ' ' A' ' 42' ' ' GLN . 14.3 mp0 -42.33 100.07 0.22 Allowed Pre-proline 0 C--O 1.236 0.379 0 O-C-N 123.47 0.481 . . . . 0.0 110.564 179.239 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -56.87 129.3 33.82 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 122.362 2.041 . . . . 0.0 112.191 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -83.89 -24.16 30.92 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.649 179.387 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.539 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.6 mtm-85 -121.26 134.53 55.18 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.149 0.499 . . . . 0.0 110.193 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.2 mt -130.68 133.34 63.52 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.313 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.598 -179.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 47.0 t -124.91 130.87 73.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 CA-C-O 120.992 0.425 . . . . 0.0 110.039 179.034 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.595 ' OG ' HD12 ' A' ' 117' ' ' LEU . 4.6 m -154.32 166.38 33.37 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.513 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 67.4 p -124.45 8.96 8.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.389 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.94 125.44 33.36 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.599 -179.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.454 HG11 ' H ' ' A' ' 299' ' ' LEU . 84.5 t -65.51 -44.44 94.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.557 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.3 m -62.68 -44.25 96.72 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.598 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 52.1 tp -62.46 -41.48 98.78 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.573 -179.341 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.445 ' O ' HD13 ' A' ' 58' ' ' LEU . 73.3 m -57.83 -44.59 86.53 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.249 -179.286 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.26 -62.1 5.44 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.896 -0.881 . . . . 0.0 110.896 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.6 t -48.16 -35.67 12.09 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.6 mt -61.76 -44.42 96.92 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.161 179.302 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.445 HD13 ' O ' ' A' ' 54' ' ' THR . 9.1 mp -65.47 -41.06 93.75 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.412 177.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.404 ' HB1' ' NE ' ' A' ' 169' ' ' ARG . . . -63.78 -41.45 97.94 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.706 -179.289 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.411 ' O ' HG23 ' A' ' 60' ' ' ILE . 8.1 tp -87.8 16.77 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.82 -179.655 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 56.34 84.49 0.08 Allowed 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.828 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.22 58.52 0.08 OUTLIER Pre-proline 0 C--N 1.328 -0.368 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -51.24 152.94 10.4 Favored 'Trans proline' 0 C--N 1.294 -2.335 0 C-N-CA 123.148 2.566 . . . . 0.0 112.206 -178.309 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.428 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -108.76 145.73 15.3 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.265 -179.685 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.68 -45.31 97.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.212 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.5 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -130.18 134.33 47.22 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.803 0.335 . . . . 0.0 110.352 -179.564 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.488 ' O ' ' N ' ' A' ' 98' ' ' LEU . 75.7 m -134.55 158.73 43.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.913 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.6 139.19 16.32 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.484 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.62 -162.82 0.09 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.893 0.378 . . . . 0.0 110.401 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.511 HG22 ' CD2' ' A' ' 297' ' ' PHE . 5.8 t -134.03 135.18 43.19 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.065 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.468 ' C ' ' O ' ' A' ' 70' ' ' THR . 0.8 OUTLIER 29.76 68.43 0.67 Allowed Pre-proline 0 N--CA 1.469 0.477 0 CA-C-O 121.138 0.494 . . . . 0.0 110.853 -179.522 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_exo -61.08 145.2 99.22 Favored 'Trans proline' 0 C--N 1.3 -1.985 0 C-N-CA 122.746 2.297 . . . . 0.0 111.842 -178.105 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.527 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 44.8 p-10 -159.86 -31.88 0.06 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.725 179.672 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.539 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 98.7 m-20 -64.45 -39.47 93.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.37 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.2 ttt180 -60.09 -48.56 81.22 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.354 -179.303 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.424 ' O ' ' O ' ' A' ' 77' ' ' ALA . 95.3 t -60.05 -25.0 31.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.16 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.539 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -45.59 172.89 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.614 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.568 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.3 p30 -61.91 177.68 0.42 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.484 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.563 ' C ' ' H ' ' A' ' 81' ' ' GLY . 36.2 p30 -45.64 85.55 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.95 0.405 . . . . 0.0 110.939 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.568 ' N ' ' O ' ' A' ' 78' ' ' ASP . 42.8 tp60 -67.35 13.56 0.07 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.235 0.541 . . . . 0.0 110.201 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.563 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 117.93 -22.55 9.79 Favored Glycine 0 N--CA 1.463 0.448 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -107.87 116.4 31.89 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.963 0.411 . . . . 0.0 110.415 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 76.1 mt -98.8 0.56 44.6 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.542 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -91.92 6.76 45.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.326 -179.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.779 ' O ' HG22 ' A' ' 89' ' ' VAL . 27.3 mt-30 -100.17 -26.96 13.76 Favored 'General case' 0 C--O 1.221 -0.441 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.733 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.1 t-105 -64.01 -40.75 97.03 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.952 -179.663 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.545 ' O ' ' N ' ' A' ' 91' ' ' LYS . 67.9 m -77.64 -53.33 7.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.053 -179.624 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -48.55 -51.05 29.57 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.919 -179.08 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.779 HG22 ' O ' ' A' ' 85' ' ' GLN . 15.7 m -68.83 -40.94 81.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.091 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.5 ' N ' HG23 ' A' ' 89' ' ' VAL . . . -71.87 -23.03 61.44 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.641 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.545 ' N ' ' O ' ' A' ' 87' ' ' SER . 65.9 tttm -61.52 -45.93 92.09 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.347 -179.31 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.441 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.6 mm-40 -90.27 -94.65 0.12 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.155 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.609 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.9 mtt180 -143.45 59.59 1.39 Allowed 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.437 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.7 pttp 34.24 26.08 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.247 0.546 . . . . 0.0 110.454 -179.568 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.609 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.4 tt -48.35 123.34 6.38 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.897 -177.769 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.452 ' O ' HD23 ' A' ' 95' ' ' LEU . 98.9 mm-40 -83.46 -170.6 3.13 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.275 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.615 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 83.0 mtp180 -73.56 137.62 44.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.984 0.421 . . . . 0.0 110.248 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.488 ' N ' ' O ' ' A' ' 67' ' ' SER . 90.1 mt -86.13 -166.18 1.47 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.899 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.532 ' O ' ' CD2' ' A' ' 99' ' ' TYR . 47.9 p90 -168.05 120.08 0.85 Allowed 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.084 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.488 ' C ' ' O ' ' A' ' 99' ' ' TYR . 43.2 mm -29.75 121.26 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 O-C-N 123.332 0.395 . . . . 0.0 110.922 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 113.87 28.17 3.25 Favored Glycine 0 N--CA 1.462 0.387 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 -179.306 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.578 ' N ' ' CD ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -143.99 45.81 0.59 Allowed Pre-proline 0 C--N 1.322 -0.594 0 CA-C-O 121.203 0.525 . . . . 0.0 110.436 179.791 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 29.6 Cg_endo -62.06 143.83 95.39 Favored 'Trans proline' 0 C--N 1.295 -2.277 0 C-N-CA 122.667 2.245 . . . . 0.0 111.815 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.455 ' O ' HG23 ' A' ' 108' ' ' VAL . 27.2 t -173.13 120.73 0.36 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.47 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.25 -40.69 64.43 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.192 179.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.16 -39.85 90.09 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.7 -179.396 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.1 -39.78 94.8 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.673 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 104' ' ' SER . 69.7 t -67.7 -43.75 86.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.596 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.5 -39.31 93.09 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.552 -179.095 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.441 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.68 -23.5 63.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.542 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.527 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.4 mm-40 -91.26 4.77 51.48 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.7 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.539 ' O ' ' NE ' ' A' ' 45' ' ' ARG . 10.7 tpt 22.51 64.52 0.34 Allowed Pre-proline 0 N--CA 1.47 0.57 0 O-C-N 123.342 0.401 . . . . 0.0 111.204 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.452 ' HG2' HD11 ' A' ' 116' ' ' ILE . 65.3 Cg_endo -79.37 169.1 19.22 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 123.085 2.524 . . . . 0.0 111.679 -177.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.515 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 98.6 m-20 -112.57 -43.67 3.45 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.116 179.567 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.4 tp -120.64 121.39 38.22 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 120.884 0.373 . . . . 0.0 110.091 179.31 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.457 HD13 HD22 ' A' ' 133' ' ' LEU . 96.9 mt -118.84 130.85 73.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-O 120.888 0.375 . . . . 0.0 110.858 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.595 HD12 ' OG ' ' A' ' 48' ' ' SER . 32.1 mt -105.69 132.55 51.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.344 -179.471 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.417 HD12 HG23 ' A' ' 139' ' ' THR . 98.1 mt -117.89 135.97 56.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.565 -179.711 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 86.9 p -71.79 152.9 42.33 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.577 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -59.96 -50.03 75.35 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.617 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -149.37 153.72 37.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.535 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 169.71 -170.55 42.81 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -63.02 -35.13 91.68 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.449 ' OD1' ' O ' ' A' ' 124' ' ' ASP . 44.1 p-10 -88.04 119.69 28.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.922 0.391 . . . . 0.0 110.578 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.444 ' O ' HD12 ' A' ' 129' ' ' LEU . 40.4 t -63.39 144.42 56.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.429 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.52 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.51 -42.76 9.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.742 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 56.0 tp -62.76 -42.34 99.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.677 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.25 -11.04 58.7 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.375 -179.253 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.444 HD12 ' O ' ' A' ' 125' ' ' SER . 83.8 mt -115.07 -24.58 8.49 Favored 'General case' 0 C--O 1.225 -0.234 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.57 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' TYR . . . . . 0.52 ' N ' ' O ' ' A' ' 126' ' ' ALA . 77.3 t80 -51.35 -49.84 60.65 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.936 -0.306 . . . . 0.0 110.612 -178.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.7 p-10 -65.77 -41.71 91.73 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.267 179.449 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.521 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 88.2 mt-30 -68.06 -36.97 80.73 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.826 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.457 HD22 HD13 ' A' ' 116' ' ' ILE . 94.1 mt -79.9 -42.19 24.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.915 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.3 t -57.05 -45.03 83.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.216 -179.052 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.7 m -62.23 -45.66 92.32 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.615 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 92.9 mt -62.48 -43.94 98.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.361 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.609 ' HB1' ' HD2' ' A' ' 138' ' ' PRO . . . -169.91 163.98 6.4 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.593 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.609 ' HD2' ' HB1' ' A' ' 137' ' ' ALA . 78.2 Cg_exo -43.17 111.94 0.26 Allowed 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.544 2.163 . . . . 0.0 112.3 179.267 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.485 HG21 ' CD1' ' A' ' 130' ' ' TYR . 17.1 m -86.07 127.59 34.71 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.487 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.439 HD12 ' HA ' ' A' ' 140' ' ' LEU . 34.9 tp -119.78 138.0 53.62 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.256 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.421 ' O ' ' OD2' ' A' ' 32' ' ' ASP . 79.2 mt -104.88 121.0 56.26 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.184 0 CA-C-O 121.068 0.461 . . . . 0.0 110.879 -179.14 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.497 HD12 HD22 ' A' ' 117' ' ' LEU . 93.2 mt -136.86 132.73 47.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.553 179.359 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.542 HD21 ' CG ' ' A' ' 241' ' ' ASP . 60.9 t30 -64.19 151.16 44.17 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.534 179.319 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.516 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 89.0 t80 -86.03 122.52 30.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.786 -179.423 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.516 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 99.1 m-20 55.3 69.16 0.76 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.547 179.576 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 36.2 p-10 -125.26 0.61 7.76 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.589 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -151.15 116.15 5.26 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.823 0.344 . . . . 0.0 110.581 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 85.3 p -63.24 168.08 4.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.564 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.403 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.7 p-90 -51.13 -15.65 0.37 Allowed 'General case' 0 C--O 1.221 -0.405 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.313 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.439 ' O ' HG23 ' A' ' 154' ' ' THR . 68.1 tp60 -71.09 -74.89 0.14 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.009 0.433 . . . . 0.0 110.581 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 11.2 t -62.68 -38.87 92.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.238 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 52.3 tp -60.23 -45.57 92.78 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.451 -178.268 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.403 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 45.5 tp -62.61 -41.69 99.15 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.597 178.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.439 HG23 ' O ' ' A' ' 150' ' ' GLN . 56.1 p -63.85 -34.8 78.75 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.202 -179.37 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.481 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.4 mm-40 -63.69 -42.05 98.06 Favored 'General case' 0 C--O 1.224 -0.262 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.371 179.308 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 91.3 mt -65.44 -38.87 91.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.182 0.515 . . . . 0.0 110.376 178.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.557 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.34 -31.78 78.48 Favored Glycine 0 C--N 1.331 0.279 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 -179.246 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.481 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.3 mt-10 -37.18 -24.99 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.848 0.356 . . . . 0.0 110.948 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.557 ' N ' ' O ' ' A' ' 157' ' ' GLY . 93.8 mt -59.71 149.25 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.385 179.127 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 76.0 p -69.13 137.54 53.48 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.904 -179.43 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 70.41 22.28 77.65 Favored Glycine 0 CA--C 1.518 0.235 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 179.453 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 61.7 m80 -124.34 -14.14 7.01 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.621 0.248 . . . . 0.0 110.454 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -66.76 -59.55 3.47 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.56 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -51.73 -49.37 62.68 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.136 -179.418 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -60.3 -41.21 92.93 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.884 0.373 . . . . 0.0 110.501 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.38 -47.58 85.17 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.472 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.64 -40.06 74.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.306 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -61.7 -50.27 73.13 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.699 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.404 ' NE ' ' HB1' ' A' ' 59' ' ' ALA . 60.0 ttt85 -65.26 -43.67 90.57 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.576 179.401 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 94.7 mt -64.48 -43.46 96.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.346 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.51 -51.26 70.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.299 -179.04 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.56 -43.73 96.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.922 0.392 . . . . 0.0 110.655 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.657 ' CE2' HD11 ' A' ' 177' ' ' LEU . 55.9 t80 -62.78 -44.29 96.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.363 179.465 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -63.57 -39.62 94.88 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.446 -179.218 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -63.15 -42.69 99.48 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.583 179.261 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -60.62 -44.81 95.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.241 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.657 HD11 ' CE2' ' A' ' 173' ' ' PHE . 85.2 mt -64.65 -41.03 96.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.871 178.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.02 -61.98 1.92 Allowed 'General case' 0 C--O 1.239 0.506 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.428 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.96 -46.8 87.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.333 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -52.97 -41.63 64.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.414 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -63.98 -33.71 76.34 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.32 179.333 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.407 ' O ' ' HG2' ' A' ' 182' ' ' GLU . 69.7 tt0 -90.95 8.75 33.59 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.631 0.729 . . . . 0.0 110.258 -178.683 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -104.56 -31.97 9.18 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 122.041 -0.412 . . . . 0.0 111.099 179.416 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.6 pt -128.07 147.87 32.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.625 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -140.0 131.36 26.79 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.463 178.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.591 HD22 ' N ' ' A' ' 186' ' ' LEU . 3.6 mm? -85.32 133.1 43.18 Favored Pre-proline 0 N--CA 1.447 -0.584 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.146 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -43.93 157.83 0.14 Allowed 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 122.597 2.198 . . . . 0.0 112.35 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 0.49 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.6 Cg_endo -63.2 115.11 2.78 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.809 2.339 . . . . 0.0 111.615 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 189' ' ' GLN . . . . . 0.49 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.7 mt-30 155.91 147.99 0.0 OUTLIER Pre-proline 0 C--O 1.232 0.177 0 O-C-N 124.393 1.058 . . . . 0.0 110.871 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -73.54 144.01 35.29 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 122.612 2.208 . . . . 0.0 112.158 177.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.496 HG23 ' OG ' ' A' ' 258' ' ' SER . 2.1 p -124.82 159.17 31.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.409 0.623 . . . . 0.0 110.147 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 192' ' ' THR . . . . . 0.485 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 35.4 p -143.2 165.47 27.35 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.048 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 193' ' ' ALA . . . . . 0.448 ' HA ' ' H ' ' A' ' 260' ' ' PHE . . . -135.4 128.89 32.42 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-O 121.364 0.602 . . . . 0.0 110.33 179.02 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.509 HD11 HD23 ' A' ' 259' ' ' LEU . 47.3 pt -146.42 148.83 16.62 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.374 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.113 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 195' ' ' VAL . . . . . 0.74 HG13 ' CD1' ' A' ' 262' ' ' PHE . 70.2 t -117.55 123.18 71.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.226 0.536 . . . . 0.0 109.973 178.706 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -134.31 107.07 7.43 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.054 0.454 . . . . 0.0 110.259 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 94.9 m -130.93 130.37 43.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.843 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.407 ' O ' ' N ' ' A' ' 201' ' ' HIS . . . -82.79 -36.84 25.28 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.295 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.22 -67.18 0.25 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.29 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.11 -10.15 59.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.425 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 201' ' ' HIS . . . . . 0.407 ' N ' ' O ' ' A' ' 198' ' ' ALA . 60.2 t-80 61.01 58.15 2.35 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.64 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 41.9 p -166.86 153.65 8.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.609 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.53 144.23 24.34 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.948 0.404 . . . . 0.0 110.441 179.178 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -135.42 138.41 43.21 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.554 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 19.4 mt -106.09 125.33 50.86 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.923 0.392 . . . . 0.0 109.974 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 206' ' ' TRP . . . . . 0.556 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 75.2 m95 -82.19 167.39 18.74 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.569 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 207' ' ' THR . . . . . 0.449 HG22 ' C ' ' A' ' 206' ' ' TRP . 0.1 OUTLIER -157.14 171.67 7.15 Favored Pre-proline 0 C--O 1.225 -0.234 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.622 -178.764 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -53.79 -36.97 84.25 Favored 'Trans proline' 0 C--N 1.301 -1.935 0 C-N-CA 122.63 2.22 . . . . 0.0 112.306 179.022 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -71.09 -34.71 71.39 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.679 -179.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 21.7 m -61.3 150.72 34.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.569 -179.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.49 -36.97 81.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.418 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 212' ' ' GLN . . . . . 0.556 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 55.3 tt0 -64.72 -40.21 94.96 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.557 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.98 -43.49 91.12 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -62.91 -44.04 97.16 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.848 0.356 . . . . 0.0 110.249 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 215' ' ' MET . . . . . 0.546 ' SD ' ' HB2' ' A' ' 304' ' ' ALA . 65.4 ttp -59.41 -48.11 82.9 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.069 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 87.1 mt -60.19 -41.16 92.35 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 217' ' ' GLU . . . . . 0.45 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.1 tp10 -57.9 -37.97 74.99 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.148 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -65.49 -38.04 88.58 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.71 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 95.4 mt -64.09 -42.78 96.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.639 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.59 45.16 0.08 OUTLIER Glycine 0 N--CA 1.462 0.393 0 N-CA-C 111.054 -0.819 . . . . 0.0 111.054 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 221' ' ' PHE . . . . . 0.45 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 26.9 m-85 -128.07 155.23 44.7 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.926 0.393 . . . . 0.0 110.509 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.474 ' C ' HD22 ' A' ' 223' ' ' LEU . 6.9 p -106.94 122.23 46.02 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-O 121.299 0.571 . . . . 0.0 110.125 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.474 HD22 ' C ' ' A' ' 222' ' ' THR . 4.3 mm? -101.32 132.9 46.63 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.144 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.51 159.46 14.92 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.485 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.19 115.23 29.92 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.416 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.489 HD12 ' N ' ' A' ' 226' ' ' LEU . 9.1 mp -53.25 156.79 3.66 Favored Pre-proline 0 N--CA 1.447 -0.623 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.796 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -60.2 145.26 98.92 Favored 'Trans proline' 0 C--N 1.302 -1.873 0 C-N-CA 122.735 2.29 . . . . 0.0 112.145 179.09 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.42 -3.01 59.01 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.544 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.19 -40.91 5.67 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.51 ' O ' ' N ' ' A' ' 233' ' ' SER . 84.8 mt -79.23 -16.85 55.87 Favored 'General case' 0 C--O 1.218 -0.562 0 CA-C-O 121.131 0.491 . . . . 0.0 110.323 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 54.3 t-20 -40.38 -49.33 2.8 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.839 0.352 . . . . 0.0 110.733 -179.397 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -87.99 15.44 7.27 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.251 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.51 ' N ' ' O ' ' A' ' 230' ' ' LEU . 77.8 p -60.59 -35.29 75.74 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.655 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 234' ' ' GLN . . . . . 0.524 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.6 tt0 -119.03 -69.33 0.86 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.753 0.311 . . . . 0.0 110.751 179.264 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.2 m -70.0 102.62 2.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.633 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -94.08 57.76 2.44 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.361 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -144.72 -122.59 1.58 Allowed Glycine 0 N--CA 1.461 0.363 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -134.84 111.59 10.01 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.059 0.456 . . . . 0.0 110.35 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 239' ' ' ARG . . . . . 0.517 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.4 mtt180 -148.05 57.94 1.09 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.664 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -69.75 -31.98 70.26 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.521 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 241' ' ' ASP . . . . . 0.542 ' CG ' HD21 ' A' ' 143' ' ' ASN . 64.9 t0 -56.92 -47.11 81.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.255 -179.004 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 242' ' ' ILE . . . . . 0.437 ' O ' ' O ' ' A' ' 239' ' ' ARG . 17.8 tt -139.95 156.63 25.41 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.263 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.391 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.445 HG22 HD13 ' A' ' 245' ' ' LEU . 96.1 mt -106.02 106.37 20.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-O 120.971 0.415 . . . . 0.0 110.468 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 244' ' ' GLN . . . . . 0.59 ' C ' HD12 ' A' ' 245' ' ' LEU . 88.2 mt-30 -110.57 110.17 20.77 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.362 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.59 HD12 ' C ' ' A' ' 244' ' ' GLN . 9.6 mp -121.77 -168.24 1.67 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.666 179.532 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 246' ' ' GLY . . . . . 0.524 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.7 -16.93 0.05 OUTLIER Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 247' ' ' GLY . . . . . 0.67 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -60.47 156.7 30.4 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 110.829 -0.908 . . . . 0.0 110.829 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -63.57 21.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.825 0.345 . . . . 0.0 110.583 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 249' ' ' ASN . . . . . 0.67 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.8 m-20 -96.85 -6.04 36.84 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.436 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 91.5 mt -79.89 -21.65 43.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.902 179.177 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.65 -51.35 70.28 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.661 -179.506 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.7 -5.1 58.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.458 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.27 -74.06 1.16 Allowed Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 80.1 mt -70.02 125.95 28.24 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.883 0.373 . . . . 0.0 110.334 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -59.53 -39.48 84.07 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.254 -179.564 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 83.27 51.77 4.02 Favored Glycine 0 CA--C 1.52 0.368 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -95.3 -15.76 22.9 Favored 'General case' 0 C--N 1.33 -0.243 0 O-C-N 122.77 -0.253 . . . . 0.0 110.661 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 258' ' ' SER . . . . . 0.496 ' OG ' HG23 ' A' ' 191' ' ' VAL . 3.4 t 174.87 89.31 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.227 0.537 . . . . 0.0 110.244 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.849 HD12 ' N ' ' A' ' 259' ' ' LEU . 0.9 OUTLIER -94.8 124.31 38.77 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.052 0.453 . . . . 0.0 111.052 -178.78 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 260' ' ' PHE . . . . . 0.448 ' H ' ' HA ' ' A' ' 193' ' ' ALA . 15.8 m-30 -93.58 146.4 23.84 Favored 'General case' 0 CA--C 1.495 -1.142 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.494 179.273 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 85.9 mt -122.18 149.24 43.91 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.564 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.74 ' CD1' HG13 ' A' ' 195' ' ' VAL . 2.6 p90 -77.23 -138.82 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.534 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 263' ' ' ALA . . . . . 0.652 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -51.39 77.03 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.407 0 O-C-N 123.415 0.447 . . . . 0.0 111.171 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 264' ' ' GLY . . . . . 0.625 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.16 104.74 0.19 Allowed Glycine 0 CA--C 1.528 0.87 0 N-CA-C 110.421 -1.072 . . . . 0.0 110.421 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 265' ' ' ASP . . . . . 0.589 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.4 m-20 -80.21 -177.9 6.32 Favored 'General case' 0 C--N 1.327 -0.394 0 O-C-N 122.671 -0.311 . . . . 0.0 110.847 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -40.7 -17.76 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.549 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 267' ' ' LYS . . . . . 0.589 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.21 -51.44 45.48 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.614 179.22 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -63.9 -46.39 85.05 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.997 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 269' ' ' ALA . . . . . 0.566 ' HB1' ' OH ' ' A' ' 273' ' ' TYR . . . -61.88 -34.92 76.9 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.657 0.741 . . . . 0.0 109.824 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -62.82 -34.66 77.77 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.292 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.43 -43.11 13.9 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.049 -179.316 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 272' ' ' ILE . . . . . 0.595 ' C ' ' H ' ' A' ' 274' ' ' ALA . 4.9 tt -51.53 -33.71 14.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.678 -178.732 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 273' ' ' TYR . . . . . 0.566 ' OH ' ' HB1' ' A' ' 269' ' ' ALA . 17.2 m-85 -54.71 -1.55 0.03 OUTLIER 'General case' 0 CA--C 1.513 -0.452 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.616 -179.271 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 274' ' ' ALA . . . . . 0.595 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.61 -39.78 70.24 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.802 179.408 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 275' ' ' ASN . . . . . 0.573 ' O ' ' N ' ' A' ' 279' ' ' ALA . 2.6 p30 -38.98 97.9 0.15 Allowed Pre-proline 0 N--CA 1.462 0.151 0 O-C-N 123.49 0.494 . . . . 0.0 110.33 -179.592 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -54.18 -42.92 63.12 Favored 'Trans proline' 0 C--N 1.303 -1.845 0 C-N-CA 122.58 2.187 . . . . 0.0 112.491 -178.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 88.5 mt -64.41 -43.02 95.69 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.015 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 91.5 mt -95.66 -1.45 50.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.863 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 279' ' ' ALA . . . . . 0.573 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.58 -34.87 77.84 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.486 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.32 20.14 0.12 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.9 -179.156 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 0.483 ' H ' ' C ' ' A' ' 279' ' ' ALA . 13.8 mt -74.65 119.53 77.1 Favored Pre-proline 0 N--CA 1.442 -0.838 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.849 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -50.57 -39.71 55.47 Favored 'Trans proline' 0 C--N 1.312 -1.36 0 C-N-CA 122.535 2.156 . . . . 0.0 112.063 178.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.73 -50.69 62.92 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.874 0.369 . . . . 0.0 110.021 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 76.9 t -61.4 -43.77 97.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.162 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -57.81 -41.2 81.71 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.089 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -91.0 0.63 57.5 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.245 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt 59.16 43.63 16.94 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.966 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -95.1 41.22 1.1 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.314 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 53.9 t -118.9 135.68 58.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-O 121.119 0.485 . . . . 0.0 109.967 -179.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -132.81 162.73 30.75 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.534 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.54 155.12 32.79 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.523 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 81.0 mt -94.09 -1.73 53.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.256 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.14 165.59 12.71 Favored Glycine 0 N--CA 1.465 0.613 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 6.8 m -87.33 -62.34 1.52 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.879 0.371 . . . . 0.0 110.947 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 295' ' ' GLU . . . . . 0.446 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.6 mm-40 -69.02 -4.07 15.48 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.755 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 24.5 p -76.92 32.32 0.14 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.68 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 297' ' ' PHE . . . . . 0.511 ' CD2' HG22 ' A' ' 70' ' ' THR . 70.8 t80 -60.43 -45.97 91.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.624 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 298' ' ' ARG . . . . . 0.615 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.1 mtt85 -81.27 134.85 35.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.543 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.454 ' H ' HG11 ' A' ' 51' ' ' VAL . 17.7 tp -113.68 117.22 30.95 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-O 120.918 0.39 . . . . 0.0 110.391 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 300' ' ' ASP . . . . . 0.639 ' H ' ' CB ' ' A' ' 303' ' ' SER . 49.9 p-10 -165.3 -176.47 4.06 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.758 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 80.2 t80 -46.81 -43.49 18.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.391 -179.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -66.92 -40.35 87.61 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 121.037 0.446 . . . . 0.0 110.723 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 303' ' ' SER . . . . . 0.639 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 60.1 p -55.99 -36.37 67.81 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.062 -179.054 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 304' ' ' ALA . . . . . 0.546 ' HB2' ' SD ' ' A' ' 215' ' ' MET . . . -57.11 -51.8 67.85 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 179.421 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 92.2 mtp -55.48 -44.45 76.52 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -65.86 -42.66 90.15 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.309 0.576 . . . . 0.0 110.398 179.228 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 307' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 303' ' ' SER . 55.6 t -63.96 -42.92 97.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.253 179.307 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 44.0 tp -59.73 -41.93 92.02 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.029 -179.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -62.87 -38.69 91.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.069 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 310' ' ' ARG . . . . . 0.446 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.7 ttt85 -63.42 -43.84 96.34 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.295 179.512 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 90.2 mt -63.1 -42.1 99.52 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.489 179.635 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -63.01 -33.36 75.25 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.304 179.293 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.48 -23.54 22.06 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.285 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.481 HD22 ' CE2' ' A' ' 315' ' ' PHE . 6.7 tt -62.31 -43.19 99.4 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 121.012 0.434 . . . . 0.0 110.526 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 315' ' ' PHE . . . . . 0.481 ' CE2' HD22 ' A' ' 314' ' ' LEU . 89.4 m-85 . . . . . 0 C--O 1.22 -0.461 0 CA-C-O 118.041 -0.98 . . . . 0.0 110.263 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -99.73 135.85 40.54 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.167 0.508 . . . . 0.0 110.403 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.492 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -92.33 178.62 1.61 Allowed Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.533 -179.797 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.492 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.0 Cg_exo -61.68 147.29 95.68 Favored 'Trans proline' 0 C--N 1.298 -2.104 0 C-N-CA 122.893 2.396 . . . . 0.0 112.164 179.547 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.498 ' HE ' HD12 ' A' ' 39' ' ' LEU . 35.3 ptt180 -136.91 142.59 42.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.636 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -79.52 117.06 20.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.459 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.443 ' O ' HG23 ' A' ' 30' ' ' ILE . 9.5 tp -111.5 130.74 64.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.468 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.6 t -71.55 142.41 50.07 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.677 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.481 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.6 t0 -139.54 -179.81 6.12 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.502 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.481 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 77.9 p -73.83 -37.34 64.87 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.655 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.8 ttt85 -46.97 -94.77 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.335 -179.198 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -165.9 -27.02 0.02 OUTLIER Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 63.4 m -168.67 105.98 0.44 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.834 0.35 . . . . 0.0 110.643 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.638 ' CD2' HD13 ' A' ' 140' ' ' LEU . 64.4 t60 -129.11 146.15 51.12 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 121.11 0.481 . . . . 0.0 110.112 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.62 HG22 ' N ' ' A' ' 39' ' ' LEU . 93.3 m -129.36 165.59 21.21 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.4 -179.684 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.62 ' N ' HG22 ' A' ' 38' ' ' THR . 79.6 mt -120.26 127.23 52.21 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.537 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -65.39 -44.78 86.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.698 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 39.0 p -165.83 155.28 12.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.374 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.483 ' CD ' ' H ' ' A' ' 42' ' ' GLN . 14.5 mp0 -45.2 101.26 0.25 Allowed Pre-proline 0 C--O 1.235 0.325 0 O-C-N 123.6 0.562 . . . . 0.0 110.558 179.227 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -57.77 130.34 38.04 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 C-N-CA 122.326 2.018 . . . . 0.0 112.315 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -82.76 -24.9 33.28 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.601 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.531 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.7 mtm-85 -120.86 134.98 55.29 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.225 0.536 . . . . 0.0 110.135 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.1 mt -130.26 133.48 63.98 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.345 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.818 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 45.7 t -125.24 130.87 72.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 CA-C-O 120.967 0.413 . . . . 0.0 109.924 179.247 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.61 ' OG ' HD12 ' A' ' 117' ' ' LEU . 4.7 m -154.87 166.48 33.38 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.527 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 72.8 p -124.49 8.88 8.38 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.313 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.68 125.69 33.37 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.857 0.36 . . . . 0.0 110.635 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.465 HG11 ' H ' ' A' ' 299' ' ' LEU . 85.5 t -65.71 -44.44 93.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.553 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.8 m -62.7 -44.34 96.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.63 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 53.8 tp -62.46 -41.41 98.73 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.613 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.447 ' O ' HD13 ' A' ' 58' ' ' LEU . 74.3 m -57.89 -44.6 86.84 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.269 -179.309 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.27 -62.12 5.42 Favored Glycine 0 N--CA 1.468 0.788 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.6 t -48.24 -35.6 12.31 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 20.1 mt -61.85 -44.02 97.67 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 120.594 -0.442 . . . . 0.0 111.383 179.216 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.447 HD13 ' O ' ' A' ' 54' ' ' THR . 9.3 mp -65.43 -41.34 93.63 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.404 177.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.82 -41.27 97.9 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.914 -179.332 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.415 ' O ' HG23 ' A' ' 60' ' ' ILE . 7.9 tp -87.66 16.55 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.918 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 56.44 84.42 0.09 Allowed 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.841 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.25 58.91 0.08 OUTLIER Pre-proline 0 C--N 1.327 -0.389 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -51.6 152.78 11.97 Favored 'Trans proline' 0 C--N 1.292 -2.437 0 C-N-CA 123.074 2.516 . . . . 0.0 112.053 -178.3 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.431 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -108.78 145.86 15.15 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.152 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.262 -179.646 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.61 -45.3 97.93 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.471 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.504 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -129.83 134.29 47.45 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.47 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.494 ' O ' ' N ' ' A' ' 98' ' ' LEU . 72.1 m -134.38 158.54 43.58 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.895 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.42 139.01 16.31 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.486 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.61 -162.98 0.09 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.953 0.406 . . . . 0.0 110.437 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.5 HG22 ' CD2' ' A' ' 297' ' ' PHE . 5.7 t -133.91 135.83 43.88 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.015 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.473 ' C ' ' O ' ' A' ' 70' ' ' THR . 1.0 OUTLIER 29.68 68.23 0.68 Allowed Pre-proline 0 N--CA 1.468 0.438 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.78 -179.68 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_exo -61.32 145.11 98.7 Favored 'Trans proline' 0 C--N 1.299 -2.072 0 C-N-CA 122.644 2.23 . . . . 0.0 111.762 -177.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.527 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 45.5 p-10 -160.15 -32.02 0.06 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.746 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.528 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 99.1 m-20 -64.29 -39.31 93.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.326 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -60.5 -47.88 84.21 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.509 -179.015 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.423 ' O ' ' O ' ' A' ' 77' ' ' ALA . 94.3 t -60.48 -24.46 31.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.528 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -45.73 173.03 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.602 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.567 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.6 p30 -61.92 177.59 0.43 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.58 -179.683 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.562 ' C ' ' H ' ' A' ' 81' ' ' GLY . 36.2 p30 -45.73 85.57 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.031 0.443 . . . . 0.0 111.069 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.567 ' N ' ' O ' ' A' ' 78' ' ' ASP . 42.4 tp60 -67.4 13.36 0.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.297 0.57 . . . . 0.0 110.172 -179.645 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.562 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 118.06 -22.53 9.71 Favored Glycine 0 C--N 1.333 0.372 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -107.82 116.04 31.24 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.056 0.455 . . . . 0.0 110.461 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 77.7 mt -98.47 0.67 45.62 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.991 0.424 . . . . 0.0 110.553 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -92.08 6.84 44.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.058 0.456 . . . . 0.0 110.387 -179.584 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.783 ' O ' HG22 ' A' ' 89' ' ' VAL . 27.3 mt-30 -100.02 -26.99 13.79 Favored 'General case' 0 C--O 1.22 -0.467 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.821 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.4 t-105 -63.8 -40.66 97.18 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.09 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.546 ' O ' ' N ' ' A' ' 91' ' ' LYS . 69.4 m -77.55 -53.27 7.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.134 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -48.9 -50.8 33.35 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.138 -179.053 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.783 HG22 ' O ' ' A' ' 85' ' ' GLN . 15.3 m -68.75 -40.62 81.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.232 179.397 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.494 ' N ' HG23 ' A' ' 89' ' ' VAL . . . -72.26 -23.07 61.15 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.678 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.546 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.0 tttm -61.32 -45.93 92.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.369 -179.374 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.439 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.8 mm-40 -90.5 -94.52 0.12 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.066 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.617 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.9 mtt180 -143.56 60.0 1.39 Allowed 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.442 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.7 pttp 34.22 25.86 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.105 0.478 . . . . 0.0 110.339 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.617 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.4 tt -48.25 123.01 5.83 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.064 -177.744 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.451 ' O ' HD23 ' A' ' 95' ' ' LEU . 98.9 mm-40 -83.08 -170.62 3.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.059 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.62 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 83.0 mtp180 -73.32 137.85 45.04 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.128 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.494 ' N ' ' O ' ' A' ' 67' ' ' SER . 90.5 mt -86.65 -165.79 1.37 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.886 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.532 ' O ' ' CD2' ' A' ' 99' ' ' TYR . 47.5 p90 -168.84 119.98 0.75 Allowed 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.154 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.492 ' C ' ' O ' ' A' ' 99' ' ' TYR . 43.9 mm -29.22 121.06 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 O-C-N 123.308 0.38 . . . . 0.0 111.125 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 114.15 27.76 3.31 Favored Glycine 0 N--CA 1.461 0.341 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 -179.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.582 ' N ' ' CD ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -143.93 45.82 0.6 Allowed Pre-proline 0 C--N 1.321 -0.649 0 CA-C-O 121.079 0.466 . . . . 0.0 110.391 179.716 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.582 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 29.6 Cg_endo -62.42 144.16 94.51 Favored 'Trans proline' 0 C--N 1.294 -2.342 0 C-N-CA 122.687 2.258 . . . . 0.0 111.727 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.456 ' O ' HG23 ' A' ' 108' ' ' VAL . 24.8 t -173.36 121.04 0.35 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.377 179.546 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.29 -40.92 64.16 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.989 0.423 . . . . 0.0 111.125 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -65.91 -39.85 90.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.865 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.94 -39.64 94.63 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.754 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 104' ' ' SER . 70.0 t -67.52 -43.71 87.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.681 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.49 -39.28 92.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.474 -179.055 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.439 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.94 -23.83 63.87 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.476 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.537 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.3 mm-40 -91.18 5.04 50.65 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.667 -179.544 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.537 ' C ' ' O ' ' A' ' 111' ' ' GLN . 10.2 tpt 21.54 64.95 0.3 Allowed Pre-proline 0 N--CA 1.469 0.516 0 CA-C-O 120.961 0.41 . . . . 0.0 111.337 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.461 ' HG2' HD11 ' A' ' 116' ' ' ILE . 61.6 Cg_endo -80.01 169.9 17.22 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 123.094 2.53 . . . . 0.0 111.517 -177.605 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.519 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 99.2 m-20 -112.34 -45.1 3.3 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.973 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 39.4 tp -119.51 121.23 38.94 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.461 HD11 ' HG2' ' A' ' 113' ' ' PRO . 96.7 mt -118.45 131.41 71.3 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.432 0 CA-C-O 120.953 0.406 . . . . 0.0 111.013 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.61 HD12 ' OG ' ' A' ' 48' ' ' SER . 32.4 mt -106.04 132.24 52.35 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 121.086 0.47 . . . . 0.0 110.156 -179.469 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.495 HD12 HG23 ' A' ' 139' ' ' THR . 98.6 mt -117.75 135.75 57.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.628 -179.521 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 85.3 p -71.17 151.32 44.51 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.62 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.42 -49.98 75.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.642 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.0 t -149.19 153.71 38.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.539 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 168.19 -169.68 41.6 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.93 -35.7 92.42 Favored Glycine 0 CA--C 1.522 0.513 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.445 ' OD1' ' O ' ' A' ' 124' ' ' ASP . 44.2 p-10 -88.2 120.18 29.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.867 0.365 . . . . 0.0 110.696 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.439 ' O ' HD12 ' A' ' 129' ' ' LEU . 41.3 t -63.6 143.78 57.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.363 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.515 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.67 -42.82 8.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.863 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.4 tp -62.78 -42.45 99.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.674 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.76 -10.43 52.58 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.382 -179.3 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.439 HD12 ' O ' ' A' ' 125' ' ' SER . 83.4 mt -116.23 -24.0 8.17 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.65 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' TYR . . . . . 0.525 ' CD1' HG21 ' A' ' 139' ' ' THR . 72.6 t80 -51.79 -49.08 63.42 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.639 -178.804 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 39.0 p-10 -65.96 -41.56 91.07 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.324 179.203 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.525 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 87.9 mt-30 -68.14 -36.68 80.08 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.874 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.457 HD12 HD11 ' A' ' 118' ' ' ILE . 96.3 mt -79.89 -42.67 23.69 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.017 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.402 ' N ' ' OG1' ' A' ' 139' ' ' THR . 11.3 t -57.37 -45.07 84.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.343 -179.018 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 20.0 m -62.36 -45.88 91.17 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.566 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 93.0 mt -62.28 -43.71 98.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.349 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.598 ' HB1' ' HD2' ' A' ' 138' ' ' PRO . . . -170.1 163.32 6.38 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.559 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.598 ' HD2' ' HB1' ' A' ' 137' ' ' ALA . 78.3 Cg_exo -41.69 110.37 0.14 Allowed 'Trans proline' 0 C--N 1.311 -1.428 0 C-N-CA 122.486 2.124 . . . . 0.0 112.344 179.092 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.525 HG21 ' CD1' ' A' ' 130' ' ' TYR . 3.0 m -87.37 127.46 35.2 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.542 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.638 HD13 ' CD2' ' A' ' 37' ' ' HIS . 34.3 tp -119.29 139.24 52.24 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.259 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.428 ' O ' ' OD2' ' A' ' 32' ' ' ASP . 81.3 mt -105.32 120.1 55.49 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.352 0 CA-C-O 121.132 0.491 . . . . 0.0 111.196 -179.59 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.48 HD12 HD22 ' A' ' 117' ' ' LEU . 97.4 mt -135.69 132.75 51.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.585 179.59 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.55 HD21 ' CG ' ' A' ' 241' ' ' ASP . 59.3 t30 -64.62 148.22 51.35 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.933 0.397 . . . . 0.0 110.38 179.264 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.515 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 87.6 t80 -82.74 122.72 28.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.973 -179.564 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.515 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 99.0 m-20 55.11 69.12 0.77 Allowed 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.784 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 34.5 p-10 -125.7 0.31 7.45 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.856 0.36 . . . . 0.0 110.636 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -150.42 115.51 5.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.691 -179.473 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 85.0 p -63.49 168.94 4.16 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.538 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.414 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.5 p-90 -51.84 -16.08 0.63 Allowed 'General case' 0 C--O 1.219 -0.505 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.326 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.436 ' O ' HG23 ' A' ' 154' ' ' THR . 67.9 tp60 -70.11 -76.05 0.11 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.891 0.377 . . . . 0.0 110.542 -179.689 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.433 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.1 t -62.48 -38.66 90.7 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.253 179.509 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 52.1 tp -60.16 -45.61 92.48 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.354 -178.29 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.414 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 45.8 tp -62.6 -41.76 99.16 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.55 178.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.436 HG23 ' O ' ' A' ' 150' ' ' GLN . 58.7 p -63.86 -34.94 79.06 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.098 -179.229 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.467 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 88.0 mm-40 -63.66 -42.03 98.13 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.23 179.291 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 91.6 mt -65.34 -38.82 91.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.192 0.52 . . . . 0.0 110.243 179.128 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.566 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.34 -32.3 80.38 Favored Glycine 0 C--N 1.332 0.316 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 -179.197 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.467 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.4 mt-10 -36.79 -25.19 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.901 0.381 . . . . 0.0 110.862 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.566 ' N ' ' O ' ' A' ' 157' ' ' GLY . 94.9 mt -59.22 148.43 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.292 179.031 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 74.6 p -69.09 137.63 53.66 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.994 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 70.48 22.14 77.72 Favored Glycine 0 N--CA 1.458 0.136 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 179.517 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 59.9 m80 -124.48 -13.96 6.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.597 0.237 . . . . 0.0 110.426 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -66.81 -59.49 3.5 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.593 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -51.92 -48.89 63.99 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.153 -179.445 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -60.55 -41.09 93.83 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.806 0.336 . . . . 0.0 110.405 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.68 -47.43 85.34 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.534 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.63 -40.27 75.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.225 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -61.58 -50.44 72.59 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.672 179.511 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -65.25 -43.66 90.66 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.586 179.472 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 94.4 mt -64.63 -43.33 96.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.441 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.4 -51.12 70.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.313 -179.074 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.63 -43.41 96.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.851 0.357 . . . . 0.0 110.635 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.662 ' CE2' HD11 ' A' ' 177' ' ' LEU . 57.7 t80 -62.94 -44.25 96.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.402 179.466 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -63.69 -39.65 94.86 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.477 -179.212 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -63.18 -42.82 99.42 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.564 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -60.63 -44.45 96.33 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.175 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.662 HD11 ' CE2' ' A' ' 173' ' ' PHE . 84.8 mt -64.44 -41.12 96.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.78 178.789 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.34 -62.14 1.83 Allowed 'General case' 0 C--O 1.24 0.553 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.281 -179.203 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.23 -47.23 84.16 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.432 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -52.73 -41.72 64.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.353 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -63.74 -33.59 75.99 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.055 0.455 . . . . 0.0 110.284 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.41 ' O ' ' HG2' ' A' ' 182' ' ' GLU . 69.8 tt0 -91.08 8.52 35.08 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.666 0.746 . . . . 0.0 110.318 -178.729 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -104.33 -32.45 9.06 Favored 'General case' 0 CA--C 1.516 -0.361 0 O-C-N 122.001 -0.437 . . . . 0.0 111.222 179.395 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.7 pt -127.9 147.57 32.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.801 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -139.78 131.26 26.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.966 0.412 . . . . 0.0 110.395 179.099 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.59 HD22 ' N ' ' A' ' 186' ' ' LEU . 3.5 mm? -85.34 133.59 42.16 Favored Pre-proline 0 N--CA 1.449 -0.516 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.193 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -43.65 157.76 0.12 Allowed 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.617 2.212 . . . . 0.0 112.372 179.376 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 0.497 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.7 Cg_endo -63.04 114.69 2.55 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 122.817 2.344 . . . . 0.0 111.664 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 189' ' ' GLN . . . . . 0.497 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.7 mt-30 155.65 148.17 0.0 OUTLIER Pre-proline 0 N--CA 1.456 -0.159 0 O-C-N 124.244 0.965 . . . . 0.0 110.885 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -73.26 144.26 36.77 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.583 2.189 . . . . 0.0 112.289 177.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.496 HG23 ' OG ' ' A' ' 258' ' ' SER . 2.1 p -124.61 158.87 31.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.461 0.648 . . . . 0.0 110.197 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 192' ' ' THR . . . . . 0.487 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 36.6 p -143.18 165.39 27.57 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.112 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 193' ' ' ALA . . . . . 0.448 ' HA ' ' H ' ' A' ' 260' ' ' PHE . . . -135.44 128.88 32.32 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-O 121.339 0.59 . . . . 0.0 110.209 179.232 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.509 HD11 HD23 ' A' ' 259' ' ' LEU . 47.7 pt -146.73 149.38 15.92 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.404 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.21 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 195' ' ' VAL . . . . . 0.736 HG13 ' CD1' ' A' ' 262' ' ' PHE . 69.4 t -117.87 123.41 71.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.402 0.62 . . . . 0.0 109.792 179.002 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -134.34 106.75 7.25 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 121.104 0.478 . . . . 0.0 110.208 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 94.7 m -130.7 130.44 43.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.943 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.413 ' O ' ' N ' ' A' ' 201' ' ' HIS . . . -82.8 -37.18 24.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.25 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.21 -66.92 0.27 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.288 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.47 -9.54 58.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.273 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' HIS . . . . . 0.413 ' N ' ' O ' ' A' ' 198' ' ' ALA . 60.1 t-80 60.32 58.27 2.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.81 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 39.5 p -167.02 153.79 8.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.568 179.348 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.36 144.19 24.45 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.054 0.454 . . . . 0.0 110.454 179.148 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -135.29 138.09 43.13 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.605 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 19.4 mt -106.04 125.44 51.0 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.055 0.455 . . . . 0.0 109.796 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 206' ' ' TRP . . . . . 0.555 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 74.5 m95 -82.15 167.14 19.03 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.587 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 207' ' ' THR . . . . . 0.46 HG22 ' C ' ' A' ' 206' ' ' TRP . 0.1 OUTLIER -157.45 171.32 7.59 Favored Pre-proline 0 C--O 1.224 -0.268 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.624 -178.909 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -53.18 -37.12 79.69 Favored 'Trans proline' 0 C--N 1.301 -1.965 0 C-N-CA 122.583 2.189 . . . . 0.0 112.448 178.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -70.84 -35.23 72.34 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.71 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 21.0 m -60.95 151.0 31.53 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.572 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.8 -36.96 82.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.485 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 212' ' ' GLN . . . . . 0.555 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 55.1 tt0 -64.69 -40.27 95.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.519 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.63 -43.58 91.71 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.631 -0.988 . . . . 0.0 110.631 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -62.88 -44.0 97.27 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.789 0.328 . . . . 0.0 110.219 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 215' ' ' MET . . . . . 0.551 ' SD ' ' HB2' ' A' ' 304' ' ' ALA . 65.1 ttp -59.32 -47.91 83.63 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.071 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 87.0 mt -60.73 -41.16 94.76 Favored 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 217' ' ' GLU . . . . . 0.449 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.6 tp10 -58.03 -37.89 75.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.35 -0.386 . . . . 0.0 109.994 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -65.38 -38.31 89.63 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.671 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 95.2 mt -63.91 -42.9 97.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.111 0.482 . . . . 0.0 110.613 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.56 44.93 0.08 OUTLIER Glycine 0 C--N 1.332 0.359 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 221' ' ' PHE . . . . . 0.449 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 26.6 m-85 -127.89 155.49 44.09 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 121.054 0.454 . . . . 0.0 110.439 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.481 ' O ' HG13 ' A' ' 191' ' ' VAL . 7.0 p -106.96 122.34 46.24 Favored 'General case' 0 C--O 1.223 -0.294 0 CA-C-O 121.331 0.586 . . . . 0.0 110.067 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.474 HD22 ' C ' ' A' ' 222' ' ' THR . 4.3 mm? -101.4 133.01 46.68 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.229 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.8 159.8 14.72 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.456 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.52 115.35 30.1 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.935 0.398 . . . . 0.0 110.339 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.498 HD12 ' N ' ' A' ' 226' ' ' LEU . 8.9 mp -53.08 156.54 3.57 Favored Pre-proline 0 N--CA 1.448 -0.559 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.817 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -59.91 145.17 98.97 Favored 'Trans proline' 0 C--N 1.299 -2.03 0 C-N-CA 122.753 2.302 . . . . 0.0 112.312 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.09 -3.35 59.07 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.516 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.2 -40.96 5.66 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.506 ' O ' ' N ' ' A' ' 233' ' ' SER . 67.7 mt -79.08 -17.8 54.52 Favored 'General case' 0 C--O 1.218 -0.587 0 CA-C-O 121.212 0.529 . . . . 0.0 110.296 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 54.5 t-20 -40.74 -49.17 3.09 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.845 -179.061 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -87.16 15.05 6.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.459 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.506 ' N ' ' O ' ' A' ' 230' ' ' LEU . 77.9 p -60.56 -34.99 74.98 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.683 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 234' ' ' GLN . . . . . 0.525 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.5 tt0 -119.73 -69.3 0.85 Allowed 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.835 179.171 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.3 m -69.3 102.19 1.68 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.022 0.439 . . . . 0.0 110.687 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -94.08 57.51 2.4 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.086 0.47 . . . . 0.0 110.365 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -144.61 -122.43 1.58 Allowed Glycine 0 C--N 1.332 0.343 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -135.64 111.78 9.67 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.161 0.505 . . . . 0.0 110.347 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 239' ' ' ARG . . . . . 0.524 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.5 mtt180 -148.08 58.26 1.09 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.707 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -69.36 -32.48 71.57 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.457 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 241' ' ' ASP . . . . . 0.55 ' CG ' HD21 ' A' ' 143' ' ' ASN . 64.7 t0 -57.04 -47.24 81.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.211 -178.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 242' ' ' ILE . . . . . 0.435 ' O ' ' O ' ' A' ' 239' ' ' ARG . 18.1 tt -139.62 155.87 25.69 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.275 0 CA-C-O 120.913 0.387 . . . . 0.0 110.44 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.445 HG22 HD13 ' A' ' 245' ' ' LEU . 96.3 mt -106.17 106.87 21.39 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 CA-C-O 121.099 0.476 . . . . 0.0 110.479 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 244' ' ' GLN . . . . . 0.595 ' O ' HD12 ' A' ' 245' ' ' LEU . 88.3 mt-30 -110.71 110.04 20.54 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.261 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.595 HD12 ' O ' ' A' ' 244' ' ' GLN . 9.5 mp -121.51 -168.2 1.65 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.766 179.497 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 246' ' ' GLY . . . . . 0.525 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 174.14 -16.54 0.05 OUTLIER Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 247' ' ' GLY . . . . . 0.67 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -61.24 156.23 34.37 Favored Glycine 0 CA--C 1.521 0.449 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -63.4 21.94 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.995 0.426 . . . . 0.0 110.647 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 249' ' ' ASN . . . . . 0.67 ' H ' ' C ' ' A' ' 247' ' ' GLY . 99.0 m-20 -97.2 -6.27 35.13 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.438 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 91.0 mt -79.65 -22.0 44.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.775 179.292 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.68 -51.43 69.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.712 -179.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.21 -5.53 58.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.47 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.08 -74.24 1.15 Allowed Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.776 -0.929 . . . . 0.0 110.776 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 83.0 mt -70.25 126.43 29.64 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.218 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -59.67 -39.44 84.47 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.081 -179.445 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 83.16 51.62 4.1 Favored Glycine 0 CA--C 1.519 0.29 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -95.9 -14.96 22.73 Favored 'General case' 0 C--N 1.331 -0.204 0 O-C-N 122.65 -0.323 . . . . 0.0 110.598 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 258' ' ' SER . . . . . 0.496 ' OG ' HG23 ' A' ' 191' ' ' VAL . 3.4 t 174.73 88.85 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.24 0.543 . . . . 0.0 110.072 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.853 HD12 ' N ' ' A' ' 259' ' ' LEU . 1.0 OUTLIER -94.61 124.28 38.55 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.254 0.549 . . . . 0.0 111.267 -179.143 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 260' ' ' PHE . . . . . 0.448 ' H ' ' HA ' ' A' ' 193' ' ' ALA . 15.7 m-30 -93.37 146.39 23.77 Favored 'General case' 0 CA--C 1.495 -1.171 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.474 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 86.1 mt -122.33 149.25 44.02 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.545 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.736 ' CD1' HG13 ' A' ' 195' ' ' VAL . 2.5 p90 -77.26 -138.77 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.578 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 263' ' ' ALA . . . . . 0.655 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -51.46 76.97 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 121.091 0.472 . . . . 0.0 111.299 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 264' ' ' GLY . . . . . 0.626 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.15 104.67 0.19 Allowed Glycine 0 CA--C 1.528 0.895 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 -179.716 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 265' ' ' ASP . . . . . 0.592 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.5 m-20 -80.31 -177.98 6.4 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 122.719 -0.283 . . . . 0.0 110.972 -179.746 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -40.3 -17.87 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.566 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 267' ' ' LYS . . . . . 0.592 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -67.94 -51.74 44.1 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.759 179.1 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -63.65 -46.47 85.48 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.216 179.43 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 269' ' ' ALA . . . . . 0.568 ' HB1' ' OH ' ' A' ' 273' ' ' TYR . . . -61.93 -34.99 77.08 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 121.539 0.685 . . . . 0.0 109.658 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -63.2 -34.46 77.69 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.158 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.49 -42.96 13.98 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.081 -179.428 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 272' ' ' ILE . . . . . 0.591 ' C ' ' H ' ' A' ' 274' ' ' ALA . 4.9 tt -51.44 -33.78 14.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.728 -178.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 273' ' ' TYR . . . . . 0.568 ' OH ' ' HB1' ' A' ' 269' ' ' ALA . 17.2 m-85 -54.64 -1.85 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.573 -179.327 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 274' ' ' ALA . . . . . 0.591 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.45 -39.9 70.7 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.952 179.381 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 275' ' ' ASN . . . . . 0.577 ' O ' ' N ' ' A' ' 279' ' ' ALA . 3.1 p30 -38.8 97.81 0.15 Allowed Pre-proline 0 N--CA 1.462 0.164 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.366 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -54.57 -42.62 66.47 Favored 'Trans proline' 0 C--N 1.303 -1.864 0 C-N-CA 122.428 2.086 . . . . 0.0 112.535 -178.634 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 89.5 mt -64.4 -42.87 95.87 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.058 0.456 . . . . 0.0 111.218 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 90.9 mt -95.7 -1.58 49.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.967 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 279' ' ' ALA . . . . . 0.577 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.3 -34.8 77.29 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.744 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.18 20.03 0.11 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.012 -179.315 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 0.481 ' H ' ' C ' ' A' ' 279' ' ' ALA . 13.8 mt -74.93 119.51 77.2 Favored Pre-proline 0 N--CA 1.445 -0.69 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.801 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -49.96 -39.96 49.56 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.593 2.195 . . . . 0.0 112.279 178.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.72 -50.52 63.24 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.038 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 75.9 t -61.42 -43.96 97.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -57.71 -41.18 81.23 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.039 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -91.17 0.24 57.57 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.133 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt 59.36 43.53 16.48 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.04 0.447 . . . . 0.0 110.906 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -94.75 41.37 1.09 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.31 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 54.3 t -119.31 135.55 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-O 121.129 0.49 . . . . 0.0 109.995 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -132.64 162.98 29.97 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.209 0.528 . . . . 0.0 110.613 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.63 155.4 32.39 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-O 121.073 0.463 . . . . 0.0 110.632 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 82.8 mt -94.35 -1.52 53.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.256 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 120.83 165.32 12.69 Favored Glycine 0 C--N 1.335 0.497 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 7.3 m -86.98 -62.38 1.52 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.864 0.364 . . . . 0.0 111.154 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 295' ' ' GLU . . . . . 0.445 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.7 mm-40 -68.79 -3.97 14.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.738 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 25.0 p -77.08 32.04 0.14 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.651 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 297' ' ' PHE . . . . . 0.5 ' CD2' HG22 ' A' ' 70' ' ' THR . 68.7 t80 -60.4 -46.18 90.93 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.629 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 298' ' ' ARG . . . . . 0.62 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.1 mtt85 -80.61 134.81 35.95 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.577 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.465 ' H ' HG11 ' A' ' 51' ' ' VAL . 18.2 tp -113.87 117.01 30.23 Favored 'General case' 0 C--O 1.23 0.075 0 CA-C-O 121.02 0.438 . . . . 0.0 110.203 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 300' ' ' ASP . . . . . 0.621 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.5 p-10 -165.03 -176.71 4.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.651 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -46.95 -42.99 18.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.356 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -67.19 -40.14 86.48 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 121.065 0.46 . . . . 0.0 110.746 178.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 303' ' ' SER . . . . . 0.621 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 59.9 p -56.3 -36.35 68.55 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.975 -179.038 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 304' ' ' ALA . . . . . 0.551 ' HB2' ' SD ' ' A' ' 215' ' ' MET . . . -57.04 -52.15 66.43 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.453 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 91.7 mtp -55.78 -43.66 77.01 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -66.22 -42.59 88.48 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.241 0.543 . . . . 0.0 110.239 179.111 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 307' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 303' ' ' SER . 55.5 t -64.04 -42.95 97.29 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.188 179.359 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 42.6 tp -60.05 -42.05 93.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.82 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -62.42 -39.34 92.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.028 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 310' ' ' ARG . . . . . 0.446 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.5 ttt85 -63.49 -44.0 95.64 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.153 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 89.8 mt -63.18 -42.11 99.31 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.103 0.478 . . . . 0.0 110.36 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt -63.16 -33.35 75.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.12 179.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.56 -23.72 21.92 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.329 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.485 HD22 ' CE2' ' A' ' 315' ' ' PHE . 6.7 tt -62.35 -43.17 99.46 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 121.075 0.464 . . . . 0.0 110.521 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 315' ' ' PHE . . . . . 0.485 ' CE2' HD22 ' A' ' 314' ' ' LEU . 90.0 m-85 . . . . . 0 C--O 1.22 -0.463 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.346 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -99.55 135.98 40.17 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.119 0.485 . . . . 0.0 110.475 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.49 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -92.16 178.55 1.66 Allowed Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.589 -179.893 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.49 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.7 Cg_exo -61.44 147.15 96.2 Favored 'Trans proline' 0 C--N 1.299 -2.046 0 C-N-CA 122.848 2.365 . . . . 0.0 112.208 179.558 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.468 ' HE ' HD12 ' A' ' 39' ' ' LEU . 35.7 ptt180 -136.12 142.36 44.24 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.585 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -79.54 116.6 19.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.521 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.443 ' O ' HG23 ' A' ' 30' ' ' ILE . 9.5 tp -111.1 130.66 64.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.564 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 13.7 t -70.79 142.25 51.34 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.987 0.422 . . . . 0.0 110.676 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.477 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.3 t0 -139.8 179.39 6.62 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.458 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.477 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 77.9 p -73.83 -37.05 64.97 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.562 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.8 ttt85 -46.51 -94.62 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.248 -179.396 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -167.06 -26.38 0.02 OUTLIER Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 55.6 m -169.35 104.94 0.37 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.807 0.337 . . . . 0.0 110.664 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.691 ' CD2' HD13 ' A' ' 140' ' ' LEU . 75.4 t60 -128.47 148.79 50.75 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.055 0.455 . . . . 0.0 110.231 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.625 HG22 ' N ' ' A' ' 39' ' ' LEU . 98.6 m -131.02 166.05 21.87 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.498 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.625 ' N ' HG22 ' A' ' 38' ' ' THR . 81.2 mt -120.78 127.19 51.73 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.408 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -65.08 -44.62 88.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.794 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 40.9 p -165.71 155.1 12.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.354 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.487 ' CD ' ' H ' ' A' ' 42' ' ' GLN . 14.5 mp0 -44.27 100.91 0.24 Allowed Pre-proline 0 C--O 1.235 0.326 0 O-C-N 123.526 0.516 . . . . 0.0 110.594 179.202 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.54 129.6 34.66 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 C-N-CA 122.344 2.029 . . . . 0.0 112.231 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -83.63 -24.69 31.32 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.609 179.455 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.539 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.4 mtm-85 -122.25 134.43 54.69 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.257 0.551 . . . . 0.0 110.177 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.0 mt -130.46 133.78 63.24 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.774 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 45.3 t -124.43 130.4 73.58 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 CA-C-O 120.911 0.386 . . . . 0.0 109.986 179.207 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.63 ' OG ' HD12 ' A' ' 117' ' ' LEU . 2.1 m -154.88 167.27 30.84 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.645 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 65.1 p -124.53 9.16 8.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.419 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.52 125.51 33.13 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.644 -179.492 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.447 HG11 ' H ' ' A' ' 299' ' ' LEU . 92.7 t -65.77 -44.51 93.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.555 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.4 m -62.51 -44.18 97.0 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.654 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 53.1 tp -62.33 -41.43 98.56 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.464 -179.417 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.445 ' O ' HD13 ' A' ' 58' ' ' LEU . 74.3 m -57.86 -44.58 86.66 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.126 -179.111 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.19 -62.41 5.19 Favored Glycine 0 N--CA 1.467 0.733 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.7 t -47.94 -35.74 11.23 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 20.1 mt -61.88 -44.13 97.44 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.348 179.299 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.445 HD13 ' O ' ' A' ' 54' ' ' THR . 9.1 mp -65.62 -41.35 92.79 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.333 177.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.67 -41.1 98.22 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.846 -179.335 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.424 ' O ' HG23 ' A' ' 60' ' ' ILE . 7.8 tp -88.35 16.66 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.914 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 56.27 84.79 0.08 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.821 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 178.83 58.34 0.07 OUTLIER Pre-proline 0 C--N 1.328 -0.358 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -51.6 153.51 10.7 Favored 'Trans proline' 0 C--N 1.293 -2.385 0 C-N-CA 123.051 2.501 . . . . 0.0 111.943 -178.065 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.435 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.2 OUTLIER -108.86 145.33 15.85 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.148 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.341 -179.677 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.36 -45.49 97.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.363 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.504 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -129.43 134.08 47.65 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 120.816 0.341 . . . . 0.0 110.489 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.503 ' O ' ' N ' ' A' ' 98' ' ' LEU . 73.8 m -134.54 158.75 43.17 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.871 -179.741 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -87.04 139.25 16.06 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 110.621 -0.991 . . . . 0.0 110.621 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.494 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.7 -162.77 0.08 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.938 0.399 . . . . 0.0 110.431 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.533 HG22 ' CD2' ' A' ' 297' ' ' PHE . 14.2 t -133.47 134.75 43.91 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.293 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.478 ' C ' ' O ' ' A' ' 70' ' ' THR . 0.6 OUTLIER 29.73 68.74 0.66 Allowed Pre-proline 0 N--CA 1.467 0.397 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.817 -179.865 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_exo -61.85 145.18 97.21 Favored 'Trans proline' 0 C--N 1.299 -2.027 0 C-N-CA 122.706 2.27 . . . . 0.0 111.723 -177.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.528 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 45.7 p-10 -159.4 -31.81 0.06 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.66 179.645 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.541 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 99.1 m-20 -64.35 -39.42 93.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.366 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.4 ttt180 -60.33 -48.16 82.95 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.505 -179.138 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.424 ' O ' ' O ' ' A' ' 77' ' ' ALA . 93.0 t -60.48 -25.1 33.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.054 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.541 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -45.51 173.04 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.592 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.569 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.4 p30 -62.01 177.59 0.44 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.577 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.558 ' C ' ' H ' ' A' ' 81' ' ' GLY . 35.5 p30 -45.34 85.67 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.036 0.446 . . . . 0.0 111.102 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.569 ' N ' ' O ' ' A' ' 78' ' ' ASP . 42.8 tp60 -67.64 13.29 0.08 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.268 0.556 . . . . 0.0 110.197 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.558 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 118.65 -22.08 9.49 Favored Glycine 0 N--CA 1.462 0.374 0 N-CA-C 110.981 -0.848 . . . . 0.0 110.981 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -108.33 116.42 31.94 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.963 0.411 . . . . 0.0 110.445 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 76.6 mt -98.74 -0.19 43.22 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.578 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -92.15 7.35 42.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.971 0.415 . . . . 0.0 110.299 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.795 ' O ' HG22 ' A' ' 89' ' ' VAL . 27.1 mt-30 -100.25 -28.15 13.14 Favored 'General case' 0 C--O 1.22 -0.455 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.795 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 68.9 t-105 -63.03 -40.47 97.82 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.833 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.551 ' O ' ' N ' ' A' ' 91' ' ' LYS . 67.5 m -77.82 -53.74 7.14 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.881 -179.342 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -48.53 -50.68 30.94 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.076 -179.134 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.795 HG22 ' O ' ' A' ' 85' ' ' GLN . 15.5 m -68.81 -40.55 81.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.161 179.495 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.494 ' N ' HG23 ' A' ' 89' ' ' VAL . . . -72.43 -22.66 61.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.572 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.551 ' N ' ' O ' ' A' ' 87' ' ' SER . 65.9 tttm -61.97 -45.67 92.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.357 -179.399 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.437 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.8 mm-40 -90.41 -94.64 0.12 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.164 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.621 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.8 mtt180 -143.12 58.73 1.41 Allowed 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.446 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.6 pttp 33.97 26.02 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.149 0.5 . . . . 0.0 110.267 -179.465 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.621 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.4 tt -48.22 123.48 6.47 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.002 -177.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.457 ' O ' HD23 ' A' ' 95' ' ' LEU . 99.0 mm-40 -83.82 -169.98 2.85 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.146 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.609 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 81.2 mtp180 -74.25 137.07 42.74 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.232 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.503 ' N ' ' O ' ' A' ' 67' ' ' SER . 91.0 mt -85.71 -165.77 1.33 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.901 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.538 ' O ' ' CD2' ' A' ' 99' ' ' TYR . 47.9 p90 -168.57 119.56 0.77 Allowed 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.13 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.502 ' C ' ' O ' ' A' ' 99' ' ' TYR . 43.0 mm -28.69 120.78 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.068 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 114.2 27.61 3.35 Favored Glycine 0 CA--C 1.519 0.315 0 N-CA-C 111.259 -0.736 . . . . 0.0 111.259 -179.353 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.574 ' N ' ' CD ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -144.52 46.39 0.62 Allowed Pre-proline 0 C--N 1.321 -0.654 0 CA-C-O 121.084 0.468 . . . . 0.0 110.511 179.773 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.574 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 28.8 Cg_endo -62.15 144.34 95.66 Favored 'Trans proline' 0 C--N 1.295 -2.273 0 C-N-CA 122.687 2.258 . . . . 0.0 111.732 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.452 ' O ' HG23 ' A' ' 108' ' ' VAL . 24.3 t -173.2 120.52 0.35 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.349 179.607 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.95 -40.3 63.16 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.011 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.27 -39.91 89.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.892 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.33 -39.97 94.96 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.769 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 104' ' ' SER . 69.6 t -67.83 -43.65 86.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.73 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.04 -38.88 92.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.476 -179.189 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.437 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.55 -23.2 62.67 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.538 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.535 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.3 mm-40 -91.0 5.88 47.05 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.746 -179.615 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.539 ' O ' ' NE ' ' A' ' 45' ' ' ARG . 10.6 tpt 22.89 64.64 0.36 Allowed Pre-proline 0 N--CA 1.467 0.416 0 CA-C-O 120.905 0.383 . . . . 0.0 111.215 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -79.04 167.41 21.95 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 123.087 2.524 . . . . 0.0 111.466 -177.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.526 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 99.2 m-20 -110.02 -41.99 4.32 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.038 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.2 tp -121.38 120.26 34.51 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.925 0.393 . . . . 0.0 109.983 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 82.1 mt -112.94 128.92 69.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 CA-C-O 120.833 0.349 . . . . 0.0 110.935 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.63 HD12 ' OG ' ' A' ' 48' ' ' SER . 29.3 mt -109.08 132.11 54.42 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.281 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.496 HD12 HG23 ' A' ' 139' ' ' THR . 99.0 mt -119.75 138.57 49.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.654 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 85.7 p -72.54 153.8 41.13 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.633 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.28 -50.09 75.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.621 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -149.32 153.8 38.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.561 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 170.68 -170.86 43.43 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -63.11 -34.12 89.11 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.449 ' OD1' ' O ' ' A' ' 124' ' ' ASP . 44.3 p-10 -87.13 120.22 28.18 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.827 0.346 . . . . 0.0 110.612 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.443 ' O ' HD12 ' A' ' 129' ' ' LEU . 37.7 t -63.18 143.94 57.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.342 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.52 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.09 -43.3 8.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.868 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.9 tp -63.03 -42.36 99.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.747 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.6 -12.1 59.64 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.372 -179.313 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.443 HD12 ' O ' ' A' ' 125' ' ' SER . 84.7 mt -114.88 -23.94 8.89 Favored 'General case' 0 C--O 1.225 -0.196 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.557 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' TYR . . . . . 0.52 ' N ' ' O ' ' A' ' 126' ' ' ALA . 79.5 t80 -51.07 -49.55 60.41 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.654 -178.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 37.6 p-10 -66.16 -42.81 88.5 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.762 -0.375 . . . . 0.0 111.255 179.421 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.519 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 88.4 mt-30 -66.94 -37.68 84.74 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.783 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.428 HD12 HD11 ' A' ' 118' ' ' ILE . 96.3 mt -80.21 -41.62 24.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.908 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.3 t -56.94 -44.68 82.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.229 -179.127 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 20.4 m -62.01 -45.1 95.08 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.378 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 94.3 mt -62.06 -43.65 97.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.305 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.666 ' HB1' ' HD2' ' A' ' 138' ' ' PRO . . . -169.44 168.47 4.82 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.649 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.666 ' HD2' ' HB1' ' A' ' 137' ' ' ALA . 52.3 Cg_exo -49.91 112.74 0.77 Allowed 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.354 2.036 . . . . 0.0 112.454 179.03 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.496 HG23 HD12 ' A' ' 118' ' ' ILE . 23.6 m -84.07 127.33 33.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.629 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.691 HD13 ' CD2' ' A' ' 37' ' ' HIS . 34.4 tp -117.71 135.89 53.73 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.15 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.438 ' O ' ' OD2' ' A' ' 32' ' ' ASP . 82.1 mt -100.09 119.03 47.61 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.286 0 CA-C-O 121.093 0.473 . . . . 0.0 111.057 -179.301 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.428 HD12 HD22 ' A' ' 117' ' ' LEU . 98.0 mt -134.84 132.23 53.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.586 179.548 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.466 ' ND2' ' OD2' ' A' ' 241' ' ' ASP . 2.1 t-20 -66.69 151.46 47.35 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.473 179.329 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.521 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 88.1 t80 -86.24 122.47 30.28 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.858 -179.59 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.521 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 98.9 m-20 55.22 69.17 0.76 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.673 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 35.0 p-10 -125.8 0.36 7.38 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.573 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -150.62 115.07 5.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.687 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 84.0 p -63.34 168.41 4.47 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.597 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.411 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.8 p-90 -51.78 -16.05 0.61 Allowed 'General case' 0 C--O 1.22 -0.453 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.386 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.446 ' O ' HG23 ' A' ' 154' ' ' THR . 68.1 tp60 -70.22 -76.01 0.11 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.896 0.379 . . . . 0.0 110.585 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.441 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.1 t -62.57 -38.81 91.53 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.224 179.516 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 54.1 tp -59.82 -45.9 90.93 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.398 -178.363 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.411 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 46.1 tp -62.63 -41.6 99.1 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.585 178.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.446 HG23 ' O ' ' A' ' 150' ' ' GLN . 61.5 p -64.11 -34.96 79.25 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.189 -179.366 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.435 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.9 mm-40 -64.11 -42.49 96.87 Favored 'General case' 0 C--O 1.225 -0.229 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.412 179.308 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 90.6 mt -65.57 -38.57 89.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.147 0.499 . . . . 0.0 110.313 179.089 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.57 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.52 -32.28 80.66 Favored Glycine 0 C--N 1.331 0.286 0 N-CA-C 110.604 -0.998 . . . . 0.0 110.604 -179.154 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.435 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.2 mt-10 -35.56 -27.07 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.841 0.353 . . . . 0.0 110.827 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.57 ' N ' ' O ' ' A' ' 157' ' ' GLY . 95.6 mt -55.95 149.16 3.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.354 178.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 69.1 p -69.53 137.25 52.32 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.903 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 71.21 21.32 78.47 Favored Glycine 0 N--CA 1.459 0.195 0 N-CA-C 111.198 -0.761 . . . . 0.0 111.198 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 57.2 m80 -122.96 -14.67 7.56 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.6 0.238 . . . . 0.0 110.507 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -65.94 -59.97 3.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.596 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -52.05 -49.42 63.5 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.166 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -60.51 -41.07 93.61 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.838 0.351 . . . . 0.0 110.483 179.446 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.61 -47.26 86.26 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.505 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.82 -40.15 75.48 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.271 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -61.77 -50.01 74.08 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.616 179.486 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -65.34 -43.65 90.21 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.556 179.42 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 93.8 mt -64.88 -43.23 96.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.377 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.45 -51.35 69.8 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.297 -179.124 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.08 -43.82 97.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.939 0.4 . . . . 0.0 110.723 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.66 ' CE2' HD11 ' A' ' 177' ' ' LEU . 57.7 t80 -63.09 -44.16 96.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.34 179.485 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -63.61 -39.64 94.89 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.498 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -63.16 -42.73 99.48 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.522 179.134 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -60.53 -44.68 95.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.22 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.66 HD11 ' CE2' ' A' ' 173' ' ' PHE . 84.6 mt -64.66 -40.94 96.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.651 178.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.14 -62.44 1.63 Allowed 'General case' 0 C--O 1.238 0.483 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.33 -179.219 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.34 -47.04 85.02 Favored 'General case' 0 C--O 1.226 -0.184 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.58 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -52.88 -41.89 64.77 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.368 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -63.97 -33.41 75.67 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.285 179.438 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.415 ' O ' ' HG2' ' A' ' 182' ' ' GLU . 70.0 tt0 -90.76 8.78 32.92 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.609 0.719 . . . . 0.0 110.317 -178.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -105.05 -31.94 8.95 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.155 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 45.3 pt -128.08 147.93 32.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.708 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -140.19 131.34 26.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.463 179.013 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.593 HD22 ' N ' ' A' ' 186' ' ' LEU . 3.6 mm? -85.63 132.63 43.89 Favored Pre-proline 0 N--CA 1.451 -0.41 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.13 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -43.45 157.59 0.11 Allowed 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.701 2.267 . . . . 0.0 112.416 179.306 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 0.501 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.6 Cg_endo -62.84 115.1 2.72 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 C-N-CA 122.781 2.321 . . . . 0.0 111.727 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 189' ' ' GLN . . . . . 0.501 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.7 mt-30 155.72 147.44 0.0 OUTLIER Pre-proline 0 C--O 1.232 0.134 0 O-C-N 124.071 0.857 . . . . 0.0 110.953 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -73.34 143.71 35.54 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.553 2.169 . . . . 0.0 112.381 177.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.5 HG23 ' OG ' ' A' ' 258' ' ' SER . 2.1 p -124.63 159.24 31.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.443 0.64 . . . . 0.0 110.217 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 192' ' ' THR . . . . . 0.493 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 36.0 p -143.45 165.49 27.4 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.082 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 193' ' ' ALA . . . . . 0.446 ' HA ' ' H ' ' A' ' 260' ' ' PHE . . . -135.4 128.75 32.18 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 121.292 0.568 . . . . 0.0 110.181 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.504 HD11 HD23 ' A' ' 259' ' ' LEU . 47.3 pt -146.46 148.87 16.55 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.381 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.276 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 195' ' ' VAL . . . . . 0.757 HG13 ' CD1' ' A' ' 262' ' ' PHE . 69.8 t -117.67 123.28 71.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.334 0.588 . . . . 0.0 109.844 178.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -134.37 107.38 7.58 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.258 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 94.0 m -130.86 130.39 43.51 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.846 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.401 ' O ' ' N ' ' A' ' 201' ' ' HIS . . . -82.74 -37.16 25.06 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.22 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.32 -67.1 0.26 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.383 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.2 -10.07 59.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.387 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' HIS . . . . . 0.401 ' N ' ' O ' ' A' ' 198' ' ' ALA . 60.2 t-80 61.01 58.25 2.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.721 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 41.4 p -167.03 153.7 8.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.595 179.364 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.6 144.32 24.35 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.467 179.249 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -135.46 138.28 43.02 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.647 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 19.6 mt -106.2 125.59 51.18 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.046 0.45 . . . . 0.0 109.876 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 206' ' ' TRP . . . . . 0.555 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 75.8 m95 -82.3 167.24 18.79 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.619 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 207' ' ' THR . . . . . 0.457 HG22 ' C ' ' A' ' 206' ' ' TRP . 0.1 OUTLIER -157.05 170.94 8.12 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-O 120.981 0.42 . . . . 0.0 110.587 -178.954 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -53.09 -37.17 79.0 Favored 'Trans proline' 0 C--N 1.301 -1.928 0 C-N-CA 122.659 2.24 . . . . 0.0 112.532 178.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -70.86 -34.78 71.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.64 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 22.4 m -61.24 150.87 33.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.641 -179.418 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.68 -36.87 82.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.471 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 212' ' ' GLN . . . . . 0.555 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 55.0 tt0 -64.91 -40.1 94.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.515 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.62 -43.66 91.59 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.649 -0.98 . . . . 0.0 110.649 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -62.83 -43.81 97.82 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.874 0.369 . . . . 0.0 110.306 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 215' ' ' MET . . . . . 0.529 ' SD ' ' HB2' ' A' ' 304' ' ' ALA . 65.2 ttp -59.31 -48.23 82.4 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.108 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 88.6 mt -60.27 -41.16 92.72 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 217' ' ' GLU . . . . . 0.453 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.1 tp10 -57.93 -37.78 74.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.14 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -65.33 -38.1 89.1 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.687 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 94.2 mt -64.14 -42.89 96.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.176 0.512 . . . . 0.0 110.653 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.61 44.82 0.08 OUTLIER Glycine 0 N--CA 1.462 0.4 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 221' ' ' PHE . . . . . 0.453 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 27.3 m-85 -127.77 155.31 44.23 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 121.065 0.46 . . . . 0.0 110.463 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.48 ' O ' HG13 ' A' ' 191' ' ' VAL . 6.6 p -106.95 122.08 45.73 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.287 0.565 . . . . 0.0 109.992 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.468 HD22 ' C ' ' A' ' 222' ' ' THR . 4.3 mm? -100.99 133.19 45.85 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.139 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.95 159.05 15.13 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.426 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.09 115.43 30.25 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.924 0.392 . . . . 0.0 110.312 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.491 HD12 ' N ' ' A' ' 226' ' ' LEU . 8.9 mp -53.62 156.53 4.51 Favored Pre-proline 0 N--CA 1.45 -0.435 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.783 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.82 145.31 98.57 Favored 'Trans proline' 0 C--N 1.3 -1.999 0 C-N-CA 122.764 2.31 . . . . 0.0 112.34 179.019 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.53 -2.95 58.96 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.473 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.26 -40.8 5.68 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 111.034 -0.827 . . . . 0.0 111.034 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.526 ' O ' ' N ' ' A' ' 233' ' ' SER . 85.7 mt -79.09 -16.85 56.16 Favored 'General case' 0 C--O 1.219 -0.54 0 CA-C-O 121.099 0.476 . . . . 0.0 110.347 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 54.3 t-20 -40.24 -49.15 2.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.857 -179.409 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -88.08 15.34 7.53 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.386 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.526 ' N ' ' O ' ' A' ' 230' ' ' LEU . 78.1 p -60.59 -35.5 76.24 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.714 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 234' ' ' GLN . . . . . 0.523 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.6 tt0 -118.38 -69.41 0.85 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.809 179.372 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.0 m -70.06 103.5 2.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.678 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -94.57 57.5 2.23 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.279 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -144.84 -122.48 1.56 Allowed Glycine 0 N--CA 1.461 0.304 0 N-CA-C 110.946 -0.861 . . . . 0.0 110.946 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -134.54 111.94 10.48 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.146 0.498 . . . . 0.0 110.339 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 239' ' ' ARG . . . . . 0.515 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.3 mtt180 -148.33 57.54 1.07 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.69 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -69.77 -31.91 70.11 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.528 179.486 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 241' ' ' ASP . . . . . 0.466 ' OD2' ' ND2' ' A' ' 143' ' ' ASN . 65.0 t0 -56.72 -47.09 80.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.304 -179.029 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 242' ' ' ILE . . . . . 0.439 ' O ' ' O ' ' A' ' 239' ' ' ARG . 17.6 tt -140.12 157.06 25.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.867 0.365 . . . . 0.0 110.468 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.439 HG22 HD13 ' A' ' 245' ' ' LEU . 96.2 mt -106.07 106.27 20.25 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.168 0 CA-C-O 121.085 0.469 . . . . 0.0 110.461 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 244' ' ' GLN . . . . . 0.596 ' O ' HD12 ' A' ' 245' ' ' LEU . 88.0 mt-30 -110.55 110.2 20.83 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.309 179.718 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.596 HD12 ' O ' ' A' ' 244' ' ' GLN . 9.6 mp -121.86 -168.12 1.65 Allowed 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.643 179.572 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 246' ' ' GLY . . . . . 0.523 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.3 -16.87 0.05 OUTLIER Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 247' ' ' GLY . . . . . 0.667 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -60.46 157.04 29.74 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -63.74 21.38 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.942 0.401 . . . . 0.0 110.601 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 249' ' ' ASN . . . . . 0.667 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.8 m-20 -97.08 -6.0 36.15 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.43 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 92.2 mt -80.09 -21.45 43.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.824 179.307 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.56 -51.31 70.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.634 -179.544 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.7 -5.25 58.24 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.488 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.16 -74.29 1.15 Allowed Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.829 -0.909 . . . . 0.0 110.829 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 81.3 mt -70.15 126.08 28.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.931 0.396 . . . . 0.0 110.328 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -59.6 -39.26 83.59 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.289 -179.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 82.91 51.68 4.14 Favored Glycine 0 CA--C 1.52 0.382 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -95.77 -15.19 22.74 Favored 'General case' 0 C--N 1.332 -0.187 0 O-C-N 122.69 -0.3 . . . . 0.0 110.616 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 258' ' ' SER . . . . . 0.5 ' OG ' HG23 ' A' ' 191' ' ' VAL . 3.3 t 174.69 88.85 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.24 0.543 . . . . 0.0 110.114 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.855 HD12 ' N ' ' A' ' 259' ' ' LEU . 0.9 OUTLIER -94.41 124.13 38.25 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.201 0.524 . . . . 0.0 111.266 -179.132 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 260' ' ' PHE . . . . . 0.446 ' H ' ' HA ' ' A' ' 193' ' ' ALA . 15.7 m-30 -93.25 146.28 23.82 Favored 'General case' 0 CA--C 1.498 -1.022 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.379 179.39 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 86.0 mt -122.27 149.68 43.37 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.622 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.757 ' CD1' HG13 ' A' ' 195' ' ' VAL . 2.7 p90 -77.17 -138.19 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.587 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 263' ' ' ALA . . . . . 0.656 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -52.34 77.18 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 121.024 0.44 . . . . 0.0 111.165 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 264' ' ' GLY . . . . . 0.616 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -178.99 104.39 0.19 Allowed Glycine 0 CA--C 1.529 0.951 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 265' ' ' ASP . . . . . 0.592 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.4 m-20 -80.14 -178.15 6.41 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.637 0.256 . . . . 0.0 110.938 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -40.31 -17.66 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.651 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 267' ' ' LYS . . . . . 0.592 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.32 -51.65 42.28 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.647 179.216 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -63.65 -46.65 84.68 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.007 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 269' ' ' ALA . . . . . 0.57 ' HB1' ' OH ' ' A' ' 273' ' ' TYR . . . -61.79 -35.02 76.94 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.392 0.615 . . . . 0.0 109.701 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -63.15 -34.12 76.93 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.158 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.72 -43.31 13.49 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.969 -179.444 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 272' ' ' ILE . . . . . 0.591 ' C ' ' H ' ' A' ' 274' ' ' ALA . 4.9 tt -51.42 -33.51 14.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.798 -178.781 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 273' ' ' TYR . . . . . 0.57 ' OH ' ' HB1' ' A' ' 269' ' ' ALA . 17.3 m-85 -54.71 -1.77 0.03 OUTLIER 'General case' 0 CA--C 1.515 -0.385 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.62 -179.4 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 274' ' ' ALA . . . . . 0.591 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.55 -39.7 70.51 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.912 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 275' ' ' ASN . . . . . 0.578 ' O ' ' N ' ' A' ' 279' ' ' ALA . 2.9 p30 -39.16 98.26 0.16 Allowed Pre-proline 0 C--O 1.226 -0.137 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.368 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.66 -42.72 65.78 Favored 'Trans proline' 0 C--N 1.303 -1.864 0 C-N-CA 122.413 2.076 . . . . 0.0 112.482 -178.575 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 88.9 mt -64.43 -42.89 95.78 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.116 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 91.1 mt -95.65 -1.6 49.81 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.984 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 279' ' ' ALA . . . . . 0.578 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.26 -34.71 77.06 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.711 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.8 m80 -74.38 20.1 0.12 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.969 -179.235 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 0.482 HD23 ' HA ' ' A' ' 281' ' ' LEU . 13.7 mt -74.93 119.35 76.42 Favored Pre-proline 0 N--CA 1.445 -0.692 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.873 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -49.53 -40.37 45.54 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.658 2.239 . . . . 0.0 112.417 178.544 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.44 -50.61 62.26 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.116 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 75.4 t -61.29 -43.91 97.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.132 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -57.86 -41.15 81.83 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.129 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -90.97 0.12 57.61 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.102 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt 59.47 42.98 16.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.048 0.452 . . . . 0.0 110.829 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -94.42 41.33 1.09 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.31 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 53.8 t -118.85 135.82 58.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-O 121.141 0.496 . . . . 0.0 110.023 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -133.01 162.71 30.98 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 121.165 0.507 . . . . 0.0 110.633 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.98 155.38 32.93 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.108 0.48 . . . . 0.0 110.589 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 81.8 mt -94.13 -1.51 54.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.173 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.31 165.53 12.66 Favored Glycine 0 N--CA 1.464 0.514 0 N-CA-C 110.494 -1.043 . . . . 0.0 110.494 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 6.9 m -87.21 -62.43 1.5 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.921 0.391 . . . . 0.0 111.015 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 295' ' ' GLU . . . . . 0.433 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.5 mm-40 -69.57 -3.74 16.12 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.653 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 27.2 p -77.17 33.18 0.15 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.574 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 297' ' ' PHE . . . . . 0.533 ' CD2' HG22 ' A' ' 70' ' ' THR . 83.8 t80 -60.28 -45.96 91.5 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.589 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 298' ' ' ARG . . . . . 0.609 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.2 mtt85 -81.57 134.36 35.49 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.574 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.447 ' H ' HG11 ' A' ' 51' ' ' VAL . 16.3 tp -114.34 119.36 36.7 Favored 'General case' 0 C--O 1.23 0.07 0 CA-C-O 120.982 0.42 . . . . 0.0 110.29 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 300' ' ' ASP . . . . . 0.619 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.1 p-10 -167.07 -174.43 2.65 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.608 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -48.23 -45.14 33.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.203 -179.476 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -65.13 -41.35 94.91 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 121.054 0.454 . . . . 0.0 110.714 178.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 303' ' ' SER . . . . . 0.619 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 53.5 p -55.61 -36.26 66.73 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.059 -179.197 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 304' ' ' ALA . . . . . 0.529 ' HB2' ' SD ' ' A' ' 215' ' ' MET . . . -56.57 -52.18 65.79 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.388 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 91.8 mtp -55.72 -44.06 77.11 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -66.25 -42.6 88.32 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.211 0.529 . . . . 0.0 110.227 179.139 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 307' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 303' ' ' SER . 55.6 t -64.03 -42.77 96.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.202 179.4 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 43.4 tp -59.73 -42.2 92.61 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.77 -179.429 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -62.75 -38.83 92.11 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.048 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 310' ' ' ARG . . . . . 0.44 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.5 ttt85 -63.46 -44.1 95.45 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.211 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 88.0 mt -63.14 -41.98 99.39 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.416 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -62.96 -33.04 74.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.152 179.43 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -90.09 -23.36 21.42 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.375 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.482 HD22 ' CE2' ' A' ' 315' ' ' PHE . 6.8 tt -62.31 -43.21 99.35 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 121.11 0.481 . . . . 0.0 110.573 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 315' ' ' PHE . . . . . 0.482 ' CE2' HD22 ' A' ' 314' ' ' LEU . 90.5 m-85 . . . . . 0 C--O 1.22 -0.477 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.326 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.477 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -99.5 136.06 39.99 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.115 0.483 . . . . 0.0 110.474 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.494 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -92.2 178.59 1.64 Allowed Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.545 -179.813 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.494 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.5 Cg_exo -61.54 147.18 96.05 Favored 'Trans proline' 0 C--N 1.299 -2.068 0 C-N-CA 122.854 2.369 . . . . 0.0 112.193 179.513 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.455 ' HE ' HD12 ' A' ' 39' ' ' LEU . 35.5 ptt180 -135.89 142.51 44.71 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.634 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -79.86 116.55 20.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.482 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.445 ' O ' HG23 ' A' ' 30' ' ' ILE . 9.4 tp -111.03 130.47 64.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.458 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 12.5 t -70.79 141.56 51.4 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.62 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.476 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.5 t0 -139.13 179.51 6.47 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.495 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.476 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 78.0 p -73.74 -37.32 65.12 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.6 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -46.3 -94.56 0.0 OUTLIER 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.357 -179.336 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -167.16 -26.56 0.02 OUTLIER Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 58.4 m -169.03 104.75 0.4 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.879 0.371 . . . . 0.0 110.668 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.68 ' CD2' HD13 ' A' ' 140' ' ' LEU . 74.2 t60 -128.57 148.44 50.77 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 121.119 0.485 . . . . 0.0 110.206 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.625 HG22 ' N ' ' A' ' 39' ' ' LEU . 98.4 m -130.83 166.14 21.49 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.458 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.625 ' N ' HG22 ' A' ' 38' ' ' THR . 81.6 mt -120.88 127.37 51.81 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.444 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -65.18 -44.61 87.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.716 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 38.9 p -165.67 154.98 12.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.377 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.497 ' CD ' ' H ' ' A' ' 42' ' ' GLN . 14.8 mp0 -44.3 101.0 0.24 Allowed Pre-proline 0 C--N 1.329 -0.306 0 O-C-N 123.419 0.449 . . . . 0.0 110.645 179.272 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -57.44 129.47 34.12 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 C-N-CA 122.347 2.031 . . . . 0.0 112.24 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -83.6 -24.67 31.4 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.621 179.548 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.539 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.5 mtm-85 -122.01 134.69 54.8 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.201 0.524 . . . . 0.0 110.256 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.2 mt -130.88 133.63 62.82 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.846 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 44.9 t -124.42 130.34 73.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-O 120.932 0.396 . . . . 0.0 109.939 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.626 ' OG ' HD12 ' A' ' 117' ' ' LEU . 2.3 m -154.8 166.89 32.05 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.504 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 69.8 p -124.55 8.83 8.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.404 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.26 125.67 33.08 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.874 0.369 . . . . 0.0 110.63 -179.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.442 HG11 ' H ' ' A' ' 299' ' ' LEU . 96.3 t -65.92 -44.51 92.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.505 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.7 m -62.69 -44.51 96.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.594 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 50.5 tp -62.32 -41.5 98.59 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.551 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.432 ' O ' HD13 ' A' ' 58' ' ' LEU . 75.4 m -57.87 -44.44 86.63 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.206 -179.133 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.14 -62.43 5.18 Favored Glycine 0 N--CA 1.467 0.717 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.7 t -48.2 -35.6 12.11 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 110.159 -0.311 . . . . 0.0 110.159 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 20.1 mt -61.87 -44.39 96.91 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.649 -0.421 . . . . 0.0 111.396 179.271 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.432 HD13 ' O ' ' A' ' 54' ' ' THR . 9.3 mp -65.5 -41.42 93.23 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.364 177.767 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.32 -41.27 98.91 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.832 -179.208 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.42 ' O ' HG23 ' A' ' 60' ' ' ILE . 8.3 tp -88.29 17.59 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.888 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 56.14 85.2 0.08 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.797 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.42 59.99 0.09 OUTLIER Pre-proline 0 C--N 1.327 -0.373 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -51.88 151.12 16.28 Favored 'Trans proline' 0 C--N 1.293 -2.363 0 C-N-CA 123.032 2.488 . . . . 0.0 112.047 -178.256 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.432 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -108.21 145.31 15.45 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.157 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.259 -179.659 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.51 -45.46 97.72 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.272 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.401 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.497 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -130.03 134.55 47.48 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 120.84 0.352 . . . . 0.0 110.491 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.476 ' O ' ' N ' ' A' ' 98' ' ' LEU . 74.8 m -134.56 158.82 43.0 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.831 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.29 138.58 16.02 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.48 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.55 -162.91 0.09 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.921 0.391 . . . . 0.0 110.474 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.529 HG22 ' CD2' ' A' ' 297' ' ' PHE . 6.1 t -133.93 135.28 43.47 Favored 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.48 ' C ' ' O ' ' A' ' 70' ' ' THR . 0.9 OUTLIER 29.65 68.74 0.65 Allowed Pre-proline 0 N--CA 1.467 0.403 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.743 -179.685 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -61.72 145.2 97.55 Favored 'Trans proline' 0 C--N 1.299 -2.062 0 C-N-CA 122.708 2.272 . . . . 0.0 111.735 -177.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.535 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 45.0 p-10 -159.65 -31.94 0.06 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.637 179.679 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.535 ' N ' ' OD1' ' A' ' 73' ' ' ASN . 99.1 m-20 -63.83 -39.92 95.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.337 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -60.08 -47.97 83.68 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.638 -179.123 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.426 ' O ' ' O ' ' A' ' 77' ' ' ALA . 93.6 t -60.49 -24.87 32.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.535 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -45.81 173.34 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.615 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.569 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.3 p30 -62.15 177.56 0.46 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.421 -179.651 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.561 ' C ' ' H ' ' A' ' 81' ' ' GLY . 36.4 p30 -45.4 85.68 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.075 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.569 ' N ' ' O ' ' A' ' 78' ' ' ASP . 43.1 tp60 -67.48 13.18 0.07 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.221 0.534 . . . . 0.0 110.142 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.561 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 118.54 -22.35 9.45 Favored Glycine 0 N--CA 1.461 0.305 0 N-CA-C 110.934 -0.866 . . . . 0.0 110.934 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -107.75 116.45 31.97 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.987 0.422 . . . . 0.0 110.453 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 75.0 mt -98.58 0.07 44.18 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.984 0.421 . . . . 0.0 110.559 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -92.63 7.38 43.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.015 0.436 . . . . 0.0 110.357 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.787 ' O ' HG22 ' A' ' 89' ' ' VAL . 27.4 mt-30 -100.12 -27.91 13.3 Favored 'General case' 0 C--O 1.222 -0.382 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.81 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 69.1 t-105 -63.49 -40.46 97.14 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.906 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.554 ' O ' ' N ' ' A' ' 91' ' ' LYS . 68.7 m -77.78 -53.79 7.1 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.952 -179.361 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -48.3 -50.57 29.55 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.111 -179.218 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.787 HG22 ' O ' ' A' ' 85' ' ' GLN . 15.7 m -69.03 -40.47 80.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.144 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.493 ' N ' HG23 ' A' ' 89' ' ' VAL . . . -72.63 -22.66 60.91 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.652 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.554 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.0 tttm -62.12 -45.62 92.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.384 -179.458 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.44 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.6 mm-40 -90.32 -94.8 0.12 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.974 0.416 . . . . 0.0 110.084 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.626 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.9 mtt180 -143.12 59.32 1.41 Allowed 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 109.595 -0.521 . . . . 0.0 109.595 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.449 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.7 pttp 33.8 25.89 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 120.968 0.413 . . . . 0.0 110.234 -179.479 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.626 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.4 tt -48.31 123.5 6.58 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.934 -177.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.451 ' O ' HD23 ' A' ' 95' ' ' LEU . 98.9 mm-40 -83.62 -170.3 2.99 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.112 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.61 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 82.3 mtp180 -73.82 137.26 43.72 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.233 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.476 ' N ' ' O ' ' A' ' 67' ' ' SER . 90.4 mt -86.32 -165.81 1.37 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.784 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.537 ' O ' ' CD2' ' A' ' 99' ' ' TYR . 48.3 p90 -169.01 120.09 0.74 Allowed 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.114 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.502 ' C ' ' O ' ' A' ' 99' ' ' TYR . 43.9 mm -28.98 121.02 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 O-C-N 123.261 0.351 . . . . 0.0 111.103 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 114.52 26.9 3.51 Favored Glycine 0 C--N 1.332 0.338 0 N-CA-C 111.281 -0.728 . . . . 0.0 111.281 -179.309 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.575 ' N ' ' CD ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -144.18 46.38 0.63 Allowed Pre-proline 0 C--N 1.322 -0.622 0 CA-C-O 121.023 0.44 . . . . 0.0 110.472 179.833 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 29.1 Cg_endo -62.13 143.92 95.23 Favored 'Trans proline' 0 C--N 1.294 -2.3 0 C-N-CA 122.677 2.251 . . . . 0.0 111.771 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.451 ' O ' HG23 ' A' ' 108' ' ' VAL . 26.5 t -173.14 120.35 0.35 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.426 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.39 -40.58 64.21 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.042 0.449 . . . . 0.0 111.145 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -66.19 -39.82 89.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.892 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.13 -39.88 94.99 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.77 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 104' ' ' SER . 71.7 t -67.77 -43.71 86.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.733 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.96 -38.97 93.23 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.555 -179.168 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.44 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.66 -23.3 62.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.473 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.537 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.4 mm-40 -90.8 5.58 47.77 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.654 -179.536 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.539 ' O ' ' NE ' ' A' ' 45' ' ' ARG . 10.3 tpt 22.88 64.5 0.36 Allowed Pre-proline 0 N--CA 1.468 0.437 0 CA-C-O 120.913 0.387 . . . . 0.0 111.22 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -78.92 167.5 22.04 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 123.079 2.519 . . . . 0.0 111.657 -177.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.522 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 99.3 m-20 -110.15 -42.05 4.28 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.077 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.8 tp -121.32 120.44 35.1 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 83.8 mt -113.42 129.09 69.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-O 120.848 0.356 . . . . 0.0 110.96 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.626 HD12 ' OG ' ' A' ' 48' ' ' SER . 29.5 mt -108.86 132.17 54.29 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.044 0.449 . . . . 0.0 110.268 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.49 HD12 HG23 ' A' ' 139' ' ' THR . 98.8 mt -119.66 138.42 50.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.709 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 85.6 p -72.63 153.77 41.07 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.612 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.12 -50.12 74.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.627 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.0 t -149.44 153.92 38.05 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.566 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 170.47 -170.98 43.43 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.89 -34.13 88.99 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.829 -0.908 . . . . 0.0 110.829 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.453 ' OD1' ' O ' ' A' ' 124' ' ' ASP . 44.5 p-10 -87.36 120.01 28.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.882 0.373 . . . . 0.0 110.652 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.444 ' O ' HD12 ' A' ' 129' ' ' LEU . 37.7 t -63.05 144.01 57.27 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.399 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.521 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.19 -43.26 8.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.836 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.3 tp -62.98 -42.45 99.84 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.739 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.49 -12.0 59.26 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.508 -179.397 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.444 HD12 ' O ' ' A' ' 125' ' ' SER . 85.1 mt -114.93 -23.93 8.87 Favored 'General case' 0 C--O 1.226 -0.159 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.586 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' TYR . . . . . 0.521 ' N ' ' O ' ' A' ' 126' ' ' ALA . 80.0 t80 -50.94 -49.49 59.76 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.643 -178.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.5 p-10 -66.09 -42.5 89.24 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.876 -0.33 . . . . 0.0 111.237 179.333 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.523 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 88.2 mt-30 -67.17 -37.85 84.44 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.874 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.429 HD12 HD11 ' A' ' 118' ' ' ILE . 96.1 mt -79.98 -41.83 25.14 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.915 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.3 t -56.86 -44.78 82.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.277 -179.066 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 20.0 m -61.86 -45.25 94.6 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.507 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 94.1 mt -62.03 -43.68 97.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.262 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.656 ' HB1' ' HD2' ' A' ' 138' ' ' PRO . . . -169.31 168.17 5.08 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.571 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.656 ' HD2' ' HB1' ' A' ' 137' ' ' ALA . 52.5 Cg_exo -49.61 113.0 0.79 Allowed 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.288 1.992 . . . . 0.0 112.35 179.078 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.49 HG23 HD12 ' A' ' 118' ' ' ILE . 23.5 m -84.27 127.41 33.94 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.622 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.68 HD13 ' CD2' ' A' ' 37' ' ' HIS . 34.4 tp -117.77 135.34 54.11 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.072 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.435 ' O ' ' OD2' ' A' ' 32' ' ' ASP . 82.3 mt -99.9 118.91 47.24 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.315 0 CA-C-O 121.181 0.515 . . . . 0.0 111.137 -179.299 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.438 HD12 HD22 ' A' ' 117' ' ' LEU . 98.1 mt -134.85 131.94 53.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.554 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.546 HD21 ' CG ' ' A' ' 241' ' ' ASP . 60.7 t30 -66.37 151.19 47.63 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.908 0.385 . . . . 0.0 110.479 179.298 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.52 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 88.2 t80 -85.96 122.25 29.73 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.883 -179.567 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.52 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 99.0 m-20 55.41 69.15 0.76 Allowed 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.672 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 35.0 p-10 -125.68 0.2 7.45 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.845 0.355 . . . . 0.0 110.604 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -150.63 115.48 5.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.706 -179.481 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 83.8 p -63.73 168.77 4.59 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.551 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.416 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.5 p-90 -52.3 -16.01 0.75 Allowed 'General case' 0 C--O 1.222 -0.389 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.417 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.433 ' O ' HG23 ' A' ' 154' ' ' THR . 68.2 tp60 -69.97 -76.88 0.09 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.508 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.441 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.0 t -62.49 -38.45 89.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.216 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 54.1 tp -59.78 -45.86 90.98 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.356 -178.457 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.416 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 46.7 tp -62.66 -41.77 99.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.527 178.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.441 ' OG1' ' O ' ' A' ' 151' ' ' SER . 62.7 p -64.0 -34.75 78.7 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.196 -179.309 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.422 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 88.0 mm-40 -64.05 -42.71 96.94 Favored 'General case' 0 C--O 1.225 -0.196 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.356 179.305 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 91.7 mt -65.52 -38.7 90.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.101 0.477 . . . . 0.0 110.277 179.163 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.575 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.37 -32.12 79.8 Favored Glycine 0 C--N 1.331 0.295 0 N-CA-C 110.68 -0.968 . . . . 0.0 110.68 -179.207 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 157' ' ' GLY . 97.3 mt-10 -35.64 -26.73 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.839 0.352 . . . . 0.0 110.858 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.575 ' N ' ' O ' ' A' ' 157' ' ' GLY . 95.3 mt -56.16 149.37 3.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.411 178.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 74.8 p -69.68 137.25 51.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.978 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 71.39 21.0 78.64 Favored Glycine 0 CA--C 1.517 0.165 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 179.477 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 56.3 m80 -122.56 -14.5 7.77 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.602 0.239 . . . . 0.0 110.454 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -65.66 -59.98 3.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.593 -179.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -52.18 -49.34 64.01 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.177 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -60.24 -41.28 92.84 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.805 0.336 . . . . 0.0 110.437 179.486 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.34 -47.17 87.13 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.59 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -57.04 -40.1 76.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.279 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -61.72 -50.43 72.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.61 179.488 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -65.25 -43.78 90.23 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.534 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 94.4 mt -64.83 -43.26 96.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.414 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.38 -51.31 69.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.355 -179.113 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.23 -43.64 97.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.614 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.663 ' CE2' HD11 ' A' ' 177' ' ' LEU . 56.9 t80 -62.92 -44.45 96.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.097 0.475 . . . . 0.0 110.396 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -63.53 -39.64 94.95 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.679 -179.315 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -63.16 -42.85 99.48 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.531 179.184 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -60.78 -44.39 96.86 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.261 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.663 HD11 ' CE2' ' A' ' 173' ' ' PHE . 84.1 mt -64.78 -40.98 96.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.687 178.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.21 -62.39 1.66 Allowed 'General case' 0 C--O 1.238 0.495 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.355 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.37 -47.02 85.16 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.54 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.01 -41.68 64.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.375 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -63.9 -33.69 76.26 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.281 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.417 ' O ' ' HG2' ' A' ' 182' ' ' GLU . 70.0 tt0 -90.64 8.73 32.83 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.616 0.722 . . . . 0.0 110.381 -178.808 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -104.84 -32.05 9.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.145 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.8 pt -128.08 147.88 32.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.791 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -140.15 131.34 26.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.426 179.182 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.593 HD22 ' N ' ' A' ' 186' ' ' LEU . 3.5 mm? -85.55 133.06 42.81 Favored Pre-proline 0 N--CA 1.451 -0.41 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.042 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -43.82 157.81 0.13 Allowed 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.649 2.232 . . . . 0.0 112.364 179.338 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 0.505 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.5 Cg_endo -62.87 114.91 2.62 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 C-N-CA 122.892 2.395 . . . . 0.0 111.657 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 189' ' ' GLN . . . . . 0.505 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.7 mt-30 155.6 147.65 0.0 OUTLIER Pre-proline 0 N--CA 1.456 -0.138 0 O-C-N 124.028 0.83 . . . . 0.0 110.824 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.35 143.92 35.86 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.614 2.209 . . . . 0.0 112.243 177.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.501 HG23 ' OG ' ' A' ' 258' ' ' SER . 2.1 p -124.58 158.84 31.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.441 0.639 . . . . 0.0 110.162 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 192' ' ' THR . . . . . 0.489 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 37.6 p -143.19 165.24 27.97 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.102 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 193' ' ' ALA . . . . . 0.447 ' HA ' ' H ' ' A' ' 260' ' ' PHE . . . -135.28 128.75 32.41 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 121.285 0.564 . . . . 0.0 110.224 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.506 HD11 HD23 ' A' ' 259' ' ' LEU . 47.4 pt -146.66 149.02 16.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.146 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 195' ' ' VAL . . . . . 0.746 HG13 ' CD1' ' A' ' 262' ' ' PHE . 69.5 t -117.77 123.41 71.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 CA-C-O 121.32 0.581 . . . . 0.0 109.903 178.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -134.27 107.25 7.55 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.161 0.505 . . . . 0.0 110.205 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 93.3 m -130.97 130.33 43.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.815 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.406 ' O ' ' N ' ' A' ' 201' ' ' HIS . . . -82.92 -37.27 24.42 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.249 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.23 -66.94 0.27 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.362 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.3 -10.17 59.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.346 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' HIS . . . . . 0.406 ' N ' ' O ' ' A' ' 198' ' ' ALA . 59.9 t-80 61.08 58.1 2.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.745 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 36.3 p -166.69 153.26 8.75 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.602 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.24 144.02 24.43 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.096 0.474 . . . . 0.0 110.416 179.209 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -135.4 138.32 43.17 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.609 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 19.9 mt -106.24 125.56 51.15 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.065 0.46 . . . . 0.0 109.925 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 206' ' ' TRP . . . . . 0.556 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 75.2 m95 -82.08 167.0 19.24 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.573 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 207' ' ' THR . . . . . 0.462 HG22 ' C ' ' A' ' 206' ' ' TRP . 0.1 OUTLIER -157.19 171.11 7.88 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.645 -178.961 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -53.19 -37.29 79.93 Favored 'Trans proline' 0 C--N 1.302 -1.913 0 C-N-CA 122.588 2.192 . . . . 0.0 112.472 178.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -70.57 -35.07 72.87 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.711 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 21.0 m -61.08 150.84 32.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.642 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.7 -36.78 81.9 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.465 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 212' ' ' GLN . . . . . 0.556 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 54.6 tt0 -64.97 -40.02 94.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.475 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.64 -43.4 92.1 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.712 -0.955 . . . . 0.0 110.712 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -63.24 -43.94 96.62 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.788 0.328 . . . . 0.0 110.229 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 215' ' ' MET . . . . . 0.521 ' SD ' ' HB2' ' A' ' 304' ' ' ALA . 65.1 ttp -59.21 -48.1 82.86 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.148 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 87.8 mt -60.42 -41.02 93.06 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 217' ' ' GLU . . . . . 0.457 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.8 tp10 -58.0 -37.67 74.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.05 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -65.53 -38.07 88.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.659 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 94.4 mt -64.09 -42.8 96.79 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.662 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.52 44.91 0.08 OUTLIER Glycine 0 CA--C 1.52 0.391 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 221' ' ' PHE . . . . . 0.457 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 26.9 m-85 -127.92 155.42 44.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.073 0.463 . . . . 0.0 110.463 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.48 ' O ' HG13 ' A' ' 191' ' ' VAL . 7.2 p -107.27 122.49 46.66 Favored 'General case' 0 C--O 1.224 -0.248 0 CA-C-O 121.371 0.605 . . . . 0.0 110.088 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.476 HD22 ' C ' ' A' ' 222' ' ' THR . 4.3 mm? -101.43 133.02 46.7 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.162 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.77 159.78 14.73 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.459 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.47 115.33 30.07 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.391 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.497 HD12 ' N ' ' A' ' 226' ' ' LEU . 8.9 mp -53.16 156.54 3.71 Favored Pre-proline 0 N--CA 1.451 -0.415 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.764 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.01 145.34 98.6 Favored 'Trans proline' 0 C--N 1.299 -2.03 0 C-N-CA 122.744 2.296 . . . . 0.0 112.298 179.083 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.28 -3.38 59.04 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.535 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -89.96 -41.22 5.66 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.518 ' O ' ' N ' ' A' ' 233' ' ' SER . 69.8 mt -78.86 -17.59 55.37 Favored 'General case' 0 C--O 1.219 -0.522 0 CA-C-O 121.13 0.491 . . . . 0.0 110.379 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 54.4 t-20 -40.41 -49.2 2.83 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.807 -179.218 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -87.59 15.15 7.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.352 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.518 ' N ' ' O ' ' A' ' 230' ' ' LEU . 77.9 p -60.59 -35.3 75.76 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.703 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 234' ' ' GLN . . . . . 0.524 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.6 tt0 -119.0 -69.33 0.86 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.868 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.3 m -69.76 102.82 2.0 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.675 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -94.37 57.56 2.31 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.34 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -144.78 -122.42 1.56 Allowed Glycine 0 N--CA 1.461 0.309 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -135.12 111.69 9.93 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 121.183 0.516 . . . . 0.0 110.341 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 239' ' ' ARG . . . . . 0.525 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.6 mtt180 -148.22 57.85 1.08 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.655 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -69.47 -32.39 71.26 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.512 179.503 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 241' ' ' ASP . . . . . 0.546 ' CG ' HD21 ' A' ' 143' ' ' ASN . 64.8 t0 -56.84 -47.1 81.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.27 -179.027 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 242' ' ' ILE . . . . . 0.44 ' O ' ' O ' ' A' ' 239' ' ' ARG . 18.1 tt -139.88 156.4 25.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.933 0.397 . . . . 0.0 110.445 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.446 HG22 HD13 ' A' ' 245' ' ' LEU . 96.2 mt -106.3 106.65 20.99 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.206 0 CA-C-O 121.1 0.476 . . . . 0.0 110.567 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 244' ' ' GLN . . . . . 0.6 ' O ' HD12 ' A' ' 245' ' ' LEU . 88.2 mt-30 -110.49 110.0 20.57 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.232 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.6 HD12 ' O ' ' A' ' 244' ' ' GLN . 9.4 mp -121.69 -168.19 1.65 Allowed 'General case' 0 C--O 1.223 -0.297 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.752 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 246' ' ' GLY . . . . . 0.524 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.51 -16.37 0.05 OUTLIER Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.974 -0.851 . . . . 0.0 110.974 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 247' ' ' GLY . . . . . 0.672 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -61.04 156.61 32.96 Favored Glycine 0 CA--C 1.521 0.464 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -63.45 21.53 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.98 0.419 . . . . 0.0 110.649 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 249' ' ' ASN . . . . . 0.672 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.9 m-20 -97.2 -6.22 35.23 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.493 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 92.6 mt -79.48 -21.99 44.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.786 179.296 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.54 -51.36 70.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.734 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.24 -5.66 58.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.459 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.15 -74.48 1.14 Allowed Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.844 -0.902 . . . . 0.0 110.844 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 82.2 mt -70.02 126.07 28.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.017 0.437 . . . . 0.0 110.315 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -59.5 -39.37 83.57 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.11 -179.468 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 82.75 51.71 4.17 Favored Glycine 0 CA--C 1.52 0.37 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -96.14 -14.81 22.53 Favored 'General case' 0 C--N 1.333 -0.138 0 O-C-N 122.683 -0.304 . . . . 0.0 110.615 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 258' ' ' SER . . . . . 0.501 ' OG ' HG23 ' A' ' 191' ' ' VAL . 3.4 t 174.77 88.59 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.194 0.521 . . . . 0.0 110.092 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.857 HD12 ' N ' ' A' ' 259' ' ' LEU . 1.0 OUTLIER -94.43 124.44 38.46 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.228 0.537 . . . . 0.0 111.179 -179.129 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 260' ' ' PHE . . . . . 0.447 ' H ' ' HA ' ' A' ' 193' ' ' ALA . 15.8 m-30 -93.28 146.41 23.73 Favored 'General case' 0 CA--C 1.499 -1.012 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.396 179.394 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 85.2 mt -122.5 149.39 43.96 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.58 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.746 ' CD1' HG13 ' A' ' 195' ' ' VAL . 2.6 p90 -77.19 -138.36 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.612 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 263' ' ' ALA . . . . . 0.656 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -52.07 76.95 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 121.049 0.452 . . . . 0.0 111.188 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 264' ' ' GLY . . . . . 0.624 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -178.76 104.51 0.19 Allowed Glycine 0 CA--C 1.528 0.85 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 265' ' ' ASP . . . . . 0.596 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.5 m-20 -80.38 -178.04 6.46 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.585 0.231 . . . . 0.0 110.928 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -40.25 -17.91 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.579 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 267' ' ' LYS . . . . . 0.596 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.13 -51.66 43.65 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.722 179.195 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -63.6 -46.68 84.69 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.254 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 269' ' ' ALA . . . . . 0.569 ' HB1' ' OH ' ' A' ' 273' ' ' TYR . . . -61.67 -35.13 77.08 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 121.404 0.621 . . . . 0.0 109.822 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -63.07 -34.37 77.44 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.176 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.49 -43.27 13.71 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.126 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 272' ' ' ILE . . . . . 0.591 ' C ' ' H ' ' A' ' 274' ' ' ALA . 4.9 tt -51.39 -33.69 14.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.767 -178.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 273' ' ' TYR . . . . . 0.569 ' OH ' ' HB1' ' A' ' 269' ' ' ALA . 17.2 m-85 -54.43 -1.78 0.03 OUTLIER 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.703 -179.504 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 274' ' ' ALA . . . . . 0.591 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.5 -39.7 70.65 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.93 179.473 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 275' ' ' ASN . . . . . 0.579 ' O ' ' N ' ' A' ' 279' ' ' ALA . 3.1 p30 -38.98 98.02 0.15 Allowed Pre-proline 0 C--O 1.226 -0.149 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.449 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -54.64 -42.61 66.73 Favored 'Trans proline' 0 C--N 1.303 -1.835 0 C-N-CA 122.376 2.051 . . . . 0.0 112.513 -178.569 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 89.2 mt -64.57 -42.86 95.38 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.038 0.447 . . . . 0.0 111.15 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 91.2 mt -95.66 -1.63 49.74 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.939 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 279' ' ' ALA . . . . . 0.579 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.3 -34.68 77.06 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.748 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.21 20.04 0.12 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.014 -179.318 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 0.481 ' H ' ' C ' ' A' ' 279' ' ' ALA . 13.8 mt -75.18 119.46 77.04 Favored Pre-proline 0 N--CA 1.447 -0.605 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.729 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -49.9 -39.88 49.01 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.644 2.23 . . . . 0.0 112.281 178.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.64 -50.59 62.87 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.066 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 78.6 t -61.32 -44.0 97.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -57.85 -41.16 81.8 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.15 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -91.06 0.05 57.62 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.104 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt 59.56 43.61 15.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.945 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -95.08 41.42 1.09 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.34 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 54.1 t -119.13 135.68 58.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-O 121.052 0.453 . . . . 0.0 110.067 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -132.58 162.35 31.52 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.22 0.533 . . . . 0.0 110.608 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.6 154.96 33.16 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-O 121.038 0.447 . . . . 0.0 110.663 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 81.5 mt -93.68 -1.56 55.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.253 -179.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.01 166.22 12.93 Favored Glycine 0 CA--C 1.521 0.439 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 7.2 m -87.77 -62.46 1.49 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.855 0.36 . . . . 0.0 110.939 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 295' ' ' GLU . . . . . 0.437 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.4 mm-40 -69.35 -3.87 15.93 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.667 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 27.0 p -77.21 32.7 0.15 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.604 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 297' ' ' PHE . . . . . 0.529 ' CD2' HG22 ' A' ' 70' ' ' THR . 70.1 t80 -60.15 -46.21 90.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.603 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 298' ' ' ARG . . . . . 0.61 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.2 mtt85 -81.0 133.66 35.53 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.535 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.442 ' H ' HG11 ' A' ' 51' ' ' VAL . 16.4 tp -114.23 119.39 36.85 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.319 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 300' ' ' ASP . . . . . 0.622 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.1 p-10 -167.52 -173.85 2.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.612 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -48.58 -45.41 37.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.236 -179.37 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -64.97 -41.52 95.38 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.09 0.471 . . . . 0.0 110.697 178.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 303' ' ' SER . . . . . 0.622 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 52.6 p -55.39 -36.14 66.09 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.016 -179.223 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 304' ' ' ALA . . . . . 0.521 ' HB2' ' SD ' ' A' ' 215' ' ' MET . . . -56.7 -51.84 67.26 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.435 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 91.5 mtp -56.15 -43.99 78.83 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -66.23 -42.75 88.22 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.152 0.501 . . . . 0.0 110.238 179.038 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 307' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 303' ' ' SER . 55.1 t -64.04 -42.74 96.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.26 179.3 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 43.0 tp -59.67 -42.33 92.62 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.741 -179.341 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -62.55 -38.8 91.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.139 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 310' ' ' ARG . . . . . 0.442 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.5 ttt85 -63.51 -44.1 95.26 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.165 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 87.8 mt -63.2 -42.02 99.25 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.353 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -62.89 -33.24 74.88 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.13 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.93 -23.36 21.6 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.365 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.479 HD22 ' CE2' ' A' ' 315' ' ' PHE . 6.7 tt -62.41 -43.11 99.59 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 121.069 0.461 . . . . 0.0 110.597 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 315' ' ' PHE . . . . . 0.479 ' CE2' HD22 ' A' ' 314' ' ' LEU . 91.2 m-85 . . . . . 0 C--O 1.22 -0.46 0 CA-C-O 117.947 -1.025 . . . . 0.0 110.381 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -99.39 135.15 41.23 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.169 0.509 . . . . 0.0 110.469 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.491 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -92.19 178.68 1.6 Allowed Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.545 -179.802 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.491 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.8 Cg_exo -61.66 147.2 95.89 Favored 'Trans proline' 0 C--N 1.298 -2.097 0 C-N-CA 122.89 2.393 . . . . 0.0 112.117 179.56 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.477 ' HE ' HD12 ' A' ' 39' ' ' LEU . 35.1 ptt180 -135.91 142.11 44.62 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.732 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -79.66 116.94 20.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.462 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.449 ' O ' HG23 ' A' ' 30' ' ' ILE . 9.4 tp -111.93 130.55 65.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.399 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 12.6 t -71.01 142.27 50.94 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.008 0.432 . . . . 0.0 110.621 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.472 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.4 t0 -139.08 179.75 6.32 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.505 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.472 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 78.3 p -73.6 -37.37 65.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.777 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.8 ttt85 -46.94 -94.76 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.233 -179.278 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -166.08 -26.73 0.02 OUTLIER Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 62.5 m -168.58 106.02 0.45 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.806 0.336 . . . . 0.0 110.65 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.658 ' CD2' HD13 ' A' ' 140' ' ' LEU . 71.5 t60 -129.23 146.64 51.1 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 121.075 0.464 . . . . 0.0 110.151 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.62 HG22 ' N ' ' A' ' 39' ' ' LEU . 97.5 m -129.86 165.68 21.51 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.41 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.62 ' N ' HG22 ' A' ' 38' ' ' THR . 79.5 mt -120.42 127.21 52.05 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.485 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -65.44 -44.8 86.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.728 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 37.8 p -165.65 155.27 12.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.445 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.497 ' CD ' ' H ' ' A' ' 42' ' ' GLN . 14.6 mp0 -44.43 100.71 0.23 Allowed Pre-proline 0 C--O 1.236 0.374 0 O-C-N 123.527 0.517 . . . . 0.0 110.634 179.193 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -57.51 129.78 35.6 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 C-N-CA 122.322 2.014 . . . . 0.0 112.337 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -83.09 -24.62 32.6 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.567 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.531 ' NE ' ' O ' ' A' ' 112' ' ' MET . 90.1 mtm-85 -121.04 134.2 55.27 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.214 0.531 . . . . 0.0 110.15 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.1 mt -130.72 133.67 63.01 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.846 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 46.4 t -124.77 131.34 72.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.619 ' OG ' HD12 ' A' ' 117' ' ' LEU . 4.4 m -154.38 166.14 34.16 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.584 179.451 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 63.3 p -124.66 8.32 8.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.395 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.6 126.15 33.68 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.801 0.334 . . . . 0.0 110.687 -179.525 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.461 HG11 ' H ' ' A' ' 299' ' ' LEU . 88.7 t -65.65 -44.61 93.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.521 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.3 m -62.55 -44.33 96.6 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.709 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 54.0 tp -62.29 -41.59 98.63 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.558 -179.464 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.451 ' O ' HD13 ' A' ' 58' ' ' LEU . 69.5 m -58.18 -44.48 88.04 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.124 -179.05 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.31 -62.19 5.35 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.7 t -48.08 -35.77 11.91 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 20.3 mt -61.78 -44.26 97.23 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 120.598 -0.441 . . . . 0.0 111.321 179.188 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.451 HD13 ' O ' ' A' ' 54' ' ' THR . 9.4 mp -65.26 -41.68 94.03 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.518 177.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.45 -41.26 98.64 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.921 -179.323 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.415 ' O ' HG23 ' A' ' 60' ' ' ILE . 8.0 tp -87.8 16.75 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.864 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 56.31 84.14 0.09 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.804 -179.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.61 58.21 0.08 OUTLIER Pre-proline 0 C--N 1.327 -0.381 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -50.93 152.9 9.43 Favored 'Trans proline' 0 C--N 1.294 -2.333 0 C-N-CA 123.033 2.488 . . . . 0.0 112.228 -178.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.43 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -108.78 146.39 14.5 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.178 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.31 -179.69 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 97.0 mt -63.65 -45.08 98.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.478 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.498 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -130.45 134.49 47.14 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 120.868 0.366 . . . . 0.0 110.49 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.489 ' O ' ' N ' ' A' ' 98' ' ' LEU . 66.9 m -134.42 158.55 43.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.922 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.81 139.43 16.35 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.494 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.85 -162.69 0.08 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.003 0.43 . . . . 0.0 110.384 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.522 HG22 ' CD2' ' A' ' 297' ' ' PHE . 14.6 t -133.57 135.37 44.27 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.314 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.474 ' C ' ' O ' ' A' ' 70' ' ' THR . 0.7 OUTLIER 29.76 68.88 0.65 Allowed Pre-proline 0 N--CA 1.469 0.475 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.857 -179.866 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -61.59 145.34 97.79 Favored 'Trans proline' 0 C--N 1.299 -2.054 0 C-N-CA 122.672 2.248 . . . . 0.0 111.873 -177.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.528 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 46.0 p-10 -160.05 -31.79 0.06 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.799 179.486 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.529 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 98.9 m-20 -64.41 -39.33 93.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.348 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -60.7 -47.97 83.88 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.481 -179.024 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.425 ' O ' ' O ' ' A' ' 77' ' ' ALA . 92.8 t -60.35 -24.86 32.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.529 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -45.52 172.85 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.695 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.566 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.7 p30 -61.72 177.48 0.41 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.448 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.565 ' C ' ' H ' ' A' ' 81' ' ' GLY . 36.3 p30 -46.07 85.65 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.016 0.436 . . . . 0.0 110.971 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.566 ' N ' ' O ' ' A' ' 78' ' ' ASP . 42.7 tp60 -67.19 13.55 0.06 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.176 0.512 . . . . 0.0 110.065 -179.637 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.565 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 117.82 -22.13 10.08 Favored Glycine 0 N--CA 1.461 0.334 0 N-CA-C 110.911 -0.876 . . . . 0.0 110.911 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -107.44 116.3 31.7 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.01 0.433 . . . . 0.0 110.454 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 75.7 mt -98.49 0.46 45.17 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 120.992 0.425 . . . . 0.0 110.582 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -92.14 6.52 46.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.027 0.441 . . . . 0.0 110.276 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.772 ' O ' HG22 ' A' ' 89' ' ' VAL . 27.1 mt-30 -100.12 -26.63 13.88 Favored 'General case' 0 C--O 1.219 -0.511 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.796 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 75.9 t-105 -64.64 -40.76 96.01 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.109 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.549 ' O ' ' N ' ' A' ' 91' ' ' LYS . 68.1 m -77.85 -53.53 7.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.316 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -48.49 -50.52 31.33 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.089 -179.126 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.772 HG22 ' O ' ' A' ' 85' ' ' GLN . 14.3 m -68.92 -40.82 81.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.209 179.387 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.499 ' N ' HG23 ' A' ' 89' ' ' VAL . . . -71.89 -23.04 61.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.725 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.549 ' N ' ' O ' ' A' ' 87' ' ' SER . 65.9 tttm -61.62 -45.67 93.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.442 -179.428 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.44 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.3 mm-40 -90.6 -94.56 0.12 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.012 0.434 . . . . 0.0 110.05 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.615 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.9 mtt180 -143.48 59.44 1.39 Allowed 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.441 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.6 pttp 34.45 25.77 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.084 0.468 . . . . 0.0 110.336 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.615 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.5 tt -48.24 123.34 6.28 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.078 -177.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.451 ' O ' HD23 ' A' ' 95' ' ' LEU . 99.0 mm-40 -83.53 -170.84 3.26 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.054 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.609 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 82.2 mtp180 -73.17 137.6 45.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.12 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.489 ' N ' ' O ' ' A' ' 67' ' ' SER . 90.3 mt -86.11 -166.29 1.5 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.868 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.536 ' O ' ' CD2' ' A' ' 99' ' ' TYR . 47.5 p90 -167.96 119.95 0.86 Allowed 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.065 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.494 ' C ' ' O ' ' A' ' 99' ' ' TYR . 42.8 mm -29.56 121.05 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.055 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 113.96 27.91 3.32 Favored Glycine 0 C--N 1.331 0.291 0 N-CA-C 111.326 -0.71 . . . . 0.0 111.326 -179.216 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.581 ' N ' ' CD ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -143.85 45.83 0.6 Allowed Pre-proline 0 C--N 1.321 -0.632 0 CA-C-O 121.087 0.47 . . . . 0.0 110.427 179.817 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.581 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 29.8 Cg_endo -62.02 143.84 95.52 Favored 'Trans proline' 0 C--N 1.294 -2.306 0 C-N-CA 122.593 2.195 . . . . 0.0 111.881 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.464 ' O ' HG23 ' A' ' 108' ' ' VAL . 24.3 t -173.26 120.6 0.34 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.283 179.53 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.02 -40.98 64.71 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.104 0.478 . . . . 0.0 111.281 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -65.93 -40.11 91.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.864 -179.475 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.98 -39.81 94.98 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.719 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 104' ' ' SER . 69.4 t -67.48 -43.87 87.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.762 179.585 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.43 -39.05 92.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.461 -179.119 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.44 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.58 -23.58 63.05 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.513 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.533 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.3 mm-40 -91.17 5.05 50.6 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.746 -179.568 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.533 ' C ' ' O ' ' A' ' 111' ' ' GLN . 10.5 tpt 22.98 64.14 0.36 Allowed Pre-proline 0 N--CA 1.469 0.511 0 CA-C-O 120.883 0.373 . . . . 0.0 111.2 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.442 ' HG2' HD11 ' A' ' 116' ' ' ILE . 65.0 Cg_endo -78.93 168.37 20.87 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 123.017 2.478 . . . . 0.0 111.758 -177.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.527 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 99.0 m-20 -112.38 -44.21 3.41 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.003 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 39.8 tp -120.67 119.48 32.94 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.456 HD13 HD22 ' A' ' 133' ' ' LEU . 96.1 mt -116.43 131.19 69.73 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.408 0 CA-C-O 120.887 0.375 . . . . 0.0 111.007 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.619 HD12 ' OG ' ' A' ' 48' ' ' SER . 28.5 mt -105.99 132.67 51.8 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.192 -179.299 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.42 HD12 HG23 ' A' ' 139' ' ' THR . 98.1 mt -118.08 136.01 56.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.695 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 86.4 p -72.09 153.45 41.69 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.603 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.14 -50.04 75.25 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.651 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -149.46 154.03 38.19 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.593 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 169.73 -170.31 42.66 Favored Glycine 0 CA--C 1.525 0.719 0 N-CA-C 110.969 -0.852 . . . . 0.0 110.969 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -63.16 -34.94 91.32 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 110.864 -0.894 . . . . 0.0 110.864 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.444 ' OD1' ' O ' ' A' ' 124' ' ' ASP . 43.9 p-10 -87.89 120.11 28.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.855 0.36 . . . . 0.0 110.607 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.446 ' O ' HD12 ' A' ' 129' ' ' LEU . 39.6 t -63.51 144.26 57.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.386 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.517 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.2 -43.13 8.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.013 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.4 tp -62.79 -42.43 99.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.752 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.8 -11.11 57.83 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.52 -179.328 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.446 HD12 ' O ' ' A' ' 125' ' ' SER . 85.1 mt -115.54 -23.99 8.53 Favored 'General case' 0 C--O 1.225 -0.23 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.668 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' TYR . . . . . 0.517 ' N ' ' O ' ' A' ' 126' ' ' ALA . 77.7 t80 -51.87 -49.62 62.6 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.666 -178.802 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.5 p-10 -65.83 -42.02 91.05 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.282 179.177 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.522 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 87.9 mt-30 -67.45 -37.04 82.37 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.949 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.456 HD22 HD13 ' A' ' 116' ' ' ILE . 94.1 mt -79.69 -42.31 24.98 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.958 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.3 t -57.12 -44.81 83.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.25 -178.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.9 m -62.33 -45.58 92.56 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.463 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 93.1 mt -62.5 -43.89 98.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.307 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.595 ' HB1' ' HD2' ' A' ' 138' ' ' PRO . . . -169.8 163.68 6.61 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.588 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.595 ' HD2' ' HB1' ' A' ' 137' ' ' ALA . 75.4 Cg_exo -43.71 111.91 0.28 Allowed 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.374 2.05 . . . . 0.0 112.3 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.458 HG21 ' CD1' ' A' ' 130' ' ' TYR . 18.2 m -85.37 127.34 34.33 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.541 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.658 HD13 ' CD2' ' A' ' 37' ' ' HIS . 34.2 tp -118.73 135.18 54.63 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 120.976 0.417 . . . . 0.0 110.077 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.425 ' O ' ' OD2' ' A' ' 32' ' ' ASP . 80.1 mt -102.01 120.04 51.13 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.345 0 CA-C-O 121.172 0.511 . . . . 0.0 111.332 -179.381 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.497 HD12 HD22 ' A' ' 117' ' ' LEU . 97.4 mt -135.79 132.94 51.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.702 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.519 ' ND2' ' H ' ' A' ' 144' ' ' TYR . 2.2 t-20 -65.81 152.03 45.31 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.99 0.424 . . . . 0.0 110.356 179.21 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.523 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 87.9 t80 -85.81 122.48 29.94 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.999 -179.5 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.523 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 99.2 m-20 55.06 69.41 0.74 Allowed 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.713 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 49.4 p-10 -123.56 0.06 8.73 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 120.853 0.359 . . . . 0.0 110.625 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -151.61 117.17 5.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.735 -179.419 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 84.6 p -63.27 167.49 5.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.557 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.411 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.7 p-90 -50.62 -15.85 0.31 Allowed 'General case' 0 C--O 1.22 -0.497 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.429 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.445 ' O ' HG23 ' A' ' 154' ' ' THR . 68.2 tp60 -71.23 -74.81 0.14 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.941 0.401 . . . . 0.0 110.443 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.448 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.2 t -62.62 -39.11 92.77 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.138 179.535 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 54.3 tp -60.35 -45.41 93.57 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.361 -178.32 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.411 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 45.9 tp -62.63 -41.62 99.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.52 178.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.448 ' OG1' ' O ' ' A' ' 151' ' ' SER . 54.6 p -64.03 -34.68 78.55 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.136 -179.292 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.445 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 88.0 mm-40 -63.93 -42.47 97.35 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.258 179.235 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 91.1 mt -65.3 -38.97 91.84 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.242 0.544 . . . . 0.0 110.249 179.132 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.571 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.17 -32.26 79.91 Favored Glycine 0 C--N 1.332 0.331 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 -179.177 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.445 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.2 mt-10 -36.16 -25.91 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.812 0.339 . . . . 0.0 110.877 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.571 ' N ' ' O ' ' A' ' 157' ' ' GLY . 95.1 mt -58.26 149.6 5.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.326 178.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 77.7 p -69.39 137.27 52.66 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.038 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 70.88 21.46 78.14 Favored Glycine 0 N--CA 1.459 0.201 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 179.54 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 59.4 m80 -123.09 -15.11 7.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.585 0.231 . . . . 0.0 110.452 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -66.28 -59.54 3.63 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.698 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -52.2 -48.83 64.84 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 120.709 -0.397 . . . . 0.0 110.101 -179.432 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -60.78 -40.99 94.63 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.839 0.352 . . . . 0.0 110.44 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.47 -47.41 85.79 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.522 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.89 -40.22 75.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.199 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -61.68 -50.22 73.35 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.62 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -65.16 -43.81 90.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.533 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 94.7 mt -64.63 -43.4 96.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.406 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.31 -51.23 70.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.446 -179.074 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.6 -43.53 96.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.867 0.365 . . . . 0.0 110.592 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.663 ' CE2' HD11 ' A' ' 177' ' ' LEU . 57.0 t80 -62.78 -44.42 96.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.144 0.497 . . . . 0.0 110.405 179.442 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -63.71 -39.68 94.92 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.394 -179.148 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -62.9 -42.82 99.91 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.573 179.152 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -60.82 -44.48 96.85 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.064 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.663 HD11 ' CE2' ' A' ' 173' ' ' PHE . 84.7 mt -64.42 -41.18 96.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.983 0.42 . . . . 0.0 110.778 178.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.08 -62.06 1.87 Allowed 'General case' 0 C--O 1.239 0.516 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.34 -179.286 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.76 -46.83 86.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.42 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.24 -41.59 65.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.275 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -63.8 -33.81 76.5 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.962 0.411 . . . . 0.0 110.23 179.378 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.412 ' O ' ' HG2' ' A' ' 182' ' ' GLU . 70.0 tt0 -90.63 8.79 32.46 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.622 0.725 . . . . 0.0 110.341 -178.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -104.73 -32.09 9.03 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.233 179.38 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.8 pt -127.95 147.74 32.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.816 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -139.98 131.38 26.87 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.31 179.18 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.589 HD22 ' N ' ' A' ' 186' ' ' LEU . 3.5 mm? -85.42 133.29 42.61 Favored Pre-proline 0 N--CA 1.45 -0.444 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.15 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -43.92 158.0 0.13 Allowed 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.706 2.271 . . . . 0.0 112.258 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 0.496 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.9 Cg_endo -63.1 114.72 2.58 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.748 2.299 . . . . 0.0 111.677 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 189' ' ' GLN . . . . . 0.496 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.7 mt-30 155.87 148.1 0.0 OUTLIER Pre-proline 0 N--CA 1.454 -0.264 0 O-C-N 124.088 0.868 . . . . 0.0 110.834 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.63 144.37 35.49 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.593 2.195 . . . . 0.0 112.095 177.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.497 HG23 ' OG ' ' A' ' 258' ' ' SER . 2.1 p -124.9 158.76 32.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.439 0.638 . . . . 0.0 110.159 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 192' ' ' THR . . . . . 0.488 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 37.0 p -143.07 165.34 27.65 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.193 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 193' ' ' ALA . . . . . 0.45 ' HA ' ' H ' ' A' ' 260' ' ' PHE . . . -135.32 128.74 32.3 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 121.43 0.634 . . . . 0.0 110.099 179.341 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.51 HD11 HD23 ' A' ' 259' ' ' LEU . 47.2 pt -146.52 149.05 16.34 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.44 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.236 179.638 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 195' ' ' VAL . . . . . 0.75 HG13 ' CD1' ' A' ' 262' ' ' PHE . 72.1 t -117.95 123.51 71.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.421 0.629 . . . . 0.0 109.691 179.048 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -134.58 107.27 7.41 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.206 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 94.1 m -130.96 130.66 43.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.868 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.401 ' O ' ' N ' ' A' ' 201' ' ' HIS . . . -82.8 -37.08 24.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.15 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.41 -67.08 0.26 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.276 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.34 -9.88 59.06 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.248 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' HIS . . . . . 0.401 ' N ' ' O ' ' A' ' 198' ' ' ALA . 60.5 t-80 60.63 58.35 2.47 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.807 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 38.8 p -167.05 153.84 8.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.553 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.4 144.18 24.41 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.031 0.443 . . . . 0.0 110.37 179.265 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -135.33 138.18 43.16 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.663 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 20.0 mt -106.25 125.55 51.14 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 206' ' ' TRP . . . . . 0.557 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 75.7 m95 -82.0 166.95 19.37 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.666 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 207' ' ' THR . . . . . 0.454 HG22 ' C ' ' A' ' 206' ' ' TRP . 0.1 OUTLIER -156.98 171.23 7.72 Favored Pre-proline 0 C--O 1.224 -0.25 0 CA-C-O 120.999 0.428 . . . . 0.0 110.562 -178.99 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.62 -37.03 83.08 Favored 'Trans proline' 0 C--N 1.301 -1.949 0 C-N-CA 122.612 2.208 . . . . 0.0 112.236 179.149 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -70.64 -35.01 72.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.729 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 22.7 m -61.24 150.57 34.22 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.698 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.41 -37.11 82.28 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.442 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 212' ' ' GLN . . . . . 0.557 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 55.0 tt0 -64.74 -40.07 94.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.538 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.8 -43.46 91.6 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -63.31 -43.5 97.66 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.813 0.339 . . . . 0.0 110.225 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 215' ' ' MET . . . . . 0.532 ' SD ' ' HB2' ' A' ' 304' ' ' ALA . 65.4 ttp -59.49 -48.03 83.21 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.34 -0.391 . . . . 0.0 109.986 -179.667 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 87.0 mt -60.71 -40.82 93.68 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 217' ' ' GLU . . . . . 0.45 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.4 tp10 -58.2 -37.66 75.22 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -65.33 -38.21 89.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.715 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 94.2 mt -64.06 -42.76 96.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.154 0.502 . . . . 0.0 110.716 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.69 44.77 0.08 OUTLIER Glycine 0 C--N 1.333 0.379 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 221' ' ' PHE . . . . . 0.45 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 27.4 m-85 -127.96 155.48 44.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.02 0.438 . . . . 0.0 110.446 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.482 ' O ' HG13 ' A' ' 191' ' ' VAL . 6.8 p -107.23 122.48 46.62 Favored 'General case' 0 C--O 1.223 -0.291 0 CA-C-O 121.368 0.604 . . . . 0.0 110.06 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.472 HD22 ' C ' ' A' ' 222' ' ' THR . 4.3 mm? -101.33 132.73 46.74 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.196 179.671 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.46 159.54 14.88 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.536 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.43 115.51 30.38 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.992 0.425 . . . . 0.0 110.318 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.497 HD12 ' N ' ' A' ' 226' ' ' LEU . 8.8 mp -53.31 156.55 3.97 Favored Pre-proline 0 N--CA 1.449 -0.515 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.764 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -60.09 145.17 99.04 Favored 'Trans proline' 0 C--N 1.3 -1.987 0 C-N-CA 122.677 2.251 . . . . 0.0 112.163 179.171 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.13 -3.22 59.05 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.545 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.14 -40.99 5.67 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.517 ' O ' ' N ' ' A' ' 233' ' ' SER . 86.0 mt -79.14 -17.04 55.75 Favored 'General case' 0 C--O 1.218 -0.581 0 CA-C-O 121.11 0.481 . . . . 0.0 110.25 -179.646 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 54.3 t-20 -40.58 -48.96 2.95 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.876 -179.3 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -87.75 15.25 7.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.493 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.517 ' N ' ' O ' ' A' ' 230' ' ' LEU . 77.9 p -60.63 -35.28 75.8 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.673 -179.646 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 234' ' ' GLN . . . . . 0.526 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.6 tt0 -118.87 -69.28 0.86 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.922 179.132 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.3 m -69.62 103.13 2.02 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.067 0.46 . . . . 0.0 110.701 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -94.55 57.33 2.22 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.305 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -144.65 -122.48 1.58 Allowed Glycine 0 C--N 1.332 0.334 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -135.07 112.09 10.27 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.256 0.551 . . . . 0.0 110.316 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 239' ' ' ARG . . . . . 0.521 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.4 mtt180 -148.31 58.05 1.08 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.661 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -69.59 -32.16 70.75 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.562 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 241' ' ' ASP . . . . . 0.453 ' OD2' ' O ' ' A' ' 144' ' ' TYR . 64.7 t0 -57.05 -46.86 82.12 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.322 -178.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 242' ' ' ILE . . . . . 0.435 ' O ' ' O ' ' A' ' 239' ' ' ARG . 17.8 tt -140.25 156.77 24.66 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.306 0 CA-C-O 120.905 0.383 . . . . 0.0 110.419 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.444 HG22 HD13 ' A' ' 245' ' ' LEU . 96.2 mt -106.39 106.87 21.4 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 CA-C-O 121.19 0.519 . . . . 0.0 110.433 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 244' ' ' GLN . . . . . 0.595 ' O ' HD12 ' A' ' 245' ' ' LEU . 88.2 mt-30 -110.78 110.35 20.95 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.283 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.595 HD12 ' O ' ' A' ' 244' ' ' GLN . 9.5 mp -121.75 -168.22 1.66 Allowed 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.622 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 246' ' ' GLY . . . . . 0.526 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.53 -16.65 0.05 OUTLIER Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 247' ' ' GLY . . . . . 0.667 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -60.72 156.9 31.07 Favored Glycine 0 CA--C 1.521 0.425 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -63.83 21.9 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.901 0.381 . . . . 0.0 110.534 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 249' ' ' ASN . . . . . 0.667 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.8 m-20 -97.56 -6.08 34.28 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.761 0.315 . . . . 0.0 110.516 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 93.0 mt -79.65 -21.76 44.41 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.868 179.285 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.6 -51.25 70.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.724 -179.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.46 -5.45 58.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.402 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.17 -74.21 1.15 Allowed Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.744 -0.942 . . . . 0.0 110.744 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 83.3 mt -70.33 126.39 29.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.927 0.394 . . . . 0.0 110.17 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -59.96 -39.04 84.27 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.159 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 82.85 51.67 4.16 Favored Glycine 0 CA--C 1.519 0.335 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -95.59 -15.2 22.96 Favored 'General case' 0 N--CA 1.463 0.189 0 O-C-N 122.666 -0.314 . . . . 0.0 110.623 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 258' ' ' SER . . . . . 0.497 ' OG ' HG23 ' A' ' 191' ' ' VAL . 3.4 t 174.72 89.02 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.195 0.521 . . . . 0.0 110.036 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.852 HD12 ' N ' ' A' ' 259' ' ' LEU . 0.9 OUTLIER -94.6 124.43 38.63 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.21 0.528 . . . . 0.0 111.291 -179.143 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 260' ' ' PHE . . . . . 0.45 ' H ' ' HA ' ' A' ' 193' ' ' ALA . 15.8 m-30 -93.42 146.3 23.85 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.311 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 86.6 mt -122.29 149.55 43.58 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.532 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.75 ' CD1' HG13 ' A' ' 195' ' ' VAL . 2.6 p90 -77.28 -138.57 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.657 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 263' ' ' ALA . . . . . 0.65 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -51.87 77.14 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 121.041 0.448 . . . . 0.0 111.27 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 264' ' ' GLY . . . . . 0.62 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.05 104.58 0.19 Allowed Glycine 0 CA--C 1.527 0.843 0 N-CA-C 110.414 -1.074 . . . . 0.0 110.414 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 265' ' ' ASP . . . . . 0.589 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.8 m-20 -80.32 -177.88 6.35 Favored 'General case' 0 CA--C 1.515 -0.393 0 O-C-N 122.681 -0.306 . . . . 0.0 110.944 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -40.65 -17.82 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.524 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 267' ' ' LYS . . . . . 0.589 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.02 -51.56 45.61 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.743 179.102 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -63.87 -46.48 84.76 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.095 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 269' ' ' ALA . . . . . 0.57 ' HB1' ' OH ' ' A' ' 273' ' ' TYR . . . -61.8 -35.13 77.29 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 121.526 0.679 . . . . 0.0 109.716 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -62.84 -34.54 77.54 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.025 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.66 -43.07 13.74 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.217 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 272' ' ' ILE . . . . . 0.592 ' C ' ' H ' ' A' ' 274' ' ' ALA . 4.9 tt -51.27 -33.71 14.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.776 -178.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 273' ' ' TYR . . . . . 0.57 ' OH ' ' HB1' ' A' ' 269' ' ' ALA . 17.2 m-85 -54.5 -1.76 0.03 OUTLIER 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.686 -179.392 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 274' ' ' ALA . . . . . 0.592 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.51 -39.86 70.53 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.906 179.502 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 275' ' ' ASN . . . . . 0.576 ' O ' ' N ' ' A' ' 279' ' ' ALA . 3.0 p30 -38.91 97.74 0.15 Allowed Pre-proline 0 C--O 1.226 -0.174 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.448 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -54.21 -42.8 64.19 Favored 'Trans proline' 0 C--N 1.303 -1.856 0 C-N-CA 122.329 2.02 . . . . 0.0 112.668 -178.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 88.4 mt -64.32 -42.86 96.09 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.089 0.471 . . . . 0.0 111.297 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 91.8 mt -95.56 -1.7 49.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.862 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 279' ' ' ALA . . . . . 0.576 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.36 -34.87 77.52 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.6 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.1 20.0 0.11 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.076 -179.31 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 0.481 ' H ' ' C ' ' A' ' 279' ' ' ALA . 13.8 mt -74.97 119.75 78.35 Favored Pre-proline 0 N--CA 1.445 -0.719 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.725 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -50.6 -39.57 55.85 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.539 2.159 . . . . 0.0 112.035 179.012 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.83 -50.37 63.86 Favored 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 73.0 t -61.54 -43.81 97.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -57.97 -41.2 82.43 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.098 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -90.93 0.31 57.54 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.083 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt 59.24 43.06 17.47 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.027 0.441 . . . . 0.0 110.976 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -94.62 41.65 1.09 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.282 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 53.9 t -119.21 135.48 59.47 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-O 121.096 0.474 . . . . 0.0 109.958 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -132.69 162.6 30.96 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.678 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.74 155.27 32.8 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 121.079 0.466 . . . . 0.0 110.667 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 82.8 mt -94.22 -1.47 54.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.176 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.49 165.81 12.72 Favored Glycine 0 C--N 1.335 0.528 0 N-CA-C 110.489 -1.044 . . . . 0.0 110.489 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 6.7 m -87.75 -62.33 1.52 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.871 0.367 . . . . 0.0 111.044 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 295' ' ' GLU . . . . . 0.442 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.5 mm-40 -69.35 -4.02 16.53 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.69 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 25.5 p -76.71 32.76 0.13 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.623 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 297' ' ' PHE . . . . . 0.522 ' CD2' HG22 ' A' ' 70' ' ' THR . 85.5 t80 -60.18 -46.07 90.98 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.624 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 298' ' ' ARG . . . . . 0.609 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.2 mtt85 -81.33 134.76 35.63 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.617 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.461 ' H ' HG11 ' A' ' 51' ' ' VAL . 16.7 tp -114.66 118.71 34.42 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-O 120.985 0.421 . . . . 0.0 110.206 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 300' ' ' ASP . . . . . 0.628 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.5 p-10 -166.15 -175.44 3.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.651 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 81.1 t80 -47.76 -44.22 28.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.209 -179.549 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -66.09 -40.74 91.04 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.107 0.48 . . . . 0.0 110.804 178.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 303' ' ' SER . . . . . 0.628 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 56.0 p -56.04 -35.73 67.22 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.951 -179.005 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 304' ' ' ALA . . . . . 0.532 ' HB2' ' SD ' ' A' ' 215' ' ' MET . . . -57.28 -51.45 69.33 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.409 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 91.1 mtp -56.46 -43.78 79.9 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -179.568 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -66.32 -42.52 88.11 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.21 0.528 . . . . 0.0 110.253 179.077 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 307' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 303' ' ' SER . 55.7 t -64.08 -42.99 97.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.135 179.364 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 42.7 tp -59.63 -42.24 92.27 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.101 -0.499 . . . . 0.0 109.73 -179.29 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -62.7 -38.71 91.48 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 310' ' ' ARG . . . . . 0.446 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.5 ttt85 -63.49 -43.81 96.17 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.218 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 88.8 mt -63.2 -42.06 99.27 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.273 179.693 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -62.89 -33.33 75.07 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.083 179.493 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.86 -23.45 21.65 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.383 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.479 HD22 ' CE2' ' A' ' 315' ' ' PHE . 6.7 tt -62.44 -43.16 99.47 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 121.079 0.466 . . . . 0.0 110.563 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 315' ' ' PHE . . . . . 0.479 ' CE2' HD22 ' A' ' 314' ' ' LEU . 91.1 m-85 . . . . . 0 C--O 1.22 -0.484 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.319 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -99.55 136.67 39.14 Favored 'General case' 0 CA--C 1.521 -0.164 0 CA-C-O 121.091 0.472 . . . . 0.0 110.442 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.492 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -91.86 178.61 1.66 Allowed Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.57 -179.827 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.492 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.2 Cg_exo -61.61 146.94 96.46 Favored 'Trans proline' 0 C--N 1.3 -2.025 0 C-N-CA 122.833 2.355 . . . . 0.0 112.144 179.564 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.456 ' HE ' HD12 ' A' ' 39' ' ' LEU . 35.3 ptt180 -136.03 142.16 44.41 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.638 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -79.34 116.69 19.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.44 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.446 ' O ' HG23 ' A' ' 30' ' ' ILE . 9.5 tp -110.98 130.53 64.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.536 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.0 t -71.0 141.76 50.97 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.638 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.477 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.5 t0 -139.33 179.51 6.49 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.532 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.477 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 77.9 p -73.8 -36.98 65.07 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.569 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.7 ttt85 -46.48 -94.43 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.296 -179.347 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -167.55 -26.49 0.02 OUTLIER Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 60.8 m -168.97 104.8 0.4 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.777 0.322 . . . . 0.0 110.657 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.688 ' CD2' HD13 ' A' ' 140' ' ' LEU . 74.6 t60 -128.65 149.0 50.84 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.087 0.47 . . . . 0.0 110.214 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.624 HG22 ' N ' ' A' ' 39' ' ' LEU . 98.2 m -131.36 166.07 22.06 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.453 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.624 ' N ' HG22 ' A' ' 38' ' ' THR . 81.9 mt -120.93 127.28 51.69 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.464 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -64.91 -44.55 89.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.718 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 40.0 p -165.71 155.08 12.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.373 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.468 ' CD ' ' H ' ' A' ' 42' ' ' GLN . 14.7 mp0 -44.3 100.9 0.24 Allowed Pre-proline 0 C--N 1.329 -0.286 0 O-C-N 123.503 0.502 . . . . 0.0 110.598 179.221 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.53 129.99 36.67 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 C-N-CA 122.305 2.003 . . . . 0.0 112.245 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -83.73 -24.78 31.05 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.558 179.577 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.538 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.6 mtm-85 -122.33 134.84 54.64 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.27 0.557 . . . . 0.0 110.234 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.2 mt -130.73 133.78 62.83 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.329 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.871 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 45.0 t -124.11 130.55 73.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 CA-C-O 120.945 0.402 . . . . 0.0 109.968 179.274 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.624 ' OG ' HD12 ' A' ' 117' ' ' LEU . 2.1 m -154.57 167.17 30.99 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.542 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 64.4 p -124.75 9.26 8.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.385 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.98 125.43 33.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.858 0.361 . . . . 0.0 110.685 -179.495 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.458 HG11 ' H ' ' A' ' 299' ' ' LEU . 93.3 t -65.63 -44.53 93.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.463 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.1 m -62.38 -44.3 96.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.618 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 49.6 tp -62.34 -41.3 98.46 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.528 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.439 ' O ' HD13 ' A' ' 58' ' ' LEU . 74.3 m -57.65 -44.43 85.65 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.286 -179.309 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.3 -62.33 5.23 Favored Glycine 0 N--CA 1.467 0.761 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.7 t -48.22 -35.59 12.21 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.9 mt -61.78 -44.43 96.9 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.648 -0.421 . . . . 0.0 111.305 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.439 HD13 ' O ' ' A' ' 54' ' ' THR . 9.3 mp -65.54 -41.26 93.26 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.333 177.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.59 -40.75 97.75 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.858 -179.266 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.42 ' O ' HG23 ' A' ' 60' ' ' ILE . 8.1 tp -89.03 16.98 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.857 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 56.17 85.33 0.07 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.797 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 178.72 59.47 0.08 OUTLIER Pre-proline 0 C--N 1.327 -0.386 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -52.18 152.55 14.61 Favored 'Trans proline' 0 C--N 1.292 -2.401 0 C-N-CA 123.048 2.499 . . . . 0.0 112.063 -178.179 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.435 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -108.65 145.27 15.79 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.171 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.271 -179.661 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.8 mt -63.57 -45.42 97.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.388 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.501 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -129.49 134.1 47.61 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.517 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.504 ' O ' ' N ' ' A' ' 98' ' ' LEU . 75.4 m -134.6 158.6 43.6 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.891 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.7 139.0 16.1 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.694 -0.962 . . . . 0.0 110.694 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.493 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.79 -162.81 0.08 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.936 0.398 . . . . 0.0 110.461 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.537 HG22 ' CD2' ' A' ' 297' ' ' PHE . 14.5 t -133.65 134.74 43.53 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.289 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.481 ' C ' ' O ' ' A' ' 70' ' ' THR . 0.1 OUTLIER 29.65 68.73 0.65 Allowed Pre-proline 0 N--CA 1.467 0.403 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.735 -179.865 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_exo -61.74 145.67 97.18 Favored 'Trans proline' 0 C--N 1.3 -2.022 0 C-N-CA 122.669 2.246 . . . . 0.0 111.708 -177.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.525 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 45.3 p-10 -159.39 -32.1 0.06 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.718 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.541 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 99.1 m-20 -64.11 -39.42 94.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.387 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -60.36 -48.32 82.25 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.555 -179.136 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.424 ' O ' ' O ' ' A' ' 77' ' ' ALA . 93.9 t -60.16 -25.1 32.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.053 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.541 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -45.68 173.1 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.635 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.571 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.5 p30 -62.41 178.03 0.45 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.505 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.556 ' C ' ' H ' ' A' ' 81' ' ' GLY . 36.2 p30 -45.0 85.63 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.096 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.571 ' N ' ' O ' ' A' ' 78' ' ' ASP . 42.1 tp60 -67.65 13.21 0.08 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.207 0.527 . . . . 0.0 110.162 -179.657 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.556 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 118.63 -22.5 9.33 Favored Glycine 0 N--CA 1.461 0.33 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -108.12 116.25 31.62 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.013 0.435 . . . . 0.0 110.381 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 76.1 mt -98.27 -0.0 44.83 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.578 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -92.34 7.4 43.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.015 0.436 . . . . 0.0 110.39 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.794 ' O ' HG22 ' A' ' 89' ' ' VAL . 27.2 mt-30 -100.24 -27.7 13.37 Favored 'General case' 0 C--O 1.222 -0.387 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.754 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 69.0 t-105 -62.94 -40.55 98.0 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.942 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.551 ' O ' ' N ' ' A' ' 91' ' ' LYS . 64.2 m -77.93 -53.59 7.28 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.958 -179.311 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -48.49 -50.77 30.26 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.052 -179.136 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.794 HG22 ' O ' ' A' ' 85' ' ' GLN . 15.8 m -68.8 -40.57 81.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.161 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.496 ' N ' HG23 ' A' ' 89' ' ' VAL . . . -72.39 -23.01 61.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.629 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.551 ' N ' ' O ' ' A' ' 87' ' ' SER . 65.9 tttm -61.84 -45.58 93.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.433 -179.463 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.442 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.8 mm-40 -90.31 -95.3 0.11 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.092 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.629 ' O ' ' N ' ' A' ' 95' ' ' LEU . 96.0 mtt180 -142.79 58.84 1.43 Allowed 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.448 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.7 pttp 33.87 25.7 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.07 0.462 . . . . 0.0 110.25 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.629 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.3 tt -48.26 123.46 6.48 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.983 -177.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.457 ' O ' HD23 ' A' ' 95' ' ' LEU . 99.0 mm-40 -83.52 -169.61 2.64 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.183 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.603 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 81.3 mtp180 -74.69 136.95 41.84 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.256 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.504 ' N ' ' O ' ' A' ' 67' ' ' SER . 91.2 mt -85.63 -165.83 1.34 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.83 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.538 ' O ' ' CD2' ' A' ' 99' ' ' TYR . 48.2 p90 -168.64 119.65 0.77 Allowed 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.152 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.503 ' C ' ' O ' ' A' ' 99' ' ' TYR . 41.7 mm -28.67 120.7 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 O-C-N 123.272 0.358 . . . . 0.0 111.104 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 114.31 27.26 3.44 Favored Glycine 0 C--N 1.331 0.296 0 N-CA-C 111.27 -0.732 . . . . 0.0 111.27 -179.34 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.572 ' N ' ' CD ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -144.36 46.72 0.65 Allowed Pre-proline 0 C--N 1.322 -0.593 0 CA-C-O 121.145 0.498 . . . . 0.0 110.484 179.783 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.572 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 28.9 Cg_endo -62.02 144.0 95.72 Favored 'Trans proline' 0 C--N 1.295 -2.263 0 C-N-CA 122.643 2.229 . . . . 0.0 111.761 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.446 ' O ' HG23 ' A' ' 108' ' ' VAL . 27.6 t -173.18 120.37 0.35 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.359 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.83 -40.21 63.49 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.119 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.36 -39.89 89.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.853 -179.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.13 -40.09 95.44 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.73 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 104' ' ' SER . 72.3 t -67.77 -43.72 86.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.672 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.81 -39.04 93.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.455 -179.185 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.442 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.5 -23.39 62.74 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.516 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.537 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.3 mm-40 -90.69 5.55 47.66 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.682 -179.503 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.538 ' O ' ' NE ' ' A' ' 45' ' ' ARG . 10.2 tpt 22.85 64.46 0.35 Allowed Pre-proline 0 N--CA 1.467 0.385 0 CA-C-O 120.949 0.404 . . . . 0.0 111.209 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -78.75 167.51 22.28 Favored 'Trans proline' 0 C--N 1.307 -1.658 0 C-N-CA 123.077 2.518 . . . . 0.0 111.594 -177.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.52 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 99.1 m-20 -109.71 -42.1 4.37 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.991 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.6 tp -121.5 120.35 34.64 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.904 0.383 . . . . 0.0 109.97 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 84.8 mt -112.78 128.84 69.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 CA-C-O 120.862 0.363 . . . . 0.0 110.998 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.624 HD12 ' OG ' ' A' ' 48' ' ' SER . 29.6 mt -109.18 132.13 54.41 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.262 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.496 HD12 HG23 ' A' ' 139' ' ' THR . 99.1 mt -119.57 138.69 49.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.687 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 85.6 p -72.3 153.75 41.34 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.571 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.16 -50.25 74.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.705 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -149.51 154.0 38.08 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.602 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 170.5 -170.84 43.34 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.93 -34.3 89.51 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.445 ' OD1' ' O ' ' A' ' 124' ' ' ASP . 44.0 p-10 -86.7 120.43 28.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.856 0.36 . . . . 0.0 110.647 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.44 ' O ' HD12 ' A' ' 129' ' ' LEU . 39.0 t -63.21 143.75 57.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.392 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.1 -43.24 8.97 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.82 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.5 tp -62.98 -42.36 99.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.716 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.67 -12.07 59.68 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.449 -179.34 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.44 HD12 ' O ' ' A' ' 125' ' ' SER . 85.1 mt -114.76 -24.07 8.88 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.578 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' TYR . . . . . 0.519 ' N ' ' O ' ' A' ' 126' ' ' ALA . 78.9 t80 -51.01 -49.73 59.88 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.819 -0.352 . . . . 0.0 110.693 -178.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.1 p-10 -66.06 -42.67 89.18 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.321 179.354 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.52 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 88.3 mt-30 -67.01 -37.71 84.66 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.818 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.434 HD12 HD11 ' A' ' 118' ' ' ILE . 96.2 mt -80.24 -41.68 24.63 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.887 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.3 t -56.77 -44.69 82.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.248 -179.134 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 18.7 m -61.72 -45.44 93.96 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.613 179.336 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 94.6 mt -61.91 -43.73 97.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.319 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.661 ' HB1' ' HD2' ' A' ' 138' ' ' PRO . . . -169.27 168.29 5.05 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.644 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.661 ' HD2' ' HB1' ' A' ' 137' ' ' ALA . 52.8 Cg_exo -49.59 113.19 0.86 Allowed 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.296 1.997 . . . . 0.0 112.393 179.053 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.496 HG23 HD12 ' A' ' 118' ' ' ILE . 24.0 m -84.59 127.36 34.02 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.617 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.688 HD13 ' CD2' ' A' ' 37' ' ' HIS . 34.7 tp -117.79 135.96 53.71 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 120.998 0.428 . . . . 0.0 110.109 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.441 ' O ' ' OD2' ' A' ' 32' ' ' ASP . 82.7 mt -99.62 118.92 46.95 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 CA-C-O 121.208 0.527 . . . . 0.0 111.089 -179.298 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.425 HD12 HD22 ' A' ' 117' ' ' LEU . 97.9 mt -135.15 132.33 52.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.574 179.588 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.551 ' ND2' ' OD2' ' A' ' 241' ' ' ASP . 2.2 t-20 -68.04 153.72 43.15 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.987 0.423 . . . . 0.0 110.405 179.296 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.542 ' H ' ' ND2' ' A' ' 143' ' ' ASN . 88.7 t80 -87.46 122.28 30.99 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.85 -179.571 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.525 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 99.0 m-20 55.11 69.38 0.74 Allowed 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.759 179.659 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 49.8 p-10 -123.6 -0.72 8.6 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.852 0.358 . . . . 0.0 110.629 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -151.01 116.29 5.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.715 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 82.8 p -62.45 167.5 4.24 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.513 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.411 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.2 p-90 -51.05 -15.76 0.36 Allowed 'General case' 0 C--O 1.221 -0.414 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.371 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.452 ' O ' HG23 ' A' ' 154' ' ' THR . 67.9 tp60 -70.92 -74.69 0.14 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.912 0.386 . . . . 0.0 110.516 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.434 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.2 t -62.81 -39.19 93.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.181 179.553 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 55.0 tp -60.05 -45.75 91.82 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.393 -178.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.411 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 46.9 tp -62.7 -41.64 99.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.619 178.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.452 HG23 ' O ' ' A' ' 150' ' ' GLN . 56.5 p -64.25 -34.94 79.26 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.226 -179.372 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.442 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.8 mm-40 -64.11 -42.57 96.83 Favored 'General case' 0 C--O 1.226 -0.161 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.389 179.332 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 90.2 mt -65.46 -38.66 90.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.152 0.501 . . . . 0.0 110.317 179.135 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.573 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.49 -32.41 81.08 Favored Glycine 0 C--N 1.331 0.287 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 -179.227 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.442 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.2 mt-10 -35.3 -27.23 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.819 0.343 . . . . 0.0 110.815 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.573 ' N ' ' O ' ' A' ' 157' ' ' GLY . 94.7 mt -55.83 149.42 3.1 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.371 178.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 72.7 p -69.82 137.58 51.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.992 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 71.1 20.96 78.33 Favored Glycine 0 N--CA 1.459 0.183 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 58.2 m80 -122.64 -14.49 7.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.641 0.258 . . . . 0.0 110.487 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -66.03 -59.93 3.32 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.584 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -51.98 -49.32 63.5 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.156 -179.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -60.59 -41.29 94.43 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.841 0.353 . . . . 0.0 110.435 179.432 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.32 -47.32 86.49 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.473 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.74 -40.27 75.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.241 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -61.53 -50.45 72.62 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.652 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -65.24 -43.7 90.56 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.584 179.451 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 94.2 mt -64.84 -43.3 96.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.4 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.4 -51.27 70.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.369 -179.11 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -63.41 -43.7 96.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.843 0.354 . . . . 0.0 110.656 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.665 ' CE2' HD11 ' A' ' 177' ' ' LEU . 57.0 t80 -62.82 -44.42 96.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.378 179.44 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 -63.16 -39.67 95.34 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.78 -179.51 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -63.32 -42.66 99.01 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.518 179.216 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -60.76 -44.59 96.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.221 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.665 HD11 ' CE2' ' A' ' 173' ' ' PHE . 84.1 mt -64.69 -40.99 96.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.723 178.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.32 -62.46 1.62 Allowed 'General case' 0 C--O 1.238 0.457 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.295 -179.252 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.35 -47.34 84.09 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.473 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -52.75 -42.02 64.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.329 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -63.78 -33.66 76.17 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.034 0.445 . . . . 0.0 110.291 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.415 ' O ' ' HG2' ' A' ' 182' ' ' GLU . 69.6 tt0 -90.81 9.06 31.7 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.552 0.691 . . . . 0.0 110.328 -178.779 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -105.11 -32.18 8.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.171 179.448 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 45.1 pt -128.15 147.76 32.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.816 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -140.25 131.36 26.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.388 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.592 HD22 ' N ' ' A' ' 186' ' ' LEU . 3.5 mm? -85.26 133.87 41.78 Favored Pre-proline 0 N--CA 1.45 -0.435 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.092 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -43.7 157.67 0.13 Allowed 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.635 2.223 . . . . 0.0 112.387 179.274 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 0.508 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 28.3 Cg_endo -63.22 114.9 2.68 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.819 2.346 . . . . 0.0 111.692 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 189' ' ' GLN . . . . . 0.508 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.7 mt-30 155.43 147.9 0.0 OUTLIER Pre-proline 0 N--CA 1.456 -0.136 0 O-C-N 124.051 0.844 . . . . 0.0 110.93 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.22 143.81 36.19 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.578 2.185 . . . . 0.0 112.316 177.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.494 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.1 p -124.87 159.3 31.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.418 0.628 . . . . 0.0 110.214 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 192' ' ' THR . . . . . 0.494 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 37.7 p -143.52 165.59 27.15 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.095 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 193' ' ' ALA . . . . . 0.439 ' HA ' ' H ' ' A' ' 260' ' ' PHE . . . -135.13 128.77 32.76 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-O 121.285 0.564 . . . . 0.0 110.229 179.319 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.513 HD11 HD23 ' A' ' 259' ' ' LEU . 47.9 pt -146.47 148.77 16.65 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.383 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.159 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 195' ' ' VAL . . . . . 0.753 HG13 ' CD1' ' A' ' 262' ' ' PHE . 69.3 t -117.52 123.31 71.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-O 121.376 0.608 . . . . 0.0 109.817 178.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -134.46 107.69 7.71 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 121.156 0.503 . . . . 0.0 110.285 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 94.8 m -131.22 130.55 43.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.834 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -82.86 -36.83 25.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.242 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.49 -67.15 0.26 Allowed 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.273 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.34 -10.1 59.35 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.299 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 60.1 t-80 60.77 58.3 2.42 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.71 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 41.6 p -166.77 153.52 8.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.565 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.65 144.49 24.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.977 0.418 . . . . 0.0 110.47 179.258 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -135.48 138.24 42.95 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.611 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 20.1 mt -106.26 125.81 51.45 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.006 0.432 . . . . 0.0 109.953 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 206' ' ' TRP . . . . . 0.563 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 76.4 m95 -82.52 167.26 18.55 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.536 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 207' ' ' THR . . . . . 0.462 HG22 ' C ' ' A' ' 206' ' ' TRP . 0.1 OUTLIER -157.25 170.71 8.5 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.617 -178.985 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -53.22 -37.04 79.94 Favored 'Trans proline' 0 C--N 1.302 -1.911 0 C-N-CA 122.652 2.235 . . . . 0.0 112.446 179.037 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -70.6 -34.94 72.69 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.657 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 22.9 m -61.56 150.45 35.97 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.633 -179.501 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.38 -36.87 81.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.436 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 212' ' ' GLN . . . . . 0.563 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 54.6 tt0 -64.73 -40.09 94.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.477 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.62 -43.54 91.83 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.669 -0.972 . . . . 0.0 110.669 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -63.34 -43.46 97.65 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.851 0.358 . . . . 0.0 110.233 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 215' ' ' MET . . . . . 0.535 ' SD ' ' HB2' ' A' ' 304' ' ' ALA . 65.4 ttp -59.1 -48.42 81.67 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.161 -179.731 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 89.0 mt -60.29 -40.96 92.31 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 217' ' ' GLU . . . . . 0.453 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 40.5 tp10 -57.93 -37.67 74.51 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.057 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -65.48 -37.76 87.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.699 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 95.0 mt -64.37 -42.82 95.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.144 0.497 . . . . 0.0 110.629 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.5 44.62 0.08 OUTLIER Glycine 0 CA--C 1.52 0.387 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 221' ' ' PHE . . . . . 0.453 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 26.4 m-85 -127.58 154.5 45.12 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 121.05 0.452 . . . . 0.0 110.535 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.476 ' O ' HG13 ' A' ' 191' ' ' VAL . 4.5 p -106.05 121.65 44.55 Favored 'General case' 0 C--O 1.224 -0.261 0 CA-C-O 121.262 0.554 . . . . 0.0 110.049 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.462 HD22 ' N ' ' A' ' 223' ' ' LEU . 4.3 mm? -100.38 133.66 44.47 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.128 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -97.36 157.94 15.72 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.475 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -104.2 115.33 30.22 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.927 0.394 . . . . 0.0 110.416 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.486 HD12 ' N ' ' A' ' 226' ' ' LEU . 9.1 mp -53.89 156.55 4.96 Favored Pre-proline 0 N--CA 1.45 -0.462 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.817 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -59.73 145.11 99.04 Favored 'Trans proline' 0 C--N 1.299 -2.052 0 C-N-CA 122.736 2.291 . . . . 0.0 112.348 179.008 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.75 -2.52 58.67 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.509 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.58 -40.42 5.67 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.532 ' O ' ' N ' ' A' ' 233' ' ' SER . 85.9 mt -79.32 -16.73 55.89 Favored 'General case' 0 C--O 1.22 -0.499 0 CA-C-O 121.085 0.469 . . . . 0.0 110.279 -179.66 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 54.8 t-20 -40.09 -48.92 2.55 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.79 -179.501 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -88.38 15.37 7.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.316 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.532 ' N ' ' O ' ' A' ' 230' ' ' LEU . 77.8 p -60.75 -35.46 76.44 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.676 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 234' ' ' GLN . . . . . 0.522 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.6 tt0 -118.28 -69.53 0.84 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.858 179.378 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.0 m -70.39 103.27 2.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.678 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -94.27 57.85 2.39 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.007 0.432 . . . . 0.0 110.319 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -145.2 -122.34 1.52 Allowed Glycine 0 C--N 1.332 0.339 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -134.1 112.42 11.14 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 121.141 0.496 . . . . 0.0 110.389 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 239' ' ' ARG . . . . . 0.461 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.2 mtt180 -148.54 56.79 1.04 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.737 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -69.49 -31.84 70.35 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.504 179.492 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 241' ' ' ASP . . . . . 0.551 ' OD2' ' ND2' ' A' ' 143' ' ' ASN . 64.8 t0 -56.58 -47.01 80.46 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.357 -179.042 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 242' ' ' ILE . . . . . 0.441 ' O ' ' O ' ' A' ' 239' ' ' ARG . 17.1 tt -140.4 157.46 24.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.88 0.371 . . . . 0.0 110.547 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.441 HG22 HD13 ' A' ' 245' ' ' LEU . 96.0 mt -105.88 106.05 19.84 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 CA-C-O 121.094 0.474 . . . . 0.0 110.505 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 244' ' ' GLN . . . . . 0.611 ' C ' HD12 ' A' ' 245' ' ' LEU . 88.3 mt-30 -110.99 110.64 21.28 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.351 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.611 HD12 ' C ' ' A' ' 244' ' ' GLN . 9.8 mp -121.98 -167.79 1.6 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.645 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 246' ' ' GLY . . . . . 0.522 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 172.79 -16.71 0.05 OUTLIER Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 247' ' ' GLY . . . . . 0.663 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -60.6 157.62 29.34 Favored Glycine 0 CA--C 1.522 0.49 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -64.05 21.01 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.966 0.412 . . . . 0.0 110.616 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 249' ' ' ASN . . . . . 0.663 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.9 m-20 -96.75 -5.7 38.0 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.523 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 91.3 mt -80.67 -20.97 41.82 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.763 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.56 -51.44 69.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.615 -179.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -89.14 -4.87 58.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.529 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.33 -74.13 1.16 Allowed Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.896 -0.881 . . . . 0.0 110.896 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 81.5 mt -70.12 125.7 27.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.978 0.418 . . . . 0.0 110.282 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -59.9 -39.26 84.79 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.334 -179.524 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 83.33 51.57 4.08 Favored Glycine 0 CA--C 1.52 0.393 0 N-CA-C 110.824 -0.91 . . . . 0.0 110.824 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -94.87 -16.7 22.69 Favored 'General case' 0 C--N 1.332 -0.17 0 O-C-N 122.739 -0.271 . . . . 0.0 110.606 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 258' ' ' SER . . . . . 0.49 ' OG ' HG23 ' A' ' 191' ' ' VAL . 3.4 t 175.47 89.49 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.159 0.504 . . . . 0.0 110.1 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.858 HD12 ' N ' ' A' ' 259' ' ' LEU . 0.9 OUTLIER -94.79 124.49 38.86 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.22 0.534 . . . . 0.0 111.229 -179.03 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 260' ' ' PHE . . . . . 0.439 ' H ' ' HA ' ' A' ' 193' ' ' ALA . 15.9 m-30 -93.98 146.8 23.67 Favored 'General case' 0 CA--C 1.5 -0.956 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.351 179.398 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 86.7 mt -122.42 150.18 42.82 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.542 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.753 ' CD1' HG13 ' A' ' 195' ' ' VAL . 2.6 p90 -77.7 -138.27 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.587 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 263' ' ' ALA . . . . . 0.655 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -51.96 77.34 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.156 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 264' ' ' GLY . . . . . 0.62 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.24 104.35 0.18 Allowed Glycine 0 CA--C 1.528 0.845 0 N-CA-C 110.474 -1.051 . . . . 0.0 110.474 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 265' ' ' ASP . . . . . 0.593 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.6 m-20 -79.98 -177.91 6.23 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 122.75 -0.265 . . . . 0.0 110.945 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -40.47 -17.83 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.567 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 267' ' ' LYS . . . . . 0.593 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.27 -51.7 42.17 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.681 179.247 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -63.56 -46.7 84.71 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.312 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 269' ' ' ALA . . . . . 0.574 ' HB1' ' OH ' ' A' ' 273' ' ' TYR . . . -61.68 -35.03 76.83 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 121.444 0.64 . . . . 0.0 109.808 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -63.14 -34.19 77.07 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.145 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.62 -43.33 13.55 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.081 -179.459 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 272' ' ' ILE . . . . . 0.593 ' C ' ' H ' ' A' ' 274' ' ' ALA . 4.9 tt -51.39 -33.78 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.875 -178.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 273' ' ' TYR . . . . . 0.574 ' OH ' ' HB1' ' A' ' 269' ' ' ALA . 17.2 m-85 -54.4 -1.73 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.649 -179.41 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 274' ' ' ALA . . . . . 0.593 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.49 -39.73 70.66 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.848 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 275' ' ' ASN . . . . . 0.58 ' O ' ' N ' ' A' ' 279' ' ' ALA . 2.8 p30 -39.22 98.29 0.16 Allowed Pre-proline 0 N--CA 1.463 0.178 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.401 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_exo -54.68 -42.69 66.12 Favored 'Trans proline' 0 C--N 1.303 -1.833 0 C-N-CA 122.356 2.037 . . . . 0.0 112.502 -178.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 89.2 mt -64.51 -42.84 95.55 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.093 0.473 . . . . 0.0 111.213 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 91.3 mt -95.59 -1.81 49.63 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.924 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 279' ' ' ALA . . . . . 0.58 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.16 -34.78 77.05 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.701 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.3 20.0 0.12 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.963 -179.312 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 0.484 HD23 ' HA ' ' A' ' 281' ' ' LEU . 13.7 mt -74.73 119.24 75.74 Favored Pre-proline 0 N--CA 1.447 -0.607 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.774 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -49.65 -40.34 46.66 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.656 2.237 . . . . 0.0 112.3 178.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.57 -50.66 62.52 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.023 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 78.0 t -61.43 -43.87 97.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.803 0.335 . . . . 0.0 110.118 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -57.64 -41.27 81.08 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.188 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -90.89 0.47 57.48 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.108 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt 59.25 42.04 19.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.784 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -93.79 41.1 1.08 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.398 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 53.7 t -118.31 136.22 56.19 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.126 0 CA-C-O 121.113 0.483 . . . . 0.0 110.009 -179.526 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -133.31 163.12 30.04 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.184 0.516 . . . . 0.0 110.626 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -120.48 154.88 34.64 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-O 121.048 0.451 . . . . 0.0 110.652 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 82.3 mt -93.41 -1.63 55.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.212 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.59 165.94 12.74 Favored Glycine 0 N--CA 1.463 0.445 0 N-CA-C 110.529 -1.028 . . . . 0.0 110.529 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 6.8 m -87.6 -62.19 1.55 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.857 0.361 . . . . 0.0 110.967 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 295' ' ' GLU . . . . . 0.435 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.4 mm-40 -69.8 -3.85 17.4 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.667 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 25.2 p -77.03 33.38 0.15 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.593 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 297' ' ' PHE . . . . . 0.537 ' CD2' HG22 ' A' ' 70' ' ' THR . 84.8 t80 -60.11 -45.99 91.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.591 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 298' ' ' ARG . . . . . 0.603 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.3 mtt85 -81.61 134.84 35.54 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.59 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.458 ' H ' HG11 ' A' ' 51' ' ' VAL . 16.0 tp -114.39 119.16 35.99 Favored 'General case' 0 C--O 1.231 0.08 0 CA-C-O 120.974 0.416 . . . . 0.0 110.204 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 300' ' ' ASP . . . . . 0.62 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.2 p-10 -166.73 -174.71 2.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.637 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 83.5 t80 -47.96 -45.07 30.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.221 -179.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -65.3 -41.2 94.33 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.017 0.437 . . . . 0.0 110.734 178.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 303' ' ' SER . . . . . 0.62 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 53.6 p -55.73 -36.62 67.44 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.059 -179.237 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 304' ' ' ALA . . . . . 0.535 ' HB2' ' SD ' ' A' ' 215' ' ' MET . . . -56.33 -52.74 63.43 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 92.4 mtp -55.21 -43.72 74.72 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -66.25 -42.31 88.76 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.137 0.494 . . . . 0.0 110.264 179.04 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 307' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 303' ' ' SER . 55.1 t -64.09 -43.02 97.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.27 179.378 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 42.3 tp -59.98 -42.26 93.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.846 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -62.33 -38.88 91.17 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.146 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 310' ' ' ARG . . . . . 0.404 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.5 ttt85 -63.87 -44.21 93.74 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.251 179.58 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 87.9 mt -63.41 -42.42 98.75 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.465 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt -62.88 -33.51 75.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.191 179.377 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -87.24 -26.25 23.59 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.318 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.712 ' C ' HD23 ' A' ' 314' ' ' LEU . 8.4 tt -62.57 -44.4 96.43 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.327 -179.516 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 . . . . . 0 C--O 1.22 -0.499 0 CA-C-O 118.005 -0.998 . . . . 0.0 110.475 179.975 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -99.67 136.05 40.17 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.002 0.43 . . . . 0.0 110.515 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.497 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -92.29 178.72 1.57 Allowed Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.523 -179.874 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.497 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.8 Cg_exo -61.58 147.3 95.73 Favored 'Trans proline' 0 C--N 1.3 -2.01 0 C-N-CA 122.819 2.346 . . . . 0.0 112.132 179.599 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.461 ' HE ' HD12 ' A' ' 39' ' ' LEU . 35.5 ptt180 -136.1 142.47 44.3 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.697 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -79.75 116.43 19.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.489 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.448 ' O ' HG23 ' A' ' 30' ' ' ILE . 9.4 tp -110.71 130.38 64.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.503 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.3 t -70.74 141.4 51.49 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.571 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.477 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.4 t0 -139.05 179.55 6.43 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.52 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.477 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 77.9 p -74.05 -36.99 64.42 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.557 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.8 ttt85 -46.38 -94.57 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.337 -179.451 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.423 ' O ' ' OG1' ' A' ' 36' ' ' THR . . . -167.17 -26.74 0.02 OUTLIER Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.423 ' OG1' ' O ' ' A' ' 35' ' ' GLY . 70.7 m -169.01 104.57 0.4 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.9 0.381 . . . . 0.0 110.613 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.681 ' CD2' HD13 ' A' ' 140' ' ' LEU . 74.3 t60 -128.46 148.33 50.72 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.081 0.467 . . . . 0.0 110.187 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.626 HG22 ' N ' ' A' ' 39' ' ' LEU . 98.0 m -130.79 166.06 21.62 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.54 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.626 ' N ' HG22 ' A' ' 38' ' ' THR . 81.2 mt -120.8 127.63 52.13 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.56 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -65.08 -44.59 88.43 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.67 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 39.8 p -165.65 154.89 12.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.416 179.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.499 ' CD ' ' H ' ' A' ' 42' ' ' GLN . 14.8 mp0 -44.32 101.07 0.24 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.607 179.381 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.23 129.51 34.58 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.391 2.061 . . . . 0.0 112.265 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -83.5 -24.78 31.57 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.527 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.538 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.6 mtm-85 -122.31 134.82 54.65 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 121.179 0.514 . . . . 0.0 110.297 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.2 mt -130.8 133.96 62.5 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.272 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.821 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 45.6 t -124.43 130.55 73.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 179.326 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.615 ' OG ' HD12 ' A' ' 117' ' ' LEU . 2.2 m -154.81 166.63 32.88 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.576 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 73.1 p -124.41 8.69 8.42 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.372 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.0 125.86 33.06 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.843 0.354 . . . . 0.0 110.653 -179.526 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.428 HG11 ' H ' ' A' ' 299' ' ' LEU . 90.8 t -66.02 -44.44 92.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.521 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.7 m -62.69 -44.39 96.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.601 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 50.3 tp -62.38 -41.48 98.67 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.529 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.443 ' O ' HD13 ' A' ' 58' ' ' LEU . 70.6 m -57.88 -44.51 86.72 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.239 -179.213 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.17 -62.31 5.28 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 179.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.7 t -48.19 -35.65 12.19 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 20.1 mt -61.81 -44.6 96.55 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.226 179.37 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.443 HD13 ' O ' ' A' ' 54' ' ' THR . 9.3 mp -65.16 -41.66 94.5 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.391 177.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.42 -41.38 98.71 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.856 -179.197 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.428 ' O ' HG23 ' A' ' 60' ' ' ILE . 8.1 tp -88.1 17.29 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.838 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 56.28 85.01 0.08 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.733 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.36 58.62 0.08 OUTLIER Pre-proline 0 C--N 1.328 -0.355 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -50.92 151.93 10.76 Favored 'Trans proline' 0 C--N 1.294 -2.319 0 C-N-CA 122.902 2.402 . . . . 0.0 112.275 -178.273 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.433 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -108.71 145.75 15.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.326 -179.691 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.76 -45.17 97.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.361 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.502 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -129.92 134.48 47.51 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 120.8 0.334 . . . . 0.0 110.541 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.48 ' O ' ' N ' ' A' ' 98' ' ' LEU . 73.3 m -134.73 158.87 43.02 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.907 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.45 138.65 15.98 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.474 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.6 -162.85 0.09 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.002 0.429 . . . . 0.0 110.453 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.53 HG22 ' CD2' ' A' ' 297' ' ' PHE . 5.8 t -133.97 135.9 43.8 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.156 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.487 ' C ' ' O ' ' A' ' 70' ' ' THR . 1.1 t 29.46 67.99 0.67 Allowed Pre-proline 0 N--CA 1.466 0.332 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.728 -179.581 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_exo -60.97 145.74 98.69 Favored 'Trans proline' 0 C--N 1.3 -2.009 0 C-N-CA 122.619 2.213 . . . . 0.0 111.99 -178.259 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.537 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 42.4 p-10 -161.06 -31.86 0.05 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.75 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.537 ' N ' ' OD1' ' A' ' 73' ' ' ASN . 99.1 m-20 -64.16 -39.41 93.94 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.343 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -60.28 -47.98 83.69 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.578 -179.214 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.427 ' O ' ' O ' ' A' ' 77' ' ' ALA . 98.7 t -60.27 -24.62 31.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.532 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -45.5 172.88 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.631 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.575 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.9 p30 -61.99 177.61 0.44 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.586 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.563 ' C ' ' H ' ' A' ' 81' ' ' GLY . 36.5 p30 -45.96 85.41 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.072 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.575 ' N ' ' O ' ' A' ' 78' ' ' ASP . 42.4 tp60 -67.43 13.66 0.07 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.203 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.563 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 118.16 -21.96 9.9 Favored Glycine 0 CA--C 1.519 0.3 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -107.86 116.51 32.09 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.008 0.432 . . . . 0.0 110.527 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 74.6 mt -98.54 0.03 44.19 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.982 0.42 . . . . 0.0 110.51 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -92.49 7.04 44.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.031 0.443 . . . . 0.0 110.387 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.773 ' O ' HG22 ' A' ' 89' ' ' VAL . 27.1 mt-30 -100.24 -27.16 13.64 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.841 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.6 t-105 -64.73 -40.46 95.35 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.035 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.557 ' O ' ' N ' ' A' ' 91' ' ' LYS . 65.8 m -77.89 -54.5 6.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.169 -179.559 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -47.42 -50.43 22.67 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.087 -179.223 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.773 HG22 ' O ' ' A' ' 85' ' ' GLN . 14.4 m -69.36 -40.54 80.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.137 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.496 ' N ' HG23 ' A' ' 89' ' ' VAL . . . -72.45 -22.76 61.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.658 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.557 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.0 tttm -62.14 -45.57 92.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.445 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.439 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.8 mm-40 -90.37 -94.8 0.12 Allowed 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.078 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.636 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.8 mtt180 -143.01 58.75 1.42 Allowed 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.455 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.6 pttp 33.68 25.8 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 120.947 0.403 . . . . 0.0 110.255 -179.243 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.636 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.3 tt -47.78 123.68 6.3 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.954 -178.02 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.453 ' O ' HD23 ' A' ' 95' ' ' LEU . 99.0 mm-40 -83.56 -170.39 3.04 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.127 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.613 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 82.2 mtp180 -73.95 137.26 43.46 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.061 0.458 . . . . 0.0 110.246 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.48 ' N ' ' O ' ' A' ' 67' ' ' SER . 90.3 mt -86.12 -165.85 1.37 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.816 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.537 ' O ' ' CD2' ' A' ' 99' ' ' TYR . 48.5 p90 -168.86 119.92 0.75 Allowed 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.137 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.509 ' C ' ' O ' ' A' ' 99' ' ' TYR . 43.7 mm -29.0 121.08 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.067 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 114.15 27.13 3.53 Favored Glycine 0 C--N 1.332 0.318 0 N-CA-C 111.261 -0.735 . . . . 0.0 111.261 -179.402 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.576 ' CD ' ' H ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -144.2 46.5 0.64 Allowed Pre-proline 0 C--N 1.324 -0.518 0 CA-C-O 120.931 0.396 . . . . 0.0 110.416 179.872 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 29.1 Cg_endo -62.1 143.77 95.14 Favored 'Trans proline' 0 C--N 1.296 -2.233 0 C-N-CA 122.677 2.251 . . . . 0.0 111.845 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.455 ' O ' HG23 ' A' ' 108' ' ' VAL . 27.4 t -173.05 120.2 0.35 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.376 179.677 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.52 -40.49 64.0 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.038 0.447 . . . . 0.0 111.086 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.23 -39.87 89.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.841 -179.406 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.23 -40.04 95.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.745 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 104' ' ' SER . 71.2 t -67.69 -43.89 86.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.793 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.71 -39.01 92.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.522 -179.296 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.439 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.5 -23.35 62.72 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.486 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.544 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.2 mm-40 -90.66 5.46 47.96 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.659 -179.49 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.544 ' C ' ' O ' ' A' ' 111' ' ' GLN . 10.5 tpt 23.49 64.23 0.38 Allowed Pre-proline 0 N--CA 1.466 0.367 0 CA-C-O 120.87 0.367 . . . . 0.0 111.02 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -78.54 167.1 23.19 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 C-N-CA 123.051 2.501 . . . . 0.0 111.866 -178.178 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.523 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 99.2 m-20 -109.83 -42.07 4.34 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.112 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 39.8 tp -121.64 120.28 34.3 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 83.7 mt -112.91 128.85 69.42 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.353 0 CA-C-O 120.934 0.397 . . . . 0.0 110.951 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.615 HD12 ' OG ' ' A' ' 48' ' ' SER . 29.4 mt -108.87 132.26 54.21 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.063 0.459 . . . . 0.0 110.183 -179.659 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.496 HD12 HG23 ' A' ' 139' ' ' THR . 98.7 mt -119.67 139.01 48.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.711 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 85.6 p -72.4 153.77 41.26 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.642 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.18 -50.16 74.76 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.631 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -149.45 154.06 38.25 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.555 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 170.64 -171.02 43.53 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -63.17 -34.04 88.89 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.447 ' OD1' ' O ' ' A' ' 124' ' ' ASP . 44.0 p-10 -86.97 119.99 27.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.867 0.365 . . . . 0.0 110.684 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.444 ' O ' HD12 ' A' ' 129' ' ' LEU . 39.8 t -62.99 143.61 57.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.425 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.04 -43.11 9.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.862 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.7 tp -63.01 -42.47 99.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.75 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.43 -12.08 59.39 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.499 -179.35 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.444 HD12 ' O ' ' A' ' 125' ' ' SER . 84.2 mt -114.94 -23.84 8.91 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.636 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' TYR . . . . . 0.519 ' N ' ' O ' ' A' ' 126' ' ' ALA . 78.4 t80 -51.0 -49.74 59.81 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.567 -178.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.1 p-10 -65.84 -42.4 90.56 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.841 -0.344 . . . . 0.0 111.208 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.523 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 88.3 mt-30 -67.45 -37.77 83.46 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.849 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.424 HD12 HD11 ' A' ' 118' ' ' ILE . 95.9 mt -80.06 -41.8 24.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.862 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.2 t -57.03 -44.43 82.88 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.166 -178.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 20.2 m -61.91 -45.09 95.24 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.463 179.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 93.8 mt -62.24 -43.59 98.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.196 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.65 ' HB1' ' HD2' ' A' ' 138' ' ' PRO . . . -169.52 167.9 5.08 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.57 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.65 ' HD2' ' HB1' ' A' ' 137' ' ' ALA . 51.9 Cg_exo -49.4 113.14 0.83 Allowed 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.298 1.998 . . . . 0.0 112.299 179.184 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.496 HG23 HD12 ' A' ' 118' ' ' ILE . 24.0 m -84.65 127.24 33.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.602 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.681 HD13 ' CD2' ' A' ' 37' ' ' HIS . 34.7 tp -117.75 136.24 53.51 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.05 -179.696 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.44 ' O ' ' OD2' ' A' ' 32' ' ' ASP . 82.6 mt -100.1 118.89 47.42 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 CA-C-O 121.149 0.5 . . . . 0.0 111.161 -179.326 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.425 HD12 HD22 ' A' ' 117' ' ' LEU . 97.8 mt -135.05 132.13 53.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.595 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.55 ' ND2' ' H ' ' A' ' 144' ' ' TYR . 2.2 t-20 -67.35 153.59 43.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.945 0.403 . . . . 0.0 110.483 179.366 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.55 ' H ' ' ND2' ' A' ' 143' ' ' ASN . 89.1 t80 -87.58 122.26 31.05 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.865 -179.523 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.522 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 99.0 m-20 55.17 69.45 0.73 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.759 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 49.3 p-10 -123.56 -0.48 8.65 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.923 0.392 . . . . 0.0 110.664 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -151.45 117.5 5.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.69 -179.502 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 83.7 p -63.4 167.78 5.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.524 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.413 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.1 p-90 -51.15 -15.64 0.37 Allowed 'General case' 0 C--O 1.223 -0.326 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.504 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.445 ' O ' HG23 ' A' ' 154' ' ' THR . 68.1 tp60 -71.28 -74.91 0.14 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.444 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.444 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.0 t -62.93 -38.84 92.61 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.263 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 54.6 tp -60.14 -45.71 92.11 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.413 -178.525 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.413 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 47.3 tp -62.62 -41.6 99.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.445 179.002 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.445 HG23 ' O ' ' A' ' 150' ' ' GLN . 57.1 p -64.23 -34.68 78.65 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.193 -179.455 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.43 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.7 mm-40 -63.99 -42.78 97.1 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.442 179.263 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 91.5 mt -65.38 -38.92 91.45 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.087 0.47 . . . . 0.0 110.245 179.103 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.579 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.2 -31.91 78.67 Favored Glycine 0 CA--C 1.519 0.288 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 -179.257 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' A' ' 157' ' ' GLY . 97.3 mt-10 -35.61 -26.73 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.815 0.34 . . . . 0.0 110.803 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.579 ' N ' ' O ' ' A' ' 157' ' ' GLY . 95.7 mt -56.62 149.87 3.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.305 179.072 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 72.4 p -69.98 137.1 51.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.983 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 72.02 19.56 78.45 Favored Glycine 0 CA--C 1.517 0.159 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 58.2 m80 -121.04 -15.05 8.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.683 0.277 . . . . 0.0 110.585 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -65.33 -60.09 3.35 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.684 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -52.01 -49.25 63.73 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 120.819 -0.352 . . . . 0.0 110.166 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -60.29 -41.26 92.99 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.956 -0.298 . . . . 0.0 110.349 179.479 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.44 -47.24 86.61 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.55 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.86 -40.23 75.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.286 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -61.81 -50.26 73.04 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.601 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 60.1 ttt85 -65.32 -43.76 89.97 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.554 179.514 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 94.9 mt -64.77 -43.31 96.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.457 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.31 -51.35 69.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.472 -179.181 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.43 -43.76 96.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.584 179.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.654 ' CE2' HD11 ' A' ' 177' ' ' LEU . 56.1 t80 -62.9 -44.35 96.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.423 179.44 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -63.61 -39.96 95.71 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.54 -179.312 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -62.89 -42.85 99.92 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.67 179.222 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -60.71 -44.62 96.37 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.201 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.654 HD11 ' CE2' ' A' ' 173' ' ' PHE . 83.6 mt -64.51 -40.96 96.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.01 0.433 . . . . 0.0 110.695 178.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.13 -62.41 1.65 Allowed 'General case' 0 C--O 1.237 0.425 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.411 -179.334 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.48 -47.01 85.46 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.519 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.2 -41.65 65.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.32 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -63.92 -33.82 76.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.002 0.429 . . . . 0.0 110.397 179.282 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.421 ' O ' ' HG2' ' A' ' 182' ' ' GLU . 69.5 tt0 -90.62 9.16 30.79 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.448 0.642 . . . . 0.0 110.439 -178.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -105.06 -32.03 8.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.165 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.5 pt -128.17 147.57 32.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.753 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -139.69 131.11 26.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.446 179.239 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.592 HD22 ' N ' ' A' ' 186' ' ' LEU . 3.6 mm? -85.3 133.23 42.96 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.977 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -43.8 157.77 0.13 Allowed 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.75 2.3 . . . . 0.0 112.223 179.35 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 0.515 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 28.0 Cg_endo -63.05 114.82 2.61 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 C-N-CA 122.821 2.347 . . . . 0.0 111.716 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 189' ' ' GLN . . . . . 0.515 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.7 mt-30 155.72 147.71 0.0 OUTLIER Pre-proline 0 N--CA 1.456 -0.144 0 O-C-N 123.76 0.662 . . . . 0.0 110.759 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -73.56 143.53 34.46 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.582 2.188 . . . . 0.0 112.082 177.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.5 HG23 ' OG ' ' A' ' 258' ' ' SER . 2.1 p -124.43 158.88 31.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.362 0.601 . . . . 0.0 110.174 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 192' ' ' THR . . . . . 0.493 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 34.8 p -143.39 165.22 28.12 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.086 -179.682 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 193' ' ' ALA . . . . . 0.441 ' HA ' ' H ' ' A' ' 260' ' ' PHE . . . -135.15 128.56 32.32 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.241 0.543 . . . . 0.0 110.201 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.508 HD11 HD23 ' A' ' 259' ' ' LEU . 47.4 pt -146.48 148.85 16.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.113 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 195' ' ' VAL . . . . . 0.748 HG13 ' CD1' ' A' ' 262' ' ' PHE . 69.1 t -117.76 123.26 71.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.278 0.561 . . . . 0.0 109.794 179.049 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -134.07 106.96 7.48 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.295 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 94.5 m -130.57 130.3 43.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.827 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.403 ' O ' ' N ' ' A' ' 201' ' ' HIS . . . -83.01 -36.73 24.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.198 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.54 -67.01 0.27 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.338 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.49 -9.43 58.54 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.268 179.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' HIS . . . . . 0.403 ' N ' ' O ' ' A' ' 198' ' ' ALA . 59.8 t-80 60.36 58.47 2.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.708 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 48.8 p -166.99 153.51 8.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.547 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.49 144.3 24.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.974 0.416 . . . . 0.0 110.51 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -135.47 138.46 43.19 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.599 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 20.0 mt -106.59 125.68 51.31 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.067 0.46 . . . . 0.0 109.834 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 206' ' ' TRP . . . . . 0.557 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 75.5 m95 -82.23 167.21 18.88 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.621 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 207' ' ' THR . . . . . 0.464 HG22 ' C ' ' A' ' 206' ' ' TRP . 0.1 OUTLIER -157.03 171.53 7.33 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.632 -179.118 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -53.85 -36.9 84.56 Favored 'Trans proline' 0 C--N 1.302 -1.917 0 C-N-CA 122.691 2.261 . . . . 0.0 112.247 179.188 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -70.64 -34.99 72.68 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.734 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 21.5 m -61.36 150.75 34.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.606 -179.399 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.67 -36.96 82.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.452 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 212' ' ' GLN . . . . . 0.557 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 54.8 tt0 -64.63 -40.22 95.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.48 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.68 -43.46 91.88 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.694 -0.963 . . . . 0.0 110.694 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -63.41 -43.53 97.26 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.816 0.341 . . . . 0.0 110.347 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 215' ' ' MET . . . . . 0.521 ' SD ' ' HB2' ' A' ' 304' ' ' ALA . 65.2 ttp -59.43 -48.06 83.1 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.232 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 87.7 mt -60.64 -40.91 93.71 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 217' ' ' GLU . . . . . 0.457 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.5 tp10 -57.79 -37.92 74.59 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -65.32 -37.98 88.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.797 0.332 . . . . 0.0 110.666 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 94.5 mt -64.26 -42.86 96.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.62 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.7 44.88 0.08 OUTLIER Glycine 0 C--N 1.333 0.369 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 221' ' ' PHE . . . . . 0.457 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 27.4 m-85 -128.02 155.11 44.83 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.038 0.447 . . . . 0.0 110.524 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.483 ' O ' HG13 ' A' ' 191' ' ' VAL . 7.2 p -106.94 122.17 45.89 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.248 0.547 . . . . 0.0 110.103 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.467 HD22 ' C ' ' A' ' 222' ' ' THR . 4.3 mm? -100.98 133.26 45.74 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.109 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -97.14 159.23 15.03 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.469 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.19 115.35 30.11 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.87 0.367 . . . . 0.0 110.36 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.495 HD12 ' N ' ' A' ' 226' ' ' LEU . 8.9 mp -53.22 156.46 3.88 Favored Pre-proline 0 N--CA 1.452 -0.345 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.744 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -60.16 145.27 98.87 Favored 'Trans proline' 0 C--N 1.3 -1.986 0 C-N-CA 122.703 2.269 . . . . 0.0 112.162 179.216 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.16 -3.25 59.05 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.528 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.14 -40.98 5.67 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 111.024 -0.831 . . . . 0.0 111.024 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.533 ' O ' ' N ' ' A' ' 233' ' ' SER . 85.1 mt -79.25 -17.13 55.34 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-O 121.113 0.482 . . . . 0.0 110.362 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 231' ' ' ASN . . . . . 0.401 ' C ' ' O ' ' A' ' 230' ' ' LEU . 55.5 t-20 -40.17 -49.12 2.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.821 -179.496 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -88.08 15.35 7.52 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.373 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.533 ' N ' ' O ' ' A' ' 230' ' ' LEU . 78.0 p -60.37 -35.6 76.09 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.651 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 234' ' ' GLN . . . . . 0.526 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.7 tt0 -118.51 -69.32 0.86 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.995 179.424 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.4 m -69.85 103.4 2.19 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.693 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -94.69 57.63 2.21 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.297 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -144.84 -122.59 1.57 Allowed Glycine 0 CA--C 1.52 0.353 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -134.81 111.66 10.09 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.114 0.483 . . . . 0.0 110.389 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 239' ' ' ARG . . . . . 0.517 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.5 mtt180 -148.04 57.72 1.09 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.762 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -69.55 -32.14 70.76 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.501 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 241' ' ' ASP . . . . . 0.461 ' OD2' ' O ' ' A' ' 144' ' ' TYR . 64.8 t0 -56.85 -47.05 81.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.378 -179.077 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 242' ' ' ILE . . . . . 0.436 ' O ' ' O ' ' A' ' 239' ' ' ARG . 17.8 tt -139.97 156.63 25.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.892 0.377 . . . . 0.0 110.479 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.441 HG22 HD13 ' A' ' 245' ' ' LEU . 96.3 mt -106.03 106.26 20.24 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.202 0 CA-C-O 121.096 0.474 . . . . 0.0 110.502 179.762 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 244' ' ' GLN . . . . . 0.601 ' O ' HD12 ' A' ' 245' ' ' LEU . 88.3 mt-30 -110.2 110.09 20.81 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.398 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.601 HD12 ' O ' ' A' ' 244' ' ' GLN . 9.5 mp -121.79 -168.38 1.69 Allowed 'General case' 0 C--O 1.225 -0.199 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.651 179.721 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 246' ' ' GLY . . . . . 0.526 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.65 -16.76 0.05 OUTLIER Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 247' ' ' GLY . . . . . 0.672 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -60.55 156.64 30.8 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -63.68 21.4 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.0 0.428 . . . . 0.0 110.643 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 249' ' ' ASN . . . . . 0.672 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.6 m-20 -97.02 -6.03 36.3 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.556 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 93.3 mt -79.68 -21.69 44.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.658 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.5 -51.34 70.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.705 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.31 -5.65 58.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.502 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.2 -74.53 1.14 Allowed Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 82.2 mt -69.83 125.92 28.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.954 0.407 . . . . 0.0 110.366 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -59.26 -39.42 82.82 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.19 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 82.39 51.88 4.2 Favored Glycine 0 CA--C 1.521 0.407 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -96.67 -14.2 22.27 Favored 'General case' 0 C--N 1.331 -0.236 0 O-C-N 122.755 -0.262 . . . . 0.0 110.597 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 258' ' ' SER . . . . . 0.5 ' OG ' HG23 ' A' ' 191' ' ' VAL . 3.5 t 174.67 88.18 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.084 0.469 . . . . 0.0 110.167 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.861 HD12 ' N ' ' A' ' 259' ' ' LEU . 1.0 OUTLIER -94.26 123.85 37.92 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.245 0.545 . . . . 0.0 111.102 -179.101 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 260' ' ' PHE . . . . . 0.441 ' H ' ' HA ' ' A' ' 193' ' ' ALA . 15.8 m-30 -92.77 146.32 23.74 Favored 'General case' 0 CA--C 1.503 -0.854 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.503 179.274 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 86.0 mt -122.3 149.59 43.51 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.519 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.748 ' CD1' HG13 ' A' ' 195' ' ' VAL . 2.6 p90 -77.46 -138.52 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.579 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 263' ' ' ALA . . . . . 0.658 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -51.9 77.29 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.114 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 264' ' ' GLY . . . . . 0.629 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.1 104.46 0.19 Allowed Glycine 0 CA--C 1.527 0.794 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 265' ' ' ASP . . . . . 0.599 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.8 m-20 -80.43 -177.85 6.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.649 0.261 . . . . 0.0 110.9 -179.517 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -40.3 -17.81 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.551 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 267' ' ' LYS . . . . . 0.599 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.36 -51.65 41.97 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.612 179.366 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -63.59 -46.77 84.3 Favored 'General case' 0 N--CA 1.461 0.095 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.237 179.387 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 269' ' ' ALA . . . . . 0.573 ' HB1' ' OH ' ' A' ' 273' ' ' TYR . . . -61.62 -35.09 76.9 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 121.263 0.554 . . . . 0.0 109.827 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -63.12 -34.37 77.46 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.167 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.49 -43.39 13.61 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.14 -179.471 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 272' ' ' ILE . . . . . 0.589 ' C ' ' H ' ' A' ' 274' ' ' ALA . 5.0 tt -51.33 -33.75 14.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.824 -178.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 273' ' ' TYR . . . . . 0.573 ' OH ' ' HB1' ' A' ' 269' ' ' ALA . 17.3 m-85 -54.45 -1.75 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.613 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 274' ' ' ALA . . . . . 0.589 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.54 -39.6 70.58 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.931 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 275' ' ' ASN . . . . . 0.58 ' O ' ' N ' ' A' ' 279' ' ' ALA . 3.2 p30 -39.21 98.0 0.15 Allowed Pre-proline 0 C--O 1.227 -0.126 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.505 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -54.27 -42.92 63.27 Favored 'Trans proline' 0 C--N 1.303 -1.824 0 C-N-CA 122.404 2.069 . . . . 0.0 112.598 -178.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 88.7 mt -64.41 -42.78 95.89 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.133 0.492 . . . . 0.0 111.2 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 91.1 mt -95.64 -1.72 49.62 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.882 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 279' ' ' ALA . . . . . 0.58 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.23 -34.83 77.24 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.703 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -74.27 20.15 0.12 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.981 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 0.487 HD23 ' HA ' ' A' ' 281' ' ' LEU . 13.8 mt -75.2 119.93 79.26 Favored Pre-proline 0 N--CA 1.449 -0.499 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.595 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -50.49 -39.68 54.73 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.725 2.284 . . . . 0.0 112.019 178.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.69 -50.43 63.32 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.082 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 73.7 t -61.44 -43.91 97.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -57.81 -41.29 81.88 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.212 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -90.92 0.05 57.61 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.201 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt 59.47 43.29 16.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.863 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -94.68 41.42 1.09 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.372 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 53.8 t -118.99 135.83 58.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.089 0.471 . . . . 0.0 110.175 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -133.04 162.89 30.51 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 121.102 0.477 . . . . 0.0 110.637 -179.599 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -120.08 155.22 33.41 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.022 0.439 . . . . 0.0 110.689 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 81.6 mt -93.87 -1.48 54.75 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.313 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.04 165.74 12.77 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.609 -0.996 . . . . 0.0 110.609 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 7.1 m -87.3 -62.27 1.54 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.875 0.369 . . . . 0.0 111.007 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 295' ' ' GLU . . . . . 0.441 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.4 mm-40 -69.49 -4.0 16.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.672 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 26.2 p -77.03 32.62 0.14 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.619 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 297' ' ' PHE . . . . . 0.53 ' CD2' HG22 ' A' ' 70' ' ' THR . 69.4 t80 -60.15 -46.19 90.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.512 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 298' ' ' ARG . . . . . 0.613 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.1 mtt85 -81.26 133.65 35.47 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 120.988 0.423 . . . . 0.0 110.507 -179.696 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.428 ' H ' HG11 ' A' ' 51' ' ' VAL . 16.3 tp -114.16 119.67 37.89 Favored 'General case' 0 C--O 1.231 0.083 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.26 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 300' ' ' ASP . . . . . 0.621 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.5 p-10 -167.53 -174.14 2.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.611 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 81.5 t80 -48.2 -45.6 34.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.2 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -64.96 -41.64 95.29 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.106 0.479 . . . . 0.0 110.718 179.022 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 303' ' ' SER . . . . . 0.621 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 53.0 p -55.13 -36.27 65.58 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.052 -179.299 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 304' ' ' ALA . . . . . 0.521 ' HB2' ' SD ' ' A' ' 215' ' ' MET . . . -56.74 -51.65 68.04 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 179.475 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 91.5 mtp -56.22 -43.98 79.12 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -66.21 -42.71 88.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.02 0.438 . . . . 0.0 110.256 178.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 307' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 303' ' ' SER . 55.5 t -64.05 -42.81 96.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.254 179.374 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 42.2 tp -59.56 -42.22 91.92 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.81 -179.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -62.76 -38.78 91.95 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.118 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 310' ' ' ARG . . . . . 0.431 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.6 ttt85 -63.34 -44.1 95.82 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.229 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 88.1 mt -63.3 -42.03 99.01 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.318 179.528 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -62.78 -33.09 74.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.166 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -90.08 -23.42 21.42 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.456 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.476 HD22 ' CE2' ' A' ' 315' ' ' PHE . 6.8 tt -62.29 -43.16 99.47 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 121.144 0.497 . . . . 0.0 110.677 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 315' ' ' PHE . . . . . 0.476 ' CE2' HD22 ' A' ' 314' ' ' LEU . 91.0 m-85 . . . . . 0 C--O 1.219 -0.517 0 CA-C-O 118.026 -0.987 . . . . 0.0 110.409 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -99.54 136.56 39.3 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.178 0.513 . . . . 0.0 110.471 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.492 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -91.9 178.61 1.66 Allowed Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.566 -179.821 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.492 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.1 Cg_exo -61.72 146.99 96.31 Favored 'Trans proline' 0 C--N 1.299 -2.071 0 C-N-CA 122.86 2.374 . . . . 0.0 112.163 179.531 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.455 ' HE ' HD12 ' A' ' 39' ' ' LEU . 35.6 ptt180 -136.21 142.34 44.07 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.653 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -79.48 116.88 19.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.475 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.441 ' O ' HG23 ' A' ' 30' ' ' ILE . 9.5 tp -111.25 130.78 64.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.564 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.8 t -71.07 142.37 50.84 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.023 0.439 . . . . 0.0 110.615 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.477 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.4 t0 -139.95 179.53 6.55 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.561 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.477 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 77.9 p -73.67 -37.12 65.36 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.604 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.8 ttt85 -46.45 -94.41 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.29 -179.366 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -167.54 -26.29 0.02 OUTLIER Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 54.8 m -169.31 104.91 0.37 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.84 0.353 . . . . 0.0 110.622 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.683 ' CD2' HD13 ' A' ' 140' ' ' LEU . 75.3 t60 -128.56 149.32 50.67 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.158 0.504 . . . . 0.0 110.142 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.622 HG22 ' N ' ' A' ' 39' ' ' LEU . 98.4 m -131.44 166.02 22.23 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.456 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.622 ' N ' HG22 ' A' ' 38' ' ' THR . 81.6 mt -120.85 127.12 51.61 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.432 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -65.02 -44.59 88.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.748 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 39.7 p -165.51 154.94 12.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.429 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.474 ' CD ' ' H ' ' A' ' 42' ' ' GLN . 14.6 mp0 -44.3 100.91 0.24 Allowed Pre-proline 0 C--O 1.235 0.33 0 O-C-N 123.551 0.532 . . . . 0.0 110.635 179.144 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.4 129.92 36.48 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 C-N-CA 122.335 2.023 . . . . 0.0 112.307 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -83.79 -24.92 30.84 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.605 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.54 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.6 mtm-85 -122.19 134.62 54.71 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.279 0.562 . . . . 0.0 110.203 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.3 mt -130.21 133.49 64.05 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.801 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 44.0 t -124.41 130.47 73.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 179.225 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.616 ' OG ' HD12 ' A' ' 117' ' ' LEU . 2.2 m -154.86 166.89 32.07 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.554 179.569 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 72.2 p -124.13 8.59 8.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.395 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.45 126.04 33.49 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.862 0.363 . . . . 0.0 110.622 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.49 HG11 ' H ' ' A' ' 299' ' ' LEU . 90.9 t -66.18 -44.51 91.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.553 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.5 m -62.43 -44.55 96.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.684 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 46.1 tp -62.45 -41.44 98.74 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.543 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.434 ' O ' HD13 ' A' ' 58' ' ' LEU . 71.8 m -58.1 -44.65 87.79 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.164 -179.061 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -63.93 -62.53 5.15 Favored Glycine 0 N--CA 1.468 0.795 0 N-CA-C 110.844 -0.903 . . . . 0.0 110.844 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.7 t -48.09 -35.51 11.49 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 20.0 mt -61.89 -44.1 97.5 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.615 -0.434 . . . . 0.0 111.397 179.214 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.434 HD13 ' O ' ' A' ' 54' ' ' THR . 9.3 mp -65.57 -41.45 92.91 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.415 177.819 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.41 -41.48 98.72 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.856 -179.297 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.421 ' O ' HG23 ' A' ' 60' ' ' ILE . 8.1 tp -87.44 17.22 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.915 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 56.33 84.37 0.09 Allowed 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.76 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.96 59.74 0.1 OUTLIER Pre-proline 0 C--N 1.328 -0.369 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -51.85 151.56 15.3 Favored 'Trans proline' 0 C--N 1.292 -2.4 0 C-N-CA 123.079 2.519 . . . . 0.0 112.041 -178.274 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.434 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -108.46 145.04 15.94 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.191 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.29 -179.65 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.8 mt -63.72 -45.47 97.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.46 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.495 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -129.42 134.1 47.67 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.537 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.503 ' O ' ' N ' ' A' ' 98' ' ' LEU . 74.6 m -134.94 158.84 43.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.859 -179.746 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.61 139.07 16.22 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.608 -0.997 . . . . 0.0 110.608 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.471 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.71 -162.97 0.09 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.962 0.41 . . . . 0.0 110.486 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.52 HG22 ' CD2' ' A' ' 297' ' ' PHE . 5.7 t -134.0 134.88 43.0 Favored 'General case' 0 CA--C 1.519 -0.25 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.477 ' C ' ' O ' ' A' ' 70' ' ' THR . 1.0 OUTLIER 29.69 68.29 0.67 Allowed Pre-proline 0 N--CA 1.467 0.415 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.816 -179.646 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_exo -61.63 144.94 97.91 Favored 'Trans proline' 0 C--N 1.299 -2.074 0 C-N-CA 122.617 2.211 . . . . 0.0 111.732 -177.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.51 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 45.8 p-10 -158.72 -31.76 0.07 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.668 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.54 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 99.1 m-20 -64.21 -39.45 94.0 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.41 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -60.49 -47.95 83.88 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.44 -178.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.42 ' O ' ' O ' ' A' ' 77' ' ' ALA . 93.4 t -60.56 -24.79 32.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.54 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -45.88 173.35 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.665 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.574 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.3 p30 -61.93 177.36 0.45 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.622 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.566 ' C ' ' H ' ' A' ' 81' ' ' GLY . 36.0 p30 -45.3 85.28 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.011 0.434 . . . . 0.0 111.13 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.574 ' N ' ' O ' ' A' ' 78' ' ' ASP . 42.7 tp60 -67.33 13.39 0.07 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.212 0.529 . . . . 0.0 110.092 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.566 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 118.49 -22.44 9.45 Favored Glycine 0 N--CA 1.461 0.362 0 N-CA-C 110.921 -0.871 . . . . 0.0 110.921 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -107.85 116.45 31.97 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.992 0.425 . . . . 0.0 110.456 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 74.6 mt -98.12 -0.1 45.01 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.972 0.415 . . . . 0.0 110.55 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -92.7 7.14 44.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.029 0.442 . . . . 0.0 110.377 -179.613 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.77 ' O ' HG22 ' A' ' 89' ' ' VAL . 27.1 mt-30 -100.32 -27.68 13.35 Favored 'General case' 0 C--O 1.219 -0.545 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.813 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.3 t-105 -64.5 -40.53 95.83 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.089 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.53 ' O ' ' N ' ' A' ' 91' ' ' LYS . 63.1 m -77.78 -55.22 5.51 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.181 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -46.86 -50.08 19.16 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.243 -179.215 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.77 HG22 ' O ' ' A' ' 85' ' ' GLN . 14.2 m -69.5 -40.96 80.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.303 179.46 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.5 ' N ' HG23 ' A' ' 89' ' ' VAL . . . -72.01 -22.63 61.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.688 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.53 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.1 tttm -62.47 -45.75 91.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.316 -179.402 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.438 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.6 mm-40 -90.01 -94.02 0.12 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.998 0.428 . . . . 0.0 110.115 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.612 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.9 mtt180 -143.61 58.52 1.38 Allowed 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.445 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.7 pttp 34.01 26.5 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.064 0.459 . . . . 0.0 110.229 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.612 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.6 tt -48.89 123.01 6.36 Favored 'General case' 0 N--CA 1.444 -0.725 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.005 -177.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.46 ' O ' HD23 ' A' ' 95' ' ' LEU . 99.0 mm-40 -83.42 -169.6 2.63 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.212 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.616 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 81.9 mtp180 -74.61 136.88 42.0 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.272 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.503 ' N ' ' O ' ' A' ' 67' ' ' SER . 91.5 mt -85.34 -165.77 1.31 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.877 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.54 ' O ' ' CD2' ' A' ' 99' ' ' TYR . 47.1 p90 -169.05 119.33 0.71 Allowed 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.044 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.502 ' C ' ' O ' ' A' ' 99' ' ' TYR . 42.9 mm -28.31 120.44 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 O-C-N 123.316 0.385 . . . . 0.0 111.192 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 114.67 27.02 3.42 Favored Glycine 0 N--CA 1.461 0.308 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 -179.189 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.574 ' N ' ' CD ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -144.44 46.51 0.63 Allowed Pre-proline 0 C--N 1.322 -0.612 0 CA-C-O 121.126 0.489 . . . . 0.0 110.442 179.798 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.574 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 28.5 Cg_endo -62.09 144.19 95.69 Favored 'Trans proline' 0 C--N 1.293 -2.346 0 C-N-CA 122.68 2.253 . . . . 0.0 111.686 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.453 ' O ' HG23 ' A' ' 108' ' ' VAL . 26.5 t -173.12 120.18 0.35 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.325 179.584 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.78 -40.27 63.56 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.038 0.447 . . . . 0.0 111.131 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.25 -39.81 89.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.877 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.3 -39.77 94.59 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.772 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 104' ' ' SER . 70.5 t -67.6 -43.81 86.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.686 179.6 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.94 -38.93 93.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.506 -179.132 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.438 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.71 -23.45 63.16 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.5 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.53 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.4 mm-40 -90.55 5.31 48.34 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.748 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.54 ' O ' ' NE ' ' A' ' 45' ' ' ARG . 10.6 tpt 23.01 64.41 0.36 Allowed Pre-proline 0 N--CA 1.468 0.45 0 CA-C-O 120.935 0.397 . . . . 0.0 111.312 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -78.65 167.42 22.55 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 123.095 2.53 . . . . 0.0 111.6 -177.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.52 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 99.0 m-20 -109.78 -41.95 4.39 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.046 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.6 tp -121.23 120.7 35.95 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 84.3 mt -113.2 128.75 69.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 CA-C-O 120.89 0.376 . . . . 0.0 110.968 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.616 HD12 ' OG ' ' A' ' 48' ' ' SER . 31.1 mt -109.6 132.09 54.46 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.207 -179.694 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.498 HD12 HG23 ' A' ' 139' ' ' THR . 98.9 mt -119.67 138.68 49.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.634 -179.669 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 85.2 p -72.16 153.9 41.37 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.583 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.08 -50.37 73.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.646 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.0 t -149.61 154.16 38.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.563 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 170.85 -170.85 43.5 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -63.08 -33.99 88.75 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.44 ' OD1' ' O ' ' A' ' 124' ' ' ASP . 43.9 p-10 -86.87 120.42 28.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.815 0.341 . . . . 0.0 110.713 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.439 ' O ' HD12 ' A' ' 129' ' ' LEU . 38.5 t -62.97 143.5 57.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.072 0.463 . . . . 0.0 110.33 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.513 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -92.82 -43.26 9.09 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.91 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.2 tp -63.04 -42.56 99.77 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.729 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.32 -11.9 58.77 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.47 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.439 HD12 ' O ' ' A' ' 125' ' ' SER . 84.8 mt -115.09 -23.87 8.82 Favored 'General case' 0 C--O 1.225 -0.228 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.631 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' TYR . . . . . 0.513 ' N ' ' O ' ' A' ' 126' ' ' ALA . 79.7 t80 -51.46 -49.45 61.74 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.578 -178.786 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.8 p-10 -66.01 -42.41 89.75 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.773 -0.371 . . . . 0.0 111.364 179.227 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.524 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 88.3 mt-30 -67.16 -37.64 84.1 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.862 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.43 HD12 HD11 ' A' ' 118' ' ' ILE . 96.4 mt -80.36 -41.64 24.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.885 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.3 t -57.09 -44.48 83.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.294 -179.007 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.7 m -62.09 -45.2 94.54 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.505 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 94.1 mt -62.23 -43.61 98.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.216 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.666 ' HB1' ' HD2' ' A' ' 138' ' ' PRO . . . -168.98 168.73 5.01 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.608 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.666 ' HD2' ' HB1' ' A' ' 137' ' ' ALA . 51.6 Cg_exo -50.4 112.89 0.83 Allowed 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.24 1.96 . . . . 0.0 112.431 179.044 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.498 HG23 HD12 ' A' ' 118' ' ' ILE . 24.0 m -84.52 127.44 34.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.679 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.683 HD13 ' CD2' ' A' ' 37' ' ' HIS . 34.8 tp -117.88 137.15 52.99 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.009 0.433 . . . . 0.0 110.09 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.439 ' O ' ' OD2' ' A' ' 32' ' ' ASP . 81.9 mt -100.79 118.94 48.24 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.303 0 CA-C-O 121.203 0.525 . . . . 0.0 111.161 -179.433 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.425 HD12 HD22 ' A' ' 117' ' ' LEU . 97.9 mt -134.97 132.34 53.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.531 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.452 HD21 ' CG ' ' A' ' 241' ' ' ASP . 56.1 t30 -67.8 154.12 42.23 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.979 0.418 . . . . 0.0 110.472 179.26 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.528 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 89.8 t80 -87.81 122.53 31.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.866 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.528 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 99.1 m-20 55.14 69.38 0.74 Allowed 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.655 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 49.6 p-10 -123.6 -0.53 8.62 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.865 0.364 . . . . 0.0 110.646 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -151.14 116.19 5.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.736 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 82.7 p -62.64 167.5 4.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.582 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.407 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.6 p-90 -51.62 -16.12 0.58 Allowed 'General case' 0 C--O 1.221 -0.44 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.33 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.443 ' O ' HG23 ' A' ' 154' ' ' THR . 68.1 tp60 -70.36 -75.4 0.12 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.94 0.4 . . . . 0.0 110.505 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 11.1 t -62.71 -39.11 93.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.211 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 56.0 tp -59.76 -45.69 91.47 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.417 -178.352 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.407 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 46.6 tp -62.7 -41.69 99.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.588 178.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.443 HG23 ' O ' ' A' ' 150' ' ' GLN . 59.3 p -64.43 -35.02 79.57 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.145 -179.281 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.439 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.5 mm-40 -63.97 -42.79 97.14 Favored 'General case' 0 C--O 1.225 -0.196 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.391 179.351 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 91.8 mt -65.39 -38.74 90.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.17 0.509 . . . . 0.0 110.27 179.211 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.568 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.48 -32.17 80.19 Favored Glycine 0 C--N 1.331 0.295 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 -179.144 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.439 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.3 mt-10 -35.65 -27.0 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.826 0.346 . . . . 0.0 110.833 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.568 ' N ' ' O ' ' A' ' 157' ' ' GLY . 95.0 mt -55.65 150.26 2.61 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.333 178.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 77.5 p -69.67 137.24 51.99 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.049 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 70.36 22.24 77.57 Favored Glycine 0 N--CA 1.458 0.149 0 N-CA-C 111.266 -0.733 . . . . 0.0 111.266 179.537 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 57.8 m80 -123.15 -13.86 7.64 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.599 0.237 . . . . 0.0 110.481 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -66.68 -59.47 3.56 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.657 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -52.32 -49.42 64.29 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.196 -179.493 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -60.38 -41.29 93.47 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.819 0.342 . . . . 0.0 110.445 179.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.41 -47.23 86.75 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.509 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.79 -40.23 75.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.271 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -61.78 -50.09 73.76 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.626 179.476 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -65.27 -43.54 90.94 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.59 179.437 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 94.1 mt -64.79 -43.29 96.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.406 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.55 -51.33 69.91 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.339 -179.015 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -63.37 -44.01 95.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.869 0.366 . . . . 0.0 110.708 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.651 ' CE2' HD11 ' A' ' 177' ' ' LEU . 54.8 t80 -63.08 -44.33 96.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.146 0.498 . . . . 0.0 110.394 179.49 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -63.71 -39.7 94.95 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.634 -179.315 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -63.12 -42.82 99.59 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.528 179.18 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -60.72 -44.54 96.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.209 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.651 HD11 ' CE2' ' A' ' 173' ' ' PHE . 85.0 mt -64.73 -41.08 96.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.764 178.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.34 -62.18 1.8 Allowed 'General case' 0 C--O 1.239 0.527 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.363 -179.233 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.41 -47.1 85.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.459 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -52.85 -41.73 64.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.381 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -63.87 -33.74 76.38 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.325 179.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.412 ' O ' ' HG2' ' A' ' 182' ' ' GLU . 69.6 tt0 -90.76 9.0 31.79 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.6 0.714 . . . . 0.0 110.312 -178.76 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -104.94 -32.01 8.97 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.221 179.38 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.4 pt -128.0 147.61 32.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.79 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -140.06 131.34 26.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.986 0.422 . . . . 0.0 110.36 179.133 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.596 HD22 ' N ' ' A' ' 186' ' ' LEU . 3.5 mm? -85.66 133.38 41.94 Favored Pre-proline 0 N--CA 1.451 -0.403 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.177 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -43.79 157.96 0.12 Allowed 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.657 2.238 . . . . 0.0 112.374 179.323 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 0.498 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.5 Cg_endo -62.89 114.72 2.54 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.829 2.353 . . . . 0.0 111.658 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 189' ' ' GLN . . . . . 0.498 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.7 mt-30 155.52 148.07 0.0 OUTLIER Pre-proline 0 N--CA 1.456 -0.145 0 O-C-N 124.208 0.942 . . . . 0.0 110.874 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -73.28 144.44 36.98 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.633 2.222 . . . . 0.0 112.282 177.598 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.493 HG23 ' OG ' ' A' ' 258' ' ' SER . 2.1 p -124.74 158.95 31.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.449 0.643 . . . . 0.0 110.143 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 192' ' ' THR . . . . . 0.488 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 37.6 p -143.3 165.29 27.89 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.133 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 193' ' ' ALA . . . . . 0.448 ' HA ' ' H ' ' A' ' 260' ' ' PHE . . . -135.18 128.79 32.68 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-O 121.314 0.578 . . . . 0.0 110.173 179.28 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.514 HD11 HD23 ' A' ' 259' ' ' LEU . 47.3 pt -146.34 148.62 16.88 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.375 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.249 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 195' ' ' VAL . . . . . 0.744 HG13 ' CD1' ' A' ' 262' ' ' PHE . 69.2 t -117.41 123.26 71.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 CA-C-O 121.36 0.6 . . . . 0.0 109.791 178.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -134.55 107.33 7.47 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 121.144 0.497 . . . . 0.0 110.254 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 94.8 m -130.92 130.67 43.77 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.855 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -82.65 -36.9 25.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.208 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.53 -67.2 0.25 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.318 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.58 -9.99 59.25 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.266 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 59.9 t-80 60.53 58.68 2.42 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.722 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 39.1 p -166.88 153.75 8.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.53 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.2 144.25 24.61 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.022 0.439 . . . . 0.0 110.457 179.183 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -135.05 137.13 42.62 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.548 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 19.4 mt -105.5 125.42 50.97 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.061 0.457 . . . . 0.0 109.867 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 206' ' ' TRP . . . . . 0.555 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 76.6 m95 -81.81 166.52 19.93 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.572 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 207' ' ' THR . . . . . 0.447 HG22 ' C ' ' A' ' 206' ' ' TRP . 0.1 OUTLIER -156.67 171.58 7.23 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.561 -178.957 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -54.01 -36.91 85.82 Favored 'Trans proline' 0 C--N 1.301 -1.965 0 C-N-CA 122.664 2.243 . . . . 0.0 112.397 178.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -70.66 -34.86 72.49 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.653 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 22.3 m -61.43 149.7 37.73 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.626 -179.452 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.58 -36.51 80.86 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.431 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 212' ' ' GLN . . . . . 0.555 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 55.3 tt0 -64.93 -40.5 95.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.53 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.27 -43.66 92.42 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -63.29 -43.06 98.95 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 215' ' ' MET . . . . . 0.573 ' SD ' ' HB2' ' A' ' 304' ' ' ALA . 64.9 ttp -59.25 -48.24 82.37 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 87.5 mt -60.53 -40.97 93.43 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 217' ' ' GLU . . . . . 0.448 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 40.7 tp10 -57.9 -38.11 75.23 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -65.19 -38.12 89.48 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.632 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 94.2 mt -64.16 -43.11 96.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.186 0.517 . . . . 0.0 110.529 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 138.27 45.38 0.08 OUTLIER Glycine 0 C--N 1.334 0.453 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 221' ' ' PHE . . . . . 0.448 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 27.2 m-85 -128.98 156.56 43.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.084 0.469 . . . . 0.0 110.463 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.484 ' O ' HG13 ' A' ' 191' ' ' VAL . 7.7 p -108.66 123.22 48.64 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.311 0.577 . . . . 0.0 110.002 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.473 HD22 ' C ' ' A' ' 222' ' ' THR . 4.3 mm? -101.55 133.11 46.73 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.128 179.671 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -97.07 159.42 14.92 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.487 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -104.64 115.1 29.74 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.949 0.404 . . . . 0.0 110.375 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.493 HD12 ' N ' ' A' ' 226' ' ' LEU . 8.9 mp -53.48 156.62 4.19 Favored Pre-proline 0 N--CA 1.449 -0.495 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.827 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -59.75 145.04 99.23 Favored 'Trans proline' 0 C--N 1.299 -2.03 0 C-N-CA 122.726 2.284 . . . . 0.0 112.363 179.095 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.51 -2.72 58.81 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.51 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.37 -40.66 5.68 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.533 ' O ' ' N ' ' A' ' 233' ' ' SER . 69.4 mt -79.12 -17.2 55.5 Favored 'General case' 0 C--O 1.219 -0.505 0 CA-C-O 121.1 0.476 . . . . 0.0 110.261 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 54.5 t-20 -40.3 -48.77 2.69 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.751 0.31 . . . . 0.0 110.78 -179.088 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -88.36 15.45 7.75 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.433 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.533 ' N ' ' O ' ' A' ' 230' ' ' LEU . 77.7 p -60.78 -35.36 76.25 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.724 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 234' ' ' GLN . . . . . 0.521 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.6 tt0 -118.54 -69.62 0.84 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.864 179.312 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 3.9 m -70.54 103.06 2.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.702 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -94.67 58.29 2.3 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.052 0.453 . . . . 0.0 110.333 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -145.31 -122.63 1.53 Allowed Glycine 0 C--N 1.332 0.342 0 N-CA-C 110.964 -0.855 . . . . 0.0 110.964 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -133.78 111.98 10.97 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.101 0.477 . . . . 0.0 110.398 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 239' ' ' ARG . . . . . 0.505 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.1 mtt180 -148.42 56.93 1.05 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.742 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -69.37 -31.78 70.41 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.47 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 241' ' ' ASP . . . . . 0.455 ' OD2' ' O ' ' A' ' 144' ' ' TYR . 64.9 t0 -56.67 -47.01 80.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.291 -178.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 242' ' ' ILE . . . . . 0.44 ' O ' ' O ' ' A' ' 239' ' ' ARG . 17.3 tt -140.46 157.48 24.43 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 CA-C-O 120.91 0.386 . . . . 0.0 110.485 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.463 HG22 HD13 ' A' ' 245' ' ' LEU . 95.8 mt -105.93 106.3 20.32 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.219 0 CA-C-O 121.165 0.507 . . . . 0.0 110.425 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 244' ' ' GLN . . . . . 0.606 ' C ' HD12 ' A' ' 245' ' ' LEU . 88.3 mt-30 -110.86 110.4 20.99 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.366 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.606 HD12 ' C ' ' A' ' 244' ' ' GLN . 9.8 mp -121.78 -167.86 1.6 Allowed 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.627 179.567 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 246' ' ' GLY . . . . . 0.521 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 172.39 -16.04 0.05 OUTLIER Glycine 0 CA--C 1.524 0.596 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 247' ' ' GLY . . . . . 0.665 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -60.96 157.56 31.07 Favored Glycine 0 CA--C 1.521 0.463 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -63.86 20.87 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.941 0.401 . . . . 0.0 110.581 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 249' ' ' ASN . . . . . 0.665 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.9 m-20 -96.86 -5.84 37.3 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.528 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 92.5 mt -80.19 -21.45 42.96 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.839 179.294 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.63 -51.43 69.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.663 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.96 -5.21 58.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.465 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.03 -74.23 1.15 Allowed Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 82.0 mt -70.31 126.15 28.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.014 0.435 . . . . 0.0 110.172 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -59.97 -39.3 85.19 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.274 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 83.11 51.67 4.09 Favored Glycine 0 CA--C 1.519 0.3 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -95.15 -16.05 22.87 Favored 'General case' 0 C--N 1.331 -0.212 0 O-C-N 122.694 -0.297 . . . . 0.0 110.585 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 258' ' ' SER . . . . . 0.493 ' OG ' HG23 ' A' ' 191' ' ' VAL . 3.4 t 175.19 89.42 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.182 0.515 . . . . 0.0 110.053 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.852 HD12 ' N ' ' A' ' 259' ' ' LEU . 1.0 OUTLIER -94.77 124.56 38.88 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.273 0.559 . . . . 0.0 111.253 -179.094 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 260' ' ' PHE . . . . . 0.448 ' H ' ' HA ' ' A' ' 193' ' ' ALA . 15.8 m-30 -93.95 146.65 23.77 Favored 'General case' 0 CA--C 1.497 -1.086 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.4 179.509 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 86.4 mt -122.32 149.54 43.6 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.573 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.744 ' CD1' HG13 ' A' ' 195' ' ' VAL . 2.6 p90 -77.69 -138.91 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.506 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 263' ' ' ALA . . . . . 0.654 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -51.08 77.59 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 121.109 0.48 . . . . 0.0 111.303 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 264' ' ' GLY . . . . . 0.624 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.93 104.57 0.18 Allowed Glycine 0 CA--C 1.527 0.816 0 N-CA-C 110.466 -1.054 . . . . 0.0 110.466 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 265' ' ' ASP . . . . . 0.589 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.6 m-20 -80.06 -177.94 6.28 Favored 'General case' 0 C--N 1.327 -0.407 0 O-C-N 122.706 -0.291 . . . . 0.0 111.001 -179.686 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -40.44 -17.81 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.587 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 267' ' ' LYS . . . . . 0.589 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.0 -51.76 43.49 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.013 0.435 . . . . 0.0 110.684 179.125 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -63.68 -46.49 85.29 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.266 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 269' ' ' ALA . . . . . 0.58 ' HB1' ' OH ' ' A' ' 273' ' ' TYR . . . -61.76 -34.81 76.53 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 121.543 0.687 . . . . 0.0 109.746 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -63.42 -34.23 77.3 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.076 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.51 -43.11 13.83 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.112 -179.396 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 272' ' ' ILE . . . . . 0.593 ' C ' ' H ' ' A' ' 274' ' ' ALA . 4.9 tt -51.44 -33.97 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.799 -178.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 273' ' ' TYR . . . . . 0.58 ' OH ' ' HB1' ' A' ' 269' ' ' ALA . 16.9 m-85 -54.43 -2.03 0.03 OUTLIER 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.615 -179.289 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 274' ' ' ALA . . . . . 0.593 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.2 -39.63 71.66 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.868 179.434 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 275' ' ' ASN . . . . . 0.579 ' O ' ' N ' ' A' ' 279' ' ' ALA . 3.9 p30 -38.78 97.71 0.14 Allowed Pre-proline 0 N--CA 1.462 0.157 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.385 -179.667 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.7 -42.57 67.27 Favored 'Trans proline' 0 C--N 1.303 -1.865 0 C-N-CA 122.367 2.045 . . . . 0.0 112.506 -178.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 88.9 mt -64.43 -42.83 95.78 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.092 0.472 . . . . 0.0 111.225 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 91.9 mt -95.97 -1.08 49.8 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.954 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 279' ' ' ALA . . . . . 0.579 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.38 -34.83 77.47 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.683 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.22 20.16 0.11 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.982 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 0.482 ' H ' ' C ' ' A' ' 279' ' ' ALA . 13.6 mt -74.67 119.39 76.43 Favored Pre-proline 0 N--CA 1.444 -0.731 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.834 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -49.87 -40.1 48.74 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.623 2.215 . . . . 0.0 112.327 178.543 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.86 -50.59 63.48 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.034 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 73.5 t -61.45 -43.85 97.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.096 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -57.64 -41.15 80.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.098 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -91.01 0.05 57.63 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.118 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt 59.94 43.67 14.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.048 0.452 . . . . 0.0 110.772 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -95.01 41.06 1.1 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.382 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 53.8 t -119.33 135.74 58.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-O 121.133 0.492 . . . . 0.0 110.033 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -133.47 163.62 28.98 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 121.236 0.541 . . . . 0.0 110.569 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.8 155.58 32.28 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 121.097 0.475 . . . . 0.0 110.645 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 82.1 mt -94.44 -1.56 53.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.232 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.03 165.38 12.66 Favored Glycine 0 N--CA 1.463 0.489 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 6.7 m -86.64 -61.59 1.7 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.849 0.356 . . . . 0.0 111.092 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 295' ' ' GLU . . . . . 0.454 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.6 mm-40 -69.53 -4.82 20.57 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.729 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 26.8 p -76.55 32.61 0.13 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.632 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 297' ' ' PHE . . . . . 0.52 ' CD2' HG22 ' A' ' 70' ' ' THR . 67.1 t80 -60.4 -46.18 90.92 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.672 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 298' ' ' ARG . . . . . 0.616 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.2 mtt85 -80.32 136.93 36.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.657 -179.586 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.49 ' H ' HG11 ' A' ' 51' ' ' VAL . 0.9 OUTLIER -114.61 116.71 29.18 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.994 0.426 . . . . 0.0 110.533 179.65 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 300' ' ' ASP . . . . . 0.624 ' H ' ' CB ' ' A' ' 303' ' ' SER . 48.7 p-10 -167.21 -174.59 2.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.616 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 80.4 t80 -48.13 -44.44 32.09 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.227 -179.465 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -65.51 -41.53 93.07 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.034 0.445 . . . . 0.0 110.662 178.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 303' ' ' SER . . . . . 0.624 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 53.8 p -55.29 -36.29 65.99 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.952 -179.087 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 304' ' ' ALA . . . . . 0.573 ' HB2' ' SD ' ' A' ' 215' ' ' MET . . . -57.07 -52.09 66.66 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.429 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 91.7 mtp -55.96 -44.32 78.35 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -66.05 -42.87 88.96 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.172 0.51 . . . . 0.0 110.199 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 307' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 303' ' ' SER . 55.7 t -63.91 -43.03 97.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.245 179.39 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 42.4 tp -60.04 -41.98 93.47 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.803 -179.418 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -62.18 -39.16 91.76 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.211 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 310' ' ' ARG . . . . . 0.45 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.7 ttt85 -63.68 -43.91 95.26 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.227 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 89.4 mt -63.1 -42.08 99.5 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.364 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -63.06 -33.77 76.14 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.076 179.523 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.38 -23.56 22.16 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.346 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.484 HD22 ' CE2' ' A' ' 315' ' ' PHE . 6.8 tt -62.35 -43.06 99.71 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 121.128 0.489 . . . . 0.0 110.56 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 315' ' ' PHE . . . . . 0.484 ' CE2' HD22 ' A' ' 314' ' ' LEU . 89.8 m-85 . . . . . 0 C--O 1.22 -0.47 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.327 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -99.67 136.29 39.82 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.04 0.448 . . . . 0.0 110.44 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.492 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -91.54 178.41 1.78 Allowed Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.584 -179.87 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.492 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.1 Cg_exo -61.72 147.66 94.82 Favored 'Trans proline' 0 C--N 1.3 -2.001 0 C-N-CA 122.882 2.388 . . . . 0.0 112.182 179.603 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.496 ' HE ' HD12 ' A' ' 39' ' ' LEU . 35.1 ptt180 -135.35 142.36 45.75 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.567 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -78.91 116.9 19.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.515 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.424 ' O ' HG23 ' A' ' 30' ' ' ILE . 9.6 tp -110.35 131.0 62.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.478 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.9 t -70.81 142.41 51.3 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.62 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.424 ' OD1' ' O ' ' A' ' 141' ' ' ILE . 24.7 t70 -140.56 177.58 7.92 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.508 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 77.9 p -73.81 -36.38 64.98 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.556 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 60.1 ttt85 -47.69 -95.22 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.409 -179.596 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.419 ' O ' ' OG1' ' A' ' 36' ' ' THR . . . -165.42 -25.51 0.02 OUTLIER Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.419 ' OG1' ' O ' ' A' ' 35' ' ' GLY . 61.2 m -169.05 106.82 0.42 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.844 0.354 . . . . 0.0 110.63 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 52.6 t-80 -129.61 144.57 51.33 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.022 0.439 . . . . 0.0 110.199 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.629 HG22 ' N ' ' A' ' 39' ' ' LEU . 96.9 m -128.63 166.5 18.77 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.455 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.629 ' N ' HG22 ' A' ' 38' ' ' THR . 80.7 mt -121.15 127.52 51.63 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.506 179.713 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -63.8 -44.4 93.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.709 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 39.6 p -165.84 154.95 11.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.439 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.493 ' CD ' ' H ' ' A' ' 42' ' ' GLN . 14.3 mp0 -43.07 100.64 0.23 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.574 179.433 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -56.94 128.99 32.16 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 122.492 2.128 . . . . 0.0 112.201 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -83.33 -24.35 32.15 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.587 179.546 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.538 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.5 mtm-85 -121.16 134.48 55.22 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.113 0.482 . . . . 0.0 110.276 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.2 mt -130.09 133.57 64.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.74 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 47.9 t -125.26 130.94 72.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.203 179.167 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.574 ' OG ' HD12 ' A' ' 117' ' ' LEU . 4.1 m -154.57 166.34 33.63 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.607 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 72.2 p -124.6 8.83 8.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.429 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.72 125.73 33.43 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.587 -179.498 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.454 HG11 ' H ' ' A' ' 299' ' ' LEU . 87.8 t -65.68 -44.63 93.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.493 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 18.1 m -62.79 -44.16 96.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.616 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 53.0 tp -62.37 -41.63 98.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.53 -179.361 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.457 ' O ' HD13 ' A' ' 58' ' ' LEU . 76.3 m -57.67 -44.74 85.96 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.329 -179.332 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.4 -62.4 5.14 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.5 t -47.52 -35.96 9.65 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.681 0.277 . . . . 0.0 110.279 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.7 mt -61.77 -44.34 97.08 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.087 179.469 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.457 HD13 ' O ' ' A' ' 54' ' ' THR . 8.9 mp -65.39 -41.23 93.9 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.137 178.262 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.401 ' HB1' ' NE ' ' A' ' 169' ' ' ARG . . . -63.86 -41.25 97.81 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.78 -179.266 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.43 ' O ' HG23 ' A' ' 60' ' ' ILE . 7.9 tp -88.1 16.77 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.843 -179.619 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 56.4 84.43 0.09 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.727 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 178.89 57.7 0.07 OUTLIER Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.269 -0.423 . . . . 0.0 109.951 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -51.09 153.83 8.51 Favored 'Trans proline' 0 C--N 1.296 -2.216 0 C-N-CA 123.035 2.49 . . . . 0.0 111.999 -177.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.428 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -109.33 146.15 15.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.366 -179.631 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.67 -45.44 97.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.15 -179.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.506 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -129.83 134.69 47.7 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.883 0.373 . . . . 0.0 110.522 -179.6 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.489 ' O ' ' N ' ' A' ' 98' ' ' LEU . 72.3 m -134.87 158.96 42.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.765 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.92 139.35 16.21 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.481 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.8 -162.67 0.08 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.876 0.369 . . . . 0.0 110.49 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.504 HG22 ' CD2' ' A' ' 297' ' ' PHE . 5.8 t -133.76 135.82 44.16 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.256 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.488 ' C ' ' O ' ' A' ' 70' ' ' THR . 1.0 OUTLIER 29.51 68.73 0.64 Allowed Pre-proline 0 N--CA 1.464 0.26 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.74 -179.487 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -61.43 144.79 98.37 Favored 'Trans proline' 0 C--N 1.301 -1.93 0 C-N-CA 122.697 2.265 . . . . 0.0 111.815 -178.097 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.528 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 45.3 p-10 -160.08 -32.3 0.06 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.592 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.537 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 99.0 m-20 -64.04 -39.51 94.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.358 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 73.2 ttt180 -60.18 -48.41 81.83 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.548 -179.378 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.426 ' O ' ' O ' ' A' ' 77' ' ' ALA . 94.9 t -59.82 -25.05 31.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.096 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.537 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -45.35 172.67 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.636 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.573 ' O ' ' N ' ' A' ' 80' ' ' GLN . 54.1 p30 -61.94 177.64 0.43 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.483 -179.68 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.563 ' C ' ' H ' ' A' ' 81' ' ' GLY . 34.4 p30 -46.28 85.58 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.957 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.573 ' N ' ' O ' ' A' ' 78' ' ' ASP . 42.9 tp60 -67.17 13.69 0.06 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.298 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.563 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 118.09 -21.98 9.94 Favored Glycine 0 CA--C 1.519 0.316 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -107.94 116.67 32.38 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.946 0.403 . . . . 0.0 110.469 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 75.4 mt -99.23 0.38 43.08 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.582 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -91.88 6.81 44.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.374 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.794 ' O ' HG22 ' A' ' 89' ' ' VAL . 27.1 mt-30 -100.03 -28.04 13.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.704 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 68.4 t-105 -63.43 -40.5 97.34 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.821 -179.517 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.552 ' O ' ' N ' ' A' ' 91' ' ' LYS . 67.9 m -77.75 -53.81 7.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.837 -179.276 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -48.25 -50.95 27.73 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.936 -179.111 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.794 HG22 ' O ' ' A' ' 85' ' ' GLN . 15.8 m -68.96 -40.44 81.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.992 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.495 ' N ' HG23 ' A' ' 89' ' ' VAL . . . -72.47 -22.6 61.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.624 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.552 ' N ' ' O ' ' A' ' 87' ' ' SER . 65.9 tttm -61.5 -45.95 92.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.429 -179.525 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.435 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.8 mm-40 -90.38 -94.48 0.12 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.251 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.624 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.9 mtt180 -143.34 59.58 1.4 Allowed 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.456 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.6 pttp 33.76 26.35 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.021 0.439 . . . . 0.0 110.388 -179.028 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.624 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.4 tt -48.09 123.07 5.78 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.912 -178.14 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.45 ' O ' HD23 ' A' ' 95' ' ' LEU . 98.9 mm-40 -83.21 -170.68 3.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.224 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.624 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 82.9 mtp180 -73.01 137.67 45.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.329 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.489 ' N ' ' O ' ' A' ' 67' ' ' SER . 88.9 mt -86.41 -165.87 1.39 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.782 -179.632 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.533 ' O ' ' CD2' ' A' ' 99' ' ' TYR . 47.7 p90 -168.29 119.7 0.81 Allowed 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.23 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.507 ' C ' ' O ' ' A' ' 99' ' ' TYR . 42.8 mm -29.29 121.43 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.935 -179.781 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 113.6 28.05 3.36 Favored Glycine 0 CA--C 1.521 0.417 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 -179.503 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.583 ' CD ' ' H ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -143.96 46.11 0.62 Allowed Pre-proline 0 C--N 1.324 -0.521 0 CA-C-O 121.044 0.45 . . . . 0.0 110.479 179.874 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.581 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 29.8 Cg_endo -62.47 143.83 93.82 Favored 'Trans proline' 0 C--N 1.298 -2.13 0 C-N-CA 122.728 2.286 . . . . 0.0 111.834 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.459 ' O ' HG23 ' A' ' 108' ' ' VAL . 26.2 t -173.14 120.68 0.36 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.435 179.656 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.4 -41.07 63.78 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.866 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -65.73 -39.95 91.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.744 -179.396 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.77 -39.56 94.55 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.681 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 104' ' ' SER . 71.3 t -67.78 -43.58 86.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.659 179.715 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.57 -39.28 93.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.491 -179.279 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.435 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.68 -23.9 63.49 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.508 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.562 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.3 mm-40 -91.32 5.11 50.54 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.658 -179.532 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.562 ' C ' ' O ' ' A' ' 111' ' ' GLN . 9.5 tpt 21.01 65.51 0.28 Allowed Pre-proline 0 N--CA 1.465 0.299 0 CA-C-O 121.042 0.449 . . . . 0.0 111.116 -179.575 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.46 ' HG2' HD11 ' A' ' 116' ' ' ILE . 61.9 Cg_endo -79.92 170.03 17.18 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 123.018 2.479 . . . . 0.0 111.617 -178.083 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.52 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 98.9 m-20 -112.52 -44.25 3.38 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.182 179.464 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 39.4 tp -120.18 121.35 38.56 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.142 179.324 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.46 HD11 ' HG2' ' A' ' 113' ' ' PRO . 96.6 mt -118.61 131.29 71.83 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.851 -179.688 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.574 HD12 ' OG ' ' A' ' 48' ' ' SER . 32.2 mt -105.95 132.01 52.56 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.222 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.479 HD12 HG23 ' A' ' 139' ' ' THR . 98.3 mt -117.26 136.08 55.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.641 -179.647 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 85.0 p -71.68 151.85 43.31 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.559 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.26 -50.01 75.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.633 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -149.35 153.77 37.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.542 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 168.57 -169.32 41.58 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -63.13 -35.41 92.05 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.447 ' OD1' ' O ' ' A' ' 124' ' ' ASP . 44.2 p-10 -88.81 120.12 29.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.859 0.362 . . . . 0.0 110.643 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.448 ' O ' HD12 ' A' ' 129' ' ' LEU . 40.6 t -63.35 144.62 56.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.467 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.518 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.92 -42.76 8.9 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.745 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.4 tp -62.79 -42.36 99.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.669 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.99 -10.59 54.74 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.483 -179.416 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.448 HD12 ' O ' ' A' ' 125' ' ' SER . 84.0 mt -115.73 -24.57 8.17 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.591 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' TYR . . . . . 0.518 ' N ' ' O ' ' A' ' 126' ' ' ALA . 74.3 t80 -50.77 -49.93 57.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.65 -179.109 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.3 p-10 -65.89 -41.91 90.92 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.827 0.346 . . . . 0.0 111.132 179.623 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.526 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 87.8 mt-30 -68.08 -36.72 80.29 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.804 -179.776 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.458 HD12 HD11 ' A' ' 118' ' ' ILE . 96.5 mt -80.09 -42.78 22.95 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.864 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.402 ' N ' ' OG1' ' A' ' 139' ' ' THR . 11.5 t -56.76 -45.47 82.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.452 -179.337 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 20.0 m -62.38 -45.93 90.91 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.568 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 93.2 mt -62.19 -43.84 98.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.463 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.596 ' HB1' ' HD2' ' A' ' 138' ' ' PRO . . . -170.04 163.04 6.53 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.598 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.596 ' HD2' ' HB1' ' A' ' 137' ' ' ALA . 77.5 Cg_exo -41.54 110.6 0.14 Allowed 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.629 2.219 . . . . 0.0 112.224 179.336 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.499 HG21 ' CD1' ' A' ' 130' ' ' TYR . 3.0 m -87.79 127.11 35.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.62 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.436 HD12 ' HA ' ' A' ' 140' ' ' LEU . 35.1 tp -119.24 139.42 51.91 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.36 179.749 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.424 ' O ' ' OD1' ' A' ' 32' ' ' ASP . 79.7 mt -105.41 120.27 55.87 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.197 0 CA-C-O 121.1 0.476 . . . . 0.0 110.942 -179.161 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.459 HD12 HD22 ' A' ' 117' ' ' LEU . 94.7 mt -136.43 132.6 49.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.562 179.358 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.548 HD21 ' CG ' ' A' ' 241' ' ' ASP . 54.3 t30 -64.55 148.99 49.62 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.91 0.386 . . . . 0.0 110.475 179.299 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.453 ' O ' ' OD2' ' A' ' 241' ' ' ASP . 87.1 t80 -82.72 122.85 28.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.84 -179.333 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.442 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 91.6 m-20 55.01 69.67 0.71 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.753 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 49.3 p-10 -124.4 0.25 8.27 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.579 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -151.53 117.31 5.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.723 -179.452 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 85.0 p -63.89 168.68 4.87 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.504 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.415 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.6 p-90 -51.21 -15.89 0.42 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.424 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.439 ' O ' HG23 ' A' ' 154' ' ' THR . 68.4 tp60 -70.9 -75.46 0.12 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.526 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.439 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.3 t -62.66 -38.58 90.88 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.318 179.473 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 51.1 tp -59.98 -45.88 91.28 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.421 -178.639 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.415 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 45.2 tp -62.64 -41.61 99.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.581 178.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.439 HG23 ' O ' ' A' ' 150' ' ' GLN . 59.3 p -63.9 -34.87 78.94 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.298 -179.631 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.494 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.4 mm-40 -63.56 -42.01 98.38 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.359 179.265 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 91.8 mt -65.6 -38.57 89.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.11 0.481 . . . . 0.0 110.341 178.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.568 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.58 -31.97 79.66 Favored Glycine 0 CA--C 1.52 0.399 0 N-CA-C 110.818 -0.913 . . . . 0.0 110.818 -179.393 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.494 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.3 mt-10 -36.99 -25.32 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.853 0.359 . . . . 0.0 110.772 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.568 ' N ' ' O ' ' A' ' 157' ' ' GLY . 92.9 mt -59.67 149.37 6.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.423 179.268 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 77.6 p -69.18 137.52 53.34 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.854 -179.458 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 70.54 22.26 77.81 Favored Glycine 0 CA--C 1.519 0.285 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 179.408 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 62.4 m80 -124.38 -14.12 6.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.715 0.293 . . . . 0.0 110.442 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -66.83 -59.87 3.16 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.579 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -51.3 -49.7 60.76 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.243 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -60.1 -41.13 91.86 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.474 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.5 -47.6 84.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.58 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.55 -40.07 74.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.331 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -61.67 -50.58 71.93 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.603 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.401 ' NE ' ' HB1' ' A' ' 59' ' ' ALA . 59.9 ttt85 -65.32 -43.66 90.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.572 179.47 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 94.3 mt -64.71 -43.15 96.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.432 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.27 -51.49 69.15 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.382 -179.283 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.51 -43.64 96.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.601 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.658 ' CE2' HD11 ' A' ' 177' ' ' LEU . 55.9 t80 -62.94 -44.01 97.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.484 179.467 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -63.65 -39.72 95.05 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.403 -179.273 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -63.07 -42.83 99.74 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.537 179.326 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -60.46 -44.79 95.51 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.322 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.658 HD11 ' CE2' ' A' ' 173' ' ' PHE . 84.6 mt -64.65 -40.97 96.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.652 178.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.0 -62.5 1.59 Allowed 'General case' 0 C--O 1.237 0.438 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.357 -179.428 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.02 -47.27 83.55 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.51 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -52.65 -41.63 63.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.423 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -64.1 -33.2 75.23 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.361 179.292 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.418 ' O ' ' HG2' ' A' ' 182' ' ' GLU . 69.5 tt0 -91.21 8.43 35.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.357 0.599 . . . . 0.0 110.423 -178.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -104.42 -32.26 9.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.037 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.4 pt -128.02 147.56 32.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.755 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -139.65 131.05 26.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.428 179.242 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.592 HD22 ' N ' ' A' ' 186' ' ' LEU . 3.6 mm? -85.4 133.0 43.21 Favored Pre-proline 0 N--CA 1.452 -0.337 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.933 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -43.61 157.68 0.12 Allowed 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.689 2.259 . . . . 0.0 112.302 179.152 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 0.522 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.7 Cg_endo -62.81 114.93 2.63 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 122.805 2.337 . . . . 0.0 111.862 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 189' ' ' GLN . . . . . 0.522 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.7 mt-30 155.52 147.75 0.0 OUTLIER Pre-proline 0 N--CA 1.456 -0.145 0 O-C-N 123.83 0.706 . . . . 0.0 110.823 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -73.4 143.83 35.52 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.643 2.228 . . . . 0.0 112.266 177.637 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.495 HG23 ' OG ' ' A' ' 258' ' ' SER . 2.1 p -124.5 159.05 31.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.245 0.545 . . . . 0.0 110.305 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 192' ' ' THR . . . . . 0.493 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 37.9 p -143.47 165.03 28.68 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.922 -179.477 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 193' ' ' ALA . . . . . 0.444 ' HA ' ' H ' ' A' ' 260' ' ' PHE . . . -135.36 128.73 32.2 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 121.159 0.504 . . . . 0.0 110.33 179.341 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.515 HD11 HD23 ' A' ' 259' ' ' LEU . 47.5 pt -146.73 148.95 16.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.993 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 195' ' ' VAL . . . . . 0.739 HG13 ' CD1' ' A' ' 262' ' ' PHE . 76.2 t -117.35 123.02 71.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.173 0.511 . . . . 0.0 110.079 178.816 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -134.22 106.46 7.16 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.371 179.705 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 95.9 m -130.48 130.71 44.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.763 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.404 ' O ' ' N ' ' A' ' 201' ' ' HIS . . . -82.95 -36.79 24.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.285 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.31 -67.07 0.26 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.348 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.31 -9.66 58.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.357 179.497 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 201' ' ' HIS . . . . . 0.404 ' N ' ' O ' ' A' ' 198' ' ' ALA . 60.2 t-80 60.72 58.19 2.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.694 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 41.1 p -167.43 153.61 7.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.569 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.27 144.18 24.51 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.953 0.406 . . . . 0.0 110.509 179.353 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -135.29 138.25 43.29 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.632 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 18.4 mt -105.98 125.12 50.62 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.0 0.428 . . . . 0.0 110.033 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 206' ' ' TRP . . . . . 0.558 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 74.1 m95 -81.84 167.2 19.26 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.596 -179.663 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 207' ' ' THR . . . . . 0.469 HG22 ' C ' ' A' ' 206' ' ' TRP . 0.1 OUTLIER -157.18 171.15 7.83 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.64 -179.056 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -53.1 -37.2 79.13 Favored 'Trans proline' 0 C--N 1.302 -1.907 0 C-N-CA 122.73 2.286 . . . . 0.0 112.377 179.041 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -70.96 -34.98 71.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.657 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 22.1 m -61.03 150.74 32.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.595 -179.434 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.46 -36.89 81.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.509 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 212' ' ' GLN . . . . . 0.558 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 54.8 tt0 -64.72 -40.29 95.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.625 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.78 -43.35 91.91 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -62.8 -44.37 96.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.807 0.337 . . . . 0.0 110.319 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 215' ' ' MET . . . . . 0.551 ' SD ' ' HB2' ' A' ' 304' ' ' ALA . 65.1 ttp -59.08 -48.27 82.2 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.233 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 87.6 mt -60.01 -41.36 91.96 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 179.497 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 217' ' ' GLU . . . . . 0.45 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 40.4 tp10 -57.84 -38.13 75.1 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.205 179.588 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -65.45 -38.23 89.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.633 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 95.1 mt -64.15 -42.95 96.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.578 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.74 45.39 0.08 OUTLIER Glycine 0 CA--C 1.521 0.456 0 N-CA-C 110.991 -0.843 . . . . 0.0 110.991 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 221' ' ' PHE . . . . . 0.45 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 25.8 m-85 -128.21 155.63 44.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.972 0.415 . . . . 0.0 110.536 -179.833 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.482 ' O ' HG13 ' A' ' 191' ' ' VAL . 7.8 p -107.07 122.4 46.4 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.16 0.505 . . . . 0.0 110.231 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.479 HD22 ' C ' ' A' ' 222' ' ' THR . 4.3 mm? -101.78 132.94 47.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.924 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.76 160.36 14.42 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.527 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.72 115.08 29.63 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.35 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.494 HD12 ' N ' ' A' ' 226' ' ' LEU . 9.0 mp -53.1 156.42 3.7 Favored Pre-proline 0 N--CA 1.452 -0.345 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.726 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -59.62 145.2 98.75 Favored 'Trans proline' 0 C--N 1.302 -1.917 0 C-N-CA 122.771 2.314 . . . . 0.0 112.33 179.09 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.3 -3.15 59.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.498 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.19 -41.08 5.63 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.519 ' O ' ' N ' ' A' ' 233' ' ' SER . 67.7 mt -79.05 -17.75 54.69 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-O 121.051 0.453 . . . . 0.0 110.427 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 231' ' ' ASN . . . . . 0.4 ' C ' ' O ' ' A' ' 230' ' ' LEU . 55.4 t-20 -40.05 -49.7 2.55 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.78 -179.496 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -87.67 15.19 7.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.096 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.519 ' N ' ' O ' ' A' ' 230' ' ' LEU . 78.0 p -60.24 -35.17 74.86 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.744 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 234' ' ' GLN . . . . . 0.522 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.6 tt0 -119.64 -69.4 0.85 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.765 179.591 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.0 m -69.7 101.88 1.77 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.614 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -93.67 57.73 2.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.413 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -144.56 -122.56 1.59 Allowed Glycine 0 CA--C 1.521 0.451 0 N-CA-C 110.906 -0.877 . . . . 0.0 110.906 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -135.4 111.21 9.38 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.017 0.436 . . . . 0.0 110.406 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 239' ' ' ARG . . . . . 0.527 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.6 mtt180 -147.79 58.27 1.11 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.678 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -69.6 -32.2 70.8 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.515 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 241' ' ' ASP . . . . . 0.548 ' CG ' HD21 ' A' ' 143' ' ' ASN . 64.7 t0 -56.9 -47.33 80.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.362 -179.208 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 242' ' ' ILE . . . . . 0.433 ' O ' ' O ' ' A' ' 239' ' ' ARG . 17.8 tt -139.61 155.98 25.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.503 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.442 HG22 HD13 ' A' ' 245' ' ' LEU . 96.2 mt -106.01 106.47 20.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-O 120.973 0.416 . . . . 0.0 110.496 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 244' ' ' GLN . . . . . 0.6 ' O ' HD12 ' A' ' 245' ' ' LEU . 88.6 mt-30 -110.34 109.87 20.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.423 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.6 HD12 ' O ' ' A' ' 244' ' ' GLN . 9.4 mp -121.63 -168.16 1.64 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.65 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 246' ' ' GLY . . . . . 0.522 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.85 -16.32 0.05 OUTLIER Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 247' ' ' GLY . . . . . 0.674 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -61.31 156.26 34.59 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -63.35 21.87 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.92 0.39 . . . . 0.0 110.622 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 249' ' ' ASN . . . . . 0.674 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.8 m-20 -97.32 -6.29 34.64 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.539 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 91.6 mt -79.58 -22.09 44.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.757 179.412 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.62 -51.65 69.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.645 -179.498 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.0 -5.6 58.42 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.52 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -80.98 -74.46 1.14 Allowed Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 81.2 mt -69.8 125.8 27.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.846 0.355 . . . . 0.0 110.38 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -59.24 -39.55 83.14 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.251 -179.632 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 83.32 51.73 4.03 Favored Glycine 0 CA--C 1.521 0.467 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -95.45 -15.57 22.87 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.715 0.293 . . . . 0.0 110.622 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 258' ' ' SER . . . . . 0.495 ' OG ' HG23 ' A' ' 191' ' ' VAL . 3.5 t 174.59 89.0 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.07 0.462 . . . . 0.0 110.244 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.861 HD12 ' N ' ' A' ' 259' ' ' LEU . 1.0 OUTLIER -94.21 124.04 37.98 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.127 0.489 . . . . 0.0 111.038 -178.92 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 260' ' ' PHE . . . . . 0.444 ' H ' ' HA ' ' A' ' 193' ' ' ALA . 16.0 m-30 -93.31 146.6 23.6 Favored 'General case' 0 CA--C 1.506 -0.722 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.481 179.149 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 85.4 mt -122.24 149.63 43.41 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.565 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.739 ' CD1' HG13 ' A' ' 195' ' ' VAL . 2.6 p90 -77.56 -139.01 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.521 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 263' ' ' ALA . . . . . 0.665 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -51.29 77.44 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.997 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 264' ' ' GLY . . . . . 0.635 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.31 104.77 0.19 Allowed Glycine 0 CA--C 1.528 0.876 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 265' ' ' ASP . . . . . 0.6 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.7 m-20 -80.4 -177.77 6.33 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.701 0.286 . . . . 0.0 110.8 -179.363 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -40.25 -17.84 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.566 179.643 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 267' ' ' LYS . . . . . 0.6 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.45 -51.7 40.7 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.635 179.449 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -63.52 -46.59 85.36 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.279 179.333 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 269' ' ' ALA . . . . . 0.568 ' HB1' ' OH ' ' A' ' 273' ' ' TYR . . . -61.78 -34.99 76.86 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.302 0.572 . . . . 0.0 109.95 179.602 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -63.31 -34.05 76.86 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.116 179.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.69 -43.41 13.42 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.928 -179.441 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 272' ' ' ILE . . . . . 0.589 ' C ' ' H ' ' A' ' 274' ' ' ALA . 4.9 tt -51.42 -33.58 14.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.667 -178.569 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 273' ' ' TYR . . . . . 0.568 ' OH ' ' HB1' ' A' ' 269' ' ' ALA . 17.3 m-85 -54.65 -1.61 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.582 -179.558 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 274' ' ' ALA . . . . . 0.589 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.74 -39.7 69.87 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.811 179.512 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 275' ' ' ASN . . . . . 0.582 ' O ' ' N ' ' A' ' 279' ' ' ALA . 3.1 p30 -39.18 98.34 0.16 Allowed Pre-proline 0 N--CA 1.461 0.108 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.457 -179.642 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -54.59 -42.83 64.61 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 C-N-CA 122.519 2.146 . . . . 0.0 112.438 -178.669 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 89.1 mt -64.57 -42.88 95.37 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.024 -179.586 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 90.9 mt -95.77 -1.47 49.68 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.809 -179.403 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 279' ' ' ALA . . . . . 0.582 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.24 -34.89 77.37 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.703 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.46 20.35 0.12 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.876 -179.09 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 0.486 HD23 ' HA ' ' A' ' 281' ' ' LEU . 13.9 mt -75.04 119.38 76.62 Favored Pre-proline 0 N--CA 1.45 -0.462 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.719 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -49.75 -40.36 47.53 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.719 2.279 . . . . 0.0 112.224 178.663 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.32 -50.83 61.5 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.263 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 78.6 t -61.28 -43.91 97.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.255 179.439 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -57.65 -41.21 80.98 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.261 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -91.0 0.13 57.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.313 179.617 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt 59.73 43.64 15.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.754 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -94.95 41.05 1.09 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.375 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 53.7 t -119.03 135.77 58.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 121.012 0.434 . . . . 0.0 110.203 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -133.07 163.35 29.45 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.638 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.8 155.34 32.74 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.657 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 79.5 mt -94.19 -1.66 53.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.312 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.37 165.79 12.73 Favored Glycine 0 CA--C 1.521 0.462 0 N-CA-C 110.658 -0.977 . . . . 0.0 110.658 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 7.1 m -87.76 -62.39 1.51 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.865 0.365 . . . . 0.0 110.91 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 295' ' ' GLU . . . . . 0.452 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.5 mm-40 -68.86 -4.24 15.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.657 -179.653 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 24.9 p -76.64 32.12 0.13 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.608 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 297' ' ' PHE . . . . . 0.504 ' CD2' HG22 ' A' ' 70' ' ' THR . 70.4 t80 -60.42 -46.3 90.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.567 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 298' ' ' ARG . . . . . 0.624 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.2 mtt85 -80.74 134.42 35.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.594 -179.589 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.454 ' H ' HG11 ' A' ' 51' ' ' VAL . 18.3 tp -113.13 116.43 29.84 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.325 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 300' ' ' ASP . . . . . 0.628 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.1 p-10 -164.7 -177.29 4.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.638 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 81.1 t80 -46.16 -43.15 14.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.406 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -67.62 -40.13 84.68 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.991 0.424 . . . . 0.0 110.692 179.283 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 303' ' ' SER . . . . . 0.628 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 59.6 p -55.74 -36.73 67.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.26 -179.239 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 304' ' ' ALA . . . . . 0.551 ' HB2' ' SD ' ' A' ' 215' ' ' MET . . . -56.95 -52.27 65.9 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 179.389 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 92.7 mtp -54.92 -44.24 74.04 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -66.0 -42.86 89.18 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.066 0.46 . . . . 0.0 110.351 178.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 307' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 303' ' ' SER . 55.6 t -64.24 -42.81 96.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.286 179.391 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 42.9 tp -59.63 -41.94 91.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.052 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -62.57 -38.9 91.89 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.295 179.325 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 310' ' ' ARG . . . . . 0.448 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.7 ttt85 -63.64 -44.05 95.0 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.291 179.482 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 89.6 mt -63.14 -42.03 99.39 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.415 179.482 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.4 ttmt -63.09 -33.09 74.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.262 179.323 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -90.02 -23.31 21.52 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.402 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.481 HD22 ' CE2' ' A' ' 315' ' ' PHE . 6.8 tt -62.24 -43.17 99.45 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.013 0.435 . . . . 0.0 110.603 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 315' ' ' PHE . . . . . 0.481 ' CE2' HD22 ' A' ' 314' ' ' LEU . 91.0 m-85 . . . . . 0 C--O 1.22 -0.481 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.394 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -99.09 135.75 40.04 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.5 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.491 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -92.11 178.45 1.7 Allowed Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.571 -179.882 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.491 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.7 Cg_exo -61.78 147.38 95.39 Favored 'Trans proline' 0 C--N 1.301 -1.929 0 C-N-CA 122.847 2.365 . . . . 0.0 112.161 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.456 HH12 HG23 ' A' ' 159' ' ' ILE . 35.2 ptt180 -135.53 141.94 45.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.628 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -79.64 116.31 19.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.498 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.452 ' O ' HG23 ' A' ' 30' ' ' ILE . 9.4 tp -110.69 130.1 64.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.553 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 8.8 t -70.35 141.37 52.26 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.646 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.477 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.3 t0 -139.0 179.42 6.51 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.516 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.477 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 77.9 p -74.26 -36.87 63.87 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.582 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 61.0 ttt85 -46.18 -94.65 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.454 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -167.3 -26.4 0.02 OUTLIER Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.966 -0.854 . . . . 0.0 110.966 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 63.2 m -169.21 104.4 0.38 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.789 0.328 . . . . 0.0 110.639 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.681 ' CD2' HD13 ' A' ' 140' ' ' LEU . 74.5 t60 -128.38 148.85 50.72 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.012 0.434 . . . . 0.0 110.291 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.629 HG22 ' N ' ' A' ' 39' ' ' LEU . 98.1 m -131.1 166.25 21.49 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.474 -179.692 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.629 ' N ' HG22 ' A' ' 38' ' ' THR . 80.8 mt -121.06 127.45 51.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.53 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -64.94 -44.65 88.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.667 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 42.2 p -166.07 154.96 11.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.507 179.608 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.52 ' CD ' ' H ' ' A' ' 42' ' ' GLN . 15.2 mp0 -43.71 100.94 0.24 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.558 179.582 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.44 128.99 31.63 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 C-N-CA 122.546 2.164 . . . . 0.0 112.191 -179.695 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -83.73 -24.56 31.13 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.611 179.527 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.533 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.6 mtm-85 -122.2 134.43 54.71 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 121.15 0.5 . . . . 0.0 110.335 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.1 mt -130.9 134.08 62.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.639 -179.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 46.0 t -124.61 130.36 73.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.169 179.069 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.644 ' OG ' HD12 ' A' ' 117' ' ' LEU . 2.0 m -154.6 167.19 30.96 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.55 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 62.6 p -125.04 9.04 8.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.468 179.68 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.47 125.38 32.99 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.591 -179.445 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.443 HG11 ' H ' ' A' ' 299' ' ' LEU . 96.0 t -65.59 -44.6 93.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.548 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.1 m -62.45 -44.35 96.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.664 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 47.8 tp -62.4 -41.37 98.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.573 -179.402 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.435 ' O ' HD13 ' A' ' 58' ' ' LEU . 75.8 m -57.57 -44.74 85.54 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.329 -179.397 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -63.92 -63.03 4.7 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.5 t -47.24 -35.94 8.31 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.768 0.318 . . . . 0.0 110.411 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.5 mt -61.8 -44.63 96.49 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.041 179.647 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.435 HD13 ' O ' ' A' ' 54' ' ' THR . 8.7 mp -65.9 -41.08 91.94 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.042 178.365 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.55 -41.3 98.45 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.688 -179.268 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.427 ' O ' HG23 ' A' ' 60' ' ' ILE . 8.1 tp -88.43 17.09 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.801 -179.493 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 56.28 84.51 0.08 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.731 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.52 59.01 0.09 OUTLIER Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.333 -0.394 . . . . 0.0 109.974 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -52.22 152.75 14.32 Favored 'Trans proline' 0 C--N 1.298 -2.126 0 C-N-CA 122.99 2.46 . . . . 0.0 112.011 -177.639 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.433 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.2 OUTLIER -108.94 145.63 15.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.379 -179.628 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.57 -45.5 97.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.038 -179.565 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.5 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -129.77 134.11 47.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.5 -179.547 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.499 ' O ' ' N ' ' A' ' 98' ' ' LEU . 74.6 m -134.61 158.76 43.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.782 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.79 139.1 16.11 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.488 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.73 -162.79 0.08 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.826 0.346 . . . . 0.0 110.506 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.541 HG22 ' CD2' ' A' ' 297' ' ' PHE . 14.7 t -133.54 134.42 43.38 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.435 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.49 ' C ' ' O ' ' A' ' 70' ' ' THR . 0.6 OUTLIER 29.68 69.51 0.62 Allowed Pre-proline 0 N--CA 1.464 0.247 0 CA-C-O 120.94 0.4 . . . . 0.0 110.685 -179.711 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -61.99 146.08 96.45 Favored 'Trans proline' 0 C--N 1.301 -1.94 0 C-N-CA 122.767 2.311 . . . . 0.0 111.817 -178.206 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.534 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 45.0 p-10 -160.14 -31.67 0.06 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.658 179.674 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.538 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 99.2 m-20 -64.71 -39.27 93.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.392 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -60.25 -48.83 80.08 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.494 -179.349 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.423 ' O ' ' O ' ' A' ' 77' ' ' ALA . 94.6 t -59.55 -25.14 30.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.185 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.538 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -45.67 172.87 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.59 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.579 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.7 p30 -62.07 177.93 0.42 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.51 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.559 ' C ' ' H ' ' A' ' 81' ' ' GLY . 35.4 p30 -45.48 85.42 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.887 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.579 ' N ' ' O ' ' A' ' 78' ' ' ASP . 41.8 tp60 -67.32 13.26 0.07 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.351 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.559 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 118.61 -22.35 9.4 Favored Glycine 0 CA--C 1.52 0.389 0 N-CA-C 110.914 -0.875 . . . . 0.0 110.914 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -107.89 116.22 31.55 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.862 0.363 . . . . 0.0 110.487 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 73.5 mt -98.42 -0.15 44.15 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.577 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -92.31 7.44 42.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.441 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.797 ' O ' HG22 ' A' ' 89' ' ' VAL . 27.2 mt-30 -100.31 -28.44 12.97 Favored 'General case' 0 C--O 1.224 -0.266 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.613 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 68.8 t-105 -63.31 -40.2 96.67 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.736 -179.388 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.557 ' O ' ' N ' ' A' ' 91' ' ' LYS . 62.3 m -78.1 -54.01 6.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.791 -179.203 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -48.02 -50.76 26.66 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.861 -179.086 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.797 HG22 ' O ' ' A' ' 85' ' ' GLN . 16.0 m -69.15 -40.33 80.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.914 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.494 ' N ' HG23 ' A' ' 89' ' ' VAL . . . -72.86 -22.37 60.79 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.612 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.557 ' N ' ' O ' ' A' ' 87' ' ' SER . 65.9 tttm -62.28 -45.41 93.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.372 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.44 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.9 mm-40 -90.38 -94.78 0.12 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.265 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.632 ' O ' ' N ' ' A' ' 95' ' ' LEU . 96.0 mtt180 -143.04 58.6 1.41 Allowed 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.093 179.704 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.457 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.7 pttp 33.68 26.09 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 121.062 0.458 . . . . 0.0 110.487 -178.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.632 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.3 tt -47.95 123.04 5.62 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.834 -178.13 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.455 ' O ' HD23 ' A' ' 95' ' ' LEU . 99.0 mm-40 -83.2 -170.45 3.05 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.366 179.657 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.606 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 81.5 mtp180 -73.91 137.07 43.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.342 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.499 ' N ' ' O ' ' A' ' 67' ' ' SER . 90.6 mt -86.02 -165.63 1.3 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.784 -179.601 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.539 ' O ' ' CD2' ' A' ' 99' ' ' TYR . 48.6 p90 -169.02 119.81 0.73 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.27 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.515 ' C ' ' O ' ' A' ' 99' ' ' TYR . 42.5 mm -28.77 121.24 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.896 -179.62 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 114.2 27.24 3.48 Favored Glycine 0 CA--C 1.521 0.462 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 -179.601 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.579 ' CD ' ' H ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -144.39 46.39 0.62 Allowed Pre-proline 0 C--N 1.324 -0.508 0 CA-C-O 121.097 0.475 . . . . 0.0 110.482 179.966 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 28.8 Cg_endo -62.14 143.89 95.16 Favored 'Trans proline' 0 C--N 1.298 -2.096 0 C-N-CA 122.728 2.285 . . . . 0.0 111.894 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.455 ' O ' HG23 ' A' ' 108' ' ' VAL . 25.5 t -173.27 120.34 0.34 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.443 179.742 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -74.13 -40.16 62.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.903 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.42 -39.89 89.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.685 -179.343 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.22 -39.96 95.05 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.645 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 104' ' ' SER . 70.2 t -67.85 -43.57 86.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.674 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.99 -38.94 93.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.479 -179.332 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.44 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.46 -23.14 62.47 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.541 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.552 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.3 mm-40 -90.99 5.68 47.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.628 -179.487 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.552 ' C ' ' O ' ' A' ' 111' ' ' GLN . 10.0 tpt 22.77 65.1 0.35 Allowed Pre-proline 0 N--CA 1.465 0.296 0 CA-C-O 120.985 0.422 . . . . 0.0 110.978 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -79.33 167.69 21.04 Favored 'Trans proline' 0 C--N 1.307 -1.605 0 C-N-CA 123.008 2.472 . . . . 0.0 111.694 -178.119 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.525 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 99.0 m-20 -110.01 -41.89 4.35 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.286 179.414 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.0 tp -121.54 120.05 33.73 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.306 179.227 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 82.7 mt -112.66 128.81 69.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.829 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.644 HD12 ' OG ' ' A' ' 48' ' ' SER . 26.9 mt -108.42 132.41 53.8 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.442 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.491 HD12 HG23 ' A' ' 139' ' ' THR . 98.9 mt -120.1 138.52 50.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.587 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 85.6 p -72.42 154.14 41.04 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.608 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.2 -50.36 73.98 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.627 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.0 t -149.75 154.21 38.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.53 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 170.47 -170.71 43.24 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.91 -33.95 88.52 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.454 ' OD1' ' O ' ' A' ' 124' ' ' ASP . 44.6 p-10 -87.43 120.08 28.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.835 0.35 . . . . 0.0 110.655 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.44 ' O ' HD12 ' A' ' 129' ' ' LEU . 38.3 t -62.95 143.93 57.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.475 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.521 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.14 -43.27 8.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.785 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 56.4 tp -62.99 -42.21 99.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.681 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.81 -11.82 59.34 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.489 -179.408 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.44 HD12 ' O ' ' A' ' 125' ' ' SER . 83.6 mt -114.73 -24.61 8.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.528 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' TYR . . . . . 0.521 ' N ' ' O ' ' A' ' 126' ' ' ALA . 78.2 t80 -50.03 -50.17 48.49 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.613 -179.039 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 37.7 p-10 -66.07 -42.9 88.79 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.928 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.522 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 88.4 mt-30 -67.08 -37.49 84.08 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.733 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.44 HD12 HD11 ' A' ' 118' ' ' ILE . 95.9 mt -80.63 -41.42 23.89 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.768 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.4 t -56.35 -44.96 80.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.366 -179.377 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.7 m -61.87 -45.19 94.84 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.539 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 94.6 mt -61.92 -43.71 97.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.392 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.66 ' HB1' ' HD2' ' A' ' 138' ' ' PRO . . . -169.79 167.98 4.82 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.674 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.66 ' HD2' ' HB1' ' A' ' 137' ' ' ALA . 51.9 Cg_exo -49.14 112.68 0.7 Allowed 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.52 2.146 . . . . 0.0 112.349 179.244 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.491 HG23 HD12 ' A' ' 118' ' ' ILE . 24.1 m -83.7 127.29 33.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.612 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.681 HD13 ' CD2' ' A' ' 37' ' ' HIS . 34.2 tp -118.01 135.49 54.13 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.318 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.438 ' O ' ' OD2' ' A' ' 32' ' ' ASP . 82.5 mt -99.85 119.06 47.38 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 CA-C-O 121.016 0.436 . . . . 0.0 110.795 -178.865 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.433 HD12 HD22 ' A' ' 117' ' ' LEU . 97.8 mt -135.1 132.68 53.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.54 179.28 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.488 ' ND2' ' H ' ' A' ' 144' ' ' TYR . 2.1 t-20 -67.26 153.44 43.67 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.475 179.478 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.512 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 88.8 t80 -87.67 121.83 30.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.697 -179.46 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.512 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 99.1 m-20 55.27 69.55 0.72 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.588 179.545 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 34.5 p-10 -125.02 -0.06 7.88 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.595 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -151.08 115.72 5.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.623 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 83.2 p -62.91 167.99 4.29 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.574 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.416 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.4 p-90 -51.65 -15.93 0.55 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.406 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.441 ' O ' HG23 ' A' ' 154' ' ' THR . 68.0 tp60 -70.47 -75.59 0.12 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.884 0.373 . . . . 0.0 110.615 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.441 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.1 t -62.87 -38.55 91.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.399 179.389 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 53.7 tp -59.73 -46.05 90.31 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.537 -178.707 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.416 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 47.9 tp -62.69 -41.47 99.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.656 179.017 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.441 HG23 ' O ' ' A' ' 150' ' ' GLN . 60.8 p -64.13 -35.18 79.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.328 -179.7 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.442 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.7 mm-40 -63.98 -42.72 97.13 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.54 179.285 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 92.2 mt -65.66 -38.49 89.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.468 178.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.579 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.59 -31.99 79.76 Favored Glycine 0 CA--C 1.52 0.371 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 -179.369 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.442 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.1 mt-10 -35.14 -27.65 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.875 0.369 . . . . 0.0 110.806 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.579 ' N ' ' O ' ' A' ' 157' ' ' GLY . 93.9 mt -55.28 150.43 2.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.46 179.13 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 70.5 p -70.39 137.15 50.23 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.781 -179.409 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 72.01 19.33 78.31 Favored Glycine 0 CA--C 1.519 0.337 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 179.314 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 57.3 m80 -120.56 -15.0 8.57 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.71 0.29 . . . . 0.0 110.494 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -65.24 -60.58 2.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.572 -179.695 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -51.15 -50.28 59.24 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.259 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -60.11 -41.36 92.43 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.54 179.543 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.29 -47.59 85.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.485 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.41 -40.41 74.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.401 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -61.68 -50.39 72.67 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.605 179.565 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -65.17 -43.72 90.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.577 179.487 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 94.6 mt -64.89 -43.18 96.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.497 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.14 -51.63 68.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.367 -179.295 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.08 -43.84 97.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.644 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.652 ' CE2' HD11 ' A' ' 177' ' ' LEU . 56.2 t80 -63.27 -43.87 96.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.452 179.492 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -63.67 -39.88 95.44 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.501 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -63.25 -42.77 99.23 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.545 179.385 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -60.32 -44.77 95.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.422 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.652 HD11 ' CE2' ' A' ' 173' ' ' PHE . 83.5 mt -64.93 -40.78 95.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.711 178.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -51.86 -62.67 1.49 Allowed 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.391 -179.47 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.37 -47.35 84.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.461 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -52.65 -41.98 64.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.474 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -63.91 -33.48 75.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.352 179.319 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.42 ' O ' ' HG2' ' A' ' 182' ' ' GLU . 69.2 tt0 -90.7 8.92 32.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.319 0.581 . . . . 0.0 110.393 -178.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -105.29 -31.92 8.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.85 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.5 pt -128.16 147.47 32.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.649 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -139.91 131.15 26.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.489 179.232 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.593 HD22 ' N ' ' A' ' 186' ' ' LEU . 3.6 mm? -85.68 132.67 43.68 Favored Pre-proline 0 N--CA 1.453 -0.325 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.922 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -43.6 157.57 0.12 Allowed 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.729 2.286 . . . . 0.0 112.389 179.145 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 0.52 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.9 Cg_endo -62.9 114.99 2.66 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 C-N-CA 122.83 2.353 . . . . 0.0 111.908 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 189' ' ' GLN . . . . . 0.52 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.7 mt-30 156.0 147.28 0.0 OUTLIER Pre-proline 0 C--O 1.231 0.099 0 O-C-N 123.794 0.684 . . . . 0.0 110.692 -179.81 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.37 143.37 34.87 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.657 2.238 . . . . 0.0 112.272 177.659 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.498 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.1 p -124.52 159.34 30.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.164 0.507 . . . . 0.0 110.372 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 192' ' ' THR . . . . . 0.498 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 36.2 p -143.65 165.16 28.41 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.85 -179.35 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 193' ' ' ALA . . . . . 0.441 ' HA ' ' H ' ' A' ' 260' ' ' PHE . . . -135.28 128.72 32.36 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 121.167 0.508 . . . . 0.0 110.407 179.205 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.509 HD11 HD23 ' A' ' 259' ' ' LEU . 47.7 pt -146.45 148.43 17.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.961 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 195' ' ' VAL . . . . . 0.751 HG13 ' CD1' ' A' ' 262' ' ' PHE . 71.7 t -117.19 122.84 70.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.082 0.468 . . . . 0.0 110.218 178.621 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -134.08 107.31 7.67 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.377 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 95.1 m -131.01 130.44 43.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.742 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -82.78 -36.91 25.23 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.399 179.638 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.07 -67.36 0.24 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.433 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.25 -9.91 59.08 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.47 179.518 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 60.0 t-80 60.95 58.53 2.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.681 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 37.1 p -167.29 153.5 7.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.609 179.441 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.47 144.43 24.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.942 0.401 . . . . 0.0 110.47 179.236 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -135.33 138.08 43.05 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.608 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 19.0 mt -105.85 125.3 50.83 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.933 0.397 . . . . 0.0 110.194 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 206' ' ' TRP . . . . . 0.558 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 75.9 m95 -82.3 167.3 18.72 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.515 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 207' ' ' THR . . . . . 0.466 HG22 ' C ' ' A' ' 206' ' ' TRP . 0.1 OUTLIER -156.94 170.94 8.11 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.588 -179.024 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -53.23 -36.92 79.64 Favored 'Trans proline' 0 C--N 1.302 -1.892 0 C-N-CA 122.77 2.313 . . . . 0.0 112.378 178.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -71.13 -34.51 71.1 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.56 -179.51 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 22.3 m -61.64 150.61 35.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.624 -179.439 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.39 -36.94 81.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.456 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 212' ' ' GLN . . . . . 0.558 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 54.5 tt0 -64.74 -40.05 94.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.567 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.94 -43.37 91.51 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.734 -0.947 . . . . 0.0 110.734 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -63.04 -43.93 97.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.839 0.352 . . . . 0.0 110.385 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 215' ' ' MET . . . . . 0.529 ' SD ' ' HB2' ' A' ' 304' ' ' ALA . 65.1 ttp -59.02 -48.63 80.91 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.297 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 89.9 mt -59.65 -41.32 90.27 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 121.01 0.434 . . . . 0.0 110.01 179.33 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 217' ' ' GLU . . . . . 0.456 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 40.3 tp10 -57.37 -38.14 73.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.317 179.527 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -65.52 -37.78 87.75 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.605 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 95.5 mt -64.31 -42.76 96.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.725 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.58 44.53 0.08 OUTLIER Glycine 0 CA--C 1.521 0.466 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 221' ' ' PHE . . . . . 0.456 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 25.8 m-85 -127.49 155.33 43.92 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.944 0.402 . . . . 0.0 110.524 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.487 ' O ' HG13 ' A' ' 191' ' ' VAL . 6.3 p -106.97 121.98 45.54 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.152 0.501 . . . . 0.0 110.242 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.468 HD22 ' C ' ' A' ' 222' ' ' THR . 4.3 mm? -100.9 133.32 45.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.989 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.98 158.92 15.19 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.506 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.05 115.29 30.03 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.516 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.492 HD12 ' N ' ' A' ' 226' ' ' LEU . 9.0 mp -53.56 156.29 4.63 Favored Pre-proline 0 N--CA 1.452 -0.35 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.71 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -59.69 145.31 98.49 Favored 'Trans proline' 0 C--N 1.302 -1.871 0 C-N-CA 122.795 2.33 . . . . 0.0 112.295 179.043 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.42 -2.91 58.95 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.556 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.31 -40.93 5.63 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.537 ' O ' ' N ' ' A' ' 233' ' ' SER . 84.3 mt -79.2 -16.88 55.87 Favored 'General case' 0 C--O 1.224 -0.267 0 CA-C-O 120.983 0.421 . . . . 0.0 110.449 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 231' ' ' ASN . . . . . 0.404 ' C ' ' O ' ' A' ' 230' ' ' LEU . 55.1 t-20 -39.5 -49.63 2.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.679 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -88.58 15.58 7.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.009 -179.592 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.537 ' N ' ' O ' ' A' ' 230' ' ' LEU . 77.8 p -60.46 -35.47 75.95 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.653 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 234' ' ' GLN . . . . . 0.526 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.6 tt0 -118.46 -69.49 0.85 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.706 179.714 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.2 m -69.91 103.71 2.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.592 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -94.73 57.41 2.17 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.439 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -144.85 -122.57 1.57 Allowed Glycine 0 CA--C 1.521 0.441 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -134.46 111.89 10.49 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.002 0.43 . . . . 0.0 110.384 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 239' ' ' ARG . . . . . 0.515 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.4 mtt180 -148.33 57.75 1.07 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.678 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -69.97 -31.69 69.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.494 179.578 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 241' ' ' ASP . . . . . 0.472 ' OD2' ' ND2' ' A' ' 143' ' ' ASN . 65.6 t0 -56.54 -47.13 80.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.365 -179.205 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 242' ' ' ILE . . . . . 0.437 ' O ' ' O ' ' A' ' 239' ' ' ARG . 17.3 tt -140.49 157.49 24.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.493 179.73 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.441 HG22 HD13 ' A' ' 245' ' ' LEU . 96.0 mt -105.92 105.88 19.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.575 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 244' ' ' GLN . . . . . 0.602 ' O ' HD12 ' A' ' 245' ' ' LEU . 88.0 mt-30 -110.06 109.98 20.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.416 179.715 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.602 HD12 ' O ' ' A' ' 244' ' ' GLN . 9.4 mp -121.95 -168.13 1.66 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.66 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 246' ' ' GLY . . . . . 0.526 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.27 -16.79 0.05 OUTLIER Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 247' ' ' GLY . . . . . 0.67 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -60.43 157.01 29.67 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -63.79 21.51 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.86 0.362 . . . . 0.0 110.553 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 249' ' ' ASN . . . . . 0.67 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.7 m-20 -97.29 -6.1 35.18 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.497 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 92.6 mt -79.81 -21.52 44.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.784 179.349 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.61 -51.53 69.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.563 -179.426 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.31 -5.34 58.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.532 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.22 -74.34 1.15 Allowed Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.934 -0.866 . . . . 0.0 110.934 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 80.1 mt -69.95 125.75 27.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.809 0.338 . . . . 0.0 110.445 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -59.09 -39.52 82.44 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.281 -179.626 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 82.52 51.97 4.13 Favored Glycine 0 CA--C 1.521 0.442 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -96.21 -14.81 22.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.717 0.294 . . . . 0.0 110.665 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 258' ' ' SER . . . . . 0.494 ' OG ' HG23 ' A' ' 191' ' ' VAL . 3.5 t 174.71 88.27 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.047 0.451 . . . . 0.0 110.321 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.86 HD12 ' N ' ' A' ' 259' ' ' LEU . 1.0 OUTLIER -93.97 123.7 37.51 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.014 0.435 . . . . 0.0 110.992 -178.819 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 260' ' ' PHE . . . . . 0.441 ' H ' ' HA ' ' A' ' 193' ' ' ALA . 15.8 m-30 -92.74 146.35 23.72 Favored 'General case' 0 CA--C 1.508 -0.672 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.532 179.051 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 86.0 mt -122.36 149.56 43.61 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.6 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.751 ' CD1' HG13 ' A' ' 195' ' ' VAL . 2.7 p90 -77.23 -138.34 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.632 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 263' ' ' ALA . . . . . 0.661 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -52.27 77.29 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.003 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 264' ' ' GLY . . . . . 0.625 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -178.93 104.54 0.19 Allowed Glycine 0 CA--C 1.527 0.829 0 N-CA-C 110.644 -0.982 . . . . 0.0 110.644 179.72 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 265' ' ' ASP . . . . . 0.6 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.9 m-20 -79.98 -178.04 6.29 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.648 0.261 . . . . 0.0 110.781 -179.407 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -40.48 -17.52 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.521 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 267' ' ' LYS . . . . . 0.6 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.47 -51.66 41.01 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.682 179.284 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -63.64 -46.81 83.99 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.198 179.272 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 269' ' ' ALA . . . . . 0.562 ' HB1' ' OH ' ' A' ' 273' ' ' TYR . . . -61.57 -34.87 76.34 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.291 0.567 . . . . 0.0 110.058 179.611 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -63.17 -34.11 76.92 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.273 179.548 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.69 -43.68 13.2 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.793 -179.385 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 272' ' ' ILE . . . . . 0.589 ' C ' ' H ' ' A' ' 274' ' ' ALA . 4.9 tt -51.37 -33.44 14.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.579 -178.441 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 273' ' ' TYR . . . . . 0.562 ' OH ' ' HB1' ' A' ' 269' ' ' ALA . 17.5 m-85 -54.76 -1.41 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.567 -179.547 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 274' ' ' ALA . . . . . 0.589 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.71 -39.74 69.95 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.755 179.448 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 275' ' ' ASN . . . . . 0.582 ' O ' ' N ' ' A' ' 279' ' ' ALA . 2.9 p30 -39.35 98.42 0.17 Allowed Pre-proline 0 C--N 1.335 -0.055 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.458 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -54.56 -43.01 62.94 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 C-N-CA 122.621 2.214 . . . . 0.0 112.344 -178.64 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 88.5 mt -64.48 -42.98 95.55 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.871 -179.39 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 91.0 mt -95.67 -1.68 49.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.839 -179.296 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 279' ' ' ALA . . . . . 0.582 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.36 -34.65 77.09 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.626 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.8 m80 -74.78 20.41 0.13 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.785 -178.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 0.483 HD23 ' HA ' ' A' ' 281' ' ' LEU . 14.0 mt -75.25 119.45 77.02 Favored Pre-proline 0 N--CA 1.449 -0.492 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.783 179.715 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -49.47 -40.18 45.04 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.681 2.254 . . . . 0.0 112.33 178.636 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -51.97 -51.06 59.75 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.283 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 78.1 t -61.2 -43.87 97.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.248 179.497 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -57.99 -41.43 82.99 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.268 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -90.59 0.05 57.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.322 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt 59.52 42.87 16.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.742 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -94.38 41.58 1.09 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.463 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 53.8 t -118.97 135.84 58.1 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-O 120.974 0.416 . . . . 0.0 110.205 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -132.99 162.65 31.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.564 -179.621 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.64 155.31 32.56 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.613 -179.713 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 79.6 mt -93.95 -1.71 54.26 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.373 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.33 165.81 12.75 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 -179.62 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 7.1 m -87.51 -62.61 1.46 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.841 0.353 . . . . 0.0 110.75 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 295' ' ' GLU . . . . . 0.432 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.6 mm-40 -69.46 -3.89 16.37 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.597 -179.627 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 27.6 p -77.06 33.4 0.15 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.664 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 297' ' ' PHE . . . . . 0.541 ' CD2' HG22 ' A' ' 70' ' ' THR . 84.8 t80 -60.33 -46.03 91.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.522 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 298' ' ' ARG . . . . . 0.606 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.3 mtt85 -81.48 133.85 35.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.552 -179.712 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.443 ' H ' HG11 ' A' ' 51' ' ' VAL . 15.8 tp -114.13 119.38 36.91 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.392 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 300' ' ' ASP . . . . . 0.621 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.0 p-10 -167.48 -174.19 2.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.629 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 85.1 t80 -47.62 -46.04 28.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.357 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -64.92 -41.58 95.42 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 120.959 0.409 . . . . 0.0 110.6 179.191 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 303' ' ' SER . . . . . 0.621 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 52.3 p -55.11 -36.47 65.75 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.206 -179.342 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 304' ' ' ALA . . . . . 0.529 ' HB2' ' SD ' ' A' ' 215' ' ' MET . . . -56.43 -52.4 64.8 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.079 179.364 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 93.2 mtp -54.64 -44.81 73.54 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -65.93 -42.88 89.52 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.082 0.468 . . . . 0.0 110.39 178.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 307' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 303' ' ' SER . 55.4 t -64.2 -42.61 96.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.378 179.359 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 43.1 tp -59.49 -41.96 91.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.186 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -62.97 -38.7 92.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.188 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 310' ' ' ARG . . . . . 0.44 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.6 ttt85 -63.38 -44.15 95.57 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.306 179.517 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 88.8 mt -63.07 -42.0 99.55 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.498 179.384 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.3 ttmt -63.0 -32.63 74.03 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.374 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -90.42 -23.25 21.09 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.442 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.483 HD22 ' CE2' ' A' ' 315' ' ' PHE . 6.8 tt -62.25 -43.16 99.45 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.528 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 315' ' ' PHE . . . . . 0.483 ' CE2' HD22 ' A' ' 314' ' ' LEU . 90.9 m-85 . . . . . 0 C--O 1.22 -0.48 0 CA-C-O 118.005 -0.998 . . . . 0.0 110.426 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -99.54 137.11 38.49 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.009 0.433 . . . . 0.0 110.502 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.496 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -92.01 178.5 1.69 Allowed Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.578 -179.881 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.496 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.3 Cg_exo -61.73 147.54 95.08 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 C-N-CA 122.827 2.351 . . . . 0.0 112.201 179.648 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.507 ' HE ' HD12 ' A' ' 39' ' ' LEU . 35.0 ptt180 -134.35 141.76 47.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.696 179.741 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -79.2 116.58 19.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.504 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.433 ' O ' HG23 ' A' ' 30' ' ' ILE . 9.5 tp -110.57 130.79 63.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.444 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 13.0 t -71.08 142.14 50.84 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.02 0.438 . . . . 0.0 110.582 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 141' ' ' ILE . 25.3 t70 -139.57 177.73 7.72 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.535 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.0 p -73.93 -36.23 64.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.717 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -48.1 -95.25 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.275 -179.379 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.414 ' O ' ' OG1' ' A' ' 36' ' ' THR . . . -164.6 -26.26 0.02 OUTLIER Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.414 ' OG1' ' O ' ' A' ' 35' ' ' GLY . 64.6 m -168.76 106.93 0.45 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.878 0.37 . . . . 0.0 110.699 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 52.0 t-80 -129.54 144.98 51.5 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.113 0.482 . . . . 0.0 110.185 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.628 HG22 ' N ' ' A' ' 39' ' ' LEU . 98.9 m -129.31 166.27 19.81 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.519 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.628 ' N ' HG22 ' A' ' 38' ' ' THR . 80.8 mt -120.72 127.93 52.46 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.503 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -64.62 -44.56 90.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.719 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 39.1 p -165.33 154.47 12.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.398 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.526 ' CD ' ' H ' ' A' ' 42' ' ' GLN . 13.8 mp0 -42.55 100.18 0.22 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.602 179.357 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -56.73 129.23 33.5 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 122.382 2.054 . . . . 0.0 112.224 -179.545 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -84.25 -23.72 30.28 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.486 179.588 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.541 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.4 mtm-85 -121.18 134.24 55.21 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 121.138 0.494 . . . . 0.0 110.251 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.0 mt -130.5 133.2 64.03 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.254 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.857 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 48.5 t -124.8 130.83 73.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 179.363 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.632 ' OG ' HD12 ' A' ' 117' ' ' LEU . 4.9 m -154.7 166.28 33.92 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.54 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 71.9 p -124.53 8.47 8.34 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.455 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.38 126.07 33.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.611 -179.474 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.403 HG11 ' H ' ' A' ' 299' ' ' LEU . 92.2 t -66.06 -44.58 91.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.6 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.1 m -62.65 -44.19 96.9 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.699 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 52.6 tp -62.39 -41.66 98.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.58 -179.392 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.46 ' O ' HD13 ' A' ' 58' ' ' LEU . 77.4 m -57.34 -44.39 84.24 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.399 -179.377 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.79 -61.73 5.62 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 179.609 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.6 t -48.62 -35.53 13.86 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.8 mt -61.82 -44.41 96.91 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.18 179.385 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.46 HD13 ' O ' ' A' ' 54' ' ' THR . 9.3 mp -65.22 -41.36 94.53 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.247 177.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.405 ' HB1' ' NE ' ' A' ' 169' ' ' ARG . . . -63.79 -40.98 97.97 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.954 -179.243 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.422 ' O ' HG23 ' A' ' 60' ' ' ILE . 8.2 tp -88.54 16.93 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.816 -179.616 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 56.36 84.3 0.09 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.763 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.25 57.63 0.07 OUTLIER Pre-proline 0 C--N 1.328 -0.368 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -50.58 153.35 7.89 Favored 'Trans proline' 0 C--N 1.295 -2.272 0 C-N-CA 122.866 2.377 . . . . 0.0 112.314 -178.326 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.435 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -109.17 145.8 15.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.329 -179.661 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 97.1 mt -63.7 -45.34 97.64 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.409 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.506 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -129.5 134.58 47.86 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.857 0.361 . . . . 0.0 110.564 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.476 ' O ' ' N ' ' A' ' 98' ' ' LEU . 73.1 m -134.93 159.2 42.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.829 -179.674 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -87.67 139.36 15.84 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.469 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -175.65 -163.66 0.12 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.957 0.408 . . . . 0.0 110.504 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.514 HG22 ' CD2' ' A' ' 297' ' ' PHE . 15.3 t -133.02 131.82 41.12 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.415 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.424 ' C ' ' O ' ' A' ' 70' ' ' THR . 11.9 p 36.88 71.53 0.94 Allowed Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.523 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_exo -60.92 144.17 99.51 Favored 'Trans proline' 0 C--N 1.302 -1.918 0 C-N-CA 122.491 2.127 . . . . 0.0 112.116 -178.66 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.533 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 44.6 p-10 -165.0 -34.67 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.678 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.533 ' N ' ' OD1' ' A' ' 73' ' ' ASN . 99.1 m-20 -63.94 -39.39 94.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.452 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -60.86 -47.73 85.02 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.655 -179.281 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.432 ' O ' ' O ' ' A' ' 77' ' ' ALA . 94.9 t -59.95 -24.48 29.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.509 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -44.77 171.64 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.63 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.575 ' O ' ' N ' ' A' ' 80' ' ' GLN . 54.0 p30 -62.19 178.41 0.39 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.638 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.559 ' C ' ' H ' ' A' ' 81' ' ' GLY . 36.2 p30 -46.96 85.4 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.952 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.575 ' N ' ' O ' ' A' ' 78' ' ' ASP . 43.2 tp60 -67.57 14.1 0.06 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.159 0.504 . . . . 0.0 110.187 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.559 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 117.87 -21.62 10.28 Favored Glycine 0 C--N 1.332 0.313 0 N-CA-C 110.841 -0.903 . . . . 0.0 110.841 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -107.91 116.63 32.31 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.971 0.415 . . . . 0.0 110.487 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 74.1 mt -98.98 0.72 44.52 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.447 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -92.03 6.46 46.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.962 0.411 . . . . 0.0 110.396 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.786 ' O ' HG22 ' A' ' 89' ' ' VAL . 27.2 mt-30 -99.9 -27.46 13.59 Favored 'General case' 0 C--O 1.223 -0.341 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.811 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.0 t-105 -64.1 -40.51 96.38 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.052 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.554 ' O ' ' N ' ' A' ' 91' ' ' LYS . 70.7 m -77.86 -53.71 7.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.163 -179.495 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -48.51 -50.68 30.84 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.016 -179.219 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.786 HG22 ' O ' ' A' ' 85' ' ' GLN . 14.8 m -68.88 -40.75 81.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 120.937 0.399 . . . . 0.0 111.081 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.5 ' N ' HG23 ' A' ' 89' ' ' VAL . . . -72.29 -22.43 61.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.649 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.554 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.0 tttm -61.6 -45.85 92.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.516 -179.61 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.437 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.6 mm-40 -90.7 -94.23 0.12 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.198 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.625 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.9 mtt180 -143.77 60.11 1.38 Allowed 'General case' 0 C--O 1.235 0.308 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.457 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.6 pttp 33.6 26.44 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 120.933 0.396 . . . . 0.0 110.25 -179.287 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.625 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.4 tt -47.97 123.28 5.97 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.958 -178.094 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.441 ' O ' HD23 ' A' ' 95' ' ' LEU . 98.7 mm-40 -83.64 -170.6 3.14 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.084 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.628 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 82.0 mtp180 -73.34 137.6 44.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.213 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.476 ' N ' ' O ' ' A' ' 67' ' ' SER . 89.7 mt -86.99 -165.38 1.27 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.727 -179.586 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.532 ' O ' ' CD2' ' A' ' 99' ' ' TYR . 48.5 p90 -168.82 120.22 0.76 Allowed 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.189 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.504 ' C ' ' O ' ' A' ' 99' ' ' TYR . 43.3 mm -29.42 121.6 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.029 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 114.07 27.87 3.3 Favored Glycine 0 CA--C 1.518 0.253 0 N-CA-C 111.224 -0.751 . . . . 0.0 111.224 -179.416 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.584 ' CD ' ' H ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -144.14 46.08 0.61 Allowed Pre-proline 0 C--N 1.323 -0.55 0 O-C-N 122.502 -0.411 . . . . 0.0 110.464 179.84 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 30.1 Cg_endo -62.14 143.83 95.08 Favored 'Trans proline' 0 C--N 1.296 -2.226 0 C-N-CA 122.686 2.257 . . . . 0.0 111.908 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.46 ' O ' HG23 ' A' ' 108' ' ' VAL . 26.5 t -173.42 120.82 0.34 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.398 179.632 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.37 -41.03 63.9 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.1 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -65.84 -39.83 91.18 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.846 -179.451 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.84 -39.76 94.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.713 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 104' ' ' SER . 69.4 t -67.55 -43.84 86.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.705 179.668 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.42 -39.29 92.81 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.524 -179.174 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.437 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.61 -23.87 63.34 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.495 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.555 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.2 mm-40 -91.38 5.15 50.45 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.674 -179.553 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.555 ' C ' ' O ' ' A' ' 111' ' ' GLN . 10.4 tpt 21.65 64.85 0.31 Allowed Pre-proline 0 N--CA 1.466 0.349 0 CA-C-O 120.882 0.372 . . . . 0.0 111.137 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.449 ' HG2' HD11 ' A' ' 116' ' ' ILE . 66.1 Cg_endo -79.12 169.69 18.79 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 122.993 2.462 . . . . 0.0 111.902 -178.137 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.525 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 99.0 m-20 -112.84 -43.52 3.42 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.102 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 39.7 tp -120.83 119.9 34.03 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.566 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.458 HD13 HD22 ' A' ' 133' ' ' LEU . 95.7 mt -117.16 130.85 71.39 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 CA-C-O 120.944 0.402 . . . . 0.0 110.892 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.632 HD12 ' OG ' ' A' ' 48' ' ' SER . 33.1 mt -105.67 132.73 51.45 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.263 -179.449 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.438 HD12 HG23 ' A' ' 139' ' ' THR . 98.1 mt -118.15 135.73 57.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.733 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 87.0 p -71.65 153.27 42.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.567 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.31 -50.03 75.24 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.679 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.0 t -149.55 154.01 38.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.505 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 169.36 -170.11 42.39 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -63.02 -35.13 91.67 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.443 ' OD1' ' O ' ' A' ' 124' ' ' ASP . 43.9 p-10 -88.3 119.42 28.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.783 0.325 . . . . 0.0 110.65 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.448 ' O ' HD12 ' A' ' 129' ' ' LEU . 41.2 t -63.3 144.53 56.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.987 0.422 . . . . 0.0 110.507 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.521 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.65 -42.66 9.06 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.857 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.7 tp -62.79 -42.34 99.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.697 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.01 -10.99 57.99 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.499 -179.449 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.448 HD12 ' O ' ' A' ' 125' ' ' SER . 84.4 mt -115.44 -24.18 8.49 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.683 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' TYR . . . . . 0.521 ' N ' ' O ' ' A' ' 126' ' ' ALA . 77.1 t80 -51.54 -49.54 61.78 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.566 -178.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.6 p-10 -65.89 -41.81 91.05 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.255 179.451 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.524 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 88.0 mt-30 -67.84 -37.07 81.41 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.87 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.458 HD22 HD13 ' A' ' 116' ' ' ILE . 94.5 mt -79.95 -42.35 24.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.944 -179.634 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.2 t -57.1 -44.91 83.66 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.294 -179.202 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.4 m -62.18 -45.74 92.05 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.631 179.364 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 92.7 mt -62.61 -43.98 98.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.377 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.612 ' HB1' ' HD2' ' A' ' 138' ' ' PRO . . . -169.67 164.26 6.58 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.524 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.612 ' HD2' ' HB1' ' A' ' 137' ' ' ALA . 77.3 Cg_exo -43.48 111.88 0.27 Allowed 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.49 2.127 . . . . 0.0 112.195 179.359 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.506 HG21 ' CD1' ' A' ' 130' ' ' TYR . 16.8 m -86.16 127.7 34.76 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.633 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.453 HD12 ' HA ' ' A' ' 140' ' ' LEU . 35.3 tp -120.32 137.69 54.12 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.089 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.425 ' O ' ' OD1' ' A' ' 32' ' ' ASP . 80.5 mt -105.32 121.17 57.1 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.336 0 CA-C-O 121.204 0.526 . . . . 0.0 111.196 -179.489 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.498 HD12 HD22 ' A' ' 117' ' ' LEU . 97.9 mt -136.02 132.61 50.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.593 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.544 ' OD1' ' N ' ' A' ' 144' ' ' TYR . 60.7 t-20 -64.52 147.36 52.96 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.893 0.378 . . . . 0.0 110.307 179.425 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.544 ' N ' ' OD1' ' A' ' 143' ' ' ASN . 87.1 t80 -82.35 122.1 27.55 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.996 -179.615 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.515 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 98.9 m-20 55.27 69.21 0.76 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.847 179.618 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 33.7 p-10 -125.15 0.57 7.84 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.891 0.377 . . . . 0.0 110.667 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -151.29 117.48 5.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.773 -179.463 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 87.4 p -64.6 168.89 5.44 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.489 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.412 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.4 p-90 -51.2 -15.37 0.35 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.498 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.447 ' O ' HG23 ' A' ' 154' ' ' THR . 67.8 tp60 -71.71 -75.15 0.14 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.398 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.438 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.0 t -62.72 -38.85 92.09 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.244 179.461 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 52.9 tp -60.12 -45.59 92.49 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.307 -178.514 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.412 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 46.2 tp -62.64 -41.78 99.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.914 0.388 . . . . 0.0 110.508 178.902 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.447 HG23 ' O ' ' A' ' 150' ' ' GLN . 57.4 p -64.04 -34.65 78.49 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.201 -179.443 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.468 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.5 mm-40 -63.87 -42.39 97.54 Favored 'General case' 0 C--O 1.227 -0.131 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.22 179.345 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 91.7 mt -65.43 -38.76 90.85 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.066 0.46 . . . . 0.0 110.151 179.086 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.572 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.47 -31.49 77.69 Favored Glycine 0 CA--C 1.52 0.388 0 N-CA-C 110.771 -0.931 . . . . 0.0 110.771 -179.297 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.468 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.4 mt-10 -37.32 -24.57 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.894 0.378 . . . . 0.0 110.837 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.572 ' N ' ' O ' ' A' ' 157' ' ' GLY . 96.0 mt -59.82 148.53 7.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.312 179.321 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 74.8 p -69.05 137.28 53.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.951 -179.548 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 71.73 20.93 78.92 Favored Glycine 0 CA--C 1.517 0.159 0 N-CA-C 111.206 -0.757 . . . . 0.0 111.206 179.539 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 58.9 m80 -123.59 -14.33 7.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.717 0.294 . . . . 0.0 110.581 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -65.29 -60.2 3.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.71 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -52.21 -49.14 64.51 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.145 -179.594 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -59.88 -41.21 91.06 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.739 0.304 . . . . 0.0 110.28 179.564 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.55 -46.7 88.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.561 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -57.62 -39.75 77.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.178 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -61.79 -50.11 73.67 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.609 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.405 ' NE ' ' HB1' ' A' ' 59' ' ' ALA . 59.9 ttt85 -65.38 -43.81 89.53 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.531 179.52 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 94.3 mt -64.55 -43.38 96.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.369 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.56 -51.21 70.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.461 -179.201 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.43 -43.96 95.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.485 179.614 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.67 ' CE2' HD11 ' A' ' 177' ' ' LEU . 56.3 t80 -62.69 -44.33 96.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.062 0.458 . . . . 0.0 110.37 179.375 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -63.26 -39.6 95.05 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.528 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -63.17 -43.02 99.44 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.615 179.175 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -60.64 -44.79 95.96 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.195 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.67 HD11 ' CE2' ' A' ' 173' ' ' PHE . 84.3 mt -64.56 -40.96 96.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.995 0.426 . . . . 0.0 110.691 178.805 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -51.56 -62.9 1.33 Allowed 'General case' 0 C--O 1.238 0.458 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.37 -179.276 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.34 -47.0 85.17 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.59 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.0 -41.68 64.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.233 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -64.04 -33.31 75.46 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.05 0.452 . . . . 0.0 110.347 179.308 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.421 ' O ' ' HG2' ' A' ' 182' ' ' GLU . 70.1 tt0 -91.21 8.4 35.97 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.436 0.636 . . . . 0.0 110.426 -178.834 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -103.99 -32.33 9.28 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.205 179.556 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.6 pt -128.04 147.65 32.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.814 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -140.1 131.36 26.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.442 179.241 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.595 HD22 ' N ' ' A' ' 186' ' ' LEU . 3.6 mm? -85.4 132.64 44.32 Favored Pre-proline 0 N--CA 1.453 -0.321 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.904 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -43.87 157.87 0.13 Allowed 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.686 2.257 . . . . 0.0 112.27 179.327 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 0.52 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 26.6 Cg_endo -62.42 115.3 2.8 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 C-N-CA 122.818 2.345 . . . . 0.0 111.759 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 189' ' ' GLN . . . . . 0.52 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 0.4 OUTLIER 155.4 147.57 0.0 OUTLIER Pre-proline 0 N--CA 1.456 -0.156 0 O-C-N 123.777 0.673 . . . . 0.0 110.758 -179.88 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -73.78 143.59 33.72 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.653 2.235 . . . . 0.0 112.017 177.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.504 HG23 ' OG ' ' A' ' 258' ' ' SER . 2.1 p -124.91 158.7 32.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.347 0.594 . . . . 0.0 110.137 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 192' ' ' THR . . . . . 0.489 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 40.1 p -143.1 164.87 28.97 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.07 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 193' ' ' ALA . . . . . 0.455 ' HA ' ' H ' ' A' ' 260' ' ' PHE . . . -135.29 128.52 31.96 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.227 0.537 . . . . 0.0 110.223 179.567 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.528 HD11 HD23 ' A' ' 259' ' ' LEU . 47.9 pt -147.44 150.3 14.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.04 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 195' ' ' VAL . . . . . 0.729 HG13 ' CD1' ' A' ' 262' ' ' PHE . 74.6 t -118.31 123.43 71.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-O 121.298 0.57 . . . . 0.0 109.793 179.128 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -134.68 106.91 7.18 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.254 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 95.9 m -131.32 131.35 43.7 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.838 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.401 ' O ' ' N ' ' A' ' 201' ' ' HIS . . . -83.03 -37.14 24.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.308 179.727 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.39 -66.92 0.27 Allowed 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.402 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.25 -10.22 59.5 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.379 179.55 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 201' ' ' HIS . . . . . 0.401 ' N ' ' O ' ' A' ' 198' ' ' ALA . 59.6 t-80 60.89 57.69 2.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.673 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 36.2 p -166.64 152.84 8.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.623 179.489 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -150.47 143.37 24.7 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.003 0.43 . . . . 0.0 110.452 179.394 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -134.87 137.68 43.45 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.598 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 16.6 mt -106.42 125.7 51.33 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.122 0.487 . . . . 0.0 109.841 -179.683 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 206' ' ' TRP . . . . . 0.556 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 74.1 m95 -82.08 167.35 18.89 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.58 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 207' ' ' THR . . . . . 0.473 HG22 ' C ' ' A' ' 206' ' ' TRP . 0.1 OUTLIER -157.26 171.06 7.94 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.64 -179.181 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -53.08 -37.19 79.0 Favored 'Trans proline' 0 C--N 1.302 -1.873 0 C-N-CA 122.649 2.233 . . . . 0.0 112.163 179.169 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -70.89 -35.41 72.31 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.774 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 210' ' ' SER . . . . . 0.4 ' HB2' ' H ' ' A' ' 207' ' ' THR . 20.0 m -60.49 150.97 29.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.603 -179.423 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.65 -37.28 83.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.535 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 212' ' ' GLN . . . . . 0.556 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 55.0 tt0 -64.68 -40.28 95.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.52 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.66 -43.44 91.99 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 110.744 -0.943 . . . . 0.0 110.744 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -63.16 -44.39 95.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.807 0.337 . . . . 0.0 110.307 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 215' ' ' MET . . . . . 0.555 ' SD ' ' HB2' ' A' ' 304' ' ' ALA . 65.3 ttp -59.27 -48.01 83.23 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.145 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 86.0 mt -60.49 -40.83 92.74 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 217' ' ' GLU . . . . . 0.451 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.4 tp10 -58.38 -37.76 75.91 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -65.31 -38.24 89.59 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.8 0.333 . . . . 0.0 110.652 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 94.0 mt -64.25 -42.92 96.29 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.509 -179.509 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.79 44.83 0.08 OUTLIER Glycine 0 C--N 1.333 0.405 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 221' ' ' PHE . . . . . 0.451 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 26.3 m-85 -127.66 154.78 44.88 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.053 0.454 . . . . 0.0 110.497 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.479 ' O ' HG13 ' A' ' 191' ' ' VAL . 7.6 p -106.33 122.16 45.68 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.209 0.528 . . . . 0.0 110.147 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.474 HD22 ' C ' ' A' ' 222' ' ' THR . 4.3 mm? -101.6 133.07 46.85 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.023 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.44 159.41 14.96 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.49 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.14 114.99 29.52 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.962 0.411 . . . . 0.0 110.31 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.494 HD12 ' N ' ' A' ' 226' ' ' LEU . 9.0 mp -53.03 156.54 3.5 Favored Pre-proline 0 N--CA 1.453 -0.319 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.69 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -60.02 145.32 98.67 Favored 'Trans proline' 0 C--N 1.301 -1.944 0 C-N-CA 122.673 2.249 . . . . 0.0 112.167 179.201 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -86.89 -3.36 59.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.578 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.69 -40.65 5.58 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.503 ' O ' ' N ' ' A' ' 233' ' ' SER . 65.5 mt -79.53 -18.43 51.87 Favored 'General case' 0 C--O 1.222 -0.389 0 CA-C-O 121.125 0.488 . . . . 0.0 110.365 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -40.76 -49.18 3.1 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.773 -179.333 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -87.04 15.09 6.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.269 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.503 ' N ' ' O ' ' A' ' 230' ' ' LEU . 77.6 p -59.74 -34.58 73.14 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.59 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 234' ' ' GLN . . . . . 0.529 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.5 tt0 -121.73 -68.99 0.86 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.813 179.386 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.3 m -66.31 102.91 0.91 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.559 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -93.83 54.25 1.94 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.415 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -142.84 -122.16 1.7 Allowed Glycine 0 CA--C 1.521 0.434 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -139.01 113.75 9.17 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.018 0.437 . . . . 0.0 110.328 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 239' ' ' ARG . . . . . 0.529 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.8 mtt180 -147.73 60.31 1.14 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.716 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -68.94 -34.12 74.83 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.518 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 241' ' ' ASP . . . . . 0.454 ' OD2' ' ND2' ' A' ' 143' ' ' ASN . 48.2 t0 -56.79 -47.58 79.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.378 -179.151 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 242' ' ' ILE . . . . . 0.433 ' O ' ' O ' ' A' ' 239' ' ' ARG . 18.9 tt -138.45 153.79 26.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.909 0.385 . . . . 0.0 110.459 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.456 HG22 HD13 ' A' ' 245' ' ' LEU . 96.4 mt -106.38 107.55 22.98 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.224 0 CA-C-O 121.095 0.474 . . . . 0.0 110.445 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 244' ' ' GLN . . . . . 0.611 ' C ' HD12 ' A' ' 245' ' ' LEU . 88.3 mt-30 -111.85 111.03 21.69 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.46 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.611 HD12 ' C ' ' A' ' 244' ' ' GLN . 9.8 mp -121.21 -168.34 1.66 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.571 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 246' ' ' GLY . . . . . 0.529 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 176.67 -17.42 0.04 OUTLIER Glycine 0 CA--C 1.524 0.602 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 247' ' ' GLY . . . . . 0.679 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -62.29 154.55 41.09 Favored Glycine 0 CA--C 1.521 0.442 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -62.62 22.3 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.924 0.392 . . . . 0.0 110.644 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 249' ' ' ASN . . . . . 0.679 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.9 m-20 -96.64 -6.33 36.89 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.49 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 99.0 mt -80.34 -22.55 41.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.705 179.32 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.65 -51.17 71.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.84 -179.515 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.24 -4.94 58.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.429 179.661 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.41 -73.89 1.17 Allowed Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 82.8 mt -70.16 126.64 30.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.018 0.437 . . . . 0.0 110.253 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -59.51 -39.06 82.62 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.392 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 83.3 51.72 4.03 Favored Glycine 0 CA--C 1.521 0.46 0 N-CA-C 110.752 -0.939 . . . . 0.0 110.752 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -95.6 -15.15 22.97 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.687 0.28 . . . . 0.0 110.633 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 258' ' ' SER . . . . . 0.504 ' OG ' HG23 ' A' ' 191' ' ' VAL . 3.3 t 174.26 88.91 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.065 0.459 . . . . 0.0 110.086 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.864 HD12 ' N ' ' A' ' 259' ' ' LEU . 1.0 OUTLIER -94.3 124.3 38.24 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.276 0.56 . . . . 0.0 111.187 -179.156 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 260' ' ' PHE . . . . . 0.455 ' H ' ' HA ' ' A' ' 193' ' ' ALA . 15.9 m-30 -93.0 146.52 23.56 Favored 'General case' 0 CA--C 1.505 -0.781 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.465 179.282 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 85.1 mt -122.08 149.85 42.97 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.534 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.729 ' CD1' HG13 ' A' ' 195' ' ' VAL . 2.6 p90 -77.7 -139.35 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.436 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 263' ' ' ALA . . . . . 0.659 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -51.34 77.66 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.123 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 264' ' ' GLY . . . . . 0.632 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.36 104.82 0.19 Allowed Glycine 0 CA--C 1.527 0.83 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 265' ' ' ASP . . . . . 0.598 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.6 m-20 -80.38 -177.67 6.28 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.769 0.318 . . . . 0.0 110.861 -179.563 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -40.45 -17.83 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.539 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 267' ' ' LYS . . . . . 0.598 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.47 -51.63 41.37 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.007 0.432 . . . . 0.0 110.7 179.448 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -63.67 -46.48 85.39 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.259 179.368 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 269' ' ' ALA . . . . . 0.573 ' HB1' ' OH ' ' A' ' 273' ' ' TYR . . . -61.77 -35.16 77.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.202 0.525 . . . . 0.0 109.732 179.589 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -63.02 -34.56 77.83 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.113 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.47 -43.27 13.73 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.192 -179.559 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 272' ' ' ILE . . . . . 0.585 ' C ' ' H ' ' A' ' 274' ' ' ALA . 4.8 tt -51.21 -33.47 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.83 -178.84 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 273' ' ' TYR . . . . . 0.573 ' OH ' ' HB1' ' A' ' 269' ' ' ALA . 17.1 m-85 -54.7 -1.53 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.603 -179.583 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 274' ' ' ALA . . . . . 0.585 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.79 -39.65 69.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.917 179.543 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 275' ' ' ASN . . . . . 0.58 ' O ' ' N ' ' A' ' 279' ' ' ALA . 3.5 p30 -39.21 97.91 0.15 Allowed Pre-proline 0 N--CA 1.462 0.128 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.55 -179.694 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -54.25 -42.9 63.42 Favored 'Trans proline' 0 C--N 1.304 -1.812 0 C-N-CA 122.32 2.013 . . . . 0.0 112.682 -178.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 89.0 mt -64.43 -42.83 95.79 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.208 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 90.6 mt -95.79 -1.35 49.86 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.883 -179.479 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 279' ' ' ALA . . . . . 0.58 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.28 -34.73 77.13 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.71 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.14 19.91 0.12 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.99 -179.266 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 0.49 HD23 ' HA ' ' A' ' 281' ' ' LEU . 13.7 mt -75.07 119.85 78.88 Favored Pre-proline 0 N--CA 1.451 -0.424 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.58 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -50.64 -39.71 56.13 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.612 2.208 . . . . 0.0 112.035 178.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.76 -50.44 63.49 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.103 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 73.6 t -61.47 -43.85 97.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 179.463 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -57.95 -41.26 82.48 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.159 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -90.84 0.05 57.58 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.154 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt 59.56 43.23 16.22 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.86 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -94.83 41.49 1.09 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.346 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 54.2 t -118.85 135.72 58.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 121.062 0.458 . . . . 0.0 110.172 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -132.74 162.45 31.4 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.111 0.481 . . . . 0.0 110.606 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.43 154.51 33.59 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.021 0.439 . . . . 0.0 110.681 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 80.9 mt -93.66 -1.69 54.94 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.24 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.83 165.72 12.64 Favored Glycine 0 CA--C 1.522 0.475 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 6.8 m -87.61 -61.9 1.62 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.902 0.382 . . . . 0.0 111.065 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 295' ' ' GLU . . . . . 0.452 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.5 mm-40 -69.22 -4.35 17.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.677 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 26.1 p -76.29 32.43 0.12 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.666 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 297' ' ' PHE . . . . . 0.514 ' CD2' HG22 ' A' ' 70' ' ' THR . 85.0 t80 -60.56 -46.18 91.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.579 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 298' ' ' ARG . . . . . 0.628 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.1 mtt85 -81.78 133.65 35.36 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 121.049 0.452 . . . . 0.0 110.54 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.403 ' H ' HG11 ' A' ' 51' ' ' VAL . 16.8 tp -113.16 118.64 35.27 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-O 120.994 0.426 . . . . 0.0 110.161 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 300' ' ' ASP . . . . . 0.632 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.4 p-10 -165.81 -176.01 3.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.592 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 83.5 t80 -47.3 -44.06 23.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.275 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -66.45 -40.64 89.54 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.035 0.445 . . . . 0.0 110.827 179.06 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 303' ' ' SER . . . . . 0.632 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 57.6 p -55.58 -36.21 66.63 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.111 -179.19 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 304' ' ' ALA . . . . . 0.555 ' HB2' ' SD ' ' A' ' 215' ' ' MET . . . -56.98 -51.67 68.28 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.46 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 91.0 mtp -56.26 -43.83 79.14 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -66.3 -42.45 88.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.037 0.446 . . . . 0.0 110.18 178.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 307' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 303' ' ' SER . 56.1 t -64.1 -42.93 97.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.209 179.376 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 42.3 tp -59.74 -42.12 92.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.863 -179.513 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -62.68 -38.82 91.87 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.08 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 310' ' ' ARG . . . . . 0.441 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.7 ttt85 -63.63 -43.73 95.99 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.308 179.554 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 89.3 mt -63.09 -42.22 99.57 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.25 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt -62.85 -33.36 75.1 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.075 179.438 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.44 -23.68 22.06 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.401 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.477 HD22 ' CE2' ' A' ' 315' ' ' PHE . 6.7 tt -62.26 -43.28 99.2 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 121.068 0.461 . . . . 0.0 110.578 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 315' ' ' PHE . . . . . 0.477 ' CE2' HD22 ' A' ' 314' ' ' LEU . 90.1 m-85 . . . . . 0 C--O 1.22 -0.479 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.404 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -99.64 135.89 40.39 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.056 0.455 . . . . 0.0 110.476 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.497 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -91.94 178.51 1.7 Allowed Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.586 -179.846 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.497 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.4 Cg_exo -61.6 147.32 95.66 Favored 'Trans proline' 0 C--N 1.299 -2.076 0 C-N-CA 122.802 2.335 . . . . 0.0 112.147 179.568 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.463 ' HE ' HD12 ' A' ' 39' ' ' LEU . 35.7 ptt180 -136.03 142.3 44.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.645 179.699 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -79.6 116.79 20.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.501 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.443 ' O ' HG23 ' A' ' 30' ' ' ILE . 9.5 tp -111.35 130.75 64.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.465 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 13.8 t -70.93 142.36 51.09 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.606 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.478 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.4 t0 -139.85 179.53 6.54 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.526 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.478 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 78.0 p -73.71 -37.12 65.25 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.64 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.7 ttt85 -46.49 -94.56 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.293 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -167.22 -26.32 0.02 OUTLIER Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.931 -0.867 . . . . 0.0 110.931 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 60.9 m -169.25 105.02 0.38 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.891 0.377 . . . . 0.0 110.665 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.68 ' CD2' HD13 ' A' ' 140' ' ' LEU . 74.7 t60 -128.5 149.44 50.59 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.116 0.484 . . . . 0.0 110.227 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.623 HG22 ' N ' ' A' ' 39' ' ' LEU . 98.5 m -131.75 165.88 22.77 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.583 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.623 ' N ' HG22 ' A' ' 38' ' ' THR . 81.6 mt -120.8 127.31 51.82 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.497 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -64.95 -44.43 89.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.721 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 39.7 p -165.81 155.08 11.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.492 179.581 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.49 ' CD ' ' H ' ' A' ' 42' ' ' GLN . 14.9 mp0 -44.22 100.96 0.24 Allowed Pre-proline 0 C--N 1.329 -0.287 0 O-C-N 123.364 0.415 . . . . 0.0 110.621 179.362 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -57.26 129.37 33.79 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 122.337 2.024 . . . . 0.0 112.271 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -83.98 -24.81 30.45 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.501 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.538 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.3 mtm-85 -121.86 134.37 54.88 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.199 0.523 . . . . 0.0 110.321 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.2 mt -130.6 133.46 63.49 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.3 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.952 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 44.9 t -124.18 130.33 73.77 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.334 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.646 ' OG ' HD12 ' A' ' 117' ' ' LEU . 2.1 m -155.48 167.65 29.69 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.523 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 66.8 p -124.45 10.31 8.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.454 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -86.02 124.78 32.85 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.723 -179.464 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.464 HG11 ' H ' ' A' ' 299' ' ' LEU . 98.9 t -65.57 -44.55 93.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.398 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.4 m -62.49 -44.18 97.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.627 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 52.3 tp -62.02 -41.54 98.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.514 -179.442 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.453 ' O ' HD13 ' A' ' 58' ' ' LEU . 71.2 m -57.67 -44.44 85.72 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.192 -179.27 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.24 -62.09 5.46 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 179.624 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.7 t -48.61 -35.51 13.78 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 57' ' ' LEU . 20.0 mt -61.82 -44.48 96.75 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.675 -0.41 . . . . 0.0 111.284 179.335 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.453 HD13 ' O ' ' A' ' 54' ' ' THR . 9.3 mp -64.96 -41.61 95.33 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.42 177.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.84 -40.48 96.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.003 -179.244 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.43 ' O ' HG23 ' A' ' 60' ' ' ILE . 7.9 tp -89.07 16.49 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.836 -179.677 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 56.48 85.08 0.08 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.733 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 178.49 58.21 0.07 OUTLIER Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.901 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -50.97 153.1 9.23 Favored 'Trans proline' 0 C--N 1.294 -2.323 0 C-N-CA 122.935 2.423 . . . . 0.0 112.329 -178.229 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.432 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -108.3 145.37 15.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.318 -179.736 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.69 -45.18 98.09 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.303 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.403 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.502 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -129.83 134.03 47.3 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.504 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.502 ' O ' ' N ' ' A' ' 98' ' ' LEU . 75.4 m -134.48 158.5 43.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.824 -179.674 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.59 139.03 16.2 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.487 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.79 -162.86 0.08 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.014 0.435 . . . . 0.0 110.465 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.538 HG22 ' CD2' ' A' ' 297' ' ' PHE . 14.9 t -133.61 134.5 43.31 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.357 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.488 ' C ' ' O ' ' A' ' 70' ' ' THR . 0.7 OUTLIER 29.62 68.71 0.65 Allowed Pre-proline 0 N--CA 1.464 0.266 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.787 -179.879 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -61.3 145.42 98.41 Favored 'Trans proline' 0 C--N 1.299 -2.077 0 C-N-CA 122.654 2.236 . . . . 0.0 111.969 -178.392 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.53 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 45.3 p-10 -158.9 -32.29 0.07 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.701 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.545 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 99.1 m-20 -64.03 -39.71 94.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.459 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -60.39 -48.1 83.2 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.704 -179.213 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.424 ' O ' ' O ' ' A' ' 77' ' ' ALA . 92.7 t -60.48 -25.03 33.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.545 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -45.66 173.04 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.601 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.575 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.6 p30 -62.05 177.86 0.42 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.533 -179.715 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.559 ' C ' ' H ' ' A' ' 81' ' ' GLY . 36.5 p30 -45.01 85.73 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.994 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.575 ' N ' ' O ' ' A' ' 78' ' ' ASP . 42.7 tp60 -67.36 13.21 0.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.119 0.485 . . . . 0.0 110.116 -179.753 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.559 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 118.23 -22.29 9.7 Favored Glycine 0 C--N 1.332 0.317 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -108.18 116.18 31.49 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.956 0.407 . . . . 0.0 110.471 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 77.8 mt -98.56 0.58 45.23 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.941 0.401 . . . . 0.0 110.484 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -92.33 7.03 44.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.024 0.44 . . . . 0.0 110.435 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.8 ' O ' HG22 ' A' ' 89' ' ' VAL . 27.1 mt-30 -100.2 -27.87 13.3 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.787 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 68.5 t-105 -62.71 -40.91 98.64 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.935 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.552 ' O ' ' N ' ' A' ' 91' ' ' LYS . 68.8 m -77.55 -53.2 7.89 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.164 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -48.79 -50.9 32.03 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.015 -179.212 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.8 HG22 ' O ' ' A' ' 85' ' ' GLN . 15.7 m -68.75 -40.74 81.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 120.88 0.371 . . . . 0.0 111.074 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.497 ' N ' HG23 ' A' ' 89' ' ' VAL . . . -71.99 -23.11 61.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.75 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.552 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.0 tttm -61.6 -45.63 93.29 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.504 -179.537 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.445 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.8 mm-40 -90.46 -95.17 0.12 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.101 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.63 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.8 mtt180 -142.81 59.46 1.43 Allowed 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.458 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.7 pttp 33.55 26.27 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 120.906 0.384 . . . . 0.0 110.132 -179.303 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.63 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.5 tt -48.5 123.23 6.35 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.006 -177.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.456 ' O ' HD23 ' A' ' 95' ' ' LEU . 99.1 mm-40 -83.95 -169.2 2.46 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.06 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.602 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 81.3 mtp180 -74.85 136.86 41.53 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.266 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.502 ' N ' ' O ' ' A' ' 67' ' ' SER . 91.5 mt -85.77 -165.93 1.38 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.718 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.537 ' O ' ' CD2' ' A' ' 99' ' ' TYR . 48.3 p90 -168.2 119.85 0.83 Allowed 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.198 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.511 ' C ' ' O ' ' A' ' 99' ' ' TYR . 42.4 mm -28.99 120.74 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.074 -179.723 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 114.62 27.6 3.25 Favored Glycine 0 CA--C 1.52 0.353 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 -179.405 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.576 ' CD ' ' H ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -144.78 46.5 0.61 Allowed Pre-proline 0 C--N 1.323 -0.578 0 O-C-N 122.549 -0.383 . . . . 0.0 110.431 179.896 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 29.0 Cg_endo -61.9 144.21 96.36 Favored 'Trans proline' 0 C--N 1.295 -2.258 0 C-N-CA 122.678 2.252 . . . . 0.0 111.93 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.457 ' O ' HG23 ' A' ' 108' ' ' VAL . 26.1 t -173.38 120.25 0.33 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.397 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.71 -40.34 63.67 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.034 0.445 . . . . 0.0 111.098 179.594 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -66.29 -40.16 89.87 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.9 -179.419 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.97 -40.07 95.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.697 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 104' ' ' SER . 70.7 t -67.45 -43.84 87.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.8 179.625 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.86 -38.84 92.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.53 -179.297 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.445 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.62 -23.34 62.92 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.414 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.547 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.5 mm-40 -90.63 5.14 49.19 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.755 -179.575 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.547 ' C ' ' O ' ' A' ' 111' ' ' GLN . 10.6 tpt 23.49 64.05 0.38 Allowed Pre-proline 0 N--CA 1.466 0.347 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.074 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -78.41 167.78 22.42 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 C-N-CA 122.949 2.433 . . . . 0.0 112.009 -178.332 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.523 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 99.0 m-20 -110.06 -42.53 4.17 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.133 179.475 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.6 tp -120.64 120.4 35.65 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 84.4 mt -113.36 129.18 69.59 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.401 0 CA-C-O 120.983 0.42 . . . . 0.0 110.942 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.646 HD12 ' OG ' ' A' ' 48' ' ' SER . 29.9 mt -109.02 132.46 54.08 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.057 0.456 . . . . 0.0 110.214 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.505 HD12 HG23 ' A' ' 139' ' ' THR . 98.9 mt -119.91 138.2 51.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.666 -179.711 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 87.4 p -71.92 153.17 42.01 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.57 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.27 -50.19 74.63 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.681 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -149.42 153.91 38.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.615 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 170.25 -170.9 43.27 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.87 -34.28 89.37 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.447 ' OD1' ' O ' ' A' ' 124' ' ' ASP . 44.1 p-10 -87.06 120.06 27.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.805 0.336 . . . . 0.0 110.66 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.447 ' O ' HD12 ' A' ' 129' ' ' LEU . 40.6 t -63.26 143.6 57.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.451 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.521 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.08 -42.76 9.23 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.866 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.5 tp -62.73 -42.35 99.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.647 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.99 -11.94 59.81 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.485 -179.409 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.447 HD12 ' O ' ' A' ' 125' ' ' SER . 84.8 mt -114.48 -24.1 8.99 Favored 'General case' 0 C--O 1.226 -0.16 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.689 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' TYR . . . . . 0.521 ' N ' ' O ' ' A' ' 126' ' ' ALA . 77.9 t80 -51.28 -49.44 61.23 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.611 -0.436 . . . . 0.0 110.576 -178.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.3 p-10 -66.07 -42.27 89.65 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.885 0.374 . . . . 0.0 111.29 179.474 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.518 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 88.2 mt-30 -67.29 -37.92 84.18 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.797 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.446 HD12 HD11 ' A' ' 118' ' ' ILE . 96.1 mt -80.33 -41.41 24.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.991 -179.681 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.1 t -57.26 -44.34 83.82 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.202 -178.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.8 m -62.11 -45.1 94.99 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.766 0.317 . . . . 0.0 110.49 179.488 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 93.5 mt -62.26 -43.64 98.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.23 -179.699 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.664 ' HB1' ' HD2' ' A' ' 138' ' ' PRO . . . -169.46 168.35 4.88 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.588 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.664 ' HD2' ' HB1' ' A' ' 137' ' ' ALA . 52.1 Cg_exo -49.67 112.93 0.78 Allowed 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.314 2.01 . . . . 0.0 112.277 179.319 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.505 HG23 HD12 ' A' ' 118' ' ' ILE . 23.0 m -84.18 127.55 34.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.636 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.68 HD13 ' CD2' ' A' ' 37' ' ' HIS . 34.5 tp -118.05 135.93 53.87 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.938 -179.733 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.438 ' O ' ' OD2' ' A' ' 32' ' ' ASP . 81.3 mt -100.38 119.01 47.9 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 CA-C-O 121.192 0.52 . . . . 0.0 111.295 -179.44 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.44 HD12 HD22 ' A' ' 117' ' ' LEU . 98.1 mt -134.98 131.83 53.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.619 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.509 ' ND2' ' OD2' ' A' ' 241' ' ' ASP . 2.1 t-20 -66.77 147.48 53.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.866 0.365 . . . . 0.0 110.406 179.289 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.463 ' O ' ' OD2' ' A' ' 241' ' ' ASP . 44.8 t80 -81.69 123.17 28.5 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.932 -179.546 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 54.64 69.57 0.71 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.802 179.656 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 34.2 p-10 -126.16 0.7 7.15 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.93 0.395 . . . . 0.0 110.74 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -150.65 114.92 5.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.743 -179.566 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 83.6 p -64.14 169.23 4.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.523 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.417 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.4 p-90 -52.1 -16.51 0.79 Allowed 'General case' 0 C--O 1.223 -0.321 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.474 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.434 ' O ' HG23 ' A' ' 154' ' ' THR . 68.1 tp60 -69.56 -76.96 0.09 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.495 -179.71 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.449 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.1 t -62.53 -38.24 89.21 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.287 179.63 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 53.1 tp -60.05 -45.74 91.84 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.351 -178.441 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.417 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 46.8 tp -62.76 -41.71 99.34 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.417 179.049 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.449 ' OG1' ' O ' ' A' ' 151' ' ' SER . 63.0 p -63.89 -34.91 79.01 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.222 -179.454 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.445 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 88.0 mm-40 -64.0 -42.52 97.16 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.256 179.308 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 90.7 mt -65.37 -38.85 91.28 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.094 0.473 . . . . 0.0 110.212 179.174 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.578 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.25 -32.4 80.55 Favored Glycine 0 CA--C 1.519 0.343 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 -179.368 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.445 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.2 mt-10 -35.88 -26.45 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.869 0.366 . . . . 0.0 110.827 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.578 ' N ' ' O ' ' A' ' 157' ' ' GLY . 95.3 mt -57.2 148.75 4.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.287 179.224 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 73.4 p -69.1 137.41 53.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.036 -179.543 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 70.85 22.18 78.22 Favored Glycine 0 N--CA 1.458 0.162 0 N-CA-C 111.286 -0.726 . . . . 0.0 111.286 179.553 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 59.0 m80 -124.16 -14.41 7.04 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.719 0.295 . . . . 0.0 110.519 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -66.16 -59.75 3.47 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.718 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -52.16 -49.04 64.57 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.159 -179.566 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -60.98 -41.09 95.78 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.95 -0.3 . . . . 0.0 110.387 179.507 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.57 -47.09 87.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.57 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -57.0 -40.22 76.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.188 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -61.49 -49.94 74.73 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.558 179.53 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -65.35 -43.67 90.13 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.467 179.526 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 94.7 mt -64.56 -43.41 96.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.468 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.38 -51.02 71.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.451 -179.099 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.51 -43.68 96.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.493 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.665 ' CE2' HD11 ' A' ' 177' ' ' LEU . 57.6 t80 -62.86 -44.52 95.91 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.072 0.463 . . . . 0.0 110.433 179.391 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -63.27 -40.0 96.16 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.579 -179.356 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -63.02 -42.73 99.88 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.646 179.226 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -60.65 -44.88 95.9 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.152 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.665 HD11 ' CE2' ' A' ' 173' ' ' PHE . 84.6 mt -64.43 -41.14 96.75 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.992 0.425 . . . . 0.0 110.67 178.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -51.92 -62.15 1.81 Allowed 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.395 -179.252 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.76 -46.61 87.07 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.568 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.3 -41.86 66.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.28 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -63.66 -33.7 76.22 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.984 0.421 . . . . 0.0 110.4 179.256 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.421 ' O ' ' HG2' ' A' ' 182' ' ' GLU . 69.8 tt0 -90.53 8.76 32.36 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.489 0.662 . . . . 0.0 110.484 -178.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -104.87 -32.29 8.87 Favored 'General case' 0 CA--C 1.515 -0.372 0 O-C-N 122.113 -0.367 . . . . 0.0 111.233 179.537 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.7 pt -128.01 147.61 32.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.826 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -139.97 131.02 26.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.331 179.348 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.597 HD22 ' N ' ' A' ' 186' ' ' LEU . 3.5 mm? -85.44 133.73 41.69 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.01 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -44.04 157.89 0.14 Allowed 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 122.703 2.269 . . . . 0.0 112.199 179.444 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 0.521 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 28.1 Cg_endo -63.13 114.8 2.62 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 C-N-CA 122.765 2.31 . . . . 0.0 111.729 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 189' ' ' GLN . . . . . 0.521 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.8 mt-30 155.4 147.99 0.0 OUTLIER Pre-proline 0 N--CA 1.455 -0.203 0 O-C-N 123.68 0.612 . . . . 0.0 110.802 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -73.53 144.29 35.77 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.621 2.214 . . . . 0.0 112.005 177.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.503 HG23 ' OG ' ' A' ' 258' ' ' SER . 2.1 p -124.92 158.83 32.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.298 0.57 . . . . 0.0 110.14 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 192' ' ' THR . . . . . 0.494 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 37.4 p -143.3 165.39 27.61 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.121 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 193' ' ' ALA . . . . . 0.446 ' HA ' ' H ' ' A' ' 260' ' ' PHE . . . -135.28 128.64 32.2 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.222 0.534 . . . . 0.0 110.189 179.492 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.508 HD11 HD23 ' A' ' 259' ' ' LEU . 47.7 pt -146.39 148.79 16.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.186 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 195' ' ' VAL . . . . . 0.749 HG13 ' CD1' ' A' ' 262' ' ' PHE . 72.1 t -117.77 123.25 71.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.272 0.558 . . . . 0.0 109.684 179.167 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -134.4 107.37 7.56 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.282 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 94.7 m -130.82 130.46 43.68 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.834 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.406 ' O ' ' N ' ' A' ' 201' ' ' HIS . . . -82.73 -37.36 24.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.265 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.41 -66.98 0.27 Allowed 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.414 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.1 -10.05 59.24 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.266 179.517 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 201' ' ' HIS . . . . . 0.406 ' N ' ' O ' ' A' ' 198' ' ' ALA . 60.0 t-80 60.81 58.13 2.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.703 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 41.0 p -166.84 153.49 8.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.52 179.486 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.32 144.05 24.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.496 179.385 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -135.34 138.4 43.34 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.641 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 20.4 mt -106.53 125.64 51.25 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.116 0.484 . . . . 0.0 109.779 -179.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 206' ' ' TRP . . . . . 0.556 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 74.8 m95 -82.12 166.99 19.21 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.655 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 207' ' ' THR . . . . . 0.466 HG22 ' C ' ' A' ' 206' ' ' TRP . 0.1 OUTLIER -156.92 171.26 7.67 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 120.98 0.419 . . . . 0.0 110.521 -179.144 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.54 -37.35 82.65 Favored 'Trans proline' 0 C--N 1.303 -1.832 0 C-N-CA 122.619 2.213 . . . . 0.0 112.186 179.225 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -70.4 -35.01 73.2 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.875 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 22.8 m -61.01 150.74 32.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.616 -179.385 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.45 -37.04 82.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.551 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 212' ' ' GLN . . . . . 0.556 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 55.0 tt0 -64.69 -40.24 95.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.543 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.5 -43.46 92.32 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.719 -0.952 . . . . 0.0 110.719 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -63.34 -43.54 97.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.71 0.291 . . . . 0.0 110.247 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 215' ' ' MET . . . . . 0.537 ' SD ' ' HB2' ' A' ' 304' ' ' ALA . 65.1 ttp -59.5 -48.01 83.31 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.207 -179.753 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 88.0 mt -60.66 -40.74 93.19 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 217' ' ' GLU . . . . . 0.459 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.7 tp10 -58.06 -37.87 75.25 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -65.22 -38.01 89.06 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.81 0.338 . . . . 0.0 110.654 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 94.3 mt -64.3 -42.62 96.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.614 -179.715 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.27 44.6 0.09 OUTLIER Glycine 0 C--N 1.333 0.408 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 221' ' ' PHE . . . . . 0.459 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 26.1 m-85 -127.66 155.44 43.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.058 0.456 . . . . 0.0 110.527 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.487 ' O ' HG13 ' A' ' 191' ' ' VAL . 7.0 p -107.16 122.23 46.09 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.224 0.535 . . . . 0.0 110.196 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.472 HD22 ' C ' ' A' ' 222' ' ' THR . 4.3 mm? -101.03 133.28 45.76 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.134 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -97.1 159.21 15.04 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.473 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.16 115.35 30.13 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-O 120.924 0.392 . . . . 0.0 110.37 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.496 HD12 ' N ' ' A' ' 226' ' ' LEU . 8.9 mp -53.37 156.67 3.96 Favored Pre-proline 0 N--CA 1.453 -0.313 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.659 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -60.19 145.3 98.81 Favored 'Trans proline' 0 C--N 1.301 -1.931 0 C-N-CA 122.629 2.219 . . . . 0.0 112.15 179.261 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.41 -3.02 59.01 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.5 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.22 -40.92 5.66 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.024 -0.831 . . . . 0.0 111.024 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.539 ' O ' ' N ' ' A' ' 233' ' ' SER . 86.3 mt -79.17 -16.82 56.04 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-O 121.019 0.438 . . . . 0.0 110.29 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 231' ' ' ASN . . . . . 0.402 ' C ' ' O ' ' A' ' 230' ' ' LEU . 54.5 t-20 -40.41 -48.89 2.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.764 -179.399 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -88.2 15.43 7.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.314 179.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.539 ' N ' ' O ' ' A' ' 230' ' ' LEU . 78.1 p -60.6 -35.51 76.3 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.648 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 234' ' ' GLN . . . . . 0.528 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.6 tt0 -118.35 -69.26 0.86 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.974 179.428 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.0 m -70.47 103.02 2.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.739 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -94.27 58.08 2.42 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.37 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -145.04 -122.53 1.55 Allowed Glycine 0 CA--C 1.519 0.324 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -134.47 111.79 10.4 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 121.175 0.512 . . . . 0.0 110.408 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 239' ' ' ARG . . . . . 0.515 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.2 mtt180 -148.25 57.56 1.07 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.762 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -69.83 -31.89 70.01 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.489 179.67 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 241' ' ' ASP . . . . . 0.509 ' OD2' ' ND2' ' A' ' 143' ' ' ASN . 64.8 t0 -56.92 -47.03 81.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.344 -179.097 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 242' ' ' ILE . . . . . 0.434 ' O ' ' O ' ' A' ' 239' ' ' ARG . 17.6 tt -140.2 157.03 25.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.912 0.387 . . . . 0.0 110.494 179.79 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.45 HG22 HD13 ' A' ' 245' ' ' LEU . 96.1 mt -106.25 106.33 20.39 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.163 0 CA-C-O 121.169 0.509 . . . . 0.0 110.466 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 244' ' ' GLN . . . . . 0.599 ' O ' HD12 ' A' ' 245' ' ' LEU . 88.2 mt-30 -110.45 110.31 21.02 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.302 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.599 HD12 ' O ' ' A' ' 244' ' ' GLN . 9.5 mp -121.87 -168.33 1.69 Allowed 'General case' 0 C--O 1.225 -0.205 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.63 179.728 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 246' ' ' GLY . . . . . 0.528 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.49 -16.9 0.05 OUTLIER Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.919 -0.873 . . . . 0.0 110.919 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 247' ' ' GLY . . . . . 0.668 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -60.45 156.98 29.78 Favored Glycine 0 CA--C 1.522 0.488 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -63.8 21.42 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.977 0.418 . . . . 0.0 110.604 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 249' ' ' ASN . . . . . 0.668 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.8 m-20 -97.04 -6.05 36.16 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.576 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 92.4 mt -79.9 -21.57 43.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.648 179.423 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.57 -51.23 70.76 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.71 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.65 -5.41 58.16 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.467 179.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.14 -74.37 1.15 Allowed Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 82.6 mt -70.08 126.01 28.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.072 0.463 . . . . 0.0 110.254 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -59.47 -39.27 83.14 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.311 -179.716 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 82.83 51.79 4.12 Favored Glycine 0 CA--C 1.521 0.41 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -95.78 -15.1 22.79 Favored 'General case' 0 C--N 1.332 -0.18 0 O-C-N 122.728 -0.278 . . . . 0.0 110.594 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 258' ' ' SER . . . . . 0.503 ' OG ' HG23 ' A' ' 191' ' ' VAL . 3.3 t 174.56 88.93 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.078 0.466 . . . . 0.0 110.108 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.861 HD12 ' N ' ' A' ' 259' ' ' LEU . 0.9 OUTLIER -94.43 124.06 38.23 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.254 0.549 . . . . 0.0 111.115 -179.081 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 260' ' ' PHE . . . . . 0.446 ' H ' ' HA ' ' A' ' 193' ' ' ALA . 15.9 m-30 -93.06 146.48 23.61 Favored 'General case' 0 CA--C 1.504 -0.818 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.345 179.349 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 85.7 mt -122.42 149.63 43.57 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.607 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.749 ' CD1' HG13 ' A' ' 195' ' ' VAL . 2.6 p90 -77.21 -138.04 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.638 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 263' ' ' ALA . . . . . 0.66 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -52.61 77.52 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.032 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 264' ' ' GLY . . . . . 0.621 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -178.99 104.32 0.18 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 265' ' ' ASP . . . . . 0.601 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.7 m-20 -80.35 -177.81 6.34 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.684 0.278 . . . . 0.0 110.954 -179.634 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -40.36 -17.69 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.561 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 267' ' ' LYS . . . . . 0.601 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.38 -51.52 43.26 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.71 179.409 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -63.75 -46.65 84.34 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.191 179.384 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 269' ' ' ALA . . . . . 0.565 ' HB1' ' OH ' ' A' ' 273' ' ' TYR . . . -61.68 -35.12 77.08 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.173 0.511 . . . . 0.0 109.738 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -63.17 -34.38 77.51 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.033 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.51 -43.12 13.83 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.185 -179.539 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 272' ' ' ILE . . . . . 0.589 ' C ' ' H ' ' A' ' 274' ' ' ALA . 4.9 tt -51.47 -33.73 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.855 -178.837 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 273' ' ' TYR . . . . . 0.565 ' OH ' ' HB1' ' A' ' 269' ' ' ALA . 17.3 m-85 -54.33 -1.89 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.646 -179.546 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 274' ' ' ALA . . . . . 0.589 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.61 -39.61 70.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.919 179.52 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 275' ' ' ASN . . . . . 0.582 ' O ' ' N ' ' A' ' 279' ' ' ALA . 3.3 p30 -39.28 98.03 0.16 Allowed Pre-proline 0 CA--C 1.528 0.108 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.52 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -54.29 -42.95 63.02 Favored 'Trans proline' 0 C--N 1.303 -1.821 0 C-N-CA 122.341 2.027 . . . . 0.0 112.638 -178.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 88.8 mt -64.45 -42.82 95.76 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.252 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 91.0 mt -95.67 -1.58 49.79 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.848 -179.506 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 279' ' ' ALA . . . . . 0.582 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.28 -34.82 77.3 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.685 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.21 20.07 0.12 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.052 -179.281 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 0.487 HD23 ' HA ' ' A' ' 281' ' ' LEU . 13.8 mt -75.19 120.04 79.8 Favored Pre-proline 0 N--CA 1.451 -0.417 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.523 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -50.91 -39.34 58.96 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.586 2.191 . . . . 0.0 111.859 179.064 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.92 -50.42 64.0 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.111 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 75.7 t -61.48 -43.91 97.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.482 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -57.79 -41.19 81.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.218 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -91.13 0.04 57.61 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.091 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt 59.44 43.71 15.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.039 0.447 . . . . 0.0 110.878 179.698 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -94.88 41.33 1.09 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.379 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 54.1 t -119.2 135.76 58.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 121.101 0.477 . . . . 0.0 110.136 -179.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -132.93 162.75 30.8 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.709 -179.689 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.77 155.3 32.78 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-O 121.013 0.435 . . . . 0.0 110.728 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 81.6 mt -94.07 -1.36 54.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.232 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.53 165.69 12.67 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.548 -1.021 . . . . 0.0 110.548 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 6.9 m -87.56 -62.4 1.5 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.921 0.391 . . . . 0.0 111.001 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 295' ' ' GLU . . . . . 0.431 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.4 mm-40 -69.6 -3.79 16.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.675 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 25.4 p -76.89 33.17 0.14 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.645 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 297' ' ' PHE . . . . . 0.538 ' CD2' HG22 ' A' ' 70' ' ' THR . 84.8 t80 -60.17 -45.85 91.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.555 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 298' ' ' ARG . . . . . 0.602 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.2 mtt85 -81.72 134.41 35.45 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.989 0.423 . . . . 0.0 110.576 -179.716 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.464 ' H ' HG11 ' A' ' 51' ' ' VAL . 16.2 tp -114.18 118.88 35.22 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-O 121.004 0.431 . . . . 0.0 110.066 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 300' ' ' ASP . . . . . 0.631 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.4 p-10 -166.39 -175.23 3.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.562 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -47.69 -44.64 27.66 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.246 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -65.63 -40.9 93.07 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.034 0.445 . . . . 0.0 110.683 178.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 303' ' ' SER . . . . . 0.631 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 54.5 p -56.16 -36.12 67.96 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.024 -179.171 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 304' ' ' ALA . . . . . 0.537 ' HB2' ' SD ' ' A' ' 215' ' ' MET . . . -56.85 -52.34 65.47 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.485 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 90.9 mtp -56.15 -43.28 78.15 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -66.37 -42.53 87.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.024 0.44 . . . . 0.0 110.155 178.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 307' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 303' ' ' SER . 55.7 t -64.13 -42.97 97.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.105 179.399 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 42.5 tp -59.77 -42.26 92.9 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.779 -179.486 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -62.33 -39.27 92.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.123 179.565 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 310' ' ' ARG . . . . . 0.436 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.4 ttt85 -63.51 -44.06 95.38 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.18 179.479 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 88.4 mt -63.37 -42.14 98.84 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.233 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -62.99 -33.26 75.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.016 179.468 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.52 -23.85 21.93 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.416 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.483 HD22 ' CE2' ' A' ' 315' ' ' PHE . 6.7 tt -62.31 -43.29 99.16 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 121.074 0.464 . . . . 0.0 110.552 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 315' ' ' PHE . . . . . 0.483 ' CE2' HD22 ' A' ' 314' ' ' LEU . 90.5 m-85 . . . . . 0 C--O 1.219 -0.507 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.45 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.327 -0.619 . . . . 0.0 109.327 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -99.59 136.4 39.58 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.045 0.45 . . . . 0.0 110.47 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.496 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -92.07 178.56 1.66 Allowed Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.563 -179.891 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.496 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.6 Cg_exo -61.73 147.16 95.93 Favored 'Trans proline' 0 C--N 1.301 -1.965 0 C-N-CA 122.79 2.327 . . . . 0.0 112.106 179.722 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.459 ' HE ' HD12 ' A' ' 39' ' ' LEU . 35.6 ptt180 -136.29 142.44 43.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.645 179.694 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -79.5 116.76 19.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.456 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.45 ' O ' HG23 ' A' ' 30' ' ' ILE . 9.5 tp -111.14 130.44 64.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.456 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 12.9 t -70.89 141.7 51.19 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.55 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.48 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.4 t0 -139.19 179.62 6.41 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.497 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.48 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 78.1 p -74.01 -36.93 64.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.604 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.8 ttt85 -46.64 -94.59 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.293 -179.463 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -166.96 -26.62 0.02 OUTLIER Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 59.3 m -169.05 105.0 0.4 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.817 0.341 . . . . 0.0 110.672 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.691 ' CD2' HD13 ' A' ' 140' ' ' LEU . 75.5 t60 -128.53 149.09 50.75 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.019 0.437 . . . . 0.0 110.289 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.623 HG22 ' N ' ' A' ' 39' ' ' LEU . 98.6 m -131.42 165.91 22.46 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.532 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.623 ' N ' HG22 ' A' ' 38' ' ' THR . 81.4 mt -120.75 127.35 51.91 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.501 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -65.09 -44.43 88.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.682 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 40.6 p -165.97 154.91 11.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.444 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.484 ' CD ' ' H ' ' A' ' 42' ' ' GLN . 14.5 mp0 -44.73 101.3 0.25 Allowed Pre-proline 0 C--N 1.329 -0.308 0 O-C-N 123.392 0.433 . . . . 0.0 110.652 179.426 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.25 129.66 35.32 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 C-N-CA 122.373 2.049 . . . . 0.0 112.288 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -83.61 -24.73 31.32 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.473 179.531 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.542 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.2 mtm-85 -122.39 134.83 54.61 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-O 121.176 0.512 . . . . 0.0 110.256 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.1 mt -130.75 133.84 62.74 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.925 -179.697 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 44.2 t -124.31 130.61 73.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 179.327 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.612 ' OG ' HD12 ' A' ' 117' ' ' LEU . 2.2 m -155.32 167.8 29.16 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.559 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 67.3 p -124.85 9.96 8.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.425 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.78 125.15 33.03 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.689 -179.513 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.456 HG11 ' H ' ' A' ' 299' ' ' LEU . 93.1 t -65.76 -44.41 93.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.48 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.8 m -62.69 -44.04 97.26 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.602 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 52.5 tp -62.15 -41.5 98.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.544 -179.397 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.459 ' O ' HD13 ' A' ' 58' ' ' LEU . 75.5 m -57.61 -44.53 85.54 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.32 -179.341 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.13 -62.31 5.29 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 179.578 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.6 t -48.24 -35.74 12.58 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' A' ' 57' ' ' LEU . 20.0 mt -61.86 -44.37 96.95 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.179 179.428 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.459 HD13 ' O ' ' A' ' 54' ' ' THR . 9.2 mp -64.97 -41.66 95.26 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.373 178.035 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.91 -40.71 97.12 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.012 -179.28 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.43 ' O ' HG23 ' A' ' 60' ' ' ILE . 7.9 tp -88.73 16.44 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.856 -179.609 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 56.46 84.58 0.09 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.671 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 178.58 57.1 0.06 OUTLIER Pre-proline 0 C--N 1.328 -0.329 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -50.55 154.25 6.66 Favored 'Trans proline' 0 C--N 1.295 -2.252 0 C-N-CA 122.912 2.408 . . . . 0.0 112.297 -178.18 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.436 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -108.96 145.64 15.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.375 -179.712 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.66 -45.25 97.98 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.263 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.335 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.509 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -129.49 133.98 47.55 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.522 -179.727 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.51 ' O ' ' N ' ' A' ' 98' ' ' LEU . 74.8 m -134.59 158.64 43.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.769 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.77 139.27 16.26 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.704 -0.959 . . . . 0.0 110.704 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.488 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.92 -162.69 0.08 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.918 0.389 . . . . 0.0 110.474 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.532 HG22 ' CD2' ' A' ' 297' ' ' PHE . 15.2 t -133.52 134.33 43.3 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.397 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.489 ' C ' ' O ' ' A' ' 70' ' ' THR . 0.6 OUTLIER 29.73 68.89 0.65 Allowed Pre-proline 0 N--CA 1.464 0.272 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.754 -179.939 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -61.27 146.67 97.11 Favored 'Trans proline' 0 C--N 1.299 -2.067 0 C-N-CA 122.655 2.237 . . . . 0.0 111.986 -178.526 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.535 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 45.3 p-10 -160.59 -32.35 0.05 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.673 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.545 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 99.1 m-20 -64.15 -39.43 94.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.451 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -60.51 -48.24 82.65 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.561 -179.346 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.418 ' O ' ' O ' ' A' ' 77' ' ' ALA . 91.6 t -60.38 -24.77 32.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.545 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -46.02 173.29 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.563 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.57 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.6 p30 -62.25 177.96 0.44 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.582 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.554 ' C ' ' H ' ' A' ' 81' ' ' GLY . 35.8 p30 -45.01 86.12 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.985 0.422 . . . . 0.0 110.946 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.57 ' N ' ' O ' ' A' ' 78' ' ' ASP . 43.1 tp60 -67.57 13.21 0.08 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.127 0.489 . . . . 0.0 110.13 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.554 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 118.51 -22.09 9.58 Favored Glycine 0 CA--C 1.519 0.306 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -108.31 116.49 32.06 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.959 0.409 . . . . 0.0 110.54 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 74.6 mt -98.57 0.17 44.41 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.485 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -92.25 7.18 43.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.013 0.435 . . . . 0.0 110.443 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.795 ' O ' HG22 ' A' ' 89' ' ' VAL . 27.0 mt-30 -100.13 -27.99 13.26 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.777 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 68.2 t-105 -62.51 -40.67 97.47 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.866 -179.638 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.55 ' O ' ' N ' ' A' ' 91' ' ' LYS . 66.1 m -77.64 -53.45 7.56 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.088 -179.389 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -48.73 -50.91 31.53 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.018 -179.193 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.795 HG22 ' O ' ' A' ' 85' ' ' GLN . 15.4 m -68.62 -40.71 82.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 120.934 0.397 . . . . 0.0 111.032 179.717 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.498 ' N ' HG23 ' A' ' 89' ' ' VAL . . . -72.05 -23.04 61.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.702 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.55 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.0 tttm -61.74 -45.68 92.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.482 -179.464 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.439 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.6 mm-40 -90.23 -95.47 0.11 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.16 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.64 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.9 mtt180 -142.59 58.87 1.44 Allowed 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.459 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.7 pttp 33.54 25.77 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 120.92 0.391 . . . . 0.0 110.19 -179.161 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.64 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.3 tt -47.86 123.75 6.49 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.924 -178.061 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.457 ' O ' HD23 ' A' ' 95' ' ' LEU . 99.0 mm-40 -83.91 -169.41 2.57 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.115 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.595 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 81.0 mtp180 -74.6 136.7 42.03 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.291 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.51 ' N ' ' O ' ' A' ' 67' ' ' SER . 90.6 mt -85.52 -165.57 1.26 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.856 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.536 ' O ' ' CD2' ' A' ' 99' ' ' TYR . 48.0 p90 -168.38 119.49 0.79 Allowed 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.254 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.511 ' C ' ' O ' ' A' ' 99' ' ' TYR . 43.3 mm -28.86 121.02 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.058 -179.709 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 113.76 27.89 3.37 Favored Glycine 0 CA--C 1.52 0.35 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 -179.452 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.58 ' CD ' ' H ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -144.48 46.65 0.64 Allowed Pre-proline 0 C--N 1.324 -0.524 0 CA-C-O 120.985 0.422 . . . . 0.0 110.425 179.856 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 29.2 Cg_endo -61.97 143.78 95.67 Favored 'Trans proline' 0 C--N 1.297 -2.161 0 C-N-CA 122.656 2.237 . . . . 0.0 111.942 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.455 ' O ' HG23 ' A' ' 108' ' ' VAL . 25.3 t -173.01 120.08 0.35 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.367 179.71 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.25 -40.41 64.66 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.075 0.464 . . . . 0.0 111.122 179.646 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.39 -39.88 89.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.926 -179.413 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.38 -40.16 95.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.729 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 104' ' ' SER . 71.7 t -67.79 -43.82 86.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.78 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.82 -38.97 92.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.578 -179.313 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.439 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.44 -23.4 62.66 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.493 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.545 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.3 mm-40 -90.29 5.23 48.1 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.652 -179.471 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.545 ' C ' ' O ' ' A' ' 111' ' ' GLN . 10.8 tpt 23.89 63.98 0.39 Allowed Pre-proline 0 N--CA 1.466 0.33 0 CA-C-O 120.939 0.399 . . . . 0.0 111.048 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -78.22 166.63 24.3 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 123.035 2.49 . . . . 0.0 112.062 -178.25 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.524 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 99.2 m-20 -109.77 -41.71 4.45 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.185 179.43 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.2 tp -121.63 120.12 33.82 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.522 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 83.2 mt -112.77 128.86 69.25 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.33 0 CA-C-O 120.941 0.401 . . . . 0.0 110.849 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.612 HD12 ' OG ' ' A' ' 48' ' ' SER . 30.1 mt -109.34 132.25 54.3 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.281 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.501 HD12 HG23 ' A' ' 139' ' ' THR . 98.9 mt -119.6 139.06 48.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.668 -179.697 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 85.1 p -72.68 153.89 40.98 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.527 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.01 -50.19 74.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.714 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.0 t -149.59 154.24 38.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.518 179.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 170.6 -171.06 43.53 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.99 -33.97 88.68 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.446 ' OD1' ' O ' ' A' ' 124' ' ' ASP . 44.0 p-10 -86.93 120.02 27.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.719 0.295 . . . . 0.0 110.685 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.436 ' O ' HD12 ' A' ' 129' ' ' LEU . 39.5 t -63.05 143.9 57.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.005 0.431 . . . . 0.0 110.453 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.527 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -92.9 -42.92 9.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.871 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.5 tp -62.98 -42.44 99.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.667 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.51 -12.5 60.48 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.524 -179.426 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.436 HD12 ' O ' ' A' ' 125' ' ' SER . 85.2 mt -114.52 -24.02 9.02 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.696 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' TYR . . . . . 0.527 ' N ' ' O ' ' A' ' 126' ' ' ALA . 80.0 t80 -50.77 -49.68 57.59 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.634 -178.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 37.8 p-10 -66.14 -42.69 88.76 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.848 0.356 . . . . 0.0 111.22 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.522 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 88.3 mt-30 -66.98 -37.89 85.06 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.823 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.435 HD12 HD11 ' A' ' 118' ' ' ILE . 96.0 mt -80.21 -41.43 25.2 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.92 -179.64 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.2 t -57.14 -44.58 83.51 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.245 -179.097 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.0 m -61.65 -45.41 94.17 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.75 0.31 . . . . 0.0 110.562 179.325 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 94.1 mt -62.18 -43.56 98.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.291 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.661 ' HB1' ' HD2' ' A' ' 138' ' ' PRO . . . -169.34 168.46 4.9 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.556 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.661 ' HD2' ' HB1' ' A' ' 137' ' ' ALA . 52.9 Cg_exo -50.35 113.68 1.13 Allowed 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.256 1.971 . . . . 0.0 112.221 179.341 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.501 HG23 HD12 ' A' ' 118' ' ' ILE . 24.1 m -84.61 127.45 34.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.494 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.691 HD13 ' CD2' ' A' ' 37' ' ' HIS . 34.4 tp -117.93 135.88 53.84 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.107 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.442 ' O ' ' OD2' ' A' ' 32' ' ' ASP . 82.2 mt -99.61 118.71 46.62 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.31 0 CA-C-O 121.221 0.534 . . . . 0.0 111.179 -179.293 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.423 HD12 HD22 ' A' ' 117' ' ' LEU . 98.0 mt -134.99 132.18 53.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.617 179.661 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.454 ' ND2' ' OD2' ' A' ' 241' ' ' ASP . 2.1 t-20 -66.9 151.5 47.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.911 0.386 . . . . 0.0 110.436 179.414 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.519 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 88.0 t80 -86.54 122.63 30.75 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.847 -179.532 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.519 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 99.1 m-20 55.23 69.17 0.76 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.769 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 35.7 p-10 -125.81 0.4 7.38 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.637 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -150.71 115.47 5.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.706 -179.512 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 83.5 p -63.3 168.18 4.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.534 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.417 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.4 p-90 -51.61 -15.72 0.5 Allowed 'General case' 0 C--O 1.223 -0.315 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.494 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.448 ' O ' HG23 ' A' ' 154' ' ' THR . 68.2 tp60 -70.8 -75.54 0.12 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.51 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.455 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.0 t -62.76 -38.71 91.63 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.28 179.474 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 53.9 tp -60.02 -45.66 92.04 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.389 -178.578 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.417 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 46.6 tp -62.73 -41.63 99.27 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.473 178.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.455 ' OG1' ' O ' ' A' ' 151' ' ' SER . 59.7 p -63.89 -34.76 78.67 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.226 -179.521 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.441 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 88.0 mm-40 -64.07 -42.42 96.99 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.309 179.257 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 90.8 mt -65.39 -38.79 91.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.033 0.444 . . . . 0.0 110.178 179.064 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.581 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.2 -32.33 80.21 Favored Glycine 0 CA--C 1.52 0.348 0 N-CA-C 110.719 -0.952 . . . . 0.0 110.719 -179.302 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.441 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.2 mt-10 -35.93 -25.98 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.858 0.361 . . . . 0.0 110.806 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.581 ' N ' ' O ' ' A' ' 157' ' ' GLY . 95.6 mt -57.99 148.99 5.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.299 179.236 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 74.7 p -69.24 137.44 53.14 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.979 -179.529 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 70.77 22.16 78.11 Favored Glycine 0 N--CA 1.458 0.165 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 179.463 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 58.1 m80 -124.32 -14.46 6.95 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.695 0.283 . . . . 0.0 110.538 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -66.05 -59.92 3.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.649 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -52.0 -48.83 64.26 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.134 -179.546 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -60.52 -41.22 93.96 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.728 0.299 . . . . 0.0 110.321 179.518 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.61 -47.18 86.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.517 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.87 -40.1 75.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.246 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -61.7 -50.33 72.88 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.579 179.532 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 60.1 ttt85 -65.44 -43.73 89.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.54 179.486 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 94.9 mt -64.72 -43.37 96.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.486 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.38 -51.23 70.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.498 -179.213 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -63.57 -43.64 96.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.533 179.687 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.652 ' CE2' HD11 ' A' ' 177' ' ' LEU . 56.6 t80 -62.9 -44.29 96.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.087 0.47 . . . . 0.0 110.442 179.417 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -63.65 -39.86 95.4 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.478 -179.23 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -62.89 -42.87 99.93 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.659 179.176 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -60.59 -44.7 95.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.207 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.652 HD11 ' CE2' ' A' ' 173' ' ' PHE . 84.2 mt -64.47 -41.05 96.73 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.994 0.425 . . . . 0.0 110.668 178.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.12 -62.18 1.8 Allowed 'General case' 0 C--O 1.237 0.431 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.382 -179.329 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.52 -46.78 86.05 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.578 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.24 -41.67 65.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.302 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -63.91 -33.67 76.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.393 179.324 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.421 ' O ' ' HG2' ' A' ' 182' ' ' GLU . 69.5 tt0 -90.54 8.94 31.51 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.437 0.637 . . . . 0.0 110.491 -178.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -105.04 -32.07 8.89 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.174 179.612 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.8 pt -128.07 147.55 32.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.842 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -139.68 131.05 26.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.395 179.337 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.593 HD22 ' N ' ' A' ' 186' ' ' LEU . 3.6 mm? -85.47 133.46 42.17 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.9 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -44.12 157.8 0.15 Allowed 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.738 2.292 . . . . 0.0 112.235 179.342 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 0.518 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.5 Cg_endo -62.89 114.69 2.53 Favored 'Trans proline' 0 C--N 1.303 -1.82 0 C-N-CA 122.813 2.342 . . . . 0.0 111.748 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 189' ' ' GLN . . . . . 0.518 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.7 mt-30 155.69 147.88 0.0 OUTLIER Pre-proline 0 C--N 1.332 -0.169 0 O-C-N 123.713 0.633 . . . . 0.0 110.838 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -73.85 144.01 34.13 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.673 2.249 . . . . 0.0 112.012 177.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.496 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.0 p -124.78 158.95 31.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.296 0.569 . . . . 0.0 110.125 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 192' ' ' THR . . . . . 0.496 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 37.5 p -143.46 165.39 27.68 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.048 -179.712 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 193' ' ' ALA . . . . . 0.443 ' HA ' ' H ' ' A' ' 260' ' ' PHE . . . -135.2 128.58 32.27 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.173 0.511 . . . . 0.0 110.264 179.516 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.516 HD11 HD23 ' A' ' 259' ' ' LEU . 47.9 pt -146.52 148.86 16.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.084 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 195' ' ' VAL . . . . . 0.75 HG13 ' CD1' ' A' ' 262' ' ' PHE . 68.8 t -117.73 123.06 71.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.312 0.577 . . . . 0.0 109.813 179.028 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -134.14 106.62 7.28 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.391 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 94.3 m -130.1 130.41 44.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.764 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -82.88 -36.81 25.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.259 179.602 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.56 -67.14 0.26 Allowed 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.361 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.28 -9.96 59.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.377 179.524 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 60.2 t-80 60.94 58.47 2.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.901 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 35.5 p -167.23 153.48 8.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.549 179.481 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.31 144.16 24.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.943 0.402 . . . . 0.0 110.485 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -135.34 138.16 43.12 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.669 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 19.5 mt -106.32 125.46 51.02 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.061 0.458 . . . . 0.0 109.842 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 206' ' ' TRP . . . . . 0.558 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 74.7 m95 -82.07 167.13 19.12 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.676 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 207' ' ' THR . . . . . 0.468 HG22 ' C ' ' A' ' 206' ' ' TRP . 0.1 OUTLIER -156.9 171.14 7.83 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.595 -179.165 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.43 -37.15 81.67 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 C-N-CA 122.598 2.198 . . . . 0.0 112.219 179.126 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -70.56 -34.95 72.8 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.836 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 21.0 m -61.28 150.91 33.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.615 -179.364 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.61 -37.04 82.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.49 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 212' ' ' GLN . . . . . 0.558 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 54.7 tt0 -64.66 -40.33 95.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.579 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.52 -43.46 92.27 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -63.29 -43.73 97.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.81 0.338 . . . . 0.0 110.288 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 215' ' ' MET . . . . . 0.531 ' SD ' ' HB2' ' A' ' 304' ' ' ALA . 65.1 ttp -59.4 -48.12 82.84 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.26 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 88.4 mt -60.49 -40.94 93.13 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.685 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 217' ' ' GLU . . . . . 0.454 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.0 tp10 -57.97 -37.74 74.75 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -65.31 -38.08 89.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.787 0.327 . . . . 0.0 110.652 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 94.7 mt -64.27 -42.71 96.32 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.58 -179.676 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.52 44.73 0.08 OUTLIER Glycine 0 CA--C 1.52 0.392 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 221' ' ' PHE . . . . . 0.454 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 26.5 m-85 -127.78 155.47 44.01 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.075 0.464 . . . . 0.0 110.522 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.486 ' O ' HG13 ' A' ' 191' ' ' VAL . 6.7 p -107.1 122.25 46.11 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.266 0.555 . . . . 0.0 110.122 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.47 HD22 ' C ' ' A' ' 222' ' ' THR . 4.3 mm? -101.17 133.15 46.15 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.056 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -97.01 159.34 14.96 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.467 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.32 115.42 30.24 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.954 0.407 . . . . 0.0 110.344 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.503 HD12 ' N ' ' A' ' 226' ' ' LEU . 8.8 mp -53.42 156.51 4.18 Favored Pre-proline 0 N--CA 1.452 -0.328 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.696 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -60.02 145.2 98.94 Favored 'Trans proline' 0 C--N 1.301 -1.929 0 C-N-CA 122.682 2.254 . . . . 0.0 112.163 179.265 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.25 -2.98 59.01 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.605 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.39 -40.83 5.63 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.539 ' O ' ' N ' ' A' ' 233' ' ' SER . 86.2 mt -79.07 -16.98 56.01 Favored 'General case' 0 C--O 1.222 -0.373 0 CA-C-O 121.069 0.461 . . . . 0.0 110.334 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 231' ' ' ASN . . . . . 0.404 ' C ' ' O ' ' A' ' 230' ' ' LEU . 53.9 t-20 -40.21 -49.12 2.66 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.732 -179.469 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -88.17 15.35 7.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.255 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.539 ' N ' ' O ' ' A' ' 230' ' ' LEU . 78.0 p -60.49 -35.68 76.51 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.712 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 234' ' ' GLN . . . . . 0.524 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.5 tt0 -118.35 -69.34 0.86 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.894 179.457 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.2 m -69.98 103.68 2.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.093 0.473 . . . . 0.0 110.691 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -94.88 57.54 2.13 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.366 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -144.92 -122.61 1.57 Allowed Glycine 0 CA--C 1.52 0.346 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -134.4 111.93 10.56 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 121.132 0.491 . . . . 0.0 110.368 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 239' ' ' ARG . . . . . 0.512 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.5 mtt180 -148.32 57.52 1.07 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.792 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -69.91 -31.87 69.88 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.539 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 241' ' ' ASP . . . . . 0.457 ' OD2' ' O ' ' A' ' 144' ' ' TYR . 64.7 t0 -56.92 -46.93 81.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.33 -179.135 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 242' ' ' ILE . . . . . 0.436 ' O ' ' O ' ' A' ' 239' ' ' ARG . 17.4 tt -140.16 156.92 25.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.9 0.381 . . . . 0.0 110.533 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.439 HG22 HD13 ' A' ' 245' ' ' LEU . 96.1 mt -106.0 106.19 20.11 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.214 0 CA-C-O 121.163 0.506 . . . . 0.0 110.529 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 244' ' ' GLN . . . . . 0.604 ' O ' HD12 ' A' ' 245' ' ' LEU . 88.3 mt-30 -110.37 110.26 20.98 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.42 179.674 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.604 HD12 ' O ' ' A' ' 244' ' ' GLN . 9.5 mp -121.97 -168.25 1.68 Allowed 'General case' 0 C--O 1.226 -0.177 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.605 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 246' ' ' GLY . . . . . 0.524 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.37 -16.7 0.05 OUTLIER Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 247' ' ' GLY . . . . . 0.67 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -60.49 157.05 29.84 Favored Glycine 0 CA--C 1.522 0.477 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -63.8 21.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.879 0.371 . . . . 0.0 110.548 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 249' ' ' ASN . . . . . 0.67 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.9 m-20 -96.95 -5.97 36.69 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.499 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 92.8 mt -79.88 -21.68 43.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.671 179.408 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.51 -51.17 71.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.784 -179.551 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.56 -5.52 58.14 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.473 179.59 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.36 -74.4 1.15 Allowed Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 81.4 mt -69.98 125.77 27.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.011 0.434 . . . . 0.0 110.332 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -59.26 -39.5 83.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.212 -179.614 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 82.65 51.93 4.11 Favored Glycine 0 CA--C 1.52 0.404 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -96.48 -14.49 22.31 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.712 0.292 . . . . 0.0 110.581 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 258' ' ' SER . . . . . 0.494 ' OG ' HG23 ' A' ' 191' ' ' VAL . 3.5 t 174.58 88.36 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.037 0.446 . . . . 0.0 110.165 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.86 HD12 ' N ' ' A' ' 259' ' ' LEU . 0.9 OUTLIER -94.2 123.98 37.93 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.183 0.516 . . . . 0.0 111.088 -179.1 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 260' ' ' PHE . . . . . 0.443 ' H ' ' HA ' ' A' ' 193' ' ' ALA . 15.9 m-30 -92.97 146.24 23.77 Favored 'General case' 0 CA--C 1.505 -0.786 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.428 179.295 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 86.7 mt -122.21 149.96 42.93 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.628 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.75 ' CD1' HG13 ' A' ' 195' ' ' VAL . 2.6 p90 -77.53 -138.23 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.619 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 263' ' ' ALA . . . . . 0.66 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -52.43 77.44 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.01 0.433 . . . . 0.0 111.074 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 264' ' ' GLY . . . . . 0.624 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -178.93 104.42 0.19 Allowed Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.666 -0.974 . . . . 0.0 110.666 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 265' ' ' ASP . . . . . 0.601 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.9 m-20 -80.45 -177.8 6.37 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 120.643 0.259 . . . . 0.0 110.862 -179.424 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -40.41 -17.62 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.548 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 267' ' ' LYS . . . . . 0.601 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.48 -51.66 40.98 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 120.998 0.428 . . . . 0.0 110.687 179.386 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -63.64 -46.72 84.4 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.212 179.394 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 269' ' ' ALA . . . . . 0.573 ' HB1' ' OH ' ' A' ' 273' ' ' TYR . . . -61.64 -35.08 76.89 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.218 0.532 . . . . 0.0 109.84 179.65 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -63.11 -34.09 76.85 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.045 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.73 -43.37 13.43 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.175 -179.557 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 272' ' ' ILE . . . . . 0.587 ' C ' ' H ' ' A' ' 274' ' ' ALA . 4.9 tt -51.43 -33.53 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.815 -178.792 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 273' ' ' TYR . . . . . 0.573 ' OH ' ' HB1' ' A' ' 269' ' ' ALA . 17.2 m-85 -54.49 -1.74 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.681 -179.599 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 274' ' ' ALA . . . . . 0.587 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.55 -39.61 70.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.842 179.525 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 275' ' ' ASN . . . . . 0.583 ' O ' ' N ' ' A' ' 279' ' ' ALA . 3.1 p30 -39.32 98.06 0.16 Allowed Pre-proline 0 C--O 1.226 -0.144 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.495 -179.662 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -54.29 -42.92 63.26 Favored 'Trans proline' 0 C--N 1.303 -1.856 0 C-N-CA 122.385 2.056 . . . . 0.0 112.533 -178.715 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 88.8 mt -64.46 -42.84 95.71 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.103 0.478 . . . . 0.0 111.138 -179.673 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 90.6 mt -95.67 -1.68 49.62 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.887 -179.523 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 279' ' ' ALA . . . . . 0.583 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.38 -34.81 77.44 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.668 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.29 20.26 0.11 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.968 -179.254 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 0.488 HD23 ' HA ' ' A' ' 281' ' ' LEU . 13.8 mt -75.47 119.89 79.11 Favored Pre-proline 0 N--CA 1.451 -0.423 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.56 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -50.49 -39.41 54.9 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 122.66 2.24 . . . . 0.0 111.951 178.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.75 -50.55 63.25 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.149 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 78.8 t -61.4 -44.02 97.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 179.479 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -57.74 -41.15 81.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.252 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -90.98 -0.03 57.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.2 179.608 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt 59.47 43.58 16.05 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.872 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -94.81 41.41 1.09 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.387 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 53.8 t -119.08 135.8 58.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.047 0.451 . . . . 0.0 110.173 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -133.01 162.56 31.37 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.645 -179.624 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.7 155.11 33.06 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.943 0.401 . . . . 0.0 110.754 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 81.4 mt -93.91 -1.43 54.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.302 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.38 165.93 12.77 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 6.5 m -87.61 -62.39 1.51 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.888 0.375 . . . . 0.0 110.945 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 295' ' ' GLU . . . . . 0.434 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.5 mm-40 -69.54 -3.83 16.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.645 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 27.2 p -76.94 33.27 0.14 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.663 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 297' ' ' PHE . . . . . 0.532 ' CD2' HG22 ' A' ' 70' ' ' THR . 85.1 t80 -60.21 -46.01 91.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.618 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 298' ' ' ARG . . . . . 0.595 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.2 mtt85 -81.71 134.6 35.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.584 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.456 ' H ' HG11 ' A' ' 51' ' ' VAL . 16.3 tp -114.27 119.07 35.73 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-O 121.006 0.431 . . . . 0.0 110.19 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 300' ' ' ASP . . . . . 0.626 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.9 p-10 -166.52 -175.09 3.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.577 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 81.5 t80 -47.78 -44.72 28.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.292 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -65.59 -41.16 93.14 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.021 0.438 . . . . 0.0 110.701 178.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 303' ' ' SER . . . . . 0.626 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 54.0 p -55.58 -36.16 66.56 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.042 -179.219 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 304' ' ' ALA . . . . . 0.531 ' HB2' ' SD ' ' A' ' 215' ' ' MET . . . -57.07 -51.65 68.43 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.418 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 90.9 mtp -56.23 -43.87 79.03 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -66.29 -42.68 88.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.029 0.442 . . . . 0.0 110.284 178.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 307' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 303' ' ' SER . 55.8 t -64.08 -42.75 96.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.208 179.377 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 42.6 tp -59.57 -42.2 91.91 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.816 -179.519 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -62.72 -38.83 92.04 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.148 179.465 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 310' ' ' ARG . . . . . 0.439 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.6 ttt85 -63.33 -44.09 95.89 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.216 179.594 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 88.3 mt -63.24 -42.06 99.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.255 179.58 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -62.85 -33.03 74.4 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.124 179.456 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -90.17 -23.32 21.35 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.352 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.479 HD22 ' CE2' ' A' ' 315' ' ' PHE . 6.8 tt -62.33 -43.23 99.3 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 121.041 0.448 . . . . 0.0 110.531 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 315' ' ' PHE . . . . . 0.479 ' CE2' HD22 ' A' ' 314' ' ' LEU . 91.7 m-85 . . . . . 0 C--O 1.22 -0.453 0 CA-C-O 117.97 -1.014 . . . . 0.0 110.436 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -99.8 135.81 40.66 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.114 0.483 . . . . 0.0 110.503 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.497 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -91.63 178.7 1.64 Allowed Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.53 -179.857 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.497 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.4 Cg_exo -61.62 147.67 94.82 Favored 'Trans proline' 0 C--N 1.3 -2.023 0 C-N-CA 122.901 2.401 . . . . 0.0 112.113 179.53 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.486 ' HE ' HD12 ' A' ' 39' ' ' LEU . 35.1 ptt180 -135.02 142.16 46.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.64 179.664 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -78.93 116.95 19.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.51 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.422 ' O ' HG23 ' A' ' 30' ' ' ILE . 9.6 tp -110.53 131.27 62.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.445 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.9 t -70.84 142.93 51.24 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.655 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 141' ' ' ILE . 24.6 t70 -141.05 177.36 8.11 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.468 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.3 p -73.15 -36.75 66.7 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.696 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -47.68 -95.01 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.303 -179.376 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -165.95 -25.28 0.02 OUTLIER Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 58.2 m -168.93 106.74 0.43 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.862 0.363 . . . . 0.0 110.632 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 50.9 t-80 -129.79 144.49 51.33 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 121.066 0.46 . . . . 0.0 110.114 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.63 HG22 ' N ' ' A' ' 39' ' ' LEU . 97.2 m -128.59 166.63 18.49 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.49 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.63 ' N ' HG22 ' A' ' 38' ' ' THR . 82.2 mt -121.15 127.8 51.9 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.43 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -64.17 -44.48 91.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.716 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 37.9 p -165.55 155.03 12.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.387 179.601 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.53 ' CD ' ' H ' ' A' ' 42' ' ' GLN . 14.4 mp0 -42.71 100.28 0.22 Allowed Pre-proline 0 C--N 1.33 -0.261 0 O-C-N 123.352 0.408 . . . . 0.0 110.594 179.261 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -56.88 129.07 32.59 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 122.313 2.008 . . . . 0.0 112.239 -179.485 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -83.82 -24.13 31.1 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.552 179.577 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.541 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.5 mtm-85 -121.18 134.11 55.2 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.202 0.525 . . . . 0.0 110.192 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.0 mt -130.43 133.51 63.68 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.272 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.798 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 47.5 t -125.0 130.89 73.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 179.32 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.601 ' OG ' HD12 ' A' ' 117' ' ' LEU . 5.0 m -154.05 166.48 32.89 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.586 179.676 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 70.0 p -124.83 8.37 8.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.435 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.81 125.87 33.59 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.643 -179.468 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.46 HG11 ' H ' ' A' ' 299' ' ' LEU . 86.5 t -65.7 -44.61 93.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.543 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.7 m -62.62 -44.15 97.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.561 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 53.5 tp -62.38 -41.58 98.74 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.534 -179.432 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.452 ' O ' HD13 ' A' ' 58' ' ' LEU . 72.5 m -57.83 -44.42 86.45 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.267 -179.198 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.4 -62.17 5.34 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 179.589 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.6 t -48.18 -35.62 12.08 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.8 mt -61.86 -44.34 97.01 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.229 179.34 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.452 HD13 ' O ' ' A' ' 54' ' ' THR . 9.2 mp -65.43 -41.49 93.48 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.246 178.025 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.406 ' HB1' ' NE ' ' A' ' 169' ' ' ARG . . . -63.58 -41.13 98.4 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.906 -179.243 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.422 ' O ' HG23 ' A' ' 60' ' ' ILE . 8.0 tp -88.21 16.73 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.857 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 56.51 84.34 0.09 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.753 -179.735 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.24 57.98 0.07 OUTLIER Pre-proline 0 C--N 1.328 -0.359 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -179.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -51.13 153.39 9.31 Favored 'Trans proline' 0 C--N 1.293 -2.351 0 C-N-CA 123.029 2.486 . . . . 0.0 112.11 -178.175 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.429 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -109.06 146.01 15.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.332 -179.681 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 97.0 mt -63.62 -45.48 97.43 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.338 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.502 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -129.8 134.58 47.66 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.519 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.482 ' O ' ' N ' ' A' ' 98' ' ' LEU . 73.3 m -134.57 158.82 43.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.838 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.99 139.36 16.17 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.496 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.93 -162.66 0.08 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.967 0.413 . . . . 0.0 110.423 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.52 HG22 ' CD2' ' A' ' 297' ' ' PHE . 13.8 t -133.45 135.49 44.58 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.389 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.482 ' C ' ' O ' ' A' ' 70' ' ' THR . 0.7 OUTLIER 29.72 68.94 0.64 Allowed Pre-proline 0 N--CA 1.466 0.354 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.729 -179.883 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_exo -61.52 145.39 97.9 Favored 'Trans proline' 0 C--N 1.3 -2.026 0 C-N-CA 122.714 2.276 . . . . 0.0 111.837 -178.059 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.527 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 46.4 p-10 -160.49 -31.96 0.06 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.742 179.69 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.533 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 99.1 m-20 -64.51 -39.21 93.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.317 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 -60.63 -48.09 83.32 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.52 -179.133 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.426 ' O ' ' O ' ' A' ' 77' ' ' ALA . 94.0 t -60.19 -24.9 31.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.373 -0.376 . . . . 0.0 109.999 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.533 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -45.45 172.69 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.648 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.568 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.7 p30 -61.67 177.57 0.4 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.513 -179.663 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.566 ' C ' ' H ' ' A' ' 81' ' ' GLY . 36.0 p30 -46.27 85.65 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.005 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.568 ' N ' ' O ' ' A' ' 78' ' ' ASP . 42.8 tp60 -67.08 13.54 0.06 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.194 0.521 . . . . 0.0 110.169 -179.822 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.566 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 117.87 -21.93 10.13 Favored Glycine 0 N--CA 1.461 0.309 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -107.83 116.29 31.69 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.985 0.422 . . . . 0.0 110.466 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 75.7 mt -98.84 0.79 44.99 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.502 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -91.94 6.5 46.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.019 0.438 . . . . 0.0 110.397 -179.682 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.783 ' O ' HG22 ' A' ' 89' ' ' VAL . 27.1 mt-30 -100.16 -27.0 13.75 Favored 'General case' 0 C--O 1.222 -0.385 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.78 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.4 t-105 -64.31 -40.64 96.34 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.021 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.551 ' O ' ' N ' ' A' ' 91' ' ' LYS . 68.5 m -77.75 -53.75 7.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.164 -179.567 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -48.33 -50.55 29.91 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.08 -179.157 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.783 HG22 ' O ' ' A' ' 85' ' ' GLN . 14.8 m -69.08 -40.88 81.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 120.9 0.381 . . . . 0.0 111.113 179.602 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.503 ' N ' HG23 ' A' ' 89' ' ' VAL . . . -71.94 -22.82 61.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.655 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.551 ' N ' ' O ' ' A' ' 87' ' ' SER . 65.8 tttm -61.64 -46.13 91.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.428 -179.512 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.441 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.8 mm-40 -90.15 -94.44 0.12 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.152 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.62 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.9 mtt180 -143.49 59.79 1.39 Allowed 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.451 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.6 pttp 33.87 26.28 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.017 0.437 . . . . 0.0 110.286 -179.405 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.62 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.5 tt -48.27 123.14 6.03 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.011 -177.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.452 ' O ' HD23 ' A' ' 95' ' ' LEU . 99.0 mm-40 -83.41 -170.6 3.13 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.148 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.62 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 82.5 mtp180 -73.12 137.85 45.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.308 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.482 ' N ' ' O ' ' A' ' 67' ' ' SER . 88.7 mt -86.58 -166.14 1.47 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.793 -179.689 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.532 ' O ' ' CD2' ' A' ' 99' ' ' TYR . 47.8 p90 -167.89 119.9 0.86 Allowed 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.198 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.5 ' C ' ' O ' ' A' ' 99' ' ' TYR . 43.4 mm -29.44 121.18 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.005 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 113.64 28.25 3.28 Favored Glycine 0 CA--C 1.519 0.342 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 -179.447 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.58 ' N ' ' CD ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -144.0 46.15 0.62 Allowed Pre-proline 0 C--N 1.323 -0.582 0 CA-C-O 121.013 0.435 . . . . 0.0 110.428 179.764 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 29.5 Cg_endo -62.29 143.87 94.55 Favored 'Trans proline' 0 C--N 1.295 -2.246 0 C-N-CA 122.684 2.256 . . . . 0.0 111.844 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.46 ' O ' HG23 ' A' ' 108' ' ' VAL . 26.8 t -173.13 120.69 0.36 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.319 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.37 -40.94 63.97 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.075 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -65.92 -39.86 90.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.814 -179.417 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.01 -39.64 94.56 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.771 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 104' ' ' SER . 69.0 t -67.72 -43.74 86.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.724 179.585 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.43 -39.29 92.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.446 -179.161 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.441 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.66 -23.71 63.29 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.496 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.549 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.3 mm-40 -91.39 5.13 50.53 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.722 -179.563 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.549 ' C ' ' O ' ' A' ' 111' ' ' GLN . 10.4 tpt 21.96 64.84 0.32 Allowed Pre-proline 0 N--CA 1.467 0.408 0 CA-C-O 120.934 0.397 . . . . 0.0 111.157 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.448 ' HG2' HD11 ' A' ' 116' ' ' ILE . 61.8 Cg_endo -79.45 169.59 18.43 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 123.023 2.482 . . . . 0.0 111.698 -177.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.491 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 98.9 m-20 -113.12 -44.07 3.31 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.022 179.6 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.3 tp -120.09 120.69 36.98 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.562 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.462 HD13 HD22 ' A' ' 133' ' ' LEU . 96.4 mt -118.24 130.87 72.46 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.342 0 CA-C-O 120.904 0.383 . . . . 0.0 110.962 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.601 HD12 ' OG ' ' A' ' 48' ' ' SER . 32.3 mt -105.77 132.71 51.56 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.04 0.448 . . . . 0.0 110.287 -179.413 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 97.9 mt -117.9 135.74 57.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.673 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 85.5 p -71.7 153.42 42.05 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.593 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.11 -50.2 74.62 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.635 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -149.34 153.8 38.0 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.52 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 169.88 -170.51 42.85 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -63.08 -35.14 91.68 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.453 ' OD1' ' O ' ' A' ' 124' ' ' ASP . 44.4 p-10 -87.75 119.52 28.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.834 0.349 . . . . 0.0 110.701 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.446 ' O ' HD12 ' A' ' 129' ' ' LEU . 41.1 t -63.47 144.51 56.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.406 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.61 -42.33 9.25 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.775 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.4 tp -62.86 -42.22 99.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.649 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.41 -11.11 59.18 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.441 -179.389 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.446 HD12 ' O ' ' A' ' 125' ' ' SER . 84.5 mt -114.92 -24.55 8.58 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.647 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' TYR . . . . . 0.519 ' N ' ' O ' ' A' ' 126' ' ' ALA . 80.8 t80 -51.37 -49.91 60.58 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.649 -178.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.8 p-10 -65.72 -41.91 91.7 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.879 0.371 . . . . 0.0 111.317 179.429 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.521 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 87.8 mt-30 -67.88 -37.16 81.43 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.847 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.462 HD22 HD13 ' A' ' 116' ' ' ILE . 93.7 mt -79.7 -42.37 24.81 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.987 -179.682 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.3 t -56.94 -44.96 83.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.298 -179.164 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.8 m -62.32 -45.58 92.6 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.58 179.484 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 92.9 mt -62.49 -44.03 98.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.391 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.613 ' HB1' ' HD2' ' A' ' 138' ' ' PRO . . . -169.86 164.2 6.39 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.598 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.613 ' HD2' ' HB1' ' A' ' 137' ' ' ALA . 74.3 Cg_exo -43.32 111.66 0.24 Allowed 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.507 2.138 . . . . 0.0 112.243 179.249 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.467 HG21 ' CD1' ' A' ' 130' ' ' TYR . 17.1 m -86.12 127.34 34.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.675 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.447 HD12 ' HA ' ' A' ' 140' ' ' LEU . 34.9 tp -119.48 137.48 53.76 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.107 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.423 ' O ' ' OD1' ' A' ' 32' ' ' ASP . 78.2 mt -104.82 120.74 55.79 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 CA-C-O 121.154 0.502 . . . . 0.0 111.213 -179.352 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.506 HD12 HD22 ' A' ' 117' ' ' LEU . 94.3 mt -136.44 132.55 49.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.576 179.543 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.55 HD21 ' CG ' ' A' ' 241' ' ' ASP . 56.1 t30 -64.47 151.65 43.77 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.941 0.4 . . . . 0.0 110.43 179.262 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.522 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 88.1 t80 -85.57 122.71 30.08 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.966 -179.492 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.522 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 99.0 m-20 54.95 69.44 0.73 Allowed 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.741 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 49.3 p-10 -123.87 0.07 8.56 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.844 0.354 . . . . 0.0 110.638 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -151.46 117.03 5.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.766 -179.487 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 85.1 p -62.91 167.6 4.59 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.558 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.409 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.5 p-90 -50.56 -15.69 0.29 Allowed 'General case' 0 C--O 1.223 -0.322 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.469 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.445 ' O ' HG23 ' A' ' 154' ' ' THR . 68.0 tp60 -71.3 -74.57 0.15 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.496 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.448 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.2 t -62.75 -39.07 92.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.18 179.572 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 52.1 tp -60.08 -45.7 92.05 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.403 -178.464 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.409 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 46.8 tp -62.67 -41.64 99.19 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.529 178.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.448 ' OG1' ' O ' ' A' ' 151' ' ' SER . 53.4 p -64.02 -34.71 78.63 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.192 -179.425 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.48 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.8 mm-40 -63.82 -42.08 97.73 Favored 'General case' 0 C--O 1.226 -0.178 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.273 179.26 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 90.8 mt -65.44 -38.82 91.0 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.096 0.474 . . . . 0.0 110.203 179.176 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.567 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.46 -31.94 79.31 Favored Glycine 0 CA--C 1.52 0.353 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 -179.267 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.48 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.3 mt-10 -37.04 -25.17 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.818 0.342 . . . . 0.0 110.799 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.567 ' N ' ' O ' ' A' ' 157' ' ' GLY . 93.4 mt -59.79 149.63 6.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.323 179.285 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 76.5 p -68.99 137.26 53.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.935 -179.493 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 70.36 22.47 77.63 Favored Glycine 0 N--CA 1.459 0.184 0 N-CA-C 111.211 -0.756 . . . . 0.0 111.211 179.442 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 62.0 m80 -124.29 -14.63 6.92 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.681 0.276 . . . . 0.0 110.48 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -67.02 -59.41 3.5 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.628 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -51.78 -49.26 63.04 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.119 -179.54 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -60.7 -41.09 94.5 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.894 -0.322 . . . . 0.0 110.45 179.479 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.48 -47.69 84.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.567 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.53 -40.25 74.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.244 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -61.56 -50.1 74.01 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.631 179.505 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.406 ' NE ' ' HB1' ' A' ' 59' ' ' ALA . 59.9 ttt85 -65.3 -43.57 90.68 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.523 179.461 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 94.4 mt -64.61 -43.38 96.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.366 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.35 -51.41 69.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.378 -179.116 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -63.51 -43.69 96.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.614 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.665 ' CE2' HD11 ' A' ' 177' ' ' LEU . 56.3 t80 -62.88 -44.32 96.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.077 0.465 . . . . 0.0 110.407 179.475 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -63.32 -39.61 95.04 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.659 -179.465 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -63.15 -42.78 99.5 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.55 179.224 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -60.76 -44.74 96.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.238 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.665 HD11 ' CE2' ' A' ' 173' ' ' PHE . 85.1 mt -64.66 -41.05 96.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.73 178.895 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.12 -62.21 1.78 Allowed 'General case' 0 C--O 1.238 0.479 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.37 -179.323 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.61 -46.66 86.54 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.58 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.27 -41.49 65.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.34 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -64.05 -33.78 76.54 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.011 0.434 . . . . 0.0 110.235 179.399 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.417 ' O ' ' HG2' ' A' ' 182' ' ' GLU . 69.7 tt0 -90.76 8.86 32.51 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.538 0.685 . . . . 0.0 110.371 -178.78 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -104.73 -32.13 9.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.18 179.492 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.7 pt -127.96 147.69 32.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.807 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -139.98 131.23 26.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.428 179.211 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.592 HD22 ' N ' ' A' ' 186' ' ' LEU . 3.5 mm? -85.38 133.15 42.95 Favored Pre-proline 0 N--CA 1.452 -0.358 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.077 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -43.78 157.86 0.13 Allowed 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.714 2.276 . . . . 0.0 112.316 179.267 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 0.51 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.6 Cg_endo -62.91 114.84 2.6 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 C-N-CA 122.804 2.336 . . . . 0.0 111.746 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 189' ' ' GLN . . . . . 0.51 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.7 mt-30 155.63 147.69 0.0 OUTLIER Pre-proline 0 N--CA 1.457 -0.113 0 O-C-N 123.916 0.76 . . . . 0.0 110.825 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -73.48 144.18 35.81 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.672 2.248 . . . . 0.0 112.213 177.725 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.496 HG23 ' OG ' ' A' ' 258' ' ' SER . 2.1 p -124.96 158.97 32.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.319 0.581 . . . . 0.0 110.212 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 192' ' ' THR . . . . . 0.492 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 35.8 p -143.28 165.11 28.38 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.034 -179.704 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 193' ' ' ALA . . . . . 0.448 ' HA ' ' H ' ' A' ' 260' ' ' PHE . . . -135.38 128.72 32.15 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 121.244 0.545 . . . . 0.0 110.281 179.395 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.511 HD11 HD23 ' A' ' 259' ' ' LEU . 47.5 pt -146.46 148.87 16.55 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.348 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.13 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 195' ' ' VAL . . . . . 0.749 HG13 ' CD1' ' A' ' 262' ' ' PHE . 69.0 t -117.59 123.23 71.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.32 0.581 . . . . 0.0 109.836 178.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -134.4 107.01 7.35 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.336 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 95.3 m -130.7 130.59 44.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.813 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.4 ' O ' ' N ' ' A' ' 201' ' ' HIS . . . -82.82 -37.04 25.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.21 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.33 -67.21 0.25 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.328 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.16 -9.84 58.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.299 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 201' ' ' HIS . . . . . 0.4 ' N ' ' O ' ' A' ' 198' ' ' ALA . 59.8 t-80 60.64 58.34 2.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.85 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 31.8 p -167.21 153.76 8.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.555 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.3 144.04 24.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.049 0.452 . . . . 0.0 110.398 179.245 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -135.18 138.01 43.23 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.714 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 19.7 mt -105.96 125.32 50.85 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.083 0.468 . . . . 0.0 109.843 -179.683 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 206' ' ' TRP . . . . . 0.554 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 74.6 m95 -81.98 166.98 19.35 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.543 -179.693 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 207' ' ' THR . . . . . 0.465 HG22 ' C ' ' A' ' 206' ' ' TRP . 0.1 OUTLIER -157.21 171.24 7.7 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.581 -179.083 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.31 -36.92 80.28 Favored 'Trans proline' 0 C--N 1.302 -1.874 0 C-N-CA 122.612 2.208 . . . . 0.0 112.32 179.093 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -70.86 -35.02 72.21 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.713 -179.759 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 21.5 m -61.16 150.64 33.62 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.602 -179.431 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.68 -37.0 82.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.445 -179.699 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 212' ' ' GLN . . . . . 0.554 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 54.9 tt0 -64.7 -40.26 95.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.498 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.71 -43.44 91.87 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -63.11 -43.96 96.97 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.803 0.335 . . . . 0.0 110.283 179.792 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 215' ' ' MET . . . . . 0.541 ' SD ' ' HB2' ' A' ' 304' ' ' ALA . 65.1 ttp -59.26 -48.12 82.81 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.123 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 87.3 mt -60.52 -41.04 93.61 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 217' ' ' GLU . . . . . 0.451 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.0 tp10 -57.94 -37.89 74.93 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.059 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -65.34 -38.18 89.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.655 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 94.2 mt -64.08 -42.93 96.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.074 0.464 . . . . 0.0 110.596 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.89 44.74 0.08 OUTLIER Glycine 0 C--N 1.332 0.339 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 221' ' ' PHE . . . . . 0.451 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 26.3 m-85 -127.74 155.64 43.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.987 0.422 . . . . 0.0 110.498 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.483 ' O ' HG13 ' A' ' 191' ' ' VAL . 7.4 p -107.36 122.49 46.7 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.285 0.564 . . . . 0.0 110.132 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.476 HD22 ' C ' ' A' ' 222' ' ' THR . 4.3 mm? -101.64 132.7 47.18 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.101 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.4 159.95 14.67 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.476 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.55 115.36 30.11 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.348 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.494 HD12 ' N ' ' A' ' 226' ' ' LEU . 8.9 mp -53.37 156.7 3.94 Favored Pre-proline 0 N--CA 1.452 -0.36 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.725 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -59.91 145.1 99.13 Favored 'Trans proline' 0 C--N 1.301 -1.959 0 C-N-CA 122.688 2.259 . . . . 0.0 112.226 179.129 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.3 -3.14 59.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.584 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.14 -41.0 5.66 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 111.034 -0.827 . . . . 0.0 111.034 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.524 ' O ' ' N ' ' A' ' 233' ' ' SER . 85.3 mt -79.12 -16.98 55.91 Favored 'General case' 0 C--O 1.22 -0.45 0 CA-C-O 121.062 0.458 . . . . 0.0 110.326 -179.694 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 54.5 t-20 -40.43 -49.06 2.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.77 -179.405 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -87.97 15.16 7.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.323 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.524 ' N ' ' O ' ' A' ' 230' ' ' LEU . 77.9 p -60.43 -35.41 75.75 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.711 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 234' ' ' GLN . . . . . 0.526 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.6 tt0 -118.8 -69.36 0.85 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.901 179.329 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.2 m -69.95 102.88 2.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.707 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -94.31 57.72 2.35 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.339 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -144.71 -122.65 1.59 Allowed Glycine 0 CA--C 1.519 0.332 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -134.79 111.62 10.06 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.125 0.488 . . . . 0.0 110.371 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 239' ' ' ARG . . . . . 0.521 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.4 mtt180 -148.03 57.94 1.09 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.672 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -69.68 -31.88 70.18 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.538 179.502 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 241' ' ' ASP . . . . . 0.55 ' CG ' HD21 ' A' ' 143' ' ' ASN . 64.7 t0 -56.98 -47.09 81.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.328 -179.096 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 242' ' ' ILE . . . . . 0.435 ' O ' ' O ' ' A' ' 239' ' ' ARG . 17.6 tt -140.19 156.92 24.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.904 0.383 . . . . 0.0 110.475 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.442 HG22 HD13 ' A' ' 245' ' ' LEU . 96.2 mt -106.17 106.58 20.85 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.199 0 CA-C-O 121.097 0.475 . . . . 0.0 110.531 179.74 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 244' ' ' GLN . . . . . 0.596 ' O ' HD12 ' A' ' 245' ' ' LEU . 88.2 mt-30 -110.51 110.17 20.79 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.363 179.687 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.596 HD12 ' O ' ' A' ' 244' ' ' GLN . 9.5 mp -121.68 -168.33 1.68 Allowed 'General case' 0 C--O 1.224 -0.264 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.639 179.635 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 246' ' ' GLY . . . . . 0.526 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.61 -16.64 0.05 OUTLIER Glycine 0 CA--C 1.523 0.564 0 N-CA-C 110.999 -0.841 . . . . 0.0 110.999 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 247' ' ' GLY . . . . . 0.67 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -60.81 156.81 31.64 Favored Glycine 0 CA--C 1.522 0.476 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -63.73 21.79 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.012 0.434 . . . . 0.0 110.643 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 249' ' ' ASN . . . . . 0.67 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.7 m-20 -97.44 -5.97 34.94 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.515 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 92.2 mt -79.78 -21.71 44.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.769 179.331 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.51 -51.37 70.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.715 -179.527 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.37 -5.48 58.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.494 179.631 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.08 -74.39 1.14 Allowed Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 81.5 mt -70.0 125.98 28.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.908 0.385 . . . . 0.0 110.297 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -59.91 -39.07 84.16 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.208 -179.502 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 83.29 51.69 4.05 Favored Glycine 0 CA--C 1.521 0.423 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -95.2 -15.67 23.09 Favored 'General case' 0 C--N 1.331 -0.214 0 O-C-N 122.746 -0.267 . . . . 0.0 110.591 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 258' ' ' SER . . . . . 0.496 ' OG ' HG23 ' A' ' 191' ' ' VAL . 3.3 t 174.54 89.3 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.099 0.476 . . . . 0.0 110.1 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.856 HD12 ' N ' ' A' ' 259' ' ' LEU . 1.0 OUTLIER -94.4 124.24 38.3 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.206 0.527 . . . . 0.0 111.259 -179.072 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 260' ' ' PHE . . . . . 0.448 ' H ' ' HA ' ' A' ' 193' ' ' ALA . 15.9 m-30 -93.34 146.41 23.75 Favored 'General case' 0 CA--C 1.501 -0.917 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.395 179.315 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 85.9 mt -122.25 149.7 43.32 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.551 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.749 ' CD1' HG13 ' A' ' 195' ' ' VAL . 2.6 p90 -77.37 -138.69 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.666 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 263' ' ' ALA . . . . . 0.655 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -51.78 77.35 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 121.035 0.445 . . . . 0.0 111.174 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 264' ' ' GLY . . . . . 0.626 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.15 104.75 0.19 Allowed Glycine 0 CA--C 1.527 0.824 0 N-CA-C 110.554 -1.019 . . . . 0.0 110.554 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 265' ' ' ASP . . . . . 0.601 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.7 m-20 -80.34 -177.94 6.39 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.64 0.257 . . . . 0.0 110.928 -179.611 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -40.26 -17.73 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.576 179.691 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 267' ' ' LYS . . . . . 0.601 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.31 -51.74 41.34 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.71 179.287 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -63.55 -46.64 85.04 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.236 179.378 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 269' ' ' ALA . . . . . 0.572 ' HB1' ' OH ' ' A' ' 273' ' ' TYR . . . -61.66 -35.04 76.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.349 0.595 . . . . 0.0 109.843 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -63.09 -34.06 76.79 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.204 179.696 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.87 -43.28 13.39 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.108 -179.473 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 272' ' ' ILE . . . . . 0.586 ' C ' ' H ' ' A' ' 274' ' ' ALA . 4.8 tt -51.31 -33.48 14.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.737 -178.82 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 273' ' ' TYR . . . . . 0.572 ' OH ' ' HB1' ' A' ' 269' ' ' ALA . 17.1 m-85 -54.81 -1.72 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.665 -179.44 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 274' ' ' ALA . . . . . 0.586 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.65 -39.81 70.11 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.952 179.428 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 275' ' ' ASN . . . . . 0.58 ' O ' ' N ' ' A' ' 279' ' ' ALA . 3.2 p30 -39.02 98.05 0.16 Allowed Pre-proline 0 C--O 1.227 -0.124 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.474 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -54.48 -42.81 64.63 Favored 'Trans proline' 0 C--N 1.303 -1.862 0 C-N-CA 122.42 2.08 . . . . 0.0 112.543 -178.623 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 89.3 mt -64.4 -42.91 95.83 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.126 0.488 . . . . 0.0 111.158 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 91.2 mt -95.57 -1.77 49.78 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.874 -179.491 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 279' ' ' ALA . . . . . 0.58 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.25 -34.87 77.36 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.755 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.2 20.11 0.11 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.998 -179.288 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 0.481 ' H ' ' C ' ' A' ' 279' ' ' ALA . 13.9 mt -75.2 119.69 78.16 Favored Pre-proline 0 N--CA 1.448 -0.545 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.688 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -49.97 -40.01 49.61 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.678 2.252 . . . . 0.0 112.238 178.697 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.56 -50.56 62.7 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.118 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 71.8 t -61.46 -43.82 97.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 110.04 -0.355 . . . . 0.0 110.04 179.536 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -57.84 -41.28 81.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.198 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -90.96 0.29 57.56 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.129 179.767 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt 59.47 43.04 16.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.844 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -94.49 41.51 1.09 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.429 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 53.8 t -119.03 135.62 58.87 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.156 0 CA-C-O 121.072 0.463 . . . . 0.0 110.111 -179.665 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -132.85 162.75 30.71 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.153 0.502 . . . . 0.0 110.629 -179.713 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.69 154.98 33.28 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.015 0.436 . . . . 0.0 110.699 -179.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 81.6 mt -93.96 -1.52 54.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.247 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.66 165.88 12.71 Favored Glycine 0 CA--C 1.521 0.45 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 6.5 m -87.8 -62.2 1.55 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.864 0.364 . . . . 0.0 111.008 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 295' ' ' GLU . . . . . 0.448 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.6 mm-40 -69.35 -4.08 16.78 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.701 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 27.0 p -76.46 32.8 0.13 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.645 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 297' ' ' PHE . . . . . 0.52 ' CD2' HG22 ' A' ' 70' ' ' THR . 85.7 t80 -60.39 -46.06 91.32 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.573 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 298' ' ' ARG . . . . . 0.62 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.2 mtt85 -81.45 135.06 35.62 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.569 -179.637 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.46 ' H ' HG11 ' A' ' 51' ' ' VAL . 17.0 tp -114.24 117.77 32.07 Favored 'General case' 0 C--O 1.231 0.085 0 CA-C-O 121.005 0.431 . . . . 0.0 110.182 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 300' ' ' ASP . . . . . 0.636 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.4 p-10 -165.42 -176.38 3.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.624 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 80.2 t80 -47.07 -43.39 20.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.348 -179.65 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -67.01 -40.49 87.3 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.024 0.44 . . . . 0.0 110.747 179.083 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 303' ' ' SER . . . . . 0.636 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 60.3 p -55.71 -36.5 67.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.074 -179.193 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 304' ' ' ALA . . . . . 0.541 ' HB2' ' SD ' ' A' ' 215' ' ' MET . . . -57.08 -51.69 68.27 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 179.46 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 91.2 mtp -55.97 -43.92 78.01 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -66.2 -42.64 88.51 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.141 0.495 . . . . 0.0 110.257 179.004 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 307' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 303' ' ' SER . 55.4 t -64.15 -42.82 96.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.26 179.374 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 43.1 tp -59.74 -42.15 92.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.871 -179.499 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -62.63 -38.78 91.57 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.237 179.421 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 310' ' ' ARG . . . . . 0.45 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.6 ttt85 -63.56 -43.86 95.8 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.246 179.538 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 90.3 mt -63.0 -42.12 99.77 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.311 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -62.94 -33.16 74.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.113 179.422 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.97 -23.31 21.57 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.318 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.481 HD22 ' CE2' ' A' ' 315' ' ' PHE . 6.7 tt -62.27 -43.19 99.4 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 121.055 0.455 . . . . 0.0 110.52 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 315' ' ' PHE . . . . . 0.481 ' CE2' HD22 ' A' ' 314' ' ' LEU . 91.2 m-85 . . . . . 0 C--O 1.22 -0.466 0 CA-C-O 118.055 -0.974 . . . . 0.0 110.405 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -99.63 136.43 39.58 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.016 0.436 . . . . 0.0 110.538 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.497 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -91.71 178.46 1.74 Allowed Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.58 -179.882 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.497 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.5 Cg_exo -61.69 147.5 95.18 Favored 'Trans proline' 0 C--N 1.3 -2.007 0 C-N-CA 122.778 2.318 . . . . 0.0 112.123 179.639 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.494 ' HE ' HD12 ' A' ' 39' ' ' LEU . 35.4 ptt180 -135.76 142.65 44.98 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.655 179.742 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -79.11 116.96 19.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.501 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.431 ' O ' HG23 ' A' ' 30' ' ' ILE . 9.6 tp -110.32 130.86 62.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.408 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 13.3 t -71.14 141.93 50.74 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.53 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.427 ' OD1' ' O ' ' A' ' 141' ' ' ILE . 25.1 t70 -139.87 177.88 7.65 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.517 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.0 p -73.73 -36.59 65.2 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.688 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.8 ttt85 -47.78 -95.25 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.269 -179.459 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -165.22 -26.06 0.02 OUTLIER Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 67.5 m -168.32 106.79 0.49 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.889 0.376 . . . . 0.0 110.652 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 52.3 t-80 -129.71 143.56 50.88 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.027 0.442 . . . . 0.0 110.152 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.627 HG22 ' N ' ' A' ' 39' ' ' LEU . 97.5 m -128.18 166.12 19.13 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.636 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.627 ' N ' HG22 ' A' ' 38' ' ' THR . 81.1 mt -120.78 127.61 52.12 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.523 179.724 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -64.42 -44.26 91.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.656 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 41.5 p -165.68 154.84 11.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.424 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.478 ' CD ' ' H ' ' A' ' 42' ' ' GLN . 13.7 mp0 -43.42 100.69 0.23 Allowed Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.636 179.467 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -56.85 129.33 34.01 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 122.399 2.066 . . . . 0.0 112.262 -179.66 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -83.88 -23.95 31.05 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.45 179.575 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.544 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.3 mtm-85 -120.9 134.26 55.29 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 121.132 0.492 . . . . 0.0 110.202 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 95.9 mt -130.65 133.48 63.39 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.939 -179.718 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 49.1 t -125.05 131.06 73.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.825 0.345 . . . . 0.0 110.119 179.335 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.617 ' OG ' HD12 ' A' ' 117' ' ' LEU . 5.1 m -154.41 166.16 34.13 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.506 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 65.0 p -124.94 8.5 8.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.501 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.71 125.75 33.44 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.686 -179.468 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.457 HG11 ' H ' ' A' ' 299' ' ' LEU . 88.6 t -65.75 -44.65 93.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.47 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 20.0 m -62.53 -44.29 96.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.605 -179.73 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 51.2 tp -62.28 -41.51 98.55 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.572 -179.454 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.459 ' O ' HD13 ' A' ' 58' ' ' LEU . 70.6 m -57.67 -44.36 85.7 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.343 -179.313 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.48 -61.91 5.55 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.929 -0.869 . . . . 0.0 110.929 179.556 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.7 t -48.51 -35.67 13.64 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 20.0 mt -61.77 -44.72 96.33 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.661 -0.416 . . . . 0.0 111.126 179.377 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.459 HD13 ' O ' ' A' ' 54' ' ' THR . 9.2 mp -64.96 -41.8 95.16 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.189 178.024 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.405 ' HB1' ' NE ' ' A' ' 169' ' ' ARG . . . -63.62 -41.27 98.29 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.947 -179.152 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.429 ' O ' HG23 ' A' ' 60' ' ' ILE . 8.0 tp -88.13 16.7 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.771 -179.619 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 56.61 84.28 0.09 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.653 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.37 57.38 0.07 OUTLIER Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.058 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -50.3 153.19 7.39 Favored 'Trans proline' 0 C--N 1.296 -2.199 0 C-N-CA 122.874 2.383 . . . . 0.0 112.388 -178.303 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.428 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.4 OUTLIER -109.03 146.38 14.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.367 -179.699 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 97.1 mt -63.79 -45.16 97.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.368 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.51 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -130.31 134.83 47.49 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.575 -179.741 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.464 ' O ' ' N ' ' A' ' 98' ' ' LEU . 73.8 m -134.52 158.73 43.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.843 -179.675 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.35 138.94 16.3 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.488 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.86 -162.7 0.08 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.996 0.427 . . . . 0.0 110.515 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.513 HG22 ' CD2' ' A' ' 297' ' ' PHE . 5.9 t -133.74 135.94 44.27 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.192 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.492 ' C ' ' O ' ' A' ' 70' ' ' THR . 1.0 OUTLIER 29.55 68.57 0.65 Allowed Pre-proline 0 N--CA 1.465 0.3 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.715 -179.7 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -61.25 144.57 98.8 Favored 'Trans proline' 0 C--N 1.301 -1.964 0 C-N-CA 122.668 2.245 . . . . 0.0 112.092 -178.435 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.519 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 45.7 p-10 -159.87 -31.61 0.06 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.717 179.709 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.537 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 98.7 m-20 -64.52 -38.92 92.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.46 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 73.2 ttt180 -60.87 -47.9 84.25 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.752 -179.368 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.422 ' O ' ' O ' ' A' ' 77' ' ' ALA . 94.6 t -60.36 -24.6 31.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.324 -0.398 . . . . 0.0 109.927 179.655 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.537 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -45.53 172.58 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.5 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.576 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.5 p30 -61.78 177.73 0.4 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.706 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.565 ' C ' ' H ' ' A' ' 81' ' ' GLY . 35.8 p30 -46.11 85.58 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.909 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.576 ' N ' ' O ' ' A' ' 78' ' ' ASP . 43.1 tp60 -67.01 13.62 0.06 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.139 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.565 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 117.78 -22.13 10.1 Favored Glycine 0 CA--C 1.52 0.355 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -107.94 116.52 32.11 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.016 0.436 . . . . 0.0 110.486 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 76.7 mt -98.83 0.86 45.16 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.453 -179.71 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -91.94 6.48 46.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.972 0.415 . . . . 0.0 110.388 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.79 ' O ' HG22 ' A' ' 89' ' ' VAL . 27.1 mt-30 -100.04 -27.27 13.65 Favored 'General case' 0 C--O 1.223 -0.29 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.77 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.5 t-105 -63.87 -40.78 97.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.015 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.555 ' O ' ' N ' ' A' ' 91' ' ' LYS . 67.7 m -77.63 -53.62 7.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.328 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -48.41 -50.85 29.36 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.972 -179.221 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.79 HG22 ' O ' ' A' ' 85' ' ' GLN . 15.1 m -68.89 -40.74 81.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 120.9 0.381 . . . . 0.0 110.984 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.498 ' N ' HG23 ' A' ' 89' ' ' VAL . . . -72.24 -22.59 61.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.704 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.555 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.0 tttm -61.47 -46.19 91.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.437 -179.545 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.438 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.6 mm-40 -90.32 -94.2 0.12 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.149 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.632 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.9 mtt180 -143.44 59.82 1.39 Allowed 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.782 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.461 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.6 pttp 33.69 26.18 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.259 -179.247 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.632 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.4 tt -47.87 123.23 5.8 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.969 -178.185 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.445 ' O ' HD23 ' A' ' 95' ' ' LEU . 98.8 mm-40 -83.51 -170.29 2.98 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.08 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.617 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 83.0 mtp180 -73.22 137.8 45.21 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.311 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.464 ' N ' ' O ' ' A' ' 67' ' ' SER . 87.9 mt -86.95 -166.03 1.46 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.721 -179.674 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.53 ' O ' ' CD2' ' A' ' 99' ' ' TYR . 48.0 p90 -168.06 120.31 0.86 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.236 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.509 ' C ' ' O ' ' A' ' 99' ' ' TYR . 43.5 mm -29.87 121.64 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.956 -179.674 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 113.72 28.12 3.31 Favored Glycine 0 CA--C 1.52 0.384 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 -179.468 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.589 ' CD ' ' H ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -143.98 45.87 0.6 Allowed Pre-proline 0 C--N 1.324 -0.536 0 CA-C-O 120.922 0.392 . . . . 0.0 110.43 179.867 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.584 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 29.8 Cg_endo -62.0 143.74 95.51 Favored 'Trans proline' 0 C--N 1.298 -2.109 0 C-N-CA 122.678 2.252 . . . . 0.0 112.004 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.462 ' O ' HG23 ' A' ' 108' ' ' VAL . 26.8 t -173.47 120.62 0.33 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.459 179.649 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.12 -41.1 64.36 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.089 0.471 . . . . 0.0 111.165 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -65.87 -40.06 91.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.792 -179.388 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.83 -39.89 95.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.698 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 104' ' ' SER . 69.6 t -67.66 -43.84 86.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.763 179.709 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.23 -39.46 92.89 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.566 -179.276 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.438 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.48 -23.5 62.81 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.469 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.561 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.3 mm-40 -91.35 4.99 51.02 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.755 -179.561 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.561 ' C ' ' O ' ' A' ' 111' ' ' GLN . 10.3 tpt 22.33 64.65 0.33 Allowed Pre-proline 0 N--CA 1.465 0.281 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.039 -179.807 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.453 ' HG2' HD11 ' A' ' 116' ' ' ILE . 67.9 Cg_endo -79.12 169.57 18.96 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 C-N-CA 122.957 2.438 . . . . 0.0 112.059 -178.395 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.485 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 99.0 m-20 -113.32 -44.16 3.27 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.172 179.399 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 41.3 tp -120.26 120.44 36.11 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.506 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.454 HD13 HD22 ' A' ' 133' ' ' LEU . 96.2 mt -117.96 131.24 71.29 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 CA-C-O 120.999 0.428 . . . . 0.0 110.884 -179.853 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.617 HD12 ' OG ' ' A' ' 48' ' ' SER . 31.4 mt -105.92 132.87 51.5 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.148 0.499 . . . . 0.0 110.204 -179.424 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.407 HD12 HG23 ' A' ' 139' ' ' THR . 97.8 mt -118.27 135.93 57.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.701 -179.721 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 85.9 p -72.09 153.74 41.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.613 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.19 -50.21 74.58 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.689 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -149.35 153.76 37.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.56 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 169.54 -170.0 42.39 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.82 -35.06 91.45 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.446 ' OD1' ' O ' ' A' ' 124' ' ' ASP . 44.1 p-10 -88.91 119.41 29.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.84 0.352 . . . . 0.0 110.7 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.449 ' O ' HD12 ' A' ' 129' ' ' LEU . 36.4 t -63.29 145.26 55.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.519 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.52 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.39 -43.8 8.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.958 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.4 tp -62.73 -42.34 99.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.73 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.49 -10.97 56.59 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.564 -179.442 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.449 HD12 ' O ' ' A' ' 125' ' ' SER . 83.9 mt -116.26 -23.59 8.33 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.651 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' TYR . . . . . 0.52 ' N ' ' O ' ' A' ' 126' ' ' ALA . 77.7 t80 -51.47 -49.6 61.46 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.674 -0.411 . . . . 0.0 110.567 -179.008 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.5 p-10 -65.83 -41.94 91.17 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.846 0.355 . . . . 0.0 111.109 179.554 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.526 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 88.1 mt-30 -67.82 -36.96 81.29 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.777 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.454 HD22 HD13 ' A' ' 116' ' ' ILE . 93.0 mt -80.27 -41.98 24.0 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.927 -179.517 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.2 t -57.5 -44.67 85.19 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.223 -179.171 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.2 m -62.3 -45.66 92.26 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.735 0.302 . . . . 0.0 110.596 179.337 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 91.8 mt -62.52 -43.86 98.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.406 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.598 ' HB1' ' HD2' ' A' ' 138' ' ' PRO . . . -170.1 163.51 6.32 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.506 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.598 ' HD2' ' HB1' ' A' ' 137' ' ' ALA . 78.5 Cg_exo -42.78 111.13 0.19 Allowed 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.469 2.112 . . . . 0.0 112.161 179.348 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.481 HG21 ' CD1' ' A' ' 130' ' ' TYR . 16.6 m -86.05 127.64 34.71 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.57 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.449 HD12 ' HA ' ' A' ' 140' ' ' LEU . 35.5 tp -119.99 138.39 53.51 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.032 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.427 ' O ' ' OD1' ' A' ' 32' ' ' ASP . 77.7 mt -105.57 120.66 56.7 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.358 0 CA-C-O 121.109 0.48 . . . . 0.0 111.291 -179.427 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.489 HD12 HD22 ' A' ' 117' ' ' LEU . 97.9 mt -135.93 132.69 50.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.627 179.602 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.533 HD21 ' CG ' ' A' ' 241' ' ' ASP . 61.0 t30 -64.42 150.87 45.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.939 0.399 . . . . 0.0 110.402 179.407 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.518 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 88.7 t80 -85.69 122.09 29.29 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.913 -179.513 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.518 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 98.8 m-20 55.63 69.01 0.78 Allowed 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.812 179.63 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 35.9 p-10 -125.4 0.01 7.63 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.683 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -150.64 115.61 5.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.76 -179.445 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 84.6 p -62.67 167.8 4.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.505 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.416 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.5 p-90 -51.09 -15.24 0.3 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.498 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.445 ' O ' HG23 ' A' ' 154' ' ' THR . 68.1 tp60 -71.34 -75.01 0.14 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.475 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.45 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.2 t -62.78 -38.83 92.18 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.031 0.444 . . . . 0.0 110.305 179.506 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 52.6 tp -60.17 -45.56 92.68 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.42 -178.576 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.416 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 45.9 tp -62.8 -41.8 99.44 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.856 0.36 . . . . 0.0 110.375 179.068 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.45 ' OG1' ' O ' ' A' ' 151' ' ' SER . 57.8 p -63.95 -34.52 78.16 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.312 -179.597 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.471 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.6 mm-40 -64.1 -42.24 96.98 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.263 179.269 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 91.4 mt -65.45 -38.83 91.01 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.182 179.102 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.574 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.34 -31.82 78.62 Favored Glycine 0 CA--C 1.52 0.406 0 N-CA-C 110.846 -0.901 . . . . 0.0 110.846 -179.396 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.471 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.2 mt-10 -36.97 -25.1 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.809 0.338 . . . . 0.0 110.706 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.574 ' N ' ' O ' ' A' ' 157' ' ' GLY . 94.4 mt -59.94 149.59 6.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.317 179.473 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 76.8 p -68.91 137.14 53.58 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.059 -179.508 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 70.63 22.0 77.89 Favored Glycine 0 N--CA 1.459 0.177 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 179.441 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 60.4 m80 -123.72 -14.83 7.16 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.786 0.327 . . . . 0.0 110.507 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -66.96 -59.31 3.6 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.686 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -51.85 -49.4 62.94 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.188 -179.655 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -60.64 -41.21 94.48 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.803 0.335 . . . . 0.0 110.316 179.522 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.46 -47.45 85.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.589 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.59 -40.27 74.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.247 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -61.57 -50.1 73.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.578 179.556 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.405 ' NE ' ' HB1' ' A' ' 59' ' ' ALA . 59.9 ttt85 -65.47 -43.63 89.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.471 179.523 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 94.8 mt -64.46 -43.48 96.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.429 179.732 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.41 -51.16 70.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.525 -179.227 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.76 -43.78 95.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.375 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.658 ' CE2' HD11 ' A' ' 177' ' ' LEU . 56.3 t80 -62.74 -44.53 95.97 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.069 0.462 . . . . 0.0 110.41 179.426 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -63.12 -39.8 95.76 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.611 -179.462 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -63.01 -42.8 99.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.617 179.197 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -60.69 -44.95 95.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.103 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.658 HD11 ' CE2' ' A' ' 173' ' ' PHE . 85.0 mt -64.52 -41.17 96.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.998 0.428 . . . . 0.0 110.642 178.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.02 -62.15 1.82 Allowed 'General case' 0 C--O 1.237 0.408 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.491 -179.32 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.86 -46.68 87.2 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.546 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.42 -41.66 66.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.176 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -63.91 -33.67 76.22 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.018 0.437 . . . . 0.0 110.387 179.266 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.423 ' O ' ' HG2' ' A' ' 182' ' ' GLU . 69.6 tt0 -90.56 8.63 33.12 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.435 0.636 . . . . 0.0 110.56 -178.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -104.55 -32.0 9.17 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.183 179.61 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.9 pt -127.99 147.74 32.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.882 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -139.77 130.97 26.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.396 179.393 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.595 HD22 ' N ' ' A' ' 186' ' ' LEU . 3.6 mm? -85.73 133.06 42.46 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.852 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -44.24 157.99 0.15 Allowed 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.747 2.298 . . . . 0.0 112.119 179.467 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 0.524 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 28.1 Cg_endo -63.08 115.21 2.82 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 C-N-CA 122.736 2.291 . . . . 0.0 111.773 179.749 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 189' ' ' GLN . . . . . 0.524 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.7 mt-30 155.61 147.63 0.0 OUTLIER Pre-proline 0 N--CA 1.454 -0.241 0 O-C-N 123.57 0.544 . . . . 0.0 110.727 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -73.81 143.73 33.85 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.767 2.311 . . . . 0.0 111.88 178.082 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.497 HG23 ' OG ' ' A' ' 258' ' ' SER . 2.1 p -124.93 158.93 32.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.24 0.543 . . . . 0.0 110.124 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 192' ' ' THR . . . . . 0.497 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 36.9 p -143.41 165.37 27.71 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.092 -179.669 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 193' ' ' ALA . . . . . 0.446 ' HA ' ' H ' ' A' ' 260' ' ' PHE . . . -135.63 128.55 31.31 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 121.207 0.527 . . . . 0.0 110.224 179.533 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.504 HD11 HD23 ' A' ' 259' ' ' LEU . 47.2 pt -146.44 149.1 16.34 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.096 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 195' ' ' VAL . . . . . 0.743 HG13 ' CD1' ' A' ' 262' ' ' PHE . 69.0 t -117.94 123.13 71.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.25 0.548 . . . . 0.0 109.767 179.11 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -134.24 107.41 7.66 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.252 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 94.7 m -131.33 130.51 42.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.823 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.404 ' O ' ' N ' ' A' ' 201' ' ' HIS . . . -82.93 -36.92 24.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.354 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.48 -66.88 0.28 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.331 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.35 -10.27 59.57 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.278 179.49 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 201' ' ' HIS . . . . . 0.404 ' N ' ' O ' ' A' ' 198' ' ' ALA . 60.0 t-80 61.42 58.16 2.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.715 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 39.4 p -167.09 153.55 8.29 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.552 179.469 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -150.97 143.63 24.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.46 179.421 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -135.04 138.03 43.51 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 120.926 0.393 . . . . 0.0 110.608 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 19.8 mt -106.16 125.39 50.94 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 121.057 0.456 . . . . 0.0 109.892 -179.696 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 206' ' ' TRP . . . . . 0.554 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 74.6 m95 -81.88 166.78 19.63 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.564 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 207' ' ' THR . . . . . 0.463 HG22 ' C ' ' A' ' 206' ' ' TRP . 0.1 OUTLIER -156.86 172.06 6.62 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.022 0.439 . . . . 0.0 110.505 -179.196 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.21 -36.85 87.23 Favored 'Trans proline' 0 C--N 1.303 -1.821 0 C-N-CA 122.624 2.216 . . . . 0.0 112.099 179.391 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -70.71 -34.84 72.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.822 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 21.3 m -61.3 150.68 34.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.642 -179.359 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.72 -36.92 82.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.472 -179.726 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 212' ' ' GLN . . . . . 0.554 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 55.0 tt0 -64.58 -40.37 95.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.491 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.71 -43.4 91.96 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -63.35 -43.8 96.66 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.924 -0.31 . . . . 0.0 110.294 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 215' ' ' MET . . . . . 0.538 ' SD ' ' HB2' ' A' ' 304' ' ' ALA . 65.1 ttp -59.53 -47.94 83.59 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.269 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 87.1 mt -60.61 -40.84 93.33 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.556 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 217' ' ' GLU . . . . . 0.453 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 40.9 tp10 -57.93 -38.03 75.17 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -65.35 -37.98 88.7 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.77 0.319 . . . . 0.0 110.672 179.716 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 94.4 mt -64.3 -42.69 96.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.521 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.51 45.07 0.08 OUTLIER Glycine 0 C--N 1.334 0.419 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 221' ' ' PHE . . . . . 0.453 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 26.1 m-85 -128.04 155.78 43.8 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.05 0.452 . . . . 0.0 110.467 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.484 ' O ' HG13 ' A' ' 191' ' ' VAL . 7.2 p -107.66 122.57 46.99 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.3 0.572 . . . . 0.0 110.182 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.476 HD22 ' C ' ' A' ' 222' ' ' THR . 4.3 mm? -101.58 132.72 47.09 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.049 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.38 160.14 14.57 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.535 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -105.55 115.13 29.72 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.973 0.416 . . . . 0.0 110.294 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.498 HD12 ' N ' ' A' ' 226' ' ' LEU . 9.0 mp -52.95 156.82 3.18 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.673 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -60.41 145.37 98.81 Favored 'Trans proline' 0 C--N 1.301 -1.945 0 C-N-CA 122.657 2.238 . . . . 0.0 112.075 179.29 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.22 -3.47 59.05 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.51 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -89.97 -41.19 5.66 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.535 ' O ' ' N ' ' A' ' 233' ' ' SER . 68.2 mt -78.78 -17.54 55.59 Favored 'General case' 0 C--O 1.223 -0.319 0 CA-C-O 120.998 0.428 . . . . 0.0 110.377 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 231' ' ' ASN . . . . . 0.403 ' C ' ' O ' ' A' ' 230' ' ' LEU . 54.7 t-20 -40.19 -49.34 2.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.789 -179.389 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -87.8 15.32 7.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.258 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.535 ' N ' ' O ' ' A' ' 230' ' ' LEU . 78.2 p -60.36 -35.61 76.09 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.645 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 234' ' ' GLN . . . . . 0.525 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.6 tt0 -119.02 -69.26 0.86 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.963 179.607 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.2 m -69.89 102.76 2.04 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.733 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -94.45 57.64 2.29 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.055 0.455 . . . . 0.0 110.364 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -144.65 -122.68 1.59 Allowed Glycine 0 CA--C 1.52 0.364 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -134.86 111.4 9.85 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 121.067 0.46 . . . . 0.0 110.433 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 239' ' ' ARG . . . . . 0.521 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.6 mtt180 -147.95 58.06 1.1 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.762 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -69.77 -32.31 70.74 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.533 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 241' ' ' ASP . . . . . 0.533 ' CG ' HD21 ' A' ' 143' ' ' ASN . 65.0 t0 -56.86 -46.95 81.44 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.395 -179.093 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 242' ' ' ILE . . . . . 0.434 ' O ' ' O ' ' A' ' 239' ' ' ARG . 18.0 tt -139.93 156.74 25.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.926 0.393 . . . . 0.0 110.492 179.691 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.448 HG22 HD13 ' A' ' 245' ' ' LEU . 96.0 mt -106.36 106.7 21.1 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.214 0 CA-C-O 121.208 0.528 . . . . 0.0 110.489 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 244' ' ' GLN . . . . . 0.604 ' O ' HD12 ' A' ' 245' ' ' LEU . 88.3 mt-30 -110.48 110.14 20.76 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.331 179.805 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.604 HD12 ' O ' ' A' ' 244' ' ' GLN . 9.4 mp -121.81 -168.48 1.71 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.577 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 246' ' ' GLY . . . . . 0.525 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.9 -16.27 0.05 OUTLIER Glycine 0 CA--C 1.524 0.614 0 N-CA-C 111.039 -0.824 . . . . 0.0 111.039 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 247' ' ' GLY . . . . . 0.674 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -61.17 156.42 33.77 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -63.45 21.81 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.933 0.397 . . . . 0.0 110.617 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 249' ' ' ASN . . . . . 0.674 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.8 m-20 -97.35 -6.14 34.87 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.523 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 92.1 mt -79.52 -22.15 44.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.677 179.423 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.55 -51.26 70.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.711 -179.456 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.23 -5.76 58.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.48 179.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.02 -74.59 1.13 Allowed Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.909 -0.876 . . . . 0.0 110.909 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 83.0 mt -69.82 125.94 28.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.023 0.44 . . . . 0.0 110.234 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -59.32 -39.44 83.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.178 -179.608 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 83.1 51.82 4.04 Favored Glycine 0 CA--C 1.521 0.433 0 N-CA-C 110.814 -0.914 . . . . 0.0 110.814 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -95.94 -14.89 22.73 Favored 'General case' 0 C--N 1.33 -0.266 0 O-C-N 122.701 -0.293 . . . . 0.0 110.616 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 258' ' ' SER . . . . . 0.497 ' OG ' HG23 ' A' ' 191' ' ' VAL . 3.4 t 174.34 88.85 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.047 0.451 . . . . 0.0 110.177 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.862 HD12 ' N ' ' A' ' 259' ' ' LEU . 0.9 OUTLIER -94.18 124.02 37.93 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.223 0.535 . . . . 0.0 111.086 -179.104 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 260' ' ' PHE . . . . . 0.446 ' H ' ' HA ' ' A' ' 193' ' ' ALA . 16.0 m-30 -93.12 146.48 23.63 Favored 'General case' 0 CA--C 1.508 -0.664 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.343 179.251 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 86.0 mt -122.35 149.83 43.24 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.629 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.743 ' CD1' HG13 ' A' ' 195' ' ' VAL . 2.6 p90 -77.65 -138.49 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.468 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 263' ' ' ALA . . . . . 0.661 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -52.03 77.54 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 121.04 0.448 . . . . 0.0 111.055 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 264' ' ' GLY . . . . . 0.632 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.03 104.71 0.19 Allowed Glycine 0 CA--C 1.526 0.724 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 265' ' ' ASP . . . . . 0.606 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.7 m-20 -80.57 -177.79 6.41 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 120.676 0.274 . . . . 0.0 110.92 -179.477 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -40.42 -17.69 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.891 0.377 . . . . 0.0 110.521 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 267' ' ' LYS . . . . . 0.606 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.33 -51.62 42.52 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.73 179.397 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -63.7 -46.54 84.99 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.223 179.368 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 269' ' ' ALA . . . . . 0.575 ' HB1' ' OH ' ' A' ' 273' ' ' TYR . . . -61.71 -35.11 77.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.856 179.52 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -63.07 -34.41 77.52 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.115 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.48 -43.07 13.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.231 -179.522 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 272' ' ' ILE . . . . . 0.587 ' C ' ' H ' ' A' ' 274' ' ' ALA . 4.9 tt -51.58 -33.72 15.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.827 -178.842 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 273' ' ' TYR . . . . . 0.575 ' OH ' ' HB1' ' A' ' 269' ' ' ALA . 17.1 m-85 -54.44 -1.71 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.738 -179.568 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 274' ' ' ALA . . . . . 0.587 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.8 -39.54 69.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.927 179.503 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 275' ' ' ASN . . . . . 0.582 ' O ' ' N ' ' A' ' 279' ' ' ALA . 3.2 p30 -39.52 98.02 0.16 Allowed Pre-proline 0 N--CA 1.461 0.103 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.562 -179.648 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -54.03 -43.02 61.99 Favored 'Trans proline' 0 C--N 1.304 -1.807 0 C-N-CA 122.372 2.048 . . . . 0.0 112.638 -178.788 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 89.0 mt -64.37 -42.93 95.92 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.14 0.495 . . . . 0.0 111.208 -179.708 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 90.7 mt -95.6 -1.67 49.87 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.894 -179.454 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 279' ' ' ALA . . . . . 0.582 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.34 -34.83 77.41 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.696 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.12 20.01 0.11 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.006 -179.293 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 0.49 HD23 ' HA ' ' A' ' 281' ' ' LEU . 13.9 mt -75.31 120.15 80.31 Favored Pre-proline 0 N--CA 1.452 -0.365 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.506 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -51.01 -39.35 59.92 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 122.637 2.225 . . . . 0.0 111.848 179.164 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.92 -50.53 63.8 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.092 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 75.5 t -61.43 -43.92 97.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.587 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -57.83 -41.19 81.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.237 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -91.11 0.38 57.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.212 179.599 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt 59.3 43.7 16.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.079 0.466 . . . . 0.0 110.962 179.606 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -95.1 41.62 1.09 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.33 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 53.9 t -119.22 135.63 58.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.02 0.438 . . . . 0.0 110.168 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -132.63 162.65 30.78 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 121.123 0.487 . . . . 0.0 110.634 -179.642 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.71 154.91 33.39 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.014 0.435 . . . . 0.0 110.745 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 80.8 mt -93.68 -1.58 55.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.275 -179.707 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.11 165.91 12.81 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 6.9 m -87.47 -62.35 1.52 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.839 0.352 . . . . 0.0 111.016 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 295' ' ' GLU . . . . . 0.441 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.5 mm-40 -69.25 -4.01 16.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.68 -179.75 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 25.9 p -76.89 32.51 0.14 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.654 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 297' ' ' PHE . . . . . 0.513 ' CD2' HG22 ' A' ' 70' ' ' THR . 73.2 t80 -60.39 -46.14 91.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.669 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 298' ' ' ARG . . . . . 0.617 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.2 mtt85 -81.19 135.0 35.72 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 120.998 0.427 . . . . 0.0 110.634 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.457 ' H ' HG11 ' A' ' 51' ' ' VAL . 16.8 tp -114.39 118.26 33.33 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.182 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 300' ' ' ASP . . . . . 0.635 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.0 p-10 -165.83 -176.2 3.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.507 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -47.08 -43.78 20.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.277 -179.674 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -66.64 -40.57 88.75 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.968 0.413 . . . . 0.0 110.726 179.12 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 303' ' ' SER . . . . . 0.635 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 59.7 p -55.92 -36.11 67.35 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.083 -179.17 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 304' ' ' ALA . . . . . 0.538 ' HB2' ' SD ' ' A' ' 215' ' ' MET . . . -57.37 -51.43 69.44 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.445 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 90.6 mtp -56.41 -43.67 79.58 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -66.37 -42.63 87.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.934 0.397 . . . . 0.0 110.17 178.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 307' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 303' ' ' SER . 56.1 t -63.95 -43.03 97.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.22 179.407 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 42.9 tp -59.67 -42.31 92.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.781 -179.471 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -62.6 -38.78 91.48 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 179.612 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 310' ' ' ARG . . . . . 0.432 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.6 ttt85 -63.51 -44.01 95.54 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.286 179.526 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 89.0 mt -63.21 -42.06 99.24 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.291 179.517 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt -62.87 -33.41 75.23 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.997 179.494 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.52 -23.36 22.05 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.46 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.476 HD22 ' CE2' ' A' ' 315' ' ' PHE . 6.8 tt -62.36 -43.1 99.62 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.63 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 315' ' ' PHE . . . . . 0.476 ' CE2' HD22 ' A' ' 314' ' ' LEU . 91.0 m-85 . . . . . 0 C--O 1.22 -0.482 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.449 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -99.58 136.75 39.04 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.079 0.466 . . . . 0.0 110.438 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.494 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -91.99 178.49 1.7 Allowed Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.615 -179.881 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.494 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.4 Cg_exo -61.65 146.99 96.38 Favored 'Trans proline' 0 C--N 1.299 -2.044 0 C-N-CA 122.872 2.381 . . . . 0.0 112.133 179.679 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.46 ' HE ' HD12 ' A' ' 39' ' ' LEU . 35.5 ptt180 -136.23 142.31 44.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.682 179.668 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -79.52 116.67 19.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.464 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.449 ' O ' HG23 ' A' ' 30' ' ' ILE . 9.5 tp -111.16 130.49 64.53 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.483 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 13.1 t -70.93 141.91 51.1 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.547 179.745 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.478 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.5 t0 -139.42 179.71 6.39 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.57 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.478 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 78.0 p -73.88 -37.21 64.79 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.626 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -46.37 -94.51 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.292 -179.446 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -167.2 -26.61 0.02 OUTLIER Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.934 -0.867 . . . . 0.0 110.934 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 60.0 m -168.98 104.78 0.4 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.876 0.37 . . . . 0.0 110.673 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.678 ' CD2' HD13 ' A' ' 140' ' ' LEU . 74.6 t60 -128.44 148.81 50.74 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 121.102 0.477 . . . . 0.0 110.247 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.623 HG22 ' N ' ' A' ' 39' ' ' LEU . 98.8 m -131.2 165.84 22.45 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.55 -179.816 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.623 ' N ' HG22 ' A' ' 38' ' ' THR . 82.0 mt -120.67 127.28 51.91 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.439 179.744 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -65.23 -44.45 88.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.698 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 39.5 p -165.66 154.66 11.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.44 179.678 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.478 ' CD ' ' H ' ' A' ' 42' ' ' GLN . 14.4 mp0 -44.78 101.3 0.25 Allowed Pre-proline 0 C--N 1.329 -0.315 0 O-C-N 123.376 0.422 . . . . 0.0 110.605 179.397 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -57.43 129.94 36.53 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 C-N-CA 122.357 2.038 . . . . 0.0 112.292 -179.672 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -83.88 -24.68 30.72 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.539 179.551 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.538 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.2 mtm-85 -122.07 134.9 54.77 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 121.203 0.525 . . . . 0.0 110.291 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 95.9 mt -130.64 133.73 63.05 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.883 -179.696 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 44.7 t -124.44 130.53 73.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 179.312 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.627 ' OG ' HD12 ' A' ' 117' ' ' LEU . 2.3 m -155.36 167.34 30.69 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.534 179.681 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 68.2 p -124.68 9.45 8.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.458 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.56 125.51 33.15 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.634 -179.5 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.44 HG11 ' H ' ' A' ' 299' ' ' LEU . 92.7 t -65.81 -44.52 92.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.469 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 20.0 m -62.77 -44.19 96.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.607 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 50.2 tp -62.24 -41.61 98.58 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.53 -179.502 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.444 ' O ' HD13 ' A' ' 58' ' ' LEU . 77.2 m -57.59 -44.65 85.53 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.394 -179.41 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.03 -62.33 5.3 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.884 -0.886 . . . . 0.0 110.884 179.612 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.7 t -48.4 -35.42 12.66 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.7 mt -61.88 -44.52 96.65 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.686 -0.405 . . . . 0.0 111.281 179.365 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.444 HD13 ' O ' ' A' ' 54' ' ' THR . 9.2 mp -65.18 -41.52 94.52 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.33 177.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.5 -41.26 98.53 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.983 -179.241 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.426 ' O ' HG23 ' A' ' 60' ' ' ILE . 8.1 tp -88.18 17.13 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.824 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 56.24 84.63 0.08 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.688 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.37 59.06 0.08 OUTLIER Pre-proline 0 C--N 1.328 -0.346 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -51.52 152.31 12.51 Favored 'Trans proline' 0 C--N 1.294 -2.301 0 C-N-CA 122.956 2.438 . . . . 0.0 112.254 -178.233 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.434 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.2 OUTLIER -108.55 145.31 15.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.37 -179.728 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.8 mt -63.56 -45.4 97.77 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.414 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.5 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -129.57 134.19 47.6 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.848 0.356 . . . . 0.0 110.495 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.493 ' O ' ' N ' ' A' ' 98' ' ' LEU . 74.8 m -134.48 158.56 43.6 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.849 -179.617 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.82 139.13 16.12 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.689 -0.964 . . . . 0.0 110.689 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.497 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.84 -162.77 0.08 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.971 0.415 . . . . 0.0 110.479 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.535 HG22 ' CD2' ' A' ' 297' ' ' PHE . 14.7 t -133.49 135.02 44.21 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.382 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.487 ' C ' ' O ' ' A' ' 70' ' ' THR . 0.7 OUTLIER 29.73 68.57 0.66 Allowed Pre-proline 0 N--CA 1.464 0.26 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.801 -179.87 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_exo -60.98 145.64 98.84 Favored 'Trans proline' 0 C--N 1.299 -2.035 0 C-N-CA 122.648 2.232 . . . . 0.0 111.981 -178.355 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.534 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 46.1 p-10 -160.11 -32.63 0.06 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.639 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.537 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 99.2 m-20 -63.71 -39.74 95.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.451 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 73.1 ttt180 -60.13 -48.08 83.24 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.728 -179.206 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.423 ' O ' ' O ' ' A' ' 77' ' ' ALA . 94.4 t -60.35 -24.73 31.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.088 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.537 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -45.76 172.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.599 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.571 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.9 p30 -62.07 177.74 0.43 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.522 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.558 ' C ' ' H ' ' A' ' 81' ' ' GLY . 35.4 p30 -45.61 85.67 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.033 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.571 ' N ' ' O ' ' A' ' 78' ' ' ASP . 43.4 tp60 -67.63 13.45 0.07 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.149 0.5 . . . . 0.0 110.135 -179.735 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.558 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 118.32 -22.1 9.72 Favored Glycine 0 CA--C 1.519 0.282 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -107.86 116.61 32.26 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.975 0.417 . . . . 0.0 110.474 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 74.4 mt -98.77 -0.14 43.25 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.937 0.399 . . . . 0.0 110.494 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -92.13 7.08 44.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.98 0.419 . . . . 0.0 110.452 -179.726 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.788 ' O ' HG22 ' A' ' 89' ' ' VAL . 27.1 mt-30 -100.42 -27.76 13.28 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.815 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.8 t-105 -63.73 -40.51 96.93 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.093 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.56 ' O ' ' N ' ' A' ' 91' ' ' LYS . 63.7 m -78.15 -54.16 6.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.118 -179.481 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -47.64 -50.51 24.31 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.06 -179.332 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.788 HG22 ' O ' ' A' ' 85' ' ' GLN . 14.9 m -69.29 -40.75 80.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.066 179.698 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.499 ' N ' HG23 ' A' ' 89' ' ' VAL . . . -72.3 -22.64 61.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.66 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.56 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.0 tttm -62.23 -45.5 93.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.422 -179.494 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.441 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.8 mm-40 -90.51 -94.37 0.12 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.153 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.628 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.9 mtt180 -143.13 58.72 1.41 Allowed 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.457 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.6 pttp 33.44 26.43 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.195 -179.226 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.628 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.4 tt -48.25 123.29 6.23 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.986 -178.092 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.455 ' O ' HD23 ' A' ' 95' ' ' LEU . 99.0 mm-40 -83.68 -169.62 2.65 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.122 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.605 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 81.4 mtp180 -74.42 137.32 42.57 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.303 -179.805 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.493 ' N ' ' O ' ' A' ' 67' ' ' SER . 90.6 mt -86.21 -165.85 1.38 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.74 -179.659 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.538 ' O ' ' CD2' ' A' ' 99' ' ' TYR . 48.4 p90 -168.74 119.77 0.76 Allowed 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.207 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.511 ' C ' ' O ' ' A' ' 99' ' ' TYR . 43.0 mm -28.67 120.74 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.085 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 114.38 27.48 3.35 Favored Glycine 0 CA--C 1.519 0.34 0 N-CA-C 111.196 -0.762 . . . . 0.0 111.196 -179.46 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.576 ' CD ' ' H ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -144.47 46.6 0.64 Allowed Pre-proline 0 C--N 1.323 -0.554 0 CA-C-O 120.979 0.419 . . . . 0.0 110.447 179.861 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 29.0 Cg_endo -62.04 144.01 95.64 Favored 'Trans proline' 0 C--N 1.296 -2.224 0 C-N-CA 122.702 2.268 . . . . 0.0 111.865 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.459 ' O ' HG23 ' A' ' 108' ' ' VAL . 26.7 t -173.24 120.23 0.34 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.423 179.718 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.83 -40.4 63.35 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.054 0.454 . . . . 0.0 111.085 179.639 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.23 -40.06 90.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.888 -179.455 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.14 -39.97 95.15 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.677 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 104' ' ' SER . 70.4 t -67.71 -43.72 86.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.731 179.705 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.74 -38.96 92.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.53 -179.26 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.441 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.65 -23.35 62.97 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.49 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.547 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.5 mm-40 -90.5 5.14 48.91 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.714 -179.555 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.547 ' C ' ' O ' ' A' ' 111' ' ' GLN . 10.6 tpt 23.27 64.33 0.37 Allowed Pre-proline 0 N--CA 1.464 0.261 0 CA-C-O 120.935 0.398 . . . . 0.0 111.077 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -78.61 167.5 22.52 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 123.062 2.508 . . . . 0.0 111.861 -178.172 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.521 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 99.0 m-20 -109.97 -42.27 4.26 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.182 179.474 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.6 tp -121.04 120.66 36.01 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 179.635 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 83.8 mt -113.44 129.0 70.0 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.39 0 CA-C-O 120.98 0.419 . . . . 0.0 110.903 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.627 HD12 ' OG ' ' A' ' 48' ' ' SER . 30.2 mt -109.18 132.27 54.28 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 121.084 0.469 . . . . 0.0 110.235 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.491 HD12 HG23 ' A' ' 139' ' ' THR . 99.0 mt -119.84 138.75 49.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.719 -179.752 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 84.9 p -72.51 153.61 41.25 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.598 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.18 -50.12 74.94 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.678 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -149.44 154.01 38.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.55 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 170.58 -170.99 43.49 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -63.09 -34.16 89.21 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.866 -0.893 . . . . 0.0 110.866 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.45 ' OD1' ' O ' ' A' ' 124' ' ' ASP . 44.3 p-10 -86.82 120.45 28.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.837 0.351 . . . . 0.0 110.705 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.443 ' O ' HD12 ' A' ' 129' ' ' LEU . 38.9 t -63.23 143.48 57.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.029 0.443 . . . . 0.0 110.495 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.52 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -92.97 -43.18 9.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.972 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.9 tp -62.85 -42.45 99.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.703 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.66 -11.83 59.13 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.53 -179.36 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.443 HD12 ' O ' ' A' ' 125' ' ' SER . 84.8 mt -114.97 -23.86 8.88 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.659 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' TYR . . . . . 0.52 ' N ' ' O ' ' A' ' 126' ' ' ALA . 80.6 t80 -51.13 -49.55 60.6 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.537 -178.868 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.0 p-10 -66.13 -42.41 89.18 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.823 0.344 . . . . 0.0 111.239 179.486 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.519 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 88.2 mt-30 -67.16 -37.81 84.41 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.813 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.431 HD12 HD11 ' A' ' 118' ' ' ILE . 96.0 mt -80.36 -41.38 24.81 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.965 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.2 t -57.23 -44.57 83.91 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.218 -179.109 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.7 m -61.97 -45.23 94.56 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.511 179.456 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 94.0 mt -62.09 -43.64 97.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.279 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.66 ' HB1' ' HD2' ' A' ' 138' ' ' PRO . . . -169.44 168.22 4.96 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.56 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.66 ' HD2' ' HB1' ' A' ' 137' ' ' ALA . 52.3 Cg_exo -49.57 112.82 0.76 Allowed 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.323 2.015 . . . . 0.0 112.282 179.214 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.491 HG23 HD12 ' A' ' 118' ' ' ILE . 23.5 m -84.49 127.53 34.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.617 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.678 HD13 ' CD2' ' A' ' 37' ' ' HIS . 34.7 tp -118.22 137.0 53.31 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.079 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.44 ' O ' ' OD2' ' A' ' 32' ' ' ASP . 81.3 mt -101.26 118.94 48.76 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.353 0 CA-C-O 121.226 0.536 . . . . 0.0 111.222 -179.419 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.431 HD12 HD22 ' A' ' 117' ' ' LEU . 98.1 mt -134.78 132.04 53.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.588 179.676 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.475 ' ND2' ' OD2' ' A' ' 241' ' ' ASP . 2.1 t-20 -66.28 151.82 46.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.895 0.378 . . . . 0.0 110.413 179.419 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.521 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 88.1 t80 -86.69 122.54 30.73 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.808 -179.581 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.521 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 99.0 m-20 55.31 69.13 0.77 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.788 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 35.9 p-10 -125.9 0.17 7.3 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.652 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -150.54 115.12 5.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.715 -179.491 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 83.9 p -63.29 168.2 4.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.602 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.417 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.7 p-90 -51.88 -15.79 0.59 Allowed 'General case' 0 C--O 1.223 -0.334 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.467 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.44 ' O ' HG23 ' A' ' 154' ' ' THR . 68.1 tp60 -70.52 -76.04 0.11 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.474 -179.673 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.444 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.1 t -62.7 -38.61 91.08 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.255 179.543 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 54.3 tp -59.93 -45.84 91.3 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.412 -178.572 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.417 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 46.7 tp -62.67 -41.64 99.19 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.497 179.011 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.444 ' OG1' ' O ' ' A' ' 151' ' ' SER . 60.1 p -64.1 -34.79 78.85 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.273 -179.482 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.415 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.9 mm-40 -64.19 -42.77 96.53 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.311 179.35 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 91.8 mt -65.37 -38.73 90.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.148 0.499 . . . . 0.0 110.268 179.122 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.579 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.23 -32.47 80.75 Favored Glycine 0 CA--C 1.519 0.317 0 N-CA-C 110.712 -0.955 . . . . 0.0 110.712 -179.306 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 157' ' ' GLY . 97.2 mt-10 -35.45 -26.93 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.828 0.347 . . . . 0.0 110.837 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.579 ' N ' ' O ' ' A' ' 157' ' ' GLY . 95.3 mt -56.46 149.81 3.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.295 179.197 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 77.1 p -69.61 137.21 52.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.997 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 71.1 21.17 78.37 Favored Glycine 0 N--CA 1.459 0.19 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 179.476 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 58.1 m80 -122.47 -14.94 7.72 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.702 0.286 . . . . 0.0 110.529 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -65.96 -59.74 3.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.748 -179.717 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -52.26 -49.3 64.34 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.209 -179.601 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -60.54 -41.22 94.05 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.957 -0.297 . . . . 0.0 110.379 179.468 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.49 -47.12 87.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.541 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.97 -40.14 75.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.244 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -61.82 -50.27 72.96 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.576 179.572 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -65.17 -43.86 90.36 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.531 179.472 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 94.6 mt -64.78 -43.29 96.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.402 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.28 -51.23 70.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.475 -179.172 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.43 -43.86 96.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.543 179.665 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.654 ' CE2' HD11 ' A' ' 177' ' ' LEU . 57.0 t80 -62.75 -44.4 96.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.06 0.457 . . . . 0.0 110.443 179.451 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -63.32 -39.8 95.56 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.617 -179.382 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -63.01 -42.76 99.9 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.599 179.223 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -60.72 -44.6 96.42 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.184 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.654 HD11 ' CE2' ' A' ' 173' ' ' PHE . 84.1 mt -64.54 -40.96 96.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.014 0.435 . . . . 0.0 110.707 178.893 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.18 -62.46 1.62 Allowed 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.368 -179.298 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.52 -46.86 85.89 Favored 'General case' 0 C--O 1.227 -0.128 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.628 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.13 -41.85 65.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.276 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -63.74 -33.79 76.43 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.982 0.42 . . . . 0.0 110.411 179.262 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.422 ' O ' ' HG2' ' A' ' 182' ' ' GLU . 69.6 tt0 -90.51 8.83 31.92 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.46 0.648 . . . . 0.0 110.508 -178.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -104.99 -32.07 8.92 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.174 179.559 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.9 pt -127.98 147.63 32.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.822 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -139.93 131.09 26.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.357 179.286 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.593 HD22 ' N ' ' A' ' 186' ' ' LEU . 3.6 mm? -85.35 133.34 42.64 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.979 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -43.93 157.82 0.14 Allowed 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.69 2.26 . . . . 0.0 112.191 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 0.521 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.9 Cg_endo -63.1 115.11 2.77 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 C-N-CA 122.795 2.33 . . . . 0.0 111.696 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 189' ' ' GLN . . . . . 0.521 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.8 mt-30 155.16 147.86 0.0 OUTLIER Pre-proline 0 C--N 1.332 -0.162 0 O-C-N 123.791 0.682 . . . . 0.0 110.832 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -73.49 144.11 35.65 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.667 2.245 . . . . 0.0 112.159 177.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.496 HG23 ' OG ' ' A' ' 258' ' ' SER . 2.1 p -125.04 158.98 32.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.291 0.567 . . . . 0.0 110.185 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 192' ' ' THR . . . . . 0.494 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 37.5 p -143.3 165.39 27.6 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.106 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 193' ' ' ALA . . . . . 0.45 ' HA ' ' H ' ' A' ' 260' ' ' PHE . . . -135.4 128.69 32.05 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.234 0.54 . . . . 0.0 110.231 179.431 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.504 HD11 HD23 ' A' ' 259' ' ' LEU . 47.6 pt -146.3 148.71 16.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.165 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 195' ' ' VAL . . . . . 0.749 HG13 ' CD1' ' A' ' 262' ' ' PHE . 70.4 t -117.51 123.01 71.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.282 0.563 . . . . 0.0 109.71 179.083 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -134.47 107.51 7.6 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.331 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 94.3 m -131.01 130.71 43.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.845 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -82.82 -37.02 25.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.231 179.682 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.55 -67.17 0.26 Allowed 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.359 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.33 -9.76 58.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.342 179.583 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 60.1 t-80 60.43 58.3 2.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.774 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 39.4 p -166.8 153.2 8.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.586 179.445 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.28 144.09 24.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.005 0.431 . . . . 0.0 110.421 179.419 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -135.3 137.87 42.9 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.619 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 19.6 mt -105.98 125.42 50.97 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.061 0.458 . . . . 0.0 109.81 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 206' ' ' TRP . . . . . 0.555 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 75.6 m95 -82.09 167.15 19.07 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.685 -179.752 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 207' ' ' THR . . . . . 0.466 HG22 ' C ' ' A' ' 206' ' ' TRP . 0.1 OUTLIER -156.99 171.38 7.53 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.624 -179.189 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -53.57 -37.22 82.85 Favored 'Trans proline' 0 C--N 1.302 -1.902 0 C-N-CA 122.661 2.24 . . . . 0.0 112.27 179.214 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -70.52 -34.88 72.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.813 -179.738 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 22.8 m -61.19 150.72 33.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.637 -179.396 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.52 -36.95 81.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.485 -179.715 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 212' ' ' GLN . . . . . 0.555 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 54.8 tt0 -64.78 -40.11 94.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.506 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.8 -43.41 91.74 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -63.33 -43.74 96.92 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.791 0.329 . . . . 0.0 110.29 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 215' ' ' MET . . . . . 0.522 ' SD ' ' HB2' ' A' ' 304' ' ' ALA . 65.1 ttp -59.39 -48.18 82.63 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.238 -179.789 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 88.2 mt -60.37 -40.9 92.49 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 179.602 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 217' ' ' GLU . . . . . 0.456 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 40.9 tp10 -57.96 -38.03 75.25 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -65.17 -37.92 88.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.67 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 94.5 mt -64.4 -42.72 95.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.141 0.496 . . . . 0.0 110.583 -179.696 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.56 44.63 0.08 OUTLIER Glycine 0 C--N 1.334 0.417 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 221' ' ' PHE . . . . . 0.456 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 25.9 m-85 -127.68 155.19 44.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.04 0.447 . . . . 0.0 110.471 -179.76 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.481 ' O ' HG13 ' A' ' 191' ' ' VAL . 6.1 p -107.05 122.35 46.29 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.272 0.558 . . . . 0.0 110.116 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.473 HD22 ' C ' ' A' ' 222' ' ' THR . 4.3 mm? -101.25 133.04 46.42 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.068 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -97.17 159.53 14.86 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.488 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.21 115.32 30.06 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.399 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.496 HD12 ' N ' ' A' ' 226' ' ' LEU . 9.0 mp -53.62 156.84 4.21 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.689 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -59.86 145.21 98.84 Favored 'Trans proline' 0 C--N 1.302 -1.916 0 C-N-CA 122.65 2.233 . . . . 0.0 112.19 179.237 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.64 -2.73 58.81 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.559 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.46 -40.68 5.65 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.535 ' O ' ' N ' ' A' ' 233' ' ' SER . 86.1 mt -79.13 -16.74 56.22 Favored 'General case' 0 C--O 1.222 -0.379 0 CA-C-O 121.02 0.438 . . . . 0.0 110.383 -179.774 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 231' ' ' ASN . . . . . 0.402 ' C ' ' O ' ' A' ' 230' ' ' LEU . 54.4 t-20 -40.29 -49.07 2.73 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.777 -179.421 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -88.24 15.44 7.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.368 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.535 ' N ' ' O ' ' A' ' 230' ' ' LEU . 77.8 p -60.52 -35.52 76.18 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.622 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 234' ' ' GLN . . . . . 0.523 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.6 tt0 -118.27 -69.37 0.85 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.958 179.508 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 3.9 m -70.39 103.03 2.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.679 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -93.99 57.92 2.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.398 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -145.12 -122.28 1.52 Allowed Glycine 0 CA--C 1.519 0.343 0 N-CA-C 110.989 -0.845 . . . . 0.0 110.989 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -134.56 111.68 10.26 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 121.114 0.483 . . . . 0.0 110.433 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 239' ' ' ARG . . . . . 0.51 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.3 mtt180 -148.12 57.24 1.08 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.696 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -69.74 -31.99 70.27 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.511 179.608 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 241' ' ' ASP . . . . . 0.475 ' OD2' ' ND2' ' A' ' 143' ' ' ASN . 65.1 t0 -56.83 -46.93 81.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.379 -179.07 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 242' ' ' ILE . . . . . 0.437 ' O ' ' O ' ' A' ' 239' ' ' ARG . 17.5 tt -140.02 156.76 25.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.888 0.375 . . . . 0.0 110.537 179.719 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.438 HG22 HD13 ' A' ' 245' ' ' LEU . 96.0 mt -105.8 105.9 19.56 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.218 0 CA-C-O 121.122 0.487 . . . . 0.0 110.511 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 244' ' ' GLN . . . . . 0.602 ' O ' HD12 ' A' ' 245' ' ' LEU . 88.3 mt-30 -110.23 110.03 20.72 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.344 179.704 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.602 HD12 ' O ' ' A' ' 244' ' ' GLN . 9.6 mp -121.86 -168.23 1.67 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.663 179.692 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 246' ' ' GLY . . . . . 0.523 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.28 -16.8 0.05 OUTLIER Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 247' ' ' GLY . . . . . 0.669 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -60.44 157.17 29.42 Favored Glycine 0 CA--C 1.522 0.49 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 -179.81 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -63.86 21.68 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.99 0.424 . . . . 0.0 110.619 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 249' ' ' ASN . . . . . 0.669 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.7 m-20 -97.43 -5.82 35.32 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.517 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 91.9 mt -80.28 -21.48 42.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.672 179.46 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.66 -51.36 70.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.702 -179.574 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.43 -5.19 58.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.453 179.643 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.15 -74.2 1.15 Allowed Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 80.4 mt -70.09 125.73 27.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.979 0.418 . . . . 0.0 110.274 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -59.7 -39.15 83.65 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.492 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 84.1 51.74 3.86 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 110.712 -0.955 . . . . 0.0 110.712 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -94.87 -16.2 23.09 Favored 'General case' 0 C--N 1.332 -0.191 0 O-C-N 122.651 -0.323 . . . . 0.0 110.654 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 258' ' ' SER . . . . . 0.496 ' OG ' HG23 ' A' ' 191' ' ' VAL . 3.3 t 174.06 89.53 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.074 0.464 . . . . 0.0 110.18 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.863 HD12 ' N ' ' A' ' 259' ' ' LEU . 1.0 OUTLIER -94.47 124.35 38.44 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.275 0.559 . . . . 0.0 111.079 -179.084 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 260' ' ' PHE . . . . . 0.45 ' H ' ' HA ' ' A' ' 193' ' ' ALA . 16.0 m-30 -93.49 146.64 23.62 Favored 'General case' 0 CA--C 1.504 -0.793 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.441 179.262 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 85.9 mt -122.46 149.91 43.22 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.567 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.749 ' CD1' HG13 ' A' ' 195' ' ' VAL . 2.6 p90 -77.61 -138.4 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.541 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 263' ' ' ALA . . . . . 0.657 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -52.24 77.51 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.048 0.452 . . . . 0.0 111.078 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 264' ' ' GLY . . . . . 0.625 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.17 104.35 0.18 Allowed Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 265' ' ' ASP . . . . . 0.601 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.8 m-20 -80.28 -177.89 6.34 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 120.685 0.279 . . . . 0.0 110.908 -179.478 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -40.44 -17.52 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.567 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 267' ' ' LYS . . . . . 0.601 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.62 -51.45 42.1 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.617 179.502 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -63.79 -46.64 84.28 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.171 179.401 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 269' ' ' ALA . . . . . 0.566 ' HB1' ' OH ' ' A' ' 273' ' ' TYR . . . -61.58 -34.99 76.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.247 0.546 . . . . 0.0 109.866 179.653 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -63.13 -34.42 77.58 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.17 179.705 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.43 -43.31 13.73 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.218 -179.517 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 272' ' ' ILE . . . . . 0.588 ' C ' ' H ' ' A' ' 274' ' ' ALA . 4.9 tt -51.42 -33.72 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.863 -178.884 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 273' ' ' TYR . . . . . 0.566 ' OH ' ' HB1' ' A' ' 269' ' ' ALA . 17.4 m-85 -54.31 -1.88 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.649 -179.587 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 274' ' ' ALA . . . . . 0.588 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.64 -39.66 70.22 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.95 179.561 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 275' ' ' ASN . . . . . 0.586 ' O ' ' N ' ' A' ' 279' ' ' ALA . 4.2 p30 -39.12 97.86 0.15 Allowed Pre-proline 0 N--CA 1.462 0.174 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.458 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -54.55 -42.97 63.27 Favored 'Trans proline' 0 C--N 1.303 -1.831 0 C-N-CA 122.372 2.048 . . . . 0.0 112.552 -178.7 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 88.9 mt -64.45 -42.97 95.66 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.128 0.49 . . . . 0.0 111.211 -179.744 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 90.8 mt -95.71 -1.38 50.09 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.923 -179.485 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 279' ' ' ALA . . . . . 0.586 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.19 -34.74 77.02 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.714 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.21 19.8 0.12 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.018 -179.27 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 0.487 HD23 ' HA ' ' A' ' 281' ' ' LEU . 13.9 mt -75.08 120.14 80.27 Favored Pre-proline 0 N--CA 1.451 -0.423 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.575 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -49.97 -39.81 49.75 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.625 2.216 . . . . 0.0 112.154 178.769 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.52 -50.56 62.57 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.084 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 79.9 t -61.79 -43.8 97.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 179.538 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -57.88 -41.77 83.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.317 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -90.43 0.33 57.34 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.119 179.724 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt 59.04 41.19 21.17 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.773 179.661 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -92.89 42.18 1.09 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.355 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 53.7 t -119.1 135.67 58.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.014 0.435 . . . . 0.0 110.246 -179.731 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -133.05 162.74 30.9 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.656 -179.626 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.77 154.96 33.42 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.965 0.412 . . . . 0.0 110.747 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 81.8 mt -93.75 -1.46 55.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.231 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.59 165.52 12.62 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 110.58 -1.008 . . . . 0.0 110.58 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 7.1 m -87.38 -62.27 1.54 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.89 0.376 . . . . 0.0 111.004 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 295' ' ' GLU . . . . . 0.438 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.5 mm-40 -69.62 -3.97 17.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.636 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 26.2 p -76.81 33.14 0.14 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.648 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 297' ' ' PHE . . . . . 0.535 ' CD2' HG22 ' A' ' 70' ' ' THR . 85.0 t80 -60.21 -46.03 91.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.477 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 298' ' ' ARG . . . . . 0.605 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.2 mtt85 -81.73 133.76 35.38 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.568 -179.726 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.44 ' H ' HG11 ' A' ' 51' ' ' VAL . 16.1 tp -114.07 119.75 38.2 Favored 'General case' 0 C--O 1.231 0.083 0 CA-C-O 120.992 0.425 . . . . 0.0 110.205 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 300' ' ' ASP . . . . . 0.622 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.2 p-10 -167.43 -174.15 2.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.551 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 84.0 t80 -48.23 -45.81 34.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.215 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -64.7 -41.48 95.99 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.033 0.444 . . . . 0.0 110.689 178.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 303' ' ' SER . . . . . 0.622 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 53.1 p -55.53 -36.09 66.37 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.954 -179.073 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 304' ' ' ALA . . . . . 0.522 ' HB2' ' SD ' ' A' ' 215' ' ' MET . . . -56.71 -51.76 67.57 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.442 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 91.0 mtp -56.13 -43.89 78.62 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -66.3 -42.81 87.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.008 0.432 . . . . 0.0 110.246 178.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 307' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 303' ' ' SER . 55.5 t -64.02 -42.77 96.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.211 179.44 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 42.3 tp -59.65 -42.29 92.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.791 -179.519 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -62.54 -38.76 91.28 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.149 179.446 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 310' ' ' ARG . . . . . 0.442 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.6 ttt85 -63.54 -43.95 95.61 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.229 179.606 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 88.3 mt -63.15 -42.15 99.39 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.303 179.57 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -62.84 -33.22 74.79 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.04 179.474 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.94 -23.51 21.55 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.377 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.478 HD22 ' CE2' ' A' ' 315' ' ' PHE . 6.8 tt -62.31 -43.19 99.39 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 121.092 0.473 . . . . 0.0 110.623 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 315' ' ' PHE . . . . . 0.478 ' CE2' HD22 ' A' ' 314' ' ' LEU . 90.8 m-85 . . . . . 0 C--O 1.22 -0.475 0 CA-C-O 118.005 -0.997 . . . . 0.0 110.42 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -99.41 135.58 40.61 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.087 0.47 . . . . 0.0 110.502 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.495 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.2 OUTLIER -92.14 178.42 1.71 Allowed Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.549 -179.842 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.495 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.3 Cg_exo -61.74 147.47 95.24 Favored 'Trans proline' 0 C--N 1.3 -2.024 0 C-N-CA 122.776 2.317 . . . . 0.0 112.168 179.603 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.482 ' HE ' HD12 ' A' ' 39' ' ' LEU . 35.2 ptt180 -136.12 142.33 44.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.735 179.682 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -79.83 116.79 20.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.406 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.447 ' O ' HG23 ' A' ' 30' ' ' ILE . 9.5 tp -111.54 130.71 64.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.411 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.1 t -71.19 142.62 50.64 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.623 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.479 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.7 t0 -139.84 179.86 6.35 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.564 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.479 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 77.9 p -73.86 -37.26 64.82 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.707 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.7 ttt85 -46.83 -94.62 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.309 -179.358 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -166.3 -26.8 0.02 OUTLIER Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 56.9 m -168.87 105.69 0.42 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.892 0.377 . . . . 0.0 110.621 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.653 ' CD2' HD13 ' A' ' 140' ' ' LEU . 69.6 t60 -128.77 147.03 50.75 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.053 0.454 . . . . 0.0 110.262 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.623 HG22 ' N ' ' A' ' 39' ' ' LEU . 99.9 m -130.05 165.73 21.6 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.582 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.623 ' N ' HG22 ' A' ' 38' ' ' THR . 80.8 mt -120.35 127.33 52.23 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.481 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -65.43 -44.62 86.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.693 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 41.2 p -165.89 155.23 11.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.46 179.61 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.489 ' CD ' ' H ' ' A' ' 42' ' ' GLN . 15.1 mp0 -45.25 101.63 0.27 Allowed Pre-proline 0 C--N 1.329 -0.295 0 O-C-N 123.388 0.43 . . . . 0.0 110.659 179.327 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -57.96 129.58 33.96 Favored 'Trans proline' 0 C--N 1.303 -1.82 0 C-N-CA 122.269 1.979 . . . . 0.0 112.231 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -82.33 -25.2 34.11 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.478 179.605 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.534 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.7 mtm-85 -120.87 134.39 55.29 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-O 121.194 0.521 . . . . 0.0 110.252 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.1 mt -129.69 133.06 65.59 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.313 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.034 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 46.0 t -124.71 130.9 73.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 179.403 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.622 ' OG ' HD12 ' A' ' 117' ' ' LEU . 4.4 m -154.99 166.5 33.4 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.541 179.578 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 66.0 p -124.27 8.99 8.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.805 0.336 . . . . 0.0 110.439 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.72 125.82 33.5 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.668 -179.514 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.471 HG11 ' H ' ' A' ' 299' ' ' LEU . 85.7 t -65.81 -44.55 92.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.547 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 18.9 m -62.63 -44.35 96.51 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.615 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 53.5 tp -62.26 -41.54 98.54 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.503 -179.403 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.45 ' O ' HD13 ' A' ' 58' ' ' LEU . 73.3 m -57.85 -44.54 86.6 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.257 -179.271 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.39 -62.01 5.48 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 179.706 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.7 t -48.74 -35.25 13.74 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.9 mt -61.8 -44.38 96.98 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.586 -0.445 . . . . 0.0 111.325 179.13 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.45 HD13 ' O ' ' A' ' 54' ' ' THR . 9.4 mp -64.74 -41.95 95.55 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.384 177.765 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.406 ' HB1' ' NE ' ' A' ' 169' ' ' ARG . . . -63.67 -41.03 98.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.033 -179.196 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.426 ' O ' HG23 ' A' ' 60' ' ' ILE . 8.0 tp -88.11 16.77 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.798 -179.726 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 56.38 84.56 0.08 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.696 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.14 58.21 0.07 OUTLIER Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.287 -0.415 . . . . 0.0 109.904 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -50.58 152.76 8.67 Favored 'Trans proline' 0 C--N 1.293 -2.365 0 C-N-CA 122.84 2.36 . . . . 0.0 112.404 -178.509 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.432 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -108.78 145.83 15.18 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.219 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.239 -179.716 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 97.0 mt -63.75 -45.06 98.32 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.366 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.559 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.501 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -130.02 134.49 47.44 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 120.836 0.351 . . . . 0.0 110.588 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.497 ' O ' ' N ' ' A' ' 98' ' ' LEU . 73.6 m -134.74 158.71 43.44 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.893 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -87.2 139.54 16.2 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.491 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.72 -162.75 0.08 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.003 0.43 . . . . 0.0 110.453 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.513 HG22 ' CD2' ' A' ' 297' ' ' PHE . 14.0 t -133.47 135.15 44.33 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.324 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.486 ' C ' ' O ' ' A' ' 70' ' ' THR . 0.1 OUTLIER 29.77 68.51 0.67 Allowed Pre-proline 0 N--CA 1.466 0.353 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.765 -179.883 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_exo -60.96 145.21 99.4 Favored 'Trans proline' 0 C--N 1.299 -2.047 0 C-N-CA 122.613 2.208 . . . . 0.0 112.017 -178.299 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.524 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 45.5 p-10 -159.83 -32.6 0.06 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.65 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.54 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 99.0 m-20 -64.0 -39.56 94.39 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.485 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.6 ttt180 -60.65 -47.87 84.29 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.721 -179.187 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.421 ' O ' ' O ' ' A' ' 77' ' ' ALA . 89.2 t -60.58 -24.59 32.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.54 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -45.85 172.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.581 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.569 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.6 p30 -61.85 177.58 0.42 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.551 -179.746 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.56 ' C ' ' H ' ' A' ' 81' ' ' GLY . 35.5 p30 -45.61 85.84 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.049 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.569 ' N ' ' O ' ' A' ' 78' ' ' ASP . 43.3 tp60 -67.34 13.32 0.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.232 0.539 . . . . 0.0 110.101 -179.713 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.56 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 118.04 -22.12 9.91 Favored Glycine 0 C--N 1.332 0.321 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -107.79 116.25 31.62 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.014 0.435 . . . . 0.0 110.419 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 77.6 mt -98.87 0.57 44.47 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.498 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -92.04 6.72 45.36 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.033 0.444 . . . . 0.0 110.327 -179.622 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.794 ' O ' HG22 ' A' ' 89' ' ' VAL . 27.2 mt-30 -100.05 -27.73 13.41 Favored 'General case' 0 C--O 1.223 -0.329 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.869 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 68.7 t-105 -63.08 -40.81 98.77 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.902 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.554 ' O ' ' N ' ' A' ' 91' ' ' LYS . 68.0 m -77.44 -53.44 7.63 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.272 -179.486 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -48.57 -50.73 31.04 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.039 -179.279 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.794 HG22 ' O ' ' A' ' 85' ' ' GLN . 15.5 m -68.87 -40.8 81.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 120.97 0.414 . . . . 0.0 111.175 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.498 ' N ' HG23 ' A' ' 89' ' ' VAL . . . -72.06 -23.05 61.3 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.763 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.554 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.0 tttm -61.51 -45.89 92.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.42 -179.439 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.444 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.8 mm-40 -90.38 -94.59 0.12 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.048 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.622 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.8 mtt180 -143.35 59.97 1.4 Allowed 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.456 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.6 pttp 33.73 26.46 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 120.861 0.362 . . . . 0.0 110.12 -179.525 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.622 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.5 tt -48.49 123.19 6.29 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.081 -178.026 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.456 ' O ' HD23 ' A' ' 95' ' ' LEU . 99.0 mm-40 -83.69 -170.18 2.94 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.007 -179.763 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.62 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 82.2 mtp180 -73.29 137.77 45.06 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.197 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.497 ' N ' ' O ' ' A' ' 67' ' ' SER . 89.3 mt -86.26 -166.15 1.46 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.777 -179.764 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.532 ' O ' ' CD2' ' A' ' 99' ' ' TYR . 47.5 p90 -168.01 119.65 0.84 Allowed 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.234 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.505 ' C ' ' O ' ' A' ' 99' ' ' TYR . 42.8 mm -29.4 120.98 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.058 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 113.92 28.03 3.28 Favored Glycine 0 C--N 1.332 0.323 0 N-CA-C 111.176 -0.77 . . . . 0.0 111.176 -179.361 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.582 ' N ' ' CD ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -143.93 45.94 0.61 Allowed Pre-proline 0 C--N 1.323 -0.566 0 O-C-N 122.481 -0.423 . . . . 0.0 110.434 179.816 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.582 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 30.2 Cg_endo -61.95 143.8 95.77 Favored 'Trans proline' 0 C--N 1.296 -2.229 0 C-N-CA 122.669 2.246 . . . . 0.0 111.971 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.46 ' O ' HG23 ' A' ' 108' ' ' VAL . 26.7 t -173.17 120.43 0.35 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.463 179.637 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.1 -41.0 64.53 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.069 0.462 . . . . 0.0 111.157 179.567 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -65.8 -39.92 91.38 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.85 -179.451 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.94 -39.67 94.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.751 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 104' ' ' SER . 70.6 t -67.4 -43.88 87.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.769 179.572 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.52 -39.11 92.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.574 -179.211 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.444 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.63 -23.85 63.35 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.448 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.554 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.3 mm-40 -91.23 4.71 51.59 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.695 -179.592 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.554 ' C ' ' O ' ' A' ' 111' ' ' GLN . 10.4 tpt 22.11 64.29 0.32 Allowed Pre-proline 0 N--CA 1.466 0.345 0 CA-C-O 120.937 0.398 . . . . 0.0 111.154 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.446 ' HG2' HD11 ' A' ' 116' ' ' ILE . 67.7 Cg_endo -78.85 169.8 18.98 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 123.072 2.515 . . . . 0.0 112.085 -178.252 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.518 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 98.8 m-20 -112.3 -44.82 3.34 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.222 -0.444 . . . . 0.0 109.974 179.63 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.2 tp -119.96 120.88 37.67 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.727 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.45 HD13 HD22 ' A' ' 133' ' ' LEU . 96.6 mt -117.82 131.36 70.79 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.417 0 CA-C-O 120.957 0.408 . . . . 0.0 110.985 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.622 HD12 ' OG ' ' A' ' 48' ' ' SER . 33.4 mt -106.17 132.2 52.51 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.117 0.484 . . . . 0.0 110.051 -179.405 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.498 HD12 HG23 ' A' ' 139' ' ' THR . 98.4 mt -117.49 135.93 56.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.791 -179.687 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 85.4 p -71.37 151.79 43.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.521 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.28 -49.94 75.61 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.712 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -149.33 153.7 37.85 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.544 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 168.7 -169.35 41.66 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -63.08 -35.41 92.05 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.452 ' OD1' ' O ' ' A' ' 124' ' ' ASP . 44.4 p-10 -88.62 120.02 29.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.839 0.352 . . . . 0.0 110.694 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.443 ' O ' HD12 ' A' ' 129' ' ' LEU . 40.7 t -63.47 144.35 57.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.012 0.434 . . . . 0.0 110.526 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.521 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.32 -42.82 9.1 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.012 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.6 tp -62.65 -42.34 99.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.657 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.05 -10.83 56.88 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.508 -179.416 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.443 HD12 ' O ' ' A' ' 125' ' ' SER . 85.5 mt -115.82 -23.96 8.4 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.62 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' TYR . . . . . 0.521 ' N ' ' O ' ' A' ' 126' ' ' ALA . 73.2 t80 -51.83 -48.9 63.72 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.569 -0.452 . . . . 0.0 110.537 -178.843 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.53 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 39.4 p-10 -66.17 -41.67 89.98 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.885 0.374 . . . . 0.0 111.34 179.26 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.53 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 87.9 mt-30 -67.83 -37.33 81.77 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.874 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.464 HD12 HD11 ' A' ' 118' ' ' ILE . 97.1 mt -79.65 -42.57 24.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.134 -179.674 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.2 t -57.78 -44.9 86.54 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.256 -178.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 18.8 m -62.19 -46.09 90.46 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.865 0.364 . . . . 0.0 110.76 179.299 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 92.3 mt -62.47 -43.63 98.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.374 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.589 ' HB1' ' HD2' ' A' ' 138' ' ' PRO . . . -170.02 163.14 6.52 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.459 179.833 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.589 ' HD2' ' HB1' ' A' ' 137' ' ' ALA . 77.4 Cg_exo -42.02 110.81 0.16 Allowed 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.531 2.154 . . . . 0.0 112.088 179.413 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.503 HG21 ' CD1' ' A' ' 130' ' ' TYR . 2.9 m -87.48 127.59 35.23 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.559 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.653 HD13 ' CD2' ' A' ' 37' ' ' HIS . 34.9 tp -119.61 139.42 52.21 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.077 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.429 ' O ' ' OD2' ' A' ' 32' ' ' ASP . 81.0 mt -105.48 120.0 55.54 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.385 0 CA-C-O 121.14 0.495 . . . . 0.0 111.341 -179.665 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.494 HD12 HD22 ' A' ' 117' ' ' LEU . 98.2 mt -135.42 132.51 52.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.683 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.546 HD21 ' CG ' ' A' ' 241' ' ' ASP . 59.1 t30 -64.71 147.8 52.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.885 0.374 . . . . 0.0 110.368 179.275 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.454 ' O ' ' OD2' ' A' ' 241' ' ' ASP . 86.5 t80 -82.41 122.69 28.33 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.046 -179.593 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.433 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 91.4 m-20 55.32 69.02 0.78 Allowed 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.951 179.695 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 34.8 p-10 -125.78 0.37 7.39 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.943 0.401 . . . . 0.0 110.68 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -150.55 115.7 5.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.747 -179.507 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 85.9 p -63.93 169.07 4.52 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.566 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.419 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.6 p-90 -51.87 -15.95 0.62 Allowed 'General case' 0 C--O 1.223 -0.341 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.49 -179.763 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.43 ' O ' HG23 ' A' ' 154' ' ' THR . 68.1 tp60 -70.41 -76.09 0.11 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.469 -179.755 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.442 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.1 t -62.47 -38.61 90.51 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.011 0.434 . . . . 0.0 110.241 179.553 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 51.1 tp -60.21 -45.48 93.02 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.334 -178.425 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.419 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 45.8 tp -62.69 -41.86 99.33 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.859 0.361 . . . . 0.0 110.398 178.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.442 ' OG1' ' O ' ' A' ' 151' ' ' SER . 57.6 p -63.89 -34.74 78.63 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.18 -179.371 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.463 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 88.1 mm-40 -63.85 -42.28 97.61 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.153 179.274 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 90.5 mt -65.28 -39.07 92.09 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.125 0.488 . . . . 0.0 110.096 179.2 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.577 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.03 -32.39 80.1 Favored Glycine 0 CA--C 1.519 0.321 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 -179.292 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.463 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.3 mt-10 -36.65 -25.09 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.82 0.343 . . . . 0.0 110.807 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.577 ' N ' ' O ' ' A' ' 157' ' ' GLY . 95.8 mt -59.56 148.53 7.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.193 179.284 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 71.3 p -68.91 137.68 54.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.12 -179.62 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 70.56 21.91 77.77 Favored Glycine 0 N--CA 1.458 0.146 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 179.61 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 60.3 m80 -124.28 -14.34 7.0 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.73 0.3 . . . . 0.0 110.569 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -66.17 -59.49 3.71 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.792 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -52.22 -48.32 65.18 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 120.679 -0.409 . . . . 0.0 110.093 -179.505 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -60.88 -40.96 95.0 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.697 0.284 . . . . 0.0 110.313 179.477 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.61 -47.17 86.64 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.6 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -57.2 -39.83 76.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.179 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -61.85 -50.3 72.79 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.569 179.566 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.406 ' NE ' ' HB1' ' A' ' 59' ' ' ALA . 60.1 ttt85 -65.5 -43.78 89.09 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.458 179.536 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 94.8 mt -64.47 -43.52 96.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.386 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.32 -50.89 71.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.474 -179.123 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.97 -43.56 95.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.454 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.658 ' CE2' HD11 ' A' ' 177' ' ' LEU . 56.7 t80 -62.67 -44.59 95.87 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.07 0.462 . . . . 0.0 110.386 179.407 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -63.38 -39.96 95.94 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.561 -179.274 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -62.9 -42.8 99.91 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.623 179.159 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -60.78 -44.69 96.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.044 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.658 HD11 ' CE2' ' A' ' 173' ' ' PHE . 84.7 mt -64.34 -41.26 96.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.058 0.456 . . . . 0.0 110.733 178.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.13 -62.19 1.79 Allowed 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.43 -179.297 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.35 -46.86 85.46 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.52 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.02 -41.6 64.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.159 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -63.8 -33.48 75.77 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.015 0.436 . . . . 0.0 110.371 179.312 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.419 ' O ' ' HG2' ' A' ' 182' ' ' GLU . 69.7 tt0 -91.1 8.22 36.62 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.476 0.655 . . . . 0.0 110.529 -178.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -103.88 -32.62 9.2 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.348 179.427 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 45.1 pt -128.0 147.75 32.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.893 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -139.74 131.2 26.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.382 179.365 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.593 HD22 ' N ' ' A' ' 186' ' ' LEU . 3.6 mm? -85.5 133.97 41.09 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.953 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -44.23 157.99 0.15 Allowed 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 122.734 2.289 . . . . 0.0 112.097 179.442 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 0.519 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.5 Cg_endo -62.93 115.05 2.7 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 C-N-CA 122.775 2.317 . . . . 0.0 111.662 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 189' ' ' GLN . . . . . 0.519 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.8 mt-30 155.23 148.33 0.0 OUTLIER Pre-proline 0 C--N 1.332 -0.176 0 O-C-N 123.833 0.708 . . . . 0.0 110.869 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -73.75 144.29 34.93 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.688 2.259 . . . . 0.0 111.881 178.042 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.495 HG23 ' OG ' ' A' ' 258' ' ' SER . 2.1 p -124.92 158.65 32.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.365 0.602 . . . . 0.0 110.12 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 192' ' ' THR . . . . . 0.491 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 35.9 p -143.22 165.31 27.81 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.245 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 193' ' ' ALA . . . . . 0.448 ' HA ' ' H ' ' A' ' 260' ' ' PHE . . . -135.31 128.63 32.11 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 121.229 0.537 . . . . 0.0 110.233 179.589 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.52 HD11 HD23 ' A' ' 259' ' ' LEU . 48.3 pt -146.7 149.38 15.93 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.362 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.161 179.683 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 195' ' ' VAL . . . . . 0.739 HG13 ' CD1' ' A' ' 262' ' ' PHE . 69.0 t -117.95 123.4 71.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.317 0.58 . . . . 0.0 109.621 179.255 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -134.38 106.71 7.21 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.253 179.741 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 95.0 m -130.34 130.47 44.48 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.897 179.611 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.402 ' O ' ' N ' ' A' ' 201' ' ' HIS . . . -83.11 -36.83 24.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.142 179.818 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.63 -66.72 0.29 Allowed 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.311 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.52 -9.75 58.95 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.231 179.599 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 201' ' ' HIS . . . . . 0.402 ' N ' ' O ' ' A' ' 198' ' ' ALA . 60.6 t-80 60.85 58.28 2.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.887 -179.836 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 36.0 p -167.11 153.64 8.33 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.554 179.546 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.64 144.18 24.22 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.02 0.438 . . . . 0.0 110.355 179.374 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -135.53 138.66 43.28 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.67 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 20.3 mt -106.64 125.53 51.12 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 -179.54 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 206' ' ' TRP . . . . . 0.557 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 73.9 m95 -82.0 167.32 18.99 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.643 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 207' ' ' THR . . . . . 0.468 HG22 ' C ' ' A' ' 206' ' ' TRP . 0.1 OUTLIER -157.17 171.59 7.25 Favored Pre-proline 0 C--O 1.224 -0.238 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.585 -179.218 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -53.58 -37.29 82.96 Favored 'Trans proline' 0 C--N 1.303 -1.84 0 C-N-CA 122.602 2.201 . . . . 0.0 112.114 179.328 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -70.45 -35.37 73.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.858 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 21.6 m -60.67 150.94 30.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.591 -179.353 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.61 -37.22 83.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.524 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 212' ' ' GLN . . . . . 0.557 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 54.9 tt0 -64.5 -40.4 95.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.515 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.59 -43.39 92.26 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -63.26 -43.96 96.48 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 215' ' ' MET . . . . . 0.547 ' SD ' ' HB2' ' A' ' 304' ' ' ALA . 65.6 ttp -59.62 -47.71 84.51 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.196 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 216' ' ' LEU . 86.0 mt -60.78 -40.81 93.96 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 217' ' ' GLU . . . . . 0.452 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.4 tp10 -58.61 -37.82 76.67 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -65.18 -38.5 90.72 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.721 0.296 . . . . 0.0 110.525 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 94.8 mt -64.09 -42.83 96.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.105 0.479 . . . . 0.0 110.504 -179.515 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.48 45.13 0.08 OUTLIER Glycine 0 C--N 1.334 0.467 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 221' ' ' PHE . . . . . 0.452 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 26.9 m-85 -128.01 155.59 44.07 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.107 0.48 . . . . 0.0 110.47 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.486 ' O ' HG13 ' A' ' 191' ' ' VAL . 7.6 p -106.8 122.29 46.1 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.263 0.554 . . . . 0.0 110.136 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.475 HD22 ' C ' ' A' ' 222' ' ' THR . 4.3 mm? -101.33 133.09 46.47 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.159 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.93 159.68 14.78 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.535 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -105.41 115.26 29.95 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.302 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.494 HD12 ' N ' ' A' ' 226' ' ' LEU . 9.0 mp -53.0 156.8 3.24 Favored Pre-proline 0 N--CA 1.452 -0.355 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.746 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -60.39 145.22 99.08 Favored 'Trans proline' 0 C--N 1.3 -1.974 0 C-N-CA 122.628 2.219 . . . . 0.0 112.121 179.208 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -86.98 -3.43 59.09 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.54 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.12 -41.1 5.64 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.523 ' O ' ' N ' ' A' ' 233' ' ' SER . 69.5 mt -79.15 -17.71 54.48 Favored 'General case' 0 C--O 1.221 -0.42 0 CA-C-O 121.082 0.468 . . . . 0.0 110.319 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 54.8 t-20 -40.72 -48.9 3.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.844 -179.163 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -87.49 15.09 7.03 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.772 0.32 . . . . 0.0 111.428 179.561 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.523 ' N ' ' O ' ' A' ' 230' ' ' LEU . 77.9 p -60.45 -35.11 75.06 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.676 -179.7 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 234' ' ' GLN . . . . . 0.523 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.5 tt0 -119.33 -69.33 0.85 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.977 179.368 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.0 m -70.18 101.4 1.86 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.633 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -93.15 58.24 2.86 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.376 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -144.81 -122.42 1.56 Allowed Glycine 0 CA--C 1.52 0.353 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -135.62 111.36 9.35 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.25 0.548 . . . . 0.0 110.34 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 239' ' ' ARG . . . . . 0.529 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.5 mtt180 -147.9 57.95 1.1 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.756 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -69.1 -32.85 72.55 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.519 179.573 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 241' ' ' ASP . . . . . 0.546 ' CG ' HD21 ' A' ' 143' ' ' ASN . 65.1 t0 -57.02 -47.14 81.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.305 -178.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 242' ' ' ILE . . . . . 0.433 ' O ' ' O ' ' A' ' 239' ' ' ARG . 18.5 tt -139.4 155.4 25.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.901 0.382 . . . . 0.0 110.504 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.444 HG22 HD13 ' A' ' 245' ' ' LEU . 96.2 mt -106.16 106.86 21.37 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.235 0 CA-C-O 121.232 0.539 . . . . 0.0 110.59 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 244' ' ' GLN . . . . . 0.601 ' O ' HD12 ' A' ' 245' ' ' LEU . 88.3 mt-30 -110.46 109.91 20.46 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.292 179.757 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.601 HD12 ' O ' ' A' ' 244' ' ' GLN . 9.4 mp -121.51 -168.28 1.66 Allowed 'General case' 0 C--O 1.225 -0.229 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.672 179.736 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 246' ' ' GLY . . . . . 0.523 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.9 -16.21 0.05 OUTLIER Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 247' ' ' GLY . . . . . 0.673 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -61.49 156.18 35.45 Favored Glycine 0 CA--C 1.521 0.457 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -63.28 21.79 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.991 0.424 . . . . 0.0 110.672 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 249' ' ' ASN . . . . . 0.673 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.8 m-20 -97.15 -6.19 35.45 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.478 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 91.7 mt -79.76 -21.97 43.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.631 179.483 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.61 -51.21 70.89 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.824 -179.566 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.38 -5.5 58.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.443 179.632 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.38 -74.39 1.15 Allowed Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 83.4 mt -69.96 125.92 28.18 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.067 0.461 . . . . 0.0 110.235 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -59.49 -39.44 83.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.139 -179.581 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 83.1 51.76 4.06 Favored Glycine 0 CA--C 1.52 0.401 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -95.92 -14.88 22.76 Favored 'General case' 0 C--N 1.331 -0.198 0 O-C-N 122.721 -0.282 . . . . 0.0 110.571 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 258' ' ' SER . . . . . 0.495 ' OG ' HG23 ' A' ' 191' ' ' VAL . 3.5 t 174.52 88.99 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.11 0.481 . . . . 0.0 110.049 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.86 HD12 ' N ' ' A' ' 259' ' ' LEU . 0.9 OUTLIER -94.47 124.3 38.42 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.367 0.603 . . . . 0.0 111.174 -179.204 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 260' ' ' PHE . . . . . 0.448 ' H ' ' HA ' ' A' ' 193' ' ' ALA . 16.0 m-30 -93.36 146.43 23.74 Favored 'General case' 0 CA--C 1.503 -0.843 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.328 179.43 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 86.5 mt -122.0 149.86 42.89 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.597 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.739 ' CD1' HG13 ' A' ' 195' ' ' VAL . 2.5 p90 -77.83 -139.0 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.431 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 263' ' ' ALA . . . . . 0.658 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -51.59 77.71 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 121.047 0.451 . . . . 0.0 111.15 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 264' ' ' GLY . . . . . 0.628 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.44 104.69 0.19 Allowed Glycine 0 CA--C 1.527 0.795 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 265' ' ' ASP . . . . . 0.601 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.9 m-20 -80.55 -177.56 6.3 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 120.632 0.253 . . . . 0.0 110.971 -179.611 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -40.45 -17.81 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.854 0.359 . . . . 0.0 110.513 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 267' ' ' LYS . . . . . 0.601 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.26 -51.7 42.24 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.684 179.438 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -63.74 -46.69 84.19 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.973 179.587 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 269' ' ' ALA . . . . . 0.58 ' HB1' ' OH ' ' A' ' 273' ' ' TYR . . . -61.44 -35.28 77.14 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 121.238 0.542 . . . . 0.0 109.753 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -63.06 -34.61 77.96 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.022 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.31 -43.2 13.92 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.393 -179.594 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 272' ' ' ILE . . . . . 0.586 ' C ' ' H ' ' A' ' 274' ' ' ALA . 4.9 tt -51.36 -33.78 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.864 -178.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 273' ' ' TYR . . . . . 0.58 ' OH ' ' HB1' ' A' ' 269' ' ' ALA . 17.1 m-85 -54.31 -2.06 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.674 -179.533 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 274' ' ' ALA . . . . . 0.586 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.54 -39.71 70.51 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.996 179.533 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 275' ' ' ASN . . . . . 0.582 ' O ' ' N ' ' A' ' 279' ' ' ALA . 4.0 p30 -38.6 97.31 0.13 Allowed Pre-proline 0 C--O 1.225 -0.185 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.556 -179.764 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 276' ' ' PRO . . . . . 0.401 ' N ' ' O ' ' A' ' 274' ' ' ALA . 47.5 Cg_exo -54.1 -42.82 63.84 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 C-N-CA 122.234 1.956 . . . . 0.0 112.696 -178.728 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 89.7 mt -64.38 -42.73 96.0 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.188 0.518 . . . . 0.0 111.266 -179.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 91.4 mt -95.97 -1.16 49.65 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.922 -179.583 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 279' ' ' ALA . . . . . 0.582 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.39 -34.94 77.71 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.662 -179.684 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -73.87 20.01 0.11 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.035 -179.339 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 0.489 HD23 ' HA ' ' A' ' 281' ' ' LEU . 13.7 mt -75.15 120.12 80.18 Favored Pre-proline 0 N--CA 1.45 -0.439 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.423 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -51.21 -39.26 62.09 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.568 2.178 . . . . 0.0 111.809 179.168 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -53.19 -50.34 64.85 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 78.1 t -61.47 -43.91 97.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 179.589 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -57.66 -41.04 80.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.186 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -91.27 0.19 57.57 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.065 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt 59.54 44.06 15.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.07 0.462 . . . . 0.0 110.935 179.782 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -95.25 41.46 1.1 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.347 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 54.6 t -119.39 135.6 59.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 121.089 0.471 . . . . 0.0 110.161 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -132.92 163.14 29.82 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.071 0.462 . . . . 0.0 110.695 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.59 155.02 33.04 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-O 121.068 0.461 . . . . 0.0 110.782 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 82.1 mt -94.23 -1.36 54.18 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.211 -179.665 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.72 165.53 12.6 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 6.8 m -87.57 -62.07 1.58 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.905 0.383 . . . . 0.0 111.146 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 295' ' ' GLU . . . . . 0.447 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.6 mm-40 -69.16 -3.97 15.65 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.721 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 25.5 p -76.56 32.39 0.13 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.648 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 297' ' ' PHE . . . . . 0.513 ' CD2' HG22 ' A' ' 70' ' ' THR . 85.9 t80 -60.47 -45.88 92.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.603 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 298' ' ' ARG . . . . . 0.62 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.1 mtt85 -81.2 135.02 35.72 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.02 0.438 . . . . 0.0 110.546 -179.698 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.471 ' H ' HG11 ' A' ' 51' ' ' VAL . 18.4 tp -113.91 117.18 30.66 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-O 121.054 0.454 . . . . 0.0 110.098 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 300' ' ' ASP . . . . . 0.621 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.6 p-10 -165.21 -176.66 4.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.533 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 81.2 t80 -47.05 -43.15 19.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.169 -179.603 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -67.11 -40.13 86.83 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.046 0.451 . . . . 0.0 110.91 179.043 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 303' ' ' SER . . . . . 0.621 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 59.9 p -56.27 -36.27 68.38 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.021 -179.093 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 304' ' ' ALA . . . . . 0.547 ' HB2' ' SD ' ' A' ' 215' ' ' MET . . . -57.32 -51.54 68.95 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.51 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 90.2 mtp -56.67 -43.11 80.1 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -179.619 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -66.48 -42.72 87.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.003 0.43 . . . . 0.0 110.09 178.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 307' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 303' ' ' SER . 55.5 t -63.94 -43.19 97.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.126 179.381 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 43.4 tp -59.9 -42.14 93.18 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.683 -179.433 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -62.24 -39.27 92.27 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 310' ' ' ARG . . . . . 0.451 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.5 ttt85 -63.75 -44.01 94.75 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.203 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 89.5 mt -63.35 -42.21 98.89 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.194 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt -62.95 -33.57 75.66 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.081 0.467 . . . . 0.0 109.977 179.494 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.53 -23.75 21.95 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.325 -179.713 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.484 HD22 ' CE2' ' A' ' 315' ' ' PHE . 6.7 tt -62.33 -43.12 99.56 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 121.111 0.482 . . . . 0.0 110.562 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 315' ' ' PHE . . . . . 0.484 ' CE2' HD22 ' A' ' 314' ' ' LEU . 90.3 m-85 . . . . . 0 C--O 1.22 -0.469 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.428 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -99.37 135.89 40.12 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.016 0.436 . . . . 0.0 110.504 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.497 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -92.01 178.39 1.74 Allowed Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.548 -179.928 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.497 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.8 Cg_exo -61.61 147.28 95.76 Favored 'Trans proline' 0 C--N 1.3 -2.018 0 C-N-CA 122.79 2.327 . . . . 0.0 112.104 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.46 ' HE ' HD12 ' A' ' 39' ' ' LEU . 35.6 ptt180 -135.79 142.16 44.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.72 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -79.71 116.51 19.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.471 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.445 ' O ' HG23 ' A' ' 30' ' ' ILE . 9.4 tp -110.94 130.68 63.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.498 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.6 t -70.71 141.99 51.53 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.563 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.475 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.4 t0 -139.68 179.39 6.61 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.568 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.475 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 78.0 p -73.92 -36.99 64.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.61 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.8 ttt85 -46.54 -94.67 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.331 -179.533 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -167.16 -26.42 0.02 OUTLIER Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 59.9 m -169.11 104.73 0.39 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.879 0.371 . . . . 0.0 110.65 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.686 ' CD2' HD13 ' A' ' 140' ' ' LEU . 75.6 t60 -128.39 148.89 50.72 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.033 0.444 . . . . 0.0 110.262 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.626 HG22 ' N ' ' A' ' 39' ' ' LEU . 98.2 m -131.23 166.04 22.04 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.62 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.626 ' N ' HG22 ' A' ' 38' ' ' THR . 81.5 mt -120.83 127.61 52.08 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.43 179.737 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -65.2 -44.55 87.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.694 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 39.9 p -165.83 154.88 11.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.448 179.667 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.495 ' CD ' ' H ' ' A' ' 42' ' ' GLN . 14.8 mp0 -44.34 101.13 0.24 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.626 179.449 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -57.39 129.59 34.79 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 C-N-CA 122.365 2.044 . . . . 0.0 112.283 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -84.1 -24.57 30.27 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.502 179.602 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.539 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.5 mtm-85 -122.29 134.17 54.67 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-O 121.147 0.498 . . . . 0.0 110.34 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.1 mt -130.43 133.76 63.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.949 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 45.4 t -124.25 130.49 73.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 179.323 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.642 ' OG ' HD12 ' A' ' 117' ' ' LEU . 2.0 m -155.38 167.75 29.36 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.556 179.813 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 59.5 p -124.9 9.44 8.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.487 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.56 125.42 33.08 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.672 -179.437 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.45 HG11 ' H ' ' A' ' 299' ' ' LEU . 95.1 t -65.92 -44.43 92.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.417 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.4 m -62.49 -44.26 96.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.651 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 51.3 tp -62.33 -41.41 98.54 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.5 -179.47 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.453 ' O ' HD13 ' A' ' 58' ' ' LEU . 75.5 m -57.7 -44.48 85.88 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.258 -179.209 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.29 -62.18 5.36 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 179.554 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.7 t -48.38 -35.51 12.75 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 57' ' ' LEU . 19.8 mt -61.87 -44.64 96.4 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.707 -0.397 . . . . 0.0 111.17 179.41 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.453 HD13 ' O ' ' A' ' 54' ' ' THR . 9.2 mp -65.01 -41.7 95.09 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.303 178.014 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.63 -40.97 98.24 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.989 -179.275 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.431 ' O ' HG23 ' A' ' 60' ' ' ILE . 8.0 tp -88.65 16.79 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.762 -179.6 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 56.41 84.82 0.08 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.674 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 178.67 57.86 0.06 OUTLIER Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.016 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -50.77 153.34 8.39 Favored 'Trans proline' 0 C--N 1.296 -2.202 0 C-N-CA 122.892 2.394 . . . . 0.0 112.38 -178.276 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.437 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.2 OUTLIER -108.93 145.44 15.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.359 -179.714 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.8 mt -63.62 -45.24 98.09 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.317 -179.736 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.502 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -129.49 134.08 47.61 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 120.848 0.356 . . . . 0.0 110.539 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.501 ' O ' ' N ' ' A' ' 98' ' ' LEU . 75.2 m -134.73 158.84 43.09 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.798 -179.637 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.99 139.15 16.01 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.489 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.81 -162.69 0.08 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.914 0.388 . . . . 0.0 110.503 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.539 HG22 ' CD2' ' A' ' 297' ' ' PHE . 14.5 t -133.49 134.43 43.46 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.404 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.491 ' C ' ' O ' ' A' ' 70' ' ' THR . 0.6 OUTLIER 29.69 68.82 0.65 Allowed Pre-proline 0 N--CA 1.464 0.226 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.754 -179.866 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -61.25 145.17 98.83 Favored 'Trans proline' 0 C--N 1.299 -2.031 0 C-N-CA 122.627 2.218 . . . . 0.0 112.062 -178.425 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.533 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 45.1 p-10 -159.14 -32.04 0.06 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.677 179.643 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.542 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 99.1 m-20 -64.1 -39.7 94.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.489 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -60.23 -48.33 82.19 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.706 -179.228 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.424 ' O ' ' O ' ' A' ' 77' ' ' ALA . 92.6 t -60.25 -24.9 32.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 179.771 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.542 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -45.71 172.98 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.555 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.575 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.2 p30 -62.18 177.89 0.43 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.564 -179.728 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.554 ' C ' ' H ' ' A' ' 81' ' ' GLY . 36.1 p30 -45.13 85.79 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.965 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.575 ' N ' ' O ' ' A' ' 78' ' ' ASP . 42.5 tp60 -67.69 13.17 0.08 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.109 -179.817 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.554 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 118.73 -22.34 9.32 Favored Glycine 0 CA--C 1.519 0.324 0 N-CA-C 110.969 -0.852 . . . . 0.0 110.969 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -108.13 116.46 32.01 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.014 0.435 . . . . 0.0 110.44 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 75.8 mt -98.71 0.4 44.49 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.491 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -92.53 7.24 44.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.971 0.415 . . . . 0.0 110.413 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.802 ' O ' HG22 ' A' ' 89' ' ' VAL . 27.0 mt-30 -100.12 -28.19 13.16 Favored 'General case' 0 C--O 1.225 -0.234 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.823 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 68.9 t-105 -62.77 -40.71 98.12 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.858 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.554 ' O ' ' N ' ' A' ' 91' ' ' LYS . 65.4 m -77.73 -53.56 7.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.148 -179.364 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -48.51 -50.76 30.48 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.965 -179.262 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.802 HG22 ' O ' ' A' ' 85' ' ' GLN . 15.7 m -68.87 -40.62 81.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 120.867 0.365 . . . . 0.0 111.005 179.76 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.497 ' N ' HG23 ' A' ' 89' ' ' VAL . . . -72.32 -22.63 61.15 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.695 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.554 ' N ' ' O ' ' A' ' 87' ' ' SER . 65.9 tttm -62.01 -45.51 93.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.512 -179.498 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.442 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.6 mm-40 -90.53 -94.85 0.12 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.134 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.636 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.9 mtt180 -142.92 58.97 1.42 Allowed 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.461 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.6 pttp 33.43 26.13 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 120.879 0.371 . . . . 0.0 110.221 -179.145 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.636 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.4 tt -48.08 123.52 6.38 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.925 -178.102 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.454 ' O ' HD23 ' A' ' 95' ' ' LEU . 99.0 mm-40 -83.88 -169.41 2.56 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.092 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.603 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 81.3 mtp180 -74.58 136.84 42.05 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.298 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.501 ' N ' ' O ' ' A' ' 67' ' ' SER . 91.3 mt -85.79 -165.82 1.35 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.762 -179.68 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.537 ' O ' ' CD2' ' A' ' 99' ' ' TYR . 48.3 p90 -168.33 119.77 0.81 Allowed 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.178 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.515 ' C ' ' O ' ' A' ' 99' ' ' TYR . 43.0 mm -28.88 120.96 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.977 -179.693 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 114.25 27.57 3.35 Favored Glycine 0 CA--C 1.52 0.344 0 N-CA-C 111.154 -0.779 . . . . 0.0 111.154 -179.543 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.582 ' CD ' ' H ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -144.63 46.62 0.63 Allowed Pre-proline 0 C--N 1.324 -0.537 0 CA-C-O 120.995 0.426 . . . . 0.0 110.479 179.885 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 29.5 Cg_endo -61.91 143.97 96.1 Favored 'Trans proline' 0 C--N 1.297 -2.153 0 C-N-CA 122.644 2.229 . . . . 0.0 111.993 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.455 ' O ' HG23 ' A' ' 108' ' ' VAL . 27.8 t -173.16 120.0 0.34 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.462 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.61 -40.46 63.8 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.035 0.445 . . . . 0.0 111.049 179.745 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.25 -39.87 89.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.88 -179.37 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.22 -39.97 95.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.75 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 104' ' ' SER . 71.3 t -67.57 -43.87 86.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.798 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.84 -38.89 92.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.578 -179.332 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.442 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.49 -23.31 62.66 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.49 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.551 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.4 mm-40 -90.64 5.3 48.56 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.687 -179.502 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.551 ' C ' ' O ' ' A' ' 111' ' ' GLN . 10.6 tpt 23.55 64.13 0.38 Allowed Pre-proline 0 N--CA 1.465 0.296 0 CA-C-O 120.896 0.379 . . . . 0.0 110.946 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -78.14 167.24 23.64 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 123.03 2.487 . . . . 0.0 112.132 -178.452 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.524 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 98.9 m-20 -109.96 -42.11 4.31 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.19 179.428 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.3 tp -121.24 120.21 34.5 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.019 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 82.5 mt -112.79 128.88 69.26 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.336 0 CA-C-O 120.918 0.389 . . . . 0.0 110.812 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.642 HD12 ' OG ' ' A' ' 48' ' ' SER . 29.2 mt -109.13 132.32 54.23 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 121.088 0.471 . . . . 0.0 110.211 -179.727 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.494 HD12 HG23 ' A' ' 139' ' ' THR . 99.1 mt -119.94 138.57 50.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.645 -179.743 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 85.9 p -72.44 154.07 41.07 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.608 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.18 -50.21 74.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.636 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.0 t -149.73 154.3 38.29 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.579 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 170.66 -170.79 43.37 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.99 -34.03 88.83 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.452 ' OD1' ' O ' ' A' ' 124' ' ' ASP . 44.5 p-10 -87.29 120.42 28.55 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.796 0.332 . . . . 0.0 110.684 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.441 ' O ' HD12 ' A' ' 129' ' ' LEU . 38.8 t -63.2 143.83 57.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.504 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.52 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.0 -43.23 9.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.928 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.6 tp -62.86 -42.35 99.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.706 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.58 -12.07 59.54 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.485 -179.49 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.441 HD12 ' O ' ' A' ' 125' ' ' SER . 85.3 mt -114.77 -23.84 8.99 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.649 -179.766 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' TYR . . . . . 0.52 ' N ' ' O ' ' A' ' 126' ' ' ALA . 79.9 t80 -50.9 -49.66 58.96 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.592 -178.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.0 p-10 -66.12 -42.6 88.97 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.861 0.363 . . . . 0.0 111.158 179.576 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.521 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 88.4 mt-30 -66.98 -37.94 85.15 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.781 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.433 HD12 HD11 ' A' ' 118' ' ' ILE . 96.0 mt -80.32 -41.38 24.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.892 -179.549 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.2 t -57.21 -44.52 83.76 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.212 -179.098 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.5 m -61.87 -45.22 94.7 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.751 0.31 . . . . 0.0 110.517 179.414 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 93.3 mt -62.18 -43.6 98.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.27 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.67 ' HB1' ' HD2' ' A' ' 138' ' ' PRO . . . -169.51 168.69 4.66 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.554 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.67 ' HD2' ' HB1' ' A' ' 137' ' ' ALA . 52.7 Cg_exo -50.38 113.04 0.87 Allowed 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.282 1.988 . . . . 0.0 112.206 179.414 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.494 HG23 HD12 ' A' ' 118' ' ' ILE . 23.4 m -83.97 127.39 33.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.609 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.686 HD13 ' CD2' ' A' ' 37' ' ' HIS . 34.8 tp -117.87 135.91 53.79 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.034 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.44 ' O ' ' OD2' ' A' ' 32' ' ' ASP . 81.7 mt -100.18 118.85 47.44 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.331 0 CA-C-O 121.174 0.512 . . . . 0.0 111.194 -179.36 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.428 HD12 HD22 ' A' ' 117' ' ' LEU . 98.1 mt -134.74 132.28 54.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.621 179.593 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.479 ' ND2' ' OD2' ' A' ' 241' ' ' ASP . 2.1 t-20 -66.97 151.42 47.66 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.905 0.383 . . . . 0.0 110.433 179.457 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.522 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 88.0 t80 -86.11 122.38 30.04 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.811 -179.52 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.522 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 98.9 m-20 55.17 69.34 0.74 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.754 179.657 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 35.8 p-10 -125.8 0.16 7.37 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.651 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -150.56 115.13 5.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.7 -179.504 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 84.5 p -63.3 168.33 4.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.542 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.422 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.6 p-90 -51.83 -15.88 0.59 Allowed 'General case' 0 C--O 1.223 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.524 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.439 ' O ' HG23 ' A' ' 154' ' ' THR . 68.1 tp60 -70.39 -76.02 0.11 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.511 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.448 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.1 t -62.7 -38.63 91.16 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.295 179.51 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 54.0 tp -60.02 -45.66 92.07 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.379 -178.571 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.422 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 46.9 tp -62.76 -41.75 99.36 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.832 0.348 . . . . 0.0 110.365 179.066 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.448 ' OG1' ' O ' ' A' ' 151' ' ' SER . 60.2 p -64.14 -34.86 79.03 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.264 -179.498 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.435 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.9 mm-40 -64.24 -42.59 96.45 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.322 179.286 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 91.6 mt -65.55 -38.82 90.68 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.037 0.446 . . . . 0.0 110.252 179.133 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.583 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.29 -32.31 80.3 Favored Glycine 0 CA--C 1.521 0.418 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 -179.387 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.442 ' C ' ' O ' ' A' ' 157' ' ' GLY . 97.1 mt-10 -35.17 -27.29 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.821 0.344 . . . . 0.0 110.764 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.583 ' N ' ' O ' ' A' ' 157' ' ' GLY . 95.5 mt -56.03 149.76 3.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.33 179.187 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 71.5 p -69.87 137.3 51.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.002 -179.557 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 71.57 20.34 78.4 Favored Glycine 0 N--CA 1.458 0.143 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 179.481 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 58.0 m80 -121.78 -14.91 8.02 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.706 0.289 . . . . 0.0 110.571 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -65.85 -59.83 3.48 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.764 -179.696 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -52.05 -49.35 63.64 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.16 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -60.76 -41.14 94.85 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.718 0.294 . . . . 0.0 110.356 179.462 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.45 -47.2 86.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.613 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -57.0 -40.16 76.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.241 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -61.65 -50.34 72.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.571 179.542 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -65.34 -43.75 89.91 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.535 179.55 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 95.2 mt -64.6 -43.47 96.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.509 179.743 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.21 -51.17 70.43 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.535 -179.216 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.44 -43.93 96.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.46 179.711 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.654 ' CE2' HD11 ' A' ' 177' ' ' LEU . 56.7 t80 -62.72 -44.45 96.18 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.04 0.448 . . . . 0.0 110.405 179.44 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -63.35 -39.88 95.75 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.616 -179.363 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -63.07 -42.78 99.74 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.617 179.224 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -60.67 -44.77 96.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.181 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.654 HD11 ' CE2' ' A' ' 173' ' ' PHE . 83.7 mt -64.36 -41.23 96.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.031 0.443 . . . . 0.0 110.698 178.885 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.08 -62.32 1.71 Allowed 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.482 -179.4 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.52 -46.9 85.81 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.552 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.12 -41.76 65.34 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.223 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -63.94 -33.52 75.91 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.976 0.417 . . . . 0.0 110.352 179.314 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.423 ' O ' ' HG2' ' A' ' 182' ' ' GLU . 69.6 tt0 -90.72 8.68 33.27 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.37 0.605 . . . . 0.0 110.52 -179.003 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -104.84 -32.12 8.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.195 179.603 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 45.4 pt -128.11 147.67 32.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.814 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -139.86 131.03 26.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.422 179.362 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.596 HD22 ' N ' ' A' ' 186' ' ' LEU . 3.6 mm? -85.59 133.14 42.56 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.901 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -43.89 157.72 0.14 Allowed 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.738 2.292 . . . . 0.0 112.138 179.38 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 0.525 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.8 Cg_endo -63.01 115.21 2.81 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 C-N-CA 122.804 2.336 . . . . 0.0 111.724 179.811 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 189' ' ' GLN . . . . . 0.525 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.7 mt-30 155.53 147.63 0.0 OUTLIER Pre-proline 0 C--N 1.332 -0.195 0 O-C-N 123.596 0.56 . . . . 0.0 110.762 -179.836 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -73.77 143.85 34.17 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.651 2.234 . . . . 0.0 111.963 178.052 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.499 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.1 p -125.03 159.09 32.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.27 0.557 . . . . 0.0 110.164 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 192' ' ' THR . . . . . 0.499 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 35.9 p -143.54 165.48 27.45 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.034 -179.636 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 193' ' ' ALA . . . . . 0.44 ' HA ' ' H ' ' A' ' 260' ' ' PHE . . . -135.38 128.58 31.89 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.159 0.504 . . . . 0.0 110.213 179.587 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.509 HD11 HD23 ' A' ' 259' ' ' LEU . 47.4 pt -146.49 148.81 16.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.048 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 195' ' ' VAL . . . . . 0.752 HG13 ' CD1' ' A' ' 262' ' ' PHE . 68.9 t -117.67 123.09 71.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-O 121.238 0.542 . . . . 0.0 109.765 179.104 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -134.3 107.29 7.56 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.332 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 95.2 m -130.96 130.6 43.63 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.756 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.406 ' O ' ' N ' ' A' ' 201' ' ' HIS . . . -82.84 -36.9 25.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.256 179.646 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.34 -67.18 0.25 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.374 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.33 -9.43 58.49 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.348 179.489 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 201' ' ' HIS . . . . . 0.406 ' N ' ' O ' ' A' ' 198' ' ' ALA . 60.2 t-80 60.27 58.42 2.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.748 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 46.4 p -167.21 153.65 8.19 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.535 179.535 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.6 144.23 24.29 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.992 0.425 . . . . 0.0 110.446 179.479 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -135.39 138.4 43.27 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.646 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 20.0 mt -106.42 125.48 51.05 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 121.11 0.481 . . . . 0.0 109.867 -179.683 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 206' ' ' TRP . . . . . 0.557 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 75.7 m95 -82.01 167.03 19.28 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.659 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 207' ' ' THR . . . . . 0.466 HG22 ' C ' ' A' ' 206' ' ' TRP . 0.1 OUTLIER -156.77 171.33 7.56 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.586 -179.156 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.87 -37.03 85.02 Favored 'Trans proline' 0 C--N 1.302 -1.879 0 C-N-CA 122.624 2.216 . . . . 0.0 112.133 179.27 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -70.47 -34.87 72.89 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.8 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 22.0 m -61.26 150.83 33.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.64 -179.419 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.59 -36.95 82.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.448 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 212' ' ' GLN . . . . . 0.557 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 54.8 tt0 -64.69 -40.29 95.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.506 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.61 -43.45 92.07 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -63.26 -43.52 97.76 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.741 0.305 . . . . 0.0 110.281 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 215' ' ' MET . . . . . 0.525 ' SD ' ' HB2' ' A' ' 304' ' ' ALA . 65.2 ttp -59.61 -48.11 82.95 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.252 -179.732 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 87.9 mt -60.49 -41.04 93.45 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 179.546 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 217' ' ' GLU . . . . . 0.455 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.3 tp10 -57.88 -37.85 74.69 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.795 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -65.36 -37.98 88.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.8 0.333 . . . . 0.0 110.679 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 94.4 mt -64.43 -42.64 95.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.606 -179.653 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.49 44.6 0.08 OUTLIER Glycine 0 C--N 1.333 0.408 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 221' ' ' PHE . . . . . 0.455 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 26.5 m-85 -127.74 155.28 44.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.04 0.447 . . . . 0.0 110.507 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.487 ' O ' HG13 ' A' ' 191' ' ' VAL . 6.5 p -106.99 122.11 45.8 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.201 0.524 . . . . 0.0 110.154 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.472 HD22 ' C ' ' A' ' 222' ' ' THR . 4.3 mm? -101.07 133.12 46.06 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.063 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.96 159.31 14.98 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.463 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.43 115.42 30.23 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.942 0.401 . . . . 0.0 110.351 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.499 HD12 ' N ' ' A' ' 226' ' ' LEU . 8.9 mp -53.47 156.77 4.04 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.686 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -60.29 145.41 98.65 Favored 'Trans proline' 0 C--N 1.301 -1.956 0 C-N-CA 122.721 2.281 . . . . 0.0 112.058 179.368 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.36 -2.92 58.96 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.546 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.31 -40.8 5.66 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.54 ' O ' ' N ' ' A' ' 233' ' ' SER . 86.2 mt -79.27 -16.75 55.96 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-O 121.006 0.431 . . . . 0.0 110.386 -179.798 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 231' ' ' ASN . . . . . 0.403 ' C ' ' O ' ' A' ' 230' ' ' LEU . 54.5 t-20 -40.21 -49.15 2.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.694 -179.577 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -88.18 15.43 7.54 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.777 0.322 . . . . 0.0 111.27 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.54 ' N ' ' O ' ' A' ' 230' ' ' LEU . 78.1 p -60.43 -35.65 76.33 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.693 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 234' ' ' GLN . . . . . 0.526 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.6 tt0 -118.35 -69.39 0.85 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.943 179.554 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.1 m -70.04 103.37 2.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.734 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -94.59 57.69 2.25 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.359 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -144.88 -122.61 1.57 Allowed Glycine 0 CA--C 1.52 0.402 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -134.4 111.7 10.37 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 121.081 0.467 . . . . 0.0 110.433 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 239' ' ' ARG . . . . . 0.517 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.3 mtt180 -148.1 57.52 1.08 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.778 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -69.92 -31.75 69.69 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.505 179.591 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 241' ' ' ASP . . . . . 0.479 ' OD2' ' ND2' ' A' ' 143' ' ' ASN . 64.9 t0 -56.85 -46.98 81.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.343 -179.163 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 242' ' ' ILE . . . . . 0.435 ' O ' ' O ' ' A' ' 239' ' ' ARG . 17.5 tt -140.27 157.11 24.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.898 0.38 . . . . 0.0 110.527 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.44 HG22 HD13 ' A' ' 245' ' ' LEU . 96.1 mt -106.12 106.17 20.08 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.196 0 CA-C-O 121.16 0.505 . . . . 0.0 110.504 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 244' ' ' GLN . . . . . 0.603 ' O ' HD12 ' A' ' 245' ' ' LEU . 88.3 mt-30 -110.5 110.39 21.11 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.405 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.603 HD12 ' O ' ' A' ' 244' ' ' GLN . 9.5 mp -121.95 -168.3 1.68 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.607 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 246' ' ' GLY . . . . . 0.526 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.53 -16.88 0.05 OUTLIER Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 247' ' ' GLY . . . . . 0.671 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -60.47 157.01 29.84 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -63.77 21.27 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.915 0.388 . . . . 0.0 110.585 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 249' ' ' ASN . . . . . 0.671 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.7 m-20 -96.87 -5.82 37.29 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.569 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 92.7 mt -80.23 -21.45 42.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.6 179.511 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.47 -51.24 70.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.8 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.72 -5.28 58.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.449 179.665 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.09 -74.39 1.14 Allowed Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.926 -0.87 . . . . 0.0 110.926 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 81.8 mt -70.13 125.95 28.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.054 0.454 . . . . 0.0 110.227 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -59.45 -39.17 82.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.321 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 82.82 51.94 4.06 Favored Glycine 0 CA--C 1.521 0.463 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -95.8 -15.16 22.71 Favored 'General case' 0 C--N 1.331 -0.203 0 O-C-N 122.723 -0.281 . . . . 0.0 110.553 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 258' ' ' SER . . . . . 0.496 ' OG ' HG23 ' A' ' 191' ' ' VAL . 3.4 t 174.5 88.9 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.104 0.478 . . . . 0.0 110.159 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.862 HD12 ' N ' ' A' ' 259' ' ' LEU . 0.9 OUTLIER -94.27 123.88 37.94 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.244 0.545 . . . . 0.0 111.098 -179.058 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 260' ' ' PHE . . . . . 0.44 ' H ' ' HA ' ' A' ' 193' ' ' ALA . 16.0 m-30 -92.85 146.4 23.66 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.316 179.244 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 86.3 mt -122.31 149.73 43.34 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.562 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.752 ' CD1' HG13 ' A' ' 195' ' ' VAL . 2.7 p90 -77.43 -138.29 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.601 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 263' ' ' ALA . . . . . 0.66 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -52.31 77.55 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 121.044 0.449 . . . . 0.0 111.034 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 264' ' ' GLY . . . . . 0.627 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.08 104.33 0.18 Allowed Glycine 0 CA--C 1.527 0.786 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 265' ' ' ASP . . . . . 0.603 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.9 m-20 -80.35 -177.68 6.27 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 120.724 0.297 . . . . 0.0 110.912 -179.488 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -40.44 -17.61 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.536 179.734 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 267' ' ' LYS . . . . . 0.603 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.48 -51.73 40.16 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.019 0.438 . . . . 0.0 110.693 179.457 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -63.58 -46.63 84.97 Favored 'General case' 0 CA--C 1.527 0.09 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.323 179.313 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 269' ' ' ALA . . . . . 0.565 ' HB1' ' OH ' ' A' ' 273' ' ' TYR . . . -61.59 -35.18 77.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.865 179.531 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -62.97 -34.4 77.43 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.163 179.615 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.49 -43.37 13.63 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.225 -179.558 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 272' ' ' ILE . . . . . 0.587 ' C ' ' H ' ' A' ' 274' ' ' ALA . 4.9 tt -51.33 -33.63 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.876 -178.827 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 273' ' ' TYR . . . . . 0.565 ' OH ' ' HB1' ' A' ' 269' ' ' ALA . 17.3 m-85 -54.45 -1.8 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.649 -179.603 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 274' ' ' ALA . . . . . 0.587 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.65 -39.51 70.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.881 179.577 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 275' ' ' ASN . . . . . 0.583 ' O ' ' N ' ' A' ' 279' ' ' ALA . 2.8 p30 -39.61 98.35 0.17 Allowed Pre-proline 0 C--N 1.333 -0.122 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.514 -179.66 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -54.24 -43.02 62.38 Favored 'Trans proline' 0 C--N 1.303 -1.856 0 C-N-CA 122.391 2.061 . . . . 0.0 112.574 -178.771 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 89.5 mt -64.46 -42.82 95.7 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.201 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 91.1 mt -95.67 -1.63 49.72 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.812 -179.461 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 279' ' ' ALA . . . . . 0.583 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.33 -34.91 77.55 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.672 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.26 20.1 0.12 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.994 -179.227 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 0.49 HD23 ' HA ' ' A' ' 281' ' ' LEU . 13.8 mt -75.21 120.01 79.66 Favored Pre-proline 0 N--CA 1.451 -0.375 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.484 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -50.83 -39.44 58.16 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.599 2.199 . . . . 0.0 111.946 179.029 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.8 -50.51 63.49 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.154 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 79.4 t -61.42 -43.96 97.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 179.488 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -57.7 -41.22 81.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.248 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -90.98 0.15 57.6 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.167 179.681 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt 59.53 43.41 16.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.035 0.445 . . . . 0.0 110.873 179.683 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -94.78 41.3 1.09 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.411 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 53.7 t -118.93 135.92 57.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.012 0.434 . . . . 0.0 110.257 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -133.08 162.85 30.64 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.053 0.454 . . . . 0.0 110.701 -179.668 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.96 155.22 33.22 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.012 0.434 . . . . 0.0 110.731 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 81.4 mt -93.9 -1.38 54.82 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.227 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.43 165.72 12.7 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 110.598 -1.001 . . . . 0.0 110.598 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 7.0 m -87.47 -62.3 1.53 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.899 0.381 . . . . 0.0 111.034 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 295' ' ' GLU . . . . . 0.437 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.5 mm-40 -69.68 -3.85 17.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.61 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 27.0 p -76.91 33.22 0.14 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.66 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 297' ' ' PHE . . . . . 0.539 ' CD2' HG22 ' A' ' 70' ' ' THR . 84.9 t80 -60.16 -45.86 91.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.58 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 298' ' ' ARG . . . . . 0.603 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.2 mtt85 -81.87 134.22 35.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.531 -179.684 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.45 ' H ' HG11 ' A' ' 51' ' ' VAL . 16.2 tp -114.46 119.52 37.15 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-O 120.996 0.427 . . . . 0.0 110.178 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 300' ' ' ASP . . . . . 0.623 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.3 p-10 -167.26 -174.44 2.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.553 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 84.5 t80 -47.92 -45.68 31.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.254 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -64.93 -41.42 95.55 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.022 0.439 . . . . 0.0 110.717 179.014 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 303' ' ' SER . . . . . 0.623 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 52.8 p -55.52 -36.24 66.51 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.086 -179.251 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 304' ' ' ALA . . . . . 0.525 ' HB2' ' SD ' ' A' ' 215' ' ' MET . . . -56.79 -51.85 67.32 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.442 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 90.9 mtp -56.14 -43.71 78.5 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -66.32 -42.64 87.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.978 0.418 . . . . 0.0 110.278 178.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 307' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 303' ' ' SER . 55.7 t -64.08 -42.84 96.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.207 179.38 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 42.3 tp -59.55 -42.27 92.01 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.863 -179.561 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -62.63 -38.8 91.67 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.163 179.415 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 310' ' ' ARG . . . . . 0.443 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.6 ttt85 -63.58 -44.07 95.13 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.251 179.549 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 88.4 mt -63.26 -42.01 99.11 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.228 179.593 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -62.84 -33.03 74.4 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.097 179.44 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -90.33 -23.31 21.17 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.417 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.477 HD22 ' CE2' ' A' ' 315' ' ' PHE . 6.8 tt -62.3 -43.22 99.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.098 0.475 . . . . 0.0 110.594 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 315' ' ' PHE . . . . . 0.477 ' CE2' HD22 ' A' ' 314' ' ' LEU . 91.0 m-85 . . . . . 0 C--O 1.219 -0.511 0 CA-C-O 118.079 -0.962 . . . . 0.0 110.414 -179.988 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -99.64 135.69 40.68 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.064 0.459 . . . . 0.0 110.456 -179.993 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.497 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -92.09 178.61 1.64 Allowed Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.61 -179.813 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.497 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 27.0 Cg_exo -61.63 147.17 96.01 Favored 'Trans proline' 0 C--N 1.3 -1.995 0 C-N-CA 122.749 2.299 . . . . 0.0 112.112 179.694 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.484 ' HE ' HD12 ' A' ' 39' ' ' LEU . 35.1 ptt180 -136.12 142.29 44.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.673 179.701 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -79.79 116.83 20.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.489 179.865 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.46 ' O ' HG23 ' A' ' 30' ' ' ILE . 9.5 tp -111.48 129.98 65.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.444 -179.988 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.2 t -70.9 142.11 51.16 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.58 179.881 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.484 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.5 t0 -138.93 179.98 6.18 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.575 -179.985 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.484 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 77.7 p -74.31 -37.23 63.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.616 179.952 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -46.69 -94.58 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.35 -179.515 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -165.8 -27.13 0.02 OUTLIER Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 179.953 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 63.2 m -168.79 106.09 0.44 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.924 0.392 . . . . 0.0 110.696 -179.929 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.643 ' CD2' HD13 ' A' ' 140' ' ' LEU . 67.4 t60 -128.92 146.72 50.87 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.044 0.449 . . . . 0.0 110.232 -179.949 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.623 HG22 ' N ' ' A' ' 39' ' ' LEU . 96.5 m -130.08 165.59 21.92 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.57 -179.848 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.623 ' N ' HG22 ' A' ' 38' ' ' THR . 80.5 mt -120.29 127.16 52.11 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.461 179.752 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -65.46 -44.61 86.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.588 -179.996 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 38.6 p -165.59 154.58 11.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.388 179.735 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.489 ' CD ' ' H ' ' A' ' 42' ' ' GLN . 14.7 mp0 -44.98 101.32 0.25 Allowed Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.631 179.436 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -57.53 129.54 34.33 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 C-N-CA 122.367 2.045 . . . . 0.0 112.247 -179.731 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -82.42 -25.13 33.95 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.491 179.631 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.537 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.7 mtm-85 -120.96 134.56 55.3 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-O 121.191 0.519 . . . . 0.0 110.28 -179.953 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.0 mt -130.28 133.59 63.79 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.923 -179.771 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 46.5 t -124.61 131.34 72.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.808 0.337 . . . . 0.0 110.126 179.373 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.617 ' OG ' HD12 ' A' ' 117' ' ' LEU . 4.7 m -154.2 165.94 34.69 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.563 179.782 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 71.5 p -124.76 8.29 8.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.463 179.942 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.66 125.8 33.44 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.672 -179.459 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.452 HG11 ' H ' ' A' ' 299' ' ' LEU . 89.9 t -65.47 -44.61 94.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.44 -179.943 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.6 m -62.52 -44.31 96.67 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.627 -179.917 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 53.1 tp -62.15 -41.58 98.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.512 -179.519 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.45 ' O ' HD13 ' A' ' 58' ' ' LEU . 72.8 m -57.74 -44.49 86.08 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.292 -179.253 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.39 -62.0 5.5 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 110.906 -0.878 . . . . 0.0 110.906 179.632 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.7 t -48.35 -35.76 13.11 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 -179.904 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 20.2 mt -61.66 -44.61 96.63 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.648 -0.421 . . . . 0.0 111.186 179.424 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.45 HD13 ' O ' ' A' ' 54' ' ' THR . 9.3 mp -64.89 -41.89 95.25 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.342 177.901 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.53 -41.19 98.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.02 -179.279 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.429 ' O ' HG23 ' A' ' 60' ' ' ILE . 8.0 tp -88.04 16.62 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.763 -179.711 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 56.45 84.11 0.09 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.736 -179.874 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.9 58.24 0.09 OUTLIER Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.019 -179.745 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -50.77 152.45 9.6 Favored 'Trans proline' 0 C--N 1.296 -2.229 0 C-N-CA 122.751 2.301 . . . . 0.0 112.473 -178.405 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.431 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -109.15 146.25 14.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.372 -179.658 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 97.0 mt -63.86 -44.91 98.24 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.357 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.459 -179.914 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.504 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -129.81 134.22 47.42 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 120.84 0.352 . . . . 0.0 110.632 -179.896 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.509 ' O ' ' N ' ' A' ' 98' ' ' LEU . 58.8 m -134.32 158.39 43.92 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.875 -179.62 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -85.46 138.16 16.11 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.749 -0.941 . . . . 0.0 110.749 179.811 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.481 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.25 -163.81 0.11 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.958 0.408 . . . . 0.0 110.515 -179.906 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.502 HG22 ' CD2' ' A' ' 297' ' ' PHE . 6.2 t -134.22 140.61 46.6 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.216 179.936 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.486 ' C ' ' O ' ' A' ' 70' ' ' THR . 0.7 OUTLIER 29.67 70.73 0.56 Allowed Pre-proline 0 N--CA 1.466 0.329 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.657 -179.935 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_exo -60.45 144.44 99.52 Favored 'Trans proline' 0 C--N 1.299 -2.036 0 C-N-CA 122.587 2.191 . . . . 0.0 112.079 -178.323 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.54 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 44.5 p-10 -164.87 -35.56 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.662 179.895 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.54 ' N ' ' OD1' ' A' ' 73' ' ' ASN . 99.0 m-20 -63.88 -39.36 94.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.433 -179.98 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 73.4 ttt180 -60.88 -47.76 84.93 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.67 -179.389 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.433 ' O ' ' O ' ' A' ' 77' ' ' ALA . 95.6 t -60.24 -23.9 29.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.113 179.716 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.512 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -45.14 172.36 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.633 179.853 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.572 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.9 p30 -62.33 178.05 0.44 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.617 -179.7 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.562 ' C ' ' H ' ' A' ' 81' ' ' GLY . 36.6 p30 -46.04 85.64 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.05 179.912 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.572 ' N ' ' O ' ' A' ' 78' ' ' ASP . 42.6 tp60 -67.4 14.04 0.06 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.121 0.486 . . . . 0.0 110.094 -179.718 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.562 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 117.48 -21.62 10.58 Favored Glycine 0 CA--C 1.519 0.339 0 N-CA-C 110.909 -0.876 . . . . 0.0 110.909 179.922 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -107.85 116.71 32.45 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.968 0.413 . . . . 0.0 110.434 179.917 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 74.2 mt -98.62 0.69 45.3 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.551 -179.764 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -92.64 6.38 47.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.99 0.424 . . . . 0.0 110.459 -179.786 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.789 ' O ' HG22 ' A' ' 89' ' ' VAL . 27.2 mt-30 -99.83 -27.46 13.61 Favored 'General case' 0 C--O 1.224 -0.289 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.861 179.953 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.4 t-105 -63.84 -40.84 97.54 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.145 -179.795 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.552 ' O ' ' N ' ' A' ' 91' ' ' LYS . 67.3 m -77.76 -53.76 7.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.304 -179.548 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -48.19 -50.81 27.83 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.003 -179.273 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.789 HG22 ' O ' ' A' ' 85' ' ' GLN . 14.7 m -68.89 -40.7 81.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 120.919 0.39 . . . . 0.0 111.059 179.757 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.499 ' N ' HG23 ' A' ' 89' ' ' VAL . . . -72.14 -22.81 61.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.721 -179.885 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.552 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.0 tttm -61.6 -46.03 91.55 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.489 -179.539 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.442 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.3 mm-40 -90.11 -94.86 0.11 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.096 -179.964 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.627 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.7 mtt180 -143.19 59.58 1.41 Allowed 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 179.812 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.46 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.6 pttp 33.6 26.45 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.221 -179.214 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.627 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.4 tt -48.12 123.14 5.9 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.904 -178.152 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.456 ' O ' HD23 ' A' ' 95' ' ' LEU . 98.8 mm-40 -83.24 -169.54 2.59 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.057 -179.835 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.612 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 81.2 mtp180 -73.9 138.26 44.19 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.174 -179.677 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.509 ' N ' ' O ' ' A' ' 67' ' ' SER . 87.9 mt -86.61 -166.58 1.6 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.707 -179.524 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.528 ' O ' ' CD2' ' A' ' 99' ' ' TYR . 46.7 p90 -167.32 119.69 0.92 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.324 179.946 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.507 ' C ' ' O ' ' A' ' 99' ' ' TYR . 44.4 mm -29.56 121.08 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.995 -179.744 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 113.2 28.78 3.21 Favored Glycine 0 CA--C 1.52 0.359 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 -179.477 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.59 ' CD ' ' H ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -143.86 45.68 0.59 Allowed Pre-proline 0 C--N 1.323 -0.555 0 CA-C-O 120.948 0.404 . . . . 0.0 110.448 179.839 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.587 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 29.9 Cg_endo -61.97 143.68 95.56 Favored 'Trans proline' 0 C--N 1.297 -2.148 0 C-N-CA 122.683 2.255 . . . . 0.0 111.989 -179.925 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.484 ' O ' HG23 ' A' ' 108' ' ' VAL . 21.1 t -173.27 120.77 0.35 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.491 179.717 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.58 -41.09 63.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.067 0.461 . . . . 0.0 111.121 179.725 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -65.85 -40.4 91.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.904 -179.372 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.07 -39.95 95.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.762 -179.909 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 104' ' ' SER . 69.6 t -67.54 -43.77 86.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.795 179.652 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.43 -39.18 92.48 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.589 -179.284 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.442 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.39 -23.59 62.72 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.455 179.858 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.551 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.3 mm-40 -90.79 4.81 50.66 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.717 -179.509 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.551 ' C ' ' O ' ' A' ' 111' ' ' GLN . 10.5 tpt 23.67 63.86 0.39 Allowed Pre-proline 0 N--CA 1.465 0.297 0 CA-C-O 120.898 0.38 . . . . 0.0 111.059 -179.993 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.445 ' HG2' HD11 ' A' ' 116' ' ' ILE . 70.6 Cg_endo -78.7 168.55 20.93 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 C-N-CA 122.938 2.425 . . . . 0.0 112.213 -178.463 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.498 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 99.0 m-20 -113.04 -44.42 3.28 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.978 179.517 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.2 tp -120.23 119.62 33.74 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.577 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.456 HD13 HD22 ' A' ' 133' ' ' LEU . 95.4 mt -116.78 131.04 70.59 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.351 0 CA-C-O 120.953 0.406 . . . . 0.0 110.918 -179.856 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.617 HD12 ' OG ' ' A' ' 48' ' ' SER . 30.9 mt -105.69 132.75 51.45 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.115 0.483 . . . . 0.0 110.279 -179.466 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.421 HD12 HG23 ' A' ' 139' ' ' THR . 98.2 mt -118.33 136.24 56.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.724 -179.729 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 85.7 p -72.18 153.08 41.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.672 179.975 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -59.96 -50.0 75.49 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.612 -179.817 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -149.45 153.91 38.02 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.571 179.799 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 170.05 -170.56 42.96 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 179.919 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -63.04 -34.77 90.88 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 179.98 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.447 ' OD1' ' O ' ' A' ' 124' ' ' ASP . 43.9 p-10 -88.04 120.4 29.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.764 0.316 . . . . 0.0 110.683 179.934 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.455 ' O ' HD12 ' A' ' 129' ' ' LEU . 40.8 t -63.45 144.12 57.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.466 -179.928 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.521 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.37 -42.82 9.08 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.031 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.6 tp -62.82 -42.36 99.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.669 -179.832 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.05 -10.93 57.64 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.543 -179.461 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.455 HD12 ' O ' ' A' ' 125' ' ' SER . 85.2 mt -115.54 -24.14 8.46 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.695 -179.918 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 130' ' ' TYR . . . . . 0.521 ' N ' ' O ' ' A' ' 126' ' ' ALA . 78.7 t80 -51.84 -49.88 61.97 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.554 -178.902 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.1 p-10 -65.91 -42.11 90.57 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.909 0.385 . . . . 0.0 111.232 179.569 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.52 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 88.0 mt-30 -67.32 -36.74 82.07 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.78 179.929 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.456 HD22 HD13 ' A' ' 116' ' ' ILE . 93.7 mt -80.38 -41.74 24.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.975 -179.541 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.2 t -57.44 -44.71 84.95 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.223 -179.109 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 18.9 m -62.23 -45.59 92.66 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.799 0.333 . . . . 0.0 110.66 179.264 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 92.1 mt -62.36 -43.85 98.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.325 -179.792 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.605 ' HB1' ' HD2' ' A' ' 138' ' ' PRO . . . -170.37 163.79 5.94 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.541 179.832 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.605 ' HD2' ' HB1' ' A' ' 137' ' ' ALA . 78.3 Cg_exo -43.36 111.24 0.22 Allowed 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.501 2.134 . . . . 0.0 112.115 179.553 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.469 HG21 ' CD1' ' A' ' 130' ' ' TYR . 17.4 m -85.44 127.55 34.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.594 179.933 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.643 HD13 ' CD2' ' A' ' 37' ' ' HIS . 34.3 tp -119.11 136.93 53.92 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.957 -179.718 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.432 ' O ' ' OD1' ' A' ' 32' ' ' ASP . 79.8 mt -103.9 119.83 53.17 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.41 0 CA-C-O 121.183 0.516 . . . . 0.0 111.308 -179.382 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.507 HD12 HD22 ' A' ' 117' ' ' LEU . 98.1 mt -135.42 132.52 52.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.651 179.657 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.481 ' ND2' ' OD2' ' A' ' 241' ' ' ASP . 2.2 t-20 -65.56 149.41 50.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.899 0.38 . . . . 0.0 110.388 179.258 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.524 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 88.1 t80 -83.07 122.5 28.42 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.002 -179.496 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.524 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 98.9 m-20 55.09 69.58 0.72 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.871 179.608 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 49.2 p-10 -123.69 -0.01 8.65 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 120.974 0.416 . . . . 0.0 110.696 179.8 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -151.59 117.25 5.41 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.767 -179.512 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 84.7 p -63.07 167.53 4.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.5 -179.811 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.419 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.6 p-90 -50.74 -15.47 0.29 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.518 -179.823 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.442 ' O ' HG23 ' A' ' 154' ' ' THR . 68.1 tp60 -71.72 -74.45 0.16 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.458 -179.843 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.451 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.2 t -62.61 -39.22 93.08 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.008 0.432 . . . . 0.0 110.274 179.408 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 53.3 tp -60.23 -45.43 93.25 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.364 -178.516 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.419 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 45.7 tp -62.74 -41.73 99.32 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.398 179.025 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.451 ' OG1' ' O ' ' A' ' 151' ' ' SER . 51.8 p -64.05 -34.64 78.47 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.284 -179.469 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.456 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 88.2 mm-40 -63.98 -42.44 97.21 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.157 179.223 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 92.9 mt -65.35 -38.95 91.63 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.068 0.461 . . . . 0.0 110.223 179.137 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.582 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.15 -32.16 79.48 Favored Glycine 0 CA--C 1.52 0.362 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 -179.367 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.456 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.2 mt-10 -36.22 -25.68 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.814 0.34 . . . . 0.0 110.741 179.95 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.582 ' N ' ' O ' ' A' ' 157' ' ' GLY . 94.9 mt -58.95 149.68 5.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.276 179.303 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 75.2 p -69.3 137.08 52.7 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.076 -179.541 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 70.98 21.67 78.31 Favored Glycine 0 C--N 1.329 0.156 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 179.518 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 59.5 m80 -123.3 -14.95 7.34 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.732 0.301 . . . . 0.0 110.573 179.912 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -66.51 -59.63 3.46 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.779 -179.744 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -51.9 -48.9 63.93 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.173 -179.645 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -60.76 -41.03 94.64 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.981 -0.288 . . . . 0.0 110.316 179.534 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.58 -47.29 86.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.575 179.81 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.8 -40.25 75.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.178 -179.828 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -61.67 -50.24 73.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.627 179.56 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -65.43 -43.76 89.45 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.506 179.532 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 95.4 mt -64.6 -43.44 96.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.51 179.694 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.33 -51.03 71.02 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.542 -179.12 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.91 -43.62 95.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.44 179.685 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.659 ' CE2' HD11 ' A' ' 177' ' ' LEU . 56.3 t80 -62.63 -44.63 95.8 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.058 0.456 . . . . 0.0 110.404 179.41 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -63.21 -39.88 95.87 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.59 -179.363 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -62.92 -42.86 99.93 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.637 179.218 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -60.61 -44.83 95.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.073 179.987 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.659 HD11 ' CE2' ' A' ' 173' ' ' PHE . 85.6 mt -64.37 -41.21 96.83 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.044 0.449 . . . . 0.0 110.672 178.901 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.06 -62.16 1.81 Allowed 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.527 -179.342 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.79 -46.54 87.32 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.571 179.803 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.36 -41.58 65.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.179 -179.994 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -63.76 -33.78 76.42 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.932 0.396 . . . . 0.0 110.336 179.305 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.427 ' O ' ' HG2' ' A' ' 182' ' ' GLU . 69.8 tt0 -90.5 8.81 31.99 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.312 0.577 . . . . 0.0 110.509 -179.031 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -104.82 -32.26 8.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.887 0.375 . . . . 0.0 111.274 179.56 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.3 pt -128.01 147.41 32.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.836 -179.861 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -139.88 131.14 26.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.336 179.346 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.596 HD22 ' N ' ' A' ' 186' ' ' LEU . 3.5 mm? -85.61 133.7 41.4 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.879 179.938 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -43.95 157.96 0.13 Allowed 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.669 2.246 . . . . 0.0 112.171 179.401 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 0.523 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.6 Cg_endo -62.95 114.78 2.58 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 C-N-CA 122.82 2.347 . . . . 0.0 111.7 179.773 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 189' ' ' GLN . . . . . 0.523 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.8 mt-30 155.56 147.89 0.0 OUTLIER Pre-proline 0 N--CA 1.455 -0.195 0 O-C-N 123.555 0.535 . . . . 0.0 110.721 -179.858 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -73.72 144.09 34.73 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.644 2.229 . . . . 0.0 111.911 178.043 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.496 HG23 ' OG ' ' A' ' 258' ' ' SER . 2.1 p -124.93 158.91 32.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.336 0.589 . . . . 0.0 110.086 179.983 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 192' ' ' THR . . . . . 0.496 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 37.1 p -143.47 165.35 27.78 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.135 -179.653 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 193' ' ' ALA . . . . . 0.441 ' HA ' ' H ' ' A' ' 260' ' ' PHE . . . -135.26 128.49 31.97 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.144 0.497 . . . . 0.0 110.181 179.618 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.508 HD11 HD23 ' A' ' 259' ' ' LEU . 47.3 pt -146.48 148.92 16.49 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.056 179.814 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 195' ' ' VAL . . . . . 0.744 HG13 ' CD1' ' A' ' 262' ' ' PHE . 70.4 t -117.74 123.22 71.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.278 0.561 . . . . 0.0 109.681 179.183 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -134.26 107.35 7.61 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.251 179.66 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 95.8 m -130.93 130.53 43.59 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.85 179.707 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -82.92 -36.92 24.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.245 179.691 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.5 -67.07 0.26 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.343 -179.939 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.52 -10.1 59.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.249 179.606 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 60.0 t-80 61.03 58.42 2.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.816 -179.959 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 37.3 p -166.88 153.33 8.46 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.5 179.573 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.08 143.77 24.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.985 0.421 . . . . 0.0 110.431 179.455 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -135.21 138.06 43.25 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.667 179.993 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 20.0 mt -106.13 125.37 50.91 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.059 0.457 . . . . 0.0 109.848 -179.633 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 206' ' ' TRP . . . . . 0.558 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 74.9 m95 -82.01 167.04 19.27 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.603 -179.787 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 207' ' ' THR . . . . . 0.465 HG22 ' C ' ' A' ' 206' ' ' TRP . 0.1 OUTLIER -156.75 171.67 7.11 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.598 -179.214 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -54.09 -36.87 86.35 Favored 'Trans proline' 0 C--N 1.303 -1.865 0 C-N-CA 122.663 2.242 . . . . 0.0 111.952 179.379 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -70.61 -34.96 72.68 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.795 -179.811 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 21.2 m -61.28 150.57 34.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.635 -179.321 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.5 -37.07 82.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.52 -179.821 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 212' ' ' GLN . . . . . 0.558 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 54.9 tt0 -64.53 -40.36 95.47 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.497 179.957 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.74 -43.39 91.91 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 179.791 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -63.4 -43.53 97.27 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.715 0.293 . . . . 0.0 110.23 179.842 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 215' ' ' MET . . . . . 0.542 ' SD ' ' HB2' ' A' ' 304' ' ' ALA . 65.1 ttp -59.51 -48.07 83.06 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.227 -179.853 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 216' ' ' LEU . 87.5 mt -60.64 -40.8 93.3 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.636 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 217' ' ' GLU . . . . . 0.453 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.1 tp10 -58.02 -37.87 75.15 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.852 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -65.29 -38.12 89.26 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.803 0.335 . . . . 0.0 110.686 179.663 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 94.0 mt -64.41 -42.6 95.98 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.587 -179.595 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.62 45.0 0.08 OUTLIER Glycine 0 C--N 1.334 0.429 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 -179.962 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 221' ' ' PHE . . . . . 0.453 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 26.5 m-85 -128.23 155.91 43.8 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.038 0.447 . . . . 0.0 110.492 -179.792 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.491 ' O ' HG13 ' A' ' 191' ' ' VAL . 8.2 p -107.62 122.44 46.71 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.191 0.519 . . . . 0.0 110.182 -179.934 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.472 HD22 ' C ' ' A' ' 222' ' ' THR . 4.3 mm? -101.12 133.29 45.86 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.053 -179.995 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -97.0 159.05 15.13 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.494 179.906 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.0 115.16 29.8 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.335 179.899 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.494 HD12 ' N ' ' A' ' 226' ' ' LEU . 9.0 mp -53.33 156.66 3.89 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.698 179.921 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -60.27 145.31 98.83 Favored 'Trans proline' 0 C--N 1.301 -1.93 0 C-N-CA 122.598 2.199 . . . . 0.0 112.12 179.296 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.21 -3.05 59.03 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.493 -179.884 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.28 -40.83 5.67 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 -179.828 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.532 ' O ' ' N ' ' A' ' 233' ' ' SER . 85.6 mt -79.44 -16.96 55.26 Favored 'General case' 0 C--O 1.222 -0.344 0 CA-C-O 121.002 0.429 . . . . 0.0 110.295 -179.694 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 231' ' ' ASN . . . . . 0.401 ' C ' ' O ' ' A' ' 230' ' ' LEU . 55.0 t-20 -40.3 -49.08 2.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.783 -179.541 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -88.08 15.44 7.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.818 0.342 . . . . 0.0 111.325 179.802 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.532 ' N ' ' O ' ' A' ' 230' ' ' LEU . 78.1 p -60.5 -35.56 76.24 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.594 -179.799 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 234' ' ' GLN . . . . . 0.525 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.7 tt0 -118.4 -69.36 0.85 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.942 179.575 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.4 m -70.0 103.05 2.15 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.65 -179.776 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -94.13 57.64 2.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.456 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -145.04 -122.1 1.51 Allowed Glycine 0 CA--C 1.521 0.433 0 N-CA-C 110.966 -0.854 . . . . 0.0 110.966 -179.993 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -135.32 112.19 10.18 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 121.172 0.51 . . . . 0.0 110.383 179.939 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 239' ' ' ARG . . . . . 0.518 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.4 mtt180 -148.28 57.81 1.07 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.709 -179.941 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -69.57 -32.09 70.65 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.482 179.617 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 241' ' ' ASP . . . . . 0.481 ' OD2' ' ND2' ' A' ' 143' ' ' ASN . 64.8 t0 -56.7 -47.12 80.62 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.436 -179.113 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 242' ' ' ILE . . . . . 0.432 ' O ' ' O ' ' A' ' 239' ' ' ARG . 17.8 tt -140.2 156.92 24.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.925 0.393 . . . . 0.0 110.52 179.758 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.442 HG22 HD13 ' A' ' 245' ' ' LEU . 96.2 mt -106.14 106.29 20.3 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.227 0 CA-C-O 121.204 0.526 . . . . 0.0 110.507 179.759 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 244' ' ' GLN . . . . . 0.603 ' O ' HD12 ' A' ' 245' ' ' LEU . 88.3 mt-30 -110.29 110.04 20.71 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.336 179.702 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.603 HD12 ' O ' ' A' ' 244' ' ' GLN . 9.4 mp -121.78 -168.18 1.66 Allowed 'General case' 0 C--O 1.225 -0.199 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.711 179.78 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 246' ' ' GLY . . . . . 0.525 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.32 -16.53 0.05 OUTLIER Glycine 0 CA--C 1.523 0.546 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 179.833 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 247' ' ' GLY . . . . . 0.669 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -60.62 157.01 30.48 Favored Glycine 0 CA--C 1.521 0.443 0 N-CA-C 110.904 -0.878 . . . . 0.0 110.904 -179.892 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -63.81 21.67 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.947 0.404 . . . . 0.0 110.559 179.899 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 249' ' ' ASN . . . . . 0.669 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.8 m-20 -97.38 -5.85 35.41 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.572 179.965 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 92.8 mt -80.13 -21.71 42.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.617 179.51 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.55 -51.28 70.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.801 -179.529 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.58 -5.29 58.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.419 179.686 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.15 -74.26 1.15 Allowed Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 -179.897 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 80.9 mt -70.14 126.05 28.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.069 0.462 . . . . 0.0 110.269 -179.87 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -59.59 -39.17 83.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.337 -179.659 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 83.0 51.87 4.04 Favored Glycine 0 CA--C 1.521 0.421 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 179.827 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -95.82 -15.13 22.71 Favored 'General case' 0 C--N 1.332 -0.17 0 O-C-N 122.632 -0.334 . . . . 0.0 110.594 -179.861 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 258' ' ' SER . . . . . 0.496 ' OG ' HG23 ' A' ' 191' ' ' VAL . 3.5 t 174.63 88.8 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.063 0.459 . . . . 0.0 110.157 179.989 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.862 HD12 ' N ' ' A' ' 259' ' ' LEU . 0.9 OUTLIER -94.26 123.96 37.98 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.309 0.576 . . . . 0.0 111.183 -179.141 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 260' ' ' PHE . . . . . 0.441 ' H ' ' HA ' ' A' ' 193' ' ' ALA . 15.9 m-30 -92.93 146.4 23.65 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.34 179.283 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 86.0 mt -122.37 149.69 43.45 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.491 -179.822 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.744 ' CD1' HG13 ' A' ' 195' ' ' VAL . 2.6 p90 -77.56 -138.39 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.563 -179.841 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 263' ' ' ALA . . . . . 0.659 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -51.99 77.48 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.006 179.986 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 264' ' ' GLY . . . . . 0.632 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.1 104.48 0.19 Allowed Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 -179.929 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 265' ' ' ASP . . . . . 0.601 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.8 m-20 -80.47 -177.69 6.33 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 120.741 0.305 . . . . 0.0 110.858 -179.562 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -40.51 -17.64 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.57 179.846 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 267' ' ' LYS . . . . . 0.601 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.54 -51.55 41.67 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.715 179.448 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -63.73 -46.75 83.95 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.15 179.483 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 269' ' ' ALA . . . . . 0.572 ' HB1' ' OH ' ' A' ' 273' ' ' TYR . . . -61.56 -35.17 77.02 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.774 179.545 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -62.87 -34.45 77.4 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.166 179.649 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.46 -43.23 13.77 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.3 -179.569 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 272' ' ' ILE . . . . . 0.584 ' C ' ' H ' ' A' ' 274' ' ' ALA . 5.0 tt -51.41 -33.55 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.904 -178.884 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 273' ' ' TYR . . . . . 0.572 ' OH ' ' HB1' ' A' ' 269' ' ' ALA . 17.1 m-85 -54.59 -1.75 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.69 -179.653 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 274' ' ' ALA . . . . . 0.584 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.64 -39.56 70.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.857 179.581 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 275' ' ' ASN . . . . . 0.583 ' O ' ' N ' ' A' ' 279' ' ' ALA . 3.0 p30 -39.51 98.23 0.16 Allowed Pre-proline 0 N--CA 1.463 0.175 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.538 -179.634 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -54.08 -43.04 61.95 Favored 'Trans proline' 0 C--N 1.303 -1.824 0 C-N-CA 122.388 2.058 . . . . 0.0 112.691 -178.821 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 89.5 mt -64.48 -42.76 95.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.14 0.495 . . . . 0.0 111.181 -179.691 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 91.4 mt -95.82 -1.52 49.43 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.884 -179.456 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 279' ' ' ALA . . . . . 0.583 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.38 -34.93 77.68 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.644 -179.812 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -74.09 20.05 0.11 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.048 -179.354 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 0.492 HD23 ' HA ' ' A' ' 281' ' ' LEU . 13.7 mt -75.06 120.23 80.68 Favored Pre-proline 0 N--CA 1.452 -0.349 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.424 179.981 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -51.12 -39.5 60.85 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.624 2.216 . . . . 0.0 111.8 179.099 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.82 -50.26 64.02 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.096 179.879 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 74.0 t -61.51 -43.93 97.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.562 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -57.86 -41.19 81.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.305 -179.942 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -90.87 -0.0 57.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.061 179.695 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt 59.47 43.1 16.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.967 0.413 . . . . 0.0 110.829 179.714 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -94.59 41.42 1.09 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.383 179.797 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 54.5 t -118.92 135.84 58.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.074 0.464 . . . . 0.0 110.179 -179.677 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -133.0 162.6 31.25 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.726 -179.663 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.58 155.4 32.3 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-O 120.956 0.408 . . . . 0.0 110.776 -179.87 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 81.5 mt -94.22 -1.47 54.02 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.281 -179.723 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.24 165.93 12.8 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.611 -0.996 . . . . 0.0 110.611 -179.838 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 7.2 m -87.64 -62.46 1.49 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.934 0.397 . . . . 0.0 111.08 -179.901 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 295' ' ' GLU . . . . . 0.44 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.6 mm-40 -69.46 -3.82 16.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.674 -179.845 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 22.7 p -76.91 32.47 0.14 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.601 -179.892 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 297' ' ' PHE . . . . . 0.502 ' CD2' HG22 ' A' ' 70' ' ' THR . 77.1 t80 -60.24 -46.08 91.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.592 -179.962 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 298' ' ' ARG . . . . . 0.612 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.1 mtt85 -80.92 134.85 35.8 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.016 0.436 . . . . 0.0 110.583 -179.742 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.452 ' H ' HG11 ' A' ' 51' ' ' VAL . 17.0 tp -114.48 118.2 33.11 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.203 179.882 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 300' ' ' ASP . . . . . 0.631 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.0 p-10 -165.78 -176.08 3.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.585 179.94 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 82.5 t80 -47.16 -43.77 21.38 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.286 -179.719 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -66.69 -40.51 88.55 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.03 0.443 . . . . 0.0 110.823 179.136 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 303' ' ' SER . . . . . 0.631 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 59.6 p -55.87 -36.18 67.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.087 -179.21 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 304' ' ' ALA . . . . . 0.542 ' HB2' ' SD ' ' A' ' 215' ' ' MET . . . -57.37 -51.48 69.23 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.52 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 91.0 mtp -56.23 -43.63 78.8 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.953 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -66.34 -42.68 87.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.986 0.422 . . . . 0.0 110.226 178.79 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 307' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 303' ' ' SER . 55.8 t -64.03 -42.95 97.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.154 179.373 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 42.7 tp -59.63 -42.28 92.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.87 -179.513 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -62.71 -38.86 92.11 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 179.465 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 310' ' ' ARG . . . . . 0.444 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.6 ttt85 -63.5 -44.12 95.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.229 179.525 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 88.7 mt -63.19 -41.97 99.26 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.23 179.655 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt -62.84 -33.34 75.05 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.99 179.461 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.86 -23.59 21.62 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.461 -179.775 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.48 HD22 ' CE2' ' A' ' 315' ' ' PHE . 6.7 tt -62.26 -43.14 99.51 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.607 -179.925 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 315' ' ' PHE . . . . . 0.48 ' CE2' HD22 ' A' ' 314' ' ' LEU . 90.9 m-85 . . . . . 0 C--O 1.221 -0.431 0 CA-C-O 117.979 -1.01 . . . . 0.0 110.503 179.947 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -100.11 136.85 39.38 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.008 0.432 . . . . 0.0 110.5 -179.929 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.498 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -91.78 178.46 1.73 Allowed Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.54 -179.911 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.498 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.7 Cg_exo -61.61 147.48 95.28 Favored 'Trans proline' 0 C--N 1.3 -2.023 0 C-N-CA 122.772 2.315 . . . . 0.0 112.179 179.627 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.465 ' HE ' HD12 ' A' ' 39' ' ' LEU . 35.6 ptt180 -136.05 142.61 44.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.699 179.766 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -78.96 117.13 19.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.574 179.918 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.433 ' O ' HG23 ' A' ' 30' ' ' ILE . 9.6 tp -110.51 130.94 62.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.395 -179.956 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.5 t -70.43 142.07 52.03 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.62 179.812 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.422 ' OD1' ' O ' ' A' ' 141' ' ' ILE . 25.8 t70 -139.9 177.42 7.98 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.452 -179.902 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.0 p -73.79 -36.26 65.01 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.693 179.925 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -47.71 -94.86 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.317 -179.525 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.422 ' O ' ' OG1' ' A' ' 36' ' ' THR . . . -165.59 -25.96 0.02 OUTLIER Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.889 -0.885 . . . . 0.0 110.889 179.913 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.422 ' OG1' ' O ' ' A' ' 35' ' ' GLY . 53.2 m -169.25 106.72 0.41 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.864 0.364 . . . . 0.0 110.665 -179.899 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.426 ' ND1' HD13 ' A' ' 140' ' ' LEU . 50.8 t-80 -129.48 146.65 51.29 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.095 0.474 . . . . 0.0 110.1 179.997 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.623 HG22 ' N ' ' A' ' 39' ' ' LEU . 96.8 m -129.89 166.07 20.74 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.653 -179.814 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.623 ' N ' HG22 ' A' ' 38' ' ' THR . 82.5 mt -121.01 127.84 52.14 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.432 179.76 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -64.12 -44.58 91.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.639 -179.905 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 42.9 p -165.96 155.25 11.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.365 179.688 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.472 ' CD ' ' H ' ' A' ' 42' ' ' GLN . 14.1 mp0 -43.34 100.7 0.23 Allowed Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.605 179.415 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -56.8 129.29 33.78 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 122.318 2.012 . . . . 0.0 112.282 -179.612 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -83.72 -24.59 31.14 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.46 179.575 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.538 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.3 mtm-85 -122.31 134.94 54.65 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.169 0.509 . . . . 0.0 110.293 -179.974 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.1 mt -130.24 133.47 64.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.92 -179.681 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 45.4 t -124.34 130.83 73.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-O 120.848 0.356 . . . . 0.0 110.062 179.384 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.622 ' OG ' HD12 ' A' ' 117' ' ' LEU . 2.2 m -154.44 166.55 32.9 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.532 179.795 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 72.5 p -124.13 8.42 8.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.521 179.917 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.3 t -86.13 125.75 33.72 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.677 -179.551 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.483 HG11 ' H ' ' A' ' 299' ' ' LEU . 87.2 t -65.64 -44.48 93.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.453 -179.984 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.4 m -62.29 -44.31 96.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.667 -179.917 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 46.1 tp -62.39 -41.3 98.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.537 -179.431 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.447 ' O ' HD13 ' A' ' 58' ' ' LEU . 71.4 m -57.79 -44.64 86.4 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.353 -179.262 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.21 -62.21 5.36 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 179.535 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.7 t -48.39 -35.52 12.84 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 -179.917 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.9 mt -61.71 -44.42 96.96 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.698 -0.401 . . . . 0.0 111.207 179.407 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.447 HD13 ' O ' ' A' ' 54' ' ' THR . 9.2 mp -64.9 -41.8 95.3 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.352 177.956 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.62 -41.05 98.33 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.098 -179.251 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.432 ' O ' HG23 ' A' ' 60' ' ' ILE . 8.0 tp -88.25 16.94 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.775 -179.644 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 56.36 84.2 0.09 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.676 -179.899 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.44 57.63 0.07 OUTLIER Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.277 -0.42 . . . . 0.0 109.994 -179.826 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -50.53 153.19 7.99 Favored 'Trans proline' 0 C--N 1.295 -2.237 0 C-N-CA 122.9 2.4 . . . . 0.0 112.426 -178.305 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.439 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -109.16 144.94 16.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.424 -179.709 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.8 mt -63.72 -45.36 97.53 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.35 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.444 -179.775 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.5 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -128.76 133.77 48.2 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.865 0.364 . . . . 0.0 110.518 -179.867 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.516 ' O ' ' N ' ' A' ' 98' ' ' LEU . 75.1 m -135.0 158.87 43.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.819 -179.648 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -87.23 139.45 16.12 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 179.828 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.481 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.88 -162.58 0.08 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.986 0.422 . . . . 0.0 110.429 -179.944 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.533 HG22 ' CD2' ' A' ' 297' ' ' PHE . 14.0 t -133.48 133.99 42.95 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.318 179.966 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.492 ' C ' ' O ' ' A' ' 70' ' ' THR . 0.6 OUTLIER 29.69 68.81 0.65 Allowed Pre-proline 0 N--CA 1.464 0.229 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.768 -179.93 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -61.09 145.36 99.01 Favored 'Trans proline' 0 C--N 1.3 -1.992 0 C-N-CA 122.648 2.232 . . . . 0.0 112.101 -178.437 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.533 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 46.1 p-10 -158.74 -32.05 0.07 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.703 179.726 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.547 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 99.1 m-20 -64.14 -39.92 95.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.579 179.825 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -60.49 -48.26 82.55 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.704 -179.207 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.415 ' O ' ' O ' ' A' ' 77' ' ' ALA . 90.4 t -60.23 -24.94 32.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.804 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.547 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -46.03 172.97 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.541 179.862 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.581 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.5 p30 -62.01 177.7 0.43 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.611 -179.691 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.558 ' C ' ' H ' ' A' ' 81' ' ' GLY . 35.6 p30 -44.76 85.72 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.0 179.924 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.581 ' N ' ' O ' ' A' ' 78' ' ' ASP . 42.7 tp60 -67.43 13.03 0.08 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.06 -179.758 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.558 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 118.62 -21.85 9.6 Favored Glycine 0 CA--C 1.519 0.328 0 N-CA-C 110.974 -0.85 . . . . 0.0 110.974 179.94 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -107.92 116.29 31.68 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.953 0.406 . . . . 0.0 110.494 179.856 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 73.2 mt -98.62 -0.01 43.91 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.436 -179.71 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -92.6 7.39 43.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.947 0.403 . . . . 0.0 110.387 -179.785 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.802 ' O ' HG22 ' A' ' 89' ' ' VAL . 27.1 mt-30 -100.07 -28.33 13.1 Favored 'General case' 0 C--O 1.224 -0.25 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.842 -179.996 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 68.9 t-105 -62.5 -40.89 98.16 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.867 -179.632 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.555 ' O ' ' N ' ' A' ' 91' ' ' LYS . 63.4 m -77.59 -53.55 7.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.195 -179.425 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -48.53 -50.73 30.76 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.013 -179.277 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.802 HG22 ' O ' ' A' ' 85' ' ' GLN . 15.4 m -68.91 -40.59 81.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 120.896 0.379 . . . . 0.0 111.048 179.723 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.496 ' N ' HG23 ' A' ' 89' ' ' VAL . . . -72.29 -22.84 61.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.8 -179.927 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.555 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.0 tttm -61.86 -45.53 93.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.429 -179.541 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.442 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.4 mm-40 -90.49 -94.92 0.12 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.13 -179.846 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.626 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.9 mtt180 -143.09 59.1 1.41 Allowed 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.828 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.462 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.7 pttp 33.37 26.77 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.242 -179.171 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.626 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.4 tt -48.71 123.58 7.08 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.951 -178.131 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.459 ' O ' HD23 ' A' ' 95' ' ' LEU . 99.1 mm-40 -84.33 -169.1 2.44 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.08 -179.937 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.609 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 81.0 mtp180 -74.86 136.64 41.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.279 -179.798 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.516 ' N ' ' O ' ' A' ' 67' ' ' SER . 90.9 mt -85.39 -165.71 1.3 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.633 -179.642 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.54 ' O ' ' CD2' ' A' ' 99' ' ' TYR . 47.7 p90 -168.32 119.49 0.8 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.209 179.982 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.516 ' C ' ' O ' ' A' ' 99' ' ' TYR . 42.8 mm -28.77 120.8 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.0 -179.63 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 114.51 27.63 3.26 Favored Glycine 0 CA--C 1.519 0.315 0 N-CA-C 111.15 -0.78 . . . . 0.0 111.15 -179.494 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.579 ' CD ' ' H ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -144.84 46.51 0.61 Allowed Pre-proline 0 C--N 1.323 -0.546 0 CA-C-O 120.891 0.377 . . . . 0.0 110.488 179.909 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.574 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 29.4 Cg_endo -61.88 144.31 96.56 Favored 'Trans proline' 0 C--N 1.296 -2.197 0 C-N-CA 122.652 2.235 . . . . 0.0 111.968 -179.942 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.449 ' O ' HG23 ' A' ' 108' ' ' VAL . 27.0 t -173.24 119.97 0.33 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.446 179.728 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.4 -40.33 64.38 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.021 0.439 . . . . 0.0 111.088 179.647 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -66.32 -39.69 89.44 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.819 -179.403 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.95 -40.04 95.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.704 -179.816 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 104' ' ' SER . 71.7 t -67.38 -43.93 87.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.712 179.681 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.87 -38.91 92.75 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.524 -179.349 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.442 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.4 -23.68 62.82 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.465 179.89 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.561 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.5 mm-40 -91.24 5.17 50.2 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.723 -179.552 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.561 ' C ' ' O ' ' A' ' 111' ' ' GLN . 10.3 tpt 22.24 64.72 0.33 Allowed Pre-proline 0 N--CA 1.465 0.277 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.043 179.985 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -78.57 169.05 20.41 Favored 'Trans proline' 0 C--N 1.304 -1.811 0 C-N-CA 122.99 2.46 . . . . 0.0 112.082 -178.461 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.423 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 98.8 m-20 -110.73 -42.76 3.96 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 121.013 0.435 . . . . 0.0 110.231 179.47 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.0 tp -119.95 120.78 37.37 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.974 179.571 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 83.7 mt -114.02 129.23 70.31 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.37 0 CA-C-O 120.936 0.398 . . . . 0.0 110.92 -179.858 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.622 HD12 ' OG ' ' A' ' 48' ' ' SER . 30.8 mt -109.24 132.03 54.51 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.048 0.451 . . . . 0.0 110.198 -179.705 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.496 HD12 HG23 ' A' ' 139' ' ' THR . 98.8 mt -119.61 138.05 51.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.706 -179.781 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 85.1 p -71.88 153.97 41.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.554 179.978 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.28 -50.35 74.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.671 -179.793 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -149.58 154.06 38.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.601 179.809 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 170.66 -170.78 43.37 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.911 -0.875 . . . . 0.0 110.911 179.824 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.96 -34.09 88.97 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 179.936 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.45 ' OD1' ' O ' ' A' ' 124' ' ' ASP . 44.4 p-10 -86.96 120.33 28.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.843 0.354 . . . . 0.0 110.673 179.953 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.45 ' O ' HD12 ' A' ' 129' ' ' LEU . 39.1 t -63.26 143.63 57.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.045 0.45 . . . . 0.0 110.447 -179.932 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.0 -43.26 9.0 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.945 -179.97 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.6 tp -62.81 -42.48 99.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.705 -179.831 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.58 -11.71 58.72 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.515 -179.444 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.45 HD12 ' O ' ' A' ' 125' ' ' SER . 84.8 mt -115.0 -24.05 8.78 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.724 -179.866 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 130' ' ' TYR . . . . . 0.519 ' N ' ' O ' ' A' ' 126' ' ' ALA . 80.8 t80 -51.22 -49.57 60.8 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.579 -178.901 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.7 p-10 -66.17 -42.33 89.06 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.8 0.333 . . . . 0.0 111.18 179.538 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.524 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 88.2 mt-30 -67.42 -37.67 83.42 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.761 179.975 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.416 HD12 HD11 ' A' ' 118' ' ' ILE . 95.6 mt -80.22 -41.89 24.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.932 -179.599 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.2 t -57.17 -44.28 83.36 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.24 -179.07 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.1 m -62.06 -45.44 93.55 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.775 0.321 . . . . 0.0 110.572 179.357 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 92.9 mt -62.28 -43.64 98.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.229 -179.774 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.658 ' HB1' ' HD2' ' A' ' 138' ' ' PRO . . . -169.25 167.85 5.31 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.566 179.897 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.658 ' HD2' ' HB1' ' A' ' 137' ' ' ALA . 50.9 Cg_exo -49.04 112.56 0.67 Allowed 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.357 2.038 . . . . 0.0 112.116 179.377 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.496 HG23 HD12 ' A' ' 118' ' ' ILE . 21.6 m -84.5 127.37 34.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.641 -179.951 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.447 HD12 ' HA ' ' A' ' 140' ' ' LEU . 36.2 tp -118.62 137.95 52.92 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.066 -179.867 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.422 ' O ' ' OD1' ' A' ' 32' ' ' ASP . 77.1 mt -102.82 120.05 52.07 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 CA-C-O 121.224 0.535 . . . . 0.0 111.118 -179.415 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.443 HD12 HD22 ' A' ' 117' ' ' LEU . 98.5 mt -135.68 131.83 50.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.585 179.662 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.434 HD21 ' CG ' ' A' ' 241' ' ' ASP . 56.4 t30 -66.42 153.82 41.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.938 0.399 . . . . 0.0 110.467 179.373 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.527 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 90.5 t80 -87.73 122.43 31.38 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.831 -179.639 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.527 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 99.1 m-20 55.3 69.33 0.75 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.778 179.633 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 49.4 p-10 -123.73 -0.4 8.57 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.664 179.925 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -151.26 116.5 5.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.778 -179.541 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 148' ' ' SER . . . . . 0.418 ' C ' ' N ' ' A' ' 150' ' ' GLN . 83.4 p -62.15 166.5 4.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.479 -179.752 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.41 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.4 p-90 -50.68 -15.48 0.28 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.545 -179.812 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.452 ' O ' HG23 ' A' ' 154' ' ' THR . 68.3 tp60 -71.52 -74.26 0.16 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.466 -179.787 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.432 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.1 t -62.86 -39.29 93.95 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.272 179.467 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 54.8 tp -59.96 -45.76 91.61 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.399 -178.581 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.41 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 46.5 tp -62.65 -41.75 99.22 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.784 0.326 . . . . 0.0 110.404 179.054 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.452 HG23 ' O ' ' A' ' 150' ' ' GLN . 56.6 p -64.57 -34.73 78.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.358 -179.551 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.45 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 86.9 mm-40 -64.05 -42.84 96.9 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.313 179.284 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 91.5 mt -65.54 -38.83 90.75 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.057 0.456 . . . . 0.0 110.187 179.147 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.58 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.21 -32.11 79.44 Favored Glycine 0 CA--C 1.52 0.344 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 -179.36 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.45 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.2 mt-10 -35.58 -26.91 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.823 0.344 . . . . 0.0 110.812 179.955 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.58 ' N ' ' O ' ' A' ' 157' ' ' GLY . 94.8 mt -56.52 150.84 2.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.264 179.312 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 72.0 p -69.66 137.3 52.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.01 -179.541 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 70.15 22.37 77.34 Favored Glycine 0 N--CA 1.459 0.2 0 N-CA-C 111.214 -0.754 . . . . 0.0 111.214 179.462 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 59.5 m80 -123.12 -13.65 7.71 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.716 0.293 . . . . 0.0 110.566 179.906 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -67.21 -59.32 3.53 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.755 -179.687 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -52.14 -49.42 63.74 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.239 -179.595 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -60.36 -41.3 93.42 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.792 0.33 . . . . 0.0 110.336 179.525 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.52 -47.05 87.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.595 179.831 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.96 -40.14 75.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.204 -179.894 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -61.64 -50.24 73.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.589 179.553 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -65.47 -43.59 89.82 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.501 179.541 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 95.0 mt -64.64 -43.47 96.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.457 179.776 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.44 -51.27 70.1 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.641 -179.232 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.72 -44.16 94.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.545 179.697 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.644 ' CE2' HD11 ' A' ' 177' ' ' LEU . 55.0 t80 -62.86 -44.43 96.13 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.069 0.461 . . . . 0.0 110.443 179.438 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -63.33 -40.06 96.28 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.598 -179.331 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -62.92 -42.71 99.88 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.63 179.191 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -60.62 -44.8 95.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.103 -179.97 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.644 HD11 ' CE2' ' A' ' 173' ' ' PHE . 85.7 mt -64.44 -41.16 96.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.01 0.434 . . . . 0.0 110.714 178.951 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.18 -62.3 1.72 Allowed 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.497 -179.351 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.45 -46.81 85.81 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.566 179.887 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.21 -41.64 65.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.238 179.987 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -63.97 -33.77 76.48 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.998 0.428 . . . . 0.0 110.353 179.315 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.423 ' O ' ' HG2' ' A' ' 182' ' ' GLU . 69.6 tt0 -90.49 8.8 32.05 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.347 0.594 . . . . 0.0 110.533 -178.998 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -104.74 -32.14 9.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.181 179.607 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.2 pt -128.13 147.79 32.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.846 -179.818 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -140.11 131.12 26.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.356 179.427 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.602 HD22 ' N ' ' A' ' 186' ' ' LEU . 3.5 mm? -85.88 133.68 40.89 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.908 179.924 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -44.33 157.97 0.15 Allowed 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.727 2.284 . . . . 0.0 112.088 179.356 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 0.526 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.7 Cg_endo -62.92 115.13 2.75 Favored 'Trans proline' 0 C--N 1.303 -1.82 0 C-N-CA 122.801 2.334 . . . . 0.0 111.774 179.768 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 189' ' ' GLN . . . . . 0.526 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.7 mt-30 155.44 148.09 0.0 OUTLIER Pre-proline 0 N--CA 1.455 -0.208 0 O-C-N 123.635 0.584 . . . . 0.0 110.758 -179.867 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -73.83 144.17 34.4 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.676 2.25 . . . . 0.0 111.914 178.044 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.496 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.1 p -125.13 158.99 32.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.307 0.575 . . . . 0.0 110.121 -179.98 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 192' ' ' THR . . . . . 0.496 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 36.9 p -143.44 165.36 27.75 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.139 -179.678 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 193' ' ' ALA . . . . . 0.444 ' HA ' ' H ' ' A' ' 260' ' ' PHE . . . -135.41 128.74 32.13 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.135 0.493 . . . . 0.0 110.194 179.543 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.504 HD11 HD23 ' A' ' 259' ' ' LEU . 47.9 pt -146.28 148.58 16.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.077 179.825 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 195' ' ' VAL . . . . . 0.754 HG13 ' CD1' ' A' ' 262' ' ' PHE . 70.2 t -117.33 122.96 71.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.277 0.56 . . . . 0.0 109.681 179.161 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -134.37 107.49 7.64 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.32 179.707 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 95.1 m -131.17 130.54 43.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.855 179.833 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -82.53 -36.84 25.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.33 179.75 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.58 -67.36 0.24 Allowed 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.425 179.981 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.49 -9.86 59.08 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.265 179.55 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 60.5 t-80 60.42 58.78 2.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.784 -179.812 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 42.9 p -167.06 153.62 8.38 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.538 179.53 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.28 144.17 24.5 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.957 0.408 . . . . 0.0 110.453 179.432 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -135.06 137.28 42.75 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.569 -179.988 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 19.6 mt -105.44 125.16 50.67 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 121.066 0.46 . . . . 0.0 109.869 -179.676 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 206' ' ' TRP . . . . . 0.557 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 75.9 m95 -81.57 166.42 20.25 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.634 -179.794 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 207' ' ' THR . . . . . 0.463 HG22 ' C ' ' A' ' 206' ' ' TRP . 0.1 OUTLIER -156.57 171.52 7.29 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.536 -179.184 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_exo -54.23 -36.78 87.21 Favored 'Trans proline' 0 C--N 1.302 -1.874 0 C-N-CA 122.679 2.253 . . . . 0.0 112.079 179.173 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -70.33 -34.97 73.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.811 -179.806 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 22.3 m -61.6 149.83 38.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.587 -179.392 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.55 -36.83 81.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.494 -179.732 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 212' ' ' GLN . . . . . 0.557 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 55.1 tt0 -64.65 -40.61 95.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.56 179.873 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.08 -43.56 93.09 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 110.591 -1.003 . . . . 0.0 110.591 179.712 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -63.5 -42.76 98.52 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 179.72 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 215' ' ' MET . . . . . 0.568 ' SD ' ' HB2' ' A' ' 304' ' ' ALA . 64.6 ttp -59.47 -48.04 83.17 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.202 -179.898 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 216' ' ' LEU . 87.6 mt -60.74 -40.67 93.25 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.556 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 217' ' ' GLU . . . . . 0.455 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 40.7 tp10 -58.03 -38.09 75.58 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.841 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -65.12 -38.18 89.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.771 0.319 . . . . 0.0 110.621 179.641 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 94.5 mt -64.41 -42.78 95.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.517 -179.537 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 138.01 45.22 0.08 OUTLIER Glycine 0 C--N 1.335 0.479 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 179.982 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 221' ' ' PHE . . . . . 0.455 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 26.7 m-85 -128.8 156.45 43.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.057 0.456 . . . . 0.0 110.523 -179.739 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.49 ' O ' HG13 ' A' ' 191' ' ' VAL . 7.8 p -108.33 122.82 47.76 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 121.204 0.526 . . . . 0.0 110.185 -179.94 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.474 HD22 ' C ' ' A' ' 222' ' ' THR . 4.3 mm? -101.38 132.92 46.7 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.055 179.933 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.9 159.57 14.84 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.54 179.85 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -104.97 115.26 29.97 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.933 0.396 . . . . 0.0 110.395 179.824 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.495 HD12 ' N ' ' A' ' 226' ' ' LEU . 8.9 mp -53.72 156.96 4.25 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.669 179.914 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -60.18 145.24 98.93 Favored 'Trans proline' 0 C--N 1.302 -1.914 0 C-N-CA 122.637 2.224 . . . . 0.0 112.108 179.374 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.6 -2.47 58.64 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.56 -179.959 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.62 -40.42 5.66 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 -179.903 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.548 ' O ' ' N ' ' A' ' 233' ' ' SER . 85.9 mt -79.59 -16.51 55.74 Favored 'General case' 0 C--O 1.223 -0.311 0 CA-C-O 120.971 0.415 . . . . 0.0 110.314 -179.735 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 231' ' ' ASN . . . . . 0.404 ' C ' ' O ' ' A' ' 230' ' ' LEU . 55.4 t-20 -40.27 -48.8 2.67 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.687 -179.566 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -88.59 15.7 7.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.804 0.335 . . . . 0.0 111.258 179.807 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.548 ' N ' ' O ' ' A' ' 230' ' ' LEU . 78.1 p -60.63 -35.79 77.04 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.738 -179.839 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 234' ' ' GLN . . . . . 0.525 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.6 tt0 -118.06 -69.6 0.84 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.021 179.535 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 3.8 m -70.46 103.41 2.45 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.673 -179.796 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -94.64 57.94 2.27 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.363 179.93 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -145.15 -122.63 1.55 Allowed Glycine 0 CA--C 1.52 0.365 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 -179.958 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -133.7 112.03 11.07 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 121.118 0.485 . . . . 0.0 110.409 179.945 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 239' ' ' ARG . . . . . 0.488 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 94.7 mtt180 -148.25 56.61 1.06 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.753 -179.979 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -69.4 -31.36 69.68 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.511 179.593 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 241' ' ' ASP . . . . . 0.456 ' OD2' ' O ' ' A' ' 144' ' ' TYR . 64.8 t0 -56.69 -46.93 80.88 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.403 -179.069 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 242' ' ' ILE . . . . . 0.436 ' O ' ' O ' ' A' ' 239' ' ' ARG . 16.9 tt -140.85 158.18 23.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.934 0.397 . . . . 0.0 110.519 179.738 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.442 HG22 HD13 ' A' ' 245' ' ' LEU . 96.0 mt -105.97 105.97 19.71 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.2 0 CA-C-O 121.155 0.503 . . . . 0.0 110.407 179.821 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 244' ' ' GLN . . . . . 0.614 ' C ' HD12 ' A' ' 245' ' ' LEU . 88.2 mt-30 -110.76 110.69 21.43 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.369 179.74 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.614 HD12 ' C ' ' A' ' 244' ' ' GLN . 9.7 mp -122.03 -167.92 1.63 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.558 179.748 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 246' ' ' GLY . . . . . 0.525 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 172.54 -16.48 0.05 OUTLIER Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 179.879 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 247' ' ' GLY . . . . . 0.663 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -60.56 157.71 29.01 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 -179.855 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -64.22 21.09 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.971 0.415 . . . . 0.0 110.609 179.962 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 249' ' ' ASN . . . . . 0.663 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.8 m-20 -96.94 -5.54 37.69 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.564 179.955 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 92.2 mt -80.84 -20.99 41.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.611 179.535 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.52 -51.35 70.27 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.79 -179.671 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -89.29 -4.93 57.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.453 179.658 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.09 -74.16 1.15 Allowed Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 -179.923 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 81.7 mt -70.13 125.71 27.56 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.015 0.436 . . . . 0.0 110.237 -179.795 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -59.57 -39.49 84.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.369 -179.709 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 83.51 51.71 4.0 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 179.767 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -94.81 -16.57 22.86 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.724 0.297 . . . . 0.0 110.597 -179.899 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 258' ' ' SER . . . . . 0.495 ' OG ' HG23 ' A' ' 191' ' ' VAL . 3.4 t 175.19 89.63 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.057 0.456 . . . . 0.0 110.124 179.996 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.862 HD12 ' N ' ' A' ' 259' ' ' LEU . 0.9 OUTLIER -94.5 124.26 38.42 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.323 0.582 . . . . 0.0 111.139 -179.042 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 260' ' ' PHE . . . . . 0.444 ' H ' ' HA ' ' A' ' 193' ' ' ALA . 16.1 m-30 -93.53 146.93 23.43 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.362 179.22 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 86.2 mt -122.44 149.77 43.38 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.599 -179.893 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.754 ' CD1' HG13 ' A' ' 195' ' ' VAL . 2.6 p90 -77.72 -138.78 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.542 -179.849 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 263' ' ' ALA . . . . . 0.659 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -51.39 78.09 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.056 179.988 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 264' ' ' GLY . . . . . 0.629 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.95 104.63 0.19 Allowed Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.679 -0.969 . . . . 0.0 110.679 -179.987 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 265' ' ' ASP . . . . . 0.604 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.7 m-20 -80.29 -177.62 6.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.671 0.272 . . . . 0.0 110.883 -179.49 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -40.54 -17.48 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.858 0.361 . . . . 0.0 110.504 179.766 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 267' ' ' LYS . . . . . 0.604 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.53 -51.66 40.58 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.672 179.476 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -63.75 -46.59 84.64 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.212 179.343 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 269' ' ' ALA . . . . . 0.578 ' HB1' ' OH ' ' A' ' 273' ' ' TYR . . . -61.49 -35.41 77.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.78 179.599 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -62.56 -34.71 77.5 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.228 179.694 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.26 -43.09 14.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.319 -179.592 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 272' ' ' ILE . . . . . 0.586 ' C ' ' H ' ' A' ' 274' ' ' ALA . 5.0 tt -51.47 -33.89 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.824 -178.823 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 273' ' ' TYR . . . . . 0.578 ' OH ' ' HB1' ' A' ' 269' ' ' ALA . 16.8 m-85 -54.31 -2.11 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.645 -179.599 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 274' ' ' ALA . . . . . 0.586 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.39 -39.58 71.08 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.969 179.5 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 275' ' ' ASN . . . . . 0.585 ' O ' ' N ' ' A' ' 279' ' ' ALA . 3.6 p30 -39.23 97.96 0.15 Allowed Pre-proline 0 C--O 1.227 -0.113 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.568 -179.691 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -54.15 -43.1 61.49 Favored 'Trans proline' 0 C--N 1.303 -1.824 0 C-N-CA 122.375 2.05 . . . . 0.0 112.611 -178.765 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 89.2 mt -64.42 -42.79 95.86 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.114 -179.64 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 91.2 mt -95.96 -1.18 49.62 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.849 -179.421 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 279' ' ' ALA . . . . . 0.585 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.5 -34.93 77.84 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.612 -179.749 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.26 20.18 0.11 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.004 -179.247 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 0.491 HD23 ' HA ' ' A' ' 281' ' ' LEU . 13.7 mt -75.03 120.11 80.08 Favored Pre-proline 0 N--CA 1.451 -0.376 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.45 179.94 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -50.96 -39.45 59.36 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.659 2.24 . . . . 0.0 111.831 179.07 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -53.0 -50.38 64.32 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.126 179.849 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 74.6 t -61.6 -43.97 97.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 179.488 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -57.55 -41.17 80.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.234 -179.958 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -90.97 0.23 57.58 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.141 179.687 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt 59.62 43.16 16.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.066 0.46 . . . . 0.0 110.891 179.662 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -94.61 41.31 1.09 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.399 179.884 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 54.1 t -119.21 135.76 58.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 121.009 0.433 . . . . 0.0 110.179 -179.741 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -133.63 163.67 28.9 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 121.026 0.441 . . . . 0.0 110.73 -179.66 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.76 155.77 31.87 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.97 0.414 . . . . 0.0 110.759 -179.797 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 82.2 mt -94.65 -1.45 53.14 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.274 -179.75 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.34 165.22 12.56 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 -179.786 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 6.6 m -86.7 -61.55 1.71 Allowed 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 120.87 0.367 . . . . 0.0 111.102 -179.84 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 295' ' ' GLU . . . . . 0.448 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.6 mm-40 -69.66 -4.56 20.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.66 -179.792 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 26.1 p -76.48 33.03 0.13 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.68 -179.891 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 297' ' ' PHE . . . . . 0.533 ' CD2' HG22 ' A' ' 70' ' ' THR . 83.3 t80 -60.52 -45.99 91.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.646 -179.956 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 298' ' ' ARG . . . . . 0.609 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.2 mtt85 -81.08 136.66 35.97 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.627 -179.598 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.483 ' H ' HG11 ' A' ' 51' ' ' VAL . 0.9 OUTLIER -114.25 116.87 29.7 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.494 179.667 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 300' ' ' ASP . . . . . 0.624 ' H ' ' CB ' ' A' ' 303' ' ' SER . 49.1 p-10 -166.84 -174.97 2.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.52 -179.799 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 78.6 t80 -47.73 -44.46 27.96 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.241 -179.684 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -65.84 -41.27 91.94 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.029 0.442 . . . . 0.0 110.782 179.017 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 303' ' ' SER . . . . . 0.624 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 54.3 p -55.36 -36.15 66.01 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.1 -179.265 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 304' ' ' ALA . . . . . 0.568 ' HB2' ' SD ' ' A' ' 215' ' ' MET . . . -57.58 -51.4 69.63 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.436 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 90.6 mtp -56.56 -44.02 80.53 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -179.936 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -66.29 -42.88 87.73 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.903 0.382 . . . . 0.0 110.184 178.86 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 307' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 303' ' ' SER . 55.9 t -63.88 -43.09 97.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.218 179.409 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 42.5 tp -59.87 -42.07 92.92 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.812 -179.618 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -62.31 -39.05 91.75 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.152 179.665 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 310' ' ' ARG . . . . . 0.45 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.8 ttt85 -63.71 -43.89 95.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.266 179.46 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 90.1 mt -63.26 -42.05 99.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.184 179.632 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt -62.85 -33.62 75.63 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.116 179.409 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.73 -23.37 21.82 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.448 -179.888 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.488 HD22 ' CE2' ' A' ' 315' ' ' PHE . 6.9 tt -62.31 -43.06 99.69 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.61 -179.936 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 315' ' ' PHE . . . . . 0.488 ' CE2' HD22 ' A' ' 314' ' ' LEU . 90.9 m-85 . . . . . 0 C--O 1.22 -0.484 0 CA-C-O 117.964 -1.017 . . . . 0.0 110.466 179.975 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -99.26 135.82 40.11 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.06 0.457 . . . . 0.0 110.493 -179.995 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.496 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -91.75 178.43 1.75 Allowed Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.637 -179.961 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.496 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.5 Cg_exo -61.57 146.87 96.56 Favored 'Trans proline' 0 C--N 1.3 -2.022 0 C-N-CA 122.808 2.339 . . . . 0.0 112.162 179.635 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.464 ' HE ' HD12 ' A' ' 39' ' ' LEU . 35.4 ptt180 -136.3 141.82 43.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.647 179.71 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -79.3 116.96 19.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.476 179.923 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.454 ' O ' HG23 ' A' ' 30' ' ' ILE . 9.4 tp -111.61 130.24 65.52 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.486 -179.985 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.2 t -71.09 142.45 50.82 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.61 179.842 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.481 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.4 t0 -139.32 179.93 6.25 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.57 -179.937 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.481 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 78.4 p -74.01 -37.12 64.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.785 179.716 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -46.78 -94.66 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.378 -179.459 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -166.17 -26.88 0.02 OUTLIER Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 179.893 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 65.0 m -168.66 105.91 0.44 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.861 0.362 . . . . 0.0 110.618 -179.921 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.651 ' CD2' HD13 ' A' ' 140' ' ' LEU . 69.5 t60 -128.75 147.22 50.76 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.988 0.423 . . . . 0.0 110.324 179.925 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.62 HG22 ' N ' ' A' ' 39' ' ' LEU . 99.9 m -130.45 165.53 22.43 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.569 -179.835 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.62 ' N ' HG22 ' A' ' 38' ' ' THR . 80.6 mt -120.64 126.98 51.62 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.485 179.731 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -65.44 -44.35 87.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.686 -179.971 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 41.0 p -165.96 154.82 11.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.405 179.669 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.486 ' CD ' ' H ' ' A' ' 42' ' ' GLN . 14.0 mp0 -45.43 101.55 0.26 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.643 179.471 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -57.6 129.64 34.76 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 122.402 2.068 . . . . 0.0 112.235 -179.643 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -82.51 -25.14 33.73 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.5 179.531 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.537 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.7 mtm-85 -120.89 134.03 55.29 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 121.185 0.517 . . . . 0.0 110.27 179.96 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.1 mt -129.82 133.21 65.13 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.273 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.966 -179.721 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 44.3 t -124.84 131.08 73.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.839 0.352 . . . . 0.0 110.101 179.313 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.63 ' OG ' HD12 ' A' ' 117' ' ' LEU . 4.9 m -154.74 166.35 33.71 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.515 179.845 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 65.3 p -124.37 8.53 8.44 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.434 179.923 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.58 125.21 32.93 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.616 -179.458 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.503 HG11 ' H ' ' A' ' 299' ' ' LEU . 94.5 t -65.5 -44.41 94.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.545 -179.938 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.6 m -62.61 -44.31 96.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.639 -179.851 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 48.4 tp -62.5 -41.48 98.85 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.57 -179.476 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.455 ' O ' HD13 ' A' ' 58' ' ' LEU . 74.6 m -57.63 -44.78 85.81 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.466 -179.438 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.36 -62.09 5.43 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 179.571 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.6 t -48.23 -35.71 12.48 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 179.951 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.7 mt -61.7 -44.46 96.89 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.11 179.331 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.455 HD13 ' O ' ' A' ' 54' ' ' THR . 9.1 mp -65.07 -41.72 94.81 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.201 178.049 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.4 ' HB1' ' NE ' ' A' ' 169' ' ' ARG . . . -63.6 -41.36 98.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.933 -179.243 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.431 ' O ' HG23 ' A' ' 60' ' ' ILE . 8.0 tp -87.7 16.81 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.755 -179.63 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 56.45 83.84 0.09 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.73 -179.862 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.89 58.04 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.005 -179.752 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -50.59 152.71 8.78 Favored 'Trans proline' 0 C--N 1.296 -2.207 0 C-N-CA 122.859 2.373 . . . . 0.0 112.38 -178.204 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.431 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -108.96 145.9 15.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.348 -179.727 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 97.0 mt -63.8 -45.18 97.89 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.357 -179.844 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.496 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -129.87 134.48 47.54 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.602 -179.745 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.499 ' O ' ' N ' ' A' ' 98' ' ' LEU . 72.7 m -134.75 158.77 43.29 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.833 -179.637 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.73 139.36 16.36 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.668 -0.973 . . . . 0.0 110.668 179.798 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.485 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.79 -162.92 0.08 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.903 0.382 . . . . 0.0 110.515 179.966 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.495 ' O ' ' C ' ' A' ' 71' ' ' THR . 5.7 t -133.93 135.38 43.52 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.245 -179.973 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.495 ' C ' ' O ' ' A' ' 70' ' ' THR . 1.1 t 29.55 68.19 0.67 Allowed Pre-proline 0 N--CA 1.466 0.328 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.64 -179.626 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -60.98 145.18 99.46 Favored 'Trans proline' 0 C--N 1.3 -1.978 0 C-N-CA 122.619 2.213 . . . . 0.0 112.068 -178.392 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.532 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 45.1 p-10 -159.37 -32.29 0.06 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.662 179.698 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.542 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 99.1 m-20 -64.07 -39.4 94.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.505 179.988 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -60.51 -48.32 82.29 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.642 -179.278 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.423 ' O ' ' O ' ' A' ' 77' ' ' ALA . 94.4 t -60.1 -24.85 31.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 179.704 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.542 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -45.77 172.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.583 179.865 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.571 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.8 p30 -61.98 177.76 0.42 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.614 -179.774 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.562 ' C ' ' H ' ' A' ' 81' ' ' GLY . 36.0 p30 -45.69 85.86 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.962 179.963 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.571 ' N ' ' O ' ' A' ' 78' ' ' ASP . 42.8 tp60 -67.33 13.62 0.06 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.146 -179.837 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.562 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 117.94 -22.04 10.03 Favored Glycine 0 CA--C 1.519 0.338 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.93 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -108.19 116.68 32.41 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.951 0.405 . . . . 0.0 110.56 179.843 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 75.4 mt -98.98 0.88 44.85 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.513 -179.767 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -92.07 6.74 45.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.985 0.421 . . . . 0.0 110.484 -179.797 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.785 ' O ' HG22 ' A' ' 89' ' ' VAL . 27.2 mt-30 -100.06 -26.28 14.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.781 179.968 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.5 t-105 -64.28 -40.99 97.1 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.02 -179.688 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.551 ' O ' ' N ' ' A' ' 91' ' ' LYS . 68.5 m -77.6 -53.55 7.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.155 -179.516 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -47.9 -51.27 23.89 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.001 -179.347 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.785 HG22 ' O ' ' A' ' 85' ' ' GLN . 15.1 m -69.01 -41.08 81.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 120.905 0.383 . . . . 0.0 111.069 179.88 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.508 ' N ' HG23 ' A' ' 89' ' ' VAL . . . -71.47 -23.57 61.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.768 -179.815 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.551 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.0 tttm -61.07 -46.06 92.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.501 -179.439 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.443 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.6 mm-40 -90.13 -94.87 0.11 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.213 179.971 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.626 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.8 mtt180 -143.19 60.13 1.41 Allowed 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 179.758 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.463 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.6 pttp 33.31 26.88 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.203 -179.082 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.626 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.4 tt -48.61 123.1 6.26 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.931 -178.193 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.45 ' O ' HD23 ' A' ' 95' ' ' LEU . 98.9 mm-40 -83.5 -169.9 2.78 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.145 179.934 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.614 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 81.7 mtp180 -73.71 137.51 44.09 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.328 -179.865 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.499 ' N ' ' O ' ' A' ' 67' ' ' SER . 89.0 mt -85.9 -166.11 1.44 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.709 -179.621 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.532 ' O ' ' CD2' ' A' ' 99' ' ' TYR . 46.7 p90 -168.01 119.48 0.84 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.311 179.962 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.513 ' C ' ' O ' ' A' ' 99' ' ' TYR . 43.1 mm -29.14 121.04 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.922 -179.701 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 113.95 28.11 3.25 Favored Glycine 0 CA--C 1.521 0.431 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 -179.597 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.588 ' CD ' ' H ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -144.0 46.0 0.61 Allowed Pre-proline 0 C--N 1.323 -0.55 0 CA-C-O 120.953 0.406 . . . . 0.0 110.503 179.891 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.583 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 30.2 Cg_endo -62.28 143.83 94.54 Favored 'Trans proline' 0 C--N 1.297 -2.138 0 C-N-CA 122.686 2.257 . . . . 0.0 111.957 -179.966 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.476 ' O ' HG23 ' A' ' 108' ' ' VAL . 23.2 t -173.33 120.73 0.34 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.417 179.754 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.58 -40.98 63.48 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.043 179.743 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -65.9 -40.31 91.39 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.864 -179.374 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.96 -39.86 95.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.687 -179.832 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 104' ' ' SER . 70.9 t -67.54 -43.76 86.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.721 179.683 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.43 -39.1 92.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.568 -179.287 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.443 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.51 -23.55 62.9 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.532 179.834 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.549 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.4 mm-40 -90.94 4.75 51.11 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.741 -179.564 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.549 ' C ' ' O ' ' A' ' 111' ' ' GLN . 9.9 tpt 23.17 64.32 0.37 Allowed Pre-proline 0 N--CA 1.464 0.271 0 CA-C-O 120.914 0.388 . . . . 0.0 111.001 -179.806 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.444 ' HG2' HD11 ' A' ' 116' ' ' ILE . 68.1 Cg_endo -78.9 168.92 20.18 Favored 'Trans proline' 0 C--N 1.304 -1.801 0 C-N-CA 122.984 2.456 . . . . 0.0 112.081 -178.415 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.483 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 98.9 m-20 -113.24 -44.01 3.3 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.103 179.452 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.2 tp -120.47 119.81 34.07 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.324 -0.398 . . . . 0.0 109.935 179.48 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.455 HD13 HD22 ' A' ' 133' ' ' LEU . 96.3 mt -117.09 131.1 70.79 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.319 0 CA-C-O 120.9 0.381 . . . . 0.0 110.892 -179.788 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.63 HD12 ' OG ' ' A' ' 48' ' ' SER . 29.7 mt -106.0 132.46 52.06 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 121.027 0.441 . . . . 0.0 110.321 -179.489 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.434 HD12 HG23 ' A' ' 139' ' ' THR . 98.1 mt -118.17 136.6 54.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.73 -179.709 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 86.5 p -71.6 152.76 42.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.548 -179.95 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.27 -50.21 74.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.659 -179.857 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -149.24 153.59 37.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.552 179.762 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 169.3 -170.17 42.41 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 179.885 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -63.04 -35.46 92.12 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 179.992 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.447 ' OD1' ' O ' ' A' ' 124' ' ' ASP . 44.1 p-10 -87.18 119.92 27.91 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.808 0.337 . . . . 0.0 110.639 179.885 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.441 ' O ' HD12 ' A' ' 129' ' ' LEU . 39.2 t -63.56 144.06 57.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.467 -179.928 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.52 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.38 -43.28 8.85 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.872 -179.935 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.8 tp -62.77 -42.35 99.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.654 -179.816 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.73 -10.91 56.64 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.512 -179.395 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.441 HD12 ' O ' ' A' ' 125' ' ' SER . 84.1 mt -116.03 -23.9 8.31 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.7 -179.902 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 130' ' ' TYR . . . . . 0.52 ' N ' ' O ' ' A' ' 126' ' ' ALA . 77.8 t80 -51.53 -49.87 61.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.521 -179.001 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.5 p-10 -65.79 -42.26 90.96 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.852 0.358 . . . . 0.0 111.15 179.628 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.523 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 87.9 mt-30 -67.52 -36.69 81.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.792 -179.97 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.455 HD22 HD13 ' A' ' 116' ' ' ILE . 94.1 mt -80.58 -42.05 22.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.871 -179.507 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.2 t -57.23 -44.76 84.07 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.259 -179.21 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.2 m -62.3 -45.8 91.63 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.806 0.336 . . . . 0.0 110.642 179.33 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 92.9 mt -62.31 -43.9 98.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.401 -179.855 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.584 ' HB1' ' HD2' ' A' ' 138' ' ' PRO . . . -169.95 162.93 6.66 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.529 179.844 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.584 ' HD2' ' HB1' ' A' ' 137' ' ' ALA . 78.4 Cg_exo -42.71 110.99 0.18 Allowed 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.536 2.157 . . . . 0.0 112.196 179.448 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.474 HG21 ' CD1' ' A' ' 130' ' ' TYR . 16.8 m -85.57 127.76 34.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.555 179.971 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.651 HD13 ' CD2' ' A' ' 37' ' ' HIS . 34.3 tp -119.48 137.94 53.46 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.088 -179.897 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.429 ' O ' ' OD2' ' A' ' 32' ' ' ASP . 80.2 mt -104.22 120.01 53.88 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 CA-C-O 121.122 0.487 . . . . 0.0 111.217 -179.348 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.494 HD12 HD22 ' A' ' 117' ' ' LEU . 97.7 mt -135.92 132.58 50.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.595 179.549 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.534 ' ND2' ' OD2' ' A' ' 241' ' ' ASP . 2.3 t-20 -65.75 148.44 51.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.902 0.382 . . . . 0.0 110.422 179.268 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.459 ' O ' ' OD2' ' A' ' 241' ' ' ASP . 42.6 t80 -81.86 123.18 28.6 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.955 -179.456 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 54.79 69.69 0.7 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.881 179.643 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 49.2 p-10 -124.45 0.24 8.24 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.679 179.849 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -151.42 116.4 5.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.695 -179.442 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 84.0 p -63.86 168.55 4.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.557 -179.941 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.416 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.6 p-90 -51.8 -16.33 0.67 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.553 -179.846 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.431 ' O ' HG23 ' A' ' 154' ' ' THR . 68.2 tp60 -70.1 -76.68 0.1 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.491 -179.744 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.447 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.1 t -62.41 -38.49 89.85 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.321 179.6 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 53.4 tp -59.82 -45.75 91.38 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.377 -178.601 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.416 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 46.3 tp -62.83 -41.72 99.44 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.472 179.012 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.447 ' OG1' ' O ' ' A' ' 151' ' ' SER . 62.2 p -64.01 -34.97 79.2 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.266 -179.592 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.448 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.7 mm-40 -64.02 -42.28 97.18 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.239 179.32 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 92.1 mt -65.51 -38.85 90.9 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.041 0.448 . . . . 0.0 110.232 179.093 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.581 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.22 -32.13 79.52 Favored Glycine 0 CA--C 1.52 0.389 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 -179.374 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.448 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.3 mt-10 -36.02 -26.19 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.804 0.335 . . . . 0.0 110.728 179.953 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.581 ' N ' ' O ' ' A' ' 157' ' ' GLY . 94.4 mt -58.11 150.16 4.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.3 179.375 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 77.1 p -69.21 137.29 53.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.01 -179.508 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 69.96 22.94 77.26 Favored Glycine 0 CA--C 1.517 0.183 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 179.452 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 59.8 m80 -124.11 -13.97 7.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.745 0.307 . . . . 0.0 110.563 179.92 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -67.19 -59.42 3.45 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.702 -179.732 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -51.76 -49.37 62.76 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.215 -179.667 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -60.45 -41.32 93.84 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.735 0.302 . . . . 0.0 110.346 179.509 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.42 -47.34 86.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.609 179.801 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.73 -40.16 75.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.252 -179.915 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -61.49 -50.26 73.45 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.575 179.573 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.4 ' NE ' ' HB1' ' A' ' 59' ' ' ALA . 60.0 ttt85 -65.52 -43.58 89.58 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.492 179.596 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 94.8 mt -64.66 -43.37 96.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.427 179.768 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.29 -51.36 69.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.566 -179.243 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.71 -43.78 95.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.53 179.727 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.654 ' CE2' HD11 ' A' ' 177' ' ' LEU . 55.1 t80 -62.87 -44.47 96.03 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.041 0.448 . . . . 0.0 110.454 179.45 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -63.48 -40.0 95.95 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.592 -179.36 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -62.9 -42.83 99.92 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.628 179.333 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -60.76 -44.7 96.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.186 179.93 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.654 HD11 ' CE2' ' A' ' 173' ' ' PHE . 84.9 mt -64.53 -41.2 96.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.02 0.438 . . . . 0.0 110.749 178.887 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.05 -62.09 1.85 Allowed 'General case' 0 C--O 1.236 0.376 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.478 -179.382 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.58 -46.66 86.48 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.609 179.784 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.28 -41.5 65.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.236 -179.984 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -64.01 -33.75 76.45 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.96 0.41 . . . . 0.0 110.424 179.278 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.422 ' O ' ' HG2' ' A' ' 182' ' ' GLU . 69.3 tt0 -90.68 8.86 32.29 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.338 0.589 . . . . 0.0 110.483 -179.019 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -104.78 -32.19 8.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.895 0.379 . . . . 0.0 111.196 179.615 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.6 pt -128.21 147.83 32.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.845 -179.847 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -140.11 131.16 26.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.393 179.364 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.597 HD22 ' N ' ' A' ' 186' ' ' LEU . 3.5 mm? -85.45 133.92 41.3 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.882 -179.996 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -43.87 157.93 0.13 Allowed 'Trans proline' 0 C--N 1.307 -1.629 0 C-N-CA 122.743 2.295 . . . . 0.0 112.125 179.316 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 0.53 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.6 Cg_endo -62.96 114.51 2.47 Favored 'Trans proline' 0 C--N 1.304 -1.807 0 C-N-CA 122.796 2.331 . . . . 0.0 111.717 179.839 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 189' ' ' GLN . . . . . 0.53 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.7 mt-30 155.13 148.26 0.0 OUTLIER Pre-proline 0 C--N 1.331 -0.207 0 O-C-N 123.643 0.589 . . . . 0.0 110.74 -179.743 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -73.47 144.55 36.45 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.695 2.263 . . . . 0.0 111.928 177.97 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.495 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.1 p -124.84 158.89 32.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.241 0.543 . . . . 0.0 110.194 179.962 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 192' ' ' THR . . . . . 0.495 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 37.6 p -143.46 165.22 28.14 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.086 -179.585 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 193' ' ' ALA . . . . . 0.444 ' HA ' ' H ' ' A' ' 260' ' ' PHE . . . -135.33 128.65 32.12 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.106 0.479 . . . . 0.0 110.285 179.534 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.511 HD11 HD23 ' A' ' 259' ' ' LEU . 47.5 pt -146.5 148.87 16.53 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.297 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.052 179.933 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 195' ' ' VAL . . . . . 0.734 HG13 ' CD1' ' A' ' 262' ' ' PHE . 74.1 t -117.6 123.06 71.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.247 0.546 . . . . 0.0 109.809 179.073 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -134.3 106.97 7.38 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.27 179.738 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 93.7 m -130.77 130.63 43.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.84 179.782 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -82.67 -37.17 25.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.313 179.675 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.37 -67.35 0.24 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.417 -179.98 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.01 -10.0 59.16 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.338 179.508 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 59.9 t-80 60.67 58.32 2.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.719 -179.81 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 41.6 p -166.99 153.29 8.22 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.537 179.643 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.31 144.07 24.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.473 179.395 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -135.34 138.28 43.23 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.642 -179.969 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 19.6 mt -106.12 125.23 50.74 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 121.027 0.442 . . . . 0.0 109.923 -179.737 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 206' ' ' TRP . . . . . 0.574 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 75.0 m95 -81.81 166.87 19.62 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.667 -179.72 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 207' ' ' THR . . . . . 0.464 HG22 ' C ' ' A' ' 206' ' ' TRP . 0.1 OUTLIER -156.61 171.89 6.81 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.607 -179.15 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -53.98 -37.3 86.06 Favored 'Trans proline' 0 C--N 1.303 -1.856 0 C-N-CA 122.654 2.236 . . . . 0.0 112.172 179.225 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -70.45 -34.81 72.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.76 -179.746 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 22.0 m -61.44 150.51 35.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.596 -179.373 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.17 -36.51 80.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.438 -179.768 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 212' ' ' GLN . . . . . 0.574 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 53.7 tt0 -64.5 -40.6 95.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.482 -179.987 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.67 -43.65 91.47 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 179.821 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -63.14 -44.26 96.05 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.719 0.295 . . . . 0.0 110.283 179.76 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 215' ' ' MET . . . . . 0.577 ' SD ' ' HB2' ' A' ' 304' ' ' ALA . 65.5 ttp -59.56 -48.21 82.53 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.221 -179.886 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 85.8 mt -60.25 -40.92 91.99 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.405 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 217' ' ' GLU . . . . . 0.456 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.0 tp10 -58.06 -38.08 75.64 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.739 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -65.3 -38.17 89.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.784 0.326 . . . . 0.0 110.568 179.677 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 219' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 219' ' ' LEU . 94.7 mt -64.4 -42.79 95.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.441 -179.595 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.54 45.84 0.08 OUTLIER Glycine 0 C--N 1.334 0.47 0 N-CA-C 111.036 -0.825 . . . . 0.0 111.036 179.958 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 221' ' ' PHE . . . . . 0.456 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 26.9 m-85 -129.0 156.02 44.46 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.027 0.441 . . . . 0.0 110.487 -179.802 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.481 ' O ' HG13 ' A' ' 191' ' ' VAL . 8.0 p -108.01 122.83 47.66 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.203 0.525 . . . . 0.0 110.208 -179.938 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.479 HD22 ' C ' ' A' ' 222' ' ' THR . 4.3 mm? -101.6 133.41 46.33 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.068 -179.94 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -97.22 159.73 14.74 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.458 179.834 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.01 115.1 29.7 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.927 0.394 . . . . 0.0 110.41 179.84 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.494 HD12 ' N ' ' A' ' 226' ' ' LEU . 9.1 mp -53.34 156.75 3.83 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.648 179.93 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -60.09 145.2 98.99 Favored 'Trans proline' 0 C--N 1.302 -1.903 0 C-N-CA 122.667 2.245 . . . . 0.0 112.139 179.283 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.48 -2.78 58.86 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.559 179.981 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.49 -40.64 5.65 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 111.004 -0.838 . . . . 0.0 111.004 -179.835 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.544 ' O ' ' N ' ' A' ' 233' ' ' SER . 84.9 mt -79.53 -16.9 55.16 Favored 'General case' 0 C--O 1.223 -0.337 0 CA-C-O 120.997 0.427 . . . . 0.0 110.368 -179.772 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 231' ' ' ASN . . . . . 0.405 ' C ' ' O ' ' A' ' 230' ' ' LEU . 54.7 t-20 -40.11 -49.12 2.58 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.678 -179.603 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -88.27 15.58 7.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.783 0.325 . . . . 0.0 111.217 179.963 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.544 ' N ' ' O ' ' A' ' 230' ' ' LEU . 78.1 p -60.62 -35.81 77.07 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.664 -179.858 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 234' ' ' GLN . . . . . 0.524 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.6 tt0 -118.21 -69.54 0.84 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.942 179.556 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.1 m -70.37 102.97 2.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.651 -179.765 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -94.31 58.04 2.4 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.442 179.949 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -145.04 -122.52 1.55 Allowed Glycine 0 CA--C 1.52 0.379 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 -179.992 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -134.34 111.77 10.46 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 121.053 0.454 . . . . 0.0 110.452 -179.981 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 239' ' ' ARG . . . . . 0.515 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.0 mtt180 -148.19 57.5 1.08 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.744 -179.97 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -69.75 -31.59 69.64 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.513 179.574 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 241' ' ' ASP . . . . . 0.534 ' OD2' ' ND2' ' A' ' 143' ' ' ASN . 65.1 t0 -56.9 -46.95 81.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.339 -179.186 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 242' ' ' ILE . . . . . 0.437 ' O ' ' O ' ' A' ' 239' ' ' ARG . 17.6 tt -140.54 157.41 24.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.865 0.364 . . . . 0.0 110.558 179.713 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.445 HG22 HD13 ' A' ' 245' ' ' LEU . 96.0 mt -106.34 106.33 20.4 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.173 0 CA-C-O 121.096 0.474 . . . . 0.0 110.448 179.89 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 244' ' ' GLN . . . . . 0.604 ' O ' HD12 ' A' ' 245' ' ' LEU . 88.3 mt-30 -110.68 110.62 21.37 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.358 179.733 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.604 HD12 ' O ' ' A' ' 244' ' ' GLN . 9.6 mp -122.02 -168.03 1.64 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.583 179.784 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 246' ' ' GLY . . . . . 0.524 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.14 -16.77 0.05 OUTLIER Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 179.895 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 247' ' ' GLY . . . . . 0.667 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -60.42 157.25 29.21 Favored Glycine 0 CA--C 1.522 0.516 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 -179.823 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -63.94 21.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.921 0.391 . . . . 0.0 110.571 179.942 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 249' ' ' ASN . . . . . 0.667 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.7 m-20 -96.8 -5.82 37.54 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.576 179.99 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 92.0 mt -80.24 -21.36 42.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.615 179.522 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.53 -51.41 69.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.773 -179.557 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.99 -5.29 58.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.459 179.662 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -80.87 -74.44 1.13 Allowed Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 -179.946 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 80.9 mt -69.87 125.69 27.5 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.058 0.456 . . . . 0.0 110.303 -179.859 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -59.33 -39.67 83.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.297 -179.641 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 83.5 51.76 3.98 Favored Glycine 0 CA--C 1.522 0.473 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 179.9 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -95.1 -16.11 22.88 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.712 0.292 . . . . 0.0 110.588 -179.848 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 258' ' ' SER . . . . . 0.494 ' OG ' HG23 ' A' ' 191' ' ' VAL . 3.4 t 174.92 89.51 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.08 0.466 . . . . 0.0 110.161 179.973 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.863 HD12 ' N ' ' A' ' 259' ' ' LEU . 0.9 OUTLIER -94.46 124.18 38.33 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.258 0.551 . . . . 0.0 111.058 -178.999 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 260' ' ' PHE . . . . . 0.444 ' H ' ' HA ' ' A' ' 193' ' ' ALA . 16.0 m-30 -93.62 146.91 23.47 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.391 179.218 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 85.5 mt -122.39 149.75 43.38 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.583 -179.933 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.734 ' CD1' HG13 ' A' ' 195' ' ' VAL . 2.6 p90 -77.99 -139.14 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.46 -179.759 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 263' ' ' ALA . . . . . 0.665 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -50.8 77.86 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.987 -179.947 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 264' ' ' GLY . . . . . 0.641 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.97 104.66 0.19 Allowed Glycine 0 CA--C 1.526 0.768 0 N-CA-C 110.721 -0.951 . . . . 0.0 110.721 -179.964 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 265' ' ' ASP . . . . . 0.601 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.7 m-20 -80.39 -177.56 6.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.722 0.296 . . . . 0.0 110.84 -179.424 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -40.49 -17.73 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.511 179.823 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 267' ' ' LYS . . . . . 0.601 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.42 -51.51 43.09 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.679 179.582 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -63.77 -46.59 84.58 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.23 179.357 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 269' ' ' ALA . . . . . 0.581 ' HB1' ' OH ' ' A' ' 273' ' ' TYR . . . -61.48 -35.15 76.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.927 179.511 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -63.07 -34.57 77.87 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.155 179.717 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.25 -43.21 13.96 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.192 -179.51 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 272' ' ' ILE . . . . . 0.588 ' C ' ' H ' ' A' ' 274' ' ' ALA . 5.0 tt -51.49 -33.92 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.839 -178.783 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 273' ' ' TYR . . . . . 0.581 ' OH ' ' HB1' ' A' ' 269' ' ' ALA . 17.0 m-85 -54.3 -1.91 0.03 OUTLIER 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.71 -179.598 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 274' ' ' ALA . . . . . 0.588 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.63 -39.45 70.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.885 179.574 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 275' ' ' ASN . . . . . 0.585 ' O ' ' N ' ' A' ' 279' ' ' ALA . 3.8 p30 -39.33 98.04 0.16 Allowed Pre-proline 0 C--O 1.226 -0.153 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.53 -179.636 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -54.19 -43.04 62.07 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 C-N-CA 122.383 2.055 . . . . 0.0 112.595 -178.753 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 89.1 mt -64.49 -42.9 95.58 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.086 -179.621 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 91.1 mt -95.87 -1.11 50.07 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.889 -179.434 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 279' ' ' ALA . . . . . 0.585 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.4 -34.92 77.68 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.666 -179.791 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.3 20.16 0.12 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.979 -179.207 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 0.494 HD23 ' HA ' ' A' ' 281' ' ' LEU . 13.6 mt -74.91 119.83 78.73 Favored Pre-proline 0 N--CA 1.452 -0.347 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.504 179.9 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -50.57 -39.74 55.43 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.598 2.199 . . . . 0.0 111.949 178.989 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.9 -50.45 63.9 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.122 179.876 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 73.4 t -61.55 -43.91 97.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 179.477 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -57.8 -41.17 81.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.274 -179.906 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -90.73 -0.1 57.59 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.184 179.622 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt 59.92 43.3 15.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.029 0.442 . . . . 0.0 110.821 179.658 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -94.93 41.3 1.09 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.382 179.809 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 54.2 t -119.23 135.82 58.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.022 0.439 . . . . 0.0 110.231 -179.737 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -133.63 163.85 28.5 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.044 0.45 . . . . 0.0 110.658 -179.577 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.81 155.88 31.72 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.94 0.4 . . . . 0.0 110.78 -179.803 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 81.4 mt -94.7 -1.59 52.77 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.25 -179.735 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 120.86 165.21 12.65 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.651 -0.98 . . . . 0.0 110.651 -179.763 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 7.0 m -86.59 -61.73 1.67 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.806 0.336 . . . . 0.0 111.092 -179.828 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 295' ' ' GLU . . . . . 0.455 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.6 mm-40 -69.04 -4.84 18.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.682 -179.686 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 26.3 p -76.48 32.22 0.13 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.641 -179.871 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 297' ' ' PHE . . . . . 0.495 ' CD1' HG22 ' A' ' 70' ' ' THR . 59.4 t80 -60.59 -46.43 90.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.713 179.944 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 298' ' ' ARG . . . . . 0.614 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.2 mtt85 -80.23 137.37 36.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.582 -179.65 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.503 ' H ' HG11 ' A' ' 51' ' ' VAL . 5.7 tp -114.38 115.8 27.91 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.453 179.868 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 300' ' ' ASP . . . . . 0.631 ' H ' ' CB ' ' A' ' 303' ' ' SER . 48.7 p-10 -165.72 -176.69 3.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.533 -179.977 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 79.0 t80 -46.59 -42.76 16.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.293 -179.791 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -67.4 -40.58 85.64 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.026 0.441 . . . . 0.0 110.756 179.196 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 303' ' ' SER . . . . . 0.631 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 60.2 p -55.62 -36.38 66.92 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.074 -179.276 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 304' ' ' ALA . . . . . 0.577 ' HB2' ' SD ' ' A' ' 215' ' ' MET . . . -57.68 -51.61 68.83 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 179.342 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 91.2 mtp -56.06 -44.14 78.59 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 179.838 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -66.11 -43.13 88.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.917 0.389 . . . . 0.0 110.166 178.837 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 307' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 303' ' ' SER . 55.9 t -63.97 -42.88 97.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.288 179.358 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 44.6 tp -59.89 -42.05 92.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.934 -179.64 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -62.33 -39.31 92.66 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.155 179.59 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 310' ' ' ARG . . . . . 0.468 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.7 ttt85 -63.6 -43.95 95.42 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.29 179.412 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 89.5 mt -63.18 -42.2 99.34 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.31 179.603 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -63.21 -33.57 75.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.079 179.456 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.85 -23.44 21.66 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.488 -179.875 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.483 HD22 ' CE2' ' A' ' 315' ' ' PHE . 6.8 tt -62.3 -43.16 99.47 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.58 -179.95 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 315' ' ' PHE . . . . . 0.483 ' CE2' HD22 ' A' ' 314' ' ' LEU . 90.5 m-85 . . . . . 0 C--O 1.22 -0.478 0 CA-C-O 118.043 -0.979 . . . . 0.0 110.482 179.981 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -99.63 135.18 41.43 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.063 0.459 . . . . 0.0 110.452 -179.885 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.497 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -92.15 178.55 1.66 Allowed Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.509 -179.829 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.497 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 27.3 Cg_exo -61.46 147.11 96.3 Favored 'Trans proline' 0 C--N 1.3 -2.008 0 C-N-CA 122.709 2.273 . . . . 0.0 112.173 179.617 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.482 ' HE ' HD12 ' A' ' 39' ' ' LEU . 35.0 ptt180 -135.98 142.35 44.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.714 179.779 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -79.9 116.86 20.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.401 179.922 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.457 ' O ' HG23 ' A' ' 30' ' ' ILE . 9.4 tp -111.64 130.12 65.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.408 179.996 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.1 t -70.85 141.95 51.25 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.621 179.763 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.476 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.0 t0 -138.85 -179.97 6.14 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.512 -179.936 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.476 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 78.1 p -73.84 -37.38 64.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.761 179.834 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.8 ttt85 -46.89 -94.72 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.366 -179.338 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.414 ' O ' ' OG1' ' A' ' 36' ' ' THR . . . -166.04 -26.99 0.02 OUTLIER Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.886 -0.885 . . . . 0.0 110.886 179.996 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.414 ' OG1' ' O ' ' A' ' 35' ' ' GLY . 75.2 m -168.29 105.87 0.47 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.924 0.392 . . . . 0.0 110.678 -179.894 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.649 ' CD2' HD13 ' A' ' 140' ' ' LEU . 68.8 t60 -129.07 146.51 51.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.071 0.463 . . . . 0.0 110.317 179.997 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.622 HG22 ' N ' ' A' ' 39' ' ' LEU . 99.8 m -129.99 165.59 21.84 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.57 -179.797 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.622 ' N ' HG22 ' A' ' 38' ' ' THR . 81.0 mt -120.38 127.25 52.13 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.483 179.727 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -65.44 -44.6 86.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.689 -179.954 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 40.7 p -165.73 154.97 12.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.404 179.599 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.5 ' CD ' ' H ' ' A' ' 42' ' ' GLN . 14.5 mp0 -45.31 101.58 0.26 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.608 179.427 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -57.7 130.32 38.05 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 C-N-CA 122.334 2.023 . . . . 0.0 112.196 -179.772 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -83.01 -24.62 32.77 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.531 179.593 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.535 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.7 mtm-85 -121.22 134.67 55.2 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-O 121.156 0.503 . . . . 0.0 110.246 -179.926 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.0 mt -130.49 133.35 63.82 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.297 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.99 -179.797 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 46.5 t -124.76 131.05 73.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 179.471 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.621 ' OG ' HD12 ' A' ' 117' ' ' LEU . 4.6 m -154.49 166.2 34.04 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.048 0.452 . . . . 0.0 110.505 179.679 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 60.9 p -124.51 8.73 8.36 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.519 179.936 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.8 125.96 33.65 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.617 -179.508 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.465 HG11 ' H ' ' A' ' 299' ' ' LEU . 84.7 t -65.68 -44.54 93.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.51 -179.99 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.0 m -62.71 -44.26 96.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.66 -179.818 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 52.1 tp -62.27 -41.65 98.66 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.6 -179.415 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.472 ' O ' HD13 ' A' ' 58' ' ' LEU . 71.9 m -57.92 -44.51 86.92 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.286 -179.326 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.41 -61.97 5.52 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 179.578 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.7 t -48.56 -35.6 13.73 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 -179.812 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 20.0 mt -61.68 -44.58 96.68 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.708 -0.397 . . . . 0.0 111.199 179.19 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.472 HD13 ' O ' ' A' ' 54' ' ' THR . 9.5 mp -64.58 -42.09 95.86 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.334 177.911 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.63 -41.23 98.28 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.044 -179.222 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.434 ' O ' HG23 ' A' ' 60' ' ' ILE . 7.9 tp -87.81 16.58 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.726 -179.618 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 56.52 83.61 0.1 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.726 -179.838 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.75 56.72 0.07 OUTLIER Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.01 -179.865 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -49.43 153.46 4.96 Favored 'Trans proline' 0 C--N 1.296 -2.228 0 C-N-CA 122.818 2.345 . . . . 0.0 112.565 -178.52 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.432 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.4 OUTLIER -109.13 146.32 14.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.4 -179.764 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 97.0 mt -63.99 -44.78 97.94 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.335 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.436 -179.986 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.504 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -130.16 134.72 47.51 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 120.851 0.358 . . . . 0.0 110.591 -179.762 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.493 ' O ' ' N ' ' A' ' 98' ' ' LEU . 72.6 m -134.79 158.86 43.1 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.912 -179.719 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.9 139.49 16.33 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 179.877 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.492 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.87 -162.46 0.08 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.98 0.419 . . . . 0.0 110.498 -179.996 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.507 HG22 ' CD2' ' A' ' 297' ' ' PHE . 5.9 t -133.86 135.99 44.07 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.179 -179.997 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.488 ' C ' ' O ' ' A' ' 70' ' ' THR . 1.0 OUTLIER 29.65 68.12 0.68 Allowed Pre-proline 0 N--CA 1.466 0.335 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.719 -179.665 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -60.69 144.92 99.61 Favored 'Trans proline' 0 C--N 1.299 -2.045 0 C-N-CA 122.573 2.182 . . . . 0.0 112.242 -178.506 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.525 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 45.2 p-10 -160.37 -32.12 0.06 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.646 179.735 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.531 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 99.1 m-20 -64.07 -39.37 93.92 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.451 -179.987 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -60.7 -47.75 84.88 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.718 -179.165 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.424 ' O ' ' O ' ' A' ' 77' ' ' ALA . 96.1 t -60.3 -24.5 31.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 179.687 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.531 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -45.71 172.81 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.594 179.835 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.568 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.6 p30 -62.01 177.77 0.42 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.605 -179.654 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.56 ' C ' ' H ' ' A' ' 81' ' ' GLY . 35.8 p30 -46.36 85.98 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.012 0.434 . . . . 0.0 110.921 179.956 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.568 ' N ' ' O ' ' A' ' 78' ' ' ASP . 43.0 tp60 -67.49 13.73 0.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.022 -179.78 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.56 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 117.91 -22.24 9.95 Favored Glycine 0 CA--C 1.518 0.269 0 N-CA-C 110.991 -0.844 . . . . 0.0 110.991 179.987 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -107.95 116.7 32.42 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.007 0.432 . . . . 0.0 110.488 179.858 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 76.5 mt -98.88 0.9 45.11 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.482 -179.783 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -91.93 6.57 45.73 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.996 0.427 . . . . 0.0 110.475 -179.749 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.777 ' O ' HG22 ' A' ' 89' ' ' VAL . 27.2 mt-30 -100.02 -26.52 13.95 Favored 'General case' 0 C--O 1.224 -0.259 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.843 179.883 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.0 t-105 -64.6 -40.86 96.26 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.121 -179.769 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.551 ' O ' ' N ' ' A' ' 91' ' ' LYS . 70.3 m -77.59 -53.55 7.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.355 -179.67 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -48.22 -50.75 28.22 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.076 -179.24 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.777 HG22 ' O ' ' A' ' 85' ' ' GLN . 14.3 m -69.08 -41.03 81.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 120.932 0.396 . . . . 0.0 111.174 179.645 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.505 ' N ' HG23 ' A' ' 89' ' ' VAL . . . -71.72 -22.95 61.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.814 -179.971 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.551 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.0 tttm -61.51 -45.97 91.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.476 -179.493 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.437 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.8 mm-40 -90.43 -94.33 0.12 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.111 -179.867 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.632 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.9 mtt180 -143.37 59.66 1.4 Allowed 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 179.767 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.459 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.6 pttp 33.74 26.08 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 120.833 0.349 . . . . 0.0 110.171 -179.354 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.632 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.3 tt -47.96 123.39 6.11 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.977 -178.076 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.447 ' O ' HD23 ' A' ' 95' ' ' LEU . 99.0 mm-40 -83.45 -170.54 3.1 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.055 -179.841 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.616 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 82.6 mtp180 -72.93 137.74 45.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.182 -179.807 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.493 ' N ' ' O ' ' A' ' 67' ' ' SER . 88.4 mt -86.32 -166.28 1.5 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.702 -179.626 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.531 ' O ' ' CD2' ' A' ' 99' ' ' TYR . 47.1 p90 -167.75 119.8 0.88 Allowed 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.223 179.938 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.508 ' C ' ' O ' ' A' ' 99' ' ' TYR . 43.0 mm -29.6 121.19 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.997 -179.645 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 113.66 28.17 3.3 Favored Glycine 0 CA--C 1.519 0.304 0 N-CA-C 111.179 -0.768 . . . . 0.0 111.179 -179.404 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.585 ' CD ' ' H ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -143.88 45.81 0.6 Allowed Pre-proline 0 C--N 1.324 -0.53 0 CA-C-O 120.947 0.403 . . . . 0.0 110.475 179.827 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.584 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 30.8 Cg_endo -62.06 143.7 95.23 Favored 'Trans proline' 0 C--N 1.296 -2.187 0 C-N-CA 122.639 2.226 . . . . 0.0 112.057 179.926 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.475 ' O ' HG23 ' A' ' 108' ' ' VAL . 22.6 t -173.27 120.77 0.35 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.41 179.649 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.28 -41.09 64.03 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.105 0.479 . . . . 0.0 111.262 179.525 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -65.92 -40.27 91.29 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.908 -179.401 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.89 -39.89 95.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.7 -179.915 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 104' ' ' SER . 69.0 t -67.43 -43.91 87.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.774 179.558 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.18 -39.18 91.83 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.554 -179.236 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.437 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.64 -23.62 63.18 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.425 179.835 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.552 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.5 mm-40 -90.83 4.68 51.09 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.703 -179.547 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.552 ' C ' ' O ' ' A' ' 111' ' ' GLN . 10.3 tpt 23.43 63.85 0.38 Allowed Pre-proline 0 N--CA 1.467 0.378 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.982 179.906 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.443 ' HG2' HD11 ' A' ' 116' ' ' ILE . 71.6 Cg_endo -78.48 168.58 21.18 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 C-N-CA 122.94 2.427 . . . . 0.0 112.28 -178.54 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.523 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 98.9 m-20 -112.7 -44.24 3.35 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.999 0.428 . . . . 0.0 109.97 179.495 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.0 tp -120.58 120.05 34.69 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.665 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.457 HD13 HD22 ' A' ' 133' ' ' LEU . 96.4 mt -117.09 131.26 70.33 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 CA-C-O 120.877 0.37 . . . . 0.0 111.017 -179.942 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.621 HD12 ' OG ' ' A' ' 48' ' ' SER . 30.0 mt -106.27 132.6 52.13 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.133 0.492 . . . . 0.0 110.234 -179.369 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.411 HD12 HG23 ' A' ' 139' ' ' THR . 98.1 mt -117.99 136.58 54.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.718 -179.705 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 86.0 p -72.17 152.93 41.94 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.644 179.979 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.36 -49.98 75.41 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.631 -179.858 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -148.99 153.43 37.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.495 179.811 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 169.53 -170.38 42.63 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 179.837 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.95 -35.31 91.89 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 179.915 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.451 ' OD1' ' O ' ' A' ' 124' ' ' ASP . 44.5 p-10 -87.71 120.0 28.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.822 0.344 . . . . 0.0 110.681 179.922 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.449 ' O ' HD12 ' A' ' 129' ' ' LEU . 39.8 t -63.62 144.22 57.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.437 -179.947 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.518 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.31 -43.34 8.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.931 180.0 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.6 tp -62.71 -42.35 99.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.684 -179.899 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.72 -11.38 58.22 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.478 -179.361 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.449 HD12 ' O ' ' A' ' 125' ' ' SER . 84.9 mt -115.64 -23.6 8.65 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.653 -179.781 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 130' ' ' TYR . . . . . 0.518 ' N ' ' O ' ' A' ' 126' ' ' ALA . 78.0 t80 -51.91 -49.71 62.54 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 120.534 -0.466 . . . . 0.0 110.548 -178.958 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.6 p-10 -65.91 -42.35 90.27 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.867 0.365 . . . . 0.0 111.268 179.512 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.521 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 87.9 mt-30 -67.0 -37.14 83.66 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.811 179.836 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.457 HD22 HD13 ' A' ' 116' ' ' ILE . 93.5 mt -79.98 -41.96 24.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.004 -179.612 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.0 t -57.48 -44.59 85.03 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.172 -178.959 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.8 m -62.25 -45.59 92.63 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.797 0.332 . . . . 0.0 110.54 179.382 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 92.3 mt -62.45 -43.79 98.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.277 -179.829 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.603 ' HB1' ' HD2' ' A' ' 138' ' ' PRO . . . -170.14 163.98 6.14 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.525 179.833 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.603 ' HD2' ' HB1' ' A' ' 137' ' ' ALA . 78.4 Cg_exo -43.81 111.89 0.28 Allowed 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.414 2.076 . . . . 0.0 112.1 179.523 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.471 HG21 ' CD1' ' A' ' 130' ' ' TYR . 17.8 m -85.97 127.54 34.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.49 179.973 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.649 HD13 ' CD2' ' A' ' 37' ' ' HIS . 34.2 tp -118.94 135.9 54.35 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.896 -179.576 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.435 ' O ' ' OD1' ' A' ' 32' ' ' ASP . 80.2 mt -102.63 119.89 51.63 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.417 0 CA-C-O 121.176 0.512 . . . . 0.0 111.466 -179.524 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.511 HD12 HD22 ' A' ' 117' ' ' LEU . 98.0 mt -135.8 132.66 51.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.615 179.791 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.549 HD21 ' CG ' ' A' ' 241' ' ' ASP . 54.5 t30 -65.62 151.7 45.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.966 0.412 . . . . 0.0 110.33 179.195 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.52 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 87.3 t80 -85.62 122.42 29.7 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.978 -179.553 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.52 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 98.9 m-20 55.13 69.33 0.74 Allowed 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.966 179.755 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 49.2 p-10 -123.44 -0.35 8.74 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 120.989 0.423 . . . . 0.0 110.711 179.866 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -151.32 117.24 5.51 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.818 -179.52 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 84.8 p -63.26 167.9 4.8 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.519 -179.77 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.419 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.4 p-90 -50.78 -15.7 0.32 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.566 -179.823 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.444 ' O ' HG23 ' A' ' 154' ' ' THR . 68.0 tp60 -71.24 -74.78 0.14 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.427 -179.726 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.449 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.1 t -62.66 -39.06 92.73 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.235 179.476 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 53.5 tp -60.25 -45.51 93.03 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.345 -178.476 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.419 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 45.7 tp -62.67 -41.92 99.35 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.83 0.348 . . . . 0.0 110.365 179.013 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.449 ' OG1' ' O ' ' A' ' 151' ' ' SER . 55.3 p -63.92 -34.65 78.45 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.282 -179.461 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.451 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.5 mm-40 -63.93 -42.37 97.37 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.175 179.269 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 92.1 mt -65.32 -39.02 91.92 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.072 0.463 . . . . 0.0 110.122 179.163 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.582 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.05 -32.29 79.77 Favored Glycine 0 CA--C 1.519 0.337 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 -179.308 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.451 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.3 mt-10 -36.48 -25.21 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.88 0.371 . . . . 0.0 110.808 179.913 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.582 ' N ' ' O ' ' A' ' 157' ' ' GLY . 95.7 mt -59.45 148.93 6.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.215 179.319 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 75.3 p -68.94 137.51 53.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.07 -179.554 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 70.6 22.13 77.88 Favored Glycine 0 N--CA 1.459 0.187 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 179.48 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 60.0 m80 -124.24 -14.62 6.95 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.673 0.273 . . . . 0.0 110.542 179.88 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -66.58 -59.44 3.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.696 -179.657 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -52.17 -48.68 64.82 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.141 -179.509 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -60.97 -40.95 95.35 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.742 0.306 . . . . 0.0 110.317 179.454 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.59 -47.31 86.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.57 179.822 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.95 -40.05 75.71 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.197 -179.787 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -61.76 -50.26 73.1 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.511 179.597 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -65.38 -43.68 89.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.493 179.595 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 95.4 mt -64.49 -43.48 96.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.395 179.71 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.23 -51.03 70.98 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.568 -179.129 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.81 -43.54 95.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.431 179.744 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.666 ' CE2' HD11 ' A' ' 177' ' ' LEU . 57.1 t80 -62.55 -44.75 95.56 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.117 0.484 . . . . 0.0 110.503 179.272 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -63.22 -39.82 95.71 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.616 -179.365 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -62.9 -42.74 99.88 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.644 179.175 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -60.97 -44.64 97.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.015 -179.944 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.666 HD11 ' CE2' ' A' ' 173' ' ' PHE . 85.1 mt -64.24 -41.25 97.07 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.033 0.445 . . . . 0.0 110.715 178.887 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.41 -62.1 1.85 Allowed 'General case' 0 C--O 1.237 0.432 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.51 -179.317 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.67 -46.71 86.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.545 179.882 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.45 -41.46 66.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.203 -179.979 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -63.77 -33.73 76.31 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.965 0.412 . . . . 0.0 110.347 179.244 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.423 ' O ' ' HG2' ' A' ' 182' ' ' GLU . 69.8 tt0 -90.57 8.56 33.47 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.483 0.659 . . . . 0.0 110.527 -178.997 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -104.51 -32.22 9.08 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.267 179.58 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.6 pt -128.01 147.78 32.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.863 -179.902 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -140.05 131.16 26.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.352 179.409 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.591 HD22 ' N ' ' A' ' 186' ' ' LEU . 3.6 mm? -85.68 133.29 42.1 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.905 179.936 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -44.1 157.89 0.14 Allowed 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.685 2.257 . . . . 0.0 112.123 179.468 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 0.523 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.5 Cg_endo -62.87 115.05 2.69 Favored 'Trans proline' 0 C--N 1.303 -1.828 0 C-N-CA 122.812 2.341 . . . . 0.0 111.701 179.887 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 189' ' ' GLN . . . . . 0.523 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.7 mt-30 155.59 148.16 0.0 OUTLIER Pre-proline 0 N--CA 1.454 -0.257 0 O-C-N 123.626 0.579 . . . . 0.0 110.726 -179.957 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -73.95 144.13 33.9 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 C-N-CA 122.657 2.238 . . . . 0.0 111.779 178.083 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.503 HG23 ' OG ' ' A' ' 258' ' ' SER . 2.1 p -125.06 158.76 32.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.276 0.56 . . . . 0.0 110.138 -179.95 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 192' ' ' THR . . . . . 0.493 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 35.6 p -143.29 165.46 27.41 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.199 -179.798 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 193' ' ' ALA . . . . . 0.445 ' HA ' ' H ' ' A' ' 260' ' ' PHE . . . -135.45 128.54 31.67 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.231 0.538 . . . . 0.0 110.206 179.597 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.506 HD11 HD23 ' A' ' 259' ' ' LEU . 47.1 pt -146.59 149.36 16.02 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.358 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.138 179.71 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 195' ' ' VAL . . . . . 0.739 HG13 ' CD1' ' A' ' 262' ' ' PHE . 69.2 t -118.14 123.31 71.45 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-O 121.385 0.612 . . . . 0.0 109.538 179.276 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -134.39 107.08 7.4 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.181 179.759 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 95.2 m -130.89 130.77 43.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.95 179.685 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.406 ' O ' ' N ' ' A' ' 201' ' ' HIS . . . -83.04 -37.03 24.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.227 179.793 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.39 -67.06 0.26 Allowed 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.346 -179.967 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.24 -9.96 59.15 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.272 179.536 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 201' ' ' HIS . . . . . 0.406 ' N ' ' O ' ' A' ' 198' ' ' ALA . 60.1 t-80 60.8 58.08 2.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.585 -179.841 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 54.4 p -166.89 153.33 8.44 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.472 179.568 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.02 143.86 24.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.454 179.509 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -135.16 138.05 43.32 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.635 179.972 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 20.0 mt -106.23 125.51 51.08 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 121.114 0.483 . . . . 0.0 109.731 -179.67 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 206' ' ' TRP . . . . . 0.56 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 74.4 m95 -81.91 166.88 19.51 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.595 -179.799 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 207' ' ' THR . . . . . 0.465 HG22 ' C ' ' A' ' 206' ' ' TRP . 0.1 OUTLIER -157.01 172.01 6.7 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.561 -179.173 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.18 -36.94 87.28 Favored 'Trans proline' 0 C--N 1.302 -1.894 0 C-N-CA 122.623 2.215 . . . . 0.0 112.022 179.477 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -70.52 -35.11 72.99 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.888 -179.917 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 21.9 m -61.18 150.63 33.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.662 -179.368 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.62 -36.84 81.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.482 -179.714 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 212' ' ' GLN . . . . . 0.56 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 54.8 tt0 -64.57 -40.44 95.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.524 179.931 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.79 -43.33 91.95 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.679 -0.969 . . . . 0.0 110.679 179.829 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -63.44 -43.7 96.67 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 179.933 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 215' ' ' MET . . . . . 0.55 ' SD ' ' HB2' ' A' ' 304' ' ' ALA . 65.6 ttp -59.64 -47.83 84.05 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.161 -179.764 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 86.7 mt -60.83 -40.68 93.68 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 179.731 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 217' ' ' GLU . . . . . 0.453 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.2 tp10 -58.27 -38.03 76.14 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.784 -0.451 . . . . 0.0 109.784 179.926 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -65.13 -38.23 89.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.836 0.351 . . . . 0.0 110.664 179.605 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 93.6 mt -64.33 -42.65 96.19 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.497 -179.587 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.6 45.22 0.08 OUTLIER Glycine 0 C--N 1.333 0.393 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 179.975 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 221' ' ' PHE . . . . . 0.453 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 26.5 m-85 -128.38 155.83 44.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.025 0.44 . . . . 0.0 110.527 -179.802 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.489 ' O ' HG13 ' A' ' 191' ' ' VAL . 8.2 p -107.56 122.61 47.02 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.262 0.553 . . . . 0.0 110.197 -179.913 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.475 HD22 ' C ' ' A' ' 222' ' ' THR . 4.3 mm? -101.52 132.92 46.89 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.082 179.884 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.65 159.84 14.71 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.508 179.883 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.46 115.27 29.97 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.955 0.407 . . . . 0.0 110.306 179.869 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.499 HD12 ' N ' ' A' ' 226' ' ' LEU . 9.0 mp -53.1 156.85 3.35 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.672 179.907 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -60.59 145.53 98.65 Favored 'Trans proline' 0 C--N 1.301 -1.96 0 C-N-CA 122.564 2.176 . . . . 0.0 112.076 179.396 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.21 -3.41 59.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.551 -179.966 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.06 -41.09 5.67 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 -179.909 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.53 ' O ' ' N ' ' A' ' 233' ' ' SER . 68.3 mt -78.97 -17.57 55.21 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-O 121.097 0.475 . . . . 0.0 110.372 -179.838 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 231' ' ' ASN . . . . . 0.401 ' C ' ' O ' ' A' ' 230' ' ' LEU . 55.0 t-20 -40.43 -49.13 2.84 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.827 -179.352 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -87.68 15.28 7.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.779 0.323 . . . . 0.0 111.34 179.748 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.53 ' N ' ' O ' ' A' ' 230' ' ' LEU . 78.1 p -60.47 -35.32 75.59 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.591 -179.749 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 234' ' ' GLN . . . . . 0.525 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.7 tt0 -119.35 -69.44 0.85 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.966 179.457 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.2 m -69.25 103.08 1.85 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.686 -179.788 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -94.77 57.19 2.12 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.381 179.951 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -144.58 -122.72 1.61 Allowed Glycine 0 C--N 1.332 0.322 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 -179.989 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -135.03 111.9 10.14 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 121.202 0.525 . . . . 0.0 110.401 179.958 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 239' ' ' ARG . . . . . 0.525 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.6 mtt180 -148.15 57.74 1.08 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.796 -179.856 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -69.43 -32.16 70.96 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.518 179.681 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 241' ' ' ASP . . . . . 0.549 ' CG ' HD21 ' A' ' 143' ' ' ASN . 65.0 t0 -57.03 -47.04 81.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.372 -179.101 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 242' ' ' ILE . . . . . 0.437 ' O ' ' O ' ' A' ' 239' ' ' ARG . 17.9 tt -139.92 156.59 25.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.944 0.402 . . . . 0.0 110.477 179.771 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.444 HG22 HD13 ' A' ' 245' ' ' LEU . 96.1 mt -106.3 106.81 21.29 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.219 0 CA-C-O 121.208 0.527 . . . . 0.0 110.498 179.776 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 244' ' ' GLN . . . . . 0.601 ' O ' HD12 ' A' ' 245' ' ' LEU . 88.2 mt-30 -110.67 110.15 20.7 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.264 179.717 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.601 HD12 ' O ' ' A' ' 244' ' ' GLN . 9.4 mp -121.71 -168.14 1.65 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.667 179.725 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 246' ' ' GLY . . . . . 0.525 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.4 -15.82 0.05 OUTLIER Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.991 -0.844 . . . . 0.0 110.991 179.851 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 247' ' ' GLY . . . . . 0.673 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -61.47 156.5 34.83 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 110.926 -0.869 . . . . 0.0 110.926 -179.893 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -63.59 21.83 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.975 0.416 . . . . 0.0 110.59 179.948 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 249' ' ' ASN . . . . . 0.673 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.9 m-20 -97.48 -6.13 34.46 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.572 179.9 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 93.5 mt -79.43 -22.11 44.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.639 179.522 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.66 -51.21 70.89 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.806 -179.445 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.09 -5.82 58.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.375 179.639 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.12 -74.47 1.14 Allowed Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 -179.956 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 83.0 mt -70.15 125.81 27.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.019 0.438 . . . . 0.0 110.168 -179.759 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -59.57 -39.2 83.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.28 -179.691 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 83.27 51.71 4.04 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 110.716 -0.954 . . . . 0.0 110.716 179.755 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -95.62 -15.33 22.83 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.709 0.29 . . . . 0.0 110.641 -179.853 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 258' ' ' SER . . . . . 0.503 ' OG ' HG23 ' A' ' 191' ' ' VAL . 3.4 t 174.58 89.07 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.058 0.456 . . . . 0.0 110.083 179.935 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.862 HD12 ' N ' ' A' ' 259' ' ' LEU . 0.9 OUTLIER -94.39 124.2 38.27 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.291 0.567 . . . . 0.0 111.165 -179.211 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 260' ' ' PHE . . . . . 0.445 ' H ' ' HA ' ' A' ' 193' ' ' ALA . 15.9 m-30 -93.1 146.68 23.47 Favored 'General case' 0 CA--C 1.506 -0.747 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.324 179.281 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 86.1 mt -122.53 149.7 43.56 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.53 -179.883 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.739 ' CD1' HG13 ' A' ' 195' ' ' VAL . 2.5 p90 -77.78 -138.56 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.472 -179.724 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 263' ' ' ALA . . . . . 0.662 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -51.72 77.4 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.985 -179.988 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 264' ' ' GLY . . . . . 0.635 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.17 104.42 0.19 Allowed Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 -179.852 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 265' ' ' ASP . . . . . 0.602 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.6 m-20 -80.41 -177.69 6.3 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.662 0.268 . . . . 0.0 110.932 -179.583 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -40.65 -17.6 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.454 179.939 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 267' ' ' LYS . . . . . 0.602 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.42 -51.59 42.25 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.992 0.425 . . . . 0.0 110.768 179.382 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -63.78 -46.61 84.46 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.126 179.397 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 269' ' ' ALA . . . . . 0.562 ' HB1' ' OH ' ' A' ' 273' ' ' TYR . . . -61.72 -35.1 77.07 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 121.129 0.49 . . . . 0.0 109.71 179.693 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -62.87 -34.91 78.38 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.213 179.672 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.27 -43.02 14.11 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.402 -179.59 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 272' ' ' ILE . . . . . 0.59 ' C ' ' H ' ' A' ' 274' ' ' ALA . 5.0 tt -51.29 -33.82 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.828 -179.006 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 273' ' ' TYR . . . . . 0.562 ' OH ' ' HB1' ' A' ' 269' ' ' ALA . 17.3 m-85 -54.15 -1.66 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.695 -179.625 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 274' ' ' ALA . . . . . 0.59 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.81 -39.88 69.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.882 179.626 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 275' ' ' ASN . . . . . 0.58 ' O ' ' N ' ' A' ' 279' ' ' ALA . 2.9 p30 -39.29 97.93 0.15 Allowed Pre-proline 0 N--CA 1.463 0.196 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.536 -179.76 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -53.87 -43.03 61.65 Favored 'Trans proline' 0 C--N 1.303 -1.828 0 C-N-CA 122.281 1.987 . . . . 0.0 112.78 -178.884 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 89.6 mt -64.28 -42.8 96.24 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 121.2 0.524 . . . . 0.0 111.346 -179.866 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 90.9 mt -95.68 -1.72 49.51 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.826 -179.499 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 279' ' ' ALA . . . . . 0.58 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.37 -34.97 77.73 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.619 -179.727 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -74.06 19.97 0.11 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.047 -179.342 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 0.491 HD23 ' HA ' ' A' ' 281' ' ' LEU . 13.8 mt -75.19 120.54 82.15 Favored Pre-proline 0 N--CA 1.451 -0.395 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.345 -179.96 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -51.54 -39.15 65.56 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.586 2.191 . . . . 0.0 111.699 179.241 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -53.08 -50.28 64.71 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 179.914 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 74.9 t -61.56 -43.96 97.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.544 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -57.74 -41.22 81.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.281 -179.918 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -91.04 0.35 57.56 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.139 179.676 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt 59.32 43.14 17.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.943 179.731 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -94.64 41.54 1.09 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.298 179.901 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 53.7 t -119.15 135.64 58.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.001 0.429 . . . . 0.0 110.169 -179.7 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -132.73 162.85 30.37 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.072 0.463 . . . . 0.0 110.753 -179.728 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.69 155.26 32.75 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.991 0.424 . . . . 0.0 110.783 -179.938 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 82.2 mt -94.1 -1.4 54.38 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.242 -179.689 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 120.87 165.28 12.66 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.549 -1.02 . . . . 0.0 110.549 -179.886 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 7.0 m -86.89 -62.29 1.54 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.853 0.359 . . . . 0.0 111.118 -179.89 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 295' ' ' GLU . . . . . 0.446 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.5 mm-40 -69.15 -4.09 16.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.667 -179.768 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 25.3 p -76.71 32.07 0.13 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.673 -179.94 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 297' ' ' PHE . . . . . 0.507 ' CD2' HG22 ' A' ' 70' ' ' THR . 69.0 t80 -60.42 -45.91 91.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.64 -179.99 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 298' ' ' ARG . . . . . 0.616 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.2 mtt85 -81.02 134.89 35.76 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 121.011 0.434 . . . . 0.0 110.597 -179.677 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.465 ' H ' HG11 ' A' ' 51' ' ' VAL . 17.6 tp -114.15 117.53 31.45 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.081 179.944 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 300' ' ' ASP . . . . . 0.619 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.4 p-10 -165.14 -176.81 4.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.543 179.911 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -46.91 -43.22 18.72 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.186 -179.655 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -67.12 -40.25 86.8 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.99 0.424 . . . . 0.0 110.853 179.053 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 303' ' ' SER . . . . . 0.619 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 59.9 p -56.12 -36.11 67.85 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.064 -179.121 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 304' ' ' ALA . . . . . 0.55 ' HB2' ' SD ' ' A' ' 215' ' ' MET . . . -57.58 -51.34 69.89 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 179.463 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 90.3 mtp -56.73 -43.39 80.6 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 108.993 -0.744 . . . . 0.0 108.993 -179.866 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -66.53 -42.54 87.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.905 0.383 . . . . 0.0 110.108 178.884 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 307' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 303' ' ' SER . 56.0 t -63.94 -43.09 97.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.112 179.344 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 42.7 tp -59.63 -42.19 92.17 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.782 -179.451 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -62.64 -38.91 92.1 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 179.522 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 310' ' ' ARG . . . . . 0.442 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.6 ttt85 -63.62 -43.95 95.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.17 179.553 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 88.4 mt -63.3 -42.08 99.01 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.156 179.693 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -62.85 -33.45 75.27 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.978 179.558 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.96 -23.27 21.59 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.47 -179.809 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.481 HD22 ' CE2' ' A' ' 315' ' ' PHE . 6.8 tt -62.42 -43.05 99.75 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.076 0.465 . . . . 0.0 110.624 -179.884 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 315' ' ' PHE . . . . . 0.481 ' CE2' HD22 ' A' ' 314' ' ' LEU . 90.9 m-85 . . . . . 0 C--O 1.22 -0.485 0 CA-C-O 117.937 -1.03 . . . . 0.0 110.479 179.964 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -99.4 136.01 39.98 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.032 0.444 . . . . 0.0 110.547 -179.962 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.498 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -92.26 178.42 1.7 Allowed Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.5 -179.924 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.498 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 27.0 Cg_exo -61.54 147.45 95.4 Favored 'Trans proline' 0 C--N 1.301 -1.958 0 C-N-CA 122.726 2.284 . . . . 0.0 112.173 179.737 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.453 ' HE ' HD12 ' A' ' 39' ' ' LEU . 35.4 ptt180 -135.7 142.18 45.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.608 179.782 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -79.73 116.34 19.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.446 179.896 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.453 ' O ' HG23 ' A' ' 30' ' ' ILE . 9.5 tp -110.71 130.25 64.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.438 -179.96 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 12.7 t -70.77 141.43 51.44 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.518 179.925 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.477 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.2 t0 -139.01 179.38 6.53 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.55 -179.928 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.477 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 78.1 p -74.04 -36.88 64.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.684 179.784 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.8 ttt85 -46.53 -94.55 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.344 -179.504 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -166.92 -26.78 0.02 OUTLIER Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 179.928 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 55.1 m -169.21 104.7 0.38 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.979 0.419 . . . . 0.0 110.665 -179.873 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.683 ' CD2' HD13 ' A' ' 140' ' ' LEU . 74.5 t60 -128.39 148.24 50.69 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.042 0.449 . . . . 0.0 110.338 179.795 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.627 HG22 ' N ' ' A' ' 39' ' ' LEU . 98.0 m -130.62 166.02 21.56 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.674 -179.889 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.627 ' N ' HG22 ' A' ' 38' ' ' THR . 82.4 mt -120.68 127.61 52.21 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.455 179.74 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -65.18 -44.55 88.12 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.653 -179.861 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 38.8 p -165.63 154.86 12.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.42 179.582 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.524 ' CD ' ' H ' ' A' ' 42' ' ' GLN . 14.8 mp0 -44.33 101.13 0.24 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.676 179.528 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -57.29 129.06 32.16 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.421 2.081 . . . . 0.0 112.183 -179.588 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -83.72 -24.76 31.07 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.478 179.619 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.538 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.8 mtm-85 -121.87 134.61 54.87 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-O 121.194 0.521 . . . . 0.0 110.303 -179.99 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 95.9 mt -130.9 133.68 62.73 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.261 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.017 -179.812 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 45.3 t -124.2 130.49 73.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 179.372 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.625 ' OG ' HD12 ' A' ' 117' ' ' LEU . 2.3 m -155.28 166.83 32.34 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.564 179.849 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 66.6 p -124.44 9.16 8.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.5 179.874 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.16 125.43 32.81 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.635 -179.436 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.444 HG11 ' H ' ' A' ' 299' ' ' LEU . 94.0 t -65.88 -44.61 92.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.51 179.967 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.7 m -62.63 -44.31 96.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.615 -179.805 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 51.0 tp -62.26 -41.57 98.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.541 -179.487 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.44 ' O ' HD13 ' A' ' 58' ' ' LEU . 74.2 m -57.59 -44.4 85.36 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.404 -179.36 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.2 -62.22 5.35 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 179.539 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.7 t -48.59 -35.47 13.6 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 -179.939 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.8 mt -61.72 -44.96 95.9 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.153 179.379 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.44 HD13 ' O ' ' A' ' 54' ' ' THR . 9.3 mp -64.85 -41.88 95.35 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.081 0.467 . . . . 0.0 111.368 177.918 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.28 -41.12 98.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.96 -179.139 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.427 ' O ' HG23 ' A' ' 60' ' ' ILE . 8.2 tp -88.58 17.05 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.71 -179.647 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 56.57 84.85 0.08 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.645 -179.991 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.65 58.86 0.09 OUTLIER Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.072 -179.819 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -50.66 151.41 10.7 Favored 'Trans proline' 0 C--N 1.297 -2.17 0 C-N-CA 122.767 2.312 . . . . 0.0 112.562 -178.366 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.432 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -108.33 145.49 15.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.325 -179.736 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 97.0 mt -63.84 -44.95 98.28 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.439 -179.785 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.497 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -130.13 134.29 47.22 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.545 -179.791 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.491 ' O ' ' N ' ' A' ' 98' ' ' LEU . 75.3 m -134.59 158.67 43.4 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.878 -179.643 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.31 138.71 16.12 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 179.799 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.476 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.62 -162.97 0.09 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.997 0.427 . . . . 0.0 110.426 -179.924 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.525 HG22 ' CD2' ' A' ' 297' ' ' PHE . 5.9 t -133.78 135.53 43.93 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.209 -179.985 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.494 ' C ' ' O ' ' A' ' 70' ' ' THR . 1.0 OUTLIER 29.5 68.12 0.67 Allowed Pre-proline 0 N--CA 1.464 0.245 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.685 -179.634 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -60.54 145.14 99.31 Favored 'Trans proline' 0 C--N 1.3 -1.98 0 C-N-CA 122.57 2.18 . . . . 0.0 112.236 -178.618 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.529 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 44.9 p-10 -160.23 -32.18 0.06 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.574 179.757 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.536 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 99.1 m-20 -63.96 -39.4 94.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.385 179.999 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -60.47 -48.21 82.78 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.684 -179.351 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.421 ' O ' ' O ' ' A' ' 77' ' ' ALA . 96.6 t -60.09 -24.4 30.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.133 179.584 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.536 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -45.98 173.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.518 179.922 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.575 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.5 p30 -62.28 177.98 0.44 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.649 -179.766 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.551 ' C ' ' H ' ' A' ' 81' ' ' GLY . 35.4 p30 -45.51 85.75 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.93 179.893 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.575 ' N ' ' O ' ' A' ' 78' ' ' ASP . 42.8 tp60 -68.03 13.48 0.08 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.058 0.456 . . . . 0.0 110.111 -179.835 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.551 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 118.41 -22.29 9.57 Favored Glycine 0 CA--C 1.52 0.352 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 179.996 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -108.02 116.5 32.06 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.954 0.407 . . . . 0.0 110.474 179.785 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 76.6 mt -98.86 0.45 44.24 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.442 -179.724 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -92.52 7.23 44.07 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.996 0.427 . . . . 0.0 110.392 -179.689 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.796 ' O ' HG22 ' A' ' 89' ' ' VAL . 27.2 mt-30 -100.1 -27.65 13.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.822 -179.966 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 69.5 t-105 -63.25 -40.91 98.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.916 -179.615 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.56 ' O ' ' N ' ' A' ' 91' ' ' LYS . 66.5 m -77.58 -53.41 7.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.263 -179.405 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -48.46 -50.82 29.81 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.906 -179.302 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.796 HG22 ' O ' ' A' ' 85' ' ' GLN . 15.6 m -68.95 -40.84 81.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 120.959 0.409 . . . . 0.0 110.993 179.829 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.503 ' N ' HG23 ' A' ' 89' ' ' VAL . . . -72.18 -22.95 61.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.806 -179.864 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.56 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.0 tttm -61.77 -45.53 93.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.537 -179.558 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.444 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.6 mm-40 -90.47 -94.99 0.12 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.162 -179.957 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.642 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.9 mtt180 -142.78 59.28 1.43 Allowed 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 179.71 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.463 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.7 pttp 33.53 25.79 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 120.86 0.362 . . . . 0.0 110.235 -179.142 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.642 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.3 tt -47.68 123.5 5.98 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.907 -178.166 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.45 ' O ' HD23 ' A' ' 95' ' ' LEU . 99.0 mm-40 -83.81 -169.91 2.81 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.098 179.952 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.612 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 82.4 mtp180 -74.04 137.04 43.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.251 -179.754 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.491 ' N ' ' O ' ' A' ' 67' ' ' SER . 90.0 mt -86.27 -165.7 1.33 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.658 -179.539 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.535 ' O ' ' CD2' ' A' ' 99' ' ' TYR . 47.9 p90 -168.89 120.05 0.75 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.182 179.981 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.519 ' C ' ' O ' ' A' ' 99' ' ' TYR . 43.6 mm -29.14 121.24 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.994 -179.585 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 114.45 27.17 3.43 Favored Glycine 0 CA--C 1.521 0.441 0 N-CA-C 111.126 -0.789 . . . . 0.0 111.126 -179.578 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.587 ' CD ' ' H ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -144.35 46.26 0.61 Allowed Pre-proline 0 C--N 1.325 -0.498 0 CA-C-O 120.866 0.365 . . . . 0.0 110.412 179.986 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 29.9 Cg_endo -61.94 143.76 95.77 Favored 'Trans proline' 0 C--N 1.297 -2.168 0 C-N-CA 122.702 2.268 . . . . 0.0 112.021 179.993 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.464 ' O ' HG23 ' A' ' 108' ' ' VAL . 26.2 t -173.32 120.06 0.33 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.474 179.82 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.26 -40.49 64.57 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.045 0.45 . . . . 0.0 111.184 179.644 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.25 -40.05 89.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.923 -179.447 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.07 -40.06 95.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.736 -179.844 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 104' ' ' SER . 71.8 t -67.56 -43.95 86.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.863 179.664 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.83 -38.79 92.18 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.631 -179.323 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.444 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.44 -23.34 62.6 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.418 179.799 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.553 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.3 mm-40 -90.53 5.02 49.49 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.699 -179.454 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.553 ' C ' ' O ' ' A' ' 111' ' ' GLN . 10.2 tpt 24.16 63.59 0.41 Allowed Pre-proline 0 N--CA 1.465 0.278 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.874 -179.981 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -77.53 167.1 24.83 Favored 'Trans proline' 0 C--N 1.303 -1.82 0 C-N-CA 122.987 2.458 . . . . 0.0 112.415 -178.779 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.526 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 99.1 m-20 -110.39 -41.97 4.24 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 121.02 0.438 . . . . 0.0 110.131 179.442 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.7 tp -121.65 120.14 33.87 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.344 -0.389 . . . . 0.0 109.957 179.549 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 83.4 mt -112.99 129.14 69.18 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.341 0 CA-C-O 120.943 0.401 . . . . 0.0 110.891 -179.882 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.625 HD12 ' OG ' ' A' ' 48' ' ' SER . 29.7 mt -109.13 132.39 54.16 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 121.108 0.48 . . . . 0.0 110.165 -179.682 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.492 HD12 HG23 ' A' ' 139' ' ' THR . 98.8 mt -119.87 139.07 48.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.697 -179.789 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 85.0 p -72.65 153.75 41.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.579 179.951 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.08 -50.06 75.19 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.616 -179.823 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.0 t -149.64 154.19 38.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.573 179.795 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 170.56 -170.96 43.46 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.954 -0.858 . . . . 0.0 110.954 179.917 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -63.1 -34.14 89.16 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 179.932 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.452 ' OD1' ' O ' ' A' ' 124' ' ' ASP . 44.6 p-10 -86.93 120.23 27.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.805 0.336 . . . . 0.0 110.742 179.97 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.437 ' O ' HD12 ' A' ' 129' ' ' LEU . 40.6 t -63.1 143.58 57.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.431 -179.894 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.524 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.15 -43.27 8.94 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.888 -179.913 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 56.0 tp -62.74 -42.54 99.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.751 -179.858 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.42 -11.97 59.11 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.551 -179.436 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.437 HD12 ' O ' ' A' ' 125' ' ' SER . 84.1 mt -115.26 -23.6 8.86 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.663 -179.85 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 130' ' ' TYR . . . . . 0.524 ' N ' ' O ' ' A' ' 126' ' ' ALA . 79.0 t80 -51.01 -49.76 59.84 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.52 -179.012 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.3 p-10 -65.99 -42.64 89.51 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.8 0.333 . . . . 0.0 111.11 179.604 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.526 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 88.2 mt-30 -67.02 -37.92 84.99 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.744 179.926 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.414 HD12 HD11 ' A' ' 118' ' ' ILE . 95.2 mt -80.22 -41.56 24.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.983 -179.535 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.3 t -57.16 -44.29 83.33 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.196 -179.219 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.3 m -61.86 -45.33 94.23 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.778 0.323 . . . . 0.0 110.476 179.472 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 92.7 mt -62.23 -43.41 97.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.161 -179.742 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.657 ' HB1' ' HD2' ' A' ' 138' ' ' PRO . . . -169.53 168.23 4.89 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.533 179.866 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.657 ' HD2' ' HB1' ' A' ' 137' ' ' ALA . 51.9 Cg_exo -50.1 113.01 0.84 Allowed 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.29 1.993 . . . . 0.0 112.106 179.437 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.492 HG23 HD12 ' A' ' 118' ' ' ILE . 23.8 m -84.24 127.51 34.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.527 -179.927 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.683 HD13 ' CD2' ' A' ' 37' ' ' HIS . 34.6 tp -117.8 135.94 53.73 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.029 -179.702 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.443 ' O ' ' OD2' ' A' ' 32' ' ' ASP . 81.8 mt -100.17 118.82 47.4 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.36 0 CA-C-O 121.204 0.526 . . . . 0.0 111.231 -179.384 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.428 HD12 HD22 ' A' ' 117' ' ' LEU . 97.8 mt -134.73 132.27 54.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.656 179.629 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.446 ' ND2' ' H ' ' A' ' 144' ' ' TYR . 2.1 t-20 -66.9 151.19 48.04 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.9 0.381 . . . . 0.0 110.402 179.368 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.521 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 87.9 t80 -85.95 122.45 30.02 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.814 -179.577 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.521 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 98.8 m-20 55.16 69.3 0.75 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.87 179.725 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 35.2 p-10 -125.84 0.08 7.34 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.722 179.907 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -150.53 115.36 5.27 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.679 -179.463 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 84.0 p -63.61 168.54 4.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.526 -179.744 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.423 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.4 p-90 -52.01 -15.72 0.61 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.555 -179.861 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.444 ' O ' HG23 ' A' ' 154' ' ' THR . 67.9 tp60 -70.5 -76.32 0.1 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.446 -179.737 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.449 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.1 t -62.64 -38.46 90.36 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.379 179.488 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 53.6 tp -60.07 -45.57 92.46 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.419 -178.668 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.423 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 47.3 tp -62.82 -41.79 99.45 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.845 0.355 . . . . 0.0 110.3 179.101 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.449 ' OG1' ' O ' ' A' ' 151' ' ' SER . 63.3 p -64.07 -34.61 78.42 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.335 -179.615 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.423 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.3 mm-40 -64.14 -42.85 96.63 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.264 179.247 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 92.4 mt -65.4 -39.0 91.65 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.989 0.423 . . . . 0.0 110.21 179.159 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.587 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.01 -32.13 79.12 Favored Glycine 0 CA--C 1.521 0.426 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 -179.358 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.442 ' C ' ' O ' ' A' ' 157' ' ' GLY . 97.3 mt-10 -35.45 -26.84 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.799 0.333 . . . . 0.0 110.731 179.968 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.587 ' N ' ' O ' ' A' ' 157' ' ' GLY . 95.8 mt -56.87 149.64 3.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.211 179.376 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 72.4 p -69.55 137.12 52.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.031 -179.587 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 71.77 20.26 78.57 Favored Glycine 0 N--CA 1.459 0.197 0 N-CA-C 111.239 -0.744 . . . . 0.0 111.239 179.487 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 57.6 m80 -121.97 -15.09 7.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.731 0.3 . . . . 0.0 110.622 179.928 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -65.74 -59.88 3.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.807 -179.741 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -52.03 -49.13 64.01 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.225 -179.717 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -60.71 -41.22 94.79 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.701 0.286 . . . . 0.0 110.308 179.411 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.39 -47.25 86.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.7 179.779 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.9 -40.24 75.93 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.261 -179.92 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -61.74 -50.15 73.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.561 179.57 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 60.1 ttt85 -65.31 -43.88 89.66 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.462 179.535 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 96.0 mt -64.44 -43.63 96.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.449 179.671 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.18 -50.97 71.19 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.608 -179.148 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -63.76 -43.83 95.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.378 179.803 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.657 ' CE2' HD11 ' A' ' 177' ' ' LEU . 56.7 t80 -62.71 -44.53 95.99 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.071 0.462 . . . . 0.0 110.447 179.388 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -63.25 -40.13 96.57 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.435 -179.294 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -62.92 -42.75 99.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.648 179.292 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -60.6 -44.88 95.78 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.116 179.961 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.657 HD11 ' CE2' ' A' ' 173' ' ' PHE . 85.5 mt -64.37 -41.09 96.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.001 0.429 . . . . 0.0 110.692 178.867 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.02 -62.17 1.8 Allowed 'General case' 0 C--O 1.237 0.416 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.491 -179.349 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.94 -46.66 87.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.523 179.902 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.38 -41.69 66.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.15 179.999 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -63.79 -33.67 76.18 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.944 0.402 . . . . 0.0 110.354 179.272 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.424 ' O ' ' HG2' ' A' ' 182' ' ' GLU . 69.6 tt0 -90.48 8.71 32.44 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.25 0.547 . . . . 0.0 110.565 -179.099 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -104.81 -32.26 8.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.232 179.676 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 45.4 pt -128.07 147.49 32.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.826 -179.879 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -139.73 131.02 26.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.335 179.436 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.596 HD22 ' N ' ' A' ' 186' ' ' LEU . 3.5 mm? -85.5 133.66 41.71 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.776 179.994 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -44.16 157.74 0.15 Allowed 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.793 2.329 . . . . 0.0 112.053 179.47 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 0.532 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.7 Cg_endo -62.92 114.88 2.62 Favored 'Trans proline' 0 C--N 1.303 -1.867 0 C-N-CA 122.727 2.284 . . . . 0.0 111.833 179.908 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 189' ' ' GLN . . . . . 0.532 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.7 mt-30 155.54 148.23 0.0 OUTLIER Pre-proline 0 N--CA 1.454 -0.238 0 O-C-N 123.438 0.461 . . . . 0.0 110.686 -179.761 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -74.13 144.18 33.3 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.736 2.291 . . . . 0.0 111.687 178.165 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.499 HG23 ' OG ' ' A' ' 258' ' ' SER . 2.1 p -124.99 158.82 32.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.195 0.521 . . . . 0.0 110.146 -179.954 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 192' ' ' THR . . . . . 0.497 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 35.8 p -143.39 165.2 28.18 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.08 -179.526 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 193' ' ' ALA . . . . . 0.444 ' HA ' ' H ' ' A' ' 260' ' ' PHE . . . -135.45 128.48 31.55 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.145 0.498 . . . . 0.0 110.188 179.677 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.507 HD11 HD23 ' A' ' 259' ' ' LEU . 47.6 pt -146.52 149.09 16.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.068 179.88 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 195' ' ' VAL . . . . . 0.74 HG13 ' CD1' ' A' ' 262' ' ' PHE . 69.0 t -117.86 123.03 71.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.236 0.541 . . . . 0.0 109.733 179.08 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -134.15 106.86 7.39 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.288 179.79 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 95.1 m -130.62 130.52 44.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.77 179.751 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -83.18 -36.58 24.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.215 179.804 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.61 -66.99 0.27 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.398 179.878 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.68 -9.36 58.53 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.313 179.487 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 60.5 t-80 60.5 58.56 2.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.856 -179.952 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 37.1 p -167.29 153.64 8.08 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.526 179.512 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.52 144.09 24.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.967 0.413 . . . . 0.0 110.431 179.376 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -135.12 138.2 43.53 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.925 0.393 . . . . 0.0 110.671 -179.994 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 19.4 mt -106.39 125.52 51.1 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 121.117 0.484 . . . . 0.0 109.794 -179.738 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 206' ' ' TRP . . . . . 0.562 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 74.8 m95 -81.85 166.94 19.52 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.641 -179.808 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 207' ' ' THR . . . . . 0.473 HG22 ' C ' ' A' ' 206' ' ' TRP . 0.1 OUTLIER -156.84 171.4 7.48 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.942 0.401 . . . . 0.0 110.569 -179.288 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -53.83 -37.2 84.8 Favored 'Trans proline' 0 C--N 1.303 -1.838 0 C-N-CA 122.603 2.202 . . . . 0.0 111.97 179.352 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -70.21 -35.19 73.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.923 -179.875 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 21.7 m -61.05 150.79 32.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.601 -179.305 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.59 -37.02 82.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.527 -179.755 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 212' ' ' GLN . . . . . 0.562 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 54.7 tt0 -64.59 -40.32 95.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.566 179.99 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.51 -43.29 92.67 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 179.833 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -63.56 -43.45 96.99 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.76 0.314 . . . . 0.0 110.335 179.897 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 215' ' ' MET . . . . . 0.526 ' SD ' ' HB2' ' A' ' 304' ' ' ALA . 65.4 ttp -59.65 -47.92 83.7 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.37 -179.928 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' A' ' 216' ' ' LEU . 88.2 mt -60.56 -40.71 92.64 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.497 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 217' ' ' GLU . . . . . 0.459 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.8 tp10 -58.23 -37.95 75.88 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.806 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -65.2 -38.19 89.71 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.849 0.356 . . . . 0.0 110.651 179.679 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 94.6 mt -64.3 -42.77 96.2 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.618 -179.674 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.71 44.87 0.08 OUTLIER Glycine 0 CA--C 1.52 0.387 0 N-CA-C 110.974 -0.85 . . . . 0.0 110.974 -179.996 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 221' ' ' PHE . . . . . 0.459 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 26.8 m-85 -128.04 155.71 43.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.087 0.47 . . . . 0.0 110.452 -179.843 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.49 ' O ' HG13 ' A' ' 191' ' ' VAL . 7.1 p -107.44 122.46 46.67 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 121.138 0.494 . . . . 0.0 110.205 -179.933 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.475 HD22 ' C ' ' A' ' 222' ' ' THR . 4.3 mm? -101.39 132.94 46.7 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.048 -179.991 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.68 159.65 14.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.519 179.876 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.34 115.02 29.55 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.335 179.867 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.496 HD12 ' N ' ' A' ' 226' ' ' LEU . 8.9 mp -53.0 156.71 3.31 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.665 179.953 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -60.65 145.61 98.56 Favored 'Trans proline' 0 C--N 1.302 -1.917 0 C-N-CA 122.599 2.199 . . . . 0.0 111.989 179.455 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.34 -3.43 59.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.502 -179.987 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -89.97 -41.21 5.66 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 111.011 -0.836 . . . . 0.0 111.011 -179.855 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.54 ' O ' ' N ' ' A' ' 233' ' ' SER . 70.0 mt -78.91 -17.57 55.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.951 0.405 . . . . 0.0 110.329 -179.845 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 231' ' ' ASN . . . . . 0.403 ' C ' ' O ' ' A' ' 230' ' ' LEU . 55.2 t-20 -39.97 -49.31 2.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.742 -179.505 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -88.05 15.41 7.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.797 0.332 . . . . 0.0 111.21 -179.996 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.54 ' N ' ' O ' ' A' ' 230' ' ' LEU . 78.1 p -60.45 -35.68 76.44 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.53 -179.862 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 234' ' ' GLN . . . . . 0.527 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.6 tt0 -118.66 -69.32 0.86 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.961 179.591 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.2 m -69.81 103.22 2.12 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.744 -179.785 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -94.66 57.53 2.2 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.392 179.953 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -144.72 -122.66 1.59 Allowed Glycine 0 CA--C 1.521 0.418 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 -179.972 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -134.73 111.5 10.0 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.075 0.464 . . . . 0.0 110.494 179.975 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 239' ' ' ARG . . . . . 0.521 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.6 mtt180 -148.03 57.49 1.09 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.682 -179.9 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -69.48 -32.21 70.97 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.522 179.654 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 241' ' ' ASP . . . . . 0.455 ' OD2' ' O ' ' A' ' 144' ' ' TYR . 64.6 t0 -56.89 -47.04 81.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.369 -179.18 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 242' ' ' ILE . . . . . 0.441 ' O ' ' O ' ' A' ' 239' ' ' ARG . 18.0 tt -139.83 156.56 25.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.824 0.345 . . . . 0.0 110.584 179.807 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.442 HG22 HD13 ' A' ' 245' ' ' LEU . 96.1 mt -106.27 106.45 20.62 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.212 0 CA-C-O 121.09 0.472 . . . . 0.0 110.569 179.858 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 244' ' ' GLN . . . . . 0.606 ' O ' HD12 ' A' ' 245' ' ' LEU . 88.2 mt-30 -110.36 110.06 20.71 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.279 179.804 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.606 HD12 ' O ' ' A' ' 244' ' ' GLN . 9.3 mp -121.89 -168.43 1.7 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.65 179.923 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 246' ' ' GLY . . . . . 0.527 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.68 -16.37 0.05 OUTLIER Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 179.865 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 247' ' ' GLY . . . . . 0.676 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -60.91 156.48 32.61 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 -179.892 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -63.31 21.28 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.967 0.413 . . . . 0.0 110.569 179.952 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 249' ' ' ASN . . . . . 0.676 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.8 m-20 -96.99 -6.2 36.01 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.551 -179.996 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 93.8 mt -79.5 -22.22 44.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.636 179.545 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.51 -51.31 70.42 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.756 -179.49 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.1 -5.85 58.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.402 179.704 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -80.93 -74.63 1.13 Allowed Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 -179.902 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 83.6 mt -70.08 126.03 28.49 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.03 0.443 . . . . 0.0 110.246 -179.885 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -59.19 -39.39 82.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.238 -179.691 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 82.89 51.84 4.08 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 179.929 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -96.46 -14.22 22.54 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.734 0.302 . . . . 0.0 110.658 -179.822 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 258' ' ' SER . . . . . 0.499 ' OG ' HG23 ' A' ' 191' ' ' VAL . 3.5 t 174.16 88.47 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.075 0.464 . . . . 0.0 110.168 179.934 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.863 HD12 ' N ' ' A' ' 259' ' ' LEU . 1.0 OUTLIER -94.11 123.93 37.8 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.204 0.526 . . . . 0.0 111.073 -179.206 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 260' ' ' PHE . . . . . 0.444 ' H ' ' HA ' ' A' ' 193' ' ' ALA . 16.0 m-30 -92.76 146.42 23.66 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.356 179.175 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 87.0 mt -122.35 149.57 43.59 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.512 -179.917 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.74 ' CD1' HG13 ' A' ' 195' ' ' VAL . 2.5 p90 -77.64 -138.43 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.484 -179.808 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 263' ' ' ALA . . . . . 0.663 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -51.97 77.51 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.965 -179.945 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 264' ' ' GLY . . . . . 0.636 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.07 104.36 0.18 Allowed Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.674 -0.971 . . . . 0.0 110.674 -179.937 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 265' ' ' ASP . . . . . 0.608 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.9 m-20 -80.48 -177.74 6.35 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.743 0.306 . . . . 0.0 110.878 -179.477 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -40.43 -17.66 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.503 179.769 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 267' ' ' LYS . . . . . 0.608 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.49 -51.6 41.5 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.965 0.412 . . . . 0.0 110.742 179.434 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -63.81 -46.63 84.25 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.196 179.373 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 269' ' ' ALA . . . . . 0.568 ' HB1' ' OH ' ' A' ' 273' ' ' TYR . . . -61.58 -35.18 77.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.152 -0.477 . . . . 0.0 109.808 179.527 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -62.91 -34.64 77.87 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.164 179.624 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.32 -43.35 13.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.243 -179.535 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 272' ' ' ILE . . . . . 0.584 ' C ' ' H ' ' A' ' 274' ' ' ALA . 4.9 tt -51.53 -33.65 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.72 -178.712 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 273' ' ' TYR . . . . . 0.568 ' OH ' ' HB1' ' A' ' 269' ' ' ALA . 17.4 m-85 -54.23 -1.85 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.702 -179.705 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 274' ' ' ALA . . . . . 0.584 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.81 -39.49 69.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.848 179.651 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 275' ' ' ASN . . . . . 0.585 ' O ' ' N ' ' A' ' 279' ' ' ALA . 3.2 p30 -39.45 98.0 0.15 Allowed Pre-proline 0 C--N 1.332 -0.163 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.592 -179.668 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -53.82 -43.17 60.38 Favored 'Trans proline' 0 C--N 1.303 -1.847 0 C-N-CA 122.361 2.04 . . . . 0.0 112.751 -178.881 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 89.0 mt -64.47 -42.87 95.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.178 -179.667 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 90.7 mt -95.68 -1.51 49.94 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.839 -179.413 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 279' ' ' ALA . . . . . 0.585 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.55 -34.84 77.75 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.562 -179.713 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.08 20.03 0.11 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.045 -179.238 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 0.491 HD23 ' HA ' ' A' ' 281' ' ' LEU . 13.9 mt -75.54 120.83 83.44 Favored Pre-proline 0 N--CA 1.452 -0.329 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.389 179.977 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_exo -51.54 -38.97 65.68 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.597 2.198 . . . . 0.0 111.617 179.339 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.78 -50.39 63.64 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.165 179.79 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 75.5 t -61.53 -43.95 97.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 179.424 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -57.7 -41.51 81.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.295 -179.992 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -90.94 0.21 57.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.186 179.641 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt 59.09 43.03 18.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.029 0.442 . . . . 0.0 110.969 179.755 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -94.42 41.74 1.09 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.342 179.856 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 54.0 t -119.03 135.8 58.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.989 0.423 . . . . 0.0 110.299 -179.812 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -132.85 162.7 30.87 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.997 0.427 . . . . 0.0 110.669 -179.635 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.81 155.36 32.72 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.974 0.416 . . . . 0.0 110.72 -179.785 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 81.4 mt -94.05 -1.5 54.34 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.225 -179.745 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 120.89 165.72 12.8 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 -179.795 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 6.9 m -87.28 -62.39 1.51 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.847 0.356 . . . . 0.0 111.04 -179.847 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 295' ' ' GLU . . . . . 0.438 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.8 mm-40 -69.53 -3.94 16.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.625 -179.762 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 27.3 p -77.03 32.63 0.14 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.612 -179.906 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 297' ' ' PHE . . . . . 0.525 ' CD2' HG22 ' A' ' 70' ' ' THR . 70.1 t80 -60.11 -45.97 91.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.549 -179.993 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 298' ' ' ARG . . . . . 0.612 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.2 mtt85 -81.32 134.13 35.53 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 121.017 0.437 . . . . 0.0 110.51 -179.761 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.444 ' H ' HG11 ' A' ' 51' ' ' VAL . 16.0 tp -114.67 119.52 36.98 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.213 -179.951 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 300' ' ' ASP . . . . . 0.62 ' H ' ' CB ' ' A' ' 303' ' ' SER . 49.4 p-10 -167.36 -174.41 2.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.523 -179.936 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -48.06 -45.49 32.42 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.183 -179.603 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -65.05 -41.45 95.14 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.062 0.458 . . . . 0.0 110.771 179.019 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 303' ' ' SER . . . . . 0.62 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 53.0 p -55.55 -35.94 66.26 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.147 -179.37 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 304' ' ' ALA . . . . . 0.526 ' HB2' ' SD ' ' A' ' 215' ' ' MET . . . -57.16 -51.6 68.66 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.478 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 90.8 mtp -56.39 -43.57 79.39 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.792 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -66.52 -42.57 87.1 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.84 0.352 . . . . 0.0 110.131 178.78 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 307' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 303' ' ' SER . 56.1 t -64.03 -42.92 97.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.229 179.394 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 42.5 tp -59.63 -42.0 91.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.827 -179.626 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -62.86 -39.0 93.06 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 179.58 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 310' ' ' ARG . . . . . 0.437 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.4 ttt85 -63.59 -44.06 95.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.322 179.514 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 87.8 mt -63.3 -42.07 99.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.215 179.58 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -62.89 -33.18 74.76 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.037 179.521 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.95 -23.46 21.55 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.559 -179.866 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.483 HD22 ' CE2' ' A' ' 315' ' ' PHE . 6.8 tt -62.34 -43.18 99.43 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.626 179.977 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 315' ' ' PHE . . . . . 0.483 ' CE2' HD22 ' A' ' 314' ' ' LEU . 91.1 m-85 . . . . . 0 C--O 1.22 -0.471 0 CA-C-O 117.979 -1.01 . . . . 0.0 110.506 179.992 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -99.6 136.5 39.43 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.041 0.448 . . . . 0.0 110.422 -179.906 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.497 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -92.05 178.44 1.72 Allowed Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.63 -179.916 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.497 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.7 Cg_exo -61.62 147.02 96.37 Favored 'Trans proline' 0 C--N 1.3 -2.018 0 C-N-CA 122.801 2.334 . . . . 0.0 112.124 179.784 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.456 ' HE ' HD12 ' A' ' 39' ' ' LEU . 35.3 ptt180 -136.06 142.25 44.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.71 179.771 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -79.56 116.62 19.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.475 179.905 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.45 ' O ' HG23 ' A' ' 30' ' ' ILE . 9.5 tp -110.88 130.36 64.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.512 -179.993 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.3 t -70.83 141.5 51.31 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.528 179.818 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.478 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.4 t0 -139.03 179.46 6.48 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.563 -179.944 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.478 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 78.1 p -74.04 -36.93 64.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.733 179.834 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.7 ttt85 -46.44 -94.57 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.351 -179.573 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -166.97 -26.68 0.02 OUTLIER Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.899 -0.881 . . . . 0.0 110.899 179.945 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 62.0 m -169.19 104.84 0.38 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.849 0.357 . . . . 0.0 110.694 -179.938 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.679 ' CD2' HD13 ' A' ' 140' ' ' LEU . 74.6 t60 -128.36 149.03 50.7 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.005 0.431 . . . . 0.0 110.3 179.941 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.625 HG22 ' N ' ' A' ' 39' ' ' LEU . 98.9 m -131.4 165.9 22.47 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.543 -179.857 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.625 ' N ' HG22 ' A' ' 38' ' ' THR . 81.7 mt -120.64 127.39 52.03 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.481 179.728 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -65.17 -44.51 88.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.706 179.975 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 40.3 p -165.68 154.62 11.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.433 179.728 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.485 ' CD ' ' H ' ' A' ' 42' ' ' GLN . 14.4 mp0 -44.55 101.34 0.25 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.642 179.437 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.25 129.36 33.76 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 C-N-CA 122.345 2.03 . . . . 0.0 112.264 -179.713 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -83.45 -24.92 31.61 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.533 179.536 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.537 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.5 mtm-85 -122.04 134.8 54.79 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-O 121.09 0.471 . . . . 0.0 110.364 -179.946 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.2 mt -130.61 133.57 63.32 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.288 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.959 -179.677 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 45.1 t -124.32 130.48 73.63 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-O 120.863 0.363 . . . . 0.0 110.115 179.238 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.619 ' OG ' HD12 ' A' ' 117' ' ' LEU . 2.4 m -154.85 166.59 33.03 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.527 179.842 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 71.4 p -124.47 8.61 8.38 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.489 179.85 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.22 125.85 33.2 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.611 -179.586 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.421 HG11 ' H ' ' A' ' 299' ' ' LEU . 86.2 t -65.86 -44.54 92.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.568 -179.962 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.9 m -62.65 -44.36 96.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.62 -179.81 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 46.5 tp -62.26 -41.66 98.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.526 -179.439 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.44 ' O ' HD13 ' A' ' 58' ' ' LEU . 76.2 m -57.58 -44.7 85.55 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.443 -179.426 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.0 -62.47 5.18 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 179.626 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.7 t -48.23 -35.62 12.29 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 -179.947 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.8 mt -61.74 -44.67 96.46 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.735 -0.386 . . . . 0.0 111.209 179.467 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.44 HD13 ' O ' ' A' ' 54' ' ' THR . 9.2 mp -65.1 -41.67 94.72 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.27 177.949 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.19 -41.42 99.18 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.966 -179.254 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.432 ' O ' HG23 ' A' ' 60' ' ' ILE . 8.3 tp -88.15 17.41 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.783 -179.637 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 56.46 84.72 0.08 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.674 -179.951 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.8 59.21 0.09 OUTLIER Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.038 -179.79 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -51.09 151.28 12.31 Favored 'Trans proline' 0 C--N 1.296 -2.197 0 C-N-CA 122.779 2.319 . . . . 0.0 112.39 -178.228 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.435 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -108.59 145.21 15.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.332 -179.632 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.8 mt -63.77 -45.17 97.96 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.274 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.37 -179.766 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.496 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -129.76 134.38 47.56 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 120.877 0.37 . . . . 0.0 110.587 -179.811 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.492 ' O ' ' N ' ' A' ' 98' ' ' LEU . 73.2 m -134.76 158.76 43.33 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.804 -179.609 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.42 138.76 16.1 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 179.794 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.47 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.79 -162.79 0.08 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.916 0.388 . . . . 0.0 110.516 -179.908 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.532 HG22 ' CD2' ' A' ' 297' ' ' PHE . 6.0 t -133.88 135.46 43.68 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.27 179.996 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.495 ' C ' ' O ' ' A' ' 70' ' ' THR . 1.0 OUTLIER 29.34 68.57 0.64 Allowed Pre-proline 0 N--CA 1.465 0.303 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.637 -179.624 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -61.21 145.67 98.34 Favored 'Trans proline' 0 C--N 1.301 -1.946 0 C-N-CA 122.654 2.236 . . . . 0.0 112.018 -178.344 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.533 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 45.0 p-10 -160.46 -31.26 0.06 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.695 179.75 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.544 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 98.8 m-20 -64.69 -38.97 92.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.47 179.959 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.6 ttt180 -60.99 -48.08 83.48 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.621 -179.347 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.424 ' O ' ' O ' ' A' ' 77' ' ' ALA . 96.7 t -60.22 -24.84 31.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.023 179.631 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.544 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -45.68 172.96 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.497 179.731 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.584 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.4 p30 -62.47 177.83 0.47 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.604 -179.709 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.558 ' C ' ' H ' ' A' ' 81' ' ' GLY . 36.5 p30 -45.05 85.34 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.988 -180.0 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.584 ' N ' ' O ' ' A' ' 78' ' ' ASP . 42.0 tp60 -67.49 13.4 0.07 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.185 -179.892 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.558 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 118.4 -22.45 9.51 Favored Glycine 0 CA--C 1.519 0.319 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 179.951 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -108.03 116.22 31.56 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.986 0.422 . . . . 0.0 110.504 179.848 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 74.7 mt -98.09 0.17 45.61 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.511 -179.725 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -92.48 7.29 43.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.43 -179.815 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.784 ' O ' HG22 ' A' ' 89' ' ' VAL . 27.2 mt-30 -100.2 -26.58 13.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.78 179.981 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.4 t-105 -64.54 -40.76 96.18 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.018 -179.647 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.556 ' O ' ' N ' ' A' ' 91' ' ' LYS . 65.3 m -77.89 -53.84 7.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.131 -179.487 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -47.67 -50.97 23.29 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.982 -179.354 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.784 HG22 ' O ' ' A' ' 85' ' ' GLN . 14.9 m -69.1 -41.14 81.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.101 179.818 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.507 ' N ' HG23 ' A' ' 89' ' ' VAL . . . -71.7 -23.18 61.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.725 -179.876 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.556 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.0 tttm -61.73 -45.78 92.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.469 -179.53 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.443 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.7 mm-40 -90.13 -95.2 0.11 Allowed 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.175 -179.913 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.638 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.9 mtt180 -142.75 59.29 1.43 Allowed 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.755 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.461 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.7 pttp 33.37 26.1 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.169 -179.061 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.638 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.3 tt -48.04 123.41 6.2 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.916 -178.142 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.456 ' O ' HD23 ' A' ' 95' ' ' LEU . 98.9 mm-40 -83.65 -169.64 2.66 Favored 'General case' 0 N--CA 1.455 -0.175 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.198 179.963 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.61 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 82.1 mtp180 -74.4 136.91 42.42 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.282 -179.82 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.492 ' N ' ' O ' ' A' ' 67' ' ' SER . 90.5 mt -85.91 -165.64 1.3 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.743 -179.63 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.537 ' O ' ' CD2' ' A' ' 99' ' ' TYR . 47.7 p90 -169.05 119.76 0.72 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.268 179.99 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.518 ' C ' ' O ' ' A' ' 99' ' ' TYR . 43.3 mm -28.76 120.91 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.017 -179.693 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 114.53 27.09 3.44 Favored Glycine 0 CA--C 1.521 0.415 0 N-CA-C 111.149 -0.78 . . . . 0.0 111.149 -179.544 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.586 ' CD ' ' H ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -144.27 46.33 0.62 Allowed Pre-proline 0 C--N 1.323 -0.57 0 CA-C-O 120.927 0.394 . . . . 0.0 110.499 179.901 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 29.3 Cg_endo -61.92 143.82 95.9 Favored 'Trans proline' 0 C--N 1.297 -2.171 0 C-N-CA 122.7 2.267 . . . . 0.0 111.975 -179.899 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.452 ' O ' HG23 ' A' ' 108' ' ' VAL . 26.2 t -173.3 120.13 0.33 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.445 179.78 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.75 -40.35 63.56 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.065 0.46 . . . . 0.0 111.041 179.744 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.25 -39.98 89.88 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.798 -179.371 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.06 -39.99 95.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.744 -179.824 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 104' ' ' SER . 70.3 t -67.65 -43.77 86.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.753 179.708 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.74 -38.99 92.68 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.561 -179.246 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.443 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.66 -23.4 63.04 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.479 179.863 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.551 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.3 mm-40 -90.18 5.15 48.21 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.713 -179.554 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.551 ' C ' ' O ' ' A' ' 111' ' ' GLN . 10.5 tpt 23.44 64.17 0.38 Allowed Pre-proline 0 N--CA 1.465 0.293 0 CA-C-O 120.859 0.361 . . . . 0.0 110.982 -179.769 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -78.22 167.27 23.45 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 C-N-CA 122.971 2.447 . . . . 0.0 112.082 -178.448 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.523 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 98.8 m-20 -110.04 -42.14 4.28 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.145 179.426 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 41.2 tp -121.19 120.65 35.84 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 179.506 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 83.5 mt -113.29 128.92 69.86 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.343 0 CA-C-O 120.978 0.418 . . . . 0.0 110.88 -179.897 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.619 HD12 ' OG ' ' A' ' 48' ' ' SER . 30.2 mt -109.42 132.27 54.29 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 121.061 0.458 . . . . 0.0 110.218 -179.73 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.49 HD12 HG23 ' A' ' 139' ' ' THR . 98.9 mt -119.8 138.96 48.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.693 -179.718 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 85.8 p -72.75 153.96 40.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.594 -179.949 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.11 -50.21 74.6 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.686 -179.855 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -149.52 153.97 38.02 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.567 179.869 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 170.66 -170.97 43.51 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 179.876 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.88 -34.13 88.97 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 179.912 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.449 ' OD1' ' O ' ' A' ' 124' ' ' ASP . 44.3 p-10 -87.03 120.67 28.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.821 0.343 . . . . 0.0 110.651 179.983 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.446 ' O ' HD12 ' A' ' 129' ' ' LEU . 36.1 t -63.26 143.79 57.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.472 -179.935 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.52 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.12 -43.81 8.68 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.944 -179.898 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 56.0 tp -62.93 -42.44 99.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.748 -179.888 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.28 -11.92 58.77 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.522 -179.421 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.446 HD12 ' O ' ' A' ' 125' ' ' SER . 84.2 mt -115.37 -23.56 8.82 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.637 -179.811 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 130' ' ' TYR . . . . . 0.52 ' N ' ' O ' ' A' ' 126' ' ' ALA . 79.4 t80 -51.09 -49.46 60.66 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.542 -178.883 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 37.7 p-10 -66.33 -42.61 87.94 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.832 0.349 . . . . 0.0 111.138 179.618 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.519 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 88.2 mt-30 -66.92 -37.53 84.51 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.74 -179.995 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.431 HD12 HD11 ' A' ' 118' ' ' ILE . 96.3 mt -80.63 -41.28 24.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.868 -179.585 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.2 t -57.13 -44.54 83.42 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.269 -179.139 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.3 m -61.93 -45.32 94.22 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.802 0.334 . . . . 0.0 110.566 179.411 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 94.0 mt -62.02 -43.63 97.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.277 -179.836 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.662 ' HB1' ' HD2' ' A' ' 138' ' ' PRO . . . -169.45 168.25 4.94 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.499 179.895 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.662 ' HD2' ' HB1' ' A' ' 137' ' ' ALA . 52.4 Cg_exo -49.95 112.82 0.79 Allowed 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.297 1.998 . . . . 0.0 112.224 179.339 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.49 HG23 HD12 ' A' ' 118' ' ' ILE . 24.0 m -84.36 127.52 34.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.644 -179.968 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.679 HD13 ' CD2' ' A' ' 37' ' ' HIS . 34.7 tp -118.03 136.68 53.39 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.09 -179.781 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.441 ' O ' ' OD2' ' A' ' 32' ' ' ASP . 81.6 mt -100.57 118.83 47.84 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 CA-C-O 121.182 0.515 . . . . 0.0 111.128 -179.319 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.42 HD12 HD22 ' A' ' 117' ' ' LEU . 97.8 mt -134.71 132.14 54.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.669 179.591 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.548 ' ND2' ' H ' ' A' ' 144' ' ' TYR . 2.2 t-20 -67.56 153.71 43.09 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.893 0.378 . . . . 0.0 110.469 179.38 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.548 ' H ' ' ND2' ' A' ' 143' ' ' ASN . 89.2 t80 -87.51 122.15 30.86 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.861 -179.55 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.525 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 99.0 m-20 55.33 69.5 0.73 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.762 179.651 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 49.5 p-10 -123.84 -0.69 8.48 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.631 179.88 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -151.07 116.14 5.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.712 -179.534 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 83.2 p -62.85 167.88 4.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.474 -179.788 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.417 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.3 p-90 -51.38 -15.81 0.46 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.517 -179.86 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.445 ' O ' HG23 ' A' ' 154' ' ' THR . 68.0 tp60 -70.71 -75.32 0.12 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.493 -179.771 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 11.1 t -62.75 -38.88 92.32 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.366 179.491 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 55.7 tp -59.91 -45.8 91.39 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.422 -178.649 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.417 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 46.8 tp -62.71 -41.63 99.25 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.425 179.057 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.445 HG23 ' O ' ' A' ' 150' ' ' GLN . 60.0 p -64.46 -35.01 79.53 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.31 -179.55 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.432 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.5 mm-40 -64.28 -42.88 96.22 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.383 179.374 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 91.5 mt -65.39 -38.91 91.4 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.072 0.463 . . . . 0.0 110.272 179.166 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.582 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.31 -32.08 79.5 Favored Glycine 0 CA--C 1.52 0.347 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 -179.382 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.44 ' C ' ' O ' ' A' ' 157' ' ' GLY . 97.1 mt-10 -35.25 -27.31 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.816 0.341 . . . . 0.0 110.821 179.894 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.582 ' N ' ' O ' ' A' ' 157' ' ' GLY . 95.1 mt -55.57 150.07 2.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.319 179.263 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 73.9 p -70.13 137.34 50.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.057 -179.59 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 72.26 18.44 78.1 Favored Glycine 0 N--CA 1.458 0.163 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 179.507 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 57.3 m80 -119.8 -15.52 8.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.747 0.308 . . . . 0.0 110.606 179.866 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -63.92 -60.78 2.83 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.655 -179.631 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -51.91 -49.42 63.09 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.201 -179.666 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -60.27 -41.24 92.9 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.752 0.31 . . . . 0.0 110.348 179.539 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.49 -47.2 86.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.576 179.851 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.94 -40.17 75.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.259 -179.894 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -61.88 -50.2 73.16 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.578 179.595 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -65.39 -43.73 89.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.492 179.532 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 95.0 mt -64.73 -43.38 96.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.488 179.739 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.36 -51.12 70.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.533 -179.215 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.46 -43.95 95.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.464 179.732 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.656 ' CE2' HD11 ' A' ' 177' ' ' LEU . 56.2 t80 -62.83 -44.45 96.1 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.085 0.469 . . . . 0.0 110.44 179.451 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -63.51 -39.98 95.85 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.566 -179.337 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -62.94 -42.77 99.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.64 179.259 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -60.73 -45.07 95.68 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.172 179.945 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.656 HD11 ' CE2' ' A' ' 173' ' ' PHE . 84.4 mt -64.61 -41.06 96.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.036 0.446 . . . . 0.0 110.693 178.918 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -51.93 -62.61 1.52 Allowed 'General case' 0 C--O 1.237 0.441 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.473 -179.343 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.89 -46.58 87.51 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.664 179.767 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.31 -41.77 65.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.281 179.939 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -63.85 -33.84 76.59 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.969 0.414 . . . . 0.0 110.371 179.256 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.425 ' O ' ' HG2' ' A' ' 182' ' ' GLU . 69.5 tt0 -90.47 9.06 30.75 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.37 0.605 . . . . 0.0 110.516 -178.998 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -105.06 -31.99 8.92 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.202 179.555 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.4 pt -128.11 147.52 32.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.828 -179.873 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -140.06 131.14 26.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.423 179.358 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.597 HD22 ' N ' ' A' ' 186' ' ' LEU . 3.6 mm? -85.63 133.08 42.61 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.844 -179.947 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -44.0 157.78 0.14 Allowed 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.714 2.276 . . . . 0.0 112.153 179.341 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 0.524 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.6 Cg_endo -62.78 115.23 2.8 Favored 'Trans proline' 0 C--N 1.304 -1.81 0 C-N-CA 122.775 2.317 . . . . 0.0 111.808 179.772 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 189' ' ' GLN . . . . . 0.524 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.8 mt-30 155.61 147.52 0.0 OUTLIER Pre-proline 0 C--N 1.332 -0.169 0 O-C-N 123.618 0.574 . . . . 0.0 110.782 -179.791 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -73.76 143.43 33.56 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.659 2.239 . . . . 0.0 111.956 177.983 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.499 HG23 ' OG ' ' A' ' 258' ' ' SER . 2.0 p -124.81 159.02 31.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.276 0.56 . . . . 0.0 110.189 179.959 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 192' ' ' THR . . . . . 0.497 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 35.7 p -143.48 165.47 27.47 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.094 -179.638 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 193' ' ' ALA . . . . . 0.443 ' HA ' ' H ' ' A' ' 260' ' ' PHE . . . -135.34 128.43 31.69 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 121.128 0.49 . . . . 0.0 110.24 179.576 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.509 HD11 HD23 ' A' ' 259' ' ' LEU . 47.8 pt -146.35 148.79 16.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.046 179.986 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 195' ' ' VAL . . . . . 0.746 HG13 ' CD1' ' A' ' 262' ' ' PHE . 70.3 t -117.6 122.89 70.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.222 0.534 . . . . 0.0 109.734 179.122 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -134.06 107.37 7.72 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.261 179.77 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 94.6 m -131.11 130.45 43.15 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.797 179.784 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.412 ' O ' ' N ' ' A' ' 201' ' ' HIS . . . -82.74 -37.24 24.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.275 179.692 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.32 -67.02 0.26 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.366 -179.973 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.31 -9.76 58.91 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.316 179.425 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 201' ' ' HIS . . . . . 0.412 ' N ' ' O ' ' A' ' 198' ' ' ALA . 59.7 t-80 60.54 58.27 2.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.628 -179.902 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 45.7 p -166.92 153.26 8.34 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.527 179.611 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.36 144.16 24.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.976 0.417 . . . . 0.0 110.442 179.488 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -135.34 138.1 43.05 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.63 -179.941 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 20.2 mt -106.28 125.56 51.15 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 121.116 0.484 . . . . 0.0 109.934 -179.701 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 206' ' ' TRP . . . . . 0.558 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 75.4 m95 -82.25 167.18 18.9 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.649 -179.727 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 207' ' ' THR . . . . . 0.467 HG22 ' C ' ' A' ' 206' ' ' TRP . 0.1 OUTLIER -156.88 171.56 7.27 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 120.943 0.402 . . . . 0.0 110.563 -179.194 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_exo -53.94 -36.89 85.2 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 C-N-CA 122.659 2.24 . . . . 0.0 112.16 179.256 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -70.55 -34.93 72.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.761 -179.772 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 21.9 m -61.56 150.54 35.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.543 -179.27 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.42 -36.97 81.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.457 -179.732 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 212' ' ' GLN . . . . . 0.558 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 54.4 tt0 -64.5 -40.28 95.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.472 179.967 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.87 -43.27 91.91 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 179.812 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -63.55 -43.46 97.03 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.752 0.31 . . . . 0.0 110.29 179.807 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 215' ' ' MET . . . . . 0.519 ' SD ' ' HB2' ' A' ' 304' ' ' ALA . 65.3 ttp -59.49 -48.25 82.36 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.234 -179.809 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 216' ' ' LEU . 88.4 mt -60.37 -40.8 92.12 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.536 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 217' ' ' GLU . . . . . 0.457 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.4 tp10 -57.99 -37.93 75.17 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 179.751 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -65.22 -37.94 88.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.847 0.356 . . . . 0.0 110.676 179.68 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 94.1 mt -64.47 -42.73 95.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.582 -179.645 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.59 44.59 0.08 OUTLIER Glycine 0 C--N 1.334 0.426 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 -179.921 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 221' ' ' PHE . . . . . 0.457 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 26.3 m-85 -127.73 155.22 44.34 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.033 0.445 . . . . 0.0 110.49 -179.82 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.484 ' O ' HG13 ' A' ' 191' ' ' VAL . 6.6 p -106.94 122.06 45.68 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.189 0.519 . . . . 0.0 110.198 -179.961 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.467 HD22 ' C ' ' A' ' 222' ' ' THR . 4.3 mm? -100.81 133.46 45.24 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.101 -179.97 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -97.24 158.76 15.29 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.44 179.916 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -104.84 115.21 29.92 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.384 179.898 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.496 HD12 ' N ' ' A' ' 226' ' ' LEU . 9.1 mp -53.32 156.57 3.95 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.705 179.86 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -60.26 145.38 98.7 Favored 'Trans proline' 0 C--N 1.301 -1.943 0 C-N-CA 122.711 2.274 . . . . 0.0 112.119 179.218 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.46 -2.89 58.93 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.557 -179.992 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.32 -40.83 5.65 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 111.029 -0.828 . . . . 0.0 111.029 -179.887 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.543 ' O ' ' N ' ' A' ' 233' ' ' SER . 86.0 mt -79.28 -16.89 55.7 Favored 'General case' 0 C--O 1.224 -0.257 0 CA-C-O 121.018 0.437 . . . . 0.0 110.356 -179.755 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 231' ' ' ASN . . . . . 0.405 ' C ' ' O ' ' A' ' 230' ' ' LEU . 54.6 t-20 -40.05 -49.23 2.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.691 -179.592 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -88.28 15.43 7.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.813 0.339 . . . . 0.0 111.277 179.935 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.543 ' N ' ' O ' ' A' ' 230' ' ' LEU . 78.1 p -60.48 -35.63 76.36 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.648 -179.77 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 234' ' ' GLN . . . . . 0.525 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.6 tt0 -118.25 -69.43 0.85 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.954 179.588 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 3.9 m -70.16 103.45 2.33 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.691 -179.744 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -94.59 57.74 2.26 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.345 180.0 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -144.99 -122.57 1.56 Allowed Glycine 0 CA--C 1.519 0.343 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 -179.977 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -134.41 111.85 10.48 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.094 0.473 . . . . 0.0 110.413 179.964 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 239' ' ' ARG . . . . . 0.513 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.4 mtt180 -148.11 57.39 1.08 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.762 -179.972 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -69.71 -31.89 70.15 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.511 179.664 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 241' ' ' ASP . . . . . 0.543 ' OD2' ' ND2' ' A' ' 143' ' ' ASN . 65.1 t0 -56.71 -46.99 80.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.404 -179.167 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 242' ' ' ILE . . . . . 0.436 ' O ' ' O ' ' A' ' 239' ' ' ARG . 17.4 tt -140.33 157.27 24.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.886 0.374 . . . . 0.0 110.524 179.748 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.444 HG22 HD13 ' A' ' 245' ' ' LEU . 96.0 mt -106.01 106.08 19.9 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.191 0 CA-C-O 121.125 0.488 . . . . 0.0 110.465 179.886 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 244' ' ' GLN . . . . . 0.602 ' O ' HD12 ' A' ' 245' ' ' LEU . 88.2 mt-30 -110.36 110.17 20.86 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.392 179.755 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.602 HD12 ' O ' ' A' ' 244' ' ' GLN . 9.5 mp -121.9 -168.19 1.66 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.641 179.774 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 246' ' ' GLY . . . . . 0.525 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.25 -16.66 0.05 OUTLIER Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.956 -0.857 . . . . 0.0 110.956 179.894 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 247' ' ' GLY . . . . . 0.67 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -60.46 157.03 29.73 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 -179.83 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -63.82 21.43 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.971 0.415 . . . . 0.0 110.58 179.945 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 249' ' ' ASN . . . . . 0.67 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.7 m-20 -97.18 -5.93 35.94 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.544 179.983 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 92.6 mt -80.2 -21.58 42.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.604 179.589 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.54 -51.24 70.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.728 -179.579 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.76 -5.33 58.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.481 179.659 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.16 -74.45 1.14 Allowed Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.911 -0.875 . . . . 0.0 110.911 -179.96 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 81.7 mt -69.89 125.93 28.2 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.977 0.418 . . . . 0.0 110.329 -179.859 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -59.22 -39.49 82.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.295 -179.711 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 82.64 51.93 4.11 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 179.95 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -96.22 -14.89 22.36 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.644 0.259 . . . . 0.0 110.541 -179.864 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 258' ' ' SER . . . . . 0.499 ' OG ' HG23 ' A' ' 191' ' ' VAL . 3.5 t 174.78 88.55 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.029 0.442 . . . . 0.0 110.194 179.978 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.86 HD12 ' N ' ' A' ' 259' ' ' LEU . 0.9 OUTLIER -94.18 124.08 37.97 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.241 0.544 . . . . 0.0 111.066 -179.058 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 260' ' ' PHE . . . . . 0.443 ' H ' ' HA ' ' A' ' 193' ' ' ALA . 15.9 m-30 -93.03 146.45 23.62 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.342 179.17 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 86.1 mt -122.41 149.82 43.29 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.529 -179.905 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.746 ' CD1' HG13 ' A' ' 195' ' ' VAL . 2.6 p90 -77.63 -138.36 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.562 -179.838 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 263' ' ' ALA . . . . . 0.66 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -52.1 77.45 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.993 -179.989 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 264' ' ' GLY . . . . . 0.633 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -178.98 104.42 0.19 Allowed Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 -179.976 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 265' ' ' ASP . . . . . 0.602 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.8 m-20 -80.47 -177.74 6.35 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 120.725 0.298 . . . . 0.0 110.896 -179.527 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -40.39 -17.71 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.853 0.358 . . . . 0.0 110.552 179.786 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 267' ' ' LYS . . . . . 0.602 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.71 -51.42 41.75 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.688 179.516 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -63.74 -46.83 83.59 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.175 179.314 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 269' ' ' ALA . . . . . 0.573 ' HB1' ' OH ' ' A' ' 273' ' ' TYR . . . -61.47 -35.05 76.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.111 0.481 . . . . 0.0 109.884 179.533 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -63.22 -34.42 77.62 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.119 179.712 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.36 -43.37 13.73 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.171 -179.572 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 272' ' ' ILE . . . . . 0.589 ' C ' ' H ' ' A' ' 274' ' ' ALA . 5.0 tt -51.37 -33.83 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.893 -178.824 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 273' ' ' TYR . . . . . 0.573 ' OH ' ' HB1' ' A' ' 269' ' ' ALA . 17.2 m-85 -54.24 -1.82 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.647 -179.638 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 274' ' ' ALA . . . . . 0.589 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.58 -39.43 70.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.87 179.603 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 275' ' ' ASN . . . . . 0.583 ' O ' ' N ' ' A' ' 279' ' ' ALA . 3.0 p30 -39.65 98.33 0.17 Allowed Pre-proline 0 N--CA 1.462 0.143 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.506 -179.638 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -54.16 -43.11 61.39 Favored 'Trans proline' 0 C--N 1.304 -1.812 0 C-N-CA 122.389 2.06 . . . . 0.0 112.619 -178.793 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 89.3 mt -64.45 -42.86 95.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.109 -179.613 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 91.0 mt -95.7 -1.64 49.57 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.872 -179.373 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 279' ' ' ALA . . . . . 0.583 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.35 -34.75 77.27 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.678 -179.85 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.4 20.1 0.12 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.966 -179.212 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 0.489 HD23 ' HA ' ' A' ' 281' ' ' LEU . 13.9 mt -75.19 120.04 79.8 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.505 179.916 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -50.69 -39.48 56.73 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.577 2.185 . . . . 0.0 111.951 179.035 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.8 -50.56 63.38 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.132 179.885 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 74.5 t -61.45 -43.79 97.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.482 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -57.98 -41.22 82.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.28 -179.972 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -90.9 0.14 57.58 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.145 179.575 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt 59.55 43.04 16.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.82 179.568 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -94.66 41.49 1.09 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.38 179.852 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 53.6 t -118.79 136.02 57.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.999 0.428 . . . . 0.0 110.193 -179.759 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -133.17 162.73 30.98 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.665 -179.639 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.9 155.22 33.13 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.968 0.413 . . . . 0.0 110.735 -179.86 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 81.0 mt -93.89 -1.49 54.69 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.235 -179.803 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.06 165.66 12.74 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.689 -0.965 . . . . 0.0 110.689 -179.735 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 6.8 m -87.15 -62.3 1.53 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.892 0.377 . . . . 0.0 111.009 -179.888 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 295' ' ' GLU . . . . . 0.436 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.6 mm-40 -69.57 -3.88 16.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.628 -179.833 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 28.1 p -77.09 32.91 0.14 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.618 -179.96 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 297' ' ' PHE . . . . . 0.532 ' CD2' HG22 ' A' ' 70' ' ' THR . 70.2 t80 -60.19 -46.06 91.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.546 -179.971 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 298' ' ' ARG . . . . . 0.61 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.3 mtt85 -81.49 134.01 35.47 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.45 -179.652 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.421 ' H ' HG11 ' A' ' 51' ' ' VAL . 16.1 tp -114.31 119.75 38.06 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.253 179.924 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 300' ' ' ASP . . . . . 0.625 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.4 p-10 -167.8 -173.9 2.27 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.524 179.95 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 84.0 t80 -48.25 -46.0 35.11 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.227 -179.644 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -64.65 -41.61 96.0 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.998 0.428 . . . . 0.0 110.702 179.015 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 303' ' ' SER . . . . . 0.625 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 52.0 p -55.44 -36.11 66.17 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.099 -179.269 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 304' ' ' ALA . . . . . 0.519 ' HB2' ' SD ' ' A' ' 215' ' ' MET . . . -56.92 -51.76 67.87 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.482 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 91.5 mtp -56.06 -43.87 78.32 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.8 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -66.38 -42.74 87.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.953 0.406 . . . . 0.0 110.207 178.798 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 307' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 303' ' ' SER . 55.2 t -64.04 -42.89 97.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.261 179.39 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 42.8 tp -59.62 -42.04 91.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.893 -179.616 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -62.87 -38.76 92.12 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.064 179.475 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 310' ' ' ARG . . . . . 0.435 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.6 ttt85 -63.5 -44.03 95.52 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.238 179.569 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 88.5 mt -63.23 -41.93 99.17 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.226 179.548 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -62.9 -33.23 74.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.083 179.492 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.85 -23.51 21.65 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.423 -179.862 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.479 HD22 ' CE2' ' A' ' 315' ' ' PHE . 6.7 tt -62.33 -43.22 99.33 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 121.06 0.457 . . . . 0.0 110.57 -179.92 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 315' ' ' PHE . . . . . 0.479 ' CE2' HD22 ' A' ' 314' ' ' LEU . 91.0 m-85 . . . . . 0 C--O 1.22 -0.498 0 CA-C-O 118.003 -0.999 . . . . 0.0 110.482 179.966 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -99.51 135.79 40.4 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.464 -179.926 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.498 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -92.11 178.48 1.69 Allowed Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.532 -179.863 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.498 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.7 Cg_exo -61.54 147.16 96.1 Favored 'Trans proline' 0 C--N 1.301 -1.961 0 C-N-CA 122.696 2.264 . . . . 0.0 112.161 179.576 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.487 ' HE ' HD12 ' A' ' 39' ' ' LEU . 35.4 ptt180 -136.33 142.39 43.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.624 179.692 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -79.7 116.78 20.08 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.453 179.872 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.46 ' O ' HG23 ' A' ' 30' ' ' ILE . 9.4 tp -111.54 130.11 65.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.46 179.969 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.4 t -71.14 141.7 50.75 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.599 179.81 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.478 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.1 t0 -138.71 -179.73 5.99 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.524 179.997 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.478 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 78.3 p -73.72 -37.51 65.1 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.856 179.84 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -46.64 -94.74 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.313 -179.411 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -166.24 -26.76 0.02 OUTLIER Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 179.919 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 63.7 m -168.42 105.72 0.46 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.857 0.361 . . . . 0.0 110.603 -179.968 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.646 ' CD2' HD13 ' A' ' 140' ' ' LEU . 68.2 t60 -128.87 146.43 50.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.038 0.447 . . . . 0.0 110.324 179.97 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.62 HG22 ' N ' ' A' ' 39' ' ' LEU . 100.0 m -129.82 165.6 21.63 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.608 -179.928 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.62 ' N ' HG22 ' A' ' 38' ' ' THR . 80.5 mt -120.3 127.37 52.3 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.466 179.683 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -65.56 -44.53 86.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.605 -179.978 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 40.8 p -165.91 154.88 11.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.456 179.743 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.482 ' CD ' ' H ' ' A' ' 42' ' ' GLN . 14.5 mp0 -45.4 101.64 0.27 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.658 179.443 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -57.66 129.83 35.65 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 C-N-CA 122.294 1.996 . . . . 0.0 112.263 -179.759 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -82.84 -24.92 33.06 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.472 179.593 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.537 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.7 mtm-85 -120.73 134.34 55.29 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 121.125 0.488 . . . . 0.0 110.264 -179.931 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.1 mt -130.23 133.29 64.33 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.091 -179.85 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 47.3 t -124.79 130.96 73.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 179.404 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.621 ' OG ' HD12 ' A' ' 117' ' ' LEU . 4.4 m -155.19 166.48 33.45 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.578 179.666 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 62.4 p -124.53 8.94 8.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.411 -179.981 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.1 t -85.38 125.53 33.05 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.655 -179.467 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.457 HG11 ' H ' ' A' ' 299' ' ' LEU . 90.8 t -65.72 -44.64 93.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.542 179.961 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.7 m -62.62 -44.39 96.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.655 -179.862 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 53.5 tp -62.18 -41.66 98.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.659 -179.459 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.465 ' O ' HD13 ' A' ' 58' ' ' LEU . 74.7 m -57.63 -44.54 85.65 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.384 -179.426 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.36 -61.98 5.52 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.941 -0.863 . . . . 0.0 110.941 179.561 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.7 t -48.48 -35.7 13.56 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 -179.979 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.9 mt -61.76 -44.56 96.65 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.644 -0.422 . . . . 0.0 111.136 179.344 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.465 HD13 ' O ' ' A' ' 54' ' ' THR . 9.4 mp -64.72 -42.07 95.5 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.329 177.961 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.405 ' HB1' ' NE ' ' A' ' 169' ' ' ARG . . . -63.54 -41.16 98.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.086 -179.197 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.43 ' O ' HG23 ' A' ' 60' ' ' ILE . 8.1 tp -88.04 16.76 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.735 -179.668 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 56.62 83.78 0.1 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.631 179.972 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.71 57.02 0.07 OUTLIER Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.049 -179.815 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -49.54 153.15 5.51 Favored 'Trans proline' 0 C--N 1.296 -2.21 0 C-N-CA 122.811 2.341 . . . . 0.0 112.638 -178.559 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.432 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -109.03 146.26 14.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.371 -179.734 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 97.0 mt -63.9 -44.86 98.13 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.298 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.488 -179.885 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.502 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -130.27 134.61 47.35 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.512 -179.774 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.485 ' O ' ' N ' ' A' ' 98' ' ' LEU . 72.2 m -134.52 158.6 43.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.859 -179.663 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.55 139.24 16.39 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 110.671 -0.972 . . . . 0.0 110.671 179.848 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.488 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.88 -162.67 0.08 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.95 0.405 . . . . 0.0 110.535 -179.992 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.511 HG22 ' CD2' ' A' ' 297' ' ' PHE . 5.8 t -133.71 135.81 44.26 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.177 -179.973 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.491 ' C ' ' O ' ' A' ' 70' ' ' THR . 0.9 OUTLIER 29.6 68.33 0.67 Allowed Pre-proline 0 N--CA 1.465 0.291 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.713 -179.689 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -60.64 145.23 99.21 Favored 'Trans proline' 0 C--N 1.3 -2.009 0 C-N-CA 122.576 2.184 . . . . 0.0 112.167 -178.566 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.523 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 46.2 p-10 -160.65 -31.97 0.05 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.674 179.74 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.529 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 98.8 m-20 -64.31 -38.96 92.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.367 179.973 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -61.15 -47.88 84.15 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.636 -179.236 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.423 ' O ' ' O ' ' A' ' 77' ' ' ALA . 94.4 t -60.21 -24.56 30.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.659 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.529 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -45.64 172.6 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.535 179.881 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.575 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.8 p30 -61.68 177.6 0.4 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.653 -179.707 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.566 ' C ' ' H ' ' A' ' 81' ' ' GLY . 36.1 p30 -45.87 85.54 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.97 179.872 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.575 ' N ' ' O ' ' A' ' 78' ' ' ASP . 43.0 tp60 -67.19 13.59 0.06 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.072 0.463 . . . . 0.0 110.12 -179.774 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.566 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 117.72 -22.0 10.2 Favored Glycine 0 C--N 1.331 0.285 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 179.981 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -107.93 116.35 31.8 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.022 0.439 . . . . 0.0 110.518 179.849 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 75.8 mt -98.8 0.57 44.63 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.516 -179.698 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -91.88 6.61 45.49 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.988 0.423 . . . . 0.0 110.47 -179.707 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.798 ' O ' HG22 ' A' ' 89' ' ' VAL . 27.2 mt-30 -99.89 -28.08 13.28 Favored 'General case' 0 C--O 1.224 -0.266 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.784 179.973 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 68.9 t-105 -63.03 -41.07 99.43 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.913 -179.722 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.556 ' O ' ' N ' ' A' ' 91' ' ' LYS . 67.4 m -77.34 -53.53 7.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.313 -179.441 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -48.4 -50.85 29.22 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.979 -179.337 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.798 HG22 ' O ' ' A' ' 85' ' ' GLN . 15.6 m -68.9 -40.83 81.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 120.914 0.388 . . . . 0.0 111.075 179.748 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.5 ' N ' HG23 ' A' ' 89' ' ' VAL . . . -72.1 -22.96 61.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.775 -179.912 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.556 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.0 tttm -61.35 -45.69 93.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.45 -179.502 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.437 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.7 mm-40 -90.73 -94.34 0.12 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.091 -179.977 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.633 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.9 mtt180 -143.36 59.95 1.4 Allowed 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.81 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.461 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.7 pttp 33.54 26.27 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 120.791 0.329 . . . . 0.0 110.115 -179.291 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.633 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.5 tt -47.97 122.84 5.45 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.995 -178.243 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.447 ' O ' HD23 ' A' ' 95' ' ' LEU . 98.9 mm-40 -83.25 -169.9 2.77 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.016 -179.882 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.614 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 83.0 mtp180 -73.51 137.88 44.7 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.29 -179.813 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.485 ' N ' ' O ' ' A' ' 67' ' ' SER . 89.0 mt -86.81 -166.2 1.5 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.701 -179.519 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.533 ' O ' ' CD2' ' A' ' 99' ' ' TYR . 47.4 p90 -167.97 120.05 0.86 Allowed 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.296 179.939 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.511 ' C ' ' O ' ' A' ' 99' ' ' TYR . 42.9 mm -29.59 121.25 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.939 -179.639 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 113.96 28.13 3.24 Favored Glycine 0 CA--C 1.519 0.341 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 -179.542 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.587 ' CD ' ' H ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -144.02 45.81 0.59 Allowed Pre-proline 0 C--N 1.324 -0.53 0 CA-C-O 120.932 0.396 . . . . 0.0 110.508 179.883 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 30.5 Cg_endo -62.0 143.72 95.5 Favored 'Trans proline' 0 C--N 1.297 -2.152 0 C-N-CA 122.667 2.245 . . . . 0.0 112.033 179.921 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.476 ' O ' HG23 ' A' ' 108' ' ' VAL . 23.1 t -173.43 120.52 0.33 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.404 179.715 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.22 -41.09 64.15 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.057 0.456 . . . . 0.0 111.231 179.652 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -65.93 -40.26 91.26 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.942 -179.412 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.87 -39.87 95.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.699 -179.852 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 104' ' ' SER . 69.5 t -67.39 -43.91 87.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.863 179.627 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.33 -39.0 91.63 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.602 -179.265 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.437 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.58 -23.49 62.96 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.013 0.435 . . . . 0.0 110.505 179.817 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.555 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.4 mm-40 -91.07 4.73 51.37 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.72 -179.5 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.555 ' C ' ' O ' ' A' ' 111' ' ' GLN . 10.6 tpt 23.56 63.85 0.38 Allowed Pre-proline 0 N--CA 1.465 0.32 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.916 179.971 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.445 ' HG2' HD11 ' A' ' 116' ' ' ILE . 69.8 Cg_endo -78.3 168.79 21.12 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 C-N-CA 122.918 2.412 . . . . 0.0 112.344 -178.645 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.525 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 98.9 m-20 -113.15 -44.16 3.29 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.939 179.639 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 39.9 tp -120.71 119.77 33.76 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.619 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.455 HD13 HD22 ' A' ' 133' ' ' LEU . 95.7 mt -116.99 131.14 70.56 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.3 0 CA-C-O 120.909 0.385 . . . . 0.0 110.949 -179.91 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.621 HD12 ' OG ' ' A' ' 48' ' ' SER . 30.7 mt -106.06 132.77 51.74 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 121.104 0.478 . . . . 0.0 110.236 -179.387 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.419 HD12 HG23 ' A' ' 139' ' ' THR . 98.0 mt -118.31 136.37 55.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.699 -179.633 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 85.9 p -71.98 153.22 41.93 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.666 179.978 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.19 -50.1 75.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.625 -179.84 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -149.37 153.82 37.99 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.535 179.823 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 169.67 -170.42 42.71 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 179.837 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -63.01 -35.05 91.57 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 110.824 -0.91 . . . . 0.0 110.824 179.986 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' A' ' 124' ' ' ASP . 43.8 p-10 -87.86 119.9 28.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.797 0.332 . . . . 0.0 110.694 179.933 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.444 ' O ' HD12 ' A' ' 129' ' ' LEU . 40.5 t -63.39 144.17 57.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.472 -179.969 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.522 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.59 -43.03 8.88 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.837 -179.874 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.3 tp -62.66 -42.42 99.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.663 -179.931 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.78 -11.04 57.64 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.518 -179.403 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.444 HD12 ' O ' ' A' ' 125' ' ' SER . 84.9 mt -115.96 -23.72 8.43 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.749 -179.868 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 130' ' ' TYR . . . . . 0.522 ' N ' ' O ' ' A' ' 126' ' ' ALA . 79.0 t80 -51.77 -49.71 62.12 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 120.501 -0.48 . . . . 0.0 110.587 -179.024 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.5 p-10 -65.81 -42.16 90.99 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.946 0.403 . . . . 0.0 111.172 179.564 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.525 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 88.1 mt-30 -67.35 -36.85 82.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.801 -179.983 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.455 HD22 HD13 ' A' ' 116' ' ' ILE . 92.8 mt -80.34 -41.85 24.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.012 -179.541 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.1 t -57.55 -44.58 85.3 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.134 -179.095 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.5 m -62.3 -45.65 92.28 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.801 0.334 . . . . 0.0 110.586 179.351 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 92.4 mt -62.49 -43.78 98.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.285 -179.772 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.601 ' HB1' ' HD2' ' A' ' 138' ' ' PRO . . . -170.19 163.86 6.13 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.451 179.869 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.601 ' HD2' ' HB1' ' A' ' 137' ' ' ALA . 78.0 Cg_exo -43.58 111.32 0.23 Allowed 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.437 2.091 . . . . 0.0 112.076 179.539 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.475 HG21 ' CD1' ' A' ' 130' ' ' TYR . 17.3 m -85.78 127.79 34.64 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.57 179.951 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.646 HD13 ' CD2' ' A' ' 37' ' ' HIS . 34.4 tp -119.65 137.67 53.74 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.244 -0.435 . . . . 0.0 109.964 -179.702 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.433 ' O ' ' OD1' ' A' ' 32' ' ' ASP . 79.6 mt -104.58 119.92 54.21 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.432 0 CA-C-O 121.154 0.502 . . . . 0.0 111.416 -179.556 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.494 HD12 HD22 ' A' ' 117' ' ' LEU . 98.4 mt -135.3 133.03 52.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.665 179.676 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.546 HD21 ' CG ' ' A' ' 241' ' ' ASP . 60.6 t30 -64.98 150.31 48.24 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.861 0.362 . . . . 0.0 110.386 179.288 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.517 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 87.9 t80 -85.27 122.45 29.47 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.936 -179.531 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.517 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 99.0 m-20 55.48 68.86 0.8 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.954 179.76 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 36.0 p-10 -125.44 0.27 7.62 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.011 0.434 . . . . 0.0 110.816 179.851 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -150.69 115.57 5.27 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.748 -179.501 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 85.0 p -63.28 168.26 4.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.49 -179.742 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.422 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.5 p-90 -51.48 -15.67 0.46 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.484 -179.836 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.444 ' O ' HG23 ' A' ' 154' ' ' THR . 68.3 tp60 -70.84 -75.65 0.12 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.414 -179.703 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.455 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.1 t -62.59 -38.76 91.4 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.992 0.425 . . . . 0.0 110.297 179.529 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 53.6 tp -60.25 -45.53 92.96 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.324 -178.493 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.422 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 45.9 tp -62.76 -41.82 99.4 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.844 0.354 . . . . 0.0 110.311 179.03 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.455 ' OG1' ' O ' ' A' ' 151' ' ' SER . 58.8 p -64.01 -34.67 78.54 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.264 -179.507 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.444 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.5 mm-40 -64.03 -42.38 97.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.171 179.256 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 91.8 mt -65.24 -39.05 92.18 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.092 0.472 . . . . 0.0 110.172 179.071 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.582 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.04 -32.25 79.6 Favored Glycine 0 CA--C 1.52 0.352 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 -179.391 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.444 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.3 mt-10 -36.42 -25.38 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.888 0.375 . . . . 0.0 110.811 179.949 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.582 ' N ' ' O ' ' A' ' 157' ' ' GLY . 95.7 mt -59.16 149.29 6.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.171 179.382 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 77.5 p -69.14 137.47 53.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.074 -179.561 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 70.66 21.9 77.91 Favored Glycine 0 N--CA 1.458 0.157 0 N-CA-C 111.274 -0.731 . . . . 0.0 111.274 179.522 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 59.3 m80 -124.02 -14.63 7.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.757 0.313 . . . . 0.0 110.56 179.979 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -66.25 -59.76 3.43 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.774 -179.753 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -52.03 -48.96 64.27 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.278 -179.695 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -60.62 -41.11 94.18 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.76 0.314 . . . . 0.0 110.334 179.463 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.68 -47.11 86.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.633 179.817 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -57.1 -39.99 76.13 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.16 -179.85 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -61.8 -50.15 73.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.525 179.619 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.405 ' NE ' ' HB1' ' A' ' 59' ' ' ALA . 59.9 ttt85 -65.38 -43.77 89.67 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.417 179.554 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 95.1 mt -64.37 -43.53 97.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.421 179.718 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.29 -50.87 71.55 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.639 -179.169 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.79 -43.7 95.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.32 179.727 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.659 ' CE2' HD11 ' A' ' 177' ' ' LEU . 56.6 t80 -62.58 -44.62 95.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.026 0.441 . . . . 0.0 110.425 179.373 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -63.4 -39.93 95.82 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.475 -179.204 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -62.85 -42.81 99.89 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.664 179.248 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -60.8 -44.68 96.53 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.069 -179.992 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.659 HD11 ' CE2' ' A' ' 173' ' ' PHE . 84.9 mt -64.29 -41.22 96.99 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.043 0.449 . . . . 0.0 110.681 178.862 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.15 -62.25 1.76 Allowed 'General case' 0 C--O 1.237 0.44 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.487 -179.382 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.64 -46.71 86.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.51 179.86 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.43 -41.67 66.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.135 -179.931 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -63.71 -33.88 76.64 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.07 0.462 . . . . 0.0 110.407 179.336 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.424 ' O ' ' HG2' ' A' ' 182' ' ' GLU . 69.6 tt0 -90.31 8.42 33.47 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-O 121.387 0.613 . . . . 0.0 110.619 -179.078 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -104.31 -32.32 9.13 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-O 120.932 0.396 . . . . 0.0 111.359 179.546 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 43.9 pt -127.88 147.53 32.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.915 -179.902 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -139.83 131.03 26.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.296 179.478 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.595 HD22 ' N ' ' A' ' 186' ' ' LEU . 3.6 mm? -85.63 133.46 41.86 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.841 179.922 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -44.28 158.06 0.15 Allowed 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.738 2.292 . . . . 0.0 112.061 179.48 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 0.527 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.7 Cg_endo -62.9 114.97 2.65 Favored 'Trans proline' 0 C--N 1.303 -1.828 0 C-N-CA 122.747 2.298 . . . . 0.0 111.776 179.801 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 189' ' ' GLN . . . . . 0.527 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.8 mt-30 155.39 148.14 0.0 OUTLIER Pre-proline 0 N--CA 1.454 -0.247 0 O-C-N 123.552 0.533 . . . . 0.0 110.772 -179.799 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -74.11 144.5 33.8 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.685 2.257 . . . . 0.0 111.777 178.185 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.498 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.1 p -125.31 158.86 33.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.271 0.557 . . . . 0.0 110.067 -179.89 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 192' ' ' THR . . . . . 0.498 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 35.4 p -143.53 165.58 27.19 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.094 -179.653 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 193' ' ' ALA . . . . . 0.446 ' HA ' ' H ' ' A' ' 260' ' ' PHE . . . -135.66 128.62 31.39 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.212 0.53 . . . . 0.0 110.244 179.625 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.504 HD11 HD23 ' A' ' 259' ' ' LEU . 47.1 pt -146.38 148.96 16.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.137 179.732 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 195' ' ' VAL . . . . . 0.742 HG13 ' CD1' ' A' ' 262' ' ' PHE . 70.4 t -117.87 123.14 71.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 121.263 0.554 . . . . 0.0 109.594 179.254 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 58.8 t80 -134.37 107.32 7.55 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.32 179.688 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 94.8 m -131.02 130.72 43.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.896 179.784 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.406 ' O ' ' N ' ' A' ' 201' ' ' HIS . . . -83.04 -37.09 24.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.252 179.741 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.44 -67.15 0.25 Allowed 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.332 179.996 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.1 -9.73 58.81 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.306 179.523 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 201' ' ' HIS . . . . . 0.406 ' N ' ' O ' ' A' ' 198' ' ' ALA . 60.1 t-80 60.52 58.36 2.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.825 -179.835 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 42.0 p -167.2 153.53 8.12 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.444 179.558 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.27 143.81 24.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.962 0.41 . . . . 0.0 110.372 179.449 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -135.18 138.34 43.56 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.691 179.939 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 20.3 mt -106.34 125.43 50.99 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 121.119 0.485 . . . . 0.0 109.745 -179.682 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 206' ' ' TRP . . . . . 0.557 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 74.3 m95 -81.96 166.83 19.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.666 -179.796 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 207' ' ' THR . . . . . 0.466 HG22 ' C ' ' A' ' 206' ' ' TRP . 0.1 OUTLIER -156.78 171.87 6.86 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 120.971 0.415 . . . . 0.0 110.562 -179.213 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -54.02 -37.2 86.28 Favored 'Trans proline' 0 C--N 1.303 -1.839 0 C-N-CA 122.637 2.224 . . . . 0.0 111.954 179.465 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -70.46 -34.96 73.01 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.953 -179.916 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 22.2 m -61.02 150.88 32.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.569 -179.351 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.66 -36.86 82.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.462 -179.709 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 212' ' ' GLN . . . . . 0.557 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 55.2 tt0 -64.77 -40.37 95.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.529 179.957 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.72 -43.32 92.13 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 179.759 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -63.4 -43.9 96.2 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.95 -0.3 . . . . 0.0 110.219 179.879 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 215' ' ' MET . . . . . 0.545 ' SD ' ' HB2' ' A' ' 304' ' ' ALA . 65.0 ttp -59.73 -47.88 83.91 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.199 -179.753 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 86.7 mt -60.65 -40.62 92.69 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 179.531 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 217' ' ' GLU . . . . . 0.456 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.5 tp10 -58.36 -37.88 76.11 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.77 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -65.21 -38.3 90.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.811 0.339 . . . . 0.0 110.648 179.696 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 94.2 mt -64.25 -42.56 96.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.554 -179.557 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.36 45.1 0.08 OUTLIER Glycine 0 C--N 1.334 0.417 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 -179.943 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 221' ' ' PHE . . . . . 0.456 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 26.6 m-85 -127.99 155.41 44.32 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.012 0.434 . . . . 0.0 110.527 -179.812 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.487 ' O ' HG13 ' A' ' 191' ' ' VAL . 6.8 p -107.06 122.31 46.22 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.093 0.473 . . . . 0.0 110.2 -179.899 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.475 HD22 ' C ' ' A' ' 222' ' ' THR . 4.3 mm? -101.33 132.81 46.7 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.107 179.967 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.64 159.79 14.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.52 179.86 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.57 115.21 29.86 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.328 179.902 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.494 HD12 ' N ' ' A' ' 226' ' ' LEU . 9.1 mp -53.22 156.86 3.54 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.584 179.926 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -60.31 145.38 98.71 Favored 'Trans proline' 0 C--N 1.301 -1.931 0 C-N-CA 122.627 2.218 . . . . 0.0 112.012 179.379 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.3 -3.26 59.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.559 -179.98 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.15 -40.99 5.66 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 -179.859 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.532 ' O ' ' N ' ' A' ' 233' ' ' SER . 85.5 mt -79.18 -17.15 55.47 Favored 'General case' 0 C--O 1.223 -0.316 0 CA-C-O 120.934 0.397 . . . . 0.0 110.301 -179.721 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 231' ' ' ASN . . . . . 0.401 ' C ' ' O ' ' A' ' 230' ' ' LEU . 54.7 t-20 -40.38 -49.21 2.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.756 -179.527 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -87.88 15.33 7.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.275 179.814 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.532 ' N ' ' O ' ' A' ' 230' ' ' LEU . 78.0 p -60.35 -35.48 75.77 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.523 -179.732 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 234' ' ' GLN . . . . . 0.527 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.7 tt0 -118.98 -69.12 0.87 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.917 0.389 . . . . 0.0 111.019 179.491 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.2 m -69.68 102.77 1.96 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.769 -179.882 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -94.27 57.45 2.33 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.341 -179.975 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -144.54 -122.63 1.6 Allowed Glycine 0 CA--C 1.52 0.359 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 179.994 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -135.13 111.53 9.79 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.082 0.468 . . . . 0.0 110.444 179.972 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 239' ' ' ARG . . . . . 0.519 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.7 mtt180 -148.05 57.88 1.09 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.723 -179.885 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -69.54 -32.27 70.98 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.522 179.65 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 241' ' ' ASP . . . . . 0.546 ' CG ' HD21 ' A' ' 143' ' ' ASN . 65.1 t0 -57.0 -46.97 81.9 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.41 -179.124 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 242' ' ' ILE . . . . . 0.437 ' O ' ' O ' ' A' ' 239' ' ' ARG . 17.7 tt -139.78 156.27 25.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.873 0.368 . . . . 0.0 110.541 179.777 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.441 HG22 HD13 ' A' ' 245' ' ' LEU . 96.2 mt -106.06 106.41 20.53 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.216 0 CA-C-O 121.233 0.54 . . . . 0.0 110.458 179.87 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 244' ' ' GLN . . . . . 0.606 ' O ' HD12 ' A' ' 245' ' ' LEU . 88.2 mt-30 -110.19 109.85 20.48 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.329 179.75 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.606 HD12 ' O ' ' A' ' 244' ' ' GLN . 9.4 mp -121.75 -168.47 1.7 Allowed 'General case' 0 C--O 1.224 -0.238 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.647 179.774 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 246' ' ' GLY . . . . . 0.527 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.81 -16.5 0.05 OUTLIER Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 179.892 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 247' ' ' GLY . . . . . 0.675 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -60.75 156.3 32.24 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 -179.858 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -63.48 21.76 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.001 0.429 . . . . 0.0 110.617 179.973 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 249' ' ' ASN . . . . . 0.675 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.7 m-20 -97.51 -5.85 34.99 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.554 179.961 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 93.6 mt -79.69 -22.16 43.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.647 179.486 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.64 -51.27 70.65 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.856 -179.543 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -87.96 -5.51 58.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.42 179.653 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.09 -74.33 1.15 Allowed Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 -179.959 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 81.4 mt -70.05 125.89 28.08 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.134 0.493 . . . . 0.0 110.104 -179.759 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -59.69 -39.29 84.08 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.266 -179.656 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 84.37 51.63 3.84 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 179.943 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -95.11 -15.62 23.24 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.698 0.285 . . . . 0.0 110.664 -179.917 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 258' ' ' SER . . . . . 0.497 ' OG ' HG23 ' A' ' 191' ' ' VAL . 3.3 t 173.76 89.4 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.033 0.444 . . . . 0.0 110.085 179.979 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.865 HD12 ' N ' ' A' ' 259' ' ' LEU . 1.0 OUTLIER -94.38 124.06 38.17 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-O 121.314 0.578 . . . . 0.0 111.144 -179.224 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 260' ' ' PHE . . . . . 0.446 ' H ' ' HA ' ' A' ' 193' ' ' ALA . 15.9 m-30 -93.04 146.72 23.42 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.378 179.269 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 86.3 mt -122.48 149.91 43.23 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.525 -179.921 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.742 ' CD1' HG13 ' A' ' 195' ' ' VAL . 2.6 p90 -78.13 -138.64 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.422 -179.696 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 263' ' ' ALA . . . . . 0.661 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -51.69 77.62 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.995 -179.921 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 264' ' ' GLY . . . . . 0.636 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.35 104.46 0.19 Allowed Glycine 0 N--CA 1.468 0.781 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 -179.798 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 265' ' ' ASP . . . . . 0.605 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.6 m-20 -80.48 -177.56 6.27 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.718 0.294 . . . . 0.0 110.966 -179.594 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -40.68 -17.54 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.428 179.859 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 267' ' ' LYS . . . . . 0.605 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.59 -51.4 42.94 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 121.013 0.435 . . . . 0.0 110.782 179.487 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -63.8 -46.72 83.9 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.143 179.399 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 269' ' ' ALA . . . . . 0.566 ' HB1' ' OH ' ' A' ' 273' ' ' TYR . . . -61.7 -35.08 77.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.767 179.646 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -62.93 -34.74 78.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.105 179.729 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.38 -43.1 13.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.409 -179.584 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 272' ' ' ILE . . . . . 0.587 ' C ' ' H ' ' A' ' 274' ' ' ALA . 4.9 tt -51.37 -33.65 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.838 -178.95 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 273' ' ' TYR . . . . . 0.566 ' OH ' ' HB1' ' A' ' 269' ' ' ALA . 17.5 m-85 -54.33 -1.67 0.03 OUTLIER 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.742 -179.563 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 274' ' ' ALA . . . . . 0.587 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.94 -39.87 69.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.883 179.648 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 275' ' ' ASN . . . . . 0.586 ' O ' ' N ' ' A' ' 279' ' ' ALA . 4.3 p30 -38.94 97.53 0.14 Allowed Pre-proline 0 C--O 1.226 -0.168 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.582 -179.68 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 276' ' ' PRO . . . . . 0.402 ' N ' ' O ' ' A' ' 274' ' ' ALA . 45.7 Cg_exo -53.95 -43.15 60.68 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 C-N-CA 122.338 2.025 . . . . 0.0 112.756 -178.884 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 89.8 mt -64.39 -42.82 95.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.136 0.493 . . . . 0.0 111.235 -179.766 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 91.2 mt -95.99 -1.14 49.61 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.849 -179.439 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 279' ' ' ALA . . . . . 0.586 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.39 -34.91 77.65 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.647 -179.762 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -73.76 19.72 0.11 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.126 -179.38 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 0.495 HD23 ' HA ' ' A' ' 281' ' ' LEU . 13.7 mt -75.2 120.84 83.52 Favored Pre-proline 0 N--CA 1.451 -0.391 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.351 179.99 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_exo -51.58 -39.11 66.05 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.633 2.222 . . . . 0.0 111.603 179.343 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.83 -50.38 63.81 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 179.818 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 79.5 t -61.84 -44.02 98.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 110.083 -0.339 . . . . 0.0 110.083 179.477 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -57.65 -41.6 81.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.301 -179.846 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -90.71 0.7 57.33 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.084 179.675 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt 58.59 41.57 22.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.115 0.483 . . . . 0.0 111.029 179.788 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -93.15 42.22 1.09 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.377 179.804 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 53.8 t -119.37 135.54 59.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 120.943 0.401 . . . . 0.0 110.223 -179.699 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -132.78 162.81 30.52 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.045 0.45 . . . . 0.0 110.703 -179.623 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.65 155.38 32.45 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.032 0.444 . . . . 0.0 110.743 -179.882 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 81.4 mt -94.37 -1.23 54.11 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.211 -179.699 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.1 165.01 12.54 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.634 -0.986 . . . . 0.0 110.634 -179.814 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 7.0 m -86.79 -62.04 1.6 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.804 0.335 . . . . 0.0 111.184 -179.95 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 295' ' ' GLU . . . . . 0.444 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.6 mm-40 -69.41 -4.07 16.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.697 -179.842 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 25.4 p -76.84 32.38 0.14 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.663 -179.887 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 297' ' ' PHE . . . . . 0.511 ' CD2' HG22 ' A' ' 70' ' ' THR . 70.5 t80 -60.33 -46.06 91.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.607 -179.908 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 298' ' ' ARG . . . . . 0.614 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.4 mtt85 -81.08 134.93 35.75 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.581 -179.699 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.457 ' H ' HG11 ' A' ' 51' ' ' VAL . 17.1 tp -114.24 118.07 32.92 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.152 179.898 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 300' ' ' ASP . . . . . 0.635 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.2 p-10 -165.69 -176.16 3.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.541 179.978 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 84.5 t80 -47.17 -43.86 21.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.275 -179.675 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -66.6 -40.63 88.95 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.08 0.466 . . . . 0.0 110.833 179.116 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 303' ' ' SER . . . . . 0.635 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 60.8 p -55.71 -36.11 66.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.159 -179.263 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 304' ' ' ALA . . . . . 0.545 ' HB2' ' SD ' ' A' ' 215' ' ' MET . . . -57.49 -51.31 69.98 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.459 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 90.6 mtp -56.71 -43.52 80.64 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -179.993 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -66.49 -42.56 87.21 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.928 0.394 . . . . 0.0 110.16 178.796 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 307' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 303' ' ' SER . 55.6 t -64.02 -43.12 97.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.08 179.352 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 43.3 tp -59.66 -42.09 92.05 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.721 -179.409 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -62.72 -38.83 92.03 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 179.565 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 310' ' ' ARG . . . . . 0.446 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.6 ttt85 -63.66 -43.88 95.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.288 179.506 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 89.4 mt -63.21 -42.1 99.23 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.185 179.602 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -62.87 -33.59 75.6 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.993 179.445 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.65 -23.46 21.89 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.507 -179.836 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.479 HD22 ' CE2' ' A' ' 315' ' ' PHE . 6.7 tt -62.32 -43.12 99.56 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 121.087 0.47 . . . . 0.0 110.629 -179.889 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 315' ' ' PHE . . . . . 0.479 ' CE2' HD22 ' A' ' 314' ' ' LEU . 90.9 m-85 . . . . . 0 C--O 1.22 -0.457 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.462 179.897 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -99.6 136.04 40.12 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.47 -179.961 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.498 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -92.41 178.45 1.68 Allowed Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.539 -179.88 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.498 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.0 Cg_exo -61.76 147.39 95.39 Favored 'Trans proline' 0 C--N 1.3 -1.996 0 C-N-CA 122.752 2.302 . . . . 0.0 112.162 179.811 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.493 ' HE ' HD12 ' A' ' 39' ' ' LEU . 35.4 ptt180 -136.85 142.47 42.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.679 179.679 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -79.59 116.97 20.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.464 179.962 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.458 ' O ' HG23 ' A' ' 30' ' ' ILE . 9.5 tp -111.48 130.25 65.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.46 -179.956 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 13.5 t -71.4 142.13 50.32 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.527 179.811 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.484 ' CG ' ' H ' ' A' ' 33' ' ' SER . 42.8 t0 -139.09 -179.56 5.92 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.629 -179.937 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.484 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 78.0 p -74.15 -37.13 64.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.755 179.863 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.7 ttt85 -47.07 -94.9 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.382 -179.521 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.415 ' O ' ' OG1' ' A' ' 36' ' ' THR . . . -165.65 -27.15 0.02 OUTLIER Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 179.92 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.415 ' OG1' ' O ' ' A' ' 35' ' ' GLY . 67.6 m -168.43 105.9 0.46 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.859 0.361 . . . . 0.0 110.635 -179.909 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.63 ' CD2' HD13 ' A' ' 140' ' ' LEU . 64.4 t60 -128.9 145.98 51.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.015 0.436 . . . . 0.0 110.267 179.896 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.617 HG22 ' N ' ' A' ' 39' ' ' LEU . 99.8 m -129.26 165.42 21.43 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.639 -179.915 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.617 ' N ' HG22 ' A' ' 38' ' ' THR . 79.6 mt -120.27 127.39 52.34 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.513 179.785 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -65.51 -44.57 86.6 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.619 -179.951 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 41.6 p -166.0 154.93 11.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.443 179.719 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.492 ' CD ' ' H ' ' A' ' 42' ' ' GLN . 14.0 mp0 -45.43 101.71 0.27 Allowed Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.673 179.503 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -57.71 130.12 37.03 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 C-N-CA 122.351 2.034 . . . . 0.0 112.233 -179.687 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -83.05 -24.68 32.67 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.448 179.631 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.536 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.9 mtm-85 -120.46 134.48 55.26 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-O 121.174 0.511 . . . . 0.0 110.28 -179.987 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 95.9 mt -129.97 133.46 64.48 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.271 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.979 -179.76 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 47.8 t -125.25 131.02 72.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.802 0.334 . . . . 0.0 110.11 179.329 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.601 ' OG ' HD12 ' A' ' 117' ' ' LEU . 4.2 m -154.72 166.31 33.84 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.606 179.81 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 65.8 p -124.85 8.23 8.12 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.483 179.931 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.1 t -85.2 125.8 33.15 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.68 -179.43 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.463 HG11 ' H ' ' A' ' 299' ' ' LEU . 91.9 t -65.7 -44.52 93.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.51 -179.994 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.8 m -62.74 -44.32 96.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.664 -179.849 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 54.4 tp -62.19 -41.56 98.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.57 -179.536 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.455 ' O ' HD13 ' A' ' 58' ' ' LEU . 72.1 m -57.72 -44.53 86.04 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.349 -179.397 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.31 -62.09 5.43 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.911 -0.876 . . . . 0.0 110.911 179.554 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.6 t -48.24 -35.76 12.63 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 -179.962 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 20.0 mt -61.77 -44.76 96.25 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.724 -0.391 . . . . 0.0 111.145 179.347 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.455 HD13 ' O ' ' A' ' 54' ' ' THR . 9.2 mp -64.88 -42.0 95.18 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.081 0.467 . . . . 0.0 111.287 178.035 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.407 ' HB1' ' NE ' ' A' ' 169' ' ' ARG . . . -63.59 -41.22 98.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.998 -179.288 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.434 ' O ' HG23 ' A' ' 60' ' ' ILE . 7.9 tp -87.89 16.53 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.694 -179.662 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 56.58 84.3 0.09 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.575 -179.973 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.59 57.74 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.147 -179.808 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -50.13 152.55 7.73 Favored 'Trans proline' 0 C--N 1.297 -2.169 0 C-N-CA 122.834 2.356 . . . . 0.0 112.475 -178.297 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.428 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -108.93 146.34 14.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.417 -179.747 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 97.1 mt -63.85 -45.03 98.2 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.351 -179.762 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.505 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -130.26 134.48 47.26 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.677 -179.857 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.478 ' O ' ' N ' ' A' ' 98' ' ' LEU . 69.0 m -134.19 158.38 43.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.839 -179.62 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.5 139.18 16.38 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 179.804 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.498 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.91 -162.6 0.08 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.934 0.397 . . . . 0.0 110.495 -179.968 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.524 HG22 ' CD2' ' A' ' 297' ' ' PHE . 14.6 t -133.55 135.88 44.61 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.394 -179.992 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.493 ' C ' ' O ' ' A' ' 70' ' ' THR . 0.0 OUTLIER 29.74 68.68 0.66 Allowed Pre-proline 0 N--CA 1.464 0.243 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.646 -179.843 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -60.9 145.23 99.35 Favored 'Trans proline' 0 C--N 1.3 -1.98 0 C-N-CA 122.643 2.229 . . . . 0.0 112.227 -178.73 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.527 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 45.6 p-10 -160.7 -32.59 0.05 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.686 179.659 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.537 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 99.0 m-20 -63.88 -39.36 94.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.488 -179.972 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 73.2 ttt180 -60.56 -48.19 82.87 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.68 -179.405 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.418 ' O ' ' O ' ' A' ' 77' ' ' ALA . 93.6 t -59.91 -24.52 29.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 110.1 -0.334 . . . . 0.0 110.1 179.607 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.537 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -46.1 173.13 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.599 179.924 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.569 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.6 p30 -61.87 177.6 0.42 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.581 -179.738 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.567 ' C ' ' H ' ' A' ' 81' ' ' GLY . 35.9 p30 -46.02 85.95 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.887 -179.942 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.569 ' N ' ' O ' ' A' ' 78' ' ' ASP . 42.6 tp60 -66.92 13.48 0.06 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.143 -179.893 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.567 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 117.76 -22.04 10.16 Favored Glycine 0 CA--C 1.519 0.293 0 N-CA-C 110.994 -0.843 . . . . 0.0 110.994 179.957 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -107.62 116.47 32.0 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.99 0.424 . . . . 0.0 110.497 179.883 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 75.2 mt -98.73 0.67 45.0 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.46 -179.738 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -91.93 6.7 45.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.957 0.408 . . . . 0.0 110.41 -179.833 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.8 ' O ' HG22 ' A' ' 89' ' ' VAL . 27.2 mt-30 -99.67 -27.63 13.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.858 179.957 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 68.7 t-105 -63.34 -41.18 98.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.03 -179.619 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.556 ' O ' ' N ' ' A' ' 91' ' ' LYS . 65.8 m -77.42 -53.33 7.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.238 -179.317 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -48.57 -51.09 29.47 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.966 -179.28 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.8 HG22 ' O ' ' A' ' 85' ' ' GLN . 15.4 m -68.78 -40.74 81.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 120.903 0.383 . . . . 0.0 110.962 179.9 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.5 ' N ' HG23 ' A' ' 89' ' ' VAL . . . -71.9 -23.11 61.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.786 179.953 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.556 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.0 tttm -60.99 -45.82 93.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.498 -179.602 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.438 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.3 mm-40 -90.82 -94.68 0.12 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.08 179.981 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.634 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.9 mtt180 -143.23 60.03 1.4 Allowed 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.794 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.462 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.6 pttp 33.57 26.23 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.222 -179.048 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.634 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.4 tt -47.62 123.31 5.69 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.92 -178.253 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.456 ' O ' HD23 ' A' ' 95' ' ' LEU . 98.8 mm-40 -83.44 -169.92 2.79 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.061 -179.997 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.613 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 82.3 mtp180 -73.61 138.03 44.6 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.166 -179.837 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.478 ' N ' ' O ' ' A' ' 67' ' ' SER . 89.8 mt -87.27 -165.93 1.43 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.717 -179.647 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.534 ' O ' ' CD2' ' A' ' 99' ' ' TYR . 48.2 p90 -168.46 120.2 0.81 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.32 179.933 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.513 ' C ' ' O ' ' A' ' 99' ' ' TYR . 43.6 mm -29.6 121.5 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.863 -179.63 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 114.22 27.94 3.24 Favored Glycine 0 CA--C 1.521 0.426 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 -179.557 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.59 ' CD ' ' H ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -144.17 46.04 0.6 Allowed Pre-proline 0 C--N 1.324 -0.541 0 CA-C-O 120.907 0.384 . . . . 0.0 110.465 179.903 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.582 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 31.0 Cg_endo -62.28 143.85 94.56 Favored 'Trans proline' 0 C--N 1.298 -2.126 0 C-N-CA 122.735 2.29 . . . . 0.0 111.996 179.932 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.464 ' O ' HG23 ' A' ' 108' ' ' VAL . 24.8 t -173.67 120.91 0.32 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.46 179.67 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.42 -41.11 63.68 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.012 0.434 . . . . 0.0 111.154 179.709 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -65.82 -40.16 91.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.856 -179.432 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.63 -39.77 95.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.708 -179.907 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 104' ' ' SER . 72.0 t -67.44 -43.82 87.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.683 179.584 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.18 -39.24 92.04 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.512 -179.233 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.438 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.75 -23.82 63.54 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.431 179.831 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.568 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.3 mm-40 -91.18 4.47 52.15 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.684 -179.574 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.568 ' C ' ' O ' ' A' ' 111' ' ' GLN . 10.4 tpt 22.11 64.56 0.32 Allowed Pre-proline 0 N--CA 1.464 0.266 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.992 -179.911 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.478 ' HG2' HD11 ' A' ' 116' ' ' ILE . 67.8 Cg_endo -78.66 170.04 18.82 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 C-N-CA 122.972 2.448 . . . . 0.0 112.21 -178.66 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.522 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 99.1 m-20 -113.07 -44.78 3.23 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 121.065 0.46 . . . . 0.0 110.088 179.544 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 39.8 tp -119.91 119.57 33.87 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.514 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.478 HD11 ' HG2' ' A' ' 113' ' ' PRO . 94.7 mt -116.94 131.15 70.49 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 CA-C-O 120.954 0.407 . . . . 0.0 110.887 -179.807 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.601 HD12 ' OG ' ' A' ' 48' ' ' SER . 31.6 mt -105.63 131.98 52.33 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 121.11 0.481 . . . . 0.0 110.125 -179.528 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.488 HD12 HG23 ' A' ' 139' ' ' THR . 98.3 mt -117.55 135.94 56.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.79 -179.726 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 85.0 p -71.57 151.54 43.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.568 -179.944 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.13 -49.85 76.0 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.678 -179.763 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.0 t -149.4 153.93 38.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.587 179.76 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 168.19 -169.56 41.53 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.875 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.87 -35.73 92.41 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -179.971 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.446 ' OD1' ' O ' ' A' ' 124' ' ' ASP . 44.1 p-10 -87.96 120.04 28.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.782 0.325 . . . . 0.0 110.632 179.871 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.454 ' O ' HD12 ' A' ' 129' ' ' LEU . 40.5 t -63.44 144.2 57.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.554 -179.956 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.518 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -94.02 -43.08 8.69 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.792 -179.814 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 56.1 tp -62.73 -42.37 99.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.562 -179.841 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.0 -10.52 54.21 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.531 -179.474 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.454 HD12 ' O ' ' A' ' 125' ' ' SER . 83.6 mt -116.02 -24.08 8.24 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.678 -179.89 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 130' ' ' TYR . . . . . 0.518 ' N ' ' O ' ' A' ' 126' ' ' ALA . 74.5 t80 -51.52 -49.55 61.71 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.456 -178.951 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.4 p-10 -65.87 -41.91 91.04 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.893 0.378 . . . . 0.0 111.163 179.607 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.526 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 87.7 mt-30 -67.85 -36.74 80.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.746 -179.905 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.453 HD22 HD13 ' A' ' 116' ' ' ILE . 95.9 mt -80.19 -42.45 23.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.955 -179.439 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.3 t -57.49 -44.94 85.35 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.355 -179.117 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.4 m -62.29 -45.95 90.94 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.639 179.409 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 92.2 mt -62.29 -43.79 98.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.325 -179.823 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.604 ' HB1' ' HD2' ' A' ' 138' ' ' PRO . . . -170.18 163.75 6.17 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.471 179.842 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.604 ' HD2' ' HB1' ' A' ' 137' ' ' ALA . 76.6 Cg_exo -42.38 110.3 0.15 Allowed 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.571 2.181 . . . . 0.0 112.035 179.454 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.515 HG21 ' CD1' ' A' ' 130' ' ' TYR . 2.8 m -87.27 127.61 35.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.463 -179.927 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.63 HD13 ' CD2' ' A' ' 37' ' ' HIS . 34.1 tp -119.78 138.72 53.17 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.163 -179.818 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.436 ' O ' ' OD1' ' A' ' 32' ' ' ASP . 81.6 mt -105.29 120.04 55.35 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.348 0 CA-C-O 121.125 0.488 . . . . 0.0 111.233 -179.439 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.49 HD12 HD22 ' A' ' 117' ' ' LEU . 97.7 mt -135.42 132.73 52.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.721 179.577 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -64.49 148.3 50.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.875 0.369 . . . . 0.0 110.37 179.364 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.515 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 86.9 t80 -82.75 122.4 28.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.96 -179.471 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.515 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 99.0 m-20 55.08 69.41 0.73 Allowed 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.827 179.648 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 35.2 p-10 -125.71 0.69 7.46 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 120.906 0.384 . . . . 0.0 110.704 179.787 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -150.9 115.92 5.29 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.668 -179.511 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 86.2 p -63.74 168.72 4.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.499 -179.805 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.423 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.3 p-90 -51.6 -15.96 0.54 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.62 -179.868 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.44 ' O ' HG23 ' A' ' 154' ' ' THR . 67.9 tp60 -70.36 -76.05 0.11 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.521 -179.748 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.458 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.0 t -62.68 -38.5 90.61 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.339 179.481 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 52.3 tp -60.1 -45.51 92.69 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.401 -178.611 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.423 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 46.5 tp -62.83 -41.84 99.49 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.861 0.362 . . . . 0.0 110.411 178.995 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.458 ' OG1' ' O ' ' A' ' 151' ' ' SER . 59.2 p -63.72 -34.76 78.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.258 -179.566 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.471 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.9 mm-40 -63.98 -42.18 97.3 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.239 179.177 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 91.6 mt -65.42 -38.89 91.27 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.092 179.118 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.582 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.25 -32.42 80.62 Favored Glycine 0 CA--C 1.52 0.375 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 -179.366 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.471 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.1 mt-10 -36.34 -25.55 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.874 0.369 . . . . 0.0 110.791 -179.98 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.582 ' N ' ' O ' ' A' ' 157' ' ' GLY . 94.8 mt -59.35 149.5 6.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.231 179.473 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 74.8 p -69.09 137.07 53.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.049 -179.558 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 71.1 21.62 78.41 Favored Glycine 0 N--CA 1.459 0.194 0 N-CA-C 111.269 -0.732 . . . . 0.0 111.269 179.509 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 60.3 m80 -123.43 -15.45 7.13 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.746 0.307 . . . . 0.0 110.568 179.989 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -66.02 -59.87 3.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.715 -179.756 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -51.62 -49.09 62.9 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.238 -179.755 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -60.83 -41.07 95.04 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.723 0.297 . . . . 0.0 110.312 179.522 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.48 -47.51 85.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.613 179.745 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.64 -40.32 75.23 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.268 -179.921 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -61.66 -50.24 73.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.65 179.525 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.407 ' NE ' ' HB1' ' A' ' 59' ' ' ALA . 59.9 ttt85 -65.38 -43.76 89.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.476 179.495 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 95.1 mt -64.53 -43.41 96.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.52 179.728 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.23 -51.05 70.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.599 -179.308 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.79 -43.67 95.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.421 179.724 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.658 ' CE2' HD11 ' A' ' 177' ' ' LEU . 57.3 t80 -62.69 -44.56 95.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.456 179.364 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -63.26 -40.04 96.28 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.527 -179.361 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -63.01 -42.77 99.92 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.624 179.277 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -60.64 -44.78 95.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.119 179.968 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.658 HD11 ' CE2' ' A' ' 173' ' ' PHE . 84.4 mt -64.29 -41.09 97.05 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.02 0.438 . . . . 0.0 110.674 178.956 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.18 -62.12 1.84 Allowed 'General case' 0 C--O 1.237 0.418 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.501 -179.387 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.78 -46.78 86.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.545 179.903 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.3 -41.72 65.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.149 179.974 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -63.72 -33.6 76.02 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.011 0.434 . . . . 0.0 110.415 179.227 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.428 ' O ' ' HG2' ' A' ' 182' ' ' GLU . 69.8 tt0 -90.7 8.61 33.62 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.27 0.557 . . . . 0.0 110.528 -179.01 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -104.58 -32.25 9.03 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.188 179.595 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 45.1 pt -128.04 147.72 32.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.816 -179.803 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -139.76 130.88 26.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.375 179.418 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.592 HD22 ' N ' ' A' ' 186' ' ' LEU . 3.6 mm? -85.46 133.24 42.64 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.808 -179.947 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -44.01 157.81 0.14 Allowed 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.704 2.269 . . . . 0.0 112.088 179.46 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 0.528 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.7 Cg_endo -63.01 114.74 2.57 Favored 'Trans proline' 0 C--N 1.303 -1.858 0 C-N-CA 122.751 2.3 . . . . 0.0 111.752 179.909 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 189' ' ' GLN . . . . . 0.528 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.8 mt-30 155.6 147.83 0.0 OUTLIER Pre-proline 0 C--N 1.331 -0.215 0 O-C-N 123.433 0.458 . . . . 0.0 110.725 -179.757 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -73.9 144.06 33.98 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.711 2.274 . . . . 0.0 111.771 178.189 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.498 HG23 ' OG ' ' A' ' 258' ' ' SER . 2.1 p -124.92 159.03 32.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.261 0.553 . . . . 0.0 110.082 -179.975 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 192' ' ' THR . . . . . 0.497 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 37.7 p -143.55 165.31 27.94 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.069 -179.506 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 193' ' ' ALA . . . . . 0.443 ' HA ' ' H ' ' A' ' 260' ' ' PHE . . . -135.55 128.54 31.48 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.122 0.487 . . . . 0.0 110.258 179.704 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.503 HD11 HD23 ' A' ' 259' ' ' LEU . 47.5 pt -146.4 148.86 16.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.1 179.928 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 195' ' ' VAL . . . . . 0.747 HG13 ' CD1' ' A' ' 262' ' ' PHE . 68.9 t -117.89 123.12 71.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.315 0.578 . . . . 0.0 109.7 179.098 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -134.26 107.36 7.62 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.309 179.745 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 94.2 m -131.13 130.53 43.21 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.802 179.871 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.411 ' O ' ' N ' ' A' ' 201' ' ' HIS . . . -82.9 -37.2 24.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.276 179.745 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.25 -67.12 0.25 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.364 179.978 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.15 -9.84 58.98 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.344 179.48 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 201' ' ' HIS . . . . . 0.411 ' N ' ' O ' ' A' ' 198' ' ' ALA . 60.0 t-80 60.85 58.16 2.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.601 -179.972 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 44.8 p -167.07 153.21 8.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.516 179.666 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.24 143.93 24.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.933 0.397 . . . . 0.0 110.426 179.532 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -135.31 138.51 43.5 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.644 -179.949 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 19.9 mt -106.45 125.42 50.98 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 121.112 0.482 . . . . 0.0 109.862 -179.721 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 206' ' ' TRP . . . . . 0.555 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 74.2 m95 -81.96 166.94 19.42 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.597 -179.713 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 207' ' ' THR . . . . . 0.475 HG22 ' C ' ' A' ' 206' ' ' TRP . 0.1 OUTLIER -157.05 171.41 7.49 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.56 -179.164 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -53.65 -37.13 83.38 Favored 'Trans proline' 0 C--N 1.303 -1.838 0 C-N-CA 122.664 2.242 . . . . 0.0 111.97 179.333 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -70.58 -35.08 72.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.844 -179.864 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 21.7 m -60.98 151.02 31.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.562 -179.31 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.81 -37.03 82.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.523 -179.767 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 212' ' ' GLN . . . . . 0.555 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 55.0 tt0 -64.64 -40.37 95.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.532 179.916 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.51 -43.34 92.55 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 179.846 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -63.31 -43.68 97.12 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.675 0.274 . . . . 0.0 110.283 179.851 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 215' ' ' MET . . . . . 0.546 ' SD ' ' HB2' ' A' ' 304' ' ' ALA . 65.3 ttp -59.65 -47.98 83.47 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.206 -179.773 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 216' ' ' LEU . 88.1 mt -60.59 -40.8 93.07 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.531 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 217' ' ' GLU . . . . . 0.459 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.8 tp10 -58.25 -38.01 76.08 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.75 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -65.13 -38.23 89.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.808 0.337 . . . . 0.0 110.671 179.677 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 94.4 mt -64.33 -42.67 96.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.572 -179.616 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.5 44.93 0.08 OUTLIER Glycine 0 CA--C 1.521 0.429 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 -179.958 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 221' ' ' PHE . . . . . 0.459 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 26.4 m-85 -127.91 155.32 44.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.045 0.45 . . . . 0.0 110.507 -179.896 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.489 ' O ' HG13 ' A' ' 191' ' ' VAL . 7.2 p -106.8 122.17 45.84 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.214 0.531 . . . . 0.0 110.202 -179.985 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.473 HD22 ' C ' ' A' ' 222' ' ' THR . 4.3 mm? -101.21 132.99 46.44 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.074 179.982 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.85 159.74 14.75 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.005 0.431 . . . . 0.0 110.504 179.86 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.75 115.25 29.92 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.382 179.93 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.508 HD12 ' N ' ' A' ' 226' ' ' LEU . 8.8 mp -52.94 156.62 3.33 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.662 179.952 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -60.47 145.45 98.71 Favored 'Trans proline' 0 C--N 1.302 -1.889 0 C-N-CA 122.68 2.253 . . . . 0.0 111.982 179.367 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.02 -3.42 59.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.57 179.994 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.04 -41.11 5.66 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 -179.884 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.537 ' O ' ' N ' ' A' ' 233' ' ' SER . 85.6 mt -79.3 -17.2 55.09 Favored 'General case' 0 C--O 1.224 -0.273 0 CA-C-O 121.037 0.446 . . . . 0.0 110.314 -179.696 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 231' ' ' ASN . . . . . 0.403 ' C ' ' O ' ' A' ' 230' ' ' LEU . 54.8 t-20 -40.23 -49.31 2.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.73 -179.642 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -87.86 15.35 7.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.828 0.347 . . . . 0.0 111.18 179.945 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.537 ' N ' ' O ' ' A' ' 230' ' ' LEU . 78.0 p -60.29 -35.54 75.79 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.594 -179.824 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 234' ' ' GLN . . . . . 0.526 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.5 tt0 -119.11 -69.29 0.86 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.898 179.643 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.2 m -69.28 103.23 1.9 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.612 -179.727 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -94.79 57.18 2.12 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.42 179.912 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -144.57 -122.84 1.62 Allowed Glycine 0 CA--C 1.522 0.48 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 -179.928 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -134.94 111.64 10.0 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.061 0.458 . . . . 0.0 110.423 -179.997 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 239' ' ' ARG . . . . . 0.523 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.6 mtt180 -148.04 58.16 1.1 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.731 -179.961 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -69.75 -32.03 70.32 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.568 179.571 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 241' ' ' ASP . . . . . 0.449 ' OD2' ' O ' ' A' ' 144' ' ' TYR . 65.4 t0 -57.08 -46.93 82.14 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.373 -179.143 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 242' ' ' ILE . . . . . 0.435 ' O ' ' O ' ' A' ' 239' ' ' ARG . 18.1 tt -140.01 156.82 25.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.91 0.386 . . . . 0.0 110.492 179.712 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.443 HG22 HD13 ' A' ' 245' ' ' LEU . 96.2 mt -106.54 106.7 21.11 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.173 0 CA-C-O 121.177 0.513 . . . . 0.0 110.523 179.85 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 244' ' ' GLN . . . . . 0.606 ' O ' HD12 ' A' ' 245' ' ' LEU . 88.2 mt-30 -110.47 110.12 20.75 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.311 179.817 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.606 HD12 ' O ' ' A' ' 244' ' ' GLN . 9.3 mp -121.86 -168.44 1.7 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.601 179.911 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 246' ' ' GLY . . . . . 0.526 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.67 -16.47 0.05 OUTLIER Glycine 0 CA--C 1.524 0.628 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 179.876 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 247' ' ' GLY . . . . . 0.677 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -60.59 156.35 31.49 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 -179.885 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -63.42 21.38 0.01 OUTLIER 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.886 0.374 . . . . 0.0 110.626 179.883 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 249' ' ' ASN . . . . . 0.677 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.6 m-20 -97.29 -5.78 35.89 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.537 179.942 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 94.8 mt -79.66 -22.11 43.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.543 179.546 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.55 -51.32 70.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.796 -179.591 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.11 -5.68 58.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.476 179.679 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -80.96 -74.69 1.13 Allowed Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 -179.925 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 81.3 mt -69.89 125.97 28.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.069 0.461 . . . . 0.0 110.249 -179.82 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -59.19 -39.52 82.83 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.248 -179.662 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 83.21 51.82 4.02 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 179.903 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -96.04 -14.95 22.56 Favored 'General case' 0 C--N 1.333 -0.152 0 O-C-N 122.729 -0.277 . . . . 0.0 110.564 -179.843 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 258' ' ' SER . . . . . 0.498 ' OG ' HG23 ' A' ' 191' ' ' VAL . 3.4 t 174.43 88.62 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.048 0.451 . . . . 0.0 110.169 -179.972 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.864 HD12 ' N ' ' A' ' 259' ' ' LEU . 1.0 OUTLIER -94.05 123.93 37.74 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.227 0.537 . . . . 0.0 111.11 -179.159 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 260' ' ' PHE . . . . . 0.443 ' H ' ' HA ' ' A' ' 193' ' ' ALA . 16.0 m-30 -92.93 146.7 23.43 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.337 179.221 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 85.7 mt -122.53 149.9 43.29 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.521 -179.868 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.747 ' CD1' HG13 ' A' ' 195' ' ' VAL . 2.6 p90 -77.57 -138.47 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.552 -179.865 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 263' ' ' ALA . . . . . 0.662 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -52.16 77.73 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.922 179.957 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 264' ' ' GLY . . . . . 0.632 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.16 104.46 0.19 Allowed Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 -179.936 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 265' ' ' ASP . . . . . 0.609 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.8 m-20 -80.49 -177.64 6.31 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.749 0.309 . . . . 0.0 110.841 -179.468 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -40.48 -17.54 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.506 179.8 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 267' ' ' LYS . . . . . 0.609 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.63 -51.59 40.52 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.687 179.516 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -63.71 -46.67 84.38 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.187 179.382 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 269' ' ' ALA . . . . . 0.569 ' HB1' ' OH ' ' A' ' 273' ' ' TYR . . . -61.64 -35.04 76.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.845 179.52 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -63.05 -34.53 77.78 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.111 179.744 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.37 -43.21 13.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.261 -179.577 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 272' ' ' ILE . . . . . 0.586 ' C ' ' H ' ' A' ' 274' ' ' ALA . 4.9 tt -51.39 -33.81 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.811 -178.802 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 273' ' ' TYR . . . . . 0.569 ' OH ' ' HB1' ' A' ' 269' ' ' ALA . 17.2 m-85 -54.27 -1.76 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.655 -179.628 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 274' ' ' ALA . . . . . 0.586 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.87 -39.41 69.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.844 179.686 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 275' ' ' ASN . . . . . 0.582 ' O ' ' N ' ' A' ' 279' ' ' ALA . 2.9 p30 -39.63 98.28 0.16 Allowed Pre-proline 0 C--N 1.333 -0.141 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.513 -179.671 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -54.02 -43.17 60.61 Favored 'Trans proline' 0 C--N 1.302 -1.874 0 C-N-CA 122.411 2.074 . . . . 0.0 112.613 -178.855 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 88.9 mt -64.47 -42.83 95.69 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.137 0.494 . . . . 0.0 111.218 -179.625 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 89.7 mt -95.67 -1.54 49.9 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.875 -179.47 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 279' ' ' ALA . . . . . 0.582 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.42 -34.65 77.17 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.646 -179.807 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.45 20.04 0.12 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.024 -179.226 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 0.492 HD23 ' HA ' ' A' ' 281' ' ' LEU . 13.9 mt -75.32 120.52 82.06 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.394 179.968 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -51.36 -39.23 63.56 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 122.625 2.217 . . . . 0.0 111.676 179.312 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.9 -50.42 63.93 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.09 179.878 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 75.2 t -61.48 -43.93 97.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 179.502 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -57.67 -41.27 81.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.317 -179.981 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -91.14 0.45 57.53 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.123 179.599 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt 59.06 43.25 17.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.042 0.448 . . . . 0.0 110.928 179.67 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -94.59 41.43 1.09 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.399 179.793 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 53.4 t -118.85 135.86 57.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.031 0.443 . . . . 0.0 110.166 -179.707 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -133.01 162.8 30.73 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.706 -179.637 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.94 155.19 33.24 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.988 0.423 . . . . 0.0 110.701 -179.743 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 80.4 mt -93.95 -1.36 54.76 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.364 -179.794 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.26 165.89 12.78 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 110.65 -0.98 . . . . 0.0 110.65 -179.747 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 6.9 m -87.75 -62.26 1.54 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.889 0.376 . . . . 0.0 111.124 -179.922 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 295' ' ' GLU . . . . . 0.441 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.7 mm-40 -69.48 -3.78 16.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.569 -179.729 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 27.6 p -76.74 32.8 0.14 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.698 -179.963 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 297' ' ' PHE . . . . . 0.524 ' CD2' HG22 ' A' ' 70' ' ' THR . 85.5 t80 -60.21 -45.92 91.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.677 179.995 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 298' ' ' ARG . . . . . 0.613 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.1 mtt85 -81.54 134.23 35.48 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.592 -179.68 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.463 ' H ' HG11 ' A' ' 51' ' ' VAL . 16.6 tp -114.04 118.35 33.84 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.115 179.969 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 300' ' ' ASP . . . . . 0.635 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.7 p-10 -165.8 -175.96 3.66 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.526 -179.934 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -47.34 -44.04 23.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.194 -179.639 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -66.33 -40.76 90.1 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.013 0.435 . . . . 0.0 110.776 179.05 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 303' ' ' SER . . . . . 0.635 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 57.6 p -55.72 -36.17 66.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.168 -179.334 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 304' ' ' ALA . . . . . 0.546 ' HB2' ' SD ' ' A' ' 215' ' ' MET . . . -57.35 -51.68 68.43 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.439 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 91.1 mtp -56.15 -43.59 78.42 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.778 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -66.54 -42.49 87.11 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.912 0.387 . . . . 0.0 110.167 178.821 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 307' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 303' ' ' SER . 55.9 t -64.13 -42.86 96.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.179 179.305 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 43.5 tp -59.68 -42.14 92.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.88 -179.588 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -62.54 -39.15 92.67 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.112 179.494 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 310' ' ' ARG . . . . . 0.438 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.5 ttt85 -63.45 -43.99 95.77 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.293 179.445 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 88.9 mt -63.34 -42.13 98.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.226 179.566 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.4 ttmt -62.84 -33.26 74.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.068 0.461 . . . . 0.0 110.108 179.485 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.84 -23.46 21.67 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.579 -179.942 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.478 HD22 ' CE2' ' A' ' 315' ' ' PHE . 6.7 tt -62.39 -43.17 99.47 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.547 -179.894 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 315' ' ' PHE . . . . . 0.478 ' CE2' HD22 ' A' ' 314' ' ' LEU . 91.0 m-85 . . . . . 0 C--O 1.219 -0.502 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.498 179.989 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -99.67 135.97 40.29 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.047 0.451 . . . . 0.0 110.485 -179.962 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.497 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.2 OUTLIER -91.64 178.43 1.76 Allowed Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.601 -179.87 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.497 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.6 Cg_exo -61.73 147.73 94.65 Favored 'Trans proline' 0 C--N 1.3 -1.987 0 C-N-CA 122.755 2.303 . . . . 0.0 112.118 179.708 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.473 ' HE ' HD12 ' A' ' 39' ' ' LEU . 35.4 ptt180 -135.48 142.34 45.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.618 179.797 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -78.95 116.84 19.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.576 179.953 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.431 ' O ' HG23 ' A' ' 30' ' ' ILE . 9.6 tp -110.17 130.86 62.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.436 -179.998 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 13.2 t -70.69 142.3 51.53 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.614 179.839 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 141' ' ' ILE . 25.2 t70 -140.25 177.56 7.9 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.481 -179.939 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 77.9 p -74.13 -36.33 64.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.529 -179.945 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -47.69 -94.96 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.347 -179.606 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -165.46 -25.83 0.02 OUTLIER Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 179.892 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 59.0 m -168.84 106.96 0.44 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.846 0.355 . . . . 0.0 110.689 -179.96 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 51.0 t-80 -129.57 144.77 51.42 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.012 0.434 . . . . 0.0 110.224 179.885 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.628 HG22 ' N ' ' A' ' 39' ' ' LEU . 97.4 m -128.95 166.24 19.53 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.582 -179.76 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.628 ' N ' HG22 ' A' ' 38' ' ' THR . 81.9 mt -121.04 127.48 51.76 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.486 179.738 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -64.05 -44.55 92.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.618 -179.829 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 40.7 p -165.68 154.75 11.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.463 179.719 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.52 ' CD ' ' H ' ' A' ' 42' ' ' GLN . 14.4 mp0 -43.36 100.86 0.23 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.595 179.61 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -57.03 128.95 31.95 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.384 2.056 . . . . 0.0 112.29 -179.637 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -83.34 -24.54 32.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.551 179.6 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.541 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.7 mtm-85 -121.03 134.43 55.29 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 121.095 0.474 . . . . 0.0 110.294 -179.985 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.0 mt -130.23 133.35 64.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.943 -179.746 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 45.9 t -124.9 131.13 73.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.817 0.341 . . . . 0.0 110.156 179.334 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.601 ' OG ' HD12 ' A' ' 117' ' ' LEU . 4.8 m -154.55 166.32 33.7 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.543 179.881 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 72.0 p -124.56 8.55 8.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.519 179.856 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.3 t -85.73 125.33 33.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.579 -179.485 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.499 HG11 ' H ' ' A' ' 299' ' ' LEU . 96.4 t -65.66 -44.46 93.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.544 179.961 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.7 m -62.48 -44.36 96.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.57 -179.841 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 46.3 tp -62.41 -41.3 98.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.516 -179.441 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.454 ' O ' HD13 ' A' ' 58' ' ' LEU . 73.7 m -57.59 -44.57 85.48 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.451 -179.326 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.43 -62.3 5.22 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 179.602 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.6 t -48.14 -35.78 12.19 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 179.807 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.5 mt -61.66 -44.79 96.29 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.038 179.474 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.454 HD13 ' O ' ' A' ' 54' ' ' THR . 9.1 mp -64.96 -41.81 95.15 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.164 178.114 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.403 ' HB1' ' NE ' ' A' ' 169' ' ' ARG . . . -63.48 -41.49 98.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.921 -179.164 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.433 ' O ' HG23 ' A' ' 60' ' ' ILE . 8.1 tp -87.9 16.94 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.711 -179.574 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 56.58 84.01 0.09 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.646 179.999 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.74 58.2 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.106 -179.803 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -50.84 152.6 9.6 Favored 'Trans proline' 0 C--N 1.298 -2.121 0 C-N-CA 122.832 2.355 . . . . 0.0 112.485 -178.264 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.431 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -108.99 145.74 15.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.348 -179.63 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.86 -45.17 97.78 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.3 -179.671 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.496 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -129.85 134.53 47.59 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.598 -179.713 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.5 ' O ' ' N ' ' A' ' 98' ' ' LEU . 75.3 m -134.83 158.79 43.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.788 -179.605 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -87.07 139.45 16.19 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.752 -0.939 . . . . 0.0 110.752 179.753 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.493 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.98 -162.49 0.08 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.931 0.396 . . . . 0.0 110.481 -179.921 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.522 HG22 ' CD2' ' A' ' 297' ' ' PHE . 14.6 t -133.67 135.35 44.03 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.353 179.942 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.496 ' C ' ' O ' ' A' ' 70' ' ' THR . 0.1 OUTLIER 29.58 68.54 0.65 Allowed Pre-proline 0 N--CA 1.463 0.222 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.705 -179.824 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -60.98 145.11 99.55 Favored 'Trans proline' 0 C--N 1.301 -1.963 0 C-N-CA 122.626 2.218 . . . . 0.0 112.155 -178.525 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.528 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 45.2 p-10 -159.54 -32.3 0.06 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.645 179.723 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.537 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 99.1 m-20 -64.12 -39.45 94.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.464 -179.992 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -60.49 -48.49 81.54 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.646 -179.284 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.424 ' O ' ' O ' ' A' ' 77' ' ' ALA . 92.8 t -59.68 -24.92 30.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.091 179.697 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.537 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -45.54 172.32 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.567 179.869 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.574 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.6 p30 -61.74 177.77 0.39 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.546 -179.732 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.56 ' C ' ' H ' ' A' ' 81' ' ' GLY . 35.6 p30 -45.92 85.8 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.847 179.98 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.574 ' N ' ' O ' ' A' ' 78' ' ' ASP . 42.8 tp60 -67.31 13.62 0.06 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.192 -179.983 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.56 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 117.93 -22.14 9.99 Favored Glycine 0 CA--C 1.52 0.364 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 179.969 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -107.62 116.39 31.87 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.932 0.396 . . . . 0.0 110.513 179.911 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 74.4 mt -98.84 0.86 45.13 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.473 -179.713 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -92.18 6.62 45.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.42 -179.811 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.795 ' O ' HG22 ' A' ' 89' ' ' VAL . 27.1 mt-30 -100.0 -27.41 13.59 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.85 179.971 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.6 t-105 -63.89 -40.74 97.23 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.981 -179.628 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.556 ' O ' ' N ' ' A' ' 91' ' ' LYS . 68.1 m -77.75 -53.84 7.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.225 -179.496 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -48.02 -50.77 26.64 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.908 -179.249 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.795 HG22 ' O ' ' A' ' 85' ' ' GLN . 15.4 m -69.07 -40.97 81.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 120.909 0.385 . . . . 0.0 110.922 179.955 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.503 ' N ' HG23 ' A' ' 89' ' ' VAL . . . -71.93 -22.89 61.41 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.71 -179.873 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.556 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.0 tttm -61.54 -45.91 92.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.482 -179.535 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.439 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.4 mm-40 -90.25 -94.57 0.12 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.151 -179.997 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.624 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.8 mtt180 -143.54 59.96 1.39 Allowed 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.734 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.466 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.7 pttp 33.32 27.1 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.338 -179.029 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.624 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.5 tt -48.55 123.12 6.24 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.915 -178.328 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.45 ' O ' HD23 ' A' ' 95' ' ' LEU . 99.0 mm-40 -83.6 -170.38 3.03 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.227 179.863 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.613 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 81.6 mtp180 -73.31 137.84 45.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.297 -179.847 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.5 ' N ' ' O ' ' A' ' 67' ' ' SER . 88.6 mt -86.09 -166.66 1.6 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.725 -179.584 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.528 ' O ' ' CD2' ' A' ' 99' ' ' TYR . 47.4 p90 -166.77 119.9 1.01 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.302 179.984 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.512 ' C ' ' O ' ' A' ' 99' ' ' TYR . 43.7 mm -29.75 121.15 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.865 -179.6 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 113.43 28.93 3.1 Favored Glycine 0 CA--C 1.522 0.492 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 -179.66 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.59 ' CD ' ' H ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -144.25 46.12 0.61 Allowed Pre-proline 0 C--N 1.325 -0.493 0 CA-C-O 120.922 0.391 . . . . 0.0 110.456 179.934 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.582 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 30.2 Cg_endo -62.01 143.72 95.45 Favored 'Trans proline' 0 C--N 1.299 -2.079 0 C-N-CA 122.733 2.289 . . . . 0.0 112.018 -179.985 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.471 ' O ' HG23 ' A' ' 108' ' ' VAL . 26.1 t -173.36 120.7 0.34 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.454 179.712 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.76 -41.0 63.06 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.056 179.767 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -65.86 -40.26 91.5 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.831 -179.383 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.97 -40.01 95.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.688 -179.777 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 104' ' ' SER . 70.7 t -67.39 -43.85 87.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.735 179.676 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.53 -39.22 92.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.577 -179.329 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.439 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.29 -23.49 62.46 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.521 179.81 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.557 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.4 mm-40 -91.25 5.08 50.55 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.698 -179.552 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.557 ' C ' ' O ' ' A' ' 111' ' ' GLN . 10.2 tpt 22.81 64.59 0.35 Allowed Pre-proline 0 N--CA 1.465 0.288 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.879 -179.85 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.447 ' HG2' HD11 ' A' ' 116' ' ' ILE . 68.4 Cg_endo -78.98 169.27 19.59 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 C-N-CA 122.975 2.45 . . . . 0.0 112.223 -178.684 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.464 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 98.8 m-20 -113.44 -44.08 3.26 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.148 179.43 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.7 tp -120.24 120.92 37.52 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.001 179.432 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.458 HD13 HD22 ' A' ' 133' ' ' LEU . 96.7 mt -118.49 131.07 72.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.795 -179.705 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.601 HD12 ' OG ' ' A' ' 48' ' ' SER . 32.4 mt -106.1 132.76 51.79 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.127 0.489 . . . . 0.0 110.298 -179.502 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.421 HD12 HG23 ' A' ' 139' ' ' THR . 98.0 mt -118.17 136.57 54.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.687 -179.753 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 87.0 p -72.07 153.47 41.7 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.566 -179.938 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.34 -50.27 74.27 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.689 -179.888 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.0 t -149.31 153.74 37.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.51 179.785 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 169.58 -169.99 42.4 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 179.89 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -63.08 -35.14 91.69 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 179.922 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.453 ' OD1' ' O ' ' A' ' 124' ' ' ASP . 44.6 p-10 -88.05 119.86 28.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.843 0.354 . . . . 0.0 110.679 179.897 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.443 ' O ' HD12 ' A' ' 129' ' ' LEU . 37.0 t -63.4 144.53 56.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.445 -179.914 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.523 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.23 -43.43 8.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.936 -179.997 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.7 tp -62.86 -42.3 99.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.655 -179.864 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.48 -11.08 57.03 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.52 -179.519 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.443 HD12 ' O ' ' A' ' 125' ' ' SER . 84.4 mt -116.08 -24.07 8.21 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.642 -179.775 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 130' ' ' TYR . . . . . 0.523 ' N ' ' O ' ' A' ' 126' ' ' ALA . 79.3 t80 -51.12 -50.18 59.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.587 -179.154 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.5 p-10 -65.82 -42.16 90.95 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.906 0.384 . . . . 0.0 111.133 179.716 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.524 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 87.7 mt-30 -67.55 -36.85 81.76 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.698 -179.882 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.458 HD22 HD13 ' A' ' 116' ' ' ILE . 93.7 mt -80.61 -42.0 22.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.952 -179.543 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.3 t -57.03 -44.87 83.32 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.283 -179.279 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.5 m -62.32 -45.78 91.66 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.812 0.339 . . . . 0.0 110.615 179.42 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 92.8 mt -62.34 -43.81 98.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.35 -179.765 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.581 ' HB1' ' HD2' ' A' ' 138' ' ' PRO . . . -170.07 162.85 6.52 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.573 179.811 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.581 ' HD2' ' HB1' ' A' ' 137' ' ' ALA . 77.5 Cg_exo -42.71 110.88 0.18 Allowed 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.562 2.175 . . . . 0.0 112.1 179.554 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.459 HG21 ' CD1' ' A' ' 130' ' ' TYR . 16.7 m -85.77 127.79 34.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.632 179.968 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.444 HD12 ' HA ' ' A' ' 140' ' ' LEU . 35.6 tp -119.77 139.06 52.9 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.127 179.974 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.425 ' O ' ' OD1' ' A' ' 32' ' ' ASP . 78.6 mt -105.65 120.78 57.0 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 CA-C-O 121.088 0.47 . . . . 0.0 111.071 -179.275 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.476 HD12 HD22 ' A' ' 117' ' ' LEU . 96.4 mt -136.33 133.05 49.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.597 179.522 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.476 ' ND2' ' OD2' ' A' ' 241' ' ' ASP . 2.1 t-20 -64.26 151.19 44.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.939 0.399 . . . . 0.0 110.4 179.468 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.517 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 89.3 t80 -86.38 122.94 31.05 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.805 -179.484 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.517 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 99.1 m-20 55.12 69.5 0.73 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.841 179.648 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 42.8 p-10 -127.54 1.06 6.22 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.917 0.389 . . . . 0.0 110.617 -179.956 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -150.45 114.76 5.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.718 -179.643 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 83.4 p -63.44 168.44 4.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.517 -179.803 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.414 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.6 p-90 -52.13 -15.66 0.63 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.599 -179.858 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.436 ' O ' HG23 ' A' ' 154' ' ' THR . 68.1 tp60 -70.62 -76.17 0.11 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.507 -179.801 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.45 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.0 t -62.79 -38.55 91.07 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.309 179.584 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 53.2 tp -59.82 -45.79 91.26 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.459 -178.636 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.414 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 46.7 tp -62.77 -41.72 99.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.431 179.051 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.45 ' OG1' ' O ' ' A' ' 151' ' ' SER . 60.4 p -63.96 -34.87 78.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.311 -179.633 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.461 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.6 mm-40 -63.89 -42.34 97.48 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.277 179.266 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 92.4 mt -65.45 -38.81 90.94 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.949 0.404 . . . . 0.0 110.215 179.027 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.579 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.32 -31.89 78.85 Favored Glycine 0 CA--C 1.521 0.442 0 N-CA-C 110.829 -0.908 . . . . 0.0 110.829 -179.428 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.461 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.3 mt-10 -36.62 -25.53 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.87 0.367 . . . . 0.0 110.814 179.976 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.579 ' N ' ' O ' ' A' ' 157' ' ' GLY . 93.9 mt -59.02 150.63 5.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.288 179.464 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 73.5 p -69.26 137.2 52.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.922 -179.435 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 69.88 22.98 77.17 Favored Glycine 0 CA--C 1.517 0.197 0 N-CA-C 111.226 -0.75 . . . . 0.0 111.226 179.408 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 61.4 m80 -124.0 -13.92 7.22 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.717 0.294 . . . . 0.0 110.576 179.91 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -67.13 -59.53 3.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.764 -179.71 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -51.49 -49.59 61.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.261 -179.718 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -60.08 -41.31 92.15 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.732 0.301 . . . . 0.0 110.374 179.484 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.44 -47.61 84.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.596 179.85 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.57 -40.25 74.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.297 -179.901 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -61.46 -50.32 73.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.621 179.613 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.403 ' NE ' ' HB1' ' A' ' 59' ' ' ALA . 59.9 ttt85 -65.65 -43.61 88.87 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.477 179.6 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 94.6 mt -64.46 -43.51 96.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.46 179.747 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.38 -51.31 69.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.616 -179.269 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.8 -44.18 94.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.49 179.686 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.659 ' CE2' HD11 ' A' ' 177' ' ' LEU . 55.1 t80 -62.76 -44.38 96.34 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.494 179.458 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -63.3 -40.0 96.13 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.621 -179.434 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -62.89 -42.74 99.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.677 179.231 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -60.78 -44.89 96.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.148 179.936 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.659 HD11 ' CE2' ' A' ' 173' ' ' PHE . 85.6 mt -64.6 -41.08 96.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.053 0.454 . . . . 0.0 110.771 178.887 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.04 -61.95 1.94 Allowed 'General case' 0 C--O 1.236 0.38 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.558 -179.415 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.83 -46.75 86.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.484 179.825 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.24 -41.41 65.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.268 -179.968 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -64.18 -33.78 76.57 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.958 0.409 . . . . 0.0 110.391 179.282 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.426 ' O ' ' HG2' ' A' ' 182' ' ' GLU . 69.4 tt0 -90.74 9.04 31.58 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.255 0.55 . . . . 0.0 110.575 -179.018 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -104.94 -32.19 8.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.045 179.746 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.4 pt -128.22 147.86 32.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.799 -179.773 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -140.05 131.1 26.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.398 179.385 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.6 HD22 ' N ' ' A' ' 186' ' ' LEU . 3.6 mm? -85.54 133.9 41.16 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.789 179.99 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -44.15 157.99 0.14 Allowed 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.773 2.315 . . . . 0.0 112.055 179.363 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 0.535 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.9 Cg_endo -63.02 114.84 2.61 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 C-N-CA 122.774 2.316 . . . . 0.0 111.786 179.783 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 189' ' ' GLN . . . . . 0.535 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.7 mt-30 155.36 148.15 0.0 OUTLIER Pre-proline 0 N--CA 1.455 -0.186 0 O-C-N 123.461 0.476 . . . . 0.0 110.67 -179.809 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -73.61 144.22 35.34 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.738 2.292 . . . . 0.0 111.861 178.001 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.498 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.1 p -124.99 158.95 32.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.232 0.539 . . . . 0.0 110.165 -179.979 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 192' ' ' THR . . . . . 0.498 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 38.5 p -143.51 165.13 28.43 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.01 -179.427 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 193' ' ' ALA . . . . . 0.444 ' HA ' ' H ' ' A' ' 260' ' ' PHE . . . -135.45 128.53 31.65 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.109 0.48 . . . . 0.0 110.231 179.543 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.505 HD11 HD23 ' A' ' 259' ' ' LEU . 47.7 pt -146.27 148.39 17.15 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.04 -179.945 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 195' ' ' VAL . . . . . 0.746 HG13 ' CD1' ' A' ' 262' ' ' PHE . 72.2 t -117.28 123.09 71.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.21 0.529 . . . . 0.0 109.909 178.962 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -134.13 107.4 7.7 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.296 179.674 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 94.5 m -130.95 130.42 43.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.853 179.797 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -82.76 -36.95 25.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.324 179.668 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.55 -67.39 0.24 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.422 179.942 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -71.93 -9.97 59.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.314 179.515 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 59.7 t-80 60.85 58.34 2.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.738 -179.877 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 39.7 p -167.18 153.39 8.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.594 179.596 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.24 144.08 24.47 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.987 0.422 . . . . 0.0 110.496 179.433 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -135.41 138.43 43.25 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.583 -179.914 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 20.1 mt -106.16 125.33 50.86 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 121.074 0.464 . . . . 0.0 109.926 -179.758 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 206' ' ' TRP . . . . . 0.569 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 74.7 m95 -81.82 166.82 19.65 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.623 -179.81 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 207' ' ' THR . . . . . 0.463 HG22 ' C ' ' A' ' 206' ' ' TRP . 0.1 OUTLIER -156.47 172.35 6.2 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.615 -179.244 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -54.42 -37.29 89.39 Favored 'Trans proline' 0 C--N 1.303 -1.825 0 C-N-CA 122.716 2.277 . . . . 0.0 112.015 179.297 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -70.45 -34.68 72.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.765 -179.75 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 21.6 m -61.5 150.57 35.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.586 -179.357 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.41 -36.47 80.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.471 -179.75 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 212' ' ' GLN . . . . . 0.569 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 54.2 tt0 -64.46 -40.81 96.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.543 179.908 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.61 -43.47 92.04 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 179.837 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -63.23 -44.14 96.09 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.761 0.315 . . . . 0.0 110.295 179.658 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 215' ' ' MET . . . . . 0.579 ' SD ' ' HB2' ' A' ' 304' ' ' ALA . 65.1 ttp -59.61 -48.0 83.39 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.314 -179.879 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 86.3 mt -60.55 -40.82 93.01 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.353 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 217' ' ' GLU . . . . . 0.456 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 40.7 tp10 -57.86 -38.2 75.29 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 179.513 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -65.26 -38.17 89.48 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.8 0.333 . . . . 0.0 110.624 179.678 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 94.6 mt -64.35 -42.82 96.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.491 -179.689 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.63 45.96 0.08 OUTLIER Glycine 0 CA--C 1.521 0.435 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 179.993 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 221' ' ' PHE . . . . . 0.456 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 26.8 m-85 -129.07 156.13 44.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.993 0.425 . . . . 0.0 110.487 -179.829 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.487 ' O ' HG13 ' A' ' 191' ' ' VAL . 7.7 p -108.1 122.7 47.43 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.112 0.482 . . . . 0.0 110.239 -179.997 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.478 HD22 ' C ' ' A' ' 222' ' ' THR . 4.3 mm? -101.43 133.17 46.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.089 -179.889 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.99 159.81 14.7 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.52 179.776 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -105.03 115.08 29.68 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.934 0.397 . . . . 0.0 110.398 179.853 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.494 HD12 ' N ' ' A' ' 226' ' ' LEU . 9.1 mp -53.37 156.86 3.79 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.574 179.954 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -60.27 145.22 99.03 Favored 'Trans proline' 0 C--N 1.302 -1.887 0 C-N-CA 122.615 2.21 . . . . 0.0 112.076 179.303 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.56 -2.78 58.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.543 -179.969 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.41 -40.67 5.67 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -179.842 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.552 ' O ' ' N ' ' A' ' 233' ' ' SER . 85.3 mt -79.29 -16.77 55.86 Favored 'General case' 0 C--O 1.224 -0.242 0 CA-C-O 120.929 0.395 . . . . 0.0 110.41 -179.821 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 231' ' ' ASN . . . . . 0.407 ' C ' ' O ' ' A' ' 230' ' ' LEU . 54.8 t-20 -39.82 -49.21 2.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.708 -179.706 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -88.55 15.71 7.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.103 -179.926 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.552 ' N ' ' O ' ' A' ' 230' ' ' LEU . 78.2 p -60.64 -35.96 77.47 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.64 -179.891 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 234' ' ' GLN . . . . . 0.527 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.7 tt0 -118.01 -69.55 0.84 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.911 179.677 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.0 m -70.56 103.36 2.48 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.658 -179.791 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -94.54 58.09 2.32 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.387 179.885 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -145.11 -122.71 1.56 Allowed Glycine 0 CA--C 1.522 0.47 0 N-CA-C 110.931 -0.868 . . . . 0.0 110.931 -179.927 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -133.71 111.7 10.79 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.052 0.454 . . . . 0.0 110.487 179.964 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 239' ' ' ARG . . . . . 0.496 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.0 mtt180 -148.18 56.88 1.07 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.741 -179.926 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 94.2 m-70 -69.66 -31.46 69.54 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.569 179.578 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 241' ' ' ASP . . . . . 0.476 ' OD2' ' ND2' ' A' ' 143' ' ' ASN . 65.2 t0 -56.87 -46.84 81.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.33 -179.147 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 242' ' ' ILE . . . . . 0.439 ' O ' ' O ' ' A' ' 239' ' ' ARG . 17.2 tt -140.71 157.86 23.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.913 0.387 . . . . 0.0 110.529 179.726 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.445 HG22 HD13 ' A' ' 245' ' ' LEU . 96.0 mt -106.28 106.13 20.02 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.198 0 CA-C-O 121.147 0.498 . . . . 0.0 110.489 179.886 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 244' ' ' GLN . . . . . 0.608 ' C ' HD12 ' A' ' 245' ' ' LEU . 88.3 mt-30 -110.68 110.62 21.36 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.375 179.765 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.608 HD12 ' C ' ' A' ' 244' ' ' GLN . 9.5 mp -122.19 -168.05 1.65 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.619 179.826 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 246' ' ' GLY . . . . . 0.527 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 172.98 -16.63 0.05 OUTLIER Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 179.901 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 247' ' ' GLY . . . . . 0.666 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -60.42 157.46 28.85 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 -179.819 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -64.21 21.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.955 0.407 . . . . 0.0 110.584 179.964 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 249' ' ' ASN . . . . . 0.666 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.8 m-20 -97.01 -5.84 36.74 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.548 179.932 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 92.5 mt -80.15 -21.18 43.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.643 179.464 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.52 -51.39 70.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.764 -179.555 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.83 -5.34 58.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.423 179.67 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.06 -74.43 1.14 Allowed Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 -179.863 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 80.1 mt -69.84 125.51 26.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.044 0.449 . . . . 0.0 110.253 -179.882 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -59.41 -39.53 83.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.29 -179.679 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 83.35 51.77 4.01 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 110.806 -0.917 . . . . 0.0 110.806 179.897 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -95.17 -16.08 22.83 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.79 0.329 . . . . 0.0 110.623 -179.883 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 258' ' ' SER . . . . . 0.492 ' OG ' HG23 ' A' ' 191' ' ' VAL . 3.4 t 174.92 89.29 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.014 0.435 . . . . 0.0 110.222 179.995 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.865 HD12 ' N ' ' A' ' 259' ' ' LEU . 0.9 OUTLIER -94.17 124.2 38.04 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.22 0.533 . . . . 0.0 111.052 -179.024 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 260' ' ' PHE . . . . . 0.444 ' H ' ' HA ' ' A' ' 193' ' ' ALA . 16.1 m-30 -93.55 146.98 23.4 Favored 'General case' 0 CA--C 1.51 -0.577 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.406 179.053 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 85.3 mt -122.46 150.02 43.08 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.537 -179.895 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.746 ' CD1' HG13 ' A' ' 195' ' ' VAL . 2.7 p90 -77.85 -138.86 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.533 -179.795 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 263' ' ' ALA . . . . . 0.662 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -51.44 78.17 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.942 -179.885 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 264' ' ' GLY . . . . . 0.631 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.88 104.57 0.19 Allowed Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 179.942 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 265' ' ' ASP . . . . . 0.601 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.8 m-20 -80.29 -177.23 6.03 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 120.692 0.282 . . . . 0.0 110.858 -179.432 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -40.7 -17.69 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.49 179.825 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 267' ' ' LYS . . . . . 0.601 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.5 -51.57 41.84 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.78 179.521 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -63.89 -46.62 84.09 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.282 179.312 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 269' ' ' ALA . . . . . 0.583 ' HB1' ' OH ' ' A' ' 273' ' ' TYR . . . -61.56 -35.1 76.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.976 179.424 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -62.89 -34.5 77.54 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.177 179.561 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.46 -43.36 13.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.223 -179.536 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 272' ' ' ILE . . . . . 0.588 ' C ' ' H ' ' A' ' 274' ' ' ALA . 5.0 tt -51.56 -33.65 15.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.704 -178.643 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 273' ' ' TYR . . . . . 0.583 ' OH ' ' HB1' ' A' ' 269' ' ' ALA . 16.9 m-85 -54.25 -1.82 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.71 -179.755 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 274' ' ' ALA . . . . . 0.588 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.75 -39.59 69.92 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.906 179.571 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 275' ' ' ASN . . . . . 0.586 ' O ' ' N ' ' A' ' 279' ' ' ALA . 3.7 p30 -39.17 97.94 0.15 Allowed Pre-proline 0 C--N 1.333 -0.15 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.576 -179.679 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo -53.97 -43.18 60.46 Favored 'Trans proline' 0 C--N 1.304 -1.814 0 C-N-CA 122.463 2.109 . . . . 0.0 112.614 -178.803 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 89.2 mt -64.5 -42.82 95.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.072 -179.563 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 91.0 mt -95.98 -1.11 49.69 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.814 -179.399 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 279' ' ' ALA . . . . . 0.586 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.49 -34.93 77.82 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.568 -179.721 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.33 20.28 0.12 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.965 -179.204 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 0.495 HD23 ' HA ' ' A' ' 281' ' ' LEU . 13.7 mt -75.16 120.03 79.72 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.43 179.859 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -50.9 -39.61 58.66 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.617 2.211 . . . . 0.0 111.781 179.172 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.75 -50.63 63.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.171 179.731 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 74.7 t -61.48 -43.99 97.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 179.487 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -57.68 -41.28 81.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.283 -179.983 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -90.68 0.21 57.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.221 179.593 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt 59.73 42.93 16.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.872 179.658 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -94.7 41.34 1.09 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.356 179.793 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 54.0 t -119.02 135.92 57.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.964 0.412 . . . . 0.0 110.237 -179.832 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -133.68 163.61 29.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.69 -179.57 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.86 155.52 32.48 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.944 0.402 . . . . 0.0 110.721 -179.735 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 80.7 mt -94.32 -1.66 53.5 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.311 -179.765 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.46 165.3 12.57 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 -179.653 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 6.8 m -86.8 -61.66 1.68 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.871 0.367 . . . . 0.0 111.066 -179.814 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 295' ' ' GLU . . . . . 0.455 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.5 mm-40 -69.55 -4.75 20.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.657 -179.704 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 25.6 p -76.14 32.82 0.12 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.617 -179.88 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 297' ' ' PHE . . . . . 0.522 ' CD2' HG22 ' A' ' 70' ' ' THR . 82.5 t80 -60.62 -46.12 91.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.662 -179.967 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 298' ' ' ARG . . . . . 0.613 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.2 mtt85 -80.76 137.11 36.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.679 -179.535 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.499 ' H ' HG11 ' A' ' 51' ' ' VAL . 4.2 tp -114.16 116.17 28.66 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.407 179.775 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 300' ' ' ASP . . . . . 0.627 ' H ' ' CB ' ' A' ' 303' ' ' SER . 48.3 p-10 -166.05 -176.17 3.65 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.497 -179.921 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 77.9 t80 -46.79 -43.44 18.33 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.226 -179.946 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -66.85 -40.81 88.04 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.991 0.424 . . . . 0.0 110.741 179.289 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 303' ' ' SER . . . . . 0.627 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 60.7 p -55.74 -36.22 67.03 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.068 -179.178 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 304' ' ' ALA . . . . . 0.579 ' HB2' ' SD ' ' A' ' 215' ' ' MET . . . -57.74 -51.61 68.83 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.085 179.385 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 91.1 mtp -55.96 -44.23 78.28 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.688 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -65.91 -43.27 88.66 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.869 0.366 . . . . 0.0 110.195 178.741 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 307' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 303' ' ' SER . 56.0 t -63.89 -43.03 97.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.249 179.463 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 43.8 tp -59.74 -42.12 92.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.938 -179.747 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -62.41 -39.24 92.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.07 179.767 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 310' ' ' ARG . . . . . 0.455 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.7 ttt85 -63.67 -43.84 95.52 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.32 179.487 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 89.5 mt -63.31 -42.04 98.99 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.325 179.563 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -62.97 -33.68 75.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.138 179.341 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.68 -23.47 21.85 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.388 -179.777 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.483 HD22 ' CE2' ' A' ' 315' ' ' PHE . 6.8 tt -62.28 -43.11 99.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.574 -179.971 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 315' ' ' PHE . . . . . 0.483 ' CE2' HD22 ' A' ' 314' ' ' LEU . 90.3 m-85 . . . . . 0 C--O 1.22 -0.478 0 CA-C-O 118.028 -0.987 . . . . 0.0 110.483 179.939 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -99.35 135.88 40.11 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.563 179.993 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.499 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -92.28 178.52 1.66 Allowed Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.572 -179.884 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.499 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 27.0 Cg_exo -61.63 147.34 95.59 Favored 'Trans proline' 0 C--N 1.301 -1.97 0 C-N-CA 122.777 2.318 . . . . 0.0 112.09 179.709 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.456 HH12 HG23 ' A' ' 159' ' ' ILE . 35.2 ptt180 -135.65 142.38 45.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.691 179.742 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -79.88 116.29 19.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.524 179.923 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.45 ' O ' HG23 ' A' ' 30' ' ' ILE . 9.4 tp -110.77 130.45 64.13 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.427 179.979 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.2 t -70.85 141.97 51.24 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.571 179.811 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.476 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.3 t0 -139.7 179.48 6.55 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.516 -179.913 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.476 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 78.5 p -73.67 -37.0 65.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.842 179.706 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.8 ttt85 -46.56 -94.66 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.354 -179.534 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.417 ' O ' ' OG1' ' A' ' 36' ' ' THR . . . -167.29 -26.55 0.02 OUTLIER Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 179.89 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.417 ' OG1' ' O ' ' A' ' 35' ' ' GLY . 64.8 m -168.76 104.37 0.42 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.908 0.385 . . . . 0.0 110.65 -179.826 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.675 ' CD2' HD13 ' A' ' 140' ' ' LEU . 73.9 t60 -128.41 147.93 50.68 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.031 0.443 . . . . 0.0 110.293 179.95 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.623 HG22 ' N ' ' A' ' 39' ' ' LEU . 98.5 m -130.48 165.93 21.61 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.66 -179.894 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.623 ' N ' HG22 ' A' ' 38' ' ' THR . 83.1 mt -120.51 127.75 52.48 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.513 179.729 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -65.33 -44.63 87.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.626 -179.901 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 42.2 p -165.77 154.77 11.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.466 179.652 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.532 ' CD ' ' H ' ' A' ' 42' ' ' GLN . 14.7 mp0 -44.32 101.31 0.25 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.644 179.495 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -57.36 129.22 32.89 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 122.378 2.052 . . . . 0.0 112.178 -179.716 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -83.61 -24.68 31.36 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.495 179.654 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.54 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.1 mtm-85 -122.02 134.98 54.8 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-O 121.133 0.492 . . . . 0.0 110.345 -179.922 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 95.9 mt -131.19 133.82 62.02 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.272 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.96 -179.711 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 45.7 t -124.38 130.38 73.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.325 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.626 ' OG ' HD12 ' A' ' 117' ' ' LEU . 2.3 m -154.94 166.64 32.93 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.548 179.865 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 67.7 p -124.59 9.31 8.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.515 179.904 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.45 125.53 33.09 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.665 -179.512 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.443 HG11 ' H ' ' A' ' 299' ' ' LEU . 98.4 t -65.86 -44.46 92.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.479 -179.982 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.5 m -62.68 -44.35 96.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.642 -179.839 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 51.1 tp -62.16 -41.6 98.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.555 -179.455 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.443 ' O ' HD13 ' A' ' 58' ' ' LEU . 76.3 m -57.6 -44.34 85.37 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.308 -179.322 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.22 -62.18 5.38 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 179.547 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.7 t -48.44 -35.65 13.32 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 -179.99 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.8 mt -61.77 -44.91 95.96 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.636 -0.426 . . . . 0.0 111.174 179.448 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.443 HD13 ' O ' ' A' ' 54' ' ' THR . 9.3 mp -64.68 -41.82 95.79 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.091 0.472 . . . . 0.0 111.382 177.86 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.404 ' HB1' ' NE ' ' A' ' 169' ' ' ARG . . . -63.6 -40.95 98.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.652 -0.703 . . . . 0.0 111.014 -179.206 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.439 ' O ' HG23 ' A' ' 60' ' ' ILE . 8.1 tp -88.6 17.18 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.724 -179.602 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 56.32 84.95 0.08 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.694 -179.977 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.24 58.99 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.081 -179.8 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -50.75 151.6 10.72 Favored 'Trans proline' 0 C--N 1.297 -2.155 0 C-N-CA 122.799 2.333 . . . . 0.0 112.579 -178.359 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.434 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -108.46 145.64 15.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.391 -179.764 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.8 mt -63.89 -44.91 98.16 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.298 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.416 -179.721 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.499 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -130.18 134.41 47.27 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.574 -179.806 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.479 ' O ' ' N ' ' A' ' 98' ' ' LEU . 72.9 m -134.67 158.82 43.09 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.83 -179.589 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.32 138.5 15.94 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 110.726 -0.949 . . . . 0.0 110.726 179.816 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.478 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.46 -163.0 0.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.96 0.41 . . . . 0.0 110.508 -179.988 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.523 HG22 ' CD2' ' A' ' 297' ' ' PHE . 5.9 t -133.75 135.39 43.91 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.242 -179.977 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.494 ' C ' ' O ' ' A' ' 70' ' ' THR . 0.9 OUTLIER 29.61 68.35 0.67 Allowed Pre-proline 0 N--CA 1.464 0.236 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.745 -179.663 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -60.98 144.59 99.61 Favored 'Trans proline' 0 C--N 1.301 -1.958 0 C-N-CA 122.548 2.165 . . . . 0.0 112.252 -178.573 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.528 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 45.4 p-10 -159.68 -31.7 0.06 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.634 179.624 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.539 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 99.1 m-20 -64.15 -39.44 94.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.415 179.998 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -60.43 -48.2 82.8 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.644 -179.242 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.425 ' O ' ' O ' ' A' ' 77' ' ' ALA . 97.0 t -60.15 -24.7 31.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.154 179.596 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.539 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -45.72 173.15 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.588 179.853 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.574 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.3 p30 -62.06 177.56 0.45 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.583 -179.689 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.556 ' C ' ' H ' ' A' ' 81' ' ' GLY . 36.2 p30 -45.46 85.86 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.942 179.99 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.574 ' N ' ' O ' ' A' ' 78' ' ' ASP . 43.0 tp60 -67.65 13.23 0.08 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.08 -179.838 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.556 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 118.52 -21.89 9.66 Favored Glycine 0 CA--C 1.519 0.321 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.985 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -108.4 116.46 32.02 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.941 0.4 . . . . 0.0 110.522 179.894 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 75.6 mt -98.79 0.49 44.5 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.451 -179.726 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -92.65 7.18 44.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.988 0.423 . . . . 0.0 110.46 -179.778 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.798 ' O ' HG22 ' A' ' 89' ' ' VAL . 27.3 mt-30 -100.03 -27.91 13.33 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.855 -179.971 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 69.3 t-105 -63.19 -40.71 98.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.877 -179.544 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.56 ' O ' ' N ' ' A' ' 91' ' ' LYS . 65.7 m -77.65 -53.68 7.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.203 -179.394 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -48.19 -50.86 27.59 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.939 -179.363 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.798 HG22 ' O ' ' A' ' 85' ' ' GLN . 15.7 m -68.89 -40.75 81.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 120.936 0.398 . . . . 0.0 111.034 179.836 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.499 ' N ' HG23 ' A' ' 89' ' ' VAL . . . -72.46 -22.65 61.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.83 -179.869 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.56 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.1 tttm -61.91 -45.41 93.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.477 -179.578 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.441 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.7 mm-40 -90.69 -94.88 0.12 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.118 -179.869 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.644 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.8 mtt180 -142.9 59.31 1.42 Allowed 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.716 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.466 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.8 pttp 33.33 25.97 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.162 -179.098 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.644 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.3 tt -47.78 123.54 6.13 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.918 -178.287 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.451 ' O ' HD23 ' A' ' 95' ' ' LEU . 99.1 mm-40 -83.8 -169.89 2.8 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.075 -179.913 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.612 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 82.4 mtp180 -74.1 137.17 43.12 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.197 -179.805 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.479 ' N ' ' O ' ' A' ' 67' ' ' SER . 90.4 mt -86.46 -165.74 1.35 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.704 -179.618 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.536 ' O ' ' CD2' ' A' ' 99' ' ' TYR . 48.6 p90 -168.87 120.14 0.75 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.297 179.972 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.518 ' C ' ' O ' ' A' ' 99' ' ' TYR . 43.3 mm -29.18 121.27 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.995 -179.563 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 114.38 27.06 3.49 Favored Glycine 0 CA--C 1.52 0.344 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 -179.575 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.587 ' CD ' ' H ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -144.27 46.2 0.61 Allowed Pre-proline 0 C--N 1.324 -0.508 0 CA-C-O 120.913 0.387 . . . . 0.0 110.511 179.946 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 29.8 Cg_endo -61.8 143.63 96.2 Favored 'Trans proline' 0 C--N 1.297 -2.146 0 C-N-CA 122.695 2.263 . . . . 0.0 111.989 -179.937 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.458 ' O ' HG23 ' A' ' 108' ' ' VAL . 26.2 t -173.19 119.97 0.34 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.489 179.698 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.19 -40.56 64.68 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.068 0.461 . . . . 0.0 111.1 179.76 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.19 -40.02 90.12 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.819 -179.368 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.02 -39.95 95.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.713 -179.768 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 104' ' ' SER . 72.0 t -67.74 -43.97 86.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.839 179.709 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.77 -38.98 92.73 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.552 -179.31 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.441 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.47 -23.3 62.61 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.434 179.867 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.554 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.5 mm-40 -90.51 5.12 49.06 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.651 -179.518 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.554 ' C ' ' O ' ' A' ' 111' ' ' GLN . 10.4 tpt 24.03 63.73 0.4 Allowed Pre-proline 0 N--CA 1.464 0.266 0 CA-C-O 120.861 0.362 . . . . 0.0 110.866 -179.967 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -77.92 167.36 23.8 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 C-N-CA 122.998 2.465 . . . . 0.0 112.392 -178.739 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.525 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 99.4 m-20 -110.49 -42.38 4.11 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.982 0.42 . . . . 0.0 110.042 179.55 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 39.8 tp -120.98 120.14 34.59 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.036 179.54 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 84.7 mt -113.21 129.19 69.38 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 CA-C-O 120.978 0.418 . . . . 0.0 110.848 -179.832 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.626 HD12 ' OG ' ' A' ' 48' ' ' SER . 29.2 mt -108.95 132.26 54.25 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.235 -179.71 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.497 HD12 HG23 ' A' ' 139' ' ' THR . 98.8 mt -119.59 138.77 49.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.712 -179.766 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 85.8 p -72.65 153.45 41.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.565 -179.998 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.21 -49.98 75.46 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.682 -179.769 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -149.55 154.07 38.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.6 179.811 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 170.36 -170.86 43.29 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 179.838 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.99 -34.17 89.24 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 179.949 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.453 ' OD1' ' O ' ' A' ' 124' ' ' ASP . 44.2 p-10 -87.33 120.27 28.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.833 0.349 . . . . 0.0 110.626 -179.942 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.435 ' O ' HD12 ' A' ' 129' ' ' LEU . 40.0 t -63.22 143.74 57.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.538 -179.976 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.521 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.23 -43.18 8.95 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.819 -179.778 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.2 tp -62.7 -42.55 99.7 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.718 -179.912 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.26 -12.23 59.56 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.574 -179.459 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.435 HD12 ' O ' ' A' ' 125' ' ' SER . 84.1 mt -114.91 -23.51 9.08 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.721 -179.797 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 130' ' ' TYR . . . . . 0.521 ' N ' ' O ' ' A' ' 126' ' ' ALA . 78.0 t80 -51.12 -49.67 60.31 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 120.586 -0.446 . . . . 0.0 110.476 -178.929 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.1 p-10 -65.81 -42.52 90.55 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.905 0.383 . . . . 0.0 111.138 179.599 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.523 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 88.2 mt-30 -67.13 -37.84 84.53 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.832 179.97 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.431 HD12 HD11 ' A' ' 118' ' ' ILE . 95.9 mt -80.39 -41.32 24.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.881 -179.505 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.2 t -57.26 -44.53 83.98 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.243 -179.236 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 18.8 m -61.77 -45.36 94.22 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.8 0.333 . . . . 0.0 110.597 179.326 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 93.0 mt -62.11 -43.55 97.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.226 -179.784 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.658 ' HB1' ' HD2' ' A' ' 138' ' ' PRO . . . -169.63 168.31 4.77 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.559 179.867 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.658 ' HD2' ' HB1' ' A' ' 137' ' ' ALA . 51.4 Cg_exo -49.94 113.25 0.92 Allowed 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.286 1.991 . . . . 0.0 112.092 179.507 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.497 HG23 HD12 ' A' ' 118' ' ' ILE . 23.8 m -84.15 127.22 33.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.594 -179.954 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.675 HD13 ' CD2' ' A' ' 37' ' ' HIS . 34.4 tp -117.66 135.23 54.14 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.988 -179.77 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.439 ' O ' ' OD2' ' A' ' 32' ' ' ASP . 81.5 mt -99.54 118.95 46.91 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 CA-C-O 121.175 0.512 . . . . 0.0 111.276 -179.336 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.438 HD12 HD22 ' A' ' 117' ' ' LEU . 98.1 mt -135.02 132.05 53.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.64 179.627 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.542 HD21 ' CG ' ' A' ' 241' ' ' ASP . 60.2 t30 -66.63 150.26 49.3 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.842 0.353 . . . . 0.0 110.428 179.4 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.517 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 87.7 t80 -85.01 122.39 29.16 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.859 -179.499 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.517 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 98.7 m-20 55.25 69.21 0.76 Allowed 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.856 179.748 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 34.9 p-10 -125.82 0.56 7.38 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.926 0.393 . . . . 0.0 110.753 179.857 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -150.85 115.73 5.26 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.699 -179.522 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 83.9 p -64.39 169.15 4.95 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.528 -179.842 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.423 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.4 p-90 -52.21 -16.12 0.75 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.559 -179.863 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.435 ' O ' HG23 ' A' ' 154' ' ' THR . 68.2 tp60 -70.07 -77.01 0.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.425 -179.712 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.453 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.1 t -62.57 -38.26 89.39 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.369 179.568 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 53.2 tp -60.06 -45.53 92.55 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.373 -178.566 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.423 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 46.8 tp -62.85 -41.74 99.48 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.821 0.343 . . . . 0.0 110.321 179.086 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.453 ' OG1' ' O ' ' A' ' 151' ' ' SER . 63.5 p -64.07 -34.75 78.74 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.285 -179.611 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.432 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.8 mm-40 -63.97 -42.77 97.14 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.316 179.235 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 92.7 mt -65.39 -39.02 91.72 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.016 0.436 . . . . 0.0 110.255 179.099 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.587 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -60.93 -32.08 78.58 Favored Glycine 0 CA--C 1.52 0.404 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 -179.468 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.439 ' C ' ' O ' ' A' ' 157' ' ' GLY . 97.2 mt-10 -35.71 -26.42 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.815 0.341 . . . . 0.0 110.744 179.93 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.587 ' N ' ' O ' ' A' ' 157' ' ' GLY . 95.7 mt -57.02 149.32 4.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.251 179.313 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 72.6 p -69.61 137.27 52.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.979 -179.535 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 71.77 20.45 78.68 Favored Glycine 0 N--CA 1.458 0.156 0 N-CA-C 111.243 -0.743 . . . . 0.0 111.243 179.457 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 56.8 m80 -122.3 -14.66 7.85 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.785 0.326 . . . . 0.0 110.64 179.816 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -65.22 -60.31 3.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.723 -179.684 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -51.85 -49.14 63.47 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.246 -179.771 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -60.66 -41.08 94.29 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.704 0.288 . . . . 0.0 110.284 179.542 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.55 -47.02 87.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.637 179.828 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -57.24 -40.03 76.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.251 -179.983 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -61.85 -50.31 72.77 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.562 179.621 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.404 ' NE ' ' HB1' ' A' ' 59' ' ' ALA . 59.9 ttt85 -65.36 -43.84 89.57 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.511 179.551 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 95.1 mt -64.65 -43.47 96.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.473 179.736 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.23 -50.92 71.35 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.627 -179.261 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.47 -43.72 96.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.363 179.747 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.659 ' CE2' HD11 ' A' ' 177' ' ' LEU . 56.1 t80 -62.7 -44.64 95.71 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.123 0.487 . . . . 0.0 110.443 179.4 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -63.33 -40.08 96.31 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.522 -179.312 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -62.95 -42.73 99.9 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.704 179.259 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -60.77 -44.85 96.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.071 179.946 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.659 HD11 ' CE2' ' A' ' 173' ' ' PHE . 84.8 mt -64.3 -41.13 97.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.033 0.444 . . . . 0.0 110.661 178.917 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -51.88 -62.51 1.58 Allowed 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.478 -179.335 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.52 -46.86 85.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.58 179.819 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.26 -41.71 65.77 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.245 -179.993 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -63.8 -33.59 76.01 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.946 0.403 . . . . 0.0 110.364 179.27 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.425 ' O ' ' HG2' ' A' ' 182' ' ' GLU . 69.6 tt0 -90.51 8.49 33.7 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.317 0.58 . . . . 0.0 110.586 -179.091 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -104.5 -32.33 9.04 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.257 179.597 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.3 pt -128.01 147.6 32.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.843 -179.878 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -139.76 130.99 26.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.347 179.506 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.598 HD22 ' N ' ' A' ' 186' ' ' LEU . 3.6 mm? -85.49 133.37 42.32 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.793 179.992 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -44.05 157.9 0.14 Allowed 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.735 2.29 . . . . 0.0 112.042 179.527 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 0.535 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.7 Cg_endo -62.96 114.87 2.62 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 122.748 2.299 . . . . 0.0 111.76 179.817 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 189' ' ' GLN . . . . . 0.535 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.8 mt-30 155.28 148.17 0.0 OUTLIER Pre-proline 0 C--N 1.331 -0.199 0 O-C-N 123.383 0.427 . . . . 0.0 110.665 -179.784 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -73.94 144.5 34.49 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 122.725 2.283 . . . . 0.0 111.734 178.126 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.498 HG23 ' OG ' ' A' ' 258' ' ' SER . 2.1 p -125.29 158.94 33.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.198 0.523 . . . . 0.0 110.12 -179.974 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 192' ' ' THR . . . . . 0.497 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 35.4 p -143.61 165.58 27.22 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.129 -179.609 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 193' ' ' ALA . . . . . 0.444 ' HA ' ' H ' ' A' ' 260' ' ' PHE . . . -135.76 128.66 31.28 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.151 0.501 . . . . 0.0 110.273 179.69 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.498 HD11 HD23 ' A' ' 259' ' ' LEU . 47.3 pt -146.3 148.76 16.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.021 179.899 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 195' ' ' VAL . . . . . 0.743 HG13 ' CD1' ' A' ' 262' ' ' PHE . 70.3 t -117.49 122.88 70.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.245 0.545 . . . . 0.0 109.692 179.112 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -134.21 107.32 7.62 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.292 179.699 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 95.2 m -131.08 130.56 43.35 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.818 179.833 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -83.09 -36.87 24.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.228 179.71 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.6 -66.95 0.27 Allowed 'General case' 0 C--O 1.231 0.129 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.402 179.997 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.42 -9.76 58.93 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.246 179.494 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 60.0 t-80 60.7 58.46 2.41 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.799 -179.844 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 40.6 p -167.16 153.25 7.96 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.505 179.55 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.26 143.92 24.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.997 0.427 . . . . 0.0 110.452 179.458 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -135.38 138.83 43.69 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.655 179.952 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 20.3 mt -106.69 125.54 51.13 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 121.134 0.492 . . . . 0.0 109.795 -179.687 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 206' ' ' TRP . . . . . 0.556 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 74.9 m95 -81.93 166.95 19.43 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.575 -179.72 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 207' ' ' THR . . . . . 0.473 HG22 ' C ' ' A' ' 206' ' ' TRP . 0.1 OUTLIER -156.94 171.62 7.2 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 120.997 0.427 . . . . 0.0 110.525 -179.223 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.06 -36.99 86.54 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 C-N-CA 122.639 2.226 . . . . 0.0 111.959 179.473 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -70.43 -35.16 73.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.906 -179.893 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 21.4 m -60.94 150.92 31.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.614 -179.296 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.58 -37.12 82.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.529 -179.751 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 212' ' ' GLN . . . . . 0.556 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 55.0 tt0 -64.56 -40.36 95.42 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.519 179.977 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.52 -43.32 92.58 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 179.804 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -63.45 -43.93 95.97 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.707 0.289 . . . . 0.0 110.276 179.883 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 215' ' ' MET . . . . . 0.525 ' SD ' ' HB2' ' A' ' 304' ' ' ALA . 65.4 ttp -59.49 -48.1 82.95 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.322 -179.805 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 216' ' ' LEU . 87.7 mt -60.38 -40.6 91.42 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 179.416 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 217' ' ' GLU . . . . . 0.462 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.9 tp10 -58.34 -37.98 76.25 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.739 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -65.14 -38.28 90.11 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.813 0.34 . . . . 0.0 110.709 179.702 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 93.9 mt -64.36 -42.65 96.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.584 -179.62 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.56 45.1 0.08 OUTLIER Glycine 0 C--N 1.333 0.379 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 -179.937 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 221' ' ' PHE . . . . . 0.462 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 27.0 m-85 -128.08 155.18 44.79 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.052 0.454 . . . . 0.0 110.487 -179.807 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.485 ' O ' HG13 ' A' ' 191' ' ' VAL . 6.4 p -106.92 122.28 46.11 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.179 0.514 . . . . 0.0 110.261 -179.987 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.473 HD22 ' C ' ' A' ' 222' ' ' THR . 4.3 mm? -101.22 133.0 46.45 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.077 -179.957 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.85 159.55 14.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.509 179.886 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.38 114.99 29.5 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.333 179.88 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.495 HD12 ' N ' ' A' ' 226' ' ' LEU . 9.1 mp -53.13 156.94 3.33 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.626 179.935 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -60.46 145.36 98.87 Favored 'Trans proline' 0 C--N 1.302 -1.903 0 C-N-CA 122.601 2.201 . . . . 0.0 112.004 179.485 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.3 -3.27 59.03 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.556 -179.989 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.01 -41.16 5.66 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 -179.885 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.536 ' O ' ' N ' ' A' ' 233' ' ' SER . 85.5 mt -79.08 -17.19 55.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.983 0.42 . . . . 0.0 110.364 -179.738 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 231' ' ' ASN . . . . . 0.404 ' C ' ' O ' ' A' ' 230' ' ' LEU . 54.8 t-20 -40.11 -49.41 2.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.757 -179.694 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -87.82 15.32 7.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.768 0.318 . . . . 0.0 111.186 -179.967 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.536 ' N ' ' O ' ' A' ' 230' ' ' LEU . 78.1 p -60.4 -35.74 76.45 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.535 -179.811 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 234' ' ' GLN . . . . . 0.525 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.6 tt0 -118.74 -69.19 0.86 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.917 179.642 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.3 m -69.73 103.11 2.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.633 -179.785 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -94.29 57.5 2.33 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.391 179.909 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -144.82 -122.42 1.56 Allowed Glycine 0 CA--C 1.521 0.43 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 -179.987 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -135.17 111.8 9.98 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 121.115 0.483 . . . . 0.0 110.468 179.983 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 239' ' ' ARG . . . . . 0.523 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.5 mtt180 -148.15 57.74 1.08 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.738 -179.894 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -69.64 -32.21 70.75 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.548 179.625 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 241' ' ' ASP . . . . . 0.542 ' CG ' HD21 ' A' ' 143' ' ' ASN . 65.1 t0 -56.94 -46.94 81.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.396 -179.159 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 242' ' ' ILE . . . . . 0.437 ' O ' ' O ' ' A' ' 239' ' ' ARG . 17.8 tt -139.84 156.43 25.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.893 0.378 . . . . 0.0 110.518 179.746 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.439 HG22 HD13 ' A' ' 245' ' ' LEU . 96.2 mt -106.24 106.34 20.4 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.188 0 CA-C-O 121.108 0.48 . . . . 0.0 110.511 179.863 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 244' ' ' GLN . . . . . 0.609 ' O ' HD12 ' A' ' 245' ' ' LEU . 88.2 mt-30 -110.25 110.06 20.74 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.261 179.76 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.609 HD12 ' O ' ' A' ' 244' ' ' GLN . 9.4 mp -121.96 -168.45 1.71 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.663 179.839 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 246' ' ' GLY . . . . . 0.525 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.54 -16.66 0.05 OUTLIER Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.911 -0.875 . . . . 0.0 110.911 179.945 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 247' ' ' GLY . . . . . 0.672 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -60.62 156.83 30.79 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -179.888 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -63.72 21.73 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.936 0.398 . . . . 0.0 110.655 179.924 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 249' ' ' ASN . . . . . 0.672 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.8 m-20 -97.34 -5.94 35.39 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.572 179.943 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 93.5 mt -79.85 -21.82 43.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.619 179.575 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.54 -51.27 70.59 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.864 -179.57 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.4 -5.54 58.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.394 179.642 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -80.93 -74.53 1.13 Allowed Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 -179.911 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 81.5 mt -69.79 125.4 26.62 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.025 0.44 . . . . 0.0 110.178 -179.816 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -59.49 -39.48 83.91 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.389 -179.739 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 84.45 51.71 3.8 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -179.938 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -94.62 -16.51 23.12 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.738 0.304 . . . . 0.0 110.597 -179.862 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 258' ' ' SER . . . . . 0.498 ' OG ' HG23 ' A' ' 191' ' ' VAL . 3.3 t 174.17 89.83 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.045 0.45 . . . . 0.0 110.119 -179.971 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.866 HD12 ' N ' ' A' ' 259' ' ' LEU . 1.0 OUTLIER -94.46 124.03 38.24 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.224 0.535 . . . . 0.0 111.088 -179.099 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 260' ' ' PHE . . . . . 0.444 ' H ' ' HA ' ' A' ' 193' ' ' ALA . 16.0 m-30 -93.18 146.85 23.37 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.332 179.166 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 86.7 mt -122.57 149.87 43.36 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.512 -179.9 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.743 ' CD1' HG13 ' A' ' 195' ' ' VAL . 2.6 p90 -77.94 -138.48 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.526 -179.813 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 263' ' ' ALA . . . . . 0.661 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -51.89 77.49 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.92 -179.942 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 264' ' ' GLY . . . . . 0.637 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.13 104.42 0.19 Allowed Glycine 0 N--CA 1.467 0.721 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 -179.986 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 265' ' ' ASP . . . . . 0.604 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.6 m-20 -80.43 -177.54 6.24 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.713 0.292 . . . . 0.0 110.91 -179.497 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -40.64 -17.56 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.852 0.358 . . . . 0.0 110.493 179.866 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 267' ' ' LYS . . . . . 0.604 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.64 -51.51 41.39 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.637 179.576 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -63.88 -46.71 83.69 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.076 179.525 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 269' ' ' ALA . . . . . 0.568 ' HB1' ' OH ' ' A' ' 273' ' ' TYR . . . -61.54 -35.12 76.85 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.839 179.552 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -62.98 -34.59 77.86 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.126 179.653 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.36 -43.3 13.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.336 -179.588 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 272' ' ' ILE . . . . . 0.584 ' C ' ' H ' ' A' ' 274' ' ' ALA . 4.9 tt -51.42 -33.63 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.826 -178.872 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 273' ' ' TYR . . . . . 0.568 ' OH ' ' HB1' ' A' ' 269' ' ' ALA . 17.4 m-85 -54.37 -1.7 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.677 -179.7 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 274' ' ' ALA . . . . . 0.584 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -72.13 -39.71 68.62 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.906 179.63 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 275' ' ' ASN . . . . . 0.588 ' O ' ' N ' ' A' ' 279' ' ' ALA . 3.9 p30 -39.36 97.78 0.15 Allowed Pre-proline 0 N--CA 1.462 0.156 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.54 -179.653 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 276' ' ' PRO . . . . . 0.402 ' N ' ' O ' ' A' ' 274' ' ' ALA . 45.5 Cg_exo -53.97 -43.31 59.36 Favored 'Trans proline' 0 C--N 1.303 -1.848 0 C-N-CA 122.363 2.042 . . . . 0.0 112.737 -178.857 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 89.4 mt -64.37 -42.83 95.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.206 -179.674 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 90.8 mt -95.94 -1.31 49.43 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.842 -179.361 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 279' ' ' ALA . . . . . 0.588 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.42 -34.89 77.66 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.604 -179.69 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -73.99 19.55 0.12 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.078 -179.224 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 0.491 HD23 ' HA ' ' A' ' 281' ' ' LEU . 14.0 mt -74.95 121.0 84.31 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.355 179.873 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_exo -51.24 -39.44 62.12 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 122.573 2.182 . . . . 0.0 111.657 179.289 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.57 -50.65 62.53 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 179.748 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 81.8 t -61.84 -43.91 98.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 179.507 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -57.57 -41.86 81.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.418 -179.871 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -90.47 1.06 57.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.215 179.572 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt 58.39 40.42 24.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.036 0.446 . . . . 0.0 110.903 179.681 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -92.36 42.41 1.1 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.37 179.781 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 54.4 t -119.16 135.79 58.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.023 0.44 . . . . 0.0 110.182 -179.724 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -132.93 162.97 30.23 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.031 0.443 . . . . 0.0 110.697 -179.663 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.92 155.02 33.57 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.968 0.413 . . . . 0.0 110.774 -179.85 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 80.9 mt -93.69 -1.39 55.26 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.278 -179.782 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.17 165.38 12.64 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 -179.725 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 6.8 m -87.13 -62.32 1.53 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.866 0.365 . . . . 0.0 111.008 -179.802 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 295' ' ' GLU . . . . . 0.444 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.6 mm-40 -69.53 -4.2 17.97 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.544 -179.738 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 29.1 p -76.66 32.51 0.13 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.662 -179.877 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 297' ' ' PHE . . . . . 0.523 ' CD2' HG22 ' A' ' 70' ' ' THR . 70.4 t80 -60.18 -46.05 91.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.565 -179.905 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 298' ' ' ARG . . . . . 0.612 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.1 mtt85 -81.09 133.45 35.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.073 0.463 . . . . 0.0 110.433 -179.712 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.443 ' H ' HG11 ' A' ' 51' ' ' VAL . 16.3 tp -114.19 119.4 36.95 Favored 'General case' 0 CA--C 1.527 0.089 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.205 -179.97 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 300' ' ' ASP . . . . . 0.626 ' H ' ' CB ' ' A' ' 303' ' ' SER . 49.9 p-10 -167.29 -174.21 2.51 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.508 -179.968 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -48.34 -45.46 35.33 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.127 -179.591 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -65.0 -41.62 95.23 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.004 0.43 . . . . 0.0 110.724 178.969 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 303' ' ' SER . . . . . 0.626 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 52.7 p -55.15 -36.04 65.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.182 -179.5 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 304' ' ' ALA . . . . . 0.525 ' HB2' ' SD ' ' A' ' 215' ' ' MET . . . -57.13 -51.49 69.08 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 110.016 -0.365 . . . . 0.0 110.016 179.459 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 90.8 mtp -56.37 -43.82 79.56 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.689 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -66.57 -42.65 86.7 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.867 0.365 . . . . 0.0 110.18 178.778 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 307' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 303' ' ' SER . 56.0 t -64.06 -42.89 97.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.192 179.401 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 43.4 tp -59.55 -42.17 91.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.827 -179.593 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -62.73 -39.0 92.71 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 179.61 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 310' ' ' ARG . . . . . 0.44 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.6 ttt85 -63.54 -44.01 95.45 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.3 179.515 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 87.9 mt -63.36 -42.0 98.87 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.188 179.56 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -62.81 -33.18 74.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.106 179.454 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -90.19 -23.13 21.38 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.564 -179.908 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.478 HD22 ' CE2' ' A' ' 315' ' ' PHE . 6.7 tt -62.43 -43.23 99.31 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.063 0.459 . . . . 0.0 110.589 -179.902 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 315' ' ' PHE . . . . . 0.478 ' CE2' HD22 ' A' ' 314' ' ' LEU . 91.3 m-85 . . . . . 0 C--O 1.22 -0.462 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.508 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -99.7 135.54 40.96 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.1 0.476 . . . . 0.0 110.406 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.48 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -92.51 178.71 1.56 Allowed Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.403 -179.686 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.48 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 27.0 Cg_exo -61.66 147.44 95.34 Favored 'Trans proline' 0 C--N 1.303 -1.833 0 C-N-CA 122.909 2.406 . . . . 0.0 112.214 179.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.492 ' HE ' HD12 ' A' ' 39' ' ' LEU . 35.2 ptt180 -136.32 142.61 43.88 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.571 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -79.94 116.77 20.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.509 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.443 ' O ' HG23 ' A' ' 30' ' ' ILE . 9.4 tp -111.45 130.53 64.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.487 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.1 t -71.24 142.5 50.56 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.607 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.478 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.4 t0 -139.45 -179.96 6.2 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.504 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.478 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 78.1 p -73.88 -37.23 64.79 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.683 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -46.69 -94.72 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.304 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -166.53 -26.75 0.02 OUTLIER Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 62.4 m -168.63 105.64 0.44 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.707 0.289 . . . . 0.0 110.531 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.656 ' CD2' HD13 ' A' ' 140' ' ' LEU . 70.0 t60 -129.01 146.63 50.93 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.224 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.619 HG22 ' N ' ' A' ' 39' ' ' LEU . 98.8 m -129.96 165.57 21.83 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.377 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.619 ' N ' HG22 ' A' ' 38' ' ' THR . 77.9 mt -120.2 127.28 52.3 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.654 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -65.42 -44.91 85.91 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.592 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 37.5 p -165.78 154.95 11.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.55 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.499 ' H ' ' CD ' ' A' ' 42' ' ' GLN . 14.7 mp0 -44.51 101.02 0.24 Allowed Pre-proline 0 C--O 1.235 0.302 0 O-C-N 123.564 0.54 . . . . 0.0 110.467 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -57.61 130.07 36.94 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.449 2.099 . . . . 0.0 112.111 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -82.95 -24.76 32.86 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.573 179.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.537 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.9 mtm-85 -121.23 134.33 55.19 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.995 0.426 . . . . 0.0 110.287 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.3 mt -130.22 133.26 64.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.515 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 46.2 t -124.73 131.04 73.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-O 121.002 0.429 . . . . 0.0 110.163 178.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.611 ' OG ' HD12 ' A' ' 117' ' ' LEU . 4.2 m -154.67 166.42 33.45 Favored 'General case' 0 C--O 1.224 -0.241 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.461 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 72.6 p -124.41 9.11 8.45 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.483 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.1 t -85.65 125.68 33.34 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.942 0.401 . . . . 0.0 110.577 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.462 HG11 ' H ' ' A' ' 299' ' ' LEU . 90.1 t -65.66 -44.52 93.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.546 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.0 m -62.51 -44.45 96.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.686 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 54.7 tp -62.35 -41.52 98.66 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.65 -179.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.447 ' O ' HD13 ' A' ' 58' ' ' LEU . 70.5 m -57.88 -44.61 86.8 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.219 -179.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.39 -62.05 5.45 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.5 t -47.55 -35.94 9.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.79 0.328 . . . . 0.0 110.144 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.7 mt -61.87 -44.64 96.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.909 0.385 . . . . 0.0 110.976 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.447 HD13 ' O ' ' A' ' 54' ' ' THR . 9.0 mp -65.17 -41.32 94.74 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.292 178.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.415 ' HB1' ' NE ' ' A' ' 169' ' ' ARG . . . -63.78 -41.19 97.99 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.631 -179.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.415 ' O ' HG23 ' A' ' 60' ' ' ILE . 7.9 tp -88.06 16.62 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.673 -179.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 56.33 84.09 0.09 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.795 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.21 57.11 0.06 OUTLIER Pre-proline 0 C--N 1.327 -0.371 0 CA-C-O 121.018 0.437 . . . . 0.0 109.907 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.417 ' HB3' HE21 ' A' ' 85' ' ' GLN . 9.7 Cg_endo -50.17 153.72 6.45 Favored 'Trans proline' 0 C--N 1.298 -2.096 0 C-N-CA 122.972 2.448 . . . . 0.0 112.492 -178.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.425 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -109.15 146.12 15.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.238 -179.728 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 97.0 mt -63.78 -45.08 98.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.116 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.503 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -130.32 134.21 47.02 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.775 0.321 . . . . 0.0 110.266 -179.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.494 ' O ' ' N ' ' A' ' 98' ' ' LEU . 72.9 m -134.47 158.71 43.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.805 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.71 139.35 16.37 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.716 -0.954 . . . . 0.0 110.716 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.488 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.78 -162.67 0.08 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.798 0.333 . . . . 0.0 110.384 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.505 HG22 ' CD2' ' A' ' 297' ' ' PHE . 5.9 t -133.97 135.36 43.43 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.096 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.467 ' C ' ' O ' ' A' ' 70' ' ' THR . 0.8 OUTLIER 29.47 68.71 0.64 Allowed Pre-proline 0 N--CA 1.468 0.475 0 CA-C-O 121.216 0.532 . . . . 0.0 110.84 -179.48 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -60.86 144.79 99.63 Favored 'Trans proline' 0 C--N 1.302 -1.911 0 C-N-CA 122.776 2.317 . . . . 0.0 112.064 -178.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.528 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 46.3 p-10 -159.79 -31.83 0.06 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.667 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.529 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 99.0 m-20 -64.29 -39.36 93.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.421 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.6 ttt180 -60.39 -48.46 81.64 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.436 -179.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.425 ' O ' ' O ' ' A' ' 77' ' ' ALA . 93.7 t -60.05 -24.52 30.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.172 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.529 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -45.82 172.95 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.53 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.57 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.5 p30 -61.94 177.64 0.43 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.433 -179.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.566 ' C ' ' H ' ' A' ' 81' ' ' GLY . 35.5 p30 -45.9 85.44 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.807 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.57 ' N ' ' O ' ' A' ' 78' ' ' ASP . 42.2 tp60 -67.14 13.65 0.06 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.261 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.566 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 117.94 -22.31 9.9 Favored Glycine 0 N--CA 1.463 0.471 0 N-CA-C 110.874 -0.891 . . . . 0.0 110.874 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -107.94 116.17 31.47 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.873 0.368 . . . . 0.0 110.348 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 75.9 mt -98.68 0.67 45.13 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.474 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -92.19 6.8 45.28 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.344 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.783 ' O ' HG22 ' A' ' 89' ' ' VAL . 88.2 mt-30 -99.91 -28.18 13.23 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.564 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 68.6 t-105 -63.44 -40.91 98.42 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.705 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.545 ' O ' ' N ' ' A' ' 91' ' ' LYS . 64.5 m -77.49 -53.68 7.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.873 -179.177 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -48.4 -51.01 28.58 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.801 -178.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.783 HG22 ' O ' ' A' ' 85' ' ' GLN . 16.0 m -68.92 -40.68 81.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.891 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.491 ' N ' HG23 ' A' ' 89' ' ' VAL . . . -72.27 -22.72 61.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.695 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.545 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.0 tttm -61.57 -45.92 92.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.449 -179.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.436 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.7 mm-40 -90.16 -94.58 0.12 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.198 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.609 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.9 mtt180 -143.38 59.3 1.4 Allowed 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.434 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.6 pttp 33.92 26.24 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 O-C-N 123.588 0.555 . . . . 0.0 110.487 -179.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.609 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.5 tt -48.29 123.07 5.94 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.648 -177.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.456 ' O ' HD23 ' A' ' 95' ' ' LEU . 98.9 mm-40 -83.11 -170.48 3.06 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.399 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.619 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 82.8 mtp180 -73.42 137.78 44.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.229 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.494 ' N ' ' O ' ' A' ' 67' ' ' SER . 88.9 mt -86.13 -166.37 1.52 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.807 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.53 ' CD2' ' O ' ' A' ' 99' ' ' TYR . 46.9 p90 -167.77 119.83 0.88 Allowed 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.106 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.487 ' C ' ' O ' ' A' ' 99' ' ' TYR . 43.2 mm -29.63 121.33 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 O-C-N 123.482 0.489 . . . . 0.0 110.891 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 113.28 28.59 3.26 Favored Glycine 0 N--CA 1.464 0.504 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.578 ' N ' ' CD ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -143.86 45.45 0.56 Allowed Pre-proline 0 C--N 1.324 -0.504 0 CA-C-O 121.321 0.582 . . . . 0.0 110.502 179.795 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 30.6 Cg_endo -61.95 143.94 95.91 Favored 'Trans proline' 0 C--N 1.298 -2.123 0 C-N-CA 122.614 2.209 . . . . 0.0 112.014 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.471 ' O ' HG23 ' A' ' 108' ' ' VAL . 21.9 t -173.18 120.84 0.36 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.534 179.311 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.3 -40.74 64.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.215 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.16 -40.29 90.42 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.69 -179.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.1 -39.98 95.22 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.659 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 104' ' ' SER . 69.4 t -67.71 -43.8 86.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.634 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.37 -39.19 92.36 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.521 -179.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.436 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.6 -23.23 62.79 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.596 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.519 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.3 mm-40 -90.95 4.31 52.3 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.716 -179.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.537 ' O ' ' NE ' ' A' ' 45' ' ' ARG . 10.3 tpt 23.97 63.82 0.4 Allowed Pre-proline 0 N--CA 1.471 0.602 0 O-C-N 123.622 0.576 . . . . 0.0 110.986 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.46 ' HG2' HD11 ' A' ' 116' ' ' ILE . 71.0 Cg_endo -78.63 168.22 21.49 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 123.019 2.48 . . . . 0.0 112.075 -178.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.511 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 98.8 m-20 -112.56 -43.78 3.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.292 179.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.0 tp -121.03 120.09 34.36 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.262 178.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.46 HD11 ' HG2' ' A' ' 113' ' ' PRO . 96.8 mt -117.14 131.14 70.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.719 -179.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.611 HD12 ' OG ' ' A' ' 48' ' ' SER . 30.1 mt -106.07 132.32 52.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.218 -179.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.447 HD12 HG23 ' A' ' 139' ' ' THR . 98.3 mt -118.08 136.71 54.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.495 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 86.6 p -71.98 152.3 42.59 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.565 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -59.97 -50.05 75.26 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.535 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -149.19 153.52 37.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.513 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 169.76 -170.73 42.95 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -63.07 -35.05 91.56 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.444 ' O ' ' OD1' ' A' ' 124' ' ' ASP . 43.9 p-10 -87.8 120.34 29.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.892 0.377 . . . . 0.0 110.635 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.441 ' O ' HD12 ' A' ' 129' ' ' LEU . 41.0 t -63.34 143.68 57.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.469 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.516 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.6 -42.74 9.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.647 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.5 tp -62.79 -42.42 99.7 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.761 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.01 -10.63 55.14 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.413 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.441 HD12 ' O ' ' A' ' 125' ' ' SER . 83.4 mt -115.59 -24.39 8.32 Favored 'General case' 0 C--O 1.224 -0.238 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.533 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . 0.516 ' N ' ' O ' ' A' ' 126' ' ' ALA . 75.1 t80 -51.39 -49.93 60.59 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.96 -0.296 . . . . 0.0 110.531 -178.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 37.6 p-10 -65.95 -42.13 90.36 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.933 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.52 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 88.2 mt-30 -67.66 -36.76 81.33 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.73 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.454 HD22 HD13 ' A' ' 116' ' ' ILE . 94.3 mt -80.22 -41.85 24.37 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.025 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.4 t -57.16 -44.88 83.88 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.204 -179.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.3 m -62.2 -45.48 93.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.616 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 92.2 mt -62.54 -43.81 98.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.336 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.592 ' HB1' ' HD2' ' A' ' 138' ' ' PRO . . . -170.05 163.47 6.4 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.563 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.592 ' HD2' ' HB1' ' A' ' 137' ' ' ALA . 77.0 Cg_exo -43.1 111.86 0.25 Allowed 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.576 2.184 . . . . 0.0 112.068 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.491 HG21 ' CD1' ' A' ' 130' ' ' TYR . 17.2 m -85.64 127.72 34.56 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.328 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.656 HD13 ' CD2' ' A' ' 37' ' ' HIS . 34.0 tp -119.45 137.23 53.91 Favored 'General case' 0 C--N 1.334 -0.078 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.404 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.431 ' O ' ' OD2' ' A' ' 32' ' ' ASP . 80.7 mt -103.4 119.75 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.844 -178.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.496 HD12 HD22 ' A' ' 117' ' ' LEU . 97.2 mt -135.75 133.09 51.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.607 179.085 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.545 HD21 ' CG ' ' A' ' 241' ' ' ASP . 60.9 t30 -65.2 150.93 47.35 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.41 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.512 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 88.2 t80 -85.91 122.38 29.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.725 -179.2 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.512 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 99.1 m-20 55.38 69.34 0.74 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.497 179.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 43.4 p-10 -126.64 0.54 6.81 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.537 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -150.34 114.79 5.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.833 0.349 . . . . 0.0 110.547 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 84.8 p -62.69 168.23 3.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.594 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.408 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.6 p-90 -51.44 -15.86 0.48 Allowed 'General case' 0 C--O 1.22 -0.461 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.299 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . 0.441 ' O ' HG23 ' A' ' 154' ' ' THR . 68.3 tp60 -70.49 -75.44 0.12 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.998 0.427 . . . . 0.0 110.613 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.445 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.2 t -62.53 -38.82 91.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.298 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 52.8 tp -60.13 -45.6 92.45 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.511 -178.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.408 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 45.8 tp -62.74 -41.59 99.26 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.604 178.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.445 ' OG1' ' O ' ' A' ' 151' ' ' SER . 59.1 p -63.67 -35.03 79.2 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.275 -179.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.459 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.8 mm-40 -63.67 -42.14 98.1 Favored 'General case' 0 C--O 1.226 -0.161 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.36 179.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 91.3 mt -65.3 -39.09 92.05 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.483 178.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.564 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -60.99 -32.29 79.63 Favored Glycine 0 C--N 1.33 0.237 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 -179.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.459 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.3 mt-10 -36.63 -25.38 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.823 0.344 . . . . 0.0 110.937 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.564 ' N ' ' O ' ' A' ' 157' ' ' GLY . 95.3 mt -58.81 148.83 6.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.455 178.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 70.8 p -69.15 137.6 53.48 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.841 -179.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 70.69 21.92 77.95 Favored Glycine 0 CA--C 1.521 0.41 0 N-CA-C 111.085 -0.806 . . . . 0.0 111.085 179.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 59.7 m80 -124.18 -14.18 7.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.562 0.22 . . . . 0.0 110.506 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -66.14 -59.96 3.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.542 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -51.39 -49.42 61.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.086 -179.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -60.58 -40.97 93.66 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.883 0.373 . . . . 0.0 110.495 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.62 -47.42 85.52 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.548 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.77 -40.06 75.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.311 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -61.64 -50.46 72.44 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.697 179.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.415 ' NE ' ' HB1' ' A' ' 59' ' ' ALA . 60.1 ttt85 -65.28 -43.79 90.07 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.46 179.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 95.3 mt -64.4 -43.53 97.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.484 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.33 -51.06 70.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.379 -179.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.76 -43.6 95.92 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.875 0.369 . . . . 0.0 110.521 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . 0.655 ' CE2' HD11 ' A' ' 177' ' ' LEU . 56.7 t80 -62.54 -44.39 96.47 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.435 179.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -63.66 -39.68 94.96 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.378 -179.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -63.08 -42.52 99.65 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.753 179.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -60.64 -44.94 95.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.209 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.655 HD11 ' CE2' ' A' ' 173' ' ' PHE . 85.4 mt -64.31 -41.1 97.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.943 178.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.13 -61.99 1.92 Allowed 'General case' 0 C--O 1.238 0.472 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.499 -179.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.71 -46.83 86.45 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.472 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.12 -41.59 65.18 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.329 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -63.75 -33.99 76.89 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.33 179.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . 0.4 ' O ' ' HG2' ' A' ' 182' ' ' GLU . 69.3 tt0 -90.75 8.56 34.01 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.39 0.614 . . . . 0.0 110.283 -178.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -104.3 -32.23 9.18 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.944 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.8 pt -128.09 147.81 32.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.865 0.364 . . . . 0.0 110.58 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -139.71 131.13 26.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.538 178.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . 0.587 HD22 ' N ' ' A' ' 186' ' ' LEU . 3.6 mm? -85.35 133.46 42.41 Favored Pre-proline 0 N--CA 1.447 -0.606 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.107 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -44.1 157.83 0.14 Allowed 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.581 2.188 . . . . 0.0 112.188 179.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . 0.489 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.7 Cg_endo -63.35 115.0 2.74 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.815 2.344 . . . . 0.0 111.561 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . 0.489 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.7 mt-30 156.05 148.14 0.0 OUTLIER Pre-proline 0 C--N 1.34 0.178 0 O-C-N 124.353 1.033 . . . . 0.0 110.94 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -73.75 144.48 35.23 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 C-N-CA 122.601 2.201 . . . . 0.0 111.765 177.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.495 HG23 ' OG ' ' A' ' 258' ' ' SER . 2.1 p -124.81 159.04 31.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.206 0.527 . . . . 0.0 110.168 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . 0.482 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 37.2 p -143.26 165.29 27.88 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 121.428 0.633 . . . . 0.0 110.852 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . 0.447 ' HA ' ' H ' ' A' ' 260' ' ' PHE . . . -135.32 128.91 32.63 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 121.276 0.56 . . . . 0.0 110.422 178.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.509 HD11 HD23 ' A' ' 259' ' ' LEU . 47.6 pt -146.64 149.09 16.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.849 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . 0.744 HG13 ' CD1' ' A' ' 262' ' ' PHE . 73.6 t -117.78 123.1 71.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.08 0.467 . . . . 0.0 110.036 178.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 58.1 t80 -134.3 106.45 7.12 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.348 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 95.3 m -130.31 130.49 44.56 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.786 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.401 ' O ' ' N ' ' A' ' 201' ' ' HIS . . . -82.99 -36.58 24.93 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.26 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.41 -67.26 0.25 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.351 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.12 -9.45 58.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.446 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . 0.402 ' ND1' ' O ' ' A' ' 201' ' ' HIS . 60.7 t-80 60.51 58.26 2.55 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.749 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 34.9 p -167.28 153.91 8.3 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.601 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.56 144.27 24.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.897 0.379 . . . . 0.0 110.417 179.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -135.32 138.49 43.48 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.41 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 18.2 mt -106.25 125.23 50.75 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.062 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' TRP . . . . . 0.556 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 74.8 m95 -82.31 167.74 18.27 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.563 -179.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . 0.455 HG22 ' C ' ' A' ' 206' ' ' TRP . 0.1 OUTLIER -157.62 171.7 7.1 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.611 -178.635 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -53.92 -37.09 85.46 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 C-N-CA 122.743 2.296 . . . . 0.0 111.992 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -70.77 -34.9 72.3 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.734 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 21.4 m -61.5 150.94 34.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.51 -179.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.76 -36.92 82.43 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.42 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' GLN . . . . . 0.556 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 55.0 tt0 -64.63 -40.29 95.22 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.59 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.88 -43.27 91.87 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -63.07 -43.97 97.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.85 0.357 . . . . 0.0 110.239 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' MET . . . . . 0.55 ' SD ' ' HB2' ' A' ' 304' ' ' ALA . 65.2 ttp -59.42 -47.79 84.11 Favored 'General case' 0 N--CA 1.461 0.103 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.207 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 86.4 mt -60.53 -40.72 92.54 Favored 'General case' 0 CA--C 1.517 -0.303 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' GLU . . . . . 0.448 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.1 tp10 -57.96 -38.04 75.26 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.201 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -65.51 -37.96 88.29 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.725 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 96.0 mt -64.28 -42.76 96.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.655 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.72 44.9 0.08 OUTLIER Glycine 0 N--CA 1.463 0.444 0 N-CA-C 111.079 -0.808 . . . . 0.0 111.079 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' PHE . . . . . 0.448 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 26.9 m-85 -127.89 155.75 43.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.761 0.315 . . . . 0.0 110.498 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.481 ' O ' HG13 ' A' ' 191' ' ' VAL . 7.4 p -107.42 122.52 46.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.21 0.529 . . . . 0.0 110.229 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.472 HD22 ' C ' ' A' ' 222' ' ' THR . 4.3 mm? -101.34 133.16 46.37 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.002 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.74 159.4 14.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.433 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.31 115.0 29.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.404 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.497 ' N ' HD12 ' A' ' 226' ' ' LEU . 8.9 mp -52.91 156.72 3.23 Favored Pre-proline 0 N--CA 1.446 -0.649 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.794 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -60.47 145.49 98.62 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.719 2.279 . . . . 0.0 112.013 179.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.2 -3.36 59.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.529 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -89.93 -41.26 5.66 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . 0.506 ' O ' ' N ' ' A' ' 233' ' ' SER . 68.3 mt -79.23 -17.15 55.33 Favored 'General case' 0 C--O 1.219 -0.532 0 CA-C-O 120.923 0.392 . . . . 0.0 110.31 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 54.4 t-20 -40.33 -49.73 2.77 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.862 0.363 . . . . 0.0 110.709 -179.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -87.7 15.43 6.91 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.115 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . 0.506 ' N ' ' O ' ' A' ' 230' ' ' LEU . 77.9 p -60.33 -35.24 75.17 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.601 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . 0.521 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.6 tt0 -119.64 -69.18 0.86 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.73 0.3 . . . . 0.0 110.679 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.3 m -69.58 102.59 1.88 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.538 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -94.28 57.4 2.32 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.357 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -144.73 -122.41 1.56 Allowed Glycine 0 N--CA 1.462 0.426 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -135.42 111.71 9.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.898 0.38 . . . . 0.0 110.379 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . 0.525 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.4 mtt180 -148.28 58.14 1.08 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.578 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -69.38 -32.7 71.9 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.618 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' ASP . . . . . 0.545 ' CG ' HD21 ' A' ' 143' ' ' ASN . 65.2 t0 -56.7 -47.3 80.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.312 -179.001 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' ILE . . . . . 0.434 ' O ' ' O ' ' A' ' 239' ' ' ARG . 18.0 tt -139.39 155.92 26.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.358 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.445 HG22 HD13 ' A' ' 245' ' ' LEU . 96.3 mt -106.08 106.49 20.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.406 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . 0.586 ' O ' HD12 ' A' ' 245' ' ' LEU . 88.2 mt-30 -110.57 109.96 20.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.291 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.586 HD12 ' O ' ' A' ' 244' ' ' GLN . 9.5 mp -121.59 -168.09 1.63 Allowed 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.723 179.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . 0.521 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.7 -16.46 0.05 OUTLIER Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . 0.666 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -61.14 156.31 33.85 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -63.33 21.81 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.772 0.32 . . . . 0.0 110.629 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . 0.666 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.9 m-20 -97.41 -6.3 34.33 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.407 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 92.0 mt -79.36 -21.98 45.05 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.945 179.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.7 -51.21 70.91 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.647 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.39 -5.74 58.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.372 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -80.87 -74.49 1.13 Allowed Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 80.9 mt -69.99 126.14 28.81 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.455 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -59.64 -39.19 83.56 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.281 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 82.63 51.94 4.11 Favored Glycine 0 CA--C 1.521 0.426 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -95.89 -15.07 22.66 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 121.199 -0.201 . . . . 0.0 110.634 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 258' ' ' SER . . . . . 0.495 ' OG ' HG23 ' A' ' 191' ' ' VAL . 3.5 t 174.85 88.71 0.0 OUTLIER 'General case' 0 C--O 1.224 -0.257 0 CA-C-O 121.089 0.471 . . . . 0.0 110.294 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.848 ' N ' HD12 ' A' ' 259' ' ' LEU . 0.9 OUTLIER -94.5 124.27 38.43 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.774 0.321 . . . . 0.0 110.874 -178.666 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 260' ' ' PHE . . . . . 0.447 ' H ' ' HA ' ' A' ' 193' ' ' ALA . 15.7 m-30 -93.52 146.13 24.01 Favored 'General case' 0 CA--C 1.499 -0.999 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.541 179.016 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 85.3 mt -122.09 149.03 44.14 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.517 -179.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.744 ' CD1' HG13 ' A' ' 195' ' ' VAL . 2.5 p90 -77.23 -138.84 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.407 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 263' ' ' ALA . . . . . 0.655 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -51.46 77.22 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.249 0 O-C-N 123.381 0.426 . . . . 0.0 110.939 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . 0.622 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.29 104.67 0.19 Allowed Glycine 0 CA--C 1.527 0.797 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 265' ' ' ASP . . . . . 0.589 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.8 m-20 -80.14 -177.8 6.24 Favored 'General case' 0 C--N 1.327 -0.394 0 O-C-N 122.79 -0.241 . . . . 0.0 110.718 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -40.78 -17.83 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.486 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 267' ' ' LYS . . . . . 0.589 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.16 -51.52 44.97 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 121.058 0.456 . . . . 0.0 110.724 179.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -63.9 -46.58 84.2 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.102 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . 0.566 ' HB1' ' OH ' ' A' ' 273' ' ' TYR . . . -61.6 -34.81 76.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.668 0.746 . . . . 0.0 110.05 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -62.98 -34.89 78.5 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.002 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.07 -43.44 13.91 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.136 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 272' ' ' ILE . . . . . 0.589 ' C ' ' H ' ' A' ' 274' ' ' ALA . 5.0 tt -51.61 -33.59 15.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.471 -178.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 273' ' ' TYR . . . . . 0.566 ' OH ' ' HB1' ' A' ' 269' ' ' ALA . 17.1 m-85 -54.62 -1.61 0.03 OUTLIER 'General case' 0 CA--C 1.512 -0.504 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.741 -179.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 274' ' ' ALA . . . . . 0.589 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.42 -39.99 70.73 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.917 179.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . 0.574 ' O ' ' N ' ' A' ' 279' ' ' ALA . 2.8 p30 -38.55 97.64 0.14 Allowed Pre-proline 0 CA--C 1.528 0.131 0 O-C-N 123.585 0.553 . . . . 0.0 110.355 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -53.75 -43.27 59.37 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 122.565 2.177 . . . . 0.0 112.509 -178.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 89.0 mt -64.42 -43.0 95.73 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.953 -179.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 91.8 mt -95.82 -1.33 49.82 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.756 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 279' ' ' ALA . . . . . 0.574 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.63 -35.18 78.75 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.352 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.13 20.35 0.11 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.892 -178.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . 0.488 ' H ' ' C ' ' A' ' 279' ' ' ALA . 13.9 mt -74.8 120.05 79.7 Favored Pre-proline 0 N--CA 1.442 -0.862 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.821 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -51.33 -39.09 63.47 Favored 'Trans proline' 0 C--N 1.313 -1.321 0 C-N-CA 122.425 2.083 . . . . 0.0 111.817 179.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.71 -50.6 63.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.947 0.403 . . . . 0.0 110.05 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 76.6 t -61.51 -43.8 97.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.199 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -57.64 -41.48 81.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.212 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -90.84 0.62 57.42 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.32 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt 59.0 43.18 18.08 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.811 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -94.52 41.6 1.09 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.377 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 54.0 t -119.16 135.6 59.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-O 120.949 0.404 . . . . 0.0 110.012 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -132.81 162.87 30.38 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.619 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.68 155.14 32.95 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.462 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 79.8 mt -94.07 -1.63 54.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.299 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 120.75 165.49 12.76 Favored Glycine 0 N--CA 1.464 0.512 0 N-CA-C 110.584 -1.006 . . . . 0.0 110.584 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 6.7 m -86.98 -62.3 1.53 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.83 0.347 . . . . 0.0 110.879 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 295' ' ' GLU . . . . . 0.446 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.9 mm-40 -69.36 -3.94 16.2 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.642 -179.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 24.5 p -77.01 32.24 0.14 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.65 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 297' ' ' PHE . . . . . 0.505 ' CD2' HG22 ' A' ' 70' ' ' THR . 68.5 t80 -60.31 -46.13 90.95 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.704 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . 0.619 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.1 mtt85 -80.76 135.09 35.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.477 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.462 ' H ' HG11 ' A' ' 51' ' ' VAL . 17.7 tp -114.09 117.07 30.23 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 120.861 0.362 . . . . 0.0 110.394 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . 0.618 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.1 p-10 -165.2 -176.63 4.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.755 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 82.8 t80 -46.51 -43.57 16.96 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.424 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -67.06 -40.24 87.03 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.001 0.429 . . . . 0.0 110.757 179.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . 0.618 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 60.2 p -56.22 -36.11 68.09 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.131 -179.086 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . 0.55 ' HB2' ' SD ' ' A' ' 215' ' ' MET . . . -57.31 -51.34 69.77 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.215 179.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 91.7 mtp -56.01 -44.18 78.43 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -65.79 -42.59 90.53 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.165 0.507 . . . . 0.0 110.437 179.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 303' ' ' SER . 55.7 t -64.06 -42.92 97.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.255 179.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 43.6 tp -59.77 -41.94 92.19 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.129 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -62.44 -39.0 91.93 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.299 179.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 310' ' ' ARG . . . . . 0.441 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.5 ttt85 -63.7 -43.79 95.56 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.374 179.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 89.4 mt -63.47 -41.94 98.6 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.572 179.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.3 ttmt -63.2 -33.29 75.16 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.35 179.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.42 -23.58 22.11 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.466 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . 0.486 HD22 ' CE2' ' A' ' 315' ' ' PHE . 6.7 tt -62.31 -43.15 99.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.491 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 315' ' ' PHE . . . . . 0.486 ' CE2' HD22 ' A' ' 314' ' ' LEU . 89.8 m-85 . . . . . 0 C--O 1.221 -0.444 0 CA-C-O 118.09 -0.957 . . . . 0.0 110.3 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -99.64 136.03 40.18 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.134 0.492 . . . . 0.0 110.475 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.482 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -92.44 178.68 1.58 Allowed Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.47 -179.692 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.482 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.7 Cg_exo -61.71 147.19 95.87 Favored 'Trans proline' 0 C--N 1.303 -1.843 0 C-N-CA 122.814 2.343 . . . . 0.0 112.211 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.487 ' HE ' HD12 ' A' ' 39' ' ' LEU . 35.5 ptt180 -136.53 142.45 43.45 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.565 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -79.63 116.88 20.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.508 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.445 ' O ' HG23 ' A' ' 30' ' ' ILE . 9.4 tp -111.13 130.39 64.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.557 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 13.9 t -71.3 142.18 50.47 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.674 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.478 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.4 t0 -139.24 -179.97 6.18 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.478 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.478 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 78.1 p -74.0 -37.05 64.54 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.671 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.8 ttt85 -46.86 -94.78 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.31 -179.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -166.07 -27.06 0.02 OUTLIER Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 62.5 m -168.71 105.76 0.44 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.757 0.313 . . . . 0.0 110.598 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.644 ' CD2' HD13 ' A' ' 140' ' ' LEU . 65.5 t60 -128.86 146.55 50.91 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 120.956 0.408 . . . . 0.0 110.222 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.619 HG22 ' N ' ' A' ' 39' ' ' LEU . 95.4 m -129.84 165.53 21.8 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.3 -179.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.619 ' N ' HG22 ' A' ' 38' ' ' THR . 78.5 mt -120.21 127.28 52.29 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.691 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -65.41 -44.86 86.1 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.606 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 38.3 p -165.64 154.97 12.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.458 179.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.491 ' H ' ' CD ' ' A' ' 42' ' ' GLN . 14.5 mp0 -44.82 101.19 0.25 Allowed Pre-proline 0 C--O 1.235 0.333 0 O-C-N 123.57 0.544 . . . . 0.0 110.505 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -57.62 130.25 37.83 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.339 2.026 . . . . 0.0 112.16 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -82.69 -25.03 33.37 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.643 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.538 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.8 mtm-85 -120.89 134.53 55.29 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.143 0.497 . . . . 0.0 110.237 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.1 mt -129.75 133.23 65.2 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.327 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.639 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 46.2 t -125.1 130.92 73.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 CA-C-O 120.942 0.401 . . . . 0.0 110.151 178.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.609 ' OG ' HD12 ' A' ' 117' ' ' LEU . 4.2 m -154.99 166.6 33.06 Favored 'General case' 0 C--O 1.225 -0.22 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.459 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 73.2 p -124.55 8.92 8.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.417 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.35 125.84 33.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.872 0.368 . . . . 0.0 110.584 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.467 HG11 ' H ' ' A' ' 299' ' ' LEU . 84.9 t -65.83 -44.58 92.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.611 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 18.5 m -62.59 -44.41 96.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.678 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 52.2 tp -62.39 -41.53 98.72 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.661 -179.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.438 ' O ' HD13 ' A' ' 58' ' ' LEU . 71.9 m -58.04 -44.61 87.48 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.183 -179.183 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.31 -62.09 5.44 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 179.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.5 t -47.89 -35.64 10.81 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.5 mt -61.82 -44.55 96.63 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.069 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.445 HD21 HE22 ' A' ' 85' ' ' GLN . 9.1 mp -65.27 -41.17 94.47 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.297 178.132 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.412 ' HB1' ' NE ' ' A' ' 169' ' ' ARG . . . -63.85 -41.45 97.8 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.611 -179.193 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.414 ' O ' HG23 ' A' ' 60' ' ' ILE . 8.0 tp -87.75 16.8 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.724 -179.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 56.32 84.39 0.09 Allowed 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.814 -179.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.28 58.44 0.08 OUTLIER Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 120.992 0.425 . . . . 0.0 109.931 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.417 ' HB3' HE21 ' A' ' 85' ' ' GLN . 10.0 Cg_endo -50.91 152.72 9.61 Favored 'Trans proline' 0 C--N 1.296 -2.205 0 C-N-CA 123.061 2.507 . . . . 0.0 112.307 -178.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.429 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -108.85 145.9 15.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.279 -179.789 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.78 -45.13 98.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.191 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.504 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -130.16 134.17 47.12 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.717 0.294 . . . . 0.0 110.389 -179.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.494 ' O ' ' N ' ' A' ' 98' ' ' LEU . 73.5 m -134.3 158.51 43.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.85 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.58 139.21 16.36 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.494 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.69 -162.83 0.09 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.86 0.362 . . . . 0.0 110.382 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.502 HG22 ' CD2' ' A' ' 297' ' ' PHE . 5.8 t -134.09 135.57 43.33 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.027 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.466 ' C ' ' O ' ' A' ' 70' ' ' THR . 0.9 OUTLIER 29.78 68.23 0.68 Allowed Pre-proline 0 N--CA 1.469 0.507 0 CA-C-O 121.181 0.515 . . . . 0.0 110.813 -179.569 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -60.8 145.23 99.3 Favored 'Trans proline' 0 C--N 1.301 -1.944 0 C-N-CA 122.737 2.291 . . . . 0.0 111.978 -178.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.539 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 44.9 p-10 -160.06 -32.62 0.06 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.674 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.539 ' N ' ' OD1' ' A' ' 73' ' ' ASN . 98.9 m-20 -63.75 -39.72 94.97 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.364 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -59.97 -48.33 82.16 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.476 -179.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.425 ' O ' ' O ' ' A' ' 77' ' ' ALA . 92.4 t -60.0 -24.75 30.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.125 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.526 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -45.64 173.0 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.53 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.565 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.3 p30 -62.06 177.69 0.44 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.424 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.564 ' C ' ' H ' ' A' ' 81' ' ' GLY . 35.1 p30 -45.81 85.64 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.985 0.421 . . . . 0.0 110.903 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.565 ' N ' ' O ' ' A' ' 78' ' ' ASP . 42.5 tp60 -67.21 13.45 0.06 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.25 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.564 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 117.92 -22.34 9.9 Favored Glycine 0 N--CA 1.463 0.439 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -107.75 116.22 31.55 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.945 0.402 . . . . 0.0 110.483 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 76.5 mt -98.71 0.63 44.96 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.478 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -92.23 6.84 45.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.917 0.389 . . . . 0.0 110.325 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.781 ' O ' HG22 ' A' ' 89' ' ' VAL . 88.5 mt-30 -99.88 -27.8 13.43 Favored 'General case' 0 C--O 1.222 -0.379 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.665 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 69.0 t-105 -63.42 -40.96 98.58 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.767 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.545 ' O ' ' N ' ' A' ' 91' ' ' LYS . 67.2 m -77.42 -53.34 7.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.888 -179.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -48.59 -51.14 29.35 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.946 -179.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.781 HG22 ' O ' ' A' ' 85' ' ' GLN . 15.9 m -68.78 -40.6 81.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.039 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.489 ' N ' HG23 ' A' ' 89' ' ' VAL . . . -72.35 -22.92 61.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.753 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.545 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.0 tttm -61.41 -45.92 92.31 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.391 -179.432 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.438 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.6 mm-40 -90.37 -94.56 0.12 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.128 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.608 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.9 mtt180 -143.49 59.63 1.39 Allowed 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.437 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.7 pttp 34.06 26.32 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.282 0.563 . . . . 0.0 110.517 -179.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.608 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.5 tt -48.32 123.15 6.09 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.856 -177.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.45 ' O ' HD23 ' A' ' 95' ' ' LEU . 98.9 mm-40 -83.31 -170.44 3.05 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.314 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.617 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 82.7 mtp180 -73.45 137.89 44.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.952 0.406 . . . . 0.0 110.231 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.494 ' N ' ' O ' ' A' ' 67' ' ' SER . 88.3 mt -86.41 -165.96 1.41 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.83 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.532 ' CD2' ' O ' ' A' ' 99' ' ' TYR . 47.1 p90 -168.51 120.0 0.79 Allowed 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.094 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.488 ' C ' ' O ' ' A' ' 99' ' ' TYR . 42.9 mm -29.67 121.4 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 O-C-N 123.392 0.433 . . . . 0.0 110.898 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 113.7 28.12 3.31 Favored Glycine 0 N--CA 1.463 0.473 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 -179.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.579 ' N ' ' CD ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -143.86 45.5 0.57 Allowed Pre-proline 0 C--N 1.324 -0.54 0 CA-C-O 121.298 0.57 . . . . 0.0 110.463 179.794 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 30.4 Cg_endo -62.14 144.03 95.32 Favored 'Trans proline' 0 C--N 1.297 -2.145 0 C-N-CA 122.572 2.181 . . . . 0.0 111.972 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.462 ' O ' HG23 ' A' ' 108' ' ' VAL . 25.3 t -173.17 120.76 0.36 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.573 179.426 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.15 -40.96 64.44 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.188 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -65.97 -40.0 90.85 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.759 -179.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.05 -39.62 94.49 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.667 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 104' ' ' SER . 71.2 t -67.58 -43.73 86.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.638 179.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.44 -39.3 92.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.527 -179.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.438 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.78 -23.67 63.47 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.561 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.526 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.4 mm-40 -90.89 4.38 52.02 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.769 -179.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.538 ' O ' ' NE ' ' A' ' 45' ' ' ARG . 10.5 tpt 22.61 64.37 0.34 Allowed Pre-proline 0 N--CA 1.471 0.598 0 O-C-N 123.5 0.5 . . . . 0.0 111.124 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.466 ' HG2' HD11 ' A' ' 116' ' ' ILE . 68.2 Cg_endo -79.33 169.4 18.87 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 123.083 2.522 . . . . 0.0 111.938 -178.093 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.524 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 98.7 m-20 -112.33 -44.72 3.35 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.174 179.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 39.1 tp -119.9 121.04 38.15 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.147 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.466 HD11 ' HG2' ' A' ' 113' ' ' PRO . 96.8 mt -118.18 131.32 71.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.769 -179.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.609 HD12 ' OG ' ' A' ' 48' ' ' SER . 31.5 mt -106.06 132.11 52.53 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.205 -179.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.497 HD12 HG23 ' A' ' 139' ' ' THR . 98.6 mt -117.76 136.08 56.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.55 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 86.4 p -71.48 151.41 43.97 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.608 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.32 -49.95 75.57 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.582 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -149.29 153.6 37.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.505 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 168.48 -169.69 41.75 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.88 -35.6 92.23 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.449 ' O ' ' OD1' ' A' ' 124' ' ' ASP . 44.3 p-10 -88.46 119.88 29.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.903 0.383 . . . . 0.0 110.598 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.446 ' O ' HD12 ' A' ' 129' ' ' LEU . 40.6 t -63.0 144.03 57.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.405 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.511 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.55 -43.07 8.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.779 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.8 tp -62.64 -42.42 99.59 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.821 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.85 -10.44 53.06 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.405 -179.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.446 HD12 ' O ' ' A' ' 125' ' ' SER . 82.1 mt -115.99 -24.3 8.16 Favored 'General case' 0 C--O 1.225 -0.222 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.56 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . 0.522 ' CD1' HG21 ' A' ' 139' ' ' THR . 71.3 t80 -51.37 -49.51 61.34 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.914 -0.314 . . . . 0.0 110.558 -178.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.2 p-10 -66.09 -41.79 90.17 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.846 -0.342 . . . . 0.0 111.054 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.523 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 87.9 mt-30 -67.91 -36.49 80.28 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.751 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.466 HD12 HD11 ' A' ' 118' ' ' ILE . 96.5 mt -80.35 -42.09 23.55 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.003 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.3 t -57.39 -45.25 84.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.293 -179.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.6 m -62.46 -45.66 92.03 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.656 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 92.2 mt -62.4 -43.78 98.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.312 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.598 ' HB1' ' HD2' ' A' ' 138' ' ' PRO . . . -170.2 163.54 6.2 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.581 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.598 ' HD2' ' HB1' ' A' ' 137' ' ' ALA . 76.0 Cg_exo -42.14 110.67 0.16 Allowed 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.561 2.174 . . . . 0.0 112.118 179.31 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.522 HG21 ' CD1' ' A' ' 130' ' ' TYR . 2.8 m -87.34 127.76 35.19 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.237 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.644 HD13 ' CD2' ' A' ' 37' ' ' HIS . 34.3 tp -119.63 139.21 52.57 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.451 179.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.431 ' O ' ' OD2' ' A' ' 32' ' ' ASP . 81.7 mt -105.11 119.93 54.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-O 120.953 0.406 . . . . 0.0 110.852 -179.206 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.48 HD12 HD22 ' A' ' 117' ' ' LEU . 97.1 mt -135.67 132.7 51.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.639 179.144 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.543 HD21 ' CG ' ' A' ' 241' ' ' ASP . 59.1 t30 -64.59 147.99 51.75 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.465 179.361 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.511 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 87.3 t80 -82.48 122.67 28.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.814 -179.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.511 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 99.0 m-20 55.05 69.31 0.75 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.561 179.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 34.2 p-10 -125.62 0.49 7.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.576 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -150.92 115.96 5.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.867 0.365 . . . . 0.0 110.642 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 85.0 p -63.76 169.11 4.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.613 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.407 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.7 p-90 -51.83 -16.13 0.64 Allowed 'General case' 0 C--O 1.22 -0.457 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.258 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . 0.435 ' O ' HG23 ' A' ' 154' ' ' THR . 68.2 tp60 -70.19 -75.98 0.11 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.021 0.438 . . . . 0.0 110.614 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 11.1 t -62.58 -38.45 90.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.265 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 51.0 tp -60.16 -45.5 92.87 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.573 -178.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.407 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 45.4 tp -62.85 -41.63 99.43 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.612 178.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.435 HG23 ' O ' ' A' ' 150' ' ' GLN . 59.6 p -63.67 -35.01 79.15 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.251 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.467 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.5 mm-40 -63.54 -41.99 98.43 Favored 'General case' 0 C--O 1.225 -0.203 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.344 179.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 91.5 mt -65.44 -39.09 91.65 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.413 178.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.562 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.09 -32.15 79.33 Favored Glycine 0 N--CA 1.46 0.264 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 -179.247 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.467 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.3 mt-10 -36.81 -25.26 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.752 0.31 . . . . 0.0 110.881 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.562 ' N ' ' O ' ' A' ' 157' ' ' GLY . 95.5 mt -59.17 148.61 6.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.346 179.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 74.7 p -69.13 137.72 53.63 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.879 -179.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 70.69 21.88 77.95 Favored Glycine 0 CA--C 1.519 0.335 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 179.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 59.8 m80 -124.35 -13.78 7.08 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 110.448 -0.204 . . . . 0.0 110.448 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -66.24 -59.9 3.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.506 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -51.79 -49.07 63.41 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.119 -179.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -60.41 -41.03 93.08 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.862 0.363 . . . . 0.0 110.448 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.58 -47.19 86.61 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.551 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -57.0 -39.96 75.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.25 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -61.69 -50.49 72.25 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.694 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.412 ' NE ' ' HB1' ' A' ' 59' ' ' ALA . 60.0 ttt85 -65.29 -43.89 89.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.458 179.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 95.3 mt -64.32 -43.55 97.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.412 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.28 -51.05 70.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.432 -179.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -63.79 -43.43 96.32 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.846 0.355 . . . . 0.0 110.539 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . 0.657 ' CE2' HD11 ' A' ' 177' ' ' LEU . 56.6 t80 -62.66 -44.44 96.26 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.084 0.468 . . . . 0.0 110.423 179.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -63.62 -39.87 95.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.475 -179.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -62.97 -42.6 99.88 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.725 179.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -60.74 -44.55 96.52 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.24 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.657 HD11 ' CE2' ' A' ' 173' ' ' PHE . 85.1 mt -64.55 -41.07 96.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.875 178.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.24 -61.95 1.95 Allowed 'General case' 0 C--O 1.239 0.515 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.426 -179.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.72 -47.12 85.68 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.358 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -52.83 -41.55 64.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.314 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -63.79 -33.71 76.28 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.36 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . 0.405 ' HG2' ' O ' ' A' ' 182' ' ' GLU . 69.6 tt0 -90.92 8.52 34.66 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.539 0.685 . . . . 0.0 110.302 -178.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -104.24 -32.22 9.22 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.088 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.4 pt -128.04 147.77 32.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.886 0.374 . . . . 0.0 110.635 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -139.93 131.31 26.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.478 179.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . 0.585 HD22 ' N ' ' A' ' 186' ' ' LEU . 3.6 mm? -85.36 133.32 42.67 Favored Pre-proline 0 N--CA 1.448 -0.559 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.088 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -44.02 157.9 0.14 Allowed 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.645 2.23 . . . . 0.0 112.194 179.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . 0.49 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.5 Cg_endo -63.12 114.78 2.61 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.716 2.277 . . . . 0.0 111.632 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . 0.49 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.7 mt-30 156.03 148.11 0.0 OUTLIER Pre-proline 0 C--N 1.34 0.194 0 O-C-N 124.401 1.063 . . . . 0.0 110.894 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -73.58 144.56 36.02 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 122.597 2.198 . . . . 0.0 111.905 177.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.496 HG23 ' OG ' ' A' ' 258' ' ' SER . 2.1 p -124.78 158.93 31.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.229 0.538 . . . . 0.0 110.109 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . 0.481 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 38.1 p -143.16 165.18 28.13 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 121.396 0.617 . . . . 0.0 110.973 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . 0.445 ' HA ' ' H ' ' A' ' 260' ' ' PHE . . . -135.15 128.93 33.03 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 121.377 0.608 . . . . 0.0 110.358 178.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.509 HD11 HD23 ' A' ' 259' ' ' LEU . 47.2 pt -146.57 148.97 16.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.972 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . 0.74 HG13 ' CD1' ' A' ' 262' ' ' PHE . 72.3 t -117.73 123.15 71.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.183 0.516 . . . . 0.0 109.932 178.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -134.35 106.91 7.33 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.289 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 94.2 m -130.85 130.44 43.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.872 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.41 ' O ' ' N ' ' A' ' 201' ' ' HIS . . . -82.73 -37.03 25.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.258 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.5 -67.08 0.26 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.297 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -71.91 -9.77 58.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.379 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . 0.41 ' N ' ' O ' ' A' ' 198' ' ' ALA . 60.3 t-80 60.38 57.97 2.7 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.591 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 47.6 p -166.66 153.38 8.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.57 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.29 144.13 24.47 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.946 0.403 . . . . 0.0 110.426 179.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -135.4 138.67 43.51 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.525 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 19.0 mt -106.21 125.26 50.77 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' TRP . . . . . 0.557 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 75.0 m95 -82.12 167.51 18.68 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.593 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . 0.45 HG22 ' C ' ' A' ' 206' ' ' TRP . 0.1 OUTLIER -157.18 171.56 7.28 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.595 -178.674 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.8 -37.26 84.63 Favored 'Trans proline' 0 C--N 1.302 -1.915 0 C-N-CA 122.598 2.199 . . . . 0.0 112.183 179.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -70.89 -34.73 71.87 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.713 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 21.4 m -61.23 151.08 32.63 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.529 -179.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.65 -37.01 82.47 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.392 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' GLN . . . . . 0.557 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 55.0 tt0 -64.8 -40.31 95.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.477 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.78 -43.39 91.82 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -62.74 -44.15 96.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.809 0.338 . . . . 0.0 110.262 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' MET . . . . . 0.546 ' SD ' ' HB2' ' A' ' 304' ' ' ALA . 65.3 ttp -59.46 -47.82 84.03 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.221 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 87.0 mt -60.4 -41.07 93.1 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' GLU . . . . . 0.448 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.3 tp10 -58.18 -38.07 75.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.074 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -65.32 -38.24 89.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.743 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 95.7 mt -64.1 -42.79 96.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.684 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.49 45.45 0.08 OUTLIER Glycine 0 N--CA 1.462 0.416 0 N-CA-C 111.111 -0.795 . . . . 0.0 111.111 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' PHE . . . . . 0.448 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 27.4 m-85 -128.29 155.6 44.34 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.83 0.347 . . . . 0.0 110.482 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.476 ' O ' HG13 ' A' ' 191' ' ' VAL . 7.5 p -107.11 122.35 46.32 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-O 121.225 0.536 . . . . 0.0 110.215 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.475 HD22 ' C ' ' A' ' 222' ' ' THR . 4.3 mm? -101.47 133.06 46.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.016 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.76 159.67 14.8 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.471 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.33 115.15 29.76 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.377 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.493 ' N ' HD12 ' A' ' 226' ' ' LEU . 9.0 mp -53.08 156.83 3.35 Favored Pre-proline 0 N--CA 1.447 -0.62 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.811 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -60.3 145.36 98.75 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 C-N-CA 122.735 2.29 . . . . 0.0 112.091 179.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.24 -3.22 59.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.521 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.07 -40.94 5.7 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . 0.503 ' O ' ' N ' ' A' ' 233' ' ' SER . 68.7 mt -79.36 -17.25 54.84 Favored 'General case' 0 C--O 1.219 -0.542 0 CA-C-O 121.04 0.447 . . . . 0.0 110.297 -179.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 54.6 t-20 -40.48 -49.51 2.89 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.842 0.354 . . . . 0.0 110.717 -179.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -87.69 15.46 6.86 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.241 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . 0.503 ' N ' ' O ' ' A' ' 230' ' ' LEU . 77.9 p -60.62 -35.2 75.56 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.608 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . 0.522 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.6 tt0 -119.54 -69.34 0.85 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.717 179.32 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.0 m -69.72 102.1 1.83 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.955 0.407 . . . . 0.0 110.592 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -93.78 57.56 2.52 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.34 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -144.63 -122.5 1.58 Allowed Glycine 0 N--CA 1.462 0.397 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -135.44 111.78 9.79 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.0 0.428 . . . . 0.0 110.374 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . 0.524 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.5 mtt180 -148.27 58.26 1.08 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.596 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -69.47 -32.35 71.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.571 179.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' ASP . . . . . 0.543 ' CG ' HD21 ' A' ' 143' ' ' ASN . 64.8 t0 -56.85 -47.3 80.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.266 -179.042 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' ILE . . . . . 0.435 ' O ' ' O ' ' A' ' 239' ' ' ARG . 17.8 tt -139.65 156.17 25.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.851 0.358 . . . . 0.0 110.371 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.451 HG22 HD13 ' A' ' 245' ' ' LEU . 96.2 mt -106.07 106.61 20.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.947 0.403 . . . . 0.0 110.382 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . 0.589 ' O ' HD12 ' A' ' 245' ' ' LEU . 88.3 mt-30 -110.55 110.06 20.63 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.329 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.589 HD12 ' O ' ' A' ' 244' ' ' GLN . 9.6 mp -121.77 -168.14 1.65 Allowed 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.634 179.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . 0.522 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.83 -16.57 0.05 OUTLIER Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . 0.668 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -61.09 156.41 33.49 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -63.49 21.63 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.783 0.325 . . . . 0.0 110.563 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . 0.668 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.8 m-20 -96.93 -6.4 35.72 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.756 0.313 . . . . 0.0 110.492 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 91.8 mt -79.5 -21.72 44.92 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.931 179.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.79 -51.36 70.32 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.648 -179.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.33 -5.45 58.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.463 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -80.91 -74.25 1.14 Allowed Glycine 0 CA--C 1.522 0.528 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 80.8 mt -70.17 126.09 28.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.888 0.375 . . . . 0.0 110.344 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -59.69 -39.22 83.82 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.336 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 83.28 51.84 4.0 Favored Glycine 0 CA--C 1.521 0.446 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -95.58 -15.52 22.74 Favored 'General case' 0 C--N 1.331 -0.223 0 O-C-N 122.823 -0.222 . . . . 0.0 110.578 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 258' ' ' SER . . . . . 0.496 ' OG ' HG23 ' A' ' 191' ' ' VAL . 3.4 t 174.77 89.14 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.161 0.505 . . . . 0.0 110.268 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.85 ' N ' HD12 ' A' ' 259' ' ' LEU . 0.9 OUTLIER -94.76 124.2 38.65 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.857 0.361 . . . . 0.0 110.985 -178.729 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 260' ' ' PHE . . . . . 0.445 ' H ' ' HA ' ' A' ' 193' ' ' ALA . 15.7 m-30 -93.61 146.41 23.83 Favored 'General case' 0 CA--C 1.497 -1.064 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.543 179.202 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 85.0 mt -122.21 148.87 44.43 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.554 -179.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.74 ' CD1' HG13 ' A' ' 195' ' ' VAL . 2.5 p90 -77.17 -139.07 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.436 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 263' ' ' ALA . . . . . 0.654 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -51.15 77.22 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.353 0 O-C-N 123.435 0.459 . . . . 0.0 111.108 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . 0.624 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.43 104.64 0.19 Allowed Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 265' ' ' ASP . . . . . 0.588 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.6 m-20 -80.14 -177.77 6.23 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 122.703 -0.293 . . . . 0.0 110.718 -179.549 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -40.8 -17.78 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.496 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 267' ' ' LYS . . . . . 0.588 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.01 -51.3 48.69 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.758 179.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -64.11 -46.5 83.92 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.98 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . 0.572 ' HB1' ' OH ' ' A' ' 273' ' ' TYR . . . -61.76 -34.83 76.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.697 0.761 . . . . 0.0 109.883 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -62.93 -35.0 78.65 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.185 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.09 -43.12 14.18 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.184 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 272' ' ' ILE . . . . . 0.589 ' C ' ' H ' ' A' ' 274' ' ' ALA . 5.0 tt -51.64 -33.77 15.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.552 -178.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 273' ' ' TYR . . . . . 0.572 ' OH ' ' HB1' ' A' ' 269' ' ' ALA . 16.8 m-85 -54.58 -1.67 0.03 OUTLIER 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.767 -179.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 274' ' ' ALA . . . . . 0.589 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.5 -39.94 70.49 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.942 179.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . 0.574 ' O ' ' N ' ' A' ' 279' ' ' ALA . 3.1 p30 -38.52 97.52 0.14 Allowed Pre-proline 0 C--N 1.339 0.135 0 O-C-N 123.532 0.52 . . . . 0.0 110.429 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -53.72 -43.17 60.23 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 C-N-CA 122.577 2.184 . . . . 0.0 112.511 -178.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 88.9 mt -64.36 -43.01 95.88 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.008 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 91.7 mt -95.95 -1.06 49.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.75 -179.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 279' ' ' ALA . . . . . 0.574 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.65 -34.93 78.08 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.501 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.32 20.36 0.11 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.841 -179.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . 0.485 ' H ' ' C ' ' A' ' 279' ' ' ALA . 13.7 mt -74.68 119.82 78.54 Favored Pre-proline 0 N--CA 1.442 -0.837 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.776 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -51.15 -39.37 61.31 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 C-N-CA 122.507 2.138 . . . . 0.0 111.922 179.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.74 -50.54 63.25 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.898 0.38 . . . . 0.0 110.033 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 76.8 t -61.42 -43.88 97.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.169 179.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -57.56 -41.21 80.6 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.207 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -91.17 0.47 57.52 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.258 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt 59.26 43.91 16.25 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.84 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -95.01 41.2 1.09 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.32 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 53.9 t -119.13 135.58 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-O 121.018 0.437 . . . . 0.0 110.061 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -132.8 162.76 30.65 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.527 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.37 155.08 32.59 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.515 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 80.8 mt -94.09 -1.75 53.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.246 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 120.89 165.38 12.69 Favored Glycine 0 N--CA 1.464 0.504 0 N-CA-C 110.489 -1.045 . . . . 0.0 110.489 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 7.3 m -87.08 -62.47 1.5 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.829 0.347 . . . . 0.0 110.971 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 295' ' ' GLU . . . . . 0.45 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.5 mm-40 -68.71 -4.35 15.46 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.687 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 24.9 p -76.78 32.16 0.13 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.674 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 297' ' ' PHE . . . . . 0.502 ' CD2' HG22 ' A' ' 70' ' ' THR . 68.3 t80 -60.48 -46.21 90.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.664 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . 0.617 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.1 mtt85 -80.68 134.89 35.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.453 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.467 ' H ' HG11 ' A' ' 51' ' ' VAL . 18.6 tp -113.7 116.7 29.85 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-O 120.942 0.401 . . . . 0.0 110.385 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . 0.619 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.2 p-10 -165.0 -176.87 4.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.723 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -46.66 -43.22 17.45 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.373 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -67.15 -40.21 86.67 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 121.028 0.442 . . . . 0.0 110.752 179.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . 0.619 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 59.6 p -56.34 -36.27 68.58 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.079 -179.023 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . 0.546 ' HB2' ' SD ' ' A' ' 215' ' ' MET . . . -57.33 -51.47 69.25 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 179.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 91.9 mtp -55.71 -44.28 77.27 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -65.8 -42.75 90.32 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.227 0.537 . . . . 0.0 110.454 179.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 303' ' ' SER . 54.9 t -64.04 -42.82 96.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.262 179.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 44.2 tp -59.77 -41.92 92.16 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.041 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -62.79 -38.77 91.95 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.116 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 310' ' ' ARG . . . . . 0.449 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.6 ttt85 -63.56 -43.83 95.91 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.32 179.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 87.7 mt -63.37 -42.09 98.83 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.46 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.4 ttmt -63.03 -33.24 75.0 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.39 179.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.84 -23.47 21.67 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.395 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . 0.486 HD22 ' CE2' ' A' ' 315' ' ' PHE . 6.7 tt -62.31 -43.27 99.22 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.488 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 315' ' ' PHE . . . . . 0.486 ' CE2' HD22 ' A' ' 314' ' ' LEU . 90.4 m-85 . . . . . 0 C--O 1.22 -0.486 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.317 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -99.5 136.48 39.37 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.174 0.512 . . . . 0.0 110.424 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.485 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -91.58 178.7 1.65 Allowed Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.469 -179.707 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.485 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.3 Cg_exo -61.76 147.51 95.14 Favored 'Trans proline' 0 C--N 1.301 -1.948 0 C-N-CA 122.955 2.437 . . . . 0.0 112.207 179.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.472 ' HE ' HD12 ' A' ' 39' ' ' LEU . 35.3 ptt180 -135.02 142.35 46.38 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.591 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -79.01 116.85 19.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.496 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.425 ' O ' HG23 ' A' ' 30' ' ' ILE . 9.5 tp -109.93 130.61 62.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.494 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.8 t -70.54 141.59 51.86 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.685 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.421 ' OD2' ' O ' ' A' ' 141' ' ' ILE . 24.8 t70 -139.83 177.1 8.19 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.452 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.4 p -73.11 -36.57 66.77 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.707 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -47.62 -95.05 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.275 -179.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -166.15 -25.54 0.02 OUTLIER Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 62.7 m -168.5 106.42 0.47 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.691 0.281 . . . . 0.0 110.633 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.574 ' CD2' HD13 ' A' ' 140' ' ' LEU . 34.0 t60 -129.79 144.2 51.18 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-O 121.016 0.436 . . . . 0.0 110.099 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.626 HG22 ' N ' ' A' ' 39' ' ' LEU . 95.9 m -128.47 166.46 18.72 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.338 -179.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.626 ' N ' HG22 ' A' ' 38' ' ' THR . 81.4 mt -121.08 127.73 51.93 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.66 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -63.93 -44.64 92.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.689 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 38.3 p -165.45 155.36 12.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.45 179.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.519 ' H ' ' CD ' ' A' ' 42' ' ' GLN . 14.3 mp0 -42.33 100.07 0.22 Allowed Pre-proline 0 C--O 1.236 0.379 0 O-C-N 123.47 0.481 . . . . 0.0 110.564 179.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -56.87 129.3 33.82 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 122.362 2.041 . . . . 0.0 112.191 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -83.89 -24.16 30.92 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.649 179.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.539 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.6 mtm-85 -121.26 134.53 55.18 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.149 0.499 . . . . 0.0 110.193 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.2 mt -130.68 133.34 63.52 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.313 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.598 -179.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 47.0 t -124.91 130.87 73.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 CA-C-O 120.992 0.425 . . . . 0.0 110.039 179.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.595 ' OG ' HD12 ' A' ' 117' ' ' LEU . 4.6 m -154.32 166.38 33.37 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.513 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 67.4 p -124.45 8.96 8.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.389 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.94 125.44 33.36 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.599 -179.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.454 HG11 ' H ' ' A' ' 299' ' ' LEU . 84.5 t -65.51 -44.44 94.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.557 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.3 m -62.68 -44.25 96.72 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.598 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 52.1 tp -62.46 -41.48 98.78 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.573 -179.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.445 ' O ' HD13 ' A' ' 58' ' ' LEU . 73.3 m -57.83 -44.59 86.53 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.249 -179.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.26 -62.1 5.44 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.896 -0.881 . . . . 0.0 110.896 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.6 t -48.16 -35.67 12.09 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.6 mt -61.76 -44.42 96.92 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.161 179.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.459 HD21 HE22 ' A' ' 85' ' ' GLN . 9.1 mp -65.47 -41.06 93.75 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.412 177.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.404 ' HB1' ' NE ' ' A' ' 169' ' ' ARG . . . -63.78 -41.45 97.94 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.706 -179.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.411 ' O ' HG23 ' A' ' 60' ' ' ILE . 8.1 tp -87.8 16.77 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.82 -179.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 56.34 84.49 0.08 Allowed 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.828 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.22 58.52 0.08 OUTLIER Pre-proline 0 C--N 1.328 -0.368 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.414 ' HB3' HE21 ' A' ' 85' ' ' GLN . 9.6 Cg_endo -51.24 152.94 10.4 Favored 'Trans proline' 0 C--N 1.294 -2.335 0 C-N-CA 123.148 2.566 . . . . 0.0 112.206 -178.309 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.428 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -108.76 145.73 15.3 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.265 -179.685 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.68 -45.31 97.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.212 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.5 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -130.18 134.33 47.22 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.803 0.335 . . . . 0.0 110.352 -179.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.488 ' O ' ' N ' ' A' ' 98' ' ' LEU . 75.7 m -134.55 158.73 43.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.913 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.6 139.19 16.32 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.484 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.62 -162.82 0.09 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.893 0.378 . . . . 0.0 110.401 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.511 HG22 ' CD2' ' A' ' 297' ' ' PHE . 5.8 t -134.03 135.18 43.19 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.065 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.468 ' C ' ' O ' ' A' ' 70' ' ' THR . 0.8 OUTLIER 29.76 68.43 0.67 Allowed Pre-proline 0 N--CA 1.469 0.477 0 CA-C-O 121.138 0.494 . . . . 0.0 110.853 -179.522 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_exo -61.08 145.2 99.22 Favored 'Trans proline' 0 C--N 1.3 -1.985 0 C-N-CA 122.746 2.297 . . . . 0.0 111.842 -178.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.527 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 44.8 p-10 -159.86 -31.88 0.06 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.725 179.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.539 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 98.7 m-20 -64.45 -39.47 93.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.37 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.2 ttt180 -60.09 -48.56 81.22 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.354 -179.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.424 ' O ' ' O ' ' A' ' 77' ' ' ALA . 95.3 t -60.05 -25.0 31.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.16 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.539 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -45.59 172.89 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.614 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.568 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.3 p30 -61.91 177.68 0.42 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.484 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.563 ' C ' ' H ' ' A' ' 81' ' ' GLY . 36.2 p30 -45.64 85.55 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.95 0.405 . . . . 0.0 110.939 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.568 ' N ' ' O ' ' A' ' 78' ' ' ASP . 42.8 tp60 -67.35 13.56 0.07 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.235 0.541 . . . . 0.0 110.201 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.563 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 117.93 -22.55 9.79 Favored Glycine 0 N--CA 1.463 0.448 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -107.87 116.4 31.89 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.963 0.411 . . . . 0.0 110.415 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 76.1 mt -98.8 0.56 44.6 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.542 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -91.92 6.76 45.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.326 -179.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.779 ' O ' HG22 ' A' ' 89' ' ' VAL . 88.3 mt-30 -100.17 -26.96 13.76 Favored 'General case' 0 C--O 1.221 -0.441 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.733 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.1 t-105 -64.01 -40.75 97.03 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.952 -179.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.545 ' O ' ' N ' ' A' ' 91' ' ' LYS . 67.9 m -77.64 -53.33 7.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.053 -179.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -48.55 -51.05 29.57 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.919 -179.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.779 HG22 ' O ' ' A' ' 85' ' ' GLN . 15.7 m -68.83 -40.94 81.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.091 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.5 ' N ' HG23 ' A' ' 89' ' ' VAL . . . -71.87 -23.03 61.44 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.641 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.545 ' N ' ' O ' ' A' ' 87' ' ' SER . 65.9 tttm -61.52 -45.93 92.09 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.347 -179.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.441 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.6 mm-40 -90.27 -94.65 0.12 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.155 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.609 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.9 mtt180 -143.45 59.59 1.39 Allowed 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.437 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.7 pttp 34.24 26.08 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.247 0.546 . . . . 0.0 110.454 -179.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.609 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.4 tt -48.35 123.34 6.38 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.897 -177.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.452 ' O ' HD23 ' A' ' 95' ' ' LEU . 98.9 mm-40 -83.46 -170.6 3.13 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.275 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.615 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 83.0 mtp180 -73.56 137.62 44.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.984 0.421 . . . . 0.0 110.248 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.488 ' N ' ' O ' ' A' ' 67' ' ' SER . 90.1 mt -86.13 -166.18 1.47 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.899 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.532 ' CD2' ' O ' ' A' ' 99' ' ' TYR . 47.9 p90 -168.05 120.08 0.85 Allowed 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.084 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.488 ' C ' ' O ' ' A' ' 99' ' ' TYR . 43.2 mm -29.75 121.26 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 O-C-N 123.332 0.395 . . . . 0.0 110.922 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 113.87 28.17 3.25 Favored Glycine 0 N--CA 1.462 0.387 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 -179.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.578 ' N ' ' CD ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -143.99 45.81 0.59 Allowed Pre-proline 0 C--N 1.322 -0.594 0 CA-C-O 121.203 0.525 . . . . 0.0 110.436 179.791 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 29.6 Cg_endo -62.06 143.83 95.39 Favored 'Trans proline' 0 C--N 1.295 -2.277 0 C-N-CA 122.667 2.245 . . . . 0.0 111.815 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.455 ' O ' HG23 ' A' ' 108' ' ' VAL . 27.2 t -173.13 120.73 0.36 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.47 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.25 -40.69 64.43 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.192 179.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.16 -39.85 90.09 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.7 -179.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.1 -39.78 94.8 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.673 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 104' ' ' SER . 69.7 t -67.7 -43.75 86.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.596 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.5 -39.31 93.09 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.552 -179.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.441 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.68 -23.5 63.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.542 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.527 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.4 mm-40 -91.26 4.77 51.48 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.7 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.539 ' O ' ' NE ' ' A' ' 45' ' ' ARG . 10.7 tpt 22.51 64.52 0.34 Allowed Pre-proline 0 N--CA 1.47 0.57 0 O-C-N 123.342 0.401 . . . . 0.0 111.204 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.452 ' HG2' HD11 ' A' ' 116' ' ' ILE . 65.3 Cg_endo -79.37 169.1 19.22 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 123.085 2.524 . . . . 0.0 111.679 -177.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.515 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 98.6 m-20 -112.57 -43.67 3.45 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.116 179.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.4 tp -120.64 121.39 38.22 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 120.884 0.373 . . . . 0.0 110.091 179.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.457 HD13 HD22 ' A' ' 133' ' ' LEU . 96.9 mt -118.84 130.85 73.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-O 120.888 0.375 . . . . 0.0 110.858 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.595 HD12 ' OG ' ' A' ' 48' ' ' SER . 32.1 mt -105.69 132.55 51.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.344 -179.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.417 HD12 HG23 ' A' ' 139' ' ' THR . 98.1 mt -117.89 135.97 56.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.565 -179.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 86.9 p -71.79 152.9 42.33 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.577 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -59.96 -50.03 75.35 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.617 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -149.37 153.72 37.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.535 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 169.71 -170.55 42.81 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -63.02 -35.13 91.68 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.449 ' O ' ' OD1' ' A' ' 124' ' ' ASP . 44.1 p-10 -88.04 119.69 28.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.922 0.391 . . . . 0.0 110.578 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.444 ' O ' HD12 ' A' ' 129' ' ' LEU . 40.4 t -63.39 144.42 56.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.429 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.52 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.51 -42.76 9.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.742 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 56.0 tp -62.76 -42.34 99.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.677 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.25 -11.04 58.7 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.375 -179.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.444 HD12 ' O ' ' A' ' 125' ' ' SER . 83.8 mt -115.07 -24.58 8.49 Favored 'General case' 0 C--O 1.225 -0.234 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.57 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . 0.52 ' N ' ' O ' ' A' ' 126' ' ' ALA . 77.3 t80 -51.35 -49.84 60.65 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.936 -0.306 . . . . 0.0 110.612 -178.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.7 p-10 -65.77 -41.71 91.73 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.267 179.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.521 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 88.2 mt-30 -68.06 -36.97 80.73 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.826 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.457 HD22 HD13 ' A' ' 116' ' ' ILE . 94.1 mt -79.9 -42.19 24.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.915 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.3 t -57.05 -45.03 83.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.216 -179.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.7 m -62.23 -45.66 92.32 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.615 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 92.9 mt -62.48 -43.94 98.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.361 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.609 ' HB1' ' HD2' ' A' ' 138' ' ' PRO . . . -169.91 163.98 6.4 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.593 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.609 ' HD2' ' HB1' ' A' ' 137' ' ' ALA . 78.2 Cg_exo -43.17 111.94 0.26 Allowed 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.544 2.163 . . . . 0.0 112.3 179.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.485 HG21 ' CD1' ' A' ' 130' ' ' TYR . 17.1 m -86.07 127.59 34.71 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.487 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.574 HD13 ' CD2' ' A' ' 37' ' ' HIS . 34.9 tp -119.78 138.0 53.62 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.256 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.421 ' O ' ' OD2' ' A' ' 32' ' ' ASP . 79.2 mt -104.88 121.0 56.26 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.184 0 CA-C-O 121.068 0.461 . . . . 0.0 110.879 -179.14 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.497 HD12 HD22 ' A' ' 117' ' ' LEU . 93.2 mt -136.86 132.73 47.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.553 179.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.542 HD21 ' CG ' ' A' ' 241' ' ' ASP . 60.9 t30 -64.19 151.16 44.17 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.534 179.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.516 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 89.0 t80 -86.03 122.52 30.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.786 -179.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.516 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 99.1 m-20 55.3 69.16 0.76 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.547 179.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 36.2 p-10 -125.26 0.61 7.76 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.589 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -151.15 116.15 5.26 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.823 0.344 . . . . 0.0 110.581 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 85.3 p -63.24 168.08 4.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.564 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.403 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.7 p-90 -51.13 -15.65 0.37 Allowed 'General case' 0 C--O 1.221 -0.405 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.313 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . 0.439 ' O ' HG23 ' A' ' 154' ' ' THR . 68.1 tp60 -71.09 -74.89 0.14 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.009 0.433 . . . . 0.0 110.581 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 11.2 t -62.68 -38.87 92.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.238 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 52.3 tp -60.23 -45.57 92.78 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.451 -178.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.403 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 45.5 tp -62.61 -41.69 99.15 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.597 178.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.439 HG23 ' O ' ' A' ' 150' ' ' GLN . 56.1 p -63.85 -34.8 78.75 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.202 -179.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.481 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.4 mm-40 -63.69 -42.05 98.06 Favored 'General case' 0 C--O 1.224 -0.262 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.371 179.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 91.3 mt -65.44 -38.87 91.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.182 0.515 . . . . 0.0 110.376 178.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.557 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.34 -31.78 78.48 Favored Glycine 0 C--N 1.331 0.279 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 -179.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.481 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.3 mt-10 -37.18 -24.99 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.848 0.356 . . . . 0.0 110.948 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.557 ' N ' ' O ' ' A' ' 157' ' ' GLY . 93.8 mt -59.71 149.25 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.385 179.127 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 76.0 p -69.13 137.54 53.48 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.904 -179.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 70.41 22.28 77.65 Favored Glycine 0 CA--C 1.518 0.235 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 179.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 61.7 m80 -124.34 -14.14 7.01 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.621 0.248 . . . . 0.0 110.454 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -66.76 -59.55 3.47 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.56 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -51.73 -49.37 62.68 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.136 -179.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -60.3 -41.21 92.93 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.884 0.373 . . . . 0.0 110.501 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.38 -47.58 85.17 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.472 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.64 -40.06 74.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.306 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -61.7 -50.27 73.13 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.699 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.404 ' NE ' ' HB1' ' A' ' 59' ' ' ALA . 60.0 ttt85 -65.26 -43.67 90.57 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.576 179.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 94.7 mt -64.48 -43.46 96.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.346 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.51 -51.26 70.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.299 -179.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.56 -43.73 96.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.922 0.392 . . . . 0.0 110.655 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . 0.657 ' CE2' HD11 ' A' ' 177' ' ' LEU . 55.9 t80 -62.78 -44.29 96.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.363 179.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -63.57 -39.62 94.88 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.446 -179.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -63.15 -42.69 99.48 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.583 179.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -60.62 -44.81 95.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.241 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.657 HD11 ' CE2' ' A' ' 173' ' ' PHE . 85.2 mt -64.65 -41.03 96.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.871 178.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.02 -61.98 1.92 Allowed 'General case' 0 C--O 1.239 0.506 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.428 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.96 -46.8 87.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.333 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -52.97 -41.63 64.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.414 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -63.98 -33.71 76.34 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.32 179.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . 0.407 ' HG2' ' O ' ' A' ' 182' ' ' GLU . 69.7 tt0 -90.95 8.75 33.59 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.631 0.729 . . . . 0.0 110.258 -178.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -104.56 -31.97 9.18 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 122.041 -0.412 . . . . 0.0 111.099 179.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.6 pt -128.07 147.87 32.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.625 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -140.0 131.36 26.79 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.463 178.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . 0.591 HD22 ' N ' ' A' ' 186' ' ' LEU . 3.6 mm? -85.32 133.1 43.18 Favored Pre-proline 0 N--CA 1.447 -0.584 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.146 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -43.93 157.83 0.14 Allowed 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 122.597 2.198 . . . . 0.0 112.35 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . 0.49 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.6 Cg_endo -63.2 115.11 2.78 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.809 2.339 . . . . 0.0 111.615 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . 0.49 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.7 mt-30 155.91 147.99 0.0 OUTLIER Pre-proline 0 C--O 1.232 0.177 0 O-C-N 124.393 1.058 . . . . 0.0 110.871 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -73.54 144.01 35.29 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 122.612 2.208 . . . . 0.0 112.158 177.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.496 HG23 ' OG ' ' A' ' 258' ' ' SER . 2.1 p -124.82 159.17 31.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.409 0.623 . . . . 0.0 110.147 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . 0.485 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 35.4 p -143.2 165.47 27.35 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.048 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . 0.448 ' HA ' ' H ' ' A' ' 260' ' ' PHE . . . -135.4 128.89 32.42 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-O 121.364 0.602 . . . . 0.0 110.33 179.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.509 HD11 HD23 ' A' ' 259' ' ' LEU . 47.3 pt -146.42 148.83 16.62 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.374 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.113 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . 0.74 HG13 ' CD1' ' A' ' 262' ' ' PHE . 70.2 t -117.55 123.18 71.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.226 0.536 . . . . 0.0 109.973 178.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -134.31 107.07 7.43 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.054 0.454 . . . . 0.0 110.259 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 94.9 m -130.93 130.37 43.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.843 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.407 ' O ' ' N ' ' A' ' 201' ' ' HIS . . . -82.79 -36.84 25.28 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.295 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.22 -67.18 0.25 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.29 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.11 -10.15 59.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.425 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . 0.407 ' N ' ' O ' ' A' ' 198' ' ' ALA . 60.2 t-80 61.01 58.15 2.35 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.64 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 41.9 p -166.86 153.65 8.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.609 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.53 144.23 24.34 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.948 0.404 . . . . 0.0 110.441 179.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -135.42 138.41 43.21 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.554 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 19.4 mt -106.09 125.33 50.86 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.923 0.392 . . . . 0.0 109.974 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' TRP . . . . . 0.556 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 75.2 m95 -82.19 167.39 18.74 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.569 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . 0.449 HG22 ' C ' ' A' ' 206' ' ' TRP . 0.1 OUTLIER -157.14 171.67 7.15 Favored Pre-proline 0 C--O 1.225 -0.234 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.622 -178.764 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -53.79 -36.97 84.25 Favored 'Trans proline' 0 C--N 1.301 -1.935 0 C-N-CA 122.63 2.22 . . . . 0.0 112.306 179.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -71.09 -34.71 71.39 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.679 -179.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 21.7 m -61.3 150.72 34.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.569 -179.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.49 -36.97 81.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.418 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' GLN . . . . . 0.556 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 55.3 tt0 -64.72 -40.21 94.96 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.557 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.98 -43.49 91.12 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -62.91 -44.04 97.16 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.848 0.356 . . . . 0.0 110.249 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' MET . . . . . 0.546 ' SD ' ' HB2' ' A' ' 304' ' ' ALA . 65.4 ttp -59.41 -48.11 82.9 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.069 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 87.1 mt -60.19 -41.16 92.35 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' GLU . . . . . 0.45 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.1 tp10 -57.9 -37.97 74.99 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.148 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -65.49 -38.04 88.58 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.71 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 95.4 mt -64.09 -42.78 96.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.639 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.59 45.16 0.08 OUTLIER Glycine 0 N--CA 1.462 0.393 0 N-CA-C 111.054 -0.819 . . . . 0.0 111.054 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' PHE . . . . . 0.45 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 26.9 m-85 -128.07 155.23 44.7 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.926 0.393 . . . . 0.0 110.509 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.474 ' C ' HD22 ' A' ' 223' ' ' LEU . 6.9 p -106.94 122.23 46.02 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-O 121.299 0.571 . . . . 0.0 110.125 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.474 HD22 ' C ' ' A' ' 222' ' ' THR . 4.3 mm? -101.32 132.9 46.63 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.144 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.51 159.46 14.92 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.485 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.19 115.23 29.92 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.416 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.489 ' N ' HD12 ' A' ' 226' ' ' LEU . 9.1 mp -53.25 156.79 3.66 Favored Pre-proline 0 N--CA 1.447 -0.623 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.796 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -60.2 145.26 98.92 Favored 'Trans proline' 0 C--N 1.302 -1.873 0 C-N-CA 122.735 2.29 . . . . 0.0 112.145 179.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.42 -3.01 59.01 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.544 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.19 -40.91 5.67 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . 0.51 ' O ' ' N ' ' A' ' 233' ' ' SER . 84.8 mt -79.23 -16.85 55.87 Favored 'General case' 0 C--O 1.218 -0.562 0 CA-C-O 121.131 0.491 . . . . 0.0 110.323 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 54.3 t-20 -40.38 -49.33 2.8 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.839 0.352 . . . . 0.0 110.733 -179.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -87.99 15.44 7.27 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.251 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . 0.51 ' N ' ' O ' ' A' ' 230' ' ' LEU . 77.8 p -60.59 -35.29 75.74 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.655 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . 0.524 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.6 tt0 -119.03 -69.33 0.86 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.753 0.311 . . . . 0.0 110.751 179.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.2 m -70.0 102.62 2.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.633 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -94.08 57.76 2.44 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.361 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -144.72 -122.59 1.58 Allowed Glycine 0 N--CA 1.461 0.363 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -134.84 111.59 10.01 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.059 0.456 . . . . 0.0 110.35 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . 0.517 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.4 mtt180 -148.05 57.94 1.09 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.664 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -69.75 -31.98 70.26 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.521 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' ASP . . . . . 0.542 ' CG ' HD21 ' A' ' 143' ' ' ASN . 64.9 t0 -56.92 -47.11 81.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.255 -179.004 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' ILE . . . . . 0.437 ' O ' ' O ' ' A' ' 239' ' ' ARG . 17.8 tt -139.95 156.63 25.41 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.263 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.391 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.445 HG22 HD13 ' A' ' 245' ' ' LEU . 96.1 mt -106.02 106.37 20.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-O 120.971 0.415 . . . . 0.0 110.468 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . 0.59 ' C ' HD12 ' A' ' 245' ' ' LEU . 88.2 mt-30 -110.57 110.17 20.77 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.362 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.59 HD12 ' C ' ' A' ' 244' ' ' GLN . 9.6 mp -121.77 -168.24 1.67 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.666 179.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . 0.524 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.7 -16.93 0.05 OUTLIER Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . 0.67 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -60.47 156.7 30.4 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 110.829 -0.908 . . . . 0.0 110.829 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -63.57 21.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.825 0.345 . . . . 0.0 110.583 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . 0.67 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.8 m-20 -96.85 -6.04 36.84 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.436 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 91.5 mt -79.89 -21.65 43.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.902 179.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.65 -51.35 70.28 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.661 -179.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.7 -5.1 58.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.458 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.27 -74.06 1.16 Allowed Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 80.1 mt -70.02 125.95 28.24 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.883 0.373 . . . . 0.0 110.334 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -59.53 -39.48 84.07 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.254 -179.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 83.27 51.77 4.02 Favored Glycine 0 CA--C 1.52 0.368 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -95.3 -15.76 22.9 Favored 'General case' 0 C--N 1.33 -0.243 0 O-C-N 122.77 -0.253 . . . . 0.0 110.661 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 258' ' ' SER . . . . . 0.496 ' OG ' HG23 ' A' ' 191' ' ' VAL . 3.4 t 174.87 89.31 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.227 0.537 . . . . 0.0 110.244 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.849 ' N ' HD12 ' A' ' 259' ' ' LEU . 0.9 OUTLIER -94.8 124.31 38.77 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.052 0.453 . . . . 0.0 111.052 -178.78 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 260' ' ' PHE . . . . . 0.448 ' H ' ' HA ' ' A' ' 193' ' ' ALA . 15.8 m-30 -93.58 146.4 23.84 Favored 'General case' 0 CA--C 1.495 -1.142 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.494 179.273 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 85.9 mt -122.18 149.24 43.91 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.564 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.74 ' CD1' HG13 ' A' ' 195' ' ' VAL . 2.6 p90 -77.23 -138.82 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.534 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 263' ' ' ALA . . . . . 0.652 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -51.39 77.03 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.407 0 O-C-N 123.415 0.447 . . . . 0.0 111.171 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . 0.625 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.16 104.74 0.19 Allowed Glycine 0 CA--C 1.528 0.87 0 N-CA-C 110.421 -1.072 . . . . 0.0 110.421 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 265' ' ' ASP . . . . . 0.589 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.4 m-20 -80.21 -177.9 6.32 Favored 'General case' 0 C--N 1.327 -0.394 0 O-C-N 122.671 -0.311 . . . . 0.0 110.847 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -40.7 -17.76 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.549 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 267' ' ' LYS . . . . . 0.589 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.21 -51.44 45.48 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.614 179.22 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -63.9 -46.39 85.05 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.997 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . 0.566 ' HB1' ' OH ' ' A' ' 273' ' ' TYR . . . -61.88 -34.92 76.9 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.657 0.741 . . . . 0.0 109.824 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -62.82 -34.66 77.77 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.292 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.43 -43.11 13.9 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.049 -179.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 272' ' ' ILE . . . . . 0.595 ' C ' ' H ' ' A' ' 274' ' ' ALA . 4.9 tt -51.53 -33.71 14.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.678 -178.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 273' ' ' TYR . . . . . 0.566 ' OH ' ' HB1' ' A' ' 269' ' ' ALA . 17.2 m-85 -54.71 -1.55 0.03 OUTLIER 'General case' 0 CA--C 1.513 -0.452 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.616 -179.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 274' ' ' ALA . . . . . 0.595 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.61 -39.78 70.24 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.802 179.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . 0.573 ' O ' ' N ' ' A' ' 279' ' ' ALA . 2.6 p30 -38.98 97.9 0.15 Allowed Pre-proline 0 N--CA 1.462 0.151 0 O-C-N 123.49 0.494 . . . . 0.0 110.33 -179.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -54.18 -42.92 63.12 Favored 'Trans proline' 0 C--N 1.303 -1.845 0 C-N-CA 122.58 2.187 . . . . 0.0 112.491 -178.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 88.5 mt -64.41 -43.02 95.69 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.015 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 91.5 mt -95.66 -1.45 50.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.863 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 279' ' ' ALA . . . . . 0.573 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.58 -34.87 77.84 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.486 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.32 20.14 0.12 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.9 -179.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . 0.483 ' H ' ' C ' ' A' ' 279' ' ' ALA . 13.8 mt -74.65 119.53 77.1 Favored Pre-proline 0 N--CA 1.442 -0.838 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.849 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -50.57 -39.71 55.47 Favored 'Trans proline' 0 C--N 1.312 -1.36 0 C-N-CA 122.535 2.156 . . . . 0.0 112.063 178.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.73 -50.69 62.92 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.874 0.369 . . . . 0.0 110.021 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 76.9 t -61.4 -43.77 97.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.162 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -57.81 -41.2 81.71 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.089 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -91.0 0.63 57.5 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.245 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt 59.16 43.63 16.94 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.966 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -95.1 41.22 1.1 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.314 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 53.9 t -118.9 135.68 58.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-O 121.119 0.485 . . . . 0.0 109.967 -179.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -132.81 162.73 30.75 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.534 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.54 155.12 32.79 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.523 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 81.0 mt -94.09 -1.73 53.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.256 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.14 165.59 12.71 Favored Glycine 0 N--CA 1.465 0.613 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 6.8 m -87.33 -62.34 1.52 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.879 0.371 . . . . 0.0 110.947 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 295' ' ' GLU . . . . . 0.446 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.6 mm-40 -69.02 -4.07 15.48 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.755 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 24.5 p -76.92 32.32 0.14 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.68 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 297' ' ' PHE . . . . . 0.511 ' CD2' HG22 ' A' ' 70' ' ' THR . 70.8 t80 -60.43 -45.97 91.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.624 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . 0.615 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.1 mtt85 -81.27 134.85 35.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.543 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.454 ' H ' HG11 ' A' ' 51' ' ' VAL . 17.7 tp -113.68 117.22 30.95 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-O 120.918 0.39 . . . . 0.0 110.391 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . 0.639 ' H ' ' CB ' ' A' ' 303' ' ' SER . 49.9 p-10 -165.3 -176.47 4.06 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.758 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 80.2 t80 -46.81 -43.49 18.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.391 -179.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -66.92 -40.35 87.61 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 121.037 0.446 . . . . 0.0 110.723 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . 0.639 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 60.1 p -55.99 -36.37 67.81 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.062 -179.054 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . 0.546 ' HB2' ' SD ' ' A' ' 215' ' ' MET . . . -57.11 -51.8 67.85 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 179.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 92.2 mtp -55.48 -44.45 76.52 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -65.86 -42.66 90.15 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.309 0.576 . . . . 0.0 110.398 179.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 303' ' ' SER . 55.6 t -63.96 -42.92 97.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.253 179.307 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 44.0 tp -59.73 -41.93 92.02 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.029 -179.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -62.87 -38.69 91.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.069 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 310' ' ' ARG . . . . . 0.446 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.7 ttt85 -63.42 -43.84 96.34 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.295 179.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 90.2 mt -63.1 -42.1 99.52 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.489 179.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -63.01 -33.36 75.25 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.304 179.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.48 -23.54 22.06 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.285 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . 0.481 HD22 ' CE2' ' A' ' 315' ' ' PHE . 6.7 tt -62.31 -43.19 99.4 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 121.012 0.434 . . . . 0.0 110.526 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 315' ' ' PHE . . . . . 0.481 ' CE2' HD22 ' A' ' 314' ' ' LEU . 89.4 m-85 . . . . . 0 C--O 1.22 -0.461 0 CA-C-O 118.041 -0.98 . . . . 0.0 110.263 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -99.73 135.85 40.54 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.167 0.508 . . . . 0.0 110.403 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.492 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -92.33 178.62 1.61 Allowed Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.533 -179.797 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.492 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.0 Cg_exo -61.68 147.29 95.68 Favored 'Trans proline' 0 C--N 1.298 -2.104 0 C-N-CA 122.893 2.396 . . . . 0.0 112.164 179.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.498 ' HE ' HD12 ' A' ' 39' ' ' LEU . 35.3 ptt180 -136.91 142.59 42.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.636 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -79.52 117.06 20.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.459 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.443 ' O ' HG23 ' A' ' 30' ' ' ILE . 9.5 tp -111.5 130.74 64.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.468 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.6 t -71.55 142.41 50.07 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.677 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.481 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.6 t0 -139.54 -179.81 6.12 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.502 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.481 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 77.9 p -73.83 -37.34 64.87 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.655 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.8 ttt85 -46.97 -94.77 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.335 -179.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -165.9 -27.02 0.02 OUTLIER Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 63.4 m -168.67 105.98 0.44 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.834 0.35 . . . . 0.0 110.643 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.638 ' CD2' HD13 ' A' ' 140' ' ' LEU . 64.4 t60 -129.11 146.15 51.12 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 121.11 0.481 . . . . 0.0 110.112 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.62 HG22 ' N ' ' A' ' 39' ' ' LEU . 93.3 m -129.36 165.59 21.21 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.4 -179.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.62 ' N ' HG22 ' A' ' 38' ' ' THR . 79.6 mt -120.26 127.23 52.21 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.537 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -65.39 -44.78 86.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.698 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 39.0 p -165.83 155.28 12.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.374 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.483 ' H ' ' CD ' ' A' ' 42' ' ' GLN . 14.5 mp0 -45.2 101.26 0.25 Allowed Pre-proline 0 C--O 1.235 0.325 0 O-C-N 123.6 0.562 . . . . 0.0 110.558 179.227 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -57.77 130.34 38.04 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 C-N-CA 122.326 2.018 . . . . 0.0 112.315 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -82.76 -24.9 33.28 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.601 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.531 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.7 mtm-85 -120.86 134.98 55.29 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.225 0.536 . . . . 0.0 110.135 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.1 mt -130.26 133.48 63.98 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.345 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.818 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 45.7 t -125.24 130.87 72.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 CA-C-O 120.967 0.413 . . . . 0.0 109.924 179.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.61 ' OG ' HD12 ' A' ' 117' ' ' LEU . 4.7 m -154.87 166.48 33.38 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.527 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 72.8 p -124.49 8.88 8.38 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.313 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.68 125.69 33.37 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.857 0.36 . . . . 0.0 110.635 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.465 HG11 ' H ' ' A' ' 299' ' ' LEU . 85.5 t -65.71 -44.44 93.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.553 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.8 m -62.7 -44.34 96.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.63 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 53.8 tp -62.46 -41.41 98.73 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.613 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.447 ' O ' HD13 ' A' ' 58' ' ' LEU . 74.3 m -57.89 -44.6 86.84 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.269 -179.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.27 -62.12 5.42 Favored Glycine 0 N--CA 1.468 0.788 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.6 t -48.24 -35.6 12.31 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 20.1 mt -61.85 -44.02 97.67 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 120.594 -0.442 . . . . 0.0 111.383 179.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.447 HD13 ' O ' ' A' ' 54' ' ' THR . 9.3 mp -65.43 -41.34 93.63 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.404 177.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.82 -41.27 97.9 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.914 -179.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.415 ' O ' HG23 ' A' ' 60' ' ' ILE . 7.9 tp -87.66 16.55 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.918 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 56.44 84.42 0.09 Allowed 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.841 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.25 58.91 0.08 OUTLIER Pre-proline 0 C--N 1.327 -0.389 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.423 ' HB3' HE21 ' A' ' 85' ' ' GLN . 9.5 Cg_endo -51.6 152.78 11.97 Favored 'Trans proline' 0 C--N 1.292 -2.437 0 C-N-CA 123.074 2.516 . . . . 0.0 112.053 -178.3 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.431 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -108.78 145.86 15.15 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.152 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.262 -179.646 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.61 -45.3 97.93 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.471 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.504 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -129.83 134.29 47.45 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.47 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.494 ' O ' ' N ' ' A' ' 98' ' ' LEU . 72.1 m -134.38 158.54 43.58 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.895 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.42 139.01 16.31 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.486 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.61 -162.98 0.09 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.953 0.406 . . . . 0.0 110.437 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.5 HG22 ' CD2' ' A' ' 297' ' ' PHE . 5.7 t -133.91 135.83 43.88 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.015 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.473 ' C ' ' O ' ' A' ' 70' ' ' THR . 1.0 OUTLIER 29.68 68.23 0.68 Allowed Pre-proline 0 N--CA 1.468 0.438 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.78 -179.68 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_exo -61.32 145.11 98.7 Favored 'Trans proline' 0 C--N 1.299 -2.072 0 C-N-CA 122.644 2.23 . . . . 0.0 111.762 -177.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.527 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 45.5 p-10 -160.15 -32.02 0.06 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.746 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.528 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 99.1 m-20 -64.29 -39.31 93.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.326 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -60.5 -47.88 84.21 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.509 -179.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.423 ' O ' ' O ' ' A' ' 77' ' ' ALA . 94.3 t -60.48 -24.46 31.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.528 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -45.73 173.03 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.602 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.567 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.6 p30 -61.92 177.59 0.43 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.58 -179.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.562 ' C ' ' H ' ' A' ' 81' ' ' GLY . 36.2 p30 -45.73 85.57 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.031 0.443 . . . . 0.0 111.069 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.567 ' N ' ' O ' ' A' ' 78' ' ' ASP . 42.4 tp60 -67.4 13.36 0.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.297 0.57 . . . . 0.0 110.172 -179.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.562 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 118.06 -22.53 9.71 Favored Glycine 0 C--N 1.333 0.372 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -107.82 116.04 31.24 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.056 0.455 . . . . 0.0 110.461 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 77.7 mt -98.47 0.67 45.62 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.991 0.424 . . . . 0.0 110.553 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -92.08 6.84 44.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.058 0.456 . . . . 0.0 110.387 -179.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.783 ' O ' HG22 ' A' ' 89' ' ' VAL . 88.4 mt-30 -100.02 -26.99 13.79 Favored 'General case' 0 C--O 1.22 -0.467 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.821 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.4 t-105 -63.8 -40.66 97.18 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.09 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.546 ' O ' ' N ' ' A' ' 91' ' ' LYS . 69.4 m -77.55 -53.27 7.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.134 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -48.9 -50.8 33.35 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.138 -179.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.783 HG22 ' O ' ' A' ' 85' ' ' GLN . 15.3 m -68.75 -40.62 81.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.232 179.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.494 ' N ' HG23 ' A' ' 89' ' ' VAL . . . -72.26 -23.07 61.15 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.678 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.546 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.0 tttm -61.32 -45.93 92.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.369 -179.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.439 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.8 mm-40 -90.5 -94.52 0.12 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.066 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.617 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.9 mtt180 -143.56 60.0 1.39 Allowed 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.442 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.7 pttp 34.22 25.86 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.105 0.478 . . . . 0.0 110.339 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.617 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.4 tt -48.25 123.01 5.83 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.064 -177.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.451 ' O ' HD23 ' A' ' 95' ' ' LEU . 98.9 mm-40 -83.08 -170.62 3.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.059 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.62 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 83.0 mtp180 -73.32 137.85 45.04 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.128 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.494 ' N ' ' O ' ' A' ' 67' ' ' SER . 90.5 mt -86.65 -165.79 1.37 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.886 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.532 ' CD2' ' O ' ' A' ' 99' ' ' TYR . 47.5 p90 -168.84 119.98 0.75 Allowed 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.154 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.492 ' C ' ' O ' ' A' ' 99' ' ' TYR . 43.9 mm -29.22 121.06 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 O-C-N 123.308 0.38 . . . . 0.0 111.125 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 114.15 27.76 3.31 Favored Glycine 0 N--CA 1.461 0.341 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 -179.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.582 ' N ' ' CD ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -143.93 45.82 0.6 Allowed Pre-proline 0 C--N 1.321 -0.649 0 CA-C-O 121.079 0.466 . . . . 0.0 110.391 179.716 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.582 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 29.6 Cg_endo -62.42 144.16 94.51 Favored 'Trans proline' 0 C--N 1.294 -2.342 0 C-N-CA 122.687 2.258 . . . . 0.0 111.727 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.456 ' O ' HG23 ' A' ' 108' ' ' VAL . 24.8 t -173.36 121.04 0.35 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.377 179.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.29 -40.92 64.16 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.989 0.423 . . . . 0.0 111.125 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -65.91 -39.85 90.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.865 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.94 -39.64 94.63 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.754 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 104' ' ' SER . 70.0 t -67.52 -43.71 87.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.681 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.49 -39.28 92.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.474 -179.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.439 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.94 -23.83 63.87 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.476 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.537 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.3 mm-40 -91.18 5.04 50.65 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.667 -179.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.537 ' C ' ' O ' ' A' ' 111' ' ' GLN . 10.2 tpt 21.54 64.95 0.3 Allowed Pre-proline 0 N--CA 1.469 0.516 0 CA-C-O 120.961 0.41 . . . . 0.0 111.337 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.461 ' HG2' HD11 ' A' ' 116' ' ' ILE . 61.6 Cg_endo -80.01 169.9 17.22 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 123.094 2.53 . . . . 0.0 111.517 -177.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.519 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 99.2 m-20 -112.34 -45.1 3.3 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.973 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 39.4 tp -119.51 121.23 38.94 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.461 HD11 ' HG2' ' A' ' 113' ' ' PRO . 96.7 mt -118.45 131.41 71.3 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.432 0 CA-C-O 120.953 0.406 . . . . 0.0 111.013 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.61 HD12 ' OG ' ' A' ' 48' ' ' SER . 32.4 mt -106.04 132.24 52.35 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 121.086 0.47 . . . . 0.0 110.156 -179.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.495 HD12 HG23 ' A' ' 139' ' ' THR . 98.6 mt -117.75 135.75 57.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.628 -179.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 85.3 p -71.17 151.32 44.51 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.62 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.42 -49.98 75.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.642 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.0 t -149.19 153.71 38.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.539 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 168.19 -169.68 41.6 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.93 -35.7 92.42 Favored Glycine 0 CA--C 1.522 0.513 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.445 ' O ' ' OD1' ' A' ' 124' ' ' ASP . 44.2 p-10 -88.2 120.18 29.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.867 0.365 . . . . 0.0 110.696 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.439 ' O ' HD12 ' A' ' 129' ' ' LEU . 41.3 t -63.6 143.78 57.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.363 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.515 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.67 -42.82 8.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.863 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.4 tp -62.78 -42.45 99.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.674 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.76 -10.43 52.58 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.382 -179.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.439 HD12 ' O ' ' A' ' 125' ' ' SER . 83.4 mt -116.23 -24.0 8.17 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.65 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . 0.525 ' CD1' HG21 ' A' ' 139' ' ' THR . 72.6 t80 -51.79 -49.08 63.42 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.639 -178.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 39.0 p-10 -65.96 -41.56 91.07 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.324 179.203 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.525 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 87.9 mt-30 -68.14 -36.68 80.08 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.874 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.457 HD12 HD11 ' A' ' 118' ' ' ILE . 96.3 mt -79.89 -42.67 23.69 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.017 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.402 ' N ' ' OG1' ' A' ' 139' ' ' THR . 11.3 t -57.37 -45.07 84.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.343 -179.018 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 20.0 m -62.36 -45.88 91.17 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.566 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 93.0 mt -62.28 -43.71 98.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.349 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.598 ' HB1' ' HD2' ' A' ' 138' ' ' PRO . . . -170.1 163.32 6.38 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.559 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.598 ' HD2' ' HB1' ' A' ' 137' ' ' ALA . 78.3 Cg_exo -41.69 110.37 0.14 Allowed 'Trans proline' 0 C--N 1.311 -1.428 0 C-N-CA 122.486 2.124 . . . . 0.0 112.344 179.092 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.525 HG21 ' CD1' ' A' ' 130' ' ' TYR . 3.0 m -87.37 127.46 35.2 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.542 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.638 HD13 ' CD2' ' A' ' 37' ' ' HIS . 34.3 tp -119.29 139.24 52.24 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.259 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.428 ' O ' ' OD2' ' A' ' 32' ' ' ASP . 81.3 mt -105.32 120.1 55.49 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.352 0 CA-C-O 121.132 0.491 . . . . 0.0 111.196 -179.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.48 HD12 HD22 ' A' ' 117' ' ' LEU . 97.4 mt -135.69 132.75 51.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.585 179.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.55 HD21 ' CG ' ' A' ' 241' ' ' ASP . 59.3 t30 -64.62 148.22 51.35 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.933 0.397 . . . . 0.0 110.38 179.264 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.515 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 87.6 t80 -82.74 122.72 28.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.973 -179.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.515 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 99.0 m-20 55.11 69.12 0.77 Allowed 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.784 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 34.5 p-10 -125.7 0.31 7.45 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.856 0.36 . . . . 0.0 110.636 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -150.42 115.51 5.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.691 -179.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 85.0 p -63.49 168.94 4.16 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.538 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.414 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.5 p-90 -51.84 -16.08 0.63 Allowed 'General case' 0 C--O 1.219 -0.505 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.326 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . 0.436 ' O ' HG23 ' A' ' 154' ' ' THR . 67.9 tp60 -70.11 -76.05 0.11 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.891 0.377 . . . . 0.0 110.542 -179.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.433 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.1 t -62.48 -38.66 90.7 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.253 179.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 52.1 tp -60.16 -45.61 92.48 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.354 -178.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.414 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 45.8 tp -62.6 -41.76 99.16 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.55 178.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.436 HG23 ' O ' ' A' ' 150' ' ' GLN . 58.7 p -63.86 -34.94 79.06 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.098 -179.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.467 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 88.0 mm-40 -63.66 -42.03 98.13 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.23 179.291 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 91.6 mt -65.34 -38.82 91.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.192 0.52 . . . . 0.0 110.243 179.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.566 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.34 -32.3 80.38 Favored Glycine 0 C--N 1.332 0.316 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 -179.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.467 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.4 mt-10 -36.79 -25.19 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.901 0.381 . . . . 0.0 110.862 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.566 ' N ' ' O ' ' A' ' 157' ' ' GLY . 94.9 mt -59.22 148.43 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.292 179.031 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 74.6 p -69.09 137.63 53.66 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.994 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 70.48 22.14 77.72 Favored Glycine 0 N--CA 1.458 0.136 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 179.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 59.9 m80 -124.48 -13.96 6.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.597 0.237 . . . . 0.0 110.426 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -66.81 -59.49 3.5 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.593 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -51.92 -48.89 63.99 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.153 -179.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -60.55 -41.09 93.83 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.806 0.336 . . . . 0.0 110.405 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.68 -47.43 85.34 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.534 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.63 -40.27 75.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.225 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -61.58 -50.44 72.59 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.672 179.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -65.25 -43.66 90.66 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.586 179.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 94.4 mt -64.63 -43.33 96.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.441 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.4 -51.12 70.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.313 -179.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.63 -43.41 96.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.851 0.357 . . . . 0.0 110.635 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . 0.662 ' CE2' HD11 ' A' ' 177' ' ' LEU . 57.7 t80 -62.94 -44.25 96.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.402 179.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -63.69 -39.65 94.86 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.477 -179.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -63.18 -42.82 99.42 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.564 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -60.63 -44.45 96.33 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.175 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.662 HD11 ' CE2' ' A' ' 173' ' ' PHE . 84.8 mt -64.44 -41.12 96.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.78 178.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.34 -62.14 1.83 Allowed 'General case' 0 C--O 1.24 0.553 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.281 -179.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.23 -47.23 84.16 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.432 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -52.73 -41.72 64.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.353 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -63.74 -33.59 75.99 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.055 0.455 . . . . 0.0 110.284 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . 0.41 ' HG2' ' O ' ' A' ' 182' ' ' GLU . 69.8 tt0 -91.08 8.52 35.08 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.666 0.746 . . . . 0.0 110.318 -178.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -104.33 -32.45 9.06 Favored 'General case' 0 CA--C 1.516 -0.361 0 O-C-N 122.001 -0.437 . . . . 0.0 111.222 179.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.7 pt -127.9 147.57 32.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.801 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -139.78 131.26 26.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.966 0.412 . . . . 0.0 110.395 179.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . 0.59 HD22 ' N ' ' A' ' 186' ' ' LEU . 3.5 mm? -85.34 133.59 42.16 Favored Pre-proline 0 N--CA 1.449 -0.516 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.193 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -43.65 157.76 0.12 Allowed 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.617 2.212 . . . . 0.0 112.372 179.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . 0.497 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.7 Cg_endo -63.04 114.69 2.55 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 122.817 2.344 . . . . 0.0 111.664 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . 0.497 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.7 mt-30 155.65 148.17 0.0 OUTLIER Pre-proline 0 N--CA 1.456 -0.159 0 O-C-N 124.244 0.965 . . . . 0.0 110.885 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -73.26 144.26 36.77 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.583 2.189 . . . . 0.0 112.289 177.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.496 HG23 ' OG ' ' A' ' 258' ' ' SER . 2.1 p -124.61 158.87 31.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.461 0.648 . . . . 0.0 110.197 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . 0.487 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 36.6 p -143.18 165.39 27.57 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.112 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . 0.448 ' HA ' ' H ' ' A' ' 260' ' ' PHE . . . -135.44 128.88 32.32 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-O 121.339 0.59 . . . . 0.0 110.209 179.232 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.509 HD11 HD23 ' A' ' 259' ' ' LEU . 47.7 pt -146.73 149.38 15.92 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.404 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.21 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . 0.736 HG13 ' CD1' ' A' ' 262' ' ' PHE . 69.4 t -117.87 123.41 71.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.402 0.62 . . . . 0.0 109.792 179.002 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -134.34 106.75 7.25 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 121.104 0.478 . . . . 0.0 110.208 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 94.7 m -130.7 130.44 43.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.943 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.413 ' O ' ' N ' ' A' ' 201' ' ' HIS . . . -82.8 -37.18 24.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.25 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.21 -66.92 0.27 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.288 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.47 -9.54 58.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.273 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . 0.413 ' N ' ' O ' ' A' ' 198' ' ' ALA . 60.1 t-80 60.32 58.27 2.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.81 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 39.5 p -167.02 153.79 8.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.568 179.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.36 144.19 24.45 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.054 0.454 . . . . 0.0 110.454 179.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -135.29 138.09 43.13 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.605 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 19.4 mt -106.04 125.44 51.0 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.055 0.455 . . . . 0.0 109.796 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' TRP . . . . . 0.555 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 74.5 m95 -82.15 167.14 19.03 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.587 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . 0.46 HG22 ' C ' ' A' ' 206' ' ' TRP . 0.1 OUTLIER -157.45 171.32 7.59 Favored Pre-proline 0 C--O 1.224 -0.268 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.624 -178.909 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -53.18 -37.12 79.69 Favored 'Trans proline' 0 C--N 1.301 -1.965 0 C-N-CA 122.583 2.189 . . . . 0.0 112.448 178.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -70.84 -35.23 72.34 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.71 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 21.0 m -60.95 151.0 31.53 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.572 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.8 -36.96 82.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.485 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' GLN . . . . . 0.555 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 55.1 tt0 -64.69 -40.27 95.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.519 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.63 -43.58 91.71 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.631 -0.988 . . . . 0.0 110.631 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -62.88 -44.0 97.27 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.789 0.328 . . . . 0.0 110.219 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' MET . . . . . 0.551 ' SD ' ' HB2' ' A' ' 304' ' ' ALA . 65.1 ttp -59.32 -47.91 83.63 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.071 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 87.0 mt -60.73 -41.16 94.76 Favored 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' GLU . . . . . 0.449 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.6 tp10 -58.03 -37.89 75.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.35 -0.386 . . . . 0.0 109.994 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -65.38 -38.31 89.63 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.671 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 95.2 mt -63.91 -42.9 97.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.111 0.482 . . . . 0.0 110.613 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.56 44.93 0.08 OUTLIER Glycine 0 C--N 1.332 0.359 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' PHE . . . . . 0.449 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 26.6 m-85 -127.89 155.49 44.09 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 121.054 0.454 . . . . 0.0 110.439 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.481 ' O ' HG13 ' A' ' 191' ' ' VAL . 7.0 p -106.96 122.34 46.24 Favored 'General case' 0 C--O 1.223 -0.294 0 CA-C-O 121.331 0.586 . . . . 0.0 110.067 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.474 HD22 ' C ' ' A' ' 222' ' ' THR . 4.3 mm? -101.4 133.01 46.68 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.229 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.8 159.8 14.72 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.456 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.52 115.35 30.1 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.935 0.398 . . . . 0.0 110.339 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.498 ' N ' HD12 ' A' ' 226' ' ' LEU . 8.9 mp -53.08 156.54 3.57 Favored Pre-proline 0 N--CA 1.448 -0.559 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.817 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -59.91 145.17 98.97 Favored 'Trans proline' 0 C--N 1.299 -2.03 0 C-N-CA 122.753 2.302 . . . . 0.0 112.312 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.09 -3.35 59.07 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.516 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.2 -40.96 5.66 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . 0.506 ' O ' ' N ' ' A' ' 233' ' ' SER . 67.7 mt -79.08 -17.8 54.52 Favored 'General case' 0 C--O 1.218 -0.587 0 CA-C-O 121.212 0.529 . . . . 0.0 110.296 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 54.5 t-20 -40.74 -49.17 3.09 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.845 -179.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -87.16 15.05 6.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.459 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . 0.506 ' N ' ' O ' ' A' ' 230' ' ' LEU . 77.9 p -60.56 -34.99 74.98 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.683 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . 0.525 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.5 tt0 -119.73 -69.3 0.85 Allowed 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.835 179.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.3 m -69.3 102.19 1.68 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.022 0.439 . . . . 0.0 110.687 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -94.08 57.51 2.4 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.086 0.47 . . . . 0.0 110.365 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -144.61 -122.43 1.58 Allowed Glycine 0 C--N 1.332 0.343 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -135.64 111.78 9.67 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.161 0.505 . . . . 0.0 110.347 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . 0.524 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.5 mtt180 -148.08 58.26 1.09 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.707 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -69.36 -32.48 71.57 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.457 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' ASP . . . . . 0.55 ' CG ' HD21 ' A' ' 143' ' ' ASN . 64.7 t0 -57.04 -47.24 81.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.211 -178.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' ILE . . . . . 0.435 ' O ' ' O ' ' A' ' 239' ' ' ARG . 18.1 tt -139.62 155.87 25.69 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.275 0 CA-C-O 120.913 0.387 . . . . 0.0 110.44 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.445 HG22 HD13 ' A' ' 245' ' ' LEU . 96.3 mt -106.17 106.87 21.39 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 CA-C-O 121.099 0.476 . . . . 0.0 110.479 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . 0.595 ' O ' HD12 ' A' ' 245' ' ' LEU . 88.3 mt-30 -110.71 110.04 20.54 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.261 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.595 HD12 ' O ' ' A' ' 244' ' ' GLN . 9.5 mp -121.51 -168.2 1.65 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.766 179.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . 0.525 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 174.14 -16.54 0.05 OUTLIER Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . 0.67 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -61.24 156.23 34.37 Favored Glycine 0 CA--C 1.521 0.449 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -63.4 21.94 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.995 0.426 . . . . 0.0 110.647 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . 0.67 ' H ' ' C ' ' A' ' 247' ' ' GLY . 99.0 m-20 -97.2 -6.27 35.13 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.438 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 91.0 mt -79.65 -22.0 44.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.775 179.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.68 -51.43 69.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.712 -179.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.21 -5.53 58.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.47 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.08 -74.24 1.15 Allowed Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.776 -0.929 . . . . 0.0 110.776 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 83.0 mt -70.25 126.43 29.64 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.218 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -59.67 -39.44 84.47 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.081 -179.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 83.16 51.62 4.1 Favored Glycine 0 CA--C 1.519 0.29 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -95.9 -14.96 22.73 Favored 'General case' 0 C--N 1.331 -0.204 0 O-C-N 122.65 -0.323 . . . . 0.0 110.598 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 258' ' ' SER . . . . . 0.496 ' OG ' HG23 ' A' ' 191' ' ' VAL . 3.4 t 174.73 88.85 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.24 0.543 . . . . 0.0 110.072 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.853 ' N ' HD12 ' A' ' 259' ' ' LEU . 1.0 OUTLIER -94.61 124.28 38.55 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.254 0.549 . . . . 0.0 111.267 -179.143 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 260' ' ' PHE . . . . . 0.448 ' H ' ' HA ' ' A' ' 193' ' ' ALA . 15.7 m-30 -93.37 146.39 23.77 Favored 'General case' 0 CA--C 1.495 -1.171 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.474 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 86.1 mt -122.33 149.25 44.02 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.545 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.736 ' CD1' HG13 ' A' ' 195' ' ' VAL . 2.5 p90 -77.26 -138.77 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.578 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 263' ' ' ALA . . . . . 0.655 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -51.46 76.97 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 121.091 0.472 . . . . 0.0 111.299 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . 0.626 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.15 104.67 0.19 Allowed Glycine 0 CA--C 1.528 0.895 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 -179.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 265' ' ' ASP . . . . . 0.592 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.5 m-20 -80.31 -177.98 6.4 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 122.719 -0.283 . . . . 0.0 110.972 -179.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -40.3 -17.87 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.566 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 267' ' ' LYS . . . . . 0.592 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -67.94 -51.74 44.1 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.759 179.1 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -63.65 -46.47 85.48 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.216 179.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . 0.568 ' HB1' ' OH ' ' A' ' 273' ' ' TYR . . . -61.93 -34.99 77.08 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 121.539 0.685 . . . . 0.0 109.658 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -63.2 -34.46 77.69 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.158 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.49 -42.96 13.98 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.081 -179.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 272' ' ' ILE . . . . . 0.591 ' C ' ' H ' ' A' ' 274' ' ' ALA . 4.9 tt -51.44 -33.78 14.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.728 -178.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 273' ' ' TYR . . . . . 0.568 ' OH ' ' HB1' ' A' ' 269' ' ' ALA . 17.2 m-85 -54.64 -1.85 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.573 -179.327 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 274' ' ' ALA . . . . . 0.591 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.45 -39.9 70.7 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.952 179.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . 0.577 ' O ' ' N ' ' A' ' 279' ' ' ALA . 3.1 p30 -38.8 97.81 0.15 Allowed Pre-proline 0 N--CA 1.462 0.164 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.366 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -54.57 -42.62 66.47 Favored 'Trans proline' 0 C--N 1.303 -1.864 0 C-N-CA 122.428 2.086 . . . . 0.0 112.535 -178.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 89.5 mt -64.4 -42.87 95.87 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.058 0.456 . . . . 0.0 111.218 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 90.9 mt -95.7 -1.58 49.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.967 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 279' ' ' ALA . . . . . 0.577 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.3 -34.8 77.29 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.744 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.18 20.03 0.11 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.012 -179.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . 0.481 ' H ' ' C ' ' A' ' 279' ' ' ALA . 13.8 mt -74.93 119.51 77.2 Favored Pre-proline 0 N--CA 1.445 -0.69 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.801 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -49.96 -39.96 49.56 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.593 2.195 . . . . 0.0 112.279 178.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.72 -50.52 63.24 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.038 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 75.9 t -61.42 -43.96 97.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -57.71 -41.18 81.23 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.039 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -91.17 0.24 57.57 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.133 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt 59.36 43.53 16.48 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.04 0.447 . . . . 0.0 110.906 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -94.75 41.37 1.09 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.31 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 54.3 t -119.31 135.55 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-O 121.129 0.49 . . . . 0.0 109.995 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -132.64 162.98 29.97 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.209 0.528 . . . . 0.0 110.613 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.63 155.4 32.39 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-O 121.073 0.463 . . . . 0.0 110.632 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 82.8 mt -94.35 -1.52 53.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.256 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 120.83 165.32 12.69 Favored Glycine 0 C--N 1.335 0.497 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 7.3 m -86.98 -62.38 1.52 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.864 0.364 . . . . 0.0 111.154 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 295' ' ' GLU . . . . . 0.445 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.7 mm-40 -68.79 -3.97 14.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.738 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 25.0 p -77.08 32.04 0.14 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.651 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 297' ' ' PHE . . . . . 0.5 ' CD2' HG22 ' A' ' 70' ' ' THR . 68.7 t80 -60.4 -46.18 90.93 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.629 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . 0.62 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.1 mtt85 -80.61 134.81 35.95 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.577 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.465 ' H ' HG11 ' A' ' 51' ' ' VAL . 18.2 tp -113.87 117.01 30.23 Favored 'General case' 0 C--O 1.23 0.075 0 CA-C-O 121.02 0.438 . . . . 0.0 110.203 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . 0.621 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.5 p-10 -165.03 -176.71 4.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.651 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -46.95 -42.99 18.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.356 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -67.19 -40.14 86.48 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 121.065 0.46 . . . . 0.0 110.746 178.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . 0.621 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 59.9 p -56.3 -36.35 68.55 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.975 -179.038 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . 0.551 ' HB2' ' SD ' ' A' ' 215' ' ' MET . . . -57.04 -52.15 66.43 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 91.7 mtp -55.78 -43.66 77.01 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -66.22 -42.59 88.48 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.241 0.543 . . . . 0.0 110.239 179.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 303' ' ' SER . 55.5 t -64.04 -42.95 97.29 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.188 179.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 42.6 tp -60.05 -42.05 93.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.82 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -62.42 -39.34 92.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.028 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 310' ' ' ARG . . . . . 0.446 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.5 ttt85 -63.49 -44.0 95.64 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.153 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 89.8 mt -63.18 -42.11 99.31 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.103 0.478 . . . . 0.0 110.36 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt -63.16 -33.35 75.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.12 179.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.56 -23.72 21.92 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.329 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . 0.485 HD22 ' CE2' ' A' ' 315' ' ' PHE . 6.7 tt -62.35 -43.17 99.46 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 121.075 0.464 . . . . 0.0 110.521 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 315' ' ' PHE . . . . . 0.485 ' CE2' HD22 ' A' ' 314' ' ' LEU . 90.0 m-85 . . . . . 0 C--O 1.22 -0.463 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.346 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -99.55 135.98 40.17 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.119 0.485 . . . . 0.0 110.475 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.49 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -92.16 178.55 1.66 Allowed Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.589 -179.893 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.49 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.7 Cg_exo -61.44 147.15 96.2 Favored 'Trans proline' 0 C--N 1.299 -2.046 0 C-N-CA 122.848 2.365 . . . . 0.0 112.208 179.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.468 ' HE ' HD12 ' A' ' 39' ' ' LEU . 35.7 ptt180 -136.12 142.36 44.24 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.585 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -79.54 116.6 19.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.521 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.443 ' O ' HG23 ' A' ' 30' ' ' ILE . 9.5 tp -111.1 130.66 64.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.564 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 13.7 t -70.79 142.25 51.34 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.987 0.422 . . . . 0.0 110.676 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.477 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.3 t0 -139.8 179.39 6.62 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.458 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.477 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 77.9 p -73.83 -37.05 64.97 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.562 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.8 ttt85 -46.51 -94.62 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.248 -179.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -167.06 -26.38 0.02 OUTLIER Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 55.6 m -169.35 104.94 0.37 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.807 0.337 . . . . 0.0 110.664 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.691 ' CD2' HD13 ' A' ' 140' ' ' LEU . 75.4 t60 -128.47 148.79 50.75 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.055 0.455 . . . . 0.0 110.231 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.625 HG22 ' N ' ' A' ' 39' ' ' LEU . 98.6 m -131.02 166.05 21.87 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.498 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.625 ' N ' HG22 ' A' ' 38' ' ' THR . 81.2 mt -120.78 127.19 51.73 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.408 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -65.08 -44.62 88.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.794 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 40.9 p -165.71 155.1 12.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.354 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.487 ' H ' ' CD ' ' A' ' 42' ' ' GLN . 14.5 mp0 -44.27 100.91 0.24 Allowed Pre-proline 0 C--O 1.235 0.326 0 O-C-N 123.526 0.516 . . . . 0.0 110.594 179.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.54 129.6 34.66 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 C-N-CA 122.344 2.029 . . . . 0.0 112.231 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -83.63 -24.69 31.32 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.609 179.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.539 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.4 mtm-85 -122.25 134.43 54.69 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.257 0.551 . . . . 0.0 110.177 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.0 mt -130.46 133.78 63.24 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.774 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 45.3 t -124.43 130.4 73.58 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 CA-C-O 120.911 0.386 . . . . 0.0 109.986 179.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.63 ' OG ' HD12 ' A' ' 117' ' ' LEU . 2.1 m -154.88 167.27 30.84 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.645 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 65.1 p -124.53 9.16 8.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.419 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.52 125.51 33.13 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.644 -179.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.447 HG11 ' H ' ' A' ' 299' ' ' LEU . 92.7 t -65.77 -44.51 93.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.555 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.4 m -62.51 -44.18 97.0 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.654 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 53.1 tp -62.33 -41.43 98.56 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.464 -179.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.445 ' O ' HD13 ' A' ' 58' ' ' LEU . 74.3 m -57.86 -44.58 86.66 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.126 -179.111 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.19 -62.41 5.19 Favored Glycine 0 N--CA 1.467 0.733 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.7 t -47.94 -35.74 11.23 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 20.1 mt -61.88 -44.13 97.44 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.348 179.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.445 HD13 ' O ' ' A' ' 54' ' ' THR . 9.1 mp -65.62 -41.35 92.79 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.333 177.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.67 -41.1 98.22 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.846 -179.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.424 ' O ' HG23 ' A' ' 60' ' ' ILE . 7.8 tp -88.35 16.66 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.914 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 56.27 84.79 0.08 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.821 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 178.83 58.34 0.07 OUTLIER Pre-proline 0 C--N 1.328 -0.358 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.416 ' HB3' HE21 ' A' ' 85' ' ' GLN . 9.2 Cg_endo -51.6 153.51 10.7 Favored 'Trans proline' 0 C--N 1.293 -2.385 0 C-N-CA 123.051 2.501 . . . . 0.0 111.943 -178.065 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.435 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.2 OUTLIER -108.86 145.33 15.85 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.148 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.341 -179.677 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.36 -45.49 97.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.363 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.504 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -129.43 134.08 47.65 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 120.816 0.341 . . . . 0.0 110.489 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.503 ' O ' ' N ' ' A' ' 98' ' ' LEU . 73.8 m -134.54 158.75 43.17 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.871 -179.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -87.04 139.25 16.06 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 110.621 -0.991 . . . . 0.0 110.621 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.494 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.7 -162.77 0.08 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.938 0.399 . . . . 0.0 110.431 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.533 HG22 ' CD2' ' A' ' 297' ' ' PHE . 14.2 t -133.47 134.75 43.91 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.293 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.478 ' C ' ' O ' ' A' ' 70' ' ' THR . 0.6 OUTLIER 29.73 68.74 0.66 Allowed Pre-proline 0 N--CA 1.467 0.397 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.817 -179.865 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_exo -61.85 145.18 97.21 Favored 'Trans proline' 0 C--N 1.299 -2.027 0 C-N-CA 122.706 2.27 . . . . 0.0 111.723 -177.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.528 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 45.7 p-10 -159.4 -31.81 0.06 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.66 179.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.541 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 99.1 m-20 -64.35 -39.42 93.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.366 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.4 ttt180 -60.33 -48.16 82.95 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.505 -179.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.424 ' O ' ' O ' ' A' ' 77' ' ' ALA . 93.0 t -60.48 -25.1 33.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.054 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.541 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -45.51 173.04 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.592 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.569 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.4 p30 -62.01 177.59 0.44 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.577 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.558 ' C ' ' H ' ' A' ' 81' ' ' GLY . 35.5 p30 -45.34 85.67 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.036 0.446 . . . . 0.0 111.102 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.569 ' N ' ' O ' ' A' ' 78' ' ' ASP . 42.8 tp60 -67.64 13.29 0.08 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.268 0.556 . . . . 0.0 110.197 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.558 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 118.65 -22.08 9.49 Favored Glycine 0 N--CA 1.462 0.374 0 N-CA-C 110.981 -0.848 . . . . 0.0 110.981 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -108.33 116.42 31.94 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.963 0.411 . . . . 0.0 110.445 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 76.6 mt -98.74 -0.19 43.22 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.578 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -92.15 7.35 42.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.971 0.415 . . . . 0.0 110.299 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.795 ' O ' HG22 ' A' ' 89' ' ' VAL . 87.9 mt-30 -100.25 -28.15 13.14 Favored 'General case' 0 C--O 1.22 -0.455 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.795 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 68.9 t-105 -63.03 -40.47 97.82 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.833 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.551 ' O ' ' N ' ' A' ' 91' ' ' LYS . 67.5 m -77.82 -53.74 7.14 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.881 -179.342 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -48.53 -50.68 30.94 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.076 -179.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.795 HG22 ' O ' ' A' ' 85' ' ' GLN . 15.5 m -68.81 -40.55 81.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.161 179.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.494 ' N ' HG23 ' A' ' 89' ' ' VAL . . . -72.43 -22.66 61.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.572 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.551 ' N ' ' O ' ' A' ' 87' ' ' SER . 65.9 tttm -61.97 -45.67 92.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.357 -179.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.437 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.8 mm-40 -90.41 -94.64 0.12 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.164 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.621 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.8 mtt180 -143.12 58.73 1.41 Allowed 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.446 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.6 pttp 33.97 26.02 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.149 0.5 . . . . 0.0 110.267 -179.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.621 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.4 tt -48.22 123.48 6.47 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.002 -177.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.457 ' O ' HD23 ' A' ' 95' ' ' LEU . 99.0 mm-40 -83.82 -169.98 2.85 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.146 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.609 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 81.2 mtp180 -74.25 137.07 42.74 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.232 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.503 ' N ' ' O ' ' A' ' 67' ' ' SER . 91.0 mt -85.71 -165.77 1.33 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.901 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.538 ' CD2' ' O ' ' A' ' 99' ' ' TYR . 47.9 p90 -168.57 119.56 0.77 Allowed 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.13 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.502 ' C ' ' O ' ' A' ' 99' ' ' TYR . 43.0 mm -28.69 120.78 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.068 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 114.2 27.61 3.35 Favored Glycine 0 CA--C 1.519 0.315 0 N-CA-C 111.259 -0.736 . . . . 0.0 111.259 -179.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.574 ' N ' ' CD ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -144.52 46.39 0.62 Allowed Pre-proline 0 C--N 1.321 -0.654 0 CA-C-O 121.084 0.468 . . . . 0.0 110.511 179.773 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.574 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 28.8 Cg_endo -62.15 144.34 95.66 Favored 'Trans proline' 0 C--N 1.295 -2.273 0 C-N-CA 122.687 2.258 . . . . 0.0 111.732 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.452 ' O ' HG23 ' A' ' 108' ' ' VAL . 24.3 t -173.2 120.52 0.35 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.349 179.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.95 -40.3 63.16 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.011 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.27 -39.91 89.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.892 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.33 -39.97 94.96 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.769 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 104' ' ' SER . 69.6 t -67.83 -43.65 86.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.73 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.04 -38.88 92.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.476 -179.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.437 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.55 -23.2 62.67 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.538 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.535 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.3 mm-40 -91.0 5.88 47.05 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.746 -179.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.539 ' O ' ' NE ' ' A' ' 45' ' ' ARG . 10.6 tpt 22.89 64.64 0.36 Allowed Pre-proline 0 N--CA 1.467 0.416 0 CA-C-O 120.905 0.383 . . . . 0.0 111.215 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -79.04 167.41 21.95 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 123.087 2.524 . . . . 0.0 111.466 -177.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.526 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 99.2 m-20 -110.02 -41.99 4.32 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.038 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.2 tp -121.38 120.26 34.51 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.925 0.393 . . . . 0.0 109.983 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 82.1 mt -112.94 128.92 69.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 CA-C-O 120.833 0.349 . . . . 0.0 110.935 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.63 HD12 ' OG ' ' A' ' 48' ' ' SER . 29.3 mt -109.08 132.11 54.42 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.281 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.496 HD12 HG23 ' A' ' 139' ' ' THR . 99.0 mt -119.75 138.57 49.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.654 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 85.7 p -72.54 153.8 41.13 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.633 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.28 -50.09 75.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.621 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -149.32 153.8 38.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.561 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 170.68 -170.86 43.43 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -63.11 -34.12 89.11 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.449 ' O ' ' OD1' ' A' ' 124' ' ' ASP . 44.3 p-10 -87.13 120.22 28.18 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.827 0.346 . . . . 0.0 110.612 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.443 ' O ' HD12 ' A' ' 129' ' ' LEU . 37.7 t -63.18 143.94 57.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.342 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.52 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.09 -43.3 8.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.868 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.9 tp -63.03 -42.36 99.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.747 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.6 -12.1 59.64 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.372 -179.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.443 HD12 ' O ' ' A' ' 125' ' ' SER . 84.7 mt -114.88 -23.94 8.89 Favored 'General case' 0 C--O 1.225 -0.196 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.557 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . 0.52 ' N ' ' O ' ' A' ' 126' ' ' ALA . 79.5 t80 -51.07 -49.55 60.41 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.654 -178.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 37.6 p-10 -66.16 -42.81 88.5 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.762 -0.375 . . . . 0.0 111.255 179.421 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.519 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 88.4 mt-30 -66.94 -37.68 84.74 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.783 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.428 HD12 HD11 ' A' ' 118' ' ' ILE . 96.3 mt -80.21 -41.62 24.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.908 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.3 t -56.94 -44.68 82.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.229 -179.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 20.4 m -62.01 -45.1 95.08 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.378 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 94.3 mt -62.06 -43.65 97.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.305 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.666 ' HB1' ' HD2' ' A' ' 138' ' ' PRO . . . -169.44 168.47 4.82 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.649 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.666 ' HD2' ' HB1' ' A' ' 137' ' ' ALA . 52.3 Cg_exo -49.91 112.74 0.77 Allowed 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.354 2.036 . . . . 0.0 112.454 179.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.496 HG23 HD12 ' A' ' 118' ' ' ILE . 23.6 m -84.07 127.33 33.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.629 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.691 HD13 ' CD2' ' A' ' 37' ' ' HIS . 34.4 tp -117.71 135.89 53.73 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.15 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.438 ' O ' ' OD2' ' A' ' 32' ' ' ASP . 82.1 mt -100.09 119.03 47.61 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.286 0 CA-C-O 121.093 0.473 . . . . 0.0 111.057 -179.301 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.428 HD12 HD22 ' A' ' 117' ' ' LEU . 98.0 mt -134.84 132.23 53.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.586 179.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.55 HD21 ' CG ' ' A' ' 241' ' ' ASP . 61.2 t30 -66.69 151.46 47.35 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.473 179.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.521 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 88.1 t80 -86.24 122.47 30.28 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.858 -179.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.521 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 98.9 m-20 55.22 69.17 0.76 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.673 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 35.0 p-10 -125.8 0.36 7.38 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.573 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -150.62 115.07 5.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.687 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 84.0 p -63.34 168.41 4.47 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.597 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.411 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.8 p-90 -51.78 -16.05 0.61 Allowed 'General case' 0 C--O 1.22 -0.453 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.386 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . 0.446 ' O ' HG23 ' A' ' 154' ' ' THR . 68.1 tp60 -70.22 -76.01 0.11 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.896 0.379 . . . . 0.0 110.585 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.441 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.1 t -62.57 -38.81 91.53 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.224 179.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 54.1 tp -59.82 -45.9 90.93 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.398 -178.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.411 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 46.1 tp -62.63 -41.6 99.1 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.585 178.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.446 HG23 ' O ' ' A' ' 150' ' ' GLN . 61.5 p -64.11 -34.96 79.25 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.189 -179.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.435 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.9 mm-40 -64.11 -42.49 96.87 Favored 'General case' 0 C--O 1.225 -0.229 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.412 179.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 90.6 mt -65.57 -38.57 89.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.147 0.499 . . . . 0.0 110.313 179.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.57 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.52 -32.28 80.66 Favored Glycine 0 C--N 1.331 0.286 0 N-CA-C 110.604 -0.998 . . . . 0.0 110.604 -179.154 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.435 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.2 mt-10 -35.56 -27.07 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.841 0.353 . . . . 0.0 110.827 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.57 ' N ' ' O ' ' A' ' 157' ' ' GLY . 95.6 mt -55.95 149.16 3.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.354 178.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 69.1 p -69.53 137.25 52.32 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.903 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 71.21 21.32 78.47 Favored Glycine 0 N--CA 1.459 0.195 0 N-CA-C 111.198 -0.761 . . . . 0.0 111.198 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 57.2 m80 -122.96 -14.67 7.56 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.6 0.238 . . . . 0.0 110.507 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -65.94 -59.97 3.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.596 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -52.05 -49.42 63.5 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.166 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -60.51 -41.07 93.61 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.838 0.351 . . . . 0.0 110.483 179.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.61 -47.26 86.26 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.505 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.82 -40.15 75.48 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.271 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -61.77 -50.01 74.08 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.616 179.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -65.34 -43.65 90.21 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.556 179.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 93.8 mt -64.88 -43.23 96.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.377 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.45 -51.35 69.8 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.297 -179.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.08 -43.82 97.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.939 0.4 . . . . 0.0 110.723 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . 0.66 ' CE2' HD11 ' A' ' 177' ' ' LEU . 57.7 t80 -63.09 -44.16 96.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.34 179.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -63.61 -39.64 94.89 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.498 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -63.16 -42.73 99.48 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.522 179.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -60.53 -44.68 95.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.22 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.66 HD11 ' CE2' ' A' ' 173' ' ' PHE . 84.6 mt -64.66 -40.94 96.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.651 178.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.14 -62.44 1.63 Allowed 'General case' 0 C--O 1.238 0.483 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.33 -179.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.34 -47.04 85.02 Favored 'General case' 0 C--O 1.226 -0.184 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.58 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -52.88 -41.89 64.77 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.368 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -63.97 -33.41 75.67 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.285 179.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . 0.415 ' HG2' ' O ' ' A' ' 182' ' ' GLU . 70.0 tt0 -90.76 8.78 32.92 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.609 0.719 . . . . 0.0 110.317 -178.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -105.05 -31.94 8.95 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.155 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 45.3 pt -128.08 147.93 32.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.708 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -140.19 131.34 26.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.463 179.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . 0.593 HD22 ' N ' ' A' ' 186' ' ' LEU . 3.6 mm? -85.63 132.63 43.89 Favored Pre-proline 0 N--CA 1.451 -0.41 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.13 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -43.45 157.59 0.11 Allowed 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.701 2.267 . . . . 0.0 112.416 179.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . 0.501 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.6 Cg_endo -62.84 115.1 2.72 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 C-N-CA 122.781 2.321 . . . . 0.0 111.727 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . 0.501 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.7 mt-30 155.72 147.44 0.0 OUTLIER Pre-proline 0 C--O 1.232 0.134 0 O-C-N 124.071 0.857 . . . . 0.0 110.953 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -73.34 143.71 35.54 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.553 2.169 . . . . 0.0 112.381 177.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.5 HG23 ' OG ' ' A' ' 258' ' ' SER . 2.1 p -124.63 159.24 31.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.443 0.64 . . . . 0.0 110.217 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . 0.493 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 36.0 p -143.45 165.49 27.4 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.082 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . 0.446 ' HA ' ' H ' ' A' ' 260' ' ' PHE . . . -135.4 128.75 32.18 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 121.292 0.568 . . . . 0.0 110.181 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.504 HD11 HD23 ' A' ' 259' ' ' LEU . 47.3 pt -146.46 148.87 16.55 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.381 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.276 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . 0.757 HG13 ' CD1' ' A' ' 262' ' ' PHE . 69.8 t -117.67 123.28 71.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.334 0.588 . . . . 0.0 109.844 178.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -134.37 107.38 7.58 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.258 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 94.0 m -130.86 130.39 43.51 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.846 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.401 ' O ' ' N ' ' A' ' 201' ' ' HIS . . . -82.74 -37.16 25.06 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.22 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.32 -67.1 0.26 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.383 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.2 -10.07 59.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.387 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . 0.401 ' N ' ' O ' ' A' ' 198' ' ' ALA . 60.2 t-80 61.01 58.25 2.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.721 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 41.4 p -167.03 153.7 8.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.595 179.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.6 144.32 24.35 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.467 179.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -135.46 138.28 43.02 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.647 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 19.6 mt -106.2 125.59 51.18 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.046 0.45 . . . . 0.0 109.876 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' TRP . . . . . 0.555 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 75.8 m95 -82.3 167.24 18.79 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.619 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . 0.457 HG22 ' C ' ' A' ' 206' ' ' TRP . 0.1 OUTLIER -157.05 170.94 8.12 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-O 120.981 0.42 . . . . 0.0 110.587 -178.954 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -53.09 -37.17 79.0 Favored 'Trans proline' 0 C--N 1.301 -1.928 0 C-N-CA 122.659 2.24 . . . . 0.0 112.532 178.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -70.86 -34.78 71.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.64 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 22.4 m -61.24 150.87 33.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.641 -179.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.68 -36.87 82.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.471 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' GLN . . . . . 0.555 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 55.0 tt0 -64.91 -40.1 94.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.515 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.62 -43.66 91.59 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.649 -0.98 . . . . 0.0 110.649 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -62.83 -43.81 97.82 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.874 0.369 . . . . 0.0 110.306 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' MET . . . . . 0.529 ' SD ' ' HB2' ' A' ' 304' ' ' ALA . 65.2 ttp -59.31 -48.23 82.4 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.108 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 88.6 mt -60.27 -41.16 92.72 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' GLU . . . . . 0.453 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.1 tp10 -57.93 -37.78 74.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.14 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -65.33 -38.1 89.1 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.687 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 94.2 mt -64.14 -42.89 96.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.176 0.512 . . . . 0.0 110.653 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.61 44.82 0.08 OUTLIER Glycine 0 N--CA 1.462 0.4 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' PHE . . . . . 0.453 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 27.3 m-85 -127.77 155.31 44.23 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 121.065 0.46 . . . . 0.0 110.463 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.48 ' O ' HG13 ' A' ' 191' ' ' VAL . 6.6 p -106.95 122.08 45.73 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.287 0.565 . . . . 0.0 109.992 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.468 HD22 ' C ' ' A' ' 222' ' ' THR . 4.3 mm? -100.99 133.19 45.85 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.139 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.95 159.05 15.13 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.426 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.09 115.43 30.25 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.924 0.392 . . . . 0.0 110.312 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.491 ' N ' HD12 ' A' ' 226' ' ' LEU . 8.9 mp -53.62 156.53 4.51 Favored Pre-proline 0 N--CA 1.45 -0.435 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.783 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.82 145.31 98.57 Favored 'Trans proline' 0 C--N 1.3 -1.999 0 C-N-CA 122.764 2.31 . . . . 0.0 112.34 179.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.53 -2.95 58.96 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.473 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.26 -40.8 5.68 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 111.034 -0.827 . . . . 0.0 111.034 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . 0.526 ' O ' ' N ' ' A' ' 233' ' ' SER . 85.7 mt -79.09 -16.85 56.16 Favored 'General case' 0 C--O 1.219 -0.54 0 CA-C-O 121.099 0.476 . . . . 0.0 110.347 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 54.3 t-20 -40.24 -49.15 2.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.857 -179.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -88.08 15.34 7.53 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.386 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . 0.526 ' N ' ' O ' ' A' ' 230' ' ' LEU . 78.1 p -60.59 -35.5 76.24 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.714 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . 0.523 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.6 tt0 -118.38 -69.41 0.85 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.809 179.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.0 m -70.06 103.5 2.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.678 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -94.57 57.5 2.23 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.279 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -144.84 -122.48 1.56 Allowed Glycine 0 N--CA 1.461 0.304 0 N-CA-C 110.946 -0.861 . . . . 0.0 110.946 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -134.54 111.94 10.48 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.146 0.498 . . . . 0.0 110.339 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . 0.515 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.3 mtt180 -148.33 57.54 1.07 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.69 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -69.77 -31.91 70.11 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.528 179.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' ASP . . . . . 0.55 ' CG ' HD21 ' A' ' 143' ' ' ASN . 65.0 t0 -56.72 -47.09 80.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.304 -179.029 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 242' ' ' ILE . . . . . 0.439 ' O ' ' O ' ' A' ' 239' ' ' ARG . 17.6 tt -140.12 157.06 25.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.867 0.365 . . . . 0.0 110.468 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.439 HG22 HD13 ' A' ' 245' ' ' LEU . 96.2 mt -106.07 106.27 20.25 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.168 0 CA-C-O 121.085 0.469 . . . . 0.0 110.461 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . 0.596 ' O ' HD12 ' A' ' 245' ' ' LEU . 88.0 mt-30 -110.55 110.2 20.83 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.309 179.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.596 HD12 ' O ' ' A' ' 244' ' ' GLN . 9.6 mp -121.86 -168.12 1.65 Allowed 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.643 179.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . 0.523 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.3 -16.87 0.05 OUTLIER Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . 0.667 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -60.46 157.04 29.74 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -63.74 21.38 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.942 0.401 . . . . 0.0 110.601 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . 0.667 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.8 m-20 -97.08 -6.0 36.15 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.43 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 92.2 mt -80.09 -21.45 43.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.824 179.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.56 -51.31 70.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.634 -179.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.7 -5.25 58.24 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.488 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.16 -74.29 1.15 Allowed Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.829 -0.909 . . . . 0.0 110.829 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 81.3 mt -70.15 126.08 28.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.931 0.396 . . . . 0.0 110.328 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -59.6 -39.26 83.59 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.289 -179.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 82.91 51.68 4.14 Favored Glycine 0 CA--C 1.52 0.382 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -95.77 -15.19 22.74 Favored 'General case' 0 C--N 1.332 -0.187 0 O-C-N 122.69 -0.3 . . . . 0.0 110.616 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 258' ' ' SER . . . . . 0.5 ' OG ' HG23 ' A' ' 191' ' ' VAL . 3.3 t 174.69 88.85 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.24 0.543 . . . . 0.0 110.114 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.855 ' N ' HD12 ' A' ' 259' ' ' LEU . 0.9 OUTLIER -94.41 124.13 38.25 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.201 0.524 . . . . 0.0 111.266 -179.132 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 260' ' ' PHE . . . . . 0.446 ' H ' ' HA ' ' A' ' 193' ' ' ALA . 15.7 m-30 -93.25 146.28 23.82 Favored 'General case' 0 CA--C 1.498 -1.022 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.379 179.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 86.0 mt -122.27 149.68 43.37 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.622 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.757 ' CD1' HG13 ' A' ' 195' ' ' VAL . 2.7 p90 -77.17 -138.19 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.587 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 263' ' ' ALA . . . . . 0.656 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -52.34 77.18 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 121.024 0.44 . . . . 0.0 111.165 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . 0.616 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -178.99 104.39 0.19 Allowed Glycine 0 CA--C 1.529 0.951 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 265' ' ' ASP . . . . . 0.592 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.4 m-20 -80.14 -178.15 6.41 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.637 0.256 . . . . 0.0 110.938 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -40.31 -17.66 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.651 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 267' ' ' LYS . . . . . 0.592 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.32 -51.65 42.28 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.647 179.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -63.65 -46.65 84.68 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.007 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . 0.57 ' HB1' ' OH ' ' A' ' 273' ' ' TYR . . . -61.79 -35.02 76.94 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.392 0.615 . . . . 0.0 109.701 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -63.15 -34.12 76.93 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.158 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.72 -43.31 13.49 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.969 -179.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 272' ' ' ILE . . . . . 0.591 ' C ' ' H ' ' A' ' 274' ' ' ALA . 4.9 tt -51.42 -33.51 14.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.798 -178.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 273' ' ' TYR . . . . . 0.57 ' OH ' ' HB1' ' A' ' 269' ' ' ALA . 17.3 m-85 -54.71 -1.77 0.03 OUTLIER 'General case' 0 CA--C 1.515 -0.385 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.62 -179.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 274' ' ' ALA . . . . . 0.591 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.55 -39.7 70.51 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.912 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . 0.578 ' O ' ' N ' ' A' ' 279' ' ' ALA . 2.9 p30 -39.16 98.26 0.16 Allowed Pre-proline 0 C--O 1.226 -0.137 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.368 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.66 -42.72 65.78 Favored 'Trans proline' 0 C--N 1.303 -1.864 0 C-N-CA 122.413 2.076 . . . . 0.0 112.482 -178.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 88.9 mt -64.43 -42.89 95.78 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.116 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 91.1 mt -95.65 -1.6 49.81 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.984 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 279' ' ' ALA . . . . . 0.578 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.26 -34.71 77.06 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.711 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.8 m80 -74.38 20.1 0.12 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.969 -179.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . 0.482 HD23 ' HA ' ' A' ' 281' ' ' LEU . 13.7 mt -74.93 119.35 76.42 Favored Pre-proline 0 N--CA 1.445 -0.692 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.873 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -49.53 -40.37 45.54 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.658 2.239 . . . . 0.0 112.417 178.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.44 -50.61 62.26 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.116 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 75.4 t -61.29 -43.91 97.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.132 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -57.86 -41.15 81.83 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.129 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -90.97 0.12 57.61 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.102 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt 59.47 42.98 16.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.048 0.452 . . . . 0.0 110.829 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -94.42 41.33 1.09 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.31 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 53.8 t -118.85 135.82 58.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-O 121.141 0.496 . . . . 0.0 110.023 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -133.01 162.71 30.98 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 121.165 0.507 . . . . 0.0 110.633 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.98 155.38 32.93 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.108 0.48 . . . . 0.0 110.589 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 81.8 mt -94.13 -1.51 54.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.173 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.31 165.53 12.66 Favored Glycine 0 N--CA 1.464 0.514 0 N-CA-C 110.494 -1.043 . . . . 0.0 110.494 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 6.9 m -87.21 -62.43 1.5 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.921 0.391 . . . . 0.0 111.015 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 295' ' ' GLU . . . . . 0.433 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.5 mm-40 -69.57 -3.74 16.12 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.653 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 27.2 p -77.17 33.18 0.15 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.574 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 297' ' ' PHE . . . . . 0.533 ' CD2' HG22 ' A' ' 70' ' ' THR . 83.8 t80 -60.28 -45.96 91.5 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.589 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . 0.609 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.2 mtt85 -81.57 134.36 35.49 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.574 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.447 ' H ' HG11 ' A' ' 51' ' ' VAL . 16.3 tp -114.34 119.36 36.7 Favored 'General case' 0 C--O 1.23 0.07 0 CA-C-O 120.982 0.42 . . . . 0.0 110.29 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . 0.619 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.1 p-10 -167.07 -174.43 2.65 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.608 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -48.23 -45.14 33.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.203 -179.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -65.13 -41.35 94.91 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 121.054 0.454 . . . . 0.0 110.714 178.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . 0.619 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 53.5 p -55.61 -36.26 66.73 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.059 -179.197 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . 0.529 ' HB2' ' SD ' ' A' ' 215' ' ' MET . . . -56.57 -52.18 65.79 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 91.8 mtp -55.72 -44.06 77.11 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -66.25 -42.6 88.32 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.211 0.529 . . . . 0.0 110.227 179.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 303' ' ' SER . 55.6 t -64.03 -42.77 96.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.202 179.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 43.4 tp -59.73 -42.2 92.61 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.77 -179.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -62.75 -38.83 92.11 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.048 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 310' ' ' ARG . . . . . 0.44 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.5 ttt85 -63.46 -44.1 95.45 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.211 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 88.0 mt -63.14 -41.98 99.39 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.416 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -62.96 -33.04 74.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.152 179.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -90.09 -23.36 21.42 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.375 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . 0.482 HD22 ' CE2' ' A' ' 315' ' ' PHE . 6.8 tt -62.31 -43.21 99.35 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 121.11 0.481 . . . . 0.0 110.573 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 315' ' ' PHE . . . . . 0.482 ' CE2' HD22 ' A' ' 314' ' ' LEU . 90.5 m-85 . . . . . 0 C--O 1.22 -0.477 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.326 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.477 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -99.5 136.06 39.99 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.115 0.483 . . . . 0.0 110.474 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.494 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -92.2 178.59 1.64 Allowed Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.545 -179.813 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.494 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.5 Cg_exo -61.54 147.18 96.05 Favored 'Trans proline' 0 C--N 1.299 -2.068 0 C-N-CA 122.854 2.369 . . . . 0.0 112.193 179.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.455 ' HE ' HD12 ' A' ' 39' ' ' LEU . 35.5 ptt180 -135.89 142.51 44.71 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.634 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -79.86 116.55 20.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.482 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.445 ' O ' HG23 ' A' ' 30' ' ' ILE . 9.4 tp -111.03 130.47 64.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.458 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 12.5 t -70.79 141.56 51.4 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.62 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.476 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.5 t0 -139.13 179.51 6.47 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.495 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.476 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 78.0 p -73.74 -37.32 65.12 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.6 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -46.3 -94.56 0.0 OUTLIER 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.357 -179.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -167.16 -26.56 0.02 OUTLIER Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 58.4 m -169.03 104.75 0.4 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.879 0.371 . . . . 0.0 110.668 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.68 ' CD2' HD13 ' A' ' 140' ' ' LEU . 74.2 t60 -128.57 148.44 50.77 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 121.119 0.485 . . . . 0.0 110.206 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.625 HG22 ' N ' ' A' ' 39' ' ' LEU . 98.4 m -130.83 166.14 21.49 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.458 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.625 ' N ' HG22 ' A' ' 38' ' ' THR . 81.6 mt -120.88 127.37 51.81 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.444 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -65.18 -44.61 87.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.716 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 38.9 p -165.67 154.98 12.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.377 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.497 ' H ' ' CD ' ' A' ' 42' ' ' GLN . 14.8 mp0 -44.3 101.0 0.24 Allowed Pre-proline 0 C--N 1.329 -0.306 0 O-C-N 123.419 0.449 . . . . 0.0 110.645 179.272 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -57.44 129.47 34.12 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 C-N-CA 122.347 2.031 . . . . 0.0 112.24 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -83.6 -24.67 31.4 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.621 179.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.539 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.5 mtm-85 -122.01 134.69 54.8 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.201 0.524 . . . . 0.0 110.256 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.2 mt -130.88 133.63 62.82 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.846 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 44.9 t -124.42 130.34 73.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-O 120.932 0.396 . . . . 0.0 109.939 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.626 ' OG ' HD12 ' A' ' 117' ' ' LEU . 2.3 m -154.8 166.89 32.05 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.504 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 69.8 p -124.55 8.83 8.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.404 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.26 125.67 33.08 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.874 0.369 . . . . 0.0 110.63 -179.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.442 HG11 ' H ' ' A' ' 299' ' ' LEU . 96.3 t -65.92 -44.51 92.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.505 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.7 m -62.69 -44.51 96.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.594 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 50.5 tp -62.32 -41.5 98.59 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.551 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.432 ' O ' HD13 ' A' ' 58' ' ' LEU . 75.4 m -57.87 -44.44 86.63 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.206 -179.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.14 -62.43 5.18 Favored Glycine 0 N--CA 1.467 0.717 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.7 t -48.2 -35.6 12.11 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 110.159 -0.311 . . . . 0.0 110.159 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 20.1 mt -61.87 -44.39 96.91 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.649 -0.421 . . . . 0.0 111.396 179.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.432 HD13 ' O ' ' A' ' 54' ' ' THR . 9.3 mp -65.5 -41.42 93.23 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.364 177.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.32 -41.27 98.91 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.832 -179.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.42 ' O ' HG23 ' A' ' 60' ' ' ILE . 8.3 tp -88.29 17.59 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.888 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 56.14 85.2 0.08 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.797 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.42 59.99 0.09 OUTLIER Pre-proline 0 C--N 1.327 -0.373 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.4 ' HB3' HE21 ' A' ' 85' ' ' GLN . 9.7 Cg_endo -51.88 151.12 16.28 Favored 'Trans proline' 0 C--N 1.293 -2.363 0 C-N-CA 123.032 2.488 . . . . 0.0 112.047 -178.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.432 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -108.21 145.31 15.45 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.157 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.259 -179.659 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.51 -45.46 97.72 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.272 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.401 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.497 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -130.03 134.55 47.48 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 120.84 0.352 . . . . 0.0 110.491 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.476 ' O ' ' N ' ' A' ' 98' ' ' LEU . 74.8 m -134.56 158.82 43.0 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.831 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.29 138.58 16.02 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.48 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.55 -162.91 0.09 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.921 0.391 . . . . 0.0 110.474 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.529 HG22 ' CD2' ' A' ' 297' ' ' PHE . 6.1 t -133.93 135.28 43.47 Favored 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.48 ' C ' ' O ' ' A' ' 70' ' ' THR . 0.9 OUTLIER 29.65 68.74 0.65 Allowed Pre-proline 0 N--CA 1.467 0.403 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.743 -179.685 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -61.72 145.2 97.55 Favored 'Trans proline' 0 C--N 1.299 -2.062 0 C-N-CA 122.708 2.272 . . . . 0.0 111.735 -177.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.535 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 45.0 p-10 -159.65 -31.94 0.06 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.637 179.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.535 ' N ' ' OD1' ' A' ' 73' ' ' ASN . 99.1 m-20 -63.83 -39.92 95.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.337 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -60.08 -47.97 83.68 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.638 -179.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.426 ' O ' ' O ' ' A' ' 77' ' ' ALA . 93.6 t -60.49 -24.87 32.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.535 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -45.81 173.34 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.615 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.569 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.3 p30 -62.15 177.56 0.46 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.421 -179.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.561 ' C ' ' H ' ' A' ' 81' ' ' GLY . 36.4 p30 -45.4 85.68 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.075 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.569 ' N ' ' O ' ' A' ' 78' ' ' ASP . 43.1 tp60 -67.48 13.18 0.07 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.221 0.534 . . . . 0.0 110.142 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.561 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 118.54 -22.35 9.45 Favored Glycine 0 N--CA 1.461 0.305 0 N-CA-C 110.934 -0.866 . . . . 0.0 110.934 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -107.75 116.45 31.97 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.987 0.422 . . . . 0.0 110.453 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 75.0 mt -98.58 0.07 44.18 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.984 0.421 . . . . 0.0 110.559 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -92.63 7.38 43.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.015 0.436 . . . . 0.0 110.357 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.787 ' O ' HG22 ' A' ' 89' ' ' VAL . 88.5 mt-30 -100.12 -27.91 13.3 Favored 'General case' 0 C--O 1.222 -0.382 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.81 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 69.1 t-105 -63.49 -40.46 97.14 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.906 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.554 ' O ' ' N ' ' A' ' 91' ' ' LYS . 68.7 m -77.78 -53.79 7.1 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.952 -179.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -48.3 -50.57 29.55 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.111 -179.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.787 HG22 ' O ' ' A' ' 85' ' ' GLN . 15.7 m -69.03 -40.47 80.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.144 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.493 ' N ' HG23 ' A' ' 89' ' ' VAL . . . -72.63 -22.66 60.91 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.652 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.554 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.0 tttm -62.12 -45.62 92.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.384 -179.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.44 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.6 mm-40 -90.32 -94.8 0.12 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.974 0.416 . . . . 0.0 110.084 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.626 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.9 mtt180 -143.12 59.32 1.41 Allowed 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 109.595 -0.521 . . . . 0.0 109.595 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.449 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.7 pttp 33.8 25.89 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 120.968 0.413 . . . . 0.0 110.234 -179.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.626 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.4 tt -48.31 123.5 6.58 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.934 -177.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.451 ' O ' HD23 ' A' ' 95' ' ' LEU . 98.9 mm-40 -83.62 -170.3 2.99 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.112 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.61 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 82.3 mtp180 -73.82 137.26 43.72 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.233 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.476 ' N ' ' O ' ' A' ' 67' ' ' SER . 90.4 mt -86.32 -165.81 1.37 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.784 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.537 ' CD2' ' O ' ' A' ' 99' ' ' TYR . 48.3 p90 -169.01 120.09 0.74 Allowed 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.114 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.502 ' C ' ' O ' ' A' ' 99' ' ' TYR . 43.9 mm -28.98 121.02 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 O-C-N 123.261 0.351 . . . . 0.0 111.103 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 114.52 26.9 3.51 Favored Glycine 0 C--N 1.332 0.338 0 N-CA-C 111.281 -0.728 . . . . 0.0 111.281 -179.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.575 ' N ' ' CD ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -144.18 46.38 0.63 Allowed Pre-proline 0 C--N 1.322 -0.622 0 CA-C-O 121.023 0.44 . . . . 0.0 110.472 179.833 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 29.1 Cg_endo -62.13 143.92 95.23 Favored 'Trans proline' 0 C--N 1.294 -2.3 0 C-N-CA 122.677 2.251 . . . . 0.0 111.771 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.451 ' O ' HG23 ' A' ' 108' ' ' VAL . 26.5 t -173.14 120.35 0.35 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.426 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.39 -40.58 64.21 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.042 0.449 . . . . 0.0 111.145 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -66.19 -39.82 89.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.892 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.13 -39.88 94.99 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.77 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 104' ' ' SER . 71.7 t -67.77 -43.71 86.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.733 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.96 -38.97 93.23 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.555 -179.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.44 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.66 -23.3 62.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.473 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.537 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.4 mm-40 -90.8 5.58 47.77 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.654 -179.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.539 ' O ' ' NE ' ' A' ' 45' ' ' ARG . 10.3 tpt 22.88 64.5 0.36 Allowed Pre-proline 0 N--CA 1.468 0.437 0 CA-C-O 120.913 0.387 . . . . 0.0 111.22 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -78.92 167.5 22.04 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 123.079 2.519 . . . . 0.0 111.657 -177.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.522 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 99.3 m-20 -110.15 -42.05 4.28 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.077 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.8 tp -121.32 120.44 35.1 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 83.8 mt -113.42 129.09 69.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-O 120.848 0.356 . . . . 0.0 110.96 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.626 HD12 ' OG ' ' A' ' 48' ' ' SER . 29.5 mt -108.86 132.17 54.29 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.044 0.449 . . . . 0.0 110.268 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.49 HD12 HG23 ' A' ' 139' ' ' THR . 98.8 mt -119.66 138.42 50.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.709 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 85.6 p -72.63 153.77 41.07 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.612 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.12 -50.12 74.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.627 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.0 t -149.44 153.92 38.05 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.566 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 170.47 -170.98 43.43 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.89 -34.13 88.99 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.829 -0.908 . . . . 0.0 110.829 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.453 ' O ' ' OD1' ' A' ' 124' ' ' ASP . 44.5 p-10 -87.36 120.01 28.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.882 0.373 . . . . 0.0 110.652 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.444 ' O ' HD12 ' A' ' 129' ' ' LEU . 37.7 t -63.05 144.01 57.27 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.399 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.521 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.19 -43.26 8.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.836 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.3 tp -62.98 -42.45 99.84 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.739 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.49 -12.0 59.26 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.508 -179.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.444 HD12 ' O ' ' A' ' 125' ' ' SER . 85.1 mt -114.93 -23.93 8.87 Favored 'General case' 0 C--O 1.226 -0.159 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.586 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . 0.521 ' N ' ' O ' ' A' ' 126' ' ' ALA . 80.0 t80 -50.94 -49.49 59.76 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.643 -178.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.5 p-10 -66.09 -42.5 89.24 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.876 -0.33 . . . . 0.0 111.237 179.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.523 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 88.2 mt-30 -67.17 -37.85 84.44 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.874 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.429 HD12 HD11 ' A' ' 118' ' ' ILE . 96.1 mt -79.98 -41.83 25.14 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.915 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.3 t -56.86 -44.78 82.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.277 -179.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 20.0 m -61.86 -45.25 94.6 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.507 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 94.1 mt -62.03 -43.68 97.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.262 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.656 ' HB1' ' HD2' ' A' ' 138' ' ' PRO . . . -169.31 168.17 5.08 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.571 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.656 ' HD2' ' HB1' ' A' ' 137' ' ' ALA . 52.5 Cg_exo -49.61 113.0 0.79 Allowed 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.288 1.992 . . . . 0.0 112.35 179.078 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.49 HG23 HD12 ' A' ' 118' ' ' ILE . 23.5 m -84.27 127.41 33.94 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.622 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.68 HD13 ' CD2' ' A' ' 37' ' ' HIS . 34.4 tp -117.77 135.34 54.11 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.072 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.435 ' O ' ' OD2' ' A' ' 32' ' ' ASP . 82.3 mt -99.9 118.91 47.24 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.315 0 CA-C-O 121.181 0.515 . . . . 0.0 111.137 -179.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.438 HD12 HD22 ' A' ' 117' ' ' LEU . 98.1 mt -134.85 131.94 53.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.554 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.546 HD21 ' CG ' ' A' ' 241' ' ' ASP . 60.7 t30 -66.37 151.19 47.63 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.908 0.385 . . . . 0.0 110.479 179.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.52 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 88.2 t80 -85.96 122.25 29.73 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.883 -179.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.52 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 99.0 m-20 55.41 69.15 0.76 Allowed 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.672 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 35.0 p-10 -125.68 0.2 7.45 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.845 0.355 . . . . 0.0 110.604 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -150.63 115.48 5.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.706 -179.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 83.8 p -63.73 168.77 4.59 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.551 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.416 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.5 p-90 -52.3 -16.01 0.75 Allowed 'General case' 0 C--O 1.222 -0.389 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.417 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . 0.433 ' O ' HG23 ' A' ' 154' ' ' THR . 68.2 tp60 -69.97 -76.88 0.09 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.508 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.441 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.0 t -62.49 -38.45 89.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.216 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 54.1 tp -59.78 -45.86 90.98 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.356 -178.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.416 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 46.7 tp -62.66 -41.77 99.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.527 178.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.441 ' OG1' ' O ' ' A' ' 151' ' ' SER . 62.7 p -64.0 -34.75 78.7 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.196 -179.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.422 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 88.0 mm-40 -64.05 -42.71 96.94 Favored 'General case' 0 C--O 1.225 -0.196 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.356 179.305 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 91.7 mt -65.52 -38.7 90.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.101 0.477 . . . . 0.0 110.277 179.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.575 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.37 -32.12 79.8 Favored Glycine 0 C--N 1.331 0.295 0 N-CA-C 110.68 -0.968 . . . . 0.0 110.68 -179.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 157' ' ' GLY . 97.3 mt-10 -35.64 -26.73 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.839 0.352 . . . . 0.0 110.858 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.575 ' N ' ' O ' ' A' ' 157' ' ' GLY . 95.3 mt -56.16 149.37 3.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.411 178.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 74.8 p -69.68 137.25 51.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.978 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 71.39 21.0 78.64 Favored Glycine 0 CA--C 1.517 0.165 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 179.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 56.3 m80 -122.56 -14.5 7.77 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.602 0.239 . . . . 0.0 110.454 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -65.66 -59.98 3.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.593 -179.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -52.18 -49.34 64.01 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.177 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -60.24 -41.28 92.84 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.805 0.336 . . . . 0.0 110.437 179.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.34 -47.17 87.13 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.59 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -57.04 -40.1 76.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.279 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -61.72 -50.43 72.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.61 179.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -65.25 -43.78 90.23 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.534 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 94.4 mt -64.83 -43.26 96.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.414 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.38 -51.31 69.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.355 -179.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.23 -43.64 97.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.614 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . 0.663 ' CE2' HD11 ' A' ' 177' ' ' LEU . 56.9 t80 -62.92 -44.45 96.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.097 0.475 . . . . 0.0 110.396 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -63.53 -39.64 94.95 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.679 -179.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -63.16 -42.85 99.48 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.531 179.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -60.78 -44.39 96.86 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.261 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.663 HD11 ' CE2' ' A' ' 173' ' ' PHE . 84.1 mt -64.78 -40.98 96.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.687 178.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.21 -62.39 1.66 Allowed 'General case' 0 C--O 1.238 0.495 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.355 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.37 -47.02 85.16 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.54 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.01 -41.68 64.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.375 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -63.9 -33.69 76.26 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.281 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . 0.417 ' HG2' ' O ' ' A' ' 182' ' ' GLU . 70.0 tt0 -90.64 8.73 32.83 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.616 0.722 . . . . 0.0 110.381 -178.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -104.84 -32.05 9.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.145 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.8 pt -128.08 147.88 32.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.791 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -140.15 131.34 26.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.426 179.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . 0.593 HD22 ' N ' ' A' ' 186' ' ' LEU . 3.5 mm? -85.55 133.06 42.81 Favored Pre-proline 0 N--CA 1.451 -0.41 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.042 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -43.82 157.81 0.13 Allowed 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.649 2.232 . . . . 0.0 112.364 179.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . 0.505 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.5 Cg_endo -62.87 114.91 2.62 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 C-N-CA 122.892 2.395 . . . . 0.0 111.657 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . 0.505 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.7 mt-30 155.6 147.65 0.0 OUTLIER Pre-proline 0 N--CA 1.456 -0.138 0 O-C-N 124.028 0.83 . . . . 0.0 110.824 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.35 143.92 35.86 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.614 2.209 . . . . 0.0 112.243 177.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.501 HG23 ' OG ' ' A' ' 258' ' ' SER . 2.1 p -124.58 158.84 31.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.441 0.639 . . . . 0.0 110.162 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . 0.489 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 37.6 p -143.19 165.24 27.97 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.102 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . 0.447 ' HA ' ' H ' ' A' ' 260' ' ' PHE . . . -135.28 128.75 32.41 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 121.285 0.564 . . . . 0.0 110.224 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.506 HD11 HD23 ' A' ' 259' ' ' LEU . 47.4 pt -146.66 149.02 16.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.146 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . 0.746 HG13 ' CD1' ' A' ' 262' ' ' PHE . 69.5 t -117.77 123.41 71.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 CA-C-O 121.32 0.581 . . . . 0.0 109.903 178.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -134.27 107.25 7.55 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.161 0.505 . . . . 0.0 110.205 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 93.3 m -130.97 130.33 43.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.815 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.406 ' O ' ' N ' ' A' ' 201' ' ' HIS . . . -82.92 -37.27 24.42 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.249 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.23 -66.94 0.27 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.362 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.3 -10.17 59.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.346 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . 0.406 ' N ' ' O ' ' A' ' 198' ' ' ALA . 59.9 t-80 61.08 58.1 2.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.745 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 36.3 p -166.69 153.26 8.75 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.602 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.24 144.02 24.43 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.096 0.474 . . . . 0.0 110.416 179.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -135.4 138.32 43.17 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.609 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 19.9 mt -106.24 125.56 51.15 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.065 0.46 . . . . 0.0 109.925 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' TRP . . . . . 0.556 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 75.2 m95 -82.08 167.0 19.24 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.573 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . 0.462 HG22 ' C ' ' A' ' 206' ' ' TRP . 0.1 OUTLIER -157.19 171.11 7.88 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.645 -178.961 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -53.19 -37.29 79.93 Favored 'Trans proline' 0 C--N 1.302 -1.913 0 C-N-CA 122.588 2.192 . . . . 0.0 112.472 178.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -70.57 -35.07 72.87 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.711 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 21.0 m -61.08 150.84 32.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.642 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.7 -36.78 81.9 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.465 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' GLN . . . . . 0.556 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 54.6 tt0 -64.97 -40.02 94.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.475 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.64 -43.4 92.1 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.712 -0.955 . . . . 0.0 110.712 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -63.24 -43.94 96.62 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.788 0.328 . . . . 0.0 110.229 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' MET . . . . . 0.521 ' SD ' ' HB2' ' A' ' 304' ' ' ALA . 65.1 ttp -59.21 -48.1 82.86 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.148 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 87.8 mt -60.42 -41.02 93.06 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' GLU . . . . . 0.457 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.8 tp10 -58.0 -37.67 74.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.05 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -65.53 -38.07 88.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.659 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 94.4 mt -64.09 -42.8 96.79 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.662 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.52 44.91 0.08 OUTLIER Glycine 0 CA--C 1.52 0.391 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' PHE . . . . . 0.457 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 26.9 m-85 -127.92 155.42 44.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.073 0.463 . . . . 0.0 110.463 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.48 ' O ' HG13 ' A' ' 191' ' ' VAL . 7.2 p -107.27 122.49 46.66 Favored 'General case' 0 C--O 1.224 -0.248 0 CA-C-O 121.371 0.605 . . . . 0.0 110.088 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.476 HD22 ' C ' ' A' ' 222' ' ' THR . 4.3 mm? -101.43 133.02 46.7 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.162 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.77 159.78 14.73 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.459 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.47 115.33 30.07 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.391 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.497 ' N ' HD12 ' A' ' 226' ' ' LEU . 8.9 mp -53.16 156.54 3.71 Favored Pre-proline 0 N--CA 1.451 -0.415 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.764 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.01 145.34 98.6 Favored 'Trans proline' 0 C--N 1.299 -2.03 0 C-N-CA 122.744 2.296 . . . . 0.0 112.298 179.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.28 -3.38 59.04 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.535 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -89.96 -41.22 5.66 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . 0.518 ' O ' ' N ' ' A' ' 233' ' ' SER . 69.8 mt -78.86 -17.59 55.37 Favored 'General case' 0 C--O 1.219 -0.522 0 CA-C-O 121.13 0.491 . . . . 0.0 110.379 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 54.4 t-20 -40.41 -49.2 2.83 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.807 -179.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -87.59 15.15 7.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.352 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . 0.518 ' N ' ' O ' ' A' ' 230' ' ' LEU . 77.9 p -60.59 -35.3 75.76 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.703 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . 0.524 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.6 tt0 -119.0 -69.33 0.86 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.868 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.3 m -69.76 102.82 2.0 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.675 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -94.37 57.56 2.31 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.34 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -144.78 -122.42 1.56 Allowed Glycine 0 N--CA 1.461 0.309 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -135.12 111.69 9.93 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 121.183 0.516 . . . . 0.0 110.341 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . 0.525 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.6 mtt180 -148.22 57.85 1.08 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.655 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -69.47 -32.39 71.26 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.512 179.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 241' ' ' ASP . . . . . 0.546 ' CG ' HD21 ' A' ' 143' ' ' ASN . 64.8 t0 -56.84 -47.1 81.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.27 -179.027 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 242' ' ' ILE . . . . . 0.44 ' O ' ' O ' ' A' ' 239' ' ' ARG . 18.1 tt -139.88 156.4 25.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.933 0.397 . . . . 0.0 110.445 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.446 HG22 HD13 ' A' ' 245' ' ' LEU . 96.2 mt -106.3 106.65 20.99 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.206 0 CA-C-O 121.1 0.476 . . . . 0.0 110.567 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . 0.6 ' O ' HD12 ' A' ' 245' ' ' LEU . 88.2 mt-30 -110.49 110.0 20.57 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.232 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.6 HD12 ' O ' ' A' ' 244' ' ' GLN . 9.4 mp -121.69 -168.19 1.65 Allowed 'General case' 0 C--O 1.223 -0.297 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.752 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . 0.524 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.51 -16.37 0.05 OUTLIER Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.974 -0.851 . . . . 0.0 110.974 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . 0.672 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -61.04 156.61 32.96 Favored Glycine 0 CA--C 1.521 0.464 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -63.45 21.53 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.98 0.419 . . . . 0.0 110.649 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . 0.672 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.9 m-20 -97.2 -6.22 35.23 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.493 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 92.6 mt -79.48 -21.99 44.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.786 179.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.54 -51.36 70.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.734 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.24 -5.66 58.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.459 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.15 -74.48 1.14 Allowed Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.844 -0.902 . . . . 0.0 110.844 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 82.2 mt -70.02 126.07 28.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.017 0.437 . . . . 0.0 110.315 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -59.5 -39.37 83.57 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.11 -179.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 82.75 51.71 4.17 Favored Glycine 0 CA--C 1.52 0.37 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -96.14 -14.81 22.53 Favored 'General case' 0 C--N 1.333 -0.138 0 O-C-N 122.683 -0.304 . . . . 0.0 110.615 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 258' ' ' SER . . . . . 0.501 ' OG ' HG23 ' A' ' 191' ' ' VAL . 3.4 t 174.77 88.59 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.194 0.521 . . . . 0.0 110.092 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.857 ' N ' HD12 ' A' ' 259' ' ' LEU . 1.0 OUTLIER -94.43 124.44 38.46 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.228 0.537 . . . . 0.0 111.179 -179.129 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 260' ' ' PHE . . . . . 0.447 ' H ' ' HA ' ' A' ' 193' ' ' ALA . 15.8 m-30 -93.28 146.41 23.73 Favored 'General case' 0 CA--C 1.499 -1.012 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.396 179.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 85.2 mt -122.5 149.39 43.96 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.58 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.746 ' CD1' HG13 ' A' ' 195' ' ' VAL . 2.6 p90 -77.19 -138.36 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.612 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 263' ' ' ALA . . . . . 0.656 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -52.07 76.95 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 121.049 0.452 . . . . 0.0 111.188 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . 0.624 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -178.76 104.51 0.19 Allowed Glycine 0 CA--C 1.528 0.85 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 265' ' ' ASP . . . . . 0.596 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.5 m-20 -80.38 -178.04 6.46 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.585 0.231 . . . . 0.0 110.928 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -40.25 -17.91 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.579 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 267' ' ' LYS . . . . . 0.596 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.13 -51.66 43.65 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.722 179.195 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -63.6 -46.68 84.69 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.254 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . 0.569 ' HB1' ' OH ' ' A' ' 273' ' ' TYR . . . -61.67 -35.13 77.08 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 121.404 0.621 . . . . 0.0 109.822 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -63.07 -34.37 77.44 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.176 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.49 -43.27 13.71 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.126 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 272' ' ' ILE . . . . . 0.591 ' C ' ' H ' ' A' ' 274' ' ' ALA . 4.9 tt -51.39 -33.69 14.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.767 -178.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 273' ' ' TYR . . . . . 0.569 ' OH ' ' HB1' ' A' ' 269' ' ' ALA . 17.2 m-85 -54.43 -1.78 0.03 OUTLIER 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.703 -179.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 274' ' ' ALA . . . . . 0.591 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.5 -39.7 70.65 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.93 179.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . 0.579 ' O ' ' N ' ' A' ' 279' ' ' ALA . 3.1 p30 -38.98 98.02 0.15 Allowed Pre-proline 0 C--O 1.226 -0.149 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.449 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -54.64 -42.61 66.73 Favored 'Trans proline' 0 C--N 1.303 -1.835 0 C-N-CA 122.376 2.051 . . . . 0.0 112.513 -178.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 89.2 mt -64.57 -42.86 95.38 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.038 0.447 . . . . 0.0 111.15 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 91.2 mt -95.66 -1.63 49.74 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.939 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 279' ' ' ALA . . . . . 0.579 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.3 -34.68 77.06 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.748 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.21 20.04 0.12 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.014 -179.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . 0.481 ' H ' ' C ' ' A' ' 279' ' ' ALA . 13.8 mt -75.18 119.46 77.04 Favored Pre-proline 0 N--CA 1.447 -0.605 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.729 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -49.9 -39.88 49.01 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.644 2.23 . . . . 0.0 112.281 178.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.64 -50.59 62.87 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.066 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 78.6 t -61.32 -44.0 97.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -57.85 -41.16 81.8 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.15 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -91.06 0.05 57.62 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.104 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt 59.56 43.61 15.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.945 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -95.08 41.42 1.09 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.34 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 54.1 t -119.13 135.68 58.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-O 121.052 0.453 . . . . 0.0 110.067 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -132.58 162.35 31.52 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.22 0.533 . . . . 0.0 110.608 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.6 154.96 33.16 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-O 121.038 0.447 . . . . 0.0 110.663 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 81.5 mt -93.68 -1.56 55.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.253 -179.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.01 166.22 12.93 Favored Glycine 0 CA--C 1.521 0.439 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 7.2 m -87.77 -62.46 1.49 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.855 0.36 . . . . 0.0 110.939 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 295' ' ' GLU . . . . . 0.437 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.4 mm-40 -69.35 -3.87 15.93 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.667 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 27.0 p -77.21 32.7 0.15 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.604 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 297' ' ' PHE . . . . . 0.529 ' CD2' HG22 ' A' ' 70' ' ' THR . 70.1 t80 -60.15 -46.21 90.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.603 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . 0.61 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.2 mtt85 -81.0 133.66 35.53 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.535 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.442 ' H ' HG11 ' A' ' 51' ' ' VAL . 16.4 tp -114.23 119.39 36.85 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.319 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . 0.622 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.1 p-10 -167.52 -173.85 2.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.612 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -48.58 -45.41 37.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.236 -179.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -64.97 -41.52 95.38 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.09 0.471 . . . . 0.0 110.697 178.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . 0.622 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 52.6 p -55.39 -36.14 66.09 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.016 -179.223 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . 0.521 ' HB2' ' SD ' ' A' ' 215' ' ' MET . . . -56.7 -51.84 67.26 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 91.5 mtp -56.15 -43.99 78.83 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -66.23 -42.75 88.22 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.152 0.501 . . . . 0.0 110.238 179.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 303' ' ' SER . 55.1 t -64.04 -42.74 96.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.26 179.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 43.0 tp -59.67 -42.33 92.62 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.741 -179.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -62.55 -38.8 91.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.139 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 310' ' ' ARG . . . . . 0.442 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.5 ttt85 -63.51 -44.1 95.26 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.165 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 87.8 mt -63.2 -42.02 99.25 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.353 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -62.89 -33.24 74.88 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.13 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.93 -23.36 21.6 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.365 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . 0.479 HD22 ' CE2' ' A' ' 315' ' ' PHE . 6.7 tt -62.41 -43.11 99.59 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 121.069 0.461 . . . . 0.0 110.597 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 315' ' ' PHE . . . . . 0.479 ' CE2' HD22 ' A' ' 314' ' ' LEU . 91.2 m-85 . . . . . 0 C--O 1.22 -0.46 0 CA-C-O 117.947 -1.025 . . . . 0.0 110.381 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -99.39 135.15 41.23 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.169 0.509 . . . . 0.0 110.469 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.491 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -92.19 178.68 1.6 Allowed Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.545 -179.802 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.491 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.8 Cg_exo -61.66 147.2 95.89 Favored 'Trans proline' 0 C--N 1.298 -2.097 0 C-N-CA 122.89 2.393 . . . . 0.0 112.117 179.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.477 ' HE ' HD12 ' A' ' 39' ' ' LEU . 35.1 ptt180 -135.91 142.11 44.62 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.732 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -79.66 116.94 20.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.462 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.449 ' O ' HG23 ' A' ' 30' ' ' ILE . 9.4 tp -111.93 130.55 65.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.399 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 12.6 t -71.01 142.27 50.94 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.008 0.432 . . . . 0.0 110.621 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.472 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.4 t0 -139.08 179.75 6.32 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.505 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.472 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 78.3 p -73.6 -37.37 65.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.777 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.8 ttt85 -46.94 -94.76 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.233 -179.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -166.08 -26.73 0.02 OUTLIER Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 62.5 m -168.58 106.02 0.45 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.806 0.336 . . . . 0.0 110.65 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.658 ' CD2' HD13 ' A' ' 140' ' ' LEU . 71.5 t60 -129.23 146.64 51.1 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 121.075 0.464 . . . . 0.0 110.151 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.62 HG22 ' N ' ' A' ' 39' ' ' LEU . 97.5 m -129.86 165.68 21.51 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.41 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.62 ' N ' HG22 ' A' ' 38' ' ' THR . 79.5 mt -120.42 127.21 52.05 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.485 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -65.44 -44.8 86.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.728 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 37.8 p -165.65 155.27 12.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.445 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.497 ' H ' ' CD ' ' A' ' 42' ' ' GLN . 14.6 mp0 -44.43 100.71 0.23 Allowed Pre-proline 0 C--O 1.236 0.374 0 O-C-N 123.527 0.517 . . . . 0.0 110.634 179.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -57.51 129.78 35.6 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 C-N-CA 122.322 2.014 . . . . 0.0 112.337 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -83.09 -24.62 32.6 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.567 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.531 ' NE ' ' O ' ' A' ' 112' ' ' MET . 90.1 mtm-85 -121.04 134.2 55.27 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.214 0.531 . . . . 0.0 110.15 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.1 mt -130.72 133.67 63.01 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.846 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 46.4 t -124.77 131.34 72.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.619 ' OG ' HD12 ' A' ' 117' ' ' LEU . 4.4 m -154.38 166.14 34.16 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.584 179.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 63.3 p -124.66 8.32 8.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.395 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.6 126.15 33.68 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.801 0.334 . . . . 0.0 110.687 -179.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.461 HG11 ' H ' ' A' ' 299' ' ' LEU . 88.7 t -65.65 -44.61 93.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.521 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.3 m -62.55 -44.33 96.6 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.709 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 54.0 tp -62.29 -41.59 98.63 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.558 -179.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.451 ' O ' HD13 ' A' ' 58' ' ' LEU . 69.5 m -58.18 -44.48 88.04 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.124 -179.05 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.31 -62.19 5.35 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.7 t -48.08 -35.77 11.91 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 20.3 mt -61.78 -44.26 97.23 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 120.598 -0.441 . . . . 0.0 111.321 179.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.451 HD13 ' O ' ' A' ' 54' ' ' THR . 9.4 mp -65.26 -41.68 94.03 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.518 177.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.45 -41.26 98.64 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.921 -179.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.415 ' O ' HG23 ' A' ' 60' ' ' ILE . 8.0 tp -87.8 16.75 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.864 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 56.31 84.14 0.09 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.804 -179.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.61 58.21 0.08 OUTLIER Pre-proline 0 C--N 1.327 -0.381 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.411 ' HB3' HE21 ' A' ' 85' ' ' GLN . 9.7 Cg_endo -50.93 152.9 9.43 Favored 'Trans proline' 0 C--N 1.294 -2.333 0 C-N-CA 123.033 2.488 . . . . 0.0 112.228 -178.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.43 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -108.78 146.39 14.5 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.178 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.31 -179.69 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 97.0 mt -63.65 -45.08 98.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.478 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.498 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -130.45 134.49 47.14 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 120.868 0.366 . . . . 0.0 110.49 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.489 ' O ' ' N ' ' A' ' 98' ' ' LEU . 66.9 m -134.42 158.55 43.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.922 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.81 139.43 16.35 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.494 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.85 -162.69 0.08 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.003 0.43 . . . . 0.0 110.384 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.522 HG22 ' CD2' ' A' ' 297' ' ' PHE . 14.6 t -133.57 135.37 44.27 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.314 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.474 ' C ' ' O ' ' A' ' 70' ' ' THR . 0.7 OUTLIER 29.76 68.88 0.65 Allowed Pre-proline 0 N--CA 1.469 0.475 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.857 -179.866 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -61.59 145.34 97.79 Favored 'Trans proline' 0 C--N 1.299 -2.054 0 C-N-CA 122.672 2.248 . . . . 0.0 111.873 -177.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.528 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 46.0 p-10 -160.05 -31.79 0.06 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.799 179.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.529 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 98.9 m-20 -64.41 -39.33 93.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.348 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -60.7 -47.97 83.88 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.481 -179.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.425 ' O ' ' O ' ' A' ' 77' ' ' ALA . 92.8 t -60.35 -24.86 32.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.529 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -45.52 172.85 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.695 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.566 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.7 p30 -61.72 177.48 0.41 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.448 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.565 ' C ' ' H ' ' A' ' 81' ' ' GLY . 36.3 p30 -46.07 85.65 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.016 0.436 . . . . 0.0 110.971 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.566 ' N ' ' O ' ' A' ' 78' ' ' ASP . 42.7 tp60 -67.19 13.55 0.06 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.176 0.512 . . . . 0.0 110.065 -179.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.565 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 117.82 -22.13 10.08 Favored Glycine 0 N--CA 1.461 0.334 0 N-CA-C 110.911 -0.876 . . . . 0.0 110.911 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -107.44 116.3 31.7 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.01 0.433 . . . . 0.0 110.454 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 75.7 mt -98.49 0.46 45.17 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 120.992 0.425 . . . . 0.0 110.582 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -92.14 6.52 46.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.027 0.441 . . . . 0.0 110.276 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.772 ' O ' HG22 ' A' ' 89' ' ' VAL . 88.0 mt-30 -100.12 -26.63 13.88 Favored 'General case' 0 C--O 1.219 -0.511 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.796 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 75.9 t-105 -64.64 -40.76 96.01 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.109 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.549 ' O ' ' N ' ' A' ' 91' ' ' LYS . 68.1 m -77.85 -53.53 7.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.316 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -48.49 -50.52 31.33 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.089 -179.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.772 HG22 ' O ' ' A' ' 85' ' ' GLN . 14.3 m -68.92 -40.82 81.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.209 179.387 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.499 ' N ' HG23 ' A' ' 89' ' ' VAL . . . -71.89 -23.04 61.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.725 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.549 ' N ' ' O ' ' A' ' 87' ' ' SER . 65.9 tttm -61.62 -45.67 93.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.442 -179.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.44 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.3 mm-40 -90.6 -94.56 0.12 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.012 0.434 . . . . 0.0 110.05 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.615 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.9 mtt180 -143.48 59.44 1.39 Allowed 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.441 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.6 pttp 34.45 25.77 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.084 0.468 . . . . 0.0 110.336 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.615 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.5 tt -48.24 123.34 6.28 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.078 -177.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.451 ' O ' HD23 ' A' ' 95' ' ' LEU . 99.0 mm-40 -83.53 -170.84 3.26 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.054 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.609 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 82.2 mtp180 -73.17 137.6 45.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.12 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.489 ' N ' ' O ' ' A' ' 67' ' ' SER . 90.3 mt -86.11 -166.29 1.5 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.868 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.536 ' CD2' ' O ' ' A' ' 99' ' ' TYR . 47.5 p90 -167.96 119.95 0.86 Allowed 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.065 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.494 ' C ' ' O ' ' A' ' 99' ' ' TYR . 42.8 mm -29.56 121.05 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.055 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 113.96 27.91 3.32 Favored Glycine 0 C--N 1.331 0.291 0 N-CA-C 111.326 -0.71 . . . . 0.0 111.326 -179.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.581 ' N ' ' CD ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -143.85 45.83 0.6 Allowed Pre-proline 0 C--N 1.321 -0.632 0 CA-C-O 121.087 0.47 . . . . 0.0 110.427 179.817 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.581 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 29.8 Cg_endo -62.02 143.84 95.52 Favored 'Trans proline' 0 C--N 1.294 -2.306 0 C-N-CA 122.593 2.195 . . . . 0.0 111.881 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.464 ' O ' HG23 ' A' ' 108' ' ' VAL . 24.3 t -173.26 120.6 0.34 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.283 179.53 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.02 -40.98 64.71 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.104 0.478 . . . . 0.0 111.281 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -65.93 -40.11 91.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.864 -179.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.98 -39.81 94.98 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.719 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 104' ' ' SER . 69.4 t -67.48 -43.87 87.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.762 179.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.43 -39.05 92.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.461 -179.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.44 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.58 -23.58 63.05 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.513 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.533 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.3 mm-40 -91.17 5.05 50.6 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.746 -179.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.533 ' C ' ' O ' ' A' ' 111' ' ' GLN . 10.5 tpt 22.98 64.14 0.36 Allowed Pre-proline 0 N--CA 1.469 0.511 0 CA-C-O 120.883 0.373 . . . . 0.0 111.2 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.442 ' HG2' HD11 ' A' ' 116' ' ' ILE . 65.0 Cg_endo -78.93 168.37 20.87 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 123.017 2.478 . . . . 0.0 111.758 -177.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.527 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 99.0 m-20 -112.38 -44.21 3.41 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.003 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 39.8 tp -120.67 119.48 32.94 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.456 HD13 HD22 ' A' ' 133' ' ' LEU . 96.1 mt -116.43 131.19 69.73 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.408 0 CA-C-O 120.887 0.375 . . . . 0.0 111.007 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.619 HD12 ' OG ' ' A' ' 48' ' ' SER . 28.5 mt -105.99 132.67 51.8 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.192 -179.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.42 HD12 HG23 ' A' ' 139' ' ' THR . 98.1 mt -118.08 136.01 56.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.695 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 86.4 p -72.09 153.45 41.69 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.603 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.14 -50.04 75.25 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.651 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -149.46 154.03 38.19 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.593 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 169.73 -170.31 42.66 Favored Glycine 0 CA--C 1.525 0.719 0 N-CA-C 110.969 -0.852 . . . . 0.0 110.969 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -63.16 -34.94 91.32 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 110.864 -0.894 . . . . 0.0 110.864 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.444 ' O ' ' OD1' ' A' ' 124' ' ' ASP . 43.9 p-10 -87.89 120.11 28.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.855 0.36 . . . . 0.0 110.607 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.446 ' O ' HD12 ' A' ' 129' ' ' LEU . 39.6 t -63.51 144.26 57.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.386 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.517 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.2 -43.13 8.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.013 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.4 tp -62.79 -42.43 99.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.752 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.8 -11.11 57.83 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.52 -179.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.446 HD12 ' O ' ' A' ' 125' ' ' SER . 85.1 mt -115.54 -23.99 8.53 Favored 'General case' 0 C--O 1.225 -0.23 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.668 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . 0.517 ' N ' ' O ' ' A' ' 126' ' ' ALA . 77.7 t80 -51.87 -49.62 62.6 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.666 -178.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.5 p-10 -65.83 -42.02 91.05 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.282 179.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.522 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 87.9 mt-30 -67.45 -37.04 82.37 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.949 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.456 HD22 HD13 ' A' ' 116' ' ' ILE . 94.1 mt -79.69 -42.31 24.98 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.958 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.3 t -57.12 -44.81 83.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.25 -178.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.9 m -62.33 -45.58 92.56 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.463 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 93.1 mt -62.5 -43.89 98.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.307 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.595 ' HB1' ' HD2' ' A' ' 138' ' ' PRO . . . -169.8 163.68 6.61 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.588 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.595 ' HD2' ' HB1' ' A' ' 137' ' ' ALA . 75.4 Cg_exo -43.71 111.91 0.28 Allowed 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.374 2.05 . . . . 0.0 112.3 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.458 HG21 ' CD1' ' A' ' 130' ' ' TYR . 18.2 m -85.37 127.34 34.33 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.541 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.658 HD13 ' CD2' ' A' ' 37' ' ' HIS . 34.2 tp -118.73 135.18 54.63 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 120.976 0.417 . . . . 0.0 110.077 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.425 ' O ' ' OD2' ' A' ' 32' ' ' ASP . 80.1 mt -102.01 120.04 51.13 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.345 0 CA-C-O 121.172 0.511 . . . . 0.0 111.332 -179.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.497 HD12 HD22 ' A' ' 117' ' ' LEU . 97.4 mt -135.79 132.94 51.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.702 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.552 HD21 ' CG ' ' A' ' 241' ' ' ASP . 54.8 t30 -65.81 152.03 45.31 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.99 0.424 . . . . 0.0 110.356 179.21 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.523 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 87.9 t80 -85.81 122.48 29.94 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.999 -179.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.523 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 99.2 m-20 55.06 69.41 0.74 Allowed 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.713 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 49.4 p-10 -123.56 0.06 8.73 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 120.853 0.359 . . . . 0.0 110.625 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -151.61 117.17 5.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.735 -179.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 84.6 p -63.27 167.49 5.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.557 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.411 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.7 p-90 -50.62 -15.85 0.31 Allowed 'General case' 0 C--O 1.22 -0.497 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.429 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . 0.445 ' O ' HG23 ' A' ' 154' ' ' THR . 68.2 tp60 -71.23 -74.81 0.14 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.941 0.401 . . . . 0.0 110.443 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.448 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.2 t -62.62 -39.11 92.77 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.138 179.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 54.3 tp -60.35 -45.41 93.57 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.361 -178.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.411 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 45.9 tp -62.63 -41.62 99.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.52 178.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.448 ' OG1' ' O ' ' A' ' 151' ' ' SER . 54.6 p -64.03 -34.68 78.55 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.136 -179.292 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.445 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 88.0 mm-40 -63.93 -42.47 97.35 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.258 179.235 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 91.1 mt -65.3 -38.97 91.84 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.242 0.544 . . . . 0.0 110.249 179.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.571 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.17 -32.26 79.91 Favored Glycine 0 C--N 1.332 0.331 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 -179.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.445 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.2 mt-10 -36.16 -25.91 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.812 0.339 . . . . 0.0 110.877 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.571 ' N ' ' O ' ' A' ' 157' ' ' GLY . 95.1 mt -58.26 149.6 5.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.326 178.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 77.7 p -69.39 137.27 52.66 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.038 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 70.88 21.46 78.14 Favored Glycine 0 N--CA 1.459 0.201 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 179.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 59.4 m80 -123.09 -15.11 7.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.585 0.231 . . . . 0.0 110.452 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -66.28 -59.54 3.63 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.698 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -52.2 -48.83 64.84 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 120.709 -0.397 . . . . 0.0 110.101 -179.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -60.78 -40.99 94.63 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.839 0.352 . . . . 0.0 110.44 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.47 -47.41 85.79 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.522 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.89 -40.22 75.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.199 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -61.68 -50.22 73.35 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.62 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -65.16 -43.81 90.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.533 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 94.7 mt -64.63 -43.4 96.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.406 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.31 -51.23 70.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.446 -179.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.6 -43.53 96.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.867 0.365 . . . . 0.0 110.592 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . 0.663 ' CE2' HD11 ' A' ' 177' ' ' LEU . 57.0 t80 -62.78 -44.42 96.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.144 0.497 . . . . 0.0 110.405 179.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -63.71 -39.68 94.92 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.394 -179.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -62.9 -42.82 99.91 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.573 179.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -60.82 -44.48 96.85 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.064 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.663 HD11 ' CE2' ' A' ' 173' ' ' PHE . 84.7 mt -64.42 -41.18 96.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.983 0.42 . . . . 0.0 110.778 178.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.08 -62.06 1.87 Allowed 'General case' 0 C--O 1.239 0.516 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.34 -179.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.76 -46.83 86.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.42 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.24 -41.59 65.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.275 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -63.8 -33.81 76.5 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.962 0.411 . . . . 0.0 110.23 179.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . 0.412 ' HG2' ' O ' ' A' ' 182' ' ' GLU . 70.0 tt0 -90.63 8.79 32.46 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.622 0.725 . . . . 0.0 110.341 -178.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -104.73 -32.09 9.03 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.233 179.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.8 pt -127.95 147.74 32.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.816 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -139.98 131.38 26.87 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.31 179.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . 0.589 HD22 ' N ' ' A' ' 186' ' ' LEU . 3.5 mm? -85.42 133.29 42.61 Favored Pre-proline 0 N--CA 1.45 -0.444 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.15 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -43.92 158.0 0.13 Allowed 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.706 2.271 . . . . 0.0 112.258 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . 0.496 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.9 Cg_endo -63.1 114.72 2.58 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.748 2.299 . . . . 0.0 111.677 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . 0.496 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.7 mt-30 155.87 148.1 0.0 OUTLIER Pre-proline 0 N--CA 1.454 -0.264 0 O-C-N 124.088 0.868 . . . . 0.0 110.834 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.63 144.37 35.49 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.593 2.195 . . . . 0.0 112.095 177.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.497 HG23 ' OG ' ' A' ' 258' ' ' SER . 2.1 p -124.9 158.76 32.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.439 0.638 . . . . 0.0 110.159 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . 0.488 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 37.0 p -143.07 165.34 27.65 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.193 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . 0.45 ' HA ' ' H ' ' A' ' 260' ' ' PHE . . . -135.32 128.74 32.3 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 121.43 0.634 . . . . 0.0 110.099 179.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.51 HD11 HD23 ' A' ' 259' ' ' LEU . 47.2 pt -146.52 149.05 16.34 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.44 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.236 179.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . 0.75 HG13 ' CD1' ' A' ' 262' ' ' PHE . 72.1 t -117.95 123.51 71.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.421 0.629 . . . . 0.0 109.691 179.048 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -134.58 107.27 7.41 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.206 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 94.1 m -130.96 130.66 43.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.868 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.401 ' O ' ' N ' ' A' ' 201' ' ' HIS . . . -82.8 -37.08 24.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.15 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.41 -67.08 0.26 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.276 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.34 -9.88 59.06 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.248 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . 0.401 ' N ' ' O ' ' A' ' 198' ' ' ALA . 60.5 t-80 60.63 58.35 2.47 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.807 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 38.8 p -167.05 153.84 8.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.553 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.4 144.18 24.41 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.031 0.443 . . . . 0.0 110.37 179.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -135.33 138.18 43.16 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.663 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 20.0 mt -106.25 125.55 51.14 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' TRP . . . . . 0.557 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 75.7 m95 -82.0 166.95 19.37 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.666 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . 0.454 HG22 ' C ' ' A' ' 206' ' ' TRP . 0.1 OUTLIER -156.98 171.23 7.72 Favored Pre-proline 0 C--O 1.224 -0.25 0 CA-C-O 120.999 0.428 . . . . 0.0 110.562 -178.99 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.62 -37.03 83.08 Favored 'Trans proline' 0 C--N 1.301 -1.949 0 C-N-CA 122.612 2.208 . . . . 0.0 112.236 179.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -70.64 -35.01 72.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.729 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 22.7 m -61.24 150.57 34.22 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.698 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.41 -37.11 82.28 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.442 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' GLN . . . . . 0.557 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 55.0 tt0 -64.74 -40.07 94.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.538 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.8 -43.46 91.6 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -63.31 -43.5 97.66 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.813 0.339 . . . . 0.0 110.225 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' MET . . . . . 0.532 ' SD ' ' HB2' ' A' ' 304' ' ' ALA . 65.4 ttp -59.49 -48.03 83.21 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.34 -0.391 . . . . 0.0 109.986 -179.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 87.0 mt -60.71 -40.82 93.68 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' GLU . . . . . 0.45 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.4 tp10 -58.2 -37.66 75.22 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -65.33 -38.21 89.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.715 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 94.2 mt -64.06 -42.76 96.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.154 0.502 . . . . 0.0 110.716 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.69 44.77 0.08 OUTLIER Glycine 0 C--N 1.333 0.379 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' PHE . . . . . 0.45 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 27.4 m-85 -127.96 155.48 44.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.02 0.438 . . . . 0.0 110.446 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.482 ' O ' HG13 ' A' ' 191' ' ' VAL . 6.8 p -107.23 122.48 46.62 Favored 'General case' 0 C--O 1.223 -0.291 0 CA-C-O 121.368 0.604 . . . . 0.0 110.06 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.472 HD22 ' C ' ' A' ' 222' ' ' THR . 4.3 mm? -101.33 132.73 46.74 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.196 179.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.46 159.54 14.88 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.536 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.43 115.51 30.38 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.992 0.425 . . . . 0.0 110.318 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.497 ' N ' HD12 ' A' ' 226' ' ' LEU . 8.8 mp -53.31 156.55 3.97 Favored Pre-proline 0 N--CA 1.449 -0.515 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.764 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -60.09 145.17 99.04 Favored 'Trans proline' 0 C--N 1.3 -1.987 0 C-N-CA 122.677 2.251 . . . . 0.0 112.163 179.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.13 -3.22 59.05 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.545 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.14 -40.99 5.67 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . 0.517 ' O ' ' N ' ' A' ' 233' ' ' SER . 86.0 mt -79.14 -17.04 55.75 Favored 'General case' 0 C--O 1.218 -0.581 0 CA-C-O 121.11 0.481 . . . . 0.0 110.25 -179.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 54.3 t-20 -40.58 -48.96 2.95 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.876 -179.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -87.75 15.25 7.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.493 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . 0.517 ' N ' ' O ' ' A' ' 230' ' ' LEU . 77.9 p -60.63 -35.28 75.8 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.673 -179.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . 0.526 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.6 tt0 -118.87 -69.28 0.86 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.922 179.132 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.3 m -69.62 103.13 2.02 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.067 0.46 . . . . 0.0 110.701 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -94.55 57.33 2.22 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.305 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -144.65 -122.48 1.58 Allowed Glycine 0 C--N 1.332 0.334 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -135.07 112.09 10.27 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.256 0.551 . . . . 0.0 110.316 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . 0.521 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.4 mtt180 -148.31 58.05 1.08 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.661 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -69.59 -32.16 70.75 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.562 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 241' ' ' ASP . . . . . 0.552 ' CG ' HD21 ' A' ' 143' ' ' ASN . 64.7 t0 -57.05 -46.86 82.12 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.322 -178.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 242' ' ' ILE . . . . . 0.435 ' O ' ' O ' ' A' ' 239' ' ' ARG . 17.8 tt -140.25 156.77 24.66 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.306 0 CA-C-O 120.905 0.383 . . . . 0.0 110.419 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.444 HG22 HD13 ' A' ' 245' ' ' LEU . 96.2 mt -106.39 106.87 21.4 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 CA-C-O 121.19 0.519 . . . . 0.0 110.433 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . 0.595 ' O ' HD12 ' A' ' 245' ' ' LEU . 88.2 mt-30 -110.78 110.35 20.95 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.283 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.595 HD12 ' O ' ' A' ' 244' ' ' GLN . 9.5 mp -121.75 -168.22 1.66 Allowed 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.622 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . 0.526 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.53 -16.65 0.05 OUTLIER Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . 0.667 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -60.72 156.9 31.07 Favored Glycine 0 CA--C 1.521 0.425 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -63.83 21.9 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.901 0.381 . . . . 0.0 110.534 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . 0.667 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.8 m-20 -97.56 -6.08 34.28 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.761 0.315 . . . . 0.0 110.516 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 93.0 mt -79.65 -21.76 44.41 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.868 179.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.6 -51.25 70.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.724 -179.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.46 -5.45 58.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.402 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.17 -74.21 1.15 Allowed Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.744 -0.942 . . . . 0.0 110.744 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 83.3 mt -70.33 126.39 29.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.927 0.394 . . . . 0.0 110.17 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -59.96 -39.04 84.27 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.159 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 82.85 51.67 4.16 Favored Glycine 0 CA--C 1.519 0.335 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -95.59 -15.2 22.96 Favored 'General case' 0 N--CA 1.463 0.189 0 O-C-N 122.666 -0.314 . . . . 0.0 110.623 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 258' ' ' SER . . . . . 0.497 ' OG ' HG23 ' A' ' 191' ' ' VAL . 3.4 t 174.72 89.02 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.195 0.521 . . . . 0.0 110.036 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.852 ' N ' HD12 ' A' ' 259' ' ' LEU . 0.9 OUTLIER -94.6 124.43 38.63 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.21 0.528 . . . . 0.0 111.291 -179.143 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 260' ' ' PHE . . . . . 0.45 ' H ' ' HA ' ' A' ' 193' ' ' ALA . 15.8 m-30 -93.42 146.3 23.85 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.311 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 86.6 mt -122.29 149.55 43.58 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.532 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.75 ' CD1' HG13 ' A' ' 195' ' ' VAL . 2.6 p90 -77.28 -138.57 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.657 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 263' ' ' ALA . . . . . 0.65 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -51.87 77.14 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 121.041 0.448 . . . . 0.0 111.27 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . 0.62 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.05 104.58 0.19 Allowed Glycine 0 CA--C 1.527 0.843 0 N-CA-C 110.414 -1.074 . . . . 0.0 110.414 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 265' ' ' ASP . . . . . 0.589 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.8 m-20 -80.32 -177.88 6.35 Favored 'General case' 0 CA--C 1.515 -0.393 0 O-C-N 122.681 -0.306 . . . . 0.0 110.944 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -40.65 -17.82 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.524 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 267' ' ' LYS . . . . . 0.589 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.02 -51.56 45.61 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.743 179.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -63.87 -46.48 84.76 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.095 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . 0.57 ' HB1' ' OH ' ' A' ' 273' ' ' TYR . . . -61.8 -35.13 77.29 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 121.526 0.679 . . . . 0.0 109.716 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -62.84 -34.54 77.54 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.025 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.66 -43.07 13.74 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.217 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 272' ' ' ILE . . . . . 0.592 ' C ' ' H ' ' A' ' 274' ' ' ALA . 4.9 tt -51.27 -33.71 14.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.776 -178.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 273' ' ' TYR . . . . . 0.57 ' OH ' ' HB1' ' A' ' 269' ' ' ALA . 17.2 m-85 -54.5 -1.76 0.03 OUTLIER 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.686 -179.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 274' ' ' ALA . . . . . 0.592 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.51 -39.86 70.53 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.906 179.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . 0.576 ' O ' ' N ' ' A' ' 279' ' ' ALA . 3.0 p30 -38.91 97.74 0.15 Allowed Pre-proline 0 C--O 1.226 -0.174 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.448 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -54.21 -42.8 64.19 Favored 'Trans proline' 0 C--N 1.303 -1.856 0 C-N-CA 122.329 2.02 . . . . 0.0 112.668 -178.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 88.4 mt -64.32 -42.86 96.09 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.089 0.471 . . . . 0.0 111.297 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 91.8 mt -95.56 -1.7 49.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.862 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 279' ' ' ALA . . . . . 0.576 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.36 -34.87 77.52 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.6 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.1 20.0 0.11 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.076 -179.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . 0.481 ' H ' ' C ' ' A' ' 279' ' ' ALA . 13.8 mt -74.97 119.75 78.35 Favored Pre-proline 0 N--CA 1.445 -0.719 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.725 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -50.6 -39.57 55.85 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.539 2.159 . . . . 0.0 112.035 179.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.83 -50.37 63.86 Favored 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 73.0 t -61.54 -43.81 97.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -57.97 -41.2 82.43 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.098 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -90.93 0.31 57.54 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.083 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt 59.24 43.06 17.47 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.027 0.441 . . . . 0.0 110.976 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -94.62 41.65 1.09 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.282 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 53.9 t -119.21 135.48 59.47 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-O 121.096 0.474 . . . . 0.0 109.958 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -132.69 162.6 30.96 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.678 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.74 155.27 32.8 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 121.079 0.466 . . . . 0.0 110.667 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 82.8 mt -94.22 -1.47 54.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.176 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.49 165.81 12.72 Favored Glycine 0 C--N 1.335 0.528 0 N-CA-C 110.489 -1.044 . . . . 0.0 110.489 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 6.7 m -87.75 -62.33 1.52 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.871 0.367 . . . . 0.0 111.044 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 295' ' ' GLU . . . . . 0.442 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.5 mm-40 -69.35 -4.02 16.53 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.69 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 25.5 p -76.71 32.76 0.13 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.623 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 297' ' ' PHE . . . . . 0.522 ' CD2' HG22 ' A' ' 70' ' ' THR . 85.5 t80 -60.18 -46.07 90.98 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.624 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . 0.609 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.2 mtt85 -81.33 134.76 35.63 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.617 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.461 ' H ' HG11 ' A' ' 51' ' ' VAL . 16.7 tp -114.66 118.71 34.42 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-O 120.985 0.421 . . . . 0.0 110.206 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . 0.628 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.5 p-10 -166.15 -175.44 3.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.651 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 81.1 t80 -47.76 -44.22 28.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.209 -179.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -66.09 -40.74 91.04 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.107 0.48 . . . . 0.0 110.804 178.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . 0.628 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 56.0 p -56.04 -35.73 67.22 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.951 -179.005 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . 0.532 ' HB2' ' SD ' ' A' ' 215' ' ' MET . . . -57.28 -51.45 69.33 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 91.1 mtp -56.46 -43.78 79.9 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -179.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -66.32 -42.52 88.11 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.21 0.528 . . . . 0.0 110.253 179.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 303' ' ' SER . 55.7 t -64.08 -42.99 97.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.135 179.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 42.7 tp -59.63 -42.24 92.27 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.101 -0.499 . . . . 0.0 109.73 -179.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -62.7 -38.71 91.48 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 310' ' ' ARG . . . . . 0.446 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.5 ttt85 -63.49 -43.81 96.17 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.218 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 88.8 mt -63.2 -42.06 99.27 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.273 179.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -62.89 -33.33 75.07 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.083 179.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.86 -23.45 21.65 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.383 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . 0.479 HD22 ' CE2' ' A' ' 315' ' ' PHE . 6.7 tt -62.44 -43.16 99.47 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 121.079 0.466 . . . . 0.0 110.563 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 315' ' ' PHE . . . . . 0.479 ' CE2' HD22 ' A' ' 314' ' ' LEU . 91.1 m-85 . . . . . 0 C--O 1.22 -0.484 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.319 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -99.55 136.67 39.14 Favored 'General case' 0 CA--C 1.521 -0.164 0 CA-C-O 121.091 0.472 . . . . 0.0 110.442 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.492 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -91.86 178.61 1.66 Allowed Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.57 -179.827 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.492 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.2 Cg_exo -61.61 146.94 96.46 Favored 'Trans proline' 0 C--N 1.3 -2.025 0 C-N-CA 122.833 2.355 . . . . 0.0 112.144 179.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.456 ' HE ' HD12 ' A' ' 39' ' ' LEU . 35.3 ptt180 -136.03 142.16 44.41 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.638 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -79.34 116.69 19.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.44 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.446 ' O ' HG23 ' A' ' 30' ' ' ILE . 9.5 tp -110.98 130.53 64.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.536 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.0 t -71.0 141.76 50.97 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.638 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.477 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.5 t0 -139.33 179.51 6.49 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.532 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.477 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 77.9 p -73.8 -36.98 65.07 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.569 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.7 ttt85 -46.48 -94.43 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.296 -179.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -167.55 -26.49 0.02 OUTLIER Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 60.8 m -168.97 104.8 0.4 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.777 0.322 . . . . 0.0 110.657 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.688 ' CD2' HD13 ' A' ' 140' ' ' LEU . 74.6 t60 -128.65 149.0 50.84 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.087 0.47 . . . . 0.0 110.214 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.624 HG22 ' N ' ' A' ' 39' ' ' LEU . 98.2 m -131.36 166.07 22.06 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.453 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.624 ' N ' HG22 ' A' ' 38' ' ' THR . 81.9 mt -120.93 127.28 51.69 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.464 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -64.91 -44.55 89.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.718 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 40.0 p -165.71 155.08 12.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.373 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.468 ' H ' ' CD ' ' A' ' 42' ' ' GLN . 14.7 mp0 -44.3 100.9 0.24 Allowed Pre-proline 0 C--N 1.329 -0.286 0 O-C-N 123.503 0.502 . . . . 0.0 110.598 179.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.53 129.99 36.67 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 C-N-CA 122.305 2.003 . . . . 0.0 112.245 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -83.73 -24.78 31.05 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.558 179.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.538 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.6 mtm-85 -122.33 134.84 54.64 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.27 0.557 . . . . 0.0 110.234 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.2 mt -130.73 133.78 62.83 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.329 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.871 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 45.0 t -124.11 130.55 73.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 CA-C-O 120.945 0.402 . . . . 0.0 109.968 179.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.624 ' OG ' HD12 ' A' ' 117' ' ' LEU . 2.1 m -154.57 167.17 30.99 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.542 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 64.4 p -124.75 9.26 8.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.385 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.98 125.43 33.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.858 0.361 . . . . 0.0 110.685 -179.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.458 HG11 ' H ' ' A' ' 299' ' ' LEU . 93.3 t -65.63 -44.53 93.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.463 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.1 m -62.38 -44.3 96.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.618 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 49.6 tp -62.34 -41.3 98.46 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.528 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.439 ' O ' HD13 ' A' ' 58' ' ' LEU . 74.3 m -57.65 -44.43 85.65 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.286 -179.309 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.3 -62.33 5.23 Favored Glycine 0 N--CA 1.467 0.761 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.7 t -48.22 -35.59 12.21 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.9 mt -61.78 -44.43 96.9 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.648 -0.421 . . . . 0.0 111.305 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.439 HD13 ' O ' ' A' ' 54' ' ' THR . 9.3 mp -65.54 -41.26 93.26 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.333 177.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.59 -40.75 97.75 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.858 -179.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.42 ' O ' HG23 ' A' ' 60' ' ' ILE . 8.1 tp -89.03 16.98 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.857 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 56.17 85.33 0.07 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.797 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 178.72 59.47 0.08 OUTLIER Pre-proline 0 C--N 1.327 -0.386 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.4 ' HB3' HE21 ' A' ' 85' ' ' GLN . 10.2 Cg_endo -52.18 152.55 14.61 Favored 'Trans proline' 0 C--N 1.292 -2.401 0 C-N-CA 123.048 2.499 . . . . 0.0 112.063 -178.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.435 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -108.65 145.27 15.79 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.171 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.271 -179.661 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.8 mt -63.57 -45.42 97.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.388 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.501 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -129.49 134.1 47.61 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.517 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.504 ' O ' ' N ' ' A' ' 98' ' ' LEU . 75.4 m -134.6 158.6 43.6 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.891 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.7 139.0 16.1 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.694 -0.962 . . . . 0.0 110.694 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.493 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.79 -162.81 0.08 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.936 0.398 . . . . 0.0 110.461 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.537 HG22 ' CD2' ' A' ' 297' ' ' PHE . 14.5 t -133.65 134.74 43.53 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.289 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.481 ' C ' ' O ' ' A' ' 70' ' ' THR . 0.1 OUTLIER 29.65 68.73 0.65 Allowed Pre-proline 0 N--CA 1.467 0.403 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.735 -179.865 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_exo -61.74 145.67 97.18 Favored 'Trans proline' 0 C--N 1.3 -2.022 0 C-N-CA 122.669 2.246 . . . . 0.0 111.708 -177.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.525 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 45.3 p-10 -159.39 -32.1 0.06 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.718 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.541 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 99.1 m-20 -64.11 -39.42 94.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.387 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -60.36 -48.32 82.25 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.555 -179.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.424 ' O ' ' O ' ' A' ' 77' ' ' ALA . 93.9 t -60.16 -25.1 32.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.053 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.541 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -45.68 173.1 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.635 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.571 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.5 p30 -62.41 178.03 0.45 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.505 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.556 ' C ' ' H ' ' A' ' 81' ' ' GLY . 36.2 p30 -45.0 85.63 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.096 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.571 ' N ' ' O ' ' A' ' 78' ' ' ASP . 42.1 tp60 -67.65 13.21 0.08 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.207 0.527 . . . . 0.0 110.162 -179.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.556 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 118.63 -22.5 9.33 Favored Glycine 0 N--CA 1.461 0.33 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -108.12 116.25 31.62 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.013 0.435 . . . . 0.0 110.381 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 76.1 mt -98.27 -0.0 44.83 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.578 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -92.34 7.4 43.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.015 0.436 . . . . 0.0 110.39 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.794 ' O ' HG22 ' A' ' 89' ' ' VAL . 88.2 mt-30 -100.24 -27.7 13.37 Favored 'General case' 0 C--O 1.222 -0.387 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.754 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 69.0 t-105 -62.94 -40.55 98.0 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.942 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.551 ' O ' ' N ' ' A' ' 91' ' ' LYS . 64.2 m -77.93 -53.59 7.28 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.958 -179.311 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -48.49 -50.77 30.26 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.052 -179.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.794 HG22 ' O ' ' A' ' 85' ' ' GLN . 15.8 m -68.8 -40.57 81.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.161 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.496 ' N ' HG23 ' A' ' 89' ' ' VAL . . . -72.39 -23.01 61.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.629 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.551 ' N ' ' O ' ' A' ' 87' ' ' SER . 65.9 tttm -61.84 -45.58 93.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.433 -179.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.442 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.8 mm-40 -90.31 -95.3 0.11 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.092 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.629 ' O ' ' N ' ' A' ' 95' ' ' LEU . 96.0 mtt180 -142.79 58.84 1.43 Allowed 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.448 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.7 pttp 33.87 25.7 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.07 0.462 . . . . 0.0 110.25 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.629 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.3 tt -48.26 123.46 6.48 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.983 -177.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.457 ' O ' HD23 ' A' ' 95' ' ' LEU . 99.0 mm-40 -83.52 -169.61 2.64 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.183 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.603 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 81.3 mtp180 -74.69 136.95 41.84 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.256 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.504 ' N ' ' O ' ' A' ' 67' ' ' SER . 91.2 mt -85.63 -165.83 1.34 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.83 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.538 ' CD2' ' O ' ' A' ' 99' ' ' TYR . 48.2 p90 -168.64 119.65 0.77 Allowed 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.152 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.503 ' C ' ' O ' ' A' ' 99' ' ' TYR . 41.7 mm -28.67 120.7 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 O-C-N 123.272 0.358 . . . . 0.0 111.104 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 114.31 27.26 3.44 Favored Glycine 0 C--N 1.331 0.296 0 N-CA-C 111.27 -0.732 . . . . 0.0 111.27 -179.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.572 ' N ' ' CD ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -144.36 46.72 0.65 Allowed Pre-proline 0 C--N 1.322 -0.593 0 CA-C-O 121.145 0.498 . . . . 0.0 110.484 179.783 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.572 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 28.9 Cg_endo -62.02 144.0 95.72 Favored 'Trans proline' 0 C--N 1.295 -2.263 0 C-N-CA 122.643 2.229 . . . . 0.0 111.761 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.446 ' O ' HG23 ' A' ' 108' ' ' VAL . 27.6 t -173.18 120.37 0.35 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.359 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.83 -40.21 63.49 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.119 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.36 -39.89 89.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.853 -179.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.13 -40.09 95.44 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.73 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 104' ' ' SER . 72.3 t -67.77 -43.72 86.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.672 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.81 -39.04 93.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.455 -179.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.442 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.5 -23.39 62.74 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.516 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.537 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.3 mm-40 -90.69 5.55 47.66 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.682 -179.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.538 ' O ' ' NE ' ' A' ' 45' ' ' ARG . 10.2 tpt 22.85 64.46 0.35 Allowed Pre-proline 0 N--CA 1.467 0.385 0 CA-C-O 120.949 0.404 . . . . 0.0 111.209 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -78.75 167.51 22.28 Favored 'Trans proline' 0 C--N 1.307 -1.658 0 C-N-CA 123.077 2.518 . . . . 0.0 111.594 -177.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.52 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 99.1 m-20 -109.71 -42.1 4.37 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.991 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.6 tp -121.5 120.35 34.64 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.904 0.383 . . . . 0.0 109.97 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 84.8 mt -112.78 128.84 69.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 CA-C-O 120.862 0.363 . . . . 0.0 110.998 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.624 HD12 ' OG ' ' A' ' 48' ' ' SER . 29.6 mt -109.18 132.13 54.41 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.262 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.496 HD12 HG23 ' A' ' 139' ' ' THR . 99.1 mt -119.57 138.69 49.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.687 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 85.6 p -72.3 153.75 41.34 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.571 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.16 -50.25 74.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.705 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -149.51 154.0 38.08 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.602 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 170.5 -170.84 43.34 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.93 -34.3 89.51 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.445 ' O ' ' OD1' ' A' ' 124' ' ' ASP . 44.0 p-10 -86.7 120.43 28.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.856 0.36 . . . . 0.0 110.647 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.44 ' O ' HD12 ' A' ' 129' ' ' LEU . 39.0 t -63.21 143.75 57.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.392 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.1 -43.24 8.97 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.82 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.5 tp -62.98 -42.36 99.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.716 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.67 -12.07 59.68 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.449 -179.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.44 HD12 ' O ' ' A' ' 125' ' ' SER . 85.1 mt -114.76 -24.07 8.88 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.578 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . 0.519 ' N ' ' O ' ' A' ' 126' ' ' ALA . 78.9 t80 -51.01 -49.73 59.88 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.819 -0.352 . . . . 0.0 110.693 -178.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.1 p-10 -66.06 -42.67 89.18 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.321 179.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.52 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 88.3 mt-30 -67.01 -37.71 84.66 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.818 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.434 HD12 HD11 ' A' ' 118' ' ' ILE . 96.2 mt -80.24 -41.68 24.63 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.887 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.3 t -56.77 -44.69 82.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.248 -179.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 18.7 m -61.72 -45.44 93.96 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.613 179.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 94.6 mt -61.91 -43.73 97.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.319 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.661 ' HB1' ' HD2' ' A' ' 138' ' ' PRO . . . -169.27 168.29 5.05 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.644 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.661 ' HD2' ' HB1' ' A' ' 137' ' ' ALA . 52.8 Cg_exo -49.59 113.19 0.86 Allowed 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.296 1.997 . . . . 0.0 112.393 179.053 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.496 HG23 HD12 ' A' ' 118' ' ' ILE . 24.0 m -84.59 127.36 34.02 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.617 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.688 HD13 ' CD2' ' A' ' 37' ' ' HIS . 34.7 tp -117.79 135.96 53.71 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 120.998 0.428 . . . . 0.0 110.109 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.441 ' O ' ' OD2' ' A' ' 32' ' ' ASP . 82.7 mt -99.62 118.92 46.95 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 CA-C-O 121.208 0.527 . . . . 0.0 111.089 -179.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.425 HD12 HD22 ' A' ' 117' ' ' LEU . 97.9 mt -135.15 132.33 52.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.574 179.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.542 HD21 ' CG ' ' A' ' 241' ' ' ASP . 56.4 t30 -68.04 153.72 43.15 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.987 0.423 . . . . 0.0 110.405 179.296 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.525 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 88.7 t80 -87.46 122.28 30.99 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.85 -179.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.525 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 99.0 m-20 55.11 69.38 0.74 Allowed 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.759 179.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 49.8 p-10 -123.6 -0.72 8.6 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.852 0.358 . . . . 0.0 110.629 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -151.01 116.29 5.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.715 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 82.8 p -62.45 167.5 4.24 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.513 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.411 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.2 p-90 -51.05 -15.76 0.36 Allowed 'General case' 0 C--O 1.221 -0.414 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.371 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . 0.452 ' O ' HG23 ' A' ' 154' ' ' THR . 67.9 tp60 -70.92 -74.69 0.14 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.912 0.386 . . . . 0.0 110.516 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.434 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.2 t -62.81 -39.19 93.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.181 179.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 55.0 tp -60.05 -45.75 91.82 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.393 -178.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.411 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 46.9 tp -62.7 -41.64 99.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.619 178.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.452 HG23 ' O ' ' A' ' 150' ' ' GLN . 56.5 p -64.25 -34.94 79.26 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.226 -179.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.442 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.8 mm-40 -64.11 -42.57 96.83 Favored 'General case' 0 C--O 1.226 -0.161 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.389 179.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 90.2 mt -65.46 -38.66 90.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.152 0.501 . . . . 0.0 110.317 179.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.573 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.49 -32.41 81.08 Favored Glycine 0 C--N 1.331 0.287 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 -179.227 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.442 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.2 mt-10 -35.3 -27.23 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.819 0.343 . . . . 0.0 110.815 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.573 ' N ' ' O ' ' A' ' 157' ' ' GLY . 94.7 mt -55.83 149.42 3.1 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.371 178.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 72.7 p -69.82 137.58 51.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.992 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 71.1 20.96 78.33 Favored Glycine 0 N--CA 1.459 0.183 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 58.2 m80 -122.64 -14.49 7.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.641 0.258 . . . . 0.0 110.487 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -66.03 -59.93 3.32 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.584 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -51.98 -49.32 63.5 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.156 -179.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -60.59 -41.29 94.43 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.841 0.353 . . . . 0.0 110.435 179.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.32 -47.32 86.49 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.473 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.74 -40.27 75.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.241 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -61.53 -50.45 72.62 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.652 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -65.24 -43.7 90.56 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.584 179.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 94.2 mt -64.84 -43.3 96.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.4 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.4 -51.27 70.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.369 -179.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -63.41 -43.7 96.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.843 0.354 . . . . 0.0 110.656 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . 0.665 ' CE2' HD11 ' A' ' 177' ' ' LEU . 57.0 t80 -62.82 -44.42 96.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.378 179.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 -63.16 -39.67 95.34 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.78 -179.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -63.32 -42.66 99.01 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.518 179.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -60.76 -44.59 96.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.221 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.665 HD11 ' CE2' ' A' ' 173' ' ' PHE . 84.1 mt -64.69 -40.99 96.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.723 178.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.32 -62.46 1.62 Allowed 'General case' 0 C--O 1.238 0.457 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.295 -179.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.35 -47.34 84.09 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.473 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -52.75 -42.02 64.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.329 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -63.78 -33.66 76.17 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.034 0.445 . . . . 0.0 110.291 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . 0.415 ' HG2' ' O ' ' A' ' 182' ' ' GLU . 69.6 tt0 -90.81 9.06 31.7 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.552 0.691 . . . . 0.0 110.328 -178.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -105.11 -32.18 8.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.171 179.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 45.1 pt -128.15 147.76 32.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.816 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -140.25 131.36 26.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.388 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . 0.592 HD22 ' N ' ' A' ' 186' ' ' LEU . 3.5 mm? -85.26 133.87 41.78 Favored Pre-proline 0 N--CA 1.45 -0.435 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.092 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -43.7 157.67 0.13 Allowed 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.635 2.223 . . . . 0.0 112.387 179.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . 0.508 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 28.3 Cg_endo -63.22 114.9 2.68 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.819 2.346 . . . . 0.0 111.692 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . 0.508 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.7 mt-30 155.43 147.9 0.0 OUTLIER Pre-proline 0 N--CA 1.456 -0.136 0 O-C-N 124.051 0.844 . . . . 0.0 110.93 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.22 143.81 36.19 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.578 2.185 . . . . 0.0 112.316 177.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.494 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.1 p -124.87 159.3 31.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.418 0.628 . . . . 0.0 110.214 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . 0.494 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 37.7 p -143.52 165.59 27.15 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.095 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . 0.439 ' HA ' ' H ' ' A' ' 260' ' ' PHE . . . -135.13 128.77 32.76 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-O 121.285 0.564 . . . . 0.0 110.229 179.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.513 HD11 HD23 ' A' ' 259' ' ' LEU . 47.9 pt -146.47 148.77 16.65 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.383 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.159 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . 0.753 HG13 ' CD1' ' A' ' 262' ' ' PHE . 69.3 t -117.52 123.31 71.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-O 121.376 0.608 . . . . 0.0 109.817 178.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -134.46 107.69 7.71 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 121.156 0.503 . . . . 0.0 110.285 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 94.8 m -131.22 130.55 43.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.834 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -82.86 -36.83 25.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.242 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.49 -67.15 0.26 Allowed 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.273 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.34 -10.1 59.35 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.299 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 60.1 t-80 60.77 58.3 2.42 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.71 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 41.6 p -166.77 153.52 8.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.565 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.65 144.49 24.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.977 0.418 . . . . 0.0 110.47 179.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -135.48 138.24 42.95 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.611 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 20.1 mt -106.26 125.81 51.45 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.006 0.432 . . . . 0.0 109.953 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' TRP . . . . . 0.563 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 76.4 m95 -82.52 167.26 18.55 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.536 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . 0.462 HG22 ' C ' ' A' ' 206' ' ' TRP . 0.1 OUTLIER -157.25 170.71 8.5 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.617 -178.985 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -53.22 -37.04 79.94 Favored 'Trans proline' 0 C--N 1.302 -1.911 0 C-N-CA 122.652 2.235 . . . . 0.0 112.446 179.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -70.6 -34.94 72.69 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.657 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 22.9 m -61.56 150.45 35.97 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.633 -179.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.38 -36.87 81.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.436 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' GLN . . . . . 0.563 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 54.6 tt0 -64.73 -40.09 94.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.477 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.62 -43.54 91.83 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.669 -0.972 . . . . 0.0 110.669 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -63.34 -43.46 97.65 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.851 0.358 . . . . 0.0 110.233 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' MET . . . . . 0.535 ' SD ' ' HB2' ' A' ' 304' ' ' ALA . 65.4 ttp -59.1 -48.42 81.67 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.161 -179.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 89.0 mt -60.29 -40.96 92.31 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' GLU . . . . . 0.453 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 40.5 tp10 -57.93 -37.67 74.51 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.057 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -65.48 -37.76 87.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.699 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 95.0 mt -64.37 -42.82 95.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.144 0.497 . . . . 0.0 110.629 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.5 44.62 0.08 OUTLIER Glycine 0 CA--C 1.52 0.387 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' PHE . . . . . 0.453 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 26.4 m-85 -127.58 154.5 45.12 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 121.05 0.452 . . . . 0.0 110.535 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.476 ' O ' HG13 ' A' ' 191' ' ' VAL . 4.5 p -106.05 121.65 44.55 Favored 'General case' 0 C--O 1.224 -0.261 0 CA-C-O 121.262 0.554 . . . . 0.0 110.049 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.462 HD22 ' N ' ' A' ' 223' ' ' LEU . 4.3 mm? -100.38 133.66 44.47 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.128 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -97.36 157.94 15.72 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.475 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -104.2 115.33 30.22 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.927 0.394 . . . . 0.0 110.416 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.486 ' N ' HD12 ' A' ' 226' ' ' LEU . 9.1 mp -53.89 156.55 4.96 Favored Pre-proline 0 N--CA 1.45 -0.462 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.817 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -59.73 145.11 99.04 Favored 'Trans proline' 0 C--N 1.299 -2.052 0 C-N-CA 122.736 2.291 . . . . 0.0 112.348 179.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.75 -2.52 58.67 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.509 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.58 -40.42 5.67 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . 0.532 ' O ' ' N ' ' A' ' 233' ' ' SER . 85.9 mt -79.32 -16.73 55.89 Favored 'General case' 0 C--O 1.22 -0.499 0 CA-C-O 121.085 0.469 . . . . 0.0 110.279 -179.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 54.8 t-20 -40.09 -48.92 2.55 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.79 -179.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -88.38 15.37 7.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.316 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . 0.532 ' N ' ' O ' ' A' ' 230' ' ' LEU . 77.8 p -60.75 -35.46 76.44 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.676 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . 0.522 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.6 tt0 -118.28 -69.53 0.84 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.858 179.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.0 m -70.39 103.27 2.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.678 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -94.27 57.85 2.39 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.007 0.432 . . . . 0.0 110.319 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -145.2 -122.34 1.52 Allowed Glycine 0 C--N 1.332 0.339 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -134.1 112.42 11.14 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 121.141 0.496 . . . . 0.0 110.389 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . 0.461 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.2 mtt180 -148.54 56.79 1.04 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.737 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -69.49 -31.84 70.35 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.504 179.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 241' ' ' ASP . . . . . 0.542 ' CG ' HD21 ' A' ' 143' ' ' ASN . 64.8 t0 -56.58 -47.01 80.46 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.357 -179.042 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 242' ' ' ILE . . . . . 0.441 ' O ' ' O ' ' A' ' 239' ' ' ARG . 17.1 tt -140.4 157.46 24.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.88 0.371 . . . . 0.0 110.547 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.441 HG22 HD13 ' A' ' 245' ' ' LEU . 96.0 mt -105.88 106.05 19.84 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 CA-C-O 121.094 0.474 . . . . 0.0 110.505 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . 0.611 ' C ' HD12 ' A' ' 245' ' ' LEU . 88.3 mt-30 -110.99 110.64 21.28 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.351 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.611 HD12 ' C ' ' A' ' 244' ' ' GLN . 9.8 mp -121.98 -167.79 1.6 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.645 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . 0.522 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 172.79 -16.71 0.05 OUTLIER Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . 0.663 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -60.6 157.62 29.34 Favored Glycine 0 CA--C 1.522 0.49 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -64.05 21.01 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.966 0.412 . . . . 0.0 110.616 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . 0.663 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.9 m-20 -96.75 -5.7 38.0 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.523 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 91.3 mt -80.67 -20.97 41.82 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.763 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.56 -51.44 69.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.615 -179.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -89.14 -4.87 58.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.529 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.33 -74.13 1.16 Allowed Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.896 -0.881 . . . . 0.0 110.896 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 81.5 mt -70.12 125.7 27.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.978 0.418 . . . . 0.0 110.282 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -59.9 -39.26 84.79 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.334 -179.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 83.33 51.57 4.08 Favored Glycine 0 CA--C 1.52 0.393 0 N-CA-C 110.824 -0.91 . . . . 0.0 110.824 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -94.87 -16.7 22.69 Favored 'General case' 0 C--N 1.332 -0.17 0 O-C-N 122.739 -0.271 . . . . 0.0 110.606 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 258' ' ' SER . . . . . 0.49 ' OG ' HG23 ' A' ' 191' ' ' VAL . 3.4 t 175.47 89.49 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.159 0.504 . . . . 0.0 110.1 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.858 ' N ' HD12 ' A' ' 259' ' ' LEU . 0.9 OUTLIER -94.79 124.49 38.86 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.22 0.534 . . . . 0.0 111.229 -179.03 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 260' ' ' PHE . . . . . 0.439 ' H ' ' HA ' ' A' ' 193' ' ' ALA . 15.9 m-30 -93.98 146.8 23.67 Favored 'General case' 0 CA--C 1.5 -0.956 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.351 179.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 86.7 mt -122.42 150.18 42.82 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.542 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.753 ' CD1' HG13 ' A' ' 195' ' ' VAL . 2.6 p90 -77.7 -138.27 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.587 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 263' ' ' ALA . . . . . 0.655 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -51.96 77.34 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.156 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . 0.62 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.24 104.35 0.18 Allowed Glycine 0 CA--C 1.528 0.845 0 N-CA-C 110.474 -1.051 . . . . 0.0 110.474 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 265' ' ' ASP . . . . . 0.593 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.6 m-20 -79.98 -177.91 6.23 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 122.75 -0.265 . . . . 0.0 110.945 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -40.47 -17.83 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.567 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 267' ' ' LYS . . . . . 0.593 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.27 -51.7 42.17 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.681 179.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -63.56 -46.7 84.71 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.312 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . 0.574 ' HB1' ' OH ' ' A' ' 273' ' ' TYR . . . -61.68 -35.03 76.83 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 121.444 0.64 . . . . 0.0 109.808 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -63.14 -34.19 77.07 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.145 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.62 -43.33 13.55 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.081 -179.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 272' ' ' ILE . . . . . 0.593 ' C ' ' H ' ' A' ' 274' ' ' ALA . 4.9 tt -51.39 -33.78 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.875 -178.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 273' ' ' TYR . . . . . 0.574 ' OH ' ' HB1' ' A' ' 269' ' ' ALA . 17.2 m-85 -54.4 -1.73 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.649 -179.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 274' ' ' ALA . . . . . 0.593 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.49 -39.73 70.66 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.848 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . 0.58 ' O ' ' N ' ' A' ' 279' ' ' ALA . 2.8 p30 -39.22 98.29 0.16 Allowed Pre-proline 0 N--CA 1.463 0.178 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.401 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_exo -54.68 -42.69 66.12 Favored 'Trans proline' 0 C--N 1.303 -1.833 0 C-N-CA 122.356 2.037 . . . . 0.0 112.502 -178.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 89.2 mt -64.51 -42.84 95.55 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.093 0.473 . . . . 0.0 111.213 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 91.3 mt -95.59 -1.81 49.63 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.924 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 279' ' ' ALA . . . . . 0.58 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.16 -34.78 77.05 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.701 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.3 20.0 0.12 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.963 -179.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . 0.484 HD23 ' HA ' ' A' ' 281' ' ' LEU . 13.7 mt -74.73 119.24 75.74 Favored Pre-proline 0 N--CA 1.447 -0.607 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.774 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -49.65 -40.34 46.66 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.656 2.237 . . . . 0.0 112.3 178.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.57 -50.66 62.52 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.023 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 78.0 t -61.43 -43.87 97.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.803 0.335 . . . . 0.0 110.118 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -57.64 -41.27 81.08 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.188 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -90.89 0.47 57.48 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.108 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt 59.25 42.04 19.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.784 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -93.79 41.1 1.08 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.398 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 53.7 t -118.31 136.22 56.19 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.126 0 CA-C-O 121.113 0.483 . . . . 0.0 110.009 -179.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -133.31 163.12 30.04 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.184 0.516 . . . . 0.0 110.626 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -120.48 154.88 34.64 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-O 121.048 0.451 . . . . 0.0 110.652 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 82.3 mt -93.41 -1.63 55.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.212 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.59 165.94 12.74 Favored Glycine 0 N--CA 1.463 0.445 0 N-CA-C 110.529 -1.028 . . . . 0.0 110.529 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 6.8 m -87.6 -62.19 1.55 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.857 0.361 . . . . 0.0 110.967 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 295' ' ' GLU . . . . . 0.435 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.4 mm-40 -69.8 -3.85 17.4 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.667 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 25.2 p -77.03 33.38 0.15 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.593 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 297' ' ' PHE . . . . . 0.537 ' CD2' HG22 ' A' ' 70' ' ' THR . 84.8 t80 -60.11 -45.99 91.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.591 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . 0.603 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.3 mtt85 -81.61 134.84 35.54 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.59 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.458 ' H ' HG11 ' A' ' 51' ' ' VAL . 16.0 tp -114.39 119.16 35.99 Favored 'General case' 0 C--O 1.231 0.08 0 CA-C-O 120.974 0.416 . . . . 0.0 110.204 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . 0.62 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.2 p-10 -166.73 -174.71 2.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.637 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 83.5 t80 -47.96 -45.07 30.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.221 -179.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -65.3 -41.2 94.33 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.017 0.437 . . . . 0.0 110.734 178.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . 0.62 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 53.6 p -55.73 -36.62 67.44 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.059 -179.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . 0.535 ' HB2' ' SD ' ' A' ' 215' ' ' MET . . . -56.33 -52.74 63.43 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 92.4 mtp -55.21 -43.72 74.72 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -66.25 -42.31 88.76 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.137 0.494 . . . . 0.0 110.264 179.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 303' ' ' SER . 55.1 t -64.09 -43.02 97.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.27 179.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 42.3 tp -59.98 -42.26 93.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.846 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -62.33 -38.88 91.17 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.146 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 310' ' ' ARG . . . . . 0.404 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.5 ttt85 -63.87 -44.21 93.74 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.251 179.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 87.9 mt -63.41 -42.42 98.75 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.465 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt -62.88 -33.51 75.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.191 179.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -87.24 -26.25 23.59 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.318 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . 0.712 HD23 ' C ' ' A' ' 314' ' ' LEU . 8.4 tt -62.57 -44.4 96.43 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.327 -179.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 . . . . . 0 C--O 1.22 -0.499 0 CA-C-O 118.005 -0.998 . . . . 0.0 110.475 179.975 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -99.67 136.05 40.17 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.002 0.43 . . . . 0.0 110.515 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.497 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -92.29 178.72 1.57 Allowed Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.523 -179.874 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.497 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.8 Cg_exo -61.58 147.3 95.73 Favored 'Trans proline' 0 C--N 1.3 -2.01 0 C-N-CA 122.819 2.346 . . . . 0.0 112.132 179.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.461 ' HE ' HD12 ' A' ' 39' ' ' LEU . 35.5 ptt180 -136.1 142.47 44.3 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.697 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -79.75 116.43 19.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.489 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.448 ' O ' HG23 ' A' ' 30' ' ' ILE . 9.4 tp -110.71 130.38 64.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.503 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.3 t -70.74 141.4 51.49 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.571 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.477 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.4 t0 -139.05 179.55 6.43 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.52 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.477 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 77.9 p -74.05 -36.99 64.42 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.557 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.8 ttt85 -46.38 -94.57 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.337 -179.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.423 ' O ' ' OG1' ' A' ' 36' ' ' THR . . . -167.17 -26.74 0.02 OUTLIER Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.423 ' OG1' ' O ' ' A' ' 35' ' ' GLY . 70.7 m -169.01 104.57 0.4 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.9 0.381 . . . . 0.0 110.613 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.681 ' CD2' HD13 ' A' ' 140' ' ' LEU . 74.3 t60 -128.46 148.33 50.72 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.081 0.467 . . . . 0.0 110.187 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.626 HG22 ' N ' ' A' ' 39' ' ' LEU . 98.0 m -130.79 166.06 21.62 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.54 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.626 ' N ' HG22 ' A' ' 38' ' ' THR . 81.2 mt -120.8 127.63 52.13 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.56 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -65.08 -44.59 88.43 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.67 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 39.8 p -165.65 154.89 12.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.416 179.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.499 ' H ' ' CD ' ' A' ' 42' ' ' GLN . 14.8 mp0 -44.32 101.07 0.24 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.607 179.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.23 129.51 34.58 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.391 2.061 . . . . 0.0 112.265 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -83.5 -24.78 31.57 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.527 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.538 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.6 mtm-85 -122.31 134.82 54.65 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 121.179 0.514 . . . . 0.0 110.297 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.2 mt -130.8 133.96 62.5 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.272 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.821 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 45.6 t -124.43 130.55 73.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 179.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.615 ' OG ' HD12 ' A' ' 117' ' ' LEU . 2.2 m -154.81 166.63 32.88 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.576 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 73.1 p -124.41 8.69 8.42 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.372 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.0 125.86 33.06 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.843 0.354 . . . . 0.0 110.653 -179.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.428 HG11 ' H ' ' A' ' 299' ' ' LEU . 90.8 t -66.02 -44.44 92.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.521 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.7 m -62.69 -44.39 96.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.601 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 50.3 tp -62.38 -41.48 98.67 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.529 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.443 ' O ' HD13 ' A' ' 58' ' ' LEU . 70.6 m -57.88 -44.51 86.72 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.239 -179.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.17 -62.31 5.28 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 179.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.7 t -48.19 -35.65 12.19 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 20.1 mt -61.81 -44.6 96.55 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.226 179.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.443 HD13 ' O ' ' A' ' 54' ' ' THR . 9.3 mp -65.16 -41.66 94.5 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.391 177.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.42 -41.38 98.71 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.856 -179.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.428 ' O ' HG23 ' A' ' 60' ' ' ILE . 8.1 tp -88.1 17.29 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.838 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 56.28 85.01 0.08 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.733 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.36 58.62 0.08 OUTLIER Pre-proline 0 C--N 1.328 -0.355 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -50.92 151.93 10.76 Favored 'Trans proline' 0 C--N 1.294 -2.319 0 C-N-CA 122.902 2.402 . . . . 0.0 112.275 -178.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.433 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -108.71 145.75 15.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.326 -179.691 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.76 -45.17 97.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.361 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.502 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -129.92 134.48 47.51 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 120.8 0.334 . . . . 0.0 110.541 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.48 ' O ' ' N ' ' A' ' 98' ' ' LEU . 73.3 m -134.73 158.87 43.02 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.907 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.45 138.65 15.98 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.474 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.6 -162.85 0.09 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.002 0.429 . . . . 0.0 110.453 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.53 HG22 ' CD2' ' A' ' 297' ' ' PHE . 5.8 t -133.97 135.9 43.8 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.156 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.487 ' C ' ' O ' ' A' ' 70' ' ' THR . 1.1 t 29.46 67.99 0.67 Allowed Pre-proline 0 N--CA 1.466 0.332 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.728 -179.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_exo -60.97 145.74 98.69 Favored 'Trans proline' 0 C--N 1.3 -2.009 0 C-N-CA 122.619 2.213 . . . . 0.0 111.99 -178.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.537 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 42.4 p-10 -161.06 -31.86 0.05 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.75 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.537 ' N ' ' OD1' ' A' ' 73' ' ' ASN . 99.1 m-20 -64.16 -39.41 93.94 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.343 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -60.28 -47.98 83.69 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.578 -179.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.427 ' O ' ' O ' ' A' ' 77' ' ' ALA . 98.7 t -60.27 -24.62 31.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.532 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -45.5 172.88 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.631 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.575 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.9 p30 -61.99 177.61 0.44 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.586 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.563 ' C ' ' H ' ' A' ' 81' ' ' GLY . 36.5 p30 -45.96 85.41 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.072 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.575 ' N ' ' O ' ' A' ' 78' ' ' ASP . 42.4 tp60 -67.43 13.66 0.07 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.203 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.563 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 118.16 -21.96 9.9 Favored Glycine 0 CA--C 1.519 0.3 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -107.86 116.51 32.09 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.008 0.432 . . . . 0.0 110.527 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 74.6 mt -98.54 0.03 44.19 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.982 0.42 . . . . 0.0 110.51 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -92.49 7.04 44.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.031 0.443 . . . . 0.0 110.387 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.773 ' O ' HG22 ' A' ' 89' ' ' VAL . 88.2 mt-30 -100.24 -27.16 13.64 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.841 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.6 t-105 -64.73 -40.46 95.35 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.035 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.557 ' O ' ' N ' ' A' ' 91' ' ' LYS . 65.8 m -77.89 -54.5 6.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.169 -179.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -47.42 -50.43 22.67 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.087 -179.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.773 HG22 ' O ' ' A' ' 85' ' ' GLN . 14.4 m -69.36 -40.54 80.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.137 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.496 ' N ' HG23 ' A' ' 89' ' ' VAL . . . -72.45 -22.76 61.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.658 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.557 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.0 tttm -62.14 -45.57 92.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.445 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.439 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.8 mm-40 -90.37 -94.8 0.12 Allowed 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.078 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.636 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.8 mtt180 -143.01 58.75 1.42 Allowed 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.455 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.6 pttp 33.68 25.8 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 120.947 0.403 . . . . 0.0 110.255 -179.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.636 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.3 tt -47.78 123.68 6.3 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.954 -178.02 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.453 ' O ' HD23 ' A' ' 95' ' ' LEU . 99.0 mm-40 -83.56 -170.39 3.04 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.127 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.613 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 82.2 mtp180 -73.95 137.26 43.46 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.061 0.458 . . . . 0.0 110.246 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.48 ' N ' ' O ' ' A' ' 67' ' ' SER . 90.3 mt -86.12 -165.85 1.37 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.816 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.537 ' CD2' ' O ' ' A' ' 99' ' ' TYR . 48.5 p90 -168.86 119.92 0.75 Allowed 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.137 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.509 ' C ' ' O ' ' A' ' 99' ' ' TYR . 43.7 mm -29.0 121.08 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.067 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 114.15 27.13 3.53 Favored Glycine 0 C--N 1.332 0.318 0 N-CA-C 111.261 -0.735 . . . . 0.0 111.261 -179.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.576 ' H ' ' CD ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -144.2 46.5 0.64 Allowed Pre-proline 0 C--N 1.324 -0.518 0 CA-C-O 120.931 0.396 . . . . 0.0 110.416 179.872 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 29.1 Cg_endo -62.1 143.77 95.14 Favored 'Trans proline' 0 C--N 1.296 -2.233 0 C-N-CA 122.677 2.251 . . . . 0.0 111.845 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.455 ' O ' HG23 ' A' ' 108' ' ' VAL . 27.4 t -173.05 120.2 0.35 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.376 179.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.52 -40.49 64.0 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.038 0.447 . . . . 0.0 111.086 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.23 -39.87 89.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.841 -179.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.23 -40.04 95.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.745 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 104' ' ' SER . 71.2 t -67.69 -43.89 86.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.793 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.71 -39.01 92.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.522 -179.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.439 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.5 -23.35 62.72 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.486 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.544 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.2 mm-40 -90.66 5.46 47.96 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.659 -179.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.544 ' C ' ' O ' ' A' ' 111' ' ' GLN . 10.5 tpt 23.49 64.23 0.38 Allowed Pre-proline 0 N--CA 1.466 0.367 0 CA-C-O 120.87 0.367 . . . . 0.0 111.02 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -78.54 167.1 23.19 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 C-N-CA 123.051 2.501 . . . . 0.0 111.866 -178.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.523 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 99.2 m-20 -109.83 -42.07 4.34 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.112 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 39.8 tp -121.64 120.28 34.3 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 83.7 mt -112.91 128.85 69.42 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.353 0 CA-C-O 120.934 0.397 . . . . 0.0 110.951 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.615 HD12 ' OG ' ' A' ' 48' ' ' SER . 29.4 mt -108.87 132.26 54.21 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.063 0.459 . . . . 0.0 110.183 -179.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.496 HD12 HG23 ' A' ' 139' ' ' THR . 98.7 mt -119.67 139.01 48.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.711 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 85.6 p -72.4 153.77 41.26 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.642 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.18 -50.16 74.76 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.631 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -149.45 154.06 38.25 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.555 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 170.64 -171.02 43.53 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -63.17 -34.04 88.89 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.447 ' O ' ' OD1' ' A' ' 124' ' ' ASP . 44.0 p-10 -86.97 119.99 27.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.867 0.365 . . . . 0.0 110.684 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.444 ' O ' HD12 ' A' ' 129' ' ' LEU . 39.8 t -62.99 143.61 57.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.425 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.04 -43.11 9.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.862 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.7 tp -63.01 -42.47 99.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.75 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.43 -12.08 59.39 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.499 -179.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.444 HD12 ' O ' ' A' ' 125' ' ' SER . 84.2 mt -114.94 -23.84 8.91 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.636 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . 0.519 ' N ' ' O ' ' A' ' 126' ' ' ALA . 78.4 t80 -51.0 -49.74 59.81 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.567 -178.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.1 p-10 -65.84 -42.4 90.56 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.841 -0.344 . . . . 0.0 111.208 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.523 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 88.3 mt-30 -67.45 -37.77 83.46 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.849 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.424 HD12 HD11 ' A' ' 118' ' ' ILE . 95.9 mt -80.06 -41.8 24.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.862 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.2 t -57.03 -44.43 82.88 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.166 -178.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 20.2 m -61.91 -45.09 95.24 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.463 179.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 93.8 mt -62.24 -43.59 98.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.196 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.65 ' HB1' ' HD2' ' A' ' 138' ' ' PRO . . . -169.52 167.9 5.08 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.57 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.65 ' HD2' ' HB1' ' A' ' 137' ' ' ALA . 51.9 Cg_exo -49.4 113.14 0.83 Allowed 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.298 1.998 . . . . 0.0 112.299 179.184 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.496 HG23 HD12 ' A' ' 118' ' ' ILE . 24.0 m -84.65 127.24 33.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.602 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.681 HD13 ' CD2' ' A' ' 37' ' ' HIS . 34.7 tp -117.75 136.24 53.51 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.05 -179.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.44 ' O ' ' OD2' ' A' ' 32' ' ' ASP . 82.6 mt -100.1 118.89 47.42 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 CA-C-O 121.149 0.5 . . . . 0.0 111.161 -179.326 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.425 HD12 HD22 ' A' ' 117' ' ' LEU . 97.8 mt -135.05 132.13 53.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.595 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.546 HD21 ' CG ' ' A' ' 241' ' ' ASP . 55.9 t30 -67.35 153.59 43.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.945 0.403 . . . . 0.0 110.483 179.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.522 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 89.1 t80 -87.58 122.26 31.05 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.865 -179.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.522 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 99.0 m-20 55.17 69.45 0.73 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.759 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 49.3 p-10 -123.56 -0.48 8.65 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.923 0.392 . . . . 0.0 110.664 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -151.45 117.5 5.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.69 -179.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 83.7 p -63.4 167.78 5.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.524 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.413 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.1 p-90 -51.15 -15.64 0.37 Allowed 'General case' 0 C--O 1.223 -0.326 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.504 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . 0.445 ' O ' HG23 ' A' ' 154' ' ' THR . 68.1 tp60 -71.28 -74.91 0.14 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.444 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.444 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.0 t -62.93 -38.84 92.61 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.263 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 54.6 tp -60.14 -45.71 92.11 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.413 -178.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.413 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 47.3 tp -62.62 -41.6 99.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.445 179.002 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.445 HG23 ' O ' ' A' ' 150' ' ' GLN . 57.1 p -64.23 -34.68 78.65 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.193 -179.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.43 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.7 mm-40 -63.99 -42.78 97.1 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.442 179.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 91.5 mt -65.38 -38.92 91.45 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.087 0.47 . . . . 0.0 110.245 179.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.579 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.2 -31.91 78.67 Favored Glycine 0 CA--C 1.519 0.288 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 -179.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' A' ' 157' ' ' GLY . 97.3 mt-10 -35.61 -26.73 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.815 0.34 . . . . 0.0 110.803 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.579 ' N ' ' O ' ' A' ' 157' ' ' GLY . 95.7 mt -56.62 149.87 3.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.305 179.072 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 72.4 p -69.98 137.1 51.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.983 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 72.02 19.56 78.45 Favored Glycine 0 CA--C 1.517 0.159 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 58.2 m80 -121.04 -15.05 8.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.683 0.277 . . . . 0.0 110.585 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -65.33 -60.09 3.35 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.684 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -52.01 -49.25 63.73 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 120.819 -0.352 . . . . 0.0 110.166 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -60.29 -41.26 92.99 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.956 -0.298 . . . . 0.0 110.349 179.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.44 -47.24 86.61 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.55 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.86 -40.23 75.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.286 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -61.81 -50.26 73.04 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.601 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 60.1 ttt85 -65.32 -43.76 89.97 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.554 179.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 94.9 mt -64.77 -43.31 96.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.457 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.31 -51.35 69.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.472 -179.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.43 -43.76 96.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.584 179.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . 0.654 ' CE2' HD11 ' A' ' 177' ' ' LEU . 56.1 t80 -62.9 -44.35 96.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.423 179.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -63.61 -39.96 95.71 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.54 -179.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -62.89 -42.85 99.92 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.67 179.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -60.71 -44.62 96.37 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.201 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.654 HD11 ' CE2' ' A' ' 173' ' ' PHE . 83.6 mt -64.51 -40.96 96.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.01 0.433 . . . . 0.0 110.695 178.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.13 -62.41 1.65 Allowed 'General case' 0 C--O 1.237 0.425 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.411 -179.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.48 -47.01 85.46 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.519 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.2 -41.65 65.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.32 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -63.92 -33.82 76.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.002 0.429 . . . . 0.0 110.397 179.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . 0.421 ' HG2' ' O ' ' A' ' 182' ' ' GLU . 69.5 tt0 -90.62 9.16 30.79 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.448 0.642 . . . . 0.0 110.439 -178.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -105.06 -32.03 8.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.165 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.5 pt -128.17 147.57 32.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.753 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -139.69 131.11 26.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.446 179.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . 0.592 HD22 ' N ' ' A' ' 186' ' ' LEU . 3.6 mm? -85.3 133.23 42.96 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.977 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -43.8 157.77 0.13 Allowed 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.75 2.3 . . . . 0.0 112.223 179.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . 0.515 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 28.0 Cg_endo -63.05 114.82 2.61 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 C-N-CA 122.821 2.347 . . . . 0.0 111.716 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . 0.515 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.7 mt-30 155.72 147.71 0.0 OUTLIER Pre-proline 0 N--CA 1.456 -0.144 0 O-C-N 123.76 0.662 . . . . 0.0 110.759 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -73.56 143.53 34.46 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.582 2.188 . . . . 0.0 112.082 177.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.5 HG23 ' OG ' ' A' ' 258' ' ' SER . 2.1 p -124.43 158.88 31.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.362 0.601 . . . . 0.0 110.174 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . 0.493 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 34.8 p -143.39 165.22 28.12 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.086 -179.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . 0.441 ' HA ' ' H ' ' A' ' 260' ' ' PHE . . . -135.15 128.56 32.32 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.241 0.543 . . . . 0.0 110.201 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.508 HD11 HD23 ' A' ' 259' ' ' LEU . 47.4 pt -146.48 148.85 16.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.113 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . 0.748 HG13 ' CD1' ' A' ' 262' ' ' PHE . 69.1 t -117.76 123.26 71.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.278 0.561 . . . . 0.0 109.794 179.049 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -134.07 106.96 7.48 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.295 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 94.5 m -130.57 130.3 43.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.827 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.403 ' O ' ' N ' ' A' ' 201' ' ' HIS . . . -83.01 -36.73 24.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.198 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.54 -67.01 0.27 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.338 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.49 -9.43 58.54 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.268 179.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . 0.403 ' N ' ' O ' ' A' ' 198' ' ' ALA . 59.8 t-80 60.36 58.47 2.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.708 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 48.8 p -166.99 153.51 8.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.547 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.49 144.3 24.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.974 0.416 . . . . 0.0 110.51 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -135.47 138.46 43.19 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.599 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 20.0 mt -106.59 125.68 51.31 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.067 0.46 . . . . 0.0 109.834 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' TRP . . . . . 0.557 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 75.5 m95 -82.23 167.21 18.88 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.621 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . 0.464 HG22 ' C ' ' A' ' 206' ' ' TRP . 0.1 OUTLIER -157.03 171.53 7.33 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.632 -179.118 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -53.85 -36.9 84.56 Favored 'Trans proline' 0 C--N 1.302 -1.917 0 C-N-CA 122.691 2.261 . . . . 0.0 112.247 179.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -70.64 -34.99 72.68 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.734 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 21.5 m -61.36 150.75 34.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.606 -179.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.67 -36.96 82.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.452 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' GLN . . . . . 0.557 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 54.8 tt0 -64.63 -40.22 95.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.48 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.68 -43.46 91.88 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.694 -0.963 . . . . 0.0 110.694 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -63.41 -43.53 97.26 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.816 0.341 . . . . 0.0 110.347 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' MET . . . . . 0.521 ' SD ' ' HB2' ' A' ' 304' ' ' ALA . 65.2 ttp -59.43 -48.06 83.1 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.232 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 87.7 mt -60.64 -40.91 93.71 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' GLU . . . . . 0.457 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.5 tp10 -57.79 -37.92 74.59 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -65.32 -37.98 88.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.797 0.332 . . . . 0.0 110.666 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 94.5 mt -64.26 -42.86 96.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.62 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.7 44.88 0.08 OUTLIER Glycine 0 C--N 1.333 0.369 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' PHE . . . . . 0.457 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 27.4 m-85 -128.02 155.11 44.83 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.038 0.447 . . . . 0.0 110.524 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.483 ' O ' HG13 ' A' ' 191' ' ' VAL . 7.2 p -106.94 122.17 45.89 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.248 0.547 . . . . 0.0 110.103 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.467 HD22 ' C ' ' A' ' 222' ' ' THR . 4.3 mm? -100.98 133.26 45.74 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.109 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -97.14 159.23 15.03 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.469 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.19 115.35 30.11 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.87 0.367 . . . . 0.0 110.36 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.495 ' N ' HD12 ' A' ' 226' ' ' LEU . 8.9 mp -53.22 156.46 3.88 Favored Pre-proline 0 N--CA 1.452 -0.345 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.744 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -60.16 145.27 98.87 Favored 'Trans proline' 0 C--N 1.3 -1.986 0 C-N-CA 122.703 2.269 . . . . 0.0 112.162 179.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.16 -3.25 59.05 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.528 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.14 -40.98 5.67 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 111.024 -0.831 . . . . 0.0 111.024 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . 0.533 ' O ' ' N ' ' A' ' 233' ' ' SER . 85.1 mt -79.25 -17.13 55.34 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-O 121.113 0.482 . . . . 0.0 110.362 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . 0.401 ' C ' ' O ' ' A' ' 230' ' ' LEU . 55.5 t-20 -40.17 -49.12 2.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.821 -179.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -88.08 15.35 7.52 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.373 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . 0.533 ' N ' ' O ' ' A' ' 230' ' ' LEU . 78.0 p -60.37 -35.6 76.09 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.651 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . 0.526 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.7 tt0 -118.51 -69.32 0.86 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.995 179.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.4 m -69.85 103.4 2.19 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.693 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -94.69 57.63 2.21 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.297 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -144.84 -122.59 1.57 Allowed Glycine 0 CA--C 1.52 0.353 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -134.81 111.66 10.09 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.114 0.483 . . . . 0.0 110.389 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . 0.517 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.5 mtt180 -148.04 57.72 1.09 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.762 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -69.55 -32.14 70.76 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.501 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 241' ' ' ASP . . . . . 0.546 ' CG ' HD21 ' A' ' 143' ' ' ASN . 64.8 t0 -56.85 -47.05 81.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.378 -179.077 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 242' ' ' ILE . . . . . 0.436 ' O ' ' O ' ' A' ' 239' ' ' ARG . 17.8 tt -139.97 156.63 25.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.892 0.377 . . . . 0.0 110.479 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.441 HG22 HD13 ' A' ' 245' ' ' LEU . 96.3 mt -106.03 106.26 20.24 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.202 0 CA-C-O 121.096 0.474 . . . . 0.0 110.502 179.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . 0.601 ' O ' HD12 ' A' ' 245' ' ' LEU . 88.3 mt-30 -110.2 110.09 20.81 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.398 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.601 HD12 ' O ' ' A' ' 244' ' ' GLN . 9.5 mp -121.79 -168.38 1.69 Allowed 'General case' 0 C--O 1.225 -0.199 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.651 179.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . 0.526 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.65 -16.76 0.05 OUTLIER Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . 0.672 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -60.55 156.64 30.8 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -63.68 21.4 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.0 0.428 . . . . 0.0 110.643 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . 0.672 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.6 m-20 -97.02 -6.03 36.3 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.556 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 93.3 mt -79.68 -21.69 44.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.658 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.5 -51.34 70.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.705 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.31 -5.65 58.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.502 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.2 -74.53 1.14 Allowed Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 82.2 mt -69.83 125.92 28.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.954 0.407 . . . . 0.0 110.366 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -59.26 -39.42 82.82 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.19 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 82.39 51.88 4.2 Favored Glycine 0 CA--C 1.521 0.407 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -96.67 -14.2 22.27 Favored 'General case' 0 C--N 1.331 -0.236 0 O-C-N 122.755 -0.262 . . . . 0.0 110.597 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 258' ' ' SER . . . . . 0.5 ' OG ' HG23 ' A' ' 191' ' ' VAL . 3.5 t 174.67 88.18 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.084 0.469 . . . . 0.0 110.167 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.861 ' N ' HD12 ' A' ' 259' ' ' LEU . 1.0 OUTLIER -94.26 123.85 37.92 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.245 0.545 . . . . 0.0 111.102 -179.101 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 260' ' ' PHE . . . . . 0.441 ' H ' ' HA ' ' A' ' 193' ' ' ALA . 15.8 m-30 -92.77 146.32 23.74 Favored 'General case' 0 CA--C 1.503 -0.854 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.503 179.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 86.0 mt -122.3 149.59 43.51 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.519 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.748 ' CD1' HG13 ' A' ' 195' ' ' VAL . 2.6 p90 -77.46 -138.52 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.579 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 263' ' ' ALA . . . . . 0.658 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -51.9 77.29 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.114 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . 0.629 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.1 104.46 0.19 Allowed Glycine 0 CA--C 1.527 0.794 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 265' ' ' ASP . . . . . 0.599 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.8 m-20 -80.43 -177.85 6.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.649 0.261 . . . . 0.0 110.9 -179.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -40.3 -17.81 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.551 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 267' ' ' LYS . . . . . 0.599 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.36 -51.65 41.97 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.612 179.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -63.59 -46.77 84.3 Favored 'General case' 0 N--CA 1.461 0.095 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.237 179.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . 0.573 ' HB1' ' OH ' ' A' ' 273' ' ' TYR . . . -61.62 -35.09 76.9 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 121.263 0.554 . . . . 0.0 109.827 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -63.12 -34.37 77.46 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.167 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.49 -43.39 13.61 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.14 -179.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 272' ' ' ILE . . . . . 0.589 ' C ' ' H ' ' A' ' 274' ' ' ALA . 5.0 tt -51.33 -33.75 14.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.824 -178.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 273' ' ' TYR . . . . . 0.573 ' OH ' ' HB1' ' A' ' 269' ' ' ALA . 17.3 m-85 -54.45 -1.75 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.613 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 274' ' ' ALA . . . . . 0.589 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.54 -39.6 70.58 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.931 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . 0.58 ' O ' ' N ' ' A' ' 279' ' ' ALA . 3.2 p30 -39.21 98.0 0.15 Allowed Pre-proline 0 C--O 1.227 -0.126 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.505 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -54.27 -42.92 63.27 Favored 'Trans proline' 0 C--N 1.303 -1.824 0 C-N-CA 122.404 2.069 . . . . 0.0 112.598 -178.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 88.7 mt -64.41 -42.78 95.89 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.133 0.492 . . . . 0.0 111.2 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 91.1 mt -95.64 -1.72 49.62 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.882 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 279' ' ' ALA . . . . . 0.58 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.23 -34.83 77.24 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.703 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -74.27 20.15 0.12 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.981 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . 0.487 HD23 ' HA ' ' A' ' 281' ' ' LEU . 13.8 mt -75.2 119.93 79.26 Favored Pre-proline 0 N--CA 1.449 -0.499 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.595 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -50.49 -39.68 54.73 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.725 2.284 . . . . 0.0 112.019 178.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.69 -50.43 63.32 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.082 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 73.7 t -61.44 -43.91 97.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -57.81 -41.29 81.88 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.212 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -90.92 0.05 57.61 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.201 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt 59.47 43.29 16.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.863 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -94.68 41.42 1.09 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.372 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 53.8 t -118.99 135.83 58.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.089 0.471 . . . . 0.0 110.175 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -133.04 162.89 30.51 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 121.102 0.477 . . . . 0.0 110.637 -179.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -120.08 155.22 33.41 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.022 0.439 . . . . 0.0 110.689 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 81.6 mt -93.87 -1.48 54.75 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.313 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.04 165.74 12.77 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.609 -0.996 . . . . 0.0 110.609 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 7.1 m -87.3 -62.27 1.54 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.875 0.369 . . . . 0.0 111.007 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 295' ' ' GLU . . . . . 0.441 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.4 mm-40 -69.49 -4.0 16.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.672 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 26.2 p -77.03 32.62 0.14 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.619 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 297' ' ' PHE . . . . . 0.53 ' CD2' HG22 ' A' ' 70' ' ' THR . 69.4 t80 -60.15 -46.19 90.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.512 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . 0.613 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.1 mtt85 -81.26 133.65 35.47 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 120.988 0.423 . . . . 0.0 110.507 -179.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.428 ' H ' HG11 ' A' ' 51' ' ' VAL . 16.3 tp -114.16 119.67 37.89 Favored 'General case' 0 C--O 1.231 0.083 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.26 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . 0.621 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.5 p-10 -167.53 -174.14 2.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.611 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 81.5 t80 -48.2 -45.6 34.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.2 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -64.96 -41.64 95.29 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.106 0.479 . . . . 0.0 110.718 179.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . 0.621 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 53.0 p -55.13 -36.27 65.58 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.052 -179.299 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . 0.521 ' HB2' ' SD ' ' A' ' 215' ' ' MET . . . -56.74 -51.65 68.04 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 179.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 91.5 mtp -56.22 -43.98 79.12 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -66.21 -42.71 88.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.02 0.438 . . . . 0.0 110.256 178.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 303' ' ' SER . 55.5 t -64.05 -42.81 96.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.254 179.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 42.2 tp -59.56 -42.22 91.92 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.81 -179.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -62.76 -38.78 91.95 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.118 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 310' ' ' ARG . . . . . 0.431 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.6 ttt85 -63.34 -44.1 95.82 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.229 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 88.1 mt -63.3 -42.03 99.01 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.318 179.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -62.78 -33.09 74.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.166 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -90.08 -23.42 21.42 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.456 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . 0.476 HD22 ' CE2' ' A' ' 315' ' ' PHE . 6.8 tt -62.29 -43.16 99.47 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 121.144 0.497 . . . . 0.0 110.677 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 315' ' ' PHE . . . . . 0.476 ' CE2' HD22 ' A' ' 314' ' ' LEU . 91.0 m-85 . . . . . 0 C--O 1.219 -0.517 0 CA-C-O 118.026 -0.987 . . . . 0.0 110.409 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -99.54 136.56 39.3 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.178 0.513 . . . . 0.0 110.471 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.492 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -91.9 178.61 1.66 Allowed Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.566 -179.821 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.492 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.1 Cg_exo -61.72 146.99 96.31 Favored 'Trans proline' 0 C--N 1.299 -2.071 0 C-N-CA 122.86 2.374 . . . . 0.0 112.163 179.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.455 ' HE ' HD12 ' A' ' 39' ' ' LEU . 35.6 ptt180 -136.21 142.34 44.07 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.653 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -79.48 116.88 19.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.475 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.441 ' O ' HG23 ' A' ' 30' ' ' ILE . 9.5 tp -111.25 130.78 64.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.564 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.8 t -71.07 142.37 50.84 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.023 0.439 . . . . 0.0 110.615 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.477 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.4 t0 -139.95 179.53 6.55 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.561 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.477 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 77.9 p -73.67 -37.12 65.36 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.604 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.8 ttt85 -46.45 -94.41 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.29 -179.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -167.54 -26.29 0.02 OUTLIER Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 54.8 m -169.31 104.91 0.37 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.84 0.353 . . . . 0.0 110.622 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.683 ' CD2' HD13 ' A' ' 140' ' ' LEU . 75.3 t60 -128.56 149.32 50.67 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.158 0.504 . . . . 0.0 110.142 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.622 HG22 ' N ' ' A' ' 39' ' ' LEU . 98.4 m -131.44 166.02 22.23 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.456 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.622 ' N ' HG22 ' A' ' 38' ' ' THR . 81.6 mt -120.85 127.12 51.61 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.432 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -65.02 -44.59 88.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.748 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 39.7 p -165.51 154.94 12.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.429 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.474 ' H ' ' CD ' ' A' ' 42' ' ' GLN . 14.6 mp0 -44.3 100.91 0.24 Allowed Pre-proline 0 C--O 1.235 0.33 0 O-C-N 123.551 0.532 . . . . 0.0 110.635 179.144 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.4 129.92 36.48 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 C-N-CA 122.335 2.023 . . . . 0.0 112.307 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -83.79 -24.92 30.84 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.605 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.54 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.6 mtm-85 -122.19 134.62 54.71 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.279 0.562 . . . . 0.0 110.203 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.3 mt -130.21 133.49 64.05 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.801 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 44.0 t -124.41 130.47 73.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 179.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.616 ' OG ' HD12 ' A' ' 117' ' ' LEU . 2.2 m -154.86 166.89 32.07 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.554 179.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 72.2 p -124.13 8.59 8.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.395 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.45 126.04 33.49 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.862 0.363 . . . . 0.0 110.622 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.49 HG11 ' H ' ' A' ' 299' ' ' LEU . 90.9 t -66.18 -44.51 91.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.553 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.5 m -62.43 -44.55 96.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.684 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 46.1 tp -62.45 -41.44 98.74 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.543 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.434 ' O ' HD13 ' A' ' 58' ' ' LEU . 71.8 m -58.1 -44.65 87.79 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.164 -179.061 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -63.93 -62.53 5.15 Favored Glycine 0 N--CA 1.468 0.795 0 N-CA-C 110.844 -0.903 . . . . 0.0 110.844 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.7 t -48.09 -35.51 11.49 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 20.0 mt -61.89 -44.1 97.5 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.615 -0.434 . . . . 0.0 111.397 179.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.439 HD21 HE22 ' A' ' 85' ' ' GLN . 9.3 mp -65.57 -41.45 92.91 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.415 177.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.41 -41.48 98.72 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.856 -179.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.421 ' O ' HG23 ' A' ' 60' ' ' ILE . 8.1 tp -87.44 17.22 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.915 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 56.33 84.37 0.09 Allowed 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.76 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.96 59.74 0.1 OUTLIER Pre-proline 0 C--N 1.328 -0.369 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.406 ' HB3' HE21 ' A' ' 85' ' ' GLN . 9.9 Cg_endo -51.85 151.56 15.3 Favored 'Trans proline' 0 C--N 1.292 -2.4 0 C-N-CA 123.079 2.519 . . . . 0.0 112.041 -178.274 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.434 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -108.46 145.04 15.94 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.191 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.29 -179.65 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.8 mt -63.72 -45.47 97.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.46 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.495 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -129.42 134.1 47.67 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.537 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.503 ' O ' ' N ' ' A' ' 98' ' ' LEU . 74.6 m -134.94 158.84 43.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.859 -179.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.61 139.07 16.22 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.608 -0.997 . . . . 0.0 110.608 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.471 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.71 -162.97 0.09 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.962 0.41 . . . . 0.0 110.486 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.52 HG22 ' CD2' ' A' ' 297' ' ' PHE . 5.7 t -134.0 134.88 43.0 Favored 'General case' 0 CA--C 1.519 -0.25 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.477 ' C ' ' O ' ' A' ' 70' ' ' THR . 1.0 OUTLIER 29.69 68.29 0.67 Allowed Pre-proline 0 N--CA 1.467 0.415 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.816 -179.646 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_exo -61.63 144.94 97.91 Favored 'Trans proline' 0 C--N 1.299 -2.074 0 C-N-CA 122.617 2.211 . . . . 0.0 111.732 -177.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.51 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 45.8 p-10 -158.72 -31.76 0.07 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.668 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.54 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 99.1 m-20 -64.21 -39.45 94.0 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.41 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -60.49 -47.95 83.88 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.44 -178.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.42 ' O ' ' O ' ' A' ' 77' ' ' ALA . 93.4 t -60.56 -24.79 32.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.54 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -45.88 173.35 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.665 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.574 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.3 p30 -61.93 177.36 0.45 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.622 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.566 ' C ' ' H ' ' A' ' 81' ' ' GLY . 36.0 p30 -45.3 85.28 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.011 0.434 . . . . 0.0 111.13 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.574 ' N ' ' O ' ' A' ' 78' ' ' ASP . 42.7 tp60 -67.33 13.39 0.07 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.212 0.529 . . . . 0.0 110.092 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.566 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 118.49 -22.44 9.45 Favored Glycine 0 N--CA 1.461 0.362 0 N-CA-C 110.921 -0.871 . . . . 0.0 110.921 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -107.85 116.45 31.97 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.992 0.425 . . . . 0.0 110.456 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 74.6 mt -98.12 -0.1 45.01 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.972 0.415 . . . . 0.0 110.55 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -92.7 7.14 44.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.029 0.442 . . . . 0.0 110.377 -179.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.77 ' O ' HG22 ' A' ' 89' ' ' VAL . 88.3 mt-30 -100.32 -27.68 13.35 Favored 'General case' 0 C--O 1.219 -0.545 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.813 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.3 t-105 -64.5 -40.53 95.83 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.089 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.53 ' O ' ' N ' ' A' ' 91' ' ' LYS . 63.1 m -77.78 -55.22 5.51 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.181 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -46.86 -50.08 19.16 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.243 -179.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.77 HG22 ' O ' ' A' ' 85' ' ' GLN . 14.2 m -69.5 -40.96 80.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.303 179.46 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.5 ' N ' HG23 ' A' ' 89' ' ' VAL . . . -72.01 -22.63 61.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.688 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.53 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.1 tttm -62.47 -45.75 91.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.316 -179.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.438 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.6 mm-40 -90.01 -94.02 0.12 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.998 0.428 . . . . 0.0 110.115 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.612 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.9 mtt180 -143.61 58.52 1.38 Allowed 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.445 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.7 pttp 34.01 26.5 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.064 0.459 . . . . 0.0 110.229 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.612 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.6 tt -48.89 123.01 6.36 Favored 'General case' 0 N--CA 1.444 -0.725 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.005 -177.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.46 ' O ' HD23 ' A' ' 95' ' ' LEU . 99.0 mm-40 -83.42 -169.6 2.63 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.212 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.616 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 81.9 mtp180 -74.61 136.88 42.0 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.272 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.503 ' N ' ' O ' ' A' ' 67' ' ' SER . 91.5 mt -85.34 -165.77 1.31 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.877 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.54 ' CD2' ' O ' ' A' ' 99' ' ' TYR . 47.1 p90 -169.05 119.33 0.71 Allowed 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.044 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.502 ' C ' ' O ' ' A' ' 99' ' ' TYR . 42.9 mm -28.31 120.44 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 O-C-N 123.316 0.385 . . . . 0.0 111.192 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 114.67 27.02 3.42 Favored Glycine 0 N--CA 1.461 0.308 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 -179.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.574 ' N ' ' CD ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -144.44 46.51 0.63 Allowed Pre-proline 0 C--N 1.322 -0.612 0 CA-C-O 121.126 0.489 . . . . 0.0 110.442 179.798 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.574 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 28.5 Cg_endo -62.09 144.19 95.69 Favored 'Trans proline' 0 C--N 1.293 -2.346 0 C-N-CA 122.68 2.253 . . . . 0.0 111.686 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.453 ' O ' HG23 ' A' ' 108' ' ' VAL . 26.5 t -173.12 120.18 0.35 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.325 179.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.78 -40.27 63.56 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.038 0.447 . . . . 0.0 111.131 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.25 -39.81 89.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.877 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.3 -39.77 94.59 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.772 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 104' ' ' SER . 70.5 t -67.6 -43.81 86.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.686 179.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.94 -38.93 93.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.506 -179.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.438 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.71 -23.45 63.16 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.5 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.53 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.4 mm-40 -90.55 5.31 48.34 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.748 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.54 ' O ' ' NE ' ' A' ' 45' ' ' ARG . 10.6 tpt 23.01 64.41 0.36 Allowed Pre-proline 0 N--CA 1.468 0.45 0 CA-C-O 120.935 0.397 . . . . 0.0 111.312 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -78.65 167.42 22.55 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 123.095 2.53 . . . . 0.0 111.6 -177.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.52 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 99.0 m-20 -109.78 -41.95 4.39 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.046 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.6 tp -121.23 120.7 35.95 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 84.3 mt -113.2 128.75 69.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 CA-C-O 120.89 0.376 . . . . 0.0 110.968 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.616 HD12 ' OG ' ' A' ' 48' ' ' SER . 31.1 mt -109.6 132.09 54.46 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.207 -179.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.498 HD12 HG23 ' A' ' 139' ' ' THR . 98.9 mt -119.67 138.68 49.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.634 -179.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 85.2 p -72.16 153.9 41.37 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.583 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.08 -50.37 73.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.646 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.0 t -149.61 154.16 38.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.563 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 170.85 -170.85 43.5 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -63.08 -33.99 88.75 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.44 ' O ' ' OD1' ' A' ' 124' ' ' ASP . 43.9 p-10 -86.87 120.42 28.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.815 0.341 . . . . 0.0 110.713 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.439 ' O ' HD12 ' A' ' 129' ' ' LEU . 38.5 t -62.97 143.5 57.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.072 0.463 . . . . 0.0 110.33 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.513 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -92.82 -43.26 9.09 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.91 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.2 tp -63.04 -42.56 99.77 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.729 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.32 -11.9 58.77 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.47 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.439 HD12 ' O ' ' A' ' 125' ' ' SER . 84.8 mt -115.09 -23.87 8.82 Favored 'General case' 0 C--O 1.225 -0.228 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.631 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . 0.513 ' N ' ' O ' ' A' ' 126' ' ' ALA . 79.7 t80 -51.46 -49.45 61.74 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.578 -178.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.8 p-10 -66.01 -42.41 89.75 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.773 -0.371 . . . . 0.0 111.364 179.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.524 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 88.3 mt-30 -67.16 -37.64 84.1 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.862 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.43 HD12 HD11 ' A' ' 118' ' ' ILE . 96.4 mt -80.36 -41.64 24.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.885 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.3 t -57.09 -44.48 83.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.294 -179.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.7 m -62.09 -45.2 94.54 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.505 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 94.1 mt -62.23 -43.61 98.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.216 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.666 ' HB1' ' HD2' ' A' ' 138' ' ' PRO . . . -168.98 168.73 5.01 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.608 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.666 ' HD2' ' HB1' ' A' ' 137' ' ' ALA . 51.6 Cg_exo -50.4 112.89 0.83 Allowed 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.24 1.96 . . . . 0.0 112.431 179.044 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.498 HG23 HD12 ' A' ' 118' ' ' ILE . 24.0 m -84.52 127.44 34.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.679 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.683 HD13 ' CD2' ' A' ' 37' ' ' HIS . 34.8 tp -117.88 137.15 52.99 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.009 0.433 . . . . 0.0 110.09 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.439 ' O ' ' OD2' ' A' ' 32' ' ' ASP . 81.9 mt -100.79 118.94 48.24 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.303 0 CA-C-O 121.203 0.525 . . . . 0.0 111.161 -179.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.425 HD12 HD22 ' A' ' 117' ' ' LEU . 97.9 mt -134.97 132.34 53.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.531 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.452 HD21 ' CG ' ' A' ' 241' ' ' ASP . 56.1 t30 -67.8 154.12 42.23 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.979 0.418 . . . . 0.0 110.472 179.26 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.528 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 89.8 t80 -87.81 122.53 31.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.866 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.528 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 99.1 m-20 55.14 69.38 0.74 Allowed 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.655 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 49.6 p-10 -123.6 -0.53 8.62 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.865 0.364 . . . . 0.0 110.646 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -151.14 116.19 5.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.736 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 82.7 p -62.64 167.5 4.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.582 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.407 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.6 p-90 -51.62 -16.12 0.58 Allowed 'General case' 0 C--O 1.221 -0.44 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.33 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . 0.443 ' O ' HG23 ' A' ' 154' ' ' THR . 68.1 tp60 -70.36 -75.4 0.12 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.94 0.4 . . . . 0.0 110.505 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 11.1 t -62.71 -39.11 93.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.211 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 56.0 tp -59.76 -45.69 91.47 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.417 -178.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.407 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 46.6 tp -62.7 -41.69 99.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.588 178.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.443 HG23 ' O ' ' A' ' 150' ' ' GLN . 59.3 p -64.43 -35.02 79.57 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.145 -179.281 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.439 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.5 mm-40 -63.97 -42.79 97.14 Favored 'General case' 0 C--O 1.225 -0.196 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.391 179.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 91.8 mt -65.39 -38.74 90.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.17 0.509 . . . . 0.0 110.27 179.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.568 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.48 -32.17 80.19 Favored Glycine 0 C--N 1.331 0.295 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 -179.144 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.439 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.3 mt-10 -35.65 -27.0 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.826 0.346 . . . . 0.0 110.833 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.568 ' N ' ' O ' ' A' ' 157' ' ' GLY . 95.0 mt -55.65 150.26 2.61 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.333 178.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 77.5 p -69.67 137.24 51.99 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.049 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 70.36 22.24 77.57 Favored Glycine 0 N--CA 1.458 0.149 0 N-CA-C 111.266 -0.733 . . . . 0.0 111.266 179.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 57.8 m80 -123.15 -13.86 7.64 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.599 0.237 . . . . 0.0 110.481 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -66.68 -59.47 3.56 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.657 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -52.32 -49.42 64.29 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.196 -179.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -60.38 -41.29 93.47 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.819 0.342 . . . . 0.0 110.445 179.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.41 -47.23 86.75 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.509 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.79 -40.23 75.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.271 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -61.78 -50.09 73.76 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.626 179.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -65.27 -43.54 90.94 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.59 179.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 94.1 mt -64.79 -43.29 96.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.406 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.55 -51.33 69.91 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.339 -179.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -63.37 -44.01 95.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.869 0.366 . . . . 0.0 110.708 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . 0.651 ' CE2' HD11 ' A' ' 177' ' ' LEU . 54.8 t80 -63.08 -44.33 96.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.146 0.498 . . . . 0.0 110.394 179.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -63.71 -39.7 94.95 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.634 -179.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -63.12 -42.82 99.59 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.528 179.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -60.72 -44.54 96.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.209 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.651 HD11 ' CE2' ' A' ' 173' ' ' PHE . 85.0 mt -64.73 -41.08 96.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.764 178.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.34 -62.18 1.8 Allowed 'General case' 0 C--O 1.239 0.527 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.363 -179.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.41 -47.1 85.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.459 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -52.85 -41.73 64.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.381 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -63.87 -33.74 76.38 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.325 179.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . 0.412 ' HG2' ' O ' ' A' ' 182' ' ' GLU . 69.6 tt0 -90.76 9.0 31.79 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.6 0.714 . . . . 0.0 110.312 -178.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -104.94 -32.01 8.97 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.221 179.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.4 pt -128.0 147.61 32.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.79 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -140.06 131.34 26.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.986 0.422 . . . . 0.0 110.36 179.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . 0.596 HD22 ' N ' ' A' ' 186' ' ' LEU . 3.5 mm? -85.66 133.38 41.94 Favored Pre-proline 0 N--CA 1.451 -0.403 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.177 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -43.79 157.96 0.12 Allowed 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.657 2.238 . . . . 0.0 112.374 179.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . 0.498 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.5 Cg_endo -62.89 114.72 2.54 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.829 2.353 . . . . 0.0 111.658 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . 0.498 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.7 mt-30 155.52 148.07 0.0 OUTLIER Pre-proline 0 N--CA 1.456 -0.145 0 O-C-N 124.208 0.942 . . . . 0.0 110.874 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -73.28 144.44 36.98 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.633 2.222 . . . . 0.0 112.282 177.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.493 HG23 ' OG ' ' A' ' 258' ' ' SER . 2.1 p -124.74 158.95 31.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.449 0.643 . . . . 0.0 110.143 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . 0.488 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 37.6 p -143.3 165.29 27.89 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.133 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . 0.448 ' HA ' ' H ' ' A' ' 260' ' ' PHE . . . -135.18 128.79 32.68 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-O 121.314 0.578 . . . . 0.0 110.173 179.28 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.514 HD11 HD23 ' A' ' 259' ' ' LEU . 47.3 pt -146.34 148.62 16.88 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.375 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.249 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . 0.744 HG13 ' CD1' ' A' ' 262' ' ' PHE . 69.2 t -117.41 123.26 71.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 CA-C-O 121.36 0.6 . . . . 0.0 109.791 178.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -134.55 107.33 7.47 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 121.144 0.497 . . . . 0.0 110.254 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 94.8 m -130.92 130.67 43.77 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.855 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -82.65 -36.9 25.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.208 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.53 -67.2 0.25 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.318 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.58 -9.99 59.25 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.266 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 59.9 t-80 60.53 58.68 2.42 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.722 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 39.1 p -166.88 153.75 8.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.53 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.2 144.25 24.61 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.022 0.439 . . . . 0.0 110.457 179.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -135.05 137.13 42.62 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.548 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 19.4 mt -105.5 125.42 50.97 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.061 0.457 . . . . 0.0 109.867 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' TRP . . . . . 0.555 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 76.6 m95 -81.81 166.52 19.93 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.572 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . 0.447 HG22 ' C ' ' A' ' 206' ' ' TRP . 0.1 OUTLIER -156.67 171.58 7.23 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.561 -178.957 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -54.01 -36.91 85.82 Favored 'Trans proline' 0 C--N 1.301 -1.965 0 C-N-CA 122.664 2.243 . . . . 0.0 112.397 178.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -70.66 -34.86 72.49 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.653 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 22.3 m -61.43 149.7 37.73 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.626 -179.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.58 -36.51 80.86 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.431 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' GLN . . . . . 0.555 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 55.3 tt0 -64.93 -40.5 95.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.53 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.27 -43.66 92.42 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -63.29 -43.06 98.95 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' MET . . . . . 0.573 ' SD ' ' HB2' ' A' ' 304' ' ' ALA . 64.9 ttp -59.25 -48.24 82.37 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 87.5 mt -60.53 -40.97 93.43 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' GLU . . . . . 0.448 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 40.7 tp10 -57.9 -38.11 75.23 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -65.19 -38.12 89.48 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.632 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 94.2 mt -64.16 -43.11 96.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.186 0.517 . . . . 0.0 110.529 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 138.27 45.38 0.08 OUTLIER Glycine 0 C--N 1.334 0.453 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' PHE . . . . . 0.448 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 27.2 m-85 -128.98 156.56 43.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.084 0.469 . . . . 0.0 110.463 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.484 ' O ' HG13 ' A' ' 191' ' ' VAL . 7.7 p -108.66 123.22 48.64 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.311 0.577 . . . . 0.0 110.002 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.473 HD22 ' C ' ' A' ' 222' ' ' THR . 4.3 mm? -101.55 133.11 46.73 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.128 179.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -97.07 159.42 14.92 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.487 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -104.64 115.1 29.74 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.949 0.404 . . . . 0.0 110.375 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.493 ' N ' HD12 ' A' ' 226' ' ' LEU . 8.9 mp -53.48 156.62 4.19 Favored Pre-proline 0 N--CA 1.449 -0.495 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.827 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -59.75 145.04 99.23 Favored 'Trans proline' 0 C--N 1.299 -2.03 0 C-N-CA 122.726 2.284 . . . . 0.0 112.363 179.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.51 -2.72 58.81 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.51 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.37 -40.66 5.68 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . 0.533 ' O ' ' N ' ' A' ' 233' ' ' SER . 69.4 mt -79.12 -17.2 55.5 Favored 'General case' 0 C--O 1.219 -0.505 0 CA-C-O 121.1 0.476 . . . . 0.0 110.261 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 54.5 t-20 -40.3 -48.77 2.69 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.751 0.31 . . . . 0.0 110.78 -179.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -88.36 15.45 7.75 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.433 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . 0.533 ' N ' ' O ' ' A' ' 230' ' ' LEU . 77.7 p -60.78 -35.36 76.25 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.724 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . 0.521 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.6 tt0 -118.54 -69.62 0.84 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.864 179.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 3.9 m -70.54 103.06 2.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.702 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -94.67 58.29 2.3 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.052 0.453 . . . . 0.0 110.333 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -145.31 -122.63 1.53 Allowed Glycine 0 C--N 1.332 0.342 0 N-CA-C 110.964 -0.855 . . . . 0.0 110.964 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -133.78 111.98 10.97 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.101 0.477 . . . . 0.0 110.398 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . 0.505 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.1 mtt180 -148.42 56.93 1.05 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.742 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -69.37 -31.78 70.41 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.47 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 241' ' ' ASP . . . . . 0.455 ' OD2' ' O ' ' A' ' 144' ' ' TYR . 64.9 t0 -56.67 -47.01 80.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.291 -178.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 242' ' ' ILE . . . . . 0.44 ' O ' ' O ' ' A' ' 239' ' ' ARG . 17.3 tt -140.46 157.48 24.43 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 CA-C-O 120.91 0.386 . . . . 0.0 110.485 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.463 HG22 HD13 ' A' ' 245' ' ' LEU . 95.8 mt -105.93 106.3 20.32 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.219 0 CA-C-O 121.165 0.507 . . . . 0.0 110.425 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . 0.606 ' C ' HD12 ' A' ' 245' ' ' LEU . 88.3 mt-30 -110.86 110.4 20.99 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.366 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.606 HD12 ' C ' ' A' ' 244' ' ' GLN . 9.8 mp -121.78 -167.86 1.6 Allowed 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.627 179.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . 0.521 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 172.39 -16.04 0.05 OUTLIER Glycine 0 CA--C 1.524 0.596 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . 0.665 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -60.96 157.56 31.07 Favored Glycine 0 CA--C 1.521 0.463 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -63.86 20.87 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.941 0.401 . . . . 0.0 110.581 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . 0.665 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.9 m-20 -96.86 -5.84 37.3 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.528 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 92.5 mt -80.19 -21.45 42.96 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.839 179.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.63 -51.43 69.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.663 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.96 -5.21 58.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.465 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.03 -74.23 1.15 Allowed Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 82.0 mt -70.31 126.15 28.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.014 0.435 . . . . 0.0 110.172 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -59.97 -39.3 85.19 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.274 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 83.11 51.67 4.09 Favored Glycine 0 CA--C 1.519 0.3 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -95.15 -16.05 22.87 Favored 'General case' 0 C--N 1.331 -0.212 0 O-C-N 122.694 -0.297 . . . . 0.0 110.585 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 258' ' ' SER . . . . . 0.493 ' OG ' HG23 ' A' ' 191' ' ' VAL . 3.4 t 175.19 89.42 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.182 0.515 . . . . 0.0 110.053 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.852 ' N ' HD12 ' A' ' 259' ' ' LEU . 1.0 OUTLIER -94.77 124.56 38.88 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.273 0.559 . . . . 0.0 111.253 -179.094 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 260' ' ' PHE . . . . . 0.448 ' H ' ' HA ' ' A' ' 193' ' ' ALA . 15.8 m-30 -93.95 146.65 23.77 Favored 'General case' 0 CA--C 1.497 -1.086 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.4 179.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 86.4 mt -122.32 149.54 43.6 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.573 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.744 ' CD1' HG13 ' A' ' 195' ' ' VAL . 2.6 p90 -77.69 -138.91 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.506 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 263' ' ' ALA . . . . . 0.654 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -51.08 77.59 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 121.109 0.48 . . . . 0.0 111.303 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . 0.624 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.93 104.57 0.18 Allowed Glycine 0 CA--C 1.527 0.816 0 N-CA-C 110.466 -1.054 . . . . 0.0 110.466 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 265' ' ' ASP . . . . . 0.589 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.6 m-20 -80.06 -177.94 6.28 Favored 'General case' 0 C--N 1.327 -0.407 0 O-C-N 122.706 -0.291 . . . . 0.0 111.001 -179.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -40.44 -17.81 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.587 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 267' ' ' LYS . . . . . 0.589 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.0 -51.76 43.49 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.013 0.435 . . . . 0.0 110.684 179.125 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -63.68 -46.49 85.29 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.266 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . 0.58 ' HB1' ' OH ' ' A' ' 273' ' ' TYR . . . -61.76 -34.81 76.53 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 121.543 0.687 . . . . 0.0 109.746 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -63.42 -34.23 77.3 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.076 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.51 -43.11 13.83 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.112 -179.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 272' ' ' ILE . . . . . 0.593 ' C ' ' H ' ' A' ' 274' ' ' ALA . 4.9 tt -51.44 -33.97 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.799 -178.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 273' ' ' TYR . . . . . 0.58 ' OH ' ' HB1' ' A' ' 269' ' ' ALA . 16.9 m-85 -54.43 -2.03 0.03 OUTLIER 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.615 -179.289 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 274' ' ' ALA . . . . . 0.593 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.2 -39.63 71.66 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.868 179.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . 0.579 ' O ' ' N ' ' A' ' 279' ' ' ALA . 3.9 p30 -38.78 97.71 0.14 Allowed Pre-proline 0 N--CA 1.462 0.157 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.385 -179.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.7 -42.57 67.27 Favored 'Trans proline' 0 C--N 1.303 -1.865 0 C-N-CA 122.367 2.045 . . . . 0.0 112.506 -178.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 88.9 mt -64.43 -42.83 95.78 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.092 0.472 . . . . 0.0 111.225 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 91.9 mt -95.97 -1.08 49.8 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.954 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 279' ' ' ALA . . . . . 0.579 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.38 -34.83 77.47 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.683 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.22 20.16 0.11 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.982 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . 0.482 ' H ' ' C ' ' A' ' 279' ' ' ALA . 13.6 mt -74.67 119.39 76.43 Favored Pre-proline 0 N--CA 1.444 -0.731 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.834 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -49.87 -40.1 48.74 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.623 2.215 . . . . 0.0 112.327 178.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.86 -50.59 63.48 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.034 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 73.5 t -61.45 -43.85 97.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.096 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -57.64 -41.15 80.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.098 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -91.01 0.05 57.63 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.118 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt 59.94 43.67 14.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.048 0.452 . . . . 0.0 110.772 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -95.01 41.06 1.1 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.382 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 53.8 t -119.33 135.74 58.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-O 121.133 0.492 . . . . 0.0 110.033 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -133.47 163.62 28.98 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 121.236 0.541 . . . . 0.0 110.569 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.8 155.58 32.28 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 121.097 0.475 . . . . 0.0 110.645 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 82.1 mt -94.44 -1.56 53.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.232 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.03 165.38 12.66 Favored Glycine 0 N--CA 1.463 0.489 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 6.7 m -86.64 -61.59 1.7 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.849 0.356 . . . . 0.0 111.092 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 295' ' ' GLU . . . . . 0.454 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.6 mm-40 -69.53 -4.82 20.57 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.729 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 26.8 p -76.55 32.61 0.13 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.632 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 297' ' ' PHE . . . . . 0.52 ' CD2' HG22 ' A' ' 70' ' ' THR . 67.1 t80 -60.4 -46.18 90.92 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.672 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . 0.616 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.2 mtt85 -80.32 136.93 36.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.657 -179.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.49 ' H ' HG11 ' A' ' 51' ' ' VAL . 0.9 OUTLIER -114.61 116.71 29.18 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.994 0.426 . . . . 0.0 110.533 179.65 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . 0.624 ' H ' ' CB ' ' A' ' 303' ' ' SER . 48.7 p-10 -167.21 -174.59 2.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.616 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 80.4 t80 -48.13 -44.44 32.09 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.227 -179.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -65.51 -41.53 93.07 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.034 0.445 . . . . 0.0 110.662 178.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . 0.624 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 53.8 p -55.29 -36.29 65.99 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.952 -179.087 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . 0.573 ' HB2' ' SD ' ' A' ' 215' ' ' MET . . . -57.07 -52.09 66.66 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 91.7 mtp -55.96 -44.32 78.35 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -66.05 -42.87 88.96 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.172 0.51 . . . . 0.0 110.199 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 303' ' ' SER . 55.7 t -63.91 -43.03 97.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.245 179.39 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 42.4 tp -60.04 -41.98 93.47 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.803 -179.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -62.18 -39.16 91.76 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.211 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 310' ' ' ARG . . . . . 0.45 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.7 ttt85 -63.68 -43.91 95.26 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.227 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 89.4 mt -63.1 -42.08 99.5 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.364 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -63.06 -33.77 76.14 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.076 179.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.38 -23.56 22.16 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.346 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . 0.484 HD22 ' CE2' ' A' ' 315' ' ' PHE . 6.8 tt -62.35 -43.06 99.71 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 121.128 0.489 . . . . 0.0 110.56 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 315' ' ' PHE . . . . . 0.484 ' CE2' HD22 ' A' ' 314' ' ' LEU . 89.8 m-85 . . . . . 0 C--O 1.22 -0.47 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.327 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -99.67 136.29 39.82 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.04 0.448 . . . . 0.0 110.44 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.492 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -91.54 178.41 1.78 Allowed Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.584 -179.87 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.492 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.1 Cg_exo -61.72 147.66 94.82 Favored 'Trans proline' 0 C--N 1.3 -2.001 0 C-N-CA 122.882 2.388 . . . . 0.0 112.182 179.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.496 ' HE ' HD12 ' A' ' 39' ' ' LEU . 35.1 ptt180 -135.35 142.36 45.75 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.567 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -78.91 116.9 19.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.515 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.424 ' O ' HG23 ' A' ' 30' ' ' ILE . 9.6 tp -110.35 131.0 62.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.478 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.9 t -70.81 142.41 51.3 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.62 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.424 ' OD1' ' O ' ' A' ' 141' ' ' ILE . 24.7 t70 -140.56 177.58 7.92 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.508 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 77.9 p -73.81 -36.38 64.98 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.556 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 60.1 ttt85 -47.69 -95.22 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.409 -179.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.419 ' O ' ' OG1' ' A' ' 36' ' ' THR . . . -165.42 -25.51 0.02 OUTLIER Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.419 ' OG1' ' O ' ' A' ' 35' ' ' GLY . 61.2 m -169.05 106.82 0.42 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.844 0.354 . . . . 0.0 110.63 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.568 ' CD2' HD13 ' A' ' 140' ' ' LEU . 33.2 t60 -129.61 144.57 51.33 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.022 0.439 . . . . 0.0 110.199 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.629 HG22 ' N ' ' A' ' 39' ' ' LEU . 96.9 m -128.63 166.5 18.77 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.455 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.629 ' N ' HG22 ' A' ' 38' ' ' THR . 80.7 mt -121.15 127.52 51.63 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.506 179.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -63.8 -44.4 93.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.709 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 39.6 p -165.84 154.95 11.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.439 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.493 ' H ' ' CD ' ' A' ' 42' ' ' GLN . 14.3 mp0 -43.07 100.64 0.23 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.574 179.433 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -56.94 128.99 32.16 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 122.492 2.128 . . . . 0.0 112.201 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -83.33 -24.35 32.15 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.587 179.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.538 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.5 mtm-85 -121.16 134.48 55.22 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.113 0.482 . . . . 0.0 110.276 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.2 mt -130.09 133.57 64.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.74 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 47.9 t -125.26 130.94 72.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.203 179.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.574 ' OG ' HD12 ' A' ' 117' ' ' LEU . 4.1 m -154.57 166.34 33.63 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.607 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 72.2 p -124.6 8.83 8.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.429 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.72 125.73 33.43 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.587 -179.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.454 HG11 ' H ' ' A' ' 299' ' ' LEU . 87.8 t -65.68 -44.63 93.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.493 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 18.1 m -62.79 -44.16 96.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.616 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 53.0 tp -62.37 -41.63 98.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.53 -179.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.457 ' O ' HD13 ' A' ' 58' ' ' LEU . 76.3 m -57.67 -44.74 85.96 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.329 -179.332 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.4 -62.4 5.14 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.5 t -47.52 -35.96 9.65 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.681 0.277 . . . . 0.0 110.279 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.7 mt -61.77 -44.34 97.08 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.087 179.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.457 HD13 ' O ' ' A' ' 54' ' ' THR . 8.9 mp -65.39 -41.23 93.9 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.137 178.262 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.401 ' HB1' ' NE ' ' A' ' 169' ' ' ARG . . . -63.86 -41.25 97.81 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.78 -179.266 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.43 ' O ' HG23 ' A' ' 60' ' ' ILE . 7.9 tp -88.1 16.77 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.843 -179.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 56.4 84.43 0.09 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.727 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 178.89 57.7 0.07 OUTLIER Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.269 -0.423 . . . . 0.0 109.951 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.411 ' HB3' HE21 ' A' ' 85' ' ' GLN . 9.7 Cg_endo -51.09 153.83 8.51 Favored 'Trans proline' 0 C--N 1.296 -2.216 0 C-N-CA 123.035 2.49 . . . . 0.0 111.999 -177.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.428 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -109.33 146.15 15.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.366 -179.631 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.67 -45.44 97.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.15 -179.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.506 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -129.83 134.69 47.7 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.883 0.373 . . . . 0.0 110.522 -179.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.489 ' O ' ' N ' ' A' ' 98' ' ' LEU . 72.3 m -134.87 158.96 42.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.765 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.92 139.35 16.21 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.481 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.8 -162.67 0.08 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.876 0.369 . . . . 0.0 110.49 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.504 HG22 ' CD2' ' A' ' 297' ' ' PHE . 5.8 t -133.76 135.82 44.16 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.256 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.488 ' C ' ' O ' ' A' ' 70' ' ' THR . 1.0 OUTLIER 29.51 68.73 0.64 Allowed Pre-proline 0 N--CA 1.464 0.26 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.74 -179.487 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -61.43 144.79 98.37 Favored 'Trans proline' 0 C--N 1.301 -1.93 0 C-N-CA 122.697 2.265 . . . . 0.0 111.815 -178.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.528 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 45.3 p-10 -160.08 -32.3 0.06 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.592 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.537 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 99.0 m-20 -64.04 -39.51 94.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.358 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 73.2 ttt180 -60.18 -48.41 81.83 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.548 -179.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.426 ' O ' ' O ' ' A' ' 77' ' ' ALA . 94.9 t -59.82 -25.05 31.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.096 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.537 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -45.35 172.67 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.636 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.573 ' O ' ' N ' ' A' ' 80' ' ' GLN . 54.1 p30 -61.94 177.64 0.43 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.483 -179.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.563 ' C ' ' H ' ' A' ' 81' ' ' GLY . 34.4 p30 -46.28 85.58 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.957 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.573 ' N ' ' O ' ' A' ' 78' ' ' ASP . 42.9 tp60 -67.17 13.69 0.06 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.298 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.563 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 118.09 -21.98 9.94 Favored Glycine 0 CA--C 1.519 0.316 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -107.94 116.67 32.38 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.946 0.403 . . . . 0.0 110.469 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 75.4 mt -99.23 0.38 43.08 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.582 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -91.88 6.81 44.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.374 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.794 ' O ' HG22 ' A' ' 89' ' ' VAL . 88.0 mt-30 -100.03 -28.04 13.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.704 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 68.4 t-105 -63.43 -40.5 97.34 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.821 -179.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.552 ' O ' ' N ' ' A' ' 91' ' ' LYS . 67.9 m -77.75 -53.81 7.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.837 -179.276 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -48.25 -50.95 27.73 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.936 -179.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.794 HG22 ' O ' ' A' ' 85' ' ' GLN . 15.8 m -68.96 -40.44 81.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.992 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.495 ' N ' HG23 ' A' ' 89' ' ' VAL . . . -72.47 -22.6 61.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.624 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.552 ' N ' ' O ' ' A' ' 87' ' ' SER . 65.9 tttm -61.5 -45.95 92.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.429 -179.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.435 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.8 mm-40 -90.38 -94.48 0.12 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.251 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.624 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.9 mtt180 -143.34 59.58 1.4 Allowed 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.456 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.6 pttp 33.76 26.35 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.021 0.439 . . . . 0.0 110.388 -179.028 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.624 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.4 tt -48.09 123.07 5.78 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.912 -178.14 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.45 ' O ' HD23 ' A' ' 95' ' ' LEU . 98.9 mm-40 -83.21 -170.68 3.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.224 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.624 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 82.9 mtp180 -73.01 137.67 45.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.329 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.489 ' N ' ' O ' ' A' ' 67' ' ' SER . 88.9 mt -86.41 -165.87 1.39 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.782 -179.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.533 ' CD2' ' O ' ' A' ' 99' ' ' TYR . 47.7 p90 -168.29 119.7 0.81 Allowed 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.23 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.507 ' C ' ' O ' ' A' ' 99' ' ' TYR . 42.8 mm -29.29 121.43 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.935 -179.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 113.6 28.05 3.36 Favored Glycine 0 CA--C 1.521 0.417 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 -179.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.583 ' H ' ' CD ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -143.96 46.11 0.62 Allowed Pre-proline 0 C--N 1.324 -0.521 0 CA-C-O 121.044 0.45 . . . . 0.0 110.479 179.874 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.581 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 29.8 Cg_endo -62.47 143.83 93.82 Favored 'Trans proline' 0 C--N 1.298 -2.13 0 C-N-CA 122.728 2.286 . . . . 0.0 111.834 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.459 ' O ' HG23 ' A' ' 108' ' ' VAL . 26.2 t -173.14 120.68 0.36 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.435 179.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.4 -41.07 63.78 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.866 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -65.73 -39.95 91.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.744 -179.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.77 -39.56 94.55 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.681 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 104' ' ' SER . 71.3 t -67.78 -43.58 86.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.659 179.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.57 -39.28 93.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.491 -179.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.435 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.68 -23.9 63.49 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.508 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.562 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.3 mm-40 -91.32 5.11 50.54 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.658 -179.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.562 ' C ' ' O ' ' A' ' 111' ' ' GLN . 9.5 tpt 21.01 65.51 0.28 Allowed Pre-proline 0 N--CA 1.465 0.299 0 CA-C-O 121.042 0.449 . . . . 0.0 111.116 -179.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.46 ' HG2' HD11 ' A' ' 116' ' ' ILE . 61.9 Cg_endo -79.92 170.03 17.18 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 123.018 2.479 . . . . 0.0 111.617 -178.083 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.52 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 98.9 m-20 -112.52 -44.25 3.38 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.182 179.464 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 39.4 tp -120.18 121.35 38.56 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.142 179.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.46 HD11 ' HG2' ' A' ' 113' ' ' PRO . 96.6 mt -118.61 131.29 71.83 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.851 -179.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.574 HD12 ' OG ' ' A' ' 48' ' ' SER . 32.2 mt -105.95 132.01 52.56 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.222 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.479 HD12 HG23 ' A' ' 139' ' ' THR . 98.3 mt -117.26 136.08 55.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.641 -179.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 85.0 p -71.68 151.85 43.31 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.559 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.26 -50.01 75.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.633 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -149.35 153.77 37.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.542 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 168.57 -169.32 41.58 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -63.13 -35.41 92.05 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.447 ' O ' ' OD1' ' A' ' 124' ' ' ASP . 44.2 p-10 -88.81 120.12 29.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.859 0.362 . . . . 0.0 110.643 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.448 ' O ' HD12 ' A' ' 129' ' ' LEU . 40.6 t -63.35 144.62 56.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.467 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.518 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.92 -42.76 8.9 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.745 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.4 tp -62.79 -42.36 99.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.669 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.99 -10.59 54.74 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.483 -179.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.448 HD12 ' O ' ' A' ' 125' ' ' SER . 84.0 mt -115.73 -24.57 8.17 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.591 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . 0.518 ' N ' ' O ' ' A' ' 126' ' ' ALA . 74.3 t80 -50.77 -49.93 57.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.65 -179.109 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.3 p-10 -65.89 -41.91 90.92 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.827 0.346 . . . . 0.0 111.132 179.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.526 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 87.8 mt-30 -68.08 -36.72 80.29 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.804 -179.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.458 HD12 HD11 ' A' ' 118' ' ' ILE . 96.5 mt -80.09 -42.78 22.95 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.864 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.402 ' N ' ' OG1' ' A' ' 139' ' ' THR . 11.5 t -56.76 -45.47 82.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.452 -179.337 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 20.0 m -62.38 -45.93 90.91 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.568 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 93.2 mt -62.19 -43.84 98.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.463 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.596 ' HB1' ' HD2' ' A' ' 138' ' ' PRO . . . -170.04 163.04 6.53 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.598 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.596 ' HD2' ' HB1' ' A' ' 137' ' ' ALA . 77.5 Cg_exo -41.54 110.6 0.14 Allowed 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.629 2.219 . . . . 0.0 112.224 179.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.499 HG21 ' CD1' ' A' ' 130' ' ' TYR . 3.0 m -87.79 127.11 35.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.62 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.568 HD13 ' CD2' ' A' ' 37' ' ' HIS . 35.1 tp -119.24 139.42 51.91 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.36 179.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.424 ' O ' ' OD1' ' A' ' 32' ' ' ASP . 79.7 mt -105.41 120.27 55.87 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.197 0 CA-C-O 121.1 0.476 . . . . 0.0 110.942 -179.161 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.459 HD12 HD22 ' A' ' 117' ' ' LEU . 94.7 mt -136.43 132.6 49.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.562 179.358 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.548 HD21 ' CG ' ' A' ' 241' ' ' ASP . 54.3 t30 -64.55 148.99 49.62 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.91 0.386 . . . . 0.0 110.475 179.299 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.453 ' O ' ' OD2' ' A' ' 241' ' ' ASP . 87.1 t80 -82.72 122.85 28.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.84 -179.333 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.442 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 91.6 m-20 55.01 69.67 0.71 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.753 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 49.3 p-10 -124.4 0.25 8.27 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.579 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -151.53 117.31 5.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.723 -179.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 85.0 p -63.89 168.68 4.87 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.504 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.415 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.6 p-90 -51.21 -15.89 0.42 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.424 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . 0.439 ' O ' HG23 ' A' ' 154' ' ' THR . 68.4 tp60 -70.9 -75.46 0.12 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.526 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.439 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.3 t -62.66 -38.58 90.88 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.318 179.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 51.1 tp -59.98 -45.88 91.28 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.421 -178.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.415 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 45.2 tp -62.64 -41.61 99.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.581 178.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.439 ' OG1' ' O ' ' A' ' 151' ' ' SER . 59.3 p -63.9 -34.87 78.94 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.298 -179.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.494 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.4 mm-40 -63.56 -42.01 98.38 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.359 179.265 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 91.8 mt -65.6 -38.57 89.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.11 0.481 . . . . 0.0 110.341 178.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.568 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.58 -31.97 79.66 Favored Glycine 0 CA--C 1.52 0.399 0 N-CA-C 110.818 -0.913 . . . . 0.0 110.818 -179.393 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.494 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.3 mt-10 -36.99 -25.32 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.853 0.359 . . . . 0.0 110.772 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.568 ' N ' ' O ' ' A' ' 157' ' ' GLY . 92.9 mt -59.67 149.37 6.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.423 179.268 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 77.6 p -69.18 137.52 53.34 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.854 -179.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 70.54 22.26 77.81 Favored Glycine 0 CA--C 1.519 0.285 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 179.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 62.4 m80 -124.38 -14.12 6.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.715 0.293 . . . . 0.0 110.442 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -66.83 -59.87 3.16 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.579 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -51.3 -49.7 60.76 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.243 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -60.1 -41.13 91.86 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.474 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.5 -47.6 84.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.58 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.55 -40.07 74.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.331 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -61.67 -50.58 71.93 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.603 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.401 ' NE ' ' HB1' ' A' ' 59' ' ' ALA . 59.9 ttt85 -65.32 -43.66 90.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.572 179.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 94.3 mt -64.71 -43.15 96.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.432 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.27 -51.49 69.15 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.382 -179.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.51 -43.64 96.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.601 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . 0.658 ' CE2' HD11 ' A' ' 177' ' ' LEU . 55.9 t80 -62.94 -44.01 97.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.484 179.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -63.65 -39.72 95.05 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.403 -179.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -63.07 -42.83 99.74 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.537 179.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -60.46 -44.79 95.51 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.322 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.658 HD11 ' CE2' ' A' ' 173' ' ' PHE . 84.6 mt -64.65 -40.97 96.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.652 178.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.0 -62.5 1.59 Allowed 'General case' 0 C--O 1.237 0.438 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.357 -179.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.02 -47.27 83.55 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.51 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -52.65 -41.63 63.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.423 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -64.1 -33.2 75.23 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.361 179.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . 0.418 ' HG2' ' O ' ' A' ' 182' ' ' GLU . 69.5 tt0 -91.21 8.43 35.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.357 0.599 . . . . 0.0 110.423 -178.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -104.42 -32.26 9.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.037 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.4 pt -128.02 147.56 32.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.755 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -139.65 131.05 26.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.428 179.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . 0.592 HD22 ' N ' ' A' ' 186' ' ' LEU . 3.6 mm? -85.4 133.0 43.21 Favored Pre-proline 0 N--CA 1.452 -0.337 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.933 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -43.61 157.68 0.12 Allowed 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.689 2.259 . . . . 0.0 112.302 179.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . 0.522 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.7 Cg_endo -62.81 114.93 2.63 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 122.805 2.337 . . . . 0.0 111.862 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . 0.522 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.7 mt-30 155.52 147.75 0.0 OUTLIER Pre-proline 0 N--CA 1.456 -0.145 0 O-C-N 123.83 0.706 . . . . 0.0 110.823 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -73.4 143.83 35.52 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.643 2.228 . . . . 0.0 112.266 177.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.495 HG23 ' OG ' ' A' ' 258' ' ' SER . 2.1 p -124.5 159.05 31.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.245 0.545 . . . . 0.0 110.305 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . 0.493 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 37.9 p -143.47 165.03 28.68 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.922 -179.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . 0.444 ' HA ' ' H ' ' A' ' 260' ' ' PHE . . . -135.36 128.73 32.2 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 121.159 0.504 . . . . 0.0 110.33 179.341 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.515 HD11 HD23 ' A' ' 259' ' ' LEU . 47.5 pt -146.73 148.95 16.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.993 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . 0.739 HG13 ' CD1' ' A' ' 262' ' ' PHE . 76.2 t -117.35 123.02 71.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.173 0.511 . . . . 0.0 110.079 178.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -134.22 106.46 7.16 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.371 179.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 95.9 m -130.48 130.71 44.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.763 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.404 ' O ' ' N ' ' A' ' 201' ' ' HIS . . . -82.95 -36.79 24.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.285 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.31 -67.07 0.26 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.348 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.31 -9.66 58.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.357 179.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . 0.404 ' N ' ' O ' ' A' ' 198' ' ' ALA . 60.2 t-80 60.72 58.19 2.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.694 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 41.1 p -167.43 153.61 7.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.569 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.27 144.18 24.51 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.953 0.406 . . . . 0.0 110.509 179.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -135.29 138.25 43.29 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.632 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 18.4 mt -105.98 125.12 50.62 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.0 0.428 . . . . 0.0 110.033 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 206' ' ' TRP . . . . . 0.558 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 74.1 m95 -81.84 167.2 19.26 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.596 -179.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . 0.469 HG22 ' C ' ' A' ' 206' ' ' TRP . 0.1 OUTLIER -157.18 171.15 7.83 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.64 -179.056 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -53.1 -37.2 79.13 Favored 'Trans proline' 0 C--N 1.302 -1.907 0 C-N-CA 122.73 2.286 . . . . 0.0 112.377 179.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -70.96 -34.98 71.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.657 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 22.1 m -61.03 150.74 32.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.595 -179.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.46 -36.89 81.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.509 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 212' ' ' GLN . . . . . 0.558 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 54.8 tt0 -64.72 -40.29 95.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.625 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.78 -43.35 91.91 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -62.8 -44.37 96.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.807 0.337 . . . . 0.0 110.319 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 215' ' ' MET . . . . . 0.551 ' SD ' ' HB2' ' A' ' 304' ' ' ALA . 65.1 ttp -59.08 -48.27 82.2 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.233 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 87.6 mt -60.01 -41.36 91.96 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 179.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 217' ' ' GLU . . . . . 0.45 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 40.4 tp10 -57.84 -38.13 75.1 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.205 179.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -65.45 -38.23 89.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.633 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 95.1 mt -64.15 -42.95 96.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.578 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.74 45.39 0.08 OUTLIER Glycine 0 CA--C 1.521 0.456 0 N-CA-C 110.991 -0.843 . . . . 0.0 110.991 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 221' ' ' PHE . . . . . 0.45 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 25.8 m-85 -128.21 155.63 44.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.972 0.415 . . . . 0.0 110.536 -179.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.482 ' O ' HG13 ' A' ' 191' ' ' VAL . 7.8 p -107.07 122.4 46.4 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.16 0.505 . . . . 0.0 110.231 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.479 HD22 ' C ' ' A' ' 222' ' ' THR . 4.3 mm? -101.78 132.94 47.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.924 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.76 160.36 14.42 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.527 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.72 115.08 29.63 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.35 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.494 ' N ' HD12 ' A' ' 226' ' ' LEU . 9.0 mp -53.1 156.42 3.7 Favored Pre-proline 0 N--CA 1.452 -0.345 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.726 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -59.62 145.2 98.75 Favored 'Trans proline' 0 C--N 1.302 -1.917 0 C-N-CA 122.771 2.314 . . . . 0.0 112.33 179.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.3 -3.15 59.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.498 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.19 -41.08 5.63 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . 0.519 ' O ' ' N ' ' A' ' 233' ' ' SER . 67.7 mt -79.05 -17.75 54.69 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-O 121.051 0.453 . . . . 0.0 110.427 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . 0.4 ' C ' ' O ' ' A' ' 230' ' ' LEU . 55.4 t-20 -40.05 -49.7 2.55 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.78 -179.496 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -87.67 15.19 7.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.096 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . 0.519 ' N ' ' O ' ' A' ' 230' ' ' LEU . 78.0 p -60.24 -35.17 74.86 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.744 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . 0.522 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.6 tt0 -119.64 -69.4 0.85 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.765 179.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.0 m -69.7 101.88 1.77 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.614 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -93.67 57.73 2.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.413 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -144.56 -122.56 1.59 Allowed Glycine 0 CA--C 1.521 0.451 0 N-CA-C 110.906 -0.877 . . . . 0.0 110.906 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -135.4 111.21 9.38 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.017 0.436 . . . . 0.0 110.406 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . 0.527 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.6 mtt180 -147.79 58.27 1.11 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.678 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -69.6 -32.2 70.8 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.515 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 241' ' ' ASP . . . . . 0.548 ' CG ' HD21 ' A' ' 143' ' ' ASN . 64.7 t0 -56.9 -47.33 80.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.362 -179.208 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 242' ' ' ILE . . . . . 0.433 ' O ' ' O ' ' A' ' 239' ' ' ARG . 17.8 tt -139.61 155.98 25.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.503 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.442 HG22 HD13 ' A' ' 245' ' ' LEU . 96.2 mt -106.01 106.47 20.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-O 120.973 0.416 . . . . 0.0 110.496 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . 0.6 ' O ' HD12 ' A' ' 245' ' ' LEU . 88.6 mt-30 -110.34 109.87 20.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.423 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.6 HD12 ' O ' ' A' ' 244' ' ' GLN . 9.4 mp -121.63 -168.16 1.64 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.65 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . 0.522 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.85 -16.32 0.05 OUTLIER Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . 0.674 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -61.31 156.26 34.59 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -63.35 21.87 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.92 0.39 . . . . 0.0 110.622 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . 0.674 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.8 m-20 -97.32 -6.29 34.64 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.539 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 91.6 mt -79.58 -22.09 44.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.757 179.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.62 -51.65 69.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.645 -179.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.0 -5.6 58.42 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.52 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -80.98 -74.46 1.14 Allowed Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 81.2 mt -69.8 125.8 27.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.846 0.355 . . . . 0.0 110.38 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -59.24 -39.55 83.14 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.251 -179.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 83.32 51.73 4.03 Favored Glycine 0 CA--C 1.521 0.467 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -95.45 -15.57 22.87 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.715 0.293 . . . . 0.0 110.622 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 258' ' ' SER . . . . . 0.495 ' OG ' HG23 ' A' ' 191' ' ' VAL . 3.5 t 174.59 89.0 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.07 0.462 . . . . 0.0 110.244 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.861 ' N ' HD12 ' A' ' 259' ' ' LEU . 1.0 OUTLIER -94.21 124.04 37.98 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.127 0.489 . . . . 0.0 111.038 -178.92 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 260' ' ' PHE . . . . . 0.444 ' H ' ' HA ' ' A' ' 193' ' ' ALA . 16.0 m-30 -93.31 146.6 23.6 Favored 'General case' 0 CA--C 1.506 -0.722 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.481 179.149 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 85.4 mt -122.24 149.63 43.41 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.565 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.739 ' CD1' HG13 ' A' ' 195' ' ' VAL . 2.6 p90 -77.56 -139.01 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.521 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 263' ' ' ALA . . . . . 0.665 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -51.29 77.44 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.997 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . 0.635 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.31 104.77 0.19 Allowed Glycine 0 CA--C 1.528 0.876 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 265' ' ' ASP . . . . . 0.6 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.7 m-20 -80.4 -177.77 6.33 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.701 0.286 . . . . 0.0 110.8 -179.363 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -40.25 -17.84 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.566 179.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 267' ' ' LYS . . . . . 0.6 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.45 -51.7 40.7 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.635 179.449 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -63.52 -46.59 85.36 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.279 179.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . 0.568 ' HB1' ' OH ' ' A' ' 273' ' ' TYR . . . -61.78 -34.99 76.86 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.302 0.572 . . . . 0.0 109.95 179.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -63.31 -34.05 76.86 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.116 179.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.69 -43.41 13.42 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.928 -179.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 272' ' ' ILE . . . . . 0.589 ' C ' ' H ' ' A' ' 274' ' ' ALA . 4.9 tt -51.42 -33.58 14.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.667 -178.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 273' ' ' TYR . . . . . 0.568 ' OH ' ' HB1' ' A' ' 269' ' ' ALA . 17.3 m-85 -54.65 -1.61 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.582 -179.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 274' ' ' ALA . . . . . 0.589 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.74 -39.7 69.87 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.811 179.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . 0.582 ' O ' ' N ' ' A' ' 279' ' ' ALA . 3.1 p30 -39.18 98.34 0.16 Allowed Pre-proline 0 N--CA 1.461 0.108 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.457 -179.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -54.59 -42.83 64.61 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 C-N-CA 122.519 2.146 . . . . 0.0 112.438 -178.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 89.1 mt -64.57 -42.88 95.37 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.024 -179.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 90.9 mt -95.77 -1.47 49.68 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.809 -179.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 279' ' ' ALA . . . . . 0.582 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.24 -34.89 77.37 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.703 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.46 20.35 0.12 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.876 -179.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . 0.486 HD23 ' HA ' ' A' ' 281' ' ' LEU . 13.9 mt -75.04 119.38 76.62 Favored Pre-proline 0 N--CA 1.45 -0.462 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.719 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -49.75 -40.36 47.53 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.719 2.279 . . . . 0.0 112.224 178.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.32 -50.83 61.5 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.263 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 78.6 t -61.28 -43.91 97.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.255 179.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -57.65 -41.21 80.98 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.261 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -91.0 0.13 57.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.313 179.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt 59.73 43.64 15.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.754 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -94.95 41.05 1.09 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.375 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 53.7 t -119.03 135.77 58.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 121.012 0.434 . . . . 0.0 110.203 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -133.07 163.35 29.45 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.638 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.8 155.34 32.74 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.657 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 79.5 mt -94.19 -1.66 53.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.312 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.37 165.79 12.73 Favored Glycine 0 CA--C 1.521 0.462 0 N-CA-C 110.658 -0.977 . . . . 0.0 110.658 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 7.1 m -87.76 -62.39 1.51 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.865 0.365 . . . . 0.0 110.91 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 295' ' ' GLU . . . . . 0.452 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.5 mm-40 -68.86 -4.24 15.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.657 -179.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 24.9 p -76.64 32.12 0.13 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.608 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 297' ' ' PHE . . . . . 0.504 ' CD2' HG22 ' A' ' 70' ' ' THR . 70.4 t80 -60.42 -46.3 90.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.567 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . 0.624 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.2 mtt85 -80.74 134.42 35.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.594 -179.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.454 ' H ' HG11 ' A' ' 51' ' ' VAL . 18.3 tp -113.13 116.43 29.84 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.325 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . 0.628 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.1 p-10 -164.7 -177.29 4.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.638 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 81.1 t80 -46.16 -43.15 14.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.406 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -67.62 -40.13 84.68 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.991 0.424 . . . . 0.0 110.692 179.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . 0.628 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 59.6 p -55.74 -36.73 67.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.26 -179.239 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . 0.551 ' HB2' ' SD ' ' A' ' 215' ' ' MET . . . -56.95 -52.27 65.9 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 179.389 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 92.7 mtp -54.92 -44.24 74.04 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -66.0 -42.86 89.18 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.066 0.46 . . . . 0.0 110.351 178.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 303' ' ' SER . 55.6 t -64.24 -42.81 96.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.286 179.391 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 42.9 tp -59.63 -41.94 91.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.052 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -62.57 -38.9 91.89 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.295 179.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 310' ' ' ARG . . . . . 0.448 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.7 ttt85 -63.64 -44.05 95.0 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.291 179.482 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 89.6 mt -63.14 -42.03 99.39 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.415 179.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.4 ttmt -63.09 -33.09 74.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.262 179.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -90.02 -23.31 21.52 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.402 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . 0.481 HD22 ' CE2' ' A' ' 315' ' ' PHE . 6.8 tt -62.24 -43.17 99.45 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.013 0.435 . . . . 0.0 110.603 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 315' ' ' PHE . . . . . 0.481 ' CE2' HD22 ' A' ' 314' ' ' LEU . 91.0 m-85 . . . . . 0 C--O 1.22 -0.481 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.394 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -99.09 135.75 40.04 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.5 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.491 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -92.11 178.45 1.7 Allowed Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.571 -179.882 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.491 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.7 Cg_exo -61.78 147.38 95.39 Favored 'Trans proline' 0 C--N 1.301 -1.929 0 C-N-CA 122.847 2.365 . . . . 0.0 112.161 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.456 ' HE ' HD12 ' A' ' 39' ' ' LEU . 35.2 ptt180 -135.53 141.94 45.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.628 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -79.64 116.31 19.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.498 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.452 ' O ' HG23 ' A' ' 30' ' ' ILE . 9.4 tp -110.69 130.1 64.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.553 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 8.8 t -70.35 141.37 52.26 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.646 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.477 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.3 t0 -139.0 179.42 6.51 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.516 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.477 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 77.9 p -74.26 -36.87 63.87 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.582 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 61.0 ttt85 -46.18 -94.65 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.454 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -167.3 -26.4 0.02 OUTLIER Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.966 -0.854 . . . . 0.0 110.966 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 63.2 m -169.21 104.4 0.38 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.789 0.328 . . . . 0.0 110.639 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.681 ' CD2' HD13 ' A' ' 140' ' ' LEU . 74.5 t60 -128.38 148.85 50.72 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.012 0.434 . . . . 0.0 110.291 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.629 HG22 ' N ' ' A' ' 39' ' ' LEU . 98.1 m -131.1 166.25 21.49 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.474 -179.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.629 ' N ' HG22 ' A' ' 38' ' ' THR . 80.8 mt -121.06 127.45 51.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.53 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -64.94 -44.65 88.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.667 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 42.2 p -166.07 154.96 11.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.507 179.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.52 ' H ' ' CD ' ' A' ' 42' ' ' GLN . 15.2 mp0 -43.71 100.94 0.24 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.558 179.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.44 128.99 31.63 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 C-N-CA 122.546 2.164 . . . . 0.0 112.191 -179.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -83.73 -24.56 31.13 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.611 179.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.533 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.6 mtm-85 -122.2 134.43 54.71 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 121.15 0.5 . . . . 0.0 110.335 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.1 mt -130.9 134.08 62.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.639 -179.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 46.0 t -124.61 130.36 73.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.169 179.069 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.644 ' OG ' HD12 ' A' ' 117' ' ' LEU . 2.0 m -154.6 167.19 30.96 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.55 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 62.6 p -125.04 9.04 8.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.468 179.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.47 125.38 32.99 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.591 -179.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.443 HG11 ' H ' ' A' ' 299' ' ' LEU . 96.0 t -65.59 -44.6 93.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.548 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.1 m -62.45 -44.35 96.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.664 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 47.8 tp -62.4 -41.37 98.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.573 -179.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.435 ' O ' HD13 ' A' ' 58' ' ' LEU . 75.8 m -57.57 -44.74 85.54 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.329 -179.397 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -63.92 -63.03 4.7 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.5 t -47.24 -35.94 8.31 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.768 0.318 . . . . 0.0 110.411 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.5 mt -61.8 -44.63 96.49 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.041 179.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.435 HD13 ' O ' ' A' ' 54' ' ' THR . 8.7 mp -65.9 -41.08 91.94 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.042 178.365 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.55 -41.3 98.45 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.688 -179.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.427 ' O ' HG23 ' A' ' 60' ' ' ILE . 8.1 tp -88.43 17.09 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.801 -179.493 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 56.28 84.51 0.08 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.731 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.52 59.01 0.09 OUTLIER Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.333 -0.394 . . . . 0.0 109.974 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.408 ' HB3' HE21 ' A' ' 85' ' ' GLN . 9.6 Cg_endo -52.22 152.75 14.32 Favored 'Trans proline' 0 C--N 1.298 -2.126 0 C-N-CA 122.99 2.46 . . . . 0.0 112.011 -177.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.433 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.2 OUTLIER -108.94 145.63 15.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.379 -179.628 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.57 -45.5 97.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.038 -179.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.5 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -129.77 134.11 47.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.5 -179.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.499 ' O ' ' N ' ' A' ' 98' ' ' LEU . 74.6 m -134.61 158.76 43.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.782 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.79 139.1 16.11 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.488 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.73 -162.79 0.08 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.826 0.346 . . . . 0.0 110.506 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.541 HG22 ' CD2' ' A' ' 297' ' ' PHE . 14.7 t -133.54 134.42 43.38 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.435 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.49 ' C ' ' O ' ' A' ' 70' ' ' THR . 0.6 OUTLIER 29.68 69.51 0.62 Allowed Pre-proline 0 N--CA 1.464 0.247 0 CA-C-O 120.94 0.4 . . . . 0.0 110.685 -179.711 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -61.99 146.08 96.45 Favored 'Trans proline' 0 C--N 1.301 -1.94 0 C-N-CA 122.767 2.311 . . . . 0.0 111.817 -178.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.534 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 45.0 p-10 -160.14 -31.67 0.06 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.658 179.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.538 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 99.2 m-20 -64.71 -39.27 93.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.392 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -60.25 -48.83 80.08 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.494 -179.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.423 ' O ' ' O ' ' A' ' 77' ' ' ALA . 94.6 t -59.55 -25.14 30.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.185 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.538 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -45.67 172.87 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.59 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.579 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.7 p30 -62.07 177.93 0.42 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.51 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.559 ' C ' ' H ' ' A' ' 81' ' ' GLY . 35.4 p30 -45.48 85.42 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.887 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.579 ' N ' ' O ' ' A' ' 78' ' ' ASP . 41.8 tp60 -67.32 13.26 0.07 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.351 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.559 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 118.61 -22.35 9.4 Favored Glycine 0 CA--C 1.52 0.389 0 N-CA-C 110.914 -0.875 . . . . 0.0 110.914 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -107.89 116.22 31.55 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.862 0.363 . . . . 0.0 110.487 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 73.5 mt -98.42 -0.15 44.15 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.577 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -92.31 7.44 42.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.441 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.797 ' O ' HG22 ' A' ' 89' ' ' VAL . 88.1 mt-30 -100.31 -28.44 12.97 Favored 'General case' 0 C--O 1.224 -0.266 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.613 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 68.8 t-105 -63.31 -40.2 96.67 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.736 -179.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.557 ' O ' ' N ' ' A' ' 91' ' ' LYS . 62.3 m -78.1 -54.01 6.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.791 -179.203 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -48.02 -50.76 26.66 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.861 -179.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.797 HG22 ' O ' ' A' ' 85' ' ' GLN . 16.0 m -69.15 -40.33 80.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.914 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.494 ' N ' HG23 ' A' ' 89' ' ' VAL . . . -72.86 -22.37 60.79 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.612 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.557 ' N ' ' O ' ' A' ' 87' ' ' SER . 65.9 tttm -62.28 -45.41 93.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.372 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.44 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.9 mm-40 -90.38 -94.78 0.12 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.265 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.632 ' O ' ' N ' ' A' ' 95' ' ' LEU . 96.0 mtt180 -143.04 58.6 1.41 Allowed 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.093 179.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.457 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.7 pttp 33.68 26.09 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 121.062 0.458 . . . . 0.0 110.487 -178.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.632 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.3 tt -47.95 123.04 5.62 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.834 -178.13 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.455 ' O ' HD23 ' A' ' 95' ' ' LEU . 99.0 mm-40 -83.2 -170.45 3.05 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.366 179.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.606 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 81.5 mtp180 -73.91 137.07 43.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.342 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.499 ' N ' ' O ' ' A' ' 67' ' ' SER . 90.6 mt -86.02 -165.63 1.3 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.784 -179.601 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.539 ' CD2' ' O ' ' A' ' 99' ' ' TYR . 48.6 p90 -169.02 119.81 0.73 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.27 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.515 ' C ' ' O ' ' A' ' 99' ' ' TYR . 42.5 mm -28.77 121.24 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.896 -179.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 114.2 27.24 3.48 Favored Glycine 0 CA--C 1.521 0.462 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 -179.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.579 ' H ' ' CD ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -144.39 46.39 0.62 Allowed Pre-proline 0 C--N 1.324 -0.508 0 CA-C-O 121.097 0.475 . . . . 0.0 110.482 179.966 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 28.8 Cg_endo -62.14 143.89 95.16 Favored 'Trans proline' 0 C--N 1.298 -2.096 0 C-N-CA 122.728 2.285 . . . . 0.0 111.894 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.455 ' O ' HG23 ' A' ' 108' ' ' VAL . 25.5 t -173.27 120.34 0.34 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.443 179.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -74.13 -40.16 62.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.903 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.42 -39.89 89.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.685 -179.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.22 -39.96 95.05 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.645 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 104' ' ' SER . 70.2 t -67.85 -43.57 86.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.674 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.99 -38.94 93.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.479 -179.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.44 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.46 -23.14 62.47 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.541 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.552 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.3 mm-40 -90.99 5.68 47.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.628 -179.487 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.552 ' C ' ' O ' ' A' ' 111' ' ' GLN . 10.0 tpt 22.77 65.1 0.35 Allowed Pre-proline 0 N--CA 1.465 0.296 0 CA-C-O 120.985 0.422 . . . . 0.0 110.978 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -79.33 167.69 21.04 Favored 'Trans proline' 0 C--N 1.307 -1.605 0 C-N-CA 123.008 2.472 . . . . 0.0 111.694 -178.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.525 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 99.0 m-20 -110.01 -41.89 4.35 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.286 179.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.0 tp -121.54 120.05 33.73 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.306 179.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 82.7 mt -112.66 128.81 69.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.829 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.644 HD12 ' OG ' ' A' ' 48' ' ' SER . 26.9 mt -108.42 132.41 53.8 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.442 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.491 HD12 HG23 ' A' ' 139' ' ' THR . 98.9 mt -120.1 138.52 50.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.587 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 85.6 p -72.42 154.14 41.04 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.608 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.2 -50.36 73.98 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.627 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.0 t -149.75 154.21 38.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.53 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 170.47 -170.71 43.24 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.91 -33.95 88.52 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.454 ' O ' ' OD1' ' A' ' 124' ' ' ASP . 44.6 p-10 -87.43 120.08 28.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.835 0.35 . . . . 0.0 110.655 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.44 ' O ' HD12 ' A' ' 129' ' ' LEU . 38.3 t -62.95 143.93 57.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.475 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.521 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.14 -43.27 8.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.785 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 56.4 tp -62.99 -42.21 99.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.681 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.81 -11.82 59.34 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.489 -179.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.44 HD12 ' O ' ' A' ' 125' ' ' SER . 83.6 mt -114.73 -24.61 8.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.528 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . 0.521 ' N ' ' O ' ' A' ' 126' ' ' ALA . 78.2 t80 -50.03 -50.17 48.49 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.613 -179.039 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 37.7 p-10 -66.07 -42.9 88.79 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.928 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.522 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 88.4 mt-30 -67.08 -37.49 84.08 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.733 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.44 HD12 HD11 ' A' ' 118' ' ' ILE . 95.9 mt -80.63 -41.42 23.89 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.768 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.4 t -56.35 -44.96 80.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.366 -179.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.7 m -61.87 -45.19 94.84 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.539 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 94.6 mt -61.92 -43.71 97.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.392 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.66 ' HB1' ' HD2' ' A' ' 138' ' ' PRO . . . -169.79 167.98 4.82 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.674 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.66 ' HD2' ' HB1' ' A' ' 137' ' ' ALA . 51.9 Cg_exo -49.14 112.68 0.7 Allowed 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.52 2.146 . . . . 0.0 112.349 179.244 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.491 HG23 HD12 ' A' ' 118' ' ' ILE . 24.1 m -83.7 127.29 33.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.612 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.681 HD13 ' CD2' ' A' ' 37' ' ' HIS . 34.2 tp -118.01 135.49 54.13 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.318 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.438 ' O ' ' OD2' ' A' ' 32' ' ' ASP . 82.5 mt -99.85 119.06 47.38 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 CA-C-O 121.016 0.436 . . . . 0.0 110.795 -178.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.433 HD12 HD22 ' A' ' 117' ' ' LEU . 97.8 mt -135.1 132.68 53.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.54 179.28 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.538 HD21 ' CG ' ' A' ' 241' ' ' ASP . 61.1 t30 -67.26 153.44 43.67 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.475 179.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.512 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 88.8 t80 -87.67 121.83 30.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.697 -179.46 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.512 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 99.1 m-20 55.27 69.55 0.72 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.588 179.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 34.5 p-10 -125.02 -0.06 7.88 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.595 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -151.08 115.72 5.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.623 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 83.2 p -62.91 167.99 4.29 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.574 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.416 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.4 p-90 -51.65 -15.93 0.55 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.406 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . 0.441 ' O ' HG23 ' A' ' 154' ' ' THR . 68.0 tp60 -70.47 -75.59 0.12 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.884 0.373 . . . . 0.0 110.615 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.441 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.1 t -62.87 -38.55 91.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.399 179.389 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 53.7 tp -59.73 -46.05 90.31 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.537 -178.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.416 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 47.9 tp -62.69 -41.47 99.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.656 179.017 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.441 ' OG1' ' O ' ' A' ' 151' ' ' SER . 60.8 p -64.13 -35.18 79.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.328 -179.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.442 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.7 mm-40 -63.98 -42.72 97.13 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.54 179.285 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 92.2 mt -65.66 -38.49 89.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.468 178.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.579 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.59 -31.99 79.76 Favored Glycine 0 CA--C 1.52 0.371 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 -179.369 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.442 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.1 mt-10 -35.14 -27.65 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.875 0.369 . . . . 0.0 110.806 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.579 ' N ' ' O ' ' A' ' 157' ' ' GLY . 93.9 mt -55.28 150.43 2.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.46 179.13 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 70.5 p -70.39 137.15 50.23 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.781 -179.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 72.01 19.33 78.31 Favored Glycine 0 CA--C 1.519 0.337 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 179.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 57.3 m80 -120.56 -15.0 8.57 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.71 0.29 . . . . 0.0 110.494 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -65.24 -60.58 2.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.572 -179.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -51.15 -50.28 59.24 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.259 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -60.11 -41.36 92.43 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.54 179.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.29 -47.59 85.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.485 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.41 -40.41 74.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.401 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -61.68 -50.39 72.67 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.605 179.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -65.17 -43.72 90.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.577 179.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 94.6 mt -64.89 -43.18 96.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.497 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.14 -51.63 68.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.367 -179.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.08 -43.84 97.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.644 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . 0.652 ' CE2' HD11 ' A' ' 177' ' ' LEU . 56.2 t80 -63.27 -43.87 96.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.452 179.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -63.67 -39.88 95.44 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.501 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -63.25 -42.77 99.23 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.545 179.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -60.32 -44.77 95.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.422 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.652 HD11 ' CE2' ' A' ' 173' ' ' PHE . 83.5 mt -64.93 -40.78 95.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.711 178.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -51.86 -62.67 1.49 Allowed 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.391 -179.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.37 -47.35 84.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.461 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -52.65 -41.98 64.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.474 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -63.91 -33.48 75.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.352 179.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . 0.42 ' HG2' ' O ' ' A' ' 182' ' ' GLU . 69.2 tt0 -90.7 8.92 32.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.319 0.581 . . . . 0.0 110.393 -178.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -105.29 -31.92 8.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.85 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.5 pt -128.16 147.47 32.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.649 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -139.91 131.15 26.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.489 179.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . 0.593 HD22 ' N ' ' A' ' 186' ' ' LEU . 3.6 mm? -85.68 132.67 43.68 Favored Pre-proline 0 N--CA 1.453 -0.325 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.922 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -43.6 157.57 0.12 Allowed 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.729 2.286 . . . . 0.0 112.389 179.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . 0.52 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.9 Cg_endo -62.9 114.99 2.66 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 C-N-CA 122.83 2.353 . . . . 0.0 111.908 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . 0.52 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.7 mt-30 156.0 147.28 0.0 OUTLIER Pre-proline 0 C--O 1.231 0.099 0 O-C-N 123.794 0.684 . . . . 0.0 110.692 -179.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.37 143.37 34.87 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.657 2.238 . . . . 0.0 112.272 177.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.498 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.1 p -124.52 159.34 30.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.164 0.507 . . . . 0.0 110.372 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . 0.498 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 36.2 p -143.65 165.16 28.41 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.85 -179.35 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . 0.441 ' HA ' ' H ' ' A' ' 260' ' ' PHE . . . -135.28 128.72 32.36 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 121.167 0.508 . . . . 0.0 110.407 179.205 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.509 HD11 HD23 ' A' ' 259' ' ' LEU . 47.7 pt -146.45 148.43 17.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.961 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . 0.751 HG13 ' CD1' ' A' ' 262' ' ' PHE . 71.7 t -117.19 122.84 70.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.082 0.468 . . . . 0.0 110.218 178.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -134.08 107.31 7.67 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.377 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 95.1 m -131.01 130.44 43.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.742 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -82.78 -36.91 25.23 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.399 179.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.07 -67.36 0.24 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.433 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.25 -9.91 59.08 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.47 179.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 60.0 t-80 60.95 58.53 2.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.681 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 37.1 p -167.29 153.5 7.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.609 179.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.47 144.43 24.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.942 0.401 . . . . 0.0 110.47 179.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -135.33 138.08 43.05 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.608 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 19.0 mt -105.85 125.3 50.83 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.933 0.397 . . . . 0.0 110.194 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 206' ' ' TRP . . . . . 0.558 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 75.9 m95 -82.3 167.3 18.72 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.515 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . 0.466 HG22 ' C ' ' A' ' 206' ' ' TRP . 0.1 OUTLIER -156.94 170.94 8.11 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.588 -179.024 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -53.23 -36.92 79.64 Favored 'Trans proline' 0 C--N 1.302 -1.892 0 C-N-CA 122.77 2.313 . . . . 0.0 112.378 178.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -71.13 -34.51 71.1 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.56 -179.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 22.3 m -61.64 150.61 35.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.624 -179.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.39 -36.94 81.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.456 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 212' ' ' GLN . . . . . 0.558 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 54.5 tt0 -64.74 -40.05 94.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.567 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.94 -43.37 91.51 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.734 -0.947 . . . . 0.0 110.734 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -63.04 -43.93 97.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.839 0.352 . . . . 0.0 110.385 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 215' ' ' MET . . . . . 0.529 ' SD ' ' HB2' ' A' ' 304' ' ' ALA . 65.1 ttp -59.02 -48.63 80.91 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.297 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 89.9 mt -59.65 -41.32 90.27 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 121.01 0.434 . . . . 0.0 110.01 179.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 217' ' ' GLU . . . . . 0.456 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 40.3 tp10 -57.37 -38.14 73.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.317 179.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -65.52 -37.78 87.75 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.605 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 95.5 mt -64.31 -42.76 96.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.725 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.58 44.53 0.08 OUTLIER Glycine 0 CA--C 1.521 0.466 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 221' ' ' PHE . . . . . 0.456 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 25.8 m-85 -127.49 155.33 43.92 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.944 0.402 . . . . 0.0 110.524 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.487 ' O ' HG13 ' A' ' 191' ' ' VAL . 6.3 p -106.97 121.98 45.54 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.152 0.501 . . . . 0.0 110.242 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.468 HD22 ' C ' ' A' ' 222' ' ' THR . 4.3 mm? -100.9 133.32 45.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.989 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.98 158.92 15.19 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.506 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.05 115.29 30.03 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.516 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.492 ' N ' HD12 ' A' ' 226' ' ' LEU . 9.0 mp -53.56 156.29 4.63 Favored Pre-proline 0 N--CA 1.452 -0.35 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.71 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -59.69 145.31 98.49 Favored 'Trans proline' 0 C--N 1.302 -1.871 0 C-N-CA 122.795 2.33 . . . . 0.0 112.295 179.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.42 -2.91 58.95 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.556 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.31 -40.93 5.63 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . 0.537 ' O ' ' N ' ' A' ' 233' ' ' SER . 84.3 mt -79.2 -16.88 55.87 Favored 'General case' 0 C--O 1.224 -0.267 0 CA-C-O 120.983 0.421 . . . . 0.0 110.449 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . 0.404 ' C ' ' O ' ' A' ' 230' ' ' LEU . 55.1 t-20 -39.5 -49.63 2.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.679 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -88.58 15.58 7.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.009 -179.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . 0.537 ' N ' ' O ' ' A' ' 230' ' ' LEU . 77.8 p -60.46 -35.47 75.95 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.653 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . 0.526 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.6 tt0 -118.46 -69.49 0.85 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.706 179.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.2 m -69.91 103.71 2.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.592 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -94.73 57.41 2.17 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.439 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -144.85 -122.57 1.57 Allowed Glycine 0 CA--C 1.521 0.441 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -134.46 111.89 10.49 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.002 0.43 . . . . 0.0 110.384 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . 0.515 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.4 mtt180 -148.33 57.75 1.07 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.678 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -69.97 -31.69 69.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.494 179.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 241' ' ' ASP . . . . . 0.538 ' CG ' HD21 ' A' ' 143' ' ' ASN . 65.6 t0 -56.54 -47.13 80.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.365 -179.205 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 242' ' ' ILE . . . . . 0.437 ' O ' ' O ' ' A' ' 239' ' ' ARG . 17.3 tt -140.49 157.49 24.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.493 179.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.441 HG22 HD13 ' A' ' 245' ' ' LEU . 96.0 mt -105.92 105.88 19.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.575 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . 0.602 ' O ' HD12 ' A' ' 245' ' ' LEU . 88.0 mt-30 -110.06 109.98 20.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.416 179.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.602 HD12 ' O ' ' A' ' 244' ' ' GLN . 9.4 mp -121.95 -168.13 1.66 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.66 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . 0.526 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.27 -16.79 0.05 OUTLIER Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . 0.67 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -60.43 157.01 29.67 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -63.79 21.51 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.86 0.362 . . . . 0.0 110.553 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . 0.67 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.7 m-20 -97.29 -6.1 35.18 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.497 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 92.6 mt -79.81 -21.52 44.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.784 179.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.61 -51.53 69.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.563 -179.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.31 -5.34 58.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.532 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.22 -74.34 1.15 Allowed Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.934 -0.866 . . . . 0.0 110.934 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 80.1 mt -69.95 125.75 27.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.809 0.338 . . . . 0.0 110.445 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -59.09 -39.52 82.44 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.281 -179.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 82.52 51.97 4.13 Favored Glycine 0 CA--C 1.521 0.442 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -96.21 -14.81 22.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.717 0.294 . . . . 0.0 110.665 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 258' ' ' SER . . . . . 0.494 ' OG ' HG23 ' A' ' 191' ' ' VAL . 3.5 t 174.71 88.27 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.047 0.451 . . . . 0.0 110.321 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.86 ' N ' HD12 ' A' ' 259' ' ' LEU . 1.0 OUTLIER -93.97 123.7 37.51 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.014 0.435 . . . . 0.0 110.992 -178.819 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 260' ' ' PHE . . . . . 0.441 ' H ' ' HA ' ' A' ' 193' ' ' ALA . 15.8 m-30 -92.74 146.35 23.72 Favored 'General case' 0 CA--C 1.508 -0.672 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.532 179.051 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 86.0 mt -122.36 149.56 43.61 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.6 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.751 ' CD1' HG13 ' A' ' 195' ' ' VAL . 2.7 p90 -77.23 -138.34 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.632 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 263' ' ' ALA . . . . . 0.661 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -52.27 77.29 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.003 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . 0.625 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -178.93 104.54 0.19 Allowed Glycine 0 CA--C 1.527 0.829 0 N-CA-C 110.644 -0.982 . . . . 0.0 110.644 179.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 265' ' ' ASP . . . . . 0.6 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.9 m-20 -79.98 -178.04 6.29 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.648 0.261 . . . . 0.0 110.781 -179.407 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -40.48 -17.52 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.521 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 267' ' ' LYS . . . . . 0.6 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.47 -51.66 41.01 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.682 179.284 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -63.64 -46.81 83.99 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.198 179.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . 0.562 ' HB1' ' OH ' ' A' ' 273' ' ' TYR . . . -61.57 -34.87 76.34 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.291 0.567 . . . . 0.0 110.058 179.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -63.17 -34.11 76.92 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.273 179.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.69 -43.68 13.2 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.793 -179.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 272' ' ' ILE . . . . . 0.589 ' C ' ' H ' ' A' ' 274' ' ' ALA . 4.9 tt -51.37 -33.44 14.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.579 -178.441 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 273' ' ' TYR . . . . . 0.562 ' OH ' ' HB1' ' A' ' 269' ' ' ALA . 17.5 m-85 -54.76 -1.41 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.567 -179.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 274' ' ' ALA . . . . . 0.589 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.71 -39.74 69.95 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.755 179.448 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . 0.582 ' O ' ' N ' ' A' ' 279' ' ' ALA . 2.9 p30 -39.35 98.42 0.17 Allowed Pre-proline 0 C--N 1.335 -0.055 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.458 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -54.56 -43.01 62.94 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 C-N-CA 122.621 2.214 . . . . 0.0 112.344 -178.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 88.5 mt -64.48 -42.98 95.55 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.871 -179.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 91.0 mt -95.67 -1.68 49.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.839 -179.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 279' ' ' ALA . . . . . 0.582 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.36 -34.65 77.09 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.626 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.8 m80 -74.78 20.41 0.13 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.785 -178.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . 0.483 HD23 ' HA ' ' A' ' 281' ' ' LEU . 14.0 mt -75.25 119.45 77.02 Favored Pre-proline 0 N--CA 1.449 -0.492 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.783 179.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -49.47 -40.18 45.04 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.681 2.254 . . . . 0.0 112.33 178.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -51.97 -51.06 59.75 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.283 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 78.1 t -61.2 -43.87 97.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.248 179.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -57.99 -41.43 82.99 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.268 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -90.59 0.05 57.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.322 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt 59.52 42.87 16.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.742 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -94.38 41.58 1.09 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.463 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 53.8 t -118.97 135.84 58.1 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-O 120.974 0.416 . . . . 0.0 110.205 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -132.99 162.65 31.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.564 -179.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.64 155.31 32.56 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.613 -179.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 79.6 mt -93.95 -1.71 54.26 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.373 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.33 165.81 12.75 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 -179.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 7.1 m -87.51 -62.61 1.46 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.841 0.353 . . . . 0.0 110.75 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 295' ' ' GLU . . . . . 0.432 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.6 mm-40 -69.46 -3.89 16.37 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.597 -179.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 27.6 p -77.06 33.4 0.15 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.664 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 297' ' ' PHE . . . . . 0.541 ' CD2' HG22 ' A' ' 70' ' ' THR . 84.8 t80 -60.33 -46.03 91.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.522 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . 0.606 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.3 mtt85 -81.48 133.85 35.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.552 -179.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.443 ' H ' HG11 ' A' ' 51' ' ' VAL . 15.8 tp -114.13 119.38 36.91 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.392 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . 0.621 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.0 p-10 -167.48 -174.19 2.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.629 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 85.1 t80 -47.62 -46.04 28.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.357 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -64.92 -41.58 95.42 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 120.959 0.409 . . . . 0.0 110.6 179.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . 0.621 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 52.3 p -55.11 -36.47 65.75 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.206 -179.342 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . 0.529 ' HB2' ' SD ' ' A' ' 215' ' ' MET . . . -56.43 -52.4 64.8 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.079 179.364 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 93.2 mtp -54.64 -44.81 73.54 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -65.93 -42.88 89.52 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.082 0.468 . . . . 0.0 110.39 178.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 303' ' ' SER . 55.4 t -64.2 -42.61 96.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.378 179.359 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 43.1 tp -59.49 -41.96 91.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.186 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -62.97 -38.7 92.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.188 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 310' ' ' ARG . . . . . 0.44 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.6 ttt85 -63.38 -44.15 95.57 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.306 179.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 88.8 mt -63.07 -42.0 99.55 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.498 179.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.3 ttmt -63.0 -32.63 74.03 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.374 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -90.42 -23.25 21.09 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.442 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . 0.483 HD22 ' CE2' ' A' ' 315' ' ' PHE . 6.8 tt -62.25 -43.16 99.45 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.528 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 315' ' ' PHE . . . . . 0.483 ' CE2' HD22 ' A' ' 314' ' ' LEU . 90.9 m-85 . . . . . 0 C--O 1.22 -0.48 0 CA-C-O 118.005 -0.998 . . . . 0.0 110.426 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -99.54 137.11 38.49 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.009 0.433 . . . . 0.0 110.502 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.496 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -92.01 178.5 1.69 Allowed Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.578 -179.881 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.496 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.3 Cg_exo -61.73 147.54 95.08 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 C-N-CA 122.827 2.351 . . . . 0.0 112.201 179.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.507 ' HE ' HD12 ' A' ' 39' ' ' LEU . 35.0 ptt180 -134.35 141.76 47.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.696 179.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -79.2 116.58 19.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.504 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.433 ' O ' HG23 ' A' ' 30' ' ' ILE . 9.5 tp -110.57 130.79 63.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.444 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 13.0 t -71.08 142.14 50.84 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.02 0.438 . . . . 0.0 110.582 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 141' ' ' ILE . 25.3 t70 -139.57 177.73 7.72 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.535 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.0 p -73.93 -36.23 64.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.717 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -48.1 -95.25 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.275 -179.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.414 ' O ' ' OG1' ' A' ' 36' ' ' THR . . . -164.6 -26.26 0.02 OUTLIER Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.414 ' OG1' ' O ' ' A' ' 35' ' ' GLY . 64.6 m -168.76 106.93 0.45 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.878 0.37 . . . . 0.0 110.699 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.566 ' CD2' HD13 ' A' ' 140' ' ' LEU . 36.4 t60 -129.54 144.98 51.5 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.113 0.482 . . . . 0.0 110.185 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.628 HG22 ' N ' ' A' ' 39' ' ' LEU . 98.9 m -129.31 166.27 19.81 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.519 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.628 ' N ' HG22 ' A' ' 38' ' ' THR . 80.8 mt -120.72 127.93 52.46 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.503 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -64.62 -44.56 90.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.719 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 39.1 p -165.33 154.47 12.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.398 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.526 ' H ' ' CD ' ' A' ' 42' ' ' GLN . 13.8 mp0 -42.55 100.18 0.22 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.602 179.357 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -56.73 129.23 33.5 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 122.382 2.054 . . . . 0.0 112.224 -179.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -84.25 -23.72 30.28 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.486 179.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.541 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.4 mtm-85 -121.18 134.24 55.21 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 121.138 0.494 . . . . 0.0 110.251 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.0 mt -130.5 133.2 64.03 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.254 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.857 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 48.5 t -124.8 130.83 73.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 179.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.632 ' OG ' HD12 ' A' ' 117' ' ' LEU . 4.9 m -154.7 166.28 33.92 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.54 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 71.9 p -124.53 8.47 8.34 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.455 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.38 126.07 33.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.611 -179.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.403 HG11 ' H ' ' A' ' 299' ' ' LEU . 92.2 t -66.06 -44.58 91.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.6 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.1 m -62.65 -44.19 96.9 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.699 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 52.6 tp -62.39 -41.66 98.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.58 -179.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.46 ' O ' HD13 ' A' ' 58' ' ' LEU . 77.4 m -57.34 -44.39 84.24 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.399 -179.377 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.79 -61.73 5.62 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 179.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.6 t -48.62 -35.53 13.86 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.8 mt -61.82 -44.41 96.91 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.18 179.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.46 HD13 ' O ' ' A' ' 54' ' ' THR . 9.3 mp -65.22 -41.36 94.53 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.247 177.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.405 ' HB1' ' NE ' ' A' ' 169' ' ' ARG . . . -63.79 -40.98 97.97 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.954 -179.243 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.422 ' O ' HG23 ' A' ' 60' ' ' ILE . 8.2 tp -88.54 16.93 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.816 -179.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 56.36 84.3 0.09 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.763 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.25 57.63 0.07 OUTLIER Pre-proline 0 C--N 1.328 -0.368 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.412 ' HB3' HE21 ' A' ' 85' ' ' GLN . 9.5 Cg_endo -50.58 153.35 7.89 Favored 'Trans proline' 0 C--N 1.295 -2.272 0 C-N-CA 122.866 2.377 . . . . 0.0 112.314 -178.326 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.435 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -109.17 145.8 15.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.329 -179.661 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 97.1 mt -63.7 -45.34 97.64 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.409 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.506 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -129.5 134.58 47.86 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.857 0.361 . . . . 0.0 110.564 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.476 ' O ' ' N ' ' A' ' 98' ' ' LEU . 73.1 m -134.93 159.2 42.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.829 -179.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -87.67 139.36 15.84 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.469 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -175.65 -163.66 0.12 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.957 0.408 . . . . 0.0 110.504 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.514 HG22 ' CD2' ' A' ' 297' ' ' PHE . 15.3 t -133.02 131.82 41.12 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.415 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.424 ' C ' ' O ' ' A' ' 70' ' ' THR . 11.9 p 36.88 71.53 0.94 Allowed Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.523 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_exo -60.92 144.17 99.51 Favored 'Trans proline' 0 C--N 1.302 -1.918 0 C-N-CA 122.491 2.127 . . . . 0.0 112.116 -178.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.533 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 44.6 p-10 -165.0 -34.67 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.678 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.533 ' N ' ' OD1' ' A' ' 73' ' ' ASN . 99.1 m-20 -63.94 -39.39 94.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.452 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -60.86 -47.73 85.02 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.655 -179.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.432 ' O ' ' O ' ' A' ' 77' ' ' ALA . 94.9 t -59.95 -24.48 29.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.509 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -44.77 171.64 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.63 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.575 ' O ' ' N ' ' A' ' 80' ' ' GLN . 54.0 p30 -62.19 178.41 0.39 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.638 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.559 ' C ' ' H ' ' A' ' 81' ' ' GLY . 36.2 p30 -46.96 85.4 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.952 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.575 ' N ' ' O ' ' A' ' 78' ' ' ASP . 43.2 tp60 -67.57 14.1 0.06 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.159 0.504 . . . . 0.0 110.187 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.559 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 117.87 -21.62 10.28 Favored Glycine 0 C--N 1.332 0.313 0 N-CA-C 110.841 -0.903 . . . . 0.0 110.841 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -107.91 116.63 32.31 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.971 0.415 . . . . 0.0 110.487 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 74.1 mt -98.98 0.72 44.52 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.447 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -92.03 6.46 46.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.962 0.411 . . . . 0.0 110.396 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.786 ' O ' HG22 ' A' ' 89' ' ' VAL . 88.3 mt-30 -99.9 -27.46 13.59 Favored 'General case' 0 C--O 1.223 -0.341 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.811 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.0 t-105 -64.1 -40.51 96.38 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.052 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.554 ' O ' ' N ' ' A' ' 91' ' ' LYS . 70.7 m -77.86 -53.71 7.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.163 -179.495 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -48.51 -50.68 30.84 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.016 -179.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.786 HG22 ' O ' ' A' ' 85' ' ' GLN . 14.8 m -68.88 -40.75 81.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 120.937 0.399 . . . . 0.0 111.081 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.5 ' N ' HG23 ' A' ' 89' ' ' VAL . . . -72.29 -22.43 61.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.649 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.554 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.0 tttm -61.6 -45.85 92.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.516 -179.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.437 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.6 mm-40 -90.7 -94.23 0.12 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.198 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.625 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.9 mtt180 -143.77 60.11 1.38 Allowed 'General case' 0 C--O 1.235 0.308 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.457 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.6 pttp 33.6 26.44 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 120.933 0.396 . . . . 0.0 110.25 -179.287 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.625 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.4 tt -47.97 123.28 5.97 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.958 -178.094 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.441 ' O ' HD23 ' A' ' 95' ' ' LEU . 98.7 mm-40 -83.64 -170.6 3.14 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.084 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.628 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 82.0 mtp180 -73.34 137.6 44.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.213 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.476 ' N ' ' O ' ' A' ' 67' ' ' SER . 89.7 mt -86.99 -165.38 1.27 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.727 -179.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.532 ' CD2' ' O ' ' A' ' 99' ' ' TYR . 48.5 p90 -168.82 120.22 0.76 Allowed 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.189 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.504 ' C ' ' O ' ' A' ' 99' ' ' TYR . 43.3 mm -29.42 121.6 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.029 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 114.07 27.87 3.3 Favored Glycine 0 CA--C 1.518 0.253 0 N-CA-C 111.224 -0.751 . . . . 0.0 111.224 -179.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.584 ' H ' ' CD ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -144.14 46.08 0.61 Allowed Pre-proline 0 C--N 1.323 -0.55 0 O-C-N 122.502 -0.411 . . . . 0.0 110.464 179.84 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 30.1 Cg_endo -62.14 143.83 95.08 Favored 'Trans proline' 0 C--N 1.296 -2.226 0 C-N-CA 122.686 2.257 . . . . 0.0 111.908 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.46 ' O ' HG23 ' A' ' 108' ' ' VAL . 26.5 t -173.42 120.82 0.34 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.398 179.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.37 -41.03 63.9 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.1 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -65.84 -39.83 91.18 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.846 -179.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.84 -39.76 94.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.713 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 104' ' ' SER . 69.4 t -67.55 -43.84 86.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.705 179.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.42 -39.29 92.81 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.524 -179.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.437 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.61 -23.87 63.34 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.495 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.555 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.2 mm-40 -91.38 5.15 50.45 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.674 -179.553 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.555 ' C ' ' O ' ' A' ' 111' ' ' GLN . 10.4 tpt 21.65 64.85 0.31 Allowed Pre-proline 0 N--CA 1.466 0.349 0 CA-C-O 120.882 0.372 . . . . 0.0 111.137 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.449 ' HG2' HD11 ' A' ' 116' ' ' ILE . 66.1 Cg_endo -79.12 169.69 18.79 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 122.993 2.462 . . . . 0.0 111.902 -178.137 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.525 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 99.0 m-20 -112.84 -43.52 3.42 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.102 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 39.7 tp -120.83 119.9 34.03 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.458 HD13 HD22 ' A' ' 133' ' ' LEU . 95.7 mt -117.16 130.85 71.39 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 CA-C-O 120.944 0.402 . . . . 0.0 110.892 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.632 HD12 ' OG ' ' A' ' 48' ' ' SER . 33.1 mt -105.67 132.73 51.45 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.263 -179.449 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.438 HD12 HG23 ' A' ' 139' ' ' THR . 98.1 mt -118.15 135.73 57.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.733 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 87.0 p -71.65 153.27 42.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.567 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.31 -50.03 75.24 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.679 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.0 t -149.55 154.01 38.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.505 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 169.36 -170.11 42.39 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -63.02 -35.13 91.67 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.443 ' O ' ' OD1' ' A' ' 124' ' ' ASP . 43.9 p-10 -88.3 119.42 28.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.783 0.325 . . . . 0.0 110.65 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.448 ' O ' HD12 ' A' ' 129' ' ' LEU . 41.2 t -63.3 144.53 56.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.987 0.422 . . . . 0.0 110.507 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.521 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.65 -42.66 9.06 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.857 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.7 tp -62.79 -42.34 99.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.697 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.01 -10.99 57.99 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.499 -179.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.448 HD12 ' O ' ' A' ' 125' ' ' SER . 84.4 mt -115.44 -24.18 8.49 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.683 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . 0.521 ' N ' ' O ' ' A' ' 126' ' ' ALA . 77.1 t80 -51.54 -49.54 61.78 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.566 -178.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.6 p-10 -65.89 -41.81 91.05 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.255 179.451 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.524 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 88.0 mt-30 -67.84 -37.07 81.41 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.87 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.458 HD22 HD13 ' A' ' 116' ' ' ILE . 94.5 mt -79.95 -42.35 24.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.944 -179.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.2 t -57.1 -44.91 83.66 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.294 -179.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.4 m -62.18 -45.74 92.05 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.631 179.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 92.7 mt -62.61 -43.98 98.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.377 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.612 ' HB1' ' HD2' ' A' ' 138' ' ' PRO . . . -169.67 164.26 6.58 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.524 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.612 ' HD2' ' HB1' ' A' ' 137' ' ' ALA . 77.3 Cg_exo -43.48 111.88 0.27 Allowed 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.49 2.127 . . . . 0.0 112.195 179.359 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.506 HG21 ' CD1' ' A' ' 130' ' ' TYR . 16.8 m -86.16 127.7 34.76 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.633 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.566 HD13 ' CD2' ' A' ' 37' ' ' HIS . 35.3 tp -120.32 137.69 54.12 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.089 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.425 ' O ' ' OD1' ' A' ' 32' ' ' ASP . 80.5 mt -105.32 121.17 57.1 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.336 0 CA-C-O 121.204 0.526 . . . . 0.0 111.196 -179.489 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.498 HD12 HD22 ' A' ' 117' ' ' LEU . 97.9 mt -136.02 132.61 50.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.593 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.544 ' OD1' ' N ' ' A' ' 144' ' ' TYR . 60.7 t-20 -64.52 147.36 52.96 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.893 0.378 . . . . 0.0 110.307 179.425 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.544 ' N ' ' OD1' ' A' ' 143' ' ' ASN . 87.1 t80 -82.35 122.1 27.55 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.996 -179.615 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.515 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 98.9 m-20 55.27 69.21 0.76 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.847 179.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 33.7 p-10 -125.15 0.57 7.84 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.891 0.377 . . . . 0.0 110.667 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -151.29 117.48 5.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.773 -179.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 87.4 p -64.6 168.89 5.44 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.489 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.412 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.4 p-90 -51.2 -15.37 0.35 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.498 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . 0.447 ' O ' HG23 ' A' ' 154' ' ' THR . 67.8 tp60 -71.71 -75.15 0.14 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.398 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.438 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.0 t -62.72 -38.85 92.09 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.244 179.461 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 52.9 tp -60.12 -45.59 92.49 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.307 -178.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.412 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 46.2 tp -62.64 -41.78 99.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.914 0.388 . . . . 0.0 110.508 178.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.447 HG23 ' O ' ' A' ' 150' ' ' GLN . 57.4 p -64.04 -34.65 78.49 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.201 -179.443 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.468 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.5 mm-40 -63.87 -42.39 97.54 Favored 'General case' 0 C--O 1.227 -0.131 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.22 179.345 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 91.7 mt -65.43 -38.76 90.85 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.066 0.46 . . . . 0.0 110.151 179.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.572 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.47 -31.49 77.69 Favored Glycine 0 CA--C 1.52 0.388 0 N-CA-C 110.771 -0.931 . . . . 0.0 110.771 -179.297 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.468 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.4 mt-10 -37.32 -24.57 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.894 0.378 . . . . 0.0 110.837 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.572 ' N ' ' O ' ' A' ' 157' ' ' GLY . 96.0 mt -59.82 148.53 7.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.312 179.321 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 74.8 p -69.05 137.28 53.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.951 -179.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 71.73 20.93 78.92 Favored Glycine 0 CA--C 1.517 0.159 0 N-CA-C 111.206 -0.757 . . . . 0.0 111.206 179.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 58.9 m80 -123.59 -14.33 7.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.717 0.294 . . . . 0.0 110.581 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -65.29 -60.2 3.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.71 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -52.21 -49.14 64.51 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.145 -179.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -59.88 -41.21 91.06 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.739 0.304 . . . . 0.0 110.28 179.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.55 -46.7 88.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.561 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -57.62 -39.75 77.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.178 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -61.79 -50.11 73.67 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.609 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.405 ' NE ' ' HB1' ' A' ' 59' ' ' ALA . 59.9 ttt85 -65.38 -43.81 89.53 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.531 179.52 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 94.3 mt -64.55 -43.38 96.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.369 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.56 -51.21 70.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.461 -179.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.43 -43.96 95.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.485 179.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . 0.67 ' CE2' HD11 ' A' ' 177' ' ' LEU . 56.3 t80 -62.69 -44.33 96.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.062 0.458 . . . . 0.0 110.37 179.375 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -63.26 -39.6 95.05 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.528 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -63.17 -43.02 99.44 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.615 179.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -60.64 -44.79 95.96 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.195 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.67 HD11 ' CE2' ' A' ' 173' ' ' PHE . 84.3 mt -64.56 -40.96 96.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.995 0.426 . . . . 0.0 110.691 178.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -51.56 -62.9 1.33 Allowed 'General case' 0 C--O 1.238 0.458 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.37 -179.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.34 -47.0 85.17 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.59 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.0 -41.68 64.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.233 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -64.04 -33.31 75.46 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.05 0.452 . . . . 0.0 110.347 179.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . 0.421 ' HG2' ' O ' ' A' ' 182' ' ' GLU . 70.1 tt0 -91.21 8.4 35.97 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.436 0.636 . . . . 0.0 110.426 -178.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -103.99 -32.33 9.28 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.205 179.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.6 pt -128.04 147.65 32.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.814 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -140.1 131.36 26.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.442 179.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . 0.595 HD22 ' N ' ' A' ' 186' ' ' LEU . 3.6 mm? -85.4 132.64 44.32 Favored Pre-proline 0 N--CA 1.453 -0.321 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.904 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -43.87 157.87 0.13 Allowed 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.686 2.257 . . . . 0.0 112.27 179.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . 0.52 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 26.6 Cg_endo -62.42 115.3 2.8 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 C-N-CA 122.818 2.345 . . . . 0.0 111.759 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . 0.52 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 0.4 OUTLIER 155.4 147.57 0.0 OUTLIER Pre-proline 0 N--CA 1.456 -0.156 0 O-C-N 123.777 0.673 . . . . 0.0 110.758 -179.88 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -73.78 143.59 33.72 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.653 2.235 . . . . 0.0 112.017 177.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.504 HG23 ' OG ' ' A' ' 258' ' ' SER . 2.1 p -124.91 158.7 32.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.347 0.594 . . . . 0.0 110.137 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . 0.489 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 40.1 p -143.1 164.87 28.97 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.07 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . 0.455 ' HA ' ' H ' ' A' ' 260' ' ' PHE . . . -135.29 128.52 31.96 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.227 0.537 . . . . 0.0 110.223 179.567 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.528 HD11 HD23 ' A' ' 259' ' ' LEU . 47.9 pt -147.44 150.3 14.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.04 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . 0.729 HG13 ' CD1' ' A' ' 262' ' ' PHE . 74.6 t -118.31 123.43 71.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-O 121.298 0.57 . . . . 0.0 109.793 179.128 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -134.68 106.91 7.18 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.254 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 95.9 m -131.32 131.35 43.7 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.838 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.401 ' O ' ' N ' ' A' ' 201' ' ' HIS . . . -83.03 -37.14 24.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.308 179.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.39 -66.92 0.27 Allowed 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.402 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.25 -10.22 59.5 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.379 179.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . 0.401 ' N ' ' O ' ' A' ' 198' ' ' ALA . 59.6 t-80 60.89 57.69 2.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.673 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 36.2 p -166.64 152.84 8.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.623 179.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -150.47 143.37 24.7 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.003 0.43 . . . . 0.0 110.452 179.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -134.87 137.68 43.45 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.598 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 16.6 mt -106.42 125.7 51.33 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.122 0.487 . . . . 0.0 109.841 -179.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 206' ' ' TRP . . . . . 0.556 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 74.1 m95 -82.08 167.35 18.89 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.58 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . 0.473 HG22 ' C ' ' A' ' 206' ' ' TRP . 0.1 OUTLIER -157.26 171.06 7.94 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.64 -179.181 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -53.08 -37.19 79.0 Favored 'Trans proline' 0 C--N 1.302 -1.873 0 C-N-CA 122.649 2.233 . . . . 0.0 112.163 179.169 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -70.89 -35.41 72.31 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.774 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . 0.4 ' HB2' ' H ' ' A' ' 207' ' ' THR . 20.0 m -60.49 150.97 29.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.603 -179.423 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.65 -37.28 83.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.535 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 212' ' ' GLN . . . . . 0.556 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 55.0 tt0 -64.68 -40.28 95.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.52 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.66 -43.44 91.99 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 110.744 -0.943 . . . . 0.0 110.744 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -63.16 -44.39 95.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.807 0.337 . . . . 0.0 110.307 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 215' ' ' MET . . . . . 0.555 ' SD ' ' HB2' ' A' ' 304' ' ' ALA . 65.3 ttp -59.27 -48.01 83.23 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.145 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 86.0 mt -60.49 -40.83 92.74 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 217' ' ' GLU . . . . . 0.451 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.4 tp10 -58.38 -37.76 75.91 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -65.31 -38.24 89.59 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.8 0.333 . . . . 0.0 110.652 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 94.0 mt -64.25 -42.92 96.29 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.509 -179.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.79 44.83 0.08 OUTLIER Glycine 0 C--N 1.333 0.405 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 221' ' ' PHE . . . . . 0.451 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 26.3 m-85 -127.66 154.78 44.88 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.053 0.454 . . . . 0.0 110.497 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.479 ' O ' HG13 ' A' ' 191' ' ' VAL . 7.6 p -106.33 122.16 45.68 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.209 0.528 . . . . 0.0 110.147 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.474 HD22 ' C ' ' A' ' 222' ' ' THR . 4.3 mm? -101.6 133.07 46.85 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.023 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.44 159.41 14.96 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.49 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.14 114.99 29.52 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.962 0.411 . . . . 0.0 110.31 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.494 ' N ' HD12 ' A' ' 226' ' ' LEU . 9.0 mp -53.03 156.54 3.5 Favored Pre-proline 0 N--CA 1.453 -0.319 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.69 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -60.02 145.32 98.67 Favored 'Trans proline' 0 C--N 1.301 -1.944 0 C-N-CA 122.673 2.249 . . . . 0.0 112.167 179.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -86.89 -3.36 59.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.578 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.69 -40.65 5.58 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . 0.503 ' O ' ' N ' ' A' ' 233' ' ' SER . 65.5 mt -79.53 -18.43 51.87 Favored 'General case' 0 C--O 1.222 -0.389 0 CA-C-O 121.125 0.488 . . . . 0.0 110.365 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -40.76 -49.18 3.1 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.773 -179.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -87.04 15.09 6.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.269 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . 0.503 ' N ' ' O ' ' A' ' 230' ' ' LEU . 77.6 p -59.74 -34.58 73.14 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.59 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . 0.529 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.5 tt0 -121.73 -68.99 0.86 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.813 179.386 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.3 m -66.31 102.91 0.91 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.559 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -93.83 54.25 1.94 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.415 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -142.84 -122.16 1.7 Allowed Glycine 0 CA--C 1.521 0.434 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -139.01 113.75 9.17 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.018 0.437 . . . . 0.0 110.328 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . 0.529 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.8 mtt180 -147.73 60.31 1.14 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.716 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -68.94 -34.12 74.83 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.518 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 241' ' ' ASP . . . . . 0.454 ' OD2' ' ND2' ' A' ' 143' ' ' ASN . 48.2 t0 -56.79 -47.58 79.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.378 -179.151 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 242' ' ' ILE . . . . . 0.433 ' O ' ' O ' ' A' ' 239' ' ' ARG . 18.9 tt -138.45 153.79 26.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.909 0.385 . . . . 0.0 110.459 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.456 HG22 HD13 ' A' ' 245' ' ' LEU . 96.4 mt -106.38 107.55 22.98 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.224 0 CA-C-O 121.095 0.474 . . . . 0.0 110.445 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . 0.611 ' C ' HD12 ' A' ' 245' ' ' LEU . 88.3 mt-30 -111.85 111.03 21.69 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.46 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.611 HD12 ' C ' ' A' ' 244' ' ' GLN . 9.8 mp -121.21 -168.34 1.66 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.571 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . 0.529 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 176.67 -17.42 0.04 OUTLIER Glycine 0 CA--C 1.524 0.602 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . 0.679 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -62.29 154.55 41.09 Favored Glycine 0 CA--C 1.521 0.442 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -62.62 22.3 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.924 0.392 . . . . 0.0 110.644 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . 0.679 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.9 m-20 -96.64 -6.33 36.89 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.49 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 99.0 mt -80.34 -22.55 41.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.705 179.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.65 -51.17 71.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.84 -179.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.24 -4.94 58.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.429 179.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.41 -73.89 1.17 Allowed Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 82.8 mt -70.16 126.64 30.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.018 0.437 . . . . 0.0 110.253 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -59.51 -39.06 82.62 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.392 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 83.3 51.72 4.03 Favored Glycine 0 CA--C 1.521 0.46 0 N-CA-C 110.752 -0.939 . . . . 0.0 110.752 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -95.6 -15.15 22.97 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.687 0.28 . . . . 0.0 110.633 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 258' ' ' SER . . . . . 0.504 ' OG ' HG23 ' A' ' 191' ' ' VAL . 3.3 t 174.26 88.91 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.065 0.459 . . . . 0.0 110.086 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.864 ' N ' HD12 ' A' ' 259' ' ' LEU . 1.0 OUTLIER -94.3 124.3 38.24 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.276 0.56 . . . . 0.0 111.187 -179.156 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 260' ' ' PHE . . . . . 0.455 ' H ' ' HA ' ' A' ' 193' ' ' ALA . 15.9 m-30 -93.0 146.52 23.56 Favored 'General case' 0 CA--C 1.505 -0.781 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.465 179.282 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 85.1 mt -122.08 149.85 42.97 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.534 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.729 ' CD1' HG13 ' A' ' 195' ' ' VAL . 2.6 p90 -77.7 -139.35 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.436 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 263' ' ' ALA . . . . . 0.659 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -51.34 77.66 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.123 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . 0.632 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.36 104.82 0.19 Allowed Glycine 0 CA--C 1.527 0.83 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 265' ' ' ASP . . . . . 0.598 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.6 m-20 -80.38 -177.67 6.28 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.769 0.318 . . . . 0.0 110.861 -179.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -40.45 -17.83 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.539 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 267' ' ' LYS . . . . . 0.598 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.47 -51.63 41.37 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.007 0.432 . . . . 0.0 110.7 179.448 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -63.67 -46.48 85.39 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.259 179.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . 0.573 ' HB1' ' OH ' ' A' ' 273' ' ' TYR . . . -61.77 -35.16 77.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.202 0.525 . . . . 0.0 109.732 179.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -63.02 -34.56 77.83 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.113 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.47 -43.27 13.73 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.192 -179.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 272' ' ' ILE . . . . . 0.585 ' C ' ' H ' ' A' ' 274' ' ' ALA . 4.8 tt -51.21 -33.47 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.83 -178.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 273' ' ' TYR . . . . . 0.573 ' OH ' ' HB1' ' A' ' 269' ' ' ALA . 17.1 m-85 -54.7 -1.53 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.603 -179.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 274' ' ' ALA . . . . . 0.585 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.79 -39.65 69.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.917 179.543 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . 0.58 ' O ' ' N ' ' A' ' 279' ' ' ALA . 3.5 p30 -39.21 97.91 0.15 Allowed Pre-proline 0 N--CA 1.462 0.128 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.55 -179.694 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -54.25 -42.9 63.42 Favored 'Trans proline' 0 C--N 1.304 -1.812 0 C-N-CA 122.32 2.013 . . . . 0.0 112.682 -178.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 89.0 mt -64.43 -42.83 95.79 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.208 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 90.6 mt -95.79 -1.35 49.86 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.883 -179.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 279' ' ' ALA . . . . . 0.58 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.28 -34.73 77.13 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.71 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.14 19.91 0.12 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.99 -179.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . 0.49 HD23 ' HA ' ' A' ' 281' ' ' LEU . 13.7 mt -75.07 119.85 78.88 Favored Pre-proline 0 N--CA 1.451 -0.424 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.58 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -50.64 -39.71 56.13 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.612 2.208 . . . . 0.0 112.035 178.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.76 -50.44 63.49 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.103 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 73.6 t -61.47 -43.85 97.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 179.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -57.95 -41.26 82.48 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.159 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -90.84 0.05 57.58 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.154 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt 59.56 43.23 16.22 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.86 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -94.83 41.49 1.09 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.346 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 54.2 t -118.85 135.72 58.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 121.062 0.458 . . . . 0.0 110.172 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -132.74 162.45 31.4 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.111 0.481 . . . . 0.0 110.606 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.43 154.51 33.59 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.021 0.439 . . . . 0.0 110.681 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 80.9 mt -93.66 -1.69 54.94 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.24 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.83 165.72 12.64 Favored Glycine 0 CA--C 1.522 0.475 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 6.8 m -87.61 -61.9 1.62 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.902 0.382 . . . . 0.0 111.065 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 295' ' ' GLU . . . . . 0.452 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.5 mm-40 -69.22 -4.35 17.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.677 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 26.1 p -76.29 32.43 0.12 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.666 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 297' ' ' PHE . . . . . 0.514 ' CD2' HG22 ' A' ' 70' ' ' THR . 85.0 t80 -60.56 -46.18 91.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.579 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . 0.628 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.1 mtt85 -81.78 133.65 35.36 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 121.049 0.452 . . . . 0.0 110.54 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.403 ' H ' HG11 ' A' ' 51' ' ' VAL . 16.8 tp -113.16 118.64 35.27 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-O 120.994 0.426 . . . . 0.0 110.161 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . 0.632 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.4 p-10 -165.81 -176.01 3.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.592 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 83.5 t80 -47.3 -44.06 23.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.275 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -66.45 -40.64 89.54 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.035 0.445 . . . . 0.0 110.827 179.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . 0.632 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 57.6 p -55.58 -36.21 66.63 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.111 -179.19 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . 0.555 ' HB2' ' SD ' ' A' ' 215' ' ' MET . . . -56.98 -51.67 68.28 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.46 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 91.0 mtp -56.26 -43.83 79.14 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -66.3 -42.45 88.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.037 0.446 . . . . 0.0 110.18 178.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 303' ' ' SER . 56.1 t -64.1 -42.93 97.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.209 179.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 42.3 tp -59.74 -42.12 92.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.863 -179.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -62.68 -38.82 91.87 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.08 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 310' ' ' ARG . . . . . 0.441 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.7 ttt85 -63.63 -43.73 95.99 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.308 179.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 89.3 mt -63.09 -42.22 99.57 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.25 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt -62.85 -33.36 75.1 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.075 179.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.44 -23.68 22.06 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.401 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . 0.477 HD22 ' CE2' ' A' ' 315' ' ' PHE . 6.7 tt -62.26 -43.28 99.2 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 121.068 0.461 . . . . 0.0 110.578 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 315' ' ' PHE . . . . . 0.477 ' CE2' HD22 ' A' ' 314' ' ' LEU . 90.1 m-85 . . . . . 0 C--O 1.22 -0.479 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.404 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -99.64 135.89 40.39 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.056 0.455 . . . . 0.0 110.476 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.497 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -91.94 178.51 1.7 Allowed Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.586 -179.846 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.497 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.4 Cg_exo -61.6 147.32 95.66 Favored 'Trans proline' 0 C--N 1.299 -2.076 0 C-N-CA 122.802 2.335 . . . . 0.0 112.147 179.568 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.463 ' HE ' HD12 ' A' ' 39' ' ' LEU . 35.7 ptt180 -136.03 142.3 44.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.645 179.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -79.6 116.79 20.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.501 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.443 ' O ' HG23 ' A' ' 30' ' ' ILE . 9.5 tp -111.35 130.75 64.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.465 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 13.8 t -70.93 142.36 51.09 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.606 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.478 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.4 t0 -139.85 179.53 6.54 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.526 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.478 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 78.0 p -73.71 -37.12 65.25 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.64 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.7 ttt85 -46.49 -94.56 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.293 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -167.22 -26.32 0.02 OUTLIER Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.931 -0.867 . . . . 0.0 110.931 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 60.9 m -169.25 105.02 0.38 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.891 0.377 . . . . 0.0 110.665 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.68 ' CD2' HD13 ' A' ' 140' ' ' LEU . 74.7 t60 -128.5 149.44 50.59 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.116 0.484 . . . . 0.0 110.227 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.623 HG22 ' N ' ' A' ' 39' ' ' LEU . 98.5 m -131.75 165.88 22.77 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.583 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.623 ' N ' HG22 ' A' ' 38' ' ' THR . 81.6 mt -120.8 127.31 51.82 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.497 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -64.95 -44.43 89.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.721 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 39.7 p -165.81 155.08 11.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.492 179.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.49 ' H ' ' CD ' ' A' ' 42' ' ' GLN . 14.9 mp0 -44.22 100.96 0.24 Allowed Pre-proline 0 C--N 1.329 -0.287 0 O-C-N 123.364 0.415 . . . . 0.0 110.621 179.362 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -57.26 129.37 33.79 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 122.337 2.024 . . . . 0.0 112.271 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -83.98 -24.81 30.45 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.501 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.538 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.3 mtm-85 -121.86 134.37 54.88 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.199 0.523 . . . . 0.0 110.321 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.2 mt -130.6 133.46 63.49 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.3 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.952 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 44.9 t -124.18 130.33 73.77 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.646 ' OG ' HD12 ' A' ' 117' ' ' LEU . 2.1 m -155.48 167.65 29.69 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.523 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 66.8 p -124.45 10.31 8.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.454 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -86.02 124.78 32.85 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.723 -179.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.464 HG11 ' H ' ' A' ' 299' ' ' LEU . 98.9 t -65.57 -44.55 93.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.398 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.4 m -62.49 -44.18 97.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.627 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 52.3 tp -62.02 -41.54 98.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.514 -179.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.453 ' O ' HD13 ' A' ' 58' ' ' LEU . 71.2 m -57.67 -44.44 85.72 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.192 -179.27 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.24 -62.09 5.46 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 179.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.7 t -48.61 -35.51 13.78 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 57' ' ' LEU . 20.0 mt -61.82 -44.48 96.75 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.675 -0.41 . . . . 0.0 111.284 179.335 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.453 HD13 ' O ' ' A' ' 54' ' ' THR . 9.3 mp -64.96 -41.61 95.33 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.42 177.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.84 -40.48 96.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.003 -179.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.43 ' O ' HG23 ' A' ' 60' ' ' ILE . 7.9 tp -89.07 16.49 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.836 -179.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 56.48 85.08 0.08 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.733 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 178.49 58.21 0.07 OUTLIER Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.901 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.409 ' HB3' HE21 ' A' ' 85' ' ' GLN . 10.2 Cg_endo -50.97 153.1 9.23 Favored 'Trans proline' 0 C--N 1.294 -2.323 0 C-N-CA 122.935 2.423 . . . . 0.0 112.329 -178.229 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.432 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -108.3 145.37 15.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.318 -179.736 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.69 -45.18 98.09 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.303 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.403 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.502 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -129.83 134.03 47.3 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.504 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.502 ' O ' ' N ' ' A' ' 98' ' ' LEU . 75.4 m -134.48 158.5 43.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.824 -179.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.59 139.03 16.2 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.487 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.79 -162.86 0.08 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.014 0.435 . . . . 0.0 110.465 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.538 HG22 ' CD2' ' A' ' 297' ' ' PHE . 14.9 t -133.61 134.5 43.31 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.357 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.488 ' C ' ' O ' ' A' ' 70' ' ' THR . 0.7 OUTLIER 29.62 68.71 0.65 Allowed Pre-proline 0 N--CA 1.464 0.266 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.787 -179.879 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -61.3 145.42 98.41 Favored 'Trans proline' 0 C--N 1.299 -2.077 0 C-N-CA 122.654 2.236 . . . . 0.0 111.969 -178.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.53 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 45.3 p-10 -158.9 -32.29 0.07 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.701 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.545 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 99.1 m-20 -64.03 -39.71 94.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.459 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -60.39 -48.1 83.2 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.704 -179.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.424 ' O ' ' O ' ' A' ' 77' ' ' ALA . 92.7 t -60.48 -25.03 33.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.545 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -45.66 173.04 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.601 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.575 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.6 p30 -62.05 177.86 0.42 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.533 -179.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.559 ' C ' ' H ' ' A' ' 81' ' ' GLY . 36.5 p30 -45.01 85.73 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.994 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.575 ' N ' ' O ' ' A' ' 78' ' ' ASP . 42.7 tp60 -67.36 13.21 0.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.119 0.485 . . . . 0.0 110.116 -179.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.559 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 118.23 -22.29 9.7 Favored Glycine 0 C--N 1.332 0.317 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -108.18 116.18 31.49 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.956 0.407 . . . . 0.0 110.471 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 77.8 mt -98.56 0.58 45.23 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.941 0.401 . . . . 0.0 110.484 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -92.33 7.03 44.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.024 0.44 . . . . 0.0 110.435 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.8 ' O ' HG22 ' A' ' 89' ' ' VAL . 88.0 mt-30 -100.2 -27.87 13.3 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.787 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 68.5 t-105 -62.71 -40.91 98.64 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.935 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.552 ' O ' ' N ' ' A' ' 91' ' ' LYS . 68.8 m -77.55 -53.2 7.89 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.164 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -48.79 -50.9 32.03 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.015 -179.212 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.8 HG22 ' O ' ' A' ' 85' ' ' GLN . 15.7 m -68.75 -40.74 81.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 120.88 0.371 . . . . 0.0 111.074 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.497 ' N ' HG23 ' A' ' 89' ' ' VAL . . . -71.99 -23.11 61.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.75 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.552 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.0 tttm -61.6 -45.63 93.29 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.504 -179.537 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.445 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.8 mm-40 -90.46 -95.17 0.12 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.101 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.63 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.8 mtt180 -142.81 59.46 1.43 Allowed 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.458 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.7 pttp 33.55 26.27 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 120.906 0.384 . . . . 0.0 110.132 -179.303 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.63 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.5 tt -48.5 123.23 6.35 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.006 -177.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.456 ' O ' HD23 ' A' ' 95' ' ' LEU . 99.1 mm-40 -83.95 -169.2 2.46 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.06 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.602 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 81.3 mtp180 -74.85 136.86 41.53 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.266 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.502 ' N ' ' O ' ' A' ' 67' ' ' SER . 91.5 mt -85.77 -165.93 1.38 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.718 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.537 ' CD2' ' O ' ' A' ' 99' ' ' TYR . 48.3 p90 -168.2 119.85 0.83 Allowed 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.198 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.511 ' C ' ' O ' ' A' ' 99' ' ' TYR . 42.4 mm -28.99 120.74 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.074 -179.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 114.62 27.6 3.25 Favored Glycine 0 CA--C 1.52 0.353 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 -179.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.576 ' H ' ' CD ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -144.78 46.5 0.61 Allowed Pre-proline 0 C--N 1.323 -0.578 0 O-C-N 122.549 -0.383 . . . . 0.0 110.431 179.896 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 29.0 Cg_endo -61.9 144.21 96.36 Favored 'Trans proline' 0 C--N 1.295 -2.258 0 C-N-CA 122.678 2.252 . . . . 0.0 111.93 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.457 ' O ' HG23 ' A' ' 108' ' ' VAL . 26.1 t -173.38 120.25 0.33 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.397 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.71 -40.34 63.67 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.034 0.445 . . . . 0.0 111.098 179.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -66.29 -40.16 89.87 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.9 -179.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.97 -40.07 95.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.697 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 104' ' ' SER . 70.7 t -67.45 -43.84 87.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.8 179.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.86 -38.84 92.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.53 -179.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.445 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.62 -23.34 62.92 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.414 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.547 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.5 mm-40 -90.63 5.14 49.19 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.755 -179.575 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.547 ' C ' ' O ' ' A' ' 111' ' ' GLN . 10.6 tpt 23.49 64.05 0.38 Allowed Pre-proline 0 N--CA 1.466 0.347 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.074 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -78.41 167.78 22.42 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 C-N-CA 122.949 2.433 . . . . 0.0 112.009 -178.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.523 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 99.0 m-20 -110.06 -42.53 4.17 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.133 179.475 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.6 tp -120.64 120.4 35.65 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 84.4 mt -113.36 129.18 69.59 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.401 0 CA-C-O 120.983 0.42 . . . . 0.0 110.942 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.646 HD12 ' OG ' ' A' ' 48' ' ' SER . 29.9 mt -109.02 132.46 54.08 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.057 0.456 . . . . 0.0 110.214 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.505 HD12 HG23 ' A' ' 139' ' ' THR . 98.9 mt -119.91 138.2 51.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.666 -179.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 87.4 p -71.92 153.17 42.01 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.57 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.27 -50.19 74.63 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.681 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -149.42 153.91 38.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.615 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 170.25 -170.9 43.27 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.87 -34.28 89.37 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.447 ' O ' ' OD1' ' A' ' 124' ' ' ASP . 44.1 p-10 -87.06 120.06 27.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.805 0.336 . . . . 0.0 110.66 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.447 ' O ' HD12 ' A' ' 129' ' ' LEU . 40.6 t -63.26 143.6 57.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.451 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.521 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.08 -42.76 9.23 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.866 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.5 tp -62.73 -42.35 99.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.647 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.99 -11.94 59.81 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.485 -179.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.447 HD12 ' O ' ' A' ' 125' ' ' SER . 84.8 mt -114.48 -24.1 8.99 Favored 'General case' 0 C--O 1.226 -0.16 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.689 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . 0.521 ' N ' ' O ' ' A' ' 126' ' ' ALA . 77.9 t80 -51.28 -49.44 61.23 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.611 -0.436 . . . . 0.0 110.576 -178.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.3 p-10 -66.07 -42.27 89.65 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.885 0.374 . . . . 0.0 111.29 179.474 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.518 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 88.2 mt-30 -67.29 -37.92 84.18 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.797 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.446 HD12 HD11 ' A' ' 118' ' ' ILE . 96.1 mt -80.33 -41.41 24.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.991 -179.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.1 t -57.26 -44.34 83.82 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.202 -178.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.8 m -62.11 -45.1 94.99 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.766 0.317 . . . . 0.0 110.49 179.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 93.5 mt -62.26 -43.64 98.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.23 -179.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.664 ' HB1' ' HD2' ' A' ' 138' ' ' PRO . . . -169.46 168.35 4.88 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.588 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.664 ' HD2' ' HB1' ' A' ' 137' ' ' ALA . 52.1 Cg_exo -49.67 112.93 0.78 Allowed 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.314 2.01 . . . . 0.0 112.277 179.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.505 HG23 HD12 ' A' ' 118' ' ' ILE . 23.0 m -84.18 127.55 34.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.636 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.68 HD13 ' CD2' ' A' ' 37' ' ' HIS . 34.5 tp -118.05 135.93 53.87 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.938 -179.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.438 ' O ' ' OD2' ' A' ' 32' ' ' ASP . 81.3 mt -100.38 119.01 47.9 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 CA-C-O 121.192 0.52 . . . . 0.0 111.295 -179.44 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.44 HD12 HD22 ' A' ' 117' ' ' LEU . 98.1 mt -134.98 131.83 53.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.619 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.55 HD21 ' CG ' ' A' ' 241' ' ' ASP . 58.9 t30 -66.77 147.48 53.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.866 0.365 . . . . 0.0 110.406 179.289 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.463 ' O ' ' OD2' ' A' ' 241' ' ' ASP . 44.8 t80 -81.69 123.17 28.5 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.932 -179.546 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 54.64 69.57 0.71 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.802 179.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 34.2 p-10 -126.16 0.7 7.15 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.93 0.395 . . . . 0.0 110.74 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -150.65 114.92 5.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.743 -179.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 83.6 p -64.14 169.23 4.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.523 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.417 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.4 p-90 -52.1 -16.51 0.79 Allowed 'General case' 0 C--O 1.223 -0.321 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.474 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . 0.434 ' O ' HG23 ' A' ' 154' ' ' THR . 68.1 tp60 -69.56 -76.96 0.09 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.495 -179.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.449 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.1 t -62.53 -38.24 89.21 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.287 179.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 53.1 tp -60.05 -45.74 91.84 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.351 -178.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.417 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 46.8 tp -62.76 -41.71 99.34 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.417 179.049 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.449 ' OG1' ' O ' ' A' ' 151' ' ' SER . 63.0 p -63.89 -34.91 79.01 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.222 -179.454 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.445 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 88.0 mm-40 -64.0 -42.52 97.16 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.256 179.308 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 90.7 mt -65.37 -38.85 91.28 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.094 0.473 . . . . 0.0 110.212 179.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.578 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.25 -32.4 80.55 Favored Glycine 0 CA--C 1.519 0.343 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 -179.368 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.445 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.2 mt-10 -35.88 -26.45 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.869 0.366 . . . . 0.0 110.827 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.578 ' N ' ' O ' ' A' ' 157' ' ' GLY . 95.3 mt -57.2 148.75 4.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.287 179.224 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 73.4 p -69.1 137.41 53.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.036 -179.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 70.85 22.18 78.22 Favored Glycine 0 N--CA 1.458 0.162 0 N-CA-C 111.286 -0.726 . . . . 0.0 111.286 179.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 59.0 m80 -124.16 -14.41 7.04 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.719 0.295 . . . . 0.0 110.519 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -66.16 -59.75 3.47 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.718 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -52.16 -49.04 64.57 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.159 -179.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -60.98 -41.09 95.78 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.95 -0.3 . . . . 0.0 110.387 179.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.57 -47.09 87.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.57 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -57.0 -40.22 76.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.188 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -61.49 -49.94 74.73 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.558 179.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -65.35 -43.67 90.13 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.467 179.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 94.7 mt -64.56 -43.41 96.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.468 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.38 -51.02 71.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.451 -179.099 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.51 -43.68 96.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.493 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . 0.665 ' CE2' HD11 ' A' ' 177' ' ' LEU . 57.6 t80 -62.86 -44.52 95.91 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.072 0.463 . . . . 0.0 110.433 179.391 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -63.27 -40.0 96.16 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.579 -179.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -63.02 -42.73 99.88 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.646 179.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -60.65 -44.88 95.9 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.152 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.665 HD11 ' CE2' ' A' ' 173' ' ' PHE . 84.6 mt -64.43 -41.14 96.75 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.992 0.425 . . . . 0.0 110.67 178.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -51.92 -62.15 1.81 Allowed 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.395 -179.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.76 -46.61 87.07 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.568 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.3 -41.86 66.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.28 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -63.66 -33.7 76.22 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.984 0.421 . . . . 0.0 110.4 179.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . 0.421 ' HG2' ' O ' ' A' ' 182' ' ' GLU . 69.8 tt0 -90.53 8.76 32.36 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.489 0.662 . . . . 0.0 110.484 -178.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -104.87 -32.29 8.87 Favored 'General case' 0 CA--C 1.515 -0.372 0 O-C-N 122.113 -0.367 . . . . 0.0 111.233 179.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.7 pt -128.01 147.61 32.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.826 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -139.97 131.02 26.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.331 179.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . 0.597 HD22 ' N ' ' A' ' 186' ' ' LEU . 3.5 mm? -85.44 133.73 41.69 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.01 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -44.04 157.89 0.14 Allowed 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 122.703 2.269 . . . . 0.0 112.199 179.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . 0.521 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 28.1 Cg_endo -63.13 114.8 2.62 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 C-N-CA 122.765 2.31 . . . . 0.0 111.729 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . 0.521 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.8 mt-30 155.4 147.99 0.0 OUTLIER Pre-proline 0 N--CA 1.455 -0.203 0 O-C-N 123.68 0.612 . . . . 0.0 110.802 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -73.53 144.29 35.77 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.621 2.214 . . . . 0.0 112.005 177.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.503 HG23 ' OG ' ' A' ' 258' ' ' SER . 2.1 p -124.92 158.83 32.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.298 0.57 . . . . 0.0 110.14 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . 0.494 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 37.4 p -143.3 165.39 27.61 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.121 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . 0.446 ' HA ' ' H ' ' A' ' 260' ' ' PHE . . . -135.28 128.64 32.2 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.222 0.534 . . . . 0.0 110.189 179.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.508 HD11 HD23 ' A' ' 259' ' ' LEU . 47.7 pt -146.39 148.79 16.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.186 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . 0.749 HG13 ' CD1' ' A' ' 262' ' ' PHE . 72.1 t -117.77 123.25 71.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.272 0.558 . . . . 0.0 109.684 179.167 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -134.4 107.37 7.56 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.282 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 94.7 m -130.82 130.46 43.68 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.834 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.406 ' O ' ' N ' ' A' ' 201' ' ' HIS . . . -82.73 -37.36 24.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.265 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.41 -66.98 0.27 Allowed 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.414 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.1 -10.05 59.24 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.266 179.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . 0.406 ' N ' ' O ' ' A' ' 198' ' ' ALA . 60.0 t-80 60.81 58.13 2.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.703 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 41.0 p -166.84 153.49 8.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.52 179.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.32 144.05 24.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.496 179.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -135.34 138.4 43.34 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.641 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 20.4 mt -106.53 125.64 51.25 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.116 0.484 . . . . 0.0 109.779 -179.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 206' ' ' TRP . . . . . 0.556 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 74.8 m95 -82.12 166.99 19.21 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.655 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . 0.466 HG22 ' C ' ' A' ' 206' ' ' TRP . 0.1 OUTLIER -156.92 171.26 7.67 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 120.98 0.419 . . . . 0.0 110.521 -179.144 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.54 -37.35 82.65 Favored 'Trans proline' 0 C--N 1.303 -1.832 0 C-N-CA 122.619 2.213 . . . . 0.0 112.186 179.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -70.4 -35.01 73.2 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.875 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 22.8 m -61.01 150.74 32.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.616 -179.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.45 -37.04 82.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.551 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 212' ' ' GLN . . . . . 0.556 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 55.0 tt0 -64.69 -40.24 95.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.543 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.5 -43.46 92.32 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.719 -0.952 . . . . 0.0 110.719 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -63.34 -43.54 97.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.71 0.291 . . . . 0.0 110.247 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 215' ' ' MET . . . . . 0.537 ' SD ' ' HB2' ' A' ' 304' ' ' ALA . 65.1 ttp -59.5 -48.01 83.31 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.207 -179.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 88.0 mt -60.66 -40.74 93.19 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 217' ' ' GLU . . . . . 0.459 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.7 tp10 -58.06 -37.87 75.25 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -65.22 -38.01 89.06 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.81 0.338 . . . . 0.0 110.654 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 94.3 mt -64.3 -42.62 96.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.614 -179.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.27 44.6 0.09 OUTLIER Glycine 0 C--N 1.333 0.408 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 221' ' ' PHE . . . . . 0.459 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 26.1 m-85 -127.66 155.44 43.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.058 0.456 . . . . 0.0 110.527 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.487 ' O ' HG13 ' A' ' 191' ' ' VAL . 7.0 p -107.16 122.23 46.09 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.224 0.535 . . . . 0.0 110.196 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.472 HD22 ' C ' ' A' ' 222' ' ' THR . 4.3 mm? -101.03 133.28 45.76 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.134 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -97.1 159.21 15.04 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.473 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.16 115.35 30.13 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-O 120.924 0.392 . . . . 0.0 110.37 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.496 ' N ' HD12 ' A' ' 226' ' ' LEU . 8.9 mp -53.37 156.67 3.96 Favored Pre-proline 0 N--CA 1.453 -0.313 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.659 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -60.19 145.3 98.81 Favored 'Trans proline' 0 C--N 1.301 -1.931 0 C-N-CA 122.629 2.219 . . . . 0.0 112.15 179.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.41 -3.02 59.01 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.5 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.22 -40.92 5.66 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.024 -0.831 . . . . 0.0 111.024 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . 0.539 ' O ' ' N ' ' A' ' 233' ' ' SER . 86.3 mt -79.17 -16.82 56.04 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-O 121.019 0.438 . . . . 0.0 110.29 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . 0.402 ' C ' ' O ' ' A' ' 230' ' ' LEU . 54.5 t-20 -40.41 -48.89 2.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.764 -179.399 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -88.2 15.43 7.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.314 179.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . 0.539 ' N ' ' O ' ' A' ' 230' ' ' LEU . 78.1 p -60.6 -35.51 76.3 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.648 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . 0.528 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.6 tt0 -118.35 -69.26 0.86 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.974 179.428 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.0 m -70.47 103.02 2.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.739 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -94.27 58.08 2.42 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.37 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -145.04 -122.53 1.55 Allowed Glycine 0 CA--C 1.519 0.324 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -134.47 111.79 10.4 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 121.175 0.512 . . . . 0.0 110.408 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . 0.515 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.2 mtt180 -148.25 57.56 1.07 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.762 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -69.83 -31.89 70.01 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.489 179.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 241' ' ' ASP . . . . . 0.55 ' CG ' HD21 ' A' ' 143' ' ' ASN . 64.8 t0 -56.92 -47.03 81.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.344 -179.097 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 242' ' ' ILE . . . . . 0.434 ' O ' ' O ' ' A' ' 239' ' ' ARG . 17.6 tt -140.2 157.03 25.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.912 0.387 . . . . 0.0 110.494 179.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.45 HG22 HD13 ' A' ' 245' ' ' LEU . 96.1 mt -106.25 106.33 20.39 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.163 0 CA-C-O 121.169 0.509 . . . . 0.0 110.466 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . 0.599 ' O ' HD12 ' A' ' 245' ' ' LEU . 88.2 mt-30 -110.45 110.31 21.02 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.302 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.599 HD12 ' O ' ' A' ' 244' ' ' GLN . 9.5 mp -121.87 -168.33 1.69 Allowed 'General case' 0 C--O 1.225 -0.205 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.63 179.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . 0.528 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.49 -16.9 0.05 OUTLIER Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.919 -0.873 . . . . 0.0 110.919 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . 0.668 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -60.45 156.98 29.78 Favored Glycine 0 CA--C 1.522 0.488 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -63.8 21.42 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.977 0.418 . . . . 0.0 110.604 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . 0.668 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.8 m-20 -97.04 -6.05 36.16 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.576 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 92.4 mt -79.9 -21.57 43.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.648 179.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.57 -51.23 70.76 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.71 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.65 -5.41 58.16 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.467 179.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.14 -74.37 1.15 Allowed Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 82.6 mt -70.08 126.01 28.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.072 0.463 . . . . 0.0 110.254 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -59.47 -39.27 83.14 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.311 -179.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 82.83 51.79 4.12 Favored Glycine 0 CA--C 1.521 0.41 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -95.78 -15.1 22.79 Favored 'General case' 0 C--N 1.332 -0.18 0 O-C-N 122.728 -0.278 . . . . 0.0 110.594 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 258' ' ' SER . . . . . 0.503 ' OG ' HG23 ' A' ' 191' ' ' VAL . 3.3 t 174.56 88.93 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.078 0.466 . . . . 0.0 110.108 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.861 ' N ' HD12 ' A' ' 259' ' ' LEU . 0.9 OUTLIER -94.43 124.06 38.23 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.254 0.549 . . . . 0.0 111.115 -179.081 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 260' ' ' PHE . . . . . 0.446 ' H ' ' HA ' ' A' ' 193' ' ' ALA . 15.9 m-30 -93.06 146.48 23.61 Favored 'General case' 0 CA--C 1.504 -0.818 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.345 179.349 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 85.7 mt -122.42 149.63 43.57 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.607 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.749 ' CD1' HG13 ' A' ' 195' ' ' VAL . 2.6 p90 -77.21 -138.04 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.638 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 263' ' ' ALA . . . . . 0.66 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -52.61 77.52 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.032 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . 0.621 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -178.99 104.32 0.18 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 265' ' ' ASP . . . . . 0.601 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.7 m-20 -80.35 -177.81 6.34 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.684 0.278 . . . . 0.0 110.954 -179.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -40.36 -17.69 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.561 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 267' ' ' LYS . . . . . 0.601 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.38 -51.52 43.26 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.71 179.409 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -63.75 -46.65 84.34 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.191 179.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . 0.565 ' HB1' ' OH ' ' A' ' 273' ' ' TYR . . . -61.68 -35.12 77.08 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.173 0.511 . . . . 0.0 109.738 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -63.17 -34.38 77.51 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.033 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.51 -43.12 13.83 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.185 -179.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 272' ' ' ILE . . . . . 0.589 ' C ' ' H ' ' A' ' 274' ' ' ALA . 4.9 tt -51.47 -33.73 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.855 -178.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 273' ' ' TYR . . . . . 0.565 ' OH ' ' HB1' ' A' ' 269' ' ' ALA . 17.3 m-85 -54.33 -1.89 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.646 -179.546 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 274' ' ' ALA . . . . . 0.589 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.61 -39.61 70.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.919 179.52 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . 0.582 ' O ' ' N ' ' A' ' 279' ' ' ALA . 3.3 p30 -39.28 98.03 0.16 Allowed Pre-proline 0 CA--C 1.528 0.108 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.52 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -54.29 -42.95 63.02 Favored 'Trans proline' 0 C--N 1.303 -1.821 0 C-N-CA 122.341 2.027 . . . . 0.0 112.638 -178.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 88.8 mt -64.45 -42.82 95.76 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.252 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 91.0 mt -95.67 -1.58 49.79 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.848 -179.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 279' ' ' ALA . . . . . 0.582 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.28 -34.82 77.3 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.685 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.21 20.07 0.12 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.052 -179.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . 0.487 HD23 ' HA ' ' A' ' 281' ' ' LEU . 13.8 mt -75.19 120.04 79.8 Favored Pre-proline 0 N--CA 1.451 -0.417 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.523 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -50.91 -39.34 58.96 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.586 2.191 . . . . 0.0 111.859 179.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.92 -50.42 64.0 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.111 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 75.7 t -61.48 -43.91 97.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -57.79 -41.19 81.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.218 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -91.13 0.04 57.61 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.091 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt 59.44 43.71 15.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.039 0.447 . . . . 0.0 110.878 179.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -94.88 41.33 1.09 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.379 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 54.1 t -119.2 135.76 58.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 121.101 0.477 . . . . 0.0 110.136 -179.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -132.93 162.75 30.8 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.709 -179.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.77 155.3 32.78 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-O 121.013 0.435 . . . . 0.0 110.728 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 81.6 mt -94.07 -1.36 54.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.232 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.53 165.69 12.67 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.548 -1.021 . . . . 0.0 110.548 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 6.9 m -87.56 -62.4 1.5 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.921 0.391 . . . . 0.0 111.001 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 295' ' ' GLU . . . . . 0.431 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.4 mm-40 -69.6 -3.79 16.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.675 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 25.4 p -76.89 33.17 0.14 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.645 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 297' ' ' PHE . . . . . 0.538 ' CD2' HG22 ' A' ' 70' ' ' THR . 84.8 t80 -60.17 -45.85 91.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.555 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . 0.602 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.2 mtt85 -81.72 134.41 35.45 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.989 0.423 . . . . 0.0 110.576 -179.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.464 ' H ' HG11 ' A' ' 51' ' ' VAL . 16.2 tp -114.18 118.88 35.22 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-O 121.004 0.431 . . . . 0.0 110.066 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . 0.631 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.4 p-10 -166.39 -175.23 3.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.562 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -47.69 -44.64 27.66 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.246 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -65.63 -40.9 93.07 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.034 0.445 . . . . 0.0 110.683 178.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . 0.631 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 54.5 p -56.16 -36.12 67.96 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.024 -179.171 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . 0.537 ' HB2' ' SD ' ' A' ' 215' ' ' MET . . . -56.85 -52.34 65.47 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.485 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 90.9 mtp -56.15 -43.28 78.15 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -66.37 -42.53 87.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.024 0.44 . . . . 0.0 110.155 178.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 303' ' ' SER . 55.7 t -64.13 -42.97 97.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.105 179.399 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 42.5 tp -59.77 -42.26 92.9 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.779 -179.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -62.33 -39.27 92.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.123 179.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 310' ' ' ARG . . . . . 0.436 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.4 ttt85 -63.51 -44.06 95.38 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.18 179.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 88.4 mt -63.37 -42.14 98.84 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.233 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -62.99 -33.26 75.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.016 179.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.52 -23.85 21.93 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.416 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . 0.483 HD22 ' CE2' ' A' ' 315' ' ' PHE . 6.7 tt -62.31 -43.29 99.16 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 121.074 0.464 . . . . 0.0 110.552 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 315' ' ' PHE . . . . . 0.483 ' CE2' HD22 ' A' ' 314' ' ' LEU . 90.5 m-85 . . . . . 0 C--O 1.219 -0.507 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.45 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.327 -0.619 . . . . 0.0 109.327 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -99.59 136.4 39.58 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.045 0.45 . . . . 0.0 110.47 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.496 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -92.07 178.56 1.66 Allowed Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.563 -179.891 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.496 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.6 Cg_exo -61.73 147.16 95.93 Favored 'Trans proline' 0 C--N 1.301 -1.965 0 C-N-CA 122.79 2.327 . . . . 0.0 112.106 179.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.459 ' HE ' HD12 ' A' ' 39' ' ' LEU . 35.6 ptt180 -136.29 142.44 43.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.645 179.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -79.5 116.76 19.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.456 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.45 ' O ' HG23 ' A' ' 30' ' ' ILE . 9.5 tp -111.14 130.44 64.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.456 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 12.9 t -70.89 141.7 51.19 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.55 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.48 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.4 t0 -139.19 179.62 6.41 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.497 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.48 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 78.1 p -74.01 -36.93 64.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.604 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.8 ttt85 -46.64 -94.59 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.293 -179.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -166.96 -26.62 0.02 OUTLIER Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 59.3 m -169.05 105.0 0.4 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.817 0.341 . . . . 0.0 110.672 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.691 ' CD2' HD13 ' A' ' 140' ' ' LEU . 75.5 t60 -128.53 149.09 50.75 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.019 0.437 . . . . 0.0 110.289 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.623 HG22 ' N ' ' A' ' 39' ' ' LEU . 98.6 m -131.42 165.91 22.46 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.532 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.623 ' N ' HG22 ' A' ' 38' ' ' THR . 81.4 mt -120.75 127.35 51.91 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.501 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -65.09 -44.43 88.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.682 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 40.6 p -165.97 154.91 11.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.444 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.484 ' H ' ' CD ' ' A' ' 42' ' ' GLN . 14.5 mp0 -44.73 101.3 0.25 Allowed Pre-proline 0 C--N 1.329 -0.308 0 O-C-N 123.392 0.433 . . . . 0.0 110.652 179.426 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.25 129.66 35.32 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 C-N-CA 122.373 2.049 . . . . 0.0 112.288 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -83.61 -24.73 31.32 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.473 179.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.542 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.2 mtm-85 -122.39 134.83 54.61 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-O 121.176 0.512 . . . . 0.0 110.256 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.1 mt -130.75 133.84 62.74 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.925 -179.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 44.2 t -124.31 130.61 73.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 179.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.612 ' OG ' HD12 ' A' ' 117' ' ' LEU . 2.2 m -155.32 167.8 29.16 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.559 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 67.3 p -124.85 9.96 8.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.425 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.78 125.15 33.03 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.689 -179.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.456 HG11 ' H ' ' A' ' 299' ' ' LEU . 93.1 t -65.76 -44.41 93.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.48 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.8 m -62.69 -44.04 97.26 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.602 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 52.5 tp -62.15 -41.5 98.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.544 -179.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.459 ' O ' HD13 ' A' ' 58' ' ' LEU . 75.5 m -57.61 -44.53 85.54 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.32 -179.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.13 -62.31 5.29 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 179.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.6 t -48.24 -35.74 12.58 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' A' ' 57' ' ' LEU . 20.0 mt -61.86 -44.37 96.95 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.179 179.428 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.459 HD13 ' O ' ' A' ' 54' ' ' THR . 9.2 mp -64.97 -41.66 95.26 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.373 178.035 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.91 -40.71 97.12 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.012 -179.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.43 ' O ' HG23 ' A' ' 60' ' ' ILE . 7.9 tp -88.73 16.44 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.856 -179.609 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 56.46 84.58 0.09 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.671 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 178.58 57.1 0.06 OUTLIER Pre-proline 0 C--N 1.328 -0.329 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.411 ' HB3' HE21 ' A' ' 85' ' ' GLN . 9.5 Cg_endo -50.55 154.25 6.66 Favored 'Trans proline' 0 C--N 1.295 -2.252 0 C-N-CA 122.912 2.408 . . . . 0.0 112.297 -178.18 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.436 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -108.96 145.64 15.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.375 -179.712 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.66 -45.25 97.98 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.263 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.335 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.509 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -129.49 133.98 47.55 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.522 -179.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.51 ' O ' ' N ' ' A' ' 98' ' ' LEU . 74.8 m -134.59 158.64 43.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.769 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.77 139.27 16.26 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.704 -0.959 . . . . 0.0 110.704 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.488 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.92 -162.69 0.08 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.918 0.389 . . . . 0.0 110.474 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.532 HG22 ' CD2' ' A' ' 297' ' ' PHE . 15.2 t -133.52 134.33 43.3 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.397 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.489 ' C ' ' O ' ' A' ' 70' ' ' THR . 0.6 OUTLIER 29.73 68.89 0.65 Allowed Pre-proline 0 N--CA 1.464 0.272 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.754 -179.939 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -61.27 146.67 97.11 Favored 'Trans proline' 0 C--N 1.299 -2.067 0 C-N-CA 122.655 2.237 . . . . 0.0 111.986 -178.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.535 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 45.3 p-10 -160.59 -32.35 0.05 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.673 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.545 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 99.1 m-20 -64.15 -39.43 94.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.451 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -60.51 -48.24 82.65 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.561 -179.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.418 ' O ' ' O ' ' A' ' 77' ' ' ALA . 91.6 t -60.38 -24.77 32.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.545 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -46.02 173.29 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.563 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.57 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.6 p30 -62.25 177.96 0.44 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.582 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.554 ' C ' ' H ' ' A' ' 81' ' ' GLY . 35.8 p30 -45.01 86.12 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.985 0.422 . . . . 0.0 110.946 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.57 ' N ' ' O ' ' A' ' 78' ' ' ASP . 43.1 tp60 -67.57 13.21 0.08 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.127 0.489 . . . . 0.0 110.13 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.554 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 118.51 -22.09 9.58 Favored Glycine 0 CA--C 1.519 0.306 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -108.31 116.49 32.06 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.959 0.409 . . . . 0.0 110.54 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 74.6 mt -98.57 0.17 44.41 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.485 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -92.25 7.18 43.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.013 0.435 . . . . 0.0 110.443 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.795 ' O ' HG22 ' A' ' 89' ' ' VAL . 87.8 mt-30 -100.13 -27.99 13.26 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.777 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 68.2 t-105 -62.51 -40.67 97.47 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.866 -179.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.55 ' O ' ' N ' ' A' ' 91' ' ' LYS . 66.1 m -77.64 -53.45 7.56 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.088 -179.389 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -48.73 -50.91 31.53 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.018 -179.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.795 HG22 ' O ' ' A' ' 85' ' ' GLN . 15.4 m -68.62 -40.71 82.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 120.934 0.397 . . . . 0.0 111.032 179.717 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.498 ' N ' HG23 ' A' ' 89' ' ' VAL . . . -72.05 -23.04 61.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.702 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.55 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.0 tttm -61.74 -45.68 92.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.482 -179.464 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.439 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.6 mm-40 -90.23 -95.47 0.11 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.16 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.64 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.9 mtt180 -142.59 58.87 1.44 Allowed 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.459 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.7 pttp 33.54 25.77 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 120.92 0.391 . . . . 0.0 110.19 -179.161 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.64 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.3 tt -47.86 123.75 6.49 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.924 -178.061 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.457 ' O ' HD23 ' A' ' 95' ' ' LEU . 99.0 mm-40 -83.91 -169.41 2.57 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.115 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.595 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 81.0 mtp180 -74.6 136.7 42.03 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.291 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.51 ' N ' ' O ' ' A' ' 67' ' ' SER . 90.6 mt -85.52 -165.57 1.26 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.856 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.536 ' CD2' ' O ' ' A' ' 99' ' ' TYR . 48.0 p90 -168.38 119.49 0.79 Allowed 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.254 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.511 ' C ' ' O ' ' A' ' 99' ' ' TYR . 43.3 mm -28.86 121.02 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.058 -179.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 113.76 27.89 3.37 Favored Glycine 0 CA--C 1.52 0.35 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 -179.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.58 ' H ' ' CD ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -144.48 46.65 0.64 Allowed Pre-proline 0 C--N 1.324 -0.524 0 CA-C-O 120.985 0.422 . . . . 0.0 110.425 179.856 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 29.2 Cg_endo -61.97 143.78 95.67 Favored 'Trans proline' 0 C--N 1.297 -2.161 0 C-N-CA 122.656 2.237 . . . . 0.0 111.942 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.455 ' O ' HG23 ' A' ' 108' ' ' VAL . 25.3 t -173.01 120.08 0.35 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.367 179.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.25 -40.41 64.66 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.075 0.464 . . . . 0.0 111.122 179.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.39 -39.88 89.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.926 -179.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.38 -40.16 95.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.729 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 104' ' ' SER . 71.7 t -67.79 -43.82 86.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.78 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.82 -38.97 92.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.578 -179.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.439 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.44 -23.4 62.66 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.493 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.545 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.3 mm-40 -90.29 5.23 48.1 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.652 -179.471 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.545 ' C ' ' O ' ' A' ' 111' ' ' GLN . 10.8 tpt 23.89 63.98 0.39 Allowed Pre-proline 0 N--CA 1.466 0.33 0 CA-C-O 120.939 0.399 . . . . 0.0 111.048 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -78.22 166.63 24.3 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 123.035 2.49 . . . . 0.0 112.062 -178.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.524 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 99.2 m-20 -109.77 -41.71 4.45 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.185 179.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.2 tp -121.63 120.12 33.82 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 83.2 mt -112.77 128.86 69.25 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.33 0 CA-C-O 120.941 0.401 . . . . 0.0 110.849 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.612 HD12 ' OG ' ' A' ' 48' ' ' SER . 30.1 mt -109.34 132.25 54.3 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.281 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.501 HD12 HG23 ' A' ' 139' ' ' THR . 98.9 mt -119.6 139.06 48.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.668 -179.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 85.1 p -72.68 153.89 40.98 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.527 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.01 -50.19 74.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.714 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.0 t -149.59 154.24 38.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.518 179.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 170.6 -171.06 43.53 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.99 -33.97 88.68 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.446 ' O ' ' OD1' ' A' ' 124' ' ' ASP . 44.0 p-10 -86.93 120.02 27.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.719 0.295 . . . . 0.0 110.685 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.436 ' O ' HD12 ' A' ' 129' ' ' LEU . 39.5 t -63.05 143.9 57.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.005 0.431 . . . . 0.0 110.453 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.527 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -92.9 -42.92 9.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.871 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.5 tp -62.98 -42.44 99.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.667 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.51 -12.5 60.48 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.524 -179.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.436 HD12 ' O ' ' A' ' 125' ' ' SER . 85.2 mt -114.52 -24.02 9.02 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.696 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . 0.527 ' N ' ' O ' ' A' ' 126' ' ' ALA . 80.0 t80 -50.77 -49.68 57.59 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.634 -178.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 37.8 p-10 -66.14 -42.69 88.76 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.848 0.356 . . . . 0.0 111.22 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.522 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 88.3 mt-30 -66.98 -37.89 85.06 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.823 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.435 HD12 HD11 ' A' ' 118' ' ' ILE . 96.0 mt -80.21 -41.43 25.2 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.92 -179.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.2 t -57.14 -44.58 83.51 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.245 -179.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.0 m -61.65 -45.41 94.17 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.75 0.31 . . . . 0.0 110.562 179.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 94.1 mt -62.18 -43.56 98.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.291 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.661 ' HB1' ' HD2' ' A' ' 138' ' ' PRO . . . -169.34 168.46 4.9 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.556 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.661 ' HD2' ' HB1' ' A' ' 137' ' ' ALA . 52.9 Cg_exo -50.35 113.68 1.13 Allowed 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.256 1.971 . . . . 0.0 112.221 179.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.501 HG23 HD12 ' A' ' 118' ' ' ILE . 24.1 m -84.61 127.45 34.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.494 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.691 HD13 ' CD2' ' A' ' 37' ' ' HIS . 34.4 tp -117.93 135.88 53.84 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.107 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.442 ' O ' ' OD2' ' A' ' 32' ' ' ASP . 82.2 mt -99.61 118.71 46.62 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.31 0 CA-C-O 121.221 0.534 . . . . 0.0 111.179 -179.293 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.423 HD12 HD22 ' A' ' 117' ' ' LEU . 98.0 mt -134.99 132.18 53.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.617 179.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.545 HD21 ' CG ' ' A' ' 241' ' ' ASP . 61.3 t30 -66.9 151.5 47.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.911 0.386 . . . . 0.0 110.436 179.414 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.519 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 88.0 t80 -86.54 122.63 30.75 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.847 -179.532 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.519 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 99.1 m-20 55.23 69.17 0.76 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.769 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 35.7 p-10 -125.81 0.4 7.38 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.637 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -150.71 115.47 5.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.706 -179.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 83.5 p -63.3 168.18 4.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.534 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.417 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.4 p-90 -51.61 -15.72 0.5 Allowed 'General case' 0 C--O 1.223 -0.315 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.494 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . 0.448 ' O ' HG23 ' A' ' 154' ' ' THR . 68.2 tp60 -70.8 -75.54 0.12 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.51 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.455 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.0 t -62.76 -38.71 91.63 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.28 179.474 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 53.9 tp -60.02 -45.66 92.04 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.389 -178.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.417 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 46.6 tp -62.73 -41.63 99.27 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.473 178.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.455 ' OG1' ' O ' ' A' ' 151' ' ' SER . 59.7 p -63.89 -34.76 78.67 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.226 -179.521 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.441 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 88.0 mm-40 -64.07 -42.42 96.99 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.309 179.257 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 90.8 mt -65.39 -38.79 91.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.033 0.444 . . . . 0.0 110.178 179.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.581 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.2 -32.33 80.21 Favored Glycine 0 CA--C 1.52 0.348 0 N-CA-C 110.719 -0.952 . . . . 0.0 110.719 -179.302 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.441 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.2 mt-10 -35.93 -25.98 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.858 0.361 . . . . 0.0 110.806 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.581 ' N ' ' O ' ' A' ' 157' ' ' GLY . 95.6 mt -57.99 148.99 5.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.299 179.236 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 74.7 p -69.24 137.44 53.14 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.979 -179.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 70.77 22.16 78.11 Favored Glycine 0 N--CA 1.458 0.165 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 179.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 58.1 m80 -124.32 -14.46 6.95 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.695 0.283 . . . . 0.0 110.538 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -66.05 -59.92 3.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.649 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -52.0 -48.83 64.26 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.134 -179.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -60.52 -41.22 93.96 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.728 0.299 . . . . 0.0 110.321 179.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.61 -47.18 86.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.517 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.87 -40.1 75.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.246 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -61.7 -50.33 72.88 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.579 179.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 60.1 ttt85 -65.44 -43.73 89.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.54 179.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 94.9 mt -64.72 -43.37 96.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.486 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.38 -51.23 70.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.498 -179.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -63.57 -43.64 96.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.533 179.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . 0.652 ' CE2' HD11 ' A' ' 177' ' ' LEU . 56.6 t80 -62.9 -44.29 96.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.087 0.47 . . . . 0.0 110.442 179.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -63.65 -39.86 95.4 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.478 -179.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -62.89 -42.87 99.93 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.659 179.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -60.59 -44.7 95.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.207 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.652 HD11 ' CE2' ' A' ' 173' ' ' PHE . 84.2 mt -64.47 -41.05 96.73 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.994 0.425 . . . . 0.0 110.668 178.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.12 -62.18 1.8 Allowed 'General case' 0 C--O 1.237 0.431 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.382 -179.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.52 -46.78 86.05 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.578 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.24 -41.67 65.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.302 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -63.91 -33.67 76.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.393 179.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . 0.421 ' HG2' ' O ' ' A' ' 182' ' ' GLU . 69.5 tt0 -90.54 8.94 31.51 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.437 0.637 . . . . 0.0 110.491 -178.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -105.04 -32.07 8.89 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.174 179.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.8 pt -128.07 147.55 32.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.842 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -139.68 131.05 26.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.395 179.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . 0.593 HD22 ' N ' ' A' ' 186' ' ' LEU . 3.6 mm? -85.47 133.46 42.17 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.9 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -44.12 157.8 0.15 Allowed 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.738 2.292 . . . . 0.0 112.235 179.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . 0.518 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.5 Cg_endo -62.89 114.69 2.53 Favored 'Trans proline' 0 C--N 1.303 -1.82 0 C-N-CA 122.813 2.342 . . . . 0.0 111.748 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . 0.518 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.7 mt-30 155.69 147.88 0.0 OUTLIER Pre-proline 0 C--N 1.332 -0.169 0 O-C-N 123.713 0.633 . . . . 0.0 110.838 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -73.85 144.01 34.13 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.673 2.249 . . . . 0.0 112.012 177.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.496 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.0 p -124.78 158.95 31.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.296 0.569 . . . . 0.0 110.125 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . 0.496 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 37.5 p -143.46 165.39 27.68 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.048 -179.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . 0.443 ' HA ' ' H ' ' A' ' 260' ' ' PHE . . . -135.2 128.58 32.27 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.173 0.511 . . . . 0.0 110.264 179.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.516 HD11 HD23 ' A' ' 259' ' ' LEU . 47.9 pt -146.52 148.86 16.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.084 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . 0.75 HG13 ' CD1' ' A' ' 262' ' ' PHE . 68.8 t -117.73 123.06 71.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.312 0.577 . . . . 0.0 109.813 179.028 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -134.14 106.62 7.28 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.391 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 94.3 m -130.1 130.41 44.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.764 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -82.88 -36.81 25.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.259 179.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.56 -67.14 0.26 Allowed 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.361 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.28 -9.96 59.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.377 179.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 60.2 t-80 60.94 58.47 2.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.901 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 35.5 p -167.23 153.48 8.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.549 179.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.31 144.16 24.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.943 0.402 . . . . 0.0 110.485 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -135.34 138.16 43.12 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.669 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 19.5 mt -106.32 125.46 51.02 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.061 0.458 . . . . 0.0 109.842 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 206' ' ' TRP . . . . . 0.558 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 74.7 m95 -82.07 167.13 19.12 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.676 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . 0.468 HG22 ' C ' ' A' ' 206' ' ' TRP . 0.1 OUTLIER -156.9 171.14 7.83 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.595 -179.165 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.43 -37.15 81.67 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 C-N-CA 122.598 2.198 . . . . 0.0 112.219 179.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -70.56 -34.95 72.8 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.836 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 21.0 m -61.28 150.91 33.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.615 -179.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.61 -37.04 82.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.49 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 212' ' ' GLN . . . . . 0.558 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 54.7 tt0 -64.66 -40.33 95.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.579 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.52 -43.46 92.27 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -63.29 -43.73 97.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.81 0.338 . . . . 0.0 110.288 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 215' ' ' MET . . . . . 0.531 ' SD ' ' HB2' ' A' ' 304' ' ' ALA . 65.1 ttp -59.4 -48.12 82.84 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.26 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 88.4 mt -60.49 -40.94 93.13 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 217' ' ' GLU . . . . . 0.454 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.0 tp10 -57.97 -37.74 74.75 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -65.31 -38.08 89.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.787 0.327 . . . . 0.0 110.652 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 94.7 mt -64.27 -42.71 96.32 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.58 -179.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.52 44.73 0.08 OUTLIER Glycine 0 CA--C 1.52 0.392 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 221' ' ' PHE . . . . . 0.454 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 26.5 m-85 -127.78 155.47 44.01 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.075 0.464 . . . . 0.0 110.522 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.486 ' O ' HG13 ' A' ' 191' ' ' VAL . 6.7 p -107.1 122.25 46.11 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.266 0.555 . . . . 0.0 110.122 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.47 HD22 ' C ' ' A' ' 222' ' ' THR . 4.3 mm? -101.17 133.15 46.15 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.056 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -97.01 159.34 14.96 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.467 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.32 115.42 30.24 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.954 0.407 . . . . 0.0 110.344 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.503 ' N ' HD12 ' A' ' 226' ' ' LEU . 8.8 mp -53.42 156.51 4.18 Favored Pre-proline 0 N--CA 1.452 -0.328 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.696 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -60.02 145.2 98.94 Favored 'Trans proline' 0 C--N 1.301 -1.929 0 C-N-CA 122.682 2.254 . . . . 0.0 112.163 179.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.25 -2.98 59.01 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.605 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.39 -40.83 5.63 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . 0.539 ' O ' ' N ' ' A' ' 233' ' ' SER . 86.2 mt -79.07 -16.98 56.01 Favored 'General case' 0 C--O 1.222 -0.373 0 CA-C-O 121.069 0.461 . . . . 0.0 110.334 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . 0.404 ' C ' ' O ' ' A' ' 230' ' ' LEU . 53.9 t-20 -40.21 -49.12 2.66 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.732 -179.469 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -88.17 15.35 7.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.255 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . 0.539 ' N ' ' O ' ' A' ' 230' ' ' LEU . 78.0 p -60.49 -35.68 76.51 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.712 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . 0.524 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.5 tt0 -118.35 -69.34 0.86 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.894 179.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.2 m -69.98 103.68 2.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.093 0.473 . . . . 0.0 110.691 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -94.88 57.54 2.13 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.366 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -144.92 -122.61 1.57 Allowed Glycine 0 CA--C 1.52 0.346 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -134.4 111.93 10.56 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 121.132 0.491 . . . . 0.0 110.368 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . 0.512 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.5 mtt180 -148.32 57.52 1.07 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.792 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -69.91 -31.87 69.88 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.539 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 241' ' ' ASP . . . . . 0.545 ' CG ' HD21 ' A' ' 143' ' ' ASN . 64.7 t0 -56.92 -46.93 81.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.33 -179.135 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 242' ' ' ILE . . . . . 0.436 ' O ' ' O ' ' A' ' 239' ' ' ARG . 17.4 tt -140.16 156.92 25.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.9 0.381 . . . . 0.0 110.533 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.439 HG22 HD13 ' A' ' 245' ' ' LEU . 96.1 mt -106.0 106.19 20.11 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.214 0 CA-C-O 121.163 0.506 . . . . 0.0 110.529 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . 0.604 ' O ' HD12 ' A' ' 245' ' ' LEU . 88.3 mt-30 -110.37 110.26 20.98 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.42 179.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.604 HD12 ' O ' ' A' ' 244' ' ' GLN . 9.5 mp -121.97 -168.25 1.68 Allowed 'General case' 0 C--O 1.226 -0.177 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.605 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . 0.524 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.37 -16.7 0.05 OUTLIER Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . 0.67 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -60.49 157.05 29.84 Favored Glycine 0 CA--C 1.522 0.477 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -63.8 21.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.879 0.371 . . . . 0.0 110.548 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . 0.67 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.9 m-20 -96.95 -5.97 36.69 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.499 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 92.8 mt -79.88 -21.68 43.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.671 179.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.51 -51.17 71.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.784 -179.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.56 -5.52 58.14 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.473 179.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.36 -74.4 1.15 Allowed Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 81.4 mt -69.98 125.77 27.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.011 0.434 . . . . 0.0 110.332 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -59.26 -39.5 83.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.212 -179.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 82.65 51.93 4.11 Favored Glycine 0 CA--C 1.52 0.404 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -96.48 -14.49 22.31 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.712 0.292 . . . . 0.0 110.581 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 258' ' ' SER . . . . . 0.494 ' OG ' HG23 ' A' ' 191' ' ' VAL . 3.5 t 174.58 88.36 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.037 0.446 . . . . 0.0 110.165 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.86 ' N ' HD12 ' A' ' 259' ' ' LEU . 0.9 OUTLIER -94.2 123.98 37.93 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.183 0.516 . . . . 0.0 111.088 -179.1 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 260' ' ' PHE . . . . . 0.443 ' H ' ' HA ' ' A' ' 193' ' ' ALA . 15.9 m-30 -92.97 146.24 23.77 Favored 'General case' 0 CA--C 1.505 -0.786 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.428 179.295 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 86.7 mt -122.21 149.96 42.93 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.628 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.75 ' CD1' HG13 ' A' ' 195' ' ' VAL . 2.6 p90 -77.53 -138.23 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.619 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 263' ' ' ALA . . . . . 0.66 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -52.43 77.44 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.01 0.433 . . . . 0.0 111.074 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . 0.624 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -178.93 104.42 0.19 Allowed Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.666 -0.974 . . . . 0.0 110.666 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 265' ' ' ASP . . . . . 0.601 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.9 m-20 -80.45 -177.8 6.37 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 120.643 0.259 . . . . 0.0 110.862 -179.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -40.41 -17.62 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.548 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 267' ' ' LYS . . . . . 0.601 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.48 -51.66 40.98 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 120.998 0.428 . . . . 0.0 110.687 179.386 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -63.64 -46.72 84.4 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.212 179.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . 0.573 ' HB1' ' OH ' ' A' ' 273' ' ' TYR . . . -61.64 -35.08 76.89 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.218 0.532 . . . . 0.0 109.84 179.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -63.11 -34.09 76.85 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.045 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.73 -43.37 13.43 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.175 -179.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 272' ' ' ILE . . . . . 0.587 ' C ' ' H ' ' A' ' 274' ' ' ALA . 4.9 tt -51.43 -33.53 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.815 -178.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 273' ' ' TYR . . . . . 0.573 ' OH ' ' HB1' ' A' ' 269' ' ' ALA . 17.2 m-85 -54.49 -1.74 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.681 -179.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 274' ' ' ALA . . . . . 0.587 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.55 -39.61 70.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.842 179.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . 0.583 ' O ' ' N ' ' A' ' 279' ' ' ALA . 3.1 p30 -39.32 98.06 0.16 Allowed Pre-proline 0 C--O 1.226 -0.144 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.495 -179.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -54.29 -42.92 63.26 Favored 'Trans proline' 0 C--N 1.303 -1.856 0 C-N-CA 122.385 2.056 . . . . 0.0 112.533 -178.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 88.8 mt -64.46 -42.84 95.71 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.103 0.478 . . . . 0.0 111.138 -179.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 90.6 mt -95.67 -1.68 49.62 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.887 -179.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 279' ' ' ALA . . . . . 0.583 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.38 -34.81 77.44 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.668 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.29 20.26 0.11 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.968 -179.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . 0.488 HD23 ' HA ' ' A' ' 281' ' ' LEU . 13.8 mt -75.47 119.89 79.11 Favored Pre-proline 0 N--CA 1.451 -0.423 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.56 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -50.49 -39.41 54.9 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 122.66 2.24 . . . . 0.0 111.951 178.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.75 -50.55 63.25 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.149 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 78.8 t -61.4 -44.02 97.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 179.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -57.74 -41.15 81.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.252 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -90.98 -0.03 57.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.2 179.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt 59.47 43.58 16.05 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.872 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -94.81 41.41 1.09 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.387 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 53.8 t -119.08 135.8 58.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.047 0.451 . . . . 0.0 110.173 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -133.01 162.56 31.37 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.645 -179.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.7 155.11 33.06 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.943 0.401 . . . . 0.0 110.754 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 81.4 mt -93.91 -1.43 54.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.302 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.38 165.93 12.77 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 6.5 m -87.61 -62.39 1.51 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.888 0.375 . . . . 0.0 110.945 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 295' ' ' GLU . . . . . 0.434 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.5 mm-40 -69.54 -3.83 16.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.645 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 27.2 p -76.94 33.27 0.14 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.663 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 297' ' ' PHE . . . . . 0.532 ' CD2' HG22 ' A' ' 70' ' ' THR . 85.1 t80 -60.21 -46.01 91.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.618 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . 0.595 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.2 mtt85 -81.71 134.6 35.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.584 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.456 ' H ' HG11 ' A' ' 51' ' ' VAL . 16.3 tp -114.27 119.07 35.73 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-O 121.006 0.431 . . . . 0.0 110.19 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . 0.626 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.9 p-10 -166.52 -175.09 3.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.577 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 81.5 t80 -47.78 -44.72 28.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.292 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -65.59 -41.16 93.14 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.021 0.438 . . . . 0.0 110.701 178.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . 0.626 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 54.0 p -55.58 -36.16 66.56 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.042 -179.219 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . 0.531 ' HB2' ' SD ' ' A' ' 215' ' ' MET . . . -57.07 -51.65 68.43 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 90.9 mtp -56.23 -43.87 79.03 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -66.29 -42.68 88.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.029 0.442 . . . . 0.0 110.284 178.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 303' ' ' SER . 55.8 t -64.08 -42.75 96.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.208 179.377 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 42.6 tp -59.57 -42.2 91.91 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.816 -179.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -62.72 -38.83 92.04 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.148 179.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 310' ' ' ARG . . . . . 0.439 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.6 ttt85 -63.33 -44.09 95.89 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.216 179.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 88.3 mt -63.24 -42.06 99.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.255 179.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -62.85 -33.03 74.4 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.124 179.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -90.17 -23.32 21.35 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.352 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . 0.479 HD22 ' CE2' ' A' ' 315' ' ' PHE . 6.8 tt -62.33 -43.23 99.3 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 121.041 0.448 . . . . 0.0 110.531 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 315' ' ' PHE . . . . . 0.479 ' CE2' HD22 ' A' ' 314' ' ' LEU . 91.7 m-85 . . . . . 0 C--O 1.22 -0.453 0 CA-C-O 117.97 -1.014 . . . . 0.0 110.436 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -99.8 135.81 40.66 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.114 0.483 . . . . 0.0 110.503 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.497 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -91.63 178.7 1.64 Allowed Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.53 -179.857 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.497 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.4 Cg_exo -61.62 147.67 94.82 Favored 'Trans proline' 0 C--N 1.3 -2.023 0 C-N-CA 122.901 2.401 . . . . 0.0 112.113 179.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.486 ' HE ' HD12 ' A' ' 39' ' ' LEU . 35.1 ptt180 -135.02 142.16 46.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.64 179.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -78.93 116.95 19.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.51 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.422 ' O ' HG23 ' A' ' 30' ' ' ILE . 9.6 tp -110.53 131.27 62.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.445 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.9 t -70.84 142.93 51.24 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.655 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 141' ' ' ILE . 24.6 t70 -141.05 177.36 8.11 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.468 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.3 p -73.15 -36.75 66.7 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.696 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -47.68 -95.01 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.303 -179.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -165.95 -25.28 0.02 OUTLIER Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 58.2 m -168.93 106.74 0.43 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.862 0.363 . . . . 0.0 110.632 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.581 ' CD2' HD13 ' A' ' 140' ' ' LEU . 36.4 t60 -129.79 144.49 51.33 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 121.066 0.46 . . . . 0.0 110.114 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.63 HG22 ' N ' ' A' ' 39' ' ' LEU . 97.2 m -128.59 166.63 18.49 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.49 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.63 ' N ' HG22 ' A' ' 38' ' ' THR . 82.2 mt -121.15 127.8 51.9 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.43 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -64.17 -44.48 91.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.716 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 37.9 p -165.55 155.03 12.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.387 179.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.53 ' H ' ' CD ' ' A' ' 42' ' ' GLN . 14.4 mp0 -42.71 100.28 0.22 Allowed Pre-proline 0 C--N 1.33 -0.261 0 O-C-N 123.352 0.408 . . . . 0.0 110.594 179.261 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -56.88 129.07 32.59 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 122.313 2.008 . . . . 0.0 112.239 -179.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -83.82 -24.13 31.1 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.552 179.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.541 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.5 mtm-85 -121.18 134.11 55.2 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.202 0.525 . . . . 0.0 110.192 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.0 mt -130.43 133.51 63.68 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.272 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.798 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 47.5 t -125.0 130.89 73.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 179.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.601 ' OG ' HD12 ' A' ' 117' ' ' LEU . 5.0 m -154.05 166.48 32.89 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.586 179.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 70.0 p -124.83 8.37 8.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.435 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.81 125.87 33.59 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.643 -179.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.46 HG11 ' H ' ' A' ' 299' ' ' LEU . 86.5 t -65.7 -44.61 93.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.543 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.7 m -62.62 -44.15 97.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.561 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 53.5 tp -62.38 -41.58 98.74 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.534 -179.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.452 ' O ' HD13 ' A' ' 58' ' ' LEU . 72.5 m -57.83 -44.42 86.45 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.267 -179.198 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.4 -62.17 5.34 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 179.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.6 t -48.18 -35.62 12.08 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.8 mt -61.86 -44.34 97.01 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.229 179.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.464 HD21 HE22 ' A' ' 85' ' ' GLN . 9.2 mp -65.43 -41.49 93.48 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.246 178.025 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.406 ' HB1' ' NE ' ' A' ' 169' ' ' ARG . . . -63.58 -41.13 98.4 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.906 -179.243 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.422 ' O ' HG23 ' A' ' 60' ' ' ILE . 8.0 tp -88.21 16.73 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.857 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 56.51 84.34 0.09 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.753 -179.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.24 57.98 0.07 OUTLIER Pre-proline 0 C--N 1.328 -0.359 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -179.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.421 ' HB3' HE21 ' A' ' 85' ' ' GLN . 9.3 Cg_endo -51.13 153.39 9.31 Favored 'Trans proline' 0 C--N 1.293 -2.351 0 C-N-CA 123.029 2.486 . . . . 0.0 112.11 -178.175 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.429 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -109.06 146.01 15.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.332 -179.681 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 97.0 mt -63.62 -45.48 97.43 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.338 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.502 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -129.8 134.58 47.66 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.519 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.482 ' O ' ' N ' ' A' ' 98' ' ' LEU . 73.3 m -134.57 158.82 43.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.838 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.99 139.36 16.17 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.496 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.93 -162.66 0.08 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.967 0.413 . . . . 0.0 110.423 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.52 HG22 ' CD2' ' A' ' 297' ' ' PHE . 13.8 t -133.45 135.49 44.58 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.389 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.482 ' C ' ' O ' ' A' ' 70' ' ' THR . 0.7 OUTLIER 29.72 68.94 0.64 Allowed Pre-proline 0 N--CA 1.466 0.354 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.729 -179.883 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_exo -61.52 145.39 97.9 Favored 'Trans proline' 0 C--N 1.3 -2.026 0 C-N-CA 122.714 2.276 . . . . 0.0 111.837 -178.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.527 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 46.4 p-10 -160.49 -31.96 0.06 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.742 179.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.533 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 99.1 m-20 -64.51 -39.21 93.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.317 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 -60.63 -48.09 83.32 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.52 -179.133 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.426 ' O ' ' O ' ' A' ' 77' ' ' ALA . 94.0 t -60.19 -24.9 31.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.373 -0.376 . . . . 0.0 109.999 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.533 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -45.45 172.69 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.648 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.568 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.7 p30 -61.67 177.57 0.4 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.513 -179.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.566 ' C ' ' H ' ' A' ' 81' ' ' GLY . 36.0 p30 -46.27 85.65 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.005 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.568 ' N ' ' O ' ' A' ' 78' ' ' ASP . 42.8 tp60 -67.08 13.54 0.06 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.194 0.521 . . . . 0.0 110.169 -179.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.566 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 117.87 -21.93 10.13 Favored Glycine 0 N--CA 1.461 0.309 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -107.83 116.29 31.69 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.985 0.422 . . . . 0.0 110.466 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 75.7 mt -98.84 0.79 44.99 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.502 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -91.94 6.5 46.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.019 0.438 . . . . 0.0 110.397 -179.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.783 ' O ' HG22 ' A' ' 89' ' ' VAL . 88.2 mt-30 -100.16 -27.0 13.75 Favored 'General case' 0 C--O 1.222 -0.385 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.78 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.4 t-105 -64.31 -40.64 96.34 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.021 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.551 ' O ' ' N ' ' A' ' 91' ' ' LYS . 68.5 m -77.75 -53.75 7.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.164 -179.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -48.33 -50.55 29.91 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.08 -179.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.783 HG22 ' O ' ' A' ' 85' ' ' GLN . 14.8 m -69.08 -40.88 81.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 120.9 0.381 . . . . 0.0 111.113 179.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.503 ' N ' HG23 ' A' ' 89' ' ' VAL . . . -71.94 -22.82 61.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.655 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.551 ' N ' ' O ' ' A' ' 87' ' ' SER . 65.8 tttm -61.64 -46.13 91.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.428 -179.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.441 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.8 mm-40 -90.15 -94.44 0.12 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.152 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.62 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.9 mtt180 -143.49 59.79 1.39 Allowed 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.451 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.6 pttp 33.87 26.28 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.017 0.437 . . . . 0.0 110.286 -179.405 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.62 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.5 tt -48.27 123.14 6.03 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.011 -177.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.452 ' O ' HD23 ' A' ' 95' ' ' LEU . 99.0 mm-40 -83.41 -170.6 3.13 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.148 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.62 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 82.5 mtp180 -73.12 137.85 45.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.308 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.482 ' N ' ' O ' ' A' ' 67' ' ' SER . 88.7 mt -86.58 -166.14 1.47 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.793 -179.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.532 ' CD2' ' O ' ' A' ' 99' ' ' TYR . 47.8 p90 -167.89 119.9 0.86 Allowed 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.198 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.5 ' C ' ' O ' ' A' ' 99' ' ' TYR . 43.4 mm -29.44 121.18 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.005 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 113.64 28.25 3.28 Favored Glycine 0 CA--C 1.519 0.342 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 -179.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.58 ' N ' ' CD ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -144.0 46.15 0.62 Allowed Pre-proline 0 C--N 1.323 -0.582 0 CA-C-O 121.013 0.435 . . . . 0.0 110.428 179.764 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 29.5 Cg_endo -62.29 143.87 94.55 Favored 'Trans proline' 0 C--N 1.295 -2.246 0 C-N-CA 122.684 2.256 . . . . 0.0 111.844 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.46 ' O ' HG23 ' A' ' 108' ' ' VAL . 26.8 t -173.13 120.69 0.36 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.319 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.37 -40.94 63.97 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.075 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -65.92 -39.86 90.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.814 -179.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.01 -39.64 94.56 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.771 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 104' ' ' SER . 69.0 t -67.72 -43.74 86.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.724 179.585 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.43 -39.29 92.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.446 -179.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.441 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.66 -23.71 63.29 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.496 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.549 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.3 mm-40 -91.39 5.13 50.53 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.722 -179.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.549 ' C ' ' O ' ' A' ' 111' ' ' GLN . 10.4 tpt 21.96 64.84 0.32 Allowed Pre-proline 0 N--CA 1.467 0.408 0 CA-C-O 120.934 0.397 . . . . 0.0 111.157 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.448 ' HG2' HD11 ' A' ' 116' ' ' ILE . 61.8 Cg_endo -79.45 169.59 18.43 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 123.023 2.482 . . . . 0.0 111.698 -177.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.491 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 98.9 m-20 -113.12 -44.07 3.31 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.022 179.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.3 tp -120.09 120.69 36.98 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.462 HD13 HD22 ' A' ' 133' ' ' LEU . 96.4 mt -118.24 130.87 72.46 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.342 0 CA-C-O 120.904 0.383 . . . . 0.0 110.962 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.601 HD12 ' OG ' ' A' ' 48' ' ' SER . 32.3 mt -105.77 132.71 51.56 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.04 0.448 . . . . 0.0 110.287 -179.413 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 97.9 mt -117.9 135.74 57.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.673 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 85.5 p -71.7 153.42 42.05 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.593 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.11 -50.2 74.62 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.635 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -149.34 153.8 38.0 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.52 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 169.88 -170.51 42.85 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -63.08 -35.14 91.68 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.453 ' O ' ' OD1' ' A' ' 124' ' ' ASP . 44.4 p-10 -87.75 119.52 28.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.834 0.349 . . . . 0.0 110.701 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.446 ' O ' HD12 ' A' ' 129' ' ' LEU . 41.1 t -63.47 144.51 56.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.406 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.61 -42.33 9.25 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.775 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.4 tp -62.86 -42.22 99.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.649 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.41 -11.11 59.18 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.441 -179.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.446 HD12 ' O ' ' A' ' 125' ' ' SER . 84.5 mt -114.92 -24.55 8.58 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.647 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . 0.519 ' N ' ' O ' ' A' ' 126' ' ' ALA . 80.8 t80 -51.37 -49.91 60.58 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.649 -178.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.8 p-10 -65.72 -41.91 91.7 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.879 0.371 . . . . 0.0 111.317 179.429 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.521 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 87.8 mt-30 -67.88 -37.16 81.43 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.847 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.462 HD22 HD13 ' A' ' 116' ' ' ILE . 93.7 mt -79.7 -42.37 24.81 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.987 -179.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.3 t -56.94 -44.96 83.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.298 -179.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.8 m -62.32 -45.58 92.6 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.58 179.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 92.9 mt -62.49 -44.03 98.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.391 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.613 ' HB1' ' HD2' ' A' ' 138' ' ' PRO . . . -169.86 164.2 6.39 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.598 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.613 ' HD2' ' HB1' ' A' ' 137' ' ' ALA . 74.3 Cg_exo -43.32 111.66 0.24 Allowed 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.507 2.138 . . . . 0.0 112.243 179.249 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.467 HG21 ' CD1' ' A' ' 130' ' ' TYR . 17.1 m -86.12 127.34 34.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.675 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.581 HD13 ' CD2' ' A' ' 37' ' ' HIS . 34.9 tp -119.48 137.48 53.76 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.107 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.423 ' O ' ' OD1' ' A' ' 32' ' ' ASP . 78.2 mt -104.82 120.74 55.79 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 CA-C-O 121.154 0.502 . . . . 0.0 111.213 -179.352 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.506 HD12 HD22 ' A' ' 117' ' ' LEU . 94.3 mt -136.44 132.55 49.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.576 179.543 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.55 HD21 ' CG ' ' A' ' 241' ' ' ASP . 56.1 t30 -64.47 151.65 43.77 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.941 0.4 . . . . 0.0 110.43 179.262 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.522 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 88.1 t80 -85.57 122.71 30.08 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.966 -179.492 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.522 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 99.0 m-20 54.95 69.44 0.73 Allowed 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.741 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 49.3 p-10 -123.87 0.07 8.56 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.844 0.354 . . . . 0.0 110.638 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -151.46 117.03 5.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.766 -179.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 85.1 p -62.91 167.6 4.59 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.558 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.409 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.5 p-90 -50.56 -15.69 0.29 Allowed 'General case' 0 C--O 1.223 -0.322 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.469 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . 0.445 ' O ' HG23 ' A' ' 154' ' ' THR . 68.0 tp60 -71.3 -74.57 0.15 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.496 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.448 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.2 t -62.75 -39.07 92.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.18 179.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 52.1 tp -60.08 -45.7 92.05 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.403 -178.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.409 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 46.8 tp -62.67 -41.64 99.19 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.529 178.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.448 ' OG1' ' O ' ' A' ' 151' ' ' SER . 53.4 p -64.02 -34.71 78.63 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.192 -179.425 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.48 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.8 mm-40 -63.82 -42.08 97.73 Favored 'General case' 0 C--O 1.226 -0.178 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.273 179.26 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 90.8 mt -65.44 -38.82 91.0 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.096 0.474 . . . . 0.0 110.203 179.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.567 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.46 -31.94 79.31 Favored Glycine 0 CA--C 1.52 0.353 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 -179.267 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.48 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.3 mt-10 -37.04 -25.17 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.818 0.342 . . . . 0.0 110.799 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.567 ' N ' ' O ' ' A' ' 157' ' ' GLY . 93.4 mt -59.79 149.63 6.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.323 179.285 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 76.5 p -68.99 137.26 53.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.935 -179.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 70.36 22.47 77.63 Favored Glycine 0 N--CA 1.459 0.184 0 N-CA-C 111.211 -0.756 . . . . 0.0 111.211 179.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 62.0 m80 -124.29 -14.63 6.92 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.681 0.276 . . . . 0.0 110.48 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -67.02 -59.41 3.5 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.628 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -51.78 -49.26 63.04 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.119 -179.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -60.7 -41.09 94.5 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.894 -0.322 . . . . 0.0 110.45 179.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.48 -47.69 84.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.567 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.53 -40.25 74.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.244 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -61.56 -50.1 74.01 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.631 179.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.406 ' NE ' ' HB1' ' A' ' 59' ' ' ALA . 59.9 ttt85 -65.3 -43.57 90.68 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.523 179.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 94.4 mt -64.61 -43.38 96.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.366 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.35 -51.41 69.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.378 -179.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -63.51 -43.69 96.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.614 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . 0.665 ' CE2' HD11 ' A' ' 177' ' ' LEU . 56.3 t80 -62.88 -44.32 96.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.077 0.465 . . . . 0.0 110.407 179.475 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -63.32 -39.61 95.04 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.659 -179.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -63.15 -42.78 99.5 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.55 179.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -60.76 -44.74 96.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.238 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.665 HD11 ' CE2' ' A' ' 173' ' ' PHE . 85.1 mt -64.66 -41.05 96.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.73 178.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.12 -62.21 1.78 Allowed 'General case' 0 C--O 1.238 0.479 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.37 -179.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.61 -46.66 86.54 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.58 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.27 -41.49 65.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.34 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -64.05 -33.78 76.54 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.011 0.434 . . . . 0.0 110.235 179.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . 0.417 ' HG2' ' O ' ' A' ' 182' ' ' GLU . 69.7 tt0 -90.76 8.86 32.51 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.538 0.685 . . . . 0.0 110.371 -178.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -104.73 -32.13 9.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.18 179.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.7 pt -127.96 147.69 32.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.807 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -139.98 131.23 26.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.428 179.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . 0.592 HD22 ' N ' ' A' ' 186' ' ' LEU . 3.5 mm? -85.38 133.15 42.95 Favored Pre-proline 0 N--CA 1.452 -0.358 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.077 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -43.78 157.86 0.13 Allowed 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.714 2.276 . . . . 0.0 112.316 179.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . 0.51 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.6 Cg_endo -62.91 114.84 2.6 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 C-N-CA 122.804 2.336 . . . . 0.0 111.746 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . 0.51 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.7 mt-30 155.63 147.69 0.0 OUTLIER Pre-proline 0 N--CA 1.457 -0.113 0 O-C-N 123.916 0.76 . . . . 0.0 110.825 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -73.48 144.18 35.81 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.672 2.248 . . . . 0.0 112.213 177.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.496 HG23 ' OG ' ' A' ' 258' ' ' SER . 2.1 p -124.96 158.97 32.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.319 0.581 . . . . 0.0 110.212 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . 0.492 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 35.8 p -143.28 165.11 28.38 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.034 -179.704 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . 0.448 ' HA ' ' H ' ' A' ' 260' ' ' PHE . . . -135.38 128.72 32.15 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 121.244 0.545 . . . . 0.0 110.281 179.395 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.511 HD11 HD23 ' A' ' 259' ' ' LEU . 47.5 pt -146.46 148.87 16.55 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.348 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.13 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . 0.749 HG13 ' CD1' ' A' ' 262' ' ' PHE . 69.0 t -117.59 123.23 71.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.32 0.581 . . . . 0.0 109.836 178.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -134.4 107.01 7.35 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.336 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 95.3 m -130.7 130.59 44.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.813 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.4 ' O ' ' N ' ' A' ' 201' ' ' HIS . . . -82.82 -37.04 25.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.21 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.33 -67.21 0.25 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.328 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.16 -9.84 58.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.299 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . 0.4 ' N ' ' O ' ' A' ' 198' ' ' ALA . 59.8 t-80 60.64 58.34 2.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.85 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 31.8 p -167.21 153.76 8.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.555 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.3 144.04 24.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.049 0.452 . . . . 0.0 110.398 179.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -135.18 138.01 43.23 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.714 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 19.7 mt -105.96 125.32 50.85 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.083 0.468 . . . . 0.0 109.843 -179.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 206' ' ' TRP . . . . . 0.554 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 74.6 m95 -81.98 166.98 19.35 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.543 -179.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . 0.465 HG22 ' C ' ' A' ' 206' ' ' TRP . 0.1 OUTLIER -157.21 171.24 7.7 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.581 -179.083 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.31 -36.92 80.28 Favored 'Trans proline' 0 C--N 1.302 -1.874 0 C-N-CA 122.612 2.208 . . . . 0.0 112.32 179.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -70.86 -35.02 72.21 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.713 -179.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 21.5 m -61.16 150.64 33.62 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.602 -179.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.68 -37.0 82.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.445 -179.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 212' ' ' GLN . . . . . 0.554 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 54.9 tt0 -64.7 -40.26 95.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.498 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.71 -43.44 91.87 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -63.11 -43.96 96.97 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.803 0.335 . . . . 0.0 110.283 179.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 215' ' ' MET . . . . . 0.541 ' SD ' ' HB2' ' A' ' 304' ' ' ALA . 65.1 ttp -59.26 -48.12 82.81 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.123 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 87.3 mt -60.52 -41.04 93.61 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 217' ' ' GLU . . . . . 0.451 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.0 tp10 -57.94 -37.89 74.93 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.059 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -65.34 -38.18 89.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.655 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 94.2 mt -64.08 -42.93 96.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.074 0.464 . . . . 0.0 110.596 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.89 44.74 0.08 OUTLIER Glycine 0 C--N 1.332 0.339 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 221' ' ' PHE . . . . . 0.451 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 26.3 m-85 -127.74 155.64 43.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.987 0.422 . . . . 0.0 110.498 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.483 ' O ' HG13 ' A' ' 191' ' ' VAL . 7.4 p -107.36 122.49 46.7 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.285 0.564 . . . . 0.0 110.132 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.476 HD22 ' C ' ' A' ' 222' ' ' THR . 4.3 mm? -101.64 132.7 47.18 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.101 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.4 159.95 14.67 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.476 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.55 115.36 30.11 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.348 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.494 ' N ' HD12 ' A' ' 226' ' ' LEU . 8.9 mp -53.37 156.7 3.94 Favored Pre-proline 0 N--CA 1.452 -0.36 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.725 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -59.91 145.1 99.13 Favored 'Trans proline' 0 C--N 1.301 -1.959 0 C-N-CA 122.688 2.259 . . . . 0.0 112.226 179.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.3 -3.14 59.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.584 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.14 -41.0 5.66 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 111.034 -0.827 . . . . 0.0 111.034 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . 0.524 ' O ' ' N ' ' A' ' 233' ' ' SER . 85.3 mt -79.12 -16.98 55.91 Favored 'General case' 0 C--O 1.22 -0.45 0 CA-C-O 121.062 0.458 . . . . 0.0 110.326 -179.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 54.5 t-20 -40.43 -49.06 2.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.77 -179.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -87.97 15.16 7.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.323 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . 0.524 ' N ' ' O ' ' A' ' 230' ' ' LEU . 77.9 p -60.43 -35.41 75.75 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.711 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . 0.526 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.6 tt0 -118.8 -69.36 0.85 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.901 179.329 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.2 m -69.95 102.88 2.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.707 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -94.31 57.72 2.35 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.339 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -144.71 -122.65 1.59 Allowed Glycine 0 CA--C 1.519 0.332 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -134.79 111.62 10.06 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.125 0.488 . . . . 0.0 110.371 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . 0.521 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.4 mtt180 -148.03 57.94 1.09 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.672 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -69.68 -31.88 70.18 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.538 179.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 241' ' ' ASP . . . . . 0.55 ' CG ' HD21 ' A' ' 143' ' ' ASN . 64.7 t0 -56.98 -47.09 81.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.328 -179.096 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 242' ' ' ILE . . . . . 0.435 ' O ' ' O ' ' A' ' 239' ' ' ARG . 17.6 tt -140.19 156.92 24.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.904 0.383 . . . . 0.0 110.475 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.442 HG22 HD13 ' A' ' 245' ' ' LEU . 96.2 mt -106.17 106.58 20.85 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.199 0 CA-C-O 121.097 0.475 . . . . 0.0 110.531 179.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . 0.596 ' O ' HD12 ' A' ' 245' ' ' LEU . 88.2 mt-30 -110.51 110.17 20.79 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.363 179.687 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.596 HD12 ' O ' ' A' ' 244' ' ' GLN . 9.5 mp -121.68 -168.33 1.68 Allowed 'General case' 0 C--O 1.224 -0.264 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.639 179.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . 0.526 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.61 -16.64 0.05 OUTLIER Glycine 0 CA--C 1.523 0.564 0 N-CA-C 110.999 -0.841 . . . . 0.0 110.999 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . 0.67 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -60.81 156.81 31.64 Favored Glycine 0 CA--C 1.522 0.476 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -63.73 21.79 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.012 0.434 . . . . 0.0 110.643 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . 0.67 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.7 m-20 -97.44 -5.97 34.94 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.515 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 92.2 mt -79.78 -21.71 44.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.769 179.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.51 -51.37 70.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.715 -179.527 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.37 -5.48 58.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.494 179.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.08 -74.39 1.14 Allowed Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 81.5 mt -70.0 125.98 28.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.908 0.385 . . . . 0.0 110.297 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -59.91 -39.07 84.16 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.208 -179.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 83.29 51.69 4.05 Favored Glycine 0 CA--C 1.521 0.423 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -95.2 -15.67 23.09 Favored 'General case' 0 C--N 1.331 -0.214 0 O-C-N 122.746 -0.267 . . . . 0.0 110.591 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 258' ' ' SER . . . . . 0.496 ' OG ' HG23 ' A' ' 191' ' ' VAL . 3.3 t 174.54 89.3 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.099 0.476 . . . . 0.0 110.1 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.856 ' N ' HD12 ' A' ' 259' ' ' LEU . 1.0 OUTLIER -94.4 124.24 38.3 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.206 0.527 . . . . 0.0 111.259 -179.072 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 260' ' ' PHE . . . . . 0.448 ' H ' ' HA ' ' A' ' 193' ' ' ALA . 15.9 m-30 -93.34 146.41 23.75 Favored 'General case' 0 CA--C 1.501 -0.917 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.395 179.315 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 85.9 mt -122.25 149.7 43.32 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.551 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.749 ' CD1' HG13 ' A' ' 195' ' ' VAL . 2.6 p90 -77.37 -138.69 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.666 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 263' ' ' ALA . . . . . 0.655 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -51.78 77.35 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 121.035 0.445 . . . . 0.0 111.174 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . 0.626 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.15 104.75 0.19 Allowed Glycine 0 CA--C 1.527 0.824 0 N-CA-C 110.554 -1.019 . . . . 0.0 110.554 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 265' ' ' ASP . . . . . 0.601 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.7 m-20 -80.34 -177.94 6.39 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.64 0.257 . . . . 0.0 110.928 -179.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -40.26 -17.73 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.576 179.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 267' ' ' LYS . . . . . 0.601 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.31 -51.74 41.34 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.71 179.287 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -63.55 -46.64 85.04 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.236 179.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . 0.572 ' HB1' ' OH ' ' A' ' 273' ' ' TYR . . . -61.66 -35.04 76.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.349 0.595 . . . . 0.0 109.843 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -63.09 -34.06 76.79 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.204 179.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.87 -43.28 13.39 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.108 -179.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 272' ' ' ILE . . . . . 0.586 ' C ' ' H ' ' A' ' 274' ' ' ALA . 4.8 tt -51.31 -33.48 14.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.737 -178.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 273' ' ' TYR . . . . . 0.572 ' OH ' ' HB1' ' A' ' 269' ' ' ALA . 17.1 m-85 -54.81 -1.72 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.665 -179.44 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 274' ' ' ALA . . . . . 0.586 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.65 -39.81 70.11 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.952 179.428 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . 0.58 ' O ' ' N ' ' A' ' 279' ' ' ALA . 3.2 p30 -39.02 98.05 0.16 Allowed Pre-proline 0 C--O 1.227 -0.124 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.474 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -54.48 -42.81 64.63 Favored 'Trans proline' 0 C--N 1.303 -1.862 0 C-N-CA 122.42 2.08 . . . . 0.0 112.543 -178.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 89.3 mt -64.4 -42.91 95.83 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.126 0.488 . . . . 0.0 111.158 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 91.2 mt -95.57 -1.77 49.78 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.874 -179.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 279' ' ' ALA . . . . . 0.58 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.25 -34.87 77.36 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.755 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.2 20.11 0.11 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.998 -179.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . 0.481 ' H ' ' C ' ' A' ' 279' ' ' ALA . 13.9 mt -75.2 119.69 78.16 Favored Pre-proline 0 N--CA 1.448 -0.545 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.688 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -49.97 -40.01 49.61 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.678 2.252 . . . . 0.0 112.238 178.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.56 -50.56 62.7 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.118 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 71.8 t -61.46 -43.82 97.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 110.04 -0.355 . . . . 0.0 110.04 179.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -57.84 -41.28 81.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.198 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -90.96 0.29 57.56 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.129 179.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt 59.47 43.04 16.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.844 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -94.49 41.51 1.09 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.429 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 53.8 t -119.03 135.62 58.87 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.156 0 CA-C-O 121.072 0.463 . . . . 0.0 110.111 -179.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -132.85 162.75 30.71 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.153 0.502 . . . . 0.0 110.629 -179.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.69 154.98 33.28 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.015 0.436 . . . . 0.0 110.699 -179.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 81.6 mt -93.96 -1.52 54.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.247 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.66 165.88 12.71 Favored Glycine 0 CA--C 1.521 0.45 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 6.5 m -87.8 -62.2 1.55 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.864 0.364 . . . . 0.0 111.008 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 295' ' ' GLU . . . . . 0.448 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.6 mm-40 -69.35 -4.08 16.78 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.701 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 27.0 p -76.46 32.8 0.13 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.645 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 297' ' ' PHE . . . . . 0.52 ' CD2' HG22 ' A' ' 70' ' ' THR . 85.7 t80 -60.39 -46.06 91.32 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.573 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . 0.62 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.2 mtt85 -81.45 135.06 35.62 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.569 -179.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.46 ' H ' HG11 ' A' ' 51' ' ' VAL . 17.0 tp -114.24 117.77 32.07 Favored 'General case' 0 C--O 1.231 0.085 0 CA-C-O 121.005 0.431 . . . . 0.0 110.182 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . 0.636 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.4 p-10 -165.42 -176.38 3.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.624 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 80.2 t80 -47.07 -43.39 20.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.348 -179.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -67.01 -40.49 87.3 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.024 0.44 . . . . 0.0 110.747 179.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . 0.636 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 60.3 p -55.71 -36.5 67.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.074 -179.193 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . 0.541 ' HB2' ' SD ' ' A' ' 215' ' ' MET . . . -57.08 -51.69 68.27 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 179.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 91.2 mtp -55.97 -43.92 78.01 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -66.2 -42.64 88.51 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.141 0.495 . . . . 0.0 110.257 179.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 303' ' ' SER . 55.4 t -64.15 -42.82 96.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.26 179.374 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 43.1 tp -59.74 -42.15 92.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.871 -179.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -62.63 -38.78 91.57 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.237 179.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 310' ' ' ARG . . . . . 0.45 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.6 ttt85 -63.56 -43.86 95.8 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.246 179.538 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 90.3 mt -63.0 -42.12 99.77 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.311 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -62.94 -33.16 74.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.113 179.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.97 -23.31 21.57 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.318 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . 0.481 HD22 ' CE2' ' A' ' 315' ' ' PHE . 6.7 tt -62.27 -43.19 99.4 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 121.055 0.455 . . . . 0.0 110.52 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 315' ' ' PHE . . . . . 0.481 ' CE2' HD22 ' A' ' 314' ' ' LEU . 91.2 m-85 . . . . . 0 C--O 1.22 -0.466 0 CA-C-O 118.055 -0.974 . . . . 0.0 110.405 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -99.63 136.43 39.58 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.016 0.436 . . . . 0.0 110.538 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.497 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -91.71 178.46 1.74 Allowed Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.58 -179.882 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.497 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.5 Cg_exo -61.69 147.5 95.18 Favored 'Trans proline' 0 C--N 1.3 -2.007 0 C-N-CA 122.778 2.318 . . . . 0.0 112.123 179.639 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.494 ' HE ' HD12 ' A' ' 39' ' ' LEU . 35.4 ptt180 -135.76 142.65 44.98 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.655 179.742 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -79.11 116.96 19.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.501 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.431 ' O ' HG23 ' A' ' 30' ' ' ILE . 9.6 tp -110.32 130.86 62.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.408 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 13.3 t -71.14 141.93 50.74 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.53 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.427 ' OD1' ' O ' ' A' ' 141' ' ' ILE . 25.1 t70 -139.87 177.88 7.65 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.517 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.0 p -73.73 -36.59 65.2 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.688 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.8 ttt85 -47.78 -95.25 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.269 -179.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -165.22 -26.06 0.02 OUTLIER Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 67.5 m -168.32 106.79 0.49 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.889 0.376 . . . . 0.0 110.652 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.56 ' CD2' HD13 ' A' ' 140' ' ' LEU . 33.4 t60 -129.71 143.56 50.88 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.027 0.442 . . . . 0.0 110.152 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.627 HG22 ' N ' ' A' ' 39' ' ' LEU . 97.5 m -128.18 166.12 19.13 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.636 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.627 ' N ' HG22 ' A' ' 38' ' ' THR . 81.1 mt -120.78 127.61 52.12 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.523 179.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -64.42 -44.26 91.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.656 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 41.5 p -165.68 154.84 11.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.424 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.478 ' H ' ' CD ' ' A' ' 42' ' ' GLN . 13.7 mp0 -43.42 100.69 0.23 Allowed Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.636 179.467 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -56.85 129.33 34.01 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 122.399 2.066 . . . . 0.0 112.262 -179.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -83.88 -23.95 31.05 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.45 179.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.544 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.3 mtm-85 -120.9 134.26 55.29 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 121.132 0.492 . . . . 0.0 110.202 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 95.9 mt -130.65 133.48 63.39 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.939 -179.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 49.1 t -125.05 131.06 73.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.825 0.345 . . . . 0.0 110.119 179.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.617 ' OG ' HD12 ' A' ' 117' ' ' LEU . 5.1 m -154.41 166.16 34.13 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.506 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 65.0 p -124.94 8.5 8.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.501 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.71 125.75 33.44 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.686 -179.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.457 HG11 ' H ' ' A' ' 299' ' ' LEU . 88.6 t -65.75 -44.65 93.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.47 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 20.0 m -62.53 -44.29 96.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.605 -179.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 51.2 tp -62.28 -41.51 98.55 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.572 -179.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.459 ' O ' HD13 ' A' ' 58' ' ' LEU . 70.6 m -57.67 -44.36 85.7 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.343 -179.313 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.48 -61.91 5.55 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.929 -0.869 . . . . 0.0 110.929 179.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.7 t -48.51 -35.67 13.64 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 20.0 mt -61.77 -44.72 96.33 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.661 -0.416 . . . . 0.0 111.126 179.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.459 HD13 ' O ' ' A' ' 54' ' ' THR . 9.2 mp -64.96 -41.8 95.16 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.189 178.024 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.405 ' HB1' ' NE ' ' A' ' 169' ' ' ARG . . . -63.62 -41.27 98.29 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.947 -179.152 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.429 ' O ' HG23 ' A' ' 60' ' ' ILE . 8.0 tp -88.13 16.7 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.771 -179.619 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 56.61 84.28 0.09 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.653 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.37 57.38 0.07 OUTLIER Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.058 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.413 ' HB3' HE21 ' A' ' 85' ' ' GLN . 9.7 Cg_endo -50.3 153.19 7.39 Favored 'Trans proline' 0 C--N 1.296 -2.199 0 C-N-CA 122.874 2.383 . . . . 0.0 112.388 -178.303 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.428 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.4 OUTLIER -109.03 146.38 14.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.367 -179.699 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 97.1 mt -63.79 -45.16 97.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.368 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.51 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -130.31 134.83 47.49 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.575 -179.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.464 ' O ' ' N ' ' A' ' 98' ' ' LEU . 73.8 m -134.52 158.73 43.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.843 -179.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.35 138.94 16.3 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.488 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.86 -162.7 0.08 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.996 0.427 . . . . 0.0 110.515 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.513 HG22 ' CD2' ' A' ' 297' ' ' PHE . 5.9 t -133.74 135.94 44.27 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.192 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.492 ' C ' ' O ' ' A' ' 70' ' ' THR . 1.0 OUTLIER 29.55 68.57 0.65 Allowed Pre-proline 0 N--CA 1.465 0.3 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.715 -179.7 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -61.25 144.57 98.8 Favored 'Trans proline' 0 C--N 1.301 -1.964 0 C-N-CA 122.668 2.245 . . . . 0.0 112.092 -178.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.519 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 45.7 p-10 -159.87 -31.61 0.06 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.717 179.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.537 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 98.7 m-20 -64.52 -38.92 92.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.46 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 73.2 ttt180 -60.87 -47.9 84.25 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.752 -179.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.422 ' O ' ' O ' ' A' ' 77' ' ' ALA . 94.6 t -60.36 -24.6 31.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.324 -0.398 . . . . 0.0 109.927 179.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.537 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -45.53 172.58 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.5 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.576 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.5 p30 -61.78 177.73 0.4 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.706 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.565 ' C ' ' H ' ' A' ' 81' ' ' GLY . 35.8 p30 -46.11 85.58 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.909 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.576 ' N ' ' O ' ' A' ' 78' ' ' ASP . 43.1 tp60 -67.01 13.62 0.06 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.139 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.565 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 117.78 -22.13 10.1 Favored Glycine 0 CA--C 1.52 0.355 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -107.94 116.52 32.11 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.016 0.436 . . . . 0.0 110.486 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 76.7 mt -98.83 0.86 45.16 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.453 -179.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -91.94 6.48 46.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.972 0.415 . . . . 0.0 110.388 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.79 ' O ' HG22 ' A' ' 89' ' ' VAL . 88.0 mt-30 -100.04 -27.27 13.65 Favored 'General case' 0 C--O 1.223 -0.29 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.77 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.5 t-105 -63.87 -40.78 97.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.015 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.555 ' O ' ' N ' ' A' ' 91' ' ' LYS . 67.7 m -77.63 -53.62 7.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.328 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -48.41 -50.85 29.36 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.972 -179.221 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.79 HG22 ' O ' ' A' ' 85' ' ' GLN . 15.1 m -68.89 -40.74 81.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 120.9 0.381 . . . . 0.0 110.984 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.498 ' N ' HG23 ' A' ' 89' ' ' VAL . . . -72.24 -22.59 61.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.704 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.555 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.0 tttm -61.47 -46.19 91.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.437 -179.545 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.438 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.6 mm-40 -90.32 -94.2 0.12 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.149 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.632 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.9 mtt180 -143.44 59.82 1.39 Allowed 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.461 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.6 pttp 33.69 26.18 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.259 -179.247 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.632 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.4 tt -47.87 123.23 5.8 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.969 -178.185 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.445 ' O ' HD23 ' A' ' 95' ' ' LEU . 98.8 mm-40 -83.51 -170.29 2.98 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.08 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.617 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 83.0 mtp180 -73.22 137.8 45.21 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.311 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.464 ' N ' ' O ' ' A' ' 67' ' ' SER . 87.9 mt -86.95 -166.03 1.46 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.721 -179.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.53 ' CD2' ' O ' ' A' ' 99' ' ' TYR . 48.0 p90 -168.06 120.31 0.86 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.236 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.509 ' C ' ' O ' ' A' ' 99' ' ' TYR . 43.5 mm -29.87 121.64 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.956 -179.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 113.72 28.12 3.31 Favored Glycine 0 CA--C 1.52 0.384 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 -179.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.589 ' H ' ' CD ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -143.98 45.87 0.6 Allowed Pre-proline 0 C--N 1.324 -0.536 0 CA-C-O 120.922 0.392 . . . . 0.0 110.43 179.867 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.584 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 29.8 Cg_endo -62.0 143.74 95.51 Favored 'Trans proline' 0 C--N 1.298 -2.109 0 C-N-CA 122.678 2.252 . . . . 0.0 112.004 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.462 ' O ' HG23 ' A' ' 108' ' ' VAL . 26.8 t -173.47 120.62 0.33 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.459 179.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.12 -41.1 64.36 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.089 0.471 . . . . 0.0 111.165 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -65.87 -40.06 91.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.792 -179.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.83 -39.89 95.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.698 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 104' ' ' SER . 69.6 t -67.66 -43.84 86.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.763 179.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.23 -39.46 92.89 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.566 -179.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.438 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.48 -23.5 62.81 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.469 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.561 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.3 mm-40 -91.35 4.99 51.02 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.755 -179.561 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.561 ' C ' ' O ' ' A' ' 111' ' ' GLN . 10.3 tpt 22.33 64.65 0.33 Allowed Pre-proline 0 N--CA 1.465 0.281 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.039 -179.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.453 ' HG2' HD11 ' A' ' 116' ' ' ILE . 67.9 Cg_endo -79.12 169.57 18.96 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 C-N-CA 122.957 2.438 . . . . 0.0 112.059 -178.395 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.485 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 99.0 m-20 -113.32 -44.16 3.27 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.172 179.399 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 41.3 tp -120.26 120.44 36.11 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.454 HD13 HD22 ' A' ' 133' ' ' LEU . 96.2 mt -117.96 131.24 71.29 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 CA-C-O 120.999 0.428 . . . . 0.0 110.884 -179.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.617 HD12 ' OG ' ' A' ' 48' ' ' SER . 31.4 mt -105.92 132.87 51.5 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.148 0.499 . . . . 0.0 110.204 -179.424 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.407 HD12 HG23 ' A' ' 139' ' ' THR . 97.8 mt -118.27 135.93 57.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.701 -179.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 85.9 p -72.09 153.74 41.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.613 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.19 -50.21 74.58 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.689 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -149.35 153.76 37.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.56 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 169.54 -170.0 42.39 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.82 -35.06 91.45 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.446 ' O ' ' OD1' ' A' ' 124' ' ' ASP . 44.1 p-10 -88.91 119.41 29.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.84 0.352 . . . . 0.0 110.7 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.449 ' O ' HD12 ' A' ' 129' ' ' LEU . 36.4 t -63.29 145.26 55.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.519 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.52 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.39 -43.8 8.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.958 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.4 tp -62.73 -42.34 99.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.73 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.49 -10.97 56.59 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.564 -179.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.449 HD12 ' O ' ' A' ' 125' ' ' SER . 83.9 mt -116.26 -23.59 8.33 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.651 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . 0.52 ' N ' ' O ' ' A' ' 126' ' ' ALA . 77.7 t80 -51.47 -49.6 61.46 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.674 -0.411 . . . . 0.0 110.567 -179.008 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.5 p-10 -65.83 -41.94 91.17 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.846 0.355 . . . . 0.0 111.109 179.554 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.526 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 88.1 mt-30 -67.82 -36.96 81.29 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.777 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.454 HD22 HD13 ' A' ' 116' ' ' ILE . 93.0 mt -80.27 -41.98 24.0 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.927 -179.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.2 t -57.5 -44.67 85.19 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.223 -179.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.2 m -62.3 -45.66 92.26 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.735 0.302 . . . . 0.0 110.596 179.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 91.8 mt -62.52 -43.86 98.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.406 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.598 ' HB1' ' HD2' ' A' ' 138' ' ' PRO . . . -170.1 163.51 6.32 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.506 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.598 ' HD2' ' HB1' ' A' ' 137' ' ' ALA . 78.5 Cg_exo -42.78 111.13 0.19 Allowed 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.469 2.112 . . . . 0.0 112.161 179.348 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.481 HG21 ' CD1' ' A' ' 130' ' ' TYR . 16.6 m -86.05 127.64 34.71 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.57 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.56 HD13 ' CD2' ' A' ' 37' ' ' HIS . 35.5 tp -119.99 138.39 53.51 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.032 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.427 ' O ' ' OD1' ' A' ' 32' ' ' ASP . 77.7 mt -105.57 120.66 56.7 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.358 0 CA-C-O 121.109 0.48 . . . . 0.0 111.291 -179.427 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.489 HD12 HD22 ' A' ' 117' ' ' LEU . 97.9 mt -135.93 132.69 50.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.627 179.602 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.533 HD21 ' CG ' ' A' ' 241' ' ' ASP . 61.0 t30 -64.42 150.87 45.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.939 0.399 . . . . 0.0 110.402 179.407 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.518 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 88.7 t80 -85.69 122.09 29.29 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.913 -179.513 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.518 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 98.8 m-20 55.63 69.01 0.78 Allowed 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.812 179.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 35.9 p-10 -125.4 0.01 7.63 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.683 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -150.64 115.61 5.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.76 -179.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 84.6 p -62.67 167.8 4.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.505 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.416 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.5 p-90 -51.09 -15.24 0.3 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.498 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . 0.445 ' O ' HG23 ' A' ' 154' ' ' THR . 68.1 tp60 -71.34 -75.01 0.14 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.475 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.45 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.2 t -62.78 -38.83 92.18 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.031 0.444 . . . . 0.0 110.305 179.506 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 52.6 tp -60.17 -45.56 92.68 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.42 -178.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.416 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 45.9 tp -62.8 -41.8 99.44 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.856 0.36 . . . . 0.0 110.375 179.068 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.45 ' OG1' ' O ' ' A' ' 151' ' ' SER . 57.8 p -63.95 -34.52 78.16 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.312 -179.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.471 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.6 mm-40 -64.1 -42.24 96.98 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.263 179.269 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 91.4 mt -65.45 -38.83 91.01 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.182 179.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.574 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.34 -31.82 78.62 Favored Glycine 0 CA--C 1.52 0.406 0 N-CA-C 110.846 -0.901 . . . . 0.0 110.846 -179.396 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.471 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.2 mt-10 -36.97 -25.1 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.809 0.338 . . . . 0.0 110.706 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.574 ' N ' ' O ' ' A' ' 157' ' ' GLY . 94.4 mt -59.94 149.59 6.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.317 179.473 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 76.8 p -68.91 137.14 53.58 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.059 -179.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 70.63 22.0 77.89 Favored Glycine 0 N--CA 1.459 0.177 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 179.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 60.4 m80 -123.72 -14.83 7.16 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.786 0.327 . . . . 0.0 110.507 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -66.96 -59.31 3.6 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.686 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -51.85 -49.4 62.94 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.188 -179.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -60.64 -41.21 94.48 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.803 0.335 . . . . 0.0 110.316 179.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.46 -47.45 85.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.589 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.59 -40.27 74.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.247 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -61.57 -50.1 73.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.578 179.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.405 ' NE ' ' HB1' ' A' ' 59' ' ' ALA . 59.9 ttt85 -65.47 -43.63 89.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.471 179.523 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 94.8 mt -64.46 -43.48 96.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.429 179.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.41 -51.16 70.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.525 -179.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.76 -43.78 95.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.375 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . 0.658 ' CE2' HD11 ' A' ' 177' ' ' LEU . 56.3 t80 -62.74 -44.53 95.97 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.069 0.462 . . . . 0.0 110.41 179.426 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -63.12 -39.8 95.76 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.611 -179.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -63.01 -42.8 99.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.617 179.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -60.69 -44.95 95.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.103 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.658 HD11 ' CE2' ' A' ' 173' ' ' PHE . 85.0 mt -64.52 -41.17 96.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.998 0.428 . . . . 0.0 110.642 178.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.02 -62.15 1.82 Allowed 'General case' 0 C--O 1.237 0.408 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.491 -179.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.86 -46.68 87.2 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.546 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.42 -41.66 66.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.176 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -63.91 -33.67 76.22 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.018 0.437 . . . . 0.0 110.387 179.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . 0.423 ' HG2' ' O ' ' A' ' 182' ' ' GLU . 69.6 tt0 -90.56 8.63 33.12 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.435 0.636 . . . . 0.0 110.56 -178.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -104.55 -32.0 9.17 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.183 179.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.9 pt -127.99 147.74 32.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.882 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -139.77 130.97 26.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.396 179.393 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . 0.595 HD22 ' N ' ' A' ' 186' ' ' LEU . 3.6 mm? -85.73 133.06 42.46 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.852 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -44.24 157.99 0.15 Allowed 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.747 2.298 . . . . 0.0 112.119 179.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . 0.524 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 28.1 Cg_endo -63.08 115.21 2.82 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 C-N-CA 122.736 2.291 . . . . 0.0 111.773 179.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . 0.524 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.7 mt-30 155.61 147.63 0.0 OUTLIER Pre-proline 0 N--CA 1.454 -0.241 0 O-C-N 123.57 0.544 . . . . 0.0 110.727 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -73.81 143.73 33.85 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.767 2.311 . . . . 0.0 111.88 178.082 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.497 HG23 ' OG ' ' A' ' 258' ' ' SER . 2.1 p -124.93 158.93 32.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.24 0.543 . . . . 0.0 110.124 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . 0.497 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 36.9 p -143.41 165.37 27.71 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.092 -179.669 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . 0.446 ' HA ' ' H ' ' A' ' 260' ' ' PHE . . . -135.63 128.55 31.31 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 121.207 0.527 . . . . 0.0 110.224 179.533 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.504 HD11 HD23 ' A' ' 259' ' ' LEU . 47.2 pt -146.44 149.1 16.34 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.096 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . 0.743 HG13 ' CD1' ' A' ' 262' ' ' PHE . 69.0 t -117.94 123.13 71.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.25 0.548 . . . . 0.0 109.767 179.11 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -134.24 107.41 7.66 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.252 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 94.7 m -131.33 130.51 42.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.823 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.404 ' O ' ' N ' ' A' ' 201' ' ' HIS . . . -82.93 -36.92 24.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.354 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.48 -66.88 0.28 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.331 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.35 -10.27 59.57 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.278 179.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . 0.404 ' N ' ' O ' ' A' ' 198' ' ' ALA . 60.0 t-80 61.42 58.16 2.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.715 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 39.4 p -167.09 153.55 8.29 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.552 179.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -150.97 143.63 24.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.46 179.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -135.04 138.03 43.51 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 120.926 0.393 . . . . 0.0 110.608 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 19.8 mt -106.16 125.39 50.94 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 121.057 0.456 . . . . 0.0 109.892 -179.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 206' ' ' TRP . . . . . 0.554 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 74.6 m95 -81.88 166.78 19.63 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.564 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . 0.463 HG22 ' C ' ' A' ' 206' ' ' TRP . 0.1 OUTLIER -156.86 172.06 6.62 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.022 0.439 . . . . 0.0 110.505 -179.196 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.21 -36.85 87.23 Favored 'Trans proline' 0 C--N 1.303 -1.821 0 C-N-CA 122.624 2.216 . . . . 0.0 112.099 179.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -70.71 -34.84 72.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.822 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 21.3 m -61.3 150.68 34.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.642 -179.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.72 -36.92 82.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.472 -179.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 212' ' ' GLN . . . . . 0.554 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 55.0 tt0 -64.58 -40.37 95.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.491 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.71 -43.4 91.96 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -63.35 -43.8 96.66 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.924 -0.31 . . . . 0.0 110.294 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 215' ' ' MET . . . . . 0.538 ' SD ' ' HB2' ' A' ' 304' ' ' ALA . 65.1 ttp -59.53 -47.94 83.59 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.269 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 87.1 mt -60.61 -40.84 93.33 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 217' ' ' GLU . . . . . 0.453 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 40.9 tp10 -57.93 -38.03 75.17 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -65.35 -37.98 88.7 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.77 0.319 . . . . 0.0 110.672 179.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 94.4 mt -64.3 -42.69 96.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.521 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.51 45.07 0.08 OUTLIER Glycine 0 C--N 1.334 0.419 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 221' ' ' PHE . . . . . 0.453 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 26.1 m-85 -128.04 155.78 43.8 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.05 0.452 . . . . 0.0 110.467 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.484 ' O ' HG13 ' A' ' 191' ' ' VAL . 7.2 p -107.66 122.57 46.99 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.3 0.572 . . . . 0.0 110.182 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.476 HD22 ' C ' ' A' ' 222' ' ' THR . 4.3 mm? -101.58 132.72 47.09 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.049 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.38 160.14 14.57 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.535 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -105.55 115.13 29.72 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.973 0.416 . . . . 0.0 110.294 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.498 ' N ' HD12 ' A' ' 226' ' ' LEU . 9.0 mp -52.95 156.82 3.18 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.673 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -60.41 145.37 98.81 Favored 'Trans proline' 0 C--N 1.301 -1.945 0 C-N-CA 122.657 2.238 . . . . 0.0 112.075 179.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.22 -3.47 59.05 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.51 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -89.97 -41.19 5.66 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . 0.535 ' O ' ' N ' ' A' ' 233' ' ' SER . 68.2 mt -78.78 -17.54 55.59 Favored 'General case' 0 C--O 1.223 -0.319 0 CA-C-O 120.998 0.428 . . . . 0.0 110.377 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . 0.403 ' C ' ' O ' ' A' ' 230' ' ' LEU . 54.7 t-20 -40.19 -49.34 2.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.789 -179.389 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -87.8 15.32 7.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.258 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . 0.535 ' N ' ' O ' ' A' ' 230' ' ' LEU . 78.2 p -60.36 -35.61 76.09 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.645 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . 0.525 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.6 tt0 -119.02 -69.26 0.86 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.963 179.607 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.2 m -69.89 102.76 2.04 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.733 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -94.45 57.64 2.29 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.055 0.455 . . . . 0.0 110.364 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -144.65 -122.68 1.59 Allowed Glycine 0 CA--C 1.52 0.364 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -134.86 111.4 9.85 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 121.067 0.46 . . . . 0.0 110.433 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . 0.521 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.6 mtt180 -147.95 58.06 1.1 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.762 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -69.77 -32.31 70.74 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.533 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 241' ' ' ASP . . . . . 0.533 ' CG ' HD21 ' A' ' 143' ' ' ASN . 65.0 t0 -56.86 -46.95 81.44 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.395 -179.093 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 242' ' ' ILE . . . . . 0.434 ' O ' ' O ' ' A' ' 239' ' ' ARG . 18.0 tt -139.93 156.74 25.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.926 0.393 . . . . 0.0 110.492 179.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.448 HG22 HD13 ' A' ' 245' ' ' LEU . 96.0 mt -106.36 106.7 21.1 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.214 0 CA-C-O 121.208 0.528 . . . . 0.0 110.489 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . 0.604 ' O ' HD12 ' A' ' 245' ' ' LEU . 88.3 mt-30 -110.48 110.14 20.76 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.331 179.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.604 HD12 ' O ' ' A' ' 244' ' ' GLN . 9.4 mp -121.81 -168.48 1.71 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.577 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . 0.525 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.9 -16.27 0.05 OUTLIER Glycine 0 CA--C 1.524 0.614 0 N-CA-C 111.039 -0.824 . . . . 0.0 111.039 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . 0.674 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -61.17 156.42 33.77 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -63.45 21.81 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.933 0.397 . . . . 0.0 110.617 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . 0.674 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.8 m-20 -97.35 -6.14 34.87 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.523 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 92.1 mt -79.52 -22.15 44.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.677 179.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.55 -51.26 70.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.711 -179.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.23 -5.76 58.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.48 179.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.02 -74.59 1.13 Allowed Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.909 -0.876 . . . . 0.0 110.909 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 83.0 mt -69.82 125.94 28.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.023 0.44 . . . . 0.0 110.234 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -59.32 -39.44 83.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.178 -179.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 83.1 51.82 4.04 Favored Glycine 0 CA--C 1.521 0.433 0 N-CA-C 110.814 -0.914 . . . . 0.0 110.814 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -95.94 -14.89 22.73 Favored 'General case' 0 C--N 1.33 -0.266 0 O-C-N 122.701 -0.293 . . . . 0.0 110.616 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 258' ' ' SER . . . . . 0.497 ' OG ' HG23 ' A' ' 191' ' ' VAL . 3.4 t 174.34 88.85 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.047 0.451 . . . . 0.0 110.177 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.862 ' N ' HD12 ' A' ' 259' ' ' LEU . 0.9 OUTLIER -94.18 124.02 37.93 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.223 0.535 . . . . 0.0 111.086 -179.104 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 260' ' ' PHE . . . . . 0.446 ' H ' ' HA ' ' A' ' 193' ' ' ALA . 16.0 m-30 -93.12 146.48 23.63 Favored 'General case' 0 CA--C 1.508 -0.664 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.343 179.251 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 86.0 mt -122.35 149.83 43.24 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.629 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.743 ' CD1' HG13 ' A' ' 195' ' ' VAL . 2.6 p90 -77.65 -138.49 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.468 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 263' ' ' ALA . . . . . 0.661 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -52.03 77.54 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 121.04 0.448 . . . . 0.0 111.055 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . 0.632 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.03 104.71 0.19 Allowed Glycine 0 CA--C 1.526 0.724 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 265' ' ' ASP . . . . . 0.606 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.7 m-20 -80.57 -177.79 6.41 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 120.676 0.274 . . . . 0.0 110.92 -179.477 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -40.42 -17.69 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.891 0.377 . . . . 0.0 110.521 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 267' ' ' LYS . . . . . 0.606 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.33 -51.62 42.52 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.73 179.397 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -63.7 -46.54 84.99 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.223 179.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . 0.575 ' HB1' ' OH ' ' A' ' 273' ' ' TYR . . . -61.71 -35.11 77.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.856 179.52 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -63.07 -34.41 77.52 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.115 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.48 -43.07 13.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.231 -179.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 272' ' ' ILE . . . . . 0.587 ' C ' ' H ' ' A' ' 274' ' ' ALA . 4.9 tt -51.58 -33.72 15.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.827 -178.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 273' ' ' TYR . . . . . 0.575 ' OH ' ' HB1' ' A' ' 269' ' ' ALA . 17.1 m-85 -54.44 -1.71 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.738 -179.568 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 274' ' ' ALA . . . . . 0.587 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.8 -39.54 69.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.927 179.503 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . 0.582 ' O ' ' N ' ' A' ' 279' ' ' ALA . 3.2 p30 -39.52 98.02 0.16 Allowed Pre-proline 0 N--CA 1.461 0.103 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.562 -179.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -54.03 -43.02 61.99 Favored 'Trans proline' 0 C--N 1.304 -1.807 0 C-N-CA 122.372 2.048 . . . . 0.0 112.638 -178.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 89.0 mt -64.37 -42.93 95.92 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.14 0.495 . . . . 0.0 111.208 -179.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 90.7 mt -95.6 -1.67 49.87 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.894 -179.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 279' ' ' ALA . . . . . 0.582 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.34 -34.83 77.41 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.696 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.12 20.01 0.11 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.006 -179.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . 0.49 HD23 ' HA ' ' A' ' 281' ' ' LEU . 13.9 mt -75.31 120.15 80.31 Favored Pre-proline 0 N--CA 1.452 -0.365 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.506 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -51.01 -39.35 59.92 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 122.637 2.225 . . . . 0.0 111.848 179.164 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.92 -50.53 63.8 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.092 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 75.5 t -61.43 -43.92 97.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -57.83 -41.19 81.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.237 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -91.11 0.38 57.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.212 179.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt 59.3 43.7 16.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.079 0.466 . . . . 0.0 110.962 179.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -95.1 41.62 1.09 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.33 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 53.9 t -119.22 135.63 58.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.02 0.438 . . . . 0.0 110.168 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -132.63 162.65 30.78 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 121.123 0.487 . . . . 0.0 110.634 -179.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.71 154.91 33.39 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.014 0.435 . . . . 0.0 110.745 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 80.8 mt -93.68 -1.58 55.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.275 -179.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.11 165.91 12.81 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 6.9 m -87.47 -62.35 1.52 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.839 0.352 . . . . 0.0 111.016 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 295' ' ' GLU . . . . . 0.441 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.5 mm-40 -69.25 -4.01 16.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.68 -179.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 25.9 p -76.89 32.51 0.14 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.654 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 297' ' ' PHE . . . . . 0.513 ' CD2' HG22 ' A' ' 70' ' ' THR . 73.2 t80 -60.39 -46.14 91.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.669 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . 0.617 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.2 mtt85 -81.19 135.0 35.72 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 120.998 0.427 . . . . 0.0 110.634 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.457 ' H ' HG11 ' A' ' 51' ' ' VAL . 16.8 tp -114.39 118.26 33.33 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.182 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . 0.635 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.0 p-10 -165.83 -176.2 3.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.507 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -47.08 -43.78 20.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.277 -179.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -66.64 -40.57 88.75 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.968 0.413 . . . . 0.0 110.726 179.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . 0.635 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 59.7 p -55.92 -36.11 67.35 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.083 -179.17 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . 0.538 ' HB2' ' SD ' ' A' ' 215' ' ' MET . . . -57.37 -51.43 69.44 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.445 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 90.6 mtp -56.41 -43.67 79.58 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -66.37 -42.63 87.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.934 0.397 . . . . 0.0 110.17 178.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 303' ' ' SER . 56.1 t -63.95 -43.03 97.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.22 179.407 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 42.9 tp -59.67 -42.31 92.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.781 -179.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -62.6 -38.78 91.48 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 179.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 310' ' ' ARG . . . . . 0.432 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.6 ttt85 -63.51 -44.01 95.54 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.286 179.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 89.0 mt -63.21 -42.06 99.24 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.291 179.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt -62.87 -33.41 75.23 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.997 179.494 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.52 -23.36 22.05 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.46 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . 0.476 HD22 ' CE2' ' A' ' 315' ' ' PHE . 6.8 tt -62.36 -43.1 99.62 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.63 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 315' ' ' PHE . . . . . 0.476 ' CE2' HD22 ' A' ' 314' ' ' LEU . 91.0 m-85 . . . . . 0 C--O 1.22 -0.482 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.449 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -99.58 136.75 39.04 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.079 0.466 . . . . 0.0 110.438 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.494 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -91.99 178.49 1.7 Allowed Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.615 -179.881 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.494 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.4 Cg_exo -61.65 146.99 96.38 Favored 'Trans proline' 0 C--N 1.299 -2.044 0 C-N-CA 122.872 2.381 . . . . 0.0 112.133 179.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.46 ' HE ' HD12 ' A' ' 39' ' ' LEU . 35.5 ptt180 -136.23 142.31 44.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.682 179.668 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -79.52 116.67 19.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.464 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.449 ' O ' HG23 ' A' ' 30' ' ' ILE . 9.5 tp -111.16 130.49 64.53 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.483 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 13.1 t -70.93 141.91 51.1 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.547 179.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.478 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.5 t0 -139.42 179.71 6.39 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.57 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.478 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 78.0 p -73.88 -37.21 64.79 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.626 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -46.37 -94.51 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.292 -179.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -167.2 -26.61 0.02 OUTLIER Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.934 -0.867 . . . . 0.0 110.934 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 60.0 m -168.98 104.78 0.4 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.876 0.37 . . . . 0.0 110.673 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.678 ' CD2' HD13 ' A' ' 140' ' ' LEU . 74.6 t60 -128.44 148.81 50.74 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 121.102 0.477 . . . . 0.0 110.247 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.623 HG22 ' N ' ' A' ' 39' ' ' LEU . 98.8 m -131.2 165.84 22.45 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.55 -179.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.623 ' N ' HG22 ' A' ' 38' ' ' THR . 82.0 mt -120.67 127.28 51.91 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.439 179.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -65.23 -44.45 88.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.698 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 39.5 p -165.66 154.66 11.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.44 179.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.478 ' H ' ' CD ' ' A' ' 42' ' ' GLN . 14.4 mp0 -44.78 101.3 0.25 Allowed Pre-proline 0 C--N 1.329 -0.315 0 O-C-N 123.376 0.422 . . . . 0.0 110.605 179.397 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -57.43 129.94 36.53 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 C-N-CA 122.357 2.038 . . . . 0.0 112.292 -179.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -83.88 -24.68 30.72 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.539 179.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.538 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.2 mtm-85 -122.07 134.9 54.77 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 121.203 0.525 . . . . 0.0 110.291 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 95.9 mt -130.64 133.73 63.05 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.883 -179.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 44.7 t -124.44 130.53 73.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 179.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.627 ' OG ' HD12 ' A' ' 117' ' ' LEU . 2.3 m -155.36 167.34 30.69 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.534 179.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 68.2 p -124.68 9.45 8.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.458 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.56 125.51 33.15 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.634 -179.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.44 HG11 ' H ' ' A' ' 299' ' ' LEU . 92.7 t -65.81 -44.52 92.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.469 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 20.0 m -62.77 -44.19 96.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.607 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 50.2 tp -62.24 -41.61 98.58 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.53 -179.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.444 ' O ' HD13 ' A' ' 58' ' ' LEU . 77.2 m -57.59 -44.65 85.53 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.394 -179.41 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.03 -62.33 5.3 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.884 -0.886 . . . . 0.0 110.884 179.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.7 t -48.4 -35.42 12.66 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.7 mt -61.88 -44.52 96.65 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.686 -0.405 . . . . 0.0 111.281 179.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.444 HD13 ' O ' ' A' ' 54' ' ' THR . 9.2 mp -65.18 -41.52 94.52 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.33 177.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.5 -41.26 98.53 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.983 -179.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.426 ' O ' HG23 ' A' ' 60' ' ' ILE . 8.1 tp -88.18 17.13 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.824 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 56.24 84.63 0.08 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.688 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.37 59.06 0.08 OUTLIER Pre-proline 0 C--N 1.328 -0.346 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.405 ' HB3' HE21 ' A' ' 85' ' ' GLN . 10.3 Cg_endo -51.52 152.31 12.51 Favored 'Trans proline' 0 C--N 1.294 -2.301 0 C-N-CA 122.956 2.438 . . . . 0.0 112.254 -178.233 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.434 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.2 OUTLIER -108.55 145.31 15.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.37 -179.728 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.8 mt -63.56 -45.4 97.77 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.414 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.5 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -129.57 134.19 47.6 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.848 0.356 . . . . 0.0 110.495 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.493 ' O ' ' N ' ' A' ' 98' ' ' LEU . 74.8 m -134.48 158.56 43.6 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.849 -179.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.82 139.13 16.12 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.689 -0.964 . . . . 0.0 110.689 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.497 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.84 -162.77 0.08 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.971 0.415 . . . . 0.0 110.479 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.535 HG22 ' CD2' ' A' ' 297' ' ' PHE . 14.7 t -133.49 135.02 44.21 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.382 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.487 ' C ' ' O ' ' A' ' 70' ' ' THR . 0.7 OUTLIER 29.73 68.57 0.66 Allowed Pre-proline 0 N--CA 1.464 0.26 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.801 -179.87 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_exo -60.98 145.64 98.84 Favored 'Trans proline' 0 C--N 1.299 -2.035 0 C-N-CA 122.648 2.232 . . . . 0.0 111.981 -178.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.534 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 46.1 p-10 -160.11 -32.63 0.06 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.639 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.537 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 99.2 m-20 -63.71 -39.74 95.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.451 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 73.1 ttt180 -60.13 -48.08 83.24 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.728 -179.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.423 ' O ' ' O ' ' A' ' 77' ' ' ALA . 94.4 t -60.35 -24.73 31.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.088 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.537 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -45.76 172.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.599 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.571 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.9 p30 -62.07 177.74 0.43 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.522 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.558 ' C ' ' H ' ' A' ' 81' ' ' GLY . 35.4 p30 -45.61 85.67 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.033 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.571 ' N ' ' O ' ' A' ' 78' ' ' ASP . 43.4 tp60 -67.63 13.45 0.07 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.149 0.5 . . . . 0.0 110.135 -179.735 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.558 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 118.32 -22.1 9.72 Favored Glycine 0 CA--C 1.519 0.282 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -107.86 116.61 32.26 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.975 0.417 . . . . 0.0 110.474 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 74.4 mt -98.77 -0.14 43.25 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.937 0.399 . . . . 0.0 110.494 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -92.13 7.08 44.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.98 0.419 . . . . 0.0 110.452 -179.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.788 ' O ' HG22 ' A' ' 89' ' ' VAL . 88.1 mt-30 -100.42 -27.76 13.28 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.815 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.8 t-105 -63.73 -40.51 96.93 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.093 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.56 ' O ' ' N ' ' A' ' 91' ' ' LYS . 63.7 m -78.15 -54.16 6.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.118 -179.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -47.64 -50.51 24.31 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.06 -179.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.788 HG22 ' O ' ' A' ' 85' ' ' GLN . 14.9 m -69.29 -40.75 80.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.066 179.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.499 ' N ' HG23 ' A' ' 89' ' ' VAL . . . -72.3 -22.64 61.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.66 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.56 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.0 tttm -62.23 -45.5 93.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.422 -179.494 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.441 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.8 mm-40 -90.51 -94.37 0.12 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.153 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.628 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.9 mtt180 -143.13 58.72 1.41 Allowed 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.457 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.6 pttp 33.44 26.43 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.195 -179.226 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.628 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.4 tt -48.25 123.29 6.23 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.986 -178.092 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.455 ' O ' HD23 ' A' ' 95' ' ' LEU . 99.0 mm-40 -83.68 -169.62 2.65 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.122 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.605 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 81.4 mtp180 -74.42 137.32 42.57 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.303 -179.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.493 ' N ' ' O ' ' A' ' 67' ' ' SER . 90.6 mt -86.21 -165.85 1.38 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.74 -179.659 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.538 ' CD2' ' O ' ' A' ' 99' ' ' TYR . 48.4 p90 -168.74 119.77 0.76 Allowed 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.207 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.511 ' C ' ' O ' ' A' ' 99' ' ' TYR . 43.0 mm -28.67 120.74 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.085 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 114.38 27.48 3.35 Favored Glycine 0 CA--C 1.519 0.34 0 N-CA-C 111.196 -0.762 . . . . 0.0 111.196 -179.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.576 ' H ' ' CD ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -144.47 46.6 0.64 Allowed Pre-proline 0 C--N 1.323 -0.554 0 CA-C-O 120.979 0.419 . . . . 0.0 110.447 179.861 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 29.0 Cg_endo -62.04 144.01 95.64 Favored 'Trans proline' 0 C--N 1.296 -2.224 0 C-N-CA 122.702 2.268 . . . . 0.0 111.865 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.459 ' O ' HG23 ' A' ' 108' ' ' VAL . 26.7 t -173.24 120.23 0.34 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.423 179.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.83 -40.4 63.35 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.054 0.454 . . . . 0.0 111.085 179.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.23 -40.06 90.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.888 -179.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.14 -39.97 95.15 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.677 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 104' ' ' SER . 70.4 t -67.71 -43.72 86.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.731 179.705 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.74 -38.96 92.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.53 -179.26 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.441 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.65 -23.35 62.97 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.49 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.547 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.5 mm-40 -90.5 5.14 48.91 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.714 -179.555 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.547 ' C ' ' O ' ' A' ' 111' ' ' GLN . 10.6 tpt 23.27 64.33 0.37 Allowed Pre-proline 0 N--CA 1.464 0.261 0 CA-C-O 120.935 0.398 . . . . 0.0 111.077 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -78.61 167.5 22.52 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 123.062 2.508 . . . . 0.0 111.861 -178.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.521 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 99.0 m-20 -109.97 -42.27 4.26 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.182 179.474 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.6 tp -121.04 120.66 36.01 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 179.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 83.8 mt -113.44 129.0 70.0 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.39 0 CA-C-O 120.98 0.419 . . . . 0.0 110.903 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.627 HD12 ' OG ' ' A' ' 48' ' ' SER . 30.2 mt -109.18 132.27 54.28 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 121.084 0.469 . . . . 0.0 110.235 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.491 HD12 HG23 ' A' ' 139' ' ' THR . 99.0 mt -119.84 138.75 49.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.719 -179.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 84.9 p -72.51 153.61 41.25 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.598 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.18 -50.12 74.94 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.678 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -149.44 154.01 38.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.55 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 170.58 -170.99 43.49 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -63.09 -34.16 89.21 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.866 -0.893 . . . . 0.0 110.866 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.45 ' O ' ' OD1' ' A' ' 124' ' ' ASP . 44.3 p-10 -86.82 120.45 28.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.837 0.351 . . . . 0.0 110.705 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.443 ' O ' HD12 ' A' ' 129' ' ' LEU . 38.9 t -63.23 143.48 57.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.029 0.443 . . . . 0.0 110.495 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.52 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -92.97 -43.18 9.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.972 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.9 tp -62.85 -42.45 99.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.703 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.66 -11.83 59.13 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.53 -179.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.443 HD12 ' O ' ' A' ' 125' ' ' SER . 84.8 mt -114.97 -23.86 8.88 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.659 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . 0.52 ' N ' ' O ' ' A' ' 126' ' ' ALA . 80.6 t80 -51.13 -49.55 60.6 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.537 -178.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.0 p-10 -66.13 -42.41 89.18 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.823 0.344 . . . . 0.0 111.239 179.486 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.519 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 88.2 mt-30 -67.16 -37.81 84.41 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.813 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.431 HD12 HD11 ' A' ' 118' ' ' ILE . 96.0 mt -80.36 -41.38 24.81 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.965 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.2 t -57.23 -44.57 83.91 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.218 -179.109 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.7 m -61.97 -45.23 94.56 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.511 179.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 94.0 mt -62.09 -43.64 97.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.279 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.66 ' HB1' ' HD2' ' A' ' 138' ' ' PRO . . . -169.44 168.22 4.96 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.56 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.66 ' HD2' ' HB1' ' A' ' 137' ' ' ALA . 52.3 Cg_exo -49.57 112.82 0.76 Allowed 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.323 2.015 . . . . 0.0 112.282 179.214 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.491 HG23 HD12 ' A' ' 118' ' ' ILE . 23.5 m -84.49 127.53 34.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.617 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.678 HD13 ' CD2' ' A' ' 37' ' ' HIS . 34.7 tp -118.22 137.0 53.31 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.079 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.44 ' O ' ' OD2' ' A' ' 32' ' ' ASP . 81.3 mt -101.26 118.94 48.76 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.353 0 CA-C-O 121.226 0.536 . . . . 0.0 111.222 -179.419 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.431 HD12 HD22 ' A' ' 117' ' ' LEU . 98.1 mt -134.78 132.04 53.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.588 179.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.55 HD21 ' CG ' ' A' ' 241' ' ' ASP . 61.0 t30 -66.28 151.82 46.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.895 0.378 . . . . 0.0 110.413 179.419 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.521 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 88.1 t80 -86.69 122.54 30.73 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.808 -179.581 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.521 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 99.0 m-20 55.31 69.13 0.77 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.788 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 35.9 p-10 -125.9 0.17 7.3 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.652 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -150.54 115.12 5.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.715 -179.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 83.9 p -63.29 168.2 4.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.602 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.417 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.7 p-90 -51.88 -15.79 0.59 Allowed 'General case' 0 C--O 1.223 -0.334 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.467 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . 0.44 ' O ' HG23 ' A' ' 154' ' ' THR . 68.1 tp60 -70.52 -76.04 0.11 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.474 -179.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.444 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.1 t -62.7 -38.61 91.08 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.255 179.543 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 54.3 tp -59.93 -45.84 91.3 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.412 -178.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.417 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 46.7 tp -62.67 -41.64 99.19 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.497 179.011 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.444 ' OG1' ' O ' ' A' ' 151' ' ' SER . 60.1 p -64.1 -34.79 78.85 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.273 -179.482 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.415 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.9 mm-40 -64.19 -42.77 96.53 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.311 179.35 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 91.8 mt -65.37 -38.73 90.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.148 0.499 . . . . 0.0 110.268 179.122 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.579 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.23 -32.47 80.75 Favored Glycine 0 CA--C 1.519 0.317 0 N-CA-C 110.712 -0.955 . . . . 0.0 110.712 -179.306 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 157' ' ' GLY . 97.2 mt-10 -35.45 -26.93 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.828 0.347 . . . . 0.0 110.837 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.579 ' N ' ' O ' ' A' ' 157' ' ' GLY . 95.3 mt -56.46 149.81 3.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.295 179.197 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 77.1 p -69.61 137.21 52.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.997 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 71.1 21.17 78.37 Favored Glycine 0 N--CA 1.459 0.19 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 179.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 58.1 m80 -122.47 -14.94 7.72 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.702 0.286 . . . . 0.0 110.529 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -65.96 -59.74 3.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.748 -179.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -52.26 -49.3 64.34 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.209 -179.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -60.54 -41.22 94.05 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.957 -0.297 . . . . 0.0 110.379 179.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.49 -47.12 87.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.541 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.97 -40.14 75.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.244 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -61.82 -50.27 72.96 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.576 179.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -65.17 -43.86 90.36 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.531 179.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 94.6 mt -64.78 -43.29 96.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.402 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.28 -51.23 70.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.475 -179.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.43 -43.86 96.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.543 179.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . 0.654 ' CE2' HD11 ' A' ' 177' ' ' LEU . 57.0 t80 -62.75 -44.4 96.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.06 0.457 . . . . 0.0 110.443 179.451 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -63.32 -39.8 95.56 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.617 -179.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -63.01 -42.76 99.9 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.599 179.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -60.72 -44.6 96.42 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.184 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.654 HD11 ' CE2' ' A' ' 173' ' ' PHE . 84.1 mt -64.54 -40.96 96.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.014 0.435 . . . . 0.0 110.707 178.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.18 -62.46 1.62 Allowed 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.368 -179.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.52 -46.86 85.89 Favored 'General case' 0 C--O 1.227 -0.128 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.628 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.13 -41.85 65.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.276 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -63.74 -33.79 76.43 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.982 0.42 . . . . 0.0 110.411 179.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . 0.422 ' HG2' ' O ' ' A' ' 182' ' ' GLU . 69.6 tt0 -90.51 8.83 31.92 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.46 0.648 . . . . 0.0 110.508 -178.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -104.99 -32.07 8.92 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.174 179.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.9 pt -127.98 147.63 32.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.822 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -139.93 131.09 26.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.357 179.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . 0.593 HD22 ' N ' ' A' ' 186' ' ' LEU . 3.6 mm? -85.35 133.34 42.64 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.979 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -43.93 157.82 0.14 Allowed 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.69 2.26 . . . . 0.0 112.191 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . 0.521 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.9 Cg_endo -63.1 115.11 2.77 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 C-N-CA 122.795 2.33 . . . . 0.0 111.696 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . 0.521 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.8 mt-30 155.16 147.86 0.0 OUTLIER Pre-proline 0 C--N 1.332 -0.162 0 O-C-N 123.791 0.682 . . . . 0.0 110.832 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -73.49 144.11 35.65 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.667 2.245 . . . . 0.0 112.159 177.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.496 HG23 ' OG ' ' A' ' 258' ' ' SER . 2.1 p -125.04 158.98 32.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.291 0.567 . . . . 0.0 110.185 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . 0.494 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 37.5 p -143.3 165.39 27.6 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.106 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . 0.45 ' HA ' ' H ' ' A' ' 260' ' ' PHE . . . -135.4 128.69 32.05 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.234 0.54 . . . . 0.0 110.231 179.431 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.504 HD11 HD23 ' A' ' 259' ' ' LEU . 47.6 pt -146.3 148.71 16.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.165 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . 0.749 HG13 ' CD1' ' A' ' 262' ' ' PHE . 70.4 t -117.51 123.01 71.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.282 0.563 . . . . 0.0 109.71 179.083 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -134.47 107.51 7.6 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.331 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 94.3 m -131.01 130.71 43.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.845 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -82.82 -37.02 25.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.231 179.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.55 -67.17 0.26 Allowed 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.359 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.33 -9.76 58.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.342 179.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 60.1 t-80 60.43 58.3 2.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.774 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 39.4 p -166.8 153.2 8.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.586 179.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.28 144.09 24.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.005 0.431 . . . . 0.0 110.421 179.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -135.3 137.87 42.9 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.619 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 19.6 mt -105.98 125.42 50.97 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.061 0.458 . . . . 0.0 109.81 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 206' ' ' TRP . . . . . 0.555 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 75.6 m95 -82.09 167.15 19.07 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.685 -179.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . 0.466 HG22 ' C ' ' A' ' 206' ' ' TRP . 0.1 OUTLIER -156.99 171.38 7.53 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.624 -179.189 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -53.57 -37.22 82.85 Favored 'Trans proline' 0 C--N 1.302 -1.902 0 C-N-CA 122.661 2.24 . . . . 0.0 112.27 179.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -70.52 -34.88 72.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.813 -179.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 22.8 m -61.19 150.72 33.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.637 -179.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.52 -36.95 81.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.485 -179.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 212' ' ' GLN . . . . . 0.555 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 54.8 tt0 -64.78 -40.11 94.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.506 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.8 -43.41 91.74 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -63.33 -43.74 96.92 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.791 0.329 . . . . 0.0 110.29 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 215' ' ' MET . . . . . 0.522 ' SD ' ' HB2' ' A' ' 304' ' ' ALA . 65.1 ttp -59.39 -48.18 82.63 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.238 -179.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 88.2 mt -60.37 -40.9 92.49 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 179.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 217' ' ' GLU . . . . . 0.456 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 40.9 tp10 -57.96 -38.03 75.25 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -65.17 -37.92 88.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.67 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 94.5 mt -64.4 -42.72 95.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.141 0.496 . . . . 0.0 110.583 -179.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.56 44.63 0.08 OUTLIER Glycine 0 C--N 1.334 0.417 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 221' ' ' PHE . . . . . 0.456 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 25.9 m-85 -127.68 155.19 44.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.04 0.447 . . . . 0.0 110.471 -179.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.481 ' O ' HG13 ' A' ' 191' ' ' VAL . 6.1 p -107.05 122.35 46.29 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.272 0.558 . . . . 0.0 110.116 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.473 HD22 ' C ' ' A' ' 222' ' ' THR . 4.3 mm? -101.25 133.04 46.42 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.068 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -97.17 159.53 14.86 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.488 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.21 115.32 30.06 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.399 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.496 ' N ' HD12 ' A' ' 226' ' ' LEU . 9.0 mp -53.62 156.84 4.21 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.689 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -59.86 145.21 98.84 Favored 'Trans proline' 0 C--N 1.302 -1.916 0 C-N-CA 122.65 2.233 . . . . 0.0 112.19 179.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.64 -2.73 58.81 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.559 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.46 -40.68 5.65 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . 0.535 ' O ' ' N ' ' A' ' 233' ' ' SER . 86.1 mt -79.13 -16.74 56.22 Favored 'General case' 0 C--O 1.222 -0.379 0 CA-C-O 121.02 0.438 . . . . 0.0 110.383 -179.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . 0.402 ' C ' ' O ' ' A' ' 230' ' ' LEU . 54.4 t-20 -40.29 -49.07 2.73 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.777 -179.421 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -88.24 15.44 7.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.368 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . 0.535 ' N ' ' O ' ' A' ' 230' ' ' LEU . 77.8 p -60.52 -35.52 76.18 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.622 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . 0.523 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.6 tt0 -118.27 -69.37 0.85 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.958 179.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 3.9 m -70.39 103.03 2.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.679 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -93.99 57.92 2.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.398 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -145.12 -122.28 1.52 Allowed Glycine 0 CA--C 1.519 0.343 0 N-CA-C 110.989 -0.845 . . . . 0.0 110.989 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -134.56 111.68 10.26 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 121.114 0.483 . . . . 0.0 110.433 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . 0.51 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.3 mtt180 -148.12 57.24 1.08 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.696 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -69.74 -31.99 70.27 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.511 179.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 241' ' ' ASP . . . . . 0.55 ' CG ' HD21 ' A' ' 143' ' ' ASN . 65.1 t0 -56.83 -46.93 81.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.379 -179.07 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 242' ' ' ILE . . . . . 0.437 ' O ' ' O ' ' A' ' 239' ' ' ARG . 17.5 tt -140.02 156.76 25.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.888 0.375 . . . . 0.0 110.537 179.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.438 HG22 HD13 ' A' ' 245' ' ' LEU . 96.0 mt -105.8 105.9 19.56 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.218 0 CA-C-O 121.122 0.487 . . . . 0.0 110.511 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . 0.602 ' O ' HD12 ' A' ' 245' ' ' LEU . 88.3 mt-30 -110.23 110.03 20.72 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.344 179.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.602 HD12 ' O ' ' A' ' 244' ' ' GLN . 9.6 mp -121.86 -168.23 1.67 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.663 179.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . 0.523 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.28 -16.8 0.05 OUTLIER Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . 0.669 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -60.44 157.17 29.42 Favored Glycine 0 CA--C 1.522 0.49 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 -179.81 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -63.86 21.68 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.99 0.424 . . . . 0.0 110.619 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . 0.669 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.7 m-20 -97.43 -5.82 35.32 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.517 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 91.9 mt -80.28 -21.48 42.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.672 179.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.66 -51.36 70.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.702 -179.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.43 -5.19 58.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.453 179.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.15 -74.2 1.15 Allowed Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 80.4 mt -70.09 125.73 27.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.979 0.418 . . . . 0.0 110.274 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -59.7 -39.15 83.65 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.492 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 84.1 51.74 3.86 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 110.712 -0.955 . . . . 0.0 110.712 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -94.87 -16.2 23.09 Favored 'General case' 0 C--N 1.332 -0.191 0 O-C-N 122.651 -0.323 . . . . 0.0 110.654 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 258' ' ' SER . . . . . 0.496 ' OG ' HG23 ' A' ' 191' ' ' VAL . 3.3 t 174.06 89.53 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.074 0.464 . . . . 0.0 110.18 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.863 ' N ' HD12 ' A' ' 259' ' ' LEU . 1.0 OUTLIER -94.47 124.35 38.44 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.275 0.559 . . . . 0.0 111.079 -179.084 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 260' ' ' PHE . . . . . 0.45 ' H ' ' HA ' ' A' ' 193' ' ' ALA . 16.0 m-30 -93.49 146.64 23.62 Favored 'General case' 0 CA--C 1.504 -0.793 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.441 179.262 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 85.9 mt -122.46 149.91 43.22 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.567 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.749 ' CD1' HG13 ' A' ' 195' ' ' VAL . 2.6 p90 -77.61 -138.4 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.541 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 263' ' ' ALA . . . . . 0.657 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -52.24 77.51 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.048 0.452 . . . . 0.0 111.078 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . 0.625 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.17 104.35 0.18 Allowed Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 265' ' ' ASP . . . . . 0.601 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.8 m-20 -80.28 -177.89 6.34 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 120.685 0.279 . . . . 0.0 110.908 -179.478 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -40.44 -17.52 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.567 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 267' ' ' LYS . . . . . 0.601 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.62 -51.45 42.1 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.617 179.502 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -63.79 -46.64 84.28 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.171 179.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . 0.566 ' HB1' ' OH ' ' A' ' 273' ' ' TYR . . . -61.58 -34.99 76.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.247 0.546 . . . . 0.0 109.866 179.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -63.13 -34.42 77.58 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.17 179.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.43 -43.31 13.73 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.218 -179.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 272' ' ' ILE . . . . . 0.588 ' C ' ' H ' ' A' ' 274' ' ' ALA . 4.9 tt -51.42 -33.72 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.863 -178.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 273' ' ' TYR . . . . . 0.566 ' OH ' ' HB1' ' A' ' 269' ' ' ALA . 17.4 m-85 -54.31 -1.88 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.649 -179.587 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 274' ' ' ALA . . . . . 0.588 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.64 -39.66 70.22 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.95 179.561 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . 0.586 ' O ' ' N ' ' A' ' 279' ' ' ALA . 4.2 p30 -39.12 97.86 0.15 Allowed Pre-proline 0 N--CA 1.462 0.174 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.458 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -54.55 -42.97 63.27 Favored 'Trans proline' 0 C--N 1.303 -1.831 0 C-N-CA 122.372 2.048 . . . . 0.0 112.552 -178.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 88.9 mt -64.45 -42.97 95.66 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.128 0.49 . . . . 0.0 111.211 -179.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 90.8 mt -95.71 -1.38 50.09 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.923 -179.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 279' ' ' ALA . . . . . 0.586 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.19 -34.74 77.02 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.714 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.21 19.8 0.12 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.018 -179.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . 0.487 HD23 ' HA ' ' A' ' 281' ' ' LEU . 13.9 mt -75.08 120.14 80.27 Favored Pre-proline 0 N--CA 1.451 -0.423 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.575 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -49.97 -39.81 49.75 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.625 2.216 . . . . 0.0 112.154 178.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.52 -50.56 62.57 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.084 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 79.9 t -61.79 -43.8 97.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 179.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -57.88 -41.77 83.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.317 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -90.43 0.33 57.34 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.119 179.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt 59.04 41.19 21.17 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.773 179.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -92.89 42.18 1.09 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.355 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 53.7 t -119.1 135.67 58.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.014 0.435 . . . . 0.0 110.246 -179.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -133.05 162.74 30.9 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.656 -179.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.77 154.96 33.42 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.965 0.412 . . . . 0.0 110.747 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 81.8 mt -93.75 -1.46 55.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.231 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.59 165.52 12.62 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 110.58 -1.008 . . . . 0.0 110.58 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 7.1 m -87.38 -62.27 1.54 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.89 0.376 . . . . 0.0 111.004 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 295' ' ' GLU . . . . . 0.438 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.5 mm-40 -69.62 -3.97 17.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.636 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 26.2 p -76.81 33.14 0.14 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.648 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 297' ' ' PHE . . . . . 0.535 ' CD2' HG22 ' A' ' 70' ' ' THR . 85.0 t80 -60.21 -46.03 91.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.477 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . 0.605 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.2 mtt85 -81.73 133.76 35.38 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.568 -179.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.44 ' H ' HG11 ' A' ' 51' ' ' VAL . 16.1 tp -114.07 119.75 38.2 Favored 'General case' 0 C--O 1.231 0.083 0 CA-C-O 120.992 0.425 . . . . 0.0 110.205 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . 0.622 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.2 p-10 -167.43 -174.15 2.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.551 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 84.0 t80 -48.23 -45.81 34.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.215 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -64.7 -41.48 95.99 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.033 0.444 . . . . 0.0 110.689 178.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . 0.622 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 53.1 p -55.53 -36.09 66.37 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.954 -179.073 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . 0.522 ' HB2' ' SD ' ' A' ' 215' ' ' MET . . . -56.71 -51.76 67.57 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.442 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 91.0 mtp -56.13 -43.89 78.62 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -66.3 -42.81 87.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.008 0.432 . . . . 0.0 110.246 178.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 303' ' ' SER . 55.5 t -64.02 -42.77 96.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.211 179.44 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 42.3 tp -59.65 -42.29 92.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.791 -179.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -62.54 -38.76 91.28 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.149 179.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 310' ' ' ARG . . . . . 0.442 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.6 ttt85 -63.54 -43.95 95.61 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.229 179.606 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 88.3 mt -63.15 -42.15 99.39 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.303 179.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -62.84 -33.22 74.79 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.04 179.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.94 -23.51 21.55 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.377 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . 0.478 HD22 ' CE2' ' A' ' 315' ' ' PHE . 6.8 tt -62.31 -43.19 99.39 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 121.092 0.473 . . . . 0.0 110.623 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 315' ' ' PHE . . . . . 0.478 ' CE2' HD22 ' A' ' 314' ' ' LEU . 90.8 m-85 . . . . . 0 C--O 1.22 -0.475 0 CA-C-O 118.005 -0.997 . . . . 0.0 110.42 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -99.41 135.58 40.61 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.087 0.47 . . . . 0.0 110.502 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.495 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.2 OUTLIER -92.14 178.42 1.71 Allowed Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.549 -179.842 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.495 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.3 Cg_exo -61.74 147.47 95.24 Favored 'Trans proline' 0 C--N 1.3 -2.024 0 C-N-CA 122.776 2.317 . . . . 0.0 112.168 179.603 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.482 ' HE ' HD12 ' A' ' 39' ' ' LEU . 35.2 ptt180 -136.12 142.33 44.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.735 179.682 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -79.83 116.79 20.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.406 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.447 ' O ' HG23 ' A' ' 30' ' ' ILE . 9.5 tp -111.54 130.71 64.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.411 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.1 t -71.19 142.62 50.64 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.623 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.479 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.7 t0 -139.84 179.86 6.35 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.564 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.479 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 77.9 p -73.86 -37.26 64.82 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.707 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.7 ttt85 -46.83 -94.62 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.309 -179.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -166.3 -26.8 0.02 OUTLIER Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 56.9 m -168.87 105.69 0.42 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.892 0.377 . . . . 0.0 110.621 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.653 ' CD2' HD13 ' A' ' 140' ' ' LEU . 69.6 t60 -128.77 147.03 50.75 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.053 0.454 . . . . 0.0 110.262 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.623 HG22 ' N ' ' A' ' 39' ' ' LEU . 99.9 m -130.05 165.73 21.6 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.582 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.623 ' N ' HG22 ' A' ' 38' ' ' THR . 80.8 mt -120.35 127.33 52.23 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.481 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -65.43 -44.62 86.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.693 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 41.2 p -165.89 155.23 11.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.46 179.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.489 ' H ' ' CD ' ' A' ' 42' ' ' GLN . 15.1 mp0 -45.25 101.63 0.27 Allowed Pre-proline 0 C--N 1.329 -0.295 0 O-C-N 123.388 0.43 . . . . 0.0 110.659 179.327 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -57.96 129.58 33.96 Favored 'Trans proline' 0 C--N 1.303 -1.82 0 C-N-CA 122.269 1.979 . . . . 0.0 112.231 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -82.33 -25.2 34.11 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.478 179.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.534 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.7 mtm-85 -120.87 134.39 55.29 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-O 121.194 0.521 . . . . 0.0 110.252 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.1 mt -129.69 133.06 65.59 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.313 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.034 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 46.0 t -124.71 130.9 73.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 179.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.622 ' OG ' HD12 ' A' ' 117' ' ' LEU . 4.4 m -154.99 166.5 33.4 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.541 179.578 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 66.0 p -124.27 8.99 8.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.805 0.336 . . . . 0.0 110.439 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.72 125.82 33.5 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.668 -179.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.471 HG11 ' H ' ' A' ' 299' ' ' LEU . 85.7 t -65.81 -44.55 92.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.547 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 18.9 m -62.63 -44.35 96.51 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.615 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 53.5 tp -62.26 -41.54 98.54 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.503 -179.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.45 ' O ' HD13 ' A' ' 58' ' ' LEU . 73.3 m -57.85 -44.54 86.6 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.257 -179.271 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.39 -62.01 5.48 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 179.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.7 t -48.74 -35.25 13.74 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.9 mt -61.8 -44.38 96.98 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.586 -0.445 . . . . 0.0 111.325 179.13 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.45 HD13 ' O ' ' A' ' 54' ' ' THR . 9.4 mp -64.74 -41.95 95.55 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.384 177.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.406 ' HB1' ' NE ' ' A' ' 169' ' ' ARG . . . -63.67 -41.03 98.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.033 -179.196 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.426 ' O ' HG23 ' A' ' 60' ' ' ILE . 8.0 tp -88.11 16.77 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.798 -179.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 56.38 84.56 0.08 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.696 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.14 58.21 0.07 OUTLIER Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.287 -0.415 . . . . 0.0 109.904 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.414 ' HB3' HE21 ' A' ' 85' ' ' GLN . 10.1 Cg_endo -50.58 152.76 8.67 Favored 'Trans proline' 0 C--N 1.293 -2.365 0 C-N-CA 122.84 2.36 . . . . 0.0 112.404 -178.509 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.432 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -108.78 145.83 15.18 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.219 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.239 -179.716 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 97.0 mt -63.75 -45.06 98.32 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.366 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.559 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.501 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -130.02 134.49 47.44 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 120.836 0.351 . . . . 0.0 110.588 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.497 ' O ' ' N ' ' A' ' 98' ' ' LEU . 73.6 m -134.74 158.71 43.44 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.893 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -87.2 139.54 16.2 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.491 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.72 -162.75 0.08 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.003 0.43 . . . . 0.0 110.453 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.513 HG22 ' CD2' ' A' ' 297' ' ' PHE . 14.0 t -133.47 135.15 44.33 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.324 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.486 ' C ' ' O ' ' A' ' 70' ' ' THR . 0.1 OUTLIER 29.77 68.51 0.67 Allowed Pre-proline 0 N--CA 1.466 0.353 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.765 -179.883 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_exo -60.96 145.21 99.4 Favored 'Trans proline' 0 C--N 1.299 -2.047 0 C-N-CA 122.613 2.208 . . . . 0.0 112.017 -178.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.524 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 45.5 p-10 -159.83 -32.6 0.06 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.65 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.54 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 99.0 m-20 -64.0 -39.56 94.39 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.485 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.6 ttt180 -60.65 -47.87 84.29 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.721 -179.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.421 ' O ' ' O ' ' A' ' 77' ' ' ALA . 89.2 t -60.58 -24.59 32.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.54 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -45.85 172.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.581 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.569 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.6 p30 -61.85 177.58 0.42 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.551 -179.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.56 ' C ' ' H ' ' A' ' 81' ' ' GLY . 35.5 p30 -45.61 85.84 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.049 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.569 ' N ' ' O ' ' A' ' 78' ' ' ASP . 43.3 tp60 -67.34 13.32 0.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.232 0.539 . . . . 0.0 110.101 -179.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.56 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 118.04 -22.12 9.91 Favored Glycine 0 C--N 1.332 0.321 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -107.79 116.25 31.62 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.014 0.435 . . . . 0.0 110.419 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 77.6 mt -98.87 0.57 44.47 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.498 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -92.04 6.72 45.36 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.033 0.444 . . . . 0.0 110.327 -179.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.794 ' O ' HG22 ' A' ' 89' ' ' VAL . 88.3 mt-30 -100.05 -27.73 13.41 Favored 'General case' 0 C--O 1.223 -0.329 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.869 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 68.7 t-105 -63.08 -40.81 98.77 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.902 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.554 ' O ' ' N ' ' A' ' 91' ' ' LYS . 68.0 m -77.44 -53.44 7.63 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.272 -179.486 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -48.57 -50.73 31.04 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.039 -179.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.794 HG22 ' O ' ' A' ' 85' ' ' GLN . 15.5 m -68.87 -40.8 81.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 120.97 0.414 . . . . 0.0 111.175 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.498 ' N ' HG23 ' A' ' 89' ' ' VAL . . . -72.06 -23.05 61.3 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.763 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.554 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.0 tttm -61.51 -45.89 92.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.42 -179.439 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.444 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.8 mm-40 -90.38 -94.59 0.12 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.048 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.622 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.8 mtt180 -143.35 59.97 1.4 Allowed 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.456 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.6 pttp 33.73 26.46 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 120.861 0.362 . . . . 0.0 110.12 -179.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.622 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.5 tt -48.49 123.19 6.29 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.081 -178.026 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.456 ' O ' HD23 ' A' ' 95' ' ' LEU . 99.0 mm-40 -83.69 -170.18 2.94 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.007 -179.763 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.62 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 82.2 mtp180 -73.29 137.77 45.06 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.197 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.497 ' N ' ' O ' ' A' ' 67' ' ' SER . 89.3 mt -86.26 -166.15 1.46 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.777 -179.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.532 ' CD2' ' O ' ' A' ' 99' ' ' TYR . 47.5 p90 -168.01 119.65 0.84 Allowed 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.234 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.505 ' C ' ' O ' ' A' ' 99' ' ' TYR . 42.8 mm -29.4 120.98 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.058 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 113.92 28.03 3.28 Favored Glycine 0 C--N 1.332 0.323 0 N-CA-C 111.176 -0.77 . . . . 0.0 111.176 -179.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.582 ' N ' ' CD ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -143.93 45.94 0.61 Allowed Pre-proline 0 C--N 1.323 -0.566 0 O-C-N 122.481 -0.423 . . . . 0.0 110.434 179.816 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.582 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 30.2 Cg_endo -61.95 143.8 95.77 Favored 'Trans proline' 0 C--N 1.296 -2.229 0 C-N-CA 122.669 2.246 . . . . 0.0 111.971 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.46 ' O ' HG23 ' A' ' 108' ' ' VAL . 26.7 t -173.17 120.43 0.35 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.463 179.637 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.1 -41.0 64.53 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.069 0.462 . . . . 0.0 111.157 179.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -65.8 -39.92 91.38 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.85 -179.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.94 -39.67 94.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.751 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 104' ' ' SER . 70.6 t -67.4 -43.88 87.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.769 179.572 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.52 -39.11 92.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.574 -179.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.444 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.63 -23.85 63.35 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.448 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.554 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.3 mm-40 -91.23 4.71 51.59 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.695 -179.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.554 ' C ' ' O ' ' A' ' 111' ' ' GLN . 10.4 tpt 22.11 64.29 0.32 Allowed Pre-proline 0 N--CA 1.466 0.345 0 CA-C-O 120.937 0.398 . . . . 0.0 111.154 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.446 ' HG2' HD11 ' A' ' 116' ' ' ILE . 67.7 Cg_endo -78.85 169.8 18.98 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 123.072 2.515 . . . . 0.0 112.085 -178.252 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.518 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 98.8 m-20 -112.3 -44.82 3.34 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.222 -0.444 . . . . 0.0 109.974 179.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.2 tp -119.96 120.88 37.67 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.45 HD13 HD22 ' A' ' 133' ' ' LEU . 96.6 mt -117.82 131.36 70.79 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.417 0 CA-C-O 120.957 0.408 . . . . 0.0 110.985 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.622 HD12 ' OG ' ' A' ' 48' ' ' SER . 33.4 mt -106.17 132.2 52.51 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.117 0.484 . . . . 0.0 110.051 -179.405 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.498 HD12 HG23 ' A' ' 139' ' ' THR . 98.4 mt -117.49 135.93 56.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.791 -179.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 85.4 p -71.37 151.79 43.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.521 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.28 -49.94 75.61 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.712 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -149.33 153.7 37.85 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.544 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 168.7 -169.35 41.66 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -63.08 -35.41 92.05 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.452 ' O ' ' OD1' ' A' ' 124' ' ' ASP . 44.4 p-10 -88.62 120.02 29.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.839 0.352 . . . . 0.0 110.694 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.443 ' O ' HD12 ' A' ' 129' ' ' LEU . 40.7 t -63.47 144.35 57.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.012 0.434 . . . . 0.0 110.526 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.521 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.32 -42.82 9.1 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.012 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.6 tp -62.65 -42.34 99.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.657 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.05 -10.83 56.88 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.508 -179.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.443 HD12 ' O ' ' A' ' 125' ' ' SER . 85.5 mt -115.82 -23.96 8.4 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.62 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . 0.521 ' N ' ' O ' ' A' ' 126' ' ' ALA . 73.2 t80 -51.83 -48.9 63.72 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.569 -0.452 . . . . 0.0 110.537 -178.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.53 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 39.4 p-10 -66.17 -41.67 89.98 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.885 0.374 . . . . 0.0 111.34 179.26 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.53 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 87.9 mt-30 -67.83 -37.33 81.77 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.874 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.464 HD12 HD11 ' A' ' 118' ' ' ILE . 97.1 mt -79.65 -42.57 24.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.134 -179.674 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.2 t -57.78 -44.9 86.54 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.256 -178.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 18.8 m -62.19 -46.09 90.46 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.865 0.364 . . . . 0.0 110.76 179.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 92.3 mt -62.47 -43.63 98.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.374 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.589 ' HB1' ' HD2' ' A' ' 138' ' ' PRO . . . -170.02 163.14 6.52 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.459 179.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.589 ' HD2' ' HB1' ' A' ' 137' ' ' ALA . 77.4 Cg_exo -42.02 110.81 0.16 Allowed 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.531 2.154 . . . . 0.0 112.088 179.413 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.503 HG21 ' CD1' ' A' ' 130' ' ' TYR . 2.9 m -87.48 127.59 35.23 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.559 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.653 HD13 ' CD2' ' A' ' 37' ' ' HIS . 34.9 tp -119.61 139.42 52.21 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.077 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.429 ' O ' ' OD2' ' A' ' 32' ' ' ASP . 81.0 mt -105.48 120.0 55.54 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.385 0 CA-C-O 121.14 0.495 . . . . 0.0 111.341 -179.665 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.494 HD12 HD22 ' A' ' 117' ' ' LEU . 98.2 mt -135.42 132.51 52.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.683 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.546 HD21 ' CG ' ' A' ' 241' ' ' ASP . 59.1 t30 -64.71 147.8 52.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.885 0.374 . . . . 0.0 110.368 179.275 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.454 ' O ' ' OD2' ' A' ' 241' ' ' ASP . 86.5 t80 -82.41 122.69 28.33 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.046 -179.593 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.433 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 91.4 m-20 55.32 69.02 0.78 Allowed 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.951 179.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 34.8 p-10 -125.78 0.37 7.39 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.943 0.401 . . . . 0.0 110.68 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -150.55 115.7 5.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.747 -179.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 85.9 p -63.93 169.07 4.52 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.566 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.419 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.6 p-90 -51.87 -15.95 0.62 Allowed 'General case' 0 C--O 1.223 -0.341 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.49 -179.763 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . 0.43 ' O ' HG23 ' A' ' 154' ' ' THR . 68.1 tp60 -70.41 -76.09 0.11 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.469 -179.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.442 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.1 t -62.47 -38.61 90.51 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.011 0.434 . . . . 0.0 110.241 179.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 51.1 tp -60.21 -45.48 93.02 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.334 -178.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.419 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 45.8 tp -62.69 -41.86 99.33 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.859 0.361 . . . . 0.0 110.398 178.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.442 ' OG1' ' O ' ' A' ' 151' ' ' SER . 57.6 p -63.89 -34.74 78.63 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.18 -179.371 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.463 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 88.1 mm-40 -63.85 -42.28 97.61 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.153 179.274 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 90.5 mt -65.28 -39.07 92.09 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.125 0.488 . . . . 0.0 110.096 179.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.577 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.03 -32.39 80.1 Favored Glycine 0 CA--C 1.519 0.321 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 -179.292 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.463 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.3 mt-10 -36.65 -25.09 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.82 0.343 . . . . 0.0 110.807 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.577 ' N ' ' O ' ' A' ' 157' ' ' GLY . 95.8 mt -59.56 148.53 7.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.193 179.284 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 71.3 p -68.91 137.68 54.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.12 -179.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 70.56 21.91 77.77 Favored Glycine 0 N--CA 1.458 0.146 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 179.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 60.3 m80 -124.28 -14.34 7.0 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.73 0.3 . . . . 0.0 110.569 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -66.17 -59.49 3.71 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.792 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -52.22 -48.32 65.18 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 120.679 -0.409 . . . . 0.0 110.093 -179.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -60.88 -40.96 95.0 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.697 0.284 . . . . 0.0 110.313 179.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.61 -47.17 86.64 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.6 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -57.2 -39.83 76.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.179 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -61.85 -50.3 72.79 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.569 179.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.406 ' NE ' ' HB1' ' A' ' 59' ' ' ALA . 60.1 ttt85 -65.5 -43.78 89.09 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.458 179.536 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 94.8 mt -64.47 -43.52 96.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.386 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.32 -50.89 71.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.474 -179.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.97 -43.56 95.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.454 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . 0.658 ' CE2' HD11 ' A' ' 177' ' ' LEU . 56.7 t80 -62.67 -44.59 95.87 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.07 0.462 . . . . 0.0 110.386 179.407 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -63.38 -39.96 95.94 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.561 -179.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -62.9 -42.8 99.91 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.623 179.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -60.78 -44.69 96.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.044 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.658 HD11 ' CE2' ' A' ' 173' ' ' PHE . 84.7 mt -64.34 -41.26 96.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.058 0.456 . . . . 0.0 110.733 178.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.13 -62.19 1.79 Allowed 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.43 -179.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.35 -46.86 85.46 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.52 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.02 -41.6 64.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.159 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -63.8 -33.48 75.77 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.015 0.436 . . . . 0.0 110.371 179.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . 0.419 ' HG2' ' O ' ' A' ' 182' ' ' GLU . 69.7 tt0 -91.1 8.22 36.62 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.476 0.655 . . . . 0.0 110.529 -178.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -103.88 -32.62 9.2 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.348 179.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 45.1 pt -128.0 147.75 32.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.893 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -139.74 131.2 26.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.382 179.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . 0.593 HD22 ' N ' ' A' ' 186' ' ' LEU . 3.6 mm? -85.5 133.97 41.09 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.953 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -44.23 157.99 0.15 Allowed 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 122.734 2.289 . . . . 0.0 112.097 179.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . 0.519 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.5 Cg_endo -62.93 115.05 2.7 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 C-N-CA 122.775 2.317 . . . . 0.0 111.662 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . 0.519 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.8 mt-30 155.23 148.33 0.0 OUTLIER Pre-proline 0 C--N 1.332 -0.176 0 O-C-N 123.833 0.708 . . . . 0.0 110.869 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -73.75 144.29 34.93 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.688 2.259 . . . . 0.0 111.881 178.042 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.495 HG23 ' OG ' ' A' ' 258' ' ' SER . 2.1 p -124.92 158.65 32.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.365 0.602 . . . . 0.0 110.12 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . 0.491 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 35.9 p -143.22 165.31 27.81 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.245 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . 0.448 ' HA ' ' H ' ' A' ' 260' ' ' PHE . . . -135.31 128.63 32.11 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 121.229 0.537 . . . . 0.0 110.233 179.589 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.52 HD11 HD23 ' A' ' 259' ' ' LEU . 48.3 pt -146.7 149.38 15.93 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.362 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.161 179.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . 0.739 HG13 ' CD1' ' A' ' 262' ' ' PHE . 69.0 t -117.95 123.4 71.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.317 0.58 . . . . 0.0 109.621 179.255 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -134.38 106.71 7.21 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.253 179.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 95.0 m -130.34 130.47 44.48 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.897 179.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.402 ' O ' ' N ' ' A' ' 201' ' ' HIS . . . -83.11 -36.83 24.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.142 179.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.63 -66.72 0.29 Allowed 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.311 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.52 -9.75 58.95 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.231 179.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . 0.402 ' N ' ' O ' ' A' ' 198' ' ' ALA . 60.6 t-80 60.85 58.28 2.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.887 -179.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 36.0 p -167.11 153.64 8.33 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.554 179.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.64 144.18 24.22 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.02 0.438 . . . . 0.0 110.355 179.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -135.53 138.66 43.28 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.67 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 20.3 mt -106.64 125.53 51.12 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 -179.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 206' ' ' TRP . . . . . 0.557 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 73.9 m95 -82.0 167.32 18.99 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.643 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . 0.468 HG22 ' C ' ' A' ' 206' ' ' TRP . 0.1 OUTLIER -157.17 171.59 7.25 Favored Pre-proline 0 C--O 1.224 -0.238 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.585 -179.218 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -53.58 -37.29 82.96 Favored 'Trans proline' 0 C--N 1.303 -1.84 0 C-N-CA 122.602 2.201 . . . . 0.0 112.114 179.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -70.45 -35.37 73.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.858 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 21.6 m -60.67 150.94 30.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.591 -179.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.61 -37.22 83.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.524 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 212' ' ' GLN . . . . . 0.557 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 54.9 tt0 -64.5 -40.4 95.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.515 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.59 -43.39 92.26 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -63.26 -43.96 96.48 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 215' ' ' MET . . . . . 0.547 ' SD ' ' HB2' ' A' ' 304' ' ' ALA . 65.6 ttp -59.62 -47.71 84.51 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.196 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 216' ' ' LEU . 86.0 mt -60.78 -40.81 93.96 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 217' ' ' GLU . . . . . 0.452 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.4 tp10 -58.61 -37.82 76.67 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -65.18 -38.5 90.72 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.721 0.296 . . . . 0.0 110.525 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 94.8 mt -64.09 -42.83 96.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.105 0.479 . . . . 0.0 110.504 -179.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.48 45.13 0.08 OUTLIER Glycine 0 C--N 1.334 0.467 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 221' ' ' PHE . . . . . 0.452 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 26.9 m-85 -128.01 155.59 44.07 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.107 0.48 . . . . 0.0 110.47 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.486 ' O ' HG13 ' A' ' 191' ' ' VAL . 7.6 p -106.8 122.29 46.1 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.263 0.554 . . . . 0.0 110.136 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.475 HD22 ' C ' ' A' ' 222' ' ' THR . 4.3 mm? -101.33 133.09 46.47 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.159 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.93 159.68 14.78 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.535 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -105.41 115.26 29.95 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.302 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.494 ' N ' HD12 ' A' ' 226' ' ' LEU . 9.0 mp -53.0 156.8 3.24 Favored Pre-proline 0 N--CA 1.452 -0.355 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.746 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -60.39 145.22 99.08 Favored 'Trans proline' 0 C--N 1.3 -1.974 0 C-N-CA 122.628 2.219 . . . . 0.0 112.121 179.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -86.98 -3.43 59.09 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.54 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.12 -41.1 5.64 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . 0.523 ' O ' ' N ' ' A' ' 233' ' ' SER . 69.5 mt -79.15 -17.71 54.48 Favored 'General case' 0 C--O 1.221 -0.42 0 CA-C-O 121.082 0.468 . . . . 0.0 110.319 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 54.8 t-20 -40.72 -48.9 3.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.844 -179.163 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -87.49 15.09 7.03 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.772 0.32 . . . . 0.0 111.428 179.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . 0.523 ' N ' ' O ' ' A' ' 230' ' ' LEU . 77.9 p -60.45 -35.11 75.06 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.676 -179.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . 0.523 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.5 tt0 -119.33 -69.33 0.85 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.977 179.368 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.0 m -70.18 101.4 1.86 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.633 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -93.15 58.24 2.86 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.376 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -144.81 -122.42 1.56 Allowed Glycine 0 CA--C 1.52 0.353 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -135.62 111.36 9.35 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.25 0.548 . . . . 0.0 110.34 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . 0.529 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.5 mtt180 -147.9 57.95 1.1 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.756 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -69.1 -32.85 72.55 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.519 179.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 241' ' ' ASP . . . . . 0.546 ' CG ' HD21 ' A' ' 143' ' ' ASN . 65.1 t0 -57.02 -47.14 81.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.305 -178.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 242' ' ' ILE . . . . . 0.433 ' O ' ' O ' ' A' ' 239' ' ' ARG . 18.5 tt -139.4 155.4 25.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.901 0.382 . . . . 0.0 110.504 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.444 HG22 HD13 ' A' ' 245' ' ' LEU . 96.2 mt -106.16 106.86 21.37 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.235 0 CA-C-O 121.232 0.539 . . . . 0.0 110.59 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . 0.601 ' O ' HD12 ' A' ' 245' ' ' LEU . 88.3 mt-30 -110.46 109.91 20.46 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.292 179.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.601 HD12 ' O ' ' A' ' 244' ' ' GLN . 9.4 mp -121.51 -168.28 1.66 Allowed 'General case' 0 C--O 1.225 -0.229 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.672 179.736 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . 0.523 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.9 -16.21 0.05 OUTLIER Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . 0.673 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -61.49 156.18 35.45 Favored Glycine 0 CA--C 1.521 0.457 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -63.28 21.79 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.991 0.424 . . . . 0.0 110.672 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . 0.673 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.8 m-20 -97.15 -6.19 35.45 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.478 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 91.7 mt -79.76 -21.97 43.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.631 179.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.61 -51.21 70.89 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.824 -179.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.38 -5.5 58.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.443 179.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.38 -74.39 1.15 Allowed Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 83.4 mt -69.96 125.92 28.18 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.067 0.461 . . . . 0.0 110.235 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -59.49 -39.44 83.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.139 -179.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 83.1 51.76 4.06 Favored Glycine 0 CA--C 1.52 0.401 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -95.92 -14.88 22.76 Favored 'General case' 0 C--N 1.331 -0.198 0 O-C-N 122.721 -0.282 . . . . 0.0 110.571 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 258' ' ' SER . . . . . 0.495 ' OG ' HG23 ' A' ' 191' ' ' VAL . 3.5 t 174.52 88.99 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.11 0.481 . . . . 0.0 110.049 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.86 ' N ' HD12 ' A' ' 259' ' ' LEU . 0.9 OUTLIER -94.47 124.3 38.42 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.367 0.603 . . . . 0.0 111.174 -179.204 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 260' ' ' PHE . . . . . 0.448 ' H ' ' HA ' ' A' ' 193' ' ' ALA . 16.0 m-30 -93.36 146.43 23.74 Favored 'General case' 0 CA--C 1.503 -0.843 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.328 179.43 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 86.5 mt -122.0 149.86 42.89 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.597 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.739 ' CD1' HG13 ' A' ' 195' ' ' VAL . 2.5 p90 -77.83 -139.0 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.431 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 263' ' ' ALA . . . . . 0.658 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -51.59 77.71 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 121.047 0.451 . . . . 0.0 111.15 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . 0.628 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.44 104.69 0.19 Allowed Glycine 0 CA--C 1.527 0.795 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 265' ' ' ASP . . . . . 0.601 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.9 m-20 -80.55 -177.56 6.3 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 120.632 0.253 . . . . 0.0 110.971 -179.611 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -40.45 -17.81 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.854 0.359 . . . . 0.0 110.513 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 267' ' ' LYS . . . . . 0.601 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.26 -51.7 42.24 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.684 179.438 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -63.74 -46.69 84.19 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.973 179.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . 0.58 ' HB1' ' OH ' ' A' ' 273' ' ' TYR . . . -61.44 -35.28 77.14 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 121.238 0.542 . . . . 0.0 109.753 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -63.06 -34.61 77.96 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.022 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.31 -43.2 13.92 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.393 -179.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 272' ' ' ILE . . . . . 0.586 ' C ' ' H ' ' A' ' 274' ' ' ALA . 4.9 tt -51.36 -33.78 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.864 -178.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 273' ' ' TYR . . . . . 0.58 ' OH ' ' HB1' ' A' ' 269' ' ' ALA . 17.1 m-85 -54.31 -2.06 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.674 -179.533 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 274' ' ' ALA . . . . . 0.586 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.54 -39.71 70.51 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.996 179.533 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . 0.582 ' O ' ' N ' ' A' ' 279' ' ' ALA . 4.0 p30 -38.6 97.31 0.13 Allowed Pre-proline 0 C--O 1.225 -0.185 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.556 -179.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 276' ' ' PRO . . . . . 0.401 ' N ' ' O ' ' A' ' 274' ' ' ALA . 47.5 Cg_exo -54.1 -42.82 63.84 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 C-N-CA 122.234 1.956 . . . . 0.0 112.696 -178.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 89.7 mt -64.38 -42.73 96.0 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.188 0.518 . . . . 0.0 111.266 -179.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 91.4 mt -95.97 -1.16 49.65 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.922 -179.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 279' ' ' ALA . . . . . 0.582 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.39 -34.94 77.71 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.662 -179.684 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -73.87 20.01 0.11 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.035 -179.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . 0.489 HD23 ' HA ' ' A' ' 281' ' ' LEU . 13.7 mt -75.15 120.12 80.18 Favored Pre-proline 0 N--CA 1.45 -0.439 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.423 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -51.21 -39.26 62.09 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.568 2.178 . . . . 0.0 111.809 179.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -53.19 -50.34 64.85 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 78.1 t -61.47 -43.91 97.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 179.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -57.66 -41.04 80.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.186 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -91.27 0.19 57.57 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.065 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt 59.54 44.06 15.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.07 0.462 . . . . 0.0 110.935 179.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -95.25 41.46 1.1 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.347 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 54.6 t -119.39 135.6 59.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 121.089 0.471 . . . . 0.0 110.161 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -132.92 163.14 29.82 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.071 0.462 . . . . 0.0 110.695 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.59 155.02 33.04 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-O 121.068 0.461 . . . . 0.0 110.782 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 82.1 mt -94.23 -1.36 54.18 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.211 -179.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.72 165.53 12.6 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 6.8 m -87.57 -62.07 1.58 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.905 0.383 . . . . 0.0 111.146 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 295' ' ' GLU . . . . . 0.447 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.6 mm-40 -69.16 -3.97 15.65 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.721 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 25.5 p -76.56 32.39 0.13 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.648 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 297' ' ' PHE . . . . . 0.513 ' CD2' HG22 ' A' ' 70' ' ' THR . 85.9 t80 -60.47 -45.88 92.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.603 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . 0.62 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.1 mtt85 -81.2 135.02 35.72 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.02 0.438 . . . . 0.0 110.546 -179.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.471 ' H ' HG11 ' A' ' 51' ' ' VAL . 18.4 tp -113.91 117.18 30.66 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-O 121.054 0.454 . . . . 0.0 110.098 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . 0.621 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.6 p-10 -165.21 -176.66 4.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.533 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 81.2 t80 -47.05 -43.15 19.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.169 -179.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -67.11 -40.13 86.83 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.046 0.451 . . . . 0.0 110.91 179.043 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . 0.621 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 59.9 p -56.27 -36.27 68.38 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.021 -179.093 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . 0.547 ' HB2' ' SD ' ' A' ' 215' ' ' MET . . . -57.32 -51.54 68.95 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.51 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 90.2 mtp -56.67 -43.11 80.1 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -179.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -66.48 -42.72 87.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.003 0.43 . . . . 0.0 110.09 178.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 303' ' ' SER . 55.5 t -63.94 -43.19 97.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.126 179.381 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 43.4 tp -59.9 -42.14 93.18 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.683 -179.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -62.24 -39.27 92.27 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 310' ' ' ARG . . . . . 0.451 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.5 ttt85 -63.75 -44.01 94.75 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.203 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 89.5 mt -63.35 -42.21 98.89 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.194 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt -62.95 -33.57 75.66 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.081 0.467 . . . . 0.0 109.977 179.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.53 -23.75 21.95 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.325 -179.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . 0.484 HD22 ' CE2' ' A' ' 315' ' ' PHE . 6.7 tt -62.33 -43.12 99.56 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 121.111 0.482 . . . . 0.0 110.562 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 315' ' ' PHE . . . . . 0.484 ' CE2' HD22 ' A' ' 314' ' ' LEU . 90.3 m-85 . . . . . 0 C--O 1.22 -0.469 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.428 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -99.37 135.89 40.12 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.016 0.436 . . . . 0.0 110.504 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.497 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -92.01 178.39 1.74 Allowed Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.548 -179.928 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.497 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.8 Cg_exo -61.61 147.28 95.76 Favored 'Trans proline' 0 C--N 1.3 -2.018 0 C-N-CA 122.79 2.327 . . . . 0.0 112.104 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.46 ' HE ' HD12 ' A' ' 39' ' ' LEU . 35.6 ptt180 -135.79 142.16 44.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.72 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -79.71 116.51 19.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.471 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.445 ' O ' HG23 ' A' ' 30' ' ' ILE . 9.4 tp -110.94 130.68 63.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.498 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.6 t -70.71 141.99 51.53 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.563 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.475 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.4 t0 -139.68 179.39 6.61 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.568 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.475 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 78.0 p -73.92 -36.99 64.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.61 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.8 ttt85 -46.54 -94.67 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.331 -179.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -167.16 -26.42 0.02 OUTLIER Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 59.9 m -169.11 104.73 0.39 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.879 0.371 . . . . 0.0 110.65 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.686 ' CD2' HD13 ' A' ' 140' ' ' LEU . 75.6 t60 -128.39 148.89 50.72 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.033 0.444 . . . . 0.0 110.262 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.626 HG22 ' N ' ' A' ' 39' ' ' LEU . 98.2 m -131.23 166.04 22.04 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.62 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.626 ' N ' HG22 ' A' ' 38' ' ' THR . 81.5 mt -120.83 127.61 52.08 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.43 179.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -65.2 -44.55 87.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.694 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 39.9 p -165.83 154.88 11.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.448 179.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.495 ' H ' ' CD ' ' A' ' 42' ' ' GLN . 14.8 mp0 -44.34 101.13 0.24 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.626 179.449 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -57.39 129.59 34.79 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 C-N-CA 122.365 2.044 . . . . 0.0 112.283 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -84.1 -24.57 30.27 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.502 179.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.539 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.5 mtm-85 -122.29 134.17 54.67 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-O 121.147 0.498 . . . . 0.0 110.34 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.1 mt -130.43 133.76 63.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.949 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 45.4 t -124.25 130.49 73.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 179.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.642 ' OG ' HD12 ' A' ' 117' ' ' LEU . 2.0 m -155.38 167.75 29.36 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.556 179.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 59.5 p -124.9 9.44 8.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.487 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.56 125.42 33.08 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.672 -179.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.45 HG11 ' H ' ' A' ' 299' ' ' LEU . 95.1 t -65.92 -44.43 92.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.417 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.4 m -62.49 -44.26 96.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.651 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 51.3 tp -62.33 -41.41 98.54 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.5 -179.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.453 ' O ' HD13 ' A' ' 58' ' ' LEU . 75.5 m -57.7 -44.48 85.88 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.258 -179.209 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.29 -62.18 5.36 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 179.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.7 t -48.38 -35.51 12.75 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 57' ' ' LEU . 19.8 mt -61.87 -44.64 96.4 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.707 -0.397 . . . . 0.0 111.17 179.41 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.453 HD13 ' O ' ' A' ' 54' ' ' THR . 9.2 mp -65.01 -41.7 95.09 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.303 178.014 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.63 -40.97 98.24 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.989 -179.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.431 ' O ' HG23 ' A' ' 60' ' ' ILE . 8.0 tp -88.65 16.79 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.762 -179.6 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 56.41 84.82 0.08 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.674 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 178.67 57.86 0.06 OUTLIER Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.016 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.411 ' HB3' HE21 ' A' ' 85' ' ' GLN . 10.1 Cg_endo -50.77 153.34 8.39 Favored 'Trans proline' 0 C--N 1.296 -2.202 0 C-N-CA 122.892 2.394 . . . . 0.0 112.38 -178.276 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.437 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.2 OUTLIER -108.93 145.44 15.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.359 -179.714 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.8 mt -63.62 -45.24 98.09 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.317 -179.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.502 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -129.49 134.08 47.61 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 120.848 0.356 . . . . 0.0 110.539 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.501 ' O ' ' N ' ' A' ' 98' ' ' LEU . 75.2 m -134.73 158.84 43.09 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.798 -179.637 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.99 139.15 16.01 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.489 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.81 -162.69 0.08 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.914 0.388 . . . . 0.0 110.503 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.539 HG22 ' CD2' ' A' ' 297' ' ' PHE . 14.5 t -133.49 134.43 43.46 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.404 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.491 ' C ' ' O ' ' A' ' 70' ' ' THR . 0.6 OUTLIER 29.69 68.82 0.65 Allowed Pre-proline 0 N--CA 1.464 0.226 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.754 -179.866 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -61.25 145.17 98.83 Favored 'Trans proline' 0 C--N 1.299 -2.031 0 C-N-CA 122.627 2.218 . . . . 0.0 112.062 -178.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.533 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 45.1 p-10 -159.14 -32.04 0.06 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.677 179.643 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.542 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 99.1 m-20 -64.1 -39.7 94.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.489 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -60.23 -48.33 82.19 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.706 -179.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.424 ' O ' ' O ' ' A' ' 77' ' ' ALA . 92.6 t -60.25 -24.9 32.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 179.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.542 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -45.71 172.98 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.555 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.575 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.2 p30 -62.18 177.89 0.43 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.564 -179.728 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.554 ' C ' ' H ' ' A' ' 81' ' ' GLY . 36.1 p30 -45.13 85.79 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.965 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.575 ' N ' ' O ' ' A' ' 78' ' ' ASP . 42.5 tp60 -67.69 13.17 0.08 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.109 -179.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.554 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 118.73 -22.34 9.32 Favored Glycine 0 CA--C 1.519 0.324 0 N-CA-C 110.969 -0.852 . . . . 0.0 110.969 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -108.13 116.46 32.01 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.014 0.435 . . . . 0.0 110.44 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 75.8 mt -98.71 0.4 44.49 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.491 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -92.53 7.24 44.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.971 0.415 . . . . 0.0 110.413 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.802 ' O ' HG22 ' A' ' 89' ' ' VAL . 87.8 mt-30 -100.12 -28.19 13.16 Favored 'General case' 0 C--O 1.225 -0.234 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.823 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 68.9 t-105 -62.77 -40.71 98.12 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.858 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.554 ' O ' ' N ' ' A' ' 91' ' ' LYS . 65.4 m -77.73 -53.56 7.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.148 -179.364 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -48.51 -50.76 30.48 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.965 -179.262 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.802 HG22 ' O ' ' A' ' 85' ' ' GLN . 15.7 m -68.87 -40.62 81.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 120.867 0.365 . . . . 0.0 111.005 179.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.497 ' N ' HG23 ' A' ' 89' ' ' VAL . . . -72.32 -22.63 61.15 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.695 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.554 ' N ' ' O ' ' A' ' 87' ' ' SER . 65.9 tttm -62.01 -45.51 93.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.512 -179.498 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.442 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.6 mm-40 -90.53 -94.85 0.12 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.134 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.636 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.9 mtt180 -142.92 58.97 1.42 Allowed 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.461 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.6 pttp 33.43 26.13 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 120.879 0.371 . . . . 0.0 110.221 -179.145 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.636 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.4 tt -48.08 123.52 6.38 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.925 -178.102 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.454 ' O ' HD23 ' A' ' 95' ' ' LEU . 99.0 mm-40 -83.88 -169.41 2.56 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.092 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.603 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 81.3 mtp180 -74.58 136.84 42.05 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.298 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.501 ' N ' ' O ' ' A' ' 67' ' ' SER . 91.3 mt -85.79 -165.82 1.35 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.762 -179.68 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.537 ' CD2' ' O ' ' A' ' 99' ' ' TYR . 48.3 p90 -168.33 119.77 0.81 Allowed 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.178 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.515 ' C ' ' O ' ' A' ' 99' ' ' TYR . 43.0 mm -28.88 120.96 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.977 -179.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 114.25 27.57 3.35 Favored Glycine 0 CA--C 1.52 0.344 0 N-CA-C 111.154 -0.779 . . . . 0.0 111.154 -179.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.582 ' H ' ' CD ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -144.63 46.62 0.63 Allowed Pre-proline 0 C--N 1.324 -0.537 0 CA-C-O 120.995 0.426 . . . . 0.0 110.479 179.885 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 29.5 Cg_endo -61.91 143.97 96.1 Favored 'Trans proline' 0 C--N 1.297 -2.153 0 C-N-CA 122.644 2.229 . . . . 0.0 111.993 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.455 ' O ' HG23 ' A' ' 108' ' ' VAL . 27.8 t -173.16 120.0 0.34 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.462 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.61 -40.46 63.8 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.035 0.445 . . . . 0.0 111.049 179.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.25 -39.87 89.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.88 -179.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.22 -39.97 95.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.75 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 104' ' ' SER . 71.3 t -67.57 -43.87 86.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.798 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.84 -38.89 92.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.578 -179.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.442 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.49 -23.31 62.66 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.49 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.551 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.4 mm-40 -90.64 5.3 48.56 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.687 -179.502 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.551 ' C ' ' O ' ' A' ' 111' ' ' GLN . 10.6 tpt 23.55 64.13 0.38 Allowed Pre-proline 0 N--CA 1.465 0.296 0 CA-C-O 120.896 0.379 . . . . 0.0 110.946 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -78.14 167.24 23.64 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 123.03 2.487 . . . . 0.0 112.132 -178.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.524 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 98.9 m-20 -109.96 -42.11 4.31 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.19 179.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.3 tp -121.24 120.21 34.5 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.019 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 82.5 mt -112.79 128.88 69.26 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.336 0 CA-C-O 120.918 0.389 . . . . 0.0 110.812 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.642 HD12 ' OG ' ' A' ' 48' ' ' SER . 29.2 mt -109.13 132.32 54.23 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 121.088 0.471 . . . . 0.0 110.211 -179.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.494 HD12 HG23 ' A' ' 139' ' ' THR . 99.1 mt -119.94 138.57 50.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.645 -179.743 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 85.9 p -72.44 154.07 41.07 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.608 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.18 -50.21 74.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.636 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.0 t -149.73 154.3 38.29 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.579 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 170.66 -170.79 43.37 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.99 -34.03 88.83 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.452 ' O ' ' OD1' ' A' ' 124' ' ' ASP . 44.5 p-10 -87.29 120.42 28.55 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.796 0.332 . . . . 0.0 110.684 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.441 ' O ' HD12 ' A' ' 129' ' ' LEU . 38.8 t -63.2 143.83 57.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.504 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.52 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.0 -43.23 9.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.928 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.6 tp -62.86 -42.35 99.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.706 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.58 -12.07 59.54 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.485 -179.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.441 HD12 ' O ' ' A' ' 125' ' ' SER . 85.3 mt -114.77 -23.84 8.99 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.649 -179.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . 0.52 ' N ' ' O ' ' A' ' 126' ' ' ALA . 79.9 t80 -50.9 -49.66 58.96 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.592 -178.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.0 p-10 -66.12 -42.6 88.97 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.861 0.363 . . . . 0.0 111.158 179.576 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.521 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 88.4 mt-30 -66.98 -37.94 85.15 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.781 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.433 HD12 HD11 ' A' ' 118' ' ' ILE . 96.0 mt -80.32 -41.38 24.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.892 -179.549 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.2 t -57.21 -44.52 83.76 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.212 -179.098 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.5 m -61.87 -45.22 94.7 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.751 0.31 . . . . 0.0 110.517 179.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 93.3 mt -62.18 -43.6 98.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.27 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.67 ' HB1' ' HD2' ' A' ' 138' ' ' PRO . . . -169.51 168.69 4.66 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.554 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.67 ' HD2' ' HB1' ' A' ' 137' ' ' ALA . 52.7 Cg_exo -50.38 113.04 0.87 Allowed 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.282 1.988 . . . . 0.0 112.206 179.414 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.494 HG23 HD12 ' A' ' 118' ' ' ILE . 23.4 m -83.97 127.39 33.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.609 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.686 HD13 ' CD2' ' A' ' 37' ' ' HIS . 34.8 tp -117.87 135.91 53.79 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.034 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.44 ' O ' ' OD2' ' A' ' 32' ' ' ASP . 81.7 mt -100.18 118.85 47.44 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.331 0 CA-C-O 121.174 0.512 . . . . 0.0 111.194 -179.36 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.428 HD12 HD22 ' A' ' 117' ' ' LEU . 98.1 mt -134.74 132.28 54.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.621 179.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.55 HD21 ' CG ' ' A' ' 241' ' ' ASP . 60.9 t30 -66.97 151.42 47.66 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.905 0.383 . . . . 0.0 110.433 179.457 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.522 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 88.0 t80 -86.11 122.38 30.04 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.811 -179.52 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.522 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 98.9 m-20 55.17 69.34 0.74 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.754 179.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 35.8 p-10 -125.8 0.16 7.37 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.651 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -150.56 115.13 5.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.7 -179.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 84.5 p -63.3 168.33 4.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.542 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.422 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.6 p-90 -51.83 -15.88 0.59 Allowed 'General case' 0 C--O 1.223 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.524 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . 0.439 ' O ' HG23 ' A' ' 154' ' ' THR . 68.1 tp60 -70.39 -76.02 0.11 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.511 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.448 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.1 t -62.7 -38.63 91.16 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.295 179.51 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 54.0 tp -60.02 -45.66 92.07 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.379 -178.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.422 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 46.9 tp -62.76 -41.75 99.36 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.832 0.348 . . . . 0.0 110.365 179.066 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.448 ' OG1' ' O ' ' A' ' 151' ' ' SER . 60.2 p -64.14 -34.86 79.03 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.264 -179.498 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.435 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.9 mm-40 -64.24 -42.59 96.45 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.322 179.286 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 91.6 mt -65.55 -38.82 90.68 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.037 0.446 . . . . 0.0 110.252 179.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.583 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.29 -32.31 80.3 Favored Glycine 0 CA--C 1.521 0.418 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 -179.387 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.442 ' C ' ' O ' ' A' ' 157' ' ' GLY . 97.1 mt-10 -35.17 -27.29 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.821 0.344 . . . . 0.0 110.764 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.583 ' N ' ' O ' ' A' ' 157' ' ' GLY . 95.5 mt -56.03 149.76 3.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.33 179.187 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 71.5 p -69.87 137.3 51.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.002 -179.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 71.57 20.34 78.4 Favored Glycine 0 N--CA 1.458 0.143 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 179.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 58.0 m80 -121.78 -14.91 8.02 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.706 0.289 . . . . 0.0 110.571 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -65.85 -59.83 3.48 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.764 -179.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -52.05 -49.35 63.64 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.16 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -60.76 -41.14 94.85 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.718 0.294 . . . . 0.0 110.356 179.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.45 -47.2 86.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.613 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -57.0 -40.16 76.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.241 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -61.65 -50.34 72.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.571 179.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -65.34 -43.75 89.91 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.535 179.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 95.2 mt -64.6 -43.47 96.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.509 179.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.21 -51.17 70.43 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.535 -179.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.44 -43.93 96.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.46 179.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . 0.654 ' CE2' HD11 ' A' ' 177' ' ' LEU . 56.7 t80 -62.72 -44.45 96.18 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.04 0.448 . . . . 0.0 110.405 179.44 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -63.35 -39.88 95.75 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.616 -179.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -63.07 -42.78 99.74 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.617 179.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -60.67 -44.77 96.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.181 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.654 HD11 ' CE2' ' A' ' 173' ' ' PHE . 83.7 mt -64.36 -41.23 96.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.031 0.443 . . . . 0.0 110.698 178.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.08 -62.32 1.71 Allowed 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.482 -179.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.52 -46.9 85.81 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.552 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.12 -41.76 65.34 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.223 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -63.94 -33.52 75.91 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.976 0.417 . . . . 0.0 110.352 179.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . 0.423 ' HG2' ' O ' ' A' ' 182' ' ' GLU . 69.6 tt0 -90.72 8.68 33.27 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.37 0.605 . . . . 0.0 110.52 -179.003 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -104.84 -32.12 8.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.195 179.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 45.4 pt -128.11 147.67 32.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.814 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -139.86 131.03 26.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.422 179.362 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . 0.596 HD22 ' N ' ' A' ' 186' ' ' LEU . 3.6 mm? -85.59 133.14 42.56 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.901 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -43.89 157.72 0.14 Allowed 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.738 2.292 . . . . 0.0 112.138 179.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . 0.525 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.8 Cg_endo -63.01 115.21 2.81 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 C-N-CA 122.804 2.336 . . . . 0.0 111.724 179.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . 0.525 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.7 mt-30 155.53 147.63 0.0 OUTLIER Pre-proline 0 C--N 1.332 -0.195 0 O-C-N 123.596 0.56 . . . . 0.0 110.762 -179.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -73.77 143.85 34.17 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.651 2.234 . . . . 0.0 111.963 178.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.499 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.1 p -125.03 159.09 32.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.27 0.557 . . . . 0.0 110.164 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . 0.499 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 35.9 p -143.54 165.48 27.45 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.034 -179.636 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . 0.44 ' HA ' ' H ' ' A' ' 260' ' ' PHE . . . -135.38 128.58 31.89 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.159 0.504 . . . . 0.0 110.213 179.587 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.509 HD11 HD23 ' A' ' 259' ' ' LEU . 47.4 pt -146.49 148.81 16.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.048 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . 0.752 HG13 ' CD1' ' A' ' 262' ' ' PHE . 68.9 t -117.67 123.09 71.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-O 121.238 0.542 . . . . 0.0 109.765 179.104 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -134.3 107.29 7.56 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.332 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 95.2 m -130.96 130.6 43.63 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.756 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.406 ' O ' ' N ' ' A' ' 201' ' ' HIS . . . -82.84 -36.9 25.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.256 179.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.34 -67.18 0.25 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.374 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.33 -9.43 58.49 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.348 179.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . 0.406 ' N ' ' O ' ' A' ' 198' ' ' ALA . 60.2 t-80 60.27 58.42 2.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.748 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 46.4 p -167.21 153.65 8.19 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.535 179.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.6 144.23 24.29 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.992 0.425 . . . . 0.0 110.446 179.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -135.39 138.4 43.27 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.646 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 20.0 mt -106.42 125.48 51.05 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 121.11 0.481 . . . . 0.0 109.867 -179.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 206' ' ' TRP . . . . . 0.557 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 75.7 m95 -82.01 167.03 19.28 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.659 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . 0.466 HG22 ' C ' ' A' ' 206' ' ' TRP . 0.1 OUTLIER -156.77 171.33 7.56 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.586 -179.156 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.87 -37.03 85.02 Favored 'Trans proline' 0 C--N 1.302 -1.879 0 C-N-CA 122.624 2.216 . . . . 0.0 112.133 179.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -70.47 -34.87 72.89 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.8 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 22.0 m -61.26 150.83 33.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.64 -179.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.59 -36.95 82.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.448 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 212' ' ' GLN . . . . . 0.557 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 54.8 tt0 -64.69 -40.29 95.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.506 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.61 -43.45 92.07 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -63.26 -43.52 97.76 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.741 0.305 . . . . 0.0 110.281 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 215' ' ' MET . . . . . 0.525 ' SD ' ' HB2' ' A' ' 304' ' ' ALA . 65.2 ttp -59.61 -48.11 82.95 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.252 -179.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 87.9 mt -60.49 -41.04 93.45 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 179.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 217' ' ' GLU . . . . . 0.455 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.3 tp10 -57.88 -37.85 74.69 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -65.36 -37.98 88.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.8 0.333 . . . . 0.0 110.679 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 94.4 mt -64.43 -42.64 95.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.606 -179.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.49 44.6 0.08 OUTLIER Glycine 0 C--N 1.333 0.408 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 221' ' ' PHE . . . . . 0.455 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 26.5 m-85 -127.74 155.28 44.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.04 0.447 . . . . 0.0 110.507 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.487 ' O ' HG13 ' A' ' 191' ' ' VAL . 6.5 p -106.99 122.11 45.8 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.201 0.524 . . . . 0.0 110.154 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.472 HD22 ' C ' ' A' ' 222' ' ' THR . 4.3 mm? -101.07 133.12 46.06 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.063 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.96 159.31 14.98 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.463 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.43 115.42 30.23 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.942 0.401 . . . . 0.0 110.351 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.499 ' N ' HD12 ' A' ' 226' ' ' LEU . 8.9 mp -53.47 156.77 4.04 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.686 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -60.29 145.41 98.65 Favored 'Trans proline' 0 C--N 1.301 -1.956 0 C-N-CA 122.721 2.281 . . . . 0.0 112.058 179.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.36 -2.92 58.96 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.546 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.31 -40.8 5.66 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . 0.54 ' O ' ' N ' ' A' ' 233' ' ' SER . 86.2 mt -79.27 -16.75 55.96 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-O 121.006 0.431 . . . . 0.0 110.386 -179.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . 0.403 ' C ' ' O ' ' A' ' 230' ' ' LEU . 54.5 t-20 -40.21 -49.15 2.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.694 -179.577 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -88.18 15.43 7.54 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.777 0.322 . . . . 0.0 111.27 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . 0.54 ' N ' ' O ' ' A' ' 230' ' ' LEU . 78.1 p -60.43 -35.65 76.33 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.693 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . 0.526 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.6 tt0 -118.35 -69.39 0.85 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.943 179.554 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.1 m -70.04 103.37 2.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.734 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -94.59 57.69 2.25 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.359 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -144.88 -122.61 1.57 Allowed Glycine 0 CA--C 1.52 0.402 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -134.4 111.7 10.37 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 121.081 0.467 . . . . 0.0 110.433 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . 0.517 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.3 mtt180 -148.1 57.52 1.08 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.778 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -69.92 -31.75 69.69 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.505 179.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 241' ' ' ASP . . . . . 0.55 ' CG ' HD21 ' A' ' 143' ' ' ASN . 64.9 t0 -56.85 -46.98 81.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.343 -179.163 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 242' ' ' ILE . . . . . 0.435 ' O ' ' O ' ' A' ' 239' ' ' ARG . 17.5 tt -140.27 157.11 24.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.898 0.38 . . . . 0.0 110.527 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.44 HG22 HD13 ' A' ' 245' ' ' LEU . 96.1 mt -106.12 106.17 20.08 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.196 0 CA-C-O 121.16 0.505 . . . . 0.0 110.504 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . 0.603 ' O ' HD12 ' A' ' 245' ' ' LEU . 88.3 mt-30 -110.5 110.39 21.11 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.405 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.603 HD12 ' O ' ' A' ' 244' ' ' GLN . 9.5 mp -121.95 -168.3 1.68 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.607 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . 0.526 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.53 -16.88 0.05 OUTLIER Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . 0.671 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -60.47 157.01 29.84 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -63.77 21.27 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.915 0.388 . . . . 0.0 110.585 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . 0.671 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.7 m-20 -96.87 -5.82 37.29 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.569 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 92.7 mt -80.23 -21.45 42.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.6 179.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.47 -51.24 70.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.8 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.72 -5.28 58.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.449 179.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.09 -74.39 1.14 Allowed Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.926 -0.87 . . . . 0.0 110.926 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 81.8 mt -70.13 125.95 28.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.054 0.454 . . . . 0.0 110.227 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -59.45 -39.17 82.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.321 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 82.82 51.94 4.06 Favored Glycine 0 CA--C 1.521 0.463 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -95.8 -15.16 22.71 Favored 'General case' 0 C--N 1.331 -0.203 0 O-C-N 122.723 -0.281 . . . . 0.0 110.553 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 258' ' ' SER . . . . . 0.496 ' OG ' HG23 ' A' ' 191' ' ' VAL . 3.4 t 174.5 88.9 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.104 0.478 . . . . 0.0 110.159 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.862 ' N ' HD12 ' A' ' 259' ' ' LEU . 0.9 OUTLIER -94.27 123.88 37.94 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.244 0.545 . . . . 0.0 111.098 -179.058 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 260' ' ' PHE . . . . . 0.44 ' H ' ' HA ' ' A' ' 193' ' ' ALA . 16.0 m-30 -92.85 146.4 23.66 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.316 179.244 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 86.3 mt -122.31 149.73 43.34 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.562 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.752 ' CD1' HG13 ' A' ' 195' ' ' VAL . 2.7 p90 -77.43 -138.29 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.601 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 263' ' ' ALA . . . . . 0.66 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -52.31 77.55 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 121.044 0.449 . . . . 0.0 111.034 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . 0.627 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.08 104.33 0.18 Allowed Glycine 0 CA--C 1.527 0.786 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 265' ' ' ASP . . . . . 0.603 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.9 m-20 -80.35 -177.68 6.27 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 120.724 0.297 . . . . 0.0 110.912 -179.488 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -40.44 -17.61 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.536 179.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 267' ' ' LYS . . . . . 0.603 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.48 -51.73 40.16 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.019 0.438 . . . . 0.0 110.693 179.457 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -63.58 -46.63 84.97 Favored 'General case' 0 CA--C 1.527 0.09 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.323 179.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . 0.565 ' HB1' ' OH ' ' A' ' 273' ' ' TYR . . . -61.59 -35.18 77.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.865 179.531 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -62.97 -34.4 77.43 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.163 179.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.49 -43.37 13.63 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.225 -179.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 272' ' ' ILE . . . . . 0.587 ' C ' ' H ' ' A' ' 274' ' ' ALA . 4.9 tt -51.33 -33.63 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.876 -178.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 273' ' ' TYR . . . . . 0.565 ' OH ' ' HB1' ' A' ' 269' ' ' ALA . 17.3 m-85 -54.45 -1.8 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.649 -179.603 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 274' ' ' ALA . . . . . 0.587 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.65 -39.51 70.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.881 179.577 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . 0.583 ' O ' ' N ' ' A' ' 279' ' ' ALA . 2.8 p30 -39.61 98.35 0.17 Allowed Pre-proline 0 C--N 1.333 -0.122 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.514 -179.66 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -54.24 -43.02 62.38 Favored 'Trans proline' 0 C--N 1.303 -1.856 0 C-N-CA 122.391 2.061 . . . . 0.0 112.574 -178.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 89.5 mt -64.46 -42.82 95.7 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.201 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 91.1 mt -95.67 -1.63 49.72 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.812 -179.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 279' ' ' ALA . . . . . 0.583 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.33 -34.91 77.55 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.672 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.26 20.1 0.12 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.994 -179.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . 0.49 HD23 ' HA ' ' A' ' 281' ' ' LEU . 13.8 mt -75.21 120.01 79.66 Favored Pre-proline 0 N--CA 1.451 -0.375 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.484 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -50.83 -39.44 58.16 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.599 2.199 . . . . 0.0 111.946 179.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.8 -50.51 63.49 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.154 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 79.4 t -61.42 -43.96 97.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 179.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -57.7 -41.22 81.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.248 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -90.98 0.15 57.6 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.167 179.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt 59.53 43.41 16.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.035 0.445 . . . . 0.0 110.873 179.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -94.78 41.3 1.09 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.411 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 53.7 t -118.93 135.92 57.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.012 0.434 . . . . 0.0 110.257 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -133.08 162.85 30.64 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.053 0.454 . . . . 0.0 110.701 -179.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.96 155.22 33.22 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.012 0.434 . . . . 0.0 110.731 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 81.4 mt -93.9 -1.38 54.82 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.227 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.43 165.72 12.7 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 110.598 -1.001 . . . . 0.0 110.598 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 7.0 m -87.47 -62.3 1.53 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.899 0.381 . . . . 0.0 111.034 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 295' ' ' GLU . . . . . 0.437 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.5 mm-40 -69.68 -3.85 17.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.61 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 27.0 p -76.91 33.22 0.14 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.66 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 297' ' ' PHE . . . . . 0.539 ' CD2' HG22 ' A' ' 70' ' ' THR . 84.9 t80 -60.16 -45.86 91.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.58 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . 0.603 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.2 mtt85 -81.87 134.22 35.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.531 -179.684 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.45 ' H ' HG11 ' A' ' 51' ' ' VAL . 16.2 tp -114.46 119.52 37.15 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-O 120.996 0.427 . . . . 0.0 110.178 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . 0.623 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.3 p-10 -167.26 -174.44 2.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.553 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 84.5 t80 -47.92 -45.68 31.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.254 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -64.93 -41.42 95.55 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.022 0.439 . . . . 0.0 110.717 179.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . 0.623 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 52.8 p -55.52 -36.24 66.51 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.086 -179.251 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . 0.525 ' HB2' ' SD ' ' A' ' 215' ' ' MET . . . -56.79 -51.85 67.32 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.442 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 90.9 mtp -56.14 -43.71 78.5 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -66.32 -42.64 87.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.978 0.418 . . . . 0.0 110.278 178.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 303' ' ' SER . 55.7 t -64.08 -42.84 96.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.207 179.38 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 42.3 tp -59.55 -42.27 92.01 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.863 -179.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -62.63 -38.8 91.67 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.163 179.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 310' ' ' ARG . . . . . 0.443 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.6 ttt85 -63.58 -44.07 95.13 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.251 179.549 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 88.4 mt -63.26 -42.01 99.11 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.228 179.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -62.84 -33.03 74.4 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.097 179.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -90.33 -23.31 21.17 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.417 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . 0.477 HD22 ' CE2' ' A' ' 315' ' ' PHE . 6.8 tt -62.3 -43.22 99.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.098 0.475 . . . . 0.0 110.594 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 315' ' ' PHE . . . . . 0.477 ' CE2' HD22 ' A' ' 314' ' ' LEU . 91.0 m-85 . . . . . 0 C--O 1.219 -0.511 0 CA-C-O 118.079 -0.962 . . . . 0.0 110.414 -179.988 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -99.64 135.69 40.68 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.064 0.459 . . . . 0.0 110.456 -179.993 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.497 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -92.09 178.61 1.64 Allowed Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.61 -179.813 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.497 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 27.0 Cg_exo -61.63 147.17 96.01 Favored 'Trans proline' 0 C--N 1.3 -1.995 0 C-N-CA 122.749 2.299 . . . . 0.0 112.112 179.694 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.484 ' HE ' HD12 ' A' ' 39' ' ' LEU . 35.1 ptt180 -136.12 142.29 44.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.673 179.701 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -79.79 116.83 20.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.489 179.865 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.46 ' O ' HG23 ' A' ' 30' ' ' ILE . 9.5 tp -111.48 129.98 65.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.444 -179.988 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.2 t -70.9 142.11 51.16 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.58 179.881 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.484 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.5 t0 -138.93 179.98 6.18 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.575 -179.985 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.484 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 77.7 p -74.31 -37.23 63.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.616 179.952 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -46.69 -94.58 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.35 -179.515 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -165.8 -27.13 0.02 OUTLIER Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 179.953 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 63.2 m -168.79 106.09 0.44 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.924 0.392 . . . . 0.0 110.696 -179.929 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.643 ' CD2' HD13 ' A' ' 140' ' ' LEU . 67.4 t60 -128.92 146.72 50.87 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.044 0.449 . . . . 0.0 110.232 -179.949 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.623 HG22 ' N ' ' A' ' 39' ' ' LEU . 96.5 m -130.08 165.59 21.92 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.57 -179.848 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.623 ' N ' HG22 ' A' ' 38' ' ' THR . 80.5 mt -120.29 127.16 52.11 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.461 179.752 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -65.46 -44.61 86.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.588 -179.996 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 38.6 p -165.59 154.58 11.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.388 179.735 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.489 ' H ' ' CD ' ' A' ' 42' ' ' GLN . 14.7 mp0 -44.98 101.32 0.25 Allowed Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.631 179.436 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -57.53 129.54 34.33 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 C-N-CA 122.367 2.045 . . . . 0.0 112.247 -179.731 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -82.42 -25.13 33.95 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.491 179.631 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.537 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.7 mtm-85 -120.96 134.56 55.3 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-O 121.191 0.519 . . . . 0.0 110.28 -179.953 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.0 mt -130.28 133.59 63.79 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.923 -179.771 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 46.5 t -124.61 131.34 72.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.808 0.337 . . . . 0.0 110.126 179.373 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.617 ' OG ' HD12 ' A' ' 117' ' ' LEU . 4.7 m -154.2 165.94 34.69 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.563 179.782 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 71.5 p -124.76 8.29 8.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.463 179.942 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.66 125.8 33.44 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.672 -179.459 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.452 HG11 ' H ' ' A' ' 299' ' ' LEU . 89.9 t -65.47 -44.61 94.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.44 -179.943 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.6 m -62.52 -44.31 96.67 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.627 -179.917 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 53.1 tp -62.15 -41.58 98.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.512 -179.519 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.45 ' O ' HD13 ' A' ' 58' ' ' LEU . 72.8 m -57.74 -44.49 86.08 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.292 -179.253 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.39 -62.0 5.5 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 110.906 -0.878 . . . . 0.0 110.906 179.632 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.7 t -48.35 -35.76 13.11 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 -179.904 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 20.2 mt -61.66 -44.61 96.63 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.648 -0.421 . . . . 0.0 111.186 179.424 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.45 HD13 ' O ' ' A' ' 54' ' ' THR . 9.3 mp -64.89 -41.89 95.25 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.342 177.901 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.53 -41.19 98.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.02 -179.279 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.429 ' O ' HG23 ' A' ' 60' ' ' ILE . 8.0 tp -88.04 16.62 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.763 -179.711 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 56.45 84.11 0.09 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.736 -179.874 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.9 58.24 0.09 OUTLIER Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.019 -179.745 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.411 ' HB3' HE21 ' A' ' 85' ' ' GLN . 10.3 Cg_endo -50.77 152.45 9.6 Favored 'Trans proline' 0 C--N 1.296 -2.229 0 C-N-CA 122.751 2.301 . . . . 0.0 112.473 -178.405 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.431 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -109.15 146.25 14.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.372 -179.658 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 97.0 mt -63.86 -44.91 98.24 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.357 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.459 -179.914 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.504 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -129.81 134.22 47.42 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 120.84 0.352 . . . . 0.0 110.632 -179.896 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.509 ' O ' ' N ' ' A' ' 98' ' ' LEU . 58.8 m -134.32 158.39 43.92 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.875 -179.62 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -85.46 138.16 16.11 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.749 -0.941 . . . . 0.0 110.749 179.811 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.481 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.25 -163.81 0.11 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.958 0.408 . . . . 0.0 110.515 -179.906 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.502 HG22 ' CD2' ' A' ' 297' ' ' PHE . 6.2 t -134.22 140.61 46.6 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.216 179.936 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.486 ' C ' ' O ' ' A' ' 70' ' ' THR . 0.7 OUTLIER 29.67 70.73 0.56 Allowed Pre-proline 0 N--CA 1.466 0.329 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.657 -179.935 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_exo -60.45 144.44 99.52 Favored 'Trans proline' 0 C--N 1.299 -2.036 0 C-N-CA 122.587 2.191 . . . . 0.0 112.079 -178.323 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.54 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 44.5 p-10 -164.87 -35.56 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.662 179.895 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.54 ' N ' ' OD1' ' A' ' 73' ' ' ASN . 99.0 m-20 -63.88 -39.36 94.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.433 -179.98 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 73.4 ttt180 -60.88 -47.76 84.93 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.67 -179.389 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.433 ' O ' ' O ' ' A' ' 77' ' ' ALA . 95.6 t -60.24 -23.9 29.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.113 179.716 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.512 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -45.14 172.36 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.633 179.853 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.572 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.9 p30 -62.33 178.05 0.44 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.617 -179.7 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.562 ' C ' ' H ' ' A' ' 81' ' ' GLY . 36.6 p30 -46.04 85.64 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.05 179.912 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.572 ' N ' ' O ' ' A' ' 78' ' ' ASP . 42.6 tp60 -67.4 14.04 0.06 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.121 0.486 . . . . 0.0 110.094 -179.718 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.562 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 117.48 -21.62 10.58 Favored Glycine 0 CA--C 1.519 0.339 0 N-CA-C 110.909 -0.876 . . . . 0.0 110.909 179.922 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -107.85 116.71 32.45 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.968 0.413 . . . . 0.0 110.434 179.917 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 74.2 mt -98.62 0.69 45.3 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.551 -179.764 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -92.64 6.38 47.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.99 0.424 . . . . 0.0 110.459 -179.786 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.789 ' O ' HG22 ' A' ' 89' ' ' VAL . 88.2 mt-30 -99.83 -27.46 13.61 Favored 'General case' 0 C--O 1.224 -0.289 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.861 179.953 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.4 t-105 -63.84 -40.84 97.54 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.145 -179.795 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.552 ' O ' ' N ' ' A' ' 91' ' ' LYS . 67.3 m -77.76 -53.76 7.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.304 -179.548 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -48.19 -50.81 27.83 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.003 -179.273 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.789 HG22 ' O ' ' A' ' 85' ' ' GLN . 14.7 m -68.89 -40.7 81.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 120.919 0.39 . . . . 0.0 111.059 179.757 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.499 ' N ' HG23 ' A' ' 89' ' ' VAL . . . -72.14 -22.81 61.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.721 -179.885 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.552 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.0 tttm -61.6 -46.03 91.55 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.489 -179.539 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.442 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.3 mm-40 -90.11 -94.86 0.11 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.096 -179.964 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.627 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.7 mtt180 -143.19 59.58 1.41 Allowed 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 179.812 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.46 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.6 pttp 33.6 26.45 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.221 -179.214 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.627 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.4 tt -48.12 123.14 5.9 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.904 -178.152 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.456 ' O ' HD23 ' A' ' 95' ' ' LEU . 98.8 mm-40 -83.24 -169.54 2.59 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.057 -179.835 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.612 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 81.2 mtp180 -73.9 138.26 44.19 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.174 -179.677 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.509 ' N ' ' O ' ' A' ' 67' ' ' SER . 87.9 mt -86.61 -166.58 1.6 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.707 -179.524 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.528 ' CD2' ' O ' ' A' ' 99' ' ' TYR . 46.7 p90 -167.32 119.69 0.92 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.324 179.946 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.507 ' C ' ' O ' ' A' ' 99' ' ' TYR . 44.4 mm -29.56 121.08 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.995 -179.744 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 113.2 28.78 3.21 Favored Glycine 0 CA--C 1.52 0.359 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 -179.477 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.59 ' H ' ' CD ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -143.86 45.68 0.59 Allowed Pre-proline 0 C--N 1.323 -0.555 0 CA-C-O 120.948 0.404 . . . . 0.0 110.448 179.839 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.587 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 29.9 Cg_endo -61.97 143.68 95.56 Favored 'Trans proline' 0 C--N 1.297 -2.148 0 C-N-CA 122.683 2.255 . . . . 0.0 111.989 -179.925 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.484 ' O ' HG23 ' A' ' 108' ' ' VAL . 21.1 t -173.27 120.77 0.35 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.491 179.717 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.58 -41.09 63.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.067 0.461 . . . . 0.0 111.121 179.725 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -65.85 -40.4 91.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.904 -179.372 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.07 -39.95 95.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.762 -179.909 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 104' ' ' SER . 69.6 t -67.54 -43.77 86.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.795 179.652 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.43 -39.18 92.48 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.589 -179.284 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.442 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.39 -23.59 62.72 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.455 179.858 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.551 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.3 mm-40 -90.79 4.81 50.66 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.717 -179.509 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.551 ' C ' ' O ' ' A' ' 111' ' ' GLN . 10.5 tpt 23.67 63.86 0.39 Allowed Pre-proline 0 N--CA 1.465 0.297 0 CA-C-O 120.898 0.38 . . . . 0.0 111.059 -179.993 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.445 ' HG2' HD11 ' A' ' 116' ' ' ILE . 70.6 Cg_endo -78.7 168.55 20.93 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 C-N-CA 122.938 2.425 . . . . 0.0 112.213 -178.463 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.498 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 99.0 m-20 -113.04 -44.42 3.28 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.978 179.517 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.2 tp -120.23 119.62 33.74 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.577 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.456 HD13 HD22 ' A' ' 133' ' ' LEU . 95.4 mt -116.78 131.04 70.59 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.351 0 CA-C-O 120.953 0.406 . . . . 0.0 110.918 -179.856 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.617 HD12 ' OG ' ' A' ' 48' ' ' SER . 30.9 mt -105.69 132.75 51.45 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.115 0.483 . . . . 0.0 110.279 -179.466 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.421 HD12 HG23 ' A' ' 139' ' ' THR . 98.2 mt -118.33 136.24 56.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.724 -179.729 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 85.7 p -72.18 153.08 41.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.672 179.975 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -59.96 -50.0 75.49 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.612 -179.817 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -149.45 153.91 38.02 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.571 179.799 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 170.05 -170.56 42.96 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 179.919 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -63.04 -34.77 90.88 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 179.98 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.447 ' O ' ' OD1' ' A' ' 124' ' ' ASP . 43.9 p-10 -88.04 120.4 29.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.764 0.316 . . . . 0.0 110.683 179.934 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.455 ' O ' HD12 ' A' ' 129' ' ' LEU . 40.8 t -63.45 144.12 57.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.466 -179.928 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.521 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.37 -42.82 9.08 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.031 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.6 tp -62.82 -42.36 99.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.669 -179.832 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.05 -10.93 57.64 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.543 -179.461 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.455 HD12 ' O ' ' A' ' 125' ' ' SER . 85.2 mt -115.54 -24.14 8.46 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.695 -179.918 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . 0.521 ' N ' ' O ' ' A' ' 126' ' ' ALA . 78.7 t80 -51.84 -49.88 61.97 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.554 -178.902 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.1 p-10 -65.91 -42.11 90.57 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.909 0.385 . . . . 0.0 111.232 179.569 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.52 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 88.0 mt-30 -67.32 -36.74 82.07 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.78 179.929 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.456 HD22 HD13 ' A' ' 116' ' ' ILE . 93.7 mt -80.38 -41.74 24.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.975 -179.541 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.2 t -57.44 -44.71 84.95 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.223 -179.109 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 18.9 m -62.23 -45.59 92.66 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.799 0.333 . . . . 0.0 110.66 179.264 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 92.1 mt -62.36 -43.85 98.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.325 -179.792 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.605 ' HB1' ' HD2' ' A' ' 138' ' ' PRO . . . -170.37 163.79 5.94 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.541 179.832 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.605 ' HD2' ' HB1' ' A' ' 137' ' ' ALA . 78.3 Cg_exo -43.36 111.24 0.22 Allowed 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.501 2.134 . . . . 0.0 112.115 179.553 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.469 HG21 ' CD1' ' A' ' 130' ' ' TYR . 17.4 m -85.44 127.55 34.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.594 179.933 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.643 HD13 ' CD2' ' A' ' 37' ' ' HIS . 34.3 tp -119.11 136.93 53.92 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.957 -179.718 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.432 ' O ' ' OD1' ' A' ' 32' ' ' ASP . 79.8 mt -103.9 119.83 53.17 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.41 0 CA-C-O 121.183 0.516 . . . . 0.0 111.308 -179.382 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.507 HD12 HD22 ' A' ' 117' ' ' LEU . 98.1 mt -135.42 132.52 52.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.651 179.657 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.544 HD21 ' CG ' ' A' ' 241' ' ' ASP . 53.7 t30 -65.56 149.41 50.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.899 0.38 . . . . 0.0 110.388 179.258 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.524 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 88.1 t80 -83.07 122.5 28.42 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.002 -179.496 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.524 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 98.9 m-20 55.09 69.58 0.72 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.871 179.608 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 49.2 p-10 -123.69 -0.01 8.65 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 120.974 0.416 . . . . 0.0 110.696 179.8 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -151.59 117.25 5.41 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.767 -179.512 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 84.7 p -63.07 167.53 4.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.5 -179.811 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.419 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.6 p-90 -50.74 -15.47 0.29 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.518 -179.823 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . 0.442 ' O ' HG23 ' A' ' 154' ' ' THR . 68.1 tp60 -71.72 -74.45 0.16 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.458 -179.843 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.451 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.2 t -62.61 -39.22 93.08 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.008 0.432 . . . . 0.0 110.274 179.408 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 53.3 tp -60.23 -45.43 93.25 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.364 -178.516 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.419 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 45.7 tp -62.74 -41.73 99.32 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.398 179.025 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.451 ' OG1' ' O ' ' A' ' 151' ' ' SER . 51.8 p -64.05 -34.64 78.47 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.284 -179.469 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.456 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 88.2 mm-40 -63.98 -42.44 97.21 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.157 179.223 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 92.9 mt -65.35 -38.95 91.63 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.068 0.461 . . . . 0.0 110.223 179.137 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.582 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.15 -32.16 79.48 Favored Glycine 0 CA--C 1.52 0.362 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 -179.367 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.456 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.2 mt-10 -36.22 -25.68 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.814 0.34 . . . . 0.0 110.741 179.95 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.582 ' N ' ' O ' ' A' ' 157' ' ' GLY . 94.9 mt -58.95 149.68 5.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.276 179.303 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 75.2 p -69.3 137.08 52.7 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.076 -179.541 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 70.98 21.67 78.31 Favored Glycine 0 C--N 1.329 0.156 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 179.518 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 59.5 m80 -123.3 -14.95 7.34 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.732 0.301 . . . . 0.0 110.573 179.912 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -66.51 -59.63 3.46 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.779 -179.744 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -51.9 -48.9 63.93 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.173 -179.645 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -60.76 -41.03 94.64 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.981 -0.288 . . . . 0.0 110.316 179.534 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.58 -47.29 86.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.575 179.81 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.8 -40.25 75.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.178 -179.828 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -61.67 -50.24 73.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.627 179.56 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -65.43 -43.76 89.45 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.506 179.532 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 95.4 mt -64.6 -43.44 96.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.51 179.694 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.33 -51.03 71.02 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.542 -179.12 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.91 -43.62 95.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.44 179.685 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . 0.659 ' CE2' HD11 ' A' ' 177' ' ' LEU . 56.3 t80 -62.63 -44.63 95.8 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.058 0.456 . . . . 0.0 110.404 179.41 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -63.21 -39.88 95.87 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.59 -179.363 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -62.92 -42.86 99.93 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.637 179.218 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -60.61 -44.83 95.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.073 179.987 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.659 HD11 ' CE2' ' A' ' 173' ' ' PHE . 85.6 mt -64.37 -41.21 96.83 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.044 0.449 . . . . 0.0 110.672 178.901 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.06 -62.16 1.81 Allowed 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.527 -179.342 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.79 -46.54 87.32 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.571 179.803 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.36 -41.58 65.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.179 -179.994 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -63.76 -33.78 76.42 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.932 0.396 . . . . 0.0 110.336 179.305 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . 0.427 ' HG2' ' O ' ' A' ' 182' ' ' GLU . 69.8 tt0 -90.5 8.81 31.99 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.312 0.577 . . . . 0.0 110.509 -179.031 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -104.82 -32.26 8.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.887 0.375 . . . . 0.0 111.274 179.56 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.3 pt -128.01 147.41 32.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.836 -179.861 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -139.88 131.14 26.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.336 179.346 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . 0.596 HD22 ' N ' ' A' ' 186' ' ' LEU . 3.5 mm? -85.61 133.7 41.4 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.879 179.938 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -43.95 157.96 0.13 Allowed 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.669 2.246 . . . . 0.0 112.171 179.401 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . 0.523 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.6 Cg_endo -62.95 114.78 2.58 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 C-N-CA 122.82 2.347 . . . . 0.0 111.7 179.773 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . 0.523 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.8 mt-30 155.56 147.89 0.0 OUTLIER Pre-proline 0 N--CA 1.455 -0.195 0 O-C-N 123.555 0.535 . . . . 0.0 110.721 -179.858 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -73.72 144.09 34.73 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.644 2.229 . . . . 0.0 111.911 178.043 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.496 HG23 ' OG ' ' A' ' 258' ' ' SER . 2.1 p -124.93 158.91 32.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.336 0.589 . . . . 0.0 110.086 179.983 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . 0.496 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 37.1 p -143.47 165.35 27.78 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.135 -179.653 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . 0.441 ' HA ' ' H ' ' A' ' 260' ' ' PHE . . . -135.26 128.49 31.97 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.144 0.497 . . . . 0.0 110.181 179.618 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.508 HD11 HD23 ' A' ' 259' ' ' LEU . 47.3 pt -146.48 148.92 16.49 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.056 179.814 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . 0.744 HG13 ' CD1' ' A' ' 262' ' ' PHE . 70.4 t -117.74 123.22 71.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.278 0.561 . . . . 0.0 109.681 179.183 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -134.26 107.35 7.61 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.251 179.66 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 95.8 m -130.93 130.53 43.59 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.85 179.707 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -82.92 -36.92 24.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.245 179.691 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.5 -67.07 0.26 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.343 -179.939 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.52 -10.1 59.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.249 179.606 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 60.0 t-80 61.03 58.42 2.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.816 -179.959 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 37.3 p -166.88 153.33 8.46 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.5 179.573 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.08 143.77 24.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.985 0.421 . . . . 0.0 110.431 179.455 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -135.21 138.06 43.25 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.667 179.993 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 20.0 mt -106.13 125.37 50.91 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.059 0.457 . . . . 0.0 109.848 -179.633 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 206' ' ' TRP . . . . . 0.558 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 74.9 m95 -82.01 167.04 19.27 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.603 -179.787 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . 0.465 HG22 ' C ' ' A' ' 206' ' ' TRP . 0.1 OUTLIER -156.75 171.67 7.11 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.598 -179.214 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -54.09 -36.87 86.35 Favored 'Trans proline' 0 C--N 1.303 -1.865 0 C-N-CA 122.663 2.242 . . . . 0.0 111.952 179.379 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -70.61 -34.96 72.68 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.795 -179.811 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 21.2 m -61.28 150.57 34.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.635 -179.321 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.5 -37.07 82.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.52 -179.821 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 212' ' ' GLN . . . . . 0.558 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 54.9 tt0 -64.53 -40.36 95.47 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.497 179.957 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.74 -43.39 91.91 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 179.791 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -63.4 -43.53 97.27 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.715 0.293 . . . . 0.0 110.23 179.842 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 215' ' ' MET . . . . . 0.542 ' SD ' ' HB2' ' A' ' 304' ' ' ALA . 65.1 ttp -59.51 -48.07 83.06 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.227 -179.853 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 216' ' ' LEU . 87.5 mt -60.64 -40.8 93.3 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.636 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 217' ' ' GLU . . . . . 0.453 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.1 tp10 -58.02 -37.87 75.15 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.852 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -65.29 -38.12 89.26 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.803 0.335 . . . . 0.0 110.686 179.663 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 94.0 mt -64.41 -42.6 95.98 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.587 -179.595 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.62 45.0 0.08 OUTLIER Glycine 0 C--N 1.334 0.429 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 -179.962 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 221' ' ' PHE . . . . . 0.453 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 26.5 m-85 -128.23 155.91 43.8 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.038 0.447 . . . . 0.0 110.492 -179.792 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.491 ' O ' HG13 ' A' ' 191' ' ' VAL . 8.2 p -107.62 122.44 46.71 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.191 0.519 . . . . 0.0 110.182 -179.934 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.472 HD22 ' C ' ' A' ' 222' ' ' THR . 4.3 mm? -101.12 133.29 45.86 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.053 -179.995 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -97.0 159.05 15.13 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.494 179.906 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.0 115.16 29.8 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.335 179.899 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.494 ' N ' HD12 ' A' ' 226' ' ' LEU . 9.0 mp -53.33 156.66 3.89 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.698 179.921 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -60.27 145.31 98.83 Favored 'Trans proline' 0 C--N 1.301 -1.93 0 C-N-CA 122.598 2.199 . . . . 0.0 112.12 179.296 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.21 -3.05 59.03 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.493 -179.884 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.28 -40.83 5.67 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 -179.828 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . 0.532 ' O ' ' N ' ' A' ' 233' ' ' SER . 85.6 mt -79.44 -16.96 55.26 Favored 'General case' 0 C--O 1.222 -0.344 0 CA-C-O 121.002 0.429 . . . . 0.0 110.295 -179.694 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . 0.401 ' C ' ' O ' ' A' ' 230' ' ' LEU . 55.0 t-20 -40.3 -49.08 2.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.783 -179.541 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -88.08 15.44 7.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.818 0.342 . . . . 0.0 111.325 179.802 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . 0.532 ' N ' ' O ' ' A' ' 230' ' ' LEU . 78.1 p -60.5 -35.56 76.24 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.594 -179.799 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . 0.525 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.7 tt0 -118.4 -69.36 0.85 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.942 179.575 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.4 m -70.0 103.05 2.15 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.65 -179.776 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -94.13 57.64 2.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.456 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -145.04 -122.1 1.51 Allowed Glycine 0 CA--C 1.521 0.433 0 N-CA-C 110.966 -0.854 . . . . 0.0 110.966 -179.993 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -135.32 112.19 10.18 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 121.172 0.51 . . . . 0.0 110.383 179.939 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . 0.518 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.4 mtt180 -148.28 57.81 1.07 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.709 -179.941 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -69.57 -32.09 70.65 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.482 179.617 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 241' ' ' ASP . . . . . 0.544 ' CG ' HD21 ' A' ' 143' ' ' ASN . 64.8 t0 -56.7 -47.12 80.62 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.436 -179.113 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 242' ' ' ILE . . . . . 0.432 ' O ' ' O ' ' A' ' 239' ' ' ARG . 17.8 tt -140.2 156.92 24.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.925 0.393 . . . . 0.0 110.52 179.758 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.442 HG22 HD13 ' A' ' 245' ' ' LEU . 96.2 mt -106.14 106.29 20.3 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.227 0 CA-C-O 121.204 0.526 . . . . 0.0 110.507 179.759 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . 0.603 ' O ' HD12 ' A' ' 245' ' ' LEU . 88.3 mt-30 -110.29 110.04 20.71 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.336 179.702 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.603 HD12 ' O ' ' A' ' 244' ' ' GLN . 9.4 mp -121.78 -168.18 1.66 Allowed 'General case' 0 C--O 1.225 -0.199 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.711 179.78 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . 0.525 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.32 -16.53 0.05 OUTLIER Glycine 0 CA--C 1.523 0.546 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 179.833 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . 0.669 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -60.62 157.01 30.48 Favored Glycine 0 CA--C 1.521 0.443 0 N-CA-C 110.904 -0.878 . . . . 0.0 110.904 -179.892 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -63.81 21.67 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.947 0.404 . . . . 0.0 110.559 179.899 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . 0.669 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.8 m-20 -97.38 -5.85 35.41 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.572 179.965 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 92.8 mt -80.13 -21.71 42.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.617 179.51 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.55 -51.28 70.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.801 -179.529 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.58 -5.29 58.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.419 179.686 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.15 -74.26 1.15 Allowed Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 -179.897 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 80.9 mt -70.14 126.05 28.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.069 0.462 . . . . 0.0 110.269 -179.87 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -59.59 -39.17 83.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.337 -179.659 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 83.0 51.87 4.04 Favored Glycine 0 CA--C 1.521 0.421 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 179.827 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -95.82 -15.13 22.71 Favored 'General case' 0 C--N 1.332 -0.17 0 O-C-N 122.632 -0.334 . . . . 0.0 110.594 -179.861 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 258' ' ' SER . . . . . 0.496 ' OG ' HG23 ' A' ' 191' ' ' VAL . 3.5 t 174.63 88.8 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.063 0.459 . . . . 0.0 110.157 179.989 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.862 ' N ' HD12 ' A' ' 259' ' ' LEU . 0.9 OUTLIER -94.26 123.96 37.98 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.309 0.576 . . . . 0.0 111.183 -179.141 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 260' ' ' PHE . . . . . 0.441 ' H ' ' HA ' ' A' ' 193' ' ' ALA . 15.9 m-30 -92.93 146.4 23.65 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.34 179.283 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 86.0 mt -122.37 149.69 43.45 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.491 -179.822 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.744 ' CD1' HG13 ' A' ' 195' ' ' VAL . 2.6 p90 -77.56 -138.39 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.563 -179.841 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 263' ' ' ALA . . . . . 0.659 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -51.99 77.48 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.006 179.986 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . 0.632 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.1 104.48 0.19 Allowed Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 -179.929 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 265' ' ' ASP . . . . . 0.601 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.8 m-20 -80.47 -177.69 6.33 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 120.741 0.305 . . . . 0.0 110.858 -179.562 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -40.51 -17.64 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.57 179.846 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 267' ' ' LYS . . . . . 0.601 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.54 -51.55 41.67 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.715 179.448 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -63.73 -46.75 83.95 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.15 179.483 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . 0.572 ' HB1' ' OH ' ' A' ' 273' ' ' TYR . . . -61.56 -35.17 77.02 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.774 179.545 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -62.87 -34.45 77.4 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.166 179.649 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.46 -43.23 13.77 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.3 -179.569 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 272' ' ' ILE . . . . . 0.584 ' C ' ' H ' ' A' ' 274' ' ' ALA . 5.0 tt -51.41 -33.55 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.904 -178.884 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 273' ' ' TYR . . . . . 0.572 ' OH ' ' HB1' ' A' ' 269' ' ' ALA . 17.1 m-85 -54.59 -1.75 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.69 -179.653 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 274' ' ' ALA . . . . . 0.584 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.64 -39.56 70.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.857 179.581 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . 0.583 ' O ' ' N ' ' A' ' 279' ' ' ALA . 3.0 p30 -39.51 98.23 0.16 Allowed Pre-proline 0 N--CA 1.463 0.175 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.538 -179.634 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -54.08 -43.04 61.95 Favored 'Trans proline' 0 C--N 1.303 -1.824 0 C-N-CA 122.388 2.058 . . . . 0.0 112.691 -178.821 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 89.5 mt -64.48 -42.76 95.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.14 0.495 . . . . 0.0 111.181 -179.691 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 91.4 mt -95.82 -1.52 49.43 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.884 -179.456 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 279' ' ' ALA . . . . . 0.583 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.38 -34.93 77.68 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.644 -179.812 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -74.09 20.05 0.11 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.048 -179.354 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . 0.492 HD23 ' HA ' ' A' ' 281' ' ' LEU . 13.7 mt -75.06 120.23 80.68 Favored Pre-proline 0 N--CA 1.452 -0.349 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.424 179.981 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -51.12 -39.5 60.85 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.624 2.216 . . . . 0.0 111.8 179.099 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.82 -50.26 64.02 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.096 179.879 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 74.0 t -61.51 -43.93 97.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.562 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -57.86 -41.19 81.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.305 -179.942 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -90.87 -0.0 57.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.061 179.695 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt 59.47 43.1 16.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.967 0.413 . . . . 0.0 110.829 179.714 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -94.59 41.42 1.09 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.383 179.797 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 54.5 t -118.92 135.84 58.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.074 0.464 . . . . 0.0 110.179 -179.677 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -133.0 162.6 31.25 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.726 -179.663 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.58 155.4 32.3 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-O 120.956 0.408 . . . . 0.0 110.776 -179.87 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 81.5 mt -94.22 -1.47 54.02 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.281 -179.723 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.24 165.93 12.8 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.611 -0.996 . . . . 0.0 110.611 -179.838 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 7.2 m -87.64 -62.46 1.49 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.934 0.397 . . . . 0.0 111.08 -179.901 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 295' ' ' GLU . . . . . 0.44 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.6 mm-40 -69.46 -3.82 16.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.674 -179.845 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 22.7 p -76.91 32.47 0.14 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.601 -179.892 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 297' ' ' PHE . . . . . 0.502 ' CD2' HG22 ' A' ' 70' ' ' THR . 77.1 t80 -60.24 -46.08 91.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.592 -179.962 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . 0.612 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.1 mtt85 -80.92 134.85 35.8 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.016 0.436 . . . . 0.0 110.583 -179.742 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.452 ' H ' HG11 ' A' ' 51' ' ' VAL . 17.0 tp -114.48 118.2 33.11 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.203 179.882 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . 0.631 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.0 p-10 -165.78 -176.08 3.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.585 179.94 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 82.5 t80 -47.16 -43.77 21.38 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.286 -179.719 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -66.69 -40.51 88.55 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.03 0.443 . . . . 0.0 110.823 179.136 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . 0.631 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 59.6 p -55.87 -36.18 67.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.087 -179.21 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . 0.542 ' HB2' ' SD ' ' A' ' 215' ' ' MET . . . -57.37 -51.48 69.23 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.52 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 91.0 mtp -56.23 -43.63 78.8 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.953 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -66.34 -42.68 87.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.986 0.422 . . . . 0.0 110.226 178.79 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 303' ' ' SER . 55.8 t -64.03 -42.95 97.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.154 179.373 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 42.7 tp -59.63 -42.28 92.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.87 -179.513 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -62.71 -38.86 92.11 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 179.465 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 310' ' ' ARG . . . . . 0.444 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.6 ttt85 -63.5 -44.12 95.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.229 179.525 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 88.7 mt -63.19 -41.97 99.26 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.23 179.655 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt -62.84 -33.34 75.05 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.99 179.461 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.86 -23.59 21.62 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.461 -179.775 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . 0.48 HD22 ' CE2' ' A' ' 315' ' ' PHE . 6.7 tt -62.26 -43.14 99.51 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.607 -179.925 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 315' ' ' PHE . . . . . 0.48 ' CE2' HD22 ' A' ' 314' ' ' LEU . 90.9 m-85 . . . . . 0 C--O 1.221 -0.431 0 CA-C-O 117.979 -1.01 . . . . 0.0 110.503 179.947 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -100.11 136.85 39.38 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.008 0.432 . . . . 0.0 110.5 -179.929 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.498 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -91.78 178.46 1.73 Allowed Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.54 -179.911 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.498 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.7 Cg_exo -61.61 147.48 95.28 Favored 'Trans proline' 0 C--N 1.3 -2.023 0 C-N-CA 122.772 2.315 . . . . 0.0 112.179 179.627 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.465 ' HE ' HD12 ' A' ' 39' ' ' LEU . 35.6 ptt180 -136.05 142.61 44.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.699 179.766 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -78.96 117.13 19.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.574 179.918 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.433 ' O ' HG23 ' A' ' 30' ' ' ILE . 9.6 tp -110.51 130.94 62.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.395 -179.956 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.5 t -70.43 142.07 52.03 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.62 179.812 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.422 ' OD1' ' O ' ' A' ' 141' ' ' ILE . 25.8 t70 -139.9 177.42 7.98 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.452 -179.902 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.0 p -73.79 -36.26 65.01 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.693 179.925 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -47.71 -94.86 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.317 -179.525 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.422 ' O ' ' OG1' ' A' ' 36' ' ' THR . . . -165.59 -25.96 0.02 OUTLIER Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.889 -0.885 . . . . 0.0 110.889 179.913 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.422 ' OG1' ' O ' ' A' ' 35' ' ' GLY . 53.2 m -169.25 106.72 0.41 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.864 0.364 . . . . 0.0 110.665 -179.899 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.63 ' CD2' HD13 ' A' ' 140' ' ' LEU . 49.3 t60 -129.48 146.65 51.29 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.095 0.474 . . . . 0.0 110.1 179.997 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.623 HG22 ' N ' ' A' ' 39' ' ' LEU . 96.8 m -129.89 166.07 20.74 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.653 -179.814 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.623 ' N ' HG22 ' A' ' 38' ' ' THR . 82.5 mt -121.01 127.84 52.14 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.432 179.76 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -64.12 -44.58 91.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.639 -179.905 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 42.9 p -165.96 155.25 11.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.365 179.688 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.472 ' H ' ' CD ' ' A' ' 42' ' ' GLN . 14.1 mp0 -43.34 100.7 0.23 Allowed Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.605 179.415 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -56.8 129.29 33.78 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 122.318 2.012 . . . . 0.0 112.282 -179.612 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -83.72 -24.59 31.14 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.46 179.575 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.538 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.3 mtm-85 -122.31 134.94 54.65 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.169 0.509 . . . . 0.0 110.293 -179.974 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.1 mt -130.24 133.47 64.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.92 -179.681 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 45.4 t -124.34 130.83 73.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-O 120.848 0.356 . . . . 0.0 110.062 179.384 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.622 ' OG ' HD12 ' A' ' 117' ' ' LEU . 2.2 m -154.44 166.55 32.9 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.532 179.795 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 72.5 p -124.13 8.42 8.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.521 179.917 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.3 t -86.13 125.75 33.72 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.677 -179.551 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.483 HG11 ' H ' ' A' ' 299' ' ' LEU . 87.2 t -65.64 -44.48 93.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.453 -179.984 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.4 m -62.29 -44.31 96.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.667 -179.917 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 46.1 tp -62.39 -41.3 98.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.537 -179.431 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.447 ' O ' HD13 ' A' ' 58' ' ' LEU . 71.4 m -57.79 -44.64 86.4 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.353 -179.262 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.21 -62.21 5.36 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 179.535 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.7 t -48.39 -35.52 12.84 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 -179.917 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.9 mt -61.71 -44.42 96.96 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.698 -0.401 . . . . 0.0 111.207 179.407 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.447 HD13 ' O ' ' A' ' 54' ' ' THR . 9.2 mp -64.9 -41.8 95.3 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.352 177.956 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.62 -41.05 98.33 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.098 -179.251 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.432 ' O ' HG23 ' A' ' 60' ' ' ILE . 8.0 tp -88.25 16.94 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.775 -179.644 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 56.36 84.2 0.09 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.676 -179.899 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.44 57.63 0.07 OUTLIER Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.277 -0.42 . . . . 0.0 109.994 -179.826 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.421 ' HB3' HE21 ' A' ' 85' ' ' GLN . 10.2 Cg_endo -50.53 153.19 7.99 Favored 'Trans proline' 0 C--N 1.295 -2.237 0 C-N-CA 122.9 2.4 . . . . 0.0 112.426 -178.305 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.439 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -109.16 144.94 16.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.424 -179.709 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.8 mt -63.72 -45.36 97.53 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.35 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.444 -179.775 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.5 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -128.76 133.77 48.2 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.865 0.364 . . . . 0.0 110.518 -179.867 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.516 ' O ' ' N ' ' A' ' 98' ' ' LEU . 75.1 m -135.0 158.87 43.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.819 -179.648 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -87.23 139.45 16.12 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 179.828 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.481 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.88 -162.58 0.08 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.986 0.422 . . . . 0.0 110.429 -179.944 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.533 HG22 ' CD2' ' A' ' 297' ' ' PHE . 14.0 t -133.48 133.99 42.95 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.318 179.966 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.492 ' C ' ' O ' ' A' ' 70' ' ' THR . 0.6 OUTLIER 29.69 68.81 0.65 Allowed Pre-proline 0 N--CA 1.464 0.229 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.768 -179.93 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -61.09 145.36 99.01 Favored 'Trans proline' 0 C--N 1.3 -1.992 0 C-N-CA 122.648 2.232 . . . . 0.0 112.101 -178.437 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.533 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 46.1 p-10 -158.74 -32.05 0.07 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.703 179.726 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.547 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 99.1 m-20 -64.14 -39.92 95.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.579 179.825 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -60.49 -48.26 82.55 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.704 -179.207 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.415 ' O ' ' O ' ' A' ' 77' ' ' ALA . 90.4 t -60.23 -24.94 32.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.804 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.547 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -46.03 172.97 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.541 179.862 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.581 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.5 p30 -62.01 177.7 0.43 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.611 -179.691 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.558 ' C ' ' H ' ' A' ' 81' ' ' GLY . 35.6 p30 -44.76 85.72 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.0 179.924 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.581 ' N ' ' O ' ' A' ' 78' ' ' ASP . 42.7 tp60 -67.43 13.03 0.08 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.06 -179.758 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.558 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 118.62 -21.85 9.6 Favored Glycine 0 CA--C 1.519 0.328 0 N-CA-C 110.974 -0.85 . . . . 0.0 110.974 179.94 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -107.92 116.29 31.68 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.953 0.406 . . . . 0.0 110.494 179.856 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 73.2 mt -98.62 -0.01 43.91 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.436 -179.71 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -92.6 7.39 43.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.947 0.403 . . . . 0.0 110.387 -179.785 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.802 ' O ' HG22 ' A' ' 89' ' ' VAL . 87.8 mt-30 -100.07 -28.33 13.1 Favored 'General case' 0 C--O 1.224 -0.25 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.842 -179.996 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 68.9 t-105 -62.5 -40.89 98.16 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.867 -179.632 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.555 ' O ' ' N ' ' A' ' 91' ' ' LYS . 63.4 m -77.59 -53.55 7.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.195 -179.425 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -48.53 -50.73 30.76 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.013 -179.277 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.802 HG22 ' O ' ' A' ' 85' ' ' GLN . 15.4 m -68.91 -40.59 81.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 120.896 0.379 . . . . 0.0 111.048 179.723 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.496 ' N ' HG23 ' A' ' 89' ' ' VAL . . . -72.29 -22.84 61.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.8 -179.927 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.555 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.0 tttm -61.86 -45.53 93.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.429 -179.541 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.442 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.4 mm-40 -90.49 -94.92 0.12 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.13 -179.846 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.626 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.9 mtt180 -143.09 59.1 1.41 Allowed 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.828 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.462 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.7 pttp 33.37 26.77 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.242 -179.171 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.626 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.4 tt -48.71 123.58 7.08 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.951 -178.131 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.459 ' O ' HD23 ' A' ' 95' ' ' LEU . 99.1 mm-40 -84.33 -169.1 2.44 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.08 -179.937 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.609 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 81.0 mtp180 -74.86 136.64 41.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.279 -179.798 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.516 ' N ' ' O ' ' A' ' 67' ' ' SER . 90.9 mt -85.39 -165.71 1.3 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.633 -179.642 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.54 ' CD2' ' O ' ' A' ' 99' ' ' TYR . 47.7 p90 -168.32 119.49 0.8 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.209 179.982 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.516 ' C ' ' O ' ' A' ' 99' ' ' TYR . 42.8 mm -28.77 120.8 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.0 -179.63 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 114.51 27.63 3.26 Favored Glycine 0 CA--C 1.519 0.315 0 N-CA-C 111.15 -0.78 . . . . 0.0 111.15 -179.494 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.579 ' H ' ' CD ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -144.84 46.51 0.61 Allowed Pre-proline 0 C--N 1.323 -0.546 0 CA-C-O 120.891 0.377 . . . . 0.0 110.488 179.909 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.574 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 29.4 Cg_endo -61.88 144.31 96.56 Favored 'Trans proline' 0 C--N 1.296 -2.197 0 C-N-CA 122.652 2.235 . . . . 0.0 111.968 -179.942 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.449 ' O ' HG23 ' A' ' 108' ' ' VAL . 27.0 t -173.24 119.97 0.33 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.446 179.728 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.4 -40.33 64.38 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.021 0.439 . . . . 0.0 111.088 179.647 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -66.32 -39.69 89.44 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.819 -179.403 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.95 -40.04 95.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.704 -179.816 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 104' ' ' SER . 71.7 t -67.38 -43.93 87.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.712 179.681 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.87 -38.91 92.75 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.524 -179.349 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.442 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.4 -23.68 62.82 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.465 179.89 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.561 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.5 mm-40 -91.24 5.17 50.2 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.723 -179.552 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.561 ' C ' ' O ' ' A' ' 111' ' ' GLN . 10.3 tpt 22.24 64.72 0.33 Allowed Pre-proline 0 N--CA 1.465 0.277 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.043 179.985 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -78.57 169.05 20.41 Favored 'Trans proline' 0 C--N 1.304 -1.811 0 C-N-CA 122.99 2.46 . . . . 0.0 112.082 -178.461 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.423 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 98.8 m-20 -110.73 -42.76 3.96 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 121.013 0.435 . . . . 0.0 110.231 179.47 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.0 tp -119.95 120.78 37.37 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.974 179.571 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 83.7 mt -114.02 129.23 70.31 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.37 0 CA-C-O 120.936 0.398 . . . . 0.0 110.92 -179.858 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.622 HD12 ' OG ' ' A' ' 48' ' ' SER . 30.8 mt -109.24 132.03 54.51 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.048 0.451 . . . . 0.0 110.198 -179.705 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.496 HD12 HG23 ' A' ' 139' ' ' THR . 98.8 mt -119.61 138.05 51.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.706 -179.781 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 85.1 p -71.88 153.97 41.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.554 179.978 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.28 -50.35 74.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.671 -179.793 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -149.58 154.06 38.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.601 179.809 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 170.66 -170.78 43.37 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.911 -0.875 . . . . 0.0 110.911 179.824 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.96 -34.09 88.97 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 179.936 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.45 ' O ' ' OD1' ' A' ' 124' ' ' ASP . 44.4 p-10 -86.96 120.33 28.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.843 0.354 . . . . 0.0 110.673 179.953 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.45 ' O ' HD12 ' A' ' 129' ' ' LEU . 39.1 t -63.26 143.63 57.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.045 0.45 . . . . 0.0 110.447 -179.932 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.0 -43.26 9.0 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.945 -179.97 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.6 tp -62.81 -42.48 99.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.705 -179.831 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.58 -11.71 58.72 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.515 -179.444 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.45 HD12 ' O ' ' A' ' 125' ' ' SER . 84.8 mt -115.0 -24.05 8.78 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.724 -179.866 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . 0.519 ' N ' ' O ' ' A' ' 126' ' ' ALA . 80.8 t80 -51.22 -49.57 60.8 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.579 -178.901 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.7 p-10 -66.17 -42.33 89.06 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.8 0.333 . . . . 0.0 111.18 179.538 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.524 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 88.2 mt-30 -67.42 -37.67 83.42 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.761 179.975 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.416 HD12 HD11 ' A' ' 118' ' ' ILE . 95.6 mt -80.22 -41.89 24.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.932 -179.599 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.2 t -57.17 -44.28 83.36 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.24 -179.07 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.1 m -62.06 -45.44 93.55 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.775 0.321 . . . . 0.0 110.572 179.357 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 92.9 mt -62.28 -43.64 98.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.229 -179.774 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.658 ' HB1' ' HD2' ' A' ' 138' ' ' PRO . . . -169.25 167.85 5.31 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.566 179.897 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.658 ' HD2' ' HB1' ' A' ' 137' ' ' ALA . 50.9 Cg_exo -49.04 112.56 0.67 Allowed 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.357 2.038 . . . . 0.0 112.116 179.377 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.496 HG23 HD12 ' A' ' 118' ' ' ILE . 21.6 m -84.5 127.37 34.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.641 -179.951 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.63 HD13 ' CD2' ' A' ' 37' ' ' HIS . 36.2 tp -118.62 137.95 52.92 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.066 -179.867 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.422 ' O ' ' OD1' ' A' ' 32' ' ' ASP . 77.1 mt -102.82 120.05 52.07 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 CA-C-O 121.224 0.535 . . . . 0.0 111.118 -179.415 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.443 HD12 HD22 ' A' ' 117' ' ' LEU . 98.5 mt -135.68 131.83 50.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.585 179.662 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.434 HD21 ' CG ' ' A' ' 241' ' ' ASP . 56.4 t30 -66.42 153.82 41.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.938 0.399 . . . . 0.0 110.467 179.373 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.527 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 90.5 t80 -87.73 122.43 31.38 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.831 -179.639 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.527 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 99.1 m-20 55.3 69.33 0.75 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.778 179.633 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 49.4 p-10 -123.73 -0.4 8.57 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.664 179.925 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -151.26 116.5 5.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.778 -179.541 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . 0.418 ' C ' ' N ' ' A' ' 150' ' ' GLN . 83.4 p -62.15 166.5 4.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.479 -179.752 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.41 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.4 p-90 -50.68 -15.48 0.28 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.545 -179.812 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . 0.452 ' O ' HG23 ' A' ' 154' ' ' THR . 68.3 tp60 -71.52 -74.26 0.16 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.466 -179.787 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.432 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.1 t -62.86 -39.29 93.95 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.272 179.467 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 54.8 tp -59.96 -45.76 91.61 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.399 -178.581 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.41 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 46.5 tp -62.65 -41.75 99.22 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.784 0.326 . . . . 0.0 110.404 179.054 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.452 HG23 ' O ' ' A' ' 150' ' ' GLN . 56.6 p -64.57 -34.73 78.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.358 -179.551 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.45 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 86.9 mm-40 -64.05 -42.84 96.9 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.313 179.284 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 91.5 mt -65.54 -38.83 90.75 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.057 0.456 . . . . 0.0 110.187 179.147 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.58 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.21 -32.11 79.44 Favored Glycine 0 CA--C 1.52 0.344 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 -179.36 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.45 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.2 mt-10 -35.58 -26.91 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.823 0.344 . . . . 0.0 110.812 179.955 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.58 ' N ' ' O ' ' A' ' 157' ' ' GLY . 94.8 mt -56.52 150.84 2.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.264 179.312 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 72.0 p -69.66 137.3 52.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.01 -179.541 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 70.15 22.37 77.34 Favored Glycine 0 N--CA 1.459 0.2 0 N-CA-C 111.214 -0.754 . . . . 0.0 111.214 179.462 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 59.5 m80 -123.12 -13.65 7.71 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.716 0.293 . . . . 0.0 110.566 179.906 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -67.21 -59.32 3.53 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.755 -179.687 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -52.14 -49.42 63.74 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.239 -179.595 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -60.36 -41.3 93.42 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.792 0.33 . . . . 0.0 110.336 179.525 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.52 -47.05 87.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.595 179.831 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.96 -40.14 75.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.204 -179.894 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -61.64 -50.24 73.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.589 179.553 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -65.47 -43.59 89.82 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.501 179.541 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 95.0 mt -64.64 -43.47 96.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.457 179.776 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.44 -51.27 70.1 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.641 -179.232 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.72 -44.16 94.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.545 179.697 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . 0.644 ' CE2' HD11 ' A' ' 177' ' ' LEU . 55.0 t80 -62.86 -44.43 96.13 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.069 0.461 . . . . 0.0 110.443 179.438 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -63.33 -40.06 96.28 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.598 -179.331 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -62.92 -42.71 99.88 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.63 179.191 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -60.62 -44.8 95.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.103 -179.97 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.644 HD11 ' CE2' ' A' ' 173' ' ' PHE . 85.7 mt -64.44 -41.16 96.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.01 0.434 . . . . 0.0 110.714 178.951 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.18 -62.3 1.72 Allowed 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.497 -179.351 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.45 -46.81 85.81 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.566 179.887 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.21 -41.64 65.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.238 179.987 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -63.97 -33.77 76.48 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.998 0.428 . . . . 0.0 110.353 179.315 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . 0.423 ' HG2' ' O ' ' A' ' 182' ' ' GLU . 69.6 tt0 -90.49 8.8 32.05 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.347 0.594 . . . . 0.0 110.533 -178.998 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -104.74 -32.14 9.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.181 179.607 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.2 pt -128.13 147.79 32.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.846 -179.818 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -140.11 131.12 26.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.356 179.427 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . 0.602 HD22 ' N ' ' A' ' 186' ' ' LEU . 3.5 mm? -85.88 133.68 40.89 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.908 179.924 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -44.33 157.97 0.15 Allowed 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.727 2.284 . . . . 0.0 112.088 179.356 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . 0.526 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.7 Cg_endo -62.92 115.13 2.75 Favored 'Trans proline' 0 C--N 1.303 -1.82 0 C-N-CA 122.801 2.334 . . . . 0.0 111.774 179.768 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . 0.526 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.7 mt-30 155.44 148.09 0.0 OUTLIER Pre-proline 0 N--CA 1.455 -0.208 0 O-C-N 123.635 0.584 . . . . 0.0 110.758 -179.867 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -73.83 144.17 34.4 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.676 2.25 . . . . 0.0 111.914 178.044 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.496 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.1 p -125.13 158.99 32.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.307 0.575 . . . . 0.0 110.121 -179.98 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . 0.496 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 36.9 p -143.44 165.36 27.75 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.139 -179.678 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . 0.444 ' HA ' ' H ' ' A' ' 260' ' ' PHE . . . -135.41 128.74 32.13 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.135 0.493 . . . . 0.0 110.194 179.543 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.504 HD11 HD23 ' A' ' 259' ' ' LEU . 47.9 pt -146.28 148.58 16.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.077 179.825 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . 0.754 HG13 ' CD1' ' A' ' 262' ' ' PHE . 70.2 t -117.33 122.96 71.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.277 0.56 . . . . 0.0 109.681 179.161 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -134.37 107.49 7.64 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.32 179.707 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 95.1 m -131.17 130.54 43.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.855 179.833 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -82.53 -36.84 25.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.33 179.75 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.58 -67.36 0.24 Allowed 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.425 179.981 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.49 -9.86 59.08 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.265 179.55 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 60.5 t-80 60.42 58.78 2.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.784 -179.812 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 42.9 p -167.06 153.62 8.38 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.538 179.53 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.28 144.17 24.5 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.957 0.408 . . . . 0.0 110.453 179.432 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -135.06 137.28 42.75 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.569 -179.988 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 19.6 mt -105.44 125.16 50.67 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 121.066 0.46 . . . . 0.0 109.869 -179.676 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 206' ' ' TRP . . . . . 0.557 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 75.9 m95 -81.57 166.42 20.25 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.634 -179.794 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . 0.463 HG22 ' C ' ' A' ' 206' ' ' TRP . 0.1 OUTLIER -156.57 171.52 7.29 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.536 -179.184 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_exo -54.23 -36.78 87.21 Favored 'Trans proline' 0 C--N 1.302 -1.874 0 C-N-CA 122.679 2.253 . . . . 0.0 112.079 179.173 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -70.33 -34.97 73.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.811 -179.806 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 22.3 m -61.6 149.83 38.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.587 -179.392 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.55 -36.83 81.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.494 -179.732 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 212' ' ' GLN . . . . . 0.557 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 55.1 tt0 -64.65 -40.61 95.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.56 179.873 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.08 -43.56 93.09 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 110.591 -1.003 . . . . 0.0 110.591 179.712 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -63.5 -42.76 98.52 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 179.72 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 215' ' ' MET . . . . . 0.568 ' SD ' ' HB2' ' A' ' 304' ' ' ALA . 64.6 ttp -59.47 -48.04 83.17 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.202 -179.898 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 216' ' ' LEU . 87.6 mt -60.74 -40.67 93.25 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.556 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 217' ' ' GLU . . . . . 0.455 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 40.7 tp10 -58.03 -38.09 75.58 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.841 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -65.12 -38.18 89.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.771 0.319 . . . . 0.0 110.621 179.641 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 94.5 mt -64.41 -42.78 95.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.517 -179.537 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 138.01 45.22 0.08 OUTLIER Glycine 0 C--N 1.335 0.479 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 179.982 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 221' ' ' PHE . . . . . 0.455 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 26.7 m-85 -128.8 156.45 43.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.057 0.456 . . . . 0.0 110.523 -179.739 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.49 ' O ' HG13 ' A' ' 191' ' ' VAL . 7.8 p -108.33 122.82 47.76 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 121.204 0.526 . . . . 0.0 110.185 -179.94 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.474 HD22 ' C ' ' A' ' 222' ' ' THR . 4.3 mm? -101.38 132.92 46.7 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.055 179.933 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.9 159.57 14.84 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.54 179.85 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -104.97 115.26 29.97 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.933 0.396 . . . . 0.0 110.395 179.824 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.495 ' N ' HD12 ' A' ' 226' ' ' LEU . 8.9 mp -53.72 156.96 4.25 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.669 179.914 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -60.18 145.24 98.93 Favored 'Trans proline' 0 C--N 1.302 -1.914 0 C-N-CA 122.637 2.224 . . . . 0.0 112.108 179.374 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.6 -2.47 58.64 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.56 -179.959 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.62 -40.42 5.66 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 -179.903 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . 0.548 ' O ' ' N ' ' A' ' 233' ' ' SER . 85.9 mt -79.59 -16.51 55.74 Favored 'General case' 0 C--O 1.223 -0.311 0 CA-C-O 120.971 0.415 . . . . 0.0 110.314 -179.735 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . 0.404 ' C ' ' O ' ' A' ' 230' ' ' LEU . 55.4 t-20 -40.27 -48.8 2.67 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.687 -179.566 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -88.59 15.7 7.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.804 0.335 . . . . 0.0 111.258 179.807 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . 0.548 ' N ' ' O ' ' A' ' 230' ' ' LEU . 78.1 p -60.63 -35.79 77.04 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.738 -179.839 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . 0.525 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.6 tt0 -118.06 -69.6 0.84 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.021 179.535 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 3.8 m -70.46 103.41 2.45 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.673 -179.796 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -94.64 57.94 2.27 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.363 179.93 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -145.15 -122.63 1.55 Allowed Glycine 0 CA--C 1.52 0.365 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 -179.958 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -133.7 112.03 11.07 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 121.118 0.485 . . . . 0.0 110.409 179.945 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . 0.488 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 94.7 mtt180 -148.25 56.61 1.06 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.753 -179.979 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -69.4 -31.36 69.68 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.511 179.593 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 241' ' ' ASP . . . . . 0.456 ' OD2' ' O ' ' A' ' 144' ' ' TYR . 64.8 t0 -56.69 -46.93 80.88 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.403 -179.069 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 242' ' ' ILE . . . . . 0.436 ' O ' ' O ' ' A' ' 239' ' ' ARG . 16.9 tt -140.85 158.18 23.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.934 0.397 . . . . 0.0 110.519 179.738 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.442 HG22 HD13 ' A' ' 245' ' ' LEU . 96.0 mt -105.97 105.97 19.71 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.2 0 CA-C-O 121.155 0.503 . . . . 0.0 110.407 179.821 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . 0.614 ' C ' HD12 ' A' ' 245' ' ' LEU . 88.2 mt-30 -110.76 110.69 21.43 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.369 179.74 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.614 HD12 ' C ' ' A' ' 244' ' ' GLN . 9.7 mp -122.03 -167.92 1.63 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.558 179.748 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . 0.525 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 172.54 -16.48 0.05 OUTLIER Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 179.879 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . 0.663 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -60.56 157.71 29.01 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 -179.855 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -64.22 21.09 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.971 0.415 . . . . 0.0 110.609 179.962 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . 0.663 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.8 m-20 -96.94 -5.54 37.69 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.564 179.955 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 92.2 mt -80.84 -20.99 41.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.611 179.535 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.52 -51.35 70.27 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.79 -179.671 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -89.29 -4.93 57.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.453 179.658 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.09 -74.16 1.15 Allowed Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 -179.923 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 81.7 mt -70.13 125.71 27.56 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.015 0.436 . . . . 0.0 110.237 -179.795 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -59.57 -39.49 84.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.369 -179.709 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 83.51 51.71 4.0 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 179.767 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -94.81 -16.57 22.86 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.724 0.297 . . . . 0.0 110.597 -179.899 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 258' ' ' SER . . . . . 0.495 ' OG ' HG23 ' A' ' 191' ' ' VAL . 3.4 t 175.19 89.63 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.057 0.456 . . . . 0.0 110.124 179.996 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.862 ' N ' HD12 ' A' ' 259' ' ' LEU . 0.9 OUTLIER -94.5 124.26 38.42 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.323 0.582 . . . . 0.0 111.139 -179.042 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 260' ' ' PHE . . . . . 0.444 ' H ' ' HA ' ' A' ' 193' ' ' ALA . 16.1 m-30 -93.53 146.93 23.43 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.362 179.22 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 86.2 mt -122.44 149.77 43.38 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.599 -179.893 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.754 ' CD1' HG13 ' A' ' 195' ' ' VAL . 2.6 p90 -77.72 -138.78 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.542 -179.849 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 263' ' ' ALA . . . . . 0.659 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -51.39 78.09 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.056 179.988 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . 0.629 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.95 104.63 0.19 Allowed Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.679 -0.969 . . . . 0.0 110.679 -179.987 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 265' ' ' ASP . . . . . 0.604 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.7 m-20 -80.29 -177.62 6.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.671 0.272 . . . . 0.0 110.883 -179.49 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -40.54 -17.48 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.858 0.361 . . . . 0.0 110.504 179.766 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 267' ' ' LYS . . . . . 0.604 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.53 -51.66 40.58 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.672 179.476 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -63.75 -46.59 84.64 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.212 179.343 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . 0.578 ' HB1' ' OH ' ' A' ' 273' ' ' TYR . . . -61.49 -35.41 77.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.78 179.599 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -62.56 -34.71 77.5 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.228 179.694 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.26 -43.09 14.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.319 -179.592 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 272' ' ' ILE . . . . . 0.586 ' C ' ' H ' ' A' ' 274' ' ' ALA . 5.0 tt -51.47 -33.89 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.824 -178.823 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 273' ' ' TYR . . . . . 0.578 ' OH ' ' HB1' ' A' ' 269' ' ' ALA . 16.8 m-85 -54.31 -2.11 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.645 -179.599 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 274' ' ' ALA . . . . . 0.586 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.39 -39.58 71.08 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.969 179.5 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . 0.585 ' O ' ' N ' ' A' ' 279' ' ' ALA . 3.6 p30 -39.23 97.96 0.15 Allowed Pre-proline 0 C--O 1.227 -0.113 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.568 -179.691 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -54.15 -43.1 61.49 Favored 'Trans proline' 0 C--N 1.303 -1.824 0 C-N-CA 122.375 2.05 . . . . 0.0 112.611 -178.765 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 89.2 mt -64.42 -42.79 95.86 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.114 -179.64 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 91.2 mt -95.96 -1.18 49.62 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.849 -179.421 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 279' ' ' ALA . . . . . 0.585 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.5 -34.93 77.84 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.612 -179.749 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.26 20.18 0.11 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.004 -179.247 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . 0.491 HD23 ' HA ' ' A' ' 281' ' ' LEU . 13.7 mt -75.03 120.11 80.08 Favored Pre-proline 0 N--CA 1.451 -0.376 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.45 179.94 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -50.96 -39.45 59.36 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.659 2.24 . . . . 0.0 111.831 179.07 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -53.0 -50.38 64.32 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.126 179.849 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 74.6 t -61.6 -43.97 97.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 179.488 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -57.55 -41.17 80.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.234 -179.958 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -90.97 0.23 57.58 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.141 179.687 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt 59.62 43.16 16.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.066 0.46 . . . . 0.0 110.891 179.662 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -94.61 41.31 1.09 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.399 179.884 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 54.1 t -119.21 135.76 58.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 121.009 0.433 . . . . 0.0 110.179 -179.741 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -133.63 163.67 28.9 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 121.026 0.441 . . . . 0.0 110.73 -179.66 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.76 155.77 31.87 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.97 0.414 . . . . 0.0 110.759 -179.797 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 82.2 mt -94.65 -1.45 53.14 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.274 -179.75 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.34 165.22 12.56 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 -179.786 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 6.6 m -86.7 -61.55 1.71 Allowed 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 120.87 0.367 . . . . 0.0 111.102 -179.84 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 295' ' ' GLU . . . . . 0.448 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.6 mm-40 -69.66 -4.56 20.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.66 -179.792 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 26.1 p -76.48 33.03 0.13 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.68 -179.891 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 297' ' ' PHE . . . . . 0.533 ' CD2' HG22 ' A' ' 70' ' ' THR . 83.3 t80 -60.52 -45.99 91.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.646 -179.956 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . 0.609 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.2 mtt85 -81.08 136.66 35.97 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.627 -179.598 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.483 ' H ' HG11 ' A' ' 51' ' ' VAL . 0.9 OUTLIER -114.25 116.87 29.7 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.494 179.667 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . 0.624 ' H ' ' CB ' ' A' ' 303' ' ' SER . 49.1 p-10 -166.84 -174.97 2.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.52 -179.799 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 78.6 t80 -47.73 -44.46 27.96 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.241 -179.684 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -65.84 -41.27 91.94 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.029 0.442 . . . . 0.0 110.782 179.017 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . 0.624 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 54.3 p -55.36 -36.15 66.01 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.1 -179.265 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . 0.568 ' HB2' ' SD ' ' A' ' 215' ' ' MET . . . -57.58 -51.4 69.63 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.436 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 90.6 mtp -56.56 -44.02 80.53 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -179.936 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -66.29 -42.88 87.73 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.903 0.382 . . . . 0.0 110.184 178.86 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 303' ' ' SER . 55.9 t -63.88 -43.09 97.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.218 179.409 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 42.5 tp -59.87 -42.07 92.92 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.812 -179.618 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -62.31 -39.05 91.75 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.152 179.665 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 310' ' ' ARG . . . . . 0.45 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.8 ttt85 -63.71 -43.89 95.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.266 179.46 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 90.1 mt -63.26 -42.05 99.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.184 179.632 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt -62.85 -33.62 75.63 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.116 179.409 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.73 -23.37 21.82 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.448 -179.888 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . 0.488 HD22 ' CE2' ' A' ' 315' ' ' PHE . 6.9 tt -62.31 -43.06 99.69 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.61 -179.936 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 315' ' ' PHE . . . . . 0.488 ' CE2' HD22 ' A' ' 314' ' ' LEU . 90.9 m-85 . . . . . 0 C--O 1.22 -0.484 0 CA-C-O 117.964 -1.017 . . . . 0.0 110.466 179.975 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -99.26 135.82 40.11 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.06 0.457 . . . . 0.0 110.493 -179.995 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.496 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -91.75 178.43 1.75 Allowed Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.637 -179.961 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.496 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.5 Cg_exo -61.57 146.87 96.56 Favored 'Trans proline' 0 C--N 1.3 -2.022 0 C-N-CA 122.808 2.339 . . . . 0.0 112.162 179.635 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.464 ' HE ' HD12 ' A' ' 39' ' ' LEU . 35.4 ptt180 -136.3 141.82 43.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.647 179.71 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -79.3 116.96 19.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.476 179.923 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.454 ' O ' HG23 ' A' ' 30' ' ' ILE . 9.4 tp -111.61 130.24 65.52 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.486 -179.985 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.2 t -71.09 142.45 50.82 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.61 179.842 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.481 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.4 t0 -139.32 179.93 6.25 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.57 -179.937 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.481 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 78.4 p -74.01 -37.12 64.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.785 179.716 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -46.78 -94.66 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.378 -179.459 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -166.17 -26.88 0.02 OUTLIER Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 179.893 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 65.0 m -168.66 105.91 0.44 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.861 0.362 . . . . 0.0 110.618 -179.921 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.651 ' CD2' HD13 ' A' ' 140' ' ' LEU . 69.5 t60 -128.75 147.22 50.76 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.988 0.423 . . . . 0.0 110.324 179.925 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.62 HG22 ' N ' ' A' ' 39' ' ' LEU . 99.9 m -130.45 165.53 22.43 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.569 -179.835 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.62 ' N ' HG22 ' A' ' 38' ' ' THR . 80.6 mt -120.64 126.98 51.62 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.485 179.731 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -65.44 -44.35 87.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.686 -179.971 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 41.0 p -165.96 154.82 11.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.405 179.669 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.486 ' H ' ' CD ' ' A' ' 42' ' ' GLN . 14.0 mp0 -45.43 101.55 0.26 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.643 179.471 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -57.6 129.64 34.76 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 122.402 2.068 . . . . 0.0 112.235 -179.643 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -82.51 -25.14 33.73 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.5 179.531 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.537 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.7 mtm-85 -120.89 134.03 55.29 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 121.185 0.517 . . . . 0.0 110.27 179.96 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.1 mt -129.82 133.21 65.13 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.273 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.966 -179.721 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 44.3 t -124.84 131.08 73.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.839 0.352 . . . . 0.0 110.101 179.313 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.63 ' OG ' HD12 ' A' ' 117' ' ' LEU . 4.9 m -154.74 166.35 33.71 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.515 179.845 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 65.3 p -124.37 8.53 8.44 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.434 179.923 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.58 125.21 32.93 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.616 -179.458 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.503 HG11 ' H ' ' A' ' 299' ' ' LEU . 94.5 t -65.5 -44.41 94.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.545 -179.938 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.6 m -62.61 -44.31 96.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.639 -179.851 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 48.4 tp -62.5 -41.48 98.85 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.57 -179.476 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.455 ' O ' HD13 ' A' ' 58' ' ' LEU . 74.6 m -57.63 -44.78 85.81 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.466 -179.438 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.36 -62.09 5.43 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 179.571 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.6 t -48.23 -35.71 12.48 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 179.951 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.7 mt -61.7 -44.46 96.89 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.11 179.331 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.464 HD21 HE22 ' A' ' 85' ' ' GLN . 9.1 mp -65.07 -41.72 94.81 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.201 178.049 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.4 ' HB1' ' NE ' ' A' ' 169' ' ' ARG . . . -63.6 -41.36 98.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.933 -179.243 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.431 ' O ' HG23 ' A' ' 60' ' ' ILE . 8.0 tp -87.7 16.81 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.755 -179.63 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 56.45 83.84 0.09 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.73 -179.862 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.89 58.04 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.005 -179.752 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.412 ' HB3' HE21 ' A' ' 85' ' ' GLN . 9.9 Cg_endo -50.59 152.71 8.78 Favored 'Trans proline' 0 C--N 1.296 -2.207 0 C-N-CA 122.859 2.373 . . . . 0.0 112.38 -178.204 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.431 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -108.96 145.9 15.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.348 -179.727 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 97.0 mt -63.8 -45.18 97.89 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.357 -179.844 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.496 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -129.87 134.48 47.54 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.602 -179.745 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.499 ' O ' ' N ' ' A' ' 98' ' ' LEU . 72.7 m -134.75 158.77 43.29 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.833 -179.637 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.73 139.36 16.36 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.668 -0.973 . . . . 0.0 110.668 179.798 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.485 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.79 -162.92 0.08 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.903 0.382 . . . . 0.0 110.515 179.966 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.495 HG22 ' CD1' ' A' ' 297' ' ' PHE . 5.7 t -133.93 135.38 43.52 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.245 -179.973 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.495 ' C ' ' O ' ' A' ' 70' ' ' THR . 1.1 t 29.55 68.19 0.67 Allowed Pre-proline 0 N--CA 1.466 0.328 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.64 -179.626 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -60.98 145.18 99.46 Favored 'Trans proline' 0 C--N 1.3 -1.978 0 C-N-CA 122.619 2.213 . . . . 0.0 112.068 -178.392 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.532 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 45.1 p-10 -159.37 -32.29 0.06 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.662 179.698 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.542 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 99.1 m-20 -64.07 -39.4 94.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.505 179.988 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -60.51 -48.32 82.29 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.642 -179.278 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.423 ' O ' ' O ' ' A' ' 77' ' ' ALA . 94.4 t -60.1 -24.85 31.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 179.704 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.542 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -45.77 172.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.583 179.865 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.571 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.8 p30 -61.98 177.76 0.42 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.614 -179.774 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.562 ' C ' ' H ' ' A' ' 81' ' ' GLY . 36.0 p30 -45.69 85.86 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.962 179.963 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.571 ' N ' ' O ' ' A' ' 78' ' ' ASP . 42.8 tp60 -67.33 13.62 0.06 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.146 -179.837 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.562 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 117.94 -22.04 10.03 Favored Glycine 0 CA--C 1.519 0.338 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.93 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -108.19 116.68 32.41 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.951 0.405 . . . . 0.0 110.56 179.843 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 75.4 mt -98.98 0.88 44.85 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.513 -179.767 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -92.07 6.74 45.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.985 0.421 . . . . 0.0 110.484 -179.797 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.785 ' O ' HG22 ' A' ' 89' ' ' VAL . 88.2 mt-30 -100.06 -26.28 14.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.781 179.968 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.5 t-105 -64.28 -40.99 97.1 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.02 -179.688 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.551 ' O ' ' N ' ' A' ' 91' ' ' LYS . 68.5 m -77.6 -53.55 7.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.155 -179.516 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -47.9 -51.27 23.89 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.001 -179.347 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.785 HG22 ' O ' ' A' ' 85' ' ' GLN . 15.1 m -69.01 -41.08 81.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 120.905 0.383 . . . . 0.0 111.069 179.88 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.508 ' N ' HG23 ' A' ' 89' ' ' VAL . . . -71.47 -23.57 61.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.768 -179.815 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.551 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.0 tttm -61.07 -46.06 92.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.501 -179.439 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.443 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.6 mm-40 -90.13 -94.87 0.11 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.213 179.971 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.626 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.8 mtt180 -143.19 60.13 1.41 Allowed 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 179.758 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.463 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.6 pttp 33.31 26.88 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.203 -179.082 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.626 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.4 tt -48.61 123.1 6.26 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.931 -178.193 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.45 ' O ' HD23 ' A' ' 95' ' ' LEU . 98.9 mm-40 -83.5 -169.9 2.78 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.145 179.934 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.614 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 81.7 mtp180 -73.71 137.51 44.09 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.328 -179.865 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.499 ' N ' ' O ' ' A' ' 67' ' ' SER . 89.0 mt -85.9 -166.11 1.44 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.709 -179.621 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.532 ' CD2' ' O ' ' A' ' 99' ' ' TYR . 46.7 p90 -168.01 119.48 0.84 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.311 179.962 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.513 ' C ' ' O ' ' A' ' 99' ' ' TYR . 43.1 mm -29.14 121.04 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.922 -179.701 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 113.95 28.11 3.25 Favored Glycine 0 CA--C 1.521 0.431 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 -179.597 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.588 ' H ' ' CD ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -144.0 46.0 0.61 Allowed Pre-proline 0 C--N 1.323 -0.55 0 CA-C-O 120.953 0.406 . . . . 0.0 110.503 179.891 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.583 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 30.2 Cg_endo -62.28 143.83 94.54 Favored 'Trans proline' 0 C--N 1.297 -2.138 0 C-N-CA 122.686 2.257 . . . . 0.0 111.957 -179.966 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.476 ' O ' HG23 ' A' ' 108' ' ' VAL . 23.2 t -173.33 120.73 0.34 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.417 179.754 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.58 -40.98 63.48 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.043 179.743 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -65.9 -40.31 91.39 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.864 -179.374 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.96 -39.86 95.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.687 -179.832 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 104' ' ' SER . 70.9 t -67.54 -43.76 86.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.721 179.683 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.43 -39.1 92.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.568 -179.287 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.443 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.51 -23.55 62.9 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.532 179.834 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.549 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.4 mm-40 -90.94 4.75 51.11 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.741 -179.564 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.549 ' C ' ' O ' ' A' ' 111' ' ' GLN . 9.9 tpt 23.17 64.32 0.37 Allowed Pre-proline 0 N--CA 1.464 0.271 0 CA-C-O 120.914 0.388 . . . . 0.0 111.001 -179.806 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.444 ' HG2' HD11 ' A' ' 116' ' ' ILE . 68.1 Cg_endo -78.9 168.92 20.18 Favored 'Trans proline' 0 C--N 1.304 -1.801 0 C-N-CA 122.984 2.456 . . . . 0.0 112.081 -178.415 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.483 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 98.9 m-20 -113.24 -44.01 3.3 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.103 179.452 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.2 tp -120.47 119.81 34.07 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.324 -0.398 . . . . 0.0 109.935 179.48 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.455 HD13 HD22 ' A' ' 133' ' ' LEU . 96.3 mt -117.09 131.1 70.79 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.319 0 CA-C-O 120.9 0.381 . . . . 0.0 110.892 -179.788 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.63 HD12 ' OG ' ' A' ' 48' ' ' SER . 29.7 mt -106.0 132.46 52.06 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 121.027 0.441 . . . . 0.0 110.321 -179.489 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.434 HD12 HG23 ' A' ' 139' ' ' THR . 98.1 mt -118.17 136.6 54.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.73 -179.709 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 86.5 p -71.6 152.76 42.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.548 -179.95 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.27 -50.21 74.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.659 -179.857 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -149.24 153.59 37.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.552 179.762 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 169.3 -170.17 42.41 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 179.885 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -63.04 -35.46 92.12 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 179.992 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.447 ' O ' ' OD1' ' A' ' 124' ' ' ASP . 44.1 p-10 -87.18 119.92 27.91 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.808 0.337 . . . . 0.0 110.639 179.885 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.441 ' O ' HD12 ' A' ' 129' ' ' LEU . 39.2 t -63.56 144.06 57.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.467 -179.928 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.52 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.38 -43.28 8.85 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.872 -179.935 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.8 tp -62.77 -42.35 99.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.654 -179.816 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.73 -10.91 56.64 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.512 -179.395 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.441 HD12 ' O ' ' A' ' 125' ' ' SER . 84.1 mt -116.03 -23.9 8.31 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.7 -179.902 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . 0.52 ' N ' ' O ' ' A' ' 126' ' ' ALA . 77.8 t80 -51.53 -49.87 61.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.521 -179.001 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.5 p-10 -65.79 -42.26 90.96 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.852 0.358 . . . . 0.0 111.15 179.628 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.523 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 87.9 mt-30 -67.52 -36.69 81.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.792 -179.97 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.455 HD22 HD13 ' A' ' 116' ' ' ILE . 94.1 mt -80.58 -42.05 22.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.871 -179.507 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.2 t -57.23 -44.76 84.07 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.259 -179.21 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.2 m -62.3 -45.8 91.63 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.806 0.336 . . . . 0.0 110.642 179.33 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 92.9 mt -62.31 -43.9 98.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.401 -179.855 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.584 ' HB1' ' HD2' ' A' ' 138' ' ' PRO . . . -169.95 162.93 6.66 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.529 179.844 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.584 ' HD2' ' HB1' ' A' ' 137' ' ' ALA . 78.4 Cg_exo -42.71 110.99 0.18 Allowed 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.536 2.157 . . . . 0.0 112.196 179.448 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.474 HG21 ' CD1' ' A' ' 130' ' ' TYR . 16.8 m -85.57 127.76 34.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.555 179.971 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.651 HD13 ' CD2' ' A' ' 37' ' ' HIS . 34.3 tp -119.48 137.94 53.46 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.088 -179.897 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.429 ' O ' ' OD2' ' A' ' 32' ' ' ASP . 80.2 mt -104.22 120.01 53.88 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 CA-C-O 121.122 0.487 . . . . 0.0 111.217 -179.348 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.494 HD12 HD22 ' A' ' 117' ' ' LEU . 97.7 mt -135.92 132.58 50.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.595 179.549 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.549 HD21 ' CG ' ' A' ' 241' ' ' ASP . 52.4 t30 -65.75 148.44 51.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.902 0.382 . . . . 0.0 110.422 179.268 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.459 ' O ' ' OD2' ' A' ' 241' ' ' ASP . 42.6 t80 -81.86 123.18 28.6 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.955 -179.456 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 54.79 69.69 0.7 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.881 179.643 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 49.2 p-10 -124.45 0.24 8.24 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.679 179.849 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -151.42 116.4 5.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.695 -179.442 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 84.0 p -63.86 168.55 4.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.557 -179.941 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.416 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.6 p-90 -51.8 -16.33 0.67 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.553 -179.846 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . 0.431 ' O ' HG23 ' A' ' 154' ' ' THR . 68.2 tp60 -70.1 -76.68 0.1 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.491 -179.744 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.447 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.1 t -62.41 -38.49 89.85 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.321 179.6 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 53.4 tp -59.82 -45.75 91.38 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.377 -178.601 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.416 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 46.3 tp -62.83 -41.72 99.44 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.472 179.012 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.447 ' OG1' ' O ' ' A' ' 151' ' ' SER . 62.2 p -64.01 -34.97 79.2 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.266 -179.592 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.448 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.7 mm-40 -64.02 -42.28 97.18 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.239 179.32 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 92.1 mt -65.51 -38.85 90.9 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.041 0.448 . . . . 0.0 110.232 179.093 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.581 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.22 -32.13 79.52 Favored Glycine 0 CA--C 1.52 0.389 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 -179.374 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.448 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.3 mt-10 -36.02 -26.19 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.804 0.335 . . . . 0.0 110.728 179.953 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.581 ' N ' ' O ' ' A' ' 157' ' ' GLY . 94.4 mt -58.11 150.16 4.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.3 179.375 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 77.1 p -69.21 137.29 53.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.01 -179.508 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 69.96 22.94 77.26 Favored Glycine 0 CA--C 1.517 0.183 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 179.452 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 59.8 m80 -124.11 -13.97 7.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.745 0.307 . . . . 0.0 110.563 179.92 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -67.19 -59.42 3.45 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.702 -179.732 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -51.76 -49.37 62.76 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.215 -179.667 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -60.45 -41.32 93.84 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.735 0.302 . . . . 0.0 110.346 179.509 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.42 -47.34 86.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.609 179.801 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.73 -40.16 75.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.252 -179.915 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -61.49 -50.26 73.45 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.575 179.573 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.4 ' NE ' ' HB1' ' A' ' 59' ' ' ALA . 60.0 ttt85 -65.52 -43.58 89.58 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.492 179.596 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 94.8 mt -64.66 -43.37 96.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.427 179.768 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.29 -51.36 69.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.566 -179.243 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.71 -43.78 95.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.53 179.727 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . 0.654 ' CE2' HD11 ' A' ' 177' ' ' LEU . 55.1 t80 -62.87 -44.47 96.03 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.041 0.448 . . . . 0.0 110.454 179.45 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -63.48 -40.0 95.95 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.592 -179.36 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -62.9 -42.83 99.92 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.628 179.333 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -60.76 -44.7 96.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.186 179.93 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.654 HD11 ' CE2' ' A' ' 173' ' ' PHE . 84.9 mt -64.53 -41.2 96.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.02 0.438 . . . . 0.0 110.749 178.887 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.05 -62.09 1.85 Allowed 'General case' 0 C--O 1.236 0.376 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.478 -179.382 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.58 -46.66 86.48 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.609 179.784 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.28 -41.5 65.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.236 -179.984 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -64.01 -33.75 76.45 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.96 0.41 . . . . 0.0 110.424 179.278 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . 0.422 ' HG2' ' O ' ' A' ' 182' ' ' GLU . 69.3 tt0 -90.68 8.86 32.29 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.338 0.589 . . . . 0.0 110.483 -179.019 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -104.78 -32.19 8.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.895 0.379 . . . . 0.0 111.196 179.615 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.6 pt -128.21 147.83 32.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.845 -179.847 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -140.11 131.16 26.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.393 179.364 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . 0.597 HD22 ' N ' ' A' ' 186' ' ' LEU . 3.5 mm? -85.45 133.92 41.3 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.882 -179.996 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -43.87 157.93 0.13 Allowed 'Trans proline' 0 C--N 1.307 -1.629 0 C-N-CA 122.743 2.295 . . . . 0.0 112.125 179.316 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . 0.53 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.6 Cg_endo -62.96 114.51 2.47 Favored 'Trans proline' 0 C--N 1.304 -1.807 0 C-N-CA 122.796 2.331 . . . . 0.0 111.717 179.839 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . 0.53 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.7 mt-30 155.13 148.26 0.0 OUTLIER Pre-proline 0 C--N 1.331 -0.207 0 O-C-N 123.643 0.589 . . . . 0.0 110.74 -179.743 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -73.47 144.55 36.45 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.695 2.263 . . . . 0.0 111.928 177.97 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.495 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.1 p -124.84 158.89 32.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.241 0.543 . . . . 0.0 110.194 179.962 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . 0.495 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 37.6 p -143.46 165.22 28.14 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.086 -179.585 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . 0.444 ' HA ' ' H ' ' A' ' 260' ' ' PHE . . . -135.33 128.65 32.12 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.106 0.479 . . . . 0.0 110.285 179.534 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.511 HD11 HD23 ' A' ' 259' ' ' LEU . 47.5 pt -146.5 148.87 16.53 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.297 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.052 179.933 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . 0.734 HG13 ' CD1' ' A' ' 262' ' ' PHE . 74.1 t -117.6 123.06 71.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.247 0.546 . . . . 0.0 109.809 179.073 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -134.3 106.97 7.38 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.27 179.738 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 93.7 m -130.77 130.63 43.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.84 179.782 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -82.67 -37.17 25.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.313 179.675 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.37 -67.35 0.24 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.417 -179.98 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.01 -10.0 59.16 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.338 179.508 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 59.9 t-80 60.67 58.32 2.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.719 -179.81 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 41.6 p -166.99 153.29 8.22 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.537 179.643 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.31 144.07 24.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.473 179.395 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -135.34 138.28 43.23 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.642 -179.969 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 19.6 mt -106.12 125.23 50.74 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 121.027 0.442 . . . . 0.0 109.923 -179.737 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 206' ' ' TRP . . . . . 0.574 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 75.0 m95 -81.81 166.87 19.62 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.667 -179.72 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . 0.464 HG22 ' C ' ' A' ' 206' ' ' TRP . 0.1 OUTLIER -156.61 171.89 6.81 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.607 -179.15 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -53.98 -37.3 86.06 Favored 'Trans proline' 0 C--N 1.303 -1.856 0 C-N-CA 122.654 2.236 . . . . 0.0 112.172 179.225 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -70.45 -34.81 72.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.76 -179.746 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 22.0 m -61.44 150.51 35.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.596 -179.373 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.17 -36.51 80.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.438 -179.768 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 212' ' ' GLN . . . . . 0.574 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 53.7 tt0 -64.5 -40.6 95.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.482 -179.987 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.67 -43.65 91.47 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 179.821 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -63.14 -44.26 96.05 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.719 0.295 . . . . 0.0 110.283 179.76 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 215' ' ' MET . . . . . 0.577 ' SD ' ' HB2' ' A' ' 304' ' ' ALA . 65.5 ttp -59.56 -48.21 82.53 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.221 -179.886 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 85.8 mt -60.25 -40.92 91.99 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.405 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 217' ' ' GLU . . . . . 0.456 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.0 tp10 -58.06 -38.08 75.64 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.739 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -65.3 -38.17 89.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.784 0.326 . . . . 0.0 110.568 179.677 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 219' ' ' LEU . 94.7 mt -64.4 -42.79 95.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.441 -179.595 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.54 45.84 0.08 OUTLIER Glycine 0 C--N 1.334 0.47 0 N-CA-C 111.036 -0.825 . . . . 0.0 111.036 179.958 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 221' ' ' PHE . . . . . 0.456 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 26.9 m-85 -129.0 156.02 44.46 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.027 0.441 . . . . 0.0 110.487 -179.802 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.481 ' O ' HG13 ' A' ' 191' ' ' VAL . 8.0 p -108.01 122.83 47.66 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.203 0.525 . . . . 0.0 110.208 -179.938 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.479 HD22 ' C ' ' A' ' 222' ' ' THR . 4.3 mm? -101.6 133.41 46.33 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.068 -179.94 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -97.22 159.73 14.74 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.458 179.834 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.01 115.1 29.7 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.927 0.394 . . . . 0.0 110.41 179.84 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.494 ' N ' HD12 ' A' ' 226' ' ' LEU . 9.1 mp -53.34 156.75 3.83 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.648 179.93 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -60.09 145.2 98.99 Favored 'Trans proline' 0 C--N 1.302 -1.903 0 C-N-CA 122.667 2.245 . . . . 0.0 112.139 179.283 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.48 -2.78 58.86 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.559 179.981 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.49 -40.64 5.65 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 111.004 -0.838 . . . . 0.0 111.004 -179.835 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . 0.544 ' O ' ' N ' ' A' ' 233' ' ' SER . 84.9 mt -79.53 -16.9 55.16 Favored 'General case' 0 C--O 1.223 -0.337 0 CA-C-O 120.997 0.427 . . . . 0.0 110.368 -179.772 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . 0.405 ' C ' ' O ' ' A' ' 230' ' ' LEU . 54.7 t-20 -40.11 -49.12 2.58 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.678 -179.603 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -88.27 15.58 7.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.783 0.325 . . . . 0.0 111.217 179.963 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . 0.544 ' N ' ' O ' ' A' ' 230' ' ' LEU . 78.1 p -60.62 -35.81 77.07 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.664 -179.858 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . 0.524 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.6 tt0 -118.21 -69.54 0.84 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.942 179.556 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.1 m -70.37 102.97 2.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.651 -179.765 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -94.31 58.04 2.4 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.442 179.949 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -145.04 -122.52 1.55 Allowed Glycine 0 CA--C 1.52 0.379 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 -179.992 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -134.34 111.77 10.46 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 121.053 0.454 . . . . 0.0 110.452 -179.981 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . 0.515 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.0 mtt180 -148.19 57.5 1.08 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.744 -179.97 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -69.75 -31.59 69.64 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.513 179.574 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 241' ' ' ASP . . . . . 0.549 ' CG ' HD21 ' A' ' 143' ' ' ASN . 65.1 t0 -56.9 -46.95 81.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.339 -179.186 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 242' ' ' ILE . . . . . 0.437 ' O ' ' O ' ' A' ' 239' ' ' ARG . 17.6 tt -140.54 157.41 24.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.865 0.364 . . . . 0.0 110.558 179.713 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.445 HG22 HD13 ' A' ' 245' ' ' LEU . 96.0 mt -106.34 106.33 20.4 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.173 0 CA-C-O 121.096 0.474 . . . . 0.0 110.448 179.89 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . 0.604 ' O ' HD12 ' A' ' 245' ' ' LEU . 88.3 mt-30 -110.68 110.62 21.37 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.358 179.733 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.604 HD12 ' O ' ' A' ' 244' ' ' GLN . 9.6 mp -122.02 -168.03 1.64 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.583 179.784 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . 0.524 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.14 -16.77 0.05 OUTLIER Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 179.895 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . 0.667 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -60.42 157.25 29.21 Favored Glycine 0 CA--C 1.522 0.516 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 -179.823 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -63.94 21.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.921 0.391 . . . . 0.0 110.571 179.942 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . 0.667 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.7 m-20 -96.8 -5.82 37.54 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.576 179.99 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 92.0 mt -80.24 -21.36 42.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.615 179.522 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.53 -51.41 69.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.773 -179.557 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.99 -5.29 58.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.459 179.662 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -80.87 -74.44 1.13 Allowed Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 -179.946 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 80.9 mt -69.87 125.69 27.5 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.058 0.456 . . . . 0.0 110.303 -179.859 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -59.33 -39.67 83.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.297 -179.641 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 83.5 51.76 3.98 Favored Glycine 0 CA--C 1.522 0.473 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 179.9 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -95.1 -16.11 22.88 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.712 0.292 . . . . 0.0 110.588 -179.848 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 258' ' ' SER . . . . . 0.494 ' OG ' HG23 ' A' ' 191' ' ' VAL . 3.4 t 174.92 89.51 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.08 0.466 . . . . 0.0 110.161 179.973 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.863 ' N ' HD12 ' A' ' 259' ' ' LEU . 0.9 OUTLIER -94.46 124.18 38.33 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.258 0.551 . . . . 0.0 111.058 -178.999 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 260' ' ' PHE . . . . . 0.444 ' H ' ' HA ' ' A' ' 193' ' ' ALA . 16.0 m-30 -93.62 146.91 23.47 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.391 179.218 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 85.5 mt -122.39 149.75 43.38 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.583 -179.933 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.734 ' CD1' HG13 ' A' ' 195' ' ' VAL . 2.6 p90 -77.99 -139.14 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.46 -179.759 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 263' ' ' ALA . . . . . 0.665 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -50.8 77.86 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.987 -179.947 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . 0.641 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.97 104.66 0.19 Allowed Glycine 0 CA--C 1.526 0.768 0 N-CA-C 110.721 -0.951 . . . . 0.0 110.721 -179.964 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 265' ' ' ASP . . . . . 0.601 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.7 m-20 -80.39 -177.56 6.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.722 0.296 . . . . 0.0 110.84 -179.424 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -40.49 -17.73 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.511 179.823 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 267' ' ' LYS . . . . . 0.601 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.42 -51.51 43.09 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.679 179.582 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -63.77 -46.59 84.58 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.23 179.357 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . 0.581 ' HB1' ' OH ' ' A' ' 273' ' ' TYR . . . -61.48 -35.15 76.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.927 179.511 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -63.07 -34.57 77.87 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.155 179.717 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.25 -43.21 13.96 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.192 -179.51 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 272' ' ' ILE . . . . . 0.588 ' C ' ' H ' ' A' ' 274' ' ' ALA . 5.0 tt -51.49 -33.92 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.839 -178.783 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 273' ' ' TYR . . . . . 0.581 ' OH ' ' HB1' ' A' ' 269' ' ' ALA . 17.0 m-85 -54.3 -1.91 0.03 OUTLIER 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.71 -179.598 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 274' ' ' ALA . . . . . 0.588 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.63 -39.45 70.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.885 179.574 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . 0.585 ' O ' ' N ' ' A' ' 279' ' ' ALA . 3.8 p30 -39.33 98.04 0.16 Allowed Pre-proline 0 C--O 1.226 -0.153 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.53 -179.636 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -54.19 -43.04 62.07 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 C-N-CA 122.383 2.055 . . . . 0.0 112.595 -178.753 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 89.1 mt -64.49 -42.9 95.58 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.086 -179.621 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 91.1 mt -95.87 -1.11 50.07 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.889 -179.434 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 279' ' ' ALA . . . . . 0.585 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.4 -34.92 77.68 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.666 -179.791 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.3 20.16 0.12 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.979 -179.207 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . 0.494 HD23 ' HA ' ' A' ' 281' ' ' LEU . 13.6 mt -74.91 119.83 78.73 Favored Pre-proline 0 N--CA 1.452 -0.347 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.504 179.9 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -50.57 -39.74 55.43 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.598 2.199 . . . . 0.0 111.949 178.989 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.9 -50.45 63.9 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.122 179.876 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 73.4 t -61.55 -43.91 97.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 179.477 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -57.8 -41.17 81.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.274 -179.906 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -90.73 -0.1 57.59 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.184 179.622 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt 59.92 43.3 15.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.029 0.442 . . . . 0.0 110.821 179.658 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -94.93 41.3 1.09 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.382 179.809 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 54.2 t -119.23 135.82 58.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.022 0.439 . . . . 0.0 110.231 -179.737 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -133.63 163.85 28.5 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.044 0.45 . . . . 0.0 110.658 -179.577 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.81 155.88 31.72 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.94 0.4 . . . . 0.0 110.78 -179.803 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 81.4 mt -94.7 -1.59 52.77 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.25 -179.735 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 120.86 165.21 12.65 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.651 -0.98 . . . . 0.0 110.651 -179.763 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 7.0 m -86.59 -61.73 1.67 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.806 0.336 . . . . 0.0 111.092 -179.828 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 295' ' ' GLU . . . . . 0.455 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.6 mm-40 -69.04 -4.84 18.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.682 -179.686 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 26.3 p -76.48 32.22 0.13 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.641 -179.871 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 297' ' ' PHE . . . . . 0.495 ' CD1' HG22 ' A' ' 70' ' ' THR . 59.4 t80 -60.59 -46.43 90.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.713 179.944 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . 0.614 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.2 mtt85 -80.23 137.37 36.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.582 -179.65 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.503 ' H ' HG11 ' A' ' 51' ' ' VAL . 5.7 tp -114.38 115.8 27.91 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.453 179.868 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . 0.631 ' H ' ' CB ' ' A' ' 303' ' ' SER . 48.7 p-10 -165.72 -176.69 3.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.533 -179.977 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 79.0 t80 -46.59 -42.76 16.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.293 -179.791 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -67.4 -40.58 85.64 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.026 0.441 . . . . 0.0 110.756 179.196 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . 0.631 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 60.2 p -55.62 -36.38 66.92 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.074 -179.276 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . 0.577 ' HB2' ' SD ' ' A' ' 215' ' ' MET . . . -57.68 -51.61 68.83 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 179.342 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 91.2 mtp -56.06 -44.14 78.59 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 179.838 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -66.11 -43.13 88.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.917 0.389 . . . . 0.0 110.166 178.837 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 303' ' ' SER . 55.9 t -63.97 -42.88 97.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.288 179.358 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 44.6 tp -59.89 -42.05 92.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.934 -179.64 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -62.33 -39.31 92.66 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.155 179.59 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 310' ' ' ARG . . . . . 0.468 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.7 ttt85 -63.6 -43.95 95.42 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.29 179.412 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 89.5 mt -63.18 -42.2 99.34 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.31 179.603 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -63.21 -33.57 75.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.079 179.456 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.85 -23.44 21.66 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.488 -179.875 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . 0.483 HD22 ' CE2' ' A' ' 315' ' ' PHE . 6.8 tt -62.3 -43.16 99.47 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.58 -179.95 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 315' ' ' PHE . . . . . 0.483 ' CE2' HD22 ' A' ' 314' ' ' LEU . 90.5 m-85 . . . . . 0 C--O 1.22 -0.478 0 CA-C-O 118.043 -0.979 . . . . 0.0 110.482 179.981 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -99.63 135.18 41.43 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.063 0.459 . . . . 0.0 110.452 -179.885 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.497 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -92.15 178.55 1.66 Allowed Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.509 -179.829 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.497 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 27.3 Cg_exo -61.46 147.11 96.3 Favored 'Trans proline' 0 C--N 1.3 -2.008 0 C-N-CA 122.709 2.273 . . . . 0.0 112.173 179.617 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.482 ' HE ' HD12 ' A' ' 39' ' ' LEU . 35.0 ptt180 -135.98 142.35 44.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.714 179.779 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -79.9 116.86 20.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.401 179.922 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.457 ' O ' HG23 ' A' ' 30' ' ' ILE . 9.4 tp -111.64 130.12 65.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.408 179.996 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.1 t -70.85 141.95 51.25 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.621 179.763 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.476 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.0 t0 -138.85 -179.97 6.14 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.512 -179.936 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.476 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 78.1 p -73.84 -37.38 64.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.761 179.834 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.8 ttt85 -46.89 -94.72 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.366 -179.338 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.414 ' O ' ' OG1' ' A' ' 36' ' ' THR . . . -166.04 -26.99 0.02 OUTLIER Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.886 -0.885 . . . . 0.0 110.886 179.996 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.414 ' OG1' ' O ' ' A' ' 35' ' ' GLY . 75.2 m -168.29 105.87 0.47 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.924 0.392 . . . . 0.0 110.678 -179.894 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.649 ' CD2' HD13 ' A' ' 140' ' ' LEU . 68.8 t60 -129.07 146.51 51.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.071 0.463 . . . . 0.0 110.317 179.997 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.622 HG22 ' N ' ' A' ' 39' ' ' LEU . 99.8 m -129.99 165.59 21.84 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.57 -179.797 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.622 ' N ' HG22 ' A' ' 38' ' ' THR . 81.0 mt -120.38 127.25 52.13 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.483 179.727 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -65.44 -44.6 86.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.689 -179.954 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 40.7 p -165.73 154.97 12.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.404 179.599 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.5 ' H ' ' CD ' ' A' ' 42' ' ' GLN . 14.5 mp0 -45.31 101.58 0.26 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.608 179.427 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -57.7 130.32 38.05 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 C-N-CA 122.334 2.023 . . . . 0.0 112.196 -179.772 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -83.01 -24.62 32.77 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.531 179.593 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.535 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.7 mtm-85 -121.22 134.67 55.2 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-O 121.156 0.503 . . . . 0.0 110.246 -179.926 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.0 mt -130.49 133.35 63.82 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.297 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.99 -179.797 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 46.5 t -124.76 131.05 73.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 179.471 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.621 ' OG ' HD12 ' A' ' 117' ' ' LEU . 4.6 m -154.49 166.2 34.04 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.048 0.452 . . . . 0.0 110.505 179.679 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 60.9 p -124.51 8.73 8.36 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.519 179.936 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.8 125.96 33.65 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.617 -179.508 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.465 HG11 ' H ' ' A' ' 299' ' ' LEU . 84.7 t -65.68 -44.54 93.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.51 -179.99 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.0 m -62.71 -44.26 96.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.66 -179.818 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 52.1 tp -62.27 -41.65 98.66 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.6 -179.415 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.472 ' O ' HD13 ' A' ' 58' ' ' LEU . 71.9 m -57.92 -44.51 86.92 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.286 -179.326 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.41 -61.97 5.52 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 179.578 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.7 t -48.56 -35.6 13.73 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 -179.812 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 20.0 mt -61.68 -44.58 96.68 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.708 -0.397 . . . . 0.0 111.199 179.19 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.479 HD21 HE22 ' A' ' 85' ' ' GLN . 9.5 mp -64.58 -42.09 95.86 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.334 177.911 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.63 -41.23 98.28 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.044 -179.222 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.434 ' O ' HG23 ' A' ' 60' ' ' ILE . 7.9 tp -87.81 16.58 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.726 -179.618 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 56.52 83.61 0.1 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.726 -179.838 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.75 56.72 0.07 OUTLIER Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.01 -179.865 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.42 ' HB3' HE21 ' A' ' 85' ' ' GLN . 9.5 Cg_endo -49.43 153.46 4.96 Favored 'Trans proline' 0 C--N 1.296 -2.228 0 C-N-CA 122.818 2.345 . . . . 0.0 112.565 -178.52 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.432 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.4 OUTLIER -109.13 146.32 14.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.4 -179.764 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 97.0 mt -63.99 -44.78 97.94 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.335 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.436 -179.986 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.504 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -130.16 134.72 47.51 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 120.851 0.358 . . . . 0.0 110.591 -179.762 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.493 ' O ' ' N ' ' A' ' 98' ' ' LEU . 72.6 m -134.79 158.86 43.1 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.912 -179.719 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.9 139.49 16.33 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 179.877 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.492 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.87 -162.46 0.08 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.98 0.419 . . . . 0.0 110.498 -179.996 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.507 HG22 ' CD2' ' A' ' 297' ' ' PHE . 5.9 t -133.86 135.99 44.07 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.179 -179.997 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.488 ' C ' ' O ' ' A' ' 70' ' ' THR . 1.0 OUTLIER 29.65 68.12 0.68 Allowed Pre-proline 0 N--CA 1.466 0.335 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.719 -179.665 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -60.69 144.92 99.61 Favored 'Trans proline' 0 C--N 1.299 -2.045 0 C-N-CA 122.573 2.182 . . . . 0.0 112.242 -178.506 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.525 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 45.2 p-10 -160.37 -32.12 0.06 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.646 179.735 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.531 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 99.1 m-20 -64.07 -39.37 93.92 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.451 -179.987 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -60.7 -47.75 84.88 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.718 -179.165 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.424 ' O ' ' O ' ' A' ' 77' ' ' ALA . 96.1 t -60.3 -24.5 31.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 179.687 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.531 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -45.71 172.81 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.594 179.835 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.568 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.6 p30 -62.01 177.77 0.42 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.605 -179.654 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.56 ' C ' ' H ' ' A' ' 81' ' ' GLY . 35.8 p30 -46.36 85.98 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.012 0.434 . . . . 0.0 110.921 179.956 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.568 ' N ' ' O ' ' A' ' 78' ' ' ASP . 43.0 tp60 -67.49 13.73 0.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.022 -179.78 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.56 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 117.91 -22.24 9.95 Favored Glycine 0 CA--C 1.518 0.269 0 N-CA-C 110.991 -0.844 . . . . 0.0 110.991 179.987 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -107.95 116.7 32.42 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.007 0.432 . . . . 0.0 110.488 179.858 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 76.5 mt -98.88 0.9 45.11 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.482 -179.783 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -91.93 6.57 45.73 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.996 0.427 . . . . 0.0 110.475 -179.749 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.777 ' O ' HG22 ' A' ' 89' ' ' VAL . 88.2 mt-30 -100.02 -26.52 13.95 Favored 'General case' 0 C--O 1.224 -0.259 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.843 179.883 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.0 t-105 -64.6 -40.86 96.26 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.121 -179.769 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.551 ' O ' ' N ' ' A' ' 91' ' ' LYS . 70.3 m -77.59 -53.55 7.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.355 -179.67 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -48.22 -50.75 28.22 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.076 -179.24 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.777 HG22 ' O ' ' A' ' 85' ' ' GLN . 14.3 m -69.08 -41.03 81.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 120.932 0.396 . . . . 0.0 111.174 179.645 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.505 ' N ' HG23 ' A' ' 89' ' ' VAL . . . -71.72 -22.95 61.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.814 -179.971 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.551 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.0 tttm -61.51 -45.97 91.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.476 -179.493 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.437 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.8 mm-40 -90.43 -94.33 0.12 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.111 -179.867 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.632 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.9 mtt180 -143.37 59.66 1.4 Allowed 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 179.767 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.459 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.6 pttp 33.74 26.08 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 120.833 0.349 . . . . 0.0 110.171 -179.354 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.632 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.3 tt -47.96 123.39 6.11 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.977 -178.076 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.447 ' O ' HD23 ' A' ' 95' ' ' LEU . 99.0 mm-40 -83.45 -170.54 3.1 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.055 -179.841 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.616 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 82.6 mtp180 -72.93 137.74 45.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.182 -179.807 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.493 ' N ' ' O ' ' A' ' 67' ' ' SER . 88.4 mt -86.32 -166.28 1.5 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.702 -179.626 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.531 ' CD2' ' O ' ' A' ' 99' ' ' TYR . 47.1 p90 -167.75 119.8 0.88 Allowed 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.223 179.938 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.508 ' C ' ' O ' ' A' ' 99' ' ' TYR . 43.0 mm -29.6 121.19 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.997 -179.645 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 113.66 28.17 3.3 Favored Glycine 0 CA--C 1.519 0.304 0 N-CA-C 111.179 -0.768 . . . . 0.0 111.179 -179.404 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.585 ' H ' ' CD ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -143.88 45.81 0.6 Allowed Pre-proline 0 C--N 1.324 -0.53 0 CA-C-O 120.947 0.403 . . . . 0.0 110.475 179.827 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.584 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 30.8 Cg_endo -62.06 143.7 95.23 Favored 'Trans proline' 0 C--N 1.296 -2.187 0 C-N-CA 122.639 2.226 . . . . 0.0 112.057 179.926 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.475 ' O ' HG23 ' A' ' 108' ' ' VAL . 22.6 t -173.27 120.77 0.35 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.41 179.649 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.28 -41.09 64.03 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.105 0.479 . . . . 0.0 111.262 179.525 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -65.92 -40.27 91.29 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.908 -179.401 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.89 -39.89 95.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.7 -179.915 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 104' ' ' SER . 69.0 t -67.43 -43.91 87.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.774 179.558 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.18 -39.18 91.83 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.554 -179.236 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.437 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.64 -23.62 63.18 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.425 179.835 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.552 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.5 mm-40 -90.83 4.68 51.09 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.703 -179.547 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.552 ' C ' ' O ' ' A' ' 111' ' ' GLN . 10.3 tpt 23.43 63.85 0.38 Allowed Pre-proline 0 N--CA 1.467 0.378 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.982 179.906 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.443 ' HG2' HD11 ' A' ' 116' ' ' ILE . 71.6 Cg_endo -78.48 168.58 21.18 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 C-N-CA 122.94 2.427 . . . . 0.0 112.28 -178.54 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.523 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 98.9 m-20 -112.7 -44.24 3.35 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.999 0.428 . . . . 0.0 109.97 179.495 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.0 tp -120.58 120.05 34.69 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.665 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.457 HD13 HD22 ' A' ' 133' ' ' LEU . 96.4 mt -117.09 131.26 70.33 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 CA-C-O 120.877 0.37 . . . . 0.0 111.017 -179.942 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.621 HD12 ' OG ' ' A' ' 48' ' ' SER . 30.0 mt -106.27 132.6 52.13 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.133 0.492 . . . . 0.0 110.234 -179.369 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.411 HD12 HG23 ' A' ' 139' ' ' THR . 98.1 mt -117.99 136.58 54.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.718 -179.705 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 86.0 p -72.17 152.93 41.94 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.644 179.979 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.36 -49.98 75.41 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.631 -179.858 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -148.99 153.43 37.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.495 179.811 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 169.53 -170.38 42.63 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 179.837 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.95 -35.31 91.89 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 179.915 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.451 ' O ' ' OD1' ' A' ' 124' ' ' ASP . 44.5 p-10 -87.71 120.0 28.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.822 0.344 . . . . 0.0 110.681 179.922 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.449 ' O ' HD12 ' A' ' 129' ' ' LEU . 39.8 t -63.62 144.22 57.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.437 -179.947 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.518 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.31 -43.34 8.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.931 180.0 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.6 tp -62.71 -42.35 99.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.684 -179.899 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.72 -11.38 58.22 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.478 -179.361 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.449 HD12 ' O ' ' A' ' 125' ' ' SER . 84.9 mt -115.64 -23.6 8.65 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.653 -179.781 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . 0.518 ' N ' ' O ' ' A' ' 126' ' ' ALA . 78.0 t80 -51.91 -49.71 62.54 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 120.534 -0.466 . . . . 0.0 110.548 -178.958 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.6 p-10 -65.91 -42.35 90.27 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.867 0.365 . . . . 0.0 111.268 179.512 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.521 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 87.9 mt-30 -67.0 -37.14 83.66 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.811 179.836 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.457 HD22 HD13 ' A' ' 116' ' ' ILE . 93.5 mt -79.98 -41.96 24.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.004 -179.612 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.0 t -57.48 -44.59 85.03 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.172 -178.959 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.8 m -62.25 -45.59 92.63 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.797 0.332 . . . . 0.0 110.54 179.382 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 92.3 mt -62.45 -43.79 98.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.277 -179.829 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.603 ' HB1' ' HD2' ' A' ' 138' ' ' PRO . . . -170.14 163.98 6.14 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.525 179.833 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.603 ' HD2' ' HB1' ' A' ' 137' ' ' ALA . 78.4 Cg_exo -43.81 111.89 0.28 Allowed 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.414 2.076 . . . . 0.0 112.1 179.523 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.471 HG21 ' CD1' ' A' ' 130' ' ' TYR . 17.8 m -85.97 127.54 34.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.49 179.973 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.649 HD13 ' CD2' ' A' ' 37' ' ' HIS . 34.2 tp -118.94 135.9 54.35 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.896 -179.576 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.435 ' O ' ' OD1' ' A' ' 32' ' ' ASP . 80.2 mt -102.63 119.89 51.63 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.417 0 CA-C-O 121.176 0.512 . . . . 0.0 111.466 -179.524 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.511 HD12 HD22 ' A' ' 117' ' ' LEU . 98.0 mt -135.8 132.66 51.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.615 179.791 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.549 HD21 ' CG ' ' A' ' 241' ' ' ASP . 54.5 t30 -65.62 151.7 45.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.966 0.412 . . . . 0.0 110.33 179.195 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.52 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 87.3 t80 -85.62 122.42 29.7 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.978 -179.553 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.52 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 98.9 m-20 55.13 69.33 0.74 Allowed 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.966 179.755 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 49.2 p-10 -123.44 -0.35 8.74 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 120.989 0.423 . . . . 0.0 110.711 179.866 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -151.32 117.24 5.51 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.818 -179.52 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 84.8 p -63.26 167.9 4.8 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.519 -179.77 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.419 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.4 p-90 -50.78 -15.7 0.32 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.566 -179.823 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . 0.444 ' O ' HG23 ' A' ' 154' ' ' THR . 68.0 tp60 -71.24 -74.78 0.14 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.427 -179.726 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.449 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.1 t -62.66 -39.06 92.73 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.235 179.476 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 53.5 tp -60.25 -45.51 93.03 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.345 -178.476 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.419 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 45.7 tp -62.67 -41.92 99.35 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.83 0.348 . . . . 0.0 110.365 179.013 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.449 ' OG1' ' O ' ' A' ' 151' ' ' SER . 55.3 p -63.92 -34.65 78.45 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.282 -179.461 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.451 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.5 mm-40 -63.93 -42.37 97.37 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.175 179.269 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 92.1 mt -65.32 -39.02 91.92 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.072 0.463 . . . . 0.0 110.122 179.163 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.582 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.05 -32.29 79.77 Favored Glycine 0 CA--C 1.519 0.337 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 -179.308 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.451 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.3 mt-10 -36.48 -25.21 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.88 0.371 . . . . 0.0 110.808 179.913 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.582 ' N ' ' O ' ' A' ' 157' ' ' GLY . 95.7 mt -59.45 148.93 6.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.215 179.319 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 75.3 p -68.94 137.51 53.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.07 -179.554 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 70.6 22.13 77.88 Favored Glycine 0 N--CA 1.459 0.187 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 179.48 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 60.0 m80 -124.24 -14.62 6.95 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.673 0.273 . . . . 0.0 110.542 179.88 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -66.58 -59.44 3.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.696 -179.657 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -52.17 -48.68 64.82 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.141 -179.509 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -60.97 -40.95 95.35 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.742 0.306 . . . . 0.0 110.317 179.454 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.59 -47.31 86.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.57 179.822 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.95 -40.05 75.71 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.197 -179.787 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -61.76 -50.26 73.1 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.511 179.597 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -65.38 -43.68 89.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.493 179.595 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 95.4 mt -64.49 -43.48 96.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.395 179.71 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.23 -51.03 70.98 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.568 -179.129 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.81 -43.54 95.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.431 179.744 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . 0.666 ' CE2' HD11 ' A' ' 177' ' ' LEU . 57.1 t80 -62.55 -44.75 95.56 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.117 0.484 . . . . 0.0 110.503 179.272 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -63.22 -39.82 95.71 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.616 -179.365 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -62.9 -42.74 99.88 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.644 179.175 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -60.97 -44.64 97.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.015 -179.944 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.666 HD11 ' CE2' ' A' ' 173' ' ' PHE . 85.1 mt -64.24 -41.25 97.07 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.033 0.445 . . . . 0.0 110.715 178.887 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.41 -62.1 1.85 Allowed 'General case' 0 C--O 1.237 0.432 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.51 -179.317 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.67 -46.71 86.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.545 179.882 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.45 -41.46 66.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.203 -179.979 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -63.77 -33.73 76.31 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.965 0.412 . . . . 0.0 110.347 179.244 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . 0.423 ' HG2' ' O ' ' A' ' 182' ' ' GLU . 69.8 tt0 -90.57 8.56 33.47 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.483 0.659 . . . . 0.0 110.527 -178.997 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -104.51 -32.22 9.08 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.267 179.58 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.6 pt -128.01 147.78 32.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.863 -179.902 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -140.05 131.16 26.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.352 179.409 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . 0.591 HD22 ' N ' ' A' ' 186' ' ' LEU . 3.6 mm? -85.68 133.29 42.1 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.905 179.936 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -44.1 157.89 0.14 Allowed 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.685 2.257 . . . . 0.0 112.123 179.468 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . 0.523 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.5 Cg_endo -62.87 115.05 2.69 Favored 'Trans proline' 0 C--N 1.303 -1.828 0 C-N-CA 122.812 2.341 . . . . 0.0 111.701 179.887 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . 0.523 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.7 mt-30 155.59 148.16 0.0 OUTLIER Pre-proline 0 N--CA 1.454 -0.257 0 O-C-N 123.626 0.579 . . . . 0.0 110.726 -179.957 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -73.95 144.13 33.9 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 C-N-CA 122.657 2.238 . . . . 0.0 111.779 178.083 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.503 HG23 ' OG ' ' A' ' 258' ' ' SER . 2.1 p -125.06 158.76 32.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.276 0.56 . . . . 0.0 110.138 -179.95 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . 0.493 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 35.6 p -143.29 165.46 27.41 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.199 -179.798 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . 0.445 ' HA ' ' H ' ' A' ' 260' ' ' PHE . . . -135.45 128.54 31.67 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.231 0.538 . . . . 0.0 110.206 179.597 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.506 HD11 HD23 ' A' ' 259' ' ' LEU . 47.1 pt -146.59 149.36 16.02 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.358 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.138 179.71 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . 0.739 HG13 ' CD1' ' A' ' 262' ' ' PHE . 69.2 t -118.14 123.31 71.45 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-O 121.385 0.612 . . . . 0.0 109.538 179.276 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -134.39 107.08 7.4 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.181 179.759 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 95.2 m -130.89 130.77 43.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.95 179.685 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.406 ' O ' ' N ' ' A' ' 201' ' ' HIS . . . -83.04 -37.03 24.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.227 179.793 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.39 -67.06 0.26 Allowed 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.346 -179.967 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.24 -9.96 59.15 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.272 179.536 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . 0.406 ' N ' ' O ' ' A' ' 198' ' ' ALA . 60.1 t-80 60.8 58.08 2.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.585 -179.841 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 54.4 p -166.89 153.33 8.44 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.472 179.568 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.02 143.86 24.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.454 179.509 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -135.16 138.05 43.32 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.635 179.972 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 20.0 mt -106.23 125.51 51.08 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 121.114 0.483 . . . . 0.0 109.731 -179.67 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 206' ' ' TRP . . . . . 0.56 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 74.4 m95 -81.91 166.88 19.51 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.595 -179.799 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . 0.465 HG22 ' C ' ' A' ' 206' ' ' TRP . 0.1 OUTLIER -157.01 172.01 6.7 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.561 -179.173 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.18 -36.94 87.28 Favored 'Trans proline' 0 C--N 1.302 -1.894 0 C-N-CA 122.623 2.215 . . . . 0.0 112.022 179.477 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -70.52 -35.11 72.99 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.888 -179.917 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 21.9 m -61.18 150.63 33.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.662 -179.368 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.62 -36.84 81.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.482 -179.714 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 212' ' ' GLN . . . . . 0.56 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 54.8 tt0 -64.57 -40.44 95.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.524 179.931 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.79 -43.33 91.95 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.679 -0.969 . . . . 0.0 110.679 179.829 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -63.44 -43.7 96.67 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 179.933 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 215' ' ' MET . . . . . 0.55 ' SD ' ' HB2' ' A' ' 304' ' ' ALA . 65.6 ttp -59.64 -47.83 84.05 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.161 -179.764 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 86.7 mt -60.83 -40.68 93.68 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 179.731 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 217' ' ' GLU . . . . . 0.453 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.2 tp10 -58.27 -38.03 76.14 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.784 -0.451 . . . . 0.0 109.784 179.926 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -65.13 -38.23 89.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.836 0.351 . . . . 0.0 110.664 179.605 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 93.6 mt -64.33 -42.65 96.19 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.497 -179.587 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.6 45.22 0.08 OUTLIER Glycine 0 C--N 1.333 0.393 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 179.975 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 221' ' ' PHE . . . . . 0.453 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 26.5 m-85 -128.38 155.83 44.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.025 0.44 . . . . 0.0 110.527 -179.802 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.489 ' O ' HG13 ' A' ' 191' ' ' VAL . 8.2 p -107.56 122.61 47.02 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.262 0.553 . . . . 0.0 110.197 -179.913 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.475 HD22 ' C ' ' A' ' 222' ' ' THR . 4.3 mm? -101.52 132.92 46.89 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.082 179.884 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.65 159.84 14.71 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.508 179.883 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.46 115.27 29.97 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.955 0.407 . . . . 0.0 110.306 179.869 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.499 ' N ' HD12 ' A' ' 226' ' ' LEU . 9.0 mp -53.1 156.85 3.35 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.672 179.907 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -60.59 145.53 98.65 Favored 'Trans proline' 0 C--N 1.301 -1.96 0 C-N-CA 122.564 2.176 . . . . 0.0 112.076 179.396 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.21 -3.41 59.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.551 -179.966 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.06 -41.09 5.67 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 -179.909 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . 0.53 ' O ' ' N ' ' A' ' 233' ' ' SER . 68.3 mt -78.97 -17.57 55.21 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-O 121.097 0.475 . . . . 0.0 110.372 -179.838 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . 0.401 ' C ' ' O ' ' A' ' 230' ' ' LEU . 55.0 t-20 -40.43 -49.13 2.84 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.827 -179.352 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -87.68 15.28 7.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.779 0.323 . . . . 0.0 111.34 179.748 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . 0.53 ' N ' ' O ' ' A' ' 230' ' ' LEU . 78.1 p -60.47 -35.32 75.59 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.591 -179.749 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . 0.525 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.7 tt0 -119.35 -69.44 0.85 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.966 179.457 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.2 m -69.25 103.08 1.85 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.686 -179.788 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -94.77 57.19 2.12 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.381 179.951 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -144.58 -122.72 1.61 Allowed Glycine 0 C--N 1.332 0.322 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 -179.989 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -135.03 111.9 10.14 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 121.202 0.525 . . . . 0.0 110.401 179.958 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . 0.525 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.6 mtt180 -148.15 57.74 1.08 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.796 -179.856 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -69.43 -32.16 70.96 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.518 179.681 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 241' ' ' ASP . . . . . 0.549 ' CG ' HD21 ' A' ' 143' ' ' ASN . 65.0 t0 -57.03 -47.04 81.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.372 -179.101 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 242' ' ' ILE . . . . . 0.437 ' O ' ' O ' ' A' ' 239' ' ' ARG . 17.9 tt -139.92 156.59 25.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.944 0.402 . . . . 0.0 110.477 179.771 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.444 HG22 HD13 ' A' ' 245' ' ' LEU . 96.1 mt -106.3 106.81 21.29 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.219 0 CA-C-O 121.208 0.527 . . . . 0.0 110.498 179.776 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . 0.601 ' O ' HD12 ' A' ' 245' ' ' LEU . 88.2 mt-30 -110.67 110.15 20.7 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.264 179.717 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.601 HD12 ' O ' ' A' ' 244' ' ' GLN . 9.4 mp -121.71 -168.14 1.65 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.667 179.725 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . 0.525 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.4 -15.82 0.05 OUTLIER Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.991 -0.844 . . . . 0.0 110.991 179.851 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . 0.673 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -61.47 156.5 34.83 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 110.926 -0.869 . . . . 0.0 110.926 -179.893 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -63.59 21.83 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.975 0.416 . . . . 0.0 110.59 179.948 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . 0.673 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.9 m-20 -97.48 -6.13 34.46 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.572 179.9 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 93.5 mt -79.43 -22.11 44.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.639 179.522 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.66 -51.21 70.89 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.806 -179.445 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.09 -5.82 58.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.375 179.639 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.12 -74.47 1.14 Allowed Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 -179.956 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 83.0 mt -70.15 125.81 27.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.019 0.438 . . . . 0.0 110.168 -179.759 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -59.57 -39.2 83.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.28 -179.691 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 83.27 51.71 4.04 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 110.716 -0.954 . . . . 0.0 110.716 179.755 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -95.62 -15.33 22.83 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.709 0.29 . . . . 0.0 110.641 -179.853 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 258' ' ' SER . . . . . 0.503 ' OG ' HG23 ' A' ' 191' ' ' VAL . 3.4 t 174.58 89.07 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.058 0.456 . . . . 0.0 110.083 179.935 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.862 ' N ' HD12 ' A' ' 259' ' ' LEU . 0.9 OUTLIER -94.39 124.2 38.27 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.291 0.567 . . . . 0.0 111.165 -179.211 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 260' ' ' PHE . . . . . 0.445 ' H ' ' HA ' ' A' ' 193' ' ' ALA . 15.9 m-30 -93.1 146.68 23.47 Favored 'General case' 0 CA--C 1.506 -0.747 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.324 179.281 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 86.1 mt -122.53 149.7 43.56 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.53 -179.883 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.739 ' CD1' HG13 ' A' ' 195' ' ' VAL . 2.5 p90 -77.78 -138.56 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.472 -179.724 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 263' ' ' ALA . . . . . 0.662 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -51.72 77.4 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.985 -179.988 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . 0.635 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.17 104.42 0.19 Allowed Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 -179.852 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 265' ' ' ASP . . . . . 0.602 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.6 m-20 -80.41 -177.69 6.3 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.662 0.268 . . . . 0.0 110.932 -179.583 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -40.65 -17.6 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.454 179.939 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 267' ' ' LYS . . . . . 0.602 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.42 -51.59 42.25 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.992 0.425 . . . . 0.0 110.768 179.382 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -63.78 -46.61 84.46 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.126 179.397 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . 0.562 ' HB1' ' OH ' ' A' ' 273' ' ' TYR . . . -61.72 -35.1 77.07 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 121.129 0.49 . . . . 0.0 109.71 179.693 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -62.87 -34.91 78.38 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.213 179.672 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.27 -43.02 14.11 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.402 -179.59 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 272' ' ' ILE . . . . . 0.59 ' C ' ' H ' ' A' ' 274' ' ' ALA . 5.0 tt -51.29 -33.82 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.828 -179.006 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 273' ' ' TYR . . . . . 0.562 ' OH ' ' HB1' ' A' ' 269' ' ' ALA . 17.3 m-85 -54.15 -1.66 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.695 -179.625 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 274' ' ' ALA . . . . . 0.59 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.81 -39.88 69.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.882 179.626 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . 0.58 ' O ' ' N ' ' A' ' 279' ' ' ALA . 2.9 p30 -39.29 97.93 0.15 Allowed Pre-proline 0 N--CA 1.463 0.196 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.536 -179.76 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -53.87 -43.03 61.65 Favored 'Trans proline' 0 C--N 1.303 -1.828 0 C-N-CA 122.281 1.987 . . . . 0.0 112.78 -178.884 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 89.6 mt -64.28 -42.8 96.24 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 121.2 0.524 . . . . 0.0 111.346 -179.866 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 90.9 mt -95.68 -1.72 49.51 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.826 -179.499 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 279' ' ' ALA . . . . . 0.58 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.37 -34.97 77.73 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.619 -179.727 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -74.06 19.97 0.11 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.047 -179.342 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . 0.491 HD23 ' HA ' ' A' ' 281' ' ' LEU . 13.8 mt -75.19 120.54 82.15 Favored Pre-proline 0 N--CA 1.451 -0.395 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.345 -179.96 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -51.54 -39.15 65.56 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.586 2.191 . . . . 0.0 111.699 179.241 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -53.08 -50.28 64.71 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 179.914 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 74.9 t -61.56 -43.96 97.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.544 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -57.74 -41.22 81.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.281 -179.918 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -91.04 0.35 57.56 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.139 179.676 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt 59.32 43.14 17.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.943 179.731 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -94.64 41.54 1.09 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.298 179.901 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 53.7 t -119.15 135.64 58.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.001 0.429 . . . . 0.0 110.169 -179.7 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -132.73 162.85 30.37 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.072 0.463 . . . . 0.0 110.753 -179.728 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.69 155.26 32.75 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.991 0.424 . . . . 0.0 110.783 -179.938 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 82.2 mt -94.1 -1.4 54.38 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.242 -179.689 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 120.87 165.28 12.66 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.549 -1.02 . . . . 0.0 110.549 -179.886 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 7.0 m -86.89 -62.29 1.54 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.853 0.359 . . . . 0.0 111.118 -179.89 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 295' ' ' GLU . . . . . 0.446 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.5 mm-40 -69.15 -4.09 16.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.667 -179.768 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 25.3 p -76.71 32.07 0.13 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.673 -179.94 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 297' ' ' PHE . . . . . 0.507 ' CD2' HG22 ' A' ' 70' ' ' THR . 69.0 t80 -60.42 -45.91 91.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.64 -179.99 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . 0.616 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.2 mtt85 -81.02 134.89 35.76 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 121.011 0.434 . . . . 0.0 110.597 -179.677 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.465 ' H ' HG11 ' A' ' 51' ' ' VAL . 17.6 tp -114.15 117.53 31.45 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.081 179.944 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . 0.619 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.4 p-10 -165.14 -176.81 4.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.543 179.911 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -46.91 -43.22 18.72 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.186 -179.655 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -67.12 -40.25 86.8 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.99 0.424 . . . . 0.0 110.853 179.053 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . 0.619 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 59.9 p -56.12 -36.11 67.85 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.064 -179.121 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . 0.55 ' HB2' ' SD ' ' A' ' 215' ' ' MET . . . -57.58 -51.34 69.89 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 179.463 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 90.3 mtp -56.73 -43.39 80.6 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 108.993 -0.744 . . . . 0.0 108.993 -179.866 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -66.53 -42.54 87.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.905 0.383 . . . . 0.0 110.108 178.884 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 303' ' ' SER . 56.0 t -63.94 -43.09 97.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.112 179.344 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 42.7 tp -59.63 -42.19 92.17 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.782 -179.451 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -62.64 -38.91 92.1 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 179.522 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 310' ' ' ARG . . . . . 0.442 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.6 ttt85 -63.62 -43.95 95.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.17 179.553 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 88.4 mt -63.3 -42.08 99.01 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.156 179.693 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -62.85 -33.45 75.27 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.978 179.558 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.96 -23.27 21.59 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.47 -179.809 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . 0.481 HD22 ' CE2' ' A' ' 315' ' ' PHE . 6.8 tt -62.42 -43.05 99.75 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.076 0.465 . . . . 0.0 110.624 -179.884 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 315' ' ' PHE . . . . . 0.481 ' CE2' HD22 ' A' ' 314' ' ' LEU . 90.9 m-85 . . . . . 0 C--O 1.22 -0.485 0 CA-C-O 117.937 -1.03 . . . . 0.0 110.479 179.964 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -99.4 136.01 39.98 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.032 0.444 . . . . 0.0 110.547 -179.962 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.498 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -92.26 178.42 1.7 Allowed Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.5 -179.924 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.498 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 27.0 Cg_exo -61.54 147.45 95.4 Favored 'Trans proline' 0 C--N 1.301 -1.958 0 C-N-CA 122.726 2.284 . . . . 0.0 112.173 179.737 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.453 ' HE ' HD12 ' A' ' 39' ' ' LEU . 35.4 ptt180 -135.7 142.18 45.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.608 179.782 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -79.73 116.34 19.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.446 179.896 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.453 ' O ' HG23 ' A' ' 30' ' ' ILE . 9.5 tp -110.71 130.25 64.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.438 -179.96 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 12.7 t -70.77 141.43 51.44 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.518 179.925 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.477 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.2 t0 -139.01 179.38 6.53 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.55 -179.928 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.477 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 78.1 p -74.04 -36.88 64.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.684 179.784 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.8 ttt85 -46.53 -94.55 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.344 -179.504 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -166.92 -26.78 0.02 OUTLIER Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 179.928 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 55.1 m -169.21 104.7 0.38 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.979 0.419 . . . . 0.0 110.665 -179.873 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.683 ' CD2' HD13 ' A' ' 140' ' ' LEU . 74.5 t60 -128.39 148.24 50.69 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.042 0.449 . . . . 0.0 110.338 179.795 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.627 HG22 ' N ' ' A' ' 39' ' ' LEU . 98.0 m -130.62 166.02 21.56 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.674 -179.889 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.627 ' N ' HG22 ' A' ' 38' ' ' THR . 82.4 mt -120.68 127.61 52.21 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.455 179.74 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -65.18 -44.55 88.12 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.653 -179.861 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 38.8 p -165.63 154.86 12.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.42 179.582 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.524 ' H ' ' CD ' ' A' ' 42' ' ' GLN . 14.8 mp0 -44.33 101.13 0.24 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.676 179.528 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -57.29 129.06 32.16 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.421 2.081 . . . . 0.0 112.183 -179.588 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -83.72 -24.76 31.07 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.478 179.619 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.538 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.8 mtm-85 -121.87 134.61 54.87 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-O 121.194 0.521 . . . . 0.0 110.303 -179.99 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 95.9 mt -130.9 133.68 62.73 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.261 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.017 -179.812 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 45.3 t -124.2 130.49 73.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 179.372 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.625 ' OG ' HD12 ' A' ' 117' ' ' LEU . 2.3 m -155.28 166.83 32.34 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.564 179.849 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 66.6 p -124.44 9.16 8.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.5 179.874 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.16 125.43 32.81 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.635 -179.436 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.444 HG11 ' H ' ' A' ' 299' ' ' LEU . 94.0 t -65.88 -44.61 92.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.51 179.967 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.7 m -62.63 -44.31 96.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.615 -179.805 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 51.0 tp -62.26 -41.57 98.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.541 -179.487 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.44 ' O ' HD13 ' A' ' 58' ' ' LEU . 74.2 m -57.59 -44.4 85.36 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.404 -179.36 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.2 -62.22 5.35 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 179.539 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.7 t -48.59 -35.47 13.6 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 -179.939 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.8 mt -61.72 -44.96 95.9 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.153 179.379 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.44 HD13 ' O ' ' A' ' 54' ' ' THR . 9.3 mp -64.85 -41.88 95.35 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.081 0.467 . . . . 0.0 111.368 177.918 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.28 -41.12 98.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.96 -179.139 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.427 ' O ' HG23 ' A' ' 60' ' ' ILE . 8.2 tp -88.58 17.05 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.71 -179.647 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 56.57 84.85 0.08 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.645 -179.991 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.65 58.86 0.09 OUTLIER Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.072 -179.819 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.4 ' HB3' HE21 ' A' ' 85' ' ' GLN . 10.5 Cg_endo -50.66 151.41 10.7 Favored 'Trans proline' 0 C--N 1.297 -2.17 0 C-N-CA 122.767 2.312 . . . . 0.0 112.562 -178.366 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.432 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -108.33 145.49 15.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.325 -179.736 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 97.0 mt -63.84 -44.95 98.28 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.439 -179.785 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.497 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -130.13 134.29 47.22 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.545 -179.791 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.491 ' O ' ' N ' ' A' ' 98' ' ' LEU . 75.3 m -134.59 158.67 43.4 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.878 -179.643 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.31 138.71 16.12 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 179.799 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.476 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.62 -162.97 0.09 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.997 0.427 . . . . 0.0 110.426 -179.924 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.525 HG22 ' CD2' ' A' ' 297' ' ' PHE . 5.9 t -133.78 135.53 43.93 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.209 -179.985 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.494 ' C ' ' O ' ' A' ' 70' ' ' THR . 1.0 OUTLIER 29.5 68.12 0.67 Allowed Pre-proline 0 N--CA 1.464 0.245 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.685 -179.634 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -60.54 145.14 99.31 Favored 'Trans proline' 0 C--N 1.3 -1.98 0 C-N-CA 122.57 2.18 . . . . 0.0 112.236 -178.618 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.529 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 44.9 p-10 -160.23 -32.18 0.06 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.574 179.757 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.536 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 99.1 m-20 -63.96 -39.4 94.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.385 179.999 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -60.47 -48.21 82.78 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.684 -179.351 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.421 ' O ' ' O ' ' A' ' 77' ' ' ALA . 96.6 t -60.09 -24.4 30.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.133 179.584 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.536 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -45.98 173.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.518 179.922 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.575 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.5 p30 -62.28 177.98 0.44 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.649 -179.766 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.551 ' C ' ' H ' ' A' ' 81' ' ' GLY . 35.4 p30 -45.51 85.75 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.93 179.893 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.575 ' N ' ' O ' ' A' ' 78' ' ' ASP . 42.8 tp60 -68.03 13.48 0.08 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.058 0.456 . . . . 0.0 110.111 -179.835 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.551 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 118.41 -22.29 9.57 Favored Glycine 0 CA--C 1.52 0.352 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 179.996 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -108.02 116.5 32.06 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.954 0.407 . . . . 0.0 110.474 179.785 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 76.6 mt -98.86 0.45 44.24 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.442 -179.724 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -92.52 7.23 44.07 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.996 0.427 . . . . 0.0 110.392 -179.689 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.796 ' O ' HG22 ' A' ' 89' ' ' VAL . 88.3 mt-30 -100.1 -27.65 13.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.822 -179.966 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 69.5 t-105 -63.25 -40.91 98.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.916 -179.615 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.56 ' O ' ' N ' ' A' ' 91' ' ' LYS . 66.5 m -77.58 -53.41 7.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.263 -179.405 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -48.46 -50.82 29.81 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.906 -179.302 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.796 HG22 ' O ' ' A' ' 85' ' ' GLN . 15.6 m -68.95 -40.84 81.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 120.959 0.409 . . . . 0.0 110.993 179.829 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.503 ' N ' HG23 ' A' ' 89' ' ' VAL . . . -72.18 -22.95 61.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.806 -179.864 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.56 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.0 tttm -61.77 -45.53 93.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.537 -179.558 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.444 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.6 mm-40 -90.47 -94.99 0.12 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.162 -179.957 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.642 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.9 mtt180 -142.78 59.28 1.43 Allowed 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 179.71 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.463 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.7 pttp 33.53 25.79 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 120.86 0.362 . . . . 0.0 110.235 -179.142 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.642 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.3 tt -47.68 123.5 5.98 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.907 -178.166 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.45 ' O ' HD23 ' A' ' 95' ' ' LEU . 99.0 mm-40 -83.81 -169.91 2.81 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.098 179.952 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.612 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 82.4 mtp180 -74.04 137.04 43.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.251 -179.754 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.491 ' N ' ' O ' ' A' ' 67' ' ' SER . 90.0 mt -86.27 -165.7 1.33 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.658 -179.539 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.535 ' CD2' ' O ' ' A' ' 99' ' ' TYR . 47.9 p90 -168.89 120.05 0.75 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.182 179.981 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.519 ' C ' ' O ' ' A' ' 99' ' ' TYR . 43.6 mm -29.14 121.24 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.994 -179.585 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 114.45 27.17 3.43 Favored Glycine 0 CA--C 1.521 0.441 0 N-CA-C 111.126 -0.789 . . . . 0.0 111.126 -179.578 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.587 ' H ' ' CD ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -144.35 46.26 0.61 Allowed Pre-proline 0 C--N 1.325 -0.498 0 CA-C-O 120.866 0.365 . . . . 0.0 110.412 179.986 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 29.9 Cg_endo -61.94 143.76 95.77 Favored 'Trans proline' 0 C--N 1.297 -2.168 0 C-N-CA 122.702 2.268 . . . . 0.0 112.021 179.993 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.464 ' O ' HG23 ' A' ' 108' ' ' VAL . 26.2 t -173.32 120.06 0.33 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.474 179.82 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.26 -40.49 64.57 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.045 0.45 . . . . 0.0 111.184 179.644 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.25 -40.05 89.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.923 -179.447 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.07 -40.06 95.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.736 -179.844 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 104' ' ' SER . 71.8 t -67.56 -43.95 86.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.863 179.664 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.83 -38.79 92.18 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.631 -179.323 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.444 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.44 -23.34 62.6 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.418 179.799 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.553 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.3 mm-40 -90.53 5.02 49.49 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.699 -179.454 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.553 ' C ' ' O ' ' A' ' 111' ' ' GLN . 10.2 tpt 24.16 63.59 0.41 Allowed Pre-proline 0 N--CA 1.465 0.278 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.874 -179.981 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -77.53 167.1 24.83 Favored 'Trans proline' 0 C--N 1.303 -1.82 0 C-N-CA 122.987 2.458 . . . . 0.0 112.415 -178.779 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.526 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 99.1 m-20 -110.39 -41.97 4.24 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 121.02 0.438 . . . . 0.0 110.131 179.442 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.7 tp -121.65 120.14 33.87 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.344 -0.389 . . . . 0.0 109.957 179.549 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 83.4 mt -112.99 129.14 69.18 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.341 0 CA-C-O 120.943 0.401 . . . . 0.0 110.891 -179.882 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.625 HD12 ' OG ' ' A' ' 48' ' ' SER . 29.7 mt -109.13 132.39 54.16 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 121.108 0.48 . . . . 0.0 110.165 -179.682 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.492 HD12 HG23 ' A' ' 139' ' ' THR . 98.8 mt -119.87 139.07 48.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.697 -179.789 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 85.0 p -72.65 153.75 41.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.579 179.951 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.08 -50.06 75.19 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.616 -179.823 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.0 t -149.64 154.19 38.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.573 179.795 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 170.56 -170.96 43.46 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.954 -0.858 . . . . 0.0 110.954 179.917 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -63.1 -34.14 89.16 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 179.932 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.452 ' O ' ' OD1' ' A' ' 124' ' ' ASP . 44.6 p-10 -86.93 120.23 27.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.805 0.336 . . . . 0.0 110.742 179.97 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.437 ' O ' HD12 ' A' ' 129' ' ' LEU . 40.6 t -63.1 143.58 57.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.431 -179.894 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.524 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.15 -43.27 8.94 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.888 -179.913 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 56.0 tp -62.74 -42.54 99.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.751 -179.858 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.42 -11.97 59.11 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.551 -179.436 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.437 HD12 ' O ' ' A' ' 125' ' ' SER . 84.1 mt -115.26 -23.6 8.86 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.663 -179.85 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . 0.524 ' N ' ' O ' ' A' ' 126' ' ' ALA . 79.0 t80 -51.01 -49.76 59.84 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.52 -179.012 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.3 p-10 -65.99 -42.64 89.51 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.8 0.333 . . . . 0.0 111.11 179.604 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.526 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 88.2 mt-30 -67.02 -37.92 84.99 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.744 179.926 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.414 HD12 HD11 ' A' ' 118' ' ' ILE . 95.2 mt -80.22 -41.56 24.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.983 -179.535 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.3 t -57.16 -44.29 83.33 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.196 -179.219 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.3 m -61.86 -45.33 94.23 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.778 0.323 . . . . 0.0 110.476 179.472 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 92.7 mt -62.23 -43.41 97.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.161 -179.742 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.657 ' HB1' ' HD2' ' A' ' 138' ' ' PRO . . . -169.53 168.23 4.89 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.533 179.866 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.657 ' HD2' ' HB1' ' A' ' 137' ' ' ALA . 51.9 Cg_exo -50.1 113.01 0.84 Allowed 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.29 1.993 . . . . 0.0 112.106 179.437 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.492 HG23 HD12 ' A' ' 118' ' ' ILE . 23.8 m -84.24 127.51 34.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.527 -179.927 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.683 HD13 ' CD2' ' A' ' 37' ' ' HIS . 34.6 tp -117.8 135.94 53.73 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.029 -179.702 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.443 ' O ' ' OD2' ' A' ' 32' ' ' ASP . 81.8 mt -100.17 118.82 47.4 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.36 0 CA-C-O 121.204 0.526 . . . . 0.0 111.231 -179.384 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.428 HD12 HD22 ' A' ' 117' ' ' LEU . 97.8 mt -134.73 132.27 54.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.656 179.629 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.551 HD21 ' CG ' ' A' ' 241' ' ' ASP . 61.0 t30 -66.9 151.19 48.04 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.9 0.381 . . . . 0.0 110.402 179.368 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.521 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 87.9 t80 -85.95 122.45 30.02 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.814 -179.577 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.521 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 98.8 m-20 55.16 69.3 0.75 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.87 179.725 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 35.2 p-10 -125.84 0.08 7.34 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.722 179.907 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -150.53 115.36 5.27 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.679 -179.463 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 84.0 p -63.61 168.54 4.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.526 -179.744 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.423 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.4 p-90 -52.01 -15.72 0.61 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.555 -179.861 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . 0.444 ' O ' HG23 ' A' ' 154' ' ' THR . 67.9 tp60 -70.5 -76.32 0.1 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.446 -179.737 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.449 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.1 t -62.64 -38.46 90.36 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.379 179.488 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 53.6 tp -60.07 -45.57 92.46 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.419 -178.668 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.423 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 47.3 tp -62.82 -41.79 99.45 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.845 0.355 . . . . 0.0 110.3 179.101 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.449 ' OG1' ' O ' ' A' ' 151' ' ' SER . 63.3 p -64.07 -34.61 78.42 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.335 -179.615 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.423 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.3 mm-40 -64.14 -42.85 96.63 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.264 179.247 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 92.4 mt -65.4 -39.0 91.65 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.989 0.423 . . . . 0.0 110.21 179.159 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.587 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.01 -32.13 79.12 Favored Glycine 0 CA--C 1.521 0.426 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 -179.358 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.442 ' C ' ' O ' ' A' ' 157' ' ' GLY . 97.3 mt-10 -35.45 -26.84 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.799 0.333 . . . . 0.0 110.731 179.968 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.587 ' N ' ' O ' ' A' ' 157' ' ' GLY . 95.8 mt -56.87 149.64 3.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.211 179.376 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 72.4 p -69.55 137.12 52.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.031 -179.587 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 71.77 20.26 78.57 Favored Glycine 0 N--CA 1.459 0.197 0 N-CA-C 111.239 -0.744 . . . . 0.0 111.239 179.487 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 57.6 m80 -121.97 -15.09 7.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.731 0.3 . . . . 0.0 110.622 179.928 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -65.74 -59.88 3.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.807 -179.741 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -52.03 -49.13 64.01 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.225 -179.717 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -60.71 -41.22 94.79 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.701 0.286 . . . . 0.0 110.308 179.411 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.39 -47.25 86.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.7 179.779 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.9 -40.24 75.93 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.261 -179.92 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -61.74 -50.15 73.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.561 179.57 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 60.1 ttt85 -65.31 -43.88 89.66 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.462 179.535 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 96.0 mt -64.44 -43.63 96.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.449 179.671 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.18 -50.97 71.19 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.608 -179.148 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -63.76 -43.83 95.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.378 179.803 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . 0.657 ' CE2' HD11 ' A' ' 177' ' ' LEU . 56.7 t80 -62.71 -44.53 95.99 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.071 0.462 . . . . 0.0 110.447 179.388 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -63.25 -40.13 96.57 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.435 -179.294 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -62.92 -42.75 99.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.648 179.292 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -60.6 -44.88 95.78 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.116 179.961 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.657 HD11 ' CE2' ' A' ' 173' ' ' PHE . 85.5 mt -64.37 -41.09 96.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.001 0.429 . . . . 0.0 110.692 178.867 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.02 -62.17 1.8 Allowed 'General case' 0 C--O 1.237 0.416 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.491 -179.349 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.94 -46.66 87.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.523 179.902 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.38 -41.69 66.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.15 179.999 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -63.79 -33.67 76.18 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.944 0.402 . . . . 0.0 110.354 179.272 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . 0.424 ' HG2' ' O ' ' A' ' 182' ' ' GLU . 69.6 tt0 -90.48 8.71 32.44 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.25 0.547 . . . . 0.0 110.565 -179.099 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -104.81 -32.26 8.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.232 179.676 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 45.4 pt -128.07 147.49 32.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.826 -179.879 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -139.73 131.02 26.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.335 179.436 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . 0.596 HD22 ' N ' ' A' ' 186' ' ' LEU . 3.5 mm? -85.5 133.66 41.71 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.776 179.994 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -44.16 157.74 0.15 Allowed 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.793 2.329 . . . . 0.0 112.053 179.47 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . 0.532 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.7 Cg_endo -62.92 114.88 2.62 Favored 'Trans proline' 0 C--N 1.303 -1.867 0 C-N-CA 122.727 2.284 . . . . 0.0 111.833 179.908 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . 0.532 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.7 mt-30 155.54 148.23 0.0 OUTLIER Pre-proline 0 N--CA 1.454 -0.238 0 O-C-N 123.438 0.461 . . . . 0.0 110.686 -179.761 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -74.13 144.18 33.3 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.736 2.291 . . . . 0.0 111.687 178.165 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.499 HG23 ' OG ' ' A' ' 258' ' ' SER . 2.1 p -124.99 158.82 32.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.195 0.521 . . . . 0.0 110.146 -179.954 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . 0.497 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 35.8 p -143.39 165.2 28.18 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.08 -179.526 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . 0.444 ' HA ' ' H ' ' A' ' 260' ' ' PHE . . . -135.45 128.48 31.55 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.145 0.498 . . . . 0.0 110.188 179.677 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.507 HD11 HD23 ' A' ' 259' ' ' LEU . 47.6 pt -146.52 149.09 16.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.068 179.88 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . 0.74 HG13 ' CD1' ' A' ' 262' ' ' PHE . 69.0 t -117.86 123.03 71.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.236 0.541 . . . . 0.0 109.733 179.08 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -134.15 106.86 7.39 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.288 179.79 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 95.1 m -130.62 130.52 44.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.77 179.751 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -83.18 -36.58 24.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.215 179.804 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.61 -66.99 0.27 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.398 179.878 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.68 -9.36 58.53 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.313 179.487 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 60.5 t-80 60.5 58.56 2.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.856 -179.952 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 37.1 p -167.29 153.64 8.08 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.526 179.512 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.52 144.09 24.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.967 0.413 . . . . 0.0 110.431 179.376 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -135.12 138.2 43.53 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.925 0.393 . . . . 0.0 110.671 -179.994 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 19.4 mt -106.39 125.52 51.1 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 121.117 0.484 . . . . 0.0 109.794 -179.738 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 206' ' ' TRP . . . . . 0.562 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 74.8 m95 -81.85 166.94 19.52 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.641 -179.808 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . 0.473 HG22 ' C ' ' A' ' 206' ' ' TRP . 0.1 OUTLIER -156.84 171.4 7.48 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.942 0.401 . . . . 0.0 110.569 -179.288 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -53.83 -37.2 84.8 Favored 'Trans proline' 0 C--N 1.303 -1.838 0 C-N-CA 122.603 2.202 . . . . 0.0 111.97 179.352 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -70.21 -35.19 73.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.923 -179.875 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 21.7 m -61.05 150.79 32.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.601 -179.305 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.59 -37.02 82.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.527 -179.755 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 212' ' ' GLN . . . . . 0.562 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 54.7 tt0 -64.59 -40.32 95.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.566 179.99 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.51 -43.29 92.67 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 179.833 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -63.56 -43.45 96.99 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.76 0.314 . . . . 0.0 110.335 179.897 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 215' ' ' MET . . . . . 0.526 ' SD ' ' HB2' ' A' ' 304' ' ' ALA . 65.4 ttp -59.65 -47.92 83.7 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.37 -179.928 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' A' ' 216' ' ' LEU . 88.2 mt -60.56 -40.71 92.64 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.497 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 217' ' ' GLU . . . . . 0.459 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.8 tp10 -58.23 -37.95 75.88 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.806 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -65.2 -38.19 89.71 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.849 0.356 . . . . 0.0 110.651 179.679 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 94.6 mt -64.3 -42.77 96.2 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.618 -179.674 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.71 44.87 0.08 OUTLIER Glycine 0 CA--C 1.52 0.387 0 N-CA-C 110.974 -0.85 . . . . 0.0 110.974 -179.996 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 221' ' ' PHE . . . . . 0.459 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 26.8 m-85 -128.04 155.71 43.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.087 0.47 . . . . 0.0 110.452 -179.843 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.49 ' O ' HG13 ' A' ' 191' ' ' VAL . 7.1 p -107.44 122.46 46.67 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 121.138 0.494 . . . . 0.0 110.205 -179.933 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.475 HD22 ' C ' ' A' ' 222' ' ' THR . 4.3 mm? -101.39 132.94 46.7 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.048 -179.991 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.68 159.65 14.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.519 179.876 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.34 115.02 29.55 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.335 179.867 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.496 ' N ' HD12 ' A' ' 226' ' ' LEU . 8.9 mp -53.0 156.71 3.31 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.665 179.953 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -60.65 145.61 98.56 Favored 'Trans proline' 0 C--N 1.302 -1.917 0 C-N-CA 122.599 2.199 . . . . 0.0 111.989 179.455 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.34 -3.43 59.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.502 -179.987 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -89.97 -41.21 5.66 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 111.011 -0.836 . . . . 0.0 111.011 -179.855 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . 0.54 ' O ' ' N ' ' A' ' 233' ' ' SER . 70.0 mt -78.91 -17.57 55.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.951 0.405 . . . . 0.0 110.329 -179.845 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . 0.403 ' C ' ' O ' ' A' ' 230' ' ' LEU . 55.2 t-20 -39.97 -49.31 2.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.742 -179.505 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -88.05 15.41 7.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.797 0.332 . . . . 0.0 111.21 -179.996 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . 0.54 ' N ' ' O ' ' A' ' 230' ' ' LEU . 78.1 p -60.45 -35.68 76.44 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.53 -179.862 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . 0.527 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.6 tt0 -118.66 -69.32 0.86 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.961 179.591 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.2 m -69.81 103.22 2.12 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.744 -179.785 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -94.66 57.53 2.2 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.392 179.953 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -144.72 -122.66 1.59 Allowed Glycine 0 CA--C 1.521 0.418 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 -179.972 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -134.73 111.5 10.0 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.075 0.464 . . . . 0.0 110.494 179.975 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . 0.521 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.6 mtt180 -148.03 57.49 1.09 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.682 -179.9 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -69.48 -32.21 70.97 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.522 179.654 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 241' ' ' ASP . . . . . 0.551 ' CG ' HD21 ' A' ' 143' ' ' ASN . 64.6 t0 -56.89 -47.04 81.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.369 -179.18 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 242' ' ' ILE . . . . . 0.441 ' O ' ' O ' ' A' ' 239' ' ' ARG . 18.0 tt -139.83 156.56 25.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.824 0.345 . . . . 0.0 110.584 179.807 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.442 HG22 HD13 ' A' ' 245' ' ' LEU . 96.1 mt -106.27 106.45 20.62 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.212 0 CA-C-O 121.09 0.472 . . . . 0.0 110.569 179.858 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . 0.606 ' O ' HD12 ' A' ' 245' ' ' LEU . 88.2 mt-30 -110.36 110.06 20.71 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.279 179.804 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.606 HD12 ' O ' ' A' ' 244' ' ' GLN . 9.3 mp -121.89 -168.43 1.7 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.65 179.923 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . 0.527 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.68 -16.37 0.05 OUTLIER Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 179.865 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . 0.676 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -60.91 156.48 32.61 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 -179.892 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -63.31 21.28 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.967 0.413 . . . . 0.0 110.569 179.952 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . 0.676 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.8 m-20 -96.99 -6.2 36.01 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.551 -179.996 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 93.8 mt -79.5 -22.22 44.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.636 179.545 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.51 -51.31 70.42 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.756 -179.49 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.1 -5.85 58.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.402 179.704 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -80.93 -74.63 1.13 Allowed Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 -179.902 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 83.6 mt -70.08 126.03 28.49 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.03 0.443 . . . . 0.0 110.246 -179.885 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -59.19 -39.39 82.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.238 -179.691 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 82.89 51.84 4.08 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 179.929 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -96.46 -14.22 22.54 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.734 0.302 . . . . 0.0 110.658 -179.822 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 258' ' ' SER . . . . . 0.499 ' OG ' HG23 ' A' ' 191' ' ' VAL . 3.5 t 174.16 88.47 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.075 0.464 . . . . 0.0 110.168 179.934 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.863 ' N ' HD12 ' A' ' 259' ' ' LEU . 1.0 OUTLIER -94.11 123.93 37.8 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.204 0.526 . . . . 0.0 111.073 -179.206 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 260' ' ' PHE . . . . . 0.444 ' H ' ' HA ' ' A' ' 193' ' ' ALA . 16.0 m-30 -92.76 146.42 23.66 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.356 179.175 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 87.0 mt -122.35 149.57 43.59 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.512 -179.917 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.74 ' CD1' HG13 ' A' ' 195' ' ' VAL . 2.5 p90 -77.64 -138.43 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.484 -179.808 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 263' ' ' ALA . . . . . 0.663 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -51.97 77.51 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.965 -179.945 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . 0.636 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.07 104.36 0.18 Allowed Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.674 -0.971 . . . . 0.0 110.674 -179.937 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 265' ' ' ASP . . . . . 0.608 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.9 m-20 -80.48 -177.74 6.35 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.743 0.306 . . . . 0.0 110.878 -179.477 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -40.43 -17.66 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.503 179.769 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 267' ' ' LYS . . . . . 0.608 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.49 -51.6 41.5 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.965 0.412 . . . . 0.0 110.742 179.434 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -63.81 -46.63 84.25 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.196 179.373 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . 0.568 ' HB1' ' OH ' ' A' ' 273' ' ' TYR . . . -61.58 -35.18 77.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.152 -0.477 . . . . 0.0 109.808 179.527 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -62.91 -34.64 77.87 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.164 179.624 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.32 -43.35 13.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.243 -179.535 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 272' ' ' ILE . . . . . 0.584 ' C ' ' H ' ' A' ' 274' ' ' ALA . 4.9 tt -51.53 -33.65 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.72 -178.712 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 273' ' ' TYR . . . . . 0.568 ' OH ' ' HB1' ' A' ' 269' ' ' ALA . 17.4 m-85 -54.23 -1.85 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.702 -179.705 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 274' ' ' ALA . . . . . 0.584 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.81 -39.49 69.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.848 179.651 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . 0.585 ' O ' ' N ' ' A' ' 279' ' ' ALA . 3.2 p30 -39.45 98.0 0.15 Allowed Pre-proline 0 C--N 1.332 -0.163 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.592 -179.668 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -53.82 -43.17 60.38 Favored 'Trans proline' 0 C--N 1.303 -1.847 0 C-N-CA 122.361 2.04 . . . . 0.0 112.751 -178.881 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 89.0 mt -64.47 -42.87 95.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.178 -179.667 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 90.7 mt -95.68 -1.51 49.94 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.839 -179.413 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 279' ' ' ALA . . . . . 0.585 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.55 -34.84 77.75 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.562 -179.713 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.08 20.03 0.11 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.045 -179.238 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . 0.491 HD23 ' HA ' ' A' ' 281' ' ' LEU . 13.9 mt -75.54 120.83 83.44 Favored Pre-proline 0 N--CA 1.452 -0.329 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.389 179.977 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_exo -51.54 -38.97 65.68 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.597 2.198 . . . . 0.0 111.617 179.339 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.78 -50.39 63.64 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.165 179.79 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 75.5 t -61.53 -43.95 97.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 179.424 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -57.7 -41.51 81.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.295 -179.992 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -90.94 0.21 57.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.186 179.641 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt 59.09 43.03 18.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.029 0.442 . . . . 0.0 110.969 179.755 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -94.42 41.74 1.09 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.342 179.856 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 54.0 t -119.03 135.8 58.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.989 0.423 . . . . 0.0 110.299 -179.812 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -132.85 162.7 30.87 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.997 0.427 . . . . 0.0 110.669 -179.635 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.81 155.36 32.72 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.974 0.416 . . . . 0.0 110.72 -179.785 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 81.4 mt -94.05 -1.5 54.34 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.225 -179.745 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 120.89 165.72 12.8 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 -179.795 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 6.9 m -87.28 -62.39 1.51 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.847 0.356 . . . . 0.0 111.04 -179.847 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 295' ' ' GLU . . . . . 0.438 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.8 mm-40 -69.53 -3.94 16.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.625 -179.762 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 27.3 p -77.03 32.63 0.14 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.612 -179.906 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 297' ' ' PHE . . . . . 0.525 ' CD2' HG22 ' A' ' 70' ' ' THR . 70.1 t80 -60.11 -45.97 91.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.549 -179.993 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . 0.612 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.2 mtt85 -81.32 134.13 35.53 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 121.017 0.437 . . . . 0.0 110.51 -179.761 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.444 ' H ' HG11 ' A' ' 51' ' ' VAL . 16.0 tp -114.67 119.52 36.98 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.213 -179.951 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . 0.62 ' H ' ' CB ' ' A' ' 303' ' ' SER . 49.4 p-10 -167.36 -174.41 2.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.523 -179.936 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -48.06 -45.49 32.42 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.183 -179.603 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -65.05 -41.45 95.14 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.062 0.458 . . . . 0.0 110.771 179.019 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . 0.62 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 53.0 p -55.55 -35.94 66.26 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.147 -179.37 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . 0.526 ' HB2' ' SD ' ' A' ' 215' ' ' MET . . . -57.16 -51.6 68.66 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.478 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 90.8 mtp -56.39 -43.57 79.39 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.792 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -66.52 -42.57 87.1 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.84 0.352 . . . . 0.0 110.131 178.78 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 303' ' ' SER . 56.1 t -64.03 -42.92 97.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.229 179.394 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 42.5 tp -59.63 -42.0 91.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.827 -179.626 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -62.86 -39.0 93.06 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 179.58 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 310' ' ' ARG . . . . . 0.437 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.4 ttt85 -63.59 -44.06 95.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.322 179.514 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 87.8 mt -63.3 -42.07 99.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.215 179.58 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -62.89 -33.18 74.76 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.037 179.521 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.95 -23.46 21.55 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.559 -179.866 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . 0.483 HD22 ' CE2' ' A' ' 315' ' ' PHE . 6.8 tt -62.34 -43.18 99.43 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.626 179.977 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 315' ' ' PHE . . . . . 0.483 ' CE2' HD22 ' A' ' 314' ' ' LEU . 91.1 m-85 . . . . . 0 C--O 1.22 -0.471 0 CA-C-O 117.979 -1.01 . . . . 0.0 110.506 179.992 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -99.6 136.5 39.43 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.041 0.448 . . . . 0.0 110.422 -179.906 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.497 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -92.05 178.44 1.72 Allowed Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.63 -179.916 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.497 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.7 Cg_exo -61.62 147.02 96.37 Favored 'Trans proline' 0 C--N 1.3 -2.018 0 C-N-CA 122.801 2.334 . . . . 0.0 112.124 179.784 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.456 ' HE ' HD12 ' A' ' 39' ' ' LEU . 35.3 ptt180 -136.06 142.25 44.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.71 179.771 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -79.56 116.62 19.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.475 179.905 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.45 ' O ' HG23 ' A' ' 30' ' ' ILE . 9.5 tp -110.88 130.36 64.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.512 -179.993 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.3 t -70.83 141.5 51.31 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.528 179.818 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.478 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.4 t0 -139.03 179.46 6.48 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.563 -179.944 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.478 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 78.1 p -74.04 -36.93 64.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.733 179.834 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.7 ttt85 -46.44 -94.57 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.351 -179.573 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -166.97 -26.68 0.02 OUTLIER Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.899 -0.881 . . . . 0.0 110.899 179.945 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 62.0 m -169.19 104.84 0.38 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.849 0.357 . . . . 0.0 110.694 -179.938 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.679 ' CD2' HD13 ' A' ' 140' ' ' LEU . 74.6 t60 -128.36 149.03 50.7 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.005 0.431 . . . . 0.0 110.3 179.941 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.625 HG22 ' N ' ' A' ' 39' ' ' LEU . 98.9 m -131.4 165.9 22.47 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.543 -179.857 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.625 ' N ' HG22 ' A' ' 38' ' ' THR . 81.7 mt -120.64 127.39 52.03 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.481 179.728 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -65.17 -44.51 88.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.706 179.975 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 40.3 p -165.68 154.62 11.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.433 179.728 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.485 ' H ' ' CD ' ' A' ' 42' ' ' GLN . 14.4 mp0 -44.55 101.34 0.25 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.642 179.437 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.25 129.36 33.76 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 C-N-CA 122.345 2.03 . . . . 0.0 112.264 -179.713 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -83.45 -24.92 31.61 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.533 179.536 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.537 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.5 mtm-85 -122.04 134.8 54.79 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-O 121.09 0.471 . . . . 0.0 110.364 -179.946 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.2 mt -130.61 133.57 63.32 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.288 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.959 -179.677 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 45.1 t -124.32 130.48 73.63 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-O 120.863 0.363 . . . . 0.0 110.115 179.238 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.619 ' OG ' HD12 ' A' ' 117' ' ' LEU . 2.4 m -154.85 166.59 33.03 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.527 179.842 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 71.4 p -124.47 8.61 8.38 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.489 179.85 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.22 125.85 33.2 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.611 -179.586 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.421 HG11 ' H ' ' A' ' 299' ' ' LEU . 86.2 t -65.86 -44.54 92.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.568 -179.962 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.9 m -62.65 -44.36 96.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.62 -179.81 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 46.5 tp -62.26 -41.66 98.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.526 -179.439 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.44 ' O ' HD13 ' A' ' 58' ' ' LEU . 76.2 m -57.58 -44.7 85.55 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.443 -179.426 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.0 -62.47 5.18 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 179.626 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.7 t -48.23 -35.62 12.29 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 -179.947 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.8 mt -61.74 -44.67 96.46 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.735 -0.386 . . . . 0.0 111.209 179.467 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.44 HD13 ' O ' ' A' ' 54' ' ' THR . 9.2 mp -65.1 -41.67 94.72 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.27 177.949 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.19 -41.42 99.18 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.966 -179.254 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.432 ' O ' HG23 ' A' ' 60' ' ' ILE . 8.3 tp -88.15 17.41 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.783 -179.637 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 56.46 84.72 0.08 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.674 -179.951 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.8 59.21 0.09 OUTLIER Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.038 -179.79 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.401 ' HB3' HE21 ' A' ' 85' ' ' GLN . 10.0 Cg_endo -51.09 151.28 12.31 Favored 'Trans proline' 0 C--N 1.296 -2.197 0 C-N-CA 122.779 2.319 . . . . 0.0 112.39 -178.228 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.435 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -108.59 145.21 15.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.332 -179.632 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.8 mt -63.77 -45.17 97.96 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.274 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.37 -179.766 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.496 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -129.76 134.38 47.56 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 120.877 0.37 . . . . 0.0 110.587 -179.811 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.492 ' O ' ' N ' ' A' ' 98' ' ' LEU . 73.2 m -134.76 158.76 43.33 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.804 -179.609 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.42 138.76 16.1 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 179.794 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.47 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.79 -162.79 0.08 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.916 0.388 . . . . 0.0 110.516 -179.908 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.532 HG22 ' CD2' ' A' ' 297' ' ' PHE . 6.0 t -133.88 135.46 43.68 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.27 179.996 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.495 ' C ' ' O ' ' A' ' 70' ' ' THR . 1.0 OUTLIER 29.34 68.57 0.64 Allowed Pre-proline 0 N--CA 1.465 0.303 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.637 -179.624 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -61.21 145.67 98.34 Favored 'Trans proline' 0 C--N 1.301 -1.946 0 C-N-CA 122.654 2.236 . . . . 0.0 112.018 -178.344 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.533 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 45.0 p-10 -160.46 -31.26 0.06 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.695 179.75 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.544 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 98.8 m-20 -64.69 -38.97 92.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.47 179.959 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.6 ttt180 -60.99 -48.08 83.48 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.621 -179.347 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.424 ' O ' ' O ' ' A' ' 77' ' ' ALA . 96.7 t -60.22 -24.84 31.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.023 179.631 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.544 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -45.68 172.96 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.497 179.731 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.584 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.4 p30 -62.47 177.83 0.47 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.604 -179.709 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.558 ' C ' ' H ' ' A' ' 81' ' ' GLY . 36.5 p30 -45.05 85.34 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.988 -180.0 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.584 ' N ' ' O ' ' A' ' 78' ' ' ASP . 42.0 tp60 -67.49 13.4 0.07 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.185 -179.892 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.558 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 118.4 -22.45 9.51 Favored Glycine 0 CA--C 1.519 0.319 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 179.951 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -108.03 116.22 31.56 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.986 0.422 . . . . 0.0 110.504 179.848 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 74.7 mt -98.09 0.17 45.61 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.511 -179.725 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -92.48 7.29 43.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.43 -179.815 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.784 ' O ' HG22 ' A' ' 89' ' ' VAL . 88.5 mt-30 -100.2 -26.58 13.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.78 179.981 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.4 t-105 -64.54 -40.76 96.18 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.018 -179.647 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.556 ' O ' ' N ' ' A' ' 91' ' ' LYS . 65.3 m -77.89 -53.84 7.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.131 -179.487 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -47.67 -50.97 23.29 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.982 -179.354 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.784 HG22 ' O ' ' A' ' 85' ' ' GLN . 14.9 m -69.1 -41.14 81.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.101 179.818 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.507 ' N ' HG23 ' A' ' 89' ' ' VAL . . . -71.7 -23.18 61.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.725 -179.876 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.556 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.0 tttm -61.73 -45.78 92.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.469 -179.53 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.443 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.7 mm-40 -90.13 -95.2 0.11 Allowed 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.175 -179.913 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.638 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.9 mtt180 -142.75 59.29 1.43 Allowed 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.755 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.461 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.7 pttp 33.37 26.1 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.169 -179.061 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.638 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.3 tt -48.04 123.41 6.2 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.916 -178.142 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.456 ' O ' HD23 ' A' ' 95' ' ' LEU . 98.9 mm-40 -83.65 -169.64 2.66 Favored 'General case' 0 N--CA 1.455 -0.175 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.198 179.963 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.61 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 82.1 mtp180 -74.4 136.91 42.42 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.282 -179.82 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.492 ' N ' ' O ' ' A' ' 67' ' ' SER . 90.5 mt -85.91 -165.64 1.3 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.743 -179.63 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.537 ' CD2' ' O ' ' A' ' 99' ' ' TYR . 47.7 p90 -169.05 119.76 0.72 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.268 179.99 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.518 ' C ' ' O ' ' A' ' 99' ' ' TYR . 43.3 mm -28.76 120.91 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.017 -179.693 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 114.53 27.09 3.44 Favored Glycine 0 CA--C 1.521 0.415 0 N-CA-C 111.149 -0.78 . . . . 0.0 111.149 -179.544 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.586 ' H ' ' CD ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -144.27 46.33 0.62 Allowed Pre-proline 0 C--N 1.323 -0.57 0 CA-C-O 120.927 0.394 . . . . 0.0 110.499 179.901 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 29.3 Cg_endo -61.92 143.82 95.9 Favored 'Trans proline' 0 C--N 1.297 -2.171 0 C-N-CA 122.7 2.267 . . . . 0.0 111.975 -179.899 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.452 ' O ' HG23 ' A' ' 108' ' ' VAL . 26.2 t -173.3 120.13 0.33 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.445 179.78 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.75 -40.35 63.56 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.065 0.46 . . . . 0.0 111.041 179.744 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.25 -39.98 89.88 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.798 -179.371 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.06 -39.99 95.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.744 -179.824 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 104' ' ' SER . 70.3 t -67.65 -43.77 86.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.753 179.708 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.74 -38.99 92.68 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.561 -179.246 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.443 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.66 -23.4 63.04 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.479 179.863 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.551 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.3 mm-40 -90.18 5.15 48.21 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.713 -179.554 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.551 ' C ' ' O ' ' A' ' 111' ' ' GLN . 10.5 tpt 23.44 64.17 0.38 Allowed Pre-proline 0 N--CA 1.465 0.293 0 CA-C-O 120.859 0.361 . . . . 0.0 110.982 -179.769 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -78.22 167.27 23.45 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 C-N-CA 122.971 2.447 . . . . 0.0 112.082 -178.448 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.523 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 98.8 m-20 -110.04 -42.14 4.28 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.145 179.426 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 41.2 tp -121.19 120.65 35.84 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 179.506 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 83.5 mt -113.29 128.92 69.86 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.343 0 CA-C-O 120.978 0.418 . . . . 0.0 110.88 -179.897 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.619 HD12 ' OG ' ' A' ' 48' ' ' SER . 30.2 mt -109.42 132.27 54.29 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 121.061 0.458 . . . . 0.0 110.218 -179.73 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.49 HD12 HG23 ' A' ' 139' ' ' THR . 98.9 mt -119.8 138.96 48.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.693 -179.718 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 85.8 p -72.75 153.96 40.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.594 -179.949 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.11 -50.21 74.6 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.686 -179.855 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -149.52 153.97 38.02 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.567 179.869 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 170.66 -170.97 43.51 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 179.876 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.88 -34.13 88.97 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 179.912 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.449 ' O ' ' OD1' ' A' ' 124' ' ' ASP . 44.3 p-10 -87.03 120.67 28.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.821 0.343 . . . . 0.0 110.651 179.983 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.446 ' O ' HD12 ' A' ' 129' ' ' LEU . 36.1 t -63.26 143.79 57.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.472 -179.935 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.52 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.12 -43.81 8.68 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.944 -179.898 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 56.0 tp -62.93 -42.44 99.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.748 -179.888 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.28 -11.92 58.77 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.522 -179.421 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.446 HD12 ' O ' ' A' ' 125' ' ' SER . 84.2 mt -115.37 -23.56 8.82 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.637 -179.811 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . 0.52 ' N ' ' O ' ' A' ' 126' ' ' ALA . 79.4 t80 -51.09 -49.46 60.66 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.542 -178.883 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 37.7 p-10 -66.33 -42.61 87.94 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.832 0.349 . . . . 0.0 111.138 179.618 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.519 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 88.2 mt-30 -66.92 -37.53 84.51 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.74 -179.995 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.431 HD12 HD11 ' A' ' 118' ' ' ILE . 96.3 mt -80.63 -41.28 24.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.868 -179.585 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.2 t -57.13 -44.54 83.42 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.269 -179.139 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.3 m -61.93 -45.32 94.22 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.802 0.334 . . . . 0.0 110.566 179.411 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 94.0 mt -62.02 -43.63 97.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.277 -179.836 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.662 ' HB1' ' HD2' ' A' ' 138' ' ' PRO . . . -169.45 168.25 4.94 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.499 179.895 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.662 ' HD2' ' HB1' ' A' ' 137' ' ' ALA . 52.4 Cg_exo -49.95 112.82 0.79 Allowed 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.297 1.998 . . . . 0.0 112.224 179.339 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.49 HG23 HD12 ' A' ' 118' ' ' ILE . 24.0 m -84.36 127.52 34.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.644 -179.968 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.679 HD13 ' CD2' ' A' ' 37' ' ' HIS . 34.7 tp -118.03 136.68 53.39 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.09 -179.781 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.441 ' O ' ' OD2' ' A' ' 32' ' ' ASP . 81.6 mt -100.57 118.83 47.84 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 CA-C-O 121.182 0.515 . . . . 0.0 111.128 -179.319 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.42 HD12 HD22 ' A' ' 117' ' ' LEU . 97.8 mt -134.71 132.14 54.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.669 179.591 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.551 HD21 ' CG ' ' A' ' 241' ' ' ASP . 56.0 t30 -67.56 153.71 43.09 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.893 0.378 . . . . 0.0 110.469 179.38 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.525 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 89.2 t80 -87.51 122.15 30.86 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.861 -179.55 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.525 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 99.0 m-20 55.33 69.5 0.73 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.762 179.651 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 49.5 p-10 -123.84 -0.69 8.48 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.631 179.88 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -151.07 116.14 5.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.712 -179.534 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 83.2 p -62.85 167.88 4.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.474 -179.788 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.417 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.3 p-90 -51.38 -15.81 0.46 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.517 -179.86 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . 0.445 ' O ' HG23 ' A' ' 154' ' ' THR . 68.0 tp60 -70.71 -75.32 0.12 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.493 -179.771 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 11.1 t -62.75 -38.88 92.32 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.366 179.491 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 55.7 tp -59.91 -45.8 91.39 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.422 -178.649 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.417 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 46.8 tp -62.71 -41.63 99.25 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.425 179.057 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.445 HG23 ' O ' ' A' ' 150' ' ' GLN . 60.0 p -64.46 -35.01 79.53 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.31 -179.55 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.432 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.5 mm-40 -64.28 -42.88 96.22 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.383 179.374 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 91.5 mt -65.39 -38.91 91.4 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.072 0.463 . . . . 0.0 110.272 179.166 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.582 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.31 -32.08 79.5 Favored Glycine 0 CA--C 1.52 0.347 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 -179.382 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.44 ' C ' ' O ' ' A' ' 157' ' ' GLY . 97.1 mt-10 -35.25 -27.31 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.816 0.341 . . . . 0.0 110.821 179.894 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.582 ' N ' ' O ' ' A' ' 157' ' ' GLY . 95.1 mt -55.57 150.07 2.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.319 179.263 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 73.9 p -70.13 137.34 50.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.057 -179.59 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 72.26 18.44 78.1 Favored Glycine 0 N--CA 1.458 0.163 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 179.507 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 57.3 m80 -119.8 -15.52 8.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.747 0.308 . . . . 0.0 110.606 179.866 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -63.92 -60.78 2.83 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.655 -179.631 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -51.91 -49.42 63.09 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.201 -179.666 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -60.27 -41.24 92.9 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.752 0.31 . . . . 0.0 110.348 179.539 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.49 -47.2 86.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.576 179.851 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.94 -40.17 75.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.259 -179.894 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -61.88 -50.2 73.16 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.578 179.595 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -65.39 -43.73 89.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.492 179.532 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 95.0 mt -64.73 -43.38 96.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.488 179.739 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.36 -51.12 70.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.533 -179.215 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.46 -43.95 95.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.464 179.732 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . 0.656 ' CE2' HD11 ' A' ' 177' ' ' LEU . 56.2 t80 -62.83 -44.45 96.1 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.085 0.469 . . . . 0.0 110.44 179.451 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -63.51 -39.98 95.85 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.566 -179.337 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -62.94 -42.77 99.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.64 179.259 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -60.73 -45.07 95.68 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.172 179.945 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.656 HD11 ' CE2' ' A' ' 173' ' ' PHE . 84.4 mt -64.61 -41.06 96.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.036 0.446 . . . . 0.0 110.693 178.918 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -51.93 -62.61 1.52 Allowed 'General case' 0 C--O 1.237 0.441 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.473 -179.343 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.89 -46.58 87.51 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.664 179.767 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.31 -41.77 65.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.281 179.939 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -63.85 -33.84 76.59 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.969 0.414 . . . . 0.0 110.371 179.256 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . 0.425 ' HG2' ' O ' ' A' ' 182' ' ' GLU . 69.5 tt0 -90.47 9.06 30.75 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.37 0.605 . . . . 0.0 110.516 -178.998 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -105.06 -31.99 8.92 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.202 179.555 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.4 pt -128.11 147.52 32.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.828 -179.873 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -140.06 131.14 26.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.423 179.358 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . 0.597 HD22 ' N ' ' A' ' 186' ' ' LEU . 3.6 mm? -85.63 133.08 42.61 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.844 -179.947 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -44.0 157.78 0.14 Allowed 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.714 2.276 . . . . 0.0 112.153 179.341 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . 0.524 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.6 Cg_endo -62.78 115.23 2.8 Favored 'Trans proline' 0 C--N 1.304 -1.81 0 C-N-CA 122.775 2.317 . . . . 0.0 111.808 179.772 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . 0.524 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.8 mt-30 155.61 147.52 0.0 OUTLIER Pre-proline 0 C--N 1.332 -0.169 0 O-C-N 123.618 0.574 . . . . 0.0 110.782 -179.791 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -73.76 143.43 33.56 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.659 2.239 . . . . 0.0 111.956 177.983 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.499 HG23 ' OG ' ' A' ' 258' ' ' SER . 2.0 p -124.81 159.02 31.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.276 0.56 . . . . 0.0 110.189 179.959 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . 0.497 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 35.7 p -143.48 165.47 27.47 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.094 -179.638 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . 0.443 ' HA ' ' H ' ' A' ' 260' ' ' PHE . . . -135.34 128.43 31.69 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 121.128 0.49 . . . . 0.0 110.24 179.576 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.509 HD11 HD23 ' A' ' 259' ' ' LEU . 47.8 pt -146.35 148.79 16.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.046 179.986 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . 0.746 HG13 ' CD1' ' A' ' 262' ' ' PHE . 70.3 t -117.6 122.89 70.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.222 0.534 . . . . 0.0 109.734 179.122 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -134.06 107.37 7.72 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.261 179.77 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 94.6 m -131.11 130.45 43.15 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.797 179.784 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.412 ' O ' ' N ' ' A' ' 201' ' ' HIS . . . -82.74 -37.24 24.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.275 179.692 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.32 -67.02 0.26 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.366 -179.973 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.31 -9.76 58.91 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.316 179.425 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . 0.412 ' N ' ' O ' ' A' ' 198' ' ' ALA . 59.7 t-80 60.54 58.27 2.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.628 -179.902 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 45.7 p -166.92 153.26 8.34 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.527 179.611 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.36 144.16 24.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.976 0.417 . . . . 0.0 110.442 179.488 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -135.34 138.1 43.05 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.63 -179.941 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 20.2 mt -106.28 125.56 51.15 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 121.116 0.484 . . . . 0.0 109.934 -179.701 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 206' ' ' TRP . . . . . 0.558 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 75.4 m95 -82.25 167.18 18.9 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.649 -179.727 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . 0.467 HG22 ' C ' ' A' ' 206' ' ' TRP . 0.1 OUTLIER -156.88 171.56 7.27 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 120.943 0.402 . . . . 0.0 110.563 -179.194 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_exo -53.94 -36.89 85.2 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 C-N-CA 122.659 2.24 . . . . 0.0 112.16 179.256 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -70.55 -34.93 72.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.761 -179.772 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 21.9 m -61.56 150.54 35.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.543 -179.27 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.42 -36.97 81.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.457 -179.732 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 212' ' ' GLN . . . . . 0.558 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 54.4 tt0 -64.5 -40.28 95.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.472 179.967 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.87 -43.27 91.91 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 179.812 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -63.55 -43.46 97.03 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.752 0.31 . . . . 0.0 110.29 179.807 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 215' ' ' MET . . . . . 0.519 ' SD ' ' HB2' ' A' ' 304' ' ' ALA . 65.3 ttp -59.49 -48.25 82.36 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.234 -179.809 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 216' ' ' LEU . 88.4 mt -60.37 -40.8 92.12 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.536 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 217' ' ' GLU . . . . . 0.457 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.4 tp10 -57.99 -37.93 75.17 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 179.751 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -65.22 -37.94 88.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.847 0.356 . . . . 0.0 110.676 179.68 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 94.1 mt -64.47 -42.73 95.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.582 -179.645 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.59 44.59 0.08 OUTLIER Glycine 0 C--N 1.334 0.426 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 -179.921 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 221' ' ' PHE . . . . . 0.457 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 26.3 m-85 -127.73 155.22 44.34 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.033 0.445 . . . . 0.0 110.49 -179.82 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.484 ' O ' HG13 ' A' ' 191' ' ' VAL . 6.6 p -106.94 122.06 45.68 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.189 0.519 . . . . 0.0 110.198 -179.961 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.467 HD22 ' C ' ' A' ' 222' ' ' THR . 4.3 mm? -100.81 133.46 45.24 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.101 -179.97 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -97.24 158.76 15.29 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.44 179.916 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -104.84 115.21 29.92 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.384 179.898 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.496 ' N ' HD12 ' A' ' 226' ' ' LEU . 9.1 mp -53.32 156.57 3.95 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.705 179.86 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -60.26 145.38 98.7 Favored 'Trans proline' 0 C--N 1.301 -1.943 0 C-N-CA 122.711 2.274 . . . . 0.0 112.119 179.218 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.46 -2.89 58.93 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.557 -179.992 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.32 -40.83 5.65 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 111.029 -0.828 . . . . 0.0 111.029 -179.887 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . 0.543 ' O ' ' N ' ' A' ' 233' ' ' SER . 86.0 mt -79.28 -16.89 55.7 Favored 'General case' 0 C--O 1.224 -0.257 0 CA-C-O 121.018 0.437 . . . . 0.0 110.356 -179.755 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . 0.405 ' C ' ' O ' ' A' ' 230' ' ' LEU . 54.6 t-20 -40.05 -49.23 2.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.691 -179.592 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -88.28 15.43 7.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.813 0.339 . . . . 0.0 111.277 179.935 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . 0.543 ' N ' ' O ' ' A' ' 230' ' ' LEU . 78.1 p -60.48 -35.63 76.36 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.648 -179.77 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . 0.525 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.6 tt0 -118.25 -69.43 0.85 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.954 179.588 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 3.9 m -70.16 103.45 2.33 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.691 -179.744 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -94.59 57.74 2.26 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.345 180.0 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -144.99 -122.57 1.56 Allowed Glycine 0 CA--C 1.519 0.343 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 -179.977 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -134.41 111.85 10.48 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.094 0.473 . . . . 0.0 110.413 179.964 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . 0.513 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.4 mtt180 -148.11 57.39 1.08 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.762 -179.972 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -69.71 -31.89 70.15 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.511 179.664 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 241' ' ' ASP . . . . . 0.551 ' CG ' HD21 ' A' ' 143' ' ' ASN . 65.1 t0 -56.71 -46.99 80.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.404 -179.167 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 242' ' ' ILE . . . . . 0.436 ' O ' ' O ' ' A' ' 239' ' ' ARG . 17.4 tt -140.33 157.27 24.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.886 0.374 . . . . 0.0 110.524 179.748 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.444 HG22 HD13 ' A' ' 245' ' ' LEU . 96.0 mt -106.01 106.08 19.9 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.191 0 CA-C-O 121.125 0.488 . . . . 0.0 110.465 179.886 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . 0.602 ' O ' HD12 ' A' ' 245' ' ' LEU . 88.2 mt-30 -110.36 110.17 20.86 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.392 179.755 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.602 HD12 ' O ' ' A' ' 244' ' ' GLN . 9.5 mp -121.9 -168.19 1.66 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.641 179.774 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . 0.525 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.25 -16.66 0.05 OUTLIER Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.956 -0.857 . . . . 0.0 110.956 179.894 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . 0.67 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -60.46 157.03 29.73 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 -179.83 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -63.82 21.43 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.971 0.415 . . . . 0.0 110.58 179.945 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . 0.67 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.7 m-20 -97.18 -5.93 35.94 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.544 179.983 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 92.6 mt -80.2 -21.58 42.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.604 179.589 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.54 -51.24 70.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.728 -179.579 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.76 -5.33 58.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.481 179.659 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.16 -74.45 1.14 Allowed Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.911 -0.875 . . . . 0.0 110.911 -179.96 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 81.7 mt -69.89 125.93 28.2 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.977 0.418 . . . . 0.0 110.329 -179.859 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -59.22 -39.49 82.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.295 -179.711 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 82.64 51.93 4.11 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 179.95 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -96.22 -14.89 22.36 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.644 0.259 . . . . 0.0 110.541 -179.864 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 258' ' ' SER . . . . . 0.499 ' OG ' HG23 ' A' ' 191' ' ' VAL . 3.5 t 174.78 88.55 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.029 0.442 . . . . 0.0 110.194 179.978 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.86 ' N ' HD12 ' A' ' 259' ' ' LEU . 0.9 OUTLIER -94.18 124.08 37.97 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.241 0.544 . . . . 0.0 111.066 -179.058 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 260' ' ' PHE . . . . . 0.443 ' H ' ' HA ' ' A' ' 193' ' ' ALA . 15.9 m-30 -93.03 146.45 23.62 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.342 179.17 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 86.1 mt -122.41 149.82 43.29 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.529 -179.905 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.746 ' CD1' HG13 ' A' ' 195' ' ' VAL . 2.6 p90 -77.63 -138.36 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.562 -179.838 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 263' ' ' ALA . . . . . 0.66 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -52.1 77.45 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.993 -179.989 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . 0.633 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -178.98 104.42 0.19 Allowed Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 -179.976 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 265' ' ' ASP . . . . . 0.602 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.8 m-20 -80.47 -177.74 6.35 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 120.725 0.298 . . . . 0.0 110.896 -179.527 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -40.39 -17.71 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.853 0.358 . . . . 0.0 110.552 179.786 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 267' ' ' LYS . . . . . 0.602 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.71 -51.42 41.75 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.688 179.516 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -63.74 -46.83 83.59 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.175 179.314 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . 0.573 ' HB1' ' OH ' ' A' ' 273' ' ' TYR . . . -61.47 -35.05 76.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.111 0.481 . . . . 0.0 109.884 179.533 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -63.22 -34.42 77.62 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.119 179.712 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.36 -43.37 13.73 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.171 -179.572 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 272' ' ' ILE . . . . . 0.589 ' C ' ' H ' ' A' ' 274' ' ' ALA . 5.0 tt -51.37 -33.83 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.893 -178.824 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 273' ' ' TYR . . . . . 0.573 ' OH ' ' HB1' ' A' ' 269' ' ' ALA . 17.2 m-85 -54.24 -1.82 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.647 -179.638 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 274' ' ' ALA . . . . . 0.589 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.58 -39.43 70.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.87 179.603 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . 0.583 ' O ' ' N ' ' A' ' 279' ' ' ALA . 3.0 p30 -39.65 98.33 0.17 Allowed Pre-proline 0 N--CA 1.462 0.143 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.506 -179.638 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -54.16 -43.11 61.39 Favored 'Trans proline' 0 C--N 1.304 -1.812 0 C-N-CA 122.389 2.06 . . . . 0.0 112.619 -178.793 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 89.3 mt -64.45 -42.86 95.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.109 -179.613 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 91.0 mt -95.7 -1.64 49.57 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.872 -179.373 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 279' ' ' ALA . . . . . 0.583 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.35 -34.75 77.27 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.678 -179.85 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.4 20.1 0.12 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.966 -179.212 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . 0.489 HD23 ' HA ' ' A' ' 281' ' ' LEU . 13.9 mt -75.19 120.04 79.8 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.505 179.916 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -50.69 -39.48 56.73 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.577 2.185 . . . . 0.0 111.951 179.035 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.8 -50.56 63.38 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.132 179.885 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 74.5 t -61.45 -43.79 97.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.482 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -57.98 -41.22 82.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.28 -179.972 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -90.9 0.14 57.58 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.145 179.575 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt 59.55 43.04 16.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.82 179.568 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -94.66 41.49 1.09 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.38 179.852 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 53.6 t -118.79 136.02 57.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.999 0.428 . . . . 0.0 110.193 -179.759 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -133.17 162.73 30.98 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.665 -179.639 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.9 155.22 33.13 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.968 0.413 . . . . 0.0 110.735 -179.86 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 81.0 mt -93.89 -1.49 54.69 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.235 -179.803 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.06 165.66 12.74 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.689 -0.965 . . . . 0.0 110.689 -179.735 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 6.8 m -87.15 -62.3 1.53 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.892 0.377 . . . . 0.0 111.009 -179.888 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 295' ' ' GLU . . . . . 0.436 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.6 mm-40 -69.57 -3.88 16.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.628 -179.833 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 28.1 p -77.09 32.91 0.14 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.618 -179.96 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 297' ' ' PHE . . . . . 0.532 ' CD2' HG22 ' A' ' 70' ' ' THR . 70.2 t80 -60.19 -46.06 91.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.546 -179.971 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . 0.61 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.3 mtt85 -81.49 134.01 35.47 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.45 -179.652 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.421 ' H ' HG11 ' A' ' 51' ' ' VAL . 16.1 tp -114.31 119.75 38.06 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.253 179.924 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . 0.625 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.4 p-10 -167.8 -173.9 2.27 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.524 179.95 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 84.0 t80 -48.25 -46.0 35.11 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.227 -179.644 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -64.65 -41.61 96.0 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.998 0.428 . . . . 0.0 110.702 179.015 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . 0.625 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 52.0 p -55.44 -36.11 66.17 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.099 -179.269 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . 0.519 ' HB2' ' SD ' ' A' ' 215' ' ' MET . . . -56.92 -51.76 67.87 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.482 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 91.5 mtp -56.06 -43.87 78.32 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.8 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -66.38 -42.74 87.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.953 0.406 . . . . 0.0 110.207 178.798 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 303' ' ' SER . 55.2 t -64.04 -42.89 97.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.261 179.39 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 42.8 tp -59.62 -42.04 91.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.893 -179.616 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -62.87 -38.76 92.12 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.064 179.475 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 310' ' ' ARG . . . . . 0.435 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.6 ttt85 -63.5 -44.03 95.52 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.238 179.569 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 88.5 mt -63.23 -41.93 99.17 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.226 179.548 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -62.9 -33.23 74.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.083 179.492 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.85 -23.51 21.65 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.423 -179.862 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . 0.479 HD22 ' CE2' ' A' ' 315' ' ' PHE . 6.7 tt -62.33 -43.22 99.33 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 121.06 0.457 . . . . 0.0 110.57 -179.92 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 315' ' ' PHE . . . . . 0.479 ' CE2' HD22 ' A' ' 314' ' ' LEU . 91.0 m-85 . . . . . 0 C--O 1.22 -0.498 0 CA-C-O 118.003 -0.999 . . . . 0.0 110.482 179.966 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -99.51 135.79 40.4 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.464 -179.926 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.498 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -92.11 178.48 1.69 Allowed Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.532 -179.863 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.498 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.7 Cg_exo -61.54 147.16 96.1 Favored 'Trans proline' 0 C--N 1.301 -1.961 0 C-N-CA 122.696 2.264 . . . . 0.0 112.161 179.576 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.487 ' HE ' HD12 ' A' ' 39' ' ' LEU . 35.4 ptt180 -136.33 142.39 43.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.624 179.692 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -79.7 116.78 20.08 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.453 179.872 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.46 ' O ' HG23 ' A' ' 30' ' ' ILE . 9.4 tp -111.54 130.11 65.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.46 179.969 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.4 t -71.14 141.7 50.75 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.599 179.81 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.478 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.1 t0 -138.71 -179.73 5.99 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.524 179.997 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.478 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 78.3 p -73.72 -37.51 65.1 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.856 179.84 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -46.64 -94.74 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.313 -179.411 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -166.24 -26.76 0.02 OUTLIER Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 179.919 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 63.7 m -168.42 105.72 0.46 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.857 0.361 . . . . 0.0 110.603 -179.968 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.646 ' CD2' HD13 ' A' ' 140' ' ' LEU . 68.2 t60 -128.87 146.43 50.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.038 0.447 . . . . 0.0 110.324 179.97 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.62 HG22 ' N ' ' A' ' 39' ' ' LEU . 100.0 m -129.82 165.6 21.63 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.608 -179.928 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.62 ' N ' HG22 ' A' ' 38' ' ' THR . 80.5 mt -120.3 127.37 52.3 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.466 179.683 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -65.56 -44.53 86.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.605 -179.978 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 40.8 p -165.91 154.88 11.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.456 179.743 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.482 ' H ' ' CD ' ' A' ' 42' ' ' GLN . 14.5 mp0 -45.4 101.64 0.27 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.658 179.443 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -57.66 129.83 35.65 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 C-N-CA 122.294 1.996 . . . . 0.0 112.263 -179.759 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -82.84 -24.92 33.06 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.472 179.593 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.537 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.7 mtm-85 -120.73 134.34 55.29 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 121.125 0.488 . . . . 0.0 110.264 -179.931 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.1 mt -130.23 133.29 64.33 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.091 -179.85 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 47.3 t -124.79 130.96 73.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 179.404 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.621 ' OG ' HD12 ' A' ' 117' ' ' LEU . 4.4 m -155.19 166.48 33.45 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.578 179.666 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 62.4 p -124.53 8.94 8.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.411 -179.981 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.1 t -85.38 125.53 33.05 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.655 -179.467 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.457 HG11 ' H ' ' A' ' 299' ' ' LEU . 90.8 t -65.72 -44.64 93.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.542 179.961 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.7 m -62.62 -44.39 96.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.655 -179.862 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 53.5 tp -62.18 -41.66 98.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.659 -179.459 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.465 ' O ' HD13 ' A' ' 58' ' ' LEU . 74.7 m -57.63 -44.54 85.65 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.384 -179.426 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.36 -61.98 5.52 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.941 -0.863 . . . . 0.0 110.941 179.561 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.7 t -48.48 -35.7 13.56 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 -179.979 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.9 mt -61.76 -44.56 96.65 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.644 -0.422 . . . . 0.0 111.136 179.344 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.465 HD13 ' O ' ' A' ' 54' ' ' THR . 9.4 mp -64.72 -42.07 95.5 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.329 177.961 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.405 ' HB1' ' NE ' ' A' ' 169' ' ' ARG . . . -63.54 -41.16 98.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.086 -179.197 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.43 ' O ' HG23 ' A' ' 60' ' ' ILE . 8.1 tp -88.04 16.76 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.735 -179.668 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 56.62 83.78 0.1 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.631 179.972 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.71 57.02 0.07 OUTLIER Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.049 -179.815 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.413 ' HB3' HE21 ' A' ' 85' ' ' GLN . 9.9 Cg_endo -49.54 153.15 5.51 Favored 'Trans proline' 0 C--N 1.296 -2.21 0 C-N-CA 122.811 2.341 . . . . 0.0 112.638 -178.559 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.432 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -109.03 146.26 14.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.371 -179.734 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 97.0 mt -63.9 -44.86 98.13 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.298 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.488 -179.885 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.502 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -130.27 134.61 47.35 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.512 -179.774 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.485 ' O ' ' N ' ' A' ' 98' ' ' LEU . 72.2 m -134.52 158.6 43.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.859 -179.663 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.55 139.24 16.39 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 110.671 -0.972 . . . . 0.0 110.671 179.848 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.488 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.88 -162.67 0.08 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.95 0.405 . . . . 0.0 110.535 -179.992 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.511 HG22 ' CD2' ' A' ' 297' ' ' PHE . 5.8 t -133.71 135.81 44.26 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.177 -179.973 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.491 ' C ' ' O ' ' A' ' 70' ' ' THR . 0.9 OUTLIER 29.6 68.33 0.67 Allowed Pre-proline 0 N--CA 1.465 0.291 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.713 -179.689 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -60.64 145.23 99.21 Favored 'Trans proline' 0 C--N 1.3 -2.009 0 C-N-CA 122.576 2.184 . . . . 0.0 112.167 -178.566 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.523 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 46.2 p-10 -160.65 -31.97 0.05 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.674 179.74 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.529 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 98.8 m-20 -64.31 -38.96 92.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.367 179.973 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -61.15 -47.88 84.15 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.636 -179.236 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.423 ' O ' ' O ' ' A' ' 77' ' ' ALA . 94.4 t -60.21 -24.56 30.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.659 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.529 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -45.64 172.6 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.535 179.881 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.575 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.8 p30 -61.68 177.6 0.4 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.653 -179.707 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.566 ' C ' ' H ' ' A' ' 81' ' ' GLY . 36.1 p30 -45.87 85.54 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.97 179.872 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.575 ' N ' ' O ' ' A' ' 78' ' ' ASP . 43.0 tp60 -67.19 13.59 0.06 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.072 0.463 . . . . 0.0 110.12 -179.774 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.566 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 117.72 -22.0 10.2 Favored Glycine 0 C--N 1.331 0.285 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 179.981 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -107.93 116.35 31.8 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.022 0.439 . . . . 0.0 110.518 179.849 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 75.8 mt -98.8 0.57 44.63 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.516 -179.698 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -91.88 6.61 45.49 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.988 0.423 . . . . 0.0 110.47 -179.707 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.798 ' O ' HG22 ' A' ' 89' ' ' VAL . 88.1 mt-30 -99.89 -28.08 13.28 Favored 'General case' 0 C--O 1.224 -0.266 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.784 179.973 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 68.9 t-105 -63.03 -41.07 99.43 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.913 -179.722 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.556 ' O ' ' N ' ' A' ' 91' ' ' LYS . 67.4 m -77.34 -53.53 7.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.313 -179.441 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -48.4 -50.85 29.22 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.979 -179.337 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.798 HG22 ' O ' ' A' ' 85' ' ' GLN . 15.6 m -68.9 -40.83 81.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 120.914 0.388 . . . . 0.0 111.075 179.748 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.5 ' N ' HG23 ' A' ' 89' ' ' VAL . . . -72.1 -22.96 61.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.775 -179.912 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.556 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.0 tttm -61.35 -45.69 93.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.45 -179.502 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.437 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.7 mm-40 -90.73 -94.34 0.12 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.091 -179.977 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.633 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.9 mtt180 -143.36 59.95 1.4 Allowed 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.81 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.461 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.7 pttp 33.54 26.27 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 120.791 0.329 . . . . 0.0 110.115 -179.291 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.633 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.5 tt -47.97 122.84 5.45 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.995 -178.243 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.447 ' O ' HD23 ' A' ' 95' ' ' LEU . 98.9 mm-40 -83.25 -169.9 2.77 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.016 -179.882 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.614 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 83.0 mtp180 -73.51 137.88 44.7 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.29 -179.813 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.485 ' N ' ' O ' ' A' ' 67' ' ' SER . 89.0 mt -86.81 -166.2 1.5 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.701 -179.519 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.533 ' CD2' ' O ' ' A' ' 99' ' ' TYR . 47.4 p90 -167.97 120.05 0.86 Allowed 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.296 179.939 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.511 ' C ' ' O ' ' A' ' 99' ' ' TYR . 42.9 mm -29.59 121.25 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.939 -179.639 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 113.96 28.13 3.24 Favored Glycine 0 CA--C 1.519 0.341 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 -179.542 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.587 ' H ' ' CD ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -144.02 45.81 0.59 Allowed Pre-proline 0 C--N 1.324 -0.53 0 CA-C-O 120.932 0.396 . . . . 0.0 110.508 179.883 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 30.5 Cg_endo -62.0 143.72 95.5 Favored 'Trans proline' 0 C--N 1.297 -2.152 0 C-N-CA 122.667 2.245 . . . . 0.0 112.033 179.921 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.476 ' O ' HG23 ' A' ' 108' ' ' VAL . 23.1 t -173.43 120.52 0.33 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.404 179.715 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.22 -41.09 64.15 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.057 0.456 . . . . 0.0 111.231 179.652 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -65.93 -40.26 91.26 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.942 -179.412 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.87 -39.87 95.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.699 -179.852 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 104' ' ' SER . 69.5 t -67.39 -43.91 87.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.863 179.627 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.33 -39.0 91.63 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.602 -179.265 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.437 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.58 -23.49 62.96 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.013 0.435 . . . . 0.0 110.505 179.817 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.555 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.4 mm-40 -91.07 4.73 51.37 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.72 -179.5 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.555 ' C ' ' O ' ' A' ' 111' ' ' GLN . 10.6 tpt 23.56 63.85 0.38 Allowed Pre-proline 0 N--CA 1.465 0.32 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.916 179.971 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.445 ' HG2' HD11 ' A' ' 116' ' ' ILE . 69.8 Cg_endo -78.3 168.79 21.12 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 C-N-CA 122.918 2.412 . . . . 0.0 112.344 -178.645 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.525 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 98.9 m-20 -113.15 -44.16 3.29 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.939 179.639 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 39.9 tp -120.71 119.77 33.76 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.619 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.455 HD13 HD22 ' A' ' 133' ' ' LEU . 95.7 mt -116.99 131.14 70.56 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.3 0 CA-C-O 120.909 0.385 . . . . 0.0 110.949 -179.91 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.621 HD12 ' OG ' ' A' ' 48' ' ' SER . 30.7 mt -106.06 132.77 51.74 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 121.104 0.478 . . . . 0.0 110.236 -179.387 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.419 HD12 HG23 ' A' ' 139' ' ' THR . 98.0 mt -118.31 136.37 55.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.699 -179.633 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 85.9 p -71.98 153.22 41.93 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.666 179.978 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.19 -50.1 75.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.625 -179.84 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -149.37 153.82 37.99 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.535 179.823 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 169.67 -170.42 42.71 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 179.837 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -63.01 -35.05 91.57 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 110.824 -0.91 . . . . 0.0 110.824 179.986 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.442 ' O ' ' OD1' ' A' ' 124' ' ' ASP . 43.8 p-10 -87.86 119.9 28.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.797 0.332 . . . . 0.0 110.694 179.933 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.444 ' O ' HD12 ' A' ' 129' ' ' LEU . 40.5 t -63.39 144.17 57.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.472 -179.969 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.522 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.59 -43.03 8.88 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.837 -179.874 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.3 tp -62.66 -42.42 99.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.663 -179.931 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.78 -11.04 57.64 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.518 -179.403 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.444 HD12 ' O ' ' A' ' 125' ' ' SER . 84.9 mt -115.96 -23.72 8.43 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.749 -179.868 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . 0.522 ' N ' ' O ' ' A' ' 126' ' ' ALA . 79.0 t80 -51.77 -49.71 62.12 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 120.501 -0.48 . . . . 0.0 110.587 -179.024 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.5 p-10 -65.81 -42.16 90.99 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.946 0.403 . . . . 0.0 111.172 179.564 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.525 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 88.1 mt-30 -67.35 -36.85 82.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.801 -179.983 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.455 HD22 HD13 ' A' ' 116' ' ' ILE . 92.8 mt -80.34 -41.85 24.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.012 -179.541 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.1 t -57.55 -44.58 85.3 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.134 -179.095 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.5 m -62.3 -45.65 92.28 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.801 0.334 . . . . 0.0 110.586 179.351 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 92.4 mt -62.49 -43.78 98.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.285 -179.772 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.601 ' HB1' ' HD2' ' A' ' 138' ' ' PRO . . . -170.19 163.86 6.13 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.451 179.869 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.601 ' HD2' ' HB1' ' A' ' 137' ' ' ALA . 78.0 Cg_exo -43.58 111.32 0.23 Allowed 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.437 2.091 . . . . 0.0 112.076 179.539 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.475 HG21 ' CD1' ' A' ' 130' ' ' TYR . 17.3 m -85.78 127.79 34.64 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.57 179.951 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.646 HD13 ' CD2' ' A' ' 37' ' ' HIS . 34.4 tp -119.65 137.67 53.74 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.244 -0.435 . . . . 0.0 109.964 -179.702 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.433 ' O ' ' OD1' ' A' ' 32' ' ' ASP . 79.6 mt -104.58 119.92 54.21 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.432 0 CA-C-O 121.154 0.502 . . . . 0.0 111.416 -179.556 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.494 HD12 HD22 ' A' ' 117' ' ' LEU . 98.4 mt -135.3 133.03 52.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.665 179.676 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.546 HD21 ' CG ' ' A' ' 241' ' ' ASP . 60.6 t30 -64.98 150.31 48.24 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.861 0.362 . . . . 0.0 110.386 179.288 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.517 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 87.9 t80 -85.27 122.45 29.47 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.936 -179.531 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.517 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 99.0 m-20 55.48 68.86 0.8 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.954 179.76 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 36.0 p-10 -125.44 0.27 7.62 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.011 0.434 . . . . 0.0 110.816 179.851 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -150.69 115.57 5.27 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.748 -179.501 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 85.0 p -63.28 168.26 4.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.49 -179.742 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.422 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.5 p-90 -51.48 -15.67 0.46 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.484 -179.836 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . 0.444 ' O ' HG23 ' A' ' 154' ' ' THR . 68.3 tp60 -70.84 -75.65 0.12 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.414 -179.703 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.455 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.1 t -62.59 -38.76 91.4 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.992 0.425 . . . . 0.0 110.297 179.529 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 53.6 tp -60.25 -45.53 92.96 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.324 -178.493 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.422 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 45.9 tp -62.76 -41.82 99.4 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.844 0.354 . . . . 0.0 110.311 179.03 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.455 ' OG1' ' O ' ' A' ' 151' ' ' SER . 58.8 p -64.01 -34.67 78.54 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.264 -179.507 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.444 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.5 mm-40 -64.03 -42.38 97.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.171 179.256 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 91.8 mt -65.24 -39.05 92.18 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.092 0.472 . . . . 0.0 110.172 179.071 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.582 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.04 -32.25 79.6 Favored Glycine 0 CA--C 1.52 0.352 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 -179.391 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.444 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.3 mt-10 -36.42 -25.38 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.888 0.375 . . . . 0.0 110.811 179.949 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.582 ' N ' ' O ' ' A' ' 157' ' ' GLY . 95.7 mt -59.16 149.29 6.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.171 179.382 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 77.5 p -69.14 137.47 53.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.074 -179.561 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 70.66 21.9 77.91 Favored Glycine 0 N--CA 1.458 0.157 0 N-CA-C 111.274 -0.731 . . . . 0.0 111.274 179.522 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 59.3 m80 -124.02 -14.63 7.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.757 0.313 . . . . 0.0 110.56 179.979 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -66.25 -59.76 3.43 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.774 -179.753 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -52.03 -48.96 64.27 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.278 -179.695 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -60.62 -41.11 94.18 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.76 0.314 . . . . 0.0 110.334 179.463 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.68 -47.11 86.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.633 179.817 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -57.1 -39.99 76.13 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.16 -179.85 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -61.8 -50.15 73.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.525 179.619 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.405 ' NE ' ' HB1' ' A' ' 59' ' ' ALA . 59.9 ttt85 -65.38 -43.77 89.67 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.417 179.554 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 95.1 mt -64.37 -43.53 97.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.421 179.718 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.29 -50.87 71.55 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.639 -179.169 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.79 -43.7 95.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.32 179.727 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . 0.659 ' CE2' HD11 ' A' ' 177' ' ' LEU . 56.6 t80 -62.58 -44.62 95.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.026 0.441 . . . . 0.0 110.425 179.373 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -63.4 -39.93 95.82 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.475 -179.204 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -62.85 -42.81 99.89 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.664 179.248 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -60.8 -44.68 96.53 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.069 -179.992 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.659 HD11 ' CE2' ' A' ' 173' ' ' PHE . 84.9 mt -64.29 -41.22 96.99 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.043 0.449 . . . . 0.0 110.681 178.862 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.15 -62.25 1.76 Allowed 'General case' 0 C--O 1.237 0.44 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.487 -179.382 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.64 -46.71 86.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.51 179.86 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.43 -41.67 66.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.135 -179.931 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -63.71 -33.88 76.64 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.07 0.462 . . . . 0.0 110.407 179.336 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . 0.424 ' HG2' ' O ' ' A' ' 182' ' ' GLU . 69.6 tt0 -90.31 8.42 33.47 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-O 121.387 0.613 . . . . 0.0 110.619 -179.078 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -104.31 -32.32 9.13 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-O 120.932 0.396 . . . . 0.0 111.359 179.546 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 43.9 pt -127.88 147.53 32.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.915 -179.902 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -139.83 131.03 26.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.296 179.478 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . 0.595 HD22 ' N ' ' A' ' 186' ' ' LEU . 3.6 mm? -85.63 133.46 41.86 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.841 179.922 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -44.28 158.06 0.15 Allowed 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.738 2.292 . . . . 0.0 112.061 179.48 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . 0.527 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.7 Cg_endo -62.9 114.97 2.65 Favored 'Trans proline' 0 C--N 1.303 -1.828 0 C-N-CA 122.747 2.298 . . . . 0.0 111.776 179.801 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . 0.527 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.8 mt-30 155.39 148.14 0.0 OUTLIER Pre-proline 0 N--CA 1.454 -0.247 0 O-C-N 123.552 0.533 . . . . 0.0 110.772 -179.799 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -74.11 144.5 33.8 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.685 2.257 . . . . 0.0 111.777 178.185 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.498 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.1 p -125.31 158.86 33.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.271 0.557 . . . . 0.0 110.067 -179.89 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . 0.498 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 35.4 p -143.53 165.58 27.19 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.094 -179.653 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . 0.446 ' HA ' ' H ' ' A' ' 260' ' ' PHE . . . -135.66 128.62 31.39 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.212 0.53 . . . . 0.0 110.244 179.625 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.504 HD11 HD23 ' A' ' 259' ' ' LEU . 47.1 pt -146.38 148.96 16.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.137 179.732 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . 0.742 HG13 ' CD1' ' A' ' 262' ' ' PHE . 70.4 t -117.87 123.14 71.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 121.263 0.554 . . . . 0.0 109.594 179.254 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 58.8 t80 -134.37 107.32 7.55 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.32 179.688 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 94.8 m -131.02 130.72 43.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.896 179.784 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.406 ' O ' ' N ' ' A' ' 201' ' ' HIS . . . -83.04 -37.09 24.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.252 179.741 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.44 -67.15 0.25 Allowed 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.332 179.996 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.1 -9.73 58.81 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.306 179.523 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . 0.406 ' N ' ' O ' ' A' ' 198' ' ' ALA . 60.1 t-80 60.52 58.36 2.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.825 -179.835 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 42.0 p -167.2 153.53 8.12 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.444 179.558 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.27 143.81 24.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.962 0.41 . . . . 0.0 110.372 179.449 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -135.18 138.34 43.56 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.691 179.939 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 20.3 mt -106.34 125.43 50.99 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 121.119 0.485 . . . . 0.0 109.745 -179.682 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 206' ' ' TRP . . . . . 0.557 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 74.3 m95 -81.96 166.83 19.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.666 -179.796 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . 0.466 HG22 ' C ' ' A' ' 206' ' ' TRP . 0.1 OUTLIER -156.78 171.87 6.86 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 120.971 0.415 . . . . 0.0 110.562 -179.213 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -54.02 -37.2 86.28 Favored 'Trans proline' 0 C--N 1.303 -1.839 0 C-N-CA 122.637 2.224 . . . . 0.0 111.954 179.465 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -70.46 -34.96 73.01 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.953 -179.916 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 22.2 m -61.02 150.88 32.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.569 -179.351 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.66 -36.86 82.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.462 -179.709 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 212' ' ' GLN . . . . . 0.557 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 55.2 tt0 -64.77 -40.37 95.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.529 179.957 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.72 -43.32 92.13 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 179.759 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -63.4 -43.9 96.2 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.95 -0.3 . . . . 0.0 110.219 179.879 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 215' ' ' MET . . . . . 0.545 ' SD ' ' HB2' ' A' ' 304' ' ' ALA . 65.0 ttp -59.73 -47.88 83.91 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.199 -179.753 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 86.7 mt -60.65 -40.62 92.69 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 179.531 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 217' ' ' GLU . . . . . 0.456 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.5 tp10 -58.36 -37.88 76.11 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.77 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -65.21 -38.3 90.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.811 0.339 . . . . 0.0 110.648 179.696 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 94.2 mt -64.25 -42.56 96.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.554 -179.557 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.36 45.1 0.08 OUTLIER Glycine 0 C--N 1.334 0.417 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 -179.943 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 221' ' ' PHE . . . . . 0.456 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 26.6 m-85 -127.99 155.41 44.32 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.012 0.434 . . . . 0.0 110.527 -179.812 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.487 ' O ' HG13 ' A' ' 191' ' ' VAL . 6.8 p -107.06 122.31 46.22 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.093 0.473 . . . . 0.0 110.2 -179.899 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.475 HD22 ' C ' ' A' ' 222' ' ' THR . 4.3 mm? -101.33 132.81 46.7 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.107 179.967 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.64 159.79 14.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.52 179.86 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.57 115.21 29.86 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.328 179.902 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.494 ' N ' HD12 ' A' ' 226' ' ' LEU . 9.1 mp -53.22 156.86 3.54 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.584 179.926 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -60.31 145.38 98.71 Favored 'Trans proline' 0 C--N 1.301 -1.931 0 C-N-CA 122.627 2.218 . . . . 0.0 112.012 179.379 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.3 -3.26 59.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.559 -179.98 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.15 -40.99 5.66 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 -179.859 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . 0.532 ' O ' ' N ' ' A' ' 233' ' ' SER . 85.5 mt -79.18 -17.15 55.47 Favored 'General case' 0 C--O 1.223 -0.316 0 CA-C-O 120.934 0.397 . . . . 0.0 110.301 -179.721 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . 0.401 ' C ' ' O ' ' A' ' 230' ' ' LEU . 54.7 t-20 -40.38 -49.21 2.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.756 -179.527 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -87.88 15.33 7.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.275 179.814 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . 0.532 ' N ' ' O ' ' A' ' 230' ' ' LEU . 78.0 p -60.35 -35.48 75.77 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.523 -179.732 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . 0.527 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.7 tt0 -118.98 -69.12 0.87 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.917 0.389 . . . . 0.0 111.019 179.491 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.2 m -69.68 102.77 1.96 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.769 -179.882 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -94.27 57.45 2.33 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.341 -179.975 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -144.54 -122.63 1.6 Allowed Glycine 0 CA--C 1.52 0.359 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 179.994 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -135.13 111.53 9.79 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.082 0.468 . . . . 0.0 110.444 179.972 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . 0.519 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.7 mtt180 -148.05 57.88 1.09 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.723 -179.885 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -69.54 -32.27 70.98 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.522 179.65 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 241' ' ' ASP . . . . . 0.546 ' CG ' HD21 ' A' ' 143' ' ' ASN . 65.1 t0 -57.0 -46.97 81.9 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.41 -179.124 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 242' ' ' ILE . . . . . 0.437 ' O ' ' O ' ' A' ' 239' ' ' ARG . 17.7 tt -139.78 156.27 25.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.873 0.368 . . . . 0.0 110.541 179.777 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.441 HG22 HD13 ' A' ' 245' ' ' LEU . 96.2 mt -106.06 106.41 20.53 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.216 0 CA-C-O 121.233 0.54 . . . . 0.0 110.458 179.87 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . 0.606 ' O ' HD12 ' A' ' 245' ' ' LEU . 88.2 mt-30 -110.19 109.85 20.48 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.329 179.75 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.606 HD12 ' O ' ' A' ' 244' ' ' GLN . 9.4 mp -121.75 -168.47 1.7 Allowed 'General case' 0 C--O 1.224 -0.238 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.647 179.774 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . 0.527 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.81 -16.5 0.05 OUTLIER Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 179.892 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . 0.675 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -60.75 156.3 32.24 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 -179.858 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -63.48 21.76 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.001 0.429 . . . . 0.0 110.617 179.973 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . 0.675 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.7 m-20 -97.51 -5.85 34.99 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.554 179.961 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 93.6 mt -79.69 -22.16 43.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.647 179.486 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.64 -51.27 70.65 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.856 -179.543 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -87.96 -5.51 58.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.42 179.653 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.09 -74.33 1.15 Allowed Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 -179.959 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 81.4 mt -70.05 125.89 28.08 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.134 0.493 . . . . 0.0 110.104 -179.759 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -59.69 -39.29 84.08 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.266 -179.656 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 84.37 51.63 3.84 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 179.943 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -95.11 -15.62 23.24 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.698 0.285 . . . . 0.0 110.664 -179.917 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 258' ' ' SER . . . . . 0.497 ' OG ' HG23 ' A' ' 191' ' ' VAL . 3.3 t 173.76 89.4 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.033 0.444 . . . . 0.0 110.085 179.979 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.865 ' N ' HD12 ' A' ' 259' ' ' LEU . 1.0 OUTLIER -94.38 124.06 38.17 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-O 121.314 0.578 . . . . 0.0 111.144 -179.224 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 260' ' ' PHE . . . . . 0.446 ' H ' ' HA ' ' A' ' 193' ' ' ALA . 15.9 m-30 -93.04 146.72 23.42 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.378 179.269 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 86.3 mt -122.48 149.91 43.23 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.525 -179.921 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.742 ' CD1' HG13 ' A' ' 195' ' ' VAL . 2.6 p90 -78.13 -138.64 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.422 -179.696 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 263' ' ' ALA . . . . . 0.661 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -51.69 77.62 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.995 -179.921 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . 0.636 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.35 104.46 0.19 Allowed Glycine 0 N--CA 1.468 0.781 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 -179.798 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 265' ' ' ASP . . . . . 0.605 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.6 m-20 -80.48 -177.56 6.27 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.718 0.294 . . . . 0.0 110.966 -179.594 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -40.68 -17.54 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.428 179.859 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 267' ' ' LYS . . . . . 0.605 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.59 -51.4 42.94 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 121.013 0.435 . . . . 0.0 110.782 179.487 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -63.8 -46.72 83.9 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.143 179.399 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . 0.566 ' HB1' ' OH ' ' A' ' 273' ' ' TYR . . . -61.7 -35.08 77.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.767 179.646 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -62.93 -34.74 78.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.105 179.729 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.38 -43.1 13.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.409 -179.584 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 272' ' ' ILE . . . . . 0.587 ' C ' ' H ' ' A' ' 274' ' ' ALA . 4.9 tt -51.37 -33.65 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.838 -178.95 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 273' ' ' TYR . . . . . 0.566 ' OH ' ' HB1' ' A' ' 269' ' ' ALA . 17.5 m-85 -54.33 -1.67 0.03 OUTLIER 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.742 -179.563 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 274' ' ' ALA . . . . . 0.587 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.94 -39.87 69.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.883 179.648 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . 0.586 ' O ' ' N ' ' A' ' 279' ' ' ALA . 4.3 p30 -38.94 97.53 0.14 Allowed Pre-proline 0 C--O 1.226 -0.168 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.582 -179.68 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 276' ' ' PRO . . . . . 0.402 ' N ' ' O ' ' A' ' 274' ' ' ALA . 45.7 Cg_exo -53.95 -43.15 60.68 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 C-N-CA 122.338 2.025 . . . . 0.0 112.756 -178.884 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 89.8 mt -64.39 -42.82 95.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.136 0.493 . . . . 0.0 111.235 -179.766 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 91.2 mt -95.99 -1.14 49.61 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.849 -179.439 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 279' ' ' ALA . . . . . 0.586 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.39 -34.91 77.65 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.647 -179.762 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -73.76 19.72 0.11 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.126 -179.38 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . 0.495 HD23 ' HA ' ' A' ' 281' ' ' LEU . 13.7 mt -75.2 120.84 83.52 Favored Pre-proline 0 N--CA 1.451 -0.391 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.351 179.99 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_exo -51.58 -39.11 66.05 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.633 2.222 . . . . 0.0 111.603 179.343 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.83 -50.38 63.81 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 179.818 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 79.5 t -61.84 -44.02 98.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 110.083 -0.339 . . . . 0.0 110.083 179.477 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -57.65 -41.6 81.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.301 -179.846 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -90.71 0.7 57.33 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.084 179.675 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt 58.59 41.57 22.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.115 0.483 . . . . 0.0 111.029 179.788 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -93.15 42.22 1.09 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.377 179.804 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 53.8 t -119.37 135.54 59.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 120.943 0.401 . . . . 0.0 110.223 -179.699 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -132.78 162.81 30.52 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.045 0.45 . . . . 0.0 110.703 -179.623 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.65 155.38 32.45 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.032 0.444 . . . . 0.0 110.743 -179.882 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 81.4 mt -94.37 -1.23 54.11 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.211 -179.699 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.1 165.01 12.54 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.634 -0.986 . . . . 0.0 110.634 -179.814 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 7.0 m -86.79 -62.04 1.6 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.804 0.335 . . . . 0.0 111.184 -179.95 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 295' ' ' GLU . . . . . 0.444 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.6 mm-40 -69.41 -4.07 16.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.697 -179.842 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 25.4 p -76.84 32.38 0.14 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.663 -179.887 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 297' ' ' PHE . . . . . 0.511 ' CD2' HG22 ' A' ' 70' ' ' THR . 70.5 t80 -60.33 -46.06 91.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.607 -179.908 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . 0.614 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.4 mtt85 -81.08 134.93 35.75 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.581 -179.699 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.457 ' H ' HG11 ' A' ' 51' ' ' VAL . 17.1 tp -114.24 118.07 32.92 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.152 179.898 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . 0.635 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.2 p-10 -165.69 -176.16 3.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.541 179.978 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 84.5 t80 -47.17 -43.86 21.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.275 -179.675 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -66.6 -40.63 88.95 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.08 0.466 . . . . 0.0 110.833 179.116 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . 0.635 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 60.8 p -55.71 -36.11 66.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.159 -179.263 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . 0.545 ' HB2' ' SD ' ' A' ' 215' ' ' MET . . . -57.49 -51.31 69.98 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.459 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 90.6 mtp -56.71 -43.52 80.64 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -179.993 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -66.49 -42.56 87.21 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.928 0.394 . . . . 0.0 110.16 178.796 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 303' ' ' SER . 55.6 t -64.02 -43.12 97.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.08 179.352 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 43.3 tp -59.66 -42.09 92.05 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.721 -179.409 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -62.72 -38.83 92.03 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 179.565 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 310' ' ' ARG . . . . . 0.446 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.6 ttt85 -63.66 -43.88 95.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.288 179.506 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 89.4 mt -63.21 -42.1 99.23 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.185 179.602 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -62.87 -33.59 75.6 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.993 179.445 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.65 -23.46 21.89 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.507 -179.836 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . 0.479 HD22 ' CE2' ' A' ' 315' ' ' PHE . 6.7 tt -62.32 -43.12 99.56 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 121.087 0.47 . . . . 0.0 110.629 -179.889 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 315' ' ' PHE . . . . . 0.479 ' CE2' HD22 ' A' ' 314' ' ' LEU . 90.9 m-85 . . . . . 0 C--O 1.22 -0.457 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.462 179.897 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -99.6 136.04 40.12 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.47 -179.961 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.498 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -92.41 178.45 1.68 Allowed Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.539 -179.88 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.498 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.0 Cg_exo -61.76 147.39 95.39 Favored 'Trans proline' 0 C--N 1.3 -1.996 0 C-N-CA 122.752 2.302 . . . . 0.0 112.162 179.811 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.493 ' HE ' HD12 ' A' ' 39' ' ' LEU . 35.4 ptt180 -136.85 142.47 42.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.679 179.679 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -79.59 116.97 20.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.464 179.962 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.458 ' O ' HG23 ' A' ' 30' ' ' ILE . 9.5 tp -111.48 130.25 65.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.46 -179.956 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 13.5 t -71.4 142.13 50.32 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.527 179.811 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.484 ' CG ' ' H ' ' A' ' 33' ' ' SER . 42.8 t0 -139.09 -179.56 5.92 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.629 -179.937 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.484 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 78.0 p -74.15 -37.13 64.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.755 179.863 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.7 ttt85 -47.07 -94.9 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.382 -179.521 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.415 ' O ' ' OG1' ' A' ' 36' ' ' THR . . . -165.65 -27.15 0.02 OUTLIER Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 179.92 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.415 ' OG1' ' O ' ' A' ' 35' ' ' GLY . 67.6 m -168.43 105.9 0.46 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.859 0.361 . . . . 0.0 110.635 -179.909 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.63 ' CD2' HD13 ' A' ' 140' ' ' LEU . 64.4 t60 -128.9 145.98 51.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.015 0.436 . . . . 0.0 110.267 179.896 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.617 HG22 ' N ' ' A' ' 39' ' ' LEU . 99.8 m -129.26 165.42 21.43 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.639 -179.915 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.617 ' N ' HG22 ' A' ' 38' ' ' THR . 79.6 mt -120.27 127.39 52.34 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.513 179.785 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -65.51 -44.57 86.6 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.619 -179.951 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 41.6 p -166.0 154.93 11.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.443 179.719 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.492 ' H ' ' CD ' ' A' ' 42' ' ' GLN . 14.0 mp0 -45.43 101.71 0.27 Allowed Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.673 179.503 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -57.71 130.12 37.03 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 C-N-CA 122.351 2.034 . . . . 0.0 112.233 -179.687 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -83.05 -24.68 32.67 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.448 179.631 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.536 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.9 mtm-85 -120.46 134.48 55.26 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-O 121.174 0.511 . . . . 0.0 110.28 -179.987 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 95.9 mt -129.97 133.46 64.48 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.271 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.979 -179.76 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 47.8 t -125.25 131.02 72.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.802 0.334 . . . . 0.0 110.11 179.329 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.601 ' OG ' HD12 ' A' ' 117' ' ' LEU . 4.2 m -154.72 166.31 33.84 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.606 179.81 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 65.8 p -124.85 8.23 8.12 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.483 179.931 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.1 t -85.2 125.8 33.15 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.68 -179.43 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.463 HG11 ' H ' ' A' ' 299' ' ' LEU . 91.9 t -65.7 -44.52 93.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.51 -179.994 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.8 m -62.74 -44.32 96.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.664 -179.849 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 54.4 tp -62.19 -41.56 98.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.57 -179.536 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.455 ' O ' HD13 ' A' ' 58' ' ' LEU . 72.1 m -57.72 -44.53 86.04 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.349 -179.397 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.31 -62.09 5.43 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.911 -0.876 . . . . 0.0 110.911 179.554 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.6 t -48.24 -35.76 12.63 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 -179.962 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 20.0 mt -61.77 -44.76 96.25 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.724 -0.391 . . . . 0.0 111.145 179.347 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.455 HD13 ' O ' ' A' ' 54' ' ' THR . 9.2 mp -64.88 -42.0 95.18 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.081 0.467 . . . . 0.0 111.287 178.035 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.407 ' HB1' ' NE ' ' A' ' 169' ' ' ARG . . . -63.59 -41.22 98.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.998 -179.288 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.434 ' O ' HG23 ' A' ' 60' ' ' ILE . 7.9 tp -87.89 16.53 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.694 -179.662 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 56.58 84.3 0.09 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.575 -179.973 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.59 57.74 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.147 -179.808 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.417 ' HB3' HE21 ' A' ' 85' ' ' GLN . 9.8 Cg_endo -50.13 152.55 7.73 Favored 'Trans proline' 0 C--N 1.297 -2.169 0 C-N-CA 122.834 2.356 . . . . 0.0 112.475 -178.297 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.428 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -108.93 146.34 14.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.417 -179.747 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 97.1 mt -63.85 -45.03 98.2 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.351 -179.762 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.505 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -130.26 134.48 47.26 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.677 -179.857 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.478 ' O ' ' N ' ' A' ' 98' ' ' LEU . 69.0 m -134.19 158.38 43.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.839 -179.62 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.5 139.18 16.38 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 179.804 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.498 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.91 -162.6 0.08 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.934 0.397 . . . . 0.0 110.495 -179.968 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.524 HG22 ' CD2' ' A' ' 297' ' ' PHE . 14.6 t -133.55 135.88 44.61 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.394 -179.992 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.493 ' C ' ' O ' ' A' ' 70' ' ' THR . 0.0 OUTLIER 29.74 68.68 0.66 Allowed Pre-proline 0 N--CA 1.464 0.243 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.646 -179.843 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -60.9 145.23 99.35 Favored 'Trans proline' 0 C--N 1.3 -1.98 0 C-N-CA 122.643 2.229 . . . . 0.0 112.227 -178.73 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.527 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 45.6 p-10 -160.7 -32.59 0.05 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.686 179.659 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.537 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 99.0 m-20 -63.88 -39.36 94.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.488 -179.972 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 73.2 ttt180 -60.56 -48.19 82.87 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.68 -179.405 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.418 ' O ' ' O ' ' A' ' 77' ' ' ALA . 93.6 t -59.91 -24.52 29.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 110.1 -0.334 . . . . 0.0 110.1 179.607 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.537 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -46.1 173.13 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.599 179.924 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.569 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.6 p30 -61.87 177.6 0.42 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.581 -179.738 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.567 ' C ' ' H ' ' A' ' 81' ' ' GLY . 35.9 p30 -46.02 85.95 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.887 -179.942 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.569 ' N ' ' O ' ' A' ' 78' ' ' ASP . 42.6 tp60 -66.92 13.48 0.06 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.143 -179.893 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.567 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 117.76 -22.04 10.16 Favored Glycine 0 CA--C 1.519 0.293 0 N-CA-C 110.994 -0.843 . . . . 0.0 110.994 179.957 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -107.62 116.47 32.0 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.99 0.424 . . . . 0.0 110.497 179.883 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 75.2 mt -98.73 0.67 45.0 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.46 -179.738 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -91.93 6.7 45.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.957 0.408 . . . . 0.0 110.41 -179.833 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.8 ' O ' HG22 ' A' ' 89' ' ' VAL . 88.4 mt-30 -99.67 -27.63 13.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.858 179.957 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 68.7 t-105 -63.34 -41.18 98.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.03 -179.619 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.556 ' O ' ' N ' ' A' ' 91' ' ' LYS . 65.8 m -77.42 -53.33 7.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.238 -179.317 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -48.57 -51.09 29.47 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.966 -179.28 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.8 HG22 ' O ' ' A' ' 85' ' ' GLN . 15.4 m -68.78 -40.74 81.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 120.903 0.383 . . . . 0.0 110.962 179.9 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.5 ' N ' HG23 ' A' ' 89' ' ' VAL . . . -71.9 -23.11 61.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.786 179.953 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.556 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.0 tttm -60.99 -45.82 93.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.498 -179.602 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.438 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.3 mm-40 -90.82 -94.68 0.12 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.08 179.981 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.634 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.9 mtt180 -143.23 60.03 1.4 Allowed 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.794 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.462 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.6 pttp 33.57 26.23 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.222 -179.048 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.634 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.4 tt -47.62 123.31 5.69 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.92 -178.253 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.456 ' O ' HD23 ' A' ' 95' ' ' LEU . 98.8 mm-40 -83.44 -169.92 2.79 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.061 -179.997 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.613 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 82.3 mtp180 -73.61 138.03 44.6 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.166 -179.837 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.478 ' N ' ' O ' ' A' ' 67' ' ' SER . 89.8 mt -87.27 -165.93 1.43 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.717 -179.647 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.534 ' CD2' ' O ' ' A' ' 99' ' ' TYR . 48.2 p90 -168.46 120.2 0.81 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.32 179.933 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.513 ' C ' ' O ' ' A' ' 99' ' ' TYR . 43.6 mm -29.6 121.5 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.863 -179.63 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 114.22 27.94 3.24 Favored Glycine 0 CA--C 1.521 0.426 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 -179.557 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.59 ' H ' ' CD ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -144.17 46.04 0.6 Allowed Pre-proline 0 C--N 1.324 -0.541 0 CA-C-O 120.907 0.384 . . . . 0.0 110.465 179.903 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.582 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 31.0 Cg_endo -62.28 143.85 94.56 Favored 'Trans proline' 0 C--N 1.298 -2.126 0 C-N-CA 122.735 2.29 . . . . 0.0 111.996 179.932 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.464 ' O ' HG23 ' A' ' 108' ' ' VAL . 24.8 t -173.67 120.91 0.32 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.46 179.67 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.42 -41.11 63.68 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.012 0.434 . . . . 0.0 111.154 179.709 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -65.82 -40.16 91.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.856 -179.432 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.63 -39.77 95.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.708 -179.907 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 104' ' ' SER . 72.0 t -67.44 -43.82 87.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.683 179.584 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.18 -39.24 92.04 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.512 -179.233 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.438 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.75 -23.82 63.54 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.431 179.831 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.568 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.3 mm-40 -91.18 4.47 52.15 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.684 -179.574 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.568 ' C ' ' O ' ' A' ' 111' ' ' GLN . 10.4 tpt 22.11 64.56 0.32 Allowed Pre-proline 0 N--CA 1.464 0.266 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.992 -179.911 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.478 ' HG2' HD11 ' A' ' 116' ' ' ILE . 67.8 Cg_endo -78.66 170.04 18.82 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 C-N-CA 122.972 2.448 . . . . 0.0 112.21 -178.66 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.522 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 99.1 m-20 -113.07 -44.78 3.23 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 121.065 0.46 . . . . 0.0 110.088 179.544 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 39.8 tp -119.91 119.57 33.87 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.514 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.478 HD11 ' HG2' ' A' ' 113' ' ' PRO . 94.7 mt -116.94 131.15 70.49 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 CA-C-O 120.954 0.407 . . . . 0.0 110.887 -179.807 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.601 HD12 ' OG ' ' A' ' 48' ' ' SER . 31.6 mt -105.63 131.98 52.33 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 121.11 0.481 . . . . 0.0 110.125 -179.528 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.488 HD12 HG23 ' A' ' 139' ' ' THR . 98.3 mt -117.55 135.94 56.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.79 -179.726 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 85.0 p -71.57 151.54 43.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.568 -179.944 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.13 -49.85 76.0 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.678 -179.763 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.0 t -149.4 153.93 38.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.587 179.76 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 168.19 -169.56 41.53 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.875 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.87 -35.73 92.41 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -179.971 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.446 ' O ' ' OD1' ' A' ' 124' ' ' ASP . 44.1 p-10 -87.96 120.04 28.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.782 0.325 . . . . 0.0 110.632 179.871 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.454 ' O ' HD12 ' A' ' 129' ' ' LEU . 40.5 t -63.44 144.2 57.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.554 -179.956 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.518 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -94.02 -43.08 8.69 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.792 -179.814 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 56.1 tp -62.73 -42.37 99.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.562 -179.841 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.0 -10.52 54.21 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.531 -179.474 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.454 HD12 ' O ' ' A' ' 125' ' ' SER . 83.6 mt -116.02 -24.08 8.24 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.678 -179.89 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . 0.518 ' N ' ' O ' ' A' ' 126' ' ' ALA . 74.5 t80 -51.52 -49.55 61.71 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.456 -178.951 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.4 p-10 -65.87 -41.91 91.04 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.893 0.378 . . . . 0.0 111.163 179.607 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.526 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 87.7 mt-30 -67.85 -36.74 80.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.746 -179.905 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.453 HD22 HD13 ' A' ' 116' ' ' ILE . 95.9 mt -80.19 -42.45 23.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.955 -179.439 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.3 t -57.49 -44.94 85.35 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.355 -179.117 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.4 m -62.29 -45.95 90.94 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.639 179.409 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 92.2 mt -62.29 -43.79 98.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.325 -179.823 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.604 ' HB1' ' HD2' ' A' ' 138' ' ' PRO . . . -170.18 163.75 6.17 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.471 179.842 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.604 ' HD2' ' HB1' ' A' ' 137' ' ' ALA . 76.6 Cg_exo -42.38 110.3 0.15 Allowed 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.571 2.181 . . . . 0.0 112.035 179.454 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.515 HG21 ' CD1' ' A' ' 130' ' ' TYR . 2.8 m -87.27 127.61 35.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.463 -179.927 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.63 HD13 ' CD2' ' A' ' 37' ' ' HIS . 34.1 tp -119.78 138.72 53.17 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.163 -179.818 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.436 ' O ' ' OD1' ' A' ' 32' ' ' ASP . 81.6 mt -105.29 120.04 55.35 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.348 0 CA-C-O 121.125 0.488 . . . . 0.0 111.233 -179.439 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.49 HD12 HD22 ' A' ' 117' ' ' LEU . 97.7 mt -135.42 132.73 52.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.721 179.577 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.531 HD21 ' CG ' ' A' ' 241' ' ' ASP . 59.7 t30 -64.49 148.3 50.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.875 0.369 . . . . 0.0 110.37 179.364 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.515 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 86.9 t80 -82.75 122.4 28.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.96 -179.471 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.515 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 99.0 m-20 55.08 69.41 0.73 Allowed 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.827 179.648 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 35.2 p-10 -125.71 0.69 7.46 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 120.906 0.384 . . . . 0.0 110.704 179.787 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -150.9 115.92 5.29 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.668 -179.511 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 86.2 p -63.74 168.72 4.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.499 -179.805 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.423 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.3 p-90 -51.6 -15.96 0.54 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.62 -179.868 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . 0.44 ' O ' HG23 ' A' ' 154' ' ' THR . 67.9 tp60 -70.36 -76.05 0.11 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.521 -179.748 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.458 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.0 t -62.68 -38.5 90.61 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.339 179.481 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 52.3 tp -60.1 -45.51 92.69 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.401 -178.611 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.423 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 46.5 tp -62.83 -41.84 99.49 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.861 0.362 . . . . 0.0 110.411 178.995 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.458 ' OG1' ' O ' ' A' ' 151' ' ' SER . 59.2 p -63.72 -34.76 78.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.258 -179.566 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.471 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.9 mm-40 -63.98 -42.18 97.3 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.239 179.177 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 91.6 mt -65.42 -38.89 91.27 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.092 179.118 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.582 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.25 -32.42 80.62 Favored Glycine 0 CA--C 1.52 0.375 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 -179.366 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.471 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.1 mt-10 -36.34 -25.55 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.874 0.369 . . . . 0.0 110.791 -179.98 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.582 ' N ' ' O ' ' A' ' 157' ' ' GLY . 94.8 mt -59.35 149.5 6.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.231 179.473 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 74.8 p -69.09 137.07 53.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.049 -179.558 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 71.1 21.62 78.41 Favored Glycine 0 N--CA 1.459 0.194 0 N-CA-C 111.269 -0.732 . . . . 0.0 111.269 179.509 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 60.3 m80 -123.43 -15.45 7.13 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.746 0.307 . . . . 0.0 110.568 179.989 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -66.02 -59.87 3.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.715 -179.756 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -51.62 -49.09 62.9 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.238 -179.755 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -60.83 -41.07 95.04 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.723 0.297 . . . . 0.0 110.312 179.522 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.48 -47.51 85.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.613 179.745 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.64 -40.32 75.23 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.268 -179.921 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -61.66 -50.24 73.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.65 179.525 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.407 ' NE ' ' HB1' ' A' ' 59' ' ' ALA . 59.9 ttt85 -65.38 -43.76 89.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.476 179.495 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 95.1 mt -64.53 -43.41 96.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.52 179.728 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.23 -51.05 70.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.599 -179.308 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.79 -43.67 95.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.421 179.724 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . 0.658 ' CE2' HD11 ' A' ' 177' ' ' LEU . 57.3 t80 -62.69 -44.56 95.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.456 179.364 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -63.26 -40.04 96.28 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.527 -179.361 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -63.01 -42.77 99.92 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.624 179.277 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -60.64 -44.78 95.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.119 179.968 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.658 HD11 ' CE2' ' A' ' 173' ' ' PHE . 84.4 mt -64.29 -41.09 97.05 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.02 0.438 . . . . 0.0 110.674 178.956 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.18 -62.12 1.84 Allowed 'General case' 0 C--O 1.237 0.418 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.501 -179.387 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.78 -46.78 86.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.545 179.903 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.3 -41.72 65.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.149 179.974 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -63.72 -33.6 76.02 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.011 0.434 . . . . 0.0 110.415 179.227 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . 0.428 ' HG2' ' O ' ' A' ' 182' ' ' GLU . 69.8 tt0 -90.7 8.61 33.62 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.27 0.557 . . . . 0.0 110.528 -179.01 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -104.58 -32.25 9.03 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.188 179.595 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 45.1 pt -128.04 147.72 32.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.816 -179.803 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -139.76 130.88 26.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.375 179.418 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . 0.592 HD22 ' N ' ' A' ' 186' ' ' LEU . 3.6 mm? -85.46 133.24 42.64 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.808 -179.947 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -44.01 157.81 0.14 Allowed 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.704 2.269 . . . . 0.0 112.088 179.46 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . 0.528 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.7 Cg_endo -63.01 114.74 2.57 Favored 'Trans proline' 0 C--N 1.303 -1.858 0 C-N-CA 122.751 2.3 . . . . 0.0 111.752 179.909 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . 0.528 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.8 mt-30 155.6 147.83 0.0 OUTLIER Pre-proline 0 C--N 1.331 -0.215 0 O-C-N 123.433 0.458 . . . . 0.0 110.725 -179.757 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -73.9 144.06 33.98 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.711 2.274 . . . . 0.0 111.771 178.189 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.498 HG23 ' OG ' ' A' ' 258' ' ' SER . 2.1 p -124.92 159.03 32.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.261 0.553 . . . . 0.0 110.082 -179.975 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . 0.497 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 37.7 p -143.55 165.31 27.94 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.069 -179.506 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . 0.443 ' HA ' ' H ' ' A' ' 260' ' ' PHE . . . -135.55 128.54 31.48 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.122 0.487 . . . . 0.0 110.258 179.704 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.503 HD11 HD23 ' A' ' 259' ' ' LEU . 47.5 pt -146.4 148.86 16.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.1 179.928 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . 0.747 HG13 ' CD1' ' A' ' 262' ' ' PHE . 68.9 t -117.89 123.12 71.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.315 0.578 . . . . 0.0 109.7 179.098 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -134.26 107.36 7.62 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.309 179.745 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 94.2 m -131.13 130.53 43.21 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.802 179.871 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.411 ' O ' ' N ' ' A' ' 201' ' ' HIS . . . -82.9 -37.2 24.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.276 179.745 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.25 -67.12 0.25 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.364 179.978 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.15 -9.84 58.98 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.344 179.48 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . 0.411 ' N ' ' O ' ' A' ' 198' ' ' ALA . 60.0 t-80 60.85 58.16 2.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.601 -179.972 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 44.8 p -167.07 153.21 8.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.516 179.666 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.24 143.93 24.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.933 0.397 . . . . 0.0 110.426 179.532 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -135.31 138.51 43.5 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.644 -179.949 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 19.9 mt -106.45 125.42 50.98 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 121.112 0.482 . . . . 0.0 109.862 -179.721 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 206' ' ' TRP . . . . . 0.555 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 74.2 m95 -81.96 166.94 19.42 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.597 -179.713 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . 0.475 HG22 ' C ' ' A' ' 206' ' ' TRP . 0.1 OUTLIER -157.05 171.41 7.49 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.56 -179.164 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -53.65 -37.13 83.38 Favored 'Trans proline' 0 C--N 1.303 -1.838 0 C-N-CA 122.664 2.242 . . . . 0.0 111.97 179.333 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -70.58 -35.08 72.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.844 -179.864 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 21.7 m -60.98 151.02 31.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.562 -179.31 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.81 -37.03 82.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.523 -179.767 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 212' ' ' GLN . . . . . 0.555 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 55.0 tt0 -64.64 -40.37 95.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.532 179.916 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.51 -43.34 92.55 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 179.846 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -63.31 -43.68 97.12 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.675 0.274 . . . . 0.0 110.283 179.851 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 215' ' ' MET . . . . . 0.546 ' SD ' ' HB2' ' A' ' 304' ' ' ALA . 65.3 ttp -59.65 -47.98 83.47 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.206 -179.773 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 216' ' ' LEU . 88.1 mt -60.59 -40.8 93.07 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.531 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 217' ' ' GLU . . . . . 0.459 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.8 tp10 -58.25 -38.01 76.08 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.75 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -65.13 -38.23 89.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.808 0.337 . . . . 0.0 110.671 179.677 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 94.4 mt -64.33 -42.67 96.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.572 -179.616 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.5 44.93 0.08 OUTLIER Glycine 0 CA--C 1.521 0.429 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 -179.958 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 221' ' ' PHE . . . . . 0.459 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 26.4 m-85 -127.91 155.32 44.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.045 0.45 . . . . 0.0 110.507 -179.896 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.489 ' O ' HG13 ' A' ' 191' ' ' VAL . 7.2 p -106.8 122.17 45.84 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.214 0.531 . . . . 0.0 110.202 -179.985 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.473 HD22 ' C ' ' A' ' 222' ' ' THR . 4.3 mm? -101.21 132.99 46.44 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.074 179.982 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.85 159.74 14.75 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.005 0.431 . . . . 0.0 110.504 179.86 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.75 115.25 29.92 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.382 179.93 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.508 ' N ' HD12 ' A' ' 226' ' ' LEU . 8.8 mp -52.94 156.62 3.33 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.662 179.952 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -60.47 145.45 98.71 Favored 'Trans proline' 0 C--N 1.302 -1.889 0 C-N-CA 122.68 2.253 . . . . 0.0 111.982 179.367 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.02 -3.42 59.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.57 179.994 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.04 -41.11 5.66 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 -179.884 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . 0.537 ' O ' ' N ' ' A' ' 233' ' ' SER . 85.6 mt -79.3 -17.2 55.09 Favored 'General case' 0 C--O 1.224 -0.273 0 CA-C-O 121.037 0.446 . . . . 0.0 110.314 -179.696 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . 0.403 ' C ' ' O ' ' A' ' 230' ' ' LEU . 54.8 t-20 -40.23 -49.31 2.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.73 -179.642 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -87.86 15.35 7.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.828 0.347 . . . . 0.0 111.18 179.945 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . 0.537 ' N ' ' O ' ' A' ' 230' ' ' LEU . 78.0 p -60.29 -35.54 75.79 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.594 -179.824 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . 0.526 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.5 tt0 -119.11 -69.29 0.86 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.898 179.643 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.2 m -69.28 103.23 1.9 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.612 -179.727 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -94.79 57.18 2.12 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.42 179.912 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -144.57 -122.84 1.62 Allowed Glycine 0 CA--C 1.522 0.48 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 -179.928 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -134.94 111.64 10.0 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.061 0.458 . . . . 0.0 110.423 -179.997 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . 0.523 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.6 mtt180 -148.04 58.16 1.1 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.731 -179.961 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -69.75 -32.03 70.32 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.568 179.571 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 241' ' ' ASP . . . . . 0.531 ' CG ' HD21 ' A' ' 143' ' ' ASN . 65.4 t0 -57.08 -46.93 82.14 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.373 -179.143 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 242' ' ' ILE . . . . . 0.435 ' O ' ' O ' ' A' ' 239' ' ' ARG . 18.1 tt -140.01 156.82 25.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.91 0.386 . . . . 0.0 110.492 179.712 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.443 HG22 HD13 ' A' ' 245' ' ' LEU . 96.2 mt -106.54 106.7 21.11 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.173 0 CA-C-O 121.177 0.513 . . . . 0.0 110.523 179.85 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . 0.606 ' O ' HD12 ' A' ' 245' ' ' LEU . 88.2 mt-30 -110.47 110.12 20.75 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.311 179.817 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.606 HD12 ' O ' ' A' ' 244' ' ' GLN . 9.3 mp -121.86 -168.44 1.7 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.601 179.911 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . 0.526 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.67 -16.47 0.05 OUTLIER Glycine 0 CA--C 1.524 0.628 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 179.876 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . 0.677 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -60.59 156.35 31.49 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 -179.885 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -63.42 21.38 0.01 OUTLIER 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.886 0.374 . . . . 0.0 110.626 179.883 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . 0.677 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.6 m-20 -97.29 -5.78 35.89 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.537 179.942 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 94.8 mt -79.66 -22.11 43.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.543 179.546 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.55 -51.32 70.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.796 -179.591 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.11 -5.68 58.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.476 179.679 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -80.96 -74.69 1.13 Allowed Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 -179.925 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 81.3 mt -69.89 125.97 28.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.069 0.461 . . . . 0.0 110.249 -179.82 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -59.19 -39.52 82.83 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.248 -179.662 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 83.21 51.82 4.02 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 179.903 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -96.04 -14.95 22.56 Favored 'General case' 0 C--N 1.333 -0.152 0 O-C-N 122.729 -0.277 . . . . 0.0 110.564 -179.843 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 258' ' ' SER . . . . . 0.498 ' OG ' HG23 ' A' ' 191' ' ' VAL . 3.4 t 174.43 88.62 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.048 0.451 . . . . 0.0 110.169 -179.972 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.864 ' N ' HD12 ' A' ' 259' ' ' LEU . 1.0 OUTLIER -94.05 123.93 37.74 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.227 0.537 . . . . 0.0 111.11 -179.159 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 260' ' ' PHE . . . . . 0.443 ' H ' ' HA ' ' A' ' 193' ' ' ALA . 16.0 m-30 -92.93 146.7 23.43 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.337 179.221 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 85.7 mt -122.53 149.9 43.29 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.521 -179.868 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.747 ' CD1' HG13 ' A' ' 195' ' ' VAL . 2.6 p90 -77.57 -138.47 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.552 -179.865 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 263' ' ' ALA . . . . . 0.662 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -52.16 77.73 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.922 179.957 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . 0.632 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.16 104.46 0.19 Allowed Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 -179.936 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 265' ' ' ASP . . . . . 0.609 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.8 m-20 -80.49 -177.64 6.31 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.749 0.309 . . . . 0.0 110.841 -179.468 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -40.48 -17.54 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.506 179.8 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 267' ' ' LYS . . . . . 0.609 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.63 -51.59 40.52 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.687 179.516 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -63.71 -46.67 84.38 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.187 179.382 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . 0.569 ' HB1' ' OH ' ' A' ' 273' ' ' TYR . . . -61.64 -35.04 76.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.845 179.52 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -63.05 -34.53 77.78 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.111 179.744 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.37 -43.21 13.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.261 -179.577 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 272' ' ' ILE . . . . . 0.586 ' C ' ' H ' ' A' ' 274' ' ' ALA . 4.9 tt -51.39 -33.81 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.811 -178.802 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 273' ' ' TYR . . . . . 0.569 ' OH ' ' HB1' ' A' ' 269' ' ' ALA . 17.2 m-85 -54.27 -1.76 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.655 -179.628 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 274' ' ' ALA . . . . . 0.586 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.87 -39.41 69.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.844 179.686 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . 0.582 ' O ' ' N ' ' A' ' 279' ' ' ALA . 2.9 p30 -39.63 98.28 0.16 Allowed Pre-proline 0 C--N 1.333 -0.141 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.513 -179.671 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -54.02 -43.17 60.61 Favored 'Trans proline' 0 C--N 1.302 -1.874 0 C-N-CA 122.411 2.074 . . . . 0.0 112.613 -178.855 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 88.9 mt -64.47 -42.83 95.69 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.137 0.494 . . . . 0.0 111.218 -179.625 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 89.7 mt -95.67 -1.54 49.9 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.875 -179.47 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 279' ' ' ALA . . . . . 0.582 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.42 -34.65 77.17 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.646 -179.807 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.45 20.04 0.12 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.024 -179.226 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . 0.492 HD23 ' HA ' ' A' ' 281' ' ' LEU . 13.9 mt -75.32 120.52 82.06 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.394 179.968 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -51.36 -39.23 63.56 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 122.625 2.217 . . . . 0.0 111.676 179.312 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.9 -50.42 63.93 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.09 179.878 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 75.2 t -61.48 -43.93 97.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 179.502 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -57.67 -41.27 81.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.317 -179.981 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -91.14 0.45 57.53 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.123 179.599 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt 59.06 43.25 17.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.042 0.448 . . . . 0.0 110.928 179.67 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -94.59 41.43 1.09 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.399 179.793 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 53.4 t -118.85 135.86 57.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.031 0.443 . . . . 0.0 110.166 -179.707 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -133.01 162.8 30.73 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.706 -179.637 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.94 155.19 33.24 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.988 0.423 . . . . 0.0 110.701 -179.743 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 80.4 mt -93.95 -1.36 54.76 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.364 -179.794 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.26 165.89 12.78 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 110.65 -0.98 . . . . 0.0 110.65 -179.747 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 6.9 m -87.75 -62.26 1.54 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.889 0.376 . . . . 0.0 111.124 -179.922 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 295' ' ' GLU . . . . . 0.441 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.7 mm-40 -69.48 -3.78 16.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.569 -179.729 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 27.6 p -76.74 32.8 0.14 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.698 -179.963 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 297' ' ' PHE . . . . . 0.524 ' CD2' HG22 ' A' ' 70' ' ' THR . 85.5 t80 -60.21 -45.92 91.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.677 179.995 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . 0.613 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.1 mtt85 -81.54 134.23 35.48 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.592 -179.68 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.463 ' H ' HG11 ' A' ' 51' ' ' VAL . 16.6 tp -114.04 118.35 33.84 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.115 179.969 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . 0.635 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.7 p-10 -165.8 -175.96 3.66 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.526 -179.934 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -47.34 -44.04 23.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.194 -179.639 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -66.33 -40.76 90.1 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.013 0.435 . . . . 0.0 110.776 179.05 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . 0.635 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 57.6 p -55.72 -36.17 66.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.168 -179.334 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . 0.546 ' HB2' ' SD ' ' A' ' 215' ' ' MET . . . -57.35 -51.68 68.43 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.439 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 91.1 mtp -56.15 -43.59 78.42 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.778 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -66.54 -42.49 87.11 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.912 0.387 . . . . 0.0 110.167 178.821 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 303' ' ' SER . 55.9 t -64.13 -42.86 96.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.179 179.305 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 43.5 tp -59.68 -42.14 92.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.88 -179.588 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -62.54 -39.15 92.67 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.112 179.494 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 310' ' ' ARG . . . . . 0.438 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.5 ttt85 -63.45 -43.99 95.77 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.293 179.445 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 88.9 mt -63.34 -42.13 98.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.226 179.566 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.4 ttmt -62.84 -33.26 74.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.068 0.461 . . . . 0.0 110.108 179.485 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.84 -23.46 21.67 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.579 -179.942 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . 0.478 HD22 ' CE2' ' A' ' 315' ' ' PHE . 6.7 tt -62.39 -43.17 99.47 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.547 -179.894 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 315' ' ' PHE . . . . . 0.478 ' CE2' HD22 ' A' ' 314' ' ' LEU . 91.0 m-85 . . . . . 0 C--O 1.219 -0.502 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.498 179.989 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -99.67 135.97 40.29 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.047 0.451 . . . . 0.0 110.485 -179.962 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.497 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.2 OUTLIER -91.64 178.43 1.76 Allowed Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.601 -179.87 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.497 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.6 Cg_exo -61.73 147.73 94.65 Favored 'Trans proline' 0 C--N 1.3 -1.987 0 C-N-CA 122.755 2.303 . . . . 0.0 112.118 179.708 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.473 ' HE ' HD12 ' A' ' 39' ' ' LEU . 35.4 ptt180 -135.48 142.34 45.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.618 179.797 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -78.95 116.84 19.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.576 179.953 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.431 ' O ' HG23 ' A' ' 30' ' ' ILE . 9.6 tp -110.17 130.86 62.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.436 -179.998 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 13.2 t -70.69 142.3 51.53 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.614 179.839 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 141' ' ' ILE . 25.2 t70 -140.25 177.56 7.9 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.481 -179.939 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 77.9 p -74.13 -36.33 64.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.529 -179.945 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -47.69 -94.96 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.347 -179.606 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -165.46 -25.83 0.02 OUTLIER Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 179.892 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 59.0 m -168.84 106.96 0.44 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.846 0.355 . . . . 0.0 110.689 -179.96 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.568 ' CD2' HD13 ' A' ' 140' ' ' LEU . 35.5 t60 -129.57 144.77 51.42 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.012 0.434 . . . . 0.0 110.224 179.885 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.628 HG22 ' N ' ' A' ' 39' ' ' LEU . 97.4 m -128.95 166.24 19.53 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.582 -179.76 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.628 ' N ' HG22 ' A' ' 38' ' ' THR . 81.9 mt -121.04 127.48 51.76 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.486 179.738 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -64.05 -44.55 92.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.618 -179.829 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 40.7 p -165.68 154.75 11.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.463 179.719 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.52 ' H ' ' CD ' ' A' ' 42' ' ' GLN . 14.4 mp0 -43.36 100.86 0.23 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.595 179.61 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -57.03 128.95 31.95 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.384 2.056 . . . . 0.0 112.29 -179.637 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -83.34 -24.54 32.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.551 179.6 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.541 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.7 mtm-85 -121.03 134.43 55.29 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 121.095 0.474 . . . . 0.0 110.294 -179.985 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.0 mt -130.23 133.35 64.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.943 -179.746 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 45.9 t -124.9 131.13 73.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.817 0.341 . . . . 0.0 110.156 179.334 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.601 ' OG ' HD12 ' A' ' 117' ' ' LEU . 4.8 m -154.55 166.32 33.7 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.543 179.881 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 72.0 p -124.56 8.55 8.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.519 179.856 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.3 t -85.73 125.33 33.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.579 -179.485 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.499 HG11 ' H ' ' A' ' 299' ' ' LEU . 96.4 t -65.66 -44.46 93.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.544 179.961 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.7 m -62.48 -44.36 96.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.57 -179.841 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 46.3 tp -62.41 -41.3 98.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.516 -179.441 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.454 ' O ' HD13 ' A' ' 58' ' ' LEU . 73.7 m -57.59 -44.57 85.48 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.451 -179.326 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.43 -62.3 5.22 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 179.602 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.6 t -48.14 -35.78 12.19 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 179.807 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.5 mt -61.66 -44.79 96.29 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.038 179.474 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.454 HD13 ' O ' ' A' ' 54' ' ' THR . 9.1 mp -64.96 -41.81 95.15 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.164 178.114 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.403 ' HB1' ' NE ' ' A' ' 169' ' ' ARG . . . -63.48 -41.49 98.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.921 -179.164 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.433 ' O ' HG23 ' A' ' 60' ' ' ILE . 8.1 tp -87.9 16.94 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.711 -179.574 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 56.58 84.01 0.09 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.646 179.999 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.74 58.2 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.106 -179.803 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.416 ' HB3' HE21 ' A' ' 85' ' ' GLN . 10.3 Cg_endo -50.84 152.6 9.6 Favored 'Trans proline' 0 C--N 1.298 -2.121 0 C-N-CA 122.832 2.355 . . . . 0.0 112.485 -178.264 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.431 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -108.99 145.74 15.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.348 -179.63 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.86 -45.17 97.78 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.3 -179.671 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.496 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -129.85 134.53 47.59 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.598 -179.713 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.5 ' O ' ' N ' ' A' ' 98' ' ' LEU . 75.3 m -134.83 158.79 43.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.788 -179.605 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -87.07 139.45 16.19 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.752 -0.939 . . . . 0.0 110.752 179.753 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.493 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.98 -162.49 0.08 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.931 0.396 . . . . 0.0 110.481 -179.921 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.522 HG22 ' CD2' ' A' ' 297' ' ' PHE . 14.6 t -133.67 135.35 44.03 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.353 179.942 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.496 ' C ' ' O ' ' A' ' 70' ' ' THR . 0.1 OUTLIER 29.58 68.54 0.65 Allowed Pre-proline 0 N--CA 1.463 0.222 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.705 -179.824 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -60.98 145.11 99.55 Favored 'Trans proline' 0 C--N 1.301 -1.963 0 C-N-CA 122.626 2.218 . . . . 0.0 112.155 -178.525 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.528 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 45.2 p-10 -159.54 -32.3 0.06 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.645 179.723 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.537 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 99.1 m-20 -64.12 -39.45 94.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.464 -179.992 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -60.49 -48.49 81.54 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.646 -179.284 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.424 ' O ' ' O ' ' A' ' 77' ' ' ALA . 92.8 t -59.68 -24.92 30.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.091 179.697 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.537 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -45.54 172.32 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.567 179.869 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.574 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.6 p30 -61.74 177.77 0.39 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.546 -179.732 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.56 ' C ' ' H ' ' A' ' 81' ' ' GLY . 35.6 p30 -45.92 85.8 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.847 179.98 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.574 ' N ' ' O ' ' A' ' 78' ' ' ASP . 42.8 tp60 -67.31 13.62 0.06 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.192 -179.983 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.56 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 117.93 -22.14 9.99 Favored Glycine 0 CA--C 1.52 0.364 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 179.969 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -107.62 116.39 31.87 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.932 0.396 . . . . 0.0 110.513 179.911 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 74.4 mt -98.84 0.86 45.13 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.473 -179.713 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -92.18 6.62 45.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.42 -179.811 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.795 ' O ' HG22 ' A' ' 89' ' ' VAL . 88.1 mt-30 -100.0 -27.41 13.59 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.85 179.971 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.6 t-105 -63.89 -40.74 97.23 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.981 -179.628 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.556 ' O ' ' N ' ' A' ' 91' ' ' LYS . 68.1 m -77.75 -53.84 7.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.225 -179.496 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -48.02 -50.77 26.64 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.908 -179.249 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.795 HG22 ' O ' ' A' ' 85' ' ' GLN . 15.4 m -69.07 -40.97 81.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 120.909 0.385 . . . . 0.0 110.922 179.955 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.503 ' N ' HG23 ' A' ' 89' ' ' VAL . . . -71.93 -22.89 61.41 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.71 -179.873 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.556 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.0 tttm -61.54 -45.91 92.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.482 -179.535 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.439 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.4 mm-40 -90.25 -94.57 0.12 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.151 -179.997 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.624 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.8 mtt180 -143.54 59.96 1.39 Allowed 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.734 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.466 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.7 pttp 33.32 27.1 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.338 -179.029 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.624 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.5 tt -48.55 123.12 6.24 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.915 -178.328 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.45 ' O ' HD23 ' A' ' 95' ' ' LEU . 99.0 mm-40 -83.6 -170.38 3.03 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.227 179.863 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.613 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 81.6 mtp180 -73.31 137.84 45.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.297 -179.847 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.5 ' N ' ' O ' ' A' ' 67' ' ' SER . 88.6 mt -86.09 -166.66 1.6 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.725 -179.584 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.528 ' CD2' ' O ' ' A' ' 99' ' ' TYR . 47.4 p90 -166.77 119.9 1.01 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.302 179.984 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.512 ' C ' ' O ' ' A' ' 99' ' ' TYR . 43.7 mm -29.75 121.15 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.865 -179.6 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 113.43 28.93 3.1 Favored Glycine 0 CA--C 1.522 0.492 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 -179.66 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.59 ' H ' ' CD ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -144.25 46.12 0.61 Allowed Pre-proline 0 C--N 1.325 -0.493 0 CA-C-O 120.922 0.391 . . . . 0.0 110.456 179.934 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.582 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 30.2 Cg_endo -62.01 143.72 95.45 Favored 'Trans proline' 0 C--N 1.299 -2.079 0 C-N-CA 122.733 2.289 . . . . 0.0 112.018 -179.985 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.471 ' O ' HG23 ' A' ' 108' ' ' VAL . 26.1 t -173.36 120.7 0.34 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.454 179.712 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.76 -41.0 63.06 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.056 179.767 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -65.86 -40.26 91.5 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.831 -179.383 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.97 -40.01 95.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.688 -179.777 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 104' ' ' SER . 70.7 t -67.39 -43.85 87.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.735 179.676 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.53 -39.22 92.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.577 -179.329 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.439 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.29 -23.49 62.46 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.521 179.81 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.557 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.4 mm-40 -91.25 5.08 50.55 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.698 -179.552 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.557 ' C ' ' O ' ' A' ' 111' ' ' GLN . 10.2 tpt 22.81 64.59 0.35 Allowed Pre-proline 0 N--CA 1.465 0.288 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.879 -179.85 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.447 ' HG2' HD11 ' A' ' 116' ' ' ILE . 68.4 Cg_endo -78.98 169.27 19.59 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 C-N-CA 122.975 2.45 . . . . 0.0 112.223 -178.684 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.464 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 98.8 m-20 -113.44 -44.08 3.26 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.148 179.43 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.7 tp -120.24 120.92 37.52 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.001 179.432 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.458 HD13 HD22 ' A' ' 133' ' ' LEU . 96.7 mt -118.49 131.07 72.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.795 -179.705 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.601 HD12 ' OG ' ' A' ' 48' ' ' SER . 32.4 mt -106.1 132.76 51.79 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.127 0.489 . . . . 0.0 110.298 -179.502 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.421 HD12 HG23 ' A' ' 139' ' ' THR . 98.0 mt -118.17 136.57 54.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.687 -179.753 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 87.0 p -72.07 153.47 41.7 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.566 -179.938 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.34 -50.27 74.27 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.689 -179.888 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.0 t -149.31 153.74 37.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.51 179.785 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 169.58 -169.99 42.4 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 179.89 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -63.08 -35.14 91.69 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 179.922 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.453 ' O ' ' OD1' ' A' ' 124' ' ' ASP . 44.6 p-10 -88.05 119.86 28.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.843 0.354 . . . . 0.0 110.679 179.897 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.443 ' O ' HD12 ' A' ' 129' ' ' LEU . 37.0 t -63.4 144.53 56.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.445 -179.914 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.523 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.23 -43.43 8.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.936 -179.997 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.7 tp -62.86 -42.3 99.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.655 -179.864 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.48 -11.08 57.03 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.52 -179.519 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.443 HD12 ' O ' ' A' ' 125' ' ' SER . 84.4 mt -116.08 -24.07 8.21 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.642 -179.775 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . 0.523 ' N ' ' O ' ' A' ' 126' ' ' ALA . 79.3 t80 -51.12 -50.18 59.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.587 -179.154 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.5 p-10 -65.82 -42.16 90.95 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.906 0.384 . . . . 0.0 111.133 179.716 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.524 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 87.7 mt-30 -67.55 -36.85 81.76 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.698 -179.882 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.458 HD22 HD13 ' A' ' 116' ' ' ILE . 93.7 mt -80.61 -42.0 22.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.952 -179.543 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.3 t -57.03 -44.87 83.32 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.283 -179.279 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.5 m -62.32 -45.78 91.66 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.812 0.339 . . . . 0.0 110.615 179.42 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 92.8 mt -62.34 -43.81 98.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.35 -179.765 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.581 ' HB1' ' HD2' ' A' ' 138' ' ' PRO . . . -170.07 162.85 6.52 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.573 179.811 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.581 ' HD2' ' HB1' ' A' ' 137' ' ' ALA . 77.5 Cg_exo -42.71 110.88 0.18 Allowed 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.562 2.175 . . . . 0.0 112.1 179.554 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.459 HG21 ' CD1' ' A' ' 130' ' ' TYR . 16.7 m -85.77 127.79 34.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.632 179.968 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.568 HD13 ' CD2' ' A' ' 37' ' ' HIS . 35.6 tp -119.77 139.06 52.9 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.127 179.974 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.425 ' O ' ' OD1' ' A' ' 32' ' ' ASP . 78.6 mt -105.65 120.78 57.0 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 CA-C-O 121.088 0.47 . . . . 0.0 111.071 -179.275 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.476 HD12 HD22 ' A' ' 117' ' ' LEU . 96.4 mt -136.33 133.05 49.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.597 179.522 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.509 HD21 ' CG ' ' A' ' 241' ' ' ASP . 61.4 t30 -64.26 151.19 44.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.939 0.399 . . . . 0.0 110.4 179.468 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.517 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 89.3 t80 -86.38 122.94 31.05 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.805 -179.484 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.517 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 99.1 m-20 55.12 69.5 0.73 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.841 179.648 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 42.8 p-10 -127.54 1.06 6.22 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.917 0.389 . . . . 0.0 110.617 -179.956 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -150.45 114.76 5.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.718 -179.643 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 83.4 p -63.44 168.44 4.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.517 -179.803 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.414 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.6 p-90 -52.13 -15.66 0.63 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.599 -179.858 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . 0.436 ' O ' HG23 ' A' ' 154' ' ' THR . 68.1 tp60 -70.62 -76.17 0.11 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.507 -179.801 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.45 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.0 t -62.79 -38.55 91.07 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.309 179.584 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 53.2 tp -59.82 -45.79 91.26 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.459 -178.636 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.414 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 46.7 tp -62.77 -41.72 99.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.431 179.051 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.45 ' OG1' ' O ' ' A' ' 151' ' ' SER . 60.4 p -63.96 -34.87 78.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.311 -179.633 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.461 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.6 mm-40 -63.89 -42.34 97.48 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.277 179.266 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 92.4 mt -65.45 -38.81 90.94 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.949 0.404 . . . . 0.0 110.215 179.027 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.579 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.32 -31.89 78.85 Favored Glycine 0 CA--C 1.521 0.442 0 N-CA-C 110.829 -0.908 . . . . 0.0 110.829 -179.428 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.461 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.3 mt-10 -36.62 -25.53 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.87 0.367 . . . . 0.0 110.814 179.976 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.579 ' N ' ' O ' ' A' ' 157' ' ' GLY . 93.9 mt -59.02 150.63 5.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.288 179.464 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 73.5 p -69.26 137.2 52.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.922 -179.435 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 69.88 22.98 77.17 Favored Glycine 0 CA--C 1.517 0.197 0 N-CA-C 111.226 -0.75 . . . . 0.0 111.226 179.408 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 61.4 m80 -124.0 -13.92 7.22 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.717 0.294 . . . . 0.0 110.576 179.91 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -67.13 -59.53 3.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.764 -179.71 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -51.49 -49.59 61.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.261 -179.718 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -60.08 -41.31 92.15 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.732 0.301 . . . . 0.0 110.374 179.484 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.44 -47.61 84.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.596 179.85 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.57 -40.25 74.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.297 -179.901 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -61.46 -50.32 73.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.621 179.613 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.403 ' NE ' ' HB1' ' A' ' 59' ' ' ALA . 59.9 ttt85 -65.65 -43.61 88.87 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.477 179.6 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 94.6 mt -64.46 -43.51 96.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.46 179.747 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.38 -51.31 69.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.616 -179.269 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.8 -44.18 94.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.49 179.686 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . 0.659 ' CE2' HD11 ' A' ' 177' ' ' LEU . 55.1 t80 -62.76 -44.38 96.34 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.494 179.458 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -63.3 -40.0 96.13 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.621 -179.434 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -62.89 -42.74 99.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.677 179.231 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -60.78 -44.89 96.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.148 179.936 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.659 HD11 ' CE2' ' A' ' 173' ' ' PHE . 85.6 mt -64.6 -41.08 96.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.053 0.454 . . . . 0.0 110.771 178.887 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.04 -61.95 1.94 Allowed 'General case' 0 C--O 1.236 0.38 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.558 -179.415 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.83 -46.75 86.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.484 179.825 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.24 -41.41 65.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.268 -179.968 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -64.18 -33.78 76.57 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.958 0.409 . . . . 0.0 110.391 179.282 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . 0.426 ' HG2' ' O ' ' A' ' 182' ' ' GLU . 69.4 tt0 -90.74 9.04 31.58 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.255 0.55 . . . . 0.0 110.575 -179.018 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -104.94 -32.19 8.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.045 179.746 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.4 pt -128.22 147.86 32.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.799 -179.773 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -140.05 131.1 26.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.398 179.385 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . 0.6 HD22 ' N ' ' A' ' 186' ' ' LEU . 3.6 mm? -85.54 133.9 41.16 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.789 179.99 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -44.15 157.99 0.14 Allowed 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.773 2.315 . . . . 0.0 112.055 179.363 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . 0.535 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.9 Cg_endo -63.02 114.84 2.61 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 C-N-CA 122.774 2.316 . . . . 0.0 111.786 179.783 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . 0.535 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.7 mt-30 155.36 148.15 0.0 OUTLIER Pre-proline 0 N--CA 1.455 -0.186 0 O-C-N 123.461 0.476 . . . . 0.0 110.67 -179.809 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -73.61 144.22 35.34 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.738 2.292 . . . . 0.0 111.861 178.001 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.498 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.1 p -124.99 158.95 32.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.232 0.539 . . . . 0.0 110.165 -179.979 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . 0.498 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 38.5 p -143.51 165.13 28.43 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.01 -179.427 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . 0.444 ' HA ' ' H ' ' A' ' 260' ' ' PHE . . . -135.45 128.53 31.65 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.109 0.48 . . . . 0.0 110.231 179.543 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.505 HD11 HD23 ' A' ' 259' ' ' LEU . 47.7 pt -146.27 148.39 17.15 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.04 -179.945 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . 0.746 HG13 ' CD1' ' A' ' 262' ' ' PHE . 72.2 t -117.28 123.09 71.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.21 0.529 . . . . 0.0 109.909 178.962 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -134.13 107.4 7.7 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.296 179.674 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 94.5 m -130.95 130.42 43.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.853 179.797 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -82.76 -36.95 25.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.324 179.668 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.55 -67.39 0.24 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.422 179.942 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -71.93 -9.97 59.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.314 179.515 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 59.7 t-80 60.85 58.34 2.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.738 -179.877 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 39.7 p -167.18 153.39 8.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.594 179.596 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.24 144.08 24.47 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.987 0.422 . . . . 0.0 110.496 179.433 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -135.41 138.43 43.25 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.583 -179.914 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 20.1 mt -106.16 125.33 50.86 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 121.074 0.464 . . . . 0.0 109.926 -179.758 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 206' ' ' TRP . . . . . 0.569 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 74.7 m95 -81.82 166.82 19.65 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.623 -179.81 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . 0.463 HG22 ' C ' ' A' ' 206' ' ' TRP . 0.1 OUTLIER -156.47 172.35 6.2 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.615 -179.244 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -54.42 -37.29 89.39 Favored 'Trans proline' 0 C--N 1.303 -1.825 0 C-N-CA 122.716 2.277 . . . . 0.0 112.015 179.297 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -70.45 -34.68 72.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.765 -179.75 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 21.6 m -61.5 150.57 35.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.586 -179.357 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.41 -36.47 80.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.471 -179.75 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 212' ' ' GLN . . . . . 0.569 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 54.2 tt0 -64.46 -40.81 96.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.543 179.908 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.61 -43.47 92.04 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 179.837 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -63.23 -44.14 96.09 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.761 0.315 . . . . 0.0 110.295 179.658 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 215' ' ' MET . . . . . 0.579 ' SD ' ' HB2' ' A' ' 304' ' ' ALA . 65.1 ttp -59.61 -48.0 83.39 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.314 -179.879 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 86.3 mt -60.55 -40.82 93.01 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.353 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 217' ' ' GLU . . . . . 0.456 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 40.7 tp10 -57.86 -38.2 75.29 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 179.513 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -65.26 -38.17 89.48 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.8 0.333 . . . . 0.0 110.624 179.678 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 94.6 mt -64.35 -42.82 96.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.491 -179.689 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.63 45.96 0.08 OUTLIER Glycine 0 CA--C 1.521 0.435 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 179.993 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 221' ' ' PHE . . . . . 0.456 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 26.8 m-85 -129.07 156.13 44.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.993 0.425 . . . . 0.0 110.487 -179.829 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.487 ' O ' HG13 ' A' ' 191' ' ' VAL . 7.7 p -108.1 122.7 47.43 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.112 0.482 . . . . 0.0 110.239 -179.997 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.478 HD22 ' C ' ' A' ' 222' ' ' THR . 4.3 mm? -101.43 133.17 46.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.089 -179.889 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.99 159.81 14.7 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.52 179.776 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -105.03 115.08 29.68 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.934 0.397 . . . . 0.0 110.398 179.853 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.494 ' N ' HD12 ' A' ' 226' ' ' LEU . 9.1 mp -53.37 156.86 3.79 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.574 179.954 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -60.27 145.22 99.03 Favored 'Trans proline' 0 C--N 1.302 -1.887 0 C-N-CA 122.615 2.21 . . . . 0.0 112.076 179.303 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.56 -2.78 58.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.543 -179.969 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.41 -40.67 5.67 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -179.842 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . 0.552 ' O ' ' N ' ' A' ' 233' ' ' SER . 85.3 mt -79.29 -16.77 55.86 Favored 'General case' 0 C--O 1.224 -0.242 0 CA-C-O 120.929 0.395 . . . . 0.0 110.41 -179.821 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . 0.407 ' C ' ' O ' ' A' ' 230' ' ' LEU . 54.8 t-20 -39.82 -49.21 2.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.708 -179.706 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -88.55 15.71 7.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.103 -179.926 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . 0.552 ' N ' ' O ' ' A' ' 230' ' ' LEU . 78.2 p -60.64 -35.96 77.47 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.64 -179.891 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . 0.527 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.7 tt0 -118.01 -69.55 0.84 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.911 179.677 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.0 m -70.56 103.36 2.48 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.658 -179.791 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -94.54 58.09 2.32 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.387 179.885 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -145.11 -122.71 1.56 Allowed Glycine 0 CA--C 1.522 0.47 0 N-CA-C 110.931 -0.868 . . . . 0.0 110.931 -179.927 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -133.71 111.7 10.79 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.052 0.454 . . . . 0.0 110.487 179.964 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . 0.496 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.0 mtt180 -148.18 56.88 1.07 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.741 -179.926 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 94.2 m-70 -69.66 -31.46 69.54 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.569 179.578 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 241' ' ' ASP . . . . . 0.509 ' CG ' HD21 ' A' ' 143' ' ' ASN . 65.2 t0 -56.87 -46.84 81.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.33 -179.147 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 242' ' ' ILE . . . . . 0.439 ' O ' ' O ' ' A' ' 239' ' ' ARG . 17.2 tt -140.71 157.86 23.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.913 0.387 . . . . 0.0 110.529 179.726 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.445 HG22 HD13 ' A' ' 245' ' ' LEU . 96.0 mt -106.28 106.13 20.02 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.198 0 CA-C-O 121.147 0.498 . . . . 0.0 110.489 179.886 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . 0.608 ' O ' HD12 ' A' ' 245' ' ' LEU . 88.3 mt-30 -110.68 110.62 21.36 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.375 179.765 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.608 HD12 ' O ' ' A' ' 244' ' ' GLN . 9.5 mp -122.19 -168.05 1.65 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.619 179.826 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . 0.527 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 172.98 -16.63 0.05 OUTLIER Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 179.901 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . 0.666 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -60.42 157.46 28.85 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 -179.819 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -64.21 21.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.955 0.407 . . . . 0.0 110.584 179.964 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . 0.666 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.8 m-20 -97.01 -5.84 36.74 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.548 179.932 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 92.5 mt -80.15 -21.18 43.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.643 179.464 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.52 -51.39 70.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.764 -179.555 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.83 -5.34 58.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.423 179.67 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.06 -74.43 1.14 Allowed Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 -179.863 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 80.1 mt -69.84 125.51 26.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.044 0.449 . . . . 0.0 110.253 -179.882 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -59.41 -39.53 83.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.29 -179.679 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 83.35 51.77 4.01 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 110.806 -0.917 . . . . 0.0 110.806 179.897 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -95.17 -16.08 22.83 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.79 0.329 . . . . 0.0 110.623 -179.883 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 258' ' ' SER . . . . . 0.492 ' OG ' HG23 ' A' ' 191' ' ' VAL . 3.4 t 174.92 89.29 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.014 0.435 . . . . 0.0 110.222 179.995 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.865 ' N ' HD12 ' A' ' 259' ' ' LEU . 0.9 OUTLIER -94.17 124.2 38.04 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.22 0.533 . . . . 0.0 111.052 -179.024 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 260' ' ' PHE . . . . . 0.444 ' H ' ' HA ' ' A' ' 193' ' ' ALA . 16.1 m-30 -93.55 146.98 23.4 Favored 'General case' 0 CA--C 1.51 -0.577 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.406 179.053 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 85.3 mt -122.46 150.02 43.08 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.537 -179.895 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.746 ' CD1' HG13 ' A' ' 195' ' ' VAL . 2.7 p90 -77.85 -138.86 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.533 -179.795 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 263' ' ' ALA . . . . . 0.662 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -51.44 78.17 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.942 -179.885 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . 0.631 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.88 104.57 0.19 Allowed Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 179.942 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 265' ' ' ASP . . . . . 0.601 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.8 m-20 -80.29 -177.23 6.03 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 120.692 0.282 . . . . 0.0 110.858 -179.432 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -40.7 -17.69 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.49 179.825 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 267' ' ' LYS . . . . . 0.601 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.5 -51.57 41.84 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.78 179.521 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -63.89 -46.62 84.09 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.282 179.312 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . 0.583 ' HB1' ' OH ' ' A' ' 273' ' ' TYR . . . -61.56 -35.1 76.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.976 179.424 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -62.89 -34.5 77.54 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.177 179.561 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.46 -43.36 13.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.223 -179.536 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 272' ' ' ILE . . . . . 0.588 ' C ' ' H ' ' A' ' 274' ' ' ALA . 5.0 tt -51.56 -33.65 15.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.704 -178.643 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 273' ' ' TYR . . . . . 0.583 ' OH ' ' HB1' ' A' ' 269' ' ' ALA . 16.9 m-85 -54.25 -1.82 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.71 -179.755 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 274' ' ' ALA . . . . . 0.588 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.75 -39.59 69.92 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.906 179.571 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . 0.586 ' O ' ' N ' ' A' ' 279' ' ' ALA . 3.7 p30 -39.17 97.94 0.15 Allowed Pre-proline 0 C--N 1.333 -0.15 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.576 -179.679 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo -53.97 -43.18 60.46 Favored 'Trans proline' 0 C--N 1.304 -1.814 0 C-N-CA 122.463 2.109 . . . . 0.0 112.614 -178.803 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 89.2 mt -64.5 -42.82 95.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.072 -179.563 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 91.0 mt -95.98 -1.11 49.69 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.814 -179.399 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 279' ' ' ALA . . . . . 0.586 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.49 -34.93 77.82 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.568 -179.721 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.33 20.28 0.12 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.965 -179.204 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . 0.495 HD23 ' HA ' ' A' ' 281' ' ' LEU . 13.7 mt -75.16 120.03 79.72 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.43 179.859 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -50.9 -39.61 58.66 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.617 2.211 . . . . 0.0 111.781 179.172 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.75 -50.63 63.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.171 179.731 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 74.7 t -61.48 -43.99 97.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 179.487 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -57.68 -41.28 81.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.283 -179.983 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -90.68 0.21 57.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.221 179.593 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt 59.73 42.93 16.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.872 179.658 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -94.7 41.34 1.09 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.356 179.793 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 54.0 t -119.02 135.92 57.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.964 0.412 . . . . 0.0 110.237 -179.832 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -133.68 163.61 29.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.69 -179.57 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.86 155.52 32.48 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.944 0.402 . . . . 0.0 110.721 -179.735 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 80.7 mt -94.32 -1.66 53.5 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.311 -179.765 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.46 165.3 12.57 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 -179.653 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 6.8 m -86.8 -61.66 1.68 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.871 0.367 . . . . 0.0 111.066 -179.814 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 295' ' ' GLU . . . . . 0.455 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.5 mm-40 -69.55 -4.75 20.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.657 -179.704 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 25.6 p -76.14 32.82 0.12 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.617 -179.88 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 297' ' ' PHE . . . . . 0.522 ' CD2' HG22 ' A' ' 70' ' ' THR . 82.5 t80 -60.62 -46.12 91.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.662 -179.967 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . 0.613 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.2 mtt85 -80.76 137.11 36.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.679 -179.535 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.499 ' H ' HG11 ' A' ' 51' ' ' VAL . 4.2 tp -114.16 116.17 28.66 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.407 179.775 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . 0.627 ' H ' ' CB ' ' A' ' 303' ' ' SER . 48.3 p-10 -166.05 -176.17 3.65 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.497 -179.921 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 77.9 t80 -46.79 -43.44 18.33 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.226 -179.946 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -66.85 -40.81 88.04 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.991 0.424 . . . . 0.0 110.741 179.289 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . 0.627 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 60.7 p -55.74 -36.22 67.03 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.068 -179.178 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . 0.579 ' HB2' ' SD ' ' A' ' 215' ' ' MET . . . -57.74 -51.61 68.83 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.085 179.385 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 91.1 mtp -55.96 -44.23 78.28 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.688 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -65.91 -43.27 88.66 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.869 0.366 . . . . 0.0 110.195 178.741 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 303' ' ' SER . 56.0 t -63.89 -43.03 97.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.249 179.463 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 43.8 tp -59.74 -42.12 92.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.938 -179.747 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -62.41 -39.24 92.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.07 179.767 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 310' ' ' ARG . . . . . 0.455 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.7 ttt85 -63.67 -43.84 95.52 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.32 179.487 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 89.5 mt -63.31 -42.04 98.99 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.325 179.563 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -62.97 -33.68 75.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.138 179.341 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.68 -23.47 21.85 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.388 -179.777 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . 0.483 HD22 ' CE2' ' A' ' 315' ' ' PHE . 6.8 tt -62.28 -43.11 99.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.574 -179.971 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 315' ' ' PHE . . . . . 0.483 ' CE2' HD22 ' A' ' 314' ' ' LEU . 90.3 m-85 . . . . . 0 C--O 1.22 -0.478 0 CA-C-O 118.028 -0.987 . . . . 0.0 110.483 179.939 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -99.35 135.88 40.11 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.563 179.993 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.499 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -92.28 178.52 1.66 Allowed Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.572 -179.884 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.499 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 27.0 Cg_exo -61.63 147.34 95.59 Favored 'Trans proline' 0 C--N 1.301 -1.97 0 C-N-CA 122.777 2.318 . . . . 0.0 112.09 179.709 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.456 HH12 HG23 ' A' ' 159' ' ' ILE . 35.2 ptt180 -135.65 142.38 45.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.691 179.742 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -79.88 116.29 19.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.524 179.923 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.45 ' O ' HG23 ' A' ' 30' ' ' ILE . 9.4 tp -110.77 130.45 64.13 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.427 179.979 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.2 t -70.85 141.97 51.24 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.571 179.811 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.476 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.3 t0 -139.7 179.48 6.55 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.516 -179.913 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.476 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 78.5 p -73.67 -37.0 65.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.842 179.706 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.8 ttt85 -46.56 -94.66 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.354 -179.534 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.417 ' O ' ' OG1' ' A' ' 36' ' ' THR . . . -167.29 -26.55 0.02 OUTLIER Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 179.89 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.417 ' OG1' ' O ' ' A' ' 35' ' ' GLY . 64.8 m -168.76 104.37 0.42 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.908 0.385 . . . . 0.0 110.65 -179.826 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.675 ' CD2' HD13 ' A' ' 140' ' ' LEU . 73.9 t60 -128.41 147.93 50.68 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.031 0.443 . . . . 0.0 110.293 179.95 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.623 HG22 ' N ' ' A' ' 39' ' ' LEU . 98.5 m -130.48 165.93 21.61 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.66 -179.894 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.623 ' N ' HG22 ' A' ' 38' ' ' THR . 83.1 mt -120.51 127.75 52.48 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.513 179.729 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -65.33 -44.63 87.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.626 -179.901 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 42.2 p -165.77 154.77 11.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.466 179.652 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.532 ' H ' ' CD ' ' A' ' 42' ' ' GLN . 14.7 mp0 -44.32 101.31 0.25 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.644 179.495 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -57.36 129.22 32.89 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 122.378 2.052 . . . . 0.0 112.178 -179.716 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -83.61 -24.68 31.36 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.495 179.654 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.54 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.1 mtm-85 -122.02 134.98 54.8 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-O 121.133 0.492 . . . . 0.0 110.345 -179.922 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 95.9 mt -131.19 133.82 62.02 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.272 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.96 -179.711 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 45.7 t -124.38 130.38 73.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.325 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.626 ' OG ' HD12 ' A' ' 117' ' ' LEU . 2.3 m -154.94 166.64 32.93 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.548 179.865 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 67.7 p -124.59 9.31 8.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.515 179.904 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.45 125.53 33.09 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.665 -179.512 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.443 HG11 ' H ' ' A' ' 299' ' ' LEU . 98.4 t -65.86 -44.46 92.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.479 -179.982 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.5 m -62.68 -44.35 96.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.642 -179.839 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 51.1 tp -62.16 -41.6 98.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.555 -179.455 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.443 ' O ' HD13 ' A' ' 58' ' ' LEU . 76.3 m -57.6 -44.34 85.37 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.308 -179.322 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.22 -62.18 5.38 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 179.547 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.7 t -48.44 -35.65 13.32 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 -179.99 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.8 mt -61.77 -44.91 95.96 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.636 -0.426 . . . . 0.0 111.174 179.448 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.443 HD13 ' O ' ' A' ' 54' ' ' THR . 9.3 mp -64.68 -41.82 95.79 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.091 0.472 . . . . 0.0 111.382 177.86 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.404 ' HB1' ' NE ' ' A' ' 169' ' ' ARG . . . -63.6 -40.95 98.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.652 -0.703 . . . . 0.0 111.014 -179.206 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.439 ' O ' HG23 ' A' ' 60' ' ' ILE . 8.1 tp -88.6 17.18 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.724 -179.602 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 56.32 84.95 0.08 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.694 -179.977 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.24 58.99 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.081 -179.8 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -50.75 151.6 10.72 Favored 'Trans proline' 0 C--N 1.297 -2.155 0 C-N-CA 122.799 2.333 . . . . 0.0 112.579 -178.359 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.434 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -108.46 145.64 15.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.391 -179.764 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.8 mt -63.89 -44.91 98.16 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.298 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.416 -179.721 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.499 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -130.18 134.41 47.27 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.574 -179.806 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.479 ' O ' ' N ' ' A' ' 98' ' ' LEU . 72.9 m -134.67 158.82 43.09 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.83 -179.589 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.32 138.5 15.94 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 110.726 -0.949 . . . . 0.0 110.726 179.816 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.478 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.46 -163.0 0.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.96 0.41 . . . . 0.0 110.508 -179.988 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.523 HG22 ' CD2' ' A' ' 297' ' ' PHE . 5.9 t -133.75 135.39 43.91 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.242 -179.977 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.494 ' C ' ' O ' ' A' ' 70' ' ' THR . 0.9 OUTLIER 29.61 68.35 0.67 Allowed Pre-proline 0 N--CA 1.464 0.236 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.745 -179.663 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -60.98 144.59 99.61 Favored 'Trans proline' 0 C--N 1.301 -1.958 0 C-N-CA 122.548 2.165 . . . . 0.0 112.252 -178.573 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.528 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 45.4 p-10 -159.68 -31.7 0.06 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.634 179.624 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.539 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 99.1 m-20 -64.15 -39.44 94.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.415 179.998 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -60.43 -48.2 82.8 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.644 -179.242 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.425 ' O ' ' O ' ' A' ' 77' ' ' ALA . 97.0 t -60.15 -24.7 31.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.154 179.596 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.539 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -45.72 173.15 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.588 179.853 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.574 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.3 p30 -62.06 177.56 0.45 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.583 -179.689 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.556 ' C ' ' H ' ' A' ' 81' ' ' GLY . 36.2 p30 -45.46 85.86 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.942 179.99 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.574 ' N ' ' O ' ' A' ' 78' ' ' ASP . 43.0 tp60 -67.65 13.23 0.08 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.08 -179.838 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.556 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 118.52 -21.89 9.66 Favored Glycine 0 CA--C 1.519 0.321 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.985 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -108.4 116.46 32.02 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.941 0.4 . . . . 0.0 110.522 179.894 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 75.6 mt -98.79 0.49 44.5 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.451 -179.726 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -92.65 7.18 44.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.988 0.423 . . . . 0.0 110.46 -179.778 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.798 ' O ' HG22 ' A' ' 89' ' ' VAL . 88.5 mt-30 -100.03 -27.91 13.33 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.855 -179.971 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 69.3 t-105 -63.19 -40.71 98.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.877 -179.544 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.56 ' O ' ' N ' ' A' ' 91' ' ' LYS . 65.7 m -77.65 -53.68 7.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.203 -179.394 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -48.19 -50.86 27.59 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.939 -179.363 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.798 HG22 ' O ' ' A' ' 85' ' ' GLN . 15.7 m -68.89 -40.75 81.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 120.936 0.398 . . . . 0.0 111.034 179.836 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.499 ' N ' HG23 ' A' ' 89' ' ' VAL . . . -72.46 -22.65 61.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.83 -179.869 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.56 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.1 tttm -61.91 -45.41 93.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.477 -179.578 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.441 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.7 mm-40 -90.69 -94.88 0.12 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.118 -179.869 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.644 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.8 mtt180 -142.9 59.31 1.42 Allowed 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.716 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.466 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.8 pttp 33.33 25.97 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.162 -179.098 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.644 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.3 tt -47.78 123.54 6.13 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.918 -178.287 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.451 ' O ' HD23 ' A' ' 95' ' ' LEU . 99.1 mm-40 -83.8 -169.89 2.8 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.075 -179.913 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.612 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 82.4 mtp180 -74.1 137.17 43.12 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.197 -179.805 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.479 ' N ' ' O ' ' A' ' 67' ' ' SER . 90.4 mt -86.46 -165.74 1.35 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.704 -179.618 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.536 ' CD2' ' O ' ' A' ' 99' ' ' TYR . 48.6 p90 -168.87 120.14 0.75 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.297 179.972 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.518 ' C ' ' O ' ' A' ' 99' ' ' TYR . 43.3 mm -29.18 121.27 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.995 -179.563 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 114.38 27.06 3.49 Favored Glycine 0 CA--C 1.52 0.344 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 -179.575 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.587 ' H ' ' CD ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -144.27 46.2 0.61 Allowed Pre-proline 0 C--N 1.324 -0.508 0 CA-C-O 120.913 0.387 . . . . 0.0 110.511 179.946 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 29.8 Cg_endo -61.8 143.63 96.2 Favored 'Trans proline' 0 C--N 1.297 -2.146 0 C-N-CA 122.695 2.263 . . . . 0.0 111.989 -179.937 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.458 ' O ' HG23 ' A' ' 108' ' ' VAL . 26.2 t -173.19 119.97 0.34 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.489 179.698 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.19 -40.56 64.68 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.068 0.461 . . . . 0.0 111.1 179.76 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.19 -40.02 90.12 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.819 -179.368 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.02 -39.95 95.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.713 -179.768 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 104' ' ' SER . 72.0 t -67.74 -43.97 86.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.839 179.709 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.77 -38.98 92.73 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.552 -179.31 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.441 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.47 -23.3 62.61 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.434 179.867 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.554 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.5 mm-40 -90.51 5.12 49.06 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.651 -179.518 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.554 ' C ' ' O ' ' A' ' 111' ' ' GLN . 10.4 tpt 24.03 63.73 0.4 Allowed Pre-proline 0 N--CA 1.464 0.266 0 CA-C-O 120.861 0.362 . . . . 0.0 110.866 -179.967 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -77.92 167.36 23.8 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 C-N-CA 122.998 2.465 . . . . 0.0 112.392 -178.739 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.525 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 99.4 m-20 -110.49 -42.38 4.11 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.982 0.42 . . . . 0.0 110.042 179.55 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 39.8 tp -120.98 120.14 34.59 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.036 179.54 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 84.7 mt -113.21 129.19 69.38 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 CA-C-O 120.978 0.418 . . . . 0.0 110.848 -179.832 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.626 HD12 ' OG ' ' A' ' 48' ' ' SER . 29.2 mt -108.95 132.26 54.25 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.235 -179.71 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.497 HD12 HG23 ' A' ' 139' ' ' THR . 98.8 mt -119.59 138.77 49.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.712 -179.766 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 85.8 p -72.65 153.45 41.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.565 -179.998 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.21 -49.98 75.46 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.682 -179.769 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -149.55 154.07 38.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.6 179.811 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 170.36 -170.86 43.29 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 179.838 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.99 -34.17 89.24 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 179.949 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.453 ' O ' ' OD1' ' A' ' 124' ' ' ASP . 44.2 p-10 -87.33 120.27 28.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.833 0.349 . . . . 0.0 110.626 -179.942 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.435 ' O ' HD12 ' A' ' 129' ' ' LEU . 40.0 t -63.22 143.74 57.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.538 -179.976 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.521 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.23 -43.18 8.95 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.819 -179.778 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.2 tp -62.7 -42.55 99.7 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.718 -179.912 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.26 -12.23 59.56 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.574 -179.459 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.435 HD12 ' O ' ' A' ' 125' ' ' SER . 84.1 mt -114.91 -23.51 9.08 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.721 -179.797 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . 0.521 ' N ' ' O ' ' A' ' 126' ' ' ALA . 78.0 t80 -51.12 -49.67 60.31 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 120.586 -0.446 . . . . 0.0 110.476 -178.929 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.1 p-10 -65.81 -42.52 90.55 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.905 0.383 . . . . 0.0 111.138 179.599 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.523 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 88.2 mt-30 -67.13 -37.84 84.53 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.832 179.97 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.431 HD12 HD11 ' A' ' 118' ' ' ILE . 95.9 mt -80.39 -41.32 24.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.881 -179.505 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.2 t -57.26 -44.53 83.98 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.243 -179.236 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 18.8 m -61.77 -45.36 94.22 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.8 0.333 . . . . 0.0 110.597 179.326 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 93.0 mt -62.11 -43.55 97.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.226 -179.784 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.658 ' HB1' ' HD2' ' A' ' 138' ' ' PRO . . . -169.63 168.31 4.77 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.559 179.867 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.658 ' HD2' ' HB1' ' A' ' 137' ' ' ALA . 51.4 Cg_exo -49.94 113.25 0.92 Allowed 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.286 1.991 . . . . 0.0 112.092 179.507 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.497 HG23 HD12 ' A' ' 118' ' ' ILE . 23.8 m -84.15 127.22 33.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.594 -179.954 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.675 HD13 ' CD2' ' A' ' 37' ' ' HIS . 34.4 tp -117.66 135.23 54.14 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.988 -179.77 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.439 ' O ' ' OD2' ' A' ' 32' ' ' ASP . 81.5 mt -99.54 118.95 46.91 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 CA-C-O 121.175 0.512 . . . . 0.0 111.276 -179.336 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.438 HD12 HD22 ' A' ' 117' ' ' LEU . 98.1 mt -135.02 132.05 53.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.64 179.627 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.542 HD21 ' CG ' ' A' ' 241' ' ' ASP . 60.2 t30 -66.63 150.26 49.3 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.842 0.353 . . . . 0.0 110.428 179.4 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.517 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 87.7 t80 -85.01 122.39 29.16 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.859 -179.499 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.517 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 98.7 m-20 55.25 69.21 0.76 Allowed 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.856 179.748 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 34.9 p-10 -125.82 0.56 7.38 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.926 0.393 . . . . 0.0 110.753 179.857 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -150.85 115.73 5.26 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.699 -179.522 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 83.9 p -64.39 169.15 4.95 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.528 -179.842 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.423 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.4 p-90 -52.21 -16.12 0.75 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.559 -179.863 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . 0.435 ' O ' HG23 ' A' ' 154' ' ' THR . 68.2 tp60 -70.07 -77.01 0.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.425 -179.712 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.453 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.1 t -62.57 -38.26 89.39 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.369 179.568 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 53.2 tp -60.06 -45.53 92.55 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.373 -178.566 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.423 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 46.8 tp -62.85 -41.74 99.48 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.821 0.343 . . . . 0.0 110.321 179.086 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.453 ' OG1' ' O ' ' A' ' 151' ' ' SER . 63.5 p -64.07 -34.75 78.74 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.285 -179.611 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.432 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.8 mm-40 -63.97 -42.77 97.14 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.316 179.235 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 92.7 mt -65.39 -39.02 91.72 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.016 0.436 . . . . 0.0 110.255 179.099 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.587 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -60.93 -32.08 78.58 Favored Glycine 0 CA--C 1.52 0.404 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 -179.468 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.439 ' C ' ' O ' ' A' ' 157' ' ' GLY . 97.2 mt-10 -35.71 -26.42 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.815 0.341 . . . . 0.0 110.744 179.93 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.587 ' N ' ' O ' ' A' ' 157' ' ' GLY . 95.7 mt -57.02 149.32 4.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.251 179.313 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 72.6 p -69.61 137.27 52.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.979 -179.535 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 71.77 20.45 78.68 Favored Glycine 0 N--CA 1.458 0.156 0 N-CA-C 111.243 -0.743 . . . . 0.0 111.243 179.457 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 56.8 m80 -122.3 -14.66 7.85 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.785 0.326 . . . . 0.0 110.64 179.816 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -65.22 -60.31 3.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.723 -179.684 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -51.85 -49.14 63.47 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.246 -179.771 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -60.66 -41.08 94.29 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.704 0.288 . . . . 0.0 110.284 179.542 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.55 -47.02 87.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.637 179.828 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -57.24 -40.03 76.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.251 -179.983 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -61.85 -50.31 72.77 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.562 179.621 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.404 ' NE ' ' HB1' ' A' ' 59' ' ' ALA . 59.9 ttt85 -65.36 -43.84 89.57 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.511 179.551 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 95.1 mt -64.65 -43.47 96.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.473 179.736 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.23 -50.92 71.35 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.627 -179.261 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.47 -43.72 96.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.363 179.747 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . 0.659 ' CE2' HD11 ' A' ' 177' ' ' LEU . 56.1 t80 -62.7 -44.64 95.71 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.123 0.487 . . . . 0.0 110.443 179.4 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -63.33 -40.08 96.31 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.522 -179.312 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -62.95 -42.73 99.9 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.704 179.259 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -60.77 -44.85 96.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.071 179.946 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.659 HD11 ' CE2' ' A' ' 173' ' ' PHE . 84.8 mt -64.3 -41.13 97.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.033 0.444 . . . . 0.0 110.661 178.917 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -51.88 -62.51 1.58 Allowed 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.478 -179.335 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.52 -46.86 85.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.58 179.819 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.26 -41.71 65.77 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.245 -179.993 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -63.8 -33.59 76.01 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.946 0.403 . . . . 0.0 110.364 179.27 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . 0.425 ' HG2' ' O ' ' A' ' 182' ' ' GLU . 69.6 tt0 -90.51 8.49 33.7 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.317 0.58 . . . . 0.0 110.586 -179.091 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -104.5 -32.33 9.04 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.257 179.597 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.3 pt -128.01 147.6 32.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.843 -179.878 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -139.76 130.99 26.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.347 179.506 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . 0.598 HD22 ' N ' ' A' ' 186' ' ' LEU . 3.6 mm? -85.49 133.37 42.32 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.793 179.992 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -44.05 157.9 0.14 Allowed 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.735 2.29 . . . . 0.0 112.042 179.527 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . 0.535 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.7 Cg_endo -62.96 114.87 2.62 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 122.748 2.299 . . . . 0.0 111.76 179.817 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . 0.535 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.8 mt-30 155.28 148.17 0.0 OUTLIER Pre-proline 0 C--N 1.331 -0.199 0 O-C-N 123.383 0.427 . . . . 0.0 110.665 -179.784 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -73.94 144.5 34.49 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 122.725 2.283 . . . . 0.0 111.734 178.126 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.498 HG23 ' OG ' ' A' ' 258' ' ' SER . 2.1 p -125.29 158.94 33.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.198 0.523 . . . . 0.0 110.12 -179.974 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . 0.497 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 35.4 p -143.61 165.58 27.22 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.129 -179.609 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . 0.444 ' HA ' ' H ' ' A' ' 260' ' ' PHE . . . -135.76 128.66 31.28 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.151 0.501 . . . . 0.0 110.273 179.69 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.498 HD11 HD23 ' A' ' 259' ' ' LEU . 47.3 pt -146.3 148.76 16.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.021 179.899 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . 0.743 HG13 ' CD1' ' A' ' 262' ' ' PHE . 70.3 t -117.49 122.88 70.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.245 0.545 . . . . 0.0 109.692 179.112 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -134.21 107.32 7.62 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.292 179.699 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 95.2 m -131.08 130.56 43.35 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.818 179.833 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -83.09 -36.87 24.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.228 179.71 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.6 -66.95 0.27 Allowed 'General case' 0 C--O 1.231 0.129 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.402 179.997 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.42 -9.76 58.93 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.246 179.494 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 60.0 t-80 60.7 58.46 2.41 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.799 -179.844 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 40.6 p -167.16 153.25 7.96 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.505 179.55 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.26 143.92 24.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.997 0.427 . . . . 0.0 110.452 179.458 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -135.38 138.83 43.69 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.655 179.952 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 20.3 mt -106.69 125.54 51.13 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 121.134 0.492 . . . . 0.0 109.795 -179.687 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 206' ' ' TRP . . . . . 0.556 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 74.9 m95 -81.93 166.95 19.43 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.575 -179.72 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . 0.473 HG22 ' C ' ' A' ' 206' ' ' TRP . 0.1 OUTLIER -156.94 171.62 7.2 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 120.997 0.427 . . . . 0.0 110.525 -179.223 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.06 -36.99 86.54 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 C-N-CA 122.639 2.226 . . . . 0.0 111.959 179.473 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -70.43 -35.16 73.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.906 -179.893 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 21.4 m -60.94 150.92 31.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.614 -179.296 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.58 -37.12 82.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.529 -179.751 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 212' ' ' GLN . . . . . 0.556 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 55.0 tt0 -64.56 -40.36 95.42 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.519 179.977 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.52 -43.32 92.58 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 179.804 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -63.45 -43.93 95.97 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.707 0.289 . . . . 0.0 110.276 179.883 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 215' ' ' MET . . . . . 0.525 ' SD ' ' HB2' ' A' ' 304' ' ' ALA . 65.4 ttp -59.49 -48.1 82.95 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.322 -179.805 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 216' ' ' LEU . 87.7 mt -60.38 -40.6 91.42 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 179.416 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 217' ' ' GLU . . . . . 0.462 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.9 tp10 -58.34 -37.98 76.25 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.739 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -65.14 -38.28 90.11 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.813 0.34 . . . . 0.0 110.709 179.702 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 93.9 mt -64.36 -42.65 96.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.584 -179.62 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.56 45.1 0.08 OUTLIER Glycine 0 C--N 1.333 0.379 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 -179.937 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 221' ' ' PHE . . . . . 0.462 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 27.0 m-85 -128.08 155.18 44.79 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.052 0.454 . . . . 0.0 110.487 -179.807 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.485 ' O ' HG13 ' A' ' 191' ' ' VAL . 6.4 p -106.92 122.28 46.11 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.179 0.514 . . . . 0.0 110.261 -179.987 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.473 HD22 ' C ' ' A' ' 222' ' ' THR . 4.3 mm? -101.22 133.0 46.45 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.077 -179.957 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.85 159.55 14.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.509 179.886 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.38 114.99 29.5 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.333 179.88 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.495 ' N ' HD12 ' A' ' 226' ' ' LEU . 9.1 mp -53.13 156.94 3.33 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.626 179.935 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -60.46 145.36 98.87 Favored 'Trans proline' 0 C--N 1.302 -1.903 0 C-N-CA 122.601 2.201 . . . . 0.0 112.004 179.485 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.3 -3.27 59.03 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.556 -179.989 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.01 -41.16 5.66 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 -179.885 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . 0.536 ' O ' ' N ' ' A' ' 233' ' ' SER . 85.5 mt -79.08 -17.19 55.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.983 0.42 . . . . 0.0 110.364 -179.738 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 231' ' ' ASN . . . . . 0.404 ' C ' ' O ' ' A' ' 230' ' ' LEU . 54.8 t-20 -40.11 -49.41 2.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.757 -179.694 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -87.82 15.32 7.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.768 0.318 . . . . 0.0 111.186 -179.967 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . 0.536 ' N ' ' O ' ' A' ' 230' ' ' LEU . 78.1 p -60.4 -35.74 76.45 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.535 -179.811 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 234' ' ' GLN . . . . . 0.525 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.6 tt0 -118.74 -69.19 0.86 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.917 179.642 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.3 m -69.73 103.11 2.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.633 -179.785 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -94.29 57.5 2.33 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.391 179.909 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -144.82 -122.42 1.56 Allowed Glycine 0 CA--C 1.521 0.43 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 -179.987 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -135.17 111.8 9.98 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 121.115 0.483 . . . . 0.0 110.468 179.983 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 239' ' ' ARG . . . . . 0.523 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.5 mtt180 -148.15 57.74 1.08 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.738 -179.894 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -69.64 -32.21 70.75 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.548 179.625 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 241' ' ' ASP . . . . . 0.542 ' CG ' HD21 ' A' ' 143' ' ' ASN . 65.1 t0 -56.94 -46.94 81.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.396 -179.159 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 242' ' ' ILE . . . . . 0.437 ' O ' ' O ' ' A' ' 239' ' ' ARG . 17.8 tt -139.84 156.43 25.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.893 0.378 . . . . 0.0 110.518 179.746 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.439 HG22 HD13 ' A' ' 245' ' ' LEU . 96.2 mt -106.24 106.34 20.4 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.188 0 CA-C-O 121.108 0.48 . . . . 0.0 110.511 179.863 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . 0.609 ' O ' HD12 ' A' ' 245' ' ' LEU . 88.2 mt-30 -110.25 110.06 20.74 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.261 179.76 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.609 HD12 ' O ' ' A' ' 244' ' ' GLN . 9.4 mp -121.96 -168.45 1.71 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.663 179.839 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . 0.525 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.54 -16.66 0.05 OUTLIER Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.911 -0.875 . . . . 0.0 110.911 179.945 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . 0.672 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -60.62 156.83 30.79 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -179.888 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -63.72 21.73 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.936 0.398 . . . . 0.0 110.655 179.924 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . 0.672 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.8 m-20 -97.34 -5.94 35.39 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.572 179.943 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 93.5 mt -79.85 -21.82 43.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.619 179.575 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.54 -51.27 70.59 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.864 -179.57 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.4 -5.54 58.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.394 179.642 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -80.93 -74.53 1.13 Allowed Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 -179.911 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 81.5 mt -69.79 125.4 26.62 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.025 0.44 . . . . 0.0 110.178 -179.816 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -59.49 -39.48 83.91 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.389 -179.739 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 84.45 51.71 3.8 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -179.938 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -94.62 -16.51 23.12 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.738 0.304 . . . . 0.0 110.597 -179.862 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 258' ' ' SER . . . . . 0.498 ' OG ' HG23 ' A' ' 191' ' ' VAL . 3.3 t 174.17 89.83 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.045 0.45 . . . . 0.0 110.119 -179.971 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.866 ' N ' HD12 ' A' ' 259' ' ' LEU . 1.0 OUTLIER -94.46 124.03 38.24 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.224 0.535 . . . . 0.0 111.088 -179.099 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 260' ' ' PHE . . . . . 0.444 ' H ' ' HA ' ' A' ' 193' ' ' ALA . 16.0 m-30 -93.18 146.85 23.37 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.332 179.166 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 86.7 mt -122.57 149.87 43.36 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.512 -179.9 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.743 ' CD1' HG13 ' A' ' 195' ' ' VAL . 2.6 p90 -77.94 -138.48 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.526 -179.813 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 263' ' ' ALA . . . . . 0.661 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -51.89 77.49 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.92 -179.942 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . 0.637 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.13 104.42 0.19 Allowed Glycine 0 N--CA 1.467 0.721 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 -179.986 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 265' ' ' ASP . . . . . 0.604 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.6 m-20 -80.43 -177.54 6.24 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.713 0.292 . . . . 0.0 110.91 -179.497 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -40.64 -17.56 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.852 0.358 . . . . 0.0 110.493 179.866 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 267' ' ' LYS . . . . . 0.604 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.64 -51.51 41.39 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.637 179.576 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -63.88 -46.71 83.69 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.076 179.525 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . 0.568 ' HB1' ' OH ' ' A' ' 273' ' ' TYR . . . -61.54 -35.12 76.85 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.839 179.552 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -62.98 -34.59 77.86 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.126 179.653 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.36 -43.3 13.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.336 -179.588 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 272' ' ' ILE . . . . . 0.584 ' C ' ' H ' ' A' ' 274' ' ' ALA . 4.9 tt -51.42 -33.63 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.826 -178.872 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 273' ' ' TYR . . . . . 0.568 ' OH ' ' HB1' ' A' ' 269' ' ' ALA . 17.4 m-85 -54.37 -1.7 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.677 -179.7 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 274' ' ' ALA . . . . . 0.584 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -72.13 -39.71 68.62 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.906 179.63 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . 0.588 ' O ' ' N ' ' A' ' 279' ' ' ALA . 3.9 p30 -39.36 97.78 0.15 Allowed Pre-proline 0 N--CA 1.462 0.156 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.54 -179.653 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 276' ' ' PRO . . . . . 0.402 ' N ' ' O ' ' A' ' 274' ' ' ALA . 45.5 Cg_exo -53.97 -43.31 59.36 Favored 'Trans proline' 0 C--N 1.303 -1.848 0 C-N-CA 122.363 2.042 . . . . 0.0 112.737 -178.857 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 89.4 mt -64.37 -42.83 95.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.206 -179.674 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 90.8 mt -95.94 -1.31 49.43 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.842 -179.361 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 279' ' ' ALA . . . . . 0.588 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.42 -34.89 77.66 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.604 -179.69 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -73.99 19.55 0.12 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.078 -179.224 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . 0.491 HD23 ' HA ' ' A' ' 281' ' ' LEU . 14.0 mt -74.95 121.0 84.31 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.355 179.873 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_exo -51.24 -39.44 62.12 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 122.573 2.182 . . . . 0.0 111.657 179.289 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.57 -50.65 62.53 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 179.748 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 81.8 t -61.84 -43.91 98.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 179.507 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -57.57 -41.86 81.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.418 -179.871 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -90.47 1.06 57.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.215 179.572 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt 58.39 40.42 24.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.036 0.446 . . . . 0.0 110.903 179.681 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -92.36 42.41 1.1 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.37 179.781 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 54.4 t -119.16 135.79 58.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.023 0.44 . . . . 0.0 110.182 -179.724 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -132.93 162.97 30.23 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.031 0.443 . . . . 0.0 110.697 -179.663 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.92 155.02 33.57 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.968 0.413 . . . . 0.0 110.774 -179.85 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 80.9 mt -93.69 -1.39 55.26 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.278 -179.782 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.17 165.38 12.64 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 -179.725 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 6.8 m -87.13 -62.32 1.53 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.866 0.365 . . . . 0.0 111.008 -179.802 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 295' ' ' GLU . . . . . 0.444 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.6 mm-40 -69.53 -4.2 17.97 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.544 -179.738 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 29.1 p -76.66 32.51 0.13 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.662 -179.877 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 297' ' ' PHE . . . . . 0.523 ' CD2' HG22 ' A' ' 70' ' ' THR . 70.4 t80 -60.18 -46.05 91.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.565 -179.905 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 298' ' ' ARG . . . . . 0.612 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.1 mtt85 -81.09 133.45 35.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.073 0.463 . . . . 0.0 110.433 -179.712 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.443 ' H ' HG11 ' A' ' 51' ' ' VAL . 16.3 tp -114.19 119.4 36.95 Favored 'General case' 0 CA--C 1.527 0.089 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.205 -179.97 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . 0.626 ' H ' ' CB ' ' A' ' 303' ' ' SER . 49.9 p-10 -167.29 -174.21 2.51 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.508 -179.968 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -48.34 -45.46 35.33 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.127 -179.591 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -65.0 -41.62 95.23 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.004 0.43 . . . . 0.0 110.724 178.969 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 303' ' ' SER . . . . . 0.626 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 52.7 p -55.15 -36.04 65.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.182 -179.5 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . 0.525 ' HB2' ' SD ' ' A' ' 215' ' ' MET . . . -57.13 -51.49 69.08 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 110.016 -0.365 . . . . 0.0 110.016 179.459 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 90.8 mtp -56.37 -43.82 79.56 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.689 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -66.57 -42.65 86.7 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.867 0.365 . . . . 0.0 110.18 178.778 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 303' ' ' SER . 56.0 t -64.06 -42.89 97.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.192 179.401 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 43.4 tp -59.55 -42.17 91.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.827 -179.593 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -62.73 -39.0 92.71 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 179.61 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 310' ' ' ARG . . . . . 0.44 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.6 ttt85 -63.54 -44.01 95.45 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.3 179.515 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 87.9 mt -63.36 -42.0 98.87 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.188 179.56 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -62.81 -33.18 74.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.106 179.454 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -90.19 -23.13 21.38 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.564 -179.908 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . 0.478 HD22 ' CE2' ' A' ' 315' ' ' PHE . 6.7 tt -62.43 -43.23 99.31 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.063 0.459 . . . . 0.0 110.589 -179.902 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 315' ' ' PHE . . . . . 0.478 ' CE2' HD22 ' A' ' 314' ' ' LEU . 91.3 m-85 . . . . . 0 C--O 1.22 -0.462 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.508 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -99.7 135.54 40.96 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.1 0.476 . . . . 0.0 110.406 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.48 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -92.51 178.71 1.56 Allowed Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.403 -179.686 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.48 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 27.0 Cg_exo -61.66 147.44 95.34 Favored 'Trans proline' 0 C--N 1.303 -1.833 0 C-N-CA 122.909 2.406 . . . . 0.0 112.214 179.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.492 ' HE ' HD12 ' A' ' 39' ' ' LEU . 35.2 ptt180 -136.32 142.61 43.88 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.571 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -79.94 116.77 20.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.509 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.443 ' O ' HG23 ' A' ' 30' ' ' ILE . 9.4 tp -111.45 130.53 64.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.487 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.1 t -71.24 142.5 50.56 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.607 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.478 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.4 t0 -139.45 -179.96 6.2 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.504 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.478 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 78.1 p -73.88 -37.23 64.79 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.683 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -46.69 -94.72 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.304 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -166.53 -26.75 0.02 OUTLIER Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 62.4 m -168.63 105.64 0.44 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.707 0.289 . . . . 0.0 110.531 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.656 ' CD2' HD13 ' A' ' 140' ' ' LEU . 70.0 t60 -129.01 146.63 50.93 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.224 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.619 HG22 ' N ' ' A' ' 39' ' ' LEU . 98.8 m -129.96 165.57 21.83 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.377 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.619 ' N ' HG22 ' A' ' 38' ' ' THR . 77.9 mt -120.2 127.28 52.3 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.654 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -65.42 -44.91 85.91 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.592 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 37.5 p -165.78 154.95 11.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.55 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.499 ' H ' ' CD ' ' A' ' 42' ' ' GLN . 14.7 mp0 -44.51 101.02 0.24 Allowed Pre-proline 0 C--O 1.235 0.302 0 O-C-N 123.564 0.54 . . . . 0.0 110.467 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -57.61 130.07 36.94 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.449 2.099 . . . . 0.0 112.111 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -82.95 -24.76 32.86 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.573 179.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.537 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.9 mtm-85 -121.23 134.33 55.19 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.995 0.426 . . . . 0.0 110.287 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.3 mt -130.22 133.26 64.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.515 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 46.2 t -124.73 131.04 73.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-O 121.002 0.429 . . . . 0.0 110.163 178.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.611 ' OG ' HD12 ' A' ' 117' ' ' LEU . 4.2 m -154.67 166.42 33.45 Favored 'General case' 0 C--O 1.224 -0.241 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.461 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 72.6 p -124.41 9.11 8.45 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.483 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.1 t -85.65 125.68 33.34 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.942 0.401 . . . . 0.0 110.577 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.462 HG11 ' H ' ' A' ' 299' ' ' LEU . 90.1 t -65.66 -44.52 93.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.546 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.0 m -62.51 -44.45 96.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.686 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 54.7 tp -62.35 -41.52 98.66 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.65 -179.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.447 ' O ' HD13 ' A' ' 58' ' ' LEU . 70.5 m -57.88 -44.61 86.8 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.219 -179.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.39 -62.05 5.45 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.5 t -47.55 -35.94 9.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.79 0.328 . . . . 0.0 110.144 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.7 mt -61.87 -44.64 96.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.909 0.385 . . . . 0.0 110.976 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.447 HD13 ' O ' ' A' ' 54' ' ' THR . 9.0 mp -65.17 -41.32 94.74 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.292 178.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.415 ' HB1' ' NE ' ' A' ' 169' ' ' ARG . . . -63.78 -41.19 97.99 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.631 -179.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.415 ' O ' HG23 ' A' ' 60' ' ' ILE . 7.9 tp -88.06 16.62 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.673 -179.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 56.33 84.09 0.09 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.795 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.21 57.11 0.06 OUTLIER Pre-proline 0 C--N 1.327 -0.371 0 CA-C-O 121.018 0.437 . . . . 0.0 109.907 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.417 ' HB3' HE21 ' A' ' 85' ' ' GLN . 9.7 Cg_endo -50.17 153.72 6.45 Favored 'Trans proline' 0 C--N 1.298 -2.096 0 C-N-CA 122.972 2.448 . . . . 0.0 112.492 -178.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.425 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -109.15 146.12 15.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.238 -179.728 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 97.0 mt -63.78 -45.08 98.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.116 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.503 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -130.32 134.21 47.02 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.775 0.321 . . . . 0.0 110.266 -179.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.494 ' O ' ' N ' ' A' ' 98' ' ' LEU . 72.9 m -134.47 158.71 43.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.805 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.71 139.35 16.37 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.716 -0.954 . . . . 0.0 110.716 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.488 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.78 -162.67 0.08 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.798 0.333 . . . . 0.0 110.384 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.505 HG22 ' CD2' ' A' ' 297' ' ' PHE . 5.9 t -133.97 135.36 43.43 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.096 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.467 ' C ' ' O ' ' A' ' 70' ' ' THR . 0.8 OUTLIER 29.47 68.71 0.64 Allowed Pre-proline 0 N--CA 1.468 0.475 0 CA-C-O 121.216 0.532 . . . . 0.0 110.84 -179.48 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -60.86 144.79 99.63 Favored 'Trans proline' 0 C--N 1.302 -1.911 0 C-N-CA 122.776 2.317 . . . . 0.0 112.064 -178.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.528 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 46.3 p-10 -159.79 -31.83 0.06 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.667 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.529 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 99.0 m-20 -64.29 -39.36 93.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.421 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.6 ttt180 -60.39 -48.46 81.64 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.436 -179.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.425 ' O ' ' O ' ' A' ' 77' ' ' ALA . 93.7 t -60.05 -24.52 30.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.172 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.529 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -45.82 172.95 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.53 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.57 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.5 p30 -61.94 177.64 0.43 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.433 -179.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.566 ' C ' ' H ' ' A' ' 81' ' ' GLY . 35.5 p30 -45.9 85.44 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.807 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.57 ' N ' ' O ' ' A' ' 78' ' ' ASP . 42.2 tp60 -67.14 13.65 0.06 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.261 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.566 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 117.94 -22.31 9.9 Favored Glycine 0 N--CA 1.463 0.471 0 N-CA-C 110.874 -0.891 . . . . 0.0 110.874 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -107.94 116.17 31.47 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.873 0.368 . . . . 0.0 110.348 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 75.9 mt -98.68 0.67 45.13 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.474 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -92.19 6.8 45.28 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.344 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.783 ' O ' HG22 ' A' ' 89' ' ' VAL . 88.2 mt-30 -99.91 -28.18 13.23 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.564 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 68.6 t-105 -63.44 -40.91 98.42 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.705 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.545 ' O ' ' N ' ' A' ' 91' ' ' LYS . 64.5 m -77.49 -53.68 7.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.873 -179.177 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -48.4 -51.01 28.58 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.801 -178.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.783 HG22 ' O ' ' A' ' 85' ' ' GLN . 16.0 m -68.92 -40.68 81.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.891 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.491 ' N ' HG23 ' A' ' 89' ' ' VAL . . . -72.27 -22.72 61.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.695 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.545 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.0 tttm -61.57 -45.92 92.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.449 -179.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.436 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.7 mm-40 -90.16 -94.58 0.12 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.198 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.609 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.9 mtt180 -143.38 59.3 1.4 Allowed 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.434 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.6 pttp 33.92 26.24 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 O-C-N 123.588 0.555 . . . . 0.0 110.487 -179.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.609 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.5 tt -48.29 123.07 5.94 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.648 -177.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.456 ' O ' HD23 ' A' ' 95' ' ' LEU . 98.9 mm-40 -83.11 -170.48 3.06 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.399 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.619 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 82.8 mtp180 -73.42 137.78 44.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.229 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.494 ' N ' ' O ' ' A' ' 67' ' ' SER . 88.9 mt -86.13 -166.37 1.52 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.807 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.53 ' CD2' ' O ' ' A' ' 99' ' ' TYR . 46.9 p90 -167.77 119.83 0.88 Allowed 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.106 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.487 ' C ' ' O ' ' A' ' 99' ' ' TYR . 43.2 mm -29.63 121.33 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 O-C-N 123.482 0.489 . . . . 0.0 110.891 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 113.28 28.59 3.26 Favored Glycine 0 N--CA 1.464 0.504 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.578 ' N ' ' CD ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -143.86 45.45 0.56 Allowed Pre-proline 0 C--N 1.324 -0.504 0 CA-C-O 121.321 0.582 . . . . 0.0 110.502 179.795 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 30.6 Cg_endo -61.95 143.94 95.91 Favored 'Trans proline' 0 C--N 1.298 -2.123 0 C-N-CA 122.614 2.209 . . . . 0.0 112.014 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.471 ' O ' HG23 ' A' ' 108' ' ' VAL . 21.9 t -173.18 120.84 0.36 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.534 179.311 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.3 -40.74 64.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.215 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.16 -40.29 90.42 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.69 -179.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.1 -39.98 95.22 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.659 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 104' ' ' SER . 69.4 t -67.71 -43.8 86.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.634 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.37 -39.19 92.36 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.521 -179.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.436 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.6 -23.23 62.79 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.596 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.519 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.3 mm-40 -90.95 4.31 52.3 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.716 -179.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.537 ' O ' ' NE ' ' A' ' 45' ' ' ARG . 10.3 tpt 23.97 63.82 0.4 Allowed Pre-proline 0 N--CA 1.471 0.602 0 O-C-N 123.622 0.576 . . . . 0.0 110.986 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.46 ' HG2' HD11 ' A' ' 116' ' ' ILE . 71.0 Cg_endo -78.63 168.22 21.49 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 123.019 2.48 . . . . 0.0 112.075 -178.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.511 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 98.8 m-20 -112.56 -43.78 3.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.292 179.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.0 tp -121.03 120.09 34.36 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.262 178.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.46 HD11 ' HG2' ' A' ' 113' ' ' PRO . 96.8 mt -117.14 131.14 70.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.719 -179.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.611 HD12 ' OG ' ' A' ' 48' ' ' SER . 30.1 mt -106.07 132.32 52.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.218 -179.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.447 HD12 HG23 ' A' ' 139' ' ' THR . 98.3 mt -118.08 136.71 54.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.495 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 86.6 p -71.98 152.3 42.59 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.565 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -59.97 -50.05 75.26 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.535 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -149.19 153.52 37.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.513 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 169.76 -170.73 42.95 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -63.07 -35.05 91.56 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.444 ' O ' ' OD1' ' A' ' 124' ' ' ASP . 43.9 p-10 -87.8 120.34 29.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.892 0.377 . . . . 0.0 110.635 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.441 ' O ' HD12 ' A' ' 129' ' ' LEU . 41.0 t -63.34 143.68 57.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.469 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.516 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.6 -42.74 9.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.647 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.5 tp -62.79 -42.42 99.7 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.761 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.01 -10.63 55.14 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.413 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.441 HD12 ' O ' ' A' ' 125' ' ' SER . 83.4 mt -115.59 -24.39 8.32 Favored 'General case' 0 C--O 1.224 -0.238 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.533 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . 0.516 ' N ' ' O ' ' A' ' 126' ' ' ALA . 75.1 t80 -51.39 -49.93 60.59 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.96 -0.296 . . . . 0.0 110.531 -178.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 37.6 p-10 -65.95 -42.13 90.36 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.933 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.52 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 88.2 mt-30 -67.66 -36.76 81.33 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.73 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.454 HD22 HD13 ' A' ' 116' ' ' ILE . 94.3 mt -80.22 -41.85 24.37 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.025 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.4 t -57.16 -44.88 83.88 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.204 -179.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.3 m -62.2 -45.48 93.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.616 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 92.2 mt -62.54 -43.81 98.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.336 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.592 ' HB1' ' HD2' ' A' ' 138' ' ' PRO . . . -170.05 163.47 6.4 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.563 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.592 ' HD2' ' HB1' ' A' ' 137' ' ' ALA . 77.0 Cg_exo -43.1 111.86 0.25 Allowed 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.576 2.184 . . . . 0.0 112.068 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.491 HG21 ' CD1' ' A' ' 130' ' ' TYR . 17.2 m -85.64 127.72 34.56 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.328 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.656 HD13 ' CD2' ' A' ' 37' ' ' HIS . 34.0 tp -119.45 137.23 53.91 Favored 'General case' 0 C--N 1.334 -0.078 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.404 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.431 ' O ' ' OD2' ' A' ' 32' ' ' ASP . 80.7 mt -103.4 119.75 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.844 -178.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.496 HD12 HD22 ' A' ' 117' ' ' LEU . 97.2 mt -135.75 133.09 51.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.607 179.085 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.545 HD21 ' CG ' ' A' ' 241' ' ' ASP . 60.9 t30 -65.2 150.93 47.35 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.41 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.512 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 88.2 t80 -85.91 122.38 29.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.725 -179.2 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.512 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 99.1 m-20 55.38 69.34 0.74 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.497 179.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 43.4 p-10 -126.64 0.54 6.81 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.537 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -150.34 114.79 5.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.833 0.349 . . . . 0.0 110.547 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 84.8 p -62.69 168.23 3.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.594 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.408 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.6 p-90 -51.44 -15.86 0.48 Allowed 'General case' 0 C--O 1.22 -0.461 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.299 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.441 ' O ' HG23 ' A' ' 154' ' ' THR . 68.3 tp60 -70.49 -75.44 0.12 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.998 0.427 . . . . 0.0 110.613 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.445 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.2 t -62.53 -38.82 91.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.298 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 52.8 tp -60.13 -45.6 92.45 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.511 -178.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.408 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 45.8 tp -62.74 -41.59 99.26 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.604 178.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.445 ' OG1' ' O ' ' A' ' 151' ' ' SER . 59.1 p -63.67 -35.03 79.2 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.275 -179.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.459 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.8 mm-40 -63.67 -42.14 98.1 Favored 'General case' 0 C--O 1.226 -0.161 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.36 179.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 91.3 mt -65.3 -39.09 92.05 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.483 178.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.564 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -60.99 -32.29 79.63 Favored Glycine 0 C--N 1.33 0.237 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 -179.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.459 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.3 mt-10 -36.63 -25.38 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.823 0.344 . . . . 0.0 110.937 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.564 ' N ' ' O ' ' A' ' 157' ' ' GLY . 95.3 mt -58.81 148.83 6.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.455 178.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 70.8 p -69.15 137.6 53.48 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.841 -179.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 70.69 21.92 77.95 Favored Glycine 0 CA--C 1.521 0.41 0 N-CA-C 111.085 -0.806 . . . . 0.0 111.085 179.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 59.7 m80 -124.18 -14.18 7.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.562 0.22 . . . . 0.0 110.506 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -66.14 -59.96 3.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.542 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -51.39 -49.42 61.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.086 -179.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -60.58 -40.97 93.66 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.883 0.373 . . . . 0.0 110.495 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.62 -47.42 85.52 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.548 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.77 -40.06 75.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.311 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -61.64 -50.46 72.44 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.697 179.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.415 ' NE ' ' HB1' ' A' ' 59' ' ' ALA . 60.1 ttt85 -65.28 -43.79 90.07 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.46 179.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 95.3 mt -64.4 -43.53 97.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.484 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.33 -51.06 70.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.379 -179.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.76 -43.6 95.92 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.875 0.369 . . . . 0.0 110.521 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.655 ' CE2' HD11 ' A' ' 177' ' ' LEU . 56.7 t80 -62.54 -44.39 96.47 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.435 179.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -63.66 -39.68 94.96 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.378 -179.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -63.08 -42.52 99.65 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.753 179.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -60.64 -44.94 95.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.209 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.655 HD11 ' CE2' ' A' ' 173' ' ' PHE . 85.4 mt -64.31 -41.1 97.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.943 178.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.13 -61.99 1.92 Allowed 'General case' 0 C--O 1.238 0.472 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.499 -179.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.71 -46.83 86.45 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.472 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.12 -41.59 65.18 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.329 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -63.75 -33.99 76.89 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.33 179.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.4 ' O ' ' HG2' ' A' ' 182' ' ' GLU . 69.3 tt0 -90.75 8.56 34.01 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.39 0.614 . . . . 0.0 110.283 -178.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -104.3 -32.23 9.18 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.944 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.8 pt -128.09 147.81 32.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.865 0.364 . . . . 0.0 110.58 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -139.71 131.13 26.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.538 178.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.587 HD22 ' N ' ' A' ' 186' ' ' LEU . 3.6 mm? -85.35 133.46 42.41 Favored Pre-proline 0 N--CA 1.447 -0.606 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.107 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -44.1 157.83 0.14 Allowed 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.581 2.188 . . . . 0.0 112.188 179.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 0.489 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.7 Cg_endo -63.35 115.0 2.74 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.815 2.344 . . . . 0.0 111.561 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . 0.489 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.7 mt-30 156.05 148.14 0.0 OUTLIER Pre-proline 0 C--N 1.34 0.178 0 O-C-N 124.353 1.033 . . . . 0.0 110.94 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -73.75 144.48 35.23 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 C-N-CA 122.601 2.201 . . . . 0.0 111.765 177.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.495 HG23 ' OG ' ' A' ' 258' ' ' SER . 2.1 p -124.81 159.04 31.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.206 0.527 . . . . 0.0 110.168 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . 0.482 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 37.2 p -143.26 165.29 27.88 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 121.428 0.633 . . . . 0.0 110.852 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . 0.447 ' HA ' ' H ' ' A' ' 260' ' ' PHE . . . -135.32 128.91 32.63 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 121.276 0.56 . . . . 0.0 110.422 178.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.509 HD11 HD23 ' A' ' 259' ' ' LEU . 47.6 pt -146.64 149.09 16.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.849 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . 0.744 HG13 ' CD1' ' A' ' 262' ' ' PHE . 73.6 t -117.78 123.1 71.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.08 0.467 . . . . 0.0 110.036 178.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 58.1 t80 -134.3 106.45 7.12 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.348 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 95.3 m -130.31 130.49 44.56 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.786 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.401 ' O ' ' N ' ' A' ' 201' ' ' HIS . . . -82.99 -36.58 24.93 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.26 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.41 -67.26 0.25 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.351 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.12 -9.45 58.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.446 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . 0.402 ' ND1' ' O ' ' A' ' 201' ' ' HIS . 60.7 t-80 60.51 58.26 2.55 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.749 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 34.9 p -167.28 153.91 8.3 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.601 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.56 144.27 24.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.897 0.379 . . . . 0.0 110.417 179.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -135.32 138.49 43.48 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.41 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 18.2 mt -106.25 125.23 50.75 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.062 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' TRP . . . . . 0.556 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 74.8 m95 -82.31 167.74 18.27 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.563 -179.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . 0.455 HG22 ' C ' ' A' ' 206' ' ' TRP . 0.1 OUTLIER -157.62 171.7 7.1 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.611 -178.635 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -53.92 -37.09 85.46 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 C-N-CA 122.743 2.296 . . . . 0.0 111.992 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -70.77 -34.9 72.3 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.734 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 21.4 m -61.5 150.94 34.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.51 -179.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.76 -36.92 82.43 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.42 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . 0.556 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 55.0 tt0 -64.63 -40.29 95.22 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.59 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.88 -43.27 91.87 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -63.07 -43.97 97.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.85 0.357 . . . . 0.0 110.239 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . 0.55 ' SD ' ' HB2' ' A' ' 304' ' ' ALA . 65.2 ttp -59.42 -47.79 84.11 Favored 'General case' 0 N--CA 1.461 0.103 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.207 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 86.4 mt -60.53 -40.72 92.54 Favored 'General case' 0 CA--C 1.517 -0.303 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . 0.448 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.1 tp10 -57.96 -38.04 75.26 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.201 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -65.51 -37.96 88.29 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.725 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 96.0 mt -64.28 -42.76 96.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.655 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.72 44.9 0.08 OUTLIER Glycine 0 N--CA 1.463 0.444 0 N-CA-C 111.079 -0.808 . . . . 0.0 111.079 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . 0.448 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 26.9 m-85 -127.89 155.75 43.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.761 0.315 . . . . 0.0 110.498 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.481 ' O ' HG13 ' A' ' 191' ' ' VAL . 7.4 p -107.42 122.52 46.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.21 0.529 . . . . 0.0 110.229 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.472 HD22 ' C ' ' A' ' 222' ' ' THR . 4.3 mm? -101.34 133.16 46.37 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.002 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.74 159.4 14.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.433 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.31 115.0 29.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.404 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.497 ' N ' HD12 ' A' ' 226' ' ' LEU . 8.9 mp -52.91 156.72 3.23 Favored Pre-proline 0 N--CA 1.446 -0.649 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.794 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -60.47 145.49 98.62 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.719 2.279 . . . . 0.0 112.013 179.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.2 -3.36 59.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.529 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -89.93 -41.26 5.66 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.506 ' O ' ' N ' ' A' ' 233' ' ' SER . 68.3 mt -79.23 -17.15 55.33 Favored 'General case' 0 C--O 1.219 -0.532 0 CA-C-O 120.923 0.392 . . . . 0.0 110.31 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 54.4 t-20 -40.33 -49.73 2.77 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.862 0.363 . . . . 0.0 110.709 -179.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -87.7 15.43 6.91 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.115 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.506 ' N ' ' O ' ' A' ' 230' ' ' LEU . 77.9 p -60.33 -35.24 75.17 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.601 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . 0.521 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.6 tt0 -119.64 -69.18 0.86 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.73 0.3 . . . . 0.0 110.679 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.3 m -69.58 102.59 1.88 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.538 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -94.28 57.4 2.32 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.357 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -144.73 -122.41 1.56 Allowed Glycine 0 N--CA 1.462 0.426 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -135.42 111.71 9.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.898 0.38 . . . . 0.0 110.379 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . 0.525 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.4 mtt180 -148.28 58.14 1.08 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.578 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -69.38 -32.7 71.9 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.618 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . 0.545 ' CG ' HD21 ' A' ' 143' ' ' ASN . 65.2 t0 -56.7 -47.3 80.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.312 -179.001 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' ILE . . . . . 0.434 ' O ' ' O ' ' A' ' 239' ' ' ARG . 18.0 tt -139.39 155.92 26.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.358 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.445 HG22 HD13 ' A' ' 245' ' ' LEU . 96.3 mt -106.08 106.49 20.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.406 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . 0.586 ' O ' HD12 ' A' ' 245' ' ' LEU . 88.2 mt-30 -110.57 109.96 20.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.291 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.586 HD12 ' O ' ' A' ' 244' ' ' GLN . 9.5 mp -121.59 -168.09 1.63 Allowed 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.723 179.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . 0.521 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.7 -16.46 0.05 OUTLIER Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . 0.666 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -61.14 156.31 33.85 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -63.33 21.81 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.772 0.32 . . . . 0.0 110.629 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . 0.666 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.9 m-20 -97.41 -6.3 34.33 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.407 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 92.0 mt -79.36 -21.98 45.05 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.945 179.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.7 -51.21 70.91 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.647 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.39 -5.74 58.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.372 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -80.87 -74.49 1.13 Allowed Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 80.9 mt -69.99 126.14 28.81 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.455 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -59.64 -39.19 83.56 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.281 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 82.63 51.94 4.11 Favored Glycine 0 CA--C 1.521 0.426 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -95.89 -15.07 22.66 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 121.199 -0.201 . . . . 0.0 110.634 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . 0.495 ' OG ' HG23 ' A' ' 191' ' ' VAL . 3.5 t 174.85 88.71 0.0 OUTLIER 'General case' 0 C--O 1.224 -0.257 0 CA-C-O 121.089 0.471 . . . . 0.0 110.294 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.848 ' N ' HD12 ' A' ' 259' ' ' LEU . 0.9 OUTLIER -94.5 124.27 38.43 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.774 0.321 . . . . 0.0 110.874 -178.666 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' PHE . . . . . 0.447 ' H ' ' HA ' ' A' ' 193' ' ' ALA . 15.7 m-30 -93.52 146.13 24.01 Favored 'General case' 0 CA--C 1.499 -0.999 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.541 179.016 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 85.3 mt -122.09 149.03 44.14 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.517 -179.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.744 ' CD1' HG13 ' A' ' 195' ' ' VAL . 2.5 p90 -77.23 -138.84 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.407 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . 0.655 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -51.46 77.22 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.249 0 O-C-N 123.381 0.426 . . . . 0.0 110.939 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . 0.622 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.29 104.67 0.19 Allowed Glycine 0 CA--C 1.527 0.797 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' ASP . . . . . 0.589 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.8 m-20 -80.14 -177.8 6.24 Favored 'General case' 0 C--N 1.327 -0.394 0 O-C-N 122.79 -0.241 . . . . 0.0 110.718 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -40.78 -17.83 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.486 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . 0.589 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.16 -51.52 44.97 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 121.058 0.456 . . . . 0.0 110.724 179.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -63.9 -46.58 84.2 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.102 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . 0.566 ' HB1' ' OH ' ' A' ' 273' ' ' TYR . . . -61.6 -34.81 76.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.668 0.746 . . . . 0.0 110.05 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -62.98 -34.89 78.5 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.002 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.07 -43.44 13.91 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.136 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 272' ' ' ILE . . . . . 0.589 ' C ' ' H ' ' A' ' 274' ' ' ALA . 5.0 tt -51.61 -33.59 15.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.471 -178.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 273' ' ' TYR . . . . . 0.566 ' OH ' ' HB1' ' A' ' 269' ' ' ALA . 17.1 m-85 -54.62 -1.61 0.03 OUTLIER 'General case' 0 CA--C 1.512 -0.504 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.741 -179.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 274' ' ' ALA . . . . . 0.589 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.42 -39.99 70.73 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.917 179.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . 0.574 ' O ' ' N ' ' A' ' 279' ' ' ALA . 2.8 p30 -38.55 97.64 0.14 Allowed Pre-proline 0 CA--C 1.528 0.131 0 O-C-N 123.585 0.553 . . . . 0.0 110.355 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -53.75 -43.27 59.37 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 122.565 2.177 . . . . 0.0 112.509 -178.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 89.0 mt -64.42 -43.0 95.73 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.953 -179.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 91.8 mt -95.82 -1.33 49.82 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.756 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 279' ' ' ALA . . . . . 0.574 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.63 -35.18 78.75 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.352 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.13 20.35 0.11 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.892 -178.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 0.488 ' H ' ' C ' ' A' ' 279' ' ' ALA . 13.9 mt -74.8 120.05 79.7 Favored Pre-proline 0 N--CA 1.442 -0.862 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.821 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -51.33 -39.09 63.47 Favored 'Trans proline' 0 C--N 1.313 -1.321 0 C-N-CA 122.425 2.083 . . . . 0.0 111.817 179.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.71 -50.6 63.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.947 0.403 . . . . 0.0 110.05 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 76.6 t -61.51 -43.8 97.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.199 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -57.64 -41.48 81.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.212 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -90.84 0.62 57.42 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.32 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt 59.0 43.18 18.08 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.811 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -94.52 41.6 1.09 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.377 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 54.0 t -119.16 135.6 59.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-O 120.949 0.404 . . . . 0.0 110.012 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -132.81 162.87 30.38 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.619 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.68 155.14 32.95 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.462 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 79.8 mt -94.07 -1.63 54.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.299 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 120.75 165.49 12.76 Favored Glycine 0 N--CA 1.464 0.512 0 N-CA-C 110.584 -1.006 . . . . 0.0 110.584 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 6.7 m -86.98 -62.3 1.53 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.83 0.347 . . . . 0.0 110.879 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 295' ' ' GLU . . . . . 0.446 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.9 mm-40 -69.36 -3.94 16.2 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.642 -179.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 24.5 p -77.01 32.24 0.14 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.65 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 297' ' ' PHE . . . . . 0.505 ' CD2' HG22 ' A' ' 70' ' ' THR . 68.5 t80 -60.31 -46.13 90.95 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.704 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . 0.619 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.1 mtt85 -80.76 135.09 35.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.477 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.462 ' H ' HG11 ' A' ' 51' ' ' VAL . 17.7 tp -114.09 117.07 30.23 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 120.861 0.362 . . . . 0.0 110.394 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . 0.618 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.1 p-10 -165.2 -176.63 4.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.755 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 82.8 t80 -46.51 -43.57 16.96 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.424 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -67.06 -40.24 87.03 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.001 0.429 . . . . 0.0 110.757 179.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . 0.618 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 60.2 p -56.22 -36.11 68.09 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.131 -179.086 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . 0.55 ' HB2' ' SD ' ' A' ' 215' ' ' MET . . . -57.31 -51.34 69.77 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.215 179.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 91.7 mtp -56.01 -44.18 78.43 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -65.79 -42.59 90.53 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.165 0.507 . . . . 0.0 110.437 179.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 303' ' ' SER . 55.7 t -64.06 -42.92 97.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.255 179.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 43.6 tp -59.77 -41.94 92.19 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.129 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -62.44 -39.0 91.93 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.299 179.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 310' ' ' ARG . . . . . 0.441 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.5 ttt85 -63.7 -43.79 95.56 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.374 179.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 89.4 mt -63.47 -41.94 98.6 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.572 179.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.3 ttmt -63.2 -33.29 75.16 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.35 179.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.42 -23.58 22.11 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.466 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.486 HD22 ' CE2' ' A' ' 315' ' ' PHE . 6.7 tt -62.31 -43.15 99.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.491 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 315' ' ' PHE . . . . . 0.486 ' CE2' HD22 ' A' ' 314' ' ' LEU . 89.8 m-85 . . . . . 0 C--O 1.221 -0.444 0 CA-C-O 118.09 -0.957 . . . . 0.0 110.3 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -99.64 136.03 40.18 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.134 0.492 . . . . 0.0 110.475 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.482 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -92.44 178.68 1.58 Allowed Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.47 -179.692 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.482 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.7 Cg_exo -61.71 147.19 95.87 Favored 'Trans proline' 0 C--N 1.303 -1.843 0 C-N-CA 122.814 2.343 . . . . 0.0 112.211 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.487 ' HE ' HD12 ' A' ' 39' ' ' LEU . 35.5 ptt180 -136.53 142.45 43.45 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.565 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -79.63 116.88 20.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.508 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.445 ' O ' HG23 ' A' ' 30' ' ' ILE . 9.4 tp -111.13 130.39 64.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.557 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 13.9 t -71.3 142.18 50.47 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.674 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.478 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.4 t0 -139.24 -179.97 6.18 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.478 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.478 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 78.1 p -74.0 -37.05 64.54 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.671 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.8 ttt85 -46.86 -94.78 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.31 -179.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -166.07 -27.06 0.02 OUTLIER Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 62.5 m -168.71 105.76 0.44 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.757 0.313 . . . . 0.0 110.598 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.644 ' CD2' HD13 ' A' ' 140' ' ' LEU . 65.5 t60 -128.86 146.55 50.91 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 120.956 0.408 . . . . 0.0 110.222 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.619 HG22 ' N ' ' A' ' 39' ' ' LEU . 95.4 m -129.84 165.53 21.8 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.3 -179.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.619 ' N ' HG22 ' A' ' 38' ' ' THR . 78.5 mt -120.21 127.28 52.29 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.691 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -65.41 -44.86 86.1 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.606 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 38.3 p -165.64 154.97 12.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.458 179.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.491 ' H ' ' CD ' ' A' ' 42' ' ' GLN . 14.5 mp0 -44.82 101.19 0.25 Allowed Pre-proline 0 C--O 1.235 0.333 0 O-C-N 123.57 0.544 . . . . 0.0 110.505 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -57.62 130.25 37.83 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.339 2.026 . . . . 0.0 112.16 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -82.69 -25.03 33.37 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.643 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.538 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.8 mtm-85 -120.89 134.53 55.29 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.143 0.497 . . . . 0.0 110.237 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.1 mt -129.75 133.23 65.2 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.327 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.639 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 46.2 t -125.1 130.92 73.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 CA-C-O 120.942 0.401 . . . . 0.0 110.151 178.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.609 ' OG ' HD12 ' A' ' 117' ' ' LEU . 4.2 m -154.99 166.6 33.06 Favored 'General case' 0 C--O 1.225 -0.22 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.459 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 73.2 p -124.55 8.92 8.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.417 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.35 125.84 33.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.872 0.368 . . . . 0.0 110.584 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.467 HG11 ' H ' ' A' ' 299' ' ' LEU . 84.9 t -65.83 -44.58 92.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.611 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 18.5 m -62.59 -44.41 96.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.678 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 52.2 tp -62.39 -41.53 98.72 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.661 -179.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.438 ' O ' HD13 ' A' ' 58' ' ' LEU . 71.9 m -58.04 -44.61 87.48 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.183 -179.183 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.31 -62.09 5.44 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 179.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.5 t -47.89 -35.64 10.81 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.5 mt -61.82 -44.55 96.63 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.069 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.445 HD21 HE22 ' A' ' 85' ' ' GLN . 9.1 mp -65.27 -41.17 94.47 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.297 178.132 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.412 ' HB1' ' NE ' ' A' ' 169' ' ' ARG . . . -63.85 -41.45 97.8 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.611 -179.193 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.414 ' O ' HG23 ' A' ' 60' ' ' ILE . 8.0 tp -87.75 16.8 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.724 -179.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 56.32 84.39 0.09 Allowed 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.814 -179.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.28 58.44 0.08 OUTLIER Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 120.992 0.425 . . . . 0.0 109.931 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.417 ' HB3' HE21 ' A' ' 85' ' ' GLN . 10.0 Cg_endo -50.91 152.72 9.61 Favored 'Trans proline' 0 C--N 1.296 -2.205 0 C-N-CA 123.061 2.507 . . . . 0.0 112.307 -178.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.429 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -108.85 145.9 15.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.279 -179.789 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.78 -45.13 98.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.191 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.504 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -130.16 134.17 47.12 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.717 0.294 . . . . 0.0 110.389 -179.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.494 ' O ' ' N ' ' A' ' 98' ' ' LEU . 73.5 m -134.3 158.51 43.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.85 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.58 139.21 16.36 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.494 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.69 -162.83 0.09 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.86 0.362 . . . . 0.0 110.382 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.502 HG22 ' CD2' ' A' ' 297' ' ' PHE . 5.8 t -134.09 135.57 43.33 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.027 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.466 ' C ' ' O ' ' A' ' 70' ' ' THR . 0.9 OUTLIER 29.78 68.23 0.68 Allowed Pre-proline 0 N--CA 1.469 0.507 0 CA-C-O 121.181 0.515 . . . . 0.0 110.813 -179.569 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -60.8 145.23 99.3 Favored 'Trans proline' 0 C--N 1.301 -1.944 0 C-N-CA 122.737 2.291 . . . . 0.0 111.978 -178.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.539 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 44.9 p-10 -160.06 -32.62 0.06 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.674 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.539 ' N ' ' OD1' ' A' ' 73' ' ' ASN . 98.9 m-20 -63.75 -39.72 94.97 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.364 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -59.97 -48.33 82.16 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.476 -179.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.425 ' O ' ' O ' ' A' ' 77' ' ' ALA . 92.4 t -60.0 -24.75 30.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.125 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.526 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -45.64 173.0 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.53 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.565 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.3 p30 -62.06 177.69 0.44 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.424 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.564 ' C ' ' H ' ' A' ' 81' ' ' GLY . 35.1 p30 -45.81 85.64 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.985 0.421 . . . . 0.0 110.903 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.565 ' N ' ' O ' ' A' ' 78' ' ' ASP . 42.5 tp60 -67.21 13.45 0.06 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.25 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.564 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 117.92 -22.34 9.9 Favored Glycine 0 N--CA 1.463 0.439 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -107.75 116.22 31.55 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.945 0.402 . . . . 0.0 110.483 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 76.5 mt -98.71 0.63 44.96 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.478 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -92.23 6.84 45.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.917 0.389 . . . . 0.0 110.325 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.781 ' O ' HG22 ' A' ' 89' ' ' VAL . 88.5 mt-30 -99.88 -27.8 13.43 Favored 'General case' 0 C--O 1.222 -0.379 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.665 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 69.0 t-105 -63.42 -40.96 98.58 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.767 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.545 ' O ' ' N ' ' A' ' 91' ' ' LYS . 67.2 m -77.42 -53.34 7.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.888 -179.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -48.59 -51.14 29.35 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.946 -179.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.781 HG22 ' O ' ' A' ' 85' ' ' GLN . 15.9 m -68.78 -40.6 81.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.039 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.489 ' N ' HG23 ' A' ' 89' ' ' VAL . . . -72.35 -22.92 61.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.753 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.545 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.0 tttm -61.41 -45.92 92.31 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.391 -179.432 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.438 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.6 mm-40 -90.37 -94.56 0.12 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.128 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.608 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.9 mtt180 -143.49 59.63 1.39 Allowed 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.437 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.7 pttp 34.06 26.32 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.282 0.563 . . . . 0.0 110.517 -179.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.608 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.5 tt -48.32 123.15 6.09 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.856 -177.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.45 ' O ' HD23 ' A' ' 95' ' ' LEU . 98.9 mm-40 -83.31 -170.44 3.05 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.314 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.617 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 82.7 mtp180 -73.45 137.89 44.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.952 0.406 . . . . 0.0 110.231 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.494 ' N ' ' O ' ' A' ' 67' ' ' SER . 88.3 mt -86.41 -165.96 1.41 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.83 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.532 ' CD2' ' O ' ' A' ' 99' ' ' TYR . 47.1 p90 -168.51 120.0 0.79 Allowed 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.094 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.488 ' C ' ' O ' ' A' ' 99' ' ' TYR . 42.9 mm -29.67 121.4 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 O-C-N 123.392 0.433 . . . . 0.0 110.898 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 113.7 28.12 3.31 Favored Glycine 0 N--CA 1.463 0.473 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 -179.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.579 ' N ' ' CD ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -143.86 45.5 0.57 Allowed Pre-proline 0 C--N 1.324 -0.54 0 CA-C-O 121.298 0.57 . . . . 0.0 110.463 179.794 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 30.4 Cg_endo -62.14 144.03 95.32 Favored 'Trans proline' 0 C--N 1.297 -2.145 0 C-N-CA 122.572 2.181 . . . . 0.0 111.972 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.462 ' O ' HG23 ' A' ' 108' ' ' VAL . 25.3 t -173.17 120.76 0.36 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.573 179.426 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.15 -40.96 64.44 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.188 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -65.97 -40.0 90.85 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.759 -179.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.05 -39.62 94.49 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.667 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 104' ' ' SER . 71.2 t -67.58 -43.73 86.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.638 179.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.44 -39.3 92.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.527 -179.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.438 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.78 -23.67 63.47 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.561 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.526 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.4 mm-40 -90.89 4.38 52.02 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.769 -179.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.538 ' O ' ' NE ' ' A' ' 45' ' ' ARG . 10.5 tpt 22.61 64.37 0.34 Allowed Pre-proline 0 N--CA 1.471 0.598 0 O-C-N 123.5 0.5 . . . . 0.0 111.124 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.466 ' HG2' HD11 ' A' ' 116' ' ' ILE . 68.2 Cg_endo -79.33 169.4 18.87 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 123.083 2.522 . . . . 0.0 111.938 -178.093 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.524 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 98.7 m-20 -112.33 -44.72 3.35 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.174 179.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 39.1 tp -119.9 121.04 38.15 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.147 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.466 HD11 ' HG2' ' A' ' 113' ' ' PRO . 96.8 mt -118.18 131.32 71.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.769 -179.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.609 HD12 ' OG ' ' A' ' 48' ' ' SER . 31.5 mt -106.06 132.11 52.53 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.205 -179.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.497 HD12 HG23 ' A' ' 139' ' ' THR . 98.6 mt -117.76 136.08 56.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.55 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 86.4 p -71.48 151.41 43.97 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.608 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.32 -49.95 75.57 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.582 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -149.29 153.6 37.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.505 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 168.48 -169.69 41.75 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.88 -35.6 92.23 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.449 ' O ' ' OD1' ' A' ' 124' ' ' ASP . 44.3 p-10 -88.46 119.88 29.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.903 0.383 . . . . 0.0 110.598 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.446 ' O ' HD12 ' A' ' 129' ' ' LEU . 40.6 t -63.0 144.03 57.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.405 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.511 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.55 -43.07 8.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.779 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.8 tp -62.64 -42.42 99.59 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.821 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.85 -10.44 53.06 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.405 -179.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.446 HD12 ' O ' ' A' ' 125' ' ' SER . 82.1 mt -115.99 -24.3 8.16 Favored 'General case' 0 C--O 1.225 -0.222 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.56 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . 0.522 ' CD1' HG21 ' A' ' 139' ' ' THR . 71.3 t80 -51.37 -49.51 61.34 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.914 -0.314 . . . . 0.0 110.558 -178.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.2 p-10 -66.09 -41.79 90.17 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.846 -0.342 . . . . 0.0 111.054 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.523 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 87.9 mt-30 -67.91 -36.49 80.28 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.751 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.466 HD12 HD11 ' A' ' 118' ' ' ILE . 96.5 mt -80.35 -42.09 23.55 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.003 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.3 t -57.39 -45.25 84.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.293 -179.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.6 m -62.46 -45.66 92.03 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.656 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 92.2 mt -62.4 -43.78 98.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.312 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.598 ' HB1' ' HD2' ' A' ' 138' ' ' PRO . . . -170.2 163.54 6.2 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.581 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.598 ' HD2' ' HB1' ' A' ' 137' ' ' ALA . 76.0 Cg_exo -42.14 110.67 0.16 Allowed 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.561 2.174 . . . . 0.0 112.118 179.31 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.522 HG21 ' CD1' ' A' ' 130' ' ' TYR . 2.8 m -87.34 127.76 35.19 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.237 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.644 HD13 ' CD2' ' A' ' 37' ' ' HIS . 34.3 tp -119.63 139.21 52.57 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.451 179.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.431 ' O ' ' OD2' ' A' ' 32' ' ' ASP . 81.7 mt -105.11 119.93 54.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-O 120.953 0.406 . . . . 0.0 110.852 -179.206 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.48 HD12 HD22 ' A' ' 117' ' ' LEU . 97.1 mt -135.67 132.7 51.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.639 179.144 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.543 HD21 ' CG ' ' A' ' 241' ' ' ASP . 59.1 t30 -64.59 147.99 51.75 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.465 179.361 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.511 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 87.3 t80 -82.48 122.67 28.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.814 -179.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.511 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 99.0 m-20 55.05 69.31 0.75 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.561 179.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 34.2 p-10 -125.62 0.49 7.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.576 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -150.92 115.96 5.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.867 0.365 . . . . 0.0 110.642 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 85.0 p -63.76 169.11 4.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.613 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.407 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.7 p-90 -51.83 -16.13 0.64 Allowed 'General case' 0 C--O 1.22 -0.457 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.258 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.435 ' O ' HG23 ' A' ' 154' ' ' THR . 68.2 tp60 -70.19 -75.98 0.11 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.021 0.438 . . . . 0.0 110.614 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 11.1 t -62.58 -38.45 90.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.265 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 51.0 tp -60.16 -45.5 92.87 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.573 -178.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.407 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 45.4 tp -62.85 -41.63 99.43 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.612 178.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.435 HG23 ' O ' ' A' ' 150' ' ' GLN . 59.6 p -63.67 -35.01 79.15 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.251 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.467 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.5 mm-40 -63.54 -41.99 98.43 Favored 'General case' 0 C--O 1.225 -0.203 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.344 179.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 91.5 mt -65.44 -39.09 91.65 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.413 178.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.562 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.09 -32.15 79.33 Favored Glycine 0 N--CA 1.46 0.264 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 -179.247 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.467 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.3 mt-10 -36.81 -25.26 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.752 0.31 . . . . 0.0 110.881 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.562 ' N ' ' O ' ' A' ' 157' ' ' GLY . 95.5 mt -59.17 148.61 6.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.346 179.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 74.7 p -69.13 137.72 53.63 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.879 -179.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 70.69 21.88 77.95 Favored Glycine 0 CA--C 1.519 0.335 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 179.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 59.8 m80 -124.35 -13.78 7.08 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 110.448 -0.204 . . . . 0.0 110.448 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -66.24 -59.9 3.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.506 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -51.79 -49.07 63.41 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.119 -179.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -60.41 -41.03 93.08 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.862 0.363 . . . . 0.0 110.448 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.58 -47.19 86.61 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.551 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -57.0 -39.96 75.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.25 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -61.69 -50.49 72.25 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.694 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.412 ' NE ' ' HB1' ' A' ' 59' ' ' ALA . 60.0 ttt85 -65.29 -43.89 89.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.458 179.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 95.3 mt -64.32 -43.55 97.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.412 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.28 -51.05 70.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.432 -179.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -63.79 -43.43 96.32 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.846 0.355 . . . . 0.0 110.539 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.657 ' CE2' HD11 ' A' ' 177' ' ' LEU . 56.6 t80 -62.66 -44.44 96.26 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.084 0.468 . . . . 0.0 110.423 179.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -63.62 -39.87 95.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.475 -179.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -62.97 -42.6 99.88 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.725 179.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -60.74 -44.55 96.52 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.24 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.657 HD11 ' CE2' ' A' ' 173' ' ' PHE . 85.1 mt -64.55 -41.07 96.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.875 178.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.24 -61.95 1.95 Allowed 'General case' 0 C--O 1.239 0.515 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.426 -179.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.72 -47.12 85.68 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.358 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -52.83 -41.55 64.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.314 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -63.79 -33.71 76.28 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.36 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.405 ' HG2' ' O ' ' A' ' 182' ' ' GLU . 69.6 tt0 -90.92 8.52 34.66 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.539 0.685 . . . . 0.0 110.302 -178.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -104.24 -32.22 9.22 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.088 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.4 pt -128.04 147.77 32.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.886 0.374 . . . . 0.0 110.635 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -139.93 131.31 26.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.478 179.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.585 HD22 ' N ' ' A' ' 186' ' ' LEU . 3.6 mm? -85.36 133.32 42.67 Favored Pre-proline 0 N--CA 1.448 -0.559 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.088 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -44.02 157.9 0.14 Allowed 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.645 2.23 . . . . 0.0 112.194 179.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 0.49 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.5 Cg_endo -63.12 114.78 2.61 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.716 2.277 . . . . 0.0 111.632 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . 0.49 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.7 mt-30 156.03 148.11 0.0 OUTLIER Pre-proline 0 C--N 1.34 0.194 0 O-C-N 124.401 1.063 . . . . 0.0 110.894 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -73.58 144.56 36.02 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 122.597 2.198 . . . . 0.0 111.905 177.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.496 HG23 ' OG ' ' A' ' 258' ' ' SER . 2.1 p -124.78 158.93 31.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.229 0.538 . . . . 0.0 110.109 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . 0.481 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 38.1 p -143.16 165.18 28.13 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 121.396 0.617 . . . . 0.0 110.973 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . 0.445 ' HA ' ' H ' ' A' ' 260' ' ' PHE . . . -135.15 128.93 33.03 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 121.377 0.608 . . . . 0.0 110.358 178.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.509 HD11 HD23 ' A' ' 259' ' ' LEU . 47.2 pt -146.57 148.97 16.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.972 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . 0.74 HG13 ' CD1' ' A' ' 262' ' ' PHE . 72.3 t -117.73 123.15 71.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.183 0.516 . . . . 0.0 109.932 178.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -134.35 106.91 7.33 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.289 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 94.2 m -130.85 130.44 43.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.872 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.41 ' O ' ' N ' ' A' ' 201' ' ' HIS . . . -82.73 -37.03 25.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.258 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.5 -67.08 0.26 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.297 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -71.91 -9.77 58.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.379 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . 0.41 ' N ' ' O ' ' A' ' 198' ' ' ALA . 60.3 t-80 60.38 57.97 2.7 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.591 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 47.6 p -166.66 153.38 8.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.57 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.29 144.13 24.47 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.946 0.403 . . . . 0.0 110.426 179.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -135.4 138.67 43.51 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.525 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 19.0 mt -106.21 125.26 50.77 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' TRP . . . . . 0.557 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 75.0 m95 -82.12 167.51 18.68 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.593 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . 0.45 HG22 ' C ' ' A' ' 206' ' ' TRP . 0.1 OUTLIER -157.18 171.56 7.28 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.595 -178.674 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.8 -37.26 84.63 Favored 'Trans proline' 0 C--N 1.302 -1.915 0 C-N-CA 122.598 2.199 . . . . 0.0 112.183 179.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -70.89 -34.73 71.87 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.713 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 21.4 m -61.23 151.08 32.63 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.529 -179.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.65 -37.01 82.47 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.392 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . 0.557 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 55.0 tt0 -64.8 -40.31 95.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.477 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.78 -43.39 91.82 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -62.74 -44.15 96.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.809 0.338 . . . . 0.0 110.262 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . 0.546 ' SD ' ' HB2' ' A' ' 304' ' ' ALA . 65.3 ttp -59.46 -47.82 84.03 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.221 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 87.0 mt -60.4 -41.07 93.1 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . 0.448 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.3 tp10 -58.18 -38.07 75.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.074 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -65.32 -38.24 89.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.743 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 95.7 mt -64.1 -42.79 96.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.684 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.49 45.45 0.08 OUTLIER Glycine 0 N--CA 1.462 0.416 0 N-CA-C 111.111 -0.795 . . . . 0.0 111.111 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . 0.448 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 27.4 m-85 -128.29 155.6 44.34 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.83 0.347 . . . . 0.0 110.482 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.476 ' O ' HG13 ' A' ' 191' ' ' VAL . 7.5 p -107.11 122.35 46.32 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-O 121.225 0.536 . . . . 0.0 110.215 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.475 HD22 ' C ' ' A' ' 222' ' ' THR . 4.3 mm? -101.47 133.06 46.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.016 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.76 159.67 14.8 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.471 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.33 115.15 29.76 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.377 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.493 ' N ' HD12 ' A' ' 226' ' ' LEU . 9.0 mp -53.08 156.83 3.35 Favored Pre-proline 0 N--CA 1.447 -0.62 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.811 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -60.3 145.36 98.75 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 C-N-CA 122.735 2.29 . . . . 0.0 112.091 179.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.24 -3.22 59.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.521 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.07 -40.94 5.7 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.503 ' O ' ' N ' ' A' ' 233' ' ' SER . 68.7 mt -79.36 -17.25 54.84 Favored 'General case' 0 C--O 1.219 -0.542 0 CA-C-O 121.04 0.447 . . . . 0.0 110.297 -179.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 54.6 t-20 -40.48 -49.51 2.89 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.842 0.354 . . . . 0.0 110.717 -179.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -87.69 15.46 6.86 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.241 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.503 ' N ' ' O ' ' A' ' 230' ' ' LEU . 77.9 p -60.62 -35.2 75.56 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.608 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . 0.522 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.6 tt0 -119.54 -69.34 0.85 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.717 179.32 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.0 m -69.72 102.1 1.83 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.955 0.407 . . . . 0.0 110.592 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -93.78 57.56 2.52 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.34 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -144.63 -122.5 1.58 Allowed Glycine 0 N--CA 1.462 0.397 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -135.44 111.78 9.79 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.0 0.428 . . . . 0.0 110.374 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . 0.524 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.5 mtt180 -148.27 58.26 1.08 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.596 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -69.47 -32.35 71.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.571 179.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . 0.543 ' CG ' HD21 ' A' ' 143' ' ' ASN . 64.8 t0 -56.85 -47.3 80.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.266 -179.042 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' ILE . . . . . 0.435 ' O ' ' O ' ' A' ' 239' ' ' ARG . 17.8 tt -139.65 156.17 25.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.851 0.358 . . . . 0.0 110.371 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.451 HG22 HD13 ' A' ' 245' ' ' LEU . 96.2 mt -106.07 106.61 20.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.947 0.403 . . . . 0.0 110.382 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . 0.589 ' O ' HD12 ' A' ' 245' ' ' LEU . 88.3 mt-30 -110.55 110.06 20.63 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.329 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.589 HD12 ' O ' ' A' ' 244' ' ' GLN . 9.6 mp -121.77 -168.14 1.65 Allowed 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.634 179.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . 0.522 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.83 -16.57 0.05 OUTLIER Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . 0.668 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -61.09 156.41 33.49 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -63.49 21.63 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.783 0.325 . . . . 0.0 110.563 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . 0.668 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.8 m-20 -96.93 -6.4 35.72 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.756 0.313 . . . . 0.0 110.492 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 91.8 mt -79.5 -21.72 44.92 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.931 179.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.79 -51.36 70.32 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.648 -179.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.33 -5.45 58.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.463 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -80.91 -74.25 1.14 Allowed Glycine 0 CA--C 1.522 0.528 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 80.8 mt -70.17 126.09 28.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.888 0.375 . . . . 0.0 110.344 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -59.69 -39.22 83.82 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.336 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 83.28 51.84 4.0 Favored Glycine 0 CA--C 1.521 0.446 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -95.58 -15.52 22.74 Favored 'General case' 0 C--N 1.331 -0.223 0 O-C-N 122.823 -0.222 . . . . 0.0 110.578 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . 0.496 ' OG ' HG23 ' A' ' 191' ' ' VAL . 3.4 t 174.77 89.14 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.161 0.505 . . . . 0.0 110.268 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.85 ' N ' HD12 ' A' ' 259' ' ' LEU . 0.9 OUTLIER -94.76 124.2 38.65 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.857 0.361 . . . . 0.0 110.985 -178.729 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 260' ' ' PHE . . . . . 0.445 ' H ' ' HA ' ' A' ' 193' ' ' ALA . 15.7 m-30 -93.61 146.41 23.83 Favored 'General case' 0 CA--C 1.497 -1.064 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.543 179.202 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 85.0 mt -122.21 148.87 44.43 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.554 -179.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.74 ' CD1' HG13 ' A' ' 195' ' ' VAL . 2.5 p90 -77.17 -139.07 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.436 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . 0.654 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -51.15 77.22 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.353 0 O-C-N 123.435 0.459 . . . . 0.0 111.108 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . 0.624 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.43 104.64 0.19 Allowed Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 265' ' ' ASP . . . . . 0.588 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.6 m-20 -80.14 -177.77 6.23 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 122.703 -0.293 . . . . 0.0 110.718 -179.549 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -40.8 -17.78 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.496 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . 0.588 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.01 -51.3 48.69 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.758 179.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -64.11 -46.5 83.92 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.98 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . 0.572 ' HB1' ' OH ' ' A' ' 273' ' ' TYR . . . -61.76 -34.83 76.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.697 0.761 . . . . 0.0 109.883 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -62.93 -35.0 78.65 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.185 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.09 -43.12 14.18 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.184 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 272' ' ' ILE . . . . . 0.589 ' C ' ' H ' ' A' ' 274' ' ' ALA . 5.0 tt -51.64 -33.77 15.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.552 -178.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 273' ' ' TYR . . . . . 0.572 ' OH ' ' HB1' ' A' ' 269' ' ' ALA . 16.8 m-85 -54.58 -1.67 0.03 OUTLIER 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.767 -179.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 274' ' ' ALA . . . . . 0.589 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.5 -39.94 70.49 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.942 179.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . 0.574 ' O ' ' N ' ' A' ' 279' ' ' ALA . 3.1 p30 -38.52 97.52 0.14 Allowed Pre-proline 0 C--N 1.339 0.135 0 O-C-N 123.532 0.52 . . . . 0.0 110.429 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -53.72 -43.17 60.23 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 C-N-CA 122.577 2.184 . . . . 0.0 112.511 -178.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 88.9 mt -64.36 -43.01 95.88 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.008 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 91.7 mt -95.95 -1.06 49.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.75 -179.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 279' ' ' ALA . . . . . 0.574 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.65 -34.93 78.08 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.501 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.32 20.36 0.11 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.841 -179.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 0.485 ' H ' ' C ' ' A' ' 279' ' ' ALA . 13.7 mt -74.68 119.82 78.54 Favored Pre-proline 0 N--CA 1.442 -0.837 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.776 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -51.15 -39.37 61.31 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 C-N-CA 122.507 2.138 . . . . 0.0 111.922 179.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.74 -50.54 63.25 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.898 0.38 . . . . 0.0 110.033 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 76.8 t -61.42 -43.88 97.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.169 179.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -57.56 -41.21 80.6 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.207 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -91.17 0.47 57.52 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.258 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt 59.26 43.91 16.25 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.84 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -95.01 41.2 1.09 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.32 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 53.9 t -119.13 135.58 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-O 121.018 0.437 . . . . 0.0 110.061 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -132.8 162.76 30.65 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.527 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.37 155.08 32.59 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.515 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 80.8 mt -94.09 -1.75 53.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.246 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 120.89 165.38 12.69 Favored Glycine 0 N--CA 1.464 0.504 0 N-CA-C 110.489 -1.045 . . . . 0.0 110.489 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 7.3 m -87.08 -62.47 1.5 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.829 0.347 . . . . 0.0 110.971 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 295' ' ' GLU . . . . . 0.45 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.5 mm-40 -68.71 -4.35 15.46 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.687 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 24.9 p -76.78 32.16 0.13 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.674 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 297' ' ' PHE . . . . . 0.502 ' CD2' HG22 ' A' ' 70' ' ' THR . 68.3 t80 -60.48 -46.21 90.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.664 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . 0.617 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.1 mtt85 -80.68 134.89 35.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.453 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.467 ' H ' HG11 ' A' ' 51' ' ' VAL . 18.6 tp -113.7 116.7 29.85 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-O 120.942 0.401 . . . . 0.0 110.385 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . 0.619 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.2 p-10 -165.0 -176.87 4.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.723 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -46.66 -43.22 17.45 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.373 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -67.15 -40.21 86.67 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 121.028 0.442 . . . . 0.0 110.752 179.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . 0.619 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 59.6 p -56.34 -36.27 68.58 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.079 -179.023 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . 0.546 ' HB2' ' SD ' ' A' ' 215' ' ' MET . . . -57.33 -51.47 69.25 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 179.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 91.9 mtp -55.71 -44.28 77.27 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -65.8 -42.75 90.32 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.227 0.537 . . . . 0.0 110.454 179.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 303' ' ' SER . 54.9 t -64.04 -42.82 96.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.262 179.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 44.2 tp -59.77 -41.92 92.16 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.041 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -62.79 -38.77 91.95 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.116 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 310' ' ' ARG . . . . . 0.449 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.6 ttt85 -63.56 -43.83 95.91 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.32 179.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 87.7 mt -63.37 -42.09 98.83 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.46 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.4 ttmt -63.03 -33.24 75.0 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.39 179.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.84 -23.47 21.67 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.395 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.486 HD22 ' CE2' ' A' ' 315' ' ' PHE . 6.7 tt -62.31 -43.27 99.22 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.488 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 315' ' ' PHE . . . . . 0.486 ' CE2' HD22 ' A' ' 314' ' ' LEU . 90.4 m-85 . . . . . 0 C--O 1.22 -0.486 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.317 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -99.5 136.48 39.37 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.174 0.512 . . . . 0.0 110.424 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.485 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -91.58 178.7 1.65 Allowed Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.469 -179.707 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.485 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.3 Cg_exo -61.76 147.51 95.14 Favored 'Trans proline' 0 C--N 1.301 -1.948 0 C-N-CA 122.955 2.437 . . . . 0.0 112.207 179.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.472 ' HE ' HD12 ' A' ' 39' ' ' LEU . 35.3 ptt180 -135.02 142.35 46.38 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.591 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -79.01 116.85 19.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.496 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.425 ' O ' HG23 ' A' ' 30' ' ' ILE . 9.5 tp -109.93 130.61 62.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.494 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.8 t -70.54 141.59 51.86 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.685 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.421 ' OD2' ' O ' ' A' ' 141' ' ' ILE . 24.8 t70 -139.83 177.1 8.19 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.452 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.4 p -73.11 -36.57 66.77 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.707 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -47.62 -95.05 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.275 -179.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -166.15 -25.54 0.02 OUTLIER Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 62.7 m -168.5 106.42 0.47 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.691 0.281 . . . . 0.0 110.633 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.574 ' CD2' HD13 ' A' ' 140' ' ' LEU . 34.0 t60 -129.79 144.2 51.18 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-O 121.016 0.436 . . . . 0.0 110.099 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.626 HG22 ' N ' ' A' ' 39' ' ' LEU . 95.9 m -128.47 166.46 18.72 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.338 -179.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.626 ' N ' HG22 ' A' ' 38' ' ' THR . 81.4 mt -121.08 127.73 51.93 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.66 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -63.93 -44.64 92.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.689 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 38.3 p -165.45 155.36 12.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.45 179.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.519 ' H ' ' CD ' ' A' ' 42' ' ' GLN . 14.3 mp0 -42.33 100.07 0.22 Allowed Pre-proline 0 C--O 1.236 0.379 0 O-C-N 123.47 0.481 . . . . 0.0 110.564 179.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -56.87 129.3 33.82 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 122.362 2.041 . . . . 0.0 112.191 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -83.89 -24.16 30.92 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.649 179.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.539 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.6 mtm-85 -121.26 134.53 55.18 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.149 0.499 . . . . 0.0 110.193 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.2 mt -130.68 133.34 63.52 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.313 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.598 -179.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 47.0 t -124.91 130.87 73.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 CA-C-O 120.992 0.425 . . . . 0.0 110.039 179.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.595 ' OG ' HD12 ' A' ' 117' ' ' LEU . 4.6 m -154.32 166.38 33.37 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.513 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 67.4 p -124.45 8.96 8.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.389 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.94 125.44 33.36 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.599 -179.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.454 HG11 ' H ' ' A' ' 299' ' ' LEU . 84.5 t -65.51 -44.44 94.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.557 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.3 m -62.68 -44.25 96.72 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.598 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 52.1 tp -62.46 -41.48 98.78 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.573 -179.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.445 ' O ' HD13 ' A' ' 58' ' ' LEU . 73.3 m -57.83 -44.59 86.53 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.249 -179.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.26 -62.1 5.44 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.896 -0.881 . . . . 0.0 110.896 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.6 t -48.16 -35.67 12.09 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.6 mt -61.76 -44.42 96.92 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.161 179.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.459 HD21 HE22 ' A' ' 85' ' ' GLN . 9.1 mp -65.47 -41.06 93.75 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.412 177.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.404 ' HB1' ' NE ' ' A' ' 169' ' ' ARG . . . -63.78 -41.45 97.94 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.706 -179.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.411 ' O ' HG23 ' A' ' 60' ' ' ILE . 8.1 tp -87.8 16.77 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.82 -179.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 56.34 84.49 0.08 Allowed 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.828 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.22 58.52 0.08 OUTLIER Pre-proline 0 C--N 1.328 -0.368 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.414 ' HB3' HE21 ' A' ' 85' ' ' GLN . 9.6 Cg_endo -51.24 152.94 10.4 Favored 'Trans proline' 0 C--N 1.294 -2.335 0 C-N-CA 123.148 2.566 . . . . 0.0 112.206 -178.309 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.428 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -108.76 145.73 15.3 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.265 -179.685 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.68 -45.31 97.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.212 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.5 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -130.18 134.33 47.22 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.803 0.335 . . . . 0.0 110.352 -179.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.488 ' O ' ' N ' ' A' ' 98' ' ' LEU . 75.7 m -134.55 158.73 43.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.913 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.6 139.19 16.32 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.484 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.62 -162.82 0.09 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.893 0.378 . . . . 0.0 110.401 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.511 HG22 ' CD2' ' A' ' 297' ' ' PHE . 5.8 t -134.03 135.18 43.19 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.065 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.468 ' C ' ' O ' ' A' ' 70' ' ' THR . 0.8 OUTLIER 29.76 68.43 0.67 Allowed Pre-proline 0 N--CA 1.469 0.477 0 CA-C-O 121.138 0.494 . . . . 0.0 110.853 -179.522 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_exo -61.08 145.2 99.22 Favored 'Trans proline' 0 C--N 1.3 -1.985 0 C-N-CA 122.746 2.297 . . . . 0.0 111.842 -178.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.527 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 44.8 p-10 -159.86 -31.88 0.06 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.725 179.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.539 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 98.7 m-20 -64.45 -39.47 93.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.37 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.2 ttt180 -60.09 -48.56 81.22 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.354 -179.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.424 ' O ' ' O ' ' A' ' 77' ' ' ALA . 95.3 t -60.05 -25.0 31.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.16 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.539 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -45.59 172.89 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.614 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.568 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.3 p30 -61.91 177.68 0.42 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.484 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.563 ' C ' ' H ' ' A' ' 81' ' ' GLY . 36.2 p30 -45.64 85.55 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.95 0.405 . . . . 0.0 110.939 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.568 ' N ' ' O ' ' A' ' 78' ' ' ASP . 42.8 tp60 -67.35 13.56 0.07 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.235 0.541 . . . . 0.0 110.201 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.563 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 117.93 -22.55 9.79 Favored Glycine 0 N--CA 1.463 0.448 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -107.87 116.4 31.89 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.963 0.411 . . . . 0.0 110.415 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 76.1 mt -98.8 0.56 44.6 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.542 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -91.92 6.76 45.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.326 -179.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.779 ' O ' HG22 ' A' ' 89' ' ' VAL . 88.3 mt-30 -100.17 -26.96 13.76 Favored 'General case' 0 C--O 1.221 -0.441 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.733 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.1 t-105 -64.01 -40.75 97.03 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.952 -179.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.545 ' O ' ' N ' ' A' ' 91' ' ' LYS . 67.9 m -77.64 -53.33 7.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.053 -179.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -48.55 -51.05 29.57 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.919 -179.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.779 HG22 ' O ' ' A' ' 85' ' ' GLN . 15.7 m -68.83 -40.94 81.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.091 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.5 ' N ' HG23 ' A' ' 89' ' ' VAL . . . -71.87 -23.03 61.44 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.641 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.545 ' N ' ' O ' ' A' ' 87' ' ' SER . 65.9 tttm -61.52 -45.93 92.09 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.347 -179.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.441 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.6 mm-40 -90.27 -94.65 0.12 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.155 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.609 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.9 mtt180 -143.45 59.59 1.39 Allowed 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.437 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.7 pttp 34.24 26.08 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.247 0.546 . . . . 0.0 110.454 -179.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.609 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.4 tt -48.35 123.34 6.38 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.897 -177.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.452 ' O ' HD23 ' A' ' 95' ' ' LEU . 98.9 mm-40 -83.46 -170.6 3.13 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.275 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.615 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 83.0 mtp180 -73.56 137.62 44.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.984 0.421 . . . . 0.0 110.248 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.488 ' N ' ' O ' ' A' ' 67' ' ' SER . 90.1 mt -86.13 -166.18 1.47 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.899 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.532 ' CD2' ' O ' ' A' ' 99' ' ' TYR . 47.9 p90 -168.05 120.08 0.85 Allowed 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.084 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.488 ' C ' ' O ' ' A' ' 99' ' ' TYR . 43.2 mm -29.75 121.26 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 O-C-N 123.332 0.395 . . . . 0.0 110.922 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 113.87 28.17 3.25 Favored Glycine 0 N--CA 1.462 0.387 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 -179.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.578 ' N ' ' CD ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -143.99 45.81 0.59 Allowed Pre-proline 0 C--N 1.322 -0.594 0 CA-C-O 121.203 0.525 . . . . 0.0 110.436 179.791 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 29.6 Cg_endo -62.06 143.83 95.39 Favored 'Trans proline' 0 C--N 1.295 -2.277 0 C-N-CA 122.667 2.245 . . . . 0.0 111.815 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.455 ' O ' HG23 ' A' ' 108' ' ' VAL . 27.2 t -173.13 120.73 0.36 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.47 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.25 -40.69 64.43 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.192 179.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.16 -39.85 90.09 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.7 -179.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.1 -39.78 94.8 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.673 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 104' ' ' SER . 69.7 t -67.7 -43.75 86.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.596 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.5 -39.31 93.09 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.552 -179.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.441 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.68 -23.5 63.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.542 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.527 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.4 mm-40 -91.26 4.77 51.48 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.7 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.539 ' O ' ' NE ' ' A' ' 45' ' ' ARG . 10.7 tpt 22.51 64.52 0.34 Allowed Pre-proline 0 N--CA 1.47 0.57 0 O-C-N 123.342 0.401 . . . . 0.0 111.204 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.452 ' HG2' HD11 ' A' ' 116' ' ' ILE . 65.3 Cg_endo -79.37 169.1 19.22 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 123.085 2.524 . . . . 0.0 111.679 -177.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.515 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 98.6 m-20 -112.57 -43.67 3.45 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.116 179.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.4 tp -120.64 121.39 38.22 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 120.884 0.373 . . . . 0.0 110.091 179.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.457 HD13 HD22 ' A' ' 133' ' ' LEU . 96.9 mt -118.84 130.85 73.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-O 120.888 0.375 . . . . 0.0 110.858 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.595 HD12 ' OG ' ' A' ' 48' ' ' SER . 32.1 mt -105.69 132.55 51.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.344 -179.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.417 HD12 HG23 ' A' ' 139' ' ' THR . 98.1 mt -117.89 135.97 56.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.565 -179.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 86.9 p -71.79 152.9 42.33 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.577 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -59.96 -50.03 75.35 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.617 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -149.37 153.72 37.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.535 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 169.71 -170.55 42.81 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -63.02 -35.13 91.68 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.449 ' O ' ' OD1' ' A' ' 124' ' ' ASP . 44.1 p-10 -88.04 119.69 28.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.922 0.391 . . . . 0.0 110.578 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.444 ' O ' HD12 ' A' ' 129' ' ' LEU . 40.4 t -63.39 144.42 56.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.429 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.52 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.51 -42.76 9.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.742 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 56.0 tp -62.76 -42.34 99.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.677 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.25 -11.04 58.7 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.375 -179.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.444 HD12 ' O ' ' A' ' 125' ' ' SER . 83.8 mt -115.07 -24.58 8.49 Favored 'General case' 0 C--O 1.225 -0.234 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.57 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . 0.52 ' N ' ' O ' ' A' ' 126' ' ' ALA . 77.3 t80 -51.35 -49.84 60.65 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.936 -0.306 . . . . 0.0 110.612 -178.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.7 p-10 -65.77 -41.71 91.73 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.267 179.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.521 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 88.2 mt-30 -68.06 -36.97 80.73 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.826 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.457 HD22 HD13 ' A' ' 116' ' ' ILE . 94.1 mt -79.9 -42.19 24.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.915 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.3 t -57.05 -45.03 83.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.216 -179.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.7 m -62.23 -45.66 92.32 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.615 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 92.9 mt -62.48 -43.94 98.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.361 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.609 ' HB1' ' HD2' ' A' ' 138' ' ' PRO . . . -169.91 163.98 6.4 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.593 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.609 ' HD2' ' HB1' ' A' ' 137' ' ' ALA . 78.2 Cg_exo -43.17 111.94 0.26 Allowed 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.544 2.163 . . . . 0.0 112.3 179.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.485 HG21 ' CD1' ' A' ' 130' ' ' TYR . 17.1 m -86.07 127.59 34.71 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.487 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.574 HD13 ' CD2' ' A' ' 37' ' ' HIS . 34.9 tp -119.78 138.0 53.62 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.256 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.421 ' O ' ' OD2' ' A' ' 32' ' ' ASP . 79.2 mt -104.88 121.0 56.26 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.184 0 CA-C-O 121.068 0.461 . . . . 0.0 110.879 -179.14 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.497 HD12 HD22 ' A' ' 117' ' ' LEU . 93.2 mt -136.86 132.73 47.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.553 179.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.542 HD21 ' CG ' ' A' ' 241' ' ' ASP . 60.9 t30 -64.19 151.16 44.17 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.534 179.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.516 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 89.0 t80 -86.03 122.52 30.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.786 -179.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.516 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 99.1 m-20 55.3 69.16 0.76 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.547 179.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 36.2 p-10 -125.26 0.61 7.76 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.589 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -151.15 116.15 5.26 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.823 0.344 . . . . 0.0 110.581 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 85.3 p -63.24 168.08 4.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.564 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.403 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.7 p-90 -51.13 -15.65 0.37 Allowed 'General case' 0 C--O 1.221 -0.405 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.313 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.439 ' O ' HG23 ' A' ' 154' ' ' THR . 68.1 tp60 -71.09 -74.89 0.14 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.009 0.433 . . . . 0.0 110.581 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 11.2 t -62.68 -38.87 92.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.238 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 52.3 tp -60.23 -45.57 92.78 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.451 -178.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.403 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 45.5 tp -62.61 -41.69 99.15 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.597 178.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.439 HG23 ' O ' ' A' ' 150' ' ' GLN . 56.1 p -63.85 -34.8 78.75 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.202 -179.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.481 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.4 mm-40 -63.69 -42.05 98.06 Favored 'General case' 0 C--O 1.224 -0.262 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.371 179.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 91.3 mt -65.44 -38.87 91.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.182 0.515 . . . . 0.0 110.376 178.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.557 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.34 -31.78 78.48 Favored Glycine 0 C--N 1.331 0.279 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 -179.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.481 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.3 mt-10 -37.18 -24.99 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.848 0.356 . . . . 0.0 110.948 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.557 ' N ' ' O ' ' A' ' 157' ' ' GLY . 93.8 mt -59.71 149.25 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.385 179.127 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 76.0 p -69.13 137.54 53.48 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.904 -179.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 70.41 22.28 77.65 Favored Glycine 0 CA--C 1.518 0.235 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 179.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 61.7 m80 -124.34 -14.14 7.01 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.621 0.248 . . . . 0.0 110.454 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -66.76 -59.55 3.47 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.56 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -51.73 -49.37 62.68 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.136 -179.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -60.3 -41.21 92.93 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.884 0.373 . . . . 0.0 110.501 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.38 -47.58 85.17 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.472 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.64 -40.06 74.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.306 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -61.7 -50.27 73.13 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.699 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.404 ' NE ' ' HB1' ' A' ' 59' ' ' ALA . 60.0 ttt85 -65.26 -43.67 90.57 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.576 179.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 94.7 mt -64.48 -43.46 96.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.346 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.51 -51.26 70.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.299 -179.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.56 -43.73 96.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.922 0.392 . . . . 0.0 110.655 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.657 ' CE2' HD11 ' A' ' 177' ' ' LEU . 55.9 t80 -62.78 -44.29 96.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.363 179.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -63.57 -39.62 94.88 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.446 -179.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -63.15 -42.69 99.48 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.583 179.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -60.62 -44.81 95.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.241 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.657 HD11 ' CE2' ' A' ' 173' ' ' PHE . 85.2 mt -64.65 -41.03 96.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.871 178.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.02 -61.98 1.92 Allowed 'General case' 0 C--O 1.239 0.506 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.428 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.96 -46.8 87.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.333 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -52.97 -41.63 64.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.414 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -63.98 -33.71 76.34 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.32 179.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.407 ' HG2' ' O ' ' A' ' 182' ' ' GLU . 69.7 tt0 -90.95 8.75 33.59 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.631 0.729 . . . . 0.0 110.258 -178.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -104.56 -31.97 9.18 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 122.041 -0.412 . . . . 0.0 111.099 179.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.6 pt -128.07 147.87 32.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.625 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -140.0 131.36 26.79 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.463 178.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.591 HD22 ' N ' ' A' ' 186' ' ' LEU . 3.6 mm? -85.32 133.1 43.18 Favored Pre-proline 0 N--CA 1.447 -0.584 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.146 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -43.93 157.83 0.14 Allowed 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 122.597 2.198 . . . . 0.0 112.35 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 0.49 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.6 Cg_endo -63.2 115.11 2.78 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.809 2.339 . . . . 0.0 111.615 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . 0.49 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.7 mt-30 155.91 147.99 0.0 OUTLIER Pre-proline 0 C--O 1.232 0.177 0 O-C-N 124.393 1.058 . . . . 0.0 110.871 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -73.54 144.01 35.29 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 122.612 2.208 . . . . 0.0 112.158 177.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.496 HG23 ' OG ' ' A' ' 258' ' ' SER . 2.1 p -124.82 159.17 31.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.409 0.623 . . . . 0.0 110.147 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . 0.485 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 35.4 p -143.2 165.47 27.35 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.048 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . 0.448 ' HA ' ' H ' ' A' ' 260' ' ' PHE . . . -135.4 128.89 32.42 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-O 121.364 0.602 . . . . 0.0 110.33 179.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.509 HD11 HD23 ' A' ' 259' ' ' LEU . 47.3 pt -146.42 148.83 16.62 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.374 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.113 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . 0.74 HG13 ' CD1' ' A' ' 262' ' ' PHE . 70.2 t -117.55 123.18 71.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.226 0.536 . . . . 0.0 109.973 178.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -134.31 107.07 7.43 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.054 0.454 . . . . 0.0 110.259 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 94.9 m -130.93 130.37 43.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.843 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.407 ' O ' ' N ' ' A' ' 201' ' ' HIS . . . -82.79 -36.84 25.28 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.295 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.22 -67.18 0.25 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.29 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.11 -10.15 59.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.425 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . 0.407 ' N ' ' O ' ' A' ' 198' ' ' ALA . 60.2 t-80 61.01 58.15 2.35 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.64 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 41.9 p -166.86 153.65 8.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.609 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.53 144.23 24.34 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.948 0.404 . . . . 0.0 110.441 179.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -135.42 138.41 43.21 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.554 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 19.4 mt -106.09 125.33 50.86 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.923 0.392 . . . . 0.0 109.974 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' TRP . . . . . 0.556 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 75.2 m95 -82.19 167.39 18.74 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.569 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . 0.449 HG22 ' C ' ' A' ' 206' ' ' TRP . 0.1 OUTLIER -157.14 171.67 7.15 Favored Pre-proline 0 C--O 1.225 -0.234 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.622 -178.764 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -53.79 -36.97 84.25 Favored 'Trans proline' 0 C--N 1.301 -1.935 0 C-N-CA 122.63 2.22 . . . . 0.0 112.306 179.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -71.09 -34.71 71.39 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.679 -179.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 21.7 m -61.3 150.72 34.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.569 -179.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.49 -36.97 81.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.418 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . 0.556 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 55.3 tt0 -64.72 -40.21 94.96 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.557 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.98 -43.49 91.12 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -62.91 -44.04 97.16 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.848 0.356 . . . . 0.0 110.249 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . 0.546 ' SD ' ' HB2' ' A' ' 304' ' ' ALA . 65.4 ttp -59.41 -48.11 82.9 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.069 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 87.1 mt -60.19 -41.16 92.35 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . 0.45 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.1 tp10 -57.9 -37.97 74.99 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.148 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -65.49 -38.04 88.58 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.71 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 95.4 mt -64.09 -42.78 96.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.639 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.59 45.16 0.08 OUTLIER Glycine 0 N--CA 1.462 0.393 0 N-CA-C 111.054 -0.819 . . . . 0.0 111.054 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . 0.45 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 26.9 m-85 -128.07 155.23 44.7 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.926 0.393 . . . . 0.0 110.509 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.474 ' C ' HD22 ' A' ' 223' ' ' LEU . 6.9 p -106.94 122.23 46.02 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-O 121.299 0.571 . . . . 0.0 110.125 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.474 HD22 ' C ' ' A' ' 222' ' ' THR . 4.3 mm? -101.32 132.9 46.63 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.144 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.51 159.46 14.92 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.485 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.19 115.23 29.92 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.416 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.489 ' N ' HD12 ' A' ' 226' ' ' LEU . 9.1 mp -53.25 156.79 3.66 Favored Pre-proline 0 N--CA 1.447 -0.623 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.796 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -60.2 145.26 98.92 Favored 'Trans proline' 0 C--N 1.302 -1.873 0 C-N-CA 122.735 2.29 . . . . 0.0 112.145 179.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.42 -3.01 59.01 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.544 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.19 -40.91 5.67 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.51 ' O ' ' N ' ' A' ' 233' ' ' SER . 84.8 mt -79.23 -16.85 55.87 Favored 'General case' 0 C--O 1.218 -0.562 0 CA-C-O 121.131 0.491 . . . . 0.0 110.323 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 54.3 t-20 -40.38 -49.33 2.8 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.839 0.352 . . . . 0.0 110.733 -179.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -87.99 15.44 7.27 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.251 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.51 ' N ' ' O ' ' A' ' 230' ' ' LEU . 77.8 p -60.59 -35.29 75.74 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.655 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . 0.524 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.6 tt0 -119.03 -69.33 0.86 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.753 0.311 . . . . 0.0 110.751 179.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.2 m -70.0 102.62 2.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.633 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -94.08 57.76 2.44 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.361 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -144.72 -122.59 1.58 Allowed Glycine 0 N--CA 1.461 0.363 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -134.84 111.59 10.01 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.059 0.456 . . . . 0.0 110.35 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . 0.517 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.4 mtt180 -148.05 57.94 1.09 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.664 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -69.75 -31.98 70.26 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.521 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . 0.542 ' CG ' HD21 ' A' ' 143' ' ' ASN . 64.9 t0 -56.92 -47.11 81.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.255 -179.004 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' ILE . . . . . 0.437 ' O ' ' O ' ' A' ' 239' ' ' ARG . 17.8 tt -139.95 156.63 25.41 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.263 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.391 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.445 HG22 HD13 ' A' ' 245' ' ' LEU . 96.1 mt -106.02 106.37 20.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-O 120.971 0.415 . . . . 0.0 110.468 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . 0.59 ' C ' HD12 ' A' ' 245' ' ' LEU . 88.2 mt-30 -110.57 110.17 20.77 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.362 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.59 HD12 ' C ' ' A' ' 244' ' ' GLN . 9.6 mp -121.77 -168.24 1.67 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.666 179.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . 0.524 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.7 -16.93 0.05 OUTLIER Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . 0.67 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -60.47 156.7 30.4 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 110.829 -0.908 . . . . 0.0 110.829 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -63.57 21.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.825 0.345 . . . . 0.0 110.583 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . 0.67 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.8 m-20 -96.85 -6.04 36.84 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.436 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 91.5 mt -79.89 -21.65 43.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.902 179.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.65 -51.35 70.28 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.661 -179.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.7 -5.1 58.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.458 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.27 -74.06 1.16 Allowed Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 80.1 mt -70.02 125.95 28.24 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.883 0.373 . . . . 0.0 110.334 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -59.53 -39.48 84.07 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.254 -179.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 83.27 51.77 4.02 Favored Glycine 0 CA--C 1.52 0.368 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -95.3 -15.76 22.9 Favored 'General case' 0 C--N 1.33 -0.243 0 O-C-N 122.77 -0.253 . . . . 0.0 110.661 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . 0.496 ' OG ' HG23 ' A' ' 191' ' ' VAL . 3.4 t 174.87 89.31 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.227 0.537 . . . . 0.0 110.244 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.849 ' N ' HD12 ' A' ' 259' ' ' LEU . 0.9 OUTLIER -94.8 124.31 38.77 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.052 0.453 . . . . 0.0 111.052 -178.78 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 260' ' ' PHE . . . . . 0.448 ' H ' ' HA ' ' A' ' 193' ' ' ALA . 15.8 m-30 -93.58 146.4 23.84 Favored 'General case' 0 CA--C 1.495 -1.142 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.494 179.273 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 85.9 mt -122.18 149.24 43.91 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.564 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.74 ' CD1' HG13 ' A' ' 195' ' ' VAL . 2.6 p90 -77.23 -138.82 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.534 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . 0.652 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -51.39 77.03 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.407 0 O-C-N 123.415 0.447 . . . . 0.0 111.171 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . 0.625 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.16 104.74 0.19 Allowed Glycine 0 CA--C 1.528 0.87 0 N-CA-C 110.421 -1.072 . . . . 0.0 110.421 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 265' ' ' ASP . . . . . 0.589 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.4 m-20 -80.21 -177.9 6.32 Favored 'General case' 0 C--N 1.327 -0.394 0 O-C-N 122.671 -0.311 . . . . 0.0 110.847 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -40.7 -17.76 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.549 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . 0.589 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.21 -51.44 45.48 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.614 179.22 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -63.9 -46.39 85.05 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.997 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . 0.566 ' HB1' ' OH ' ' A' ' 273' ' ' TYR . . . -61.88 -34.92 76.9 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.657 0.741 . . . . 0.0 109.824 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -62.82 -34.66 77.77 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.292 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.43 -43.11 13.9 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.049 -179.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 272' ' ' ILE . . . . . 0.595 ' C ' ' H ' ' A' ' 274' ' ' ALA . 4.9 tt -51.53 -33.71 14.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.678 -178.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 273' ' ' TYR . . . . . 0.566 ' OH ' ' HB1' ' A' ' 269' ' ' ALA . 17.2 m-85 -54.71 -1.55 0.03 OUTLIER 'General case' 0 CA--C 1.513 -0.452 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.616 -179.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 274' ' ' ALA . . . . . 0.595 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.61 -39.78 70.24 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.802 179.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . 0.573 ' O ' ' N ' ' A' ' 279' ' ' ALA . 2.6 p30 -38.98 97.9 0.15 Allowed Pre-proline 0 N--CA 1.462 0.151 0 O-C-N 123.49 0.494 . . . . 0.0 110.33 -179.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -54.18 -42.92 63.12 Favored 'Trans proline' 0 C--N 1.303 -1.845 0 C-N-CA 122.58 2.187 . . . . 0.0 112.491 -178.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 88.5 mt -64.41 -43.02 95.69 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.015 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 91.5 mt -95.66 -1.45 50.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.863 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 279' ' ' ALA . . . . . 0.573 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.58 -34.87 77.84 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.486 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.32 20.14 0.12 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.9 -179.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 0.483 ' H ' ' C ' ' A' ' 279' ' ' ALA . 13.8 mt -74.65 119.53 77.1 Favored Pre-proline 0 N--CA 1.442 -0.838 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.849 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -50.57 -39.71 55.47 Favored 'Trans proline' 0 C--N 1.312 -1.36 0 C-N-CA 122.535 2.156 . . . . 0.0 112.063 178.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.73 -50.69 62.92 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.874 0.369 . . . . 0.0 110.021 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 76.9 t -61.4 -43.77 97.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.162 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -57.81 -41.2 81.71 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.089 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -91.0 0.63 57.5 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.245 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt 59.16 43.63 16.94 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.966 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -95.1 41.22 1.1 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.314 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 53.9 t -118.9 135.68 58.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-O 121.119 0.485 . . . . 0.0 109.967 -179.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -132.81 162.73 30.75 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.534 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.54 155.12 32.79 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.523 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 81.0 mt -94.09 -1.73 53.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.256 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.14 165.59 12.71 Favored Glycine 0 N--CA 1.465 0.613 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 6.8 m -87.33 -62.34 1.52 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.879 0.371 . . . . 0.0 110.947 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 295' ' ' GLU . . . . . 0.446 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.6 mm-40 -69.02 -4.07 15.48 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.755 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 24.5 p -76.92 32.32 0.14 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.68 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 297' ' ' PHE . . . . . 0.511 ' CD2' HG22 ' A' ' 70' ' ' THR . 70.8 t80 -60.43 -45.97 91.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.624 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . 0.615 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.1 mtt85 -81.27 134.85 35.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.543 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.454 ' H ' HG11 ' A' ' 51' ' ' VAL . 17.7 tp -113.68 117.22 30.95 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-O 120.918 0.39 . . . . 0.0 110.391 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . 0.639 ' H ' ' CB ' ' A' ' 303' ' ' SER . 49.9 p-10 -165.3 -176.47 4.06 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.758 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 80.2 t80 -46.81 -43.49 18.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.391 -179.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -66.92 -40.35 87.61 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 121.037 0.446 . . . . 0.0 110.723 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . 0.639 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 60.1 p -55.99 -36.37 67.81 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.062 -179.054 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . 0.546 ' HB2' ' SD ' ' A' ' 215' ' ' MET . . . -57.11 -51.8 67.85 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 179.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 92.2 mtp -55.48 -44.45 76.52 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -65.86 -42.66 90.15 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.309 0.576 . . . . 0.0 110.398 179.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 303' ' ' SER . 55.6 t -63.96 -42.92 97.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.253 179.307 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 44.0 tp -59.73 -41.93 92.02 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.029 -179.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -62.87 -38.69 91.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.069 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 310' ' ' ARG . . . . . 0.446 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.7 ttt85 -63.42 -43.84 96.34 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.295 179.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 90.2 mt -63.1 -42.1 99.52 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.489 179.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -63.01 -33.36 75.25 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.304 179.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.48 -23.54 22.06 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.285 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.481 HD22 ' CE2' ' A' ' 315' ' ' PHE . 6.7 tt -62.31 -43.19 99.4 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 121.012 0.434 . . . . 0.0 110.526 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 315' ' ' PHE . . . . . 0.481 ' CE2' HD22 ' A' ' 314' ' ' LEU . 89.4 m-85 . . . . . 0 C--O 1.22 -0.461 0 CA-C-O 118.041 -0.98 . . . . 0.0 110.263 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -99.73 135.85 40.54 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.167 0.508 . . . . 0.0 110.403 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.492 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -92.33 178.62 1.61 Allowed Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.533 -179.797 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.492 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.0 Cg_exo -61.68 147.29 95.68 Favored 'Trans proline' 0 C--N 1.298 -2.104 0 C-N-CA 122.893 2.396 . . . . 0.0 112.164 179.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.498 ' HE ' HD12 ' A' ' 39' ' ' LEU . 35.3 ptt180 -136.91 142.59 42.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.636 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -79.52 117.06 20.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.459 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.443 ' O ' HG23 ' A' ' 30' ' ' ILE . 9.5 tp -111.5 130.74 64.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.468 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.6 t -71.55 142.41 50.07 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.677 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.481 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.6 t0 -139.54 -179.81 6.12 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.502 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.481 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 77.9 p -73.83 -37.34 64.87 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.655 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.8 ttt85 -46.97 -94.77 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.335 -179.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -165.9 -27.02 0.02 OUTLIER Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 63.4 m -168.67 105.98 0.44 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.834 0.35 . . . . 0.0 110.643 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.638 ' CD2' HD13 ' A' ' 140' ' ' LEU . 64.4 t60 -129.11 146.15 51.12 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 121.11 0.481 . . . . 0.0 110.112 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.62 HG22 ' N ' ' A' ' 39' ' ' LEU . 93.3 m -129.36 165.59 21.21 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.4 -179.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.62 ' N ' HG22 ' A' ' 38' ' ' THR . 79.6 mt -120.26 127.23 52.21 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.537 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -65.39 -44.78 86.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.698 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 39.0 p -165.83 155.28 12.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.374 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.483 ' H ' ' CD ' ' A' ' 42' ' ' GLN . 14.5 mp0 -45.2 101.26 0.25 Allowed Pre-proline 0 C--O 1.235 0.325 0 O-C-N 123.6 0.562 . . . . 0.0 110.558 179.227 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -57.77 130.34 38.04 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 C-N-CA 122.326 2.018 . . . . 0.0 112.315 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -82.76 -24.9 33.28 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.601 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.531 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.7 mtm-85 -120.86 134.98 55.29 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.225 0.536 . . . . 0.0 110.135 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.1 mt -130.26 133.48 63.98 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.345 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.818 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 45.7 t -125.24 130.87 72.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 CA-C-O 120.967 0.413 . . . . 0.0 109.924 179.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.61 ' OG ' HD12 ' A' ' 117' ' ' LEU . 4.7 m -154.87 166.48 33.38 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.527 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 72.8 p -124.49 8.88 8.38 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.313 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.68 125.69 33.37 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.857 0.36 . . . . 0.0 110.635 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.465 HG11 ' H ' ' A' ' 299' ' ' LEU . 85.5 t -65.71 -44.44 93.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.553 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.8 m -62.7 -44.34 96.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.63 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 53.8 tp -62.46 -41.41 98.73 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.613 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.447 ' O ' HD13 ' A' ' 58' ' ' LEU . 74.3 m -57.89 -44.6 86.84 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.269 -179.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.27 -62.12 5.42 Favored Glycine 0 N--CA 1.468 0.788 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.6 t -48.24 -35.6 12.31 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 20.1 mt -61.85 -44.02 97.67 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 120.594 -0.442 . . . . 0.0 111.383 179.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.447 HD13 ' O ' ' A' ' 54' ' ' THR . 9.3 mp -65.43 -41.34 93.63 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.404 177.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.82 -41.27 97.9 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.914 -179.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.415 ' O ' HG23 ' A' ' 60' ' ' ILE . 7.9 tp -87.66 16.55 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.918 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 56.44 84.42 0.09 Allowed 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.841 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.25 58.91 0.08 OUTLIER Pre-proline 0 C--N 1.327 -0.389 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.423 ' HB3' HE21 ' A' ' 85' ' ' GLN . 9.5 Cg_endo -51.6 152.78 11.97 Favored 'Trans proline' 0 C--N 1.292 -2.437 0 C-N-CA 123.074 2.516 . . . . 0.0 112.053 -178.3 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.431 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -108.78 145.86 15.15 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.152 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.262 -179.646 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.61 -45.3 97.93 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.471 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.504 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -129.83 134.29 47.45 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.47 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.494 ' O ' ' N ' ' A' ' 98' ' ' LEU . 72.1 m -134.38 158.54 43.58 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.895 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.42 139.01 16.31 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.486 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.61 -162.98 0.09 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.953 0.406 . . . . 0.0 110.437 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.5 HG22 ' CD2' ' A' ' 297' ' ' PHE . 5.7 t -133.91 135.83 43.88 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.015 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.473 ' C ' ' O ' ' A' ' 70' ' ' THR . 1.0 OUTLIER 29.68 68.23 0.68 Allowed Pre-proline 0 N--CA 1.468 0.438 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.78 -179.68 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_exo -61.32 145.11 98.7 Favored 'Trans proline' 0 C--N 1.299 -2.072 0 C-N-CA 122.644 2.23 . . . . 0.0 111.762 -177.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.527 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 45.5 p-10 -160.15 -32.02 0.06 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.746 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.528 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 99.1 m-20 -64.29 -39.31 93.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.326 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -60.5 -47.88 84.21 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.509 -179.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.423 ' O ' ' O ' ' A' ' 77' ' ' ALA . 94.3 t -60.48 -24.46 31.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.528 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -45.73 173.03 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.602 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.567 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.6 p30 -61.92 177.59 0.43 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.58 -179.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.562 ' C ' ' H ' ' A' ' 81' ' ' GLY . 36.2 p30 -45.73 85.57 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.031 0.443 . . . . 0.0 111.069 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.567 ' N ' ' O ' ' A' ' 78' ' ' ASP . 42.4 tp60 -67.4 13.36 0.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.297 0.57 . . . . 0.0 110.172 -179.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.562 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 118.06 -22.53 9.71 Favored Glycine 0 C--N 1.333 0.372 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -107.82 116.04 31.24 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.056 0.455 . . . . 0.0 110.461 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 77.7 mt -98.47 0.67 45.62 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.991 0.424 . . . . 0.0 110.553 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -92.08 6.84 44.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.058 0.456 . . . . 0.0 110.387 -179.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.783 ' O ' HG22 ' A' ' 89' ' ' VAL . 88.4 mt-30 -100.02 -26.99 13.79 Favored 'General case' 0 C--O 1.22 -0.467 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.821 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.4 t-105 -63.8 -40.66 97.18 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.09 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.546 ' O ' ' N ' ' A' ' 91' ' ' LYS . 69.4 m -77.55 -53.27 7.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.134 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -48.9 -50.8 33.35 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.138 -179.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.783 HG22 ' O ' ' A' ' 85' ' ' GLN . 15.3 m -68.75 -40.62 81.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.232 179.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.494 ' N ' HG23 ' A' ' 89' ' ' VAL . . . -72.26 -23.07 61.15 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.678 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.546 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.0 tttm -61.32 -45.93 92.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.369 -179.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.439 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.8 mm-40 -90.5 -94.52 0.12 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.066 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.617 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.9 mtt180 -143.56 60.0 1.39 Allowed 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.442 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.7 pttp 34.22 25.86 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.105 0.478 . . . . 0.0 110.339 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.617 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.4 tt -48.25 123.01 5.83 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.064 -177.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.451 ' O ' HD23 ' A' ' 95' ' ' LEU . 98.9 mm-40 -83.08 -170.62 3.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.059 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.62 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 83.0 mtp180 -73.32 137.85 45.04 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.128 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.494 ' N ' ' O ' ' A' ' 67' ' ' SER . 90.5 mt -86.65 -165.79 1.37 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.886 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.532 ' CD2' ' O ' ' A' ' 99' ' ' TYR . 47.5 p90 -168.84 119.98 0.75 Allowed 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.154 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.492 ' C ' ' O ' ' A' ' 99' ' ' TYR . 43.9 mm -29.22 121.06 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 O-C-N 123.308 0.38 . . . . 0.0 111.125 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 114.15 27.76 3.31 Favored Glycine 0 N--CA 1.461 0.341 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 -179.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.582 ' N ' ' CD ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -143.93 45.82 0.6 Allowed Pre-proline 0 C--N 1.321 -0.649 0 CA-C-O 121.079 0.466 . . . . 0.0 110.391 179.716 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.582 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 29.6 Cg_endo -62.42 144.16 94.51 Favored 'Trans proline' 0 C--N 1.294 -2.342 0 C-N-CA 122.687 2.258 . . . . 0.0 111.727 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.456 ' O ' HG23 ' A' ' 108' ' ' VAL . 24.8 t -173.36 121.04 0.35 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.377 179.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.29 -40.92 64.16 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.989 0.423 . . . . 0.0 111.125 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -65.91 -39.85 90.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.865 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.94 -39.64 94.63 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.754 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 104' ' ' SER . 70.0 t -67.52 -43.71 87.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.681 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.49 -39.28 92.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.474 -179.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.439 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.94 -23.83 63.87 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.476 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.537 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.3 mm-40 -91.18 5.04 50.65 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.667 -179.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.537 ' C ' ' O ' ' A' ' 111' ' ' GLN . 10.2 tpt 21.54 64.95 0.3 Allowed Pre-proline 0 N--CA 1.469 0.516 0 CA-C-O 120.961 0.41 . . . . 0.0 111.337 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.461 ' HG2' HD11 ' A' ' 116' ' ' ILE . 61.6 Cg_endo -80.01 169.9 17.22 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 123.094 2.53 . . . . 0.0 111.517 -177.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.519 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 99.2 m-20 -112.34 -45.1 3.3 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.973 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 39.4 tp -119.51 121.23 38.94 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.461 HD11 ' HG2' ' A' ' 113' ' ' PRO . 96.7 mt -118.45 131.41 71.3 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.432 0 CA-C-O 120.953 0.406 . . . . 0.0 111.013 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.61 HD12 ' OG ' ' A' ' 48' ' ' SER . 32.4 mt -106.04 132.24 52.35 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 121.086 0.47 . . . . 0.0 110.156 -179.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.495 HD12 HG23 ' A' ' 139' ' ' THR . 98.6 mt -117.75 135.75 57.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.628 -179.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 85.3 p -71.17 151.32 44.51 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.62 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.42 -49.98 75.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.642 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.0 t -149.19 153.71 38.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.539 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 168.19 -169.68 41.6 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.93 -35.7 92.42 Favored Glycine 0 CA--C 1.522 0.513 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.445 ' O ' ' OD1' ' A' ' 124' ' ' ASP . 44.2 p-10 -88.2 120.18 29.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.867 0.365 . . . . 0.0 110.696 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.439 ' O ' HD12 ' A' ' 129' ' ' LEU . 41.3 t -63.6 143.78 57.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.363 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.515 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.67 -42.82 8.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.863 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.4 tp -62.78 -42.45 99.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.674 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.76 -10.43 52.58 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.382 -179.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.439 HD12 ' O ' ' A' ' 125' ' ' SER . 83.4 mt -116.23 -24.0 8.17 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.65 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . 0.525 ' CD1' HG21 ' A' ' 139' ' ' THR . 72.6 t80 -51.79 -49.08 63.42 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.639 -178.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 39.0 p-10 -65.96 -41.56 91.07 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.324 179.203 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.525 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 87.9 mt-30 -68.14 -36.68 80.08 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.874 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.457 HD12 HD11 ' A' ' 118' ' ' ILE . 96.3 mt -79.89 -42.67 23.69 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.017 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.402 ' N ' ' OG1' ' A' ' 139' ' ' THR . 11.3 t -57.37 -45.07 84.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.343 -179.018 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 20.0 m -62.36 -45.88 91.17 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.566 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 93.0 mt -62.28 -43.71 98.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.349 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.598 ' HB1' ' HD2' ' A' ' 138' ' ' PRO . . . -170.1 163.32 6.38 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.559 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.598 ' HD2' ' HB1' ' A' ' 137' ' ' ALA . 78.3 Cg_exo -41.69 110.37 0.14 Allowed 'Trans proline' 0 C--N 1.311 -1.428 0 C-N-CA 122.486 2.124 . . . . 0.0 112.344 179.092 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.525 HG21 ' CD1' ' A' ' 130' ' ' TYR . 3.0 m -87.37 127.46 35.2 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.542 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.638 HD13 ' CD2' ' A' ' 37' ' ' HIS . 34.3 tp -119.29 139.24 52.24 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.259 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.428 ' O ' ' OD2' ' A' ' 32' ' ' ASP . 81.3 mt -105.32 120.1 55.49 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.352 0 CA-C-O 121.132 0.491 . . . . 0.0 111.196 -179.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.48 HD12 HD22 ' A' ' 117' ' ' LEU . 97.4 mt -135.69 132.75 51.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.585 179.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.55 HD21 ' CG ' ' A' ' 241' ' ' ASP . 59.3 t30 -64.62 148.22 51.35 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.933 0.397 . . . . 0.0 110.38 179.264 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.515 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 87.6 t80 -82.74 122.72 28.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.973 -179.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.515 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 99.0 m-20 55.11 69.12 0.77 Allowed 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.784 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 34.5 p-10 -125.7 0.31 7.45 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.856 0.36 . . . . 0.0 110.636 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -150.42 115.51 5.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.691 -179.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 85.0 p -63.49 168.94 4.16 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.538 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.414 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.5 p-90 -51.84 -16.08 0.63 Allowed 'General case' 0 C--O 1.219 -0.505 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.326 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.436 ' O ' HG23 ' A' ' 154' ' ' THR . 67.9 tp60 -70.11 -76.05 0.11 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.891 0.377 . . . . 0.0 110.542 -179.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.433 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.1 t -62.48 -38.66 90.7 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.253 179.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 52.1 tp -60.16 -45.61 92.48 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.354 -178.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.414 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 45.8 tp -62.6 -41.76 99.16 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.55 178.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.436 HG23 ' O ' ' A' ' 150' ' ' GLN . 58.7 p -63.86 -34.94 79.06 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.098 -179.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.467 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 88.0 mm-40 -63.66 -42.03 98.13 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.23 179.291 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 91.6 mt -65.34 -38.82 91.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.192 0.52 . . . . 0.0 110.243 179.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.566 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.34 -32.3 80.38 Favored Glycine 0 C--N 1.332 0.316 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 -179.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.467 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.4 mt-10 -36.79 -25.19 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.901 0.381 . . . . 0.0 110.862 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.566 ' N ' ' O ' ' A' ' 157' ' ' GLY . 94.9 mt -59.22 148.43 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.292 179.031 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 74.6 p -69.09 137.63 53.66 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.994 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 70.48 22.14 77.72 Favored Glycine 0 N--CA 1.458 0.136 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 179.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 59.9 m80 -124.48 -13.96 6.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.597 0.237 . . . . 0.0 110.426 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -66.81 -59.49 3.5 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.593 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -51.92 -48.89 63.99 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.153 -179.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -60.55 -41.09 93.83 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.806 0.336 . . . . 0.0 110.405 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.68 -47.43 85.34 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.534 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.63 -40.27 75.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.225 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -61.58 -50.44 72.59 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.672 179.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -65.25 -43.66 90.66 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.586 179.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 94.4 mt -64.63 -43.33 96.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.441 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.4 -51.12 70.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.313 -179.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.63 -43.41 96.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.851 0.357 . . . . 0.0 110.635 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.662 ' CE2' HD11 ' A' ' 177' ' ' LEU . 57.7 t80 -62.94 -44.25 96.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.402 179.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -63.69 -39.65 94.86 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.477 -179.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -63.18 -42.82 99.42 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.564 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -60.63 -44.45 96.33 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.175 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.662 HD11 ' CE2' ' A' ' 173' ' ' PHE . 84.8 mt -64.44 -41.12 96.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.78 178.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.34 -62.14 1.83 Allowed 'General case' 0 C--O 1.24 0.553 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.281 -179.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.23 -47.23 84.16 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.432 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -52.73 -41.72 64.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.353 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -63.74 -33.59 75.99 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.055 0.455 . . . . 0.0 110.284 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.41 ' HG2' ' O ' ' A' ' 182' ' ' GLU . 69.8 tt0 -91.08 8.52 35.08 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.666 0.746 . . . . 0.0 110.318 -178.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -104.33 -32.45 9.06 Favored 'General case' 0 CA--C 1.516 -0.361 0 O-C-N 122.001 -0.437 . . . . 0.0 111.222 179.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.7 pt -127.9 147.57 32.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.801 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -139.78 131.26 26.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.966 0.412 . . . . 0.0 110.395 179.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.59 HD22 ' N ' ' A' ' 186' ' ' LEU . 3.5 mm? -85.34 133.59 42.16 Favored Pre-proline 0 N--CA 1.449 -0.516 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.193 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -43.65 157.76 0.12 Allowed 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.617 2.212 . . . . 0.0 112.372 179.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 0.497 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.7 Cg_endo -63.04 114.69 2.55 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 122.817 2.344 . . . . 0.0 111.664 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . 0.497 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.7 mt-30 155.65 148.17 0.0 OUTLIER Pre-proline 0 N--CA 1.456 -0.159 0 O-C-N 124.244 0.965 . . . . 0.0 110.885 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -73.26 144.26 36.77 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.583 2.189 . . . . 0.0 112.289 177.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.496 HG23 ' OG ' ' A' ' 258' ' ' SER . 2.1 p -124.61 158.87 31.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.461 0.648 . . . . 0.0 110.197 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . 0.487 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 36.6 p -143.18 165.39 27.57 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.112 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . 0.448 ' HA ' ' H ' ' A' ' 260' ' ' PHE . . . -135.44 128.88 32.32 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-O 121.339 0.59 . . . . 0.0 110.209 179.232 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.509 HD11 HD23 ' A' ' 259' ' ' LEU . 47.7 pt -146.73 149.38 15.92 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.404 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.21 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . 0.736 HG13 ' CD1' ' A' ' 262' ' ' PHE . 69.4 t -117.87 123.41 71.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.402 0.62 . . . . 0.0 109.792 179.002 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -134.34 106.75 7.25 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 121.104 0.478 . . . . 0.0 110.208 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 94.7 m -130.7 130.44 43.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.943 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.413 ' O ' ' N ' ' A' ' 201' ' ' HIS . . . -82.8 -37.18 24.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.25 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.21 -66.92 0.27 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.288 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.47 -9.54 58.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.273 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . 0.413 ' N ' ' O ' ' A' ' 198' ' ' ALA . 60.1 t-80 60.32 58.27 2.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.81 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 39.5 p -167.02 153.79 8.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.568 179.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.36 144.19 24.45 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.054 0.454 . . . . 0.0 110.454 179.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -135.29 138.09 43.13 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.605 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 19.4 mt -106.04 125.44 51.0 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.055 0.455 . . . . 0.0 109.796 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' TRP . . . . . 0.555 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 74.5 m95 -82.15 167.14 19.03 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.587 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . 0.46 HG22 ' C ' ' A' ' 206' ' ' TRP . 0.1 OUTLIER -157.45 171.32 7.59 Favored Pre-proline 0 C--O 1.224 -0.268 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.624 -178.909 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -53.18 -37.12 79.69 Favored 'Trans proline' 0 C--N 1.301 -1.965 0 C-N-CA 122.583 2.189 . . . . 0.0 112.448 178.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -70.84 -35.23 72.34 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.71 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 21.0 m -60.95 151.0 31.53 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.572 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.8 -36.96 82.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.485 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . 0.555 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 55.1 tt0 -64.69 -40.27 95.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.519 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.63 -43.58 91.71 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.631 -0.988 . . . . 0.0 110.631 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -62.88 -44.0 97.27 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.789 0.328 . . . . 0.0 110.219 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . 0.551 ' SD ' ' HB2' ' A' ' 304' ' ' ALA . 65.1 ttp -59.32 -47.91 83.63 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.071 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 87.0 mt -60.73 -41.16 94.76 Favored 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . 0.449 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.6 tp10 -58.03 -37.89 75.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.35 -0.386 . . . . 0.0 109.994 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -65.38 -38.31 89.63 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.671 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 95.2 mt -63.91 -42.9 97.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.111 0.482 . . . . 0.0 110.613 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.56 44.93 0.08 OUTLIER Glycine 0 C--N 1.332 0.359 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . 0.449 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 26.6 m-85 -127.89 155.49 44.09 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 121.054 0.454 . . . . 0.0 110.439 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.481 ' O ' HG13 ' A' ' 191' ' ' VAL . 7.0 p -106.96 122.34 46.24 Favored 'General case' 0 C--O 1.223 -0.294 0 CA-C-O 121.331 0.586 . . . . 0.0 110.067 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.474 HD22 ' C ' ' A' ' 222' ' ' THR . 4.3 mm? -101.4 133.01 46.68 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.229 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.8 159.8 14.72 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.456 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.52 115.35 30.1 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.935 0.398 . . . . 0.0 110.339 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.498 ' N ' HD12 ' A' ' 226' ' ' LEU . 8.9 mp -53.08 156.54 3.57 Favored Pre-proline 0 N--CA 1.448 -0.559 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.817 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -59.91 145.17 98.97 Favored 'Trans proline' 0 C--N 1.299 -2.03 0 C-N-CA 122.753 2.302 . . . . 0.0 112.312 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.09 -3.35 59.07 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.516 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.2 -40.96 5.66 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.506 ' O ' ' N ' ' A' ' 233' ' ' SER . 67.7 mt -79.08 -17.8 54.52 Favored 'General case' 0 C--O 1.218 -0.587 0 CA-C-O 121.212 0.529 . . . . 0.0 110.296 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 54.5 t-20 -40.74 -49.17 3.09 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.845 -179.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -87.16 15.05 6.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.459 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.506 ' N ' ' O ' ' A' ' 230' ' ' LEU . 77.9 p -60.56 -34.99 74.98 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.683 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . 0.525 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.5 tt0 -119.73 -69.3 0.85 Allowed 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.835 179.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.3 m -69.3 102.19 1.68 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.022 0.439 . . . . 0.0 110.687 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -94.08 57.51 2.4 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.086 0.47 . . . . 0.0 110.365 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -144.61 -122.43 1.58 Allowed Glycine 0 C--N 1.332 0.343 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -135.64 111.78 9.67 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.161 0.505 . . . . 0.0 110.347 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . 0.524 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.5 mtt180 -148.08 58.26 1.09 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.707 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -69.36 -32.48 71.57 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.457 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . 0.55 ' CG ' HD21 ' A' ' 143' ' ' ASN . 64.7 t0 -57.04 -47.24 81.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.211 -178.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' ILE . . . . . 0.435 ' O ' ' O ' ' A' ' 239' ' ' ARG . 18.1 tt -139.62 155.87 25.69 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.275 0 CA-C-O 120.913 0.387 . . . . 0.0 110.44 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.445 HG22 HD13 ' A' ' 245' ' ' LEU . 96.3 mt -106.17 106.87 21.39 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 CA-C-O 121.099 0.476 . . . . 0.0 110.479 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . 0.595 ' O ' HD12 ' A' ' 245' ' ' LEU . 88.3 mt-30 -110.71 110.04 20.54 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.261 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.595 HD12 ' O ' ' A' ' 244' ' ' GLN . 9.5 mp -121.51 -168.2 1.65 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.766 179.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . 0.525 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 174.14 -16.54 0.05 OUTLIER Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . 0.67 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -61.24 156.23 34.37 Favored Glycine 0 CA--C 1.521 0.449 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -63.4 21.94 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.995 0.426 . . . . 0.0 110.647 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . 0.67 ' H ' ' C ' ' A' ' 247' ' ' GLY . 99.0 m-20 -97.2 -6.27 35.13 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.438 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 91.0 mt -79.65 -22.0 44.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.775 179.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.68 -51.43 69.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.712 -179.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.21 -5.53 58.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.47 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.08 -74.24 1.15 Allowed Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.776 -0.929 . . . . 0.0 110.776 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 83.0 mt -70.25 126.43 29.64 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.218 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -59.67 -39.44 84.47 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.081 -179.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 83.16 51.62 4.1 Favored Glycine 0 CA--C 1.519 0.29 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -95.9 -14.96 22.73 Favored 'General case' 0 C--N 1.331 -0.204 0 O-C-N 122.65 -0.323 . . . . 0.0 110.598 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . 0.496 ' OG ' HG23 ' A' ' 191' ' ' VAL . 3.4 t 174.73 88.85 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.24 0.543 . . . . 0.0 110.072 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.853 ' N ' HD12 ' A' ' 259' ' ' LEU . 1.0 OUTLIER -94.61 124.28 38.55 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.254 0.549 . . . . 0.0 111.267 -179.143 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 260' ' ' PHE . . . . . 0.448 ' H ' ' HA ' ' A' ' 193' ' ' ALA . 15.7 m-30 -93.37 146.39 23.77 Favored 'General case' 0 CA--C 1.495 -1.171 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.474 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 86.1 mt -122.33 149.25 44.02 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.545 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.736 ' CD1' HG13 ' A' ' 195' ' ' VAL . 2.5 p90 -77.26 -138.77 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.578 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . 0.655 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -51.46 76.97 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 121.091 0.472 . . . . 0.0 111.299 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . 0.626 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.15 104.67 0.19 Allowed Glycine 0 CA--C 1.528 0.895 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 -179.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 265' ' ' ASP . . . . . 0.592 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.5 m-20 -80.31 -177.98 6.4 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 122.719 -0.283 . . . . 0.0 110.972 -179.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -40.3 -17.87 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.566 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . 0.592 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -67.94 -51.74 44.1 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.759 179.1 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -63.65 -46.47 85.48 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.216 179.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . 0.568 ' HB1' ' OH ' ' A' ' 273' ' ' TYR . . . -61.93 -34.99 77.08 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 121.539 0.685 . . . . 0.0 109.658 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -63.2 -34.46 77.69 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.158 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.49 -42.96 13.98 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.081 -179.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 272' ' ' ILE . . . . . 0.591 ' C ' ' H ' ' A' ' 274' ' ' ALA . 4.9 tt -51.44 -33.78 14.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.728 -178.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 273' ' ' TYR . . . . . 0.568 ' OH ' ' HB1' ' A' ' 269' ' ' ALA . 17.2 m-85 -54.64 -1.85 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.573 -179.327 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 274' ' ' ALA . . . . . 0.591 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.45 -39.9 70.7 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.952 179.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . 0.577 ' O ' ' N ' ' A' ' 279' ' ' ALA . 3.1 p30 -38.8 97.81 0.15 Allowed Pre-proline 0 N--CA 1.462 0.164 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.366 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -54.57 -42.62 66.47 Favored 'Trans proline' 0 C--N 1.303 -1.864 0 C-N-CA 122.428 2.086 . . . . 0.0 112.535 -178.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 89.5 mt -64.4 -42.87 95.87 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.058 0.456 . . . . 0.0 111.218 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 90.9 mt -95.7 -1.58 49.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.967 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 279' ' ' ALA . . . . . 0.577 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.3 -34.8 77.29 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.744 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.18 20.03 0.11 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.012 -179.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 0.481 ' H ' ' C ' ' A' ' 279' ' ' ALA . 13.8 mt -74.93 119.51 77.2 Favored Pre-proline 0 N--CA 1.445 -0.69 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.801 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -49.96 -39.96 49.56 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.593 2.195 . . . . 0.0 112.279 178.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.72 -50.52 63.24 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.038 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 75.9 t -61.42 -43.96 97.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -57.71 -41.18 81.23 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.039 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -91.17 0.24 57.57 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.133 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt 59.36 43.53 16.48 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.04 0.447 . . . . 0.0 110.906 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -94.75 41.37 1.09 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.31 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 54.3 t -119.31 135.55 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-O 121.129 0.49 . . . . 0.0 109.995 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -132.64 162.98 29.97 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.209 0.528 . . . . 0.0 110.613 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.63 155.4 32.39 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-O 121.073 0.463 . . . . 0.0 110.632 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 82.8 mt -94.35 -1.52 53.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.256 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 120.83 165.32 12.69 Favored Glycine 0 C--N 1.335 0.497 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 7.3 m -86.98 -62.38 1.52 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.864 0.364 . . . . 0.0 111.154 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 295' ' ' GLU . . . . . 0.445 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.7 mm-40 -68.79 -3.97 14.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.738 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 25.0 p -77.08 32.04 0.14 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.651 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 297' ' ' PHE . . . . . 0.5 ' CD2' HG22 ' A' ' 70' ' ' THR . 68.7 t80 -60.4 -46.18 90.93 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.629 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . 0.62 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.1 mtt85 -80.61 134.81 35.95 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.577 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.465 ' H ' HG11 ' A' ' 51' ' ' VAL . 18.2 tp -113.87 117.01 30.23 Favored 'General case' 0 C--O 1.23 0.075 0 CA-C-O 121.02 0.438 . . . . 0.0 110.203 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . 0.621 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.5 p-10 -165.03 -176.71 4.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.651 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -46.95 -42.99 18.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.356 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -67.19 -40.14 86.48 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 121.065 0.46 . . . . 0.0 110.746 178.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . 0.621 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 59.9 p -56.3 -36.35 68.55 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.975 -179.038 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . 0.551 ' HB2' ' SD ' ' A' ' 215' ' ' MET . . . -57.04 -52.15 66.43 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 91.7 mtp -55.78 -43.66 77.01 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -66.22 -42.59 88.48 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.241 0.543 . . . . 0.0 110.239 179.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 303' ' ' SER . 55.5 t -64.04 -42.95 97.29 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.188 179.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 42.6 tp -60.05 -42.05 93.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.82 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -62.42 -39.34 92.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.028 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 310' ' ' ARG . . . . . 0.446 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.5 ttt85 -63.49 -44.0 95.64 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.153 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 89.8 mt -63.18 -42.11 99.31 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.103 0.478 . . . . 0.0 110.36 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt -63.16 -33.35 75.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.12 179.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.56 -23.72 21.92 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.329 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.485 HD22 ' CE2' ' A' ' 315' ' ' PHE . 6.7 tt -62.35 -43.17 99.46 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 121.075 0.464 . . . . 0.0 110.521 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 315' ' ' PHE . . . . . 0.485 ' CE2' HD22 ' A' ' 314' ' ' LEU . 90.0 m-85 . . . . . 0 C--O 1.22 -0.463 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.346 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -99.55 135.98 40.17 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.119 0.485 . . . . 0.0 110.475 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.49 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -92.16 178.55 1.66 Allowed Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.589 -179.893 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.49 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.7 Cg_exo -61.44 147.15 96.2 Favored 'Trans proline' 0 C--N 1.299 -2.046 0 C-N-CA 122.848 2.365 . . . . 0.0 112.208 179.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.468 ' HE ' HD12 ' A' ' 39' ' ' LEU . 35.7 ptt180 -136.12 142.36 44.24 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.585 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -79.54 116.6 19.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.521 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.443 ' O ' HG23 ' A' ' 30' ' ' ILE . 9.5 tp -111.1 130.66 64.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.564 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 13.7 t -70.79 142.25 51.34 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.987 0.422 . . . . 0.0 110.676 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.477 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.3 t0 -139.8 179.39 6.62 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.458 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.477 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 77.9 p -73.83 -37.05 64.97 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.562 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.8 ttt85 -46.51 -94.62 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.248 -179.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -167.06 -26.38 0.02 OUTLIER Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 55.6 m -169.35 104.94 0.37 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.807 0.337 . . . . 0.0 110.664 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.691 ' CD2' HD13 ' A' ' 140' ' ' LEU . 75.4 t60 -128.47 148.79 50.75 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.055 0.455 . . . . 0.0 110.231 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.625 HG22 ' N ' ' A' ' 39' ' ' LEU . 98.6 m -131.02 166.05 21.87 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.498 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.625 ' N ' HG22 ' A' ' 38' ' ' THR . 81.2 mt -120.78 127.19 51.73 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.408 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -65.08 -44.62 88.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.794 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 40.9 p -165.71 155.1 12.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.354 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.487 ' H ' ' CD ' ' A' ' 42' ' ' GLN . 14.5 mp0 -44.27 100.91 0.24 Allowed Pre-proline 0 C--O 1.235 0.326 0 O-C-N 123.526 0.516 . . . . 0.0 110.594 179.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.54 129.6 34.66 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 C-N-CA 122.344 2.029 . . . . 0.0 112.231 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -83.63 -24.69 31.32 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.609 179.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.539 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.4 mtm-85 -122.25 134.43 54.69 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.257 0.551 . . . . 0.0 110.177 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.0 mt -130.46 133.78 63.24 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.774 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 45.3 t -124.43 130.4 73.58 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 CA-C-O 120.911 0.386 . . . . 0.0 109.986 179.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.63 ' OG ' HD12 ' A' ' 117' ' ' LEU . 2.1 m -154.88 167.27 30.84 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.645 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 65.1 p -124.53 9.16 8.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.419 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.52 125.51 33.13 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.644 -179.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.447 HG11 ' H ' ' A' ' 299' ' ' LEU . 92.7 t -65.77 -44.51 93.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.555 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.4 m -62.51 -44.18 97.0 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.654 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 53.1 tp -62.33 -41.43 98.56 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.464 -179.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.445 ' O ' HD13 ' A' ' 58' ' ' LEU . 74.3 m -57.86 -44.58 86.66 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.126 -179.111 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.19 -62.41 5.19 Favored Glycine 0 N--CA 1.467 0.733 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.7 t -47.94 -35.74 11.23 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 20.1 mt -61.88 -44.13 97.44 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.348 179.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.445 HD13 ' O ' ' A' ' 54' ' ' THR . 9.1 mp -65.62 -41.35 92.79 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.333 177.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.67 -41.1 98.22 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.846 -179.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.424 ' O ' HG23 ' A' ' 60' ' ' ILE . 7.8 tp -88.35 16.66 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.914 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 56.27 84.79 0.08 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.821 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 178.83 58.34 0.07 OUTLIER Pre-proline 0 C--N 1.328 -0.358 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.416 ' HB3' HE21 ' A' ' 85' ' ' GLN . 9.2 Cg_endo -51.6 153.51 10.7 Favored 'Trans proline' 0 C--N 1.293 -2.385 0 C-N-CA 123.051 2.501 . . . . 0.0 111.943 -178.065 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.435 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.2 OUTLIER -108.86 145.33 15.85 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.148 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.341 -179.677 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.36 -45.49 97.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.363 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.504 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -129.43 134.08 47.65 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 120.816 0.341 . . . . 0.0 110.489 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.503 ' O ' ' N ' ' A' ' 98' ' ' LEU . 73.8 m -134.54 158.75 43.17 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.871 -179.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -87.04 139.25 16.06 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 110.621 -0.991 . . . . 0.0 110.621 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.494 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.7 -162.77 0.08 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.938 0.399 . . . . 0.0 110.431 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.533 HG22 ' CD2' ' A' ' 297' ' ' PHE . 14.2 t -133.47 134.75 43.91 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.293 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.478 ' C ' ' O ' ' A' ' 70' ' ' THR . 0.6 OUTLIER 29.73 68.74 0.66 Allowed Pre-proline 0 N--CA 1.467 0.397 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.817 -179.865 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_exo -61.85 145.18 97.21 Favored 'Trans proline' 0 C--N 1.299 -2.027 0 C-N-CA 122.706 2.27 . . . . 0.0 111.723 -177.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.528 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 45.7 p-10 -159.4 -31.81 0.06 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.66 179.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.541 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 99.1 m-20 -64.35 -39.42 93.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.366 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.4 ttt180 -60.33 -48.16 82.95 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.505 -179.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.424 ' O ' ' O ' ' A' ' 77' ' ' ALA . 93.0 t -60.48 -25.1 33.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.054 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.541 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -45.51 173.04 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.592 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.569 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.4 p30 -62.01 177.59 0.44 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.577 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.558 ' C ' ' H ' ' A' ' 81' ' ' GLY . 35.5 p30 -45.34 85.67 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.036 0.446 . . . . 0.0 111.102 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.569 ' N ' ' O ' ' A' ' 78' ' ' ASP . 42.8 tp60 -67.64 13.29 0.08 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.268 0.556 . . . . 0.0 110.197 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.558 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 118.65 -22.08 9.49 Favored Glycine 0 N--CA 1.462 0.374 0 N-CA-C 110.981 -0.848 . . . . 0.0 110.981 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -108.33 116.42 31.94 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.963 0.411 . . . . 0.0 110.445 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 76.6 mt -98.74 -0.19 43.22 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.578 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -92.15 7.35 42.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.971 0.415 . . . . 0.0 110.299 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.795 ' O ' HG22 ' A' ' 89' ' ' VAL . 87.9 mt-30 -100.25 -28.15 13.14 Favored 'General case' 0 C--O 1.22 -0.455 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.795 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 68.9 t-105 -63.03 -40.47 97.82 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.833 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.551 ' O ' ' N ' ' A' ' 91' ' ' LYS . 67.5 m -77.82 -53.74 7.14 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.881 -179.342 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -48.53 -50.68 30.94 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.076 -179.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.795 HG22 ' O ' ' A' ' 85' ' ' GLN . 15.5 m -68.81 -40.55 81.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.161 179.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.494 ' N ' HG23 ' A' ' 89' ' ' VAL . . . -72.43 -22.66 61.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.572 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.551 ' N ' ' O ' ' A' ' 87' ' ' SER . 65.9 tttm -61.97 -45.67 92.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.357 -179.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.437 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.8 mm-40 -90.41 -94.64 0.12 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.164 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.621 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.8 mtt180 -143.12 58.73 1.41 Allowed 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.446 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.6 pttp 33.97 26.02 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.149 0.5 . . . . 0.0 110.267 -179.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.621 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.4 tt -48.22 123.48 6.47 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.002 -177.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.457 ' O ' HD23 ' A' ' 95' ' ' LEU . 99.0 mm-40 -83.82 -169.98 2.85 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.146 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.609 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 81.2 mtp180 -74.25 137.07 42.74 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.232 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.503 ' N ' ' O ' ' A' ' 67' ' ' SER . 91.0 mt -85.71 -165.77 1.33 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.901 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.538 ' CD2' ' O ' ' A' ' 99' ' ' TYR . 47.9 p90 -168.57 119.56 0.77 Allowed 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.13 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.502 ' C ' ' O ' ' A' ' 99' ' ' TYR . 43.0 mm -28.69 120.78 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.068 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 114.2 27.61 3.35 Favored Glycine 0 CA--C 1.519 0.315 0 N-CA-C 111.259 -0.736 . . . . 0.0 111.259 -179.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.574 ' N ' ' CD ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -144.52 46.39 0.62 Allowed Pre-proline 0 C--N 1.321 -0.654 0 CA-C-O 121.084 0.468 . . . . 0.0 110.511 179.773 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.574 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 28.8 Cg_endo -62.15 144.34 95.66 Favored 'Trans proline' 0 C--N 1.295 -2.273 0 C-N-CA 122.687 2.258 . . . . 0.0 111.732 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.452 ' O ' HG23 ' A' ' 108' ' ' VAL . 24.3 t -173.2 120.52 0.35 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.349 179.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.95 -40.3 63.16 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.011 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.27 -39.91 89.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.892 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.33 -39.97 94.96 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.769 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 104' ' ' SER . 69.6 t -67.83 -43.65 86.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.73 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.04 -38.88 92.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.476 -179.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.437 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.55 -23.2 62.67 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.538 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.535 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.3 mm-40 -91.0 5.88 47.05 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.746 -179.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.539 ' O ' ' NE ' ' A' ' 45' ' ' ARG . 10.6 tpt 22.89 64.64 0.36 Allowed Pre-proline 0 N--CA 1.467 0.416 0 CA-C-O 120.905 0.383 . . . . 0.0 111.215 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -79.04 167.41 21.95 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 123.087 2.524 . . . . 0.0 111.466 -177.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.526 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 99.2 m-20 -110.02 -41.99 4.32 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.038 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.2 tp -121.38 120.26 34.51 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.925 0.393 . . . . 0.0 109.983 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 82.1 mt -112.94 128.92 69.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 CA-C-O 120.833 0.349 . . . . 0.0 110.935 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.63 HD12 ' OG ' ' A' ' 48' ' ' SER . 29.3 mt -109.08 132.11 54.42 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.281 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.496 HD12 HG23 ' A' ' 139' ' ' THR . 99.0 mt -119.75 138.57 49.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.654 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 85.7 p -72.54 153.8 41.13 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.633 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.28 -50.09 75.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.621 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -149.32 153.8 38.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.561 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 170.68 -170.86 43.43 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -63.11 -34.12 89.11 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.449 ' O ' ' OD1' ' A' ' 124' ' ' ASP . 44.3 p-10 -87.13 120.22 28.18 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.827 0.346 . . . . 0.0 110.612 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.443 ' O ' HD12 ' A' ' 129' ' ' LEU . 37.7 t -63.18 143.94 57.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.342 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.52 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.09 -43.3 8.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.868 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.9 tp -63.03 -42.36 99.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.747 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.6 -12.1 59.64 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.372 -179.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.443 HD12 ' O ' ' A' ' 125' ' ' SER . 84.7 mt -114.88 -23.94 8.89 Favored 'General case' 0 C--O 1.225 -0.196 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.557 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . 0.52 ' N ' ' O ' ' A' ' 126' ' ' ALA . 79.5 t80 -51.07 -49.55 60.41 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.654 -178.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 37.6 p-10 -66.16 -42.81 88.5 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.762 -0.375 . . . . 0.0 111.255 179.421 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.519 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 88.4 mt-30 -66.94 -37.68 84.74 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.783 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.428 HD12 HD11 ' A' ' 118' ' ' ILE . 96.3 mt -80.21 -41.62 24.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.908 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.3 t -56.94 -44.68 82.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.229 -179.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 20.4 m -62.01 -45.1 95.08 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.378 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 94.3 mt -62.06 -43.65 97.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.305 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.666 ' HB1' ' HD2' ' A' ' 138' ' ' PRO . . . -169.44 168.47 4.82 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.649 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.666 ' HD2' ' HB1' ' A' ' 137' ' ' ALA . 52.3 Cg_exo -49.91 112.74 0.77 Allowed 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.354 2.036 . . . . 0.0 112.454 179.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.496 HG23 HD12 ' A' ' 118' ' ' ILE . 23.6 m -84.07 127.33 33.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.629 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.691 HD13 ' CD2' ' A' ' 37' ' ' HIS . 34.4 tp -117.71 135.89 53.73 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.15 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.438 ' O ' ' OD2' ' A' ' 32' ' ' ASP . 82.1 mt -100.09 119.03 47.61 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.286 0 CA-C-O 121.093 0.473 . . . . 0.0 111.057 -179.301 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.428 HD12 HD22 ' A' ' 117' ' ' LEU . 98.0 mt -134.84 132.23 53.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.586 179.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.55 HD21 ' CG ' ' A' ' 241' ' ' ASP . 61.2 t30 -66.69 151.46 47.35 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.473 179.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.521 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 88.1 t80 -86.24 122.47 30.28 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.858 -179.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.521 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 98.9 m-20 55.22 69.17 0.76 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.673 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 35.0 p-10 -125.8 0.36 7.38 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.573 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -150.62 115.07 5.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.687 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 84.0 p -63.34 168.41 4.47 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.597 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.411 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.8 p-90 -51.78 -16.05 0.61 Allowed 'General case' 0 C--O 1.22 -0.453 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.386 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.446 ' O ' HG23 ' A' ' 154' ' ' THR . 68.1 tp60 -70.22 -76.01 0.11 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.896 0.379 . . . . 0.0 110.585 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.441 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.1 t -62.57 -38.81 91.53 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.224 179.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 54.1 tp -59.82 -45.9 90.93 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.398 -178.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.411 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 46.1 tp -62.63 -41.6 99.1 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.585 178.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.446 HG23 ' O ' ' A' ' 150' ' ' GLN . 61.5 p -64.11 -34.96 79.25 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.189 -179.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.435 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.9 mm-40 -64.11 -42.49 96.87 Favored 'General case' 0 C--O 1.225 -0.229 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.412 179.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 90.6 mt -65.57 -38.57 89.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.147 0.499 . . . . 0.0 110.313 179.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.57 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.52 -32.28 80.66 Favored Glycine 0 C--N 1.331 0.286 0 N-CA-C 110.604 -0.998 . . . . 0.0 110.604 -179.154 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.435 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.2 mt-10 -35.56 -27.07 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.841 0.353 . . . . 0.0 110.827 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.57 ' N ' ' O ' ' A' ' 157' ' ' GLY . 95.6 mt -55.95 149.16 3.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.354 178.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 69.1 p -69.53 137.25 52.32 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.903 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 71.21 21.32 78.47 Favored Glycine 0 N--CA 1.459 0.195 0 N-CA-C 111.198 -0.761 . . . . 0.0 111.198 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 57.2 m80 -122.96 -14.67 7.56 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.6 0.238 . . . . 0.0 110.507 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -65.94 -59.97 3.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.596 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -52.05 -49.42 63.5 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.166 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -60.51 -41.07 93.61 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.838 0.351 . . . . 0.0 110.483 179.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.61 -47.26 86.26 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.505 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.82 -40.15 75.48 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.271 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -61.77 -50.01 74.08 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.616 179.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -65.34 -43.65 90.21 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.556 179.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 93.8 mt -64.88 -43.23 96.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.377 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.45 -51.35 69.8 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.297 -179.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.08 -43.82 97.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.939 0.4 . . . . 0.0 110.723 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.66 ' CE2' HD11 ' A' ' 177' ' ' LEU . 57.7 t80 -63.09 -44.16 96.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.34 179.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -63.61 -39.64 94.89 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.498 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -63.16 -42.73 99.48 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.522 179.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -60.53 -44.68 95.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.22 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.66 HD11 ' CE2' ' A' ' 173' ' ' PHE . 84.6 mt -64.66 -40.94 96.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.651 178.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.14 -62.44 1.63 Allowed 'General case' 0 C--O 1.238 0.483 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.33 -179.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.34 -47.04 85.02 Favored 'General case' 0 C--O 1.226 -0.184 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.58 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -52.88 -41.89 64.77 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.368 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -63.97 -33.41 75.67 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.285 179.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.415 ' HG2' ' O ' ' A' ' 182' ' ' GLU . 70.0 tt0 -90.76 8.78 32.92 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.609 0.719 . . . . 0.0 110.317 -178.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -105.05 -31.94 8.95 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.155 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 45.3 pt -128.08 147.93 32.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.708 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -140.19 131.34 26.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.463 179.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.593 HD22 ' N ' ' A' ' 186' ' ' LEU . 3.6 mm? -85.63 132.63 43.89 Favored Pre-proline 0 N--CA 1.451 -0.41 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.13 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -43.45 157.59 0.11 Allowed 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.701 2.267 . . . . 0.0 112.416 179.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 0.501 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.6 Cg_endo -62.84 115.1 2.72 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 C-N-CA 122.781 2.321 . . . . 0.0 111.727 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . 0.501 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.7 mt-30 155.72 147.44 0.0 OUTLIER Pre-proline 0 C--O 1.232 0.134 0 O-C-N 124.071 0.857 . . . . 0.0 110.953 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -73.34 143.71 35.54 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.553 2.169 . . . . 0.0 112.381 177.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.5 HG23 ' OG ' ' A' ' 258' ' ' SER . 2.1 p -124.63 159.24 31.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.443 0.64 . . . . 0.0 110.217 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . 0.493 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 36.0 p -143.45 165.49 27.4 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.082 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . 0.446 ' HA ' ' H ' ' A' ' 260' ' ' PHE . . . -135.4 128.75 32.18 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 121.292 0.568 . . . . 0.0 110.181 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.504 HD11 HD23 ' A' ' 259' ' ' LEU . 47.3 pt -146.46 148.87 16.55 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.381 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.276 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . 0.757 HG13 ' CD1' ' A' ' 262' ' ' PHE . 69.8 t -117.67 123.28 71.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.334 0.588 . . . . 0.0 109.844 178.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -134.37 107.38 7.58 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.258 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 94.0 m -130.86 130.39 43.51 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.846 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.401 ' O ' ' N ' ' A' ' 201' ' ' HIS . . . -82.74 -37.16 25.06 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.22 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.32 -67.1 0.26 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.383 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.2 -10.07 59.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.387 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . 0.401 ' N ' ' O ' ' A' ' 198' ' ' ALA . 60.2 t-80 61.01 58.25 2.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.721 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 41.4 p -167.03 153.7 8.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.595 179.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.6 144.32 24.35 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.467 179.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -135.46 138.28 43.02 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.647 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 19.6 mt -106.2 125.59 51.18 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.046 0.45 . . . . 0.0 109.876 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' TRP . . . . . 0.555 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 75.8 m95 -82.3 167.24 18.79 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.619 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . 0.457 HG22 ' C ' ' A' ' 206' ' ' TRP . 0.1 OUTLIER -157.05 170.94 8.12 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-O 120.981 0.42 . . . . 0.0 110.587 -178.954 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -53.09 -37.17 79.0 Favored 'Trans proline' 0 C--N 1.301 -1.928 0 C-N-CA 122.659 2.24 . . . . 0.0 112.532 178.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -70.86 -34.78 71.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.64 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 22.4 m -61.24 150.87 33.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.641 -179.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.68 -36.87 82.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.471 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . 0.555 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 55.0 tt0 -64.91 -40.1 94.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.515 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.62 -43.66 91.59 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.649 -0.98 . . . . 0.0 110.649 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -62.83 -43.81 97.82 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.874 0.369 . . . . 0.0 110.306 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . 0.529 ' SD ' ' HB2' ' A' ' 304' ' ' ALA . 65.2 ttp -59.31 -48.23 82.4 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.108 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 88.6 mt -60.27 -41.16 92.72 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . 0.453 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.1 tp10 -57.93 -37.78 74.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.14 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -65.33 -38.1 89.1 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.687 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 94.2 mt -64.14 -42.89 96.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.176 0.512 . . . . 0.0 110.653 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.61 44.82 0.08 OUTLIER Glycine 0 N--CA 1.462 0.4 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . 0.453 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 27.3 m-85 -127.77 155.31 44.23 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 121.065 0.46 . . . . 0.0 110.463 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.48 ' O ' HG13 ' A' ' 191' ' ' VAL . 6.6 p -106.95 122.08 45.73 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.287 0.565 . . . . 0.0 109.992 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.468 HD22 ' C ' ' A' ' 222' ' ' THR . 4.3 mm? -100.99 133.19 45.85 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.139 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.95 159.05 15.13 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.426 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.09 115.43 30.25 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.924 0.392 . . . . 0.0 110.312 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.491 ' N ' HD12 ' A' ' 226' ' ' LEU . 8.9 mp -53.62 156.53 4.51 Favored Pre-proline 0 N--CA 1.45 -0.435 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.783 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.82 145.31 98.57 Favored 'Trans proline' 0 C--N 1.3 -1.999 0 C-N-CA 122.764 2.31 . . . . 0.0 112.34 179.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.53 -2.95 58.96 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.473 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.26 -40.8 5.68 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 111.034 -0.827 . . . . 0.0 111.034 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.526 ' O ' ' N ' ' A' ' 233' ' ' SER . 85.7 mt -79.09 -16.85 56.16 Favored 'General case' 0 C--O 1.219 -0.54 0 CA-C-O 121.099 0.476 . . . . 0.0 110.347 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 54.3 t-20 -40.24 -49.15 2.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.857 -179.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -88.08 15.34 7.53 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.386 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.526 ' N ' ' O ' ' A' ' 230' ' ' LEU . 78.1 p -60.59 -35.5 76.24 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.714 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . 0.523 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.6 tt0 -118.38 -69.41 0.85 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.809 179.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.0 m -70.06 103.5 2.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.678 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -94.57 57.5 2.23 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.279 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -144.84 -122.48 1.56 Allowed Glycine 0 N--CA 1.461 0.304 0 N-CA-C 110.946 -0.861 . . . . 0.0 110.946 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -134.54 111.94 10.48 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.146 0.498 . . . . 0.0 110.339 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . 0.515 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.3 mtt180 -148.33 57.54 1.07 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.69 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -69.77 -31.91 70.11 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.528 179.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . 0.55 ' CG ' HD21 ' A' ' 143' ' ' ASN . 65.0 t0 -56.72 -47.09 80.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.304 -179.029 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' ILE . . . . . 0.439 ' O ' ' O ' ' A' ' 239' ' ' ARG . 17.6 tt -140.12 157.06 25.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.867 0.365 . . . . 0.0 110.468 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.439 HG22 HD13 ' A' ' 245' ' ' LEU . 96.2 mt -106.07 106.27 20.25 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.168 0 CA-C-O 121.085 0.469 . . . . 0.0 110.461 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . 0.596 ' O ' HD12 ' A' ' 245' ' ' LEU . 88.0 mt-30 -110.55 110.2 20.83 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.309 179.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.596 HD12 ' O ' ' A' ' 244' ' ' GLN . 9.6 mp -121.86 -168.12 1.65 Allowed 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.643 179.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . 0.523 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.3 -16.87 0.05 OUTLIER Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . 0.667 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -60.46 157.04 29.74 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -63.74 21.38 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.942 0.401 . . . . 0.0 110.601 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . 0.667 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.8 m-20 -97.08 -6.0 36.15 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.43 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 92.2 mt -80.09 -21.45 43.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.824 179.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.56 -51.31 70.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.634 -179.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.7 -5.25 58.24 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.488 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.16 -74.29 1.15 Allowed Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.829 -0.909 . . . . 0.0 110.829 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 81.3 mt -70.15 126.08 28.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.931 0.396 . . . . 0.0 110.328 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -59.6 -39.26 83.59 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.289 -179.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 82.91 51.68 4.14 Favored Glycine 0 CA--C 1.52 0.382 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -95.77 -15.19 22.74 Favored 'General case' 0 C--N 1.332 -0.187 0 O-C-N 122.69 -0.3 . . . . 0.0 110.616 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . 0.5 ' OG ' HG23 ' A' ' 191' ' ' VAL . 3.3 t 174.69 88.85 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.24 0.543 . . . . 0.0 110.114 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.855 ' N ' HD12 ' A' ' 259' ' ' LEU . 0.9 OUTLIER -94.41 124.13 38.25 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.201 0.524 . . . . 0.0 111.266 -179.132 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 260' ' ' PHE . . . . . 0.446 ' H ' ' HA ' ' A' ' 193' ' ' ALA . 15.7 m-30 -93.25 146.28 23.82 Favored 'General case' 0 CA--C 1.498 -1.022 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.379 179.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 86.0 mt -122.27 149.68 43.37 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.622 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.757 ' CD1' HG13 ' A' ' 195' ' ' VAL . 2.7 p90 -77.17 -138.19 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.587 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . 0.656 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -52.34 77.18 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 121.024 0.44 . . . . 0.0 111.165 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . 0.616 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -178.99 104.39 0.19 Allowed Glycine 0 CA--C 1.529 0.951 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 265' ' ' ASP . . . . . 0.592 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.4 m-20 -80.14 -178.15 6.41 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.637 0.256 . . . . 0.0 110.938 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -40.31 -17.66 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.651 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . 0.592 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.32 -51.65 42.28 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.647 179.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -63.65 -46.65 84.68 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.007 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . 0.57 ' HB1' ' OH ' ' A' ' 273' ' ' TYR . . . -61.79 -35.02 76.94 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.392 0.615 . . . . 0.0 109.701 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -63.15 -34.12 76.93 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.158 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.72 -43.31 13.49 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.969 -179.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 272' ' ' ILE . . . . . 0.591 ' C ' ' H ' ' A' ' 274' ' ' ALA . 4.9 tt -51.42 -33.51 14.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.798 -178.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 273' ' ' TYR . . . . . 0.57 ' OH ' ' HB1' ' A' ' 269' ' ' ALA . 17.3 m-85 -54.71 -1.77 0.03 OUTLIER 'General case' 0 CA--C 1.515 -0.385 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.62 -179.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 274' ' ' ALA . . . . . 0.591 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.55 -39.7 70.51 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.912 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . 0.578 ' O ' ' N ' ' A' ' 279' ' ' ALA . 2.9 p30 -39.16 98.26 0.16 Allowed Pre-proline 0 C--O 1.226 -0.137 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.368 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.66 -42.72 65.78 Favored 'Trans proline' 0 C--N 1.303 -1.864 0 C-N-CA 122.413 2.076 . . . . 0.0 112.482 -178.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 88.9 mt -64.43 -42.89 95.78 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.116 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 91.1 mt -95.65 -1.6 49.81 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.984 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 279' ' ' ALA . . . . . 0.578 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.26 -34.71 77.06 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.711 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.8 m80 -74.38 20.1 0.12 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.969 -179.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 0.482 HD23 ' HA ' ' A' ' 281' ' ' LEU . 13.7 mt -74.93 119.35 76.42 Favored Pre-proline 0 N--CA 1.445 -0.692 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.873 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -49.53 -40.37 45.54 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.658 2.239 . . . . 0.0 112.417 178.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.44 -50.61 62.26 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.116 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 75.4 t -61.29 -43.91 97.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.132 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -57.86 -41.15 81.83 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.129 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -90.97 0.12 57.61 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.102 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt 59.47 42.98 16.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.048 0.452 . . . . 0.0 110.829 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -94.42 41.33 1.09 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.31 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 53.8 t -118.85 135.82 58.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-O 121.141 0.496 . . . . 0.0 110.023 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -133.01 162.71 30.98 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 121.165 0.507 . . . . 0.0 110.633 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.98 155.38 32.93 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.108 0.48 . . . . 0.0 110.589 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 81.8 mt -94.13 -1.51 54.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.173 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.31 165.53 12.66 Favored Glycine 0 N--CA 1.464 0.514 0 N-CA-C 110.494 -1.043 . . . . 0.0 110.494 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 6.9 m -87.21 -62.43 1.5 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.921 0.391 . . . . 0.0 111.015 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 295' ' ' GLU . . . . . 0.433 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.5 mm-40 -69.57 -3.74 16.12 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.653 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 27.2 p -77.17 33.18 0.15 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.574 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 297' ' ' PHE . . . . . 0.533 ' CD2' HG22 ' A' ' 70' ' ' THR . 83.8 t80 -60.28 -45.96 91.5 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.589 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . 0.609 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.2 mtt85 -81.57 134.36 35.49 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.574 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.447 ' H ' HG11 ' A' ' 51' ' ' VAL . 16.3 tp -114.34 119.36 36.7 Favored 'General case' 0 C--O 1.23 0.07 0 CA-C-O 120.982 0.42 . . . . 0.0 110.29 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . 0.619 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.1 p-10 -167.07 -174.43 2.65 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.608 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -48.23 -45.14 33.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.203 -179.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -65.13 -41.35 94.91 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 121.054 0.454 . . . . 0.0 110.714 178.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . 0.619 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 53.5 p -55.61 -36.26 66.73 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.059 -179.197 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . 0.529 ' HB2' ' SD ' ' A' ' 215' ' ' MET . . . -56.57 -52.18 65.79 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 91.8 mtp -55.72 -44.06 77.11 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -66.25 -42.6 88.32 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.211 0.529 . . . . 0.0 110.227 179.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 303' ' ' SER . 55.6 t -64.03 -42.77 96.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.202 179.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 43.4 tp -59.73 -42.2 92.61 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.77 -179.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -62.75 -38.83 92.11 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.048 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 310' ' ' ARG . . . . . 0.44 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.5 ttt85 -63.46 -44.1 95.45 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.211 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 88.0 mt -63.14 -41.98 99.39 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.416 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -62.96 -33.04 74.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.152 179.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -90.09 -23.36 21.42 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.375 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.482 HD22 ' CE2' ' A' ' 315' ' ' PHE . 6.8 tt -62.31 -43.21 99.35 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 121.11 0.481 . . . . 0.0 110.573 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 315' ' ' PHE . . . . . 0.482 ' CE2' HD22 ' A' ' 314' ' ' LEU . 90.5 m-85 . . . . . 0 C--O 1.22 -0.477 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.326 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.477 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -99.5 136.06 39.99 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.115 0.483 . . . . 0.0 110.474 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.494 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -92.2 178.59 1.64 Allowed Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.545 -179.813 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.494 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.5 Cg_exo -61.54 147.18 96.05 Favored 'Trans proline' 0 C--N 1.299 -2.068 0 C-N-CA 122.854 2.369 . . . . 0.0 112.193 179.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.455 ' HE ' HD12 ' A' ' 39' ' ' LEU . 35.5 ptt180 -135.89 142.51 44.71 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.634 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -79.86 116.55 20.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.482 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.445 ' O ' HG23 ' A' ' 30' ' ' ILE . 9.4 tp -111.03 130.47 64.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.458 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 12.5 t -70.79 141.56 51.4 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.62 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.476 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.5 t0 -139.13 179.51 6.47 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.495 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.476 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 78.0 p -73.74 -37.32 65.12 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.6 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -46.3 -94.56 0.0 OUTLIER 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.357 -179.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -167.16 -26.56 0.02 OUTLIER Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 58.4 m -169.03 104.75 0.4 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.879 0.371 . . . . 0.0 110.668 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.68 ' CD2' HD13 ' A' ' 140' ' ' LEU . 74.2 t60 -128.57 148.44 50.77 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 121.119 0.485 . . . . 0.0 110.206 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.625 HG22 ' N ' ' A' ' 39' ' ' LEU . 98.4 m -130.83 166.14 21.49 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.458 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.625 ' N ' HG22 ' A' ' 38' ' ' THR . 81.6 mt -120.88 127.37 51.81 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.444 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -65.18 -44.61 87.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.716 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 38.9 p -165.67 154.98 12.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.377 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.497 ' H ' ' CD ' ' A' ' 42' ' ' GLN . 14.8 mp0 -44.3 101.0 0.24 Allowed Pre-proline 0 C--N 1.329 -0.306 0 O-C-N 123.419 0.449 . . . . 0.0 110.645 179.272 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -57.44 129.47 34.12 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 C-N-CA 122.347 2.031 . . . . 0.0 112.24 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -83.6 -24.67 31.4 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.621 179.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.539 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.5 mtm-85 -122.01 134.69 54.8 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.201 0.524 . . . . 0.0 110.256 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.2 mt -130.88 133.63 62.82 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.846 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 44.9 t -124.42 130.34 73.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-O 120.932 0.396 . . . . 0.0 109.939 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.626 ' OG ' HD12 ' A' ' 117' ' ' LEU . 2.3 m -154.8 166.89 32.05 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.504 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 69.8 p -124.55 8.83 8.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.404 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.26 125.67 33.08 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.874 0.369 . . . . 0.0 110.63 -179.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.442 HG11 ' H ' ' A' ' 299' ' ' LEU . 96.3 t -65.92 -44.51 92.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.505 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.7 m -62.69 -44.51 96.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.594 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 50.5 tp -62.32 -41.5 98.59 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.551 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.432 ' O ' HD13 ' A' ' 58' ' ' LEU . 75.4 m -57.87 -44.44 86.63 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.206 -179.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.14 -62.43 5.18 Favored Glycine 0 N--CA 1.467 0.717 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.7 t -48.2 -35.6 12.11 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 110.159 -0.311 . . . . 0.0 110.159 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 20.1 mt -61.87 -44.39 96.91 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.649 -0.421 . . . . 0.0 111.396 179.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.432 HD13 ' O ' ' A' ' 54' ' ' THR . 9.3 mp -65.5 -41.42 93.23 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.364 177.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.32 -41.27 98.91 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.832 -179.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.42 ' O ' HG23 ' A' ' 60' ' ' ILE . 8.3 tp -88.29 17.59 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.888 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 56.14 85.2 0.08 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.797 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.42 59.99 0.09 OUTLIER Pre-proline 0 C--N 1.327 -0.373 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.4 ' HB3' HE21 ' A' ' 85' ' ' GLN . 9.7 Cg_endo -51.88 151.12 16.28 Favored 'Trans proline' 0 C--N 1.293 -2.363 0 C-N-CA 123.032 2.488 . . . . 0.0 112.047 -178.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.432 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -108.21 145.31 15.45 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.157 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.259 -179.659 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.51 -45.46 97.72 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.272 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.401 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.497 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -130.03 134.55 47.48 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 120.84 0.352 . . . . 0.0 110.491 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.476 ' O ' ' N ' ' A' ' 98' ' ' LEU . 74.8 m -134.56 158.82 43.0 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.831 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.29 138.58 16.02 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.48 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.55 -162.91 0.09 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.921 0.391 . . . . 0.0 110.474 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.529 HG22 ' CD2' ' A' ' 297' ' ' PHE . 6.1 t -133.93 135.28 43.47 Favored 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.48 ' C ' ' O ' ' A' ' 70' ' ' THR . 0.9 OUTLIER 29.65 68.74 0.65 Allowed Pre-proline 0 N--CA 1.467 0.403 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.743 -179.685 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -61.72 145.2 97.55 Favored 'Trans proline' 0 C--N 1.299 -2.062 0 C-N-CA 122.708 2.272 . . . . 0.0 111.735 -177.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.535 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 45.0 p-10 -159.65 -31.94 0.06 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.637 179.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.535 ' N ' ' OD1' ' A' ' 73' ' ' ASN . 99.1 m-20 -63.83 -39.92 95.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.337 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -60.08 -47.97 83.68 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.638 -179.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.426 ' O ' ' O ' ' A' ' 77' ' ' ALA . 93.6 t -60.49 -24.87 32.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.535 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -45.81 173.34 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.615 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.569 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.3 p30 -62.15 177.56 0.46 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.421 -179.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.561 ' C ' ' H ' ' A' ' 81' ' ' GLY . 36.4 p30 -45.4 85.68 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.075 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.569 ' N ' ' O ' ' A' ' 78' ' ' ASP . 43.1 tp60 -67.48 13.18 0.07 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.221 0.534 . . . . 0.0 110.142 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.561 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 118.54 -22.35 9.45 Favored Glycine 0 N--CA 1.461 0.305 0 N-CA-C 110.934 -0.866 . . . . 0.0 110.934 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -107.75 116.45 31.97 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.987 0.422 . . . . 0.0 110.453 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 75.0 mt -98.58 0.07 44.18 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.984 0.421 . . . . 0.0 110.559 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -92.63 7.38 43.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.015 0.436 . . . . 0.0 110.357 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.787 ' O ' HG22 ' A' ' 89' ' ' VAL . 88.5 mt-30 -100.12 -27.91 13.3 Favored 'General case' 0 C--O 1.222 -0.382 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.81 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 69.1 t-105 -63.49 -40.46 97.14 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.906 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.554 ' O ' ' N ' ' A' ' 91' ' ' LYS . 68.7 m -77.78 -53.79 7.1 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.952 -179.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -48.3 -50.57 29.55 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.111 -179.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.787 HG22 ' O ' ' A' ' 85' ' ' GLN . 15.7 m -69.03 -40.47 80.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.144 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.493 ' N ' HG23 ' A' ' 89' ' ' VAL . . . -72.63 -22.66 60.91 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.652 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.554 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.0 tttm -62.12 -45.62 92.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.384 -179.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.44 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.6 mm-40 -90.32 -94.8 0.12 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.974 0.416 . . . . 0.0 110.084 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.626 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.9 mtt180 -143.12 59.32 1.41 Allowed 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 109.595 -0.521 . . . . 0.0 109.595 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.449 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.7 pttp 33.8 25.89 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 120.968 0.413 . . . . 0.0 110.234 -179.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.626 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.4 tt -48.31 123.5 6.58 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.934 -177.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.451 ' O ' HD23 ' A' ' 95' ' ' LEU . 98.9 mm-40 -83.62 -170.3 2.99 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.112 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.61 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 82.3 mtp180 -73.82 137.26 43.72 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.233 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.476 ' N ' ' O ' ' A' ' 67' ' ' SER . 90.4 mt -86.32 -165.81 1.37 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.784 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.537 ' CD2' ' O ' ' A' ' 99' ' ' TYR . 48.3 p90 -169.01 120.09 0.74 Allowed 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.114 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.502 ' C ' ' O ' ' A' ' 99' ' ' TYR . 43.9 mm -28.98 121.02 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 O-C-N 123.261 0.351 . . . . 0.0 111.103 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 114.52 26.9 3.51 Favored Glycine 0 C--N 1.332 0.338 0 N-CA-C 111.281 -0.728 . . . . 0.0 111.281 -179.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.575 ' N ' ' CD ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -144.18 46.38 0.63 Allowed Pre-proline 0 C--N 1.322 -0.622 0 CA-C-O 121.023 0.44 . . . . 0.0 110.472 179.833 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 29.1 Cg_endo -62.13 143.92 95.23 Favored 'Trans proline' 0 C--N 1.294 -2.3 0 C-N-CA 122.677 2.251 . . . . 0.0 111.771 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.451 ' O ' HG23 ' A' ' 108' ' ' VAL . 26.5 t -173.14 120.35 0.35 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.426 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.39 -40.58 64.21 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.042 0.449 . . . . 0.0 111.145 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -66.19 -39.82 89.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.892 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.13 -39.88 94.99 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.77 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 104' ' ' SER . 71.7 t -67.77 -43.71 86.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.733 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.96 -38.97 93.23 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.555 -179.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.44 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.66 -23.3 62.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.473 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.537 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.4 mm-40 -90.8 5.58 47.77 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.654 -179.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.539 ' O ' ' NE ' ' A' ' 45' ' ' ARG . 10.3 tpt 22.88 64.5 0.36 Allowed Pre-proline 0 N--CA 1.468 0.437 0 CA-C-O 120.913 0.387 . . . . 0.0 111.22 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -78.92 167.5 22.04 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 123.079 2.519 . . . . 0.0 111.657 -177.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.522 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 99.3 m-20 -110.15 -42.05 4.28 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.077 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.8 tp -121.32 120.44 35.1 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 83.8 mt -113.42 129.09 69.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-O 120.848 0.356 . . . . 0.0 110.96 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.626 HD12 ' OG ' ' A' ' 48' ' ' SER . 29.5 mt -108.86 132.17 54.29 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.044 0.449 . . . . 0.0 110.268 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.49 HD12 HG23 ' A' ' 139' ' ' THR . 98.8 mt -119.66 138.42 50.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.709 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 85.6 p -72.63 153.77 41.07 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.612 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.12 -50.12 74.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.627 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.0 t -149.44 153.92 38.05 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.566 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 170.47 -170.98 43.43 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.89 -34.13 88.99 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.829 -0.908 . . . . 0.0 110.829 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.453 ' O ' ' OD1' ' A' ' 124' ' ' ASP . 44.5 p-10 -87.36 120.01 28.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.882 0.373 . . . . 0.0 110.652 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.444 ' O ' HD12 ' A' ' 129' ' ' LEU . 37.7 t -63.05 144.01 57.27 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.399 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.521 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.19 -43.26 8.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.836 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.3 tp -62.98 -42.45 99.84 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.739 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.49 -12.0 59.26 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.508 -179.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.444 HD12 ' O ' ' A' ' 125' ' ' SER . 85.1 mt -114.93 -23.93 8.87 Favored 'General case' 0 C--O 1.226 -0.159 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.586 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . 0.521 ' N ' ' O ' ' A' ' 126' ' ' ALA . 80.0 t80 -50.94 -49.49 59.76 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.643 -178.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.5 p-10 -66.09 -42.5 89.24 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.876 -0.33 . . . . 0.0 111.237 179.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.523 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 88.2 mt-30 -67.17 -37.85 84.44 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.874 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.429 HD12 HD11 ' A' ' 118' ' ' ILE . 96.1 mt -79.98 -41.83 25.14 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.915 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.3 t -56.86 -44.78 82.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.277 -179.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 20.0 m -61.86 -45.25 94.6 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.507 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 94.1 mt -62.03 -43.68 97.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.262 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.656 ' HB1' ' HD2' ' A' ' 138' ' ' PRO . . . -169.31 168.17 5.08 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.571 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.656 ' HD2' ' HB1' ' A' ' 137' ' ' ALA . 52.5 Cg_exo -49.61 113.0 0.79 Allowed 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.288 1.992 . . . . 0.0 112.35 179.078 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.49 HG23 HD12 ' A' ' 118' ' ' ILE . 23.5 m -84.27 127.41 33.94 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.622 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.68 HD13 ' CD2' ' A' ' 37' ' ' HIS . 34.4 tp -117.77 135.34 54.11 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.072 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.435 ' O ' ' OD2' ' A' ' 32' ' ' ASP . 82.3 mt -99.9 118.91 47.24 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.315 0 CA-C-O 121.181 0.515 . . . . 0.0 111.137 -179.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.438 HD12 HD22 ' A' ' 117' ' ' LEU . 98.1 mt -134.85 131.94 53.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.554 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.546 HD21 ' CG ' ' A' ' 241' ' ' ASP . 60.7 t30 -66.37 151.19 47.63 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.908 0.385 . . . . 0.0 110.479 179.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.52 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 88.2 t80 -85.96 122.25 29.73 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.883 -179.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.52 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 99.0 m-20 55.41 69.15 0.76 Allowed 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.672 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 35.0 p-10 -125.68 0.2 7.45 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.845 0.355 . . . . 0.0 110.604 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -150.63 115.48 5.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.706 -179.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 83.8 p -63.73 168.77 4.59 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.551 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.416 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.5 p-90 -52.3 -16.01 0.75 Allowed 'General case' 0 C--O 1.222 -0.389 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.417 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.433 ' O ' HG23 ' A' ' 154' ' ' THR . 68.2 tp60 -69.97 -76.88 0.09 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.508 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.441 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.0 t -62.49 -38.45 89.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.216 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 54.1 tp -59.78 -45.86 90.98 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.356 -178.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.416 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 46.7 tp -62.66 -41.77 99.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.527 178.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.441 ' OG1' ' O ' ' A' ' 151' ' ' SER . 62.7 p -64.0 -34.75 78.7 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.196 -179.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.422 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 88.0 mm-40 -64.05 -42.71 96.94 Favored 'General case' 0 C--O 1.225 -0.196 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.356 179.305 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 91.7 mt -65.52 -38.7 90.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.101 0.477 . . . . 0.0 110.277 179.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.575 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.37 -32.12 79.8 Favored Glycine 0 C--N 1.331 0.295 0 N-CA-C 110.68 -0.968 . . . . 0.0 110.68 -179.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 157' ' ' GLY . 97.3 mt-10 -35.64 -26.73 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.839 0.352 . . . . 0.0 110.858 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.575 ' N ' ' O ' ' A' ' 157' ' ' GLY . 95.3 mt -56.16 149.37 3.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.411 178.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 74.8 p -69.68 137.25 51.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.978 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 71.39 21.0 78.64 Favored Glycine 0 CA--C 1.517 0.165 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 179.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 56.3 m80 -122.56 -14.5 7.77 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.602 0.239 . . . . 0.0 110.454 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -65.66 -59.98 3.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.593 -179.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -52.18 -49.34 64.01 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.177 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -60.24 -41.28 92.84 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.805 0.336 . . . . 0.0 110.437 179.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.34 -47.17 87.13 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.59 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -57.04 -40.1 76.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.279 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -61.72 -50.43 72.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.61 179.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -65.25 -43.78 90.23 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.534 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 94.4 mt -64.83 -43.26 96.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.414 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.38 -51.31 69.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.355 -179.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.23 -43.64 97.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.614 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.663 ' CE2' HD11 ' A' ' 177' ' ' LEU . 56.9 t80 -62.92 -44.45 96.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.097 0.475 . . . . 0.0 110.396 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -63.53 -39.64 94.95 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.679 -179.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -63.16 -42.85 99.48 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.531 179.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -60.78 -44.39 96.86 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.261 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.663 HD11 ' CE2' ' A' ' 173' ' ' PHE . 84.1 mt -64.78 -40.98 96.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.687 178.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.21 -62.39 1.66 Allowed 'General case' 0 C--O 1.238 0.495 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.355 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.37 -47.02 85.16 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.54 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.01 -41.68 64.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.375 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -63.9 -33.69 76.26 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.281 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.417 ' HG2' ' O ' ' A' ' 182' ' ' GLU . 70.0 tt0 -90.64 8.73 32.83 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.616 0.722 . . . . 0.0 110.381 -178.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -104.84 -32.05 9.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.145 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.8 pt -128.08 147.88 32.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.791 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -140.15 131.34 26.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.426 179.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.593 HD22 ' N ' ' A' ' 186' ' ' LEU . 3.5 mm? -85.55 133.06 42.81 Favored Pre-proline 0 N--CA 1.451 -0.41 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.042 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -43.82 157.81 0.13 Allowed 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.649 2.232 . . . . 0.0 112.364 179.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 0.505 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.5 Cg_endo -62.87 114.91 2.62 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 C-N-CA 122.892 2.395 . . . . 0.0 111.657 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . 0.505 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.7 mt-30 155.6 147.65 0.0 OUTLIER Pre-proline 0 N--CA 1.456 -0.138 0 O-C-N 124.028 0.83 . . . . 0.0 110.824 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.35 143.92 35.86 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.614 2.209 . . . . 0.0 112.243 177.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.501 HG23 ' OG ' ' A' ' 258' ' ' SER . 2.1 p -124.58 158.84 31.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.441 0.639 . . . . 0.0 110.162 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . 0.489 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 37.6 p -143.19 165.24 27.97 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.102 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . 0.447 ' HA ' ' H ' ' A' ' 260' ' ' PHE . . . -135.28 128.75 32.41 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 121.285 0.564 . . . . 0.0 110.224 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.506 HD11 HD23 ' A' ' 259' ' ' LEU . 47.4 pt -146.66 149.02 16.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.146 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . 0.746 HG13 ' CD1' ' A' ' 262' ' ' PHE . 69.5 t -117.77 123.41 71.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 CA-C-O 121.32 0.581 . . . . 0.0 109.903 178.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -134.27 107.25 7.55 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.161 0.505 . . . . 0.0 110.205 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 93.3 m -130.97 130.33 43.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.815 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.406 ' O ' ' N ' ' A' ' 201' ' ' HIS . . . -82.92 -37.27 24.42 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.249 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.23 -66.94 0.27 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.362 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.3 -10.17 59.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.346 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . 0.406 ' N ' ' O ' ' A' ' 198' ' ' ALA . 59.9 t-80 61.08 58.1 2.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.745 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 36.3 p -166.69 153.26 8.75 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.602 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.24 144.02 24.43 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.096 0.474 . . . . 0.0 110.416 179.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -135.4 138.32 43.17 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.609 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 19.9 mt -106.24 125.56 51.15 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.065 0.46 . . . . 0.0 109.925 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' TRP . . . . . 0.556 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 75.2 m95 -82.08 167.0 19.24 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.573 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . 0.462 HG22 ' C ' ' A' ' 206' ' ' TRP . 0.1 OUTLIER -157.19 171.11 7.88 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.645 -178.961 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -53.19 -37.29 79.93 Favored 'Trans proline' 0 C--N 1.302 -1.913 0 C-N-CA 122.588 2.192 . . . . 0.0 112.472 178.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -70.57 -35.07 72.87 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.711 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 21.0 m -61.08 150.84 32.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.642 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.7 -36.78 81.9 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.465 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . 0.556 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 54.6 tt0 -64.97 -40.02 94.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.475 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.64 -43.4 92.1 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.712 -0.955 . . . . 0.0 110.712 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -63.24 -43.94 96.62 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.788 0.328 . . . . 0.0 110.229 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . 0.521 ' SD ' ' HB2' ' A' ' 304' ' ' ALA . 65.1 ttp -59.21 -48.1 82.86 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.148 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 87.8 mt -60.42 -41.02 93.06 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . 0.457 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.8 tp10 -58.0 -37.67 74.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.05 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -65.53 -38.07 88.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.659 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 94.4 mt -64.09 -42.8 96.79 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.662 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.52 44.91 0.08 OUTLIER Glycine 0 CA--C 1.52 0.391 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . 0.457 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 26.9 m-85 -127.92 155.42 44.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.073 0.463 . . . . 0.0 110.463 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.48 ' O ' HG13 ' A' ' 191' ' ' VAL . 7.2 p -107.27 122.49 46.66 Favored 'General case' 0 C--O 1.224 -0.248 0 CA-C-O 121.371 0.605 . . . . 0.0 110.088 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.476 HD22 ' C ' ' A' ' 222' ' ' THR . 4.3 mm? -101.43 133.02 46.7 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.162 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.77 159.78 14.73 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.459 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.47 115.33 30.07 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.391 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.497 ' N ' HD12 ' A' ' 226' ' ' LEU . 8.9 mp -53.16 156.54 3.71 Favored Pre-proline 0 N--CA 1.451 -0.415 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.764 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.01 145.34 98.6 Favored 'Trans proline' 0 C--N 1.299 -2.03 0 C-N-CA 122.744 2.296 . . . . 0.0 112.298 179.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.28 -3.38 59.04 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.535 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -89.96 -41.22 5.66 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.518 ' O ' ' N ' ' A' ' 233' ' ' SER . 69.8 mt -78.86 -17.59 55.37 Favored 'General case' 0 C--O 1.219 -0.522 0 CA-C-O 121.13 0.491 . . . . 0.0 110.379 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 54.4 t-20 -40.41 -49.2 2.83 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.807 -179.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -87.59 15.15 7.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.352 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.518 ' N ' ' O ' ' A' ' 230' ' ' LEU . 77.9 p -60.59 -35.3 75.76 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.703 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . 0.524 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.6 tt0 -119.0 -69.33 0.86 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.868 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.3 m -69.76 102.82 2.0 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.675 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -94.37 57.56 2.31 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.34 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -144.78 -122.42 1.56 Allowed Glycine 0 N--CA 1.461 0.309 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -135.12 111.69 9.93 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 121.183 0.516 . . . . 0.0 110.341 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . 0.525 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.6 mtt180 -148.22 57.85 1.08 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.655 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -69.47 -32.39 71.26 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.512 179.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . 0.546 ' CG ' HD21 ' A' ' 143' ' ' ASN . 64.8 t0 -56.84 -47.1 81.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.27 -179.027 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' ILE . . . . . 0.44 ' O ' ' O ' ' A' ' 239' ' ' ARG . 18.1 tt -139.88 156.4 25.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.933 0.397 . . . . 0.0 110.445 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.446 HG22 HD13 ' A' ' 245' ' ' LEU . 96.2 mt -106.3 106.65 20.99 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.206 0 CA-C-O 121.1 0.476 . . . . 0.0 110.567 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . 0.6 ' O ' HD12 ' A' ' 245' ' ' LEU . 88.2 mt-30 -110.49 110.0 20.57 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.232 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.6 HD12 ' O ' ' A' ' 244' ' ' GLN . 9.4 mp -121.69 -168.19 1.65 Allowed 'General case' 0 C--O 1.223 -0.297 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.752 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . 0.524 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.51 -16.37 0.05 OUTLIER Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.974 -0.851 . . . . 0.0 110.974 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . 0.672 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -61.04 156.61 32.96 Favored Glycine 0 CA--C 1.521 0.464 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -63.45 21.53 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.98 0.419 . . . . 0.0 110.649 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . 0.672 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.9 m-20 -97.2 -6.22 35.23 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.493 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 92.6 mt -79.48 -21.99 44.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.786 179.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.54 -51.36 70.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.734 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.24 -5.66 58.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.459 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.15 -74.48 1.14 Allowed Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.844 -0.902 . . . . 0.0 110.844 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 82.2 mt -70.02 126.07 28.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.017 0.437 . . . . 0.0 110.315 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -59.5 -39.37 83.57 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.11 -179.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 82.75 51.71 4.17 Favored Glycine 0 CA--C 1.52 0.37 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -96.14 -14.81 22.53 Favored 'General case' 0 C--N 1.333 -0.138 0 O-C-N 122.683 -0.304 . . . . 0.0 110.615 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . 0.501 ' OG ' HG23 ' A' ' 191' ' ' VAL . 3.4 t 174.77 88.59 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.194 0.521 . . . . 0.0 110.092 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.857 ' N ' HD12 ' A' ' 259' ' ' LEU . 1.0 OUTLIER -94.43 124.44 38.46 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.228 0.537 . . . . 0.0 111.179 -179.129 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 260' ' ' PHE . . . . . 0.447 ' H ' ' HA ' ' A' ' 193' ' ' ALA . 15.8 m-30 -93.28 146.41 23.73 Favored 'General case' 0 CA--C 1.499 -1.012 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.396 179.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 85.2 mt -122.5 149.39 43.96 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.58 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.746 ' CD1' HG13 ' A' ' 195' ' ' VAL . 2.6 p90 -77.19 -138.36 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.612 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . 0.656 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -52.07 76.95 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 121.049 0.452 . . . . 0.0 111.188 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . 0.624 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -178.76 104.51 0.19 Allowed Glycine 0 CA--C 1.528 0.85 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 265' ' ' ASP . . . . . 0.596 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.5 m-20 -80.38 -178.04 6.46 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.585 0.231 . . . . 0.0 110.928 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -40.25 -17.91 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.579 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . 0.596 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.13 -51.66 43.65 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.722 179.195 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -63.6 -46.68 84.69 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.254 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . 0.569 ' HB1' ' OH ' ' A' ' 273' ' ' TYR . . . -61.67 -35.13 77.08 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 121.404 0.621 . . . . 0.0 109.822 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -63.07 -34.37 77.44 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.176 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.49 -43.27 13.71 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.126 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 272' ' ' ILE . . . . . 0.591 ' C ' ' H ' ' A' ' 274' ' ' ALA . 4.9 tt -51.39 -33.69 14.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.767 -178.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 273' ' ' TYR . . . . . 0.569 ' OH ' ' HB1' ' A' ' 269' ' ' ALA . 17.2 m-85 -54.43 -1.78 0.03 OUTLIER 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.703 -179.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 274' ' ' ALA . . . . . 0.591 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.5 -39.7 70.65 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.93 179.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . 0.579 ' O ' ' N ' ' A' ' 279' ' ' ALA . 3.1 p30 -38.98 98.02 0.15 Allowed Pre-proline 0 C--O 1.226 -0.149 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.449 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -54.64 -42.61 66.73 Favored 'Trans proline' 0 C--N 1.303 -1.835 0 C-N-CA 122.376 2.051 . . . . 0.0 112.513 -178.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 89.2 mt -64.57 -42.86 95.38 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.038 0.447 . . . . 0.0 111.15 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 91.2 mt -95.66 -1.63 49.74 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.939 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 279' ' ' ALA . . . . . 0.579 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.3 -34.68 77.06 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.748 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.21 20.04 0.12 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.014 -179.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 0.481 ' H ' ' C ' ' A' ' 279' ' ' ALA . 13.8 mt -75.18 119.46 77.04 Favored Pre-proline 0 N--CA 1.447 -0.605 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.729 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -49.9 -39.88 49.01 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.644 2.23 . . . . 0.0 112.281 178.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.64 -50.59 62.87 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.066 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 78.6 t -61.32 -44.0 97.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -57.85 -41.16 81.8 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.15 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -91.06 0.05 57.62 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.104 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt 59.56 43.61 15.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.945 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -95.08 41.42 1.09 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.34 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 54.1 t -119.13 135.68 58.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-O 121.052 0.453 . . . . 0.0 110.067 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -132.58 162.35 31.52 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.22 0.533 . . . . 0.0 110.608 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.6 154.96 33.16 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-O 121.038 0.447 . . . . 0.0 110.663 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 81.5 mt -93.68 -1.56 55.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.253 -179.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.01 166.22 12.93 Favored Glycine 0 CA--C 1.521 0.439 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 7.2 m -87.77 -62.46 1.49 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.855 0.36 . . . . 0.0 110.939 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 295' ' ' GLU . . . . . 0.437 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.4 mm-40 -69.35 -3.87 15.93 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.667 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 27.0 p -77.21 32.7 0.15 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.604 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 297' ' ' PHE . . . . . 0.529 ' CD2' HG22 ' A' ' 70' ' ' THR . 70.1 t80 -60.15 -46.21 90.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.603 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . 0.61 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.2 mtt85 -81.0 133.66 35.53 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.535 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.442 ' H ' HG11 ' A' ' 51' ' ' VAL . 16.4 tp -114.23 119.39 36.85 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.319 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . 0.622 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.1 p-10 -167.52 -173.85 2.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.612 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -48.58 -45.41 37.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.236 -179.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -64.97 -41.52 95.38 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.09 0.471 . . . . 0.0 110.697 178.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . 0.622 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 52.6 p -55.39 -36.14 66.09 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.016 -179.223 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . 0.521 ' HB2' ' SD ' ' A' ' 215' ' ' MET . . . -56.7 -51.84 67.26 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 91.5 mtp -56.15 -43.99 78.83 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -66.23 -42.75 88.22 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.152 0.501 . . . . 0.0 110.238 179.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 303' ' ' SER . 55.1 t -64.04 -42.74 96.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.26 179.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 43.0 tp -59.67 -42.33 92.62 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.741 -179.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -62.55 -38.8 91.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.139 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 310' ' ' ARG . . . . . 0.442 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.5 ttt85 -63.51 -44.1 95.26 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.165 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 87.8 mt -63.2 -42.02 99.25 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.353 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -62.89 -33.24 74.88 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.13 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.93 -23.36 21.6 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.365 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.479 HD22 ' CE2' ' A' ' 315' ' ' PHE . 6.7 tt -62.41 -43.11 99.59 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 121.069 0.461 . . . . 0.0 110.597 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 315' ' ' PHE . . . . . 0.479 ' CE2' HD22 ' A' ' 314' ' ' LEU . 91.2 m-85 . . . . . 0 C--O 1.22 -0.46 0 CA-C-O 117.947 -1.025 . . . . 0.0 110.381 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -99.39 135.15 41.23 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.169 0.509 . . . . 0.0 110.469 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.491 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -92.19 178.68 1.6 Allowed Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.545 -179.802 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.491 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.8 Cg_exo -61.66 147.2 95.89 Favored 'Trans proline' 0 C--N 1.298 -2.097 0 C-N-CA 122.89 2.393 . . . . 0.0 112.117 179.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.477 ' HE ' HD12 ' A' ' 39' ' ' LEU . 35.1 ptt180 -135.91 142.11 44.62 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.732 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -79.66 116.94 20.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.462 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.449 ' O ' HG23 ' A' ' 30' ' ' ILE . 9.4 tp -111.93 130.55 65.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.399 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 12.6 t -71.01 142.27 50.94 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.008 0.432 . . . . 0.0 110.621 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.472 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.4 t0 -139.08 179.75 6.32 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.505 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.472 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 78.3 p -73.6 -37.37 65.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.777 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.8 ttt85 -46.94 -94.76 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.233 -179.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -166.08 -26.73 0.02 OUTLIER Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 62.5 m -168.58 106.02 0.45 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.806 0.336 . . . . 0.0 110.65 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.658 ' CD2' HD13 ' A' ' 140' ' ' LEU . 71.5 t60 -129.23 146.64 51.1 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 121.075 0.464 . . . . 0.0 110.151 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.62 HG22 ' N ' ' A' ' 39' ' ' LEU . 97.5 m -129.86 165.68 21.51 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.41 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.62 ' N ' HG22 ' A' ' 38' ' ' THR . 79.5 mt -120.42 127.21 52.05 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.485 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -65.44 -44.8 86.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.728 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 37.8 p -165.65 155.27 12.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.445 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.497 ' H ' ' CD ' ' A' ' 42' ' ' GLN . 14.6 mp0 -44.43 100.71 0.23 Allowed Pre-proline 0 C--O 1.236 0.374 0 O-C-N 123.527 0.517 . . . . 0.0 110.634 179.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -57.51 129.78 35.6 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 C-N-CA 122.322 2.014 . . . . 0.0 112.337 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -83.09 -24.62 32.6 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.567 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.531 ' NE ' ' O ' ' A' ' 112' ' ' MET . 90.1 mtm-85 -121.04 134.2 55.27 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.214 0.531 . . . . 0.0 110.15 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.1 mt -130.72 133.67 63.01 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.846 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 46.4 t -124.77 131.34 72.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.619 ' OG ' HD12 ' A' ' 117' ' ' LEU . 4.4 m -154.38 166.14 34.16 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.584 179.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 63.3 p -124.66 8.32 8.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.395 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.6 126.15 33.68 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.801 0.334 . . . . 0.0 110.687 -179.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.461 HG11 ' H ' ' A' ' 299' ' ' LEU . 88.7 t -65.65 -44.61 93.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.521 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.3 m -62.55 -44.33 96.6 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.709 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 54.0 tp -62.29 -41.59 98.63 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.558 -179.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.451 ' O ' HD13 ' A' ' 58' ' ' LEU . 69.5 m -58.18 -44.48 88.04 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.124 -179.05 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.31 -62.19 5.35 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.7 t -48.08 -35.77 11.91 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 20.3 mt -61.78 -44.26 97.23 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 120.598 -0.441 . . . . 0.0 111.321 179.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.451 HD13 ' O ' ' A' ' 54' ' ' THR . 9.4 mp -65.26 -41.68 94.03 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.518 177.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.45 -41.26 98.64 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.921 -179.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.415 ' O ' HG23 ' A' ' 60' ' ' ILE . 8.0 tp -87.8 16.75 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.864 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 56.31 84.14 0.09 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.804 -179.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.61 58.21 0.08 OUTLIER Pre-proline 0 C--N 1.327 -0.381 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.411 ' HB3' HE21 ' A' ' 85' ' ' GLN . 9.7 Cg_endo -50.93 152.9 9.43 Favored 'Trans proline' 0 C--N 1.294 -2.333 0 C-N-CA 123.033 2.488 . . . . 0.0 112.228 -178.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.43 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -108.78 146.39 14.5 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.178 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.31 -179.69 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 97.0 mt -63.65 -45.08 98.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.478 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.498 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -130.45 134.49 47.14 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 120.868 0.366 . . . . 0.0 110.49 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.489 ' O ' ' N ' ' A' ' 98' ' ' LEU . 66.9 m -134.42 158.55 43.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.922 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.81 139.43 16.35 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.494 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.85 -162.69 0.08 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.003 0.43 . . . . 0.0 110.384 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.522 HG22 ' CD2' ' A' ' 297' ' ' PHE . 14.6 t -133.57 135.37 44.27 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.314 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.474 ' C ' ' O ' ' A' ' 70' ' ' THR . 0.7 OUTLIER 29.76 68.88 0.65 Allowed Pre-proline 0 N--CA 1.469 0.475 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.857 -179.866 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -61.59 145.34 97.79 Favored 'Trans proline' 0 C--N 1.299 -2.054 0 C-N-CA 122.672 2.248 . . . . 0.0 111.873 -177.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.528 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 46.0 p-10 -160.05 -31.79 0.06 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.799 179.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.529 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 98.9 m-20 -64.41 -39.33 93.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.348 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -60.7 -47.97 83.88 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.481 -179.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.425 ' O ' ' O ' ' A' ' 77' ' ' ALA . 92.8 t -60.35 -24.86 32.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.529 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -45.52 172.85 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.695 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.566 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.7 p30 -61.72 177.48 0.41 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.448 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.565 ' C ' ' H ' ' A' ' 81' ' ' GLY . 36.3 p30 -46.07 85.65 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.016 0.436 . . . . 0.0 110.971 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.566 ' N ' ' O ' ' A' ' 78' ' ' ASP . 42.7 tp60 -67.19 13.55 0.06 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.176 0.512 . . . . 0.0 110.065 -179.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.565 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 117.82 -22.13 10.08 Favored Glycine 0 N--CA 1.461 0.334 0 N-CA-C 110.911 -0.876 . . . . 0.0 110.911 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -107.44 116.3 31.7 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.01 0.433 . . . . 0.0 110.454 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 75.7 mt -98.49 0.46 45.17 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 120.992 0.425 . . . . 0.0 110.582 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -92.14 6.52 46.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.027 0.441 . . . . 0.0 110.276 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.772 ' O ' HG22 ' A' ' 89' ' ' VAL . 88.0 mt-30 -100.12 -26.63 13.88 Favored 'General case' 0 C--O 1.219 -0.511 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.796 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 75.9 t-105 -64.64 -40.76 96.01 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.109 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.549 ' O ' ' N ' ' A' ' 91' ' ' LYS . 68.1 m -77.85 -53.53 7.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.316 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -48.49 -50.52 31.33 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.089 -179.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.772 HG22 ' O ' ' A' ' 85' ' ' GLN . 14.3 m -68.92 -40.82 81.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.209 179.387 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.499 ' N ' HG23 ' A' ' 89' ' ' VAL . . . -71.89 -23.04 61.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.725 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.549 ' N ' ' O ' ' A' ' 87' ' ' SER . 65.9 tttm -61.62 -45.67 93.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.442 -179.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.44 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.3 mm-40 -90.6 -94.56 0.12 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.012 0.434 . . . . 0.0 110.05 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.615 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.9 mtt180 -143.48 59.44 1.39 Allowed 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.441 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.6 pttp 34.45 25.77 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.084 0.468 . . . . 0.0 110.336 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.615 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.5 tt -48.24 123.34 6.28 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.078 -177.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.451 ' O ' HD23 ' A' ' 95' ' ' LEU . 99.0 mm-40 -83.53 -170.84 3.26 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.054 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.609 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 82.2 mtp180 -73.17 137.6 45.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.12 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.489 ' N ' ' O ' ' A' ' 67' ' ' SER . 90.3 mt -86.11 -166.29 1.5 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.868 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.536 ' CD2' ' O ' ' A' ' 99' ' ' TYR . 47.5 p90 -167.96 119.95 0.86 Allowed 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.065 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.494 ' C ' ' O ' ' A' ' 99' ' ' TYR . 42.8 mm -29.56 121.05 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.055 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 113.96 27.91 3.32 Favored Glycine 0 C--N 1.331 0.291 0 N-CA-C 111.326 -0.71 . . . . 0.0 111.326 -179.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.581 ' N ' ' CD ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -143.85 45.83 0.6 Allowed Pre-proline 0 C--N 1.321 -0.632 0 CA-C-O 121.087 0.47 . . . . 0.0 110.427 179.817 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.581 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 29.8 Cg_endo -62.02 143.84 95.52 Favored 'Trans proline' 0 C--N 1.294 -2.306 0 C-N-CA 122.593 2.195 . . . . 0.0 111.881 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.464 ' O ' HG23 ' A' ' 108' ' ' VAL . 24.3 t -173.26 120.6 0.34 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.283 179.53 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.02 -40.98 64.71 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.104 0.478 . . . . 0.0 111.281 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -65.93 -40.11 91.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.864 -179.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.98 -39.81 94.98 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.719 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 104' ' ' SER . 69.4 t -67.48 -43.87 87.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.762 179.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.43 -39.05 92.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.461 -179.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.44 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.58 -23.58 63.05 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.513 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.533 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.3 mm-40 -91.17 5.05 50.6 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.746 -179.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.533 ' C ' ' O ' ' A' ' 111' ' ' GLN . 10.5 tpt 22.98 64.14 0.36 Allowed Pre-proline 0 N--CA 1.469 0.511 0 CA-C-O 120.883 0.373 . . . . 0.0 111.2 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.442 ' HG2' HD11 ' A' ' 116' ' ' ILE . 65.0 Cg_endo -78.93 168.37 20.87 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 123.017 2.478 . . . . 0.0 111.758 -177.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.527 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 99.0 m-20 -112.38 -44.21 3.41 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.003 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 39.8 tp -120.67 119.48 32.94 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.456 HD13 HD22 ' A' ' 133' ' ' LEU . 96.1 mt -116.43 131.19 69.73 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.408 0 CA-C-O 120.887 0.375 . . . . 0.0 111.007 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.619 HD12 ' OG ' ' A' ' 48' ' ' SER . 28.5 mt -105.99 132.67 51.8 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.192 -179.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.42 HD12 HG23 ' A' ' 139' ' ' THR . 98.1 mt -118.08 136.01 56.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.695 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 86.4 p -72.09 153.45 41.69 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.603 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.14 -50.04 75.25 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.651 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -149.46 154.03 38.19 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.593 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 169.73 -170.31 42.66 Favored Glycine 0 CA--C 1.525 0.719 0 N-CA-C 110.969 -0.852 . . . . 0.0 110.969 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -63.16 -34.94 91.32 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 110.864 -0.894 . . . . 0.0 110.864 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.444 ' O ' ' OD1' ' A' ' 124' ' ' ASP . 43.9 p-10 -87.89 120.11 28.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.855 0.36 . . . . 0.0 110.607 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.446 ' O ' HD12 ' A' ' 129' ' ' LEU . 39.6 t -63.51 144.26 57.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.386 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.517 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.2 -43.13 8.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.013 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.4 tp -62.79 -42.43 99.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.752 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.8 -11.11 57.83 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.52 -179.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.446 HD12 ' O ' ' A' ' 125' ' ' SER . 85.1 mt -115.54 -23.99 8.53 Favored 'General case' 0 C--O 1.225 -0.23 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.668 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . 0.517 ' N ' ' O ' ' A' ' 126' ' ' ALA . 77.7 t80 -51.87 -49.62 62.6 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.666 -178.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.5 p-10 -65.83 -42.02 91.05 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.282 179.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.522 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 87.9 mt-30 -67.45 -37.04 82.37 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.949 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.456 HD22 HD13 ' A' ' 116' ' ' ILE . 94.1 mt -79.69 -42.31 24.98 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.958 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.3 t -57.12 -44.81 83.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.25 -178.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.9 m -62.33 -45.58 92.56 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.463 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 93.1 mt -62.5 -43.89 98.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.307 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.595 ' HB1' ' HD2' ' A' ' 138' ' ' PRO . . . -169.8 163.68 6.61 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.588 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.595 ' HD2' ' HB1' ' A' ' 137' ' ' ALA . 75.4 Cg_exo -43.71 111.91 0.28 Allowed 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.374 2.05 . . . . 0.0 112.3 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.458 HG21 ' CD1' ' A' ' 130' ' ' TYR . 18.2 m -85.37 127.34 34.33 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.541 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.658 HD13 ' CD2' ' A' ' 37' ' ' HIS . 34.2 tp -118.73 135.18 54.63 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 120.976 0.417 . . . . 0.0 110.077 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.425 ' O ' ' OD2' ' A' ' 32' ' ' ASP . 80.1 mt -102.01 120.04 51.13 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.345 0 CA-C-O 121.172 0.511 . . . . 0.0 111.332 -179.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.497 HD12 HD22 ' A' ' 117' ' ' LEU . 97.4 mt -135.79 132.94 51.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.702 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.552 HD21 ' CG ' ' A' ' 241' ' ' ASP . 54.8 t30 -65.81 152.03 45.31 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.99 0.424 . . . . 0.0 110.356 179.21 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.523 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 87.9 t80 -85.81 122.48 29.94 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.999 -179.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.523 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 99.2 m-20 55.06 69.41 0.74 Allowed 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.713 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 49.4 p-10 -123.56 0.06 8.73 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 120.853 0.359 . . . . 0.0 110.625 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -151.61 117.17 5.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.735 -179.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 84.6 p -63.27 167.49 5.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.557 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.411 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.7 p-90 -50.62 -15.85 0.31 Allowed 'General case' 0 C--O 1.22 -0.497 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.429 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.445 ' O ' HG23 ' A' ' 154' ' ' THR . 68.2 tp60 -71.23 -74.81 0.14 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.941 0.401 . . . . 0.0 110.443 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.448 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.2 t -62.62 -39.11 92.77 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.138 179.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 54.3 tp -60.35 -45.41 93.57 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.361 -178.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.411 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 45.9 tp -62.63 -41.62 99.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.52 178.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.448 ' OG1' ' O ' ' A' ' 151' ' ' SER . 54.6 p -64.03 -34.68 78.55 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.136 -179.292 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.445 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 88.0 mm-40 -63.93 -42.47 97.35 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.258 179.235 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 91.1 mt -65.3 -38.97 91.84 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.242 0.544 . . . . 0.0 110.249 179.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.571 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.17 -32.26 79.91 Favored Glycine 0 C--N 1.332 0.331 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 -179.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.445 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.2 mt-10 -36.16 -25.91 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.812 0.339 . . . . 0.0 110.877 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.571 ' N ' ' O ' ' A' ' 157' ' ' GLY . 95.1 mt -58.26 149.6 5.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.326 178.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 77.7 p -69.39 137.27 52.66 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.038 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 70.88 21.46 78.14 Favored Glycine 0 N--CA 1.459 0.201 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 179.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 59.4 m80 -123.09 -15.11 7.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.585 0.231 . . . . 0.0 110.452 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -66.28 -59.54 3.63 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.698 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -52.2 -48.83 64.84 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 120.709 -0.397 . . . . 0.0 110.101 -179.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -60.78 -40.99 94.63 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.839 0.352 . . . . 0.0 110.44 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.47 -47.41 85.79 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.522 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.89 -40.22 75.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.199 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -61.68 -50.22 73.35 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.62 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -65.16 -43.81 90.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.533 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 94.7 mt -64.63 -43.4 96.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.406 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.31 -51.23 70.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.446 -179.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.6 -43.53 96.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.867 0.365 . . . . 0.0 110.592 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.663 ' CE2' HD11 ' A' ' 177' ' ' LEU . 57.0 t80 -62.78 -44.42 96.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.144 0.497 . . . . 0.0 110.405 179.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -63.71 -39.68 94.92 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.394 -179.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -62.9 -42.82 99.91 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.573 179.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -60.82 -44.48 96.85 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.064 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.663 HD11 ' CE2' ' A' ' 173' ' ' PHE . 84.7 mt -64.42 -41.18 96.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.983 0.42 . . . . 0.0 110.778 178.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.08 -62.06 1.87 Allowed 'General case' 0 C--O 1.239 0.516 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.34 -179.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.76 -46.83 86.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.42 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.24 -41.59 65.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.275 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -63.8 -33.81 76.5 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.962 0.411 . . . . 0.0 110.23 179.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.412 ' HG2' ' O ' ' A' ' 182' ' ' GLU . 70.0 tt0 -90.63 8.79 32.46 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.622 0.725 . . . . 0.0 110.341 -178.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -104.73 -32.09 9.03 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.233 179.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.8 pt -127.95 147.74 32.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.816 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -139.98 131.38 26.87 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.31 179.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.589 HD22 ' N ' ' A' ' 186' ' ' LEU . 3.5 mm? -85.42 133.29 42.61 Favored Pre-proline 0 N--CA 1.45 -0.444 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.15 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -43.92 158.0 0.13 Allowed 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.706 2.271 . . . . 0.0 112.258 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 0.496 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.9 Cg_endo -63.1 114.72 2.58 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.748 2.299 . . . . 0.0 111.677 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . 0.496 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.7 mt-30 155.87 148.1 0.0 OUTLIER Pre-proline 0 N--CA 1.454 -0.264 0 O-C-N 124.088 0.868 . . . . 0.0 110.834 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.63 144.37 35.49 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.593 2.195 . . . . 0.0 112.095 177.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.497 HG23 ' OG ' ' A' ' 258' ' ' SER . 2.1 p -124.9 158.76 32.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.439 0.638 . . . . 0.0 110.159 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . 0.488 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 37.0 p -143.07 165.34 27.65 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.193 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . 0.45 ' HA ' ' H ' ' A' ' 260' ' ' PHE . . . -135.32 128.74 32.3 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 121.43 0.634 . . . . 0.0 110.099 179.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.51 HD11 HD23 ' A' ' 259' ' ' LEU . 47.2 pt -146.52 149.05 16.34 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.44 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.236 179.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . 0.75 HG13 ' CD1' ' A' ' 262' ' ' PHE . 72.1 t -117.95 123.51 71.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.421 0.629 . . . . 0.0 109.691 179.048 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -134.58 107.27 7.41 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.206 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 94.1 m -130.96 130.66 43.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.868 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.401 ' O ' ' N ' ' A' ' 201' ' ' HIS . . . -82.8 -37.08 24.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.15 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.41 -67.08 0.26 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.276 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.34 -9.88 59.06 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.248 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . 0.401 ' N ' ' O ' ' A' ' 198' ' ' ALA . 60.5 t-80 60.63 58.35 2.47 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.807 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 38.8 p -167.05 153.84 8.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.553 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.4 144.18 24.41 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.031 0.443 . . . . 0.0 110.37 179.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -135.33 138.18 43.16 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.663 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 20.0 mt -106.25 125.55 51.14 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' TRP . . . . . 0.557 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 75.7 m95 -82.0 166.95 19.37 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.666 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . 0.454 HG22 ' C ' ' A' ' 206' ' ' TRP . 0.1 OUTLIER -156.98 171.23 7.72 Favored Pre-proline 0 C--O 1.224 -0.25 0 CA-C-O 120.999 0.428 . . . . 0.0 110.562 -178.99 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.62 -37.03 83.08 Favored 'Trans proline' 0 C--N 1.301 -1.949 0 C-N-CA 122.612 2.208 . . . . 0.0 112.236 179.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -70.64 -35.01 72.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.729 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 22.7 m -61.24 150.57 34.22 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.698 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.41 -37.11 82.28 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.442 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . 0.557 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 55.0 tt0 -64.74 -40.07 94.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.538 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.8 -43.46 91.6 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -63.31 -43.5 97.66 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.813 0.339 . . . . 0.0 110.225 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . 0.532 ' SD ' ' HB2' ' A' ' 304' ' ' ALA . 65.4 ttp -59.49 -48.03 83.21 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.34 -0.391 . . . . 0.0 109.986 -179.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 87.0 mt -60.71 -40.82 93.68 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . 0.45 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.4 tp10 -58.2 -37.66 75.22 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -65.33 -38.21 89.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.715 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 94.2 mt -64.06 -42.76 96.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.154 0.502 . . . . 0.0 110.716 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.69 44.77 0.08 OUTLIER Glycine 0 C--N 1.333 0.379 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . 0.45 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 27.4 m-85 -127.96 155.48 44.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.02 0.438 . . . . 0.0 110.446 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.482 ' O ' HG13 ' A' ' 191' ' ' VAL . 6.8 p -107.23 122.48 46.62 Favored 'General case' 0 C--O 1.223 -0.291 0 CA-C-O 121.368 0.604 . . . . 0.0 110.06 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.472 HD22 ' C ' ' A' ' 222' ' ' THR . 4.3 mm? -101.33 132.73 46.74 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.196 179.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.46 159.54 14.88 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.536 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.43 115.51 30.38 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.992 0.425 . . . . 0.0 110.318 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.497 ' N ' HD12 ' A' ' 226' ' ' LEU . 8.8 mp -53.31 156.55 3.97 Favored Pre-proline 0 N--CA 1.449 -0.515 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.764 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -60.09 145.17 99.04 Favored 'Trans proline' 0 C--N 1.3 -1.987 0 C-N-CA 122.677 2.251 . . . . 0.0 112.163 179.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.13 -3.22 59.05 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.545 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.14 -40.99 5.67 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.517 ' O ' ' N ' ' A' ' 233' ' ' SER . 86.0 mt -79.14 -17.04 55.75 Favored 'General case' 0 C--O 1.218 -0.581 0 CA-C-O 121.11 0.481 . . . . 0.0 110.25 -179.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 54.3 t-20 -40.58 -48.96 2.95 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.876 -179.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -87.75 15.25 7.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.493 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.517 ' N ' ' O ' ' A' ' 230' ' ' LEU . 77.9 p -60.63 -35.28 75.8 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.673 -179.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . 0.526 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.6 tt0 -118.87 -69.28 0.86 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.922 179.132 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.3 m -69.62 103.13 2.02 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.067 0.46 . . . . 0.0 110.701 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -94.55 57.33 2.22 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.305 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -144.65 -122.48 1.58 Allowed Glycine 0 C--N 1.332 0.334 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -135.07 112.09 10.27 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.256 0.551 . . . . 0.0 110.316 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . 0.521 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.4 mtt180 -148.31 58.05 1.08 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.661 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -69.59 -32.16 70.75 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.562 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . 0.552 ' CG ' HD21 ' A' ' 143' ' ' ASN . 64.7 t0 -57.05 -46.86 82.12 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.322 -178.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' ILE . . . . . 0.435 ' O ' ' O ' ' A' ' 239' ' ' ARG . 17.8 tt -140.25 156.77 24.66 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.306 0 CA-C-O 120.905 0.383 . . . . 0.0 110.419 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.444 HG22 HD13 ' A' ' 245' ' ' LEU . 96.2 mt -106.39 106.87 21.4 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 CA-C-O 121.19 0.519 . . . . 0.0 110.433 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . 0.595 ' O ' HD12 ' A' ' 245' ' ' LEU . 88.2 mt-30 -110.78 110.35 20.95 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.283 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.595 HD12 ' O ' ' A' ' 244' ' ' GLN . 9.5 mp -121.75 -168.22 1.66 Allowed 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.622 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . 0.526 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.53 -16.65 0.05 OUTLIER Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . 0.667 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -60.72 156.9 31.07 Favored Glycine 0 CA--C 1.521 0.425 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -63.83 21.9 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.901 0.381 . . . . 0.0 110.534 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . 0.667 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.8 m-20 -97.56 -6.08 34.28 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.761 0.315 . . . . 0.0 110.516 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 93.0 mt -79.65 -21.76 44.41 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.868 179.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.6 -51.25 70.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.724 -179.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.46 -5.45 58.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.402 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.17 -74.21 1.15 Allowed Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.744 -0.942 . . . . 0.0 110.744 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 83.3 mt -70.33 126.39 29.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.927 0.394 . . . . 0.0 110.17 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -59.96 -39.04 84.27 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.159 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 82.85 51.67 4.16 Favored Glycine 0 CA--C 1.519 0.335 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -95.59 -15.2 22.96 Favored 'General case' 0 N--CA 1.463 0.189 0 O-C-N 122.666 -0.314 . . . . 0.0 110.623 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . 0.497 ' OG ' HG23 ' A' ' 191' ' ' VAL . 3.4 t 174.72 89.02 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.195 0.521 . . . . 0.0 110.036 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.852 ' N ' HD12 ' A' ' 259' ' ' LEU . 0.9 OUTLIER -94.6 124.43 38.63 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.21 0.528 . . . . 0.0 111.291 -179.143 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 260' ' ' PHE . . . . . 0.45 ' H ' ' HA ' ' A' ' 193' ' ' ALA . 15.8 m-30 -93.42 146.3 23.85 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.311 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 86.6 mt -122.29 149.55 43.58 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.532 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.75 ' CD1' HG13 ' A' ' 195' ' ' VAL . 2.6 p90 -77.28 -138.57 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.657 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . 0.65 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -51.87 77.14 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 121.041 0.448 . . . . 0.0 111.27 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . 0.62 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.05 104.58 0.19 Allowed Glycine 0 CA--C 1.527 0.843 0 N-CA-C 110.414 -1.074 . . . . 0.0 110.414 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 265' ' ' ASP . . . . . 0.589 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.8 m-20 -80.32 -177.88 6.35 Favored 'General case' 0 CA--C 1.515 -0.393 0 O-C-N 122.681 -0.306 . . . . 0.0 110.944 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -40.65 -17.82 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.524 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . 0.589 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.02 -51.56 45.61 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.743 179.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -63.87 -46.48 84.76 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.095 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . 0.57 ' HB1' ' OH ' ' A' ' 273' ' ' TYR . . . -61.8 -35.13 77.29 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 121.526 0.679 . . . . 0.0 109.716 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -62.84 -34.54 77.54 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.025 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.66 -43.07 13.74 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.217 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 272' ' ' ILE . . . . . 0.592 ' C ' ' H ' ' A' ' 274' ' ' ALA . 4.9 tt -51.27 -33.71 14.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.776 -178.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 273' ' ' TYR . . . . . 0.57 ' OH ' ' HB1' ' A' ' 269' ' ' ALA . 17.2 m-85 -54.5 -1.76 0.03 OUTLIER 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.686 -179.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 274' ' ' ALA . . . . . 0.592 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.51 -39.86 70.53 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.906 179.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . 0.576 ' O ' ' N ' ' A' ' 279' ' ' ALA . 3.0 p30 -38.91 97.74 0.15 Allowed Pre-proline 0 C--O 1.226 -0.174 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.448 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -54.21 -42.8 64.19 Favored 'Trans proline' 0 C--N 1.303 -1.856 0 C-N-CA 122.329 2.02 . . . . 0.0 112.668 -178.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 88.4 mt -64.32 -42.86 96.09 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.089 0.471 . . . . 0.0 111.297 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 91.8 mt -95.56 -1.7 49.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.862 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 279' ' ' ALA . . . . . 0.576 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.36 -34.87 77.52 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.6 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.1 20.0 0.11 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.076 -179.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 0.481 ' H ' ' C ' ' A' ' 279' ' ' ALA . 13.8 mt -74.97 119.75 78.35 Favored Pre-proline 0 N--CA 1.445 -0.719 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.725 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -50.6 -39.57 55.85 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.539 2.159 . . . . 0.0 112.035 179.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.83 -50.37 63.86 Favored 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 73.0 t -61.54 -43.81 97.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -57.97 -41.2 82.43 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.098 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -90.93 0.31 57.54 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.083 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt 59.24 43.06 17.47 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.027 0.441 . . . . 0.0 110.976 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -94.62 41.65 1.09 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.282 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 53.9 t -119.21 135.48 59.47 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-O 121.096 0.474 . . . . 0.0 109.958 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -132.69 162.6 30.96 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.678 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.74 155.27 32.8 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 121.079 0.466 . . . . 0.0 110.667 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 82.8 mt -94.22 -1.47 54.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.176 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.49 165.81 12.72 Favored Glycine 0 C--N 1.335 0.528 0 N-CA-C 110.489 -1.044 . . . . 0.0 110.489 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 6.7 m -87.75 -62.33 1.52 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.871 0.367 . . . . 0.0 111.044 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 295' ' ' GLU . . . . . 0.442 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.5 mm-40 -69.35 -4.02 16.53 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.69 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 25.5 p -76.71 32.76 0.13 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.623 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 297' ' ' PHE . . . . . 0.522 ' CD2' HG22 ' A' ' 70' ' ' THR . 85.5 t80 -60.18 -46.07 90.98 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.624 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . 0.609 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.2 mtt85 -81.33 134.76 35.63 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.617 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.461 ' H ' HG11 ' A' ' 51' ' ' VAL . 16.7 tp -114.66 118.71 34.42 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-O 120.985 0.421 . . . . 0.0 110.206 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . 0.628 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.5 p-10 -166.15 -175.44 3.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.651 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 81.1 t80 -47.76 -44.22 28.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.209 -179.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -66.09 -40.74 91.04 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.107 0.48 . . . . 0.0 110.804 178.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . 0.628 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 56.0 p -56.04 -35.73 67.22 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.951 -179.005 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . 0.532 ' HB2' ' SD ' ' A' ' 215' ' ' MET . . . -57.28 -51.45 69.33 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 91.1 mtp -56.46 -43.78 79.9 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -179.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -66.32 -42.52 88.11 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.21 0.528 . . . . 0.0 110.253 179.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 303' ' ' SER . 55.7 t -64.08 -42.99 97.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.135 179.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 42.7 tp -59.63 -42.24 92.27 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.101 -0.499 . . . . 0.0 109.73 -179.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -62.7 -38.71 91.48 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 310' ' ' ARG . . . . . 0.446 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.5 ttt85 -63.49 -43.81 96.17 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.218 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 88.8 mt -63.2 -42.06 99.27 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.273 179.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -62.89 -33.33 75.07 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.083 179.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.86 -23.45 21.65 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.383 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.479 HD22 ' CE2' ' A' ' 315' ' ' PHE . 6.7 tt -62.44 -43.16 99.47 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 121.079 0.466 . . . . 0.0 110.563 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 315' ' ' PHE . . . . . 0.479 ' CE2' HD22 ' A' ' 314' ' ' LEU . 91.1 m-85 . . . . . 0 C--O 1.22 -0.484 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.319 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -99.55 136.67 39.14 Favored 'General case' 0 CA--C 1.521 -0.164 0 CA-C-O 121.091 0.472 . . . . 0.0 110.442 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.492 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -91.86 178.61 1.66 Allowed Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.57 -179.827 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.492 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.2 Cg_exo -61.61 146.94 96.46 Favored 'Trans proline' 0 C--N 1.3 -2.025 0 C-N-CA 122.833 2.355 . . . . 0.0 112.144 179.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.456 ' HE ' HD12 ' A' ' 39' ' ' LEU . 35.3 ptt180 -136.03 142.16 44.41 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.638 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -79.34 116.69 19.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.44 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.446 ' O ' HG23 ' A' ' 30' ' ' ILE . 9.5 tp -110.98 130.53 64.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.536 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.0 t -71.0 141.76 50.97 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.638 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.477 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.5 t0 -139.33 179.51 6.49 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.532 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.477 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 77.9 p -73.8 -36.98 65.07 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.569 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.7 ttt85 -46.48 -94.43 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.296 -179.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -167.55 -26.49 0.02 OUTLIER Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 60.8 m -168.97 104.8 0.4 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.777 0.322 . . . . 0.0 110.657 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.688 ' CD2' HD13 ' A' ' 140' ' ' LEU . 74.6 t60 -128.65 149.0 50.84 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.087 0.47 . . . . 0.0 110.214 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.624 HG22 ' N ' ' A' ' 39' ' ' LEU . 98.2 m -131.36 166.07 22.06 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.453 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.624 ' N ' HG22 ' A' ' 38' ' ' THR . 81.9 mt -120.93 127.28 51.69 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.464 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -64.91 -44.55 89.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.718 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 40.0 p -165.71 155.08 12.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.373 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.468 ' H ' ' CD ' ' A' ' 42' ' ' GLN . 14.7 mp0 -44.3 100.9 0.24 Allowed Pre-proline 0 C--N 1.329 -0.286 0 O-C-N 123.503 0.502 . . . . 0.0 110.598 179.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.53 129.99 36.67 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 C-N-CA 122.305 2.003 . . . . 0.0 112.245 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -83.73 -24.78 31.05 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.558 179.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.538 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.6 mtm-85 -122.33 134.84 54.64 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.27 0.557 . . . . 0.0 110.234 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.2 mt -130.73 133.78 62.83 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.329 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.871 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 45.0 t -124.11 130.55 73.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 CA-C-O 120.945 0.402 . . . . 0.0 109.968 179.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.624 ' OG ' HD12 ' A' ' 117' ' ' LEU . 2.1 m -154.57 167.17 30.99 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.542 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 64.4 p -124.75 9.26 8.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.385 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.98 125.43 33.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.858 0.361 . . . . 0.0 110.685 -179.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.458 HG11 ' H ' ' A' ' 299' ' ' LEU . 93.3 t -65.63 -44.53 93.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.463 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.1 m -62.38 -44.3 96.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.618 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 49.6 tp -62.34 -41.3 98.46 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.528 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.439 ' O ' HD13 ' A' ' 58' ' ' LEU . 74.3 m -57.65 -44.43 85.65 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.286 -179.309 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.3 -62.33 5.23 Favored Glycine 0 N--CA 1.467 0.761 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.7 t -48.22 -35.59 12.21 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.9 mt -61.78 -44.43 96.9 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.648 -0.421 . . . . 0.0 111.305 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.439 HD13 ' O ' ' A' ' 54' ' ' THR . 9.3 mp -65.54 -41.26 93.26 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.333 177.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.59 -40.75 97.75 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.858 -179.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.42 ' O ' HG23 ' A' ' 60' ' ' ILE . 8.1 tp -89.03 16.98 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.857 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 56.17 85.33 0.07 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.797 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 178.72 59.47 0.08 OUTLIER Pre-proline 0 C--N 1.327 -0.386 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.4 ' HB3' HE21 ' A' ' 85' ' ' GLN . 10.2 Cg_endo -52.18 152.55 14.61 Favored 'Trans proline' 0 C--N 1.292 -2.401 0 C-N-CA 123.048 2.499 . . . . 0.0 112.063 -178.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.435 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -108.65 145.27 15.79 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.171 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.271 -179.661 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.8 mt -63.57 -45.42 97.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.388 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.501 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -129.49 134.1 47.61 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.517 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.504 ' O ' ' N ' ' A' ' 98' ' ' LEU . 75.4 m -134.6 158.6 43.6 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.891 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.7 139.0 16.1 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.694 -0.962 . . . . 0.0 110.694 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.493 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.79 -162.81 0.08 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.936 0.398 . . . . 0.0 110.461 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.537 HG22 ' CD2' ' A' ' 297' ' ' PHE . 14.5 t -133.65 134.74 43.53 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.289 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.481 ' C ' ' O ' ' A' ' 70' ' ' THR . 0.1 OUTLIER 29.65 68.73 0.65 Allowed Pre-proline 0 N--CA 1.467 0.403 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.735 -179.865 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_exo -61.74 145.67 97.18 Favored 'Trans proline' 0 C--N 1.3 -2.022 0 C-N-CA 122.669 2.246 . . . . 0.0 111.708 -177.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.525 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 45.3 p-10 -159.39 -32.1 0.06 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.718 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.541 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 99.1 m-20 -64.11 -39.42 94.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.387 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -60.36 -48.32 82.25 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.555 -179.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.424 ' O ' ' O ' ' A' ' 77' ' ' ALA . 93.9 t -60.16 -25.1 32.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.053 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.541 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -45.68 173.1 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.635 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.571 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.5 p30 -62.41 178.03 0.45 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.505 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.556 ' C ' ' H ' ' A' ' 81' ' ' GLY . 36.2 p30 -45.0 85.63 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.096 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.571 ' N ' ' O ' ' A' ' 78' ' ' ASP . 42.1 tp60 -67.65 13.21 0.08 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.207 0.527 . . . . 0.0 110.162 -179.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.556 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 118.63 -22.5 9.33 Favored Glycine 0 N--CA 1.461 0.33 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -108.12 116.25 31.62 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.013 0.435 . . . . 0.0 110.381 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 76.1 mt -98.27 -0.0 44.83 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.578 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -92.34 7.4 43.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.015 0.436 . . . . 0.0 110.39 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.794 ' O ' HG22 ' A' ' 89' ' ' VAL . 88.2 mt-30 -100.24 -27.7 13.37 Favored 'General case' 0 C--O 1.222 -0.387 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.754 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 69.0 t-105 -62.94 -40.55 98.0 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.942 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.551 ' O ' ' N ' ' A' ' 91' ' ' LYS . 64.2 m -77.93 -53.59 7.28 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.958 -179.311 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -48.49 -50.77 30.26 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.052 -179.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.794 HG22 ' O ' ' A' ' 85' ' ' GLN . 15.8 m -68.8 -40.57 81.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.161 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.496 ' N ' HG23 ' A' ' 89' ' ' VAL . . . -72.39 -23.01 61.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.629 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.551 ' N ' ' O ' ' A' ' 87' ' ' SER . 65.9 tttm -61.84 -45.58 93.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.433 -179.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.442 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.8 mm-40 -90.31 -95.3 0.11 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.092 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.629 ' O ' ' N ' ' A' ' 95' ' ' LEU . 96.0 mtt180 -142.79 58.84 1.43 Allowed 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.448 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.7 pttp 33.87 25.7 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.07 0.462 . . . . 0.0 110.25 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.629 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.3 tt -48.26 123.46 6.48 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.983 -177.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.457 ' O ' HD23 ' A' ' 95' ' ' LEU . 99.0 mm-40 -83.52 -169.61 2.64 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.183 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.603 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 81.3 mtp180 -74.69 136.95 41.84 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.256 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.504 ' N ' ' O ' ' A' ' 67' ' ' SER . 91.2 mt -85.63 -165.83 1.34 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.83 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.538 ' CD2' ' O ' ' A' ' 99' ' ' TYR . 48.2 p90 -168.64 119.65 0.77 Allowed 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.152 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.503 ' C ' ' O ' ' A' ' 99' ' ' TYR . 41.7 mm -28.67 120.7 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 O-C-N 123.272 0.358 . . . . 0.0 111.104 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 114.31 27.26 3.44 Favored Glycine 0 C--N 1.331 0.296 0 N-CA-C 111.27 -0.732 . . . . 0.0 111.27 -179.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.572 ' N ' ' CD ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -144.36 46.72 0.65 Allowed Pre-proline 0 C--N 1.322 -0.593 0 CA-C-O 121.145 0.498 . . . . 0.0 110.484 179.783 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.572 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 28.9 Cg_endo -62.02 144.0 95.72 Favored 'Trans proline' 0 C--N 1.295 -2.263 0 C-N-CA 122.643 2.229 . . . . 0.0 111.761 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.446 ' O ' HG23 ' A' ' 108' ' ' VAL . 27.6 t -173.18 120.37 0.35 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.359 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.83 -40.21 63.49 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.119 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.36 -39.89 89.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.853 -179.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.13 -40.09 95.44 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.73 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 104' ' ' SER . 72.3 t -67.77 -43.72 86.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.672 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.81 -39.04 93.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.455 -179.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.442 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.5 -23.39 62.74 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.516 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.537 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.3 mm-40 -90.69 5.55 47.66 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.682 -179.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.538 ' O ' ' NE ' ' A' ' 45' ' ' ARG . 10.2 tpt 22.85 64.46 0.35 Allowed Pre-proline 0 N--CA 1.467 0.385 0 CA-C-O 120.949 0.404 . . . . 0.0 111.209 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -78.75 167.51 22.28 Favored 'Trans proline' 0 C--N 1.307 -1.658 0 C-N-CA 123.077 2.518 . . . . 0.0 111.594 -177.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.52 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 99.1 m-20 -109.71 -42.1 4.37 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.991 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.6 tp -121.5 120.35 34.64 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.904 0.383 . . . . 0.0 109.97 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 84.8 mt -112.78 128.84 69.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 CA-C-O 120.862 0.363 . . . . 0.0 110.998 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.624 HD12 ' OG ' ' A' ' 48' ' ' SER . 29.6 mt -109.18 132.13 54.41 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.262 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.496 HD12 HG23 ' A' ' 139' ' ' THR . 99.1 mt -119.57 138.69 49.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.687 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 85.6 p -72.3 153.75 41.34 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.571 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.16 -50.25 74.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.705 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -149.51 154.0 38.08 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.602 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 170.5 -170.84 43.34 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.93 -34.3 89.51 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.445 ' O ' ' OD1' ' A' ' 124' ' ' ASP . 44.0 p-10 -86.7 120.43 28.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.856 0.36 . . . . 0.0 110.647 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.44 ' O ' HD12 ' A' ' 129' ' ' LEU . 39.0 t -63.21 143.75 57.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.392 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.1 -43.24 8.97 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.82 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.5 tp -62.98 -42.36 99.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.716 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.67 -12.07 59.68 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.449 -179.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.44 HD12 ' O ' ' A' ' 125' ' ' SER . 85.1 mt -114.76 -24.07 8.88 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.578 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . 0.519 ' N ' ' O ' ' A' ' 126' ' ' ALA . 78.9 t80 -51.01 -49.73 59.88 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.819 -0.352 . . . . 0.0 110.693 -178.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.1 p-10 -66.06 -42.67 89.18 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.321 179.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.52 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 88.3 mt-30 -67.01 -37.71 84.66 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.818 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.434 HD12 HD11 ' A' ' 118' ' ' ILE . 96.2 mt -80.24 -41.68 24.63 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.887 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.3 t -56.77 -44.69 82.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.248 -179.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 18.7 m -61.72 -45.44 93.96 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.613 179.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 94.6 mt -61.91 -43.73 97.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.319 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.661 ' HB1' ' HD2' ' A' ' 138' ' ' PRO . . . -169.27 168.29 5.05 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.644 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.661 ' HD2' ' HB1' ' A' ' 137' ' ' ALA . 52.8 Cg_exo -49.59 113.19 0.86 Allowed 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.296 1.997 . . . . 0.0 112.393 179.053 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.496 HG23 HD12 ' A' ' 118' ' ' ILE . 24.0 m -84.59 127.36 34.02 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.617 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.688 HD13 ' CD2' ' A' ' 37' ' ' HIS . 34.7 tp -117.79 135.96 53.71 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 120.998 0.428 . . . . 0.0 110.109 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.441 ' O ' ' OD2' ' A' ' 32' ' ' ASP . 82.7 mt -99.62 118.92 46.95 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 CA-C-O 121.208 0.527 . . . . 0.0 111.089 -179.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.425 HD12 HD22 ' A' ' 117' ' ' LEU . 97.9 mt -135.15 132.33 52.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.574 179.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.542 HD21 ' CG ' ' A' ' 241' ' ' ASP . 56.4 t30 -68.04 153.72 43.15 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.987 0.423 . . . . 0.0 110.405 179.296 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.525 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 88.7 t80 -87.46 122.28 30.99 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.85 -179.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.525 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 99.0 m-20 55.11 69.38 0.74 Allowed 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.759 179.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 49.8 p-10 -123.6 -0.72 8.6 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.852 0.358 . . . . 0.0 110.629 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -151.01 116.29 5.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.715 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 82.8 p -62.45 167.5 4.24 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.513 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.411 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.2 p-90 -51.05 -15.76 0.36 Allowed 'General case' 0 C--O 1.221 -0.414 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.371 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.452 ' O ' HG23 ' A' ' 154' ' ' THR . 67.9 tp60 -70.92 -74.69 0.14 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.912 0.386 . . . . 0.0 110.516 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.434 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.2 t -62.81 -39.19 93.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.181 179.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 55.0 tp -60.05 -45.75 91.82 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.393 -178.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.411 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 46.9 tp -62.7 -41.64 99.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.619 178.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.452 HG23 ' O ' ' A' ' 150' ' ' GLN . 56.5 p -64.25 -34.94 79.26 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.226 -179.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.442 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.8 mm-40 -64.11 -42.57 96.83 Favored 'General case' 0 C--O 1.226 -0.161 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.389 179.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 90.2 mt -65.46 -38.66 90.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.152 0.501 . . . . 0.0 110.317 179.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.573 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.49 -32.41 81.08 Favored Glycine 0 C--N 1.331 0.287 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 -179.227 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.442 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.2 mt-10 -35.3 -27.23 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.819 0.343 . . . . 0.0 110.815 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.573 ' N ' ' O ' ' A' ' 157' ' ' GLY . 94.7 mt -55.83 149.42 3.1 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.371 178.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 72.7 p -69.82 137.58 51.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.992 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 71.1 20.96 78.33 Favored Glycine 0 N--CA 1.459 0.183 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 58.2 m80 -122.64 -14.49 7.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.641 0.258 . . . . 0.0 110.487 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -66.03 -59.93 3.32 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.584 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -51.98 -49.32 63.5 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.156 -179.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -60.59 -41.29 94.43 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.841 0.353 . . . . 0.0 110.435 179.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.32 -47.32 86.49 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.473 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.74 -40.27 75.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.241 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -61.53 -50.45 72.62 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.652 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -65.24 -43.7 90.56 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.584 179.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 94.2 mt -64.84 -43.3 96.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.4 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.4 -51.27 70.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.369 -179.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -63.41 -43.7 96.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.843 0.354 . . . . 0.0 110.656 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.665 ' CE2' HD11 ' A' ' 177' ' ' LEU . 57.0 t80 -62.82 -44.42 96.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.378 179.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 -63.16 -39.67 95.34 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.78 -179.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -63.32 -42.66 99.01 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.518 179.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -60.76 -44.59 96.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.221 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.665 HD11 ' CE2' ' A' ' 173' ' ' PHE . 84.1 mt -64.69 -40.99 96.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.723 178.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.32 -62.46 1.62 Allowed 'General case' 0 C--O 1.238 0.457 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.295 -179.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.35 -47.34 84.09 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.473 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -52.75 -42.02 64.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.329 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -63.78 -33.66 76.17 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.034 0.445 . . . . 0.0 110.291 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.415 ' HG2' ' O ' ' A' ' 182' ' ' GLU . 69.6 tt0 -90.81 9.06 31.7 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.552 0.691 . . . . 0.0 110.328 -178.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -105.11 -32.18 8.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.171 179.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 45.1 pt -128.15 147.76 32.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.816 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -140.25 131.36 26.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.388 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.592 HD22 ' N ' ' A' ' 186' ' ' LEU . 3.5 mm? -85.26 133.87 41.78 Favored Pre-proline 0 N--CA 1.45 -0.435 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.092 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -43.7 157.67 0.13 Allowed 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.635 2.223 . . . . 0.0 112.387 179.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 0.508 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 28.3 Cg_endo -63.22 114.9 2.68 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.819 2.346 . . . . 0.0 111.692 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . 0.508 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.7 mt-30 155.43 147.9 0.0 OUTLIER Pre-proline 0 N--CA 1.456 -0.136 0 O-C-N 124.051 0.844 . . . . 0.0 110.93 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.22 143.81 36.19 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.578 2.185 . . . . 0.0 112.316 177.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.494 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.1 p -124.87 159.3 31.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.418 0.628 . . . . 0.0 110.214 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . 0.494 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 37.7 p -143.52 165.59 27.15 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.095 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . 0.439 ' HA ' ' H ' ' A' ' 260' ' ' PHE . . . -135.13 128.77 32.76 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-O 121.285 0.564 . . . . 0.0 110.229 179.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.513 HD11 HD23 ' A' ' 259' ' ' LEU . 47.9 pt -146.47 148.77 16.65 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.383 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.159 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . 0.753 HG13 ' CD1' ' A' ' 262' ' ' PHE . 69.3 t -117.52 123.31 71.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-O 121.376 0.608 . . . . 0.0 109.817 178.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -134.46 107.69 7.71 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 121.156 0.503 . . . . 0.0 110.285 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 94.8 m -131.22 130.55 43.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.834 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -82.86 -36.83 25.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.242 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.49 -67.15 0.26 Allowed 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.273 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.34 -10.1 59.35 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.299 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 60.1 t-80 60.77 58.3 2.42 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.71 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 41.6 p -166.77 153.52 8.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.565 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.65 144.49 24.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.977 0.418 . . . . 0.0 110.47 179.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -135.48 138.24 42.95 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.611 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 20.1 mt -106.26 125.81 51.45 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.006 0.432 . . . . 0.0 109.953 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' TRP . . . . . 0.563 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 76.4 m95 -82.52 167.26 18.55 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.536 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . 0.462 HG22 ' C ' ' A' ' 206' ' ' TRP . 0.1 OUTLIER -157.25 170.71 8.5 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.617 -178.985 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -53.22 -37.04 79.94 Favored 'Trans proline' 0 C--N 1.302 -1.911 0 C-N-CA 122.652 2.235 . . . . 0.0 112.446 179.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -70.6 -34.94 72.69 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.657 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 22.9 m -61.56 150.45 35.97 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.633 -179.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.38 -36.87 81.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.436 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . 0.563 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 54.6 tt0 -64.73 -40.09 94.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.477 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.62 -43.54 91.83 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.669 -0.972 . . . . 0.0 110.669 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -63.34 -43.46 97.65 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.851 0.358 . . . . 0.0 110.233 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . 0.535 ' SD ' ' HB2' ' A' ' 304' ' ' ALA . 65.4 ttp -59.1 -48.42 81.67 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.161 -179.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 89.0 mt -60.29 -40.96 92.31 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . 0.453 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 40.5 tp10 -57.93 -37.67 74.51 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.057 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -65.48 -37.76 87.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.699 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 95.0 mt -64.37 -42.82 95.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.144 0.497 . . . . 0.0 110.629 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.5 44.62 0.08 OUTLIER Glycine 0 CA--C 1.52 0.387 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . 0.453 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 26.4 m-85 -127.58 154.5 45.12 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 121.05 0.452 . . . . 0.0 110.535 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.476 ' O ' HG13 ' A' ' 191' ' ' VAL . 4.5 p -106.05 121.65 44.55 Favored 'General case' 0 C--O 1.224 -0.261 0 CA-C-O 121.262 0.554 . . . . 0.0 110.049 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.462 HD22 ' N ' ' A' ' 223' ' ' LEU . 4.3 mm? -100.38 133.66 44.47 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.128 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -97.36 157.94 15.72 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.475 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -104.2 115.33 30.22 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.927 0.394 . . . . 0.0 110.416 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.486 ' N ' HD12 ' A' ' 226' ' ' LEU . 9.1 mp -53.89 156.55 4.96 Favored Pre-proline 0 N--CA 1.45 -0.462 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.817 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -59.73 145.11 99.04 Favored 'Trans proline' 0 C--N 1.299 -2.052 0 C-N-CA 122.736 2.291 . . . . 0.0 112.348 179.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.75 -2.52 58.67 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.509 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.58 -40.42 5.67 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.532 ' O ' ' N ' ' A' ' 233' ' ' SER . 85.9 mt -79.32 -16.73 55.89 Favored 'General case' 0 C--O 1.22 -0.499 0 CA-C-O 121.085 0.469 . . . . 0.0 110.279 -179.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 54.8 t-20 -40.09 -48.92 2.55 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.79 -179.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -88.38 15.37 7.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.316 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.532 ' N ' ' O ' ' A' ' 230' ' ' LEU . 77.8 p -60.75 -35.46 76.44 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.676 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . 0.522 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.6 tt0 -118.28 -69.53 0.84 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.858 179.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.0 m -70.39 103.27 2.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.678 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -94.27 57.85 2.39 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.007 0.432 . . . . 0.0 110.319 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -145.2 -122.34 1.52 Allowed Glycine 0 C--N 1.332 0.339 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -134.1 112.42 11.14 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 121.141 0.496 . . . . 0.0 110.389 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . 0.461 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.2 mtt180 -148.54 56.79 1.04 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.737 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -69.49 -31.84 70.35 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.504 179.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . 0.542 ' CG ' HD21 ' A' ' 143' ' ' ASN . 64.8 t0 -56.58 -47.01 80.46 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.357 -179.042 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' ILE . . . . . 0.441 ' O ' ' O ' ' A' ' 239' ' ' ARG . 17.1 tt -140.4 157.46 24.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.88 0.371 . . . . 0.0 110.547 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.441 HG22 HD13 ' A' ' 245' ' ' LEU . 96.0 mt -105.88 106.05 19.84 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 CA-C-O 121.094 0.474 . . . . 0.0 110.505 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . 0.611 ' C ' HD12 ' A' ' 245' ' ' LEU . 88.3 mt-30 -110.99 110.64 21.28 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.351 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.611 HD12 ' C ' ' A' ' 244' ' ' GLN . 9.8 mp -121.98 -167.79 1.6 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.645 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . 0.522 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 172.79 -16.71 0.05 OUTLIER Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . 0.663 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -60.6 157.62 29.34 Favored Glycine 0 CA--C 1.522 0.49 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -64.05 21.01 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.966 0.412 . . . . 0.0 110.616 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . 0.663 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.9 m-20 -96.75 -5.7 38.0 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.523 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 91.3 mt -80.67 -20.97 41.82 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.763 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.56 -51.44 69.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.615 -179.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -89.14 -4.87 58.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.529 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.33 -74.13 1.16 Allowed Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.896 -0.881 . . . . 0.0 110.896 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 81.5 mt -70.12 125.7 27.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.978 0.418 . . . . 0.0 110.282 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -59.9 -39.26 84.79 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.334 -179.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 83.33 51.57 4.08 Favored Glycine 0 CA--C 1.52 0.393 0 N-CA-C 110.824 -0.91 . . . . 0.0 110.824 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -94.87 -16.7 22.69 Favored 'General case' 0 C--N 1.332 -0.17 0 O-C-N 122.739 -0.271 . . . . 0.0 110.606 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . 0.49 ' OG ' HG23 ' A' ' 191' ' ' VAL . 3.4 t 175.47 89.49 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.159 0.504 . . . . 0.0 110.1 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.858 ' N ' HD12 ' A' ' 259' ' ' LEU . 0.9 OUTLIER -94.79 124.49 38.86 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.22 0.534 . . . . 0.0 111.229 -179.03 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 260' ' ' PHE . . . . . 0.439 ' H ' ' HA ' ' A' ' 193' ' ' ALA . 15.9 m-30 -93.98 146.8 23.67 Favored 'General case' 0 CA--C 1.5 -0.956 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.351 179.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 86.7 mt -122.42 150.18 42.82 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.542 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.753 ' CD1' HG13 ' A' ' 195' ' ' VAL . 2.6 p90 -77.7 -138.27 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.587 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . 0.655 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -51.96 77.34 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.156 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . 0.62 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.24 104.35 0.18 Allowed Glycine 0 CA--C 1.528 0.845 0 N-CA-C 110.474 -1.051 . . . . 0.0 110.474 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 265' ' ' ASP . . . . . 0.593 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.6 m-20 -79.98 -177.91 6.23 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 122.75 -0.265 . . . . 0.0 110.945 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -40.47 -17.83 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.567 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . 0.593 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.27 -51.7 42.17 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.681 179.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -63.56 -46.7 84.71 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.312 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . 0.574 ' HB1' ' OH ' ' A' ' 273' ' ' TYR . . . -61.68 -35.03 76.83 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 121.444 0.64 . . . . 0.0 109.808 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -63.14 -34.19 77.07 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.145 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.62 -43.33 13.55 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.081 -179.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 272' ' ' ILE . . . . . 0.593 ' C ' ' H ' ' A' ' 274' ' ' ALA . 4.9 tt -51.39 -33.78 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.875 -178.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 273' ' ' TYR . . . . . 0.574 ' OH ' ' HB1' ' A' ' 269' ' ' ALA . 17.2 m-85 -54.4 -1.73 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.649 -179.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 274' ' ' ALA . . . . . 0.593 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.49 -39.73 70.66 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.848 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . 0.58 ' O ' ' N ' ' A' ' 279' ' ' ALA . 2.8 p30 -39.22 98.29 0.16 Allowed Pre-proline 0 N--CA 1.463 0.178 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.401 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_exo -54.68 -42.69 66.12 Favored 'Trans proline' 0 C--N 1.303 -1.833 0 C-N-CA 122.356 2.037 . . . . 0.0 112.502 -178.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 89.2 mt -64.51 -42.84 95.55 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.093 0.473 . . . . 0.0 111.213 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 91.3 mt -95.59 -1.81 49.63 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.924 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 279' ' ' ALA . . . . . 0.58 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.16 -34.78 77.05 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.701 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.3 20.0 0.12 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.963 -179.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 0.484 HD23 ' HA ' ' A' ' 281' ' ' LEU . 13.7 mt -74.73 119.24 75.74 Favored Pre-proline 0 N--CA 1.447 -0.607 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.774 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -49.65 -40.34 46.66 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.656 2.237 . . . . 0.0 112.3 178.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.57 -50.66 62.52 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.023 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 78.0 t -61.43 -43.87 97.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.803 0.335 . . . . 0.0 110.118 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -57.64 -41.27 81.08 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.188 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -90.89 0.47 57.48 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.108 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt 59.25 42.04 19.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.784 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -93.79 41.1 1.08 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.398 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 53.7 t -118.31 136.22 56.19 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.126 0 CA-C-O 121.113 0.483 . . . . 0.0 110.009 -179.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -133.31 163.12 30.04 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.184 0.516 . . . . 0.0 110.626 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -120.48 154.88 34.64 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-O 121.048 0.451 . . . . 0.0 110.652 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 82.3 mt -93.41 -1.63 55.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.212 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.59 165.94 12.74 Favored Glycine 0 N--CA 1.463 0.445 0 N-CA-C 110.529 -1.028 . . . . 0.0 110.529 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 6.8 m -87.6 -62.19 1.55 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.857 0.361 . . . . 0.0 110.967 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 295' ' ' GLU . . . . . 0.435 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.4 mm-40 -69.8 -3.85 17.4 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.667 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 25.2 p -77.03 33.38 0.15 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.593 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 297' ' ' PHE . . . . . 0.537 ' CD2' HG22 ' A' ' 70' ' ' THR . 84.8 t80 -60.11 -45.99 91.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.591 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . 0.603 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.3 mtt85 -81.61 134.84 35.54 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.59 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.458 ' H ' HG11 ' A' ' 51' ' ' VAL . 16.0 tp -114.39 119.16 35.99 Favored 'General case' 0 C--O 1.231 0.08 0 CA-C-O 120.974 0.416 . . . . 0.0 110.204 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . 0.62 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.2 p-10 -166.73 -174.71 2.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.637 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 83.5 t80 -47.96 -45.07 30.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.221 -179.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -65.3 -41.2 94.33 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.017 0.437 . . . . 0.0 110.734 178.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . 0.62 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 53.6 p -55.73 -36.62 67.44 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.059 -179.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . 0.535 ' HB2' ' SD ' ' A' ' 215' ' ' MET . . . -56.33 -52.74 63.43 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 92.4 mtp -55.21 -43.72 74.72 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -66.25 -42.31 88.76 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.137 0.494 . . . . 0.0 110.264 179.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 303' ' ' SER . 55.1 t -64.09 -43.02 97.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.27 179.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 42.3 tp -59.98 -42.26 93.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.846 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -62.33 -38.88 91.17 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.146 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 310' ' ' ARG . . . . . 0.404 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.5 ttt85 -63.87 -44.21 93.74 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.251 179.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 87.9 mt -63.41 -42.42 98.75 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.465 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt -62.88 -33.51 75.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.191 179.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -87.24 -26.25 23.59 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.318 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.712 HD23 ' C ' ' A' ' 314' ' ' LEU . 8.4 tt -62.57 -44.4 96.43 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.327 -179.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 315' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 . . . . . 0 C--O 1.22 -0.499 0 CA-C-O 118.005 -0.998 . . . . 0.0 110.475 179.975 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -99.67 136.05 40.17 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.002 0.43 . . . . 0.0 110.515 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.497 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -92.29 178.72 1.57 Allowed Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.523 -179.874 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.497 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.8 Cg_exo -61.58 147.3 95.73 Favored 'Trans proline' 0 C--N 1.3 -2.01 0 C-N-CA 122.819 2.346 . . . . 0.0 112.132 179.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.461 ' HE ' HD12 ' A' ' 39' ' ' LEU . 35.5 ptt180 -136.1 142.47 44.3 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.697 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -79.75 116.43 19.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.489 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.448 ' O ' HG23 ' A' ' 30' ' ' ILE . 9.4 tp -110.71 130.38 64.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.503 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.3 t -70.74 141.4 51.49 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.571 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.477 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.4 t0 -139.05 179.55 6.43 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.52 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.477 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 77.9 p -74.05 -36.99 64.42 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.557 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.8 ttt85 -46.38 -94.57 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.337 -179.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.423 ' O ' ' OG1' ' A' ' 36' ' ' THR . . . -167.17 -26.74 0.02 OUTLIER Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.423 ' OG1' ' O ' ' A' ' 35' ' ' GLY . 70.7 m -169.01 104.57 0.4 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.9 0.381 . . . . 0.0 110.613 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.681 ' CD2' HD13 ' A' ' 140' ' ' LEU . 74.3 t60 -128.46 148.33 50.72 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.081 0.467 . . . . 0.0 110.187 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.626 HG22 ' N ' ' A' ' 39' ' ' LEU . 98.0 m -130.79 166.06 21.62 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.54 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.626 ' N ' HG22 ' A' ' 38' ' ' THR . 81.2 mt -120.8 127.63 52.13 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.56 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -65.08 -44.59 88.43 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.67 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 39.8 p -165.65 154.89 12.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.416 179.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.499 ' H ' ' CD ' ' A' ' 42' ' ' GLN . 14.8 mp0 -44.32 101.07 0.24 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.607 179.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.23 129.51 34.58 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.391 2.061 . . . . 0.0 112.265 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -83.5 -24.78 31.57 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.527 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.538 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.6 mtm-85 -122.31 134.82 54.65 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 121.179 0.514 . . . . 0.0 110.297 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.2 mt -130.8 133.96 62.5 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.272 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.821 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 45.6 t -124.43 130.55 73.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 179.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.615 ' OG ' HD12 ' A' ' 117' ' ' LEU . 2.2 m -154.81 166.63 32.88 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.576 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 73.1 p -124.41 8.69 8.42 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.372 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.0 125.86 33.06 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.843 0.354 . . . . 0.0 110.653 -179.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.428 HG11 ' H ' ' A' ' 299' ' ' LEU . 90.8 t -66.02 -44.44 92.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.521 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.7 m -62.69 -44.39 96.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.601 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 50.3 tp -62.38 -41.48 98.67 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.529 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.443 ' O ' HD13 ' A' ' 58' ' ' LEU . 70.6 m -57.88 -44.51 86.72 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.239 -179.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.17 -62.31 5.28 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 179.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.7 t -48.19 -35.65 12.19 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 20.1 mt -61.81 -44.6 96.55 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.226 179.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.443 HD13 ' O ' ' A' ' 54' ' ' THR . 9.3 mp -65.16 -41.66 94.5 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.391 177.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.42 -41.38 98.71 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.856 -179.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.428 ' O ' HG23 ' A' ' 60' ' ' ILE . 8.1 tp -88.1 17.29 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.838 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 56.28 85.01 0.08 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.733 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.36 58.62 0.08 OUTLIER Pre-proline 0 C--N 1.328 -0.355 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -50.92 151.93 10.76 Favored 'Trans proline' 0 C--N 1.294 -2.319 0 C-N-CA 122.902 2.402 . . . . 0.0 112.275 -178.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.433 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -108.71 145.75 15.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.326 -179.691 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.76 -45.17 97.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.361 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.502 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -129.92 134.48 47.51 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 120.8 0.334 . . . . 0.0 110.541 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.48 ' O ' ' N ' ' A' ' 98' ' ' LEU . 73.3 m -134.73 158.87 43.02 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.907 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.45 138.65 15.98 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.474 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.6 -162.85 0.09 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.002 0.429 . . . . 0.0 110.453 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.53 HG22 ' CD2' ' A' ' 297' ' ' PHE . 5.8 t -133.97 135.9 43.8 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.156 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.487 ' C ' ' O ' ' A' ' 70' ' ' THR . 1.1 t 29.46 67.99 0.67 Allowed Pre-proline 0 N--CA 1.466 0.332 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.728 -179.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_exo -60.97 145.74 98.69 Favored 'Trans proline' 0 C--N 1.3 -2.009 0 C-N-CA 122.619 2.213 . . . . 0.0 111.99 -178.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.537 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 42.4 p-10 -161.06 -31.86 0.05 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.75 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.537 ' N ' ' OD1' ' A' ' 73' ' ' ASN . 99.1 m-20 -64.16 -39.41 93.94 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.343 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -60.28 -47.98 83.69 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.578 -179.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.427 ' O ' ' O ' ' A' ' 77' ' ' ALA . 98.7 t -60.27 -24.62 31.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.532 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -45.5 172.88 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.631 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.575 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.9 p30 -61.99 177.61 0.44 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.586 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.563 ' C ' ' H ' ' A' ' 81' ' ' GLY . 36.5 p30 -45.96 85.41 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.072 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.575 ' N ' ' O ' ' A' ' 78' ' ' ASP . 42.4 tp60 -67.43 13.66 0.07 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.203 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.563 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 118.16 -21.96 9.9 Favored Glycine 0 CA--C 1.519 0.3 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -107.86 116.51 32.09 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.008 0.432 . . . . 0.0 110.527 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 74.6 mt -98.54 0.03 44.19 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.982 0.42 . . . . 0.0 110.51 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -92.49 7.04 44.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.031 0.443 . . . . 0.0 110.387 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.773 ' O ' HG22 ' A' ' 89' ' ' VAL . 88.2 mt-30 -100.24 -27.16 13.64 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.841 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.6 t-105 -64.73 -40.46 95.35 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.035 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.557 ' O ' ' N ' ' A' ' 91' ' ' LYS . 65.8 m -77.89 -54.5 6.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.169 -179.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -47.42 -50.43 22.67 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.087 -179.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.773 HG22 ' O ' ' A' ' 85' ' ' GLN . 14.4 m -69.36 -40.54 80.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.137 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.496 ' N ' HG23 ' A' ' 89' ' ' VAL . . . -72.45 -22.76 61.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.658 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.557 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.0 tttm -62.14 -45.57 92.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.445 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.439 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.8 mm-40 -90.37 -94.8 0.12 Allowed 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.078 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.636 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.8 mtt180 -143.01 58.75 1.42 Allowed 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.455 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.6 pttp 33.68 25.8 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 120.947 0.403 . . . . 0.0 110.255 -179.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.636 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.3 tt -47.78 123.68 6.3 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.954 -178.02 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.453 ' O ' HD23 ' A' ' 95' ' ' LEU . 99.0 mm-40 -83.56 -170.39 3.04 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.127 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.613 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 82.2 mtp180 -73.95 137.26 43.46 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.061 0.458 . . . . 0.0 110.246 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.48 ' N ' ' O ' ' A' ' 67' ' ' SER . 90.3 mt -86.12 -165.85 1.37 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.816 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.537 ' CD2' ' O ' ' A' ' 99' ' ' TYR . 48.5 p90 -168.86 119.92 0.75 Allowed 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.137 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.509 ' C ' ' O ' ' A' ' 99' ' ' TYR . 43.7 mm -29.0 121.08 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.067 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 114.15 27.13 3.53 Favored Glycine 0 C--N 1.332 0.318 0 N-CA-C 111.261 -0.735 . . . . 0.0 111.261 -179.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.576 ' H ' ' CD ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -144.2 46.5 0.64 Allowed Pre-proline 0 C--N 1.324 -0.518 0 CA-C-O 120.931 0.396 . . . . 0.0 110.416 179.872 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 29.1 Cg_endo -62.1 143.77 95.14 Favored 'Trans proline' 0 C--N 1.296 -2.233 0 C-N-CA 122.677 2.251 . . . . 0.0 111.845 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.455 ' O ' HG23 ' A' ' 108' ' ' VAL . 27.4 t -173.05 120.2 0.35 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.376 179.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.52 -40.49 64.0 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.038 0.447 . . . . 0.0 111.086 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.23 -39.87 89.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.841 -179.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.23 -40.04 95.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.745 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 104' ' ' SER . 71.2 t -67.69 -43.89 86.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.793 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.71 -39.01 92.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.522 -179.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.439 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.5 -23.35 62.72 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.486 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.544 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.2 mm-40 -90.66 5.46 47.96 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.659 -179.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.544 ' C ' ' O ' ' A' ' 111' ' ' GLN . 10.5 tpt 23.49 64.23 0.38 Allowed Pre-proline 0 N--CA 1.466 0.367 0 CA-C-O 120.87 0.367 . . . . 0.0 111.02 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -78.54 167.1 23.19 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 C-N-CA 123.051 2.501 . . . . 0.0 111.866 -178.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.523 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 99.2 m-20 -109.83 -42.07 4.34 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.112 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 39.8 tp -121.64 120.28 34.3 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 83.7 mt -112.91 128.85 69.42 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.353 0 CA-C-O 120.934 0.397 . . . . 0.0 110.951 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.615 HD12 ' OG ' ' A' ' 48' ' ' SER . 29.4 mt -108.87 132.26 54.21 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.063 0.459 . . . . 0.0 110.183 -179.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.496 HD12 HG23 ' A' ' 139' ' ' THR . 98.7 mt -119.67 139.01 48.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.711 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 85.6 p -72.4 153.77 41.26 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.642 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.18 -50.16 74.76 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.631 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -149.45 154.06 38.25 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.555 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 170.64 -171.02 43.53 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -63.17 -34.04 88.89 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.447 ' O ' ' OD1' ' A' ' 124' ' ' ASP . 44.0 p-10 -86.97 119.99 27.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.867 0.365 . . . . 0.0 110.684 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.444 ' O ' HD12 ' A' ' 129' ' ' LEU . 39.8 t -62.99 143.61 57.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.425 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.04 -43.11 9.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.862 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.7 tp -63.01 -42.47 99.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.75 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.43 -12.08 59.39 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.499 -179.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.444 HD12 ' O ' ' A' ' 125' ' ' SER . 84.2 mt -114.94 -23.84 8.91 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.636 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . 0.519 ' N ' ' O ' ' A' ' 126' ' ' ALA . 78.4 t80 -51.0 -49.74 59.81 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.567 -178.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.1 p-10 -65.84 -42.4 90.56 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.841 -0.344 . . . . 0.0 111.208 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.523 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 88.3 mt-30 -67.45 -37.77 83.46 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.849 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.424 HD12 HD11 ' A' ' 118' ' ' ILE . 95.9 mt -80.06 -41.8 24.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.862 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.2 t -57.03 -44.43 82.88 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.166 -178.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 20.2 m -61.91 -45.09 95.24 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.463 179.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 93.8 mt -62.24 -43.59 98.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.196 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.65 ' HB1' ' HD2' ' A' ' 138' ' ' PRO . . . -169.52 167.9 5.08 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.57 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.65 ' HD2' ' HB1' ' A' ' 137' ' ' ALA . 51.9 Cg_exo -49.4 113.14 0.83 Allowed 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.298 1.998 . . . . 0.0 112.299 179.184 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.496 HG23 HD12 ' A' ' 118' ' ' ILE . 24.0 m -84.65 127.24 33.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.602 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.681 HD13 ' CD2' ' A' ' 37' ' ' HIS . 34.7 tp -117.75 136.24 53.51 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.05 -179.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.44 ' O ' ' OD2' ' A' ' 32' ' ' ASP . 82.6 mt -100.1 118.89 47.42 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 CA-C-O 121.149 0.5 . . . . 0.0 111.161 -179.326 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.425 HD12 HD22 ' A' ' 117' ' ' LEU . 97.8 mt -135.05 132.13 53.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.595 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.546 HD21 ' CG ' ' A' ' 241' ' ' ASP . 55.9 t30 -67.35 153.59 43.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.945 0.403 . . . . 0.0 110.483 179.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.522 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 89.1 t80 -87.58 122.26 31.05 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.865 -179.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.522 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 99.0 m-20 55.17 69.45 0.73 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.759 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 49.3 p-10 -123.56 -0.48 8.65 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.923 0.392 . . . . 0.0 110.664 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -151.45 117.5 5.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.69 -179.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 83.7 p -63.4 167.78 5.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.524 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.413 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.1 p-90 -51.15 -15.64 0.37 Allowed 'General case' 0 C--O 1.223 -0.326 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.504 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.445 ' O ' HG23 ' A' ' 154' ' ' THR . 68.1 tp60 -71.28 -74.91 0.14 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.444 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.444 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.0 t -62.93 -38.84 92.61 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.263 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 54.6 tp -60.14 -45.71 92.11 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.413 -178.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.413 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 47.3 tp -62.62 -41.6 99.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.445 179.002 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.445 HG23 ' O ' ' A' ' 150' ' ' GLN . 57.1 p -64.23 -34.68 78.65 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.193 -179.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.43 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.7 mm-40 -63.99 -42.78 97.1 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.442 179.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 91.5 mt -65.38 -38.92 91.45 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.087 0.47 . . . . 0.0 110.245 179.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.579 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.2 -31.91 78.67 Favored Glycine 0 CA--C 1.519 0.288 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 -179.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' A' ' 157' ' ' GLY . 97.3 mt-10 -35.61 -26.73 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.815 0.34 . . . . 0.0 110.803 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.579 ' N ' ' O ' ' A' ' 157' ' ' GLY . 95.7 mt -56.62 149.87 3.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.305 179.072 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 72.4 p -69.98 137.1 51.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.983 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 72.02 19.56 78.45 Favored Glycine 0 CA--C 1.517 0.159 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 58.2 m80 -121.04 -15.05 8.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.683 0.277 . . . . 0.0 110.585 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -65.33 -60.09 3.35 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.684 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -52.01 -49.25 63.73 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 120.819 -0.352 . . . . 0.0 110.166 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -60.29 -41.26 92.99 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.956 -0.298 . . . . 0.0 110.349 179.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.44 -47.24 86.61 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.55 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.86 -40.23 75.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.286 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -61.81 -50.26 73.04 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.601 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 60.1 ttt85 -65.32 -43.76 89.97 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.554 179.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 94.9 mt -64.77 -43.31 96.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.457 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.31 -51.35 69.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.472 -179.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.43 -43.76 96.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.584 179.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.654 ' CE2' HD11 ' A' ' 177' ' ' LEU . 56.1 t80 -62.9 -44.35 96.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.423 179.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -63.61 -39.96 95.71 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.54 -179.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -62.89 -42.85 99.92 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.67 179.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -60.71 -44.62 96.37 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.201 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.654 HD11 ' CE2' ' A' ' 173' ' ' PHE . 83.6 mt -64.51 -40.96 96.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.01 0.433 . . . . 0.0 110.695 178.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.13 -62.41 1.65 Allowed 'General case' 0 C--O 1.237 0.425 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.411 -179.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.48 -47.01 85.46 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.519 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.2 -41.65 65.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.32 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -63.92 -33.82 76.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.002 0.429 . . . . 0.0 110.397 179.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.421 ' HG2' ' O ' ' A' ' 182' ' ' GLU . 69.5 tt0 -90.62 9.16 30.79 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.448 0.642 . . . . 0.0 110.439 -178.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -105.06 -32.03 8.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.165 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.5 pt -128.17 147.57 32.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.753 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -139.69 131.11 26.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.446 179.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.592 HD22 ' N ' ' A' ' 186' ' ' LEU . 3.6 mm? -85.3 133.23 42.96 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.977 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -43.8 157.77 0.13 Allowed 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.75 2.3 . . . . 0.0 112.223 179.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 0.515 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 28.0 Cg_endo -63.05 114.82 2.61 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 C-N-CA 122.821 2.347 . . . . 0.0 111.716 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . 0.515 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.7 mt-30 155.72 147.71 0.0 OUTLIER Pre-proline 0 N--CA 1.456 -0.144 0 O-C-N 123.76 0.662 . . . . 0.0 110.759 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -73.56 143.53 34.46 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.582 2.188 . . . . 0.0 112.082 177.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.5 HG23 ' OG ' ' A' ' 258' ' ' SER . 2.1 p -124.43 158.88 31.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.362 0.601 . . . . 0.0 110.174 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . 0.493 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 34.8 p -143.39 165.22 28.12 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.086 -179.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . 0.441 ' HA ' ' H ' ' A' ' 260' ' ' PHE . . . -135.15 128.56 32.32 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.241 0.543 . . . . 0.0 110.201 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.508 HD11 HD23 ' A' ' 259' ' ' LEU . 47.4 pt -146.48 148.85 16.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.113 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . 0.748 HG13 ' CD1' ' A' ' 262' ' ' PHE . 69.1 t -117.76 123.26 71.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.278 0.561 . . . . 0.0 109.794 179.049 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -134.07 106.96 7.48 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.295 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 94.5 m -130.57 130.3 43.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.827 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.403 ' O ' ' N ' ' A' ' 201' ' ' HIS . . . -83.01 -36.73 24.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.198 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.54 -67.01 0.27 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.338 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.49 -9.43 58.54 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.268 179.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . 0.403 ' N ' ' O ' ' A' ' 198' ' ' ALA . 59.8 t-80 60.36 58.47 2.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.708 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 48.8 p -166.99 153.51 8.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.547 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.49 144.3 24.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.974 0.416 . . . . 0.0 110.51 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -135.47 138.46 43.19 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.599 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 20.0 mt -106.59 125.68 51.31 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.067 0.46 . . . . 0.0 109.834 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' TRP . . . . . 0.557 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 75.5 m95 -82.23 167.21 18.88 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.621 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . 0.464 HG22 ' C ' ' A' ' 206' ' ' TRP . 0.1 OUTLIER -157.03 171.53 7.33 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.632 -179.118 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -53.85 -36.9 84.56 Favored 'Trans proline' 0 C--N 1.302 -1.917 0 C-N-CA 122.691 2.261 . . . . 0.0 112.247 179.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -70.64 -34.99 72.68 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.734 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 21.5 m -61.36 150.75 34.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.606 -179.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.67 -36.96 82.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.452 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . 0.557 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 54.8 tt0 -64.63 -40.22 95.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.48 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.68 -43.46 91.88 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.694 -0.963 . . . . 0.0 110.694 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -63.41 -43.53 97.26 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.816 0.341 . . . . 0.0 110.347 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . 0.521 ' SD ' ' HB2' ' A' ' 304' ' ' ALA . 65.2 ttp -59.43 -48.06 83.1 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.232 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 87.7 mt -60.64 -40.91 93.71 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . 0.457 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.5 tp10 -57.79 -37.92 74.59 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -65.32 -37.98 88.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.797 0.332 . . . . 0.0 110.666 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 94.5 mt -64.26 -42.86 96.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.62 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.7 44.88 0.08 OUTLIER Glycine 0 C--N 1.333 0.369 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . 0.457 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 27.4 m-85 -128.02 155.11 44.83 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.038 0.447 . . . . 0.0 110.524 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.483 ' O ' HG13 ' A' ' 191' ' ' VAL . 7.2 p -106.94 122.17 45.89 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.248 0.547 . . . . 0.0 110.103 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.467 HD22 ' C ' ' A' ' 222' ' ' THR . 4.3 mm? -100.98 133.26 45.74 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.109 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -97.14 159.23 15.03 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.469 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.19 115.35 30.11 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.87 0.367 . . . . 0.0 110.36 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.495 ' N ' HD12 ' A' ' 226' ' ' LEU . 8.9 mp -53.22 156.46 3.88 Favored Pre-proline 0 N--CA 1.452 -0.345 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.744 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -60.16 145.27 98.87 Favored 'Trans proline' 0 C--N 1.3 -1.986 0 C-N-CA 122.703 2.269 . . . . 0.0 112.162 179.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.16 -3.25 59.05 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.528 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.14 -40.98 5.67 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 111.024 -0.831 . . . . 0.0 111.024 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.533 ' O ' ' N ' ' A' ' 233' ' ' SER . 85.1 mt -79.25 -17.13 55.34 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-O 121.113 0.482 . . . . 0.0 110.362 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . 0.401 ' C ' ' O ' ' A' ' 230' ' ' LEU . 55.5 t-20 -40.17 -49.12 2.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.821 -179.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -88.08 15.35 7.52 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.373 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.533 ' N ' ' O ' ' A' ' 230' ' ' LEU . 78.0 p -60.37 -35.6 76.09 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.651 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . 0.526 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.7 tt0 -118.51 -69.32 0.86 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.995 179.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.4 m -69.85 103.4 2.19 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.693 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -94.69 57.63 2.21 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.297 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -144.84 -122.59 1.57 Allowed Glycine 0 CA--C 1.52 0.353 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -134.81 111.66 10.09 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.114 0.483 . . . . 0.0 110.389 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . 0.517 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.5 mtt180 -148.04 57.72 1.09 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.762 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -69.55 -32.14 70.76 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.501 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . 0.546 ' CG ' HD21 ' A' ' 143' ' ' ASN . 64.8 t0 -56.85 -47.05 81.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.378 -179.077 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' ILE . . . . . 0.436 ' O ' ' O ' ' A' ' 239' ' ' ARG . 17.8 tt -139.97 156.63 25.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.892 0.377 . . . . 0.0 110.479 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.441 HG22 HD13 ' A' ' 245' ' ' LEU . 96.3 mt -106.03 106.26 20.24 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.202 0 CA-C-O 121.096 0.474 . . . . 0.0 110.502 179.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . 0.601 ' O ' HD12 ' A' ' 245' ' ' LEU . 88.3 mt-30 -110.2 110.09 20.81 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.398 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.601 HD12 ' O ' ' A' ' 244' ' ' GLN . 9.5 mp -121.79 -168.38 1.69 Allowed 'General case' 0 C--O 1.225 -0.199 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.651 179.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . 0.526 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.65 -16.76 0.05 OUTLIER Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . 0.672 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -60.55 156.64 30.8 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -63.68 21.4 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.0 0.428 . . . . 0.0 110.643 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . 0.672 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.6 m-20 -97.02 -6.03 36.3 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.556 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 93.3 mt -79.68 -21.69 44.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.658 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.5 -51.34 70.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.705 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.31 -5.65 58.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.502 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.2 -74.53 1.14 Allowed Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 82.2 mt -69.83 125.92 28.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.954 0.407 . . . . 0.0 110.366 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -59.26 -39.42 82.82 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.19 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 82.39 51.88 4.2 Favored Glycine 0 CA--C 1.521 0.407 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -96.67 -14.2 22.27 Favored 'General case' 0 C--N 1.331 -0.236 0 O-C-N 122.755 -0.262 . . . . 0.0 110.597 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . 0.5 ' OG ' HG23 ' A' ' 191' ' ' VAL . 3.5 t 174.67 88.18 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.084 0.469 . . . . 0.0 110.167 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.861 ' N ' HD12 ' A' ' 259' ' ' LEU . 1.0 OUTLIER -94.26 123.85 37.92 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.245 0.545 . . . . 0.0 111.102 -179.101 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 260' ' ' PHE . . . . . 0.441 ' H ' ' HA ' ' A' ' 193' ' ' ALA . 15.8 m-30 -92.77 146.32 23.74 Favored 'General case' 0 CA--C 1.503 -0.854 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.503 179.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 86.0 mt -122.3 149.59 43.51 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.519 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.748 ' CD1' HG13 ' A' ' 195' ' ' VAL . 2.6 p90 -77.46 -138.52 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.579 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . 0.658 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -51.9 77.29 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.114 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . 0.629 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.1 104.46 0.19 Allowed Glycine 0 CA--C 1.527 0.794 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 265' ' ' ASP . . . . . 0.599 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.8 m-20 -80.43 -177.85 6.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.649 0.261 . . . . 0.0 110.9 -179.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -40.3 -17.81 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.551 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . 0.599 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.36 -51.65 41.97 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.612 179.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -63.59 -46.77 84.3 Favored 'General case' 0 N--CA 1.461 0.095 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.237 179.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . 0.573 ' HB1' ' OH ' ' A' ' 273' ' ' TYR . . . -61.62 -35.09 76.9 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 121.263 0.554 . . . . 0.0 109.827 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -63.12 -34.37 77.46 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.167 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.49 -43.39 13.61 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.14 -179.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 272' ' ' ILE . . . . . 0.589 ' C ' ' H ' ' A' ' 274' ' ' ALA . 5.0 tt -51.33 -33.75 14.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.824 -178.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 273' ' ' TYR . . . . . 0.573 ' OH ' ' HB1' ' A' ' 269' ' ' ALA . 17.3 m-85 -54.45 -1.75 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.613 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 274' ' ' ALA . . . . . 0.589 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.54 -39.6 70.58 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.931 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . 0.58 ' O ' ' N ' ' A' ' 279' ' ' ALA . 3.2 p30 -39.21 98.0 0.15 Allowed Pre-proline 0 C--O 1.227 -0.126 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.505 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -54.27 -42.92 63.27 Favored 'Trans proline' 0 C--N 1.303 -1.824 0 C-N-CA 122.404 2.069 . . . . 0.0 112.598 -178.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 88.7 mt -64.41 -42.78 95.89 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.133 0.492 . . . . 0.0 111.2 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 91.1 mt -95.64 -1.72 49.62 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.882 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 279' ' ' ALA . . . . . 0.58 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.23 -34.83 77.24 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.703 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -74.27 20.15 0.12 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.981 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 0.487 HD23 ' HA ' ' A' ' 281' ' ' LEU . 13.8 mt -75.2 119.93 79.26 Favored Pre-proline 0 N--CA 1.449 -0.499 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.595 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -50.49 -39.68 54.73 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.725 2.284 . . . . 0.0 112.019 178.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.69 -50.43 63.32 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.082 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 73.7 t -61.44 -43.91 97.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -57.81 -41.29 81.88 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.212 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -90.92 0.05 57.61 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.201 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt 59.47 43.29 16.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.863 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -94.68 41.42 1.09 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.372 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 53.8 t -118.99 135.83 58.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.089 0.471 . . . . 0.0 110.175 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -133.04 162.89 30.51 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 121.102 0.477 . . . . 0.0 110.637 -179.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -120.08 155.22 33.41 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.022 0.439 . . . . 0.0 110.689 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 81.6 mt -93.87 -1.48 54.75 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.313 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.04 165.74 12.77 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.609 -0.996 . . . . 0.0 110.609 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 7.1 m -87.3 -62.27 1.54 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.875 0.369 . . . . 0.0 111.007 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 295' ' ' GLU . . . . . 0.441 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.4 mm-40 -69.49 -4.0 16.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.672 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 26.2 p -77.03 32.62 0.14 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.619 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 297' ' ' PHE . . . . . 0.53 ' CD2' HG22 ' A' ' 70' ' ' THR . 69.4 t80 -60.15 -46.19 90.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.512 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . 0.613 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.1 mtt85 -81.26 133.65 35.47 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 120.988 0.423 . . . . 0.0 110.507 -179.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.428 ' H ' HG11 ' A' ' 51' ' ' VAL . 16.3 tp -114.16 119.67 37.89 Favored 'General case' 0 C--O 1.231 0.083 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.26 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . 0.621 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.5 p-10 -167.53 -174.14 2.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.611 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 81.5 t80 -48.2 -45.6 34.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.2 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -64.96 -41.64 95.29 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.106 0.479 . . . . 0.0 110.718 179.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . 0.621 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 53.0 p -55.13 -36.27 65.58 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.052 -179.299 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . 0.521 ' HB2' ' SD ' ' A' ' 215' ' ' MET . . . -56.74 -51.65 68.04 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 179.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 91.5 mtp -56.22 -43.98 79.12 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -66.21 -42.71 88.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.02 0.438 . . . . 0.0 110.256 178.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 303' ' ' SER . 55.5 t -64.05 -42.81 96.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.254 179.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 42.2 tp -59.56 -42.22 91.92 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.81 -179.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -62.76 -38.78 91.95 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.118 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 310' ' ' ARG . . . . . 0.431 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.6 ttt85 -63.34 -44.1 95.82 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.229 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 88.1 mt -63.3 -42.03 99.01 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.318 179.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -62.78 -33.09 74.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.166 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -90.08 -23.42 21.42 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.456 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.476 HD22 ' CE2' ' A' ' 315' ' ' PHE . 6.8 tt -62.29 -43.16 99.47 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 121.144 0.497 . . . . 0.0 110.677 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 315' ' ' PHE . . . . . 0.476 ' CE2' HD22 ' A' ' 314' ' ' LEU . 91.0 m-85 . . . . . 0 C--O 1.219 -0.517 0 CA-C-O 118.026 -0.987 . . . . 0.0 110.409 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -99.54 136.56 39.3 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.178 0.513 . . . . 0.0 110.471 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.492 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -91.9 178.61 1.66 Allowed Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.566 -179.821 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.492 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.1 Cg_exo -61.72 146.99 96.31 Favored 'Trans proline' 0 C--N 1.299 -2.071 0 C-N-CA 122.86 2.374 . . . . 0.0 112.163 179.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.455 ' HE ' HD12 ' A' ' 39' ' ' LEU . 35.6 ptt180 -136.21 142.34 44.07 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.653 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -79.48 116.88 19.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.475 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.441 ' O ' HG23 ' A' ' 30' ' ' ILE . 9.5 tp -111.25 130.78 64.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.564 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.8 t -71.07 142.37 50.84 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.023 0.439 . . . . 0.0 110.615 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.477 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.4 t0 -139.95 179.53 6.55 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.561 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.477 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 77.9 p -73.67 -37.12 65.36 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.604 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.8 ttt85 -46.45 -94.41 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.29 -179.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -167.54 -26.29 0.02 OUTLIER Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 54.8 m -169.31 104.91 0.37 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.84 0.353 . . . . 0.0 110.622 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.683 ' CD2' HD13 ' A' ' 140' ' ' LEU . 75.3 t60 -128.56 149.32 50.67 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.158 0.504 . . . . 0.0 110.142 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.622 HG22 ' N ' ' A' ' 39' ' ' LEU . 98.4 m -131.44 166.02 22.23 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.456 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.622 ' N ' HG22 ' A' ' 38' ' ' THR . 81.6 mt -120.85 127.12 51.61 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.432 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -65.02 -44.59 88.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.748 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 39.7 p -165.51 154.94 12.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.429 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.474 ' H ' ' CD ' ' A' ' 42' ' ' GLN . 14.6 mp0 -44.3 100.91 0.24 Allowed Pre-proline 0 C--O 1.235 0.33 0 O-C-N 123.551 0.532 . . . . 0.0 110.635 179.144 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.4 129.92 36.48 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 C-N-CA 122.335 2.023 . . . . 0.0 112.307 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -83.79 -24.92 30.84 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.605 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.54 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.6 mtm-85 -122.19 134.62 54.71 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.279 0.562 . . . . 0.0 110.203 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.3 mt -130.21 133.49 64.05 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.801 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 44.0 t -124.41 130.47 73.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 179.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.616 ' OG ' HD12 ' A' ' 117' ' ' LEU . 2.2 m -154.86 166.89 32.07 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.554 179.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 72.2 p -124.13 8.59 8.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.395 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.45 126.04 33.49 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.862 0.363 . . . . 0.0 110.622 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.49 HG11 ' H ' ' A' ' 299' ' ' LEU . 90.9 t -66.18 -44.51 91.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.553 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.5 m -62.43 -44.55 96.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.684 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 46.1 tp -62.45 -41.44 98.74 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.543 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.434 ' O ' HD13 ' A' ' 58' ' ' LEU . 71.8 m -58.1 -44.65 87.79 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.164 -179.061 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -63.93 -62.53 5.15 Favored Glycine 0 N--CA 1.468 0.795 0 N-CA-C 110.844 -0.903 . . . . 0.0 110.844 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.7 t -48.09 -35.51 11.49 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 20.0 mt -61.89 -44.1 97.5 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.615 -0.434 . . . . 0.0 111.397 179.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.439 HD21 HE22 ' A' ' 85' ' ' GLN . 9.3 mp -65.57 -41.45 92.91 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.415 177.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.41 -41.48 98.72 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.856 -179.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.421 ' O ' HG23 ' A' ' 60' ' ' ILE . 8.1 tp -87.44 17.22 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.915 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 56.33 84.37 0.09 Allowed 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.76 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.96 59.74 0.1 OUTLIER Pre-proline 0 C--N 1.328 -0.369 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.406 ' HB3' HE21 ' A' ' 85' ' ' GLN . 9.9 Cg_endo -51.85 151.56 15.3 Favored 'Trans proline' 0 C--N 1.292 -2.4 0 C-N-CA 123.079 2.519 . . . . 0.0 112.041 -178.274 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.434 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -108.46 145.04 15.94 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.191 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.29 -179.65 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.8 mt -63.72 -45.47 97.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.46 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.495 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -129.42 134.1 47.67 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.537 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.503 ' O ' ' N ' ' A' ' 98' ' ' LEU . 74.6 m -134.94 158.84 43.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.859 -179.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.61 139.07 16.22 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.608 -0.997 . . . . 0.0 110.608 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.471 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.71 -162.97 0.09 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.962 0.41 . . . . 0.0 110.486 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.52 HG22 ' CD2' ' A' ' 297' ' ' PHE . 5.7 t -134.0 134.88 43.0 Favored 'General case' 0 CA--C 1.519 -0.25 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.477 ' C ' ' O ' ' A' ' 70' ' ' THR . 1.0 OUTLIER 29.69 68.29 0.67 Allowed Pre-proline 0 N--CA 1.467 0.415 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.816 -179.646 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_exo -61.63 144.94 97.91 Favored 'Trans proline' 0 C--N 1.299 -2.074 0 C-N-CA 122.617 2.211 . . . . 0.0 111.732 -177.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.51 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 45.8 p-10 -158.72 -31.76 0.07 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.668 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.54 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 99.1 m-20 -64.21 -39.45 94.0 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.41 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -60.49 -47.95 83.88 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.44 -178.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.42 ' O ' ' O ' ' A' ' 77' ' ' ALA . 93.4 t -60.56 -24.79 32.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.54 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -45.88 173.35 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.665 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.574 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.3 p30 -61.93 177.36 0.45 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.622 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.566 ' C ' ' H ' ' A' ' 81' ' ' GLY . 36.0 p30 -45.3 85.28 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.011 0.434 . . . . 0.0 111.13 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.574 ' N ' ' O ' ' A' ' 78' ' ' ASP . 42.7 tp60 -67.33 13.39 0.07 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.212 0.529 . . . . 0.0 110.092 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.566 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 118.49 -22.44 9.45 Favored Glycine 0 N--CA 1.461 0.362 0 N-CA-C 110.921 -0.871 . . . . 0.0 110.921 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -107.85 116.45 31.97 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.992 0.425 . . . . 0.0 110.456 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 74.6 mt -98.12 -0.1 45.01 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.972 0.415 . . . . 0.0 110.55 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -92.7 7.14 44.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.029 0.442 . . . . 0.0 110.377 -179.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.77 ' O ' HG22 ' A' ' 89' ' ' VAL . 88.3 mt-30 -100.32 -27.68 13.35 Favored 'General case' 0 C--O 1.219 -0.545 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.813 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.3 t-105 -64.5 -40.53 95.83 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.089 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.53 ' O ' ' N ' ' A' ' 91' ' ' LYS . 63.1 m -77.78 -55.22 5.51 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.181 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -46.86 -50.08 19.16 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.243 -179.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.77 HG22 ' O ' ' A' ' 85' ' ' GLN . 14.2 m -69.5 -40.96 80.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.303 179.46 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.5 ' N ' HG23 ' A' ' 89' ' ' VAL . . . -72.01 -22.63 61.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.688 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.53 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.1 tttm -62.47 -45.75 91.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.316 -179.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.438 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.6 mm-40 -90.01 -94.02 0.12 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.998 0.428 . . . . 0.0 110.115 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.612 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.9 mtt180 -143.61 58.52 1.38 Allowed 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.445 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.7 pttp 34.01 26.5 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.064 0.459 . . . . 0.0 110.229 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.612 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.6 tt -48.89 123.01 6.36 Favored 'General case' 0 N--CA 1.444 -0.725 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.005 -177.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.46 ' O ' HD23 ' A' ' 95' ' ' LEU . 99.0 mm-40 -83.42 -169.6 2.63 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.212 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.616 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 81.9 mtp180 -74.61 136.88 42.0 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.272 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.503 ' N ' ' O ' ' A' ' 67' ' ' SER . 91.5 mt -85.34 -165.77 1.31 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.877 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.54 ' CD2' ' O ' ' A' ' 99' ' ' TYR . 47.1 p90 -169.05 119.33 0.71 Allowed 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.044 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.502 ' C ' ' O ' ' A' ' 99' ' ' TYR . 42.9 mm -28.31 120.44 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 O-C-N 123.316 0.385 . . . . 0.0 111.192 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 114.67 27.02 3.42 Favored Glycine 0 N--CA 1.461 0.308 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 -179.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.574 ' N ' ' CD ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -144.44 46.51 0.63 Allowed Pre-proline 0 C--N 1.322 -0.612 0 CA-C-O 121.126 0.489 . . . . 0.0 110.442 179.798 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.574 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 28.5 Cg_endo -62.09 144.19 95.69 Favored 'Trans proline' 0 C--N 1.293 -2.346 0 C-N-CA 122.68 2.253 . . . . 0.0 111.686 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.453 ' O ' HG23 ' A' ' 108' ' ' VAL . 26.5 t -173.12 120.18 0.35 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.325 179.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.78 -40.27 63.56 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.038 0.447 . . . . 0.0 111.131 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.25 -39.81 89.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.877 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.3 -39.77 94.59 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.772 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 104' ' ' SER . 70.5 t -67.6 -43.81 86.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.686 179.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.94 -38.93 93.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.506 -179.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.438 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.71 -23.45 63.16 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.5 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.53 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.4 mm-40 -90.55 5.31 48.34 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.748 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.54 ' O ' ' NE ' ' A' ' 45' ' ' ARG . 10.6 tpt 23.01 64.41 0.36 Allowed Pre-proline 0 N--CA 1.468 0.45 0 CA-C-O 120.935 0.397 . . . . 0.0 111.312 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -78.65 167.42 22.55 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 123.095 2.53 . . . . 0.0 111.6 -177.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.52 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 99.0 m-20 -109.78 -41.95 4.39 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.046 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.6 tp -121.23 120.7 35.95 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 84.3 mt -113.2 128.75 69.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 CA-C-O 120.89 0.376 . . . . 0.0 110.968 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.616 HD12 ' OG ' ' A' ' 48' ' ' SER . 31.1 mt -109.6 132.09 54.46 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.207 -179.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.498 HD12 HG23 ' A' ' 139' ' ' THR . 98.9 mt -119.67 138.68 49.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.634 -179.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 85.2 p -72.16 153.9 41.37 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.583 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.08 -50.37 73.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.646 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.0 t -149.61 154.16 38.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.563 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 170.85 -170.85 43.5 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -63.08 -33.99 88.75 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.44 ' O ' ' OD1' ' A' ' 124' ' ' ASP . 43.9 p-10 -86.87 120.42 28.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.815 0.341 . . . . 0.0 110.713 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.439 ' O ' HD12 ' A' ' 129' ' ' LEU . 38.5 t -62.97 143.5 57.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.072 0.463 . . . . 0.0 110.33 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.513 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -92.82 -43.26 9.09 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.91 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.2 tp -63.04 -42.56 99.77 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.729 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.32 -11.9 58.77 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.47 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.439 HD12 ' O ' ' A' ' 125' ' ' SER . 84.8 mt -115.09 -23.87 8.82 Favored 'General case' 0 C--O 1.225 -0.228 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.631 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . 0.513 ' N ' ' O ' ' A' ' 126' ' ' ALA . 79.7 t80 -51.46 -49.45 61.74 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.578 -178.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.8 p-10 -66.01 -42.41 89.75 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.773 -0.371 . . . . 0.0 111.364 179.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.524 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 88.3 mt-30 -67.16 -37.64 84.1 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.862 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.43 HD12 HD11 ' A' ' 118' ' ' ILE . 96.4 mt -80.36 -41.64 24.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.885 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.3 t -57.09 -44.48 83.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.294 -179.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.7 m -62.09 -45.2 94.54 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.505 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 94.1 mt -62.23 -43.61 98.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.216 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.666 ' HB1' ' HD2' ' A' ' 138' ' ' PRO . . . -168.98 168.73 5.01 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.608 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.666 ' HD2' ' HB1' ' A' ' 137' ' ' ALA . 51.6 Cg_exo -50.4 112.89 0.83 Allowed 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.24 1.96 . . . . 0.0 112.431 179.044 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.498 HG23 HD12 ' A' ' 118' ' ' ILE . 24.0 m -84.52 127.44 34.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.679 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.683 HD13 ' CD2' ' A' ' 37' ' ' HIS . 34.8 tp -117.88 137.15 52.99 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.009 0.433 . . . . 0.0 110.09 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.439 ' O ' ' OD2' ' A' ' 32' ' ' ASP . 81.9 mt -100.79 118.94 48.24 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.303 0 CA-C-O 121.203 0.525 . . . . 0.0 111.161 -179.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.425 HD12 HD22 ' A' ' 117' ' ' LEU . 97.9 mt -134.97 132.34 53.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.531 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.452 HD21 ' CG ' ' A' ' 241' ' ' ASP . 56.1 t30 -67.8 154.12 42.23 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.979 0.418 . . . . 0.0 110.472 179.26 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.528 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 89.8 t80 -87.81 122.53 31.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.866 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.528 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 99.1 m-20 55.14 69.38 0.74 Allowed 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.655 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 49.6 p-10 -123.6 -0.53 8.62 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.865 0.364 . . . . 0.0 110.646 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -151.14 116.19 5.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.736 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 82.7 p -62.64 167.5 4.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.582 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.407 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.6 p-90 -51.62 -16.12 0.58 Allowed 'General case' 0 C--O 1.221 -0.44 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.33 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.443 ' O ' HG23 ' A' ' 154' ' ' THR . 68.1 tp60 -70.36 -75.4 0.12 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.94 0.4 . . . . 0.0 110.505 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 11.1 t -62.71 -39.11 93.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.211 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 56.0 tp -59.76 -45.69 91.47 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.417 -178.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.407 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 46.6 tp -62.7 -41.69 99.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.588 178.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.443 HG23 ' O ' ' A' ' 150' ' ' GLN . 59.3 p -64.43 -35.02 79.57 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.145 -179.281 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.439 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.5 mm-40 -63.97 -42.79 97.14 Favored 'General case' 0 C--O 1.225 -0.196 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.391 179.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 91.8 mt -65.39 -38.74 90.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.17 0.509 . . . . 0.0 110.27 179.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.568 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.48 -32.17 80.19 Favored Glycine 0 C--N 1.331 0.295 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 -179.144 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.439 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.3 mt-10 -35.65 -27.0 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.826 0.346 . . . . 0.0 110.833 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.568 ' N ' ' O ' ' A' ' 157' ' ' GLY . 95.0 mt -55.65 150.26 2.61 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.333 178.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 77.5 p -69.67 137.24 51.99 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.049 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 70.36 22.24 77.57 Favored Glycine 0 N--CA 1.458 0.149 0 N-CA-C 111.266 -0.733 . . . . 0.0 111.266 179.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 57.8 m80 -123.15 -13.86 7.64 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.599 0.237 . . . . 0.0 110.481 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -66.68 -59.47 3.56 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.657 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -52.32 -49.42 64.29 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.196 -179.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -60.38 -41.29 93.47 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.819 0.342 . . . . 0.0 110.445 179.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.41 -47.23 86.75 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.509 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.79 -40.23 75.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.271 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -61.78 -50.09 73.76 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.626 179.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -65.27 -43.54 90.94 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.59 179.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 94.1 mt -64.79 -43.29 96.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.406 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.55 -51.33 69.91 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.339 -179.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -63.37 -44.01 95.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.869 0.366 . . . . 0.0 110.708 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.651 ' CE2' HD11 ' A' ' 177' ' ' LEU . 54.8 t80 -63.08 -44.33 96.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.146 0.498 . . . . 0.0 110.394 179.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -63.71 -39.7 94.95 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.634 -179.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -63.12 -42.82 99.59 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.528 179.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -60.72 -44.54 96.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.209 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.651 HD11 ' CE2' ' A' ' 173' ' ' PHE . 85.0 mt -64.73 -41.08 96.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.764 178.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.34 -62.18 1.8 Allowed 'General case' 0 C--O 1.239 0.527 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.363 -179.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.41 -47.1 85.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.459 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -52.85 -41.73 64.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.381 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -63.87 -33.74 76.38 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.325 179.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.412 ' HG2' ' O ' ' A' ' 182' ' ' GLU . 69.6 tt0 -90.76 9.0 31.79 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.6 0.714 . . . . 0.0 110.312 -178.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -104.94 -32.01 8.97 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.221 179.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.4 pt -128.0 147.61 32.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.79 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -140.06 131.34 26.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.986 0.422 . . . . 0.0 110.36 179.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.596 HD22 ' N ' ' A' ' 186' ' ' LEU . 3.5 mm? -85.66 133.38 41.94 Favored Pre-proline 0 N--CA 1.451 -0.403 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.177 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -43.79 157.96 0.12 Allowed 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.657 2.238 . . . . 0.0 112.374 179.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 0.498 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.5 Cg_endo -62.89 114.72 2.54 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.829 2.353 . . . . 0.0 111.658 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . 0.498 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.7 mt-30 155.52 148.07 0.0 OUTLIER Pre-proline 0 N--CA 1.456 -0.145 0 O-C-N 124.208 0.942 . . . . 0.0 110.874 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -73.28 144.44 36.98 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.633 2.222 . . . . 0.0 112.282 177.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.493 HG23 ' OG ' ' A' ' 258' ' ' SER . 2.1 p -124.74 158.95 31.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.449 0.643 . . . . 0.0 110.143 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . 0.488 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 37.6 p -143.3 165.29 27.89 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.133 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . 0.448 ' HA ' ' H ' ' A' ' 260' ' ' PHE . . . -135.18 128.79 32.68 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-O 121.314 0.578 . . . . 0.0 110.173 179.28 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.514 HD11 HD23 ' A' ' 259' ' ' LEU . 47.3 pt -146.34 148.62 16.88 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.375 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.249 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . 0.744 HG13 ' CD1' ' A' ' 262' ' ' PHE . 69.2 t -117.41 123.26 71.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 CA-C-O 121.36 0.6 . . . . 0.0 109.791 178.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -134.55 107.33 7.47 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 121.144 0.497 . . . . 0.0 110.254 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 94.8 m -130.92 130.67 43.77 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.855 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -82.65 -36.9 25.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.208 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.53 -67.2 0.25 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.318 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.58 -9.99 59.25 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.266 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 59.9 t-80 60.53 58.68 2.42 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.722 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 39.1 p -166.88 153.75 8.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.53 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.2 144.25 24.61 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.022 0.439 . . . . 0.0 110.457 179.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -135.05 137.13 42.62 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.548 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 19.4 mt -105.5 125.42 50.97 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.061 0.457 . . . . 0.0 109.867 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' TRP . . . . . 0.555 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 76.6 m95 -81.81 166.52 19.93 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.572 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . 0.447 HG22 ' C ' ' A' ' 206' ' ' TRP . 0.1 OUTLIER -156.67 171.58 7.23 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.561 -178.957 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -54.01 -36.91 85.82 Favored 'Trans proline' 0 C--N 1.301 -1.965 0 C-N-CA 122.664 2.243 . . . . 0.0 112.397 178.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -70.66 -34.86 72.49 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.653 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 22.3 m -61.43 149.7 37.73 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.626 -179.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.58 -36.51 80.86 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.431 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . 0.555 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 55.3 tt0 -64.93 -40.5 95.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.53 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.27 -43.66 92.42 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -63.29 -43.06 98.95 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . 0.573 ' SD ' ' HB2' ' A' ' 304' ' ' ALA . 64.9 ttp -59.25 -48.24 82.37 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 87.5 mt -60.53 -40.97 93.43 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . 0.448 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 40.7 tp10 -57.9 -38.11 75.23 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -65.19 -38.12 89.48 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.632 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 94.2 mt -64.16 -43.11 96.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.186 0.517 . . . . 0.0 110.529 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 138.27 45.38 0.08 OUTLIER Glycine 0 C--N 1.334 0.453 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . 0.448 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 27.2 m-85 -128.98 156.56 43.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.084 0.469 . . . . 0.0 110.463 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.484 ' O ' HG13 ' A' ' 191' ' ' VAL . 7.7 p -108.66 123.22 48.64 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.311 0.577 . . . . 0.0 110.002 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.473 HD22 ' C ' ' A' ' 222' ' ' THR . 4.3 mm? -101.55 133.11 46.73 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.128 179.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -97.07 159.42 14.92 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.487 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -104.64 115.1 29.74 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.949 0.404 . . . . 0.0 110.375 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.493 ' N ' HD12 ' A' ' 226' ' ' LEU . 8.9 mp -53.48 156.62 4.19 Favored Pre-proline 0 N--CA 1.449 -0.495 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.827 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -59.75 145.04 99.23 Favored 'Trans proline' 0 C--N 1.299 -2.03 0 C-N-CA 122.726 2.284 . . . . 0.0 112.363 179.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.51 -2.72 58.81 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.51 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.37 -40.66 5.68 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.533 ' O ' ' N ' ' A' ' 233' ' ' SER . 69.4 mt -79.12 -17.2 55.5 Favored 'General case' 0 C--O 1.219 -0.505 0 CA-C-O 121.1 0.476 . . . . 0.0 110.261 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 54.5 t-20 -40.3 -48.77 2.69 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.751 0.31 . . . . 0.0 110.78 -179.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -88.36 15.45 7.75 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.433 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.533 ' N ' ' O ' ' A' ' 230' ' ' LEU . 77.7 p -60.78 -35.36 76.25 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.724 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . 0.521 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.6 tt0 -118.54 -69.62 0.84 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.864 179.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 3.9 m -70.54 103.06 2.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.702 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -94.67 58.29 2.3 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.052 0.453 . . . . 0.0 110.333 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -145.31 -122.63 1.53 Allowed Glycine 0 C--N 1.332 0.342 0 N-CA-C 110.964 -0.855 . . . . 0.0 110.964 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -133.78 111.98 10.97 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.101 0.477 . . . . 0.0 110.398 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . 0.505 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.1 mtt180 -148.42 56.93 1.05 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.742 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -69.37 -31.78 70.41 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.47 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . 0.455 ' OD2' ' O ' ' A' ' 144' ' ' TYR . 64.9 t0 -56.67 -47.01 80.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.291 -178.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' ILE . . . . . 0.44 ' O ' ' O ' ' A' ' 239' ' ' ARG . 17.3 tt -140.46 157.48 24.43 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 CA-C-O 120.91 0.386 . . . . 0.0 110.485 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.463 HG22 HD13 ' A' ' 245' ' ' LEU . 95.8 mt -105.93 106.3 20.32 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.219 0 CA-C-O 121.165 0.507 . . . . 0.0 110.425 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . 0.606 ' C ' HD12 ' A' ' 245' ' ' LEU . 88.3 mt-30 -110.86 110.4 20.99 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.366 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.606 HD12 ' C ' ' A' ' 244' ' ' GLN . 9.8 mp -121.78 -167.86 1.6 Allowed 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.627 179.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . 0.521 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 172.39 -16.04 0.05 OUTLIER Glycine 0 CA--C 1.524 0.596 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . 0.665 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -60.96 157.56 31.07 Favored Glycine 0 CA--C 1.521 0.463 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -63.86 20.87 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.941 0.401 . . . . 0.0 110.581 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . 0.665 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.9 m-20 -96.86 -5.84 37.3 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.528 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 92.5 mt -80.19 -21.45 42.96 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.839 179.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.63 -51.43 69.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.663 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.96 -5.21 58.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.465 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.03 -74.23 1.15 Allowed Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 82.0 mt -70.31 126.15 28.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.014 0.435 . . . . 0.0 110.172 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -59.97 -39.3 85.19 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.274 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 83.11 51.67 4.09 Favored Glycine 0 CA--C 1.519 0.3 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -95.15 -16.05 22.87 Favored 'General case' 0 C--N 1.331 -0.212 0 O-C-N 122.694 -0.297 . . . . 0.0 110.585 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . 0.493 ' OG ' HG23 ' A' ' 191' ' ' VAL . 3.4 t 175.19 89.42 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.182 0.515 . . . . 0.0 110.053 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.852 ' N ' HD12 ' A' ' 259' ' ' LEU . 1.0 OUTLIER -94.77 124.56 38.88 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.273 0.559 . . . . 0.0 111.253 -179.094 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 260' ' ' PHE . . . . . 0.448 ' H ' ' HA ' ' A' ' 193' ' ' ALA . 15.8 m-30 -93.95 146.65 23.77 Favored 'General case' 0 CA--C 1.497 -1.086 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.4 179.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 86.4 mt -122.32 149.54 43.6 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.573 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.744 ' CD1' HG13 ' A' ' 195' ' ' VAL . 2.6 p90 -77.69 -138.91 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.506 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . 0.654 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -51.08 77.59 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 121.109 0.48 . . . . 0.0 111.303 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . 0.624 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.93 104.57 0.18 Allowed Glycine 0 CA--C 1.527 0.816 0 N-CA-C 110.466 -1.054 . . . . 0.0 110.466 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 265' ' ' ASP . . . . . 0.589 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.6 m-20 -80.06 -177.94 6.28 Favored 'General case' 0 C--N 1.327 -0.407 0 O-C-N 122.706 -0.291 . . . . 0.0 111.001 -179.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -40.44 -17.81 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.587 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . 0.589 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.0 -51.76 43.49 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.013 0.435 . . . . 0.0 110.684 179.125 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -63.68 -46.49 85.29 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.266 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . 0.58 ' HB1' ' OH ' ' A' ' 273' ' ' TYR . . . -61.76 -34.81 76.53 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 121.543 0.687 . . . . 0.0 109.746 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -63.42 -34.23 77.3 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.076 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.51 -43.11 13.83 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.112 -179.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 272' ' ' ILE . . . . . 0.593 ' C ' ' H ' ' A' ' 274' ' ' ALA . 4.9 tt -51.44 -33.97 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.799 -178.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 273' ' ' TYR . . . . . 0.58 ' OH ' ' HB1' ' A' ' 269' ' ' ALA . 16.9 m-85 -54.43 -2.03 0.03 OUTLIER 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.615 -179.289 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 274' ' ' ALA . . . . . 0.593 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.2 -39.63 71.66 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.868 179.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . 0.579 ' O ' ' N ' ' A' ' 279' ' ' ALA . 3.9 p30 -38.78 97.71 0.14 Allowed Pre-proline 0 N--CA 1.462 0.157 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.385 -179.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.7 -42.57 67.27 Favored 'Trans proline' 0 C--N 1.303 -1.865 0 C-N-CA 122.367 2.045 . . . . 0.0 112.506 -178.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 88.9 mt -64.43 -42.83 95.78 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.092 0.472 . . . . 0.0 111.225 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 91.9 mt -95.97 -1.08 49.8 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.954 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 279' ' ' ALA . . . . . 0.579 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.38 -34.83 77.47 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.683 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.22 20.16 0.11 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.982 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 0.482 ' H ' ' C ' ' A' ' 279' ' ' ALA . 13.6 mt -74.67 119.39 76.43 Favored Pre-proline 0 N--CA 1.444 -0.731 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.834 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -49.87 -40.1 48.74 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.623 2.215 . . . . 0.0 112.327 178.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.86 -50.59 63.48 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.034 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 73.5 t -61.45 -43.85 97.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.096 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -57.64 -41.15 80.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.098 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -91.01 0.05 57.63 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.118 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt 59.94 43.67 14.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.048 0.452 . . . . 0.0 110.772 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -95.01 41.06 1.1 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.382 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 53.8 t -119.33 135.74 58.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-O 121.133 0.492 . . . . 0.0 110.033 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -133.47 163.62 28.98 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 121.236 0.541 . . . . 0.0 110.569 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.8 155.58 32.28 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 121.097 0.475 . . . . 0.0 110.645 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 82.1 mt -94.44 -1.56 53.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.232 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.03 165.38 12.66 Favored Glycine 0 N--CA 1.463 0.489 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 6.7 m -86.64 -61.59 1.7 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.849 0.356 . . . . 0.0 111.092 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 295' ' ' GLU . . . . . 0.454 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.6 mm-40 -69.53 -4.82 20.57 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.729 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 26.8 p -76.55 32.61 0.13 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.632 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 297' ' ' PHE . . . . . 0.52 ' CD2' HG22 ' A' ' 70' ' ' THR . 67.1 t80 -60.4 -46.18 90.92 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.672 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . 0.616 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.2 mtt85 -80.32 136.93 36.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.657 -179.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.49 ' H ' HG11 ' A' ' 51' ' ' VAL . 0.9 OUTLIER -114.61 116.71 29.18 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.994 0.426 . . . . 0.0 110.533 179.65 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . 0.624 ' H ' ' CB ' ' A' ' 303' ' ' SER . 48.7 p-10 -167.21 -174.59 2.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.616 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 80.4 t80 -48.13 -44.44 32.09 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.227 -179.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -65.51 -41.53 93.07 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.034 0.445 . . . . 0.0 110.662 178.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . 0.624 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 53.8 p -55.29 -36.29 65.99 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.952 -179.087 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . 0.573 ' HB2' ' SD ' ' A' ' 215' ' ' MET . . . -57.07 -52.09 66.66 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 91.7 mtp -55.96 -44.32 78.35 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -66.05 -42.87 88.96 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.172 0.51 . . . . 0.0 110.199 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 303' ' ' SER . 55.7 t -63.91 -43.03 97.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.245 179.39 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 42.4 tp -60.04 -41.98 93.47 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.803 -179.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -62.18 -39.16 91.76 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.211 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 310' ' ' ARG . . . . . 0.45 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.7 ttt85 -63.68 -43.91 95.26 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.227 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 89.4 mt -63.1 -42.08 99.5 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.364 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -63.06 -33.77 76.14 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.076 179.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.38 -23.56 22.16 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.346 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.484 HD22 ' CE2' ' A' ' 315' ' ' PHE . 6.8 tt -62.35 -43.06 99.71 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 121.128 0.489 . . . . 0.0 110.56 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 315' ' ' PHE . . . . . 0.484 ' CE2' HD22 ' A' ' 314' ' ' LEU . 89.8 m-85 . . . . . 0 C--O 1.22 -0.47 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.327 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -99.67 136.29 39.82 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.04 0.448 . . . . 0.0 110.44 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.492 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -91.54 178.41 1.78 Allowed Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.584 -179.87 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.492 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.1 Cg_exo -61.72 147.66 94.82 Favored 'Trans proline' 0 C--N 1.3 -2.001 0 C-N-CA 122.882 2.388 . . . . 0.0 112.182 179.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.496 ' HE ' HD12 ' A' ' 39' ' ' LEU . 35.1 ptt180 -135.35 142.36 45.75 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.567 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -78.91 116.9 19.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.515 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.424 ' O ' HG23 ' A' ' 30' ' ' ILE . 9.6 tp -110.35 131.0 62.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.478 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.9 t -70.81 142.41 51.3 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.62 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.424 ' OD1' ' O ' ' A' ' 141' ' ' ILE . 24.7 t70 -140.56 177.58 7.92 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.508 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 77.9 p -73.81 -36.38 64.98 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.556 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 60.1 ttt85 -47.69 -95.22 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.409 -179.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.419 ' O ' ' OG1' ' A' ' 36' ' ' THR . . . -165.42 -25.51 0.02 OUTLIER Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.419 ' OG1' ' O ' ' A' ' 35' ' ' GLY . 61.2 m -169.05 106.82 0.42 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.844 0.354 . . . . 0.0 110.63 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.568 ' CD2' HD13 ' A' ' 140' ' ' LEU . 33.2 t60 -129.61 144.57 51.33 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.022 0.439 . . . . 0.0 110.199 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.629 HG22 ' N ' ' A' ' 39' ' ' LEU . 96.9 m -128.63 166.5 18.77 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.455 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.629 ' N ' HG22 ' A' ' 38' ' ' THR . 80.7 mt -121.15 127.52 51.63 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.506 179.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -63.8 -44.4 93.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.709 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 39.6 p -165.84 154.95 11.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.439 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.493 ' H ' ' CD ' ' A' ' 42' ' ' GLN . 14.3 mp0 -43.07 100.64 0.23 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.574 179.433 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -56.94 128.99 32.16 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 122.492 2.128 . . . . 0.0 112.201 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -83.33 -24.35 32.15 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.587 179.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.538 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.5 mtm-85 -121.16 134.48 55.22 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.113 0.482 . . . . 0.0 110.276 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.2 mt -130.09 133.57 64.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.74 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 47.9 t -125.26 130.94 72.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.203 179.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.574 ' OG ' HD12 ' A' ' 117' ' ' LEU . 4.1 m -154.57 166.34 33.63 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.607 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 72.2 p -124.6 8.83 8.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.429 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.72 125.73 33.43 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.587 -179.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.454 HG11 ' H ' ' A' ' 299' ' ' LEU . 87.8 t -65.68 -44.63 93.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.493 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 18.1 m -62.79 -44.16 96.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.616 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 53.0 tp -62.37 -41.63 98.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.53 -179.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.457 ' O ' HD13 ' A' ' 58' ' ' LEU . 76.3 m -57.67 -44.74 85.96 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.329 -179.332 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.4 -62.4 5.14 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.5 t -47.52 -35.96 9.65 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.681 0.277 . . . . 0.0 110.279 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.7 mt -61.77 -44.34 97.08 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.087 179.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.457 HD13 ' O ' ' A' ' 54' ' ' THR . 8.9 mp -65.39 -41.23 93.9 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.137 178.262 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.401 ' HB1' ' NE ' ' A' ' 169' ' ' ARG . . . -63.86 -41.25 97.81 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.78 -179.266 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.43 ' O ' HG23 ' A' ' 60' ' ' ILE . 7.9 tp -88.1 16.77 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.843 -179.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 56.4 84.43 0.09 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.727 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 178.89 57.7 0.07 OUTLIER Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.269 -0.423 . . . . 0.0 109.951 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.411 ' HB3' HE21 ' A' ' 85' ' ' GLN . 9.7 Cg_endo -51.09 153.83 8.51 Favored 'Trans proline' 0 C--N 1.296 -2.216 0 C-N-CA 123.035 2.49 . . . . 0.0 111.999 -177.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.428 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -109.33 146.15 15.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.366 -179.631 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.67 -45.44 97.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.15 -179.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.506 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -129.83 134.69 47.7 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.883 0.373 . . . . 0.0 110.522 -179.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.489 ' O ' ' N ' ' A' ' 98' ' ' LEU . 72.3 m -134.87 158.96 42.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.765 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.92 139.35 16.21 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.481 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.8 -162.67 0.08 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.876 0.369 . . . . 0.0 110.49 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.504 HG22 ' CD2' ' A' ' 297' ' ' PHE . 5.8 t -133.76 135.82 44.16 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.256 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.488 ' C ' ' O ' ' A' ' 70' ' ' THR . 1.0 OUTLIER 29.51 68.73 0.64 Allowed Pre-proline 0 N--CA 1.464 0.26 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.74 -179.487 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -61.43 144.79 98.37 Favored 'Trans proline' 0 C--N 1.301 -1.93 0 C-N-CA 122.697 2.265 . . . . 0.0 111.815 -178.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.528 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 45.3 p-10 -160.08 -32.3 0.06 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.592 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.537 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 99.0 m-20 -64.04 -39.51 94.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.358 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 73.2 ttt180 -60.18 -48.41 81.83 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.548 -179.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.426 ' O ' ' O ' ' A' ' 77' ' ' ALA . 94.9 t -59.82 -25.05 31.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.096 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.537 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -45.35 172.67 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.636 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.573 ' O ' ' N ' ' A' ' 80' ' ' GLN . 54.1 p30 -61.94 177.64 0.43 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.483 -179.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.563 ' C ' ' H ' ' A' ' 81' ' ' GLY . 34.4 p30 -46.28 85.58 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.957 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.573 ' N ' ' O ' ' A' ' 78' ' ' ASP . 42.9 tp60 -67.17 13.69 0.06 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.298 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.563 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 118.09 -21.98 9.94 Favored Glycine 0 CA--C 1.519 0.316 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -107.94 116.67 32.38 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.946 0.403 . . . . 0.0 110.469 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 75.4 mt -99.23 0.38 43.08 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.582 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -91.88 6.81 44.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.374 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.794 ' O ' HG22 ' A' ' 89' ' ' VAL . 88.0 mt-30 -100.03 -28.04 13.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.704 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 68.4 t-105 -63.43 -40.5 97.34 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.821 -179.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.552 ' O ' ' N ' ' A' ' 91' ' ' LYS . 67.9 m -77.75 -53.81 7.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.837 -179.276 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -48.25 -50.95 27.73 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.936 -179.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.794 HG22 ' O ' ' A' ' 85' ' ' GLN . 15.8 m -68.96 -40.44 81.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.992 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.495 ' N ' HG23 ' A' ' 89' ' ' VAL . . . -72.47 -22.6 61.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.624 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.552 ' N ' ' O ' ' A' ' 87' ' ' SER . 65.9 tttm -61.5 -45.95 92.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.429 -179.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.435 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.8 mm-40 -90.38 -94.48 0.12 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.251 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.624 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.9 mtt180 -143.34 59.58 1.4 Allowed 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.456 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.6 pttp 33.76 26.35 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.021 0.439 . . . . 0.0 110.388 -179.028 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.624 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.4 tt -48.09 123.07 5.78 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.912 -178.14 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.45 ' O ' HD23 ' A' ' 95' ' ' LEU . 98.9 mm-40 -83.21 -170.68 3.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.224 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.624 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 82.9 mtp180 -73.01 137.67 45.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.329 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.489 ' N ' ' O ' ' A' ' 67' ' ' SER . 88.9 mt -86.41 -165.87 1.39 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.782 -179.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.533 ' CD2' ' O ' ' A' ' 99' ' ' TYR . 47.7 p90 -168.29 119.7 0.81 Allowed 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.23 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.507 ' C ' ' O ' ' A' ' 99' ' ' TYR . 42.8 mm -29.29 121.43 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.935 -179.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 113.6 28.05 3.36 Favored Glycine 0 CA--C 1.521 0.417 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 -179.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.583 ' H ' ' CD ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -143.96 46.11 0.62 Allowed Pre-proline 0 C--N 1.324 -0.521 0 CA-C-O 121.044 0.45 . . . . 0.0 110.479 179.874 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.581 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 29.8 Cg_endo -62.47 143.83 93.82 Favored 'Trans proline' 0 C--N 1.298 -2.13 0 C-N-CA 122.728 2.286 . . . . 0.0 111.834 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.459 ' O ' HG23 ' A' ' 108' ' ' VAL . 26.2 t -173.14 120.68 0.36 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.435 179.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.4 -41.07 63.78 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.866 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -65.73 -39.95 91.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.744 -179.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.77 -39.56 94.55 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.681 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 104' ' ' SER . 71.3 t -67.78 -43.58 86.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.659 179.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.57 -39.28 93.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.491 -179.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.435 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.68 -23.9 63.49 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.508 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.562 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.3 mm-40 -91.32 5.11 50.54 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.658 -179.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.562 ' C ' ' O ' ' A' ' 111' ' ' GLN . 9.5 tpt 21.01 65.51 0.28 Allowed Pre-proline 0 N--CA 1.465 0.299 0 CA-C-O 121.042 0.449 . . . . 0.0 111.116 -179.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.46 ' HG2' HD11 ' A' ' 116' ' ' ILE . 61.9 Cg_endo -79.92 170.03 17.18 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 123.018 2.479 . . . . 0.0 111.617 -178.083 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.52 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 98.9 m-20 -112.52 -44.25 3.38 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.182 179.464 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 39.4 tp -120.18 121.35 38.56 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.142 179.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.46 HD11 ' HG2' ' A' ' 113' ' ' PRO . 96.6 mt -118.61 131.29 71.83 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.851 -179.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.574 HD12 ' OG ' ' A' ' 48' ' ' SER . 32.2 mt -105.95 132.01 52.56 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.222 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.479 HD12 HG23 ' A' ' 139' ' ' THR . 98.3 mt -117.26 136.08 55.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.641 -179.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 85.0 p -71.68 151.85 43.31 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.559 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.26 -50.01 75.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.633 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -149.35 153.77 37.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.542 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 168.57 -169.32 41.58 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -63.13 -35.41 92.05 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.447 ' O ' ' OD1' ' A' ' 124' ' ' ASP . 44.2 p-10 -88.81 120.12 29.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.859 0.362 . . . . 0.0 110.643 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.448 ' O ' HD12 ' A' ' 129' ' ' LEU . 40.6 t -63.35 144.62 56.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.467 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.518 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.92 -42.76 8.9 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.745 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.4 tp -62.79 -42.36 99.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.669 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.99 -10.59 54.74 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.483 -179.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.448 HD12 ' O ' ' A' ' 125' ' ' SER . 84.0 mt -115.73 -24.57 8.17 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.591 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . 0.518 ' N ' ' O ' ' A' ' 126' ' ' ALA . 74.3 t80 -50.77 -49.93 57.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.65 -179.109 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.3 p-10 -65.89 -41.91 90.92 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.827 0.346 . . . . 0.0 111.132 179.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.526 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 87.8 mt-30 -68.08 -36.72 80.29 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.804 -179.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.458 HD12 HD11 ' A' ' 118' ' ' ILE . 96.5 mt -80.09 -42.78 22.95 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.864 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.402 ' N ' ' OG1' ' A' ' 139' ' ' THR . 11.5 t -56.76 -45.47 82.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.452 -179.337 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 20.0 m -62.38 -45.93 90.91 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.568 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 93.2 mt -62.19 -43.84 98.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.463 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.596 ' HB1' ' HD2' ' A' ' 138' ' ' PRO . . . -170.04 163.04 6.53 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.598 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.596 ' HD2' ' HB1' ' A' ' 137' ' ' ALA . 77.5 Cg_exo -41.54 110.6 0.14 Allowed 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.629 2.219 . . . . 0.0 112.224 179.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.499 HG21 ' CD1' ' A' ' 130' ' ' TYR . 3.0 m -87.79 127.11 35.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.62 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.568 HD13 ' CD2' ' A' ' 37' ' ' HIS . 35.1 tp -119.24 139.42 51.91 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.36 179.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.424 ' O ' ' OD1' ' A' ' 32' ' ' ASP . 79.7 mt -105.41 120.27 55.87 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.197 0 CA-C-O 121.1 0.476 . . . . 0.0 110.942 -179.161 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.459 HD12 HD22 ' A' ' 117' ' ' LEU . 94.7 mt -136.43 132.6 49.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.562 179.358 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.548 HD21 ' CG ' ' A' ' 241' ' ' ASP . 54.3 t30 -64.55 148.99 49.62 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.91 0.386 . . . . 0.0 110.475 179.299 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.453 ' O ' ' OD2' ' A' ' 241' ' ' ASP . 87.1 t80 -82.72 122.85 28.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.84 -179.333 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.442 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 91.6 m-20 55.01 69.67 0.71 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.753 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 49.3 p-10 -124.4 0.25 8.27 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.579 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -151.53 117.31 5.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.723 -179.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 85.0 p -63.89 168.68 4.87 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.504 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.415 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.6 p-90 -51.21 -15.89 0.42 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.424 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.439 ' O ' HG23 ' A' ' 154' ' ' THR . 68.4 tp60 -70.9 -75.46 0.12 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.526 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.439 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.3 t -62.66 -38.58 90.88 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.318 179.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 51.1 tp -59.98 -45.88 91.28 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.421 -178.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.415 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 45.2 tp -62.64 -41.61 99.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.581 178.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.439 ' OG1' ' O ' ' A' ' 151' ' ' SER . 59.3 p -63.9 -34.87 78.94 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.298 -179.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.494 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.4 mm-40 -63.56 -42.01 98.38 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.359 179.265 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 91.8 mt -65.6 -38.57 89.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.11 0.481 . . . . 0.0 110.341 178.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.568 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.58 -31.97 79.66 Favored Glycine 0 CA--C 1.52 0.399 0 N-CA-C 110.818 -0.913 . . . . 0.0 110.818 -179.393 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.494 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.3 mt-10 -36.99 -25.32 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.853 0.359 . . . . 0.0 110.772 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.568 ' N ' ' O ' ' A' ' 157' ' ' GLY . 92.9 mt -59.67 149.37 6.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.423 179.268 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 77.6 p -69.18 137.52 53.34 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.854 -179.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 70.54 22.26 77.81 Favored Glycine 0 CA--C 1.519 0.285 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 179.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 62.4 m80 -124.38 -14.12 6.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.715 0.293 . . . . 0.0 110.442 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -66.83 -59.87 3.16 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.579 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -51.3 -49.7 60.76 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.243 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -60.1 -41.13 91.86 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.474 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.5 -47.6 84.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.58 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.55 -40.07 74.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.331 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -61.67 -50.58 71.93 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.603 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.401 ' NE ' ' HB1' ' A' ' 59' ' ' ALA . 59.9 ttt85 -65.32 -43.66 90.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.572 179.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 94.3 mt -64.71 -43.15 96.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.432 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.27 -51.49 69.15 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.382 -179.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.51 -43.64 96.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.601 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.658 ' CE2' HD11 ' A' ' 177' ' ' LEU . 55.9 t80 -62.94 -44.01 97.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.484 179.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -63.65 -39.72 95.05 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.403 -179.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -63.07 -42.83 99.74 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.537 179.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -60.46 -44.79 95.51 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.322 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.658 HD11 ' CE2' ' A' ' 173' ' ' PHE . 84.6 mt -64.65 -40.97 96.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.652 178.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.0 -62.5 1.59 Allowed 'General case' 0 C--O 1.237 0.438 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.357 -179.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.02 -47.27 83.55 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.51 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -52.65 -41.63 63.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.423 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -64.1 -33.2 75.23 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.361 179.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.418 ' HG2' ' O ' ' A' ' 182' ' ' GLU . 69.5 tt0 -91.21 8.43 35.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.357 0.599 . . . . 0.0 110.423 -178.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -104.42 -32.26 9.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.037 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.4 pt -128.02 147.56 32.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.755 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -139.65 131.05 26.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.428 179.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.592 HD22 ' N ' ' A' ' 186' ' ' LEU . 3.6 mm? -85.4 133.0 43.21 Favored Pre-proline 0 N--CA 1.452 -0.337 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.933 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -43.61 157.68 0.12 Allowed 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.689 2.259 . . . . 0.0 112.302 179.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 0.522 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.7 Cg_endo -62.81 114.93 2.63 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 122.805 2.337 . . . . 0.0 111.862 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . 0.522 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.7 mt-30 155.52 147.75 0.0 OUTLIER Pre-proline 0 N--CA 1.456 -0.145 0 O-C-N 123.83 0.706 . . . . 0.0 110.823 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -73.4 143.83 35.52 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.643 2.228 . . . . 0.0 112.266 177.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.495 HG23 ' OG ' ' A' ' 258' ' ' SER . 2.1 p -124.5 159.05 31.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.245 0.545 . . . . 0.0 110.305 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . 0.493 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 37.9 p -143.47 165.03 28.68 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.922 -179.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . 0.444 ' HA ' ' H ' ' A' ' 260' ' ' PHE . . . -135.36 128.73 32.2 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 121.159 0.504 . . . . 0.0 110.33 179.341 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.515 HD11 HD23 ' A' ' 259' ' ' LEU . 47.5 pt -146.73 148.95 16.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.993 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . 0.739 HG13 ' CD1' ' A' ' 262' ' ' PHE . 76.2 t -117.35 123.02 71.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.173 0.511 . . . . 0.0 110.079 178.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -134.22 106.46 7.16 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.371 179.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 95.9 m -130.48 130.71 44.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.763 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.404 ' O ' ' N ' ' A' ' 201' ' ' HIS . . . -82.95 -36.79 24.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.285 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.31 -67.07 0.26 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.348 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.31 -9.66 58.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.357 179.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . 0.404 ' N ' ' O ' ' A' ' 198' ' ' ALA . 60.2 t-80 60.72 58.19 2.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.694 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 41.1 p -167.43 153.61 7.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.569 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.27 144.18 24.51 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.953 0.406 . . . . 0.0 110.509 179.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -135.29 138.25 43.29 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.632 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 18.4 mt -105.98 125.12 50.62 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.0 0.428 . . . . 0.0 110.033 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' TRP . . . . . 0.558 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 74.1 m95 -81.84 167.2 19.26 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.596 -179.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . 0.469 HG22 ' C ' ' A' ' 206' ' ' TRP . 0.1 OUTLIER -157.18 171.15 7.83 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.64 -179.056 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -53.1 -37.2 79.13 Favored 'Trans proline' 0 C--N 1.302 -1.907 0 C-N-CA 122.73 2.286 . . . . 0.0 112.377 179.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -70.96 -34.98 71.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.657 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 22.1 m -61.03 150.74 32.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.595 -179.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.46 -36.89 81.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.509 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . 0.558 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 54.8 tt0 -64.72 -40.29 95.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.625 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.78 -43.35 91.91 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -62.8 -44.37 96.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.807 0.337 . . . . 0.0 110.319 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . 0.551 ' SD ' ' HB2' ' A' ' 304' ' ' ALA . 65.1 ttp -59.08 -48.27 82.2 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.233 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 87.6 mt -60.01 -41.36 91.96 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 179.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . 0.45 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 40.4 tp10 -57.84 -38.13 75.1 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.205 179.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -65.45 -38.23 89.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.633 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 95.1 mt -64.15 -42.95 96.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.578 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.74 45.39 0.08 OUTLIER Glycine 0 CA--C 1.521 0.456 0 N-CA-C 110.991 -0.843 . . . . 0.0 110.991 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . 0.45 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 25.8 m-85 -128.21 155.63 44.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.972 0.415 . . . . 0.0 110.536 -179.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.482 ' O ' HG13 ' A' ' 191' ' ' VAL . 7.8 p -107.07 122.4 46.4 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.16 0.505 . . . . 0.0 110.231 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.479 HD22 ' C ' ' A' ' 222' ' ' THR . 4.3 mm? -101.78 132.94 47.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.924 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.76 160.36 14.42 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.527 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.72 115.08 29.63 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.35 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.494 ' N ' HD12 ' A' ' 226' ' ' LEU . 9.0 mp -53.1 156.42 3.7 Favored Pre-proline 0 N--CA 1.452 -0.345 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.726 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -59.62 145.2 98.75 Favored 'Trans proline' 0 C--N 1.302 -1.917 0 C-N-CA 122.771 2.314 . . . . 0.0 112.33 179.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.3 -3.15 59.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.498 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.19 -41.08 5.63 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.519 ' O ' ' N ' ' A' ' 233' ' ' SER . 67.7 mt -79.05 -17.75 54.69 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-O 121.051 0.453 . . . . 0.0 110.427 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . 0.4 ' C ' ' O ' ' A' ' 230' ' ' LEU . 55.4 t-20 -40.05 -49.7 2.55 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.78 -179.496 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -87.67 15.19 7.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.096 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.519 ' N ' ' O ' ' A' ' 230' ' ' LEU . 78.0 p -60.24 -35.17 74.86 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.744 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . 0.522 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.6 tt0 -119.64 -69.4 0.85 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.765 179.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.0 m -69.7 101.88 1.77 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.614 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -93.67 57.73 2.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.413 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -144.56 -122.56 1.59 Allowed Glycine 0 CA--C 1.521 0.451 0 N-CA-C 110.906 -0.877 . . . . 0.0 110.906 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -135.4 111.21 9.38 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.017 0.436 . . . . 0.0 110.406 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . 0.527 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.6 mtt180 -147.79 58.27 1.11 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.678 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -69.6 -32.2 70.8 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.515 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . 0.548 ' CG ' HD21 ' A' ' 143' ' ' ASN . 64.7 t0 -56.9 -47.33 80.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.362 -179.208 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 242' ' ' ILE . . . . . 0.433 ' O ' ' O ' ' A' ' 239' ' ' ARG . 17.8 tt -139.61 155.98 25.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.503 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.442 HG22 HD13 ' A' ' 245' ' ' LEU . 96.2 mt -106.01 106.47 20.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-O 120.973 0.416 . . . . 0.0 110.496 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . 0.6 ' O ' HD12 ' A' ' 245' ' ' LEU . 88.6 mt-30 -110.34 109.87 20.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.423 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.6 HD12 ' O ' ' A' ' 244' ' ' GLN . 9.4 mp -121.63 -168.16 1.64 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.65 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . 0.522 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.85 -16.32 0.05 OUTLIER Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . 0.674 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -61.31 156.26 34.59 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -63.35 21.87 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.92 0.39 . . . . 0.0 110.622 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . 0.674 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.8 m-20 -97.32 -6.29 34.64 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.539 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 91.6 mt -79.58 -22.09 44.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.757 179.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.62 -51.65 69.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.645 -179.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.0 -5.6 58.42 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.52 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -80.98 -74.46 1.14 Allowed Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 81.2 mt -69.8 125.8 27.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.846 0.355 . . . . 0.0 110.38 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -59.24 -39.55 83.14 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.251 -179.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 83.32 51.73 4.03 Favored Glycine 0 CA--C 1.521 0.467 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -95.45 -15.57 22.87 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.715 0.293 . . . . 0.0 110.622 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . 0.495 ' OG ' HG23 ' A' ' 191' ' ' VAL . 3.5 t 174.59 89.0 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.07 0.462 . . . . 0.0 110.244 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.861 ' N ' HD12 ' A' ' 259' ' ' LEU . 1.0 OUTLIER -94.21 124.04 37.98 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.127 0.489 . . . . 0.0 111.038 -178.92 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 260' ' ' PHE . . . . . 0.444 ' H ' ' HA ' ' A' ' 193' ' ' ALA . 16.0 m-30 -93.31 146.6 23.6 Favored 'General case' 0 CA--C 1.506 -0.722 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.481 179.149 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 85.4 mt -122.24 149.63 43.41 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.565 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.739 ' CD1' HG13 ' A' ' 195' ' ' VAL . 2.6 p90 -77.56 -139.01 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.521 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . 0.665 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -51.29 77.44 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.997 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . 0.635 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.31 104.77 0.19 Allowed Glycine 0 CA--C 1.528 0.876 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 265' ' ' ASP . . . . . 0.6 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.7 m-20 -80.4 -177.77 6.33 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.701 0.286 . . . . 0.0 110.8 -179.363 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -40.25 -17.84 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.566 179.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . 0.6 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.45 -51.7 40.7 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.635 179.449 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -63.52 -46.59 85.36 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.279 179.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . 0.568 ' HB1' ' OH ' ' A' ' 273' ' ' TYR . . . -61.78 -34.99 76.86 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.302 0.572 . . . . 0.0 109.95 179.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -63.31 -34.05 76.86 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.116 179.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.69 -43.41 13.42 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.928 -179.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 272' ' ' ILE . . . . . 0.589 ' C ' ' H ' ' A' ' 274' ' ' ALA . 4.9 tt -51.42 -33.58 14.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.667 -178.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 273' ' ' TYR . . . . . 0.568 ' OH ' ' HB1' ' A' ' 269' ' ' ALA . 17.3 m-85 -54.65 -1.61 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.582 -179.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 274' ' ' ALA . . . . . 0.589 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.74 -39.7 69.87 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.811 179.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . 0.582 ' O ' ' N ' ' A' ' 279' ' ' ALA . 3.1 p30 -39.18 98.34 0.16 Allowed Pre-proline 0 N--CA 1.461 0.108 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.457 -179.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -54.59 -42.83 64.61 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 C-N-CA 122.519 2.146 . . . . 0.0 112.438 -178.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 89.1 mt -64.57 -42.88 95.37 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.024 -179.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 90.9 mt -95.77 -1.47 49.68 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.809 -179.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 279' ' ' ALA . . . . . 0.582 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.24 -34.89 77.37 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.703 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.46 20.35 0.12 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.876 -179.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 0.486 HD23 ' HA ' ' A' ' 281' ' ' LEU . 13.9 mt -75.04 119.38 76.62 Favored Pre-proline 0 N--CA 1.45 -0.462 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.719 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -49.75 -40.36 47.53 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.719 2.279 . . . . 0.0 112.224 178.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.32 -50.83 61.5 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.263 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 78.6 t -61.28 -43.91 97.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.255 179.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -57.65 -41.21 80.98 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.261 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -91.0 0.13 57.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.313 179.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt 59.73 43.64 15.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.754 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -94.95 41.05 1.09 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.375 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 53.7 t -119.03 135.77 58.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 121.012 0.434 . . . . 0.0 110.203 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -133.07 163.35 29.45 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.638 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.8 155.34 32.74 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.657 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 79.5 mt -94.19 -1.66 53.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.312 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.37 165.79 12.73 Favored Glycine 0 CA--C 1.521 0.462 0 N-CA-C 110.658 -0.977 . . . . 0.0 110.658 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 7.1 m -87.76 -62.39 1.51 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.865 0.365 . . . . 0.0 110.91 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 295' ' ' GLU . . . . . 0.452 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.5 mm-40 -68.86 -4.24 15.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.657 -179.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 24.9 p -76.64 32.12 0.13 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.608 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 297' ' ' PHE . . . . . 0.504 ' CD2' HG22 ' A' ' 70' ' ' THR . 70.4 t80 -60.42 -46.3 90.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.567 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . 0.624 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.2 mtt85 -80.74 134.42 35.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.594 -179.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.454 ' H ' HG11 ' A' ' 51' ' ' VAL . 18.3 tp -113.13 116.43 29.84 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.325 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . 0.628 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.1 p-10 -164.7 -177.29 4.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.638 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 81.1 t80 -46.16 -43.15 14.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.406 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -67.62 -40.13 84.68 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.991 0.424 . . . . 0.0 110.692 179.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . 0.628 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 59.6 p -55.74 -36.73 67.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.26 -179.239 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . 0.551 ' HB2' ' SD ' ' A' ' 215' ' ' MET . . . -56.95 -52.27 65.9 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 179.389 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 92.7 mtp -54.92 -44.24 74.04 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -66.0 -42.86 89.18 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.066 0.46 . . . . 0.0 110.351 178.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 303' ' ' SER . 55.6 t -64.24 -42.81 96.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.286 179.391 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 42.9 tp -59.63 -41.94 91.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.052 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -62.57 -38.9 91.89 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.295 179.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 310' ' ' ARG . . . . . 0.448 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.7 ttt85 -63.64 -44.05 95.0 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.291 179.482 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 89.6 mt -63.14 -42.03 99.39 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.415 179.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.4 ttmt -63.09 -33.09 74.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.262 179.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -90.02 -23.31 21.52 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.402 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.481 HD22 ' CE2' ' A' ' 315' ' ' PHE . 6.8 tt -62.24 -43.17 99.45 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.013 0.435 . . . . 0.0 110.603 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 315' ' ' PHE . . . . . 0.481 ' CE2' HD22 ' A' ' 314' ' ' LEU . 91.0 m-85 . . . . . 0 C--O 1.22 -0.481 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.394 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -99.09 135.75 40.04 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.5 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.491 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -92.11 178.45 1.7 Allowed Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.571 -179.882 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.491 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.7 Cg_exo -61.78 147.38 95.39 Favored 'Trans proline' 0 C--N 1.301 -1.929 0 C-N-CA 122.847 2.365 . . . . 0.0 112.161 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.456 ' HE ' HD12 ' A' ' 39' ' ' LEU . 35.2 ptt180 -135.53 141.94 45.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.628 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -79.64 116.31 19.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.498 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.452 ' O ' HG23 ' A' ' 30' ' ' ILE . 9.4 tp -110.69 130.1 64.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.553 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 8.8 t -70.35 141.37 52.26 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.646 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.477 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.3 t0 -139.0 179.42 6.51 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.516 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.477 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 77.9 p -74.26 -36.87 63.87 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.582 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 61.0 ttt85 -46.18 -94.65 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.454 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -167.3 -26.4 0.02 OUTLIER Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.966 -0.854 . . . . 0.0 110.966 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 63.2 m -169.21 104.4 0.38 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.789 0.328 . . . . 0.0 110.639 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.681 ' CD2' HD13 ' A' ' 140' ' ' LEU . 74.5 t60 -128.38 148.85 50.72 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.012 0.434 . . . . 0.0 110.291 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.629 HG22 ' N ' ' A' ' 39' ' ' LEU . 98.1 m -131.1 166.25 21.49 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.474 -179.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.629 ' N ' HG22 ' A' ' 38' ' ' THR . 80.8 mt -121.06 127.45 51.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.53 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -64.94 -44.65 88.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.667 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 42.2 p -166.07 154.96 11.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.507 179.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.52 ' H ' ' CD ' ' A' ' 42' ' ' GLN . 15.2 mp0 -43.71 100.94 0.24 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.558 179.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.44 128.99 31.63 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 C-N-CA 122.546 2.164 . . . . 0.0 112.191 -179.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -83.73 -24.56 31.13 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.611 179.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.533 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.6 mtm-85 -122.2 134.43 54.71 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 121.15 0.5 . . . . 0.0 110.335 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.1 mt -130.9 134.08 62.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.639 -179.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 46.0 t -124.61 130.36 73.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.169 179.069 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.644 ' OG ' HD12 ' A' ' 117' ' ' LEU . 2.0 m -154.6 167.19 30.96 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.55 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 62.6 p -125.04 9.04 8.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.468 179.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.47 125.38 32.99 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.591 -179.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.443 HG11 ' H ' ' A' ' 299' ' ' LEU . 96.0 t -65.59 -44.6 93.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.548 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.1 m -62.45 -44.35 96.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.664 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 47.8 tp -62.4 -41.37 98.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.573 -179.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.435 ' O ' HD13 ' A' ' 58' ' ' LEU . 75.8 m -57.57 -44.74 85.54 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.329 -179.397 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -63.92 -63.03 4.7 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.5 t -47.24 -35.94 8.31 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.768 0.318 . . . . 0.0 110.411 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.5 mt -61.8 -44.63 96.49 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.041 179.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.435 HD13 ' O ' ' A' ' 54' ' ' THR . 8.7 mp -65.9 -41.08 91.94 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.042 178.365 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.55 -41.3 98.45 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.688 -179.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.427 ' O ' HG23 ' A' ' 60' ' ' ILE . 8.1 tp -88.43 17.09 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.801 -179.493 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 56.28 84.51 0.08 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.731 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.52 59.01 0.09 OUTLIER Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.333 -0.394 . . . . 0.0 109.974 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.408 ' HB3' HE21 ' A' ' 85' ' ' GLN . 9.6 Cg_endo -52.22 152.75 14.32 Favored 'Trans proline' 0 C--N 1.298 -2.126 0 C-N-CA 122.99 2.46 . . . . 0.0 112.011 -177.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.433 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.2 OUTLIER -108.94 145.63 15.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.379 -179.628 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.57 -45.5 97.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.038 -179.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.5 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -129.77 134.11 47.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.5 -179.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.499 ' O ' ' N ' ' A' ' 98' ' ' LEU . 74.6 m -134.61 158.76 43.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.782 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.79 139.1 16.11 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.488 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.73 -162.79 0.08 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.826 0.346 . . . . 0.0 110.506 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.541 HG22 ' CD2' ' A' ' 297' ' ' PHE . 14.7 t -133.54 134.42 43.38 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.435 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.49 ' C ' ' O ' ' A' ' 70' ' ' THR . 0.6 OUTLIER 29.68 69.51 0.62 Allowed Pre-proline 0 N--CA 1.464 0.247 0 CA-C-O 120.94 0.4 . . . . 0.0 110.685 -179.711 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -61.99 146.08 96.45 Favored 'Trans proline' 0 C--N 1.301 -1.94 0 C-N-CA 122.767 2.311 . . . . 0.0 111.817 -178.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.534 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 45.0 p-10 -160.14 -31.67 0.06 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.658 179.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.538 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 99.2 m-20 -64.71 -39.27 93.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.392 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -60.25 -48.83 80.08 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.494 -179.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.423 ' O ' ' O ' ' A' ' 77' ' ' ALA . 94.6 t -59.55 -25.14 30.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.185 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.538 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -45.67 172.87 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.59 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.579 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.7 p30 -62.07 177.93 0.42 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.51 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.559 ' C ' ' H ' ' A' ' 81' ' ' GLY . 35.4 p30 -45.48 85.42 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.887 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.579 ' N ' ' O ' ' A' ' 78' ' ' ASP . 41.8 tp60 -67.32 13.26 0.07 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.351 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.559 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 118.61 -22.35 9.4 Favored Glycine 0 CA--C 1.52 0.389 0 N-CA-C 110.914 -0.875 . . . . 0.0 110.914 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -107.89 116.22 31.55 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.862 0.363 . . . . 0.0 110.487 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 73.5 mt -98.42 -0.15 44.15 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.577 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -92.31 7.44 42.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.441 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.797 ' O ' HG22 ' A' ' 89' ' ' VAL . 88.1 mt-30 -100.31 -28.44 12.97 Favored 'General case' 0 C--O 1.224 -0.266 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.613 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 68.8 t-105 -63.31 -40.2 96.67 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.736 -179.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.557 ' O ' ' N ' ' A' ' 91' ' ' LYS . 62.3 m -78.1 -54.01 6.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.791 -179.203 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -48.02 -50.76 26.66 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.861 -179.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.797 HG22 ' O ' ' A' ' 85' ' ' GLN . 16.0 m -69.15 -40.33 80.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.914 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.494 ' N ' HG23 ' A' ' 89' ' ' VAL . . . -72.86 -22.37 60.79 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.612 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.557 ' N ' ' O ' ' A' ' 87' ' ' SER . 65.9 tttm -62.28 -45.41 93.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.372 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.44 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.9 mm-40 -90.38 -94.78 0.12 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.265 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.632 ' O ' ' N ' ' A' ' 95' ' ' LEU . 96.0 mtt180 -143.04 58.6 1.41 Allowed 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.093 179.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.457 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.7 pttp 33.68 26.09 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 121.062 0.458 . . . . 0.0 110.487 -178.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.632 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.3 tt -47.95 123.04 5.62 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.834 -178.13 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.455 ' O ' HD23 ' A' ' 95' ' ' LEU . 99.0 mm-40 -83.2 -170.45 3.05 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.366 179.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.606 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 81.5 mtp180 -73.91 137.07 43.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.342 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.499 ' N ' ' O ' ' A' ' 67' ' ' SER . 90.6 mt -86.02 -165.63 1.3 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.784 -179.601 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.539 ' CD2' ' O ' ' A' ' 99' ' ' TYR . 48.6 p90 -169.02 119.81 0.73 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.27 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.515 ' C ' ' O ' ' A' ' 99' ' ' TYR . 42.5 mm -28.77 121.24 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.896 -179.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 114.2 27.24 3.48 Favored Glycine 0 CA--C 1.521 0.462 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 -179.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.579 ' H ' ' CD ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -144.39 46.39 0.62 Allowed Pre-proline 0 C--N 1.324 -0.508 0 CA-C-O 121.097 0.475 . . . . 0.0 110.482 179.966 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 28.8 Cg_endo -62.14 143.89 95.16 Favored 'Trans proline' 0 C--N 1.298 -2.096 0 C-N-CA 122.728 2.285 . . . . 0.0 111.894 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.455 ' O ' HG23 ' A' ' 108' ' ' VAL . 25.5 t -173.27 120.34 0.34 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.443 179.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -74.13 -40.16 62.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.903 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.42 -39.89 89.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.685 -179.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.22 -39.96 95.05 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.645 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 104' ' ' SER . 70.2 t -67.85 -43.57 86.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.674 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.99 -38.94 93.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.479 -179.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.44 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.46 -23.14 62.47 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.541 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.552 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.3 mm-40 -90.99 5.68 47.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.628 -179.487 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.552 ' C ' ' O ' ' A' ' 111' ' ' GLN . 10.0 tpt 22.77 65.1 0.35 Allowed Pre-proline 0 N--CA 1.465 0.296 0 CA-C-O 120.985 0.422 . . . . 0.0 110.978 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -79.33 167.69 21.04 Favored 'Trans proline' 0 C--N 1.307 -1.605 0 C-N-CA 123.008 2.472 . . . . 0.0 111.694 -178.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.525 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 99.0 m-20 -110.01 -41.89 4.35 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.286 179.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.0 tp -121.54 120.05 33.73 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.306 179.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 82.7 mt -112.66 128.81 69.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.829 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.644 HD12 ' OG ' ' A' ' 48' ' ' SER . 26.9 mt -108.42 132.41 53.8 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.442 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.491 HD12 HG23 ' A' ' 139' ' ' THR . 98.9 mt -120.1 138.52 50.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.587 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 85.6 p -72.42 154.14 41.04 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.608 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.2 -50.36 73.98 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.627 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.0 t -149.75 154.21 38.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.53 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 170.47 -170.71 43.24 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.91 -33.95 88.52 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.454 ' O ' ' OD1' ' A' ' 124' ' ' ASP . 44.6 p-10 -87.43 120.08 28.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.835 0.35 . . . . 0.0 110.655 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.44 ' O ' HD12 ' A' ' 129' ' ' LEU . 38.3 t -62.95 143.93 57.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.475 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.521 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.14 -43.27 8.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.785 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 56.4 tp -62.99 -42.21 99.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.681 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.81 -11.82 59.34 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.489 -179.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.44 HD12 ' O ' ' A' ' 125' ' ' SER . 83.6 mt -114.73 -24.61 8.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.528 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . 0.521 ' N ' ' O ' ' A' ' 126' ' ' ALA . 78.2 t80 -50.03 -50.17 48.49 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.613 -179.039 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 37.7 p-10 -66.07 -42.9 88.79 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.928 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.522 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 88.4 mt-30 -67.08 -37.49 84.08 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.733 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.44 HD12 HD11 ' A' ' 118' ' ' ILE . 95.9 mt -80.63 -41.42 23.89 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.768 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.4 t -56.35 -44.96 80.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.366 -179.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.7 m -61.87 -45.19 94.84 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.539 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 94.6 mt -61.92 -43.71 97.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.392 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.66 ' HB1' ' HD2' ' A' ' 138' ' ' PRO . . . -169.79 167.98 4.82 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.674 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.66 ' HD2' ' HB1' ' A' ' 137' ' ' ALA . 51.9 Cg_exo -49.14 112.68 0.7 Allowed 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.52 2.146 . . . . 0.0 112.349 179.244 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.491 HG23 HD12 ' A' ' 118' ' ' ILE . 24.1 m -83.7 127.29 33.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.612 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.681 HD13 ' CD2' ' A' ' 37' ' ' HIS . 34.2 tp -118.01 135.49 54.13 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.318 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.438 ' O ' ' OD2' ' A' ' 32' ' ' ASP . 82.5 mt -99.85 119.06 47.38 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 CA-C-O 121.016 0.436 . . . . 0.0 110.795 -178.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.433 HD12 HD22 ' A' ' 117' ' ' LEU . 97.8 mt -135.1 132.68 53.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.54 179.28 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.538 HD21 ' CG ' ' A' ' 241' ' ' ASP . 61.1 t30 -67.26 153.44 43.67 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.475 179.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.512 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 88.8 t80 -87.67 121.83 30.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.697 -179.46 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.512 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 99.1 m-20 55.27 69.55 0.72 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.588 179.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 34.5 p-10 -125.02 -0.06 7.88 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.595 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -151.08 115.72 5.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.623 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 83.2 p -62.91 167.99 4.29 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.574 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.416 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.4 p-90 -51.65 -15.93 0.55 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.406 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.441 ' O ' HG23 ' A' ' 154' ' ' THR . 68.0 tp60 -70.47 -75.59 0.12 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.884 0.373 . . . . 0.0 110.615 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.441 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.1 t -62.87 -38.55 91.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.399 179.389 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 53.7 tp -59.73 -46.05 90.31 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.537 -178.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.416 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 47.9 tp -62.69 -41.47 99.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.656 179.017 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.441 ' OG1' ' O ' ' A' ' 151' ' ' SER . 60.8 p -64.13 -35.18 79.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.328 -179.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.442 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.7 mm-40 -63.98 -42.72 97.13 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.54 179.285 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 92.2 mt -65.66 -38.49 89.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.468 178.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.579 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.59 -31.99 79.76 Favored Glycine 0 CA--C 1.52 0.371 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 -179.369 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.442 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.1 mt-10 -35.14 -27.65 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.875 0.369 . . . . 0.0 110.806 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.579 ' N ' ' O ' ' A' ' 157' ' ' GLY . 93.9 mt -55.28 150.43 2.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.46 179.13 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 70.5 p -70.39 137.15 50.23 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.781 -179.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 72.01 19.33 78.31 Favored Glycine 0 CA--C 1.519 0.337 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 179.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 57.3 m80 -120.56 -15.0 8.57 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.71 0.29 . . . . 0.0 110.494 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -65.24 -60.58 2.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.572 -179.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -51.15 -50.28 59.24 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.259 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -60.11 -41.36 92.43 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.54 179.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.29 -47.59 85.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.485 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.41 -40.41 74.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.401 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -61.68 -50.39 72.67 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.605 179.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -65.17 -43.72 90.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.577 179.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 94.6 mt -64.89 -43.18 96.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.497 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.14 -51.63 68.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.367 -179.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.08 -43.84 97.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.644 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.652 ' CE2' HD11 ' A' ' 177' ' ' LEU . 56.2 t80 -63.27 -43.87 96.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.452 179.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -63.67 -39.88 95.44 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.501 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -63.25 -42.77 99.23 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.545 179.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -60.32 -44.77 95.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.422 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.652 HD11 ' CE2' ' A' ' 173' ' ' PHE . 83.5 mt -64.93 -40.78 95.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.711 178.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -51.86 -62.67 1.49 Allowed 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.391 -179.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.37 -47.35 84.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.461 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -52.65 -41.98 64.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.474 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -63.91 -33.48 75.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.352 179.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.42 ' HG2' ' O ' ' A' ' 182' ' ' GLU . 69.2 tt0 -90.7 8.92 32.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.319 0.581 . . . . 0.0 110.393 -178.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -105.29 -31.92 8.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.85 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.5 pt -128.16 147.47 32.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.649 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -139.91 131.15 26.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.489 179.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.593 HD22 ' N ' ' A' ' 186' ' ' LEU . 3.6 mm? -85.68 132.67 43.68 Favored Pre-proline 0 N--CA 1.453 -0.325 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.922 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -43.6 157.57 0.12 Allowed 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.729 2.286 . . . . 0.0 112.389 179.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 0.52 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.9 Cg_endo -62.9 114.99 2.66 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 C-N-CA 122.83 2.353 . . . . 0.0 111.908 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . 0.52 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.7 mt-30 156.0 147.28 0.0 OUTLIER Pre-proline 0 C--O 1.231 0.099 0 O-C-N 123.794 0.684 . . . . 0.0 110.692 -179.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.37 143.37 34.87 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.657 2.238 . . . . 0.0 112.272 177.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.498 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.1 p -124.52 159.34 30.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.164 0.507 . . . . 0.0 110.372 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . 0.498 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 36.2 p -143.65 165.16 28.41 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.85 -179.35 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . 0.441 ' HA ' ' H ' ' A' ' 260' ' ' PHE . . . -135.28 128.72 32.36 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 121.167 0.508 . . . . 0.0 110.407 179.205 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.509 HD11 HD23 ' A' ' 259' ' ' LEU . 47.7 pt -146.45 148.43 17.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.961 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . 0.751 HG13 ' CD1' ' A' ' 262' ' ' PHE . 71.7 t -117.19 122.84 70.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.082 0.468 . . . . 0.0 110.218 178.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -134.08 107.31 7.67 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.377 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 95.1 m -131.01 130.44 43.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.742 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -82.78 -36.91 25.23 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.399 179.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.07 -67.36 0.24 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.433 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.25 -9.91 59.08 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.47 179.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 60.0 t-80 60.95 58.53 2.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.681 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 37.1 p -167.29 153.5 7.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.609 179.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.47 144.43 24.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.942 0.401 . . . . 0.0 110.47 179.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -135.33 138.08 43.05 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.608 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 19.0 mt -105.85 125.3 50.83 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.933 0.397 . . . . 0.0 110.194 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' TRP . . . . . 0.558 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 75.9 m95 -82.3 167.3 18.72 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.515 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . 0.466 HG22 ' C ' ' A' ' 206' ' ' TRP . 0.1 OUTLIER -156.94 170.94 8.11 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.588 -179.024 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -53.23 -36.92 79.64 Favored 'Trans proline' 0 C--N 1.302 -1.892 0 C-N-CA 122.77 2.313 . . . . 0.0 112.378 178.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -71.13 -34.51 71.1 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.56 -179.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 22.3 m -61.64 150.61 35.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.624 -179.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.39 -36.94 81.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.456 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . 0.558 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 54.5 tt0 -64.74 -40.05 94.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.567 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.94 -43.37 91.51 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.734 -0.947 . . . . 0.0 110.734 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -63.04 -43.93 97.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.839 0.352 . . . . 0.0 110.385 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . 0.529 ' SD ' ' HB2' ' A' ' 304' ' ' ALA . 65.1 ttp -59.02 -48.63 80.91 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.297 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 89.9 mt -59.65 -41.32 90.27 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 121.01 0.434 . . . . 0.0 110.01 179.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . 0.456 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 40.3 tp10 -57.37 -38.14 73.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.317 179.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -65.52 -37.78 87.75 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.605 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 95.5 mt -64.31 -42.76 96.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.725 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.58 44.53 0.08 OUTLIER Glycine 0 CA--C 1.521 0.466 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . 0.456 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 25.8 m-85 -127.49 155.33 43.92 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.944 0.402 . . . . 0.0 110.524 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.487 ' O ' HG13 ' A' ' 191' ' ' VAL . 6.3 p -106.97 121.98 45.54 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.152 0.501 . . . . 0.0 110.242 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.468 HD22 ' C ' ' A' ' 222' ' ' THR . 4.3 mm? -100.9 133.32 45.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.989 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.98 158.92 15.19 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.506 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.05 115.29 30.03 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.516 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.492 ' N ' HD12 ' A' ' 226' ' ' LEU . 9.0 mp -53.56 156.29 4.63 Favored Pre-proline 0 N--CA 1.452 -0.35 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.71 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -59.69 145.31 98.49 Favored 'Trans proline' 0 C--N 1.302 -1.871 0 C-N-CA 122.795 2.33 . . . . 0.0 112.295 179.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.42 -2.91 58.95 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.556 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.31 -40.93 5.63 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.537 ' O ' ' N ' ' A' ' 233' ' ' SER . 84.3 mt -79.2 -16.88 55.87 Favored 'General case' 0 C--O 1.224 -0.267 0 CA-C-O 120.983 0.421 . . . . 0.0 110.449 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . 0.404 ' C ' ' O ' ' A' ' 230' ' ' LEU . 55.1 t-20 -39.5 -49.63 2.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.679 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -88.58 15.58 7.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.009 -179.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.537 ' N ' ' O ' ' A' ' 230' ' ' LEU . 77.8 p -60.46 -35.47 75.95 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.653 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . 0.526 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.6 tt0 -118.46 -69.49 0.85 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.706 179.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.2 m -69.91 103.71 2.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.592 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -94.73 57.41 2.17 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.439 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -144.85 -122.57 1.57 Allowed Glycine 0 CA--C 1.521 0.441 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -134.46 111.89 10.49 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.002 0.43 . . . . 0.0 110.384 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . 0.515 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.4 mtt180 -148.33 57.75 1.07 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.678 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -69.97 -31.69 69.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.494 179.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . 0.538 ' CG ' HD21 ' A' ' 143' ' ' ASN . 65.6 t0 -56.54 -47.13 80.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.365 -179.205 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 242' ' ' ILE . . . . . 0.437 ' O ' ' O ' ' A' ' 239' ' ' ARG . 17.3 tt -140.49 157.49 24.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.493 179.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.441 HG22 HD13 ' A' ' 245' ' ' LEU . 96.0 mt -105.92 105.88 19.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.575 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . 0.602 ' O ' HD12 ' A' ' 245' ' ' LEU . 88.0 mt-30 -110.06 109.98 20.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.416 179.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.602 HD12 ' O ' ' A' ' 244' ' ' GLN . 9.4 mp -121.95 -168.13 1.66 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.66 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . 0.526 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.27 -16.79 0.05 OUTLIER Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . 0.67 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -60.43 157.01 29.67 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -63.79 21.51 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.86 0.362 . . . . 0.0 110.553 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . 0.67 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.7 m-20 -97.29 -6.1 35.18 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.497 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 92.6 mt -79.81 -21.52 44.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.784 179.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.61 -51.53 69.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.563 -179.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.31 -5.34 58.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.532 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.22 -74.34 1.15 Allowed Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.934 -0.866 . . . . 0.0 110.934 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 80.1 mt -69.95 125.75 27.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.809 0.338 . . . . 0.0 110.445 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -59.09 -39.52 82.44 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.281 -179.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 82.52 51.97 4.13 Favored Glycine 0 CA--C 1.521 0.442 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -96.21 -14.81 22.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.717 0.294 . . . . 0.0 110.665 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . 0.494 ' OG ' HG23 ' A' ' 191' ' ' VAL . 3.5 t 174.71 88.27 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.047 0.451 . . . . 0.0 110.321 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.86 ' N ' HD12 ' A' ' 259' ' ' LEU . 1.0 OUTLIER -93.97 123.7 37.51 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.014 0.435 . . . . 0.0 110.992 -178.819 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 260' ' ' PHE . . . . . 0.441 ' H ' ' HA ' ' A' ' 193' ' ' ALA . 15.8 m-30 -92.74 146.35 23.72 Favored 'General case' 0 CA--C 1.508 -0.672 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.532 179.051 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 86.0 mt -122.36 149.56 43.61 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.6 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.751 ' CD1' HG13 ' A' ' 195' ' ' VAL . 2.7 p90 -77.23 -138.34 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.632 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . 0.661 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -52.27 77.29 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.003 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . 0.625 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -178.93 104.54 0.19 Allowed Glycine 0 CA--C 1.527 0.829 0 N-CA-C 110.644 -0.982 . . . . 0.0 110.644 179.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 265' ' ' ASP . . . . . 0.6 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.9 m-20 -79.98 -178.04 6.29 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.648 0.261 . . . . 0.0 110.781 -179.407 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -40.48 -17.52 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.521 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . 0.6 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.47 -51.66 41.01 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.682 179.284 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -63.64 -46.81 83.99 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.198 179.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . 0.562 ' HB1' ' OH ' ' A' ' 273' ' ' TYR . . . -61.57 -34.87 76.34 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.291 0.567 . . . . 0.0 110.058 179.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -63.17 -34.11 76.92 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.273 179.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.69 -43.68 13.2 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.793 -179.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 272' ' ' ILE . . . . . 0.589 ' C ' ' H ' ' A' ' 274' ' ' ALA . 4.9 tt -51.37 -33.44 14.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.579 -178.441 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 273' ' ' TYR . . . . . 0.562 ' OH ' ' HB1' ' A' ' 269' ' ' ALA . 17.5 m-85 -54.76 -1.41 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.567 -179.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 274' ' ' ALA . . . . . 0.589 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.71 -39.74 69.95 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.755 179.448 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . 0.582 ' O ' ' N ' ' A' ' 279' ' ' ALA . 2.9 p30 -39.35 98.42 0.17 Allowed Pre-proline 0 C--N 1.335 -0.055 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.458 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -54.56 -43.01 62.94 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 C-N-CA 122.621 2.214 . . . . 0.0 112.344 -178.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 88.5 mt -64.48 -42.98 95.55 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.871 -179.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 91.0 mt -95.67 -1.68 49.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.839 -179.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 279' ' ' ALA . . . . . 0.582 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.36 -34.65 77.09 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.626 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.8 m80 -74.78 20.41 0.13 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.785 -178.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 0.483 HD23 ' HA ' ' A' ' 281' ' ' LEU . 14.0 mt -75.25 119.45 77.02 Favored Pre-proline 0 N--CA 1.449 -0.492 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.783 179.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -49.47 -40.18 45.04 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.681 2.254 . . . . 0.0 112.33 178.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -51.97 -51.06 59.75 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.283 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 78.1 t -61.2 -43.87 97.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.248 179.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -57.99 -41.43 82.99 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.268 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -90.59 0.05 57.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.322 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt 59.52 42.87 16.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.742 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -94.38 41.58 1.09 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.463 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 53.8 t -118.97 135.84 58.1 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-O 120.974 0.416 . . . . 0.0 110.205 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -132.99 162.65 31.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.564 -179.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.64 155.31 32.56 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.613 -179.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 79.6 mt -93.95 -1.71 54.26 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.373 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.33 165.81 12.75 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 -179.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 7.1 m -87.51 -62.61 1.46 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.841 0.353 . . . . 0.0 110.75 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 295' ' ' GLU . . . . . 0.432 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.6 mm-40 -69.46 -3.89 16.37 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.597 -179.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 27.6 p -77.06 33.4 0.15 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.664 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 297' ' ' PHE . . . . . 0.541 ' CD2' HG22 ' A' ' 70' ' ' THR . 84.8 t80 -60.33 -46.03 91.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.522 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . 0.606 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.3 mtt85 -81.48 133.85 35.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.552 -179.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.443 ' H ' HG11 ' A' ' 51' ' ' VAL . 15.8 tp -114.13 119.38 36.91 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.392 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . 0.621 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.0 p-10 -167.48 -174.19 2.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.629 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 85.1 t80 -47.62 -46.04 28.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.357 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -64.92 -41.58 95.42 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 120.959 0.409 . . . . 0.0 110.6 179.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . 0.621 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 52.3 p -55.11 -36.47 65.75 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.206 -179.342 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . 0.529 ' HB2' ' SD ' ' A' ' 215' ' ' MET . . . -56.43 -52.4 64.8 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.079 179.364 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 93.2 mtp -54.64 -44.81 73.54 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -65.93 -42.88 89.52 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.082 0.468 . . . . 0.0 110.39 178.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 303' ' ' SER . 55.4 t -64.2 -42.61 96.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.378 179.359 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 43.1 tp -59.49 -41.96 91.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.186 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -62.97 -38.7 92.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.188 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 310' ' ' ARG . . . . . 0.44 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.6 ttt85 -63.38 -44.15 95.57 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.306 179.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 88.8 mt -63.07 -42.0 99.55 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.498 179.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.3 ttmt -63.0 -32.63 74.03 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.374 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -90.42 -23.25 21.09 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.442 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.483 HD22 ' CE2' ' A' ' 315' ' ' PHE . 6.8 tt -62.25 -43.16 99.45 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.528 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 315' ' ' PHE . . . . . 0.483 ' CE2' HD22 ' A' ' 314' ' ' LEU . 90.9 m-85 . . . . . 0 C--O 1.22 -0.48 0 CA-C-O 118.005 -0.998 . . . . 0.0 110.426 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -99.54 137.11 38.49 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.009 0.433 . . . . 0.0 110.502 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.496 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -92.01 178.5 1.69 Allowed Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.578 -179.881 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.496 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.3 Cg_exo -61.73 147.54 95.08 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 C-N-CA 122.827 2.351 . . . . 0.0 112.201 179.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.507 ' HE ' HD12 ' A' ' 39' ' ' LEU . 35.0 ptt180 -134.35 141.76 47.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.696 179.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -79.2 116.58 19.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.504 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.433 ' O ' HG23 ' A' ' 30' ' ' ILE . 9.5 tp -110.57 130.79 63.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.444 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 13.0 t -71.08 142.14 50.84 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.02 0.438 . . . . 0.0 110.582 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 141' ' ' ILE . 25.3 t70 -139.57 177.73 7.72 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.535 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.0 p -73.93 -36.23 64.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.717 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -48.1 -95.25 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.275 -179.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.414 ' O ' ' OG1' ' A' ' 36' ' ' THR . . . -164.6 -26.26 0.02 OUTLIER Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.414 ' OG1' ' O ' ' A' ' 35' ' ' GLY . 64.6 m -168.76 106.93 0.45 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.878 0.37 . . . . 0.0 110.699 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.566 ' CD2' HD13 ' A' ' 140' ' ' LEU . 36.4 t60 -129.54 144.98 51.5 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.113 0.482 . . . . 0.0 110.185 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.628 HG22 ' N ' ' A' ' 39' ' ' LEU . 98.9 m -129.31 166.27 19.81 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.519 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.628 ' N ' HG22 ' A' ' 38' ' ' THR . 80.8 mt -120.72 127.93 52.46 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.503 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -64.62 -44.56 90.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.719 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 39.1 p -165.33 154.47 12.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.398 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.526 ' H ' ' CD ' ' A' ' 42' ' ' GLN . 13.8 mp0 -42.55 100.18 0.22 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.602 179.357 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -56.73 129.23 33.5 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 122.382 2.054 . . . . 0.0 112.224 -179.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -84.25 -23.72 30.28 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.486 179.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.541 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.4 mtm-85 -121.18 134.24 55.21 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 121.138 0.494 . . . . 0.0 110.251 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.0 mt -130.5 133.2 64.03 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.254 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.857 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 48.5 t -124.8 130.83 73.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 179.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.632 ' OG ' HD12 ' A' ' 117' ' ' LEU . 4.9 m -154.7 166.28 33.92 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.54 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 71.9 p -124.53 8.47 8.34 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.455 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.38 126.07 33.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.611 -179.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.403 HG11 ' H ' ' A' ' 299' ' ' LEU . 92.2 t -66.06 -44.58 91.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.6 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.1 m -62.65 -44.19 96.9 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.699 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 52.6 tp -62.39 -41.66 98.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.58 -179.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.46 ' O ' HD13 ' A' ' 58' ' ' LEU . 77.4 m -57.34 -44.39 84.24 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.399 -179.377 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.79 -61.73 5.62 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 179.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.6 t -48.62 -35.53 13.86 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.8 mt -61.82 -44.41 96.91 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.18 179.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.46 HD13 ' O ' ' A' ' 54' ' ' THR . 9.3 mp -65.22 -41.36 94.53 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.247 177.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.405 ' HB1' ' NE ' ' A' ' 169' ' ' ARG . . . -63.79 -40.98 97.97 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.954 -179.243 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.422 ' O ' HG23 ' A' ' 60' ' ' ILE . 8.2 tp -88.54 16.93 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.816 -179.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 56.36 84.3 0.09 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.763 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.25 57.63 0.07 OUTLIER Pre-proline 0 C--N 1.328 -0.368 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.412 ' HB3' HE21 ' A' ' 85' ' ' GLN . 9.5 Cg_endo -50.58 153.35 7.89 Favored 'Trans proline' 0 C--N 1.295 -2.272 0 C-N-CA 122.866 2.377 . . . . 0.0 112.314 -178.326 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.435 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -109.17 145.8 15.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.329 -179.661 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 97.1 mt -63.7 -45.34 97.64 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.409 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.506 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -129.5 134.58 47.86 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.857 0.361 . . . . 0.0 110.564 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.476 ' O ' ' N ' ' A' ' 98' ' ' LEU . 73.1 m -134.93 159.2 42.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.829 -179.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -87.67 139.36 15.84 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.469 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -175.65 -163.66 0.12 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.957 0.408 . . . . 0.0 110.504 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.514 HG22 ' CD2' ' A' ' 297' ' ' PHE . 15.3 t -133.02 131.82 41.12 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.415 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.424 ' C ' ' O ' ' A' ' 70' ' ' THR . 11.9 p 36.88 71.53 0.94 Allowed Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.523 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_exo -60.92 144.17 99.51 Favored 'Trans proline' 0 C--N 1.302 -1.918 0 C-N-CA 122.491 2.127 . . . . 0.0 112.116 -178.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.533 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 44.6 p-10 -165.0 -34.67 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.678 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.533 ' N ' ' OD1' ' A' ' 73' ' ' ASN . 99.1 m-20 -63.94 -39.39 94.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.452 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -60.86 -47.73 85.02 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.655 -179.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.432 ' O ' ' O ' ' A' ' 77' ' ' ALA . 94.9 t -59.95 -24.48 29.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.509 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -44.77 171.64 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.63 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.575 ' O ' ' N ' ' A' ' 80' ' ' GLN . 54.0 p30 -62.19 178.41 0.39 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.638 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.559 ' C ' ' H ' ' A' ' 81' ' ' GLY . 36.2 p30 -46.96 85.4 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.952 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.575 ' N ' ' O ' ' A' ' 78' ' ' ASP . 43.2 tp60 -67.57 14.1 0.06 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.159 0.504 . . . . 0.0 110.187 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.559 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 117.87 -21.62 10.28 Favored Glycine 0 C--N 1.332 0.313 0 N-CA-C 110.841 -0.903 . . . . 0.0 110.841 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -107.91 116.63 32.31 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.971 0.415 . . . . 0.0 110.487 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 74.1 mt -98.98 0.72 44.52 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.447 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -92.03 6.46 46.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.962 0.411 . . . . 0.0 110.396 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.786 ' O ' HG22 ' A' ' 89' ' ' VAL . 88.3 mt-30 -99.9 -27.46 13.59 Favored 'General case' 0 C--O 1.223 -0.341 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.811 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.0 t-105 -64.1 -40.51 96.38 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.052 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.554 ' O ' ' N ' ' A' ' 91' ' ' LYS . 70.7 m -77.86 -53.71 7.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.163 -179.495 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -48.51 -50.68 30.84 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.016 -179.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.786 HG22 ' O ' ' A' ' 85' ' ' GLN . 14.8 m -68.88 -40.75 81.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 120.937 0.399 . . . . 0.0 111.081 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.5 ' N ' HG23 ' A' ' 89' ' ' VAL . . . -72.29 -22.43 61.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.649 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.554 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.0 tttm -61.6 -45.85 92.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.516 -179.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.437 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.6 mm-40 -90.7 -94.23 0.12 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.198 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.625 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.9 mtt180 -143.77 60.11 1.38 Allowed 'General case' 0 C--O 1.235 0.308 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.457 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.6 pttp 33.6 26.44 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 120.933 0.396 . . . . 0.0 110.25 -179.287 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.625 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.4 tt -47.97 123.28 5.97 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.958 -178.094 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.441 ' O ' HD23 ' A' ' 95' ' ' LEU . 98.7 mm-40 -83.64 -170.6 3.14 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.084 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.628 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 82.0 mtp180 -73.34 137.6 44.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.213 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.476 ' N ' ' O ' ' A' ' 67' ' ' SER . 89.7 mt -86.99 -165.38 1.27 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.727 -179.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.532 ' CD2' ' O ' ' A' ' 99' ' ' TYR . 48.5 p90 -168.82 120.22 0.76 Allowed 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.189 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.504 ' C ' ' O ' ' A' ' 99' ' ' TYR . 43.3 mm -29.42 121.6 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.029 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 114.07 27.87 3.3 Favored Glycine 0 CA--C 1.518 0.253 0 N-CA-C 111.224 -0.751 . . . . 0.0 111.224 -179.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.584 ' H ' ' CD ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -144.14 46.08 0.61 Allowed Pre-proline 0 C--N 1.323 -0.55 0 O-C-N 122.502 -0.411 . . . . 0.0 110.464 179.84 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 30.1 Cg_endo -62.14 143.83 95.08 Favored 'Trans proline' 0 C--N 1.296 -2.226 0 C-N-CA 122.686 2.257 . . . . 0.0 111.908 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.46 ' O ' HG23 ' A' ' 108' ' ' VAL . 26.5 t -173.42 120.82 0.34 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.398 179.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.37 -41.03 63.9 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.1 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -65.84 -39.83 91.18 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.846 -179.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.84 -39.76 94.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.713 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 104' ' ' SER . 69.4 t -67.55 -43.84 86.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.705 179.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.42 -39.29 92.81 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.524 -179.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.437 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.61 -23.87 63.34 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.495 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.555 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.2 mm-40 -91.38 5.15 50.45 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.674 -179.553 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.555 ' C ' ' O ' ' A' ' 111' ' ' GLN . 10.4 tpt 21.65 64.85 0.31 Allowed Pre-proline 0 N--CA 1.466 0.349 0 CA-C-O 120.882 0.372 . . . . 0.0 111.137 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.449 ' HG2' HD11 ' A' ' 116' ' ' ILE . 66.1 Cg_endo -79.12 169.69 18.79 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 122.993 2.462 . . . . 0.0 111.902 -178.137 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.525 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 99.0 m-20 -112.84 -43.52 3.42 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.102 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 39.7 tp -120.83 119.9 34.03 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.458 HD13 HD22 ' A' ' 133' ' ' LEU . 95.7 mt -117.16 130.85 71.39 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 CA-C-O 120.944 0.402 . . . . 0.0 110.892 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.632 HD12 ' OG ' ' A' ' 48' ' ' SER . 33.1 mt -105.67 132.73 51.45 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.263 -179.449 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.438 HD12 HG23 ' A' ' 139' ' ' THR . 98.1 mt -118.15 135.73 57.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.733 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 87.0 p -71.65 153.27 42.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.567 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.31 -50.03 75.24 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.679 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.0 t -149.55 154.01 38.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.505 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 169.36 -170.11 42.39 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -63.02 -35.13 91.67 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.443 ' O ' ' OD1' ' A' ' 124' ' ' ASP . 43.9 p-10 -88.3 119.42 28.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.783 0.325 . . . . 0.0 110.65 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.448 ' O ' HD12 ' A' ' 129' ' ' LEU . 41.2 t -63.3 144.53 56.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.987 0.422 . . . . 0.0 110.507 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.521 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.65 -42.66 9.06 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.857 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.7 tp -62.79 -42.34 99.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.697 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.01 -10.99 57.99 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.499 -179.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.448 HD12 ' O ' ' A' ' 125' ' ' SER . 84.4 mt -115.44 -24.18 8.49 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.683 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . 0.521 ' N ' ' O ' ' A' ' 126' ' ' ALA . 77.1 t80 -51.54 -49.54 61.78 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.566 -178.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.6 p-10 -65.89 -41.81 91.05 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.255 179.451 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.524 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 88.0 mt-30 -67.84 -37.07 81.41 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.87 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.458 HD22 HD13 ' A' ' 116' ' ' ILE . 94.5 mt -79.95 -42.35 24.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.944 -179.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.2 t -57.1 -44.91 83.66 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.294 -179.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.4 m -62.18 -45.74 92.05 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.631 179.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 92.7 mt -62.61 -43.98 98.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.377 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.612 ' HB1' ' HD2' ' A' ' 138' ' ' PRO . . . -169.67 164.26 6.58 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.524 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.612 ' HD2' ' HB1' ' A' ' 137' ' ' ALA . 77.3 Cg_exo -43.48 111.88 0.27 Allowed 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.49 2.127 . . . . 0.0 112.195 179.359 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.506 HG21 ' CD1' ' A' ' 130' ' ' TYR . 16.8 m -86.16 127.7 34.76 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.633 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.566 HD13 ' CD2' ' A' ' 37' ' ' HIS . 35.3 tp -120.32 137.69 54.12 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.089 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.425 ' O ' ' OD1' ' A' ' 32' ' ' ASP . 80.5 mt -105.32 121.17 57.1 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.336 0 CA-C-O 121.204 0.526 . . . . 0.0 111.196 -179.489 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.498 HD12 HD22 ' A' ' 117' ' ' LEU . 97.9 mt -136.02 132.61 50.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.593 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.544 ' OD1' ' N ' ' A' ' 144' ' ' TYR . 60.7 t-20 -64.52 147.36 52.96 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.893 0.378 . . . . 0.0 110.307 179.425 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.544 ' N ' ' OD1' ' A' ' 143' ' ' ASN . 87.1 t80 -82.35 122.1 27.55 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.996 -179.615 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.515 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 98.9 m-20 55.27 69.21 0.76 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.847 179.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 33.7 p-10 -125.15 0.57 7.84 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.891 0.377 . . . . 0.0 110.667 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -151.29 117.48 5.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.773 -179.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 87.4 p -64.6 168.89 5.44 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.489 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.412 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.4 p-90 -51.2 -15.37 0.35 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.498 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.447 ' O ' HG23 ' A' ' 154' ' ' THR . 67.8 tp60 -71.71 -75.15 0.14 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.398 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.438 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.0 t -62.72 -38.85 92.09 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.244 179.461 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 52.9 tp -60.12 -45.59 92.49 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.307 -178.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.412 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 46.2 tp -62.64 -41.78 99.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.914 0.388 . . . . 0.0 110.508 178.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.447 HG23 ' O ' ' A' ' 150' ' ' GLN . 57.4 p -64.04 -34.65 78.49 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.201 -179.443 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.468 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.5 mm-40 -63.87 -42.39 97.54 Favored 'General case' 0 C--O 1.227 -0.131 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.22 179.345 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 91.7 mt -65.43 -38.76 90.85 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.066 0.46 . . . . 0.0 110.151 179.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.572 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.47 -31.49 77.69 Favored Glycine 0 CA--C 1.52 0.388 0 N-CA-C 110.771 -0.931 . . . . 0.0 110.771 -179.297 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.468 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.4 mt-10 -37.32 -24.57 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.894 0.378 . . . . 0.0 110.837 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.572 ' N ' ' O ' ' A' ' 157' ' ' GLY . 96.0 mt -59.82 148.53 7.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.312 179.321 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 74.8 p -69.05 137.28 53.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.951 -179.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 71.73 20.93 78.92 Favored Glycine 0 CA--C 1.517 0.159 0 N-CA-C 111.206 -0.757 . . . . 0.0 111.206 179.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 58.9 m80 -123.59 -14.33 7.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.717 0.294 . . . . 0.0 110.581 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -65.29 -60.2 3.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.71 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -52.21 -49.14 64.51 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.145 -179.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -59.88 -41.21 91.06 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.739 0.304 . . . . 0.0 110.28 179.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.55 -46.7 88.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.561 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -57.62 -39.75 77.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.178 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -61.79 -50.11 73.67 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.609 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.405 ' NE ' ' HB1' ' A' ' 59' ' ' ALA . 59.9 ttt85 -65.38 -43.81 89.53 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.531 179.52 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 94.3 mt -64.55 -43.38 96.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.369 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.56 -51.21 70.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.461 -179.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.43 -43.96 95.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.485 179.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.67 ' CE2' HD11 ' A' ' 177' ' ' LEU . 56.3 t80 -62.69 -44.33 96.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.062 0.458 . . . . 0.0 110.37 179.375 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -63.26 -39.6 95.05 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.528 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -63.17 -43.02 99.44 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.615 179.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -60.64 -44.79 95.96 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.195 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.67 HD11 ' CE2' ' A' ' 173' ' ' PHE . 84.3 mt -64.56 -40.96 96.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.995 0.426 . . . . 0.0 110.691 178.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -51.56 -62.9 1.33 Allowed 'General case' 0 C--O 1.238 0.458 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.37 -179.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.34 -47.0 85.17 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.59 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.0 -41.68 64.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.233 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -64.04 -33.31 75.46 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.05 0.452 . . . . 0.0 110.347 179.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.421 ' HG2' ' O ' ' A' ' 182' ' ' GLU . 70.1 tt0 -91.21 8.4 35.97 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.436 0.636 . . . . 0.0 110.426 -178.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -103.99 -32.33 9.28 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.205 179.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.6 pt -128.04 147.65 32.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.814 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -140.1 131.36 26.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.442 179.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.595 HD22 ' N ' ' A' ' 186' ' ' LEU . 3.6 mm? -85.4 132.64 44.32 Favored Pre-proline 0 N--CA 1.453 -0.321 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.904 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -43.87 157.87 0.13 Allowed 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.686 2.257 . . . . 0.0 112.27 179.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 0.52 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 26.6 Cg_endo -62.42 115.3 2.8 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 C-N-CA 122.818 2.345 . . . . 0.0 111.759 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . 0.52 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 0.4 OUTLIER 155.4 147.57 0.0 OUTLIER Pre-proline 0 N--CA 1.456 -0.156 0 O-C-N 123.777 0.673 . . . . 0.0 110.758 -179.88 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -73.78 143.59 33.72 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.653 2.235 . . . . 0.0 112.017 177.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.504 HG23 ' OG ' ' A' ' 258' ' ' SER . 2.1 p -124.91 158.7 32.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.347 0.594 . . . . 0.0 110.137 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . 0.489 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 40.1 p -143.1 164.87 28.97 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.07 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . 0.455 ' HA ' ' H ' ' A' ' 260' ' ' PHE . . . -135.29 128.52 31.96 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.227 0.537 . . . . 0.0 110.223 179.567 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.528 HD11 HD23 ' A' ' 259' ' ' LEU . 47.9 pt -147.44 150.3 14.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.04 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . 0.729 HG13 ' CD1' ' A' ' 262' ' ' PHE . 74.6 t -118.31 123.43 71.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-O 121.298 0.57 . . . . 0.0 109.793 179.128 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -134.68 106.91 7.18 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.254 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 95.9 m -131.32 131.35 43.7 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.838 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.401 ' O ' ' N ' ' A' ' 201' ' ' HIS . . . -83.03 -37.14 24.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.308 179.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.39 -66.92 0.27 Allowed 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.402 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.25 -10.22 59.5 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.379 179.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . 0.401 ' N ' ' O ' ' A' ' 198' ' ' ALA . 59.6 t-80 60.89 57.69 2.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.673 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 36.2 p -166.64 152.84 8.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.623 179.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -150.47 143.37 24.7 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.003 0.43 . . . . 0.0 110.452 179.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -134.87 137.68 43.45 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.598 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 16.6 mt -106.42 125.7 51.33 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.122 0.487 . . . . 0.0 109.841 -179.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' TRP . . . . . 0.556 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 74.1 m95 -82.08 167.35 18.89 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.58 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . 0.473 HG22 ' C ' ' A' ' 206' ' ' TRP . 0.1 OUTLIER -157.26 171.06 7.94 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.64 -179.181 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -53.08 -37.19 79.0 Favored 'Trans proline' 0 C--N 1.302 -1.873 0 C-N-CA 122.649 2.233 . . . . 0.0 112.163 179.169 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -70.89 -35.41 72.31 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.774 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . 0.4 ' HB2' ' H ' ' A' ' 207' ' ' THR . 20.0 m -60.49 150.97 29.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.603 -179.423 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.65 -37.28 83.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.535 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . 0.556 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 55.0 tt0 -64.68 -40.28 95.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.52 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.66 -43.44 91.99 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 110.744 -0.943 . . . . 0.0 110.744 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -63.16 -44.39 95.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.807 0.337 . . . . 0.0 110.307 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . 0.555 ' SD ' ' HB2' ' A' ' 304' ' ' ALA . 65.3 ttp -59.27 -48.01 83.23 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.145 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 86.0 mt -60.49 -40.83 92.74 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . 0.451 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.4 tp10 -58.38 -37.76 75.91 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -65.31 -38.24 89.59 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.8 0.333 . . . . 0.0 110.652 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 94.0 mt -64.25 -42.92 96.29 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.509 -179.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.79 44.83 0.08 OUTLIER Glycine 0 C--N 1.333 0.405 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . 0.451 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 26.3 m-85 -127.66 154.78 44.88 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.053 0.454 . . . . 0.0 110.497 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.479 ' O ' HG13 ' A' ' 191' ' ' VAL . 7.6 p -106.33 122.16 45.68 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.209 0.528 . . . . 0.0 110.147 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.474 HD22 ' C ' ' A' ' 222' ' ' THR . 4.3 mm? -101.6 133.07 46.85 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.023 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.44 159.41 14.96 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.49 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.14 114.99 29.52 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.962 0.411 . . . . 0.0 110.31 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.494 ' N ' HD12 ' A' ' 226' ' ' LEU . 9.0 mp -53.03 156.54 3.5 Favored Pre-proline 0 N--CA 1.453 -0.319 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.69 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -60.02 145.32 98.67 Favored 'Trans proline' 0 C--N 1.301 -1.944 0 C-N-CA 122.673 2.249 . . . . 0.0 112.167 179.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -86.89 -3.36 59.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.578 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.69 -40.65 5.58 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.503 ' O ' ' N ' ' A' ' 233' ' ' SER . 65.5 mt -79.53 -18.43 51.87 Favored 'General case' 0 C--O 1.222 -0.389 0 CA-C-O 121.125 0.488 . . . . 0.0 110.365 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -40.76 -49.18 3.1 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.773 -179.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -87.04 15.09 6.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.269 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.503 ' N ' ' O ' ' A' ' 230' ' ' LEU . 77.6 p -59.74 -34.58 73.14 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.59 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . 0.529 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.5 tt0 -121.73 -68.99 0.86 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.813 179.386 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.3 m -66.31 102.91 0.91 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.559 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -93.83 54.25 1.94 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.415 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -142.84 -122.16 1.7 Allowed Glycine 0 CA--C 1.521 0.434 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -139.01 113.75 9.17 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.018 0.437 . . . . 0.0 110.328 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . 0.529 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.8 mtt180 -147.73 60.31 1.14 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.716 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -68.94 -34.12 74.83 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.518 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . 0.454 ' OD2' ' ND2' ' A' ' 143' ' ' ASN . 48.2 t0 -56.79 -47.58 79.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.378 -179.151 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 242' ' ' ILE . . . . . 0.433 ' O ' ' O ' ' A' ' 239' ' ' ARG . 18.9 tt -138.45 153.79 26.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.909 0.385 . . . . 0.0 110.459 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.456 HG22 HD13 ' A' ' 245' ' ' LEU . 96.4 mt -106.38 107.55 22.98 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.224 0 CA-C-O 121.095 0.474 . . . . 0.0 110.445 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . 0.611 ' C ' HD12 ' A' ' 245' ' ' LEU . 88.3 mt-30 -111.85 111.03 21.69 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.46 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.611 HD12 ' C ' ' A' ' 244' ' ' GLN . 9.8 mp -121.21 -168.34 1.66 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.571 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . 0.529 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 176.67 -17.42 0.04 OUTLIER Glycine 0 CA--C 1.524 0.602 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . 0.679 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -62.29 154.55 41.09 Favored Glycine 0 CA--C 1.521 0.442 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -62.62 22.3 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.924 0.392 . . . . 0.0 110.644 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . 0.679 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.9 m-20 -96.64 -6.33 36.89 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.49 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 99.0 mt -80.34 -22.55 41.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.705 179.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.65 -51.17 71.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.84 -179.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.24 -4.94 58.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.429 179.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.41 -73.89 1.17 Allowed Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 82.8 mt -70.16 126.64 30.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.018 0.437 . . . . 0.0 110.253 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -59.51 -39.06 82.62 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.392 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 83.3 51.72 4.03 Favored Glycine 0 CA--C 1.521 0.46 0 N-CA-C 110.752 -0.939 . . . . 0.0 110.752 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -95.6 -15.15 22.97 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.687 0.28 . . . . 0.0 110.633 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . 0.504 ' OG ' HG23 ' A' ' 191' ' ' VAL . 3.3 t 174.26 88.91 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.065 0.459 . . . . 0.0 110.086 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.864 ' N ' HD12 ' A' ' 259' ' ' LEU . 1.0 OUTLIER -94.3 124.3 38.24 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.276 0.56 . . . . 0.0 111.187 -179.156 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 260' ' ' PHE . . . . . 0.455 ' H ' ' HA ' ' A' ' 193' ' ' ALA . 15.9 m-30 -93.0 146.52 23.56 Favored 'General case' 0 CA--C 1.505 -0.781 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.465 179.282 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 85.1 mt -122.08 149.85 42.97 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.534 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.729 ' CD1' HG13 ' A' ' 195' ' ' VAL . 2.6 p90 -77.7 -139.35 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.436 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . 0.659 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -51.34 77.66 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.123 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . 0.632 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.36 104.82 0.19 Allowed Glycine 0 CA--C 1.527 0.83 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 265' ' ' ASP . . . . . 0.598 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.6 m-20 -80.38 -177.67 6.28 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.769 0.318 . . . . 0.0 110.861 -179.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -40.45 -17.83 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.539 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . 0.598 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.47 -51.63 41.37 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.007 0.432 . . . . 0.0 110.7 179.448 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -63.67 -46.48 85.39 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.259 179.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . 0.573 ' HB1' ' OH ' ' A' ' 273' ' ' TYR . . . -61.77 -35.16 77.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.202 0.525 . . . . 0.0 109.732 179.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -63.02 -34.56 77.83 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.113 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.47 -43.27 13.73 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.192 -179.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 272' ' ' ILE . . . . . 0.585 ' C ' ' H ' ' A' ' 274' ' ' ALA . 4.8 tt -51.21 -33.47 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.83 -178.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 273' ' ' TYR . . . . . 0.573 ' OH ' ' HB1' ' A' ' 269' ' ' ALA . 17.1 m-85 -54.7 -1.53 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.603 -179.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 274' ' ' ALA . . . . . 0.585 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.79 -39.65 69.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.917 179.543 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . 0.58 ' O ' ' N ' ' A' ' 279' ' ' ALA . 3.5 p30 -39.21 97.91 0.15 Allowed Pre-proline 0 N--CA 1.462 0.128 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.55 -179.694 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -54.25 -42.9 63.42 Favored 'Trans proline' 0 C--N 1.304 -1.812 0 C-N-CA 122.32 2.013 . . . . 0.0 112.682 -178.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 89.0 mt -64.43 -42.83 95.79 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.208 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 90.6 mt -95.79 -1.35 49.86 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.883 -179.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 279' ' ' ALA . . . . . 0.58 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.28 -34.73 77.13 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.71 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.14 19.91 0.12 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.99 -179.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 0.49 HD23 ' HA ' ' A' ' 281' ' ' LEU . 13.7 mt -75.07 119.85 78.88 Favored Pre-proline 0 N--CA 1.451 -0.424 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.58 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -50.64 -39.71 56.13 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.612 2.208 . . . . 0.0 112.035 178.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.76 -50.44 63.49 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.103 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 73.6 t -61.47 -43.85 97.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 179.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -57.95 -41.26 82.48 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.159 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -90.84 0.05 57.58 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.154 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt 59.56 43.23 16.22 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.86 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -94.83 41.49 1.09 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.346 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 54.2 t -118.85 135.72 58.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 121.062 0.458 . . . . 0.0 110.172 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -132.74 162.45 31.4 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.111 0.481 . . . . 0.0 110.606 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.43 154.51 33.59 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.021 0.439 . . . . 0.0 110.681 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 80.9 mt -93.66 -1.69 54.94 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.24 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.83 165.72 12.64 Favored Glycine 0 CA--C 1.522 0.475 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 6.8 m -87.61 -61.9 1.62 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.902 0.382 . . . . 0.0 111.065 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 295' ' ' GLU . . . . . 0.452 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.5 mm-40 -69.22 -4.35 17.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.677 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 26.1 p -76.29 32.43 0.12 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.666 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 297' ' ' PHE . . . . . 0.514 ' CD2' HG22 ' A' ' 70' ' ' THR . 85.0 t80 -60.56 -46.18 91.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.579 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . 0.628 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.1 mtt85 -81.78 133.65 35.36 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 121.049 0.452 . . . . 0.0 110.54 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.403 ' H ' HG11 ' A' ' 51' ' ' VAL . 16.8 tp -113.16 118.64 35.27 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-O 120.994 0.426 . . . . 0.0 110.161 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . 0.632 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.4 p-10 -165.81 -176.01 3.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.592 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 83.5 t80 -47.3 -44.06 23.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.275 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -66.45 -40.64 89.54 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.035 0.445 . . . . 0.0 110.827 179.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . 0.632 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 57.6 p -55.58 -36.21 66.63 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.111 -179.19 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . 0.555 ' HB2' ' SD ' ' A' ' 215' ' ' MET . . . -56.98 -51.67 68.28 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.46 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 91.0 mtp -56.26 -43.83 79.14 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -66.3 -42.45 88.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.037 0.446 . . . . 0.0 110.18 178.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 303' ' ' SER . 56.1 t -64.1 -42.93 97.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.209 179.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 42.3 tp -59.74 -42.12 92.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.863 -179.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -62.68 -38.82 91.87 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.08 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 310' ' ' ARG . . . . . 0.441 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.7 ttt85 -63.63 -43.73 95.99 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.308 179.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 89.3 mt -63.09 -42.22 99.57 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.25 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt -62.85 -33.36 75.1 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.075 179.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.44 -23.68 22.06 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.401 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.477 HD22 ' CE2' ' A' ' 315' ' ' PHE . 6.7 tt -62.26 -43.28 99.2 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 121.068 0.461 . . . . 0.0 110.578 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 315' ' ' PHE . . . . . 0.477 ' CE2' HD22 ' A' ' 314' ' ' LEU . 90.1 m-85 . . . . . 0 C--O 1.22 -0.479 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.404 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -99.64 135.89 40.39 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.056 0.455 . . . . 0.0 110.476 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.497 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -91.94 178.51 1.7 Allowed Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.586 -179.846 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.497 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.4 Cg_exo -61.6 147.32 95.66 Favored 'Trans proline' 0 C--N 1.299 -2.076 0 C-N-CA 122.802 2.335 . . . . 0.0 112.147 179.568 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.463 ' HE ' HD12 ' A' ' 39' ' ' LEU . 35.7 ptt180 -136.03 142.3 44.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.645 179.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -79.6 116.79 20.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.501 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.443 ' O ' HG23 ' A' ' 30' ' ' ILE . 9.5 tp -111.35 130.75 64.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.465 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 13.8 t -70.93 142.36 51.09 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.606 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.478 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.4 t0 -139.85 179.53 6.54 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.526 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.478 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 78.0 p -73.71 -37.12 65.25 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.64 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.7 ttt85 -46.49 -94.56 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.293 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -167.22 -26.32 0.02 OUTLIER Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.931 -0.867 . . . . 0.0 110.931 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 60.9 m -169.25 105.02 0.38 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.891 0.377 . . . . 0.0 110.665 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.68 ' CD2' HD13 ' A' ' 140' ' ' LEU . 74.7 t60 -128.5 149.44 50.59 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.116 0.484 . . . . 0.0 110.227 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.623 HG22 ' N ' ' A' ' 39' ' ' LEU . 98.5 m -131.75 165.88 22.77 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.583 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.623 ' N ' HG22 ' A' ' 38' ' ' THR . 81.6 mt -120.8 127.31 51.82 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.497 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -64.95 -44.43 89.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.721 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 39.7 p -165.81 155.08 11.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.492 179.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.49 ' H ' ' CD ' ' A' ' 42' ' ' GLN . 14.9 mp0 -44.22 100.96 0.24 Allowed Pre-proline 0 C--N 1.329 -0.287 0 O-C-N 123.364 0.415 . . . . 0.0 110.621 179.362 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -57.26 129.37 33.79 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 122.337 2.024 . . . . 0.0 112.271 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -83.98 -24.81 30.45 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.501 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.538 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.3 mtm-85 -121.86 134.37 54.88 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.199 0.523 . . . . 0.0 110.321 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.2 mt -130.6 133.46 63.49 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.3 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.952 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 44.9 t -124.18 130.33 73.77 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.646 ' OG ' HD12 ' A' ' 117' ' ' LEU . 2.1 m -155.48 167.65 29.69 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.523 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 66.8 p -124.45 10.31 8.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.454 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -86.02 124.78 32.85 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.723 -179.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.464 HG11 ' H ' ' A' ' 299' ' ' LEU . 98.9 t -65.57 -44.55 93.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.398 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.4 m -62.49 -44.18 97.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.627 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 52.3 tp -62.02 -41.54 98.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.514 -179.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.453 ' O ' HD13 ' A' ' 58' ' ' LEU . 71.2 m -57.67 -44.44 85.72 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.192 -179.27 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.24 -62.09 5.46 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 179.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.7 t -48.61 -35.51 13.78 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 57' ' ' LEU . 20.0 mt -61.82 -44.48 96.75 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.675 -0.41 . . . . 0.0 111.284 179.335 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.453 HD13 ' O ' ' A' ' 54' ' ' THR . 9.3 mp -64.96 -41.61 95.33 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.42 177.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.84 -40.48 96.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.003 -179.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.43 ' O ' HG23 ' A' ' 60' ' ' ILE . 7.9 tp -89.07 16.49 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.836 -179.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 56.48 85.08 0.08 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.733 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 178.49 58.21 0.07 OUTLIER Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.901 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.409 ' HB3' HE21 ' A' ' 85' ' ' GLN . 10.2 Cg_endo -50.97 153.1 9.23 Favored 'Trans proline' 0 C--N 1.294 -2.323 0 C-N-CA 122.935 2.423 . . . . 0.0 112.329 -178.229 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.432 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -108.3 145.37 15.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.318 -179.736 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.69 -45.18 98.09 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.303 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.403 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.502 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -129.83 134.03 47.3 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.504 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.502 ' O ' ' N ' ' A' ' 98' ' ' LEU . 75.4 m -134.48 158.5 43.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.824 -179.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.59 139.03 16.2 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.487 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.79 -162.86 0.08 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.014 0.435 . . . . 0.0 110.465 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.538 HG22 ' CD2' ' A' ' 297' ' ' PHE . 14.9 t -133.61 134.5 43.31 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.357 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.488 ' C ' ' O ' ' A' ' 70' ' ' THR . 0.7 OUTLIER 29.62 68.71 0.65 Allowed Pre-proline 0 N--CA 1.464 0.266 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.787 -179.879 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -61.3 145.42 98.41 Favored 'Trans proline' 0 C--N 1.299 -2.077 0 C-N-CA 122.654 2.236 . . . . 0.0 111.969 -178.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.53 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 45.3 p-10 -158.9 -32.29 0.07 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.701 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.545 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 99.1 m-20 -64.03 -39.71 94.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.459 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -60.39 -48.1 83.2 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.704 -179.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.424 ' O ' ' O ' ' A' ' 77' ' ' ALA . 92.7 t -60.48 -25.03 33.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.545 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -45.66 173.04 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.601 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.575 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.6 p30 -62.05 177.86 0.42 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.533 -179.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.559 ' C ' ' H ' ' A' ' 81' ' ' GLY . 36.5 p30 -45.01 85.73 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.994 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.575 ' N ' ' O ' ' A' ' 78' ' ' ASP . 42.7 tp60 -67.36 13.21 0.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.119 0.485 . . . . 0.0 110.116 -179.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.559 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 118.23 -22.29 9.7 Favored Glycine 0 C--N 1.332 0.317 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -108.18 116.18 31.49 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.956 0.407 . . . . 0.0 110.471 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 77.8 mt -98.56 0.58 45.23 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.941 0.401 . . . . 0.0 110.484 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -92.33 7.03 44.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.024 0.44 . . . . 0.0 110.435 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.8 ' O ' HG22 ' A' ' 89' ' ' VAL . 88.0 mt-30 -100.2 -27.87 13.3 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.787 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 68.5 t-105 -62.71 -40.91 98.64 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.935 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.552 ' O ' ' N ' ' A' ' 91' ' ' LYS . 68.8 m -77.55 -53.2 7.89 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.164 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -48.79 -50.9 32.03 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.015 -179.212 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.8 HG22 ' O ' ' A' ' 85' ' ' GLN . 15.7 m -68.75 -40.74 81.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 120.88 0.371 . . . . 0.0 111.074 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.497 ' N ' HG23 ' A' ' 89' ' ' VAL . . . -71.99 -23.11 61.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.75 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.552 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.0 tttm -61.6 -45.63 93.29 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.504 -179.537 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.445 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.8 mm-40 -90.46 -95.17 0.12 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.101 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.63 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.8 mtt180 -142.81 59.46 1.43 Allowed 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.458 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.7 pttp 33.55 26.27 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 120.906 0.384 . . . . 0.0 110.132 -179.303 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.63 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.5 tt -48.5 123.23 6.35 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.006 -177.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.456 ' O ' HD23 ' A' ' 95' ' ' LEU . 99.1 mm-40 -83.95 -169.2 2.46 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.06 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.602 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 81.3 mtp180 -74.85 136.86 41.53 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.266 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.502 ' N ' ' O ' ' A' ' 67' ' ' SER . 91.5 mt -85.77 -165.93 1.38 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.718 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.537 ' CD2' ' O ' ' A' ' 99' ' ' TYR . 48.3 p90 -168.2 119.85 0.83 Allowed 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.198 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.511 ' C ' ' O ' ' A' ' 99' ' ' TYR . 42.4 mm -28.99 120.74 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.074 -179.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 114.62 27.6 3.25 Favored Glycine 0 CA--C 1.52 0.353 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 -179.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.576 ' H ' ' CD ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -144.78 46.5 0.61 Allowed Pre-proline 0 C--N 1.323 -0.578 0 O-C-N 122.549 -0.383 . . . . 0.0 110.431 179.896 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 29.0 Cg_endo -61.9 144.21 96.36 Favored 'Trans proline' 0 C--N 1.295 -2.258 0 C-N-CA 122.678 2.252 . . . . 0.0 111.93 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.457 ' O ' HG23 ' A' ' 108' ' ' VAL . 26.1 t -173.38 120.25 0.33 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.397 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.71 -40.34 63.67 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.034 0.445 . . . . 0.0 111.098 179.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -66.29 -40.16 89.87 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.9 -179.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.97 -40.07 95.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.697 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 104' ' ' SER . 70.7 t -67.45 -43.84 87.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.8 179.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.86 -38.84 92.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.53 -179.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.445 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.62 -23.34 62.92 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.414 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.547 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.5 mm-40 -90.63 5.14 49.19 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.755 -179.575 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.547 ' C ' ' O ' ' A' ' 111' ' ' GLN . 10.6 tpt 23.49 64.05 0.38 Allowed Pre-proline 0 N--CA 1.466 0.347 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.074 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -78.41 167.78 22.42 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 C-N-CA 122.949 2.433 . . . . 0.0 112.009 -178.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.523 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 99.0 m-20 -110.06 -42.53 4.17 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.133 179.475 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.6 tp -120.64 120.4 35.65 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 84.4 mt -113.36 129.18 69.59 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.401 0 CA-C-O 120.983 0.42 . . . . 0.0 110.942 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.646 HD12 ' OG ' ' A' ' 48' ' ' SER . 29.9 mt -109.02 132.46 54.08 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.057 0.456 . . . . 0.0 110.214 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.505 HD12 HG23 ' A' ' 139' ' ' THR . 98.9 mt -119.91 138.2 51.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.666 -179.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 87.4 p -71.92 153.17 42.01 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.57 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.27 -50.19 74.63 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.681 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -149.42 153.91 38.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.615 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 170.25 -170.9 43.27 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.87 -34.28 89.37 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.447 ' O ' ' OD1' ' A' ' 124' ' ' ASP . 44.1 p-10 -87.06 120.06 27.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.805 0.336 . . . . 0.0 110.66 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.447 ' O ' HD12 ' A' ' 129' ' ' LEU . 40.6 t -63.26 143.6 57.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.451 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.521 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.08 -42.76 9.23 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.866 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.5 tp -62.73 -42.35 99.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.647 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.99 -11.94 59.81 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.485 -179.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.447 HD12 ' O ' ' A' ' 125' ' ' SER . 84.8 mt -114.48 -24.1 8.99 Favored 'General case' 0 C--O 1.226 -0.16 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.689 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . 0.521 ' N ' ' O ' ' A' ' 126' ' ' ALA . 77.9 t80 -51.28 -49.44 61.23 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.611 -0.436 . . . . 0.0 110.576 -178.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.3 p-10 -66.07 -42.27 89.65 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.885 0.374 . . . . 0.0 111.29 179.474 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.518 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 88.2 mt-30 -67.29 -37.92 84.18 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.797 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.446 HD12 HD11 ' A' ' 118' ' ' ILE . 96.1 mt -80.33 -41.41 24.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.991 -179.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.1 t -57.26 -44.34 83.82 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.202 -178.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.8 m -62.11 -45.1 94.99 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.766 0.317 . . . . 0.0 110.49 179.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 93.5 mt -62.26 -43.64 98.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.23 -179.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.664 ' HB1' ' HD2' ' A' ' 138' ' ' PRO . . . -169.46 168.35 4.88 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.588 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.664 ' HD2' ' HB1' ' A' ' 137' ' ' ALA . 52.1 Cg_exo -49.67 112.93 0.78 Allowed 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.314 2.01 . . . . 0.0 112.277 179.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.505 HG23 HD12 ' A' ' 118' ' ' ILE . 23.0 m -84.18 127.55 34.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.636 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.68 HD13 ' CD2' ' A' ' 37' ' ' HIS . 34.5 tp -118.05 135.93 53.87 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.938 -179.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.438 ' O ' ' OD2' ' A' ' 32' ' ' ASP . 81.3 mt -100.38 119.01 47.9 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 CA-C-O 121.192 0.52 . . . . 0.0 111.295 -179.44 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.44 HD12 HD22 ' A' ' 117' ' ' LEU . 98.1 mt -134.98 131.83 53.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.619 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.55 HD21 ' CG ' ' A' ' 241' ' ' ASP . 58.9 t30 -66.77 147.48 53.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.866 0.365 . . . . 0.0 110.406 179.289 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.463 ' O ' ' OD2' ' A' ' 241' ' ' ASP . 44.8 t80 -81.69 123.17 28.5 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.932 -179.546 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 54.64 69.57 0.71 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.802 179.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 34.2 p-10 -126.16 0.7 7.15 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.93 0.395 . . . . 0.0 110.74 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -150.65 114.92 5.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.743 -179.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 83.6 p -64.14 169.23 4.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.523 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.417 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.4 p-90 -52.1 -16.51 0.79 Allowed 'General case' 0 C--O 1.223 -0.321 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.474 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.434 ' O ' HG23 ' A' ' 154' ' ' THR . 68.1 tp60 -69.56 -76.96 0.09 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.495 -179.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.449 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.1 t -62.53 -38.24 89.21 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.287 179.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 53.1 tp -60.05 -45.74 91.84 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.351 -178.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.417 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 46.8 tp -62.76 -41.71 99.34 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.417 179.049 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.449 ' OG1' ' O ' ' A' ' 151' ' ' SER . 63.0 p -63.89 -34.91 79.01 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.222 -179.454 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.445 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 88.0 mm-40 -64.0 -42.52 97.16 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.256 179.308 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 90.7 mt -65.37 -38.85 91.28 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.094 0.473 . . . . 0.0 110.212 179.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.578 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.25 -32.4 80.55 Favored Glycine 0 CA--C 1.519 0.343 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 -179.368 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.445 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.2 mt-10 -35.88 -26.45 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.869 0.366 . . . . 0.0 110.827 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.578 ' N ' ' O ' ' A' ' 157' ' ' GLY . 95.3 mt -57.2 148.75 4.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.287 179.224 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 73.4 p -69.1 137.41 53.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.036 -179.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 70.85 22.18 78.22 Favored Glycine 0 N--CA 1.458 0.162 0 N-CA-C 111.286 -0.726 . . . . 0.0 111.286 179.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 59.0 m80 -124.16 -14.41 7.04 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.719 0.295 . . . . 0.0 110.519 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -66.16 -59.75 3.47 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.718 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -52.16 -49.04 64.57 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.159 -179.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -60.98 -41.09 95.78 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.95 -0.3 . . . . 0.0 110.387 179.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.57 -47.09 87.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.57 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -57.0 -40.22 76.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.188 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -61.49 -49.94 74.73 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.558 179.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -65.35 -43.67 90.13 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.467 179.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 94.7 mt -64.56 -43.41 96.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.468 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.38 -51.02 71.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.451 -179.099 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.51 -43.68 96.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.493 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.665 ' CE2' HD11 ' A' ' 177' ' ' LEU . 57.6 t80 -62.86 -44.52 95.91 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.072 0.463 . . . . 0.0 110.433 179.391 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -63.27 -40.0 96.16 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.579 -179.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -63.02 -42.73 99.88 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.646 179.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -60.65 -44.88 95.9 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.152 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.665 HD11 ' CE2' ' A' ' 173' ' ' PHE . 84.6 mt -64.43 -41.14 96.75 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.992 0.425 . . . . 0.0 110.67 178.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -51.92 -62.15 1.81 Allowed 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.395 -179.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.76 -46.61 87.07 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.568 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.3 -41.86 66.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.28 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -63.66 -33.7 76.22 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.984 0.421 . . . . 0.0 110.4 179.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.421 ' HG2' ' O ' ' A' ' 182' ' ' GLU . 69.8 tt0 -90.53 8.76 32.36 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.489 0.662 . . . . 0.0 110.484 -178.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -104.87 -32.29 8.87 Favored 'General case' 0 CA--C 1.515 -0.372 0 O-C-N 122.113 -0.367 . . . . 0.0 111.233 179.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.7 pt -128.01 147.61 32.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.826 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -139.97 131.02 26.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.331 179.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.597 HD22 ' N ' ' A' ' 186' ' ' LEU . 3.5 mm? -85.44 133.73 41.69 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.01 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -44.04 157.89 0.14 Allowed 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 122.703 2.269 . . . . 0.0 112.199 179.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 0.521 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 28.1 Cg_endo -63.13 114.8 2.62 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 C-N-CA 122.765 2.31 . . . . 0.0 111.729 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . 0.521 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.8 mt-30 155.4 147.99 0.0 OUTLIER Pre-proline 0 N--CA 1.455 -0.203 0 O-C-N 123.68 0.612 . . . . 0.0 110.802 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -73.53 144.29 35.77 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.621 2.214 . . . . 0.0 112.005 177.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.503 HG23 ' OG ' ' A' ' 258' ' ' SER . 2.1 p -124.92 158.83 32.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.298 0.57 . . . . 0.0 110.14 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . 0.494 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 37.4 p -143.3 165.39 27.61 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.121 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . 0.446 ' HA ' ' H ' ' A' ' 260' ' ' PHE . . . -135.28 128.64 32.2 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.222 0.534 . . . . 0.0 110.189 179.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.508 HD11 HD23 ' A' ' 259' ' ' LEU . 47.7 pt -146.39 148.79 16.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.186 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . 0.749 HG13 ' CD1' ' A' ' 262' ' ' PHE . 72.1 t -117.77 123.25 71.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.272 0.558 . . . . 0.0 109.684 179.167 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -134.4 107.37 7.56 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.282 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 94.7 m -130.82 130.46 43.68 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.834 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.406 ' O ' ' N ' ' A' ' 201' ' ' HIS . . . -82.73 -37.36 24.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.265 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.41 -66.98 0.27 Allowed 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.414 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.1 -10.05 59.24 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.266 179.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . 0.406 ' N ' ' O ' ' A' ' 198' ' ' ALA . 60.0 t-80 60.81 58.13 2.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.703 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 41.0 p -166.84 153.49 8.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.52 179.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.32 144.05 24.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.496 179.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -135.34 138.4 43.34 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.641 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 20.4 mt -106.53 125.64 51.25 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.116 0.484 . . . . 0.0 109.779 -179.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' TRP . . . . . 0.556 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 74.8 m95 -82.12 166.99 19.21 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.655 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . 0.466 HG22 ' C ' ' A' ' 206' ' ' TRP . 0.1 OUTLIER -156.92 171.26 7.67 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 120.98 0.419 . . . . 0.0 110.521 -179.144 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.54 -37.35 82.65 Favored 'Trans proline' 0 C--N 1.303 -1.832 0 C-N-CA 122.619 2.213 . . . . 0.0 112.186 179.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -70.4 -35.01 73.2 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.875 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 22.8 m -61.01 150.74 32.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.616 -179.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.45 -37.04 82.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.551 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . 0.556 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 55.0 tt0 -64.69 -40.24 95.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.543 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.5 -43.46 92.32 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.719 -0.952 . . . . 0.0 110.719 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -63.34 -43.54 97.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.71 0.291 . . . . 0.0 110.247 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . 0.537 ' SD ' ' HB2' ' A' ' 304' ' ' ALA . 65.1 ttp -59.5 -48.01 83.31 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.207 -179.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 88.0 mt -60.66 -40.74 93.19 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . 0.459 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.7 tp10 -58.06 -37.87 75.25 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -65.22 -38.01 89.06 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.81 0.338 . . . . 0.0 110.654 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 94.3 mt -64.3 -42.62 96.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.614 -179.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.27 44.6 0.09 OUTLIER Glycine 0 C--N 1.333 0.408 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . 0.459 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 26.1 m-85 -127.66 155.44 43.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.058 0.456 . . . . 0.0 110.527 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.487 ' O ' HG13 ' A' ' 191' ' ' VAL . 7.0 p -107.16 122.23 46.09 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.224 0.535 . . . . 0.0 110.196 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.472 HD22 ' C ' ' A' ' 222' ' ' THR . 4.3 mm? -101.03 133.28 45.76 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.134 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -97.1 159.21 15.04 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.473 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.16 115.35 30.13 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-O 120.924 0.392 . . . . 0.0 110.37 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.496 ' N ' HD12 ' A' ' 226' ' ' LEU . 8.9 mp -53.37 156.67 3.96 Favored Pre-proline 0 N--CA 1.453 -0.313 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.659 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -60.19 145.3 98.81 Favored 'Trans proline' 0 C--N 1.301 -1.931 0 C-N-CA 122.629 2.219 . . . . 0.0 112.15 179.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.41 -3.02 59.01 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.5 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.22 -40.92 5.66 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.024 -0.831 . . . . 0.0 111.024 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.539 ' O ' ' N ' ' A' ' 233' ' ' SER . 86.3 mt -79.17 -16.82 56.04 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-O 121.019 0.438 . . . . 0.0 110.29 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . 0.402 ' C ' ' O ' ' A' ' 230' ' ' LEU . 54.5 t-20 -40.41 -48.89 2.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.764 -179.399 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -88.2 15.43 7.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.314 179.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.539 ' N ' ' O ' ' A' ' 230' ' ' LEU . 78.1 p -60.6 -35.51 76.3 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.648 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . 0.528 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.6 tt0 -118.35 -69.26 0.86 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.974 179.428 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.0 m -70.47 103.02 2.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.739 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -94.27 58.08 2.42 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.37 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -145.04 -122.53 1.55 Allowed Glycine 0 CA--C 1.519 0.324 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -134.47 111.79 10.4 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 121.175 0.512 . . . . 0.0 110.408 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . 0.515 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.2 mtt180 -148.25 57.56 1.07 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.762 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -69.83 -31.89 70.01 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.489 179.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . 0.55 ' CG ' HD21 ' A' ' 143' ' ' ASN . 64.8 t0 -56.92 -47.03 81.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.344 -179.097 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 242' ' ' ILE . . . . . 0.434 ' O ' ' O ' ' A' ' 239' ' ' ARG . 17.6 tt -140.2 157.03 25.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.912 0.387 . . . . 0.0 110.494 179.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.45 HG22 HD13 ' A' ' 245' ' ' LEU . 96.1 mt -106.25 106.33 20.39 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.163 0 CA-C-O 121.169 0.509 . . . . 0.0 110.466 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . 0.599 ' O ' HD12 ' A' ' 245' ' ' LEU . 88.2 mt-30 -110.45 110.31 21.02 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.302 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.599 HD12 ' O ' ' A' ' 244' ' ' GLN . 9.5 mp -121.87 -168.33 1.69 Allowed 'General case' 0 C--O 1.225 -0.205 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.63 179.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . 0.528 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.49 -16.9 0.05 OUTLIER Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.919 -0.873 . . . . 0.0 110.919 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . 0.668 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -60.45 156.98 29.78 Favored Glycine 0 CA--C 1.522 0.488 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -63.8 21.42 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.977 0.418 . . . . 0.0 110.604 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . 0.668 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.8 m-20 -97.04 -6.05 36.16 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.576 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 92.4 mt -79.9 -21.57 43.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.648 179.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.57 -51.23 70.76 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.71 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.65 -5.41 58.16 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.467 179.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.14 -74.37 1.15 Allowed Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 82.6 mt -70.08 126.01 28.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.072 0.463 . . . . 0.0 110.254 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -59.47 -39.27 83.14 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.311 -179.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 82.83 51.79 4.12 Favored Glycine 0 CA--C 1.521 0.41 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -95.78 -15.1 22.79 Favored 'General case' 0 C--N 1.332 -0.18 0 O-C-N 122.728 -0.278 . . . . 0.0 110.594 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . 0.503 ' OG ' HG23 ' A' ' 191' ' ' VAL . 3.3 t 174.56 88.93 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.078 0.466 . . . . 0.0 110.108 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.861 ' N ' HD12 ' A' ' 259' ' ' LEU . 0.9 OUTLIER -94.43 124.06 38.23 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.254 0.549 . . . . 0.0 111.115 -179.081 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 260' ' ' PHE . . . . . 0.446 ' H ' ' HA ' ' A' ' 193' ' ' ALA . 15.9 m-30 -93.06 146.48 23.61 Favored 'General case' 0 CA--C 1.504 -0.818 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.345 179.349 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 85.7 mt -122.42 149.63 43.57 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.607 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.749 ' CD1' HG13 ' A' ' 195' ' ' VAL . 2.6 p90 -77.21 -138.04 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.638 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . 0.66 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -52.61 77.52 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.032 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . 0.621 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -178.99 104.32 0.18 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 265' ' ' ASP . . . . . 0.601 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.7 m-20 -80.35 -177.81 6.34 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.684 0.278 . . . . 0.0 110.954 -179.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -40.36 -17.69 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.561 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . 0.601 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.38 -51.52 43.26 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.71 179.409 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -63.75 -46.65 84.34 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.191 179.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . 0.565 ' HB1' ' OH ' ' A' ' 273' ' ' TYR . . . -61.68 -35.12 77.08 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.173 0.511 . . . . 0.0 109.738 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -63.17 -34.38 77.51 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.033 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.51 -43.12 13.83 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.185 -179.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 272' ' ' ILE . . . . . 0.589 ' C ' ' H ' ' A' ' 274' ' ' ALA . 4.9 tt -51.47 -33.73 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.855 -178.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 273' ' ' TYR . . . . . 0.565 ' OH ' ' HB1' ' A' ' 269' ' ' ALA . 17.3 m-85 -54.33 -1.89 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.646 -179.546 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 274' ' ' ALA . . . . . 0.589 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.61 -39.61 70.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.919 179.52 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . 0.582 ' O ' ' N ' ' A' ' 279' ' ' ALA . 3.3 p30 -39.28 98.03 0.16 Allowed Pre-proline 0 CA--C 1.528 0.108 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.52 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -54.29 -42.95 63.02 Favored 'Trans proline' 0 C--N 1.303 -1.821 0 C-N-CA 122.341 2.027 . . . . 0.0 112.638 -178.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 88.8 mt -64.45 -42.82 95.76 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.252 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 91.0 mt -95.67 -1.58 49.79 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.848 -179.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 279' ' ' ALA . . . . . 0.582 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.28 -34.82 77.3 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.685 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.21 20.07 0.12 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.052 -179.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 0.487 HD23 ' HA ' ' A' ' 281' ' ' LEU . 13.8 mt -75.19 120.04 79.8 Favored Pre-proline 0 N--CA 1.451 -0.417 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.523 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -50.91 -39.34 58.96 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.586 2.191 . . . . 0.0 111.859 179.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.92 -50.42 64.0 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.111 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 75.7 t -61.48 -43.91 97.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -57.79 -41.19 81.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.218 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -91.13 0.04 57.61 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.091 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt 59.44 43.71 15.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.039 0.447 . . . . 0.0 110.878 179.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -94.88 41.33 1.09 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.379 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 54.1 t -119.2 135.76 58.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 121.101 0.477 . . . . 0.0 110.136 -179.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -132.93 162.75 30.8 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.709 -179.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.77 155.3 32.78 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-O 121.013 0.435 . . . . 0.0 110.728 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 81.6 mt -94.07 -1.36 54.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.232 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.53 165.69 12.67 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.548 -1.021 . . . . 0.0 110.548 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 6.9 m -87.56 -62.4 1.5 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.921 0.391 . . . . 0.0 111.001 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 295' ' ' GLU . . . . . 0.431 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.4 mm-40 -69.6 -3.79 16.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.675 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 25.4 p -76.89 33.17 0.14 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.645 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 297' ' ' PHE . . . . . 0.538 ' CD2' HG22 ' A' ' 70' ' ' THR . 84.8 t80 -60.17 -45.85 91.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.555 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . 0.602 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.2 mtt85 -81.72 134.41 35.45 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.989 0.423 . . . . 0.0 110.576 -179.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.464 ' H ' HG11 ' A' ' 51' ' ' VAL . 16.2 tp -114.18 118.88 35.22 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-O 121.004 0.431 . . . . 0.0 110.066 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . 0.631 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.4 p-10 -166.39 -175.23 3.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.562 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -47.69 -44.64 27.66 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.246 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -65.63 -40.9 93.07 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.034 0.445 . . . . 0.0 110.683 178.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . 0.631 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 54.5 p -56.16 -36.12 67.96 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.024 -179.171 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . 0.537 ' HB2' ' SD ' ' A' ' 215' ' ' MET . . . -56.85 -52.34 65.47 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.485 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 90.9 mtp -56.15 -43.28 78.15 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -66.37 -42.53 87.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.024 0.44 . . . . 0.0 110.155 178.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 303' ' ' SER . 55.7 t -64.13 -42.97 97.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.105 179.399 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 42.5 tp -59.77 -42.26 92.9 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.779 -179.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -62.33 -39.27 92.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.123 179.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 310' ' ' ARG . . . . . 0.436 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.4 ttt85 -63.51 -44.06 95.38 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.18 179.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 88.4 mt -63.37 -42.14 98.84 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.233 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -62.99 -33.26 75.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.016 179.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.52 -23.85 21.93 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.416 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.483 HD22 ' CE2' ' A' ' 315' ' ' PHE . 6.7 tt -62.31 -43.29 99.16 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 121.074 0.464 . . . . 0.0 110.552 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 315' ' ' PHE . . . . . 0.483 ' CE2' HD22 ' A' ' 314' ' ' LEU . 90.5 m-85 . . . . . 0 C--O 1.219 -0.507 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.45 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.327 -0.619 . . . . 0.0 109.327 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -99.59 136.4 39.58 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.045 0.45 . . . . 0.0 110.47 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.496 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -92.07 178.56 1.66 Allowed Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.563 -179.891 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.496 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.6 Cg_exo -61.73 147.16 95.93 Favored 'Trans proline' 0 C--N 1.301 -1.965 0 C-N-CA 122.79 2.327 . . . . 0.0 112.106 179.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.459 ' HE ' HD12 ' A' ' 39' ' ' LEU . 35.6 ptt180 -136.29 142.44 43.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.645 179.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -79.5 116.76 19.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.456 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.45 ' O ' HG23 ' A' ' 30' ' ' ILE . 9.5 tp -111.14 130.44 64.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.456 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 12.9 t -70.89 141.7 51.19 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.55 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.48 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.4 t0 -139.19 179.62 6.41 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.497 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.48 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 78.1 p -74.01 -36.93 64.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.604 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.8 ttt85 -46.64 -94.59 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.293 -179.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -166.96 -26.62 0.02 OUTLIER Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 59.3 m -169.05 105.0 0.4 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.817 0.341 . . . . 0.0 110.672 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.691 ' CD2' HD13 ' A' ' 140' ' ' LEU . 75.5 t60 -128.53 149.09 50.75 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.019 0.437 . . . . 0.0 110.289 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.623 HG22 ' N ' ' A' ' 39' ' ' LEU . 98.6 m -131.42 165.91 22.46 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.532 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.623 ' N ' HG22 ' A' ' 38' ' ' THR . 81.4 mt -120.75 127.35 51.91 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.501 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -65.09 -44.43 88.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.682 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 40.6 p -165.97 154.91 11.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.444 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.484 ' H ' ' CD ' ' A' ' 42' ' ' GLN . 14.5 mp0 -44.73 101.3 0.25 Allowed Pre-proline 0 C--N 1.329 -0.308 0 O-C-N 123.392 0.433 . . . . 0.0 110.652 179.426 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.25 129.66 35.32 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 C-N-CA 122.373 2.049 . . . . 0.0 112.288 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -83.61 -24.73 31.32 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.473 179.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.542 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.2 mtm-85 -122.39 134.83 54.61 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-O 121.176 0.512 . . . . 0.0 110.256 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.1 mt -130.75 133.84 62.74 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.925 -179.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 44.2 t -124.31 130.61 73.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 179.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.612 ' OG ' HD12 ' A' ' 117' ' ' LEU . 2.2 m -155.32 167.8 29.16 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.559 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 67.3 p -124.85 9.96 8.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.425 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.78 125.15 33.03 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.689 -179.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.456 HG11 ' H ' ' A' ' 299' ' ' LEU . 93.1 t -65.76 -44.41 93.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.48 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.8 m -62.69 -44.04 97.26 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.602 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 52.5 tp -62.15 -41.5 98.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.544 -179.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.459 ' O ' HD13 ' A' ' 58' ' ' LEU . 75.5 m -57.61 -44.53 85.54 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.32 -179.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.13 -62.31 5.29 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 179.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.6 t -48.24 -35.74 12.58 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' A' ' 57' ' ' LEU . 20.0 mt -61.86 -44.37 96.95 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.179 179.428 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.459 HD13 ' O ' ' A' ' 54' ' ' THR . 9.2 mp -64.97 -41.66 95.26 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.373 178.035 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.91 -40.71 97.12 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.012 -179.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.43 ' O ' HG23 ' A' ' 60' ' ' ILE . 7.9 tp -88.73 16.44 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.856 -179.609 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 56.46 84.58 0.09 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.671 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 178.58 57.1 0.06 OUTLIER Pre-proline 0 C--N 1.328 -0.329 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.411 ' HB3' HE21 ' A' ' 85' ' ' GLN . 9.5 Cg_endo -50.55 154.25 6.66 Favored 'Trans proline' 0 C--N 1.295 -2.252 0 C-N-CA 122.912 2.408 . . . . 0.0 112.297 -178.18 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.436 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -108.96 145.64 15.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.375 -179.712 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.66 -45.25 97.98 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.263 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.335 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.509 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -129.49 133.98 47.55 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.522 -179.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.51 ' O ' ' N ' ' A' ' 98' ' ' LEU . 74.8 m -134.59 158.64 43.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.769 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.77 139.27 16.26 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.704 -0.959 . . . . 0.0 110.704 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.488 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.92 -162.69 0.08 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.918 0.389 . . . . 0.0 110.474 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.532 HG22 ' CD2' ' A' ' 297' ' ' PHE . 15.2 t -133.52 134.33 43.3 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.397 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.489 ' C ' ' O ' ' A' ' 70' ' ' THR . 0.6 OUTLIER 29.73 68.89 0.65 Allowed Pre-proline 0 N--CA 1.464 0.272 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.754 -179.939 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -61.27 146.67 97.11 Favored 'Trans proline' 0 C--N 1.299 -2.067 0 C-N-CA 122.655 2.237 . . . . 0.0 111.986 -178.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.535 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 45.3 p-10 -160.59 -32.35 0.05 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.673 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.545 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 99.1 m-20 -64.15 -39.43 94.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.451 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -60.51 -48.24 82.65 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.561 -179.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.418 ' O ' ' O ' ' A' ' 77' ' ' ALA . 91.6 t -60.38 -24.77 32.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.545 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -46.02 173.29 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.563 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.57 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.6 p30 -62.25 177.96 0.44 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.582 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.554 ' C ' ' H ' ' A' ' 81' ' ' GLY . 35.8 p30 -45.01 86.12 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.985 0.422 . . . . 0.0 110.946 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.57 ' N ' ' O ' ' A' ' 78' ' ' ASP . 43.1 tp60 -67.57 13.21 0.08 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.127 0.489 . . . . 0.0 110.13 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.554 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 118.51 -22.09 9.58 Favored Glycine 0 CA--C 1.519 0.306 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -108.31 116.49 32.06 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.959 0.409 . . . . 0.0 110.54 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 74.6 mt -98.57 0.17 44.41 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.485 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -92.25 7.18 43.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.013 0.435 . . . . 0.0 110.443 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.795 ' O ' HG22 ' A' ' 89' ' ' VAL . 87.8 mt-30 -100.13 -27.99 13.26 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.777 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 68.2 t-105 -62.51 -40.67 97.47 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.866 -179.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.55 ' O ' ' N ' ' A' ' 91' ' ' LYS . 66.1 m -77.64 -53.45 7.56 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.088 -179.389 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -48.73 -50.91 31.53 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.018 -179.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.795 HG22 ' O ' ' A' ' 85' ' ' GLN . 15.4 m -68.62 -40.71 82.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 120.934 0.397 . . . . 0.0 111.032 179.717 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.498 ' N ' HG23 ' A' ' 89' ' ' VAL . . . -72.05 -23.04 61.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.702 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.55 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.0 tttm -61.74 -45.68 92.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.482 -179.464 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.439 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.6 mm-40 -90.23 -95.47 0.11 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.16 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.64 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.9 mtt180 -142.59 58.87 1.44 Allowed 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.459 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.7 pttp 33.54 25.77 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 120.92 0.391 . . . . 0.0 110.19 -179.161 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.64 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.3 tt -47.86 123.75 6.49 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.924 -178.061 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.457 ' O ' HD23 ' A' ' 95' ' ' LEU . 99.0 mm-40 -83.91 -169.41 2.57 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.115 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.595 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 81.0 mtp180 -74.6 136.7 42.03 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.291 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.51 ' N ' ' O ' ' A' ' 67' ' ' SER . 90.6 mt -85.52 -165.57 1.26 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.856 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.536 ' CD2' ' O ' ' A' ' 99' ' ' TYR . 48.0 p90 -168.38 119.49 0.79 Allowed 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.254 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.511 ' C ' ' O ' ' A' ' 99' ' ' TYR . 43.3 mm -28.86 121.02 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.058 -179.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 113.76 27.89 3.37 Favored Glycine 0 CA--C 1.52 0.35 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 -179.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.58 ' H ' ' CD ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -144.48 46.65 0.64 Allowed Pre-proline 0 C--N 1.324 -0.524 0 CA-C-O 120.985 0.422 . . . . 0.0 110.425 179.856 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 29.2 Cg_endo -61.97 143.78 95.67 Favored 'Trans proline' 0 C--N 1.297 -2.161 0 C-N-CA 122.656 2.237 . . . . 0.0 111.942 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.455 ' O ' HG23 ' A' ' 108' ' ' VAL . 25.3 t -173.01 120.08 0.35 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.367 179.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.25 -40.41 64.66 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.075 0.464 . . . . 0.0 111.122 179.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.39 -39.88 89.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.926 -179.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.38 -40.16 95.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.729 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 104' ' ' SER . 71.7 t -67.79 -43.82 86.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.78 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.82 -38.97 92.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.578 -179.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.439 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.44 -23.4 62.66 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.493 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.545 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.3 mm-40 -90.29 5.23 48.1 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.652 -179.471 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.545 ' C ' ' O ' ' A' ' 111' ' ' GLN . 10.8 tpt 23.89 63.98 0.39 Allowed Pre-proline 0 N--CA 1.466 0.33 0 CA-C-O 120.939 0.399 . . . . 0.0 111.048 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -78.22 166.63 24.3 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 123.035 2.49 . . . . 0.0 112.062 -178.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.524 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 99.2 m-20 -109.77 -41.71 4.45 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.185 179.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.2 tp -121.63 120.12 33.82 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 83.2 mt -112.77 128.86 69.25 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.33 0 CA-C-O 120.941 0.401 . . . . 0.0 110.849 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.612 HD12 ' OG ' ' A' ' 48' ' ' SER . 30.1 mt -109.34 132.25 54.3 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.281 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.501 HD12 HG23 ' A' ' 139' ' ' THR . 98.9 mt -119.6 139.06 48.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.668 -179.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 85.1 p -72.68 153.89 40.98 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.527 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.01 -50.19 74.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.714 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.0 t -149.59 154.24 38.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.518 179.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 170.6 -171.06 43.53 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.99 -33.97 88.68 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.446 ' O ' ' OD1' ' A' ' 124' ' ' ASP . 44.0 p-10 -86.93 120.02 27.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.719 0.295 . . . . 0.0 110.685 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.436 ' O ' HD12 ' A' ' 129' ' ' LEU . 39.5 t -63.05 143.9 57.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.005 0.431 . . . . 0.0 110.453 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.527 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -92.9 -42.92 9.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.871 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.5 tp -62.98 -42.44 99.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.667 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.51 -12.5 60.48 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.524 -179.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.436 HD12 ' O ' ' A' ' 125' ' ' SER . 85.2 mt -114.52 -24.02 9.02 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.696 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . 0.527 ' N ' ' O ' ' A' ' 126' ' ' ALA . 80.0 t80 -50.77 -49.68 57.59 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.634 -178.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 37.8 p-10 -66.14 -42.69 88.76 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.848 0.356 . . . . 0.0 111.22 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.522 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 88.3 mt-30 -66.98 -37.89 85.06 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.823 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.435 HD12 HD11 ' A' ' 118' ' ' ILE . 96.0 mt -80.21 -41.43 25.2 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.92 -179.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.2 t -57.14 -44.58 83.51 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.245 -179.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.0 m -61.65 -45.41 94.17 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.75 0.31 . . . . 0.0 110.562 179.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 94.1 mt -62.18 -43.56 98.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.291 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.661 ' HB1' ' HD2' ' A' ' 138' ' ' PRO . . . -169.34 168.46 4.9 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.556 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.661 ' HD2' ' HB1' ' A' ' 137' ' ' ALA . 52.9 Cg_exo -50.35 113.68 1.13 Allowed 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.256 1.971 . . . . 0.0 112.221 179.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.501 HG23 HD12 ' A' ' 118' ' ' ILE . 24.1 m -84.61 127.45 34.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.494 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.691 HD13 ' CD2' ' A' ' 37' ' ' HIS . 34.4 tp -117.93 135.88 53.84 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.107 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.442 ' O ' ' OD2' ' A' ' 32' ' ' ASP . 82.2 mt -99.61 118.71 46.62 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.31 0 CA-C-O 121.221 0.534 . . . . 0.0 111.179 -179.293 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.423 HD12 HD22 ' A' ' 117' ' ' LEU . 98.0 mt -134.99 132.18 53.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.617 179.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.545 HD21 ' CG ' ' A' ' 241' ' ' ASP . 61.3 t30 -66.9 151.5 47.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.911 0.386 . . . . 0.0 110.436 179.414 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.519 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 88.0 t80 -86.54 122.63 30.75 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.847 -179.532 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.519 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 99.1 m-20 55.23 69.17 0.76 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.769 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 35.7 p-10 -125.81 0.4 7.38 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.637 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -150.71 115.47 5.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.706 -179.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 83.5 p -63.3 168.18 4.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.534 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.417 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.4 p-90 -51.61 -15.72 0.5 Allowed 'General case' 0 C--O 1.223 -0.315 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.494 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.448 ' O ' HG23 ' A' ' 154' ' ' THR . 68.2 tp60 -70.8 -75.54 0.12 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.51 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.455 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.0 t -62.76 -38.71 91.63 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.28 179.474 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 53.9 tp -60.02 -45.66 92.04 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.389 -178.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.417 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 46.6 tp -62.73 -41.63 99.27 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.473 178.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.455 ' OG1' ' O ' ' A' ' 151' ' ' SER . 59.7 p -63.89 -34.76 78.67 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.226 -179.521 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.441 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 88.0 mm-40 -64.07 -42.42 96.99 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.309 179.257 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 90.8 mt -65.39 -38.79 91.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.033 0.444 . . . . 0.0 110.178 179.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.581 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.2 -32.33 80.21 Favored Glycine 0 CA--C 1.52 0.348 0 N-CA-C 110.719 -0.952 . . . . 0.0 110.719 -179.302 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.441 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.2 mt-10 -35.93 -25.98 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.858 0.361 . . . . 0.0 110.806 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.581 ' N ' ' O ' ' A' ' 157' ' ' GLY . 95.6 mt -57.99 148.99 5.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.299 179.236 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 74.7 p -69.24 137.44 53.14 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.979 -179.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 70.77 22.16 78.11 Favored Glycine 0 N--CA 1.458 0.165 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 179.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 58.1 m80 -124.32 -14.46 6.95 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.695 0.283 . . . . 0.0 110.538 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -66.05 -59.92 3.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.649 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -52.0 -48.83 64.26 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.134 -179.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -60.52 -41.22 93.96 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.728 0.299 . . . . 0.0 110.321 179.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.61 -47.18 86.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.517 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.87 -40.1 75.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.246 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -61.7 -50.33 72.88 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.579 179.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 60.1 ttt85 -65.44 -43.73 89.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.54 179.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 94.9 mt -64.72 -43.37 96.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.486 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.38 -51.23 70.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.498 -179.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -63.57 -43.64 96.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.533 179.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.652 ' CE2' HD11 ' A' ' 177' ' ' LEU . 56.6 t80 -62.9 -44.29 96.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.087 0.47 . . . . 0.0 110.442 179.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -63.65 -39.86 95.4 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.478 -179.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -62.89 -42.87 99.93 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.659 179.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -60.59 -44.7 95.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.207 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.652 HD11 ' CE2' ' A' ' 173' ' ' PHE . 84.2 mt -64.47 -41.05 96.73 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.994 0.425 . . . . 0.0 110.668 178.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.12 -62.18 1.8 Allowed 'General case' 0 C--O 1.237 0.431 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.382 -179.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.52 -46.78 86.05 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.578 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.24 -41.67 65.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.302 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -63.91 -33.67 76.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.393 179.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.421 ' HG2' ' O ' ' A' ' 182' ' ' GLU . 69.5 tt0 -90.54 8.94 31.51 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.437 0.637 . . . . 0.0 110.491 -178.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -105.04 -32.07 8.89 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.174 179.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.8 pt -128.07 147.55 32.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.842 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -139.68 131.05 26.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.395 179.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.593 HD22 ' N ' ' A' ' 186' ' ' LEU . 3.6 mm? -85.47 133.46 42.17 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.9 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -44.12 157.8 0.15 Allowed 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.738 2.292 . . . . 0.0 112.235 179.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 0.518 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.5 Cg_endo -62.89 114.69 2.53 Favored 'Trans proline' 0 C--N 1.303 -1.82 0 C-N-CA 122.813 2.342 . . . . 0.0 111.748 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . 0.518 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.7 mt-30 155.69 147.88 0.0 OUTLIER Pre-proline 0 C--N 1.332 -0.169 0 O-C-N 123.713 0.633 . . . . 0.0 110.838 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -73.85 144.01 34.13 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.673 2.249 . . . . 0.0 112.012 177.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.496 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.0 p -124.78 158.95 31.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.296 0.569 . . . . 0.0 110.125 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . 0.496 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 37.5 p -143.46 165.39 27.68 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.048 -179.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . 0.443 ' HA ' ' H ' ' A' ' 260' ' ' PHE . . . -135.2 128.58 32.27 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.173 0.511 . . . . 0.0 110.264 179.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.516 HD11 HD23 ' A' ' 259' ' ' LEU . 47.9 pt -146.52 148.86 16.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.084 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . 0.75 HG13 ' CD1' ' A' ' 262' ' ' PHE . 68.8 t -117.73 123.06 71.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.312 0.577 . . . . 0.0 109.813 179.028 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -134.14 106.62 7.28 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.391 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 94.3 m -130.1 130.41 44.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.764 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -82.88 -36.81 25.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.259 179.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.56 -67.14 0.26 Allowed 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.361 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.28 -9.96 59.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.377 179.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 60.2 t-80 60.94 58.47 2.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.901 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 35.5 p -167.23 153.48 8.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.549 179.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.31 144.16 24.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.943 0.402 . . . . 0.0 110.485 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -135.34 138.16 43.12 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.669 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 19.5 mt -106.32 125.46 51.02 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.061 0.458 . . . . 0.0 109.842 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' TRP . . . . . 0.558 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 74.7 m95 -82.07 167.13 19.12 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.676 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . 0.468 HG22 ' C ' ' A' ' 206' ' ' TRP . 0.1 OUTLIER -156.9 171.14 7.83 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.595 -179.165 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.43 -37.15 81.67 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 C-N-CA 122.598 2.198 . . . . 0.0 112.219 179.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -70.56 -34.95 72.8 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.836 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 21.0 m -61.28 150.91 33.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.615 -179.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.61 -37.04 82.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.49 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . 0.558 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 54.7 tt0 -64.66 -40.33 95.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.579 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.52 -43.46 92.27 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -63.29 -43.73 97.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.81 0.338 . . . . 0.0 110.288 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . 0.531 ' SD ' ' HB2' ' A' ' 304' ' ' ALA . 65.1 ttp -59.4 -48.12 82.84 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.26 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 88.4 mt -60.49 -40.94 93.13 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . 0.454 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.0 tp10 -57.97 -37.74 74.75 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -65.31 -38.08 89.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.787 0.327 . . . . 0.0 110.652 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 94.7 mt -64.27 -42.71 96.32 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.58 -179.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.52 44.73 0.08 OUTLIER Glycine 0 CA--C 1.52 0.392 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . 0.454 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 26.5 m-85 -127.78 155.47 44.01 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.075 0.464 . . . . 0.0 110.522 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.486 ' O ' HG13 ' A' ' 191' ' ' VAL . 6.7 p -107.1 122.25 46.11 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.266 0.555 . . . . 0.0 110.122 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.47 HD22 ' C ' ' A' ' 222' ' ' THR . 4.3 mm? -101.17 133.15 46.15 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.056 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -97.01 159.34 14.96 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.467 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.32 115.42 30.24 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.954 0.407 . . . . 0.0 110.344 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.503 ' N ' HD12 ' A' ' 226' ' ' LEU . 8.8 mp -53.42 156.51 4.18 Favored Pre-proline 0 N--CA 1.452 -0.328 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.696 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -60.02 145.2 98.94 Favored 'Trans proline' 0 C--N 1.301 -1.929 0 C-N-CA 122.682 2.254 . . . . 0.0 112.163 179.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.25 -2.98 59.01 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.605 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.39 -40.83 5.63 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.539 ' O ' ' N ' ' A' ' 233' ' ' SER . 86.2 mt -79.07 -16.98 56.01 Favored 'General case' 0 C--O 1.222 -0.373 0 CA-C-O 121.069 0.461 . . . . 0.0 110.334 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . 0.404 ' C ' ' O ' ' A' ' 230' ' ' LEU . 53.9 t-20 -40.21 -49.12 2.66 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.732 -179.469 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -88.17 15.35 7.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.255 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.539 ' N ' ' O ' ' A' ' 230' ' ' LEU . 78.0 p -60.49 -35.68 76.51 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.712 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . 0.524 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.5 tt0 -118.35 -69.34 0.86 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.894 179.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.2 m -69.98 103.68 2.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.093 0.473 . . . . 0.0 110.691 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -94.88 57.54 2.13 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.366 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -144.92 -122.61 1.57 Allowed Glycine 0 CA--C 1.52 0.346 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -134.4 111.93 10.56 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 121.132 0.491 . . . . 0.0 110.368 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . 0.512 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.5 mtt180 -148.32 57.52 1.07 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.792 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -69.91 -31.87 69.88 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.539 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . 0.545 ' CG ' HD21 ' A' ' 143' ' ' ASN . 64.7 t0 -56.92 -46.93 81.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.33 -179.135 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 242' ' ' ILE . . . . . 0.436 ' O ' ' O ' ' A' ' 239' ' ' ARG . 17.4 tt -140.16 156.92 25.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.9 0.381 . . . . 0.0 110.533 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.439 HG22 HD13 ' A' ' 245' ' ' LEU . 96.1 mt -106.0 106.19 20.11 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.214 0 CA-C-O 121.163 0.506 . . . . 0.0 110.529 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . 0.604 ' O ' HD12 ' A' ' 245' ' ' LEU . 88.3 mt-30 -110.37 110.26 20.98 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.42 179.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.604 HD12 ' O ' ' A' ' 244' ' ' GLN . 9.5 mp -121.97 -168.25 1.68 Allowed 'General case' 0 C--O 1.226 -0.177 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.605 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . 0.524 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.37 -16.7 0.05 OUTLIER Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . 0.67 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -60.49 157.05 29.84 Favored Glycine 0 CA--C 1.522 0.477 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -63.8 21.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.879 0.371 . . . . 0.0 110.548 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . 0.67 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.9 m-20 -96.95 -5.97 36.69 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.499 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 92.8 mt -79.88 -21.68 43.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.671 179.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.51 -51.17 71.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.784 -179.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.56 -5.52 58.14 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.473 179.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.36 -74.4 1.15 Allowed Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 81.4 mt -69.98 125.77 27.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.011 0.434 . . . . 0.0 110.332 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -59.26 -39.5 83.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.212 -179.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 82.65 51.93 4.11 Favored Glycine 0 CA--C 1.52 0.404 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -96.48 -14.49 22.31 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.712 0.292 . . . . 0.0 110.581 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . 0.494 ' OG ' HG23 ' A' ' 191' ' ' VAL . 3.5 t 174.58 88.36 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.037 0.446 . . . . 0.0 110.165 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.86 ' N ' HD12 ' A' ' 259' ' ' LEU . 0.9 OUTLIER -94.2 123.98 37.93 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.183 0.516 . . . . 0.0 111.088 -179.1 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 260' ' ' PHE . . . . . 0.443 ' H ' ' HA ' ' A' ' 193' ' ' ALA . 15.9 m-30 -92.97 146.24 23.77 Favored 'General case' 0 CA--C 1.505 -0.786 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.428 179.295 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 86.7 mt -122.21 149.96 42.93 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.628 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.75 ' CD1' HG13 ' A' ' 195' ' ' VAL . 2.6 p90 -77.53 -138.23 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.619 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . 0.66 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -52.43 77.44 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.01 0.433 . . . . 0.0 111.074 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . 0.624 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -178.93 104.42 0.19 Allowed Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.666 -0.974 . . . . 0.0 110.666 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 265' ' ' ASP . . . . . 0.601 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.9 m-20 -80.45 -177.8 6.37 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 120.643 0.259 . . . . 0.0 110.862 -179.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -40.41 -17.62 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.548 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . 0.601 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.48 -51.66 40.98 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 120.998 0.428 . . . . 0.0 110.687 179.386 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -63.64 -46.72 84.4 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.212 179.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . 0.573 ' HB1' ' OH ' ' A' ' 273' ' ' TYR . . . -61.64 -35.08 76.89 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.218 0.532 . . . . 0.0 109.84 179.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -63.11 -34.09 76.85 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.045 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.73 -43.37 13.43 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.175 -179.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 272' ' ' ILE . . . . . 0.587 ' C ' ' H ' ' A' ' 274' ' ' ALA . 4.9 tt -51.43 -33.53 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.815 -178.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 273' ' ' TYR . . . . . 0.573 ' OH ' ' HB1' ' A' ' 269' ' ' ALA . 17.2 m-85 -54.49 -1.74 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.681 -179.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 274' ' ' ALA . . . . . 0.587 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.55 -39.61 70.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.842 179.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . 0.583 ' O ' ' N ' ' A' ' 279' ' ' ALA . 3.1 p30 -39.32 98.06 0.16 Allowed Pre-proline 0 C--O 1.226 -0.144 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.495 -179.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -54.29 -42.92 63.26 Favored 'Trans proline' 0 C--N 1.303 -1.856 0 C-N-CA 122.385 2.056 . . . . 0.0 112.533 -178.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 88.8 mt -64.46 -42.84 95.71 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.103 0.478 . . . . 0.0 111.138 -179.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 90.6 mt -95.67 -1.68 49.62 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.887 -179.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 279' ' ' ALA . . . . . 0.583 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.38 -34.81 77.44 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.668 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.29 20.26 0.11 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.968 -179.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 0.488 HD23 ' HA ' ' A' ' 281' ' ' LEU . 13.8 mt -75.47 119.89 79.11 Favored Pre-proline 0 N--CA 1.451 -0.423 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.56 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -50.49 -39.41 54.9 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 122.66 2.24 . . . . 0.0 111.951 178.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.75 -50.55 63.25 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.149 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 78.8 t -61.4 -44.02 97.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 179.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -57.74 -41.15 81.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.252 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -90.98 -0.03 57.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.2 179.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt 59.47 43.58 16.05 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.872 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -94.81 41.41 1.09 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.387 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 53.8 t -119.08 135.8 58.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.047 0.451 . . . . 0.0 110.173 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -133.01 162.56 31.37 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.645 -179.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.7 155.11 33.06 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.943 0.401 . . . . 0.0 110.754 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 81.4 mt -93.91 -1.43 54.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.302 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.38 165.93 12.77 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 6.5 m -87.61 -62.39 1.51 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.888 0.375 . . . . 0.0 110.945 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 295' ' ' GLU . . . . . 0.434 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.5 mm-40 -69.54 -3.83 16.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.645 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 27.2 p -76.94 33.27 0.14 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.663 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 297' ' ' PHE . . . . . 0.532 ' CD2' HG22 ' A' ' 70' ' ' THR . 85.1 t80 -60.21 -46.01 91.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.618 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . 0.595 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.2 mtt85 -81.71 134.6 35.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.584 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.456 ' H ' HG11 ' A' ' 51' ' ' VAL . 16.3 tp -114.27 119.07 35.73 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-O 121.006 0.431 . . . . 0.0 110.19 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . 0.626 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.9 p-10 -166.52 -175.09 3.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.577 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 81.5 t80 -47.78 -44.72 28.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.292 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -65.59 -41.16 93.14 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.021 0.438 . . . . 0.0 110.701 178.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . 0.626 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 54.0 p -55.58 -36.16 66.56 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.042 -179.219 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . 0.531 ' HB2' ' SD ' ' A' ' 215' ' ' MET . . . -57.07 -51.65 68.43 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 90.9 mtp -56.23 -43.87 79.03 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -66.29 -42.68 88.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.029 0.442 . . . . 0.0 110.284 178.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 303' ' ' SER . 55.8 t -64.08 -42.75 96.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.208 179.377 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 42.6 tp -59.57 -42.2 91.91 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.816 -179.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -62.72 -38.83 92.04 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.148 179.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 310' ' ' ARG . . . . . 0.439 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.6 ttt85 -63.33 -44.09 95.89 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.216 179.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 88.3 mt -63.24 -42.06 99.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.255 179.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -62.85 -33.03 74.4 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.124 179.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -90.17 -23.32 21.35 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.352 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.479 HD22 ' CE2' ' A' ' 315' ' ' PHE . 6.8 tt -62.33 -43.23 99.3 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 121.041 0.448 . . . . 0.0 110.531 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 315' ' ' PHE . . . . . 0.479 ' CE2' HD22 ' A' ' 314' ' ' LEU . 91.7 m-85 . . . . . 0 C--O 1.22 -0.453 0 CA-C-O 117.97 -1.014 . . . . 0.0 110.436 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -99.8 135.81 40.66 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.114 0.483 . . . . 0.0 110.503 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.497 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -91.63 178.7 1.64 Allowed Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.53 -179.857 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.497 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.4 Cg_exo -61.62 147.67 94.82 Favored 'Trans proline' 0 C--N 1.3 -2.023 0 C-N-CA 122.901 2.401 . . . . 0.0 112.113 179.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.486 ' HE ' HD12 ' A' ' 39' ' ' LEU . 35.1 ptt180 -135.02 142.16 46.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.64 179.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -78.93 116.95 19.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.51 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.422 ' O ' HG23 ' A' ' 30' ' ' ILE . 9.6 tp -110.53 131.27 62.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.445 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.9 t -70.84 142.93 51.24 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.655 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 141' ' ' ILE . 24.6 t70 -141.05 177.36 8.11 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.468 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.3 p -73.15 -36.75 66.7 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.696 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -47.68 -95.01 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.303 -179.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -165.95 -25.28 0.02 OUTLIER Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 58.2 m -168.93 106.74 0.43 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.862 0.363 . . . . 0.0 110.632 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.581 ' CD2' HD13 ' A' ' 140' ' ' LEU . 36.4 t60 -129.79 144.49 51.33 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 121.066 0.46 . . . . 0.0 110.114 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.63 HG22 ' N ' ' A' ' 39' ' ' LEU . 97.2 m -128.59 166.63 18.49 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.49 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.63 ' N ' HG22 ' A' ' 38' ' ' THR . 82.2 mt -121.15 127.8 51.9 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.43 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -64.17 -44.48 91.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.716 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 37.9 p -165.55 155.03 12.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.387 179.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.53 ' H ' ' CD ' ' A' ' 42' ' ' GLN . 14.4 mp0 -42.71 100.28 0.22 Allowed Pre-proline 0 C--N 1.33 -0.261 0 O-C-N 123.352 0.408 . . . . 0.0 110.594 179.261 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -56.88 129.07 32.59 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 122.313 2.008 . . . . 0.0 112.239 -179.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -83.82 -24.13 31.1 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.552 179.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.541 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.5 mtm-85 -121.18 134.11 55.2 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.202 0.525 . . . . 0.0 110.192 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.0 mt -130.43 133.51 63.68 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.272 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.798 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 47.5 t -125.0 130.89 73.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 179.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.601 ' OG ' HD12 ' A' ' 117' ' ' LEU . 5.0 m -154.05 166.48 32.89 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.586 179.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 70.0 p -124.83 8.37 8.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.435 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.81 125.87 33.59 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.643 -179.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.46 HG11 ' H ' ' A' ' 299' ' ' LEU . 86.5 t -65.7 -44.61 93.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.543 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.7 m -62.62 -44.15 97.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.561 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 53.5 tp -62.38 -41.58 98.74 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.534 -179.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.452 ' O ' HD13 ' A' ' 58' ' ' LEU . 72.5 m -57.83 -44.42 86.45 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.267 -179.198 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.4 -62.17 5.34 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 179.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.6 t -48.18 -35.62 12.08 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.8 mt -61.86 -44.34 97.01 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.229 179.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.464 HD21 HE22 ' A' ' 85' ' ' GLN . 9.2 mp -65.43 -41.49 93.48 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.246 178.025 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.406 ' HB1' ' NE ' ' A' ' 169' ' ' ARG . . . -63.58 -41.13 98.4 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.906 -179.243 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.422 ' O ' HG23 ' A' ' 60' ' ' ILE . 8.0 tp -88.21 16.73 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.857 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 56.51 84.34 0.09 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.753 -179.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.24 57.98 0.07 OUTLIER Pre-proline 0 C--N 1.328 -0.359 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -179.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.421 ' HB3' HE21 ' A' ' 85' ' ' GLN . 9.3 Cg_endo -51.13 153.39 9.31 Favored 'Trans proline' 0 C--N 1.293 -2.351 0 C-N-CA 123.029 2.486 . . . . 0.0 112.11 -178.175 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.429 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -109.06 146.01 15.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.332 -179.681 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 97.0 mt -63.62 -45.48 97.43 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.338 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.502 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -129.8 134.58 47.66 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.519 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.482 ' O ' ' N ' ' A' ' 98' ' ' LEU . 73.3 m -134.57 158.82 43.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.838 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.99 139.36 16.17 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.496 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.93 -162.66 0.08 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.967 0.413 . . . . 0.0 110.423 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.52 HG22 ' CD2' ' A' ' 297' ' ' PHE . 13.8 t -133.45 135.49 44.58 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.389 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.482 ' C ' ' O ' ' A' ' 70' ' ' THR . 0.7 OUTLIER 29.72 68.94 0.64 Allowed Pre-proline 0 N--CA 1.466 0.354 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.729 -179.883 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_exo -61.52 145.39 97.9 Favored 'Trans proline' 0 C--N 1.3 -2.026 0 C-N-CA 122.714 2.276 . . . . 0.0 111.837 -178.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.527 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 46.4 p-10 -160.49 -31.96 0.06 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.742 179.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.533 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 99.1 m-20 -64.51 -39.21 93.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.317 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 -60.63 -48.09 83.32 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.52 -179.133 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.426 ' O ' ' O ' ' A' ' 77' ' ' ALA . 94.0 t -60.19 -24.9 31.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.373 -0.376 . . . . 0.0 109.999 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.533 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -45.45 172.69 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.648 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.568 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.7 p30 -61.67 177.57 0.4 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.513 -179.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.566 ' C ' ' H ' ' A' ' 81' ' ' GLY . 36.0 p30 -46.27 85.65 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.005 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.568 ' N ' ' O ' ' A' ' 78' ' ' ASP . 42.8 tp60 -67.08 13.54 0.06 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.194 0.521 . . . . 0.0 110.169 -179.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.566 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 117.87 -21.93 10.13 Favored Glycine 0 N--CA 1.461 0.309 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -107.83 116.29 31.69 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.985 0.422 . . . . 0.0 110.466 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 75.7 mt -98.84 0.79 44.99 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.502 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -91.94 6.5 46.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.019 0.438 . . . . 0.0 110.397 -179.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.783 ' O ' HG22 ' A' ' 89' ' ' VAL . 88.2 mt-30 -100.16 -27.0 13.75 Favored 'General case' 0 C--O 1.222 -0.385 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.78 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.4 t-105 -64.31 -40.64 96.34 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.021 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.551 ' O ' ' N ' ' A' ' 91' ' ' LYS . 68.5 m -77.75 -53.75 7.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.164 -179.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -48.33 -50.55 29.91 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.08 -179.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.783 HG22 ' O ' ' A' ' 85' ' ' GLN . 14.8 m -69.08 -40.88 81.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 120.9 0.381 . . . . 0.0 111.113 179.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.503 ' N ' HG23 ' A' ' 89' ' ' VAL . . . -71.94 -22.82 61.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.655 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.551 ' N ' ' O ' ' A' ' 87' ' ' SER . 65.8 tttm -61.64 -46.13 91.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.428 -179.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.441 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.8 mm-40 -90.15 -94.44 0.12 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.152 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.62 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.9 mtt180 -143.49 59.79 1.39 Allowed 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.451 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.6 pttp 33.87 26.28 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.017 0.437 . . . . 0.0 110.286 -179.405 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.62 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.5 tt -48.27 123.14 6.03 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.011 -177.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.452 ' O ' HD23 ' A' ' 95' ' ' LEU . 99.0 mm-40 -83.41 -170.6 3.13 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.148 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.62 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 82.5 mtp180 -73.12 137.85 45.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.308 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.482 ' N ' ' O ' ' A' ' 67' ' ' SER . 88.7 mt -86.58 -166.14 1.47 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.793 -179.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.532 ' CD2' ' O ' ' A' ' 99' ' ' TYR . 47.8 p90 -167.89 119.9 0.86 Allowed 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.198 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.5 ' C ' ' O ' ' A' ' 99' ' ' TYR . 43.4 mm -29.44 121.18 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.005 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 113.64 28.25 3.28 Favored Glycine 0 CA--C 1.519 0.342 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 -179.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.58 ' N ' ' CD ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -144.0 46.15 0.62 Allowed Pre-proline 0 C--N 1.323 -0.582 0 CA-C-O 121.013 0.435 . . . . 0.0 110.428 179.764 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 29.5 Cg_endo -62.29 143.87 94.55 Favored 'Trans proline' 0 C--N 1.295 -2.246 0 C-N-CA 122.684 2.256 . . . . 0.0 111.844 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.46 ' O ' HG23 ' A' ' 108' ' ' VAL . 26.8 t -173.13 120.69 0.36 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.319 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.37 -40.94 63.97 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.075 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -65.92 -39.86 90.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.814 -179.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.01 -39.64 94.56 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.771 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 104' ' ' SER . 69.0 t -67.72 -43.74 86.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.724 179.585 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.43 -39.29 92.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.446 -179.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.441 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.66 -23.71 63.29 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.496 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.549 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.3 mm-40 -91.39 5.13 50.53 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.722 -179.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.549 ' C ' ' O ' ' A' ' 111' ' ' GLN . 10.4 tpt 21.96 64.84 0.32 Allowed Pre-proline 0 N--CA 1.467 0.408 0 CA-C-O 120.934 0.397 . . . . 0.0 111.157 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.448 ' HG2' HD11 ' A' ' 116' ' ' ILE . 61.8 Cg_endo -79.45 169.59 18.43 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 123.023 2.482 . . . . 0.0 111.698 -177.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.491 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 98.9 m-20 -113.12 -44.07 3.31 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.022 179.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.3 tp -120.09 120.69 36.98 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.462 HD13 HD22 ' A' ' 133' ' ' LEU . 96.4 mt -118.24 130.87 72.46 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.342 0 CA-C-O 120.904 0.383 . . . . 0.0 110.962 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.601 HD12 ' OG ' ' A' ' 48' ' ' SER . 32.3 mt -105.77 132.71 51.56 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.04 0.448 . . . . 0.0 110.287 -179.413 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 97.9 mt -117.9 135.74 57.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.673 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 85.5 p -71.7 153.42 42.05 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.593 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.11 -50.2 74.62 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.635 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -149.34 153.8 38.0 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.52 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 169.88 -170.51 42.85 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -63.08 -35.14 91.68 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.453 ' O ' ' OD1' ' A' ' 124' ' ' ASP . 44.4 p-10 -87.75 119.52 28.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.834 0.349 . . . . 0.0 110.701 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.446 ' O ' HD12 ' A' ' 129' ' ' LEU . 41.1 t -63.47 144.51 56.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.406 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.61 -42.33 9.25 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.775 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.4 tp -62.86 -42.22 99.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.649 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.41 -11.11 59.18 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.441 -179.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.446 HD12 ' O ' ' A' ' 125' ' ' SER . 84.5 mt -114.92 -24.55 8.58 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.647 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . 0.519 ' N ' ' O ' ' A' ' 126' ' ' ALA . 80.8 t80 -51.37 -49.91 60.58 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.649 -178.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.8 p-10 -65.72 -41.91 91.7 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.879 0.371 . . . . 0.0 111.317 179.429 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.521 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 87.8 mt-30 -67.88 -37.16 81.43 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.847 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.462 HD22 HD13 ' A' ' 116' ' ' ILE . 93.7 mt -79.7 -42.37 24.81 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.987 -179.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.3 t -56.94 -44.96 83.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.298 -179.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.8 m -62.32 -45.58 92.6 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.58 179.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 92.9 mt -62.49 -44.03 98.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.391 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.613 ' HB1' ' HD2' ' A' ' 138' ' ' PRO . . . -169.86 164.2 6.39 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.598 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.613 ' HD2' ' HB1' ' A' ' 137' ' ' ALA . 74.3 Cg_exo -43.32 111.66 0.24 Allowed 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.507 2.138 . . . . 0.0 112.243 179.249 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.467 HG21 ' CD1' ' A' ' 130' ' ' TYR . 17.1 m -86.12 127.34 34.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.675 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.581 HD13 ' CD2' ' A' ' 37' ' ' HIS . 34.9 tp -119.48 137.48 53.76 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.107 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.423 ' O ' ' OD1' ' A' ' 32' ' ' ASP . 78.2 mt -104.82 120.74 55.79 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 CA-C-O 121.154 0.502 . . . . 0.0 111.213 -179.352 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.506 HD12 HD22 ' A' ' 117' ' ' LEU . 94.3 mt -136.44 132.55 49.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.576 179.543 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.55 HD21 ' CG ' ' A' ' 241' ' ' ASP . 56.1 t30 -64.47 151.65 43.77 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.941 0.4 . . . . 0.0 110.43 179.262 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.522 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 88.1 t80 -85.57 122.71 30.08 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.966 -179.492 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.522 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 99.0 m-20 54.95 69.44 0.73 Allowed 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.741 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 49.3 p-10 -123.87 0.07 8.56 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.844 0.354 . . . . 0.0 110.638 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -151.46 117.03 5.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.766 -179.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 85.1 p -62.91 167.6 4.59 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.558 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.409 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.5 p-90 -50.56 -15.69 0.29 Allowed 'General case' 0 C--O 1.223 -0.322 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.469 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.445 ' O ' HG23 ' A' ' 154' ' ' THR . 68.0 tp60 -71.3 -74.57 0.15 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.496 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.448 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.2 t -62.75 -39.07 92.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.18 179.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 52.1 tp -60.08 -45.7 92.05 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.403 -178.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.409 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 46.8 tp -62.67 -41.64 99.19 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.529 178.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.448 ' OG1' ' O ' ' A' ' 151' ' ' SER . 53.4 p -64.02 -34.71 78.63 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.192 -179.425 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.48 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.8 mm-40 -63.82 -42.08 97.73 Favored 'General case' 0 C--O 1.226 -0.178 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.273 179.26 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 90.8 mt -65.44 -38.82 91.0 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.096 0.474 . . . . 0.0 110.203 179.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.567 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.46 -31.94 79.31 Favored Glycine 0 CA--C 1.52 0.353 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 -179.267 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.48 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.3 mt-10 -37.04 -25.17 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.818 0.342 . . . . 0.0 110.799 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.567 ' N ' ' O ' ' A' ' 157' ' ' GLY . 93.4 mt -59.79 149.63 6.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.323 179.285 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 76.5 p -68.99 137.26 53.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.935 -179.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 70.36 22.47 77.63 Favored Glycine 0 N--CA 1.459 0.184 0 N-CA-C 111.211 -0.756 . . . . 0.0 111.211 179.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 62.0 m80 -124.29 -14.63 6.92 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.681 0.276 . . . . 0.0 110.48 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -67.02 -59.41 3.5 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.628 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -51.78 -49.26 63.04 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.119 -179.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -60.7 -41.09 94.5 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.894 -0.322 . . . . 0.0 110.45 179.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.48 -47.69 84.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.567 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.53 -40.25 74.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.244 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -61.56 -50.1 74.01 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.631 179.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.406 ' NE ' ' HB1' ' A' ' 59' ' ' ALA . 59.9 ttt85 -65.3 -43.57 90.68 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.523 179.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 94.4 mt -64.61 -43.38 96.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.366 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.35 -51.41 69.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.378 -179.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -63.51 -43.69 96.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.614 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.665 ' CE2' HD11 ' A' ' 177' ' ' LEU . 56.3 t80 -62.88 -44.32 96.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.077 0.465 . . . . 0.0 110.407 179.475 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -63.32 -39.61 95.04 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.659 -179.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -63.15 -42.78 99.5 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.55 179.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -60.76 -44.74 96.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.238 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.665 HD11 ' CE2' ' A' ' 173' ' ' PHE . 85.1 mt -64.66 -41.05 96.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.73 178.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.12 -62.21 1.78 Allowed 'General case' 0 C--O 1.238 0.479 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.37 -179.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.61 -46.66 86.54 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.58 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.27 -41.49 65.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.34 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -64.05 -33.78 76.54 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.011 0.434 . . . . 0.0 110.235 179.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.417 ' HG2' ' O ' ' A' ' 182' ' ' GLU . 69.7 tt0 -90.76 8.86 32.51 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.538 0.685 . . . . 0.0 110.371 -178.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -104.73 -32.13 9.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.18 179.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.7 pt -127.96 147.69 32.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.807 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -139.98 131.23 26.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.428 179.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.592 HD22 ' N ' ' A' ' 186' ' ' LEU . 3.5 mm? -85.38 133.15 42.95 Favored Pre-proline 0 N--CA 1.452 -0.358 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.077 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -43.78 157.86 0.13 Allowed 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.714 2.276 . . . . 0.0 112.316 179.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 0.51 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.6 Cg_endo -62.91 114.84 2.6 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 C-N-CA 122.804 2.336 . . . . 0.0 111.746 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . 0.51 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.7 mt-30 155.63 147.69 0.0 OUTLIER Pre-proline 0 N--CA 1.457 -0.113 0 O-C-N 123.916 0.76 . . . . 0.0 110.825 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -73.48 144.18 35.81 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.672 2.248 . . . . 0.0 112.213 177.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.496 HG23 ' OG ' ' A' ' 258' ' ' SER . 2.1 p -124.96 158.97 32.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.319 0.581 . . . . 0.0 110.212 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . 0.492 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 35.8 p -143.28 165.11 28.38 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.034 -179.704 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . 0.448 ' HA ' ' H ' ' A' ' 260' ' ' PHE . . . -135.38 128.72 32.15 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 121.244 0.545 . . . . 0.0 110.281 179.395 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.511 HD11 HD23 ' A' ' 259' ' ' LEU . 47.5 pt -146.46 148.87 16.55 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.348 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.13 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . 0.749 HG13 ' CD1' ' A' ' 262' ' ' PHE . 69.0 t -117.59 123.23 71.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.32 0.581 . . . . 0.0 109.836 178.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -134.4 107.01 7.35 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.336 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 95.3 m -130.7 130.59 44.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.813 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.4 ' O ' ' N ' ' A' ' 201' ' ' HIS . . . -82.82 -37.04 25.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.21 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.33 -67.21 0.25 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.328 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.16 -9.84 58.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.299 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . 0.4 ' N ' ' O ' ' A' ' 198' ' ' ALA . 59.8 t-80 60.64 58.34 2.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.85 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 31.8 p -167.21 153.76 8.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.555 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.3 144.04 24.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.049 0.452 . . . . 0.0 110.398 179.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -135.18 138.01 43.23 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.714 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 19.7 mt -105.96 125.32 50.85 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.083 0.468 . . . . 0.0 109.843 -179.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' TRP . . . . . 0.554 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 74.6 m95 -81.98 166.98 19.35 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.543 -179.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . 0.465 HG22 ' C ' ' A' ' 206' ' ' TRP . 0.1 OUTLIER -157.21 171.24 7.7 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.581 -179.083 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.31 -36.92 80.28 Favored 'Trans proline' 0 C--N 1.302 -1.874 0 C-N-CA 122.612 2.208 . . . . 0.0 112.32 179.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -70.86 -35.02 72.21 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.713 -179.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 21.5 m -61.16 150.64 33.62 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.602 -179.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.68 -37.0 82.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.445 -179.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . 0.554 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 54.9 tt0 -64.7 -40.26 95.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.498 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.71 -43.44 91.87 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -63.11 -43.96 96.97 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.803 0.335 . . . . 0.0 110.283 179.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . 0.541 ' SD ' ' HB2' ' A' ' 304' ' ' ALA . 65.1 ttp -59.26 -48.12 82.81 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.123 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 87.3 mt -60.52 -41.04 93.61 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . 0.451 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.0 tp10 -57.94 -37.89 74.93 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.059 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -65.34 -38.18 89.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.655 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 94.2 mt -64.08 -42.93 96.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.074 0.464 . . . . 0.0 110.596 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.89 44.74 0.08 OUTLIER Glycine 0 C--N 1.332 0.339 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . 0.451 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 26.3 m-85 -127.74 155.64 43.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.987 0.422 . . . . 0.0 110.498 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.483 ' O ' HG13 ' A' ' 191' ' ' VAL . 7.4 p -107.36 122.49 46.7 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.285 0.564 . . . . 0.0 110.132 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.476 HD22 ' C ' ' A' ' 222' ' ' THR . 4.3 mm? -101.64 132.7 47.18 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.101 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.4 159.95 14.67 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.476 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.55 115.36 30.11 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.348 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.494 ' N ' HD12 ' A' ' 226' ' ' LEU . 8.9 mp -53.37 156.7 3.94 Favored Pre-proline 0 N--CA 1.452 -0.36 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.725 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -59.91 145.1 99.13 Favored 'Trans proline' 0 C--N 1.301 -1.959 0 C-N-CA 122.688 2.259 . . . . 0.0 112.226 179.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.3 -3.14 59.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.584 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.14 -41.0 5.66 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 111.034 -0.827 . . . . 0.0 111.034 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.524 ' O ' ' N ' ' A' ' 233' ' ' SER . 85.3 mt -79.12 -16.98 55.91 Favored 'General case' 0 C--O 1.22 -0.45 0 CA-C-O 121.062 0.458 . . . . 0.0 110.326 -179.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 54.5 t-20 -40.43 -49.06 2.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.77 -179.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -87.97 15.16 7.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.323 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.524 ' N ' ' O ' ' A' ' 230' ' ' LEU . 77.9 p -60.43 -35.41 75.75 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.711 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . 0.526 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.6 tt0 -118.8 -69.36 0.85 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.901 179.329 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.2 m -69.95 102.88 2.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.707 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -94.31 57.72 2.35 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.339 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -144.71 -122.65 1.59 Allowed Glycine 0 CA--C 1.519 0.332 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -134.79 111.62 10.06 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.125 0.488 . . . . 0.0 110.371 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . 0.521 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.4 mtt180 -148.03 57.94 1.09 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.672 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -69.68 -31.88 70.18 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.538 179.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . 0.55 ' CG ' HD21 ' A' ' 143' ' ' ASN . 64.7 t0 -56.98 -47.09 81.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.328 -179.096 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 242' ' ' ILE . . . . . 0.435 ' O ' ' O ' ' A' ' 239' ' ' ARG . 17.6 tt -140.19 156.92 24.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.904 0.383 . . . . 0.0 110.475 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.442 HG22 HD13 ' A' ' 245' ' ' LEU . 96.2 mt -106.17 106.58 20.85 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.199 0 CA-C-O 121.097 0.475 . . . . 0.0 110.531 179.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . 0.596 ' O ' HD12 ' A' ' 245' ' ' LEU . 88.2 mt-30 -110.51 110.17 20.79 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.363 179.687 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.596 HD12 ' O ' ' A' ' 244' ' ' GLN . 9.5 mp -121.68 -168.33 1.68 Allowed 'General case' 0 C--O 1.224 -0.264 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.639 179.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . 0.526 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.61 -16.64 0.05 OUTLIER Glycine 0 CA--C 1.523 0.564 0 N-CA-C 110.999 -0.841 . . . . 0.0 110.999 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . 0.67 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -60.81 156.81 31.64 Favored Glycine 0 CA--C 1.522 0.476 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -63.73 21.79 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.012 0.434 . . . . 0.0 110.643 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . 0.67 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.7 m-20 -97.44 -5.97 34.94 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.515 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 92.2 mt -79.78 -21.71 44.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.769 179.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.51 -51.37 70.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.715 -179.527 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.37 -5.48 58.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.494 179.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.08 -74.39 1.14 Allowed Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 81.5 mt -70.0 125.98 28.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.908 0.385 . . . . 0.0 110.297 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -59.91 -39.07 84.16 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.208 -179.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 83.29 51.69 4.05 Favored Glycine 0 CA--C 1.521 0.423 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -95.2 -15.67 23.09 Favored 'General case' 0 C--N 1.331 -0.214 0 O-C-N 122.746 -0.267 . . . . 0.0 110.591 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . 0.496 ' OG ' HG23 ' A' ' 191' ' ' VAL . 3.3 t 174.54 89.3 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.099 0.476 . . . . 0.0 110.1 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.856 ' N ' HD12 ' A' ' 259' ' ' LEU . 1.0 OUTLIER -94.4 124.24 38.3 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.206 0.527 . . . . 0.0 111.259 -179.072 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 260' ' ' PHE . . . . . 0.448 ' H ' ' HA ' ' A' ' 193' ' ' ALA . 15.9 m-30 -93.34 146.41 23.75 Favored 'General case' 0 CA--C 1.501 -0.917 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.395 179.315 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 85.9 mt -122.25 149.7 43.32 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.551 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.749 ' CD1' HG13 ' A' ' 195' ' ' VAL . 2.6 p90 -77.37 -138.69 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.666 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . 0.655 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -51.78 77.35 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 121.035 0.445 . . . . 0.0 111.174 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . 0.626 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.15 104.75 0.19 Allowed Glycine 0 CA--C 1.527 0.824 0 N-CA-C 110.554 -1.019 . . . . 0.0 110.554 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 265' ' ' ASP . . . . . 0.601 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.7 m-20 -80.34 -177.94 6.39 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.64 0.257 . . . . 0.0 110.928 -179.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -40.26 -17.73 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.576 179.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . 0.601 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.31 -51.74 41.34 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.71 179.287 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -63.55 -46.64 85.04 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.236 179.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . 0.572 ' HB1' ' OH ' ' A' ' 273' ' ' TYR . . . -61.66 -35.04 76.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.349 0.595 . . . . 0.0 109.843 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -63.09 -34.06 76.79 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.204 179.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.87 -43.28 13.39 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.108 -179.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 272' ' ' ILE . . . . . 0.586 ' C ' ' H ' ' A' ' 274' ' ' ALA . 4.8 tt -51.31 -33.48 14.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.737 -178.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 273' ' ' TYR . . . . . 0.572 ' OH ' ' HB1' ' A' ' 269' ' ' ALA . 17.1 m-85 -54.81 -1.72 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.665 -179.44 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 274' ' ' ALA . . . . . 0.586 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.65 -39.81 70.11 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.952 179.428 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . 0.58 ' O ' ' N ' ' A' ' 279' ' ' ALA . 3.2 p30 -39.02 98.05 0.16 Allowed Pre-proline 0 C--O 1.227 -0.124 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.474 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -54.48 -42.81 64.63 Favored 'Trans proline' 0 C--N 1.303 -1.862 0 C-N-CA 122.42 2.08 . . . . 0.0 112.543 -178.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 89.3 mt -64.4 -42.91 95.83 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.126 0.488 . . . . 0.0 111.158 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 91.2 mt -95.57 -1.77 49.78 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.874 -179.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 279' ' ' ALA . . . . . 0.58 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.25 -34.87 77.36 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.755 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.2 20.11 0.11 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.998 -179.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 0.481 ' H ' ' C ' ' A' ' 279' ' ' ALA . 13.9 mt -75.2 119.69 78.16 Favored Pre-proline 0 N--CA 1.448 -0.545 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.688 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -49.97 -40.01 49.61 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.678 2.252 . . . . 0.0 112.238 178.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.56 -50.56 62.7 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.118 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 71.8 t -61.46 -43.82 97.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 110.04 -0.355 . . . . 0.0 110.04 179.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -57.84 -41.28 81.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.198 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -90.96 0.29 57.56 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.129 179.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt 59.47 43.04 16.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.844 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -94.49 41.51 1.09 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.429 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 53.8 t -119.03 135.62 58.87 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.156 0 CA-C-O 121.072 0.463 . . . . 0.0 110.111 -179.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -132.85 162.75 30.71 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.153 0.502 . . . . 0.0 110.629 -179.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.69 154.98 33.28 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.015 0.436 . . . . 0.0 110.699 -179.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 81.6 mt -93.96 -1.52 54.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.247 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.66 165.88 12.71 Favored Glycine 0 CA--C 1.521 0.45 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 6.5 m -87.8 -62.2 1.55 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.864 0.364 . . . . 0.0 111.008 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 295' ' ' GLU . . . . . 0.448 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.6 mm-40 -69.35 -4.08 16.78 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.701 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 27.0 p -76.46 32.8 0.13 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.645 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 297' ' ' PHE . . . . . 0.52 ' CD2' HG22 ' A' ' 70' ' ' THR . 85.7 t80 -60.39 -46.06 91.32 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.573 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . 0.62 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.2 mtt85 -81.45 135.06 35.62 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.569 -179.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.46 ' H ' HG11 ' A' ' 51' ' ' VAL . 17.0 tp -114.24 117.77 32.07 Favored 'General case' 0 C--O 1.231 0.085 0 CA-C-O 121.005 0.431 . . . . 0.0 110.182 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . 0.636 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.4 p-10 -165.42 -176.38 3.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.624 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 80.2 t80 -47.07 -43.39 20.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.348 -179.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -67.01 -40.49 87.3 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.024 0.44 . . . . 0.0 110.747 179.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . 0.636 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 60.3 p -55.71 -36.5 67.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.074 -179.193 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . 0.541 ' HB2' ' SD ' ' A' ' 215' ' ' MET . . . -57.08 -51.69 68.27 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 179.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 91.2 mtp -55.97 -43.92 78.01 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -66.2 -42.64 88.51 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.141 0.495 . . . . 0.0 110.257 179.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 303' ' ' SER . 55.4 t -64.15 -42.82 96.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.26 179.374 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 43.1 tp -59.74 -42.15 92.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.871 -179.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -62.63 -38.78 91.57 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.237 179.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 310' ' ' ARG . . . . . 0.45 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.6 ttt85 -63.56 -43.86 95.8 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.246 179.538 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 90.3 mt -63.0 -42.12 99.77 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.311 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -62.94 -33.16 74.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.113 179.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.97 -23.31 21.57 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.318 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.481 HD22 ' CE2' ' A' ' 315' ' ' PHE . 6.7 tt -62.27 -43.19 99.4 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 121.055 0.455 . . . . 0.0 110.52 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 315' ' ' PHE . . . . . 0.481 ' CE2' HD22 ' A' ' 314' ' ' LEU . 91.2 m-85 . . . . . 0 C--O 1.22 -0.466 0 CA-C-O 118.055 -0.974 . . . . 0.0 110.405 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -99.63 136.43 39.58 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.016 0.436 . . . . 0.0 110.538 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.497 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -91.71 178.46 1.74 Allowed Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.58 -179.882 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.497 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.5 Cg_exo -61.69 147.5 95.18 Favored 'Trans proline' 0 C--N 1.3 -2.007 0 C-N-CA 122.778 2.318 . . . . 0.0 112.123 179.639 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.494 ' HE ' HD12 ' A' ' 39' ' ' LEU . 35.4 ptt180 -135.76 142.65 44.98 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.655 179.742 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -79.11 116.96 19.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.501 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.431 ' O ' HG23 ' A' ' 30' ' ' ILE . 9.6 tp -110.32 130.86 62.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.408 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 13.3 t -71.14 141.93 50.74 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.53 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.427 ' OD1' ' O ' ' A' ' 141' ' ' ILE . 25.1 t70 -139.87 177.88 7.65 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.517 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.0 p -73.73 -36.59 65.2 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.688 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.8 ttt85 -47.78 -95.25 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.269 -179.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -165.22 -26.06 0.02 OUTLIER Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 67.5 m -168.32 106.79 0.49 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.889 0.376 . . . . 0.0 110.652 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.56 ' CD2' HD13 ' A' ' 140' ' ' LEU . 33.4 t60 -129.71 143.56 50.88 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.027 0.442 . . . . 0.0 110.152 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.627 HG22 ' N ' ' A' ' 39' ' ' LEU . 97.5 m -128.18 166.12 19.13 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.636 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.627 ' N ' HG22 ' A' ' 38' ' ' THR . 81.1 mt -120.78 127.61 52.12 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.523 179.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -64.42 -44.26 91.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.656 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 41.5 p -165.68 154.84 11.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.424 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.478 ' H ' ' CD ' ' A' ' 42' ' ' GLN . 13.7 mp0 -43.42 100.69 0.23 Allowed Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.636 179.467 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -56.85 129.33 34.01 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 122.399 2.066 . . . . 0.0 112.262 -179.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -83.88 -23.95 31.05 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.45 179.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.544 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.3 mtm-85 -120.9 134.26 55.29 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 121.132 0.492 . . . . 0.0 110.202 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 95.9 mt -130.65 133.48 63.39 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.939 -179.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 49.1 t -125.05 131.06 73.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.825 0.345 . . . . 0.0 110.119 179.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.617 ' OG ' HD12 ' A' ' 117' ' ' LEU . 5.1 m -154.41 166.16 34.13 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.506 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 65.0 p -124.94 8.5 8.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.501 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.71 125.75 33.44 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.686 -179.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.457 HG11 ' H ' ' A' ' 299' ' ' LEU . 88.6 t -65.75 -44.65 93.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.47 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 20.0 m -62.53 -44.29 96.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.605 -179.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 51.2 tp -62.28 -41.51 98.55 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.572 -179.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.459 ' O ' HD13 ' A' ' 58' ' ' LEU . 70.6 m -57.67 -44.36 85.7 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.343 -179.313 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.48 -61.91 5.55 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.929 -0.869 . . . . 0.0 110.929 179.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.7 t -48.51 -35.67 13.64 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 20.0 mt -61.77 -44.72 96.33 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.661 -0.416 . . . . 0.0 111.126 179.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.459 HD13 ' O ' ' A' ' 54' ' ' THR . 9.2 mp -64.96 -41.8 95.16 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.189 178.024 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.405 ' HB1' ' NE ' ' A' ' 169' ' ' ARG . . . -63.62 -41.27 98.29 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.947 -179.152 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.429 ' O ' HG23 ' A' ' 60' ' ' ILE . 8.0 tp -88.13 16.7 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.771 -179.619 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 56.61 84.28 0.09 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.653 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.37 57.38 0.07 OUTLIER Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.058 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.413 ' HB3' HE21 ' A' ' 85' ' ' GLN . 9.7 Cg_endo -50.3 153.19 7.39 Favored 'Trans proline' 0 C--N 1.296 -2.199 0 C-N-CA 122.874 2.383 . . . . 0.0 112.388 -178.303 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.428 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.4 OUTLIER -109.03 146.38 14.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.367 -179.699 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 97.1 mt -63.79 -45.16 97.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.368 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.51 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -130.31 134.83 47.49 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.575 -179.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.464 ' O ' ' N ' ' A' ' 98' ' ' LEU . 73.8 m -134.52 158.73 43.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.843 -179.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.35 138.94 16.3 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.488 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.86 -162.7 0.08 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.996 0.427 . . . . 0.0 110.515 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.513 HG22 ' CD2' ' A' ' 297' ' ' PHE . 5.9 t -133.74 135.94 44.27 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.192 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.492 ' C ' ' O ' ' A' ' 70' ' ' THR . 1.0 OUTLIER 29.55 68.57 0.65 Allowed Pre-proline 0 N--CA 1.465 0.3 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.715 -179.7 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -61.25 144.57 98.8 Favored 'Trans proline' 0 C--N 1.301 -1.964 0 C-N-CA 122.668 2.245 . . . . 0.0 112.092 -178.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.519 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 45.7 p-10 -159.87 -31.61 0.06 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.717 179.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.537 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 98.7 m-20 -64.52 -38.92 92.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.46 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 73.2 ttt180 -60.87 -47.9 84.25 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.752 -179.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.422 ' O ' ' O ' ' A' ' 77' ' ' ALA . 94.6 t -60.36 -24.6 31.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.324 -0.398 . . . . 0.0 109.927 179.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.537 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -45.53 172.58 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.5 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.576 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.5 p30 -61.78 177.73 0.4 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.706 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.565 ' C ' ' H ' ' A' ' 81' ' ' GLY . 35.8 p30 -46.11 85.58 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.909 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.576 ' N ' ' O ' ' A' ' 78' ' ' ASP . 43.1 tp60 -67.01 13.62 0.06 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.139 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.565 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 117.78 -22.13 10.1 Favored Glycine 0 CA--C 1.52 0.355 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -107.94 116.52 32.11 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.016 0.436 . . . . 0.0 110.486 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 76.7 mt -98.83 0.86 45.16 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.453 -179.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -91.94 6.48 46.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.972 0.415 . . . . 0.0 110.388 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.79 ' O ' HG22 ' A' ' 89' ' ' VAL . 88.0 mt-30 -100.04 -27.27 13.65 Favored 'General case' 0 C--O 1.223 -0.29 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.77 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.5 t-105 -63.87 -40.78 97.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.015 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.555 ' O ' ' N ' ' A' ' 91' ' ' LYS . 67.7 m -77.63 -53.62 7.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.328 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -48.41 -50.85 29.36 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.972 -179.221 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.79 HG22 ' O ' ' A' ' 85' ' ' GLN . 15.1 m -68.89 -40.74 81.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 120.9 0.381 . . . . 0.0 110.984 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.498 ' N ' HG23 ' A' ' 89' ' ' VAL . . . -72.24 -22.59 61.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.704 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.555 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.0 tttm -61.47 -46.19 91.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.437 -179.545 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.438 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.6 mm-40 -90.32 -94.2 0.12 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.149 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.632 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.9 mtt180 -143.44 59.82 1.39 Allowed 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.461 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.6 pttp 33.69 26.18 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.259 -179.247 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.632 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.4 tt -47.87 123.23 5.8 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.969 -178.185 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.445 ' O ' HD23 ' A' ' 95' ' ' LEU . 98.8 mm-40 -83.51 -170.29 2.98 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.08 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.617 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 83.0 mtp180 -73.22 137.8 45.21 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.311 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.464 ' N ' ' O ' ' A' ' 67' ' ' SER . 87.9 mt -86.95 -166.03 1.46 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.721 -179.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.53 ' CD2' ' O ' ' A' ' 99' ' ' TYR . 48.0 p90 -168.06 120.31 0.86 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.236 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.509 ' C ' ' O ' ' A' ' 99' ' ' TYR . 43.5 mm -29.87 121.64 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.956 -179.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 113.72 28.12 3.31 Favored Glycine 0 CA--C 1.52 0.384 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 -179.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.589 ' H ' ' CD ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -143.98 45.87 0.6 Allowed Pre-proline 0 C--N 1.324 -0.536 0 CA-C-O 120.922 0.392 . . . . 0.0 110.43 179.867 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.584 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 29.8 Cg_endo -62.0 143.74 95.51 Favored 'Trans proline' 0 C--N 1.298 -2.109 0 C-N-CA 122.678 2.252 . . . . 0.0 112.004 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.462 ' O ' HG23 ' A' ' 108' ' ' VAL . 26.8 t -173.47 120.62 0.33 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.459 179.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.12 -41.1 64.36 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.089 0.471 . . . . 0.0 111.165 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -65.87 -40.06 91.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.792 -179.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.83 -39.89 95.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.698 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 104' ' ' SER . 69.6 t -67.66 -43.84 86.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.763 179.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.23 -39.46 92.89 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.566 -179.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.438 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.48 -23.5 62.81 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.469 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.561 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.3 mm-40 -91.35 4.99 51.02 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.755 -179.561 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.561 ' C ' ' O ' ' A' ' 111' ' ' GLN . 10.3 tpt 22.33 64.65 0.33 Allowed Pre-proline 0 N--CA 1.465 0.281 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.039 -179.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.453 ' HG2' HD11 ' A' ' 116' ' ' ILE . 67.9 Cg_endo -79.12 169.57 18.96 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 C-N-CA 122.957 2.438 . . . . 0.0 112.059 -178.395 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.485 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 99.0 m-20 -113.32 -44.16 3.27 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.172 179.399 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 41.3 tp -120.26 120.44 36.11 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.454 HD13 HD22 ' A' ' 133' ' ' LEU . 96.2 mt -117.96 131.24 71.29 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 CA-C-O 120.999 0.428 . . . . 0.0 110.884 -179.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.617 HD12 ' OG ' ' A' ' 48' ' ' SER . 31.4 mt -105.92 132.87 51.5 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.148 0.499 . . . . 0.0 110.204 -179.424 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.407 HD12 HG23 ' A' ' 139' ' ' THR . 97.8 mt -118.27 135.93 57.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.701 -179.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 85.9 p -72.09 153.74 41.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.613 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.19 -50.21 74.58 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.689 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -149.35 153.76 37.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.56 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 169.54 -170.0 42.39 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.82 -35.06 91.45 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.446 ' O ' ' OD1' ' A' ' 124' ' ' ASP . 44.1 p-10 -88.91 119.41 29.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.84 0.352 . . . . 0.0 110.7 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.449 ' O ' HD12 ' A' ' 129' ' ' LEU . 36.4 t -63.29 145.26 55.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.519 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.52 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.39 -43.8 8.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.958 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.4 tp -62.73 -42.34 99.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.73 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.49 -10.97 56.59 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.564 -179.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.449 HD12 ' O ' ' A' ' 125' ' ' SER . 83.9 mt -116.26 -23.59 8.33 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.651 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . 0.52 ' N ' ' O ' ' A' ' 126' ' ' ALA . 77.7 t80 -51.47 -49.6 61.46 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.674 -0.411 . . . . 0.0 110.567 -179.008 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.5 p-10 -65.83 -41.94 91.17 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.846 0.355 . . . . 0.0 111.109 179.554 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.526 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 88.1 mt-30 -67.82 -36.96 81.29 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.777 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.454 HD22 HD13 ' A' ' 116' ' ' ILE . 93.0 mt -80.27 -41.98 24.0 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.927 -179.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.2 t -57.5 -44.67 85.19 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.223 -179.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.2 m -62.3 -45.66 92.26 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.735 0.302 . . . . 0.0 110.596 179.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 91.8 mt -62.52 -43.86 98.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.406 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.598 ' HB1' ' HD2' ' A' ' 138' ' ' PRO . . . -170.1 163.51 6.32 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.506 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.598 ' HD2' ' HB1' ' A' ' 137' ' ' ALA . 78.5 Cg_exo -42.78 111.13 0.19 Allowed 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.469 2.112 . . . . 0.0 112.161 179.348 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.481 HG21 ' CD1' ' A' ' 130' ' ' TYR . 16.6 m -86.05 127.64 34.71 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.57 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.56 HD13 ' CD2' ' A' ' 37' ' ' HIS . 35.5 tp -119.99 138.39 53.51 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.032 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.427 ' O ' ' OD1' ' A' ' 32' ' ' ASP . 77.7 mt -105.57 120.66 56.7 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.358 0 CA-C-O 121.109 0.48 . . . . 0.0 111.291 -179.427 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.489 HD12 HD22 ' A' ' 117' ' ' LEU . 97.9 mt -135.93 132.69 50.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.627 179.602 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.533 HD21 ' CG ' ' A' ' 241' ' ' ASP . 61.0 t30 -64.42 150.87 45.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.939 0.399 . . . . 0.0 110.402 179.407 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.518 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 88.7 t80 -85.69 122.09 29.29 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.913 -179.513 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.518 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 98.8 m-20 55.63 69.01 0.78 Allowed 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.812 179.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 35.9 p-10 -125.4 0.01 7.63 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.683 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -150.64 115.61 5.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.76 -179.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 84.6 p -62.67 167.8 4.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.505 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.416 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.5 p-90 -51.09 -15.24 0.3 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.498 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.445 ' O ' HG23 ' A' ' 154' ' ' THR . 68.1 tp60 -71.34 -75.01 0.14 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.475 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.45 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.2 t -62.78 -38.83 92.18 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.031 0.444 . . . . 0.0 110.305 179.506 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 52.6 tp -60.17 -45.56 92.68 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.42 -178.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.416 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 45.9 tp -62.8 -41.8 99.44 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.856 0.36 . . . . 0.0 110.375 179.068 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.45 ' OG1' ' O ' ' A' ' 151' ' ' SER . 57.8 p -63.95 -34.52 78.16 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.312 -179.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.471 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.6 mm-40 -64.1 -42.24 96.98 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.263 179.269 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 91.4 mt -65.45 -38.83 91.01 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.182 179.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.574 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.34 -31.82 78.62 Favored Glycine 0 CA--C 1.52 0.406 0 N-CA-C 110.846 -0.901 . . . . 0.0 110.846 -179.396 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.471 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.2 mt-10 -36.97 -25.1 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.809 0.338 . . . . 0.0 110.706 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.574 ' N ' ' O ' ' A' ' 157' ' ' GLY . 94.4 mt -59.94 149.59 6.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.317 179.473 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 76.8 p -68.91 137.14 53.58 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.059 -179.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 70.63 22.0 77.89 Favored Glycine 0 N--CA 1.459 0.177 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 179.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 60.4 m80 -123.72 -14.83 7.16 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.786 0.327 . . . . 0.0 110.507 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -66.96 -59.31 3.6 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.686 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -51.85 -49.4 62.94 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.188 -179.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -60.64 -41.21 94.48 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.803 0.335 . . . . 0.0 110.316 179.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.46 -47.45 85.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.589 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.59 -40.27 74.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.247 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -61.57 -50.1 73.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.578 179.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.405 ' NE ' ' HB1' ' A' ' 59' ' ' ALA . 59.9 ttt85 -65.47 -43.63 89.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.471 179.523 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 94.8 mt -64.46 -43.48 96.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.429 179.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.41 -51.16 70.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.525 -179.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.76 -43.78 95.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.375 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.658 ' CE2' HD11 ' A' ' 177' ' ' LEU . 56.3 t80 -62.74 -44.53 95.97 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.069 0.462 . . . . 0.0 110.41 179.426 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -63.12 -39.8 95.76 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.611 -179.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -63.01 -42.8 99.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.617 179.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -60.69 -44.95 95.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.103 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.658 HD11 ' CE2' ' A' ' 173' ' ' PHE . 85.0 mt -64.52 -41.17 96.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.998 0.428 . . . . 0.0 110.642 178.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.02 -62.15 1.82 Allowed 'General case' 0 C--O 1.237 0.408 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.491 -179.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.86 -46.68 87.2 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.546 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.42 -41.66 66.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.176 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -63.91 -33.67 76.22 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.018 0.437 . . . . 0.0 110.387 179.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.423 ' HG2' ' O ' ' A' ' 182' ' ' GLU . 69.6 tt0 -90.56 8.63 33.12 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.435 0.636 . . . . 0.0 110.56 -178.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -104.55 -32.0 9.17 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.183 179.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.9 pt -127.99 147.74 32.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.882 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -139.77 130.97 26.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.396 179.393 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.595 HD22 ' N ' ' A' ' 186' ' ' LEU . 3.6 mm? -85.73 133.06 42.46 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.852 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -44.24 157.99 0.15 Allowed 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.747 2.298 . . . . 0.0 112.119 179.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 0.524 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 28.1 Cg_endo -63.08 115.21 2.82 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 C-N-CA 122.736 2.291 . . . . 0.0 111.773 179.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . 0.524 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.7 mt-30 155.61 147.63 0.0 OUTLIER Pre-proline 0 N--CA 1.454 -0.241 0 O-C-N 123.57 0.544 . . . . 0.0 110.727 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -73.81 143.73 33.85 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.767 2.311 . . . . 0.0 111.88 178.082 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.497 HG23 ' OG ' ' A' ' 258' ' ' SER . 2.1 p -124.93 158.93 32.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.24 0.543 . . . . 0.0 110.124 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . 0.497 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 36.9 p -143.41 165.37 27.71 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.092 -179.669 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . 0.446 ' HA ' ' H ' ' A' ' 260' ' ' PHE . . . -135.63 128.55 31.31 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 121.207 0.527 . . . . 0.0 110.224 179.533 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.504 HD11 HD23 ' A' ' 259' ' ' LEU . 47.2 pt -146.44 149.1 16.34 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.096 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . 0.743 HG13 ' CD1' ' A' ' 262' ' ' PHE . 69.0 t -117.94 123.13 71.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.25 0.548 . . . . 0.0 109.767 179.11 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -134.24 107.41 7.66 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.252 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 94.7 m -131.33 130.51 42.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.823 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.404 ' O ' ' N ' ' A' ' 201' ' ' HIS . . . -82.93 -36.92 24.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.354 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.48 -66.88 0.28 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.331 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.35 -10.27 59.57 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.278 179.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . 0.404 ' N ' ' O ' ' A' ' 198' ' ' ALA . 60.0 t-80 61.42 58.16 2.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.715 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 39.4 p -167.09 153.55 8.29 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.552 179.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -150.97 143.63 24.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.46 179.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -135.04 138.03 43.51 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 120.926 0.393 . . . . 0.0 110.608 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 19.8 mt -106.16 125.39 50.94 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 121.057 0.456 . . . . 0.0 109.892 -179.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' TRP . . . . . 0.554 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 74.6 m95 -81.88 166.78 19.63 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.564 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . 0.463 HG22 ' C ' ' A' ' 206' ' ' TRP . 0.1 OUTLIER -156.86 172.06 6.62 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.022 0.439 . . . . 0.0 110.505 -179.196 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.21 -36.85 87.23 Favored 'Trans proline' 0 C--N 1.303 -1.821 0 C-N-CA 122.624 2.216 . . . . 0.0 112.099 179.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -70.71 -34.84 72.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.822 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 21.3 m -61.3 150.68 34.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.642 -179.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.72 -36.92 82.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.472 -179.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . 0.554 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 55.0 tt0 -64.58 -40.37 95.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.491 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.71 -43.4 91.96 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -63.35 -43.8 96.66 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.924 -0.31 . . . . 0.0 110.294 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . 0.538 ' SD ' ' HB2' ' A' ' 304' ' ' ALA . 65.1 ttp -59.53 -47.94 83.59 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.269 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 87.1 mt -60.61 -40.84 93.33 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . 0.453 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 40.9 tp10 -57.93 -38.03 75.17 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -65.35 -37.98 88.7 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.77 0.319 . . . . 0.0 110.672 179.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 94.4 mt -64.3 -42.69 96.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.521 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.51 45.07 0.08 OUTLIER Glycine 0 C--N 1.334 0.419 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . 0.453 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 26.1 m-85 -128.04 155.78 43.8 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.05 0.452 . . . . 0.0 110.467 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.484 ' O ' HG13 ' A' ' 191' ' ' VAL . 7.2 p -107.66 122.57 46.99 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.3 0.572 . . . . 0.0 110.182 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.476 HD22 ' C ' ' A' ' 222' ' ' THR . 4.3 mm? -101.58 132.72 47.09 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.049 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.38 160.14 14.57 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.535 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -105.55 115.13 29.72 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.973 0.416 . . . . 0.0 110.294 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.498 ' N ' HD12 ' A' ' 226' ' ' LEU . 9.0 mp -52.95 156.82 3.18 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.673 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -60.41 145.37 98.81 Favored 'Trans proline' 0 C--N 1.301 -1.945 0 C-N-CA 122.657 2.238 . . . . 0.0 112.075 179.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.22 -3.47 59.05 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.51 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -89.97 -41.19 5.66 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.535 ' O ' ' N ' ' A' ' 233' ' ' SER . 68.2 mt -78.78 -17.54 55.59 Favored 'General case' 0 C--O 1.223 -0.319 0 CA-C-O 120.998 0.428 . . . . 0.0 110.377 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . 0.403 ' C ' ' O ' ' A' ' 230' ' ' LEU . 54.7 t-20 -40.19 -49.34 2.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.789 -179.389 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -87.8 15.32 7.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.258 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.535 ' N ' ' O ' ' A' ' 230' ' ' LEU . 78.2 p -60.36 -35.61 76.09 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.645 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . 0.525 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.6 tt0 -119.02 -69.26 0.86 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.963 179.607 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.2 m -69.89 102.76 2.04 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.733 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -94.45 57.64 2.29 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.055 0.455 . . . . 0.0 110.364 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -144.65 -122.68 1.59 Allowed Glycine 0 CA--C 1.52 0.364 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -134.86 111.4 9.85 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 121.067 0.46 . . . . 0.0 110.433 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . 0.521 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.6 mtt180 -147.95 58.06 1.1 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.762 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -69.77 -32.31 70.74 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.533 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . 0.533 ' CG ' HD21 ' A' ' 143' ' ' ASN . 65.0 t0 -56.86 -46.95 81.44 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.395 -179.093 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 242' ' ' ILE . . . . . 0.434 ' O ' ' O ' ' A' ' 239' ' ' ARG . 18.0 tt -139.93 156.74 25.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.926 0.393 . . . . 0.0 110.492 179.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.448 HG22 HD13 ' A' ' 245' ' ' LEU . 96.0 mt -106.36 106.7 21.1 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.214 0 CA-C-O 121.208 0.528 . . . . 0.0 110.489 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . 0.604 ' O ' HD12 ' A' ' 245' ' ' LEU . 88.3 mt-30 -110.48 110.14 20.76 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.331 179.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.604 HD12 ' O ' ' A' ' 244' ' ' GLN . 9.4 mp -121.81 -168.48 1.71 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.577 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . 0.525 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.9 -16.27 0.05 OUTLIER Glycine 0 CA--C 1.524 0.614 0 N-CA-C 111.039 -0.824 . . . . 0.0 111.039 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . 0.674 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -61.17 156.42 33.77 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -63.45 21.81 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.933 0.397 . . . . 0.0 110.617 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . 0.674 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.8 m-20 -97.35 -6.14 34.87 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.523 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 92.1 mt -79.52 -22.15 44.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.677 179.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.55 -51.26 70.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.711 -179.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.23 -5.76 58.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.48 179.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.02 -74.59 1.13 Allowed Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.909 -0.876 . . . . 0.0 110.909 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 83.0 mt -69.82 125.94 28.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.023 0.44 . . . . 0.0 110.234 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -59.32 -39.44 83.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.178 -179.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 83.1 51.82 4.04 Favored Glycine 0 CA--C 1.521 0.433 0 N-CA-C 110.814 -0.914 . . . . 0.0 110.814 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -95.94 -14.89 22.73 Favored 'General case' 0 C--N 1.33 -0.266 0 O-C-N 122.701 -0.293 . . . . 0.0 110.616 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . 0.497 ' OG ' HG23 ' A' ' 191' ' ' VAL . 3.4 t 174.34 88.85 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.047 0.451 . . . . 0.0 110.177 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.862 ' N ' HD12 ' A' ' 259' ' ' LEU . 0.9 OUTLIER -94.18 124.02 37.93 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.223 0.535 . . . . 0.0 111.086 -179.104 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 260' ' ' PHE . . . . . 0.446 ' H ' ' HA ' ' A' ' 193' ' ' ALA . 16.0 m-30 -93.12 146.48 23.63 Favored 'General case' 0 CA--C 1.508 -0.664 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.343 179.251 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 86.0 mt -122.35 149.83 43.24 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.629 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.743 ' CD1' HG13 ' A' ' 195' ' ' VAL . 2.6 p90 -77.65 -138.49 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.468 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . 0.661 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -52.03 77.54 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 121.04 0.448 . . . . 0.0 111.055 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . 0.632 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.03 104.71 0.19 Allowed Glycine 0 CA--C 1.526 0.724 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 265' ' ' ASP . . . . . 0.606 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.7 m-20 -80.57 -177.79 6.41 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 120.676 0.274 . . . . 0.0 110.92 -179.477 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -40.42 -17.69 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.891 0.377 . . . . 0.0 110.521 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . 0.606 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.33 -51.62 42.52 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.73 179.397 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -63.7 -46.54 84.99 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.223 179.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . 0.575 ' HB1' ' OH ' ' A' ' 273' ' ' TYR . . . -61.71 -35.11 77.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.856 179.52 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -63.07 -34.41 77.52 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.115 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.48 -43.07 13.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.231 -179.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 272' ' ' ILE . . . . . 0.587 ' C ' ' H ' ' A' ' 274' ' ' ALA . 4.9 tt -51.58 -33.72 15.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.827 -178.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 273' ' ' TYR . . . . . 0.575 ' OH ' ' HB1' ' A' ' 269' ' ' ALA . 17.1 m-85 -54.44 -1.71 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.738 -179.568 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 274' ' ' ALA . . . . . 0.587 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.8 -39.54 69.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.927 179.503 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . 0.582 ' O ' ' N ' ' A' ' 279' ' ' ALA . 3.2 p30 -39.52 98.02 0.16 Allowed Pre-proline 0 N--CA 1.461 0.103 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.562 -179.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -54.03 -43.02 61.99 Favored 'Trans proline' 0 C--N 1.304 -1.807 0 C-N-CA 122.372 2.048 . . . . 0.0 112.638 -178.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 89.0 mt -64.37 -42.93 95.92 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.14 0.495 . . . . 0.0 111.208 -179.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 90.7 mt -95.6 -1.67 49.87 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.894 -179.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 279' ' ' ALA . . . . . 0.582 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.34 -34.83 77.41 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.696 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.12 20.01 0.11 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.006 -179.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 0.49 HD23 ' HA ' ' A' ' 281' ' ' LEU . 13.9 mt -75.31 120.15 80.31 Favored Pre-proline 0 N--CA 1.452 -0.365 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.506 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -51.01 -39.35 59.92 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 122.637 2.225 . . . . 0.0 111.848 179.164 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.92 -50.53 63.8 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.092 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 75.5 t -61.43 -43.92 97.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -57.83 -41.19 81.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.237 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -91.11 0.38 57.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.212 179.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt 59.3 43.7 16.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.079 0.466 . . . . 0.0 110.962 179.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -95.1 41.62 1.09 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.33 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 53.9 t -119.22 135.63 58.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.02 0.438 . . . . 0.0 110.168 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -132.63 162.65 30.78 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 121.123 0.487 . . . . 0.0 110.634 -179.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.71 154.91 33.39 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.014 0.435 . . . . 0.0 110.745 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 80.8 mt -93.68 -1.58 55.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.275 -179.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.11 165.91 12.81 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 6.9 m -87.47 -62.35 1.52 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.839 0.352 . . . . 0.0 111.016 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 295' ' ' GLU . . . . . 0.441 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.5 mm-40 -69.25 -4.01 16.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.68 -179.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 25.9 p -76.89 32.51 0.14 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.654 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 297' ' ' PHE . . . . . 0.513 ' CD2' HG22 ' A' ' 70' ' ' THR . 73.2 t80 -60.39 -46.14 91.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.669 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . 0.617 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.2 mtt85 -81.19 135.0 35.72 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 120.998 0.427 . . . . 0.0 110.634 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.457 ' H ' HG11 ' A' ' 51' ' ' VAL . 16.8 tp -114.39 118.26 33.33 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.182 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . 0.635 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.0 p-10 -165.83 -176.2 3.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.507 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -47.08 -43.78 20.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.277 -179.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -66.64 -40.57 88.75 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.968 0.413 . . . . 0.0 110.726 179.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . 0.635 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 59.7 p -55.92 -36.11 67.35 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.083 -179.17 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . 0.538 ' HB2' ' SD ' ' A' ' 215' ' ' MET . . . -57.37 -51.43 69.44 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.445 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 90.6 mtp -56.41 -43.67 79.58 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -66.37 -42.63 87.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.934 0.397 . . . . 0.0 110.17 178.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 303' ' ' SER . 56.1 t -63.95 -43.03 97.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.22 179.407 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 42.9 tp -59.67 -42.31 92.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.781 -179.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -62.6 -38.78 91.48 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 179.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 310' ' ' ARG . . . . . 0.432 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.6 ttt85 -63.51 -44.01 95.54 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.286 179.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 89.0 mt -63.21 -42.06 99.24 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.291 179.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt -62.87 -33.41 75.23 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.997 179.494 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.52 -23.36 22.05 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.46 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.476 HD22 ' CE2' ' A' ' 315' ' ' PHE . 6.8 tt -62.36 -43.1 99.62 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.63 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 315' ' ' PHE . . . . . 0.476 ' CE2' HD22 ' A' ' 314' ' ' LEU . 91.0 m-85 . . . . . 0 C--O 1.22 -0.482 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.449 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -99.58 136.75 39.04 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.079 0.466 . . . . 0.0 110.438 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.494 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -91.99 178.49 1.7 Allowed Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.615 -179.881 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.494 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.4 Cg_exo -61.65 146.99 96.38 Favored 'Trans proline' 0 C--N 1.299 -2.044 0 C-N-CA 122.872 2.381 . . . . 0.0 112.133 179.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.46 ' HE ' HD12 ' A' ' 39' ' ' LEU . 35.5 ptt180 -136.23 142.31 44.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.682 179.668 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -79.52 116.67 19.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.464 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.449 ' O ' HG23 ' A' ' 30' ' ' ILE . 9.5 tp -111.16 130.49 64.53 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.483 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 13.1 t -70.93 141.91 51.1 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.547 179.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.478 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.5 t0 -139.42 179.71 6.39 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.57 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.478 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 78.0 p -73.88 -37.21 64.79 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.626 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -46.37 -94.51 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.292 -179.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -167.2 -26.61 0.02 OUTLIER Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.934 -0.867 . . . . 0.0 110.934 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 60.0 m -168.98 104.78 0.4 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.876 0.37 . . . . 0.0 110.673 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.678 ' CD2' HD13 ' A' ' 140' ' ' LEU . 74.6 t60 -128.44 148.81 50.74 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 121.102 0.477 . . . . 0.0 110.247 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.623 HG22 ' N ' ' A' ' 39' ' ' LEU . 98.8 m -131.2 165.84 22.45 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.55 -179.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.623 ' N ' HG22 ' A' ' 38' ' ' THR . 82.0 mt -120.67 127.28 51.91 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.439 179.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -65.23 -44.45 88.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.698 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 39.5 p -165.66 154.66 11.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.44 179.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.478 ' H ' ' CD ' ' A' ' 42' ' ' GLN . 14.4 mp0 -44.78 101.3 0.25 Allowed Pre-proline 0 C--N 1.329 -0.315 0 O-C-N 123.376 0.422 . . . . 0.0 110.605 179.397 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -57.43 129.94 36.53 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 C-N-CA 122.357 2.038 . . . . 0.0 112.292 -179.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -83.88 -24.68 30.72 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.539 179.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.538 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.2 mtm-85 -122.07 134.9 54.77 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 121.203 0.525 . . . . 0.0 110.291 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 95.9 mt -130.64 133.73 63.05 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.883 -179.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 44.7 t -124.44 130.53 73.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 179.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.627 ' OG ' HD12 ' A' ' 117' ' ' LEU . 2.3 m -155.36 167.34 30.69 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.534 179.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 68.2 p -124.68 9.45 8.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.458 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.56 125.51 33.15 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.634 -179.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.44 HG11 ' H ' ' A' ' 299' ' ' LEU . 92.7 t -65.81 -44.52 92.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.469 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 20.0 m -62.77 -44.19 96.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.607 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 50.2 tp -62.24 -41.61 98.58 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.53 -179.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.444 ' O ' HD13 ' A' ' 58' ' ' LEU . 77.2 m -57.59 -44.65 85.53 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.394 -179.41 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.03 -62.33 5.3 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.884 -0.886 . . . . 0.0 110.884 179.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.7 t -48.4 -35.42 12.66 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.7 mt -61.88 -44.52 96.65 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.686 -0.405 . . . . 0.0 111.281 179.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.444 HD13 ' O ' ' A' ' 54' ' ' THR . 9.2 mp -65.18 -41.52 94.52 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.33 177.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.5 -41.26 98.53 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.983 -179.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.426 ' O ' HG23 ' A' ' 60' ' ' ILE . 8.1 tp -88.18 17.13 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.824 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 56.24 84.63 0.08 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.688 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.37 59.06 0.08 OUTLIER Pre-proline 0 C--N 1.328 -0.346 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.405 ' HB3' HE21 ' A' ' 85' ' ' GLN . 10.3 Cg_endo -51.52 152.31 12.51 Favored 'Trans proline' 0 C--N 1.294 -2.301 0 C-N-CA 122.956 2.438 . . . . 0.0 112.254 -178.233 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.434 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.2 OUTLIER -108.55 145.31 15.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.37 -179.728 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.8 mt -63.56 -45.4 97.77 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.414 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.5 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -129.57 134.19 47.6 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.848 0.356 . . . . 0.0 110.495 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.493 ' O ' ' N ' ' A' ' 98' ' ' LEU . 74.8 m -134.48 158.56 43.6 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.849 -179.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.82 139.13 16.12 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.689 -0.964 . . . . 0.0 110.689 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.497 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.84 -162.77 0.08 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.971 0.415 . . . . 0.0 110.479 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.535 HG22 ' CD2' ' A' ' 297' ' ' PHE . 14.7 t -133.49 135.02 44.21 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.382 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.487 ' C ' ' O ' ' A' ' 70' ' ' THR . 0.7 OUTLIER 29.73 68.57 0.66 Allowed Pre-proline 0 N--CA 1.464 0.26 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.801 -179.87 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_exo -60.98 145.64 98.84 Favored 'Trans proline' 0 C--N 1.299 -2.035 0 C-N-CA 122.648 2.232 . . . . 0.0 111.981 -178.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.534 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 46.1 p-10 -160.11 -32.63 0.06 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.639 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.537 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 99.2 m-20 -63.71 -39.74 95.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.451 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 73.1 ttt180 -60.13 -48.08 83.24 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.728 -179.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.423 ' O ' ' O ' ' A' ' 77' ' ' ALA . 94.4 t -60.35 -24.73 31.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.088 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.537 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -45.76 172.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.599 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.571 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.9 p30 -62.07 177.74 0.43 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.522 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.558 ' C ' ' H ' ' A' ' 81' ' ' GLY . 35.4 p30 -45.61 85.67 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.033 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.571 ' N ' ' O ' ' A' ' 78' ' ' ASP . 43.4 tp60 -67.63 13.45 0.07 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.149 0.5 . . . . 0.0 110.135 -179.735 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.558 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 118.32 -22.1 9.72 Favored Glycine 0 CA--C 1.519 0.282 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -107.86 116.61 32.26 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.975 0.417 . . . . 0.0 110.474 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 74.4 mt -98.77 -0.14 43.25 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.937 0.399 . . . . 0.0 110.494 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -92.13 7.08 44.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.98 0.419 . . . . 0.0 110.452 -179.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.788 ' O ' HG22 ' A' ' 89' ' ' VAL . 88.1 mt-30 -100.42 -27.76 13.28 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.815 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.8 t-105 -63.73 -40.51 96.93 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.093 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.56 ' O ' ' N ' ' A' ' 91' ' ' LYS . 63.7 m -78.15 -54.16 6.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.118 -179.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -47.64 -50.51 24.31 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.06 -179.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.788 HG22 ' O ' ' A' ' 85' ' ' GLN . 14.9 m -69.29 -40.75 80.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.066 179.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.499 ' N ' HG23 ' A' ' 89' ' ' VAL . . . -72.3 -22.64 61.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.66 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.56 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.0 tttm -62.23 -45.5 93.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.422 -179.494 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.441 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.8 mm-40 -90.51 -94.37 0.12 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.153 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.628 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.9 mtt180 -143.13 58.72 1.41 Allowed 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.457 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.6 pttp 33.44 26.43 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.195 -179.226 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.628 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.4 tt -48.25 123.29 6.23 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.986 -178.092 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.455 ' O ' HD23 ' A' ' 95' ' ' LEU . 99.0 mm-40 -83.68 -169.62 2.65 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.122 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.605 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 81.4 mtp180 -74.42 137.32 42.57 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.303 -179.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.493 ' N ' ' O ' ' A' ' 67' ' ' SER . 90.6 mt -86.21 -165.85 1.38 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.74 -179.659 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.538 ' CD2' ' O ' ' A' ' 99' ' ' TYR . 48.4 p90 -168.74 119.77 0.76 Allowed 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.207 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.511 ' C ' ' O ' ' A' ' 99' ' ' TYR . 43.0 mm -28.67 120.74 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.085 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 114.38 27.48 3.35 Favored Glycine 0 CA--C 1.519 0.34 0 N-CA-C 111.196 -0.762 . . . . 0.0 111.196 -179.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.576 ' H ' ' CD ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -144.47 46.6 0.64 Allowed Pre-proline 0 C--N 1.323 -0.554 0 CA-C-O 120.979 0.419 . . . . 0.0 110.447 179.861 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 29.0 Cg_endo -62.04 144.01 95.64 Favored 'Trans proline' 0 C--N 1.296 -2.224 0 C-N-CA 122.702 2.268 . . . . 0.0 111.865 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.459 ' O ' HG23 ' A' ' 108' ' ' VAL . 26.7 t -173.24 120.23 0.34 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.423 179.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.83 -40.4 63.35 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.054 0.454 . . . . 0.0 111.085 179.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.23 -40.06 90.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.888 -179.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.14 -39.97 95.15 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.677 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 104' ' ' SER . 70.4 t -67.71 -43.72 86.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.731 179.705 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.74 -38.96 92.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.53 -179.26 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.441 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.65 -23.35 62.97 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.49 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.547 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.5 mm-40 -90.5 5.14 48.91 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.714 -179.555 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.547 ' C ' ' O ' ' A' ' 111' ' ' GLN . 10.6 tpt 23.27 64.33 0.37 Allowed Pre-proline 0 N--CA 1.464 0.261 0 CA-C-O 120.935 0.398 . . . . 0.0 111.077 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -78.61 167.5 22.52 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 123.062 2.508 . . . . 0.0 111.861 -178.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.521 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 99.0 m-20 -109.97 -42.27 4.26 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.182 179.474 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.6 tp -121.04 120.66 36.01 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 179.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 83.8 mt -113.44 129.0 70.0 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.39 0 CA-C-O 120.98 0.419 . . . . 0.0 110.903 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.627 HD12 ' OG ' ' A' ' 48' ' ' SER . 30.2 mt -109.18 132.27 54.28 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 121.084 0.469 . . . . 0.0 110.235 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.491 HD12 HG23 ' A' ' 139' ' ' THR . 99.0 mt -119.84 138.75 49.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.719 -179.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 84.9 p -72.51 153.61 41.25 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.598 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.18 -50.12 74.94 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.678 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -149.44 154.01 38.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.55 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 170.58 -170.99 43.49 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -63.09 -34.16 89.21 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.866 -0.893 . . . . 0.0 110.866 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.45 ' O ' ' OD1' ' A' ' 124' ' ' ASP . 44.3 p-10 -86.82 120.45 28.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.837 0.351 . . . . 0.0 110.705 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.443 ' O ' HD12 ' A' ' 129' ' ' LEU . 38.9 t -63.23 143.48 57.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.029 0.443 . . . . 0.0 110.495 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.52 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -92.97 -43.18 9.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.972 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.9 tp -62.85 -42.45 99.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.703 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.66 -11.83 59.13 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.53 -179.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.443 HD12 ' O ' ' A' ' 125' ' ' SER . 84.8 mt -114.97 -23.86 8.88 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.659 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . 0.52 ' N ' ' O ' ' A' ' 126' ' ' ALA . 80.6 t80 -51.13 -49.55 60.6 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.537 -178.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.0 p-10 -66.13 -42.41 89.18 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.823 0.344 . . . . 0.0 111.239 179.486 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.519 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 88.2 mt-30 -67.16 -37.81 84.41 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.813 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.431 HD12 HD11 ' A' ' 118' ' ' ILE . 96.0 mt -80.36 -41.38 24.81 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.965 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.2 t -57.23 -44.57 83.91 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.218 -179.109 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.7 m -61.97 -45.23 94.56 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.511 179.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 94.0 mt -62.09 -43.64 97.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.279 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.66 ' HB1' ' HD2' ' A' ' 138' ' ' PRO . . . -169.44 168.22 4.96 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.56 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.66 ' HD2' ' HB1' ' A' ' 137' ' ' ALA . 52.3 Cg_exo -49.57 112.82 0.76 Allowed 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.323 2.015 . . . . 0.0 112.282 179.214 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.491 HG23 HD12 ' A' ' 118' ' ' ILE . 23.5 m -84.49 127.53 34.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.617 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.678 HD13 ' CD2' ' A' ' 37' ' ' HIS . 34.7 tp -118.22 137.0 53.31 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.079 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.44 ' O ' ' OD2' ' A' ' 32' ' ' ASP . 81.3 mt -101.26 118.94 48.76 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.353 0 CA-C-O 121.226 0.536 . . . . 0.0 111.222 -179.419 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.431 HD12 HD22 ' A' ' 117' ' ' LEU . 98.1 mt -134.78 132.04 53.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.588 179.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.55 HD21 ' CG ' ' A' ' 241' ' ' ASP . 61.0 t30 -66.28 151.82 46.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.895 0.378 . . . . 0.0 110.413 179.419 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.521 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 88.1 t80 -86.69 122.54 30.73 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.808 -179.581 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.521 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 99.0 m-20 55.31 69.13 0.77 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.788 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 35.9 p-10 -125.9 0.17 7.3 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.652 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -150.54 115.12 5.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.715 -179.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 83.9 p -63.29 168.2 4.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.602 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.417 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.7 p-90 -51.88 -15.79 0.59 Allowed 'General case' 0 C--O 1.223 -0.334 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.467 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.44 ' O ' HG23 ' A' ' 154' ' ' THR . 68.1 tp60 -70.52 -76.04 0.11 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.474 -179.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.444 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.1 t -62.7 -38.61 91.08 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.255 179.543 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 54.3 tp -59.93 -45.84 91.3 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.412 -178.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.417 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 46.7 tp -62.67 -41.64 99.19 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.497 179.011 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.444 ' OG1' ' O ' ' A' ' 151' ' ' SER . 60.1 p -64.1 -34.79 78.85 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.273 -179.482 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.415 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.9 mm-40 -64.19 -42.77 96.53 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.311 179.35 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 91.8 mt -65.37 -38.73 90.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.148 0.499 . . . . 0.0 110.268 179.122 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.579 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.23 -32.47 80.75 Favored Glycine 0 CA--C 1.519 0.317 0 N-CA-C 110.712 -0.955 . . . . 0.0 110.712 -179.306 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 157' ' ' GLY . 97.2 mt-10 -35.45 -26.93 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.828 0.347 . . . . 0.0 110.837 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.579 ' N ' ' O ' ' A' ' 157' ' ' GLY . 95.3 mt -56.46 149.81 3.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.295 179.197 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 77.1 p -69.61 137.21 52.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.997 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 71.1 21.17 78.37 Favored Glycine 0 N--CA 1.459 0.19 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 179.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 58.1 m80 -122.47 -14.94 7.72 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.702 0.286 . . . . 0.0 110.529 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -65.96 -59.74 3.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.748 -179.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -52.26 -49.3 64.34 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.209 -179.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -60.54 -41.22 94.05 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.957 -0.297 . . . . 0.0 110.379 179.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.49 -47.12 87.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.541 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.97 -40.14 75.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.244 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -61.82 -50.27 72.96 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.576 179.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -65.17 -43.86 90.36 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.531 179.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 94.6 mt -64.78 -43.29 96.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.402 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.28 -51.23 70.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.475 -179.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.43 -43.86 96.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.543 179.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.654 ' CE2' HD11 ' A' ' 177' ' ' LEU . 57.0 t80 -62.75 -44.4 96.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.06 0.457 . . . . 0.0 110.443 179.451 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -63.32 -39.8 95.56 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.617 -179.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -63.01 -42.76 99.9 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.599 179.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -60.72 -44.6 96.42 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.184 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.654 HD11 ' CE2' ' A' ' 173' ' ' PHE . 84.1 mt -64.54 -40.96 96.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.014 0.435 . . . . 0.0 110.707 178.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.18 -62.46 1.62 Allowed 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.368 -179.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.52 -46.86 85.89 Favored 'General case' 0 C--O 1.227 -0.128 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.628 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.13 -41.85 65.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.276 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -63.74 -33.79 76.43 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.982 0.42 . . . . 0.0 110.411 179.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.422 ' HG2' ' O ' ' A' ' 182' ' ' GLU . 69.6 tt0 -90.51 8.83 31.92 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.46 0.648 . . . . 0.0 110.508 -178.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -104.99 -32.07 8.92 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.174 179.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.9 pt -127.98 147.63 32.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.822 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -139.93 131.09 26.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.357 179.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.593 HD22 ' N ' ' A' ' 186' ' ' LEU . 3.6 mm? -85.35 133.34 42.64 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.979 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -43.93 157.82 0.14 Allowed 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.69 2.26 . . . . 0.0 112.191 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 0.521 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.9 Cg_endo -63.1 115.11 2.77 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 C-N-CA 122.795 2.33 . . . . 0.0 111.696 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . 0.521 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.8 mt-30 155.16 147.86 0.0 OUTLIER Pre-proline 0 C--N 1.332 -0.162 0 O-C-N 123.791 0.682 . . . . 0.0 110.832 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -73.49 144.11 35.65 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.667 2.245 . . . . 0.0 112.159 177.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.496 HG23 ' OG ' ' A' ' 258' ' ' SER . 2.1 p -125.04 158.98 32.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.291 0.567 . . . . 0.0 110.185 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . 0.494 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 37.5 p -143.3 165.39 27.6 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.106 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . 0.45 ' HA ' ' H ' ' A' ' 260' ' ' PHE . . . -135.4 128.69 32.05 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.234 0.54 . . . . 0.0 110.231 179.431 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.504 HD11 HD23 ' A' ' 259' ' ' LEU . 47.6 pt -146.3 148.71 16.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.165 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . 0.749 HG13 ' CD1' ' A' ' 262' ' ' PHE . 70.4 t -117.51 123.01 71.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.282 0.563 . . . . 0.0 109.71 179.083 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -134.47 107.51 7.6 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.331 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 94.3 m -131.01 130.71 43.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.845 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -82.82 -37.02 25.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.231 179.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.55 -67.17 0.26 Allowed 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.359 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.33 -9.76 58.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.342 179.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 60.1 t-80 60.43 58.3 2.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.774 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 39.4 p -166.8 153.2 8.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.586 179.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.28 144.09 24.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.005 0.431 . . . . 0.0 110.421 179.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -135.3 137.87 42.9 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.619 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 19.6 mt -105.98 125.42 50.97 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.061 0.458 . . . . 0.0 109.81 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' TRP . . . . . 0.555 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 75.6 m95 -82.09 167.15 19.07 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.685 -179.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . 0.466 HG22 ' C ' ' A' ' 206' ' ' TRP . 0.1 OUTLIER -156.99 171.38 7.53 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.624 -179.189 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -53.57 -37.22 82.85 Favored 'Trans proline' 0 C--N 1.302 -1.902 0 C-N-CA 122.661 2.24 . . . . 0.0 112.27 179.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -70.52 -34.88 72.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.813 -179.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 22.8 m -61.19 150.72 33.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.637 -179.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.52 -36.95 81.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.485 -179.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . 0.555 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 54.8 tt0 -64.78 -40.11 94.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.506 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.8 -43.41 91.74 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -63.33 -43.74 96.92 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.791 0.329 . . . . 0.0 110.29 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . 0.522 ' SD ' ' HB2' ' A' ' 304' ' ' ALA . 65.1 ttp -59.39 -48.18 82.63 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.238 -179.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 88.2 mt -60.37 -40.9 92.49 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 179.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . 0.456 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 40.9 tp10 -57.96 -38.03 75.25 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -65.17 -37.92 88.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.67 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 94.5 mt -64.4 -42.72 95.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.141 0.496 . . . . 0.0 110.583 -179.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.56 44.63 0.08 OUTLIER Glycine 0 C--N 1.334 0.417 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . 0.456 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 25.9 m-85 -127.68 155.19 44.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.04 0.447 . . . . 0.0 110.471 -179.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.481 ' O ' HG13 ' A' ' 191' ' ' VAL . 6.1 p -107.05 122.35 46.29 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.272 0.558 . . . . 0.0 110.116 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.473 HD22 ' C ' ' A' ' 222' ' ' THR . 4.3 mm? -101.25 133.04 46.42 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.068 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -97.17 159.53 14.86 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.488 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.21 115.32 30.06 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.399 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.496 ' N ' HD12 ' A' ' 226' ' ' LEU . 9.0 mp -53.62 156.84 4.21 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.689 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -59.86 145.21 98.84 Favored 'Trans proline' 0 C--N 1.302 -1.916 0 C-N-CA 122.65 2.233 . . . . 0.0 112.19 179.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.64 -2.73 58.81 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.559 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.46 -40.68 5.65 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.535 ' O ' ' N ' ' A' ' 233' ' ' SER . 86.1 mt -79.13 -16.74 56.22 Favored 'General case' 0 C--O 1.222 -0.379 0 CA-C-O 121.02 0.438 . . . . 0.0 110.383 -179.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . 0.402 ' C ' ' O ' ' A' ' 230' ' ' LEU . 54.4 t-20 -40.29 -49.07 2.73 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.777 -179.421 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -88.24 15.44 7.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.368 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.535 ' N ' ' O ' ' A' ' 230' ' ' LEU . 77.8 p -60.52 -35.52 76.18 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.622 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . 0.523 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.6 tt0 -118.27 -69.37 0.85 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.958 179.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 3.9 m -70.39 103.03 2.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.679 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -93.99 57.92 2.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.398 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -145.12 -122.28 1.52 Allowed Glycine 0 CA--C 1.519 0.343 0 N-CA-C 110.989 -0.845 . . . . 0.0 110.989 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -134.56 111.68 10.26 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 121.114 0.483 . . . . 0.0 110.433 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . 0.51 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.3 mtt180 -148.12 57.24 1.08 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.696 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -69.74 -31.99 70.27 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.511 179.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . 0.55 ' CG ' HD21 ' A' ' 143' ' ' ASN . 65.1 t0 -56.83 -46.93 81.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.379 -179.07 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 242' ' ' ILE . . . . . 0.437 ' O ' ' O ' ' A' ' 239' ' ' ARG . 17.5 tt -140.02 156.76 25.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.888 0.375 . . . . 0.0 110.537 179.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.438 HG22 HD13 ' A' ' 245' ' ' LEU . 96.0 mt -105.8 105.9 19.56 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.218 0 CA-C-O 121.122 0.487 . . . . 0.0 110.511 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . 0.602 ' O ' HD12 ' A' ' 245' ' ' LEU . 88.3 mt-30 -110.23 110.03 20.72 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.344 179.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.602 HD12 ' O ' ' A' ' 244' ' ' GLN . 9.6 mp -121.86 -168.23 1.67 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.663 179.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . 0.523 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.28 -16.8 0.05 OUTLIER Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . 0.669 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -60.44 157.17 29.42 Favored Glycine 0 CA--C 1.522 0.49 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 -179.81 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -63.86 21.68 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.99 0.424 . . . . 0.0 110.619 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . 0.669 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.7 m-20 -97.43 -5.82 35.32 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.517 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 91.9 mt -80.28 -21.48 42.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.672 179.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.66 -51.36 70.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.702 -179.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.43 -5.19 58.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.453 179.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.15 -74.2 1.15 Allowed Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 80.4 mt -70.09 125.73 27.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.979 0.418 . . . . 0.0 110.274 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -59.7 -39.15 83.65 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.492 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 84.1 51.74 3.86 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 110.712 -0.955 . . . . 0.0 110.712 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -94.87 -16.2 23.09 Favored 'General case' 0 C--N 1.332 -0.191 0 O-C-N 122.651 -0.323 . . . . 0.0 110.654 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . 0.496 ' OG ' HG23 ' A' ' 191' ' ' VAL . 3.3 t 174.06 89.53 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.074 0.464 . . . . 0.0 110.18 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.863 ' N ' HD12 ' A' ' 259' ' ' LEU . 1.0 OUTLIER -94.47 124.35 38.44 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.275 0.559 . . . . 0.0 111.079 -179.084 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 260' ' ' PHE . . . . . 0.45 ' H ' ' HA ' ' A' ' 193' ' ' ALA . 16.0 m-30 -93.49 146.64 23.62 Favored 'General case' 0 CA--C 1.504 -0.793 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.441 179.262 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 85.9 mt -122.46 149.91 43.22 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.567 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.749 ' CD1' HG13 ' A' ' 195' ' ' VAL . 2.6 p90 -77.61 -138.4 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.541 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . 0.657 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -52.24 77.51 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.048 0.452 . . . . 0.0 111.078 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . 0.625 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.17 104.35 0.18 Allowed Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 265' ' ' ASP . . . . . 0.601 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.8 m-20 -80.28 -177.89 6.34 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 120.685 0.279 . . . . 0.0 110.908 -179.478 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -40.44 -17.52 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.567 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . 0.601 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.62 -51.45 42.1 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.617 179.502 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -63.79 -46.64 84.28 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.171 179.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . 0.566 ' HB1' ' OH ' ' A' ' 273' ' ' TYR . . . -61.58 -34.99 76.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.247 0.546 . . . . 0.0 109.866 179.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -63.13 -34.42 77.58 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.17 179.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.43 -43.31 13.73 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.218 -179.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 272' ' ' ILE . . . . . 0.588 ' C ' ' H ' ' A' ' 274' ' ' ALA . 4.9 tt -51.42 -33.72 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.863 -178.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 273' ' ' TYR . . . . . 0.566 ' OH ' ' HB1' ' A' ' 269' ' ' ALA . 17.4 m-85 -54.31 -1.88 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.649 -179.587 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 274' ' ' ALA . . . . . 0.588 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.64 -39.66 70.22 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.95 179.561 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . 0.586 ' O ' ' N ' ' A' ' 279' ' ' ALA . 4.2 p30 -39.12 97.86 0.15 Allowed Pre-proline 0 N--CA 1.462 0.174 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.458 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -54.55 -42.97 63.27 Favored 'Trans proline' 0 C--N 1.303 -1.831 0 C-N-CA 122.372 2.048 . . . . 0.0 112.552 -178.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 88.9 mt -64.45 -42.97 95.66 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.128 0.49 . . . . 0.0 111.211 -179.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 90.8 mt -95.71 -1.38 50.09 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.923 -179.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 279' ' ' ALA . . . . . 0.586 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.19 -34.74 77.02 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.714 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.21 19.8 0.12 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.018 -179.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 0.487 HD23 ' HA ' ' A' ' 281' ' ' LEU . 13.9 mt -75.08 120.14 80.27 Favored Pre-proline 0 N--CA 1.451 -0.423 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.575 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -49.97 -39.81 49.75 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.625 2.216 . . . . 0.0 112.154 178.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.52 -50.56 62.57 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.084 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 79.9 t -61.79 -43.8 97.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 179.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -57.88 -41.77 83.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.317 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -90.43 0.33 57.34 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.119 179.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt 59.04 41.19 21.17 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.773 179.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -92.89 42.18 1.09 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.355 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 53.7 t -119.1 135.67 58.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.014 0.435 . . . . 0.0 110.246 -179.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -133.05 162.74 30.9 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.656 -179.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.77 154.96 33.42 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.965 0.412 . . . . 0.0 110.747 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 81.8 mt -93.75 -1.46 55.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.231 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.59 165.52 12.62 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 110.58 -1.008 . . . . 0.0 110.58 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 7.1 m -87.38 -62.27 1.54 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.89 0.376 . . . . 0.0 111.004 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 295' ' ' GLU . . . . . 0.438 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.5 mm-40 -69.62 -3.97 17.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.636 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 26.2 p -76.81 33.14 0.14 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.648 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 297' ' ' PHE . . . . . 0.535 ' CD2' HG22 ' A' ' 70' ' ' THR . 85.0 t80 -60.21 -46.03 91.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.477 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . 0.605 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.2 mtt85 -81.73 133.76 35.38 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.568 -179.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.44 ' H ' HG11 ' A' ' 51' ' ' VAL . 16.1 tp -114.07 119.75 38.2 Favored 'General case' 0 C--O 1.231 0.083 0 CA-C-O 120.992 0.425 . . . . 0.0 110.205 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . 0.622 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.2 p-10 -167.43 -174.15 2.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.551 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 84.0 t80 -48.23 -45.81 34.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.215 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -64.7 -41.48 95.99 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.033 0.444 . . . . 0.0 110.689 178.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . 0.622 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 53.1 p -55.53 -36.09 66.37 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.954 -179.073 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . 0.522 ' HB2' ' SD ' ' A' ' 215' ' ' MET . . . -56.71 -51.76 67.57 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.442 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 91.0 mtp -56.13 -43.89 78.62 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -66.3 -42.81 87.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.008 0.432 . . . . 0.0 110.246 178.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 303' ' ' SER . 55.5 t -64.02 -42.77 96.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.211 179.44 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 42.3 tp -59.65 -42.29 92.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.791 -179.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -62.54 -38.76 91.28 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.149 179.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 310' ' ' ARG . . . . . 0.442 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.6 ttt85 -63.54 -43.95 95.61 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.229 179.606 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 88.3 mt -63.15 -42.15 99.39 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.303 179.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -62.84 -33.22 74.79 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.04 179.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.94 -23.51 21.55 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.377 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.478 HD22 ' CE2' ' A' ' 315' ' ' PHE . 6.8 tt -62.31 -43.19 99.39 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 121.092 0.473 . . . . 0.0 110.623 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 315' ' ' PHE . . . . . 0.478 ' CE2' HD22 ' A' ' 314' ' ' LEU . 90.8 m-85 . . . . . 0 C--O 1.22 -0.475 0 CA-C-O 118.005 -0.997 . . . . 0.0 110.42 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -99.41 135.58 40.61 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.087 0.47 . . . . 0.0 110.502 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.495 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.2 OUTLIER -92.14 178.42 1.71 Allowed Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.549 -179.842 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.495 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.3 Cg_exo -61.74 147.47 95.24 Favored 'Trans proline' 0 C--N 1.3 -2.024 0 C-N-CA 122.776 2.317 . . . . 0.0 112.168 179.603 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.482 ' HE ' HD12 ' A' ' 39' ' ' LEU . 35.2 ptt180 -136.12 142.33 44.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.735 179.682 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -79.83 116.79 20.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.406 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.447 ' O ' HG23 ' A' ' 30' ' ' ILE . 9.5 tp -111.54 130.71 64.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.411 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.1 t -71.19 142.62 50.64 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.623 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.479 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.7 t0 -139.84 179.86 6.35 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.564 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.479 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 77.9 p -73.86 -37.26 64.82 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.707 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.7 ttt85 -46.83 -94.62 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.309 -179.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -166.3 -26.8 0.02 OUTLIER Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 56.9 m -168.87 105.69 0.42 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.892 0.377 . . . . 0.0 110.621 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.653 ' CD2' HD13 ' A' ' 140' ' ' LEU . 69.6 t60 -128.77 147.03 50.75 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.053 0.454 . . . . 0.0 110.262 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.623 HG22 ' N ' ' A' ' 39' ' ' LEU . 99.9 m -130.05 165.73 21.6 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.582 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.623 ' N ' HG22 ' A' ' 38' ' ' THR . 80.8 mt -120.35 127.33 52.23 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.481 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -65.43 -44.62 86.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.693 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 41.2 p -165.89 155.23 11.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.46 179.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.489 ' H ' ' CD ' ' A' ' 42' ' ' GLN . 15.1 mp0 -45.25 101.63 0.27 Allowed Pre-proline 0 C--N 1.329 -0.295 0 O-C-N 123.388 0.43 . . . . 0.0 110.659 179.327 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -57.96 129.58 33.96 Favored 'Trans proline' 0 C--N 1.303 -1.82 0 C-N-CA 122.269 1.979 . . . . 0.0 112.231 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -82.33 -25.2 34.11 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.478 179.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.534 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.7 mtm-85 -120.87 134.39 55.29 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-O 121.194 0.521 . . . . 0.0 110.252 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.1 mt -129.69 133.06 65.59 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.313 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.034 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 46.0 t -124.71 130.9 73.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 179.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.622 ' OG ' HD12 ' A' ' 117' ' ' LEU . 4.4 m -154.99 166.5 33.4 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.541 179.578 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 66.0 p -124.27 8.99 8.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.805 0.336 . . . . 0.0 110.439 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.72 125.82 33.5 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.668 -179.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.471 HG11 ' H ' ' A' ' 299' ' ' LEU . 85.7 t -65.81 -44.55 92.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.547 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 18.9 m -62.63 -44.35 96.51 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.615 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 53.5 tp -62.26 -41.54 98.54 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.503 -179.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.45 ' O ' HD13 ' A' ' 58' ' ' LEU . 73.3 m -57.85 -44.54 86.6 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.257 -179.271 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.39 -62.01 5.48 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 179.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.7 t -48.74 -35.25 13.74 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.9 mt -61.8 -44.38 96.98 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.586 -0.445 . . . . 0.0 111.325 179.13 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.45 HD13 ' O ' ' A' ' 54' ' ' THR . 9.4 mp -64.74 -41.95 95.55 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.384 177.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.406 ' HB1' ' NE ' ' A' ' 169' ' ' ARG . . . -63.67 -41.03 98.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.033 -179.196 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.426 ' O ' HG23 ' A' ' 60' ' ' ILE . 8.0 tp -88.11 16.77 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.798 -179.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 56.38 84.56 0.08 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.696 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.14 58.21 0.07 OUTLIER Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.287 -0.415 . . . . 0.0 109.904 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.414 ' HB3' HE21 ' A' ' 85' ' ' GLN . 10.1 Cg_endo -50.58 152.76 8.67 Favored 'Trans proline' 0 C--N 1.293 -2.365 0 C-N-CA 122.84 2.36 . . . . 0.0 112.404 -178.509 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.432 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -108.78 145.83 15.18 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.219 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.239 -179.716 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 97.0 mt -63.75 -45.06 98.32 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.366 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.559 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.501 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -130.02 134.49 47.44 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 120.836 0.351 . . . . 0.0 110.588 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.497 ' O ' ' N ' ' A' ' 98' ' ' LEU . 73.6 m -134.74 158.71 43.44 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.893 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -87.2 139.54 16.2 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.491 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.72 -162.75 0.08 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.003 0.43 . . . . 0.0 110.453 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.513 HG22 ' CD2' ' A' ' 297' ' ' PHE . 14.0 t -133.47 135.15 44.33 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.324 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.486 ' C ' ' O ' ' A' ' 70' ' ' THR . 0.1 OUTLIER 29.77 68.51 0.67 Allowed Pre-proline 0 N--CA 1.466 0.353 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.765 -179.883 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_exo -60.96 145.21 99.4 Favored 'Trans proline' 0 C--N 1.299 -2.047 0 C-N-CA 122.613 2.208 . . . . 0.0 112.017 -178.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.524 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 45.5 p-10 -159.83 -32.6 0.06 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.65 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.54 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 99.0 m-20 -64.0 -39.56 94.39 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.485 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.6 ttt180 -60.65 -47.87 84.29 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.721 -179.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.421 ' O ' ' O ' ' A' ' 77' ' ' ALA . 89.2 t -60.58 -24.59 32.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.54 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -45.85 172.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.581 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.569 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.6 p30 -61.85 177.58 0.42 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.551 -179.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.56 ' C ' ' H ' ' A' ' 81' ' ' GLY . 35.5 p30 -45.61 85.84 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.049 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.569 ' N ' ' O ' ' A' ' 78' ' ' ASP . 43.3 tp60 -67.34 13.32 0.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.232 0.539 . . . . 0.0 110.101 -179.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.56 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 118.04 -22.12 9.91 Favored Glycine 0 C--N 1.332 0.321 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -107.79 116.25 31.62 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.014 0.435 . . . . 0.0 110.419 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 77.6 mt -98.87 0.57 44.47 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.498 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -92.04 6.72 45.36 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.033 0.444 . . . . 0.0 110.327 -179.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.794 ' O ' HG22 ' A' ' 89' ' ' VAL . 88.3 mt-30 -100.05 -27.73 13.41 Favored 'General case' 0 C--O 1.223 -0.329 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.869 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 68.7 t-105 -63.08 -40.81 98.77 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.902 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.554 ' O ' ' N ' ' A' ' 91' ' ' LYS . 68.0 m -77.44 -53.44 7.63 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.272 -179.486 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -48.57 -50.73 31.04 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.039 -179.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.794 HG22 ' O ' ' A' ' 85' ' ' GLN . 15.5 m -68.87 -40.8 81.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 120.97 0.414 . . . . 0.0 111.175 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.498 ' N ' HG23 ' A' ' 89' ' ' VAL . . . -72.06 -23.05 61.3 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.763 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.554 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.0 tttm -61.51 -45.89 92.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.42 -179.439 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.444 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.8 mm-40 -90.38 -94.59 0.12 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.048 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.622 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.8 mtt180 -143.35 59.97 1.4 Allowed 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.456 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.6 pttp 33.73 26.46 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 120.861 0.362 . . . . 0.0 110.12 -179.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.622 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.5 tt -48.49 123.19 6.29 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.081 -178.026 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.456 ' O ' HD23 ' A' ' 95' ' ' LEU . 99.0 mm-40 -83.69 -170.18 2.94 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.007 -179.763 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.62 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 82.2 mtp180 -73.29 137.77 45.06 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.197 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.497 ' N ' ' O ' ' A' ' 67' ' ' SER . 89.3 mt -86.26 -166.15 1.46 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.777 -179.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.532 ' CD2' ' O ' ' A' ' 99' ' ' TYR . 47.5 p90 -168.01 119.65 0.84 Allowed 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.234 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.505 ' C ' ' O ' ' A' ' 99' ' ' TYR . 42.8 mm -29.4 120.98 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.058 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 113.92 28.03 3.28 Favored Glycine 0 C--N 1.332 0.323 0 N-CA-C 111.176 -0.77 . . . . 0.0 111.176 -179.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.582 ' N ' ' CD ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -143.93 45.94 0.61 Allowed Pre-proline 0 C--N 1.323 -0.566 0 O-C-N 122.481 -0.423 . . . . 0.0 110.434 179.816 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.582 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 30.2 Cg_endo -61.95 143.8 95.77 Favored 'Trans proline' 0 C--N 1.296 -2.229 0 C-N-CA 122.669 2.246 . . . . 0.0 111.971 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.46 ' O ' HG23 ' A' ' 108' ' ' VAL . 26.7 t -173.17 120.43 0.35 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.463 179.637 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.1 -41.0 64.53 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.069 0.462 . . . . 0.0 111.157 179.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -65.8 -39.92 91.38 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.85 -179.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.94 -39.67 94.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.751 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 104' ' ' SER . 70.6 t -67.4 -43.88 87.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.769 179.572 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.52 -39.11 92.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.574 -179.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.444 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.63 -23.85 63.35 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.448 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.554 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.3 mm-40 -91.23 4.71 51.59 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.695 -179.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.554 ' C ' ' O ' ' A' ' 111' ' ' GLN . 10.4 tpt 22.11 64.29 0.32 Allowed Pre-proline 0 N--CA 1.466 0.345 0 CA-C-O 120.937 0.398 . . . . 0.0 111.154 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.446 ' HG2' HD11 ' A' ' 116' ' ' ILE . 67.7 Cg_endo -78.85 169.8 18.98 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 123.072 2.515 . . . . 0.0 112.085 -178.252 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.518 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 98.8 m-20 -112.3 -44.82 3.34 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.222 -0.444 . . . . 0.0 109.974 179.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.2 tp -119.96 120.88 37.67 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.45 HD13 HD22 ' A' ' 133' ' ' LEU . 96.6 mt -117.82 131.36 70.79 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.417 0 CA-C-O 120.957 0.408 . . . . 0.0 110.985 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.622 HD12 ' OG ' ' A' ' 48' ' ' SER . 33.4 mt -106.17 132.2 52.51 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.117 0.484 . . . . 0.0 110.051 -179.405 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.498 HD12 HG23 ' A' ' 139' ' ' THR . 98.4 mt -117.49 135.93 56.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.791 -179.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 85.4 p -71.37 151.79 43.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.521 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.28 -49.94 75.61 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.712 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -149.33 153.7 37.85 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.544 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 168.7 -169.35 41.66 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -63.08 -35.41 92.05 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.452 ' O ' ' OD1' ' A' ' 124' ' ' ASP . 44.4 p-10 -88.62 120.02 29.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.839 0.352 . . . . 0.0 110.694 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.443 ' O ' HD12 ' A' ' 129' ' ' LEU . 40.7 t -63.47 144.35 57.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.012 0.434 . . . . 0.0 110.526 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.521 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.32 -42.82 9.1 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.012 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.6 tp -62.65 -42.34 99.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.657 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.05 -10.83 56.88 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.508 -179.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.443 HD12 ' O ' ' A' ' 125' ' ' SER . 85.5 mt -115.82 -23.96 8.4 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.62 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . 0.521 ' N ' ' O ' ' A' ' 126' ' ' ALA . 73.2 t80 -51.83 -48.9 63.72 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.569 -0.452 . . . . 0.0 110.537 -178.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.53 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 39.4 p-10 -66.17 -41.67 89.98 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.885 0.374 . . . . 0.0 111.34 179.26 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.53 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 87.9 mt-30 -67.83 -37.33 81.77 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.874 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.464 HD12 HD11 ' A' ' 118' ' ' ILE . 97.1 mt -79.65 -42.57 24.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.134 -179.674 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.2 t -57.78 -44.9 86.54 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.256 -178.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 18.8 m -62.19 -46.09 90.46 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.865 0.364 . . . . 0.0 110.76 179.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 92.3 mt -62.47 -43.63 98.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.374 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.589 ' HB1' ' HD2' ' A' ' 138' ' ' PRO . . . -170.02 163.14 6.52 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.459 179.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.589 ' HD2' ' HB1' ' A' ' 137' ' ' ALA . 77.4 Cg_exo -42.02 110.81 0.16 Allowed 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.531 2.154 . . . . 0.0 112.088 179.413 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.503 HG21 ' CD1' ' A' ' 130' ' ' TYR . 2.9 m -87.48 127.59 35.23 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.559 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.653 HD13 ' CD2' ' A' ' 37' ' ' HIS . 34.9 tp -119.61 139.42 52.21 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.077 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.429 ' O ' ' OD2' ' A' ' 32' ' ' ASP . 81.0 mt -105.48 120.0 55.54 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.385 0 CA-C-O 121.14 0.495 . . . . 0.0 111.341 -179.665 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.494 HD12 HD22 ' A' ' 117' ' ' LEU . 98.2 mt -135.42 132.51 52.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.683 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.546 HD21 ' CG ' ' A' ' 241' ' ' ASP . 59.1 t30 -64.71 147.8 52.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.885 0.374 . . . . 0.0 110.368 179.275 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.454 ' O ' ' OD2' ' A' ' 241' ' ' ASP . 86.5 t80 -82.41 122.69 28.33 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.046 -179.593 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.433 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 91.4 m-20 55.32 69.02 0.78 Allowed 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.951 179.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 34.8 p-10 -125.78 0.37 7.39 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.943 0.401 . . . . 0.0 110.68 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -150.55 115.7 5.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.747 -179.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 85.9 p -63.93 169.07 4.52 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.566 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.419 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.6 p-90 -51.87 -15.95 0.62 Allowed 'General case' 0 C--O 1.223 -0.341 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.49 -179.763 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.43 ' O ' HG23 ' A' ' 154' ' ' THR . 68.1 tp60 -70.41 -76.09 0.11 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.469 -179.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.442 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.1 t -62.47 -38.61 90.51 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.011 0.434 . . . . 0.0 110.241 179.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 51.1 tp -60.21 -45.48 93.02 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.334 -178.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.419 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 45.8 tp -62.69 -41.86 99.33 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.859 0.361 . . . . 0.0 110.398 178.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.442 ' OG1' ' O ' ' A' ' 151' ' ' SER . 57.6 p -63.89 -34.74 78.63 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.18 -179.371 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.463 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 88.1 mm-40 -63.85 -42.28 97.61 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.153 179.274 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 90.5 mt -65.28 -39.07 92.09 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.125 0.488 . . . . 0.0 110.096 179.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.577 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.03 -32.39 80.1 Favored Glycine 0 CA--C 1.519 0.321 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 -179.292 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.463 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.3 mt-10 -36.65 -25.09 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.82 0.343 . . . . 0.0 110.807 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.577 ' N ' ' O ' ' A' ' 157' ' ' GLY . 95.8 mt -59.56 148.53 7.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.193 179.284 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 71.3 p -68.91 137.68 54.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.12 -179.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 70.56 21.91 77.77 Favored Glycine 0 N--CA 1.458 0.146 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 179.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 60.3 m80 -124.28 -14.34 7.0 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.73 0.3 . . . . 0.0 110.569 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -66.17 -59.49 3.71 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.792 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -52.22 -48.32 65.18 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 120.679 -0.409 . . . . 0.0 110.093 -179.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -60.88 -40.96 95.0 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.697 0.284 . . . . 0.0 110.313 179.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.61 -47.17 86.64 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.6 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -57.2 -39.83 76.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.179 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -61.85 -50.3 72.79 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.569 179.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.406 ' NE ' ' HB1' ' A' ' 59' ' ' ALA . 60.1 ttt85 -65.5 -43.78 89.09 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.458 179.536 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 94.8 mt -64.47 -43.52 96.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.386 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.32 -50.89 71.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.474 -179.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.97 -43.56 95.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.454 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.658 ' CE2' HD11 ' A' ' 177' ' ' LEU . 56.7 t80 -62.67 -44.59 95.87 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.07 0.462 . . . . 0.0 110.386 179.407 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -63.38 -39.96 95.94 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.561 -179.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -62.9 -42.8 99.91 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.623 179.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -60.78 -44.69 96.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.044 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.658 HD11 ' CE2' ' A' ' 173' ' ' PHE . 84.7 mt -64.34 -41.26 96.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.058 0.456 . . . . 0.0 110.733 178.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.13 -62.19 1.79 Allowed 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.43 -179.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.35 -46.86 85.46 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.52 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.02 -41.6 64.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.159 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -63.8 -33.48 75.77 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.015 0.436 . . . . 0.0 110.371 179.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.419 ' HG2' ' O ' ' A' ' 182' ' ' GLU . 69.7 tt0 -91.1 8.22 36.62 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.476 0.655 . . . . 0.0 110.529 -178.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -103.88 -32.62 9.2 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.348 179.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 45.1 pt -128.0 147.75 32.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.893 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -139.74 131.2 26.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.382 179.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.593 HD22 ' N ' ' A' ' 186' ' ' LEU . 3.6 mm? -85.5 133.97 41.09 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.953 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -44.23 157.99 0.15 Allowed 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 122.734 2.289 . . . . 0.0 112.097 179.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 0.519 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.5 Cg_endo -62.93 115.05 2.7 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 C-N-CA 122.775 2.317 . . . . 0.0 111.662 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . 0.519 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.8 mt-30 155.23 148.33 0.0 OUTLIER Pre-proline 0 C--N 1.332 -0.176 0 O-C-N 123.833 0.708 . . . . 0.0 110.869 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -73.75 144.29 34.93 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.688 2.259 . . . . 0.0 111.881 178.042 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.495 HG23 ' OG ' ' A' ' 258' ' ' SER . 2.1 p -124.92 158.65 32.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.365 0.602 . . . . 0.0 110.12 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . 0.491 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 35.9 p -143.22 165.31 27.81 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.245 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . 0.448 ' HA ' ' H ' ' A' ' 260' ' ' PHE . . . -135.31 128.63 32.11 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 121.229 0.537 . . . . 0.0 110.233 179.589 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.52 HD11 HD23 ' A' ' 259' ' ' LEU . 48.3 pt -146.7 149.38 15.93 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.362 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.161 179.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . 0.739 HG13 ' CD1' ' A' ' 262' ' ' PHE . 69.0 t -117.95 123.4 71.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.317 0.58 . . . . 0.0 109.621 179.255 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -134.38 106.71 7.21 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.253 179.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 95.0 m -130.34 130.47 44.48 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.897 179.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.402 ' O ' ' N ' ' A' ' 201' ' ' HIS . . . -83.11 -36.83 24.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.142 179.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.63 -66.72 0.29 Allowed 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.311 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.52 -9.75 58.95 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.231 179.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . 0.402 ' N ' ' O ' ' A' ' 198' ' ' ALA . 60.6 t-80 60.85 58.28 2.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.887 -179.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 36.0 p -167.11 153.64 8.33 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.554 179.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.64 144.18 24.22 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.02 0.438 . . . . 0.0 110.355 179.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -135.53 138.66 43.28 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.67 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 20.3 mt -106.64 125.53 51.12 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 -179.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' TRP . . . . . 0.557 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 73.9 m95 -82.0 167.32 18.99 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.643 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . 0.468 HG22 ' C ' ' A' ' 206' ' ' TRP . 0.1 OUTLIER -157.17 171.59 7.25 Favored Pre-proline 0 C--O 1.224 -0.238 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.585 -179.218 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -53.58 -37.29 82.96 Favored 'Trans proline' 0 C--N 1.303 -1.84 0 C-N-CA 122.602 2.201 . . . . 0.0 112.114 179.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -70.45 -35.37 73.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.858 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 21.6 m -60.67 150.94 30.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.591 -179.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.61 -37.22 83.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.524 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . 0.557 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 54.9 tt0 -64.5 -40.4 95.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.515 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.59 -43.39 92.26 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -63.26 -43.96 96.48 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . 0.547 ' SD ' ' HB2' ' A' ' 304' ' ' ALA . 65.6 ttp -59.62 -47.71 84.51 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.196 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 216' ' ' LEU . 86.0 mt -60.78 -40.81 93.96 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . 0.452 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.4 tp10 -58.61 -37.82 76.67 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -65.18 -38.5 90.72 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.721 0.296 . . . . 0.0 110.525 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 94.8 mt -64.09 -42.83 96.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.105 0.479 . . . . 0.0 110.504 -179.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.48 45.13 0.08 OUTLIER Glycine 0 C--N 1.334 0.467 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . 0.452 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 26.9 m-85 -128.01 155.59 44.07 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.107 0.48 . . . . 0.0 110.47 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.486 ' O ' HG13 ' A' ' 191' ' ' VAL . 7.6 p -106.8 122.29 46.1 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.263 0.554 . . . . 0.0 110.136 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.475 HD22 ' C ' ' A' ' 222' ' ' THR . 4.3 mm? -101.33 133.09 46.47 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.159 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.93 159.68 14.78 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.535 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -105.41 115.26 29.95 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.302 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.494 ' N ' HD12 ' A' ' 226' ' ' LEU . 9.0 mp -53.0 156.8 3.24 Favored Pre-proline 0 N--CA 1.452 -0.355 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.746 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -60.39 145.22 99.08 Favored 'Trans proline' 0 C--N 1.3 -1.974 0 C-N-CA 122.628 2.219 . . . . 0.0 112.121 179.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -86.98 -3.43 59.09 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.54 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.12 -41.1 5.64 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.523 ' O ' ' N ' ' A' ' 233' ' ' SER . 69.5 mt -79.15 -17.71 54.48 Favored 'General case' 0 C--O 1.221 -0.42 0 CA-C-O 121.082 0.468 . . . . 0.0 110.319 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 54.8 t-20 -40.72 -48.9 3.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.844 -179.163 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -87.49 15.09 7.03 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.772 0.32 . . . . 0.0 111.428 179.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.523 ' N ' ' O ' ' A' ' 230' ' ' LEU . 77.9 p -60.45 -35.11 75.06 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.676 -179.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . 0.523 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.5 tt0 -119.33 -69.33 0.85 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.977 179.368 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.0 m -70.18 101.4 1.86 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.633 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -93.15 58.24 2.86 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.376 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -144.81 -122.42 1.56 Allowed Glycine 0 CA--C 1.52 0.353 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -135.62 111.36 9.35 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.25 0.548 . . . . 0.0 110.34 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . 0.529 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.5 mtt180 -147.9 57.95 1.1 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.756 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -69.1 -32.85 72.55 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.519 179.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . 0.546 ' CG ' HD21 ' A' ' 143' ' ' ASN . 65.1 t0 -57.02 -47.14 81.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.305 -178.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 242' ' ' ILE . . . . . 0.433 ' O ' ' O ' ' A' ' 239' ' ' ARG . 18.5 tt -139.4 155.4 25.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.901 0.382 . . . . 0.0 110.504 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.444 HG22 HD13 ' A' ' 245' ' ' LEU . 96.2 mt -106.16 106.86 21.37 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.235 0 CA-C-O 121.232 0.539 . . . . 0.0 110.59 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . 0.601 ' O ' HD12 ' A' ' 245' ' ' LEU . 88.3 mt-30 -110.46 109.91 20.46 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.292 179.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.601 HD12 ' O ' ' A' ' 244' ' ' GLN . 9.4 mp -121.51 -168.28 1.66 Allowed 'General case' 0 C--O 1.225 -0.229 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.672 179.736 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . 0.523 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.9 -16.21 0.05 OUTLIER Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . 0.673 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -61.49 156.18 35.45 Favored Glycine 0 CA--C 1.521 0.457 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -63.28 21.79 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.991 0.424 . . . . 0.0 110.672 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . 0.673 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.8 m-20 -97.15 -6.19 35.45 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.478 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 91.7 mt -79.76 -21.97 43.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.631 179.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.61 -51.21 70.89 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.824 -179.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.38 -5.5 58.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.443 179.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.38 -74.39 1.15 Allowed Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 83.4 mt -69.96 125.92 28.18 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.067 0.461 . . . . 0.0 110.235 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -59.49 -39.44 83.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.139 -179.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 83.1 51.76 4.06 Favored Glycine 0 CA--C 1.52 0.401 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -95.92 -14.88 22.76 Favored 'General case' 0 C--N 1.331 -0.198 0 O-C-N 122.721 -0.282 . . . . 0.0 110.571 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . 0.495 ' OG ' HG23 ' A' ' 191' ' ' VAL . 3.5 t 174.52 88.99 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.11 0.481 . . . . 0.0 110.049 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.86 ' N ' HD12 ' A' ' 259' ' ' LEU . 0.9 OUTLIER -94.47 124.3 38.42 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.367 0.603 . . . . 0.0 111.174 -179.204 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 260' ' ' PHE . . . . . 0.448 ' H ' ' HA ' ' A' ' 193' ' ' ALA . 16.0 m-30 -93.36 146.43 23.74 Favored 'General case' 0 CA--C 1.503 -0.843 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.328 179.43 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 86.5 mt -122.0 149.86 42.89 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.597 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.739 ' CD1' HG13 ' A' ' 195' ' ' VAL . 2.5 p90 -77.83 -139.0 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.431 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . 0.658 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -51.59 77.71 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 121.047 0.451 . . . . 0.0 111.15 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . 0.628 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.44 104.69 0.19 Allowed Glycine 0 CA--C 1.527 0.795 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 265' ' ' ASP . . . . . 0.601 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.9 m-20 -80.55 -177.56 6.3 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 120.632 0.253 . . . . 0.0 110.971 -179.611 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -40.45 -17.81 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.854 0.359 . . . . 0.0 110.513 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . 0.601 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.26 -51.7 42.24 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.684 179.438 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -63.74 -46.69 84.19 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.973 179.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . 0.58 ' HB1' ' OH ' ' A' ' 273' ' ' TYR . . . -61.44 -35.28 77.14 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 121.238 0.542 . . . . 0.0 109.753 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -63.06 -34.61 77.96 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.022 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.31 -43.2 13.92 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.393 -179.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 272' ' ' ILE . . . . . 0.586 ' C ' ' H ' ' A' ' 274' ' ' ALA . 4.9 tt -51.36 -33.78 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.864 -178.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 273' ' ' TYR . . . . . 0.58 ' OH ' ' HB1' ' A' ' 269' ' ' ALA . 17.1 m-85 -54.31 -2.06 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.674 -179.533 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 274' ' ' ALA . . . . . 0.586 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.54 -39.71 70.51 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.996 179.533 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . 0.582 ' O ' ' N ' ' A' ' 279' ' ' ALA . 4.0 p30 -38.6 97.31 0.13 Allowed Pre-proline 0 C--O 1.225 -0.185 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.556 -179.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 276' ' ' PRO . . . . . 0.401 ' N ' ' O ' ' A' ' 274' ' ' ALA . 47.5 Cg_exo -54.1 -42.82 63.84 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 C-N-CA 122.234 1.956 . . . . 0.0 112.696 -178.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 89.7 mt -64.38 -42.73 96.0 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.188 0.518 . . . . 0.0 111.266 -179.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 91.4 mt -95.97 -1.16 49.65 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.922 -179.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 279' ' ' ALA . . . . . 0.582 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.39 -34.94 77.71 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.662 -179.684 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -73.87 20.01 0.11 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.035 -179.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 0.489 HD23 ' HA ' ' A' ' 281' ' ' LEU . 13.7 mt -75.15 120.12 80.18 Favored Pre-proline 0 N--CA 1.45 -0.439 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.423 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -51.21 -39.26 62.09 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.568 2.178 . . . . 0.0 111.809 179.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -53.19 -50.34 64.85 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 78.1 t -61.47 -43.91 97.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 179.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -57.66 -41.04 80.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.186 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -91.27 0.19 57.57 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.065 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt 59.54 44.06 15.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.07 0.462 . . . . 0.0 110.935 179.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -95.25 41.46 1.1 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.347 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 54.6 t -119.39 135.6 59.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 121.089 0.471 . . . . 0.0 110.161 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -132.92 163.14 29.82 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.071 0.462 . . . . 0.0 110.695 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.59 155.02 33.04 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-O 121.068 0.461 . . . . 0.0 110.782 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 82.1 mt -94.23 -1.36 54.18 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.211 -179.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.72 165.53 12.6 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 6.8 m -87.57 -62.07 1.58 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.905 0.383 . . . . 0.0 111.146 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 295' ' ' GLU . . . . . 0.447 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.6 mm-40 -69.16 -3.97 15.65 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.721 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 25.5 p -76.56 32.39 0.13 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.648 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 297' ' ' PHE . . . . . 0.513 ' CD2' HG22 ' A' ' 70' ' ' THR . 85.9 t80 -60.47 -45.88 92.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.603 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . 0.62 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.1 mtt85 -81.2 135.02 35.72 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.02 0.438 . . . . 0.0 110.546 -179.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.471 ' H ' HG11 ' A' ' 51' ' ' VAL . 18.4 tp -113.91 117.18 30.66 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-O 121.054 0.454 . . . . 0.0 110.098 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . 0.621 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.6 p-10 -165.21 -176.66 4.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.533 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 81.2 t80 -47.05 -43.15 19.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.169 -179.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -67.11 -40.13 86.83 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.046 0.451 . . . . 0.0 110.91 179.043 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . 0.621 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 59.9 p -56.27 -36.27 68.38 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.021 -179.093 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . 0.547 ' HB2' ' SD ' ' A' ' 215' ' ' MET . . . -57.32 -51.54 68.95 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.51 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 90.2 mtp -56.67 -43.11 80.1 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -179.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -66.48 -42.72 87.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.003 0.43 . . . . 0.0 110.09 178.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 303' ' ' SER . 55.5 t -63.94 -43.19 97.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.126 179.381 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 43.4 tp -59.9 -42.14 93.18 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.683 -179.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -62.24 -39.27 92.27 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 310' ' ' ARG . . . . . 0.451 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.5 ttt85 -63.75 -44.01 94.75 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.203 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 89.5 mt -63.35 -42.21 98.89 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.194 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt -62.95 -33.57 75.66 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.081 0.467 . . . . 0.0 109.977 179.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.53 -23.75 21.95 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.325 -179.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.484 HD22 ' CE2' ' A' ' 315' ' ' PHE . 6.7 tt -62.33 -43.12 99.56 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 121.111 0.482 . . . . 0.0 110.562 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 315' ' ' PHE . . . . . 0.484 ' CE2' HD22 ' A' ' 314' ' ' LEU . 90.3 m-85 . . . . . 0 C--O 1.22 -0.469 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.428 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -99.37 135.89 40.12 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.016 0.436 . . . . 0.0 110.504 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.497 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -92.01 178.39 1.74 Allowed Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.548 -179.928 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.497 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.8 Cg_exo -61.61 147.28 95.76 Favored 'Trans proline' 0 C--N 1.3 -2.018 0 C-N-CA 122.79 2.327 . . . . 0.0 112.104 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.46 ' HE ' HD12 ' A' ' 39' ' ' LEU . 35.6 ptt180 -135.79 142.16 44.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.72 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -79.71 116.51 19.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.471 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.445 ' O ' HG23 ' A' ' 30' ' ' ILE . 9.4 tp -110.94 130.68 63.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.498 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.6 t -70.71 141.99 51.53 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.563 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.475 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.4 t0 -139.68 179.39 6.61 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.568 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.475 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 78.0 p -73.92 -36.99 64.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.61 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.8 ttt85 -46.54 -94.67 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.331 -179.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -167.16 -26.42 0.02 OUTLIER Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 59.9 m -169.11 104.73 0.39 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.879 0.371 . . . . 0.0 110.65 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.686 ' CD2' HD13 ' A' ' 140' ' ' LEU . 75.6 t60 -128.39 148.89 50.72 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.033 0.444 . . . . 0.0 110.262 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.626 HG22 ' N ' ' A' ' 39' ' ' LEU . 98.2 m -131.23 166.04 22.04 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.62 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.626 ' N ' HG22 ' A' ' 38' ' ' THR . 81.5 mt -120.83 127.61 52.08 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.43 179.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -65.2 -44.55 87.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.694 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 39.9 p -165.83 154.88 11.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.448 179.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.495 ' H ' ' CD ' ' A' ' 42' ' ' GLN . 14.8 mp0 -44.34 101.13 0.24 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.626 179.449 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -57.39 129.59 34.79 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 C-N-CA 122.365 2.044 . . . . 0.0 112.283 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -84.1 -24.57 30.27 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.502 179.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.539 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.5 mtm-85 -122.29 134.17 54.67 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-O 121.147 0.498 . . . . 0.0 110.34 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.1 mt -130.43 133.76 63.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.949 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 45.4 t -124.25 130.49 73.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 179.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.642 ' OG ' HD12 ' A' ' 117' ' ' LEU . 2.0 m -155.38 167.75 29.36 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.556 179.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 59.5 p -124.9 9.44 8.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.487 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.56 125.42 33.08 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.672 -179.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.45 HG11 ' H ' ' A' ' 299' ' ' LEU . 95.1 t -65.92 -44.43 92.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.417 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.4 m -62.49 -44.26 96.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.651 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 51.3 tp -62.33 -41.41 98.54 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.5 -179.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.453 ' O ' HD13 ' A' ' 58' ' ' LEU . 75.5 m -57.7 -44.48 85.88 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.258 -179.209 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.29 -62.18 5.36 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 179.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.7 t -48.38 -35.51 12.75 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 57' ' ' LEU . 19.8 mt -61.87 -44.64 96.4 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.707 -0.397 . . . . 0.0 111.17 179.41 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.453 HD13 ' O ' ' A' ' 54' ' ' THR . 9.2 mp -65.01 -41.7 95.09 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.303 178.014 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.63 -40.97 98.24 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.989 -179.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.431 ' O ' HG23 ' A' ' 60' ' ' ILE . 8.0 tp -88.65 16.79 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.762 -179.6 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 56.41 84.82 0.08 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.674 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 178.67 57.86 0.06 OUTLIER Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.016 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.411 ' HB3' HE21 ' A' ' 85' ' ' GLN . 10.1 Cg_endo -50.77 153.34 8.39 Favored 'Trans proline' 0 C--N 1.296 -2.202 0 C-N-CA 122.892 2.394 . . . . 0.0 112.38 -178.276 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.437 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.2 OUTLIER -108.93 145.44 15.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.359 -179.714 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.8 mt -63.62 -45.24 98.09 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.317 -179.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.502 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -129.49 134.08 47.61 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 120.848 0.356 . . . . 0.0 110.539 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.501 ' O ' ' N ' ' A' ' 98' ' ' LEU . 75.2 m -134.73 158.84 43.09 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.798 -179.637 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.99 139.15 16.01 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.489 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.81 -162.69 0.08 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.914 0.388 . . . . 0.0 110.503 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.539 HG22 ' CD2' ' A' ' 297' ' ' PHE . 14.5 t -133.49 134.43 43.46 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.404 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.491 ' C ' ' O ' ' A' ' 70' ' ' THR . 0.6 OUTLIER 29.69 68.82 0.65 Allowed Pre-proline 0 N--CA 1.464 0.226 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.754 -179.866 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -61.25 145.17 98.83 Favored 'Trans proline' 0 C--N 1.299 -2.031 0 C-N-CA 122.627 2.218 . . . . 0.0 112.062 -178.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.533 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 45.1 p-10 -159.14 -32.04 0.06 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.677 179.643 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.542 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 99.1 m-20 -64.1 -39.7 94.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.489 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -60.23 -48.33 82.19 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.706 -179.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.424 ' O ' ' O ' ' A' ' 77' ' ' ALA . 92.6 t -60.25 -24.9 32.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 179.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.542 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -45.71 172.98 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.555 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.575 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.2 p30 -62.18 177.89 0.43 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.564 -179.728 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.554 ' C ' ' H ' ' A' ' 81' ' ' GLY . 36.1 p30 -45.13 85.79 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.965 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.575 ' N ' ' O ' ' A' ' 78' ' ' ASP . 42.5 tp60 -67.69 13.17 0.08 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.109 -179.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.554 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 118.73 -22.34 9.32 Favored Glycine 0 CA--C 1.519 0.324 0 N-CA-C 110.969 -0.852 . . . . 0.0 110.969 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -108.13 116.46 32.01 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.014 0.435 . . . . 0.0 110.44 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 75.8 mt -98.71 0.4 44.49 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.491 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -92.53 7.24 44.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.971 0.415 . . . . 0.0 110.413 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.802 ' O ' HG22 ' A' ' 89' ' ' VAL . 87.8 mt-30 -100.12 -28.19 13.16 Favored 'General case' 0 C--O 1.225 -0.234 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.823 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 68.9 t-105 -62.77 -40.71 98.12 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.858 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.554 ' O ' ' N ' ' A' ' 91' ' ' LYS . 65.4 m -77.73 -53.56 7.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.148 -179.364 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -48.51 -50.76 30.48 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.965 -179.262 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.802 HG22 ' O ' ' A' ' 85' ' ' GLN . 15.7 m -68.87 -40.62 81.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 120.867 0.365 . . . . 0.0 111.005 179.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.497 ' N ' HG23 ' A' ' 89' ' ' VAL . . . -72.32 -22.63 61.15 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.695 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.554 ' N ' ' O ' ' A' ' 87' ' ' SER . 65.9 tttm -62.01 -45.51 93.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.512 -179.498 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.442 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.6 mm-40 -90.53 -94.85 0.12 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.134 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.636 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.9 mtt180 -142.92 58.97 1.42 Allowed 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.461 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.6 pttp 33.43 26.13 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 120.879 0.371 . . . . 0.0 110.221 -179.145 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.636 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.4 tt -48.08 123.52 6.38 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.925 -178.102 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.454 ' O ' HD23 ' A' ' 95' ' ' LEU . 99.0 mm-40 -83.88 -169.41 2.56 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.092 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.603 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 81.3 mtp180 -74.58 136.84 42.05 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.298 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.501 ' N ' ' O ' ' A' ' 67' ' ' SER . 91.3 mt -85.79 -165.82 1.35 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.762 -179.68 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.537 ' CD2' ' O ' ' A' ' 99' ' ' TYR . 48.3 p90 -168.33 119.77 0.81 Allowed 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.178 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.515 ' C ' ' O ' ' A' ' 99' ' ' TYR . 43.0 mm -28.88 120.96 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.977 -179.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 114.25 27.57 3.35 Favored Glycine 0 CA--C 1.52 0.344 0 N-CA-C 111.154 -0.779 . . . . 0.0 111.154 -179.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.582 ' H ' ' CD ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -144.63 46.62 0.63 Allowed Pre-proline 0 C--N 1.324 -0.537 0 CA-C-O 120.995 0.426 . . . . 0.0 110.479 179.885 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 29.5 Cg_endo -61.91 143.97 96.1 Favored 'Trans proline' 0 C--N 1.297 -2.153 0 C-N-CA 122.644 2.229 . . . . 0.0 111.993 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.455 ' O ' HG23 ' A' ' 108' ' ' VAL . 27.8 t -173.16 120.0 0.34 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.462 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.61 -40.46 63.8 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.035 0.445 . . . . 0.0 111.049 179.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.25 -39.87 89.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.88 -179.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.22 -39.97 95.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.75 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 104' ' ' SER . 71.3 t -67.57 -43.87 86.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.798 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.84 -38.89 92.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.578 -179.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.442 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.49 -23.31 62.66 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.49 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.551 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.4 mm-40 -90.64 5.3 48.56 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.687 -179.502 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.551 ' C ' ' O ' ' A' ' 111' ' ' GLN . 10.6 tpt 23.55 64.13 0.38 Allowed Pre-proline 0 N--CA 1.465 0.296 0 CA-C-O 120.896 0.379 . . . . 0.0 110.946 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -78.14 167.24 23.64 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 123.03 2.487 . . . . 0.0 112.132 -178.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.524 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 98.9 m-20 -109.96 -42.11 4.31 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.19 179.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.3 tp -121.24 120.21 34.5 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.019 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 82.5 mt -112.79 128.88 69.26 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.336 0 CA-C-O 120.918 0.389 . . . . 0.0 110.812 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.642 HD12 ' OG ' ' A' ' 48' ' ' SER . 29.2 mt -109.13 132.32 54.23 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 121.088 0.471 . . . . 0.0 110.211 -179.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.494 HD12 HG23 ' A' ' 139' ' ' THR . 99.1 mt -119.94 138.57 50.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.645 -179.743 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 85.9 p -72.44 154.07 41.07 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.608 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.18 -50.21 74.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.636 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.0 t -149.73 154.3 38.29 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.579 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 170.66 -170.79 43.37 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.99 -34.03 88.83 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.452 ' O ' ' OD1' ' A' ' 124' ' ' ASP . 44.5 p-10 -87.29 120.42 28.55 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.796 0.332 . . . . 0.0 110.684 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.441 ' O ' HD12 ' A' ' 129' ' ' LEU . 38.8 t -63.2 143.83 57.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.504 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.52 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.0 -43.23 9.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.928 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.6 tp -62.86 -42.35 99.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.706 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.58 -12.07 59.54 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.485 -179.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.441 HD12 ' O ' ' A' ' 125' ' ' SER . 85.3 mt -114.77 -23.84 8.99 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.649 -179.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . 0.52 ' N ' ' O ' ' A' ' 126' ' ' ALA . 79.9 t80 -50.9 -49.66 58.96 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.592 -178.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.0 p-10 -66.12 -42.6 88.97 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.861 0.363 . . . . 0.0 111.158 179.576 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.521 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 88.4 mt-30 -66.98 -37.94 85.15 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.781 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.433 HD12 HD11 ' A' ' 118' ' ' ILE . 96.0 mt -80.32 -41.38 24.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.892 -179.549 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.2 t -57.21 -44.52 83.76 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.212 -179.098 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.5 m -61.87 -45.22 94.7 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.751 0.31 . . . . 0.0 110.517 179.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 93.3 mt -62.18 -43.6 98.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.27 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.67 ' HB1' ' HD2' ' A' ' 138' ' ' PRO . . . -169.51 168.69 4.66 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.554 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.67 ' HD2' ' HB1' ' A' ' 137' ' ' ALA . 52.7 Cg_exo -50.38 113.04 0.87 Allowed 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.282 1.988 . . . . 0.0 112.206 179.414 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.494 HG23 HD12 ' A' ' 118' ' ' ILE . 23.4 m -83.97 127.39 33.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.609 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.686 HD13 ' CD2' ' A' ' 37' ' ' HIS . 34.8 tp -117.87 135.91 53.79 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.034 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.44 ' O ' ' OD2' ' A' ' 32' ' ' ASP . 81.7 mt -100.18 118.85 47.44 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.331 0 CA-C-O 121.174 0.512 . . . . 0.0 111.194 -179.36 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.428 HD12 HD22 ' A' ' 117' ' ' LEU . 98.1 mt -134.74 132.28 54.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.621 179.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.55 HD21 ' CG ' ' A' ' 241' ' ' ASP . 60.9 t30 -66.97 151.42 47.66 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.905 0.383 . . . . 0.0 110.433 179.457 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.522 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 88.0 t80 -86.11 122.38 30.04 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.811 -179.52 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.522 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 98.9 m-20 55.17 69.34 0.74 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.754 179.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 35.8 p-10 -125.8 0.16 7.37 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.651 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -150.56 115.13 5.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.7 -179.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 84.5 p -63.3 168.33 4.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.542 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.422 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.6 p-90 -51.83 -15.88 0.59 Allowed 'General case' 0 C--O 1.223 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.524 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.439 ' O ' HG23 ' A' ' 154' ' ' THR . 68.1 tp60 -70.39 -76.02 0.11 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.511 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.448 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.1 t -62.7 -38.63 91.16 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.295 179.51 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 54.0 tp -60.02 -45.66 92.07 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.379 -178.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.422 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 46.9 tp -62.76 -41.75 99.36 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.832 0.348 . . . . 0.0 110.365 179.066 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.448 ' OG1' ' O ' ' A' ' 151' ' ' SER . 60.2 p -64.14 -34.86 79.03 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.264 -179.498 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.435 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.9 mm-40 -64.24 -42.59 96.45 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.322 179.286 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 91.6 mt -65.55 -38.82 90.68 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.037 0.446 . . . . 0.0 110.252 179.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.583 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.29 -32.31 80.3 Favored Glycine 0 CA--C 1.521 0.418 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 -179.387 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.442 ' C ' ' O ' ' A' ' 157' ' ' GLY . 97.1 mt-10 -35.17 -27.29 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.821 0.344 . . . . 0.0 110.764 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.583 ' N ' ' O ' ' A' ' 157' ' ' GLY . 95.5 mt -56.03 149.76 3.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.33 179.187 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 71.5 p -69.87 137.3 51.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.002 -179.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 71.57 20.34 78.4 Favored Glycine 0 N--CA 1.458 0.143 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 179.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 58.0 m80 -121.78 -14.91 8.02 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.706 0.289 . . . . 0.0 110.571 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -65.85 -59.83 3.48 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.764 -179.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -52.05 -49.35 63.64 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.16 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -60.76 -41.14 94.85 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.718 0.294 . . . . 0.0 110.356 179.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.45 -47.2 86.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.613 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -57.0 -40.16 76.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.241 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -61.65 -50.34 72.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.571 179.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -65.34 -43.75 89.91 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.535 179.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 95.2 mt -64.6 -43.47 96.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.509 179.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.21 -51.17 70.43 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.535 -179.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.44 -43.93 96.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.46 179.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.654 ' CE2' HD11 ' A' ' 177' ' ' LEU . 56.7 t80 -62.72 -44.45 96.18 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.04 0.448 . . . . 0.0 110.405 179.44 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -63.35 -39.88 95.75 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.616 -179.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -63.07 -42.78 99.74 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.617 179.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -60.67 -44.77 96.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.181 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.654 HD11 ' CE2' ' A' ' 173' ' ' PHE . 83.7 mt -64.36 -41.23 96.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.031 0.443 . . . . 0.0 110.698 178.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.08 -62.32 1.71 Allowed 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.482 -179.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.52 -46.9 85.81 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.552 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.12 -41.76 65.34 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.223 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -63.94 -33.52 75.91 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.976 0.417 . . . . 0.0 110.352 179.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.423 ' HG2' ' O ' ' A' ' 182' ' ' GLU . 69.6 tt0 -90.72 8.68 33.27 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.37 0.605 . . . . 0.0 110.52 -179.003 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -104.84 -32.12 8.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.195 179.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 45.4 pt -128.11 147.67 32.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.814 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -139.86 131.03 26.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.422 179.362 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.596 HD22 ' N ' ' A' ' 186' ' ' LEU . 3.6 mm? -85.59 133.14 42.56 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.901 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -43.89 157.72 0.14 Allowed 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.738 2.292 . . . . 0.0 112.138 179.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 0.525 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.8 Cg_endo -63.01 115.21 2.81 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 C-N-CA 122.804 2.336 . . . . 0.0 111.724 179.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . 0.525 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.7 mt-30 155.53 147.63 0.0 OUTLIER Pre-proline 0 C--N 1.332 -0.195 0 O-C-N 123.596 0.56 . . . . 0.0 110.762 -179.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -73.77 143.85 34.17 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.651 2.234 . . . . 0.0 111.963 178.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.499 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.1 p -125.03 159.09 32.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.27 0.557 . . . . 0.0 110.164 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . 0.499 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 35.9 p -143.54 165.48 27.45 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.034 -179.636 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . 0.44 ' HA ' ' H ' ' A' ' 260' ' ' PHE . . . -135.38 128.58 31.89 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.159 0.504 . . . . 0.0 110.213 179.587 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.509 HD11 HD23 ' A' ' 259' ' ' LEU . 47.4 pt -146.49 148.81 16.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.048 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . 0.752 HG13 ' CD1' ' A' ' 262' ' ' PHE . 68.9 t -117.67 123.09 71.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-O 121.238 0.542 . . . . 0.0 109.765 179.104 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -134.3 107.29 7.56 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.332 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 95.2 m -130.96 130.6 43.63 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.756 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.406 ' O ' ' N ' ' A' ' 201' ' ' HIS . . . -82.84 -36.9 25.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.256 179.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.34 -67.18 0.25 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.374 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.33 -9.43 58.49 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.348 179.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . 0.406 ' N ' ' O ' ' A' ' 198' ' ' ALA . 60.2 t-80 60.27 58.42 2.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.748 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 46.4 p -167.21 153.65 8.19 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.535 179.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.6 144.23 24.29 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.992 0.425 . . . . 0.0 110.446 179.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -135.39 138.4 43.27 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.646 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 20.0 mt -106.42 125.48 51.05 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 121.11 0.481 . . . . 0.0 109.867 -179.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' TRP . . . . . 0.557 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 75.7 m95 -82.01 167.03 19.28 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.659 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . 0.466 HG22 ' C ' ' A' ' 206' ' ' TRP . 0.1 OUTLIER -156.77 171.33 7.56 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.586 -179.156 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.87 -37.03 85.02 Favored 'Trans proline' 0 C--N 1.302 -1.879 0 C-N-CA 122.624 2.216 . . . . 0.0 112.133 179.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -70.47 -34.87 72.89 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.8 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 22.0 m -61.26 150.83 33.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.64 -179.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.59 -36.95 82.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.448 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . 0.557 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 54.8 tt0 -64.69 -40.29 95.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.506 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.61 -43.45 92.07 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -63.26 -43.52 97.76 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.741 0.305 . . . . 0.0 110.281 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . 0.525 ' SD ' ' HB2' ' A' ' 304' ' ' ALA . 65.2 ttp -59.61 -48.11 82.95 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.252 -179.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 87.9 mt -60.49 -41.04 93.45 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 179.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . 0.455 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.3 tp10 -57.88 -37.85 74.69 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -65.36 -37.98 88.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.8 0.333 . . . . 0.0 110.679 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 94.4 mt -64.43 -42.64 95.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.606 -179.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.49 44.6 0.08 OUTLIER Glycine 0 C--N 1.333 0.408 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . 0.455 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 26.5 m-85 -127.74 155.28 44.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.04 0.447 . . . . 0.0 110.507 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.487 ' O ' HG13 ' A' ' 191' ' ' VAL . 6.5 p -106.99 122.11 45.8 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.201 0.524 . . . . 0.0 110.154 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.472 HD22 ' C ' ' A' ' 222' ' ' THR . 4.3 mm? -101.07 133.12 46.06 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.063 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.96 159.31 14.98 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.463 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.43 115.42 30.23 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.942 0.401 . . . . 0.0 110.351 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.499 ' N ' HD12 ' A' ' 226' ' ' LEU . 8.9 mp -53.47 156.77 4.04 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.686 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -60.29 145.41 98.65 Favored 'Trans proline' 0 C--N 1.301 -1.956 0 C-N-CA 122.721 2.281 . . . . 0.0 112.058 179.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.36 -2.92 58.96 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.546 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.31 -40.8 5.66 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.54 ' O ' ' N ' ' A' ' 233' ' ' SER . 86.2 mt -79.27 -16.75 55.96 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-O 121.006 0.431 . . . . 0.0 110.386 -179.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . 0.403 ' C ' ' O ' ' A' ' 230' ' ' LEU . 54.5 t-20 -40.21 -49.15 2.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.694 -179.577 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -88.18 15.43 7.54 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.777 0.322 . . . . 0.0 111.27 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.54 ' N ' ' O ' ' A' ' 230' ' ' LEU . 78.1 p -60.43 -35.65 76.33 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.693 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . 0.526 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.6 tt0 -118.35 -69.39 0.85 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.943 179.554 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.1 m -70.04 103.37 2.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.734 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -94.59 57.69 2.25 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.359 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -144.88 -122.61 1.57 Allowed Glycine 0 CA--C 1.52 0.402 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -134.4 111.7 10.37 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 121.081 0.467 . . . . 0.0 110.433 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . 0.517 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.3 mtt180 -148.1 57.52 1.08 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.778 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -69.92 -31.75 69.69 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.505 179.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . 0.55 ' CG ' HD21 ' A' ' 143' ' ' ASN . 64.9 t0 -56.85 -46.98 81.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.343 -179.163 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 242' ' ' ILE . . . . . 0.435 ' O ' ' O ' ' A' ' 239' ' ' ARG . 17.5 tt -140.27 157.11 24.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.898 0.38 . . . . 0.0 110.527 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.44 HG22 HD13 ' A' ' 245' ' ' LEU . 96.1 mt -106.12 106.17 20.08 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.196 0 CA-C-O 121.16 0.505 . . . . 0.0 110.504 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . 0.603 ' O ' HD12 ' A' ' 245' ' ' LEU . 88.3 mt-30 -110.5 110.39 21.11 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.405 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.603 HD12 ' O ' ' A' ' 244' ' ' GLN . 9.5 mp -121.95 -168.3 1.68 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.607 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . 0.526 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.53 -16.88 0.05 OUTLIER Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . 0.671 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -60.47 157.01 29.84 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -63.77 21.27 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.915 0.388 . . . . 0.0 110.585 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . 0.671 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.7 m-20 -96.87 -5.82 37.29 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.569 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 92.7 mt -80.23 -21.45 42.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.6 179.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.47 -51.24 70.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.8 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.72 -5.28 58.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.449 179.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.09 -74.39 1.14 Allowed Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.926 -0.87 . . . . 0.0 110.926 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 81.8 mt -70.13 125.95 28.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.054 0.454 . . . . 0.0 110.227 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -59.45 -39.17 82.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.321 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 82.82 51.94 4.06 Favored Glycine 0 CA--C 1.521 0.463 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -95.8 -15.16 22.71 Favored 'General case' 0 C--N 1.331 -0.203 0 O-C-N 122.723 -0.281 . . . . 0.0 110.553 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . 0.496 ' OG ' HG23 ' A' ' 191' ' ' VAL . 3.4 t 174.5 88.9 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.104 0.478 . . . . 0.0 110.159 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.862 ' N ' HD12 ' A' ' 259' ' ' LEU . 0.9 OUTLIER -94.27 123.88 37.94 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.244 0.545 . . . . 0.0 111.098 -179.058 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 260' ' ' PHE . . . . . 0.44 ' H ' ' HA ' ' A' ' 193' ' ' ALA . 16.0 m-30 -92.85 146.4 23.66 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.316 179.244 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 86.3 mt -122.31 149.73 43.34 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.562 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.752 ' CD1' HG13 ' A' ' 195' ' ' VAL . 2.7 p90 -77.43 -138.29 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.601 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . 0.66 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -52.31 77.55 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 121.044 0.449 . . . . 0.0 111.034 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . 0.627 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.08 104.33 0.18 Allowed Glycine 0 CA--C 1.527 0.786 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 265' ' ' ASP . . . . . 0.603 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.9 m-20 -80.35 -177.68 6.27 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 120.724 0.297 . . . . 0.0 110.912 -179.488 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -40.44 -17.61 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.536 179.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . 0.603 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.48 -51.73 40.16 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.019 0.438 . . . . 0.0 110.693 179.457 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -63.58 -46.63 84.97 Favored 'General case' 0 CA--C 1.527 0.09 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.323 179.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . 0.565 ' HB1' ' OH ' ' A' ' 273' ' ' TYR . . . -61.59 -35.18 77.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.865 179.531 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -62.97 -34.4 77.43 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.163 179.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.49 -43.37 13.63 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.225 -179.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 272' ' ' ILE . . . . . 0.587 ' C ' ' H ' ' A' ' 274' ' ' ALA . 4.9 tt -51.33 -33.63 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.876 -178.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 273' ' ' TYR . . . . . 0.565 ' OH ' ' HB1' ' A' ' 269' ' ' ALA . 17.3 m-85 -54.45 -1.8 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.649 -179.603 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 274' ' ' ALA . . . . . 0.587 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.65 -39.51 70.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.881 179.577 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . 0.583 ' O ' ' N ' ' A' ' 279' ' ' ALA . 2.8 p30 -39.61 98.35 0.17 Allowed Pre-proline 0 C--N 1.333 -0.122 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.514 -179.66 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -54.24 -43.02 62.38 Favored 'Trans proline' 0 C--N 1.303 -1.856 0 C-N-CA 122.391 2.061 . . . . 0.0 112.574 -178.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 89.5 mt -64.46 -42.82 95.7 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.201 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 91.1 mt -95.67 -1.63 49.72 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.812 -179.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 279' ' ' ALA . . . . . 0.583 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.33 -34.91 77.55 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.672 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.26 20.1 0.12 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.994 -179.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 0.49 HD23 ' HA ' ' A' ' 281' ' ' LEU . 13.8 mt -75.21 120.01 79.66 Favored Pre-proline 0 N--CA 1.451 -0.375 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.484 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -50.83 -39.44 58.16 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.599 2.199 . . . . 0.0 111.946 179.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.8 -50.51 63.49 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.154 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 79.4 t -61.42 -43.96 97.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 179.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -57.7 -41.22 81.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.248 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -90.98 0.15 57.6 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.167 179.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt 59.53 43.41 16.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.035 0.445 . . . . 0.0 110.873 179.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -94.78 41.3 1.09 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.411 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 53.7 t -118.93 135.92 57.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.012 0.434 . . . . 0.0 110.257 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -133.08 162.85 30.64 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.053 0.454 . . . . 0.0 110.701 -179.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.96 155.22 33.22 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.012 0.434 . . . . 0.0 110.731 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 81.4 mt -93.9 -1.38 54.82 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.227 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.43 165.72 12.7 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 110.598 -1.001 . . . . 0.0 110.598 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 7.0 m -87.47 -62.3 1.53 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.899 0.381 . . . . 0.0 111.034 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 295' ' ' GLU . . . . . 0.437 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.5 mm-40 -69.68 -3.85 17.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.61 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 27.0 p -76.91 33.22 0.14 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.66 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 297' ' ' PHE . . . . . 0.539 ' CD2' HG22 ' A' ' 70' ' ' THR . 84.9 t80 -60.16 -45.86 91.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.58 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . 0.603 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.2 mtt85 -81.87 134.22 35.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.531 -179.684 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.45 ' H ' HG11 ' A' ' 51' ' ' VAL . 16.2 tp -114.46 119.52 37.15 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-O 120.996 0.427 . . . . 0.0 110.178 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . 0.623 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.3 p-10 -167.26 -174.44 2.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.553 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 84.5 t80 -47.92 -45.68 31.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.254 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -64.93 -41.42 95.55 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.022 0.439 . . . . 0.0 110.717 179.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . 0.623 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 52.8 p -55.52 -36.24 66.51 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.086 -179.251 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . 0.525 ' HB2' ' SD ' ' A' ' 215' ' ' MET . . . -56.79 -51.85 67.32 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.442 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 90.9 mtp -56.14 -43.71 78.5 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -66.32 -42.64 87.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.978 0.418 . . . . 0.0 110.278 178.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 303' ' ' SER . 55.7 t -64.08 -42.84 96.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.207 179.38 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 42.3 tp -59.55 -42.27 92.01 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.863 -179.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -62.63 -38.8 91.67 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.163 179.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 310' ' ' ARG . . . . . 0.443 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.6 ttt85 -63.58 -44.07 95.13 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.251 179.549 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 88.4 mt -63.26 -42.01 99.11 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.228 179.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -62.84 -33.03 74.4 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.097 179.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -90.33 -23.31 21.17 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.417 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.477 HD22 ' CE2' ' A' ' 315' ' ' PHE . 6.8 tt -62.3 -43.22 99.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.098 0.475 . . . . 0.0 110.594 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 315' ' ' PHE . . . . . 0.477 ' CE2' HD22 ' A' ' 314' ' ' LEU . 91.0 m-85 . . . . . 0 C--O 1.219 -0.511 0 CA-C-O 118.079 -0.962 . . . . 0.0 110.414 -179.988 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -99.64 135.69 40.68 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.064 0.459 . . . . 0.0 110.456 -179.993 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.497 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -92.09 178.61 1.64 Allowed Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.61 -179.813 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.497 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 27.0 Cg_exo -61.63 147.17 96.01 Favored 'Trans proline' 0 C--N 1.3 -1.995 0 C-N-CA 122.749 2.299 . . . . 0.0 112.112 179.694 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.484 ' HE ' HD12 ' A' ' 39' ' ' LEU . 35.1 ptt180 -136.12 142.29 44.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.673 179.701 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -79.79 116.83 20.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.489 179.865 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.46 ' O ' HG23 ' A' ' 30' ' ' ILE . 9.5 tp -111.48 129.98 65.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.444 -179.988 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.2 t -70.9 142.11 51.16 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.58 179.881 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.484 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.5 t0 -138.93 179.98 6.18 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.575 -179.985 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.484 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 77.7 p -74.31 -37.23 63.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.616 179.952 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -46.69 -94.58 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.35 -179.515 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -165.8 -27.13 0.02 OUTLIER Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 179.953 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 63.2 m -168.79 106.09 0.44 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.924 0.392 . . . . 0.0 110.696 -179.929 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.643 ' CD2' HD13 ' A' ' 140' ' ' LEU . 67.4 t60 -128.92 146.72 50.87 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.044 0.449 . . . . 0.0 110.232 -179.949 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.623 HG22 ' N ' ' A' ' 39' ' ' LEU . 96.5 m -130.08 165.59 21.92 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.57 -179.848 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.623 ' N ' HG22 ' A' ' 38' ' ' THR . 80.5 mt -120.29 127.16 52.11 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.461 179.752 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -65.46 -44.61 86.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.588 -179.996 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 38.6 p -165.59 154.58 11.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.388 179.735 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.489 ' H ' ' CD ' ' A' ' 42' ' ' GLN . 14.7 mp0 -44.98 101.32 0.25 Allowed Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.631 179.436 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -57.53 129.54 34.33 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 C-N-CA 122.367 2.045 . . . . 0.0 112.247 -179.731 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -82.42 -25.13 33.95 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.491 179.631 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.537 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.7 mtm-85 -120.96 134.56 55.3 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-O 121.191 0.519 . . . . 0.0 110.28 -179.953 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.0 mt -130.28 133.59 63.79 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.923 -179.771 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 46.5 t -124.61 131.34 72.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.808 0.337 . . . . 0.0 110.126 179.373 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.617 ' OG ' HD12 ' A' ' 117' ' ' LEU . 4.7 m -154.2 165.94 34.69 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.563 179.782 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 71.5 p -124.76 8.29 8.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.463 179.942 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.66 125.8 33.44 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.672 -179.459 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.452 HG11 ' H ' ' A' ' 299' ' ' LEU . 89.9 t -65.47 -44.61 94.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.44 -179.943 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.6 m -62.52 -44.31 96.67 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.627 -179.917 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 53.1 tp -62.15 -41.58 98.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.512 -179.519 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.45 ' O ' HD13 ' A' ' 58' ' ' LEU . 72.8 m -57.74 -44.49 86.08 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.292 -179.253 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.39 -62.0 5.5 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 110.906 -0.878 . . . . 0.0 110.906 179.632 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.7 t -48.35 -35.76 13.11 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 -179.904 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 20.2 mt -61.66 -44.61 96.63 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.648 -0.421 . . . . 0.0 111.186 179.424 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.45 HD13 ' O ' ' A' ' 54' ' ' THR . 9.3 mp -64.89 -41.89 95.25 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.342 177.901 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.53 -41.19 98.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.02 -179.279 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.429 ' O ' HG23 ' A' ' 60' ' ' ILE . 8.0 tp -88.04 16.62 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.763 -179.711 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 56.45 84.11 0.09 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.736 -179.874 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.9 58.24 0.09 OUTLIER Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.019 -179.745 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.411 ' HB3' HE21 ' A' ' 85' ' ' GLN . 10.3 Cg_endo -50.77 152.45 9.6 Favored 'Trans proline' 0 C--N 1.296 -2.229 0 C-N-CA 122.751 2.301 . . . . 0.0 112.473 -178.405 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.431 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -109.15 146.25 14.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.372 -179.658 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 97.0 mt -63.86 -44.91 98.24 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.357 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.459 -179.914 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.504 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -129.81 134.22 47.42 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 120.84 0.352 . . . . 0.0 110.632 -179.896 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.509 ' O ' ' N ' ' A' ' 98' ' ' LEU . 58.8 m -134.32 158.39 43.92 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.875 -179.62 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -85.46 138.16 16.11 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.749 -0.941 . . . . 0.0 110.749 179.811 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.481 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.25 -163.81 0.11 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.958 0.408 . . . . 0.0 110.515 -179.906 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.502 HG22 ' CD2' ' A' ' 297' ' ' PHE . 6.2 t -134.22 140.61 46.6 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.216 179.936 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.486 ' C ' ' O ' ' A' ' 70' ' ' THR . 0.7 OUTLIER 29.67 70.73 0.56 Allowed Pre-proline 0 N--CA 1.466 0.329 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.657 -179.935 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_exo -60.45 144.44 99.52 Favored 'Trans proline' 0 C--N 1.299 -2.036 0 C-N-CA 122.587 2.191 . . . . 0.0 112.079 -178.323 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.54 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 44.5 p-10 -164.87 -35.56 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.662 179.895 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.54 ' N ' ' OD1' ' A' ' 73' ' ' ASN . 99.0 m-20 -63.88 -39.36 94.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.433 -179.98 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 73.4 ttt180 -60.88 -47.76 84.93 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.67 -179.389 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.433 ' O ' ' O ' ' A' ' 77' ' ' ALA . 95.6 t -60.24 -23.9 29.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.113 179.716 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.512 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -45.14 172.36 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.633 179.853 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.572 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.9 p30 -62.33 178.05 0.44 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.617 -179.7 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.562 ' C ' ' H ' ' A' ' 81' ' ' GLY . 36.6 p30 -46.04 85.64 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.05 179.912 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.572 ' N ' ' O ' ' A' ' 78' ' ' ASP . 42.6 tp60 -67.4 14.04 0.06 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.121 0.486 . . . . 0.0 110.094 -179.718 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.562 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 117.48 -21.62 10.58 Favored Glycine 0 CA--C 1.519 0.339 0 N-CA-C 110.909 -0.876 . . . . 0.0 110.909 179.922 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -107.85 116.71 32.45 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.968 0.413 . . . . 0.0 110.434 179.917 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 74.2 mt -98.62 0.69 45.3 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.551 -179.764 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -92.64 6.38 47.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.99 0.424 . . . . 0.0 110.459 -179.786 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.789 ' O ' HG22 ' A' ' 89' ' ' VAL . 88.2 mt-30 -99.83 -27.46 13.61 Favored 'General case' 0 C--O 1.224 -0.289 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.861 179.953 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.4 t-105 -63.84 -40.84 97.54 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.145 -179.795 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.552 ' O ' ' N ' ' A' ' 91' ' ' LYS . 67.3 m -77.76 -53.76 7.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.304 -179.548 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -48.19 -50.81 27.83 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.003 -179.273 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.789 HG22 ' O ' ' A' ' 85' ' ' GLN . 14.7 m -68.89 -40.7 81.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 120.919 0.39 . . . . 0.0 111.059 179.757 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.499 ' N ' HG23 ' A' ' 89' ' ' VAL . . . -72.14 -22.81 61.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.721 -179.885 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.552 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.0 tttm -61.6 -46.03 91.55 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.489 -179.539 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.442 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.3 mm-40 -90.11 -94.86 0.11 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.096 -179.964 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.627 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.7 mtt180 -143.19 59.58 1.41 Allowed 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 179.812 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.46 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.6 pttp 33.6 26.45 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.221 -179.214 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.627 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.4 tt -48.12 123.14 5.9 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.904 -178.152 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.456 ' O ' HD23 ' A' ' 95' ' ' LEU . 98.8 mm-40 -83.24 -169.54 2.59 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.057 -179.835 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.612 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 81.2 mtp180 -73.9 138.26 44.19 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.174 -179.677 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.509 ' N ' ' O ' ' A' ' 67' ' ' SER . 87.9 mt -86.61 -166.58 1.6 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.707 -179.524 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.528 ' CD2' ' O ' ' A' ' 99' ' ' TYR . 46.7 p90 -167.32 119.69 0.92 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.324 179.946 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.507 ' C ' ' O ' ' A' ' 99' ' ' TYR . 44.4 mm -29.56 121.08 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.995 -179.744 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 113.2 28.78 3.21 Favored Glycine 0 CA--C 1.52 0.359 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 -179.477 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.59 ' H ' ' CD ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -143.86 45.68 0.59 Allowed Pre-proline 0 C--N 1.323 -0.555 0 CA-C-O 120.948 0.404 . . . . 0.0 110.448 179.839 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.587 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 29.9 Cg_endo -61.97 143.68 95.56 Favored 'Trans proline' 0 C--N 1.297 -2.148 0 C-N-CA 122.683 2.255 . . . . 0.0 111.989 -179.925 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.484 ' O ' HG23 ' A' ' 108' ' ' VAL . 21.1 t -173.27 120.77 0.35 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.491 179.717 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.58 -41.09 63.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.067 0.461 . . . . 0.0 111.121 179.725 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -65.85 -40.4 91.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.904 -179.372 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.07 -39.95 95.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.762 -179.909 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 104' ' ' SER . 69.6 t -67.54 -43.77 86.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.795 179.652 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.43 -39.18 92.48 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.589 -179.284 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.442 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.39 -23.59 62.72 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.455 179.858 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.551 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.3 mm-40 -90.79 4.81 50.66 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.717 -179.509 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.551 ' C ' ' O ' ' A' ' 111' ' ' GLN . 10.5 tpt 23.67 63.86 0.39 Allowed Pre-proline 0 N--CA 1.465 0.297 0 CA-C-O 120.898 0.38 . . . . 0.0 111.059 -179.993 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.445 ' HG2' HD11 ' A' ' 116' ' ' ILE . 70.6 Cg_endo -78.7 168.55 20.93 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 C-N-CA 122.938 2.425 . . . . 0.0 112.213 -178.463 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.498 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 99.0 m-20 -113.04 -44.42 3.28 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.978 179.517 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.2 tp -120.23 119.62 33.74 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.577 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.456 HD13 HD22 ' A' ' 133' ' ' LEU . 95.4 mt -116.78 131.04 70.59 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.351 0 CA-C-O 120.953 0.406 . . . . 0.0 110.918 -179.856 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.617 HD12 ' OG ' ' A' ' 48' ' ' SER . 30.9 mt -105.69 132.75 51.45 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.115 0.483 . . . . 0.0 110.279 -179.466 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.421 HD12 HG23 ' A' ' 139' ' ' THR . 98.2 mt -118.33 136.24 56.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.724 -179.729 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 85.7 p -72.18 153.08 41.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.672 179.975 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -59.96 -50.0 75.49 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.612 -179.817 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -149.45 153.91 38.02 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.571 179.799 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 170.05 -170.56 42.96 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 179.919 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -63.04 -34.77 90.88 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 179.98 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.447 ' O ' ' OD1' ' A' ' 124' ' ' ASP . 43.9 p-10 -88.04 120.4 29.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.764 0.316 . . . . 0.0 110.683 179.934 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.455 ' O ' HD12 ' A' ' 129' ' ' LEU . 40.8 t -63.45 144.12 57.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.466 -179.928 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.521 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.37 -42.82 9.08 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.031 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.6 tp -62.82 -42.36 99.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.669 -179.832 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.05 -10.93 57.64 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.543 -179.461 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.455 HD12 ' O ' ' A' ' 125' ' ' SER . 85.2 mt -115.54 -24.14 8.46 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.695 -179.918 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . 0.521 ' N ' ' O ' ' A' ' 126' ' ' ALA . 78.7 t80 -51.84 -49.88 61.97 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.554 -178.902 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.1 p-10 -65.91 -42.11 90.57 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.909 0.385 . . . . 0.0 111.232 179.569 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.52 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 88.0 mt-30 -67.32 -36.74 82.07 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.78 179.929 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.456 HD22 HD13 ' A' ' 116' ' ' ILE . 93.7 mt -80.38 -41.74 24.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.975 -179.541 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.2 t -57.44 -44.71 84.95 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.223 -179.109 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 18.9 m -62.23 -45.59 92.66 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.799 0.333 . . . . 0.0 110.66 179.264 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 92.1 mt -62.36 -43.85 98.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.325 -179.792 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.605 ' HB1' ' HD2' ' A' ' 138' ' ' PRO . . . -170.37 163.79 5.94 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.541 179.832 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.605 ' HD2' ' HB1' ' A' ' 137' ' ' ALA . 78.3 Cg_exo -43.36 111.24 0.22 Allowed 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.501 2.134 . . . . 0.0 112.115 179.553 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.469 HG21 ' CD1' ' A' ' 130' ' ' TYR . 17.4 m -85.44 127.55 34.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.594 179.933 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.643 HD13 ' CD2' ' A' ' 37' ' ' HIS . 34.3 tp -119.11 136.93 53.92 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.957 -179.718 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.432 ' O ' ' OD1' ' A' ' 32' ' ' ASP . 79.8 mt -103.9 119.83 53.17 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.41 0 CA-C-O 121.183 0.516 . . . . 0.0 111.308 -179.382 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.507 HD12 HD22 ' A' ' 117' ' ' LEU . 98.1 mt -135.42 132.52 52.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.651 179.657 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.544 HD21 ' CG ' ' A' ' 241' ' ' ASP . 53.7 t30 -65.56 149.41 50.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.899 0.38 . . . . 0.0 110.388 179.258 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.524 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 88.1 t80 -83.07 122.5 28.42 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.002 -179.496 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.524 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 98.9 m-20 55.09 69.58 0.72 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.871 179.608 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 49.2 p-10 -123.69 -0.01 8.65 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 120.974 0.416 . . . . 0.0 110.696 179.8 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -151.59 117.25 5.41 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.767 -179.512 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 84.7 p -63.07 167.53 4.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.5 -179.811 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.419 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.6 p-90 -50.74 -15.47 0.29 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.518 -179.823 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.442 ' O ' HG23 ' A' ' 154' ' ' THR . 68.1 tp60 -71.72 -74.45 0.16 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.458 -179.843 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.451 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.2 t -62.61 -39.22 93.08 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.008 0.432 . . . . 0.0 110.274 179.408 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 53.3 tp -60.23 -45.43 93.25 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.364 -178.516 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.419 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 45.7 tp -62.74 -41.73 99.32 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.398 179.025 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.451 ' OG1' ' O ' ' A' ' 151' ' ' SER . 51.8 p -64.05 -34.64 78.47 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.284 -179.469 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.456 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 88.2 mm-40 -63.98 -42.44 97.21 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.157 179.223 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 92.9 mt -65.35 -38.95 91.63 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.068 0.461 . . . . 0.0 110.223 179.137 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.582 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.15 -32.16 79.48 Favored Glycine 0 CA--C 1.52 0.362 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 -179.367 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.456 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.2 mt-10 -36.22 -25.68 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.814 0.34 . . . . 0.0 110.741 179.95 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.582 ' N ' ' O ' ' A' ' 157' ' ' GLY . 94.9 mt -58.95 149.68 5.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.276 179.303 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 75.2 p -69.3 137.08 52.7 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.076 -179.541 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 70.98 21.67 78.31 Favored Glycine 0 C--N 1.329 0.156 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 179.518 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 59.5 m80 -123.3 -14.95 7.34 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.732 0.301 . . . . 0.0 110.573 179.912 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -66.51 -59.63 3.46 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.779 -179.744 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -51.9 -48.9 63.93 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.173 -179.645 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -60.76 -41.03 94.64 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.981 -0.288 . . . . 0.0 110.316 179.534 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.58 -47.29 86.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.575 179.81 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.8 -40.25 75.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.178 -179.828 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -61.67 -50.24 73.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.627 179.56 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -65.43 -43.76 89.45 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.506 179.532 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 95.4 mt -64.6 -43.44 96.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.51 179.694 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.33 -51.03 71.02 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.542 -179.12 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.91 -43.62 95.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.44 179.685 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.659 ' CE2' HD11 ' A' ' 177' ' ' LEU . 56.3 t80 -62.63 -44.63 95.8 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.058 0.456 . . . . 0.0 110.404 179.41 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -63.21 -39.88 95.87 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.59 -179.363 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -62.92 -42.86 99.93 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.637 179.218 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -60.61 -44.83 95.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.073 179.987 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.659 HD11 ' CE2' ' A' ' 173' ' ' PHE . 85.6 mt -64.37 -41.21 96.83 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.044 0.449 . . . . 0.0 110.672 178.901 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.06 -62.16 1.81 Allowed 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.527 -179.342 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.79 -46.54 87.32 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.571 179.803 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.36 -41.58 65.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.179 -179.994 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -63.76 -33.78 76.42 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.932 0.396 . . . . 0.0 110.336 179.305 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.427 ' HG2' ' O ' ' A' ' 182' ' ' GLU . 69.8 tt0 -90.5 8.81 31.99 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.312 0.577 . . . . 0.0 110.509 -179.031 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -104.82 -32.26 8.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.887 0.375 . . . . 0.0 111.274 179.56 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.3 pt -128.01 147.41 32.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.836 -179.861 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -139.88 131.14 26.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.336 179.346 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.596 HD22 ' N ' ' A' ' 186' ' ' LEU . 3.5 mm? -85.61 133.7 41.4 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.879 179.938 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -43.95 157.96 0.13 Allowed 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.669 2.246 . . . . 0.0 112.171 179.401 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 0.523 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.6 Cg_endo -62.95 114.78 2.58 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 C-N-CA 122.82 2.347 . . . . 0.0 111.7 179.773 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . 0.523 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.8 mt-30 155.56 147.89 0.0 OUTLIER Pre-proline 0 N--CA 1.455 -0.195 0 O-C-N 123.555 0.535 . . . . 0.0 110.721 -179.858 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -73.72 144.09 34.73 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.644 2.229 . . . . 0.0 111.911 178.043 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.496 HG23 ' OG ' ' A' ' 258' ' ' SER . 2.1 p -124.93 158.91 32.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.336 0.589 . . . . 0.0 110.086 179.983 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . 0.496 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 37.1 p -143.47 165.35 27.78 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.135 -179.653 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . 0.441 ' HA ' ' H ' ' A' ' 260' ' ' PHE . . . -135.26 128.49 31.97 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.144 0.497 . . . . 0.0 110.181 179.618 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.508 HD11 HD23 ' A' ' 259' ' ' LEU . 47.3 pt -146.48 148.92 16.49 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.056 179.814 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . 0.744 HG13 ' CD1' ' A' ' 262' ' ' PHE . 70.4 t -117.74 123.22 71.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.278 0.561 . . . . 0.0 109.681 179.183 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -134.26 107.35 7.61 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.251 179.66 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 95.8 m -130.93 130.53 43.59 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.85 179.707 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -82.92 -36.92 24.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.245 179.691 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.5 -67.07 0.26 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.343 -179.939 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.52 -10.1 59.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.249 179.606 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 60.0 t-80 61.03 58.42 2.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.816 -179.959 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 37.3 p -166.88 153.33 8.46 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.5 179.573 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.08 143.77 24.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.985 0.421 . . . . 0.0 110.431 179.455 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -135.21 138.06 43.25 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.667 179.993 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 20.0 mt -106.13 125.37 50.91 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.059 0.457 . . . . 0.0 109.848 -179.633 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 206' ' ' TRP . . . . . 0.558 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 74.9 m95 -82.01 167.04 19.27 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.603 -179.787 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . 0.465 HG22 ' C ' ' A' ' 206' ' ' TRP . 0.1 OUTLIER -156.75 171.67 7.11 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.598 -179.214 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -54.09 -36.87 86.35 Favored 'Trans proline' 0 C--N 1.303 -1.865 0 C-N-CA 122.663 2.242 . . . . 0.0 111.952 179.379 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -70.61 -34.96 72.68 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.795 -179.811 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 21.2 m -61.28 150.57 34.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.635 -179.321 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.5 -37.07 82.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.52 -179.821 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . 0.558 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 54.9 tt0 -64.53 -40.36 95.47 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.497 179.957 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.74 -43.39 91.91 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 179.791 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -63.4 -43.53 97.27 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.715 0.293 . . . . 0.0 110.23 179.842 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . 0.542 ' SD ' ' HB2' ' A' ' 304' ' ' ALA . 65.1 ttp -59.51 -48.07 83.06 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.227 -179.853 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 216' ' ' LEU . 87.5 mt -60.64 -40.8 93.3 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.636 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . 0.453 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.1 tp10 -58.02 -37.87 75.15 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.852 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -65.29 -38.12 89.26 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.803 0.335 . . . . 0.0 110.686 179.663 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 94.0 mt -64.41 -42.6 95.98 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.587 -179.595 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.62 45.0 0.08 OUTLIER Glycine 0 C--N 1.334 0.429 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 -179.962 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . 0.453 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 26.5 m-85 -128.23 155.91 43.8 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.038 0.447 . . . . 0.0 110.492 -179.792 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.491 ' O ' HG13 ' A' ' 191' ' ' VAL . 8.2 p -107.62 122.44 46.71 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.191 0.519 . . . . 0.0 110.182 -179.934 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.472 HD22 ' C ' ' A' ' 222' ' ' THR . 4.3 mm? -101.12 133.29 45.86 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.053 -179.995 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -97.0 159.05 15.13 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.494 179.906 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.0 115.16 29.8 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.335 179.899 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.494 ' N ' HD12 ' A' ' 226' ' ' LEU . 9.0 mp -53.33 156.66 3.89 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.698 179.921 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -60.27 145.31 98.83 Favored 'Trans proline' 0 C--N 1.301 -1.93 0 C-N-CA 122.598 2.199 . . . . 0.0 112.12 179.296 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.21 -3.05 59.03 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.493 -179.884 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.28 -40.83 5.67 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 -179.828 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.532 ' O ' ' N ' ' A' ' 233' ' ' SER . 85.6 mt -79.44 -16.96 55.26 Favored 'General case' 0 C--O 1.222 -0.344 0 CA-C-O 121.002 0.429 . . . . 0.0 110.295 -179.694 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . 0.401 ' C ' ' O ' ' A' ' 230' ' ' LEU . 55.0 t-20 -40.3 -49.08 2.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.783 -179.541 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -88.08 15.44 7.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.818 0.342 . . . . 0.0 111.325 179.802 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.532 ' N ' ' O ' ' A' ' 230' ' ' LEU . 78.1 p -60.5 -35.56 76.24 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.594 -179.799 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . 0.525 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.7 tt0 -118.4 -69.36 0.85 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.942 179.575 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.4 m -70.0 103.05 2.15 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.65 -179.776 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -94.13 57.64 2.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.456 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -145.04 -122.1 1.51 Allowed Glycine 0 CA--C 1.521 0.433 0 N-CA-C 110.966 -0.854 . . . . 0.0 110.966 -179.993 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -135.32 112.19 10.18 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 121.172 0.51 . . . . 0.0 110.383 179.939 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . 0.518 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.4 mtt180 -148.28 57.81 1.07 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.709 -179.941 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -69.57 -32.09 70.65 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.482 179.617 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . 0.544 ' CG ' HD21 ' A' ' 143' ' ' ASN . 64.8 t0 -56.7 -47.12 80.62 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.436 -179.113 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 242' ' ' ILE . . . . . 0.432 ' O ' ' O ' ' A' ' 239' ' ' ARG . 17.8 tt -140.2 156.92 24.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.925 0.393 . . . . 0.0 110.52 179.758 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.442 HG22 HD13 ' A' ' 245' ' ' LEU . 96.2 mt -106.14 106.29 20.3 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.227 0 CA-C-O 121.204 0.526 . . . . 0.0 110.507 179.759 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . 0.603 ' O ' HD12 ' A' ' 245' ' ' LEU . 88.3 mt-30 -110.29 110.04 20.71 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.336 179.702 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.603 HD12 ' O ' ' A' ' 244' ' ' GLN . 9.4 mp -121.78 -168.18 1.66 Allowed 'General case' 0 C--O 1.225 -0.199 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.711 179.78 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . 0.525 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.32 -16.53 0.05 OUTLIER Glycine 0 CA--C 1.523 0.546 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 179.833 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . 0.669 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -60.62 157.01 30.48 Favored Glycine 0 CA--C 1.521 0.443 0 N-CA-C 110.904 -0.878 . . . . 0.0 110.904 -179.892 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -63.81 21.67 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.947 0.404 . . . . 0.0 110.559 179.899 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . 0.669 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.8 m-20 -97.38 -5.85 35.41 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.572 179.965 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 92.8 mt -80.13 -21.71 42.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.617 179.51 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.55 -51.28 70.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.801 -179.529 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.58 -5.29 58.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.419 179.686 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.15 -74.26 1.15 Allowed Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 -179.897 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 80.9 mt -70.14 126.05 28.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.069 0.462 . . . . 0.0 110.269 -179.87 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -59.59 -39.17 83.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.337 -179.659 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 83.0 51.87 4.04 Favored Glycine 0 CA--C 1.521 0.421 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 179.827 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -95.82 -15.13 22.71 Favored 'General case' 0 C--N 1.332 -0.17 0 O-C-N 122.632 -0.334 . . . . 0.0 110.594 -179.861 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . 0.496 ' OG ' HG23 ' A' ' 191' ' ' VAL . 3.5 t 174.63 88.8 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.063 0.459 . . . . 0.0 110.157 179.989 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.862 ' N ' HD12 ' A' ' 259' ' ' LEU . 0.9 OUTLIER -94.26 123.96 37.98 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.309 0.576 . . . . 0.0 111.183 -179.141 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 260' ' ' PHE . . . . . 0.441 ' H ' ' HA ' ' A' ' 193' ' ' ALA . 15.9 m-30 -92.93 146.4 23.65 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.34 179.283 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 86.0 mt -122.37 149.69 43.45 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.491 -179.822 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.744 ' CD1' HG13 ' A' ' 195' ' ' VAL . 2.6 p90 -77.56 -138.39 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.563 -179.841 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . 0.659 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -51.99 77.48 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.006 179.986 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . 0.632 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.1 104.48 0.19 Allowed Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 -179.929 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 265' ' ' ASP . . . . . 0.601 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.8 m-20 -80.47 -177.69 6.33 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 120.741 0.305 . . . . 0.0 110.858 -179.562 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -40.51 -17.64 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.57 179.846 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . 0.601 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.54 -51.55 41.67 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.715 179.448 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -63.73 -46.75 83.95 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.15 179.483 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . 0.572 ' HB1' ' OH ' ' A' ' 273' ' ' TYR . . . -61.56 -35.17 77.02 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.774 179.545 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -62.87 -34.45 77.4 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.166 179.649 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.46 -43.23 13.77 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.3 -179.569 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 272' ' ' ILE . . . . . 0.584 ' C ' ' H ' ' A' ' 274' ' ' ALA . 5.0 tt -51.41 -33.55 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.904 -178.884 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 273' ' ' TYR . . . . . 0.572 ' OH ' ' HB1' ' A' ' 269' ' ' ALA . 17.1 m-85 -54.59 -1.75 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.69 -179.653 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 274' ' ' ALA . . . . . 0.584 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.64 -39.56 70.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.857 179.581 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . 0.583 ' O ' ' N ' ' A' ' 279' ' ' ALA . 3.0 p30 -39.51 98.23 0.16 Allowed Pre-proline 0 N--CA 1.463 0.175 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.538 -179.634 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -54.08 -43.04 61.95 Favored 'Trans proline' 0 C--N 1.303 -1.824 0 C-N-CA 122.388 2.058 . . . . 0.0 112.691 -178.821 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 89.5 mt -64.48 -42.76 95.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.14 0.495 . . . . 0.0 111.181 -179.691 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 91.4 mt -95.82 -1.52 49.43 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.884 -179.456 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 279' ' ' ALA . . . . . 0.583 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.38 -34.93 77.68 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.644 -179.812 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -74.09 20.05 0.11 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.048 -179.354 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 0.492 HD23 ' HA ' ' A' ' 281' ' ' LEU . 13.7 mt -75.06 120.23 80.68 Favored Pre-proline 0 N--CA 1.452 -0.349 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.424 179.981 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -51.12 -39.5 60.85 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.624 2.216 . . . . 0.0 111.8 179.099 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.82 -50.26 64.02 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.096 179.879 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 74.0 t -61.51 -43.93 97.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.562 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -57.86 -41.19 81.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.305 -179.942 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -90.87 -0.0 57.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.061 179.695 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt 59.47 43.1 16.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.967 0.413 . . . . 0.0 110.829 179.714 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -94.59 41.42 1.09 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.383 179.797 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 54.5 t -118.92 135.84 58.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.074 0.464 . . . . 0.0 110.179 -179.677 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -133.0 162.6 31.25 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.726 -179.663 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.58 155.4 32.3 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-O 120.956 0.408 . . . . 0.0 110.776 -179.87 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 81.5 mt -94.22 -1.47 54.02 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.281 -179.723 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.24 165.93 12.8 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.611 -0.996 . . . . 0.0 110.611 -179.838 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 7.2 m -87.64 -62.46 1.49 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.934 0.397 . . . . 0.0 111.08 -179.901 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 295' ' ' GLU . . . . . 0.44 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.6 mm-40 -69.46 -3.82 16.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.674 -179.845 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 22.7 p -76.91 32.47 0.14 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.601 -179.892 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 297' ' ' PHE . . . . . 0.502 ' CD2' HG22 ' A' ' 70' ' ' THR . 77.1 t80 -60.24 -46.08 91.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.592 -179.962 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . 0.612 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.1 mtt85 -80.92 134.85 35.8 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.016 0.436 . . . . 0.0 110.583 -179.742 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.452 ' H ' HG11 ' A' ' 51' ' ' VAL . 17.0 tp -114.48 118.2 33.11 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.203 179.882 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . 0.631 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.0 p-10 -165.78 -176.08 3.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.585 179.94 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 82.5 t80 -47.16 -43.77 21.38 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.286 -179.719 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -66.69 -40.51 88.55 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.03 0.443 . . . . 0.0 110.823 179.136 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . 0.631 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 59.6 p -55.87 -36.18 67.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.087 -179.21 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . 0.542 ' HB2' ' SD ' ' A' ' 215' ' ' MET . . . -57.37 -51.48 69.23 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.52 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 91.0 mtp -56.23 -43.63 78.8 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.953 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -66.34 -42.68 87.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.986 0.422 . . . . 0.0 110.226 178.79 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 303' ' ' SER . 55.8 t -64.03 -42.95 97.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.154 179.373 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 42.7 tp -59.63 -42.28 92.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.87 -179.513 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -62.71 -38.86 92.11 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 179.465 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 310' ' ' ARG . . . . . 0.444 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.6 ttt85 -63.5 -44.12 95.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.229 179.525 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 88.7 mt -63.19 -41.97 99.26 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.23 179.655 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt -62.84 -33.34 75.05 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.99 179.461 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.86 -23.59 21.62 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.461 -179.775 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.48 HD22 ' CE2' ' A' ' 315' ' ' PHE . 6.7 tt -62.26 -43.14 99.51 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.607 -179.925 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 315' ' ' PHE . . . . . 0.48 ' CE2' HD22 ' A' ' 314' ' ' LEU . 90.9 m-85 . . . . . 0 C--O 1.221 -0.431 0 CA-C-O 117.979 -1.01 . . . . 0.0 110.503 179.947 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -100.11 136.85 39.38 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.008 0.432 . . . . 0.0 110.5 -179.929 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.498 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -91.78 178.46 1.73 Allowed Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.54 -179.911 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.498 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.7 Cg_exo -61.61 147.48 95.28 Favored 'Trans proline' 0 C--N 1.3 -2.023 0 C-N-CA 122.772 2.315 . . . . 0.0 112.179 179.627 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.465 ' HE ' HD12 ' A' ' 39' ' ' LEU . 35.6 ptt180 -136.05 142.61 44.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.699 179.766 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -78.96 117.13 19.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.574 179.918 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.433 ' O ' HG23 ' A' ' 30' ' ' ILE . 9.6 tp -110.51 130.94 62.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.395 -179.956 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.5 t -70.43 142.07 52.03 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.62 179.812 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.422 ' OD1' ' O ' ' A' ' 141' ' ' ILE . 25.8 t70 -139.9 177.42 7.98 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.452 -179.902 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.0 p -73.79 -36.26 65.01 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.693 179.925 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -47.71 -94.86 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.317 -179.525 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.422 ' O ' ' OG1' ' A' ' 36' ' ' THR . . . -165.59 -25.96 0.02 OUTLIER Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.889 -0.885 . . . . 0.0 110.889 179.913 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.422 ' OG1' ' O ' ' A' ' 35' ' ' GLY . 53.2 m -169.25 106.72 0.41 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.864 0.364 . . . . 0.0 110.665 -179.899 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.63 ' CD2' HD13 ' A' ' 140' ' ' LEU . 49.3 t60 -129.48 146.65 51.29 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.095 0.474 . . . . 0.0 110.1 179.997 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.623 HG22 ' N ' ' A' ' 39' ' ' LEU . 96.8 m -129.89 166.07 20.74 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.653 -179.814 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.623 ' N ' HG22 ' A' ' 38' ' ' THR . 82.5 mt -121.01 127.84 52.14 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.432 179.76 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -64.12 -44.58 91.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.639 -179.905 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 42.9 p -165.96 155.25 11.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.365 179.688 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.472 ' H ' ' CD ' ' A' ' 42' ' ' GLN . 14.1 mp0 -43.34 100.7 0.23 Allowed Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.605 179.415 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -56.8 129.29 33.78 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 122.318 2.012 . . . . 0.0 112.282 -179.612 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -83.72 -24.59 31.14 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.46 179.575 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.538 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.3 mtm-85 -122.31 134.94 54.65 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.169 0.509 . . . . 0.0 110.293 -179.974 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.1 mt -130.24 133.47 64.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.92 -179.681 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 45.4 t -124.34 130.83 73.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-O 120.848 0.356 . . . . 0.0 110.062 179.384 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.622 ' OG ' HD12 ' A' ' 117' ' ' LEU . 2.2 m -154.44 166.55 32.9 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.532 179.795 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 72.5 p -124.13 8.42 8.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.521 179.917 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.3 t -86.13 125.75 33.72 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.677 -179.551 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.483 HG11 ' H ' ' A' ' 299' ' ' LEU . 87.2 t -65.64 -44.48 93.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.453 -179.984 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.4 m -62.29 -44.31 96.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.667 -179.917 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 46.1 tp -62.39 -41.3 98.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.537 -179.431 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.447 ' O ' HD13 ' A' ' 58' ' ' LEU . 71.4 m -57.79 -44.64 86.4 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.353 -179.262 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.21 -62.21 5.36 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 179.535 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.7 t -48.39 -35.52 12.84 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 -179.917 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.9 mt -61.71 -44.42 96.96 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.698 -0.401 . . . . 0.0 111.207 179.407 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.447 HD13 ' O ' ' A' ' 54' ' ' THR . 9.2 mp -64.9 -41.8 95.3 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.352 177.956 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.62 -41.05 98.33 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.098 -179.251 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.432 ' O ' HG23 ' A' ' 60' ' ' ILE . 8.0 tp -88.25 16.94 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.775 -179.644 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 56.36 84.2 0.09 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.676 -179.899 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.44 57.63 0.07 OUTLIER Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.277 -0.42 . . . . 0.0 109.994 -179.826 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.421 ' HB3' HE21 ' A' ' 85' ' ' GLN . 10.2 Cg_endo -50.53 153.19 7.99 Favored 'Trans proline' 0 C--N 1.295 -2.237 0 C-N-CA 122.9 2.4 . . . . 0.0 112.426 -178.305 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.439 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -109.16 144.94 16.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.424 -179.709 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.8 mt -63.72 -45.36 97.53 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.35 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.444 -179.775 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.5 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -128.76 133.77 48.2 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.865 0.364 . . . . 0.0 110.518 -179.867 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.516 ' O ' ' N ' ' A' ' 98' ' ' LEU . 75.1 m -135.0 158.87 43.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.819 -179.648 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -87.23 139.45 16.12 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 179.828 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.481 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.88 -162.58 0.08 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.986 0.422 . . . . 0.0 110.429 -179.944 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.533 HG22 ' CD2' ' A' ' 297' ' ' PHE . 14.0 t -133.48 133.99 42.95 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.318 179.966 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.492 ' C ' ' O ' ' A' ' 70' ' ' THR . 0.6 OUTLIER 29.69 68.81 0.65 Allowed Pre-proline 0 N--CA 1.464 0.229 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.768 -179.93 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -61.09 145.36 99.01 Favored 'Trans proline' 0 C--N 1.3 -1.992 0 C-N-CA 122.648 2.232 . . . . 0.0 112.101 -178.437 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.533 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 46.1 p-10 -158.74 -32.05 0.07 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.703 179.726 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.547 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 99.1 m-20 -64.14 -39.92 95.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.579 179.825 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -60.49 -48.26 82.55 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.704 -179.207 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.415 ' O ' ' O ' ' A' ' 77' ' ' ALA . 90.4 t -60.23 -24.94 32.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.804 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.547 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -46.03 172.97 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.541 179.862 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.581 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.5 p30 -62.01 177.7 0.43 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.611 -179.691 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.558 ' C ' ' H ' ' A' ' 81' ' ' GLY . 35.6 p30 -44.76 85.72 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.0 179.924 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.581 ' N ' ' O ' ' A' ' 78' ' ' ASP . 42.7 tp60 -67.43 13.03 0.08 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.06 -179.758 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.558 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 118.62 -21.85 9.6 Favored Glycine 0 CA--C 1.519 0.328 0 N-CA-C 110.974 -0.85 . . . . 0.0 110.974 179.94 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -107.92 116.29 31.68 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.953 0.406 . . . . 0.0 110.494 179.856 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 73.2 mt -98.62 -0.01 43.91 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.436 -179.71 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -92.6 7.39 43.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.947 0.403 . . . . 0.0 110.387 -179.785 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.802 ' O ' HG22 ' A' ' 89' ' ' VAL . 87.8 mt-30 -100.07 -28.33 13.1 Favored 'General case' 0 C--O 1.224 -0.25 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.842 -179.996 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 68.9 t-105 -62.5 -40.89 98.16 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.867 -179.632 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.555 ' O ' ' N ' ' A' ' 91' ' ' LYS . 63.4 m -77.59 -53.55 7.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.195 -179.425 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -48.53 -50.73 30.76 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.013 -179.277 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.802 HG22 ' O ' ' A' ' 85' ' ' GLN . 15.4 m -68.91 -40.59 81.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 120.896 0.379 . . . . 0.0 111.048 179.723 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.496 ' N ' HG23 ' A' ' 89' ' ' VAL . . . -72.29 -22.84 61.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.8 -179.927 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.555 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.0 tttm -61.86 -45.53 93.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.429 -179.541 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.442 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.4 mm-40 -90.49 -94.92 0.12 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.13 -179.846 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.626 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.9 mtt180 -143.09 59.1 1.41 Allowed 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.828 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.462 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.7 pttp 33.37 26.77 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.242 -179.171 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.626 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.4 tt -48.71 123.58 7.08 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.951 -178.131 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.459 ' O ' HD23 ' A' ' 95' ' ' LEU . 99.1 mm-40 -84.33 -169.1 2.44 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.08 -179.937 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.609 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 81.0 mtp180 -74.86 136.64 41.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.279 -179.798 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.516 ' N ' ' O ' ' A' ' 67' ' ' SER . 90.9 mt -85.39 -165.71 1.3 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.633 -179.642 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.54 ' CD2' ' O ' ' A' ' 99' ' ' TYR . 47.7 p90 -168.32 119.49 0.8 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.209 179.982 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.516 ' C ' ' O ' ' A' ' 99' ' ' TYR . 42.8 mm -28.77 120.8 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.0 -179.63 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 114.51 27.63 3.26 Favored Glycine 0 CA--C 1.519 0.315 0 N-CA-C 111.15 -0.78 . . . . 0.0 111.15 -179.494 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.579 ' H ' ' CD ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -144.84 46.51 0.61 Allowed Pre-proline 0 C--N 1.323 -0.546 0 CA-C-O 120.891 0.377 . . . . 0.0 110.488 179.909 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.574 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 29.4 Cg_endo -61.88 144.31 96.56 Favored 'Trans proline' 0 C--N 1.296 -2.197 0 C-N-CA 122.652 2.235 . . . . 0.0 111.968 -179.942 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.449 ' O ' HG23 ' A' ' 108' ' ' VAL . 27.0 t -173.24 119.97 0.33 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.446 179.728 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.4 -40.33 64.38 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.021 0.439 . . . . 0.0 111.088 179.647 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -66.32 -39.69 89.44 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.819 -179.403 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.95 -40.04 95.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.704 -179.816 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 104' ' ' SER . 71.7 t -67.38 -43.93 87.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.712 179.681 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.87 -38.91 92.75 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.524 -179.349 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.442 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.4 -23.68 62.82 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.465 179.89 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.561 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.5 mm-40 -91.24 5.17 50.2 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.723 -179.552 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.561 ' C ' ' O ' ' A' ' 111' ' ' GLN . 10.3 tpt 22.24 64.72 0.33 Allowed Pre-proline 0 N--CA 1.465 0.277 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.043 179.985 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -78.57 169.05 20.41 Favored 'Trans proline' 0 C--N 1.304 -1.811 0 C-N-CA 122.99 2.46 . . . . 0.0 112.082 -178.461 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.423 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 98.8 m-20 -110.73 -42.76 3.96 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 121.013 0.435 . . . . 0.0 110.231 179.47 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.0 tp -119.95 120.78 37.37 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.974 179.571 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 83.7 mt -114.02 129.23 70.31 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.37 0 CA-C-O 120.936 0.398 . . . . 0.0 110.92 -179.858 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.622 HD12 ' OG ' ' A' ' 48' ' ' SER . 30.8 mt -109.24 132.03 54.51 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.048 0.451 . . . . 0.0 110.198 -179.705 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.496 HD12 HG23 ' A' ' 139' ' ' THR . 98.8 mt -119.61 138.05 51.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.706 -179.781 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 85.1 p -71.88 153.97 41.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.554 179.978 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.28 -50.35 74.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.671 -179.793 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -149.58 154.06 38.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.601 179.809 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 170.66 -170.78 43.37 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.911 -0.875 . . . . 0.0 110.911 179.824 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.96 -34.09 88.97 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 179.936 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.45 ' O ' ' OD1' ' A' ' 124' ' ' ASP . 44.4 p-10 -86.96 120.33 28.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.843 0.354 . . . . 0.0 110.673 179.953 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.45 ' O ' HD12 ' A' ' 129' ' ' LEU . 39.1 t -63.26 143.63 57.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.045 0.45 . . . . 0.0 110.447 -179.932 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.0 -43.26 9.0 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.945 -179.97 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.6 tp -62.81 -42.48 99.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.705 -179.831 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.58 -11.71 58.72 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.515 -179.444 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.45 HD12 ' O ' ' A' ' 125' ' ' SER . 84.8 mt -115.0 -24.05 8.78 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.724 -179.866 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . 0.519 ' N ' ' O ' ' A' ' 126' ' ' ALA . 80.8 t80 -51.22 -49.57 60.8 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.579 -178.901 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.7 p-10 -66.17 -42.33 89.06 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.8 0.333 . . . . 0.0 111.18 179.538 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.524 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 88.2 mt-30 -67.42 -37.67 83.42 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.761 179.975 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.416 HD12 HD11 ' A' ' 118' ' ' ILE . 95.6 mt -80.22 -41.89 24.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.932 -179.599 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.2 t -57.17 -44.28 83.36 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.24 -179.07 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.1 m -62.06 -45.44 93.55 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.775 0.321 . . . . 0.0 110.572 179.357 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 92.9 mt -62.28 -43.64 98.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.229 -179.774 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.658 ' HB1' ' HD2' ' A' ' 138' ' ' PRO . . . -169.25 167.85 5.31 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.566 179.897 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.658 ' HD2' ' HB1' ' A' ' 137' ' ' ALA . 50.9 Cg_exo -49.04 112.56 0.67 Allowed 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.357 2.038 . . . . 0.0 112.116 179.377 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.496 HG23 HD12 ' A' ' 118' ' ' ILE . 21.6 m -84.5 127.37 34.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.641 -179.951 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.63 HD13 ' CD2' ' A' ' 37' ' ' HIS . 36.2 tp -118.62 137.95 52.92 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.066 -179.867 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.422 ' O ' ' OD1' ' A' ' 32' ' ' ASP . 77.1 mt -102.82 120.05 52.07 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 CA-C-O 121.224 0.535 . . . . 0.0 111.118 -179.415 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.443 HD12 HD22 ' A' ' 117' ' ' LEU . 98.5 mt -135.68 131.83 50.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.585 179.662 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.434 HD21 ' CG ' ' A' ' 241' ' ' ASP . 56.4 t30 -66.42 153.82 41.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.938 0.399 . . . . 0.0 110.467 179.373 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.527 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 90.5 t80 -87.73 122.43 31.38 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.831 -179.639 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.527 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 99.1 m-20 55.3 69.33 0.75 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.778 179.633 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 49.4 p-10 -123.73 -0.4 8.57 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.664 179.925 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -151.26 116.5 5.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.778 -179.541 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . 0.418 ' C ' ' N ' ' A' ' 150' ' ' GLN . 83.4 p -62.15 166.5 4.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.479 -179.752 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.41 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.4 p-90 -50.68 -15.48 0.28 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.545 -179.812 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.452 ' O ' HG23 ' A' ' 154' ' ' THR . 68.3 tp60 -71.52 -74.26 0.16 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.466 -179.787 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.432 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.1 t -62.86 -39.29 93.95 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.272 179.467 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 54.8 tp -59.96 -45.76 91.61 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.399 -178.581 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.41 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 46.5 tp -62.65 -41.75 99.22 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.784 0.326 . . . . 0.0 110.404 179.054 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.452 HG23 ' O ' ' A' ' 150' ' ' GLN . 56.6 p -64.57 -34.73 78.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.358 -179.551 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.45 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 86.9 mm-40 -64.05 -42.84 96.9 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.313 179.284 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 91.5 mt -65.54 -38.83 90.75 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.057 0.456 . . . . 0.0 110.187 179.147 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.58 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.21 -32.11 79.44 Favored Glycine 0 CA--C 1.52 0.344 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 -179.36 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.45 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.2 mt-10 -35.58 -26.91 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.823 0.344 . . . . 0.0 110.812 179.955 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.58 ' N ' ' O ' ' A' ' 157' ' ' GLY . 94.8 mt -56.52 150.84 2.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.264 179.312 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 72.0 p -69.66 137.3 52.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.01 -179.541 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 70.15 22.37 77.34 Favored Glycine 0 N--CA 1.459 0.2 0 N-CA-C 111.214 -0.754 . . . . 0.0 111.214 179.462 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 59.5 m80 -123.12 -13.65 7.71 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.716 0.293 . . . . 0.0 110.566 179.906 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -67.21 -59.32 3.53 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.755 -179.687 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -52.14 -49.42 63.74 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.239 -179.595 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -60.36 -41.3 93.42 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.792 0.33 . . . . 0.0 110.336 179.525 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.52 -47.05 87.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.595 179.831 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.96 -40.14 75.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.204 -179.894 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -61.64 -50.24 73.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.589 179.553 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -65.47 -43.59 89.82 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.501 179.541 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 95.0 mt -64.64 -43.47 96.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.457 179.776 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.44 -51.27 70.1 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.641 -179.232 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.72 -44.16 94.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.545 179.697 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.644 ' CE2' HD11 ' A' ' 177' ' ' LEU . 55.0 t80 -62.86 -44.43 96.13 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.069 0.461 . . . . 0.0 110.443 179.438 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -63.33 -40.06 96.28 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.598 -179.331 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -62.92 -42.71 99.88 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.63 179.191 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -60.62 -44.8 95.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.103 -179.97 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.644 HD11 ' CE2' ' A' ' 173' ' ' PHE . 85.7 mt -64.44 -41.16 96.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.01 0.434 . . . . 0.0 110.714 178.951 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.18 -62.3 1.72 Allowed 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.497 -179.351 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.45 -46.81 85.81 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.566 179.887 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.21 -41.64 65.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.238 179.987 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -63.97 -33.77 76.48 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.998 0.428 . . . . 0.0 110.353 179.315 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.423 ' HG2' ' O ' ' A' ' 182' ' ' GLU . 69.6 tt0 -90.49 8.8 32.05 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.347 0.594 . . . . 0.0 110.533 -178.998 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -104.74 -32.14 9.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.181 179.607 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.2 pt -128.13 147.79 32.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.846 -179.818 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -140.11 131.12 26.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.356 179.427 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.602 HD22 ' N ' ' A' ' 186' ' ' LEU . 3.5 mm? -85.88 133.68 40.89 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.908 179.924 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -44.33 157.97 0.15 Allowed 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.727 2.284 . . . . 0.0 112.088 179.356 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 0.526 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.7 Cg_endo -62.92 115.13 2.75 Favored 'Trans proline' 0 C--N 1.303 -1.82 0 C-N-CA 122.801 2.334 . . . . 0.0 111.774 179.768 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . 0.526 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.7 mt-30 155.44 148.09 0.0 OUTLIER Pre-proline 0 N--CA 1.455 -0.208 0 O-C-N 123.635 0.584 . . . . 0.0 110.758 -179.867 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -73.83 144.17 34.4 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.676 2.25 . . . . 0.0 111.914 178.044 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.496 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.1 p -125.13 158.99 32.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.307 0.575 . . . . 0.0 110.121 -179.98 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . 0.496 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 36.9 p -143.44 165.36 27.75 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.139 -179.678 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . 0.444 ' HA ' ' H ' ' A' ' 260' ' ' PHE . . . -135.41 128.74 32.13 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.135 0.493 . . . . 0.0 110.194 179.543 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.504 HD11 HD23 ' A' ' 259' ' ' LEU . 47.9 pt -146.28 148.58 16.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.077 179.825 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . 0.754 HG13 ' CD1' ' A' ' 262' ' ' PHE . 70.2 t -117.33 122.96 71.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.277 0.56 . . . . 0.0 109.681 179.161 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -134.37 107.49 7.64 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.32 179.707 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 95.1 m -131.17 130.54 43.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.855 179.833 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -82.53 -36.84 25.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.33 179.75 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.58 -67.36 0.24 Allowed 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.425 179.981 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.49 -9.86 59.08 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.265 179.55 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 60.5 t-80 60.42 58.78 2.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.784 -179.812 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 42.9 p -167.06 153.62 8.38 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.538 179.53 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.28 144.17 24.5 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.957 0.408 . . . . 0.0 110.453 179.432 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -135.06 137.28 42.75 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.569 -179.988 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 19.6 mt -105.44 125.16 50.67 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 121.066 0.46 . . . . 0.0 109.869 -179.676 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 206' ' ' TRP . . . . . 0.557 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 75.9 m95 -81.57 166.42 20.25 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.634 -179.794 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . 0.463 HG22 ' C ' ' A' ' 206' ' ' TRP . 0.1 OUTLIER -156.57 171.52 7.29 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.536 -179.184 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_exo -54.23 -36.78 87.21 Favored 'Trans proline' 0 C--N 1.302 -1.874 0 C-N-CA 122.679 2.253 . . . . 0.0 112.079 179.173 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -70.33 -34.97 73.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.811 -179.806 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 22.3 m -61.6 149.83 38.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.587 -179.392 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.55 -36.83 81.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.494 -179.732 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . 0.557 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 55.1 tt0 -64.65 -40.61 95.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.56 179.873 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.08 -43.56 93.09 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 110.591 -1.003 . . . . 0.0 110.591 179.712 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -63.5 -42.76 98.52 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 179.72 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . 0.568 ' SD ' ' HB2' ' A' ' 304' ' ' ALA . 64.6 ttp -59.47 -48.04 83.17 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.202 -179.898 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 216' ' ' LEU . 87.6 mt -60.74 -40.67 93.25 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.556 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . 0.455 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 40.7 tp10 -58.03 -38.09 75.58 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.841 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -65.12 -38.18 89.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.771 0.319 . . . . 0.0 110.621 179.641 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 94.5 mt -64.41 -42.78 95.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.517 -179.537 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 138.01 45.22 0.08 OUTLIER Glycine 0 C--N 1.335 0.479 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 179.982 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . 0.455 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 26.7 m-85 -128.8 156.45 43.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.057 0.456 . . . . 0.0 110.523 -179.739 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.49 ' O ' HG13 ' A' ' 191' ' ' VAL . 7.8 p -108.33 122.82 47.76 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 121.204 0.526 . . . . 0.0 110.185 -179.94 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.474 HD22 ' C ' ' A' ' 222' ' ' THR . 4.3 mm? -101.38 132.92 46.7 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.055 179.933 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.9 159.57 14.84 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.54 179.85 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -104.97 115.26 29.97 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.933 0.396 . . . . 0.0 110.395 179.824 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.495 ' N ' HD12 ' A' ' 226' ' ' LEU . 8.9 mp -53.72 156.96 4.25 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.669 179.914 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -60.18 145.24 98.93 Favored 'Trans proline' 0 C--N 1.302 -1.914 0 C-N-CA 122.637 2.224 . . . . 0.0 112.108 179.374 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.6 -2.47 58.64 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.56 -179.959 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.62 -40.42 5.66 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 -179.903 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.548 ' O ' ' N ' ' A' ' 233' ' ' SER . 85.9 mt -79.59 -16.51 55.74 Favored 'General case' 0 C--O 1.223 -0.311 0 CA-C-O 120.971 0.415 . . . . 0.0 110.314 -179.735 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . 0.404 ' C ' ' O ' ' A' ' 230' ' ' LEU . 55.4 t-20 -40.27 -48.8 2.67 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.687 -179.566 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -88.59 15.7 7.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.804 0.335 . . . . 0.0 111.258 179.807 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.548 ' N ' ' O ' ' A' ' 230' ' ' LEU . 78.1 p -60.63 -35.79 77.04 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.738 -179.839 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . 0.525 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.6 tt0 -118.06 -69.6 0.84 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.021 179.535 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 3.8 m -70.46 103.41 2.45 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.673 -179.796 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -94.64 57.94 2.27 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.363 179.93 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -145.15 -122.63 1.55 Allowed Glycine 0 CA--C 1.52 0.365 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 -179.958 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -133.7 112.03 11.07 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 121.118 0.485 . . . . 0.0 110.409 179.945 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . 0.488 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 94.7 mtt180 -148.25 56.61 1.06 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.753 -179.979 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -69.4 -31.36 69.68 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.511 179.593 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . 0.456 ' OD2' ' O ' ' A' ' 144' ' ' TYR . 64.8 t0 -56.69 -46.93 80.88 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.403 -179.069 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 242' ' ' ILE . . . . . 0.436 ' O ' ' O ' ' A' ' 239' ' ' ARG . 16.9 tt -140.85 158.18 23.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.934 0.397 . . . . 0.0 110.519 179.738 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.442 HG22 HD13 ' A' ' 245' ' ' LEU . 96.0 mt -105.97 105.97 19.71 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.2 0 CA-C-O 121.155 0.503 . . . . 0.0 110.407 179.821 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . 0.614 ' C ' HD12 ' A' ' 245' ' ' LEU . 88.2 mt-30 -110.76 110.69 21.43 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.369 179.74 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.614 HD12 ' C ' ' A' ' 244' ' ' GLN . 9.7 mp -122.03 -167.92 1.63 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.558 179.748 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . 0.525 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 172.54 -16.48 0.05 OUTLIER Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 179.879 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . 0.663 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -60.56 157.71 29.01 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 -179.855 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -64.22 21.09 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.971 0.415 . . . . 0.0 110.609 179.962 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . 0.663 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.8 m-20 -96.94 -5.54 37.69 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.564 179.955 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 92.2 mt -80.84 -20.99 41.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.611 179.535 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.52 -51.35 70.27 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.79 -179.671 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -89.29 -4.93 57.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.453 179.658 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.09 -74.16 1.15 Allowed Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 -179.923 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 81.7 mt -70.13 125.71 27.56 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.015 0.436 . . . . 0.0 110.237 -179.795 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -59.57 -39.49 84.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.369 -179.709 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 83.51 51.71 4.0 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 179.767 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -94.81 -16.57 22.86 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.724 0.297 . . . . 0.0 110.597 -179.899 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . 0.495 ' OG ' HG23 ' A' ' 191' ' ' VAL . 3.4 t 175.19 89.63 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.057 0.456 . . . . 0.0 110.124 179.996 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.862 ' N ' HD12 ' A' ' 259' ' ' LEU . 0.9 OUTLIER -94.5 124.26 38.42 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.323 0.582 . . . . 0.0 111.139 -179.042 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 260' ' ' PHE . . . . . 0.444 ' H ' ' HA ' ' A' ' 193' ' ' ALA . 16.1 m-30 -93.53 146.93 23.43 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.362 179.22 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 86.2 mt -122.44 149.77 43.38 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.599 -179.893 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.754 ' CD1' HG13 ' A' ' 195' ' ' VAL . 2.6 p90 -77.72 -138.78 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.542 -179.849 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . 0.659 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -51.39 78.09 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.056 179.988 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . 0.629 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.95 104.63 0.19 Allowed Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.679 -0.969 . . . . 0.0 110.679 -179.987 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 265' ' ' ASP . . . . . 0.604 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.7 m-20 -80.29 -177.62 6.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.671 0.272 . . . . 0.0 110.883 -179.49 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -40.54 -17.48 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.858 0.361 . . . . 0.0 110.504 179.766 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . 0.604 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.53 -51.66 40.58 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.672 179.476 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -63.75 -46.59 84.64 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.212 179.343 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . 0.578 ' HB1' ' OH ' ' A' ' 273' ' ' TYR . . . -61.49 -35.41 77.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.78 179.599 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -62.56 -34.71 77.5 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.228 179.694 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.26 -43.09 14.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.319 -179.592 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 272' ' ' ILE . . . . . 0.586 ' C ' ' H ' ' A' ' 274' ' ' ALA . 5.0 tt -51.47 -33.89 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.824 -178.823 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 273' ' ' TYR . . . . . 0.578 ' OH ' ' HB1' ' A' ' 269' ' ' ALA . 16.8 m-85 -54.31 -2.11 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.645 -179.599 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 274' ' ' ALA . . . . . 0.586 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.39 -39.58 71.08 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.969 179.5 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . 0.585 ' O ' ' N ' ' A' ' 279' ' ' ALA . 3.6 p30 -39.23 97.96 0.15 Allowed Pre-proline 0 C--O 1.227 -0.113 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.568 -179.691 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -54.15 -43.1 61.49 Favored 'Trans proline' 0 C--N 1.303 -1.824 0 C-N-CA 122.375 2.05 . . . . 0.0 112.611 -178.765 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 89.2 mt -64.42 -42.79 95.86 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.114 -179.64 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 91.2 mt -95.96 -1.18 49.62 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.849 -179.421 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 279' ' ' ALA . . . . . 0.585 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.5 -34.93 77.84 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.612 -179.749 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.26 20.18 0.11 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.004 -179.247 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 0.491 HD23 ' HA ' ' A' ' 281' ' ' LEU . 13.7 mt -75.03 120.11 80.08 Favored Pre-proline 0 N--CA 1.451 -0.376 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.45 179.94 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -50.96 -39.45 59.36 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.659 2.24 . . . . 0.0 111.831 179.07 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -53.0 -50.38 64.32 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.126 179.849 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 74.6 t -61.6 -43.97 97.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 179.488 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -57.55 -41.17 80.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.234 -179.958 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -90.97 0.23 57.58 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.141 179.687 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt 59.62 43.16 16.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.066 0.46 . . . . 0.0 110.891 179.662 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -94.61 41.31 1.09 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.399 179.884 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 54.1 t -119.21 135.76 58.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 121.009 0.433 . . . . 0.0 110.179 -179.741 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -133.63 163.67 28.9 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 121.026 0.441 . . . . 0.0 110.73 -179.66 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.76 155.77 31.87 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.97 0.414 . . . . 0.0 110.759 -179.797 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 82.2 mt -94.65 -1.45 53.14 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.274 -179.75 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.34 165.22 12.56 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 -179.786 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 6.6 m -86.7 -61.55 1.71 Allowed 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 120.87 0.367 . . . . 0.0 111.102 -179.84 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 295' ' ' GLU . . . . . 0.448 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.6 mm-40 -69.66 -4.56 20.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.66 -179.792 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 26.1 p -76.48 33.03 0.13 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.68 -179.891 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 297' ' ' PHE . . . . . 0.533 ' CD2' HG22 ' A' ' 70' ' ' THR . 83.3 t80 -60.52 -45.99 91.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.646 -179.956 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . 0.609 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.2 mtt85 -81.08 136.66 35.97 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.627 -179.598 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.483 ' H ' HG11 ' A' ' 51' ' ' VAL . 0.9 OUTLIER -114.25 116.87 29.7 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.494 179.667 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . 0.624 ' H ' ' CB ' ' A' ' 303' ' ' SER . 49.1 p-10 -166.84 -174.97 2.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.52 -179.799 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 78.6 t80 -47.73 -44.46 27.96 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.241 -179.684 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -65.84 -41.27 91.94 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.029 0.442 . . . . 0.0 110.782 179.017 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . 0.624 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 54.3 p -55.36 -36.15 66.01 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.1 -179.265 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . 0.568 ' HB2' ' SD ' ' A' ' 215' ' ' MET . . . -57.58 -51.4 69.63 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.436 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 90.6 mtp -56.56 -44.02 80.53 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -179.936 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -66.29 -42.88 87.73 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.903 0.382 . . . . 0.0 110.184 178.86 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 303' ' ' SER . 55.9 t -63.88 -43.09 97.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.218 179.409 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 42.5 tp -59.87 -42.07 92.92 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.812 -179.618 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -62.31 -39.05 91.75 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.152 179.665 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 310' ' ' ARG . . . . . 0.45 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.8 ttt85 -63.71 -43.89 95.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.266 179.46 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 90.1 mt -63.26 -42.05 99.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.184 179.632 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt -62.85 -33.62 75.63 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.116 179.409 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.73 -23.37 21.82 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.448 -179.888 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.488 HD22 ' CE2' ' A' ' 315' ' ' PHE . 6.9 tt -62.31 -43.06 99.69 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.61 -179.936 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 315' ' ' PHE . . . . . 0.488 ' CE2' HD22 ' A' ' 314' ' ' LEU . 90.9 m-85 . . . . . 0 C--O 1.22 -0.484 0 CA-C-O 117.964 -1.017 . . . . 0.0 110.466 179.975 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -99.26 135.82 40.11 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.06 0.457 . . . . 0.0 110.493 -179.995 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.496 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -91.75 178.43 1.75 Allowed Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.637 -179.961 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.496 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.5 Cg_exo -61.57 146.87 96.56 Favored 'Trans proline' 0 C--N 1.3 -2.022 0 C-N-CA 122.808 2.339 . . . . 0.0 112.162 179.635 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.464 ' HE ' HD12 ' A' ' 39' ' ' LEU . 35.4 ptt180 -136.3 141.82 43.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.647 179.71 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -79.3 116.96 19.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.476 179.923 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.454 ' O ' HG23 ' A' ' 30' ' ' ILE . 9.4 tp -111.61 130.24 65.52 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.486 -179.985 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.2 t -71.09 142.45 50.82 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.61 179.842 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.481 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.4 t0 -139.32 179.93 6.25 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.57 -179.937 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.481 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 78.4 p -74.01 -37.12 64.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.785 179.716 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -46.78 -94.66 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.378 -179.459 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -166.17 -26.88 0.02 OUTLIER Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 179.893 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 65.0 m -168.66 105.91 0.44 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.861 0.362 . . . . 0.0 110.618 -179.921 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.651 ' CD2' HD13 ' A' ' 140' ' ' LEU . 69.5 t60 -128.75 147.22 50.76 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.988 0.423 . . . . 0.0 110.324 179.925 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.62 HG22 ' N ' ' A' ' 39' ' ' LEU . 99.9 m -130.45 165.53 22.43 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.569 -179.835 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.62 ' N ' HG22 ' A' ' 38' ' ' THR . 80.6 mt -120.64 126.98 51.62 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.485 179.731 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -65.44 -44.35 87.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.686 -179.971 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 41.0 p -165.96 154.82 11.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.405 179.669 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.486 ' H ' ' CD ' ' A' ' 42' ' ' GLN . 14.0 mp0 -45.43 101.55 0.26 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.643 179.471 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -57.6 129.64 34.76 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 122.402 2.068 . . . . 0.0 112.235 -179.643 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -82.51 -25.14 33.73 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.5 179.531 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.537 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.7 mtm-85 -120.89 134.03 55.29 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 121.185 0.517 . . . . 0.0 110.27 179.96 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.1 mt -129.82 133.21 65.13 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.273 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.966 -179.721 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 44.3 t -124.84 131.08 73.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.839 0.352 . . . . 0.0 110.101 179.313 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.63 ' OG ' HD12 ' A' ' 117' ' ' LEU . 4.9 m -154.74 166.35 33.71 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.515 179.845 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 65.3 p -124.37 8.53 8.44 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.434 179.923 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.58 125.21 32.93 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.616 -179.458 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.503 HG11 ' H ' ' A' ' 299' ' ' LEU . 94.5 t -65.5 -44.41 94.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.545 -179.938 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.6 m -62.61 -44.31 96.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.639 -179.851 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 48.4 tp -62.5 -41.48 98.85 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.57 -179.476 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.455 ' O ' HD13 ' A' ' 58' ' ' LEU . 74.6 m -57.63 -44.78 85.81 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.466 -179.438 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.36 -62.09 5.43 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 179.571 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.6 t -48.23 -35.71 12.48 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 179.951 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.7 mt -61.7 -44.46 96.89 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.11 179.331 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.464 HD21 HE22 ' A' ' 85' ' ' GLN . 9.1 mp -65.07 -41.72 94.81 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.201 178.049 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.4 ' HB1' ' NE ' ' A' ' 169' ' ' ARG . . . -63.6 -41.36 98.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.933 -179.243 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.431 ' O ' HG23 ' A' ' 60' ' ' ILE . 8.0 tp -87.7 16.81 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.755 -179.63 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 56.45 83.84 0.09 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.73 -179.862 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.89 58.04 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.005 -179.752 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.412 ' HB3' HE21 ' A' ' 85' ' ' GLN . 9.9 Cg_endo -50.59 152.71 8.78 Favored 'Trans proline' 0 C--N 1.296 -2.207 0 C-N-CA 122.859 2.373 . . . . 0.0 112.38 -178.204 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.431 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -108.96 145.9 15.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.348 -179.727 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 97.0 mt -63.8 -45.18 97.89 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.357 -179.844 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.496 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -129.87 134.48 47.54 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.602 -179.745 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.499 ' O ' ' N ' ' A' ' 98' ' ' LEU . 72.7 m -134.75 158.77 43.29 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.833 -179.637 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.73 139.36 16.36 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.668 -0.973 . . . . 0.0 110.668 179.798 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.485 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.79 -162.92 0.08 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.903 0.382 . . . . 0.0 110.515 179.966 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.495 HG22 ' CD1' ' A' ' 297' ' ' PHE . 5.7 t -133.93 135.38 43.52 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.245 -179.973 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.495 ' C ' ' O ' ' A' ' 70' ' ' THR . 1.1 t 29.55 68.19 0.67 Allowed Pre-proline 0 N--CA 1.466 0.328 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.64 -179.626 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -60.98 145.18 99.46 Favored 'Trans proline' 0 C--N 1.3 -1.978 0 C-N-CA 122.619 2.213 . . . . 0.0 112.068 -178.392 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.532 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 45.1 p-10 -159.37 -32.29 0.06 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.662 179.698 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.542 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 99.1 m-20 -64.07 -39.4 94.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.505 179.988 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -60.51 -48.32 82.29 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.642 -179.278 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.423 ' O ' ' O ' ' A' ' 77' ' ' ALA . 94.4 t -60.1 -24.85 31.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 179.704 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.542 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -45.77 172.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.583 179.865 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.571 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.8 p30 -61.98 177.76 0.42 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.614 -179.774 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.562 ' C ' ' H ' ' A' ' 81' ' ' GLY . 36.0 p30 -45.69 85.86 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.962 179.963 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.571 ' N ' ' O ' ' A' ' 78' ' ' ASP . 42.8 tp60 -67.33 13.62 0.06 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.146 -179.837 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.562 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 117.94 -22.04 10.03 Favored Glycine 0 CA--C 1.519 0.338 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.93 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -108.19 116.68 32.41 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.951 0.405 . . . . 0.0 110.56 179.843 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 75.4 mt -98.98 0.88 44.85 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.513 -179.767 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -92.07 6.74 45.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.985 0.421 . . . . 0.0 110.484 -179.797 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.785 ' O ' HG22 ' A' ' 89' ' ' VAL . 88.2 mt-30 -100.06 -26.28 14.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.781 179.968 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.5 t-105 -64.28 -40.99 97.1 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.02 -179.688 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.551 ' O ' ' N ' ' A' ' 91' ' ' LYS . 68.5 m -77.6 -53.55 7.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.155 -179.516 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -47.9 -51.27 23.89 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.001 -179.347 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.785 HG22 ' O ' ' A' ' 85' ' ' GLN . 15.1 m -69.01 -41.08 81.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 120.905 0.383 . . . . 0.0 111.069 179.88 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.508 ' N ' HG23 ' A' ' 89' ' ' VAL . . . -71.47 -23.57 61.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.768 -179.815 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.551 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.0 tttm -61.07 -46.06 92.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.501 -179.439 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.443 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.6 mm-40 -90.13 -94.87 0.11 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.213 179.971 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.626 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.8 mtt180 -143.19 60.13 1.41 Allowed 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 179.758 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.463 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.6 pttp 33.31 26.88 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.203 -179.082 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.626 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.4 tt -48.61 123.1 6.26 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.931 -178.193 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.45 ' O ' HD23 ' A' ' 95' ' ' LEU . 98.9 mm-40 -83.5 -169.9 2.78 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.145 179.934 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.614 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 81.7 mtp180 -73.71 137.51 44.09 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.328 -179.865 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.499 ' N ' ' O ' ' A' ' 67' ' ' SER . 89.0 mt -85.9 -166.11 1.44 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.709 -179.621 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.532 ' CD2' ' O ' ' A' ' 99' ' ' TYR . 46.7 p90 -168.01 119.48 0.84 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.311 179.962 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.513 ' C ' ' O ' ' A' ' 99' ' ' TYR . 43.1 mm -29.14 121.04 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.922 -179.701 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 113.95 28.11 3.25 Favored Glycine 0 CA--C 1.521 0.431 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 -179.597 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.588 ' H ' ' CD ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -144.0 46.0 0.61 Allowed Pre-proline 0 C--N 1.323 -0.55 0 CA-C-O 120.953 0.406 . . . . 0.0 110.503 179.891 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.583 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 30.2 Cg_endo -62.28 143.83 94.54 Favored 'Trans proline' 0 C--N 1.297 -2.138 0 C-N-CA 122.686 2.257 . . . . 0.0 111.957 -179.966 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.476 ' O ' HG23 ' A' ' 108' ' ' VAL . 23.2 t -173.33 120.73 0.34 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.417 179.754 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.58 -40.98 63.48 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.043 179.743 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -65.9 -40.31 91.39 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.864 -179.374 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.96 -39.86 95.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.687 -179.832 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 104' ' ' SER . 70.9 t -67.54 -43.76 86.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.721 179.683 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.43 -39.1 92.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.568 -179.287 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.443 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.51 -23.55 62.9 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.532 179.834 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.549 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.4 mm-40 -90.94 4.75 51.11 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.741 -179.564 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.549 ' C ' ' O ' ' A' ' 111' ' ' GLN . 9.9 tpt 23.17 64.32 0.37 Allowed Pre-proline 0 N--CA 1.464 0.271 0 CA-C-O 120.914 0.388 . . . . 0.0 111.001 -179.806 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.444 ' HG2' HD11 ' A' ' 116' ' ' ILE . 68.1 Cg_endo -78.9 168.92 20.18 Favored 'Trans proline' 0 C--N 1.304 -1.801 0 C-N-CA 122.984 2.456 . . . . 0.0 112.081 -178.415 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.483 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 98.9 m-20 -113.24 -44.01 3.3 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.103 179.452 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.2 tp -120.47 119.81 34.07 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.324 -0.398 . . . . 0.0 109.935 179.48 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.455 HD13 HD22 ' A' ' 133' ' ' LEU . 96.3 mt -117.09 131.1 70.79 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.319 0 CA-C-O 120.9 0.381 . . . . 0.0 110.892 -179.788 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.63 HD12 ' OG ' ' A' ' 48' ' ' SER . 29.7 mt -106.0 132.46 52.06 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 121.027 0.441 . . . . 0.0 110.321 -179.489 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.434 HD12 HG23 ' A' ' 139' ' ' THR . 98.1 mt -118.17 136.6 54.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.73 -179.709 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 86.5 p -71.6 152.76 42.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.548 -179.95 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.27 -50.21 74.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.659 -179.857 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -149.24 153.59 37.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.552 179.762 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 169.3 -170.17 42.41 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 179.885 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -63.04 -35.46 92.12 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 179.992 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.447 ' O ' ' OD1' ' A' ' 124' ' ' ASP . 44.1 p-10 -87.18 119.92 27.91 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.808 0.337 . . . . 0.0 110.639 179.885 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.441 ' O ' HD12 ' A' ' 129' ' ' LEU . 39.2 t -63.56 144.06 57.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.467 -179.928 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.52 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.38 -43.28 8.85 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.872 -179.935 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.8 tp -62.77 -42.35 99.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.654 -179.816 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.73 -10.91 56.64 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.512 -179.395 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.441 HD12 ' O ' ' A' ' 125' ' ' SER . 84.1 mt -116.03 -23.9 8.31 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.7 -179.902 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . 0.52 ' N ' ' O ' ' A' ' 126' ' ' ALA . 77.8 t80 -51.53 -49.87 61.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.521 -179.001 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.5 p-10 -65.79 -42.26 90.96 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.852 0.358 . . . . 0.0 111.15 179.628 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.523 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 87.9 mt-30 -67.52 -36.69 81.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.792 -179.97 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.455 HD22 HD13 ' A' ' 116' ' ' ILE . 94.1 mt -80.58 -42.05 22.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.871 -179.507 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.2 t -57.23 -44.76 84.07 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.259 -179.21 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.2 m -62.3 -45.8 91.63 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.806 0.336 . . . . 0.0 110.642 179.33 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 92.9 mt -62.31 -43.9 98.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.401 -179.855 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.584 ' HB1' ' HD2' ' A' ' 138' ' ' PRO . . . -169.95 162.93 6.66 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.529 179.844 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.584 ' HD2' ' HB1' ' A' ' 137' ' ' ALA . 78.4 Cg_exo -42.71 110.99 0.18 Allowed 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.536 2.157 . . . . 0.0 112.196 179.448 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.474 HG21 ' CD1' ' A' ' 130' ' ' TYR . 16.8 m -85.57 127.76 34.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.555 179.971 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.651 HD13 ' CD2' ' A' ' 37' ' ' HIS . 34.3 tp -119.48 137.94 53.46 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.088 -179.897 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.429 ' O ' ' OD2' ' A' ' 32' ' ' ASP . 80.2 mt -104.22 120.01 53.88 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 CA-C-O 121.122 0.487 . . . . 0.0 111.217 -179.348 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.494 HD12 HD22 ' A' ' 117' ' ' LEU . 97.7 mt -135.92 132.58 50.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.595 179.549 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.549 HD21 ' CG ' ' A' ' 241' ' ' ASP . 52.4 t30 -65.75 148.44 51.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.902 0.382 . . . . 0.0 110.422 179.268 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.459 ' O ' ' OD2' ' A' ' 241' ' ' ASP . 42.6 t80 -81.86 123.18 28.6 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.955 -179.456 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 54.79 69.69 0.7 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.881 179.643 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 49.2 p-10 -124.45 0.24 8.24 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.679 179.849 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -151.42 116.4 5.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.695 -179.442 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 84.0 p -63.86 168.55 4.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.557 -179.941 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.416 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.6 p-90 -51.8 -16.33 0.67 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.553 -179.846 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.431 ' O ' HG23 ' A' ' 154' ' ' THR . 68.2 tp60 -70.1 -76.68 0.1 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.491 -179.744 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.447 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.1 t -62.41 -38.49 89.85 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.321 179.6 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 53.4 tp -59.82 -45.75 91.38 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.377 -178.601 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.416 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 46.3 tp -62.83 -41.72 99.44 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.472 179.012 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.447 ' OG1' ' O ' ' A' ' 151' ' ' SER . 62.2 p -64.01 -34.97 79.2 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.266 -179.592 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.448 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.7 mm-40 -64.02 -42.28 97.18 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.239 179.32 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 92.1 mt -65.51 -38.85 90.9 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.041 0.448 . . . . 0.0 110.232 179.093 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.581 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.22 -32.13 79.52 Favored Glycine 0 CA--C 1.52 0.389 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 -179.374 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.448 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.3 mt-10 -36.02 -26.19 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.804 0.335 . . . . 0.0 110.728 179.953 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.581 ' N ' ' O ' ' A' ' 157' ' ' GLY . 94.4 mt -58.11 150.16 4.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.3 179.375 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 77.1 p -69.21 137.29 53.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.01 -179.508 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 69.96 22.94 77.26 Favored Glycine 0 CA--C 1.517 0.183 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 179.452 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 59.8 m80 -124.11 -13.97 7.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.745 0.307 . . . . 0.0 110.563 179.92 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -67.19 -59.42 3.45 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.702 -179.732 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -51.76 -49.37 62.76 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.215 -179.667 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -60.45 -41.32 93.84 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.735 0.302 . . . . 0.0 110.346 179.509 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.42 -47.34 86.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.609 179.801 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.73 -40.16 75.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.252 -179.915 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -61.49 -50.26 73.45 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.575 179.573 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.4 ' NE ' ' HB1' ' A' ' 59' ' ' ALA . 60.0 ttt85 -65.52 -43.58 89.58 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.492 179.596 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 94.8 mt -64.66 -43.37 96.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.427 179.768 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.29 -51.36 69.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.566 -179.243 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.71 -43.78 95.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.53 179.727 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.654 ' CE2' HD11 ' A' ' 177' ' ' LEU . 55.1 t80 -62.87 -44.47 96.03 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.041 0.448 . . . . 0.0 110.454 179.45 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -63.48 -40.0 95.95 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.592 -179.36 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -62.9 -42.83 99.92 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.628 179.333 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -60.76 -44.7 96.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.186 179.93 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.654 HD11 ' CE2' ' A' ' 173' ' ' PHE . 84.9 mt -64.53 -41.2 96.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.02 0.438 . . . . 0.0 110.749 178.887 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.05 -62.09 1.85 Allowed 'General case' 0 C--O 1.236 0.376 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.478 -179.382 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.58 -46.66 86.48 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.609 179.784 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.28 -41.5 65.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.236 -179.984 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -64.01 -33.75 76.45 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.96 0.41 . . . . 0.0 110.424 179.278 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.422 ' HG2' ' O ' ' A' ' 182' ' ' GLU . 69.3 tt0 -90.68 8.86 32.29 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.338 0.589 . . . . 0.0 110.483 -179.019 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -104.78 -32.19 8.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.895 0.379 . . . . 0.0 111.196 179.615 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.6 pt -128.21 147.83 32.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.845 -179.847 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -140.11 131.16 26.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.393 179.364 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.597 HD22 ' N ' ' A' ' 186' ' ' LEU . 3.5 mm? -85.45 133.92 41.3 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.882 -179.996 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -43.87 157.93 0.13 Allowed 'Trans proline' 0 C--N 1.307 -1.629 0 C-N-CA 122.743 2.295 . . . . 0.0 112.125 179.316 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 0.53 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.6 Cg_endo -62.96 114.51 2.47 Favored 'Trans proline' 0 C--N 1.304 -1.807 0 C-N-CA 122.796 2.331 . . . . 0.0 111.717 179.839 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . 0.53 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.7 mt-30 155.13 148.26 0.0 OUTLIER Pre-proline 0 C--N 1.331 -0.207 0 O-C-N 123.643 0.589 . . . . 0.0 110.74 -179.743 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -73.47 144.55 36.45 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.695 2.263 . . . . 0.0 111.928 177.97 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.495 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.1 p -124.84 158.89 32.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.241 0.543 . . . . 0.0 110.194 179.962 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . 0.495 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 37.6 p -143.46 165.22 28.14 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.086 -179.585 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . 0.444 ' HA ' ' H ' ' A' ' 260' ' ' PHE . . . -135.33 128.65 32.12 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.106 0.479 . . . . 0.0 110.285 179.534 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.511 HD11 HD23 ' A' ' 259' ' ' LEU . 47.5 pt -146.5 148.87 16.53 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.297 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.052 179.933 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . 0.734 HG13 ' CD1' ' A' ' 262' ' ' PHE . 74.1 t -117.6 123.06 71.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.247 0.546 . . . . 0.0 109.809 179.073 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -134.3 106.97 7.38 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.27 179.738 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 93.7 m -130.77 130.63 43.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.84 179.782 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -82.67 -37.17 25.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.313 179.675 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.37 -67.35 0.24 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.417 -179.98 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.01 -10.0 59.16 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.338 179.508 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 59.9 t-80 60.67 58.32 2.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.719 -179.81 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 41.6 p -166.99 153.29 8.22 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.537 179.643 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.31 144.07 24.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.473 179.395 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -135.34 138.28 43.23 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.642 -179.969 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 19.6 mt -106.12 125.23 50.74 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 121.027 0.442 . . . . 0.0 109.923 -179.737 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 206' ' ' TRP . . . . . 0.574 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 75.0 m95 -81.81 166.87 19.62 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.667 -179.72 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . 0.464 HG22 ' C ' ' A' ' 206' ' ' TRP . 0.1 OUTLIER -156.61 171.89 6.81 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.607 -179.15 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -53.98 -37.3 86.06 Favored 'Trans proline' 0 C--N 1.303 -1.856 0 C-N-CA 122.654 2.236 . . . . 0.0 112.172 179.225 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -70.45 -34.81 72.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.76 -179.746 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 22.0 m -61.44 150.51 35.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.596 -179.373 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.17 -36.51 80.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.438 -179.768 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . 0.574 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 53.7 tt0 -64.5 -40.6 95.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.482 -179.987 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.67 -43.65 91.47 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 179.821 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -63.14 -44.26 96.05 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.719 0.295 . . . . 0.0 110.283 179.76 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . 0.577 ' SD ' ' HB2' ' A' ' 304' ' ' ALA . 65.5 ttp -59.56 -48.21 82.53 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.221 -179.886 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 85.8 mt -60.25 -40.92 91.99 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.405 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . 0.456 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.0 tp10 -58.06 -38.08 75.64 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.739 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -65.3 -38.17 89.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.784 0.326 . . . . 0.0 110.568 179.677 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 219' ' ' LEU . 94.7 mt -64.4 -42.79 95.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.441 -179.595 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.54 45.84 0.08 OUTLIER Glycine 0 C--N 1.334 0.47 0 N-CA-C 111.036 -0.825 . . . . 0.0 111.036 179.958 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . 0.456 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 26.9 m-85 -129.0 156.02 44.46 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.027 0.441 . . . . 0.0 110.487 -179.802 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.481 ' O ' HG13 ' A' ' 191' ' ' VAL . 8.0 p -108.01 122.83 47.66 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.203 0.525 . . . . 0.0 110.208 -179.938 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.479 HD22 ' C ' ' A' ' 222' ' ' THR . 4.3 mm? -101.6 133.41 46.33 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.068 -179.94 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -97.22 159.73 14.74 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.458 179.834 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.01 115.1 29.7 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.927 0.394 . . . . 0.0 110.41 179.84 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.494 ' N ' HD12 ' A' ' 226' ' ' LEU . 9.1 mp -53.34 156.75 3.83 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.648 179.93 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -60.09 145.2 98.99 Favored 'Trans proline' 0 C--N 1.302 -1.903 0 C-N-CA 122.667 2.245 . . . . 0.0 112.139 179.283 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.48 -2.78 58.86 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.559 179.981 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.49 -40.64 5.65 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 111.004 -0.838 . . . . 0.0 111.004 -179.835 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.544 ' O ' ' N ' ' A' ' 233' ' ' SER . 84.9 mt -79.53 -16.9 55.16 Favored 'General case' 0 C--O 1.223 -0.337 0 CA-C-O 120.997 0.427 . . . . 0.0 110.368 -179.772 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . 0.405 ' C ' ' O ' ' A' ' 230' ' ' LEU . 54.7 t-20 -40.11 -49.12 2.58 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.678 -179.603 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -88.27 15.58 7.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.783 0.325 . . . . 0.0 111.217 179.963 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.544 ' N ' ' O ' ' A' ' 230' ' ' LEU . 78.1 p -60.62 -35.81 77.07 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.664 -179.858 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . 0.524 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.6 tt0 -118.21 -69.54 0.84 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.942 179.556 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.1 m -70.37 102.97 2.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.651 -179.765 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -94.31 58.04 2.4 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.442 179.949 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -145.04 -122.52 1.55 Allowed Glycine 0 CA--C 1.52 0.379 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 -179.992 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -134.34 111.77 10.46 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 121.053 0.454 . . . . 0.0 110.452 -179.981 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . 0.515 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.0 mtt180 -148.19 57.5 1.08 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.744 -179.97 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -69.75 -31.59 69.64 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.513 179.574 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . 0.549 ' CG ' HD21 ' A' ' 143' ' ' ASN . 65.1 t0 -56.9 -46.95 81.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.339 -179.186 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 242' ' ' ILE . . . . . 0.437 ' O ' ' O ' ' A' ' 239' ' ' ARG . 17.6 tt -140.54 157.41 24.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.865 0.364 . . . . 0.0 110.558 179.713 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.445 HG22 HD13 ' A' ' 245' ' ' LEU . 96.0 mt -106.34 106.33 20.4 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.173 0 CA-C-O 121.096 0.474 . . . . 0.0 110.448 179.89 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . 0.604 ' O ' HD12 ' A' ' 245' ' ' LEU . 88.3 mt-30 -110.68 110.62 21.37 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.358 179.733 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.604 HD12 ' O ' ' A' ' 244' ' ' GLN . 9.6 mp -122.02 -168.03 1.64 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.583 179.784 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . 0.524 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.14 -16.77 0.05 OUTLIER Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 179.895 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . 0.667 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -60.42 157.25 29.21 Favored Glycine 0 CA--C 1.522 0.516 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 -179.823 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -63.94 21.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.921 0.391 . . . . 0.0 110.571 179.942 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . 0.667 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.7 m-20 -96.8 -5.82 37.54 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.576 179.99 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 92.0 mt -80.24 -21.36 42.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.615 179.522 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.53 -51.41 69.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.773 -179.557 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.99 -5.29 58.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.459 179.662 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -80.87 -74.44 1.13 Allowed Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 -179.946 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 80.9 mt -69.87 125.69 27.5 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.058 0.456 . . . . 0.0 110.303 -179.859 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -59.33 -39.67 83.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.297 -179.641 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 83.5 51.76 3.98 Favored Glycine 0 CA--C 1.522 0.473 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 179.9 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -95.1 -16.11 22.88 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.712 0.292 . . . . 0.0 110.588 -179.848 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . 0.494 ' OG ' HG23 ' A' ' 191' ' ' VAL . 3.4 t 174.92 89.51 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.08 0.466 . . . . 0.0 110.161 179.973 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.863 ' N ' HD12 ' A' ' 259' ' ' LEU . 0.9 OUTLIER -94.46 124.18 38.33 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.258 0.551 . . . . 0.0 111.058 -178.999 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 260' ' ' PHE . . . . . 0.444 ' H ' ' HA ' ' A' ' 193' ' ' ALA . 16.0 m-30 -93.62 146.91 23.47 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.391 179.218 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 85.5 mt -122.39 149.75 43.38 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.583 -179.933 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.734 ' CD1' HG13 ' A' ' 195' ' ' VAL . 2.6 p90 -77.99 -139.14 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.46 -179.759 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . 0.665 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -50.8 77.86 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.987 -179.947 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . 0.641 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.97 104.66 0.19 Allowed Glycine 0 CA--C 1.526 0.768 0 N-CA-C 110.721 -0.951 . . . . 0.0 110.721 -179.964 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 265' ' ' ASP . . . . . 0.601 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.7 m-20 -80.39 -177.56 6.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.722 0.296 . . . . 0.0 110.84 -179.424 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -40.49 -17.73 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.511 179.823 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . 0.601 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.42 -51.51 43.09 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.679 179.582 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -63.77 -46.59 84.58 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.23 179.357 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . 0.581 ' HB1' ' OH ' ' A' ' 273' ' ' TYR . . . -61.48 -35.15 76.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.927 179.511 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -63.07 -34.57 77.87 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.155 179.717 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.25 -43.21 13.96 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.192 -179.51 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 272' ' ' ILE . . . . . 0.588 ' C ' ' H ' ' A' ' 274' ' ' ALA . 5.0 tt -51.49 -33.92 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.839 -178.783 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 273' ' ' TYR . . . . . 0.581 ' OH ' ' HB1' ' A' ' 269' ' ' ALA . 17.0 m-85 -54.3 -1.91 0.03 OUTLIER 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.71 -179.598 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 274' ' ' ALA . . . . . 0.588 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.63 -39.45 70.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.885 179.574 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . 0.585 ' O ' ' N ' ' A' ' 279' ' ' ALA . 3.8 p30 -39.33 98.04 0.16 Allowed Pre-proline 0 C--O 1.226 -0.153 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.53 -179.636 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -54.19 -43.04 62.07 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 C-N-CA 122.383 2.055 . . . . 0.0 112.595 -178.753 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 89.1 mt -64.49 -42.9 95.58 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.086 -179.621 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 91.1 mt -95.87 -1.11 50.07 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.889 -179.434 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 279' ' ' ALA . . . . . 0.585 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.4 -34.92 77.68 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.666 -179.791 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.3 20.16 0.12 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.979 -179.207 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 0.494 HD23 ' HA ' ' A' ' 281' ' ' LEU . 13.6 mt -74.91 119.83 78.73 Favored Pre-proline 0 N--CA 1.452 -0.347 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.504 179.9 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -50.57 -39.74 55.43 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.598 2.199 . . . . 0.0 111.949 178.989 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.9 -50.45 63.9 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.122 179.876 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 73.4 t -61.55 -43.91 97.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 179.477 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -57.8 -41.17 81.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.274 -179.906 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -90.73 -0.1 57.59 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.184 179.622 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt 59.92 43.3 15.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.029 0.442 . . . . 0.0 110.821 179.658 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -94.93 41.3 1.09 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.382 179.809 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 54.2 t -119.23 135.82 58.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.022 0.439 . . . . 0.0 110.231 -179.737 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -133.63 163.85 28.5 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.044 0.45 . . . . 0.0 110.658 -179.577 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.81 155.88 31.72 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.94 0.4 . . . . 0.0 110.78 -179.803 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 81.4 mt -94.7 -1.59 52.77 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.25 -179.735 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 120.86 165.21 12.65 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.651 -0.98 . . . . 0.0 110.651 -179.763 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 7.0 m -86.59 -61.73 1.67 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.806 0.336 . . . . 0.0 111.092 -179.828 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 295' ' ' GLU . . . . . 0.455 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.6 mm-40 -69.04 -4.84 18.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.682 -179.686 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 26.3 p -76.48 32.22 0.13 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.641 -179.871 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 297' ' ' PHE . . . . . 0.495 ' CD1' HG22 ' A' ' 70' ' ' THR . 59.4 t80 -60.59 -46.43 90.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.713 179.944 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . 0.614 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.2 mtt85 -80.23 137.37 36.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.582 -179.65 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.503 ' H ' HG11 ' A' ' 51' ' ' VAL . 5.7 tp -114.38 115.8 27.91 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.453 179.868 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . 0.631 ' H ' ' CB ' ' A' ' 303' ' ' SER . 48.7 p-10 -165.72 -176.69 3.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.533 -179.977 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 79.0 t80 -46.59 -42.76 16.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.293 -179.791 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -67.4 -40.58 85.64 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.026 0.441 . . . . 0.0 110.756 179.196 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . 0.631 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 60.2 p -55.62 -36.38 66.92 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.074 -179.276 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . 0.577 ' HB2' ' SD ' ' A' ' 215' ' ' MET . . . -57.68 -51.61 68.83 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 179.342 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 91.2 mtp -56.06 -44.14 78.59 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 179.838 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -66.11 -43.13 88.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.917 0.389 . . . . 0.0 110.166 178.837 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 303' ' ' SER . 55.9 t -63.97 -42.88 97.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.288 179.358 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 44.6 tp -59.89 -42.05 92.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.934 -179.64 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -62.33 -39.31 92.66 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.155 179.59 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 310' ' ' ARG . . . . . 0.468 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.7 ttt85 -63.6 -43.95 95.42 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.29 179.412 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 89.5 mt -63.18 -42.2 99.34 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.31 179.603 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -63.21 -33.57 75.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.079 179.456 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.85 -23.44 21.66 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.488 -179.875 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.483 HD22 ' CE2' ' A' ' 315' ' ' PHE . 6.8 tt -62.3 -43.16 99.47 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.58 -179.95 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 315' ' ' PHE . . . . . 0.483 ' CE2' HD22 ' A' ' 314' ' ' LEU . 90.5 m-85 . . . . . 0 C--O 1.22 -0.478 0 CA-C-O 118.043 -0.979 . . . . 0.0 110.482 179.981 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -99.63 135.18 41.43 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.063 0.459 . . . . 0.0 110.452 -179.885 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.497 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -92.15 178.55 1.66 Allowed Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.509 -179.829 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.497 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 27.3 Cg_exo -61.46 147.11 96.3 Favored 'Trans proline' 0 C--N 1.3 -2.008 0 C-N-CA 122.709 2.273 . . . . 0.0 112.173 179.617 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.482 ' HE ' HD12 ' A' ' 39' ' ' LEU . 35.0 ptt180 -135.98 142.35 44.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.714 179.779 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -79.9 116.86 20.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.401 179.922 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.457 ' O ' HG23 ' A' ' 30' ' ' ILE . 9.4 tp -111.64 130.12 65.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.408 179.996 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.1 t -70.85 141.95 51.25 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.621 179.763 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.476 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.0 t0 -138.85 -179.97 6.14 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.512 -179.936 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.476 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 78.1 p -73.84 -37.38 64.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.761 179.834 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.8 ttt85 -46.89 -94.72 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.366 -179.338 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.414 ' O ' ' OG1' ' A' ' 36' ' ' THR . . . -166.04 -26.99 0.02 OUTLIER Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.886 -0.885 . . . . 0.0 110.886 179.996 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.414 ' OG1' ' O ' ' A' ' 35' ' ' GLY . 75.2 m -168.29 105.87 0.47 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.924 0.392 . . . . 0.0 110.678 -179.894 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.649 ' CD2' HD13 ' A' ' 140' ' ' LEU . 68.8 t60 -129.07 146.51 51.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.071 0.463 . . . . 0.0 110.317 179.997 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.622 HG22 ' N ' ' A' ' 39' ' ' LEU . 99.8 m -129.99 165.59 21.84 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.57 -179.797 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.622 ' N ' HG22 ' A' ' 38' ' ' THR . 81.0 mt -120.38 127.25 52.13 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.483 179.727 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -65.44 -44.6 86.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.689 -179.954 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 40.7 p -165.73 154.97 12.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.404 179.599 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.5 ' H ' ' CD ' ' A' ' 42' ' ' GLN . 14.5 mp0 -45.31 101.58 0.26 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.608 179.427 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -57.7 130.32 38.05 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 C-N-CA 122.334 2.023 . . . . 0.0 112.196 -179.772 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -83.01 -24.62 32.77 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.531 179.593 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.535 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.7 mtm-85 -121.22 134.67 55.2 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-O 121.156 0.503 . . . . 0.0 110.246 -179.926 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.0 mt -130.49 133.35 63.82 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.297 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.99 -179.797 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 46.5 t -124.76 131.05 73.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 179.471 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.621 ' OG ' HD12 ' A' ' 117' ' ' LEU . 4.6 m -154.49 166.2 34.04 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.048 0.452 . . . . 0.0 110.505 179.679 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 60.9 p -124.51 8.73 8.36 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.519 179.936 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.8 125.96 33.65 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.617 -179.508 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.465 HG11 ' H ' ' A' ' 299' ' ' LEU . 84.7 t -65.68 -44.54 93.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.51 -179.99 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.0 m -62.71 -44.26 96.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.66 -179.818 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 52.1 tp -62.27 -41.65 98.66 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.6 -179.415 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.472 ' O ' HD13 ' A' ' 58' ' ' LEU . 71.9 m -57.92 -44.51 86.92 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.286 -179.326 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.41 -61.97 5.52 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 179.578 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.7 t -48.56 -35.6 13.73 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 -179.812 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 20.0 mt -61.68 -44.58 96.68 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.708 -0.397 . . . . 0.0 111.199 179.19 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.479 HD21 HE22 ' A' ' 85' ' ' GLN . 9.5 mp -64.58 -42.09 95.86 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.334 177.911 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.63 -41.23 98.28 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.044 -179.222 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.434 ' O ' HG23 ' A' ' 60' ' ' ILE . 7.9 tp -87.81 16.58 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.726 -179.618 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 56.52 83.61 0.1 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.726 -179.838 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.75 56.72 0.07 OUTLIER Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.01 -179.865 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.42 ' HB3' HE21 ' A' ' 85' ' ' GLN . 9.5 Cg_endo -49.43 153.46 4.96 Favored 'Trans proline' 0 C--N 1.296 -2.228 0 C-N-CA 122.818 2.345 . . . . 0.0 112.565 -178.52 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.432 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.4 OUTLIER -109.13 146.32 14.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.4 -179.764 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 97.0 mt -63.99 -44.78 97.94 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.335 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.436 -179.986 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.504 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -130.16 134.72 47.51 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 120.851 0.358 . . . . 0.0 110.591 -179.762 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.493 ' O ' ' N ' ' A' ' 98' ' ' LEU . 72.6 m -134.79 158.86 43.1 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.912 -179.719 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.9 139.49 16.33 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 179.877 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.492 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.87 -162.46 0.08 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.98 0.419 . . . . 0.0 110.498 -179.996 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.507 HG22 ' CD2' ' A' ' 297' ' ' PHE . 5.9 t -133.86 135.99 44.07 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.179 -179.997 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.488 ' C ' ' O ' ' A' ' 70' ' ' THR . 1.0 OUTLIER 29.65 68.12 0.68 Allowed Pre-proline 0 N--CA 1.466 0.335 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.719 -179.665 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -60.69 144.92 99.61 Favored 'Trans proline' 0 C--N 1.299 -2.045 0 C-N-CA 122.573 2.182 . . . . 0.0 112.242 -178.506 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.525 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 45.2 p-10 -160.37 -32.12 0.06 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.646 179.735 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.531 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 99.1 m-20 -64.07 -39.37 93.92 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.451 -179.987 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -60.7 -47.75 84.88 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.718 -179.165 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.424 ' O ' ' O ' ' A' ' 77' ' ' ALA . 96.1 t -60.3 -24.5 31.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 179.687 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.531 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -45.71 172.81 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.594 179.835 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.568 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.6 p30 -62.01 177.77 0.42 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.605 -179.654 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.56 ' C ' ' H ' ' A' ' 81' ' ' GLY . 35.8 p30 -46.36 85.98 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.012 0.434 . . . . 0.0 110.921 179.956 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.568 ' N ' ' O ' ' A' ' 78' ' ' ASP . 43.0 tp60 -67.49 13.73 0.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.022 -179.78 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.56 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 117.91 -22.24 9.95 Favored Glycine 0 CA--C 1.518 0.269 0 N-CA-C 110.991 -0.844 . . . . 0.0 110.991 179.987 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -107.95 116.7 32.42 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.007 0.432 . . . . 0.0 110.488 179.858 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 76.5 mt -98.88 0.9 45.11 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.482 -179.783 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -91.93 6.57 45.73 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.996 0.427 . . . . 0.0 110.475 -179.749 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.777 ' O ' HG22 ' A' ' 89' ' ' VAL . 88.2 mt-30 -100.02 -26.52 13.95 Favored 'General case' 0 C--O 1.224 -0.259 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.843 179.883 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.0 t-105 -64.6 -40.86 96.26 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.121 -179.769 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.551 ' O ' ' N ' ' A' ' 91' ' ' LYS . 70.3 m -77.59 -53.55 7.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.355 -179.67 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -48.22 -50.75 28.22 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.076 -179.24 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.777 HG22 ' O ' ' A' ' 85' ' ' GLN . 14.3 m -69.08 -41.03 81.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 120.932 0.396 . . . . 0.0 111.174 179.645 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.505 ' N ' HG23 ' A' ' 89' ' ' VAL . . . -71.72 -22.95 61.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.814 -179.971 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.551 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.0 tttm -61.51 -45.97 91.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.476 -179.493 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.437 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.8 mm-40 -90.43 -94.33 0.12 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.111 -179.867 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.632 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.9 mtt180 -143.37 59.66 1.4 Allowed 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 179.767 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.459 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.6 pttp 33.74 26.08 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 120.833 0.349 . . . . 0.0 110.171 -179.354 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.632 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.3 tt -47.96 123.39 6.11 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.977 -178.076 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.447 ' O ' HD23 ' A' ' 95' ' ' LEU . 99.0 mm-40 -83.45 -170.54 3.1 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.055 -179.841 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.616 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 82.6 mtp180 -72.93 137.74 45.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.182 -179.807 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.493 ' N ' ' O ' ' A' ' 67' ' ' SER . 88.4 mt -86.32 -166.28 1.5 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.702 -179.626 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.531 ' CD2' ' O ' ' A' ' 99' ' ' TYR . 47.1 p90 -167.75 119.8 0.88 Allowed 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.223 179.938 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.508 ' C ' ' O ' ' A' ' 99' ' ' TYR . 43.0 mm -29.6 121.19 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.997 -179.645 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 113.66 28.17 3.3 Favored Glycine 0 CA--C 1.519 0.304 0 N-CA-C 111.179 -0.768 . . . . 0.0 111.179 -179.404 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.585 ' H ' ' CD ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -143.88 45.81 0.6 Allowed Pre-proline 0 C--N 1.324 -0.53 0 CA-C-O 120.947 0.403 . . . . 0.0 110.475 179.827 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.584 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 30.8 Cg_endo -62.06 143.7 95.23 Favored 'Trans proline' 0 C--N 1.296 -2.187 0 C-N-CA 122.639 2.226 . . . . 0.0 112.057 179.926 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.475 ' O ' HG23 ' A' ' 108' ' ' VAL . 22.6 t -173.27 120.77 0.35 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.41 179.649 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.28 -41.09 64.03 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.105 0.479 . . . . 0.0 111.262 179.525 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -65.92 -40.27 91.29 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.908 -179.401 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.89 -39.89 95.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.7 -179.915 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 104' ' ' SER . 69.0 t -67.43 -43.91 87.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.774 179.558 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.18 -39.18 91.83 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.554 -179.236 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.437 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.64 -23.62 63.18 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.425 179.835 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.552 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.5 mm-40 -90.83 4.68 51.09 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.703 -179.547 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.552 ' C ' ' O ' ' A' ' 111' ' ' GLN . 10.3 tpt 23.43 63.85 0.38 Allowed Pre-proline 0 N--CA 1.467 0.378 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.982 179.906 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.443 ' HG2' HD11 ' A' ' 116' ' ' ILE . 71.6 Cg_endo -78.48 168.58 21.18 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 C-N-CA 122.94 2.427 . . . . 0.0 112.28 -178.54 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.523 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 98.9 m-20 -112.7 -44.24 3.35 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.999 0.428 . . . . 0.0 109.97 179.495 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.0 tp -120.58 120.05 34.69 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.665 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.457 HD13 HD22 ' A' ' 133' ' ' LEU . 96.4 mt -117.09 131.26 70.33 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 CA-C-O 120.877 0.37 . . . . 0.0 111.017 -179.942 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.621 HD12 ' OG ' ' A' ' 48' ' ' SER . 30.0 mt -106.27 132.6 52.13 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.133 0.492 . . . . 0.0 110.234 -179.369 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.411 HD12 HG23 ' A' ' 139' ' ' THR . 98.1 mt -117.99 136.58 54.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.718 -179.705 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 86.0 p -72.17 152.93 41.94 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.644 179.979 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.36 -49.98 75.41 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.631 -179.858 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -148.99 153.43 37.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.495 179.811 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 169.53 -170.38 42.63 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 179.837 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.95 -35.31 91.89 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 179.915 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.451 ' O ' ' OD1' ' A' ' 124' ' ' ASP . 44.5 p-10 -87.71 120.0 28.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.822 0.344 . . . . 0.0 110.681 179.922 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.449 ' O ' HD12 ' A' ' 129' ' ' LEU . 39.8 t -63.62 144.22 57.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.437 -179.947 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.518 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.31 -43.34 8.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.931 180.0 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.6 tp -62.71 -42.35 99.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.684 -179.899 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.72 -11.38 58.22 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.478 -179.361 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.449 HD12 ' O ' ' A' ' 125' ' ' SER . 84.9 mt -115.64 -23.6 8.65 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.653 -179.781 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . 0.518 ' N ' ' O ' ' A' ' 126' ' ' ALA . 78.0 t80 -51.91 -49.71 62.54 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 120.534 -0.466 . . . . 0.0 110.548 -178.958 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.6 p-10 -65.91 -42.35 90.27 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.867 0.365 . . . . 0.0 111.268 179.512 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.521 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 87.9 mt-30 -67.0 -37.14 83.66 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.811 179.836 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.457 HD22 HD13 ' A' ' 116' ' ' ILE . 93.5 mt -79.98 -41.96 24.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.004 -179.612 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.0 t -57.48 -44.59 85.03 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.172 -178.959 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.8 m -62.25 -45.59 92.63 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.797 0.332 . . . . 0.0 110.54 179.382 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 92.3 mt -62.45 -43.79 98.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.277 -179.829 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.603 ' HB1' ' HD2' ' A' ' 138' ' ' PRO . . . -170.14 163.98 6.14 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.525 179.833 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.603 ' HD2' ' HB1' ' A' ' 137' ' ' ALA . 78.4 Cg_exo -43.81 111.89 0.28 Allowed 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.414 2.076 . . . . 0.0 112.1 179.523 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.471 HG21 ' CD1' ' A' ' 130' ' ' TYR . 17.8 m -85.97 127.54 34.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.49 179.973 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.649 HD13 ' CD2' ' A' ' 37' ' ' HIS . 34.2 tp -118.94 135.9 54.35 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.896 -179.576 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.435 ' O ' ' OD1' ' A' ' 32' ' ' ASP . 80.2 mt -102.63 119.89 51.63 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.417 0 CA-C-O 121.176 0.512 . . . . 0.0 111.466 -179.524 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.511 HD12 HD22 ' A' ' 117' ' ' LEU . 98.0 mt -135.8 132.66 51.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.615 179.791 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.549 HD21 ' CG ' ' A' ' 241' ' ' ASP . 54.5 t30 -65.62 151.7 45.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.966 0.412 . . . . 0.0 110.33 179.195 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.52 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 87.3 t80 -85.62 122.42 29.7 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.978 -179.553 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.52 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 98.9 m-20 55.13 69.33 0.74 Allowed 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.966 179.755 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 49.2 p-10 -123.44 -0.35 8.74 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 120.989 0.423 . . . . 0.0 110.711 179.866 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -151.32 117.24 5.51 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.818 -179.52 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 84.8 p -63.26 167.9 4.8 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.519 -179.77 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.419 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.4 p-90 -50.78 -15.7 0.32 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.566 -179.823 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.444 ' O ' HG23 ' A' ' 154' ' ' THR . 68.0 tp60 -71.24 -74.78 0.14 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.427 -179.726 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.449 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.1 t -62.66 -39.06 92.73 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.235 179.476 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 53.5 tp -60.25 -45.51 93.03 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.345 -178.476 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.419 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 45.7 tp -62.67 -41.92 99.35 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.83 0.348 . . . . 0.0 110.365 179.013 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.449 ' OG1' ' O ' ' A' ' 151' ' ' SER . 55.3 p -63.92 -34.65 78.45 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.282 -179.461 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.451 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.5 mm-40 -63.93 -42.37 97.37 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.175 179.269 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 92.1 mt -65.32 -39.02 91.92 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.072 0.463 . . . . 0.0 110.122 179.163 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.582 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.05 -32.29 79.77 Favored Glycine 0 CA--C 1.519 0.337 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 -179.308 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.451 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.3 mt-10 -36.48 -25.21 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.88 0.371 . . . . 0.0 110.808 179.913 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.582 ' N ' ' O ' ' A' ' 157' ' ' GLY . 95.7 mt -59.45 148.93 6.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.215 179.319 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 75.3 p -68.94 137.51 53.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.07 -179.554 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 70.6 22.13 77.88 Favored Glycine 0 N--CA 1.459 0.187 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 179.48 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 60.0 m80 -124.24 -14.62 6.95 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.673 0.273 . . . . 0.0 110.542 179.88 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -66.58 -59.44 3.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.696 -179.657 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -52.17 -48.68 64.82 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.141 -179.509 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -60.97 -40.95 95.35 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.742 0.306 . . . . 0.0 110.317 179.454 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.59 -47.31 86.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.57 179.822 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.95 -40.05 75.71 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.197 -179.787 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -61.76 -50.26 73.1 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.511 179.597 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -65.38 -43.68 89.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.493 179.595 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 95.4 mt -64.49 -43.48 96.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.395 179.71 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.23 -51.03 70.98 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.568 -179.129 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.81 -43.54 95.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.431 179.744 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.666 ' CE2' HD11 ' A' ' 177' ' ' LEU . 57.1 t80 -62.55 -44.75 95.56 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.117 0.484 . . . . 0.0 110.503 179.272 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -63.22 -39.82 95.71 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.616 -179.365 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -62.9 -42.74 99.88 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.644 179.175 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -60.97 -44.64 97.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.015 -179.944 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.666 HD11 ' CE2' ' A' ' 173' ' ' PHE . 85.1 mt -64.24 -41.25 97.07 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.033 0.445 . . . . 0.0 110.715 178.887 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.41 -62.1 1.85 Allowed 'General case' 0 C--O 1.237 0.432 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.51 -179.317 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.67 -46.71 86.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.545 179.882 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.45 -41.46 66.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.203 -179.979 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -63.77 -33.73 76.31 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.965 0.412 . . . . 0.0 110.347 179.244 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.423 ' HG2' ' O ' ' A' ' 182' ' ' GLU . 69.8 tt0 -90.57 8.56 33.47 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.483 0.659 . . . . 0.0 110.527 -178.997 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -104.51 -32.22 9.08 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.267 179.58 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.6 pt -128.01 147.78 32.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.863 -179.902 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -140.05 131.16 26.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.352 179.409 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.591 HD22 ' N ' ' A' ' 186' ' ' LEU . 3.6 mm? -85.68 133.29 42.1 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.905 179.936 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -44.1 157.89 0.14 Allowed 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.685 2.257 . . . . 0.0 112.123 179.468 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 0.523 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.5 Cg_endo -62.87 115.05 2.69 Favored 'Trans proline' 0 C--N 1.303 -1.828 0 C-N-CA 122.812 2.341 . . . . 0.0 111.701 179.887 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . 0.523 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.7 mt-30 155.59 148.16 0.0 OUTLIER Pre-proline 0 N--CA 1.454 -0.257 0 O-C-N 123.626 0.579 . . . . 0.0 110.726 -179.957 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -73.95 144.13 33.9 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 C-N-CA 122.657 2.238 . . . . 0.0 111.779 178.083 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.503 HG23 ' OG ' ' A' ' 258' ' ' SER . 2.1 p -125.06 158.76 32.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.276 0.56 . . . . 0.0 110.138 -179.95 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . 0.493 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 35.6 p -143.29 165.46 27.41 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.199 -179.798 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . 0.445 ' HA ' ' H ' ' A' ' 260' ' ' PHE . . . -135.45 128.54 31.67 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.231 0.538 . . . . 0.0 110.206 179.597 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.506 HD11 HD23 ' A' ' 259' ' ' LEU . 47.1 pt -146.59 149.36 16.02 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.358 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.138 179.71 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . 0.739 HG13 ' CD1' ' A' ' 262' ' ' PHE . 69.2 t -118.14 123.31 71.45 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-O 121.385 0.612 . . . . 0.0 109.538 179.276 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -134.39 107.08 7.4 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.181 179.759 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 95.2 m -130.89 130.77 43.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.95 179.685 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.406 ' O ' ' N ' ' A' ' 201' ' ' HIS . . . -83.04 -37.03 24.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.227 179.793 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.39 -67.06 0.26 Allowed 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.346 -179.967 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.24 -9.96 59.15 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.272 179.536 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . 0.406 ' N ' ' O ' ' A' ' 198' ' ' ALA . 60.1 t-80 60.8 58.08 2.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.585 -179.841 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 54.4 p -166.89 153.33 8.44 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.472 179.568 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.02 143.86 24.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.454 179.509 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -135.16 138.05 43.32 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.635 179.972 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 20.0 mt -106.23 125.51 51.08 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 121.114 0.483 . . . . 0.0 109.731 -179.67 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 206' ' ' TRP . . . . . 0.56 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 74.4 m95 -81.91 166.88 19.51 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.595 -179.799 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . 0.465 HG22 ' C ' ' A' ' 206' ' ' TRP . 0.1 OUTLIER -157.01 172.01 6.7 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.561 -179.173 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.18 -36.94 87.28 Favored 'Trans proline' 0 C--N 1.302 -1.894 0 C-N-CA 122.623 2.215 . . . . 0.0 112.022 179.477 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -70.52 -35.11 72.99 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.888 -179.917 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 21.9 m -61.18 150.63 33.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.662 -179.368 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.62 -36.84 81.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.482 -179.714 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . 0.56 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 54.8 tt0 -64.57 -40.44 95.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.524 179.931 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.79 -43.33 91.95 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.679 -0.969 . . . . 0.0 110.679 179.829 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -63.44 -43.7 96.67 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 179.933 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . 0.55 ' SD ' ' HB2' ' A' ' 304' ' ' ALA . 65.6 ttp -59.64 -47.83 84.05 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.161 -179.764 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 86.7 mt -60.83 -40.68 93.68 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 179.731 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . 0.453 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.2 tp10 -58.27 -38.03 76.14 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.784 -0.451 . . . . 0.0 109.784 179.926 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -65.13 -38.23 89.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.836 0.351 . . . . 0.0 110.664 179.605 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 93.6 mt -64.33 -42.65 96.19 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.497 -179.587 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.6 45.22 0.08 OUTLIER Glycine 0 C--N 1.333 0.393 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 179.975 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . 0.453 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 26.5 m-85 -128.38 155.83 44.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.025 0.44 . . . . 0.0 110.527 -179.802 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.489 ' O ' HG13 ' A' ' 191' ' ' VAL . 8.2 p -107.56 122.61 47.02 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.262 0.553 . . . . 0.0 110.197 -179.913 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.475 HD22 ' C ' ' A' ' 222' ' ' THR . 4.3 mm? -101.52 132.92 46.89 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.082 179.884 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.65 159.84 14.71 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.508 179.883 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.46 115.27 29.97 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.955 0.407 . . . . 0.0 110.306 179.869 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.499 ' N ' HD12 ' A' ' 226' ' ' LEU . 9.0 mp -53.1 156.85 3.35 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.672 179.907 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -60.59 145.53 98.65 Favored 'Trans proline' 0 C--N 1.301 -1.96 0 C-N-CA 122.564 2.176 . . . . 0.0 112.076 179.396 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.21 -3.41 59.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.551 -179.966 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.06 -41.09 5.67 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 -179.909 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.53 ' O ' ' N ' ' A' ' 233' ' ' SER . 68.3 mt -78.97 -17.57 55.21 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-O 121.097 0.475 . . . . 0.0 110.372 -179.838 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . 0.401 ' C ' ' O ' ' A' ' 230' ' ' LEU . 55.0 t-20 -40.43 -49.13 2.84 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.827 -179.352 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -87.68 15.28 7.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.779 0.323 . . . . 0.0 111.34 179.748 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.53 ' N ' ' O ' ' A' ' 230' ' ' LEU . 78.1 p -60.47 -35.32 75.59 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.591 -179.749 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . 0.525 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.7 tt0 -119.35 -69.44 0.85 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.966 179.457 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.2 m -69.25 103.08 1.85 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.686 -179.788 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -94.77 57.19 2.12 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.381 179.951 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -144.58 -122.72 1.61 Allowed Glycine 0 C--N 1.332 0.322 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 -179.989 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -135.03 111.9 10.14 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 121.202 0.525 . . . . 0.0 110.401 179.958 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . 0.525 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.6 mtt180 -148.15 57.74 1.08 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.796 -179.856 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -69.43 -32.16 70.96 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.518 179.681 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . 0.549 ' CG ' HD21 ' A' ' 143' ' ' ASN . 65.0 t0 -57.03 -47.04 81.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.372 -179.101 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 242' ' ' ILE . . . . . 0.437 ' O ' ' O ' ' A' ' 239' ' ' ARG . 17.9 tt -139.92 156.59 25.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.944 0.402 . . . . 0.0 110.477 179.771 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.444 HG22 HD13 ' A' ' 245' ' ' LEU . 96.1 mt -106.3 106.81 21.29 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.219 0 CA-C-O 121.208 0.527 . . . . 0.0 110.498 179.776 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . 0.601 ' O ' HD12 ' A' ' 245' ' ' LEU . 88.2 mt-30 -110.67 110.15 20.7 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.264 179.717 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.601 HD12 ' O ' ' A' ' 244' ' ' GLN . 9.4 mp -121.71 -168.14 1.65 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.667 179.725 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . 0.525 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.4 -15.82 0.05 OUTLIER Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.991 -0.844 . . . . 0.0 110.991 179.851 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . 0.673 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -61.47 156.5 34.83 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 110.926 -0.869 . . . . 0.0 110.926 -179.893 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -63.59 21.83 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.975 0.416 . . . . 0.0 110.59 179.948 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . 0.673 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.9 m-20 -97.48 -6.13 34.46 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.572 179.9 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 93.5 mt -79.43 -22.11 44.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.639 179.522 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.66 -51.21 70.89 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.806 -179.445 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.09 -5.82 58.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.375 179.639 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.12 -74.47 1.14 Allowed Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 -179.956 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 83.0 mt -70.15 125.81 27.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.019 0.438 . . . . 0.0 110.168 -179.759 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -59.57 -39.2 83.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.28 -179.691 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 83.27 51.71 4.04 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 110.716 -0.954 . . . . 0.0 110.716 179.755 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -95.62 -15.33 22.83 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.709 0.29 . . . . 0.0 110.641 -179.853 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . 0.503 ' OG ' HG23 ' A' ' 191' ' ' VAL . 3.4 t 174.58 89.07 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.058 0.456 . . . . 0.0 110.083 179.935 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.862 ' N ' HD12 ' A' ' 259' ' ' LEU . 0.9 OUTLIER -94.39 124.2 38.27 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.291 0.567 . . . . 0.0 111.165 -179.211 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 260' ' ' PHE . . . . . 0.445 ' H ' ' HA ' ' A' ' 193' ' ' ALA . 15.9 m-30 -93.1 146.68 23.47 Favored 'General case' 0 CA--C 1.506 -0.747 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.324 179.281 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 86.1 mt -122.53 149.7 43.56 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.53 -179.883 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.739 ' CD1' HG13 ' A' ' 195' ' ' VAL . 2.5 p90 -77.78 -138.56 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.472 -179.724 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . 0.662 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -51.72 77.4 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.985 -179.988 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . 0.635 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.17 104.42 0.19 Allowed Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 -179.852 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 265' ' ' ASP . . . . . 0.602 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.6 m-20 -80.41 -177.69 6.3 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.662 0.268 . . . . 0.0 110.932 -179.583 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -40.65 -17.6 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.454 179.939 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . 0.602 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.42 -51.59 42.25 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.992 0.425 . . . . 0.0 110.768 179.382 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -63.78 -46.61 84.46 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.126 179.397 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . 0.562 ' HB1' ' OH ' ' A' ' 273' ' ' TYR . . . -61.72 -35.1 77.07 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 121.129 0.49 . . . . 0.0 109.71 179.693 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -62.87 -34.91 78.38 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.213 179.672 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.27 -43.02 14.11 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.402 -179.59 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 272' ' ' ILE . . . . . 0.59 ' C ' ' H ' ' A' ' 274' ' ' ALA . 5.0 tt -51.29 -33.82 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.828 -179.006 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 273' ' ' TYR . . . . . 0.562 ' OH ' ' HB1' ' A' ' 269' ' ' ALA . 17.3 m-85 -54.15 -1.66 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.695 -179.625 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 274' ' ' ALA . . . . . 0.59 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.81 -39.88 69.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.882 179.626 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . 0.58 ' O ' ' N ' ' A' ' 279' ' ' ALA . 2.9 p30 -39.29 97.93 0.15 Allowed Pre-proline 0 N--CA 1.463 0.196 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.536 -179.76 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -53.87 -43.03 61.65 Favored 'Trans proline' 0 C--N 1.303 -1.828 0 C-N-CA 122.281 1.987 . . . . 0.0 112.78 -178.884 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 89.6 mt -64.28 -42.8 96.24 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 121.2 0.524 . . . . 0.0 111.346 -179.866 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 90.9 mt -95.68 -1.72 49.51 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.826 -179.499 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 279' ' ' ALA . . . . . 0.58 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.37 -34.97 77.73 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.619 -179.727 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -74.06 19.97 0.11 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.047 -179.342 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 0.491 HD23 ' HA ' ' A' ' 281' ' ' LEU . 13.8 mt -75.19 120.54 82.15 Favored Pre-proline 0 N--CA 1.451 -0.395 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.345 -179.96 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -51.54 -39.15 65.56 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.586 2.191 . . . . 0.0 111.699 179.241 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -53.08 -50.28 64.71 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 179.914 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 74.9 t -61.56 -43.96 97.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.544 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -57.74 -41.22 81.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.281 -179.918 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -91.04 0.35 57.56 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.139 179.676 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt 59.32 43.14 17.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.943 179.731 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -94.64 41.54 1.09 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.298 179.901 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 53.7 t -119.15 135.64 58.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.001 0.429 . . . . 0.0 110.169 -179.7 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -132.73 162.85 30.37 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.072 0.463 . . . . 0.0 110.753 -179.728 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.69 155.26 32.75 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.991 0.424 . . . . 0.0 110.783 -179.938 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 82.2 mt -94.1 -1.4 54.38 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.242 -179.689 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 120.87 165.28 12.66 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.549 -1.02 . . . . 0.0 110.549 -179.886 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 7.0 m -86.89 -62.29 1.54 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.853 0.359 . . . . 0.0 111.118 -179.89 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 295' ' ' GLU . . . . . 0.446 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.5 mm-40 -69.15 -4.09 16.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.667 -179.768 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 25.3 p -76.71 32.07 0.13 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.673 -179.94 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 297' ' ' PHE . . . . . 0.507 ' CD2' HG22 ' A' ' 70' ' ' THR . 69.0 t80 -60.42 -45.91 91.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.64 -179.99 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . 0.616 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.2 mtt85 -81.02 134.89 35.76 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 121.011 0.434 . . . . 0.0 110.597 -179.677 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.465 ' H ' HG11 ' A' ' 51' ' ' VAL . 17.6 tp -114.15 117.53 31.45 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.081 179.944 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . 0.619 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.4 p-10 -165.14 -176.81 4.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.543 179.911 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -46.91 -43.22 18.72 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.186 -179.655 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -67.12 -40.25 86.8 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.99 0.424 . . . . 0.0 110.853 179.053 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . 0.619 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 59.9 p -56.12 -36.11 67.85 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.064 -179.121 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . 0.55 ' HB2' ' SD ' ' A' ' 215' ' ' MET . . . -57.58 -51.34 69.89 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 179.463 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 90.3 mtp -56.73 -43.39 80.6 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 108.993 -0.744 . . . . 0.0 108.993 -179.866 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -66.53 -42.54 87.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.905 0.383 . . . . 0.0 110.108 178.884 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 303' ' ' SER . 56.0 t -63.94 -43.09 97.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.112 179.344 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 42.7 tp -59.63 -42.19 92.17 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.782 -179.451 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -62.64 -38.91 92.1 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 179.522 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 310' ' ' ARG . . . . . 0.442 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.6 ttt85 -63.62 -43.95 95.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.17 179.553 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 88.4 mt -63.3 -42.08 99.01 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.156 179.693 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -62.85 -33.45 75.27 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.978 179.558 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.96 -23.27 21.59 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.47 -179.809 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.481 HD22 ' CE2' ' A' ' 315' ' ' PHE . 6.8 tt -62.42 -43.05 99.75 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.076 0.465 . . . . 0.0 110.624 -179.884 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 315' ' ' PHE . . . . . 0.481 ' CE2' HD22 ' A' ' 314' ' ' LEU . 90.9 m-85 . . . . . 0 C--O 1.22 -0.485 0 CA-C-O 117.937 -1.03 . . . . 0.0 110.479 179.964 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -99.4 136.01 39.98 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.032 0.444 . . . . 0.0 110.547 -179.962 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.498 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -92.26 178.42 1.7 Allowed Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.5 -179.924 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.498 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 27.0 Cg_exo -61.54 147.45 95.4 Favored 'Trans proline' 0 C--N 1.301 -1.958 0 C-N-CA 122.726 2.284 . . . . 0.0 112.173 179.737 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.453 ' HE ' HD12 ' A' ' 39' ' ' LEU . 35.4 ptt180 -135.7 142.18 45.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.608 179.782 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -79.73 116.34 19.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.446 179.896 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.453 ' O ' HG23 ' A' ' 30' ' ' ILE . 9.5 tp -110.71 130.25 64.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.438 -179.96 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 12.7 t -70.77 141.43 51.44 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.518 179.925 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.477 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.2 t0 -139.01 179.38 6.53 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.55 -179.928 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.477 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 78.1 p -74.04 -36.88 64.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.684 179.784 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.8 ttt85 -46.53 -94.55 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.344 -179.504 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -166.92 -26.78 0.02 OUTLIER Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 179.928 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 55.1 m -169.21 104.7 0.38 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.979 0.419 . . . . 0.0 110.665 -179.873 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.683 ' CD2' HD13 ' A' ' 140' ' ' LEU . 74.5 t60 -128.39 148.24 50.69 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.042 0.449 . . . . 0.0 110.338 179.795 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.627 HG22 ' N ' ' A' ' 39' ' ' LEU . 98.0 m -130.62 166.02 21.56 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.674 -179.889 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.627 ' N ' HG22 ' A' ' 38' ' ' THR . 82.4 mt -120.68 127.61 52.21 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.455 179.74 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -65.18 -44.55 88.12 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.653 -179.861 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 38.8 p -165.63 154.86 12.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.42 179.582 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.524 ' H ' ' CD ' ' A' ' 42' ' ' GLN . 14.8 mp0 -44.33 101.13 0.24 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.676 179.528 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -57.29 129.06 32.16 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.421 2.081 . . . . 0.0 112.183 -179.588 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -83.72 -24.76 31.07 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.478 179.619 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.538 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.8 mtm-85 -121.87 134.61 54.87 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-O 121.194 0.521 . . . . 0.0 110.303 -179.99 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 95.9 mt -130.9 133.68 62.73 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.261 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.017 -179.812 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 45.3 t -124.2 130.49 73.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 179.372 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.625 ' OG ' HD12 ' A' ' 117' ' ' LEU . 2.3 m -155.28 166.83 32.34 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.564 179.849 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 66.6 p -124.44 9.16 8.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.5 179.874 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.16 125.43 32.81 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.635 -179.436 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.444 HG11 ' H ' ' A' ' 299' ' ' LEU . 94.0 t -65.88 -44.61 92.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.51 179.967 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.7 m -62.63 -44.31 96.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.615 -179.805 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 51.0 tp -62.26 -41.57 98.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.541 -179.487 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.44 ' O ' HD13 ' A' ' 58' ' ' LEU . 74.2 m -57.59 -44.4 85.36 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.404 -179.36 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.2 -62.22 5.35 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 179.539 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.7 t -48.59 -35.47 13.6 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 -179.939 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.8 mt -61.72 -44.96 95.9 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.153 179.379 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.44 HD13 ' O ' ' A' ' 54' ' ' THR . 9.3 mp -64.85 -41.88 95.35 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.081 0.467 . . . . 0.0 111.368 177.918 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.28 -41.12 98.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.96 -179.139 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.427 ' O ' HG23 ' A' ' 60' ' ' ILE . 8.2 tp -88.58 17.05 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.71 -179.647 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 56.57 84.85 0.08 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.645 -179.991 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.65 58.86 0.09 OUTLIER Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.072 -179.819 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.4 ' HB3' HE21 ' A' ' 85' ' ' GLN . 10.5 Cg_endo -50.66 151.41 10.7 Favored 'Trans proline' 0 C--N 1.297 -2.17 0 C-N-CA 122.767 2.312 . . . . 0.0 112.562 -178.366 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.432 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -108.33 145.49 15.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.325 -179.736 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 97.0 mt -63.84 -44.95 98.28 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.439 -179.785 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.497 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -130.13 134.29 47.22 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.545 -179.791 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.491 ' O ' ' N ' ' A' ' 98' ' ' LEU . 75.3 m -134.59 158.67 43.4 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.878 -179.643 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.31 138.71 16.12 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 179.799 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.476 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.62 -162.97 0.09 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.997 0.427 . . . . 0.0 110.426 -179.924 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.525 HG22 ' CD2' ' A' ' 297' ' ' PHE . 5.9 t -133.78 135.53 43.93 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.209 -179.985 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.494 ' C ' ' O ' ' A' ' 70' ' ' THR . 1.0 OUTLIER 29.5 68.12 0.67 Allowed Pre-proline 0 N--CA 1.464 0.245 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.685 -179.634 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -60.54 145.14 99.31 Favored 'Trans proline' 0 C--N 1.3 -1.98 0 C-N-CA 122.57 2.18 . . . . 0.0 112.236 -178.618 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.529 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 44.9 p-10 -160.23 -32.18 0.06 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.574 179.757 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.536 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 99.1 m-20 -63.96 -39.4 94.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.385 179.999 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -60.47 -48.21 82.78 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.684 -179.351 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.421 ' O ' ' O ' ' A' ' 77' ' ' ALA . 96.6 t -60.09 -24.4 30.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.133 179.584 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.536 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -45.98 173.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.518 179.922 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.575 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.5 p30 -62.28 177.98 0.44 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.649 -179.766 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.551 ' C ' ' H ' ' A' ' 81' ' ' GLY . 35.4 p30 -45.51 85.75 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.93 179.893 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.575 ' N ' ' O ' ' A' ' 78' ' ' ASP . 42.8 tp60 -68.03 13.48 0.08 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.058 0.456 . . . . 0.0 110.111 -179.835 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.551 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 118.41 -22.29 9.57 Favored Glycine 0 CA--C 1.52 0.352 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 179.996 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -108.02 116.5 32.06 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.954 0.407 . . . . 0.0 110.474 179.785 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 76.6 mt -98.86 0.45 44.24 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.442 -179.724 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -92.52 7.23 44.07 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.996 0.427 . . . . 0.0 110.392 -179.689 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.796 ' O ' HG22 ' A' ' 89' ' ' VAL . 88.3 mt-30 -100.1 -27.65 13.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.822 -179.966 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 69.5 t-105 -63.25 -40.91 98.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.916 -179.615 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.56 ' O ' ' N ' ' A' ' 91' ' ' LYS . 66.5 m -77.58 -53.41 7.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.263 -179.405 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -48.46 -50.82 29.81 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.906 -179.302 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.796 HG22 ' O ' ' A' ' 85' ' ' GLN . 15.6 m -68.95 -40.84 81.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 120.959 0.409 . . . . 0.0 110.993 179.829 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.503 ' N ' HG23 ' A' ' 89' ' ' VAL . . . -72.18 -22.95 61.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.806 -179.864 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.56 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.0 tttm -61.77 -45.53 93.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.537 -179.558 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.444 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.6 mm-40 -90.47 -94.99 0.12 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.162 -179.957 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.642 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.9 mtt180 -142.78 59.28 1.43 Allowed 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 179.71 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.463 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.7 pttp 33.53 25.79 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 120.86 0.362 . . . . 0.0 110.235 -179.142 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.642 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.3 tt -47.68 123.5 5.98 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.907 -178.166 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.45 ' O ' HD23 ' A' ' 95' ' ' LEU . 99.0 mm-40 -83.81 -169.91 2.81 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.098 179.952 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.612 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 82.4 mtp180 -74.04 137.04 43.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.251 -179.754 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.491 ' N ' ' O ' ' A' ' 67' ' ' SER . 90.0 mt -86.27 -165.7 1.33 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.658 -179.539 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.535 ' CD2' ' O ' ' A' ' 99' ' ' TYR . 47.9 p90 -168.89 120.05 0.75 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.182 179.981 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.519 ' C ' ' O ' ' A' ' 99' ' ' TYR . 43.6 mm -29.14 121.24 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.994 -179.585 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 114.45 27.17 3.43 Favored Glycine 0 CA--C 1.521 0.441 0 N-CA-C 111.126 -0.789 . . . . 0.0 111.126 -179.578 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.587 ' H ' ' CD ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -144.35 46.26 0.61 Allowed Pre-proline 0 C--N 1.325 -0.498 0 CA-C-O 120.866 0.365 . . . . 0.0 110.412 179.986 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 29.9 Cg_endo -61.94 143.76 95.77 Favored 'Trans proline' 0 C--N 1.297 -2.168 0 C-N-CA 122.702 2.268 . . . . 0.0 112.021 179.993 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.464 ' O ' HG23 ' A' ' 108' ' ' VAL . 26.2 t -173.32 120.06 0.33 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.474 179.82 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.26 -40.49 64.57 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.045 0.45 . . . . 0.0 111.184 179.644 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.25 -40.05 89.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.923 -179.447 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.07 -40.06 95.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.736 -179.844 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 104' ' ' SER . 71.8 t -67.56 -43.95 86.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.863 179.664 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.83 -38.79 92.18 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.631 -179.323 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.444 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.44 -23.34 62.6 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.418 179.799 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.553 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.3 mm-40 -90.53 5.02 49.49 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.699 -179.454 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.553 ' C ' ' O ' ' A' ' 111' ' ' GLN . 10.2 tpt 24.16 63.59 0.41 Allowed Pre-proline 0 N--CA 1.465 0.278 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.874 -179.981 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -77.53 167.1 24.83 Favored 'Trans proline' 0 C--N 1.303 -1.82 0 C-N-CA 122.987 2.458 . . . . 0.0 112.415 -178.779 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.526 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 99.1 m-20 -110.39 -41.97 4.24 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 121.02 0.438 . . . . 0.0 110.131 179.442 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.7 tp -121.65 120.14 33.87 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.344 -0.389 . . . . 0.0 109.957 179.549 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 83.4 mt -112.99 129.14 69.18 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.341 0 CA-C-O 120.943 0.401 . . . . 0.0 110.891 -179.882 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.625 HD12 ' OG ' ' A' ' 48' ' ' SER . 29.7 mt -109.13 132.39 54.16 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 121.108 0.48 . . . . 0.0 110.165 -179.682 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.492 HD12 HG23 ' A' ' 139' ' ' THR . 98.8 mt -119.87 139.07 48.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.697 -179.789 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 85.0 p -72.65 153.75 41.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.579 179.951 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.08 -50.06 75.19 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.616 -179.823 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.0 t -149.64 154.19 38.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.573 179.795 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 170.56 -170.96 43.46 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.954 -0.858 . . . . 0.0 110.954 179.917 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -63.1 -34.14 89.16 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 179.932 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.452 ' O ' ' OD1' ' A' ' 124' ' ' ASP . 44.6 p-10 -86.93 120.23 27.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.805 0.336 . . . . 0.0 110.742 179.97 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.437 ' O ' HD12 ' A' ' 129' ' ' LEU . 40.6 t -63.1 143.58 57.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.431 -179.894 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.524 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.15 -43.27 8.94 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.888 -179.913 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 56.0 tp -62.74 -42.54 99.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.751 -179.858 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.42 -11.97 59.11 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.551 -179.436 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.437 HD12 ' O ' ' A' ' 125' ' ' SER . 84.1 mt -115.26 -23.6 8.86 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.663 -179.85 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . 0.524 ' N ' ' O ' ' A' ' 126' ' ' ALA . 79.0 t80 -51.01 -49.76 59.84 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.52 -179.012 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.3 p-10 -65.99 -42.64 89.51 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.8 0.333 . . . . 0.0 111.11 179.604 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.526 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 88.2 mt-30 -67.02 -37.92 84.99 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.744 179.926 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.414 HD12 HD11 ' A' ' 118' ' ' ILE . 95.2 mt -80.22 -41.56 24.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.983 -179.535 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.3 t -57.16 -44.29 83.33 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.196 -179.219 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.3 m -61.86 -45.33 94.23 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.778 0.323 . . . . 0.0 110.476 179.472 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 92.7 mt -62.23 -43.41 97.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.161 -179.742 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.657 ' HB1' ' HD2' ' A' ' 138' ' ' PRO . . . -169.53 168.23 4.89 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.533 179.866 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.657 ' HD2' ' HB1' ' A' ' 137' ' ' ALA . 51.9 Cg_exo -50.1 113.01 0.84 Allowed 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.29 1.993 . . . . 0.0 112.106 179.437 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.492 HG23 HD12 ' A' ' 118' ' ' ILE . 23.8 m -84.24 127.51 34.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.527 -179.927 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.683 HD13 ' CD2' ' A' ' 37' ' ' HIS . 34.6 tp -117.8 135.94 53.73 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.029 -179.702 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.443 ' O ' ' OD2' ' A' ' 32' ' ' ASP . 81.8 mt -100.17 118.82 47.4 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.36 0 CA-C-O 121.204 0.526 . . . . 0.0 111.231 -179.384 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.428 HD12 HD22 ' A' ' 117' ' ' LEU . 97.8 mt -134.73 132.27 54.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.656 179.629 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.551 HD21 ' CG ' ' A' ' 241' ' ' ASP . 61.0 t30 -66.9 151.19 48.04 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.9 0.381 . . . . 0.0 110.402 179.368 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.521 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 87.9 t80 -85.95 122.45 30.02 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.814 -179.577 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.521 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 98.8 m-20 55.16 69.3 0.75 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.87 179.725 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 35.2 p-10 -125.84 0.08 7.34 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.722 179.907 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -150.53 115.36 5.27 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.679 -179.463 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 84.0 p -63.61 168.54 4.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.526 -179.744 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.423 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.4 p-90 -52.01 -15.72 0.61 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.555 -179.861 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.444 ' O ' HG23 ' A' ' 154' ' ' THR . 67.9 tp60 -70.5 -76.32 0.1 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.446 -179.737 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.449 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.1 t -62.64 -38.46 90.36 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.379 179.488 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 53.6 tp -60.07 -45.57 92.46 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.419 -178.668 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.423 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 47.3 tp -62.82 -41.79 99.45 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.845 0.355 . . . . 0.0 110.3 179.101 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.449 ' OG1' ' O ' ' A' ' 151' ' ' SER . 63.3 p -64.07 -34.61 78.42 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.335 -179.615 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.423 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.3 mm-40 -64.14 -42.85 96.63 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.264 179.247 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 92.4 mt -65.4 -39.0 91.65 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.989 0.423 . . . . 0.0 110.21 179.159 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.587 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.01 -32.13 79.12 Favored Glycine 0 CA--C 1.521 0.426 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 -179.358 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.442 ' C ' ' O ' ' A' ' 157' ' ' GLY . 97.3 mt-10 -35.45 -26.84 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.799 0.333 . . . . 0.0 110.731 179.968 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.587 ' N ' ' O ' ' A' ' 157' ' ' GLY . 95.8 mt -56.87 149.64 3.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.211 179.376 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 72.4 p -69.55 137.12 52.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.031 -179.587 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 71.77 20.26 78.57 Favored Glycine 0 N--CA 1.459 0.197 0 N-CA-C 111.239 -0.744 . . . . 0.0 111.239 179.487 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 57.6 m80 -121.97 -15.09 7.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.731 0.3 . . . . 0.0 110.622 179.928 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -65.74 -59.88 3.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.807 -179.741 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -52.03 -49.13 64.01 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.225 -179.717 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -60.71 -41.22 94.79 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.701 0.286 . . . . 0.0 110.308 179.411 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.39 -47.25 86.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.7 179.779 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.9 -40.24 75.93 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.261 -179.92 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -61.74 -50.15 73.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.561 179.57 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 60.1 ttt85 -65.31 -43.88 89.66 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.462 179.535 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 96.0 mt -64.44 -43.63 96.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.449 179.671 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.18 -50.97 71.19 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.608 -179.148 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -63.76 -43.83 95.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.378 179.803 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.657 ' CE2' HD11 ' A' ' 177' ' ' LEU . 56.7 t80 -62.71 -44.53 95.99 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.071 0.462 . . . . 0.0 110.447 179.388 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -63.25 -40.13 96.57 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.435 -179.294 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -62.92 -42.75 99.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.648 179.292 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -60.6 -44.88 95.78 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.116 179.961 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.657 HD11 ' CE2' ' A' ' 173' ' ' PHE . 85.5 mt -64.37 -41.09 96.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.001 0.429 . . . . 0.0 110.692 178.867 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.02 -62.17 1.8 Allowed 'General case' 0 C--O 1.237 0.416 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.491 -179.349 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.94 -46.66 87.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.523 179.902 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.38 -41.69 66.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.15 179.999 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -63.79 -33.67 76.18 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.944 0.402 . . . . 0.0 110.354 179.272 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.424 ' HG2' ' O ' ' A' ' 182' ' ' GLU . 69.6 tt0 -90.48 8.71 32.44 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.25 0.547 . . . . 0.0 110.565 -179.099 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -104.81 -32.26 8.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.232 179.676 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 45.4 pt -128.07 147.49 32.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.826 -179.879 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -139.73 131.02 26.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.335 179.436 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.596 HD22 ' N ' ' A' ' 186' ' ' LEU . 3.5 mm? -85.5 133.66 41.71 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.776 179.994 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -44.16 157.74 0.15 Allowed 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.793 2.329 . . . . 0.0 112.053 179.47 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 0.532 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.7 Cg_endo -62.92 114.88 2.62 Favored 'Trans proline' 0 C--N 1.303 -1.867 0 C-N-CA 122.727 2.284 . . . . 0.0 111.833 179.908 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . 0.532 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.7 mt-30 155.54 148.23 0.0 OUTLIER Pre-proline 0 N--CA 1.454 -0.238 0 O-C-N 123.438 0.461 . . . . 0.0 110.686 -179.761 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -74.13 144.18 33.3 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.736 2.291 . . . . 0.0 111.687 178.165 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.499 HG23 ' OG ' ' A' ' 258' ' ' SER . 2.1 p -124.99 158.82 32.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.195 0.521 . . . . 0.0 110.146 -179.954 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . 0.497 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 35.8 p -143.39 165.2 28.18 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.08 -179.526 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . 0.444 ' HA ' ' H ' ' A' ' 260' ' ' PHE . . . -135.45 128.48 31.55 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.145 0.498 . . . . 0.0 110.188 179.677 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.507 HD11 HD23 ' A' ' 259' ' ' LEU . 47.6 pt -146.52 149.09 16.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.068 179.88 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . 0.74 HG13 ' CD1' ' A' ' 262' ' ' PHE . 69.0 t -117.86 123.03 71.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.236 0.541 . . . . 0.0 109.733 179.08 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -134.15 106.86 7.39 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.288 179.79 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 95.1 m -130.62 130.52 44.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.77 179.751 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -83.18 -36.58 24.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.215 179.804 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.61 -66.99 0.27 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.398 179.878 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.68 -9.36 58.53 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.313 179.487 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 60.5 t-80 60.5 58.56 2.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.856 -179.952 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 37.1 p -167.29 153.64 8.08 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.526 179.512 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.52 144.09 24.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.967 0.413 . . . . 0.0 110.431 179.376 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -135.12 138.2 43.53 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.925 0.393 . . . . 0.0 110.671 -179.994 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 19.4 mt -106.39 125.52 51.1 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 121.117 0.484 . . . . 0.0 109.794 -179.738 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 206' ' ' TRP . . . . . 0.562 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 74.8 m95 -81.85 166.94 19.52 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.641 -179.808 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . 0.473 HG22 ' C ' ' A' ' 206' ' ' TRP . 0.1 OUTLIER -156.84 171.4 7.48 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.942 0.401 . . . . 0.0 110.569 -179.288 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -53.83 -37.2 84.8 Favored 'Trans proline' 0 C--N 1.303 -1.838 0 C-N-CA 122.603 2.202 . . . . 0.0 111.97 179.352 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -70.21 -35.19 73.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.923 -179.875 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 21.7 m -61.05 150.79 32.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.601 -179.305 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.59 -37.02 82.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.527 -179.755 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . 0.562 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 54.7 tt0 -64.59 -40.32 95.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.566 179.99 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.51 -43.29 92.67 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 179.833 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -63.56 -43.45 96.99 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.76 0.314 . . . . 0.0 110.335 179.897 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . 0.526 ' SD ' ' HB2' ' A' ' 304' ' ' ALA . 65.4 ttp -59.65 -47.92 83.7 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.37 -179.928 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' A' ' 216' ' ' LEU . 88.2 mt -60.56 -40.71 92.64 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.497 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . 0.459 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.8 tp10 -58.23 -37.95 75.88 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.806 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -65.2 -38.19 89.71 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.849 0.356 . . . . 0.0 110.651 179.679 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 94.6 mt -64.3 -42.77 96.2 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.618 -179.674 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.71 44.87 0.08 OUTLIER Glycine 0 CA--C 1.52 0.387 0 N-CA-C 110.974 -0.85 . . . . 0.0 110.974 -179.996 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . 0.459 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 26.8 m-85 -128.04 155.71 43.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.087 0.47 . . . . 0.0 110.452 -179.843 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.49 ' O ' HG13 ' A' ' 191' ' ' VAL . 7.1 p -107.44 122.46 46.67 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 121.138 0.494 . . . . 0.0 110.205 -179.933 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.475 HD22 ' C ' ' A' ' 222' ' ' THR . 4.3 mm? -101.39 132.94 46.7 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.048 -179.991 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.68 159.65 14.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.519 179.876 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.34 115.02 29.55 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.335 179.867 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.496 ' N ' HD12 ' A' ' 226' ' ' LEU . 8.9 mp -53.0 156.71 3.31 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.665 179.953 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -60.65 145.61 98.56 Favored 'Trans proline' 0 C--N 1.302 -1.917 0 C-N-CA 122.599 2.199 . . . . 0.0 111.989 179.455 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.34 -3.43 59.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.502 -179.987 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -89.97 -41.21 5.66 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 111.011 -0.836 . . . . 0.0 111.011 -179.855 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.54 ' O ' ' N ' ' A' ' 233' ' ' SER . 70.0 mt -78.91 -17.57 55.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.951 0.405 . . . . 0.0 110.329 -179.845 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . 0.403 ' C ' ' O ' ' A' ' 230' ' ' LEU . 55.2 t-20 -39.97 -49.31 2.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.742 -179.505 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -88.05 15.41 7.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.797 0.332 . . . . 0.0 111.21 -179.996 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.54 ' N ' ' O ' ' A' ' 230' ' ' LEU . 78.1 p -60.45 -35.68 76.44 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.53 -179.862 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . 0.527 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.6 tt0 -118.66 -69.32 0.86 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.961 179.591 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.2 m -69.81 103.22 2.12 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.744 -179.785 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -94.66 57.53 2.2 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.392 179.953 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -144.72 -122.66 1.59 Allowed Glycine 0 CA--C 1.521 0.418 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 -179.972 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -134.73 111.5 10.0 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.075 0.464 . . . . 0.0 110.494 179.975 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . 0.521 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.6 mtt180 -148.03 57.49 1.09 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.682 -179.9 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -69.48 -32.21 70.97 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.522 179.654 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . 0.551 ' CG ' HD21 ' A' ' 143' ' ' ASN . 64.6 t0 -56.89 -47.04 81.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.369 -179.18 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 242' ' ' ILE . . . . . 0.441 ' O ' ' O ' ' A' ' 239' ' ' ARG . 18.0 tt -139.83 156.56 25.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.824 0.345 . . . . 0.0 110.584 179.807 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.442 HG22 HD13 ' A' ' 245' ' ' LEU . 96.1 mt -106.27 106.45 20.62 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.212 0 CA-C-O 121.09 0.472 . . . . 0.0 110.569 179.858 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . 0.606 ' O ' HD12 ' A' ' 245' ' ' LEU . 88.2 mt-30 -110.36 110.06 20.71 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.279 179.804 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.606 HD12 ' O ' ' A' ' 244' ' ' GLN . 9.3 mp -121.89 -168.43 1.7 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.65 179.923 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . 0.527 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.68 -16.37 0.05 OUTLIER Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 179.865 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . 0.676 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -60.91 156.48 32.61 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 -179.892 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -63.31 21.28 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.967 0.413 . . . . 0.0 110.569 179.952 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . 0.676 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.8 m-20 -96.99 -6.2 36.01 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.551 -179.996 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 93.8 mt -79.5 -22.22 44.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.636 179.545 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.51 -51.31 70.42 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.756 -179.49 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.1 -5.85 58.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.402 179.704 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -80.93 -74.63 1.13 Allowed Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 -179.902 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 83.6 mt -70.08 126.03 28.49 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.03 0.443 . . . . 0.0 110.246 -179.885 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -59.19 -39.39 82.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.238 -179.691 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 82.89 51.84 4.08 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 179.929 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -96.46 -14.22 22.54 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.734 0.302 . . . . 0.0 110.658 -179.822 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . 0.499 ' OG ' HG23 ' A' ' 191' ' ' VAL . 3.5 t 174.16 88.47 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.075 0.464 . . . . 0.0 110.168 179.934 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.863 ' N ' HD12 ' A' ' 259' ' ' LEU . 1.0 OUTLIER -94.11 123.93 37.8 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.204 0.526 . . . . 0.0 111.073 -179.206 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 260' ' ' PHE . . . . . 0.444 ' H ' ' HA ' ' A' ' 193' ' ' ALA . 16.0 m-30 -92.76 146.42 23.66 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.356 179.175 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 87.0 mt -122.35 149.57 43.59 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.512 -179.917 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.74 ' CD1' HG13 ' A' ' 195' ' ' VAL . 2.5 p90 -77.64 -138.43 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.484 -179.808 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . 0.663 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -51.97 77.51 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.965 -179.945 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . 0.636 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.07 104.36 0.18 Allowed Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.674 -0.971 . . . . 0.0 110.674 -179.937 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 265' ' ' ASP . . . . . 0.608 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.9 m-20 -80.48 -177.74 6.35 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.743 0.306 . . . . 0.0 110.878 -179.477 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -40.43 -17.66 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.503 179.769 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . 0.608 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.49 -51.6 41.5 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.965 0.412 . . . . 0.0 110.742 179.434 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -63.81 -46.63 84.25 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.196 179.373 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . 0.568 ' HB1' ' OH ' ' A' ' 273' ' ' TYR . . . -61.58 -35.18 77.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.152 -0.477 . . . . 0.0 109.808 179.527 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -62.91 -34.64 77.87 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.164 179.624 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.32 -43.35 13.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.243 -179.535 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 272' ' ' ILE . . . . . 0.584 ' C ' ' H ' ' A' ' 274' ' ' ALA . 4.9 tt -51.53 -33.65 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.72 -178.712 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 273' ' ' TYR . . . . . 0.568 ' OH ' ' HB1' ' A' ' 269' ' ' ALA . 17.4 m-85 -54.23 -1.85 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.702 -179.705 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 274' ' ' ALA . . . . . 0.584 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.81 -39.49 69.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.848 179.651 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . 0.585 ' O ' ' N ' ' A' ' 279' ' ' ALA . 3.2 p30 -39.45 98.0 0.15 Allowed Pre-proline 0 C--N 1.332 -0.163 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.592 -179.668 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -53.82 -43.17 60.38 Favored 'Trans proline' 0 C--N 1.303 -1.847 0 C-N-CA 122.361 2.04 . . . . 0.0 112.751 -178.881 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 89.0 mt -64.47 -42.87 95.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.178 -179.667 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 90.7 mt -95.68 -1.51 49.94 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.839 -179.413 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 279' ' ' ALA . . . . . 0.585 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.55 -34.84 77.75 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.562 -179.713 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.08 20.03 0.11 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.045 -179.238 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 0.491 HD23 ' HA ' ' A' ' 281' ' ' LEU . 13.9 mt -75.54 120.83 83.44 Favored Pre-proline 0 N--CA 1.452 -0.329 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.389 179.977 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_exo -51.54 -38.97 65.68 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.597 2.198 . . . . 0.0 111.617 179.339 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.78 -50.39 63.64 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.165 179.79 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 75.5 t -61.53 -43.95 97.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 179.424 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -57.7 -41.51 81.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.295 -179.992 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -90.94 0.21 57.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.186 179.641 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt 59.09 43.03 18.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.029 0.442 . . . . 0.0 110.969 179.755 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -94.42 41.74 1.09 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.342 179.856 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 54.0 t -119.03 135.8 58.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.989 0.423 . . . . 0.0 110.299 -179.812 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -132.85 162.7 30.87 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.997 0.427 . . . . 0.0 110.669 -179.635 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.81 155.36 32.72 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.974 0.416 . . . . 0.0 110.72 -179.785 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 81.4 mt -94.05 -1.5 54.34 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.225 -179.745 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 120.89 165.72 12.8 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 -179.795 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 6.9 m -87.28 -62.39 1.51 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.847 0.356 . . . . 0.0 111.04 -179.847 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 295' ' ' GLU . . . . . 0.438 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.8 mm-40 -69.53 -3.94 16.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.625 -179.762 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 27.3 p -77.03 32.63 0.14 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.612 -179.906 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 297' ' ' PHE . . . . . 0.525 ' CD2' HG22 ' A' ' 70' ' ' THR . 70.1 t80 -60.11 -45.97 91.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.549 -179.993 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . 0.612 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.2 mtt85 -81.32 134.13 35.53 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 121.017 0.437 . . . . 0.0 110.51 -179.761 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.444 ' H ' HG11 ' A' ' 51' ' ' VAL . 16.0 tp -114.67 119.52 36.98 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.213 -179.951 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . 0.62 ' H ' ' CB ' ' A' ' 303' ' ' SER . 49.4 p-10 -167.36 -174.41 2.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.523 -179.936 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -48.06 -45.49 32.42 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.183 -179.603 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -65.05 -41.45 95.14 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.062 0.458 . . . . 0.0 110.771 179.019 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . 0.62 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 53.0 p -55.55 -35.94 66.26 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.147 -179.37 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . 0.526 ' HB2' ' SD ' ' A' ' 215' ' ' MET . . . -57.16 -51.6 68.66 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.478 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 90.8 mtp -56.39 -43.57 79.39 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.792 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -66.52 -42.57 87.1 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.84 0.352 . . . . 0.0 110.131 178.78 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 303' ' ' SER . 56.1 t -64.03 -42.92 97.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.229 179.394 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 42.5 tp -59.63 -42.0 91.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.827 -179.626 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -62.86 -39.0 93.06 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 179.58 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 310' ' ' ARG . . . . . 0.437 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.4 ttt85 -63.59 -44.06 95.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.322 179.514 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 87.8 mt -63.3 -42.07 99.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.215 179.58 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -62.89 -33.18 74.76 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.037 179.521 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.95 -23.46 21.55 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.559 -179.866 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.483 HD22 ' CE2' ' A' ' 315' ' ' PHE . 6.8 tt -62.34 -43.18 99.43 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.626 179.977 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 315' ' ' PHE . . . . . 0.483 ' CE2' HD22 ' A' ' 314' ' ' LEU . 91.1 m-85 . . . . . 0 C--O 1.22 -0.471 0 CA-C-O 117.979 -1.01 . . . . 0.0 110.506 179.992 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -99.6 136.5 39.43 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.041 0.448 . . . . 0.0 110.422 -179.906 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.497 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -92.05 178.44 1.72 Allowed Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.63 -179.916 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.497 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.7 Cg_exo -61.62 147.02 96.37 Favored 'Trans proline' 0 C--N 1.3 -2.018 0 C-N-CA 122.801 2.334 . . . . 0.0 112.124 179.784 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.456 ' HE ' HD12 ' A' ' 39' ' ' LEU . 35.3 ptt180 -136.06 142.25 44.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.71 179.771 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -79.56 116.62 19.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.475 179.905 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.45 ' O ' HG23 ' A' ' 30' ' ' ILE . 9.5 tp -110.88 130.36 64.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.512 -179.993 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.3 t -70.83 141.5 51.31 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.528 179.818 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.478 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.4 t0 -139.03 179.46 6.48 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.563 -179.944 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.478 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 78.1 p -74.04 -36.93 64.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.733 179.834 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.7 ttt85 -46.44 -94.57 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.351 -179.573 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -166.97 -26.68 0.02 OUTLIER Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.899 -0.881 . . . . 0.0 110.899 179.945 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 62.0 m -169.19 104.84 0.38 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.849 0.357 . . . . 0.0 110.694 -179.938 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.679 ' CD2' HD13 ' A' ' 140' ' ' LEU . 74.6 t60 -128.36 149.03 50.7 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.005 0.431 . . . . 0.0 110.3 179.941 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.625 HG22 ' N ' ' A' ' 39' ' ' LEU . 98.9 m -131.4 165.9 22.47 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.543 -179.857 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.625 ' N ' HG22 ' A' ' 38' ' ' THR . 81.7 mt -120.64 127.39 52.03 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.481 179.728 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -65.17 -44.51 88.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.706 179.975 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 40.3 p -165.68 154.62 11.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.433 179.728 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.485 ' H ' ' CD ' ' A' ' 42' ' ' GLN . 14.4 mp0 -44.55 101.34 0.25 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.642 179.437 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.25 129.36 33.76 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 C-N-CA 122.345 2.03 . . . . 0.0 112.264 -179.713 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -83.45 -24.92 31.61 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.533 179.536 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.537 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.5 mtm-85 -122.04 134.8 54.79 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-O 121.09 0.471 . . . . 0.0 110.364 -179.946 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.2 mt -130.61 133.57 63.32 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.288 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.959 -179.677 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 45.1 t -124.32 130.48 73.63 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-O 120.863 0.363 . . . . 0.0 110.115 179.238 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.619 ' OG ' HD12 ' A' ' 117' ' ' LEU . 2.4 m -154.85 166.59 33.03 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.527 179.842 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 71.4 p -124.47 8.61 8.38 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.489 179.85 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.22 125.85 33.2 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.611 -179.586 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.421 HG11 ' H ' ' A' ' 299' ' ' LEU . 86.2 t -65.86 -44.54 92.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.568 -179.962 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.9 m -62.65 -44.36 96.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.62 -179.81 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 46.5 tp -62.26 -41.66 98.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.526 -179.439 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.44 ' O ' HD13 ' A' ' 58' ' ' LEU . 76.2 m -57.58 -44.7 85.55 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.443 -179.426 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.0 -62.47 5.18 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 179.626 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.7 t -48.23 -35.62 12.29 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 -179.947 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.8 mt -61.74 -44.67 96.46 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.735 -0.386 . . . . 0.0 111.209 179.467 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.44 HD13 ' O ' ' A' ' 54' ' ' THR . 9.2 mp -65.1 -41.67 94.72 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.27 177.949 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.19 -41.42 99.18 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.966 -179.254 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.432 ' O ' HG23 ' A' ' 60' ' ' ILE . 8.3 tp -88.15 17.41 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.783 -179.637 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 56.46 84.72 0.08 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.674 -179.951 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.8 59.21 0.09 OUTLIER Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.038 -179.79 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.401 ' HB3' HE21 ' A' ' 85' ' ' GLN . 10.0 Cg_endo -51.09 151.28 12.31 Favored 'Trans proline' 0 C--N 1.296 -2.197 0 C-N-CA 122.779 2.319 . . . . 0.0 112.39 -178.228 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.435 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -108.59 145.21 15.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.332 -179.632 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.8 mt -63.77 -45.17 97.96 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.274 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.37 -179.766 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.496 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -129.76 134.38 47.56 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 120.877 0.37 . . . . 0.0 110.587 -179.811 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.492 ' O ' ' N ' ' A' ' 98' ' ' LEU . 73.2 m -134.76 158.76 43.33 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.804 -179.609 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.42 138.76 16.1 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 179.794 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.47 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.79 -162.79 0.08 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.916 0.388 . . . . 0.0 110.516 -179.908 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.532 HG22 ' CD2' ' A' ' 297' ' ' PHE . 6.0 t -133.88 135.46 43.68 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.27 179.996 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.495 ' C ' ' O ' ' A' ' 70' ' ' THR . 1.0 OUTLIER 29.34 68.57 0.64 Allowed Pre-proline 0 N--CA 1.465 0.303 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.637 -179.624 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -61.21 145.67 98.34 Favored 'Trans proline' 0 C--N 1.301 -1.946 0 C-N-CA 122.654 2.236 . . . . 0.0 112.018 -178.344 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.533 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 45.0 p-10 -160.46 -31.26 0.06 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.695 179.75 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.544 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 98.8 m-20 -64.69 -38.97 92.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.47 179.959 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.6 ttt180 -60.99 -48.08 83.48 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.621 -179.347 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.424 ' O ' ' O ' ' A' ' 77' ' ' ALA . 96.7 t -60.22 -24.84 31.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.023 179.631 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.544 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -45.68 172.96 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.497 179.731 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.584 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.4 p30 -62.47 177.83 0.47 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.604 -179.709 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.558 ' C ' ' H ' ' A' ' 81' ' ' GLY . 36.5 p30 -45.05 85.34 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.988 -180.0 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.584 ' N ' ' O ' ' A' ' 78' ' ' ASP . 42.0 tp60 -67.49 13.4 0.07 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.185 -179.892 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.558 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 118.4 -22.45 9.51 Favored Glycine 0 CA--C 1.519 0.319 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 179.951 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -108.03 116.22 31.56 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.986 0.422 . . . . 0.0 110.504 179.848 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 74.7 mt -98.09 0.17 45.61 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.511 -179.725 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -92.48 7.29 43.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.43 -179.815 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.784 ' O ' HG22 ' A' ' 89' ' ' VAL . 88.5 mt-30 -100.2 -26.58 13.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.78 179.981 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.4 t-105 -64.54 -40.76 96.18 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.018 -179.647 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.556 ' O ' ' N ' ' A' ' 91' ' ' LYS . 65.3 m -77.89 -53.84 7.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.131 -179.487 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -47.67 -50.97 23.29 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.982 -179.354 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.784 HG22 ' O ' ' A' ' 85' ' ' GLN . 14.9 m -69.1 -41.14 81.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.101 179.818 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.507 ' N ' HG23 ' A' ' 89' ' ' VAL . . . -71.7 -23.18 61.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.725 -179.876 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.556 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.0 tttm -61.73 -45.78 92.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.469 -179.53 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.443 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.7 mm-40 -90.13 -95.2 0.11 Allowed 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.175 -179.913 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.638 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.9 mtt180 -142.75 59.29 1.43 Allowed 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.755 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.461 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.7 pttp 33.37 26.1 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.169 -179.061 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.638 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.3 tt -48.04 123.41 6.2 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.916 -178.142 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.456 ' O ' HD23 ' A' ' 95' ' ' LEU . 98.9 mm-40 -83.65 -169.64 2.66 Favored 'General case' 0 N--CA 1.455 -0.175 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.198 179.963 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.61 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 82.1 mtp180 -74.4 136.91 42.42 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.282 -179.82 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.492 ' N ' ' O ' ' A' ' 67' ' ' SER . 90.5 mt -85.91 -165.64 1.3 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.743 -179.63 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.537 ' CD2' ' O ' ' A' ' 99' ' ' TYR . 47.7 p90 -169.05 119.76 0.72 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.268 179.99 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.518 ' C ' ' O ' ' A' ' 99' ' ' TYR . 43.3 mm -28.76 120.91 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.017 -179.693 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 114.53 27.09 3.44 Favored Glycine 0 CA--C 1.521 0.415 0 N-CA-C 111.149 -0.78 . . . . 0.0 111.149 -179.544 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.586 ' H ' ' CD ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -144.27 46.33 0.62 Allowed Pre-proline 0 C--N 1.323 -0.57 0 CA-C-O 120.927 0.394 . . . . 0.0 110.499 179.901 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 29.3 Cg_endo -61.92 143.82 95.9 Favored 'Trans proline' 0 C--N 1.297 -2.171 0 C-N-CA 122.7 2.267 . . . . 0.0 111.975 -179.899 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.452 ' O ' HG23 ' A' ' 108' ' ' VAL . 26.2 t -173.3 120.13 0.33 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.445 179.78 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.75 -40.35 63.56 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.065 0.46 . . . . 0.0 111.041 179.744 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.25 -39.98 89.88 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.798 -179.371 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.06 -39.99 95.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.744 -179.824 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 104' ' ' SER . 70.3 t -67.65 -43.77 86.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.753 179.708 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.74 -38.99 92.68 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.561 -179.246 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.443 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.66 -23.4 63.04 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.479 179.863 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.551 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.3 mm-40 -90.18 5.15 48.21 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.713 -179.554 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.551 ' C ' ' O ' ' A' ' 111' ' ' GLN . 10.5 tpt 23.44 64.17 0.38 Allowed Pre-proline 0 N--CA 1.465 0.293 0 CA-C-O 120.859 0.361 . . . . 0.0 110.982 -179.769 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -78.22 167.27 23.45 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 C-N-CA 122.971 2.447 . . . . 0.0 112.082 -178.448 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.523 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 98.8 m-20 -110.04 -42.14 4.28 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.145 179.426 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 41.2 tp -121.19 120.65 35.84 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 179.506 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 83.5 mt -113.29 128.92 69.86 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.343 0 CA-C-O 120.978 0.418 . . . . 0.0 110.88 -179.897 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.619 HD12 ' OG ' ' A' ' 48' ' ' SER . 30.2 mt -109.42 132.27 54.29 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 121.061 0.458 . . . . 0.0 110.218 -179.73 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.49 HD12 HG23 ' A' ' 139' ' ' THR . 98.9 mt -119.8 138.96 48.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.693 -179.718 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 85.8 p -72.75 153.96 40.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.594 -179.949 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.11 -50.21 74.6 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.686 -179.855 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -149.52 153.97 38.02 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.567 179.869 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 170.66 -170.97 43.51 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 179.876 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.88 -34.13 88.97 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 179.912 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.449 ' O ' ' OD1' ' A' ' 124' ' ' ASP . 44.3 p-10 -87.03 120.67 28.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.821 0.343 . . . . 0.0 110.651 179.983 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.446 ' O ' HD12 ' A' ' 129' ' ' LEU . 36.1 t -63.26 143.79 57.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.472 -179.935 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.52 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.12 -43.81 8.68 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.944 -179.898 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 56.0 tp -62.93 -42.44 99.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.748 -179.888 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.28 -11.92 58.77 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.522 -179.421 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.446 HD12 ' O ' ' A' ' 125' ' ' SER . 84.2 mt -115.37 -23.56 8.82 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.637 -179.811 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . 0.52 ' N ' ' O ' ' A' ' 126' ' ' ALA . 79.4 t80 -51.09 -49.46 60.66 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.542 -178.883 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 37.7 p-10 -66.33 -42.61 87.94 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.832 0.349 . . . . 0.0 111.138 179.618 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.519 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 88.2 mt-30 -66.92 -37.53 84.51 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.74 -179.995 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.431 HD12 HD11 ' A' ' 118' ' ' ILE . 96.3 mt -80.63 -41.28 24.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.868 -179.585 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.2 t -57.13 -44.54 83.42 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.269 -179.139 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.3 m -61.93 -45.32 94.22 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.802 0.334 . . . . 0.0 110.566 179.411 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 94.0 mt -62.02 -43.63 97.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.277 -179.836 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.662 ' HB1' ' HD2' ' A' ' 138' ' ' PRO . . . -169.45 168.25 4.94 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.499 179.895 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.662 ' HD2' ' HB1' ' A' ' 137' ' ' ALA . 52.4 Cg_exo -49.95 112.82 0.79 Allowed 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.297 1.998 . . . . 0.0 112.224 179.339 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.49 HG23 HD12 ' A' ' 118' ' ' ILE . 24.0 m -84.36 127.52 34.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.644 -179.968 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.679 HD13 ' CD2' ' A' ' 37' ' ' HIS . 34.7 tp -118.03 136.68 53.39 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.09 -179.781 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.441 ' O ' ' OD2' ' A' ' 32' ' ' ASP . 81.6 mt -100.57 118.83 47.84 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 CA-C-O 121.182 0.515 . . . . 0.0 111.128 -179.319 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.42 HD12 HD22 ' A' ' 117' ' ' LEU . 97.8 mt -134.71 132.14 54.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.669 179.591 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.551 HD21 ' CG ' ' A' ' 241' ' ' ASP . 56.0 t30 -67.56 153.71 43.09 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.893 0.378 . . . . 0.0 110.469 179.38 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.525 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 89.2 t80 -87.51 122.15 30.86 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.861 -179.55 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.525 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 99.0 m-20 55.33 69.5 0.73 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.762 179.651 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 49.5 p-10 -123.84 -0.69 8.48 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.631 179.88 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -151.07 116.14 5.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.712 -179.534 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 83.2 p -62.85 167.88 4.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.474 -179.788 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.417 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.3 p-90 -51.38 -15.81 0.46 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.517 -179.86 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.445 ' O ' HG23 ' A' ' 154' ' ' THR . 68.0 tp60 -70.71 -75.32 0.12 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.493 -179.771 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 11.1 t -62.75 -38.88 92.32 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.366 179.491 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 55.7 tp -59.91 -45.8 91.39 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.422 -178.649 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.417 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 46.8 tp -62.71 -41.63 99.25 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.425 179.057 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.445 HG23 ' O ' ' A' ' 150' ' ' GLN . 60.0 p -64.46 -35.01 79.53 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.31 -179.55 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.432 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.5 mm-40 -64.28 -42.88 96.22 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.383 179.374 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 91.5 mt -65.39 -38.91 91.4 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.072 0.463 . . . . 0.0 110.272 179.166 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.582 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.31 -32.08 79.5 Favored Glycine 0 CA--C 1.52 0.347 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 -179.382 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.44 ' C ' ' O ' ' A' ' 157' ' ' GLY . 97.1 mt-10 -35.25 -27.31 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.816 0.341 . . . . 0.0 110.821 179.894 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.582 ' N ' ' O ' ' A' ' 157' ' ' GLY . 95.1 mt -55.57 150.07 2.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.319 179.263 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 73.9 p -70.13 137.34 50.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.057 -179.59 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 72.26 18.44 78.1 Favored Glycine 0 N--CA 1.458 0.163 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 179.507 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 57.3 m80 -119.8 -15.52 8.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.747 0.308 . . . . 0.0 110.606 179.866 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -63.92 -60.78 2.83 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.655 -179.631 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -51.91 -49.42 63.09 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.201 -179.666 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -60.27 -41.24 92.9 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.752 0.31 . . . . 0.0 110.348 179.539 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.49 -47.2 86.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.576 179.851 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.94 -40.17 75.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.259 -179.894 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -61.88 -50.2 73.16 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.578 179.595 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -65.39 -43.73 89.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.492 179.532 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 95.0 mt -64.73 -43.38 96.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.488 179.739 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.36 -51.12 70.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.533 -179.215 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.46 -43.95 95.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.464 179.732 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.656 ' CE2' HD11 ' A' ' 177' ' ' LEU . 56.2 t80 -62.83 -44.45 96.1 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.085 0.469 . . . . 0.0 110.44 179.451 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -63.51 -39.98 95.85 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.566 -179.337 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -62.94 -42.77 99.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.64 179.259 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -60.73 -45.07 95.68 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.172 179.945 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.656 HD11 ' CE2' ' A' ' 173' ' ' PHE . 84.4 mt -64.61 -41.06 96.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.036 0.446 . . . . 0.0 110.693 178.918 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -51.93 -62.61 1.52 Allowed 'General case' 0 C--O 1.237 0.441 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.473 -179.343 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.89 -46.58 87.51 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.664 179.767 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.31 -41.77 65.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.281 179.939 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -63.85 -33.84 76.59 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.969 0.414 . . . . 0.0 110.371 179.256 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.425 ' HG2' ' O ' ' A' ' 182' ' ' GLU . 69.5 tt0 -90.47 9.06 30.75 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.37 0.605 . . . . 0.0 110.516 -178.998 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -105.06 -31.99 8.92 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.202 179.555 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.4 pt -128.11 147.52 32.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.828 -179.873 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -140.06 131.14 26.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.423 179.358 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.597 HD22 ' N ' ' A' ' 186' ' ' LEU . 3.6 mm? -85.63 133.08 42.61 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.844 -179.947 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -44.0 157.78 0.14 Allowed 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.714 2.276 . . . . 0.0 112.153 179.341 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 0.524 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.6 Cg_endo -62.78 115.23 2.8 Favored 'Trans proline' 0 C--N 1.304 -1.81 0 C-N-CA 122.775 2.317 . . . . 0.0 111.808 179.772 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . 0.524 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.8 mt-30 155.61 147.52 0.0 OUTLIER Pre-proline 0 C--N 1.332 -0.169 0 O-C-N 123.618 0.574 . . . . 0.0 110.782 -179.791 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -73.76 143.43 33.56 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.659 2.239 . . . . 0.0 111.956 177.983 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.499 HG23 ' OG ' ' A' ' 258' ' ' SER . 2.0 p -124.81 159.02 31.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.276 0.56 . . . . 0.0 110.189 179.959 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . 0.497 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 35.7 p -143.48 165.47 27.47 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.094 -179.638 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . 0.443 ' HA ' ' H ' ' A' ' 260' ' ' PHE . . . -135.34 128.43 31.69 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 121.128 0.49 . . . . 0.0 110.24 179.576 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.509 HD11 HD23 ' A' ' 259' ' ' LEU . 47.8 pt -146.35 148.79 16.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.046 179.986 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . 0.746 HG13 ' CD1' ' A' ' 262' ' ' PHE . 70.3 t -117.6 122.89 70.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.222 0.534 . . . . 0.0 109.734 179.122 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -134.06 107.37 7.72 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.261 179.77 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 94.6 m -131.11 130.45 43.15 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.797 179.784 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.412 ' O ' ' N ' ' A' ' 201' ' ' HIS . . . -82.74 -37.24 24.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.275 179.692 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.32 -67.02 0.26 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.366 -179.973 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.31 -9.76 58.91 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.316 179.425 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . 0.412 ' N ' ' O ' ' A' ' 198' ' ' ALA . 59.7 t-80 60.54 58.27 2.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.628 -179.902 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 45.7 p -166.92 153.26 8.34 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.527 179.611 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.36 144.16 24.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.976 0.417 . . . . 0.0 110.442 179.488 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -135.34 138.1 43.05 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.63 -179.941 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 20.2 mt -106.28 125.56 51.15 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 121.116 0.484 . . . . 0.0 109.934 -179.701 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 206' ' ' TRP . . . . . 0.558 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 75.4 m95 -82.25 167.18 18.9 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.649 -179.727 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . 0.467 HG22 ' C ' ' A' ' 206' ' ' TRP . 0.1 OUTLIER -156.88 171.56 7.27 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 120.943 0.402 . . . . 0.0 110.563 -179.194 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_exo -53.94 -36.89 85.2 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 C-N-CA 122.659 2.24 . . . . 0.0 112.16 179.256 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -70.55 -34.93 72.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.761 -179.772 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 21.9 m -61.56 150.54 35.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.543 -179.27 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.42 -36.97 81.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.457 -179.732 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . 0.558 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 54.4 tt0 -64.5 -40.28 95.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.472 179.967 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.87 -43.27 91.91 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 179.812 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -63.55 -43.46 97.03 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.752 0.31 . . . . 0.0 110.29 179.807 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . 0.519 ' SD ' ' HB2' ' A' ' 304' ' ' ALA . 65.3 ttp -59.49 -48.25 82.36 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.234 -179.809 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 216' ' ' LEU . 88.4 mt -60.37 -40.8 92.12 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.536 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . 0.457 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.4 tp10 -57.99 -37.93 75.17 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 179.751 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -65.22 -37.94 88.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.847 0.356 . . . . 0.0 110.676 179.68 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 94.1 mt -64.47 -42.73 95.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.582 -179.645 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.59 44.59 0.08 OUTLIER Glycine 0 C--N 1.334 0.426 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 -179.921 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . 0.457 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 26.3 m-85 -127.73 155.22 44.34 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.033 0.445 . . . . 0.0 110.49 -179.82 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.484 ' O ' HG13 ' A' ' 191' ' ' VAL . 6.6 p -106.94 122.06 45.68 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.189 0.519 . . . . 0.0 110.198 -179.961 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.467 HD22 ' C ' ' A' ' 222' ' ' THR . 4.3 mm? -100.81 133.46 45.24 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.101 -179.97 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -97.24 158.76 15.29 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.44 179.916 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -104.84 115.21 29.92 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.384 179.898 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.496 ' N ' HD12 ' A' ' 226' ' ' LEU . 9.1 mp -53.32 156.57 3.95 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.705 179.86 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -60.26 145.38 98.7 Favored 'Trans proline' 0 C--N 1.301 -1.943 0 C-N-CA 122.711 2.274 . . . . 0.0 112.119 179.218 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.46 -2.89 58.93 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.557 -179.992 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.32 -40.83 5.65 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 111.029 -0.828 . . . . 0.0 111.029 -179.887 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.543 ' O ' ' N ' ' A' ' 233' ' ' SER . 86.0 mt -79.28 -16.89 55.7 Favored 'General case' 0 C--O 1.224 -0.257 0 CA-C-O 121.018 0.437 . . . . 0.0 110.356 -179.755 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . 0.405 ' C ' ' O ' ' A' ' 230' ' ' LEU . 54.6 t-20 -40.05 -49.23 2.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.691 -179.592 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -88.28 15.43 7.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.813 0.339 . . . . 0.0 111.277 179.935 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.543 ' N ' ' O ' ' A' ' 230' ' ' LEU . 78.1 p -60.48 -35.63 76.36 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.648 -179.77 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . 0.525 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.6 tt0 -118.25 -69.43 0.85 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.954 179.588 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 3.9 m -70.16 103.45 2.33 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.691 -179.744 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -94.59 57.74 2.26 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.345 180.0 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -144.99 -122.57 1.56 Allowed Glycine 0 CA--C 1.519 0.343 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 -179.977 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -134.41 111.85 10.48 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.094 0.473 . . . . 0.0 110.413 179.964 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . 0.513 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.4 mtt180 -148.11 57.39 1.08 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.762 -179.972 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -69.71 -31.89 70.15 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.511 179.664 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . 0.551 ' CG ' HD21 ' A' ' 143' ' ' ASN . 65.1 t0 -56.71 -46.99 80.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.404 -179.167 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 242' ' ' ILE . . . . . 0.436 ' O ' ' O ' ' A' ' 239' ' ' ARG . 17.4 tt -140.33 157.27 24.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.886 0.374 . . . . 0.0 110.524 179.748 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.444 HG22 HD13 ' A' ' 245' ' ' LEU . 96.0 mt -106.01 106.08 19.9 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.191 0 CA-C-O 121.125 0.488 . . . . 0.0 110.465 179.886 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . 0.602 ' O ' HD12 ' A' ' 245' ' ' LEU . 88.2 mt-30 -110.36 110.17 20.86 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.392 179.755 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.602 HD12 ' O ' ' A' ' 244' ' ' GLN . 9.5 mp -121.9 -168.19 1.66 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.641 179.774 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . 0.525 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.25 -16.66 0.05 OUTLIER Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.956 -0.857 . . . . 0.0 110.956 179.894 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . 0.67 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -60.46 157.03 29.73 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 -179.83 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -63.82 21.43 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.971 0.415 . . . . 0.0 110.58 179.945 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . 0.67 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.7 m-20 -97.18 -5.93 35.94 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.544 179.983 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 92.6 mt -80.2 -21.58 42.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.604 179.589 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.54 -51.24 70.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.728 -179.579 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.76 -5.33 58.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.481 179.659 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.16 -74.45 1.14 Allowed Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.911 -0.875 . . . . 0.0 110.911 -179.96 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 81.7 mt -69.89 125.93 28.2 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.977 0.418 . . . . 0.0 110.329 -179.859 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -59.22 -39.49 82.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.295 -179.711 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 82.64 51.93 4.11 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 179.95 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -96.22 -14.89 22.36 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.644 0.259 . . . . 0.0 110.541 -179.864 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . 0.499 ' OG ' HG23 ' A' ' 191' ' ' VAL . 3.5 t 174.78 88.55 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.029 0.442 . . . . 0.0 110.194 179.978 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.86 ' N ' HD12 ' A' ' 259' ' ' LEU . 0.9 OUTLIER -94.18 124.08 37.97 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.241 0.544 . . . . 0.0 111.066 -179.058 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 260' ' ' PHE . . . . . 0.443 ' H ' ' HA ' ' A' ' 193' ' ' ALA . 15.9 m-30 -93.03 146.45 23.62 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.342 179.17 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 86.1 mt -122.41 149.82 43.29 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.529 -179.905 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.746 ' CD1' HG13 ' A' ' 195' ' ' VAL . 2.6 p90 -77.63 -138.36 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.562 -179.838 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . 0.66 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -52.1 77.45 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.993 -179.989 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . 0.633 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -178.98 104.42 0.19 Allowed Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 -179.976 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 265' ' ' ASP . . . . . 0.602 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.8 m-20 -80.47 -177.74 6.35 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 120.725 0.298 . . . . 0.0 110.896 -179.527 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -40.39 -17.71 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.853 0.358 . . . . 0.0 110.552 179.786 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . 0.602 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.71 -51.42 41.75 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.688 179.516 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -63.74 -46.83 83.59 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.175 179.314 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . 0.573 ' HB1' ' OH ' ' A' ' 273' ' ' TYR . . . -61.47 -35.05 76.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.111 0.481 . . . . 0.0 109.884 179.533 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -63.22 -34.42 77.62 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.119 179.712 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.36 -43.37 13.73 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.171 -179.572 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 272' ' ' ILE . . . . . 0.589 ' C ' ' H ' ' A' ' 274' ' ' ALA . 5.0 tt -51.37 -33.83 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.893 -178.824 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 273' ' ' TYR . . . . . 0.573 ' OH ' ' HB1' ' A' ' 269' ' ' ALA . 17.2 m-85 -54.24 -1.82 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.647 -179.638 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 274' ' ' ALA . . . . . 0.589 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.58 -39.43 70.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.87 179.603 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . 0.583 ' O ' ' N ' ' A' ' 279' ' ' ALA . 3.0 p30 -39.65 98.33 0.17 Allowed Pre-proline 0 N--CA 1.462 0.143 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.506 -179.638 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -54.16 -43.11 61.39 Favored 'Trans proline' 0 C--N 1.304 -1.812 0 C-N-CA 122.389 2.06 . . . . 0.0 112.619 -178.793 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 89.3 mt -64.45 -42.86 95.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.109 -179.613 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 91.0 mt -95.7 -1.64 49.57 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.872 -179.373 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 279' ' ' ALA . . . . . 0.583 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.35 -34.75 77.27 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.678 -179.85 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.4 20.1 0.12 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.966 -179.212 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 0.489 HD23 ' HA ' ' A' ' 281' ' ' LEU . 13.9 mt -75.19 120.04 79.8 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.505 179.916 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -50.69 -39.48 56.73 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.577 2.185 . . . . 0.0 111.951 179.035 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.8 -50.56 63.38 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.132 179.885 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 74.5 t -61.45 -43.79 97.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.482 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -57.98 -41.22 82.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.28 -179.972 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -90.9 0.14 57.58 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.145 179.575 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt 59.55 43.04 16.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.82 179.568 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -94.66 41.49 1.09 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.38 179.852 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 53.6 t -118.79 136.02 57.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.999 0.428 . . . . 0.0 110.193 -179.759 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -133.17 162.73 30.98 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.665 -179.639 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.9 155.22 33.13 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.968 0.413 . . . . 0.0 110.735 -179.86 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 81.0 mt -93.89 -1.49 54.69 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.235 -179.803 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.06 165.66 12.74 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.689 -0.965 . . . . 0.0 110.689 -179.735 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 6.8 m -87.15 -62.3 1.53 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.892 0.377 . . . . 0.0 111.009 -179.888 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 295' ' ' GLU . . . . . 0.436 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.6 mm-40 -69.57 -3.88 16.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.628 -179.833 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 28.1 p -77.09 32.91 0.14 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.618 -179.96 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 297' ' ' PHE . . . . . 0.532 ' CD2' HG22 ' A' ' 70' ' ' THR . 70.2 t80 -60.19 -46.06 91.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.546 -179.971 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . 0.61 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.3 mtt85 -81.49 134.01 35.47 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.45 -179.652 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.421 ' H ' HG11 ' A' ' 51' ' ' VAL . 16.1 tp -114.31 119.75 38.06 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.253 179.924 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . 0.625 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.4 p-10 -167.8 -173.9 2.27 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.524 179.95 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 84.0 t80 -48.25 -46.0 35.11 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.227 -179.644 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -64.65 -41.61 96.0 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.998 0.428 . . . . 0.0 110.702 179.015 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . 0.625 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 52.0 p -55.44 -36.11 66.17 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.099 -179.269 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . 0.519 ' HB2' ' SD ' ' A' ' 215' ' ' MET . . . -56.92 -51.76 67.87 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.482 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 91.5 mtp -56.06 -43.87 78.32 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.8 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -66.38 -42.74 87.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.953 0.406 . . . . 0.0 110.207 178.798 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 303' ' ' SER . 55.2 t -64.04 -42.89 97.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.261 179.39 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 42.8 tp -59.62 -42.04 91.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.893 -179.616 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -62.87 -38.76 92.12 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.064 179.475 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 310' ' ' ARG . . . . . 0.435 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.6 ttt85 -63.5 -44.03 95.52 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.238 179.569 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 88.5 mt -63.23 -41.93 99.17 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.226 179.548 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -62.9 -33.23 74.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.083 179.492 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.85 -23.51 21.65 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.423 -179.862 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.479 HD22 ' CE2' ' A' ' 315' ' ' PHE . 6.7 tt -62.33 -43.22 99.33 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 121.06 0.457 . . . . 0.0 110.57 -179.92 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 315' ' ' PHE . . . . . 0.479 ' CE2' HD22 ' A' ' 314' ' ' LEU . 91.0 m-85 . . . . . 0 C--O 1.22 -0.498 0 CA-C-O 118.003 -0.999 . . . . 0.0 110.482 179.966 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -99.51 135.79 40.4 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.464 -179.926 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.498 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -92.11 178.48 1.69 Allowed Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.532 -179.863 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.498 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.7 Cg_exo -61.54 147.16 96.1 Favored 'Trans proline' 0 C--N 1.301 -1.961 0 C-N-CA 122.696 2.264 . . . . 0.0 112.161 179.576 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.487 ' HE ' HD12 ' A' ' 39' ' ' LEU . 35.4 ptt180 -136.33 142.39 43.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.624 179.692 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -79.7 116.78 20.08 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.453 179.872 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.46 ' O ' HG23 ' A' ' 30' ' ' ILE . 9.4 tp -111.54 130.11 65.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.46 179.969 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 14.4 t -71.14 141.7 50.75 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.599 179.81 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.478 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.1 t0 -138.71 -179.73 5.99 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.524 179.997 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.478 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 78.3 p -73.72 -37.51 65.1 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.856 179.84 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -46.64 -94.74 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.313 -179.411 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -166.24 -26.76 0.02 OUTLIER Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 179.919 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 63.7 m -168.42 105.72 0.46 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.857 0.361 . . . . 0.0 110.603 -179.968 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.646 ' CD2' HD13 ' A' ' 140' ' ' LEU . 68.2 t60 -128.87 146.43 50.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.038 0.447 . . . . 0.0 110.324 179.97 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.62 HG22 ' N ' ' A' ' 39' ' ' LEU . 100.0 m -129.82 165.6 21.63 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.608 -179.928 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.62 ' N ' HG22 ' A' ' 38' ' ' THR . 80.5 mt -120.3 127.37 52.3 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.466 179.683 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -65.56 -44.53 86.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.605 -179.978 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 40.8 p -165.91 154.88 11.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.456 179.743 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.482 ' H ' ' CD ' ' A' ' 42' ' ' GLN . 14.5 mp0 -45.4 101.64 0.27 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.658 179.443 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -57.66 129.83 35.65 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 C-N-CA 122.294 1.996 . . . . 0.0 112.263 -179.759 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -82.84 -24.92 33.06 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.472 179.593 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.537 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.7 mtm-85 -120.73 134.34 55.29 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 121.125 0.488 . . . . 0.0 110.264 -179.931 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.1 mt -130.23 133.29 64.33 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.091 -179.85 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 47.3 t -124.79 130.96 73.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 179.404 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.621 ' OG ' HD12 ' A' ' 117' ' ' LEU . 4.4 m -155.19 166.48 33.45 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.578 179.666 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 62.4 p -124.53 8.94 8.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.411 -179.981 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.1 t -85.38 125.53 33.05 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.655 -179.467 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.457 HG11 ' H ' ' A' ' 299' ' ' LEU . 90.8 t -65.72 -44.64 93.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.542 179.961 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.7 m -62.62 -44.39 96.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.655 -179.862 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 53.5 tp -62.18 -41.66 98.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.659 -179.459 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.465 ' O ' HD13 ' A' ' 58' ' ' LEU . 74.7 m -57.63 -44.54 85.65 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.384 -179.426 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.36 -61.98 5.52 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.941 -0.863 . . . . 0.0 110.941 179.561 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.7 t -48.48 -35.7 13.56 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 -179.979 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.9 mt -61.76 -44.56 96.65 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.644 -0.422 . . . . 0.0 111.136 179.344 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.465 HD13 ' O ' ' A' ' 54' ' ' THR . 9.4 mp -64.72 -42.07 95.5 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.329 177.961 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.405 ' HB1' ' NE ' ' A' ' 169' ' ' ARG . . . -63.54 -41.16 98.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.086 -179.197 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.43 ' O ' HG23 ' A' ' 60' ' ' ILE . 8.1 tp -88.04 16.76 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.735 -179.668 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 56.62 83.78 0.1 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.631 179.972 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.71 57.02 0.07 OUTLIER Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.049 -179.815 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.413 ' HB3' HE21 ' A' ' 85' ' ' GLN . 9.9 Cg_endo -49.54 153.15 5.51 Favored 'Trans proline' 0 C--N 1.296 -2.21 0 C-N-CA 122.811 2.341 . . . . 0.0 112.638 -178.559 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.432 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -109.03 146.26 14.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.371 -179.734 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 97.0 mt -63.9 -44.86 98.13 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.298 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.488 -179.885 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.502 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -130.27 134.61 47.35 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.512 -179.774 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.485 ' O ' ' N ' ' A' ' 98' ' ' LEU . 72.2 m -134.52 158.6 43.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.859 -179.663 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.55 139.24 16.39 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 110.671 -0.972 . . . . 0.0 110.671 179.848 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.488 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.88 -162.67 0.08 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.95 0.405 . . . . 0.0 110.535 -179.992 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.511 HG22 ' CD2' ' A' ' 297' ' ' PHE . 5.8 t -133.71 135.81 44.26 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.177 -179.973 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.491 ' C ' ' O ' ' A' ' 70' ' ' THR . 0.9 OUTLIER 29.6 68.33 0.67 Allowed Pre-proline 0 N--CA 1.465 0.291 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.713 -179.689 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -60.64 145.23 99.21 Favored 'Trans proline' 0 C--N 1.3 -2.009 0 C-N-CA 122.576 2.184 . . . . 0.0 112.167 -178.566 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.523 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 46.2 p-10 -160.65 -31.97 0.05 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.674 179.74 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.529 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 98.8 m-20 -64.31 -38.96 92.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.367 179.973 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -61.15 -47.88 84.15 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.636 -179.236 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.423 ' O ' ' O ' ' A' ' 77' ' ' ALA . 94.4 t -60.21 -24.56 30.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.659 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.529 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -45.64 172.6 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.535 179.881 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.575 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.8 p30 -61.68 177.6 0.4 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.653 -179.707 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.566 ' C ' ' H ' ' A' ' 81' ' ' GLY . 36.1 p30 -45.87 85.54 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.97 179.872 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.575 ' N ' ' O ' ' A' ' 78' ' ' ASP . 43.0 tp60 -67.19 13.59 0.06 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.072 0.463 . . . . 0.0 110.12 -179.774 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.566 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 117.72 -22.0 10.2 Favored Glycine 0 C--N 1.331 0.285 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 179.981 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -107.93 116.35 31.8 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.022 0.439 . . . . 0.0 110.518 179.849 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 75.8 mt -98.8 0.57 44.63 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.516 -179.698 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -91.88 6.61 45.49 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.988 0.423 . . . . 0.0 110.47 -179.707 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.798 ' O ' HG22 ' A' ' 89' ' ' VAL . 88.1 mt-30 -99.89 -28.08 13.28 Favored 'General case' 0 C--O 1.224 -0.266 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.784 179.973 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 68.9 t-105 -63.03 -41.07 99.43 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.913 -179.722 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.556 ' O ' ' N ' ' A' ' 91' ' ' LYS . 67.4 m -77.34 -53.53 7.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.313 -179.441 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -48.4 -50.85 29.22 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.979 -179.337 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.798 HG22 ' O ' ' A' ' 85' ' ' GLN . 15.6 m -68.9 -40.83 81.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 120.914 0.388 . . . . 0.0 111.075 179.748 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.5 ' N ' HG23 ' A' ' 89' ' ' VAL . . . -72.1 -22.96 61.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.775 -179.912 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.556 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.0 tttm -61.35 -45.69 93.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.45 -179.502 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.437 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.7 mm-40 -90.73 -94.34 0.12 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.091 -179.977 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.633 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.9 mtt180 -143.36 59.95 1.4 Allowed 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.81 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.461 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.7 pttp 33.54 26.27 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 120.791 0.329 . . . . 0.0 110.115 -179.291 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.633 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.5 tt -47.97 122.84 5.45 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.995 -178.243 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.447 ' O ' HD23 ' A' ' 95' ' ' LEU . 98.9 mm-40 -83.25 -169.9 2.77 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.016 -179.882 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.614 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 83.0 mtp180 -73.51 137.88 44.7 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.29 -179.813 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.485 ' N ' ' O ' ' A' ' 67' ' ' SER . 89.0 mt -86.81 -166.2 1.5 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.701 -179.519 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.533 ' CD2' ' O ' ' A' ' 99' ' ' TYR . 47.4 p90 -167.97 120.05 0.86 Allowed 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.296 179.939 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.511 ' C ' ' O ' ' A' ' 99' ' ' TYR . 42.9 mm -29.59 121.25 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.939 -179.639 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 113.96 28.13 3.24 Favored Glycine 0 CA--C 1.519 0.341 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 -179.542 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.587 ' H ' ' CD ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -144.02 45.81 0.59 Allowed Pre-proline 0 C--N 1.324 -0.53 0 CA-C-O 120.932 0.396 . . . . 0.0 110.508 179.883 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 30.5 Cg_endo -62.0 143.72 95.5 Favored 'Trans proline' 0 C--N 1.297 -2.152 0 C-N-CA 122.667 2.245 . . . . 0.0 112.033 179.921 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.476 ' O ' HG23 ' A' ' 108' ' ' VAL . 23.1 t -173.43 120.52 0.33 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.404 179.715 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.22 -41.09 64.15 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.057 0.456 . . . . 0.0 111.231 179.652 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -65.93 -40.26 91.26 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.942 -179.412 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.87 -39.87 95.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.699 -179.852 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 104' ' ' SER . 69.5 t -67.39 -43.91 87.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.863 179.627 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.33 -39.0 91.63 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.602 -179.265 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.437 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.58 -23.49 62.96 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.013 0.435 . . . . 0.0 110.505 179.817 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.555 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.4 mm-40 -91.07 4.73 51.37 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.72 -179.5 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.555 ' C ' ' O ' ' A' ' 111' ' ' GLN . 10.6 tpt 23.56 63.85 0.38 Allowed Pre-proline 0 N--CA 1.465 0.32 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.916 179.971 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.445 ' HG2' HD11 ' A' ' 116' ' ' ILE . 69.8 Cg_endo -78.3 168.79 21.12 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 C-N-CA 122.918 2.412 . . . . 0.0 112.344 -178.645 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.525 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 98.9 m-20 -113.15 -44.16 3.29 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.939 179.639 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 39.9 tp -120.71 119.77 33.76 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.619 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.455 HD13 HD22 ' A' ' 133' ' ' LEU . 95.7 mt -116.99 131.14 70.56 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.3 0 CA-C-O 120.909 0.385 . . . . 0.0 110.949 -179.91 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.621 HD12 ' OG ' ' A' ' 48' ' ' SER . 30.7 mt -106.06 132.77 51.74 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 121.104 0.478 . . . . 0.0 110.236 -179.387 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.419 HD12 HG23 ' A' ' 139' ' ' THR . 98.0 mt -118.31 136.37 55.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.699 -179.633 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 85.9 p -71.98 153.22 41.93 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.666 179.978 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.19 -50.1 75.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.625 -179.84 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -149.37 153.82 37.99 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.535 179.823 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 169.67 -170.42 42.71 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 179.837 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -63.01 -35.05 91.57 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 110.824 -0.91 . . . . 0.0 110.824 179.986 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.442 ' O ' ' OD1' ' A' ' 124' ' ' ASP . 43.8 p-10 -87.86 119.9 28.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.797 0.332 . . . . 0.0 110.694 179.933 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.444 ' O ' HD12 ' A' ' 129' ' ' LEU . 40.5 t -63.39 144.17 57.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.472 -179.969 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.522 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.59 -43.03 8.88 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.837 -179.874 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.3 tp -62.66 -42.42 99.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.663 -179.931 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.78 -11.04 57.64 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.518 -179.403 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.444 HD12 ' O ' ' A' ' 125' ' ' SER . 84.9 mt -115.96 -23.72 8.43 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.749 -179.868 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . 0.522 ' N ' ' O ' ' A' ' 126' ' ' ALA . 79.0 t80 -51.77 -49.71 62.12 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 120.501 -0.48 . . . . 0.0 110.587 -179.024 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.5 p-10 -65.81 -42.16 90.99 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.946 0.403 . . . . 0.0 111.172 179.564 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.525 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 88.1 mt-30 -67.35 -36.85 82.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.801 -179.983 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.455 HD22 HD13 ' A' ' 116' ' ' ILE . 92.8 mt -80.34 -41.85 24.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.012 -179.541 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.1 t -57.55 -44.58 85.3 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.134 -179.095 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.5 m -62.3 -45.65 92.28 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.801 0.334 . . . . 0.0 110.586 179.351 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 92.4 mt -62.49 -43.78 98.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.285 -179.772 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.601 ' HB1' ' HD2' ' A' ' 138' ' ' PRO . . . -170.19 163.86 6.13 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.451 179.869 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.601 ' HD2' ' HB1' ' A' ' 137' ' ' ALA . 78.0 Cg_exo -43.58 111.32 0.23 Allowed 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.437 2.091 . . . . 0.0 112.076 179.539 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.475 HG21 ' CD1' ' A' ' 130' ' ' TYR . 17.3 m -85.78 127.79 34.64 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.57 179.951 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.646 HD13 ' CD2' ' A' ' 37' ' ' HIS . 34.4 tp -119.65 137.67 53.74 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.244 -0.435 . . . . 0.0 109.964 -179.702 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.433 ' O ' ' OD1' ' A' ' 32' ' ' ASP . 79.6 mt -104.58 119.92 54.21 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.432 0 CA-C-O 121.154 0.502 . . . . 0.0 111.416 -179.556 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.494 HD12 HD22 ' A' ' 117' ' ' LEU . 98.4 mt -135.3 133.03 52.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.665 179.676 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.546 HD21 ' CG ' ' A' ' 241' ' ' ASP . 60.6 t30 -64.98 150.31 48.24 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.861 0.362 . . . . 0.0 110.386 179.288 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.517 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 87.9 t80 -85.27 122.45 29.47 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.936 -179.531 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.517 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 99.0 m-20 55.48 68.86 0.8 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.954 179.76 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 36.0 p-10 -125.44 0.27 7.62 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.011 0.434 . . . . 0.0 110.816 179.851 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -150.69 115.57 5.27 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.748 -179.501 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 85.0 p -63.28 168.26 4.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.49 -179.742 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.422 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.5 p-90 -51.48 -15.67 0.46 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.484 -179.836 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.444 ' O ' HG23 ' A' ' 154' ' ' THR . 68.3 tp60 -70.84 -75.65 0.12 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.414 -179.703 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.455 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.1 t -62.59 -38.76 91.4 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.992 0.425 . . . . 0.0 110.297 179.529 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 53.6 tp -60.25 -45.53 92.96 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.324 -178.493 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.422 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 45.9 tp -62.76 -41.82 99.4 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.844 0.354 . . . . 0.0 110.311 179.03 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.455 ' OG1' ' O ' ' A' ' 151' ' ' SER . 58.8 p -64.01 -34.67 78.54 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.264 -179.507 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.444 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.5 mm-40 -64.03 -42.38 97.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.171 179.256 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 91.8 mt -65.24 -39.05 92.18 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.092 0.472 . . . . 0.0 110.172 179.071 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.582 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.04 -32.25 79.6 Favored Glycine 0 CA--C 1.52 0.352 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 -179.391 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.444 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.3 mt-10 -36.42 -25.38 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.888 0.375 . . . . 0.0 110.811 179.949 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.582 ' N ' ' O ' ' A' ' 157' ' ' GLY . 95.7 mt -59.16 149.29 6.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.171 179.382 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 77.5 p -69.14 137.47 53.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.074 -179.561 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 70.66 21.9 77.91 Favored Glycine 0 N--CA 1.458 0.157 0 N-CA-C 111.274 -0.731 . . . . 0.0 111.274 179.522 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 59.3 m80 -124.02 -14.63 7.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.757 0.313 . . . . 0.0 110.56 179.979 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -66.25 -59.76 3.43 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.774 -179.753 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -52.03 -48.96 64.27 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.278 -179.695 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -60.62 -41.11 94.18 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.76 0.314 . . . . 0.0 110.334 179.463 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.68 -47.11 86.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.633 179.817 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -57.1 -39.99 76.13 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.16 -179.85 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -61.8 -50.15 73.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.525 179.619 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.405 ' NE ' ' HB1' ' A' ' 59' ' ' ALA . 59.9 ttt85 -65.38 -43.77 89.67 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.417 179.554 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 95.1 mt -64.37 -43.53 97.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.421 179.718 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.29 -50.87 71.55 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.639 -179.169 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.79 -43.7 95.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.32 179.727 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.659 ' CE2' HD11 ' A' ' 177' ' ' LEU . 56.6 t80 -62.58 -44.62 95.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.026 0.441 . . . . 0.0 110.425 179.373 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -63.4 -39.93 95.82 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.475 -179.204 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -62.85 -42.81 99.89 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.664 179.248 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -60.8 -44.68 96.53 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.069 -179.992 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.659 HD11 ' CE2' ' A' ' 173' ' ' PHE . 84.9 mt -64.29 -41.22 96.99 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.043 0.449 . . . . 0.0 110.681 178.862 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.15 -62.25 1.76 Allowed 'General case' 0 C--O 1.237 0.44 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.487 -179.382 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.64 -46.71 86.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.51 179.86 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.43 -41.67 66.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.135 -179.931 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -63.71 -33.88 76.64 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.07 0.462 . . . . 0.0 110.407 179.336 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.424 ' HG2' ' O ' ' A' ' 182' ' ' GLU . 69.6 tt0 -90.31 8.42 33.47 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-O 121.387 0.613 . . . . 0.0 110.619 -179.078 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -104.31 -32.32 9.13 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-O 120.932 0.396 . . . . 0.0 111.359 179.546 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 43.9 pt -127.88 147.53 32.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.915 -179.902 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -139.83 131.03 26.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.296 179.478 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.595 HD22 ' N ' ' A' ' 186' ' ' LEU . 3.6 mm? -85.63 133.46 41.86 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.841 179.922 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -44.28 158.06 0.15 Allowed 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.738 2.292 . . . . 0.0 112.061 179.48 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 0.527 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.7 Cg_endo -62.9 114.97 2.65 Favored 'Trans proline' 0 C--N 1.303 -1.828 0 C-N-CA 122.747 2.298 . . . . 0.0 111.776 179.801 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . 0.527 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.8 mt-30 155.39 148.14 0.0 OUTLIER Pre-proline 0 N--CA 1.454 -0.247 0 O-C-N 123.552 0.533 . . . . 0.0 110.772 -179.799 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -74.11 144.5 33.8 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.685 2.257 . . . . 0.0 111.777 178.185 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.498 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.1 p -125.31 158.86 33.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.271 0.557 . . . . 0.0 110.067 -179.89 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . 0.498 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 35.4 p -143.53 165.58 27.19 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.094 -179.653 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . 0.446 ' HA ' ' H ' ' A' ' 260' ' ' PHE . . . -135.66 128.62 31.39 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.212 0.53 . . . . 0.0 110.244 179.625 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.504 HD11 HD23 ' A' ' 259' ' ' LEU . 47.1 pt -146.38 148.96 16.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.137 179.732 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . 0.742 HG13 ' CD1' ' A' ' 262' ' ' PHE . 70.4 t -117.87 123.14 71.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 121.263 0.554 . . . . 0.0 109.594 179.254 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 58.8 t80 -134.37 107.32 7.55 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.32 179.688 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 94.8 m -131.02 130.72 43.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.896 179.784 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.406 ' O ' ' N ' ' A' ' 201' ' ' HIS . . . -83.04 -37.09 24.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.252 179.741 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.44 -67.15 0.25 Allowed 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.332 179.996 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.1 -9.73 58.81 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.306 179.523 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . 0.406 ' N ' ' O ' ' A' ' 198' ' ' ALA . 60.1 t-80 60.52 58.36 2.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.825 -179.835 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 42.0 p -167.2 153.53 8.12 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.444 179.558 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.27 143.81 24.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.962 0.41 . . . . 0.0 110.372 179.449 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -135.18 138.34 43.56 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.691 179.939 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 20.3 mt -106.34 125.43 50.99 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 121.119 0.485 . . . . 0.0 109.745 -179.682 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 206' ' ' TRP . . . . . 0.557 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 74.3 m95 -81.96 166.83 19.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.666 -179.796 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . 0.466 HG22 ' C ' ' A' ' 206' ' ' TRP . 0.1 OUTLIER -156.78 171.87 6.86 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 120.971 0.415 . . . . 0.0 110.562 -179.213 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -54.02 -37.2 86.28 Favored 'Trans proline' 0 C--N 1.303 -1.839 0 C-N-CA 122.637 2.224 . . . . 0.0 111.954 179.465 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -70.46 -34.96 73.01 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.953 -179.916 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 22.2 m -61.02 150.88 32.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.569 -179.351 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.66 -36.86 82.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.462 -179.709 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . 0.557 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 55.2 tt0 -64.77 -40.37 95.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.529 179.957 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.72 -43.32 92.13 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 179.759 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -63.4 -43.9 96.2 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.95 -0.3 . . . . 0.0 110.219 179.879 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . 0.545 ' SD ' ' HB2' ' A' ' 304' ' ' ALA . 65.0 ttp -59.73 -47.88 83.91 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.199 -179.753 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 86.7 mt -60.65 -40.62 92.69 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 179.531 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . 0.456 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.5 tp10 -58.36 -37.88 76.11 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.77 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -65.21 -38.3 90.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.811 0.339 . . . . 0.0 110.648 179.696 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 94.2 mt -64.25 -42.56 96.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.554 -179.557 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.36 45.1 0.08 OUTLIER Glycine 0 C--N 1.334 0.417 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 -179.943 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . 0.456 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 26.6 m-85 -127.99 155.41 44.32 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.012 0.434 . . . . 0.0 110.527 -179.812 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.487 ' O ' HG13 ' A' ' 191' ' ' VAL . 6.8 p -107.06 122.31 46.22 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.093 0.473 . . . . 0.0 110.2 -179.899 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.475 HD22 ' C ' ' A' ' 222' ' ' THR . 4.3 mm? -101.33 132.81 46.7 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.107 179.967 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.64 159.79 14.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.52 179.86 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.57 115.21 29.86 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.328 179.902 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.494 ' N ' HD12 ' A' ' 226' ' ' LEU . 9.1 mp -53.22 156.86 3.54 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.584 179.926 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -60.31 145.38 98.71 Favored 'Trans proline' 0 C--N 1.301 -1.931 0 C-N-CA 122.627 2.218 . . . . 0.0 112.012 179.379 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.3 -3.26 59.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.559 -179.98 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.15 -40.99 5.66 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 -179.859 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.532 ' O ' ' N ' ' A' ' 233' ' ' SER . 85.5 mt -79.18 -17.15 55.47 Favored 'General case' 0 C--O 1.223 -0.316 0 CA-C-O 120.934 0.397 . . . . 0.0 110.301 -179.721 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . 0.401 ' C ' ' O ' ' A' ' 230' ' ' LEU . 54.7 t-20 -40.38 -49.21 2.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.756 -179.527 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -87.88 15.33 7.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.275 179.814 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.532 ' N ' ' O ' ' A' ' 230' ' ' LEU . 78.0 p -60.35 -35.48 75.77 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.523 -179.732 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . 0.527 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.7 tt0 -118.98 -69.12 0.87 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.917 0.389 . . . . 0.0 111.019 179.491 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.2 m -69.68 102.77 1.96 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.769 -179.882 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -94.27 57.45 2.33 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.341 -179.975 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -144.54 -122.63 1.6 Allowed Glycine 0 CA--C 1.52 0.359 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 179.994 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -135.13 111.53 9.79 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.082 0.468 . . . . 0.0 110.444 179.972 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . 0.519 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.7 mtt180 -148.05 57.88 1.09 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.723 -179.885 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -69.54 -32.27 70.98 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.522 179.65 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . 0.546 ' CG ' HD21 ' A' ' 143' ' ' ASN . 65.1 t0 -57.0 -46.97 81.9 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.41 -179.124 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 242' ' ' ILE . . . . . 0.437 ' O ' ' O ' ' A' ' 239' ' ' ARG . 17.7 tt -139.78 156.27 25.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.873 0.368 . . . . 0.0 110.541 179.777 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.441 HG22 HD13 ' A' ' 245' ' ' LEU . 96.2 mt -106.06 106.41 20.53 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.216 0 CA-C-O 121.233 0.54 . . . . 0.0 110.458 179.87 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . 0.606 ' O ' HD12 ' A' ' 245' ' ' LEU . 88.2 mt-30 -110.19 109.85 20.48 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.329 179.75 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.606 HD12 ' O ' ' A' ' 244' ' ' GLN . 9.4 mp -121.75 -168.47 1.7 Allowed 'General case' 0 C--O 1.224 -0.238 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.647 179.774 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . 0.527 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.81 -16.5 0.05 OUTLIER Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 179.892 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . 0.675 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -60.75 156.3 32.24 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 -179.858 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -63.48 21.76 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.001 0.429 . . . . 0.0 110.617 179.973 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . 0.675 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.7 m-20 -97.51 -5.85 34.99 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.554 179.961 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 93.6 mt -79.69 -22.16 43.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.647 179.486 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.64 -51.27 70.65 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.856 -179.543 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -87.96 -5.51 58.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.42 179.653 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.09 -74.33 1.15 Allowed Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 -179.959 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 81.4 mt -70.05 125.89 28.08 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.134 0.493 . . . . 0.0 110.104 -179.759 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -59.69 -39.29 84.08 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.266 -179.656 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 84.37 51.63 3.84 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 179.943 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -95.11 -15.62 23.24 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.698 0.285 . . . . 0.0 110.664 -179.917 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . 0.497 ' OG ' HG23 ' A' ' 191' ' ' VAL . 3.3 t 173.76 89.4 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.033 0.444 . . . . 0.0 110.085 179.979 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.865 ' N ' HD12 ' A' ' 259' ' ' LEU . 1.0 OUTLIER -94.38 124.06 38.17 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-O 121.314 0.578 . . . . 0.0 111.144 -179.224 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 260' ' ' PHE . . . . . 0.446 ' H ' ' HA ' ' A' ' 193' ' ' ALA . 15.9 m-30 -93.04 146.72 23.42 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.378 179.269 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 86.3 mt -122.48 149.91 43.23 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.525 -179.921 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.742 ' CD1' HG13 ' A' ' 195' ' ' VAL . 2.6 p90 -78.13 -138.64 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.422 -179.696 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . 0.661 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -51.69 77.62 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.995 -179.921 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . 0.636 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.35 104.46 0.19 Allowed Glycine 0 N--CA 1.468 0.781 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 -179.798 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 265' ' ' ASP . . . . . 0.605 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.6 m-20 -80.48 -177.56 6.27 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.718 0.294 . . . . 0.0 110.966 -179.594 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -40.68 -17.54 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.428 179.859 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . 0.605 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.59 -51.4 42.94 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 121.013 0.435 . . . . 0.0 110.782 179.487 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -63.8 -46.72 83.9 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.143 179.399 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . 0.566 ' HB1' ' OH ' ' A' ' 273' ' ' TYR . . . -61.7 -35.08 77.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.767 179.646 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -62.93 -34.74 78.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.105 179.729 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.38 -43.1 13.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.409 -179.584 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 272' ' ' ILE . . . . . 0.587 ' C ' ' H ' ' A' ' 274' ' ' ALA . 4.9 tt -51.37 -33.65 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.838 -178.95 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 273' ' ' TYR . . . . . 0.566 ' OH ' ' HB1' ' A' ' 269' ' ' ALA . 17.5 m-85 -54.33 -1.67 0.03 OUTLIER 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.742 -179.563 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 274' ' ' ALA . . . . . 0.587 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.94 -39.87 69.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.883 179.648 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . 0.586 ' O ' ' N ' ' A' ' 279' ' ' ALA . 4.3 p30 -38.94 97.53 0.14 Allowed Pre-proline 0 C--O 1.226 -0.168 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.582 -179.68 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 276' ' ' PRO . . . . . 0.402 ' N ' ' O ' ' A' ' 274' ' ' ALA . 45.7 Cg_exo -53.95 -43.15 60.68 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 C-N-CA 122.338 2.025 . . . . 0.0 112.756 -178.884 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 89.8 mt -64.39 -42.82 95.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.136 0.493 . . . . 0.0 111.235 -179.766 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 91.2 mt -95.99 -1.14 49.61 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.849 -179.439 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 279' ' ' ALA . . . . . 0.586 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.39 -34.91 77.65 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.647 -179.762 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -73.76 19.72 0.11 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.126 -179.38 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 0.495 HD23 ' HA ' ' A' ' 281' ' ' LEU . 13.7 mt -75.2 120.84 83.52 Favored Pre-proline 0 N--CA 1.451 -0.391 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.351 179.99 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_exo -51.58 -39.11 66.05 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.633 2.222 . . . . 0.0 111.603 179.343 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.83 -50.38 63.81 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 179.818 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 79.5 t -61.84 -44.02 98.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 110.083 -0.339 . . . . 0.0 110.083 179.477 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -57.65 -41.6 81.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.301 -179.846 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -90.71 0.7 57.33 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.084 179.675 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt 58.59 41.57 22.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.115 0.483 . . . . 0.0 111.029 179.788 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -93.15 42.22 1.09 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.377 179.804 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 53.8 t -119.37 135.54 59.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 120.943 0.401 . . . . 0.0 110.223 -179.699 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -132.78 162.81 30.52 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.045 0.45 . . . . 0.0 110.703 -179.623 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.65 155.38 32.45 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.032 0.444 . . . . 0.0 110.743 -179.882 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 81.4 mt -94.37 -1.23 54.11 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.211 -179.699 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.1 165.01 12.54 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.634 -0.986 . . . . 0.0 110.634 -179.814 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 7.0 m -86.79 -62.04 1.6 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.804 0.335 . . . . 0.0 111.184 -179.95 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 295' ' ' GLU . . . . . 0.444 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.6 mm-40 -69.41 -4.07 16.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.697 -179.842 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 25.4 p -76.84 32.38 0.14 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.663 -179.887 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 297' ' ' PHE . . . . . 0.511 ' CD2' HG22 ' A' ' 70' ' ' THR . 70.5 t80 -60.33 -46.06 91.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.607 -179.908 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . 0.614 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.4 mtt85 -81.08 134.93 35.75 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.581 -179.699 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.457 ' H ' HG11 ' A' ' 51' ' ' VAL . 17.1 tp -114.24 118.07 32.92 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.152 179.898 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . 0.635 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.2 p-10 -165.69 -176.16 3.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.541 179.978 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 84.5 t80 -47.17 -43.86 21.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.275 -179.675 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -66.6 -40.63 88.95 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.08 0.466 . . . . 0.0 110.833 179.116 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . 0.635 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 60.8 p -55.71 -36.11 66.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.159 -179.263 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . 0.545 ' HB2' ' SD ' ' A' ' 215' ' ' MET . . . -57.49 -51.31 69.98 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.459 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 90.6 mtp -56.71 -43.52 80.64 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -179.993 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -66.49 -42.56 87.21 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.928 0.394 . . . . 0.0 110.16 178.796 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 303' ' ' SER . 55.6 t -64.02 -43.12 97.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.08 179.352 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 43.3 tp -59.66 -42.09 92.05 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.721 -179.409 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -62.72 -38.83 92.03 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 179.565 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 310' ' ' ARG . . . . . 0.446 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.6 ttt85 -63.66 -43.88 95.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.288 179.506 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 89.4 mt -63.21 -42.1 99.23 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.185 179.602 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -62.87 -33.59 75.6 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.993 179.445 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.65 -23.46 21.89 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.507 -179.836 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.479 HD22 ' CE2' ' A' ' 315' ' ' PHE . 6.7 tt -62.32 -43.12 99.56 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 121.087 0.47 . . . . 0.0 110.629 -179.889 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 315' ' ' PHE . . . . . 0.479 ' CE2' HD22 ' A' ' 314' ' ' LEU . 90.9 m-85 . . . . . 0 C--O 1.22 -0.457 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.462 179.897 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -99.6 136.04 40.12 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.47 -179.961 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.498 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -92.41 178.45 1.68 Allowed Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.539 -179.88 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.498 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.0 Cg_exo -61.76 147.39 95.39 Favored 'Trans proline' 0 C--N 1.3 -1.996 0 C-N-CA 122.752 2.302 . . . . 0.0 112.162 179.811 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.493 ' HE ' HD12 ' A' ' 39' ' ' LEU . 35.4 ptt180 -136.85 142.47 42.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.679 179.679 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -79.59 116.97 20.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.464 179.962 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.458 ' O ' HG23 ' A' ' 30' ' ' ILE . 9.5 tp -111.48 130.25 65.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.46 -179.956 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 13.5 t -71.4 142.13 50.32 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.527 179.811 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.484 ' CG ' ' H ' ' A' ' 33' ' ' SER . 42.8 t0 -139.09 -179.56 5.92 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.629 -179.937 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.484 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 78.0 p -74.15 -37.13 64.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.755 179.863 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.7 ttt85 -47.07 -94.9 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.382 -179.521 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.415 ' O ' ' OG1' ' A' ' 36' ' ' THR . . . -165.65 -27.15 0.02 OUTLIER Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 179.92 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.415 ' OG1' ' O ' ' A' ' 35' ' ' GLY . 67.6 m -168.43 105.9 0.46 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.859 0.361 . . . . 0.0 110.635 -179.909 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.63 ' CD2' HD13 ' A' ' 140' ' ' LEU . 64.4 t60 -128.9 145.98 51.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.015 0.436 . . . . 0.0 110.267 179.896 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.617 HG22 ' N ' ' A' ' 39' ' ' LEU . 99.8 m -129.26 165.42 21.43 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.639 -179.915 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.617 ' N ' HG22 ' A' ' 38' ' ' THR . 79.6 mt -120.27 127.39 52.34 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.513 179.785 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -65.51 -44.57 86.6 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.619 -179.951 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 41.6 p -166.0 154.93 11.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.443 179.719 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.492 ' H ' ' CD ' ' A' ' 42' ' ' GLN . 14.0 mp0 -45.43 101.71 0.27 Allowed Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.673 179.503 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -57.71 130.12 37.03 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 C-N-CA 122.351 2.034 . . . . 0.0 112.233 -179.687 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -83.05 -24.68 32.67 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.448 179.631 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.536 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.9 mtm-85 -120.46 134.48 55.26 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-O 121.174 0.511 . . . . 0.0 110.28 -179.987 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 95.9 mt -129.97 133.46 64.48 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.271 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.979 -179.76 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 47.8 t -125.25 131.02 72.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.802 0.334 . . . . 0.0 110.11 179.329 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.601 ' OG ' HD12 ' A' ' 117' ' ' LEU . 4.2 m -154.72 166.31 33.84 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.606 179.81 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 65.8 p -124.85 8.23 8.12 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.483 179.931 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.1 t -85.2 125.8 33.15 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.68 -179.43 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.463 HG11 ' H ' ' A' ' 299' ' ' LEU . 91.9 t -65.7 -44.52 93.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.51 -179.994 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.8 m -62.74 -44.32 96.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.664 -179.849 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 54.4 tp -62.19 -41.56 98.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.57 -179.536 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.455 ' O ' HD13 ' A' ' 58' ' ' LEU . 72.1 m -57.72 -44.53 86.04 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.349 -179.397 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.31 -62.09 5.43 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.911 -0.876 . . . . 0.0 110.911 179.554 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.6 t -48.24 -35.76 12.63 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 -179.962 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 20.0 mt -61.77 -44.76 96.25 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.724 -0.391 . . . . 0.0 111.145 179.347 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.455 HD13 ' O ' ' A' ' 54' ' ' THR . 9.2 mp -64.88 -42.0 95.18 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.081 0.467 . . . . 0.0 111.287 178.035 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.407 ' HB1' ' NE ' ' A' ' 169' ' ' ARG . . . -63.59 -41.22 98.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.998 -179.288 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.434 ' O ' HG23 ' A' ' 60' ' ' ILE . 7.9 tp -87.89 16.53 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.694 -179.662 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 56.58 84.3 0.09 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.575 -179.973 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.59 57.74 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.147 -179.808 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.417 ' HB3' HE21 ' A' ' 85' ' ' GLN . 9.8 Cg_endo -50.13 152.55 7.73 Favored 'Trans proline' 0 C--N 1.297 -2.169 0 C-N-CA 122.834 2.356 . . . . 0.0 112.475 -178.297 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.428 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -108.93 146.34 14.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.417 -179.747 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 97.1 mt -63.85 -45.03 98.2 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.351 -179.762 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.505 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -130.26 134.48 47.26 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.677 -179.857 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.478 ' O ' ' N ' ' A' ' 98' ' ' LEU . 69.0 m -134.19 158.38 43.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.839 -179.62 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.5 139.18 16.38 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 179.804 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.498 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.91 -162.6 0.08 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.934 0.397 . . . . 0.0 110.495 -179.968 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.524 HG22 ' CD2' ' A' ' 297' ' ' PHE . 14.6 t -133.55 135.88 44.61 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.394 -179.992 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.493 ' C ' ' O ' ' A' ' 70' ' ' THR . 0.0 OUTLIER 29.74 68.68 0.66 Allowed Pre-proline 0 N--CA 1.464 0.243 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.646 -179.843 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -60.9 145.23 99.35 Favored 'Trans proline' 0 C--N 1.3 -1.98 0 C-N-CA 122.643 2.229 . . . . 0.0 112.227 -178.73 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.527 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 45.6 p-10 -160.7 -32.59 0.05 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.686 179.659 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.537 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 99.0 m-20 -63.88 -39.36 94.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.488 -179.972 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 73.2 ttt180 -60.56 -48.19 82.87 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.68 -179.405 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.418 ' O ' ' O ' ' A' ' 77' ' ' ALA . 93.6 t -59.91 -24.52 29.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 110.1 -0.334 . . . . 0.0 110.1 179.607 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.537 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -46.1 173.13 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.599 179.924 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.569 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.6 p30 -61.87 177.6 0.42 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.581 -179.738 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.567 ' C ' ' H ' ' A' ' 81' ' ' GLY . 35.9 p30 -46.02 85.95 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.887 -179.942 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.569 ' N ' ' O ' ' A' ' 78' ' ' ASP . 42.6 tp60 -66.92 13.48 0.06 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.143 -179.893 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.567 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 117.76 -22.04 10.16 Favored Glycine 0 CA--C 1.519 0.293 0 N-CA-C 110.994 -0.843 . . . . 0.0 110.994 179.957 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -107.62 116.47 32.0 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.99 0.424 . . . . 0.0 110.497 179.883 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 75.2 mt -98.73 0.67 45.0 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.46 -179.738 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -91.93 6.7 45.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.957 0.408 . . . . 0.0 110.41 -179.833 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.8 ' O ' HG22 ' A' ' 89' ' ' VAL . 88.4 mt-30 -99.67 -27.63 13.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.858 179.957 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 68.7 t-105 -63.34 -41.18 98.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.03 -179.619 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.556 ' O ' ' N ' ' A' ' 91' ' ' LYS . 65.8 m -77.42 -53.33 7.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.238 -179.317 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -48.57 -51.09 29.47 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.966 -179.28 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.8 HG22 ' O ' ' A' ' 85' ' ' GLN . 15.4 m -68.78 -40.74 81.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 120.903 0.383 . . . . 0.0 110.962 179.9 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.5 ' N ' HG23 ' A' ' 89' ' ' VAL . . . -71.9 -23.11 61.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.786 179.953 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.556 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.0 tttm -60.99 -45.82 93.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.498 -179.602 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.438 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.3 mm-40 -90.82 -94.68 0.12 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.08 179.981 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.634 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.9 mtt180 -143.23 60.03 1.4 Allowed 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.794 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.462 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.6 pttp 33.57 26.23 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.222 -179.048 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.634 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.4 tt -47.62 123.31 5.69 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.92 -178.253 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.456 ' O ' HD23 ' A' ' 95' ' ' LEU . 98.8 mm-40 -83.44 -169.92 2.79 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.061 -179.997 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.613 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 82.3 mtp180 -73.61 138.03 44.6 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.166 -179.837 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.478 ' N ' ' O ' ' A' ' 67' ' ' SER . 89.8 mt -87.27 -165.93 1.43 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.717 -179.647 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.534 ' CD2' ' O ' ' A' ' 99' ' ' TYR . 48.2 p90 -168.46 120.2 0.81 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.32 179.933 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.513 ' C ' ' O ' ' A' ' 99' ' ' TYR . 43.6 mm -29.6 121.5 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.863 -179.63 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 114.22 27.94 3.24 Favored Glycine 0 CA--C 1.521 0.426 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 -179.557 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.59 ' H ' ' CD ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -144.17 46.04 0.6 Allowed Pre-proline 0 C--N 1.324 -0.541 0 CA-C-O 120.907 0.384 . . . . 0.0 110.465 179.903 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.582 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 31.0 Cg_endo -62.28 143.85 94.56 Favored 'Trans proline' 0 C--N 1.298 -2.126 0 C-N-CA 122.735 2.29 . . . . 0.0 111.996 179.932 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.464 ' O ' HG23 ' A' ' 108' ' ' VAL . 24.8 t -173.67 120.91 0.32 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.46 179.67 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.42 -41.11 63.68 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.012 0.434 . . . . 0.0 111.154 179.709 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -65.82 -40.16 91.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.856 -179.432 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.63 -39.77 95.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.708 -179.907 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 104' ' ' SER . 72.0 t -67.44 -43.82 87.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.683 179.584 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.18 -39.24 92.04 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.512 -179.233 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.438 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.75 -23.82 63.54 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.431 179.831 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.568 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.3 mm-40 -91.18 4.47 52.15 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.684 -179.574 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.568 ' C ' ' O ' ' A' ' 111' ' ' GLN . 10.4 tpt 22.11 64.56 0.32 Allowed Pre-proline 0 N--CA 1.464 0.266 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.992 -179.911 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.478 ' HG2' HD11 ' A' ' 116' ' ' ILE . 67.8 Cg_endo -78.66 170.04 18.82 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 C-N-CA 122.972 2.448 . . . . 0.0 112.21 -178.66 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.522 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 99.1 m-20 -113.07 -44.78 3.23 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 121.065 0.46 . . . . 0.0 110.088 179.544 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 39.8 tp -119.91 119.57 33.87 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.514 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.478 HD11 ' HG2' ' A' ' 113' ' ' PRO . 94.7 mt -116.94 131.15 70.49 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 CA-C-O 120.954 0.407 . . . . 0.0 110.887 -179.807 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.601 HD12 ' OG ' ' A' ' 48' ' ' SER . 31.6 mt -105.63 131.98 52.33 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 121.11 0.481 . . . . 0.0 110.125 -179.528 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.488 HD12 HG23 ' A' ' 139' ' ' THR . 98.3 mt -117.55 135.94 56.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.79 -179.726 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 85.0 p -71.57 151.54 43.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.568 -179.944 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.13 -49.85 76.0 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.678 -179.763 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.0 t -149.4 153.93 38.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.587 179.76 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 168.19 -169.56 41.53 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.875 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.87 -35.73 92.41 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -179.971 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.446 ' O ' ' OD1' ' A' ' 124' ' ' ASP . 44.1 p-10 -87.96 120.04 28.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.782 0.325 . . . . 0.0 110.632 179.871 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.454 ' O ' HD12 ' A' ' 129' ' ' LEU . 40.5 t -63.44 144.2 57.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.554 -179.956 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.518 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -94.02 -43.08 8.69 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.792 -179.814 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 56.1 tp -62.73 -42.37 99.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.562 -179.841 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.0 -10.52 54.21 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.531 -179.474 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.454 HD12 ' O ' ' A' ' 125' ' ' SER . 83.6 mt -116.02 -24.08 8.24 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.678 -179.89 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . 0.518 ' N ' ' O ' ' A' ' 126' ' ' ALA . 74.5 t80 -51.52 -49.55 61.71 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.456 -178.951 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.4 p-10 -65.87 -41.91 91.04 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.893 0.378 . . . . 0.0 111.163 179.607 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.526 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 87.7 mt-30 -67.85 -36.74 80.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.746 -179.905 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.453 HD22 HD13 ' A' ' 116' ' ' ILE . 95.9 mt -80.19 -42.45 23.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.955 -179.439 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.3 t -57.49 -44.94 85.35 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.355 -179.117 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.4 m -62.29 -45.95 90.94 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.639 179.409 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 92.2 mt -62.29 -43.79 98.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.325 -179.823 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.604 ' HB1' ' HD2' ' A' ' 138' ' ' PRO . . . -170.18 163.75 6.17 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.471 179.842 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.604 ' HD2' ' HB1' ' A' ' 137' ' ' ALA . 76.6 Cg_exo -42.38 110.3 0.15 Allowed 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.571 2.181 . . . . 0.0 112.035 179.454 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.515 HG21 ' CD1' ' A' ' 130' ' ' TYR . 2.8 m -87.27 127.61 35.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.463 -179.927 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.63 HD13 ' CD2' ' A' ' 37' ' ' HIS . 34.1 tp -119.78 138.72 53.17 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.163 -179.818 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.436 ' O ' ' OD1' ' A' ' 32' ' ' ASP . 81.6 mt -105.29 120.04 55.35 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.348 0 CA-C-O 121.125 0.488 . . . . 0.0 111.233 -179.439 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.49 HD12 HD22 ' A' ' 117' ' ' LEU . 97.7 mt -135.42 132.73 52.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.721 179.577 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.531 HD21 ' CG ' ' A' ' 241' ' ' ASP . 59.7 t30 -64.49 148.3 50.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.875 0.369 . . . . 0.0 110.37 179.364 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.515 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 86.9 t80 -82.75 122.4 28.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.96 -179.471 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.515 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 99.0 m-20 55.08 69.41 0.73 Allowed 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.827 179.648 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 35.2 p-10 -125.71 0.69 7.46 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 120.906 0.384 . . . . 0.0 110.704 179.787 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -150.9 115.92 5.29 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.668 -179.511 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 86.2 p -63.74 168.72 4.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.499 -179.805 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.423 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.3 p-90 -51.6 -15.96 0.54 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.62 -179.868 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.44 ' O ' HG23 ' A' ' 154' ' ' THR . 67.9 tp60 -70.36 -76.05 0.11 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.521 -179.748 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.458 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.0 t -62.68 -38.5 90.61 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.339 179.481 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 52.3 tp -60.1 -45.51 92.69 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.401 -178.611 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.423 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 46.5 tp -62.83 -41.84 99.49 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.861 0.362 . . . . 0.0 110.411 178.995 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.458 ' OG1' ' O ' ' A' ' 151' ' ' SER . 59.2 p -63.72 -34.76 78.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.258 -179.566 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.471 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.9 mm-40 -63.98 -42.18 97.3 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.239 179.177 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 91.6 mt -65.42 -38.89 91.27 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.092 179.118 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.582 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.25 -32.42 80.62 Favored Glycine 0 CA--C 1.52 0.375 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 -179.366 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.471 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.1 mt-10 -36.34 -25.55 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.874 0.369 . . . . 0.0 110.791 -179.98 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.582 ' N ' ' O ' ' A' ' 157' ' ' GLY . 94.8 mt -59.35 149.5 6.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.231 179.473 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 74.8 p -69.09 137.07 53.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.049 -179.558 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 71.1 21.62 78.41 Favored Glycine 0 N--CA 1.459 0.194 0 N-CA-C 111.269 -0.732 . . . . 0.0 111.269 179.509 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 60.3 m80 -123.43 -15.45 7.13 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.746 0.307 . . . . 0.0 110.568 179.989 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -66.02 -59.87 3.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.715 -179.756 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -51.62 -49.09 62.9 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.238 -179.755 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -60.83 -41.07 95.04 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.723 0.297 . . . . 0.0 110.312 179.522 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.48 -47.51 85.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.613 179.745 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.64 -40.32 75.23 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.268 -179.921 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -61.66 -50.24 73.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.65 179.525 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.407 ' NE ' ' HB1' ' A' ' 59' ' ' ALA . 59.9 ttt85 -65.38 -43.76 89.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.476 179.495 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 95.1 mt -64.53 -43.41 96.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.52 179.728 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.23 -51.05 70.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.599 -179.308 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.79 -43.67 95.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.421 179.724 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.658 ' CE2' HD11 ' A' ' 177' ' ' LEU . 57.3 t80 -62.69 -44.56 95.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.456 179.364 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -63.26 -40.04 96.28 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.527 -179.361 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -63.01 -42.77 99.92 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.624 179.277 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -60.64 -44.78 95.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.119 179.968 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.658 HD11 ' CE2' ' A' ' 173' ' ' PHE . 84.4 mt -64.29 -41.09 97.05 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.02 0.438 . . . . 0.0 110.674 178.956 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.18 -62.12 1.84 Allowed 'General case' 0 C--O 1.237 0.418 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.501 -179.387 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.78 -46.78 86.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.545 179.903 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.3 -41.72 65.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.149 179.974 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -63.72 -33.6 76.02 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.011 0.434 . . . . 0.0 110.415 179.227 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.428 ' HG2' ' O ' ' A' ' 182' ' ' GLU . 69.8 tt0 -90.7 8.61 33.62 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.27 0.557 . . . . 0.0 110.528 -179.01 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -104.58 -32.25 9.03 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.188 179.595 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 45.1 pt -128.04 147.72 32.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.816 -179.803 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -139.76 130.88 26.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.375 179.418 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.592 HD22 ' N ' ' A' ' 186' ' ' LEU . 3.6 mm? -85.46 133.24 42.64 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.808 -179.947 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -44.01 157.81 0.14 Allowed 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.704 2.269 . . . . 0.0 112.088 179.46 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 0.528 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.7 Cg_endo -63.01 114.74 2.57 Favored 'Trans proline' 0 C--N 1.303 -1.858 0 C-N-CA 122.751 2.3 . . . . 0.0 111.752 179.909 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . 0.528 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.8 mt-30 155.6 147.83 0.0 OUTLIER Pre-proline 0 C--N 1.331 -0.215 0 O-C-N 123.433 0.458 . . . . 0.0 110.725 -179.757 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -73.9 144.06 33.98 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.711 2.274 . . . . 0.0 111.771 178.189 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.498 HG23 ' OG ' ' A' ' 258' ' ' SER . 2.1 p -124.92 159.03 32.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.261 0.553 . . . . 0.0 110.082 -179.975 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . 0.497 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 37.7 p -143.55 165.31 27.94 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.069 -179.506 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . 0.443 ' HA ' ' H ' ' A' ' 260' ' ' PHE . . . -135.55 128.54 31.48 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.122 0.487 . . . . 0.0 110.258 179.704 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.503 HD11 HD23 ' A' ' 259' ' ' LEU . 47.5 pt -146.4 148.86 16.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.1 179.928 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . 0.747 HG13 ' CD1' ' A' ' 262' ' ' PHE . 68.9 t -117.89 123.12 71.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.315 0.578 . . . . 0.0 109.7 179.098 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -134.26 107.36 7.62 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.309 179.745 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 94.2 m -131.13 130.53 43.21 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.802 179.871 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.411 ' O ' ' N ' ' A' ' 201' ' ' HIS . . . -82.9 -37.2 24.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.276 179.745 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.25 -67.12 0.25 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.364 179.978 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.15 -9.84 58.98 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.344 179.48 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . 0.411 ' N ' ' O ' ' A' ' 198' ' ' ALA . 60.0 t-80 60.85 58.16 2.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.601 -179.972 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 44.8 p -167.07 153.21 8.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.516 179.666 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.24 143.93 24.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.933 0.397 . . . . 0.0 110.426 179.532 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -135.31 138.51 43.5 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.644 -179.949 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 19.9 mt -106.45 125.42 50.98 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 121.112 0.482 . . . . 0.0 109.862 -179.721 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 206' ' ' TRP . . . . . 0.555 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 74.2 m95 -81.96 166.94 19.42 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.597 -179.713 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . 0.475 HG22 ' C ' ' A' ' 206' ' ' TRP . 0.1 OUTLIER -157.05 171.41 7.49 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.56 -179.164 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -53.65 -37.13 83.38 Favored 'Trans proline' 0 C--N 1.303 -1.838 0 C-N-CA 122.664 2.242 . . . . 0.0 111.97 179.333 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -70.58 -35.08 72.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.844 -179.864 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 21.7 m -60.98 151.02 31.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.562 -179.31 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.81 -37.03 82.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.523 -179.767 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . 0.555 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 55.0 tt0 -64.64 -40.37 95.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.532 179.916 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.51 -43.34 92.55 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 179.846 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -63.31 -43.68 97.12 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.675 0.274 . . . . 0.0 110.283 179.851 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . 0.546 ' SD ' ' HB2' ' A' ' 304' ' ' ALA . 65.3 ttp -59.65 -47.98 83.47 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.206 -179.773 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 216' ' ' LEU . 88.1 mt -60.59 -40.8 93.07 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.531 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . 0.459 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.8 tp10 -58.25 -38.01 76.08 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.75 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -65.13 -38.23 89.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.808 0.337 . . . . 0.0 110.671 179.677 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 94.4 mt -64.33 -42.67 96.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.572 -179.616 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.5 44.93 0.08 OUTLIER Glycine 0 CA--C 1.521 0.429 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 -179.958 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . 0.459 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 26.4 m-85 -127.91 155.32 44.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.045 0.45 . . . . 0.0 110.507 -179.896 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.489 ' O ' HG13 ' A' ' 191' ' ' VAL . 7.2 p -106.8 122.17 45.84 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.214 0.531 . . . . 0.0 110.202 -179.985 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.473 HD22 ' C ' ' A' ' 222' ' ' THR . 4.3 mm? -101.21 132.99 46.44 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.074 179.982 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.85 159.74 14.75 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.005 0.431 . . . . 0.0 110.504 179.86 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.75 115.25 29.92 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.382 179.93 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.508 ' N ' HD12 ' A' ' 226' ' ' LEU . 8.8 mp -52.94 156.62 3.33 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.662 179.952 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -60.47 145.45 98.71 Favored 'Trans proline' 0 C--N 1.302 -1.889 0 C-N-CA 122.68 2.253 . . . . 0.0 111.982 179.367 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.02 -3.42 59.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.57 179.994 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.04 -41.11 5.66 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 -179.884 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.537 ' O ' ' N ' ' A' ' 233' ' ' SER . 85.6 mt -79.3 -17.2 55.09 Favored 'General case' 0 C--O 1.224 -0.273 0 CA-C-O 121.037 0.446 . . . . 0.0 110.314 -179.696 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . 0.403 ' C ' ' O ' ' A' ' 230' ' ' LEU . 54.8 t-20 -40.23 -49.31 2.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.73 -179.642 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -87.86 15.35 7.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.828 0.347 . . . . 0.0 111.18 179.945 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.537 ' N ' ' O ' ' A' ' 230' ' ' LEU . 78.0 p -60.29 -35.54 75.79 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.594 -179.824 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . 0.526 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.5 tt0 -119.11 -69.29 0.86 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.898 179.643 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.2 m -69.28 103.23 1.9 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.612 -179.727 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -94.79 57.18 2.12 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.42 179.912 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -144.57 -122.84 1.62 Allowed Glycine 0 CA--C 1.522 0.48 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 -179.928 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -134.94 111.64 10.0 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.061 0.458 . . . . 0.0 110.423 -179.997 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . 0.523 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.6 mtt180 -148.04 58.16 1.1 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.731 -179.961 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -69.75 -32.03 70.32 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.568 179.571 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . 0.531 ' CG ' HD21 ' A' ' 143' ' ' ASN . 65.4 t0 -57.08 -46.93 82.14 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.373 -179.143 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 242' ' ' ILE . . . . . 0.435 ' O ' ' O ' ' A' ' 239' ' ' ARG . 18.1 tt -140.01 156.82 25.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.91 0.386 . . . . 0.0 110.492 179.712 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.443 HG22 HD13 ' A' ' 245' ' ' LEU . 96.2 mt -106.54 106.7 21.11 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.173 0 CA-C-O 121.177 0.513 . . . . 0.0 110.523 179.85 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . 0.606 ' O ' HD12 ' A' ' 245' ' ' LEU . 88.2 mt-30 -110.47 110.12 20.75 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.311 179.817 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.606 HD12 ' O ' ' A' ' 244' ' ' GLN . 9.3 mp -121.86 -168.44 1.7 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.601 179.911 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . 0.526 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.67 -16.47 0.05 OUTLIER Glycine 0 CA--C 1.524 0.628 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 179.876 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . 0.677 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -60.59 156.35 31.49 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 -179.885 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -63.42 21.38 0.01 OUTLIER 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.886 0.374 . . . . 0.0 110.626 179.883 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . 0.677 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.6 m-20 -97.29 -5.78 35.89 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.537 179.942 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 94.8 mt -79.66 -22.11 43.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.543 179.546 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.55 -51.32 70.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.796 -179.591 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.11 -5.68 58.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.476 179.679 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -80.96 -74.69 1.13 Allowed Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 -179.925 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 81.3 mt -69.89 125.97 28.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.069 0.461 . . . . 0.0 110.249 -179.82 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -59.19 -39.52 82.83 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.248 -179.662 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 83.21 51.82 4.02 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 179.903 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -96.04 -14.95 22.56 Favored 'General case' 0 C--N 1.333 -0.152 0 O-C-N 122.729 -0.277 . . . . 0.0 110.564 -179.843 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . 0.498 ' OG ' HG23 ' A' ' 191' ' ' VAL . 3.4 t 174.43 88.62 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.048 0.451 . . . . 0.0 110.169 -179.972 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.864 ' N ' HD12 ' A' ' 259' ' ' LEU . 1.0 OUTLIER -94.05 123.93 37.74 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.227 0.537 . . . . 0.0 111.11 -179.159 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 260' ' ' PHE . . . . . 0.443 ' H ' ' HA ' ' A' ' 193' ' ' ALA . 16.0 m-30 -92.93 146.7 23.43 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.337 179.221 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 85.7 mt -122.53 149.9 43.29 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.521 -179.868 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.747 ' CD1' HG13 ' A' ' 195' ' ' VAL . 2.6 p90 -77.57 -138.47 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.552 -179.865 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . 0.662 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -52.16 77.73 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.922 179.957 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . 0.632 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.16 104.46 0.19 Allowed Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 -179.936 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 265' ' ' ASP . . . . . 0.609 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.8 m-20 -80.49 -177.64 6.31 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.749 0.309 . . . . 0.0 110.841 -179.468 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -40.48 -17.54 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.506 179.8 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . 0.609 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.63 -51.59 40.52 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.687 179.516 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -63.71 -46.67 84.38 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.187 179.382 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . 0.569 ' HB1' ' OH ' ' A' ' 273' ' ' TYR . . . -61.64 -35.04 76.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.845 179.52 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -63.05 -34.53 77.78 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.111 179.744 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.37 -43.21 13.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.261 -179.577 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 272' ' ' ILE . . . . . 0.586 ' C ' ' H ' ' A' ' 274' ' ' ALA . 4.9 tt -51.39 -33.81 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.811 -178.802 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 273' ' ' TYR . . . . . 0.569 ' OH ' ' HB1' ' A' ' 269' ' ' ALA . 17.2 m-85 -54.27 -1.76 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.655 -179.628 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 274' ' ' ALA . . . . . 0.586 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.87 -39.41 69.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.844 179.686 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . 0.582 ' O ' ' N ' ' A' ' 279' ' ' ALA . 2.9 p30 -39.63 98.28 0.16 Allowed Pre-proline 0 C--N 1.333 -0.141 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.513 -179.671 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -54.02 -43.17 60.61 Favored 'Trans proline' 0 C--N 1.302 -1.874 0 C-N-CA 122.411 2.074 . . . . 0.0 112.613 -178.855 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 88.9 mt -64.47 -42.83 95.69 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.137 0.494 . . . . 0.0 111.218 -179.625 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 89.7 mt -95.67 -1.54 49.9 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.875 -179.47 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 279' ' ' ALA . . . . . 0.582 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.42 -34.65 77.17 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.646 -179.807 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.45 20.04 0.12 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.024 -179.226 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 0.492 HD23 ' HA ' ' A' ' 281' ' ' LEU . 13.9 mt -75.32 120.52 82.06 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.394 179.968 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -51.36 -39.23 63.56 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 122.625 2.217 . . . . 0.0 111.676 179.312 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.9 -50.42 63.93 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.09 179.878 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 75.2 t -61.48 -43.93 97.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 179.502 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -57.67 -41.27 81.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.317 -179.981 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -91.14 0.45 57.53 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.123 179.599 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt 59.06 43.25 17.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.042 0.448 . . . . 0.0 110.928 179.67 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -94.59 41.43 1.09 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.399 179.793 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 53.4 t -118.85 135.86 57.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.031 0.443 . . . . 0.0 110.166 -179.707 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -133.01 162.8 30.73 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.706 -179.637 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.94 155.19 33.24 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.988 0.423 . . . . 0.0 110.701 -179.743 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 80.4 mt -93.95 -1.36 54.76 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.364 -179.794 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.26 165.89 12.78 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 110.65 -0.98 . . . . 0.0 110.65 -179.747 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 6.9 m -87.75 -62.26 1.54 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.889 0.376 . . . . 0.0 111.124 -179.922 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 295' ' ' GLU . . . . . 0.441 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.7 mm-40 -69.48 -3.78 16.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.569 -179.729 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 27.6 p -76.74 32.8 0.14 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.698 -179.963 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 297' ' ' PHE . . . . . 0.524 ' CD2' HG22 ' A' ' 70' ' ' THR . 85.5 t80 -60.21 -45.92 91.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.677 179.995 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . 0.613 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.1 mtt85 -81.54 134.23 35.48 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.592 -179.68 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.463 ' H ' HG11 ' A' ' 51' ' ' VAL . 16.6 tp -114.04 118.35 33.84 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.115 179.969 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . 0.635 ' H ' ' CB ' ' A' ' 303' ' ' SER . 50.7 p-10 -165.8 -175.96 3.66 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.526 -179.934 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -47.34 -44.04 23.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.194 -179.639 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -66.33 -40.76 90.1 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.013 0.435 . . . . 0.0 110.776 179.05 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . 0.635 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 57.6 p -55.72 -36.17 66.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.168 -179.334 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . 0.546 ' HB2' ' SD ' ' A' ' 215' ' ' MET . . . -57.35 -51.68 68.43 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.439 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 91.1 mtp -56.15 -43.59 78.42 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.778 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -66.54 -42.49 87.11 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.912 0.387 . . . . 0.0 110.167 178.821 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 303' ' ' SER . 55.9 t -64.13 -42.86 96.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.179 179.305 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 43.5 tp -59.68 -42.14 92.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.88 -179.588 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -62.54 -39.15 92.67 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.112 179.494 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 310' ' ' ARG . . . . . 0.438 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.5 ttt85 -63.45 -43.99 95.77 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.293 179.445 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 88.9 mt -63.34 -42.13 98.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.226 179.566 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.4 ttmt -62.84 -33.26 74.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.068 0.461 . . . . 0.0 110.108 179.485 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.84 -23.46 21.67 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.579 -179.942 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.478 HD22 ' CE2' ' A' ' 315' ' ' PHE . 6.7 tt -62.39 -43.17 99.47 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.547 -179.894 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 315' ' ' PHE . . . . . 0.478 ' CE2' HD22 ' A' ' 314' ' ' LEU . 91.0 m-85 . . . . . 0 C--O 1.219 -0.502 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.498 179.989 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -99.67 135.97 40.29 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.047 0.451 . . . . 0.0 110.485 -179.962 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.497 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.2 OUTLIER -91.64 178.43 1.76 Allowed Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.601 -179.87 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.497 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 26.6 Cg_exo -61.73 147.73 94.65 Favored 'Trans proline' 0 C--N 1.3 -1.987 0 C-N-CA 122.755 2.303 . . . . 0.0 112.118 179.708 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.473 ' HE ' HD12 ' A' ' 39' ' ' LEU . 35.4 ptt180 -135.48 142.34 45.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.618 179.797 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -78.95 116.84 19.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.576 179.953 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.431 ' O ' HG23 ' A' ' 30' ' ' ILE . 9.6 tp -110.17 130.86 62.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.436 -179.998 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 13.2 t -70.69 142.3 51.53 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.614 179.839 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 141' ' ' ILE . 25.2 t70 -140.25 177.56 7.9 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.481 -179.939 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 77.9 p -74.13 -36.33 64.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.529 -179.945 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -47.69 -94.96 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.347 -179.606 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -165.46 -25.83 0.02 OUTLIER Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 179.892 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 59.0 m -168.84 106.96 0.44 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.846 0.355 . . . . 0.0 110.689 -179.96 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.568 ' CD2' HD13 ' A' ' 140' ' ' LEU . 35.5 t60 -129.57 144.77 51.42 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.012 0.434 . . . . 0.0 110.224 179.885 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.628 HG22 ' N ' ' A' ' 39' ' ' LEU . 97.4 m -128.95 166.24 19.53 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.582 -179.76 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.628 ' N ' HG22 ' A' ' 38' ' ' THR . 81.9 mt -121.04 127.48 51.76 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.486 179.738 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -64.05 -44.55 92.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.618 -179.829 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 40.7 p -165.68 154.75 11.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.463 179.719 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.52 ' H ' ' CD ' ' A' ' 42' ' ' GLN . 14.4 mp0 -43.36 100.86 0.23 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.595 179.61 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -57.03 128.95 31.95 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.384 2.056 . . . . 0.0 112.29 -179.637 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -83.34 -24.54 32.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.551 179.6 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.541 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.7 mtm-85 -121.03 134.43 55.29 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 121.095 0.474 . . . . 0.0 110.294 -179.985 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 96.0 mt -130.23 133.35 64.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.943 -179.746 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 45.9 t -124.9 131.13 73.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.817 0.341 . . . . 0.0 110.156 179.334 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.601 ' OG ' HD12 ' A' ' 117' ' ' LEU . 4.8 m -154.55 166.32 33.7 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.543 179.881 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 72.0 p -124.56 8.55 8.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.519 179.856 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.3 t -85.73 125.33 33.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.579 -179.485 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.499 HG11 ' H ' ' A' ' 299' ' ' LEU . 96.4 t -65.66 -44.46 93.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.544 179.961 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.7 m -62.48 -44.36 96.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.57 -179.841 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 46.3 tp -62.41 -41.3 98.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.516 -179.441 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.454 ' O ' HD13 ' A' ' 58' ' ' LEU . 73.7 m -57.59 -44.57 85.48 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.451 -179.326 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.43 -62.3 5.22 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 179.602 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.6 t -48.14 -35.78 12.19 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 179.807 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.5 mt -61.66 -44.79 96.29 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.038 179.474 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.454 HD13 ' O ' ' A' ' 54' ' ' THR . 9.1 mp -64.96 -41.81 95.15 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.164 178.114 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.403 ' HB1' ' NE ' ' A' ' 169' ' ' ARG . . . -63.48 -41.49 98.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.921 -179.164 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.433 ' O ' HG23 ' A' ' 60' ' ' ILE . 8.1 tp -87.9 16.94 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.711 -179.574 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 56.58 84.01 0.09 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.646 179.999 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.74 58.2 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.106 -179.803 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.416 ' HB3' HE21 ' A' ' 85' ' ' GLN . 10.3 Cg_endo -50.84 152.6 9.6 Favored 'Trans proline' 0 C--N 1.298 -2.121 0 C-N-CA 122.832 2.355 . . . . 0.0 112.485 -178.264 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.431 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -108.99 145.74 15.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.348 -179.63 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.86 -45.17 97.78 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.3 -179.671 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.496 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -129.85 134.53 47.59 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.598 -179.713 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.5 ' O ' ' N ' ' A' ' 98' ' ' LEU . 75.3 m -134.83 158.79 43.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.788 -179.605 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -87.07 139.45 16.19 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.752 -0.939 . . . . 0.0 110.752 179.753 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.493 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.98 -162.49 0.08 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.931 0.396 . . . . 0.0 110.481 -179.921 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.522 HG22 ' CD2' ' A' ' 297' ' ' PHE . 14.6 t -133.67 135.35 44.03 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.353 179.942 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.496 ' C ' ' O ' ' A' ' 70' ' ' THR . 0.1 OUTLIER 29.58 68.54 0.65 Allowed Pre-proline 0 N--CA 1.463 0.222 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.705 -179.824 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -60.98 145.11 99.55 Favored 'Trans proline' 0 C--N 1.301 -1.963 0 C-N-CA 122.626 2.218 . . . . 0.0 112.155 -178.525 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.528 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 45.2 p-10 -159.54 -32.3 0.06 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.645 179.723 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.537 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 99.1 m-20 -64.12 -39.45 94.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.464 -179.992 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -60.49 -48.49 81.54 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.646 -179.284 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.424 ' O ' ' O ' ' A' ' 77' ' ' ALA . 92.8 t -59.68 -24.92 30.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.091 179.697 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.537 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -45.54 172.32 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.567 179.869 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.574 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.6 p30 -61.74 177.77 0.39 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.546 -179.732 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.56 ' C ' ' H ' ' A' ' 81' ' ' GLY . 35.6 p30 -45.92 85.8 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.847 179.98 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.574 ' N ' ' O ' ' A' ' 78' ' ' ASP . 42.8 tp60 -67.31 13.62 0.06 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.192 -179.983 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.56 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 117.93 -22.14 9.99 Favored Glycine 0 CA--C 1.52 0.364 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 179.969 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -107.62 116.39 31.87 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.932 0.396 . . . . 0.0 110.513 179.911 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 74.4 mt -98.84 0.86 45.13 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.473 -179.713 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -92.18 6.62 45.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.42 -179.811 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.795 ' O ' HG22 ' A' ' 89' ' ' VAL . 88.1 mt-30 -100.0 -27.41 13.59 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.85 179.971 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.6 t-105 -63.89 -40.74 97.23 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.981 -179.628 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.556 ' O ' ' N ' ' A' ' 91' ' ' LYS . 68.1 m -77.75 -53.84 7.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.225 -179.496 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -48.02 -50.77 26.64 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.908 -179.249 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.795 HG22 ' O ' ' A' ' 85' ' ' GLN . 15.4 m -69.07 -40.97 81.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 120.909 0.385 . . . . 0.0 110.922 179.955 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.503 ' N ' HG23 ' A' ' 89' ' ' VAL . . . -71.93 -22.89 61.41 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.71 -179.873 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.556 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.0 tttm -61.54 -45.91 92.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.482 -179.535 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.439 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.4 mm-40 -90.25 -94.57 0.12 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.151 -179.997 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.624 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.8 mtt180 -143.54 59.96 1.39 Allowed 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.734 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.466 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.7 pttp 33.32 27.1 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.338 -179.029 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.624 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.5 tt -48.55 123.12 6.24 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.915 -178.328 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.45 ' O ' HD23 ' A' ' 95' ' ' LEU . 99.0 mm-40 -83.6 -170.38 3.03 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.227 179.863 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.613 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 81.6 mtp180 -73.31 137.84 45.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.297 -179.847 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.5 ' N ' ' O ' ' A' ' 67' ' ' SER . 88.6 mt -86.09 -166.66 1.6 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.725 -179.584 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.528 ' CD2' ' O ' ' A' ' 99' ' ' TYR . 47.4 p90 -166.77 119.9 1.01 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.302 179.984 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.512 ' C ' ' O ' ' A' ' 99' ' ' TYR . 43.7 mm -29.75 121.15 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.865 -179.6 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 113.43 28.93 3.1 Favored Glycine 0 CA--C 1.522 0.492 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 -179.66 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.59 ' H ' ' CD ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -144.25 46.12 0.61 Allowed Pre-proline 0 C--N 1.325 -0.493 0 CA-C-O 120.922 0.391 . . . . 0.0 110.456 179.934 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.582 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 30.2 Cg_endo -62.01 143.72 95.45 Favored 'Trans proline' 0 C--N 1.299 -2.079 0 C-N-CA 122.733 2.289 . . . . 0.0 112.018 -179.985 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.471 ' O ' HG23 ' A' ' 108' ' ' VAL . 26.1 t -173.36 120.7 0.34 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.454 179.712 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.76 -41.0 63.06 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.056 179.767 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -65.86 -40.26 91.5 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.831 -179.383 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.97 -40.01 95.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.688 -179.777 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 104' ' ' SER . 70.7 t -67.39 -43.85 87.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.735 179.676 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.53 -39.22 92.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.577 -179.329 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.439 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.29 -23.49 62.46 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.521 179.81 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.557 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.4 mm-40 -91.25 5.08 50.55 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.698 -179.552 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.557 ' C ' ' O ' ' A' ' 111' ' ' GLN . 10.2 tpt 22.81 64.59 0.35 Allowed Pre-proline 0 N--CA 1.465 0.288 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.879 -179.85 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.447 ' HG2' HD11 ' A' ' 116' ' ' ILE . 68.4 Cg_endo -78.98 169.27 19.59 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 C-N-CA 122.975 2.45 . . . . 0.0 112.223 -178.684 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.464 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 98.8 m-20 -113.44 -44.08 3.26 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.148 179.43 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.7 tp -120.24 120.92 37.52 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.001 179.432 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.458 HD13 HD22 ' A' ' 133' ' ' LEU . 96.7 mt -118.49 131.07 72.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.795 -179.705 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.601 HD12 ' OG ' ' A' ' 48' ' ' SER . 32.4 mt -106.1 132.76 51.79 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.127 0.489 . . . . 0.0 110.298 -179.502 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.421 HD12 HG23 ' A' ' 139' ' ' THR . 98.0 mt -118.17 136.57 54.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.687 -179.753 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 87.0 p -72.07 153.47 41.7 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.566 -179.938 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.34 -50.27 74.27 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.689 -179.888 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.0 t -149.31 153.74 37.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.51 179.785 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 169.58 -169.99 42.4 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 179.89 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -63.08 -35.14 91.69 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 179.922 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.453 ' O ' ' OD1' ' A' ' 124' ' ' ASP . 44.6 p-10 -88.05 119.86 28.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.843 0.354 . . . . 0.0 110.679 179.897 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.443 ' O ' HD12 ' A' ' 129' ' ' LEU . 37.0 t -63.4 144.53 56.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.445 -179.914 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.523 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.23 -43.43 8.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.936 -179.997 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.7 tp -62.86 -42.3 99.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.655 -179.864 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.48 -11.08 57.03 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.52 -179.519 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.443 HD12 ' O ' ' A' ' 125' ' ' SER . 84.4 mt -116.08 -24.07 8.21 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.642 -179.775 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . 0.523 ' N ' ' O ' ' A' ' 126' ' ' ALA . 79.3 t80 -51.12 -50.18 59.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.587 -179.154 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.5 p-10 -65.82 -42.16 90.95 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.906 0.384 . . . . 0.0 111.133 179.716 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.524 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 87.7 mt-30 -67.55 -36.85 81.76 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.698 -179.882 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.458 HD22 HD13 ' A' ' 116' ' ' ILE . 93.7 mt -80.61 -42.0 22.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.952 -179.543 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.3 t -57.03 -44.87 83.32 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.283 -179.279 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 19.5 m -62.32 -45.78 91.66 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.812 0.339 . . . . 0.0 110.615 179.42 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 92.8 mt -62.34 -43.81 98.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.35 -179.765 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.581 ' HB1' ' HD2' ' A' ' 138' ' ' PRO . . . -170.07 162.85 6.52 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.573 179.811 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.581 ' HD2' ' HB1' ' A' ' 137' ' ' ALA . 77.5 Cg_exo -42.71 110.88 0.18 Allowed 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.562 2.175 . . . . 0.0 112.1 179.554 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.459 HG21 ' CD1' ' A' ' 130' ' ' TYR . 16.7 m -85.77 127.79 34.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.632 179.968 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.568 HD13 ' CD2' ' A' ' 37' ' ' HIS . 35.6 tp -119.77 139.06 52.9 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.127 179.974 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.425 ' O ' ' OD1' ' A' ' 32' ' ' ASP . 78.6 mt -105.65 120.78 57.0 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 CA-C-O 121.088 0.47 . . . . 0.0 111.071 -179.275 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.476 HD12 HD22 ' A' ' 117' ' ' LEU . 96.4 mt -136.33 133.05 49.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.597 179.522 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.509 HD21 ' CG ' ' A' ' 241' ' ' ASP . 61.4 t30 -64.26 151.19 44.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.939 0.399 . . . . 0.0 110.4 179.468 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.517 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 89.3 t80 -86.38 122.94 31.05 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.805 -179.484 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.517 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 99.1 m-20 55.12 69.5 0.73 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.841 179.648 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 42.8 p-10 -127.54 1.06 6.22 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.917 0.389 . . . . 0.0 110.617 -179.956 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -150.45 114.76 5.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.718 -179.643 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 83.4 p -63.44 168.44 4.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.517 -179.803 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.414 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.6 p-90 -52.13 -15.66 0.63 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.599 -179.858 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.436 ' O ' HG23 ' A' ' 154' ' ' THR . 68.1 tp60 -70.62 -76.17 0.11 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.507 -179.801 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.45 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.0 t -62.79 -38.55 91.07 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.309 179.584 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 53.2 tp -59.82 -45.79 91.26 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.459 -178.636 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.414 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 46.7 tp -62.77 -41.72 99.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.431 179.051 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.45 ' OG1' ' O ' ' A' ' 151' ' ' SER . 60.4 p -63.96 -34.87 78.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.311 -179.633 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.461 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.6 mm-40 -63.89 -42.34 97.48 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.277 179.266 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 92.4 mt -65.45 -38.81 90.94 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.949 0.404 . . . . 0.0 110.215 179.027 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.579 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -61.32 -31.89 78.85 Favored Glycine 0 CA--C 1.521 0.442 0 N-CA-C 110.829 -0.908 . . . . 0.0 110.829 -179.428 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.461 ' OE2' ' NE2' ' A' ' 155' ' ' GLN . 97.3 mt-10 -36.62 -25.53 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.87 0.367 . . . . 0.0 110.814 179.976 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.579 ' N ' ' O ' ' A' ' 157' ' ' GLY . 93.9 mt -59.02 150.63 5.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.288 179.464 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 73.5 p -69.26 137.2 52.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.922 -179.435 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 69.88 22.98 77.17 Favored Glycine 0 CA--C 1.517 0.197 0 N-CA-C 111.226 -0.75 . . . . 0.0 111.226 179.408 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 61.4 m80 -124.0 -13.92 7.22 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.717 0.294 . . . . 0.0 110.576 179.91 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -67.13 -59.53 3.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.764 -179.71 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -51.49 -49.59 61.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.261 -179.718 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -60.08 -41.31 92.15 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.732 0.301 . . . . 0.0 110.374 179.484 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.44 -47.61 84.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.596 179.85 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.57 -40.25 74.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.297 -179.901 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -61.46 -50.32 73.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.621 179.613 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.403 ' NE ' ' HB1' ' A' ' 59' ' ' ALA . 59.9 ttt85 -65.65 -43.61 88.87 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.477 179.6 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 94.6 mt -64.46 -43.51 96.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.46 179.747 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.38 -51.31 69.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.616 -179.269 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.8 -44.18 94.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.49 179.686 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.659 ' CE2' HD11 ' A' ' 177' ' ' LEU . 55.1 t80 -62.76 -44.38 96.34 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.494 179.458 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -63.3 -40.0 96.13 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.621 -179.434 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -62.89 -42.74 99.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.677 179.231 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -60.78 -44.89 96.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.148 179.936 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.659 HD11 ' CE2' ' A' ' 173' ' ' PHE . 85.6 mt -64.6 -41.08 96.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.053 0.454 . . . . 0.0 110.771 178.887 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.04 -61.95 1.94 Allowed 'General case' 0 C--O 1.236 0.38 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.558 -179.415 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.83 -46.75 86.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.484 179.825 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.24 -41.41 65.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.268 -179.968 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -64.18 -33.78 76.57 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.958 0.409 . . . . 0.0 110.391 179.282 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.426 ' HG2' ' O ' ' A' ' 182' ' ' GLU . 69.4 tt0 -90.74 9.04 31.58 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.255 0.55 . . . . 0.0 110.575 -179.018 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -104.94 -32.19 8.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.045 179.746 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.4 pt -128.22 147.86 32.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.799 -179.773 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -140.05 131.1 26.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.398 179.385 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.6 HD22 ' N ' ' A' ' 186' ' ' LEU . 3.6 mm? -85.54 133.9 41.16 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.789 179.99 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -44.15 157.99 0.14 Allowed 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.773 2.315 . . . . 0.0 112.055 179.363 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 0.535 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.9 Cg_endo -63.02 114.84 2.61 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 C-N-CA 122.774 2.316 . . . . 0.0 111.786 179.783 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . 0.535 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.7 mt-30 155.36 148.15 0.0 OUTLIER Pre-proline 0 N--CA 1.455 -0.186 0 O-C-N 123.461 0.476 . . . . 0.0 110.67 -179.809 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -73.61 144.22 35.34 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.738 2.292 . . . . 0.0 111.861 178.001 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.498 ' CG2' ' N ' ' A' ' 192' ' ' THR . 2.1 p -124.99 158.95 32.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.232 0.539 . . . . 0.0 110.165 -179.979 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . 0.498 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 38.5 p -143.51 165.13 28.43 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.01 -179.427 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . 0.444 ' HA ' ' H ' ' A' ' 260' ' ' PHE . . . -135.45 128.53 31.65 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.109 0.48 . . . . 0.0 110.231 179.543 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.505 HD11 HD23 ' A' ' 259' ' ' LEU . 47.7 pt -146.27 148.39 17.15 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.04 -179.945 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . 0.746 HG13 ' CD1' ' A' ' 262' ' ' PHE . 72.2 t -117.28 123.09 71.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.21 0.529 . . . . 0.0 109.909 178.962 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -134.13 107.4 7.7 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.296 179.674 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 94.5 m -130.95 130.42 43.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.853 179.797 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -82.76 -36.95 25.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.324 179.668 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.55 -67.39 0.24 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.422 179.942 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -71.93 -9.97 59.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.314 179.515 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 59.7 t-80 60.85 58.34 2.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.738 -179.877 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 39.7 p -167.18 153.39 8.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.594 179.596 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.24 144.08 24.47 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.987 0.422 . . . . 0.0 110.496 179.433 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -135.41 138.43 43.25 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.583 -179.914 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 20.1 mt -106.16 125.33 50.86 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 121.074 0.464 . . . . 0.0 109.926 -179.758 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 206' ' ' TRP . . . . . 0.569 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 74.7 m95 -81.82 166.82 19.65 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.623 -179.81 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . 0.463 HG22 ' C ' ' A' ' 206' ' ' TRP . 0.1 OUTLIER -156.47 172.35 6.2 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.615 -179.244 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -54.42 -37.29 89.39 Favored 'Trans proline' 0 C--N 1.303 -1.825 0 C-N-CA 122.716 2.277 . . . . 0.0 112.015 179.297 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -70.45 -34.68 72.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.765 -179.75 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 21.6 m -61.5 150.57 35.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.586 -179.357 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.41 -36.47 80.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.471 -179.75 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . 0.569 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 54.2 tt0 -64.46 -40.81 96.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.543 179.908 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.61 -43.47 92.04 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 179.837 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -63.23 -44.14 96.09 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.761 0.315 . . . . 0.0 110.295 179.658 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . 0.579 ' SD ' ' HB2' ' A' ' 304' ' ' ALA . 65.1 ttp -59.61 -48.0 83.39 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.314 -179.879 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 86.3 mt -60.55 -40.82 93.01 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.353 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . 0.456 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 40.7 tp10 -57.86 -38.2 75.29 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 179.513 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -65.26 -38.17 89.48 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.8 0.333 . . . . 0.0 110.624 179.678 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 94.6 mt -64.35 -42.82 96.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.491 -179.689 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.63 45.96 0.08 OUTLIER Glycine 0 CA--C 1.521 0.435 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 179.993 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . 0.456 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 26.8 m-85 -129.07 156.13 44.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.993 0.425 . . . . 0.0 110.487 -179.829 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.487 ' O ' HG13 ' A' ' 191' ' ' VAL . 7.7 p -108.1 122.7 47.43 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.112 0.482 . . . . 0.0 110.239 -179.997 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.478 HD22 ' C ' ' A' ' 222' ' ' THR . 4.3 mm? -101.43 133.17 46.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.089 -179.889 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.99 159.81 14.7 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.52 179.776 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -105.03 115.08 29.68 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.934 0.397 . . . . 0.0 110.398 179.853 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.494 ' N ' HD12 ' A' ' 226' ' ' LEU . 9.1 mp -53.37 156.86 3.79 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.574 179.954 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -60.27 145.22 99.03 Favored 'Trans proline' 0 C--N 1.302 -1.887 0 C-N-CA 122.615 2.21 . . . . 0.0 112.076 179.303 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.56 -2.78 58.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.543 -179.969 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.41 -40.67 5.67 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -179.842 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.552 ' O ' ' N ' ' A' ' 233' ' ' SER . 85.3 mt -79.29 -16.77 55.86 Favored 'General case' 0 C--O 1.224 -0.242 0 CA-C-O 120.929 0.395 . . . . 0.0 110.41 -179.821 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . 0.407 ' C ' ' O ' ' A' ' 230' ' ' LEU . 54.8 t-20 -39.82 -49.21 2.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.708 -179.706 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -88.55 15.71 7.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.103 -179.926 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.552 ' N ' ' O ' ' A' ' 230' ' ' LEU . 78.2 p -60.64 -35.96 77.47 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.64 -179.891 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . 0.527 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.7 tt0 -118.01 -69.55 0.84 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.911 179.677 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.0 m -70.56 103.36 2.48 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.658 -179.791 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -94.54 58.09 2.32 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.387 179.885 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -145.11 -122.71 1.56 Allowed Glycine 0 CA--C 1.522 0.47 0 N-CA-C 110.931 -0.868 . . . . 0.0 110.931 -179.927 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -133.71 111.7 10.79 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.052 0.454 . . . . 0.0 110.487 179.964 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . 0.496 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.0 mtt180 -148.18 56.88 1.07 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.741 -179.926 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 94.2 m-70 -69.66 -31.46 69.54 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.569 179.578 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . 0.509 ' CG ' HD21 ' A' ' 143' ' ' ASN . 65.2 t0 -56.87 -46.84 81.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.33 -179.147 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 242' ' ' ILE . . . . . 0.439 ' O ' ' O ' ' A' ' 239' ' ' ARG . 17.2 tt -140.71 157.86 23.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.913 0.387 . . . . 0.0 110.529 179.726 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.445 HG22 HD13 ' A' ' 245' ' ' LEU . 96.0 mt -106.28 106.13 20.02 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.198 0 CA-C-O 121.147 0.498 . . . . 0.0 110.489 179.886 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . 0.608 ' O ' HD12 ' A' ' 245' ' ' LEU . 88.3 mt-30 -110.68 110.62 21.36 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.375 179.765 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.608 HD12 ' O ' ' A' ' 244' ' ' GLN . 9.5 mp -122.19 -168.05 1.65 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.619 179.826 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . 0.527 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 172.98 -16.63 0.05 OUTLIER Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 179.901 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . 0.666 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -60.42 157.46 28.85 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 -179.819 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -64.21 21.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.955 0.407 . . . . 0.0 110.584 179.964 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . 0.666 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.8 m-20 -97.01 -5.84 36.74 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.548 179.932 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 92.5 mt -80.15 -21.18 43.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.643 179.464 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.52 -51.39 70.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.764 -179.555 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.83 -5.34 58.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.423 179.67 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -81.06 -74.43 1.14 Allowed Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 -179.863 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 80.1 mt -69.84 125.51 26.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.044 0.449 . . . . 0.0 110.253 -179.882 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -59.41 -39.53 83.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.29 -179.679 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 83.35 51.77 4.01 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 110.806 -0.917 . . . . 0.0 110.806 179.897 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -95.17 -16.08 22.83 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.79 0.329 . . . . 0.0 110.623 -179.883 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . 0.492 ' OG ' HG23 ' A' ' 191' ' ' VAL . 3.4 t 174.92 89.29 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.014 0.435 . . . . 0.0 110.222 179.995 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.865 ' N ' HD12 ' A' ' 259' ' ' LEU . 0.9 OUTLIER -94.17 124.2 38.04 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.22 0.533 . . . . 0.0 111.052 -179.024 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 260' ' ' PHE . . . . . 0.444 ' H ' ' HA ' ' A' ' 193' ' ' ALA . 16.1 m-30 -93.55 146.98 23.4 Favored 'General case' 0 CA--C 1.51 -0.577 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.406 179.053 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 85.3 mt -122.46 150.02 43.08 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.537 -179.895 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.746 ' CD1' HG13 ' A' ' 195' ' ' VAL . 2.7 p90 -77.85 -138.86 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.533 -179.795 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . 0.662 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -51.44 78.17 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.942 -179.885 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . 0.631 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.88 104.57 0.19 Allowed Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 179.942 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 265' ' ' ASP . . . . . 0.601 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.8 m-20 -80.29 -177.23 6.03 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 120.692 0.282 . . . . 0.0 110.858 -179.432 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -40.7 -17.69 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.49 179.825 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . 0.601 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.5 -51.57 41.84 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.78 179.521 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -63.89 -46.62 84.09 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.282 179.312 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . 0.583 ' HB1' ' OH ' ' A' ' 273' ' ' TYR . . . -61.56 -35.1 76.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.976 179.424 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -62.89 -34.5 77.54 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.177 179.561 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.46 -43.36 13.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.223 -179.536 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 272' ' ' ILE . . . . . 0.588 ' C ' ' H ' ' A' ' 274' ' ' ALA . 5.0 tt -51.56 -33.65 15.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.704 -178.643 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 273' ' ' TYR . . . . . 0.583 ' OH ' ' HB1' ' A' ' 269' ' ' ALA . 16.9 m-85 -54.25 -1.82 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.71 -179.755 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 274' ' ' ALA . . . . . 0.588 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -71.75 -39.59 69.92 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.906 179.571 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . 0.586 ' O ' ' N ' ' A' ' 279' ' ' ALA . 3.7 p30 -39.17 97.94 0.15 Allowed Pre-proline 0 C--N 1.333 -0.15 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.576 -179.679 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 276' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo -53.97 -43.18 60.46 Favored 'Trans proline' 0 C--N 1.304 -1.814 0 C-N-CA 122.463 2.109 . . . . 0.0 112.614 -178.803 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 89.2 mt -64.5 -42.82 95.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.072 -179.563 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 91.0 mt -95.98 -1.11 49.69 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.814 -179.399 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 279' ' ' ALA . . . . . 0.586 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.49 -34.93 77.82 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.568 -179.721 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -74.33 20.28 0.12 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.965 -179.204 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 0.495 HD23 ' HA ' ' A' ' 281' ' ' LEU . 13.7 mt -75.16 120.03 79.72 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.43 179.859 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -50.9 -39.61 58.66 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.617 2.211 . . . . 0.0 111.781 179.172 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.75 -50.63 63.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.171 179.731 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 74.7 t -61.48 -43.99 97.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 179.487 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -57.68 -41.28 81.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.283 -179.983 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -90.68 0.21 57.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.221 179.593 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt 59.73 42.93 16.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.872 179.658 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -94.7 41.34 1.09 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.356 179.793 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 54.0 t -119.02 135.92 57.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.964 0.412 . . . . 0.0 110.237 -179.832 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -133.68 163.61 29.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.69 -179.57 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.86 155.52 32.48 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.944 0.402 . . . . 0.0 110.721 -179.735 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 80.7 mt -94.32 -1.66 53.5 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.311 -179.765 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.46 165.3 12.57 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 -179.653 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 6.8 m -86.8 -61.66 1.68 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.871 0.367 . . . . 0.0 111.066 -179.814 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 295' ' ' GLU . . . . . 0.455 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.5 mm-40 -69.55 -4.75 20.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.657 -179.704 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 25.6 p -76.14 32.82 0.12 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.617 -179.88 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 297' ' ' PHE . . . . . 0.522 ' CD2' HG22 ' A' ' 70' ' ' THR . 82.5 t80 -60.62 -46.12 91.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.662 -179.967 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . 0.613 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.2 mtt85 -80.76 137.11 36.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.679 -179.535 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.499 ' H ' HG11 ' A' ' 51' ' ' VAL . 4.2 tp -114.16 116.17 28.66 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.407 179.775 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . 0.627 ' H ' ' CB ' ' A' ' 303' ' ' SER . 48.3 p-10 -166.05 -176.17 3.65 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.497 -179.921 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 77.9 t80 -46.79 -43.44 18.33 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.226 -179.946 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -66.85 -40.81 88.04 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.991 0.424 . . . . 0.0 110.741 179.289 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . 0.627 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 60.7 p -55.74 -36.22 67.03 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.068 -179.178 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . 0.579 ' HB2' ' SD ' ' A' ' 215' ' ' MET . . . -57.74 -51.61 68.83 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.085 179.385 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 91.1 mtp -55.96 -44.23 78.28 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.688 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -65.91 -43.27 88.66 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.869 0.366 . . . . 0.0 110.195 178.741 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 303' ' ' SER . 56.0 t -63.89 -43.03 97.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.249 179.463 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 43.8 tp -59.74 -42.12 92.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.938 -179.747 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -62.41 -39.24 92.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.07 179.767 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 310' ' ' ARG . . . . . 0.455 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.7 ttt85 -63.67 -43.84 95.52 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.32 179.487 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 89.5 mt -63.31 -42.04 98.99 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.325 179.563 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -62.97 -33.68 75.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.138 179.341 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -89.68 -23.47 21.85 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.388 -179.777 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.483 HD22 ' CE2' ' A' ' 315' ' ' PHE . 6.8 tt -62.28 -43.11 99.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.574 -179.971 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 315' ' ' PHE . . . . . 0.483 ' CE2' HD22 ' A' ' 314' ' ' LEU . 90.3 m-85 . . . . . 0 C--O 1.22 -0.478 0 CA-C-O 118.028 -0.987 . . . . 0.0 110.483 179.939 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -99.35 135.88 40.11 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.563 179.993 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.499 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -92.28 178.52 1.66 Allowed Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.572 -179.884 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.499 ' CD ' ' CB ' ' A' ' 26' ' ' TRP . 27.0 Cg_exo -61.63 147.34 95.59 Favored 'Trans proline' 0 C--N 1.301 -1.97 0 C-N-CA 122.777 2.318 . . . . 0.0 112.09 179.709 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.456 HH12 HG23 ' A' ' 159' ' ' ILE . 35.2 ptt180 -135.65 142.38 45.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.691 179.742 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -79.88 116.29 19.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.524 179.923 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.45 ' O ' HG23 ' A' ' 30' ' ' ILE . 9.4 tp -110.77 130.45 64.13 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.427 179.979 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.2 t -70.85 141.97 51.24 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.571 179.811 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.476 ' CG ' ' H ' ' A' ' 33' ' ' SER . 43.3 t0 -139.7 179.48 6.55 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.516 -179.913 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.476 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 78.5 p -73.67 -37.0 65.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.842 179.706 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.8 ttt85 -46.56 -94.66 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.354 -179.534 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.417 ' O ' ' OG1' ' A' ' 36' ' ' THR . . . -167.29 -26.55 0.02 OUTLIER Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 179.89 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.417 ' OG1' ' O ' ' A' ' 35' ' ' GLY . 64.8 m -168.76 104.37 0.42 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.908 0.385 . . . . 0.0 110.65 -179.826 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.675 ' CD2' HD13 ' A' ' 140' ' ' LEU . 73.9 t60 -128.41 147.93 50.68 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.031 0.443 . . . . 0.0 110.293 179.95 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.623 HG22 ' N ' ' A' ' 39' ' ' LEU . 98.5 m -130.48 165.93 21.61 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.66 -179.894 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.623 ' N ' HG22 ' A' ' 38' ' ' THR . 83.1 mt -120.51 127.75 52.48 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.513 179.729 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -65.33 -44.63 87.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.626 -179.901 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 42.2 p -165.77 154.77 11.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.466 179.652 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.532 ' H ' ' CD ' ' A' ' 42' ' ' GLN . 14.7 mp0 -44.32 101.31 0.25 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.644 179.495 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -57.36 129.22 32.89 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 122.378 2.052 . . . . 0.0 112.178 -179.716 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -83.61 -24.68 31.36 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.495 179.654 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.54 ' NE ' ' O ' ' A' ' 112' ' ' MET . 89.1 mtm-85 -122.02 134.98 54.8 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-O 121.133 0.492 . . . . 0.0 110.345 -179.922 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 95.9 mt -131.19 133.82 62.02 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.272 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.96 -179.711 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 45.7 t -124.38 130.38 73.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.325 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.626 ' OG ' HD12 ' A' ' 117' ' ' LEU . 2.3 m -154.94 166.64 32.93 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.548 179.865 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 67.7 p -124.59 9.31 8.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.515 179.904 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 t -85.45 125.53 33.09 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.665 -179.512 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.443 HG11 ' H ' ' A' ' 299' ' ' LEU . 98.4 t -65.86 -44.46 92.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.479 -179.982 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.5 m -62.68 -44.35 96.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.642 -179.839 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 51.1 tp -62.16 -41.6 98.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.555 -179.455 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.443 ' O ' HD13 ' A' ' 58' ' ' LEU . 76.3 m -57.6 -44.34 85.37 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.308 -179.322 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.22 -62.18 5.38 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 179.547 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.7 t -48.44 -35.65 13.32 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 -179.99 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 19.8 mt -61.77 -44.91 95.96 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.636 -0.426 . . . . 0.0 111.174 179.448 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.443 HD13 ' O ' ' A' ' 54' ' ' THR . 9.3 mp -64.68 -41.82 95.79 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.091 0.472 . . . . 0.0 111.382 177.86 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.404 ' HB1' ' NE ' ' A' ' 169' ' ' ARG . . . -63.6 -40.95 98.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.652 -0.703 . . . . 0.0 111.014 -179.206 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.439 ' O ' HG23 ' A' ' 60' ' ' ILE . 8.1 tp -88.6 17.18 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.724 -179.602 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 56.32 84.95 0.08 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.694 -179.977 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 179.24 58.99 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.081 -179.8 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -50.75 151.6 10.72 Favored 'Trans proline' 0 C--N 1.297 -2.155 0 C-N-CA 122.799 2.333 . . . . 0.0 112.579 -178.359 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.434 ' CG2' ' O ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -108.46 145.64 15.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.391 -179.764 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.8 mt -63.89 -44.91 98.16 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.298 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.416 -179.721 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.499 ' O ' ' O ' ' A' ' 48' ' ' SER . . . -130.18 134.41 47.27 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.574 -179.806 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.479 ' O ' ' N ' ' A' ' 98' ' ' LEU . 72.9 m -134.67 158.82 43.09 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.83 -179.589 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.32 138.5 15.94 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 110.726 -0.949 . . . . 0.0 110.726 179.816 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.478 ' CB ' ' HE ' ' A' ' 298' ' ' ARG . . . -176.46 -163.0 0.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.96 0.41 . . . . 0.0 110.508 -179.988 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.523 HG22 ' CD2' ' A' ' 297' ' ' PHE . 5.9 t -133.75 135.39 43.91 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.242 -179.977 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.494 ' C ' ' O ' ' A' ' 70' ' ' THR . 0.9 OUTLIER 29.61 68.35 0.67 Allowed Pre-proline 0 N--CA 1.464 0.236 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.745 -179.663 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -60.98 144.59 99.61 Favored 'Trans proline' 0 C--N 1.301 -1.958 0 C-N-CA 122.548 2.165 . . . . 0.0 112.252 -178.573 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.528 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 45.4 p-10 -159.68 -31.7 0.06 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.634 179.624 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.539 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 99.1 m-20 -64.15 -39.44 94.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.415 179.998 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -60.43 -48.2 82.8 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.644 -179.242 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.425 ' O ' ' O ' ' A' ' 77' ' ' ALA . 97.0 t -60.15 -24.7 31.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.154 179.596 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.539 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -45.72 173.15 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.588 179.853 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.574 ' O ' ' N ' ' A' ' 80' ' ' GLN . 53.3 p30 -62.06 177.56 0.45 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.583 -179.689 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.556 ' C ' ' H ' ' A' ' 81' ' ' GLY . 36.2 p30 -45.46 85.86 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.942 179.99 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.574 ' N ' ' O ' ' A' ' 78' ' ' ASP . 43.0 tp60 -67.65 13.23 0.08 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.08 -179.838 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.556 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . 118.52 -21.89 9.66 Favored Glycine 0 CA--C 1.519 0.321 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.985 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -108.4 116.46 32.02 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.941 0.4 . . . . 0.0 110.522 179.894 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 75.6 mt -98.79 0.49 44.5 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.451 -179.726 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -92.65 7.18 44.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.988 0.423 . . . . 0.0 110.46 -179.778 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.798 ' O ' HG22 ' A' ' 89' ' ' VAL . 88.5 mt-30 -100.03 -27.91 13.33 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.855 -179.971 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 69.3 t-105 -63.19 -40.71 98.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.877 -179.544 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.56 ' O ' ' N ' ' A' ' 91' ' ' LYS . 65.7 m -77.65 -53.68 7.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.203 -179.394 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -48.19 -50.86 27.59 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.939 -179.363 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.798 HG22 ' O ' ' A' ' 85' ' ' GLN . 15.7 m -68.89 -40.75 81.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 120.936 0.398 . . . . 0.0 111.034 179.836 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.499 ' N ' HG23 ' A' ' 89' ' ' VAL . . . -72.46 -22.65 61.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.83 -179.869 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.56 ' N ' ' O ' ' A' ' 87' ' ' SER . 66.1 tttm -61.91 -45.41 93.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.477 -179.578 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.441 ' OE1' ' O ' ' A' ' 110' ' ' ALA . 79.7 mm-40 -90.69 -94.88 0.12 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.118 -179.869 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.644 ' O ' ' N ' ' A' ' 95' ' ' LEU . 95.8 mtt180 -142.9 59.31 1.42 Allowed 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.716 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.466 ' C ' ' O ' ' A' ' 93' ' ' ARG . 22.8 pttp 33.33 25.97 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.162 -179.098 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.644 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.3 tt -47.78 123.54 6.13 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.918 -178.287 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.451 ' O ' HD23 ' A' ' 95' ' ' LEU . 99.1 mm-40 -83.8 -169.89 2.8 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.075 -179.913 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.612 ' NH1' ' NE ' ' A' ' 298' ' ' ARG . 82.4 mtp180 -74.1 137.17 43.12 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.197 -179.805 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.479 ' N ' ' O ' ' A' ' 67' ' ' SER . 90.4 mt -86.46 -165.74 1.35 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.704 -179.618 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.536 ' CD2' ' O ' ' A' ' 99' ' ' TYR . 48.6 p90 -168.87 120.14 0.75 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.297 179.972 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.518 ' C ' ' O ' ' A' ' 99' ' ' TYR . 43.3 mm -29.18 121.27 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.995 -179.563 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 114.38 27.06 3.49 Favored Glycine 0 CA--C 1.52 0.344 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 -179.575 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.587 ' H ' ' CD ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -144.27 46.2 0.61 Allowed Pre-proline 0 C--N 1.324 -0.508 0 CA-C-O 120.913 0.387 . . . . 0.0 110.511 179.946 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 102' ' ' GLU . 29.8 Cg_endo -61.8 143.63 96.2 Favored 'Trans proline' 0 C--N 1.297 -2.146 0 C-N-CA 122.695 2.263 . . . . 0.0 111.989 -179.937 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.458 ' O ' HG23 ' A' ' 108' ' ' VAL . 26.2 t -173.19 119.97 0.34 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.489 179.698 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.19 -40.56 64.68 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.068 0.461 . . . . 0.0 111.1 179.76 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.19 -40.02 90.12 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.819 -179.368 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.02 -39.95 95.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.713 -179.768 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 104' ' ' SER . 72.0 t -67.74 -43.97 86.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.839 179.709 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.77 -38.98 92.73 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.552 -179.31 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.441 ' O ' ' OE1' ' A' ' 92' ' ' GLU . . . -59.47 -23.3 62.61 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.434 179.867 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.554 ' O ' ' C ' ' A' ' 112' ' ' MET . 99.5 mm-40 -90.51 5.12 49.06 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.651 -179.518 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.554 ' C ' ' O ' ' A' ' 111' ' ' GLN . 10.4 tpt 24.03 63.73 0.4 Allowed Pre-proline 0 N--CA 1.464 0.266 0 CA-C-O 120.861 0.362 . . . . 0.0 110.866 -179.967 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -77.92 167.36 23.8 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 C-N-CA 122.998 2.465 . . . . 0.0 112.392 -178.739 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.525 ' OD1' ' NH2' ' A' ' 45' ' ' ARG . 99.4 m-20 -110.49 -42.38 4.11 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.982 0.42 . . . . 0.0 110.042 179.55 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 39.8 tp -120.98 120.14 34.59 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.036 179.54 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 84.7 mt -113.21 129.19 69.38 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 CA-C-O 120.978 0.418 . . . . 0.0 110.848 -179.832 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.626 HD12 ' OG ' ' A' ' 48' ' ' SER . 29.2 mt -108.95 132.26 54.25 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.235 -179.71 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.497 HD12 HG23 ' A' ' 139' ' ' THR . 98.8 mt -119.59 138.77 49.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.712 -179.766 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 85.8 p -72.65 153.45 41.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.565 -179.998 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.21 -49.98 75.46 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.682 -179.769 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.9 t -149.55 154.07 38.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.6 179.811 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 170.36 -170.86 43.29 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 179.838 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.99 -34.17 89.24 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 179.949 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.453 ' O ' ' OD1' ' A' ' 124' ' ' ASP . 44.2 p-10 -87.33 120.27 28.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.833 0.349 . . . . 0.0 110.626 -179.942 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.435 ' O ' HD12 ' A' ' 129' ' ' LEU . 40.0 t -63.22 143.74 57.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.538 -179.976 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.521 ' O ' ' N ' ' A' ' 130' ' ' TYR . . . -93.23 -43.18 8.95 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.819 -179.778 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.2 tp -62.7 -42.55 99.7 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.718 -179.912 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.26 -12.23 59.56 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.574 -179.459 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.435 HD12 ' O ' ' A' ' 125' ' ' SER . 84.1 mt -114.91 -23.51 9.08 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.721 -179.797 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . 0.521 ' N ' ' O ' ' A' ' 126' ' ' ALA . 78.0 t80 -51.12 -49.67 60.31 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 120.586 -0.446 . . . . 0.0 110.476 -178.929 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 132' ' ' GLN . 38.1 p-10 -65.81 -42.52 90.55 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.905 0.383 . . . . 0.0 111.138 179.599 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.523 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 88.2 mt-30 -67.13 -37.84 84.53 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.832 179.97 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.431 HD12 HD11 ' A' ' 118' ' ' ILE . 95.9 mt -80.39 -41.32 24.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.881 -179.505 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.2 t -57.26 -44.53 83.98 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.243 -179.236 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 18.8 m -61.77 -45.36 94.22 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.8 0.333 . . . . 0.0 110.597 179.326 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 93.0 mt -62.11 -43.55 97.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.226 -179.784 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.658 ' HB1' ' HD2' ' A' ' 138' ' ' PRO . . . -169.63 168.31 4.77 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.559 179.867 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.658 ' HD2' ' HB1' ' A' ' 137' ' ' ALA . 51.4 Cg_exo -49.94 113.25 0.92 Allowed 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.286 1.991 . . . . 0.0 112.092 179.507 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.497 HG23 HD12 ' A' ' 118' ' ' ILE . 23.8 m -84.15 127.22 33.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.594 -179.954 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.675 HD13 ' CD2' ' A' ' 37' ' ' HIS . 34.4 tp -117.66 135.23 54.14 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.988 -179.77 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.439 ' O ' ' OD2' ' A' ' 32' ' ' ASP . 81.5 mt -99.54 118.95 46.91 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 CA-C-O 121.175 0.512 . . . . 0.0 111.276 -179.336 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.438 HD12 HD22 ' A' ' 117' ' ' LEU . 98.1 mt -135.02 132.05 53.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.64 179.627 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.542 HD21 ' CG ' ' A' ' 241' ' ' ASP . 60.2 t30 -66.63 150.26 49.3 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.842 0.353 . . . . 0.0 110.428 179.4 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.517 ' CE2' ' OD2' ' A' ' 145' ' ' ASP . 87.7 t80 -85.01 122.39 29.16 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.859 -179.499 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.517 ' OD2' ' CE2' ' A' ' 144' ' ' TYR . 98.7 m-20 55.25 69.21 0.76 Allowed 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.856 179.748 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 34.9 p-10 -125.82 0.56 7.38 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.926 0.393 . . . . 0.0 110.753 179.857 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -150.85 115.73 5.26 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.699 -179.522 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 83.9 p -64.39 169.15 4.95 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.528 -179.842 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.423 ' O ' ' CB ' ' A' ' 153' ' ' LEU . 65.4 p-90 -52.21 -16.12 0.75 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.559 -179.863 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.435 ' O ' HG23 ' A' ' 154' ' ' THR . 68.2 tp60 -70.07 -77.01 0.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.425 -179.712 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.453 ' O ' ' OG1' ' A' ' 154' ' ' THR . 11.1 t -62.57 -38.26 89.39 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.369 179.568 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 53.2 tp -60.06 -45.53 92.55 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.373 -178.566 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.423 ' CB ' ' O ' ' A' ' 149' ' ' TRP . 46.8 tp -62.85 -41.74 99.48 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.821 0.343 . . . . 0.0 110.321 179.086 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.453 ' OG1' ' O ' ' A' ' 151' ' ' SER . 63.5 p -64.07 -34.75 78.74 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.285 -179.611 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.432 ' NE2' ' OE2' ' A' ' 158' ' ' GLU . 87.8 mm-40 -63.97 -42.77 97.14 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.316 179.235 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 92.7 mt -65.39 -39.02 91.72 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.016 0.436 . . . . 0.0 110.255 179.099 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.587 ' O ' ' N ' ' A' ' 159' ' ' ILE . . . -60.93 -32.08 78.58 Favored Glycine 0 CA--C 1.52 0.404 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 -179.468 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.439 ' C ' ' O ' ' A' ' 157' ' ' GLY . 97.2 mt-10 -35.71 -26.42 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.815 0.341 . . . . 0.0 110.744 179.93 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.587 ' N ' ' O ' ' A' ' 157' ' ' GLY . 95.7 mt -57.02 149.32 4.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.251 179.313 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 72.6 p -69.61 137.27 52.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.979 -179.535 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 71.77 20.45 78.68 Favored Glycine 0 N--CA 1.458 0.156 0 N-CA-C 111.243 -0.743 . . . . 0.0 111.243 179.457 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 56.8 m80 -122.3 -14.66 7.85 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.785 0.326 . . . . 0.0 110.64 179.816 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -65.22 -60.31 3.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.723 -179.684 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -51.85 -49.14 63.47 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.246 -179.771 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -60.66 -41.08 94.29 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.704 0.288 . . . . 0.0 110.284 179.542 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.55 -47.02 87.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.637 179.828 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -57.24 -40.03 76.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.251 -179.983 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -61.85 -50.31 72.77 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.562 179.621 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.404 ' NE ' ' HB1' ' A' ' 59' ' ' ALA . 59.9 ttt85 -65.36 -43.84 89.57 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.511 179.551 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 95.1 mt -64.65 -43.47 96.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.473 179.736 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.23 -50.92 71.35 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.627 -179.261 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.47 -43.72 96.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.363 179.747 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.659 ' CE2' HD11 ' A' ' 177' ' ' LEU . 56.1 t80 -62.7 -44.64 95.71 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.123 0.487 . . . . 0.0 110.443 179.4 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -63.33 -40.08 96.31 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.522 -179.312 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -62.95 -42.73 99.9 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.704 179.259 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -60.77 -44.85 96.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.071 179.946 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.659 HD11 ' CE2' ' A' ' 173' ' ' PHE . 84.8 mt -64.3 -41.13 97.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.033 0.444 . . . . 0.0 110.661 178.917 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -51.88 -62.51 1.58 Allowed 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.478 -179.335 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.52 -46.86 85.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.58 179.819 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -53.26 -41.71 65.77 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.245 -179.993 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -63.8 -33.59 76.01 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.946 0.403 . . . . 0.0 110.364 179.27 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.425 ' HG2' ' O ' ' A' ' 182' ' ' GLU . 69.6 tt0 -90.51 8.49 33.7 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.317 0.58 . . . . 0.0 110.586 -179.091 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -104.5 -32.33 9.04 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.257 179.597 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.3 pt -128.01 147.6 32.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.843 -179.878 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -139.76 130.99 26.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.347 179.506 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.598 HD22 ' N ' ' A' ' 186' ' ' LEU . 3.6 mm? -85.49 133.37 42.32 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.793 179.992 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -44.05 157.9 0.14 Allowed 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.735 2.29 . . . . 0.0 112.042 179.527 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 0.535 ' O ' ' CB ' ' A' ' 189' ' ' GLN . 27.7 Cg_endo -62.96 114.87 2.62 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 122.748 2.299 . . . . 0.0 111.76 179.817 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . 0.535 ' CB ' ' O ' ' A' ' 188' ' ' PRO . 3.8 mt-30 155.28 148.17 0.0 OUTLIER Pre-proline 0 C--N 1.331 -0.199 0 O-C-N 123.383 0.427 . . . . 0.0 110.665 -179.784 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -73.94 144.5 34.49 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 122.725 2.283 . . . . 0.0 111.734 178.126 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.498 HG23 ' OG ' ' A' ' 258' ' ' SER . 2.1 p -125.29 158.94 33.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.198 0.523 . . . . 0.0 110.12 -179.974 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . 0.497 ' N ' ' CG2' ' A' ' 191' ' ' VAL . 35.4 p -143.61 165.58 27.22 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.129 -179.609 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . 0.444 ' HA ' ' H ' ' A' ' 260' ' ' PHE . . . -135.76 128.66 31.28 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.151 0.501 . . . . 0.0 110.273 179.69 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.498 HD11 HD23 ' A' ' 259' ' ' LEU . 47.3 pt -146.3 148.76 16.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.021 179.899 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . 0.743 HG13 ' CD1' ' A' ' 262' ' ' PHE . 70.3 t -117.49 122.88 70.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.245 0.545 . . . . 0.0 109.692 179.112 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -134.21 107.32 7.62 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.292 179.699 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 95.2 m -131.08 130.56 43.35 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.818 179.833 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -83.09 -36.87 24.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.228 179.71 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -40.6 -66.95 0.27 Allowed 'General case' 0 C--O 1.231 0.129 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.402 179.997 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -72.42 -9.76 58.93 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.246 179.494 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 60.0 t-80 60.7 58.46 2.41 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.799 -179.844 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 40.6 p -167.16 153.25 7.96 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.505 179.55 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -151.26 143.92 24.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.997 0.427 . . . . 0.0 110.452 179.458 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -135.38 138.83 43.69 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.655 179.952 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 20.3 mt -106.69 125.54 51.13 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 121.134 0.492 . . . . 0.0 109.795 -179.687 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 206' ' ' TRP . . . . . 0.556 ' CE2' ' OE1' ' A' ' 212' ' ' GLN . 74.9 m95 -81.93 166.95 19.43 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.575 -179.72 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . 0.473 HG22 ' C ' ' A' ' 206' ' ' TRP . 0.1 OUTLIER -156.94 171.62 7.2 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 120.997 0.427 . . . . 0.0 110.525 -179.223 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.06 -36.99 86.54 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 C-N-CA 122.639 2.226 . . . . 0.0 111.959 179.473 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -70.43 -35.16 73.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.906 -179.893 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 21.4 m -60.94 150.92 31.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.614 -179.296 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -61.58 -37.12 82.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.529 -179.751 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 212' ' ' GLN . . . . . 0.556 ' OE1' ' CE2' ' A' ' 206' ' ' TRP . 55.0 tt0 -64.56 -40.36 95.42 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.519 179.977 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.52 -43.32 92.58 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 179.804 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -63.45 -43.93 95.97 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.707 0.289 . . . . 0.0 110.276 179.883 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . 0.525 ' SD ' ' HB2' ' A' ' 304' ' ' ALA . 65.4 ttp -59.49 -48.1 82.95 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.322 -179.805 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 216' ' ' LEU . 87.7 mt -60.38 -40.6 91.42 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 179.416 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 217' ' ' GLU . . . . . 0.462 ' OE1' ' O ' ' A' ' 221' ' ' PHE . 41.9 tp10 -58.34 -37.98 76.25 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.739 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -65.14 -38.28 90.11 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.813 0.34 . . . . 0.0 110.709 179.702 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 93.9 mt -64.36 -42.65 96.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.584 -179.62 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 137.56 45.1 0.08 OUTLIER Glycine 0 C--N 1.333 0.379 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 -179.937 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . 0.462 ' O ' ' OE1' ' A' ' 217' ' ' GLU . 27.0 m-85 -128.08 155.18 44.79 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.052 0.454 . . . . 0.0 110.487 -179.807 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.485 ' O ' HG13 ' A' ' 191' ' ' VAL . 6.4 p -106.92 122.28 46.11 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.179 0.514 . . . . 0.0 110.261 -179.987 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.473 HD22 ' C ' ' A' ' 222' ' ' THR . 4.3 mm? -101.22 133.0 46.45 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.077 -179.957 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -96.85 159.55 14.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.509 179.886 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.38 114.99 29.5 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.333 179.88 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.495 ' N ' HD12 ' A' ' 226' ' ' LEU . 9.1 mp -53.13 156.94 3.33 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.626 179.935 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 227' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -60.46 145.36 98.87 Favored 'Trans proline' 0 C--N 1.302 -1.903 0 C-N-CA 122.601 2.201 . . . . 0.0 112.004 179.485 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -87.3 -3.27 59.03 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.556 -179.989 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -90.01 -41.16 5.66 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 -179.885 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.536 ' O ' ' N ' ' A' ' 233' ' ' SER . 85.5 mt -79.08 -17.19 55.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.983 0.42 . . . . 0.0 110.364 -179.738 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . 0.404 ' C ' ' O ' ' A' ' 230' ' ' LEU . 54.8 t-20 -40.11 -49.41 2.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.757 -179.694 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -87.82 15.32 7.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.768 0.318 . . . . 0.0 111.186 -179.967 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.536 ' N ' ' O ' ' A' ' 230' ' ' LEU . 78.1 p -60.4 -35.74 76.45 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.535 -179.811 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . 0.525 ' OE1' ' N ' ' A' ' 246' ' ' GLY . 58.6 tt0 -118.74 -69.19 0.86 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.917 179.642 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 4.3 m -69.73 103.11 2.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.633 -179.785 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -94.29 57.5 2.33 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.391 179.909 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -144.82 -122.42 1.56 Allowed Glycine 0 CA--C 1.521 0.43 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 -179.987 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -135.17 111.8 9.98 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 121.115 0.483 . . . . 0.0 110.468 179.983 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . 0.523 ' NH1' ' OE1' ' A' ' 244' ' ' GLN . 95.5 mtt180 -148.15 57.74 1.08 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.738 -179.894 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 240' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -69.64 -32.21 70.75 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.548 179.625 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . 0.542 ' CG ' HD21 ' A' ' 143' ' ' ASN . 65.1 t0 -56.94 -46.94 81.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.396 -179.159 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 242' ' ' ILE . . . . . 0.437 ' O ' ' O ' ' A' ' 239' ' ' ARG . 17.8 tt -139.84 156.43 25.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.893 0.378 . . . . 0.0 110.518 179.746 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.439 HG22 HD13 ' A' ' 245' ' ' LEU . 96.2 mt -106.24 106.34 20.4 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.188 0 CA-C-O 121.108 0.48 . . . . 0.0 110.511 179.863 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . 0.609 ' O ' HD12 ' A' ' 245' ' ' LEU . 88.2 mt-30 -110.25 110.06 20.74 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.261 179.76 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.609 HD12 ' O ' ' A' ' 244' ' ' GLN . 9.4 mp -121.96 -168.45 1.71 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.663 179.839 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . 0.525 ' N ' ' OE1' ' A' ' 234' ' ' GLN . . . 173.54 -16.66 0.05 OUTLIER Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.911 -0.875 . . . . 0.0 110.911 179.945 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . 0.672 ' C ' ' H ' ' A' ' 249' ' ' ASN . . . -60.62 156.83 30.79 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -179.888 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -63.72 21.73 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.936 0.398 . . . . 0.0 110.655 179.924 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . 0.672 ' H ' ' C ' ' A' ' 247' ' ' GLY . 98.8 m-20 -97.34 -5.94 35.39 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.572 179.943 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 93.5 mt -79.85 -21.82 43.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.619 179.575 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.54 -51.27 70.59 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.864 -179.57 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -88.4 -5.54 58.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.394 179.642 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -80.93 -74.53 1.13 Allowed Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 -179.911 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 81.5 mt -69.79 125.4 26.62 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.025 0.44 . . . . 0.0 110.178 -179.816 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -59.49 -39.48 83.91 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.389 -179.739 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 84.45 51.71 3.8 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -179.938 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -94.62 -16.51 23.12 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.738 0.304 . . . . 0.0 110.597 -179.862 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . 0.498 ' OG ' HG23 ' A' ' 191' ' ' VAL . 3.3 t 174.17 89.83 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.045 0.45 . . . . 0.0 110.119 -179.971 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.866 ' N ' HD12 ' A' ' 259' ' ' LEU . 1.0 OUTLIER -94.46 124.03 38.24 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.224 0.535 . . . . 0.0 111.088 -179.099 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 260' ' ' PHE . . . . . 0.444 ' H ' ' HA ' ' A' ' 193' ' ' ALA . 16.0 m-30 -93.18 146.85 23.37 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.332 179.166 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 86.7 mt -122.57 149.87 43.36 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.512 -179.9 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.743 ' CD1' HG13 ' A' ' 195' ' ' VAL . 2.6 p90 -77.94 -138.48 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.526 -179.813 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . 0.661 ' N ' ' CG ' ' A' ' 262' ' ' PHE . . . -51.89 77.49 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.92 -179.942 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . 0.637 ' N ' ' O ' ' A' ' 262' ' ' PHE . . . -179.13 104.42 0.19 Allowed Glycine 0 N--CA 1.467 0.721 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 -179.986 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 265' ' ' ASP . . . . . 0.604 ' O ' ' N ' ' A' ' 267' ' ' LYS . 98.6 m-20 -80.43 -177.54 6.24 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.713 0.292 . . . . 0.0 110.91 -179.497 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 266' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -40.64 -17.56 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.852 0.358 . . . . 0.0 110.493 179.866 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . 0.604 ' N ' ' O ' ' A' ' 265' ' ' ASP . 88.8 tttt -68.64 -51.51 41.39 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.637 179.576 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -63.88 -46.71 83.69 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.076 179.525 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . 0.568 ' HB1' ' OH ' ' A' ' 273' ' ' TYR . . . -61.54 -35.12 76.85 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.839 179.552 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -62.98 -34.59 77.86 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.126 179.653 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -85.36 -43.3 13.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.336 -179.588 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 272' ' ' ILE . . . . . 0.584 ' C ' ' H ' ' A' ' 274' ' ' ALA . 4.9 tt -51.42 -33.63 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.826 -178.872 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 273' ' ' TYR . . . . . 0.568 ' OH ' ' HB1' ' A' ' 269' ' ' ALA . 17.4 m-85 -54.37 -1.7 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.677 -179.7 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 274' ' ' ALA . . . . . 0.584 ' H ' ' C ' ' A' ' 272' ' ' ILE . . . -72.13 -39.71 68.62 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.906 179.63 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . 0.588 ' O ' ' N ' ' A' ' 279' ' ' ALA . 3.9 p30 -39.36 97.78 0.15 Allowed Pre-proline 0 N--CA 1.462 0.156 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.54 -179.653 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 276' ' ' PRO . . . . . 0.402 ' N ' ' O ' ' A' ' 274' ' ' ALA . 45.5 Cg_exo -53.97 -43.31 59.36 Favored 'Trans proline' 0 C--N 1.303 -1.848 0 C-N-CA 122.363 2.042 . . . . 0.0 112.737 -178.857 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 89.4 mt -64.37 -42.83 95.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.206 -179.674 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 90.8 mt -95.94 -1.31 49.43 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.842 -179.361 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 279' ' ' ALA . . . . . 0.588 ' N ' ' O ' ' A' ' 275' ' ' ASN . . . -62.42 -34.89 77.66 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.604 -179.69 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 280' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -73.99 19.55 0.12 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.078 -179.224 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 0.491 HD23 ' HA ' ' A' ' 281' ' ' LEU . 14.0 mt -74.95 121.0 84.31 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.355 179.873 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_exo -51.24 -39.44 62.12 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 122.573 2.182 . . . . 0.0 111.657 179.289 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.57 -50.65 62.53 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 179.748 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 81.8 t -61.84 -43.91 98.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 179.507 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -57.57 -41.86 81.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.418 -179.871 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -90.47 1.06 57.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.215 179.572 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt 58.39 40.42 24.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.036 0.446 . . . . 0.0 110.903 179.681 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -92.36 42.41 1.1 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.37 179.781 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 54.4 t -119.16 135.79 58.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.023 0.44 . . . . 0.0 110.182 -179.724 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -132.93 162.97 30.23 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.031 0.443 . . . . 0.0 110.697 -179.663 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -119.92 155.02 33.57 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.968 0.413 . . . . 0.0 110.774 -179.85 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 80.9 mt -93.69 -1.39 55.26 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.278 -179.782 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 121.17 165.38 12.64 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 -179.725 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 6.8 m -87.13 -62.32 1.53 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.866 0.365 . . . . 0.0 111.008 -179.802 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 295' ' ' GLU . . . . . 0.444 ' C ' ' H ' ' A' ' 297' ' ' PHE . 79.6 mm-40 -69.53 -4.2 17.97 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.544 -179.738 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 29.1 p -76.66 32.51 0.13 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.662 -179.877 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 297' ' ' PHE . . . . . 0.523 ' CD2' HG22 ' A' ' 70' ' ' THR . 70.4 t80 -60.18 -46.05 91.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.565 -179.905 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . 0.612 ' NE ' ' NH1' ' A' ' 97' ' ' ARG . 85.1 mtt85 -81.09 133.45 35.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.073 0.463 . . . . 0.0 110.433 -179.712 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.443 ' H ' HG11 ' A' ' 51' ' ' VAL . 16.3 tp -114.19 119.4 36.95 Favored 'General case' 0 CA--C 1.527 0.089 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.205 -179.97 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . 0.626 ' H ' ' CB ' ' A' ' 303' ' ' SER . 49.9 p-10 -167.29 -174.21 2.51 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.508 -179.968 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -48.34 -45.46 35.33 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.127 -179.591 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -65.0 -41.62 95.23 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.004 0.43 . . . . 0.0 110.724 178.969 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 303' ' ' SER . . . . . 0.626 ' CB ' ' H ' ' A' ' 300' ' ' ASP . 52.7 p -55.15 -36.04 65.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.182 -179.5 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . 0.525 ' HB2' ' SD ' ' A' ' 215' ' ' MET . . . -57.13 -51.49 69.08 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 110.016 -0.365 . . . . 0.0 110.016 179.459 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 305' ' ' MET . . . . . . . . . . . . . 90.8 mtp -56.37 -43.82 79.56 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.689 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -66.57 -42.65 86.7 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.867 0.365 . . . . 0.0 110.18 178.778 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 303' ' ' SER . 56.0 t -64.06 -42.89 97.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.192 179.401 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 43.4 tp -59.55 -42.17 91.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.827 -179.593 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 309' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -62.73 -39.0 92.71 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 179.61 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 310' ' ' ARG . . . . . 0.44 ' O ' ' N ' ' A' ' 314' ' ' LEU . 61.6 ttt85 -63.54 -44.01 95.45 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.3 179.515 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 87.9 mt -63.36 -42.0 98.87 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.188 179.56 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -62.81 -33.18 74.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.106 179.454 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -90.19 -23.13 21.38 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.564 -179.908 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.478 HD22 ' CE2' ' A' ' 315' ' ' PHE . 6.7 tt -62.43 -43.23 99.31 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.063 0.459 . . . . 0.0 110.589 -179.902 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 315' ' ' PHE . . . . . 0.478 ' CE2' HD22 ' A' ' 314' ' ' LEU . 91.3 m-85 . . . . . 0 C--O 1.22 -0.462 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.508 179.989 . . . . . . . . 1 1 . 1 stop_ save_